<SEC-DOCUMENT>0001104659-23-005017.txt : 20230119
<SEC-HEADER>0001104659-23-005017.hdr.sgml : 20230119
<ACCEPTANCE-DATETIME>20230119161858
ACCESSION NUMBER:		0001104659-23-005017
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		50
FILED AS OF DATE:		20230119
DATE AS OF CHANGE:		20230119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sesen Bio, Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262025616
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-267891
		FILM NUMBER:		23537638

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		STREET 2:		SUITE 1800
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-444-8550

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		STREET 2:		SUITE 1800
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eleven Biotherapeutics, Inc.
		DATE OF NAME CHANGE:	20100223
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm2227887-17_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<html>
  <head>
    <title>tm2227887-17_424b3 - none - 130.7978203s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:775.71pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">&#8202;Filed Pursuant to Rule 424(b)(3)</font>&#8203;</div>
        <div style="margin-top:1.8pt; text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">&#8202;Registration No. 333-267891</font>&#8203;</div>
        <table style="width:456pt;margin-top:4pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="height:96pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0pt 0pt; width:222pt;">
              <div style="position:relative;text-align:center;">
                <img src="lg_sesenbio-4c.jpg" alt="[MISSING IMAGE: lg_sesenbio-4c.jpg]" height="117" width="197" >
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:36pt 0pt 20pt 0pt; width:222pt;text-align:left;vertical-align:bottom;">
              <div style="position:relative;text-align:center;">
                <img src="lg_carismatherapeutics-4c.jpg" alt="[MISSING IMAGE: lg_carismatherapeutics-4c.jpg]" height="53" width="200" >
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSED MERGER</font>
          <br >
          <font style="letter-spacing:-0.2pt;">YOUR VOTE IS VERY IMPORTANT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:3pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">To the stockholders of Sesen Bio, Inc. and CARISMA Therapeutics Inc.: </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc., a Delaware corporation, or Sesen Bio, and CARISMA Therapeutics Inc., a Delaware corporation, or Carisma, entered into an Agreement and Plan of Merger and Reorganization on September&#160;20, 2022, which was subsequently amended on December 29, 2022, collectively referred to herein as the Merger Agreement, pursuant to which a wholly-owned subsidiary of Sesen Bio will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio, which transaction is referred to herein as the merger. We refer to the surviving corporation following the merger as the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time of the merger, each outstanding share of Carisma capital stock (including shares of Carisma common stock issued in connection with the Carisma pre-closing financing described below) will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201; Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of the accompanying proxy statement/prospectus. Also at the effective time of the merger, each outstanding option to purchase shares of Carisma common stock will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the exchange ratio. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement Amendment was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock, which exchange ratio does not give effect to the proposed reverse stock split described in the accompanying proxy statement/prospectus. The final exchange ratio is subject to adjustment prior to the closing of the merger based on Sesen Bio&#8217;s net cash at the closing of the merger and the aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company.</font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to the consummation of the merger, certain investors have agreed to purchase shares of Carisma common stock, at a purchase price of $15.60 per share, for an aggregate purchase price of approximately $30.6&#160;million. We refer to this transaction as the Carisma pre-closing financing. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. The shares of Carisma common stock that are issued in the Carisma pre-closing financing will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tTMAER">172</a> of the accompanying proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus.</font></div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">Each share of Sesen Bio common stock, each option to purchase Sesen Bio common stock and each Sesen Bio restricted stock unit that is outstanding at the effective time of the merger will remain outstanding in accordance with its terms and such shares of common stock, options and restricted stock&#160;units, subject to the proposed reverse stock split, will be unaffected by the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of closing of the merger being at least $75.0&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Additionally, at or prior to the effective time of the merger, Sesen Bio will enter into a Contingent Value Rights Agreement and, as provided in the Merger Agreement, Sesen Bio will declare a dividend payable to Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time of the merger with respect to the receipt of one contingent value right, or a CVR, for each outstanding share of Sesen Bio common stock held by such stockholders on such date. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">certain proceeds payable by F. Hoffmann-La Roche Ltd and Hoffman-La Roche Inc., or collectively, Roche, if any, pursuant to the Asset Purchase Agreement by and among Sesen Bio and Roche, or the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, subject to certain customary deductions, including for expenses and taxes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, prior to the closing of the merger, Sesen Bio will, in addition to the CVRs, declare a special cash dividend to Sesen Bio stockholders of record prior to the merger, which would be contingent upon Sesen Bio stockholder approval of Proposal Nos. 1 and 2 and the satisfaction or waiver of other customary closing conditions to the merger. The amount of the special cash dividend will be the amount by which Sesen Bio&#8217;s estimated net cash as of the closing of the merger exceeds $75.0 million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is currently listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; Sesen Bio has filed an initial listing application for the combined company with the Nasdaq Capital Market. After completion of the merger, Sesen Bio is expected to be renamed &#8220;Carisma Therapeutics Inc.&#8221; and to trade under the symbol &#8220;CARM.&#8221; On January 18, 2023, the last trading day before the date of the accompanying proxy statement/prospectus, the closing sale price of Sesen Bio common stock was $ 0.6322 per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders are cordially invited to attend the special meeting of Sesen Bio stockholders, or the Sesen Bio special meeting, which is being held in order to obtain the stockholder approvals necessary to complete the merger and related matters. The Sesen Bio special meeting will be held at 10:00 a.m., Eastern Time, on Thursday, March 2, 2023, unless postponed or adjourned to a later date, for the purpose of considering and voting upon the matters set forth in the Notice of Special Meeting of Stockholders and the accompanying proxy statement/prospectus. The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast. Sesen Bio stockholders will be able to attend the meeting online, vote during the meeting until polls are closed, and submit questions during the meeting by registering in advance at www.proxydocs.com/SESN. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">As described in the accompanying proxy statement/prospectus, certain Carisma stockholders (solely in their respective capacities as Carisma stockholders) holding approximately 97.23% of the outstanding shares of Carisma capital stock as of January 4, 2023 (subject to customary cutbacks in the event of certain triggering events) and certain Sesen Bio stockholders (solely in their respective capacities as Sesen Bio stockholders), are parties to support agreements with Carisma and Sesen Bio whereby such stockholders have agreed, subject to the effectiveness of the registration statement on Form&#160;S-4, to vote their shares in favor of the transactions contemplated therein, including, with respect to such Carisma stockholders, adoption of the Merger Agreement and approval of the merger and, with respect to such Sesen Bio stockholders, the issuance of Sesen Bio common stock in the merger pursuant to the Merger Agreement, subject to the terms of the support agreements. Following the effectiveness of the registration statement on Form S-4, of which the accompanying proxy statement/prospectus is a part, and pursuant to the Merger Agreement and the support agreements, Carisma stockholders holding a sufficient number of shares of Carisma capital stock to adopt the Merger Agreement and approve the merger and related transactions are expected to execute written consents providing for such adoption and approval, subject to the terms and limitations set forth in the support agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, each of the Sesen Bio and Carisma boards of directors have approved the Merger Agreement and have determined that it is advisable to consummate the merger. The Sesen Bio board of directors has approved the proposals described in the accompanying proxy statement/prospectus and unanimously recommends that its stockholders vote &#8220;FOR&#8221; the proposals described in the accompanying proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">More information about Sesen Bio, Carisma, the Merger Agreement and the transactions contemplated thereby and the proposals being considered at the Sesen Bio special meeting is contained in the accompanying proxy statement/prospectus. Sesen Bio urges you to read the accompanying proxy statement/prospectus carefully and in its entirety. IN PARTICULAR, YOU SHOULD CAREFULLY CONSIDER THE MATTERS DISCUSSED UNDER THE SECTION ENTITLED &#8220;RISK FACTORS&#8221; BEGINNING ON PAGE&#160;<a href="#tRIFA">26</a> OF THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma are excited about the opportunities the proposed merger brings to both Sesen Bio&#8217;s and Carisma&#8217;s stockholders, and thank you for your consideration and continued support. </font>
        </div>
        <table style="width:436pt;height:40pt;margin-left:20pt;margin-top:4.10000000000002pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Steven Kelly </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:2.9pt; width:456pt; line-height:11pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of the accompanying proxy statement/</font>&#8203;<font style="letter-spacing:-0.2pt;">prospectus. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The accompanying proxy statement/prospectus is dated January&#160;19, 2023, and is first being mailed to Sesen Bio stockholders on or about January&#160;24, 2023.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:3pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;text-align:center; width:456pt;">
          <img src="lg_sesenbio-4c.jpg" alt="[MISSING IMAGE: lg_sesenbio-4c.jpg]" height="117" width="197" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">245 First Street, Suite 1800</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Cambridge, MA 02142</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(617) 444-8550</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF SPECIAL MEETING OF STOCKHOLDERS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO BE HELD ON MARCH 2, 2023</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dear stockholders of Sesen Bio, Inc.: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On behalf of the board of directors of Sesen Bio, Inc., a Delaware corporation, or Sesen Bio, we are pleased to deliver this proxy statement/prospectus for a special meeting of stockholders of Sesen Bio, including any adjournment or postponement thereof, or the Sesen Bio special meeting, and for the proposed transactions between Sesen Bio and CARISMA Therapeutics Inc., a Delaware corporation, or Carisma, pursuant to which Seahawk Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Sesen Bio, or Merger Sub, will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio, or the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast on March 2, 2023 at 10:00 a.m. Eastern Time for the following purposes: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock, $0.001 par value per share, or Sesen Bio common stock, to stockholders of Carisma pursuant to the terms of the Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022, or the Original Merger Agreement, and as amended by the First Amendment thereto, dated as of December 29, 2022, or the Merger Agreement Amendment and, together with the Original Merger Agreement, the Merger Agreement, by and among Sesen Bio, Merger Sub and Carisma, copies of which are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-2</font><font style="letter-spacing:0.2pt;">, respectively, to the accompanying proxy statement/prospectus, and the change of control of Sesen Bio resulting from the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the restated certificate of incorporation of Sesen Bio, as amended, or the Sesen Bio Certificate of Incorporation, to (a) effect a reverse stock split of the issued and outstanding shares of Sesen Bio common stock, at a ratio of 1-for-20, with the implementation and timing of the reverse stock split to be determined in the discretion of the Sesen Bio board of directors and as agreed to by Carisma at or prior to the closing of the merger, or in the sole discretion of the Sesen Bio board of directors if Proposal No. 1 is not approved, and (b) if and when the reverse stock split is effected, reduce the number of authorized shares of Sesen Bio common stock to 100,000,000, in the form attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to the accompanying proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment and restatement of the Sesen Bio, Inc. 2014 Stock Incentive Plan, as amended, or the 2014 Incentive Plan, to, among other things, (a)&#160;increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 Incentive Plan, and (b)&#160;extend the term of the 2014 Incentive Plan to the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan, as amended, or the 2014 ESPP, to increase the number of shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of Sesen Bio common stock reserved for issuance under the 2014 ESPP to 6,568,655 shares of Sesen Bio common stock; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an adjournment of the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 and 2; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to transact such other business as may properly come before the Sesen Bio special meeting or any adjournment or postponement thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has fixed January 17, 2023 as the record date for the determination of Sesen Bio stockholders entitled to notice of, and to vote at, the Sesen Bio special meeting and any adjournment or postponement thereof, or the record date. Only holders of record of shares of Sesen Bio common stock at the close of business on the record date are entitled to notice of, and to vote at, the Sesen Bio special meeting. At the close of business on the record date, Sesen Bio had 202,759,043 shares of common stock outstanding and entitled to vote. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast. You may attend the Sesen Bio special meeting, vote your shares and submit questions electronically during the Sesen Bio special meeting. Whether or not you expect to attend the Sesen Bio special meeting, you are respectfully requested to promptly either (i)&#160;sign, date and return the enclosed proxy card or voting instruction form, or (ii)&#160;vote via telephone or the internet by following the instructions provided on the enclosed proxy card or voting instruction form. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to attend the Sesen Bio special meeting, you must register in advance at www.proxydocs.com/SESN. After completing your registration, you will receive further instructions via email, including a unique link that will allow you to access the Sesen Bio special meeting and to vote and submit questions during the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your proxy card or voting instruction form. If you are a beneficial owner of shares registered in the name of a broker, bank or other nominee, you will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. Please be sure to follow the instructions found on your proxy card or voting instruction form. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Your vote is important. The affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal Nos. 1, 3, 4 and 5. The affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date for the Sesen Bio special meeting entitled to vote on the matter is required for approval of Proposal No. 2.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 1 is conditioned upon the approval of Proposal No. 2, and the merger cannot be consummated without the approval of Proposal Nos. 1 and 2. Proposal Nos. 3 and 4 are conditioned upon the approval of Proposal Nos. 1 and 2. Proposal No. 2 is not conditioned on the approval of any other proposal.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if you plan to attend the Sesen Bio special meeting, Sesen Bio requests that you sign and return the enclosed proxy card or voting instruction form to ensure that your shares will be represented at the Sesen Bio special meeting if you are unable to attend.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS HAS DETERMINED AND BELIEVES THAT EACH OF THE PROPOSALS OUTLINED ABOVE IS ADVISABLE TO, AND IN THE BEST INTERESTS OF, SESEN BIO AND ITS STOCKHOLDERS AND HAS APPROVED EACH SUCH PROPOSAL. THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; EACH SUCH PROPOSAL.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By Order of the Sesen Bio Board of Directors, </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Mark Sullivan</font>
          <br >
          <font style="font-style:italic;letter-spacing:0.2pt;">General Counsel and Corporate Secretary</font>
          <br >
          <font style="letter-spacing:0.2pt;">Cambridge, Massachusetts</font> <br ><font style="letter-spacing:0.2pt;">January&#160;19, 2023 </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPLANATORY NOTE</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The issuance of all shares of Sesen Bio common stock in exchange for each outstanding share of Carisma capital stock, other than shares of Sesen Bio common stock issued in exchange for shares of Carisma common stock issued in connection with the Carisma pre-closing financing, is intended to be covered by this registration statement on Form S-4 of which the accompanying proxy statement/prospectus is a part. There is no difference between the Sesen Bio common stock that will be issued in exchange for each share of Carisma common stock issued in the pre-closing financing and the Sesen Bio common stock that will be issued in exchange for each other outstanding share of Carisma capital stock, except that the shares of Sesen Bio common stock that will be issued as transaction consideration in exchange for each share of Carisma common stock issued in the pre-closing financing will not be registered under the Securities Act of 1933, as amended, or the Securities Act, and will be subject to restrictions on resale. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REFERENCES TO ADDITIONAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus incorporates important business and financial information about Sesen Bio that is not included in or delivered with this document. You may obtain this information without charge through the Securities and Exchange Commission, or the SEC, website (www.sec.gov) or upon your written or oral request by contacting the Corporate Secretary of Sesen Bio, Inc., 245 First Street, Suite&#160;1800, Cambridge, MA 02142 or by calling (617) 444-8550. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">To ensure timely delivery of these documents, any request should be made no later than February 23, 2023 to receive them before the Sesen Bio special meeting.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For additional details about where you can find information about Sesen Bio, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROXY STATEMENT/PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus, which forms part of a registration statement on Form S-4 filed with the SEC by Sesen Bio (File No. 333-267891), constitutes a prospectus of Sesen Bio under Section&#160;5 of the Securities Act with respect to shares of Sesen Bio common stock to be issued pursuant to the Merger Agreement. This document also constitutes a notice of meeting and a proxy statement under Section&#160;14(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, with respect to the Sesen Bio special meeting at which Sesen Bio stockholders will be asked to consider and vote on, among other matters, a proposal to approve the issuance of shares of Sesen Bio common stock pursuant to the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No one has been authorized to provide you with information that is different from that contained in, or incorporated by reference into, this proxy statement/prospectus. This proxy statement/prospectus is dated January&#160;19, 2023. The information contained in this proxy statement/prospectus is accurate only as of that date or, in the case of information in a document incorporated by reference, as of the date of such document, unless the information specifically indicates that another date applies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This proxy statement/prospectus does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction in which or from any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The information concerning Sesen Bio contained in this proxy statement/prospectus or incorporated by reference has been provided by Sesen Bio, and the information concerning Carisma contained in this proxy statement/prospectus has been provided by Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All references in this proxy statement/prospectus to &#8220;Sesen Bio&#8221; and &#8220;Carisma&#8221; refer to Sesen Bio, Inc. and CARISMA Therapeutics Inc., respectively. All references in this proxy statement/prospectus to &#8220;Merger Sub&#8221; refer to Seahawk Merger Sub, Inc., a newly formed, wholly-owned subsidiary of Sesen Bio. All references in this proxy statement/prospectus to the &#8220;combined company&#8221; refer to Sesen Bio and its wholly-owned subsidiary, Carisma, following completion of the merger. Except as otherwise noted, references to &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to both Sesen Bio and Carisma. All references in this proxy statement/prospectus to &#8220;Sesen Bio common stock&#8221; refer to the common stock of Sesen Bio, $0.001 par value per share, and all references in this proxy statement/prospectus to &#8220;Carisma common stock&#8221; refer to the common stock of Carisma, $0.0001 par value per share.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:3.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:602.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tQAAA"><font style="letter-spacing:0.2pt;">QUESTIONS AND ANSWERS ABOUT THE MERGER </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tQAAA">1</a></font> <a href="#tQAAA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU"><font style="letter-spacing:0.2pt;">PROSPECTUS SUMMARY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSU">11</a></font> <a href="#tPRSU"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMPAD"><font style="letter-spacing:0.2pt;">MARKET PRICE AND DIVIDEND INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMPAD">25</a></font> <a href="#tMPAD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRIFA">26</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRRTT"><font style="letter-spacing:0.2pt;">Risks Related to the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRRTT">26</a></font> <a href="#tRRTT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRRTT1"><font style="letter-spacing:0.2pt;">Risks Related to the Proposed Reverse Stock Split </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRRTT1">31</a></font> <a href="#tRRTT1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRRTS"><font style="letter-spacing:0.2pt;">Risks Related to Sesen Bio </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRRTS">32</a></font> <a href="#tRRTS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRRTC"><font style="letter-spacing:0.2pt;">Risks Related to Carisma </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRRTC">57</a></font> <a href="#tRRTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSCF"><font style="letter-spacing:0.2pt;">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSCF">118</a></font> <a href="#tCSCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTSMO"><font style="letter-spacing:0.2pt;">THE SPECIAL MEETING OF SESEN BIO STOCKHOLDERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTSMO">121</a></font> <a href="#tTSMO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTHME"><font style="letter-spacing:0.2pt;">THE MERGER </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTHME">125</a></font> <a href="#tTHME"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tBOTM"><font style="letter-spacing:0.2pt;">Background of the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tBOTM">125</a></font> <a href="#tBOTM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSBRF"><font style="letter-spacing:0.2pt;">Sesen Bio Reasons for the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSBRF">134</a></font> <a href="#tSBRF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCRFT"><font style="letter-spacing:0.2pt;">Carisma Reasons for the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCRFT">137</a></font> <a href="#tCRFT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOOSB"><font style="letter-spacing:0.2pt;">Opinion of Sesen Bio&#8217;s Financial Advisor </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOOSB">139</a></font> <a href="#tOOSB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCUFP"><font style="letter-spacing:0.2pt;">Certain Unaudited Financial Projections </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCUFP">145</a></font> <a href="#tCUFP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tIOSB"><font style="letter-spacing:0.2pt;">Interests of Sesen Bio Directors and Executive Officers in the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tIOSB">148</a></font> <a href="#tIOSB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tIOCD"><font style="letter-spacing:0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tIOCD">153</a></font> <a href="#tIOCD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tFOTM"><font style="letter-spacing:0.2pt;">Form of the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFOTM">156</a></font> <a href="#tFOTM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tETOT"><font style="letter-spacing:0.2pt;">Effective Time of the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tETOT">156</a></font> <a href="#tETOT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tMCAE"><font style="letter-spacing:0.2pt;">Merger Consideration and Exchange Ratio </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMCAE">156</a></font> <a href="#tMCAE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSBFN"><font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Final Net Cash </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSBFN">158</a></font> <a href="#tSBFN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPFEC"><font style="letter-spacing:0.2pt;">Procedures for Exchanging Carisma Stock Certificates </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPFEC">159</a></font> <a href="#tPFEC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tREAP"><font style="letter-spacing:0.2pt;">Regulatory Approvals </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tREAP">160</a></font> <a href="#tREAP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tMUFI"><font style="letter-spacing:0.2pt;">Material U.S. Federal Income Tax Consequences of the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMUFI">160</a></font> <a href="#tMUFI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tMUFI1"><font style="letter-spacing:0.2pt;">Material U.S. Federal Income Tax Consequences of the Special Cash Dividend </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMUFI1">162</a></font> <a href="#tMUFI1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tNALI"><font style="letter-spacing:0.2pt;">Nasdaq Listing </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNALI">165</a></font> <a href="#tNALI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tAAT"><font style="letter-spacing:0.2pt;">Anticipated Accounting Treatment </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAAT">166</a></font> <a href="#tAAT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tARAD"><font style="letter-spacing:0.2pt;">Appraisal Rights and Dissenters&#8217; Rights </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tARAD">166</a></font> <a href="#tARAD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tLRTM"><font style="letter-spacing:0.2pt;">Litigation Related to the Merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLRTM">169</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTMA"><font style="letter-spacing:0.2pt;">THE MERGER AGREEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTMA">171</a></font> <a href="#tTMA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tARTT"><font style="letter-spacing:0.2pt;">AGREEMENTS RELATED TO THE MERGER </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tARTT">192</a></font> <a href="#tARTT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCVAG"><font style="letter-spacing:0.2pt;">CVR Agreement </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCVAG">192</a></font> <a href="#tCVAG"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSAAW"><font style="letter-spacing:0.2pt;">Support Agreements and Written Consents </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSAAW">197</a></font> <a href="#tSAAW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSUAG"><font style="letter-spacing:0.2pt;">Subscription Agreement </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSUAG">198</a></font> <a href="#tSUAG"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tLOAG"><font style="letter-spacing:0.2pt;">Lock-Up Agreements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLOAG">199</a></font> <a href="#tLOAG"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMBST"><font style="letter-spacing:0.2pt;">MATTERS BEING SUBMITTED TO A VOTE OF SESEN BIO STOCKHOLDERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMBST">201</a></font> <a href="#tMBST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tPN1A"><font style="letter-spacing:0.2pt;">Proposal No. 1: Approval, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Merger Agreement and the change of control of Sesen Bio resulting from the merger </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN1A">201</a></font> <a href="#tPN1A"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:650.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tPN2A"><font style="letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common&#160;stock </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN2A">203</a></font> <a href="#tPN2A"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN3A"><font style="letter-spacing:0.2pt;">Proposal No. 3: Approval of an amendment and restatement of the 2014 Incentive Plan </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN3A">212</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN4A"><font style="letter-spacing:0.2pt;">Proposal No. 4: Approval of an amendment to the 2014 ESPP </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN4A">224</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN5A"><font style="letter-spacing:0.2pt;">Proposal No. 5: Approval of possible adjournment of the Sesen Bio special meeting </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN5A">229</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSBB"><font style="letter-spacing:0.2pt;">SESEN BIO BUSINESS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSBB">230</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOVE"><font style="letter-spacing:0.2pt;">Overview </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOVE">230</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCUST"><font style="letter-spacing:0.2pt;">Current Strategy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCUST">230</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSBHP"><font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Historical Pipeline Product Candidates </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSBHP">231</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCOM"><font style="letter-spacing:0.2pt;">Competition </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCOM">233</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSAM"><font style="letter-spacing:0.2pt;">Sales and Marketing </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSAM">234</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tMAN"><font style="letter-spacing:0.2pt;">Manufacturing </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMAN">234</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tINPR"><font style="letter-spacing:0.2pt;">Intellectual Property </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tINPR">234</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSBOB"><font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s OUS Business Development Partnering </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSBOB">235</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tGORE"><font style="letter-spacing:0.2pt;">Government Regulation </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tGORE">236</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tEMP"><font style="letter-spacing:0.2pt;">Employees </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEMP">246</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCOIN"><font style="letter-spacing:0.2pt;">Corporate Information </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCOIN">246</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tLEPR"><font style="letter-spacing:0.2pt;">Legal Proceedings </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLEPR">247</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCABU"><font style="letter-spacing:0.2pt;">CARISMA BUSINESS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCABU">249</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOVE1"><font style="letter-spacing:0.2pt;">Overview </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOVE1">249</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCATE"><font style="letter-spacing:0.2pt;">Carisma&#8217;s Team </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCATE">252</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCAST"><font style="letter-spacing:0.2pt;">Carisma&#8217;s Strategy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCAST">252</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tBAC"><font style="letter-spacing:0.2pt;">Background </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tBAC">254</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tMAD"><font style="letter-spacing:0.2pt;">Manufacturing and Delivery </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMAD">286</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tINPR1"><font style="letter-spacing:0.2pt;">Intellectual Property </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tINPR1">287</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCOM1"><font style="letter-spacing:0.2pt;">Competition </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCOM1">292</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tGORE1"><font style="letter-spacing:0.2pt;">Government Regulation </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tGORE1">293</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tEAHC"><font style="letter-spacing:0.2pt;">Employees and Human Capital Resources </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEAHC">309</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tFAC"><font style="letter-spacing:0.2pt;">Facilities </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFAC">309</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tLEPR1"><font style="letter-spacing:0.2pt;">Legal Proceedings </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLEPR1">309</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tSBMD"><font style="letter-spacing:0.2pt;">SESEN BIO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSBMD">310</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCMDA"><font style="letter-spacing:0.2pt;">CARISMA MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCMDA">326</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMFTM"><font style="letter-spacing:0.2pt;">MANAGEMENT FOLLOWING THE MERGER </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMFTM">342</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSBEC"><font style="letter-spacing:0.2pt;">SESEN BIO EXECUTIVE COMPENSATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSBEC">349</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCEC"><font style="letter-spacing:0.2pt;">CARISMA EXECUTIVE COMPENSATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCEC">360</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tRPTO"><font style="letter-spacing:0.2pt;">RELATED PARTY TRANSACTIONS OF DIRECTORS AND EXECUTIVE OFFICERS OF THE COMBINED COMPANY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRPTO">368</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUPFC"><font style="letter-spacing:0.2pt;">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUPFC">372</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOSB"><font style="letter-spacing:0.2pt;">DESCRIPTION OF SESEN BIO CAPITAL STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOSB">383</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCORO"><font style="letter-spacing:0.2pt;">COMPARISON OF RIGHTS OF HOLDERS OF SESEN BIO STOCK AND CARISMA </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCORO">386</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:287.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:323.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPSOS"><font style="letter-spacing:0.2pt;">PRINCIPAL STOCKHOLDERS OF SESEN BIO </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPSOS">395</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPSOC"><font style="letter-spacing:0.2pt;">PRINCIPAL STOCKHOLDERS OF CARISMA </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPSOC">397</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPSOT"><font style="letter-spacing:0.2pt;">PRINCIPAL STOCKHOLDERS OF THE COMBINED COMPANY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPSOT">400</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA">LEGAL MATTERS</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tLEMA">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tLEMA">&#8203;</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tLEMA">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <a href="#tLEMA">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <a href="#tLEMA">403</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tLEMA">&#8203;</a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a href="#tLEMA">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP">EXPERTS </a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tEXP">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tEXP">&#8203;</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tEXP">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <a href="#tEXP">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <a href="#tEXP">403</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tEXP">&#8203;</a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a href="#tEXP">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF">WHERE YOU CAN FIND MORE INFORMATION </a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tWYCF">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tWYCF">&#8203;</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tWYCF">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <a href="#tWYCF">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <a href="#tWYCF">404</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tWYCF">&#8203;</a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a href="#tWYCF">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTRNO">TRADEMARK NOTICE </a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tTRNO">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tTRNO">&#8203;</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tTRNO">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <a href="#tTRNO">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <a href="#tTRNO">405</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">
              <a href="#tTRNO">&#8203;</a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a href="#tTRNO">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tOTMA"><font style="letter-spacing:0.2pt;">OTHER MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOTMA">406</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fISCF"><font style="letter-spacing:0.2pt;">Index to Sesen Bio&#8217;s Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fISCF">F-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fISCS"><font style="letter-spacing:0.2pt;">Index to Carisma&#8217;s Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fISCS">F-70</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAAPM"><font style="letter-spacing:0.2pt;">Annex A-1&#8201;&#8211;&#8201;Agreement and Plan of Merger and Reorganization </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAAPM">A-1-1</a></font> <a href="#tAAPM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tFAAP"><font style="letter-spacing:0.2pt;">Annex A-2&#8201;&#8211;&#8201;First Amendment to Agreement and Plan of Merger and Reorganization </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tFAAP">A-2-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANNB"><font style="letter-spacing:0.2pt;">Annex B&#8201;&#8211;&#8201;Opinion of SVB Securities LLC, dated December 29, 2022 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANNB">B-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANNC"><font style="letter-spacing:0.2pt;">Annex C&#8201;&#8211;&#8201;Form of Carisma Support Agreement </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANNC">C-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANND"><font style="letter-spacing:0.2pt;">Annex D&#8201;&#8211;&#8201;Form of Sesen Bio Support Agreement </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANND">D-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANNE"><font style="letter-spacing:0.2pt;">Annex E&#8201;&#8211;&#8201;Form of Lock-Up Agreement </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANNE">E-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANNF"><font style="letter-spacing:0.2pt;">Annex F&#8201;&#8211;&#8201;Form of Contingent Value Rights Agreement </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANNF">F-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#AnnexG"><font style="letter-spacing:0.2pt;">Annex G&#8201;&#8211;&#8201;Certificate of Amendment for the Reverse Stock Split </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#AnnexG">G-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tANNH"><font style="letter-spacing:0.2pt;">Annex H&#8201;&#8211;&#8201;Appraisal Rights (Section&#160;262 of the Delaware General Corporation Law) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tANNH">H-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAnnexI"><font style="letter-spacing:0.2pt;">Annex I &#8201;&#8211;&#8201; Amended and Restated 2014 Stock Incentive Plan</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAnnexI">I-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAnnexJ"><font style="letter-spacing:0.2pt;">Annex J&#8201;&#8211;&#8201;Amendment No. 2 to the 2014 Employee Stock Purchase Plan</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAnnexJ">J-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">iii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tQAAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">QUESTIONS AND ANSWERS ABOUT THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Except where specifically noted, the following information and all other information contained in this proxy statement/prospectus does not give effect to the proposed reverse stock split described in the section entitled &#8220;Matters Being Submitted to a Vote of Sesen Bio Stockholders&#8201;&#8212;&#8201;Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8221; beginning on page <a href="#tPN2A">203</a> of this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following section provides answers to frequently asked questions about the merger. This section, however, provides only summary information. For a more complete response to each of these questions and for additional information, refer to the cross-referenced sections in this proxy statement/prospectus. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What is the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc., or Sesen Bio, Seahawk Merger Sub, Inc., or Merger Sub, and CARISMA Therapeutics Inc., or Carisma, entered into an Agreement and Plan of Merger and Reorganization, or the Original Merger Agreement, on September&#160;20, 2022, and entered into the First Amendment thereto on December&#160;29, 2022, or the Merger Agreement Amendment, and together with the Original Merger Agreement, the Merger Agreement. The Merger Agreement contains the terms and conditions of the proposed business combination of Sesen Bio and Carisma. Under the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio, or the merger. After the completion of the merger, Sesen Bio will change its corporate name from &#8220;Sesen Bio, Inc.&#8221; to &#8220;Carisma Therapeutics Inc.&#8221; as contemplated by the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the effective time of the merger, or the effective time, each outstanding share of Carisma common stock and Carisma preferred stock, or collectively, Carisma capital stock, including shares of Carisma common stock issued in connection with the Carisma pre-closing financing as defined below, will be converted into the right to receive a number of shares of Sesen Bio common stock equal to an exchange ratio, or the exchange ratio, described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMA">171</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also at the effective time, each outstanding option to purchase shares of Carisma common stock, or a Carisma option, will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the exchange ratio. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each share of Sesen Bio common stock, each option to purchase Sesen Bio common stock, or a Sesen Bio option, and each Sesen Bio restricted stock unit convertible into Sesen Bio common stock (including both time-based restricted stock&#160;units and performance-based restricted stock&#160;units), or a Sesen Bio RSU, that is outstanding at the effective time will remain outstanding in accordance with its terms and such shares of Sesen Bio common stock, Sesen Bio options and Sesen Bio RSUs, subject to the proposed reverse stock split, will be unaffected by the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company, and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, or the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of closing of the merger being at least $75.0 million. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Why are the two companies proposing to merge?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma believe that the merger will provide Carisma with substantial capital resources, positioning it to become a pre-eminent clinical-stage biopharmaceutical company focused on advancement of Carisma&#8217;s proprietary cell therapy platform that utilizes engineered macrophages and monocytes to potentially transform the treatment of cancer and other serious disorders. For a discussion of Sesen Bio&#8217;s and Carisma&#8217;s reasons for the merger, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Sesen Bio Reasons for the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Carisma Reasons for the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages&#160;<a href="#tSBRF">134</a> and <a href="#tCRFT">137</a>, respectively, of this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Why am I receiving this proxy statement/prospectus?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">You are receiving this proxy statement/prospectus because you have been identified as a Sesen Bio stockholder as of the record date and you are entitled to vote at the Sesen Bio special meeting to approve the matters set forth herein. This document serves as: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a proxy statement of Sesen Bio used to solicit proxies for the Sesen Bio special meeting to vote on the matters set forth herein; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a prospectus of Sesen Bio used to offer shares of Sesen Bio common stock in exchange for shares of Carisma capital stock (excluding shares of Sesen Bio common stock issued as transaction&#160;consideration in exchange for shares of Carisma common stock issued in the Carisma pre-closing financing) in the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What is the Carisma pre-closing financing?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein, or, as subsequently amended and restated, the subscription agreement, pursuant to which such investors agreed to purchase shares of Carisma common stock at an aggregate purchase price of approximately $30.6&#160;million, or the Carisma pre-closing financing. Immediately after the merger, the shares of Carisma common stock issued in the Carisma pre-closing financing are expected to represent approximately&#160;8.4% of the outstanding shares of capital stock of the combined company. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What will Sesen Bio stockholders receive in the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">At the effective time, Sesen Bio stockholders will continue to own and hold their existing shares of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All outstanding and unexercised Sesen Bio options granted (i)&#160;pursuant to the Sesen Bio, Inc. 2014 Stock Incentive Plan, as amended, or the 2014 Incentive Plan, or the Eleven Biotherapeutics, Inc. 2009 Stock Incentive Plan, as amended and restated, or the 2009 Incentive Plan, or (ii)&#160;as an inducement grant under Nasdaq Listing Rule&#160;5635(c)(4) will remain in effect pursuant to their terms and will be unaffected by the merger. All outstanding and unvested Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. All outstanding and unexercised warrants to purchase Sesen Bio common stock, or Sesen Bio warrants, immediately prior to the effective time (other than certain Sesen Bio warrants that Sesen Bio may be required to repurchase at such warrant holder&#8217;s option as of a result of the merger) will remain in effect pursuant to their terms and will be unaffected by the merger. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, at or prior to the effective time, Sesen Bio will enter into a Contingent Value Rights Agreement, or the CVR Agreement, and, as provided in the Merger Agreement, Sesen Bio intends to declare a dividend payable to Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time with respect to the receipt of one contingent value right, or a CVR, for each outstanding share of Sesen Bio common stock held by such stockholders on such date. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of certain proceeds payable by F. Hoffmann-La Roche Ltd and Hoffman-La Roche Inc., or Roche, if any, pursuant to the Asset Purchase Agreement by and among Sesen Bio and Roche, or the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, subject to certain customary deductions, including for expenses and taxes. For a more detailed description of the CVRs and the CVR Agreement, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, prior to the closing of the merger, Sesen Bio will, in addition to the CVRs, declare a special cash dividend, or the special cash dividend, to Sesen Bio stockholders of record prior to the merger, which would be contingent upon Sesen Bio stockholder approval of Proposal Nos. 1 and 2 and the satisfaction </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or waiver of other customary closing conditions to the merger. The amount of the special cash dividend will be the amount by which Sesen Bio&#8217;s estimated net cash as of the closing of the merger exceeds $75.0 million. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What will Carisma stockholders and Carisma optionholders receive in the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma stockholders will receive shares of Sesen Bio common stock, and Carisma optionholders will receive options to purchase Sesen Bio common stock. Applying the exchange ratio, immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of the closing of the merger being at least $75.0&#160;million. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with the merger, each outstanding and unexercised Carisma option will be assumed by Sesen Bio and converted into an option to purchase Sesen Bio common stock, with the number of shares and exercise price being appropriately adjusted to reflect the exchange ratio between Sesen Bio common stock and Carisma common stock determined in accordance with the Merger Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For a more complete description of what Carisma stockholders and optionholders will receive in the merger, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tTMA">171</a> and <a href="#tTMAER">172</a>, respectively, of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. For a description of the effect of the Carisma pre-closing financing on current Sesen Bio and Carisma stockholders, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSUAG">198</a> of this proxy statement/prospectus. </font></div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What will happen to Sesen Bio if, for any reason, the merger does not close?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, review and evaluate another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio or dissolve and liquidate its assets. If Sesen Bio decides to dissolve and liquidate its assets, Sesen Bio would be required to pay all of its debts and contractual obligations, and to set aside certain reserves for potential future claims. There can be no assurances as to the amount or timing of available cash left, if any, to distribute to Sesen Bio stockholders after paying the debts and other obligations of Sesen Bio and setting aside funds for reserves. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What is required to consummate the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, in order for the merger to close, the following proposals must be approved by the requisite vote of Sesen Bio stockholders at the Sesen Bio special meeting: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Proposal No. 1:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Original Merger Agreement, as amended by the Merger Agreement Amendment, copies of which are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-2</font><font style="letter-spacing:0.2pt;">, respectively, to this proxy statement/prospectus, and the change of control of Sesen Bio resulting from the merger; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Proposal No. 2:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;to consider and vote upon a proposal to approve an amendment to the Sesen Bio Certificate of Incorporation, to (a) effect a reverse stock split of the issued and outstanding shares of Sesen Bio common stock at a ratio of 1-for-20, with the implementation and timing of the reverse stock split to be determined in the discretion of the Sesen Bio board of directors and as agreed to by Carisma at or prior to the closing of the merger, or in the sole discretion of the Sesen Bio board of directors if Proposal No. 1 is not approved, and (b) if and when the reverse stock split is effected, reduce the number of authorized shares of Sesen Bio common stock to 100,000,000, in the form attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma stockholders must adopt the Merger Agreement, thereby approving the merger and the related transactions. The adoption of the Merger Agreement and the approval of the merger and related transactions by the Carisma stockholders requires the affirmative vote (or written consent) of the holders of a majority of the Carisma capital stock, voting together as a single class, (ii)&#160;at least two-thirds of the Carisma Series&#160;A preferred stock, Carisma special voting preferred stock, Carisma Series&#160;B preferred stock and Carisma Series&#160;B special voting preferred stock, voting together as a single class, (iii)&#160;a majority of the Carisma Series&#160;A preferred stock and Carisma special voting preferred stock, voting together as a single class and (iv)&#160;at least two-thirds of the Carisma Series&#160;B preferred stock and Carisma Series&#160;B special voting preferred stock, voting together as a single class. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, certain Carisma stockholders (solely in their respective capacities as Carisma stockholders) holding approximately 97.23% of the outstanding shares of Carisma capital stock (subject to customary cutbacks in the event of certain triggering events) are parties to support agreements with Sesen Bio and Carisma, whereby such stockholders have agreed, subject to the effectiveness of the registration statement on Form S-4, to vote their shares in favor of, among other things, the adoption or approval of the Merger Agreement and the transactions contemplated therein, subject to the terms of the support agreements. In addition, following the effectiveness of the registration statement on Form&#160;S-4, of which this proxy statement/prospectus is a part, and pursuant to the conditions of the Merger Agreement and the support agreements, Carisma stockholders who are party to the support agreements will each execute written consents approving the merger and related transactions, subject to the terms and limitations set forth in the support agreements. Therefore, holders of a sufficient number of shares of Carisma common stock required to adopt the Merger Agreement, thereby approving the merger, have agreed to adopt the Merger Agreement via written consent, subject to the terms and limitations set forth in the support agreements. Carisma stockholders, including those who are parties to support agreements, are being requested to execute written consents providing such approvals. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the requirement of obtaining the stockholder approvals described above, each of the other closing conditions set forth in the Merger Agreement must be satisfied or waived. For a more complete description of the closing conditions under the Merger Agreement, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tCCM5">176</a> of this proxy statement/prospectus. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What stockholder votes are required to approve the proposals at the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Approval of Proposal Nos. 1, 3, 4 and 5 each requires the affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote thereon. Approval of Proposal No. 2 requires the affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date, January 17, 2023, for the Sesen Bio special meeting, or the record date, entitled to vote on the matter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Votes will be counted by the inspector of election appointed for the Sesen Bio special meeting, who will separately count &#8220;FOR&#8221; and &#8220;AGAINST&#8221; votes, abstentions and broker non-votes. Abstentions and broker non-votes will be treated as shares of Sesen Bio common stock present for the purpose of determining the presence of a quorum for the transaction of business at the Sesen Bio special meeting. Abstentions and broker non-votes will have the same effect as &#8220;AGAINST&#8221; votes for Proposal No. 2, but will have no effect on the outcome of Proposal Nos. 1, 3, 4 and 5. Proposal Nos. 2 and 5 are matters on which Sesen Bio expects brokers, banks or other nominees to have authority to vote uninstructed shares and, therefore, broker non-votes are not expected with respect to these proposals. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Who will be the directors of the combined company following the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Immediately following completion of the merger, the combined company&#8217;s board of directors is expected to be composed of seven directors, consisting of six directors designated by Carisma and one director designated by Sesen Bio. It is anticipated that Thomas R. Cannell will be the Sesen Bio designated director following the closing of the merger, and that all other current Sesen Bio directors will resign as of the closing of the merger. Carisma will appoint the remaining directors to the Sesen Bio board of directors to fill the resulting vacancies. It is anticipated that Sanford Zweifach, Regina </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Hodits, Briggs Morrison, Bj&#246;rn Odlander, Chidozie Ugwumba and Steven Kelly will be appointed to the board of directors of the combined company by Carisma. Sanford Zweifach is expected to be appointed as chair of the board of the directors of the combined company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The staggered structure of the Sesen Bio board of directors will remain in place for the combined company following the completion of the merger. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Who will be the executive officers of the combined company immediately following the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Immediately following completion of the merger, the combined company&#8217;s executive management team is expected to consist of the members of Carisma&#8217;s executive management team prior to the merger, including: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:436pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:212pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:212pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Steven Kelly </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Richard Morris </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Chief Scientific Officer</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the merger to Sesen Bio stockholders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders will not sell, exchange or dispose of any shares of Sesen Bio common stock as a result of the merger. Thus, there will be no material U.S. federal income tax consequences to Sesen Bio stockholders as a result of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the merger to Carisma U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger,</font><font style="letter-spacing:0.2pt;">&#8221; in the opinion of Wilmer Cutler Pickering Hale and Dorr LLP, or WilmerHale, and Hogan Lovells US LLP, or Hogan Lovells, the merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended, or the Code, and a Carisma U.S. holder (as defined on page <a href="#tUSHCA">161</a>) will not recognize gain or loss for U.S. federal income tax purposes upon the receipt of shares of Sesen Bio common stock in exchange for shares of Carisma capital stock in the merger, except to the extent such a Carisma U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI">160</a> of this proxy statement/prospectus for a more complete description of the material U.S. federal income tax consequences of the merger to Carisma U.S. holders. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax treatment of Sesen Bio U.S. holders&#8217; (as defined on page <a href="#tMUFI3">193</a>) receipt of the CVRs is unclear. Sesen Bio intends to report the issuance of the CVRs to Sesen Bio U.S. holders under the terms expressed in the form of the CVR Agreement included in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;"> to this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus as a distribution of property with respect to Sesen Bio common stock. In such case, each Sesen Bio U.S. holder will be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes and after taking into account the special cash dividend paid to Sesen Bio U.S. holders, if any, as described below), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining value. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of this distribution to be treated as other than a dividend for U.S. federal income tax purposes. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus for a more complete description of the </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio U.S. holders, including possible alternative treatments. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The tax consequences to you of the receipt of CVRs will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the special cash dividend that Sesen Bio will declare and pay to Sesen Bio U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In connection with the merger, the Sesen Bio board of directors will declare and pay a special cash dividend to Sesen Bio stockholders of record prior to the effective time consisting of Sesen Bio&#8217;s available cash in an aggregate amount expected to be approximately $70.0&#160;million, assuming Sesen Bio&#8217;s net cash as of the closing of the merger (after taking into account the proposed cash dividend) is $75.0&#160;million. The U.S. federal income tax consequences of the Sesen Bio U.S. holders&#8217; receipt of a special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus for a general description of the tax consequences of the special cash dividend that Sesen Bio may pay. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The tax consequences to you of the special cash dividend will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.49pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.49pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the proposed reverse stock split to Sesen Bio U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the proposed reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code. In general, and subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#MUIT6">209</a> of this proxy statement/prospectus, if the proposed reverse stock split qualifies as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code, a Sesen Bio U.S. holder should not recognize gain or loss upon the proposed reverse stock split, except to the extent a Sesen Bio U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. As discussed in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; on page&#160;<a href="#MUIT6">209</a> of this proxy statement/prospectus, these consequences assume that distribution of the CVRs and any cash distributed pursuant to a special cash dividend will be treated for U.S. federal income tax purposes as separate and distinct from the proposed reverse stock split. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No.&#160;2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#MUIT6">209</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for a more complete description of the material U.S. federal income tax consequences of the proposed reverse stock split to Sesen Bio U.S. holders. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The tax consequences to you of the proposed reverse stock split will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">As a Sesen Bio stockholder, how does the Sesen Bio board of directors recommend that I vote?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">After careful consideration, the Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; all of the proposals described in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What risks should I consider in deciding whether to vote in favor of the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">You should carefully review the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus which sets forth certain risks and uncertainties related to the merger, risks and uncertainties to which the combined company&#8217;s business will be subject, and risks and uncertainties to which each of Sesen Bio and Carisma, as independent companies, are subject. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Who can vote at the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Only Sesen Bio stockholders of record at the close of business on the record date will be entitled to vote at the Sesen Bio special meeting. The Sesen Bio board of directors has fixed January 17, 2023 as the record date for the Sesen Bio special meeting. As of the record date, there were 202,759,043 shares of Sesen Bio common stock outstanding and entitled to vote. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stockholder of Record: Shares Registered in Your Name</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If, at the close of business on the record date, your shares of Sesen Bio common stock were registered directly in your name with Sesen Bio&#8217;s transfer agent, Computershare Trust Company, Inc., then you are a Sesen Bio stockholder of record. As a Sesen Bio stockholder of record, you may vote virtually at the Sesen Bio special meeting or vote by proxy. Whether or not you plan to attend the Sesen Bio special meeting, please vote as soon as possible by completing and returning the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed on the proxy card to ensure your vote is counted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders are invited to attend the special meeting, which will be a virtual meeting held exclusively via live webcast. In order to attend the Sesen Bio special meeting, you must register in advance at www.proxydocs.com/SESN. After completing your registration, you will receive further instructions via email, including a unique link that will allow you to access the Sesen Bio special meeting and to vote and submit questions during the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your proxy card. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Similar Organization</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If, at the close of business on the record date, your shares of Sesen Bio common stock were not held in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Sesen Bio special meeting. As a beneficial owner, you have the right to direct your broker or other agent how to vote the shares in your account. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You are also invited to attend and vote at the Sesen Bio special meeting. After completing your registration in advance at www.proxydocs.com/SESN, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your voting instruction form. You will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. You may be instructed to obtain a legal proxy from your broker, bank or other nominee and to submit a copy in advance of the meeting. Further instructions will be provided to you as part of your registration process. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">How many votes do I have?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On each matter to be voted upon, you have one vote for each share of Sesen Bio common stock you own as of the record date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What is the quorum requirement?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A quorum of Sesen Bio stockholders is necessary to hold a valid meeting. A quorum will be present if Sesen Bio stockholders holding at least a majority in voting power of the shares of Sesen Bio common stock outstanding and entitled to vote at the Sesen Bio special meeting are present or represented by proxy at the Sesen Bio special meeting. As of the record date, there were 202,759,043 shares of Sesen Bio common stock outstanding and entitled to vote. Your shares of Sesen Bio common stock will be counted toward the quorum at the Sesen Bio special meeting only if you attend the Sesen Bio special meeting or are represented by proxy at the Sesen Bio special meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What are &#8220;broker non-votes?&#8221;</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If you hold shares beneficially in &#8220;street name&#8221; and do not provide your broker, bank or other nominee with voting instructions, your shares may constitute &#8220;broker non-votes.&#8221; Broker non-votes occur on a matter when banks, brokers and other nominees are not permitted to vote on certain non-discretionary matters without instructions from the beneficial owner and instructions are not given. These matters are referred to as &#8220;non-routine&#8221; matters. Proposal Nos. 1, 3 and 4 are anticipated to be non-routine matters, and Proposal Nos. 2 and 5 are anticipated to be routine matters. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">If my shares of Sesen Bio common stock are held in &#8220;street name,&#8221; will my broker, bank or other nominee vote my shares for me?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Unless your broker, bank or other nominee has discretionary authority to vote on certain matters, your broker will not be able to vote your shares of Sesen Bio common stock on matters without instructions from you. If you do not give instructions to your broker, your broker can vote your shares of Sesen Bio common stock with respect to discretionary, routine items but not with respect to non-discretionary, non-routine items. Brokers are not expected to have discretionary authority to vote for any of the proposals other than Proposal Nos. 2 and 5. To make sure that your vote is counted, you should instruct your broker to vote your shares, following the procedures provided by your broker. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">How can I view the list of Sesen Bio stockholders eligible to vote at the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The list of Sesen Bio stockholders of record entitled to vote at the Sesen Bio special meeting will be made available for ten days prior to the Sesen Bio special meeting, at the Sesen Bio offices at 245 First Street, Suite 1800, Cambridge, MA 02142. Please contact Sesen Bio&#8217;s Corporate Secretary at (617) 444-8550 if you wish to inspect the list of stockholders eligible to vote at the Sesen Bio special meeting prior to the Sesen Bio special meeting. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">When do you expect the merger to be consummated?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma currently anticipate that the merger will close in the first quarter of 2023, but the companies cannot predict the exact timing. For more information, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCCM5">176</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What do I need to do now?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio urges you to read this proxy statement/prospectus carefully, including its annexes, and to consider how the merger affects you. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder of record, you may provide your proxy instructions in one of three ways prior to the Sesen Bio special meeting: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Over the internet.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares over the internet by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">By telephone.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by telephone by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">By mail.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by completing, dating and signing the proxy card and promptly mailing it in the postage-paid envelope provided. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Please provide your proxy instructions only once, unless you are revoking a previously delivered proxy instruction, and as soon as possible so that your shares can be voted at the Sesen Bio special meeting. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">When and where is the Sesen Bio special meeting and may I vote in person?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast at 10:00 a.m., Eastern Time, on March 2, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to attend the Sesen Bio special meeting, you must register in advance at www.proxydocs.com/SESN. After completing your registration, you will receive further instructions via email, including a unique link that will allow you to access the Sesen Bio special meeting and to vote and submit questions during the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your proxy card. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held in &#8220;street name&#8221; by a broker, bank or other nominee, you are also invited to attend and vote your shares at the Sesen Bio special meeting. After completing your registration in advance at www.proxydocs.com/SESN, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your voting instruction form. You will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. You may be instructed to obtain a legal proxy from your broker, bank or other nominee and to submit a copy in advance of the meeting. Further instructions will be provided to you as part of your registration process. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if you plan to attend the Sesen Bio special meeting, Sesen Bio requests that you sign and return the enclosed proxy card or voting instruction form to ensure that your shares will be represented at the Sesen Bio special meeting if you become unable to attend. Please be sure to follow the instructions found on your proxy card or voting instruction form. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What if I have technical difficulties or trouble accessing the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Technical assistance will be available one hour prior to and during the Sesen Bio special meeting. Information related to technical assistance will be provided in the email you receive with your unique link that will allow you to access the Sesen Bio special meeting. We recommend that you log in at least 15 minutes before the Sesen Bio special meeting to ensure you are logged in when the Sesen Bio special meeting starts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">What happens if I do not return a proxy card or otherwise provide proxy instructions, as applicable?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder of record, the failure to return your proxy card or otherwise provide proxy instructions will have the same effect as voting &#8220;AGAINST&#8221; Proposal No. 2, and will have no effect with respect to Proposal Nos. 1, 3, 4, and 5. If your shares of Sesen Bio common stock are held in &#8220;street name,&#8221; and you do not provide voting instructions, your broker, bank or other nominee may still vote your shares of Sesen Bio common stock with respect to discretionary, routine items, but may not vote your shares of Sesen Bio common stock with respect to non-discretionary, non-routine items. Brokers are not expected to have discretionary authority to vote for any of the proposals other than Proposal Nos. 2 and 5. To make sure that your vote is counted, you should instruct your broker to vote your shares, following the procedures provided by your broker. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">May I change or revoke my vote after I have submitted a proxy or provided proxy instructions?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders of record may change or revoke their vote at any time before their proxy is voted at the Sesen Bio special meeting by doing any one of the following things: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">submitting a new proxy via the internet or telephone by following the instructions on the enclosed proxy card; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">signing another proxy card and arranging for delivery of that proxy card by mail by 11:59 p.m., Eastern Time, the day before the Sesen Bio special meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:63pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">giving Sesen Bio&#8217;s Corporate Secretary a written notice before the Sesen Bio special meeting that you want to revoke your proxy; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">voting during the Sesen Bio special meeting. Your attendance at the Sesen Bio special meeting alone will not revoke a previously submitted proxy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a Sesen Bio stockholder who owns shares of Sesen Bio common stock in &#8220;street name&#8221; has instructed a broker to vote its shares of Sesen Bio common stock, the stockholder must follow directions received from its broker to change those instructions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your vote will be counted in accordance with the last instruction received prior to the closing of the polls, whether your instruction is received by internet, telephone, mail or at the Sesen Bio special meeting. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Who is paying for this proxy solicitation?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma will share equally the cost of printing and filing this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and the proxy card. Sesen Bio also may be required to reimburse banks, brokers and other custodians, nominees and fiduciaries or their respective agents for reasonable expenses incurred in forwarding proxy materials to beneficial owners of Sesen Bio common stock. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has engaged MacKenzie Partners, Inc., or MacKenzie Partners, to assist in the solicitation of proxies and provide related advice and informational support. Sesen Bio will pay the fees of MacKenzie Partners, which Sesen Bio expects to be approximately $20,000, plus reimbursement of out-of-pocket expenses. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Who can help answer my questions?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If you would like to request documents from Sesen Bio or Carisma, please send a request in writing or by telephone to either Sesen Bio or Carisma at the following addresses: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;margin-bottom:5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:202pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio, Inc.</font>
                <br >
                <font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font>
                <br >
                <font style="letter-spacing:0.2pt;">Cambridge, Massachusetts 02142</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (617) 444-8550</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: ir@sesenbio.com </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:202pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA Therapeutics Inc</font><font style="letter-spacing:0.2pt;">.</font>
                <br >
                <font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font>
                <br >
                <font style="letter-spacing:0.2pt;">Philadelphia, PA 19104</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (267) 491-6422</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: info@carismatx.com</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder and would like additional copies, without charge, of this proxy statement/prospectus or if you have questions about the merger, including the procedures for voting your shares, you should contact Sesen Bio&#8217;s proxy solicitor: </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_mackenziepartners-bw.jpg" alt="[MISSING IMAGE: lg_mackenziepartners-bw.jpg]" height="57" width="192" >
        </div>
        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">MacKenzie Partners, Inc. </font>
          <br >
          <font style="letter-spacing:0.2pt;">1407 Broadway, 27th Floor </font>
          <br >
          <font style="letter-spacing:0.2pt;">New York, New York 10018 </font>
          <br >
          <font style="letter-spacing:0.2pt;">(800) 322-2885 </font>
          <br >
          <font style="letter-spacing:0.2pt;">proxy@mackenziepartners.com</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">This summary highlights selected information from this proxy statement/prospectus and may not contain all of the information that is important to you. To better understand the merger, the proposals being considered at the Sesen Bio special meeting, you should read this entire proxy statement/prospectus carefully, including the Original Merger Agreement, attached as Annex A-1, the Merger Agreement Amendment, attached as Annex&#160;A-2, the opinion of SVB Securities LLC, or SVB Securities, attached as Annex B and the other annexes to which you are referred herein. For more information, see the section entitled &#8220;Where You Can Find More Information&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. Except where specifically noted, the following information and all other information contained in this proxy statement/prospectus does not give effect to the proposed reverse stock split described in the section entitled &#8220;Matters Being Submitted to a Vote of Sesen Bio Stockholders&#8201;&#8212;&#8201;Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8221; beginning on page <a href="#tPN2A">203</a> of this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Companies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio, Inc.</font> <br ><font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA 02142</font> <br ><font style="letter-spacing:0.2pt;">(617) 444-8550 </font></div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company focused on targeted fusion protein therapeutics for the treatment of patients with cancer. Sesen Bio&#8217;s most advanced product candidate, Vicineum&#8482;, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive bladder cancer, or NMIBC. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the United States Food and Drug Administration, or FDA. Sesen Bio has turned its primary focus to consummating a strategic transaction with the goal of maximizing shareholder value. As a result of such decision and Sesen Bio&#8217;s subsequent decision to enter into the proposed merger with Carisma, Sesen Bio no longer plans to pursue regulatory approval of Vicineum for NMIBC in the European Union, or the E.U., and has started to wind down certain of its manufacturing operations and business development partnerships. Additionally, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. If the merger is consummated, the combined company does not expect to pursue further development of Vicineum.</font>
          </div>
          <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CARISMA Therapeutics Inc.</font> <br ><font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font> <br ><font style="letter-spacing:0.2pt;">Philadelphia, Pennsylvania 19104</font> <br ><font style="letter-spacing:0.2pt;">(267) 491-6422 </font></div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor macrophages for the treatment of solid tumors. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Seahawk Merger Sub, Inc.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Merger Sub is a wholly-owned subsidiary of Sesen Bio, formed solely for the purposes of carrying out the merger. </font>
          </div>
          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">The Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tTHME">125</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If the merger is completed, Merger Sub will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio. After the completion of the merger, Sesen Bio will change its corporate name from &#8220;Sesen Bio, Inc.&#8221; to &#8220;Carisma Therapeutics Inc.&#8221; as contemplated by the Merger Agreement. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, each outstanding share of Carisma capital stock will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of this proxy statement/prospectus. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock, which exchange ratio does not give effect to the proposed reverse stock split. The final exchange ratio is subject to adjustment prior to the closing of the merger based on Sesen Bio&#8217;s net cash at the closing of the merger and the aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company.</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Also at the effective time, each outstanding Carisma option will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with the number of shares and exercise price being appropriately adjusted to reflect the exchange ratio between Sesen Bio common stock and Carisma common stock determined in accordance with the Merger Agreement. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Each share of Sesen Bio common stock, each Sesen Bio option and each Sesen Bio RSU that is outstanding at the effective time will remain outstanding in accordance with its terms and each such share of Sesen Bio common stock, Sesen Bio option and Sesen Bio RSU, subject to the proposed reverse stock split, will be unaffected by the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of the closing of the merger being at least $75.0 million. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Reasons for the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tSBRF">134</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">After consideration and consultation of its senior management, consultants and advisors, outside legal counsel and financial advisor, the Sesen Bio board of directors unanimously determined that the Merger Agreement, the merger and other transactions contemplated thereby are advisable and in the best interests of Sesen Bio and Sesen Bio stockholders. The Sesen Bio board of directors considered various reasons to reach its determination. For example: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the financial condition and prospects of Sesen Bio and the risks associated with continuing to operate Sesen Bio on a stand-alone basis, particularly in light of Sesen Bio&#8217;s July&#160;2022 decision to voluntarily pause further development of Vicineum for the treatment of NMIBC and reduce its workforce, which was based on a thorough reassessment of Vicineum following FDA feedback on the requirements for an additional Phase&#160;3 clinical trial, the evolving competitive landscape and the resulting financial analysis; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">that the Sesen Bio board of directors and its financial advisor undertook a comprehensive and thorough process of reviewing and analyzing potential strategic alternatives and merger partner candidates and Sesen Bio board of directors&#8217; view that no alternatives to the merger, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash, were reasonably likely to create greater value to Sesen Bio stockholders; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; conclusion that the merger would provide existing Sesen Bio stockholders a significant opportunity to participate in the potential growth of the combined company following the merger, which will focus on Carisma&#8217;s product pipeline, while also potentially receiving certain cash payments following the closing of the merger on account of the CVR Agreement and the special cash dividend; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after a thorough review of strategic alternatives and discussions with Sesen Bio&#8217;s senior management, outside legal counsel and financial advisor, that the merger is more favorable to Sesen Bio stockholders than the potential value that might have resulted </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">from other strategic alternatives available to Sesen Bio, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash; </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after thorough discussion with Sesen Bio management and Sesen Bio&#8217;s consultants and advisors, that a potential liquidation and dissolution was not reasonably likely to create greater value for Sesen Bio stockholders than a strategic alternative transaction based on, among other things, the need to hold back a meaningful amount of the Company&#8217;s current cash balance to cover current and potential future liabilities, including those triggered by a liquidation strategy; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief that, as a result of arm&#8217;s length negotiations with Carisma, Sesen Bio and its representatives negotiated the highest exchange ratio to which Carisma was willing to agree, and that the other terms of the Merger Agreement include the most favorable terms to Sesen Bio in the aggregate to which Carisma was willing to agree; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; positive view, based on the scientific, regulatory and technical due diligence conducted by Sesen Bio management and advisors, of the regulatory pathway for, and potential significant market opportunity of, Carisma&#8217;s product candidates, which will be the focus of the combined company. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">After consideration and consultation with Carisma senior management, its financial advisors and legal counsel, and consideration of a wide variety of factors, the Carisma board of directors concluded that a merger with Sesen Bio, together with the additional financing committed from the Carisma pre-closing financing, was the best option to generate capital resources to support the advancement of Carisma&#8217;s pipeline and fund a combined organization. The Carisma board of directors considered various reasons to reach its determination. For example: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the merger will provide current Carisma stockholders with greater liquidity by owning publicly-traded stock, and expanding both the access to capital for Carisma and the range of investors potentially available as a public company, compared to the investors Carisma could otherwise gain access to if it continued to operate as a privately-held company;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the potential benefits from increased public market awareness of Carisma and its pipeline;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the historical and current information concerning Carisma&#8217;s business, including its financial performance and condition, operations, management and pre-clinical and clinical data;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the competitive nature of the industry in which Carisma operates;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; fiduciary duties to Carisma stockholders;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; belief that no alternatives to the merger were reasonably likely to create greater value for Carisma stockholders, after reviewing the various financing and other strategic alternatives that were considered by the Carisma board of directors; and</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the projected financial position, operations, management structure, operating plans, and anticipated cash burn rate of the combined company, including the ability to support the combined company&#8217;s current and planned clinical trials and operations), as further discussed in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8201;&#8212;&#8201;Liquidity and Capital Resources&#8201;&#8212;&#8201;Funding Requirements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tFUNDRE1">335</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus.</font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">For additional information, see the sections entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Sesen Bio Reasons for the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Carisma Reasons for the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tOOSB">139</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio retained SVB Securities as its financial advisor in connection with the merger and the other transactions contemplated by the Merger Agreement. On December 29, 2022, SVB Securities rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion to the Sesen Bio board of directors dated December 29, 2022 that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">undertaken by SVB Securities in preparing its opinion, the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement was fair, from a financial point of view, to Sesen Bio. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
            <font style="font-weight:normal;letter-spacing:0.2pt;">The full text of the written opinion of SVB Securities, dated December 29, 2022, which describes the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, is attached as </font><font style="font-style:italic;font-weight:normal;letter-spacing:0.2pt;">Annex B</font><font style="font-weight:normal;letter-spacing:0.2pt;"> to this proxy statement/prospectus and is incorporated herein by reference. </font><font style="letter-spacing:-0.2pt;">SVB Securities&#8217; financial advisory services and opinion were provided for the information and assistance of Sesen Bio board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of the Sesen Bio board of directors&#8217; consideration of the merger and the opinion of SVB Securities addressed only the fairness, from a financial point of view, as of the date thereof, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. The opinion of SVB Securities did not address any other term or aspect of the Merger Agreement or the merger and does not constitute a recommendation to any stockholder of Sesen Bio as to whether or how such holder should vote with respect to the merger or otherwise act with respect to the merger or any other matter.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The full text of the written opinion of SVB Securities should be read carefully in its entirety for a description of the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Overview of the Merger Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Merger Consideration </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMA">171</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, each outstanding share of Carisma capital stock will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of this proxy statement/prospectus. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock, which exchange ratio does not give effect to the proposed reverse stock split. The final exchange ratio is subject to adjustment prior to the closing of the merger based on Sesen Bio&#8217;s net cash at the closing of the merger and the aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company.</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Also at the effective time, each outstanding Carisma option will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with the number of shares and exercise price being appropriately adjusted to reflect the exchange ratio between Sesen Bio common stock and Carisma common stock determined in accordance with the Merger Agreement. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of the closing of the merger being at least $75.0 million. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">For a more complete description of the merger consideration, see the sections entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; in this proxy statement/</font>&#8203;<font style="font-style:normal;letter-spacing:0.2pt;">prospectus. </font></div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Treatment of Sesen Bio Equity Awards and Warrants </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMAER7">174</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Sesen Bio Equity Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, all outstanding and unexercised Sesen Bio options granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan or as an inducement grant under Nasdaq Listing Rule&#160;5635(c)(4) </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio options and the exercise prices for such Sesen Bio options will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, all outstanding Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio RSUs will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Sesen Bio Warrants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, all Sesen Bio warrants (other than certain Sesen Bio warrants that Sesen Bio may be required to repurchase at such warrant holder&#8217;s option as of a result of the merger) will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying such Sesen Bio warrants and the exercise prices for such Sesen Bio warrants will be appropriately adjusted to reflect the proposed reverse stock split, if approved. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Treatment of Carisma Options and Carisma Plan </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMAER9">174</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, Sesen Bio will assume the CARISMA Therapeutics Inc. 2017 Stock Incentive Plan, as amended, or the Carisma Plan, and each Carisma option in accordance with the terms of the Carisma Plan and the terms of the stock option agreement by which such Carisma option is evidenced but with such changes to such documents as Carisma and Sesen Bio mutually agree are appropriate to reflect the substitution of each Carisma option for a Sesen Bio option. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, each Carisma option outstanding and unexercised immediately prior to the effective time, whether or not vested, will be converted into a Sesen Bio option. From and after the effective time, each Carisma option assumed by Sesen Bio may be exercised for such number of shares of Sesen Bio common stock as is determined by multiplying the number of shares of Carisma common stock subject to the Carisma option, as in effect immediately prior to the effective time, by the exchange ratio and rounding that result down to the nearest whole number of shares of Sesen Bio common stock. The per share exercise price of the converted Carisma option will be determined by dividing the per share exercise price of the Carisma option, as in effect prior to the effective time, by the exchange ratio and rounding that result up to the nearest whole cent. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Conditions to the Completion of the Merger </font><font style="letter-spacing:0.2pt;">(see page <a href="#tCCM5">176</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">To complete the merger, Sesen Bio stockholders must approve Proposal Nos. 1 and 2 and Carisma stockholders must adopt the Merger Agreement and approve the merger and the related transactions. Additionally, each of the other closing conditions set forth in the Merger Agreement must be satisfied or waived (including Sesen Bio having net cash as of the closing of the merger greater than or equal to $75.0&#160;million). </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">No Solicitation</font><font style="letter-spacing:0.2pt;">(see page <a href="#tNSON">179</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Each of Sesen Bio and Carisma agreed that during the period commencing on the date of the Original Merger Agreement and continuing until the earlier to occur of the termination of the Merger Agreement and the effective time, or the pre-closing period, except as described below, Sesen Bio and Carisma will not, nor will either party authorize any of the directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors or representatives retained by it or any of its subsidiaries to, directly or indirectly: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of, any &#8220;acquisition proposal&#8221; or &#8220;acquisition inquiry&#8221; &#8203;(each as defined in the Merger Agreement) or take any action that could reasonably be expected to lead to an acquisition proposal or acquisition inquiry; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">furnish any non-public information regarding the party and its subsidiaries to any person in connection with or in response to an acquisition proposal or acquisition inquiry; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">engage in discussions or negotiations with any person with respect to any acquisition proposal or acquisition inquiry; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">approve, endorse or recommend an acquisition proposal; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">execute or enter into any letter of intent or any contract contemplating or otherwise relating to any &#8220;acquisition transaction&#8221; as defined below (other than a confidentiality agreement permitted by the Merger Agreement); or </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">publicly propose to do any of the above. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Termination of the Merger Agreement </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMAER10">188</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Either Sesen Bio or Carisma can terminate the Merger Agreement under certain circumstances, which would prevent the merger from being consummated. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Termination Fees</font><font style="letter-spacing:0.2pt;">(see page <a href="#tTERFEE123">190</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If the Merger Agreement is terminated under certain circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay Sesen Bio a termination fee of $5.49&#160;million and/or reimburse Sesen Bio&#8217;s expenses up to a maximum of $1.75&#160;million. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tCVAG">192</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement and the CVR Agreement, Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive one CVR for each share of Sesen Bio common stock held of record as of immediately prior to the effective time. Each CVR will represent the right to receive contingent cash payments (i) upon the occurrence of a certain triggering event, entitling CVR holders to a pro rata portion of the $30.0 million milestone payment to be made by Roche to Sesen Bio upon Roche&#8217;s initiation of a Phase 3 clinical trial with legacy IL-6 antagonist antibody technology previously owned by Sesen Bio for a certain indication if initiated prior to December 31, 2026, pursuant to the Roche Asset Purchase Agreement, less certain permitted deductions and (ii) from proceeds from any sale of Sesen Bio&#8217;s non-cash assets, subject to certain customary deductions, including for expenses and taxes.</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The sole right of the holders of the CVRs is to receive cash from Sesen Bio, if any, through the rights agent in accordance with the CVR Agreement. The CVRs are not transferable, except in certain limited circumstances, will not be certificated or evidenced by any instrument and will not be registered with the SEC or listed for trading on any exchange. The CVRs will not have any voting or dividend rights, will not represent any equity or ownership interest in Sesen Bio or its subsidiaries, and interest will not accrue on any amounts payable on the CVRs. The CVR Agreement will be effective prior to the closing of the merger and will continue in effect until the earlier of March&#160;31, 2027 or the payment of all amounts payable thereunder, unless and until earlier termination of the Merger Agreement. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Support Agreements and Written Consents</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tSAAW">197</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In order to induce Sesen Bio to enter into the Merger Agreement, certain stockholders of Carisma (solely in their respective capacities as Carisma stockholders) are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed (a)&#160;to vote all of his, her or its shares of Carisma capital stock (subject to customary cutbacks in the event of certain triggering events) in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;adoption and approval of an amendment to Carisma&#8217;s certificate of incorporation, or the Carisma Certificate of Incorporation, to increase the authorized shares of Carisma common stock; (iii)&#160;acknowledgement that the approval given thereby is irrevocable and that the stockholder is aware of the stockholder&#8217;s rights to demand appraisal for its shares pursuant to Section&#160;262 of the Delaware General Corporation Law, or the DGCL; and (iv)&#160;acknowledgement that by the stockholder&#8217;s approval of the merger, the stockholder is (a)&#160;waiving its appraisal rights under the DGCL with respect to its shares, and (b)&#160;waiving any notice that may have been or may be required relating to the merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Carisma stockholder, to vote against (subject to customary cutbacks in the event of certain triggering events) any such competing acquisition proposal and any action in furtherance of any competing acquisition proposal. These signatories have also granted an irrevocable proxy to Carisma and its designee to vote their respective shares of Carisma common stock in accordance with the support agreements. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In addition, in order to induce Carisma to enter into the Merger Agreement, certain stockholders of Sesen Bio (solely in their respective capacities as Sesen Bio stockholders) are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed, to vote all of his, her or its shares of Sesen Bio common stock in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the Merger Agreement and the transactions contemplated thereby; (iii)&#160;the change of control of Sesen Bio resulting from the merger pursuant to Nasdaq rules; (iv)&#160;the approval of the equity plan amendment proposals; and (v)&#160;a waiver of any notice that may have been or may be required relating to the merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a Sesen Bio stockholder, to vote against any competing acquisition proposal and any action in furtherance of any such competing acquisition proposal. These signatories have also granted an irrevocable proxy to Sesen Bio and its designee to vote their respective shares of Sesen Bio common stock in accordance with the support agreements. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Agreements</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tLOAG">199</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As a condition to the closing of the merger, certain stockholders of each of Sesen Bio and Carisma and their affiliates have entered into lock-up agreements, pursuant to which such parties have agreed not to, except in limited circumstances, and among other restrictions, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of or lend, directly or indirectly, any shares of Sesen Bio common stock or any securities convertible into, exercisable or exchangeable for or that represent the right to receive Sesen Bio common stock (including, Sesen Bio common stock or such other securities which may be deemed to be beneficially owned by the signatory in accordance with the rules and regulations of the SEC and securities of Sesen Bio which may be issued upon exercise of a Sesen Bio option, Sesen Bio RSU or Sesen Bio warrant) during the period commencing at the effective time and continuing until the date that is 180&#160;days after the effective time. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Certain directors and executive officers of both Sesen Bio and Carisma are party to a lock-up agreement. Carisma stockholders who have executed lock-up agreements, as of January 4, 2023, beneficially owned in the aggregate approximately 97.23% of the outstanding shares of Carisma capital stock on an as converted to Carisma common stock basis. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Subscription Agreement</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tSUAG">198</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein, pursuant to which such investors have agreed to purchase shares of Carisma common stock at an aggregate purchase price of approximately $30.6&#160;million. The subscription agreement contains customary representations and warranties of Carisma and also contains customary representations and warranties of the purchasers party thereto. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The subscription agreement may not be changed, waived, amended or modified, except by an instrument in writing executed by Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing. The subscription agreement will terminate upon the earlier to occur of (i)&#160;such date and time that the Merger Agreement is terminated in accordance with its terms, (ii)&#160;upon the mutual written agreement of Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing (provided that Carisma and a purchaser may terminate the commitment of the applicable purchaser without the consent of any other party), and (iii)&#160;if the closing of the merger has not occurred on or before January&#160;31, 2023 (as such date may be extended in the event that a request for additional information is made by any governmental body or in the event that the SEC has not declared the registration statement on Form S-4, of which this proxy statement/prospectus is a </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">part, effective under the Securities Act by the date which is 60&#160;days prior to the end date), other than as a result of a willful breach of a purchaser&#8217;s obligations under the subscription agreement. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">On December 29, 2022, immediately prior to the execution and delivery of the Merger Agreement Amendment, Carisma entered into an amended and restated subscription agreement with the investors party to the original subscription agreement, pursuant to which the parties thereto clarified that shares of Carisma common stock issued in the pre-closing financing will not be registered under the Securities Act and will be subject to restrictions on resale and agreed, among other things, to enter into a registration rights agreement to provide for the registration of the resale of the shares of common stock purchased by such investors in connection with the Carisma pre-closing financing.</font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Stock Market Listing</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tNALI">165</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application for the combined company with Nasdaq. If such application is accepted, Sesen Bio anticipates that the combined company&#8217;s common stock will be listed on the Nasdaq Capital Market following the closing of the merger under the trading symbol &#8220;CARM.&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Management Following the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tMFTM">342</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The following table lists the names, ages as of January 4, 2023 and positions of the individuals who are expected to serve as executive officers and directors of the combined company following completion of the merger. </font>
          </div>
          <table style="width:456pt;height:173.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:198pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Name </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:36pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Age </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:198pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Position </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:-0.2pt;">Executive Officers</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;text-align:center;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:198pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Steven Kelly </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">57 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Richard Morris </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">49 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">33 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Chief Scientific Officer </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;text-align:center;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:198pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">66 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Director, Chair of the Board </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">61 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">53 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">63 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">64 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">40 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                <font style="letter-spacing:0.2pt;">Director</font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="margin-top:12.5pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tIOSB">148</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In considering the recommendation of the Sesen Bio board of directors with respect to issuing shares of Sesen Bio common stock as contemplated by the Merger Agreement and the other matters to be acted upon by Sesen Bio stockholders at the Sesen Bio special meeting, Sesen Bio stockholders should be aware that certain members of the Sesen Bio board of directors and certain Sesen Bio executive officers have interests in the merger that may be different from, or in addition to, the interests of Sesen Bio stockholders, including, among others, severance benefits, the acceleration of equity vesting, continued indemnification and the potential ability to sell an increased number of shares of common stock of the combined company in accordance with Rule&#160;144 under the Securities Act. As of January 4, 2023, Sesen Bio&#8217;s directors, executive officers and affiliates of Sesen Bio&#8217;s directors and executive officers, owned, in the aggregate, less than 1% of the shares of Sesen Bio common stock, which for purposes of this subsection excludes any Sesen Bio common stock issuable upon exercise of Sesen Bio options or vesting of Sesen Bio RSUs held by such individual. As of January 4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, (i)&#160;unvested Sesen Bio options covering 3,499,202 shares of Sesen Bio common stock and vested Sesen Bio options covering 8,215,261 shares of Sesen Bio common stock and (ii)&#160;unvested Sesen Bio RSUs covering 3,559,892 shares of Sesen Bio common stock. Each of Sesen Bio&#8217;s executive officers and directors have </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">also entered into a support agreement in connection with the merger, whereby such executive officers and directors have agreed to vote their shares in favor of the proposals described in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Further, Thomas R. Cannell, D.V.M., Sesen Bio&#8217;s President and Chief Executive Officer and a member of the Sesen Bio board of directors, is expected to continue as a member of the combined company&#8217;s board of directors following the merger. The compensation arrangements with Sesen Bio&#8217;s directors and executive officers are discussed in greater detail in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tIOCD">153</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In considering the recommendation of the Carisma board of directors with respect to approving the merger and related transactions, Carisma stockholders should be aware that certain members of the Carisma board of directors and certain Carisma executive officers have interests in the merger that may be different from, or in addition to, the interests of Carisma stockholders. As of January 4, 2023, Carisma&#8217;s current directors and executive officers owned, in the aggregate, approximately 2.36% of the outstanding shares of Carisma capital stock, excluding, for this purpose any Carisma shares issuable upon exercise or settlement of Carisma stock options held by such individuals. Each of Carisma&#8217;s executive officers and the majority of Carisma&#8217;s directors have also entered into a support agreement in connection with the merger, whereby such executive officers and directors have agreed to vote their shares in favor of adoption of the Merger Agreement and approval of the merger. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Further, certain Carisma directors and executive officers are expected to become directors and executive officers of the combined company following the merger. The compensation arrangements with Carisma&#8217;s directors and executive officers are discussed in greater detail in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tMUFI">160</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; in the opinion of WilmerHale and Hogan Lovells, the merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, and a Carisma U.S. holder will not recognize gain or loss for U.S. federal income tax purposes upon the receipt of shares of Sesen Bio common stock in exchange for shares of Carisma capital stock in the merger, except to the extent such a Carisma U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If the merger does not qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, then each Carisma U.S. holder would recognize gain or loss upon the exchange of shares of Carisma capital stock for Sesen Bio common stock in the merger equal to the difference between the fair market value of the shares of Sesen Bio common stock received in exchange for the shares of Carisma capital stock (plus any cash received in lieu of a fractional share) and such Carisma U.S. holder&#8217;s adjusted tax basis in the shares of Carisma capital stock surrendered. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Since the Sesen Bio stockholders will not sell, exchange or dispose of any shares of Sesen Bio common stock as a result of the merger, there will be no material U.S. federal income tax consequences to Sesen Bio stockholders as a result of the merger. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; for a more complete description of the material U.S. federal income tax consequences of the merger to U.S. holders of Carisma capital stock. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of Receipt of CVRs</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tARTT">192</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The U.S. federal income tax treatment of the Sesen Bio U.S. holders&#8217; receipt of the CVRs is unclear. Sesen Bio intends to report the issuance of the CVRs to Sesen Bio U.S. holders under the terms expressed in the form of the CVR Agreement included in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus as a distribution </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">of property with respect to Sesen Bio common stock. In such case, each Sesen Bio U.S. holder will be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes after taking into account the special cash dividend as described below), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining value. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of this distribution to be treated as other than a dividend for U.S. federal income tax purposes. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tARTT">192</a> of this proxy statement/prospectus for a more complete description of the material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio U.S. holders, including possible alternative treatments. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The tax consequences to you of the receipt of CVRs will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of Receipt of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tMUFI1">162</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In connection with the merger, the Sesen Bio board of directors will declare and pay a special cash dividend to Sesen Bio stockholders of record prior to the effective time consisting of Sesen Bio&#8217;s available cash in an aggregate amount expected to be approximately $70.0&#160;million, assuming Sesen Bio&#8217;s net cash as of closing of the merger is $75.0&#160;million. The U.S. federal income tax consequences of the Sesen Bio U.S. holders&#8217; receipt of such special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus for a general description of the tax consequences of the special cash dividend that Sesen Bio will pay in connection with the consummation of the merger, subject to Sesen Bio having net cash as of the closing of the merger greater than or equal to $75.0&#160;million. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The tax consequences to you of the special cash dividend will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;"> (see page <a href="#MUIT6">209</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the proposed reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code. In general, and subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#160;&#8212; Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#MUIT6">209</a> of this proxy statement/prospectus, if the proposed reverse stock split qualifies as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code, a Sesen Bio U.S. holder should not recognize gain or loss upon the proposed reverse stock split, except to the extent a Sesen Bio U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. As discussed in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock &#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#MUIT6">209</a> of this proxy statement/prospectus, these consequences assume that distribution of the CVRs and any cash distributed pursuant to a special cash </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">dividend will be treated for U.S. federal income tax purposes as separate and distinct from the proposed reverse stock split. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#MUIT6">209</a> of this proxy statement/prospectus for a more complete description of the material U.S. federal income tax consequences of the proposed reverse stock split to Sesen Bio U.S. holders. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The tax consequences to you of the proposed reverse stock split will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tRIFA">26</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Both Sesen Bio and Carisma are subject to various risks associated with their businesses and their industries. In addition, the merger poses a number of risks to each company and its respective stockholders, including the possibility that the merger may not be completed and the following risks: </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to the Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The exchange ratio will not change or otherwise be adjusted based on the market price of Sesen Bio common stock as the exchange ratio depends on the Sesen Bio net cash at the closing of the merger and not the market price of Sesen Bio common stock, so the merger consideration at the closing of the merger may have a greater or lesser value than at the time the Merger Agreement was signed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Sesen Bio stockholders and Carisma stockholders may not realize a benefit from the merger commensurate with the ownership dilution they will experience in connection with the merger and the Carisma pre-closing financing and the conversion of the Carisma convertible note. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Failure to complete the merger may result in either Sesen Bio or Carisma paying a termination fee to the other party and could significantly harm the market price of Sesen Bio common stock and negatively affect the future business and operations of each company. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The issuance of Sesen Bio common stock to Carisma stockholders pursuant to the Merger Agreement and the resulting change in control from the merger must be approved by Sesen Bio stockholders, and the Merger Agreement and transactions contemplated thereby must be approved by the Carisma stockholders. Failure to obtain these approvals would prevent the closing of the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Some Sesen Bio and Carisma executive officers and directors have interests in the merger that are different from the Sesen Bio stockholders and Carisma stockholders and that may influence them to support or approve the merger without regard to the interests of the Sesen Bio stockholders and Carisma stockholders. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If the conditions to the merger are not satisfied or waived, the merger will not occur. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide to pursue a liquidation and dissolution of Sesen Bio. In such an event, there can be no assurances as to the amount or timing of available cash left, if any, to distribute to Sesen Bio stockholders after paying its debts and other obligations and setting aside funds for reserves. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Sesen Bio stockholders may not receive any payment on the CVRs from the proceeds related to either the Roche Asset Purchase Agreement or any sale of Sesen Bio&#8217;s non-cash assets and therefore the CVRs may expire valueless, result in lower returns than anticipated or none at all. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Sesen Bio is substantially dependent on its remaining employees to facilitate the consummation of the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Sesen Bio has incurred significant losses since its inception and anticipates that it will continue to incur losses for the foreseeable future if the merger is not completed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">With the exception of specified regulatory, development and commercial milestones under the Roche Asset Purchase Agreement, Sesen Bio currently has no potential source of revenue and may never become profitable. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If the merger is not completed and Sesen Bio resumes clinical development of Vicineum, Sesen Bio will need substantial additional funding. If Sesen Bio is unable to raise capital when needed, Sesen Bio could be forced to delay, reduce or eliminate its product development programs or commercialization efforts. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If Sesen Bio is unable to regain compliance with the listing requirements of the Nasdaq Capital Market, Sesen Bio common stock may be delisted from the Nasdaq Capital Market which could have a material adverse effect on Sesen Bio&#8217;s business and could make it more difficult for Sesen Bio stockholders to sell their shares of Sesen Bio common stock. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to Carisma</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Carisma has incurred significant losses since its inception. Carisma expects to continue to incur significant expenses and operating losses for the foreseeable future and may never achieve or maintain profitability. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Carisma has never generated revenue from product sales and may never achieve or maintain profitability. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Carisma is heavily dependent on the success of its lead product candidate, CT-0508, which will require significant clinical testing before it can seek marketing approval and potentially launch commercial sales. If CT-0508 does not receive marketing approval or is not successfully commercialized, or if there is significant delay in doing so, Carisma&#8217;s business will be harmed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Carisma will need substantial additional funding for its continuing operations. If Carisma is unable to raise capital when needed or on acceptable terms, it could be forced to delay, reduce or eliminate its discovery or product development programs or commercialization efforts. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Cell therapy is a rapidly evolving area of science, and the approach Carisma is taking to discover and develop product candidates by utilizing genetically modified macrophages is novel and may never lead to approved or marketable products. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Even if any of Carisma&#8217;s product candidates receives marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, and the market opportunity for any of its product candidates, if approved, may be smaller than it estimates. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Carisma relies, and expects to continue to rely, on third parties to conduct its clinical trials, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, which may prevent or delay Carisma&#8217;s ability to seek or obtain marketing approval for or commercialize its product candidates or otherwise harm its business. If Carisma is not able to maintain these third-party relationships or if these arrangements are terminated, it may have to alter its development and commercialization plans and its business could be adversely affected. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">If Carisma is unable to obtain, maintain and enforce patent protection for its technology and product candidates or if the scope of the patent protection obtained is not sufficiently broad, its competitors could develop and commercialize technology and products similar or identical to Carisma&#8217;s, and its ability to successfully develop and commercialize its technology and product candidates may be adversely affected and Carisma may not be able to compete effectively in its market. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to the Ownership of the Common Stock of the Combined Company</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The market price of the combined company&#8217;s common stock is expected to be volatile, and the market price of the combined company&#8217;s common stock may drop following the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The combined company will incur additional costs and increased demands upon management as a result of complying with the laws and regulations affecting public companies. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Once the combined company is no longer a &#8220;smaller reporting company&#8221; or otherwise no longer qualifies for applicable exemptions, the combined company will be subject to additional laws and regulations affecting public companies that will increase the combined company&#8217;s costs and the demands on management and could harm the combined company&#8217;s operating results. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Provisions that will be in the combined company&#8217;s certificate of incorporation and bylaws and provisions under Delaware law could make an acquisition of the combined company, which may be beneficial to its stockholders, more difficult and may prevent attempts by its stockholders to replace or remove its management. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">An active trading market for the combined company&#8217;s common stock may not develop and its stockholders may not be able to resell their shares of common stock for a profit, if at all. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">These risks and other risks are discussed in greater detail under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. Sesen Bio and Carisma both encourage you to read and consider all of these risks carefully. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Regulatory Approvals</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tREAP">160</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In the U.S., Sesen Bio must comply with applicable federal and state securities laws and the rules and regulations of Nasdaq in connection with the issuance of shares of Sesen Bio common stock and the filing of this proxy statement/prospectus with the SEC. Sesen Bio does not intend to seek any regulatory approval from antitrust authorities to consummate the transactions. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Anticipated Accounting Treatment</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tAAT">166</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The merger is expected to be accounted for as a reverse recapitalization under U.S. generally accepted accounting principles, or U.S. GAAP, because the primary assets of Sesen Bio are cash, cash equivalents and marketable securities. For financial reporting purposes, Carisma has been determined to be the accounting acquirer based upon the terms of the merger including: (i)&#160;Carisma stockholders and holders of securities convertible into Carisma common stock are expected to own approximately 66% of the combined company (based on estimates made at the time of signing the Original Merger Agreement), (ii)&#160;Carisma will hold the majority (six of seven) of board seats of the combined company and (iii)&#160;Carisma management will hold all key positions in the management of the combined company. Accordingly, the merger is expected to be treated as the equivalent of Carisma issuing stock to acquire the net assets of Sesen Bio. As a result of the merger, the net assets of Sesen Bio will be recorded at their acquisition-date fair value in the consolidated financial statements of Carisma and the reported operating results prior to the merger will be those of Carisma. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Unaudited Pro Forma Condensed Combined Financial Information</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus for additional information. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Appraisal Rights and Dissenters&#8217; Rights</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tAAT">166</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Holders of Sesen Bio common stock are not entitled to appraisal rights in connection with the merger under Delaware law. Holders of Carisma capital stock are entitled to appraisal rights in connection with the merger under Delaware law. For more information about such rights, see the provisions of Section&#160;262 of the DGCL attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;"> and the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Appraisal Rights and Dissenters&#8217; Rights</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Comparison of Stockholder Rights</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tCORO">386</a>) </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Both Sesen Bio and Carisma are incorporated under the laws of the State of Delaware and, accordingly, the rights of the stockholders of each are currently, and will continue to be, governed by the DGCL. If the merger is completed, Carisma stockholders will become stockholders of Sesen Bio, and their rights will be governed by the DGCL, Sesen Bio&#8217;s amended and restated bylaws, or the Sesen Bio Bylaws, and the Sesen Bio Certificate of Incorporation, as may be further amended by Proposal No. 2 if approved by the Sesen Bio stockholders at the Sesen Bio special meeting. The rights of Sesen Bio stockholders contained in the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws differ from the rights of Carisma stockholders under the Carisma Certificate of Incorporation, and Carisma&#8217;s bylaws, or the Carisma Bylaws, as more fully described under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Comparison of Rights of Holders of Sesen Bio Stock and Carisma Stock</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Litigation Related to the Merger</font><font style="letter-spacing:0.2pt;"> (see page&#160;<a href="#tLRTM">169</a>)</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio received two letters on October 21, 2022 and one letter on November 4, 2022 on behalf of purported stockholders demanding that Sesen Bio amend this proxy statement/prospectus to provide </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">additional disclosures that such stockholders allege were improperly omitted from this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, including information regarding the financial projections with respect to Carisma, the financial analyses performed by SVB Securities in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement. In addition, Sesen Bio received a books and records demand, dated November 18, 2022, on behalf of a purported stockholder of Sesen Bio, seeking access to certain relevant books and records of Sesen Bio, pursuant to Section 220 of the DGCL, in connection with the merger and the securities and derivative litigations arising out of the CRL that Sesen Bio received from the FDA. Further, on November 28, 2022, a purported Sesen Bio stockholder filed a complaint in the U.S. District Court for the Southern District of New York against Sesen Bio and the Sesen Bio board of directors, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:22-cv-10085 (S.D.N.Y.). Subsequently, on December 20, 2022, the purported stockholder voluntarily dismissed the complaint and on December 21, 2022, filed a new complaint as a putative class action in the Court of Chancery for the State of Delaware, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 2022-1186 (Del. Ch. Dec. 21, 2022). The demand letters assert claims against Sesen Bio and the Sesen Bio board of directors under Section 14(a) of the Exchange Act and Rule 14a-9 promulgated thereunder for allegedly false and misleading statements in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and under Section 20(a) of the Exchange Act for alleged &#8220;control person&#8221; liability with respect to such allegedly false and misleading statements. The putative class action asserts claims against Sesen Bio and the Sesen Bio board of directors for breach of fiduciary duty based on the same allegedly false and misleading statements. Sesen Bio believes that the allegations in these stockholder demands and the complaint are without merit. At this time, no assessment can be made as to the likely outcomes or whether the outcomes will be material to Sesen Bio. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement &#8212; Litigation Relating to the Merger</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus for additional information.</font></div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMPAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:212pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MARKET PRICE AND DIVIDEND INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; Carisma is a private company and shares of Carisma common stock are not publicly traded. The closing price of Sesen Bio common stock on September&#160;20, 2022, the last trading day prior to the public announcement of the merger, was $0.6692 per share, and the closing price of Sesen Bio common stock on January 18, 2023, the last practicable trading day prior to the date of this proxy statement/prospectus, was $0.6322 per share, each as reported on the Nasdaq Capital Market. Because the market price of Sesen Bio common stock is subject to fluctuation, the market value of the shares of Sesen Bio common stock that Carisma stockholders will be entitled to receive in the merger may increase or decrease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Assuming stockholder approval of Proposal Nos. 1 and 2 and successful application for initial listing on the Nasdaq Capital Market, following the consummation of the merger, the Sesen Bio common stock will trade on the Nasdaq Capital Market under the new name, &#8220;Carisma Therapeutics Inc.,&#8221; and new trading symbol &#8220;CARM.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of January 17, 2023, the record date for the Sesen Bio special meeting, there were approximately 25&#160;holders of record of Sesen Bio common stock. As of January 17, 2023, there were 32 holders of record of Carisma capital stock. This number does not include stockholders for whom shares were held in &#8220;street name.&#8221; For detailed information regarding the beneficial ownership of certain Sesen Bio stockholders upon consummation of the merger, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of the Combined Company</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOT">400</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has never declared or paid any cash dividends on the Sesen Bio common stock and does not anticipate paying cash dividends on the Sesen Bio common stock for the foreseeable future, other than the special cash dividend that Sesen Bio will pay to Sesen Bio stockholders in connection with the consummation of the merger, subject to Sesen Bio having net cash as of the closing of the merger greater than or equal to $75.0 million. Carisma has never declared or paid any cash dividends on the Carisma common stock and does not anticipate paying cash dividends on the Carisma common stock for the foreseeable future. Notwithstanding the foregoing, any determination to pay cash dividends subsequent to the merger will be at the discretion of the combined company&#8217;s then-current board of directors and will depend upon a number of factors, including the combined company&#8217;s results of operations, financial condition, future prospects, contractual restrictions, restrictions imposed by applicable law and other factors the then-current board of directors deems relevant. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a><a name="tRRTT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The combined company will be faced with a market environment that cannot be predicted and that involves significant risks, many of which will be beyond its control. In addition to the other information contained in this proxy statement/prospectus, you should carefully consider the material risks described below and those described in the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; beginning on page <a href="#tCSCF">118</a> of this proxy statement/prospectus before deciding how to vote your shares of Sesen Bio common stock.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The exchange ratio will not change or otherwise be adjusted based on the market price of Sesen Bio common stock as the exchange ratio depends on the Sesen Bio net cash at the closing of the merger and not the market price of Sesen Bio common stock, so the merger consideration at the closing of the merger may have a greater or lesser value than at the time the Merger Agreement was signed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement has set the calculation of the exchange ratio for the Carisma capital stock, and the exchange ratio is based on the fully-diluted capitalization of Carisma and Sesen Bio, in each case immediately prior to the closing of the merger (after giving effect to the Carisma pre-closing financing) as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The closing price of Sesen Bio common stock on September 20, 2022, the last trading day prior to the public announcement of the merger, was $0.6692 per share. The Merger Agreement does not include a price-based termination right. Therefore, if before the completion of the merger the market price of Sesen Bio common stock declines from the market price on the date of the Original Merger Agreement, then Carisma stockholders could receive merger consideration with substantially lower value than the value of such merger consideration on the date of the Original Merger Agreement. Similarly, if before the completion of the merger the market price of Sesen Bio common stock increases from the market price of Sesen Bio common stock on the date of the Original Merger Agreement, then Carisma stockholders could receive merger consideration with substantially greater value than the value of such merger consideration on the date of the Original Merger Agreement. Because the exchange ratio does not adjust as a direct result of changes in the market price of Sesen Bio common stock, changes in the market price of Sesen Bio common stock will change the value of the total merger consideration payable to Carisma stockholders pursuant to the Original Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock price changes may result from a variety of factors, including changes in Sesen Bio&#8217;s or Carisma&#8217;s respective businesses, operations and prospects, reductions or changes in U.S. government spending or budgetary policies, market assessments of the likelihood that the merger will be completed, interest rates, federal, state and local legislation, governmental regulation, legal developments in the industry segments in which Sesen Bio or Carisma operate, the timing of the merger, and general market, industry and economic conditions, including pandemics and other public health emergencies. Recent events surrounding the global economy, geopolitics and the COVID-19 pandemic continue to evolve and have introduced unusually high levels of volatility into financial and stock markets, and may affect the value of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio stockholders and Carisma stockholders may not realize a benefit from the merger commensurate with the ownership dilution they will experience in connection with the merger and the Carisma pre-closing financing and the conversion of the Carisma convertible note.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the combined company is unable to realize the full strategic and financial benefits currently anticipated from the merger, Sesen Bio stockholders and Carisma stockholders will have experienced substantial dilution of their ownership interests in their respective companies, including as a result of the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, without receiving any commensurate benefit, or only receiving part of the commensurate benefit to the extent the combined company is able to realize only part of the strategic and financial benefits currently anticipated from the merger and the Carisma pre-closing financing. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure to complete the merger may result in either Sesen Bio or Carisma paying a termination fee to the other party and could significantly harm the market price of Sesen Bio common stock and negatively affect the future business and operations of each company.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and the Merger Agreement is terminated under certain circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay Sesen Bio a termination fee of $5.49&#160;million and/or reimburse Sesen Bio&#8217;s expenses up to a maximum of $1.75&#160;million. Even if a termination fee or reimbursement of expenses of the other party are not payable in connection with a termination of the Merger Agreement, each of Sesen Bio and Carisma will have incurred significant fees and expenses, which must be paid whether or not the merger is completed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if the Merger Agreement is terminated and the Sesen Bio board of directors or Carisma board of directors determines to seek another business combination, there can be no assurance that either Sesen Bio or Carisma will be able to find a partner and close an alternative transaction on terms that are as favorable or more favorable than the terms set forth in the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The issuance of Sesen Bio common stock to Carisma stockholders pursuant to the Merger Agreement and the resulting change in control from the merger must be approved by Sesen Bio stockholders, and the Merger Agreement and transactions contemplated thereby must be approved by the Carisma stockholders. Failure to obtain these approvals would prevent the closing of the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before the merger can be completed, the Sesen Bio stockholders must approve, among other things, the issuance of Sesen Bio common stock to Carisma stockholders pursuant to the Merger Agreement and the resulting change in control from the merger, and Carisma stockholders must adopt the Merger Agreement and approve the merger and the related transactions. Failure to obtain the required stockholder approvals may result in a material delay in, or the abandonment of, the merger. Any delay in completing the merger may materially adversely affect the timing and benefits that are expected to be achieved from the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The merger may be completed even though certain events occur prior to the closing of the merger that materially and adversely affect Sesen Bio or Carisma.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides that either Sesen Bio or Carisma can refuse to complete the merger if there is a material adverse change affecting the other party between September&#160;20, 2022, the date of the Original Merger Agreement, and the closing of the merger. However, certain types of changes do not permit either party to refuse to complete the merger, even if such change could be said to have a material adverse effect on Sesen Bio or Carisma, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">general business, economic or political conditions or conditions generally affecting the industries in which Sesen Bio or Carisma, as applicable, operates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any natural disaster, epidemic, pandemic (including COVID-19), certain COVID-19 measures or responses, any acts of war, armed hostilities or terrorism; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">with respect to Sesen Bio, any change in the trading price or trading volume of Sesen Bio common stock, excluding any underlying effect that may have caused such change, unless such effect is otherwise exempt from causing a material adverse effect under the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any change in, or any compliance with or action taken for the purpose of complying with, applicable laws or U.S. GAAP, or interpretations thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">with respect to any product or product candidate of Sesen Bio or its subsidiaries or Carisma or its subsidiaries, as applicable, the request of the FDA to refile, amend, or temporarily delay making any regulatory application or filing related to such product or product candidate or the protocol for any clinical trial relating to such product or product candidate, unless in the event of repeated or continued adverse decisions with respect to the applicable party&#8217;s product or product candidates by the FDA; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the taking of any action or failure to take action by Sesen Bio or Carisma, as applicable, expressly required to comply with the terms of the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If adverse changes occur and Sesen Bio and Carisma still complete the merger, the market price of the combined company&#8217;s common stock may suffer. This in turn may reduce the value of the merger to the Sesen Bio stockholders, Carisma stockholders or both. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Some Sesen Bio and Carisma executive officers and directors have interests in the merger that are different from the Sesen Bio stockholders and Carisma stockholders and that may influence them to support or approve the merger without regard to the interests of the Sesen Bio stockholders and Carisma stockholders.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain executive officers and directors of Sesen Bio and Carisma participate in arrangements that provide them with interests in the merger that are different from the interests of the Sesen Bio stockholders and Carisma stockholders, including, among others, severance benefits, the acceleration of equity vesting, continued indemnification and the potential ability to sell an increased number of shares of common stock of the combined company in accordance with Rule&#160;144 under the Securities Act. Further, Thomas R. Cannell, D.V.M., Sesen Bio&#8217;s President and Chief Executive Officer and a current member of the Sesen Bio board of directors, is expected to continue as a member of the combined company&#8217;s board of directors following the merger. The compensation arrangements with Sesen Bio&#8217;s executive officers and directors are discussed in greater detail in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation&#8201;&#8212;&#8201;Director Compensation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages&#160;<a href="#tIOSB">148</a> and 16, respectively, of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These interests, among others, may influence the executive officers and directors of Sesen Bio and Carisma to support or approve the merger. For more information concerning the interests of Sesen Bio&#8217;s and Carisma&#8217;s respective executive officers and directors, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger&#8221;</font><font style="letter-spacing:0.2pt;"> and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tIOSB">148</a> and <a href="#tIOCD">153</a>, respectively, of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The market price of the combined company&#8217;s common stock following the merger may decline as a result of the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The market price of the combined company&#8217;s common stock may decline as a result of the merger for a number of reasons, including if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">investors react negatively to the prospects of the combined company&#8217;s product candidates, business and financial condition following the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effect of the merger on the combined company&#8217;s business and prospects is not consistent with the expectations of financial or industry analysts; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company does not achieve the perceived benefits of the merger as rapidly or to the extent anticipated by financial or industry analysts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.02pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio stockholders and Carisma stockholders will have a reduced ownership and voting interest in, and will exercise less influence over the management of, the combined company following the closing of the merger as compared to their current ownership and voting interest in the respective companies.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is completed, the current Sesen Bio stockholders and Carisma stockholders will own a smaller&#160;percentage of the combined company than their ownership in their respective companies prior to the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of closing being $75.0 million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Raising additional capital may cause dilution to the combined company&#8217;s stockholders, restrict its operations or require it to relinquish rights to its technologies or product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as the combined company, operating as Carisma, can generate substantial revenues from product sales, Carisma expects to finance its cash needs through a combination of public and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">private equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. Although Carisma may receive future payments under its collaboration with Moderna&#160;Inc., or Moderna, Carisma does not currently have any other committed external source of funds. The terms of any financing may adversely affect the holdings or the rights of the combined company&#8217;s stockholders and the issuance of additional securities, whether equity or debt, by the combined company, or the possibility of such issuance, may cause the market price of the combined company&#8217;s shares of common stock to decline. To the extent that the combined company raises additional capital through the sale of equity or convertible debt securities, the ownership interest of the combined company&#8217;s stockholders will be diluted, and the terms of those securities may include liquidation or other preferences that adversely affect the rights of such stockholders. Debt financing and preferred equity financing, if available, would increase the combined company&#8217;s fixed payment obligations and may involve agreements that include covenants limiting or restricting the combined company&#8217;s operations and ability to take specific actions, such as incurring additional debt, making acquisitions, engaging in acquisition, merger or collaboration transactions, selling or licensing the combined company&#8217;s assets, making capital expenditures, redeeming its stock, making certain investments, declaring dividends or other operating restrictions that could adversely impact the combined company&#8217;s ability to conduct its business. The combined company could also be required to meet certain milestones in connection with debt financing and the failure to achieve such milestones by certain dates may force the combined company to relinquish rights to some of its technologies or product candidates or otherwise agree to terms unfavorable to the combined company which could have a material adverse effect on the combined company&#8217;s business, operating results and prospects. The combined company also could be required to seek funds through arrangements with collaborators or otherwise at an earlier stage than otherwise would be desirable. If the combined company raises funds through additional collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, the combined company may have to relinquish valuable rights to its intellectual property, future revenue streams, discovery programs or product candidates, grant licenses on terms that may not be favorable to the combined company or grant rights to develop and market product candidates that the combined company would otherwise prefer to develop and market itself, any of which may have a material adverse effect on the combined company&#8217;s business, operating results and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">During the pendency of the merger, Sesen Bio and Carisma may not be able to enter into a business combination with another party on more favorable terms because of restrictions in the Merger Agreement, which could adversely affect their respective business prospects.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Covenants in the Merger Agreement impede the ability of Sesen Bio and Carisma to make acquisitions during the pendency of the merger, subject to specified exceptions. As a result, if the merger is not completed, the parties may be at a disadvantage to their competitors during such period. In addition, while the Merger Agreement is in effect, each party is generally prohibited from soliciting, initiating or knowingly encouraging, inducing or facilitating any inquiries, indications of interest, proposals or offers that constitute or may reasonably be expected to lead to certain transactions involving a third party, including a merger, sale of assets or other business combination, subject to specified exceptions. Any such transactions could be favorable to such party&#8217;s stockholders, but the parties may be unable to pursue them. For more information, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;No Solicitation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tNSON">179</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain provisions of the Merger Agreement may discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the transactions contemplated by the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The terms of the Merger Agreement prohibit each of Sesen Bio and Carisma from soliciting alternative takeover proposals or cooperating with persons making unsolicited takeover proposals, except in limited circumstances when the Sesen Bio board of directors or the Carisma board of directors, as applicable, determines in good faith that an unsolicited alternative takeover proposal is or is reasonably likely to result in a superior takeover proposal and that failure to cooperate with the proponent of the proposal is reasonably likely to be inconsistent with the applicable board&#8217;s fiduciary duties. Any such transactions could be favorable to Sesen Bio stockholders or Carisma stockholders, as applicable. In addition, if Sesen Bio terminates the Merger Agreement under certain circumstances, including terminating because of a decision of Sesen Bio to enter into a definitive agreement with respect to a superior offer, Sesen Bio would be required to pay a termination fee of $7.6&#160;million to Carisma and/or reimburse Carisma&#8217;s expenses up to a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">maximum of $1.75&#160;million. This termination fee described above may discourage third parties from submitting alternative takeover proposals to Sesen Bio stockholders, and may cause the Sesen Bio board of directors to be less inclined to recommend an alternative takeover proposal. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Because the lack of a public market for Carisma common stock makes it difficult to evaluate the value of Carisma common stock, the Carisma stockholders may receive shares of Sesen Bio common stock in the merger that have a value that is less than, or greater than, the fair market value of Carisma common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The outstanding common stock of Carisma is privately held and is not traded in any public market. The lack of a public market makes it extremely difficult to determine the fair market value of Carisma. Because the&#160;percentage of Sesen Bio common stock to be issued to Carisma stockholders was determined based on negotiations between the parties, it is possible the value of Sesen Bio common stock to be received by Carisma stockholders will be less than the fair market value of Carisma, or the value of Sesen Bio&#8217;s common stock to be received by Carisma stockholders may be more than the aggregate fair market value for Carisma. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the conditions to the merger are not satisfied or waived, the merger will not occur.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if the transactions contemplated by the Merger Agreement are approved by Sesen Bio stockholders and Carisma stockholders, certain other specified conditions set forth in the Merger Agreement must be satisfied, to the extent permitted by applicable law, or waived to complete the merger, including approval from Nasdaq to maintain the listing of the Sesen Bio common stock on the Nasdaq Capital Market following the merger and the listing of the shares of Sesen Bio common stock being issued in the merger and the conversion of the Carisma convertible note. These conditions are set forth in the Merger Agreement and each material condition to the completion of the merger is described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCCM5">176</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. Sesen Bio and Carisma cannot assure you that all of the conditions will be satisfied or waived. If the conditions are not satisfied or waived, the merger will not occur or will be delayed, and Sesen Bio and Carisma each may lose some or all of the intended benefits of the merger. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The merger may fail to qualify as a &#8220;reorganization&#8221; for U.S. federal income tax purposes, resulting in recognition of taxable gain or loss by Carisma stockholders in respect of their Carisma capital stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma intend for the merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI">160</a> of this proxy statement/prospectus. In the event that the merger does not qualify as a &#8220;reorganization,&#8221; the merger would result in taxable gain or loss for each Carisma stockholder, with the amount of such gain or loss determined by the amount that each Carisma stockholder&#8217;s adjusted tax basis in the Carisma capital stock surrendered is less or more than the fair market value of the Sesen Bio common stock and any cash in lieu of a fractional share received in exchange therefor. Each Carisma stockholder is urged to consult with his, her or its own tax advisor with respect to the tax consequences of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Future sales of shares by existing stockholders could cause the combined company&#8217;s stock price to decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If existing Sesen Bio stockholders and Carisma stockholders sell, or indicate an intention to sell, substantial amounts of the combined company&#8217;s common stock in the public market after the merger, the trading price of the common stock of the combined company could decline. Based on shares outstanding as of December 29, 2022, the date the Merger Agreement Amendment was executed, and taking into account the consummation of the Carisma pre-closing financing, the conversion of Carisma&#8217;s $35.0 million outstanding convertible note and an assumed exchange ratio of 37.7924, the combined company is expected to have outstanding a total of approximately 883,803,409 shares of common stock (prior to giving effect to the proposed reverse stock split) immediately following the completion of the merger. Not all shares of Sesen Bio common stock will be freely tradable, without restriction, in the public market. For example, an aggregate of 265,069,468 shares of the combined company&#8217;s common stock will be subject to the lock-up agreements required under the Merger Agreement as of the closing of the merger. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRRTT1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The historical unaudited pro&#160;forma condensed combined financial information may not be representative of the combined company&#8217;s results after the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The historical unaudited pro&#160;forma condensed combined financial information included elsewhere in this proxy statement/prospectus has been presented for informational purposes only and is not necessarily indicative of the financial position or results of operations that actually would have occurred had the merger been completed as of the date indicated, nor is it indicative of future operating results or financial position. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lawsuits have been filed, and additional lawsuits may be filed in the future, against Sesen Bio, the members of the Sesen Bio board of directors, Carisma and/or the members of the Carisma board of directors arising out of the merger, which may delay or prevent the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additional putative stockholder complaints, including stockholder class action complaints, and other complaints may be filed against Sesen Bio, the Sesen Bio board of directors, Carisma, and/or the Carisma board of directors in connection with the transactions contemplated by the Merger Agreement. For example, in December 2022, a complaint was filed in the Court of Chancery for the State of Delaware against Sesen Bio and the members of its board of directors. The outcome of litigation is uncertain, and Sesen Bio and Carisma may not be successful in defending against any such future claims. Lawsuits that may be filed against Sesen Bio, the Sesen Bio board of directors, Carisma, and/or the Carisma board of directors could delay or prevent the merger, divert the attention of the management teams and employees of Sesen Bio and Carisma from day-to-day business and otherwise adversely affect the business and financial condition of Sesen Bio, Carisma or the combined company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Proposed Reverse Stock Split</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The proposed reverse stock split may not increase the combined company&#8217;s stock price over the long-term.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">One of the purposes of the proposed reverse stock split is to increase the per-share market price of the Sesen Bio common stock. It cannot be assured, however, that the proposed reverse stock split will accomplish this objective for any meaningful period of time. While it is expected that the reduction in the number of outstanding shares of Sesen Bio common stock will proportionally increase the per-share market price of Sesen Bio common stock, it cannot be assured that the proposed reverse stock split will increase the per-share market price of Sesen Bio common stock by a multiple of the proposed reverse stock split ratio, or result in any permanent or sustained increase in the per-share market price of Sesen Bio common stock, which is dependent upon many factors, including the combined company&#8217;s business and financial performance, general market conditions and prospects for future success. Thus, while the stock price of the combined company might meet the continued listing requirements for the Nasdaq Capital Market initially, it cannot be assured that it will continue to do so. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The proposed reverse stock split may decrease the liquidity of the combined company&#8217;s common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although the Sesen Bio board of directors believes that the anticipated increase in the per-share market price of the combined company&#8217;s common stock as a result of the proposed reverse stock split could encourage interest in the combined company&#8217;s common stock and possibly promote greater liquidity for stockholders of the combined company, such liquidity could also be adversely affected by the reduced number of shares outstanding after the proposed reverse stock split. The reduction in the number of outstanding shares may lead to reduced trading and a smaller number of market makers for the combined company&#8217;s common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Should the market price of the combined company&#8217;s common stock decline after the proposed reverse stock split, the&#160;percentage decline may be greater, due to the smaller number of shares outstanding, than it would have been prior to the proposed reverse stock split. The proposed reverse stock split may be viewed negatively by the market and, consequently, may lead to a decrease in the combined company&#8217;s overall market capitalization. If the per-share market price does not increase in proportion to the exact ratio of the proposed reverse stock split, then the value of the combined company, as measured by its stock capitalization, will be reduced. In some cases, the per-share market price of companies that have effected reverse stock splits subsequently declined back to pre-reverse split levels, and accordingly, it cannot be assured that the total market value of the combined company&#8217;s common stock will remain the same after the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRRTS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">proposed reverse stock split is effected, or that the proposed reverse stock split will not have an adverse effect on the price of the combined company&#8217;s common stock due to the reduced number of outstanding shares after the proposed reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide to pursue a liquidation and dissolution of Sesen Bio. In such an event, there can be no assurances as to the amount or timing of available cash left, if any, to distribute to Sesen Bio stockholders after paying its debts and other obligations and setting aside funds for reserves.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Sesen Bio has entered into the Merger Agreement with Carisma, the closing of the merger may be delayed or may not occur at all and there can be no assurance that the merger will deliver the anticipated benefits Sesen Bio expects or enhance stockholder value. If the merger is not completed and the Merger Agreement is terminated under certain circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million. Even if a termination fee is not payable in connection with a termination of the Merger Agreement, Sesen Bio will have incurred significant fees and expenses, which must be paid whether or not the merger is completed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, attempt to complete another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio. Any of these alternatives would be costly and time-consuming and would require that Sesen Bio obtain additional funding. Sesen Bio expects that it would be difficult to secure financing in a timely manner, on favorable terms or at all. Sesen Bio can make no assurances that it would be able to obtain additional financing or find a partner and close an alternative transaction on terms that are as favorable or more favorable than the terms set forth in the Merger Agreement or that any such alternatives are possible or would be successful, if pursued. To the extent that Sesen Bio seeks and is able to raise additional capital through the sale of equity or convertible debt securities, Sesen Bio stockholders&#8217; ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect their rights as a common stockholder. Debt financing or preferred equity financing, if available, may involve agreements that include covenants limiting or restricting Sesen Bio&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If Sesen Bio raises funds through strategic transactions or marketing, distribution, or licensing arrangements with third parties, Sesen Bio may have to relinquish valuable rights to its technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to it. Even if Sesen Bio is able to pursue such alternatives, the failure to complete the merger may result in negative publicity and/or a negative impression of Sesen Bio in the investment community, could significantly harm the market price of Sesen Bio common stock and may affect Sesen Bio&#8217;s relationship with employees and other partners in the business community. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide that it is in the best interests of the Sesen Bio stockholders to dissolve the company and liquidate its assets. In that event, the amount of cash available for distribution to the Sesen Bio stockholders would depend heavily on the timing of such decision and, ultimately, such liquidation since the amount of cash available for distribution continues to decrease as Sesen Bio funds its operations and incurs fees and expenses related to the merger. In addition, if the Sesen Bio board of directors were to approve and recommend, and the Sesen Bio stockholders were to approve, a dissolution of Sesen Bio, it would be required under the DGCL to pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, prior to making any distributions in liquidation to the Sesen Bio stockholders. As a result of this requirement, a portion of Sesen Bio&#8217;s assets may need to be reserved pending the resolution of such obligations. In addition, Sesen Bio may be subject to litigation or other claims related to a liquidation and dissolution of the company. If a liquidation and dissolution were pursued, the Sesen Bio board of directors, in consultation with its advisors, would need to evaluate these matters and make a determination about a reasonable amount to reserve. Accordingly, the Sesen Bio stockholders could lose all or a significant portion of their investment in the event of a liquidation and dissolution of Sesen Bio. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio stockholders may not receive any payment on the CVRs from the proceeds related to either the Roche Asset Purchase Agreement or any sale of Sesen Bio&#8217;s non-cash assets and therefore the CVRs may expire valueless, result in lower returns than anticipated or none at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The right of Sesen Bio stockholders to receive future payment on the CVRs from the proceeds related to the Roche Asset Purchase Agreement will be contingent upon the occurrence of a certain triggering event, entitling CVR holders to a pro rata portion of the $30.0 million milestone payment to be made by Roche to Sesen Bio upon Roche&#8217;s initiation of a Phase 3 clinical trial with legacy IL-6 antagonist antibody technology previously owned by Sesen Bio for a certain indication if initiated prior to December 31, 2026, pursuant to the Roche Asset Purchase Agreement, less certain permitted deductions. Sesen Bio may not receive any future payment pursuant to the Roche Asset Purchase Agreement after the closing of the merger. If this milestone is not achieved for any reason within the time period specified in the CVR Agreement or the consideration received is not greater than the amounts permitted to be retained or deducted by Sesen Bio, no payments will be made under the CVRs from the proceeds related to the Roche Asset Purchase Agreement, resulting in a lower return for Sesen Bio stockholders with respect to the CVRs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The right of Sesen Bio stockholders to receive future payment on the CVRs from the proceeds from any sale of Sesen Bio&#8217;s non-cash assets (net of customary deductions) existing as of the date of the Original Merger Agreement is dependent on Sesen Bio finding a partner to which, it can sell, transfer, license, assign or otherwise divest such non-cash assets. The Sesen Bio board of directors may elect not to divest any of Sesen Bio&#8217;s non-cash assets, resulting in a lower return for Sesen Bio stockholders with respect to the CVRs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, if Sesen Bio does not receive any future payment pursuant to the Roche Asset Purchase Agreement and it does not divest any of its non-cash assets, Sesen Bio stockholders will not receive any payments on the CVRs and the CVRs will expire valueless.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, the CVRs will be unsecured obligations of the combined company and all payments under the CVRs, all other obligations under the CVR Agreement and the CVRs and any rights or claims relating thereto will be subordinated in right of payment to the prior payment in full of all current or future senior obligations of the combined company. For more information about the CVR Agreement, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The U.S. federal income tax treatment of the CVRs is unclear and there can be no assurance that the Internal Revenue Service would not assert, or that a court would not sustain, a position that could result in adverse U.S. federal income tax consequences to holders of the CVRs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax treatment of the CVRs is unclear. There is no legal authority directly addressing the U.S. federal income tax treatment of the receipt of, and payments on, the CVRs, and there can be no assurance that the Internal Revenue Service, or the IRS, would not assert, or that a court would not sustain, a position that could result in adverse U.S. federal income tax consequences to holders of the CVRs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As discussed in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs,</font><font style="letter-spacing:0.2pt;">&#8221; Sesen Bio intends to treat the issuance of the CVRs as a distribution of property with respect to its stock. However, there is no authority directly addressing whether contingent value rights with characteristics similar to the CVRs should be treated as a distribution of property with respect to the corporation&#8217;s stock, a distribution of equity, a &#8220;debt instrument&#8221; or an &#8220;open transaction&#8221; for U.S. federal income tax purposes. Although Sesen Bio will estimate the value of the CVRs for purposes of reporting on Form 1099 to Sesen Bio stockholders, the value of the CVRs is uncertain and the IRS or a court could determine that the value of the CVRs at the time of issuance was higher. In such case, the Sesen Bio stockholders could be treated as having additional income or gain upon receipt of the CVRs as described further in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tCVAG">192</a> of this proxy statement/prospectus. Further, notwithstanding Sesen Bio&#8217;s position that the receipt of CVRs, the receipt of any cash distributed pursuant to a special cash dividend and the proposed reverse stock split are appropriately treated as separate transactions, it is possible that the IRS or a court could </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">determine that the Sesen Bio stockholders&#8217; receipt of the CVRs, the receipt of any cash distributed pursuant to a special cash dividend and the proposed reverse stock split constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to Sesen Bio&#8217;s position, which could result in adverse U.S. federal income tax consequences to holders of the CVRs. The tax consequences of such alternative treatments are described below under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs,</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio is substantially dependent on its remaining employees to facilitate the consummation of the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, Sesen Bio had 17 full-time employees. Sesen Bio&#8217;s ability to successfully complete the merger depends in large part on its ability to retain certain remaining personnel. Despite Sesen Bio&#8217;s efforts to retain these employees, one or more may terminate their employment with Sesen Bio on short notice. The loss of the services of certain employees could potentially harm Sesen Bio&#8217;s ability to consummate the merger, to run its day-to-day business operations, as well as to fulfill its reporting obligations as a public company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has never paid and, other than in connection with the merger, does not intend to pay any cash dividends in the foreseeable future.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has never paid cash dividends on any of its capital stock. Pursuant to the terms of the Merger Agreement, Sesen Bio will, in addition to the CVRs, declare and pay a special cash dividend to its stockholders of record prior to the merger, which would be contingent upon Sesen Bio stockholder approval of Proposal Nos. 1 and 2 and the satisfaction or waiver of other customary closing conditions to the merger. The amount of the special cash dividend will be the amount by which Sesen Bio&#8217;s estimated net cash as of the closing of the merger exceeds $75.0 million. Other than such special cash dividend in connection with the closing of the merger, Sesen Bio does not currently anticipate declaring or paying cash dividends on its capital stock in the foreseeable future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio may not be able to enter into a transaction with a suitable acquiror or licensee for Vicineum or any transaction entered into may not be on terms that are favorable to Sesen Bio.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July 15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. As a result of such decision, the primary paths available to derive value from the Vicineum asset are to find a suitable acquiror or licensee for the asset. Supporting diligence activities conducted by potential acquirors or licensees and negotiating the financial and other terms of an agreement or license are typically long and complex processes, and the results of such processes cannot be predicted. There can be no assurance that Sesen Bio will enter into any transaction as a result of this effort or that any transaction entered into will be on terms that are favorable to Sesen Bio. Furthermore, if Sesen Bio enters into and completes a transaction relating to Vicineum, Sesen Bio cannot predict the impact that such transaction might have on its stock price. Sesen Bio also cannot predict the impact on its stock price if Sesen Bio fails to enter into and complete a transaction relating to Vicineum.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In connection with Sesen Bio&#8217;s strategic decision to voluntarily pause further development of Vicineum in the United States, Sesen Bio may become involved in disagreements or disputes with its licensees, licensors and other counterparties relating to the development and/or commercialization of Vicineum, which may be time consuming, costly and could divert its efforts and attention from consummating the merger and harm Sesen Bio&#8217;s efforts to seek a partner to continue development of Vicineum.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into various agreements and licenses with licensees, licensors and other counterparties related to the development and/or commercialization of Vicineum. These agreements and licenses impose a variety of obligations on Sesen Bio and the counterparties to such agreements and licenses. On July 15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. As a result of such decision and Sesen Bio&#8217;s subsequent decision to enter into the Merger Agreement, Sesen Bio has begun the process of winding down its operations relating to Vicineum, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">advisor for the potential sale of Vicineum. In addition, on December 23, 2022, Sesen Bio terminated the Qilu License Agreement, upon which Sesen Bio regained the rights to develop, manufacture and commercialize Vicineum in Greater China. However, Sesen Bio does not plan to develop or commercialize Vicineum in that region or any other, as it is pursuing the merger with Carisma. Disagreements and disputes between Sesen Bio and certain counterparties have arisen related to such wind-down efforts and additional disagreements or disputes may arise in the future between Sesen Bio and its counterparties regarding each parties&#8217; obligations under the respective agreement or license relating to Vicineum.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any such disagreement or dispute could become time consuming, costly and could divert Sesen Bio&#8217;s efforts and attention from consummating the merger and could harm its efforts to seek a partner to continue development of Vicineum. Any disagreements or disputes with such parties that lead to litigation, arbitration or similar proceedings will result in Sesen Bio incurring significant legal expenses, as well as potential significant legal liability.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, any disagreements or disputes over Sesen Bio&#8217;s obligations or intellectual property that it has licensed or acquired may prevent or impair its ability to maintain its current arrangements on acceptable terms. If Sesen Bio fails to meet its obligations under these agreements or licenses in a material respect, the respective counterparty may have the right to terminate the respective agreement or license and to re-obtain the related technology as well as aspects of any intellectual property controlled by Sesen Bio and developed during the period the agreement or license was in force that relates to the applicable technology. While Sesen Bio would expect to exercise its rights and remedies available to it in the event Sesen Bio fails to meet its obligations under such agreement or license in any material respect and otherwise seek to preserve its rights under the technology licensed to or acquired by it, Sesen Bio may not be able to do so in a timely manner, at an acceptable cost or at all. Any uncured, material breach under any agreement or license relating to Vicineum could result in Sesen Bio&#8217;s loss of rights and may lead to a complete termination of the respective agreement or license. Termination of one of these agreements or licenses for any reason could prevent Sesen Bio from completing a transaction to sell or license Vicineum.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Financial Position and Need for Additional Capital if the Merger is Not Completed </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has incurred significant losses since its inception and anticipates that it will continue to incur losses for the foreseeable future if the merger is not completed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a specialty pharmaceutical company with a limited operating history. Over the past few&#160;years, Sesen Bio has focused primarily on developing its lead product candidate, Vicineum for the treatment of NMIBC. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. to conserve cash while considering strategic alternatives. Since its inception, Sesen Bio has received no revenues from sales of its products, has incurred significant operating losses and expects to continue to incur operating losses for the foreseeable future. Sesen Bio had net losses of $0.3&#160;million, $22.4&#160;million and $107.5&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. Sesen Bio incurred negative cash flows from operating activities of $68.9&#160;million, $30.8&#160;million and $37.5&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. As of September&#160;30, 2022, Sesen Bio had cash, cash equivalents and marketable securities of $184.9&#160;million, net working capital (current assets less current liabilities) of $157.7&#160;million and an accumulated deficit of $328.6&#160;million. Sesen Bio has financed its operations to date primarily through private placements of its common stock, preferred stock, common stock warrants and convertible bridge notes, venture debt borrowings, its initial public offering, its follow-on public offerings, sales effected in at-the-market, or ATM offerings, and its out-licensing and outside the U.S., or OUS, business development partnership agreements. The majority of Sesen Bio&#8217;s revenue to date has been from milestone payments received under its out-licensing and OUS business development partnership agreements. If the merger is not completed and Sesen Bio does not pursue a liquidation and dissolution or alternative strategic transaction and despite the 2022 restructuring plan, as defined below, Sesen Bio expects to continue to incur significant expenses and operating losses for the foreseeable future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expects to incur losses for the foreseeable future, and Sesen Bio expects these losses to continue as it: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">addresses its ongoing securities litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintains, expands and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reduces its personnel and incurs related severance and employee-related costs in connection with the restructuring plan announced following the decision to pause further development of Vicineum in the U.S., or the 2022 restructuring plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">winds down activities with its contract manufacturing organizations, or CMOs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">explores, evaluates and pursues a liquidation and dissolution or alternative strategic transaction if the merger is not completed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">With the exception of specified regulatory, development and commercial milestones under the Roche Asset Purchase Agreement, Sesen Bio currently has no potential source of revenue and may never become profitable.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company with a limited operating history. Sesen Bio&#8217;s ability to become and remain profitable depends on its ability to generate revenue. Although Sesen Bio may be entitled to certain payments under the Roche Asset Purchase Agreement, Sesen Bio has not commercialized any of its product candidates. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development in the U.S. of Vicineum. This decision enables Sesen Bio to conserve cash while it prepares to consummate the merger. There can be no guarantee that the merger will be completed within the anticipated timing or at all. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, it does not expect to generate significant revenue unless and until Sesen Bio or one of its business development partners, if any, obtains marketing approval for, and commercializes, Vicineum for the treatment of NMIBC. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio&#8217;s ability to generate revenue from Vicineum will depend on a number of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to obtain regulatory approval for, and successfully commercialize, Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to complete and submit applications to, and obtaining regulatory approval from, non-U.S. regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the size of the markets in the territories for which Sesen Bio or its business development partners, if any, gain regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to find a suitable contract sales organization, or CSO, to help it market and promote Vicineum, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to develop and maintain effective medical affairs, sales, marketing and distribution to market and sell Vicineum, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to enter into and maintain commercially reasonable agreements with wholesalers, distributors and other third parties in its supply chain; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s success in establishing a commercially viable price for Vicineum, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s success in defending against potential competition and other developments in its market generally; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to manufacture commercial quantities of Vicineum at acceptable cost levels; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to obtain coverage and adequate reimbursement from third-party payors, including government payors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s or any business development partners&#8217; ability to successfully complete development activities, including necessary clinical trials, for Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and Vicineum is approved for commercial sale, Vicineum may not gain market acceptance or achieve commercial success. If Sesen Bio&#8217;s addressable market is not as significant as Sesen Bio estimates, the indication approved by regulatory authorities is narrower than Sesen Bio expects or the treatment population is narrowed by competition, physician choice or clinical practice guidelines, Sesen Bio may not generate significant revenue from sales of Vicineum. In addition, if Sesen Bio resumes clinical development of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Vicineum for the treatment of NMIBC, Sesen Bio would anticipate incurring significant costs associated with commercializing Vicineum, if approved. Sesen Bio may not achieve profitability soon after generating product sales from Vicineum, if ever. If Sesen Bio is unable to generate product revenues from Vicineum, Sesen Bio may not become profitable and may be unable to continue operations without continued funding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio achieves profitability, it may not be able to sustain or increase profitability on a quarterly or annual basis. Its failure to become and remain profitable would depress the value of Sesen Bio and could impair its ability to raise capital, expand its business, maintain its development efforts, obtain drug approvals, diversify its offerings or continue its operations. A decline in the value of Sesen Bio could also cause you to lose all or part of your investment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the merger is not completed and Sesen Bio resumes clinical development of Vicineum, Sesen Bio will need substantial additional funding. If Sesen Bio is unable to raise capital when needed, Sesen Bio could be forced to delay, reduce or eliminate its product development programs or commercialization efforts.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has devoted substantial financial resources to clinical trial for Vicineum for the treatment of NMIBC and functions associated with operating as a public company. If the merger is not completed, Sesen Bio expects to continue to spend substantial amounts if it were to continue the clinical development of Vicineum for the treatment of NMIBC, and, if approved, commercialize Vicineum. Accordingly, Sesen Bio would need to obtain substantial additional funding in connection with its continuing operations if the merger is not completed. If Sesen Bio is unable to raise capital when needed or on attractive terms, Sesen Bio could be forced to delay, reduce or eliminate its research and development programs or any future commercialization efforts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of continuing the clinical development of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the success of its commercialization of Vicineum for the treatment of NMIBC, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the outcome, timing and cost of the regulatory approval process for Vicineum for the treatment of NMIBC by the FDA and comparable non-U.S. regulatory authorities, including the potential for the FDA to require that Sesen Bio perform more studies and clinical trials than those Sesen Bio currently expects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of the implementation of commercial-scale manufacturing activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to establish and maintain commercial arrangements on favorable terms, if at all, particularly manufacturing, marketing and distribution arrangements for Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing Sesen Bio&#8217;s intellectual property rights and defending any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to make milestone, royalty and other payments to third-party licensors under its in-licensing agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which Sesen Bio in-license or acquire rights to other products, product candidates or technologies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effect of competing technological and market developments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio cannot be certain that additional funding will be available when needed on acceptable terms, or at all. If Sesen Bio is unable to raise additional capital in sufficient amounts, when required or on acceptable terms, Sesen Bio also could be required to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seek out-licensing or commercialization partners to assist in the clinical development or commercialization of Vicineum for the treatment of NMIBC in the U.S. and other markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">delay, limit, reduce or terminate the clinical development of Vicineum for the treatment of NMIBC; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">significantly curtail Sesen Bio&#8217;s operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Clinical Development and Regulatory Approval of Vicineum if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has been dependent on its lead product candidate, Vicineum for the treatment of NMIBC. If Sesen Bio resumes clinical development of Vicineum and is unable to obtain marketing approval for or successfully commercialize its lead product candidate, either alone or through an out-license or OUS business development partnership, or experiences significant delays in doing so, its business could be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio currently has no products approved for sale and has invested a significant portion of its efforts and financial resources in the development of Vicineum. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA. As a result of this decision, Sesen Bio no longer plans to pursue regulatory approval of Vicineum for NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and even if Sesen Bio resumes clinical development of Vicineum for NMIBC, Sesen Bio may be unable to address the issues identified in the complete response letter, or CRL, from the FDA or resubmit a biologics license application, or BLA, for Vicineum, or address the concerns identified in the European Medicines Agency, or EMA, Withdrawal Assessment Report or resubmit its marketing authorization application, or MAA, for Vysyneum, including because of a lack of capital or otherwise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if the issues identified in the CRL or the concerns identified in the EMA Withdrawal Assessment Report are resolved to the satisfaction of the FDA or the EMA, respectively, the FDA and the European Commission retain the right not to approve a BLA or MAA, respectively, or to require additional information, or to raise additional issues with regard to regulatory approval, which could further delay or prevent its approval or limit product labelling claims. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and Sesen Bio resumes clinical development, Sesen Bio&#8217;s prospects would be substantially dependent on its ability to obtain marketing approval for and commercialize Vicineum for the treatment of NMIBC. In addition, either the substance of the issues identified by the FDA in the CRL, or the CRL itself, or the concerns identified in the EMA Withdrawal Assessment Report could have an adverse impact on future efforts to obtain marketing authorization for Vicineum from other non-U.S. regulatory authorities, or on Sesen Bio&#8217;s future efforts to commercialize Vicineum and gain acceptance of Vicineum from third-party payors. The success of Vicineum would depend on several factors, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully completing the clinical development of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">addressing the issues identified in the CRL that Sesen Bio received from the FDA and the concerns identified in the EMA Withdrawal Assessment Report; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">receiving marketing approvals from the FDA, the European Commission or comparable non-U.S. regulatory authorities, including Sesen Bio&#8217;s ability to address the issues identified by the FDA in the CRL or the EMA Withdrawal Assessment Report; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">developing and maintaining the commercial manufacturing supply and distribution chain for Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">performance of future out-licensing or OUS business development partners (if any); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent of any required post-marketing approval commitments to applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining and maintaining patent, trade secret protection and regulatory exclusivity, both in the U.S. and internationally; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">protecting Sesen Bio&#8217;s rights in its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">launching commercial sales, if and when marketing approval is received; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">demonstrating an acceptable safety profile prior to and following any marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining marketplace acceptance, if approved, by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing and maintaining pricing sufficient to realize a meaningful return on Sesen Bio&#8217;s investment; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">competition with other therapies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio is unable to develop, receive marketing approval for, or successfully commercialize Vicineum or experience delays as a result of any of these factors or otherwise, its business could be materially harmed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If additional clinical trials of Vicineum for the treatment of NMIBC fail to demonstrate safety and efficacy to the satisfaction of the FDA, the EMA or other non-U.S. regulatory authorities or do not otherwise produce favorable results, Sesen Bio will be unable to complete the development and potential commercialization of Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and additional clinical trials of Vicineum fail to demonstrate safety and efficacy to the satisfaction of the FDA, the EMA or other non-U.S. regulatory authorities or do not otherwise produce favorable results, Sesen Bio will be unable to complete the development and potential commercialization of Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before obtaining marketing approval from regulatory authorities for the sale of Vicineum for the treatment of NMIBC, Sesen Bio must complete pre-clinical development and conduct extensive clinical trials to demonstrate the safety and efficacy of Vicineum in humans. In order to address the issues identified in the CRL that Sesen Bio received from the FDA for the BLA for Vicineum and the concerns identified in the EMA Withdrawal Assessment Report, Sesen Bio would need to complete one or more additional clinical trials. Such trials would require Sesen Bio to incur substantial additional costs and would delay the potential commercialization of Vicineum for the treatment of NMIBC. Clinical testing is expensive, difficult to design and implement, can take many&#160;years to complete and is uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. Further, the outcome of pre-clinical studies and early clinical trials may not be predictive of the success of later clinical trials, and preliminary results of a clinical trial do not necessarily predict final results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if such clinical trials are successfully completed as planned, the results may not support approval of Vicineum for the treatment of NMIBC under the laws and regulations of the FDA, the European Commission or comparable non-U.S. regulatory authorities. Even if Sesen Bio resumes clinical development of Vicineum, Sesen Bio cannot be certain that additional clinical data will demonstrate Vicineum is both safe and effective for its intended uses to the satisfaction of the FDA, the EMA or comparable non-U.S. regulatory authorities. Pre-clinical and clinical data and analyses are often able to be interpreted in different ways. Even if Sesen Bio views its results favorably, it may be unable to demonstrate safety and efficacy of Vicineum for the treatment of NMIBC to the satisfaction of the FDA, the EMA or other non-U.S. regulatory authorities. If a regulatory authority has a different view, Sesen Bio may still fail to obtain regulatory approval of Vicineum. This, in turn, would prevent Sesen Bio from commercializing Vicineum and its ability to generate revenues in the future would be materially impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and Sesen Bio experiences delays or difficulties in the enrollment of patients in clinical trials, its receipt of necessary regulatory approvals could be delayed or prevented.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio may not be able to initiate or continue clinical trials for Vicineum if Sesen Bio is unable to locate and enroll a sufficient number of patients to participate in these trials as required by the FDA or similar non-U.S. regulatory authorities. Sesen Bio has previously experienced difficulties with clinical trial enrollment and retention, which led to the early termination of its Phase&#160;3 trial of Vicineum for the treatment of squamous </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">cell carcinoma of the head and neck, or SCCHN, in 2008, and Sesen Bio may experience difficulties in patient enrollment in its clinical trials in the future for a variety of reasons. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject enrollment is affected by a number of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the severity of the disease under investigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the eligibility criteria for the clinical trial in question; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the size of the patient population for the disease; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the size of the patient population required for statistically significant analysis of the clinical trial&#8217;s primary endpoints; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the design of the clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the clinicians&#8217; and patients&#8217; perceived risks and benefits of the product candidate under study, including relative to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the efforts to facilitate timely enrollment in clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the patient referral practices of physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any ongoing clinical trials conducted by competitors for the same indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk that patients enrolled in clinical trials will drop out of the clinical trials before completion; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability to monitor patients adequately during and after treatment; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the proximity and availability of clinical trial sites for prospective patients. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, Sesen Bio&#8217;s ability to successfully initiate, enroll and complete a clinical trial in any country outside of the U.S., should Sesen Bio decide to do so, is subject to numerous risks unique to conducting business in such countries, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">difficulty in establishing or managing relationships with contract research organizations, or CROs, and physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">different or additional standards for the conduct of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">absence in some countries of established groups with sufficient regulatory expertise for review of the protocols associated with Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ensuring that clinical trial quality is sufficient to meet the standards of the FDA or other regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s inability to locate qualified local consultants, physicians and partners; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential burden of complying with a variety of non-U.S. laws, medical standards and regulatory requirements, including the regulation of pharmaceutical and biotechnology products and treatments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Sesen Bio&#8217;s clinical trials would compete with other clinical trials for other product candidates that are in the same therapeutic areas as Vicineum, and this competition will reduce the number and types of patients available to Sesen Bio, because some patients who might have opted to enroll in Sesen Bio&#8217;s trials may instead opt to enroll in a trial being conducted by one of its competitors. Since the number of qualified clinical investigators is limited, Sesen Bio expects to conduct some of its clinical trials at the same clinical trial sites that some of its competitors use, which will reduce the number of patients who are available for Sesen Bio&#8217;s clinical trials in such clinical trial site. Moreover, because Vicineum represents a departure from more commonly used methods for cancer treatment, potential patients and their doctors may be inclined to use conventional therapies, such as chemotherapy, rather than enroll patients in any of Sesen Bio&#8217;s clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s inability to enroll a sufficient number of patients for its clinical trials would result in significant delays, could require Sesen Bio to abandon one or more clinical trials altogether and could delay or prevent its receipt of necessary regulatory approvals. Enrollment delays in its clinical trials may result </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">in increased development costs for its product candidates, which would cause the value of the company to decline and limit its ability to obtain additional financing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Vicineum for the treatment of NMIBC may cause undesirable side effects, serious adverse events or have other properties that could delay or halt clinical trials, delay or prevent its regulatory approval, limit the commercial profile of its labeling, if approved, or result in significant negative consequences following any marketing approval.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, undesirable side effects or serious adverse events caused by Vicineum for the treatment of NMIBC could cause Sesen Bio or regulatory authorities to interrupt, delay or halt respective clinical trials and could result in a restrictive label or the delay or denial of regulatory approval by the FDA or other comparable non-U.S. regulatory authorities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There were no Grade 4 or Grade 5 serious adverse events that were considered by the clinical investigators to be related to Vicineum during the Phase&#160;1 and Phase&#160;2 clinical trials of Vicineum for the treatment of bacillus Calmette-Gu&#233;rin, or BCG, unresponsive NMIBC. There was one Grade 5 serious adverse event, or death, which was determined by the clinical investigator to be unrelated to Vicineum. The most common reported treatment-related adverse events were an abnormally frequent passage of small amounts of urine, blood in the urine and painful urination, the majority of which were considered to be mild or moderate in severity. No patients discontinued treatment due to a Vicineum-related adverse event during the Phase&#160;1 and Phase&#160;2 clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the May&#160;29, 2019 data cutoff date, in patients across all cohorts (n=133) of Sesen Bio&#8217;s Phase&#160;3 VISTA Trial of Vicineum for the treatment of BCG-unresponsive NMIBC, 88% experienced at least one adverse event, with 95% of adverse events being Grade 1 or 2. The most commonly reported treatment-related adverse events were dysuria (14%), hematuria (13%) and urinary tract infection (12%)&#8201;&#8212;&#8201;all of which are consistent with the profile of bladder cancer patients and the use of catheterization for treatment delivery. These adverse events were determined by the clinical investigators to be manageable and reversible, and only four patients (3%) discontinued treatment due to an adverse event. Serious adverse events, regardless of treatment attribution, were reported in 14% of patients. There were four treatment-related serious adverse events reported in three patients including acute kidney injury (Grade 3), pyrexia (Grade 2), cholestatic hepatitis (Grade 4) and renal failure (Grade 5 or death). There were no age-related increases in adverse events observed in the VISTA Trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, side effects and serious adverse events or further safety or toxicity issues that Sesen Bio may experience in its clinical trials or in post-marketing experience, if approved, could lead to the FDA&#8217;s or other comparable non-U.S. regulatory authority&#8217;s imposition of a risk evaluation and mitigation strategy, or REMS, or other post-marketing obligations, which could hinder Sesen Bio from generating revenues or achieving profitability. Results of Sesen Bio&#8217;s clinical trials could reveal an unacceptably high severity and prevalence of side effects or serious adverse events. As a result, Sesen Bio&#8217;s clinical trials could be suspended or terminated, and the FDA or comparable non-U.S. regulatory authorities could order Sesen Bio to cease further development or deny approval of Vicineum for the treatment of NMIBC. The related drug-side effects or serious adverse events in Sesen Bio&#8217;s clinical trials could affect clinical trial patient recruitment or the ability of enrolled patients to complete the clinical trial or result in potential product liability claims. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and receives marketing approval, and Sesen Bio or others later identify undesirable side effects or serious adverse events caused by Vicineum, a number of potentially significant negative consequences could result, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio may suspend or be forced to suspend marketing of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio may be obliged to conduct a product recall or product withdrawal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities may suspend, vary, or withdraw their approvals of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities may order the seizure or recall of Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities may require additional warnings on the label or a REMS or other post-marketing obligations that could diminish the usage or otherwise limit the commercial success of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio may be required to conduct post-marketing studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio could be sued and held liable for harm caused to patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio could be required to pay fines and face other administrative, civil and criminal penalties; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s reputation may suffer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any of these events could prevent Sesen Bio from achieving or maintaining market acceptance of Vicineum for the treatment of NMIBC, if approved. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The marketing approval process is expensive, time-consuming and uncertain. As a result, even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, it cannot predict when or if it, or any licensees or partners, if any, will obtain marketing approval to commercialize Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securing marketing approval requires the submission of extensive pre-clinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s quality, safety, and efficacy. The process of obtaining marketing approvals, both in the U.S. and abroad, is expensive and may take many&#160;years, especially if additional clinical trials are required, if approval is obtained at all. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following its discussions with the FDA. As a result of this decision, Sesen Bio no longer plans to pursue regulatory approval of Vysyneum for the treatment of NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, the FDA or other comparable non-U.S. regulatory authorities may determine that Vicineum is not safe, effective or of appropriate quality, is only moderately effective or has undesirable or unintended side effects, toxicities or other characteristics that preclude Sesen Bio obtaining marketing approval or prevent or limit commercial use. Any marketing approval Sesen Bio ultimately obtains may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The different requirements and expectations of the non-U.S. regulatory authorities compared with the FDA may lengthen the regulatory review process, require Sesen Bio to conduct additional studies or clinical trials, increase its development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of these product candidates or lead to significant post approval limitations or restrictions. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and experiences delays in obtaining regulatory approvals, the commercial prospects for its product candidates may be harmed and its ability to generate revenues will be materially impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, failure to obtain marketing approval in non-U.S. jurisdictions would prevent Vicineum for the treatment of NMIBC from being marketed abroad, and any approval Sesen Bio may be granted for Vicineum for the treatment of NMIBC in the U.S. would not assure approval of product candidates in non-U.S. jurisdictions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to market and sell any product candidate that Sesen Bio may develop outside of the U.S., Sesen Bio or its third-party licensees or commercialization partners, if any, must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The regulatory approval process outside the U.S. generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">outside the U.S. it is required that the product be approved for reimbursement before the product can be sold in that country. Sesen Bio or these third parties may not obtain approvals from regulatory authorities outside the U.S. on a timely basis, if at all. For example, on March&#160;5, 2021, Sesen Bio submitted its MAA to the EMA for Vicineum for the treatment of BCG-unresponsive NMIBC under the EMA&#8217;s centralized procedure. On August&#160;20, 2021, Sesen Bio withdrew its MAA to the EMA for Vysyneum for the treatment of BCG-unresponsive NMIBC. Additionally, on October&#160;20, 2021, the EMA issued its Withdrawal Assessment Report relating to Sesen Bio&#8217;s MAA for Vysyneum, as is consistent with the EMA&#8217;s standard practice when an MAA is withdrawn. The Assessment Report reflects the initial assessment and corresponding questions from the EMA and identifies major objections in the areas of quality, good clinical practice, efficacy and safety. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following its discussions with the FDA. As a result of this decision, Sesen Bio no longer plans to pursue regulatory approval of Vysyneum for the treatment NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the U.S. does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio may not be able to file for marketing approvals and may not receive necessary approvals to commercialize its products in any market. If Sesen Bio is unable to obtain approval of its product candidates by regulatory authorities in other jurisdictions, the commercial prospects of its product candidates may be significantly diminished, and its business prospects could decline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than Sesen Bio does.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The development and commercialization of new biologics products is highly competitive. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would face competition from both large and small pharmaceutical, biopharmaceutical and biotechnology companies, academic institutions and other research organizations. There are a number of large pharmaceutical, biopharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of NMIBC. For instance, in January&#160;2020, the FDA approved Merck &amp; Co., Inc.&#8217;s Keytruda (pembrolizumab) as a systemic monotherapy to treat patients with BCG-unresponsive NMIBC with non-muscle invasive carcinoma in situ, or CIS, with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy. In addition, FerGene Inc. is developing Adstiladrin (nadofaragene firadenovec (rAd-IFN/Syn3) for BCG-unresponsive NMIBC for the U.S. market. On May&#160;17, 2020, the FDA issued a CRL that indicated outstanding questions regarding chemistry, manufacturing and controls, or CMC, issues of Adstiladrin. In September&#160;2020, CG Oncology (CG0070, a recombinant adenovirus type&#160;5, same type as Adstiladrin) initiated a Phase&#160;3 study for the treatment of BCG-unresponsive patients with expected primary and study completion dates of December&#160;2022 and December&#160;2024, respectively. A combination trial with CG0070 and pembrolizumab was initiated in December&#160;2020 (active not recruiting) with a primary completion date of June&#160;2023. In December&#160;2020, ImmunityBio (Anktiva/N-803 in combination with BCG) released preliminary Phase&#160;2 data for the CIS cohort and filed its BLA with the FDA in May&#160;2022. However, the Phase&#160;2 trial did not include a BCG only control arm. The BLA for Anktiva was accepted by the FDA in July&#160;2022 and a PDUFA date of May&#160;23, 2023 has been set. In May&#160;2020, the preliminary results of the Phase&#160;2 study of Tecentriq for the treatment of BCG-unresponsive CIS patients were presented at American Society of Clinical Oncology, or ASCO, by the National Cancer Institute, or the NCI, which sponsored the trial. The data showed that the trial did not meet its primary endpoint and further development of Tecentriq remains uncertain. Finally, another route of administration for checkpoint inhibitors is currently being evaluated by Pfizer with the subcutaneous administration of Sasanlimab (PF-06801591) for the treatment of BCG-unresponsive NMIBC patients. There is intense and rapidly evolving competition in the biotechnology, biopharmaceutical and antibody fragment and immuno-oncology therapeutics fields. Some of these competitive products and therapies are based on scientific </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">approaches that are similar to Sesen Bio&#8217;s approach, and others are based on entirely different approaches, including the emerging use of generic intravesical chemotherapy agents, such as mytomycin-C, Gemcytabine and Gemcytobine + Docetaxel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, its commercial opportunity could be reduced or eliminated if its competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than product candidates that Sesen Bio may develop. Sesen Bio&#8217;s competitors also may obtain FDA or other regulatory approval for their products more rapidly than Sesen Bio may obtain approval for Vicineum, which could result in its competitors establishing a strong market position before Sesen Bio is able to enter the market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, Sesen Bio&#8217;s ability to compete may be affected in many cases by insurers or other third-party payors, particularly Medicare, seeking to encourage the use of generic drug products. Generic products are currently being used as part of the standard of care for the indications that Sesen Bio has been pursuing, and additional products are expected to become available on a generic basis over the coming&#160;years. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and Vicineum achieves marketing approval, Sesen Bio expects that it will be priced at a significant premium over competitive generic products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">More established companies may have a competitive advantage over Sesen Bio due to their greater size, cash resources and institutional experience. Compared to Sesen Bio, many of its competitors may have significantly greater financial, technical and human resources. As a result of these factors, its competitors may obtain regulatory approval of their product candidates before Sesen Bio is able to, which may limit its ability to develop or commercialize its product candidates. Sesen Bio&#8217;s competitors may also develop drugs that are safer, more effective, more widely used and less expensive than Sesen Bio&#8217;s and may also be more successful than Sesen Bio in manufacturing and marketing their products. These appreciable advantages could render Vicineum obsolete or non-competitive before Sesen Bio can recover the expenses of development and commercialization. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Dependence on Third Parties if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has historically relied on third parties to conduct its pre-clinical studies and clinical trials. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and if these third parties do not successfully carry out their contractual duties or meet expected deadlines, Sesen Bio may not be able to obtain regulatory approval for or commercialize Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio relies on domestic and international third-party CROs to monitor and manage data for its pre-clinical and clinical programs. Sesen Bio relies on these parties for execution of its pre-clinical studies and clinical trials, and Sesen Bio controls only some aspects of their activities. Nevertheless, Sesen Bio is responsible for ensuring that each of its pre-clinical studies and clinical trials is conducted in accordance with the applicable protocol and legal, regulatory and scientific standards, and its reliance on the CROs does not relieve Sesen Bio of its regulatory responsibilities. Sesen Bio also relies on third parties to assist in conducting its pre-clinical studies in accordance with the FDA&#8217;s current Good Laboratory Practice, or GLP, and the Animal Welfare Act requirements. Sesen Bio and its CROs are required to comply with U.S.&#160;federal regulations and current Good Clinical Practices, or GCP, which are international standards meant to protect the rights and health of patients and assure the credibility of clinical trial data that are enforced by the FDA and comparable non-U.S. regulatory authorities for all of its product candidates in clinical development. Regulatory authorities enforce GCP through periodic inspections of trial sponsors, principal investigators and trial sites. If Sesen Bio or any of its CROs fail to comply with applicable GCP, the clinical data generated in its clinical trials may be deemed unreliable and the FDA or comparable non-U.S. regulatory authorities may require Sesen Bio to perform additional clinical trials before approving its marketing applications. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;27, 2021, the FDA published a Warning Letter, or the FDA Warning Letter, issued to a former clinical investigator in Sesen Bio&#8217;s VISTA trial for Vicineum arising from a 2021 FDA inspection related to the review of Sesen Bio&#8217;s BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. Sesen Bio discontinued use of the clinical site and the clinical investigator over four&#160;years ago when it learned of professional misconduct by the clinical investigator that was unrelated to the VISTA trial. The FDA Warning Letter indicated that the clinical investigator did not comply with applicable statutory requirements and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">applicable regulations regarding conduct of clinical investigations. The clinical investigator&#8217;s medical license was temporarily suspended on May&#160;29, 2017, due to inaccurate recordkeeping, which was unassociated with Sesen Bio and the patients in the VISTA trial. Sesen Bio notified the FDA of the misconduct at that time. There was no evidence found that patients were harmed by the clinical investigator&#8217;s actions. Sesen Bio included the corresponding patient data from the clinical site in the BLA submission to the FDA, which were thoroughly analyzed and discussed during the BLA review. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of its clinical trials comply with GCP requirements. In addition, its clinical trials must be conducted with product produced under current good manufacturing process, or cGMP, requirements. Failure to comply with these regulations may require Sesen Bio to repeat pre-clinical studies and clinical trials, which would delay the regulatory approval process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s CROs are not its employees, and except for remedies available to Sesen Bio under its agreements with such CROs, Sesen Bio cannot control whether or not they devote sufficient time and resources to its ongoing clinical, non-clinical and pre-clinical programs. If CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines or if the quality or accuracy of the data they obtain is compromised due to the failure to adhere to its protocols, regulatory requirements or for other reasons, its pre-clinical studies and clinical trials may be extended, delayed or terminated and Sesen Bio may not be able to obtain regulatory approval for or successfully commercialize its product candidates. As a result, its results of operations and the commercial prospects for its product candidates would be harmed, its costs could increase and its ability to generate revenues could be delayed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because Sesen Bio relied, and will continue to rely, on third parties, its internal capacity to perform these functions is limited. Outsourcing these functions involves risk that third parties may not perform to its standards, may not produce results in a timely manner or may fail to perform at all. In addition, the use of third-party service providers requires Sesen Bio to disclose its proprietary information to these parties, which could increase the risk that this information will be misappropriated. Sesen Bio currently has a small number of employees, which limits the internal resources Sesen Bio has available to identify and monitor its third-party providers. To the extent Sesen Bio is unable to identify and successfully manage the performance of third-party service providers in the future, its business may be adversely affected. Though Sesen Bio carefully manages its relationships with its CROs, there can be no assurance that Sesen Bio will not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse impact on its business, financial condition and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would likely be dependent on third-party manufacturers, as well as third parties for Sesen Bio&#8217;s supply chain, which would expose Sesen Bio to a number of risks that may delay development, regulatory approval and commercialization or result in higher product costs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with Sesen Bio&#8217;s decision to voluntarily pause further development of Vicineum, Sesen Bio terminated its agreements with its CMOs and requested that such manufacturers cease all work under the respective agreements and refrain from incurring any additional costs or expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would likely be dependent on third-party manufacturers, as well as third parties for Sesen Bio&#8217;s supply chain. Sesen Bio&#8217;s reliance on third-party manufacturers would expose it to certain risks that it would not be subject to if Sesen Bio manufactured Vicineum itself, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">It may be difficult or impossible for Sesen Bio to find replacement manufacturers on acceptable terms quickly, or at all. Identifying alternate manufacturers may be difficult because the number of potential manufacturers that have the necessary expertise to produce biologics is limited. Additionally, the FDA must approve any alternative manufacturer before Sesen Bio may use the alternative manufacturer to produce clinical supply of Vicineum. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The development of manufacturing capabilities to produce clinical supply of Vicineum may require Sesen Bio&#8217;s third-party manufacturers to invest substantial additional funds and to hire and retain </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">technical personnel who have the necessary manufacturing experience. Sesen Bio&#8217;s third-party manufacturers may fail to devote sufficient time and resources to develop the capabilities to manufacture Vicineum. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Because of the complex nature of Vicineum, Sesen Bio&#8217;s third-party manufacturers, or other third parties it relies on, may encounter difficulties in achieving the volume of production needed to satisfy its clinical supply demands, may not be able to achieve such volume at an acceptable cost, may experience technical issues that impact comparability, quality, or compliance with applicable regulations governing the manufacture of biological products, and may experience shortages of qualified personnel to adequately staff production operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s third-party manufacturers could default on their agreements with Sesen Bio to meet its requirements for supply of Vicineum, or they may terminate or decide not to renew their agreements with Sesen Bio, based on their own business priorities, at a time that is costly or damaging to Sesen Bio. If Sesen Bio&#8217;s third-party manufacturers were to terminate its arrangements or fail to meet its manufacturing demands, Sesen Bio may be delayed in its ability to obtain and maintain regulatory approval of Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If any third-party manufacturer makes improvements in the manufacturing process for Vicineum, Sesen Bio may not own, or may have to share, the intellectual property rights to such improvements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A third-party manufacturer may gain knowledge from working with Sesen Bio that could be used to supply one of its competitors with a product that competes with Sesen Bio&#8217;s. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s reliance on third-party manufacturers reduces its control over production and supply of Vicineum but does not relieve Sesen Bio of its responsibility to ensure compliance with applicable legal and regulatory standards. The FDA and other non-U.S. regulatory authorities require that Sesen Bio&#8217;s product candidates and any products that it may eventually commercialize be manufactured according to cGMP and similar non-U.S. standards. Methods of manufacture as well as validation of manufacturing procedures and quality control systems are reviewed by regulatory authorities, such as the FDA and other comparable non-U.S. regulatory authorities, to determine their effect on the quality, purity and potency of product candidates. All such manufacturing procedures, validation programs and quality assessment activities must be properly documented in accordance with regulatory requirements. Any failure by Sesen Bio&#8217;s third-party manufacturers to comply with cGMP or similar non-U.S. standards, including any failure to deliver sufficient quantities of product candidates in a timely manner, could lead to a delay in or failure to obtain regulatory approval of Vicineum for the treatment of NMIBC if Sesen Bio resumes clinical development of Vicineum. For example, Sesen Bio may be unable to resolve the issues raised in the CRL pertaining to a recent pre-approval inspection and product quality. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, a failure by Sesen Bio&#8217;s third-party manufactures to comply with cGMP or similar non-U.S. standards could be the basis for the FDA or any other non-U.S. regulatory authorities to issue a warning or untitled letter, withdraw approvals for product candidates previously granted to Sesen Bio or take other regulatory or legal action, including recall or seizure, total or partial suspension of production, suspension of ongoing clinical trials, refusal to approve pending applications or supplemental applications, detention of product, refusal to permit the import or export of products, injunction, imposing administrative or civil penalties or pursuing criminal prosecution. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and if Sesen Bio or its third-party manufacturers fail to comply with environmental, health and safety laws and regulations, Sesen Bio could become subject to fines or penalties or incur significant costs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMBIC and engages third-party manufacturers, such manufacturers would be subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Any such operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may produce hazardous waste products. Historically, Sesen Bio has generally contracted with third parties for the disposal of these materials and wastes. Sesen Bio cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from its use of hazardous materials, Sesen Bio could be held </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">liable for any resulting damages and any liability could exceed its resources. Sesen Bio also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although Sesen Bio maintains workers&#8217; compensation insurance to cover it for costs and expenses it may incur due to injuries to its employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. Sesen Bio does not maintain insurance for environmental liability or toxic tort claims that may be asserted against it in connection with its storage or disposal of biological, hazardous or radioactive materials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if Sesen Bio resumes clinical development of Vicineum, Sesen Bio may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair its research, development or production efforts. Sesen Bio&#8217;s failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, with respect to the operations of third-party contract manufacturers, if any, it is possible that if they fail to operate in compliance with applicable environmental, health and safety laws and regulations or properly dispose of wastes associated with its products, Sesen Bio could be held liable for any resulting damages, suffer reputational harm or experience a disruption in the manufacture and supply of its product candidates or products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Intellectual Property if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and is unable to obtain and maintain patent protection for its technology or products, or if its licensors are unable to obtain and maintain patent protection for the technology or products that Sesen Bio licenses from them, or if the scope of the patent protection obtained is not sufficiently broad, Sesen Bio&#8217;s competitors could develop and commercialize technology and products similar or identical to theirs, and its ability to successfully commercialize it technology and products may be impaired.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio&#8217;s success depends in large part on the ability of both it and its licensors&#8217; to obtain and maintain patent protection in the U.S. and other countries with respect to Vicineum and its other proprietary technology and product candidates. Sesen Bio and its licensors have sought to protect Sesen Bio&#8217;s proprietary position by filing patent applications in the U.S. and abroad related to its novel technologies and product candidates. The patent prosecution process is expensive and time-consuming, and Sesen Bio may not be able to file and prosecute all necessary or desirable patent applications in jurisdictions of interest at a reasonable cost or in a timely manner. It is also possible that Sesen Bio will fail to identify patentable aspects of its research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, Sesen Bio does not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that it licenses from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of Sesen Bio&#8217;s business. If such licensors fail to maintain such patents, or lose rights to those patents, the rights Sesen Bio has licensed may be reduced or eliminated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent&#160;years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of Sesen Bio&#8217;s and its licensors&#8217; patent rights are highly uncertain. Sesen Bio&#8217;s and its licensors&#8217; pending and future patent applications may not result in patents being issued which protect its technology or products or which effectively prevent others from commercializing competitive technologies and products. In addition, the laws of non-U.S. countries may not protect Sesen Bio&#8217;s rights to the same extent as the laws of the U.S. For example, European patent law restricts the patentability of methods of treatment of the human body more than U.S. law does. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions are typically not published until 18&#160;months after filing, or in some cases not at all. Therefore, Sesen Bio cannot know with certainty whether it or its licensors were the first to make the inventions claimed in its owned or licensed patents or pending patent applications, or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">that Sesen Bio or its licensors were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of Sesen Bio&#8217;s owned or licensed patent rights are highly uncertain. Sesen Bio&#8217;s pending and future patent applications may not result in patents being issued which protect its technology or products, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. In particular, during prosecution of any patent application, the issuance of any patents based on the application may depend upon Sesen Bio&#8217;s ability to generate additional pre-clinical or clinical data that support the patentability of its proposed claims. Sesen Bio may not be able to generate sufficient additional data on a timely basis, or at all. Moreover, changes in either the patent laws or interpretation of the patent laws in the U.S. and other countries may diminish the value of Sesen Bio&#8217;s patents or narrow the scope of Sesen Bio&#8217;s patent protection. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, Sesen Bio may be subject to a third-party preissuance submission of prior art to the U.S. Patent and Trademark Office, or the USPTO, or become involved in opposition, derivation, reexamination, inter partes review, post-grant review or interference proceedings challenging its patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, Sesen Bio&#8217;s patent rights, allow third parties to commercialize its technology or products and compete directly with Sesen Bio, without payment to it, or result in Sesen Bio&#8217;s inability to manufacture or commercialize products without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by Sesen Bio&#8217;s patents and patent applications is threatened, it could dissuade companies from collaborating with Sesen Bio to license, develop or commercialize current or future product candidates. In addition, invalidation of Sesen Bio&#8217;s patent rights by third parties could jeopardize the anticipated revenue streams from current licensees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio&#8217;s owned and licensed patent applications issue as patents, they may not issue in a form that will provide Sesen Bio with any meaningful protection, prevent competitors from competing with Sesen Bio or otherwise provide Sesen Bio with any competitive advantage. Sesen Bio&#8217;s competitors may be able to circumvent Sesen Bio&#8217;s owned or licensed patents by developing similar or alternative technologies or products in a non-infringing manner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and Sesen Bio&#8217;s owned and licensed patents may be challenged in the courts or patent offices in the U.S. and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit Sesen Bio&#8217;s ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of its technology and products. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, Sesen Bio&#8217;s owned and licensed patent portfolio may not provide it with sufficient rights to exclude others from commercializing products similar or identical to Sesen Bio&#8217;s. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio may not be able to protect its intellectual property rights throughout the world.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, filing, prosecuting and defending patents on Vicineum and Sesen Bio&#8217;s other product candidates and technologies throughout the world would be prohibitively expensive, and Sesen Bio&#8217;s or its licensors&#8217; intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws and practices of countries outside the U.S. do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Moreover, the intellectual property laws of the U.S. change over time. For example, several United States Supreme Court cases have redefined what is considered to be patentable subject matter. Consequently, if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio and its licensors may not be able to prevent third parties from practicing Sesen Bio&#8217;s and its licensors&#8217; inventions in all countries inside or outside the U.S., or from selling or importing products made using Sesen Bio&#8217;s and its licensors&#8217; inventions in and into the U.S. or other jurisdictions. Competitors may use Sesen Bio&#8217;s technologies in jurisdictions where it has not obtained patent protection to develop their own products and may export infringing products to territories where Sesen Bio or its licensors have patent protection, but where enforcement is not as strong as in the U.S. These products may compete with Sesen Bio&#8217;s products in jurisdictions where it does not have any issued patents and Sesen Bio&#8217;s patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in non-U.S. jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biopharmaceuticals, which could make it difficult for Sesen Bio to stop the infringement of Sesen Bio&#8217;s or its licensor&#8217;s patents or marketing of competing products in violation of Sesen Bio&#8217;s proprietary rights generally in those countries. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, proceedings to enforce Sesen Bio&#8217;s patent rights in non-U.S. jurisdictions could result in substantial cost and divert its efforts and attention from other aspects of its business, could put Sesen Bio&#8217;s and its licensors&#8217; patents at risk of being invalidated or being interpreted narrowly and put Sesen Bio&#8217;s and its licensors&#8217; patent applications at risk of not issuing and could provoke third parties to assert claims against Sesen Bio or its licensors. Sesen Bio or its licensors may not prevail in any lawsuits that Sesen Bio or its licensors initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The laws of certain countries outside of the U.S. may not protect Sesen Bio&#8217;s rights to the same extent as the laws of the U.S., and such laws may also be subject to change. For example, methods of treatment and manufacturing processes may not be patentable in certain jurisdictions, and the requirements for patentability may differ in certain countries, particularly developing countries. Furthermore, generic and/or biosimilar product manufacturers or other competitors may challenge the scope, validity or enforceability of Sesen Bio&#8217;s or its licensors&#8217; patents, requiring Sesen Bio or its licensors to engage in complex, lengthy and costly litigation or other proceedings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Generic or biosimilar product manufacturers may develop, seek approval for, and generic versions or biosimilar versions, respectively, of Sesen Bio&#8217;s products. The FDA has published several guidance documents on biosimilar product development. If a biosimilar product is also found to be interchangeable with a reference product, it may be substituted for the reference product. Complexities associated with the larger, and often more complex, structures of biological products, as well as the process by which such products are manufactured, pose significant hurdles to implementation, which are still being worked out by the FDA. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Vicineum is approved by the FDA, the approval of a biologic product biosimilar to or interchangeable with Vicineum could have a material impact on Sesen Bio&#8217;s business. In particular, a biosimilar could be significantly less costly to bring to market and priced significantly lower than Sesen Bio&#8217;s products, if approved by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many countries, including E.U. countries, have compulsory licensing laws under which a patent owner may be compelled under certain circumstances to grant licenses to third parties. In those countries, Sesen Bio and its licensors may have limited remedies if patents are infringed or if Sesen Bio or its licensors are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit Sesen Bio&#8217;s potential revenue opportunities. Accordingly, Sesen Bio&#8217;s and its licensors&#8217; efforts to enforce intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that Sesen Bio owns or licenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has been dependent on its license agreements with the University of Zurich, or Zurich, Micromet AG, or Micromet, and XOMA Ireland Limited, or XOMA, and if Sesen Bio cannot meet the requirements under the agreements, it could lose important rights to Vicineum, which could have material adverse effect on Sesen Bio&#8217;s business if it resumes clinical development of Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has an exclusive license agreement with Zurich, or the Zurich License Agreement. Pursuant to the Zurich License Agreement, Sesen Bio was granted an exclusive license, with the right to sublicense, under certain patents primarily relating, in part, to Sesen Bio&#8217;s targeting agents, EpCAM chimera and immunoconjugates (including aspects of Vicineum for the treatment of NMIBC and Vicineum for the treatment of SCCHN) and methods of use, to make, use, sell and import products that would otherwise infringe such patents in the field of the treatment, stasis and palliation of disease in humans. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Sesen Bio fails to meet its obligations under the Zurich License Agreement, Zurich may have the right to terminate Sesen Bio&#8217;s license, and upon the effective date of such termination, Sesen Bio&#8217;s right to use the licensed Zurich patent rights would end. To the extent such licensed technology or patent rights relate to Sesen Bio&#8217;s product candidates, Sesen Bio would expect to exercise all rights and remedies available to it, including attempting to cure any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">breach by Sesen Bio, and otherwise seek to preserve its rights under the patent rights licensed to Sesen Bio, but it may not be able to do so in a timely manner, at an acceptable cost to Sesen Bio or at all. Any uncured, material breach under the Zurich License Agreement could result in Sesen Bio&#8217;s loss of rights to practice the patent rights licensed to it under the Zurich License Agreement, and to the extent such patent rights and other technology relate to its product candidates or other of its compounds, it could have a material adverse effect on Sesen Bio&#8217;s ability to complete a sale of its Vicineum asset to a potential partner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has a license agreement with Micromet, or the Micromet License Agreement, which grants it non-exclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Sesen Bio fails to meet its obligations under the Micromet License Agreement, Micromet may have the right to terminate Sesen Bio&#8217;s license, and upon the effective date of such termination, Sesen Bio&#8217;s right to use the licensed Micromet patent rights would end. To the extent such licensed technology or patent rights relate to Sesen Bio&#8217;s product candidates, Sesen Bio would expect to exercise all rights and remedies available to it, including attempting to cure any breach by Sesen Bio, and otherwise seek to preserve its rights under the patent rights licensed to it, but Sesen Bio may not be able to do so in a timely manner, at an acceptable cost to Sesen Bio or at all. Any uncured, material breach under the Micromet License Agreement could result in Sesen Bio&#8217;s loss of rights to practice the patent rights licensed to it under the Micromet License Agreement, and to the extent such patent rights and other technology relate to its product candidates or other of its compounds, it could have a material adverse effect on Sesen Bio&#8217;s ability to complete a sale of its Vicineum asset to a potential partner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has a license agreement with XOMA, or the XOMA License Agreement, which grants Sesen Bio non-exclusive rights, with certain sublicense rights, to certain XOMA patent rights and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Sesen Bio&#8217;s fails to meet its obligations under the XOMA License Agreement, XOMA may have the right to terminate Sesen Bio&#8217;s license, and upon the effective date of such termination, Sesen Bio&#8217;s right to use the licensed XOMA patent rights and related know-how would end. To the extent such licensed technology or patent rights relate to Sesen Bio&#8217;s product candidates, Sesen Bio would expect to exercise all rights and remedies available to it, including attempting to cure any breach by Sesen Bio, and otherwise seek to preserve its rights under the patent rights licensed to it, but Sesen Bio may not be able to do so in a timely manner, at an acceptable cost to Sesen Bio or at all. Any uncured, material breach under the XOMA License Agreement could result in Sesen Bio&#8217;s loss of rights to practice the patent rights licensed to it under the XOMA License Agreement, and to the extent such patent rights and other technology relate to Sesen Bio&#8217;s product candidates or other of its compounds, it could have a material adverse effect on Sesen Bio&#8217;s ability to complete a sale of its Vicineum asset to a potential partner. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio may become involved in lawsuits to protect or enforce its patents or other intellectual property, which could be expensive, time consuming and unsuccessful.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and Sesen Bio does not pursue a liquidation and dissolution or alternative strategic transaction, competitors may infringe Sesen Bio&#8217;s issued patents or other intellectual property. To counter infringement or unauthorized use, Sesen Bio may be required to file infringement claims, which can be expensive and time consuming. Any claims Sesen Bio asserts against perceived infringers could provoke these parties to assert counterclaims against it alleging that Sesen Bio infringes their patents, trademarks or other intellectual property. In addition, in a patent infringement proceeding, a court may decide that a patent of Sesen Bio&#8217;s is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly or refuse to stop the other party from using the technology at issue on the grounds that Sesen Bio&#8217;s patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of Sesen Bio&#8217;s patents at risk of being invalidated or interpreted narrowly. In a trademark infringement proceeding, Sesen Bio could be enjoined from continued use of a trademark deemed to be infringing and forced to rebrand product packaging, product inserts, market and advertising materials, resulting in a loss of sales and established goodwill in that name or mark. In addition, Sesen Bio could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if it is found to have willfully infringed a trademark. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of Sesen Bio&#8217;s confidential information could be compromised by disclosure during this type of litigation. Even if resolved in Sesen Bio&#8217;s favor, litigation or other legal proceedings relating to intellectual property claims may cause Sesen Bio to incur significant expenses and could distract its technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of Sesen Bio&#8217;s common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Third parties may initiate legal proceedings alleging that Sesen Bio is infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of Sesen Bio&#8217;s business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s only prospective revenue streams currently depends upon the ability of Roche to develop, manufacture, market and/or sell certain of Sesen Bio&#8217;s legacy technology without infringing the proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries. Sesen Bio or Roche may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to Sesen Bio&#8217;s current or former products and technology, including interference or derivation proceedings before the USPTO. The risks of being involved in such litigation and proceedings may increase as Sesen Bio gains the greater visibility associated with seeking strategic alternatives. Third parties may assert infringement claims against Sesen Bio or Roche based on existing patents or patents that may be granted in the future. Sesen Bio may not be aware of all such intellectual property rights potentially relating to its former product candidates and their uses. Thus, Sesen Bio does not know with certainty that any product candidate, or commercialization thereof, does not and will not infringe or otherwise violate any third party&#8217;s intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio or Roche are found to infringe a third party&#8217;s intellectual property rights, Sesen Bio could be required to obtain a license from such third party to continue developing and marketing Sesen Bio&#8217;s products and technology. However, Sesen Bio may not be able to obtain any required license on commercially reasonable terms or at all. Even if Sesen Bio were able to obtain a license, it could be non-exclusive, thereby giving its competitors access to the same technologies licensed to Sesen Bio. Sesen Bio or Roche could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, Sesen Bio or Roche could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if Sesen Bio or Roche is found to have willfully infringed a patent. A finding of infringement could prevent Roche from commercializing Sesen Bio&#8217;s former product candidates. Claims that Sesen Bio has misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on Sesen Bio&#8217;s ability to profit from the Roche Asset Purchase Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Regulatory Compliance if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s failure to comply with data protection laws and regulations could lead to government enforcement actions and significant penalties against Sesen Bio, and adversely impact its operating results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The regulatory environment surrounding information security, data collection, and privacy is increasingly demanding. In the U.S., Sesen Bio is subject to a number of data protection laws and regulations (i.e., laws and regulations that address privacy and data security) at both the federal and state levels. The legislative and regulatory landscape for data protection continues to evolve, and in recent&#160;years there has been an increasing focus on privacy and data security issues. Numerous federal and state laws, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws, such as Section&#160;5 of the Federal Trade Commission Act, govern the collection, use, and disclosure of health-related and other personal information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Sesen Bio may obtain health information from third parties that are subject to privacy and security requirements in the U.S. under the Health Insurance Portability and Accountability Act, or HIPAA. Although Sesen Bio is not directly subject to HIPAA&#8201;&#8212;&#8201;other than potentially with respect to providing certain employee benefits&#8201;&#8212;&#8201;Sesen Bio could be subject to criminal penalties if Sesen Bio knowingly obtains, uses or discloses individually identifiable health information maintained by a HIPAA-covered entity in a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">manner that is not authorized or permitted by HIPAA. Finally, a data breach affecting sensitive personal information, including health information, could result in significant legal and financial exposure and reputational damages that could potentially have an adverse effect on Sesen Bio&#8217;s business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to U.S. data protection laws and regulations, Sesen Bio also may be subject to European and other international data protection requirements, such as the E.U. General Data Protection Regulation. Sesen Bio failures to comply with data privacy and security laws and regulations, or changes in the way in which these laws are implemented, could lead to unfavorable outcomes, including increased compliance costs, delays or impediments in the development of new products, increased operating costs, diversion of management time and attention, regulatory liability as a result of government enforcement actions and significant penalties against Sesen Bio, civil liability as a result of claims initiated by data subjects (including claims initiated as class actions) contracting parties or other third parties as a result of non-compliance with data protection laws and/or contractual obligations, and adverse publicity that could negatively affect Sesen Bio&#8217;s operating results, financial condition and Sesen Bio&#8217;s overall and business. Federal regulators, state attorneys general, and plaintiffs&#8217; attorneys, including class action attorneys, have been and will likely continue to be active in this space. Such liabilities could adversely impact Sesen Bio&#8217;s results of operations, financial condition and its overall business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, laws and regulations governing any international operations Sesen Bio may have in the future may preclude Sesen Bio from developing, manufacturing and selling certain products outside of the U.S. and require Sesen Bio to develop and implement costly compliance programs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, Sesen Bio must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which Sesen Bio operates. The Foreign Corrupt Practices Act, or the FCPA, prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly or indirectly, to any non-U.S. official, political party or candidate for the purpose of influencing any act or decision of the non-U.S. entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the U.S. to comply with certain accounting provisions requiring Sesen Bio to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered non-U.S. officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Various laws, regulations and executive orders also restrict the use and dissemination outside of the U.S., or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, and if Sesen Bio expands its presence outside of the U.S., it will require Sesen Bio to dedicate additional resources to comply with these laws, and these laws may preclude Sesen Bio from developing, manufacturing, or selling certain products and product candidates outside of the U.S., which could limit Sesen Bio&#8217;s growth potential and increase its development costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, Sesen Bio&#8217;s employees may engage in misconduct or other improper </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">activities, including non-compliance with regulatory standards and requirements, which could cause significant liability for Sesen Bio and harm its reputation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, Sesen Bio could be exposed to the risk of employee fraud or other misconduct, including intentional failure to comply with FDA regulations or similar regulations of comparable non-U.S. regulatory authorities, failure to provide accurate information to the FDA or comparable non-U.S. regulatory authorities, including the competent authorities of the E.U. member states, failure to comply with manufacturing standards Sesen Bio has established, if any, failure to comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable non-U.S. regulatory authorities, and failure to report financial information or data accurately or disclose unauthorized activities to Sesen Bio. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to Sesen Bio&#8217;s reputation. It is not always possible to identify and deter employee misconduct, and the precautions Sesen Bio takes to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting Sesen Bio from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards or regulations. If any such actions are instituted against Sesen Bio, and it is not successful in defending itself or asserting its rights, those actions could have a significant impact on its business and results of operations, including the imposition of significant fines or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Business if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio relies significantly on information technology and any failure, inadequacy, interruption or security lapse of that technology, including any cyber security incidents, could materially adversely affect its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the ordinary course of business, Sesen Bio relies on information technology networks and systems, some of which are provided, hosted or managed by third parties, to collect, store, process and transmit electronic data. In addition, Sesen Bio handles certain data, including proprietary business information and personal information that is subject to data protection laws and regulations. Despite the implementation of security measures, Sesen Bio&#8217;s internal computer systems and those of third parties with which it contracts are vulnerable to damage from cyber-attacks, computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. System failures, accidents or security breaches could cause interruptions in Sesen Bio&#8217;s operations and could result in a material disruption of its clinical and commercialization activities, if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and business operations, in addition to possibly requiring substantial expenditures of resources to remedy. The loss of clinical trial data could result in delays in Sesen Bio&#8217;s regulatory approval efforts, if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and significantly increase its costs to recover or reproduce the data. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although Sesen Bio has implemented processes, procedures, and controls to help mitigate the risks associated with a cyber security incident, there can be no assurance that these measures will be sufficient for all possible situations. Even security measures that are appropriate, reasonable, and/or in accordance with applicable legal requirements may not be able to protect the networks, systems and information that Sesen Bio maintains and those of third parties with which Sesen Bio contracts. Unauthorized parties, whether within or outside Sesen Bio, may disrupt or gain access to its systems, or those of third parties with whom Sesen Bio does business, through human error, misfeasance, fraud, trickery or other forms of deceit, including break-ins, use of stolen credentials, social engineering, phishing, ransomware, computer viruses or other malicious codes, and similar means of unauthorized and destructive tampering. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted cyber security incidents evolve and generally are not recognized until launched against a target. Accordingly, Sesen Bio may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, making it impossible for Sesen Bio to entirely mitigate this risk. While Sesen Bio has experienced, and expects to continue to experience, threats and disruptions to its information technology infrastructure, none of them to date has had a material impact on its business or operations. To the extent that any disruption or security breach were to result in a loss of, or damage to, its data or applications, or inappropriate disclosure of confidential or proprietary information, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">its clinical development of Vicineum for the treatment of NMIBC could be delayed if Sesen Bio resumes such clinical development, or Sesen Bio could be subject to regulatory and other government investigations, enforcement actions, or incur liability, substantial fines or costs, any of which could materially adversely affect its business, its reputation, results of operations and financial condition. Although Sesen Bio maintains insurance coverage for various cyber security risks, there can be no guarantee that all costs or losses incurred will be fully insured. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio and certain of its officers have been named as defendants in three pending securities class action lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert Sesen Bio management&#8217;s time and attention from Sesen Bio&#8217;s business, and have a material adverse effect on Sesen Bio&#8217;s results of operations. These lawsuits, and any other lawsuits to which Sesen Bio is subject, will be costly to defend and are uncertain in their outcome.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7, 2021, three substantially identical securities class action lawsuits captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Bibb v. Sesen Bio, Inc., et. al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07025, </font><font style="font-style:italic;letter-spacing:0.2pt;">Cizek v. Sesen Bio, Inc., et.&#160;al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07309 and </font><font style="font-style:italic;letter-spacing:0.2pt;">Markman v. Sesen Bio, Inc. et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-08308 were filed against Sesen Bio and certain of its officers in the U.S. District Court for the Southern District of New York. The three complaints alleged violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by Sesen Bio concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints sought compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption </font><font style="font-style:italic;letter-spacing:0.2pt;">In re Sesen Bio, Inc. Securities Litigation</font><font style="letter-spacing:0.2pt;">, Master File No. 1:21-cv-07025-AKH, or the Securities Litigation, and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj as the lead plaintiffs, or collectively, the Lead Plaintiffs, under the Private Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. On November&#160;24, 2021, defendants filed a motion to transfer venue to the U.S. District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed an amended class action complaint, or the Amended Complaint. The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. The defendants moved to dismiss the Amended Complaint on March&#160;7, 2022, and that motion was fully briefed on May&#160;6, 2022. On June&#160;3, 2022, before the court ruled on the motion to dismiss, the parties requested that the court hold any decision on the motion to dismiss in abeyance to provide the parties with an opportunity to engage in mediation. On June&#160;30, 2022 and July&#160;6, 2022, Sesen Bio and the plaintiffs engaged in mediation sessions in an attempt to resolve the Securities Litigation and continued to discuss a potential settlement over the following weeks. On July&#160;19, 2022, the parties reached an agreement in principle to settle the Securities Litigation. Pursuant to that agreement, Sesen Bio and the individual defendants will pay or cause to be paid to members of the class who submit timely and valid proofs of claims. In exchange, the Lead Plaintiffs will dismiss the action and all class members who do not timely and validly opt-out of the settlement will provide broad customary releases to Sesen Bio and the individual defendants. On August&#160;3, 2022, the parties entered into a Stipulation and Agreement of Settlement to settle the Securities Litigation, which was filed with the court on August&#160;17, 2022. The Stipulation and Agreement of Settlement related to the Securities Litigation provides for a settlement payment of $21.0&#160;million to the class and the dismissal of all claims against Sesen Bio and the other defendants. The settlement payment is being funded by Sesen Bio and its insurance carriers. On September&#160;1, 2022, the U.S. District Court for the Southern District of New York issued an order denying the motions to appoint a different lead plaintiff. On September&#160;28, 2022, the court issued an order granting preliminary approval of the proposed settlement of the Securities Litigation. The court has set a final settlement approval hearing for January&#160;23, 2023 at 10:00&#160;a.m. local time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, the Sesen Bio board of directors and the individual defendants continue to deny all allegations of any wrongdoing, but are seeking to settle the Securities Litigation to avoid the uncertainty, risk, expense and distraction of protracted litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio may be the target of similar litigation in the future. The market price of its common stock has experienced and may continue to experience volatility, and in the past, companies that have experienced volatility in the market price of their stock have been subject to securities litigation. Any future litigation could result in substantial costs and divert Sesen Bio management&#8217;s attention from other business concerns, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">which could seriously harm its business. Sesen Bio maintains liability insurance; however, if any costs or expenses associated with the pending lawsuits or any other litigation exceed Sesen Bio&#8217;s insurance coverage, Sesen Bio may be forced to bear some or all costs and expenses directly, which could adversely affect its business, financial condition, results of operations or stock price. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Ownership of Sesen Bio Common Stock if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio is unable to regain compliance with the listing requirements of the Nasdaq Capital Market, Sesen Bio common stock may be delisted from the Nasdaq Capital Market which could have a material adverse effect on Sesen Bio&#8217;s business and could make it more difficult for Sesen Bio stockholders to sell their shares of Sesen Bio common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is listed on the Nasdaq Capital Market, and Sesen Bio is therefore subject to Nasdaq&#8217;s continued listing requirements, including requirements with respect to the market value of publicly-held shares, market value of listed shares, minimum bid price per share, and minimum stockholders&#8217; equity, among others, and requirements relating to board and committee independence. If Sesen Bio fails to satisfy one or more of the requirements, it may be delisted from the Nasdaq Capital Market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;24, 2022, Sesen Bio received notice from Nasdaq that it was not currently in compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule&#160;5450(a)(1). The Nasdaq notice indicated that, consistent with Nasdaq Listing Rule&#160;5810(c)(3)(A), Sesen Bio had 180 calendar days, or until July&#160;25, 2022, to regain compliance with the minimum bid price requirement by having the closing bid price of Sesen Bio common stock meet or exceed $1.00 per share for at least ten consecutive business days. On July&#160;26, 2022, Sesen Bio received approval to transfer the listing of Sesen Bio common stock from the Nasdaq Global Market to the Nasdaq Capital Market. As a result, Sesen Bio was granted a second 180-day grace period, or until January&#160;23, 2023, to regain compliance with the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio does not regain compliance by January&#160;23, 2023, it will receive notification from Nasdaq that Sesen Bio common stock is subject to delisting. At that time, Sesen Bio plans to appeal the delisting determination to a Nasdaq hearings panel. Such notification will have no immediate effect on Sesen Bio&#8217;s listing on the Nasdaq Capital Market, nor will it have an immediate effect on the trading of Sesen Bio common stock pending such hearing. However, there can be no assurance that Sesen Bio will be able to regain compliance with Nasdaq&#8217;s minimum bid price requirement. If Sesen Bio regains compliance with Nasdaq&#8217;s minimum bid price requirement, there can be no assurance that Sesen Bio will be able to maintain compliance with the continued listing requirements for the Nasdaq Capital Market or that Sesen Bio common stock will not be delisted from the Nasdaq Capital Market in the future. In addition, Sesen Bio may be unable to meet other applicable listing requirements of the Nasdaq Capital Market, including maintaining minimum levels of stockholders&#8217; equity or market values of Sesen Bio common stock in which case, Sesen Bio common stock could be delisted notwithstanding Sesen Bio&#8217;s ability to demonstrate compliance with the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Delisting from the Nasdaq Capital Market would adversely affect Sesen Bio&#8217;s ability to consummate the merger and may adversely affect Sesen Bio&#8217;s ability to raise additional financing through the public or private sale of equity securities, significantly affect the ability of investors to trade Sesen Bio common stock, or negatively affect the value and liquidity of Sesen Bio common stock. Delisting also could have other negative results, including the potential loss of employee confidence, the loss of institutional investors or interest in business development opportunities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio is delisted from Nasdaq and Sesen Bio is not able to list Sesen Bio common stock on another exchange, Sesen Bio common stock could be quoted on the OTC Bulletin Board or in the &#8220;pink sheets.&#8221; As a result, Sesen Bio could face significant adverse consequences including, among others: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a limited availability of market quotations for Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a determination that Sesen Bio common stock is a &#8220;penny stock&#8221; which will require brokers trading in Sesen Bio common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for Sesen Bio&#8217;s securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a limited amount of news and little or no analyst coverage for Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio would no longer qualify for exemptions from state securities registration requirements, which may require Sesen Bio to comply with applicable state securities laws; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a decreased ability to issue additional securities (including pursuant to short-form registration statements on Form S-3) or obtain additional financing in the future. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio common stock becomes subject to the penny stock rules, it would become more difficult to trade shares of Sesen Bio common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If Sesen Bio does not retain its listing on Nasdaq and if the price of Sesen Bio common stock is less than $5.00, Sesen Bio common stock may be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i)&#160;the purchaser&#8217;s written acknowledgment of the receipt of a risk disclosure statement; (ii)&#160;a written agreement to transactions involving penny stocks; and (iii)&#160;a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for Sesen Bio common stock, and therefore stockholders may have difficulty selling their shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Provisions in the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws and under Delaware law could make an acquisition of Sesen Bio, which may be beneficial to Sesen Bio stockholders, more difficult and may prevent attempts by Sesen Bio stockholders to replace or remove Sesen Bio&#8217;s current management.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Provisions in the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws may discourage, delay or prevent a merger, acquisition or other change in control of Sesen Bio that Sesen Bio stockholders may consider favorable, including transactions in which Sesen Bio stockholders might otherwise receive a premium for their shares of Sesen Bio common stock. These provisions could also limit the price that investors might be willing to pay in the future for shares of Sesen Bio common stock, thereby depressing the market price of Sesen Bio common stock. In addition, because the Sesen Bio board of directors is responsible for appointing the members of Sesen Bio&#8217;s management team, these provisions may frustrate or prevent any attempts by Sesen Bio stockholders to replace or remove Sesen Bio&#8217;s current management by making it more difficult for Sesen Bio stockholders to replace members of the Sesen Bio board of directors. Among other things, these provisions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establish a classified board of directors such that only one of three classes of directors is elected each year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">allow the authorized number of directors to be changed only by resolution of the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">limit the manner in which stockholders can remove directors from the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">require that Sesen Bio stockholder actions must be affected at a duly called stockholder meeting and prohibit actions by Sesen Bio stockholders by written consent; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">limit who may call stockholder meetings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">authorize the Sesen Bio board of directors to issue preferred stock without stockholder approval, which could be used to institute a &#8220;poison pill&#8221; that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by the Sesen Bio board of directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRRTC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">require the approval of the holders of at least 75% of the votes that all Sesen Bio stockholders would be entitled to cast to amend or repeal specified provisions of the Sesen Bio Certificate of Incorporation or Sesen Bio Bylaws. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, because Sesen Bio is incorporated in Delaware, Sesen Bio is governed by the provisions of Section&#160;203 of the DGCL, which prohibits a person who owns in excess of 15% of Sesen Bio&#8217;s outstanding voting stock from merging or combining with Sesen Bio for a period of three&#160;years after the date of the transaction in which the person acquired in excess of 15% of Sesen Bio&#8217;s outstanding voting stock, unless the merger or combination is approved in a prescribed manner. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Financial Position and Need for Additional Capital</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma has incurred significant losses since its inception. Carisma expects to continue to incur significant expenses and operating losses for the foreseeable future and may never achieve or maintain profitability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since inception, Carisma has incurred significant operating losses. Carisma&#8217;s net losses were $40.8&#160;million for the year ended December&#160;31, 2021 and $28.3&#160;million for the year ended December&#160;31, 2020. As of September&#160;30, 2022, Carisma had $70.6&#160;million in cash, cash equivalents and marketable securities and an accumulated deficit of $141.5&#160;million. To date, Carisma has not yet commercialized any products or generated any revenue from product sales and has financed its operations primarily with proceeds from sales of Carisma&#8217;s preferred stock, proceeds from Carisma&#8217;s collaboration with Moderna, research tax credits and convertible debt financing. Carisma has devoted substantially all of its financial resources and efforts to pursuing discovery, research and development of its product candidates. Carisma is still in the early stages of development of its lead product candidate, CT-0508, and initiated its first clinical trial in 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to continue to incur significant expenses and operating losses for the foreseeable future. Upon the closing of the merger, Carisma will also incur additional costs associated with operating as a public company. Carisma anticipates that its expenses will increase substantially if and as it: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enhances the capabilities of its CAR-M platform; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducts its ongoing Phase&#160;1 clinical trial of CT-0508; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial utilizing CT-0508 in combination with pembrolizumab; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">develops other CT-0508 combination studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">advances CT-0508 for additional indications or any other product candidate into clinical development; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial of CT-0525 for solid tumors that overexpress HER2;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial of CT-1119 for advanced mesothelin-positive solid tumors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial of CT-0729 for PSMA positive castrate resistant prostate cancer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducts discovery and pre-clinical testing of the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics for up to twelve oncology targets, as well as multiple other targets and indications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducts discovery and pre-clinical testing of its autologous cell therapy pipeline to gather information to apply to the development of off-the-shelf engineered macrophage therapeutics; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">develops iPSC-derived iCAR-M, or iCAR-M, and other macrophage therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">develops </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed LNP/mRNA CAR-M therapies for cancer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">develops viral vectors to effectively engineer human monocytes and macrophages, including the Vpx lentiviral vector and Carisma&#8217;s Ad5f35 vector; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducts discovery and pre-clinical testing of other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seeks marketing approval for CT-0508 or any other product candidate if it successfully completes clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">scales up its external manufacturing capabilities and capabilities to support clinical trials of CT-0508 or any other product candidates and for commercialization of any product candidate for which it may obtain marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishes a sales, marketing and distribution infrastructure to commercialize any product candidate for which it may obtain marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in-licenses or acquires additional technologies or product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">makes any payments under its existing or future strategic collaboration agreements, global exclusive rights licensing agreements or sponsored research agreements, including with Moderna, University of Pennsylvania and New York University; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintains, expands, enforces and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">hires additional clinical, regulatory, manufacturing, quality control, development and scientific personnel; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adds operational, financial and management information systems and personnel, including personnel to support its discovery, product development and planned future commercialization efforts and its operations as a public company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because of the numerous risks and uncertainties associated with pharmaceutical product development, Carisma is unable to accurately predict the timing or amount of increased expenses or when, or if, it will be able to achieve or maintain profitability. Carisma&#8217;s expenses could increase beyond its expectations if, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma is required by regulatory authorities in the United States, Europe or other jurisdictions to perform trials or studies in addition to, or different than, those that it currently expects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there are any delays in establishing appropriate manufacturing arrangements for or completing the development of any of Carisma&#8217;s product candidates; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there are any third-party challenges to Carisma&#8217;s intellectual property or Carisma needs to defend against any intellectual property-related claim. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Carisma obtains marketing approval for and is successful in commercializing one or more of its product candidates, Carisma expects to incur substantial additional discovery and product development and other expenditures to develop and market additional product candidates or to expand the approved indications of any marketed product. Carisma may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect its business. The size of Carisma&#8217;s future net losses will depend, in part, on the rate of future growth of its expenses and Carisma&#8217;s ability to generate revenue. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma has never generated revenue from product sales and may never achieve or maintain profitability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma only recently initiated clinical development of its lead product candidate, CT-0508, and is in the pre-clinical testing stages for its other product candidates. Carisma expects that it will be a number of&#160;years, if ever, before it has a product candidate ready for commercialization. To become and remain profitable, Carisma must succeed in completing development of, obtaining marketing approval for and eventually commercializing, one or more products that generate significant revenue. The ability to achieve this success will require Carisma to be effective in a range of challenging activities, including completing clinical development of CT-0508, completing discovery, pre-clinical testing and clinical development of CT-0508 in the combination setting and for additional indications, timely filing and receiving acceptance of its Investigational New Drug applications, or INDs, in order to commence its planned or future clinical trials, including for CT-0525, CT-1119 and, CT-0729, successfully enrolling subjects in, and completing, its ongoing and planned clinical trials, scaling up its manufacturing processes and capabilities to support clinical trials </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of CT-0508 or of other product candidates, obtaining marketing approval for CT-0508 or any other product candidates, manufacturing, marketing and selling any products for which Carisma may obtain marketing approval and maintaining a continued acceptable safety profile of its products following approval. Carisma may never succeed in these activities and, even if it does, may never generate revenues that are significant enough to achieve profitability. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Carisma does achieve profitability, it may not be able to sustain or increase profitability on a quarterly or annual basis. Carisma&#8217;s failure to become and remain profitable would depress the value of its company and could impair its ability to raise capital, expand its business, maintain its discovery and product development efforts, diversify its pipeline of product candidates or even continue its operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is heavily dependent on the success of its lead product candidate, CT-0508, which will require significant clinical testing before it can seek marketing approval and potentially launch commercial sales. If CT-0508 does not receive marketing approval or is not successfully commercialized, or if there is significant delay in doing so, Carisma&#8217;s business will be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma only recently initiated its first clinical trial, has no products that are approved for commercial sale and may never be able to develop marketable products. Carisma expects that a substantial portion of its efforts and expenditures for the foreseeable future will be devoted to CT-0508 and related combination sub-studies of the synergistic potential and utility of CT-0508. Carisma&#8217;s business currently depends heavily on the successful development, marketing approval and commercialization of CT-0508 and the success of related combination sub-studies. Carisma cannot be certain that CT-0508 or any combination therapy will achieve success in ongoing or future clinical trials, receive marketing approval or be successfully commercialized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma were required to discontinue development of CT-0508, or if CT-0508 does not receive marketing approval for one or more of the indications Carisma pursues, fails to achieve significant market acceptance, or fails to receive adequate reimbursement, Carisma may be delayed by many&#160;years in its ability to achieve profitability, if ever, and may not be able to generate sufficient revenue to continue its business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma will need substantial additional funding for its continuing operations. If Carisma is unable to raise capital when needed or on acceptable terms, it could be forced to delay, reduce or eliminate its discovery or product development programs or commercialization efforts.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to devote substantial financial resources to its ongoing and planned activities, particularly as it conducts its ongoing clinical trial of CT-0508 and pursues related combination strategies, prepares for, initiates and conducts its planned clinical trials of CT-0525, CT-1119 and CT-0729 and advances its discovery programs and continues its product development efforts. Carisma expects its expenses to increase substantially in connection with its ongoing activities, particularly as it advances its pre-clinical activities and clinical trials. In addition, if Carisma obtains marketing approval for CT-0508 or any other product candidate it is developing or develops in the future, it expects to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution. Furthermore, upon the closing of the merger, it expects to incur additional costs associated with operating as a public company. Accordingly, Carisma will need to obtain substantial additional funding in connection with its continuing operations. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. In addition, attempting to secure additional financing may divert the time and attention of Carisma management from day-to-day activities and distract from its discovery and product development efforts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the progress, costs and results of its ongoing clinical trial of CT-0508 and other planned and future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope, progress, costs and results of pre-clinical testing and clinical trials of CT-0508 for additional combinations, targets and indications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of and development requirements for additional indications for CT-0508 or for any other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the success of its collaborations with Moderna or others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its ability to scale up its manufacturing processes and capabilities to support clinical trials of CT-0508 and other product candidates it is developing and develops in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of regulatory review of CT-0508 and other product candidates it is developing and may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential changes in the regulatory environment and enforcement rules; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the payment of license fees and other costs of its technology license arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of future commercialization activities, including product manufacturing, sales, marketing and distribution, for CT-0508 and other product candidates it is developing and may develop in the future for which it may receive marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its ability to obtain and maintain acceptance of any approved products by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the amount and timing of revenue, if any, received from commercial sales of CT-0508 and any other product candidates it is developing or develops in the future for which it receives marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential changes in pharmaceutical pricing and reimbursement infrastructure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of raw materials for use in production of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing its intellectual property and proprietary rights and defending any intellectual property-related claims; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which it in-licenses or acquires additional technologies or product candidates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma management has concluded that there is substantial doubt about Carisma&#8217;s ability to continue as a going concern. As a result, Carisma management has included disclosures in Note 2 of the consolidated financial statements and Carisma&#8217;s independent auditor included an explanatory paragraph in its report on Carisma&#8217;s consolidated financial statements as of and for the year ended December&#160;31, 2021 with respect to this uncertainty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Carisma had cash, cash equivalents and marketable securities of $70.6&#160;million. Immediately prior to the consummation of the merger, certain investors have agreed to purchase shares of Carisma common stock for an aggregate purchase price of approximately $30.6&#160;million. Carisma believes that following consummation of the pre-closing financing and the merger, it will have cash, cash equivalents and marketable securities sufficient to sustain its operating expenses and capital expenditure requirements at least through the end of 2024. However, Carisma has based this estimate on assumptions that may prove to be wrong, and its operating plan may change as a result of many factors currently unknown to Carisma. In addition, changing circumstances could cause Carisma to consume capital significantly faster than it currently anticipates, and Carisma may need to spend more than currently expected because of circumstances beyond its control. As a result, Carisma could deplete its capital resources sooner than it currently expects. In addition, because the successful development of CT-0508, CT-0525, CT-1119, CT-0729 and any combination studies or other product candidates that it pursues is highly uncertain, at this time Carisma cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the development of any product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Identifying potential product candidates and conducting pre-clinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes&#160;years to complete, and Carisma may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, Carisma&#8217;s product candidates, if approved, may not achieve commercial success. Carisma will not generate </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">commercial revenues unless and until it can achieve sales of products, which it does not anticipate for a number of&#160;years, if at all. Accordingly, Carisma will need to obtain substantial additional financing to achieve its business objectives. Adequate additional financing may not be available to Carisma on acceptable terms, or at all, and may be impacted by the economic climate and market conditions. For example, market volatility resulting from the COVID-19 pandemic, any other future infectious diseases, epidemics or pandemics or general U.S. or global economic or market conditions could also adversely impact Carisma&#8217;s ability to access capital as and when needed. Alternatively, Carisma may seek additional capital due to favorable market conditions or strategic considerations, even if it believes it has sufficient funds for its current or future operating plans. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s limited operating history may make it difficult for you to evaluate the success of Carisma&#8217;s business to date and to assess the combined company&#8217;s future viability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma was formed as Carma Therapeutics LLC, a Pennsylvania limited liability company, in April&#160;2016 and converted to a Delaware corporation in May&#160;2017. Carisma is a clinical-stage cell therapy company with a limited operating history. Cell therapy product development is a highly speculative undertaking and involves a substantial degree of risk. Carisma&#8217;s operations to date have been limited to organizing and staffing its company, business planning, capital raising, establishing and maintaining its intellectual property portfolio, building its pipeline of product candidates, conducting drug discovery activities, undertaking pre-clinical studies, manufacturing process development studies, conducting early-stage clinical trials, and providing general and administrative support for these operations. Carisma&#8217;s prospects must be considered in light of the uncertainties, risks, expenses and difficulties frequently encountered by companies in their early stages of operations. Carisma has not yet demonstrated its ability to successfully develop any product candidate, obtain marketing approvals, manufacture a commercial scale product or arrange for a third party to do so on its behalf, or conduct sales, marketing and distribution activities necessary for successful product commercialization. Consequently, any predictions you make about the combined company&#8217;s future success or viability may not be as accurate as they could be if Carisma had a longer operating history or a history of successfully developing, obtaining marketing approval for and commercializing products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, as Carisma&#8217;s business grows, Carisma may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown obstacles. Carisma will need to transition at some point from a company with a discovery and pre-clinical and clinical focus to a company capable of supporting commercial activities. Carisma may not be successful in such a transition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As Carisma continues to build its business, Carisma expects its financial condition and operating results to fluctuate significantly from quarter to quarter and year to year due to a variety of factors, many of which are beyond Carisma&#8217;s control. Accordingly, you should not rely upon the results of any quarterly or annual periods as indications of future operating performance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The COVID-19 pandemic may affect Carisma&#8217;s pre-clinical studies and clinical trials, disrupt regulatory activities, disrupt Carisma&#8217;s manufacturing and supply chain or have other adverse effects on Carisma&#8217;s business and operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The COVID-19 pandemic has caused many governments to implement measures to slow the spread of the virus through quarantines, travel restrictions, heightened border scrutiny and other measures. The pandemic and government measures taken in response have also had a significant impact, both directly and indirectly, on businesses and commerce, as worker shortages have occurred; supply chains have been disrupted; facilities and production have been suspended; and demand for certain goods and services, such as medical services and supplies, has spiked, while demand for other goods and services, such as travel, has fallen. The future progression of the pandemic and its effects on Carisma&#8217;s business and operations are uncertain. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma and the third-party manufacturers and clinical research organizations that it engages may face disruptions that could affect Carisma&#8217;s ability to initiate and complete pre-clinical studies or clinical trials, including disruptions in procuring items that are essential for Carisma&#8217;s discovery and product development activities, such as, for example, raw materials used in the manufacturing of its product candidates, laboratory </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">supplies for its ongoing and planned pre-clinical studies and clinical trials, or animals that are used for pre-clinical testing, in each case, for which there may be shortages because of ongoing efforts to address the pandemic, or disruptions in Carisma&#8217;s ability to obtain necessary site approvals or other delays at clinical trial sites. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of the COVID-19 pandemic, Carisma may experience further disruptions that could severely impact Carisma&#8217;s business, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disruptions related to Carisma&#8217;s ongoing and planned clinical trials or future clinical trials arising from delays in completing pre-clinical studies required to begin clinical development; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">manufacturing disruptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability to obtain necessary site approvals or other delays at clinical trial sites; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as Carisma&#8217;s clinical trial sites and hospital staff supporting the conduct of Carisma&#8217;s clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on travel imposed or recommended by foreign, federal or state governments, employers and others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">interruption of clinical trial subject visits and study procedures, which may impact the integrity of subject data and clinical study endpoints; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">interruption or delays in the operations of the FDA, or other regulatory authorities, which may impact review and approval timelines; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">limitations on employee resources that would otherwise be focused on the conduct of Carisma&#8217;s pre-clinical studies and clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">difficulties recruiting or retaining patients for Carisma&#8217;s clinical trials if patients are affected by the virus or are fearful of visiting or traveling to clinical trial sites because of the virus; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">risk that participants enrolled in its clinical trials will acquire COVID-19 while the clinical trial is ongoing, which could impact the results of the clinical trial, including by increasing the number of observed adverse events and refusal of the FDA, to accept data from clinical trials in these affected geographies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The response to the COVID-19 pandemic may redirect resources with respect to regulatory and intellectual property matters in a way that would adversely impact its ability to pursue marketing approvals and protect its intellectual property. In addition, Carisma may face impediments to regulatory meetings and potential approvals due to measures intended to limit in-person interactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, third parties, including manufacturers, medical institutions, clinical investigators, contract research organizations and consultants with whom Carisma conducts business, are similarly adjusting their operations and assessing their capacity in light of the COVID-19 pandemic. If these third parties continue to experience shutdowns or business disruptions, Carisma&#8217;s ability to conduct its business in the manner and on the timelines presently planned could be materially and negatively impacted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The COVID-19 pandemic continues to evolve and has already caused significant disruptions in the financial markets, and may continue to cause such disruptions, which could impact Carisma&#8217;s ability to raise additional funds through public offerings and may also impact the volatility of Carisma&#8217;s stock price and trading in its stock. Moreover, it is possible the pandemic will further significantly impact economies worldwide, which could result in adverse effects on Carisma&#8217;s business and operations. Carisma cannot be certain what the overall impact of the COVID-19 pandemic will be on its business, and it has the potential to materially and adversely affect Carisma&#8217;s business, financial condition, results of operations and prospects. To the extent the COVID-19 pandemic adversely affects Carisma&#8217;s business, financial condition and results of operations, it may also have the effect of heightening many of the other risks and uncertainties described in this &#8220;Risk Factors&#8221; section. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in tax law may adversely affect Carisma or its investors.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The rules dealing with U.S. federal, state and local income taxation are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect Carisma or holders of Carisma&#8217;s common stock. In recent&#160;years, many such changes have been made and changes are likely to continue to occur in the future. It cannot be predicted whether, when, in what form or with what effective dates tax laws, regulations and rulings may be enacted, promulgated or issued, which could result in an increase in Carisma&#8217;s or its stockholders&#8217; tax liability or require changes in the manner in which Carisma operates in order to minimize or mitigate any adverse effects of changes in tax law. Prospective investors should consult their tax advisors regarding the potential consequences of changes in tax law on Carisma&#8217;s business and on the ownership and disposition of Carisma common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s ability to use its net operating loss carryforwards, or NOLs, and research and development tax credit carryforwards to offset future taxable income may be subject to certain limitations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has a history of cumulative losses and anticipates that it will continue to incur significant losses in the foreseeable future. As a result, Carisma does not know whether or when it will generate taxable income necessary to utilize its NOLs or research and development tax credit carryforwards. As of December&#160;31, 2021, Carisma had federal, state and local NOLs of $76.4&#160;million, $76.4&#160;million and $71.2&#160;million, respectively, and federal research and development tax credit carryforwards totaling $3.9&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, under Section&#160;382 of the Code and corresponding provisions of state law, a corporation that undergoes an &#8220;ownership change,&#8221; generally defined as a greater than 50&#160;percentage point change (by value) in its equity ownership by certain stockholders over a three year period, is subject to limitations on its ability to utilize its pre-change NOLs and research and development tax credit carryforwards to offset future taxable income. Carisma has not conducted a study to assess whether any such ownership changes have occurred. Carisma may have experienced such ownership changes in the past and may experience such ownership changes in the future (which may be outside its control). As a result, if and to the extent Carisma earns net taxable income, its ability to use its pre-change NOLs and research and development tax credit carryforwards to offset such taxable income may be subject to limitations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Discovery Programs and Research and Development of Carisma&#8217;s Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cell therapy is a rapidly evolving area of science, and the approach Carisma is taking to discover and develop product candidates by utilizing genetically modified macrophages is novel and may never lead to approved or marketable products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cell therapy has yet to be broadly applied to solid tumors, inflammatory disease, fibrotic disease or neurodegeneration. The discovery, research and development of engineered macrophages to treat disease is an emerging field and Carisma&#8217;s CAR-M platform, which is the first CAR-M to be evaluated in a human clinical trial, is a relatively new technology. Carisma&#8217;s future success depends on the successful development of this novel therapeutic approach. The scientific evidence to support the feasibility of developing product candidates based on these discoveries is both preliminary and limited. Carisma has only preliminary results from its Phase&#160;1 clinical trial of CT-0508 and expects clinical updates in the next 18&#160;months. As such, there may be adverse effects or limited favorable results from treatment with any of Carisma&#8217;s current or future product candidates that it cannot predict at this time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s success also depends on its successful application of its proprietary macrophage engineering platform in the combination setting and to other indications by reprogramming the target specificity of its CAR-M cell product and developing product candidates against a plethora of tumor associated antigens, including in therapeutic areas beyond oncology. However, Carisma&#8217;s macrophage engineering platform may not allow it to generate new INDs to expand its pipeline on Carisma&#8217;s anticipated timeline or in a cost-efficient manner or at all, which could cause the potential value of Carisma&#8217;s business to decline and materially harm Carisma&#8217;s business prospects. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of these factors, it is more difficult for Carisma to predict the time and cost of product candidate development, and Carisma cannot predict whether the application of macrophage engineering platform will result in the development and marketing approval of any products. Any development problems Carisma experiences in the future related to its macrophage engineering platform or any of its discovery programs may cause significant delays or unanticipated costs or may prevent the development of a commercially viable product. Any of these factors may prevent Carisma from completing its clinical trials or pre-clinical studies or commercializing any product candidates it may develop on a timely or profitable basis, if at all. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is early in its development efforts. If Carisma is unable to commercialize its product candidates or experiences significant delays in doing so, its business will be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is early in its development efforts. Carisma initiated its first Phase&#160;1 clinical trial of CT-0508 in 2021 and expects to evaluate a combination of CT-0508 with pembrolizumab in an upcoming Phase&#160;1 clinical trial. Carisma expects to submit INDs for CT-0525 in the third quarter of 2023 and for CT-1119 in 2025. CT-0729 is still in the discovery stage. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to generate revenues from product sales, which it does not expect will occur for a number of&#160;years, if ever, will depend heavily on the successful development, marketing approval and eventual commercialization of CT-0508, including in the combination setting, or one or more of its other product candidates, which may never occur. The success of CT-0508 and Carisma&#8217;s other product candidates will depend on several factors, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully completing pre-clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully initiating future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully enrolling patients in and completing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">scaling up manufacturing processes and capabilities to support clinical trials of CT-0508 and any other product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">applying for and receiving marketing approvals from applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining and maintaining intellectual property protection and regulatory exclusivity for CT-0508 and any other product candidates it is developing or may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">making arrangements with third-party manufacturers, or establishing commercial manufacturing capabilities, for both clinical and commercial supplies of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing sales, marketing and distribution capabilities and launching commercial sales of its products, if and when approved, whether alone or in collaboration with others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acceptance of CT-0508 and any other product candidates, if and when approved, by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">effectively competing with other therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining and maintaining coverage, adequate pricing and adequate reimbursement from third-party payors, including government payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintaining, enforcing, defending and protecting its rights in its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">not infringing, misappropriating or otherwise violating others&#8217; intellectual property or proprietary rights; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintaining a continued acceptable safety profile of its products following receipt of any marketing approvals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma does not achieve one or more of these factors in a timely manner or at all, it could experience significant delays or an inability to successfully develop and commercialize its product candidates, which would materially harm Carisma&#8217;s business. As a company, Carisma has limited experience in clinical development, having only recently advanced CT-0508 into an early-stage clinical trial. Any predictions </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">about the future success or viability of CT-0508 or any product candidates Carisma is developing or may develop in the future may not be as accurate as they could be if Carisma had a history of conducting clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Drug development involves a lengthy and expensive process, with an uncertain outcome. The results of pre-clinical studies and early clinical trials may not be predictive of future results. Carisma may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of CT-0508 or its other product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma only recently initiated its first clinical trial of CT-0508 and its other product candidates are in pre-clinical development. The risk of failure for CT-0508 and Carisma&#8217;s other product candidates is high. It is impossible to predict when or if CT-0508 or any of Carisma&#8217;s other product candidates will prove effective or safe in humans or will receive marketing approval. Before obtaining marketing approval from regulatory authorities for the sale of a product candidate, Carisma must complete pre-clinical development and then conduct extensive clinical trials to demonstrate the safety and efficacy of such product candidate in humans. Clinical trials may fail to demonstrate that CT-0508 or any of Carisma&#8217;s other product candidates are safe for humans and effective for indicated uses. Even if the clinical trials are successful, changes in marketing approval policies during the development period, changes in or the enactment or promulgation of additional statutes, regulations or guidance or changes in regulatory review for each submitted product application may cause delays in the approval or rejection of an application. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before Carisma can commence clinical trials for a product candidate, it must complete extensive pre-clinical testing and studies, manufacturing process development studies, and analytical development studies that support its planned INDs and other applications to regulatory authorities in the United States or similar applications in other jurisdictions. Carisma cannot be certain of the timely completion or outcome of its pre-clinical testing and studies and cannot predict if the outcome of its pre-clinical testing and studies will ultimately support the further development of its current or future product candidates or whether regulatory authorities will accept its proposed clinical programs. As a result, Carisma may not be able to submit applications to initiate clinical development of product candidates on the timelines Carisma expects, if at all, and the submission of these applications may not result in regulatory authorities allowing clinical trials to begin. Furthermore, product candidates are subject to continued pre-clinical safety studies, which may be conducted concurrently with Carisma&#8217;s clinical testing. The outcomes of these safety studies may delay the launch of or enrollment in future clinical trials and could impact Carisma&#8217;s ability to continue to conduct its clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical testing is expensive, difficult to design and implement, can take many&#160;years to complete and is uncertain as to the outcome. Carisma cannot guarantee that any of its clinical trials will be conducted as planned or completed on schedule, or at all. A failure of one or more clinical trials can occur at any stage of testing, which may result from a multitude of factors, including, among other things, flaws in study design, dose selection issues, placebo effects, patient enrollment criteria and failure to demonstrate favorable safety or efficacy traits. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, pre-clinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in pre-clinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products. Furthermore, the failure of any of Carisma&#8217;s product candidates to demonstrate safety and efficacy in any clinical trial could negatively impact the perception of its other product candidates or cause regulatory authorities to require additional testing before approving any of its product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent its ability to receive marketing approval or commercialize any product candidates, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulators or institutional review boards, or IRBs, may not authorize Carisma or its investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may experience delays in reaching, or fail to reach, agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulators may determine that the planned design of Carisma&#8217;s clinical trials is flawed or inadequate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">clinical trials of Carisma&#8217;s product candidates may produce negative or inconclusive results, and Carisma may decide, or regulators may require Carisma, to conduct additional clinical trials or abandon product development programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may be unable to establish clinical endpoints that applicable regulatory authorities consider clinically meaningful, or, if Carisma seeks accelerated approval, biomarker efficacy endpoints that applicable regulatory authorities consider likely to predict clinical benefit; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">pre-clinical testing may produce results based on which Carisma may decide, or regulators may require Carisma, to conduct additional pre-clinical studies before it proceeds with certain clinical trials, limits the scope of its clinical trials, halt ongoing clinical trials or abandon product development programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of patients required for clinical trials of Carisma&#8217;s product candidates may be larger than it anticipates, enrollment in these clinical trials may be slower than Carisma anticipates or participants may drop out of these clinical trials at a higher rate than Carisma anticipates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to Carisma in a timely manner, or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may decide, or regulators or IRBs may require Carisma, to suspend or terminate clinical trials of its product candidates for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulators or IRBs may require Carisma to perform additional or unanticipated clinical trials to obtain approval or Carisma may be subject to additional post-marketing testing requirements to maintain marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulators may revise the requirements for approving Carisma&#8217;s product candidates, or such requirements may not be as it anticipates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost of clinical trials of Carisma&#8217;s product candidates may be greater than it anticipates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the supply or quality of Carisma&#8217;s product candidates or other materials necessary to conduct clinical trials of its product candidates may be insufficient or inadequate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates may have undesirable side effects or other unexpected characteristics, causing Carisma or its clinical investigators, regulators or IRBs to suspend or terminate the trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulators may withdraw their approval of a product or impose restrictions on its distribution; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">business interruptions resulting from the COVID-19 pandemic may result in adverse effects on Carisma&#8217;s business and operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is required to conduct additional clinical trials or other testing of its product candidates beyond those that it currently contemplates, if Carisma is unable to successfully complete clinical trials of its product candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive, if there are safety concerns or if Carisma determines that the observed safety or efficacy profile would not be competitive in the marketplace, it may: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">incur unplanned costs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">be delayed in obtaining marketing approval for its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">not obtain marketing approval at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain marketing approval in some countries and not in others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain approval for indications or patient populations that are not as broad as intended or desired; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">be subject to additional post-marketing testing requirements; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">have the product removed from the market after obtaining marketing approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product development costs will also increase if it experiences delays in pre-clinical studies or clinical trials or in obtaining marketing approvals. Carisma does not know whether any of its pre-clinical studies or clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Carisma may also determine to change the design or protocol of one or more of its clinical trials, including to add additional patients or arms, which could result in increased costs and expenses or delays. Significant pre-clinical study or clinical trial delays also could shorten any periods during which Carisma may have the exclusive right to commercialize its product candidates or allow its competitors to bring products to market before Carisma does and impair Carisma&#8217;s ability to successfully commercialize its product candidates and may harm Carisma&#8217;s business and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, cancer therapies are sometimes characterized as first-line, second-line, or third-line, and the FDA often approves new therapies initially only for second-line or third-line use. When cancer is detected early enough, first-line therapy, usually hormone therapy, surgery, radiation therapy or a combination of these, is sometimes adequate to cure the cancer or prolong life without a cure. Second- and third-line therapies are administered to patients when prior therapy is not effective. For any of Carisma&#8217;s products that prove to be sufficiently beneficial, Carisma would expect to seek approval potentially as a first-line therapy, but any product candidates Carisma develops, even if approved, may not be approved for first-line therapy, and, prior to any such approvals, Carisma may have to conduct additional clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The results of early-stage clinical trials and pre-clinical studies may not be predictive of future results. Initial success in clinical trials may not be indicative of results obtained when these trials are completed or in later stage trials.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The outcome of pre-clinical testing and early clinical trials may not be predictive of the success of later clinical trials, and preliminary or interim results of a clinical trial do not necessarily predict final results. In addition, initial success in clinical trials may not be indicative of results obtained when such trials are completed. In particular, the small number of patients in Carisma&#8217;s ongoing early clinical trials may make the results of these trials less predictive of the outcome of later clinical trials. For example, even if successful, the results of Carisma&#8217;s Phase&#160;1 clinical trial of CT-0508 may not be predictive of the results of further clinical trials of CT-0508 or any of Carisma&#8217;s other product candidates. Carisma&#8217;s product candidates may also fail to show the desired safety and efficacy in clinical development despite positive results in pre-clinical studies or having successfully advanced through initial clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, pre-clinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in pre-clinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products. Carisma&#8217;s current or future clinical trials may not ultimately be successful or support further clinical development of any of its product candidates and Carisma cannot assure you that any clinical trials that it may conduct will demonstrate consistent or adequate efficacy and safety to support marketing approval. There is a high failure rate for product candidates proceeding through clinical trials. Many companies in the biopharmaceutical industry have suffered significant setbacks in late-stage clinical trials even after achieving promising results in pre-clinical testing and earlier-stage clinical trials, and Carisma cannot be certain that it will not face similar setbacks. Any such setbacks in Carisma&#8217;s clinical development could materially harm Carisma&#8217;s business and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interim and preliminary results from Carisma&#8217;s clinical trials that it announces or publishes from time to time may change as more participant data become available and are subject to audit and verification procedures, which could result in material changes in the final data.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, Carisma may announce or publish interim or preliminary results from its clinical trials, including its Phase&#160;1 clinical trial of CT-0508. Interim results from clinical trials that Carisma may complete are subject to the risk that one or more of the clinical outcomes may materially change as participant enrollment continues and more participant data become available. Carisma also makes assumptions, estimations, calculations, and conclusions as part of its analyses of data, and Carisma may not have received or had the opportunity to fully evaluate all data. Preliminary or interim results also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data Carisma previously published. As a result, interim and preliminary data should be viewed with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">caution until the final data are available. Adverse differences between preliminary or interim data and final data could be material and could significantly harm Carisma&#8217;s reputation and business prospects and may cause the trading price of Carisma common stock to fluctuate significantly. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma experiences delays or difficulties in the enrollment of patients in its clinical trials for CT-0508 or any of its other product candidates, its receipt of necessary marketing approvals could be delayed or prevented.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Identifying and qualifying patients to participate in clinical trials for CT-0508 and any other product candidates in the future is critical to Carisma&#8217;s success. Successful and timely completion of clinical trials will require that Carisma enroll a sufficient number of patients who remain in the trial until its conclusion. Carisma may not be able to initiate or continue clinical trials for its product candidates if it is unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA or similar regulatory authorities outside of the United States. In particular, group 2 for Carisma&#8217;s Phase&#160;1 clinical trial of CT-0508 is currently open for enrollment with an additional nine patients to be dosed in the study and Carisma is preparing to advance other products into clinical development. In addition, some of Carisma&#8217;s competitors have ongoing clinical trials for product candidates that treat the same indications as Carisma&#8217;s product candidates, and patients who would otherwise be eligible for Carisma&#8217;s clinical trials may instead enroll in clinical trials of Carisma&#8217;s competitors&#8217; product candidates. Carisma cannot predict how successful it will be at enrolling subjects in future clinical trials. Patient enrollment is affected by a variety of other factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the prevalence and severity of the disease under investigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the eligibility criteria for the trial in question; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the perceived risks and benefits of the product candidate under trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the requirements of the trial protocols; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of existing treatments for the indications for which Carisma is conducting clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability to recruit clinical trial investigators with the appropriate competencies and experience; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the efforts to facilitate timely enrollment in clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability to identify specific patient populations based on specific genetic mutations or other factors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the patient referral practices of physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability to monitor patients adequately during and after treatment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to obtain and maintain patient consents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the proximity and availability of clinical trial sites for prospective patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the conduct of clinical trials by competitors for product candidates that treat the same indications or address the same patient populations as Carisma&#8217;s product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost to, or lack of adequate compensation for, prospective patients; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the impact of the ongoing COVID-19 pandemic. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s inability to locate and enroll a sufficient number of patients for its clinical trials would result in significant delays, could require it to abandon one or more clinical trials altogether and could delay or prevent its receipt of necessary marketing approvals. Enrollment delays in Carisma&#8217;s clinical trials may result in increased development costs for its product candidates, which could cause the value of Carisma&#8217;s business to decline and limit its ability to obtain additional financing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If serious adverse events, undesirable side effects or unexpected characteristics are identified during the development of CT-0508 or any of Carisma&#8217;s other product candidates, Carisma may need to abandon or limit its further clinical development of those product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Enrollment in group 1 of Carisma&#8217;s first in human Phase&#160;1 clinical trial of CT-0508 has been completed with nine patients successfully dosed and group 2 is currently open for enrollment with nine additional </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">patients to be dosed in the trial. If CT-0508 or any other product candidate is associated with serious adverse events or undesirable side effects in clinical trials or have characteristics that are unexpected in clinical trials or pre-clinical testing, Carisma may need to abandon development of such product candidate or limit development to more narrow uses or subpopulations in which the serious adverse events, undesirable side effects or unexpected characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. In pharmaceutical development, many compounds that initially show promise in early-stage or clinical testing are later found to cause side effects that delay or prevent further development of the compound. For example, while CT-0508 has been generally well tolerated based on preliminary clinical results from Carisma&#8217;s Phase&#160;1 clinical trial, such results may not be predictive or indicative of the successful development, marketing approval and eventual commercialization of CT-0508. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, if results of Carisma&#8217;s clinical trials reveal undesirable side effects, Carisma, regulatory authorities or the IRBs at the institutions in which Carisma&#8217;s studies are conducted could suspend or terminate its clinical trials, regulatory authorities could order Carisma to cease clinical trials or deny approval of its product candidates for any or all targeted indications or Carisma could be forced to materially modify the design of its clinical trials. Treatment-related side effects could also affect patient recruitment or the ability of enrolled patients to complete any of Carisma&#8217;s clinical trials or result in potential liability claims. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma elects or is forced to suspend or terminate any clinical trial of its product candidates, the commercial prospects of such product candidate will be harmed, and Carisma&#8217;s ability to generate revenues from sales of such product candidate will be delayed or eliminated. Any of these occurrences could materially harm Carisma&#8217;s business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If any of Carisma&#8217;s product candidates receives marketing approval and Carisma, or others, later discover that the drug is less effective than previously believed or causes undesirable side effects that were not previously identified, Carisma&#8217;s ability to market the drug could be compromised.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma only recently initiated clinical development of its lead product candidate, CT-0508, and is in the pre-clinical testing stages for its other product candidates. Clinical trials will be conducted in carefully defined subsets of patients who have agreed to enter into clinical trials. Consequently, it is possible that Carisma&#8217;s clinical trials may indicate an apparent positive effect of a product candidate that is greater than the actual positive effect, if any, or alternatively fail to identify undesirable side effects. If one or more of Carisma&#8217;s product candidates receives marketing approval, and Carisma, or others, later discover that they are less effective than previously believed, or cause undesirable side effects, a number of potentially significant negative consequences could result, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdrawal or limitation by regulatory authorities of approvals of such product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seizure of the product by regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">recall of the product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on the marketing of the product or the manufacturing process for any component thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">requirement by regulatory authorities of additional warnings on the label; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">requirement that Carisma implement a risk evaluation and mitigation strategy or create a medication guide outlining the risks of such side effects for distribution to patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">commitment to expensive post-marketing studies as a prerequisite of approval by regulatory authorities of such product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the product may become less competitive; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">initiation of regulatory investigations and government enforcement actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">initiation of legal action against Carisma to hold it liable for harm caused to patients; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">harm to Carisma&#8217;s reputation and resulting harm to physician or patient acceptance of its products. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any of these events could prevent Carisma from achieving or maintaining market acceptance of a particular product candidate, if approved, and could significantly harm Carisma&#8217;s business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may expend its limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because Carisma has limited financial and managerial resources, it focuses on discovery programs and product candidates that it identifies for specific indications. As a result, Carisma may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Carisma&#8217;s resource allocation decisions may cause it to fail to capitalize on viable commercial products or profitable market opportunities. Carisma&#8217;s spending on current and future discovery and product development programs and product candidates for specific indications may not yield any commercially viable products. If Carisma does not accurately evaluate the commercial potential or target market for a particular product candidate, it may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for Carisma to retain sole development and commercialization rights to such product candidate. Failure to allocate resources or capitalize on strategies in a successful manner will have an adverse impact on Carisma&#8217;s business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may develop CT-0508 in combination with other drugs. If the FDA or similar regulatory authorities outside of the United States do not approve these other drugs, revoke their approval of such drugs, or if safety, efficacy, manufacturing or supply issues arise with the drugs Carisma chooses to evaluate in combination with CT-0508, Carisma may be unable to obtain approval of CT-0508 or market CT-0508.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2022, Carisma submitted a clinical protocol amendment to the CT-0508 IND for a CAR-M / anti-PD-1 (CT-0508 and pembrolizumab) combination strategy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma did not develop or obtain marketing approval for, nor has Carisma manufactured or sold, any of the currently approved drugs that it may study in combination with CT-0508. If the FDA or similar regulatory authorities outside of the United States revoke their approval of any drug or drugs in combination with which Carisma determines to develop CT-0508, Carisma will not be able to market CT-0508 in combination with such revoked drugs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If safety or efficacy issues arise with any of these drugs, Carisma could experience significant regulatory delays, and the FDA or similar regulatory authorities outside of the United States may require Carisma to redesign or terminate the applicable clinical trials. If the drugs Carisma uses are replaced as the standard of care for the indications it chooses for CT-0508, the FDA or similar regulatory authorities outside of the United States may require Carisma to conduct additional clinical trials. In addition, if manufacturing or other issues result in a shortage of supply of the drugs with which Carisma determines to combine with CT-0508, it may not be able to complete clinical development of CT-0508 on its current timeline or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if CT-0508 were to receive marketing approval or be commercialized for use in combination with other existing drugs, Carisma would continue to be subject to the risks that the FDA or similar regulatory authorities outside of the United States could revoke approval of the drug used in combination with CT-0508 or that safety, efficacy, manufacturing or supply issues could arise with these existing drugs. Combination therapies are commonly used for the treatment of cancer, and Carisma would be subject to similar risks if it develops any of its other product candidates for use in combination with other drugs or for indications other than cancer. This could result in Carisma&#8217;s own products being removed from the market or being less successful commercially. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may not be successful in its efforts to identify or discover additional potential product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A key element of Carisma&#8217;s strategy is to apply its macrophage engineering platform to address a broad array of indications and targets to generate next-generation therapeutics, including three programs for indications outside of oncology. The discovery efforts that Carisma is conducting may not be successful in identifying product candidates that are useful in treating cancer or other diseases. Carisma&#8217;s discovery </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">engine may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for a number of reasons, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential product candidates may, on further study, be shown to have harmful side effects or other characteristics that indicate that they are unlikely to be drugs that will receive marketing approval or achieve market acceptance; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential product candidates may not be effective in treating their targeted diseases. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Discovery programs to identify new product candidates require substantial technical, financial and human resources. Carisma may choose to focus its efforts and resources on a potential product candidate that ultimately proves to be unsuccessful. If Carisma is unable to identify additional suitable product candidates for pre-clinical and clinical development, it will limit its potential to obtain revenues from sale of products in future periods, which likely would result in significant harm to Carisma&#8217;s financial position and adversely impact its stock price. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adverse public perception of genetic medicine, and gene therapy in particular, may negatively impact regulatory approval of, or demand for, Carisma&#8217;s potential products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The clinical and commercial success of Carisma&#8217;s potential products will depend in part on public acceptance of the use of gene therapy for the prevention or treatment of human diseases. Public attitudes may be influenced by claims that gene therapy is unsafe, unethical, or immoral, and, consequently, Carisma&#8217;s products may not gain the acceptance of the public or the medical community. Adverse public attitudes may adversely impact Carisma&#8217;s ability to enroll clinical trials. Moreover, Carisma&#8217;s success will depend upon physicians prescribing, and their patients being willing to receive, treatments that involve the use of product candidates that Carisma may develop in lieu of, or in addition to, existing treatments with which they are already familiar and for which greater clinical data may be available. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Commercialization of Carisma&#8217;s Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if any of Carisma&#8217;s product candidates receives marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, and the market opportunity for any of its product candidates, if approved, may be smaller than it estimates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any of Carisma&#8217;s product candidates receives marketing approval, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. For example, current cancer treatments, such as chemotherapy and radiation therapy, are well established in the medical community and doctors may continue to rely on these and similar treatments. Efforts to educate the medical community and third-party payors on the benefits of Carisma&#8217;s product candidates may require significant resources and may not be successful. If Carisma&#8217;s product candidates do not achieve an adequate level of acceptance, Carisma may not generate significant revenues from product sales and it may not become profitable. The degree of market acceptance of Carisma&#8217;s product candidates, if approved for commercial sale, will depend on a number of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the efficacy and potential advantages of Carisma&#8217;s product candidates compared to the advantages and relative risks of alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effectiveness of sales and marketing efforts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to offer its products, if approved, for sale at competitive prices; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the clinical indications for which the product is approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost of treatment in relation to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the convenience and ease of administration compared to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the strength of marketing and distribution support; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing of market introduction of competitive products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of third-party coverage and adequate reimbursement, and patients&#8217; willingness to pay out of pocket for required co-payments or in the absence of third-party coverage or adequate reimbursement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">product labeling or product insert requirements of the FDA, the EMA or other regulatory authorities, including any limitations or warnings contained in a product&#8217;s approved labeling; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the prevalence and severity of any side effects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">support from patient advocacy groups; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any restrictions on the use of Carisma&#8217;s products, if approved, together with other medications. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s assessment of the potential market opportunity for its product candidates is based on industry and market data that it obtained from industry publications, research, surveys and studies conducted by third parties and Carisma&#8217;s analysis of these data, research, surveys and studies. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. While Carisma believes these industry publications and third-party research, surveys and studies are reliable, it has not independently verified such data. Carisma&#8217;s estimates of the potential market opportunities for its product candidates include a number of key assumptions based on its industry knowledge, industry publications and third-party research, surveys and studies, which may be based on a small sample size and fail to accurately reflect market opportunities. While Carisma believes that its internal assumptions are reasonable, no independent source has verified such assumptions. If any of Carisma&#8217;s assumptions or estimates, or these publications, research, surveys or studies prove to be inaccurate, then the actual market for any of its product candidates may be smaller than it expects, and as a result Carisma&#8217;s revenues from product sales may be limited and it may be more difficult for Carisma to achieve or maintain profitability. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to establish sales, marketing and distribution capabilities or enter into sales, marketing and distribution agreements with third parties, it may not be successful in commercializing its product candidates if and when they are approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not have a sales or marketing infrastructure and has no experience as a company in the sale, marketing or distribution of biopharmaceutical products. To achieve commercial success for any product for which Carisma may obtain marketing approval, it will need to establish a sales, marketing and distribution organization, either itself or through collaborations or other arrangements with third parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently expects that it would build its own focused, specialized sales and marketing organization to support the commercialization in the United States of product candidates for which it receives marketing approval and that can be commercialized with such capabilities. There are risks involved with Carisma establishing its own sales, marketing and distribution capabilities. For example, recruiting and training a sales force is expensive and time-consuming and could delay any product launch. If the commercial launch of a product candidate for which Carisma recruit a sales force and establish marketing capabilities is delayed or does not occur for any reason, Carisma would have prematurely or unnecessarily incurred these commercialization expenses. These efforts may be costly, and Carisma&#8217;s investment would be lost if it cannot retain or reposition its sales and marketing personnel. In general, the cost of establishing and maintaining a sales and marketing organization may exceed the cost-effectiveness of doing so. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Factors that may inhibit Carisma&#8217;s efforts to commercialize its products on its own include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its inability to recruit, train and retain adequate numbers of effective sales, marketing, coverage or reimbursement, customer service, medical affairs and other support personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its inability to equip sales personnel with effective materials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its inability to effectively manage a geographically dispersed sales and marketing team; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to prescribe any future products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement and other acceptance by payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability to price its products at a sufficient price point to ensure an adequate and attractive level of profitability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restricted or closed distribution channels that make it difficult to distribute its products to segments of the patient population; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the lack of complementary products to be offered by sales personnel, which may put Carisma at a competitive disadvantage relative to companies with more extensive product lines; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">unforeseen costs and expenses associated with creating an independent sales and marketing organization. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to establish its own sales, marketing and distribution capabilities and it enters into arrangements with third parties to perform these services, Carisma&#8217;s revenues from product sales and its profitability, if any, are likely to be lower than if it were to market, sell and distribute any products that it develops itself. In addition, Carisma may not be successful in entering into arrangements with third parties to sell, market and distribute its product candidates or may be unable to do so on terms that are acceptable to Carisma. Carisma likely will have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market its products effectively. If Carisma does not establish sales, marketing and distribution capabilities successfully, either on its own or in collaboration with third parties, it will not be successful in commercializing its product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma faces substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than it does, thus rendering Carisma&#8217;s products non-competitive, obsolete or reducing the size of its market.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The biopharmaceutical industry, and in particular the cell therapy field, is characterized by intense investment and competition aimed at rapidly advancing new technologies. Carisma&#8217;s platform and therapeutic product candidates are expected to face substantial competition from multiple technologies, marketed products and numerous other therapies being developed by third parties that use protein degradation, antibody therapy, inhibitory nucleic acid, gene editing or gene therapy development platforms and from companies focused on more traditional therapeutic modalities, such as small molecule inhibitors. The competition is likely to come from multiple sources, including biopharmaceutical companies, academic research institutions, governmental agencies and private research institutions that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization. The competition is likely to come from multiple sources, including major pharmaceutical, specialty pharmaceutical and biotechnology companies, academic institutions, government agencies and public and private research institutions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is aware of a number of companies generally pursuing the development of myeloid cell therapies, including, among others Myeloid Therapeutics, Shoreline Biosciences, Inceptor Bio, Thunder Bio, Resolution Therapeutics, CellOrigin, Sirpant Therapeutics, and others. Carisma is also facing competition from companies pursuing autologous T-cell therapies, allogenic T-cell therapies, NK and other cell therapies, direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed cell therapies and other macrophage-targeted oncology therapeutics. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many of the companies against which Carisma is competing or against which it may compete in the future have significantly greater financial resources and expertise in research and development, manufacturing, pre-clinical testing, conducting clinical trials, obtaining marketing approvals and marketing approved products than Carisma does. These competitors also compete with Carisma in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, its development programs. Carisma&#8217;s commercial opportunity could be reduced or eliminated if its competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that Carisma may develop. Carisma&#8217;s competitors also may obtain FDA or other marketing approval for their products more rapidly than Carisma may obtain approval for its products, which could result in Carisma&#8217;s competitors establishing a strong market position </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">before Carisma is able to enter the market. In addition, Carisma&#8217;s ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products. There are generic products currently on the market for certain of the indications that Carisma is pursuing, and additional products are expected to become available on a generic basis over the coming&#160;years. If Carisma&#8217;s product candidates are approved, it expects that they will be priced at a significant premium over competitive generic products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Technology in the biopharmaceutical industry has undergone rapid and significant change, and Carisma expects that it will continue to do so. Any products or processes that Carisma develops may become obsolete or uneconomical before it recovers any expenses incurred in connection with their development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Mergers and acquisitions in the biopharmaceutical industry may result in even more resources being concentrated among a smaller number of Carisma&#8217;s competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with Carisma in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, Carisma&#8217;s programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has pursued and may in the future pursue the in-license or acquisition of rights to complementary technologies and product candidates on an opportunistic basis. However, Carisma may be unable to in-license or acquire any additional technologies or product candidates from third parties. The acquisition and licensing of technologies and product candidates is a competitive area, and a number of more established companies also have similar strategies to in-license or acquire technologies and product candidates that Carisma may consider attractive. These established companies may have a competitive advantage over Carisma due to their size, cash resources and greater development and commercialization capabilities. In addition, companies that perceive Carisma to be a competitor may be unwilling to assign or license rights to Carisma. Carisma also may be unable to in-license or acquire the relevant technology or product candidate on terms that would allow Carisma to make an appropriate return on its investment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if Carisma is able to commercialize any product candidates, the products may become subject to unfavorable pricing regulations, third-party coverage or reimbursement practices or healthcare reform initiatives, which could harm its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The regulations that govern marketing approvals, pricing, coverage and reimbursement for new drug products vary widely from country to country. Current and future legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. To obtain reimbursement or pricing approval in some countries, Carisma may be required to conduct a clinical trial that compares the cost effectiveness of its product candidate to other available therapies. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, Carisma might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay its commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenues, if any, Carisma is able to generate from the sale of the product in that country. Adverse pricing limitations may hinder Carisma&#8217;s ability to recoup its investment in one or more product candidates, even if its product candidates obtain marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to commercialize any product candidates successfully also will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. The availability of coverage and adequacy of reimbursement by governmental healthcare programs such as Medicare and Medicaid, private health insurers and other third-party payors are essential for most patients to be able to afford medical services and pharmaceutical products, including Carisma&#8217;s product candidates. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Increasingly, government authorities and third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. Coverage and reimbursement may not be available for any product that Carisma commercializes and, even if these are available, the level of reimbursement may not be satisfactory. Reimbursement may affect the demand for, or the price of, any product candidate for which it obtains marketing approval. Obtaining and maintaining adequate reimbursement for Carisma&#8217;s products may be difficult. Carisma may be required to conduct expensive pharmacoeconomic studies to justify coverage and reimbursement or the level of reimbursement relative to other therapies. If coverage and adequate reimbursement are not available or reimbursement is available only to limited levels, Carisma may not be able to successfully commercialize any product candidate for which it obtains marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There may be significant delays in obtaining coverage and reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar regulatory authorities outside of the United States. Moreover, eligibility for coverage and reimbursement does not imply that a drug will be paid for in all cases or at a rate that covers its costs, including research, development, intellectual property, manufacture, sale and distribution expenses. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover Carisma&#8217;s costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies. Carisma&#8217;s inability to promptly obtain coverage and adequate reimbursement rates from both government-funded and private payors for any approved products that it develops could have a material adverse effect on its operating results, its ability to raise capital needed to commercialize products and its overall financial condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No uniform policy for coverage and reimbursement for products exists among third-party payors in the United States. Therefore, coverage and reimbursement for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require Carisma to provide scientific and clinical support for the use of its product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Furthermore, rules and regulations regarding reimbursement change frequently, in some cases on short notice, and Carisma believes that changes in these rules and regulations are likely. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that Carisma&#8217;s product candidates, even if they are approved for sale in the United States, in the European Union or in other countries, will be considered medically reasonable and necessary for a specific indication or cost-effective by third-party payors, or that coverage and an adequate level of reimbursement will be available or that third-party payors&#8217; reimbursement policies will not adversely affect Carisma&#8217;s ability to sell its product candidates profitably. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical trial and product liability lawsuits against Carisma could divert its resources and could cause Carisma to incur substantial liabilities and to limit commercialization of any products that it may develop.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma faces an inherent risk of clinical trial and product liability exposure related to the testing of its product candidates in human clinical trials and will face an even greater risk if it commercially sells any products that it may develop. While Carisma currently has no products that have been approved for commercial sale, the ongoing, planned and future use of product candidates by Carisma in clinical trials, and the sale of any approved products in the future, may expose Carisma to liability claims. These claims might be made by patients that use the product, healthcare providers, pharmaceutical companies or others selling such products. On occasion, large judgments have been awarded in class action lawsuits based on products that had unanticipated adverse effects. If Carisma cannot successfully defend itself against claims that its product candidates or products caused injuries, it will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">decreased demand for any product candidates or products that it may develop; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">termination of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdrawal of marketing approval, recall, restriction on the approval or a &#8220;black box&#8221; warning or contraindication for an approved drug; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdrawal of clinical trial participants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">significant costs to defend any related litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">substantial monetary awards to trial participants or patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">loss of revenue; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">injury to Carisma&#8217;s reputation and significant negative media attention; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reduced resources of Carisma management to pursue its business strategy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">distraction of management&#8217;s attention from Carisma&#8217;s primary business; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability to commercialize any products that Carisma may develop. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently holds $10.0&#160;million in product liability insurance coverage in the aggregate, with a per incident limit of $10.0&#160;million, which may not be adequate to cover all liabilities that it may incur. Carisma may need to increase its insurance coverage as it expands its clinical trials or if it commences commercialization of its product candidates. Insurance coverage is increasingly expensive. Carisma may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. If a successful clinical trial or product liability claim or series of claims is brought against Carisma for uninsured liabilities or in excess of insured liabilities, its assets may not be sufficient to cover such claims and its business operations could be impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Dependence on Third Parties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma relies, and expects to continue to rely, on third parties to conduct its clinical trials, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, which may prevent or delay Carisma&#8217;s ability to seek or obtain marketing approval for or commercialize its product candidates or otherwise harm its business. If Carisma is not able to maintain these third-party relationships or if these arrangements are terminated, it may have to alter its development and commercialization plans and its business could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma relies, and expects to continue to rely, on third-party clinical research organizations, in addition to other third parties such as research collaboratives, clinical data management organizations, medical institutions and clinical investigators, to conduct its ongoing Phase&#160;1 clinical trial of CT-0508 and related combinations studies, its planned clinical trials of CT-0525, CT-1119 and CT-0729 and any other clinical trials it conducts. Carisma does not plan to independently conduct clinical trials of its product candidates or any other product candidates that it may develop. These contract research organizations and other third parties play a significant role in the conduct and timing of these trials and subsequent collection and analysis of data. These third-party arrangements might terminate for a variety of reasons, including a failure to perform by the third parties. If Carisma needs to enter into alternative arrangements, its product development activities might be delayed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s reliance on these third parties for discovery and product development activities reduces its control over these activities but does relieve Carisma of its responsibilities. For example, Carisma will remain responsible for ensuring that each of its clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires Carisma to comply with standards, commonly referred to as good clinical practices, or GCPs, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. Regulatory authorities in Europe and other jurisdictions have similar requirements. Regulatory authorities enforce these GCPs through periodic inspections of trial sponsors, principal investigators and trial sites. If Carisma or any of its contract research organizations or trial sites fail to comply with applicable GCPs, the clinical data generated in its clinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">trials may be deemed unreliable, and the FDA or comparable foreign regulatory authorities may require Carisma to perform additional clinical trials before approving its marketing applications. Carisma is also required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within specified timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct Carisma&#8217;s clinical trials in accordance with regulatory requirements or Carisma&#8217;s stated protocols, Carisma will not be able to obtain, or may be delayed in obtaining, marketing approvals for its product candidates and will not be able to, or may be delayed in its efforts to, successfully develop and commercialize its product candidates. Furthermore, these third parties may also have relationships with other entities, some of which may be Carisma&#8217;s competitors. In addition, principal investigators for Carisma&#8217;s clinical trials may serve as scientific advisors or consultants to Carisma from time to time and may receive cash or equity compensation in connection with such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, or the FDA concludes that the financial relationship may have affected the interpretation of the trial, the integrity of the data generated at the applicable clinical trial site may be questioned, and the utility of the clinical trial itself may be jeopardized, which could result in the delay or rejection of any marketing application Carisma submits to the FDA. Any such delay or rejection could prevent Carisma from commercializing its product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any of Carisma&#8217;s relationships with these third parties terminate, it may not be able to enter into arrangements with alternative third parties or do so on commercially reasonable terms. Switching or adding additional contract research organizations, investigators and other third parties involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new contract research organization commences work. As a result, delays can occur, which could materially impact Carisma&#8217;s ability to meet its desired clinical development timelines. The COVID-19 pandemic and government measures taken in response have also had a significant impact on many contract research organizations. Although Carisma plans to carefully manage its relationships with its contract research organizations, investigators and other third parties, it may nonetheless encounter challenges or delays in the future, which could have a material and adverse impact on Carisma&#8217;s business, financial condition and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma relies on third-party contract manufacturing organizations for the manufacture of both drug substance and finished drug product of its product candidates for pre-clinical and clinical testing and expect to continue to do so for commercialization. This reliance on third parties increases the risk that Carisma will not have sufficient quantities of its product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair Carisma&#8217;s development or commercialization efforts.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not own or operate, and currently has no plans to establish, any manufacturing facilities. Carisma relies, and expects to continue to rely, on third-party contract manufacturing organizations for both drug substance and finished drug product, as well as for commercial manufacture if any of its product candidates receive marketing approval. Carisma also currently relies on these third parties for the manufacture of plasmid and viral vectors, patient leukapheresis material logistics, as well as packaging, labeling, sterilization, storage, distribution and other production logistics. This reliance on third parties increases the risk that Carisma will not have sufficient quantities of its product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair Carisma&#8217;s development or commercialization efforts. Carisma may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms. Even if Carisma is able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reliance on the third party for regulatory compliance and quality assurance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possible breach of the manufacturing agreement by the third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential failure to manufacture Carisma&#8217;s product candidate or product according to its specifications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential failure to manufacture Carisma&#8217;s product candidate or product according to its schedule or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possible misappropriation of Carisma&#8217;s proprietary information, including its trade secrets and know-how; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for Carisma. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma or its third-party manufacturers may encounter shortages in the raw materials or active pharmaceutical ingredients necessary to produce Carisma&#8217;s product candidates in the quantities needed for its clinical trials or, if its product candidates are approved, in sufficient quantities for commercialization or to meet an increase in demand, as a result of capacity constraints or delays or disruptions in the market for the raw materials or active pharmaceutical ingredients, including shortages caused by the purchase of such raw materials or active pharmaceutical ingredients by its competitors or others. The failure of Carisma or its third-party manufacturers to obtain the raw materials or active pharmaceutical ingredients necessary to manufacture sufficient quantities of its product candidates, may have a material adverse effect on Carisma&#8217;s business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s third-party manufacturers are subject to inspection and approval by regulatory authorities before Carisma can commence the manufacture and sale of any of its product candidates, and thereafter subject to ongoing inspection from time to time. Third-party manufacturers may not be able to comply with cGMP, regulations or similar regulatory requirements outside of the United States. Carisma&#8217;s failure, or the failure of its third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on Carisma, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of Carisma&#8217;s products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates and any products that it may develop may compete with other product candidates and products for access to manufacturing facilities. As a result, Carisma may not obtain access to these facilities on a priority basis or at all. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for Carisma. Any performance failure on the part of Carisma&#8217;s existing or future manufacturers could delay clinical development or marketing approval. Carisma does not currently have arrangements in place for redundant supply or a second source for bulk drug substance. If any of Carisma&#8217;s current contract manufacturers cannot perform as agreed, it may be required to replace such manufacturers. Although Carisma believes that there are several potential alternative manufacturers who could manufacture its product candidates, it may incur added costs and delays in identifying and qualifying any such replacement or be unable to reach agreement with an alternative manufacturer. In addition, the COVID-19 pandemic may impact Carisma&#8217;s ability to procure sufficient supplies for the development of its product candidates. The extent of this impact will depend on the severity and duration of the spread of the virus, and the actions undertaken to contain COVID-19 or treat its effects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s current and anticipated future dependence upon others for the manufacture of its product candidates or products may adversely affect its future profit margins and its ability to commercialize any products that receive marketing approval on a timely and competitive basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma expects to depend on collaborations with third parties for the research, development and commercialization of certain of its product candidates. If Carisma&#8217;s collaborations are not successful, it may not be able to capitalize on the market potential of these product candidates and its business could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma anticipates seeking third-party collaborators for the research, development and commercialization of certain of its product candidates. For example, Carisma entered into a strategic collaboration with Moderna in January&#160;2022 focused on the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics for up to twelve product candidates. In collaboration with Moderna, Carisma has established a myeloid tropic LNP/mRNA </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M platform for oncology targets, which enables an off-the-shelf approach wherein the patient&#8217;s own myeloid cells are engineered directly within their body via the administration of a myeloid-tropic LNP encapsulating macrophage reprogramming mRNA CAR constructs, removing the requirement for </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> cell manufacturing entirely. As part of the collaboration, Carisma received a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">$45.0&#160;million up-front cash payment from Moderna, in addition to future research funding, milestone payments and royalties. Concurrent with entering into the collaboration agreement, Moderna made an investment in Carisma in the form of a $35.0&#160;million convertible note. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s likely collaborators for any other collaboration arrangements include large and mid-size pharmaceutical companies and biotechnology companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any such arrangements with third parties will likely limit Carisma&#8217;s control over the amount and timing of resources that its collaborators dedicate to the development or commercialization of its product candidates Carisma may seek to develop with them. Carisma&#8217;s ability to generate revenues from these arrangements will depend on its collaborators&#8217; abilities and efforts to successfully perform the functions assigned to them in these arrangements. Carisma cannot predict the success of any collaboration that it enters into. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Collaborations involving Carisma&#8217;s discovery programs or any product candidates it may develop, including its collaboration with Moderna, pose the following risks to Carisma: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators have significant discretion in determining the amount and timing of efforts and resources that they will apply to these collaborations; for example, Carisma&#8217;s collaboration with Moderna is managed by a joint steering committee, which is comprised of representatives from Carisma and Moderna, with Moderna having final decision-making authority, subject to specified limitations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators may not perform their obligations as expected; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators may not pursue development of Carisma&#8217;s product candidates or may elect not to continue or renew development programs based on results of clinical trials or other studies, changes in the collaborators&#8217; strategic focus or available funding, or external factors, such as an acquisition or business combination, that divert resources or create competing priorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators may not pursue development and commercialization of any product candidates that achieve marketing approval or may elect not to continue or renew commercialization programs based on results of clinical trials or other studies, changes in the collaborators&#8217; strategic focus or available funding, or external factors, such as an acquisition or business combination, that may divert resources or create competing priorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may not have access to, or may be restricted from disclosing, certain information regarding product candidates being developed or commercialized under a collaboration and, consequently, may have limited ability to inform its stockholders about the status of such product candidates on a discretionary basis; for example, data, results and know-how generated in the performance of the Moderna collaboration is deemed the confidential information of Moderna, which Carisma may not disclose except under limited circumstances; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with Carisma&#8217;s product candidates and products if the collaborators believe that the competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than Carisma&#8217;s; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">product candidates discovered in collaboration with Carisma may be viewed by Carisma&#8217;s collaborators as competitive with their own product candidates or products, which may cause collaborators to cease to devote resources to the commercialization of Carisma&#8217;s product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a collaborator may fail to comply with applicable regulatory requirements regarding the development, manufacture, distribution or marketing of a product candidate or product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a collaborator may seek to renegotiate or terminate their relationship with Carisma due to unsatisfactory clinical results, manufacturing issues, a change in business strategy, a change of control or other reasons; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a collaborator with marketing and distribution rights to one or more of Carisma&#8217;s product candidates that achieve marketing approval may not commit sufficient resources to the marketing and distribution of such product or products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disagreements with collaborators, including disagreements over intellectual property or proprietary rights, contract interpretation or the preferred course of development, might cause delays or terminations of the research, development or commercialization of product candidates, might lead to additional responsibilities for Carisma with respect to product candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may lose certain valuable rights under circumstances identified in its collaborations, including if it undergoes a change of control; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators may not properly obtain, maintain, enforce, defend or protect Carisma&#8217;s intellectual property or proprietary rights or may use its proprietary information in such a way as to potentially lead to disputes or legal proceedings that could jeopardize or invalidate its intellectual property or proprietary information or expose Carisma to potential litigation; for example, Moderna has the first right to prosecute, enforce or defend certain patent rights under its agreement with Carisma, and although Carisma may have the right to assume the prosecution, enforcement or defense of such patent rights if Moderna does not, Carisma&#8217;s ability to do so may be compromised by Moderna&#8217;s actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disputes may arise with respect to the ownership of intellectual property developed pursuant to Carisma&#8217;s collaborations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborators may infringe, misappropriate or otherwise violate the intellectual property or proprietary rights of third parties, which may expose Carisma to litigation and potential liability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaborations may be terminated, and, if terminated, Carisma could be required to raise additional capital to pursue further development or commercialization of the applicable product candidates; for example, Moderna has the right to terminate its agreement with Carisma for convenience in its entirety or with respect to a specific product or target on ninety days&#8217; prior notice, in connection with a material breach of the agreement by Carisma that remains uncured for a specified period of time or in the event of specified insolvency events involving Carisma; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner, or at all. If a present or future collaborator of Carisma&#8217;s were to be involved in a business combination, the continued pursuit and emphasis on its product development or commercialization program under such collaboration could be delayed, diminished or terminated. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any collaborations that Carisma enters into do not result in the successful development and commercialization of products or if one of Carisma&#8217;s collaborators terminates its agreement with it, Carisma may not receive any future research funding or milestone or royalty payments under the collaboration. If Carisma does not receive the funding it expects under these agreements, its development of its product candidates could be delayed and it may need additional resources to develop its product candidates. All of the risks relating to product development, marketing approval and commercialization described in this proxy statement/prospectus also apply to the activities of Carisma&#8217;s collaborators. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma may in the future decide to collaborate with biopharmaceutical companies for the development and potential commercialization of any product candidates it may develop. These relationships, or those like them, may require Carisma to incur non-recurring and other charges, increase Carisma&#8217;s near- and long-term expenditures, issue securities that dilute Carisma&#8217;s existing stockholders, or disrupt Carisma&#8217;s management and business. In addition, Carisma could face significant competition in seeking appropriate collaborators, and the negotiation process is time-consuming and complex. Carisma&#8217;s ability to reach a definitive collaboration agreement will depend, among other things, upon its assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#8217;s evaluation of several factors. If Carisma licenses rights to any product candidates it or its collaborators may develop, Carisma may not be able to realize the benefit of such transactions if it is unable to successfully integrate them with its existing operations and company culture. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may seek to establish additional collaborations. If Carisma is not able to establish or maintain additional collaborations, on commercially reasonable terms, it may have to alter its development and commercialization plans and its business could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To realize the full potential of Carisma&#8217;s macrophage engineering platform and accelerate the development of additional macrophage engineering programs, Carisma plans to continue to selectively pursue collaborations with leading biopharmaceutical companies with particular experience, including development and commercial expertise and capabilities. Carisma faces significant competition in attracting appropriate collaborators, and a number of more established companies may also be pursuing strategies to license or acquire third-party intellectual property rights that it considers attractive. These established companies may have a competitive advantage over Carisma due to their size, financial resources and greater clinical development and commercialization capabilities. In addition, companies that perceive Carisma to be a competitor may be unwilling to assign or license rights to Carisma. Whether Carisma reaches a definitive agreement for a collaboration will depend, among other things, upon its assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA or other regulatory authorities, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing products, the existence of uncertainty with respect to Carisma&#8217;s ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge, the terms of any existing collaboration agreements, and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with Carisma for its product candidate. Carisma may also be restricted under future license agreements from entering into agreements on certain terms with potential collaborators. Collaborations are complex and time-consuming to negotiate, document and execute. In addition, there have been a significant number of recent business combinations among large biopharmaceutical companies that have resulted in a reduced number of potential future collaborators. Any collaboration Carisma may enter into may limit its ability to enter into future agreements on particular terms or covering similar target indications with other potential collaborators. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to reach agreements with suitable collaborators on a timely basis, on acceptable terms or at all, it may have to curtail the development of a product candidate, reduce or delay its development program or one or more of Carisma&#8217;s other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase its expenditures and undertake development or commercialization activities at its own expense. If Carisma elects to fund and undertake development or commercialization activities on its own, it may need to obtain additional expertise and additional capital, which may not be available to Carisma on acceptable terms or at all. If Carisma fails to enter into collaborations and does not have sufficient funds or expertise to undertake the necessary development and commercialization activities, it may not be able to further develop its product candidates or bring them to market and generate revenue from product sales, which could have an adverse effect on its business, prospects, financial condition and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma has a number of academic collaborations to supplement its internal discovery and product development program. If any such collaborator decides to discontinue or devote less resources to such research, Carisma&#8217;s discovery programs could be diminished.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s discovery engine is supplemented by academic collaborations to expand its platform, which Carisma relies upon to advance its development and commercialization plans for its product candidates. In August&#160;2020, Carisma entered into a scientific research and licensing agreement with Nathaniel R. Landau, Ph.D. and NYU Langone Health through which it obtained exclusive rights to develop their Vpx lentiviral vector globally for all indications. Carisma also has an ongoing discovery program in neurodegeneration being pursued through a sponsored research agreement with Dr.&#160;Saar Gill, Associate Professor of Medicine at the University of Pennsylvania and co-founder of Carisma, to develop CAR macrophages and microglia targeted against protein aggregates associated with neurodegenerative disease pathology. In addition, Carisma from time to time may enter into academic research collaborations to explore the development of new technologies and indications. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While these academic institutions have contractual obligations to Carisma, they are independent entities and are not under Carisma&#8217;s control or the control of Carisma&#8217;s officers or directors. Carisma&#8217;s research and licensing agreements with academic collaborators generally provide academic collaborators with license maintenance fees, development and regulatory milestone payments, royalties on net sales of products and a portion of sublicense income that Carisma receives. Upon the scheduled expiration of any academic collaboration, Carisma may not be able to renew the related agreement or any renewal could be on terms less favorable to Carisma than those contained in the existing agreement. Furthermore, either Carisma or the academic institution generally may terminate the sponsored research agreement for convenience following a specified notice period. If any of these academic institutions decides to not renew or to terminate the related agreement or decides to devote fewer resources to such activities, Carisma&#8217;s discovery efforts would be diminished, while its royalty obligations, if any, would continue unmodified. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Any acquisitions or in-license transactions that Carisma completes could disrupt its business, cause dilution to its stockholders or reduce its financial resources.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has licensed three patent families from the University of Pennsylvania and one patent family from New York University and may enter into transactions to in-license or acquire other businesses, intellectual property, technologies, product candidates or products. If Carisma determines to pursue a particular transaction, it may not be able to complete the transaction on favorable terms, or at all. Any in-licenses or acquisitions Carisma completes may not strengthen its competitive position, and these transactions may be viewed negatively by customers or investors. Carisma may decide to incur debt in connection with an in-license or acquisition or issue its common stock or other equity securities to the stockholders of the target company, which would reduce the&#160;percentage ownership of its existing stockholders. Carisma could incur losses resulting from undiscovered liabilities that are not covered by the indemnification it may obtain from the seller. In addition, Carisma may not be able to successfully integrate the acquired personnel, technologies and operations into its existing business in an effective, timely and nondisruptive manner. In-license and acquisition transactions may also divert management attention from day-to-day responsibilities, increase its expenses and reduce its cash available for operations and other uses. Carisma cannot predict the number, timing or size of additional future in-licenses or acquisitions or the effect that any such transactions might have on its operating results. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to obtain, maintain and enforce patent protection for its technology and product candidates or if the scope of the patent protection obtained is not sufficiently broad, its competitors could develop and commercialize technology and products similar or identical to Carisma&#8217;s, and its ability to successfully develop and commercialize its technology and product candidates may be adversely affected and Carisma may not be able to compete effectively in its market.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial success depends in part on its ability to obtain, maintain and enforce protection of the intellectual property it may own solely and jointly with others or may license from others, particularly patents, in the United States and other countries with respect to any proprietary technology and product candidates. Carisma seeks to protect its proprietary position by filing patent applications in the United States and abroad related to its technologies and product candidates that are important to its business and by in-licensing intellectual property related to such technologies and product candidates. If Carisma is unable to obtain, maintain or enforce patent protection with respect to any proprietary technology or product candidate, its business, financial condition, results of operations and prospects could be materially harmed. Any disclosure to or misappropriation by third parties of Carisma&#8217;s confidential proprietary information could enable competitors to quickly duplicate or surpass Carisma&#8217;s technological achievements, thus eroding Carisma&#8217;s competitive position in its market. Moreover, the patent applications Carisma owns, co-owns or licenses may fail to result in issued patents in the United States or in other foreign countries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent prosecution process is expensive, time-consuming and complex, and Carisma may not be able to file, prosecute, maintain, defend or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that Carisma will fail to identify patentable aspects of its research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, Carisma does not have the right to control the preparation, filing and prosecution of patent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">applications, or to maintain, enforce and defend the patents, covering technology that Carisma licenses from third parties. Therefore, these in-licensed patents and applications may not be prepared, filed, prosecuted, maintained, defended and enforced in a manner consistent with the best interests of its business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The patent position of biopharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent&#160;years been the subject of much litigation. In addition, the scope of patent protection outside of the United States is uncertain and laws of foreign countries may not protect Carisma&#8217;s rights to the same extent as the laws of the United States or vice versa. For example, European patent law restricts the patentability of methods of treatment of the human body more than United States law does. With respect to both owned and in-licensed patent rights, Carisma cannot predict whether the patent applications Carisma and its licensors are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors. Further, Carisma may not be aware of all third-party intellectual property rights potentially relating to its product candidates. In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&#160;months after filing, or in some cases not published at all. Therefore, neither Carisma nor its licensors can know with certainty whether either Carisma or its licensors were the first to make the inventions claimed in the patents and patent applications Carisma owns or in-licenses now or in the future, or that either Carisma or its licensors were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of its patent rights are highly uncertain. Moreover, its owned or in-licensed pending and future patent applications may not result in patents being issued which protects its technology and product candidates, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of its patents and its ability to obtain, protect, maintain, defend and enforce its patent rights, narrow the scope of its patent protection and, more generally, could affect the value or narrow the scope of its patent rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, Carisma or its licensors may be subject to a third-party preissuance submission of prior art to the USPTO or become involved in opposition, derivation, revocation, reexamination, inter partes review, post-grant review or interference proceedings challenging its patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, its patent rights, allow third parties to commercialize its technology or product candidates and compete directly with it, without payment to it, or result in its inability to manufacture or commercialize products without infringing third-party patent rights. If the breadth or strength of protection provided by its patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with it to license, develop or commercialize current or future product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s owned or licensed patent estate includes patent applications, many of which are at an early stage of prosecution. The coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Even if its owned or in-licensed patent applications issue as patents, they may not issue in a form that will provide it with any meaningful protection, prevent competitors from competing with it or otherwise provide it with any competitive advantage. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and its owned and in-licensed patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit its ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of its technology and product candidates. Such proceedings also may result in substantial cost and require significant time from its management and employees, even if the eventual outcome is favorable to Carisma. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. Furthermore, its competitors may be able to circumvent its owned or in-licensed patents by developing similar or alternative technologies or products in a non-infringing manner. As a result, its patent portfolio may not provide it with sufficient rights to exclude others from commercializing technology and products similar or identical to any of its technology and product candidates. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patent terms may be inadequate to protect Carisma&#8217;s competitive position with respect to its current or future product candidates for an adequate amount of time.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20&#160;years from its earliest U.S. non-provisional filing date. Various extensions may be available, but there is no assurance that any such extensions will be obtained, and the life of a patent, and the protection it affords, is limited. Even if patents covering Carisma&#8217;s current or future product candidates are obtained, once the patent life has expired, it may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, its patent portfolio may not provide it with sufficient rights to exclude others from commercializing products similar or identical to Carisma&#8217;s. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">In the United States, patent term can also be adjusted due to delays that occur during examination of patent applications, which may extend the term of a patent beyond 20&#160;years. There is a risk that Carisma may take action that detracts from any accrued patent term adjustment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">It is necessary to pay certain maintenance fees, also referred to as annuities or renewal fees in some countries, throughout the lifetime of a patent at regular intervals. Failure to pay these fees can cause a granted patent to prematurely expire, without an opportunity for revival. There is a risk that Carisma may be unable to maintain patent protection for certain patents in all markets due to finite availability of resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to obtain licenses from third parties on commercially reasonable terms or fail to comply with its obligations under such agreements, its business could be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It may be necessary for it to use the patented or proprietary technology of third parties to commercialize its products, in which case Carisma would be required to obtain a license from these third parties. If Carisma is unable to license such technology, or if Carisma is forced to license such technology on unfavorable terms, its business could be materially harmed. If Carisma is unable to obtain a necessary license, Carisma may be unable to develop or commercialize the affected product candidate(s), which could materially harm its business and the third parties owning such intellectual property rights could seek either an injunction prohibiting its sales or an obligation on its part to pay royalties and/or other forms of compensation. Even if Carisma is able to obtain a license, it may be non-exclusive, thereby giving its competitors access to the same technologies licensed to it. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights Carisma has, Carisma may be required to expend significant time and resources to redesign its technology, product candidates, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If Carisma is unable to do so, Carisma may be unable to develop or commercialize the affected technology and product candidates, which could harm its business, financial condition, results of operations and prospects significantly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, if Carisma fails to comply with its obligations under any license agreements, its counterparties may have the right to terminate these agreements, in which event Carisma might not be able to develop, manufacture or market, or may be forced to cease developing, manufacturing or marketing, any product that is covered by these agreements or may face other penalties under such agreements. Such an occurrence could materially adversely affect the value of the product candidate being developed under any such agreement. Termination of these agreements or reduction or elimination of its rights under these agreements, or restrictions on its ability to freely assign or sublicense its rights under such agreements when it is in the interest of its business to do so, may result in it having to negotiate new or restated agreements with less favorable terms, cause it to lose its rights under these agreements, including its rights to important intellectual property or technology or impede, or delay or prohibit the further development or commercialization of one or more product candidates that rely on such agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma does not obtain patent term extension for any product candidates it may develop, its business may be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, the term of a patent that covers an FDA-approved drug may, in certain cases, be eligible for a patent term extension under the Drug Price Competition and Patent Term Restoration Act of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1984, or the Hatch-Waxman Act, as compensation for the loss of a patent term during the FDA regulatory review process for a drug product subject to the provisions of the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term extension of up to five&#160;years, but patent extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval. Only one patent among those eligible for an extension and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions are available in Europe and certain other non-United States jurisdictions to extend the term of a patent that covers an approved drug. While, in the future, if and when its product candidates receive FDA approval, Carisma expects to apply for patent term extensions on patents covering those product candidates, there is no guarantee that the applicable authorities, including the FDA, will agree with its assessment of whether such extensions should be granted, and even if granted, the length of such extensions. Carisma may not be granted patent term extension either in the United States or in any foreign country because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the term of extension, as well as the scope of patent protection during any such extension, afforded by the governmental authority could be less than requests. If Carisma is unable to obtain any patent term extension or the term of any such extension is less than it requests, its competitors may obtain approval of competing products following the expiration of its patent rights, and its business, financial condition, results of operations and prospects could be materially harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes to patent laws in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing its ability to protect its products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Changes in either the patent laws or interpretation of patent laws in the United States, including patent reform legislation such as the Leahy-Smith America Invents Act, or the Leahy-Smith Act, could increase the uncertainties and costs surrounding the prosecution of its owned or in-licensed patent applications and the maintenance, enforcement or defense of its owned or in-licensed issued patents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the patent positions of companies in the development and commercialization of pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and wakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on Carisma&#8217;s patent rights and its ability to protect, defend and enforce its patent rights in the future. Similarly, changes in patent law and regulations in other countries or jurisdictions, changes in the governmental bodies that enforce them or changes in how the relevant governmental authority enforces patent laws or regulations may weaken Carisma&#8217;s ability to obtain new patents or to enforce patents that Carisma owns or has licensed or that Carisma may obtain in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The federal government retains certain rights in inventions created using its financial assistance under the Bayh-Dole Act. The federal government retains a &#8220;nonexclusive, nontransferable, irrevocable, paid-up license&#8221; for its own benefit. The Bayh-Dole Act also provides federal agencies with &#8220;march-in rights&#8221;. March-in rights allow the government, in specified circumstances, to require the contractor or successors in title to the patent to grant a &#8220;nonexclusive, partially exclusive, or exclusive license&#8221; to a &#8220;responsible applicant or applicants.&#8221; If the patent owner refuses to do so, the government may grant the license itself. Carisma collaborates with a number of universities with respect to certain of its research and development. Carisma cannot be sure that any co-developed intellectual property will be free from government rights pursuant to the Bayh-Dole Act. If, in the future, Carisma co-owns or in-licenses technology which is critical to its business that is developed in whole or in part with federal funds subject to the Bayh-Dole Act, its ability to enforce or otherwise exploit patents covering such technology may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Although Carisma or its licensors are not currently involved in any litigation, Carisma may become involved in lawsuits to protect or enforce its patent, the patents of its licensors or other intellectual property rights, which could be expensive, time-consuming and unsuccessful.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Competitors and other third parties may infringe, misappropriate or otherwise violate Carisma&#8217;s or its licensor&#8217;s issued patents, the patents of its licensors or other intellectual property. It may be difficult to detect </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">infringers who do not advertise the components that are used in their products. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor&#8217;s product. To counter infringement or misappropriation, Carisma or its licensors may need to file infringement, misappropriation or other intellectual property related claims, which can be expensive and time-consuming and can distract its management and scientific personnel. There can be no assurance that Carisma will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for&#160;years before they are concluded. Any claims Carisma asserts against perceived infringers could provoke such parties to assert counterclaims against it, alleging that it infringes, misappropriates or otherwise violates their intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in a patent infringement proceeding, such parties could counterclaim that the patents Carisma or its licensors have asserted are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including novelty, non-obviousness, enablement, or written description. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. Third parties may institute such claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post-grant review, inter partes review, interference proceedings, derivation proceedings, and equivalent proceedings in foreign jurisdictions, such as opposition proceedings. The outcome following legal assertions of invalidity and unenforceability is unpredictable. Similarly, if Carisma or its licensors assert trademark infringement claims, a court may determine that the marks Carisma or its licensors have asserted are invalid or unenforceable, or that the party against whom Carisma or its licensors have asserted trademark infringement has superior rights to the marks in question. In this case, Carisma could ultimately be forced to cease use of such trademarks, which could materially harm its business and negatively affect its position in the marketplace. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An adverse result in any such proceeding could put one or more of its owned or in-licensed patents at risk of being invalidated, held unenforceable or interpreted narrowly, could put any of its owned or in-licensed patent applications at risk of not yielding an issued patent, and could limit its or its licensor&#8217;s ability to assert those patents against those parties, or other competitors, and curtail or preclude its ability to exclude third parties from developing and commercializing similar or competitive products. A court may also refuse to stop the third party from using the technology at issue in a proceeding on the grounds that its owned or in-licensed patents do not cover such technology. Even if Carisma establishes infringement, a court may not order the third party to stop using the technology at issue and instead award only monetary damages to Carisma, which may not be an adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of its confidential information or trade secrets could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of its common stock. Any of the foregoing could allow such third parties to develop and commercialize competing technologies and products and have a material adverse impact on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Interference or derivation proceedings provoked by third parties or brought by Carisma or declared by the USPTO may be necessary to determine the priority of inventions with respect to its patents or patent applications. An unfavorable outcome could require it to cease using the related technology or to attempt to license rights to it from the prevailing party. Carisma&#8217;s business could be harmed if the prevailing party does not offer it a license on commercially reasonable terms or at all, or if a non-exclusive license is offered and its competitors gain access to the same technology. Its defense of litigation or interference or derivation proceedings may fail and, even if successful, may result in substantial costs and distract its management, technical personnel and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on its ability to raise the funds necessary to continue its clinical trials, continue its research programs, license necessary technology from third parties, or enter into development partnerships that would help it bring its product candidates to market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any such litigation or proceedings could substantially increase Carisma&#8217;s operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of Carisma&#8217;s competitors may be able to sustain the costs of such litigation or proceedings more effectively than Carisma can because of their greater financial resources in one or more aspects, or for other reasons. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise Carisma&#8217;s ability to compete in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may need to license intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A third party may hold intellectual property, including patent rights, that are important or necessary to the development of Carisma&#8217;s products. It may be necessary for it to use the patented or proprietary technology of a third party to commercialize its own technology or products, in which case it would be required to obtain a license from such third party. A license to such intellectual property may not be available or may not be available on commercially reasonable terms, which could have a material adverse effect on Carisma&#8217;s business and financial condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The licensing and acquisition of third-party intellectual property rights is a competitive practice, and companies that may be more established, or have greater resources than Carisma, may also be pursuing strategies to license or acquire third-party intellectual property rights that it may consider necessary or attractive in order to commercialize its product candidates. More established companies may have a competitive advantage over Carisma due to their larger size and cash resources or greater clinical development and commercialization capabilities. Carisma may not be able to successfully complete such negotiations and ultimately acquire the rights to the intellect al property surrounding the additional product candidates that it may seek to acquire. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Third parties may initiate legal proceedings alleging that Carisma is infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial success depends upon its ability and the ability of its collaborators to develop, manufacture, market and sell its product candidates and use its proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property and proprietary rights of third parties. There is considerable patent and other intellectual property litigation in the biopharmaceutical industry. Carisma may become party to, or threatened with, adversarial proceedings or litigation regarding intellectual property rights with respect to its technology and product candidates, including interference proceedings, post grant review, </font><font style="font-style:italic;letter-spacing:0.2pt;">inter partes</font><font style="letter-spacing:0.2pt;"> review, and derivation proceedings before the USPTO and similar proceedings in foreign jurisdictions, such as opposition proceedings before the European Patent Office. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which Carisma is pursuing development candidates. As the biopharmaceutical industry expands and more patents are issued, the risk increases that its technologies or product candidates that Carisma may identify may be subject to claims of infringement of the patent rights of third parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The legal threshold for initiating litigation or contested proceedings is low, so even lawsuits or proceedings with a low probability of success might be initiated and require significant resources to defend. Litigation and contested proceedings can also be expensive and time-consuming, and its adversaries in these proceedings may have the ability to dedicate substantially greater resources to prosecuting these legal actions than Carisma can. The risks of being involved in such litigation and proceedings may increase if and as its product candidates near commercialization and as Carisma gains the greater visibility associated with being a public company. Third parties may assert infringement claims against it based on existing patents or patents that may be granted in the future, regardless of merit. Even if Carisma diligently searches third-party patents for potential infringement by its products or product candidates, it may not successfully find patents its products or product candidates may infringe. Carisma may not be aware of all such intellectual property rights potentially relating to its technology and product candidates and their uses, or Carisma may incorrectly conclude that third-party intellectual property is invalid or that its activities and product candidates do not infringe such intellectual property. Thus, Carisma does not know with certainty that its technology and product candidates, or its development and commercialization thereof, do not and will not infringe, misappropriate or otherwise violate any third party&#8217;s intellectual property. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Third parties may assert that Carisma is employing its proprietary technology without authorization. There may be third-party patents or patent applications with claims to materials, formulations or methods, such as methods of manufacture or methods for treatment, related to the discovery, use or manufacture of the product candidates that Carisma may identify or related to its technologies. Because patent applications can take many&#160;years to issue, there may be currently pending patent applications which may later result in issued patents that the product candidates that Carisma may identify may infringe. In addition, third parties may obtain patents in the future and claim that use of its technologies infringe upon these patents. Moreover, as noted above, there may be existing patents that Carisma is not aware of or that Carisma has incorrectly concluded are invalid or not infringed by its activities. If any third-party patents were held by a court of competent jurisdiction to cover, for example, the manufacturing process of the product candidates that Carisma may identify, any molecules formed during the manufacturing process or any final product itself, the holders of any such patents may be able to block its ability to commercialize such product candidate unless Carisma obtained a license under the applicable patents, or until such patents expire. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Parties making claims against it may obtain injunctive or other equitable relief, which could effectively block its ability to further develop and commercialize the product candidates that Carisma may identify. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from its business. In the event of a successful claim of infringement against us, Carisma may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, pay royalties, redesign its infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may choose to take a license or, if it is found to infringe, misappropriate or otherwise violate a third party&#8217;s intellectual property rights, it could also be required to obtain a license from such third party to continue developing, manufacturing and marketing its technology and product candidates. However, it may not be able to obtain any required license on commercially reasonable terms or at all. Even if it is able to obtain a license, it could be non-exclusive, thereby giving its competitors and other third parties access to the same technologies licensed to it and could require it to make substantial licensing and royalty payments. Carisma could be forced, including by court order, to cease developing, manufacturing and commercializing the infringing technology or product. In addition, Carisma could be found liable for significant monetary damages, including treble damages and attorneys&#8217; fees, if Carisma is found to have willfully infringed a patent or other intellectual property right, it could be forced to indemnify its customers or collaborators. A finding of infringement could prevent it from commercializing its product candidates or force it to cease some of its business operations, which could materially harm its business. In addition, Carisma may be forced to redesign its product candidates, seek new regulatory approvals and indemnify third parties pursuant to contractual agreements. Claims that Carisma has misappropriated the confidential information or trade secrets of third parties could have a similar material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If its trademarks and trade names are not adequately protected, then Carisma may not be able to build name recognition in its markets of interest and its business may be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While Carisma seeks to protect the trademarks and trade names it uses in the United States and in other countries, it may be unsuccessful in obtaining registrations or otherwise protecting these trademarks and trade names, which it needs to build name recognition in its markets of interest and among potential partners or customers. Carisma relies on both registration and common law protection for its trademarks. Its registered or unregistered trademarks or trade names may be challenged, infringed, diluted or declared generic, or determined to be infringing on other marks. At times, competitors may adopt trademarks and trade names similar to ours, or collaborators may fail to use Carisma&#8217;s trade names or trademarks, thereby impeding its ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of its registered or unregistered trademarks. If Carisma is unable to protect its rights to trademarks and trade names, Carisma may be prevented from using such marks and names unless Carisma enters into appropriate royalty, license or coexistence agreements, which may not be available or may not be available on commercially reasonable terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During trademark registration proceedings, Carisma may receive rejections. Although Carisma would be given an opportunity to respond to those rejections, it may be unable to overcome such rejections. In </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against its trademarks, and its trademarks may not survive such proceedings. Effective trademark protection may not be available or may not be sought in every country in which its products are made available. Any name Carisma proposes to use for its products in the United States must be approved by the FDA, regardless of whether Carisma has registered it, or applied to register it, as a trademark. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA objects to any of its proposed product names, Carisma may be required to expend significant additional resources in an effort to identify a usable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. If Carisma is unable to establish name recognition based on its trademarks and trade names, Carisma may not be able to compete effectively and its business may be adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may license its trademarks and trade names to third parties, such as distributors and collaborators. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of or failure to use our trademarks and trade names by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks, and trade names. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, trade secrets, know-how, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect Carisma&#8217;s business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property litigation or other legal proceedings relating to intellectual property could cause it to spend substantial resources and distract its personnel from their normal responsibilities.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if resolved in its favor, litigation or other legal proceedings relating to intellectual property claims may cause it to incur significant expenses and could distract its technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of its common stock. Such litigation or proceedings could substantially increase its operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. Carisma may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of its competitors may be able to sustain the costs of such litigation or proceedings more effectively than Carisma can because of their greater financial resources and may also have an advantage in such proceedings due to their more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of intellectual property litigation or other proceedings could compromise its ability to compete in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and its patent protection could be reduced or eliminated for non-compliance with these requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Periodic maintenance, renewal and annuity fees and various other government fees on any issued patent and pending patent application must be paid to the USPTO and foreign patent agencies in several stages or annually over the lifetime of its patents and patent applications. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In certain circumstances, Carisma relies on its licensing partners to pay these fees to, or comply with the procedural and documentary rules of, the relevant patent agency. With respect to its patents, Carisma relies on an annuity service, outside firms and outside counsel to remind it of the due dates and to make payment after Carisma instructs them to do so. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include failure to respond to official actions within prescribed time limits, non-payment of fees </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and failure to properly legalize and submit formal documents. In such an event, potential competitors might be able to enter the market with similar or identical products or technology. If Carisma or its licensors fail to maintain the patents and patent applications covering its product candidates, it would have a material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma fails to comply with its obligations in its current and future intellectual property licenses and funding arrangements with third parties, or otherwise experience disruptions to its business relationships with its licensors, Carisma could lose intellectual property rights that are important to its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is party to a number license and research agreements. Some of these agreements provide Carisma with the intellectual property rights required for the development of its product candidates, including the license agreement with the University of Pennsylvania. These licenses and research agreements and similar agreements in the future may impose diligence, development and commercialization timelines, and milestone payment, royalty, insurance and other obligations on Carisma. If Carisma fails to comply with such obligations, the parties to these agreements may decide to terminate the agreements or require Carisma to grant them certain rights, in which Carisma may not be able to develop, manufacture, or market any products without the rights granted to it by these agreements and may face other penalties. Any such occurrences could adversely affect the value of any product candidate being developed, including CT-0508. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For a variety of purposes, Carisma will likely enter into additional licensing and funding arrangements with third parties that may impose similar obligations on Carisma. Termination of these agreements or reduction or elimination of its rights under these agreements may result in it having to negotiate new or restated agreements with less favorable terms, or cause it to lose its rights under these agreements, including its rights to important intellectual property or technology, which would have a material adverse effect on its business, financial condition, results of operations and prospects. While Carisma still faces all of the risks described herein with respect to such agreements, Carisma cannot prevent third parties from also accessing those technologies. In addition, its licenses may place restrictions on its future business opportunities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the above risks, intellectual property rights that Carisma licenses in the future may include sublicenses under intellectual property owned by third parties, in some cases through multiple tiers. The actions of its licensors may therefore affect its rights to use its sublicensed intellectual property, even if Carisma is in compliance with all of the obligations under its license agreements. Should its licensors or any of the upstream licensors fail to comply with their obligations under the agreements pursuant to which they obtain the rights that are sublicensed to Carisma, or should such agreements be terminated or amended, its ability to develop and commercialize its product candidates may be materially harmed. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Disputes may arise regarding intellectual property subject to a licensing agreement, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope of rights granted under the license agreement and other interpretation related issues; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which its technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sublicensing of patent and other rights under its collaborative development relationships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its diligence obligations under the license agreement and what activities satisfy those diligence obligations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by its licensors and it and its partners; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the payment obligations with respect to licensed technology. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the agreements under which Carisma currently licenses intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what Carisma believes to be the scope of its rights to the relevant intellectual property or technology or increase what Carisma believes to be its financial or other obligations under the relevant agreement, either of which could have a material adverse effect on its business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that Carisma has licensed prevent or impair its ability to maintain its current licensing arrangements on commercially acceptable terms, Carisma may be unable to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">successfully develop and commercialize the affected technology and product candidates, which could have a material adverse effect on its business, financial conditions, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, licensors could retain the right to prosecute and defend the intellectual property rights licensed to Carisma, in which case Carisma would depend on its licensors to control the prosecution, maintenance and enforcement of all of its licensed and sublicensed intellectual property, and even when it does have such rights, Carisma may require the cooperation of its licensors and upstream licensors, which may not be forthcoming. Licensors may determine not to pursue litigation against other companies or may pursue such litigation less aggressively than Carisma would. Its business could be adversely affected if Carisma or its licensors are unable to prosecute, maintain and enforce its licensed and sublicensed intellectual property effectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s current or future licensors may have relied on third-party consultants or collaborators or on funds from third parties such that its licensors are not the sole and exclusive owners of the patents and patent applications Carisma in-licenses. If other third parties have ownership rights to patents or patent applications Carisma in-licenses, they may be able to license such patents to its competitors, and its competitors could market competing products and technology. This could have a material adverse effect on its competitive position, business, financial conditions, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In spite of its best efforts, its licensors might conclude that Carisma has materially breached its license agreements and might therefore terminate the license agreements, thereby removing its ability to develop and commercialize product candidates and technology covered by these license agreements. If these in-licenses are terminated, or if the underlying intellectual property fails to provide the intended exclusivity, competitors would have the freedom to seek regulatory approval of, and to market, products and technologies identical to its. This could have a material adverse effect on its competitive position, business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may not be able to protect its intellectual property and proprietary rights throughout the world.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and the laws of foreign countries may not protect its rights to the same extent as the laws of the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States, and even where such protection is nominally available, judicial and governmental enforcement of such intellectual property rights may be lacking. Consequently, Carisma may not be able to prevent third parties from practicing its inventions in all countries outside the United States, or from selling or importing products made using its inventions in and into the United States or other jurisdictions. Competitors may use its technologies in jurisdictions where Carisma has not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where Carisma has patent protection or licenses but enforcement is not as strong as that in the United States. These products may compete with its products, and its patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for it to stop the infringement of its patents or marketing of competing products in violation of its intellectual property and proprietary rights generally. In addition, certain jurisdictions do not protect to the same extent or at all inventions that constitute new methods of treatment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Proceedings to enforce its intellectual property and proprietary rights in foreign jurisdictions could result in substantial costs and divert its efforts and attention from other aspects of its business, could put its patents at risk of being invalidated, held unenforceable or interpreted narrowly, could put its patent applications at risk of not issuing, and could provoke third parties to assert claims against Carisma. Carisma may not prevail in any lawsuits that Carisma initiates, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, its efforts to enforce its intellectual property and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that Carisma develops or licenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If Carisma or any of its licensors are forced to grant a license to third parties with respect to any patents relevant to its business, its competitive position may be impaired, and its business, financial condition, results of operations and prospects may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may be subject to claims challenging the inventorship or ownership of its patents and other intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma or its licensors may be subject to claims that former employees, collaborators or other third parties have an interest in its owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor. For example, Carisma or its licensors may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing its product candidates. Although it is Carisma&#8217;s policy to require its employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, Carisma may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that Carisma regards as its own, and Carisma cannot be certain that its agreements with such parties will be upheld in the face of a potential challenge, or that they will not be breached, for which Carisma may not have an adequate remedy. The assignment of intellectual property rights may not be self-executing or the assignment agreements may be breached, and litigation may be necessary to defend against these and other claims challenging inventorship or its or its licensors&#8217; ownership of its owned or in-licensed patents, trade secrets or other intellectual property. If Carisma or its licensors fail in defending any such claims, in addition to paying monetary damages, Carisma may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to its product candidates. Even if Carisma is successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may be subject to claims by third parties asserting that its employees, consultants or contractors have wrongfully used or disclosed confidential information of third parties, including of their current or former employers or claims asserting Carisma has misappropriated their intellectual property, or is claiming ownership of what Carisma regards as its own intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of Carisma&#8217;s employees, consultants and contractors have been previously employed at universities or other biopharmaceutical companies, including its competitors or potential competitors. Although Carisma tries to ensure that its employees, consultants and contractors do not use the proprietary information or know-how of others in their work for Carisma, Carisma may be subject to claims that these individuals or Carisma have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employer. Litigation may be necessary to defend against these claims. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma fails in prosecuting or defending any such claims, in addition to paying monetary damages, Carisma may lose valuable intellectual property rights or personnel, which could have a material adverse effect on its competitive business position and prospects. Such intellectual property rights could be awarded to a third party, and Carisma could be required to obtain a license from such third party to commercialize its technology or products, which license may not be available on commercially reasonable terms, or at all, or such license may be non-exclusive. Even if Carisma is successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to its management and employees. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to protect the confidentiality of its trade secrets, its business and competitive position would be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to seeking patents for some of its technology and product candidates, Carisma also relies on trade secrets and confidentiality agreements to protect its unpatented know-how, technology and other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">proprietary information, to maintain its competitive position. Carisma seeks to protect its trade secrets and other proprietary technology, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as its employees, corporate collaborators, outside scientific collaborators, contract research organizations, contract manufacturers, consultants, advisors and other third parties. Carisma may have also entered into confidentiality and invention or patent assignment agreements with its employees and consultants, but Carisma cannot guarantee that it has entered into such agreements with each party that may have or has had access to its trade secrets or proprietary technology. To the extent Carisma becomes involved in litigation that may require discovery of its trade secrets, know-how and other proprietary technology, Carisma will seek to secure protective orders from the court that bind the parties with access to the discovered information. Despite these efforts, any of these parties may breach the agreements and disclose its proprietary information, including its trade secrets, and Carisma may not be able to obtain adequate remedies for such breaches. Detecting the disclosure or misappropriation of a trade secret and enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside of the United States are less willing or unwilling to protect trade secrets. In addition, Carisma cannot be certain that proprietary technical information and related confidential documents that Carisma has shared with its collaborators and/or submitted to governmental agencies, including regulatory agencies for evaluation and supervision of pharmaceutical products, will be kept confidential. If any of its trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, Carisma would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with Carisma. If any of its trade secrets were to be disclosed to or independently developed by a competitor or other third party, its competitive position would be materially and adversely harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property rights do not necessarily address all potential threats to Carisma.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The degree of future protection afforded by Carisma&#8217;s intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect its business or permit it to maintain its competitive advantage. For example: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">others may be able to make product candidates that are similar to Carisma&#8217;s but that are not covered by the claims of the patents that it owns or licenses; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma, or its license partners or current or future collaborators, might not have been the first to make the inventions covered by the issued patent or pending patent applications that it licenses or may own in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma, or its license partners or current or future collaborators, might not have been the first to file patent applications covering its inventions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">others may independently develop similar or alternative technologies or duplicate any of its technologies without infringing its owned or in-licensed intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it is possible that its owned or in-licensed pending patent applications or those Carisma may own or in-license in the future will not lead to issued patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">claims of issued patents that Carisma holds rights to may be held invalid or unenforceable, including as a result of legal challenges by its competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its competitors might conduct research, development, testing or commercialization activities in countries where Carisma does not have patent rights and then use the information learned from such activities to develop competitive products for sale in its major commercial markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that any of its patents, or any of its pending patent applications, if issued, or those of its licensors, will include claims having a scope sufficient to protect its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that any patents issued to it or its licensors will provide a basis for an exclusive market for its commercially viable product candidates or will provide it with any competitive advantages; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the U.S. Supreme Court, other federal courts, Congress, the USPTO or similar foreign authorities may change the standards of patentability and any such changes could narrow or invalidate, or change the scope of, Carisma&#8217;s or its licensors&#8217; patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">patent terms may be inadequate to protect its competitive position on its product candidates for an adequate amount of time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that its commercial activities or product candidates will not infringe upon the patents of others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that it will be able to successfully commercialize its product candidates on a substantial scale, if approved, before the relevant patents that it owns or licenses expire; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may not develop additional proprietary technologies that are patentable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the patents of others may harm its business; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Should any of these events occur, they could have a material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Regulatory Approval and Other Legal Compliance Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The regulatory approval process of the FDA is lengthy, time-consuming and inherently unpredictable, and if Carisma is ultimately unable to obtain marketing approval for its product candidates, its business will be substantially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The time required to obtain approval by the FDA is unpredictable but typically takes many&#160;years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions. Carisma has not obtained marketing approval for any product candidate and it is possible that none of its existing product candidates, or any product candidates it may seek to develop in the future will ever obtain marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates could fail to receive marketing approval for many reasons, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA may disagree with the design or implementation of Carisma&#8217;s clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may be unable to demonstrate to the satisfaction of the FDA that a product candidate is safe and effective for its proposed indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">results of clinical trials may not meet the level of statistical significance required by the FDA for approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA may disagree with Carisma&#8217;s interpretation of data from pre-clinical studies or clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">data collected from clinical trials of Carisma&#8217;s product candidates may not be sufficient to support the submission of an NDA to the FDA or other submission or to obtain marketing approval in the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the FDA may find deficiencies with or fail to approve the manufacturing processes or facilities of third-party manufacturers with which Carisma contracts for clinical and commercial supplies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the approval policies or regulations of the FDA may significantly change in a manner rendering Carisma&#8217;s clinical data insufficient for approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This lengthy approval process as well as the unpredictability of future clinical trial results may result in Carisma failing to obtain marketing approval to market any of its product candidates, which would significantly harm its business, results of operations and prospects. The FDA has substantial discretion in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the approval process and determining when or whether marketing approval will be obtained for any of Carisma&#8217;s product candidates. Even if Carisma believes the data collected from clinical trials of its product candidates are promising, such data may not be sufficient to support approval by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, even if Carisma were to obtain approval, regulatory authorities may approve any of Carisma&#8217;s product candidates for fewer or more limited indications than it requests, may not approve the price it intends to charge for its products, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for Carisma&#8217;s product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if Carisma completes the necessary pre-clinical studies and clinical trials, the marketing approval process is expensive, time-consuming and uncertain and may prevent Carisma from obtaining approvals for the commercialization of some or all of its product candidates. If Carisma is not able to obtain, or if there are delays in obtaining, required regulatory approvals, it will not be able to commercialize, or will be delayed in commercializing, its product candidates, and its ability to generate revenue will be materially impaired.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, export and import are subject to comprehensive regulation by the FDA and other regulatory authorities in the United States and by the EMA and other regulatory authorities outside of the United States. Failure to obtain marketing approval for a product candidate will prevent Carisma from commercializing the product candidate. Carisma has not submitted an application for or received marketing approval for any of its product candidates in the United States or in any other jurisdiction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has only limited experience in filing and supporting the applications necessary to gain marketing approvals and expect to rely on third-party clinical research organizations or other third-party consultants or vendors to assist it in this process. Securing marketing approval requires the submission of extensive pre-clinical and clinical data and supporting information, including manufacturing information, to the various regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Carisma&#8217;s product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude Carisma obtaining marketing approval or prevent or limit commercial use. New cancer drugs frequently are indicated only for patient populations that have not responded to an existing therapy or have relapsed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The process of obtaining marketing approvals, both in the United States and abroad, is expensive, may take many&#160;years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that Carisma&#8217;s data is insufficient for approval and require additional pre-clinical, clinical or other studies. In addition, varying interpretations of the data obtained from pre-clinical and clinical testing could delay, limit or prevent marketing approval of a product candidate. Any marketing approval Carisma ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma experiences delays in obtaining approval or if it fails to obtain approval of its product candidates, the commercial prospects for its product candidates may be harmed and its ability to generate revenues will be materially impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure to obtain marketing approval in foreign jurisdictions would prevent Carisma&#8217;s product candidates from being marketed in such jurisdictions, which, in turn, would materially impair Carisma&#8217;s ability to generate revenue. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to market and sell its products in the European Union and many other foreign jurisdictions, Carisma and its collaborators must obtain separate marketing approvals and comply with numerous and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The marketing approval process outside the United States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country. Carisma or these third parties may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. The failure to obtain approval in one jurisdiction may negatively impact Carisma&#8217;s ability to obtain approval elsewhere. Carisma may not be able to file for marketing approvals and may not receive necessary approvals to commercialize its products in any jurisdiction, which would materially impair its ability to generate revenue. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, Carisma could face heightened risks with respect to seeking marketing approval in the United Kingdom as a result of the withdrawal of the United Kingdom from the European Union, commonly referred to as Brexit. The United Kingdom is no longer part of the European Single Market and European Union Customs Union. As of January&#160;1, 2021, the Medicines and Healthcare products Regulatory Agency, or the MHRA, became responsible for supervising medicines and medical devices in Great Britain, comprising England, Scotland and Wales under domestic law, whereas Northern Ireland will continue to be subject to European Union rules under the Northern Ireland Protocol. The MHRA will rely on the Human Medicines Regulations&#160;2012 (SI 2012/1916) (as amended), or the HMR, as the basis for regulating medicines. The HMR has been incorporated into the domestic law of the body of European Union law instruments governing medicinal products that pre-existed prior to the United Kingdom&#8217;s withdrawal from the European Union. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of Brexit or otherwise, may force Carisma to restrict or delay efforts to seek regulatory approval in the United Kingdom for its product candidates, which could significantly and materially harm Carisma&#8217;s business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects that it will be subject to additional risks in commercializing any of its product candidates that receive marketing approval outside the United States, including tariffs, trade barriers and regulatory requirements; economic weakness, including inflation, or political instability in particular foreign economies and markets; compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country; and workforce uncertainty in countries where labor unrest is more common than in the United States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Inadequate funding for the FDA, the SEC and other government agencies, including from government shutdowns, or other disruptions to these agencies&#8217; operations, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of Carisma&#8217;s business may rely, which could negatively impact its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent&#160;years as a result. Disruptions at the FDA and other agencies may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect Carisma&#8217;s business. In addition, government funding of the SEC and other government agencies on which Carisma&#8217;s operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Disruptions at the FDA and other agencies may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect Carisma&#8217;s business. For example, over the last several&#160;years the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process Carisma&#8217;s regulatory submissions, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which could have a material adverse effect on Carisma&#8217;s business. Further, future government shutdowns could impact Carisma&#8217;s ability to access the public markets and obtain necessary capital in order to properly capitalize and continue Carisma&#8217;s operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Separately, in response to the COVID-19 pandemic, a number of companies announced in 2021 receipt of complete response letters due to the FDA&#8217;s inability to complete required inspections for their applications. Following a period of false starts and temporary suspensions due to the omicron variant, the FDA resumed domestic inspections in February&#160;2022 and indicated that it would conduct foreign inspections beginning in April&#160;2022 on a prioritized basis. However, the FDA may not be able to continue its current pace and review timelines could be extended, including where a pre-approval inspection or an inspection of clinical sites is required and due to the ongoing COVID-19 pandemic and travel restrictions, the FDA is unable to complete such required inspections during the review period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a prolonged government shutdown or other disruption occurs, it could significantly impact the ability of the FDA to timely review and process Carisma&#8217;s regulatory submissions, which could have a material adverse effect on its business. Future shutdowns or other disruptions could also affect other government agencies such as the SEC, which may also impact Carisma&#8217;s business by delaying review of its public filings, to the extent such review is necessary, and Carisma&#8217;s ability to access the public markets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory requirements governing gene therapy products are periodically updated and may continue to change in the future.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA has established the Office of Tissues and Advanced Therapies, or the OTAT, within the Center for Biologics Evaluation and Research, or the CBER, to consolidate the review of gene therapy and related products, and has established the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER in its review. Gene therapy clinical trials conducted at institutions that receive funding for recombinant DNA research from the U.S. National Institutes of Health, or the NIH, also are potentially subject to review by the Office of Biotechnology Activities&#8217; Recombinant DNA Advisory Committee, or the RAC; however, the NIH announced that the RAC will only publicly review clinical trials if the trials cannot be evaluated by standard oversight bodies and pose unusual risks. Although the FDA decides whether individual gene therapy protocols may proceed, the RAC public review process, if undertaken, can delay the initiation of a clinical trial, even if the FDA has reviewed the trial design and details and approved its initiation. Conversely, the FDA can put an IND on a clinical hold even if the RAC has provided a favorable review or an exemption from in-depth, public review. If Carisma were to engage an NIH-funded institution to conduct a clinical trial, that institution&#8217;s institutional biosafety committee, or IBC, as well as its IRB would need to review the proposed clinical trial to assess the safety of the trial. In addition, adverse developments in clinical trials of gene therapy products conducted by others may cause the FDA or other oversight bodies to change the requirements for approval of Carisma&#8217;s product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA has issued various guidance documents regarding gene therapies, including final guidance documents released in January&#160;2020 relating to chemistry, manufacturing and controls information for gene therapy INDs, gene therapies for rare diseases and gene therapies for retinal disorders. Although the FDA has indicated that these and other guidance documents it previously issued are not legally binding, Carisma believes that its compliance with them is likely necessary to gain approval for any gene therapy product candidate that Carisma may develop. The guidance documents provide additional factors that the FDA will consider at each of the above stages of development and relate to, among other things, the proper pre-clinical assessment of gene therapies; the chemistry, manufacturing, and control information that should be included in an IND application; the proper design of tests to measure product potency in support of an IND or BLA application; and measures to observe delayed adverse effects in subjects who have been exposed to investigational gene therapies when the risk of such effects is high. Further, the FDA usually recommends that sponsors observe subjects for potential gene therapy-related delayed adverse events for a 15-year period, including a minimum of five&#160;years of annual examinations followed by 10&#160;years of annual queries, either in person or by questionnaire. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, for a gene therapy product, the FDA also will not approve the product if the manufacturer is not in compliance with good tissue practices, or GTP. These standards are found in FDA regulations and guidance that govern the methods used in, and the facilities and controls used for, the manufacture of human cells, tissues, and cellular and tissue based products, or HCT/Ps, which are human cells or tissue intended </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for implantation, transplant, infusion, or transfer into a human recipient. The primary intent of the GTP requirements is to ensure that cell and tissue based products are manufactured in a manner designed to prevent the introduction, transmission, and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through screening and testing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Finally, ethical, social and legal concerns about gene therapy, genetic testing and genetic research could result in additional regulations or prohibiting the processes that Carisma may use. Federal and state agencies, congressional committees and foreign governments have expressed their intentions to further regulate biotechnology. More restrictive regulations or claims that Carisma&#8217;s product candidates are unsafe or pose a hazard could prevent Carisma from commercializing any products. New government requirements may be established that could delay or prevent regulatory approval of Carisma&#8217;s product candidates under development. It is impossible to predict whether legislative changes will be enacted, regulations, policies or guidance changed, or interpretations by agencies or courts changed, or what the impact of such changes, if any, may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As Carisma advances its product candidates through clinical development, it will be required to consult with these regulatory and advisory groups, and comply with applicable guidelines. These regulatory review committees and advisory groups and any new guidelines they promulgate may lengthen the regulatory review process, require Carisma to perform additional studies, increase Carisma&#8217;s development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of Carisma&#8217;s product candidates or lead to significant post-approval limitations or restrictions. Delay or failure to obtain, or unexpected costs in obtaining, the regulatory approval necessary to bring a potential product to market could decrease Carisma&#8217;s ability to generate sufficient product revenue. </font>
        </div>
        <div style="margin-top:9.72pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if Carisma, or any collaborators, obtains marketing approvals for its product candidates, the terms of approvals and ongoing regulation of its products may limit how Carisma, or any collaborators, manufacture and market its products, which could materially impair Carisma&#8217;s ability to generate revenue.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Once marketing approval has been granted, an approved product and its manufacturer and marketer are subject to ongoing review and extensive regulation. Carisma, and any collaborators, must therefore comply with requirements concerning advertising and promotion for any of its product candidates for which Carisma or they obtain marketing approval. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#8217;s approved labeling. Thus, Carisma, and any collaborators will not be able to promote any products developed for indications or uses for which they are not approved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, manufacturers of approved products and those manufacturers&#8217; facilities are required to comply with extensive FDA requirements, including ensuring that quality control and manufacturing procedures conform to cGMPs, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. Carisma, its third-party manufacturers, any collaborators and their third-party manufacturers could be subject to periodic unannounced inspections by the FDA to monitor and ensure compliance with cGMPs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, assuming Carisma, or any collaborators, receive marketing approval for one or more of their product candidates, Carisma, and any collaborators, and Carisma and any collaborators&#8217; respective third-party manufacturers will continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma and such collaborators are not able to comply with post-approval regulatory requirements, Carisma and such collaborators could have the marketing approvals for their products withdrawn by regulatory authorities and Carisma or such collaborators&#8217;, ability to market any future products could be limited, which could adversely affect Carisma&#8217;s ability to achieve or sustain profitability. Further, the cost of compliance with post-approval regulations may have a negative effect on Carisma&#8217;s business, operating results, financial condition and prospects. </font>
        </div>
        <div style="margin-top:9.62pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may seek certain designations for its product candidates, including Breakthrough Therapy, Fast Track and Priority Review designations in the United States, but it might not receive such designations, and even if it does, such designations may not lead to a faster development or regulatory review or approval process.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may seek certain designations for one or more of its product candidates that could expedite review and approval by the FDA. A Breakthrough Therapy product is defined as a product that is intended, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">alone or in combination with one or more other products, to treat a serious condition, and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For products that have been designated as Breakthrough Therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may also designate a product for Fast Track review if it is intended, whether alone or in combination with one or more other products, for the treatment of a serious or life-threatening disease or condition, and it demonstrates the potential to address unmet medical needs for such a disease or condition. For Fast Track products, sponsors may have greater interactions with the FDA and the FDA may initiate review of sections of a Fast Track product&#8217;s application before the application is complete. This rolling review may be available if the FDA determines, after preliminary evaluation of clinical data submitted by the sponsor, that a Fast Track product may be effective. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma may also seek a priority review designation for one or more of its product candidates. If the FDA determines that a product candidate offers major advances in treatment or provides a treatment where no adequate therapy exists, the FDA may designate the product candidate for priority review. A priority review designation means that the goal for the FDA to review an application is six&#160;months, rather than the standard review period of ten&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These designations are within the discretion of the FDA. Accordingly, even if Carisma believes that one of its product candidates meets the criteria for these designations, the FDA may disagree and instead determine not to make such designation. Further, even if Carisma receives a designation, the receipt of such designation for a product candidate may not result in a faster development or regulatory review or approval process compared to products considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA, including the Fast Track designation Carisma received for CT-0508. In addition, even if one or more of Carisma&#8217;s product candidates qualifies for these designations, the FDA may later decide that the product candidates no longer meet the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma, or its collaborators, may seek approval from the FDA or comparable foreign regulatory authorities to use accelerated development pathways for its product candidates. If Carisma, or its collaborators, are not able to use such pathways, Carisma, or they, may be required to conduct additional clinical trials beyond those that are contemplated, which would increase the expense of obtaining, and delay the receipt of, necessary marketing approvals, if Carisma, or they, receive them at all. In addition, even if an accelerated approval pathway is available to Carisma, or its collaborators, it may not lead to expedited approval of Carisma&#8217;s product candidates, or approval at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Federal Food, Drug, and Cosmetic Act and implementing regulations, the FDA may grant accelerated approval to a product candidate to treat a serious or life-threatening condition that provides meaningful therapeutic benefit over available therapies, upon a determination that the product has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease, such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit measurement of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a drug. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage, but is a clinically important improvement from a patient and public health perspective. Prior to seeking such accelerated approval, Carisma, or its collaborators, will continue to seek feedback from the FDA or comparable foreign regulatory agencies and otherwise evaluate Carisma&#8217;s, or their, ability to seek and receive such accelerated approval. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that the FDA or foreign regulatory agencies will agree with Carisma&#8217;s, or its collaborators&#8217;, surrogate endpoints or intermediate clinical endpoints in any of Carisma&#8217;s, or their, clinical trials, or that Carisma, or its collaborators, will decide to pursue or submit any additional application for accelerated approval or any other form of expedited development, review or approval. Similarly, there can be no assurance that, after feedback from the FDA or comparable foreign regulatory agencies, Carisma, or its collaborators, will continue to pursue or apply for accelerated approval or any other form of expedited development, review or approval. Furthermore, for any submission of an application for accelerated approval or application under another expedited regulatory designation, there can be no assurance that such submission or application will be accepted for filing or that any expedited development, review or approval will be granted on a timely basis, or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A failure to obtain accelerated approval or any other form of expedited development, review or approval for Carisma&#8217;s product candidates, or withdrawal of a product candidate, would result in a longer time period until commercialization of such product candidate, could increase the cost of development of such product candidate and could harm Carisma&#8217;s competitive position in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may not be able to obtain orphan drug exclusivity for any product candidates it may develop, and even if it does, that exclusivity may not prevent the FDA or the EMA from approving other competing products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is a drug or biologic intended to treat a rare disease or condition. A similar regulatory scheme governs approval of orphan products by the EMA in the European Union. Generally, if a product candidate with an orphan drug designation subsequently receives the first marketing approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or the EMA from approving another marketing application for the same product for the same therapeutic indication for that time period. The applicable period is seven&#160;years in the United States and ten&#160;years in the European Union. The exclusivity period in the European Union can be reduced to six&#160;years if a product no longer meets the criteria for orphan drug designation, in particular if the product is sufficiently profitable so that market exclusivity is no longer justified. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order for the FDA to grant orphan drug exclusivity to one of Carisma&#8217;s products, the agency must find that the product is indicated for the treatment of a condition or disease with a patient population of fewer than 200,000 individuals annually in the United States. The FDA may conclude that the condition or disease for which Carisma seeks orphan drug exclusivity does not meet this standard. Even if Carisma obtains orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different products can be approved for the same condition. In addition, even after an orphan drug is approved, the FDA and comparable foreign regulatory authorities such as the EMA can subsequently approve the same product for the same condition if the FDA or such other authorities conclude that the later product is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. Orphan drug exclusivity may also be lost if the FDA or EMA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of the patients with the rare disease or condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2017, the Congress passed the FDA Reauthorization Act of 2017, or the FDARA. The FDARA, among other things, codified the FDA&#8217;s pre-existing regulatory interpretation, to require that a drug sponsor demonstrate the clinical superiority of an orphan drug that is otherwise the same as a previously approved drug for the same rare disease in order to receive orphan drug exclusivity. Under omnibus legislation signed by former President Trump in December&#160;2020, the requirement for a product to show clinical superiority applies to drugs and biologics that received orphan drug designation before enactment of FDARA in 2017, but have not yet been approved or licensed by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA and Congress may further reevaluate the Orphan Drug Act and its regulations and policies. This may be particularly true in light of a decision from the Court of Appeals for the </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1</font><font style="letter-spacing:0.2pt;">1th Circuit in September&#160;2021 finding that, for the purpose of determining the scope of exclusivity, the term &#8220;same disease or condition&#8221; means the designated &#8220;rare disease or condition&#8221; and could not be interpreted by the FDA to mean the &#8220;indication or use.&#8221; Thus, the court concluded, orphan drug exclusivity applies to the entire designated disease or condition rather than the &#8220;indication or use.&#8221; Carisma does not know if, when, or how the FDA may change the orphan drug regulations and policies in the future, and it is uncertain how any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">changes might affect Carisma&#8217;s business. Depending on what changes the FDA may make to its orphan drug regulations and policies, Carisma&#8217;s business could be adversely impacted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to successfully develop companion diagnostics for its product candidates and secure clearance or approval of such devices by the FDA and other regulatory authorities, or Carisma experiences significant delays in doing so, Carisma may not realize the full commercial potential of its therapeutics.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma believes that its success will depend, in part, on its ability to develop companion diagnostics, which are assays or tests to identify an appropriate patient population for these product candidates. Carisma has little experience in the development of diagnostics and may not be successful in developing appropriate diagnostics to pair with any of its therapeutic product candidates that receive marketing approval. Companion diagnostics are subject to regulation by the FDA and similar regulatory authorities outside the United States as medical devices and require separate regulatory approval prior to commercialization. Given Carisma&#8217;s limited experience in developing diagnostics, it relies and expects to continue to rely in part or in whole on third parties for their design and manufacture. Carisma also may in the future depend on other third parties for the development of other companion diagnostics for its therapeutic product candidates. If Carisma or its collaborators are unable to successfully develop companion diagnostics for Carisma&#8217;s therapeutic product candidates, or experience delays in doing so: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the development of Carisma&#8217;s therapeutic product candidates may be adversely affected if Carisma is unable to appropriately select patients for enrollment in its clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s therapeutic product candidates may not receive marketing approval if safe and effective use of a therapeutic product candidate depends on an in vitro diagnostic; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma may not realize the full commercial potential of any therapeutics that receive marketing approval if, among other reasons, Carisma is unable to appropriately select patients who are likely to benefit from therapy with its medicines. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of any of these events, Carisma&#8217;s business would be harmed, possibly materially. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Any product candidate for which Carisma, or any collaborators, obtain marketing approval could be subject to post-marketing restrictions or withdrawal from the market and Carisma, or any collaborators, may be subject to substantial penalties if Carisma, or any collaborators, fail to comply with regulatory requirements or if Carisma, or any collaborators, experience unanticipated problems with its products when and if any of them are approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any product candidate for which Carisma, or any collaborators, obtain marketing approval, as well as the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA, EMA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, cGMP requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping. Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval, including the requirement to implement a risk evaluation and mitigation strategy. New cancer drugs frequently are indicated only for patient populations that have not responded to an existing therapy or have relapsed. If any of Carisma&#8217;s product candidates receives marketing approval, the accompanying label may limit the approved use of its drug in this way, which could limit sales of the product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may also impose requirements for costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product, including the adoption and implementation of risk evaluation and mitigation strategies. The FDA and other regulatory agencies, including the Department of Justice, or the DOJ, closely regulate and monitor the post-approval marketing and promotion of drugs to ensure they are marketed and distributed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA, DOJ and other regulatory agencies impose stringent restrictions on manufacturers&#8217; communications regarding off-label use, and if Carisma does not market its products for their approved indications, it may be subject to enforcement action for off-label marketing by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">FDA and other federal and state enforcement agencies. Violations of the Federal Food, Drug, and Cosmetic Act and other statutes, including the False Claims Act, relating to the promotion and advertising of prescription drugs may lead to investigations and enforcement actions alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, later discovery of previously unknown side effects or other problems with Carisma&#8217;s products or its manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on such products, manufacturers or manufacturing processes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions and warnings on the labeling or marketing of a product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on product distribution or use; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">requirements to conduct post-marketing studies or clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">receipt of warning letters or untitled letters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdrawal of the products from the market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal to approve pending applications or supplements to approved applications that Carisma submits; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">recall of products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fines, restitution or disgorgement of profits or revenues; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">suspension or withdrawal of marketing approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">suspension of any ongoing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">damage to relationships with any potential collaborators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">unfavorable press coverage and damage to Carisma&#8217;s reputation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal to permit the import or export of Carisma&#8217;s products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">product seizure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">injunctions or the imposition of civil or criminal penalties; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">litigation involving patients using Carisma&#8217;s products. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, manufacturers of approved products and those manufacturers&#8217; facilities are required to comply with extensive FDA requirements, including ensuring that quality control and manufacturing procedures conform to cGMPs applicable to drug manufacturers or quality assurance standards applicable to medical device manufacturers, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. Carisma, any contract manufacturers it may engage in the future, its collaborators and their contract manufacturers will also be subject to other regulatory requirements, including submissions of safety and other post-marketing information and reports, registration and listing requirements, requirements regarding the distribution of samples to clinicians, recordkeeping, and costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product such as the requirement to implement a risk evaluation and mitigation strategy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s relationships with healthcare providers, physicians and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose Carisma to civil, criminal and administrative sanctions, contractual damages, reputational harm and diminished future profits and earnings.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers, physicians and third-party payors will play a primary role in the recommendation and prescription of any drugs for which Carisma obtains marketing approval. Carisma&#8217;s future arrangements with third-party payors, healthcare providers and physicians may expose it to broadly applicable state and federal fraud and abuse and other healthcare laws and regulations that may constrain the business or financial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">arrangements and relationships through which Carisma markets, sells and distributes any drugs for which it obtains marketing approval. These include the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Anti-Kickback Statute,</font><font style="letter-spacing:0.2pt;"> which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, paying, or receiving remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchasing, ordering, leasing, arranging for, or recommending the purchasing, ordering, or leasing of, any good or service for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare or Medicaid; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">False Claims Act &#8212;</font><font style="letter-spacing:0.2pt;"> the federal civil and criminal false claims laws, including the civil False Claims Act, and Civil Monetary Penalties Law, which prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, false or fraudulent claims for payment or knowingly making, using or causing to made or used a false record or statement material to a false or fraudulent claim or to avoid, decrease or conceal an obligation to pay money to the federal government, or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">HIPAA &#8212;</font><font style="letter-spacing:0.2pt;"> the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters, and apply regardless of the payor (e.g., public or private); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">HIPAA and HITECH &#8212;</font><font style="letter-spacing:0.2pt;"> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, which impose obligations on HIPAA covered entities and their business associates, including mandatory contractual terms and required implementation of administrative, physical and technical safeguards to maintain the privacy and security of individually identifiable health information; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Transparency Requirements &#8212;</font><font style="letter-spacing:0.2pt;"> the federal physician transparency requirements known as the Physician Payments Sunshine Act, under the Patient Protection and Affordable Care Act, as amended by the Health Care Education Reconciliation Act, or the Affordable Care Act, which requires manufacturers of drugs, medical devices, biological and medical supplies covered by Medicare, Medicaid, or State Children&#8217;s Health Insurance Program to report annually to the Centers for Medicare &amp; Medicaid Services, or CMS, within the United States Department of Health and Human Services, information related to payments and other transfers of value made by that entity to physicians, other healthcare providers and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Analogous State, Local and Foreign Laws &#8212;</font><font style="letter-spacing:0.2pt;"> analogous state, local and foreign fraud and abuse laws and regulations, such as state anti-kickback and false claims laws, which may be broader than similar federal laws, can apply to claims involving healthcare items or services regardless of payor, and are enforced by many different federal and state agencies as well as through private actions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures. State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not pre-empted by HIPAA, thus complicating compliance efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Efforts to ensure that Carisma&#8217;s business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that Carisma&#8217;s business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If Carisma&#8217;s operations are found to be in violation of any of these laws or any other governmental regulations that may apply to Carisma, it may be subject to significant civil, criminal and/or administrative penalties, damages, fines, individual imprisonment, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting obligations and oversight if Carisma becomes subject to a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of its operations. If any of the physicians or other healthcare providers or entities with whom Carisma expects to do business is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the European Union. The provision of benefits or advantages to physicians is governed by the national anti-bribery laws of European Union Member States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compliance with global privacy and data security requirements could result in additional costs and liabilities to Carisma or inhibit its ability to collect and process data globally, and the failure to comply with such requirements could subject Carisma to significant fines and penalties, which may have a material adverse effect on its business, financial condition or results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The regulatory framework for the collection, use, safeguarding, sharing, transfer and other processing of information worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. Globally, virtually every jurisdiction in which Carisma operates has established its own data security and privacy frameworks with which it must comply. For example, the collection, use, disclosure, transfer, or other processing of personal data regarding individuals in the European Union, including personal health data, is subject to the E.U. General Data Protection Regulation, or the GDPR, which took effect across all member states of the European Economic Area, or EEA, in May&#160;2018. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR increases Carisma&#8217;s obligations with respect to clinical trials conducted in the EEA by expanding the definition of personal data to include coded data and requiring changes to informed consent practices and more detailed notices for clinical trial subjects and investigators. In addition, the GDPR also imposes strict rules on the transfer of personal data to countries outside the European Union, including the United States and, as a result, increases the scrutiny that clinical trial sites located in the EEA should apply to transfers of personal data from such sites to countries that are considered to lack an adequate level of data protection, such as the United States. The GDPR also permits data protection authorities to require destruction of improperly gathered or used personal information and/or impose substantial fines for violations of the GDPR, which can be up to four&#160;percent of global revenues or 20.0&#160;million Euros, whichever is greater, and it also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. In addition, the GDPR provides that European Union member states may make their own further laws and regulations limiting the processing of personal data, including genetic, biometric or health data. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Similar actions are either in place or under way in the United States. There are a broad variety of data protection laws that are applicable to Carisma&#8217;s activities, and a wide range of enforcement agencies at both the state and federal levels that can review companies for privacy and data security concerns based on general consumer protection laws. The Federal Trade Commission and state Attorneys General all are aggressive in reviewing privacy and data security protections for consumers. New laws also are being considered at both the state and federal levels. For example, the California Consumer Privacy Act, or CCPA, which went into effect on January&#160;1, 2020, is creating similar risks and obligations as those created by the GDPR, though CCPA does exempt certain information collected as part of a clinical trial subject to the Federal Policy for the Protection of Human Subjects (the Common Rule). Many other states are considering similar legislation. A broad range of legislative measures also have been introduced at the federal level. Accordingly, failure to comply with federal and state laws (both those currently in effect and future legislation) regarding privacy and security of personal information could expose Carisma to fines and penalties under such laws. There also is the threat of consumer class actions related to these laws and the overall protection of personal data. Even if Carisma is not determined to have violated these laws, government investigations </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm Carisma&#8217;s reputation and business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Given the breadth and depth of changes in data protection obligations, preparing for and complying with such requirements is rigorous and time intensive and requires significant resources and a review of Carisma&#8217;s technologies, systems and practices, as well as those of any third-party collaborators, service providers, contractors or consultants that process or transfer personal data. The GDPR and other changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, such as healthcare data or other personal information from Carisma&#8217;s clinical trials, could require Carisma to change its business practices and put in place additional compliance mechanisms, may interrupt or delay its development, regulatory and commercialization activities and increase its cost of doing business, and could lead to government enforcement actions, private litigation and significant fines and penalties against Carisma and could have a material adverse effect on its business, financial condition or results of operations. Similarly, failure to comply with federal and state laws regarding privacy and security of personal information could expose Carisma to fines and penalties under such laws. Even if Carisma is not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm Carisma&#8217;s reputation and business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current and future legislation may increase the difficulty and cost for Carisma and any collaborators to obtain marketing approval of and commercialize product candidates and affect the prices Carisma, or any collaborators, may obtain.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could, among other things, prevent or delay marketing approval of Carisma&#8217;s product candidates, restrict or regulate post-approval activities, impact pricing and reimbursement and affect Carisma&#8217;s ability, or the ability of any collaborators, to profitably sell or commercialize any product candidates for which Carisma, or any collaborators, obtain marketing approval. The pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by legislative initiatives. In particular, there have been and continue to be a number of initiatives at the U.S. federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare. Current laws, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that Carisma, or any collaborators, may receive for any FDA approved products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, or the MMA, changed the way Medicare covers and pays for pharmaceutical products. The legislation expanded Medicare coverage for prescription drugs purchased through a pharmacy by the elderly and disabled and introduced a new reimbursement methodology based on average sales prices for physician-administered drugs. In addition, this statute provides authority for limiting the number of drugs that will be covered in any therapeutic class, subject to certain exceptions. Cost reduction initiatives and other provisions of this statute could decrease the coverage and price that Carisma receives for any approved products. While the MMA applies only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. Therefore, any reduction in reimbursement that results from the MMA may result in a similar reduction in payments from private payors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2010, then-President Obama signed into law the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, or collectively the ACA. In addition, other legislative changes have been proposed and adopted since the ACA was enacted. In August&#160;2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the&#160;years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. These changes included aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect in April&#160;2013 and will remain in effect through 2031 under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act. The American Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers and increased the statute of limitations period for the government to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">recover overpayments to providers from three to five&#160;years. Further, with passage of the Inflation Reduction Act in August&#160;2022, Congress extended the expansion of the Patient Protection and Affordable Care Act premium tax credits through 2025. Those subsidies were originally extended through 2022 under the American Rescue Plan&#160;Act of 2021. These laws may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices Carisma may obtain for any of its product candidates for which it may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since enactment of the ACA, there have been and continue to be, numerous legal challenges and Congressional actions to repeal and replace provisions of the law. For example, with enactment of the Tax Cuts for Jobs Act, or TCJA, in 2017, Congress repealed the &#8220;individual mandate.&#8221; The repeal of this provision, which requires most Americans to carry a minimal level of health insurance, became effective in 2019. Further, on December&#160;14, 2018, a U.S. District Court judge in the Northern District of Texas ruled that the individual mandate portion of the ACA is an essential and inseverable feature of the ACA and therefore because the mandate was repealed as part of the TCJA, the remaining provisions of the ACA are invalid as well. The U.S. Supreme Court heard this case on November&#160;10, 2020 and on June&#160;17, 2021, dismissed this action after finding that the plaintiffs do not have standing to challenge the constitutionality of the ACA. Litigation and legislation over the ACA are likely to continue, with unpredictable and uncertain results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Trump Administration also took executive actions to undermine or delay implementation of the ACA, including directing federal agencies with authorities and responsibilities under the ACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the ACA that would impose a fiscal or regulatory burden on states, individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. On January&#160;28, 2021, however, President Biden rescinded those orders and issued a new Executive Order which directs federal agencies to reconsider rules and other policies that limit Americans&#8217; access to health care, and consider actions that will protect and strengthen that access. Under this Order, federal agencies are directed to re-examine: policies that undermine protections for people with pre-existing conditions, including complications related to COVID-19; demonstrations and waivers under Medicaid and the ACA that may reduce coverage or undermine the programs, including work requirements; policies that undermine the Health Insurance Marketplace or other markets for health insurance; policies that make it more difficult to enroll in Medicaid and the ACA; and policies that reduce affordability of coverage or financial assistance, including for dependents. This Executive Order also directs the U.S. Department of Health and Human Services to create a special enrollment period for the Health Insurance Marketplace in response to the COVID-19 pandemic. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects that these healthcare reforms, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, new payment methodologies and additional downward pressure on the price that Carisma receives for any approved product and/or the level of reimbursement physicians receive for administering any approved product it might bring to market. Reductions in reimbursement levels may negatively impact the prices Carisma receives or the frequency with which its products are prescribed or administered. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. Accordingly, such reforms, if enacted, could have an adverse effect on anticipated revenue from product candidates that Carisma may successfully develop and for which it may obtain marketing approval and may affect Carisma&#8217;s overall financial condition and ability to develop or commercialize product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The prices of prescription pharmaceuticals in the United States and foreign jurisdictions are subject to considerable legislative and executive actions and could impact the prices Carisma obtains for its drug products, if and when approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The prices of prescription pharmaceuticals have also been the subject of considerable discussion in the United States. There have been several recent U.S. congressional inquiries, as well as proposed and enacted state and federal legislation designed to, among other things, bring more transparency to pharmaceutical pricing, review the relationship between pricing and manufacturer patient programs, and reduce the costs of pharmaceuticals under Medicare and Medicaid. In 2020, President Trump issued several executive orders intended to lower the costs of prescription products and certain provisions in these orders have been incorporated into regulations. These regulations include an interim final rule implementing a most favored </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">nation model for prices that would tie Medicare Part&#160;B payments for certain physician-administered pharmaceuticals to the lowest price paid in other economically advanced countries, effective January&#160;1, 2021. That rule, however, has been subject to a nationwide preliminary injunction and, on December&#160;29, 2021, CMS issued a final rule to rescind it. With issuance of this rule, CMS stated that it will explore all options to incorporate value into payments for Medicare Part&#160;B pharmaceuticals and improve beneficiaries&#8217; access to evidence-based care. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in October&#160;2020, HHS and the FDA published a final rule allowing states and other entities to develop a Section&#160;804 Importation Program, or SIP, to import certain prescription drugs from Canada into the United States. The final rule is currently the subject of ongoing litigation, but at least six states (Vermont, Colorado, Florida, Maine, New Mexico, and New Hampshire) have passed laws allowing for the importation of drugs from Canada with the intent of developing SIPs for review and approval by the FDA. Further, on November&#160;20, 2020, HHS finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part&#160;D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January&#160;1, 2022 to January&#160;1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a new safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which has been delayed until January&#160;1, 2026 by the Infrastructure Investment and Jobs Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">More recently, with passage of the Inflation Reduction Act in August&#160;2022, Congress authorized Medicare beginning in 2026 to negotiate lower prices for certain costly single-source drug and biologic products that do not have competing generics or biosimilars. This provision is limited in terms of the number of pharmaceuticals whose prices can be negotiated in any given year and it only applies to drug products that have been approved for at least 9&#160;years and biologics that have been licensed for 13&#160;years. Drugs and biologics that have been approved for a single rare disease or condition are categorically excluded from price negotiation. Further, the new legislation provides that if pharmaceutical companies raise prices in Medicare faster than the rate of inflation, they must pay rebates back to the government for the difference. The new law also caps Medicare out-of-pocket drug costs at an estimated $4,000 a year in 2024 and, thereafter beginning in 2025, at $2,000 a year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, health care organizations and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. These measures could reduce the ultimate demand for Carisma&#8217;s products, once approved, or put pressure on its product pricing. Carisma expects that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for its product candidates or additional pricing pressures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In other countries, particularly the countries of the European Union, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a drug. To obtain reimbursement or pricing approval in some countries, Carisma, or its collaborators, may be required to conduct a clinical trial that compares the cost-effectiveness of its drug to other available therapies. If reimbursement of Carisma&#8217;s drugs is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, its business could be materially harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is subject to anti-corruption laws, as well as export control laws, customs laws, sanctions laws and other laws governing its operations. If Carisma fails to comply with these laws, it could be subject to civil or criminal penalties, other remedial measures and legal expenses, which could adversely affect its business, results of operations and financial condition.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s operations are subject to anti-corruption laws, including the FCPA, the Bribery Act, and other anticorruption laws that apply in countries where Carisma does business and may do business in the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">future. The FCPA, the Bribery Act, and these other laws generally prohibit Carisma, its officers and its employees and intermediaries from bribing, being bribed or making other prohibited payments to government officials or other persons to obtain or retain business or gain some other business advantage. Carisma may in the future operate in jurisdictions that pose a high risk of potential FCPA or Bribery Act violations, and it may participate in collaborations and relationships with third parties whose actions could potentially subject Carisma to liability under the FCPA, the Bribery Act, or local anti-corruption laws. In addition, Carisma cannot predict the nature, scope or effect of future regulatory requirements to which its international operations might be subject or the manner in which existing laws might be administered or interpreted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is also subject to other laws and regulations governing its international operations, including regulations administered by the governments of the United States, United Kingdom, and authorities in the European Union, including applicable export control regulations, economic sanctions on countries and persons, customs requirements and currency exchange regulations, which is collectively referred to as Trade Control Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There is no assurance that Carisma will be completely effective in ensuring its compliance with all applicable anti-corruption laws, including the FCPA, the Bribery Act, or other legal requirements, including Trade Control Laws. If Carisma is not in compliance with the FCPA, the Bribery Act, and other anti-corruption laws or Trade Control Laws, it may be subject to criminal and civil penalties, disgorgement and other sanctions and remedial measures, and legal expenses, which could have an adverse impact on its business, financial condition, results of operations and liquidity. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions. Likewise, any investigation of any potential violations of the FCPA, the Bribery Act, other anti-corruption laws or Trade Control Laws by the United States, the United Kingdom or other authorities could also have an adverse impact on Carisma&#8217;s reputation, business, results of operations and financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is subject to stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data privacy and security and changes in such laws, regulations, policies, contractual obligations and failure to comply with such requirements could subject Carisma to significant fines and penalties, which may have a material adverse effect on Carisma&#8217;s business, financial condition or results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is subject to data privacy and protection laws and regulations that apply to the collection, transmission, storage and use of personally-identifying information, which among other things, impose certain requirements relating to the privacy, security and transmission of personal information, including comprehensive regulatory systems in the United States, the European Union and the United Kingdom. The legislative and regulatory landscape for privacy and data protection continues to evolve in jurisdictions worldwide, and there has been an increasing focus on privacy and data protection issues with the potential to affect Carisma&#8217;s business. Failure to comply with any of these laws and regulations could result in an enforcement action against Carisma, including fines, imprisonment of company officials and public censure, claims for damages by affected individuals, damage to Carisma&#8217;s reputation and loss of goodwill, any of which could have a material adverse effect on Carisma&#8217;s business, financial condition, results of operations or prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There are numerous U.S. federal and state laws and regulations related to the privacy and security of personal information. In particular, regulations promulgated pursuant to HIPAA establish privacy and security standards that limit the use and disclosure of individually identifiable health information, or protected health information, and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and ensure the confidentiality, integrity and availability of electronic protected health information. Determining whether protected health information has been handled in compliance with applicable privacy standards and Carisma&#8217;s contractual obligations can be complex and may be subject to changing interpretation. These obligations may be applicable to some or all of Carisma&#8217;s business activities now or in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to properly protect the privacy and security of protected health information, it could be found to have breached its contracts. Further, if Carisma fails to comply with applicable privacy laws, including applicable HIPAA privacy and security standards, it could face civil and criminal penalties. HHS enforcement activity can result in financial liability and reputational harm, and responses to such enforcement activity can consume significant internal resources. In addition, state attorneys general are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">authorized to bring civil actions seeking either injunctions or damages in response to violations that threaten the privacy of state residents. Carisma cannot be sure how these regulations will be interpreted, enforced or applied to its operations. In addition to the risks associated with enforcement activities and potential contractual liabilities, Carisma&#8217;s ongoing efforts to comply with evolving laws and regulations at the federal and state level may be costly and require ongoing modifications to its policies, procedures and systems. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2018, California passed into law the California Consumer Privacy Act, or the CCPA, which took effect on January&#160;1, 2020 and imposed many requirements on businesses that process the personal information of California residents. Many of the CCPA&#8217;s requirements are similar to those found in the General Data Protection Regulation, or the GDPR, including requiring businesses to provide notice to data subjects regarding the information collected about them and how such information is used and shared, and providing data subjects the right to request access to such personal information and, in certain cases, request the erasure of such personal information. The CCPA also affords California residents the right to opt-out of &#8220;sales&#8221; of their personal information. The CCPA contains significant penalties for companies that violate its requirements. In November&#160;2020, California voters passed a ballot initiative for the California Privacy Rights Act, or the CPRA, which will significantly expand the CCPA to incorporate additional GDPR-like provisions including requiring that the use, retention, and sharing of personal information of California residents be reasonably necessary and proportionate to the purposes of collection or processing, granting additional protections for sensitive personal information, and requiring greater disclosures related to notice to residents regarding retention of information. Most CPRA provisions will take effect on January&#160;1, 2023, though the obligations will apply to any personal information collected after January&#160;1, 2022. These provisions may apply to some of Carisma&#8217;s business activities. In addition, other states, including Virginia and Colorado, already have passed state privacy laws. Other states will be considering these laws in the future. These laws may impact Carisma&#8217;s business activities, including Carisma&#8217;s identification of research subjects, relationships with business partners and ultimately the marketing and distribution of its products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Similar to the laws in the United States, there are significant privacy and data security laws that apply in Europe and other countries. The collection, use, disclosure, transfer, or other processing of personal data, including personal health data, regarding individuals who are located in the European Economic Area, or EEA, and the processing of personal data that takes place in the EEA, is regulated by the GDPR, which went into effect in May&#160;2018 and which imposes obligations on companies that operate in Carisma&#8217;s industry with respect to the processing of personal data and the cross-border transfer of such data. The GDPR imposes onerous accountability obligations requiring data controllers and processors to maintain a record of their data processing and policies. If Carisma&#8217;s or its partners&#8217; or service providers&#8217; privacy or data security measures fail to comply with the GDPR requirements, Carisma may be subject to litigation, regulatory investigations, enforcement notices requiring it to change the way it uses personal data and/or fines of up to 20.0&#160;million Euros or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher, as well as compensation claims by affected individuals, negative publicity, reputational harm and a potential loss of business and goodwill. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The GDPR places restrictions on the cross-border transfer of personal data from the European Union to countries that have not been found by the European Commission to offer adequate data protection legislation, such as the United States. There are ongoing concerns about the ability of companies to transfer personal data from the European Union to other countries. In July&#160;2020, the Court of Justice of the European Union, or the CJEU invalidated the European Union-United States Privacy Shield, one of the mechanisms used to legitimize the transfer of personal data from the EEA to the United States. The CJEU decision also drew into question the long-term viability of an alternative means of data transfer, the standard contractual clauses, for transfers of personal data from the EEA to the United States. While Carisma is not self-certified under the Privacy Shield, this CJEU decision may lead to increased scrutiny on data transfers from the EEA to the United States, generally, and increase Carisma&#8217;s costs of compliance with data privacy legislation as well as its costs of negotiating appropriate privacy and security agreements with its vendors and business partners. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the withdrawal of the United Kingdom from the European Union, the UK Data Protection Act 2018 applies to the processing of personal data that takes place in the United Kingdom and includes parallel obligations to those set forth by GDPR. As with other issues related to Brexit, there are open </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">questions about how personal data will be protected in the United Kingdom and whether personal information can transfer from the European Union to the United Kingdom. Following the withdrawal of the United Kingdom from the European Union, the UK Data Protection Act 2018 applies to the processing of personal data that takes place in the United Kingdom and includes parallel obligations to those set forth by GDPR. While the Data Protection Act of 2018 in the United Kingdom that &#8220;implements&#8221; and complements the GDPR, has achieved Royal Assent on May&#160;23, 2018 and is now effective in the United Kingdom, it is still unclear whether transfer of data from the EEA to the United Kingdom will remain lawful under GDPR. The U.K. government has already determined that it considers all European Union and EEA member states to be adequate for the purposes of data protection, ensuring that data flows from the United Kingdom to the European Union/EEA remain unaffected. In addition, a recent decision from the EC appears to deem the United Kingdom as being &#8220;essentially adequate&#8221; for purposes of data transfer from the European Union to the United Kingdom, although this decision may be re-evaluated in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beyond GDPR, there are privacy and data security laws in a growing number of countries around the world. While many loosely follow GDPR as a model, other laws contain different or conflicting provisions. These laws will impact Carisma&#8217;s ability to conduct its business activities, including both its clinical trials and any eventual sale and distribution of commercial products, through increased compliance costs, costs associated with contracting and potential enforcement actions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Carisma continues to address the implications of the recent changes to data privacy regulations, data privacy remains an evolving landscape at both the domestic and international level, with new regulations coming into effect and continued legal challenges, and Carisma&#8217;s efforts to comply with the evolving data protection rules may be unsuccessful. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with Carisma&#8217;s practices. Carisma must devote significant resources to understanding and complying with this changing landscape. Failure to comply with laws regarding data protection would expose Carisma to risk of enforcement actions taken by data protection authorities in the EEA and elsewhere and carries with it the potential for significant penalties if Carisma is found to be non-compliant. Similarly, failure to comply with federal and state laws in the United States regarding privacy and security of personal information could expose Carisma to penalties under such laws. Any such failure to comply with data protection and privacy laws could result in government-imposed fines or orders requiring that Carisma change its practices, claims for damages or other liabilities, regulatory investigations and enforcement action, litigation and significant costs for remediation, any of which could adversely affect Carisma&#8217;s business. Even if Carisma is not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm Carisma&#8217;s business, financial condition, results of operations or prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma employees, independent contractors, consultants, collaborators and vendors engage in misconduct or other improper activities, including non-compliance with regulatory standards and/or requirements and insider trading, Carisma could sustain significant liability and harm to its reputation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is exposed to the risk of fraud or other misconduct by its employees, independent contractors, consultants, collaborators and vendors. Misconduct by these partners could include intentional failures to comply with FDA regulations or similar regulations of comparable foreign regulatory authorities, provide accurate information to the FDA or comparable foreign regulatory authorities, comply with manufacturing standards, comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable foreign regulatory authorities, report financial information or data accurately or disclose unauthorized activities to Carisma. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to Carisma&#8217;s reputation. This could include violations of HIPAA, other U.S. federal and state laws, and requirements of foreign jurisdictions, including the GDPR. Carisma is also exposed to risks in connection with any insider trading violations by employees or others affiliated with Carisma. It is not always possible to identify and deter employee or third-party misconduct, and the precautions that Carisma takes to detect and prevent these activities may not be effective in controlling unknown or unmanaged risks or losses or in protecting Carisma from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards, regulations, guidance or codes of conduct. If any such actions are instituted against Carisma, and Carisma is not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">successful in defending itself or asserting its rights, those actions could have a significant impact on its business and results of operations, including the imposition of significant fines or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma or any third-party manufacturer it engages now or in the future fails to comply with environmental, health and safety laws and regulations, Carisma could become subject to fines or penalties or incur costs or liabilities that could significantly harm its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma and third-party manufacturers it engages now are, and any third-party manufacturer it may engage in the future will be, subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, Carisma&#8217;s operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may also produce hazardous waste products. Although Carisma contracts with third parties for the disposal of these materials and waste products, it cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of Carisma&#8217;s hazardous materials, Carisma could be held liable for any resulting damages, and any liability could exceed its resources. Carisma also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma maintains general liability insurance as well as workers&#8217; compensation insurance to cover costs and expenses it may incur due to injuries to its employees resulting from the use of hazardous materials, but this insurance may not provide adequate coverage against potential liabilities. Carisma does not maintain insurance for environmental liability or toxic tort claims that may be asserted against it. In addition, Carisma may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current or future environmental laws and regulations may impair Carisma&#8217;s research, development or production efforts, which could adversely affect its business, financial condition, results of operations or prospects. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Employee Matters and Managing Growth</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s future success depends on its ability to retain key executives and experienced scientists and to attract, retain and motivate qualified personnel.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is highly dependent on the research and development, clinical, financial, operational and other business expertise of its executive officers, as well as the other principal members of its management, scientific and clinical teams. Although Carisma has entered into employment agreements with certain of its executive officers, each of them may terminate their employment with Carisma at any time. Carisma does not maintain &#8220;key person&#8221; insurance for any of its executives or other employees. Recruiting and retaining qualified scientific, clinical, manufacturing, accounting, legal and sales and marketing personnel will also be critical to Carisma&#8217;s success. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The loss of the services of Carisma&#8217;s executive officers or other key employees, including temporary loss due to illness, could impede the achievement of its discovery programs, development and commercialization objectives and seriously harm its ability to successfully implement its business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in Carisma&#8217;s industry with the breadth of skills and experience required to successfully develop, gain marketing approval of and commercialize products. Competition to hire from this limited pool is intense, and Carisma may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous biopharmaceutical companies for similar personnel. Carisma also experiences competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, Carisma relies on consultants and advisors, including scientific and clinical advisors, to assist it in formulating its discovery, research and development and commercialization strategy. Carisma&#8217;s consultants and advisors may be employed by employers other than Carisma and may have commitments under consulting or advisory contracts with other entities that may limit their availability to Carisma. Failure to succeed in clinical trials may make it even more challenging to recruit and retain qualified scientific personnel. Carisma&#8217;s success as a public company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">also depends on implementing and maintaining internal controls and the accuracy and timeliness of its financial reporting. If Carisma is unable to continue to attract and retain high quality personnel, its ability to pursue its growth strategy will be limited. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma expects to expand its development and regulatory capabilities and potentially implement sales, marketing and distribution capabilities, and as a result, it may encounter difficulties in managing its growth, which could disrupt its operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to experience significant growth in the number of its employees and the scope of its operations, particularly as it functions as a public company and in the areas of product development, clinical, regulatory affairs, manufacturing and quality control and, if any of its product candidates receives marketing approval, sales, marketing and distribution. To manage Carisma&#8217;s anticipated future growth, it must continue to implement and improve its managerial, operational and financial systems, expand its facilities and continue to recruit and train additional qualified personnel. Future growth will impose significant added responsibilities on members of management, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">identifying, recruiting, integrating, maintaining and motivating additional employees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">managing its internal development efforts effectively, including the clinical and regulatory review process for CT-0508 and other product candidates Carisma is developing or may develop in the future, while complying with its contractual obligations to contractors and other third parties; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">improving its operational, financial and management controls, reporting systems and procedures. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s future financial performance and its ability to advance development of and, if approved, commercialize CT-0508 and any other product candidate Carisma is developing or may develop in the future will depend, in part, on Carisma&#8217;s ability to effectively manage any future growth. Due to Carisma&#8217;s limited financial resources and the limited experience of its management team in managing a company with such anticipated growth, Carisma may not be able to effectively manage the expansion of its operations or recruit and train additional qualified personnel. If Carisma does not effectively manage the expansion of its operations, Carisma could experience weaknesses in its infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The expansion of Carisma&#8217;s operations also could lead to significant costs and may divert Carisma&#8217;s management and business development resources. Any inability to manage growth could delay the execution of Carisma&#8217;s business plans or disrupt its operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of the biopharmaceutical companies, and in particular cell therapy companies, that Carisma competes against for qualified personnel and consultants have greater financial and other resources, different risk profiles and a longer history in the industry than Carisma does. They also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what Carisma has to offer. If Carisma is unable to continue to attract and retain high-quality personnel and consultants, the rate and success at which Carisma can develop product candidates and operate its business will be limited. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s internal computer systems, or those of its collaborators, vendors, suppliers, contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of Carisma&#8217;s product development programs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s internal computer systems and those of any collaborators, vendors, suppliers, contractors or consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. Such systems are also vulnerable to service interruptions or to security breaches from inadvertent or intentional actions by Carisma&#8217;s employees, third-party vendors and/or business partners, or from cyber-attacks by malicious third parties. Cyber-attacks are increasing in their frequency, sophistication and intensity, and have become increasingly difficult to detect. Cyber-attacks could include the deployment of harmful malware, ransomware, denial-of-service attacks, unauthorized access to or deletion of files, social engineering and other means to affect service reliability and threaten the confidentiality, integrity and availability of information. Cyber-attacks also could include phishing attempts or email fraud to cause payments or information to be transmitted to an unintended recipient. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma experiences any material system failure, accident, cyber-attack or security that causes interruptions in its operations, it could result in a material disruption of Carisma&#8217;s development programs and its business operations, whether due to a loss of its trade secrets or other proprietary information or other similar disruptions. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in Carisma&#8217;s marketing approval efforts and significantly increase its costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of, or damage to, Carisma&#8217;s data or applications, or inappropriate disclosure of confidential or proprietary information, Carisma could incur liability, its competitive position could be harmed and the further development and commercialization of its product candidates could be delayed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s employees, independent contractors, including principal investigators, consultants and vendors and any third parties it may engage in connection with discovery programs, research, development, regulatory, manufacturing, quality assurance and other pharmaceutical functions and commercialization may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading, which could cause significant liability for Carisma and harm its reputation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is exposed to the risk of fraud or other misconduct by its employees, independent contractors, including principal investigators, consultants and vendors and any other third parties it engages. Misconduct by these parties could include intentional, reckless or negligent conduct or unauthorized activities that include failures to comply with FDA regulations or similar regulations of comparable foreign regulatory authorities, provide complete and accurate information to the FDA or comparable foreign regulatory authorities, comply with manufacturing standards, comply with federal and state data privacy, security, fraud and other healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable foreign regulatory authorities, report complete financial information or data accurately or disclose unauthorized activities to Carisma. Misconduct by employees and other third parties could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to Carisma&#8217;s reputation. This could include violations of HIPAA, other U.S. federal and state law, and requirements of non-U.S. jurisdictions, including the European Union Data Protection Directive. Carisma is also exposed to risks in connection with any insider trading violations by employees or others affiliated with Carisma. It is not always possible to identify and deter misconduct by employees and other third parties, and the precautions Carisma takes to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting Carisma from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards, regulations, guidance or codes of conduct. Additionally, Carisma is subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against Carisma, and it is not successful in defending itself or asserting its rights, those actions could have a significant impact on Carisma&#8217;s business and results of operations, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgements, possible exclusion from participation in Medicare, Medicaid, other U.S. federal healthcare programs or healthcare programs in other jurisdictions, integrity oversight and reporting obligations to resolve allegations of non-compliance, individual imprisonment, other sanctions, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of Carisma&#8217;s operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Ownership of the Common Stock of the Combined Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The market price of the combined company&#8217;s common stock is expected to be volatile, and the market price of the combined company&#8217;s common stock may drop following the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The market price of the combined company&#8217;s common stock following the merger could be subject to significant fluctuations. Some of the factors that may cause the market price of the combined company&#8217;s common stock to fluctuate include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">results of clinical trials and pre-clinical studies of the combined company&#8217;s product candidates, or those of the combined company&#8217;s competitors or the combined company&#8217;s existing or future collaborators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to meet or exceed financial and development projections the combined company may provide to the public; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to meet or exceed the financial and development projections of the investment community; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the combined company does not achieve the perceived benefits of the merger as rapidly or to the extent anticipated by financial or industry analysts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">announcements of significant acquisitions, strategic collaborations, joint ventures or capital commitments by the combined company or its competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">actions taken by regulatory agencies with respect to the combined company&#8217;s product candidates, clinical studies, manufacturing process or sales and marketing terms; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disputes or other developments relating to proprietary rights, including patents, litigation matters, and the combined company&#8217;s ability to obtain patent protection for its technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">additions or departures of qualified scientific and management personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">significant lawsuits, including patent or stockholder litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if securities or industry analysts do not publish research or reports about the combined company&#8217;s business, or if they issue adverse or misleading opinions regarding its business and stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in the market valuations of similar companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">general market or macroeconomic conditions or market conditions in the biopharmaceutical sector; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sales of securities by the combined company or its stockholders in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the combined company fails to raise an adequate amount of capital to fund its operations and continued development of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">trading volume of the combined company&#8217;s common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">announcements by competitors of new commercial products, clinical progress or lack thereof, significant contracts, commercial relationships or capital commitments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adverse publicity relating to product candidates, including with respect to other products in such markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the introduction of technological innovations or new therapies that compete with the products and services of the combined company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">period-to-period fluctuations in the combined company&#8217;s financial results. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of the combined company&#8217;s common stock. In addition, a recession, depression or other sustained adverse market event could materially and adversely affect the combined company&#8217;s business and the value of its common stock. In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against such companies. Furthermore, market volatility may lead to increased shareholder activism if the combined company experiences a market valuation that activists believe is not reflective of its intrinsic value. Activist campaigns that contest or conflict with the combined company&#8217;s strategic direction or seek changes in the composition of its board of directors could have an adverse effect on the combined company&#8217;s operating results and financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The combined company will incur additional costs and increased demands upon management as a result of complying with the laws and regulations affecting public companies.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The combined company will incur significant legal, accounting and other expenses as a public company that Carisma did not incur as a private company, including costs associated with public company reporting obligations under the Exchange Act. The combined company&#8217;s management team will consist of the executive officers of Carisma prior to the merger, some of whom have not previously managed and operated a public company. These executive officers and other personnel will need to devote substantial time to gaining expertise related to public company reporting requirements and compliance with applicable laws and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">regulations to ensure that the combined company complies with all of these requirements. Any changes the combined company makes to comply with these obligations may not be sufficient to allow it to satisfy its obligations as a public company on a timely basis, or at all. These reporting requirements, rules and regulations, coupled with the increase in potential litigation exposure associated with being a public company, could also make it more difficult for the combined company to attract and retain qualified persons to serve on the board of directors or on board committees or to serve as executive officers, or to obtain certain types of insurance, including directors&#8217; and officers&#8217; insurance, on acceptable terms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Once the combined company is no longer a &#8220;smaller reporting company&#8221; or otherwise no longer qualifies for applicable exemptions, the combined company will be subject to additional laws and regulations affecting public companies that will increase the combined company&#8217;s costs and the demands on management and could harm the combined company&#8217;s operating results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The combined company will be subject to the reporting requirements of the Exchange Act, which requires, among other things, that the combined company file with the SEC annual, quarterly and current reports with respect to the combined company&#8217;s business and financial condition as well as other disclosure and corporate governance requirements. However, as a &#8220;smaller reporting company,&#8221; as defined in Item&#160;10(f)(1) of Regulation&#160;S-K, the combined company may take advantage of certain exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2022 and reduced disclosure obligations regarding executive compensation in the combined company&#8217;s periodic reports and proxy statements. Once the combined company no longer qualifies as a smaller reporting company or otherwise no longer qualifies for these exemptions, the combined company will be required to comply with these additional legal and regulatory requirements applicable to public companies and will incur significant legal, accounting and other expenses to do so. If the combined company is not able to comply with the requirements in a timely manner or at all, the combined company&#8217;s financial condition or the market price of the combined company&#8217;s common stock may be harmed. For example, if the combined company or its independent auditor identifies deficiencies in the combined company&#8217;s internal control over financial reporting that are deemed to be material weaknesses, then the combined company could face additional costs to remedy those deficiencies, the market price of the combined company&#8217;s stock could decline or the combined company could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Provisions that will be in the combined company&#8217;s certificate of incorporation and bylaws and provisions under Delaware law could make an acquisition of the combined company, which may be beneficial to its stockholders, more difficult and may prevent attempts by its stockholders to replace or remove its management.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is completed, the Sesen Bio Bylaws and the Sesen Bio Certificate of Incorporation, as amended by the amendment thereto attached to this proxy statement/prospectus as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;">, assuming Proposal No. 2 is approved by Sesen Bio stockholders at the Sesen Bio special meeting, will become the combined company&#8217;s certificate of incorporation and bylaws. Provisions that will be included in the combined company&#8217;s certificate of incorporation and bylaws may discourage, delay or prevent a merger, acquisition or other change in control of the combined company that stockholders may consider favorable, including transactions in which its common stockholders might otherwise receive a premium price for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of the combined company&#8217;s common stock, thereby depressing the market price of its common stock. In addition, because the combined company&#8217;s board of directors will be responsible for appointing the members of the combined company&#8217;s management team, these provisions may frustrate or prevent any attempts by the combined company&#8217;s stockholders to replace or remove its current management by making it more difficult for stockholders to replace members of the combined company&#8217;s board of directors. Among other things, these provisions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establish a classified board of directors such that only one of three classes of directors is elected each year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">allow the authorized number of the combined company&#8217;s directors to be changed only by resolution of its board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">limit the manner in which stockholders can remove directors from the combined company&#8217;s board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and for nominations to the combined company&#8217;s board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">limit who may call stockholder meetings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prohibit actions by the combined company&#8217;s stockholders by written consent; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">require that stockholder actions be effected at a duly called stockholders meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">authorize the combined company&#8217;s board of directors to issue preferred stock without stockholder approval, which could be used to institute a &#8220;poison pill&#8221; that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by the combined company&#8217;s board of directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">require the approval of the holders of at least 75% of the votes that all combined company stockholders would be entitled to cast to amend or repeal certain provisions of the combined company&#8217;s certificate of incorporation or bylaws. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, because the combined company is incorporated in Delaware, it is governed by the provisions of Section&#160;203 of the DGCL which prohibits a person who owns 15% or more of the combined company&#8217;s outstanding voting stock from merging or combining with the combined company for a period of three&#160;years after the date of the transaction in which the person acquired 15% or more of the combined company&#8217;s outstanding voting stock, unless the merger or combination is approved in a manner prescribed by the statute. For more information about provisions that will be included in the combined company&#8217;s certificate of incorporation and bylaws, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Comparison of Rights of Holders of Sesen Bio Stock and Carisma Stock</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCORO">386</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">An active trading market for the combined company&#8217;s common stock may not develop and its stockholders may not be able to resell their shares of common stock for a profit, if at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to the merger, there had been no public market for shares of Carisma capital stock. An active trading market for the combined company&#8217;s shares of common stock may never develop or be sustained. If an active market for the combined company&#8217;s common stock does not develop or is not sustained, it may be difficult for its stockholders to sell their shares at an attractive price or at all. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">After completion of the merger, the combined company&#8217;s executive officers, directors and principal stockholders will have the ability to control or significantly influence all matters submitted to the combined company&#8217;s stockholders for approval.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the completion of the merger, and giving effect to the issuance of the shares of common stock of Carisma prior to the closing of the merger pursuant to the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, it is anticipated that the combined company&#8217;s executive officers, directors and principal stockholders will, in the aggregate, beneficially own approximately 56.94% of the combined company&#8217;s outstanding shares of common stock, subject to certain assumptions, including, but not limited to, Sesen Bio&#8217;s net cash as of closing being at least $75.0&#160;million. As a result, if these stockholders were to choose to act together, they would be able to control or significantly influence all matters submitted to the combined company&#8217;s stockholders for approval, as well as the combined company&#8217;s management and affairs. For example, these persons, if they choose to act together, would control or significantly influence the election of directors and approval of any merger, consolidation or sale of all or substantially all of the combined company&#8217;s assets. This concentration of voting power could delay or prevent an acquisition of the combined company on terms that other stockholders may desire. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about the combined company, its business or its market, its stock price and trading volume could decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The trading market for the combined company&#8217;s common stock will be influenced by the research and reports that equity research analysts publish about it and its business. Equity research analysts may elect not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:112pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to provide research coverage of the combined company&#8217;s common stock after the completion of the merger, and such lack of research coverage may adversely affect the market price of its common stock. In the event it does have equity research analyst coverage, the combined company will not have any control over the analysts or the content and opinions included in their reports. The price of the combined company&#8217;s common stock could decline if one or more equity research analysts downgrade its stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of the combined company or fails to publish reports on it regularly, demand for its common stock could decrease, which in turn could cause its stock price or trading volume to decline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The combined company will have broad discretion in the use of the cash and cash equivalents of the combined company as well as the proceeds from the Carisma pre-closing financing and may invest or spend the proceeds in ways with which you do not agree and in ways that may not increase the value of your investment.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The combined company will have broad discretion over the use of the cash and cash equivalents of the combined company and the proceeds from the Carisma pre-closing financing. You may not agree with the combined company&#8217;s decisions, and its use of the proceeds may not yield any return on your investment. The combined company&#8217;s failure to apply these resources effectively could compromise its ability to pursue its growth strategy and the combined company might not be able to yield a significant return, if any, on its investment of these net proceeds. You will not have the opportunity to influence the combined company&#8217;s decisions on how to use its cash resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio fails to consummate a strategic transaction with respect to Vicineum, the combined company will be responsible for unwinding related contractual relationships, which may adversely impact the business, financial condition and results of operations of the combined company following the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July 15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase 3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA. If the merger is consummated, the combined company does not expect to pursue further development of Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Although Sesen Bio is seeking to consummate a strategic transaction with respect to Vicineum and has engaged a financial advisor for the potential sale of Vicineum, in the event that a transaction is delayed or does not occur, the combined company will be responsible for unwinding contractual relationships related to Vicineum, which could divert the attention of the management teams and employees of the combined company from day-to-day business, result in liability, impose additional costs and otherwise adversely affect the business and financial condition of the combined company. The combined company may also experience the same risks related to disagreements and disputes with certain licensees, licensors and other counterparties as discussed above in &#8220;</font><font style="letter-spacing:0.2pt;">Risk Factors&#8201;&#8212;&#8201;Risks Related to the Merger&#8201;&#8212;&#8201;In connection with Sesen Bio&#8217;s strategic decision to voluntarily pause further development of Vicineum in the United States, Sesen Bio may become involved in disagreements or disputes with its licensees, licensors and other counterparties relating to the development and/or commercialization of Vicineum, which may be time consuming, costly and could divert its efforts and attention from consummating the merger and harm Sesen Bio&#8217;s efforts to seek a partner to continue development of Vicineum</font><font style="font-style:normal;letter-spacing:0.2pt;">.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCSCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus contains forward-looking statements (including within the meaning of Section&#160;21E of the Exchange Act and Section&#160;27A of the Securities Act) concerning, among other things, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the expected benefits of, and potential value created by, the merger for the Sesen Bio stockholders and Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the likelihood of the satisfaction of certain conditions to the completion of the merger and whether and when the merger will be completed and the listing of the Sesen Bio common stock to be issued on the Nasdaq Capital Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the expected amount of the Sesen Bio net cash on the anticipated closing date or the merger, or the closing date, and Sesen Bio&#8217;s ability to control and correctly estimate its operating expenses and its expenses associated with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the expected number of Sesen Bio securities included in the fully diluted number of outstanding shares of Sesen Bio common stock for purposes of calculating the exchange ratio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements regarding the CVRs to be granted to Sesen Bio stockholders, pursuant to the Merger Agreement and the CVR Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements regarding the special cash dividend that Sesen Bio may pay to Sesen Bio stockholders in connection with the completion of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements of the plans, strategies and objectives of management for future operations, including the execution of integration plans and the anticipated timing of filings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements of plans to develop and commercialize additional products candidates, including planned pre-clinical, clinical, regulatory and manufacturing activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements concerning the attraction and retention of highly qualified personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements concerning the ability to protect and enhance the combined company&#8217;s product candidates and intellectual property; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements concerning developments and projections relating to the combined company&#8217;s competitors or industry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements concerning the combined company&#8217;s projected financial performance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any statements regarding expectations concerning Sesen Bio&#8217;s or Carisma&#8217;s relationships and actions with third parties; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">future regulatory, judicial and legislative changes in Sesen Bio&#8217;s or Carisma&#8217;s industry. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These forward-looking statements should not be relied upon as predictions of future events as Sesen Bio and Carisma cannot assure you that the events or circumstances reflected in these statements will be achieved or will occur. You can identify forward-looking statements by the use of forward-looking terminology including &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;pro&#160;forma,&#8221; &#8220;estimates,&#8221; or &#8220;anticipates&#8221; or the negative of these words and phrases or other variations of these words and phrases or comparable terminology. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The events and circumstances reflected in forward-looking statements may not be achieved or occur and actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders and Carisma stockholders may not realize a benefit from the merger commensurate with the ownership dilution they will experience in connection with the merger, including the Carisma pre-closing financing, and the conversion of the Carisma convertible note; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the merger consideration may have greater or lesser value at the closing of the merger than at the time the Merger Agreement is signed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to complete the merger may result in either party paying a termination fee or expenses to the other party and could harm the future business and operations of the applicable company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the conditions to the merger are not met, including failure to obtain stockholder approval for the merger, or failure to comply with the listing standards of Nasdaq, the merger may not occur; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing of the consummation of the merger is uncertain as is the ability of each of Sesen Bio and Carisma to consummate the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the merger may be completed even though material adverse changes may occur; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio may not be able to correctly estimate its operating expenses and its expenses associated with the merger and may have a significantly lower net cash on the anticipated closing date than currently estimated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio may not be able to maintain its Nasdaq listing until the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">as a result of any adjustments in the exchange ratio, Sesen Bio stockholders or Carisma stockholders may own less of the combined company after the closing of the merger than is currently anticipated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">executive officers and directors of each company have interests in the merger that are different from yours, which may cause them to support or approve the merger without regard to your interests; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the market price of combined company&#8217;s common stock may decline following the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conditions to payment under the CVRs may not be met and the CVRs may never deliver any value to the Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions in the Merger Agreement may prevent Sesen Bio and Carisma from entering into a business combination with another party at a favorable price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain provisions of the Merger Agreement may discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the arrangements contemplated by the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Carisma stockholders may receive consideration in the merger that is greater or less than the fair market value of the Carisma shares due to the lack of a public market for Carisma shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the merger does not qualify as a tax-free reorganization for U.S. federal income tax purposes, the receipt of Sesen Bio common stock pursuant to the merger could be fully taxable to all Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company may never earn a profit; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company will be subject to the uncertainties associated with the clinical development and regulatory approval of its product candidates including potential delays in the commencement, enrollment and completion of clinical trials and that the results of prior clinical trials may not be predictive of future results; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company will be required to raise additional funds to finance its operations and remain a going concern and may be required to do so sooner than it expects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company may not be able to raise additional funds when necessary, and/or on acceptable terms; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company&#8217;s small public float, low market capitalization, limited operating history, and lack of revenue may make it difficult and expensive for the combined company to raise additional funds; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the pro&#160;forma combined financial statements may not be an indication of the combined company&#8217;s financial condition or results of operations following the completion of the merger and the transactions contemplated thereby; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma may not be able to protect their respective intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there may be changes in expected or existing competition for the combined company&#8217;s product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:16pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the merger will result in changes to the combined company&#8217;s board of directors that may affect the combined company&#8217;s business strategy and operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">both companies expect that the price of the combined company&#8217;s common stock may be volatile and may fluctuate substantially following the merger and the transactions contemplated thereby; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the combined company were to be delisted from Nasdaq, it could reduce the visibility, liquidity and price of its common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a significant portion of the combined company&#8217;s total outstanding shares of common stock may be sold into the public market at any point, which could cause the market price of the combined company&#8217;s common stock to drop significantly, even if the combined company is doing well; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there may be adverse reactions or changes in business relationships resulting from announcement or completion of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company will have broad discretion in the use of its cash reserves and may not use them effectively; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company expects to continue to incur increased costs as a result of operating as a public company, and its management will be required to devote substantial time to compliance initiatives and corporate governance practices; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the combined company does not anticipate paying any cash dividends on its capital stock in the foreseeable future, other than the special cash dividend that Sesen Bio may pay to Sesen Bio stockholders in connection with the consummation of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provisions in the combined company&#8217;s certificate of incorporation, its bylaws or Delaware law might discourage, delay or prevent a change in control of the company or changes in its management, which may depress the price of its common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the COVID-19 pandemic may have an adverse effect on the business of Sesen Bio, Carisma and the combined company, the medical community and the global economy; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">securities analysts&#8217; published reports could cause a decline in the price of the combined company&#8217;s stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The foregoing risks should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere. Sesen Bio and Carisma can give no assurance that the conditions to the merger will be satisfied. For further discussion of the factors that may cause Sesen Bio, Carisma or the combined company&#8217;s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied in such forward-looking statements, or for a discussion of risks associated with the ability of Sesen Bio and Carisma to complete the merger and the effect of the merger on the business of Sesen Bio, Carisma and the combined company, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additional factors that could cause actual results to differ materially from those expressed in the forward-looking statements are discussed in reports filed with the SEC by Sesen Bio. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any of these risks or uncertainties materialize or any of these assumptions prove incorrect, the results of operations of Sesen Bio, Carisma or the combined company could differ materially from the forward-looking statements. All forward-looking statements in this proxy statement/prospectus are current only as of the date of this proxy statement/prospectus. Sesen Bio and Carisma do not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any statement is made, the occurrence of unanticipated events or any new information that becomes available in the future.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTSMO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SPECIAL MEETING OF SESEN BIO STOCKHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Date, Time and Place</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be held on March 2, 2023, at www.proxydocs.com/SESN commencing at 10:00 a.m., Eastern Time, which will be a virtual meeting held exclusively via live webcast. Sesen Bio is sending this proxy statement/prospectus to Sesen Bio stockholders in connection with the solicitation of proxies by the Sesen Bio board of directors for use at the Sesen Bio special meeting and any adjournments or postponements of the Sesen Bio special meeting. This proxy statement/prospectus is first being furnished to Sesen Bio stockholders on or about January&#160;24, 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Purposes of the Sesen Bio Special Meeting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The purposes of the Sesen Bio special meeting are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Original Merger Agreement, as amended by the Merger Agreement Amendment, copies of which are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annexes A-1 and A-2</font><font style="letter-spacing:0.2pt;">, respectively, to this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, and the change of control of Sesen Bio resulting from the merger; </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the Sesen Bio Certificate of Incorporation, to (a) effect a reverse stock split of the issued and outstanding shares of Sesen Bio common stock at a ratio of 1-for-20, with the implementation and timing of the reverse stock split to be determined in the discretion of the Sesen Bio board of directors and as agreed to by Carisma at or prior to the closing of the merger, or in the sole discretion of the Sesen Bio board of directors if Proposal No. 1 is not approved, and (b) if and when the reverse stock split is effected, reduce the number of authorized shares of Sesen Bio common stock, in the form attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment and restatement of the 2014 Incentive Plan to, among other things, (a)&#160;increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 Incentive Plan, and (b)&#160;extend the term of the 2014 Incentive Plan to the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the 2014 ESPP to increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 ESPP to 6,568,655 shares of Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an adjournment of the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 or 2; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to transact such other business as may properly come before the Sesen Bio special meeting or any adjournment or postponement thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Sesen Bio Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Merger Agreement and has approved such proposal. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No.&#160;1 to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the merger pursuant to the terms of the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the authorized shares of Sesen </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Bio common stock, as described in this proxy statement/prospectus and has approved the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and has approved such proposal. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 2 to approve the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split, as described in this proxy statement/prospectus. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the amendment and restatement of the 2014 Incentive Plan, as described in this proxy statement/prospectus. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 3 to approve the amendment and restatement of the 2014 Incentive Plan, as described in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the amendment to the 2014 ESPP, as described in this proxy statement/prospectus. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 4 to approve the amendment to the 2014 ESPP, as described in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable, and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the adjournment of the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 or 2 and has approved such proposal. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 5 to adjourn the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 or 2. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Record Date and Voting Power</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Only holders of record of Sesen Bio common stock at the close of business on the record date, January&#160;17, 2023, are entitled to notice of, and to vote at, the Sesen Bio special meeting. There were 25&#160;holders of record of Sesen Bio common stock at the close of business on the record date. At the close of business on the record date, 202,759,043 shares of Sesen Bio common stock were issued and outstanding. Each share of Sesen Bio common stock entitles the holder thereof to one vote on each matter submitted for stockholder approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting and Revocation of Proxies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The proxy accompanying this proxy statement/prospectus is solicited on behalf of the Sesen Bio board of directors for use at the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are the &#8220;record holder&#8221; of your shares, meaning that you own your shares in your own name and not through a broker, bank or other nominee, you may vote in one of three ways prior to the Sesen Bio special meeting: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">You may vote over the internet.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">You may vote by telephone.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">You may vote by mail.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote by completing, dating and signing the enclosed proxy card and promptly mailing it in the postage-paid envelope provided. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may also vote during the Sesen Bio special meeting. To be admitted to the Sesen Bio special meeting and vote your shares, you must register in advance at www.proxydocs.com/SESN and provide the control number as set forth on the proxy card. After completing your registration, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All proxies that are executed or are otherwise submitted over the internet or by telephone will be voted on the matters set forth in this proxy statement in accordance with the stockholders&#8217; instructions. However, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">if no choice is specified on a proxy as to one or more of the proposals, the proxy will be voted in accordance with the Sesen Bio board of directors&#8217; recommendations on such proposals as set forth in this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">After you have submitted a proxy, you may still change your vote and revoke your proxy by doing any one of the following things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">submitting a new proxy via the internet or telephone by following the instructions on the enclosed proxy card; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">signing another proxy card and arranging for delivery of that proxy card by mail by 11:59&#160;p.m., Eastern Time, the day before the Sesen Bio special meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">giving Sesen Bio&#8217;s Corporate Secretary a written notice before the Sesen Bio special meeting that you want to revoke your proxy; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">voting during the Sesen Bio special meeting. Your attendance at the Sesen Bio special meeting alone will not revoke a previously submitted proxy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will count your vote in accordance with the last instruction Sesen Bio receives from you prior to the closing of the polls, whether your instruction is received by internet, telephone, mail, or at the Sesen Bio special meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shares Held in &#8220;Street Name&#8221;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If the shares of Sesen Bio common stock you own are held in &#8220;street name&#8221; by a broker, bank or other nominee, then that broker, bank or other nominee, as the record holder of your shares of Sesen Bio common stock, is required to vote your shares of Sesen Bio common stock according to your instructions. In order to vote your shares of Sesen Bio common stock, change your vote or revoke your instructions, you will need to follow the directions your broker, bank or other nominee provides you. Many brokers, banks or other nominees also offer the option of providing for voting over the internet or by telephone, instructions for which, if available, would be provided by such broker, bank or other nominee on the voting instruction form that it delivers to you. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you do not give instructions to your broker, bank or other nominee, such nominee can vote your shares of Sesen Bio common stock with respect to &#8220;discretionary&#8221; items but not with respect to &#8220;non-discretionary&#8221; items. Discretionary items are proposals considered routine under certain rules applicable to brokers and on which your broker may vote shares of Sesen Bio common stock held in &#8220;street name&#8221; in the absence of your voting instructions. On non-discretionary items for which you do not give your broker instructions, your shares of Sesen Bio common stock will be treated as broker non-votes. It is anticipated that Proposal Nos. 1, 3 and 4 will be non-discretionary. To make sure that your vote is counted, you should instruct your broker to vote your shares, following the procedures provided by the institution that holds your shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held in &#8220;street name,&#8221; you are also invited to attend and vote your shares of Sesen Bio common stock at the Sesen Bio special meeting live via webcast. After completing your registration in advance at www.proxydocs.com/SESN, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your voting instruction form. You will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. You may be instructed to obtain a legal proxy from your broker, bank or nominee and to submit a copy in advance of the meeting. Further instructions will be provided to you as part of your registration process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares of Sesen Bio common stock are held in &#8220;street name,&#8221; you must follow the instructions provided by your broker, bank or other nominee to revoke your voting instructions, or, if you have obtained a legal proxy to vote your shares of Sesen Bio common stock at the Sesen Bio special meeting, by attending the Sesen Bio special meeting and voting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The presence, in person or represented by proxy, of Sesen Bio stockholders holding at least a majority in voting power of the shares of Sesen Bio common stock issued and outstanding and entitled to vote at the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:176pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio special meeting is necessary to constitute a quorum at the Sesen Bio special meeting. Abstentions and broker non-votes will be treated as shares present for the purpose of determining the presence of a quorum for the transaction of business at the Sesen Bio special meeting. Approval of Proposal Nos. 1, 3, 4 and 5 requires the affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter. Approval of Proposal No. 2 requires the affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock entitled to vote on the record date for the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Votes will be counted by the inspector of election appointed for the Sesen Bio special meeting, who will separately count &#8220;FOR&#8221; and &#8220;AGAINST&#8221; votes, abstentions and broker non-votes. Abstentions will have the same effect as a vote &#8220;AGAINST&#8221; Proposal No. 2, but will have no effect on the outcome of Proposal Nos.&#160;1, 3, 4 and 5. Proposal Nos. 2 and 5 are matters on which Sesen Bio expects brokers, banks or other nominees to have discretionary authority to vote uninstructed shares and, therefore, broker non votes are not expected with respect to these proposals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Proposal No. 1 is conditioned upon the approval of Proposal No. 2, and the merger cannot be consummated without the approval of Proposal Nos. 1 and 2. Proposal Nos. 3 and 4 are conditioned upon Proposal Nos. 1 and 2. Proposal No. 2 is not conditioned on the approval of any other proposal. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Solicitation of Proxies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to solicitation by mail, the directors, officers, employees and agents of Sesen Bio and Carisma may solicit proxies from Sesen Bio stockholders by personal interview, telephone or otherwise. Sesen Bio and Carisma will share equally the cost of printing and filing this proxy statement/prospectus and the proxy card. Sesen Bio also may be required to reimburse brokers, banks and other custodians, nominees and fiduciaries or their respective agents for reasonable expenses incurred in forwarding proxy materials to beneficial owners of Sesen Bio common stock. Sesen Bio has engaged MacKenzie Partners to assist in the solicitation of proxies and provide related advice and informational support. Sesen Bio will pay the fees of MacKenzie Partners, which Sesen Bio expects to be approximately $20,000, plus reimbursement of out-of-pocket expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this proxy statement/prospectus, the Sesen Bio board of directors does not know of any business to be presented at the Sesen Bio special meeting other than as set forth in the notice accompanying this proxy statement/prospectus. If any other matters should properly come before the Sesen Bio special meeting, it is intended that the shares of Sesen Bio common stock represented by proxies will be voted with respect to such matters in accordance with the judgment of the persons voting the proxies. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTHME">&#8203;</a><a name="tBOTM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">This section and the section entitled &#8220;The Merger Agreement&#8221; in this proxy statement/prospectus describe the material aspects of the merger, including the Merger Agreement. While Sesen Bio and Carisma believe that this description covers the material terms of the merger and the Merger Agreement, it may not contain all of the information that is important to you. You should read carefully this entire proxy statement/prospectus for a more complete understanding of the merger and the Merger Agreement, including the Original Merger Agreement, as amended by the Merger Agreement Amendment, attached as Annexes A-1 and A-2, respectively, the opinion of SVB Securities attached as Annex B, and the other documents to which you are referred herein. See the section entitled &#8220;Where You Can Find More Information&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In an effort to enhance stockholder value, the Sesen Bio board of directors, in consultation with members of the Sesen Bio management team, regularly reviews and discusses Sesen Bio&#8217;s near and long-term operating and strategic priorities. Among other things, these reviews and discussions focus on the opportunities and risks associated with Sesen Bio&#8217;s development programs, financial condition and its strategic relationships and potential long-term strategic options. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;22, 2022, the Sesen Bio board of directors held a meeting at which members of Sesen Bio management, Michael O&#8217;Donnell, M.D., regulatory consultant to Sesen Bio, Neal D. Shore, M.D., FACS, clinical consultant to Sesen Bio, and a representative of Hogan Lovells, Sesen Bio&#8217;s outside legal counsel, were present. During the meeting, Dr.&#160;O&#8217;Donnell and Dr.&#160;Shore reviewed, among other things, the potential trial size scenarios for an additional Phase&#160;3 clinical trial for Vicineum, which the FDA previously confirmed would be required for a potential resubmission of a BLA. A discussion ensued regarding Sesen Bio&#8217;s cash runway and potential financing needs and the commercial viability of Vicineum if Sesen Bio conducted a successful clinical trial. Sesen Bio management discussed strategic alternatives for Sesen Bio, including conducting an additional Phase&#160;3 clinical trial for Vicineum, exploring a potential strategic transaction, and acquiring a new product. Monica Forbes, Sesen Bio&#8217;s Chief Financial Officer, discussed the estimated financial impacts of an additional Phase&#160;3 clinical trial for Vicineum, including the estimated time to achieve profitability and the need for additional financing to achieve profitability, with the estimated growth in Sesen Bio value barely outpacing the estimated dilution to existing stockholders. A discussion ensued regarding the process and timeline for conducting an additional Phase&#160;3 clinical trial for Vicineum, the financial impacts of the additional Phase&#160;3 clinical trial and whether other companies would be interested in a strategic acquisition of Vicineum. Following discussion, the Sesen Bio board of directors authorized and directed Sesen Bio management to continue planning for an additional Phase&#160;3 clinical trial for Vicineum and indicated that it would evaluate whether to conduct an additional Phase&#160;3 clinical trial in the third quarter of 2022 following an anticipated June&#160;2022 meeting with the FDA. Erin Clark, Sesen Bio&#8217;s Vice President of Corporate Strategy and Investor Relations, reviewed next steps for exploring a potential strategic alternative transaction, including the engagement of a financial advisor, and a possible timeline for a strategic alternative review process. Ms.&#160;Clark also discussed that Sesen Bio management would assess the feasibility of acquiring a new product and prepare a recommendation for the Sesen Bio board of directors to consider. Following further discussion, the Sesen Bio board of directors authorized Sesen Bio management to evaluate potential strategic alternatives, including (i)&#160;conducting an additional Phase&#160;3 clinical trial for Vicineum, (ii)&#160;exploring a potential strategic transaction, and (iii)&#160;acquiring a new product, in order to maximize value for Sesen Bio&#8217;s stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following the April&#160;22, 2022 board meeting, Sesen Bio management thoroughly evaluated four highly-qualified financial advisors, including SVB Securities. Sesen Bio management provided a summary of its evaluation and made a recommendation to the Sesen Bio board of directors. On May&#160;2, 2022, the Sesen Bio board of directors authorized by unanimous written consent the engagement of SVB Securities to serve as Sesen Bio&#8217;s financial advisor in connection with a process to review potential strategic alternative transactions based on, among other factors, the qualifications, professional reputation and industry expertise of SVB Securities. This engagement was memorialized in an engagement letter, dated May&#160;6, 2022, between Sesen Bio and SVB Securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;3, 2022, following the approval of the Sesen Bio board of directors to engage SVB Securities to serve as Sesen Bio&#8217;s financial advisor in connection with a process to review potential strategic alternative </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">transactions, Sesen Bio announced that it initiated a process to evaluate potential strategic alternatives with the goal of maximizing stockholder value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;9, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of SVB Securities and Hogan Lovells were present. During the meeting, Dr.&#160;Rachelle Dillon, Ph.D., Sesen Bio&#8217;s Executive Director of Clinical Operations, provided a summary of Sesen Bio&#8217;s activities in planning for an additional Phase&#160;3 clinical trial for Vicineum. In addition, at the meeting, representatives of SVB Securities reviewed potential strategic alternative transactions for Sesen Bio. Representatives of SVB Securities and Ms.&#160;Clark reviewed the status of the identification of potential counterparties for a strategic transaction, the proposed timeline for a potential strategic transaction and estimated wind-down costs in the event of a strategic transaction. A discussion ensued regarding potential strategic alternatives for Sesen Bio. Sesen Bio management discussed with the Sesen Bio board of directors potential ways to monetize potential milestone payments remaining under a 2016 license agreement with Roche, pursuant to which Sesen Bio had granted Roche an exclusive, worldwide license to develop and commercialize all patent rights and know-how related to the legacy IL-6 program, or the Roche licensed intellectual property, and had received $42.5&#160;million in milestone payments to date. The Sesen Bio board of directors authorized Sesen Bio management to pursue a potential transaction with Roche related to the Roche licensed intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;11, 2022, Sesen Bio management updated the Sesen Bio board of directors on discussions with senior management at Roche, who requested a formal proposal for a potential transaction related to the Roche licensed intellectual property. Sesen Bio management provided proposed terms for a potential transaction with Roche for the Sesen Bio board of directors&#8217; review and consideration. Subsequently, Sesen Bio management engaged in negotiations with Roche for a potential transaction related to the Roche licensed intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;25, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Members of Sesen Bio management provided an update on Sesen Bio&#8217;s activities in planning for an additional Phase&#160;3 clinical trial. Members of Sesen Bio management also provided an overview of the strategic alternative review process, including the proposed selection methodology and key evaluation criteria for identifying potential counterparties for a strategic transaction. A discussion ensued regarding strategic considerations for pursuing the additional Phase&#160;3 clinical trial or a strategic alternative transaction. Sesen Bio&#8217;s non-employee directors also met in executive session with a representative of Hogan Lovells to discuss a potential conflict of interest of a Sesen Bio director affiliated with a potential counterparty for a strategic transaction. All non-employee directors, including the director with a potential conflict of interest, agreed that the director would be recused from discussions of the strategic alternative review process until the potential conflict of interest no longer exists. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During May&#160;2022, at the direction of Sesen Bio following approvals from the Sesen Bio board of directors at the meeting held on April&#160;22, 2022 and by unanimous written consent of the Sesen Bio board of directors on May&#160;2, 2022, SVB Securities contacted 130 companies to determine the level of interest in a potential strategic transaction with Sesen Bio. Of those companies, 62 expressed interest in the strategic alternative review process and, at the direction of Sesen Bio, SVB Securities requested that such companies submit non-binding indications of interest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From May&#160;18, 2022 to June&#160;7, 2022, 42 companies submitted non-binding indications of interest with respect to a potential strategic transaction with Sesen Bio based on publicly available information, including indications from Carisma and the companies referred to as Party A, Party B, Party C and Party D, as described below: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The indication of interest from Carisma proposed a reverse merger transaction with an ascribed value of Sesen Bio of $110.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Carisma of $196.0&#160;million, with an implied ownership interest in the combined company of approximately 30.0% for existing Sesen Bio stockholders. Carisma&#8217;s proposal also contemplated a concurrent financing of $30.0&#160;million committed by existing Carisma investors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The indication of interest from Party A, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $150.0&#160;million (assuming closing net cash of </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">$100.0&#160;million) and an ascribed value of Party A of $249.0&#160;million, with an implied ownership interest in the combined company of approximately 40.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The indication of interest from Party B, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $100.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Party B of $200.0&#160;million, with an implied ownership interest in the combined company of approximately 33.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The indication of interest from Party C, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $130.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Party C of $310.0&#160;million, with an implied ownership interest in the combined company of approximately 30.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The indication of interest from Party D, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $106.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Party D of $159.0&#160;million, with an implied ownership interest in the combined company of approximately 40.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also during this period, Sesen Bio entered into confidentiality agreements with 18 of the companies that submitted indications of interest. 17 of the 18 confidentiality agreements, including those of Carisma, Party A, Party B, Party C and Party D, contained standstill provisions that expired 24 months after their execution. The remaining confidentiality agreement contained a standstill provision that expires 12&#160;months after its execution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From May&#160;20, 2022 to June&#160;7, 2022, members of Sesen Bio management and representatives of SVB Securities analyzed the 42 indications of interest using the following key evaluation criteria discussed by the Sesen Bio board of directors at a meeting on May&#160;25, 2022: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">business assessment, including each company&#8217;s proof of concept data generated to date, clinical development stage, pipeline depth, magnitude of potential clinical impact, existing standard of care, potential competitors, commercial potential, intellectual property, platform technology or drug discovery capabilities, scientific personnel and manufacturing capabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">management and board quality, including prior public company executive experience, and investor quality, including duration of investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">public company readiness, including analysis of existing potential public company infrastructure and existing audited financials and/or retention of an independent registered public accounting firm; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ability/need to raise contingent financing with consideration given for any existing investor commitments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">material inflection points, including meaningful clinical data readouts or regulatory submissions for programs in the relative near term; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ability to reach inflection points with pro&#160;forma cash; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">current Sesen Bio stockholder ownership post-transaction. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on this analysis, members of Sesen Bio management identified 15 potential counterparties, including Carisma, Party A, Party B, Party C and Party D, to present to Sesen Bio management and/or the Sesen Bio board of directors. Since the company affiliated with the Sesen Bio director who had a potential conflict of interest was not one of the 15 potential counterparties identified, such director was able to resume full participation in discussions of the strategic alternative review process because the potential for a conflict of interest no longer existed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;15 and 16, 2022, the Sesen Bio board of directors held a meeting in person and by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells and SVB Securities were present. Sesen Bio&#8217;s directors met in executive session with Ms.&#160;Clark and a representative of Hogan Lovells present. Dr.&#160;Thomas Cannell, Sesen Bio&#8217;s President and Chief Executive Officer, provided an update on recent changes in the NMIBC landscape and the strategic alternative review process. A discussion ensued regarding strategic considerations for an additional Phase&#160;3 clinical trial and a strategic </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">127</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">alternative transaction. Sesen Bio&#8217;s directors then met in executive session with a representative of Hogan Lovells present to further discuss, among other things, the potential alternatives for Sesen Bio, which included conducting an additional Phase&#160;3 clinical trial for Vicineum, exploring a potential strategic transaction, acquiring a new product, and liquidation. During this executive session, the Sesen Bio board of directors considered the cost, infrastructure needs, and time that would be involved in acquiring a new product and developing it for commercialization and determined not to pursue that strategic alternative at this time. Members of Sesen Bio management team and representatives of SVB Securities rejoined the meeting at which time Ms.&#160;Clark provided an update on the strategic alternative review process. Ms.&#160;Clark discussed the potential benefits of a reverse merger transaction for Sesen Bio stockholders, reviewed the proposed timeline and estimated wind-down costs in the event of a strategic transaction. Ms.&#160;Clark also discussed that Sesen Bio was exploring the potential sale of the Vicineum asset in the event the Sesen Bio board of directors determined to cease further development of Vicineum. A discussion ensued among the members of the Sesen Bio board of directors. Representatives of SVB Securities (i)&#160;reviewed the selection methodology and key evaluation criteria that members of Sesen Bio management, with the assistance of SVB Securities, used to analyze the 42 indications of interest received by Sesen Bio to identify 15 potential counterparties to present to the Sesen Bio board of directors and/or Sesen Bio management, (ii)&#160;provided perspectives on each of the 15 potential counterparties, (iii)&#160;discussed next steps in the strategic alternative review process, and (iv)&#160;reviewed the timeline for a potential strategic transaction. Members of Sesen Bio management and representatives of SVB Securities responded to questions regarding the key evaluation criteria. Following discussion, the Sesen Bio board of directors authorized SVB Securities to move forward with presentations, with the five potential counterparties meeting the most key evaluation criteria, including Party A, Party B and Party C, to present to the full Sesen Bio board of directors and the remaining ten potential counterparties identified based on the key evaluation criteria, including Carisma and Party D, to present first to Sesen Bio management and then, if warranting further consideration, to the full Sesen Bio board of directors. Dr.&#160;Dillon joined the meeting and provided an update on Sesen Bio&#8217;s activities in planning for an additional Phase&#160;3 clinical trial, including the projected timeline and next steps for evaluating whether to pursue an additional Phase&#160;3 clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Over the course of June and July&#160;2022, ten potential counterparties presented to Sesen Bio management and five potential counterparties, including two (Carisma and Party D) that first presented to Sesen Bio management, presented to the full Sesen Bio board of directors about their respective businesses. Prior to the commencement of the presentations, two of the initial five potential counterparties that were identified to present to the Sesen Bio board of directors voluntarily withdrew from the process. At the direction of the Sesen Bio board of directors, SVB Securities informed the other potential counterparties that had submitted indications of interest that they were not advancing to the next stage of discussions based on determinations by the Sesen Bio board of directors, informed by the perspectives of Sesen Bio management and SVB Securities, that each such counterparty was not reasonably likely to provide the best opportunity to maximize value for Sesen Bio&#8217;s current stockholders based on most of the key evaluation criteria. Following these presentations, the Sesen Bio board of directors further evaluated its initial business assessment of the five potential counterparties that presented to the Sesen Bio board of directors and provided feedback to Sesen Bio management in advance of the July&#160;25, 2022 board meeting to facilitate robust discussions before selecting the lead counterparties. During this period, Sesen Bio management also engaged in discussions with Roche about the possibility of Roche purchasing the Roche licensed intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;13, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and a representative of Hogan Lovells were present. Dr.&#160;Cannell provided an update on the negotiations of an asset purchase agreement between Sesen Bio and Roche, pursuant to which Roche would purchase the Roche licensed intellectual property for up to $70.0&#160;million, including a $40.0&#160;million payment to Sesen Bio upon execution of the agreement and an additional $30.0&#160;million payment to Sesen Bio upon the achievement by Roche of a specified milestone. A discussion ensued regarding, among other things, the associated proceeds having the potential to increase the range and attractiveness of strategic alternatives for Sesen Bio to consider and create the opportunity for a CVR that could provide enhanced value to Sesen Bio&#8217;s stockholders. Following discussion, the Sesen Bio board of directors unanimously approved and authorized Sesen Bio management to execute the Roche Asset Purchase Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">128</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and a representative of Hogan Lovells were present. Dr.&#160;Cannell provided an update on Sesen Bio&#8217;s July&#160;11, 2022 meeting with the FDA to discuss an additional Phase&#160;3 clinical trial for Vicineum, including the required design elements of an additional Phase&#160;3 clinical trial confirmed by the FDA. Dr.&#160;Cannell discussed that based on the agreed upon design elements and resulting trial size, estimated timing for enrollment and timing of sufficient data for BLA resubmission, a U.S. launch was projected between mid-2030 to mid-2033 with total trial cost estimated between $200.0&#160;million and $243.0&#160;million (assuming an approximately 1,000-patient trial). Ms.&#160;Forbes reviewed the estimated financial impact of an additional Phase&#160;3 clinical trial for Vicineum, including the estimated time to achieve profitability, the need for significant additional financing to achieve profitability, the anticipated negative return with dilution to existing stockholders outpacing the estimated growth in Sesen Bio&#8217;s value, and that the current cash runway was projected to run out before the first major inflection point of data disclosure was projected to occur. Ms.&#160;Forbes also reviewed the total estimated, risk-adjusted valuation of Sesen Bio, timing of first inflection point and cash runway in the case of an additional Phase&#160;3 clinical trial and in the case of a strategic alternative transaction. Members of management discussed the estimated impact of a potential liquidation, including that a meaningful amount of Sesen Bio&#8217;s current cash balance would need to be held back to cover current liabilities and future potential liabilities triggered by a liquidation strategy. Based on the FDA feedback on the requirements for an additional Phase&#160;3 clinical trial, the evolving competitive landscape and the resulting financial analysis for an additional Phase&#160;3 clinical trial, as well as the view that liquidation was not reasonably likely to create greater value for Sesen Bio stockholders than a strategic alternative transaction, Sesen Bio management recommended pausing further development of Vicineum in the U.S. and pursuing a strategic alternative transaction. Ms.&#160;Forbes also reviewed estimated wind-down costs in the event of a strategic transaction and possible next steps if the Sesen Bio board of directors were to approve pausing further development of Vicineum and pursue a strategic alternative transaction. Following discussion, the Sesen Bio board of directors unanimously approved pausing further development of Vicineum in the U.S., pursuing a strategic alternative transaction and implementing a restructuring plan to reduce operating expenses and to better align its workforce with the needs of its business following the decision to pause further development of Vicineum in the U.S. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;18, 2022, Sesen Bio announced that it made the strategic decision to voluntarily pause further development of Vicineum in the U.S. based on discussions with the FDA and a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial for Vicineum for the treatment of NMIBC. Sesen Bio also announced that it would turn its primary focus to the assessment of strategic alternatives and that it intended to seek a partner with larger infrastructure for the further development of Vicineum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also on July&#160;18, 2022, Sesen Bio announced that it had entered into the Roche Asset Purchase Agreement following execution of such agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;25, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Ms.&#160;Clark reviewed management&#8217;s proposed corporate strategy for 2022, including pursuing a potential strategic alternative transaction or, in the event a strategic alternative transaction is not completed, a liquidation and dissolution. Ms.&#160;Clark then reviewed the five remaining potential counterparties, Carisma, Party A, Party B, Party C and Party D, the presentations made by each potential counterparty and the due diligence conducted to date on each of the potential counterparties, including their respective business, management, board and investor quality, public company readiness, ability/need to raise contingent financing, material near-term inflection points, and ability to reach inflection points with pro&#160;forma cash. Following discussion, the Sesen Bio board of directors determined to prioritize discussions with Carisma, Party A and Party B based on the business assessment of each such counterparty after the presentations to the Sesen Bio board of directors, the terms of each such counterparty&#8217;s proposed indication of interest, and the results of due diligence conducted to date, and authorized and directed Sesen Bio management and SVB Securities to move forward with Carisma, Party A and Party B into a technical due diligence process, including a comprehensive business, regulatory, intellectual property, legal and financial analysis of all three potential counterparties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the period from July&#160;25, 2022 through August&#160;19, 2022, members of Sesen Bio management and representatives of SVB Securities engaged in deep technical due diligence activities with each of Carisma, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">129</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Party A and Party B, and, at the direction of the Sesen Bio board of directors, SVB Securities informed the other remaining counterparties that Sesen Bio was prioritizing discussions with other parties. On August&#160;4, 2022, at the direction of the Sesen Bio board of directors, Sesen Bio management terminated diligence activities and discussions with Party B based on the due diligence and business discussions conducted to date, particularly the potential regulatory risks related to Party B&#8217;s lead program that were discussed by the Sesen Bio board of directors in the July&#160;25, 2022 meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;11, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Ms.&#160;Clark provided an update on the strategic alternative review process, including an overview of the due diligence process and possible timeline for the two remaining potential counterparties. A discussion ensued, including about the possibility that based on Sesen Bio&#8217;s estimated cash balance, Sesen Bio could issue a special cash dividend of up to $25.0 million in the aggregate to Sesen Bio stockholders to deliver additional value to Sesen Bio stockholders as a result of the payment received by Sesen Bio pursuant to the Roche APA and careful management of operating expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the period from August&#160;11, 2022 through August&#160;18, 2022, members of Sesen Bio management and representatives of SVB Securities engaged in additional due diligence activities with each of Carisma and Party A. Also during this period, Sesen Bio management proposed to Carisma that Sesen Bio be permitted to issue a special cash dividend of up to $25.0 million to Sesen Bio stockholders.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on the key evaluation criteria and the technical and other due diligence activities undertaken to date by Sesen Bio management on each of Carisma and Party A, the Sesen Bio board of directors and Sesen Bio management conducted an additional due diligence call with key opinion leaders about Carisma&#8217;s proprietary cell therapy platform on August&#160;19, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on August&#160;19, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. During the meeting, a representative of Hogan Lovells reviewed the fiduciary duties of the Sesen Bio board of directors in the context of considering a potential reverse merger transaction. Ms.&#160;Clark reviewed the key evaluation criteria that Sesen Bio management, with the assistance of SVB Securities, used to analyze the potential counterparties and the technical and other due diligence activities undertaken to date by Sesen Bio management and Sesen Bio&#8217;s consultants and advisors on each of Carisma and Party A. Based on the thorough assessment performed by Sesen Bio management and Sesen Bio&#8217;s consultants and advisors, including technical due diligence, and the belief that a transaction with Carisma would provide value to Sesen Bio stockholders with significant upside potential, Sesen Bio management proposed that Sesen Bio pursue a reverse merger transaction with Carisma. Following discussion, the Sesen Bio board of directors approved and authorized Sesen Bio management to enter into negotiations with Carisma. In determining to pursue a reverse merger transaction with Carisma, the Sesen Bio board of directors considered that, in its judgment, Carisma provided the best opportunity to maximize value for Sesen Bio&#8217;s current stockholders, including after considering the potential advantages of Carisma over Party A with respect to the potential breadth and application of Carisma&#8217;s scientific platform, the potential value inflection milestones during the anticipated cash runways for the two parties, and a comparison of the potential risks regarding regulatory approval of each. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2022, Sesen Bio delivered a counterproposal to Carisma representing a $20&#160;million premium to Sesen Bio&#8217;s estimated cash balance at closing. Also on August&#160;19, 2022, representatives of Hogan Lovells delivered a first draft of the proposed merger agreement for the transaction to representatives of WilmerHale, Carisma&#8217;s outside legal counsel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the period from August&#160;19, 2022 through September&#160;20, 2022, representatives of Sesen Bio, including Hogan Lovells, and representatives of Carisma, including WilmerHale, completed confirmatory due diligence on each other and negotiated the terms of the merger agreement, including the definition of net cash, the calculation of the exchange ratio, the representations and warranties and operating covenants of each party, the amount of the termination fees and the expense reimbursement cap, and the terms of the forms of CVR Agreement, support agreement, and lock-up agreement. In evaluating and negotiating the exchange ratio, Sesen Bio considered Carisma&#8217;s valuation based on its last financing round along with other factors that favored increasing the Sesen Bio valuation, including a decline in general market conditions </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">130</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and limited opportunities available for privately-held biotechnology companies to access the capital markets for financing through an initial public offering. Also during this period, Carisma engaged in discussions with potential investors for an equity financing in Carisma that would close immediately prior to the closing of Sesen Bio&#8217;s transaction with Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;23, 2022, Carisma delivered a revised proposal with a stated value for Sesen Bio of $140.0&#160;million, which represented a $15.0&#160;million premium to Sesen Bio&#8217;s estimated cash balance at closing, and agreeing to a $125.0&#160;million cash minimum and permitting Sesen Bio to issue a special cash dividend of excess cash and subject to the minimum net cash condition. On August&#160;24, 2022, Sesen Bio requested more information on Carisma&#8217;s revised proposal. On August 26, 2022, Sesen Bio and Carisma agreed to a $100.0 million cash minimum and to permit Sesen Bio to issue a special cash dividend of an aggregate amount of up to $25.0 million subject to the $100.0 million cash minimum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;14, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Dr.&#160;Cannell and Ms.&#160;Clark provided an update on the negotiations with Carisma, the anticipated timing of Carisma&#8217;s pre-closing financing and the anticipated timeline for a potential transaction with Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells and SVB Securities were present. Sesen Bio&#8217;s directors met in executive session with representatives of Hogan Lovells to discuss, among other things, the potential benefits and risks of the proposed transaction with Carisma. Following the executive session, Ms.&#160;Clark reviewed the anticipated timeline and next steps for the proposed transaction with Carisma and the estimated wind-down costs if the proposed transaction with Carisma were completed. Representatives of SVB Securities reviewed SVB Securities&#8217; financial analysis of the proposed transaction with Carisma. Following discussion with the directors, SVB Securities then rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated September&#160;20, 2022, that, as of such date and based upon and subject to the assumptions made, and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, the exchange ratio to be paid by Sesen Bio pursuant to the terms of the Original Merger Agreement was fair, from a financial point of view, to Sesen Bio. During the meeting, a representative from Hogan Lovells again reviewed the fiduciary duties of the Sesen Bio board of directors in connection with the proposed transaction with Carisma and reviewed the material terms of the Original Merger Agreement. The Sesen Bio board of directors discussed various considerations with respect to the proposed transaction with Carisma, as summarized in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Reasons for the Merger.</font><font style="letter-spacing:0.2pt;">&#8221; Following discussion, the Sesen Bio board of directors unanimously (i)&#160;determined that the merger and other transactions contemplated by the Original Merger Agreement are advisable and in the best interests of Sesen Bio and its stockholders, (ii)&#160;approved and declared advisable the Merger Agreement, the merger and the other transactions contemplated by the Merger Agreement, and (iii)&#160;resolved to recommend that the Sesen Bio stockholders approve the issuance of shares of Sesen Bio common stock to Carisma stockholders in the merger and the other proposals contemplated by the Original Merger Agreement. Later on September&#160;20, 2022, Sesen Bio and Carisma executed the Original Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;21, 2022, Sesen Bio and Carisma issued a joint press release announcing the execution of the Original Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Between September&#160;29, 2022 and November&#160;17, 2022, the Sesen Bio board of directors held three meetings by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. At each meeting, Ms.&#160;Clark provided an update on preparation for the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;18, 2022, Bradley L. Radoff and Michael Torok and their affiliates, collectively referred to as the Investor Group, filed a Schedule&#160;13D with the SEC disclosing their beneficial ownership of 5.7% of the outstanding shares of Sesen Bio common stock and their intent to vote against the merger and the transactions related thereto. On December&#160;1, 2022, the Investor Group amended the Schedule&#160;13D to disclose beneficial ownership of 7.4% of the outstanding shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Between November&#160;18, 2022 and December&#160;17, 2022, representatives of SVB Securities and representatives of Sesen Bio engaged with the Investor Group regarding their views on the merger. During </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">131</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">this time, representatives of SVB Securities and representatives of Sesen Bio also engaged with other Sesen Bio stockholders regarding their views on the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Between December&#160;13, 2022 and December&#160;17, 2022, members of Sesen Bio management and members of Carisma management discussed the Investor Group&#8217;s Schedule&#160;13D filings and opposition to the merger, engagement with the Investor Group and feedback received from the Investor Group on the amount of a potential special cash dividend to Sesen Bio stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;17, 2022, Sesen Bio entered into a confidentiality agreement with the Investor Group to facilitate the sharing of certain information with the Investor Group. The confidentiality agreement required Sesen Bio to notify the Investor Group, by the earlier of December&#160;29, 2022 or two business days following the Investor Group&#8217;s agreement to vote in favor of the merger, that the information shared with the Investor Group does not constitute material, non-public information as of such date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Between December&#160;17, 2022 and December&#160;23, 2022, representatives of Sesen Bio and Carisma and their respective advisors engaged with the Investor Group and Olshan Frome Wolosky LLP, or Olshan, the Investor Group&#8217;s outside legal counsel, regarding the merger and the transactions related thereto. During such discussions, the Investor Group demanded, among other things, an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders and an expanded CVR to include Sesen Bio&#8217;s legacy assets, including Vicineum. During this time, representatives of Sesen Bio also engaged with other Sesen Bio stockholders regarding their views on the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Between December&#160;20, 2022 and December&#160;21, 2022, members of Sesen Bio management and members of Carisma management discussed the status of engagement with the Investor Group, including the Investor Group&#8217;s demands for an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders and an expanded CVR to include Sesen Bio&#8217;s legacy assets, net cash for funding the combined company&#8217;s operations and Sesen Bio&#8217;s expected net cash as of immediately prior to the closing of the merger. Members of Sesen Bio management and members of Carisma management discussed that a $100.0 million special cash dividend to Sesen Bio stockholders would make the merger unfeasible (including that Carisma advised that such special cash dividend would be unacceptable) and potentially introduce significant risk to Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;21, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Ms.&#160;Clark provided an update on engagement with the Investor Group, including the demand for an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders instead of the potential special cash dividend to Sesen Bio stockholders of up to $25.0&#160;million as set forth in the Original Merger Agreement. Members of Sesen Bio management reviewed with the Sesen Bio board of directors the estimated wind-down costs for Sesen Bio through March&#160;1, 2023 and that estimated net cash at the closing of the merger based on such wind-down costs was approximately $145.0 million, or approximately $75.0 million after a $70.0 million special cash dividend to Sesen Bio stockholders in connection with the merger. Ms.&#160;Clark reviewed with the Sesen Bio board of directors that in the event the merger is not completed, a court-managed liquidation would likely provide greater value to Sesen Bio stockholders compared to other potential strategic alternatives available to Sesen Bio due to the additional time, costs and associated risks to pursue other potential strategic alternatives, such as starting a new strategic review process, in-licensing or acquiring a new asset in a new disease and/or therapeutic area. Ms.&#160;Clark also provided an update on the anticipated timeline for the Sesen Bio special meeting. A discussion ensued among the Sesen Bio directors and others in attendance regarding a court-managed liquidation process, the Investor Group&#8217;s opposition to the merger, stockholder feedback Sesen Bio had received to date regarding the merger, and the potential size of an increased special cash dividend and related considerations, including that a $100.0 million special cash dividend to Sesen Bio stockholders would make the merger unfeasible (including that Carisma advised that such special cash dividend would be unacceptable) and potentially introduce significant risk to Sesen Bio. Based on the estimated wind-down costs through March&#160;1, 2023 and estimated net cash at the closing of the merger, members of Sesen Bio management recommended that the Sesen Bio board of directors authorize an increase of the amount of the potential special cash dividend in connection with the merger up to $75.0 million. Following discussion and management&#8217;s recommendation, the Sesen Bio board of directors authorized an increase of the amount of the potential special cash dividend in connection with the merger up to $75.0&#160;million, subject to agreement with Carisma. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">132</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;23, 2022, members of Carisma management advised members of Sesen Bio management that the Carisma board of directors had authorized a decrease to the minimum net cash requirement from $100.0&#160;million to $75.0&#160;million, which members of Carisma management advised that it believed was a sufficient amount to operate the combined company&#8217;s business as currently contemplated following the closing, with authorization for any excess cash above $75.0&#160;million to be part of a special cash dividend paid to Sesen Bio stockholders in connection with the merger, which was estimated to be approximately $70.0&#160;million. Members of Sesen Bio management and members of Carisma management discussed amending the CVR to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;23, 2022, representatives of Sesen Bio and Carisma and their respective advisors continued engaging with the Investor Group regarding the merger and the transactions related thereto. During such discussions, representatives of SVB Securities and representatives of Evercore Group L.L.C., or Evercore, Carisma&#8217;s financial advisor, communicated that Sesen Bio and Carisma had determined to significantly increase the amount of the special cash dividend by $45.0&#160;million to approximately $70.0&#160;million and amend the CVR Agreement to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum), which would increase the value paid to Sesen Bio stockholders upon completion of the merger. Representatives of SVB Securities and representatives of Evercore communicated that a special cash dividend of approximately $70.0&#160;million would leave the combined company with net cash of $75.0&#160;million to fund its operations, based on Sesen Bio&#8217;s expected net cash of approximately $145.0&#160;million as of immediately prior to the closing of the merger and prior to the issuance of the special cash dividend. In response, the Investor Group reiterated to representatives of SVB Securities and representatives of Evercore its demand for an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders and intent to vote against the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;23, 2022, representatives of Hogan Lovells and representatives of WilmerHale negotiated the terms of the merger agreement amendment and form of CVR Agreement, which would increase the amount of the special cash dividend to be paid to Sesen Bio stockholders from up to $25.0&#160;million to the amount of cash available after Sesen Bio meets the $75.0&#160;million net cash minimum and amend the form of CVR Agreement to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;29, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells and SVB Securities were present. Sesen Bio&#8217;s directors met in executive session with representatives of Hogan Lovells to review, among other things, the Sesen Bio board of directors&#8217; previous evaluation of strategic alternatives, including liquidation, that the Sesen Bio board of directors conducted before approving the merger. The Sesen Bio board of directors confirmed that it continues to believe such transaction maximizes stockholder value and is in the best interest of the Sesen Bio stockholders. Following the executive session, Ms.&#160;Clark provided an update on engagement with the Investor Group, including the Investor Group&#8217;s continued demand for an approximate $100.0 million special cash dividend to Sesen Bio stockholders, which the Sesen Bio board of directors agreed would make the merger unfeasible (including that Carisma advised that such special cash dividend would be unacceptable) and potentially introduce significant risk to Sesen Bio. Ms.&#160;Clark then reviewed the draft merger agreement amendment which would (i)&#160;reduce the minimum net cash of Sesen Bio required at the closing of the merger from $100.0&#160;million to $75.0&#160;million, (ii)&#160;increase the amount of the special cash dividend to be paid to Sesen Bio stockholders to the amount of cash available after Sesen Bio meets the $75.0&#160;million net cash minimum as of the closing of the merger, which was estimated to be approximately $70.0&#160;million, and (iii)&#160;amend the form of CVR Agreement to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum), in addition to any proceeds from the milestone payment under the Roche Asset Purchase Agreement, as part of the CVR. Representatives of SVB Securities reviewed SVB Securities&#8217; financial analysis of the proposed transaction with Carisma pursuant to the terms of the Merger Agreement. Following discussion with the Sesen Bio directors, SVB Securities then rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated December&#160;29, 2022, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, the exchange ratio to be paid by Sesen Bio pursuant to the terms of the Merger Agreement was fair, from a financial point of view, to Sesen Bio. Ms.&#160;Clark reviewed with the Sesen </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">133</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSBRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Bio board of directors the prior discussions from December&#160;21, 2022 that in the event the merger is not completed, a court-managed liquidation would likely provide greater value to Sesen Bio stockholders compared to other potential strategic alternatives available to Sesen Bio. Ms.&#160;Clark reviewed that, if the Sesen Bio board of directors were to approve and recommend, and Sesen Bio stockholders were to approve, a liquidation of Sesen Bio, Sesen Bio would be required under Delaware corporate law to notify potential claimants and pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, which may be sizeable, prior to making any distributions in liquidation to Sesen Bio stockholders. Ms.&#160;Clark noted that as a result of such requirement, a portion of Sesen Bio&#8217;s assets would need to be reserved pending the resolution of such obligations, the timing of any such resolution would be uncertain, and Sesen Bio may become subject to litigation or other claims related to a dissolution and liquidation of Sesen Bio. Representatives of Hogan Lovells reviewed with the Sesen Bio board of directors the Investor Group&#8217;s Schedule&#160;13D filings and opposition to the merger, engagement with the Investor Group to date and other matters related to the Investor Group, including potential responses and related considerations. A discussion ensued regarding engagement with the Investor Group, the terms of the Merger Agreement Amendment and the potential for a court-managed liquidation in the event the merger is not completed. Following discussion, the Sesen Bio board of directors unanimously (i)&#160;determined that the Merger Agreement Amendment and the transactions contemplated thereby are advisable and in the best interests of Sesen Bio and its stockholders, and (ii)&#160;approved and declared advisable the Merger Agreement Amendment and the transactions contemplated by the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Later on December&#160;29, 2022, Sesen Bio and Carisma executed the Merger Agreement Amendment and issued a joint press release announcing the execution of the Merger Agreement Amendment and providing an update on engagement with the Investor Group. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;3, 2023, the Investor Group issued a press release reiterating their intent to vote against the merger notwithstanding the increase to the amount of the expected special cash dividend in connection with the merger up to $70.0&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;4, 2023, Sesen Bio issued a press release reiterating its confidence in the merger, detailing the terms of the Merger Agreement Amendment and correcting certain factual errors made by the Investor Group in its January&#160;3, 2023 press release. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;5, 2023, the Investor Group issued an open letter to the Sesen Bio board of directors regarding their intent to vote against the merger and further amended their Schedule&#160;13D to disclose beneficial ownership of 8.4% of the outstanding shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Between January&#160;10 and January&#160;12, 2023, representatives of Sesen Bio and its legal and financial advisors engaged in discussions with the Investor Group and their legal counsel regarding the Investor Group&#8217;s views on the merger. In addition, between January&#160;11 and January&#160;16, 2023, representatives of Sesen Bio engaged in discussions with other Sesen Bio stockholders regarding their views on the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Reasons for the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the course of its evaluation of the Merger Agreement and the transactions contemplated by the Merger Agreement, the Sesen Bio board of directors held numerous meetings, consulted with Sesen Bio&#8217;s senior management, Sesen Bio&#8217;s consultants and advisors, outside legal counsel and financial advisor, and reviewed and assessed a significant amount of information. In reaching its decision to approve the Merger Agreement and the transactions contemplated by the Merger Agreement, the Sesen Bio board of directors considered a number of factors that it viewed as supporting its decision to approve the Merger Agreement, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the financial condition and prospects of Sesen Bio and the risks associated with continuing to operate Sesen Bio on a stand-alone basis, particularly in light of Sesen Bio&#8217;s July&#160;2022 decision to voluntarily pause further development of Vicineum for the treatment of NMIBC and reduce its workforce, which was based on a thorough reassessment of Vicineum following FDA feedback on the requirements for an additional Phase&#160;3 clinical trial, the evolving competitive landscape and the resulting financial analysis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">134</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that the Sesen Bio board of directors and its financial advisor undertook a comprehensive and thorough process of reviewing and analyzing potential strategic alternatives and merger partner candidates and Sesen Bio board of directors&#8217; view that no alternatives to the merger, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash, were reasonably likely to create greater value to Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; conclusion that the merger would provide existing Sesen Bio stockholders a significant opportunity to participate in the potential growth of the combined company following the merger, which will focus on Carisma&#8217;s product pipeline, while also potentially receiving certain cash payments following the closing of the merger on account of the CVR Agreement and the special cash dividend; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after a thorough review of strategic alternatives and discussions with Sesen Bio&#8217;s senior management, outside legal counsel and financial advisor, that the merger is more favorable to Sesen Bio stockholders than the potential value that might have resulted from other strategic alternatives available to Sesen Bio, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after thorough discussion with Sesen Bio management and Sesen Bio&#8217;s consultants and advisors, that a potential liquidation and dissolution was not reasonably likely to create greater value for Sesen Bio stockholders than a strategic alternative transaction based on, among other things, the need to hold back a meaningful amount of the Company&#8217;s current cash balance to cover current and potential future liabilities, including those triggered by a liquidation strategy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief that, as a result of arm&#8217;s length negotiations with Carisma, Sesen Bio and its representatives negotiated the highest exchange ratio to which Carisma was willing to agree, and that the other terms of the Merger Agreement include the most favorable terms to Sesen Bio in the aggregate to which Carisma was willing to agree; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; positive view, based on the scientific, regulatory and technical due diligence conducted by Sesen Bio management and advisors, of the regulatory pathway for, and potential significant market opportunity of, Carisma&#8217;s product candidates, which will be the focus of the combined company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; consideration of the expected cash balances of the combined company as of the closing of the merger resulting from the approximately $75.0 million of net cash expected to be held by Sesen Bio upon completion of the merger together with the cash Carisma currently holds and the $30.6&#160;million of expected gross proceeds from the Carisma pre-closing financing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; view, following a review with Sesen Bio&#8217;s management and advisors of Carisma&#8217;s current development and clinical trial plans, of the likelihood that the combined company would possess sufficient cash resources at the closing of the merger, or have access to sufficient resources, to fund continued development of Carisma&#8217;s product pipeline through upcoming value inflection points; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the prospects of and risks associated with the other strategic candidates that had made proposals for a strategic transaction with Sesen Bio based on the scientific, technical and other due diligence conducted by Sesen Bio&#8217;s management and advisors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; view that the combined company will be led by an experienced senior management team from Carisma and a board of directors with representation from each of the current boards of directors of Carisma and Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the current financial market conditions and historical market prices, volatility and trading information with respect to Sesen Bio common stock; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the opinion of SVB Securities, rendered orally to the Sesen Bio board of directors on December&#160;29, 2022 (and subsequently confirmed in writing as of December&#160;29, 2022) that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">135</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">review undertaken by SVB Securities in preparing its opinion, the exchange ratio was fair, from a financial point of view, to Sesen Bio, as more fully described below in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tOOSB">139</a> in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors also reviewed the terms of the Merger Agreement and related transaction documents, including those described below, and concluded that the terms of the Merger Agreement and related transaction documents, in the aggregate, were reasonable under the circumstances: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the calculation of the exchange ratio, closing net cash and the estimated number of shares of Sesen Bio common stock to be issued in the merger, including that the valuation of Sesen Bio under the Merger Agreement would be reduced to the extent that Sesen Bio&#8217;s closing net cash is less than $75.0 million and increased to the extent Sesen Bio&#8217;s closing net cash exceeds $75.0 million, which would result in a decrease or increase, as applicable, in the ownership of the pre-merger Sesen Bio stockholders in the combined company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and nature of the conditions to Sesen Bio&#8217;s and Carisma&#8217;s respective obligations to complete the merger and the likelihood that the merger will be completed on a timely basis, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tCCM5">176</a> in this proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the respective rights of, and limitations on, Sesen Bio and Carisma under the Merger Agreement to consider and engage in discussions regarding unsolicited acquisition proposals under certain circumstances, and the limitations on the board of directors of each party to change its recommendation in favor of the merger, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;No Solicitation</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tNSON">179</a> in this proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential termination fee of $7.6&#160;million, in the case of the fee payable by Sesen Bio, or $5.49&#160;million, in the case of the fee payable by Carisma, and related reimbursement of certain transaction expenses of up to $1.75&#160;million, which could become payable by either Sesen Bio or Carisma to the other party if the Merger Agreement is terminated in certain circumstances, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Termination Fee</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tTERFEE123">190</a> in this proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the lock-up agreements, pursuant to which certain stockholders of Carisma and Sesen Bio, respectively, have, subject to certain exceptions, agreed not to transfer their shares of the combined company common stock during the period of 180&#160;days following the completion of the merger, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Lock-Up Agreements</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tLOAG">199</a> in this proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the support agreements, pursuant to which certain stockholders of Carisma and Sesen Bio, respectively, have agreed, solely in their capacities as stockholders, to vote their shares of Carisma common stock or Sesen Bio common stock, respectively, in favor of the proposals submitted to them in connection with the merger and against any alternative acquisition proposals, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Support Agreements and Written Consents</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tSAAW">197</a> in this proxy statement/prospectus; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the CVR Agreement, pursuant to which Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive a CVR for each outstanding share of Sesen Bio common stock held by such Sesen Bio stockholders representing the contractual right to receive contingent cash payments upon the receipt of Sesen Bio of certain proceeds payable by Roche during a certain period following closing or of proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tCVAG">192</a> in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the course of its deliberations, the Sesen Bio board of directors also considered a variety of risks and other countervailing factors related to entering into the merger, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the $7.6&#160;million termination fee payable by Sesen Bio and Sesen Bio&#8217;s expense reimbursement obligations upon the occurrence of certain events and the potential effect of such termination fee in </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">136</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCRFT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">deterring other potential acquirors from proposing an alternative acquisition that may be more advantageous to Sesen Bio stockholders; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the substantial expenses to be incurred by Sesen Bio in connection with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the prohibition on Sesen Bio to solicit alternative acquisition proposals during the pendency of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possible volatility of the trading price of Sesen Bio common stock resulting from the announcement, pendency or completion of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk that the merger might not be consummated in a timely manner or at all and the potential effect of the public announcement of the merger or the failure to complete the merger on the reputation of Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scientific, technical, regulatory and other risks and uncertainties associated with development and commercialization of Carisma&#8217;s product pipeline; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the various other risks associated with the combined company and the proposed transaction, including those described in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Cautionary Statement Concerning Forward-Looking Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tRIFA">26</a> and <a href="#tCSCF">118</a>, respectively, in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The foregoing information and factors considered by the Sesen Bio board of directors are not intended to be exhaustive but are believed to include all of the material factors considered by the Sesen Bio board of directors. In view of the wide variety of factors considered in connection with its evaluation of the merger and the complexity of these matters, the Sesen Bio board of directors did not find it useful to attempt, and did not attempt, to quantify, rank or otherwise assign relative weights to these factors. In considering the factors described above, individual members of the Sesen Bio board of directors may have given different weight to different factors. The Sesen Bio board of directors conducted an overall analysis of the factors described above, including thorough discussions with, and questioning of, Sesen Bio&#8217;s senior management team, outside legal counsel and financial advisor, and considered the factors overall to be favorable to, and to support, its determination. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Reasons for the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the course of reaching its decision to approve the merger, the Carisma board of directors held numerous meetings, consulted with Carisma&#8217;s senior management, its financial advisors and legal counsel, and considered a wide variety of factors. Ultimately, the Carisma board of directors concluded that a merger with Sesen Bio, together with the additional financing committed from the Carisma pre-closing financing, was the best option to generate capital resources to support the advancement of Carisma&#8217;s pipeline and fund a combined organization. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additional factors that the Carisma board of directors considered included the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the merger will provide current Carisma stockholders with greater liquidity by owning publicly-traded stock, and expanding both the access to capital for Carisma and the range of investors potentially available as a public company, compared to the investors Carisma could otherwise gain access to if it continued to operate as a privately-held company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential benefits from increased public market awareness of Carisma and its pipeline; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the historical and current information concerning Carisma&#8217;s business, including its financial performance and condition, operations, management and pre-clinical and clinical data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the competitive nature of the industry in which Carisma operates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; fiduciary duties to Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; belief that no alternatives to the merger were reasonably likely to create greater value for Carisma stockholders, after reviewing the various financing and other strategic alternatives that were considered by the Carisma board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">137</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the projected financial position, operations, management structure, operating plans, and anticipated cash burn rate of the combined company, including the ability to support the combined company&#8217;s current and planned clinical trials and operations), as further discussed in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8212; Liquidity and Capital Resources &#8212; Funding Requirements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tFUNDRE1">335</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus; </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the business, history, operations, financial resources, assets, technology and credibility of Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of appraisal rights under the DGCL to holders of Carisma&#8217;s capital stock who comply with the required procedures under the DGCL, which allow such holders to seek appraisal of the fair value of their shares of Carisma capital stock as determined by the Delaware Court of Chancery; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the terms and conditions of the Merger Agreement, including the following: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the determination that the expected relative&#160;percentage ownership of Sesen Bio stockholders and Carisma stockholders in the combined company was appropriate, based on the Carisma board of directors&#8217; judgment and assessment of the approximate valuations of Sesen Bio (including the value of the net cash Sesen Bio is expected to provide to the combined company) and Carisma;</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the expectation that the merger will be treated as a reorganization for U.S. federal income tax purposes, with the result that in the merger Carisma stockholders will generally not recognize taxable gain or loss for U.S. federal income tax purposes;</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;font-family:Times New Roman, Times, serif;">
          <!--blacklining:none;-->
          <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">the limited number and nature of the conditions of the obligation of Sesen Bio to complete the merger;</font> </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;font-family:Times New Roman, Times, serif;">
          <!--blacklining:none;-->
          <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">the condition to Carisma&#8217;s obligation to complete the merger based on a minimum amount of net cash of Sesen Bio as of the closing of the merger;</font> </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;font-family:Times New Roman, Times, serif;">
          <!--blacklining:none;-->
          <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">the right of Carisma under the Merger Agreement to consider certain unsolicited acquisition proposals under certain circumstances should Carisma receive a superior proposal;</font> </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the conclusion of the Carisma board of directors that the potential termination fees payable by Sesen Bio or Carisma to the other party, and the circumstances when such fee may be payable, were reasonable; and</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the belief that the other terms of the Merger Agreement, including the parties&#8217; representations, warranties and covenants, and the conditions to their respective obligations, were reasonable in light of the entire transaction;</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the shares of Sesen Bio common stock issued to Carisma stockholders in connection with the merger will be registered on a Form&#160;S-4 registration statement and will become freely tradable for Carisma stockholders who are not affiliates of Carisma and who are not parties to lock-up agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability to obtain a Nasdaq listing and the change of the combined company&#8217;s name to &#8220;Carisma Therapeutics Inc.&#8221; upon the closing of the merger; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the likelihood that the merger will be completed on a timely basis. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors also considered a number of uncertainties and risks in its deliberations concerning the merger and the other transactions contemplated by the Merger Agreement, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possibility that the merger might not be completed and the potential adverse effect of the public announcement of the merger on the reputation of Carisma and the ability of Carisma to obtain financing in the future in the event the merger is not completed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk that future sales of common stock by existing Sesen Bio stockholders may cause the price of Sesen Bio common stock to fall, thus reducing the potential value of Sesen Bio common stock received by Carisma stockholders following the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">138</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOOSB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the exchange ratio used to establish the number of shares of Sesen Bio common stock to be issued to Carisma stockholders in the merger is fixed, except for adjustments including due to Sesen Bio&#8217;s net cash and the respective companies&#8217; outstanding capital stock at closing, and thus the relative&#160;percentage ownership of Sesen Bio stockholders and Carisma stockholders in the combined organization immediately following the completion of the merger is similarly fixed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the termination fee payable by Carisma to Sesen Bio upon the occurrence of certain events, and the potential effect of such termination fee in deterring other potential acquirers from proposing an alternative transaction that may be more advantageous to Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential reduction of Sesen Bio&#8217;s net cash prior to the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possibility that Sesen Bio could, under certain circumstances, consider unsolicited acquisition proposals if superior to the merger or change its recommendation to approve the merger upon certain events; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk that the merger might not be completed in a timely manner or at all, for a variety of reasons, such as the failure of Sesen Bio to obtain the required stockholder vote, and the potential adverse effect on the reputation of Sesen Bio and the ability of Sesen Bio to obtain financing in the future in the event the merger is not completed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs involved in connection with completing the merger, the time and effort of Carisma senior management required to complete the merger, the related disruptions or potential disruptions to Carisma&#8217;s business operations and future prospects, including its relationships with its employees, suppliers and partners and others that do business or may do business in the future with Carisma, and related administrative challenges associated with combining the companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the additional expenses and obligations to which Carisma&#8217;s business will be subject following the merger that Carisma has not previously been subject to, and the operational changes to Carisma&#8217;s business, in each case that may result from being a public company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the fact that the representations and warranties in the Merger Agreement do not survive the closing of the merger and the potential risk of liabilities that may arise post-closing; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">various other risks associated with the combined organization and the merger, including the risks described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing information is not intended to be exhaustive, but summarizes the material factors considered by the Carisma board of directors in its consideration of the Merger Agreement and the transactions contemplated. The Carisma board of directors concluded that the benefits, advantages and opportunities of a potential transaction outweighed the uncertainties and risks described above. After considering these and other factors, the Carisma board of directors unanimously approved the Merger Agreement, the merger and the other transactions contemplated by the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Introduction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio retained SVB Securities as its financial advisor in connection with the merger and the other transactions contemplated by the Merger Agreement. In connection with this engagement, the Sesen Bio board of directors requested that SVB Securities evaluate the fairness, from a financial point of view, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. On December&#160;29, 2022, SVB Securities rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated December&#160;29, 2022, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement was fair, from a financial point of view, to Sesen Bio. In providing its opinion, SVB Securities noted that the exchange ratio is subject to certain adjustments set forth in the Merger Agreement, and SVB Securities expressed no opinion as to any such adjustments. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">139</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="font-weight:normal;letter-spacing:0.2pt;">The full text of the written opinion of SVB Securities, dated December&#160;29, 2022, which describes the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, is attached as </font><font style="font-style:italic;font-weight:normal;letter-spacing:0.2pt;">Annex B</font><font style="font-weight:normal;letter-spacing:0.2pt;"> to this proxy statement/prospectus and is incorporated herein by reference. The summary of the written opinion of SVB Securities set forth below is qualified in its entirety by the full text of the written opinion attached hereto as </font><font style="font-style:italic;font-weight:normal;letter-spacing:0.2pt;">Annex B</font><font style="font-weight:normal;letter-spacing:0.2pt;">. </font><font style="letter-spacing:-0.2pt;">SVB Securities&#8217; financial advisory services and opinion were provided for the information and assistance of the Sesen Bio board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of the Sesen Bio board of directors&#8217; consideration of the merger and the opinion of SVB Securities addressed only the fairness, from a financial point of view, as of the date thereof, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. The opinion of SVB Securities did not address any other term or aspect of the Merger Agreement or the merger and does not constitute a recommendation to any stockholder of Sesen Bio as to whether or how such holder should vote with respect to the merger or otherwise act with respect to the merger or any other matter.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The full text of the written opinion of SVB Securities should be read carefully in its entirety for a description of the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with rendering the opinion described above and performing its related financial analyses, SVB Securities reviewed, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Original Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a draft of the Merger Agreement Amendment, dated December&#160;29, 2022; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a draft of the form of CVR Agreement to be entered into prior to the closing of the merger by Sesen Bio and a rights agent, dated December&#160;29, 2022; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021, as filed by Sesen Bio with the SEC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods ended March&#160;31, 2022, June&#160;30, 2022 and September 30, 2022 (including any amendments thereto), as filed by Sesen Bio with the SEC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain Current Reports on Form 8-K (including any amendments thereto), as filed by Sesen Bio with, or furnished by Sesen Bio to, the SEC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain internal information, primarily related to expense forecasts, relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of Sesen Bio, as furnished to SVB Securities by the management of Sesen Bio; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain internal information relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of Carisma, including the Financial Projections (as defined below), and furnished to, and approved for use by, SVB Securities by Sesen Bio for purposes of SVB Securities&#8217; analysis, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Certain Unaudited Financial Projections</font><font style="letter-spacing:0.2pt;">,&#8221; which are referred to in this summary of the opinion of SVB Securities as the &#8220;Financial Projections,&#8221; and which are collectively referred to in this summary of the opinion of SVB Securities as the &#8220;Internal Data&#8221;. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities also conducted discussions with members of the senior management of Sesen Bio and Carisma and their respective advisors and representatives regarding the Internal Data as well as the past and current business, operations, financial condition and prospects of each of Sesen Bio and Carisma. In addition, SVB Securities reviewed certain financial data for Carisma and compared that data to similar publicly available market, financial and other data for certain other companies, the securities of which are publicly traded, that SVB Securities believed to be comparable in certain respects to Carisma. SVB Securities also conducted such other financial studies and analyses and took into account such other information as SVB Securities deemed appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities assumed, without independent verification or any responsibility therefor, the accuracy and completeness of the financial, legal, regulatory, tax, accounting and other information supplied to, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">140</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">discussed with, or reviewed by SVB Securities for purposes of its opinion and, with Sesen Bio&#8217;s consent, SVB Securities relied upon such information as being complete and accurate. In that regard, SVB Securities was advised by Sesen Bio, and assumed, at Sesen Bio&#8217;s direction, that the Internal Data (including, without limitation, the Financial Projections) were reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of Sesen Bio and Carisma as to the matters covered thereby and SVB Securities relied, at Sesen Bio&#8217;s direction, on the Internal Data for purposes of SVB Securities&#8217; analysis and its opinion. SVB Securities expressed no view or opinion as to the Internal Data (including, without limitation, the Financial Projections) or the assumptions on which they were based. The Sesen Bio board of directors was aware that the management of Sesen Bio did not provide SVB Securities with, and SVB Securities did not otherwise have access to, financial forecasts regarding Sesen Bio&#8217;s business, other than the expense forecasts described above. Accordingly, SVB Securities did not perform a discounted cash flow analysis or any multiples-based analysis with respect to Sesen Bio. In addition, at Sesen Bio&#8217;s direction, SVB Securities did not make any independent evaluation or appraisal of any of the assets or liabilities (contingent, derivative, off-balance-sheet or otherwise) of Sesen Bio or Carisma, nor was SVB Securities furnished with any such evaluation or appraisal, and SVB Securities was not asked to conduct, and did not conduct, a physical inspection of the properties or assets of Sesen Bio or Carisma. Furthermore, at Sesen Bio&#8217;s direction, SVB Securities ascribed no value to the contingent value rights issuable pursuant to the CVR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities assumed, at Sesen Bio&#8217;s direction, that the final executed Merger Agreement would not differ in any respect material to SVB Securities&#8217; analysis or its opinion from the last draft of the Merger Agreement reviewed by SVB Securities. SVB Securities also assumed, at Sesen Bio&#8217;s direction, that the representations and warranties made by Carisma and Sesen Bio and Merger Sub in the Merger Agreement and the related agreements were and would continue to be true and correct in all respects material to SVB Securities&#8217; analysis. Furthermore, SVB Securities assumed, at Sesen Bio&#8217;s direction, that the merger would be consummated on the terms set forth in the Merger Agreement and in accordance with all applicable laws and other relevant documents or requirements, without delay or the waiver, modification or amendment of any term, condition or agreement, the effect of which would be material to SVB Securities&#8217; analysis or SVB Securities&#8217; opinion and that, in the course of obtaining the necessary governmental, regulatory and other approvals, consents, releases and waivers for the merger, no delay, limitation, restriction, condition or other change would be imposed, the effect of which would be material to SVB Securities&#8217; analysis or SVB Securities&#8217; opinion. SVB Securities did not evaluate and did not express any opinion as to the solvency or fair value of Sesen Bio or Carisma, or their respective abilities to pay their obligations when they come due, or as to the impact of the merger on such matters, under any state, federal or other laws relating to bankruptcy, insolvency, or similar matters. SVB Securities is not a legal, regulatory, tax or accounting advisor, and SVB Securities expressed no opinion as to any legal, regulatory, tax or accounting matters. SVB Securities expressed no view or opinion as to the price or range of prices at which the shares of stock or other securities or instruments of Sesen Bio or any third party may trade at any time, including subsequent to the announcement or consummation of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The opinion of SVB Securities expressed no view as to, and did not address, Sesen Bio&#8217;s underlying business decision to proceed with or effect the merger, or the relative merits of the merger as compared to any alternative business strategies or transactions that might be available to Sesen Bio or in which Sesen Bio might engage. The opinion of SVB Securities was limited to and addressed only the fairness, from a financial point of view, as of the date of its opinion, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. SVB Securities was not asked to, nor did it express any view on, and its opinion did not address, any other term or aspect of the Merger Agreement or the other transactions contemplated by the Merger Agreement, including, without limitation, the structure or form of the merger or the other transactions contemplated by the Merger Agreement, or any other agreements or arrangements contemplated by the Merger Agreement or entered into in connection with or otherwise contemplated by the merger or the other transactions contemplated by the Merger Agreement, including, without limitation, the fairness of the merger or any other term or aspect of the merger to, or any consideration to be received in connection therewith by, or the impact of the merger on, the holders of any class of securities, creditors or other constituencies of Sesen Bio or any other party. In addition, SVB Securities expressed no view or opinion as to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to be paid or payable to any of the officers, directors or employees of Sesen Bio or any other party, or class of such persons in connection with the merger or the other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">141</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">transactions contemplated by the Merger Agreement, whether relative to the exchange ratio to be paid by Sesen Bio pursuant to the terms of the Merger Agreement or otherwise. The opinion of SVB Securities was necessarily based on financial, economic, monetary, currency, market and other conditions and circumstances as in effect on, and the information made available to SVB Securities as of, the date of its written opinion, and SVB Securities does not have any obligation or responsibility to update, revise or reaffirm its opinion based on circumstances, developments or events occurring after the date of its opinion. SVB Securities&#8217; opinion does not constitute a recommendation to any stockholder of Sesen Bio as to whether or how such stockholder should vote with respect to the merger or otherwise act with respect to the merger or the other transactions contemplated by the Merger Agreement or any other matter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities&#8217; financial advisory services and its opinion were provided for the information and assistance of the Sesen Bio board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of its consideration of the merger and the other transactions contemplated by the Merger Agreement. SVB Securities&#8217; opinion was authorized by the SVB Securities LLC Fairness Opinion Review Committee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of Financial Analyses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material financial analyses prepared by SVB Securities and reviewed with the Sesen Bio board of directors in connection its opinion, which was delivered orally to the Sesen Bio board of directors on December&#160;29, 2022 and subsequently confirmed in its written opinion, dated December&#160;29, 2022. For purposes of the analyses described below, SVB Securities was directed to rely upon the Internal Data, including the Financial Projections. The summary set forth below does not purport to be a complete description of the financial analyses performed or factors considered by, and underlying the opinion of, SVB Securities, nor does the order of the analyses described below represent the relative importance or weight given to those analyses by SVB Securities. The preparation of a fairness opinion is a complex analytical process involving various determinations as to the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances and, therefore, a fairness opinion is not readily susceptible to summary description. In arriving at its opinion, SVB Securities did not draw, in isolation, conclusions from or with regard to any factor or analysis that it considered. Accordingly, SVB Securities believes that its analyses must be considered as a whole and that selecting portions of such analyses and factors without considering all analyses and factors, could create a misleading or incomplete view of the processes underlying SVB Securities&#8217; financial analyses and its opinion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities may have deemed various assumptions more or less probable than other assumptions, so the reference ranges resulting from any particular portion of the analyses summarized below should not be taken to be the view of SVB Securities as to the actual value of Carisma. Some of the summaries of the financial analyses set forth below include information presented in tabular format. In order to fully understand the financial analyses, the tables must be read together with the text of each summary, as the tables alone do not constitute a complete description of the financial analyses performed by SVB Securities. In its analyses, SVB Securities made numerous assumptions with respect to industry performance, general business and economic conditions and other matters, many of which are beyond the control of Sesen Bio or any other parties to the merger and the other transactions contemplated by the Merger Agreement. None of Sesen Bio, Carisma, Merger Sub, SVB Securities or any other person assumes responsibility if future results are materially different from those discussed. Any estimates contained in these analyses are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than as set forth below. In addition, analyses relating to the value of Sesen Bio or Carisma do not purport to be appraisals or reflect the prices at which these companies may actually be sold. Accordingly, the assumptions and estimates used in, and the results derived from, the financial analyses are inherently subject to substantial uncertainty. Except as otherwise noted, the following quantitative information, to the extent that it is based on market data, is based on market data as it existed on or before December&#160;29, 2022 and is not necessarily indicative of current market conditions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities&#8217; financial analyses and opinion were only one of many factors taken into consideration by the Sesen Bio board of directors in its evaluation of the merger, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Sesen Bio Reasons for the Merger</font><font style="letter-spacing:0.2pt;">.&#8221; Consequently, the analyses described below should not be viewed as determinative of the views of the Sesen Bio board of directors or management of Sesen Bio </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">142</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with respect to the exchange ratio or as to whether the Sesen Bio board of directors would have been willing to determine that a different exchange ratio was fair. The exchange ratio, as well as the type of consideration payable in the merger, was determined through arm&#8217;s-length negotiations between Sesen Bio and Carisma and was approved by the Sesen Bio board of directors. SVB Securities provided advice to Sesen Bio during these negotiations. However, SVB Securities did not recommend any specific exchange ratio or other financial terms to Sesen Bio or the Sesen Bio board of directors or that any specific exchange ratio or other financial terms constituted the only appropriate consideration for the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In preparing its analysis, SVB Securities took into account that the exchange ratio contained in the Merger Agreement is calculated by attributing equity values of $90.0&#160;million and $196.0&#160;million to Sesen Bio and Carisma, respectively, subject to certain adjustments set forth in the Merger Agreement and before giving effect to the Carisma pre-closing financing. SVB Securities expressed no opinion as to any such adjustments. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Valuation Analysis&#8201;&#8212;&#8201;Discounted Cash Flow</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A discounted cash flow analysis is a traditional valuation methodology used to derive a valuation of an asset or set of assets by calculating the &#8220;present value&#8221; of estimated future cash flows of the asset or set of assets. &#8220;Present value&#8221; refers to the current value of future cash flows or amounts and is obtained by discounting those future cash flows or amounts by a discount rate that takes into account assumptions and estimates of risk, the opportunity cost of capital, expected returns and other appropriate factors, and then adding the present value equivalent of the terminal value of the business at the end of the applicable projection period. SVB Securities performed a discounted cash flow analysis to calculate the estimated present value of the stand-alone, unlevered, after-tax free cash flows that Carisma was forecasted to generate from January&#160;1, 2023 through December&#160;31, 2041, which unlevered, after-tax free cash flows were derived from the Financial Projections on which SVB Securities relied. The time period of the Financial Projections was determined by Sesen Bio assuming U.S. approval and launch of CT-0508 in fiscal year 2027 with a 12-year exclusivity period (ending in fiscal year 2038), which Sesen Bio believes is consistent with current exclusivity for biological products, and includes a 3-year drop off period to account for the anticipated gradual decline in sales once generic competition is projected to enter the market in fiscal year 2039. Sesen Bio advised SVB Securities that it believed it was reasonable to forecast revenues through this projection period. SVB Securities estimated the net present value of unlevered, after-tax free flows after fiscal year 2041 by assuming an annual decline ranging from 10% to 30% of such cash flows in perpetuity, at the direction of Sesen Bio management, which range was determined by Sesen Bio management after taking into account (i)&#160;the uncertainty of the future regulatory pathway for generic cellular therapies, (ii) the potential for market entry of competing therapeutic products following the loss of exclusivity for CT-0508 and (iii) that revenue from the Moderna partnership is expected to begin declining after 2041. These cash flows were discounted to present value as of January&#160;1, 2023, using a discount rate ranging from 11% to 13%, derived from a weighted average cost of capital calculation for Carisma, which SVB Securities performed utilizing the capital asset pricing model with inputs that SVB Securities determined were relevant based on publicly available data and SVB Securities&#8217; professional judgment, including target capital structure, levered and unlevered betas for certain companies deemed by SVB Securities to be comparable to Carisma, size and equity market risk premiums and yields for U.S. treasury bonds, and adjusted for an estimated net cash balance of $9.0 million as of December&#160;31, 2022, as provided by management of Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This analysis resulted in an implied equity value for Carisma of approximately $225.0 million to $335.0&#160;million and a corresponding implied exchange ratio of approximately 43.4142x to 64.3783x. The implied equity value for Carisma and corresponding exchange ratio derived from the discounted cash flow analysis performed by SVB Securities in connection with the opinion delivered by SVB Securities with respect to the Original Merger Agreement were approximately $210 million to $320 million and 26.4261x to 40.0919x, respectively. The differences are attributable to a revised estimated cash balance for Carisma as of December 31, 2022 as provided by management of Carisma of $9.0 million as compared to an estimated cash balance of ($6.0) million as provided by management of Carisma reflected in the discounted cash flow analysis performed by SVB Securities in connection with the opinion delivered by SVB Securities on September&#160;20, 2022, resulting in an increase in the implied value of Carisma of $15 million, and a reduction in the equity value attributed to Sesen Bio for purposes of the exchange ratio pursuant to the Merger </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">143</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Agreement Amendment from $140 million to $90 million which, together with the revised implied equity value for Carisma, results in an increase to the implied exchange ratio derived from SVB Securities&#8217; analysis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Additional Factors Observed by SVB Securities&#8201;&#8212;&#8201;Carisma Valuation Analysis&#8201;&#8212;&#8201;Selected Public Companies </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As additional factors not part of its financial analysis but noted for reference purposes, SVB Securities reviewed publicly available information relating to the market capitalization of certain U.S.-listed publicly traded biopharmaceutical companies focused on cellular-based therapeutics whose lead products at the time of this analysis were (1)&#160;being developed for the treatment of oncology targets and (2)&#160;in early clinical development, selected based on SVB Securities&#8217; professional judgment and experience. These companies, which are referred to as the Selected Companies, were: </font>
        </div>
        <table style="width:456pt;height:80.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:154.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Company </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:73.77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Lead Relevant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Program </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:79.78pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Indication </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Enterprise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Adjusted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:154.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Arcellx, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:73.77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">CART-ddBCMA </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:79.78pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Multiple Myeloma </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,579</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,298</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,089</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Celularity Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:73.77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">CYNK-001 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:79.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">AML </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">164</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">161</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">142</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adicet Bio, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:73.77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">ADI-001 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:79.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">NHL </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">350</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">67</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities noted that although such companies had certain financial and operating characteristics that could be considered similar to those of Carisma, none of the companies had the same management, make-up, technology, size or mix of businesses as Carisma and, accordingly, there were inherent limitations on the applicability of such companies to the valuation analysis of Carisma. In selecting the Selected Companies, based on its professional judgment and expertise, SVB Securities excluded numerous companies meeting the selection criteria described above. These companies were excluded because either (i) the company used technology that, in SVB Securities&#8217; judgment, differed significantly from Carisma&#8217;s autologous CAR-M immunotherapy technology, (ii) in SVB Securities&#8217; judgment, a substantial portion of the company&#8217;s market value was attributable to non-cell therapy assets or other platform technologies, or (iii) the company traded at a negative enterprise value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities calculated the aggregate enterprise value of each of the Selected Companies based upon the closing price of the common stock of each Selected Company on December 28, 2022 and the fully-diluted number of shares outstanding, using the treasury stock method. Using the 25</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> and 75</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> percentile of the Selected Companies, SVB Securities derived an enterprise value range for Carisma and then added Carisma&#8217;s estimated net cash for year ending December&#160;31, 2022 of $9.0 million to derive adjusted equity values for Carisma. SVB Securities then applied a 20% illiquidity discount to the derived adjusted equity values for Carisma. The results of this analysis are summarized as follows: </font>
        </div>
        <table style="width:416pt;height:56.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:350.67pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Adjusted Equity </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:350.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">25</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Percentile </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">105</td>
            <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">75</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Percentile </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">615</td>
            <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities compared these adjusted equity valuations to the proposed Carisma valuation of $196.0&#160;million based on the proposed valuation and ownership ratio in the Merger Agreement and also compared the resulting implied exchange ratio range of approximately 19.6579x to 117.9667x to the exchange ratio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing analysis differs from the selected companies analysis performed by SVB Securities in connection with the opinion delivered by SVB Securities with respect to the Original Merger Agreement, which resulted in a range of adjusted equity values of approximately $205 million (25</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> percentile) to $715&#160;million (75</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> percentile) and a resulting implied exchange ratio range of approximately 25.8592x to 89.5943x. These differences are attributable to: (1) changes in closing stock prices between September 19, 2022 and December 28, 2022; (2) the exclusion of Lyell Immunopharma, Inc. and Nkarta, Inc. from SVB Securities&#8217; Selected Companies analysis in connection with its opinion with respect to the Merger Agreement Amendment because the companies traded at a negative enterprise value; (3) the revised estimated cash </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">144</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCUFP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">balance for Carisma as of December 31, 2022 of $9 million as provided by management of Carisma; and (4) the reduction in the equity value attributed to Sesen Bio for purposes of the exchange ratio pursuant to the Merger Agreement Amendment from $140 million to $90 million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities is a full-service securities firm engaged in securities trading and brokerage activities as well as investment banking and financial advisory services. In the ordinary course of business, SVB Securities and its affiliates currently are providing and may in the future provide investment banking and commercial banking services to Sesen Bio, Carisma or their respective affiliates and would expect to receive customary fees for the rendering of such services. In the past two years, SVB Securities has not received any fees for investment banking services from Carisma. In the ordinary course of business, SVB Securities and its affiliates have in the past and may in the future hold positions, for their own account or the accounts of their customers, in equity, debt or other securities of Sesen Bio, Carisma or their respective affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Consistent with applicable legal and regulatory requirements, SVB Securities has adopted policies and procedures to establish and maintain the independence of its research department and personnel. As a result, SVB Securities&#8217; research analysts may hold views, make statements or investment recommendations and/or publish research reports with respect to Sesen Bio and the merger and other participants in the merger that differ from the views of SVB Securities&#8217; investment banking personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors selected SVB Securities to act as Sesen Bio&#8217;s financial advisor in connection with the merger based on SVB Securities&#8217; qualifications, reputation, experience and expertise in the biopharmaceutical industry, its knowledge of and involvement in recent transactions in the biopharmaceutical industry and its relationship and familiarity with Sesen Bio and its business. SVB Securities is an internationally recognized investment banking firm that has substantial experience in transactions similar to the merger and the other transactions contemplated by the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with SVB Securities&#8217; services as financial advisor to Sesen Bio, Sesen Bio has agreed to pay SVB Securities an aggregate fee of $2.5&#160;million, $750,000 of which became payable upon the rendering by SVB Securities of the opinion on September&#160;20, 2022 with respect to the Original Merger Agreement and the remainder of which is payable contingent upon consummation of the merger. Sesen Bio has agreed to pay SVB Securities a fee of $500,000 in connection with its opinion with respect to the Merger Agreement Amendment, which fee is not creditable against the $2.5 million fee described above. In addition, Sesen Bio has agreed to reimburse certain of SVB Securities&#8217; expenses arising, and to indemnify SVB Securities against certain liabilities that may arise, out of SVB Securities&#8217; engagement. The terms of the fee arrangement between SVB Securities and Sesen Bio, which are customary in transactions of this nature, were negotiated at arm&#8217;s length between SVB Securities and Sesen Bio, and the Sesen Bio board of directors was aware of the arrangement, including the fact that a significant portion of the fee payable to SVB Securities is contingent upon the completion of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain Unaudited Financial Projections</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a matter of course, Sesen Bio does not publicly disclose long-term projections of future financial results due to the inherent unpredictability and subjectivity of underlying assumptions and estimates. However, in connection with the Sesen Bio board of directors&#8217; evaluation of the merger, Carisma management provided to Sesen Bio management certain financial information relating to Carisma, and Sesen Bio management then, on the basis of various assumptions made by Sesen Bio management, prepared certain financial projections with respect to Carisma, such projections referred to herein as the Financial Projections. The Financial Projections were furnished to, and approved for use by, SVB Securities by Sesen Bio for purposes of SVB Securities&#8217; analyses, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tOOSB">139</a> of this proxy statement/prospectus, and made available to the Sesen Bio board of directors. A summary of the Financial Projections is set forth below.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The inclusion of the Financial Projections should not be deemed an admission or representation by Sesen Bio, SVB Securities, Carisma or any of their respective officers, directors, affiliates, advisors, or other representatives with respect to such Financial Projections. The Financial Projections are not included to influence your views on the merger and are summarized in this proxy statement/prospectus solely to provide </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">145</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">stockholders access to certain non-public information provided to and considered by the Sesen Bio board of directors in connection with its evaluation of the merger and provided to Sesen Bio&#8217;s financial advisor, SVB Securities, to assist with its financial analyses, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">&#8221;. The information from the Financial Projections should be evaluated, if at all, in conjunction with the historical financial statements and other information regarding Carisma in this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections were not prepared with a view toward public disclosure, nor were they prepared with a view toward compliance with published guidelines of the SEC, the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information, or GAAP. Neither the independent registered public accounting firm of Sesen Bio nor Carisma nor any other independent accountant has audited, reviewed, compiled, examined or performed any procedures with respect to the accompanying unaudited prospective financial information for the purpose of its inclusion herein, and accordingly, neither the independent registered public accounting firm of Sesen Bio nor Carisma nor any other independent accountant expresses an opinion or provides any form of assurance with respect thereto for the purpose of this proxy statement/prospectus. The reports of Ernst &amp; Young LLP and KPMG LLP included in this proxy statement/prospectus relate to the consolidated financial statements of Sesen Bio and Carisma, respectively. The reports do not extend to the Financial Projections and should not be read to do so. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections include unlevered free cash flow, total adjusted revenue and earnings before interest and taxes, which are &#8220;non-GAAP financial measures&#8221; and which are financial performance measures that are not calculated in accordance with GAAP. Non-GAAP financial measures should not be viewed as a substitute for GAAP financial measures and may be different from non-GAAP financial measures used by other companies. Furthermore, there are limitations inherent in non-GAAP financial measures because they exclude charges and credits that are required to be included in a GAAP presentation. Accordingly, non-GAAP financial measures should be considered together with, and not as an alternative to, financial measures prepared in accordance with GAAP. The SEC rules that would otherwise require a reconciliation of a non-GAAP financial measure to a GAAP financial measure do not apply to non-GAAP financial measures provided to a board of directors or a financial advisor in connection with a proposed business combination transaction such as the merger if the disclosure is included in a document such as this proxy statement/prospectus. In addition, reconciliations of non-GAAP financial measures to a GAAP financial measure were not provided to or relied upon by SVB Securities in connection with rendering its fairness opinion with respect to the merger, as further described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">&#8221;. Accordingly, Sesen Bio has not provided a reconciliation of the financial measures included in the Financial Projections to the relevant GAAP financial measures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The financial projections prepared by Carisma and supplied to Sesen Bio were prepared solely for internal use as part of Carisma&#8217;s ongoing strategic planning processes and are subjective in many respects. As a result, the Financial Projections, are susceptible to multiple interpretations and periodic revisions based on actual experience and business developments. Although Carisma and Sesen Bio believe their respective assumptions to be reasonable, all financial projections are inherently uncertain, and Carisma and Sesen Bio expect that differences will exist between actual and projected results. Although presented with numerical specificity, the Financial Projections reflect numerous variables, estimates, and assumptions made by Carisma&#8217;s and Sesen Bio&#8217;s respective management at the time the initial financial projections were prepared by Carisma and prepared by Sesen Bio, and also reflect general business, economic, market, and financial conditions and other matters, all of which are difficult to predict and many of which are beyond Carisma&#8217;s and Sesen Bio&#8217;s control. In addition, the Financial Projections cover an extended period of time, and this information by its nature becomes subject to greater uncertainty with each successive year. Accordingly, there can be no assurance that the estimates and assumptions made in preparing the Financial Projections will prove accurate or that any of the Financial Projections will be realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections included certain assumptions relating to, among others things, Carisma&#8217;s and Sesen Bio&#8217;s respective expectations, which may not prove to be accurate, relating to the business, earnings, cash flow, assets, liabilities and prospects of Carisma, industry metrics and the regulatory and commercial probability of success and revenue and expenses adjusted on the basis thereof. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">146</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections were prepared using the following material assumptions: (i) risk-adjusted sales of CT-0508 only for the treatment of breast cancer and gastric cancer</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1</font><font style="letter-spacing:0.2pt;"> in the U.S., the E.U. Five (France, Germany, Italy, Spain and the United Kingdom) and Japan beginning with U.S. approval and launch in fiscal year 2027, E.U. Five approval and launch in fiscal year 2028, and Japan approval and launch in fiscal year 2029, with projected peak market share to be achieved five years post-launch in each region in the range of 0.6% to 50% depending on line of treatment and the anticipated competitive landscape (which includes the possibility of new competitive products); (ii) product exclusivity for a period of 12 years, which Sesen Bio believes is consistent with current exclusivity for biological products; (iii) a decline in sales after loss of exclusivity by 30% in the first year, 55% in the second year, and 75% in the third year; (iv) an estimated 75% market access; (v) an estimated 97% compliance/adherence to treatment; (vi) net annual price per patient of approximately $342,000 in the U.S. in fiscal year 2027, $262,000 in the E.U. Five in fiscal year 2028, and $267,000 in Japan in fiscal year 2029, each increasing 2% annually; (vii) costs associated with CT-0508 would include clinical development costs (including $50.0 million for a pivotal trial beginning in fiscal year 2024), technology transfer costs, cost of goods sold at approximately $75,000 per patient, other supporting research and development and general and administrative costs, as well as milestone and royalty obligations associated with the Penn License Agreement; and (viii) risk-adjusted estimated development, regulatory, and commercial milestone income and royalties on net sales of products that are commercialized and associated with Carisma&#8217;s strategic partnership with Moderna. The risk adjustment applied to projected cash flows associated with CT-0508 and the Moderna partnership was based upon phase success rates for CAR-T therapies from Phase 1 to approval, as reported in &#8220;Clinical Development Success Rates and Contributing Factors 2011-2020,&#8221; or the CDSR Report, a study of clinical drug development success rates published by Biotechnology Innovation Organization, Informa Pharma Intelligence and QLS Advisors LLC in February 2021. CAR-T is currently the closest analog against which to compare new CAR-M therapies.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections are subject to many risks and uncertainties and you are urged to review the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus for a description of risk factors relating to the merger and Carisma&#8217;s business. You should also read the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Cautionary Statement Concerning Forward-Looking Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCSCF">118</a> of this proxy statement/prospectus for additional information regarding the risks inherent in forward-looking information such as the Financial Projections. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The inclusion of the Financial Projections herein should not be regarded as an indication that Sesen Bio, SVB Securities, Carisma or any of their respective affiliates or representatives considered or consider the Financial Projections to be necessarily indicative of actual future events, and the Financial Projections should not be relied upon as such. The Financial Projections do not take into account any circumstances or events occurring after the date they were prepared. Sesen Bio and the combined company do not intend to, and disclaim any obligation to, update, correct, or otherwise revise the Financial Projections to reflect circumstances existing or arising after the date the Financial Projections were generated or to reflect the occurrence of future events, even in the event that any or all of the assumptions or other information underlying the Financial Projections are shown to be in error. Furthermore, the Financial Projections do not take into account the effect of any failure of the merger to be consummated and should not be viewed as accurate or continuing in that context. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In light of the foregoing factors and the uncertainties inherent in financial projections, stockholders are cautioned not to place undue reliance, if any, on the Financial Projections.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table, which is subject to the financial projection statements above, presents (in millions) a summary of the Financial Projections prepared by the management of Sesen Bio solely for use by SVB Securities in connection with the rendering of its fairness opinion and performing related financial analysis and made available to the Sesen Bio board of directors. The time period of the Financial Projections was </font>
        </div>
      </div>
      <div style="margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Financial Projections include monotherapy only in breast cancer and gastric cancer as initial market opportunities, and does not include potential upside from expansion into other HER-2 positive solid tumors such as colon, bladder, and liver, or heme malignancy in mono or combo therapy with a checkpoint inhibitor, as well as non-oncology indications such as liver fibrosis, neurodegeneration, and autoimmune disorders.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:1.99000000000001pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">147</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIOSB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">determined by Sesen Bio assuming U.S. approval and launch of CT-0508 in fiscal year 2027 with a 12-year exclusivity period (ending in fiscal year 2038), which Sesen Bio believes is consistent with current exclusivity for biological products, and includes a 3-year drop off period to account for the anticipated gradual decline in sales once generic competition is projected to enter the market in fiscal year 2039. Sesen Bio management and the Sesen Bio board of directors believed the time period of the Financial Projections was reasonable, particularly for the use and preparation of financial forecasts in the biotechnology industry given the anticipated timing for the initiation of commercial sales and the anticipated period of patent term exclusivity for CT-0508.</font>
        </div>
        <table style="width:456pt;height:67pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:172.65pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="58">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Projected Financial Information for Carisma on a Risk-Adjusted Basis </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">($ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2026E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2027E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2028E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2029E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2030E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2031E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2032E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total Adjusted Revenue</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">15</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">73</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">104</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">130</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">151</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">159</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Earnings Before Interest and Taxes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">82<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">62</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">85</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">110</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">86<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">14<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">12<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">48</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">66</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">79</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:79pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:155.98pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="52">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Projected Financial Information for Carisma on a Risk-Adjusted Basis </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:155.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">($ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2033E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2034E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2035E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2036E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2037E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2038E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2039E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2040E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2041E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:155.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total Adjusted Revenue</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">165</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">169</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">188</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">201</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">221</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">167</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">128</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:155.98pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Earnings Before Interest and Taxes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">115</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">119</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">137</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">149</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">161</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">169</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">167</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">143</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">112</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:155.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">92</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">95</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">108</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">126</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">134</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">116</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">93</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Equal to total risk-adjusted revenue. The risk adjustment applied to projected cash flows associated with CT-0508 (probability of success factor of 17%) and the Moderna partnership (cumulative probability of success factor of 6%) was based upon phase success rates for CAR-T therapies from Phase I to approval, as reported in the CDSR Report. CAR-T is currently the closest analog against which to compare new CAR-M therapies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Earnings before interest and taxes is defined as total adjusted revenue less cost of goods sold, outbound milestones and royalties, research and development expense, sales and marketing expense, general and administrative expense and depreciation expense. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Unlevered free cash flow is defined as earnings before interest and taxes, less tax expense (if profitable), plus depreciation and amortization, less capital expenditures, and less change in net working capital. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.81pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendation of the Sesen Bio board of directors with respect to issuing shares of Sesen Bio common stock as contemplated by the Merger Agreement and the other matters to be acted upon by Sesen Bio stockholders at the Sesen Bio special meeting, Sesen Bio stockholders should be aware that certain members of the Sesen Bio board of directors and certain Sesen Bio executive officers have interests in the merger that may be different from, or in addition to, the interests of Sesen Bio stockholders. These interests may present them with actual or potential conflicts of interest, and these interests, to the extent material, are described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each of the Sesen Bio board of directors and the Carisma board of directors were aware of these potential conflicts of interest and considered them, among other matters, in reaching their respective decisions to approve the Merger Agreement and the merger, and to recommend, as applicable, that Sesen Bio stockholders approve the proposals to be presented to Sesen Bio stockholders for consideration at the Sesen Bio special meeting as contemplated by this proxy statement/prospectus, and that Carisma stockholders sign and return the written consent as contemplated by this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ownership Interests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January&#160;4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, less than one&#160;percent of the shares of Sesen Bio common stock, which for purposes of this subsection excludes any Sesen Bio common stock issuable upon (i)&#160;exercise of Sesen Bio options held by such individual or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">148</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&#160;vesting of Sesen Bio RSUs held by such individual. The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal Nos. 1, 3, 4 and 5. The affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date for the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 2. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Sesen Bio</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tPSOS">395</a> of this proxy statement/prospectus for a description of the beneficial ownership of Sesen Bio&#8217;s directors and officers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effect of the Merger on Sesen Bio Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January&#160;4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, unvested Sesen Bio options covering 3,499,202 shares of Sesen Bio common stock and vested Sesen Bio options covering 8,215,261 shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All outstanding and unexercised Sesen Bio options granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan or as an inducement grant under Nasdaq Listing Rule&#160;5635(c)(4) will remain in effect pursuant to their terms and will be unaffected by the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table presents certain information concerning the outstanding Sesen Bio options held by Sesen Bio&#8217;s directors and current executive officers as of January&#160;4, 2023. All of the Sesen Bio options in the table below were out-of-the-money as of January&#160;4, 2023, on which date the closing price per share of Sesen Bio common stock was $0.6340. The number of shares of Sesen Bio common stock underlying such Sesen Bio options will be adjusted appropriately to reflect the proposed reverse stock split. </font>
        </div>
        <table style="width:456pt;height:233.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.57pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Vested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Vested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,346,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.62</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,453,125</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.46</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Monica Forbes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,028,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.64</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">531,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.18</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">952,739</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.68</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">235,937</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.34</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Minori Rosales, M.D., Ph.D </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">623,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.73</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark R. Sullivan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">735,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.45</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">285,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.13</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">321,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.29</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">32,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.79</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">295,444</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.40</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">39,056</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.80</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter K Honig, M.D., M.P.H </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">119,861</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.03</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">130,139</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.09</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D., F.R.C.S.C., F.A.C.S </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">119,861</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.03</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">130,139</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.09</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">295,444</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.40</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">39,056</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.80</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.51pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effect of the Merger on Sesen Bio RSUs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, unvested Sesen Bio RSUs covering 3,559,892 shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All outstanding Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table presents certain information concerning the outstanding Sesen Bio RSUs held by Sesen Bio&#8217;s directors and current executive officers as of January 4, 2023. All of the Sesen Bio RSUs in the table below were unvested as of January 4, 2023 and the value of such RSUs was calculated based on the closing price per share of Sesen Bio common stock on January 4, 2023, which was $0.6340. The number of shares of Sesen Bio common stock underlying such Sesen Bio RSUs will be adjusted appropriately to reflect the proposed reverse stock split. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">149</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTOESBEO123">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:224.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:313.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">RSUs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">RSUs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,213,600</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">769,422</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Monica Forbes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">913,375</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">579,080</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">595,217</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">377,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Minori Rosales, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark R. Sullivan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">637,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">404,302</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,360</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,360</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter K Honig, M.D., M.P.H. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,360</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D., F.R.C.S.C., F.A.C.S. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,360</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,360</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.7pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Positions Following the Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M., Sesen Bio&#8217;s President and Chief Executive Officer and a member of the Sesen Bio board of directors, is expected to remain a member of the board of directors of the combined company and will receive compensation to be paid to directors of the combined company. For a description of Sesen Bio&#8217;s non-employee director compensation policy and the amounts paid to Sesen Bio&#8217;s non-employee directors in 2021, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation&#8201;&#8212;&#8201;Director Compensation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page 16 of this proxy statement/prospectus. Pursuant to the terms of the Merger Agreement, effective upon the effective time, all other then-current Sesen Bio directors will resign. Upon the resignation of such directors, all unvested Sesen Bio options and Sesen Bio RSUs held by such directors will be vested in full. All out-of-the money Sesen Bio options will be canceled for no consideration. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination of Existing Sesen Bio Executive Officers Following the Merger and Related Severance Payments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into employment agreements with each of its executive officers providing that (i)&#160;upon the termination of each such executive officer&#8217;s employment without &#8220;cause&#8221; or (ii)&#160;if such executive officer terminates his or her employment with Sesen Bio for &#8220;good reason,&#8221; in each case within 12&#160;months (or 18&#160;months for Dr.&#160;Cannell) following a &#8220;change in control transaction,&#8221; as each such term is defined in the respective employment agreements, Sesen Bio is obligated to, among other things, (w)&#160;pay the executive officer an amount equal to his or her base salary for 12&#160;months (24&#160;months for Dr.&#160;Cannell), payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (x)&#160;pay Dr.&#160;Cannell an amount equal to two times his target bonus payment for the year in which the termination of employment occurs, (y)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide the executive officer and certain of his or her dependents with group health and dental insurance for a period of up to 12&#160;months (24&#160;months for Dr.&#160;Cannell), and (z)&#160;accelerate in full the vesting of all outstanding equity awards held by such executive officer. For a description of the employment agreements of Sesen Bio&#8217;s named executive officers, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation&#8201;&#8212;&#8201;Summary Compensation Table&#8201;&#8212;&#8201;Narrative to Summary Compensation Table</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page 1 of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, effective immediately after the effective time, Sesen Bio will terminate the employment of all then-current Sesen Bio executive officers and each such termination will be deemed to be an involuntary termination without &#8220;cause&#8221; after a &#8220;change in control transaction.&#8221; Accordingly, all such executive officers will be entitled to the benefits afforded to each such executive officer in the event of his or her termination without &#8220;cause&#8221; within the period provided for under such executive officer&#8217;s employment agreement following a &#8220;change in control transaction.&#8221; Pursuant to the terms of the Merger Agreement, any severance payments or benefits payable to such executive officers pursuant to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">150</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">their respective employment agreements will, to the maximum extent permitted by Section&#160;409A of the Code, be paid in a lump sum as soon as practicable following the effective time, provided that the executive officer consents to his or her severance being paid in a lump sum (to the extent such consent is required). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to pay the severance payments to Dr.&#160;Cannell, Ms.&#160;Forbes, Dr.&#160;MacDonald, Dr.&#160;Rosales and Mr.&#160;Sullivan pursuant to their respective employment agreements is contingent upon the executive&#8217;s execution and non-revocation of a release of claims in favor of Sesen Bio. In addition, Sesen Bio&#8217;s obligation to pay such severance payments is subject to the executive&#8217;s compliance with certain restrictive covenants, including non-competition and non-solicitation (of employees and customers) covenants, which run for one year following the executive&#8217;s termination of employment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Taxation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent that any severance or other compensation payment to Dr.&#160;Cannell, Ms.&#160;Forbes, Dr.&#160;Rosales and Mr.&#160;Sullivan pursuant to his or her employment agreement or any other agreement constitutes an &#8220;excess parachute payment&#8221; within the meaning of Sections&#160;280G and 4999 of the Code, then he or she will receive the full amount of such severance and other payments, or a reduced amount intended to avoid the application of Sections&#160;280G and 4999 of the Code, whichever provides the executive with the highest amount on an after-tax basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2022 Retention Program</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to a retention program that was approved by the Sesen Bio board of directors and the Sesen Bio compensation committee on August&#160;28, 2022, certain employees of Sesen Bio, including Ms.&#160;Forbes, Dr.&#160;MacDonald and Mr.&#160;Sullivan, received a cash bonus award, which vests in full upon the earlier of the completion of a potential strategic transaction and the employee&#8217;s termination of employment without cause, subject to the employee&#8217;s continued employment through that time. Pursuant to the retention program, Ms.&#160;Forbes was awarded a cash bonus of $199,894, Dr.&#160;MacDonald was awarded a cash bonus of CAD&#160;$121,153 and Mr.&#160;Sullivan was awarded a cash bonus of $191,013. The foregoing cash bonuses will vest and be paid in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Golden Parachute Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This section sets forth the information required by Item&#160;402(t) of Regulation&#160;S-K regarding the compensation that is based on or otherwise relates to the merger and that is payable or may become payable to Sesen Bio&#8217;s named executive officers. This compensation is referred to as &#8220;golden parachute&#8221; compensation by the applicable SEC disclosure rules. For purposes of calculating these amounts, Sesen Bio has assumed: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effective time occurred on January 4, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a price per share of Sesen Bio common stock of $0.40, which represents the average closing market price of Sesen Bio common stock over the first five business days following the public announcement on September&#160;21, 2022 of the entry into the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the employment of the named executive officer will be terminated on such date in a manner that entitles the named executive officer to receive the severance payments and benefits under the terms of the employment agreement with the named executive officer (as described above). The employment of the named executive officer is expected to be terminated effective immediately after the closing of the merger; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the named executive officer does not enter into a new agreement or otherwise becomes legally entitled to, prior to the effective time, additional compensation or benefits. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The amounts set forth in the table are estimates based on multiple assumptions that may or may not actually occur, including assumptions described below and elsewhere in this proxy statement/prospectus and in the footnotes to the table. Furthermore, the amounts set forth in the table do not reflect any reductions in payments or benefits that could result from the operation of Section&#160;280G of the Code modified cutback provision that is in the employment agreements of Dr.&#160;Cannell and Ms.&#160;Forbes, as described above. As a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">151</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">result, the actual amounts, if any, that Sesen Bio&#8217;s named executive officers will receive, may materially differ from the amounts set forth in the table. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">For a narrative description of the terms and conditions applicable to the payments quantified in the table below, see the section entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger&#8201;&#8212;&#8201;Termination of Existing Sesen Bio Executive Officers Following the Merger and Related Severance Payments</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTOESBEO123">150</a> of this proxy statement/prospectus. </font>
        </div>
        <table style="width:456pt;height:80.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:228.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Cash</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Health </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Benefits </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Continuation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:228.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,729,688</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,066,690</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,796,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Monica Forbes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">599,681</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">577,850</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,344</td>
            <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,210,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark Sullivan</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">573,038</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">369,080</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,344</td>
            <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">975,462</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts listed in this column represent (i)&#160;cash severance amounts payable to the named executive officer pursuant to his or her employment agreement equal to 12&#160;months (24&#160;months for Dr.&#160;Cannell) of base salary continuation ($1,153,125 for Dr.&#160;Cannell; $399,788 for Ms.&#160;Forbes; and $382,025 for Mr.&#160;Sullivan), which amounts are payable to the executive in installments over 12&#160;months (24&#160;months for Dr.&#160;Cannell) following the executive&#8217;s termination of employment; (ii)&#160;a cash severance amount payable to Dr.&#160;Cannell equal to two times his annual target bonus payment for calendar year 2022 ($576,563), payable in a lump sum following Dr.&#160;Cannell&#8217;s termination of employment, and (iii)&#160;a cash retention bonus payable to each of Ms.&#160;Forbes ($199,894) and Mr.&#160;Sullivan ($191,013) in a lump sum in connection with the closing of the merger. The cash severance payments payable to Dr.&#160;Cannell, Ms.&#160;Forbes and Mr.&#160;Sullivan pursuant to their respective employment agreements are a double-trigger benefit in that they will be paid only if the executive experiences a qualifying termination of employment within 12&#160;months (18&#160;months for Dr.&#160;Cannell) following the closing of the merger. The cash retention bonuses payable to Ms.&#160;Forbes and Mr.&#160;Sullivan are a single-trigger benefit in that they will be paid upon the consummation of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts listed in this column represent (i)&#160;the value of the full acceleration of vesting of the unvested stock options held by the named executive officer ($581,250 for Dr.&#160;Cannell; $212,500 for Ms.&#160;Forbes; and $114,000 for Mr.&#160;Sullivan), and (ii)&#160;the value of the full acceleration of vesting of the unvested restricted stock&#160;units held by the named executive officer ($485,440 for Dr.&#160;Cannell; $365,350 for Ms.&#160;Forbes; and $255,080 for Mr.&#160;Sullivan;). The acceleration of vesting of the named executive officers&#8217; unvested equity awards is a double-trigger benefit in that it will occur only if the executive experiences a qualifying termination of employment within 12&#160;months (18&#160;months for Dr.&#160;Cannell) following the closing of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts listed in this column represent the value of continued group health and dental insurance benefits to be provided to the named executive officer (and his or her eligible dependents) pursuant to their respective employment agreements for a period of up to 24&#160;months for Dr.&#160;Cannell and up to 12&#160;months for each of Ms.&#160;Forbes and Mr.&#160;Sullivan. This is a double-trigger benefit in that it will be provided only if the executive experiences a qualifying termination of employment within 12&#160;months (18&#160;months for Dr.&#160;Cannell) following the closing of the merger. As of the date of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, Dr.&#160;Cannell is not enrolled in Sesen Bio&#8217;s group health and dental insurance benefits and, therefore, would not receive any health benefit continuation payments in connection with his qualifying termination of employment. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification and Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, from the effective time through the sixth anniversary of the date on which the effective time occurs, each of Sesen Bio and the surviving corporation is required to indemnify and hold harmless each person who is or has served as a director or officer of Sesen Bio or Carisma against all claims, all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">152</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIOCD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">completed proceeding arising out of or pertaining to the fact that such person is or was a director or officer of Sesen Bio, to the fullest extent permitted under the DGCL for directors or officers of Delaware corporations. In addition, each such director and officer, or former director and officer, is entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, the provisions of the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Sesen Bio will not be amended, modified or repealed for a period of six&#160;years from the effective time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the effective time, were officers or directors of Sesen Bio, unless such modification is required by applicable law. The Carisma Certificate of Incorporation and Carisma Bylaws, as the surviving corporation in the merger, shall contain provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers than those that are presently set forth in the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that Sesen Bio shall maintain directors&#8217; and officers&#8217; liability insurance policies commencing at the closing of the merger, on commercially available terms and conditions with coverage limits customary for U.S. public companies similarly situated to Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendation of the Carisma board of directors with respect to approving the merger, stockholders should be aware that certain members of the Carisma board of directors and certain Carisma executive officers have interests in the merger that may be different from, or in addition to, the interests of Carisma stockholders. These interests may present them with actual or potential conflicts of interest, and these interests, to the extent material, are described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each of the Sesen Bio board of directors and the Carisma board of directors were aware of these potential conflicts of interest and considered them, among other matters, in reaching their respective decisions to approve the Merger Agreement and the merger, and to recommend, as applicable, that Sesen Bio stockholders approve the proposals to be presented to Sesen Bio stockholders for consideration at the Sesen Bio special meeting as contemplated by this proxy statement/prospectus, and that Carisma stockholders sign and return the written consent as contemplated by this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ownership Interests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, Carisma&#8217;s directors and current executive officers owned, in the aggregate approximately 2.36% of the outstanding shares of Carisma capital stock, which for purposes of this subsection excludes any shares of Carisma common stock issuable upon exercise or settlement of Carisma options held by each such individual. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tPSOC">397</a> of this proxy statement/prospectus for a description of the beneficial ownership of Carisma&#8217;s directors and officers.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain Carisma stockholders affiliated with Carisma directors also currently hold shares of Carisma capital stock. The table below sets forth the ownership of Carisma capital stock by affiliates of Carisma&#8217;s directors as of January 4, 2023. These Carisma stockholders have also agreed to purchase shares in the Carisma pre-closing financing, which is conditioned upon the satisfaction and waiver of the conditions to the merger as well as certain other conditions. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Related Party Transactions of Directors and Executive Officers of the Combined Company &#8212; Carisma Transactions &#8212; Carisma Pre-Closing Financing</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCARPREC123">369</a> of this proxy statement/prospectus for a description of such relationships. </font>
        </div>
        <table style="width:456pt;height:86.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:379.59pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Stockholder</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital Stock Held</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,204,160</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,485,912</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">961,492</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">998,079</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">153</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;947,762 shares of Carisma common stock issuable upon conversion of the Carisma Series A preferred stock and (ii) 256,398 shares of Carisma common stock issuable upon conversion of the Carisma Series B preferred stock held by AbbVie Biotechnology Ltd. AbbVie Biotechnology Ltd. holds voting and investment control over the shares. The Board of Directors of AbbVie Biotechnology Ltd. consists of Lindsey Bristow, Jonathan C. Clipper, Stephen Muldoon and Arthur Price. Each of Ms. Bristow and each of Messrs. Clipper, Muldoon and Price may be deemed to share voting and investment power with respect to the shares held by AbbVie Biotechnology Ltd. and disclaim beneficial ownership of all shares held by AbbVie Biotechnology Ltd., except to the extent of their pecuniary interest therein, if any. Margarita Chavez is employed as a Managing Director of AbbVie Ventures and is a member of the Carisma board of directors. Ms. Chavez disclaims beneficial ownership of all shares held by AbbVie Biotechnology Ltd. except to the extent of her pecuniary interest therein, if any. The business address of AbbVie Biotechnology Ltd. is Thistle House, 4 Burnaby Street, Hamilton HM 11, Bermuda.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i) 250,647 shares of Carisma common stock issuable upon conversion of the Carisma Series A preferred stock, (ii)&#160;937,501 shares of Carisma common stock issuable upon the conversion of the Carisma special voting preferred stock and (iii)&#160;297,764 shares of Carisma common stock issuable upon the conversion of the Carisma Series B special voting preferred stock held by HealthCap VII, L.P. HealthCap VII GP SA, a Swiss registered L.C.C., is the sole general partner of HealthCap VII, L.P. and has voting and investment control over the shares. HealthCap VII GP SA disclaims beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of its pecuniary interest therein. Fabrice Bernhard is the General Manager of HealthCap VII GP SA. Dag Richter, Daniel Schafer and Frans Wuite are each Directors of HealthCap VII GP SA. Each of Messrs. Bernhard, Richter, Schafer and Wuite may be deemed to share voting and investment power with respect to the shares held by HealthCap VII L.P. and disclaim beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of their pecuniary interest therein. Bj&#246;rn Odlander is a Managing Partner of HealthCap and is a member of the Carisma board of directors. Dr. Odlander disclaims beneficial ownership of all shares held by HealthCap VII L.P. except to the extent of his pecuniary interest therein, if any. The business address of HealthCap VII L.P. is c/o HealthCap VII GP SA, Avenue Villamont 23, CH 1005&#160;Lausanne Switzerland.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 961,492 shares of Carisma common stock issuable upon conversion of the Carisma Series B preferred stock held by SymBiosis II, LLC, which exercises voting and investment control of the shares. Chidozie Ugwumba is the Managing Partner of Symbiosis II, LLC and as such has sole voting and investment control over the shares. Mr. Ugwumba is also a member of the Carisma board of directors. The business address of Symbiosis II, LLC is 609 S.W. 8th Street, Suite 365, Bentonville, Arkansas&#160;72712.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;798,072 shares of Carisma common stock issuable upon conversion of the Carisma Series A preferred stock and (ii)&#160;200,007 shares of Carisma common stock issuable upon conversion of the Carisma Series B preferred stock held by Wellington Life Sciences V GmbH &amp; Co. KG, or the Wellington Fund. The Wellington Fund is represented by Wellington Life Sciences Venture Capital Consulting GmbH, or the Wellington General Partner. The Wellington General Partner holds voting and investment control over the shares. Dr.&#160;Regina Hodits and Dr. Rainer Strohmenger, in their functions as managing directors of the Wellington General Partner, have individual signatory power as well as voting and/or investment control over the shares. Dr.&#160;Regina Hodits is a member of the Carisma board of directors. Dr.&#160;Regina Hodits disclaims beneficial ownership of all shares held by the Wellington Fund except to the extent of her pecuniary interest therein, if any. The business address of the Wellington Fund and the Wellington General Partner is Tuerkenstrasse 5, 80333 Munich, Germany.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effect of the Merger on Carisma Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, Carisma&#8217;s directors and current executive officers owned, in the aggregate, unvested Carisma options covering 328,143 shares of Carisma common stock and vested Carisma options covering&#160;672,186 shares of Carisma common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Merger Agreement, each option to purchase shares of Carisma common stock that is outstanding and unexercised immediately prior to the effective time under the Carisma Plan and that, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">154</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">following assumption by Sesen Bio at the effective time, will be eligible to be registered on Form S-8, whether or not vested, will be converted into and become an option to purchase shares of Sesen Bio common stock. Sesen Bio will assume the Carisma Plan and each such outstanding Carisma option in accordance with the terms (as in effect as of the date of the Original Merger Agreement) of the Carisma Plan and the terms of the stock option agreement by which such Carisma option is evidenced. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table presents certain information concerning the outstanding Carisma options held by Carisma directors and current executive officers as of January 4, 2023. The number of shares of Carisma common stock underlying such Carisma options and the exercise price of such Carisma options will be adjusted appropriately to reflect the exchange ratio. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement &#8212; Treatment of Carisma Options</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER7">174</a> of this proxy statement/prospectus for a more detailed description of the treatment of Carisma options in the merger. </font>
        </div>
        <table style="width:456pt;height:218.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:217.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Vested Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Vested Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Steven Kelly </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">445,814</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.59</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">102,657</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Richard Morris </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">69,004</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">105,322</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">101,343</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.38</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">27,657</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Margarita Chavez </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,700</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.76</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">21,632</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.86</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">26,325</td>
            <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">70,875</td>
            <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.81pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Support Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each of Carisma&#8217;s executive officers and the majority of Carisma&#8217;s directors have also entered into a support agreement in connection with the merger, whereby such executive officers and directors have agreed to vote their shares in favor of adoption of the Merger Agreement and approval of the merger. For a more detailed discussion of the support agreements, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Support Agreements and Written Consents</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSAAW">197</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Management Following the Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Management Following the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMFTM">342</a> of this proxy statement/prospectus, certain members of the Carisma board of directors and Carisma executive officers are expected to become the directors and executive officers of the combined company upon the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification and Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, from the effective time through the sixth anniversary of the date on which the effective time occurs, each of Sesen Bio and the surviving corporation in the merger is required to indemnify and hold harmless each person who is or has served as a director or officer of Sesen Bio or Carisma against all claims, all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or completed proceeding arising out of or pertaining to the fact that such person is or was a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">155</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tFOTM">&#8203;</a><a name="tETOT">&#8203;</a><a name="tMCAE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">director or officer of Sesen Bio, to the fullest extent permitted under the DGCL for directors or officers of Delaware corporations. In addition, each such director and officer, or former director and officer, is entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, the provisions of the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Sesen Bio will not be amended, modified or repealed for a period of six&#160;years from the effective time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the effective time, were officers or directors of Sesen Bio, unless such modification is required by applicable law. The Carisma Certificate of Incorporation and the Carisma Bylaws, as the surviving corporation in the merger, shall contain provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers than those that are presently set forth in the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that Sesen Bio shall maintain directors&#8217; and officers&#8217; liability insurance policies commencing at the closing of the merger, on commercially available terms and conditions with coverage limits customary for U.S. public companies similarly situated to Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Form of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides that at the effective time, Merger Sub will be merged with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After completion of the merger, Sesen Bio will change its corporate name from &#8220;Sesen Bio, Inc.&#8221; to &#8220;Carisma Therapeutics Inc.&#8221; as contemplated by the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effective Time of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement requires the parties to consummate the merger as promptly as practicable (and in any event within two business days) after all of the conditions to the consummation of the merger contained in the Merger Agreement are satisfied or waived. The merger will become effective upon the filing of a certificate of merger with the Secretary of State of the State of Delaware or at such later time as is agreed by Sesen Bio and Carisma and specified in the certificate of merger. Neither Sesen Bio nor Carisma can predict the exact timing of the consummation of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger Consideration and Exchange Ratio</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, upon the terms and subject to the conditions set forth in the Merger Agreement, each outstanding share of Carisma&#8217;s capital stock (including shares of Carisma capital stock sold in the Carisma pre-closing financing but excluding (i)&#160;shares of Carisma capital stock to be canceled pursuant to the Merger Agreement and (ii)&#160;Carisma common stock held by holders of Carisma common stock who have exercised and perfected appraisal rights or dissenters&#8217; rights) will be automatically converted solely into the right to receive a number of shares of Sesen Bio common stock and each outstanding Carisma option will become exercisable for shares of Sesen Bio common stock, in each case, equal to the exchange ratio described in more detail below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No fractional shares of Sesen Bio common stock will be issued in connection with the merger, and no certificates or scrip for any such fractional shares will be issued. Any fractional shares of Sesen Bio common stock resulting from the conversion of Carisma capital stock will receive cash (without interest and subject to applicable tax withholding) in an amount equal to such fractional part of a share of Sesen Bio common stock multiplied by the last reported sale price of Sesen Bio common stock at 4:00&#160;p.m., Eastern Time, end of regular trading hours on Nasdaq on the last day prior to the effective time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exchange Ratio</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The exchange ratio is calculated using a formula intended to allocate existing Sesen Bio and Carisma stockholders a&#160;percentage of the combined company. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">156</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">capitalization as of December 29, 2022, the date the Merger Agreement Amendment was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock. This estimate is subject to adjustment prior to the closing of the merger for net cash at the cash determination time and aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing (and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on the estimates set forth above, and certain other assumptions, Sesen Bio stockholders would own approximately 25.2% of the common stock of the combined company post-merger, and Carisma stockholders would own approximately 74.8% of the common stock of the combined company post-merger, of which the shares issued in the Carisma pre-closing financing and the shares issued upon the conversion of the Carisma convertible note are expected to represent approximately 8.4% and 11.3%, respectively, of the common stock of the combined company post-merger. For more information on the Carisma pre-closing financing, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSUAG">198</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The exchange ratio formula is the quotient obtained (rounded to four decimal places) by dividing the number of Carisma merger shares (defined below) by the Carisma outstanding shares (defined below), in which: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Aggregate valuation&#8221; means the sum of the (i)&#160;Carisma valuation plus (ii)&#160;the Sesen Bio valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Carisma valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma merger shares&#8221; means the product determined by multiplying (i)&#160;the post-closing Sesen Bio shares by (ii)&#160;the Carisma allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma outstanding shares&#8221; means the total number of shares of Carisma capital stock outstanding immediately prior to the effective time expressed on a fully-diluted and as-converted to Carisma common stock basis and assuming, without limitation or duplication, (i)&#160;the exercise of all Carisma options outstanding as of immediately prior to the effective time, (ii)&#160;the closing of the Carisma pre-closing financing, and (iii)&#160;the issuance of shares of Carisma common stock issuable in respect of all other outstanding options, restricted stock awards, warrants or rights to receive such shares, whether conditional or unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation of the Merger. Carisma outstanding shares shall also include all shares of the Carisma issued in the Carisma pre-closing financing prior to the effective time and excludes any shares issued upon the conversion of the Carisma convertible note. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma valuation&#8221; means (i)&#160;$196.0&#160;million, plus (ii)&#160;the amount of gross proceeds from the Carisma pre-closing financing prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Sesen Bio valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio outstanding shares&#8221; means the total number of shares of Sesen Bio common stock outstanding immediately prior to the effective time expressed on a fully-diluted and as converted to Sesen Bio common stock basis, assuming, without limitation or duplication, the issuance of shares of Sesen Bio common stock in respect of all Sesen Bio options, Sesen Bio RSUs, Sesen Bio warrants and other outstanding options, warrants or rights to receive such shares, in each case, outstanding as of immediately prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio valuation&#8221; means $140.0&#160;million, minus the amount by which net cash at the cash determination time is less than $125.0&#160;million, plus the amount by which net cash at the cash determination time is greater than $125.0&#160;million. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Post-closing Sesen Bio shares&#8221; mean the quotient determined by dividing (i)&#160;the Sesen Bio outstanding shares by (ii)&#160;the Sesen Bio allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">157</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSBFN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s Final Net Cash</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, Sesen Bio&#8217;s &#8220;final net cash&#8221; means, as of the cash determination time (which is as of 8:00&#160;p.m. Eastern Time on the last business day prior to the anticipated closing date) the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">cash and cash equivalents, marketable securities and other short-term investments of Sesen Bio and its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s accounts receivable (including any tax refund claims pending as of the date of the Original Merger Agreement), deposits and interest; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Seen Bio&#8217;s deposits, prepaid expenses and other prepaid assets which are reflected on the most recent balance sheet and do not constitute restricted cash of Sesen Bio and its subsidiaries; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">50% of the cost of settling any transaction litigation to the extent actually paid in cash by Sesen Bio prior to the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;">, the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any unpaid transaction expenses of Sesen Bio or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any unpaid indebtedness of Sesen Bio and/or its subsidiaries outstanding as of the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any accounts payable, accrued expenses or short or long term liabilities that are or will become payable in cash, including any such accounts payable, accrued expenses or short or long term liabilities under any Sesen Bio contracts that were in effect prior to the effective time or associated with the termination of any Sesen Bio contracts which were in effect prior to the effective time, or the termination before, at or after the effective time, of all current or former employees of Sesen Bio and its subsidiaries (even if the applicable expenses or amounts are due and payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any unpaid employer portion of payroll or employment taxes incurred in connection with the grant, exercise, conversion, settlement or cancellation of Sesen Bio RSUs, Sesen Bio options, equity compensation and other change in control or severance payments (including bonuses payable) due under the Merger Agreement or CVRs issued to holders of Sesen Bio RSUs or Sesen Bio options or otherwise as compensation (either incurred prior to or at the time of the Merger, and for the avoidance of doubt, not calculated as of the close of business on the business day prior to the closing date) in each case, incurred in connection with the merger by Sesen Bio at or prior to the effective time (even if payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any pre-payment, termination, &#8220;end of term&#8221; or similar fee or charge payable to any lender in connection with the repayment of indebtedness by Sesen Bio at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the amount of any cash dividend declared (or to be declared) but not yet paid as part of the pre-closing dividend; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost and/or premium of the directors&#8217; and officer&#8217;s &#8220;tail policy&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost of settling any legal proceeding or other dispute existing as of the date of the Original Merger Agreement, as well as the unpaid deductible amount under Sesen Bio&#8217;s insurance reasonably expected to be payable in connection with legal proceedings existing as of the date of the Original Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each component of net cash, to the extent applicable, shall be determined in accordance with U.S. GAAP, applied on a basis consistent with the application of U.S. GAAP in the preparation of Sesen Bio&#8217;s most recent audited or reviewed financial statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Not more than ten nor less than five calendar days prior to the anticipated closing date, Sesen Bio will deliver to Carisma a schedule, or the net cash schedule, setting forth, in reasonable detail, Sesen Bio&#8217;s good faith estimated calculation of its net cash at the cash determination time, prepared and certified by Sesen Bio&#8217;s Chief Executive Officer and Chief Financial Officer (or if there is no chief financial officer at such time, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">158</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPFEC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the principal financial and accounting officer of Sesen Bio) together with the work papers and back-up materials used or useful in preparing the net cash schedule, as reasonably requested by Carisma. Within three business days after delivery of the net cash schedule (the last day of such period referred to as the response date), Carisma will have the right to dispute all or any part of the net cash schedule by delivering a written notice to that effect to Sesen Bio (referred to herein as a dispute notice). Any dispute notice will identify in reasonable detail to the extent then known, the nature and amounts of any proposed revisions to Sesen Bio&#8217;s net cash calculation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma disputes the net cash schedule prior to 8:00&#160;pm Eastern Time on the response date, the parties will promptly, and in no event later than one calendar day after the response date, meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of net cash. If the parties are unable to negotiate an agreed-upon determination of net cash thereof within two calendar days after the delivery of a dispute notice (or such other period as Sesen Bio and Carisma may mutually agree upon in writing), then any remaining disagreements as to the calculation of net cash will be referred to Deloitte &amp; Touche LLP or another independent auditor of recognized national standing mutually agreed upon by Sesen Bio and Carisma. The determination of the amount of net cash made by such auditor shall be final and binding on Sesen Bio and Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s net cash balance is subject to numerous factors, some of which are outside of Sesen Bio&#8217;s control. The actual amount of net cash will depend significantly on the timing of the closing of the merger. In addition, the closing of the merger could be delayed if Sesen Bio and Carisma are not able to agree upon the amount of Sesen Bio&#8217;s net cash as of the cash determination time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Procedures for Exchanging Carisma Stock Certificates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides that, at the effective time, Sesen Bio will deposit with an exchange agent acceptable to Sesen Bio and Carisma evidence of book-entry shares representing the shares of Sesen Bio common stock issuable to Carisma stockholders and a sufficient amount of cash to make payments in lieu of fractional shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides that, promptly after the effective time, the exchange agent will mail to each record holder of Carisma capital stock immediately prior to the effective time a letter of transmittal and instructions for surrendering and exchanging Carisma stock certificates or transfer of book-entry shares held by such record holder in exchange for book-entry shares of Sesen Bio common stock. Upon surrender of a Carisma stock certificate or transfer of book-entry shares for exchange to the exchange agent, together with a duly signed letter of transmittal and such other documents as the exchange agent or Sesen Bio may reasonably require, the Carisma stock certificate or book-entry share surrendered will be cancelled and the holder of such Carisma stock certificate or book-entry share will be entitled to receive the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">book-entry shares representing the number of whole shares of Sesen Bio common stock that such holder has the right to receive pursuant to the provisions of the Merger Agreement, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">cash in lieu of any fractional share of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From and after the effective time, until it is surrendered, each certificate or book-entry share that previously evidenced shares of Carisma capital stock will be deemed to represent only the right to receive shares of Sesen Bio common stock, and cash in lieu of any fractional share of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any Carisma stock certificate has been lost, stolen or destroyed, Sesen Bio may, in its discretion, and as a condition precedent to the delivery of any book-entry shares of Sesen Bio common stock, require the owner of such lost, stolen or destroyed certificate to provide an affidavit claiming such certificate has been lost, stolen or destroyed and, at Sesen Bio&#8217;s discretion, may also require such owner to indemnify Sesen Bio against any claim suffered by Sesen Bio related to the lost, stolen or destroyed certificate or any Sesen Bio common stock issued in exchange thereof as Sesen Bio may reasonably request. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will not pay dividends or other distributions on any shares of Sesen Bio common stock to be issued in exchange for shares of Carisma capital stock represented by any unsurrendered Carisma stock certificate or book-entry share until such Carisma stock certificate is surrendered, or book-entry share transferred, as provided in the Merger Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">159</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tREAP">&#8203;</a><a name="tMUFI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory Approvals</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the U.S., Sesen Bio must comply with applicable federal and state securities laws and the rules and regulations of Nasdaq in connection with the issuance of shares of Sesen Bio common stock and the filing of this proxy statement/prospectus with the SEC. Sesen Bio does not intend to seek any regulatory approval from antitrust authorities to consummate the transactions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of the merger to Carisma U.S. holders (as defined below), but does not purport to be a complete analysis of all potential tax consequences that may be relevant to Carisma U.S. holders. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Carisma U.S. holder. Carisma has not sought and does not intend to seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Carisma U.S. holders that hold Carisma capital stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences that may be relevant to a Carisma U.S. holder&#8217;s particular circumstances, including the impact of the alternative minimum tax, the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code. In addition, it does not address consequences relevant to Carisma U.S. holders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons holding Carisma capital stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">banks, insurance companies and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons deemed to sell Carisma capital stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons who hold or received Carisma capital stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Carisma capital stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Carisma capital stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">160</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUSHCA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the following discussion does not address: (a)&#160;the tax consequences of transactions effectuated before, after or at the same time as the merger, whether or not they are in connection with the merger, including, without limitation, transactions in which shares of Carisma capital stock are acquired or disposed of other than in exchange for shares of Sesen Bio common stock in the merger, (b)&#160;the tax consequences to holders of convertible notes or options or warrants of Carisma, or (c)&#160;the tax consequences of the ownership of shares of Sesen Bio common stock following the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT HOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE MERGER ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Carisma U.S. holder&#8221; is a beneficial owner of Carisma capital stock that, for U.S. federal income tax purposes, is or is treated as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an individual who is a citizen or resident of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a corporation created or organized under the laws of the U.S., any state thereof, or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a trust that (i)&#160;is subject to the primary supervision of a U.S. court and the control of one or more &#8220;United States persons&#8221; &#8203;(within the meaning of Section&#160;7701(a)(30) of the Code) over all of its substantial decisions or (ii)&#160;has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Tax Characterization of the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the opinion of WilmerHale and Hogan Lovells, the merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code and the material U.S. federal income tax consequences of the merger to Carisma U.S. holders are as described below under the heading &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Tax Treatment of Carisma U.S.&#160;Holders in the Merger</font><font style="letter-spacing:0.2pt;">.&#8221; These opinions are based on facts and representations contained in representation letters provided to WilmerHale and Hogan Lovells by Sesen Bio, Merger Sub and Carisma and certain assumptions, including that the merger is completed in the manner set forth in the Merger Agreement and the registration statement on Form&#160;S-4 of which this proxy statement/prospectus forms a part. The accuracy of such facts, representations and assumptions, could affect the conclusions set forth in such opinions. The opinions will not be binding on the IRS or the courts.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger does not qualify as a tax-free &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code (including if the IRS successfully challenges the qualification of the merger as such), then each Carisma U.S. holder generally would recognize gain or loss on the exchange of Carisma capital stock for Sesen Bio common stock in the merger equal to the difference between (x)&#160;the fair market value of the shares of Sesen Bio common stock received in exchange for the Carisma capital stock plus any cash received in lieu of a fractional share and (y)&#160;such Carisma U.S. holder&#8217;s adjusted tax basis in the shares of Carisma capital stock surrendered. The remainder of this discussion assumes that the merger will be treated as a tax-free &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code in accordance with the opinions referred to above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Tax Treatment of Carisma U.S. Holders in the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The material U.S. federal income tax consequences to a U.S. holder of Carisma capital stock as a result of the merger will be as follows: (i)&#160;except as described below with respect to the receipt of cash in lieu of a fractional share of Sesen Bio common stock, a Carisma U.S. holder generally will not recognize gain or loss upon the exchange of the holder&#8217;s Carisma capital stock for Sesen Bio common stock, (ii)&#160;a Carisma U.S. holder generally will obtain an aggregate adjusted tax basis in the Sesen Bio common stock the holder receives in the merger equal to the holder&#8217;s adjusted tax basis in the Carisma capital stock exchanged therefor, reduced by the basis allocable to any fractional share of Sesen Bio common stock for which cash is received, and (iii)&#160;the holding period of the shares of Sesen Bio common stock received by a Carisma U.S. holder in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">161</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMUFI1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the merger will include the holding period of the shares of Carisma capital stock surrendered in exchange therefor. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of Carisma capital stock surrendered to the shares of Sesen Bio common stock received. Carisma U.S. holders of shares of Carisma capital stock acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash in Lieu of Fractional Share</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Carisma U.S. holder that receives cash in lieu of a fractional share of Sesen Bio common stock generally will be treated as having received such fractional share and then as having received such cash in redemption of the fractional share. A Carisma U.S. holder generally will recognize gain or loss equal to the difference between the amount of cash received in lieu of the fractional share of Sesen Bio common stock and the portion of the U.S. holder&#8217;s aggregate adjusted tax basis in the shares of Carisma capital stock allocable to the fractional share. Such gain or loss generally will be capital gain or loss and will be long-term capital gain or loss if the Carisma U.S. holder&#8217;s holding period for the Carisma capital stock surrendered in the merger exceeds one year at the effective time. Long-term capital gains of certain non-corporate holders of Carisma capital stock, including individuals, are generally taxed at preferential rates. The deductibility of capital losses is subject to limitations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reporting Requirements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Carisma U.S. holder who receives shares of Sesen Bio common stock in the merger is required to retain permanent records pertaining to the merger and make such records available to any authorized IRS officers and employees. Such records should specifically include information regarding the amount, basis, and the fair market value of the Carisma capital stock exchanged and the amount of Sesen Bio common stock and cash received in exchange therefor. Carisma U.S. holders who owned immediately before the merger at least one&#160;percent (by vote or value) of the total outstanding stock of Carisma are required to attach a statement to their tax returns for the year in which the merger is consummated that contains the information listed in Treasury Regulation&#160;Section&#160;1.368-3(b). Such statement must include the Carisma U.S. holder&#8217;s tax basis in such holder&#8217;s Carisma capital stock surrendered in the merger, the fair market value of such stock, the date of the merger and the name and employer identification number of each of Carisma and Sesen Bio. Carisma U.S. holders are urged to consult with their tax advisors to comply with these rules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Backup Withholding and Information Reporting</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Carisma U.S. holder may, under certain circumstances, be subject to information reporting and backup withholding on any payments of cash in lieu of fractional shares, unless such holder properly establishes an exemption or provides its correct tax identification number and otherwise complies with the applicable requirements of the backup withholding rules. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be refunded or credited against a payee&#8217;s U.S.&#160;federal income tax liability, if any, so long as such payee furnishes the required information to the IRS in a timely manner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The foregoing summary is of a general nature only and is not intended to be, and should not be construed to be, legal, business or tax advice to any particular Carisma stockholder. This summary does not take into account your particular circumstances and does not address consequences that may be particular to you. Therefore, you should consult your tax advisor regarding the particular consequences of the merger to you.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of receipt of the special cash dividend to Sesen Bio stockholders, but does not purport to be a complete analysis of all potential tax consequences that may be relevant to a Sesen Bio stockholder. The effects of other U.S.&#160;federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Sesen Bio stockholder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">162</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has not sought and does not intend to seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of receipt of the special cash dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Sesen Bio stockholders that hold Sesen Bio common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences that may be relevant to a Sesen Bio stockholder&#8217;s particular circumstances, including the impact of the alternative minimum tax, the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code . In addition, it does not address consequences relevant to Sesen Bio stockholders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons holding Sesen Bio common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">banks, insurance companies and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons subject to special tax accounting rules as a result of any item of gross income with respect to Sesen Bio common stock being taken into account in an &#8220;applicable financial statement&#8221; &#8203;(as defined in the Code); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons deemed to sell Sesen Bio common stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons who hold or received Sesen Bio common stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Sesen Bio common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Sesen Bio common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Sesen Bio non-U.S. holder&#8221; means a beneficial owner of Sesen Bio common stock that is neither a Sesen Bio U.S. holder (which, for purposes of this discussion, has the same meaning as in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;) nor a partnership (or other entity treated as a partnership) for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT SESEN BIO STOCKHOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE SPECIAL CASH DIVIDEND ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The discussion below assumes that the distribution of CVRs and the special cash dividend will be treated for U.S. federal income tax purposes as transactions that are separate and distinct from the proposed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">163</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">reverse stock split. However, it is possible that the IRS or a court could determine that the proposed reverse stock split and the receipt of CVRs or the special cash dividend constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. If the proposed reverse stock split and the special cash dividend and the receipt of the CVRs are treated as a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes, then a Sesen Bio stockholder generally should recognize gain (but not loss) equal to the lesser of (i)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs received (assuming the receipt of CVRs is treated as a distribution of property as described in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;the excess (if any) of (A)&#160;the sum of (1)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs and (2)&#160;the fair market value of the Sesen Bio shares received in the proposed reverse stock split over (B)&#160;the Sesen Bio stockholder&#8217;s adjusted tax basis in the Sesen Bio common stock surrendered in the proposed reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Consequences to Sesen Bio U.S. Holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax consequences of a Sesen Bio U.S. holder&#8217;s receipt of a special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Consequences to Sesen Bio Non-U.S. Holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax consequences of a Sesen Bio non-U.S. holder&#8217;s receipt of a special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio non-U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio non-U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of any special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. However, if Sesen Bio cannot determine at the time of the special cash dividend whether or not such special cash dividend will exceed current and accumulated earnings and profits, Sesen Bio or the applicable withholding agent is expected to withhold on the special cash dividend at the rate applicable to dividends, as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Taxable Dividends. Dividend payments to a Sesen Bio non-U.S. holder will generally be subject to withholding at a 30% rate. If a Sesen Bio non-U.S. holder is eligible for a lower treaty rate, then withholding will be at the lower treaty rate only if such Sesen Bio non-U.S. holder provides a valid IRS Form W-8BEN or W-8BEN-E (or applicable successor form) certifying such Sesen Bio non-U.S. holder&#8217;s qualification for the reduced rate. If a Sesen Bio non-U.S. holder holds the stock through a financial institution or other intermediary, the Sesen Bio non-U.S. holder will be required to provide appropriate documentation to the intermediary, which then will be required to provide certification to the applicable withholding agent, either directly or through other intermediaries. Sesen Bio non-U.S. holders who do not timely provide the applicable withholding agent with the required certification, but who qualify for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to the discussion below regarding backup withholding, if the special cash dividend is effectively connected with a Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the U.S. (and, if required by an applicable income tax treaty, the Sesen Bio non-U.S. holder maintains a permanent establishment in the U.S. to which the special cash dividend is attributable), the Sesen Bio non-U.S. holder will be exempt from U.S. federal withholding tax and the special cash dividend generally will be subject to U.S. federal income tax on a net income basis in the same manner as if such Sesen Bio non-U.S. holder were a U.S. holder. To </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">164</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tNALI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">claim the exemption, the Sesen Bio non-U.S. holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI (or applicable successor form), certifying that the special cash dividend is effectively connected with the Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the United States. A Sesen Bio non-U.S. holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) of all or a portion of its effectively connected earnings and profits for the taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Non-Dividend Distributions. To the extent that the distribution is treated as capital gain from the sale or exchange of Sesen Bio common stock, such gain generally will not be subject to U.S. federal income tax unless (i)&#160;such gain is effectively connected with the conduct by a Sesen Bio non-U.S. holder of a trade or business in the United States (and, if an income tax treaty applies, the gain is generally attributable to a U.S. permanent establishment maintained by such Sesen Bio non-U.S. holder), (ii)&#160;in the case of gain realized by a Sesen Bio non-U.S. holder that is an individual, such Sesen Bio non-U.S. holder is present in the United States for 183&#160;days or more in the taxable year of the sale and certain other conditions are met or (iii)&#160;Sesen Bio is or has been a United States real property holding corporation, or a USRPHC, for U.S. federal income tax purposes and, if the shares are &#8220;regularly traded on an established securities market,&#8221; such Sesen Bio non-U.S. holder owned, directly or indirectly, at any time during the five-year period ending on the date of the distribution, more than 5% of the shares of Sesen Bio common stock and such Sesen Bio non-U.S. holder is not eligible for any treaty exemption. The shares will be considered &#8220;regularly traded&#8221; if they are traded on an established securities market located in the United States and are regularly quoted by brokers or dealers making a market in the shares. Sesen Bio believes it is not, and has not been, a USRPHC for U.S. federal income tax purposes. In addition, although not free from doubt, Sesen Bio believes that Sesen Bio common shares currently should be considered to be regularly traded. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder should consult its tax advisor regarding its entitlement to benefits and the various rules under applicable tax treaties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Information Reporting and Backup Withholding</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In general, the special cash dividend received by Sesen Bio U.S. holders will be reported to the IRS unless the holder is an exempt recipient. Backup withholding, currently at a rate of 24%, may apply unless the Sesen Bio U.S. holder (1)&#160;is an exempt recipient or (2)&#160;provides a certificate (generally on an IRS Form&#160;W-9) containing the Sesen Bio U.S. holder&#8217;s name, address, correct federal taxpayer identification number and statement that the Sesen Bio U.S. holder is a U.S. person and is not subject to backup withholding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder will not be subject to backup withholding with respect to the special cash dividend, provided the Sesen Bio Non-U.S. holder certifies its non-U.S. status, such as by providing a valid IRS Form W-8BEN or W-8ECI or W-8BEN-E, or otherwise establishes an exemption. However, information returns will be filed with the IRS in connection with the special cash dividend, regardless of whether any tax was actually withheld. Copies of these information returns may also be made available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the Sesen Bio non-U.S. holder resides or is established. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a Sesen Bio U.S. holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Nasdaq Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock currently is listed on Nasdaq under the symbol &#8220;SESN.&#8221; Sesen Bio has agreed to use commercially reasonable efforts to (i)&#160;maintain its existing listing on Nasdaq through the closing of the merger, (ii)&#160;prepare and submit a Nasdaq notification form for the listing of the shares of Sesen Bio common stock to be issued in connection with the merger, and to cause such shares to be approved for listing (subject to official notice of issuance), (iii)&#160;effect the proposed reverse stock split and (iv)&#160;file an initial listing application for the Sesen Bio common stock on Nasdaq and to cause such application to be approved prior to the effective time. In addition, under the Merger Agreement, each party&#8217;s obligation to complete the merger is subject to the satisfaction or waiver by each of the parties prior to the closing of the merger of various conditions, including that the existing shares of Sesen Bio common stock must have been continually </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">165</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tAAT">&#8203;</a><a name="tARAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">listed on Nasdaq, and Sesen Bio must have caused the shares of Sesen Bio common stock to be issued in the merger to be approved for listing on Nasdaq as of the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application with Nasdaq pursuant to Nasdaq &#8220;business combination&#8221; rules. If such application is accepted, Sesen Bio anticipates that the shares of Sesen Bio common stock will be listed on Nasdaq following the closing of the merger under the trading symbol &#8220;CARM.&#8221; In order to meet the requirements for listing on Nasdaq, the post-merger combined company will be required to satisfy Nasdaq&#8217;s initial listing requirements, including the financial and liquidity requirements for the applicable Nasdaq market tier upon which the post-merger combined company&#8217;s shares will trade following the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anticipated Accounting Treatment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The merger is expected to be accounted for as a reverse recapitalization under U.S. GAAP because the primary assets of Sesen Bio are cash, cash equivalents and marketable securities. For financial reporting purposes, Carisma has been determined to be the accounting acquirer based upon the terms of the merger including: (i)&#160;Carisma stockholders and holders of securities convertible into Carisma common stock are expected to own approximately 74.8% of the combined company (based on estimates made at the time of the signing of the Merger Agreement), (ii)&#160;Carisma will hold the majority (six of seven) of board seats of the combined company and (iii)&#160;Carisma management will hold all key positions in the management of the combined company. Accordingly, the merger is expected to be treated as the equivalent of Carisma issuing stock to acquire the net assets of Sesen Bio. As a result of the merger, the net assets of Sesen Bio will be recorded at their acquisition-date fair value in the consolidated financial statements of Carisma and the reported operating results prior to the merger will be those of Carisma. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Unaudited Pro Forma Condensed Combined Financial Information</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tUPFC">372</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appraisal Rights and Dissenters&#8217; Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is completed, Carisma stockholders who do not deliver a written consent approving the merger are entitled to appraisal rights under Section&#160;262 of the DGCL, or Section&#160;262, provided that they comply with the conditions established by Section&#160;262. Holders of Sesen Bio common stock are not entitled to appraisal rights under Delaware law in connection with the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The discussion below is not a complete summary regarding a Carisma stockholder&#8217;s appraisal rights under Delaware law and is qualified in its entirety by reference to the text of the relevant provisions of Delaware law, which is attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. Carisma stockholders intending to exercise appraisal rights should carefully review </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;">. Failure to follow precisely any of the statutory procedures set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;"> may result in a termination or waiver of these rights. This summary does not constitute legal or other advice, nor does it constitute a recommendation that Carisma stockholders exercise their appraisal rights under Delaware law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under Section&#160;262, where a merger is adopted by stockholders by written consent in lieu of a meeting of stockholders pursuant to Section&#160;228 of the DGCL, either the constituent corporation before the effective date of the merger, or the surviving corporation within 10&#160;days after the effective date of the merger, must notify each stockholder of the constituent corporation entitled to appraisal rights of the approval of the merger, the effective date of the merger and that appraisal rights are available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is completed, within 10&#160;days after the effective date Carisma will notify Carisma stockholders that the merger has been approved, the effective date and that appraisal rights are available to any Carisma stockholder who has not approved the merger. Carisma stockholders who desire to exercise their appraisal rights must deliver a written demand for appraisal to Carisma within 20&#160;days after the date of mailing of that notice, and that Carisma stockholder must not have delivered a written consent approving the merger. A demand for appraisal must reasonably inform Carisma of the identity of the Carisma stockholder and that such Carisma stockholder intends thereby to demand appraisal of the shares of Carisma common stock held by such Carisma stockholder. Failure to deliver a written consent approving the merger will not in and of itself constitute a written demand for appraisal satisfying the requirements of Section&#160;262. All demands for appraisal should be addressed to CARISMA Therapeutics Inc., 3675 Market </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">166</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Street, Suite 200, Philadelphia, PA 19104, Attention: Corporate Secretary, Email: legal@carismatx.com, and should be executed by, or on behalf of, the record holder of shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ALL DEMANDS MUST BE RECEIVED BY CARISMA WITHIN 20 DAYS AFTER THE DATE CARISMA MAILS A NOTICE TO CARISMA STOCKHOLDERS NOTIFYING THEM THAT THE MERGER HAS BEEN APPROVED, THE EFFECTIVE DATE OF THE MERGER AND THAT APPRAISAL RIGHTS ARE AVAILABLE TO ANY CARISMA STOCKHOLDER WHO HAS NOT APPROVED THE MERGER.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a Carisma stockholder, and fail to deliver a written demand for appraisal within the time period specified above, you will be entitled to receive the merger consideration for your shares of Carisma capital stock as provided for in the Merger Agreement, but you will have no appraisal rights with respect to your shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To be effective, a demand for appraisal by a Carisma stockholder must be made by, or in the name of, the registered stockholder, fully and correctly, as the Carisma stockholder&#8217;s name appears on the Carisma stockholder&#8217;s stock certificate(s). Beneficial owners who do not also hold the shares of record may exercise appraisal rights directly, rather than relying on the record owner of their shares of Carisma capital stock to demand appraisal on their behalf. In order for a beneficial owner to assert appraisal rights with respect to any shares, such owner must maintain continuous beneficial ownership of such shares through the effective date of the merger and provide documentary evidence of such ownership, as more fully described in Section&#160;262(d)(3) of the DGCL. If shares of Carisma capital stock are owned of record or beneficially in a fiduciary capacity, such as by a trustee, guardian or custodian, execution of a demand for appraisal should be made by or for the fiduciary; and if the shares of Carisma capital stock are owned of record or beneficially by more than one person, as in a joint tenancy or tenancy in common, the demand should be executed by or for all joint owners. An authorized agent, including an authorized agent for two or more joint owners, may execute the demand for appraisal for a Carisma stockholder; however, the agent must identify the record/</font>&#8203;<font style="letter-spacing:0.2pt;">beneficial owner or owners and expressly disclose the fact that, in executing the demand, he or she is acting as agent for the record/beneficial owner. A record owner, such as a broker, who holds shares of Carisma capital stock as a custodian for others, may exercise the record owner&#8217;s right of appraisal with respect to the shares of Carisma capital stock held for one or more beneficial owners, while not exercising this right for other beneficial owners. In that case, the written demand should state the number of shares of Carisma capital stock as to which appraisal is sought. Where no number of shares of Carisma capital stock is expressly mentioned, the demand will be presumed to cover all shares of Carisma capital stock held in the name of the record owner. In addition, the Carisma stockholder must hold the shares of Carisma capital stock continuously through the effective time and on the date of making a demand. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you hold your shares of Carisma capital stock in a brokerage account or in other custodian form and you do not wish to exercise appraisal rights directly as a beneficial owner, you should consult with your broker, bank or other custodian to determine the appropriate procedures for the making of a demand for appraisal by the custodian. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At any time within 60&#160;days after the effective time, any Carisma stockholder who has demanded an appraisal, but has neither commenced an appraisal proceeding or joined an appraisal proceeding as a named party, has the right to withdraw such Carisma stockholder&#8217;s demand and accept the terms of the merger by delivering a written withdrawal to Carisma. If, following a demand for appraisal, you have withdrawn your demand for appraisal in accordance with Section&#160;262, you will have the right to receive the merger consideration for your shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Within 120&#160;days after the effective time, any Carisma stockholder who has delivered a demand for appraisal in accordance with Section&#160;262 will, upon written request to the surviving corporation, be entitled to receive a written statement setting forth the aggregate number of shares of Carisma capital stock not voted in favor of the Merger Agreement and with respect to which demands for appraisal rights have been received and the aggregate number of holders of these shares of Carisma capital stock. This written statement will be mailed to the requesting Carisma stockholder within 10&#160;days after the Carisma stockholder&#8217;s written request is received by the surviving corporation or within 10&#160;days after expiration of the period for delivery of demands for appraisal, whichever is later. Within 120&#160;days after the effective time, either the surviving corporation or any Carisma stockholder who has delivered a demand for appraisal in accordance </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">167</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">with Section&#160;262 may file a petition in the Delaware Court of Chancery demanding a determination of the fair value of the shares of Carisma capital stock held by all such Carisma stockholders. Upon the filing of the petition by a Carisma stockholder, service of a copy of the petition must be made upon the surviving corporation. The surviving corporation has no obligation to file a petition in the Delaware Court of Chancery in the event there are dissenting Carisma stockholders, and Sesen Bio, which is expected to be the surviving corporation, has no present intent to file a petition in the Delaware Court of Chancery. Accordingly, the failure of a Carisma stockholder to file a petition within the period specified could nullify the Carisma stockholder&#8217;s previously written demand for appraisal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a petition for appraisal is duly filed by a Carisma stockholder and a copy of the petition is delivered to the surviving corporation, the surviving corporation will then be obligated, within 20&#160;days after receiving service of a copy of the petition, to provide the Delaware Court of Chancery with a duly verified list containing the names and addresses of all Carisma stockholders who have demanded an appraisal of their shares of Carisma capital stock and with whom agreements as to the value of their shares of Carisma capital stock have not been reached by the surviving corporation. After notice to dissenting Carisma stockholders who demanded appraisal of their shares of Carisma capital stock, the Delaware Court of Chancery is empowered to conduct a hearing upon the petition, and to determine those Carisma stockholders who have complied with Section&#160;262 and who have become entitled to the appraisal rights provided thereby. The Delaware Court of Chancery may require the Carisma stockholders who have demanded appraisal for their shares of Carisma capital stock to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any Carisma stockholder fails to comply with that direction, the Delaware Court of Chancery may dismiss the proceedings as to that Carisma stockholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After determination of the Carisma stockholders entitled to appraisal of their shares of Carisma capital stock, the Delaware Court of Chancery will appraise the &#8220;fair value&#8221; of the shares of Carisma capital stock owned by those Carisma stockholders. This value will be exclusive of any element of value arising from the accomplishment or expectation of the merger, but may include a fair rate of interest, if any, upon the amount determined to be the fair value. When the value is determined, the Delaware Court of Chancery will direct the payment of the value, with interest thereon accrued during the pendency of the proceeding, if the Delaware Court of Chancery so determines, to the Carisma stockholders entitled to receive the same, upon surrender by the holders of the certificates representing those shares of Carisma capital stock. At any time before the entry of judgment in the proceedings, the surviving corporation may pay to each Carisma stockholder entitled to appraisal an amount in cash, in which case interest shall accrue thereafter only upon the sum of (i)&#160;the difference, if any, between the amount so paid and the fair value of the shares of Carisma capital stock subject to appraisal as determined by the Delaware Court of Chancery and (ii)&#160;interest theretofore accrued, unless paid at that time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In determining fair value, and, if applicable, a fair rate of interest, the Delaware Court of Chancery is required to take into account all relevant factors. In </font><font style="font-style:italic;letter-spacing:0.2pt;">Weinberger v. UOP, Inc.</font><font style="letter-spacing:0.2pt;">, the Delaware Supreme Court discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that &#8220;proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible in court&#8221; should be considered, and that &#8220;fair price obviously requires consideration of all relevant factors involving the value of a company.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;262 provides that fair value is to be &#8220;exclusive of any element of value arising from the accomplishment or expectation of the merger.&#8221; In </font><font style="font-style:italic;letter-spacing:0.2pt;">Cede &amp; Co. v. Technicolor, Inc.</font><font style="letter-spacing:0.2pt;">, the Delaware Supreme Court stated that this exclusion is a &#8220;narrow exclusion [that] does not encompass known elements of value,&#8221; but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. In Weinberger, the Delaware Supreme Court construed Section&#160;262 to mean that &#8220;elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You should be aware that the fair value of your shares of Carisma capital stock as determined under Section&#160;262 could be more than, the same as, or less than the value that you are entitled to receive under the terms of the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Costs of the appraisal proceeding may be imposed upon the surviving corporation and the Carisma stockholders participating in the appraisal proceeding by the Delaware Court of Chancery as the Court </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">168</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLRTM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">deems equitable in the circumstances. Upon the application of a Carisma stockholder, the Delaware Court of Chancery may order all or a portion of the expenses incurred by any Carisma stockholder in connection with the appraisal proceeding, including, without limitation, reasonable attorneys&#8217; fees and the fees and expenses of experts, to be charged pro&#160;rata against the value of all shares of Carisma capital stock entitled to appraisal. In the absence of such a determination of assessment, each party bears its own expenses. Any Carisma stockholder who had demanded appraisal rights will not, after the effective time, be entitled to vote shares of Carisma capital stock subject to that demand for any purpose or to receive payments of dividends or any other distribution with respect to those shares of Carisma capital stock, other than with respect to payment as of a record date prior to the effective time; however, if no petition for appraisal is filed within 120&#160;days after the effective time, or if the Carisma stockholder delivers a written withdrawal of his or her demand for appraisal and an acceptance of the terms of the merger within 60&#160;days after the effective time, then the right of that Carisma stockholder to appraisal will cease and that Carisma stockholder will be entitled to receive the merger consideration for shares of his or her Carisma capital stock pursuant to the Merger Agreement. Any withdrawal of a demand for appraisal made more than 60&#160;days after the effective time may only be made with the written approval of the surviving corporation. No appraisal proceeding in the Delaware Court of Chancery will be dismissed as to any stockholder without the approval of the court. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Failure to follow the steps required by Section&#160;262 for perfecting appraisal rights may result in the loss of appraisal rights. In view of the complexity of Section&#160;262, Carisma stockholders who may wish to dissent from the merger and pursue appraisal rights should consult their legal advisors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Litigation Related to the Merger</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio received (a) one demand letter on October 21, 2022, attaching a draft complaint, sent on behalf of Thomas Budzinski, a purported stockholder of Sesen Bio (the &#8220;Budzinski Demand&#8221;), (b) one demand letter on October 21, 2022, sent on behalf of Derick Passmore, a purported stockholder of Sesen Bio (the &#8220;Passmore Demand&#8221;) and (c) one demand letter on November&#160;4, 2022, sent on behalf of Ryan McKinley, a purported stockholder of Sesen Bio (the &#8220;McKinley Demand&#8221; and together with the Budzinski Demand and the Passmore Demand, the &#8220;Demand Letters&#8221;). In addition, Sesen Bio received a books and records demand, dated November&#160;18, 2022 (the &#8220;Section 220 Demand&#8221;), on behalf of a purported stockholder of Sesen Bio seeking access to certain relevant books and records of Sesen Bio pursuant to Section 220 of the DGCL in connection with the merger and the securities and derivative litigations arising out of the CRL that Sesen Bio received from the FDA.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each of the Budzinski Demand, the Passmore Demand and the McKinley Demand alleges omissions of material information with respect to the merger from this proxy statement/prospectus, including information regarding the financial projections with respect to Carisma, the financial analyses performed by SVB Securities in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement, and demands that Sesen Bio promptly provide stockholders with additional disclosure. In addition, the Budzinski Demand includes a draft complaint, which asserts claims against Sesen Bio and the Sesen Bio board of directors under Section 14(a) of the Exchange Act and Rule&#160;14a-9 promulgated thereunder for allegedly false and misleading statements in this proxy statement/prospectus and under Section 20(a) of the Exchange Act for alleged &#8220;control person&#8221; liability with respect to such allegedly false and misleading statements. The Section 220 Demand states that the purpose of the demand is to, among other things, investigate purported questions of director independence and disinterestedness and the possibility of wrongdoing, mismanagement, and/or material non-disclosure related to the Sesen Bio board&#8217;s approval of the merger and the other transactions contemplated thereby and to determine whether suit should be brought in connection therewith.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, on November 28, 2022, a purported Sesen Bio stockholder filed a complaint in the U.S. District Court for the Southern District of New York against Sesen Bio and the Sesen Bio board of directors, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No.&#160;1:22-cv-10085 (S.D.N.Y.) (the &#8220;Original Keller Complaint&#8221;). The Original Keller Complaint made assertions similar to the Demand Letters and sought, among other relief, an order enjoining the merger and an award for plaintiffs&#8217; fees and costs. On December&#160;20, 2022, the purported stockholder voluntarily dismissed his complaint and on December&#160;21, 2022, filed a new complaint as a putative class action in the Court of Chancery for the State of Delaware, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 2022-1186 (Del. Ch. Dec. 21, 2022) (the &#8220;New Keller </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">169</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:444pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Complaint&#8221;). Along with the complaint, the purported stockholder filed motions for expedited proceedings and for a preliminary injunction to enjoin the Sesen Bio special meeting. The New Keller Complaint and associated filings contain substantially the same assertions as the Original Keller Complaint and the Demand Letters.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio believes that the claims asserted in the Demand Letters, the Section 220 Demand and the New Keller Complaint are without merit.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders and Carisma stockholders may serve additional demands and/or file additional lawsuits challenging the merger, which may name Sesen Bio, Carisma, members of the Sesen Bio board of directors, members of the Carisma board of directors and/or others as defendants. No assurance can be made as to the outcome of such additional demands, lawsuits, the Demand Letters, the Section 220 Demand or the Keller Complaint, including the amount of costs associated with defending, settling, or any other liabilities that may be incurred in connection with the litigation or settlement of, such claims. If any additional demands are served and/or any additional lawsuits filed, absent new or different allegations that are material, Sesen Bio will not necessarily announce such additional demands and/or complaints.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">170</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE MERGER AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material terms of the Merger Agreement. Copies of the Original Merger Agreement and the Merger Agreement Amendment are attached as Annexes A-1 and A-2, respectively, to this proxy statement/prospectus and are incorporated by reference into this proxy statement/prospectus. The Merger Agreement has been attached to this proxy statement/prospectus to provide you with information regarding its terms. It is not intended to provide any other factual information about Sesen Bio, Carisma or Merger Sub. The following description does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement. You should refer to the full text of the Merger Agreement for details of the merger and the terms and conditions of the Merger Agreement.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains representations and warranties that Sesen Bio and Merger Sub, on the one hand, and Carisma, on the other hand, have made to one another as of specific dates. These representations and warranties have been made for the benefit of the other parties to the Merger Agreement and may be intended not as statements of fact but rather as a way of allocating the risk to one of the parties if those statements prove to be incorrect. In addition, the assertions embodied in the representations and warranties are qualified by information in confidential disclosure schedules exchanged by the parties in connection with signing the Merger Agreement. While Sesen Bio and Carisma do not believe that these disclosure schedules contain information required to be publicly disclosed under the applicable securities laws, other than information that has already been so disclosed, the disclosure schedules do contain information that modifies, qualifies and creates exceptions to the representations and warranties set forth in the attached Merger Agreement. Accordingly, you should not rely on the representations and warranties as current characterizations of factual information about Sesen Bio and Carisma because they were made as of specific dates, may be intended merely as a risk allocation mechanism between Sesen Bio, Merger Sub and Carisma and are modified by the disclosure schedules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Merger Sub was formed as a wholly-owned subsidiary of Sesen Bio for the sole purpose of completing the merger transaction. Under the Merger Agreement at the effective time, Merger Sub will merge with and into Carisma, with Carisma surviving as the wholly-owned subsidiary of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Completion and Effectiveness of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The consummation of the merger will take place as promptly as practicable, but in no event later than the second business day after all of the conditions to completion of the merger are satisfied or waived, including certain approvals by the stockholders of Sesen Bio and Carisma. Sesen Bio and Carisma are working to complete the merger and expect that the merger will be completed in the first quarter of 2023, after the Sesen Bio special meeting of stockholders. However, Sesen Bio and Carisma cannot predict the completion of the merger or the exact timing of the completion of the merger because it is subject to various conditions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger Consideration</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, upon the terms and subject to the conditions set forth in the Merger Agreement, each outstanding share of Carisma&#8217;s capital stock (including shares of Carisma capital stock sold in the Carisma pre-closing financing but excluding (i)&#160;shares of Carisma capital stock to be canceled pursuant to the Merger Agreement and (ii)&#160;Carisma common stock held by holders of Carisma common stock who have exercised and perfected appraisal rights or dissenters&#8217; rights) will be automatically converted solely into the right to receive a number of shares of Sesen Bio common stock and each outstanding Carisma option will become exercisable for shares of Sesen Bio common stock, in each case, equal to the exchange ratio described in more detail below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No fractional shares of Sesen Bio common stock will be issued in connection with the merger, and no certificates or scrip for any such fractional shares will be issued. Any fractional shares of Sesen Bio common stock resulting from the conversion of Carisma capital stock will receive cash (without interest and subject to applicable tax withholding) in an amount equal to such fractional part of a share of Sesen Bio common stock multiplied by the last reported sale price of Sesen Bio common stock at 4:00&#160;p.m., Eastern Time, end of regular trading hours on Nasdaq on the last day prior to the effective time. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">171</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMAER">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exchange Ratio</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The exchange ratio is calculated using a formula intended to allocate existing Sesen Bio and Carisma stockholders a&#160;percentage of the combined company. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock. This estimate is subject to adjustment prior to the closing of the merger for net cash at the cash determination time and aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing (and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on the estimates set forth above, and certain other assumptions, Sesen Bio stockholders would own approximately 25.2% of the common stock of the combined company post-merger, and Carisma stockholders would own approximately 74.8% of the common stock of the combined company post-merger, of which the shares issued in the Carisma pre-closing financing and the shares issued upon the conversion of the Carisma convertible note are expected to represent approximately 8.4% and 11.3%, respectively, of the common stock of the combined company post-merger. For more information on the Carisma pre-closing financing, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSUAG">198</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The exchange ratio formula is the quotient obtained (rounded to four decimal places) by dividing the number of Carisma merger shares (defined below) by the Carisma outstanding shares (defined below), in which: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Aggregate valuation&#8221; means the sum of the (i)&#160;Carisma valuation plus (ii)&#160;the Sesen Bio valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Carisma valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma merger shares&#8221; means the product determined by multiplying (i)&#160;the post-closing Sesen Bio shares by (ii)&#160;the Carisma allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma outstanding shares&#8221; means the total number of shares of Carisma capital stock outstanding immediately prior to the effective time expressed on a fully-diluted and as-converted to Carisma common stock basis and assuming, without limitation or duplication, (i)&#160;the exercise of all Carisma options outstanding as of immediately prior to the effective time, (ii)&#160;the closing of the Carisma pre-closing financing, and (iii)&#160;the issuance of shares of Carisma common stock issuable in respect of all other outstanding options, restricted stock awards, warrants or rights to receive such shares, whether conditional or unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation of the Merger. Carisma outstanding shares shall also include all shares of the Carisma issued in the Carisma pre-closing financing prior to the effective time and excludes any shares issued upon the conversion of the Carisma convertible note. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Carisma valuation&#8221; means (i)&#160;$196.0&#160;million, plus (ii)&#160;the amount of gross proceeds from the Carisma pre-closing financing prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Sesen Bio valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio outstanding shares&#8221; means the total number of shares of Sesen Bio common stock outstanding immediately prior to the effective time expressed on a fully-diluted and as converted to Sesen Bio common stock basis, assuming, without limitation or duplication, the issuance of shares of Sesen Bio common stock in respect of all Sesen Bio options, Sesen Bio RSUs, Sesen Bio warrants and other outstanding options, warrants or rights to receive such shares, in each case, outstanding as of immediately prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio valuation&#8221; means $140.0&#160;million, minus the amount by which net cash at the cash determination time is less than $125.0&#160;million, plus the amount by which net cash at the cash </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">172</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">determination time is greater than $125.0&#160;million. However, and pursuant to the terms of the Merger Agreement Amendment, Sesen Bio expects to only have approximately $75.0 million of net cash at the cash determination time. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Post-closing Sesen Bio shares&#8221; mean the quotient determined by dividing (i)&#160;the Sesen Bio outstanding shares by (ii)&#160;the Sesen Bio allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Calculation of Sesen Bio&#8217;s Final Net Cash</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, Sesen Bio&#8217;s &#8220;final net cash&#8221; means, as of the cash determination time (which is as of 8:00&#160;p.m. Eastern Time on the last business day prior to the anticipated closing date) the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">cash and cash equivalents, marketable securities and other short-term investments of Sesen Bio and its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s accounts receivable (including any tax refund claims pending as of the date of the Original Merger Agreement), deposits and interest; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Seen Bio&#8217;s deposits, prepaid expenses and other prepaid assets which are reflected on the most recent balance sheet and do not constitute restricted cash of Sesen Bio and its subsidiaries; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">50% of the cost of settling any transaction litigation to the extent actually paid in cash by Sesen Bio prior to the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;">, the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any unpaid transaction expenses of Sesen Bio or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any unpaid indebtedness of Sesen Bio and/or its subsidiaries outstanding as of the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any accounts payable, accrued expenses or short or long term liabilities that are or will become payable in cash, including any such accounts payable, accrued expenses or short or long term liabilities under any Sesen Bio contracts that were in effect prior to the effective time or associated with the termination of any Sesen Bio contracts which were in effect prior to the effective time or the termination before, at or after the effective time, of all current or former employees of Sesen Bio and its subsidiaries (even if the applicable expenses or amounts are due and payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any unpaid employer portion of payroll or employment taxes incurred in connection with the grant, exercise, conversion, settlement or cancellation of Sesen Bio RSUs, Sesen Bio options, equity compensation and other change in control or severance payments (including bonuses payable) due under the Merger Agreement or CVRs issued to holders of Sesen Bio RSUs or Sesen Bio options or otherwise as compensation (either incurred prior to or at the time of the Merger, and for the avoidance of doubt, not calculated as of the close of business on the business day prior to the closing date) in each case, incurred in connection with the merger by Sesen Bio at or prior to the effective time (even if payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any pre-payment, termination, &#8220;end of term&#8221; or similar fee or charge payable to any lender in connection with the repayment of indebtedness by Sesen Bio at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the amount of any cash dividend declared (or to be declared) but not yet paid as part of the pre-closing dividend; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost and/or premium of the directors&#8217; and officer&#8217;s &#8220;tail policy&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost of settling any legal proceeding or other dispute existing as of the date of the Original Merger Agreement, as well as the unpaid deductible amount under Sesen Bio&#8217;s insurance reasonably expected to be payable in connection with legal proceedings existing as of the date of the Original Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each component of net cash, to the extent applicable, shall be determined in accordance with U.S. GAAP, applied on a basis consistent with the application of U.S. GAAP in the preparation of Sesen Bio&#8217;s most recent audited or reviewed financial statements. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">173</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMAER7">&#8203;</a><a name="tTMAER9">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Not more than ten nor less than five calendar days prior to the anticipated closing date, Sesen Bio will deliver to Carisma the net cash schedule setting forth, in reasonable detail, Sesen Bio&#8217;s good faith estimated calculation of its net cash at the cash determination time, prepared and certified by Sesen Bio&#8217;s Chief Executive Officer and Chief Financial Officer (or if there is no chief financial officer at such time, the principal financial and accounting officer) together with the work papers and back-up materials used or useful in preparing the net cash schedule, as reasonably requested by Carisma. Within three business days after delivery of the net cash schedule (the last day of such period referred to as the response date), Carisma will have the right to dispute all or any part or parts of the net cash schedule by delivering a written notice to that effect to Sesen Bio (referred to herein as a dispute notice). Any dispute notice will identify in reasonable detail to the extent then known, the nature and amounts of any proposed revisions to Sesen Bio&#8217;s net cash calculation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma disputes the net cash schedule prior to 8:00&#160;pm Eastern Time on the response date, the parties shall promptly, and in no event later than one calendar day after the response date, meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of net cash. If the parties are unable to negotiate an agreed-upon determination of net cash within two calendar days after the delivery of the dispute notice (or such other period as Sesen Bio and Carisma may mutually agree upon in writing), then any remaining disagreements as to the calculation of net cash will be referred to Deloitte &amp; Touche LLP or another independent auditor of recognized national standing mutually agreed upon by Sesen Bio and Carisma. The determination of the amount of net cash made by such auditor shall be final and binding on Sesen Bio and Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s net cash balance is subject to numerous factors, some of which are outside of Sesen Bio&#8217;s control. The actual amount of net cash will depend significantly on the timing of the closing of the merger. In addition, the closing of the merger could be delayed if Sesen Bio and Carisma are not able to agree upon the amount of Sesen Bio&#8217;s net cash as of the cash determination time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Sesen Bio Equity Awards and Warrants</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Equity Awards</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, all outstanding and unexercised Sesen Bio options granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan or as an inducement grant under Nasdaq Listing Rule 5635(c)(4) will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio options and the exercise prices for such Sesen Bio options will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, all outstanding Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio RSUs will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Warrants</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, all Sesen Bio warrants (other than certain Sesen Bio warrants that Sesen Bio may be required to repurchase at such warrant holder&#8217;s option as of a result of the merger) will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying such Sesen Bio warrants and the exercise prices for such Sesen Bio warrants will be appropriately adjusted to reflect the proposed reverse stock split, if approved.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Carisma Options</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Merger Agreement, each Carisma option that is outstanding and unexercised immediately prior to the effective time under the Carisma Plan and that, following assumption by Sesen Bio at the effective time, will be eligible to be registered on Form S-8, whether or not vested, will be converted into and become an option to purchase Sesen Bio common stock. Sesen Bio will assume the Carisma Plan and each such Carisma option in accordance with the terms (as in effect as of the date of the Original Merger Agreement) of the Carisma Plan and the terms of the stock option agreement by which such Carisma option </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">174</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">is evidenced (but with changes to such documents as Sesen Bio and Carisma mutually agree are appropriate to reflect the substitution of the Carisma options for an option to purchase shares of Sesen Bio common stock). All other Carisma options that are outstanding and unexercised as of immediately prior to the effective time shall be canceled immediately prior to the effective time. All rights with respect to Carisma common stock subject to Carisma options assumed by Sesen Bio shall thereupon be converted into rights with respect to Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, from and after the effective time: (i)&#160;each Carisma option assumed by Sesen Bio may be exercised solely for shares of Sesen Bio common stock; (ii)&#160;the number of shares of Sesen Bio common stock subject to each Carisma option assumed by Sesen Bio shall be determined by multiplying (A)&#160;the number of shares of Carisma common stock that were subject to such Carisma option, as in effect immediately prior to the effective time, by (B)&#160;the exchange ratio, and rounding the resulting number down to the nearest whole number of shares of Sesen Bio common stock; (iii)&#160;the per share exercise price for the Sesen Bio common stock issuable upon the exercise of each Carisma option assumed by Sesen Bio shall be determined by dividing (A)&#160;the per share exercise price of Carisma common stock subject to such Carisma option, as in effect immediately prior to the effective time, by (B)&#160;the exchange ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv)&#160;any restriction on the exercise of any Carisma option assumed by Sesen Bio shall continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Carisma option shall otherwise remain unchanged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, to the extent provided under the terms of a Carisma option and the Carisma Plan, such Carisma option may be further adjusted as necessary to reflect Sesen Bio&#8217;s substitution of the Carisma options with options to purchase Sesen Bio common stock (such as by making any change in control or similar definition related to Sesen Bio and having any provision that provides for the adjustment of Carisma options upon the occurrence of certain corporate events related to corporate events that relate to Sesen Bio and/or Sesen Bio common stock); and (y)&#160;the Sesen Bio board of directors or a committee thereof shall succeed to the authority and responsibility of the Carisma board of directors or any committee thereof with respect to each Carisma option assumed by Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Carisma Convertible Note</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Merger Agreement, as of immediately after the effective time, the Carisma convertible note shall convert into shares of Sesen Bio common stock in accordance with the convertible note conversion agreement, as amended or supplemented. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors and Officers of Sesen Bio Following the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, each of the current directors who will not continue as directors of Sesen Bio or the combined company following the consummation of the merger will resign effective as of the closing of the merger. Additionally, pursuant to the Merger Agreement, the employment and service of each officer of Sesen Bio will terminate. Effective as of the effective time, the Sesen Bio board of directors is expected to be comprised of seven directors, to serve in the class assigned to director. Pursuant to the terms of the Merger Agreement, one such director will be designated by Sesen Bio, and six such directors will be designated by Carisma. It is anticipated that Thomas R. Cannell will be the Sesen Bio designated director following the closing of the merger, and that all other current Sesen Bio directors will resign as of the closing of the merger. Carisma will appoint the remaining directors to the Sesen Bio board of directors to fill the resulting vacancies. It is anticipated that Sanford Zweifach, Regina Hodits, Briggs Morrison, Bj&#246;rn Odlander, Chidozie Ugwumba, and Steven Kelly will be appointed to the board of directors of the combined company by Carisma. Sanford Zweifach is expected to be appointed as chair of the board of directors of the combined company. It is anticipated that Sesen Bio&#8217;s executive officers upon the closing of the merger will be Steven Kelly, Richard Morris and Michael Klichinsky. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendments to the Sesen Bio Certificate of Incorporation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stockholders of record of Sesen Bio common stock on the record date will also be asked to approve Proposal No. 2, which include a series of alternative amendments to the Sesen Bio Certificate of Incorporation to effect the proposed reverse stock split in connection with consummation of the merger, which requires </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">175</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCCM5">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock entitled to vote on the record date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has agreed to amend the Sesen Bio Certificate of Incorporation to change its name to &#8220;Carisma Therapeutics Inc.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is entitled, but under no obligation, to sell, transfer, license, assign or otherwise divest any of its non-cash assets existing as of the date of the Original Merger Agreement, in a transaction or series of transactions; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such sale, transfer, license or other disposition, each, an asset disposition, must be expressly approved by the Sesen Bio board of directors. Pursuant to the Merger Agreement, Sesen Bio shall keep Carisma reasonably apprised of any developments related to an asset disposition. Without limiting the foregoing, Sesen Bio shall provide Carisma with notice of Sesen Bio&#8217;s intention to enter into any definitive written agreement providing for the consummation of an asset disposition or otherwise to consummate an asset disposition, at least ten business days prior to the execution or such definitive written agreement or to otherwise consummate an asset disposition. Sesen Bio shall not enter into a definitive written agreement or otherwise consummate an asset disposition that would result in a material continuing obligation without first obtaining the prior written consent of Carisma, such consent not to be unreasonably withheld, delayed or conditioned. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conditions to the Completion of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following contains a description of all material conditions to the completion of the merger. Each party&#8217;s obligation to effect the merger and otherwise consummate the other transactions contemplated by the Merger Agreement at the closing of the merger, is subject to the satisfaction or, the extent permitted by applicable law, the written waiver by each of the parties, at or prior to the closing of the merger, of various conditions, which include the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">no temporary restraining order, preliminary or permanent injunction or other order preventing the consummation of the transactions contemplated by the Merger Agreement shall have been issued by any court of competent jurisdiction or other governmental body of competent jurisdiction and remain in effect and there shall not be any law which has the effect of making the transactions contemplated by the Merger Agreement illegal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma shall have obtained the &#8220;required Carisma stockholder vote,&#8221; whereby the affirmative vote (or written consent) of (i)&#160;the holders of a majority of the Carisma capital stock, voting together as a single class, (ii)&#160;the holders of at least two-thirds of the Carisma Series&#160;A Preferred Stock, Carisma Special Voting Preferred Stock, Carisma Series&#160;B Preferred Stock and Carisma Series&#160;B Special Voting Preferred Stock, voting together as a single class, (iii)&#160;the holders of a majority of the Carisma Series&#160;A Preferred Stock and Carisma Special Voting Preferred Stock, voting together as a single class, and (iv)&#160;the holders of at least two-thirds of the Carisma Series&#160;B Preferred Stock and Carisma Series&#160;B Special Voting Preferred Stock, voting together as a single class, must have (x)&#160;adopted and approved the Merger Agreement and the transactions contemplated by the Merger Agreement, (y)&#160;acknowledged that the approval given thereby is irrevocable and that the Carisma stockholders are aware of their rights to demand appraisal for their respective shares and (z)&#160;acknowledged that by their approval of the merger they are not entitled to appraisal rights with respect to their shares in connection with the merger and thereby waive any rights to receive payment of the fair value of their capital stock under the DGCL; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio shall have obtained the &#8220;required Sesen Bio stockholder vote,&#8221; whereby the affirmative vote of (i)&#160;the holders of a majority of the outstanding shares of Sesen Bio common stock entitled to vote on the record date for the Sesen Bio special meeting must have approved Proposal No. 2 and (ii)&#160;the holders of a majority in voting power of the votes cast by the holders of all Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to thereon must have approved Proposal No. 1; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the existing shares of Sesen Bio common stock must have been continually listed on Nasdaq as of and from the date of the Original Merger Agreement through the closing date, the approval of the </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">176</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">listing of additional shares of Sesen Bio common stock on Nasdaq must have been obtained, and the shares of Sesen Bio common stock to be issued in the merger and the conversion pursuant to the Merger Agreement must have been approved for listing on Nasdaq; and </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the registration statement on Form S-4, of which this proxy statement/prospectus is a part, must have become effective in accordance with the Securities Act and must not be subject to any stop order or proceeding (or any proceeding threatened by the SEC) seeking a stop order with respect to such registration statement that has not been withdrawn. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the obligation of Sesen Bio and Merger Sub to effect the merger and otherwise consummate the other transactions contemplated by the Merger Agreement at the closing of the merger is further subject to the satisfaction or written waiver by Sesen Bio of the following conditions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the representations and warranties of Carisma regarding certain matters related to due organization, authority, vote required, non-contravention, and financial advisors in the Merger Agreement must be true and correct in all material respects on and as of the closing date with the same force and effect as if made on and as of such date, representations and warranties regarding the capitalization of Carisma and absence of a Carisma material adverse effect in the Merger Agreement must be true and correct in all respects, except for de minimis inaccuracies in the case of capitalization, on and as of the closing date with the same force and effect as if made on and as of such date, and the remaining representations and warranties of Carisma in the Merger Agreement shall be true and correct on and as of the closing date with the same force and effect as if made on and the closing date, except where the failure to be true and correct would not have a Carisma material adverse effect (in all cases, except to the extent such representations and warranties are specifically made as of a particular date, in which case as of such date); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma shall have performed or complied in all material respects with the agreements and covenants required to be performed or complied with by it under the Merger Agreement at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio shall have received a certificate executed by the Chief Executive Officer or Chief Executive Officer of Carisma certifying that certain closing conditions have been duly satisfied and that the information set forth in an allocation certificate delivered by Carisma is true and accurate in all respects as of the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio shall have received (i)&#160;an original signed statement from Carisma that the Carisma common stock is not a &#8220;United States real property interest,&#8221; as defined in Section&#160;897(c) of the Code, conforming to the requirements of Treasury Regulations&#160;Section&#160;1.1445-2(c)(3) and 1.897-2(h), and (ii)&#160;an original signed notice to be delivered to the IRS by Sesen Bio in accordance with the provisions of Treasury Regulations&#160;Section&#160;1.897-2(h)(2), together with written authorization for Sesen Bio to deliver such notice to the IRS on behalf of Carisma following the closing of the merger, each dated as of the closing date, duly executed by an authorized officer of Carisma, and in form and substance reasonably acceptable to Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain investor agreements between Carisma and its stockholders must have been terminated; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Carisma lock-up agreements will continue to be in full force and effect as of immediately following the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the obligation of Carisma to effect the merger and otherwise consummate the transactions to be consummated at the closing of the merger is further subject to the satisfaction or written waiver by Carisma of the following conditions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the representations and warranties of Parent and Merger Sub regarding certain matters related to due organization, authority, vote required, non-contravention, and financial advisors in the Merger Agreement must be true and correct in all material respects on and as of the closing date with the same force and effect as if made on and as of such date, representations and warranties regarding the capitalization of Sesen Bio and Merger Sub and absence of a Sesen Bio material adverse effect in the Merger Agreement must be true and correct in all respects, except for de minimis inaccuracies in the case of capitalization, on and as of the closing date with the same force and effect as if made on and as of such date, and the remaining representations and warranties of Sesen Bio and Merger Sub in </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">177</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the Merger Agreement shall be true and correct on and as of the closing date with the same force and effect as if made on and as of the closing date, except where the failure to be true and correct would not have a Sesen Bio material adverse effect (in all cases, except to the extent such representations and warranties are specifically made as of a particular date, in which case as of such date); </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio and Merger Sub shall have performed or complied in all material respects with the agreements and covenants required to be performed or complied with by each of them under the Merger Agreement at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma shall have received (i)&#160;a certificate by the Chief Executive Officer or Chief Financial Officer of Sesen Bio certifying that certain closing conditions have been duly satisfied, (ii)&#160;a copy of the CVR Agreement duly executed by Sesen Bio and the rights agent (as defined therein) and (iii)&#160;a written resignation, in form reasonably satisfactory to Carisma, dated as of the closing date and effective as of the closing, executed by each of the officers and directors, from their positions as such, of Sesen Bio who are not to continue as directors or officers (as applicable) of Sesen Bio after the closing of the merger, which such resignations not affecting such officer&#8217;s or director&#8217;s status as an employee (if applicable) including any characterization of their cessation from employment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Sesen Bio lock-up agreements will continue to be in full force and effect as of immediately following the effective time; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s final net cash shall have been determined to be greater than or equal to $75.0&#160;million. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Representations and Warranties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains customary representations and warranties of Sesen Bio and Carisma for a transaction of this type relating to, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">corporate organization and power, and similar corporate matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">organizational documents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">authority to enter into the Merger Agreement and the related agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">votes required for completion of the merger and approval of the proposals that will come before the Sesen Bio special meeting and that will be the subject of the Carisma stockholder written consent; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">except as otherwise specifically disclosed in the Merger Agreement, the fact that the consummation of the merger would not contravene the organizational documents, certain laws, governmental authorization or certain contracts of the parties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">result in any encumbrance on the parties&#8217; assets or require the consent of any third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">capitalization; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">financial statements and with respect to Sesen Bio, documents filed with the SEC and the accuracy of information contained in those documents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">material changes or events; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">title to assets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ownership of real property and leasehold interests; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">intellectual property; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">privacy and data security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the validity of material contracts to which the parties or their subsidiaries are a party and any violation, default or breach to such material contracts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory compliance, permits and restrictions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">178</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tNSON">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">legal proceedings and orders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">employee and labor matters and benefit plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">environmental matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">insurance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any brokerage or finder&#8217;s fee or other fee or commission in connection with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain transactions or relationships with affiliates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with anti-bribery laws; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">with respect to Sesen Bio, the valid issuance in the merger of Sesen Bio common stock and the opinion of SVB Securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The representations and warranties are, in many respects, qualified by materiality and knowledge and will not survive the merger, but their accuracy forms the basis of one of the conditions to the obligations of Sesen Bio and Carisma to complete the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will declare a dividend to its common stockholders of record consisting of (a)&#160;one CVR for each outstanding share of Sesen Bio common stock held by such stockholder as of such date, representing the right to receive contingent payments upon the occurrence of certain events as well as proceeds from any sale of Sesen Bio&#8217;s non-cash assets, as set forth in, and subject to and in accordance with the terms and conditions of, the CVR Agreement, in the form attached hereto as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;">, and (b)&#160;cash in an amount expected to be approximately $70.0&#160;million in the aggregate, subject to Sesen Bio&#8217;s estimated net cash as of the closing of the merger being greater than or equal to $75.0 million and subject to the satisfaction of certain obligations of Sesen Bio under the Merger Agreement. The record date for the pre-closing dividend shall be a date agreed upon by Carisma and Sesen Bio prior to the day on which the effective time occurs and the payment date for which shall be three business days after the effective time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the payment of such dividend may be conditioned upon the occurrence of the effective time. In connection with the pre-closing dividend, Sesen Bio shall cause the CVR Agreement to be duly authorized, executed and delivered by Sesen Bio and a rights agent selected by Sesen Bio with Carisma&#8217;s prior approval (such approval not to be unreasonably withheld, delayed or conditioned). For more information related to the CVRs, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No Solicitation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as expressly permitted by the Merger Agreement, each of Sesen Bio and Carisma agreed that during the pre-closing period, except as described below, Sesen Bio and Carisma will not, nor will either party authorize any of the directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors or representatives retained by it or any of its subsidiaries to, directly or indirectly: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of, any acquisition proposal or acquisition inquiry (each as defined below) or take any action that could reasonably be expected to lead to an acquisition proposal or acquisition inquiry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">furnish any non-public information regarding the party and its subsidiaries to any person in connection with or in response to an acquisition proposal or acquisition inquiry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">engage in discussions or negotiations with any person with respect to any acquisition proposal or acquisition inquiry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approve, endorse or recommend an acquisition proposal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">179</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">execute or enter into any letter of intent or any contract contemplating or otherwise relating to any acquisition transaction, as defined below (other than a confidentiality agreement permitted under the Merger Agreement); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">publicly propose to do any of the above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that each of Carisma and Sesen Bio will immediately cease and cause to be terminated any existing discussions, negotiations and communications with any person that relate to any acquisition proposal or acquisition inquiry as of the date of the Original Merger Agreement and request the destruction or return of any non-public information of Sesen Bio or Carisma and their respective subsidiaries, as applicable, provided to such person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An &#8220;acquisition inquiry&#8221; means, with respect to a party, an inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by Carisma or any of its affiliates, on the one hand, or Sesen Bio or any of its affiliates, on the other hand, to the other party) that could reasonably be expected to lead to an acquisition proposal, other than (i)&#160;with respect to Sesen Bio, solely with respect to an asset disposition and (ii)&#160;with respect to Carisma, solely with respect to the Carisma pre-closing financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An &#8220;acquisition proposal&#8221; means, with respect to a party, any offer or proposal, whether written or oral (other than an offer or proposal made or submitted by or on behalf of Carisma or any of its affiliates, on the one hand, or by or on behalf of Sesen Bio or any of its affiliates, on the other hand, to the other party) contemplating or otherwise relating to any acquisition transaction with such party, other than (i)&#160;with respect to Sesen Bio, solely with respect to an asset disposition and (ii)&#160;with respect to Carisma, solely with respect to the Carisma pre-closing financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An &#8220;acquisition transaction&#8221; means any transaction or series of related transactions (other than the asset disposition) involving: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (A)&#160;in which a party is a constituent entity; (B)&#160;in which a person or &#8220;group&#8221; (as defined in the Exchange Act and the rules promulgated thereunder) of persons directly or indirectly acquires beneficial or record ownership of securities representing more than 15% of the outstanding securities of any class of voting securities of a party or any of its subsidiaries; or (C)&#160;in which a party or any of its subsidiaries issues securities representing more than 15% of the outstanding securities of any class of voting securities of such party or any of its subsidiaries; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that in the case of Carisma, to the extent the Carisma pre-closing financing is effected in accordance with the terms and conditions of the Merger Agreement, the Carisma pre-closing financing shall not constitute an acquisition transaction; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or account for 15% or more of the consolidated book value or the fair market value of the assets of Sesen Bio or Carisma and their respective subsidiaries, as applicable, taken as a whole. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the foregoing, before obtaining the applicable approvals of the stockholders of Sesen Bio or Carisma required to consummate the merger, as applicable, each party may furnish non-public information regarding such party and its subsidiaries to, and enter into discussions or negotiations with, any person in response to a bona fide written unsolicited acquisition proposal by such person, which such party&#8217;s board of directors determines in good faith, after consultation with such party&#8217;s outside legal counsel and financial advisors, constitutes or is reasonably likely to result in a &#8220;superior offer,&#8221; &#8203;(as defined below) (and is not withdrawn) if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">neither such party nor any of its representative has breached the no solicitation provisions of the Merger Agreement in any material respects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">such party&#8217;s board of directors concludes in good faith, after consultation with such party&#8217;s outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties of such party&#8217;s board of directors under applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">180</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at least two business days&#8217; prior to initially furnishing any such nonpublic information to, or entering into discussions with, such person, such party gives the other party written notice of the identity of such person and of that party&#8217;s intention to furnish non-public information to, or enter into discussions with, such person ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">such party receives from the person an executed confidentiality agreement containing provisions (including nondisclosure provisions, use restrictions, non-solicitation provisions and no hire provisions) at least as favorable to such party as those contained in the confidentiality agreement between Sesen Bio and Carisma; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at least two business days prior to furnishing any non-public information to such person, such party furnishes the same non-public information to the other party (to the extent such information has not been previously furnished). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A &#8220;superior offer&#8221; means an unsolicited bona fide written acquisition proposal (with all references to 15% in the definition of acquisition transaction being treated as references to 70% for these purposes) that: (a)&#160;was not obtained or made as a direct or indirect result of a breach of (or in violation of) the Merger Agreement; (b)&#160;is on terms and conditions that the Sesen Bio board of directors or the Carisma board of directors, as applicable, determines in good faith, based on such matters that it deems relevant (including the likelihood of consummation thereof, the financing terms thereof, any termination or break-up fees and conditions to consummation), as well as any written offer by the other party to the Merger Agreement to amend the terms of the Merger Agreement, and following consultation with its outside legal counsel and financial advisors, if any, are more favorable to Sesen Bio stockholders or Carisma stockholders, as applicable, than the terms of the transaction contemplated by the Merger Agreement; (c)&#160;is not subject to any financing conditions (and if financing is required, such financing is then fully committed to the person); and (d)&#160;is reasonably capable of being completed on the terms proposed without unreasonable delay. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that each party will promptly advise the other in writing of such acquisition proposal or acquisition inquiry (including the identity of the person making or submitting such acquisition proposal or acquisition inquiry (subject to any confidentiality restrictions that may be in place between the applicable party and such person as of the date of the Original Merger Agreement), and a copy of the acquisition proposal or acquisition inquiry, or if the acquisition proposal or acquisition inquiry is not written, the terms thereof, and the material terms thereof). Each party shall keep the other party reasonably informed with respect to the status and terms of any such acquisition proposal or acquisition inquiry and any material modification or proposed material modification thereto. In addition to the foregoing, each party shall provide the other party with reasonable advance written notice of a meeting of the Sesen Bio board of directors or Carisma board of directors, as applicable, (or any committee thereof) at which such board of directors (or any committee thereof) is reasonably expected to consider an acquisition proposal or acquisition inquiry it has received. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in Board Recommendation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As described above, and subject to the provisions described below, (i)&#160;the Sesen Bio board of directors recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; all of the proposals described in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and (ii)&#160;the Carisma board of directors recommends that Carisma stockholders execute the written consent to approve the merger, the Merger Agreement, and the transactions contemplated therein, substantially in accordance with the terms of the Merger Agreement and the other agreements contemplated by the Merger Agreement. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Merger Agreement, subject to certain exceptions described below, Sesen Bio agreed that the Sesen Bio board of directors may not take any of the following actions, each of which are referred to in this proxy statement/prospectus as a Sesen Bio board of directors adverse recommendation change: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withhold, amend, withdraw or modify (or publicly propose to withhold, amend, withdraw or modify) Sesen Bio board of directors&#8217; recommendation in favor of the proposals described in this proxy statement/prospectus in a manner adverse to Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">resolve, or have any committee of the Sesen Bio board of directors resolve, to withhold, amend, withdraw or modify the Sesen Bio board of directors&#8217; recommendation in favor of the proposals described in this proxy statement/prospectus in a manner adverse to Carisma; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">181</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any acquisition proposal shall be adopted or proposed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, notwithstanding the foregoing, at any time prior to the approval of the proposals to be considered at the Sesen Bio special meeting by the required Sesen Bio stockholder vote, if Sesen Bio has received a bona fide written superior offer, the Sesen Bio board of directors may make a Sesen Bio board of directors adverse recommendation change if, but only if, following the receipt of and on account of such superior offer: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Sesen Bio board of directors recommendation would constitute a violation of the Sesen Bio board of directors&#8217; fiduciary duties under applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio has, and has caused its financial advisors and outside legal counsel to, during the required four business day notice period, or the required notice period, negotiate with Carisma in good faith to make such adjustments to the terms and conditions of the Merger Agreement so that such acquisition proposal ceases to constitute a superior offer; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if after Carisma shall have delivered to Sesen Bio a written offer to alter the terms or conditions of the Merger Agreement during the required notice period, the Sesen Bio board of directors shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Sesen Bio board of directors recommendation would constitute a violation of the Sesen Bio board of directors&#8217; fiduciary duties under applicable law (after taking into account such alterations of the terms and conditions of the Merger Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that (x)&#160;Carisma receives written notice from Sesen Bio confirming that the Sesen Bio board of directors has determined to change its recommendation during the required notice period, which notice shall include a description in reasonable detail of the reasons for such Sesen Bio board of directors adverse recommendation change, and written copies of any relevant transaction with any party making a potential superior offer, (y)&#160;during any required notice period, Carisma shall be entitled to deliver to Sesen Bio one or more counterproposals to such acquisition proposal and Sesen Bio will, and will cause its representatives to, negotiate with Carisma in good faith (to the extent Carisma desires to negotiate) to make such adjustments in the terms and conditions of the Merger Agreement so that the applicable acquisition proposal ceases to constitute a superior offer, and (z)&#160;in the event of any material amendment to any superior offer (including any revision in the amount, form or mix of consideration the Sesen Bio stockholders would receive as a result of such potential superior offer), Sesen Bio shall be required to provide Carisma with notice of such material amendment and the required notice period shall be extended, if applicable, to ensure that at least two business days remain in the required notice period following such notification during which the parties shall comply again with the requirements in this provision and the Sesen Bio board of directors shall not make a Sesen Bio board of directors adverse recommendation change prior to the end of such notice period so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Merger Agreement, subject to certain exceptions described below, Carisma agreed that the Carisma board of directors may not take any of the following actions, each of which are referred to in this proxy statement/prospectus as a Carisma board of directors adverse recommendation change: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdraw or modify (or publicly propose to withdraw or modify) the Carisma board of directors recommendation in a manner adverse to Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">resolve or have any committee of the Carisma board of directors withdraw or modify the Carisma board of directors recommendation in a manner adverse to Sesen; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any acquisition proposal shall be adopted or proposed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, notwithstanding the foregoing, at any time prior to the approval and adoption of the Merger Agreement by the required Carisma stockholder vote, if Carisma has received a bona fide written superior offer, the Carisma board of directors may make a Carisma board of directors adverse recommendation change if, but only if, following the receipt of and on account of such superior offer: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">182</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Carisma board of directors determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Carisma board of directors recommendation would constitute a violation of the Carisma board of directors&#8217; fiduciary duties under applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma has, and has caused its financial advisors and outside legal counsel to, during the required notice period, negotiate with Sesen Bio in good faith to make such adjustments to the terms and conditions of the Merger Agreement so that such acquisition proposal ceases to constitute a superior offer; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if after Sesen Bio shall have delivered to Carisma a written offer to alter the terms or conditions of the Merger Agreement during the required notice period, the Carisma board of directors shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Carisma board of directors recommendation would constitute a violation of the Carisma board of directors&#8217; fiduciary duties under applicable law (after taking into account such alterations of the terms and conditions of the Merger Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (x)&#160;Sesen Bio receives written notice from Carisma confirming that the Carisma board of directors has determined to change its recommendation at least four business days in advance of the Carisma board of directors adverse recommendation change, which notice shall include a description in reasonable detail of the reasons for such Carisma board of directors adverse recommendation change, and written copies of any relevant transaction agreements with any party making a potential superior offer, (y)&#160;during any required notice period, Sesen Bio shall be entitled to deliver to Carisma one or more counterproposals to such acquisition proposal and Carisma will, and cause its representatives to, negotiate with Sesen Bio in good faith (to the extent Sesen Bio desires to negotiate) to make such adjustments in the terms and conditions of the Merger Agreement so that the applicable acquisition proposal ceases to constitute a superior offer, and (z)&#160;in the event of any material amendment to any superior offer (including any revision in the amount, form or mix of consideration Carisma stockholders would receive as a result of such potential superior offer), Carisma shall be required to provide Sesen Bio with notice of such material amendment and the required notice period shall be extended, if applicable, to ensure that at least two business days remain in the notice period following such notification during which the parties shall comply again with the requirements in this provision and the Carisma board of directors shall not make a Carisma board of directors adverse recommendation change prior to the end of such notice period as so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Meetings of Sesen Bio stockholders; Consent of Carisma stockholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is obligated under the Merger Agreement to call, give notice of and hold the Sesen Bio special meeting for the purposes of considering the approval of, among the other items noted herein, the amendment of the Sesen Bio Certificate of Incorporation to effect the proposed reverse stock split, the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the transactions contemplated under the Merger Agreement and change of control of Sesen Bio resulting therefrom, and the equity plan amendment proposals. Carisma is obligated under the Merger Agreement to obtain the written consent of its stockholders sufficient to adopt the Merger Agreement and approve the merger and related transactions and deliver to Sesen Bio such written consent within five business days following the registration statement on Form S-4, of which this proxy statement/prospectus is a part, being declared effective by the SEC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Covenants; Conduct of Business Pending the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as expressly permitted by the Merger Agreement, as required by applicable law, in connection with any COVID-19 measures of COVID-19 response, or unless Carisma shall have otherwise consented in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the pre-closing period, Sesen Bio will and will cause its subsidiaries to, (i)&#160;use commercially reasonable efforts to conduct its business and operations in the ordinary course of business and (ii)&#160;conduct its business and operations in compliance in all material respects with all applicable laws, including timely making all filings required by the SEC, and the requirements of certain material contracts. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">183</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has also agreed that, except as expressly permitted by the Merger Agreement, as required by applicable law, in connection with the asset disposition and the pre-closing dividend, in connection with any COVID-19 measures or COVID-19 response, or for certain limited exceptions with the prior written consent of Carisma (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the pre-closing period, it will not, nor shall it cause or permit its subsidiaries to, do any of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with the payment of the exercise price and/or withholding taxes incurred upon the exercise of any Sesen Bio option or vesting of Sesen Bio RSUs in accordance with the terms of such award in effect on the date of the Original Merger Agreement); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell, issue, grant, pledge, or otherwise dispose of or encumber or authorize the issuance of: any capital stock or other security of Sesen Bio (except for Sesen Bio common stock issued upon the valid exercise or settlement of outstanding Sesen Bio options, Sesen Bio warrants or the vesting of Sesen Bio RSUs, as applicable, in accordance with their terms as in effect as of the date of the Original Merger Agreement); any option, warrant or right to acquire any capital stock or any other security; or any other instrument convertible into or exchangeable for any capital stock or other security of Sesen Bio or any of its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">amend the organizational documents of Sesen Bio or any of its subsidiaries, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split, or similar transaction except, for the avoidance of doubt, the transactions contemplated under the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">form any subsidiary or acquire any equity interest, or other interest in any other entity, or enter into any joint venture with any other entity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) lend money to any person, (B)&#160;incur or guarantee any indebtedness for borrowed money, issue or sell any debt securities or options, warrants, call or other rights to acquire any debt securities, (C)&#160;guarantee any debt securities of others, or (D)&#160;make any capital expenditure or commitment in excess of $250,000; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">other than as required by applicable law or by the terms of a Sesen Bio employee plan as in effect on the date of the Original Merger Agreement and disclosed in certain sections of the confidential disclosure schedules, adopt, terminate, establish or enter into any Sesen Bio employee plan; cause or permit any Sesen Bio employee plan to be amended in any material respect; pay any bonus or make any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, benefits or other compensation or remuneration payable to, any current or former employee, independent contractor, officer or director of Sesen Bio or any of its subsidiaries; or increase or otherwise modify the severance, retention or change of control benefits offered to any current or former employee, independent contractor, officer or director of Sesen Bio or any of its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any contract with a labor union, labor organization, or similar person except as otherwise required by applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) hire or engage, or offer to hire, any director, officer, employee or consultant, or (B)&#160;enter into, amend or extend the term of any employment or consulting agreement with any current or former employee, independent contractor, officer or director of Sesen Bio or any of its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any material transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any encumbrance with respect to such assets or properties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make, change or revoke any material tax election, file any material amended tax return, settle or compromise any income or other material tax liability, enter into any tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial contracts entered into in the ordinary course of business the principal subject matter of which is not </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">184</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material taxes (other than pursuant to an extension of time to file any tax return granted in the ordinary course of business of not more than six&#160;months), or change any material accounting method in respect of taxes; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) sell, assign, transfer, allow to lapse or expire, pledge, abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of Sesen Bio or any of its subsidiaries in any material Sesen Bio intellectual property, or (B)&#160;license, sublicense or otherwise encumber (other than pursuant to a non-exclusive license granted to contract research organizations, including clinical trial sites and clinical trial services provides, or contract manufacturing organizations, in each case, (x)&#160;with whom Sesen Bio or any of its subsidiaries has previously entered into contracts prior to the effective time and (y)&#160;who are engaged to provide services directly related to clinical studies and manufacturing of any product candidate of Sesen Bio, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that the scope of any such non-exclusive license grant is limited to only the extent necessary for such persons to perform their obligations under the respective contracts) any right, title or interest of Sesen Bio or any of its subsidiaries in any material Sesen Bio intellectual property; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into, amend or terminate certain material contracts (or any contract that would have been a material contract if in effect on or prior to the date of the Original Merger Agreement); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) materially change pricing or royalties or other payments set or charged by Sesen Bio or any of its subsidiaries to its customers or licensees or (B)&#160;agree to materially change pricing or royalties or other payments set or charged by persons who have licensed intellectual property rights to Sesen Bio or any of its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make any expenditures, incur any liabilities or discharge or satisfy any liabilities, in each case, other than those expenditures or liabilities that will not survive the closing of the merger, are discharged or satisfied prior to the closing of the merger, and/or are taken into account in the calculation of net cash; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">waive, settle or compromise any pending or threatened legal proceeding against Sesen Bio or any of its subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any restriction on the operations or business of Sesen Bio or its subsidiaries (nor on Carisma or any of its subsidiaries, from and after the closing of the merger), (2)&#160;involve any equitable relief and (3)&#160;do not involve admission of any wrongdoing by Sesen Bio or any of its subsidiaries; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">agree, resolve, or commit to do any of the foregoing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the generality of the foregoing, nothing set forth above shall restrict (i)&#160;Sesen Bio or any of its subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 measures or otherwise take any COVID-19 response and (ii)&#160;Sesen Bio&#8217;s right to effectuate one or more asset dispositions or the pre-closing dividend, each on the on the terms and subject to the applicable limitations set forth in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has agreed that, except as expressly permitted by the Merger Agreement, as required by applicable law, in connection with any COVID-19 measures or COVID-19 response, or unless Sesen Bio shall have otherwise consented in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the pre-closing period, each of Carisma and its subsidiaries will (i)&#160;use commercially reasonable efforts to conduct its respective business and operations in the ordinary course of business and (ii)&#160;conduct its business and operations in compliance in all material respects with all applicable laws and the requirements of certain material contracts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has also agreed that, except (i)&#160;as expressly permitted in the Merger Agreement, as required by applicable law, in connection with any COVID-19 measures or COVID-19 response, or with the prior written consent of Sesen Bio (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the pre-closing period, it will not, nor will it cause or permit any of its subsidiaries to, do any of the following: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">185</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of capital stock or other securities (except in connection with the payment of the exercise price and/or withholding taxes incurred upon the exercise of any Carisma option in accordance with the terms of such award in effect on the date of the Original Merger Agreement); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">except as contemplated by the Carisma pre-closing financing or the conversion of the Carisma convertible note, sell, issue, grant, pledge, or otherwise dispose of or encumber or authorize the issuance of: any capital stock or other security of Carisma or any of its subsidiaries (except for shares of outstanding Carisma common stock issued upon the valid exercise or settlement of Carisma options in accordance with their terms as in effect as of the date of the Original Merger Agreement); any option, warrant or right to acquire any capital stock or any other security, other than options grants to employees and service providers in the ordinary course of business; or any other instrument convertible into or exchangeable for any capital stock or any other security of Carisma or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">amend the organizational documents of Carisma or its subsidiaries, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split, or similar transaction except, for the avoidance of doubt, the transactions contemplated under the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">form any subsidiary or acquire any equity interest, or other interest in any other entity or enter into a joint venture with any other entity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(A) lend money to any person (except for the advancement of reasonable expenses to employees, directors and consultants in the ordinary course of business), (B)&#160;incur or guarantee any indebtedness for borrowed money, other than in the ordinary course of business, (C)&#160;guarantee any debt securities of others or (D)&#160;except as contemplated by Carisma&#8217;s capital expenditure budget and operating budget made available to Sesen Bio, make any capital expenditure or commitment in excess of $350,000; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any encumbrance with respect to such assets or properties, except in the ordinary course of business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell, assign, license, sublicense, transfer, allow to lapse or expire, pledge abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of Carisma or any of its subsidiaries in any material Carisma intellectual property rights (other than pursuant to a non-exclusive license in the ordinary course of business); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make, change or revoke any material tax election, file any material amended tax return, settle or compromise any income or other material tax liability, enter into any tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial contracts entered into in the ordinary course of business the principal subject matter of which is not taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material taxes (other than pursuant to an extension of time to file any tax return granted in the ordinary course of business of not more than six&#160;months), or change any material accounting method in respect of taxes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into, materially amend or terminate any Carisma material contract (or any contract that would have been a Carisma material contract if in effect on or prior to the date of the Original Merger Agreement) other than in the ordinary course of business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">waive, settle or compromise any pending or threatened legal proceeding against Carisma or any of its subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any material restriction on the operations or business of Carisma or its subsidiaries (nor, following the closing of the merger, on Sesen Bio or any of its subsidiaries), (2)&#160;involve any equitable relief and (3)&#160;involve admission of any wrongdoing by Carisma or any of its subsidiaries; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">186</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">agree, resolve or commit to do any of the foregoing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the generality of the foregoing, nothing set forth above shall restrict Carisma or any of its subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 measures or otherwise take any COVID-19 response. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each of Sesen Bio and Carisma has agreed to use its commercially reasonable efforts to cause to be taken all actions necessary to consummate the merger and the other transactions contemplated by the Merger Agreement. In connection therewith, each party has agreed to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">file or otherwise submit all applications and notices required to be filed in connection with the merger and the other transactions contemplated by the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">use reasonable best efforts to lift any injunction prohibiting, or any other legal bar to, the merger or the other transactions contemplated by the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">use commercially reasonable efforts to resolve the matters set forth on a schedule without any material continuing obligation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">use commercially reasonable efforts to satisfy the conditions precedent to the consummation of the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, Sesen Bio and Carisma have further agreed that Sesen Bio will use its commercially reasonable efforts to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintain its existing listing of its common stock on Nasdaq and to obtain approval for listing of the combined company on Nasdaq; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if required by the rules and regulations of Nasdaq, to prepare and submit to Nasdaq a notification form for the listing of the shares of Sesen Bio common stock to be issued in connection with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prepare and timely submit to Nasdaq a notification form of the proposed reverse stock split and to submit a copy of the amendment to Sesen Bio&#8217;s certificate of incorporation to effect the proposed reverse stock split, certified by the Secretary of State of the State of Delaware to Nasdaq on the date of closing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if required by Nasdaq Listing Rule&#160;5110, to file an initial listing application for Sesen Bio common stock on Nasdaq and to cause such listing application to be approved; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in the event of receipt of a Nasdaq delisting determination, Sesen Bio will request a hearing to appeal the delisting determination and will pay the appropriate fee to Nasdaq to appeal the delisting determination. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification and Insurance for Directors and Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Merger Agreement, from the effective time through the sixth anniversary of the date on which the effective time occurs, each of Sesen Bio and the surviving corporation will, jointly and severally, indemnify and hold harmless each person who is now, or has been at any time prior to the date of the Original Merger Agreement, or who becomes prior to the effective time, a director, officer, fiduciary or agent of Sesen Bio or Carisma and their respective subsidiaries, respectively, the indemnified parties, against all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or completed proceeding arising out of or pertaining to the fact that the indemnified party is or was an indemnified party, whether asserted or claimed prior to, at or after the effective time, in each case, to the fullest extent permitted under applicable law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each indemnified party will also be entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation from each of Sesen Bio and the surviving corporation, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">187</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMAER10">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">jointly and severally, upon receipt by Sesen Bio or the surviving corporation from the indemnified party of a request therefor; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such person to whom expenses are advanced provides an undertaking to Sesen Bio, to the extent then required by the DGCL, to repay such advances if it is ultimately determined that such person is not entitled to indemnification </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that the provisions of Sesen Bio&#8217;s organizational documents with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Sesen Bio that are presently set forth in the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws shall not be amended, modified or repealed for a period of six&#160;years from the effective time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the effective time, were officers or directors of Sesen Bio, unless such modification is required by applicable law. The certificate of incorporation and bylaws of the surviving corporation shall contain, and Sesen Bio shall cause the certificate of incorporation and bylaws of the surviving corporation to so contain, provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers as those presently set forth in the Carisma Certificate of Incorporation and the Carisma Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From and after the effective time, (i)&#160;the surviving corporation shall fulfill and honor, and Sesen Bio shall cause the surviving corporation to fulfill and honor, in all respects the obligations of Carisma to its indemnified parties as of immediately prior to the closing of the merger pursuant to any indemnification provisions under Carisma&#8217;s organizational documents and pursuant to any indemnification agreements between Carisma and such indemnified parties, with respect to claims arising out of matters occurring at or prior to the effective time and (ii)&#160;Sesen Bio shall fulfill and honor in all respects the obligations of Sesen Bio to its indemnified parties as of immediately prior to the closing of the merger pursuant to any indemnification provisions under Sesen Bio&#8217;s organizational documents and pursuant to any indemnification agreements between Sesen Bio and such indemnified parties, with respect to claims arising out of matters occurring at or prior to the effective time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From and after the effective time, Sesen Bio will maintain director and officers&#8217; liability insurance policies, with an effective date as of the date of closing, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Sesen Bio. In addition, prior to the effective time, Sesen Bio will secure and purchase a six-year prepaid &#8220;tail policy&#8221; through Sesen Bio&#8217;s recognized broker of record for the non-cancellable extension on Sesen Bio&#8217;s existing directors&#8217; and officers&#8217; liability insurance policy with limits of liability no less than $20.0&#160;million, in each case. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement may be terminated at any time prior to the effective time (whether before or after the required Carisma stockholder vote and the required Sesen Bio stockholder vote) have been obtained, unless otherwise specified below: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by mutual written consent of Sesen Bio and Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by either Sesen Bio or Carisma if the transactions contemplated by the Merger Agreement shall not have been consummated by January&#160;31, 2023 (subject to possible extension as provided in the Merger Agreement), or the end date</font><font style="font-style:italic;letter-spacing:0.2pt;">; provided</font><font style="letter-spacing:0.2pt;">, however, that this right to terminate the Merger Agreement will not be available to any party whose action or failure to act has been a principal cause of the failure of the transactions contemplated by the Merger Agreement to occur on or before the end date and such action or failure to act constitutes a breach of the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, further, however, that, in the event that a request for additional information has been made by any governmental body, or in the event that the SEC has not declared effective under the Securities Act the registration statement by the date which is 60&#160;days prior to the end date, then either Carisma or Sesen Bio shall be entitled to extend the end date to the date that is 60&#160;days after the date that the SEC has declared effective the registration statement under the Securities Act, but in any event no more than 60&#160;days after the original end date, by written notice to the other party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by either Sesen Bio or Carisma if a court of competent jurisdiction or other governmental body has issued a final and non-appealable order, decree or ruling or has taken any other action, having </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">188</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the effect of permanently restraining, enjoining or otherwise prohibiting the merger or any of the other transactions contemplated by the Merger Agreement; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by Sesen Bio if Carisma stockholder written consent evidencing the required Carisma stockholder vote has not been obtained within ten business days of the registration statement, of which this proxy statement/prospectus is a part, becoming effective; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however,</font><font style="letter-spacing:0.2pt;"> that once such vote has been obtained, Sesen Bio may not terminate the Merger Agreement pursuant to this provision; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by either Sesen Bio or Carisma if the Sesen Bio special meeting shall have been held and completed and the Sesen Bio stockholders shall have taken a final vote and shall not have approved Proposal Nos. 1 and 2 at the Sesen Bio special meeting; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, however, that the right to terminate the Merger Agreement pursuant to this provision will not be available to Sesen Bio if Sesen Bio&#8217;s actions or failure to act has been a principal cause of the failure to obtain the required Sesen Bio stockholder vote and such action or failure to act constitutes a breach by Sesen Bio of the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by Carisma, at any time prior to the required Sesen Bio stockholder vote being obtained, if any of the following circumstances shall occur, each of the following, a Sesen Bio triggering event: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio has failed to include in the proxy statement/prospectus the Sesen Bio board of directors recommendation or has made a Sesen Bio adverse recommendation change; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors, or any committee thereof, had publicly approved, endorsed or recommended any acquisition proposal; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into any letter of intent or similar document relating to any acquisition proposal (other than a confidentiality agreement permitted under the Merger Agreement); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by Sesen Bio, at any time prior to the required Carisma stockholder vote being obtained, if any of the following circumstances shall occur, each a Carisma triggering event: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Carisma board of directors has made a Carisma board of directors adverse recommendation change; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Carisma board of directors, or any committee thereof, has publicly approved, endorsed or recommended any acquisition proposal; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma has entered into any letter of intent or similar document relating to any acquisition proposal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by Carisma, upon a breach of any representation, warranty, covenant or agreement set forth in the Merger Agreement by Parent or Merger Sub or if any representation or warranty of Sesen Bio or Merger Sub has become inaccurate, in either case such that certain closing conditions would not be satisfied as of time of such breach or inaccuracy; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that Carisma is not then in material breach of any representation, warranty covenant or agreement under the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that if such breach or inaccuracy is curable by the end date by Parent or Merger Sub, then the Merger Agreement will not terminate pursuant to this provision as a result of such particular breach or inaccuracy until the expiration of a 30-day period commencing upon delivery of written notice from Carisma to Sesen Bio or Merger Sub of such breach or inaccuracy and Carisma&#8217;s intention to terminate pursuant to this provision (it being understood that the Merger Agreement will not terminate pursuant to this provision as a result of such particular breach or inaccuracy if such breach by Sesen Bio or Merger Sub is cured prior to such termination becoming effective); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by Sesen Bio, upon a breach of any representation, warranty, covenant or agreement set forth in the Merger Agreement by Carisma or if any representation or warranty of Carisma has become inaccurate, in either case such that certain closing conditions would not be satisfied as of time of such breach or inaccuracy; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that Sesen Bio is not then in material breach of any representation, warranty covenant or agreement under the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, further</font><font style="letter-spacing:0.2pt;">, that if such breach or inaccuracy is curable by the end date by Carisma, then the Merger Agreement will not terminate pursuant to this provision as a result of a particular breach or inaccuracy until </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">189</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTERFEE123">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the expiration of a 30-day period commencing upon delivery of written notice from Sesen Bio to Carisma of such breach or inaccuracy and Sesen Bio&#8217;s intention to terminate pursuant to this provision (it being understood that the Merger Agreement will not terminate pursuant to this provision as a result of such particular breach or inaccuracy if such breach by Carisma is cured prior to such termination becoming effective). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination Fee</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fee payable by Sesen Bio</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio must pay Carisma a termination fee of $7.6&#160;million if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Merger agreement is terminated by Sesen Bio or Carisma pursuant to clause (b)&#160;above (and the required Sesen Bio stockholder vote has not been obtained by Sesen Bio) or clause (e)&#160;above; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at any time after the date of the Original Merger Agreement and prior to the Sesen Bio special meeting, an acquisition proposal with respect to Sesen Bio shall have been publicly announced or disclosed or otherwise communicated to Sesen Bio or the Sesen Bio board of directors (and shall not have been withdrawn); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">within 12&#160;months after the date of such termination, Sesen Bio consummates any subsequent transaction that is an acquisition transaction; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Merger Agreement is terminated by Carisma pursuant to clause (f)&#160;above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Merger Agreement is terminated pursuant to clause (iv)&#160;above by Carisma, then Sesen Bio will pay the termination fee to Carisma within two business days of such termination. If the Merger Agreement is terminated by either Carisma or Sesen Bio pursuant to clause (e)&#160;above or by Carisma pursuant to clauses (f)&#160;or (h)&#160;above, then Sesen Bio shall reimburse Carisma for all reasonable out of pocket fees and expenses incurred by Carisma in connection with the Merger Agreement and the transactions contemplated thereby, up to a maximum of $1.75&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fee payable by Carisma</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma must pay Sesen Bio a termination fee of $5.49&#160;million if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Merger agreement is terminated by Sesen Bio pursuant to clause (b)&#160;above (and the required Carisma stockholder vote has not been obtained by Carisma) or clause (d)&#160;above; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at any time after the date of the Original Merger Agreement and before obtaining the required Carisma stockholder vote, an acquisition proposal with respect to Carisma shall have been publicly announced or disclosed or otherwise communicated to Carisma or the Carisma board of directors (and shall not have been withdrawn); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">within 12&#160;months after the date of such Merger Agreement termination, Carisma consummates any subsequent transaction that is an acquisition transaction; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Merger Agreement is terminated by Sesen Bio pursuant to clause (g)&#160;above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the Merger Agreement is terminated pursuant to clause (iv)&#160;above by Sesen Bio, then Carisma will pay the termination fee to Sesen Bio within two business days of such termination. If the Merger Agreement is terminated by Sesen Bio pursuant to clauses (d), (g), or (i)&#160;above, then Carisma shall reimburse Sesen Bio for all reasonable out of pocket fees and expenses incurred by Sesen Bio in connection with the Merger Agreement and the transactions contemplated thereby, up to a maximum of $1.75&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement may be amended by the parties at any time if such amendment is in writing, is approved by the boards of directors of each party to the Merger Agreement and is signed by each party to the Merger Agreement; provided, however, that after any approval of the Merger Agreement by a party&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">190</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:440pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">stockholders, no amendment will be made which by law requires further approval by such stockholders without the further approval of such stockholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fees and Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides all fees and expenses incurred in connection with the Merger Agreement and the transactions contemplated thereby shall be paid by the party incurring such expenses, except as described above in the section entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Termination Fee</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTERFEE123">190</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, and except that Sesen Bio and Carisma will share equally in any fees and expenses, other than attorneys&#8217; and accountants&#8217; fees and expenses, incurred in relation to the filings by the parties to the Merger Agreement under any filing requirement under antitrust or merger control laws applicable to the Merger Agreement and the transactions contemplated therein. Sesen Bio and Carisma shall also share equally all fees and expenses incurred in relation to (i)&#160;the printing and filing with the SEC of the registration statement on Form S-4, of which this proxy statement/prospectus is a part, and any amendments or supplements thereto and paid to a financial printer or the SEC and (ii)&#160;those filings with Nasdaq contemplated by the Merger Agreement. </font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">191</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tARTT">&#8203;</a><a name="tCVAG">&#8203;</a><a name="tMFIT5">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENTS RELATED TO THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CVR Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will enter into the CVR Agreement with a rights agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement and the CVR Agreement, for each share of Sesen Bio common stock held after giving effect to the proposed reverse stock split if approved and implemented, Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive one CVR. Each CVR will entitle such Sesen Bio stockholder to receive (i) a pro&#160;rata portion of the $30.0&#160;million milestone payment to be made by Roche to Sesen Bio upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with legacy IL-6 antagonist antibody technology previously owned by Sesen Bio for a certain indication if initiated prior to December&#160;31, 2026, pursuant to the Roche Asset Purchase Agreement, less certain permitted deductions and (ii) a pro rata portion of the proceeds from any sale of Sesen Bio&#8217;s non-cash assets existing as of the date of the Original Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The CVR Agreement also provides that neither Sesen Bio, nor its affiliates, may, without the prior written consent of holders of at least 33% of the then-outstanding CVRs: (i)&#160;amend, restate, supplement, terminate or otherwise modify the Roche Asset Purchase Agreement in a manner materially adversely affecting the holders&#8217; rights under the CVR Agreement; (ii)&#160;in the event that Roche fails to make the milestone payment at the time rightfully due and payable, take action with respect to, or unreasonably waive or fail to enforce, the right to receive the applicable payments which are rightfully due and payable under the Roche Asset Purchase Agreement, in a manner materially adversely affecting the holders&#8217; rights under the CVR Agreement; or (iii)&#160;agree to any of the foregoing. Further, during the period between signing the CVR Agreement and December 31, 2023, Sesen Bio agreed to use commercially reasonable efforts to effectuate a disposition of any and all assets, tangible and intangible related to Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, including the negotiation and execution of a sale agreement and completion of the transactions contemplated thereby. Further, Sesen Bio agreed not to take any actions for the primary purpose of frustrating the payment of CVR payments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The sole right of the holders of the CVRs is to receive cash from Sesen Bio, if any, through the rights agent in accordance with the CVR Agreement. The CVRs are not transferable, except in certain limited circumstances, will not be certificated or evidenced by any instrument and will not be registered with the SEC or listed for trading on any exchange. The CVRs will not have any voting or dividend rights, will not represent any equity or ownership interest in Sesen Bio or its subsidiaries, and interest will not accrue on any amounts payable on the CVRs. The CVR Agreement will be effective prior to the closing of the merger and will continue in effect until the earlier of (i) March&#160;31, 2027 for the Roche payments or December 31, 2023 for the payment of any proceeds from the sale of Sesen Bio&#8217;s legacy assets and (ii) the payment of all amounts payable thereunder, unless and until earlier terminated upon termination of the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The foregoing description of the CVR Agreement does not purport to be complete and is qualified in its entirety by the full text of the form of CVR Agreement, which is included in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio stockholders who receive CVRs with respect to Sesen Bio common stock, but this discussion does not purport to be a complete analysis of all potential tax consequences that may be relevant to a Sesen Bio stockholder. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Sesen Bio U.S. holder. Sesen Bio has not sought and does not intend to seek any opinions of counsel or rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of the receipt of CVRs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">192</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMUFI3">&#8203;</a><a name="tSBUH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Sesen Bio U.S. holders that hold Sesen Bio common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a Sesen Bio U.S. holder&#8217;s particular circumstances, including the impact of the alternative minimum tax or the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code. In addition, it does not address consequences relevant to Sesen Bio U.S. holders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons holding Sesen Bio common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">banks, insurance companies, and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons subject to special tax accounting rules as a result of any item of gross income with respect to Sesen Bio common stock being taken into account in an &#8220;applicable financial statement&#8221; &#8203;(as defined in the Code); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons deemed to sell Sesen Bio common stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons who hold or received Sesen Bio common stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Sesen Bio common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Sesen Bio common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT HOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE RECEIPT OF CVRs ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Sesen Bio U.S. holder&#8221; is a beneficial owner of Sesen Bio common stock that, for U.S. federal income tax purposes, is or is treated as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an individual who is a citizen or resident of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a corporation created or organized under the laws of the U.S., any state thereof, or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a trust that (i)&#160;is subject to the primary supervision of a U.S. court and the control of one or more &#8220;United States persons&#8221; &#8203;(within the meaning of Section&#160;7701(a)(30) of the Code) over all of its </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">193</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tALTERT3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">substantial decisions or (ii)&#160;has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Sesen Bio non-U.S. holder&#8221; means a beneficial owner of Sesen Bio common stock that is neither a Sesen Bio U.S. holder nor a partnership (or other entity treated as a partnership) for U.S. federal income tax purposes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Alternative Treatment of the Receipt of CVRs and the Proposed Reverse Stock Split as a Single Recapitalization </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the proposed reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code that is separate from Sesen Bio&#8217;s distribution of the CVRs and the special cash dividend. Notwithstanding that Sesen Bio will report the receipt of CVRs, the receipt of the special cash dividend, and the proposed reverse stock split as separate transactions, it is possible that the IRS or a court could determine that the receipt of the CVRs or the special cash dividend, and the proposed reverse stock split constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. In such case, the tax consequences of the receipt of CVRs and the proposed reverse stock split would differ from those described below and would depend in part on many of the same considerations described below, including whether the CVRs should be treated as property, equity or debt instruments or should be subject to the &#8220;open transaction&#8221; doctrine. In general, if the CVRs are treated as property and are not subject to the &#8220;open transaction&#8221; doctrine, and the receipt of the CVRs, the special cash dividend, and the proposed reverse stock split constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes, then a Sesen Bio stockholder should recognize gain (but not loss) equal to the lesser of (i)&#160;the fair market value of the CVRs received plus the amount of the special cash dividend, and (ii)&#160;the excess (if any) of (A)&#160;the sum of (1)&#160;the fair market value of the CVRs received plus the amount of the special cash dividend and (2)&#160;the fair market value of the Sesen Bio shares received in the proposed reverse stock split over (B)&#160;the Sesen Bio stockholder&#8217;s adjusted tax basis in the Sesen Bio common stock surrendered in the proposed reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Receipt of CVRs by Sesen Bio U.S. holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion assumes that the distribution of CVRs and the special cash dividend to Sesen Bio U.S. holders will be treated for U.S. federal income tax purposes as transactions that are separate and distinct from the proposed reverse stock split. If, contrary to that assumption, the distribution of CVRs to Sesen Bio U.S. holders were integrated for tax purposes with the proposed reverse stock split, this could affect the calculation of the extent to which the distribution constitutes a taxable dividend or capital gain. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There is substantial uncertainty as to the tax treatment of the CVRs. Specifically, there is no authority directly addressing whether contingent value rights with characteristics similar to the CVRs should be treated as a distribution of property with respect to Sesen Bio common stock, a distribution of equity, a &#8220;debt instrument&#8221; or an &#8220;open transaction&#8221; for U.S. federal income tax purposes. As a result, it is not possible to express a definitive conclusion as to the U.S. federal income tax treatment of receipt of the CVRs or receipt of any payments pursuant to the CVRs. Based on the specific characteristics of the CVRs, Sesen Bio intends to treat the issuance of the CVRs as a distribution of property with respect to its stock. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any description of the intended tax consequences summarized below. No opinion of counsel or ruling has been or will be sought from the IRS regarding the tax treatment of the CVRs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Provided that the issuance of the CVRs is treated as a distribution of property with respect to Sesen Bio common stock, each Sesen Bio U.S. holder should be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes and after taking into account the special cash dividend as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining value. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of this distribution to be treated as other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">194</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">than a dividend for U.S. federal income tax purposes. Sesen Bio U.S. holders will receive a Form 1099-DIV notifying them of the portion of the CVR value that is treated as a non-dividend distribution (or a dividend to the extent of Sesen Bio&#8217;s earnings and profits) for U.S. federal income tax purposes. Although Sesen Bio will estimate the value of the CVRs for purposes of reporting on Form 1099 to Sesen Bio U.S. holders, the value of the CVRs is uncertain and the IRS or a court could determine that the value of the CVRs at the time of issuance was higher. In such case the Sesen Bio U.S. holders could be treated as having additional income or gain upon receipt of the CVRs as described above. A Sesen Bio U.S. holder&#8217;s initial tax basis in such holder&#8217;s CVRs should equal the fair market value of such CVRs on the date of their issuance. The holding period of such CVRs should begin on the day after the date of issuance. Future payments received by a Sesen Bio U.S. holder with respect to a CVR would likely be treated as a non-taxable return of such Sesen Bio U.S. holder&#8217;s adjusted tax basis in the CVR to the extent thereof, and payments in excess of such amount would likely be treated as ordinary income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, the treatment of the future payments, if any, pursuant to the CVRs is uncertain and alternative treatments are possible, although not expected. One such possible treatment is that the CVRs could be treated as one or more &#8220;debt instruments.&#8221; If that were to be the case, then the payments, if any, received with respect to the CVRs would likely be treated as payments in retirement of a &#8220;debt instrument,&#8221; except to the extent interest is imputed under complex rules under the Code. In such a case, a Sesen Bio U.S. holder would be required to include any such interest in income on an annual basis, whether or not currently paid. As discussed above, Sesen Bio does not intend to report the issuance of the CVRs as a distribution of a &#8220;debt instrument&#8221; for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is also possible that the issuance of the CVRs could be treated as a distribution of equity for U.S. federal income tax purposes, in which case Sesen Bio U.S. holders should not recognize gain or loss as a result of the issuance of the CVRs. Each Sesen Bio U.S. holder&#8217;s tax basis in such holder&#8217;s Sesen Bio common stock would be allocated between such holder&#8217;s Sesen Bio common stock and such holder&#8217;s CVRs. The holding period of such CVRs should include the Sesen Bio U.S. holder&#8217;s holding period of such holder&#8217;s Sesen Bio common stock. The future payments, if any, on a CVR received by a Sesen Bio U.S. holder could be treated as dividends to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits at the time of such payments (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in the CVR, and finally as capital gain from the sale or exchange of the CVR with respect to any remaining amount. As discussed above, Sesen Bio does not intend to report the issuance of the CVRs as a distribution of equity for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is also possible that the issuance of the CVRs could be treated as subject to the &#8220;open transaction&#8221; doctrine if the value of the CVRs at closing cannot be &#8220;reasonably ascertained.&#8221; If the receipt of CVRs were treated as an &#8220;open transaction&#8221; for U.S. federal income tax purposes, each Sesen Bio U.S. holder should not immediately take the CVRs into account in determining whether such holder must recognize income or gain, if any, on the receipt of the CVRs and such holder would not take any tax basis in the CVRs. Rather, the Sesen Bio U.S. holder&#8217;s U.S. federal income tax consequences would be determined in line with the discussion above based on whether the CVRs are treated as a distribution of property or of equity at the time the payments, if any, with respect to the CVRs is received or deemed received in accordance with the Sesen Bio U.S. holder&#8217;s regular method of accounting. As discussed above, Sesen Bio does not intend to report the issuance of the CVRs as an open transaction for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The CVRs should generally be treated as capital assets for U.S. federal income tax purposes once issued. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Receipt of CVRs by Sesen Bio Non-U.S. Holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Provided that the issuance of the CVRs is treated as a distribution of property with respect to Sesen Bio common stock, each Sesen Bio non-U.S. holder should be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio non-U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio non-U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes and after taking into account the special cash dividend as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8212;Material U.S. Federal Income Tax Consequences of the Special Cash </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">195</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus), then as a non-taxable return of capital to the extent of the Sesen Bio non-U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the distribution of the CVRs to be treated as other than a dividend for U.S. federal income tax purposes. However, if Sesen Bio cannot determine at the time of the distribution of the CVRs whether or not the amount of such distribution will exceed current and accumulated earnings and profits, Sesen Bio or the applicable withholding agent may withhold (potentially by utilizing cash that otherwise would be distributed to such holder with respect to the special cash dividend or other property of such Sesen Bio non-U.S. holder held in an account with the applicable withholding agent) at the rate applicable to dividends, as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Taxable Dividends. Dividend payments will generally be subject to withholding at a 30% rate. If a Sesen Bio non-U.S. holder is eligible for a lower treaty rate, withholding will be at such lower treaty rate only if such Sesen Bio non-U.S. holder provides a valid IRS Form W-8BEN or W-8BEN-E (or applicable successor form) certifying such Sesen Bio non-U.S. holder&#8217;s qualification for the reduced rate. If a Sesen Bio non-U.S. holder holds the stock through a financial institution or other intermediary, the Sesen Bio non-U.S. holder will be required to provide appropriate documentation to the intermediary, which then will be required to provide certification to the applicable withholding agent, either directly or through other intermediaries. Sesen Bio non-U.S. holders who do not timely provide the applicable withholding agent with the required certification, but who qualify for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the discussions below regarding backup withholding, if the issuance of the CVRs is effectively connected with a Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Sesen Bio non-U.S. holder maintains a permanent establishment in the United States to which the special cash dividend is attributable), the Sesen Bio non-U.S. holder will be exempt from U.S. federal withholding tax and the distribution of the CVRs generally will be subject to U.S. federal income tax on a net income basis in the same manner as if such Sesen Bio non-U.S. holder were a U.S. holder. To claim the exemption, the Sesen Bio non-U.S. holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI (or applicable successor form), certifying that the distribution is effectively connected with the Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the United States. A Sesen Bio non-U.S. holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) of all or a portion of its effectively connected earnings and profits for the taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any withholding required by Sesen Bio or other applicable withholding agents may be satisfied by Sesen Bio or such agent by withholding a portion of the issued CVRs, from the special cash dividend or from other property of the Sesen Bio non-U.S. holder held in an account with the applicable withholding agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Non-Dividend Distributions. To the extent that the issuance of the CVRs is treated as capital gain from the sale or exchange of Sesen Bio common stock, such gain generally will not be subject to U.S. federal income tax unless (i)&#160;such gain is effectively connected with the conduct by a Sesen Bio non-U.S. holder of a trade or business in the United States (and, if an income tax treaty applies, the gain is generally attributable to a U.S. permanent establishment maintained by such Sesen Bio non-U.S. holder), (ii)&#160;in the case of gain realized by a Sesen Bio non-U.S. holder that is an individual, such Sesen Bio non-U.S. holder is present in the United States for 183&#160;days or more in the taxable year of the sale and certain other conditions are met or (iii)&#160;Sesen Bio is or has been a USRPHC for U.S. federal income tax purposes and, if the shares are &#8220;regularly traded on an established securities market,&#8221; such Sesen Bio non-U.S. holder owned, directly or indirectly, at any time during the five-year period ending on the date of the distribution, more than 5% of the shares of Sesen Bio common stock and such Sesen Bio non-U.S. holder is not eligible for any treaty exemption. The shares will be considered &#8220;regularly traded&#8221; if they are traded on an established securities market located in the United States and are regularly quoted by brokers or dealers making a market in the shares. Sesen Bio believes it is not, and has not been, a USRPHC for U.S. federal income tax purposes. In addition, although not free from doubt, Sesen Bio believes that Sesen Bio common shares currently should be considered to be regularly traded. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">196</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSAAW">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder should consult its tax advisor regarding its entitlement to benefits and the various rules under applicable tax treaties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Information Reporting and Backup Withholding</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, the issuance of the CVRs to Sesen Bio U.S. holders will be reported to the IRS unless the holder is an exempt recipient. Backup withholding, currently at a rate of 24%, may apply unless the Sesen Bio U.S. holder (1)&#160;is an exempt recipient or (2)&#160;provides a certificate (generally on an IRS Form W-9) containing the Sesen Bio U.S. holder&#8217;s name, address, correct federal taxpayer identification number and statement that the Sesen Bio U.S. holder is a U.S. person and is not subject to backup withholding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder will not be subject to backup withholding with respect to the issuance of the CVRs, provided the Sesen Bio non-U.S. holder certifies its non-U.S. status, such as by providing a valid IRS Form W-8BEN or W-8ECI or W-8BEN-E, or otherwise establishes an exemption. However, information returns will be filed with the IRS in connection with the issuance of the CVRs, regardless of whether any tax was actually withheld. Copies of these information returns may also be made available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the Sesen Bio non-U.S. holder resides or is established. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLEASE CONSULT YOUR TAX ADVISOR WITH RESPECT TO THE PROPER CHARACTERIZATION OF THE RECEIPT OF THE CVRs.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Support Agreements and Written Consents</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to induce Sesen Bio to enter into the Merger Agreement, certain stockholders of Carisma are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed, solely in his, her or its capacity as a stockholder of Carisma, to vote all of his, her or its shares of Carisma capital stock (subject to customary cutbacks in the event of certain triggering events) in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;adoption and approval of an amendment to the Carisma Certificate of Incorporation to increase the authorized shares of Carisma common stock; (iii)&#160;acknowledgement that the approval given thereby is irrevocable and that the stockholder is aware of the stockholder&#8217;s rights to demand appraisal for its shares pursuant to Section&#160;262 of the DGCL; and (iv)&#160;acknowledgement that by the stockholder&#8217;s approval of the merger, the stockholder is (a)&#160;waiving its appraisal rights under the DGCL with respect to its shares; and (b)&#160;waiving any notice that may have been or may be required relating to the merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a Carisma stockholder, to vote against (subject to customary cutbacks in the event of certain triggering events) any such competing acquisition proposal and any action in furtherance of any competing acquisition proposal. These signatories have also granted an irrevocable proxy to Carisma and its designee to vote their respective shares of Carisma common stock in accordance with the support agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, in order to induce Carisma to enter into the Merger Agreement, certain stockholders of Sesen Bio are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed, solely in his or her capacity as a stockholder of Sesen Bio (if applicable), to vote all of his or her shares of Sesen Bio common stock in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the Merger Agreement and the transactions contemplated thereby; (iii)&#160;the change of control of Sesen Bio resulting from the Merger pursuant to Nasdaq rules; (iv)&#160;the approval of the equity plan amendment proposals; and (v)&#160;a waiver of any notice that may have been or may be required relating to the Merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a Sesen Bio stockholder, to vote against any competing acquisition proposal and any action in furtherance of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">197</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSUAG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any such competing acquisition proposal. These signatories have also granted an irrevocable proxy to Sesen Bio and its designee to vote their respective shares of Sesen Bio common stock in accordance with the support agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, the Carisma stockholders who are party to a support agreement (including any affiliated entities) owned an aggregate of 97.23% of the outstanding shares of Carisma common stock. Following the effectiveness of the registration statement of which this proxy statement/prospectus is a part and pursuant to the Merger Agreement, these stockholders will execute a written consent providing for such adoption and approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under these support agreements, subject to certain exceptions, such stockholders have also agreed not to sell or transfer the shares of Carisma capital stock subject to the support agreement held by them, or any voting rights with respect thereto, until the effective time. To the extent that any such sale or transfer is permitted pursuant to the exceptions included in the support agreement, each person to which any shares of Carisma capital stock subject to the support agreement are so sold or transferred shall be bound by the terms and provisions of the support agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing descriptions of the support agreements do not purport to be complete and are qualified in their entirety by the full text of the forms of support agreements, which are attached in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex C</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex&#160;D</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Subscription Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein, pursuant to which the investors have agreed to purchase shares of Carisma common stock at an aggregate purchase price of approximately $30.6&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The shares of Carisma common stock issued in the Carisma pre-closing financing will be converted into shares of Sesen Bio common stock in the merger in accordance with the exchange ratio. The consummation of the transactions contemplated by the subscription agreement is conditioned on the satisfaction or waiver of the conditions set forth in the Merger Agreement. All shares of Sesen Bio common stock issued in exchange for shares of Carisma common stock issued in the Carisma pre-closing financing will be subject to restrictions on resale following the closing of the merger. On December 29, 2022, immediately prior to the execution and delivery of the Merger Agreement Amendment, Carisma entered into an amended and restated subscription agreement with the investors party to the original subscription agreement, pursuant to which the parties thereto clarified that shares of Carisma common stock issued in the pre-closing financing will not be registered under the Securities Act and will be subject to restrictions on resale and agreed, among other things, to enter into a registration rights agreement to provide for the registration of the resale of the shares of common stock purchased by such investors in connection with the Carisma pre-closing financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subscription agreement contains customary representations and warranties of Carisma and also contains customary representations and warranties of the purchasers party thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each purchaser&#8217;s obligation to purchase shares of Carisma common stock from Carisma pursuant to the subscription agreement is subject to the satisfaction or waiver of certain conditions, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s representations and warranties in the subscription agreement being true and correct in all material respects as of the closing date for the Carisma pre-closing financing, subject to certain exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma having performed and complied in all material respects with all covenants, agreements, obligations and conditions required to be performed or complied with by it on or prior to the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma having filed the charter amendment with the Secretary of State of the State of Delaware; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the delivery of a compliance certificate by the Chief Executive Officer or the Chief Financial Officer of Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">198</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLOAG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the satisfaction or waiver of all conditions to the closing of the merger set forth in the Merger Agreement (other than the condition regarding the Carisma pre-closing financing and other than those conditions which, by their nature, are to be satisfied at the closing of the merger) and the closing of merger being set to occur substantially concurrently with the closing of the Carisma pre-closing financing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all authorizations, approvals or permits, if any, required under applicable state securities laws having been obtained; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the delivery of a fully executed registration rights agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s obligation to sell shares of Carisma common stock to each purchaser pursuant to the subscription agreement is subject to the satisfaction or waiver of certain conditions, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the representations and warranties made by such purchaser being true and correct in all material respects as of the closing date of the Carisma pre-closing financing, subject to certain exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">such purchaser having performed and complied with all covenants, agreements, obligations and conditions required to be performed or complied with by it on or prior to the closing date; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the satisfaction or waiver of all conditions to the closing of the merger set forth in the Merger Agreement (other than the condition regarding the Carisma pre-closing financing and other than those conditions which, by their nature, are to be satisfied at the closing of the merger) and the closing of merger being set to occur substantially concurrently with the closing of the Carisma pre-closing financing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subscription agreement may not be changed, waived, amended or modified, except by an instrument in writing executed by Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing. The subscription agreement will terminate upon the earlier to occur of (i)&#160;such date and time that the Merger Agreement is terminated in accordance with its terms, (ii)&#160;upon the mutual written agreement of Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing (provided that Carisma and a purchaser may terminate the commitment of the applicable purchaser without the consent of any other party), and (iii)&#160;if the closing of the merger has not occurred on or before January&#160;31, 2023 (as such date may be extended in the event that a request for additional information is made by any governmental body or in the event that the SEC has not declared the registration statement effective under the Securities Act by the date which is 60&#160;days prior to the end date), other than as a result of a willful breach of a purchaser&#8217;s obligations under the subscription agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-Up Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a condition to the closing of the merger, certain stockholders of each of Sesen Bio and Carisma and their affiliates, have entered into lock-up agreements, pursuant to which such parties have agreed not to, except in limited circumstances and among other restrictions, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of or lend, directly or indirectly, any shares of Sesen Bio common stock or any securities convertible into, exercisable or exchangeable for or that represent the right to receive Sesen Bio common stock (including without limitation, Sesen Bio common stock or such other securities which may be deemed to be beneficially owned by the signatory in accordance with the rules and regulations of the SEC and securities of Sesen Bio which may be issued upon exercise of a Sesen Bio option, Sesen Bio RSU or Sesen Bio warrant), during the period commencing at the effective time and continuing until the date that is 180&#160;days after the effective time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing description of the lock-up agreements do not purport to be complete and are qualified in their entirety by the full text of the form of lock-up agreement, which is attached in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex E</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain directors and executive officers of both Sesen Bio and Carisma are party to a lock-up agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain Carisma stockholders party to Carisma support agreements are also party to lock-up agreements. Carisma stockholders who have executed lock-up agreements, as of January 4, 2023, beneficially </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">199</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:464pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">owned in the aggregate approximately 97.23% of the outstanding shares of Carisma capital stock on an as converted to Carisma common stock basis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application with Nasdaq pursuant to the Nasdaq Stock Market LLC &#8220;business combination&#8221; rules. If such application is accepted, Sesen Bio anticipates that Sesen Bio common stock will be listed on Nasdaq following the closing of the merger under the trading symbol &#8220;CARM.&#8221; In order to meet the requirements for listing on Nasdaq, the post-merger combined company will be required to satisfy Nasdaq&#8217;s initial listing requirements, including the financial and liquidity requirements for the applicable Nasdaq market tier upon which the post-merger combined company&#8217;s shares will trade following the merger. Certain Nasdaq market tiers and standards require companies seeking to list to demonstrate a minimum &#8220;Market Value of Unrestricted Publicly Held Shares&#8221; as of the effective time of the closing of a business combination. Per current Nasdaq Listing Rules, the &#8220;Market Value of Unrestricted Publicly Held Shares&#8221; may not include the value of any securities subject to resale restrictions, including the types of restrictions set forth in the Sesen Bio and Carisma lock-up agreements.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">200</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMBST">&#8203;</a><a name="tPN1A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MATTERS BEING SUBMITTED TO A VOTE OF SESEN BIO STOCKHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 1: Approval, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Merger Agreement and the change of control of Sesen Bio resulting from the merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock pursuant to the terms of the Merger Agreement and the change of control of Sesen Bio resulting from the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including, Sesen Bio&#8217;s net cash as of closing being at least $75.0 million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The terms of, reasons for and other aspects of the Merger Agreement, the merger and the issuance of Sesen Bio common stock in the merger are described in detail in the other sections in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. A copy of the Original Merger Agreement and the Merger Agreement Amendment are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annexes A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">A-2</font><font style="letter-spacing:0.2pt;">, respectively, to this proxy statement/prospectus. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Nasdaq Listing Rule&#160;5635(a) requires a company listed on Nasdaq to obtain stockholder approval prior to the issuance of common stock (or other securities convertible into or exercisable for common stock) in connection with the acquisition of the stock or assets of another company, if such securities are not issued in a public offering and (i)&#160;the common stock has, or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding before the issuance of such securities, or (ii)&#160;the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of such securities. The potential issuance of the shares of Sesen Bio common stock in the merger will exceed the 20% threshold under the Nasdaq Listing Rules. Accordingly, in order to ensure compliance with Nasdaq Listing Rule&#160;5635(a), Sesen Bio must obtain the approval of Sesen Bio stockholders for the issuance of these shares of Sesen Bio common stock in the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Nasdaq Listing Rule&#160;5635(b) requires a company listed on Nasdaq to obtain stockholder approval prior to an issuance of securities that will result in a &#8220;change of control&#8221; of the company. Although Nasdaq has not adopted any rule as to what constitutes a &#8220;change of control&#8221; for purposes of Rule&#160;5635(b), Nasdaq has previously indicated that the acquisition of, or right to acquire, by a single investor or affiliated investor group, as little as 20% of the common stock (or securities convertible into or exercisable for common stock) or voting power of an issuer could constitute a change of control. In addition, the staff of Nasdaq has advised Sesen Bio that Nasdaq deems the merger to be a &#8220;change of control.&#8221; Accordingly, in order to ensure compliance with Nasdaq Listing Rule&#160;5635(b), Sesen Bio must obtain the approval of Sesen Bio stockholders for the potential change in control of Sesen Bio resulting from the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The terms of, reasons for and other aspects of the Merger Agreement, the merger, the issuance of shares of Sesen Bio common stock pursuant to the terms of the Merger Agreement and the resulting change of control are described in detail in the other sections in this proxy statement/prospectus. A copy of the Original Merger Agreement and the Merger Agreement Amendment are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annexes A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">A-2 to</font><font style="letter-spacing:0.2pt;"> this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 1. Abstentions will have no effect on Proposal No. 1. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">201</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 1 TO APPROVE, FOR PURPOSES OF NASDAQ LISTING RULE 5635(a) and (b), THE ISSUANCE OF SHARES OF SESEN BIO COMMON STOCK PURSUANT TO THE TERMS OF THE MERGER AGREEMENT AND THE CHANGE OF CONTROL OF SESEN BIO RESULTING FROM THE MERGER. PROPOSAL NO. 1 IS CONDITIONED UPON THE APPROVAL OF PROPOSAL NO. 2, AND THE MERGER CANNOT BE CONSUMMATED WITHOUT THE APPROVAL OF PROPOSAL NOS. 1 AND 2. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">202</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN2A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve an amendment to the Sesen Bio Certificate of Incorporation to effect the proposed reverse stock split and reduce the authorized shares of Sesen Bio common stock. Upon the effectiveness of the amendment to the Sesen Bio Certificate of Incorporation effecting the reverse stock split, or the split effective time, the issued and outstanding shares of Sesen Bio common stock immediately prior to the split effective time will be reclassified into a smaller number of shares of Sesen Bio common stock, at a ratio of 1-for-20. If the merger is not consummated, then the implementation and timing of the reverse stock split would be in the Sesen Bio board of directors&#8217; sole discretion. If and when the reverse stock split is effected, the amendment to the Sesen Bio Certificate of Incorporation will also reduce the number of authorized shares of Sesen Bio common stock from 400,000,000 to 100,000,000. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may determine to effect the reverse stock split, if it is approved by the Sesen Bio stockholders, even if Proposal No. 1 is not approved and the merger is not consummated. If the Sesen Bio stockholders approve Proposal No. 2, and the Sesen Bio board of directors decides to implement it, the reverse stock split will become effective on the date of the filing of the amendment to the Sesen Bio Certificate of Incorporation with the Secretary of State of the State of Delaware. The form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus has been approved by the Sesen Bio board of directors. By approving the reverse stock split, Sesen Bio stockholders also will be approving the form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Purpose</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors approved Proposal No.&#160;2 approving the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split for the following reasons: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The reverse stock split may be necessary to increase Sesen Bio&#8217;s stock price to meet Nasdaq&#8217;s $4.00 minimum bid price requirement upon the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors believes effecting the reverse stock split may be necessary to raise the per share trading price of Sesen Bio&#8217;s common stock to regain compliance with the Nasdaq Listing Rules to remain listed on the Nasdaq Capital Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the reverse stock split and the related amendment to the Sesen Bio Certificate of Incorporation will be required in order to make sufficient shares of Sesen Bio common stock available for issuance to Carisma stockholders pursuant to the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors believes a higher stock price may help generate investor interest in Sesen Bio and help Sesen Bio attract and retain employees; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the reverse stock split successfully increases the per share price of Sesen Bio common stock, the Sesen Bio board of directors believes this increase may increase trading volume in Sesen Bio common stock and facilitate future financings by Sesen Bio. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reasons for the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Requirements for Listing on Nasdaq</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is quoted on the Nasdaq Capital Market under the symbol &#8220;SESN,&#8221; and Sesen Bio is therefore subject to its continued listing requirements, including requirements with respect to the market value of publicly-held shares, market value of listed shares, minimum bid price per share and minimum stockholder&#8217;s equity, among others, and requirements relating to board and committee independence. If Sesen Bio fails to satisfy one or more of the requirements, Sesen Bio may be delisted from Nasdaq. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">203</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application with Nasdaq to seek listing of the combined company on the Nasdaq Capital Market upon the closing of the merger. According to Nasdaq Listing Rule&#160;5110, an issuer must apply for initial listing in connection with a transaction whereby the issuer combines with a non-Nasdaq entity, resulting in a change of control of the issuer and potentially allowing the non-Nasdaq entity to obtain a Nasdaq listing. Accordingly, the listing standards of Nasdaq will require Sesen Bio to have, among other things, a $4.00 per share minimum bid price upon the closing of the merger. As of January&#160;18, 2023 the closing price of Sesen Bio common stock was $0.6322 per share. If Sesen Bio stockholders do not approve Proposal No. 2, the merger will not be able to occur because continued listing on Nasdaq is a condition to the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Requirements for Continued Listing on Nasdaq</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent the merger is not completed, the primary objective for the reverse stock split will be to raise the per share trading price of Sesen Bio&#8217;s common stock to regain compliance with the Nasdaq Listing Rules to remain listed on the Nasdaq Capital Market. The reverse stock split will have the immediate effect of increasing the bid price of the Sesen Bio common stock, which should help ensure a share price high enough to regain compliance with the $1.00 per share minimum bid price requirement. However, there can be no assurance that the trading price of Sesen Bio common stock would be maintained at such level or that Sesen Bio will be able to maintain the listing of Sesen Bio common stock on the Nasdaq Capital Market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As previously disclosed, on January&#160;24, 2022, Sesen Bio received written notice from Nasdaq indicating that Sesen Bio was not in compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule&#160;5450(a)(1). Sesen Bio was given until July&#160;25, 2022, to regain compliance with the minimum bid price requirement. In response, Sesen Bio submitted an application to transfer the listing of the Sesen Bio common stock from the Nasdaq Global Market to the Nasdaq Capital Market. On July&#160;26, 2022, Sesen Bio received approval from Nasdaq to transfer the listing of Sesen Bio common stock from the Nasdaq Global Market to the Nasdaq Capital Market. As a result, Sesen Bio has been granted a second 180-day grace period, or until January&#160;23, 2023, to regain compliance with the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio common stock was transferred to the Nasdaq Capital Market effective at the opening of business on July&#160;28, 2022. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and requires that listed companies meet certain financial and liquidity requirements and comply with Nasdaq&#8217;s corporate governance requirements. To regain compliance with the minimum bid price requirement and qualify for continued listing on the Nasdaq Capital Market, the minimum bid price per share of the Sesen Bio common stock must be at least $1.00 for at least ten consecutive business days during the second 180-day grace period. If Sesen Bio does not regain compliance during this second grace period, its common stock would be subject to delisting by Nasdaq. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Potential Increased Investor Interest</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent the merger is not completed, another principal reason for the reverse stock split would be to generate investor interest in Sesen Bio common stock. On January&#160;18, 2023, Sesen Bio common stock closed at $0.6322 per share. An investment in Sesen Bio common stock may not appeal to brokerage firms that are reluctant to recommend lower priced securities to their clients. Investors may also be dissuaded from purchasing lower priced stocks because the brokerage commissions, as a&#160;percentage of the total transaction, tend to be higher for such stocks. Moreover, the analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage of lower priced stocks. Also, Sesen Bio believes that most investment funds are reluctant to invest in lower priced stocks. Accordingly, the Sesen Bio board of directors believes that a higher stock price may generate investor interest in Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Criteria to be Used for Determining Whether to Implement the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In determining whether to implement the reverse stock split following receipt of Sesen Bio stockholder approval of Proposal No. 2, Sesen Bio and/or Carisma (solely in connection with the merger) may consider, among other things, various factors, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the historical trading prices and trading volume of Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">204</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s capitalization (including the number of shares of Sesen Bio common stock issued and outstanding); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the then-prevailing trading price and trading volume of the Sesen Bio common stock and the anticipated or actual impact of the reverse stock split on the trading price and trading volume of Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability of Sesen Bio to continue its listing on the Nasdaq Capital Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential devaluation of Sesen Bio common stock as a result of the reverse stock split; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the anticipated impact of a particular ratio on Sesen Bio&#8217;s ability to reduce administrative and transactional costs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prevailing general market and economic conditions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event the Sesen Bio board of directors determines to implement the reverse stock split in connection with the merger, the total number of issued and outstanding shares of Sesen Bio common stock after the consummation of the transactions contemplated by the Merger Agreement, together with the total number of shares of Sesen Bio common stock then reserved for issuance or obligated to be issued by Sesen Bio pursuant to any agreement or arrangement or otherwise, including the Merger Agreement, will not exceed the total number of shares of Sesen Bio common stock then authorized under the Sesen Bio Certificate of Incorporation, as amended. Sesen Bio currently estimates that it will issue a maximum of 660,858,446 shares of Sesen Bio common stock (before giving effect to the reverse stock split) in connection with the transactions related to the merger (including to investors in the Carisma pre-closing financing and upon conversion of the Carisma convertible note). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principal Effects of the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A reverse stock split refers to a reduction in the number of outstanding shares of a class of a corporation&#8217;s capital stock, which may be accomplished, as in this case, by reclassifying and combining all of the outstanding shares of Sesen Bio common stock into a proportionately smaller number of shares of Sesen Bio common stock. If the Sesen Bio board of directors decides to implement a 1-for-20 reverse stock split of Sesen Bio common stock, then a Sesen Bio stockholder holding 10,000 shares of Sesen Bio common stock before the reverse stock split would instead hold 500 shares of Sesen Bio common stock immediately after the reverse stock split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If approved and implemented, the principal effects of the reverse stock split would include the following, all of which have been considered by the Sesen Bio board of directors in approving the reverse stock split: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The number of outstanding shares of Sesen Bio common stock will be reduced and each Sesen Bio stockholder will own fewer shares of Sesen Bio common stock than they currently own. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The number of shares of Sesen Bio common stock reserved and available for issuance under Sesen Bio&#8217;s equity-based compensation plans and the number of shares of Sesen Bio common stock issuable upon the exercise of outstanding Sesen Bio options and Sesen Bio warrants, or upon the conversion of outstanding Sesen Bio RSUs, will be reduced proportionately based on the ratio selected by the Sesen Bio board of directors, and the exercise price of all outstanding Sesen Bio options and Sesen Bio warrants will be increased proportionately. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Except for adjustments that may result from the treatment of fractional shares resulting from the reverse stock split, which are explained below under the section entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Fractional Shares</font><font style="letter-spacing:0.2pt;">,&#8221; each Sesen Bio stockholder will hold the same&#160;percentage of Sesen Bio common stock immediately following the reverse stock split as the stockholder held immediately prior to the reverse stock split. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The voting rights, rights to dividends and distributions and other rights of Sesen Bio common stock will not be changed as a result of the reverse stock split. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The reverse stock split will not affect the number of authorized shares of Sesen Bio preferred stock or the par value of Sesen Bio common stock or preferred stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">205</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The number of authorized shares of Sesen Bio common stock will be reduced from 400,000,000 to 100,000,000. Authorized shares represent the number of shares of Sesen Bio common stock that Sesen Bio is permitted to issue under the Sesen Bio Certificate of Incorporation. Therefore, Proposal No. 2 would have the effect of reducing the number of shares of Sesen Bio common stock available for future issuance after giving effect to the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The reverse stock split will not affect Sesen Bio continuing to be subject to the periodic reporting requirements of the Exchange Act. The reverse stock split is not intended as, and will not have the effect of, a &#8220;going private transaction&#8221; covered by Rule&#160;13e-3 under the Exchange Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The reverse stock split will be effected simultaneously for all outstanding shares of Sesen Bio common stock. The reverse stock split will affect all Sesen Bio stockholders uniformly and will not affect any Sesen Bio stockholder&#8217;s&#160;percentage interest in Sesen Bio, except for immaterial adjustments that may result from the treatment of fractional shares as described below. Shares of Sesen Bio common stock issued pursuant to the reverse stock split will remain fully paid and nonassessable. The reverse stock split does not affect the total proportionate ownership of Sesen Bio following the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table, which is for illustrative purposes only, illustrates the effects of a 1-for-20 reverse stock split (without giving effect to the treatment of fractional shares): </font>
        </div>
        <table style="width:456pt;height:65.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:185.65pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Issued</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Outstanding</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Authorized</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Reserved for</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Issuance</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Authorized</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unreserved for</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Issuance</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Authorized </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:185.65pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">As of January 4, 2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">202,759,043</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,017,998</td>
            <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">170,222,959</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">400,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">1-for-20 Reverse Split </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">10,137,952</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,350,899</td>
            <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">8,511,147</td>
            <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">100,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These estimates do not reflect the potential effects of the treatment of fractional shares that may result from the proposed reverse stock split. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes outstanding 186,600 Sesen Bio warrants, 15,304,313 Sesen Bio options, 4,695,007 Sesen Bio RSUs, 4,532,078 shares of Sesen Bio common stock reserved for future issuance under the 2014 Incentive Plan and 2,300,000 shares of Sesen Bio common stock reserved for future issuance under the 2014 ESPP as of January 4, 2023. Does not include any shares of Sesen Bio common stock issuable upon the exercise or conversion of securities that may have been issued since January 4, 2023 or any shares of Sesen Bio common stock reserved or to be reserved in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain Risks Associated with the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There are risks associated with the reverse stock split, which have been considered by the Sesen Bio board of directors in recommending to Sesen Bio stockholders the reverse stock split for approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">One of the effects of the reverse stock split will be to effectively increase the number of authorized shares of Sesen Bio common stock which are unissued relative to shares of Sesen Bio common stock which are issued. This could result in the Sesen Bio board of directors being able to issue more shares of Sesen Bio common stock without further stockholder approval. Therefore, the Sesen Bio board of directors has determined, if the reverse stock split is effected, to reduce the number of authorized shares of Sesen Bio common stock from 400,000,000 to 100,000,000. For example, before the reverse stock split, Sesen Bio estimates as of January 4, 2023, that Sesen Bio&#8217;s authorized but unallocated shares of Sesen Bio common stock immediately prior to the closing of the merger would be approximately 170,222,959 compared to issued and outstanding shares of Sesen Bio common stock of approximately 202,759,043. If Sesen Bio effects the reverse stock split using a 1-for-20 ratio, the authorized but unallocated shares of Sesen Bio common stock immediately prior to the closing of the merger would be approximately 88,511,149 compared to issued and outstanding shares of Sesen Bio common stock of approximately 10,137,952. Sesen Bio currently estimates that it will issue a maximum of 660,858,446 shares of Sesen Bio common stock (before giving effect to the reverse stock split) in connection with the transactions related to the merger (including to investors in the Carisma pre-closing financing and upon conversion of the Carisma convertible note). With respect to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">206</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">authorized but unallocated shares of Sesen Bio common stock available after the consummation of the merger, the combined company could use such shares that are available for issuance in future equity financing transactions, which could result in additional dilution to the stockholders of the combined company, or to oppose a hostile takeover attempt or delay or prevent future changes in control or changes in or removal of management, including transactions that are favored by a majority of such stockholders or in which such stockholders might otherwise receive a premium for their shares of the combined company&#8217;s common stock over then-current market prices or benefit in some other manner. Sesen Bio currently has no plans to issue shares of Sesen Bio common stock, other than in connection with the merger and to satisfy obligations under the Sesen Bio warrants, Sesen Bio options and Sesen Bio RSUs from time to time as such Sesen Bio warrants, Sesen Bio options and Sesen Bio RSUs are exercised, or vested and settled, for shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio cannot predict whether the reverse stock split will increase the market price for Sesen Bio common stock. The history of similar stock split combinations for companies in like circumstances is varied. There is no assurance that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the market price per share of Sesen Bio common stock after the reverse stock split will rise in proportion to the reduction in the number of shares of Sesen Bio common stock outstanding before the reverse stock split; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the reverse stock split will result in a per share price that will attract brokers and investors who do not trade in lower priced stocks or promote greater liquidity for Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the bid price per share will exceed the $1.00 minimum bid price as required by Nasdaq for continued listing on the Nasdaq Capital Market; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">that Sesen Bio will otherwise meet the requirements of Nasdaq for initial listing on the Nasdaq Capital Market, including the $4.00 minimum bid price upon the closing of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The market price of Sesen Bio common stock will also be based on the performance of Sesen Bio and other factors, some of which are unrelated to the number of outstanding shares of Sesen Bio common stock. If the reverse stock split is effected and the market price of Sesen Bio common stock declines, the&#160;percentage decline as an absolute number and as a&#160;percentage of the overall market capitalization of Sesen Bio may be greater than would occur in the absence of a reverse stock split. Furthermore, the liquidity of Sesen Bio common stock could be adversely affected by the reduced number of shares of Sesen Bio common stock that would be outstanding after the reverse stock split. In addition, there can be no assurance that Sesen Bio common stock will not be delisted due to a failure to meet other listing requirements even if the market price per share of Sesen Bio common stock after reverse stock split is in excess of the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since the reverse stock split will decrease the number of shares of Sesen Bio common stock held by Sesen Bio stockholders, the reverse stock split may increase the number of Sesen Bio stockholders who hold less than a &#8220;round lot,&#8221; or 100 shares of Sesen Bio common stock. Typically, the transaction costs to stockholders selling &#8220;odd lots&#8221; are higher on a per share basis. Consequently, the reverse stock split could increase the transaction costs to existing Sesen Bio stockholders in the event they wish to sell all or a portion of their shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Procedure for Effecting the Reverse Stock Split and Exchange of Stock Certificates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio stockholders approve the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split, and if the Sesen Bio board of directors still believes that a reverse stock split is in the best interests of Sesen Bio and Sesen Bio stockholders, Sesen Bio will file the amendment to the Sesen Bio Certificate of Incorporation with the Secretary of State of the State of Delaware at such time as the Sesen Bio board of directors has determined to be the appropriate split effective time. Beginning at the split effective time, each certificate representing pre-split shares of Sesen Bio common stock will be deemed for all corporate purposes to evidence ownership of post-split shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus has been approved by the Sesen Bio board of directors. By approving the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">207</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">reverse stock split, Sesen Bio stockholders also will be approving the form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As soon as practicable after the split effective time, Sesen Bio stockholders will be notified that the reverse stock split has been effected. Sesen Bio expects that the Sesen Bio transfer agent will act as exchange agent for purposes of implementing the exchange of stock certificates, if any. Holders of pre-split shares of Sesen Bio common stock holding all of their shares electronically in book-entry form with Sesen Bio&#8217;s transfer agent do not need to take any action to receive post-split shares. Holders of pre-split shares of Sesen Bio common stock held in certificated form will be asked to surrender to the exchange agent certificates representing pre-split shares of Sesen Bio common stock in exchange for certificates representing post-split shares of Sesen Bio common stock in accordance with the procedures to be set forth in a letter of transmittal to be sent by Sesen Bio. Upon receipt of the holder&#8217;s pre-split certificate(s) and the properly completed and executed letter of transmittal, the holder will be issued the appropriate number of shares of Sesen Bio common stock electronically in book-entry form under the Direct Registration System. No new shares in book-entry form will be reflected until the holder surrenders the holder&#8217;s outstanding pre-split certificate(s), together with the properly completed and executed letter of transmittal, to the exchange agent. Any pre-split shares of Sesen Bio common stock submitted for transfer, whether pursuant to a sale or other disposition, or otherwise, will automatically be exchanged for post-split shares of Sesen Bio common stock. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio stockholders should not destroy any stock certificate(s) and should not submit any certificate(s) unless and until requested to do so.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fractional Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No fractional shares of Sesen Bio common stock will be issued in connection with the reverse stock split. Sesen Bio stockholders of record who otherwise would be entitled to receive a fractional share of Sesen Bio common stock because they hold a number of pre-split shares of Sesen Bio common stock not evenly divisible by the number of pre-split shares to be reclassified into one post-split share, will be entitled to a cash payment in lieu thereof at a price equal to the fraction to which the Sesen Bio stockholder would otherwise be entitled multiplied by the closing price of Sesen Bio common stock on Nasdaq on the date of the split effective time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, holders of certificated shares must first surrender to the exchange agent the certificates representing such pre-split shares of Sesen Bio common stock. The ownership of a fractional interest will not give the holder thereof any voting, dividend, or other rights except to receive payment therefor as described herein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By approving the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split, Sesen Bio stockholders will be approving the combination of 20 outstanding shares of Sesen Bio common stock into one share of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders should be aware that, under the escheat laws of the various jurisdictions where Sesen Bio stockholders reside, where Sesen Bio is domiciled, and where the funds will be deposited, sums due for fractional interests that are not timely claimed after the split effective date of the reverse stock split may be required to be paid to the designated agent for each such jurisdiction, unless correspondence has been received by Sesen Bio or the exchange agent concerning ownership of such funds within the time permitted in such jurisdiction. Thereafter, Sesen Bio stockholders otherwise entitled to receive such funds will have to seek to obtain them directly from the state to which they were paid. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accounting Consequences</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The par value per share of Sesen Bio common stock will remain unchanged at $0.001 per share after the reverse stock split. As a result, at the split effective time of the reverse stock split, the stated capital on Sesen Bio&#8217;s balance sheet attributable to Sesen Bio common stock will be reduced proportionately based on the ratio, from its present amount, and the additional paid-in capital account will be increased for the amount by which the stated capital is reduced. After the reverse stock split (and disregarding the impact of shares of Sesen Bio common stock issued in the merger), net income or loss per share, and other per share amounts will be increased because there will be fewer shares of Sesen Bio common stock outstanding. In future financial statements, net loss per share and other per share amounts for periods ending before the reverse stock split will be restated to give retroactive effect to the reverse stock split. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">208</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="MUIT6">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Anti-Takeover Effect</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although the increased proportion of unissued authorized shares of Sesen Bio common stock to issued shares of Sesen Bio common stock could, under certain circumstances, have an anti-takeover effect, for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Sesen Bio board of directors or contemplating a tender offer or other transaction for the combination of Sesen Bio with another company, the reverse stock split is not being proposed in response to any effort of which Sesen Bio is aware to accumulate shares of Sesen Bio common stock or obtain control of Sesen Bio, other than in connection with the merger, nor is it part of a plan by management to recommend a series of similar amendments to the Sesen Bio board of directors and Sesen Bio stockholders. Other than the proposals being submitted to Sesen Bio stockholders for their consideration at the Sesen Bio special meeting, the Sesen Bio board of directors does not currently contemplate recommending the adoption of any other actions that could be construed to affect the ability of third parties to take over or effect a change of control of Sesen Bio. For more information, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Description of Sesen Bio Capital Stock&#8201;&#8212;&#8201;Anti-Takeover Effect of Sesen Bio&#8217;s Certificate of Incorporation and Bylaw Provisions</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tANTIT">384</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of the reverse stock split to Sesen Bio U.S. holders (which, for purposes of this discussion, has the same meaning as in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;), but does not purport to be a complete analysis of all potential tax consequences that may be relevant to Sesen Bio U.S. holders. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Sesen Bio U.S. holder. Sesen Bio has not sought and does not intend to seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of the reverse stock split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Sesen Bio U.S. holders that hold Sesen Bio common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences that may be relevant to a Sesen Bio U.S. holder&#8217;s particular circumstances, including the impact of the alternative minimum tax or the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code. In addition, it does not address consequences relevant to Sesen Bio U.S. holders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons holding Sesen Bio common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">banks, insurance companies, and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">209</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons subject to special tax accounting rules as a result of any item of gross income with respect to Sesen Bio common stock being taken into account in an &#8220;applicable financial statement&#8221; &#8203;(as defined in the Code); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons deemed to sell Sesen Bio common stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons who hold or received Sesen Bio common stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Sesen Bio common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Sesen Bio common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT SESEN BIO STOCKHOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code. In general, and subject to the qualifications set forth below, if the reverse stock split qualifies as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code, a Sesen Bio U.S. holder should not recognize gain or loss upon the reverse stock split, except to the extent a Sesen Bio U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. In addition, provided that the reverse stock split qualifies as a &#8220;recapitalization,&#8221; a Sesen Bio U.S. holder&#8217;s aggregate tax basis in the shares of Sesen Bio common stock received pursuant to the reverse stock split should equal the aggregate tax basis of the shares of Sesen Bio common stock surrendered excluding any portion of such basis that is allocated to any fractional share of Sesen Bio common stock, and such Sesen Bio U.S. holder&#8217;s holding period in the shares of Sesen Bio common stock received should include the holding period in the shares of Sesen Bio common stock surrendered. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of Sesen Bio common stock surrendered, for the shares of Sesen Bio common stock received pursuant to the reverse stock split. Holders of shares of Sesen Bio common stock acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio U.S. holder that receives cash in lieu of a fractional share of Sesen Bio common stock pursuant to the reverse stock split should recognize capital gain or loss in an amount equal to the difference between the amount of cash received and the Sesen Bio U.S. holder&#8217;s tax basis in the shares of Sesen Bio common stock surrendered that is allocated to such fractional share of Sesen Bio common stock. Such capital gain or loss should be long-term capital gain or loss if the Sesen Bio U.S. holder&#8217;s holding period for Sesen Bio common stock surrendered exceeded one year at the effective time of the reverse stock split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion assumes that the distribution of CVRs and the special cash dividend to Sesen Bio U.S. holders will be treated for U.S. federal income tax purposes as transactions that are separate and distinct from the reverse stock split. However, it is possible that the IRS or a court could determine that the reverse stock split and the receipt of CVRs or the special cash dividend constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. For a discussion of such treatment with respect to the CVRs or the special cash dividend, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs&#8201;&#8212;&#8201;Alternative Treatment of the Receipt of CVRs and the Proposed Reverse Stock Split as a Single Recapitalization</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tALTERT3">194</a> of this proxy statement/prospectus and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus. If the reverse stock split, the special cash dividend, and receipt of CVRs are treated as a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes, then a Sesen Bio U.S. holder generally should recognize gain (but not loss) equal to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">210</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:316pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the lesser of (i)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs received (assuming the receipt of CVRs is treated as a distribution of property as described in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;the excess (if any) of (A)&#160;the sum of (1)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs received and (2)&#160;the fair market value of the Sesen Bio shares received in the reverse stock split over (B)&#160;the Sesen Bio U.S. holder&#8217;s adjusted tax basis in the Sesen Bio common stock surrendered in the reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reservation of Right to Abandon Reverse Stock Split</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding approval of this Proposal No.&#160;2 by Sesen Bio stockholders, the Sesen Bio board of directors may, in its sole discretion, abandon the proposed amendments and determine prior to the effectiveness of any filing with the Secretary of State of the State of Delaware not to effect the reverse stock split, as permitted under Section 242(c) of the Delaware General Corporation Law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date for the Sesen Bio special meeting entitled to vote on the matter is required for approval of Proposal No. 2. Abstentions will have the same effect as votes &#8220;AGAINST&#8221; Proposal No. 2. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 2 TO APPROVE AN AMENDMENT TO THE SESEN BIO CERTIFICATE OF INCORPORATION TO EFFECT THE REVERSE STOCK SPLIT. THE APPROVAL OF PROPOSAL NO. 2 IS REQUIRED TO CONSUMMATE THE MERGER. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">211</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN3A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 3: Approval of an amendment and restatement of the 2014 Incentive Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why Sesen Bio is Requesting Sesen Bio Stockholder Approval of the Amendment and Restatement of the 2014 Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is asking the Sesen Bio stockholders to approve the amendment and restatement of the 2014 Incentive Plan, or the Amended and Restated Plan. The Sesen Bio board of directors believes that the combined company&#8217;s growth and success will depend, in large part, on its ability to maintain a competitive position by attracting, retaining and motivating key employees with experience and ability to advance the combined company&#8217;s clinical and business objectives, thereby creating value for all of the combined company&#8217;s stakeholders. Central to these objectives will be a stock-based compensation program. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The 2014 Incentive Plan was originally adopted by the Sesen Bio board of directors in December&#160;2013 and approved by the Sesen Bio stockholders in January&#160;2014. The 2014 Incentive Plan was amended by the Sesen Bio board of directors on April&#160;19, 2019 and approved by the Sesen Bio stockholders on June&#160;19, 2019 and was further amended by the Sesen Bio board of directors on March&#160;12, 2021 and approved by the Sesen Bio stockholders on May&#160;3, 2021. On January&#160;17, 2023, the Sesen Bio board of directors adopted, subject to stockholder approval, the amendment and restatement of the 2014 Incentive Plan. At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve the amendment and restatement of the 2014 Incentive Plan to (i)&#160;increase the number of shares of Sesen Bio common stock reserved for future issuance under the 2014 Incentive Plan by a number of shares of Sesen Bio common stock equal to 12.79% of the fully diluted capitalization of Sesen Bio, determined as of immediately following the closing of the merger, minus the number of shares that remain available for the grant of awards under the 2014 Incentive Plan as of the closing of the merger, (ii)&#160;establish a maximum aggregate number of shares of Sesen Bio common stock that may be granted as incentive stock options, (iii)&#160;extend the term of the 2014 Incentive Plan to the tenth (10th) anniversary of the closing of the merger, and (iv)&#160;revise certain provisions in the 2014 Incentive Plan to address certain changes in law and accounting relating to (1)&#160;the Sesen Bio board of directors&#8217; ability to delegate authority to make awards under the Amended and Restated Plan, (2)&#160;the satisfaction of withholding taxes with shares of Sesen Bio common stock, and (3)&#160;the effect on awards outstanding under the Amended and Restated Plan of any clawback policy that Sesen Bio has in effect or may adopt after the effective date of the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan will be used, following the closing of the merger, to grant equity awards to the combined company&#8217;s projected employees, officers, non-employee directors, consultants and advisors. The number of shares remaining available for issuance under the 2014 Incentive Plan is insufficient to meet these needs and would thus impede the combined company&#8217;s ability to properly compensate, motivate, incentivize and retain key talent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors determined the requested number of shares for the Amended and Restated Plan, in consultation with Carisma, based on projected annual equity awards to eligible participants, projected employee recognition and promotion awards and anticipated new-hire awards. If Sesen Bio stockholders approve the Amended and Restated Plan then, subject to adjustment in the event of stock splits and other similar events, including the proposed reverse stock split, awards may be made under the Amended and Restated Plan for up to the sum of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a number of shares of Sesen Bio common stock equal to 12.79% of the fully diluted capitalization of Sesen Bio, determined as of immediately following the closing of the merger, minus the number of shares of Sesen Bio common stock that remain available for the grant of awards under the 2014 Incentive Plan as of the closing of the merger; plus </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">25,313,283 shares of Sesen Bio common stock; plus</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares as is equal to the sum of (x)&#160;the number of shares of common stock reserved for issuance under the 2009 Incentive Plan, or the prior plan, that remained available for grant under the prior plan immediately prior to Sesen Bio&#8217;s initial public offering and (y)&#160;the number of shares of Sesen Bio common stock subject to (I)&#160;outstanding Sesen Bio awards granted under the prior plan and (II)&#160;stock options assumed by Sesen Bio in the merger, or, the awards described in the foregoing clauses (I)&#160;and (II)&#160;together, the Outstanding Awards, in each case which Outstanding Awards expire, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">212</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">terminate or are otherwise surrendered, canceled, forfeited or repurchased by Sesen Bio at their original issuance price pursuant to a contractual repurchase right. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Up to 252,000,000 of the shares of Sesen Bio common stock available for issuance under the Amended and Restated Plan may be issued as incentive stock options under the Amended and Restated Plan, subject to adjustment under the terms of the Amended and Restated Plan, including in the event the proposed reverse stock split occurs. The Amended and Restated Plan will have a term of ten&#160;years following the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The proposed Amended and Restated Plan includes several features that are consistent with protecting the interests of Sesen Bio stockholders and sound corporate governance practices, as described below. If Sesen Bio stockholders do not approve the Amended and Restated Plan, the 2014 Incentive Plan will remain in effect pursuant to its terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table includes information regarding (i) all of Sesen Bio&#8217;s outstanding equity awards as of January 4, 2023 (under all of Sesen Bio&#8217;s equity-based compensation plans or arrangements under which shares of Sesen Bio common stock may be issued, including inducement grants made by Sesen Bio but excluding the 2014 ESPP) before giving effect to any equitable adjustments that may be made in connection with the distribution of the CVRs and any special cash dividend, including outstanding stock options granted under the Carisma equity incentive plan, which Sesen Bio will assume as part of the merger on an as-converted basis (assuming the merger was consummated as of January 4, 2023 at an assumed exchange ratio of 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock), (ii) shares available for future awards under the 2014 Incentive Plan as of January 4, 2023 and (iii)&#160;the number of shares of Sesen Bio common stock outstanding as of January 4, 2023 (including the number of shares of Sesen Bio common stock that will be issued in the merger (based on shares outstanding as of January 4, 2023 and taking into account the consummation of the Carisma pre-closing financing and the conversion of the Carisma convertible note and an assumed exchange ratio of 37.7924), prior to giving effect to the proposed reverse stock split): </font>
        </div>
        <table style="width:456pt;height:256pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Number of outstanding Sesen Bio options under Sesen Bio equity incentive plans and inducement grants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">15,304,313</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted average exercise price of outstanding Sesen Bio options under Sesen Bio equity incentive plans and inducement grants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">1.82</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted average remaining contractual term of outstanding Sesen Bio options under Sesen Bio equity incentive plans and inducement grants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7.175</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:388.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Number of outstanding Sesen Bio RSUs under Sesen Bio equity incentive plans </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">4,695,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Sesen Bio remaining shares of Sesen Bio common stock available under the 2014 Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">4,532,078</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:388.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Estimated number of outstanding Carisma options under Carisma equity incentive plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">1,802,246</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:388.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average exercise price of Carisma options under Carisma equity incentive plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">1.92</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted average remaining contractual term of outstanding Carisma options under Carisma equity incentive plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7.666</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Estimated number of shares requested for approval under the Amended and </font>
                <br >
                <font style="letter-spacing:0.2pt;">Restated Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">79,902,694</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total number of shares of Sesen Bio common stock authorized for issuance under the 2014 </font>
                <br >
                <font style="letter-spacing:0.2pt;">Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">25,313,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Estimated number of shares of Sesen Bio common stock outstanding following the closing </font>
                <br >
                <font style="letter-spacing:0.2pt;">of the merger </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">656,865,489</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.51pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, there were no outstanding shares of restricted stock, no stock appreciation rights, or SARs, nor any other stock-based awards under the 2014 Incentive Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expects that the proposed share pool under the Amended and Restated Plan will allow the combined company to continue to grant market-competitive equity awards for approximately 3 years, but the actual duration of the share pool may vary based on changes in participation and the combined company&#8217;s stock price. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">213</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Amended and Restated Plan is not approved by Sesen Bio stockholders, the combined company will not be able to make long-term equity incentive awards that are sufficient to meet its needs. The inability to make competitive equity awards to retain talented employees in a highly competitive market could have an adverse impact on the combined company&#8217;s business and future prospects. Further, if the Amended and Restated Plan is not approved, the combined company could be forced to increase cash compensation, which will reduce the resources the combined company intends to allocate to meeting its clinical and business needs and objectives. Therefore, the approval of the Amended and Restated Plan is vital to the combined company&#8217;s future success. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Highlights of the Amended and Restated Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan includes several features that are consistent with protecting the interests of Sesen Bio stockholders and sound corporate governance practices. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Evergreen.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Amended and Restated Plan does not include an &#8220;evergreen&#8221; or other provision that provides for automatic increases in the number of shares available for grant under the Amended and Restated Plan. Therefore, stockholders of the combined company will have a say in the combined company&#8217;s equity compensation programs because any increase to the maximum share reserve in the Amended and Restated Plan is subject to approval by the combined company&#8217;s stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Clawback Policy</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In accepting an award granted under the Amended and Restated Plan, a participant agrees to be bound by any clawback policy that Sesen Bio has in effect or may adopt in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Automatic Vesting of Awards on a Change in Control Event</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Amended and Restated Plan does not provide for the automatic vesting of awards in connection with a change in control event. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Limits on Liberal Share Recycling</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Amended and Restated Plan prohibits the re-granting of (i)&#160;Sesen Bio shares withheld or delivered to satisfy the exercise price of an award or to satisfy tax withholding obligations and (ii)&#160;Sesen Bio shares that were subject to a SAR and were not issued upon the net settlement or net exercise of such award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Repricing of Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Amended and Restated Plan prohibits the direct or indirect repricing of stock options or SARs without stockholder approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Discounted Options or SARs</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All options and SARs must have an exercise or measurement price that is at least equal to the fair market value of the underlying Sesen Bio common stock on the date of grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Material Amendments Require Stockholder Approval</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Stockholder approval is required prior to an amendment of the Amended and Restated Plan that would (i)&#160;materially increase the number of Sesen Bio&#8217;s shares authorized (other than as provided under the Amended and Restated Plan with respect to certain corporate events or substitute awards), (ii)&#160;expand the types of awards that may be granted, or (iii)&#160;materially expand the class of participants eligible to participate in the Amended and Restated Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reasons Sesen Bio&#8217;s Stockholders Should Approve the Amended and Restated Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Incentivizes, Retains and Motivates Talent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;It is critical to the combined company&#8217;s success that it incentivizes, retains and motivates the best talent in what is a tremendously competitive labor market. The combined company&#8217;s equity-based compensation program will be a key component in its ability to pay market-competitive compensation to its employees and other service providers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Aligns with a Pay-for-Performance Compensation Philosophy</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Sesen Bio believes that equity-based compensation is fundamentally performance-based. As the value of Sesen Bio common stock appreciates, its employees and other service providers receive greater compensation while Sesen Bio stockholders receive a greater return on their investment. Conversely, if the stock price does not appreciate following the grant of an equity award, then employees would not realize any compensation benefit in respect of stock options and would receive lower than intended compensation in respect of Sesen Bio RSUs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Aligns Employee and Director Interests with Stockholder Interests</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Providing employees and non-employee directors with compensation in the form of equity directly aligns the interests of those employees and directors with the interests of the combined company&#8217;s stockholders. If the Amended and Restated Plan </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">214</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">is approved by Sesen Bio stockholders, the combined company will be able to continue fostering this alignment between its employees and non-employee directors and stockholders by granting meaningful equity-based incentives. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Consistent with Stockholder Interests and Sound Corporate Governance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As described under the heading above entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Highlights of the Amended and Restated Plan</font><font style="letter-spacing:0.2pt;">&#8221; and more thoroughly below, the Amended and Restated Plan purposefully includes features that are consistent with the interests of the stockholders of the combined company and sound corporate governance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of the Amended and Restated Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Types of Awards; Shares Available for Awards; Share Counting Rules</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan provides for the grant of incentive stock options intended to qualify under Section&#160;422 of the Code, nonstatutory stock options, SARs, restricted stock, RSUs, and other stock-based awards, or collectively, the awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to adjustment in the event of stock splits, stock dividends and other similar events, including the proposed reverse stock split, awards may be made under the Amended and Restated Plan for up to the sum of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a number of shares of Sesen Bio common stock equal to 12.79% of the fully diluted capitalization of Sesen Bio, determined as of immediately following the closing of the merger, minus the number of shares that remain available for the grant of awards under the 2014 Incentive Plan as of the closing of the merger; plus </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">25,313,283 shares of Sesen Bio common stock; plus</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares of Sesen Bio common stock as is equal to the sum of (x)&#160;the number of shares of Sesen Bio common stock reserved for issuance under the prior plan that remained available for grant under the prior plan immediately prior to Sesen Bio&#8217;s initial public offering and (y)&#160;the number of shares of Sesen Bio common stock subject to Outstanding Awards, which Outstanding Awards expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased by Sesen Bio at their original issuance price pursuant to a contractual repurchase right. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Up to 252,000,000 of the shares of Sesen Bio common stock available for issuance under the Amended and Restated Plan may be issued as incentive stock options under the Amended and Restated Plan, subject to adjustment under the terms of the Amended and Restated Plan, including in the event the proposed reverse stock split occurs. Shares of Sesen Bio common stock issued under the Amended and Restated Plan may consist in whole or in part of authorized but unissued shares or treasury shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of counting the number of shares available for the grant of awards under the Amended and Restated Plan, all shares of common stock covered by SARs will be counted against the number of shares available for the grant of awards. However, SARs that may be settled only in cash will not be so counted. In addition, if Sesen Bio grants a SAR in tandem with an option for the same number of shares of Sesen Bio common stock and provides that only one such award may be exercised, or the tandem SAR, only the shares covered by the option, and not the shares covered by the tandem SAR, will be so counted, and the expiration of one in connection with the other&#8217;s exercise will not restore shares to the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Shares covered by awards under the Amended and Restated Plan that expire or are terminated, surrendered, or cancelled without having been fully exercised or are forfeited in whole or in part (including as the result of shares subject to such award being repurchased by Sesen Bio at the original issuance price pursuant to a contractual repurchase right) or that result in any shares not being issued (including as a result of a SAR that was settleable either in cash or in stock actually being settled in cash) will again be available for the grant of awards under the Amended and Restated Plan (subject, in the case of incentive stock options, to any limitations under the Code). In the case of the exercise of a SAR, the number of shares counted against the shares available for the grant of awards under the Amended and Restated Plan will be the full number of shares subject to the SAR multiplied by the&#160;percentage of the SAR actually exercised, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">215</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">regardless of the number of shares actually used to settle the SAR upon exercise, and the shares covered by a tandem SAR will not again become available for grant upon the expiration or termination of the tandem SAR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Shares of Sesen Bio common stock that are delivered (by actual delivery, attestation, or net exercise) to Sesen Bio by a participant to purchase shares of Sesen Bio common stock upon exercise of an award or to satisfy tax withholding obligations (including shares retained from the award creating the tax obligation) will not be added back to the number of shares available for the future grant of awards under the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with a merger or consolidation of an entity with Sesen Bio or Sesen Bio&#8217;s acquisition of property or stock of an entity, the Sesen Bio board of directors may grant awards under the Amended and Restated Plan in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof on such terms as the Sesen Bio board of directors determines appropriate in the circumstances, notwithstanding any limitation on awards contained in the Amended and Restated Plan. No such substitute awards shall count against the overall share limit, except as required by reason of Section&#160;422 and related provisions of the Code. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Descriptions of Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant who is awarded an option receives the right to purchase a specified number of shares of Sesen Bio common stock at a specified exercise price and subject to the other terms and conditions that are specified in connection with the award agreement. An option that is not intended to be an &#8220;incentive stock option&#8221; is a &#8220;nonstatutory stock option.&#8221; Options may not be granted at an exercise price that is less than 100% of the fair market value of Sesen Bio common stock on the date of grant. If the Sesen Bio board of directors approves the grant of an option with an exercise price to be determined on a future date, the exercise price may not be less than 100% of the fair market value of Sesen Bio common stock on that future date. Under present law, incentive stock options may not be granted at an exercise price less than 110% of the fair market value in the case of stock options granted to participants who hold more than 10% of the total combined voting power of all classes of Sesen Bio&#8217;s stock or any of Sesen Bio&#8217;s subsidiaries. Under the terms of the Amended and Restated Plan, options may not be granted for a term in excess of ten&#160;years (and, under present law, five&#160;years in the case of incentive stock options granted to participants who hold greater than 10% of the total combined voting power of all classes of Sesen Bio&#8217;s stock or any of Sesen Bio&#8217;s subsidiaries). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan permits participants to pay the exercise price of options using one or more of the following manners of payment: (i)&#160;payment by cash or by check, (ii)&#160;except as may otherwise be provided in the applicable award agreement or approved by the Sesen Bio board of directors, in connection with a &#8220;cashless exercise&#8221; through a broker, (iii)&#160;to the extent provided in the applicable award agreement or approved by the Sesen Bio board of directors, and subject to certain conditions, by delivery to Sesen Bio (either by actual delivery or attestation) of shares of common stock owned by the participant valued at their fair market value, (iv)&#160;to the extent provided in an applicable nonstatutory stock option award agreement or approved by the Sesen Bio board of directors, by delivery of a notice of &#8220;net exercise&#8221; as a result of which Sesen Bio will retain a number of shares of Sesen Bio common stock otherwise issuable pursuant to the stock option equal to the aggregate exercise price for the portion of the option being exercised divided by the fair market value of Sesen Bio common stock on the date of exercise, (v)&#160;to the extent permitted by applicable law and provided for in the applicable award agreement or approved by the Sesen Bio board of directors, by any other lawful means as the Sesen Bio board of directors may determine, or (vi)&#160;by any combination of these forms of payment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January 18, 2023, the closing sale price of Sesen Bio common stock on Nasdaq was $0.6322 per share.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant who is awarded a SAR receives, upon exercise, a number of shares of Sesen Bio common stock, or cash (or a combination of shares of Sesen Bio common stock and cash) determined by reference to appreciation, from and after the date of grant, in the fair market value of a share of Sesen Bio common stock over the measurement price. The Amended and Restated Plan provides that the measurement price of a SAR may not be less than 100% of the fair market value of Sesen Bio </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">216</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">common stock on the date the SAR is granted (provided, however, that if the Sesen Bio board of directors approves the grant of a SAR effective as of a future date, the measurement price will not be less than 100% of the fair market value on such future date) and that SARs may not be granted with a term in excess of 10&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Limitation on Repricing of Options or SARs.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;With respect to options and SARs, unless such action is approved by Sesen Bio stockholders or otherwise permitted under the terms of the Amended and Restated Plan in connection with certain changes in capitalization and reorganization events, Sesen Bio may not (1)&#160;amend any outstanding option or SAR granted under the Amended and Restated Plan to provide an exercise price or measurement price per share that is lower than the then-current exercise price or measurement price per share of such outstanding option or SAR, (2)&#160;cancel any outstanding option or SAR (whether or not granted under the Amended and Restated Plan) and grant in substitution for such awards new awards under the Amended and Restated Plan (other than certain substitute awards issued in connection with a merger or consolidation of an entity with Sesen Bio or an acquisition by Sesen Bio, described above) covering the same or a different number of shares of Sesen Bio common stock and having an exercise price or measurement price per share lower than the then-current exercise price or measurement price per share of the canceled option or SAR, (3)&#160;cancel in exchange for a cash payment any outstanding option or SAR with an exercise price or measurement price per share above the then-current fair market value of Sesen Bio common stock, or (4)&#160;take any other action under the Amended and Restated Plan that constitutes a &#8220;repricing&#8221; within the meaning of the rules of the Nasdaq Stock Market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A participant who is granted an award of restricted stock is entitled to acquire shares of Sesen Bio common stock, subject to Sesen Bio&#8217;s right to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) in the event that the conditions specified in the applicable award are not satisfied prior to the end of the applicable restriction period established for such award. Unless otherwise provided in the applicable award agreement, any dividends (whether paid in cash, stock or property) declared and paid by Sesen Bio with respect to shares of restricted stock will be paid to the participant only if and when such shares become free from the restrictions on transferability and forfeitability that apply to such shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Unit Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A participant who is granted an RSU award is entitled to receive shares of Sesen Bio common stock, or cash equal to the fair market value of such shares or a combination of cash and shares, to be delivered at the time such award vests or on a deferred basis pursuant to the terms and conditions established by the Sesen Bio board of directors. The Sesen Bio board of directors may provide that settlement of RSUs will be deferred, on a mandatory basis or at the election of the participant, in a manner that complies with Section&#160;409A of the Code. A participant has no voting rights with respect to any RSU. An RSU award agreement may provide the applicable participant with the right to receive an amount equal to any dividends or other distributions declared and paid on an equal number of outstanding shares of Sesen Bio common stock. Any such dividend equivalents may be settled in cash and/or shares of Sesen Bio common stock and may be subject to the same restrictions on transfer and forfeitability as the RSUs with respect to which such dividend equivalents are awarded, in each case to the extent provided in the applicable award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Stock-Based Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Amended and Restated Plan, the Sesen Bio board of directors may grant other awards of shares of Sesen Bio common stock, and other awards that are valued in whole or in part by reference to, or are otherwise based on, shares of Sesen Bio common stock or other property, having such terms and conditions as the Sesen Bio board of directors may determine. Sesen Bio refers to these types of awards as other stock-based awards. Other stock-based awards may be available as a form of payment in settlement of other awards granted under the Amended and Restated Plan or as payment in lieu of compensation to which a participant is otherwise entitled. Other stock-based awards may be paid in shares of Sesen Bio common stock or in cash, as the Sesen Bio board of directors may determine. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Eligibility to Receive Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All employees, officers or directors of the combined company or an affiliate of the combined company, and consultants or advisors to the combined company or an affiliate of the combined company are eligible to participate in the Amended and Restated Plan. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">217</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, following the closing of the merger, approximately 94 employees, 6 non-employee directors and 1 non-employee consultant of the combined company will be eligible to participate in the Amended and Restated Plan.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Transferability of Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Awards may not be sold, assigned, transferred, pledged or otherwise encumbered by a participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an incentive stock option, pursuant to a qualified domestic relations order. During the life of the participant, awards are exercisable only by the participant. However, the Sesen Bio board of directors may permit or provide in an award for the gratuitous transfer of the award by the participant to or for the benefit of any immediate family member, family trust or other entity established for the benefit of the participant and/or an immediate family member thereof if Sesen Bio would be eligible to use a Form S-8 under the Securities Act for the registration of the sale of the common stock subject to such award to the proposed transferee. Further, Sesen Bio is not required to recognize any such permitted transfer until such time as the permitted transferee has, as a condition to the transfer, delivered to Sesen Bio a written instrument in form and substance satisfactory to Sesen Bio confirming that such transferee will be bound by all of the terms and conditions of the award. None of the restrictions described in this paragraph prohibit a transfer from the participant to Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">No Rights as a Stockholder; Clawback</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the provisions of the applicable award, no participant or designated beneficiary will have any rights as a Sesen Bio stockholder with respect to any shares of Sesen Bio common stock to be distributed with respect to an award granted under the Amended and Restated Plan until becoming a record holder of such shares of Sesen Bio common stock. In accepting an award granted under the Amended and Restated Plan, a participant agrees to be bound by any clawback policy that Sesen Bio has in effect or may adopt in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Effective Date</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The effective date of the 2014 Incentive Plan was February&#160;11, 2014, which was immediately prior to the closing of the initial public offering of Sesen Bio common stock on the Nasdaq Global Market. The Amended and Restated Plan will be effective as of the date of the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Amended and Restated Plan will terminate automatically on the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger (but any awards previously granted under the Amended and Restated Plan may extend beyond such date) unless it is earlier terminated by the Sesen Bio board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">New Plan Benefits</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because the grant of awards under the Amended and Restated Plan is within the discretion of the Sesen Bio board of directors and the Sesen Bio compensation committee, Sesen Bio cannot determine the dollar value or number of shares of Sesen Bio common stock that will in the future be received by or allocated to any participant in the Amended and Restated Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Administration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan will be administered by the Sesen Bio board of directors. The Sesen Bio board of directors has the authority to grant awards and to adopt, amend and repeal the administrative rules, guidelines and practices relating to the Amended and Restated Plan and to construe and interpret the terms of the Amended and Restated Plan and any award agreements entered into under the Amended and Restated Plan. The Sesen Bio board of directors may correct any defect, supply any omission or reconcile any inconsistency in the Amended and Restated Plan or any award under the Amended and Restated Plan in the manner and to the extent it deems expedient, and it is the sole and final judge of such expediency. All decisions by the Sesen Bio board of directors are made in its sole discretion and are final and binding on all persons having or claiming any interest in the Amended and Restated Plan or in any award under the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Amended and Restated Plan, the Sesen Bio board of directors may delegate any or all of its powers under the Amended and Restated Plan to one or more committees or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">218</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">subcommittees of the Sesen Bio board of directors. The Sesen Bio board of directors has authorized the Sesen Bio compensation committee to administer certain aspects of the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to any requirements of applicable law, the Sesen Bio board of directors may, by resolution, delegate to one or more persons (including Sesen Bio&#8217;s officers) or bodies, which Sesen Bio refers to as &#8220;delegated persons,&#8221; the power to grant awards (subject to any limitations under the Amended and Restated Plan) to eligible service providers of Sesen Bio to exercise such other powers under the Amended and Restated Plan as the Sesen Bio board of directors may determine, provided that the Sesen Bio board of directors must fix (i)&#160;the maximum number of awards, and the maximum number of shares issuable upon exercise of those awards, that may be issued by the delegated persons, (ii)&#160;the time period during which those awards, and during which the shares issuable upon exercise of those awards, may be issued, and (iii)&#160;the minimum amount of consideration (if any) for which awards may be issued, and a minimum amount of consideration for the shares issuable upon exercise of those awards. Further, no delegated person will be authorized to grant awards to any &#8220;executive officer&#8221; &#8203;(as defined by Rule&#160;3b-7 under the Exchange Act) or to any &#8220;officer&#8221; of Sesen Bio (as defined by Rule&#160;16a-1 under the Exchange Act). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to applicable limitations contained in the Amended and Restated Plan, the Sesen Bio board of directors, the Sesen Bio compensation committee, or any other committee or subcommittee of the Sesen Bio board of directors or delegated person to whom the Sesen Bio board of directors has delegated authority pursuant to the Amended and Restated Plan, as the case may be, selects the recipients of awards and determines (i)&#160;the number of shares of Sesen Bio common stock, cash or other consideration covered by awards and the terms and conditions of such awards, including the dates upon which such awards become exercisable or otherwise vest, (ii)&#160;the exercise or measurement price of awards, if any, and (iii)&#160;the duration of awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in the Amended and Restated Plan, each award under the Amended and Restated Plan may be made alone or in addition or in relation to any other award. The terms of each award need not be identical, and the Sesen Bio board of directors need not treat participants uniformly. The Sesen Bio board of directors will determine the effect on an award of the disability, death, termination or other cessation of employment or service, authorized leave of absence or other change in the employment or other service status of a participant, and the extent to which, and the period during which, the participant (or the participant&#8217;s legal representative, conservator, guardian or designated beneficiary) may exercise rights or receive any benefits under an award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may at any time provide that any award will become immediately exercisable in whole or in part, free from some or all restrictions or conditions or otherwise realizable in whole or in part, as the case may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Sesen Bio common stock other than an ordinary cash dividend, Sesen Bio is required by the Amended and Restated Plan to make equitable adjustments (or make substitute awards, if applicable), in a manner determined by the board of directors, to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and class of securities available under the Amended and Restated Plan and the number and class of securities available for issuance as incentive stock options under the Amended and Restated Plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the share counting rules under the Amended and Restated Plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and class of securities and exercise price per share of each outstanding Sesen Bio option; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the share and per-share provisions and measurement price of each outstanding SAR; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares and the repurchase price per share subject to each outstanding restricted stock award or Sesen Bio RSU award; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the share and per-share related provisions and purchase price, if any, of any outstanding other stock-based award. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">219</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event Sesen Bio effects a split of Sesen Bio common stock by means of a stock dividend and the exercise price of and the number of shares subject to an outstanding option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then a participant who exercises an option between the record date and the distribution date for such stock dividend will be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Sesen Bio common stock acquired upon such option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will indemnify and hold harmless each director, officer, employee or agent to whom any duty or power relating to the administration or interpretation of the Amended and Restated Plan has been or will be delegated against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of a claim with the Sesen Bio board of director&#8217;s approval) arising out of any act or omission to act concerning the Amended and Restated Plan unless arising out of such person&#8217;s own fraud or bad faith. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided under the Amended and Restated Plan with respect to repricing outstanding stock options or SARs and with respect to actions requiring stockholder approval, the Sesen Bio board of directors may amend, modify or terminate any outstanding award, including but not limited to, substituting for the award another award of the same or a different type, changing the date of exercise or realization, and converting an incentive stock option to a nonstatutory stock option. The participant&#8217;s consent to any such action will be required unless the Sesen Bio board of directors determines that the action, taking into account any related action, does not materially and adversely affect the participant&#8217;s rights under the Amended and Restated Plan or the change is otherwise permitted under the terms of the Amended and Restated Plan in connection with certain corporate events. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reorganization Events</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan contains provisions addressing the consequences of any reorganization event. A reorganization event is defined under the Amended and Restated Plan as (a)&#160;any merger or consolidation of Sesen Bio with or into another entity as a result of which all of Sesen Bio common stock is converted into or exchanged for the right to receive cash, securities or other property, or is canceled, (b)&#160;any transfer or disposition of all of Sesen Bio common stock for cash, securities or other property pursuant to a share exchange or other transaction or (c)&#160;Sesen Bio&#8217;s liquidation or dissolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Provisions Applicable to Awards Other than Restricted Stock.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Amended and Restated Plan, if a reorganization event occurs, the Sesen Bio board of directors may take any one or more of the following actions as to all or any (or any portion of) outstanding awards other than restricted stock on such terms as the Sesen Bio board of directors determines (except to the extent specifically provided otherwise in an applicable award agreement or another agreement between a participant and Sesen Bio): (1)&#160;provide that such awards will be assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (2)&#160;upon written notice to a participant, provide that all of the participant&#8217;s unvested and/or exercised awards will terminate immediately prior to the consummation of the reorganization event unless exercised by the participant (to the extent then exercisable) within a specified period following the date of such notice, (3)&#160;provide that outstanding awards will become exercisable, realizable, or deliverable, or restrictions applicable to an award will lapse, in whole or in part prior to or upon such reorganization event, (4)&#160;in the event of a reorganization event under the terms of which holders of Sesen Bio common stock will receive upon consummation of the reorganization event a cash payment for each share surrendered in the reorganization event, which Sesen Bio refers to as the &#8220;Acquisition Price&#8221;, make or provide for a cash payment to participants with respect to each award held by a participant equal to (A)&#160;the number of shares of Sesen Bio common stock subject to the vested portion of the award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such reorganization event) multiplied by (B)&#160;the excess, if any, of (I)&#160;the Acquisition Price over (II)&#160;the exercise, measurement or purchase price of such award and any applicable tax withholdings, in exchange for the termination of such award, (5)&#160;provide that, in connection with Sesen Bio&#8217;s liquidation or dissolution, awards will convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings) and (6)&#160;any combination of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors is not obligated to treat all awards, all awards held by a participant, or all awards of the same type, identically. Certain RSU awards that are subject to Section&#160;409A of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">220</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Code will be settled in accordance with the terms of the applicable award agreement or as otherwise specified in the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Provisions Applicable to Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the occurrence of a reorganization event other than Sesen Bio&#8217;s liquidation or dissolution, Sesen Bio&#8217;s repurchase and other rights with respect to outstanding restricted stock will inure to the benefit of Sesen Bio&#8217;s successor and will, unless the Sesen Bio board of directors determines otherwise, apply to the cash, securities or other property which Sesen Bio common stock is converted into or exchanged for pursuant to such reorganization event in the same manner and to the same extent as they applied to such restricted stock. However, the Sesen Bio board of directors may either provide for termination or deemed satisfaction of such repurchase or other rights under the instrument evidencing any restricted stock or any other agreement between a participant and Sesen Bio, either initially or by amendment. Upon the occurrence of a reorganization event involving Sesen Bio&#8217;s liquidation or dissolution, except to the extent specifically provided to the contrary in the instrument evidencing any award of restricted stock or any other agreement between the participant and Sesen Bio, all restrictions and conditions on all restricted stock then outstanding will automatically be deemed terminated or satisfied. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Provisions for Foreign Participants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may establish one or more sub-plans under the Amended and Restated Plan to satisfy applicable securities, tax or other laws of various jurisdictions. The Sesen Bio board of directors will establish such sub-plans by adopting supplements to the Amended and Restated Plan containing any limitations on the board of director&#8217;s discretion under the Amended and Restated Plan and any additional terms and conditions not otherwise inconsistent with the Amended and Restated Plan as the Sesen Bio board of directors deems necessary or desirable. All supplements adopted by the Sesen Bio board of directors will be deemed to be part of the Amended and Restated Plan, but each supplement will only apply to participants within the affected jurisdiction. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Withholding</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The participant must satisfy all applicable federal, state, and local or other income and employment tax withholding obligations before Sesen Bio will deliver stock certificates or otherwise recognize ownership of Sesen Bio common stock under an award. Sesen Bio may elect to satisfy the withholding obligations through additional withholding on salary or wages. If Sesen Bio elects not to or cannot withhold from other compensation, the participant must pay Sesen Bio the full amount, if any, required for withholding or have a broker tender to Sesen Bio cash equal to the withholding obligations. Payment of withholding obligations is due before Sesen Bio will issue any shares on exercise, vesting or release from forfeiture of an award or at the same time as payment of the exercise or purchase price, unless Sesen Bio determines otherwise. If provided for in an award or approved by the Sesen Bio board of directors, a participant may satisfy the tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Sesen Bio common stock, including shares retained from the award creating the tax obligation, valued at their fair market value. However, except as otherwise provided by the Sesen Bio board of directors, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed Sesen Bio&#8217;s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income), except that, to the extent that Sesen Bio is able to retain shares of Sesen Bio common stock having a fair market value that exceeds the statutory minimum applicable withholding tax without financial accounting implications or Sesen Bio is withholding in a jurisdiction that does not have a statutory minimum withholding tax, Sesen Bio may retain such number of shares (up to the number of shares having a fair market value equal to the maximum individual statutory rate of tax) as Sesen Bio will determine to be necessary to satisfy the tax liability associated with any award. Shares used to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Amendment or Termination</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio receives stockholder approval of the Amended and Restated Plan, no award may be granted under the Amended and Restated Plan after the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger, but awards previously granted may extend beyond that date. The Sesen Bio board of directors may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">221</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">amend, suspend or terminate the Amended and Restated Plan or any portion of the Amended and Restated Plan at any time, except that (i)&#160;no amendment may be made to the plan to permit an option or SAR to be repriced without stockholder approval and (ii)&#160;no amendment that would require stockholder approval under the rules of the Nasdaq Stock Market may be made effective unless and until such amendment has been approved by Sesen Bio stockholders. If at any time the approval of Sesen Bio stockholders is required as to any other modification or amendment under Section&#160;422 of the Code or any successor provision with respect to incentive stock options, the Sesen Bio board of directors may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Amended and Restated Plan adopted in accordance with the procedures described above will apply to, and be binding on the holders of, all awards outstanding under the Amended and Restated Plan at the time the amendment is adopted, provided that the Sesen Bio board of directors determines that such amendment, taking into account any related action, does not materially and adversely affect the rights of participants under the Amended and Restated Plan. No award will be made that is conditioned on stockholder approval of any amendment to the Amended and Restated Plan unless the award provides that (i)&#160;it will terminate or be forfeited if stockholder approval of such amendment is not obtained within no more than 12&#160;months from the date the award was granted and (ii)&#160;it may not be exercised or settled (or otherwise result in the issuance of shares of Sesen Bio common stock) prior to the receipt of such Sesen Bio stockholder approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Federal Income Tax Consequences</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following summarizes the federal income tax consequences of awards that may be granted under the Amended and Restated Plan. This summary is based on the federal tax laws in effect as of the date of this proxy statement/prospectus. In addition, this summary assumes that all awards are exempt from, or comply with, the rules under Section&#160;409A of the Code regarding nonqualified deferred compensation. Changes to these laws could alter the tax consequences described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Incentive Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;An optionee who is granted an incentive stock option does not recognize taxable income at the time the option is granted or upon its exercise, although the exercise may subject the optionee to the alternative minimum tax. Upon a disposition of the shares more than two&#160;years after grant of the option and one year after exercise of the option, any gain or loss is treated as long-term capital gain or loss. If these holding periods are not satisfied, the optionee recognizes ordinary income at the time of disposition equal to the difference between the exercise price and the lower of (i)&#160;the fair market value of the shares at the date of the option exercise or (ii)&#160;the sale price of the shares. Any gain or loss recognized on such a premature disposition of the shares to the extent not recognized as taxable income as provided above, will be long-term or short-term capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Nonstatutory Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;An optionee does not recognize taxable income at the time the option is granted. Upon exercise, the optionee recognizes taxable income generally measured by the excess of the then fair market value of the shares over the exercise price. Any taxable income recognized in connection with an option exercise by an employee of the combined company is subject to tax withholding by Sesen Bio. Upon a disposition of such shares by the optionee, any difference between the sale price and the optionee&#8217;s exercise price, to the extent not recognized as taxable income as provided above, is treated as long-term or short-term capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A holder of a SAR does not recognize taxable income at the time a SAR is granted. Upon exercise, the participant will recognize ordinary income in an amount equal to the amount of cash received and the fair market value of the shares received, and if granted to an employee, tax withholding is generally due. Any additional gain or loss recognized upon any later disposition of the shares would be capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant will not have income upon the grant of restricted stock unless an election under Section&#160;83(b) of the Code is made within 30&#160;days of the date of grant. If a timely 83(b) election is made, then a participant will have ordinary income equal to the fair market value of the stock on the date of grant less the purchase price, if any. When the stock is sold, the participant will have capital gain or loss equal to the difference between the sales proceeds and the fair market value of the stock on the date of grant. If the participant does not make an 83(b) election, then when the stock vests the participant will have ordinary income equal to the fair market value of the stock on the vesting date less the purchase price, if any. When the stock is sold, the participant will have capital gain or loss equal to the sales proceeds </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">222</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:240pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">less the value of the stock on the vesting date. Any capital gain or loss will be long-term if the participant held the stock for more than one year, and otherwise will be short-term. If the participant is an employee, any ordinary income generally is subject to withholding of income and employment taxes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Units</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant generally will recognize no income upon the grant of a restricted stock unit. Upon the settlement and/or payment of Sesen Bio RSUs, participants normally will recognize ordinary income in the year of receipt in an amount equal to the cash received and the fair market value of any nonrestricted shares received. If the participant is an employee, such ordinary income generally is subject to withholding taxes. Upon the sale of any shares received, any gain or loss, based on the difference between the sale price and the fair market value on the settlement date, will be taxed as short term or long term capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Stock-Based Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The tax consequences associated with any other stock-based award granted under the Amended and Restated Plan will vary depending on the specific terms of such award. Among the relevant factors are whether or not the award has a readily ascertainable fair market value, whether or not the award is subject to forfeiture provisions or restrictions on transfer, the nature of the property to be received by the participant under the award, and the participant&#8217;s holding period and tax basis for the award or underlying common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Tax Consequences to Sesen Bio</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;There will be no tax consequences to Sesen Bio except that Sesen Bio will be entitled to a deduction when a participant has ordinary income, subject to the limitations of Section&#160;162(m) of the Code. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 3. Abstentions will have no effect on Proposal No. 3. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 3 TO APPROVE THE AMENDED AND RESTATED PLAN. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">223</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN4A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 4: Approval of an amendment to the 2014 ESPP</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve an amendment to the 2014 ESPP to increase, subject to adjustment in the event of stock splits and other similar events, including the proposed reverse stock split, the number of shares of Sesen Bio common stock reserved for issuance under the 2014 ESPP to 6,568,655 shares of Sesen Bio common stock, referred to in Proposal No.&#160;4 as the ESPP Increase. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2014 ESPP was adopted by the Sesen Bio board of directors on December&#160;18, 2013 and approved by Sesen Bio stockholders on January&#160;14, 2014. The 2014 ESPP was amended on May&#160;3, 2021 to increase the number of shares of Sesen Bio common stock available for issuance under the 2014 ESPP. On November&#160;17, 2022, the Sesen Bio board of directors adopted, subject to stockholder approval and the closing of the merger, Amendment No. 2 to the 2014 ESPP to increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 ESPP. The 2014 ESPP, as amended by the ESPP Increase, will provide eligible employees with the opportunity to purchase, subject to adjustment in the event of stock splits and other similar events, including the proposed reverse stock split, up to an aggregate of 6,568,655 shares of Sesen Bio common stock. As of January 4, 2023, 2.3&#160;million shares of Sesen Bio common stock had been reserved for issuance under the 2014 ESPP. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio believes that the availability of an adequate reserve of shares of Sesen Bio common stock for issuance under the 2014 ESPP will benefit the combined company by providing employees with an opportunity to acquire shares of Sesen Bio common stock, and will enable the combined company to attract, retain and motivate key employees with experience and ability. Further, Sesen Bio believes it is in the best interest of the combined company to encourage stock ownership by its employees. Therefore, Sesen Bio considers approval of the ESPP Increase vital to the future success of the combined company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of the 2014 ESPP</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All of the combined company&#8217;s employees, including directors who are employees, and all employees of any of the combined company&#8217;s subsidiaries designated by the Sesen Bio board of directors from time to time, are eligible to participate in the 2014 ESPP provided that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">such person is customarily employed by Sesen Bio or a designated subsidiary of Sesen Bio for more than 20 hours a week and for more than five&#160;months in a calendar year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">such person has been employed by Sesen Bio or a designated subsidiary of Sesen Bio for at least six&#160;months prior to enrolling in the 2014 ESPP; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">such person was an employee of Sesen Bio or a designated subsidiary of Sesen Bio on the first day of the applicable plan period. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No employee is eligible to receive an option to purchase Sesen Bio common stock that would result in the employee owning 5% or more of the total combined voting power or value of Sesen Bio&#8217;s capital stock or the capital stock of any of Sesen Bio&#8217;s subsidiaries immediately after the grant of such option. For purposes of determining stock ownership of an employee, certain attribution rules under the Code will apply, and all Sesen Bio capital stock which the employee has a contractual right to purchase will be treated as stock owned by the employee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has made, and it expects the combined company to continue to make one or more offerings to its eligible employees to purchase Sesen Bio common stock under the 2014 ESPP. Each offering consists of a six-month offering period during which payroll deductions are made and held for the purchase of Sesen Bio common stock at the end of the offering period. The Sesen Bio board of directors may, in its discretion, choose a different plan period of no more than 12&#160;months for offerings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to any offering under the 2014 ESPP, an employee may authorize a payroll deduction in any dollar amount up to a maximum of 15% of the compensation such employee receives during the plan period (or during such shorter period during which payroll deductions are made). Compensation is defined under the 2014 ESPP to mean the amount of money reportable on the employee&#8217;s federal income tax </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">224</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">withholding statement, excluding overtime, shift premium, incentive or bonus awards, allowances and reimbursements for expenses such as relocation allowances for travel expenses, income or gains associated with the grant or vesting of restricted stock, income or gains on the exercise of stock options or SARs, and similar items, but including, in the case of salespersons, sales commissions to the extent determined by the Sesen Bio board of directors. The Sesen Bio board of directors may, in its discretion, designate a lower maximum contribution rate, and a minimum payroll deduction may be established from time to time by the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On the first day of each plan period, Sesen Bio will grant to each eligible employee who is then a participant in the 2014 ESPP an option to purchase up to a number of shares of Sesen Bio common stock determined by dividing (a)&#160;the product of $2,083 and the number of full&#160;months in the plan period by (b)&#160;the closing price of a share of Sesen Bio common stock on the first day of the plan period (as determined under the 2014 ESPP). No employee may be granted an option under the 2014 ESPP that permits his or her rights to purchase Sesen Bio common stock under the 2014 ESPP and any other employee stock purchase plans of Sesen Bio or a subsidiary of Sesen Bio to accrue at a rate that exceeds $25,000 of the fair market value of Sesen Bio common stock (determined on the date the option is granted) for each calendar year in which the option is outstanding at any time. Further, the Sesen Bio board of directors may, in its discretion, set a fixed maximum number of shares of Sesen Bio common stock that each eligible employee may purchase per plan period, so long as that number is not greater than the number of shares of Sesen Bio common stock determined by using the formula described above and is subject to $25,000 limitation described above. Each employee who continues to be a participant in the 2014 ESPP on the last business day of the plan period (referred to as the exercise date) is deemed to have exercised the option at the option price on such date and will be deemed to have purchased from Sesen Bio the number of whole shares of Sesen Bio common stock reserved for purposes of the 2014 ESPP that such employee&#8217;s accumulated payroll deductions on the exercise date will pay for, up to the maximum number determined as set forth above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the 2014 ESPP, the option price will be determined by the Sesen Bio board of directors for each plan period and the option price will be at least 85% of the applicable closing price of Sesen Bio common stock (determined as provided under the 2014 ESPP). If the Sesen Bio board of directors does not make a determination of the option price, the option price will be 85% of the lesser of the closing price of Sesen Bio common stock (determined as provided under the 2014 ESPP) on either (a)&#160;the first business day of the plan period or (b)&#160;the exercise date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any balance remaining in an employee&#8217;s payroll deduction account at the end of a plan period will be automatically refunded to the employee, except that any balance that is less than the purchase price of one share of Sesen Bio common stock will be carried forward for the following offering, unless the employee elects not to participate in the following offering, in which case the balance in the employee&#8217;s account will be refunded. An employee may withdraw the balance accumulated in such employee&#8217;s account and withdraw from participation in an offering at any time prior to the close of business on the fifteenth business day prior to the end of the plan period. Any employee who so withdraws may not begin participating again during the remainder of the plan period but may participate in any subsequent offering in accordance with the terms and conditions established by the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any employee&#8217;s employment ends before the last business day of a plan period, the employee&#8217;s account balance will be refunded to the employee (without any reductions for payroll deductions). In the event of the employee&#8217;s death before the last business day of a plan period, Sesen Bio will, upon notification of such death, pay the balance of the employee&#8217;s account to the executor or administrator of the employee&#8217;s estate, or if no executor or administrator has been appointed to Sesen Bio&#8217;s knowledge, to any other person Sesen Bio designate in its discretion. If, before the last business day of a plan period, a designated subsidiary in which an employee is employed ceases to be a subsidiary of Sesen Bio, or if the employee is transferred to a subsidiary that is not a designated subsidiary, the employee will be deemed to have terminated employment for purposes of the 2014 ESPP. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Options under the 2014 ESPP are not transferable by a participating employee other than by will or the laws of descent and distribution, and are exercisable during the employee&#8217;s lifetime only by the employee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All funds received or held by Sesen Bio under the 2014 ESPP may be combined with other corporate funds and may be used for any corporate purposes. Shares of Sesen Bio common stock may be issued upon </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">225</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">exercise of an option from authorized but unissued shares of Sesen Bio common stock, from shares held in Sesen Bio&#8217;s treasury, or from any other proper source. In the event the total number of shares of Sesen Bio common stock specified in elections to be purchased under any offering plus the number of shares of Sesen Bio common stock purchased under previous offerings under the 2014 ESPP exceeds the maximum number of shares of Sesen Bio common stock issuable under the 2014 ESPP, the Sesen Bio board of directors will allot the shares of Sesen Bio common stock then available on a pro-rata basis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2014 ESPP will be administered by the Sesen Bio board of directors or by a committee appointed by the Sesen Bio board of directors. The Sesen Bio board of directors or such committee has the authority to make rules and regulations for the administration of the 2014 ESPP and its interpretation and decisions with regard thereto will be final and conclusive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the ESPP Increase is approved, up to 6,568,655 shares of Sesen Bio common stock will be available for issuance under the 2014 ESPP. Sesen Bio will be required to make equitable adjustments in the manner determined by the Sesen Bio board of directors to the number and class of securities available under the 2014 ESPP and the option price to reflect stock splits, reverse stock splits, stock dividends, recapitalizations, combinations of shares, reclassifications of shares, spin-offs and other similar changes in capitalization or any distribution to holders of Sesen Bio common stock other than an ordinary cash dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the occurrence of a reorganization event (as defined below), the Sesen Bio board of directors is authorized to take any one or more of the following actions as to outstanding options under the 2014 ESPP: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that options will be assumed, or substantially equivalent options will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">upon written notice to employees, provide that all outstanding options will be terminated immediately prior to the consummation of the reorganization event and that all such outstanding options will become exercisable to the extent of accumulated payroll deductions as of a date specified by the Sesen Bio board of directors in such notice, which date will not be less than 10&#160;days preceding the effective date of the reorganization event; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">upon written notice to employees, provide that all outstanding options will be cancelled as of a date prior to the effective date of the reorganization event and that all accumulated payroll deductions will be returned to participating employees on such date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">upon the occurrence of a reorganization event in which holders of Sesen Bio common stock will receive a cash payment for each share surrendered in the reorganization event, or the acquisition price, change the last day of the plan period to be the date of the consummation of the reorganization event and make or provide for a cash payment to each employee equal to the acquisition price times the number of shares of Sesen Bio common stock that the employee&#8217;s accumulated payroll deductions as of immediately prior to the reorganization event could purchase at the option price, where the acquisition price is treated as the fair market value of the common stock and where the number of shares of Sesen Bio common stock that could be purchased is subject to the limitations set forth in the 2014 ESPP, minus the result of multiplying such number of shares of Sesen Bio common stock by the option price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that, in connection with a liquidation or dissolution of Sesen Bio, options will convert into the right to receive liquidation proceeds (net of the option price); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any combination of the foregoing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A &#8220;reorganization event&#8221; is defined under the 2014 ESPP as (i)&#160;any merger or consolidation of Sesen Bio with or into another entity as a result of which all of Sesen Bio common stock is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (ii)&#160;a transfer or disposition of all of Sesen Bio common stock for cash, securities or other property pursuant to a share exchange or other transaction, or (iii)&#160;Sesen Bio&#8217;s liquidation or dissolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to comply with the laws of any foreign jurisdiction, Sesen Bio may grant options to employees or employees of designated subsidiaries who are citizens or residents of such foreign jurisdiction with terms that are less favorable (but not more favorable) than the terms of options granted under the 2014 ESPP to employees who are residents of the United States. Sesen Bio&#8217;s employees or employees of Sesen Bio&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">226</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">designated subsidiaries who are citizens or residents of a foreign jurisdiction may be excluded from eligibility under the 2014 ESPP if the grant of an option under the 2014 ESPP to a citizen or resident of the foreign jurisdiction is prohibited under the laws of such jurisdiction or if compliance with the laws of the foreign jurisdiction would cause the 2014 ESPP to violate the terms of Section&#160;423 of the Code. Sesen Bio may add one or more appendices to the 2014 ESPP describing the operation of the 2014 ESPP in those foreign jurisdictions in which employees are excluded from participation or granted less favorable options. The Sesen Bio board of directors may from time to time establish one or more sub-plans under the 2014 ESPP with respect to one or more of Sesen Bio&#8217;s designated subsidiaries, provided such sub-plan complies with Section&#160;423 of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may at any time, and from time to time, amend or suspend the 2014 ESPP or any portion of the 2014 ESPP. Sesen Bio is required under the 2014 ESPP to obtain stockholder approval for any amendment if such approval is required by Section&#160;423 of the Code. Further, the Sesen Bio board of directors may not make any amendment that would cause the 2014 ESPP to fail to comply with Section&#160;423 of the Code. The Sesen Bio board of directors may terminate the 2014 ESPP at any time. Upon termination, Sesen Bio will refund all amounts in the accounts of participating employees. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Federal Income Tax Consequences</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following generally summarizes the United States federal income tax consequences that will arise with respect to participation in the 2014 ESPP and with respect to the sale of Sesen Bio common stock acquired under the 2014 ESPP. This summary is based on the tax laws in effect as of the date of this proxy statement/prospectus. Changes to these laws could alter the tax consequences described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Tax Consequences to Participants</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant will not have income upon enrolling in the 2014 ESPP or upon purchasing stock at the end of a plan period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A participant may have both ordinary income and a capital gain or loss upon the sale of Sesen Bio common stock that was acquired under the 2014 ESPP. The amount of each type of income and loss will depend on when the participant sells the stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the participant sells the Sesen Bio common stock more than two&#160;years after the commencement of the 2014 ESPP period during which the Sesen Bio common stock was purchased and more than one year after the date that the participant purchased the stock, at a profit (the sales proceeds exceed the purchase price), then the participant will have ordinary income equal to the lesser of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">15% of the value of the Sesen Bio common stock on the day the plan period commenced; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the participant&#8217;s profit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any excess profit will be long-term capital gain. If the participant sells the Sesen Bio common stock at a loss (if sales proceeds are less than the purchase price) after satisfying these waiting periods, then the loss will be a long-term capital loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the participant sells the Sesen Bio common stock prior to satisfying these waiting periods, then he or she will have engaged in a disqualifying disposition. Upon a disqualifying disposition, the participant will have ordinary income equal to the value of the Sesen Bio common stock on the day he or she purchased the stock less the purchase price. The participant also will have a capital gain or loss equal to the difference between the sales proceeds and the value of the Sesen Bio common stock on the day he or she purchased the Sesen Bio common stock. This capital gain or loss will be long-term if the participant has held the Sesen Bio common stock for more than one year and otherwise will be short-term. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Tax Consequences to Sesen Bio.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;There will be no tax consequences to Sesen Bio except that Sesen Bio will be entitled to a deduction when a participant has ordinary income upon a disqualifying disposition. Any such deduction will be subject to the limitations of Section&#160;162(m) of the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">227</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:388pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New Plan&#160;Benefits</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Participation in the 2014 ESPP is discretionary. The benefits received by any individual under the 2014 ESPP are dependent upon the individual&#8217;s decision to participate in the 2014 ESPP, the amount that the individual decides to contribute to the 2014 ESPP and the fair market value of Sesen Bio common stock on the exercise date. As a result, it is not possible to determine the benefits that will be received under the 2014 ESPP by Sesen Bio named executive officers, other executive officers and other employees if the ESPP Increase is approved by the Sesen Bio stockholders. Non-employee directors, consultants and advisors are not eligible to participate in the 2014 ESPP.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 4. Abstentions will have no effect on Proposal No. 4. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 4 TO APPROVE AN AMENDMENT TO THE 2014 ESPP. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">228</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN5A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:300pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 5: Approval of possible adjournment of the Sesen Bio special meeting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve one or more adjournments of the Sesen Bio special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 and 2. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the number of shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting voting in favor of Proposal Nos. 1 or 2 is insufficient to approve such proposal at the time of the Sesen Bio special meeting, then Sesen Bio may move to adjourn the Sesen Bio special meeting in order to enable the Sesen Bio board of directors to solicit additional proxies in respect of such proposals. In that event, Sesen Bio stockholders will be asked to vote only upon the adjournment proposal, Proposal No. 5, and not on any other proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio currently does not intend to propose adjournment at the Sesen Bio special meeting if there are sufficient votes to approve Proposal Nos. 1 and 2. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 5. Abstentions will have no effect on Proposal No. 5. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 5 TO APPROVE THE ADJOURNMENT OF THE SESEN BIO SPECIAL MEETING, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF PROPOSAL NOS. 1 OR 2.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">229</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBB">&#8203;</a><a name="tOVE">&#8203;</a><a name="tCUST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company that was previously focused on advancing targeted fusion protein therapeutics, or TFPTs, for the treatment of patients with cancer. Sesen Bio&#8217;s most advanced product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule, or EpCAM, antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of NMIBC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA, which are further described below. Sesen Bio has turned its primary focus to consummating a strategic transaction with the goal of maximizing shareholder value. Additionally, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following the decision to pause further development of Vicineum in the U.S. The 2022 restructuring plan includes an incremental reduction in Sesen Bio&#8217;s workforce as well as additional cost-saving initiatives intended to preserve capital during the pendency of the merger and while Sesen Bio seeks a potential partner for the further development of Vicineum. The 2022 restructuring plan is expected to be substantially completed in connection with the closing of the merger, which is expected to occur in the first quarter of 2023.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In May&#160;2022, Sesen Bio announced that it had commenced a process to explore and evaluate strategic alternatives to enhance stockholder value, and had engaged a financial advisor to assist Sesen Bio in this process. Sesen Bio then commenced an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic acquisition or other transaction as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Background of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tBOTM">125</a> of this proxy statement/prospectus. On September&#160;21, 2022, Sesen Bio announced that it had entered into the Original Merger Agreement, which was subsequently amended on December 29, 2022. Although Sesen Bio has entered into the Original Merger Agreement and the Merger Agreement Amendment and intends to consummate the merger, there is no assurance that it will be able to successfully consummate the merger on a timely basis, or at all. If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, attempt to complete another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio or dissolve and liquidate its assets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide that it is in the best interests of the Sesen Bio stockholders to dissolve the company and liquidate its assets. In that event, the amount of cash available for distribution to the Sesen Bio stockholders would depend heavily on the timing of such decision and, ultimately, such liquidation, since the amount of cash available for distribution continues to decrease as Sesen Bio funds its operations and incurs fees and expenses related to the merger. In addition, if the Sesen Bio board of directors were to approve and recommend, and the Sesen Bio stockholders were to approve, a dissolution of Sesen Bio, it would be required under Delaware law to pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, prior to making any distributions in liquidation to the Sesen Bio stockholders. As a result of this requirement, a portion of Sesen Bio&#8217;s assets may need to be reserved pending the resolution of such obligations. In addition, Sesen Bio may be subject to litigation or other claims related to a liquidation and dissolution of the company. If a liquidation and dissolution were pursued, the Sesen Bio board of directors, in consultation with its advisors, would need to evaluate these matters and make a determination about a reasonable </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">230</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBHP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">amount to reserve. Accordingly, the Sesen Bio stockholders could lose all or a significant portion of their investment in the event of a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s Historical Pipeline Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TFPT Platform</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s historical product candidates are based on its proprietary TFPT platform and are focused on addressing areas of unmet medical need in cancer. Sesen Bio&#8217;s novel TFPTs have been designed to overcome the efficacy and safety challenges of existing antibody-drug conjugates, or ADCs, and were being developed for both local and systemic-administration. Sesen Bio&#8217;s TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its proprietary recombinant one-step, microbial manufacturing process. Sesen Bio&#8217;s TFPT platform uses protein binding antibody fragments, which include Fabs, single chain variable domains, and non-covalent scFv dimers, derived from the domains of antibodies that confer antigen recognition. Sesen Bio selects antibody fragments for its product candidates depending upon the target therapeutic indication. Sesen Bio targets tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and that also have limited expression in normal cells. For local administrations, Sesen Bio utilizes an immunogenic cytotoxic protein payload designed to both target cancer cells and promote a heightened local immune response against the tumor. For systemic-administrations, Sesen Bio uses deBouganin, a plant-derived, protein payload of reduced immunogenic potential that Sesen Bio believes can be repeatedly administered via infusion without the generation of an efficacy-limiting immune response against the payload. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Locally-administered TFPTs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio utilizes its TFPTs with immunogenic cytotoxic protein payloads for tumors that can be targeted locally rather than systemically. Local administration allows for the TFPT to reach the tumor without being cleared by the immune system, which enables Sesen Bio to maximize the concentration of TFPTs directly to tumors. Sesen Bio&#8217;s locally-administered TFPT Vicineum, which has been its lead product candidate in development for the treatment of NMIBC, contains a targeting antibody binding domain that is designed to bind to EpCAM, a protein over-expressed in many cancers. This binding domain is genetically fused to a truncated form of exotoxin A, or ETA, which is an immunogenic cytotoxic protein payload that is produced by the bacterial species Pseudomonas. This product candidate is designed to bind to EpCAM on the surface of cancer cells. The TFPT-EpCAM complex is subsequently internalized into the cell and, once inside the cell, the TFPT is cleaved by a cellular enzyme to release the cytotoxic protein payload, thus enabling cancer cell killing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also believes that its TFPTs designed for local administration may not only directly kill cancer cells through targeted delivery of a cytotoxic protein payload, but also potentiate an anti-cancer therapeutic immune response. This immune response is believed to be triggered by the immunogenic cell death of the cancer cells due to the payload&#8217;s mechanism of action and the subsequent release of tumor antigens and the immunologically active setting created by the nature of the cytotoxic protein payloads. Sesen Bio believes that this immune response may also enhance the action of checkpoint inhibitors, that require a pre-existing immune response for maximum efficacy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s most advanced locally-administered TFPT product candidate is Vicineum, in development for the treatment of NMIBC and recurrent, locally advanced or metastatic EpCAM-expressing SCCHN. This TFPT is not, however, suitable for systemic-administration over multiple doses because the body&#8217;s immune system would recognize and eliminate foreign proteins, such as ETA, prior to their reaching targeted cancer cells. Sesen Bio has deferred further development of Vicineum for the treatment of SCCHN in order to focus its efforts and resources on development and, if approved, the commercialization of Vicineum for the treatment of NMIBC. Sesen Bio had also been exploring collaborations for the development of Vicineum for the treatment of SCCHN. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Vicineum for the treatment of NMIBC</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio completed the follow-up stage of its single-arm, multi-center, open-label Phase&#160;3 clinical trial of Vicineum as a monotherapy in patients with BCG-unresponsive NMIBC, or the VISTA Trial in May&#160;2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">231</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The VISTA Trial completed enrollment in April&#160;2018 with a total of 133 patients. In December&#160;2020, Sesen Bio submitted its completed BLA for Vicineum for the treatment of BCG-unresponsive NMIBC to the FDA, which was accepted for filing by the FDA in February&#160;2021. The FDA granted Priority Review for the BLA and set a target Prescription Drug User Fee Act, or PDUFA, date for a decision on the BLA of August&#160;18, 2021. On August&#160;13, 2021, Sesen Bio received a CRL from the FDA indicating that the FDA had determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. On August&#160;20, 2021, Sesen Bio withdrew its MAA to the EMA for Vysyneum for the treatment of BCG-unresponsive NMIBC in order to pause its plans to pursue regulatory approval of Vysyneum in the E.U. until there was more clarity from the FDA on next steps for Vicineum in the U.S. Vysyneum is the proprietary brand name that was conditionally approved by the EMA for oportuzumab monatox in the E.U. In October&#160;2021, the EMA issued its Withdrawal Assessment Report relating to its MAA for Vysyneum, as is consistent with the EMA&#8217;s standard practice when an MAA is withdrawn. The EMA Withdrawal Assessment Report reflects the initial assessment and corresponding questions from the EMA and identifies major objections in the areas of quality, good clinical practice, efficacy and safety. As a result of Sesen Bio&#8217;s decision on July&#160;15, 2022 to pause further development of Vicineum in the U.S., Sesen Bio no longer plans to pursue regulatory approval of Vysyneum for NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2021 and December&#160;2021, Sesen Bio participated in a CMC Type A meeting and a Clinical Type A meeting, respectively, with the FDA to discuss issues raised in the CRL and design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed would be required for a potential resubmission of a BLA. In March&#160;2022, Sesen Bio participated in a Type C meeting with the FDA. During the Type C meeting, the FDA agreed to a majority of Sesen Bio&#8217;s proposed protocol and statistical analysis plan design elements for an additional Phase&#160;3 clinical trial. On July&#160;11, 2022, Sesen Bio participated in a Type B meeting with the FDA to discuss outstanding items related to Sesen Bio&#8217;s proposed protocol and statistical analysis plan design elements for an additional Phase&#160;3 clinical trial. As discussed above, on July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. If the merger is consummated, the combined company does not expect to pursue further development of Vicineum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Systemically-administered TFPTs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also utilizes its TFPTs with a de-immunized payload where systemic-administration is required. Sesen Bio&#8217;s systemically-administered TFPTs are built around deBouganin. Since the body&#8217;s immune system naturally recognizes and attempts to eliminate foreign proteins, Sesen Bio designed its systemically-administered TFPTs with a deBouganin payload to avoid inducing an immunogenic response. DeBouganin is constructed by mutating the immunogenic T-cell epitopes from bouganin so that they are not recognized as foreign by the immune system. However, Sesen Bio also believes that deBouganin may enhance the action of checkpoint inhibitors as a result of the promotion of a local tumor immune response following the death of cancer cells. Sesen Bio&#8217;s systemically-administered product candidate is VB6-845d for the treatment of multiple types of EpCAM-positive solid tumors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sale of EBI-031 Legacy Technology to Roche</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, Sesen Bio entered into a license agreement with Roche, or the Roche License Agreement, pursuant to which Sesen Bio granted Roche an exclusive, worldwide license, including the right to sublicense, to its patent rights and know-how related to its monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio, or collectively, the Licensed Intellectual Property. Under the Roche License Agreement, Roche was required to continue developing, at its cost, EBI-031 and any other product made from the Licensed Intellectual Property that contains an IL-6 antagonist monoclonal antibody, or the Roche Licensed Product, and pursue ongoing patent prosecution, at its cost. At the time of the Roche License Agreement, EBI-031, which was derived using Sesen Bio&#8217;s previous AMP-Rx platform, was in pre-clinical development as an intravitreal injection for diabetic macular edema and uveitis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio executed the Roche Asset Purchase Agreement pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio for up to $70.0&#160;million. As a result of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">232</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCOM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Roche Asset Purchase Agreement, the Roche License Agreement was terminated resulting in no further diligence, milestone or royalty payment obligations under the Roche License Agreement. Pursuant to the Roche Asset Purchase Agreement, Roche made a $40.0&#160;million payment to Sesen Bio upon execution of the Roche Asset Purchase Agreement. The Roche Asset Purchase Agreement also provides that Roche will make an additional $30.0&#160;million payable to Sesen Bio upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a certain indication if initiated prior to December&#160;31, 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The pharmaceutical industry is highly competitive, subject to rapid and significant technological change and has a strong emphasis on developing proprietary products. While Sesen Bio believes that its next generation TFPT platform, knowledge, experience and scientific resources provide Sesen Bio with competitive advantages, Sesen Bio faces competition from both large and small pharmaceutical and biotechnology companies, academic institutions and other research organizations; specifically with companies, institutions and organizations that are actively researching and developing products that attach proprietary cell-killing payloads to antibodies for targeted delivery to cancer cells. Sesen Bio&#8217;s competitors include, but are not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">NMIBC: Merck &amp; Co., Inc. (Keytruda/pembrolizumab and BCG) (approved drugs), Endo Pharmaceuticals Inc. (Valstar/valrubicin) (approved drug), FerGene Inc. (Adstiladrin/nadofaragene firadenovec (rAd-IFN/Syn3)), Medical Enterprises Ltd. (Synergo RITE plus mitomycin C), Aadi, LLC (ABI-009), ImmunityBio (Anktiva/N-803 in combination with BCG), CG Oncology. (CG0070), Theralase Technologies Inc. (TLD-1433 photodynamic compound), Bristol-Myers Squibb (Opdivo/nivolumab with or without BCG or BMS-986205), F. Hoffmann-La Roche AG (Tecentriq/Atezolizumab), AstraZeneca (Imfinzi/durvalumab with or without BCG or External Beam Radiotherapy), Eli Lilly and Company (Gemcitabine) and Telormedix SA (Vesimune); Pfizer, Inc. (Sasanlimab) as well as the emerging use of generic intravesical chemotherapy agents, such as mytomycin-C, Gemcytabine and Gemcytobine + Docetaxel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">SCCHN: Bristol-Myers Squibb Company (Opdivo/nivolumab) (approved drug), Eli Lilly and Company, and Merck (Erbitux, pembrolizumab) (approved drugs); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Multiple types of solid tumors: Amgen Inc. (Panitumumab) (approved drug), Bayer AG and Onyx Pharmaceuticals (Sorafenib) (approved drug), Bristol-Myers Squibb Company, Eli Lilly and Company, and Merck (Erbitux) (approved drug), F. Hoffmann-La Roche AG (Bevacizumab) (approved drug), Genentech, Inc. (Bevacizumab, Erlotinib and Trastuzumab) (approved drugs), Pfizer, Inc. (Sunitinib) and Trion Research GmbH (Removab); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In addition to competition from alternative treatments, Sesen Bio may also face competition from products that are biosimilar to, and possibly interchangeable with, its product candidates. Biosimilar products are expected to become available over the coming&#160;years. Even if Sesen Bio&#8217;s product candidates achieve marketing approval, they may be priced at a significant premium over competitive biosimilar products if any have been approved by then and insurers or other third-party payors may encourage or even require the use of lower priced biosimilar products. Even if Sesen Bio treatments receive market authorization, they may not be listed on the formularies of payors (public or private insurers) or reimbursed. This may impact the uptake of the drug as a treatment option for patients and/or the price at which the drug can be sold at. Further, if the drug is reimbursed it may be at a narrower indication than the full scope of market authorization. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of Sesen Bio&#8217;s competitors have significantly greater financial resources and expertise in research and development, manufacturing, pre-clinical studies, conducting clinical trials, obtaining regulatory approval and marketing than Sesen Bio does. These competitors are also active in seeking patent protection and licensing arrangements in anticipation of collecting royalties for use of technology that they have developed. Moreover, specialized biologics, biopharmaceutical and biotechnology companies may prove to be significant competitors, particularly through collaborative arrangements with large and established companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s commercial opportunity could be substantially limited in the event that its competitors develop and commercialize products that are more effective, safer, less toxic, more convenient or cheaper </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">233</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSAM">&#8203;</a><a name="tMAN">&#8203;</a><a name="tINPR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">than its comparable products. In geographies that are critical to Sesen Bio&#8217;s commercial success, competitors may also obtain regulatory approvals before Sesen Bio, resulting in its competitors building a strong market position in advance of its product&#8217;s entry. Sesen Bio believes the factors determining the success of its programs will be the drug design, effectiveness against multi-drug resistance mechanisms, efficacy, safety, price and convenience of its product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sales and Marketing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio does not currently have the sales and marketing infrastructure in place that would be necessary to sell and market products. Sesen Bio has no current plans to build the infrastructure that would be needed to successfully market and sell any successful drug candidate on its own, and would therefore need to seek strategic alliances and partnership with third parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio previously leased a 31,100 square foot manufacturing, laboratory, warehouse and office facility in Winnipeg, Manitoba, with classified fermentation suite and post-production processing capabilities that were dedicated to producing its pre-clinical study and clinical trial batches of Vicineum. In September&#160;2017, Sesen Bio completed the manufacturing of all Vicineum necessary for its Phase&#160;3 VISTA Trial and for its Cooperative Research and Development Agreement, or CRADA, with the NCI. In conjunction with this achievement, Sesen Bio ended its manufacturing activities at its facility in Winnipeg and completed the technology transfer process to outsource future Vicineum clinical and commercial manufacturing to third-party manufacturers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2018, Sesen Bio entered into a Master Bioprocessing Services Agreement with Fujifilm Diosynth Biotechnologies U.S.A., Inc., or the Fujifilm MSA, for the manufacturing process and technology transfer of Vicineum drug substance production. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2019, Sesen Bio entered into a Commercial Manufacturing and Supply Agreement with Baxter, or the Baxter CMSA, for the manufacturing process and technology transfer of Vicineum drug product production. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, Sesen Bio entered into a Global Supply Agreement with Qilu pursuant to which Qilu will be part of the manufacturing network for, if approved, global commercial supply of Vicineum drug substance and drug product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with Sesen Bio&#8217;s decision to voluntarily pause further development of Vicineum, Sesen Bio commenced the process to wind down its manufacturing operations by terminating the Fujifilm MSA and Baxter CMSA on July&#160;17, 2022 and July&#160;20, 2022, respectively. Sesen Bio requested that Fujifilm and Baxter cease all work under the respective agreements and refrain from incurring any additional costs or expenses. As a result of the termination, and in accordance with the terms of the Fujifilm MSA, Sesen Bio has the responsibility to pay Fujifilm for certain non-manufacturing stage services and current Good Manufacturing Practice batches of drug substance of Vicineum. In addition, Sesen Bio terminated its Global Supply Agreement with Qilu on December 23, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio currently owns or exclusively licenses approximately 13 families of patents and applications, which generally relate to its TFPT-based product candidates and evolving its platform of targeting agents, cytotoxins (such as deBouganin) and linker technologies. As Sesen Bio&#8217;s product candidates evolve through clinical development, the company continues to monitor advancements and bolster patent coverage where possible. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio exclusively license two families under the Zurich License Agreement, which, among other things, include composition of matter claims directed to EpCAM antibody chimeras, EpCAM antibody chimera-cytotoxin conjugates, and their potential use in treating bladder and head and neck cancer. These families claim all or portions of Vicineum, as well as methods of treating bladder and head and neck cancer consist of issued patents in the U.S., Europe, Canada, China, Israel and Japan and also include pending applications in the U.S. The expiry dates of the patents in this family are April&#160;2024 and June&#160;2025, subject </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">234</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBOB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to any applicable patent term adjustment or extension that may be available on a jurisdictional basis. See the section entitled &#8220;Our Vicineum License Agreements&#8221; in Sesen Bio&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 for additional information. In addition to the Zurich portfolio, Sesen Bio owns two issued U.S. patents related to Vicineum. The expiry date of these patents is February&#160;2029, subject to any applicable patent term extension that may be available on a jurisdictional basis. In addition, Sesen Bio has patent families relating to treatment regimens using Vicineum that include issued patents in the U.S., Australia and Japan and patent applications in Canada and Europe. These patents will expire in 2036. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, Sesen Bio has a license agreement with Micromet AG, or Micromet, or the Micromet License Agreement, now part of Amgen, Inc., which grants Sesen Bio non-exclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products. These patents (which are now expired) cover some key aspects of Vicineum. Under the terms of the License Agreement with Micromet, as of December 31, 2021, even though the patents have expired, Sesen Bio may be obligated to pay up to &euro;2.4 million in milestone payments for the first product candidate that achieves applicable regulatory and sales-based development milestones (approximately $2.7 million at exchange rates in effect on December 31, 2021). Sesen Bio is also required to pay up to a 3.5% royalty on the net sales for products covered by the agreement, which includes Vicineum. The royalty rate owed to Micromet in a particular country will be reduced to 1.5% if there are no valid claims covering the product in that country. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. Finally, Sesen Bio is required to pay to Micromet an annual license maintenance fee of &euro;50,000 (approximately $56,625 at exchange rates in effect as of December 31, 2021), which can be credited towards any royalty payment Sesen Bio owes to Micromet. Sesen Bio recorded an expense of &euro;0.7 million ($0.9 million) related to achievement of a development milestone in the three months ended December 31, 2020, due to the submission of its BLA for Vicineum with the FDA in December 2020. Sesen Bio recorded an expense of &euro;0.5 million ($0.6 million) related to the submission of the MAA to the EMA for Vysyneum in the first quarter of 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has a license agreement with XOMA Ireland Limited, or XOMA, or the XOMA License Agreement, which grants Sesen Bio non-exclusive rights, with certain sublicense rights, to certain XOMA patent rights (which are now expired) and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems. These patents and related know-how cover some key aspects of Vicineum. Under the terms of the License Agreement with XOMA, even though the patents have expired, Sesen Bio is required to pay up to $0.25 million in milestone payments for a product candidate that incorporates know-how under the license and achieves applicable clinical development milestones. Sesen Bio is also required to pay a 2.5% royalty on the net sales for products incorporating XOMA&#8217;s technology, which includes Vicineum. Sesen Bio has the right to reduce the amount of royalties owed to XOMA on a country-by-country basis by the amount of royalties paid to other third parties, provided that the royalty rate to XOMA may not be less than 1.75% of net sales. In addition, the foregoing royalty rates are reduced by 50% with respect to products that are not covered by a valid patent claim in the country of sale. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s OUS Business Development Partnering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with Sesen Bio&#8217;s decision to voluntarily pause further development of Vicineum, Sesen Bio has commenced the process to wind down its OUS business development partnerships in the Middle East and North Africa region, or MENA, and Turkey by providing notice of termination for its exclusive license agreements in these respective regions on July&#160;20, 2022. In connection with the termination of the exclusive license agreement with Sesen Bio&#8217;s partner in MENA, Sesen Bio was required to refund the $3.0&#160;million upfront payment paid to the company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Greater China</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;30, 2020, Sesen Bio and its wholly-owned subsidiary, Viventia Bio, Inc., entered into the Qilu License Agreement pursuant to which Sesen Bio granted Qilu an exclusive, sublicensable, royalty-bearing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">235</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tGORE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">license, under certain intellectual property owned or exclusively licensed by Sesen Bio, to develop, manufacture and commercialize Vicineum for the treatment of BCG-unresponsive NMIBC and other types of cancer in China, Hong Kong, Macau and Taiwan, or Greater China. Sesen Bio also granted Qilu a non-exclusive, sublicensable, royalty-bearing sublicense, under certain other intellectual property licensed by Sesen Bio to develop, manufacture and commercialize Vicineum in Greater China. Sesen Bio retains (i)&#160;development and commercialization rights in the rest of the world excluding Greater China and (ii)&#160;manufacturing rights with respect to Vicineum in the rest of the world excluding Greater China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During 2020, Sesen Bio received a total of $10.0&#160;million in net proceeds associated with the Qilu License Agreement. Sesen Bio is also entitled to receive up to an additional $23.0&#160;million upon the achievement of certain technology transfer, development and regulatory milestones, as well as a 12% royalty based upon annual net sales of Vicineum in Greater China. The royalties are payable upon the first commercial sale of Vicineum in a region and continuing until the latest of (i)&#160;twelve&#160;years after the first commercial sale of Vicineum in such region, (ii)&#160;the expiration of the last valid patent claim covering or claiming the composition of matter, method of treatment, or method of manufacture of Vicineum in such region, and (iii)&#160;the expiration of regulatory or data exclusivity for Vicineum in such region. The royalty rate is subject to reduction under certain circumstances, including when there is no valid claim of a licensed patent that covers Vicineum in a particular region or no data or regulatory exclusivity of Vicineum in a particular region. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The IND for Vicineum submitted by Qilu to the Center for Drug Evaluation of the China National Medical Products Administration was accepted for review in January&#160;2021 and approved in March&#160;2021, resulting in a $3.0&#160;million milestone payment from Qilu, the first milestone payment out of the $23.0&#160;million in potential milestone payments. Sesen Bio recorded $2.8&#160;million (net of value-added tax, or VAT) as license revenue during the three-month period ended March&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as &#8220;Technology Transfer&#8221;. An agreement that is designated as a Technology Transfer shall be entitled to a tax incentive of VAT recovery. As such, Sesen Bio recorded $0.9&#160;million of revenue during the three&#160;months ended June&#160;30, 2021, for additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen Bio an amount equal to its recovery of VAT. Sesen Bio will not be subject to VAT on future potential milestone payments to Qilu. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;20, 2021 Sesen Bio and Qilu announced the enrollment of the first patient in China in a Phase&#160;3 clinical trial to assess the efficacy and safety of Vicineum in patients with BCG-unresponsive NMIBC. The open-label, single-arm, multi-center bridging trial will evaluate the efficacy and safety of Vicineum in approximately 53 patients with carcinoma in situ, or CIS, with or without papillary disease, high-grade Ta papillary disease or T1 papillary disease of any grade. Patients will be required to have failed previous treatment with BCG for inclusion in the trial. The primary endpoints are the complete response rate (for CIS patients) and the recurrence-free rate (for papillary patients) at six&#160;months, with the complete response rate and the recurrence-free rate at three&#160;months, safety and tolerability as the secondary endpoints. Based on the Qilu License Agreement, the trial is being run at the sole cost of Qilu. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December 23, 2022, Sesen Bio terminated the Qilu License Agreement. In connection with the termination of the Qilu License Agreement, Sesen Bio will make a one-time aggregate payment to Qilu of $1,400,000, which consists of a $1,200,000 termination fee payable upon the termination of the Qilu License Agreement and a $200,000 payment payable upon Sesen Bio&#8217;s receipt of certain clinical data and chemistry, manufacturing, and controls data from Qilu. As a result of the termination of the Qilu License Agreement, all rights to Vicineum in China, Hong Kong, Macau and Taiwan have reverted to Sesen Bio. Sesen Bio currently retains all global rights to Vicineum. Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Government Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a clinical-stage biologics company, Sesen Bio is subject to extensive regulation by the FDA, and other national, supranational, state, provincial and local regulatory agencies. Sesen Bio is also subject to extensive regulation by similar governmental authorities in other countries in which it operates. In the United States, the Federal Food, Drug, and Cosmetic Act, or FDCA, and the Public Health Service Act, or PHSA and their implementing regulations set forth, among other things, requirements for the research, testing, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">236</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">development, manufacture, quality control, safety, effectiveness, approval, post-approval monitoring and reporting, labeling, storage, record keeping, distribution, import, export, advertising and promotion of Sesen Bio&#8217;s product candidates. Although the discussion below focuses on regulation in the United States, Sesen Bio may seek marketing approval in other countries were it to resume development of Vicineum. Generally, Sesen Bio&#8217;s activities in other countries will be subject to regulation that is similar in nature and scope to that imposed in the United States, although there can be important differences. Additionally, some significant aspects of regulation in the E.U. are addressed in a centralized way through the European Commission following the opinion of the EMA, but country-specific regulation in the individual European Union Member States, or E.U. Member States, remains essential in many respects. The process of obtaining regulatory marketing approvals and the subsequent compliance with appropriate supranational, federal, state, provincial, local and non-U.S. statutes and regulations require the expenditure of substantial time and financial resources, and Sesen Bio may not be successful in any given jurisdiction were it to resume development of Vicineum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Government Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, drug products are regulated by the FDA under the FDCA and other laws, including, in the case of biologics, the PHSA. Drug products are also subject to other federal, state and local statutes and regulations. A failure to comply with any applicable requirements during the product development, approval, or post-approval periods may lead to administrative or judicial sanctions, including, among other things, the imposition by the FDA or an institutional review board, or IRB, of a hold on clinical trials, refusal to approve pending marketing applications or supplements, withdrawal of approval, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, or administrative, civil and/or criminal investigation, penalties or prosecution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Were Sesen Bio to resume development of Vicineum, the FDA would regulate Vicineum in the United States as a biologic. Biologics require the submission of a BLA and approval by the FDA prior to being marketed in the United States. Manufacturers of biologics may also be subject to state and local regulation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The steps required before a biologic may be marketed in the United States generally include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">completion of pre-clinical studies, animal studies and formulation studies, some in compliance with the FDA&#8217;s current Good Laboratory Practices, or GLP, regulations, and the Animal Welfare Act administered and enforced by the United States Department of Agriculture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">submission to the FDA of an IND to support human clinical testing, which must become effective before human clinical trials may commence; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approval by an IRB before each trial may be initiated at each clinical site; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">performance of adequate and well-controlled clinical trials under protocols submitted to the FDA and reviewed and approved by each IRB, conducted in accordance with federal regulations and current Good Clinical Practices, or GCP, to establish the safety, purity and potency of the biologic for each targeted indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">submission of a BLA to the FDA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">satisfactory completion of an FDA Advisory Committee review, if applicable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">satisfactory completion of an FDA inspection of the manufacturing facilities at which the biologic is produced to assess compliance with cGMP and to assure that the facilities, methods and controls are adequate; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">FDA review and approval of a BLA. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-clinical Studies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pre-clinical studies include laboratory evaluation of product chemistry, formulation and toxicity, as well as animal studies to assess the characteristics and potential safety and efficacy of the product candidate. The conduct of the pre-clinical studies must comply with federal regulations and requirements, including, as applicable, GLP and the Animal Welfare Act. The results of the pre-clinical studies, together with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">237</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">manufacturing information and analytical data, are submitted to the FDA as part of an IND. The FDA evaluates the IND to determine whether there is an adequate basis for starting the product candidate in initial clinical trials, and the IND must become effective before human clinical trials may be commenced. Additional pre-clinical studies may continue after the IND is submitted. A 30-day waiting period after the submission of each IND is required prior to the commencement of clinical testing in humans. If during this 30-day period the FDA does not raise any concerns or issues that must be addressed prior to the commencement of clinical trials or does not impose a clinical hold, the IND becomes effective 30&#160;days following the FDA&#8217;s receipt of the IND and the clinical trial proposed in the IND may begin. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Clinical Trials</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials involve the administration of the product candidate to healthy volunteers or patients under the supervision of qualified investigators. Clinical trials are subject to extensive regulation and must be conducted in compliance with (i)&#160;federal regulations, (ii)&#160;GCP standards, which set safeguards to protect the rights and health of patients and establish standards for conducting, recording data from, and reporting results of clinical trials, and (iii)&#160;protocols detailing the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated, if any. Non-U.S. studies conducted under an IND generally must meet the same requirements that apply to studies being conducted in the United States. The informed written consent of each study patient must be obtained before the patient may begin participation in the clinical trial. The study protocol, study plan, and informed consent forms for each clinical trial must be reviewed and approved by an IRB for each clinical site, and the study must be conducted under the auspices of an IRB for each trial site. Investigators and IRBs must also comply with FDA regulations and guidelines, including those regarding oversight of study patient informed consent, complying with the study protocol and investigational plan, adequately monitoring the clinical trial, and timely reporting of adverse events. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The clinical trial program for a product candidate is generally divided into three phases. Although the phases are usually conducted sequentially, they may overlap or be combined. The three phases are as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;1.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Phase&#160;1 involves the initial introduction of a product candidate into humans. Phase&#160;1 clinical trials are typically conducted in healthy human subjects, but in some situations are conducted in patients with the target disease or condition. These clinical trials are generally designed to evaluate the safety, metabolism, pharmacokinetic, or PK, properties and pharmacologic actions of the product candidate in humans, the side effects associated with increasing doses and, if possible, to gain early evidence of effectiveness. During Phase&#160;1 clinical trials, sufficient information about the product candidate&#8217;s PK properties and pharmacological effects may be obtained to inform and support the design of Phase&#160;2 clinical trials. The total number of participants included in Phase&#160;1 clinical trials varies, but is generally in the range of 20 to 80; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;2.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Phase&#160;2 includes the controlled clinical trials conducted to obtain initial evidence of effectiveness of the product candidate for a particular indication(s) in patients with the target disease or condition, to determine dosage tolerance and optimal dosage, and to gather additional information on possible adverse side effects and safety risks associated with the product candidate. Phase&#160;2 clinical trials are typically well-controlled, closely monitored, and conducted in a limited patient population, usually involving no more than several hundred participants; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;3.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Phase&#160;3 clinical trials are clinical trials conducted in an expanded patient population at geographically dispersed clinical trial sites. They are performed after preliminary evidence suggesting effectiveness of the product candidate has been obtained and are intended to further evaluate dosage, clinical effectiveness and safety, to establish the overall benefit-risk relationship of the product candidate and to provide an adequate basis for regulatory approval. Phase&#160;3 clinical trials usually involve several hundred to several thousand participants. In most cases, the FDA requires two adequate and well controlled Phase&#160;3 clinical trials to demonstrate the efficacy of the product candidate, although a single Phase&#160;3 clinical trial with other confirmatory evidence may be sufficient in certain instances. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The decision to suspend or terminate development of a product candidate may be made by either a health authority body, such as the FDA, by an IRB, or by a company for various reasons and during any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">238</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">phase of clinical trials. The FDA may order the temporary or permanent discontinuation of a clinical trial at any time or impose other sanctions if it believes that the clinical trial either is not being conducted in accordance with FDA requirements or presents an unacceptable risk to the clinical trial patients. In some cases, clinical trials are overseen by a data safety monitoring board, or DSMB, which is an independent group of qualified experts organized by the trial sponsor to evaluate at designated points in time whether or not a trial may move forward and/or should be modified. These decisions are based on unblinded access to data from the ongoing trial and generally involve determinations regarding the benefit-risk ratio for study patients and the scientific integrity and validity of the clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, there are requirements for the registration of certain clinical trials of product candidates on public registries, such as www.clinicaltrials.gov, and the submission of certain information pertaining to these trials, including clinical trial results, after trial completion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, a sponsor submits extensive information about the product candidate to the FDA in the form of a BLA to request marketing approval for the product candidate in specified indications. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Biologics License Applications</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to obtain approval to market a biologic in the United States, a marketing application must be submitted to the FDA that provides data establishing the safety and effectiveness of the product candidate for the proposed indication. The application includes all relevant data available from pertinent pre-clinical studies and clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls and proposed labeling, among other things. Data can come from company-sponsored clinical trials intended to test the safety and effectiveness of a product candidate, or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and effectiveness of the product candidate to the satisfaction of the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Prescription Drug User Fee Act, the fees payable to the FDA for reviewing an original BLA, as well as annual program fees for approved products, can be substantial, subject to certain limited deferrals, waivers and reductions that may be available. The FDA has 60&#160;days from receipt of a BLA to determine whether the application will be accepted for filing based on the agency&#8217;s threshold determination that it is sufficiently complete to permit substantive review. The FDA may refuse to accept for filing any BLA that it deems incomplete or not properly reviewable at the time of submission, in which case the BLA will have to be updated and resubmitted. The FDA&#8217;s PDUFA review goal is to review 90% of priority BLA applications within six&#160;months of filing and 90% of standard applications within 10&#160;months of filing, but the FDA can and frequently does extend this review timeline to consider certain later-submitted information or information intended to clarify or supplement information provided in the initial submission. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may not complete its review or approve a BLA within these established goal review times. The FDA reviews the BLA to determine, among other things, whether the proposed product is safe, pure, and potent for its intended use, and whether the product is being manufactured in compliance with cGMP. The FDA may also refer applications for novel product candidates which present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before approving a BLA, the FDA will inspect the facilities at which the product candidate is manufactured or the facilities that are significantly involved in the product development and distribution process and will not approve the product candidate unless cGMP compliance is satisfactory. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP. Under the Pediatric Research Equity Act, certain BLAs must include an assessment, generally based on clinical trial data, of the safety and effectiveness of the biological product in relevant pediatric populations. The FDA may waive or defer the requirement for a pediatric assessment, either at a company&#8217;s request or by its own initiative, including waivers for certain products not likely to be used in a substantial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">239</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">number of pediatric patients. Products with orphan drug designation are exempt from these requirements for orphan-designated indications with no formal waiver process required. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the FDA evaluates the BLA and the manufacturing facilities, it issues either an approval letter or a CRL. A CRL generally outlines the deficiencies in the submission and may require substantial additional testing or information in order for the FDA to reconsider the application. On August&#160;13, 2021, Sesen Bio received a CRL from the FDA indicating that the FDA had determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. If Sesen Bio were to resume development of Vicineum, it would be required to address these deficiencies to the FDA&#8217;s satisfaction in a resubmission of a BLA. The FDA&#8217;s PDUFA review goal is to review such resubmissions within two or six&#160;months of receipt, depending on the type of information included. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval and deny approval of a resubmitted BLA. FDA approval of any application may include many delays or never be granted. An approval letter authorizes commercial marketing of the product candidate with specific prescribing information for specific indications. As a condition of BLA approval, the FDA may require a risk evaluation and mitigation strategy, or REMS, to help ensure that the benefits of the product outweigh the potential risks. REMS can include Medication Guides, communication plans for healthcare professionals, and also may include elements to assure safe use, or ETASU. ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patient registries. The requirement for a REMS can materially affect the potential market and profitability of the biologic. Moreover, product approval may require substantial post-approval testing and surveillance to monitor the biologic&#8217;s safety, purity, or potency, which can be costly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Changes to some of the conditions established in an approved application, including changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA approval of a new BLA or a supplemental BLA before the change can be implemented. A supplemental BLA for a new indication typically requires clinical data similar to that in the original application, and the FDA generally uses the same procedures and actions in reviewing a supplemental BLA as it does in reviewing a new BLA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Product approvals may be withdrawn if compliance with regulatory standards is not maintained or if safety or manufacturing problems occur following initial marketing. For example, quality control and manufacturing procedures must conform, on an ongoing basis, to cGMP requirements, and the FDA periodically inspects manufacturing facilities to assess compliance with cGMP. Accordingly, manufacturers must continue to spend time, money and effort to maintain cGMP compliance. In addition, new or modified government requirements, including from new legislation, may be established that could delay or prevent regulatory approval of Sesen Bio&#8217;s product candidates under development or affect its ability to maintain product approvals it has obtained. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Biosimilars and Market Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Biologics Price Competition and Innovation Act of 2009, or BPCIA, the FDA can approve products that are biosimilar to (but not generic copies of) innovative biologics on the basis of less extensive data than is required by a full BLA. To be biosimilar, a biological product must be highly similar to an already-licensed FDA biological product, or reference product and can have no clinically meaningful differences in safety, purity and potency from the reference product. An interchangeable biosimilar product must meet additional standards for interchangeability and, if approved, may be substituted for the reference product. At this juncture, it is unclear whether any biosimilar product deemed &#8220;interchangeable&#8221; by the FDA, in fact, will be readily substituted by pharmacies, which are governed by state pharmacy law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After an innovator has marketed its product for four&#160;years, a manufacturer may file an application for approval of a &#8220;biosimilar&#8221; version of the innovator product. However, although an application for approval of a biosimilar may be filed four&#160;years after approval of the innovator product, qualified innovative biological products receive 12&#160;years of regulatory exclusivity, meaning that the FDA may not approve a biosimilar version until 12&#160;years after the innovative biological product was first approved by the FDA under the PHSA. The BPCIA also provides a mechanism for innovators to enforce the patents that protect </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">240</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">innovative biological products and for biosimilar applicants to challenge the patents. Such patent litigation may begin as early as four&#160;years after the innovative biological product is first approved by the FDA. Although the patents for the reference biologic may be challenged by the biosimilar applicant during that time period pursuant to the BPCIA statutory patent challenge framework, no biosimilar or interchangeable product will be licensed by the FDA until the end of the exclusivity period. The first biologic product candidate submitted under the abbreviated approval pathway that is determined to be interchangeable with the reference product has exclusivity against any other determinations of interchangeability to the reference product for the lesser of (i)&#160;one year after first commercial marketing of the interchangeable biosimilar product, (ii)&#160;18&#160;months after approval of the interchangeable biosimilar product if there is no legal challenge, (iii)&#160;18&#160;months after the resolution in the interchangeable biosimilar product applicant&#8217;s favor of a lawsuit challenging the reference product&#8217;s patents, and (iv)&#160;42&#160;months after approval of the interchangeable biosimilar product if a lawsuit is ongoing within the 42-month period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The objectives of the BPCIA are conceptually similar to those of the Hatch-Waxman Act, which established abbreviated pathways for the approval of generic drugs. The FDA has published several guidance documents providing direction on developing and obtaining approval of biosimilar product candidates. The guidance documents to date explain, among other things, that the FDA will approve a biosimilar product if there are no clinically meaningful differences between the biological product and the reference product in terms of safety, purity and potency. A determination of biosimilarity may be based upon: (1)&#160;analytical studies showing that the biological product is highly similar to, with no clinically meaningful differences from, the reference product, (2)&#160;animal studies, including toxicity assessments, and/or (3)&#160;a clinical trial or trials (including assessment of immunogenicity and PKs) that are sufficient to demonstrate safety, purity and potency in one or more appropriate conditions of use for which the reference product is licensed and for which licensure is sought for the biological product. The FDA recommends that sponsors use a stepwise approach to developing the data and information needed to support biosimilarity. At each step, the sponsor should evaluate the extent of residual uncertainty of biosimilarity that remains and incorporate the FDA&#8217;s advice for additional studies to address remaining uncertainty. To meet the higher standard for interchangeability the sponsor must demonstrate, in addition to biosimilarity, that the proposed biological product can be expected to produce the same clinical result and, if administered more than once to any given patient, the safety risk and potential for diminished efficacy associated with switching between the proposed biological product and the reference product is not greater than continuing to use the reference product. A biological product that is determined to be interchangeable may be substituted for the reference product without the intervention of the prescribing healthcare provider. In March&#160;2015, the FDA approved the first biosimilar product under the BPCIA, and it has approved other biosimilar products since then. If Sesen Bio were to resume development of Vicineum and obtain approval by the FDA, the approval of a biosimilar to Vicineum could have a material impact on Sesen Bio. In particular, a biosimilar could be significantly less costly to bring to market and priced significantly lower than Vicineum, if approved by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The &#8220;Purple Book,&#8221; first published by the FDA in September&#160;2014, lists biological products, including any biosimilar and interchangeable biological products licensed by the FDA under the PHSA. The lists include the date a biological product was licensed under Section&#160;351(a) of the PHSA and whether the FDA evaluated the biological product for reference product exclusivity under Section&#160;351(k)(7) of the PHSA. The Purple Book will also enable a user to see whether a biological product licensed under Section&#160;351(k) of the PHSA has been determined by the FDA to be biosimilar to or interchangeable with a reference biological product. Biosimilar and interchangeable biological products licensed under Section&#160;351(k) of the PHSA will be listed under the reference product to which biosimilarity or interchangeability was demonstrated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Advertising and Promotion</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA and other federal regulatory agencies closely regulate the marketing and promotion of biologics through standards and regulations for, among other things, direct-to-consumer advertising, communications regarding unapproved uses, industry-sponsored scientific and educational activities, and promotional activities involving the internet. A biologic cannot be promoted before it is approved. After approval, promotion of a biologic can include only those claims relating to safety and effectiveness that are consistent with the labeling approved by the FDA. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">241</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers are permitted, however, to prescribe products for unapproved uses (also known as &#8220;off-label&#8221; uses)&#8201;&#8212;&#8201;that is, uses not approved by the FDA and therefore not described in the product&#8217;s labeling&#8201;&#8212;&#8201;because the FDA does not regulate the practice of medicine. However, the FDA restricts manufacturers&#8217; communications regarding unapproved uses. Broadly speaking, a manufacturer may not promote a product for an unapproved use, but may engage in non-promotional, balanced communication regarding unapproved uses under specified conditions. Failure to comply with applicable FDA requirements and restrictions in this area may subject a company to adverse publicity and enforcement action by the FDA, the United States Department of Justice, or DOJ, or the Office of Inspector General of the United States Department of Health and Human Services, or HHS, as well as state authorities. Such enforcement action could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Post-approval Regulation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After regulatory approval of a product is obtained, a company is required to comply with a number of post-approval requirements. For example, as a condition of BLA approval, the FDA may require post-marketing testing, including Phase&#160;4 clinical trials, and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization. Regulatory approval of oncology products often requires that patients in clinical trials be followed for long periods to determine the overall survival benefit of the product. In addition, as a holder of an approved BLA, a company would be required to report adverse reactions and production problems to the FDA, to provide updated safety and efficacy information, and to comply with requirements concerning advertising and promotional labeling for any of its products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The manufacturing of Sesen Bio&#8217;s product candidates is required to comply with applicable FDA manufacturing requirements contained in the FDA&#8217;s cGMP regulations. Biologic manufacturers and other entities involved in the manufacture and distribution of approved biologics are also required to register their establishments and list any products they make with the FDA and to comply with related requirements in certain states. The FDA and certain state agencies periodically inspect manufacturing facilities to assess compliance with cGMP and other laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Discovery of problems with a product after approval may result in serious and extensive restrictions on a product or the manufacturer or holder of an approved BLA, as well as lead to potential market disruptions. These restrictions may include suspension of product manufacturing until the FDA is assured that quality standards can be met, continuing oversight of manufacturing by the FDA under a &#8220;consent decree,&#8221; which frequently includes the imposition of costs and continuing inspections over a period of many&#160;years, as well as possible withdrawal of the product from the market. Other potential consequences include interruption of production, issuance of warning letters or other enforcement letters, refusal to approve pending BLAs or supplements to approved BLAs, product seizure or detention, and injunctions or imposition of civil and/or criminal penalties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation, correction, and reporting of any deviations from cGMP and impose reporting and documentation requirements upon a company and any third-party manufacturers that a company may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Newly discovered or developed safety or effectiveness data may require changes to a product&#8217;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures, such as additional post-market clinical trials to assess new safety risks or distribution-related or other restrictions under a REMS. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patent Term Extension</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Were Sesen Bio to resume development of Vicineum, depending upon the timing, duration and specifics of the FDA approval, some of its U.S. patents may be eligible for limited patent term extension. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">242</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The provisions of the Hatch-Waxman Act permit a patent term extension of up to five&#160;years as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14&#160;years from the product&#8217;s approval date. The patent term restoration period is generally one-half the time between the effective date of an IND and the submission date of a BLA plus the time between the submission date of a BLA and the approval of that application. Only one patent applicable to an approved product is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, were Sesen Bio to resume development of Vicineum, Sesen Bio may apply for patent term extension for one of its currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant BLA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many other countries also provide for patent term extensions or similar extensions of patent protection for biologic products. For example, in Japan, it may be possible to extend the patent term for up to five&#160;years and in Europe, it may be possible to obtain a supplementary patent certificate that would effectively extend patent protection for up to five&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Foreign Corrupt Practices Act</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FCPA prohibits any United States individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any non-U.S. official, political party or candidate for the purpose of influencing any act or decision of the non-U.S. entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring such companies to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">European Union and other International Government Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to regulations in the United States, Sesen Bio will be subject to a variety of regulations in other jurisdictions governing, among other things, clinical trials and any commercial sales and distribution of its product candidates. Whether or not Sesen Bio obtains FDA approval for a product candidate, it must obtain the requisite approvals from regulatory authorities in countries outside of the United States prior to the commencement of clinical trials or marketing of a product in those countries should Sesen Bio resume development of Vicineum. Some countries outside of the United States have a similar process that requires the submission of a CTA much like the IND prior to the commencement of human clinical trials. In the E.U., for example, a CTA must be submitted to the competent authorities of the E.U. Member States where the clinical trial is conducted and to an independent ethics committee, much like the FDA and IRB, respectively. Once the CTA is approved in accordance with a country&#8217;s requirements, clinical trial development may proceed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Marketing Authorization Application for Biologic Medicinal Products</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Should Sesen Bio resume development of Vicineum and seek regulatory approval under E.U. regulatory systems, it must submit a marketing authorization application. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the E.U., a marketing authorization for a medicinal product can be obtained through a centralized, mutual recognition, decentralized procedure, or national procedure (single country). The centralized procedure is mandatory for certain medicinal products, including orphan medicinal products and certain biologic products and optional for certain other products, including medicinal products that are a significant therapeutic, scientific or technical innovation, or whose authorization would be in the interest of public or animal health. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In accordance with the centralized procedure, the applicant can submit a single application for marketing authorization to the EMA which will provide a positive opinion regarding the application if it meets certain quality, safety, and efficacy requirements. Based on the opinion of the EMA, the European </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">243</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Commission takes a final decision to grant a centralized marketing authorization which permits the marketing of a product in all 27 E.U. Member States and three of the four European Free Trade Association States&#8201;&#8212;&#8201;Iceland, Liechtenstein and Norway. Under the centralized procedure in the E.U., the maximum timeframe for the evaluation of a marketing authorization application is 210&#160;days (excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the EMA CHMP. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For other countries outside of the E.U., such as the United Kingdom and countries in Eastern Europe, Latin America or Asia, the requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. Internationally, clinical trials are generally required to be conducted in accordance with GCPs, applicable regulatory requirements of each jurisdiction and the medical ethics principles that have their origin in the Declaration of Helsinki. If Sesen Bio fails to comply with applicable non-U.S. regulatory requirements, it may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Advertising, Promotion and Compliance</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the E.U., the advertising and promotion of Sesen Bio&#8217;s products will also be subject to E.U. laws and E.U. Member States&#8217; national laws governing promotion of medicinal products, interactions with physicians, misleading and comparative advertising and unfair commercial practices. Other E.U. Member State national legislation may also apply to the advertising and promotion of medicinal products. These laws require that promotional materials and advertising in relation to medicinal products comply with the product&#8217;s Summary of Product Characteristics, or SmPC, as approved by the competent authorities. The SmPC is the document that provides information to physicians concerning the safe and effective use of the medicinal product. The SmPC forms an intrinsic and integral part of the marketing authorization granted for the medicinal product. Promotion of a medicinal product that does not comply with the SmPC is considered to constitute off-label promotion and is prohibited in the E.U. The applicable laws at the E.U. level and in the individual E.U. Member States also prohibit the direct-to-consumer advertising of prescription-only medicinal products. Violations of the rules governing the promotion of medicinal products in the E.U. could be penalized by administrative measures, fines and imprisonment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During all phases of development (pre- and post-marketing), failure to comply with applicable regulatory requirements may result in administrative or judicial sanctions. These penalties could include the imposition of a clinical hold on trials, refusal to approve pending applications, withdrawal of an approval, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, product detention or refusal to permit the import or export of products, injunctions, fines, civil penalties or criminal prosecution. Any agency or judicial enforcement action could have a material adverse effect on Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Orphan Drug Designation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may grant Orphan Drug Designation to biologics intended to treat a rare disease or condition that affects fewer than 200,000 individuals in the United States or a disease or condition that affects more than 200,000 individuals in the United States but there is no reasonable expectation that the cost of developing and making the biologic would be recovered from sales in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, Orphan Drug Designation entitles a party to financial incentives, such as opportunities for grant funding towards clinical trial costs, tax credits for certain research and user fee waivers under certain circumstances. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation, the product is entitled to seven&#160;years of market exclusivity, which means the FDA may not approve any other application for a biologic for the same indication for a period of seven&#160;years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity. The FDA can revoke a product&#8217;s orphan drug exclusivity under certain circumstances, including when the product sponsor is unable to assure the availability of sufficient quantities of the product to meet patient needs. Orphan drug exclusivity does not prevent the FDA from approving a different drug for the same disease or condition, or the same biologic for a different disease or condition. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">244</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the E.U., medicinal products: (a)&#160;that are used to diagnose, treat or prevent life-threatening or chronically debilitating conditions that affect no more than five in 10,000 people in the E.U.; or (b)&#160;that are used to treat or prevent life-threatening, seriously debilitating or serious and chronic conditions and that, for economic reasons, would be unlikely to be developed without incentives; and (c)&#160;where no satisfactory method of diagnosis, prevention or treatment of the condition concerned exists, or, if such a method exists, the medicinal product would be of significant benefit to those affected by the condition, may be granted an orphan designation in the E.U. The application for orphan designation must be submitted to the EMA and approved by the European Commission before an application is made for marketing authorization for the product. Once designated, Orphan medicinal product designation also entitles a party to financial incentives such as reduction of fees or fee waivers. Moreover, ten&#160;years of market exclusivity is granted following marketing authorization, if the product continues to be designated as an orphan medicinal product upon grant of the marketing authorization. During this ten-year period, with a limited number of exceptions, neither the competent authorities of the E.U. Member States, the EMA, or the European Commission are permitted to accept applications or grant marketing authorization for other similar medicinal products with the same therapeutic indication. However, marketing authorization may be granted to a similar medicinal product with the same orphan indication during the ten-year period with the consent of the marketing authorization holder for the original orphan medicinal product or if the manufacturer of the original orphan medicinal product is unable to supply sufficient quantities. Marketing authorization may also be granted to a similar medicinal product with the same orphan indication if this latter product is demonstrated to be safer, more effective or otherwise clinically superior to the original orphan medicinal product. This period of market exclusivity may be reduced to six&#160;years, at the end of the fifth year, if the orphan designation criteria are no longer met, including where it can be demonstrated on the basis of available evidence that the product is sufficiently profitable not to justify maintenance of market exclusivity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Orphan drug designation must be requested before submission of an application for marketing approval or marketing authorization. Orphan drug designation does not convey any advantage in, nor shorten the duration of the regulatory review and approval process. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Expedited Programs in the United States and Other Jurisdictions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, a product may be granted Fast Track designation if it is intended for the treatment of a serious or life-threatening condition and demonstrates the potential to address unmet medical needs for such condition. With Fast Track designation, the sponsor may be eligible for more frequent opportunities to obtain the FDA&#8217;s feedback, and the FDA may initiate review of sections of a BLA before the application is complete. This Rolling Review is available if the applicant provides, and the FDA approves, a schedule for the remaining information. Even if a product receives Fast Track designation, the designation can be rescinded and provides no assurance that a product will be reviewed or approved more expeditiously than would otherwise have been the case, or that the product will be approved at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">FDA may designate a product candidate as a breakthrough therapy if it finds that the product candidate is intended, alone or in combination with one or more other product candidates or approved products, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the product candidate may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. For product candidates designated as breakthrough therapies, more frequent interaction and communication between the FDA and the sponsor can help to identify the most efficient path for clinical development. Product candidates designated as breakthrough therapies by the FDA may also be eligible for Priority Review. The receipt of a breakthrough therapy designation for a product candidate may not result in a faster development process, review or approval compared to product candidates considered for approval under conventional FDA procedures and, in any event, does not assure ultimate approval by the FDA. In addition, even if a product candidate qualifies as a breakthrough therapy, the FDA may later decide that the product candidate no longer meets the conditions for designation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accelerated approval under FDA regulations allows a product designed to treat a serious or life-threatening disease or condition that provides a meaningful therapeutic advantage over available therapies to be approved on the basis of either an intermediate clinical endpoint or a surrogate endpoint that is reasonably likely to predict clinical benefit. Approvals of this kind typically include requirements for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">245</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tEMP">&#8203;</a><a name="tCOIN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">confirmatory clinical trials to be conducted with due diligence to validate the surrogate endpoint or otherwise confirm clinical benefit and for all promotional materials to be submitted to the FDA for review prior to dissemination. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may grant Priority Review designation to a product candidate, which sets the target date for FDA action on the application at six&#160;months from FDA filing, or eight&#160;months from the sponsor&#8217;s submission. Priority Review may be granted where a product is intended to treat a serious or life-threatening disease or condition and, if approved, has the potential to provide a safe and effective therapy where no satisfactory alternative therapy exists or a significant improvement in safety or efficacy compared to available therapy. If criteria are not met for Priority Review, the standard FDA review period is ten&#160;months from FDA filing or 12&#160;months from sponsor submission. Priority Review designation does not change the scientific/medical standard for approval or the quality of evidence necessary to support approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Centralized Procedure in the E.U., the maximum timeframe for the evaluation of a marketing authorization application is 210&#160;days (excluding &#8220;clock stops,&#8221; when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP. Accelerated evaluation might be granted by CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, which should be justified and assessed on a case-by-case basis. In this circumstance, EMA ensures that the opinion of CHMP is given within 150&#160;days. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Environmental and Safety Laws</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is subject to a variety of federal, provincial and local regulations relating to the use, handling, storage and disposal of hazardous materials, including chemicals and radioactive and biological materials. Sesen Bio&#8217;s operations involve such hazardous materials and produce such hazardous waste products. Although Sesen Bio believes that its safety procedures for handling and disposing of these materials comply with the standards prescribed by federal, provincial and local regulations, the risk of accidental contamination or injury from these materials cannot be eliminated. Radioactive materials in Canada come under federal jurisdiction. Canada&#8217;s Nuclear Safety and Control Act 1997 c.9 contains a general prohibition against any activity, including possession of radioactive material, except in accordance with the terms and conditions set out in a federal license issued by the Canadian Nuclear Safety Commission. The Nuclear Substances and Radiation Devices Regulation does however, exempt licensing requirements for small quantities of radioactive substances that either meet concentrations set out in a schedule to the Regulation or, for radioactive substances not set out in the schedule, that meet certain regulatory criteria. Sesen Bio&#8217;s operations do not currently require a federal license issued by the Canadian Nuclear Safety Commission. Sesen Bio&#8217;s operations in Canada may be subject to license approvals, notification requirements and investigation and enforcement for air and water and waste matters. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, Sesen Bio employed 17 individuals, all of whom are full-time employees. Sesen Bio has never had a work stoppage, and none of its employees are represented by a labor organization or covered by collective bargaining arrangements. Sesen Bio considers its relationship with its employees to be good. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Corporate Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a Delaware corporation formed in February&#160;2008. Sesen Bio&#8217;s principal executive offices are located in Cambridge, Massachusetts. Sesen Bio&#8217;s website address is www.sesenbio.com. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Acquisition of Viventia</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, Sesen Bio entered into a Share Purchase Agreement with Viventia Bio, Inc., a corporation incorporated under the laws of the Province of Ontario, Canada, the shareholders of Viventia named therein, collectively, the selling shareholders, and, solely in its capacity as seller representative, Clairmark Investments Ltd., a corporation incorporated under the laws of the Province of Ontario, Canada, or Clairmark, pursuant to which Sesen Bio agreed to and simultaneously completed the acquisition of all of the outstanding capital stock of Viventia from the Selling Shareholders, or the Viventia Acquisition. In </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">246</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tLEPR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">connection with the closing of the Viventia Acquisition, Sesen Bio issued 4.0&#160;million shares of Sesen Bio common stock to the selling shareholders according to their pro&#160;rata share of Viventia&#8217;s then-outstanding shares of common stock, which represented approximately 19.9% of Sesen Bio voting power as of immediately prior to the issuance of such shares of common stock. Clairmark is an affiliate of Leslie L. Dan, who served on the Sesen Bio board of directors until his retirement in July&#160;2019. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the Viventia Acquisition, Sesen Bio is obligated to pay to the selling shareholders certain post-closing contingent cash payments upon the achievement of specified milestones and based upon net sales, in each case subject to the terms and conditions set forth in the Share Purchase Agreement, including: (i)&#160;a one-time milestone payment of $12.5&#160;million payable upon the first sale of Vicineum, in the United States; (ii)&#160;a one-time milestone payment of $7.0&#160;million payable upon the first sale of Vicineum in any one of certain specified European countries; (iii)&#160;a one-time milestone payment of $3.0&#160;million payable upon the first sale of Vicineum in Japan; and (iv)&#160;and quarterly earn-out payments equal to 2% of net sales of Vicineum during specified earn-out periods. Such earn-out payments are payable with respect to net sales in a country beginning on the date of the first sale in such country and ending on the earlier of (i)&#160;December&#160;31, 2033, and (ii)&#160;fifteen&#160;years after the date of such sale, subject to early termination in certain circumstances if a biosimilar product is on the market in the applicable country. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Share Purchase Agreement, Sesen Bio, its affiliates, licensees and subcontractors are required to use commercially reasonable efforts, for the first seven&#160;years following the closing of the Viventia Acquisition, to achieve marketing authorizations throughout the world and, during the applicable earn-out period, to commercialize Vicineum in the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China and Canada. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio makes available free of charge annual reports on Form 10-K, quarterly reports on Form&#160;10-Q, current reports on Form 8-K and amendments to those reports, as soon as reasonably practicable after they are electronically filed or furnished to the SEC, on Sesen Bio&#8217;s website at www.sesenbio.com or by contacting Sesen Bio at (617) 444-8850. The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC at www.sec.gov. The inclusion of any website address in this proxy statement/prospectus is an inactive textual reference only, and information contained on or accessible through these websites is not a part of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s corporate headquarters are currently located in Cambridge, Massachusetts and consists of approximately 150 square feet, where Sesen Bio occupies office space under a lease that was executed in October&#160;2016. The initial term of the lease expired in July&#160;2017, with the lease now continuing on a month-to-month basis unless terminated by either party with the requisite notice. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has office space in Philadelphia, Pennsylvania, where Sesen Bio occupies office space under a lease executed in December&#160;2017. The initial term of the lease expired in May&#160;2018, which now continues on a month-to-month basis unless terminated by either party with the requisite notice. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7,2021, three substantially identical securities class action lawsuits captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Bibb v. Sesen Bio, Inc., et. al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07025, </font><font style="font-style:italic;letter-spacing:0.2pt;">Cizek v. Sesen Bio, Inc., et.&#160;al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07309 and </font><font style="font-style:italic;letter-spacing:0.2pt;">Markman v. Sesen Bio, Inc. et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-08308 were filed against Sesen Bio and certain of its officers in the U.S. District Court for the Southern District of New York. The three complaints alleged violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by Sesen Bio concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints sought compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption </font><font style="font-style:italic;letter-spacing:0.2pt;">In re Sesen Bio, Inc. Securities Litigation</font><font style="letter-spacing:0.2pt;">, Master File No. 1:21-cv-07025-AKH, and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj as the Lead Plaintiffs under the Private </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">247</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:128pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. On November&#160;24, 2021, defendants filed a motion to transfer venue to the U.S. District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed the Amended Complaint. The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. The defendants moved to dismiss the Amended Complaint on March&#160;7, 2022, and that motion was fully briefed on May&#160;6, 2022. On June&#160;3, 2022, before the court ruled on the motion to dismiss, the parties requested that the court hold any decision on the motion to dismiss in abeyance to provide the parties with an opportunity to engage in mediation. On June&#160;30, 2022 and July&#160;6, 2022, Sesen Bio and the plaintiffs engaged in mediation sessions in an attempt to resolve the Securities Litigation and continued to discuss a potential settlement over the following weeks. On July&#160;19, 2022, the parties reached an agreement in principle to settle the Securities Litigation. Pursuant to that agreement, Sesen Bio and the individual defendants will pay or cause to be paid to members of the class who submit timely and valid proofs of claims. In exchange, the Lead Plaintiffs will dismiss the action and all class members who do not timely and validly opt-out of the settlement will provide broad customary releases to Sesen Bio and the individual defendants. On August&#160;3, 2022, the parties entered into a Stipulation and Agreement of Settlement to settle the Securities Litigation, which was filed with the court on August&#160;17, 2022. The Stipulation and Agreement of Settlement related to the Securities Litigation provides for a settlement payment of $21.0&#160;million to the class and the dismissal of all claims against Sesen Bio and the other defendants. The settlement payment is being funded by Sesen Bio and its insurance carriers. On September&#160;1, 2022, the U.S. District Court for the Southern District of New York issued an order denying the motions to appoint a different lead plaintiff. On September&#160;28, 2022, the court issued an order granting preliminary approval of the proposed settlement of the Securities Litigation. The court has set a final settlement approval hearing for January&#160;23, 2023 at 10:00&#160;a.m. Eastern Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On November 28, 2022, a purported Sesen Bio stockholder filed a complaint in the U.S. District Court for the Southern District of New York against Sesen Bio and the Sesen Bio board of directors, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:22-cv-10085 (S.D.N.Y.). The Original Keller Complaint asserts claims against Sesen Bio and the Sesen Bio board of directors under Section 14(a) of the Exchange Act and Rule&#160;14a-9 promulgated thereunder for allegedly false and misleading statements in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and under Section 20(a) of the Exchange Act for alleged &#8220;control person&#8221; liability with respect to such allegedly false and misleading statements and seeks, among other relief, an order enjoining the merger and an award for plaintiffs&#8217; fees and costs. On December 20, 2022, the purported stockholder voluntarily dismissed his complaint and on December&#160;21, 2022, filed a new complaint as a putative class action in the Court of Chancery for the State of Delaware, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 2022-1186 (Del. Ch. Dec. 21, 2022). Along with the complaint, the purported stockholder filed motions for expedited proceedings and for a preliminary injunction to enjoin the Sesen Bio special meeting. The New Keller Complaint and associated filings contain substantially the same assertions as the Original Keller Complaint and the Demand Letters. Sesen Bio believes that the claims asserted in the Demand Letters, the Section&#160;220 Demand and the New Keller Complaint are without merit. At this time, no assessment can be made as to the likely outcome or whether the outcome will be material to Sesen Bio.</font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">248</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCABU">&#8203;</a><a name="tOVE1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is a clinical stage cell therapy company focused on utilizing Carisma&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. Carisma has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells. Macrophages and monocytes are part of the innate immune system and can detect and degrade harmful substances through a process referred to as phagocytosis, in which the harmful substance is engulfed and destroyed and in turn leads to the activation of a broad immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To harness the powerful immunologic functions of macrophages against cancer, Carisma has developed a proprietary Chimeric Antigen Receptor Macrophage, or CAR-M, platform technology. Chimeric antigen receptors, or CARs, are synthetically engineered receptors that are designed to bestow immune cells with the ability to target specific antigens on the surface of cancer cells. By introducing CARs into macrophage and monocyte cells, Carisma aims to redirect their potent innate immune functions against cancer. Carisma&#8217;s CAR-M platform technology incorporates proprietary tumor targeting constructs, vectors to deliver CARs to macrophages and monocytes and novel manufacturing processes. Carisma&#8217;s CAR-M therapeutics are designed to infiltrate the solid tumor microenvironment, kill cancer cells via targeted phagocytosis, and activate other immune cells, such as T-cells, to initiate a robust anti-tumor immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s lead product candidate CT-0508, the first CAR-M to be evaluated in a human clinical trial, is an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous cell therapy product candidate, wherein immune cells from blood drawn from a patient are engineered outside of the body and reinfused into the same patient. CT-0508 is intended to treat solid tumors that overexpress HER2, a protein that is overexpressed on the surface of a variety of solid tumors, including breast cancer, gastric cancer, esophageal cancer, salivary gland cancer, and numerous others. Carisma has completed enrollment of the first group of patients in a Phase&#160;1 clinical trial of CT-0508, with nine patients having been successfully dosed. In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the tumor microenvironment, or TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. Carisma anticipates providing multiple clinical data updates over the next 18&#160;months. In the combination setting, Carisma has observed the synergistic potential of CT-0508 with a PD1 blocking T-cell checkpoint inhibitor in pre-clinical models, enabling a combination trial with pembrolizumab. Carisma submitted a clinical protocol amendment to the FDA in September&#160;2022 to allow Carisma to treat patients with the co-administration of CT-0508 and pembrolizumab. The FDA has granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors and Carisma plans to prioritize development for this indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beyond CT-0508, Carisma has a broad pipeline of cell therapy assets in various stages of pre-clinical development. In addition to the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> CAR-M cell therapies, Carisma is also developing </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M gene therapies, wherein immune cells are directly engineered within the patient&#8217;s body. To advance its </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics, Carisma established a strategic collaboration with ModernaTX, Inc., or Moderna, focused on the development and potential commercialization of up to 12 product candidates, of which four have already been nominated. In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s myeloid cell specific lipid nanoparticle/mRNA, or LNP/mRNA, technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology gene therapies. Carisma believes this approach has the potential to enable a series of off-the-shelf product candidates to target a patient&#8217;s own myeloid cells against cancer cells directly within their body. As part of the agreement with Moderna, Carisma received a $45.0&#160;million up-front cash payment and an investment by Moderna in the form of a $35.0&#160;million convertible note, in addition to future research funding and the opportunity for milestone payments and royalties. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">249</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:125.43pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Through its robust internal discovery engine, Carisma is building upon its platform to enhance and expand the utility of macrophage cell and gene therapies, leading to the creation of multiple product candidates with the potential to treat cancer and other serious diseases. By replacing the targeting domain of the CAR, Carisma can reprogram the target antigen specificity of the CAR-M cell product and develop candidates against a range of cancer indications and therapeutic areas beyond oncology. As a result, Carisma believes the flexibility of its macrophage and monocyte cell engineering platform will allow Carisma to generate new product candidates suitable for clinical development in a cost-efficient manner to expand its pipeline. In addition to acting as a first line of defense in the innate immune system, macrophages are found in all tissues in the body where they serve key regulatory functions such as wound healing, termination of immune responses, and tissue regeneration. Using its macrophage and monocyte </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineering platform, Carisma is pursuing early research and development of multiple assets for the potential treatment of diseases beyond oncology, including liver fibrosis, neurodegeneration, and other immunologic and inflammatory diseases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">By investing in early platform research and accessing key enabling technologies, Carisma is enhancing and expanding its platform capabilities and reinforcing its leadership position in the engineered macrophage field. Carisma has developed proprietary CAR-M platform enhancements directed toward key product parameters that are important for efficacy, safety, and patient access to its CAR-M therapies. Carisma plans to apply these technology enhancements to future CAR-M product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Pipeline Programs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Using its proprietary CAR-M platform technology, Carisma is developing a broad pipeline of product candidates, with a strong initial focus in oncology. Carisma&#8217;s </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous CAR-M product candidates are summarized in the table below. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d8-tbl_pipelin4c.jpg" alt="[MISSING IMAGE: tm2227887d8-tbl_pipelin4c.jpg]" height="244" width="578" >
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">250</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is also advancing discovery-stage candidates across a range of therapeutic areas, as summarized in the following table. </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d8-tbl_oncolog4c.jpg" alt="[MISSING IMAGE: tm2227887d8-tbl_oncolog4c.jpg]" height="347" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s lead product candidate, CT-0508, is an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous cell therapy product candidate intended to treat solid tumors that overexpress HER2, a protein that is overexpressed on the surface of a variety of solid tumors including breast cancer, gastric cancer, esophageal cancer, salivary gland cancer and numerous others. CT-0508 is produced by engineering a patient&#8217;s own monocyte-derived macrophages from blood drawn from the patient with a chimeric adenoviral vector, Ad5f35, containing an anti-HER2 CAR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has completed enrollment of the first group of patients in a Phase&#160;1 clinical trial, with nine patients successfully dosed. The second group is currently open for enrollment, with nine additional patients to be dosed. In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. Carisma anticipates providing multiple clinical data updates over the next 18&#160;months. In the combination setting, Carisma has observed the synergistic potential of CT-0508 with a PD1 blocking T-cell checkpoint inhibitor in pre-clinical models, enabling a combination trial with pembrolizumab. Carisma submitted a clinical protocol amendment to the FDA in September&#160;2022 to allow it to treat patients with the co-administration of CT-0508 and pembrolizumab. The FDA has granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors and Carisma plans to prioritize development for this indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is currently in the pre-clinical stage for another product candidate, CT-0525, which is also intended to treat solid tumors that overexpress HER2. By leveraging its discovery engine and preliminary clinical data from its Phase&#160;1 clinical trial of CT-0508, Carisma is building upon its CAR-M platform to generate next-generation therapeutics that may increase potential efficacy and patient access. Notably, Carisma has developed a novel approach to CAR-M therapy to accelerate the manufacturing process, increase the cell yield, and improve upon the potential anti-tumor effect by engineering patients&#8217; monocytes directly, without </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> differentiation into macrophages, as Carisma currently does for CT-0508. Carisma refers to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">251</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCATE">&#8203;</a><a name="tCAST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">this CAR-Monocyte approach as CAR-Mono. By increasing the cell yield, the CAR-Mono approach enables a larger potential dose, which may improve tumor control. The CAR-Mono approach reduces manufacturing time and leverages an automated, closed-system manufacturing process. CT-0525 is Carisma&#8217;s first CAR-Mono product candidate and is currently in the pre-clinical process development stage. Carisma expects to submit an IND to the FDA for CT-0525 in the third quarter of 2023 and initiate clinical development shortly thereafter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is also expanding its pipeline to include multiple tumor targets, encompassing diverse solid tumor indications with significant unmet medical needs, including the following product candidates: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CT-1119:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CT-1119 is a mesothelin targeted CAR-M that Carisma plans to evaluate in patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. Carisma has identified a lead construct for CT-1119 and expects to submit an IND to the FDA in 2025. In November 2022, Carisma presented preliminary and limited data demonstrating that CT-1119 can mediate phagocytosis, tumor cell killing, and pro-inflammatory cytokine release and control tumor growth in pre-clinical lung cancer models. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CT-0729:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CT-0729 is a prostate-specific membrane antigen, or PSMA, targeted CAR-M that Carisma plans to evaluate in patients with advanced, PSMA positive metastatic castrate resistant prostate cancer. CT-0729 is in the discovery stage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s current CAR-M cell therapy pipeline is informing the discovery and pre-clinical development of off-the-shelf engineered macrophage therapeutics. Carisma is developing </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed LNP/mRNA CAR-M therapies for cancer through its collaboration with Moderna. In addition, Carisma is establishing an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> allogeneic, induced pluripotent stem cell, or iPSC, derived macrophage and monocyte platform with the potential to develop iPSC-derived CAR-M and other macrophage therapies for indications in oncology and beyond, including indications such as liver fibrosis, neurodegeneration and auto-immunity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Team</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma was founded in 2016 by leading cell therapy experts from the University of Pennsylvania. Dr.&#160;Saar Gill is a co-inventor of the CAR-M technology and a co-founder of Carisma. He is an Associate Professor of Medicine in the Division of Hematology-Oncology at the University of Pennsylvania. Dr.&#160;Michael Klichinsky, Pharm.D., Ph.D., is a co-inventor of the CAR-M technology, a scientific co-founder of Carisma, and Carisma&#8217;s current Chief Scientific Officer. Dr.&#160;Carl June, a co-inventor of the CAR-M technology, is the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania. He also is currently Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine and Director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, and Scientific Advisor to Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s executive team has decades of experience in business operations, discovery, development, and manufacturing of advanced therapeutics for the treatment of serious diseases. Steven Kelly, Carisma&#8217;s Chief Executive Officer, brings over 35&#160;years of experience in the biopharmaceutical industry at all phases of the business across multiple therapeutic categories. Carisma&#8217;s Chief Technology and Development Officer, Dr.&#160;Daniel Cushing, Ph.D., brings over 30&#160;years of experience in the biopharmaceutical industry and is responsible for product development at Carisma. Richard Morris, Carisma&#8217;s Chief Financial Officer, has more than 25&#160;years of experience in building and growing successful biotechnology organizations, with a focus on capital fundraising (including initial public offerings), financial strategy and operations execution, and business development efforts. Carisma&#8217;s Chief Business Officer, Tom Wilton, has over 25&#160;years of biopharmaceutical industry experience, including corporate strategy, business development, research and development operations, and marketing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s vision is to become a leading cell therapy company, developing and ultimately commercializing macrophage-based cell therapies that positively transform the treatment of cancer and other serious diseases. To achieve its vision, Carisma has developed its macrophage engineering platform, a pipeline of assets spanning numerous indications with unmet medical needs, a robust discovery engine, broad CAR-M </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">252</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">intellectual property, robust manufacturing capabilities, and a dedicated executive team with extensive experience in cell therapy and drug development, manufacturing and commercialization and leading scientific expertise in the field. The key components of Carisma&#8217;s strategy are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Advance Carisma&#8217;s lead product candidate, CT-0508, through clinical development for the treatment of HER2 overexpressing solid tumors.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CT-0508 is an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> gene-modified autologous CAR-M cell therapy product candidate intended to treat solid tumors that overexpress HER2. Carisma has completed enrollment of the first group of patients in a Phase&#160;1 clinical trial, with nine patients successfully dosed. The second group is currently open for enrollment, with nine additional patients to be dosed. In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. Additionally, the FDA granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors and Carisma plans to prioritize development for this indication. Carisma also plans to initiate multiple sub-studies to expand the utility of CT-0508, including combination therapy with a PD1 blocking T-cell checkpoint inhibitor in pre-clinical models, enabling a combination trial with pembrolizumab. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Invest in Carisma&#8217;s CAR-Mono platform technology to further extend its leadership position in macrophage and monocyte based cellular therapy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As part of its ongoing platform enhancement effort, Carisma has developed its CAR-Mono approach, which significantly reduces manufacturing time and leverages an automated, closed-system manufacturing process. Carisma is currently in the pre-clinical process development stage for CT-0525, Carisma&#8217;s first anti-HER2 CAR-Mono product candidate, and expects to submit an IND in the third quarter of 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Advance Carisma&#8217;s pre-clinical CAR-M oncology pipeline candidates to clinical development stage.</font><font style="letter-spacing:0.2pt;"> Beyond its initial HER2 target, Carisma is expanding its pipeline into multiple tumor targets and constructs. CT-1119 is a mesothelin targeted CAR-M that Carisma plans to evaluate in patients with advanced mesothelin-positive solid tumors, with an IND expected to be submitted in 2025. In November 2022, Carisma presented preliminary and limited data demonstrating that CT-1119 can mediate phagocytosis, tumor cell killing, and pro-inflammatory cytokine release and control tumor growth in pre-clinical lung cancer models. Additionally, CT-0729 is a PSMA targeted CAR-M intended for use against metastatic castrate resistant prostate cancer and is currently in the discovery stage. Carisma is also developing product candidates targeting other cancer antigens. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Build next-generation technologies to expand the scope and capabilities of Carisma&#8217;s platform.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Beyond its CAR-M and CAR-Mono technologies, Carisma is pursuing multiple platform enhancements for its CAR constructs, editing technologies and therapeutic delivery vehicles. Further, Carisma is actively developing a gene edited iPSC-derived macrophage platform and leveraging delivery technologies for its mRNA-based </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M platform for oncology. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Harness the potential of Carisma&#8217;s platform to develop novel product candidates to address therapeutic areas beyond oncology.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;While Carisma has initially been an oncology focused company, Carisma believes the breadth of the myeloid engineering platform enables significant opportunities outside of oncology. Based on early data related to Carisma&#8217;s novel therapeutic approach, Carisma believes its platform has significant potential across multiple therapeutic areas, including fibrosis, neurodegeneration, autoimmunity, and chronic inflammation, which are currently in the discovery stage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Selectively enter into strategic partnerships and collaborations to maximize the potential of Carisma&#8217;s platform.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Given the breadth of opportunities enabled by Carisma&#8217;s platform, Carisma may opportunistically enter into strategic collaborations intended to advance and accelerate its development programs, expand into new therapeutic areas and enhance the capabilities of its platform. Carisma currently has a broad strategic collaboration with Moderna focused on the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics for up to 12 oncology targets, of which four have already been nominated. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">253</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tBAC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cellular Immunotherapy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cellular immunotherapy is a type of immuno-oncology approach whereby human immune cells are utilized to recognize and destroy cancer cells in a targeted manner. To date, cellular immunotherapy has focused on the transfer of T-cells or natural killer, or NK, cells. For example, T-cells with intrinsic tumor reactivity, such as tumor infiltrating lymphocytes, have been utilized, as well as T-cells genetically engineered with tumor targeting T-cell receptors, or TCRs, or CARs, have been tested in a variety of hematologic malignancies and solid tumors. The only FDA approved genetically modified cellular immunotherapies for cancer are CAR T-cell therapies for B cell hematologic malignancies expressing CD19 or multiple myeloma expressing B-cell maturation antigen, or BCMA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Despite the incredible promise shown by cell therapies for hematologic malignancies, the success has not been replicated in the solid tumor setting. There are numerous challenges impacting T and NK cell immunotherapy in patients with solid tumors, such as the inability of cells to appropriately access the tumor microenvironment, overcome immunosuppression in the tumor microenvironment and overcome target antigen heterogeneity. Importantly, there have been challenges in targeting solid tumors with CAR T-cells without inducing toxicities against normal tissues or inducing severe systemic cytokine release syndrome, or CRS. To date, no CAR therapies for the treatment of solid tumors have received marketing approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Macrophages and Monocytes and the Tumor Microenvironment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages play a vital role in the innate immune system, the body&#8217;s first line of defense against foreign pathogens. Macrophages are highly plastic innate cells that mediate a multitude of protective and homeostatic functions, including elimination of pathogens through phagocytosis, clearance of cellular debris, induction or regulation of inflammation, antigen presentation, and tissue remodeling. Macrophages can arise from circulating bone marrow-derived monocytes or embryonic precursors and are found in all tissues in the human body. Depending on the environmental cues, macrophages can actively adopt distinct activation states, or phenotypes, to either initiate or terminate immune responses. While macrophage activation states are complex, they can be categorized into two general subsets: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Classically activated (M1):</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;M1 macrophages are pro-inflammatory and are associated with anti-tumoral functions. They initiate or enhance immune responses by recruiting T-cells, upregulating antigen processing machinery and co-stimulatory ligands, and secreting pro-inflammatory factors cytokines and chemokines, and ultimately promote T-cell responses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Alternatively activated (M2):</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;M2 macrophages are immunosuppressive and are associated with pro-tumoral functions. They accelerate tumor invasion and metastasis and promote angiogenesis (or formation of new blood vessels) by secreting inhibitory cytokines and upregulating immunosuppressive cell surface molecules, and ultimately inhibit T-cell responses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages are typically the most abundant immune cell in the TME of most cancers, where they generally adopt an M2 phenotype and are therefore associated with poor prognostic outcomes and increased intratumoral immunosuppression. For example, numerous studies have shown that patients with more M2 macrophages in their tumors have reduced responses to immune checkpoint inhibitors such as pembrolizumab. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Given the generally negative role of M2 macrophages in the TME, there have been numerous therapeutic approaches focused on inhibiting tumor associated macrophage, or TAM, infiltration or survival. Other approaches have sought to convert TAMs from an M2 to an M1 phenotype. While numerous studies have shown that TAM infiltration is typically associated with poor prognostic outcome, macrophages have been shown to have potent anti-tumor capabilities if appropriately activated and targeted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Opportunity for Engineered Macrophages in Treating Cancer</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma believes macrophage and monocyte cell therapies hold promise in addressing the limitations of other cell types and transforming the cell therapy treatment paradigm for solid tumors. The inherent biology of macrophages and monocytes offers several potential advantages that directly apply to current barriers for cell therapy efficacy in the solid tumor context. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">254</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages and monocytes are actively recruited into solid tumors, while other immune cells such as T-cells are often actively excluded. Macrophages are professional phagocytic cells capable of directly killing tumor cells through this unique mechanism. In addition to direct killing, macrophages can secrete pro-inflammatory factors that convert the immunosuppressive TME into an environment that promotes immunity. Importantly, macrophages and monocytes are professional antigen presenting cells, meaning they can directly present tumor-derived antigens to T-cells leading to anti-tumor T-cell responses, a phenomenon known as epitope spreading. Epitope spreading enables activity against tumor cells which either lack or lose expression of the initial antigen targeted by the CAR&#8201;&#8212;&#8201;a key challenge for cell therapies&#8201;&#8212;&#8201;and ultimately enables macrophages and monocytes to overcome target antigen heterogeneity within the patient&#8217;s cancer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma believes an approach which harnesses the direct effector functions of macrophages or monocytes, optimizes their activation status toward an inflammatory M1 phenotype, and redirects phagocytosis with molecular specificity would represent a major advance in cancer immunotherapy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Novel Platform</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CAR-M have the potential to address the key challenges involved in treating solid tumors: </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d8-fc_problem4c.jpg" alt="[MISSING IMAGE: tm2227887d8-fc_problem4c.jpg]" height="367" width="597" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">CAR-M have the ability to infiltrate solid tumors, phagocytose and destroy tumor cells directly, and present tumor-derived antigens leading to activation of the adaptive immune system. CAR-M mount anti-tumor immunity in numerous ways. First, CAR-M leverage the natural tumor-homing ability of macrophages and monocytes, the naturally most abundant immune cells in the TME, to traffic to both primary tumors and metastases, enabling engineered macrophages to act as a &#8220;Trojan horse,&#8221; tricking the tumor into recruiting engineered, anti-tumor CAR-M as if they were normal monocytes or macrophages. Once within the tumor, CAR-M directly kill antigen-expressing tumor cells through phagocytosis and secretion of cytotoxic factors. CAR-M secrete inflammatory cytokines and chemokines that promote a pro-inflammatory environment and lead to the recruitment of T-cells and other leukocytes. Finally, CAR-M serve as professional antigen-presenting cells for T-cells, inducing epitope spreading, systemic anti-tumor immunity, and immune memory against tumor antigens, expanding anti-tumor immunity to target negative tumor cells and potentially preventing antigen negative relapse. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">255</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_tumor4c.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_tumor4c.jpg]" height="245" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Historically, macrophages have been challenging to genetically engineer due to their inherent resistance to most commonly used genetic manipulation methods. Furthermore, controlling the activation state of macrophages has been a long-standing challenge. Carisma believes that it has overcome these challenges with its proprietary platform that efficiently engineers macrophage-based cell therapies and enables control of their activation state. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s proprietary platform enables the therapeutic use of engineered macrophages and monocytes for the treatment of cancer and other serious diseases and disorders. In its first application, solid tumors that overexpress HER2, the CAR-M platform is designed to identify and eradicate HER2 overexpressing tumor cells. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Currently, CAR-M are an individualized therapy that begin with the isolation of monocytes, the pre-cursor cell to macrophages, from blood drawn from a patient through a process called apheresis. The cells are purified, cultured, differentiated, and engineered with a CAR which bestows the macrophage with the ability to identify and eradicate cancer cells. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To enable its proprietary CAR-M therapy, Carisma had to overcome several key technical challenges, which are summarized by its platform capabilities: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Gene Delivery</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Carisma has identified Ad5f35, a chimeric adenoviral vector, as a highly efficient vector for introducing genes such as CARs into primary human macrophages and monocytes. Carisma has further developed additional proprietary technologies for </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> macrophage engineering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Activation State</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Carisma demonstrated that Ad5f35 transduction leads to M1 polarization of human macrophages and monocytes and renders them resistant to conversion to M2 by immunosuppressive environments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tumor targeting</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Carisma demonstrated that macrophage function can be harnessed against tumors in a targeted fashion via CARs. Carisma&#8217;s CARs enable antigen specific activation of macrophages and monocytes, antigen specific cancer cell phagocytosis and killing, and antigen specific release of pro-inflammatory cytokines and chemokines. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">T-cell activation</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;By appropriately engineering and polarizing CAR-M, Carisma has demonstrated that they are able to recruit and activate T-cells&#8201;&#8212;&#8201;a key aspect to solid tumor immunotherapy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cell manufacturing processes</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Carisma has developed manufacturing processes that enable the production of genetically engineered macrophages or monocytes for therapeutic use. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the case of Carisma&#8217;s lead product, CT-0508, a chimeric adenoviral vector, or Ad5f35, is used to deliver an anti-HER2 CAR which enables the macrophages to detect, phagocytose, kill, release inflammatory mediators, and initiate an immune reaction in response to HER2 overexpressing tumor cells. The resulting CAR-M, which are adenovirally transduced and locked into a pro-inflammatory M1 phenotype during the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">256</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">manufacturing process, are cryopreserved and shipped back to the patient for reinfusion. Reinfused CAR-M rapidly egress from peripheral blood and infiltrate tumor sites. Once in the tumor, CAR-M are activated by tumor-associated antigen engagement with the CAR, signaling via an intracellular signaling domain to phagocytose the tumor cell and release pro-inflammatory cytokines and chemokines that &#8220;warm up&#8221; the TME. They produce locally acting mediators that reprogram the TME, drawing in T-cells and NK cells, activating nearby antigen presenting cells, or APCs, such as dendritic cells, or DCs, and repolarizing immunosuppressive TAMs toward an M1 phenotype. In addition to direct phagocytosis of tumor cells, CAR-M present a patient&#8217;s unique array of tumor antigens to T-cells, leading to a broad adaptive immune response that has the potential to generate broad anti-tumor immunity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-clinical Data</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma evaluated its CAR-M platform in a variety of pre-clinical </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> model systems and published its foundational data in Nature Biotechnology in March&#160;2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">First, Carisma found that Ad5f35 led to the efficient transduction of human macrophages and could be utilized to produce human CAR-M. CAR-M mediated potent antigen-specific phagocytosis and tumor killing in a targeted fashion. CAR-M took on an activated M1 phenotype, expressed pro-inflammatory cytokines and chemokines, converted bystander M2 macrophages toward an M1 phenotype, recruited T-cells, and increased antigen presentation to activate T-cells. Enhanced anti-tumor T-cell responses mediated by CAR-M were noted in humanized murine models and the findings are summarized below. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Human CAR-M Anti-Tumoral Function </font><font style="font-style:italic;letter-spacing:-0.2pt;">In Vitro</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_human4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_human4c.jpg]" height="159" width="599" >
        </div>
        <div style="margin-top:9.4pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">* SKOV3 = Human HER2+ ovarian cancer cell line </font>
          <br >
          <font style="letter-spacing:0.2pt;">* UTD = Untransduced </font>
          <br >
          <font style="letter-spacing:0.2pt;">* CAR = Anti-HER2 human CAR-M </font>
          <br >
          <font style="letter-spacing:0.2pt;">* Delta</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">Z</font><font style="letter-spacing:0.2pt;"> = CAR-M with a non-signaling control CAR </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CAR-M were able to traffic to established tumors and co-localized with metastatic foci in the lung after intravenous administration without a pre-conditioning regimen. CAR-M treatment induced significant reduction in tumor burden and improved overall survival compared to mice treated with control macrophages in multiple mouse tumor models. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Transduction of macrophages with Ad5f35 led to the induction of a durable M1 phenotype. Despite the purported plasticity of macrophage phenotype, Ad5f35 transduced macrophages did not convert to M2 upon stimulation. CAR-M maintained a pro-inflammatory M1 state within the TME, while control macrophages were converted to M2. Additionally, CAR-M induced a pro-inflammatory signature in the surrounding TME. Given that solid tumors are rich in TAMs, Carisma evaluated the bidirectional interaction of CAR-M and M2 macrophages. While M2 macrophages failed to convert CAR-M from M1 to M2, CAR-M converted M2 macrophages to M1. Additionally, the presence of M2 macrophages did not impact the tumor killing capacity of CAR-M, highlighting their resistance to the immunosuppressive components of the TME. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Finally, CAR-M were shown to interact with cells of the adaptive immune system. CAR-M upregulated antigen presentation pathways and demonstrated heightened T-cell stimulation capacity as compared to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">257</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">control macrophages. Notably, CAR-M were able to present antigens to T-cells following phagocytosis. In addition, CAR-M were able to directly recruit various subtypes of T-cells. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To further its understanding of CAR-M, Carisma sought to model their function in fully immunocompetent mouse models which have an intact TME and immune system, enabling recapitulation of the complex immunological environment in human cancer patients. Toward that goal, Carisma developed a murine surrogate CAR-M to demonstrate the mechanism of action of CAR-M </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> in mice which have a fully intact immune system. First, Carisma validated comparability between human and murine CAR-M. Carisma demonstrated that the same vector utilized in its clinical pipeline, Ad5f35, could be used to engineer primary murine macrophages, and confirmed that T-cells were viable, expressed CAR, and were similarly polarized to an M1 phenotype. Functional studies showed CAR-M mediated tumor killing of target cancer cells and enhanced the </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> function of T-cells. Furthermore, murine CAR-M released pro-inflammatory cytokines similarly to human CAR-M. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pre-clinical immunocompetent solid tumor models were established via subcutaneous, or SC, injection and engraftment of the murine colorectal cancer cell line, or CT26, engineered to express human HER2. In this model, intratumoral, or IT, CAR-M monotherapy significantly reduced tumor growth and prolonged overall survival compared to untransduced macrophages (macrophages not expressing a CAR). By rechallenging complete responders several&#160;months post tumor clearance with the same tumor cells lacking HER2 expression, Carisma was able to demonstrate that CAR-M therapy leads to epitope spreading and immune memory which confers protection against antigen-negative relapse. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-M Control Tumor Progression, Improve Survival and Induce Long-Term Protection against Antigen-negative Relapse</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.6pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_contrl4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_contrl4c.jpg]" height="249" width="593" >
        </div>
        <div style="margin-top:8.21pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">* UTD-M = Untransduced macrophage </font>
        </div>
        <div style="margin-top:10.1pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">CT26-HER2+ tumors were implanted subcutaneously in immunocompetent syngeneic mice. After 15&#160;days, mice were treated with intratumoral CAR-M, UTD-M, or left untreated. CAR-M significantly reduced tumor progression. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:3.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">CAR-M significantly increased long term survival compared to control groups. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(C)</font>
          <br >
        </div>
        <div style=" margin-top:3.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Mice achieving complete responses, or CR, post CAR-M therapy were re-challenged with HER2-negative CT26-Wt tumors to model antigen negative relapse. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(D)</font>
          <br >
        </div>
        <div style=" margin-top:3.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Na&#239;ve mice succumbed to disease within 35&#160;days, while 100% of the mice from the CAR-M treatment group survived, indicating long-term tumor protection against antigen negative relapse. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(E)</font>
          <br >
        </div>
        <div style=" margin-top:3.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">T-cell depletion reversed CAR-M induced protection against antigen negative relapse, indicating that CAR-M treatment led to epitope spreading and anti-tumor T-cell memory. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Analysis of the tumor microenvironment of mice receiving CAR-M therapy demonstrated the ability of Carisma&#8217;s therapy to recruit additional immune cells, including T-cells, into the tumor. CAR-M led to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">258</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:50.58pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">immune activation in the TME associated with T-cell expansion, activation, and modulation of the overall T-cell repertoire of tumor infiltrating lymphocytes&#8201;&#8212;&#8201;suggesting the induction of a broad anti-tumor immune response. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-M Reprogram the TME and Prime T-cells</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_reprogra4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_reprogra4c.jpg]" height="397" width="547" >
        </div>
        <div style="margin-top:7.19pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Immunohistochemistry assessment showed that CAR-M treatment increased tumor CD8+ T-cell infiltration in the CT26-HER2+ model indicating activation of the TME. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Flow cytometric analysis showed increased tumor infiltration of T-cells, NK cells, activated CD86+ DCs and tumor associated antigen specific CD8 T-cells (gp70 Tet+) in CAR-M treated mice, suggesting epitope spreading. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Combined, these results demonstrate that CAR-M have the potential to overcome some of the key challenges cell therapies encounter in the solid tumor setting and represent a novel immunotherapeutic platform that can be broadly applied to diverse tumor antigen targets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is applying its CAR-M platform to a broad pipeline of product candidates, and Carisma intends to build a fully integrated immunotherapy company spanning autologous cell therapy, allogeneic cell therapy, and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> macrophage gene therapy. Carisma currently owns all rights to its product candidates and programs outside of its Moderna collaboration, which is limited to direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed CAR-M in the field of oncology. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">259</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Macrophage and Monocyte Engineering Platform</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_macrop4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_macrop4clr.jpg]" height="332" width="608" >
        </div>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Gene Delivery</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the core of Carisma&#8217;s platform are its proprietary viral and non-viral approaches for delivering different payloads into macrophages and monocytes and engineering them into a variety of phenotypes depending on the disease which they are intended to treat. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For its initial solid tumor programs, Carisma&#8217;s adenoviral vector enables Carisma to generate an abundant supply of CAR-M cells and engineer the cells to be locked into an M1 phenotype. Carisma selected Ad5f35 after testing commonly utilized viral and non-viral approaches and demonstrating Ad5f35&#8217;s high efficiency in transducing primary human monocytes and macrophages. Ad5f35 can transduce macrophages with high efficiency, viability and reproducibility amongst donors. In addition to being highly efficient, transduction with Ad5f35 polarizes and locks macrophages into an M1 phenotype. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to Ad5f35, Carisma&#8217;s platform includes two other proprietary methods for delivering genes into macrophages. The first is a modified lentiviral vector, or Vpx-LV, which carries viral protein X. Vpx-LV depletes SAMHD1 and permits lentiviral transduction of primary human monocytes, macrophages, and dendritic cells. Vpx-LV was developed by Dr.&#160;Nathaniel Landau at New York University, and Carisma holds a global exclusive license to develop this vector. Unlike Ad5f35, which induces a potent M1 phenotype upon transduction, Vpx-LV has minimal impact on macrophage phenotype and can be utilized as a flexible tool to generate M0, M1, or M2 polarized myeloid cell therapies with durable gene expression. Additionally, Carisma has developed a proprietary non-viral mRNA-based approach to transiently engineered macrophage and a companion method to induce a durable pro-inflammatory M1 phenotype. Carisma has successfully generated M1-primed non-viral CAR-M using a research manufacturing process consisting of mRNA transfection to deliver the CAR transgene followed by IFN&beta; priming to polarize the cells to an M1 anti-tumoral phenotype. Non-viral CAR-M demonstrated high viability, high CAR expression, M1 polarization and anti-tumoral function </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> similar to Ad5f35 engineered CAR-M. Additionally, in partnership with Moderna, Carisma is developing a myeloid tropic LNP/mRNA platform to program CAR-M directly </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Approach to Pipeline</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s proprietary technology and engineering capabilities enabled it to pioneer the CAR-M field and conduct the first in human CAR-M clinical trial, establishing its leading position in the engineered </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">260</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">macrophage space. Carisma&#8217;s goal is to advance </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous cell therapies and off-the-shelf therapies including allogeneic cell therapies and direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogramming approaches in oncology and other indications: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Expansion: Building Upon the Learnings of Autologous Cell Therapy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-tbl_exvivo4c.jpg" alt="[MISSING IMAGE: tm2227887d1-tbl_exvivo4c.jpg]" height="255" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:13.39pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the first iteration of its platform is the CAR macrophage, Carisma has expanded its capabilities to include multiple myeloid cell types (monocytes, macrophages, and dendritic cells), multiple gene delivery modalities (Ad5f35, Vpx-LV, and mRNA), various phenotypes (M1, M2, and subtypes thereof), and a broad variety of payloads including CARs, immune ligands, secreted or tethered cytokines, transcription factors, and other genes that enhance efficacy. Importantly, Carisma has expanded its platform to enable </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineering of myeloid cells directly within the patient&#8217;s body. Additionally, Carisma has established a robust process to edit the genome of human myeloid cells by utilizing tools such as CRISPR/Cas9, enabling gene edited macrophages with inhibitory pathways such as SIRP&alpha; genetically removed from the cell product. Carisma&#8217;s engineered macrophage platform enables fine tuning the activation state of the engineered macrophage or monocyte. Finally, Carisma has established a novel Engineered Myeloid Microenvironment Converter, or EM-C, platform that utilizes proprietary synthetic cytokine switch receptors to generate engineered macrophages that respond to M2 cytokines with M1 responses (for oncology applications) or to generate engineered macrophages that respond to M1 cytokines with M2 responses, for auto-immune or chronic inflammatory diseases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Pipeline of Product Candidates and Discovery Programs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Using its proprietary CAR-M platform, Carisma is developing a broad pipeline of product candidates, with an initial focus in oncology. </font>
        </div>
        <div style="position:relative;margin-top:10.1pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-tbl_pipelin4c.jpg" alt="[MISSING IMAGE: tm2227887d4-tbl_pipelin4c.jpg]" height="203" width="466" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">261</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lead Product Candidate: CT-0508</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CT-0508 is a cell product comprised of autologous, peripheral blood monocyte-derived, pro inflammatory macrophages, transduced with a chimeric adenoviral vector, Ad5f35, containing an anti-HER2 CAR. The anti-HER2 CAR is a first-generation CAR composed of a fully human single-chain variable fragment, or scFv, derived from the monoclonal antibody trastuzumab, which is specific for human HER2. The anti-HER2 scFv is fused to a CAR backbone containing a cluster of differentiation CD8 hinge, CD8 transmembrane domain, and a CD3&#950; intracellular domain. The CAR is cloned into an adenoviral vector backbone and transduced into monocyte-derived macrophages. Based on the pre-clinical data generated to date, CT-0508 CAR-M are able to specifically recognize HER2 overexpressing tumor cells, which triggers both direct killing of tumor cells and phagocytosis. Additionally, CAR engagement by HER2 on tumor cells results in the secretion of a broad array of pro-inflammatory cytokines and chemokines, which contribute to the recruitment and activation of additional immune cells to the TME, including effector T-cells and other antigen presenting cells. CT-0508 CAR-M are antigen presenting cells, and after phagocytosing tumor cells they process tumor-derived antigens and present them to T-cells, leading to T-cell immunity against tumor antigens. This additional activation of the adaptive immune system amplifies anti-tumor immune response and can lead to long term immune memory not only against HER2, the primary target, but other tumor specific neoantigens as well. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Phase&#160;1 clinical trial of CT-0508 is currently ongoing. As of September&#160;1, 2022, five clinical sites were open for screening and enrollment: (i)&#160;the University of Pennsylvania Abramson Cancer Center, (ii)&#160;the University of North Carolina Lineberger Comprehensive Cancer Center, (iii)&#160;the City of Hope National Medical Center, (iv)&#160;the MD Anderson Cancer Center, and (v)&#160;the Sarah Cannon Cancer Research Institute. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA has granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors. The components of CT-0508 cells are shown below: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key Components of First-Generation CAR Construct</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.4pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_key4c.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_key4c.jpg]" height="137" width="277" >
        </div>
        <div style="text-indent:20pt; margin-top:13.79pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Figure Legend: CT-0508 is an autologous monocyte derived macrophage cell product engineered with the adenoviral vector Ad5f35 to express an anti-HER2 CAR. The CAR is comprised of a single chain variable fragment derived from a humanized anti-HER2 antibody which provides specificity against the target antigen. The scFv is linked to a hinge domain derived from the human CD8 protein, which enables extension and flexibility from the cell membrane surface. The hinge is linked to a CD8 transmembrane, or TM, domain which spans the cell membrane, linking the extracellular portion of the CAR to the intracellular portion of the CAR, which is comprised of CD3&#950;. CD3&#950; signaling is activated when the CAR binds to the target antigen, leading to macrophage activation, phagocytosis, tumor cell killing, and release of pro-inflammatory factors such as cytokines and chemokines. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">262</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0508 Therapy for HER2+ Solid Tumors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While therapies targeting solid tumors that overexpress HER2 have led to improved survival in breast and gastric or gastro-esophageal junction cancers, there remains an unmet need in patients with advanced HER2 positive, or HER2+, cancers and HER2 expressing cancers, including metastatic lung, ovarian, colon, bladder, and other cancers for which there are no HER2 targeted agents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Approximately 20% of breast cancers overexpress HER2, a protein that is overexpressed on the surface of a variety of solid tumors. In addition to breast, gastric, and gastroesophageal junction cancers, HER2 is also overexpressed in a number of solid tumor indications including but not limited to bladder cancer, ovarian cancer, lung cancer and colon cancer. </font>
        </div>
        <table style="width:376pt;margin-left:40pt;margin-top:9.99999999999999pt;border-collapse: collapse;border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.25pt 0pt; width:0pt;" colspan="5">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">HER2 Positivity Frequencies Across Tumor Types </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Tumor type </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">HER2 positivity (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Bladder cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8&#8201;&#8211;&#8201;70 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Breast cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11.0&#8201;&#8211;&#8201;25.0 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Cervical cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2.8&#8201;&#8211;&#8201;3.9 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Colorectal cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1.6&#8201;&#8211;&#8201;5.0 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Esophageal cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12.0&#8201;&#8211;&#8201;14.0 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Extrahepatic Cholangiocarcinoma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">6.3&#8201;&#8211;&#8201;9.0 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Gallbladder cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9.8&#8201;&#8211;&#8201;12.8 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Gastric adenocarcinoma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">7.0&#8201;&#8211;&#8201;34.0 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ovarian cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">26 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Salivary duct carcinoma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">30&#8201;&#8211;&#8201;40 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Salivary mucoepidermoid carcinomas </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">17.6 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Testicular cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2.4 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Uterine cancer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3.0</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.29pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0508 Clinical Study Design&#8201;&#8212;&#8201;Study 101</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ongoing Phase&#160;1 clinical trial of CT-0508 is a single-arm, open-label study of systemic intravenous administration of CT-0508. This study is intended to evaluate safety, tolerability, cell trafficking, cell-manufacturing feasibility, and preliminary evidence of efficacy in approximately 18 subjects with locally advanced or metastatic solid tumors overexpressing HER2 who have failed available therapies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A summary of the clinical trial design, dosing regimen, sample collection regimen, and primary and secondary objectives are shown below: </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-org_clinic4c.jpg" alt="[MISSING IMAGE: tm2227887d1-org_clinic4c.jpg]" height="232" width="579" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">263</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filgrastim, or recombinant G-CSF, is administered to patients five days prior to apheresis to mobilize monocytes into the peripheral blood, increasing the available circulating monocyte count prior to collection by apheresis. The CT-0508 cell product is then prepared, cryopreserved, and released following quality control testing. The first three participants in the study were hospitalized for eight days after the first infusion of CT-0508 (Day 1 to Day 8) as part of the pre-determined study design. There is no preparative chemotherapy prior to the cell product infusion. The first group of nine patients have been treated with an intra-participant dose escalation regimen consisting of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Day 1:</font><font style="letter-spacing:0.2pt;"> Up to 0.5 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> cells; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Day 3:</font><font style="letter-spacing:0.2pt;"> Up to 1.5 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> cells; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Day 5:</font><font style="letter-spacing:0.2pt;"> Up to 3.0 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> cells. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AE reporting begins at the start of mobilization and continues until any toxicities resolve or are deemed irreversible. Participants are continually reassessed for evidence of acute and/or cumulative toxicity. Approximately nine participants in the second group of patients will receive up to 5.0 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> total manufactured CT-0508 cells in a single infusion on Day 1. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">HER2 has several advantages as a target antigen for CAR-M. In addition to being expressed in a variety of solid tumor types with significant unmet medical needs, HER2 is not shed or internalized and is only expressed at low levels in non-tumor tissues. As HER2 expression is typically maintained over the course of disease, CT-0508 may be developed for treatment of metastatic disease, for example, in the liver and lung, as well as primary tumors. Additionally, HER2 is typically not lost after patients with metastatic cancer progress on available HER2 targeted therapies, rendering HER2 refractory patients potentially eligible for CT-0508 therapy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Participants enrolled in Study 101 undergo one pre-treatment and two on-treatment biopsies to assess CT-0508 trafficking, impact on the TME, induction of anti-tumor T-cell immunity, and other biomarkers. Blood samples are also collected over a period of 52 weeks for evaluation of pharmacokinetics and biomarkers associated with safety and efficacy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based upon clinical data, Carisma may seek Regenerative Medicine Advanced Therapy, or RMAT, and PRIority MEdicine, or PRIME, designations for CT-0508, which provide an expedited developmental and approval pathway, in the United States and the European Union, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0508 Clinical Data&#8201;&#8212;&#8201;Study 101</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Enrollment of the first group of nine patients in the Phase&#160;1 clinical trial of CT-0508 has been completed and enrollment in the second group is currently ongoing. Carisma successfully generated CT-0508 product for all participants enrolled in the first group of the study with an average cell viability of 89%, an average purity of 85%, and an average CAR transduction of 81%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has reported on the safety, clinical response, and correlative studies for the first nine patients dosed in the first group of the clinical trial. Of such patients, two had HER2 overexpression levels of 2+ by immunohistochemistry staining, or IHC, with additional fluorescent in-situ hybridization FISH confirmation; and seven had levels of HER2 3+ by IHC. HER2 grading was performed based on the ASCO/</font>&#8203;<font style="letter-spacing:0.2pt;">CAP guidelines. Patients in the trial had three median prior therapies with a range of two to 11. Patients had a median of two prior HER2 targeted therapies, with a range of zero to nine. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CT-0508 was well tolerated with no dose-limiting toxicities. The majority (55.5%) of subjects with treatment-emergent adverse events, or TEAEs, by maximum severity were Grades 1 and 2. One subject experienced an unrelated Grade 4 TEAE (related to progression of disease of the patient&#8217;s cancer). For subjects with TEAEs considered related to CT-0508, the majority (66.6%) were Grades 1 and 2, and none were Grades 4 or 5 severity. With respect to TEAEs of special interest, six patients experienced CRS, and all of these were Grades 1 and 2. There were no episodes of immune cell therapy associated neurotoxic syndrome, or ICANS, reported. No patients had severe CRS. No AEs, or SAEs, led to CT-0508 dose modification or discontinuation. No major organ toxicity was observed. The majority of AEs, regardless of relatedness, were Grades 1 and 2. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">264</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:22.0599999999999pt;margin-left:69.66pt;width:456pt;">
        <table style="width:376pt;margin-left:40pt;margin-top:0pt;border-collapse: collapse;border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.25pt 0pt; width:0pt;" colspan="5">
              <font style="letter-spacing:-0.2pt;">Overview of Subjects with Treatment-Emergent Adverse Events (Safety Population) </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
              <font style="letter-spacing:0.2pt;">Category </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
              <font style="letter-spacing:0.2pt;">n = 9 (%) </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
              <font style="letter-spacing:0.2pt;">Treatment-Emergent Adverse Event (TEAE) </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
              <font style="letter-spacing:0.2pt;">9 (100.0) </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
              <font style="letter-spacing:0.2pt;">TEAE, Related to CT-0508 </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
              <font style="letter-spacing:0.2pt;">8 (88.9) </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
              <font style="letter-spacing:0.2pt;">TEAE, Serious AE </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
              <font style="letter-spacing:0.2pt;">4 (44.4) </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
              <font style="letter-spacing:0.2pt;">TEAE, Serious AE Related to CT-0508 </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
              <font style="letter-spacing:0.2pt;">2 (22.2) </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
              <font style="letter-spacing:0.2pt;">TEAE, AEs of Special Interest</font>
            </td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
              <font style="letter-spacing:0.2pt;">7 (77.8)</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
              <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
              <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                <!--blacklining:none;-->
                <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 1</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">3 (33.3)</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
              <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
              <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                <!--blacklining:none;-->
                <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 2</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">4 (44.4)</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
              <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
              <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                <!--blacklining:none;-->
                <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 3</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">0 (0.0) </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
              <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
              <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                <!--blacklining:none;-->
                <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 4</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:5.75pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">0 (0.0) </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
              <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
              <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                <!--blacklining:none;-->
                <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 5 </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">0 (0.0)</font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
              <font style="letter-spacing:0.2pt;">Discontinued CT-0508 due to TEAE </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
              <font style="letter-spacing:0.2pt;">0 (0.0)</font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.19pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of AEs by Preferred Term and by Severity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-bc_adverse4c.jpg" alt="[MISSING IMAGE: tm2227887d4-bc_adverse4c.jpg]" height="271" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The best overall response was stable disease per RECIST 1.1 criteria. A best overall response of stable disease was observed in five out of nine patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Transient and low-grade fever was observed in seven out of nine patients post CT-0508 infusion. All fevers resolved within 48 hours. In concordance with clinical observations, a transient increase in serum&#160;IL-6, a pro-inflammatory cytokine, was observed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma evaluated the pharmacokinetics, or PK, of CT-0508 in the peripheral blood and the tumor. Similar peripheral blood PK was observed for all nine participants with CT-0508 detectable only on infusion days for four to eight hours post-infusion, consistent with rapid migration of CAR-M from the blood to tissues following infusion. CT-0508 was detected within the TME of eight out of nine evaluable patients assessed to date using RNAscope&#8482; technology as shown below. These data suggest that CT-0508 rapidly egresses from the peripheral blood and successfully traffic to the biopsied tumor mass. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">265</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:109.58pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0508 Rapidly Migrates Out of the Blood and is Detected within the TME of 8/9 Participants Evaluated</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_rapidly4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_rapidly4c.jpg]" height="170" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To evaluate the mechanism of action of CT-0508, single cell RNA sequencing, or scRNAseq, analysis was performed on fresh tumor biopsy to investigate changes within the TME following CT-0508 infusion. Analysis of screening (n=5), Day 8 post-infusion (n=5) and Week 4 post-infusion (n=3) biopsies revealed increases in CD8 T-cells, macrophages, and neutrophils on treatment consistent with inflammation and activation of an immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">These increases were also associated with reprogramming of the infiltrating macrophages toward an M1 phenotype by Week 4. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Single Cell RNAseq Analysis Demonstrates Remodeling of the Tumor Immune Landscape Following CT-0508 Infusion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_single4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_single4clr.jpg]" height="181" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To evaluate whether CT-0508 was able to initiate anti-tumor adaptive immunity, TCR repertoire analysis was performed utilizing the Adaptive Biotechnologies&#8482; TCR sequencing platform. The analysis was performed on peripheral blood and tumor tissue. Peripheral blood TCR repertoire analysis revealed an expansion of T-cell clones in the blood of participants post CT-0508 infusion, indicative of the initiation of an adaptive immune response. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">266</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:53.11pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Early Expansion of T-cells in the Periphery Following CT-0508 Infusion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-bc_mostpreva4c.jpg" alt="[MISSING IMAGE: tm2227887d4-bc_mostpreva4c.jpg]" height="293" width="581" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Based on scRNAseq analysis, the frequency of effector T-cells increased in all three participants with available screening and Week 4 biopsies (shown below). Furthermore, Carisma evaluated T-cell subtypes and found that Participant 1 demonstrated an increase in proliferating and effector memory CD8 T-cells, Participant 2 demonstrated an increase of all subsets except for activated CD8 T-cells, and Participant 4 demonstrated an increase in activated CD4, activated CD8 and effector memory CD8 T-cells. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Frequency of effector T-cells in TME</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-bc_frequen4c.jpg" alt="[MISSING IMAGE: tm2227887d4-bc_frequen4c.jpg]" height="228" width="437" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Differential gene expression analysis performed on biopsies collected at Week 4 post-CT-0508 infusion demonstrated an increased expression of genes associated with cytotoxic CD8 T-cell activation when compared to pre-treatment expression TME samples from six patients analyzed by RNA sequencing. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">267</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Increased T-Cell Activation in the TME</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-tbl_selct4c.jpg" alt="[MISSING IMAGE: tm2227887d4-tbl_selct4c.jpg]" height="174" width="571" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">TCR repertoire analysis of the TME revealed that newly expanded peripheral clones accumulated over time within the TME, suggesting that these clones are tumor reactive. Expanding T-cell clonotypes from patient 1, 2 and 4 at Week 4 post-infusion clustered with cells expressing high levels of CD8&alpha;, perforin, granzyme B, Ki67, IFN&#947;, and PD1 demonstrated their activated and/or proliferating CD8 cytotoxic T lymphocyte phenotype. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Peripherally Expanded T-cell Clones Accumulate in the TME and Adopt a Cytotoxic Phenotype</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_pt4comp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_pt4comp4c.jpg]" height="168" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:12.61pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While preliminary, the clinical data to date confirmed that CT-0508 is successfully manufactured from heavily pre-treated solid tumor patients, has been well tolerated, traffics to the tumor, activates the TME, and may initiate anti-tumor adaptive immunity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional CT-0508 Studies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0508 and Pembrolizumab combination sub study</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This open-label sub study will assess the safety and feasibility of co-administering CT-0508 in combination with the PD-1 inhibitor, pembrolizumab. The target population for this sub study are subjects at least 18&#160;years of age who meet inclusion criteria per the main protocol and have HER2 over-expressing solid tumors and meet the sub study specific eligibility criteria. Carisma expects to report clinical data for this sub study in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0508 Intraperitoneal administration sub study</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This sub study has been designed to assess the safety and feasibility of CT-0508 via regional administration into the peritoneal cavity. The target population for this sub study are subjects at least 18&#160;years of age who meet inclusion criteria per the main protocol, that have HER2 over-expressing gynecological cancers including but not limited to ovarian, fallopian tube, primary peritoneal, and endometrial cancers, who have disease spread mainly within the peritoneal cavity that meet the sub study specific eligibility criteria. Subjects will be enrolled at select clinical sites participating in Study 101 that have the capability to enroll and adequately treat subjects with intraperitoneal administration of CT-0508. Carisma expects to report clinical data for this sub study in the second half of 2023. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">268</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:5.95000000000005pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0508 Biodistribution sub study</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">This open-label sub study is designed to evaluate the whole body biodistribution of CT-0508 after intravenous administration using radiolabeled CT-0508 and longitudinal PET/CT imaging. This sub study includes </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">89</font><font style="letter-spacing:0.2pt;">Zr-oxine radiolabeling a fraction of the CT-0508 cell product, followed by administration on Day&#160;1 and PET/CT imaging approximately on Day 1, 4, 8, 15, and 28 to assess trafficking and biodistribution of CT-0508. The target population for this sub study are subjects at least 18&#160;years of age that meet inclusion criteria per the main protocol. Subjects will be enrolled at specific sites in Study 101 that have the capability to perform </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">89</font><font style="letter-spacing:0.2pt;">Zr-oxine labeling, administration, and routine PET/CT analysis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Synergistic Potential of CAR-M Therapy with T-Cell Checkpoint Inhibitors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Blocking the immune checkpoint molecule programmed cell death 1, or PD-1, has revolutionized cancer treatment for patients with a multitude of solid tumor indications. Pembrolizumab is a potent humanized immunoglobulin G4, or IgG4, monoclonal antibody, or mAb, with high specificity of binding to the PD-1 receptor, inhibiting its interaction with programmed cell death ligand 1, or PD-L1, and programmed cell death ligand 2, or PD-L2. While pembrolizumab is currently indicated for the treatment of patients across several solid tumor indications, the majority of patients have either primary or secondary resistance to immune checkpoint blockade and may benefit from combinatorial therapy that could overcome immune cell exclusion, poor antigen presentation, low T-cell infiltration, high TAM infiltration, a lack of productive co-stimulation, low mutational burden, IT immunosuppression, and a low frequency of tumor reactive T-cell clones. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Based on the data generated during pre-clinical development, CT-0508 cell product is able to specifically recognize, cancer cells through the binding of the CAR to HER2 expressed on the surface of these cells. This interaction triggers activation of the CAR-macrophages and results in direct anti-tumor effect by killing and phagocytosis of the tumor cells. In addition, CT-0508 recruits T-cells, activates the TME, and as professional antigen presenting cells, can process and present tumor associated antigen and/or neoantigens expressed by the tumor cells, leading to T-cell immunity against these specific antigens. However, this indirect anti-tumor effect involves the engagement of T-cells that may be actively suppressed, or exhausted, within the tumor micro-environment by a variety of factors including secreted immune-modulatory factors and inhibitory ligands expressed on both immune and tumor cells. Additionally, several studies have demonstrated that patients with low mutational burden, low MHC expression, defective antigen presentation, low CD8+&#160;T-cell infiltration, or minimal Th1 cytokine signatures tend to be unresponsive to PD-1 blockade. Therefore, based on the mechanism of action of CT-0508 and the limitations of PD-1 blockade, the combination of CAR-M therapy with PD-1 blockade therapy may be beneficial by enhancing antigen presentation (innate immunity) to initiate a robust anti-tumor T-cell response (adaptive immunity). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-M and PD-1 blockade combination therapy: Pre-clinical Development</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To model the combination of CT-0508 cell therapy with anti-PD-1 inhibitors, Carisma used a murine colorectal cancer cell line engineered to overexpress human HER2. Tumors were established in the flank of the immune competent mice and 14&#160;days post tumor inoculation, mice were randomized and received either murine CAR-M alone (IV), murine PD-1 blockade alone (IP) or a combination of both treatments. Using a regimen where CAR-M was injected first when the tumor was well established, followed by the anti-PD-1 inhibitor a few days later, neither murine CAR-M (Anti-HER2 muCAR-Mac) nor murine anti-PD1 monotherapy had a significant effect on tumor growth and overall survival. However, when co-administered the combination of both therapies resulted in significant tumor growth delay associated with prolonged survival of the mice (all mice in the combination group survived until the end of the study). All mice treated with the combination of Anti-HER2 muCAR-Mac and anti-PD1 mAb completely cleared their tumors (below). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">269</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:61.5599999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Assessment of Tumor Burden and overall survival in a Syngeneic Mouse Model of Colon Carcinoma in response to treatment with IV CAR-M and Anti-PD-1 Therapy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_asses4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_asses4c.jpg]" height="489" width="608" >
        </div>
        <div style="margin-top:7.19pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Anti-HER2 muCAR-Mac are murine CAR-M and muUTD-Mac are untransduced murine CAR-M. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To determine the impact of Anti-HER2 muCAR-Mac and anti-PD-1 mAb combination therapy on tumor burden, tumor volumes were recorded during the treatment period (depicted in the left panel above) and mice were monitored for survival (depicted in the right panel above). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the IV CAR-M alone and in combination with anti-PD-1 therapy study described above, Carisma has performed studies with IT administered murine CAR-M. In this study, anti-PD-1 therapy was administered four times, at 3-day intervals starting 14&#160;days post tumor inoculation (CAR-M therapy initiated on Day 15). IT murine CAR-M and anti-PD-1 therapy improved tumor control and significantly improved survival probability. Cumulative survival for all groups: 0% CR CTRL, 8.3% CR anti-PD-1, 38.9% CR CAR-M and 66.7% CR CAR-M and anti-PD-1: </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">270</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT CAR-M and Anti-PD-1 Combination Therapy Improves Survival in the CT26-HER2 Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_itcar4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_itcar4c.jpg]" height="245" width="513" >
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Analysis of immune cell populations in the TME showed that macrophages were more abundant in the CAR-M samples while other myeloid cells and DCs showed the greatest infiltration in the combination group. A significant increase in total tumor infiltrating T-cells, and in particular helper T-cells, was noted in the combination therapy. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Profound TME Modulation in Response to IT CAR-M and CAR-M +Anti-PD-1 Combination Therapy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_profnd4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_profnd4clr.jpg]" height="441" width="579" >
        </div>
        <div style="text-indent:20pt; margin-top:12.01pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Analysis of the TCR repertoire demonstrated that IT administration of CAR-M in combination with a PD-1 blocking monoclonal antibody led to increased frequency of T-cells in the periphery and significantly modulated the TCR repertoire in the TME suggesting enhanced adaptive anti-tumor immunity. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">271</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:38.55pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Based on these data, CAR-M and pembrolizumab represent a potentially synergistic immunotherapeutic combination regimen that combines CAR-M to infiltrate the TME, degrade the tumor via phagocytosis, and recruit and prime T-cells and pembrolizumab to prevent or reverse T-cell exhaustion. Patients with HER2 overexpressing tumors, such as metastatic breast cancer, gastric cancer, ovarian cancer, esophageal cancer, and others are generally poor responders to pembrolizumab. Carisma plans to evaluate CT-0508 in combination with pembrolizumab in an upcoming Phase&#160;1 clinical trial. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional Pipeline Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s additional pipeline candidates are CAR-M therapies that incorporate all of the core elements of its macrophage cell engineering platform, along with certain new platform enhancements that Carisma is currently developing. The CT-1119 product candidate targets the mesothelin tumor associated antigen that is found on lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and numerous other solid tumors. The CT-0729 product candidate targets the PSMA tumor associated antigen that is found on prostate cancer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-1119 (Anti-Mesothelin CAR-M)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Mesothelin is a well validated tumor associated antigen. Mesothelin has been shown to be aberrantly expressed on the surface of tumor cells and plays an important role in promoting cancer invasion and proliferation. Mesothelin has been demonstrated to be expressed at high levels in mesothelioma, lung cancer, ovarian cancer, pancreatic cancer, and other solid tumors with limited expression in normal tissue, though recent data suggests inflammation may induce expression. There are no approved anti-mesothelin agents and no approved cell therapies targeting any of the solid tumor types that overexpress mesothelin. Mesothelin positive solid tumors represent a significant unmet medical need. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">While there are no mesothelin targeted approved agents, numerous clinical trials have been conducted targeting mesothelin and safety has been established with a variety of modalities including monoclonal antibodies, antibody drug conjugates, and CAR-T-cells. Targeting mesothelin enables a similar strategy to Carisma&#8217;s CT-0508 HER2 Phase&#160;1 trial in that it enables (i)&#160;a basket trial design that includes patients with diverse tumor types and (ii)&#160;separate arms for systemic and regional administration. There is a significant opportunity for regional administration of CT-1119, including intraperitoneal administration for mesothelin positive ovarian cancer with peritoneal metastasis and intrapleural administration for patients with malignant mesothelioma and lung tumors. There is also a significant opportunity for patients with mesothelin positive solid tumors with systemic metastasis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To develop a mesothelin targeted CAR-M, Carisma has screened anti-mesothelin scFv&#8217;s using mRNA to identify humanized anti-mesothelin binders. Carisma obtained exclusive rights to a humanized anti-mesothelin scFv from the University of Pennsylvania. Carisma demonstrated that human CAR-M engineered with an Ad5f35 vector show high viability and efficiently express an anti-mesothelin (meso) CAR. Similar to CT-0508, CT-1119 adopts an M1 macrophage activation state. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">CT-1119 effectively phagocytose mesothelin positive lung cancer (A549) and ovarian cancer (MesOV) cells as shown by two independent phagocytosis assays. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To evaluate the effector function of CT-1119, Carisma utilized mesothelin positive lung adenocarcinoma (A549) and ovarian cystadenocarcinoma (MesOV) cell lines. </font><font style="font-style:italic;letter-spacing:0.2pt;">In vitro</font><font style="letter-spacing:0.2pt;">, CT-1119 shows robust killing of lung cancer cells expressing mesothelin and CAR engagement induces the release of the pro-inflammatory cytokine TNF-&alpha; following stimulation with mesothelin expressing but not wild type (Wt) cell lines: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">272</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-1119 Kill and Produce Cytokine in Response to Biologically Relevant Targets</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.01pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_119ct4c.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_119ct4c.jpg]" height="301" width="547" >
        </div>
        <div style="text-indent:20pt; margin-top:12.2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to evaluate the direct anti-tumor activity of CT-1119 in a relevant animal model, Carisma engrafted immunodeficient NSG-S mice with A549 lung adenocarcinoma cells expressing mesothelin by intravenous administration, which creates a lung metastasis model. CT1119 demonstrated the ability to reduce tumor progression and reduced the number of metastatic tumor nodules. </font>
        </div>
        <div style="position:relative;margin-top:9.4pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_ct1119a5494c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_ct1119a5494c.jpg]" height="304" width="361" >
        </div>
        <div style="text-indent:20pt; margin-top:12.21pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These findings demonstrate that CT-1119, an autologous human anti-mesothelin CAR-M, can effectively phagocytose and kill target tumor cells as well as initiate pro-inflammatory cytokine production in response to mesothelin. Carisma believes that CAR-M is a feasible approach for the treatment of mesothelin expressing solid tumors and is advancing the development of this program toward a clinical trial. The IND is expected to be submitted in 2025. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0729 (PSMA CAR-M)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prostate-specific membrane antigen, or PSMA, is highly specific to prostate cancer cells. </font><font style="font-style:italic;letter-spacing:0.2pt;">In vitro</font><font style="letter-spacing:0.2pt;"> studies have been conducted demonstrating that Carisma can: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">273</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Express anti-PSMA CARs on human macrophages </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Mediate phagocytosis of PSMA overexpressing tumor cells </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Induce killing of PSMA overexpressing tumor cells </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Initiate cytokine release in a PSMA specific manner </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Generate M1 polarized anti-PSMA CAR-M </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CT-0729 is in the discovery stage and a lead construct has not yet been nominated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono: Pre-clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Currently, the CAR-M platform requires differentiation of circulating monocytes into macrophage </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> prior to transduction with Ad5f35 to express the CAR. </font><font style="font-style:italic;letter-spacing:0.2pt;">Ex vivo</font><font style="letter-spacing:0.2pt;"> differentiation takes approximately one week and is associated with the loss of a fraction of cells during the differentiation process. Carisma hypothesized that monocytes could be directly engineered to express CARs, shortening the </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> manufacturing process from approximately eight days to approximately one to two days. By bypassing </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> differentiation, CAR monocytes will be administered to patients, wherein they will traffic to and enter tumor tissue, differentiating into macrophages </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> rather than </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo.</font><font style="letter-spacing:0.2pt;"> CAR-Mono are a precursor to the CAR macrophage. Carisma further hypothesized that CAR-Mono may have improved tumor trafficking potential, given their smaller size and increased chemokine receptor expression. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To determine the feasibility of generating CAR monocytes, or CAR-Mono, Carisma conducted </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> time course studies to assess cell viability and CAR expression compared to untransduced monocytes. Following transduction with Ad5f35, CAR expression and cell viability were tracked </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> for 28&#160;days. Viability was high (&gt;90%) and CAR expression was high (&gt;80%), and both stayed high for the entire 28&#160;days of culture. Durable CAR expression is critical to enable the cells to (a)&#160;retain CAR expression while trafficking to the tumor, (b)&#160;retain CAR expression during differentiation into CAR macrophages, and (c)&#160;to enable sustained anti-tumor activity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s first CAR-Mono program is CT-0525, an autologous anti-HER2 CAR-Mono. CT-0525 is an advanced pre-clinical program, and Carisma plans to submit an IND for CT-0525 in the third quarter of 2023, followed by initiation of a Phase&#160;1 clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The M1 phenotype of Carisma&#8217;s CAR-M platform is an important aspect of the mechanism of action. As monocytes are the precursors to macrophages, differentiation and cell morphology was evaluated after two days and seven days of culture. After seven days in culture, CAR-Mono showed a progressively increasing M1 phenotype (high CD80 and CD86 expression) and expressed CAR. Compared to untransduced monocytes cultured for two or seven days </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;">, Ad5f35 transduced CAR-Mono upregulated M1 markers CD80 and CD86, confirming that Ad5f35 transduction similarly induces an M1 macrophage phenotype when added at the monocyte stage. Importantly, CAR-Mono-derived CAR-M had a similar morphology to CAR-M generated using the standard method&#8201;&#8212;&#8201;confirming morphologically that CAR-Mono differentiate into CAR-M. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To confirm that CAR-Mono differentiate into CAR-M and take on an M1 phenotype </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, NSG-S mice were engrafted with NCI-H2444 (Non-Small Cell Lung Cancer). NSG-S mice are highly immunodeficient mice that express human Interleukin (IL)-3, human GM-CSF, and human stem cell factor. These animals support enhanced engraftment of myeloid cells compared to NOD/SCID Il2rg-/- (NSG) mice, they are ideal for studies investigating the adoptive transfer of myeloid cells. Untransduced control or CAR-Mono were intratumorally injected (N=3 donors) and tumors were harvested seven days post injection. Human immune cells were enriched using flow sorting and processed for scRNA sequencing. By comparing the gene expression of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> differentiated untransduced and CAR monocytes, Carisma&#8217;s data suggest that the monocytes have the potential to differentiate into macrophages and adopt an M1 like phenotype. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CAR-M are able to directly kill tumor cells via phagocytosis and release of cytotoxic mediators such as TNF&alpha;. Carisma evaluated the direct tumor killing capacity of CAR-Mono at Day 2 (monocyte phase) and Day 7 (macrophage phase). AU565, a HER2+ breast cancer cell line, was utilized as the target tumor cell. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">274</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s data show that CAR-Mono mediated effective killing at Day 2 and that fully differentiated CAR-Mono-derived CAR-M (Day 7) also efficiently cleared tumor cells. When comparing CAR-Mono-derived CAR-M (Day 7) to CT-0508, Carisma found that CAR-Mono led to improved tumor killing and inflammatory cytokine production. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono-derived CAR-M Show Robust Tumor Killing Activity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_carmno4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_carmno4c.jpg]" height="284" width="578" >
        </div>
        <div style="margin-top:18.69pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono-derived CAR-M Cocultures Show Robust Proinflammatory Cytokine Production</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_cyto4c.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_cyto4c.jpg]" height="258" width="591" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma previously demonstrated that CT-0508 CAR-M are locked into an M1 phenotype by Ad5f35 transduction, and resist M2 conversion by immunosuppressive cytokines. Carisma evaluated whether CAR-Mono similarly resisted M2 environments by culturing the cells for seven days in the presence of M-CSF (differentiation factor) or M-CSF plus the immunosuppressive cytokines IL-10 and TGF-&beta; during differentiation. CAR-Mono showed resistance to polarization and continued to express CD86 (M1) and not CD163 (M2) as demonstrated by flow cytometry and bulk RNA sequencing of untransduced and CAR-Mono-derived CAR-M. Additionally, untransduced monocytes but not CAR-Mono significantly upregulated CD163 in response to IL-10 and TGF-&beta;. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">275</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono Are Protected Against M2 Polarization</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.6pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_polar4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_polar4c.jpg]" height="219" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:13.99pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">An important element to Carisma&#8217;s cell therapies is the long-term expression of its engineered CAR payloads by human myeloid cells. To evaluate persistence </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, monocytes were engineered with a modified Ad5f35 vector that induces the co-expression of CAR and luciferase under a single promoter by using a ribosomal skip site. This approach enables the ability to track luciferase using bioluminescent imaging and infer not only the viable persistence but also the CAR expression of human monocytes in mice. Ad5f35 engineered CAR-Luciferase Mono was injected intravenously into NSG or NSG-S mice and imaged for 180&#160;days. While both NSG and NSG-S mice are immunodeficient, only NSG-S mice constitutively express human cytokines that promote myeloid cell survival (GM-CSF, IL3, and SCF). Carisma found that human CAR-Mono persisted for at least 180&#160;days </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, independent of cytokine support. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0525 Show Long Term Persistence </font><font style="font-style:italic;letter-spacing:-0.2pt;">In Vivo</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.5pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_persis4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_persis4c.jpg]" height="327" width="576" >
        </div>
        <div style="text-indent:20pt; margin-top:14pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To determine whether CAR-Mono are able to control tumor growth in xenograft models, Carisma utilized a SKOV3 HER2+ ovarian cancer intraperitoneal carcinomatosis model. Anti-HER2 CAR-Mono significantly suppressed tumor growth and prolonged survival up to 120&#160;days post treatment, while mice that received untransduced control monocytes or mice that were left untreated only survived for &lt;60&#160;days. Carisma is currently evaluating CAR-Mono in immunocompetent models. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">276</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:9.62pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0525 Suppress Tumor Growth </font><font style="font-style:italic;letter-spacing:-0.2pt;">In Vivo</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_tumor4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_tumor4c.jpg]" height="220" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In summary, CAR-Mono were successfully generated with high efficiency and viability in a rapid, one-to-two day manufacturing process. CAR-Mono demonstrated stable CAR expression and viability </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;">, and persisted for at least six&#160;months </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo.</font><font style="letter-spacing:0.2pt;"> CAR-Mono differentiated into CAR-M efficiently and adopted an M1 macrophage phenotype, and resisted conversion to M2 in immunosuppressive environments. CAR-Mono were able to kill tumors cells in the monocyte phase and the macrophage phase. CAR-Mono controlled tumor growth in a xenograft mouse model of cancer. Based on the pre-clinical data to date, Carisma believes that CAR-Mono represents a potentially promising approach for cancer immunotherapy, while meaningfully expanding Carisma&#8217;s proprietary platform. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Next Generation Constructs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s discovery team is developing a next generation CAR-M platform utilizing enhanced CAR constructs to increase potency and functionality of the engineered cells. This includes optimization of each element of the CAR itself&#8201;&#8212;&#8201;the binder (which gives the CAR specificity to a target antigen), the hinge (which connects the binder to the transmembrane domain and gives the CAR length and flexibility), the transmembrane domain (which spans the cell membrane), and the intracellular signaling domains (which are responsible for activation of immune cell function). It is well accepted in the immunology field that T-cells require multiple signals for activation&#8201;&#8212;&#8201;signal 1 deriving from the TCR, and signal 2 deriving from co-stimulatory receptors such as CD28 or 4-1BB. Thus, all approved CAR-T products are second generation CARs, incorporating CD3&#950; as a primary signaling domain and either 4-1BB or CD28 as co-stimulatory domains. Third generation CARs, incorporating three signaling domains, have also been evaluated in T-cells. Unlike T-cells, macrophages do </font><font style="font-style:italic;letter-spacing:0.2pt;">not</font><font style="letter-spacing:0.2pt;"> require co-stimulation for activation and can be activated through a single signal, such as through an Fc receptor. However, multiple signaling pathways have the ability to enhance the macrophage response and may improve targeT-cell killing, cytokine/chemokine release, and macrophage activation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Next Generation CAR-M Constructs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has been routinely developing and evaluating novel CAR-M constructs. Carisma&#8217;s well-established CAR-M assays enable a distinct opportunity to identify improved constructs in an efficient manner. Based on Carisma&#8217;s early findings, CD3&#950; is a potent activator of macrophage function and induces phagocytosis, cytokine release, chemokine release, killing, and activation of pro-inflammatory genes. Given this finding, Carisma has been evaluating the addition of other innate immune receptors such as Toll-like receptors, CD40, MyD88, Dectin-1, to CD3&#950; to improve upon CAR-M functionality. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">277</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-fc_antibody4c.jpg" alt="[MISSING IMAGE: tm2227887d4-fc_antibody4c.jpg]" height="276" width="370" >
        </div>
        <div style="margin-top:13.52pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Next Generation Construct: Pre-clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s preliminary data assessing tumor cell killing activity with CAR variants at a low &#8220;stress test&#8221; dose shows increased potency at low effector (macrophage) to target (tumor cell) ratios. CD40 is an activating receptor found on antigen presenting cells including macrophages that is activated after binding to CD40-Ligand, typically expressed on activated T-cells. CD40 signals through numerous second messengers leading to the activation of NF-&#1008;B and other transcription factors that induce a potent M1 phenotype and activate antigen presenting cells. MyD88 is expressed in macrophages and acts as an adaptor that plays a pivotal role in the signaling of Toll-like receptors. Carisma has found that addition of MyD88 and CD40 to CD3&#950; CAR-M, in a specific sequence with a specific hinge domain, leads to a significant improvement to macrophage anti-tumor activity. </font>
        </div>
        <div style="margin-top:11.02pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Addition of the MyD88/CD40 pathway significantly increases CAR-M potency</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.11pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_poten4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_poten4c.jpg]" height="269" width="480" >
        </div>
        <div style="text-indent:20pt; margin-top:10.32pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further testing of the M88-CD40-CD3&#950; CAR and other novel CAR-M are ongoing. Leading second/</font>&#8203;<font style="letter-spacing:0.2pt;">third generation CAR candidates may be incorporated into future autologous, allogeneic, or </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> LNP programs. </font></div>
        <div style="margin-top:10.92pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Novel Modalities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is applying learnings from its autologous CAR-M data, tools, and processes to establish off-the-shelf engineered macrophage therapeutics. To broaden the application of CAR myeloid cell therapy, Carisma </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">278</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">is actively seeking to develop a gene edited iPSC-derived macrophage platform. The goal is to establish a process to generate allogeneic, iPSC-derived M1, M2, or CAR myeloid cells. One approach is using allogeneic iPSC myeloid cells manufactured using the following summary process: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iPSC-Derived Myeloid Cells: Summary</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_ipsc4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_ipsc4clr.jpg]" height="412" width="547" >
        </div>
        <div style="text-indent:20pt; margin-top:11.31pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Initial </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> studies show that iPSCs can be converted to monocytes or macrophages, skewed to an M1 or M2 phenotype with cytokine culture, and can be engineered with Carisma&#8217;s proprietary vectors to express tumor targeting CARs. In addition to offering an allogeneic, universal donor platform, iPSCs are expandable cells&#8201;&#8212;&#8201;unlike primary human monocytes or macrophages which are terminally differentiated. In the first 15&#160;days of the process, Carisma noted &gt;1,000x expansion. It took approximately 15&#160;days to generate iPSC-derived monocytes and approximately 20&#160;days to generate iPSC-derived macrophages. The process is currently being performed in a non-GMP research environment at research scale but has the potential to be developed into a commercial scale, GMP process in the future. The macrophages generated with this process express canonical macrophage markers, appear macrophage-like with Giemsa staining and microscopic evaluation, and importantly demonstrate cell-to-cell uniformity in morphology. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iCAR-M Production</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_icar4c.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_icar4c.jpg]" height="180" width="516" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">279</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iCAR-M Anti-Tumor Activity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to confirm that iPSC-derived macrophages are effectively redirected against tumor associated antigens, Carisma introduced the anti-HER2 CAR into iPSC-derived macrophages using Ad5f35. Engineered iPSC-derived macrophages efficiently expressed CAR, upregulated M1 markers, and demonstrated an acceptable viability. To evaluate anti-tumor function, Carisma conducted an </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> killing assay in which AU565 HER2+ breast cancer cells were cultured alone, together with iPSC-derived control macrophages, or iPSC-derived CAR-M. As shown below, while the control iPSC macrophages had minimal anti-tumor effect (orange), the iPSC-derived CAR-M cleared tumor cells over approximately 72 hours. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iPSC-Derived CAR-M Exert Potent Anti-Tumor Activity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_ipscmacs4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_ipscmacs4c.jpg]" height="315" width="502" >
        </div>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While iCAR-M appear to be able to exert direct anti-tumor functionality, there are inherent complexities that will be critical to inform the ultimate allogeneic macrophage strategy. CAR-M exert anti-tumor immunity through tumor infiltration, phagocytosis, cytokine/chemokine release, TME activation, T-cell recruitment, and antigen presentation. To enable an allogeneic off-the-shelf iCAR-M program, the cells will inherently be either MHC mismatched or MHC-edited (for example, MHC-I and MHC-II may be deleted using CRISPR/</font>&#8203;<font style="letter-spacing:0.2pt;">Cas9 editing to generate universally accepted macrophages), and thus may have limited direct antigen presentation potential. However, iCAR-M are expected to maintain the other mechanisms of action, as summarized below. Future studies will evaluate whether allogeneic CAR-M are capable of inducing epitope spreading, as indirect mechanisms of antigen presentation have not been ruled out. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Importantly, the iPSC-derived myeloid cell platform, combined with Carisma&#8217;s gene engineering capabilities, has the potential to be produced in multiple ways. First, iPSC-derived myeloid cells can be expanded, qualified, and banked prior to being used as a master cell bank source for the production of engineered myeloid cell therapies. In this example, iPSC-derived myeloid cells would be engineered with Carisma&#8217;s proprietary methods (Ad5f35, Vpx-LV, modified mRNA, or other) after differentiation into the desired myeloid cell subtype. Alternatively, Carisma is optimizing methods to introduce the CAR (or other genetic payload) at the iPSC stage using targeted integration into desired genomic loci, isolating iPSC clones with integrated genes and additional potential genetic edits, and differentiating these cells into monocytes or macrophages, and skewing them to an M1 phenotype using Carisma&#8217;s proprietary polarization processes. For this approach, care must be taken to ensure that the CAR (or other payload) is not epigenetically downregulated or lost during the myeloid differentiation process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the current focus of Carisma&#8217;s discovery efforts is to ultimately generate iCAR-M, the platform is expected to be readily adaptable to either develop (a)&#160;myeloid cells engineered with other anti-tumor </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">280</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:323.47pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">payloads, or (b)&#160;myeloid cells engineered with payloads designed to ameliorate disease outside of oncology. Notably, Carisma has early non-oncology programs in liver fibrosis, neurodegeneration, and auto-immunity/</font>&#8203;<font style="letter-spacing:0.2pt;">chronic inflammation which can be combined with the iPSC-derived myeloid cell platform. Currently, Carisma&#8217;s pipeline is focused on autologous approaches and direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogramming, and the allogeneic iPSC-derived platform is at the pre-clinical discovery stage. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP/mRNA Platform (Moderna Collaboration)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In collaboration with Moderna, Carisma is developing an mRNA based </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M platform for oncology. This approach is highly differentiated in the cell therapy space&#8201;&#8212;&#8201;not only because it relies on myeloid cells as the engineered effectors, but also because it utilizes direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogramming of a patients&#8217; own cells with a well-validated LNP/mRNA platform. By engineering a patients&#8217; own cells directly within their body, </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous or allogeneic cell manufacturing is entirely bypassed&#8201;&#8212;&#8201;significantly increasing the commercial potential of the therapy. Importantly, while this approach enables an off-the-shelf therapy, the engineered cells are autologous, as it is the patients&#8217; own cells being engineered into CAR-M </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, or directly within their body. This strategic partnership enables Carisma to apply the learnings gleaned from autologous CAR-M development to expand its pipeline to up to 12 additional oncology candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Studies with the myeloid tropic LNP have shown mRNA delivery is specific for myeloid cells (monocytes, macrophages, dendritic cells). Based on clinical data using other (non-CAR) payloads, Moderna has previously demonstrated that the LNP was well-tolerated after systemic administration and could furthermore be re-dosed. Preliminary data have demonstrated that the LNP is efficient in transfecting myeloid cells </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">. In addition, preliminary data confirms high CAR expression, viability, and CAR-M function, and availability of pre-clinical data is expected mid-2023. The platform summary for the </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M approach is shown below: </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">281</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Myeloid Tropic LNP/mRNA Platform (Moderna Collaboration)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_myloid4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_myloid4clr.jpg]" height="658" width="456" >
        </div>
        <div style="margin-top:18.69pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">LNP/mRNA Pre-clinical Data (Moderna Collaboration): Pre-clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">In vitro</font><font style="letter-spacing:0.2pt;"> pre-clinical studies with the myeloid tropic LNP/mRNA platform have shown efficient transfection. Carisma has optimized conditions for </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> LNP/mRNA delivery to human and murine monocytes/macrophages, as well as primary murine myeloid cells to establish various relevant murine tumor models. Carisma&#8217;s goal was to establish a platform with high viability (&gt;70%), high transfection efficiency (&gt;70%), and significantly increased CAR-M killing activity compared to untransfected control macrophages. Key data for the anti-HER2 CAR constructs CTX_001 and CTX_219 are shown in the figures below: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">282</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Transfection is Well Tolerated by Human Macrophages</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_lnp4c.jpg]" height="209" width="544" >
        </div>
        <div style="margin-top:18.69pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineering leads to Dose Dependent CAR Expression</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_2lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_2lnp4c.jpg]" height="200" width="544" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to CAR expression and viability, Carisma has shown that one day post transfection, CTX001 and CTX219 mediate potent killing activity against target AU565 cells. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineered CAR-M Display Effective Killing Function</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_3lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_3lnp4c.jpg]" height="223" width="533" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Statistical analysis was determined using Two-way ANOVA, * p&lt;0.5 **** p&lt;0.0001. The data were generated from N=3 donors (3 technical replicates per donor). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">283</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Transfection is Well Tolerated by Human Monocytes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.7pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_4lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_4lnp4c.jpg]" height="231" width="565" >
        </div>
        <div style="margin-top:17.39pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineering leads to Dose Dependent CAR Expression in Monocytes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.7pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_5lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_5lnp4c.jpg]" height="215" width="559" >
        </div>
        <div style="text-indent:20pt; margin-top:13.4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to CAR expression and viability, Carisma has shown that monocytes engineered with LNP/mRNA encoding the CARs CTX001 and CTX219 mediate potent killing activity against target AU565 breast cancer cells. These findings demonstrate similarity between LNP engineered macrophage and monocyte effector function. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineered CAR-Mono Display Effective Killing Function</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_6lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_6lnp4c.jpg]" height="229" width="533" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">284</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Statistical analysis was determined using Two-way ANOVA, * p&lt;0.5 **** p&lt;0.0001. The data were generated from N=3 donors (three technical replicates per donor). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To model direct reprogramming of TAMs to CAR-M, Carisma generated tumor spheroids comprised of HER2+ breast cancer cells and human TAMs.&#160;Carisma confirmed that the macrophages embedded within these spheroids adopted an M2, TAM-like phenotype. Carisma added LNPs (containing CAR mRNA and an M1 polarizing gene) directly to the tumor spheroids and found that the reprogrammed TAMs mediated tumor spheroid shrinking over a 72-hour period. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directly Reprogramming Myeloid Cells </font><font style="font-style:italic;letter-spacing:-0.2pt;">within Tumors</font><font style="letter-spacing:-0.2pt;"> with LNP/mRNA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_reprobw.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_reprobw.jpg]" height="201" width="517" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The first four indications have been nominated by Moderna, spanning both solid tumors and hematologic malignancies. Pre-clinical platform optimization, as well as target discovery and CAR development, are ongoing in parallel. Early </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> proof of concept is expected in 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EM-C: A novel platform for regulation of inflammation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cytokines in tissue microenvironments regulate the balance between pro- and anti-inflammatory signaling. Dysregulated cytokine expression causes deleterious immunosuppression or inflammation, underpinning the pathophysiology of numerous diseases. As examples, anti-inflammatory cytokines in solid tumors suppress immune activation and safeguard the tumor, whereas pro-inflammatory cytokines in rheumatoid arthritis drive chronic inflammation. Rebalancing inflammation/immunosuppression by targeting aberrant cytokine signaling offers a generalizable approach to treating many diseases, but systemic cytokine blockade carries risks such as increased risk of serious infection. Cellular immunotherapies may offer a localized platform that could activate in response to cytokines then proportionately remodel the microenvironment&#8217;s inflammatory state as needed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages are tissue infiltrating homeostatic regulators responsible for the initiation and resolution of inflammation. Carisma leveraged the ability of macrophages to regulate inflammation by generating macrophages that express genetically engineered, synthetic cytokine switch receptors (SR). Carisma termed this platform EM-C and evaluated its modular ability to convert immunosuppressive M2 signals into pro-inflammatory M1 responses for solid tumor microenvironment conversion, or vice versa for the conversion of pro-inflammatory M1 signals into immunosuppressive M2 responses for auto-immune or inflammatory diseases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EM-Cs were generated by expressing SRs in primary human macrophages. First, Carisma generated SRs that convert immunosuppressive signals into inflammatory signals&#8201;&#8212;&#8201;focusing on IL-10. To convert IL-10 (a cytokine well known to polarize macrophages toward an M2 phenotype) in the TME into a pro-inflammatory signal, an IL-10 SR was designed by fusing the extracellular domain of the IL-10 receptor to an engineered portion of the IFN&#955; receptor. The </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> response of IL-10 EM-Cs to IL-10 was monitored by the expression of M1 and M2 markers. While control untransduced or CAR (a control irrelevant construct) expressing macrophages responded to IL-10 through the downregulation of M1 markers and upregulation of M2 markers, IL10-SR EM-Cs upregulated M1 markers and downregulated M2 markers. These data and others demonstrate that Carisma&#8217;s IL10-SR EM-Cs can induce an inflammatory response when exposed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">285</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tMAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to immunosuppressive conditions. Carisma has generated numerous additional EM-Cs that respond to other immunosuppressive factors, such as TGF&beta;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Conversely, Carisma sought to develop EM-Cs that can convert inflammatory cytokines into anti-inflammatory responses. As myeloid cells are recruited to sites of inflammation. This approach would enable a myeloid cell therapy that accumulates at inflammatory sites and locally shuts down inflammation. This approach may have broad utility in autoimmunity, chronic inflammation, fibrosis, transplant, and graft versus host disease. Carisma generated EM-Cs targeting IFN-&#947; and demonstrated that while control untransduced or CAR (an irrelevant payload) macrophages respond to IFN-&#947; by upregulating M1 markers and downregulating M2 markers, IFN-&#947; SR EM-Cs responded to IFN-&#947; by downregulating M1 markers and upregulating M2 markers. These data demonstrate that Carisma&#8217;s proprietary EM-C platform can be broadly utilized to generate engineered macrophages with the ability to control the inflammatory nature of environments, and act as living converters, with broad potential applicability to oncology, autoimmunity, chronic inflammation, and other indications. This platform offers broad opportunity for strategic partnership. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Macrophages Expressing Cytokine Switch Receptors Can Invert</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pro- or Anti-Inflammatory Signals</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_macro4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_macro4c.jpg]" height="267" width="570" >
        </div>
        <div style="margin-top:17.39pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indications Beyond Oncology</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Carisma is an oncology focused company, the macrophage engineering platform Carisma has established offers broad opportunity to develop cell therapies for indications beyond oncology. Carisma has numerous early-stage research programs designed to produce development candidates for liver fibrosis, neurodegenerative disease, and autoimmunity/chronic inflammation. Carisma&#8217;s new product candidates will incorporate all the core elements of its macrophage cell engineering platform, plus certain indication specific modifications uniquely designed to address the pathology of each indication. While autologous cell therapy may be utilized for proof of concept, these indications have the potential to be combined with Carisma&#8217;s allogeneic or off-the-shelf therapeutic approaches. Indications beyond oncology offer opportunities for strategic partnerships to accelerate the development of these programs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing and Delivery</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not own or operate, and currently has no plans to establish, any manufacturing facilities. Carisma currently relies on and expects to continue to rely on third-party contract development manufacturing organizations, or CDMOs, for the manufacturing and release testing of viral vectors and cell drug products. Carisma also currently relies on third parties for patient leukapheresis material logistics as well as to package, label, store, and distribute the cell drug products. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">286</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tINPR1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has established and will continue to establish arrangements with contract manufacturers to supply clinical materials and manufacturing capabilities for Carisma&#8217;s clinical trials. Carisma currently obtains its supplies from these manufacturers on a purchase order basis and does not have long-term supply arrangements in place. Should any of these manufacturers become unavailable to Carisma for any reason, Carisma believes that there are several potential replacements, although Carisma may incur some delay in identifying and qualifying such replacements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma also plans to continue to expand the scope and number of its collaborations to further develop its manufacturing capabilities and to minimize manufacturing risk. As Carisma scales to commercialization, it expects to increase its capacity with its current suppliers and evaluate other options to secure commercial scale capacity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing Process for CT-0508</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A CDMO is used to produce cGMP lots of viral vector. The CT-0508 drug substance process begins by isolating the monocyte population from a single fresh patient leukopak mobilized by donor pretreatment with filgrastim. The resulting monocytes are cultured in the presence of a cytokine and other factors to induce differentiation into macrophages. The resulting macrophages are then transduced with the Ad5f35 vector encoding an anti-HER2 CAR. The resulting cells are then harvested as drug substance. Macrophages derived from a single leukopak from one patient comprise one batch of CT-0508. Final formulation is performed and transferred into freezing bags to generate drug product. The drug product is carefully frozen in a controlled process and then placed into secured storage and maintained at a temperature of &gt;-135&#8304; Celsius. Safety and specification tests are performed and if found acceptable the product is released and shipped to clinical trial sites. The current process from receipt of leukopak to drug product and cryopreservation is eight days. </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-fc_carm4c.jpg" alt="[MISSING IMAGE: tm2227887d4-fc_carm4c.jpg]" height="218" width="605" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma plans to continue to invest in process improvements to reduce the overall manufacturing process time and improve costs for the viral vector and cell drug product. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma strives to protect and enhance its proprietary technology, inventions and improvements that Carisma believes are commercially important to the development of its business, including through seeking, maintaining and defending patent rights, whether developed internally or licensed from third parties. Carisma also intends to rely on trade secrets related to its proprietary technology platform and its know-how, continuing technological innovation and in-licensing opportunities to develop, strengthen and maintain its proprietary position in the fields of cancer and other indications including those related to neurodegeneration, liver fibrosis and autoimmune disease, which may be important for the development of Carisma&#8217;s business. Carisma additionally may rely on regulatory protection afforded through data exclusivity, market exclusivity and patent term extensions, where available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial success may depend, in part, on its ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">287</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">its business, defend, and enforce its patents, preserve the confidentiality of its trade secrets and operate without infringing the valid enforceable patents and proprietary rights of third parties. Carisma&#8217;s ability to stop third parties from making, using, selling, offering to sell or importing its products may depend on the extent to which it has rights under valid and enforceable licenses, patents or trade secrets that cover these activities. With respect to both Carisma&#8217;s owned and licensed intellectual property, Carisma cannot be sure that patents will be granted with respect to any of its pending patent applications or with respect to any patent applications filed by Carisma in the future, nor can it be sure that any of its existing patents or any patents that may be granted to Carisma in the future will be commercially useful in protecting its commercial products and methods of manufacturing such products, as well as being held valid if challenged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently controls over 15 granted patents and over 41 patent applications pending in several jurisdictions, including the United States, Europe, Australia, Brazil, Canada, China, Israel, Japan, Korea, Mexico, New Zealand, and Singapore. Intellectual property is a critical component of Carisma&#8217;s business plan for maximizing return on its investments. Carisma is actively developing intellectual property and will continue to maintain and defend United States and international patent rights for its products, technology, and development and improvement of its discovery platforms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To maintain its competitive position in the market, Carisma has spent considerable effort securing intellectual property rights, including several patent rights related to its proprietary CAR technology and myeloid cell engineering technology. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exclusively Licensed Intellectual Property&#8201;&#8212;&#8201;UPenn</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has exclusive rights to three patent families, and non-exclusive rights to related know-how by virtue of a license agreement with the University of Pennsylvania. These patent families are directed to, among other things, methods of efficiently expressing CARs in myeloid cells, including monocytes, macrophages, and dendritic cells and enhancing effector activity, as well as the modified cells and compositions including such modified cells for use in several indications including various oncology targets. The applications will have an expiration date of no earlier than 2036. This licensed patent portfolio includes:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes eight issued U.S. patents and three pending U.S. patent applications relating to modified macrophages, monocytes and dendric cells comprising CARs. These U.S. patents are expected to expire in 2036, absent any term adjustments or extensions. Corresponding foreign applications have been filed and are pending in Australia, Brazil, Canada, China, Europe, Israel, India, Japan, Korea, Mexico, New Zealand, Russia, Singapore, Thailand and South Africa.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending U.S. patent application relating to modified macrophages, monocytes and dendric cells in protein aggregate-associated disorders. Patent applications in this family are expected to expire in 2039, absent any term adjustments or extensions. Corresponding foreign applications have been filed and are pending in Australia, Canada, China, Europe, Israel, Japan, Korea, New Zealand, and Singapore.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending U.S. patent application relating to activation of antigen presenting cells. Patent applications in this family are expected to expire in 2040, absent any term adjustments or extensions. A corresponding foreign application has been filed in Europe.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exclusively Licensed Intellectual Property&#8201;&#8212;&#8201;NYU</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has exclusive rights to one patent family, and non-exclusive rights to related know-how by virtue of a license agreement with New York University, or NYU. The rights granted under the NYU license are to all indications for human use. This licensed patent portfolio includes: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes one U.S. patent relating to a chimeric HIV-1 vector with an SIV minimal Vpx packaging domain and method of making virions with enhanced infectivity for macrophages and dendric cells. The U.S. patent is expected to expire in 2033, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">288</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Owned Intellectual Property</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently owns four U.S. patent families. This owned patent portfolio includes:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes one issued U.S. patent and two pending U.S. patent applications relating to macrophages, monocytes and dendric cells comprising novel CAR constructs. Patent applications in this family are expected to expire in 2041, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending Patent Cooperation Treaty, or PCT, application relating to mRNA transfection of macrophages, monocytes and dendric cells comprising CARs. Patent applications in this family are expected to expire in 2041, absent any term adjustments or extensions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending PCT application relating to modified immune cells for fibrosis and inflammation. Patent applications in this family are expected to expire in 2041, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending PCT application relating to self-polarizing immune cells. Patent applications in this family are expected to expire in 2042, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma will also seek to generate additional intellectual property that covers enhancements to all aspects of the platform, including novel CARs, combinations, gene editing and manufacturing improvements. Where appropriate, Carisma will also look to in-license relevant technology from third parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patent Term and Patent Term Extensions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The term of individual patents depends upon the legal term for patents in the countries in which they are obtained. In most countries, including the United States, the patent term is 20&#160;years from the earliest filing date of a non-provisional patent application. In the United States, a patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in examining and granting a patent or may be shortened if a patent is terminally disclaimed over an earlier filed patent. The term of a patent that covers a drug, biological product or medical device approved pursuant to a pre-market approval may also be eligible for patent term extension, or PTE, when FDA approval is granted, provided statutory and regulatory requirements are met. The length of the PTE is related to the length of time the drug is under regulatory review while the patent is in force. The Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act, permits a patent term extension of up to five&#160;years beyond the expiration date set for the patent. Patent extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval, only one patent applicable to each regulatory review period may be granted an extension and only those claims regarding the approved drug are extended. Similar provisions are available in Europe and other foreign jurisdictions to extend the term of a patent that covers an approved drug. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trademarks</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s trademark portfolio currently includes registered U.S. trademarks for Carisma in the United States, Europe, Great Britain and Japan. In order to supplement the protection of its brand, Carisma also has a registered internet domain name. Going forward, Carisma will consider additional trademarks to enhance its brand and support its products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trade Secrets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma relies, in some circumstances, on trade secrets to protect its unpatented technology. However, trade secrets can be difficult to protect in certain circumstances. Carisma seeks to protect its trade secrets and proprietary technology and processes, including through confidentiality agreements with its employees, consultants, scientific advisors and contractors. Carisma also seeks to preserve the integrity and confidentiality of its data and trade secrets by maintaining physical security of its premises and physical and electronic security of its information technology systems. While Carisma has confidence in these individuals, organizations and systems, agreements or security measures may be breached. Carisma may not have adequate remedies for any breach and could lose its trade secrets through such a breach. In addition, Carisma&#8217;s trade secrets may otherwise become known or be independently discovered by competitors. To the extent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">289</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">that its consultants, contractors or collaborators use intellectual property owned by others in their work for Carisma, disputes may arise as to the rights in related or resulting trade secrets, know-how and inventions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Collaboration Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, Carisma entered into a Collaboration and License Agreement with Moderna providing for a broad strategic partnership to discover, develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered CAR-M therapeutics for up to 12 oncology programs. Carisma refers to this agreement as the Moderna Collaboration Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s LNP/</font>&#8203;<font style="letter-spacing:0.2pt;">mRNA technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology medications. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Moderna Collaboration Agreement, the parties initiate research programs during a research term, focused on the discovery and research of products directed to biological targets. Either party may nominate a target for inclusion in a research program, subject to certain exclusions. Carisma refers to a target included in a research program pursuant to designated procedures as a research target. Moderna may replace research targets pursuant to designated procedures. The first four research targets have been nominated and all programs are currently in the discovery phase at Carisma. Moderna funds the cost of Carisma&#8217;s activities in accordance with an agreed research budget.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moderna has the right to designate up to 12 research targets as development targets during a specified development target nomination period upon payment of a development target designation milestone payment. Moderna can replace development targets with research targets during a specified period of time. If Moderna exercises its right to designate a development target, Moderna will have a worldwide, exclusive license under patents and know-how controlled by Carisma to develop and commercialize products directed to the applicable development target, subject to certain diligence obligations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Commencing a specified time after the effective date of the Moderna Collaboration Agreement, Moderna will have the right to nominate targets relating to diseases outside the field of oncology for inclusion in research programs in specified circumstances. Such right is subject to the same exclusions as Moderna&#8217;s right to nominate other targets for inclusion in research programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the term of the Moderna Collaboration Agreement, Carisma and its affiliates are subject to various exclusivity obligations under which Carisma is not permitted to research, develop or commercialize particular products outside of the collaboration, including products for use as </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> therapies in the field of oncology, products directed to any target included in the collaboration, or products containing a polypeptide provided by Carisma to Moderna in connection with a research program that are directed to any development target. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Moderna Collaboration Agreement, Carisma received a $45.0&#160;million up-front cash payment. Assuming Moderna develops and commercializes 12 products, each directed to a different development target, Carisma is also eligible to receive up to between $247.0 million and $253.0 million per product in development target designation, development, regulatory and commercial milestone payments. In addition, Carisma is eligible to receive mid to high single digit tiered royalties on net sales of any products that are commercialized under the agreement, which may be subject to reductions. Moderna has also agreed to cover the cost of certain milestone payments and royalties Carisma owes to a licensor under one of its intellectual property in-license agreements that Carisma is sublicensing to Moderna under the Moderna Collaboration Agreement, which royalties Moderna may deduct in part from any royalties owed to Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless earlier terminated, the Moderna Collaboration Agreement will expire upon the expiration of all royalty obligations thereunder. The royalty period for each product developed under the Moderna Collaboration Agreement will expire on a country-by-country basis upon the later of (1)&#160;the expiration of the last-to-expire valid patent claim of specified patents, (2)&#160;the expiration of regulatory-based exclusivity for such product in such country or (3)&#160;ten years after the first commercial sale with respect to such product in such country. Moderna has the right to terminate the Moderna Collaboration Agreement for convenience in its entirety or with respect to a specific product or target on ninety days&#8217; prior notice. Either Carisma or Moderna may terminate the Moderna Collaboration Agreement in its entirety if the other party is in material </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">290</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tUNPLA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">breach and such breach is not cured within the specified cure period, except in the case of Moderna&#8217;s breach of its diligence obligations, termination by Carisma is limited to the applicable target and product. In addition, either Carisma or Moderna may terminate the Moderna Collaboration Agreement in the event of specified insolvency events involving the other party. As an alternative to termination in the event of Carisma&#8217;s uncured material breach of certain sections of the agreement, Moderna has the option to continue the collaboration under the agreement with reduced payment obligations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">University of Pennsylvania License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2017, Carisma entered into a license agreement with the Trustees of the University of Pennsylvania, or Penn, which was amended in February&#160;2018, January&#160;2019, March&#160;2020 and June&#160;2021. Carisma refers to this agreement as the Penn License Agreement. Pursuant to the Penn License Agreement, Penn granted Carisma (1)&#160;an exclusive, worldwide license, with specified rights to sublicense, under Penn&#8217;s interest in specified patents related to CAR macrophages, monocytes or dendritic cells, which Carisma refers to collectively as CAR-M, (2)&#160;an exclusive, worldwide license, with specified rights to sublicense, under Penn&#8217;s interest in specified patents related to CAR-M directed to mesothelin, and (3)&#160;a nonexclusive, worldwide license under Penn&#8217;s interest in specified know-how related to CAR-M, with limited rights to sublicense only in combination with specified products or patents. These licensed patents and know-how arose primarily from research conducted by Dr.&#160;Saar Gill and Dr.&#160;Michael Klichinsky at the University of Pennsylvania, co-founders of Carisma. The foregoing licenses are subject to rights retained by Penn for specified non-commercial uses and rights retained by the United States government. Under the Penn License agreement, Carisma is obligated to use commercially reasonable efforts to pursue development and commercialization of at least one CAR-M product in oncology and non-oncology fields. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is responsible for paying Penn an annual license maintenance fee in the low tens of thousands of dollars, payable until Carisma&#8217;s first payment of a royalty. Carisma is required to pay Penn up to $10.9&#160;million per product in development and regulatory milestone payments, up to $30.0&#160;million per product in commercial milestone payments, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. While the agreement remains in effect, Carisma is required to pay Penn low to mid-single digit&#160;percentage tiered royalties on annual net sales of licensed products, which may be subject to reductions. Penn is guaranteed a minimum royalty payment amount in the low hundreds of thousands of dollars for each year after the first commercial sale of a licensed product. Carisma must also pay Penn a&#160;percentage in the mid-single digits to low double digits of certain types of income Carisma receives from sublicensees. In addition, Carisma is required to pay Penn an annual alliance management fee in the low tens of thousands of dollars, ending after several&#160;years, unless Carisma provides funding to Penn for research and development activities that extend beyond a specified date, in which case Carisma will continue to owe the alliance management fee for each year in which Carisma continues to fund such activities. Carisma also paid Penn an upfront fee in the low hundreds of thousands of dollars for the license to the patents related to the mesothelin binder that is incorporated into the CAR design for Carisma&#8217;s mesothelin product candidate. Carisma is responsible for a pro&#160;rata share of costs relating to the prosecution and maintenance of the licensed patents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The royalty period for each licensed product will expire on a product-by-product basis upon the later of (1) the expiration of the last-to-expire valid patent claim of the licensed patents covering such product in the country of sale or in the country of manufacture, or (2) the expiration of regulatory-based exclusivity for such product in the country of sale. The license agreement remains in effect until the later of (1)&#160;expiration or abandonment of the last licensed patent or (2)&#160;loss of regulatory exclusivity. Carisma may terminate the agreement for convenience upon thirty days&#8217; prior notice. Penn may terminate the agreement for Carisma&#8217;s material breach, subject to a specified cure period, except for certain breaches for which Penn may terminate immediately. Penn may also terminate if Carisma becomes the subject of a specified insolvency event. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New York University License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In July&#160;2020, Carisma entered into a license agreement with NYU. Carisma refers to this agreement as the NYU License Agreement. Pursuant to the NYU License Agreement, NYU granted Carisma (1)&#160;an exclusive, worldwide license, with specified rights to sublicense, under NYU&#8217;s interest in specified patents related to the Vpx-LV and (2)&#160;a nonexclusive, worldwide license, with specified rights to sublicense, under </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">291</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCOM1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NYU&#8217;s interest in specified know-how related to the Vpx-LV, in each case to develop, manufacture, use and sell products developed using the Vpx-LV, which Carisma refers to as Licensed Products. The foregoing licenses are subject to rights retained by NYU to use, and to permit other non-commercial entities to use, the licensed patents and licensed know-how for educational and research purposes, as well as rights retained by the United States government. Under the NYU License Agreement, Carisma is obligated to use reasonable diligence to carry out a specified development plan and to obtain regulatory approval for Licensed Products in the U.S. and each of the other countries in which Carisma or its sublicensees intend to produce, use, and/or sell Licensed Products, as well as to begin the regular commercial production, use, and sale of the Licensed Products in good faith in accordance with the development plan and to continue diligently thereafter to commercialize the Licensed Products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is required to pay NYU an annual license maintenance fee in the mid tens of thousands of dollars; up to $1,685,000 per Licensed Product in development and regulatory milestone payments; and low single digit&#160;percentage tiered royalties on annual net sales of Licensed Products on a country-by-country basis until the later of (1)&#160;12&#160;years after first commercial sale of a Licensed Product in such country or (2)&#160;expiration of the last to expire licensed patent. Carisma must also pay NYU a&#160;percentage in the low single digits to low double digits of certain types of income Carisma receives from sublicensees or assignees of the agreement. Carisma is also responsible for all costs relating to the prosecution, maintenance, and defense of the licensed patents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The NYU License Agreement remains in effect until the expiration of all royalty terms in all countries. Either party may terminate the NYU License Agreement for the other party&#8217;s uncured material breach or insolvency or bankruptcy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The biopharmaceutical industry, and in particular the cell therapy field, is characterized by intense investment and competition aimed at rapidly advancing new technologies, intense competition, and a strong emphasis on intellectual property and proprietary products. Carisma&#8217;s platform and therapeutic product candidates are expected to face substantial competition from multiple technologies, marketed products, and numerous other therapies being developed by other biopharmaceutical companies, academic research institutions, governmental agencies, and public and private research institutions. Many of Carisma&#8217;s potential competitors have substantially greater financial, technical, and other resources, such as larger research and development staff, established manufacturing capabilities and facilities, and experienced marketing organizations with well-established sales forces, and any product candidates that Carisma successfully develops and commercializes will compete with existing therapies and new therapies that may become available in the future. In addition, there is substantial patent infringement litigation in the biopharmaceutical industry, and, in the future, Carisma may bring or defend such litigation against its competitors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The key competitive factors affecting the success of Carisma&#8217;s product candidates, if approved, are likely to be their efficacy, safety, convenience and price, the level of competition, and the availability of coverage and adequate reimbursement from third-party payors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unlike other cell therapy approaches, Carisma&#8217;s CAR-M platform is based on engineering macrophages and monocytes with proprietary vectors, constructs, and processes, enabling a differentiated platform from other cell therapy competitors that primarily focus on T or NK cells. While Carisma believes that its scientific expertise, novel technology, and intellectual property position offer competitive advantages, Carisma faces competition from multiple other cell therapy technologies and companies. Other companies developing engineered myeloid cell therapies include, among others, Myeloid Therapeutics, Shoreline Biosciences, Inceptor Bio, Thunder Bio, Resolution Therapeutics, CellOrigin, Sirpant Therapeutics, and others. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Due to the broad promise of cell therapies, and the potential of myeloid cell-based approaches to expand cell therapy efficacy into solid tumors, Carisma expects increasing competition from new and existing companies across several fronts, which include, among others: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Myeloid cell therapies:</font><font style="letter-spacing:0.2pt;"> Myeloid Therapeutics, Shoreline Biosciences, Inceptor Bio, Thunder Bio, CellOrigin, Deverra </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">292</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tGORE1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Autologous T-cell therapies:</font><font style="letter-spacing:0.2pt;"> Adaptimmune Therapeutics, Autolus Therapeutics, Bluebird, Bristol Myers Squibb, Kite/Gilead, Novartis, Gracell, TCR2, Poseida, Vor, TMunity, among others </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Allogeneic T-cell therapies:</font><font style="letter-spacing:0.2pt;"> Allogene, Atara, Century, Cellectis, Celyad, CRISPR, Fate, Gracell, Kite/</font>&#8203;<font style="letter-spacing:0.2pt;">Gilead, Legend, Poseida, Precision Bio, Sana, Vor, among others </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">NK and other cell therapies:</font><font style="letter-spacing:0.2pt;"> Artiva, Celularity, Century, Editas, Fate, Fortress, ImmunityBio, Nkarta, NKGen, Takeda, Adicet, Gamida Cell, among others </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Direct in vivo reprogrammed cell therapies:</font><font style="letter-spacing:0.2pt;"> Umoja, Ensoma, Interius, Tidal/Sanofi, BioNTech </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to competition from other cell therapy companies, any products that Carisma develops may also face competition from other types of therapies. Other companies developing non-cell therapies, including gene therapies, include Gilead, ALX Oncology, Trillium, Five-Prime, Immune-Onc, Pionyr, Infinity, NextCure, OncoResponse, Curis, Faron, Apexigen, Pfizer, Dren, and multiple biotechnology and pharmaceutical companies developing other directly competitive technologies such as small molecules, immune agonists, antibodies, bi/tri specific antibodies, antibody drug conjugates, and other solid tumor therapeutics. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma also competes with third parties for retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, its programs. Carisma may pursue the in-license or acquisition of rights to complementary technologies and product candidates on an opportunistic basis. The acquisition and licensing of technologies and product candidates is a competitive area, and a number of more established companies also have similar strategies to in-license or acquire technologies and product candidates that Carisma may consider attractive. These established companies may have a competitive advantage over Carisma due to their size, cash resources and greater development and commercialization capabilities. In addition, companies that perceive Carisma to be a competitor may be unwilling to assign or license rights to Carisma. Carisma also may be unable to in-license or acquire the relevant technology or product candidate on terms that would allow it to make an appropriate return on its investment.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial opportunity could be reduced or eliminated if its competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that it may develop. Carisma&#8217;s competitors also may obtain FDA or other regulatory approval for their products more rapidly than it may obtain approval for Carisma&#8217;s, which could result in its competitors establishing a strong market position before it is able to enter the market. In addition, Carisma&#8217;s ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Government Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Government authorities in the United States, at the federal, state and local level, and in other countries and jurisdictions, including the European Union, extensively regulate, among other things, the research, development, testing, manufacture, pricing, reimbursement, sales, quality control, approval, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and reporting, and import and export of pharmaceutical products, including biological products. The processes for obtaining marketing approvals in the United States and in foreign countries and jurisdictions, along with subsequent compliance with applicable statutes and regulations and other regulatory authorities, require the expenditure of substantial time and financial resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Licensure and Regulation of Biologics in the United States</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, Carisma&#8217;s product candidates are regulated as biological products, or biologics, under the PHSA and the FDCA, and its implementing regulations and guidance. A company, institution, or organization which takes responsibility for the initiation and management of a clinical development program for such products, and for their regulatory approval, is typically referred to as a sponsor. The failure of a sponsor to comply with the applicable U.S. requirements at any time during the product development process, including pre-clinical testing, clinical testing, the approval process, or post-approval process, may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">293</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">subject a sponsor to delays in the conduct of the study, regulatory review, and approval, and/or administrative or judicial sanctions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A sponsor seeking approval to market and distribute a new biologic in the United States generally must satisfactorily complete each of the following steps: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">pre-clinical laboratory tests, animal studies, and formulation studies all performed in accordance with the FDA&#8217;s GLP regulations and standards and other applicable regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">completion of the manufacture, under cGMP conditions, of the drug substance and drug product that the sponsor intends to use in human clinical trials along with required analytical and stability testing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">design of a clinical protocol and submission to the FDA of an IND application for human clinical testing, which must become effective before human clinical trials may begin; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approval by an independent institutional review board, or IRB, representing each clinical site before each clinical trial may be initiated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">performance of adequate and well-controlled human clinical trials to establish the safety, potency, and purity of the product candidate for each proposed indication, in accordance with current GCP; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">preparation and submission to the FDA of a BLA for a biologic product requesting marketing for one or more proposed indications, including submission of detailed information on the manufacture and composition of the product in clinical development and proposed labelling; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">review of the product by an FDA advisory committee, where appropriate or if applicable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities, including those of third parties, at which the product, or components thereof, are produced to assess compliance with cGMP requirements and to assure that the facilities, methods, and controls are adequate to preserve the product&#8217;s identity, strength, quality, and purity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">satisfactory completion of any FDA audits of the pre-clinical studies and clinical trial sites to assure compliance with GLP, as applicable, and GCP, and the integrity of clinical data in support of the BLA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">payment of user PDUFA, securing FDA approval of the BLA and licensure of the new biologic product; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with any post-approval requirements, including the potential requirement to implement a or REMS and any post-approval studies or other post-marketing commitments required by the FDA. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-clinical Studies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before testing any biologic product candidate in humans, the product candidate must undergo pre-clinical testing. Pre-clinical tests include laboratory evaluations of product chemistry, formulation and stability, as well as studies to evaluate the potential for efficacy and toxicity in animal studies. The conduct of the pre-clinical tests and formulation of the compounds for testing must comply with federal regulations and requirements, including GLP regulations and standards and the United States Department of Agriculture&#8217;s Animal Welfare Act, if applicable. The results of the pre-clinical tests, together with manufacturing information and analytical data, are submitted to the FDA as part of an IND application. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investigational New Drug Application</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An IND is an exemption from the FDCA that allows an unapproved product candidate to be shipped in interstate commerce for use in an investigational clinical trial and a request for FDA authorization to administer such investigational product to humans. The IND automatically becomes effective 30&#160;days after receipt by the FDA, unless before that time the FDA raises concerns or questions about the product or conduct of the proposed clinical trial, including concerns that human research subjects will be exposed to unreasonable health risks. In that case, the IND sponsor and the FDA must resolve any outstanding FDA </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">294</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">concerns before the clinical trials can begin or recommence. As a result, submission of the IND may result in the FDA not allowing the trials to commence or allowing the trial to commence on the terms originally specified by the sponsor in the IND. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If the FDA raises concerns or questions either during this initial 30-day period, or at any time during the IND process, it may choose to impose a partial or complete clinical hold. Clinical holds are imposed by the FDA whenever there is concern for patient safety and may be a result of new data, findings, or developments in clinical, pre-clinical, and/or chemistry, manufacturing, and controls. This order issued by the FDA would delay either a proposed clinical trial or cause suspension of an ongoing trial, until all outstanding concerns have been adequately addressed and the FDA has notified the company that investigations may proceed. This could cause significant delays or difficulties in completing Carisma&#8217;s planned clinical trial or future clinical trials in a timely manner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Following the issuance of a clinical hold or partial clinical hold, a clinical investigation may only resume once the FDA has notified the sponsor that the investigation may proceed. The FDA will base that determination on information provided by the sponsor correcting the deficiencies previously cited or otherwise satisfying the FDA that the investigation can proceed or recommence. Occasionally, clinical holds are imposed due to manufacturing issues that may present safety issues for the clinical study subjects. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Expanded Access to an Investigational Drug for Treatment Use</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Expanded access, sometimes called &#8220;compassionate use,&#8221; is the use of investigational products outside of clinical trials to treat patients with serious or immediately life-threatening diseases or conditions when there are no comparable or satisfactory alternative treatment options. The rules and regulations related to expanded access are intended to improve access to investigational products for patients who may benefit from investigational therapies. FDA regulations allow access to investigational products under an IND by the company or the treating physician for treatment purposes on a case-by-case basis for: individual patients (single-patient IND applications for treatment in emergency settings and non-emergency settings); intermediate-size patient populations; and larger populations for use of the investigational product under a treatment protocol or treatment IND application. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When considering an IND application for expanded access to an investigational product with the purpose of treating a patient or a group of patients, the sponsor and treating physicians or investigators will determine suitability when all of the following criteria apply: patient(s) have a serious or immediately life-threatening disease or condition, and there is no comparable or satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition; the potential patient benefit justifies the potential risks of the treatment and the potential risks are not unreasonable in the context or condition to be treated; and the expanded use of the investigational drug for the requested treatment will not interfere initiation, conduct, or completion of clinical investigations that could support marketing approval of the product or otherwise compromise the potential development of the product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There is no obligation for a sponsor to make its drug products available for expanded access; however, as required by the 21st Century Cures Act, or Cures Act, passed in 2016, if a sponsor has a policy regarding how it evaluates and responds to expanded access requests, sponsors are required to make such policies publicly available upon the earlier of initiation of a Phase&#160;2 or Phase&#160;3 clinical trial, or 15&#160;days after the investigational drug or biologic receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced therapy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to and separate from expanded access, on May&#160;30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational products that have completed a Phase&#160;1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a manufacturer to make its investigational products available to eligible patients as a result of the Right to Try Act. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Human Clinical Trials in Support of a BLA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials involve the administration of the investigational product candidate to healthy volunteers or patients with the disease or condition to be treated under the supervision of a qualified principal </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">295</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">investigator in accordance with GCP requirements. Clinical trials are conducted under protocols detailing, among other things, the objectives of the trial, inclusion and exclusion criteria, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A sponsor who wishes to conduct a clinical trial outside the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. When a foreign clinical trial is conducted under an IND, all FDA IND requirements must be met unless waived. When a foreign clinical trial is not conducted under an IND, the sponsor must ensure that the trial complies with certain regulatory requirements, including GCP requirements, of the FDA in order to use the trial as support for an IND or application for marketing approval. The GCP requirements encompass both ethical and data integrity standards for clinical trials. The FDA&#8217;s regulations are intended to help ensure the protection of human subjects enrolled in non-IND foreign clinical trials, as well as the quality and integrity of the resulting data. They further help ensure that non-IND foreign trials are conducted in a manner comparable to that required for clinical trials in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, each clinical trial must be reviewed and approved by an IRB either centrally or individually at each institution at which the clinical trial will be conducted. The IRB will consider, among other things, clinical trial design, patient informed consent, ethical factors, the safety of human subjects, and the possible liability of the institution. An IRB must operate in compliance with FDA regulations. The FDA, IRB, or the clinical trial sponsor may suspend or discontinue a clinical trial at any time for various reasons, including a finding that the clinical trial is not being conducted in accordance with FDA requirements or that the participants are being exposed to an unacceptable health risk. Clinical testing also must satisfy extensive GCP rules and the requirements for informed consent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board, or DSMB. This group may recommend continuation of the trial as planned, changes in trial conduct, or cessation of the trial at designated check points based on certain available data from the trial to which only the DSMB has access. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials typically are conducted in three sequential phases, but the phases may overlap or be combined. Additional studies may be required after approval. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;1</font><font style="letter-spacing:0.2pt;"> clinical trials are initially conducted in a limited population to test the product candidate for safety, including adverse effects, dose tolerance, absorption, metabolism, distribution, excretion, and pharmacodynamics in healthy humans or, on occasion, in patients, such as cancer patients. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;2</font><font style="letter-spacing:0.2pt;"> clinical trials are generally conducted in a limited patient population to identify possible adverse effects and safety risks, evaluate the efficacy of the product candidate for specific targeted indications and determine dose tolerance and optimal dosage. Multiple Phase&#160;2 clinical trials may be conducted by the sponsor to obtain information prior to beginning larger and more costly Phase&#160;3 clinical trials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;3</font><font style="letter-spacing:0.2pt;"> clinical trials proceed if the Phase&#160;2 clinical trials demonstrate that a dose range of the product candidate is potentially effective and has an acceptable safety profile. Phase&#160;3 clinical trials are undertaken within an expanded patient population to further evaluate dosage, provide substantial evidence of clinical efficacy, and further test for safety in an expanded and diverse patient population at multiple, geographically dispersed clinical trial sites. A well-controlled, statistically robust Phase&#160;3 trial may be designed to deliver the data that regulatory authorities will use to decide whether or not to approve, and, if approved, how to appropriately label a biologic; such Phase&#160;3 studies are referred to as &#8220;pivotal.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In some cases, the FDA may approve a BLA for a product but require the sponsor to conduct additional clinical trials to further assess the product&#8217;s safety and effectiveness after approval. Such post-approval trials are typically referred to as Phase&#160;4 clinical trials. These studies are used to gain additional experience from the treatment of patients in the intended therapeutic indication and to document a clinical benefit in the case of biologics approved under accelerated approval regulations. If the FDA approves a product while a company has ongoing clinical trials that were not necessary for approval, a company may be able to use the data from these clinical trials to meet all or part of any Phase&#160;4 clinical trial requirement or to request a change </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">296</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">in the product labeling. The failure to exercise due diligence with regard to conducting Phase&#160;4 clinical trials could result in withdrawal of approval for products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A clinical trial may combine the elements of more than one phase and the FDA often requires more than one Phase&#160;3 trial to support marketing approval of a product candidate. A company&#8217;s designation of a clinical trial as being of a particular phase is not necessarily indicative that the study will be sufficient to satisfy the FDA requirements of that phase because this determination cannot be made until the protocol and data have been submitted to and reviewed by the FDA. Generally, pivotal trials are Phase&#160;3 trials, but they may be Phase&#160;2 trials if the design provides a well-controlled and reliable assessment of clinical benefit, particularly in an area of unmet medical need. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Finally, sponsors of clinical trials are required to register and disclose certain clinical trial information on a public registry (clinicaltrials.gov) maintained by the U.S. National Institutes of Health, or NIH. In particular, information related to the product, patient population, phase of investigation, study sites and investigators and other aspects of the clinical trial is made public as part of the registration of the clinical trial. Both NIH and the FDA have recently signaled the government&#8217;s willingness to begin enforcing those requirements against non-compliant clinical trial sponsors. The failure to submit clinical trial information to clinicaltrials.gov, as required, is a prohibited act under the FDCA with violations subject to potential civil monetary penalties of up to $10,000 for each day the violation continues. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Special Regulations and Guidance Governing Gene Therapy Products</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA has defined a gene therapy product as one that mediates its effects by transcription and/or translation of transferred genetic material and/or by integrating into the host genome and which is administered as nucleic acids, viruses, or genetically engineered microorganisms. The products may be used to modify cells </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> or transferred to cells </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> prior to administration to the recipient. Within the FDA, the Center for Biologics Evaluation and Research, or CBER, regulates gene therapy products. Within CBER, the review of gene therapy and related products is consolidated in the OTAT, and the FDA has established the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER on its reviews. CBER works closely with the Local Biosafety Board, a federal advisory committee, in reviewing proposed and ongoing gene therapy protocols and engaging in a public discussion of scientific, safety, ethical, and societal issues related to those protocols. The NIH and the Recombinant DNA Advisory Committee, or RAC, a federal advisory committee, also advise the FDA on gene therapy issues and other issues related to emerging technologies. The FDA and the NIH have published guidance documents with respect to the development and submission of gene therapy protocols. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA has issued various guidance documents regarding gene therapies, including final guidance documents released in January&#160;2020 relating to chemistry, manufacturing and controls information for gene therapy INDs, gene therapies for rare diseases and gene therapies for retinal disorders, as well as draft guidance in January&#160;2021 for Human Gene Therapy for Neurodegenerative Diseases. Although the FDA has indicated that these and other guidance documents it previously issued are not legally binding, Carisma believes that its compliance with them is likely necessary to gain approval for any gene therapy product candidate Carisma may develop. The guidance documents provide additional factors that the FDA will consider at each of the above stages of development and relate to, among other things, the proper pre-clinical assessment of gene therapies; the chemistry, manufacturing, and control information that should be included in an IND application; the proper design of tests to measure product potency in support of an IND or BLA application; and measures to observe delayed adverse effects in subjects who have been exposed to investigational gene therapies when the risk of such effects is high. Further, the FDA usually recommends that sponsors observe subjects for potential gene therapy-related delayed adverse events for a 15-year period, including a minimum of five&#160;years of annual examinations followed by 10&#160;years of annual queries, either in person or by questionnaire. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, to facilitate adverse event reporting and dissemination of additional information about gene therapy trials, the FDA and the NIH established the Genetic Modification Clinical Research Information System, or GeMCRIS. Investigators and sponsors of human gene transfer trials can utilize this web-based system to report serious adverse events and to provide annual reports. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">297</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Finally, for a gene therapy product, the FDA also will not approve the product if the manufacturer is not in compliance with good tissue practices, or GTP. These standards are found in FDA regulations and guidance that govern the methods used in, and the facilities and controls used for, the manufacture of human cells, tissues, and cellular and tissue-based products, or HCT/Ps, which are human cells or tissue intended for implantation, transplant, infusion, or transfer into a human recipient. The primary intent of the GTP requirements is to ensure thatT-cell and tissue-based products are manufactured in a manner designed to prevent the introduction, transmission, and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through screening and testing. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pediatric Studies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Pediatric Research Equity Act of 2003, or PREA, a BLA or supplement thereto must contain data that are adequate to assess the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. Sponsors must also submit pediatric study plans prior to the assessment data. Those plans must contain an outline of the proposed pediatric study or studies the sponsor plans to conduct, including study objectives and design, any deferral or waiver requests, and other information required by regulation. The sponsor, the FDA, and the FDA&#8217;s internal review committee must then review the information submitted, consult with each other, and agree upon a final plan. The FDA or the sponsor may request an amendment to the plan at any time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may, on its own initiative or at the request of the sponsor, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements. A deferral may be granted for several reasons, including a finding that the product or therapeutic candidate is ready for approval for use in adults before pediatric trials are completed. The FDA is required to send a PREA Non-Compliance letter to sponsors who have failed to submit their pediatric assessments under PREA, have failed to seek or obtain a deferral or deferral extension or have failed to request approval for a required pediatric formulation. Unless otherwise required by regulation, the pediatric data requirements do not apply to products with orphan designation, although FDA has recently taken steps to limit what it considers abuse of this statutory exemption in PREA. The FDA also maintains a list of diseases that are exempt from PREA requirements due to low prevalence of disease in the pediatric population. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Compliance with cGMP Requirements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with its review of a BLA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in full compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. The PHSA emphasizes the importance of manufacturing control for products like biologics whose attributes cannot be precisely defined. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Manufacturers and others involved in the manufacture and distribution of products must also register their establishments with the FDA and certain state agencies. Both domestic and foreign manufacturing establishments must register and provide additional information to the FDA upon their initial participation in the manufacturing process. Any product manufactured by or imported from a facility that has not registered, whether foreign or domestic, is deemed misbranded under the FDCA. Establishments may be subject to periodic unannounced inspections by government authorities to ensure compliance with cGMPs and other laws. Inspections must follow a &#8220;risk-based schedule&#8221; that may result in certain establishments being inspected more frequently. Manufacturers may also have to provide, on request, electronic or physical records regarding their establishments. Delaying, denying, limiting, or refusing inspection by the FDA may lead to a product being deemed to be adulterated. Changes to the manufacturing process, specifications or container closure system for an approved product are strictly regulated and often require prior FDA approval before being implemented. The FDA&#8217;s regulations also require, among other things, the investigation and correction of any deviations from cGMP and the imposition of reporting and documentation requirements upon the sponsor and any third-party manufacturers involved in producing the approved product. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">298</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Submission and Filing of a BLA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The results of product candidate development, pre-clinical testing, and clinical trials, including negative or ambiguous results as well as positive findings, are submitted to the FDA as part of a BLA requesting license to market the product. The BLA must contain extensive manufacturing information and detailed information on the composition of the product and proposed labeling as well as payment of a user fee. Under federal law, the submission of most BLAs is subject to an application user fee, which for federal fiscal year 2022 is $3,117,218 for an application requiring clinical data. The sponsor of a licensed BLA is also subject to an annual program fee, which for federal fiscal year 2022 is $369,413. Certain exceptions and waivers are available for some of these fees, such as an exception from the application fee for products with orphan designation and a waiver for certain small businesses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following submission of a BLA, the FDA has 60&#160;days to conduct a preliminary review of the application and it must inform the sponsor within that period of time whether the BLA is sufficiently complete to permit substantive review. In the event that FDA determines that an application does not satisfy this standard, it will issue a Refuse to File, or RTF, determination to the sponsor. The FDA may request additional information and studies, and the application must be resubmitted with the additional information. The resubmitted application is also subject to review before the FDA accepts it for filing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals and policies agreed to by the FDA under the PDUFA, the FDA has ten&#160;months in which to complete its initial review of a standard application and respond to the sponsor, and six&#160;months for a priority review of the application. The FDA does not always meet its PDUFA goal dates for standard and priority BLAs. The review process may often be significantly extended by FDA requests for additional information or clarification. The review process and the PDUFA goal date may be extended by three&#160;months if the FDA requests or if the sponsor otherwise provides additional information or clarification regarding information already provided in the submission within the last three&#160;months before the PDUFA goal date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may also refer the application to an advisory committee for review, evaluation, and recommendation as to whether the application should be approved. In particular, the FDA may refer applications for novel biologic products or biologic products that present difficult questions of safety or efficacy to an advisory committee. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates, and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The FDA&#8217;s Decision on a BLA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the PHSA, the FDA may approve a BLA if it determines that the product is safe, pure, and potent, and the facility where the product will be manufactured meets standards designed to ensure that it continues to be safe, pure, and potent. Specifically, the FDA must determine that the expected benefits of the proposed product outweigh its potential risks to patients. This &#8220;benefit-risk&#8221; assessment is informed by the extensive body of evidence about the proposed product in the BLA. On the basis of the FDA&#8217;s evaluation of the application and accompanying information, including the results of the inspection of the manufacturing facilities and any FDA audits of pre-clinical and clinical trial sites to assure compliance with GCPs, the FDA may issue a complete response letter, or CRL, or an approval letter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the application is not approved, the FDA will issue a CRL, which will contain the conditions that must be met in order to secure final approval of the application and will outline recommended actions the sponsor might take to obtain approval of the application. Sponsors that receive a CRL may submit to the FDA information that represents a complete response to the issues identified by the FDA, withdraw the application or request a hearing. The FDA will not approve an application until issues identified in the CRL have been addressed. If a CRL is issued, the sponsor will have one year to respond to the deficiencies identified by the FDA, at which time the FDA can deem the application withdrawn or, in its discretion, grant the sponsor an additional six-month extension to respond. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An approval letter, on the other hand, authorizes commercial marketing of the product with specific prescribing information for specific indications. The FDA may limit the approved indication(s) for use of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">299</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the product. It may also require that contraindications, warnings, or precautions be included in the product labeling. In addition, the FDA may call for post-approval studies, including Phase&#160;4 clinical trials, to further assess the product&#8217;s efficacy and/or safety after approval. The agency may also require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution restrictions or other risk management mechanisms, including REMS, to help ensure that the benefits of the product outweigh the potential risks. REMS can include medication guides, communication plans for healthcare professionals, and elements to assure safe use, or ETASU. ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patent registries. The FDA may prevent or limit further marketing of a product based on the results of post-market studies or surveillance programs. After approval, many types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further testing requirements and FDA review and approval. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Expedited Review Programs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA is authorized to expedite the review of applications in several ways. None of these expedited programs changes the standards for approval but each may help expedite the development or approval process governing product candidates. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fast Track designation.&nbsp;&nbsp;&nbsp;The sponsor of a product candidate may request the FDA to designate the product for a specific indication as a Fast Track product concurrent with or after the filing of the IND. Candidate products are eligible for Fast Track designation if </font><font style="font-style:italic;letter-spacing:0.2pt;">they</font><font style="letter-spacing:0.2pt;"> are intended to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition. Fast Track designation applies to the combination of the product candidate and the specific indication for which it is being studied. In addition to other benefits, such as the ability to have greater interactions with the FDA, the FDA may initiate review of sections of a Fast Track application before the application is complete, a process known as rolling review. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Breakthrough therapy designation.&nbsp;&nbsp;&nbsp;To qualify for the breakthrough therapy program, product candidates must be intended to treat a serious or life-threatening disease or condition and preliminary clinical evidence must indicate that such product candidates may demonstrate substantial improvement on one or more clinically significant endpoints over existing therapies. The FDA will seek to ensure the sponsor of a breakthrough therapy product candidate receives intensive guidance on an efficient drug development program, intensive involvement of senior managers and experienced staff on a proactive, collaborative and cross-disciplinary review and rolling review. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Priority review.&nbsp;&nbsp;&nbsp;A product candidate is eligible for priority review if it treats a serious condition and, if approved, it would be a significant improvement in the safety or effectiveness of the treatment, diagnosis or prevention compared to marketed products. FDA aims to complete its review of priority review applications within six&#160;months as opposed to 10&#160;months for standard review. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Accelerated approval.&nbsp;&nbsp;&nbsp;Drug or biologic products studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive accelerated approval. Accelerated approval means that a product candidate may be approved on the basis of adequate and well controlled clinical trials establishing that the product candidate has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity and prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require that a sponsor of a drug or biologic product candidate receiving accelerated approval perform adequate and well controlled post-marketing clinical trials. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Regenerative advanced therapy.&nbsp;&nbsp;&nbsp;With passage of the Cures Act, Congress authorized the FDA to accelerate review and approval of products designated as regenerative advanced therapies. A product is eligible for this designation if it is a regenerative medicine therapy that is intended to treat, modify, reverse or cure a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the product candidate has the potential to address unmet medical needs for such disease or condition. The benefits of a regenerative advanced therapy designation include early </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">300</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">interactions with the FDA to expedite development and review, benefits available to breakthrough therapies, potential eligibility for priority review and accelerated approval based on surrogate or intermediate endpoints. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Post-Approval Regulation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If regulatory approval for marketing of a product or new indication for an existing product is obtained, the sponsor will be required to comply with all regular post-approval regulatory requirements as well as any post-approval requirements that the FDA have imposed as part of the approval process. The sponsor will be required to report certain adverse reactions and production problems to the FDA, provide updated safety and efficacy information and comply with requirements concerning advertising and promotional labeling requirements. Manufacturers and certain of their subcontractors are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements, including cGMP regulations, which impose certain procedural and documentation requirements upon manufacturers. Accordingly, the sponsor and its third-party manufacturers must continue to expend time, money, and effort in the areas of production and quality control to maintain compliance with cGMP regulations and other regulatory requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A product may also be subject to official lot release, meaning that the manufacturer is required to perform certain tests on each lot of the product before it is released for distribution. If the product is subject to official lot release, the manufacturer must submit samples of each lot, together with a release protocol showing a summary of the history of manufacture of the lot and the results of all of the manufacturer&#8217;s tests performed on the lot, to the FDA. The FDA may in addition perform certain confirmatory tests on lots of some products before releasing the lots for distribution. Finally, the FDA will conduct laboratory research related to the safety, purity, potency, and effectiveness of pharmaceutical products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fines, warning letters or holds on post-approval clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of product license approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">product seizure or detention, or refusal to permit the import or export of products; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">injunctions or the imposition of civil or criminal penalties. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Products may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability. If a company is found to have promoted off-label uses, it may become subject to adverse public relations and administrative and judicial enforcement by the FDA, the Department of Justice, or the Office of the Inspector General of the Department of Health and Human Services, as well as state authorities. This could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes drug products. In September&#160;2021, the FDA published final regulations which describe the types of evidence that the agency will consider in determining the intended use of a biologic product. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">301</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Orphan Drug Designation and Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Orphan drug designation in the United States is designed to encourage sponsors to develop products intended for rare diseases or conditions. In the United States, a rare disease or condition is statutorily defined as a condition that affects fewer than 200,000 individuals in the United States or that affects more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making available the biologic for the disease or condition will be recovered from sales of the product in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Orphan drug designation qualifies a company for tax credits and market exclusivity for seven&#160;years following the date of the product&#8217;s marketing approval if granted by the FDA. An application for designation as an orphan product can be made any time prior to the filing of an application for approval to market the product. A product becomes an orphan when it receives orphan drug designation from the Office of Orphan Products Development at the FDA based on acceptable confidential requests made under the regulatory provisions. The product must then go through the review and approval process like any other product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A sponsor may request orphan drug designation of a previously unapproved product or new orphan indication for an already marketed product. In addition, a sponsor of a product that is otherwise the same product as an already approved orphan drug may seek and obtain orphan drug designation for the subsequent product for the same rare disease or condition if it can present a plausible hypothesis that its product may be clinically superior to the first drug. More than one sponsor may receive orphan drug designation for the same product for the same rare disease or condition, but each sponsor seeking orphan drug designation must file a complete request for designation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a product with orphan designation receives the first FDA approval for the disease or condition for which it has such designation or for a select indication or use within the rare disease or condition for which it was designated, the product generally will receive orphan drug exclusivity. Orphan drug exclusivity means that the FDA may not approve another sponsor&#8217;s marketing application for the same product for the same indication for seven&#160;years, except in certain limited circumstances. If a product designated as an orphan drug ultimately receives marketing approval for an indication broader than what was designated in its orphan drug application, it may not be entitled to exclusivity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The period of exclusivity begins on the date that the marketing application is approved by the FDA. Orphan drug exclusivity will not bar approval of another product under certain circumstances, including if a subsequent product with the same drug for the same condition is shown to be clinically superior to the approved product on the basis of greater efficacy or safety, or providing a major contribution to patient care, or if the company with orphan drug exclusivity is not able to meet market demand. Under Omnibus legislation enacted in December&#160;2020, the requirement for a product to show clinical superiority applies to drugs and biologics that received orphan drug designation before enactment of FDARA in 2017, but have not yet been approved or licensed by FDA. In addition, the FDA may approve a second application for the same product for a different use or a second application for a clinically superior version of the product for the same use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA and Congress may further reevaluate the Orphan Drug Act and its regulations and policies. This may be particularly true in light of a decision from the Court of Appeals for the 11</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Circuit in September&#160;2021 finding that, for the purpose of determining the scope of exclusivity, the term &#8220;same disease or condition&#8221; means the designated &#8220;rare disease or condition&#8221; and could not be interpreted by the FDA to mean the &#8220;indication or use.&#8221; </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pediatric Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pediatric exclusivity is another type of non-patent exclusivity in the United States and for biologics, if granted, provides for the attachment of an additional six&#160;months of regulatory exclusivity to the term of any existing regulatory exclusivity, including orphan exclusivity. This six-month exclusivity may be granted if a BLA sponsor submits pediatric data that fairly respond to a written request from the FDA for such data. The data do not need to show the product to be effective in the pediatric population studied; rather, if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the additional protection is granted. If reports </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">302</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of requested pediatric studies are submitted to and accepted by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity that cover the product are extended by six&#160;months. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Biosimilars and Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The 2010 Patient Protection and Affordable Care Act, which was signed into law in March&#160;2010, included a subtitle called the BPCIA. The BPCIA established a regulatory scheme authorizing the FDA to approve biosimilars and interchangeable biosimilars. A biosimilar is a biological product that is highly similar to an existing FDA-licensed &#8220;reference product.&#8221; As of January&#160;1, 2021, the FDA has approved 29 biosimilar products for use in the United States. To date, the FDA has approved a number of biosimilars, and the first interchangeable biosimilar product was approved on July&#160;30, 2021, and a second product previously approved as a biosimilar was designated as interchangeable in October&#160;2021. The FDA has also issued numerous guidance documents outlining its approach to reviewing and licensing biosimilars and interchangeable biosimilars under the PHSA, including a draft guidance issued in November&#160;2020 that seeks to provide additional clarity to manufacturers of interchangeable biosimilars. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the BPCIA, a manufacturer may submit an application for licensure of a biologic product that is &#8220;biosimilar to&#8221; or &#8220;interchangeable with&#8221; a previously approved biological product or &#8220;reference product.&#8221; In order for the FDA to approve a biosimilar product, it must find that there are no clinically meaningful differences between the reference product and proposed biosimilar product in terms of safety, purity, and potency. For the FDA to approve a biosimilar product as interchangeable with a reference product, the agency must find that the biosimilar product can be expected to produce the same clinical results as the reference product, and (for products administered multiple times) that the biologic and the reference biologic may be switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four&#160;years following the date of approval of the reference product. The FDA may not approve a biosimilar product until 12&#160;years from the date on which the reference product was approved. Even if a product is considered to be a reference product eligible for exclusivity, another company could market a competing version of that product if the FDA approves a full BLA for such product containing the sponsor&#8217;s own pre-clinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity, and potency of their product. The BPCIA also created certain exclusivity periods for biosimilars approved as interchangeable products. There have been recent government proposals to reduce the 12-year reference product exclusivity period, but none has been enacted to date. At the same time, since passage of the BPCIA, many states have passed laws or amendments to laws, which address pharmacy practices involving biosimilar products. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Federal and State Data Privacy and Security Laws</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under HIPAA, the U.S. Department of Health and Human Services has issued regulations to protect the privacy and security of protected health information used or disclosed by covered entities including certain healthcare providers, health plans, and healthcare clearinghouses. HIPAA also regulates standardization of data content, codes, and formats used in healthcare transactions and standardization of identifiers for health plans and providers. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their regulations, including the omnibus final rule published on January&#160;25, 2013, also imposes certain obligations on the business associates of covered entities that obtain protected health information in providing services to or on behalf of covered entities. In addition to federal privacy regulations, there are a number of state laws governing confidentiality and security of health information that are applicable to Carisma&#8217;s business. In addition to possible federal civil and criminal penalties for HIPAA violations, state attorneys general are authorized to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. Accordingly, state attorneys general (along with private plaintiffs) have brought civil actions seeking injunctions and damages resulting from alleged violations of HIPAA&#8217;s privacy and security rules. New laws and regulations governing privacy and security may be adopted in the future as well. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">303</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, California recently enacted legislation that has been dubbed the first &#8220;GDPR-like&#8221; law in the United States, the CCPA. The CCPA creates new individual privacy rights for consumers (as that word is broadly defined in the law) and places increased privacy and security obligations on entities handling personal data of consumers or households. The CCPA went into effect on January&#160;1, 2020 and requires covered companies to provide new disclosures to California consumers, provide such consumers new ways to opt-out of certain sales of personal information, and allow for a new cause of action for data breaches. The CCPA could impact Carisma&#8217;s business activities depending on how it is interpreted and exemplifies the vulnerability of Carisma&#8217;s business to not only cyber threats but also the evolving regulatory environment related to personal data and protected health information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available under such laws, it is possible that some of Carisma&#8217;s current or future business activities, including certain clinical research, sales, and marketing practices and the provision of certain items and services to Carisma&#8217;s customers, could be subject to challenge under one or more of such privacy and data security laws. The heightening compliance environment and the need to build and maintain robust and secure systems to comply with different privacy compliance and/or reporting requirements in multiple jurisdictions could increase the possibility that a healthcare company may fail to comply fully with one or more of these requirements. If Carisma&#8217;s operations are found to be in violation of any of the privacy or data security laws or regulations described above that are applicable to Carisma, or any other laws that apply to Carisma, Carisma may be subject to penalties, including potentially significant criminal, civil, and administrative penalties, damages, fines, imprisonment, contractual damages, reputational harm, diminished profits and future earnings, additional reporting requirements, and/or oversight if Carisma becomes subject to a consent decree or similar agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of Carisma&#8217;s operations, any of which could adversely affect Carisma&#8217;s ability to operate its business and its results of operations. To the extent that any of Carisma&#8217;s product candidates, once approved, are sold in a foreign country, Carisma may be subject to similar foreign laws. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patent Term Restoration and Extension</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, a patent claiming a new biologic product, its method of use or its method of manufacture may be eligible for a limited patent term extension under the Hatch-Waxman Act, which permits a patent extension of up to five&#160;years for patent term lost during product development and FDA regulatory review. Assuming grant of the patent for which the extension is sought, the restoration period for a patent covering a product is typically one-half the time between the effective date of the IND clearing clinical studies and the submission date of the BLA, plus the time between the submission date of the BLA and the ultimate approval date. Patent term restoration cannot be used to extend the remaining term of a patent past a total of 14&#160;years from the product&#8217;s approval date in the United States. Only one patent applicable to an approved product is eligible for the extension, and the application for the extension must be submitted prior to the expiration of the patent for which extension is sought. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. The USPTO reviews and approves the application for any patent term extension in consultation with the FDA. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">FDA Approval of Companion Diagnostics</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2014, the FDA issued final guidance clarifying the requirements that will apply to approval of therapeutic products and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> companion diagnostics. According to the guidance, for novel drugs, a companion diagnostic device and its corresponding therapeutic should be approved or cleared contemporaneously by the FDA for the use indicated in the therapeutic product&#8217;s labeling. Approval or clearance of the companion diagnostic device will ensure that the device has been adequately evaluated and has adequate performance characteristics in the intended population. In July&#160;2016, the FDA issued a draft guidance intended to assist sponsors of the drug therapeutic and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> companion diagnostic device on issues related to co-development of the products. The 2014 guidance also explains that a companion diagnostic device used to make treatment decisions in clinical trials of a biologic product candidate generally will be considered an investigational device, unless it is employed for an intended use for which the device is already approved or cleared. If used to make critical treatment decisions, such as patient selection, the diagnostic device generally will be considered a significant risk device under the FDA&#8217;s Investigational Device </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">304</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Exemption, or IDE, regulations. Thus, the sponsor of the diagnostic device will be required to comply with the IDE regulations. According to the guidance, if a diagnostic device and a product are to be studied together to support their respective approvals, both products can be studied in the same investigational study, if the study meets both the requirements of the IDE regulations and the IND regulations. The guidance provides that depending on the details of the study plan and subjects, a sponsor may seek to submit an IND alone, or both an IND and an IDE. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2020, the FDA issued additional guidance which describes considerations for the development and labeling of companion diagnostic devices to support the indicated uses of multiple biological oncology products, when appropriate. The 2020 guidance expands on the policy statement in the 2014 guidance by recommending that companion diagnostic developers consider a number of factors when determining whether their test could be developed, or the labeling for approved companion diagnostics could be revised through a supplement, to support a broader labeling claim such as use with a specific group of oncology therapeutic products (rather than listing an individual therapeutic product(s)). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the FDCA, </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> diagnostics, including companion diagnostics, are regulated as medical devices. In the United States, the FDCA and its implementing regulations, and other federal and state statutes and regulations govern, among other things, medical device design and development, pre-clinical and clinical testing, premarket clearance or approval, registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post market surveillance. Unless an exemption applies, diagnostic tests require marketing clearance or approval from the FDA prior to commercial distribution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA previously has required </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> companion diagnostics intended to select the patients who will respond to the product candidate to obtain pre-market approval, or PMA, simultaneously with approval of the therapeutic product candidate. The PMA process, including the gathering of clinical and pre-clinical data and the submission to and review by the FDA, can take several&#160;years or longer. It involves a rigorous premarket review during which the sponsor must prepare and provide the FDA with reasonable assurance of the device&#8217;s safety and effectiveness and information about the device and its components regarding, among other things, device design, manufacturing and labeling. PMA applications are subject to an application fee. For federal fiscal year 2022, the standard fee is $374,858 and the small business fee is $93,714. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Coverage, Pricing, and Reimbursement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which Carisma may seek regulatory approval by the FDA or other government authorities. In the United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use any product candidates Carisma may develop unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of such product candidates. Even if any product candidates Carisma may develop are approved, sales of such product candidates will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers, and managed care organizations, provide coverage, and establish adequate reimbursement levels for, such product candidates. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity, and reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the approved products for a particular indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to the costs required to obtain FDA or other comparable marketing approvals. Nonetheless, product candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to cover any product candidates Carisma may develop could reduce physician utilization of such product candidates once approved and have a material adverse effect on Carisma&#8217;s sales, results of operations and financial condition. Additionally, a payor&#8217;s decision </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">305</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to payor. Third-party reimbursement and coverage may not be available to enable Carisma to maintain price levels sufficient to realize an appropriate return on Carisma&#8217;s investment in product development. In addition, any companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to any companion diagnostics. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The containment of healthcare costs also has become a priority of federal, state and foreign governments and the prices of pharmaceuticals have been a focus in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement, and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#8217;s revenue generated from the sale of any approved products. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators receive marketing approval, less favorable coverage policies and reimbursement rates may be implemented in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Outside the United States, ensuring adequate coverage and payment for any product candidates Carisma may develop will face challenges. Pricing of prescription pharmaceuticals is subject to governmental control in many countries. Pricing negotiations with governmental authorities can extend well beyond the receipt of regulatory marketing approval for a product and may require Carisma to conduct a clinical trial that compares the cost effectiveness of any product candidates Carisma may develop to other available therapies. The conduct of such a clinical trial could be expensive and result in delays in Carisma&#8217;s commercialization efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies (so called health technology assessments) in order to obtain reimbursement or pricing approval. For example, the European Union provides options for its member states to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. European Union member states may approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other member states allow companies to fix their own prices for products but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the European Union have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage healthcare expenditures, especially in light of the severe fiscal and debt crises experienced by many countries in the European Union. The downward pressure on healthcare costs in general, particularly prescription products, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. Political, economic, and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various European Union member states, and parallel trade (arbitrage between low-priced and high-priced member states), can further reduce prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of Carisma&#8217;s products, if approved in those countries. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Healthcare Law and Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers and third-party payors play a primary role in the recommendation and prescription of pharmaceutical products that are granted marketing approval. Arrangements with providers, consultants, third-party payors, and customers are subject to broadly applicable fraud and abuse, anti-kickback, false claims laws, reporting of payments to physicians and teaching physicians and patient privacy laws and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">306</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">regulations and other healthcare laws and regulations that may constrain Carisma&#8217;s business and/or financial arrangements. Restrictions under applicable federal and state healthcare laws and regulations, include the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, paying, receiving, or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal civil and criminal false claims laws, including the civil False Claims Act, and civil monetary penalties laws, which prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false, fictitious, or fraudulent or knowingly making, using, or causing to made or used a false record or statement to avoid, decrease, or conceal an obligation to pay money to the federal government; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Foreign Corrupt Practices Act, which prohibits companies and their intermediaries from making, or offering or promising to make improper payments to non-U.S. officials for the purpose of obtaining or retaining business or otherwise seeking favorable treatment; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal transparency requirements under the ACA, which require certain manufacturers of drugs, devices, biologics and medical supplies to report annually to the CMS within the U.S. Department of Health and Human Services, information related to payments and other transfers of value made by that entity to physicians, other healthcare providers, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring pharmaceutical manufacturers to report information related to payments to physicians and other healthcare providers or marketing expenditures. In addition, certain state and local laws require drug manufacturers to register pharmaceutical sales representatives in the jurisdiction. State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma&#8217;s operations are found to be in violation of any of these laws or any other governmental regulations that may apply to Carisma, Carisma may be subject to significant civil, criminal, and administrative penalties, damages, fines, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, and the curtailment or restructuring of Carisma&#8217;s operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Healthcare Reform</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. There have been a number of federal and state proposals during the last few&#160;years regarding the pricing of pharmaceutical and biopharmaceutical products, limiting coverage and reimbursement for drugs and other medical products, government control and other changes to the healthcare system in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2010, the United States Congress enacted the ACA, which, among other things, includes changes to the coverage and payment for products under government healthcare programs. Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, in August&#160;2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the&#160;years 2012 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of up to 2% per fiscal year, which will remain in effect through 2031 pursuant to the Coronavirus Aid, Relief and Economic Security Act or CARES Act. The American Taxpayer Relief Act of 2012, which was enacted in January&#160;2013, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers, and cancer treatment centers, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">307</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years. Further, with passage of the Inflation Reduction Act in August&#160;2022, Congress extended the expansion of ACA premium tax credits through 2025. Those subsidies were originally extended through 2022 under the American Rescue Plan&#160;Act of 2021. These laws may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices Carisma may obtain for any of Carisma&#8217;s product candidates for which Carisma may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since enactment of the ACA, there have been, and continue to be, numerous legal challenges and Congressional actions to repeal and replace provisions of the law. For example, with enactment of the Tax Cuts and Jobs Act of 2017, or the TCJA, which was signed by President Trump on December&#160;22, 2017, Congress repealed the &#8220;individual mandate.&#8221; The repeal of this provision, which requires most Americans to carry a minimal level of health insurance, became effective in 2019 Further, on December&#160;14, 2018, a U.S. District Court judge in the Northern District of Texas ruled that the individual mandate portion of the PPACA is an essential and inseverable feature of the ACA and therefore because the mandate was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. The U.S. Supreme Court heard this case on November&#160;10, 2020 and, on June&#160;17, 2021, dismissed this action after finding that the plaintiffs do not have standing to challenge the constitutionality of the ACA. Litigation and legislation over the ACA are likely to continue, with unpredictable and uncertain results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although the previous administration took executive actions to undermine or delay implementation of the ACA, those actions were rescinded with issuance of an Executive Order on January&#160;28, 2021, by President Biden which directs federal agencies to reconsider rules and other policies that limit Americans&#8217; access to health care, and consider actions that will protect and strengthen that access. Under this Executive Order, federal agencies are directed to re-examine: policies that undermine protections for people with pre-existing conditions, including complications related to COVID-19; demonstrations and waivers under Medicaid and the ACA that may reduce coverage or undermine the programs, including work requirements; policies that undermine the Health Insurance Marketplace or other markets for health insurance; policies that make it more difficult to enroll in Medicaid and the ACA; and policies that reduce affordability of coverage or financial assistance, including for dependents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The prices of prescription pharmaceuticals have also been the subject of considerable discussion in the United States. There have been several recent U.S. congressional inquiries, as well as proposed and enacted state and federal legislation designed to, among other things, bring more transparency to pharmaceutical pricing, review the relationship between pricing and manufacturer patient programs, and reduce the costs of pharmaceuticals under Medicare and Medicaid. In 2020, President Trump issued several executive orders intended to lower the costs of prescription products and certain provisions in these orders have been incorporated into regulations. These regulations include an interim final rule implementing a most favored nation model for prices that would tie Medicare Part&#160;B payments for certain physician-administered pharmaceuticals to the lowest price paid in other economically advanced countries, effective January&#160;1, 2021. That rule, however, has been subject to a nationwide preliminary injunction and, on December&#160;29, 2021, CMS issued a final rule to rescind it. With issuance of this rule, CMS stated that it will explore all options to incorporate value into payments for Medicare Part&#160;B pharmaceuticals and improve beneficiaries&#8217; access to evidence-based care. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in October&#160;2020, HHS and the FDA published a final rule allowing states and other entities to develop a Section&#160;804 Importation Program, or SIP, to import certain prescription products from Canada into the United States. The final rule is currently the subject of ongoing litigation, but at least six states (Vermont, Colorado, Florida, Maine, New Mexico, and New Hampshire) have passed laws allowing for the importation of products from Canada with the intent of developing SIPs for review and approval by the FDA. Further, on November&#160;20, 2020, HHS finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part&#160;D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January&#160;1, 2022 to January&#160;1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a new safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which has been delayed until January&#160;1, 2026, by the Infrastructure Investment and Jobs Act. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">308</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tEAHC">&#8203;</a><a name="tFAC">&#8203;</a><a name="tLEPR1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">More recently, with passage of the Inflation Reduction Act in August&#160;2022, Congress authorized Medicare beginning in 2026 to negotiate lower prices for certain costly single-source drug and biologic products that do not have competing generics or biosimilars. This provision is limited in terms of the number of pharmaceuticals whose prices can be negotiated in any given year and it only applies to drug products that have been approved for at least 9&#160;years and biologics that have been licensed for 13&#160;years. Drugs and biologics that have been approved for a single rare disease or condition are categorically excluded from Medicare price negotiations. Further, the new legislation provides that if pharmaceutical companies raise prices in Medicare faster than the rate of inflation, they must pay rebates back to the government for the difference. The new law also caps Medicare out-of-pocket drug costs at an estimated $4,000 a year in 2024 and, thereafter beginning in 2025, at $2,000 a year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;9, 2021, President Biden signed Executive Order 14063, which focuses on, among other things, the price of pharmaceuticals. The Order directs HHS to create a plan within 45&#160;days to combat &#8220;excessive pricing of prescription pharmaceuticals and enhance domestic pharmaceutical supply chains, to reduce the prices paid by the federal government for such pharmaceuticals, and to address the recurrent problem of price gouging.&#8221; On September&#160;9, 2021, HHS released its plan to reduce pharmaceutical prices. The key features of that plan are to: (a)&#160;make pharmaceutical prices more affordable and equitable for all consumers and throughout the health care system by supporting pharmaceutical price negotiations with manufacturers; (b)&#160;improve and promote competition throughout the prescription pharmaceutical industry by supporting market changes that strengthen supply chains, promote biosimilars, and increase transparency; and (c)&#160;foster scientific innovation to promote better healthcare and improve health by supporting public and private research and making sure that market incentives promote discovery of valuable and accessible new treatments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. A number of states, for example, require pharmaceutical manufacturers and other entities in the supply chain, including health carriers, pharmacy benefit managers, wholesale distributors, to disclose information about pricing of pharmaceuticals. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. These measures could reduce the ultimate demand for Carisma&#8217;s products, once approved, or put pressure on Carisma&#8217;s product pricing. Carisma expects that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for Carisma&#8217;s product candidates or additional pricing pressures. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees and Human Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January 4, 2023, Carisma had 94 full-time employees, including a total of 33 employees with M.D. or Ph.D. degrees. Of these full-time employees, 85 are engaged in research and development activities. None of Carisma&#8217;s employees are represented by labor unions or covered by collective bargaining agreements. Carisma considers its relationship with its employees to be good. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s human capital objectives are focused on attracting, developing, and retaining talent. Cash compensation plans and equity grants are designed to attract, retain and to motivate employees, directors, and select consultants to achieve our corporate objectives. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Facilities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s principal facilities consist of office and laboratory space in Philadelphia, Pennsylvania. Carisma occupies approximately 4,369 square feet of office space under a lease that is expected to expire in January&#160;2030 and approximately 3,600 square feet of laboratory space under a lease that expires in October&#160;2023. Carisma believes that its facilities are sufficient to meet its current needs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is currently not a party to any material legal proceedings.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">309</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBMD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF</font>
          <br >
          <font style="letter-spacing:-0.2pt;">FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following discussion and analysis should be read in conjunction with Sesen Bio&#8217;s financial statements and related notes included elsewhere in this proxy statement/prospectus. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Sesen Bio&#8217;s actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set out under the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus and elsewhere in this proxy statement/prospectus. See also the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; beginning on page&#160;<a href="#tCSCF">118</a> of this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company that was previously focused on advancing TFPTs for the treatment of patients with cancer. Sesen Bio&#8217;s most advanced product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an EpCAM antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of NMIBC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA, which are further described below. Sesen Bio no longer plans to pursue regulatory approval of Vicineum for NMIBC in the E.U. and has started to wind down certain of its manufacturing operations and business development partnerships. Sesen Bio has turned its primary focus to consummating a strategic transaction with the goal of maximizing shareholder value. Additionally, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In May&#160;2022, Sesen Bio announced that it had commenced a process to explore and evaluate strategic alternatives to enhance stockholder value, and had engaged a financial advisor to assist Sesen Bio in this process. Sesen Bio then commenced an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic acquisition or other transaction as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Background of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tBOTM">125</a> of this proxy statement/prospectus. On September&#160;21, 2022, Sesen Bio announced that it had entered into the Merger Agreement. Although Sesen Bio has entered into the Merger Agreement and intends to consummate the merger, there is no assurance that it will be able to successfully consummate the merger on a timely basis, or at all. If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, attempt to complete another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio or dissolve and liquidate its assets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide that it is in the best interests of the Sesen Bio stockholders to dissolve the company and liquidate its assets. In that event, the amount of cash available for distribution to the Sesen Bio stockholders would depend heavily on the timing of such decision and, ultimately, such liquidation, since the amount of cash available for distribution continues to decrease as Sesen Bio funds its operations and incurs fees and expenses related to the merger. In addition, if the Sesen Bio board of directors were to approve and recommend, and the Sesen Bio stockholders were to approve, a dissolution of Sesen Bio, it would be required under Delaware corporate law to pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, prior to making any distributions in liquidation to the Sesen Bio stockholders. As a result of this requirement, a portion of Sesen Bio&#8217;s assets may need to be reserved pending the resolution of such obligations. In addition, Sesen Bio may be subject to litigation or other claims related to a liquidation and dissolution of the company. If a liquidation and dissolution were pursued, the Sesen Bio board of directors, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">310</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in consultation with its advisors, would need to evaluate these matters and make a determination about a reasonable amount to reserve. Accordingly, the Sesen Bio stockholders could lose all or a significant portion of their investment in the event of a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Recent Events</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2022 Restructuring Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio approved the 2022 restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following the decision to voluntarily pause further development of Vicineum in the United States. Execution of the 2022 restructuring plan is expected to be substantially completed in connection with the closing of the merger with Carisma, which is expected to occur in the first quarter of 2023. The 2022 restructuring plan includes an incremental reduction in Sesen Bio&#8217;s workforce as well as additional cost-saving initiatives intended to preserve capital during the pendency of the merger with Carisma and while Sesen Bio seeks a potential partner for the further development of Vicineum. Sesen Bio has also incurred one-time cash costs associated with the termination of certain contracts and all other activities under the 2022 restructuring plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sale of Legacy Technology to Roche</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio executed the Roche Asset Purchase Agreement pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio for up to $70&#160;million. As a result of the Roche Asset Purchase Agreement, the exclusive license agreement between Roche and Sesen Bio was terminated resulting in no further diligence, milestone or royalty payment obligations under such license agreement. Pursuant to the Roche Asset Purchase Agreement, Roche made a $40&#160;million payment to Sesen Bio upon execution of the Roche Asset Purchase Agreement. The Roche Asset Purchase Agreement also provides that Roche will make an additional $30&#160;million payable to Sesen Bio upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a defined indication if initiated prior to December&#160;31, 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2022 Retention Program</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;28, 2022, the Sesen Bio board of directors and the Sesen Bio compensation committee approved a retention program for certain employees pursuant to which Sesen Bio will provide a cash incentive designed to retain such employees. Pursuant to this retention program, certain of Sesen Bio&#8217;s employees, including certain executive officers, will receive a cash bonus award, which vests in full upon the earlier of the completion of a strategic transaction and termination without cause, subject to continued employment through that time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Components of Sesen Bio&#8217;s Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">License and Related Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">License revenue consists of revenue recognized pursuant to Sesen Bio&#8217;s OUS business development partnership agreements, including the Qilu License Agreement, and the Roche Asset Purchase Agreement, which is assessed under ASC Topic 606, Revenue. Sesen Bio has terminated all of its OUS business development partnership agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist primarily of costs incurred for the development of Vicineum for the treatment of NMIBC, which include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">employee-related expenses, including salaries, benefits, travel and share-based compensation expense; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenses incurred under agreements with CROs and investigative sites that conduct Sesen Bio&#8217;s clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenses associated with developing manufacturing capabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">311</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenses associated with transferring manufacturing capabilities to CMOs for commercial-scale production; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance of facilities, insurance and other supplies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenses associated with regulatory activities; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenses associated with license milestone fees. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expenses research and development costs as incurred. Sesen Bio recognizes external development costs based on an evaluation of the progress to completion of specific tasks using information and data provided to Sesen Bio by its vendors and its clinical sites. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio allocates direct research and development expenses, consisting principally of external costs, such as fees paid to investigators, consultants, central laboratories and CROs in connection with its clinical trials, costs related to manufacturing or purchasing clinical trial materials and technology transfer and license milestone fees, to specific product programs. Sesen Bio does not allocate employee and contractor-related costs, costs associated with its platform and facility expenses, including depreciation or other indirect costs, to specific product programs because these costs may be deployed across multiple product programs under research and development and, as such, are separately classified. The table below provides research and development expenses incurred for Vicineum for the treatment of NMIBC and other expenses by category. Sesen Bio expects to significantly reduce its research and development expenses during the pendency of the proposed merger with Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio did not allocate research and development expenses to any other specific product program during the periods presented (in thousands): </font>
        </div>
        <table style="width:456pt;height:183pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Programs: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Vicineum for the treatment of NMIBC </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">813</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,989</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">29,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,888</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total direct program expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">813</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,989</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">29,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,888</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Personnel and other expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Employee and contractor-related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,840</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,732</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">6,920</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,392</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Platform-related lab expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">133</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Facility expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">150</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">124</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">428</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">392</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">103</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">483</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">468</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total personnel and other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,118</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,978</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">7,931</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:-0.2pt;">Total Research and Development</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,931</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">4,967</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">37,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">18,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and Administrative</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses consist primarily of salaries and related costs for personnel, including share-based compensation and benefits, in executive, operational, finance, legal, business development and human resource functions. Other general and administrative expenses include facility-related costs, professional fees for legal, estimated payments to settle litigation, insurance, investment banking fees, patent, consulting and accounting services, and pre-commercial United States market research. Sesen Bio expects its general and administrative expenses to increase due to increases in professional and advisory fees during the pendency of the proposed merger with Carisma. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with the Viventia Acquisition in September&#160;2016, Sesen Bio recorded contingent consideration pertaining to the amounts potentially payable to Viventia&#8217;s shareholders pursuant to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">312</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">terms of the Share Purchase Agreement among Sesen Bio, Viventia and the other signatories thereto and are based on regulatory approval in certain markets and future revenue levels. The fair value of contingent consideration is assessed at each balance sheet date and changes, if any, to the fair value are recognized in earnings (or loss) for the period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Income, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other income, net consists primarily of interest income earned on cash and cash equivalents and, to a lesser extent, any gains or losses on foreign exchange. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Provision for Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Benefit for income taxes is driven by the intangible impairment charge, changing the value of deferred tax liabilities. Provision for income taxes consists of income taxes incurred to non-U.S. jurisdictions pursuant to Sesen Bio&#8217;s OUS business development partnership agreements, including the Qilu License Agreement, which was terminated on December 23, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the three&#160;months ended September&#160;30, 2022 and 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:288.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/(Decrease) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dollars </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:259.97pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except&#160;percentages) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,931</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,967</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(2,036<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(41<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">8,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,699</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(558<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(6<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,425</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">98<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(31,700<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(100<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,800<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(114,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">112,200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(98<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(63,112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">83,331</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(132<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Income from Operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">19,781</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">63,112</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(43,331<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(69<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">675</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">67,500<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Income Before Taxes</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">63,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(42,656<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(68<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Benefit from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">8,561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,561<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(100<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:259.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Income After Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(51,217<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(71<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.3pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Revenue for the three&#160;months ended September&#160;30, 2022 was $40.0&#160;million, which was due to the execution of the Roche Asset Purchase Agreement for EBI-031 and all other IL-6 antagonist monoclonal antibody technology. Sesen Bio did not record any revenue for the three&#160;months ended September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $2.9&#160;million for the three&#160;months ended September&#160;30, 2022, compared to $5.0&#160;million for the three&#160;months ended September&#160;30, 2021. The decrease of $2.0&#160;million was </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">313</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">primarily due to a decrease in costs associated with manufacturing ($1.9&#160;million) and a decrease in other R&amp;D related costs ($0.1&#160;million), driven by the strategic decision to voluntarily pause further development of Vicineum in the U.S. in the third quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $8.1&#160;million for the three&#160;months ended September&#160;30, 2022, compared to $8.7&#160;million for the three&#160;months ended September&#160;30, 2021. The decrease of $0.6&#160;million was primarily due to a decrease in marketing and commercialization expenses, which were incurred in the third quarter of 2021 in preparation for potential commercial launch of Vicineum but were discontinued as a result of the Complete Response Letter from the FDA received in August&#160;2021 ($2.3&#160;million) and a decrease in professional fees for accounting services ($0.4&#160;million). This was partially offset by an increase in legal expense ($1.3&#160;million), driven by legal fees associated with Sesen Bio&#8217;s assessment of strategic alternatives incurred in the third quarter of 2022 ($2.2&#160;million), partially offset by a decrease in legal fees associated with the internal review completed in February 2022 ($0.4&#160;million) and other legal expenses ($0.5&#160;million). Additionally, financial advisor fees increased due to financial advisor fees associated with Sesen Bio&#8217;s assessment of strategic alternatives incurred in the third quarter of 2022 ($0.8&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restructuring Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Restructuring charges were $10.9&#160;million for the three&#160;months ended September&#160;30, 2022 compared to $5.5&#160;million for the three&#160;months ended September&#160;30, 2021. The expense for the third quarter of 2022 consisted of severance and other employee-related costs ($6.9&#160;million) and termination of certain contracts and other associated costs ($4.0&#160;million) associated with the 2022 restructuring plan following the decision to voluntarily pause further development of Vicineum in the United States. The expense for the third quarter of 2021 consisted of severance and other employee-related costs ($2.8&#160;million) and termination of certain contracts ($2.7&#160;million) associated with the restructuring plan Sesen Bio approved on August&#160;30, 2021 to reduce operating expenses and better align its workforce with the needs of its business following the receipt of the CRL in August&#160;2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Intangibles impairment</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Intangibles impairment charge for the three&#160;months ended September&#160;30, 2022 was zero compared to $31.7&#160;million in the three&#160;months ended September&#160;30, 2021. In August&#160;2021, Sesen Bio received a CRL from the FDA regarding its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. As a result an impairment analysis was conducted, which concluded that the carrying value of its intangible asset of Vicineum U.S. rights was fully impaired as of September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The non-cash change in fair value of contingent consideration was a gain of $1.8&#160;million for the three&#160;months ended September&#160;30, 2022, compared to a gain of $114.0&#160;million for the three&#160;months ended September&#160;30, 2021. The decrease in the fair value of contingent consideration of $1.8&#160;million for the three&#160;months ended September&#160;30, 2022 was due to Sesen Bio&#8217;s conclusion that it no longer expects to owe any future earnout payments related to the Greater China region since Qilu has informed Sesen Bio that it no longer intends to commercialize Vicineum in the Greater China region. Accordingly, Sesen Bio reduced its remaining $1.8&#160;million of contingent consideration liabilities to zero as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of contingent consideration was a gain of $114.0&#160;million for the three&#160;months ended September&#160;30, 2021. This was primarily driven by the receipt of a CRL from the FDA, in which the FDA determined that it cannot approve the BLA for Vicineum in its present form. Due to the inherent uncertainty in the path forward for Vicineum at the time, Sesen Bio reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of contingent consideration was based. The most significant and impactful assumptions in Sesen Bio&#8217;s revenue projection models are timing of product launch and probabilities of clinical and regulatory success, or POS; Sesen Bio expected delays in the start of commercialization and estimated lower POS as a direct result of the CRL. Sesen Bio anticipated needing to conduct an additional clinical trial, which would lead to delays in the start of commercialization globally. Sesen Bio had assessed a range of commercialization timeline assumptions and applied a probability to each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">314</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">outcome based on management&#8217;s best estimate. In addition, Sesen Bio assumed a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. The milestone payments constitute debt-like obligations, and the high-yield debt index rate applied to the milestones in order to determine the estimated fair value was 7.5% as of September&#160;30, 2021. The discount rate applied to the 2% earnout payment due on forecasted Vicineum revenues was derived from Sesen Bio&#8217;s estimated weighted-average cost of capital, or WACC, and this WACC-derived discount rate was 8.6% as of September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Benefit (Provision) from Income Taxes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio did not record a benefit or loss for the three&#160;months ended September&#160;30, 2022. In the third quarter of 2021, Sesen Bio determined that the fair value of the Vicineum U.S. rights was zero, which resulted in an impairment charge of $31.7&#160;million. In connection with this impairment charge, in the third quarter of 2021, Sesen Bio reduced the associated deferred tax liability which resulted in an $8.6&#160;million income tax benefit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net income</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the three&#160;months ended September&#160;30, 2022, net income was $20.5&#160;million, compared to $71.7&#160;million for the three&#160;months ended September&#160;30, 2021. In the third quarter of 2022, Sesen Bio recorded revenue of $40.0&#160;million related to the execution of the Roche Asset Purchase Agreement and non-cash income of $1.8&#160;million related to changes in the fair value of contingent consideration, partially offset by operating expenses of $22.0&#160;million. In the third quarter of 2021, Sesen Bio recorded net non-cash income of $90.9&#160;million, which includes changes in the fair value of contingent consideration, income tax benefit and intangible impairment charge. Additionally, Sesen Bio recorded R&amp;D, G&amp;A and restructuring charges of $19.2&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the nine&#160;months ended September&#160;30, 2022 and 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:273.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:266.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/(Decrease) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:266.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dollars </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:266.64pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except&#160;percentages) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,456</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">511<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,456</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">511<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">37,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">18,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">19,363</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">106<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">32,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">20,797</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,908</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">57<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,425</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">98<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(3,936<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(12<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(52,240<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">240</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">57,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">24,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">137<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Loss from Operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,052<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,508<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">456</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income (expense), net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(45<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">912</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,027<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss Before Taxes</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">1,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Benefit from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(4,398<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(53<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:266.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Loss After Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(3,030<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">33<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.81pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Revenue for the nine&#160;months ended September&#160;30, 2022 was $40.0&#160;million, which was due to the execution of the Roche Asset Purchase Agreement. Revenue for the nine&#160;months ended September&#160;30, 2021 </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">315</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">was $6.5&#160;million, which was due to achieving the IND milestone in China pursuant to the Qilu License Agreement, clinical supply revenue resulting from the delivery of drug product to Qilu and license revenue for additional purchase price due to the recovery of VAT by Qilu. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $37.6&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to $18.3&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $19.4&#160;million was primarily due to the expense of prepaid balances related to consumables and manufacturing reservations as the balances were deemed to have no future value ($25.2&#160;million) in the second quarter of 2022. Additionally, employee-related compensation increased, primarily due to the retention programs implemented in the fourth quarter of 2021 and third quarter of 2022 ($2.6&#160;million). The increase was partially offset by decreased costs associated with manufacturing ($6.1&#160;million), clinical and manufacturing related consulting fees ($2.0&#160;million), and other individually immaterial R&amp;D costs ($0.3&#160;million), driven by the strategic decision to voluntarily pause further development of Vicineum in the U.S. in the third quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $32.7&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to $20.8&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $11.9&#160;million was primarily due to an increase in legal expense ($14.6&#160;million) driven by the preliminary settlements of the securities and derivative litigation net of expected insurance recovery ($8.2&#160;million) and legal fees associated with Sesen Bio&#8217;s assessment of strategic alternatives ($2.6&#160;million). Additionally, legal fees related to the internal review ($2.8&#160;million), securities litigation counseling ($0.9&#160;million) and other legal expenses ($0.1&#160;million) increased during the nine&#160;months ended September&#160;30, 2022. In addition, employee-related compensation increased, primarily driven by the retention programs implemented in the fourth quarter of 2021 and third quarter of 2022 ($1.3&#160;million). This was partially offset by decreases in marketing and commercial expenses ($4.0&#160;million), which were incurred during the first half of 2021 in preparation for potential commercial launch of Vicineum but were discontinued as a result of the CRL received in August&#160;2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restructuring Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Restructuring charges were $10.9&#160;million for the nine&#160;months ended September&#160;30, 2022 compared to $5.5&#160;million for the nine&#160;months ended September&#160;30, 2021. The expense for the nine&#160;months ended September&#160;30, 2022 consisted of severance and other employee-related costs ($6.9&#160;million) and termination of certain contracts and other associated costs ($4.0&#160;million) following the decision to pause further development of Vicineum in the U.S. The expense for the nine&#160;months ended September&#160;30, 2021 consisted of severance and other employee-related costs ($2.8&#160;million) and termination of certain contracts ($2.7&#160;million) following the receipt of the CRL in August&#160;2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The non-cash change in fair value of contingent consideration was a gain of $52.0&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to a gain of $52.2&#160;million for the nine&#160;months ended September&#160;30, 2021. The decrease in the fair value of contingent consideration of $52.0&#160;million for the nine&#160;months ended September&#160;30, 2022 was driven by Sesen Bio&#8217;s strategic decision to voluntarily pause further development of Vicineum in the U.S. and its conclusion that Sesen Bio no longer expects to owe any future earnout payments related to the Greater China region since Qilu has informed Sesen Bio that it no longer intends to commercialize Vicineum in the Greater China region. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications for the size, timeline and costs for an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Additionally, during the second quarter of 2022, Sesen Bio observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage. Sesen Bio continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such, is seeking a partner that can execute further development to realize the full potential of Vicineum. Sesen Bio </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">316</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:55.9400000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">expects that any partner who acquires Vicineum from Sesen Bio will be obligated to make any payments to the former shareholders of Viventia under the Share Purchase Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of contingent consideration was a gain of $52.2&#160;million for the nine&#160;months ended September&#160;30, 2021. This was primarily driven by the receipt of a CRL in August&#160;2021, in which the FDA determined that it could not approve the BLA for Vicineum in its present form. Due to the inherent uncertainty in the path forward for Vicineum at the time, Sesen Bio reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of its contingent consideration is based. The most significant and impactful assumptions in Sesen Bio&#8217;s revenue projection models are timing of product launch and POS; Sesen Bio expected delays in the start of commercialization and estimate lower POS as a direct result of the CRL. Sesen Bio anticipated needing to conduct an additional clinical trial, which would lead to delays in the start of commercialization globally. Sesen Bio had assessed a range of commercialization timeline assumptions and applied a probability to each outcome based on management&#8217;s best estimate. In addition, Sesen Bio assumed a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. The milestone payments constitute debt-like obligations, and the high-yield debt index rate applied to the milestones in order to determine the estimated fair value was 7.5% as of September&#160;30, 2021. The discount rate applied to the 2% earnout payment due on forecasted Vicineum revenues was derived from Sesen Bio&#8217;s estimated WACC, and this WACC-derived discount rate was 8.6% as of September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Provision for Income Taxes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022, Sesen Bio recorded a benefit from income taxes of $3.9&#160;million. In the second quarter of 2022, Sesen Bio determined that the fair value of the Vicineum E.U. rights was zero, which resulted in an impairment charge of $14.7&#160;million. In connection with this impairment charge, in the second quarter of 2022, Sesen Bio reduced the associated deferred tax liability to zero, which resulted in a $4.0&#160;million income tax benefit, partially offset by $0.1&#160;million income tax paid to foreign jurisdictions pursuant to the Qilu License Agreement. Please refer to Note 8, &#8220;Intangible Assets and Goodwill,&#8221; in the Notes to Condensed Consolidated Financial Statements in Sesen Bio&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022 for further information regarding the impairment charge. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2021, Sesen Bio recorded a benefit from income taxes of $8.3&#160;million. In the third quarter of 2021, Sesen Bio determined that the fair value of the Vicineum United States rights were zero, which resulted in an impairment charge of $31.7&#160;million. In connection with this impairment charge, in the third quarter of 2021, Sesen Bio reduced the associated deferred tax liability which resulted in an $8.6&#160;million income tax benefit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Loss</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022 net loss was $12.3&#160;million, compared to net loss of $9.3&#160;million, for the nine&#160;months ended September&#160;30, 2021. The increase of $3.0&#160;million was due to an increase in operating expense ($33.0&#160;million), primarily driven by the reduction of Sesen Bio&#8217;s prepaid balances related to consumables and manufacturing reservations in the second quarter of 2022 ($25.2&#160;million) and the preliminary settlements of the securities and derivative litigation net of expected insurance recovery ($8.2&#160;million). Additionally, the benefit from income taxes decreased ($4.4&#160;million) in 2022 compared to 2021. This was partially offset by increased revenue ($33.5&#160;million) primarily driven by the execution of the Roche Asset Purchase agreement. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">317</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Years Ended December&#160;31, 2021 and December&#160;31, 2020</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:261.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:263.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/(Decrease) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:263.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dollars </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:263.19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except&#160;percentages) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,308</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">136<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,308</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">136<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">25,312</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">29,191</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(3,879<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(13<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">29,393</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">14,302</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">15,091</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">106<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(11,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(45,660<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">408<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">35,093</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">32,313</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,780</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Loss from Operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,549<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,077<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">12,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(59<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other (expense) income: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">125</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(148<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Loss and Comprehensive Loss Before Taxes</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">12,343</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(59<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Benefit (provision) for income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">9,718</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(673<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:263.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Loss and Comprehensive Loss After Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">22,061</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(98<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:15.41pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Revenue for the year ended December&#160;31, 2021 was $26.5&#160;million, primarily due to the $20.0&#160;million milestone achieved pursuant to the Roche License Agreement upon initiating a Phase&#160;II clinical trial, $5.0&#160;million related to the Qilu License Agreement (achievement of the IND milestone, clinical supply revenue, and license revenue for additional purchase price due to the recovery of VAT), and $1.5&#160;million upfront milestone revenue achieved pursuant to the MENA License Agreement. Revenue for the year ended December&#160;31, 2020 was $11.2&#160;million, which was due to the recognition of revenue pursuant to the Qilu License Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $25.3&#160;million for the year ended December&#160;31, 2021, compared to $29.2&#160;million for the year ended December&#160;31, 2020. The decrease of $3.9&#160;million was primarily due to lower costs associated with technology transfer and manufacturing ($7.4&#160;million). This was partially offset by increases in employee-related compensation driven by increased headcount as part of the commercial build and the retention program implemented after receipt of the CRL in August&#160;2021 ($2.1&#160;million), regulatory and clinical consulting fees ($1.0&#160;million) and certain other R&amp;D expense, none of which were individually material ($0.5&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $29.4&#160;million for the year ended December&#160;31, 2021, compared to $14.3&#160;million for the year ended December&#160;31, 2020. The increase of $15.1&#160;million was primarily due to increases in employee-related compensation ($5.0&#160;million), legal costs ($4.8&#160;million), and marketing and commercial expenses ($4.1&#160;million) driven by preparation for the commercial launch of Vicineum prior to the issuance of the CRL in August&#160;2021. Additionally, increases in accounting services ($0.4&#160;million), insurance expenses ($0.4&#160;million), IT expenses ($0.3&#160;million) and others ($0.1&#160;million) contributed to the increase. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restructuring Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;30, 2021, Sesen Bio approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following receipt of the CRL from the FDA regarding the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">318</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">BLA for Vicineum for the treatment of BCG-unresponsive NMIBC, or the 2021 restructuring plan. The 2021 restructuring plan included a reduction in Sesen Bio&#8217;s workforce by 18 positions (or approximately 35% of its workforce) as well as additional cost-saving initiatives intended to preserve capital while it continued development of Vicineum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Restructuring expenses were $5.5&#160;million for the year ended December&#160;31, 2021, compared to no restructuring expenses for the year ended December&#160;31, 2020. The increase was due to one-time costs associated with the 2021 restructuring plan implemented in response to the CRL for severance and other employee-related costs ($2.8&#160;million) and termination of certain contracts ($2.7&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Intangibles Impairment Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio recorded an intangibles impairment charge of $31.7&#160;million during the year ended December&#160;31, 2021. Sesen Bio did not record any impairment charges during the year ended December&#160;31, 2020. In August&#160;2021, Sesen Bio received a CRL from the FDA regarding its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The impairment charge of $31.7&#160;million for the year ended December&#160;31, 2021 relates to the full impairment of its U.S. in-process research and development asset due to expected delays in the start of commercialization and lower probabilities of success, combined with higher operating expenses expected to be incurred prior to commercialization, resulting in lower expected future cash flows estimated in the U.S. market at this time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The non-cash change in fair value of contingent consideration was income of $56.8&#160;million for the year ended December&#160;31, 2021, compared to income of $11.2&#160;million for the year ended December&#160;31, 2020. The decrease in the fair value of contingent consideration of $45.7&#160;million from the year ended December&#160;31, 2020 to the year ended December&#160;31, 2021, was driven by the receipt of a CRL from the FDA, regarding its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. Due to the inherent uncertainty in the path forward for Vicineum, Sesen Bio reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of the contingent consideration is based. The most significant and impactful assumptions in Sesen Bio&#8217;s revenue projection models are timing of product launch and probabilities of clinical and regulatory success POS; Sesen Bio expects delays in the start of commercialization and estimate lower POS as a direct result of the CRL and its withdrawal of the MAA. Sesen Bio will need to conduct an additional clinical trial, which will lead to delays in the start of commercialization globally. Sesen Bio has assessed a range of commercialization timeline assumptions and applied a probability to each outcome based on management&#8217;s best estimate. In addition, Sesen Bio assumed a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. Sesen Bio participated in Type A Meetings with the FDA on October&#160;29, 2021 and December&#160;8, 2021 to discuss questions related to CMC and clinical issues raised in the CRL. Both meetings helped Sesen Bio determine the appropriate path forward for Vicineum. Any changes in these assumptions and estimates or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of contingent consideration was income of $11.2&#160;million for the year ended December&#160;31, 2020. This was primarily attributable to significantly higher discount rates as a result of financial market conditions as of the year ended December&#160;31, 2020, offset by changes to the competitive landscape. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other (expense) income, net</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other expense, net was $0.1&#160;million for the year ended December&#160;31, 2021, compared to other income of $0.1&#160;million for the year ended December&#160;31, 2020. The change of $0.2&#160;million was due primarily to lower interest income. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Provision for Income Taxes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the twelve&#160;months ended December&#160;31, 2021, Sesen Bio recorded a benefit from income taxes of $8.3&#160;million. In the third quarter of 2021, Sesen Bio determined that the fair value of the Vicineum U.S. in-process research and development asset was zero, which resulted in an impairment charge of $31.7&#160;million. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">319</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with this impairment charge, in the third quarter of 2021, Sesen Bio wrote-down the associated deferred tax liability by $8.6&#160;million as a benefit. See Note 8, &#8220;Intangibles and Goodwill,&#8221; to Sesen Bio&#8217;s audited annual consolidated financial statements for the fiscal year ended December&#160;31, 2021 for further information regarding the impairment charge. For the twelve&#160;months ended December&#160;31, 2020, Sesen Bio recorded a provision for income taxes of $1.4&#160;million. This provision consisted of income taxes paid to non-U.S. jurisdictions pursuant to Sesen Bio&#8217;s commercialization partnership agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Sesen Bio had cash, cash equivalents and marketable securities of $184.9&#160;million, net working capital of $157.7&#160;million and an accumulated deficit of $328.6&#160;million. Sesen Bio incurred cash flows from operating activities of $22.2&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to negative cash flows of $56.3&#160;million for the nine&#160;months ended September&#160;30, 2021. Sesen Bio believes that, based on its current operating plans and financial forecasts, its cash, cash equivalents and marketable securities of $184.9&#160;million as of September&#160;30, 2022, are sufficient to fund Sesen Bio&#8217;s current operating plan for at least twelve&#160;months from the date of Sesen Bio&#8217;s Form 10-Q filing on November&#160;7, 2022 for the fiscal quarter ended September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic transaction, on September&#160;20, 2022, Sesen Bio entered into the Merger Agreement with Carisma and Merger Sub, pursuant to which, among other things, and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma continuing as its wholly-owned subsidiary and the surviving corporation of the merger. The Sesen Bio board of directors unanimously approved the Merger Agreement and resolved to recommend that Sesen Bio stockholders approve the proposals described in the Merger Agreement. If the merger is completed, the business of Carisma will continue as the business of the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The merger is expected to close in the first quarter of 2023. Consummation of the merger is subject to certain closing conditions, including, among other things, (a)&#160;approval by Sesen Bio stockholders of the proposals described in the Merger Agreement, (b)&#160;approval by Carisma&#8217;s stockholders of, among other things, the adoption of the Merger Agreement, (c)&#160;Nasdaq&#8217;s approval of the listing of the shares of Sesen Bio common stock to be issued in connection with the merger, (d)&#160;the effectiveness of a registration statement on Form S-4 to register the shares of Sesen Bio common stock to be issued in connection with the merger, and (e)&#160;Sesen Bio having net cash as of closing of the merger greater than or equal to $75.0&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains certain termination rights of each of Sesen Bio and Carisma. Upon termination of the Merger Agreement under specified circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay Sesen Bio a termination fee of $5.49&#160;million and/or reimburse Sesen Bio expenses up to a maximum of $1.75&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future operations are highly dependent on the success of the merger and there can be no assurances that the merger will be successfully consummated. In the event that Sesen Bio does not complete the merger with Carisma, Sesen Bio may continue to explore strategic alternatives, including, without limitation, another strategic transaction and/or pursue a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since Sesen Bio&#8217;s inception, Sesen Bio has received no revenue from sales of its products, and Sesen Bio anticipates that operating losses will continue for the foreseeable future. Sesen Bio has financed its operations to date primarily through private placements of its common stock, preferred stock, common stock warrants and convertible bridge notes, venture debt borrowings, its IPO, follow-on public offerings, sales effected in ATM offerings, its OUS business development partnerships and license agreements, sale of assets, and, to a lesser extent, from a collaboration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into an Open Market Sale Agreement with Jefferies LLC, or Jefferies, dated November&#160;29, 2019, as amended by Amendment No. 1 dated October&#160;30, 2020, Amendment No. 2 dated February&#160;17, 2021 and Amendment No. 3, dated June&#160;1, 2021, or as amended, the Sale Agreement, under </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">320</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which Sesen Bio may issue and sell shares of Sesen Bio common stock from time to time through Jefferies, or the ATM Offering. In June and July&#160;2021, Sesen Bio filed prospectus supplements with the SEC in connection with the offer and sale of up to an aggregate of $200&#160;million of Sesen Bio common stock pursuant to the Sale Agreement of which $97.8&#160;million of common shares remain available for future issuance as of September&#160;30, 2022. Sales of common stock under the Sale Agreement are made by any method that is deemed to be an ATM offering as defined in Rule&#160;415(a)(4) of the Securities Act of 1933, including but not limited to sales made directly on or through the Nasdaq Stock Market or any other existing trading market for Sesen Bio common stock. Sesen Bio may sell shares of Sesen Bio common stock efficiently from time to time but have no obligation to sell any of Sesen Bio common stock and may at any time suspend offers under the Sale Agreement or terminate the Sale Agreement. Subject to the terms and conditions of the Sale Agreement, Jefferies will use its commercially reasonable efforts to sell Sesen Bio common stock from time to time, as the sales agent, based upon Sesen Bio&#8217;s instructions, which include a prohibition on sales below a minimum price set by Sesen Bio from time to time. Sesen Bio has provided Jefferies with customary indemnification rights, and Jefferies is entitled to a commission at a fixed rate equal to 3.0% of the gross proceeds for each sale of Sesen Bio common stock under the Sale Agreement. Sesen Bio did not sell any shares of common stock pursuant to the Sale Agreement during the nine&#160;months ended September&#160;30, 2022. Sesen Bio raised $175.0&#160;million of net proceeds from the sale of 56.9&#160;million shares of Sesen Bio common stock at a weighted-average price of $3.17 per share during the nine&#160;months ended September&#160;30, 2021, including $38.2&#160;million of net proceeds from the sale of 9.8&#160;million shares of Sesen Bio common stock at a weighted-average price of $4.01 per share during the three&#160;months ended September&#160;30, 2021. Share issue costs, including sales agent commissions, related to the ATM Offering totaled $1.2&#160;million and $5.4&#160;million for the three and nine&#160;months ended September&#160;30, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Funding Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future funding requirements will depend on the outcome of the proposed merger with Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is subject to a number of risks similar to other clinical companies that have determined to focus primarily on pursuing a strategic transaction, including, but not limited to, those which are described under in the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">26</a> of the proxy statement/prospectus. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will incur substantial expenses if and as Sesen Bio: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">addresses its ongoing securities litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintains, expands and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reduces personnel and incur related severance and employee-related costs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">winds down activities with its CMOs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">terminates its property leases; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">explores, evaluates and pursues any strategic alternatives if the merger is not completed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the outcome and the timing of the proposed merger with Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the outcome and timing of any pending or future litigation involving Sesen Bio or its business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of maintaining and enforcing Sesen Bio&#8217;s intellectual property rights and defending any intellectual property-related claims; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to make milestone, royalty and other payments to third-party licensors under its licensing agreements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as Sesen Bio can generate substantial revenues, Sesen Bio expects to finance its cash needs through a combination of equity offerings, debt financings, or government or other third-party funding. To the extent that Sesen Bio raises additional capital through the sale of equity or convertible debt securities, the ownership interests of existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of existing Sesen Bio stockholders. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">321</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Debt financing, if available, may involve agreements that include liens or other restrictive covenants limiting Sesen Bio&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If Sesen Bio is unable to raise additional funds when needed, Sesen Bio may be required to delay, limit, reduce or terminate its assessment of strategic alternatives. If Sesen Bio does not successfully consummate the proposed merger with Carisma, the Sesen Bio board of directors may decide to explore other strategic alternatives, including, without limitation, another strategic transaction and/or a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contractual and Other Obligations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For information related to Sesen Bio&#8217;s cash requirements from known contractual and other obligations, see the description of Contingent Consideration in Note 5 &#8220;Fair Value Measurement and Financial Instruments,&#8221; the information in Note 10 &#8220;Commitments and Contingencies&#8221;, Sesen Bio&#8217;s leases in Note&#160;11&#160;&#8220;Leases&#8221;, and the description of Sesen Bio&#8217;s license agreements in Note 17, &#8220;License Agreements&#8221; of &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Financial Statements&#8201;&#8212;&#8201;Notes to Condensed Consolidated Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tNTCC">F-48</a> of this proxy statement/prospectus.. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Flows</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of Sesen Bio&#8217;s cash flows for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:91.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Provided by (Used in) Operating Activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">22,214</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,278<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Used in Investing Activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(113,733<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Provided by Financing Activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">176,129</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(91,519<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">119,847</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:15.51pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Cash Used in Operating Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by operating activities was $22.2&#160;million for the nine&#160;months ended September&#160;30, 2022 and consisted primarily of a net loss of $12.3&#160;million, adjusted for non-cash items including, a decrease in the fair value of contingent consideration ($52.0&#160;million), intangible impairment charge ($27.8&#160;million), share-based compensation ($5.9&#160;million), and a net increase in operating assets and liabilities ($52.9&#160;million). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in operating activities was $56.3&#160;million for the nine&#160;months ended September&#160;30, 2021 and consisted primarily of a net loss of $9.3&#160;million, which includes $6.5&#160;million of revenue recognized pursuant to certain of Sesen Bio&#8217;s out-license agreements, adjusted for non-cash items, including share-based compensation ($3.4&#160;million), a decrease in the fair value of contingent consideration ($52.2&#160;million), increase in impairment charge ($31.7&#160;million), and a net decrease in operating assets and liabilities of ($29.9&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Cash Used in Investing activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in investing activities was $113.7&#160;million for the nine&#160;months ended September&#160;30, 2022 and consisted of marketable security purchases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in investing activities consisted of de minimis purchases and sales or property and equipment during the nine&#160;months ended September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Cash Provided by Financing activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities was zero for the nine&#160;months ended September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities was $176.1&#160;million for the nine&#160;months ended September&#160;30, 2021 and consisted primarily of $175.0&#160;million net proceeds from the sale of common stock under the ATM Offering. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">322</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Accounting Policies and Use of Estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of Sesen Bio&#8217;s condensed consolidated financial statements in accordance with U.S.&#160;GAAP and the rules and regulations of the SEC require the use of estimates and assumptions, based on complex judgments considered reasonable, and affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Sesen Bio&#8217;s critical accounting policies are those policies which involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on Sesen Bio&#8217;s financial condition or results of operations. Sesen Bio&#8217;s management has determined that Sesen Bio&#8217;s most critical accounting policies are those relating to the fair value of indefinite-lived intangible assets, goodwill; contingent consideration; revenue recognition; development and regulatory milestone payments and other costs; and research and development costs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value of Indefinite-Lived Intangible Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s intangible assets consist of indefinite-lived, acquired IPR&amp;D worldwide product rights to Vicineum as a result of the acquisition of Viventia in 2016. IPR&amp;D assets acquired in a business combination are considered indefinite-lived until the completion or abandonment of the associated research and development efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Indefinite-lived intangible assets are quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of indefinite-lived intangible assets requires management to estimate the future discounted cash flows of an asset using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. Sesen Bio recognizes an impairment loss when and to the extent that the estimated fair value of an intangible asset is less than its carrying value. In addition, on a quarterly basis, Sesen Bio performs a qualitative review of its business operations to determine whether events or changes in circumstances have occurred which could indicate that the carrying value of its intangible assets was not recoverable. If an impairment indicator is identified, an interim impairment assessment is performed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, Sesen Bio observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage. Sesen Bio has also experienced a sustained decline in share price and a resulting decrease in its market capitalization. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Sesen Bio management updated the discounted cash flow model using the market participant approach and considered preliminary terms of potential partnering deal to conclude the fair value of its intangible asset of Vicineum E.U. rights. Sesen Bio concluded that the carrying value of its intangible asset of Vicineum E.U. rights of $14.7&#160;million was fully impaired as of June&#160;30, 2022 and was reduced to zero in the second quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on Sesen Bio&#8217;s condensed consolidated balance sheets is the result of its acquisition of Viventia in September&#160;2016 and represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets acquired under the acquisition method of accounting. Goodwill is not amortized; rather than recording periodic amortization, goodwill is quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of goodwill requires management to estimate the future discounted cash flows of a reporting unit using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. If the fair value of the equity of a reporting unit exceeds the reporting unit&#8217;s carrying value, including goodwill, then goodwill is considered not to be impaired. Sesen Bio recognizes a goodwill impairment when and to the extent that the fair value of the equity of a reporting unit is less than the reporting unit&#8217;s carrying value, including goodwill. Sesen Bio has only one reporting unit. In addition, on a quarterly basis, Sesen Bio performs a qualitative review of its business operations to determine whether events </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">323</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or changes in circumstances have occurred which could have a material adverse effect on the estimated fair value of each reporting unit and thus indicate a potential impairment of the goodwill carrying value. If an impairment indicator is identified, an interim impairment assessment is performed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, Sesen Bio observed continued trends in its market capitalization as compared to the carrying value of its single reporting unit as well as changes in certain assumptions in the fair value of the business including market share, size, length and cost of a clinical trial, and time to potential market launch. Sesen Bio identified these changes as potential impairment indicators and performed a quantitative impairment analysis in advance of its typical annual assessment date of October&#160;1. Sesen Bio reassessed the underlying assumptions used to develop its revenue projections, which were then used as significant inputs to determine the fair value of equity. Sesen Bio updated its revenue forecast models based on further expected launch delays in both U.S. and OUS regions. Sesen Bio also recently observed an evolution of the current treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage resulting in lower projected peak market share for Vicineum. Sesen Bio also considered other factors including the preliminary valuations of strategic alternatives during the fair value assessment. As a result of the interim impairment test, Sesen Bio concluded that the carrying value of its goodwill of $13.1&#160;million was fully impaired as of June&#160;30, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Contingent consideration on Sesen Bio&#8217;s condensed consolidated balance sheets is the result of Sesen Bio&#8217;s acquisition of Viventia in September&#160;2016 and represents the discounted present value of future commercial launch milestones and net sales earnout payments due to the former shareholders of Viventia pursuant to the Share Purchase Agreement. Contingent consideration is measured at its estimated fair value on a recurring basis at each reporting period, with fluctuations in value resulting in a non-cash charge to earnings (or loss) during the period. The estimated fair value measurement is based on significant unobservable inputs (Level&#160;3 within the fair value hierarchy), including internally developed financial forecasts, probabilities of success and timing of certain milestone events and achievements, which are unpredictable and inherently uncertain. Actual future cash flows may differ from the assumptions used to estimate the fair value of contingent consideration. The valuation of contingent consideration requires the use of significant assumptions and judgments, which management believes are consistent with those that would be made by a market participant. Management reviews its assumptions and judgments on an ongoing basis as additional market and other data is obtained, and any future changes in the assumptions and judgments utilized by management may cause the estimated fair value of contingent consideration to fluctuate materially, resulting in earnings volatility. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The estimated fair value of Sesen Bio&#8217;s contingent consideration was determined using probabilities of successful achievement of regulatory milestones and commercial sales, the period in which these milestones and sales were expected to be achieved through 2033, the level of commercial sales of Vicineum forecasted for the U.S., Europe, Japan, China and other potential markets. Earnouts were determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout was derived from Sesen Bio&#8217;s estimated weighted-average cost of capital, which has fluctuated from 9.3% as of December&#160;31, 2021. Milestone payments constitute debt-like obligations, and therefore a high-yield debt index rate was applied to the milestones in order to determine the estimated fair value. This index rate was 8.0% as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Sesen Bio continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such, Sesen Bio is seeking a partner for the further development of Vicineum. Accordingly, during the second quarter of 2022, Sesen Bio concluded that it was no longer expected to pay related milestone and earnout payments to the former shareholders of Viventia, with the exception of the potential 2% earnout payment related to the Greater China region since those territory rights had been out-licensed. Qilu held the exclusive license to develop Vicineum in the Greater China region, and accordingly, the $1.8&#160;million estimated earnout payment in the Greater China region remained as long-term contingent consideration as of June&#160;30, 2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">324</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:24pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Qilu has informed Sesen Bio that it no longer intends to commercialize Vicineum in the Greater China region. Therefore, Sesen Bio terminated the Qilu License Agreement, upon which Sesen Bio regained the rights to develop, manufacture and commercialize Vicineum in Greater China. However, Sesen Bio does not plan to develop or commercialize Vicineum in that region or any other, as Sesen Bio is pursuing the merger with Carisma. Sesen Bio is also seeking to sell or out-license Vicineum and all the related obligations related to Vicineum. Sesen Bio expects that any partner who acquires or licenses Vicineum from Sesen Bio will be obligated to make any payments, including those related to sales in the Greater China region (if any), that become payable to the former shareholders of Viventia under the Share Purchase Agreement. If a sale or license of Vicineum has not occurred at the time the merger is completed, Carisma has indicated it may continue to seek a sale or license of Vicineum and has no plans to develop Vicineum. Accordingly, as of September&#160;30, 2022, Sesen Bio concluded that it no longer expects to owe any future earnout payments related to the Greater China region and reduced its remaining $1.8&#160;million of contingent consideration liabilities to zero as of September&#160;30, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and research and development credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is recorded to the extent it is more likely than not that some portion or all of the deferred tax assets will not be realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unrecognized income tax benefits represent income tax positions taken on income tax returns that have not been recognized in the financial statements. Sesen Bio recognizes the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit is recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Sesen Bio recognizes accrued interest and penalties related to uncertain tax positions as income tax expense in its condensed consolidated statements of operations. As of September&#160;30, 2022 and December&#160;31, 2021, Sesen Bio did not have any uncertain tax positions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are expensed in the period incurred. Research and development expenses consist of both internal and external costs associated with all basic research activities, clinical development activities and technical efforts required to develop a product candidate. Internal research and development consist primarily of personnel costs, including salaries, benefits and share-based compensation, facilities leases, research-related overhead, pre-approval regulatory and clinical trial costs, manufacturing and other contracted services, license fees and other external costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In certain circumstances, Sesen Bio is required to make advance payments to vendors for goods or services that will be received in the future for use in research and development activities. In such circumstances, the advance payments are recorded as prepaid assets and expensed when the activity has been performed or when the goods have been received. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recently Issued Accounting Standards</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Recently issued accounting standards are discussed in of &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Financial Statements&#8201;&#8212;&#8201;Notes to Condensed Consolidated Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tNTCC">F-48</a> of this proxy statement/prospectus.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">325</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCMDA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF </font>
          <br >
          <font style="letter-spacing:-0.2pt;">FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following discussion and analysis of Carisma&#8217;s financial condition and results of operations should be read in conjunction with Carisma&#8217;s consolidated financial statements and the related notes included elsewhere in this proxy statement/prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this proxy statement/prospectus, including information with respect to Carisma&#8217;s plans and strategy for its business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set out under the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus, Carisma&#8217;s actual results could differ materially from the results described in or implied by these forward-looking statements. See also the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; beginning on page <a href="#tCSCF">118</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is a clinical stage cell therapy company focused on utilizing Carisma&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. Carisma has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells. Macrophages and monocytes are part of the innate immune system and can detect and degrade harmful substances through a process referred to as phagocytosis, in which the harmful substance is engulfed and destroyed and in turn leads to the activation of a broad immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To harness the powerful immunologic functions of macrophages against cancer, Carisma has developed a proprietary Chimeric Antigen Receptor Macrophage, or CAR-M, platform technology. Chimeric antigen receptors, or CARs, are synthetically engineered receptors that are designed to bestow immune cells with the ability to target specific antigens on the surface of cancer cells. By introducing CARs into macrophage and monocyte cells, Carisma aims to redirect their potent innate immune functions against cancer. Carisma&#8217;s CAR-M platform technology incorporates proprietary tumor targeting constructs, vectors to deliver CARs to macrophages and monocytes and novel manufacturing processes. Carisma&#8217;s CAR-M therapeutics are designed to infiltrate the solid tumor microenvironment, kill cancer cells via targeted phagocytosis, and activate other immune cells, such as T-cells, to initiate a robust anti-tumor immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beyond CT-0508, Carisma has a broad pipeline of cell therapy assets in various stages of pre-clinical development. In addition to the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> CAR-M cell therapies, Carisma is also developing </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M gene therapies, wherein immune cells are directly engineered within the patient&#8217;s body. To advance its </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics, Carisma established a strategic collaboration with Moderna focused on the development and potential commercialization of up to 12 product candidates, of which four have already been nominated. In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s LNP/mRNA technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology gene therapies. Carisma believes this approach has the potential to enable a series of off-the-shelf product candidates to target a patient&#8217;s own myeloid cells against cancer cells directly within their body. As part of the agreement with Moderna, Carisma received a $45.0&#160;million up-front cash payment and an investment by Moderna in the form of a $35.0&#160;million convertible note, in addition to future research funding and the opportunity for milestone payments and royalties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Through its robust internal discovery engine, Carisma is building upon its platform to enhance and expand the utility of macrophage cell and gene therapies, leading to the creation of multiple product candidates with the potential to treat cancer and other serious diseases. By replacing the targeting domain of the CAR, Carisma can reprogram the target antigen specificity of the CAR-M cell product and develop candidates against a range of cancer indications and therapeutic areas beyond oncology. As a result, Carisma believes the flexibility of its macrophage and monocyte cell engineering platform will allow Carisma to generate new product candidates suitable for clinical development in a cost-efficient manner to expand its pipeline. In addition to acting as a first line of defense in the innate immune system, macrophages are found in all tissues in the body where they serve key regulatory functions such as wound healing, termination of immune responses and tissue regeneration. Using its macrophage and monocyte </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineering </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">326</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">platform, Carisma is pursuing early research and development of multiple assets for the potential treatment of diseases beyond oncology, including liver fibrosis, neurodegeneration, and other immunologic and inflammatory diseases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">By investing in early platform research and accessing key enabling technologies, Carisma is enhancing and expanding its platform capabilities and reinforcing its leadership position in the engineered macrophage field. Carisma has developed proprietary CAR-M platform enhancements directed toward key product parameters that are important for efficacy, safety and patient access to its CAR-M therapies. Carisma plans to apply these technology enhancements to future CAR-M product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma was formed as Carma Therapeutics LLC, a Pennsylvania limited liability company, in April&#160;2016 and converted to a Delaware corporation in May&#160;2017. To date, Carisma has not yet commercialized any products or generated any revenue from product sales and has financed its operations primarily with proceeds from sales of Carisma&#8217;s preferred stock, proceeds from Carisma&#8217;s collaboration with Moderna, research tax credits and convertible debt financing. Carisma&#8217;s operations to date have been limited to organizing and staffing its company, business planning, capital raising, establishing and maintaining its intellectual property portfolio, building its pipeline of product candidates, conducting drug discovery activities, undertaking pre-clinical studies, manufacturing process development studies, conducting early-stage clinical trials, and providing general and administrative support for these operations. Carisma has devoted substantially all of its financial resources and efforts to pursuing discovery, research and development of its product candidates. Carisma only recently initiated clinical development of its lead product candidate, CT-0508, and is in the pre-clinical testing stages for its other product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s net losses were $40.8&#160;million for the year ended December&#160;31, 2021 and $28.3&#160;million for the year ended December&#160;31, 2020. As of September&#160;30, 2022, Carisma had $70.6&#160;million in cash, cash equivalents and marketable securities and an accumulated deficit of $141.5&#160;million. Carisma expects to devote substantial financial resources to its ongoing and planned activities, particularly as it conducts its ongoing clinical trial of CT-0508 and pursues related combination strategies, prepares for, initiates and conducts its planned clinical trials of CT-0525, CT-1119 and CT-0729 and advances its discovery programs and continues its product development efforts. In addition, if Carisma obtains marketing approval for CT-0508 or any other product candidate it is developing or develops in the future, it expects to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution. Furthermore, upon the closing of the merger, it expects to incur additional costs associated with operating as a public company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, Carisma will need to obtain substantial additional funding in connection with its continuing operations. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. In addition, attempting to secure additional financing may divert the time and attention of Carisma management from day-to-day activities and distract from its discovery and product development efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of the numerous risks and uncertainties associated with pharmaceutical product development, Carisma is unable to accurately predict the timing or amount of increased expenses or when, or if, it will be able to achieve or maintain profitability. Carisma may never succeed in these activities and, even if it does, may never generate revenues that are significant enough to achieve profitability. Even if Carisma does achieve profitability, it may not be able to sustain or increase profitability on a quarterly or annual basis. Carisma&#8217;s failure to become and remain profitable would depress the value of its company and could impair its ability to raise capital, expand its business, maintain its discovery and product development efforts, diversify its pipeline of product candidates or even continue its operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Collaboration and License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, Carisma entered into the Moderna Collaboration Agreement, which provides for a broad strategic partnership with Moderna to discover, develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered CAR-M therapeutics for up to 12 oncology programs. Under the Moderna Collaboration Agreement, the parties initiate research programs during a research term, focused on the discovery and research of products directed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">327</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to biological targets. Either party may nominate a target for inclusion in a research program, subject to certain exclusions. Carisma refers to a target included in a research program pursuant to designated procedures as a research target. Moderna may replace research targets pursuant to designated procedures. The first four research targets have been nominated and all programs are currently in the discovery phase at Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s LNP/mRNA technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology gene therapies. Carisma believes this approach has the potential to enable a series of off-the-shelf product candidates to target a patient&#8217;s own myeloid cells against cancer cells directly within their body. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The collaboration is managed by a joint steering committee, or JSC, which is comprised of representatives from Carisma and Moderna. Decisions of the JSC are made by consensus, with each party having one vote. If the JSC is unable to agree, and the parties&#8217; executives are not able to resolve the dispute, then Moderna has final decision-making authority, subject to specified limitations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Moderna Collaboration Agreement, Carisma received a $45.0&#160;million up-front cash payment. Assuming Moderna develops and commercializes 12 products, each directed to a different Development Target, Carisma is also eligible to receive up to between $247.0&#160;million and $253.0&#160;million per product in development target designation, development, regulatory and commercial milestone payments. In addition, Carisma is eligible to receive mid to high single digit tiered royalties on net sales of any products that are commercialized under the agreement, which may be subject to reductions. Moderna has also agreed to cover the cost of certain milestone payments and royalties Carisma owes to a licensor under one of its intellectual property in-license agreements that Carisma is sublicensing to Moderna under the Moderna Collaboration Agreement, which royalties Moderna may deduct in part from any royalties owed to Carisma. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Impact of the COVID-19 Pandemic</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is carefully monitoring the COVID-19 pandemic which continues to evolve worldwide. The continued spread of COVID-19 and the measures taken by governmental authorities, and any future epidemic disease outbreaks, could cause difficulties recruiting or retaining patients for Carisma&#8217;s clinical trials, disrupt the supply chain and the manufacture or shipment of pre-clinical materials, delay, limit or prevent Carisma&#8217;s employees and third parties from continuing research and development activities which could delay Carisma&#8217;s pre-clinical studies, and increase its development costs and/or have a material adverse effect on Carisma&#8217;s business, financial condition and results of operations. The effect of the COVID-19 pandemic on Carisma&#8217;s development timelines is difficult to assess or predict. The future impact of the COVID-19 pandemic on Carisma&#8217;s industry, the healthcare system and Carisma&#8217;s current and future operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted with confidence. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Financial Operations Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenues</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To date, Carisma has not generated any revenue from product sales and does not expect to generate any revenue from the sale of products for the foreseeable future. Carisma&#8217;s revenues to date have been generated from the Moderna Collaboration Agreement. Moderna reimburses Carisma for all costs incurred by it in connection with its research and development activities under the Moderna Collaboration Agreement plus a reasonable margin for the respective services performed. Carisma expects that its revenue for at least the next several&#160;years will be derived primarily from Moderna Collaboration Agreement, other current collaboration agreements and any additional collaborations that it may enter into in the future. To date, Carisma has not received any royalties under the Moderna Collaboration Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist primarily of costs incurred for Carisma&#8217;s research activities, including discovery efforts and the development of product candidates, and include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenses incurred to conduct the necessary pre-clinical studies and clinical trials required to obtain regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">328</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">salaries, benefits and other related costs, including stock-based compensation expense, for personnel engaged in research and development functions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">costs of funding research performed by third parties, including pursuant to agreements with CROs, as well as investigative sites and consultants that conduct Carisma&#8217;s pre-clinical studies and clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expenses incurred under agreements with CMOs, including manufacturing scale-up expenses and the cost of acquiring and manufacturing pre-clinical study and clinical trial materials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">costs of outside consultants, including their fees, stock-based compensation and related travel expenses; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs of laboratory supplies and acquiring materials for pre-clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">facility-related expenses, which include direct depreciation costs of equipment and expenses for rent and maintenance of facilities and other operating costs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">third-party licensing fees. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are central to Carisma&#8217;s business model. Product candidates in later stages of clinical development will generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. Carisma expects its research and development expenses to increase significantly over the next several&#160;years as it increases personnel costs, including stock-based compensation, conducts ongoing and planned clinical trials for CT-0508, conducts research and development activities under the Moderna Collaboration Agreement and conducts other clinical and pre-clinical activities for other product candidates and prepares regulatory filings for any of its product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The successful development of Carisma&#8217;s current or future product candidates is highly uncertain. At this time, Carisma cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the development of any product candidates. The success of CT-0508 and Carisma&#8217;s other product candidates will depend on several factors, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully completing pre-clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully initiating future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully enrolling patients in and completing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">scaling up manufacturing processes and capabilities to support clinical trials of CT-0508 and any other product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">applying for and receiving marketing approvals from applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining and maintaining intellectual property protection and regulatory exclusivity for CT-0508 and any other product candidates it is developing or may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">making arrangements with third-party manufacturers, or establishing commercial manufacturing capabilities, for both clinical and commercial supplies of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing sales, marketing and distribution capabilities and launching commercial sales of its products, if and when approved, whether alone or in collaboration with others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acceptance of CT-0508 and any other product candidates, if and when approved, by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">effectively competing with other therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining and maintaining coverage, adequate pricing and adequate reimbursement from third-party payors, including government payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintaining, enforcing, defending and protecting its rights in its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">not infringing, misappropriating or otherwise violating others&#8217; intellectual property or proprietary rights; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">329</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintaining a continued acceptable safety profile of its products following receipt of any marketing approvals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A change in the outcome of any of these variables with respect to the development, manufacture or commercialization activities of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate. For example, if Carisma is required to conduct additional clinical trials or other testing of its product candidates beyond those that it currently contemplates, if Carisma is unable to successfully complete clinical trials of its product candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive, if there are safety concerns or if Carisma determines that the observed safety or efficacy profile would not be competitive in the marketplace, it could be required to expend significant additional financial resources and time on the completion of clinical development. Product commercialization will take several&#160;years, and Carisma expects to spend a significant amount in development costs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and administrative expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expense consists primarily of personnel expenses, including salaries, benefits and stock-based compensation expense for employees in executive, finance, accounting, business development and human resource functions. General and administrative expense also includes corporate facility costs, including rent, utilities, depreciation and maintenance, and costs not otherwise included in research and development expense, legal fees related to intellectual property and corporate matters as well as fees for accounting and consulting services. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects that its general and administrative expense will increase in the future to support its continued research and development activities, potential commercialization efforts and increased costs of operating as a public company. These increases will likely include increased costs related to the hiring of additional personnel and fees to outside consultants, lawyers and accountants, among other expenses. Increased costs associated with being a public company will also include expenses related to services associated with maintaining compliance with the requirements of Nasdaq and the SEC, insurance and investor relations costs. If any of Carisma&#8217;s current or future product candidates obtains marketing approval, Carisma expects that it would incur significantly increased expenses associated with sales and marketing efforts. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Interest expense consists of interest on the Carisma convertible note that was entered into concurrently with the Moderna Collaboration Agreement including non-cash interest expense associated with the amortization of the debt discount. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Change in fair value of derivative liability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Change in fair value of the derivative liability for the redemption feature of the Carisma convertible note reflects the non-cash charge for changes in the fair value of the derivative liability that is subject to re-measurement at each balance sheet date until Carisma&#8217;s obligations under the Carisma convertible note are satisfied. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income tax provision</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since inception, Carisma has incurred significant net losses. As of December&#160;31, 2021, Carisma had net operating loss carryforwards, or NOLs, for federal and state income tax purposes of $76.4&#160;million. Carisma has provided a valuation allowance against the full amount of its deferred tax assets since, in the opinion of Carisma management, based upon its historical and anticipated future losses, it is more likely than not that the benefits will not be realized. As of September&#160;30, 2022, Carisma remained in a full valuation allowance position. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s utilization of its NOLs may be subject to a substantial annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50&#160;percent, as defined under Sections&#160;382 and 383 of the Code, respectively, as well as similar state </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">330</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provisions. Carisma has recorded a valuation allowance on all of its deferred tax assets, including its deferred tax assets related to its NOLs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:11.01pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Nine Months Ended September&#160;30, 2022 and 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s results of operations for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:159pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,103</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">38,536</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">24,597</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,407</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">3,852</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">46,943</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,449</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,449<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value of derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,278<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.5pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Collaboration Revenues</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Collaboration revenues were $6.1&#160;million for the nine&#160;months ended September&#160;30, 2022, which related to the research and development activities completed under the Moderna Collaboration Agreement that Carisma executed in January&#160;2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development Expenses</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma tracks outsourced development, outsourced personnel costs and other external research and development costs of its CT-0508 program. Carisma does not track its internal research and development costs on a program-by-program basis. The following table summarizes Carisma&#8217;s research and development expenses for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">CT-0508 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,044</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,965</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,178</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,676</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other clinical and pre-clinical development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,541</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2,822</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,773</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">8,134</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">38,536</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">24,597</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses for the nine&#160;months ended September&#160;30, 2022 were $38.5&#160;million, compared to $24.6&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $13.9&#160;million was primarily attributable to a $7.6&#160;million increase in facilities and other expenses primarily due to the additional leases entered into during the nine&#160;months ended September&#160;30, 2022, a $5.5&#160;million increase in Carisma&#8217;s personnel costs attributable to an increase in its research and development employee headcount, and a $0.7&#160;million increase in the pre-clinical discovery work associated with the Moderna Collaboration Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative Expenses</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s general and administrative expenses for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">331</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal and professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5,209</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,016</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,080</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,958</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">471</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">586</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">647</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">292</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total general and administrative expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8,407</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,852</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:10.41pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses for the nine&#160;months ended September&#160;30, 2022 were $8.4&#160;million, compared to $3.9&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $4.6&#160;million was primarily attributable to a $4.2&#160;million increase in legal and professional fees in support of Carisma&#8217;s patent portfolio, expanding infrastructure in preparation to operate as a public company and an increase legal fees incurred in connection with the merger, a $0.1&#160;million increase in personnel costs attributable to an increase in employee headcount and a $0.4&#160;million increase in other expenses attributable to the increase in travel and public relations in preparation to operate as a public company. </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest (Expense) Income, net</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma recognized $2.3&#160;million in interest (expense) income, net for the nine&#160;months ended September&#160;30, 2022, which was attributable primarily to the outstanding principal balance associated with the Carisma convertible note issued to Moderna in January&#160;2022 including non-cash interest expense associated with the amortization of the debt discount partially offset by interest income of $0.3&#160;million. </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Derivative Liability</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma recognized a $1.4&#160;million non-cash charge for the increase in fair value of the derivative liability associated with the redemption feature of the Carisma convertible note with Moderna. The increase was attributable to the timing in which Carisma estimates a settlement event for the derivative to occur. </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Years Ended December&#160;31, 2021 and 2020</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:128.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">34,387</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">23,292</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,407</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">5,086</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,794</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,378</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,794<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,378<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">29</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.33pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development Expenses</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s research and development expenses for the year ended December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">CT-0508 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,570</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,225</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,490</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,850</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other clinical and pre-clinical development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,035</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,812</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,292</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,405</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">34,387</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">23,292</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">332</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:15.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses for the year ended December&#160;31, 2021 were $34.4&#160;million, compared to $23.3&#160;million for the year ended December&#160;31, 2021. The increase of $11.1&#160;million was primarily due to an increase in Carisma&#8217;s personnel costs of $3.6&#160;million attributable to an increase in Carisma&#8217;s research and development employee headcount and higher stock-based compensation and $3.9&#160;million increase attributable to an increase in facilities and supplies due to increased use of lab spaces and increased lab supplies as Carisma continued increasing its clinical and pre-clinical work. Carisma also had a $3.3&#160;million increase in its direct costs associated with CT-0508 as it initiated its Phase&#160;1 clinical trial in early 2021, and an increase in other clinical and pre-clinical development expenses of $0.2&#160;million as Carisma continues to further discover and develop earlier stage product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s general and administrative expenses for the year ended December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,446</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,479</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal and professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,321</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,300</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">869</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">641</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">771</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">666</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total general and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,407</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5,086</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses for the year ended December&#160;31, 2021 were $6.4&#160;million, compared to $5.1&#160;million for the year ended December&#160;31, 2020. The increase of $1.3&#160;million was primarily attributable to a $1.0&#160;million increase in legal and professional fees in support of Carisma&#8217;s patent portfolio and expanding infrastructure in preparation to operate as a public company as well as a $0.2&#160;million increase in facilities and supplies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sources of Liquidity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Carisma had $70.6&#160;million in cash, cash equivalents and marketable securities and an accumulated deficit of $141.5&#160;million. To date, Carisma has not yet commercialized any products or generated any revenue from product sales and has financed its operations primarily with proceeds from sales of Carisma&#8217;s preferred stock, proceeds from Carisma&#8217;s collaboration with Moderna, research tax credits and convertible debt financing. Since June&#160;2018, Carisma has sold convertible preferred stock, raising aggregate gross proceeds of $122.2&#160;million. In January&#160;2022, Carisma received $80.0&#160;million from Moderna comprised of an upfront non-refundable payment of $45.0&#160;million in connection with the Moderna Collaboration Agreement and $35.0&#160;million in connection with the Carisma convertible note. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Carisma Convertible Note</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If not earlier converted or repaid, the Carisma convertible note is payable on demand beginning in July&#160;2023 and accrues interest at an annual rate beginning at 0.33% through March&#160;2022 and then increases by 0.767% each month thereafter, capped at an annual rate of 8.0% in January&#160;2023. Upon the completion of a qualified financing event, the outstanding principal and accrued interest under the Carisma convertible note will automatically convert into shares of Carisma issued in connection with the qualified financing at a conversion price equal to the lesser of (a)&#160;90% of the purchase price paid by other investors in such qualified financing and (b)&#160;$21.06 per share on an as converted to common stock basis. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">333</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Flows</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table shows a summary of Carisma&#8217;s cash flows for the periods indicated (in thousands): </font>
        </div>
        <table style="width:456pt;height:97.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:230.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:230.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:230.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash provided by (used in) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:230.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">11,984</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,207<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(37,328<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,012<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:230.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Investing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,526<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(440<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:230.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">34,777</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">72,258</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:230.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net change in cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">392</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,771<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,237<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">44,806</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash Flows from Operating Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, Carisma provided $12.0&#160;million of net cash in operating activities. Cash provided by operating activities reflected Carisma&#8217;s net loss of $44.5&#160;million that was offset by $7.9&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation, reductions in the operating right of use, or ROU, assets, amortization of the debt discount on the Carisma convertible note, change in fair value of the derivative liability, and non-cash interest on the finance liability from the failed sale-leaseback and the accretion on marketable securities and a $48.6&#160;million net change in Carisma&#8217;s operating assets and liabilities, which was primarily attributable to the upfront non-refundable payment received from Moderna pursuant to the Moderna Collaboration Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2021, Carisma used $28.2&#160;million of net cash in operating activities. Cash used in operating activities reflected Carisma&#8217;s net loss of $28.4&#160;million that was offset by $1.2&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation and reductions in the operating ROU assets and a $1.0&#160;million net reduction in Carisma&#8217;s operating assets and liabilities attributable to the timing in which Carisma makes payments to its vendors for research and development activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2021, Carisma used $37.3&#160;million of net cash in operating activities. Cash used in operating activities reflected Carisma&#8217;s net loss of $40.8&#160;million that was offset by $2.0&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation and reductions in the operating ROU assets and a $1.5&#160;million net change in Carisma&#8217;s operating assets and liabilities attributable to the timing in which Carisma pays its vendors for research and development activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2020, Carisma used $27.0&#160;million of net cash in operating activities. Cash used in operating activities reflected Carisma&#8217;s net loss of $28.3&#160;million that was offset by $1.8&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation and reductions in the operating ROU assets and a $0.5&#160;million net change in Carisma&#8217;s operating assets and liabilities attributable to the timing in which Carisma pays its vendors for research and development activities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash Flows from Investing Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, Carisma used $46.4&#160;million of net cash in investing activities. Cash used in investing activities reflected purchases of marketable securities of $84.0&#160;million offset by $42.0&#160;million of proceeds from the sale of marketable securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022 and 2021 and for the&#160;years ended December&#160;31, 2021 and 2020, Carisma used $4.3&#160;million, $1.5&#160;million, $1.9&#160;million and $0.4&#160;million, respectively, for the purchase of property and equipment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash Flows from Financing Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, Carisma received $34.8&#160;million of net cash from financing activities, primarily attributable to the $35.0&#160;million in proceeds from the Carisma convertible </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">334</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFUNDRE1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">note, partially offset by $0.8&#160;million in payments made on financing leases. Immediately prior to completion of the merger, the outstanding principal and unpaid interest of the Carisma convertible note will convert into shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2021 and for the year ended December&#160;31, 2021, Carisma received $16.0&#160;million of net cash from financing activities, primarily attributable to the net proceeds from the sale of its Series&#160;B convertible preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2020, Carisma received $72.3&#160;million of net cash from financing activities attributable from the sale of its Series&#160;A and Series&#160;B convertible preferred stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Funding Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to devote substantial financial resources to its ongoing and planned activities, particularly as it conducts its ongoing clinical trial of CT-0508 and pursues related combination strategies, prepares for, initiates and conducts its planned clinical trials of CT-0525, CT-1119 and CT-0729 and advances its discovery programs and continues its product development efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects its expenses to increase substantially in connection with its ongoing activities, particularly as it advances its pre-clinical activities and clinical trials. In addition, if Carisma obtains marketing approval for CT-0508 or any other product candidate it is developing or develops in the future, it expects to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution. Furthermore, upon the closing of the merger, it expects to incur additional costs associated with operating as a public company. Accordingly, Carisma will need to obtain substantial additional funding in connection with its continuing operations. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. In addition, attempting to secure additional financing may divert the time and attention of Carisma management from day-to-day activities and distract from its discovery and product development efforts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the progress, costs and results of its ongoing clinical trial of CT-0508 and other planned and future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope, progress, costs and results of pre-clinical testing and clinical trials of CT-0508 for additional combinations, targets and indications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of and development requirements for additional indications for CT-0508 or for any other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the success of its collaborations with Moderna or others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its ability to scale up its manufacturing processes and capabilities to support clinical trials of CT-0508 and other product candidates it is developing and develops in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of regulatory review of CT-0508 and other product candidates it is developing and may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential changes in the regulatory environment and enforcement rules; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the payment of license fees and other costs of its technology license arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of future commercialization activities, including product manufacturing, sales, marketing and distribution, for CT-0508 and other product candidates it is developing and may develop in the future for which it may receive marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">its ability to obtain and maintain acceptance of any approved products by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">335</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the amount and timing of revenue, if any, received from commercial sales of CT-0508 and any other product candidates it is developing or develops in the future for which it receives marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential changes in pharmaceutical pricing and reimbursement infrastructure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of raw materials for use in production of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing its intellectual property and proprietary rights and defending any intellectual property- related claims; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which it in-licenses or acquires additional technologies or product candidates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Carisma had cash, cash equivalents and marketable securities of $70.6&#160;million. Immediately prior to the consummation of the merger, certain investors have agreed to purchase shares of Carisma common stock for an aggregate purchase price of approximately $30.6&#160;million. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. Carisma believes that following consummation of the pre-closing financing and the merger, it will have cash, cash equivalents and marketable securities sufficient to sustain its operating expenses and capital expenditure requirements at least through the end of 2024. However, Carisma has based this estimate on assumptions that may prove to be wrong, and its operating plan may change as a result of many factors currently unknown to Carisma. In addition, changing circumstances could cause Carisma to consume capital significantly faster than it currently anticipates, and Carisma may need to spend more than currently expected because of circumstances beyond its control. As a result, Carisma could deplete its capital resources sooner than it currently expects. In addition, because the successful development of CT-0508, CT-0525, CT-1119, CT-0729 and any combination studies or other product candidates that it pursues is highly uncertain, at this time Carisma cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the development of any product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently anticipates that it will use the expected cash balances of the combined company as of the closing of the merger resulting from the net cash expected to be provided by Sesen Bio upon completion of the merger, together with Carisma&#8217;s existing cash resources and the expected gross proceeds from the Carisma pre-closing financing, as follows:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approximately $44.0 million to $55.0 million for the advancement of CT-0508 for treatment of solid tumors that overexpress HER2, including completion of its ongoing Phase 1 clinical trial and related combination studies;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approximately $28.0 million to $35.0 million for the advancement of CT-0525 for treatment of solid tumors that overexpress HER2, including submission of an IND to the FDA in the third quarter of 2023 and the initiation of clinical development shortly thereafter; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the remainder for preclinical studies for research stage programs, working capital and other general corporate purposes.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This expected use of anticipated funds available to the combined company following the closing of the merger represents Carisma&#8217;s intentions based upon its current plans for the combined company and business conditions. The amounts and timing of the combined company&#8217;s actual expenditures may vary significantly depending on numerous factors, including the progress of the combined company&#8217;s development efforts, the status of and results from clinical trials and preclinical studies, the timing of regulatory submissions, as well as any collaborations that the combined company may enter into with third parties for its product candidates, and any unforeseen cash needs. As a result, the combined company&#8217;s management will retain broad discretion over the allocation of the anticipated funds available to the combined company following the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on Carisma&#8217;s planned use of the anticipated funds available to the combined company following the closing of the merger, Carisma estimates that such funds will be sufficient to enable the combined company to complete its ongoing Phase 1 clinical trial of CT-0508 and the related sub study evaluating the combination of CT-0508 and pembrolizumab, and initiate a Phase 1 clinical trial of CT-0525 following </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">336</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">submission of an IND to the FDA. Carisma has based these estimates on assumptions that may prove to be wrong, and the combined company could use its capital resources sooner than Carisma currently expects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Identifying potential product candidates and conducting pre-clinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes&#160;years to complete, and Carisma may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, Carisma&#8217;s product candidates, if approved, may not achieve commercial success. Carisma will not generate commercial revenues unless and until it can achieve sales of products, which it does not anticipate for a number of&#160;years, if at all. Accordingly, Carisma will need to obtain substantial additional financing to achieve its business objectives. Adequate additional financing may not be available to Carisma on acceptable terms, or at all, and may be impacted by the economic climate and market conditions. For example, market volatility resulting from the COVID-19 pandemic, any other future infectious diseases, epidemics or pandemics or general U.S. or global economic or market conditions could also adversely impact Carisma&#8217;s ability to access capital as and when needed. Alternatively, Carisma may seek additional capital due to favorable market conditions or strategic considerations, even if it believes it has sufficient funds for its current or future operating plans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as the combined company, operating as Carisma, can generate substantial revenues from product sales, Carisma expects to finance its cash needs through a combination of public and private equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. To the extent that Carisma raises additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of those securities may include liquidation or other preferences that adversely affect your rights as a holder of Carisma common stock. Debt financing and preferred equity financing, if available, would increase Carisma&#8217;s fixed payment obligations and may involve agreements that include covenants limiting or restricting Carisma&#8217;s operations and ability to take specific actions, such as incurring additional debt, making acquisitions, engaging in acquisition, merger or collaboration transactions, selling or licensing Carisma&#8217;s assets, making capital expenditures, redeeming its stock, making certain investments, declaring dividends or other operating restrictions that could adversely impact Carisma&#8217;s ability to conduct its business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma raises funds through additional collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, Carisma may have to relinquish valuable rights to its intellectual property, future revenue streams, discovery programs or product candidates, grant licenses on terms that may not be favorable to Carisma or grant rights to develop and market product candidates that Carisma would otherwise prefer to develop and market itself, any of which may have a material adverse effect on Carisma&#8217;s business, operating results and prospects. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contractual Obligations and Commitments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s contractual obligations and commitments at September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:216.91pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Less than</font>
                <br >
                <font style="letter-spacing:-0.16pt;">1 Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">1 to 3 Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">4 to 5 Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">More than</font>
                <br >
                <font style="letter-spacing:-0.16pt;">5 Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:216.91pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Contractual obligations: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216.91pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating lease commitments</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,907</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,539</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">654</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">469</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216.91pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance lease commitments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,137</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">763</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:216.91pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Convertible promissory note</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">37,338</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">37,338</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:216.91pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total contractual obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">46,145</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">44,014</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,417</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">469</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reflects obligations pursuant to Carisma&#8217;s office and laboratory leases in Philadelphia, Pennsylvania. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reflects principal and interest payments pursuant to the Carisma convertible note issued to Moderna in January&#160;2022. The table above assumes cash settlement at the contractual maturity date in July&#160;31, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">337</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2023. Settlement may be through the conversion of outstanding principal and interest into shares of Carisma capital stock that may be issued in connection with a qualified or unqualified financing event and prior to maturity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The commitment amounts in the table above are associated with contracts that are enforceable and legally binding and that specify all significant terms, including fixed or minimum services to be used, fixed, minimum or variable price provisions, and the approximate timing of the actions under the contracts. Carisma&#8217;s contracts with CMOs, CROs and other third parties for the manufacture of its product candidates and to support pre-clinical research studies and clinical testing are generally cancelable by Carisma upon prior notice and do not contain any minimum purchase commitments. Payments due upon cancellation consisting only of payments for services provided or expenses incurred, including noncancelable obligations of Carisma&#8217;s service providers, up to the date of cancellation are not included in the table above as the amount and timing of such payments are not known. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table above does not include any potential milestone or royalty payments that Carisma may be required to make under license agreement with Penn and under licensing agreements with other third parties not considered material. Carisma excluded these milestone and royalty payments given that the timing and likelihood of any such payments cannot be reasonably estimated at this time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">University of Pennsylvania License</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2017, Carisma entered into a license agreement with Penn for certain intellectual property licenses, which was amended in February&#160;2018, January&#160;2019, March&#160;2020 and June&#160;2021. Carisma is responsible for paying Penn an annual license maintenance fee in the low tens of thousands of dollars, payable until Carisma&#8217;s first payment of a royalty. Carisma is required to pay Penn up to $10.9&#160;million per product in development and regulatory milestone payments, up to $30.0&#160;million per product in commercial milestone payments, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. While the license agreement remains in effect, Carisma is required to pay Penn low to mid-single digit&#160;percentage tiered royalties on annual net sales of licensed products, which may be subject to reductions. Penn is guaranteed a minimum royalty payment amount in the low hundreds of thousands of dollars for each year after the first commercial sale of a licensed product. Carisma must also pay Penn a&#160;percentage in the mid-single digits to low double digits of certain types of income Carisma receives from sublicensees. In addition, Carisma is required to pay Penn an annual alliance management fee in the low tens of thousands of dollars, ending after several&#160;years, unless Carisma provides funding to Penn for research and development activities that extend beyond a specified date, in which case Carisma will continue to owe the alliance management fee for each year in which Carisma continues to fund such activities. Carisma also paid Penn an upfront fee in the low hundreds of thousands of dollars for the license to the patents related to the mesothelin binder that is incorporated into the CAR design for Carisma&#8217;s mesothelin product candidate. Carisma is responsible for a pro&#160;rata share of costs relating to the prosecution and maintenance of the licensed patents. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Accounting Policies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma management&#8217;s discussion and analysis of its financial condition and results of operations are based on its consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of the consolidated financial statements requires Carisma to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in its consolidated financial statements. On an ongoing basis, Carisma evaluates its estimates and judgments, including those related to accrued expenses, fair value of Carisma common stock and stock-based compensation. Carisma bases its estimates on historical experience, known trends and events, and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Carisma&#8217;s significant accounting policies are described in more detail in Note 3 to its audited consolidated financial statements included elsewhere in this proxy statement/prospectus, Carisma believes </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">338</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the following accounting policies are the most critical to the judgments and estimates used in the preparation of its consolidated financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenues from Contracts</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma accounts for its revenue in accordance with Accounting Standards Codification, or ASC, 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue from Contracts with Customers</font><font style="letter-spacing:0.2pt;">, or ASC 606. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps at inception of the agreement or upon material modification of the agreement: (i)&#160;identifies the contract(s) with a customer; (ii)&#160;identifies the performance obligations in the contract; (iii)&#160;determines the transaction price, including variable consideration, if any; (iv)&#160;allocates the transaction price to the performance obligations in the contract; and (v)&#160;recognizes revenue when (or as) the entity satisfies a performance obligation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma considers the pattern of satisfaction of the performance obligations under step (v)&#160;above to be a critical accounting estimate. More specifically, the determination of the level of achievement of research and development service performance obligations, whose pattern of satisfaction is measured using costs incurred to date as compared to total costs incurred and expected to be incurred in the future is driven by a critical accounting estimate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In estimating the costs expected to be incurred in the future, Carisma management uses its most recent budget and long-range plan, adjusted for any pertinent information. While this is Carisma&#8217;s best estimate as of the reporting period, costs expected to be incurred in the future require management&#8217;s judgment as the scope and timing of research and development activities may change significantly over time. Carisma may adjust the scope of its research and development activities based on several factors, such as additional work needed to support advancement of product candidate or change in the number of patients in trials. Further, research and development services may no longer be within the scope of a collaboration agreement, as has been the case with certain of Carisma&#8217;s programs. The timing of when research and development costs are expected to be incurred may change as a result of external factors, such as delays caused by manufacturing or supply chain, or difficulty in enrolling patients; or internal factors, such as prioritization of programs. Carisma&#8217;s estimate of the scope and timing of research and development services performed relative to the actual scope and timing may have a significant impact on revenue recognition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Accruals</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist primarily of costs incurred in connection with the development of Carisma&#8217;s product candidates. Carisma expenses research and development costs as incurred. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma accrues expenses for pre-clinical studies and activities performed by third parties based upon estimates of the proportion of work completed over the term of the individual trial and patient enrollment rates in accordance with agreements with third parties. Carisma determines the estimates by reviewing contracts, vendor agreements and purchase orders, and through discussions with its internal clinical personnel and external service providers as to the progress or stage of completion of activities or services and the agreed-upon fee to be paid for such services. However, actual costs and timing of clinical trials are highly uncertain, subject to risks and may change depending upon a number of factors, including Carisma&#8217;s clinical development plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma makes estimates of its accrued expenses as of each balance sheet date in its consolidated financial statements based on facts and circumstances known at that time. If the actual timing of the performance of services or the level of effort varies from the estimate, Carisma will adjust the accrual accordingly. Non-refundable advance payments for goods and services, including fees for process development or manufacturing and distribution of pre-clinical supplies that will be used in future research and development activities, are deferred and recognized as expense in the period that the related goods are consumed or services are performed. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">339</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Milestone payments within Carisma&#8217;s licensing and collaboration arrangements are recognized when achievement of the milestone is deemed probable to occur. To the extent products are commercialized and future economic benefit has been established, commercial milestones that become probable are capitalized and amortized over the estimated remaining useful life of the intellectual property. In addition, Carisma accrues royalty expense and sublicense non-royalty payments, as applicable, for the amount it is obligated to pay, with adjustments as sales are made. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma measures compensation expense for all stock-based awards based on the estimated fair value of the award on the grant date. Carisma uses the Black-Scholes option pricing model to value its stock option awards. Carisma recognizes compensation expense on a straight-line basis over the requisite service period, which is generally the vesting period of the award. Carisma has not issued awards where vesting is subject to a market or performance condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Black-Scholes option pricing model requires the use of subjective assumptions that include the expected stock price volatility and the fair value of the underlying common stock on the date of grant. See Note 8 to Carisma&#8217;s audited consolidated financial statements and Note 8 to Carisma&#8217;s unaudited interim consolidated financial statements included elsewhere in this proxy statement/prospectus for information concerning certain of the specific assumptions Carisma used in applying the Black-Scholes option pricing model to determine the estimated fair value of its stock options granted during the&#160;years ended December&#160;31, 2021 and 2020 and for the nine&#160;months ended September&#160;30, 2022 and 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Estimating the fair value of common stock</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is required to estimate the fair value of Carisma common stock underlying its stock-based awards. Because Carisma common stock is not currently publicly traded, the fair value of Carisma common stock has been estimated on each grant date by the Carisma board of directors, with input from Carisma management, considering its most recently available third-party valuation of Carisma common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors considered various objective and subjective factors to estimate the estimated fair value of Carisma common stock, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the estimated value of all classes of securities outstanding; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the anticipated capital structure that will directly impact the value of the currently outstanding securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s results of operations and financial position; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the status of Carisma&#8217;s research and development efforts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the composition of, and changes to, Carisma&#8217;s management team and the Carisma board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the lack of liquidity of Carisma common stock as a private company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s stage of development and business strategy and the material risks related to its business and industry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">external market conditions affecting the life sciences and biotechnology industry sectors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the likelihood of achieving a liquidity event for the holders of Carisma common stock, such as an initial public offering, or a sale of the company, given the prevailing market conditions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the market value and volatility of comparable companies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In estimating the fair value of Carisma common stock, the Carisma board of directors considered the subjective factors discussed above in conjunction with the most recent valuations of Carisma common stock that were prepared by an independent third party. The independent valuation prepared as of February&#160;28, 2022 was utilized by the Carisma board of directors when estimating the fair value of Carisma common stock for the awards granted after such date and through September&#160;30, 2022. The independent valuation prepared as of April&#160;1, 2021 was utilized by the Carisma board of directors when estimating the fair value </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">340</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:200pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of Carisma common stock for the awards granted after such date and through December&#160;31, 2021. These third-party valuations resulted in an estimated fair value of Carisma common stock of $2.68 and $2.77 per share as of February&#160;28, 2022 and April&#160;1, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Redemption feature</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The redemption feature of the Carisma convertible note with Moderna is marked-to-market each reporting period with the changes in fair value recorded to other expense in the consolidated statements of operations until the obligations under the Carisma convertible note are satisfied. The fair value of the redemption feature of the Carisma convertible note is estimated by using a discounted cash flow method in conjunction with assuming the probability of completing a qualified financing. During the nine&#160;months ended September&#160;30, 2022, the discount factor used was 12% and a 90% probability of completing a qualified financing prior to the maturity date of the Carisma convertible note was assumed. The estimated time of conversion ranged from three to twelve&#160;months. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent Accounting Pronouncements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See Note 3 to Carisma&#8217;s unaudited interim consolidated financial statements included elsewhere in this proxy statement/prospectus for a description of recent accounting pronouncements applicable to its consolidated financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Off-Balance Sheet Arrangements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not have any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Carisma does not engage in off-balance sheet financing arrangements. In addition, Carisma does not engage in trading activities involving non-exchange traded contracts. Carisma therefore believes that it is not materially exposed to any financing, liquidity, market or credit risk that could arise if it had engaged in these relationships. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Qualitative and Quantitative Disclosures About Market Risk</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is exposed to market risks in the ordinary course of its business. These risks primarily include interest rate sensitivities. Carisma&#8217;s interest-earning assets consist of cash, cash equivalents and marketable securities. Interest income earned on these assets was de minimis for the&#160;years ended December&#160;31, 2021 and 2020 and for the nine&#160;months ended September&#160;30, 2022 and 2021.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">341</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tMFTM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT FOLLOWING THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:11.02pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Officers and Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The combined company&#8217;s board of directors will initially be fixed at seven members, consisting of six directors designated by Carisma and one director designated by Sesen Bio. The staggered structure of the current Sesen Bio board of directors will remain in place for the combined company&#8217;s board of directors following the completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the name, age as of January 4, 2023 and position of each of the individuals who are expected to serve as executive officers and directors of the combined company. </font>
        </div>
        <table style="width:456pt;height:173.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:204pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:24pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Age </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:204pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:-0.2pt;">Executive Officers</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Steven Kelly </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">57 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">President and Chief Executive Officer, Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Richard Morris </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">49 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">33 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Chief Scientific Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">66 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Director, Chair </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">61 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">53 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">63 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">64 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">40 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
              <font style="letter-spacing:0.2pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.51pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Officers</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Steven Kelly</font><font style="letter-spacing:0.2pt;"> has served as Carisma&#8217;s President and Chief Executive Officer and as a member of the Carisma board of directors since February&#160;2018. Prior to joining Carisma, Mr.&#160;Kelly served as Chief Executive Officer of Pinteon Therapeutics, a biotechnology company, from April&#160;2014 to July&#160;2015 and as the Chief Executive Officer of Theracrine, Inc., a biopharmaceutical company, from June&#160;2011 to August&#160;2012. Mr.&#160;Kelly currently serves on the board of directors of Artelo Biosciences, Inc. (Nasdaq: ARTL). Mr.&#160;Kelly received a B.S. from the University of Oregon and an M.B.A. from Cornell University. Carisma believes Mr.&#160;Kelly is qualified to serve as a member of the combined company&#8217;s board of directors because of his extensive knowledge of Carisma based on his current role as its President and Chief Executive Officer, as well as his significant biopharmaceutical industry and management experience. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Richard Morris</font><font style="letter-spacing:0.2pt;"> has served as Carisma&#8217;s Chief Financial Officer since June&#160;2021. Prior to joining Carisma, Mr.&#160;Morris served as Chief Financial Officer of Passage Bio, Inc., a genetic medicines company, from October&#160;2019 to May&#160;2021 and as Executive Vice President and Chief Financial Officer of Context Therapeutics, LLC, a biopharmaceutical company, or Context, from November&#160;2017 to July&#160;2019. Prior to Context, Mr. Morris served as Chief Financial Officer of Vitae Pharmaceuticals Incorporated, a biopharmaceutical company, from 2014 to October 2016, and held several senior financial roles over 12 years at ViroPharma Incorporated, a biopharmaceutical company, including Chief Accounting Officer and Vice President, Financial and Strategic Planning. Mr.&#160;Morris received a B.S. in Accounting from Saint Joseph&#8217;s University and has been a CPA since 1999. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Michael Klichinsky,</font><font style="letter-spacing:0.2pt;"> </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pharm.D., Ph.D.</font><font style="letter-spacing:0.2pt;"> has served as Carisma&#8217;s Chief Scientific Officer since April&#160;2022. He co-founded Carisma in 2016 and served as Vice President of Discovery of Carisma from October 2018 to April 2021 and as Senior Vice President of Research of Carisma from April 2021 to April&#160;2022. Dr.&#160;Klichinsky received a Doctor of Pharmacy from the University of Sciences in Philadelphia and a Ph.D. in Pharmacology from the University of Pennsylvania. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Sanford Zweifach</font><font style="letter-spacing:0.2pt;"> has served as a member and Chair of the Carisma board of directors since November&#160;2021. Mr.&#160;Zweifach has served as the Founder and President of Pelican Consulting Group, a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">342</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">biotechnology consulting firm, since December&#160;2019. Mr.&#160;Zweifach founded and served as Chief Executive Officer of Nuvelution Pharma, Inc., a pharmaceutical company, from June&#160;2015 to November&#160;2019. Mr.&#160;Zweifach currently serves on the boards of directors of Essa Pharma Inc. (Nasdaq: EPIX) and Compugen Ltd. (Nasdaq: CGEN). Mr.&#160;Zweifach received a B.A. in Biology from University of California San Diego and a M.S. in Human Physiology from University of California Davis. Carisma believes Mr.&#160;Zweifach is qualified to serve as Chair of the combined company&#8217;s board of directors because of his extensive experience in the biopharmaceutical industry and service on the boards of other public and private biopharmaceutical companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Thomas R. Cannell, </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">D.V.M.</font><font style="letter-spacing:0.2pt;">, has served as Sesen Bio&#8217;s President and Chief Executive Officer and a member of the Sesen Bio board of directors since August&#160;2018. Prior to joining Sesen Bio, Dr.&#160;Cannell served as Orexigen Therapeutics, Inc.&#8217;s Chief Operating Officer &amp; President of Global Commercial Products from July&#160;2016 to July&#160;2018, and as its Chief Commercial Officer from March&#160;2015 to June&#160;2016. Prior to Orexigen, Dr.&#160;Cannell spent 27&#160;years with Merck &amp; Co., Inc., where he held senior leadership positions in global commercialization, consumer marketing, and sales operations and management for both development-stage programs and approved marketed products. Dr.&#160;Cannell received a D.V.M. from Washington State University. Carisma believes Dr.&#160;Cannell is qualified to serve as a member of the combined company&#8217;s board of directors because of his extensive industry experience and scientific background. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Regina Hodits</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">, Ph.D.,</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since June 2018. Dr.&#160;Hodits has served as a Managing Partner at Wellington Partners, a venture capital firm investing in companies mainly in areas of technology, life sciences and digital media, since 2010. Prior to that, Dr.&#160;Hodits served as Partner of Atlas Ventures from 2004 to 2010. She currently serves on the board of directors of Onward Medical. Dr.&#160;Hodits received a Master&#8217;s degree in Chemical Engineering and a Ph.D. in biochemistry from Technical University of Vienna, Austria. Carisma believes Dr.&#160;Hodits is qualified to serve as a member of the combined company&#8217;s board of directors because of her scientific background and training in biochemistry, extensive experience with biopharmaceutical companies and service on the boards of other biopharmaceutical companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Briggs Morrison</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">, M.D.,</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since July&#160;2020. Dr.&#160;Morrison has served as President, Head of Research and Development of Syndax Pharmaceuticals Inc., a biopharmaceutical company, since February 2022; he was previously Chief Executive Officer of Syndax Pharmaceuticals Inc. from June&#160;2015. Dr.&#160;Morrison currently serves on the boards of directors of Repare Therapeutics Inc. (Nasdaq: RPTX), Werewolf Therapeutics Inc. (Nasdaq: HOWL), Arvinas, Inc. (Nasdaq: ARVN) and Syndax Pharmaceuticals Inc. (Nasdaq: SNDX). Dr.&#160;Morrison received an M.D. from the University of Connecticut and a B.S. in Biology from Georgetown University. Carisma believes Dr.&#160;Morrison is qualified to serve as a member of the combined company&#8217;s board of directors due to his extensive executive leadership experience, medical background and training, and extensive service on the boards of other public and private biopharmaceutical companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Bj&#246;rn Odlander,</font><font style="letter-spacing:0.2pt;"> </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">M.D., Ph.D.</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since February&#160;2022. Dr.&#160;Odlander is a co-founder of HealthCap, a family of venture capital funds investing globally in life sciences, where he has been a Managing Partner since 1996. Dr.&#160;Odlander received a M.D. and Ph.D. from Karolinska Institute. Dr.&#160;Odlander is qualified to serve as a member of the combined company&#8217;s board of directors with his medical background and training, industry background and extensive experience of investments in the life-science sector. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Chidozie Ugwumba</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since December 2020. Mr.&#160;Ugwumba has served as Managing Partner of SymBiosis, a venture capital firm focused on investments in biotherapeutics, since August&#160;2021. Prior to SymBiosis, Mr.&#160;Ugwumba served as a Managing Director and the Co-Head of the Direct and Impact Investment Group of WIT, LLC, an investment management entity affiliated with Walton Enterprises, from 2018 to 2021 and on the Private Credit and Infrastructure teams at Partners Group, a global private investment manager, from 2015 to 2018. Mr.&#160;Ugwumba currently serves on the board of directors of Clene, Inc. (Nasdaq: CLNN). Mr.&#160;Ugwumba received an M.B.A. from Cornell University and a B.A. in Political Science from Amherst College. Carisma believes Mr.&#160;Ugwumba is qualified to serve as a member of the combined company&#8217;s board of directors because of his significant experience and expertise in biopharmaceutical investments and his overall industry knowledge. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">343</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Independence</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Applicable Nasdaq Listing Rules require that the combined company&#8217;s board of directors be comprised of a majority of independent directors. Based upon information requested from and provided by each proposed director concerning his or her background, employment and affiliations, including family relationships, Carisma expects that the combined company&#8217;s board of directors will determine that each member of the combined company&#8217;s board of directors, except Mr.&#160;Kelly, Carisma&#8217;s current President and Chief Executive Officer, who will serve as President and Chief Executive Officer of the combined company, and Dr.&#160;Cannell, Sesen Bio&#8217;s current President and Chief Executive Officer, will qualify as an &#8220;independent director&#8221; as defined under applicable Nasdaq Listing Rules. In making such determination, the combined company&#8217;s board of directors will consider the current and prior relationships that each director has with Carisma and Sesen Bio and all other facts and circumstances that the company&#8217;s board of directors deems relevant in determining the independence of each director, including the interests of each director in the merger, any relevant related party transactions and the beneficial ownership of Carisma or Sesen Bio common stock by each director. See the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Related Party Transactions of Directors and Executive Officers of the Combined Company</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tIOCD">153</a>, <a href="#tRPTO">368</a> and <a href="#tPSOC">397</a>, respectively, of this proxy statement/prospectus for additional information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Nasdaq Listing Rules require that, subject to specified exceptions, each member of the combined company&#8217;s audit, compensation and nominating and corporate governance committees be independent under the Exchange Act. Audit committee members must also satisfy the independence criteria set forth in Rule&#160;10A-3 under the Exchange Act, and compensation committee members must also satisfy the independence criteria set forth in Rule&#160;10C-1 under the Exchange Act. Under applicable Nasdaq Listing Rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the combined company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In order to be considered independent for purposes of Rule&#160;10A-3, a member of an audit committee of the combined company may not, other than in his or her capacity as a member of the audit committee, the combined company&#8217;s board of directors, or any other committee of the combined company&#8217;s board of directors, accept, directly or indirectly, any consulting, advisory or other compensatory fee from the combined company or any of its subsidiaries or otherwise be an affiliated person of the combined company or any of its subsidiaries. In order to be considered independent for purposes of Rule&#160;10C-1, the board of directors must consider, for each member of a compensation committee of the combined company, all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member, including, but not limited to: (1)&#160;the source of compensation of the director, including any consulting advisory or other compensatory fee paid by such company to the director; and (2)&#160;whether the director is affiliated with the company or any of its subsidiaries or affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There are no family relationships among any of the proposed directors or officers of the combined company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Composition of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors currently consists of six members divided into three staggered classes, with one class elected at each annual meeting to serve for a three-year term. The staggered structure of the current Sesen Bio board of directors will remain in place for the combined company&#8217;s board of directors following the completion of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Committees of the Board of Directors Following the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has an established audit committee, compensation committee, nominating and corporate governance committee and science committee, each of which operate pursuant to a charter adopted by the Sesen Bio board of directors. After completion of the merger, the combined company&#8217;s board of directors will continue to have such standing committees. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">344</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Audit Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio audit committee include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">appointing, approving the compensation of, and assessing the independence of, Sesen Bio&#8217;s registered public accounting firm; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">overseeing the work of the independent registered public accounting firm, including through the receipt and consideration of reports and other communications from such firm; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and discussing with management and the independent registered public accounting firm&#160;(x)&#160;the annual and quarterly financial statements and related disclosures (including any interim financial statements to be included in Sesen Bio&#8217;s periodic disclosures filed with the SEC); (y)&#160;earnings press releases; and (z)&#160;litigation or other legal matters that could have a significant impact on Sesen Bio&#8217;s financial results; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">monitoring internal control over financial reporting, disclosure controls and procedures and code of business conduct and ethics; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">overseeing Sesen Bio&#8217;s internal audit function; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">working with Sesen Bio&#8217;s Chief Compliance Officer to evaluate and define the goals of Sesen Bio&#8217;s ethics and compliance programs, evaluate the adequacy of Sesen Bio&#8217;s internal controls over compliance and develop proposals for improving Sesen Bio&#8217;s internal controls; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">overseeing Sesen Bio&#8217;s risk assessment and risk management policies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">meeting independently with Sesen Bio&#8217;s internal audit advisor, if applicable, and the independent registered public accounting firm and management; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and approving or ratifying any related person transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">preparing the audit committee report required by SEC rules; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The audit committee of the combined company is expected to retain these duties and responsibilities following the completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the audit committee. Sesen Bio and Carisma believe that, following the completion of the merger, the composition of the audit committee will meet the requirements for independence under current Nasdaq and SEC rules and regulations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio compensation committee include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and approving, or making recommendations to the Sesen Bio board of directors with respect to, the compensation of the chief executive officer and other executive officers, taking into consideration the executive officer&#8217;s performance as it relates to both legal compliance and compliance with Sesen Bio&#8217;s internal policies and procedures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and approving termination benefits and separation pay to executive officers, taking into consideration the circumstances surrounding the particular executive officer&#8217;s departure and performance as it relates to both legal compliance and compliance with Sesen Bio&#8217;s internal policies and procedures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">overseeing an evaluation of Sesen Bio&#8217;s senior executives, including the establishment of corporate goals and objectives applicable to the chief executive officer and other executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and approving, or making recommendations to the Sesen Bio board of directors with respect to, the terms of any binding offer letters, employment agreements, termination agreements or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">345</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">arrangements, change-in-control agreements, severance agreements, indemnification agreements or other material compensatory agreements with the chief executive officer or the other executive officers; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to incentive-compensation and equity-based plans that are subject to approval by the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">overseeing and administering Sesen Bio stock option, stock incentive, employee stock purchase and other equity-based plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">retaining the services, following the determination of independence under applicable Nasdaq Listing Rules and Exchange Act rules, of Sesen Bio&#8217;s compensation consultant, as well as overseeing and considering the recommendations of the compensation consultant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to director compensation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing, if deemed advisable by the Sesen Bio board of directors, and monitoring compliance with, stock ownership guidelines for the chief executive officer, directors and other executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and discussing annually with management the compensation disclosure required by SEC rules; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">preparing the compensation committee report required by SEC rules; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The compensation committee of the combined company is expected to retain these duties and responsibilities following completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the compensation committee. Sesen Bio and Carisma believe that, following the completion of the merger, the composition of the compensation governance committee will meet the requirements for independence under current Nasdaq and SEC rules and regulations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Nominating and Corporate Governance Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio nominating and corporate governance committee include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">identifying individuals qualified to become members of the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">recommending to the Sesen Bio board of directors the persons to be nominated for election as directors and to each of the board committees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to board leadership structure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to management succession planning; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to the adequacy of the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">developing and recommending corporate governance guidelines to the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">overseeing a periodic evaluation of the Sesen Bio board of directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The nominating and corporate governance committee of the combined company is expected to retain these duties and responsibilities following completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the nominating and corporate governance committee. Sesen Bio and Carisma believe that, following the completion of the merger, the composition of the nominating and corporate governance committee will meet the requirements for independence under current Nasdaq and SEC rules and regulations. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">346</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Science Committee</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio science committee include:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and advising on the overall strategy, direction and effectiveness of Sesen Bio&#8217;s research and development, or R&amp;D, initiatives, programs and related investments, and on Sesen Bio&#8217;s progress in achieving our long-term strategic R&amp;D goals and objectives, including preclinical studies and clinical trial design;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and advising on opportunities and risks associated with Sesen Bio&#8217;s R&amp;D initiatives, programs and related investments;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and advising on Sesen Bio&#8217;s significant medical affairs strategies and initiatives;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and advising on trends and innovation in research and development to enhance Sesen Bio&#8217;s R&amp;D capabilities; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the science committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The science committee of the combined company is expected to retain these duties and responsibilities following completion of the merger.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the science committee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Committee Interlocks and Insider Participation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the compensation committee. None of the proposed executive officers of the combined company serve, or in the past year has served, as a member of the board of directors or compensation committee, or other committee serving an equivalent function, of any other entity that has one or more of its executive officers who is proposed to serve on the combined company&#8217;s board of directors or compensation committee following the completion of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Code of Business Conduct and Ethics</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The combined company will adopt a written code of business conduct and ethics, substantially in the form of Sesen Bio&#8217;s current Code of Business Conduct and Ethics, that applies to its directors, officers and employees, including the principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, of the combined company. The combined company will post a current copy of the code on its website, www.carismatx.com. In addition, the combined company intends to post on its website all disclosures that are required by law or Nasdaq Listing Rules concerning any amendments to, or waivers from, any provision of the code of business conduct and ethics. The information contained on, or that can be accessed through, the website is not a part of this prospectus. The website address is included in this prospectus solely as an inactive textual reference. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to the merger, Carisma did not have a formal policy to provide any cash or equity compensation to its non-employee directors for their service on the Carisma board of directors or committees of the Carisma board of directors. In connection with Mr.&#160;Zweifach&#8217;s election as a member and Chair of the Carisma board of directors in November&#160;2021, the Carisma board of directors authorized an annual cash retainer of $75,000 to be paid to Mr.&#160;Zweifach in equal quarterly installments and a grant to Mr.&#160;Zweifach of options to purchase 97,200 shares of Carisma common stock. In connection with Mr.&#160;Morrison&#8217;s election as a member of the Carisma board of directors in July&#160;2020, the Carisma board of directors authorized a grant to Mr.&#160;Morrison of options to purchase 33,332 shares of Carisma common stock. For additional information on compensation paid to directors of Carisma, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation&#8201;&#8212;&#8201;Carisma Director Compensation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCADCT">367</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger and the transition of the board of directors, the combined company expects to evaluate Sesen Bio&#8217;s director compensation practices and finalize the combined company&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">347</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:568pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">non-employee director compensation program, pursuant to which non-employee directors will be eligible to receive compensation for service on the board of directors of the combined company and its committees. The board of directors of the combined company expects to review director compensation periodically to ensure that director compensation remains competitive such that the combined company is able to recruit and retain qualified directors. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">348</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBEC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO EXECUTIVE COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s named executive officers for 2022 are Thomas R. Cannell, D.V.M., its President and Chief Executive Officer, Monica Forbes, its Chief Financial Officer, and Mark Sullivan, its General Counsel, Chief Compliance Officer and Corporate Secretary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding compensation awarded to, earned by or paid to each of Sesen Bio&#8217;s named executive officers for the&#160;years ended December&#160;31, 2022 and 2021. </font>
        </div>
        <table style="width:456pt;height:168.14pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:135.9pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Salary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bonus </font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards ($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Non-equity </font>
                <br >
                <font style="letter-spacing:-0.16pt;">incentive </font>
                <br >
                <font style="letter-spacing:-0.16pt;">plan </font>
                <br >
                <font style="letter-spacing:-0.16pt;">compensation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">All other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.48999999999998pt;height:6.89pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.5pt;">
            <td style="padding:3.267pt 0pt 1.14pt 0pt; width:135.9pt;text-align:left;" rowspan="2">
              <div style="margin-left:9.5pt; text-indent:-9.5pt; text-align:justify; line-height:11.39pt; padding-bottom:0.63pt;">
                <font style="letter-spacing:0.19pt;">Thomas R. Cannell, D.V.M.</font><font style=" position:relative; bottom:4pt;font-size:6pt;letter-spacing:0.14pt;">&#65279;(1)</font>
                <br >
                <font style="letter-spacing:0.19pt;">President and Chief Executive </font>
                <br >
                <font style="letter-spacing:0.19pt;">Officer </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:24.75pt; text-align:right; white-space:nowrap;">574,345</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:24.75pt; text-align:right; white-space:nowrap;">813,112</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.267pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,391,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.39pt;height:22.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.5pt;">
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">558,362</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,123,086</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">236,250</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,921,698</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.48999999999998pt;height:6.64pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.5pt;">
            <td style="padding:3.517pt 0pt 1.14pt 0pt; width:135.9pt;white-space:normal;text-align:left;" rowspan="2">
              <div style="margin-left:9.5pt; text-indent:-9.5pt; text-align:justify; line-height:11.39pt; padding-bottom:0.63pt;">
                <font style="letter-spacing:0.19pt;">Monica Forbes</font><font style=" position:relative; bottom:4pt;font-size:6pt;letter-spacing:0.14pt;">&#65279;(2)</font>
                <br >
                <font style="letter-spacing:0.19pt;">Chief Financial Officer and Treasurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:24.75pt; text-align:right; white-space:nowrap;">388,785</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:24.75pt; text-align:right; white-space:nowrap;">484,229</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.517pt 0pt 1.633pt 0pt; line-height:11.39pt; min-width:30.75pt; text-align:right; white-space:nowrap;">877,015</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.39pt;height:22.77pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.5pt;">
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">377,958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">148,778</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,195,695</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">145,447</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 9.13pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,871,878</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.39pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.5pt;">
            <td style="padding:2.26pt 0pt 9.13pt 0pt; width:135.9pt;white-space:normal;text-align:left;">
              <div style="margin-left:9.5pt; text-indent:-9.5pt;">
                <font style="letter-spacing:0.19pt;">Mark Sullivan</font><font style=" position:relative; bottom:4pt;font-size:6pt;letter-spacing:0.14pt;">&#65279;(3)</font>
                <br >
                <font style="letter-spacing:0.19pt;">General Counsel, Chief Compliance Officer and Corporate Secretary </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">380,129</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">303,196</td>
            <td style="padding:0pt;padding-left:5.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:11.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.26pt 0pt 9.13pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">687,325</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.55pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Dr.&#160;Cannell&#8217;s base salary was increased from $562,500 to $576,563, effective March&#160;1, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Ms.&#160;Forbes&#8217; base salary was increased from $380,750 to $399,788, effective March&#160;1, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Mr.&#160;Sullivan&#8217;s base salary was $382,025 effective March&#160;1, 2022. Mr.&#160;Sullivan was not a named executive officer for fiscal year 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Stock awards&#8221; column reflect the aggregate grant date fair value of performance-based restricted stock&#160;units and restricted stock&#160;units awarded during the year computed in accordance with the provisions of Financial Accounting Standards Board Accounting Standard Codification, or ASC, Topic 718. See Note 14 to Sesen Bio&#8217;s financial statements appearing at the end of Sesen Bio&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 regarding assumptions underlying the valuation of equity awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Option awards&#8221; column reflect the aggregate grant date fair value of stock options awarded during the year computed in accordance with the provisions of Financial Accounting Standards Board Accounting Standard Codification, or ASC, Topic 718. See Note 14 to Sesen Bio&#8217;s financial statements appearing at the end of Sesen Bio&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 regarding assumptions underlying the valuation of equity awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:2.09pt; width:436pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">For the year ended December&#160;31, 2022, the grant-date fair value of stock options was determined using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model: </font>
        </div>
        <table style="width:436pt;height:116.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:378.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:378.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair market value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grant exercise price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.9</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.11<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">71.77<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">349</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Non-equity incentive plan compensation&#8221; column reflect bonuses that were earned by Sesen Bio&#8217;s executive officers in the fiscal year ending December&#160;31, 2021 based on the achievement of pre-established performance goals that were previously communicated to Sesen Bio&#8217;s executive officers. See &#8220;Bonus Compensation&#8221; below for additional information. As of the date of this proxy statement/prospectus, the determination of performance-based bonuses for the fiscal year ending December&#160;31, 2022 has not yet been made. It is anticipated that these amounts will be determined in the first quarter of 2023, at which time Sesen Bio will disclose the amounts of such bonuses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For Dr.&#160;Cannell and Ms.&#160;Forbes, for the fiscal&#160;years 2022 and 2021, and Mr.&#160;Sullivan, for the fiscal year 2022, the amounts reported reflect discretionary 401(k) matching contributions contributed to Sesen Bio&#8217;s 401(k) retirement plan as approved by the Sesen Bio compensation committee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Narrative to Summary Compensation Table</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Employment Agreements with Named Executive Officers</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;7, 2018, Sesen Bio entered into an employment agreement with Dr.&#160;Cannell, which provides that his employment will continue until either Sesen Bio or Dr.&#160;Cannell provides notice of termination in accordance with the terms of the agreement. In addition, Sesen Bio entered into a non-competition, non-solicitation, confidentiality and assignment agreement with Dr.&#160;Cannell, which prohibits him from competing with Sesen Bio, soliciting Sesen Bio&#8217;s employees and customers and disclosing confidential information during the term of his employment and for one year following the conclusion of his service with Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Dr.&#160;Cannell&#8217;s employment agreement, he is entitled to receive an annual base salary, which will be reviewed at least annually and will be subject to increase (but not decrease) from time to time, as determined by the Sesen Bio board of directors. In February&#160;2022, the Sesen Bio compensation committee approved an increase in Dr.&#160;Cannell&#8217;s annual base salary to $576,563, effective March&#160;1, 2022. In addition, pursuant to his employment agreement, Dr.&#160;Cannell is eligible to receive an annual cash bonus, which is based on the achievement of individual and corporate performance objectives, calculated as a&#160;percentage of his annual base salary, and which will be determined by the Sesen Bio board of directors, in its sole discretion. Dr.&#160;Cannell&#8217;s target annual bonus for 2021 and 2022 was 50% of his annual base salary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Monica Forbes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;26, 2019, Sesen Bio entered into an employment agreement with Ms.&#160;Forbes in connection with her appointment as Sesen Bio&#8217;s Chief Financial Officer and Treasurer. Ms.&#160;Forbes&#8217; employment agreement provides that her employment will continue until either Sesen Bio or Ms.&#160;Forbes provides notice of termination in accordance with the terms of the agreement. In addition, Sesen Bio entered into a non-competition, non-solicitation, confidentiality and assignment agreement with Ms.&#160;Forbes, which prohibits her from competing with Sesen Bio, soliciting Sesen Bio&#8217;s employees and customers and disclosing confidential information during the term of her employment and for one year following the conclusion of her service with Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Ms.&#160;Forbes&#8217; employment agreement, she is entitled to receive an annual base salary, which will be reviewed at least annually and will be subject to increase (but not decrease) from time to time, as determined by the Sesen Bio board of directors. In February&#160;2022, the Sesen Bio compensation committee approved an increase in Ms.&#160;Forbes&#8217; annual base salary to $400,000, effective March&#160;1, 2022. In addition, pursuant to her employment agreement, Ms.&#160;Forbes is eligible to receive an annual cash bonus based on the achievement of individual and corporate performance objectives, calculated as a&#160;percentage of her annual base salary, and which will be determined by the Sesen Bio board of directors, in its sole discretion. Ms.&#160;Forbes&#8217; annual target bonus for 2021 and 2022 was 40% of her annual base salary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Mark Sullivan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;26, 2019, Sesen Bio entered into an employment agreement with Mr.&#160;Sullivan. Mr.&#160;Sullivan&#8217;s employment agreement provides that his employment will continue until either Sesen Bio or Mr.&#160;Sullivan </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">350</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provides notice of termination in accordance with the terms of the agreement. In addition, Sesen Bio entered into a non-competition, non-solicitation, confidentiality and assignment agreement with Mr.&#160;Sullivan, which prohibits him from competing with Sesen Bio, soliciting Sesen Bio&#8217;s employees and customers and disclosing confidential information during the term of his employment and for one year following the conclusion of his service with Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Mr.&#160;Sullivan&#8217;s employment agreement, he is entitled to receive an annual base salary, which will be reviewed at least annually and will be subject to increase (but not decrease) from time to time, as determined by the Sesen Bio board of directors. In February&#160;2022, the Sesen Bio compensation committee approved an increase in Mr.&#160;Sullivan&#8217;s annual base salary to $382,025, effective March&#160;1, 2022. In addition, pursuant to his employment agreement, Mr.&#160;Sullivan is eligible to receive an annual cash bonus based on the achievement of individual and corporate performance objectives, calculated as a&#160;percentage of his annual base salary, and which will be determined by the Sesen Bio board of directors, in its sole discretion. Mr.&#160;Sullivan&#8217;s annual target bonus for 2021 and 2022 was 40% of his annual base salary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Equity Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although Sesen Bio does not have a formal policy with respect to the grant of equity incentive awards to its executive officers, or any formal equity ownership guidelines applicable to them, Sesen Bio believes that equity grants provide its executives with a strong link to its long-term performance, create an ownership culture and help to align the interests of its executives and Sesen Bio stockholders. In addition, Sesen Bio believes that equity grants with a time-based vesting feature promote executive retention by incentivizing its executive officers to remain in Sesen Bio&#8217;s employment during the vesting period. Accordingly, the Sesen Bio board of directors periodically reviews the equity incentive compensation of its executive officers and from time to time may grant equity incentive awards to them, including in the form of Sesen Bio options and Sesen Bio RSUs (both time-based RSUs and performance-based RSUs, or Sesen Bio PSUs). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;18, 2022, Sesen Bio granted Dr.&#160;Cannell an award of 606,800 RSUs. Each Sesen Bio RSU represents a contingent right to receive one share of Sesen Bio common stock. The Sesen Bio RSU award vests annually in equal amounts over a four year period following the grant date, subject to Dr.&#160;Cannell&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;18, 2022, Sesen Bio also granted Dr.&#160;Cannell an award of 606,800 Sesen Bio PSUs. Each Sesen Bio PSU represents a contingent right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria related to completing patient enrollment for the new clinical trial. Subject to continued employment, such Sesen Bio PSUs vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone. On February&#160;19, 2021, Sesen Bio granted Dr.&#160;Cannell options to purchase 2,000,000 shares of Sesen Bio common stock at an exercise price of $3.17 per share. These options vest 6.25% every three&#160;months over four&#160;years commencing on February&#160;19, 2021, subject to Dr.&#160;Cannell&#8217;s continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;18, 2022, Sesen Bio granted Ms.&#160;Forbes an award of 542,250 RSUs. Each Sesen Bio RSU represents a contingent right to receive one share of Sesen Bio common stock. The Sesen Bio RSU award vests annually in equal amounts over a four year period following the grant date, subject to Ms.&#160;Forbes&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;18, 2022, Sesen Bio also granted Ms.&#160;Forbes an award of 180,750 Sesen Bio PSUs. Each Sesen Bio PSU represents a contingent right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria related to completing patient enrollment for the new clinical trial. Subject to continued employment, such Sesen Bio PSUs vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone. On February&#160;19, 2021, Sesen Bio granted Ms.&#160;Forbes options to purchase 580,000 shares of Sesen Bio common stock at an exercise price of $3.17 per share. These options vest 6.25% every three&#160;months over four&#160;years commencing on February&#160;19, 2021, subject to Ms.&#160;Forbes&#8217; continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;18, 2022, Sesen Bio granted Mr.&#160;Sullivan an award of 339,525 RSUs. Each Sesen Bio RSU represents a contingent right to receive one share of Sesen Bio common stock. The Sesen Bio RSU award vests annually in equal amounts over a four year period following the grant date, subject to Mr.&#160;Sullivan&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;18, 2022, Sesen Bio also granted Mr.&#160;Sullivan an award of 113,175 Sesen Bio PSUs. Each Sesen Bio PSU represents a contingent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">351</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria related to completing patient enrollment for the new clinical trial. Subject to continued employment, such Sesen Bio PSUs vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone. On February&#160;19, 2021, Sesen Bio granted Mr.&#160;Sullivan options to purchase 300,000 shares of Sesen Bio common stock at an exercise price of $3.17 per share. These options vest 6.25% every three&#160;months over four&#160;years commencing on February&#160;19, 2021, subject to Mr.&#160;Sullivan&#8217;s continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, on September&#160;9, 2021, the Sesen Bio board of directors and Sesen Bio compensation committee approved a retention program, or the 2021 retention program, for all current employees, except for the Chief Executive Officer, pursuant to which Sesen Bio has provided certain incentives designed to retain such employees. Pursuant to the 2021 retention program and effective as of October&#160;1, 2021, Sesen Bio&#8217;s executive officers, except for the Chief Executive Officer, were granted a Sesen Bio PSU award equal to the value of approximately fifty&#160;percent of the executive officer&#8217;s then-current base salary. Under the 2021 retention program, Ms.&#160;Forbes was granted an award of 190,375 Sesen Bio PSUs and Mr.&#160;Sullivan was granted an award of 185,000 Sesen Bio PSUs. Each Sesen Bio PSU represents a contingent right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria. Subject to continued employment, such awards vest on September&#160;30, 2023 upon the determination by the Sesen Bio compensation committee of the level of achievement of certain key milestones consisting of a clinical trial milestone (weighted 50%), an employee retention milestone (weighted 30%) and a cash management milestone (weighted 20%). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Bonus Compensation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio prepares a detailed set of overall corporate objectives for each fiscal year for use under the Sesen Bio annual bonus plan. These corporate objectives are initially prepared by management, reviewed (and revised, if determined appropriate) by the Sesen Bio compensation committee, and then presented to the full Sesen Bio board of directors for approval. The Sesen Bio compensation committee assigns weighting to the corporate objectives, but uses its judgment to determine a&#160;percentage that it believes fairly represents Sesen Bio&#8217;s achievement level for the applicable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to the fiscal year ended December&#160;31, 2021, each of Sesen Bio&#8217;s named executive officers was eligible to receive a performance-based bonus based on the achievement of corporate objectives and individual objectives. Since Sesen Bio&#8217;s Chief Executive Officer is responsible for the overall performance of Sesen Bio&#8217;s business, his annual bonus was based solely on Sesen Bio&#8217;s overall performance in achieving corporate objectives. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2022, the Sesen Bio compensation committee reviewed Sesen Bio&#8217;s 2021 corporate performance against Sesen Bio&#8217;s corporate objectives and noted that while Sesen Bio made substantial progress on Sesen Bio regulatory and financial goals during 2021, Sesen Bio had certain corporate setbacks as well. Further, the Sesen Bio compensation committee and the Sesen Bio board of directors determined to modify certain corporate objectives related to commercialization, which were determined to be no longer applicable in light of the CRL, as further described below. The weighting of the remaining corporate objectives was adjusted accordingly. Such objectives and outcomes included the following: </font>
        </div>
        <table style="width:456pt;height:143.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 Corporate Objective </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Outcome </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighting </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:36pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Score </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Achieve FDA acceptance of the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC after 1Q 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio exceeded the target for this objective. The BLA for Vicineum was accepted with Priority Review during Q1 2021, which was earlier than the target. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">22% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">24 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Receive FDA approval of the BLA in the second half of 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio did not meet this objective. The FDA issued a Complete Response Letter regarding Sesen Bio&#8217;s BLA for Vicineum. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">22% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Submit the MAA for Vysyneum for the treatment of BCG-unresponsive NMIBC to the </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio did not meet this objective. While Sesen Bio submitted the MAA earlier than its target date, Sesen Bio withdrew the MAA </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">6% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">352</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:188.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 Corporate Objective </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Outcome </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighting </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:36pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Score </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">EMA after Q1 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">in order to pause its plans to pursue regulatory approval of Vysyneum in the E.U. until there is more clarity from the FDA on next steps for Vicineum in the U.S. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Strengthen balance sheet and extend cash runway by finishing fiscal 2021 with $40.0&#160;million -$50.0&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio exceeded the target for this objective by ending fiscal 2021 with a strong balance sheet of $163.0&#160;million in cash and cash equivalents. The strength of Sesen Bio&#8217;s balance sheet will be critical to supporting Sesen Bio&#8217;s business going forward, including future clinical development of Vicineum. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">50% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">60 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:192pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">100%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">84</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:16pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result, and as noted in the table below, the Sesen Bio compensation committee and the Sesen Bio board of directors approved 2021 performance cash bonus payments to Sesen Bio&#8217;s named executive officers based on an assessment of corporate performance during 2021. </font>
        </div>
        <table style="width:456pt;height:70pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:193.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Target </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:193.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Annual </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Base Salary ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Annual </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Bonus (%)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Annual </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Bonus ($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Company </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Scorecard </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Result </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Final </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Award </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:193.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">562,500</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">50<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">281,250</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">84<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">236,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:193.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Monica Forbes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">380,750</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">40<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">152,300</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">84<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">145,447</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">2021 target annual bonus opportunity was a&#160;percentage of 2021 base salary. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">It is anticipated that the Sesen Bio compensation committee will review Sesen Bio&#8217;s 2022 corporate performance against Sesen Bio&#8217;s corporate objectives in the first quarter of 2023 in order to determine 2022 performance cash bonus payments to Sesen Bio&#8217;s named executive officers, at which time Sesen Bio will disclose the amounts of such bonuses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Outstanding Equity Awards at December&#160;31, 2022</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding all outstanding equity awards held by each of Sesen Bio&#8217;s named executive officers as of December&#160;31, 2022. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">353</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:363.83pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:130.71pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:130.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares or&#160;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">units of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">stock that </font>
                <br >
                <font style="letter-spacing:-0.16pt;">have not </font>
                <br >
                <font style="letter-spacing:-0.16pt;">vested </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Market </font>
                <br >
                <font style="letter-spacing:-0.16pt;">value of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares of&#160;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">units of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">stock that </font>
                <br >
                <font style="letter-spacing:-0.16pt;">have not </font>
                <br >
                <font style="letter-spacing:-0.16pt;">vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity </font>
                <br >
                <font style="letter-spacing:-0.16pt;">incentive plan </font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards: </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">unearned </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares, units </font>
                <br >
                <font style="letter-spacing:-0.16pt;">or other rights </font>
                <br >
                <font style="letter-spacing:-0.16pt;">that have not </font>
                <br >
                <font style="letter-spacing:-0.16pt;">vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity </font>
                <br >
                <font style="letter-spacing:-0.16pt;">incentive plan </font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards: </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Market or </font>
                <br >
                <font style="letter-spacing:-0.16pt;">payout value </font>
                <br >
                <font style="letter-spacing:-0.16pt;">of unearned </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares, units </font>
                <br >
                <font style="letter-spacing:-0.16pt;">or other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">rights that </font>
                <br >
                <font style="letter-spacing:-0.16pt;">have not </font>
                <br >
                <font style="letter-spacing:-0.16pt;">vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:6.53pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.27pt 0pt 0.5pt 0pt; width:130.71pt;text-align:left;" rowspan="5">
              <div style="white-space:nowrap; line-height:10.8pt; padding-bottom:-0.0100000000000004pt;">
                <font style="letter-spacing:0.18pt;">Thomas R. Cannell, D.V.M. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="5">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,350,000</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.60</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8/7/2028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.27pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">937,500</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">62,500<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">0.8285</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/21/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">996,875</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">453,125<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">0.8911</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/13/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.53pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">875,000</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,125,000<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">3.17</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/19/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">606,800<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(7)</font> </font></td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">370,148<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">606,800<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(8)</font> </font></td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">370,148<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:6.28pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.54pt 0pt 0.5pt 0pt; width:130.71pt;text-align:left;" rowspan="6">
              <div style="white-space:nowrap; line-height:10.8pt; padding-bottom:-0.0100000000000099pt;">
                <font style="letter-spacing:0.18pt;">Monica Forbes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="6">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:29.25pt; text-align:right; white-space:nowrap;">195,000</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:29.25pt; text-align:right; white-space:nowrap;">45,000<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.16</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8/1/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.54pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">227,500</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">52,500<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(6)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.13</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8/26/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">316,250</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">143,750<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">0.8911</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/13/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.55pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">253,750</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">326,250<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">3.17</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/19/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;height:14.28pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">542,250<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(9)</font> </font></td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">330,773<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">190,375<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(10)</font> </font></td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.56pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">116,129<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;height:14.28pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">180,750<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(11)</font> </font></td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">110,258<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;height:6.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.57pt 0pt 0.5pt 0pt; width:130.71pt;text-align:left;" rowspan="6">
              <div style="white-space:nowrap; line-height:10.8pt; padding-bottom:-0.0100000000000099pt;">
                <font style="letter-spacing:0.18pt;">Mark Sullivan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="6">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:29.25pt; text-align:right; white-space:nowrap;">243,750</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:29.25pt; text-align:right; white-space:nowrap;">16,250<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(12)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.00</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/27/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; line-height:10.8pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">162,500</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">37,500<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.16</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8/1/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.57pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">178,750</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">81,250<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">0.8911</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/13/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">131,250</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">168,750<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">3.17</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/19/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.58pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;height:14.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">339,525<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(13)</font> </font></td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">207,110<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">185,000<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(14)</font> </font></td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">112,850<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;height:18.28pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.07pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">113,175<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(15)</font> </font></td>
            <td style="padding:0pt;padding-left:8.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.59pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">69,037<font style="position:absolute;"><font style=" position:relative; bottom:2.55357142857143pt;font-size:5.5pt;">(16)</font></font></td>
            <td style="padding:0pt;padding-left:7.7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 25% of the shares underlying the option vesting on August&#160;7, 2019, the first anniversary of the grant date, and 6.25% of the shares underlying the option vesting quarterly thereafter until the fourth anniversary of the grant date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on February&#160;21, 2019. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on February&#160;13, 2020. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on February&#160;19, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 25% of the shares underlying the option vesting on August&#160;1, 2020, the first anniversary of the grant date, and 6.25% of the shares underlying the option vesting quarterly thereafter until the fourth anniversary of the grant date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on August&#160;26, 2019. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Restricted stock&#160;units granted on February&#160;18, 2022 vest annually in equal amounts over a four year period following the grant date, subject to continued employment. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Performance-based restricted stock&#160;units granted on February&#160;18, 2022 vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone, subject to continued employment, as described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Narrative to Summary Compensation Table&#8201;&#8212;&#8201;Equity Awards</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">354</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Restricted stock&#160;units granted on February&#160;18, 2022 vest annually in equal amounts over a four year period following the grant date, subject to continued employment. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Performance-based restricted stock&#160;units granted on October&#160;1, 2021 vest on September&#160;30, 2023 upon the determination by the Sesen Bio compensation committee of the level of achievement of certain key milestones consisting of a clinical trial milestone, an employee retention milestone and a cash management milestone, subject to continued employment, as described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Narrative to Summary Compensation Table&#8201;&#8212;&#8201;Equity Awards</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Performance-based restricted stock&#160;units granted on February&#160;18, 2022 vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone, subject to continued employment, as described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Narrative to Summary Compensation Table&#8201;&#8212;&#8201;Equity Awards</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on February&#160;27, 2019. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(13)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Restricted stock&#160;units granted on February&#160;18, 2022 vest annually in equal amounts over a four year period following the grant date, subject to continued employment. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(14)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Performance-based restricted stock&#160;units granted on October&#160;1, 2021 vest on September&#160;30, 2023 upon the determination by the Sesen Bio compensation committee of the level of achievement of certain key milestones consisting of a clinical trial milestone, an employee retention milestone and a cash management milestone, subject to continued employment, as described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Narrative to Summary Compensation Table&#8201;&#8212;&#8201;Equity Awards</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(15)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Performance-based restricted stock&#160;units granted on February&#160;18, 2022 vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone, subject to continued employment, as described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Narrative to Summary Compensation Table&#8201;&#8212;&#8201;Equity Awards</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(16)</font>
          <br >
        </div>
        <div style=" margin-top:3.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based on the per share closing market price of the Sesen Bio common stock on December&#160;31, 2022 of $0.61. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Payments to Named Executive Officers Upon Termination or Change in Control Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to their respective employment agreements with Sesen Bio, upon execution and effectiveness of a release of claims, each of Dr.&#160;Cannell, Ms.&#160;Forbes and Mr.&#160;Sullivan will be entitled to severance payments if his or her employment is terminated under specified circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dr.&#160;Cannell.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If Sesen Bio terminates Dr.&#160;Cannell&#8217;s employment without cause, as defined in his employment agreement, or if Dr.&#160;Cannell terminates his employment with Sesen Bio for good reason, as defined in his employment agreement, absent a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to (i)&#160;pay Dr.&#160;Cannell&#8217;s base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;pay Dr.&#160;Cannell an amount equal to his target bonus payment for the year in which the termination of employment occurs, prorated for the portion of the year in which he was employed, and (iii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Dr.&#160;Cannell and certain of his dependents with group health and dental insurance for a period up to 12&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio terminates Dr.&#160;Cannell&#8217;s employment without cause or if Dr.&#160;Cannell terminates his employment with Sesen Bio for good reason, in each case within 18&#160;months following a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to (i)&#160;pay Dr.&#160;Cannell an amount equal to his base salary for 24&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;pay Dr.&#160;Cannell an amount equal to two times his target bonus payment for the year in which the termination of employment occurs, (iii)&#160;accelerate in full the vesting of all of Dr.&#160;Cannell&#8217;s outstanding equity awards, and (iv)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Dr.&#160;Cannell and certain of his dependents with group health and dental insurance for a period of up to 24&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ms.&#160;Forbes.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If Sesen Bio terminates Ms.&#160;Forbes&#8217; employment without cause, as defined in her employment agreement, or if Ms.&#160;Forbes terminates her employment with Sesen Bio for good reason, as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">355</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">defined in her employment agreement, absent a change in control transaction, as defined in her employment agreement, Sesen Bio is obligated to (i)&#160;pay Ms.&#160;Forbes&#8217; base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, and (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Ms.&#160;Forbes and certain of her dependents with group health and dental insurance for a period of up to 12&#160;months. In addition, if, prior to September&#160;30, 2023, Sesen Bio terminates Ms.&#160;Forbes&#8217; employment without cause, then each Sesen Bio PSU earned as of the time of such termination of employment based on the achievement of the applicable performance milestone, as determined by the Sesen Bio compensation committee in its sole discretion, will become vested as of the date of such termination of employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio terminates Ms.&#160;Forbes employment without cause or if Ms.&#160;Forbes terminates her employment with Sesen Bio for good reason, in each case within 12&#160;months following a change in control transaction, as defined in her employment agreement, Sesen Bio is obligated to (i)&#160;pay Ms.&#160;Forbes&#8217; base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Ms.&#160;Forbes and certain of her dependents with group health and dental insurance for a period of 12&#160;months, and (iii)&#160;accelerate in full the vesting of all of Ms.&#160;Forbes&#8217; outstanding equity awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Mr.&#160;Sullivan.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If Sesen Bio terminates Mr.&#160;Sullivan&#8217;s employment without cause, as defined in his employment agreement, or if Mr.&#160;Sullivan terminates his employment with Sesen Bio for good reason, as defined in his employment agreement, absent a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to (i)&#160;pay Mr.&#160;Sullivan&#8217;s base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices and (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Mr.&#160;Sullivan and certain of his dependents with group health and dental insurance for a period of up to 12&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio terminates Mr.&#160;Sullivan&#8217;s employment without cause or if Mr.&#160;Sullivan terminates his employment with Sesen Bio for good reason, in each case within 12&#160;months following a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to: (i)&#160;pay Mr.&#160;Sullivan&#8217;s base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Mr.&#160;Sullivan and certain of his dependents with group health and dental insurance for a period of 12&#160;months, and (iii)&#160;accelerate in full the vesting of all of Mr.&#160;Sullivan&#8217;s outstanding equity awards. In addition, if, prior to September&#160;30, 2023, Sesen Bio terminates Mr.&#160;Sullivan&#8217;s employment without cause, then each Sesen Bio PSU earned as of the time of such termination of employment based on the achievement of the applicable performance milestone, as determined by the Sesen Bio compensation committee in its sole discretion, will become vested as of the date of such termination of employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to pay the severance payments to Dr.&#160;Cannell, Ms.&#160;Forbes and Mr.&#160;Sullivan pursuant to their respective employment agreements, as described above, is contingent upon the executive&#8217;s execution and non-revocation of a release of claims in favor of Sesen Bio. In addition, Sesen Bio&#8217;s obligation to pay such severance payments is subject to such executive officer&#8217;s compliance with certain restrictive covenants, including non-competition and non-solicitation (of employees and customers) covenants, which run for one year following the executive&#8217;s termination of employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Taxation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To the extent that any severance or other compensation payment to Dr.&#160;Cannell or Ms.&#160;Forbes pursuant to his or her employment agreement or any other agreement constitutes an &#8220;excess parachute payment&#8221; within the meaning of Sections&#160;280G and 4999 of the Code, then he or she will receive the full amount of such severance and other payments, or a reduced amount intended to avoid the application of Sections&#160;280G and 4999 of the Code, whichever provides the executive with the highest amount on an after-tax basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">401(k) Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio maintains a defined contribution 401(k) retirement plan for its employees in which substantially all of Sesen Bio&#8217;s full-time U.S. employees are eligible to participate, including its executive officers. Participants may contribute a&#160;percentage of their annual compensation to this plan, subject to statutory limitations. Sesen Bio made matching contributions of $45,517 to the plan for the year ended December&#160;31, 2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">356</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:149.63pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitation of Liability and Indemnification</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Certificate of Incorporation limits the personal liability of directors for breach of fiduciary duty to the maximum extent permitted by the DGCL and provides that no director will have personal liability to Sesen Bio or to Sesen Bio stockholders for monetary damages for breach of fiduciary duty as a director. However, these provisions do not eliminate or limit the liability of any of Sesen Bio&#8217;s directors: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for any breach of the director&#8217;s duty of loyalty to Sesen Bio or Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for voting for or assenting to unlawful payments of dividends, stock repurchases or other distributions; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for any transaction from which the director derived an improper personal benefit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Any amendment to or repeal of these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to such amendment or repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of the Sesen Bio directors will be further limited to the greatest extent permitted by the DGCL. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Sesen Bio Certificate of Incorporation provides that Sesen Bio must indemnify its directors and officers and Sesen Bio must advance expenses, including attorneys&#8217; fees, to its directors and officers in connection with legal proceedings, subject to very limited exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio maintains a general liability insurance policy that covers specified liabilities of its directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers. In addition, Sesen Bio has entered into indemnification agreements with all of its directors and executive officers. These indemnification agreements may require Sesen Bio, among other things, to indemnify each such director and executive officer for some expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by him or her in any action or proceeding arising out of his or her service as one of its directors or executive officers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Some of Sesen Bio&#8217;s non-employee directors may, through their relationships with their employers, be insured or indemnified against specified liabilities incurred in their capacities as members of the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, executive officers or persons controlling Sesen Bio, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">357</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s non-employee directors are compensated for their services on the Sesen Bio board of directors as follows: </font>
        </div>
        <table style="width:456pt;height:244pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:314.75pt;">
              <font style="letter-spacing:-0.2pt;">Compensation</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Annual Board Cash Retainer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:129.25pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$40,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional Retainer for Non-Executive Chair of the Board </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:129.25pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$30,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional Retainers for Committee Chairs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Audit </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$15,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Compensation </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$10,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Nominating and Corporate Governance </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$8,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Science </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$10,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional Retainers for Committee Members </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Audit </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$7,500</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Compensation </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$5,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Nominating and Corporate Governance </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$4,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Science </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 1pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$5,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Annual Equity Award (non-employee directors) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0.5pt 0.833pt 0pt; width:129.25pt;text-align:right;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:right;">
                <font style="letter-spacing:0.2pt;">65,000 Sesen Bio options and</font>
                <br >
                <font style="letter-spacing:0.2pt;">40,000 Sesen Bio RSUs</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Initial Equity Award (non-employee directors) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0.5pt 0.833pt 0pt; width:129.25pt;text-align:right;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:right;">
                <font style="letter-spacing:0.2pt;">130,000 Sesen Bio options and</font>
                <br >
                <font style="letter-spacing:0.2pt;">80,000 Sesen Bio RSUs</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:6.31pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio compensation committee engages Radford, its independent compensation consultant, to provide advice on the competitiveness of Sesen Bio&#8217;s non-employee director compensation program and ensure that both cash and equity components of Sesen Bio&#8217;s non-employee director compensation program remain market competitive. In February&#160;2022, the Sesen Bio compensation committee and Sesen Bio board of directors, based on a market analysis prepared by Radford, approved annual board, chair and committee cash retainers, as well as a combination of options and Sesen Bio RSUs for both the initial and annual equity awards to non-employee directors. In its approvals, the Sesen Bio compensation committee and the Sesen Bio board of directors considered the time commitment and responsibilities of Sesen Bio&#8217;s directors as well as the size of the Sesen Bio board of directors. Consistent with the prior year, cash compensation aligns with the 50th&#160;percentile of the Radford market analysis and equity compensation aligns with the 75th&#160;percentile of the Radford market analysis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio options granted to Sesen Bio&#8217;s non-employee directors will have an exercise price equal to the fair market value of the Sesen Bio common stock on the date of grant and will expire ten&#160;years after the date of grant. The initial stock options granted to Sesen Bio&#8217;s non-employee directors will, subject to the director&#8217;s continued service on the Sesen Bio board of directors, vest monthly in equal amounts over a three-year period following the grant date. The annual stock options granted to Sesen Bio&#8217;s non-employee directors will, subject to the director&#8217;s continued service on Sesen Bio board of directors, vest monthly in equal amounts over a one-year period following the grant date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The initial restricted stock&#160;units granted to Sesen Bio&#8217;s non-employee directors will vest annually in equal amounts over a three-year period following the grant date. The annual restricted stock&#160;units granted to Sesen Bio&#8217;s non-employee directors will vest on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of Sesen Bio&#8217;s common stock and is subject to continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each annual cash fee will be payable in arrears in four equal quarterly installments on the last day of each quarter, provided that the amount of each payment will be prorated for any portion of a quarter that a director is not serving on the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each member of the Sesen Bio board of directors will also be entitled to reimbursement for reasonable travel and other expenses incurred in connection with attending meetings of the Sesen Bio board of directors and any committee on which he or she serves. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">358</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:55pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below shows all compensation to Sesen Bio&#8217;s non-employee directors during 2022. </font>
        </div>
        <table style="width:416pt;height:101.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:226.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees Earned or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid in Cash ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:226.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">93,000</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,560</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">157,639</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:226.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,560</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">124,639</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:226.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">51,500</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,560</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">116,139</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:226.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter K Honig, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,500</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,560</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">117,139</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:226.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">59,000</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,560</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">123,639</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On June&#160;22, 2022, Dr.&#160;Duker, Mr.&#160;Keyes, Ms.&#160;Bourdow, Mr.&#160;Honig and Mr.&#160;Jewett each received 40,000 restricted stock&#160;units that vest on June&#160;23, 2023. The amounts reported in the &#8220;Stock Awards&#8221; column reflect the aggregate grant date fair value of restricted stock&#160;units awarded during the year computed in accordance with the provisions of Financial Accounting Standards Board Accounting Standard Codification, or ASC, Topic 718. See Note 14 to Sesen Bio&#8217;s financial statements appearing at the end of Sesen Bio&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 regarding assumptions underlying the valuation of equity awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Following the annual meeting of stockholders held on June&#160;22, 2022, Dr.&#160;Duker, Mr.&#160;Keyes, Ms.&#160;Bourdow, Mr.&#160;Honig and Mr.&#160;Jewett each received an option to purchase 65,000 shares of Sesen Bio common stock at an exercise price of $0.79 per share. These stock options vest over twelve&#160;months, with 1/12</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> of the shares underlying the option vesting at the end of each one-month period following June&#160;22, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Option Awards&#8221; column reflect the aggregate grant date fair value of stock-based compensation awarded during the year computed in accordance with the provisions of Financial Accounting Standards Board ASC Topic 718. See footnote 6 to the &#8220;Summary Compensation Table&#8221; above and Note 14 to Sesen Bio&#8217;s financial statements appearing at the end of Sesen Bio&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 regarding assumptions underlying the valuation of equity awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During 2022, Sesen Bio did not provide any additional compensation to Dr.&#160;Cannell, its President and Chief Executive Officer, for his service as a director. Dr.&#160;Cannell&#8217;s compensation as a named executive officer is set forth above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Executive Compensation&#8201;&#8212;&#8201;Summary Compensation Table</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below shows all stock options held by each of Sesen Bio&#8217;s non-employee directors as of December&#160;31, 2022. </font>
        </div>
        <table style="width:416pt;height:101.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:356.1pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Outstanding</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">288,787</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter K Honig, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">185,000</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">185,000</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">269,500</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">269,500</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">359</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCEC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA EXECUTIVE COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This section describes the material elements of compensation awarded to, earned by or paid to each of Carisma&#8217;s named executive officers in 2022. Carisma&#8217;s &#8220;named executive officers&#8221; for 2022 are (i)&#160;Steven Kelly, Carisma&#8217;s President and Chief Executive Officer, (ii)&#160;Richard Morris, Carisma&#8217;s Chief Financial Officer, and (iii)&#160;Michael Klichinsky, Carisma&#8217;s Chief Scientific Officer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding compensation awarded to, earned by, or paid to each of Carisma&#8217;s named executive officers for the&#160;years ended December&#160;31, 2022 and 2021. </font>
        </div>
        <table style="width:456pt;height:107.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:237.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Salary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:237.46pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Steven Kelly</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">President &amp; Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">440,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">440,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">416,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">158,080</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">482,883</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,057,111</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:237.46pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Richard Morris</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Financial Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">400,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">400,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">227,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">73,255</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">606,630</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">907,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:237.46pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(4)</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Scientific Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">340,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">340,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">300,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">87,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">163,430</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">551,180</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:6.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As of the date of this proxy statement/prospectus, the Carisma board of directors has not yet determined the bonus amounts that its named executive officers are entitled to for 2022. It is anticipated that 2022 bonus amounts will be determined in the first quarter of 2023, at which time Carisma will disclose the amounts of such bonuses. See &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Narrative Disclosure to Summary Compensation Table&#8201;&#8212;&#8201;Bonus Compensation</font><font style="letter-spacing:0.2pt;">&#8221; below for information on how the amount of bonuses are determined by Carisma. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Option awards&#8221; column reflect the grant date fair value of Carisma options awarded during the year computed in accordance with the provisions of Financial Accounting Standard Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. See Note 3 to Carisma&#8217;s consolidated financial statements appearing at the end of this proxy/statement prospectus regarding assumptions underlying the valuation of option awards. These amounts reflect the accounting cost for these stock options and do not reflect the actual economic value that may be realized by the named executive officer upon the vesting of the stock options, the exercise of the stock options or the sale of the common stock underlying such stock options. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Mr.&#160;Morris was appointed as Carisma&#8217;s Chief Financial Officer on June&#160;1, 2021. His annual base salary for 2021 was $390,000. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Dr.&#160;Klichinsky was appointed as Carisma&#8217;s Chief Scientific Officer in April 2022. Prior to that, he served as Senior Vice President of Research for Carisma. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:9.83pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Narrative Disclosure to Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Base Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma uses base compensation or salaries to recognize the experience, skills, knowledge and responsibilities required of its executive officers. None of the Carisma named executive officers is currently party to an employment agreement or other agreement or arrangement that provides for automatic or scheduled increases in base compensation or salary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the year ended December&#160;31, 2022, Carisma paid Mr.&#160;Kelly, Mr.&#160;Morris and Dr.&#160;Klichinsky annual base compensation of $440,000, $400,000 and $340,000, respectively. For the year ended December 31, 2021, Carisma paid Mr. Kelly, Mr. Morris and Dr. Klichinsky annual base compensation of $416,000, $227,500 and $300,000, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Bonus Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors may, in its discretion, award bonuses to the Carisma named executive officers from time to time. The Carisma named executive officers are eligible for annual performance-based </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">360</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:64pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">bonuses up to a specified&#160;percentage of their base compensation or salary, subject to approval by the Carisma board of directors. Performance-based bonuses, which are calculated as a&#160;percentage of base compensation or salary, are designed to motivate Carisma&#8217;s executive officers to achieve annual goals based on Carisma&#8217;s strategic, financial and operating performance objectives. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this proxy statement/prospectus, the Carisma board of directors has not yet determined the bonus amounts that its named executive officers are entitled to for 2022. It is anticipated that 2022 bonus amounts will be determined in the first quarter of 2023, at which time the Company will disclose the amounts of such bonuses. With respect to 2021 performance, the Carisma board of directors awarded performance-based bonuses of $158,080, $73,255 and $87,750, respectively, to Mr.&#160;Kelly, Mr.&#160;Morris and Dr.&#160;Klichinsky. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Incentives</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although Carisma does not have a formal policy with respect to the grant of equity incentive awards to its executive officers, or any formal equity ownership guidelines applicable to them, Carisma believes that equity grants provide its executives with a strong link to Carisma&#8217;s long-term performance, create an ownership culture and help to align the interests of Carisma executive officers and Carisma stockholders. Accordingly, Carisma uses stock options to compensate its executive officers in the form of initial grants in connection with the commencement of employment and also at various other times, if Carisma or they have performed as expected or better than expected. In addition, Carisma believes that equity grants with a time-based vesting feature promote executive retention because this feature incentivizes its executive officers to remain in Carisma&#8217;s employment during the vesting period. The option awards that Carisma has granted to its executive officers typically become exercisable as to 25% of the shares underlying the option on the first anniversary of the vesting commencement date and as to an additional 2.0833% of the original number of shares underlying the option monthly thereafter. Vesting rights cease upon termination of employment and exercise rights for previously vested stock options cease shortly after termination, though exercisability is extended in the case of death or disability. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma executive officers are eligible to participate in the Carisma Plan. All Carisma options have been granted pursuant to the Carisma Plan. For a description of the Carisma Plan, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">&#8212;&#8201;2017 Stock Incentive Plan</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSTOIP">364</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">None of the Carisma executive officers is currently party to an employment agreement that provides for the automatic award of stock options. To date, Carisma has not maintained a practice of granting additional equity on an annual basis, but has retained discretion to provide additional targeted grants in certain circumstances. Accordingly, the Carisma board of directors periodically reviews the equity incentive compensation of the Carisma executive officers, including the Carisma named executive officers, and from time to time may grant equity incentive awards to them in the form of stock options. Carisma did not grant stock option awards to the Carisma named executive officers during the year ended December&#160;31, 2022, but has done so in prior years, as described in more detail in the &#8220;Outstanding Equity Awards at December&#160;31, 2022&#8221; table below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the exercise of an option, the holder has no rights as a stockholder with respect to the shares subject to such option, including no voting rights and no right to receive dividends or dividend equivalents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has historically granted stock options with exercise prices that are equal to the fair market value of Carisma common stock on the date of grant as determined by the Carisma board of directors, based on a number of objective and subjective factors. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">361</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Outstanding Equity Awards at December&#160;31, 2022</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding all outstanding equity awards held by each of Carisma&#8217;s named executive officers as of December&#160;31, 2022. </font>
        </div>
        <table style="width:456pt;height:163pt;margin-top:4pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:144.47pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="19">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:144.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">price ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:144.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Steven Kelly </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">329,471</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.18</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9/18/2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">112,541</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">106,459<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/31/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:144.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Richard Morris </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">65,372</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">108,954<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5/31/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:144.47pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">30,000</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.19</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11/01/2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.18</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10/21/2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">30,319</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">28,681<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(6)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/31/2031</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This Carisma option is fully vested. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four&#160;years, with 25% of the shares vested on April 1, 2022 and 2.0833% of the original number of shares vested thereafter in equal monthly installments through April 1, 2025, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four&#160;years, with 25% of the shares vested on June&#160;1, 2022 and 2.0833% of the original number of shares vesting thereafter in equal monthly installments through June&#160;1, 2025, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This Carisma option is fully vested. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This Carisma option is fully vested. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four years, with 25% of the shares vested on April 1, 2022 and 2.0833% of the original number of shares vested thereafter in equal monthly installments through April 1, 2025, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employment Agreements with Named Executive Officers</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has entered into written employment agreements with each of its executive officers. These agreements set forth the terms of the executive officer&#8217;s compensation, including base salary, annual discretionary bonus eligibility and severance benefits, among other matters. The employment agreements with the Carisma named executive officers are summarized below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Agreement with Steven Kelly</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;12, 2018, Carisma entered into an offer letter, or the Kelly Agreement, with Mr.&#160;Kelly in connection with his employment as Carisma&#8217;s President and Chief Executive Officer. Under the Kelly Agreement, Mr.&#160;Kelly is an at-will employee and his employment with Carisma can be terminated by Mr.&#160;Kelly or Carisma at any time and for any reason. Pursuant to the Kelly Agreement, Mr.&#160;Kelly&#8217;s annualized base salary may be adjusted from time to time in accordance with normal business practice and in the sole discretion of Carisma. He is eligible to receive an annual performance bonus of up to a specified&#160;percentage of his base salary for the applicable calendar year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Kelly Agreement, in the event of the termination of Mr.&#160;Kelly&#8217;s employment by Carisma without cause or by him for good reason, Mr.&#160;Kelly is entitled, subject to his execution of and compliance with a separation and release of claims agreement in Carisma&#8217;s favor and his continued compliance with certain restrictive covenants, to (i)&#160;continued payment of his base salary for a period of 12&#160;months following the date his release of claims becomes effective and (ii)&#160;payment of a pro-rated portion of his annual target discretionary bonus. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">362</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the date of the Kelly Agreement, the Carisma board of directors approved increases to Mr.&#160;Kelly&#8217;s annualized base salary to $416,000 for 2021 and $440,000 for 2022. The Carisma board of directors has authorized an annual performance bonus&#160;percentage of 40% for Mr.&#160;Kelly. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Agreement with Richard Morris</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;15, 2021, Carisma entered into an offer letter, or the Morris Agreement, with Mr.&#160;Morris in connection with his employment as Carisma&#8217;s Chief Financial Officer. Under the Morris Agreement, Mr.&#160;Morris is an at-will employee, and his employment with Carisma can be terminated by Mr.&#160;Morris or Carisma at any time and for any reason. Pursuant to the Morris Agreement, Mr.&#160;Morris&#8217;s annualized base salary may be adjusted from time to time in accordance with normal business practice and in the sole discretion of Carisma. He is eligible to receive an annual performance bonus of up to a specified&#160;percentage of his base salary for the applicable calendar year. The Morris Agreement also provided for an initial grant of options to purchase 174,326 shares of Carisma common stock, subject to the approval of the Carisma board of directors, or the Morris Grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Morris Agreement, in the event of the termination of Mr.&#160;Morris&#8217; employment by Carisma without cause or by him for good reason, Mr.&#160;Morris is entitled, subject to his execution of and compliance with a separation and release of claims agreement in Carisma&#8217;s favor and his continued compliance with certain restrictive covenants, to (i)&#160;continued payment of his base salary for a period of 12&#160;months following the date his release of claims becomes effective and (ii)&#160;payment of a pro-rated portion of his annual target discretionary bonus. In addition, in the event that Mr.&#160;Morris&#8217; employment is terminated by Carisma without cause or by Mr.&#160;Morris for good reason, within 12&#160;months following a change in control event (as defined in the Carisma Plan), then 100% of the unvested portion of the Morris Grant shall be accelerated and immediately vest and become exercisable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the Morris Agreement, the Carisma board of directors approved an annualized base salary of $390,000 for 2021 and an annual performance bonus&#160;percentage of 35% for Mr.&#160;Morris. In 2022, the Carisma board of directors authorized an increase in Mr.&#160;Morris&#8217; annualized base salary to $400,000. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Agreement with Michael Klichinsky</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;18, 2018, Carisma entered into an offer letter, or the Klichinsky Agreement, with Dr.&#160;Klichinsky in connection with his employment as Carisma&#8217;s Vice President of Discovery Research. Under the Klichinsky Agreement, Dr.&#160;Klichinsky is an at-will employee, and his employment with Carisma can be terminated by Dr.&#160;Klichinsky or Carisma at any time and for any reason. Pursuant to the Klichinsky Agreement, Dr.&#160;Klichinsky&#8217;s annualized base salary may be adjusted from time to time in accordance with normal business practice and in the sole discretion of Carisma. He is eligible to receive an annual performance bonus of up to a specified&#160;percentage of his base salary for the applicable calendar year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Klichinsky Agreement, in the event of the termination of Dr.&#160;Klichinsky&#8217;s employment by Carisma without cause or by him for good reason, Dr.&#160;Klichinsky is entitled, subject to his execution of and compliance with a separation and release of claims agreement in Carisma&#8217;s favor and his continued compliance with certain restrictive covenants, to (i)&#160;continued payment of his base salary for a period of 12&#160;months following the date his release of claims becomes effective and (ii)&#160;payment of a pro-rated portion of his annual target discretionary bonus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After the date of the Klichinsky Agreement, the Carisma board of directors approved an increase to Dr.&#160;Klichinsky&#8217;s annualized base salary to $300,000 for 2021. In 2022, Dr.&#160;Klichinsky was promoted to Chief Scientific Officer of Carisma, and the Carisma board of directors approved an increase to his annualized base salary to $340,000 and an increase of his annual performance bonus&#160;percentage to 35%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employee Invention, Non-Disclosure, Non-Competition and Non-Solicitation Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each of Carisma&#8217;s executive officers has entered into standard forms of agreements with respect to proprietary and confidential information, developments, non-competition, and non-solicitation. Under these agreements, each executive officer has agreed to protect Carisma&#8217;s confidential and proprietary information during and after the executive officer&#8217;s employment with Carisma, not to compete with Carisma </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">363</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSTOIP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">during his or her employment and for a period generally lasting for one year after the termination of his or her employment, and not to solicit Carisma&#8217;s employees, consultants, clients or customers during his or her employment and for a period generally lasting for one year after the termination of his or her employment. In addition, under these agreements, each executive officer has agreed that Carisma owns all developments and inventions that are developed by such executive officer within the scope of and during the period of his or her employment with Carisma that are related to Carisma&#8217;s business or research and development conducted or planned to be conducted by Carisma at the time such development is created. Each executive officer has also agreed to provide Carisma with a non-exclusive, royalty-free, perpetual license to use any prior inventions that such executive officer incorporates into inventions assigned to Carisma under these agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2017 Stock Incentive Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors adopted, and the Carisma stockholders approved, the Carisma Plan in September&#160;2017. The Carisma Plan was amended on June 22, 2018, December&#160;21, 2020, November&#160;9, 2021 and April&#160;7, 2022 to increase the number of shares of Carisma common stock available for issuance under the Carisma Plan. At the effective time of the merger, Sesen Bio will assume the Carisma Plan and each Carisma option in accordance with the terms of the Carisma Plan and the applicable stock option agreements evidencing by which such Carisma options but with such changes to such documents as Carisma and Sesen Bio mutually agree are appropriate to reflect the substitution of the Carisma option for a Sesen Bio option. The material terms of the Carisma Plan are summarized below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock&#160;units and other stock-based awards. Carisma&#8217;s employees, officers, directors, as well as its consultants and advisors, are eligible to receive awards under the Carisma Plan. Incentive stock options, however, may only be granted to Carisma employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Authorized Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As of January&#160;4, 2023, Carisma had reserved an aggregate of 2,664,018 shares of Carisma common stock for the issuance of awards under the Carisma Plan. As of January&#160;4, 2023, 1,802,246 stock options were issued and outstanding under the Carisma Plan to purchase shares of Carisma common stock at a weighted average exercise price of $1.92 per share and 748,753 shares of Carisma common stock remained available for the issuance of future awards under the Carisma Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan&#160;Administration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Pursuant to the terms of the Carisma Plan, the Carisma board of directors (or a committee delegated by the Carisma board of directors) administers the Carisma Plan and, subject to any limitations in the Carisma Plan, selects the recipients of awards and determines: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares of Carisma common stock covered by options and the dates upon which the options become exercisable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the type of options to be granted; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the duration of options, which may not be in excess of ten&#160;years; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the exercise price of options, which must be at least equal to the fair market value of a share of Carisma common stock on the date of grant; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares of Carisma common stock subject to any stock appreciation rights, restricted stock awards, restricted stock&#160;units or other stock-based awards and the terms and conditions of such awards, including conditions for repurchase, issue price and repurchase price (though the measurement price of stock appreciation rights must be at least equal to the fair market value of a share of Carisma common stock on the date of grant and the duration of such awards may not be in excess of ten&#160;years). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transferability of Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Carisma Plan prohibits awards from being sold, assigned, transferred, pledged, hypothecated or otherwise encumbered by the person to whom such awards are granted, either voluntarily or by operation of law, and, during the life of a participant in the Carisma Plan, awards are exercisable only by the participant, except that certain awards may be transferred to family members through gifts or domestic relations orders or to an executor or guardian upon the death or disability of the participant. Carisma is not required to recognize any such permitted transfer until such time as a permitted </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">364</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">transferee delivers to Carisma a written instrument, as a condition to such transfer, in form and substance satisfactory to Carisma confirming that such transferee shall be bound by all of the terms and conditions of the applicable award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effect of Certain Changes in Capitalization.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Upon the occurrence of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Carisma common stock other than an ordinary cash dividend, under the terms of the Carisma Plan, Carisma is required to equitably adjust (or make substitute awards, if applicable), in the manner determined by the Carisma board of directors: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and class of securities available under the Carisma Plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and class of securities and exercise price per share of each outstanding option; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the share and per-share provisions and the measurement price of each outstanding stock appreciation right; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares subject to and the repurchase price per share subject to each outstanding award of restricted stock; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the share and per-share related provisions and the purchase price, if any, of each outstanding restricted stock unit award and each outstanding other stock-based award. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effect of Certain Corporate Transactions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Upon the occurrence of a merger or other reorganization event (as defined in the Carisma Plan), the Carisma board of directors may, on such terms as the Carisma board of directors determines (except to the extent specifically provided otherwise in an applicable award agreement or other agreement between the participant and Carisma), take any one or more of the following actions pursuant to the Carisma Plan as to all or any (or any portion of) outstanding awards, other than awards of restricted stock: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that outstanding awards will be assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">upon written notice to a participant, provide that all of the participant&#8217;s unexercised and/or unvested awards will terminate immediately prior to the consummation of the reorganization event unless exercised by the participant (to the extent then exercisable) within a specified period following the date of the notice; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that outstanding awards will become exercisable, realizable or deliverable, or restrictions applicable to an award will lapse, in whole or in part, prior to or upon such reorganization event; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in the event of a reorganization event pursuant to which holders of shares of Carisma common stock will receive a cash payment for each share surrendered in the reorganization event, make or provide for a cash payment to participants with respect to each award held by a participant equal to (1)&#160;the number of shares of Carisma common stock subject to the vested portion of the award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such reorganization event) multiplied by (2)&#160;the excess, if any, (A)&#160;of the cash payment for each share of Carisma common stock surrendered in the reorganization event, over (B)&#160;the exercise, measurement or purchase price of such award and any applicable tax withholdings, in exchange for the termination of such award; and/or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that, in connection with Carisma&#8217;s liquidation or dissolution, awards will convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors is not obligated under the Carisma Plan to treat all awards, all awards held by a participant, or all awards of the same type, identically. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the case of certain restricted stock&#160;units, no assumption or substitution is permitted, and the restricted stock&#160;units will instead be settled in accordance with the terms of the applicable restricted stock unit agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">365</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the occurrence of a reorganization event other than Carisma&#8217;s liquidation or dissolution, Carisma&#8217;s repurchase and other rights with respect to outstanding awards of restricted stock will continue for the benefit of the succeeding company and will, unless the Carisma board of directors determines otherwise, apply to the cash, securities, or other property which the Carisma common stock was converted into or exchanged for pursuant to the reorganization event in the same manner and to the same extent as they applied to the shares of Carisma common stock subject to the restricted stock award. However, the Carisma board of directors may provide for the termination or deemed satisfaction of such repurchase or other rights under the restricted stock award agreement or in any other agreement between a participant and Carisma, either initially or by amendment, or provide for forfeiture of such restricted stock if issued at no cost. Upon Carisma&#8217;s liquidation or dissolution, except to the extent specifically provided to the contrary in the restricted stock award agreement or any other agreement between the participant and Carisma, all restrictions and conditions on all restricted stock awards then outstanding will automatically be deemed terminated or satisfied. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the provisions of the Carisma Plan described above related to reorganization events, except to the extent specifically provided to the contrary in the applicable award agreement or in any other agreement between a participant and Carisma: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each stock option granted under the Carisma Plan will be immediately exercisable in full if, on or prior to the first anniversary of the date of the consummation of the change in control event (as defined in the Carisma Plan), the participant&#39;s employment with Carisma or the acquiring or succeeding corporation is terminated for good reason (as defined in the Carisma Plan) by the participant or is terminated without cause (as defined in the Carisma Plan) by Carisma or the acquiring or succeeding corporation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each award of restricted stock or restricted stock units will immediately become free from all conditions or restrictions if, on or prior to the first anniversary of the date of the consummation of the change in control event, the participant&#39;s employment with Carisma or the acquiring or succeeding corporation is terminated for good reason by the participant or is terminated without cause by Carisma or the acquiring or succeeding corporation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors may specify in an award agreement at the time of the grant the effect of a change in control event on any stock appreciation right or other stock-based award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acceleration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;At any time, the Carisma board of directors may provide that any award under the Carisma Plan will become immediately exercisable in whole or in part, free of some or all restrictions or conditions, or otherwise realizable in whole or in part, as the case may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Amendment of Plan and Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Carisma board of directors may amend, suspend, or terminate the Carisma Plan or any portion thereof at any time, however if approval of the Carisma stockholders as to any modification or amendment is required under the Internal Revenue Code of 1986, as amended, with respect to incentive stock options, the Carisma board of directors may not effect such modification or amendment without such approval. The Carisma board of directors may amend, modify or terminate any outstanding award, however the participant&#8217;s consent to such action is required unless the Carisma board of directors determines that the action, taking into account any related action, does not materially and adversely affect the participant&#8217;s rights under the Carisma Plan or the change is otherwise permitted by the Carisma Plan. Furthermore, the Carisma board of directors may amend any outstanding award granted under the Carisma Plan to provide an exercise price per share that is lower than the then-current exercise price per share of such award or, without stockholder approval, cancel any outstanding award and grant in substitution therefor new awards under the Carisma Plan covering the same or a different number of shares of Carisma common stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No award may be granted under the Carisma Plan on or after the date that is ten&#160;years following the earlier of (i)&#160;the date on which the Carisma Plan was adopted by the Carisma board of directors or (ii)&#160;the date the Carisma Plan was approved by the Carisma stockholders, but all awards previously granted may extend beyond such date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">366</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCADCT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:207.5pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Payments to Named Executive Officers Upon Termination or Change in Control</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma named executive officers are entitled to certain payments upon termination or a change in control as set forth above under the sections entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Employment Agreements with Named Executive Officers</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;&#8212;&#160;</font><font style="font-style:italic;letter-spacing:0.2pt;">2017 Stock Incentive Plan&#8201;&#8212;&#8201;Effect of Certain Corporate Transactions</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below shows all compensation to non-employee directors of Carisma during the year ended December&#160;31, 2022. </font>
        </div>
        <table style="width:456pt;height:107.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:274.38pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees Earned or Paid </font>
                <br >
                <font style="letter-spacing:-0.16pt;">in Cash ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:274.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Margarita Chavez</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:274.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">75,000<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:19.655pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.43pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Ms. Chavez is not expected to serve as a director of the combined company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As of December 31, 2022, the aggregate number of shares of the Carisma common stock subject to outstanding option awards for each non-employee director was as follows: Mr. Morrison, 51,332 shares; and Mr. Zweifach, 97,200 shares. These amounts reflect the aggregate grant date fair value of Carisma options previously awarded, computed in accordance with the provisions of ASC Topic&#160;718. See Note 3 to Carisma&#8217;s consolidated financial statements appearing at the end of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus regarding assumptions underlying the valuation of option awards. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents fees paid in connection with Mr. Zweifach&#8217;s service as Chair of the Carisma board of directors for the year ended December&#160;31, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2022, Carisma did not provide any additional compensation to Mr.&#160;Kelly, its President and Chief Executive Officer, for his service as a director. Mr.&#160;Kelly&#8217;s compensation as a named executive officer is set forth above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation&#8201;&#8212;&#8201;Summary Compensation Table</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">367</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tRPTO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RELATED PARTY TRANSACTIONS OF DIRECTORS AND</font>
          <br >
          <font style="letter-spacing:-0.2pt;">EXECUTIVE OFFICERS OF THE COMBINED COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the compensation arrangements, including employment, termination of employment and change in control arrangements, with Sesen Bio&#8217;s and Carisma&#8217;s directors and executive officers, including those discussed in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Management Following the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on pages <a href="#tMFTM">342</a>, <a href="#tSBEC">349</a> and <a href="#tCEC">360</a>, respectively, of this proxy statement/prospectus, the following is a description of each transaction occurring since January&#160;1, 2019 and any currently proposed transactions in which: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">either Sesen Bio or Carisma was or is to be a participant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of Sesen Bio&#8217;s or Carisma&#8217;s the total assets at year end for the last two completed fiscal&#160;years; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any director, executive officer, holder of more than 5% of the voting securities of Sesen Bio, Carisma, or an affiliate or immediate family member of the foregoing persons, had or will have a direct or indirect material interest. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Manufacturing and Office Lease</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio leases a manufacturing, laboratory, and office facility in Winnipeg, Manitoba, from an affiliate of Leslie Dan, a former director of Sesen Bio who retired from the Sesen Bio board of directors in July&#160;2019, under a two-year renewable lease through September&#160;2022 with a right to renew the lease for one subsequent three-year term. For the&#160;years ended December&#160;31, 2021, 2020 and 2019, Sesen Bio had a rent expense for this facility of $327,000, $301,000 and $320,000, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Protoden License</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is party to an intellectual property license agreement under which Sesen Bio pays fees to Protoden Technologies Inc., or Protoden, a company owned by an affiliate of Mr.&#160;Dan. Pursuant to the agreement, Sesen Bio has an exclusive, perpetual, irrevocable and non-royalty bearing license, with the right to sublicense, under certain patents and technology to make, use and sell products that utilize such patents and technology. The annual fee is $100,000. Beginning on January&#160;1, 2025, the licenses granted to Sesen Bio will require no further payments to Protoden. Sesen Bio paid $100,000 under this license agreement to Protoden in each of the&#160;years ended December&#160;31, 2021, 2020 and 2019. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Private Placements of Securities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Series&#160;A Convertible Preferred Stock Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, November&#160;2018 and March&#160;2020, Carisma and CARISMA Therapeutics S.&#224; r.l., a soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e organized under the laws of Luxembourg and a subsidiary of Carisma, or Carisma Europe, as applicable, issued and sold an aggregate of 5,201,017 shares of the Carisma Series&#160;A preferred stock, $0.0001 par value per share and an aggregate of 937,501 Class&#160;B Shares, with a nominal value of one tenth of one eurocent (EUR 0.001), of Carisma Europe, or the Class&#160;B exchangeable shares, of which (i)&#160;4,701,925 shares of Series&#160;A preferred stock and all of the Class&#160;B exchangeable shares were sold at a price per share of $10.40 in cash, for an aggregate purchase price of $58,650,030.40 and (ii)&#160;499,092 shares of Carisma Series&#160;A preferred stock were sold at a price per share of $8.06 against payment by cancellation or conversion of indebtedness of Carisma to the applicable purchaser, including interest. Carisma also issued one share of Special Voting Preferred Stock of Carisma, $0.0001 par value per share, to the holder of the Class&#160;B exchangeable shares, which share shall be automatically cancelled at such time as all Class&#160;B exchangeable shares have been exchanged for capital stock of Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the aggregate number of shares of the Carisma Series&#160;A preferred stock and Class&#160;B exchangeable shares that were issued and sold to Carisma directors, executive officers and holders </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">368</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCARPREC123">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of more than 5% of Carisma voting securities and their affiliates in the transactions and the aggregate amount of consideration for such shares: </font>
        </div>
        <table style="width:456pt;height:122.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Purchaser</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Series&#160;A</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Class&#160;B</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exchangeable Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">947,762</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">8,500,003.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">250,647</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">11,000,017.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with IPG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">947,186</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">8,500,003.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">480,770</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">5,000,008.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">309,594</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,750,009.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">673,076</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">6,999,990.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">798,072</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">8,299,948.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">See section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOC">397</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information about shares held by these entities. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Series&#160;B Convertible Preferred Stock Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020 and February&#160;2021, Carisma and Carisma Europe, as applicable, issued and sold an aggregate of 3,499,866 shares of the Carisma Series&#160;B preferred stock, $0.0001 par value per share and an aggregate of 297,764 Class&#160;B-1 Shares, with a nominal value of one tenth of one eurocent (EUR 0.001), of Carisma Europe, or the Class&#160;B-1 exchangeable shares, all of which were sold at a price per share of $15.60 in cash, for an aggregate purchase price of $59,243,028.00. Carisma also issued one share of Carisma Series&#160;B special voting preferred stock, $0.0001 par value per share, to the holder of the Class&#160;B-1 exchangeable shares, which share shall be automatically cancelled at such time as all Class&#160;B-1 exchangeable shares have been exchanged for capital stock of Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the aggregate number of shares of the Carisma Series&#160;B preferred stock and Class&#160;B-1 exchangeable shares that were issued and sold to Carisma directors, executive officers and holders of more than 5% of Carisma voting securities and their affiliates in the transactions and the aggregate amount of consideration for such shares: </font>
        </div>
        <table style="width:456pt;height:152.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Purchaser</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Series&#160;B</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Class&#160;B-1</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exchangeable Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">256,398</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">3,999,808.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,410</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">99,996.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">4,645,118.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with IPG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">577,120</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">9,003,072.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">134,609</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,099,900.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">961,492</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">14,999,275.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">170,131</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,654,043.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">168,681</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,631,423.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,007</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">3,120,109.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.4pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">See section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOC">397</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information about shares held by these entities. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Carisma Pre-Closing Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein in connection with the Carisma pre-closing financing. Pursuant to the Subscription Agreement, the investors agreed to purchase an aggregate of 1,964,101 shares of Carisma common stock, at a price of $15.60 per share, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">369</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for aggregate gross proceeds of $30.6&#160;million. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the merger as well as certain other conditions. Seven of the investors or their affiliates are beneficial holders of more than 5% of Carisma&#8217;s capital stock, and the table below sets forth the number of shares of Carisma common stock expected to be purchased by such holders at the closing of the Carisma pre-closing financing: </font>
        </div>
        <table style="width:416pt;height:122.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Purchaser</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">243,590</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">3,800,004.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">303,205</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">4,729,998.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">160,256</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">2,499,993.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">205,128</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">3,199,996.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">179,487</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">2,799,997.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">44,872</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">700,003.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">211,538</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">3,299,992.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">See section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOC">397</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information about shares held by these entities. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has agreed to enter into a registration rights agreement with the investors party to the subscription agreement to provide for the registration of the resale of the shares of common stock purchased by such investors in connection with the Carisma pre-closing financing. The registration rights agreement will also provide these investors rights to require Carisma to register additional shares held by such investors under specified circumstances and to participate in future registrations of securities by Carisma under specified circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Agreements with Carisma Stockholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investor Rights Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma and Carisma Europe entered into an amended and restated investor rights agreement, or the Investor Rights Agreement, with certain holders of Carisma common stock, the Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including certain holders of 5% of Carisma&#8217;s capital stock, and including certain affiliates of Carisma&#8217;s directors and their affiliates. The Investor Rights Agreement provides such holders with certain registration rights, including the right to demand that Carisma file a registration statement or request that their shares be covered by a registration statement that Carisma is otherwise filing. The Investor Rights Agreement also provides certain major investors with certain information and observer rights. The Investor Rights Agreement is expected to be terminated in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Voting Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma and Carisma Europe entered into an amended and restated voting agreement, or the Voting Agreement, with certain holders of Carisma common stock, Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including certain holders of 5% of Carisma&#8217;s capital stock, and including certain of Carisma&#8217;s directors and their affiliates. Pursuant to the Voting Agreement, such holders party thereto agreed to vote their shares in favor of the election of certain directors and specified transactions approved by the requisite majority of the shares of voting capital stock held by such holders. The Voting Agreement is expected to be terminated in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Right of First Refusal and Co-Sale Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma entered into an amended and restated right of first refusal and co-sale agreement, or the ROFR Agreement, with certain holders of Carisma common stock, the Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">370</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:140pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">certain holders of 5% of its capital stock, and including certain of Carisma&#8217;s directors and their affiliates. Pursuant to the ROFR Agreement, Carisma has a right of first refusal in respect of certain sales of securities by certain holders of its capital stock. To the extent Carisma does not exercise such right in full, certain holders of its capital stock are granted certain rights of first refusal and co-sale in respect of such sales. The ROFR Agreement is expected to be terminated in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Share Exchange and Voting Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma and Carisma Europe entered into an amended and restated share exchange and voting agreement, or the Share Exchange Agreement, with certain holders of the Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including certain holders of 5% of its capital stock, and including certain of Carisma&#8217;s directors and their affiliates. The Share Exchange Agreement provides for the exchange of the Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares for shares of Series&#160;A preferred stock and Series&#160;B preferred stock, respectively, either voluntarily or automatically, upon certain circumstances as set forth therein. In connection with the closing of the merger, the Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares will be exchanged into Carisma preferred stock, and the Share Exchange Agreement will terminate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2017, Carisma entered into the Penn License Agreement with Penn. Pursuant to the Penn License Agreement, Carisma is responsible for paying Penn an annual license maintenance fee in the low tens of thousands of dollars, payable until Carisma&#8217;s first payment of a royalty. Carisma is required to pay Penn up to $10.9&#160;million per product in development and regulatory milestone payments, up to $30.0&#160;million per product in commercial milestone payments, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. Penn is a holder of 5% or more of the Carisma capital stock. For additional detail on the Penn License Agreement see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Business&#8201;&#8212;&#8201;University of Pennsylvania License Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tUNPLA">291</a> of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that Carisma will provide indemnification, and advancement of expenses to, directors and officers to the fullest extent permitted by applicable law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Policies for Approval of Related Party Transactions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not have a written policy regarding the review and approval of related person transactions. Nevertheless, with respect to such transactions, it has been the practice of the Carisma board of directors to consider the nature of and business reasons for such transactions, how the terms of such transactions compared to those which might be obtained from unaffiliated third parties and whether such transactions were otherwise fair to and in the best interests of, or not contrary to, Carisma&#8217;s best interests.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">371</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tUPFC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, Sesen Bio, Merger Sub, and Carisma entered into the Original Merger Agreement (as amended by the Merger Agreement Amendment dated as of December&#160;29, 2022, the Merger Agreement) pursuant to which, among other things, and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma continuing as a wholly-owned subsidiary of Sesen Bio and the surviving corporation of the merger. At the effective time of the merger, Sesen Bio will change its name to &#8220;Carisma Therapeutics Inc.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement in connection with the Carisma pre-closing financing, pursuant to which certain investors agreed to purchase shares of Carisma common stock at an aggregate purchase price of $30.6&#160;million. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. The shares of Carisma common stock issued in the Carisma pre-closing financing will be converted into shares of Sesen Bio common stock in the merger in accordance with the exchange ratio. As of immediately after the effective time of the merger, the Carisma convertible note will automatically convert into a number of shares of Sesen Bio common stock calculated in accordance with the terms of the Carisma convertible note and based on the exchange ratio for the conversion of Carisma capital stock into Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will enter into the CVR Agreement with a rights agent pursuant to which Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive one CVR for each outstanding share of Sesen Bio common stock held by such stockholders on such date. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of certain proceeds payable by Roche, if any, pursuant to the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, subject to certain customary deductions, including for expenses and taxes. The CVRs will not have any voting or dividend rights, will not represent any equity or ownership interest in Sesen Bio or its subsidiaries, and interest will not accrue on any amounts payable on the CVRs. Prior to the effective time, Sesen Bio will declare a pre-closing dividend to its common stockholders of record consisting of (a)&#160;one CVR for each outstanding share of Sesen Bio common stock held by such stockholder as of such date, representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the CVR Agreement and (b)&#160;a special cash dividend expected to be approximately $70.0&#160;million in the aggregate, subject to Sesen Bio&#8217;s estimated net cash as of the closing of the merger being greater than or equal to $75.0 million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the effective time of the merger, each outstanding share of Carisma capital stock, including shares of Carisma common stock issued in connection with the Carisma pre-closing financing, will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio. The exchange ratio was estimated at the time of the execution of the Merger Agreement Amendment on December&#160;29, 2022 to be 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock and is subject to adjustment prior to the closing for, among other things, Sesen Bio&#8217;s net cash at the cash determination time. Because Sesen Bio&#8217;s final net cash will not be determined until the closing, and because the number of shares of Sesen Bio common stock issuable to Carisma stockholders is determined based on, among other things, Sesen Bio&#8217;s final net cash, Sesen Bio stockholders cannot be certain of the exact number of shares that will be&#160;issued to Carisma stockholders when Sesen Bio stockholders vote on the proposals at the Sesen Bio special meeting. The exchange ratio referenced above is an estimate only and the final exchange ratio will be determined pursuant to a formula described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following selected unaudited pro&#160;forma condensed combined financial data gives effect to the (i)&#160;merger, (ii)&#160;the Carisma pre-closing financing, (iii)&#160;the automatic conversion of the Carisma convertible note, and (iv)&#160;the pre-closing dividend. Additionally, the unaudited pro&#160;forma condensed combined balance sheet reflects the proceeds received by Sesen Bio in connection with the Roche Asset Purchase Agreement in July&#160;2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">372</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:40pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The merger is accounted for as a reverse recapitalization under U.S. GAAP because the primary assets of Sesen Bio are cash, cash equivalents, and marketable securities. For financial reporting purposes, Carisma has been determined to be the accounting acquirer based upon the terms of the merger and other factors including: (i)&#160;Carisma stockholders and other persons holding securities that are convertible into Carisma common stock are expected to own approximately 74.8% of the fully diluted closing Sesen Bio common stock immediately following the effective time of the merger (based on estimates made at the time of the execution of the Merger Agreement), (ii)&#160;Carisma will hold the majority (six of seven) of board seats of the combined company, and (iii)&#160;Carisma&#8217;s management will hold all key positions in the management of the combined company. The &#8220;fully diluted closing Sesen Bio common stock&#8221; as used herein means (x)&#160;the number of outstanding shares of Sesen Bio common stock, which amount excludes the shares of Sesen Bio common stock available for issuance under the 2014 Incentive Plan and the 2009 Incentive Plan, as well as inducement grants made outside of the Sesen Bio stockholder-approved plans and out-of-the-money Sesen Bio options, </font><font style="font-style:italic;letter-spacing:0.2pt;">plus</font><font style="letter-spacing:0.2pt;"> (y)&#160;the number of outstanding shares of Carisma common stock, which amount includes the shares of Carisma common stock available for issuance under the Carisma Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial information was prepared in accordance with Article&#160;11 of Regulation&#160;S-X. The Sesen Bio and Carisma unaudited pro&#160;forma condensed combined balance sheet data assume that the merger took place on September&#160;30, 2022, and combines the Sesen Bio and Carisma historical balance sheets at September&#160;30, 2022. The Sesen Bio and Carisma unaudited pro&#160;forma condensed combined statements of operations data assume that the merger took place as of January&#160;1, 2021 and combines the historical results of Sesen Bio and Carisma for the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021. The historical financial statements of Sesen Bio and Carisma, which are included in this proxy statement/prospectus, have been adjusted to give pro&#160;forma effect to events that are (i)&#160;directly attributable to the merger, (ii)&#160;factually supportable, and (iii)&#160;with respect to the statements of operations, expected to have a continuing impact on the combined results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements are based on the assumptions and adjustments that are described in the accompanying notes. The unaudited pro&#160;forma condensed combined financial statements and pro&#160;forma adjustments have been prepared based on preliminary estimates of fair value of assets acquired and liabilities assumed. A final determination of these estimated fair values will be based on the actual net tangible assets of Sesen Bio that exist as of the date of completion of the merger. Differences between these preliminary estimates and the final fair value of assets and liabilities acquired may occur and these differences could have a material impact on the accompanying unaudited pro&#160;forma condensed combined financial statements and the combined company&#8217;s future results of operations and financial position. The actual amounts recorded as of the completion of the merger may differ materially from the information presented in these unaudited pro&#160;forma condensed combined financial statements as a result of the amount of cash used by Sesen Bio&#8217;s operations between the signing of the Merger Agreement and the closing of the merger; the timing of the closing of the merger; and other changes in Sesen Bio&#8217;s assets and liabilities that occur prior to the completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements do not give effect to the potential impact of current financial conditions, regulatory matters, operating efficiencies or other savings or expenses that may be associated with the merger. The unaudited pro&#160;forma condensed combined financial statements have been prepared for illustrative purposes only and are not necessarily indicative of the financial position or results of operations in future periods or the results that actually would have been realized had Sesen Bio and Carisma been a combined company during the specified period. The unaudited pro&#160;forma condensed combined financial statements, including the notes thereto, should be read in conjunction with the separate historical audited financial statements of Sesen Bio and Carisma for the year ended December&#160;31, 2021 and the unaudited condensed financial statements of Sesen Bio and Carisma for the nine&#160;months ended September&#160;30, 2022 included elsewhere in this proxy statement/prospectus. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">373</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Pro Forma Condensed Combined Balance Sheet </font>
          <br >
          <font style="letter-spacing:-0.2pt;">As of September&#160;30, 2022 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:570.17pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:247.49pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">CARISMA </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transactions </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro Forma </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Combined </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.17pt 0pt 0.69pt 0pt; width:247.49pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">ASSETS</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.42pt 0pt 0.69pt 0pt; width:247.49pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">Current assets</font><font style="font-weight:normal;letter-spacing:0.18pt;">: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">28,943</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,107</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">A</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">37,257</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Short-term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">41,705</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">106,427</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">148,132</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accounts receivable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,297</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,297</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:1.24pt 0pt 0.965pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.77pt; margin-bottom:-0.499999999999994pt;">
                <font style="letter-spacing:0.18pt;">Prepaid expenses and other current </font>
                <br >
                <font style="letter-spacing:0.18pt;">assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">2,290</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">527</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">2,817</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.18pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.18pt;">Total current assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">72,938</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">192,358</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">202,503</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.44pt 0pt 0.67pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.44pt 0pt 0.67pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,336</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,336</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.44pt 0pt 0.67pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,677</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,677</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.42pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Right of use assets&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">6,121</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">6,121</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.18pt 0pt 2.305pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:18pt;">
                <font style="letter-spacing:-0.18pt;">Total assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">87,736</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">199,724</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">224,667</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:247.49pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:-0.18pt;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLERS&#8217; EQUITY (DEFICIT)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">Current liabilities</font><font style="font-weight:normal;letter-spacing:0.18pt;">: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,084</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">514</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,599</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,997</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">33,800</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">B</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">39,926</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Deferred revenues </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,230</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,230</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.46pt 0pt 0.65pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,184</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,184</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.46pt 0pt 0.65pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,006</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,006</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.46pt 0pt 0.65pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Convertible promissory notes </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">33,175</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(33,175<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">C</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.44pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">157</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">381</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">538</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.22pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.18pt;">Total current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">53,834</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">34,695</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(36,046<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,483</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.47pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.47pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Deferred revenues, noncurrent </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.47pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,189</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(5,189<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">C</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.48pt 0pt 0.63pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Operating lease liabilities, noncurrent </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,003</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,003</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.48pt 0pt 0.63pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Finance lease liabilities, noncurrent </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">703</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">703</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.46pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Other noncurrent liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">307</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">307</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.21pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.18pt;">Total liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">106,036</div>
            </td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">34,695</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(41,235<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">D</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">99,496</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.22pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(107,808<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.24pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
              <font style="letter-spacing:-0.18pt;">Stockholders&#8217; equity (deficit):</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.49pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Common stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">596</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">798</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.49pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,141</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">493,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(225,920<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">268,850</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.97000000000003pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.49pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accumulated other comprehensive income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.48pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:9pt;">
                <font style="letter-spacing:0.18pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(141,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(328,567<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">325,734</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(144,317<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.05pt 0pt 0.5pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Total stockholders&#8217; equity (deficit) attributable to Carisma and </font>
                <br >
                <font style="letter-spacing:0.18pt;">Sesen Bio </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(140,503<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">165,029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">100,645</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">125,171</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.3pt 0pt 0.965pt 0pt; width:247.49pt;text-align:left;">
              <div style="margin-left:18pt; text-indent:-9pt; line-height:10.77pt; margin-bottom:-0.499999999999994pt;">
                <font style="letter-spacing:0.18pt;">Equity attributable to noncontrolling </font>
                <br >
                <font style="letter-spacing:0.18pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(14,395<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.965pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.965pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">F</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.23pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.18pt;">Total stockholders&#8217; equity (deficit)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(126,108<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">165,029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">86,250</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">125,171</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.05pt 0pt 1.715pt 0pt; width:247.49pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt; line-height:10.77pt; margin-bottom:-0.499999999999994pt;">
                <font style="letter-spacing:-0.18pt;">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">87,736</td>
            <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">199,724</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">224,667</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited pro&#160;forma condensed combined financial statements </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">374</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:218pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unaudited Pro Forma Condensed Combined Statements of Operations </font>
          <br >
          <font style="letter-spacing:-0.2pt;">For the Nine Months Ended September&#160;30, 2022 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:339pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:176.53pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">CARISMA</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Transaction </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro Forma </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Combined </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,103</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">I</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">6,103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">38,536</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">37,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">76,172</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">8,407</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">32,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">41,112</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">46,943</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">57,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">103,995</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,052<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(97,892<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Non-operating income (expense): </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of derivative </font>
                <br >
                <font style="letter-spacing:0.2pt;">liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,369</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">G</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income (expense), net </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,278<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,551</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">G</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss before income taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,920</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">96,752</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">3,920</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">92,877</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40.16<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.12<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,108</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">596,215</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">H</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">797,124</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited pro&#160;forma condensed combined financial statements </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">375</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:245pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unaudited Pro Forma Condensed Combined Statements of Operations </font>
          <br >
          <font style="letter-spacing:-0.2pt;">For the Year Ended December&#160;31, 2021 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:312pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:176.53pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">CARISMA </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Transaction </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro Forma </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Combined </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3pt; text-align:right; white-space:nowrap;">J</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating Expenses: </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">34,387</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,312</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">59,699</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,407</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,393</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">35,800</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,794</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">35,093</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">75,887</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,794<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,549<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(69,343<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Non-operating income (expense): </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss before income taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(69,393<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(61,120<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(37.62<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.00<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.08<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,084</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">182,323</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">607,511</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">H</td>
            <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">790,918</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited pro&#160;forma condensed combined financial statements </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">376</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Description of Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Merger Transaction</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, Sesen Bio and Carisma entered into the Original Merger Agreement, as amended by the First Amendment thereto on December&#160;29, 2022, pursuant to which a wholly-owned subsidiary of Sesen Bio will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio. After completion of the merger, Sesen Bio is expected to be renamed &#8220;Carisma Therapeutics Inc.&#8221; and to trade under the symbol &#8220;CARM.&#8221; As of October&#160;14, 2022, the Sesen Bio common stock is listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the effective time of the merger, each outstanding share of Carisma capital stock (including shares of Carisma common stock issued in connection with the Carisma pre-closing financing) will be converted into the right to receive shares of Sesen Bio common stock equal to the exchange ratio. Based on estimates made at the time of the Merger Agreement, the exchange ratio was initially estimated to be 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock and is subject to adjustment prior to the closing. Among other things, the exchange ratio will be adjusted to the extent that Sesen Bio&#8217;s net cash at closing is less than or greater than $75.0&#160;million and based on the amount of the Carisma pre-closing financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio currently estimates, assuming the closing of the merger occurred on December&#160;31, 2022, that (i)&#160;it would have approximately $75.0&#160;million in net cash immediately prior to closing, (ii)&#160;the Carisma pre-closing financing amount will be $30.6&#160;million, (iii)&#160;the outstanding shares of Sesen Bio common stock, Sesen Bio RSUs, Sesen Bio options and Sesen Bio warrants as of the closing will be equal to 222,944,963 and (iv)&#160;the outstanding shares of Carisma capital stock as of the closing on a fully diluted and as-converted basis will be equal to 14,855,514. Accordingly, it is currently estimated that the exchange ratio at closing will be 37.7924 and, based solely on such exchange ratio, at closing: (a)&#160;Carisma stockholders as of immediately prior to the merger (not including the shares of Carisma common stock issued in the Carisma pre-closing financing) are expected to own approximately 66.4% of the fully diluted closing Sesen Bio common stock, (b)&#160;the shares of Carisma common stock issued in the Carisma pre-closing financing to Carisma stockholders as of immediately prior to the merger are expected to represent approximately 8.4% of the fully diluted closing Sesen Bio common stock, (c)&#160;the Sesen Bio stockholders as of immediately prior to the merger (excluding for this purpose certain out-of-the-money Sesen Bio options) are expected to own approximately 25.2% of the fully diluted closing Sesen Bio common stock, (d)&#160;the shares of Sesen Bio common stock issued upon the conversion of the Carisma convertible note are expected to represent approximately 11.3% of the fully diluted closing Sesen Bio common stock, and (e)&#160;the shares of Carisma capital stock available for issuance under the Carisma Plan as of immediately prior to the merger are expected to represent approximately 10.7% of the fully diluted closing Sesen Bio common stock, in each case, subject to adjustment of the exchange ratio as set forth in the Merger Agreement and described herein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because Sesen Bio&#8217;s final net cash will not be determined until the closing, Sesen Bio stockholders cannot be certain of the exact number of shares that will be issued to Carisma stockholders when Sesen Bio stockholders vote on the proposals at the Sesen Bio special meeting. The exchange ratio referenced above is an estimate only and the final exchange ratio will be determined pursuant to a formula described in more detail in the Merger Agreement and in this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the effective time of the merger, each Carisma option that is outstanding and unexercised immediately prior to the effective time granted under the Carisma Plan, or otherwise, whether or not vested, will be, along with the Carisma Plan, assumed by Sesen Bio and will become an option to purchase solely that number of shares of Sesen Bio common stock equal to the product obtained by multiplying (i)&#160;the number of shares of Carisma common stock by (ii)&#160;the exchange ratio, and rounding the resulting number down to the nearest whole number of shares of Sesen Bio common stock. The per share exercise price for Sesen Bio common stock issuable upon exercise of each Carisma option assumed shall be determined by dividing (a)&#160;the per share exercise price of Carisma common stock by (b)&#160;the exchange ratio and rounding the resulting exercise price up to the nearest whole cent. Any restriction on the exercise of any Carisma option </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">377</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">assumed will continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Carisma option shall otherwise remain unchanged. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-Closing Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a condition of the Merger Agreement, certain investors have entered into the subscription agreement with Carisma pursuant to which such investors have agreed, subject to the terms and conditions of the subscription agreement, to purchase shares of Carisma common stock prior to closing for an aggregate purchase price of $30.6&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-Closing Dividend</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will declare a pre-closing dividend to its stockholders consisting of the right to receive contingent payments as discussed in greater detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus and a special cash dividend that is expected to be approximately $70.0&#160;million in the aggregate, subject to Sesen Bio&#8217;s estimated net cash as of the closing of the merger being greater than or equal to $75.0 million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Conversion of Carisma Convertible Note</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon completion of the merger, Carisma&#8217;s $35.0&#160;million convertible note and accrued interest will convert into shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Contingent Value Rights Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will enter into the CVR Agreement with a rights agent pursuant to which Sesen Bio stockholders will receive one CVR for each share of Sesen Bio common stock held. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of certain proceeds payable by Roche, if any, pursuant to the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum. The CVR will be recognized when the achievement of the milestone payment becomes probable. The CVRs will not have any voting or dividend rights and will not represent any equity or ownership interest in Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sesen Bio Sale of Legacy Technology to Roche</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio executed the Roche Asset Purchase Agreement pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio. Sesen Bio received an upfront payment from Roche of $40.0&#160;million upon execution of the Roche Asset Purchase Agreement. In addition, Sesen Bio is eligible to receive an additional $30.0&#160;million payment from Roche upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a defined indication if initiated prior to December&#160;31, 2026 which will be paid to Sesen Bio stockholders through the CVR Agreement. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Basis of Presentation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements were prepared in accordance with the regulations of the SEC. The unaudited pro&#160;forma condensed combined balance sheet as of September&#160;30, 2022 is presented as if the merger had been completed on September&#160;30, 2022. The unaudited pro&#160;forma condensed combined statements of operations for the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021 assumes that the merger occurred on January&#160;1, 2021, and combines the historical results of Carisma and Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, the unaudited pro&#160;forma condensed combined balance sheet and statements of operations data reflect the other transactions that will have occurred at or prior to the completion of the merger. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">378</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For accounting purposes, Carisma is considered to be the acquiring company and the merger will be accounted for as a reverse recapitalization of Sesen Bio by Carisma because at the closing of the merger, the primary pre-combination assets of Sesen Bio will be cash, cash equivalents and marketable securities. The final exchange ratio will be determined based on a net cash calculation prior to the closing. Sesen Bio currently estimates that it will have approximately $75.0&#160;million in net cash immediately prior to the closing of the merger, assuming for this purpose that the closing of the merger occurred on December&#160;31, 2022. The exchange ratio will be adjusted dollar-for-dollar by the amount that the net cash amount is less than $75.0&#160;million. The pro&#160;forma financial statements reflect Sesen Bio management&#8217;s estimates of the fair value of Sesen Bio&#8217;s net assets that will be contributed to Carisma as part of the merger. However, the actual exchange ratio will vary based on the net cash calculation prior to the closing as described above and that difference could be material. A 10% decrease in Sesen Bio&#8217;s net cash would increase the exchange ratio by 9.1%. A 10% increase in Sesen Bio&#8217;s net cash could decrease the exchange ratio by 7.7%. As such, the estimated exchange ratio reflected in these unaudited pro&#160;forma condensed combined financial statements does not purport to represent what the actual exchange ratio will be when the merger is completed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Under reverse recapitalization accounting, the assets and liabilities of Sesen Bio will be recorded, as of the completion of the merger, at their fair values which are expected to approximate book values because of the short-term nature of the instruments. No goodwill or intangible assets are expected to be recognized. The historical financial statements of Sesen Bio and Carisma, which are provided elsewhere in this proxy statement/prospectus, have been adjusted to give pro&#160;forma effect to events that are (i)&#160;directly attributable to the merger, (ii)&#160;factually supportable, and (iii)&#160;with respect to the statements of operations, expected to have a continuing impact on the combined results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustments related to the Carisma pre-closing financing for aggregate cash proceeds of $30.6&#160;million and reflect the conversion of the Carisma convertible note into shares of Sesen Bio common stock effective as of immediately after the effective time of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements also give effect to the other transactions that are not directly attributable to the merger but are deemed relevant to the pro&#160;forma financial position and operations of the combined companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent there are significant changes to the business following completion of the merger, the assumptions and estimates set forth in the unaudited pro&#160;forma condensed combined financial statements could change significantly. Accordingly, the pro&#160;forma adjustments are subject to further adjustments as additional information becomes available and as additional analyses are conducted following the completion of the merger. There can be no assurances that these additional analyses will not result in material changes to the estimates of fair value. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">Pro Forma Adjustments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The pro&#160;forma adjustments were based on the preliminary information available at the time of the preparation of the unaudited pro&#160;forma condensed combined financial information. The unaudited pro&#160;forma condensed combined financial information, including the notes thereto, are qualified in their entirety by reference to, and should be read in conjunction with, the separate historical audited financial statements of Sesen Bio and Carisma for the year ended December&#160;31, 2021 and the unaudited condensed financial statements of Sesen Bio and Carisma for the nine&#160;months ended September&#160;30, 2022 included elsewhere in this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Merger Transaction Adjustments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">A</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reflects (i)&#160;approximately $30.6&#160;million in proceeds from the Carisma pre-closing financing, (ii)&#160;payment of a $70.0&#160;million special cash dividend (iii)&#160;payment of total estimated unpaid transaction costs and (iv)&#160;payment of severance costs upon consummation of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">379</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:208pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:114pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:265.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">CARISMA </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:265.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from Carisma pre-closing financing, net of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">30,640</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">30,640</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:265.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Special cash dividend payment to Sesen Bio stockholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:265.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payment of transaction costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(7,333<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(7,700<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(15,033<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:265.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payment of severance costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,400<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,400<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:265.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">23,307</td>
            <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(86,100<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">B</font>
          <br >
        </div>
        <div style=" margin-top:11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reflects payment of total estimated unpaid transaction costs as of September&#160;30, 2022 in connection with the merger and settlement of accrued interest upon conversion of the Carisma convertible note: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:72pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">CARISMA </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unpaid transaction costs as of September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(290<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,315<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued interest for Carisma convertible note </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(556<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(556<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(846<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">C</font>
          <br >
        </div>
        <div style=" margin-top:11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Settlement of the Carisma convertible note and related derivative liability through the issuance of Sesen Bio common stock upon completion of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">D</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Conversion of Carisma convertible preferred stock into common stock of the combined company upon completion of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">E</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To record the (i)&#160;exchange ratio adjustment to Carisma&#8217;s common stock outstanding, (ii)&#160;conversion of Carisma convertible preferred stock into common stock, (iii)&#160;the elimination of Carisma&#8217;s noncontrolling interest upon conversion of Carisma convertible preferred stock, (iv)&#160;sale of Carisma common stock, net of issuance costs, in connection with Carisma pre-closing financing, (v)&#160;automatic conversion of the Carisma convertible note, (vi)&#160;elimination of Sesen Bio&#8217;s historical equity carrying value, (vii)&#160;issuance of common stock upon the acceleration of unvested Sesen Bio RSUs and PSUs upon closing of the merger, (viii)&#160;special cash dividend payment to Sesen Bio stockholders, (ix)&#160;post-combination stock-based compensation expense for Sesen Bio options and Sesen Bio RSUs and (x)&#160;payment of transaction and severance costs: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">380</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:357pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:22.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:208.28pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">comprehensive</font>
                <br >
                <font style="letter-spacing:-0.16pt;">income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Noncontrolling</font>
                <br >
                <font style="letter-spacing:-0.16pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:208.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Adjustment to Carisma common stock outstanding in connection with the Exchange Ratio </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">42,422</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(43<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock upon conversion of Carisma convertible preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">341,209</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">341</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">107,467</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock upon conversion of Carisma noncontrolling interest </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">34,301</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">34</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,395<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock upon completion of Pre-Closing Financing </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">74,228</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">75</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">30,565</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">30,640</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock upon settlement of </font>
                <br >
                <font style="letter-spacing:0.2pt;">Carisma convertible promissory note, accrued </font>
                <br >
                <font style="letter-spacing:0.2pt;">interest and related derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">98,068</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">40,647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(1,825<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">38,920</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Elimination of Sesen Bio&#8217;s historical carrying values </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(328,802<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">328,567</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of shares of common stock of the continuing company to Sesen Bio shareholders</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4,695</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Special dividend payment to Sesen Bio shareholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Post-combination stock-based compensation costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,008</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(1,008<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Payment of transaction costs and severance expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(21,118<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(21,118<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:208.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma Adjustment </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">594,923</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">596</td>
            <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(225,920<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">325,734</td>
            <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,395<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">86,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:12pt;margin-bottom:97.64pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">F</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Issuance of common stock upon conversion of Carisma noncontrolling interests. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">G</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Elimination of interest expense and change in fair value of derivative liability associated with the Carisma convertible note and related derivative, respectively, that were settled upon completion of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">H</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The pro&#160;forma combined basic and diluted earnings per share have been adjusted to reflect the pro&#160;forma net loss for the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021. In addition, the number of shares used in calculating the pro&#160;forma combined basic and diluted net income per share has been adjusted to reflect the estimated total number of shares of common stock of the combined company that would be outstanding as of the closing. The following table sets forth the calculation of the pro&#160;forma weighted average number of common shares outstanding&#8201;&#8212;&#8201;basic and diluted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">381</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:353pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:180pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Effect of applying estimated exchange ratio to Carisma common stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,758</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">39,886</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Conversion of Carisma preferred stock and noncontrolling interest </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">375,510</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">370,200</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock in connection with Carisma pre-closing financing </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">74,228</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">74,228</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock upon settlement of Carisma convertible note, accrued interest and related derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">98,068</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">98,068</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of shares of common stock of the combined company to Sesen Bio stockholders </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">7,651</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">25,129</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">596,215</td>
            <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">607,511</td>
            <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other Transaction Adjustments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">I</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Elimination of one time payments received in connection with the Roche Asset Purchase Agreement in July&#160;2022 of $40.0&#160;million. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">J</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Elimination of development milestone revenue received from Roche during the year ended December&#160;31, 2021 related to the assets sold to Roche in July&#160;2022.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">382</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tDOSB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SESEN BIO CAPITAL STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following description of Sesen Bio&#8217;s capital stock is not complete and may not contain all the information you should consider before investing in Sesen Bio&#8217;s capital stock. This description is summarized from, and qualified in its entirety by reference to, the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws, which have been publicly filed with the SEC. See the section entitled &#8220;Where You Can Find More Information&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. The following information does not give effect to the proposed reverse stock split described in Proposal No. 2 in this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is authorized to issue up to 400,000,000 shares of common stock with a par value of $0.001 per share. As of January&#160;4, 2023, there were 202,759,043 shares of common stock outstanding and no shares of preferred stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rights of Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Voting Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Holders of Sesen Bio common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders. When a quorum is present at any meeting, a plurality of the votes properly cast for election to any office shall elect to such office and a majority of the votes properly cast upon any question other than an election to an office shall decide the question, except when a larger vote is required by law, by the Sesen Bio Certificate of Incorporation or by the Sesen Bio Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws do not provide for cumulative voting rights. Because of this, the holders of a majority of the shares of Sesen Bio common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they should so choose. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the preferences that may be applicable to any then outstanding preferred stock, the holders of outstanding Sesen Bio common stock are entitled to receive dividends, if any, as may be declared from time to time by the Sesen Bio board of directors out of legally available funds. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Liquidation Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event of Sesen Bio&#8217;s liquidation or dissolution, the holders of Sesen Bio common stock are entitled to receive proportionately all assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any holders of then outstanding preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The terms of Sesen Bio common stock do not include any preemptive, conversion or subscription rights, nor any redemption or sinking fund provisions. Sesen Bio common stock is not subject to future calls or assessments by Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors is authorized to issue up to 5,000,000 shares of preferred stock in one or more series, with such rights, preferences and privileges as shall be determined by the Sesen Bio board of directors. The rights, preferences and privileges of the holders of Sesen Bio common stock are subject to, and may be adversely affected by, the rights of shares of any series of preferred stock that Sesen Bio may classify and issue in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fully Paid and Nonassessable</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of Sesen Bio&#8217;s outstanding shares of common stock are fully paid and nonassessable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Options</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, there were 16,202,254 shares of Sesen Bio common stock issuable upon the exercise of outstanding Sesen Bio options, at a weighted-average exercise price of $1.83 per share. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Restricted Stock Units</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September 30, 2022, there were 4,695,007 shares of Sesen Bio common stock issuable upon the vesting and settlement of outstanding Sesen Bio RSUs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">383</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tANTIT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September 30, 2022, there were 198,535 shares of Sesen Bio common stock issuable upon the exercise of outstanding warrants, with a weighted-average exercise price of $3.57 per share. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anti-Takeover Effect of Sesen Bio&#8217;s Certificate of Incorporation and Bylaw Provisions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws contain provisions that could make it more difficult to complete an acquisition of Sesen Bio by means of a tender offer, a proxy contest or otherwise or the removal and replacement of its incumbent officers and directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Staggered Board; Removal of Directors.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws divide the Sesen Bio board of directors into three classes with staggered three-year terms. In addition, The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that directors may be removed only for cause and only by the affirmative vote of the holders of 75% of Sesen Bio common stock present in person or by proxy and entitled to vote. Under the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws, any vacancy on the Sesen Bio board of directors, including a vacancy resulting from an enlargement of the Sesen Bio board of directors, may be filled only by vote of a majority of Sesen Bio directors then in office. Furthermore, the Sesen Bio Certificate of Incorporation provides that the authorized number of directors may be changed only by the resolution of the Sesen Bio board of directors. The classification of the Sesen Bio board of directors and the limitations on the ability of Sesen Bio stockholders to remove directors, change the authorized number of directors and fill vacancies could make it more difficult for a third party to acquire, or discourage a third party from seeking to acquire, control of Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stockholder Action; Special Meeting of stockholders; Advance Notice Requirements for stockholder Proposals and Director Nominations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that any action required or permitted to be taken by Sesen Bio stockholders at an annual meeting or special meeting of stockholders may only be taken if it is properly brought before such meeting and may not be taken by written action in lieu of a meeting. The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws also provide that, except as otherwise required by law, special meetings of the stockholders can only be called by the chairman of the Sesen Bio board of directors, the Sesen Bio chief executive officer or the Sesen Bio board of directors. In addition, the Sesen Bio Bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of stockholders, including proposed nominations of candidates for election to the Sesen Bio board of directors. Stockholders at an annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the Sesen Bio board of directors, or by a stockholder of record on the record date for the meeting who is entitled to vote at the meeting and who has delivered timely written notice in proper form to the Sesen Bio corporate secretary of the stockholder&#8217;s intention to bring such business before the meeting. These provisions could have the effect of delaying until the next stockholder meeting stockholder actions that are favored by the holders of a majority of Sesen Bio outstanding voting securities. These provisions also could discourage a third party from making a tender offer for Sesen Bio common stock because even if the third party acquired a majority of Sesen Bio&#8217;s outstanding voting stock, it would be able to take action as a stockholder, such as electing new directors or approving a merger, only at a duly called stockholders meeting and not by written consent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Super-Majority Voting.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The DGCL provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation&#8217;s certificate of incorporation or bylaws unless a corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires a greater&#160;percentage. The Sesen Bio Bylaws may be amended or repealed by a majority vote of the Sesen Bio board of directors or the affirmative vote of the holders of at least 75% of the votes that all Sesen Bio stockholders would be entitled to cast in any annual election of directors. In addition, the affirmative vote of the holders of at least 75% of the votes that all Sesen Bio stockholders would be entitled to cast in any election of directors is required to amend or repeal or to adopt any provisions inconsistent with any of the provisions of the Sesen Bio Certificate of Incorporation described above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware Law.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Sesen Bio is subject to the provisions of Section&#160;203 of the DGCL. In general, Section&#160;203 prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">384</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:104pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">an &#8220;interested stockholder&#8221; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section&#160;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding upon consummation of the transaction, excluding for purposes of determining the number of shares outstanding (1)&#160;shares owned by persons who are directors and also officers and (2)&#160;shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">on or subsequent to the consummation of the transaction, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66-2/3% of the outstanding voting stock which is not owned by the interested stockholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;203 defines a business combination to include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any merger or consolidation involving the corporation and the interested stockholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, Section&#160;203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transfer agent and registrar for Sesen Bio common stock is Computershare Trust Company, Inc. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">385</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCORO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">COMPARISON OF RIGHTS OF HOLDERS OF SESEN BIO STOCK AND CARISMA STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Both Sesen Bio and Carisma are incorporated under the laws of the State of Delaware and, accordingly, the rights of the stockholders of each are currently, and will continue to be, governed by the DGCL. If the merger is completed, Carisma stockholders will become stockholders of Sesen Bio, and their rights will be governed by the DGCL, the Sesen Bio Bylaws and the Sesen Bio Certificate of Incorporation, as amended by the amendment thereto attached to this proxy statement/prospectus as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;">, assuming Proposal No. 2 is approved by Sesen Bio stockholders at the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below summarizes the material differences between the current rights of Carisma stockholders under the Carisma Certificate of Incorporation and the Carisma Bylaws, and the rights of Sesen Bio stockholders, post-merger, under the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws, each as amended, as applicable, and as in effect immediately following the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Sesen Bio and Carisma believe that the summary tables cover the material differences between the rights of their respective stockholders prior to the merger and the rights of Sesen Bio stockholders following the merger, these summary tables may not contain all of the information that is important to you. These summaries are not intended to be a complete discussion of the respective rights of Sesen Bio stockholders and Carisma stockholders and are qualified in their entirety by reference to the DGCL and the various documents of Sesen Bio and Carisma that are referred to in the summaries. You should carefully read this entire proxy statement/prospectus and the other documents referred to in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for a more complete understanding of the differences between being a stockholder of Sesen Bio or Carisma before the merger and being a stockholder of Sesen Bio after the merger. Sesen Bio has filed copies of the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws with the SEC and will send copies of the documents referred to in this proxy statement/prospectus to you upon your request. Carisma will also send copies of its documents referred to in this proxy statement/prospectus to you upon your request. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current Carisma Rights Versus Post-Merger Sesen Bio Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Elections; Voting; Procedural Matters</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Authorized Capital Stock </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation authorizes the issuance of up to 14,910,158 shares of common stock, par value $0.0001 per share, and 10,946,041 shares of preferred stock, par value of $0.0001 per share. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation authorizes the issuance of up to 400,000,000 shares of common stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Number of Directors </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that the number of directors that constitute the Carisma board of directors is established by the Carisma stockholders or the Carisma board of directors. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that the number of directors that constitute the Sesen Bio board of directors is established by the Sesen Bio board of directors. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Stockholder Nominations and Proposals </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Bylaws do not contain advance notice requirements for stockholder proposals. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Bylaws provide that in order for a stockholder to make a director nomination or propose business at an annual meeting of stockholders, the stockholder must give timely written notice to the Sesen Bio </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">386</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Secretary, which must be received not less than 90&#160;days nor more than 120&#160;days prior to the first anniversary of the preceding year&#8217;s annual meeting (with certain adjustments if the date of the annual meeting is advanced by more than 20&#160;days, or delayed by more than 60&#160;days, from the first anniversary of the preceding year&#8217;s annual meeting). </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Quorum </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Bylaws provide that the holders of a majority in voting power of the shares of the Carisma capital stock issued and outstanding and entitled to vote at the meeting, present in person, present by means of remote communication in a manner, if any, authorized by the Carisma board of directors in its sole discretion, or represented by proxy, shall constitute a quorum for the transaction of business. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Bylaws provide that the holders of a majority in voting power of the shares of Sesen Bio capital stock issued and outstanding and entitled to vote at the meeting, present in person, present by means of remote communication in a manner, if any, authorized by the Sesen Bio in its sole discretion, or represented by proxy, shall constitute a quorum for the transaction of business. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Structure of Board of Directors; Term of Directors; Election of Directors </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div>
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that the directors shall be elected at the annual meeting of stockholders. Each director holds office until the next annual meeting of stockholders or until a successor is elected and qualified, or until such director&#8217;s earlier death resignation or removal.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">The holders of record of the Carisma Series&#160;B preferred stock and Series&#160;B Special Voting preferred stock, exclusively and as a separate class, shall be entitled to elect one director, and the holders of record of the Carisma Series&#160;A preferred stock and Special Voting preferred stock, exclusively and together as a single class, shall be entitled to elect three directors. The holders of record of Carisma capital stock, exclusively and voting together as a single class, shall be entitled to elect the balance of the total number of directors. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide for the division of the Sesen Bio board of directors into three staggered classes. Each director shall serve for a term ending on the date of the third annual meeting of stockholders following the annual meeting of stockholders at which such director was elected, provided, however, that the term of each director shall continue until the election and qualification of such director&#8217;s successor and be subject to such director&#8217;s earlier death, resignation or removal. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">387</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Removal of Directors </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide for the removal of any one or more or all the directors, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except that directors elected by the holders of a particular class or series of stock may be removed without cause only by the vote of the holders of a majority of the outstanding shares of such class or series. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide for the removal of any of its directors only for cause and requires the affirmative vote of the holders of at least seventy-five&#160;percent of the votes which all the stockholders would be entitled to cast in any annual election of directors or class of directors. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Special Meetings </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Bylaws provide that special meetings of stockholders may be called at any time by only the Carisma board of directors, the Chair of the Carisma board of directors, the Carisma Chief Executive Officer, or the Carisma President, and may not be called by any other person or persons. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that a special meeting of stockholders may be called only by the Sesen Bio board of directors, the Chair of the Sesen Bio board of directors or the Sesen Bio Chief Executive Officer, and may not be called by any other person or persons. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Cumulative Voting </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that there shall be no cumulative voting. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that there shall be no cumulative voting. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Vacancies </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that, subject to the rights of holders of any series of Carisma preferred stock to elect directors, unless and until filled by the stockholders, any vacancy or newly-created directorship on the Carisma board of directors may be filled by vote of a majority of the directors then in office, although less than a quorum, or by a sole remaining director. A vacancy in any directorship filled by the holders of any class or series shall be filled only by vote or written consent in lieu of a meeting of the holders of such class or series or by any remaining director or directors elected by the holders of such class or series. A director elected to fill a vacancy shall be elected for the unexpired term of </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that any vacancy occurring on the Sesen Bio board of directors shall be filled only by vote of a majority of the directors then in office, although less than a quorum, or by a sole remaining director and shall not be filled by the stockholders. A director elected to fill a vacancy shall hold office until the next election of the class for which such director shall have been chosen, subject to the election and qualification of a successor and to such director&#8217;s earlier death, resignation or removal. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">388</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:5.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:144pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">such director&#8217;s predecessor in office, and a director chosen to fill a position resulting from a newly-created directorship shall hold office until the next annual meeting of stockholders and until a successor is elected and qualified, or until such director&#8217;s earlier death, resignation or removal. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Voting Stock </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144pt;">
              <div>
                <font style="letter-spacing:0.2pt;">Under the Carisma Certificate of Incorporation and the Carisma Bylaws, each stockholder shall have one vote for each share of stock entitled to vote held of record by such stockholder.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">Each holder of Carisma preferred stock shall be entitled to cast the number of votes equal to the number of whole shares of Carisma common stock into which such shares of preferred stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter; provided that each holder of the Carisma Special Voting preferred stock and Series&#160;B Special Voting preferred stock shall be entitled to cast the number of votes equal to the number of votes to which the holders of the Class&#160;B Exchangeable Shares and the Class&#160;B-1 Exchangeable Shares of CARISMA Therapeutics S.&#224; r.l., or Carisma Europe, respectively, would be entitled to cast if such exchangeable shares had, before the record date for such vote, been exchanged for shares of the applicable series of Carisma preferred stock pursuant to the terms of the Amended and Restated Share Exchange and Voting Agreement, dated December&#160;22, 2020, by and among Carisma, Carisma Europe and the holders of such exchangeable shares. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Under the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws, each stockholder shall at every meeting of the stockholders be entitled to one vote for each share of stock held by such stockholder. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">389</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Stockholder Action by Written Consent </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Under the Carisma Certificate of Incorporation and the Carisma Bylaws, any action required or permitted to be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote on such action were present and voted. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws provide that stockholders may not take any action by written consent in lieu of a meeting. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Notice of Stockholder Meeting </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Under the Carisma Bylaws, notice of each meeting of stockholders shall be given not less than 10 or more than 60&#160;days before the date of the meeting to each stockholder entitled to vote at such meeting. Without limiting the manner by which notice otherwise may be given to stockholders, any notice shall be effective if given by a form of electronic transmission consented to (in a manner consistent with the DGCL) by the stockholder to whom the notice is given. The notice of all meetings shall state the place, if any, date and time of the meeting and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting. The notice of a special meeting shall state, in addition, the purpose or purposes for which the meeting is called. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Under the Sesen Bio Bylaws, notice of each stockholder meeting must specify the place, date and time of the meeting and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting, and, in the case of a special meeting, the purpose(s) for which the meeting is called. Notice shall be given not less than 10 nor more than 60&#160;days before the date of the meeting to each stockholder entitled to vote at such meeting. Without limiting the manner by which notice otherwise may be given to stockholders, any notice shall be effective if given by a form of electronic transmission consented to (in a manner consistent with the DGCL) by the stockholder to whom the notice is given. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Conversion Rights and Protective Provisions </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that holders of Carisma preferred stock have the right to convert such shares into shares of Carisma common stock at any time at a conversion rate in accordance with the terms of the Carisma Certificate of Incorporation. In addition, upon </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation does not provide that stockholders have preemptive, conversion or other protective rights. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">390</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">either (i)&#160;the closing of the sale of shares of Carisma common stock in a firm-commitment underwritten public offering in which the price is at least $46.80 per share and which results in at least $50&#160;million of proceeds or (ii)&#160;the date and time, or the occurrence of an event, specified by vote or written consent in accordance with the terms of the Carisma Certificate of Incorporation, all outstanding shares of Carisma preferred stock will be converted into shares of Carisma common stock. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Right of First Refusal </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Pursuant to an Amended and Restated Right of First Refusal and Co-Sale Agreement, dated December&#160;22, 2020, or the ROFR Agreement, certain stockholders party to the ROFR Agreement, or a Key Holder, wishing to transfer any shares of Carisma capital stock must first provide Carisma with the right to purchase such shares. In such an event, if Carisma does not elect to exercise its right of first refusal in full, certain investors party to the ROFR Agreement, or the Investors, have a secondary right of first refusal to purchase all or any portion of the shares of Carisma common stock which are proposed for sale or transfer by the Key Holders. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio does not have a right of first refusal in place. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Right of Co-Sale </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Pursuant to the ROFR Agreement, each Investor has a right of co-sale with respect to any Carisma capital stock proposed to be transferred or sold by any Key Holder which is not earlier purchased by Carisma by exercise of its right of first refusal (as described above) or by any Investor by exercise of their secondary right of first refusal (as described above). </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio does not have a right of co-sale in place. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Right of First Offer </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Pursuant to an Amended and Restated Investor Rights Agreement, dated December&#160;22, </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio does not have a right of first offer place. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">391</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">2020, or the Investor Rights Agreement, if Carisma or Carisma Europe proposes to offer or sell certain new securities, Carisma and/or Carisma Europe, as applicable, must first offer such new securities to certain investors party to the Investor Rights Agreement. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Forum Selection </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that unless Carisma consents in writing to the selection of an alternative forum, the Court of Chancery in the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i)&#160;any derivative action or proceeding brought on behalf of Carisma, (ii)&#160;any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of Carisma to Carisma or Carisma stockholders, (iii)&#160;any action asserting a claim against Carisma, its directors, officers or employees arising pursuant to any provision of the DGCL or the Carisma Certificate of Incorporation or the Carisma Bylaws or (iv)&#160;any action asserting a claim against Carisma, its directors, officers or employees governed by the internal affairs doctrine. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws do not provide for a specific forum. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Registration Rights </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Under the Investor Rights Agreement, certain holders of Carisma capital stock that are party to the Investor Rights Agreement have certain registration rights, including the right to demand that Carisma file a registration statement, so called &#8220;demand&#8221; registration rights, or request that their shares be covered by a registration statement that Carisma is otherwise filing, so-called &#8220;piggyback&#8221; registration rights. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div>
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws do not provide registration rights to holders of Sesen Bio common stock. </font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">In connection with the closing of the Carsima pre-closing financing, the combined company has agreed to enter into a registration rights agreement to provide for the registration of the resale of the shares of common stock purchased by the investors in connection with the Carisma pre-closing financing. </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">392</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Indemnification of Officers and Directors and Advancement of Expenses; Limitation on Personal Liability</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Indemnification; Advancement of Expenses </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that Carisma shall provide indemnification of (and advancement of expenses to) directors, officers, and agents of Carisma (and any other persons to which the DGCL permits Carisma to provide indemnification), to the fullest extent permitted by applicable law through bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or otherwise, in excess of the indemnification and advancement otherwise permitted by Section&#160;145 of the DGCL. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div>
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that Sesen Bio shall indemnify its directors and officers if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Sesen Bio, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that Sesen Bio will pay the expenses incurred by or on behalf of an indemnitee in defending an action, suit, proceeding or investigation or any appeal therefrom in advance of its final disposition, provided, however, that such payment of expenses in advance of the final disposition of the proceeding will be made only upon receipt of an undertaking by or on behalf of the indemnitee to repay all amounts so advanced in the event that it shall ultimately be determined by final judicial decision from which there is no further right to appeal that the indemnitee is not entitled to be indemnified. </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Dividends</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">Declaration and Payment of Dividends </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation states that the dividend rights of the holders of Carisma common stock are subject to and qualified by the rights, powers, and preferences of the holders of the Carisma preferred stock. Carisma shall not declare, pay or set aside dividends on shares of any other class or series of Carisma capital stock (other than dividends on shares of Carisma common stock payable in shares of Carisma common stock) unless (in addition to obtaining any of the consents required in the Carisma </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that holders of Sesen Bio common stock are entitled to receive dividends as may be lawfully declared from time to time by the Sesen Bio board of directors. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">393</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Certificate of Incorporation) the holders of the Carisma Series&#160;A and Series&#160;B preferred stock receive certain dividends as set forth in the Carisma Certificate of Incorporation. The Carisma Special Voting preferred stock and Series&#160;B Special Voting preferred stock shall not be entitled to receive any dividends. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Amendments to Certificate of Incorporation or Bylaws</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">General Provisions </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div>
                <font style="letter-spacing:0.2pt;">Provisions of the Carisma Certificate of Incorporation may be amended, altered or repealed in the manner prescribed by the DGCL and the Carisma Certificate of Incorporation. The Carisma Certificate of Incorporation provides that the affirmative vote of the holders of at least two-thirds of the voting power represented by the outstanding shares of the Carisma preferred stock, voting together as a single class are required to authorize amend, waive, alter or repeal any provision of the Carisma Certificate of Incorporation or the Carisma Bylaws, in a manner that adversely affects the powers, preferences or rights of the Carisma preferred stock.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that the Carisma Bylaws may be altered, amended or repealed, in whole or in part, or new bylaws may be adopted by the Carisma board of directors or by the affirmative vote of the holders of a majority of the shares of the Carisma capital stock issued and outstanding and entitled to vote at any annual meeting of stockholders, or at any special meeting of stockholders, provided notice of such alteration, amendment, repeal or adoption of new bylaws shall have been stated in the notice of such special meeting. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div>
                <font style="letter-spacing:0.2pt;">Provisions of the Sesen Bio Certificate of Incorporation may be amended, altered or repealed in the manner prescribed by the DGCL and the Sesen Bio Certificate of Incorporation.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that the Sesen Bio board of directors has the power to amend, alter or repeal the Sesen Bio Bylaws by the affirmative vote of a majority of the directors present at any regular or special meeting of the Sesen Bio board of directors at which a quorum is present.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that the stockholders have the power to amend, alter or repeal the Sesen Bio Bylaws by the affirmative vote of the holders of at least seventy-five&#160;percent of the votes that all the stockholders would be entitled to cast in any annual election of directors or class of directors.</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">394</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tPSOS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL STOCKHOLDERS OF SESEN BIO</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except where specifically noted, the following information and all of the information in this proxy statement/prospectus does not give effect to the proposed reverse stock split. The table below sets forth the beneficial ownership of Sesen Bio common stock as of January&#160;4, 2023 by the following individuals or entities: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of Sesen Bio&#8217;s directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of Sesen Bio&#8217;s named executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all of Sesen Bio&#8217;s current directors and executive officers as a group; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each person or entity known by Sesen Bio to own beneficially more than 5% of the outstanding shares of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The column entitled &#8220;Percentage&#8221; is based on a total of 202,759,043 shares of Sesen Bio common stock outstanding as of January&#160;4, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to Sesen Bio common stock. Shares of Sesen Bio common stock (i)&#160;subject to Sesen Bio options that are currently exercisable or exercisable within 60&#160;days after January&#160;4, 2023 and (ii)&#160;underlying Sesen Bio RSUs that are expected to vest and settle within 60&#160;days after January&#160;4, 2023 are considered outstanding and beneficially owned by the person holding such Sesen Bio option or Sesen Bio RSU, as applicable, for the purpose of calculating the&#160;percentage ownership of that person but not for the purpose of calculating the&#160;percentage ownership of any other person. Except as otherwise set forth below, the persons and entities in this table have sole voting and investment power with respect to all of the shares of Sesen Bio common stock beneficially owned by them, subject to applicable community property laws, where applicable. Except as otherwise set forth below, the address of each beneficial owner is c/o&#160;Sesen Bio, Inc., 245 First Street, Suite 1800, Cambridge, Massachusetts 02142. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as contemplated by the merger and the Carisma pre-closing financing, Sesen Bio does not know of any arrangements the operation of which may at a subsequent date result in a change in control of Sesen Bio. </font>
        </div>
        <table style="width:456pt;height:238pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:350.01pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors and Named Executive Officers:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">332,120</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter K Honing, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">140,972</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrie L. Bourdow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">312,833</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jason A. Keyes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">312,833</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">140,972</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">4,437,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Monica Forbes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,090,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">969,926</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current executive officers and directors as a group (10 persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">8,672,906</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">4.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Greater than 5% stockholders:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Vanguard Group</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12,366,756</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">6.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:350.01pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Bradley L. Radoff, The Radoff Family Foundation, JEC II Associates, LLC, The&#160;K. Peter Heiland 2008 Irrevocable Trust and Michael Torok</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(11)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">17,046,704</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">8.4<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents less than 1% of the issued and outstanding shares of Sesen Bio common stock as of January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.41pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 332,120 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">395</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:4pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 140,972 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 312,833 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 312,833 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 140,972 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 4,437,500 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 1,090,000 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 969,926 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 8,672,906 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Holdings for The Vanguard Group are as of December&#160;31, 2021 and are based solely on information on Schedule&#160;13G filed on February&#160;10, 2022. As reported therein, The Vanguard Group reports sole voting power over 0 shares of Sesen Bio common stock, shared voting power over 343,061 shares of Sesen Bio common stock, sole dispositive power over 11,951,290 shares of Sesen Bio common stock and shared dispositive power over 415,466 shares of Sesen Bio common stock. The address of the principal business office of The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based solely on information provided on an amended Schedule 13D filed jointly on January&#160;5, 2023 by Bradley&#160;L. Radoff, The Radoff Family Foundation, JEC II Associates, LLC, the K. Peter Heiland 2008 Irrevocable Trust and Michael Torok. As reported therein, as of January&#160;3, 2023, Mr. Radoff reports sole voting power over 8,641,865 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 8,641,865 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of January&#160;3, 2023, the Radoff Family Foundation reports sole voting power over 1,879,344, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 1,879,344 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of January&#160;3, 2023, JEC II Associates,&#160;LLC reports sole voting power over 6,379,839 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 6,379,839 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of November&#160;29, 2022, the K.&#160;Peter Heiland 2008 Irrevocable Trust reports sole voting power over 1,000,000 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 1,000,000 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of January&#160;3, 2023, Mr. Torok reports sole voting power over 8,404,839 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 8,404,839 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. The address of the principal business office of Mr. Radoff and the Radoff Family Foundation is 2727 Kirby Drive, Unit 29L, Houston, Texas 77098. The address of the principal business office of each of JEC II Associates, LLC, the K. Peter Heiland 2008 Irrevocable Trust and Mr. Torok is 68 Mazzeo Drive, Randolph, Massachusetts 02368. Mr. Radoff, the Radoff Family Foundation, JEC II Associates, LLC, the K. Peter Heiland 2008 Irrevocable Trust and Mr. Torok may be deemed to beneficially own as a group the 17,046,704 shares of Sesen Bio common stock owned in the aggregate by all of them, constituting approximately 8.4% of the outstanding shares of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">396</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tPSOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL STOCKHOLDERS OF CARISMA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information with respect to the beneficial ownership of Carisma capital stock on an as converted basis as of January&#160;4, 2023 by: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of Carisma&#8217;s directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of Carisma&#8217;s named executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all of Carisma&#8217;s directors and executive officers as a group; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each person or entity known by Carisma to beneficially own more than 5% of Carisma capital stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The&#160;percentage of beneficial ownership prior to the merger and the Carisma pre-closing financing in the table below is based on 11,089,167 shares outstanding as of January&#160;4, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules require that Carisma includes shares of Carisma common stock issuable pursuant to the exercise of Carisma options that are either immediately exercisable or exercisable within 60&#160;days of January&#160;4, 2023. These shares of Carisma common stock are deemed to be outstanding and beneficially owned by the person holding those Carisma options for the purpose of calculating the&#160;percentage ownership of that person, but they are not treated as outstanding for the purpose of calculating the&#160;percentage ownership of any other person. Unless otherwise indicated, Carisma believes that the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, based on information provided to Carisma by such persons or entities, subject to applicable community property laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise set forth below, the address of each person or entity listed in the table is c/o&#160;CARISMA Therapeutics Inc., 3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104. </font>
        </div>
        <table style="width:456pt;height:310pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:355.01pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors and Named Executive Officers:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Margarita Chavez </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Steven Kelly</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">454,939</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.94<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., PhD.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">358,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.21<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Richard Morris</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">76,268</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">38,249</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sanford Zweifach</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">30,375</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current executive officers and directors as a group (9 persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">958,632</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.45<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Greater than 5% stockholders:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,204,160</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.86<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,485,912</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.40<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with IPG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,524,306</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.75<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">615,379</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.55<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(11)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">961,492</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.67<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(12)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">969,725</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.74<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(13)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">841,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.59<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(14)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">998,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents less than 1% of the issued and outstanding shares of Carisma common stock as of January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">397</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 454,939 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;255,000 shares of Carisma common stock and (ii)&#160;103,801 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 76,268 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;6,410 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock and (ii)&#160;31,839 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 30,375 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60 days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;255,000 shares of Carisma common stock, (ii)&#160;6,410 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock and (iii)&#160;697,222 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;947,762 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;256,398 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by AbbVie Biotechnology Ltd. AbbVie Biotechnology Ltd. holds voting and investment control over the shares. The Board of Directors of AbbVie Biotechnology Ltd. consists of Lindsey Bristow, Jonathan C. Clipper, Stephen Muldoon and Arthur Price. Each of Ms. Bristow and each of Messrs. Clipper, Muldoon and Price may be deemed to share voting and investment power with respect to the shares held by AbbVie Biotechnology Ltd. and disclaim beneficial ownership of all shares held by AbbVie Biotechnology Ltd., except to the extent of their pecuniary interest therein, if any. Margarita Chavez is employed as a Managing Director of AbbVie Ventures and is a member of the Carisma board of directors. Ms.&#160;Chavez disclaims beneficial ownership of all shares held by AbbVie Biotechnology Ltd. except to the extent of her pecuniary interest therein, if any. The business address of AbbVie Biotechnology Ltd. is Thistle House, 4 Burnaby Street, Hamilton&#160;HM&#160;11, Bermuda. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;250,647 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock, (ii)&#160;937,501 shares of Carisma common stock issuable upon the conversion of the Carisma special voting preferred stock and (iii)&#160;297,764 shares of Carisma common stock issuable upon the conversion of the Carisma Series&#160;B special voting preferred stock held by HealthCap VII, L.P. HealthCap VII GP SA, a Swiss registered L.C.C., is the sole general partner of HealthCap VII, L.P. and has voting and investment control over the shares. HealthCap VII GP SA disclaims beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of its pecuniary interest therein. Fabrice Bernhard is the General Manager of HealthCap VII GP SA. Dag Richter, Daniel Schafer and Frans Wuite are each Directors of HealthCap VII GP SA. Each of Messrs. Bernhard, Richter, Schafer and Wuite may be deemed to share voting and investment power with respect to the shares held by HealthCap VII L.P. and disclaim beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of their pecuniary interest therein. Bj&#246;rn Odlander is a Managing Partner of HealthCap and is a member of the Carisma board of directors. Dr.&#160;Odlander disclaims beneficial ownership of all shares held by HealthCap VII L.P. except to the extent of his pecuniary interest therein, if any. The business address of HealthCap VII L.P. is c/o&#160;HealthCap VII GP SA, Avenue Villamont 23, CH&#160;1005&#160;Lausanne Switzerland. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;(a)&#160;947,186 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (b)&#160;237,376 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by IPG Cayman LP, (ii)&#160;141,026 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by IPG USA SCO LP and (iii)&#160;198,718 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by CT SPV Investment LP., or collectively, the IPG entities. IP Group, Inc. has voting and investment control over the shares held by the IPG entities. The business address of the IPG entities is c/o&#160;IP Group, Inc., 1 Righter Parkway, Suite 260, Wilmington, Delaware 19803. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">398</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;480,770 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;134,609 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by MRL Ventures Fund, LLC. MRL Ventures Fund, LLC holds investment and voting control over the shares. Peter Dudek, Sunil Patel, Dean Li, Joe Miletich, Caroline Litchfield and George Adonna are members of the investment committee of MRL Ventures Fund, LLC. Each of Messrs. Dudek, Patel, Li, Miletich, Litchfield and Adonna may be deemed to share voting and investment power with respect to the shares held by MRL Ventures Fund, LLC and disclaim beneficial ownership of all shares held by MRL Ventures Fund, LLC, except to the extent of their pecuniary interest therein. The business address of MRL Ventures Fund, LLC is One Merck Drive, Whitehouse Station, New Jersey 08889. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 961,492 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by SymBiosis II, LLC, which exercises voting and investment control of the shares. Chidozie Ugwumba is the Managing Partner of Symbiosis II, LLC and as such has sole voting and investment control over the shares. Mr.&#160;Ugwumba is also a member of the Carisma board of directors. The business address of Symbiosis II, LLC is 609 S.W. 8th Street, Suite 365, Bentonville, Arkansas 72712. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;490,000 shares of Carisma common stock, (ii)&#160;309,594 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (iii)&#160;170,131 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock, held by The Trustees of the University of Pennsylvania. The Board of Trustees of the University of Pennsylvania has voting and dispositive power over the shares. The Board of Trustees of the University of Pennsylvania is comprised of more than three individuals who have authority over the voting and disposition of the share. A business address of The Trustees of the University of Pennsylvania is 2929 Walnut Street, Suite 300, Philadelphia, Pennsylvania 19104. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(13)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;673,076 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;168,681 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by TPG Biotechnology Partners V, L.P., a Delaware limited partnership. The general partner of TPG Biotechnology Partners V, L.P. is TPG Biotechnology GenPar&#160;V, L.P., a Delaware limited partnership, whose general partner is TPG Biotech GenPar V Advisors, LLC, a Delaware limited liability company, whose sole member is TPG Operating Group I, L.P., a Delaware limited partnership, whose general partner is TPG Holdings I-A, LLC, a Delaware limited liability company, whose managing member is TPG GPCo, LLC, a Delaware limited liability company, whose managing member is TPG Inc., a Delaware corporation, whose shares of Class&#160;B common&#160;stock (which represent a majority of the combined voting power of the common stock) are held by TPG Group Holdings (SBS), L.P., a Delaware limited partnership, whose general partner is TPG Group Holdings (SBS) Advisors, LLC, a Delaware limited liability company, whose managing member is TPG GP A, LLC, a Delaware limited liability company, which is owned by entities owned by David Bonderman, James G. Coulter and Jon Winkelried. Messrs. Bonderman, Coulter and Winkelried may therefore be deemed to share voting and investment power with respect to, and thus beneficially own the securities directly held by TPG Biotechnology Partners V, L.P. Messrs. Bonderman, Coulter and Winkelried disclaim beneficial ownership of the securities directly held by TPG Biotechnology Partners V, L.P. except to the extent of their pecuniary interest therein. The address of each of TPG GP A, LLC and Messrs. Bonderman, Coulter and Winkelried is 301 Commerce Street, Suite 3300, Fort Worth, Texas&#160;76102. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(14)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;798,072 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;200,007 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by Wellington Life Sciences V GmbH &amp; Co. KG, or the Wellington Fund. The Wellington Fund is represented by Wellington Life Sciences Venture Capital Consulting GmbH, or the Wellington General Partner. The Wellington General Partner holds voting and investment control over the shares. Dr. Regina Hodits and Dr. Rainer Strohmenger, in their functions as managing directors of the Wellington General Partner, have individual signatory power as well as voting and/or investment control over the shares. Dr. Regina Hodits is a member of the Carisma board of directors. Dr.&#160;Regina Hodits disclaims beneficial ownership of all shares held by the Wellington Fund except to the extent of her pecuniary interest therein, if any. The business address of the Wellington Fund and the Wellington General Partner is Tuerkenstrasse 5, 80333 Munich, Germany. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">399</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tPSOT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:100.73pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL STOCKHOLDERS OF THE COMBINED COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Except where specifically noted, the following information and all of the information in this proxy statement/prospectus does not give effect to the proposed reverse stock split. The table below sets forth certain information with respect to the beneficial ownership of the common stock of the combined company upon consummation of the merger based on beneficial ownership of Sesen Bio common stock and Carisma common stock as of January&#160;4, 2023 (assuming the closing of the merger occurred on January&#160;24, 2023) by: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each director of the combined company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each named executive officer of the combined company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all of the combined company&#8217;s directors and executive officers as a group; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each person or entity expected by Carisma and Sesen Bio to become the beneficial owner of more than 5% of the common stock of the combined company upon the consummation of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The table assumes effectiveness of the Carisma pre-closing financing, an exchange ratio of 37.7924, that the closing of the merger occurred on January&#160;4, 2023 and that the conversion of the Carisma convertible note occurred immediately after the effective time of the merger. Assuming a closing date of January&#160;4, 2023, immediately prior to the merger and after the closing of the Carisma pre-closing financing and conversion of the Carisma convertible note, Carisma is expected to have 15,689,808 shares of common stock outstanding and Sesen Bio is expected to have 202,759,043 shares of common stock outstanding. Upon the closing of the merger on the assumed date of January&#160;4, 2023, the 15,689,808 shares of Carisma common stock would be converted into the right to receive an aggregate of 591,720,707 shares of Sesen Bio common stock such that there would be a total of 794,479,750 shares of common stock of the combined company outstanding upon the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include (a)&#160;shares of Sesen Bio common stock (i)&#160;subject to Sesen Bio options that are currently exercisable or exercisable within 60&#160;days after January&#160;4, 2023 and (ii)&#160;underlying Sesen Bio RSUs that are expected to vest and settle within 60&#160;days after January&#160;4, 2023 and (b)&#160;shares of Carisma common stock issuable pursuant to the exercise of Carisma options that are either immediately exercisable or exercisable within 60&#160;days of January&#160;4, 2023. Such shares of Sesen Bio common stock or Carisma common stock are, in each case, deemed to be outstanding and beneficially owned by the person holding such Sesen Bio option, Sesen Bio RSU or Carisma option, as applicable, for the purpose of calculating the&#160;percentage ownership of that person, but they are not treated as outstanding for the purpose of calculating the&#160;percentage ownership of any other person. Except as otherwise set forth below, Sesen Bio and Carisma believe that the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws. Except as otherwise set forth below, the address of each person or entity listed in the table is c/o&#160;CARISMA Therapeutics Inc., 3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">400</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:316pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:350.01pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors and Named Executive Officers:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">4,437,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Steven Kelly</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">17,193,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.12<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">13,559,964</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.70<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Richard Morris</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,882,335</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,445,515</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sanford Zweifach</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,147,944</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current executive officers and directors as a group (9 persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">40,666,495</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.05<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Greater than 5% stockholders:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">54,713,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.88<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">67,615,025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.50<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with IPG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">57,607,182</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.24<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Moderna Biotech Ventures, LLC.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(11)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">99,641,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">12.52<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(12)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">44,089,370</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.54<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(13)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">43,431,480</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.46<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(14)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">45,714,330</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.75<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents less than 1% of the issued and outstanding shares of common stock of the combined company as of January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 4,437,500 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 17,193,237 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;9,637,062 shares of common stock of the combined company and (ii)&#160;3,922,902 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 2,882,335 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;242,249 shares of common stock of the combined company and (ii)&#160;1,203,266 shares of common stock issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 1,147,944 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;9,879,311 shares of common stock of the combined company and (ii)&#160;30,787,183 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 54,713,947 shares of common stock of the combined company held by AbbVie Biotechnology Ltd. AbbVie Biotechnology Ltd. holds voting and investment control over the shares. The Board of Directors of AbbVie Biotechnology Ltd. consists of Lindsey Bristow, Jonathan C. Clipper, Stephen Muldoon and Arthur Price. Each of Ms.&#160;Bristow and each of Messrs. Clipper, Muldoon and Price may be deemed to share voting and investment power with respect to the shares held by AbbVie Biotechnology Ltd. and disclaim beneficial ownership of all shares held by AbbVie Biotechnology </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">401</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:8pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Ltd., except to the extent of their pecuniary interest therein, if any. Margarita Chavez is employed as a Managing Director of AbbVie Ventures and is a member of the Carisma board of directors. Ms.&#160;Chavez disclaims beneficial ownership of all shares held by AbbVie Biotechnology Ltd. except to the extent of her pecuniary interest therein, if any. The business address of AbbVie Biotechnology Ltd. is Thistle House, 4 Burnaby Street, Hamilton HM 11, Bermuda. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 67,615,025 shares of common stock of the combined company held by HealthCap VII, L.P. HealthCap VII GP SA, a Swiss registered L.C.C., is the sole general partner of HealthCap VII, L.P. and has voting and investment control over the shares. HealthCap VII GP SA disclaims beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of their pecuniary interest therein. Fabrice Bernhard is the General Manager of HealthCap VII GP SA. Dag Richter, Daniel Schafer and Frans Wuite are each Directors of HealthCap VII GP SA. Each of Messrs. Bernhard, Richter, Schafer and Wuite may be deemed to share voting and investment power with respect to the shares held by HealthCap VII L.P. and disclaim beneficial ownership of all shares held by HealthCap&#160;VII L.P., except to the extent of their pecuniary interest therein. Bj&#246;rn Odlander is a Managing Partner of HealthCap and is a member of the Carisma board of directors. Dr.&#160;Odlander disclaims beneficial ownership of all shares held by HealthCap VII L.P. except to the extent of his pecuniary interest therein, if any. The business address of HealthCap VII L.P. is c/o&#160;HealthCap VII GP&#160;SA, Avenue Villamont 23, CH 1005 Lausanne Switzerland. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;44,767,441 shares of common stock of the combined company held by IPG Cayman&#160;LP, (ii)&#160;5,329,711 shares of common stock of the combined company held by IPG USA SCO LP and (iii)&#160;7,510,030 shares of common stock of the combined company held by CT SPV Investment LP, or collectively, the IPG entities. IP Group, Inc. has voting and investment control over the shares held by the IPG entities. The business address of the IPG entities is c/o&#160;IP Group, Inc., 1 Righter Parkway, Suite&#160;260, Wilmington, Delaware 19803. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 99,641,170 shares of common stock of the combined company held by ModernaTX, Inc. ModernaTX, Inc. is wholly owned by Moderna, Inc., a publicly-traded company. The business address of ModernaTX, Inc. is 200 Technology Square, Cambridge, MA 02139. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 44,089,370 shares of common stock of the combined company held by SymBiosis II, LLC, which exercises voting and investment control of the shares. Chidozie Ugwumba is the Managing Partner of Symbiosis II, LLC and as such has sole voting and investment control over the shares. Mr.&#160;Ugwumba is also a member of the Carisma board of directors. The business address of Symbiosis&#160;II, LLC is 609 S.W. 8th Street, Suite 365, Bentonville, Arkansas 72712. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(13)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 43,431,480 shares of common stock of the combined company held by The Trustees of the University of Pennsylvania. The Board of Trustees of the University of Pennsylvania has voting and dispositive power over the shares. The Board of Trustees of the University of Pennsylvania is comprised of more than three individuals who have authority over the voting and disposition of the share. A business address of The Trustees of the University of Pennsylvania is 2929 Walnut Street, Suite 300, Philadelphia, Pennsylvania 19104. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(14)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 45,714,330 shares of common stock of the combined company held by Wellington Life Sciences V GmbH &amp; Co. KG, or the Wellington Fund. The Wellington Fund is represented by Wellington Life Sciences Venture Capital Consulting GmbH, or the Wellington General Partner. The Wellington General Partner holds voting and investment control over the shares. Dr.&#160;Regina Hodits and Dr.&#160;Rainer Strohmenger, in their functions as managing directors of the Wellington General Partner, have individual signatory power as well as voting and/or investment control over the shares. Dr.&#160;Regina Hodits is a member of the Carisma board of directors. Dr.&#160;Regina Hodits disclaims beneficial ownership of all shares held by the Wellington Fund except to the extent of her pecuniary interest therein, if any. The business address of the Wellington Fund and the Wellington General Partner is Tuerkenstrasse 5, 80333 Munich, Germany. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">402</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:376pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Hogan Lovells US LLP, Philadelphia, Pennsylvania, will pass on the validity of the Sesen Bio common stock offered by this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of Sesen Bio, Inc. at December&#160;31, 2021 and 2020, and for each of the three&#160;years in the period ended December&#160;31, 2021, included in the Proxy Statement of Sesen Bio,&#160;Inc., which is referred to and made part of this Prospectus and Registration Statement, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of CARISMA Therapeutics Inc. as of December&#160;31, 2021 and 2020, and for the&#160;years then ended, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. The audit report covering the December&#160;31, 2021 consolidated financial statements contains an explanatory paragraph that states that CARISMA Therapeutics Inc.&#8217;s recurring losses and negative cash flows from operations raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of that uncertainty. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">403</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:117pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio files annual, quarterly and current reports, proxy statements and other information with the SEC. Sesen Bio&#8217;s SEC filings are available to the public electronically at the SEC&#8217;s website at www.sec.gov. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also makes available free of charge on or through its website at www.ir.sesenbio.com, its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section&#160;13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after Sesen Bio electronically files such material with or otherwise furnishes it to the SEC. The website addresses for the SEC and Sesen Bio are inactive textual references, and information on those websites are not part of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this proxy statement/prospectus, Sesen Bio has filed with the SEC a registration statement on Form S-4, of which this proxy statement/prospectus is a part, under the Securities Act to register the shares of Sesen Bio common stock that Sesen Bio will issue to Carisma stockholders in the merger. This proxy statement/prospectus is a part of that registration statement and constitutes a prospectus of Sesen Bio, as well as a proxy statement of Sesen Bio for its special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has supplied all information contained in this proxy statement/prospectus relating to Sesen Bio, and Carisma has supplied all information contained in this proxy statement/prospectus relating to Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you would like to request documents from Sesen Bio or Carisma, please send a request in writing or by telephone to either Sesen Bio or Carisma at the following addresses: </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio, Inc.</font>
                <br >
                <font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font>
                <br >
                <font style="letter-spacing:0.2pt;">Cambridge, Massachusetts 02142</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (617) 444-8550</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: ir@sesenbio.com </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA Therapeutics Inc</font><font style="letter-spacing:0.2pt;">.</font>
                <br >
                <font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font>
                <br >
                <font style="letter-spacing:0.2pt;">Philadelphia, PA 19104</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (267) 491-6422</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: info@carismatx.com</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder and would like additional copies, without charge, of this proxy statement/prospectus or if you have questions about the merger, including the procedures for voting your shares, you should contact Sesen Bio&#8217;s proxy solicitor: </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_mackenziepartners-bw.jpg" alt="[MISSING IMAGE: lg_mackenziepartners-bw.jpg]" height="57" width="192" >
        </div>
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">MacKenzie Partners, Inc. </font>
          <br >
          <font style="letter-spacing:0.2pt;">1407 Broadway, 27th Floor </font>
          <br >
          <font style="letter-spacing:0.2pt;">New York, New York 10018 </font>
          <br >
          <font style="letter-spacing:0.2pt;">(800) 322-2885</font>
          <br >
          <font style="letter-spacing:0.2pt;">proxy@mackenziepartners.com </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">404</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tTRNO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:560pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">TRADEMARK NOTICE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus contains trademarks, service marks and trade names of Sesen Bio, Inc. and CARISMA Therapeutics Inc., including their respective names and logos. Other trademarks, service marks and trade names referred to in this proxy statement/prospectus are the property of their respective owners. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">405</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tOTMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OTHER MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;16(a) Beneficial Ownership Reporting Compliance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;16(a) of the Exchange Act requires Sesen Bio&#8217;s directors, certain officers and persons who own more than 10% of Sesen Bio common stock to file reports of ownership and reports of changes in ownership of Sesen Bio common stock and other equity securities of Sesen Bio with the SEC. Directors, certain officers and greater than 10% stockholders are required by SEC regulations to furnish Sesen Bio with copies of all Section&#160;16(a) forms they file. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To Sesen Bio&#8217;s knowledge, based solely on a review of the copies of reports furnished to Sesen Bio and the written representations of Sesen Bio&#8217;s directors and officers, Sesen Bio believes that during the year ended December&#160;31, 2021, Sesen Bio&#8217;s officers, directors and greater than 10% stockholders complied with all Section&#160;16(a) filing requirements, except for the following: a Form 3 for Elly Ryu reporting her beneficial ownership upon being named a Section&#160;16 officer was filed late on May&#160;10, 2021 and a Form 4 for Jane Henderson reporting one transaction was filed late on May&#160;10, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stockholder Proposals Pursuant to Rule&#160;14a-8</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholders of Sesen Bio may submit proposals on matters appropriate for stockholder action at meetings of Sesen Bio stockholders in accordance with Rule&#160;14a-8 promulgated under the Exchange Act. For such proposals to be included in Sesen Bio&#8217;s proxy materials relating to the 2023 annual meeting of stockholders, all applicable requirements of Rule&#160;14a-8 must be satisfied and such proposals must have been received at Sesen Bio&#8217;s principal offices no later than December&#160;29, 2022, the date that is 120&#160;days prior to the first anniversary of the date of the proxy statement was released to stockholders in connection with the 2022 annual meeting of stockholders. If, however, the Sesen Bio 2023 annual meeting of stockholders is not held within 30&#160;days from the anniversary of the 2022 annual meeting of stockholders, then the deadline will be a reasonable time prior to the time Sesen Bio begins to print and send its proxy materials. All such proposals must comply with all applicable requirements of Rule&#160;14a-8 and, prior to consummation of the merger, should be sent to Sesen Bio&#8217;s executive offices, 245 First Street, Suite 1800 Cambridge, MA 02142, Attention: Corporate Secretary by the close of business on the required deadline. After the consummation of the merger, such proposals should be sent to the combined company&#8217;s Corporate Secretary at CARISMA Therapeutics Inc., 3675 Market Street, Suite 200, Philadelphia, PA 19104, Attention: Corporate Secretary, Email: legal@carismatx.com, by the close of business on the required deadline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Nominations and Stockholder Proposals Under the Sesen Bio Bylaws</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio Bylaws also establish an advance notice procedure for nominations for election to the Sesen Bio board of directors and other matters that stockholders wish to present for action at an annual meeting of stockholders other than those to be included in the proxy statement. In general, notice must be received at Sesen Bio&#8217;s principal offices at 245 First Street, Suite 1800 Cambridge, MA 02142, Attention:&#160;Corporate Secretary, not less than 90 calendar days before nor more than 120 calendar days before the one year anniversary of the previous year&#8217;s annual meeting of stockholders. Therefore, to be presented at Sesen Bio&#8217;s 2023 annual meeting, such a proposal must be received no earlier than February&#160;22, 2023 and no later than March&#160;24, 2023. However, if the date of the annual meeting of stockholders is more than 20&#160;days earlier or more than 60&#160;days later than such anniversary date, notice must be received no earlier than 120 calendar days prior to such annual meeting of stockholders and no later than the close of business on the later of (A)&#160;90&#160;days prior to such annual meeting of stockholders and (B)&#160;10&#160;days following the day on which notice of the date of such annual meeting of stockholders was mailed or public announcement of the date of such annual meeting of stockholders was first made, whichever first occurs. If the stockholder fails to give notice by these dates, then the persons named as proxies in the proxies solicited by the Sesen Bio board of directors for the 2023 annual meeting of stockholders may exercise discretionary voting power regarding any such proposal. Stockholders are advised to review the Sesen Bio Bylaws which also specify requirements as to the form and content of a stockholder&#8217;s notice. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to satisfying the foregoing advanced notice requirements under the Sesen Bio Bylaws, to comply with the universal proxy rules under the Exchange Act, shareholders who intend to solicit proxies in support of director nominees other than the Sesen Bio&#8217;s nominees must provide notice that sets forth the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">406</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:120pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">information required by Rule&#160;14a-19 under the Exchange Act no later than April&#160;23, 2023. These requirements are separate from, and in addition to, the SEC&#8217;s requirements that a stockholder must meet in order to have a stockholder proposal included in the proxy statement. A copy of the full text of these bylaw provisions may be obtained from Sesen Bio&#8217;s website at www.ir.sesenbio.com/corporate-governance. Proposals or nominations not meeting these requirements will not be entertained at the 2023 Annual Meeting of stockholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Communications with the Sesen Bio Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stockholders who wish to communicate with the Sesen Bio board of directors may do so by writing to Dr.&#160;Jay S. Duker, Chair of the Sesen Bio board of directors, Sesen Bio, Inc., 245 First Street, Suite 1800, Cambridge, MA 02142. Communications will be forwarded to other directors if they relate to substantive matters that the Chair of the Sesen Bio board of directors, in consultation with Sesen Bio&#8217;s legal counsel, considers appropriate for attention by the other directors. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances or matters as to which Sesen Bio tends to receive repetitive or duplicative communications. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">&#8220;Householding&#8221;&#8201;&#8212;&#8201;Stockholders Sharing the Same Address</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC has adopted rules that permit companies and intermediaries (such as brokers) to implement a delivery procedure called &#8220;householding.&#8221; Under this procedure, multiple stockholders who reside at the same address may receive a single copy of Sesen Bio&#8217;s proxy materials unless the affected stockholder has provided other instructions. This procedure reduces printing costs and postage fees, and helps protect the environment as well. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expects that a number of brokers with account holders who are Sesen Bio stockholders will be &#8220;householding&#8221; Sesen Bio&#8217;s proxy materials. A single set of proxy materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from one or more of the affected stockholders. Once you have received notice from your broker that it will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. Sesen Bio stockholders may revoke their consent at any time by contacting your broker. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon written or oral request, Sesen Bio will undertake to promptly deliver a separate copy of proxy materials to any stockholder at a shared address to which a single copy of any of those documents was delivered. To receive a separate copy of proxy materials now or in the future, you may write to Sesen Bio at Sesen Bio, Inc., 245 First Street, Suite 1800 Cambridge, MA 02142, Attention: Corporate Secretary, or by calling (617) 444-8550. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any stockholders who share the same address and currently receive multiple copies of Sesen Bio&#8217;s proxy materials who wish to receive only one copy in the future can contact their broker, bank or other holder of record to request information about &#8220;householding&#8221; or Sesen Bio&#8217;s Corporate Secretary at the address or telephone number listed above.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">407</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="TOC4">&#8203;</a><a name="fISCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:318.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO SESEN BIO&#8217;S CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:272.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:424pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Audited Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tROIR"><font style="letter-spacing:0.2pt;">Report of Independent Registered Public Accounting Firm (PCAOB ID: 42) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROIR">F-2</a></font> <a href="#tROIR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCBS"><font style="letter-spacing:0.2pt;">Consolidated Balance Sheets </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCBS">F-5</a></font> <a href="#tCBS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOO"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations and Comprehensive Loss </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOO">F-6</a></font> <a href="#tCSOO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOC"><font style="letter-spacing:0.2pt;">Consolidated Statements of Changes in Stockholders&#8217; Equity (Deficit) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC">F-7</a></font> <a href="#tCSOC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOC1"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC1">F-8</a></font> <a href="#tCSOC1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTCF"><font style="letter-spacing:0.2pt;">Notes to Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTCF">F-9</a></font> <a href="#tNTCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Unaudited Condensed Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCCBS"><font style="letter-spacing:0.2pt;">Condensed Consolidated Balance Sheets as of September&#160;30, 2022 and December&#160;31, 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCBS">F-43</a></font> <a href="#tCCBS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO">F-44</a></font> <a href="#tCCSO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO1"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO1">F-45</a></font> <a href="#tCCSO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO2"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity for the Three and Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO2">F-46</a></font> <a href="#tCCSO2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO3"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Cash Flows for the Three and Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO3">F-47</a></font> <a href="#tCCSO3"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTCC"><font style="letter-spacing:0.2pt;">Notes to Condensed Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTCC">F-48</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tROIR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:52pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Report of Independent Registered Public Accounting Firm</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the Shareholders and the Board of Directors of Sesen Bio, Inc. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion on the Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated balance sheets of Sesen Bio, Inc. (the &#8220;Company&#8221;) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; (deficit) equity, and cash flows for each of the three&#160;years in the period ended December&#160;31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the three&#160;years in the period ended December&#160;31, 2021, in conformity with U.S. generally accepted accounting principles. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February&#160;28, 2022 expressed an unqualified opinion thereon. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis for Opinion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Audit Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1)&#160;relates to accounts or disclosures that are material to the financial statements and (2)&#160;involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which they relate. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-bottom:5pt;margin-top:0pt;border-collapse: collapse;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:-0.2pt;">Fair Value of Contingent Consideration</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Description of the Matter</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">As discussed in Notes 3 and 5 to the consolidated financial statements under the caption &#8220;Contingent Consideration,&#8221; the Company uses a discounted cash flow model to estimate the fair value of the contingent consideration liability each reporting period, which represents the present value of projected future cash flows associated with regulatory approval milestones and royalties on net sales due to the selling shareholders of Viventia Bio Inc. Fluctuations in the fair value of the liability result in a charge to earnings (or loss) during the period. As of December&#160;31, 2021, the Company estimated the fair value of the contingent consideration liability as $52.0&#160;million and recorded the change in fair value of $56.8&#160;million as operating income for the year ended December&#160;31, 2021. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Auditing the fair value of the contingent consideration liability required significant auditor judgment due to the high degree of subjectivity in evaluating certain assumptions used to estimate the fair value. In particular, the fair value measurement was sensitive to the significant assumptions underlying the projected commercial sales of Vicineum and probabilities of success and timing of certain milestone events and achievements. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">How We Addressed the Matter in Our Audit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the development of the significant assumptions over the Company&#8217;s process to estimate the fair value of the contingent consideration liability. This included testing controls over management&#8217;s review of the significant estimation assumptions and methods used to develop the fair value estimate, the accuracy of the calculations included within the fair value model, and the underlying data used in the model. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">To test the estimated fair value of the contingent consideration liability, our audit procedures included, among others, assessing the terms of the arrangement, evaluating the methodology used and testing the key inputs and significant assumptions discussed above. We evaluated the significant assumptions in light of observable industry and economic trends and standards, external data sources, probability of success benchmarks, and regulatory factors. Our procedures included evaluating the data sources used by management in determining its significant assumptions and included an evaluation of available information that either corroborated or contradicted management&#8217;s conclusions. In addition, we involved our valuation professionals to assess the methodology used to determine the fair value of the contingent consideration liability, which included performing corroborative fair value calculations. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:-0.2pt;">Impairment Evaluation of Goodwill and Indefinite-Lived Intangible Assets</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Description of the Matter</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">As discussed in Notes 3 and 8 to the consolidated financial statements under the captions &#8220;Indefinite-Lived Intangible Assets&#8221; and &#8220;Goodwill,&#8221; the Company&#8217;s intangible assets consist of indefinite-lived, acquired in-process research and development (IPR&amp;D) worldwide product rights to Vicineum as a result of the acquisition of Viventia in 2016. Goodwill on the Company&#8217;s consolidated balance sheets is the result of the Company&#8217;s acquisition of Viventia in September&#160;2016 and represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets acquired under the acquisition method of accounting. Indefinite-lived intangible assets are quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Goodwill is quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of IPR&amp;D requires management to estimate the future discounted cash flows of the underlying asset. Impairment testing of goodwill requires management to estimate the future discounted cash flows of the Company&#8217;s one reporting unit. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:245pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Auditing management&#8217;s impairment assessments required significant auditor judgment due to the high degree of subjectivity in evaluating certain assumptions used to estimate the fair value of the reporting unit for and the IPR&amp;D. In particular, the fair value estimates of goodwill and of IPR&amp;D were sensitive to the significant assumptions underlying the projected commercial sales of Vicineum. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">How We Addressed the Matter in Our Audit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the development of the significant assumptions over the Company&#8217;s goodwill and indefinite-lived intangible asset impairment review processes. This included testing controls over management&#8217;s review of the quantitative impairment analyses of goodwill and IPR&amp;D, including the significant estimation assumptions and methods used, the accuracy of the calculations included within the valuation models, and the underlying data used in those models. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">To test the impairment evaluations over goodwill and IPR&amp;D assets, our audit procedures included, among others, evaluating the methodology and valuation models used and testing the key inputs and significant assumptions discussed above. We evaluated the significant assumptions in light of observable industry and economic trends and standards, external data sources, probability of success benchmarks, and regulatory factors. Our procedures included evaluating the data sources used by management in determining its significant assumptions and included an evaluation of available information that either corroborated or contradicted management&#8217;s conclusions. In addition, we inspected the Company&#8217;s reconciliation of the fair value of the reporting unit to the market capitalization of the Company and assessed the results. We involved our valuation professionals to assess the methodology and valuation of the discounted cash flow models, including evaluating the reasonableness of certain significant assumptions.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ Ernst &amp; Young LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have served as the Company&#8217;s auditor since 2010. </font> <br ><font style="letter-spacing:0.2pt;">Boston, Massachusetts </font> <br ><font style="letter-spacing:0.2pt;">February&#160;28, 2022</font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED BALANCE SHEETS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:581pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">162,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,389</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,011</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,482</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">18,476</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,478</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restricted Cash </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">205,605</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">62,867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current assets: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">46,400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Goodwill </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Long term prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">349</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">35,142</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">59,956</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:40pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">122,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities and Stockholders&#8217; Equity (Deficit)</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,853</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,102</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,973</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">460</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">489</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">11,568</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">18,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current liabilities: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred tax liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,969</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">12,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other non-current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total non-current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">57,469</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">114,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Total Liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">69,037</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">132,050</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Stockholders&#8217; Equity (Deficit): </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Preferred stock, $0.001 par value per share; 5,000,000 shares authorized at </font>
                <br >
                <font style="letter-spacing:0.2pt;">December&#160;31, 2021 and 2020; no shares issued and outstanding at December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2021 and 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Common stock, $0.001 par value per share; 400,000,000 and 200,000,000 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">authorized at December&#160;31, 2021 and 2020; 199,463,645 and 140,449,647 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">issued and outstanding at December&#160;31, 2021 and 2020, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">140</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">306,554</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(315,921<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total Stockholders&#8217; Equity (Deficit) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(9,227<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Liabilities and Stockholders&#8217; Equity </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">122,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCSOO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:251pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands, except per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:310pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:303.55pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:303.55pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt;text-align:left;" colspan="13">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total Revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,312</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">24,663</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,393</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">14,302</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">12,208</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(11,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">71,620</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">35,093</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">32,313</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">108,491</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from Operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,549<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(21,077<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(108,491<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">125</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss Before Taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(20,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Benefit (provision) from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Loss and Comprehensive Loss After Taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deemed dividend on adjustment of exercise price of certain warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(147<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss attributable to common stockholders&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(22,544<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per common share&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.19<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(1.18<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average common shares outstanding&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">182,323</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">118,221</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">90,929</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCSOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:93pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (DEFICIT) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands, except share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:466pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:13.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity (Deficit)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2018</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">77,456,180</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">77</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">230,154</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(186,024<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">44,207</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options and vesting of RSAs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">89,812</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Sales of common stock under 2014 ESPP </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">10,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock and common stock warrants, net of issuance costs of $2.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">20,410,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">21</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">27,812</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">27,833</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">6,772,928</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">5,474</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,481</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 1.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $0.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">2,062,206</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,934</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1,936</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2019</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">106,801,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">107</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">266,717</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(293,524<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(26,700<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">12,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Sales of common stock under 2014 ESPP </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">28,186</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">238,110</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $1.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">33,369,942</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">33</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">37,925</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">37,958</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">140,449,647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">140</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">306,554</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(315,921<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(9,227<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">33,610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">2,048,059</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,124</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,126</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $5.4&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">56,932,329</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">57</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">174,905</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">174,962</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCSOC1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CASH FLOWS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:582.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.22pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Operating Activities:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Adjustments to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">85</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">122</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(11,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,620</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivable (net) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(24,493<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(17,964<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,304<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(5,188<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(249<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">535</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,424<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(2,035<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,556</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(68,878<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(30,837<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(37,521<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Investing Activities:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Purchases of equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(136<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(4<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(8<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(136<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Financing Activities:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:317.22pt;white-space:normal;text-align:left;">
              <div style="margin-left:40pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of common stock and common stock warrants, net of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">27,833</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,481</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of common stock under ATM Offering, net </font>
                <br >
                <font style="letter-spacing:0.2pt;">of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">174,962</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">37,958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,936</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from sale of common stock pursuant to ESPP </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">176,129</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">38,113</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">35,356</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net increase (decrease) in cash, cash equivalents and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">107,247</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">7,268</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,301<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;beginning of period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">55,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">48,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">50,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;end of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">162,656</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">55,409</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">48,141</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Reconciliation of cash, cash equivalents and restricted cash:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">162,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">52,389</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">48,121</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Short term restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Long term restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:50pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total cash, cash equivalents and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">162,656</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">55,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">48,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental cash flow disclosure: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Cash paid for amounts included in the measurement of lease </font>
                <br >
                <font style="letter-spacing:0.2pt;">liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">154</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">153</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental disclosure of non-cash operating activities: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Right-of-use assets related to the adoption of ASC 842 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Right-of-use assets obtained in exchange for lease obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">290</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental disclosure of non-cash financing activities: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.167pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Deemed Dividend on adjustment of exercise price on certain </font>
                <br >
                <font style="letter-spacing:0.2pt;">warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tNTCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.&nbsp;&nbsp;&nbsp;DESCRIPTION OF BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. (&#8220;Sesen&#8221; or the &#8220;Company&#8221;), a Delaware corporation formed in February&#160;2008, is a late-stage clinical company advancing targeted fusion protein therapeutics (&#8220;TFPTs&#8221;) for the treatment of patients with cancer. The Company&#8217;s most advanced product candidate, Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule (&#8220;EpCAM&#8221;) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with bacillus Calmette-Gu&#233;rin (&#8220;BCG&#8221;). The Company has an ongoing single-arm, multi-center, open-label Phase&#160;3 VISTA clinical trial of Vicineum as a monotherapy in patients with BCG-unresponsive NMIBC (the &#8220;VISTA Trial&#8221;). The VISTA Trial completed enrollment in April&#160;2018 with a total of 133 patients. On December&#160;18, 2020, the Company submitted its completed Biologics License Application (the &#8220;BLA&#8221;) for Vicineum for the treatment of BCG-unresponsive NMIBC to the United States Food and Drug Administration (&#8220;FDA&#8221;). On February&#160;12, 2021, the FDA notified the Company that it has accepted for filing the BLA. The FDA also granted Priority Review for the BLA and set a target Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) date for a decision on the BLA of August&#160;18, 2021. On July&#160;13, 2021, the Company participated in a productive Late-Cycle Meeting with the FDA regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. In the meeting, the FDA confirmed that there was no Advisory Committee meeting planned at that time, and that no post-marketing requirements, including a confirmatory trial, had been identified at that time. Also in the meeting, the Company and the FDA discussed remaining questions related to manufacturing facilities inspection, product quality information requests and additional information related to chemistry, manufacturing and controls (&#8220;CMC&#8221;), and a timeline to submit additional supporting information was agreed upon. On August&#160;13, 2021, the Company received a complete response letter (&#8220;CRL&#8221;) from the FDA indicating that the FDA had determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company participated in Type A Meetings with the FDA on October&#160;29, 2021 and December&#160;8, 2021 to discuss questions related to CMC and clinical issues raised in the CRL. Both meetings helped the Company determine the appropriate path forward for Vicineum. Any changes in these assumptions and estimates or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. The Company believes it has a clear understanding of what additional information regarding CMC is required for resubmission of a BLA. Additionally, although not an issue raised in the CRL, the FDA confirmed that Vicineum manufactured using the proposed commercial process is comparable to Vicineum used in prior clinical trials. The FDA also confirmed that the Company can utilize Vicineum manufactured during process validation for any future clinical trials needed to address issues raised in the CRL, and that these potential trials can proceed while addressing CMC issues. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Viventia Acquisition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, the Company entered into a Share Purchase Agreement with Viventia Bio, Inc., a corporation incorporated under the laws of the Province of Ontario, Canada (&#8220;Viventia&#8221;), the shareholders of Viventia named therein (the &#8220;Selling Shareholders&#8221;) and, solely in its capacity as seller representative, Clairmark Investments Ltd., a corporation incorporated under the laws of the Province of Ontario, Canada (&#8220;Clairmark&#8221;) (the &#8220;Share Purchase Agreement&#8221;), pursuant to which the Company agreed to and simultaneously completed the acquisition of all of the outstanding capital stock of Viventia from the Selling Shareholders (the &#8220;Viventia Acquisition&#8221;). In connection with the closing of the Viventia Acquisition, the Company issued 4.0&#160;million shares of its common stock to the Selling Shareholders, which at that time represented approximately 19.9% of the voting power of the Company as of immediately prior to the issuance of such shares. Clairmark is an affiliate of Leslie L. Dan, a director of the Company until his retirement in July&#160;2019. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Share Purchase Agreement, the Company is obligated to pay to the Selling Shareholders certain post-closing contingent cash payments upon the achievement of specified milestones </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and based upon net sales, in each case subject to the terms and conditions set forth in the Share Purchase Agreement, including: (i)&#160;a one-time milestone payment of $12.5&#160;million payable upon the first sale of Vicineum (the &#8220;Purchased Product&#8221;), in the United States; (ii)&#160;a one-time milestone payment of $7.0&#160;million payable upon the first sale of the Purchased Product in any one of certain specified European countries; (iii)&#160;a one-time milestone payment of $3.0&#160;million payable upon the first sale of the Purchased Product in Japan; and (iv)&#160;quarterly earn-out payments equal to 2% of net sales of the Purchased Product during specified earn-out periods. Such earn-out payments are payable with respect to net sales in a country beginning on the date of the first sale in such country and ending on the earlier of (i)&#160;December&#160;31, 2033, and (ii)&#160;fifteen&#160;years after the date of such sale, subject to early termination in certain circumstances if a biosimilar product is on the market in the applicable country. Under the Share Purchase Agreement, the Company, its affiliates, licensees and subcontractors are required to use commercially reasonable efforts, for the first seven&#160;years following the closing of the Viventia Acquisition, to achieve marketing authorizations throughout the world and, during the applicable earn-out period, to commercialize the Purchased Product in the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China and Canada. Certain of these payments are payable to individuals or affiliates of individuals that became employees or members of the Company&#8217;s board of directors. However, as of December&#160;31, 2021, none of these individuals are active employees or members of the Company&#8217;s board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the Company had cash and cash equivalents of $162.6&#160;million and an accumulated deficit of $316.3&#160;million. The Company incurred negative cash flows from operating activities of $68.9&#160;million, $30.8&#160;million and $37.5&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. Since the Company&#8217;s inception, it has received no revenue from sales of its products, and the Company anticipates that operating losses will continue for the foreseeable future as it seeks to address the issues raised in the CRL it received for a BLA for Vicineum for the treatment of BCG unresponsive NMIBC and the concerns identified in the EMA Withdrawal Assessment Report, complete the follow-up stage of the ongoing Phase&#160;3 VISTA Trial of Vicineum for the treatment of BCG-unresponsive NMIBC, complete any additional clinical trials for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, and seek marketing approval from the FDA and the European Commission and, if approved, commercialize Vicineum. The Company has financed its operations to date primarily through private placements of its common stock, preferred stock, common stock warrants and convertible bridge notes, venture debt borrowings, its initial public offering (&#8220;IPO&#8221;), follow-on public offerings, sales effected in &#8220;at-the-market&#8221; &#8203;(&#8220;ATM&#8221;) offerings, commercialization partnership and out-license agreements. See &#8220;Note 12. Stockholders&#8217; Equity&#8221; below for information regarding the Company&#8217;s recently completed equity financings. Management believes that the Company&#8217;s cash and cash equivalents as of December&#160;31, 2021 will be sufficient to fund the Company&#8217;s current operating plan for at least the next twelve&#160;months from the date these consolidated financial statements were issued. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Funding Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s future success is dependent on its ability to develop, and if approved, commercialize its product candidates, including Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, and ultimately upon its ability to attain profitable operations. In order to commercialize its product candidates, including Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, the Company needs to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks similar to other late-stage clinical companies, including, but not limited to, successful discovery and development of its product candidates, raising additional capital, development and commercialization by its competitors of new technological innovations, protection of proprietary technology and market acceptance of its products. The successful discovery, development and, if approved, commercialization of product candidates, including Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, requires substantial working capital, and the Company expects to seek additional funds through equity or debt financings or through additional outside of United States (&#8220;OUS&#8221;) business development partnerships, collaborations, licensing transactions or other sources. The Company may be unable to obtain equity or debt financings or enter into additional OUS business development partnerships, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">collaborations or licensing transactions at favorable terms, or at all, and, if necessary, may be required to implement cost reduction strategies. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company will incur substantial expenses if and as it: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">addresses the issues identified in the CRL it received from the FDA for its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC and the concerns identified in the European Medicines Agency&#8217;s (&#8220;EMA&#8221;) Withdrawal Assessment Report, which the Company expects will include the completion of an additional Phase&#160;3 clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seeks marketing approvals for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishes and implement sales, marketing and distribution capabilities and scale up and validate external manufacturing capabilities to commercialize Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintains, expands and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">hires additional clinical, regulatory, quality control, scientific and management personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">expands its operational, financial and management systems and personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducts research and pre-clinical and clinical development of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, and its other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seeks to discover and develop additional product candidates; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in-licenses or acquires the rights to other products, product candidates or technologies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope, initiation, progress, timing, costs and results of laboratory testing and clinical trials for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG and its other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ongoing COVID-19 pandemic and its impact on the Company&#8217;s business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Company&#8217;s ability to establish additional OUS business development partnerships, collaborations or licensing arrangements on favorable terms, if at all, particularly manufacturing, marketing and distribution arrangements for its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of the implementation of commercial-scale manufacturing activities, including those associated with the manufacturing process and technology transfer to third-party manufacturers to facilitate such commercial-scale manufacturing of Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of establishing and implementing sales, marketing and distribution capabilities for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing its intellectual property rights and defending any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Company&#8217;s obligation to make milestone, royalty and other payments to third-party licensors under its licensing agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which the Company in-licenses or acquires rights to other products, product candidates or technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the outcome, timing and cost of regulatory review by the FDA, EMA and comparable non-US regulatory authorities for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, including the potential for the FDA, EMA or comparable non-US regulatory authorities to require that the Company perform more studies or clinical trials than those that it currently expects to perform; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Company&#8217;s ability to achieve certain future regulatory, development and commercialization milestones under its out-license and OUS business development partnership agreements </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effect of competing technological and market developments; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the revenue, if any, received from commercial sales of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, if approved. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as the Company can generate substantial product revenues from commercial sales, the Company expects to finance its cash needs through a combination of equity offerings, debt financings, government or other third-party funding, strategic collaborations, OUS business development partnership agreements, partnerships, alliances, and licensing arrangements. The Company does not have any committed external source of funds other than the amounts payable under the license agreement with F.&#160;Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (collectively, &#8220;Roche&#8221;) and the license agreement with Qilu Pharmaceutical, Co., Ltd. (&#8220;Qilu&#8221;). To the extent the Company raises additional capital through the sale of equity or convertible debt securities, the ownership interests of existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of existing stockholders. Debt financing, if available, may involve agreements that include liens or other restrictive covenants limiting the Company&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If the Company raises additional funds through government or other third-party funding, strategic OUS business development partnerships, collaborations, alliances or licensing arrangements, the Company may have to relinquish valuable rights to its technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to the Company. If the Company is unable to raise additional funds when needed, the Company may be required to delay, limit, reduce or terminate its product development or future commercialization efforts or grant rights to develop and market products or product candidates that the Company would otherwise prefer to develop and market itself. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The COVID-19 pandemic has negatively impacted the global economy, disrupted business operations and created significant volatility and disruption to financial markets. Significant uncertainty remains as to the potential impact of the COVID-19 pandemic on the Company&#8217;s operations, and on the global economy as a whole. The extent and duration of the pandemic could continue to disrupt global markets and may affect the Company&#8217;s ability to raise additional capital in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the ASC and Accounting Standards Updates (&#8220;ASUs&#8221;), promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of financial statements in accordance with GAAP and the rules and regulations of the SEC requires the use of estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company&#8217;s business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most significant estimates and judgments impact the fair value of intangible assets, goodwill and contingent consideration; income taxes (including the valuation allowance for deferred tax assets); research and development expenses; and going concern considerations. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principles of Consolidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s consolidated financial statements include the accounts of the Company, its wholly owned subsidiary Viventia and its indirect subsidiaries, Viventia Bio USA Inc. and Viventia Biotech (EU) Limited. All intercompany transactions and balances have been eliminated in consolidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Translation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The functional currency of the Company and each of its subsidiaries is the US dollar. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.&nbsp;&nbsp;&nbsp;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash, Cash Equivalents, Restricted Cash and Concentration of Credit Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s cash is held on deposit in demand accounts at a large financial institution in amounts in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage limit of $250,000 per depositor, per FDIC-insured bank, per ownership category. Restricted cash represents cash held by the Company&#8217;s primary commercial bank to collateralize a letter of credit issued related to a license agreement and the credit limit on the Company&#8217;s corporate credit card, and are classified as short term and long term, respectively. The Company considers all highly liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. Financial instruments that potentially subject the Company to credit risk principally consists of cash equivalents and accounts receivable. As of December&#160;31, 2021 and 2020, the Company limited its credit risk associated with cash equivalents by placing investments in highly-rated money market funds. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred, and costs of improvements and renewals are capitalized. Depreciation is recognized using the straight-line method over the estimated useful lives of the relative assets. The Company uses an estimated useful life of five&#160;years for lab equipment, four&#160;years for furniture and fixtures, three&#160;years for computer equipment and software and the lesser of five&#160;years or the remaining lease term for leasehold improvements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indefinite-Lived Intangible Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s intangible assets consist of indefinite-lived, acquired in-process research and development (&#8220;IPR&amp;D&#8221;) worldwide product rights to Vicineum as a result of the acquisition of Viventia in 2016. IPR&amp;D assets acquired in a business combination are considered indefinite-lived until the completion or abandonment of the associated research and development efforts. Amortization over the estimated useful life will commence at the time of Vicineum&#8217;s commercial launch in the respective markets, if approved. If regulatory approval to market Vicineum for the treatment of BCG-unresponsive NMIBC is not obtained, the Company will immediately expense the related capitalized cost. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Indefinite-lived intangible assets are quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of indefinite-lived intangible assets requires management to estimate the future discounted cash flows of an asset using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. The Company recognizes an impairment loss when and to the extent that the estimated fair value of an intangible asset is less than its carrying value. In addition, on a quarterly basis, the Company performs a qualitative review of its business operations to determine whether events or changes in circumstances have occurred which could indicate that the carrying value of its intangible assets was not recoverable. If an impairment indicator is identified, an interim impairment assessment is performed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2021, the Company received a CRL from the FDA regarding its BLA for Vicineum for the treatment of NMIBC, its lead product candidate. In the CRL, the FDA determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/</font>&#8203;<font style="letter-spacing:0.2pt;">statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">product quality. Given the inherent uncertainty in the development plans for Vicineum (and Vysyneum in the EMA) as a result of the CRL and the withdrawal of the Company&#8217;s marketing authorization application (&#8220;MAA&#8221;), an interim impairment analysis was conducted in the third quarter of 2021, which concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum US rights was fully impaired as of September&#160;30, 2021. The $31.7&#160;million of impairment charges were due to delays in the expected start of commercialization and lower probabilities of success, combined with higher operating expenses expected to be incurred prior to commercialization, resulting in lower expected future cash flows estimated in the US market. However, while similar delays in timelines and reduced probabilities of success also affected the estimated fair value of the Company&#8217;s intangible asset of Vicineum EU rights, this asset was not impaired as of September&#160;30, 2021. At that time, management assessed that the carrying value of the Vicineum EU rights is not at significant risk of impairment in the future within the current range of commercialization timelines and probability of clinical and regulatory success (&#8220;POS&#8221;) assumptions. This is primarily due to the fact that the Company expects the Vicineum sales outside of the US to be two to three times the expected sales volume in the US, based on management&#8217;s reassessment of the total addressable global market for high-risk NMIBC during the quarter ended June&#160;30, 2019, wherein management determined that both the global market size and the estimated potential Vicineum commercial sales within the global market were likely higher than the Company&#8217;s previous estimate. In addition, the EU asset is burdened with significantly less expense than the US asset, as the Company&#8217;s strategic operating plan is to sublicense Vicineum to business development partners in all regions outside the US, including the EU, with it earning a potential combination of upfront, milestone, and royalty payments, and the business development partner bearing the majority of regulatory and commercialization costs. The Company participated in Type A Meetings with the FDA on October&#160;29, 2021 and December&#160;8, 2021 to discuss questions related to CMC and clinical issues raised in the CRL. Both meetings helped the Company determine the appropriate path forward for Vicineum. Based upon the outcome of these meetings, the Company plans to conduct an additional Phase&#160;3 clinical trial. Also, during the Clinical Type A Meeting, the Company aligned with FDA to include patients with less than adequate BCG into its new clinical trial. The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum EU rights was not impaired as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not recognize any impairment charges during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on the Company&#8217;s consolidated balance sheets is the result of the Company&#8217;s acquisition of Viventia in September&#160;2016 and represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets acquired under the acquisition method of accounting. Goodwill is not amortized; rather than recording periodic amortization, goodwill is quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of goodwill requires management to estimate the future discounted cash flows of a reporting unit using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. If the fair value of the equity of a reporting unit exceeds the reporting unit&#8217;s carrying value, including goodwill, then goodwill is considered not to be impaired. The Company recognizes a goodwill impairment when and to the extent that the fair value of the equity of a reporting unit is less than the reporting unit&#8217;s carrying value, including goodwill. The Company has only one reporting unit. In addition, on a quarterly basis, the Company performs a qualitative review of its business operations to determine whether events or changes in circumstances have occurred which could have a material adverse effect on the estimated fair value of each reporting unit and thus indicate a potential impairment of the goodwill carrying value. If an impairment indicator is identified, an interim impairment assessment is performed. Given the inherent uncertainty in the development plans for Vicineum as a result of the CRL and the Company&#8217;s withdrawal of its MAA, an impairment analysis was conducted in the third quarter of 2021. While an impairment was recognized in one of the Company&#8217;s intangible assets, Vicineum US Rights, the Company concluded that the carrying value of its goodwill of $13.1&#160;million was not impaired as of September&#160;30, 2021. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that there was no goodwill impairment as of December&#160;31, 2021. Management believes the Company has sufficient future cash flows from additional geographic regions outside the US to support the value of its goodwill. The Company projects future cash flows based on various timeline assumptions and applies a probability to each outcome based on management&#8217;s best estimate. In addition, probabilities of success in achieving certain clinical and regulatory success can also have a material effect on the estimated fair value of the equity of its reporting unit as of the impairment assessment date. The Company will continue to evaluate timelines for commercialization and probability of success of development of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on the annual testing and quarterly reviews performed, the Company concluded that there was no goodwill impairment during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company uses a discounted cash flow model to estimate the fair value of the contingent consideration liability each reporting period, which represents the present value of projected future cash flows associated with regulatory approval milestones and royalties on net sales due to the selling shareholders of Viventia Bio Inc. as a result of the Viventia Acquisition in September&#160;2016. See &#8220;Note 1. Description of Business&#8221; for additional information. Contingent consideration is measured at its estimated fair value on a recurring basis at each reporting period, with fluctuations in value resulting in a non-cash charge to earnings (or loss) during the period. The estimated fair value measurement is based on significant unobservable inputs (Level&#160;3 within the fair value hierarchy), including internally developed financial forecasts, probabilities of success and timing of certain milestone events and achievements, which are inherently uncertain. Actual future cash flows may differ from the assumptions used to estimate the fair value of contingent consideration. The valuation of contingent consideration requires the use of significant assumptions and judgments, which management believes are consistent with those that would be made by a market participant. Management reviews its assumptions and judgments on an ongoing basis as additional market and other data is obtained, and any future changes in the assumptions and judgments utilized by management may cause the estimated fair value of contingent consideration to fluctuate materially, resulting in earnings volatility. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. The Company reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of its contingent consideration is based. The most significant and impactful assumptions in the Company&#8217;s revenue projection models are timing of product launch and probabilities of clinical and regulatory success (&#8220;POS&#8221;); the Company expects delays in the start of commercialization and estimates lower POS as a direct result of the CRL. The Company plans to conduct an additional clinical trial, which will lead to delays in the start of commercialization globally. The Company has assessed a range of commercialization timeline assumptions and applied a probability to each outcome based on management&#8217;s best estimate. In addition, the Company now assumes a lower POS in achieving certain clinical and regulatory milestones in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the range of approximately 45% to 55% globally. Any changes in these assumptions and estimates, or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. The fair value of the Company&#8217;s contingent consideration is determined based on the present value of projected future cash flows associated with sales-based milestones and earnouts on net sales and is heavily dependent on discount rates to estimate the fair value at each reporting period. Earnouts are determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout is derived from the Company&#8217;s estimated weighted-average cost of capital (&#8220;WACC&#8221;), which has fluctuated from 8.8% as of December&#160;31, 2020, to 7.8% as of March&#160;31, 2021, 6.8% as of June&#160;30, 2021, 8.6% as of September&#160;30, 2021, and 9.3% as of December&#160;31, 2021. Milestone payments constitute debt-like obligations, and therefore a high-yield debt index rate is applied to the milestones in order to determine the estimated fair value. This index rate changed from 8.4% as of December&#160;31, 2020, to 7.4% as of March&#160;31, 2021, 6.6% as of June&#160;30, 2021, 7.5% as of September&#160;30, 2021, and 8.0% as of December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Effective January&#160;1, 2019, the Company adopted ASC Topic 842, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 842&#8221;) using the optional transition method outlined in ASU No. 2018-11, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases (Topic 842), Targeted Improvements</font><font style="letter-spacing:0.2pt;">. The adoption of ASC 842 represents a change in accounting principle that aims to increase transparency and comparability among organizations by requiring the recognition of right-of-use assets and lease liabilities on the balance sheet for both operating and finance leases. In addition, the standard requires enhanced disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. The reported results for the year ended December&#160;31, 2021, 2020 and 2019 reflect the application of ASC 842 guidance, while the reported results for priors were prepared in accordance with the previous ASC Topic 840, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 840&#8221;) guidance. The adoption of ASC 842 resulted in the recognition of operating lease right-of-use assets and corresponding lease liabilities of $0.2&#160;million on the Company&#8217;s consolidated balance sheet as of January&#160;1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s financial condition, results of operations or cash flows; however, the adoption did result in significant changes to the Company&#8217;s financial statement disclosures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As part of the adoption of ASC 842, the Company utilized certain practical expedients outlined in the guidance. These practical expedients include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Accounting policy election to use the short-term lease exception by asset class; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Election of the practical expedient package during transition, which includes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">An entity need not reassess whether any expired or existing contracts are or contain leases; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">An entity need not reassess the classification for any expired or existing leases. As a result, all leases that were classified as operating leases in accordance with ASC 840 are classified as operating leases under ASC 842, and all leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases under ASC 842; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.41pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">An entity need not reassess initial direct costs for any existing leases. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s lease portfolio as of the adoption date and as of December&#160;31, 2021 includes: a property lease for manufacturing, laboratory, warehouse and office space in Winnipeg, Manitoba, a property lease for its headquarters in Cambridge, MA, and a property lease for office space in Philadelphia, PA. The Company determines if an arrangement is a lease at the inception of the contract and has made a policy election to not separate out non-lease components from lease components, for all classes of underlying assets. The asset components of the Company&#8217;s operating leases are recorded as operating lease right-of-use assets and reported within other assets on the Company&#8217;s consolidated balance sheet. The short-term and long-term liability components are recorded in other current liabilities and other liabilities, respectively, on the Company&#8217;s consolidated balance sheet. As of December&#160;31, 2021, the Company did not have any finance leases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Right-of-use assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term at the commencement date. Existing leases in the Company&#8217;s lease portfolio as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">of the adoption date were valued as of January&#160;1, 2019. The Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments, if an implicit rate of return is not provided with the lease contract. Operating lease right-of-use assets are adjusted for incentives received. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Operating lease costs are recognized on a straight-line basis over the lease term, in accordance with ASC 842, and also include variable operating costs incurred during the period. Lease costs also include amounts related to short-term leases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are expensed in the period incurred. Research and development expenses consist of both internal and external costs associated with all basic research activities, clinical development activities and technical efforts required to develop a product candidate. Internal research and development consist primarily of personnel costs, including salaries, benefits and share-based compensation, facilities leases, research-related overhead, pre-approval regulatory and clinical trial costs, manufacturing and other contracted services, license fees and other external costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In certain circumstances, the Company is required to make advance payments to vendors for goods or services that will be received in the future for use in research and development activities. In such circumstances, the advance payments are recorded as prepaid assets and expensed when the activity has been performed or when the goods have been received. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes the grant-date fair value of share-based awards granted as compensation as expense on a straight-line basis over the requisite service period, which is generally the vesting period of the award. To date, the Company has not issued awards where vesting is subject to market conditions. From time to time, the Company has granted to its executives&#8217; stock option awards which contain both performance-based and service-based vesting criteria. Performance milestone events are specific to the Company&#8217;s corporate goals, including certain clinical development objectives related to the new clinical trial, regulatory and financial objectives. Share-based compensation expense associated with performance-based vesting criteria is recognized using the accelerated attribution method if the performance condition is considered probable of achievement in management&#8217;s judgment. The fair value of stock options is estimated at the time of grant using the Black-Scholes option pricing model, which requires the use of inputs and assumptions such as the fair value of the underlying stock, exercise price of the option, expected term, risk-free interest rate, expected volatility and dividend yield. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of each grant of options during the&#160;years ended December&#160;31, 2021, 2020 and 2019 was determined using the following methods and assumptions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected Term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Due to the lack of historical exercise data and given the plain vanilla nature of the options granted by the Company, the expected term is determined using the &#8220;simplified&#8221; method, as prescribed in SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) No. 107 (&#8220;SAB 107&#8221;), whereby the expected life equals the arithmetic average of the vesting term (generally four&#160;years) and the original contractual term (ten&#160;years) of the option, taking into consideration multiple vesting tranches. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Risk-Free Interest Rate.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The risk-free rate is based on the interest rate payable on United States Treasury securities in effect at the time of grant for a period that is commensurate with the assumed expected term. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected Volatility.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The expected volatility is based on historical volatilities of a representative group of publicly traded biopharmaceutical companies, including the Company&#8217;s own volatility, which were commensurate with the assumed expected term, as prescribed in SAB 107. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividend Yield.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The dividend yield is 0% because the Company has never declared or paid, and for the foreseeable future does not expect to declare or pay, a dividend on its common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss (&#8220;NOL&#8221;) and research and development credit (&#8220;R&amp;D credit&#8221;) carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is recorded to the extent it is more likely than not that some portion or all of the deferred tax assets will not be realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unrecognized income tax benefits represent income tax positions taken on income tax returns that have not been recognized in the financial statements. The Company recognizes the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit is recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The Company recognizes accrued interest and penalties related to uncertain tax positions as income tax expense in its consolidated statements of operations. As of December&#160;31, 2021 and 2020, the Company did not have any uncertain tax positions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue Recognition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company records revenue from out-license agreements and OUS business development partnership agreements, including the License Agreement with Roche and its OUS partnerships. Under each of these agreements, the Company granted the counterparty an exclusive license to develop and commercialize the underlying licensed product. These agreements contain up-front license fees, development and regulatory milestone payments, sales-based milestone payments, and sales-based royalty payments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company determines whether the out-license agreements and OUS business development partnership agreements are in scope of ASC 606, which it adopted as of January&#160;1, 2018. Under ASC 606, in determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under these agreements, management performs the following steps: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Identification of the contract; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3)</font>
          <br >
        </div>
        <div style=" margin-top:7.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Measurement of the transaction price, including the constraint on variable consideration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Allocation of the transaction price to the performance obligations; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Recognition of revenue when or as the Company satisfies each performance obligation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Development and Regulatory Milestones and Other Payments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the inception of an arrangement that includes development milestone payments, management evaluates whether the development milestones are considered probable of being reached and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated development milestone value is included in the transaction price. Development milestone payments that are not within the Company&#8217;s control or the licensee&#8217;s control, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. For payments pursuant to sales milestones and royalty payments, the Company will not recognize revenue until the subsequent sale of a licensed product occurs. For arrangements with one than one performance obligations, the milestones are generally allocated entirely to the license performance obligation, as (1)&#160;the terms of milestone and royalty payments relate specifically to the license and (2)&#160;allocating milestones and royalties to the license performance obligation is consistent with the overall allocation objective, because management&#8217;s estimate of milestones and royalties approximates the standalone selling price of the license. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2021, a $20&#160;million milestone was achieved due to Roche initiating a Phase&#160;II clinical trial. The Company invoiced Roche $20&#160;million with payment terms of 30&#160;days following the achievement of the corresponding milestone event, pursuant to the Roche License Agreement. Management evaluated the transaction under ASC 606 and determined it is probable that a significant revenue reversal will not occur in future periods, which was not the case in the previous quarter. Accordingly, the Company recorded $20&#160;million as license revenue and accounts receivables in the fourth quarter of 2021. In January&#160;2022, the payment of $20&#160;million was received. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.71pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognized $26.5&#160;million of license revenue related to the Roche, Qilu and MENA License Agreements during the year ended December&#160;31, 2021 and $11.2&#160;million of license revenue related to the Qilu License Agreement during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:10.71pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.&nbsp;&nbsp;&nbsp;RECENT ACCOUNTING PRONOUNCEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adopted in 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2019, the FASB issued ASU No. 2019-12, </font><font style="font-style:italic;letter-spacing:0.2pt;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</font><font style="letter-spacing:0.2pt;"> (&#8220;ASU 2019-12&#8221;). ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments in ASU 2019-12 also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal&#160;years, and interim periods within those fiscal&#160;years, beginning after December&#160;15, 2020. Early adoption is permitted. The method with which the amendments in this ASU are to be applied varies depending on the nature of the tax item impacted by amendment. The Company adopted this guidance effective January&#160;1, 2021, and it did not have a material impact on its financial position, results of operations or cash flows. </font>
        </div>
        <div style="margin-top:10.72pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.&nbsp;&nbsp;&nbsp;FAIR VALUE MEASUREMENT AND FINANCIAL INSTRUMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The carrying values of cash and cash equivalents, restricted cash, prepaid expenses and other current assets, and accounts payable on the Company&#8217;s consolidated balance sheets approximated their fair values as of December&#160;31, 2021 and 2020 due to their short-term nature. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.61pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain of the Company&#8217;s financial instruments are measured at fair value using a three-level hierarchy that prioritizes the inputs used to measure fair value. This fair value hierarchy prioritizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.62pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;1</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:5.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for identical instruments in active markets, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.61pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;2</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:5.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.62pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;3</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:5.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Inputs are unobservable and reflect the Company&#8217;s own assumptions, based on the best information available, including the Company&#8217;s own data. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.52pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following tables set forth the carrying amounts and fair values of the Company&#8217;s financial instruments measured at fair value on a recurring basis as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:456pt;height:146.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration&#8201;&#8211;&#8201;short term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration&#8201;&#8211;&#8201;long term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:158.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,374</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,374</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,374</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration, current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:214.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates transfers between fair value levels at the end of each reporting period. There were no transfers of assets or liabilities between fair value levels during the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The estimated fair value of the Company&#8217;s contingent consideration was determined using probabilities of successful achievement of regulatory milestones and commercial sales, the period in which these milestones and sales are expected to be achieved ranging from 2025 to 2033, the level of commercial sales of Vicineum forecasted for the US, Europe, Japan, China and other potential markets and discount rates ranging from 8.0% to 9.3% as of December&#160;31, 2021 and 8.4% to 8.8% as of December&#160;31, 2020. There have been no changes to the valuation methods utilized during the year ended December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary by quarter of the change in the fair value of the Company&#8217;s contingent consideration liability, measured on a recurring basis at each reporting period, for the year ended December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:164pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">108,840</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">48,160</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at March&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">157,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">13,600</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at June&#160;30, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">170,600</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(114,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at September&#160;30, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">56,600</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(4,600<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2021, current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2021, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the change in the fair value of the Company&#8217;s total contingent consideration liability, measured on a recurring basis at each reporting period, for the year ended December&#160;31, 2021. </font>
        </div>
        <table style="width:416pt;height:55.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">108,840</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration&#8201;&#8211;&#8201;short term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,985<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration&#8201;&#8211;&#8201;long term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(47,855<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the Company&#8217;s contingent consideration is determined based on the present value of projected future cash flows associated with sales-based milestones and earnouts on net sales and is heavily </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">dependent on discount rates to estimate the fair value at each reporting period. Earnouts are determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout is derived from the Company&#8217;s WACC, which has fluctuated from 8.8% as of December&#160;31, 2020, to 7.8% as of March&#160;31, 2021, 6.8% as of June&#160;30, 2021, 8.6% as of September&#160;30, 2021, and 9.3% as of December&#160;31, 2021. Milestone payments constitute debt-like obligations, and therefore a high-yield debt index rate is applied to the milestones in order to determine the estimated fair value. This index rate changed from 8.4% as of December&#160;31, 2020, to 7.4% as of March&#160;31, 2021, 6.6% as of June&#160;30, 2021, 7.5% as of September&#160;30, 2021, and 8.0% as of December&#160;31, 2021. The decrease in the fair value of contingent consideration of $56.8&#160;million for the year ended December&#160;31, 2021 was driven by the receipt of the CRL from the FDA, in which the FDA determined that it could not approve the BLA for Vicineum in its present form, and the Company&#8217;s withdrawal of its MAA with EMA. In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. Incorporating the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021, the Company reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of its contingent consideration is based. The most significant and impactful assumptions in the Company&#8217;s revenue projection models are timing of commercial product launch and probabilities of clinical and regulatory success; the Company expects delays in the start of commercialization and estimates lower POS as a direct result of the CRL and the Company&#8217;s withdrawal of its MAA. The Company plans to conduct an additional Phase&#160;3 clinical trial in order to resubmit a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, which will lead to delays in the start of commercialization globally. The Company has assessed a commercialization timeline assumption and applied a probability to each outcome based on management&#8217;s best estimate. In addition, the Company now assumes a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. Any changes in these assumptions and estimates as a result of these meetings, or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.&nbsp;&nbsp;&nbsp;RECEIVABLES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The accounts receivable balance as of December&#160;31, 2021 is $21.0&#160;million, comprised primarily of a $20&#160;million milestone achieved in December&#160;2021 due to Roche initiating a Phase&#160;II clinical trial. The Company invoiced Roche $20&#160;million with payment terms of 30&#160;days following the achievement of the corresponding milestone event, pursuant to the Roche License Agreement. In January&#160;2022 the payment of $20&#160;million was received. Additionally, in June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. As such, the Company recorded $0.9&#160;million of revenue and accounts receivable for the additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen an amount equal to its recovery of VAT. The Company will not be subject to VAT on future potential milestone payments from Qilu. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The other receivable balance as of December&#160;31, 2021 is $3.5&#160;million. The Company recorded $3.4&#160;million to other receivables in the fourth quarter of 2021 for German VAT recovery related to drug substance sent to Baxter. The Company received a payment for $1.8&#160;million in January&#160;2022 and expects to collect the remaining balance. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accounts receivable and other receivable balances as of December&#160;31, 2020 were de minims. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.&nbsp;&nbsp;&nbsp;PROPERTY AND EQUIPMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the composition of property and equipment, net as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:143pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lab equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">569</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">570</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Furniture and fixtures </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">99</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment, gross </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,009</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,004</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(966<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(881<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total Property and Equipment, Net</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.71pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation expense was $0.1&#160;million, $0.1&#160;million and $0.2&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.&nbsp;&nbsp;&nbsp;INTANGIBLES AND GOODWILL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intangibles</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Intangible assets on the Company&#8217;s consolidated balance sheet are the result of the Viventia Acquisition in September&#160;2016. The following table sets forth the composition of intangible assets as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:82.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">IPR&amp;D intangible assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Vicineum United States rights </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Vicineum European Union rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total Intangibles</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">46,400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the acquired intangible assets for the US and EU rights of Vicineum is determined using a risk-adjusted discounted cash flow approach, which includes probability adjustments for projected revenues and operating expenses based on the success rates assigned to each stage of development for each geographical region; as well as discount rates applied to the projected cash flows. In August&#160;2021, the Company received a CRL from the FDA regarding its BLA for Vicineum for the treatment of NMIBC, the Company&#8217;s lead product candidate. In the CRL, the FDA determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. Given the inherent uncertainty in the development plans for Vicineum as a result of the CRL and the Company&#8217;s withdrawal of its MAA, an impairment analysis was conducted in the third quarter of 2021, which concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum United States rights was fully impaired as of September&#160;30, 2021. The $31.7&#160;million of impairment charges as of September&#160;30, 2021 are due to delays in the expected start of commercialization and lower probabilities of success, combined with higher operating expenses expected to be incurred prior to commercialization, resulting in lower expected future cash flows estimated in the US market. At this time, management has assessed that the carrying value of the Vicineum EU rights is not at significant risk of impairment in the future within the current range of commercialization timelines and POS assumptions. This is primarily due to the fact that the Company expects the Vicineum sales outside of the US to be two to three times the expected sales volume in the US, based on management&#8217;s reassessment of the total addressable global market for high-risk NMIBC during the quarter ended June&#160;30, 2019, wherein management determined that both the global market size </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and the estimated potential Vicineum commercial sales within the global market were likely higher than the Company&#8217;s previous estimate. In addition, the EU asset is burdened with significantly less expense than the US asset, as the Company&#8217;s strategic operating plan is to sublicense Vicineum to business development partners in all regions outside the US, including the EU, with it earning a potential combination of upfront, milestone, and royalty payments, and the business development partner bearing the majority of regulatory and commercialization costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum EU rights was not impaired as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not recognize any impairment charges during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on the Company&#8217;s consolidated balance sheet is the result of the Viventia Acquisition in September&#160;2016. Goodwill had a carrying value of $13.1&#160;million as of December&#160;31, 2021 and 2020. Given the inherent uncertainty in the development plans for Vicineum as a result of the CRL and the Company&#8217;s withdrawal of its MAA, a quantitative impairment analysis was conducted during the third quarter of 2021, in advance of the Company&#8217;s typical annual assessment date of October&#160;1. While an impairment was recognized in one of its intangible assets, Vicineum US Rights, the Company concluded that the carrying value of its goodwill of $13.1&#160;million was not impaired as of September&#160;30, 2021, with the fair value of equity of the reporting unit exceeding the estimated carrying value of the reporting unit by approximately 45%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that there was no goodwill impairment as of December&#160;31, 2021. The Company believes it has sufficient future cash flows from additional geographic regions outside the US to support the value of its goodwill. The Company projects future cash flows based on various timeline assumptions and applies a probability to each outcome based on management&#8217;s best estimate. In addition, probabilities of success in achieving certain clinical and regulatory success in the Company&#8217;s current development profile (ranging from 45% to 55% globally) also have a material effect on the estimated fair value of its reporting unit as of the impairment assessment date. The Company will continue to evaluate its timelines for commercialization and probability of success of development of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on the annual testing and quarterly reviews performed, the Company concluded that there was no goodwill impairment during the year ended December&#160;31, 2020. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.&nbsp;&nbsp;&nbsp;ACCRUED EXPENSES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the composition of accrued expenses as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:112.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,841</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,372</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payroll-related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">2,967</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,892</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restructuring charge related </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,497</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,941</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">684</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">9</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">25</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Accrued Expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,973</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.71pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company may become subject to legal proceedings, claims, and litigation arising in the ordinary course of business. When the Company becomes aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. In accordance with authoritative guidance, the Company records loss contingencies in its financial statements only for matters in which losses are probable and can be reasonably estimated. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum estimated liability. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the nature of the specific claim if the likelihood of a potential loss is reasonably possible, and the amount involved is material. The Company continuously assesses the potential liability related to the Company&#8217;s pending litigation and revises its estimates when additional information becomes available. The Company is not currently a party to any material legal proceedings, other than as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7, 2021, three substantially identical securities class action lawsuits captioned Bibb v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07025, Cizek v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07309, and Markman v. Sesen Bio, Inc. et al., Case No. 1:21-cv-08308 were filed against the Company and certain of its officers in the US District Court for the Southern District of New York. The three complaints allege violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints seek compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption In re Sesen Bio, Inc. Securities Litigation, Master File No. 1:21-cv-07025-AKH (the &#8220;Securities Litigation&#8221;), and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj (&#8220;Lead Plaintiffs&#8221;) collectively as the lead plaintiffs under the Private Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. The court has not ruled on those motions at this time. On November&#160;24, 2021, defendants filed a motion to transfer venue to the US District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not yet ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed an amended class action complaint (the &#8220;Amended Complaint&#8221;). The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. Defendants&#8217; response to the Amended Complaint is due to be filed on March&#160;7, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2021 and September&#160;24, 2021, two substantially similar derivative lawsuits captioned Myers v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11538 and D&#8217;Arcy v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11577 were filed against the Company&#8217;s board of directors and certain of its officers in the US District Court for the District of Massachusetts, with the Company named as a nominal defendant. On January&#160;12, 2022, a third derivative complaint captioned Tang v. Sesen Bio, Inc., et al., was filed in Superior Court in Massachusetts against the Company&#8217;s board of directors and certain of its officers in the US District </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Court for the District of Massachusetts, with the Company named as nominal defendant, but no defendant has yet been served. The three derivative complaints allege breach of fiduciary duties, waste of corporate assets, and violations of federal securities laws based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The D&#8217;Arcy complaint further alleges unjust enrichment, abuse of control, gross mismanagement and aiding and abetting thereof. The three derivative complaints seek unspecified damages, restitution and disgorgement of profits, benefits and compensation obtained by the defendants and costs and expenses, including attorneys&#8217; fees. On October&#160;18, 2021, the court consolidated the two federal cases under the caption In re Sesen Bio, Inc. Derivative Litigation, Lead Case No. 1:21-cv-11538 (the &#8220;Federal Derivative Litigation&#8221;). On December&#160;22, 2021, the court entered a joint stipulation among the parties to stay the Federal Derivative Litigation until after a ruling on any motion to dismiss filed by defendants in the Securities Litigation. Defendants intend to seek a similar stay of the state court derivative litigation in the event any defendant is served. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company believes that these lawsuits are without merit and intends to vigorously defend against them. The lawsuits are in the early stages and, at this time, no assessment can be made as to the likely outcome or whether the outcome will be material to the Company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Employment Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has entered into employment agreements and offer letters with certain of its key executives, providing for separation payments and benefits in certain circumstances, as defined in the agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.&nbsp;&nbsp;&nbsp;LEASES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for operating leases under ASC Topic 842, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases.</font><font style="letter-spacing:0.2pt;"> The Company&#8217;s lease portfolio includes an operating lease for its 31,100 square foot facility in Winnipeg, Manitoba which consists of manufacturing, laboratory, warehouse and office space. In September&#160;2020, the Company entered into an extension of this lease for an additional two&#160;years, through September&#160;2022, with a right to extend the lease for one subsequent three-year term. The minimum monthly rent under this lease is CAD $18,100 (approximately $14,300 at exchange rates in effect on December&#160;31, 2021). In addition to rent expense, the Company expects to incur CAD $18,200 per month related to operating expenses (approximately $14,300 at exchange rates in effect on December&#160;31, 2021). Operating lease cost under this lease, including the related operating costs, were $0.3&#160;million and $0.3&#160;million for the year ended December&#160;31, 2021 and $0.3&#160;million and $0.3&#160;million for the year ended December&#160;31, 2020, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The asset component of the Company&#8217;s operating leases is recorded as operating lease right-of-use assets and reported within other assets on the Company&#8217;s consolidated balance sheets. The short-term lease liability is recorded in other current liabilities and the long-term lease liability is recorded in other liabilities on the Company&#8217;s consolidated balance sheets. Operating lease cost is recognized on a straight-line basis over the term of the lease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Company has short-term property leases for modular office space for 1) its corporate headquarters in Cambridge, MA and 2) office space in Philadelphia, PA. The short-term leases renew every three&#160;months to six&#160;months and currently extend through June&#160;2022 and May&#160;2022, respectively. The minimum monthly rent for these office spaces is $2,100 and $18,400, respectively, which is subject to change if and as the Company adds space to or deducts space from the leases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The components of lease cost for the&#160;years ended December&#160;31, 2021 and 2020 is as follows (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Lease Cost:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease (including related operating costs) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">301</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Short term property leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">262</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">261</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:264.81pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total lease costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">589</div>
            </td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">562</div>
            </td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:62.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:264.81pt;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Supplemental Information:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average remaining lease term (years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.75</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.75</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average discount rate&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">12<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">12<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.1pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the Company&#8217;s future minimum lease payments under non-cancelable leases as of December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:340.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:340.41pt;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Minimum Lease Payments:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total future minimum lease payments (2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">129</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:340.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less: Amounts representing present value adjustment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:340.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">124</div>
            </td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.1pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.&nbsp;&nbsp;&nbsp;STOCKHOLDERS&#8217; EQUITY DEFICIT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Financings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">ATM Offering</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2019, the Company entered into an Open Market Sale Agreement </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">SM</font><font style="letter-spacing:0.2pt;"> (the &#8220;Sale Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;), under which the Company may issue and sell shares of its common stock, par value $0.001 per share, from time to time (the &#8220;ATM Offering&#8221;) for an aggregate sales price of up to $35&#160;million through Jefferies. In October&#160;2020 and February&#160;2021, the Company entered into Amendments No. 1 and No. 2 to the Sale Agreement, respectively. Amendments No. 1 and No. 2 modified the Sale Agreement to reflect that the Company may issue and sell shares of its common stock from time to time for an aggregate sales price of up to an additional $50.0&#160;million and $34.5&#160;million, respectively. In June&#160;2021, the Company entered into Amendment No. 3 to the Sale Agreement, which modified the Sale Agreement to remove the maximum dollar amount of shares of common stock that may be sold pursuant to the Sale Agreement. In June and July&#160;2021, the Company filed prospectus supplements with the SEC in connection with the offer and sale of up to an aggregate of $200&#160;million of common stock pursuant to the Sale Agreement. Sales are made by any method that is deemed to be an ATM offering as defined in Rule&#160;415(a)(4) of the Securities Act of 1933, as amended, including but not limited to sales made directly on or through the Nasdaq Global Market or any other existing trading market for the Company&#8217;s common stock. The Company may sell shares of its common stock efficiently from time to time but has no obligation to sell any of its common stock and may at any time suspend offers under the Sale Agreement or terminate the Sale Agreement. Subject to the terms and conditions of the Sale Agreement, Jefferies will use its commercially reasonable efforts to sell common stock from time to time, as the sales agent, based upon the Company&#8217;s instructions, which include a prohibition on sales below a minimum price set by the Company from time to time. The Company has provided Jefferies with customary indemnification rights, and Jefferies is entitled to a commission at a fixed rate equal to 3.0% of the gross proceeds for each sale of common stock under the Sale Agreement. The Company raised $175.0&#160;million of net proceeds from the sale of 56.9&#160;million shares of common stock at a weighted-average price of $3.17 per share during the year ended December&#160;31, 2021, compared to $38.0&#160;million of net proceeds from the sale of 33.4&#160;million shares of common stock at a weighted-average price of $1.17 per share during the year ended December&#160;31, 2020. Share issuance costs, including sales agent commissions, related to the ATM Offering totaled $5.4&#160;million and $1.2&#160;million during the year ended December&#160;31, 2021 and 2020, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">June&#160;2019 Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2019, the Company raised $27.8&#160;million of net proceeds from the sale of 20.4&#160;million shares of common stock and accompanying warrants to purchase an additional 20.4&#160;million shares of common stock in an underwritten public offering (the &#8220;June&#160;2019 Financing&#8221;). The combined purchase price for each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">share of common stock and accompanying warrant was $1.47. Subject to certain ownership limitations, the warrants issued in the June&#160;2019 Financing were exercisable immediately upon issuance at an exercise price of $1.47 per share, subject to adjustments as provided under the terms of such warrants, and had a one-year term that expired on June&#160;21, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;), the Company is authorized to issue 5.0&#160;million shares of &#8220;blank check&#8221; preferred stock, $0.001 par value per share, which enables its board of directors, from time to time, to create one or more series of preferred stock. Each series of preferred stock issued shall have the rights, preferences, privileges and restrictions as designated by the board of directors. The issuance of any series of preferred stock could affect, among other things, the dividend, voting and liquidation rights of the Company&#8217;s common stock. The Company had no preferred stock issued and outstanding as of December&#160;31, 2021 and 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Following approval by the Company&#8217;s stockholders on May&#160;3, 2021, an amendment became effective to the Certificate of Incorporation that increased the number of authorized shares of common stock from 200&#160;million to 400&#160;million, of which 199&#160;million and 140&#160;million shares were issued and outstanding as of December&#160;31, 2021 and 2020, respectively. In addition, the Company had reserved for issuance the following amounts of shares of its common stock for the purposes described below as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:456pt;height:142.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Shares of common stock issued </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">140,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Shares of common stock reserved for issuance for: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,247</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">RSUs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for grant under 2014 Stock Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,933</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4,863</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for sale under 2014 Employee Stock Purchase Plan </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">2,300</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total shares of common stock issued and reserved for issuance</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">229,640</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">157,707</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.4pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The voting, dividend and liquidation rights of holders of shares of common stock are subject to and qualified by the rights, powers and preferences of holders of shares of preferred stock. Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders; provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#8217;s Certificate of Incorporation that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more such series, to vote thereon. There shall be no cumulative voting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dividends may be declared and paid on the common stock from funds lawfully available thereof as and when determined by the board of directors and subject to any preferential dividend or other rights of any then-outstanding preferred stock. The Company has never declared or paid, and for the foreseeable future does not expect to declare or pay, dividends on its common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the dissolution or liquidation of the Company, whether voluntary or involuntary, holders of common stock will be entitled to receive all assets of the Company available for distribution to its stockholders, subject to any preferential or other rights of any then-outstanding preferred stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">All of the Company&#8217;s outstanding warrants are non-tradeable and equity-classified because they meet the derivative scope exception under ASC Topic 815-40, </font><font style="letter-spacing:0.2pt;">Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Own Equity</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 815-40&#8221;)</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;"> The following table sets forth the Company&#8217;s warrant activity for the year ended December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:108pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:41.92pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:20.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Exercised) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:37.92pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Cancelled) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jun-2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.47</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Jun-2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mar-2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mar-2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,705</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,573<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2017 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Nov-2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">487</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(475<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May-2015 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.83</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Nov-2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2014 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">11.04</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Nov-2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:114.65pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:41.92pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,247</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,048<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Exercise price shown (i)&#160;reflects modification described below and (ii)&#160;subject to further adjustment based on down round provision added by amendment described below. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2021, the Company received proceeds of $1.1&#160;million from the exercises of 1.6&#160;million 2018 Warrants and 0.5&#160;million 2017 Warrants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrant Modifications</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2019, the Company entered into transactions with holders of its outstanding 2018 Warrants and 2017 Warrants to purchase the Company&#8217;s common stock. At such time, the 2018 Warrants and 2017 Warrants utilized the same form of warrant, which contained a prohibition on variable rate transactions (as defined therein). Warrant holders agreed to waive such prohibition in exchange for certain concessions from the Company. Management evaluated the warrants after modifications and determined that they continued to be equity-classified under the derivative scope exception of ASC 815-40. The warrants were revalued immediately before and immediately after the modifications to calculate the $1.1&#160;million incremental value of the modified warrants. The Company considers this incremental value to be akin to an offering cost since the modifications were directly related to enabling the ATM Offering and would not have otherwise been incurred. Therefore, in the fourth quarter of 2019, management initially capitalized the $1.1&#160;million to deferred financing cost asset, with an offsetting credit to additional paid-in capital, and then reclassified the deferred financing cost asset to reduce the ATM Offering proceeds within equity as proceeds were received from sales of common stock under the ATM Offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2018 Warrants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2019, the Company entered into transactions with the holders of its outstanding 2018 Warrants pursuant to which such holders either (i)&#160;exercised their warrants pursuant to a Warrant Exercise Agreement (the &#8220;2018 Warrant Exercise Agreements&#8221;) or (ii)&#160;amended their warrants pursuant to a Warrant Amendment Agreement (the &#8220;2018 Warrant Amendment Agreements&#8221;). As consideration for those holders executing the 2018 Warrant Exercise Agreements, the Company reduced the exercise price of the warrants from $1.20 to $0.60 per share of the Company&#8217;s common stock, resulting in proceeds of $2.0&#160;million from the exercise of 3.4&#160;million warrants. Pursuant to the 2018 Warrant Amendment Agreements, the prohibition on certain variable rate transactions included in the 2018 Warrants was amended to exclude ATM offerings and the exercise price of the warrants was reduced from $1.20 to the lesser of (a)&#160;$0.95 per share of common stock and (b)&#160;the exercise price as determined from time to time pursuant to the anti-dilution provisions in the 2018 Warrant Amendment Agreements. During the second quarter of 2020, the anti-dilution provision was triggered to lower the exercise price of the warrants to $0.55; as such, the Company recognized a deemed dividend of approximately $0.1&#160;million which reduced the income available to common stockholders. As the Company has an accumulated deficit balance, there is no overall impact to additional paid-in capital, as the deemed dividend is recorded as offsetting debit and credit entries to additional paid-in capital. Therefore, the amounts were not presented on the Statement of Stockholders&#8217; (Deficit) Equity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the 2018 Warrant Exercise Agreements and 2018 Warrant Amendment Agreements, the Company entered into an amendment to the Securities Purchase Agreement dated March&#160;21, 2018 related </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to the March&#160;2018 Financing, by and among the Company and each purchaser identified on the signature pages thereto, with certain holders representing greater than 50.1% of the securities issued based on initial subscription amounts, pursuant to which the prohibition on variable rate transactions, including ATM offerings, was deleted in its entirety. </font>
        </div>
        <div style="margin-top:9.92pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2017 Warrants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2019, the Company entered into transactions with the holders of its outstanding 2017 Warrants pursuant to which such holders either (i)&#160;exercised their warrants pursuant to a Warrant Exercise Agreement (the &#8220;2017 Warrant Exercise Agreements&#8221;) or (ii)&#160;amended their warrants pursuant to a Warrant Amendment Agreement (the &#8220;2017 Warrant Amendment Agreements&#8221;). As consideration for those holders executing the 2017 Warrant Exercise Agreements, the Company reduced the exercise price of the warrants from $0.80 to $0.55 per share of the Company&#8217;s common stock. Pursuant to the 2017 Warrant Amendment Agreements, the prohibition on certain variable rate transactions, including ATM offerings, included in the 2017 Warrants was deleted in its entirety and the exercise price of the warrants was reduced from $0.80 to the lesser of (a)&#160;$0.55 per share of common stock and (b)&#160;the exercise price as determined from time to time pursuant to the anti-dilution provisions in the 2017 Warrant Amendment Agreements. As of December&#160;31, 2021, there has been no adjustment to the exercise price of these warrants. </font>
        </div>
        <div style="margin-top:9.92pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">13.&nbsp;&nbsp;&nbsp;EARNINGS (LOSS) PER SHARE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A net loss cannot be diluted. Therefore, when the Company is in a net loss position, basic and diluted loss per common share are the same. If the Company achieves profitability, the denominator of a diluted earnings per common share calculation includes both the weighted-average number of shares outstanding and the number of common stock equivalents, if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include warrants, stock options and non-vested restricted stock awards and&#160;units using the treasury stock method, along with the effect, if any, from outstanding convertible securities. The majority of the Company&#8217;s outstanding warrants to purchase common stock have participation rights to any dividends that may be declared in the future and are therefore considered to be participating securities. Participating securities have the effect of diluting both basic and diluted earnings per share during periods of income. During periods of loss, no loss is allocated to the participating securities since the holders have no contractual obligation to share in the losses of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, an entity that presents earnings per share shall recognize the value of the effect of an anti-dilution provision in an equity-classified freestanding financial instrument in the period the anti-dilution provision is triggered. That effect shall be treated as a deemed dividend and as a reduction of income available to common stockholders in basic earnings per share. The deemed dividend is added back to income available to common stockholders when applying the treasury stock method for diluted earnings per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For periods with net income, diluted net earnings per share is calculated by either (i)&#160;adjusting the weighted-average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period as determined using the treasury stock method or (ii)&#160;the two-class method considering common stock equivalents, whichever is more dilutive. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The two-class method was not applied for the twelve&#160;months ended December&#160;31, 2021, 2020 and 2019 as the Company&#8217;s participating securities do not have any obligation to absorb net losses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of the diluted net loss per share calculation, common stock equivalents are excluded from the calculation if their effect would be anti-dilutive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities outstanding as of December&#160;31, 2021, 2020 and 2019 have been excluded from the denominator of the diluted loss per share of common stock outstanding calculation (in thousands): </font>
        </div>
        <table style="width:416pt;height:59.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,247</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,895</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">10,147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:296.88pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,902</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">12,394</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">29,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">14.&nbsp;&nbsp;&nbsp;SHARE-BASED COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the amount of share-based compensation expense recognized by the Company by line item on its Consolidated Statements of Operations and Comprehensive Loss for the&#160;years ended December&#160;31, 2021, 2020 and 2019 (in thousands): </font>
        </div>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">973</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">350</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">188</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">4,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,407</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:296.88pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Share Based Compensation</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Stock Incentive Plan, as amended (the &#8220;2014 Plan&#8221;), was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 Plan became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and provides for the grant of incentive and non-qualified stock options, restricted stock awards and restricted stock&#160;units, stock appreciation rights and other stock-based awards, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to the Company&#8217;s employees, officers, directors, consultants and advisors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the Annual Meeting of the Company&#8217;s stockholders in June&#160;2019, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that (i)&#160;increased by 7.9&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan and (ii)&#160;eliminated the &#8220;evergreen&#8221; or automatic replenishment provision of the 2014 Plan, pursuant to which the number of shares of common stock authorized for issuance under the 2014 Plan was automatically increased on an annual basis. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that increased by 12&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan. There were approximately 8.9&#160;million shares of common stock available for issuance under the 2014 Plan as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stock options outstanding under the 2014 Plan generally vest over a four-year period at the rate of 25% of the grant vesting on the first anniversary of the date of grant and 6.25% of the grant vesting at the end of each successive three-month period thereafter. Stock options granted under the 2014 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 12.8&#160;million stock options outstanding under the 2014 Plan as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;9, 2021, the Board of Directors and the Compensation Committee of the Company approved a retention program for all current employees, except for the Chief Executive Officer, pursuant to which the Company will provide certain incentives designed to retain such employees (the &#8220;Retention Program&#8221;). Pursuant to the Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s non-executive employees received a combination of a cash bonus award and a one-time restricted stock unit (&#8220;RSU&#8221;) award which vests in full on September&#160;30, 2022, subject to continued employment through September&#160;30, 2022. Each RSU represents a contingent right to receive one share of the Company&#8217;s common stock. The Company recorded an expense of $0.5&#160;million for retention-related RSUs for the year ended December&#160;31, 2021. Additionally, the Company expensed $0.6&#160;million in relation to the cash bonus portion of the retention program. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also pursuant to the Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s executive officers, except for the Chief Executive Officer, were granted a one-time performance-based restricted stock unit (&#8220;PSU&#8221;) award equal to the value of approximately fifty&#160;percent of current base salary. Each PSU represents a contingent right to receive one share of the Company&#8217;s common stock upon the satisfaction of pre-determined performance criteria. Subject to continued employment, such awards vest on September&#160;30, 2023 upon the determination by the Compensation Committee of the level of achievement of certain key milestones consisting of a clinical trial milestone, an employee retention milestone and cash management milestones. As none of the retention milestones were met in the year ended December&#160;31, 2021 and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:141.39pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">achievement was deemed not probable, the Company did not record expenses for retention-related PSUs. As of December&#160;31, 2021, the unrecognized compensation expense for the retention-related PSUs, granted on October&#160;1, 2021, was $0.4&#160;million. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A summary of the status of restricted stock&#160;units is presented below: </font>
        </div>
        <table style="width:416pt;height:87pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.03pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Restricted Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Units</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,482</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted PSU </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">559</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">3,041</div>
            </td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The weighted average remaining contractual life of unvested RSUs and PSUs as of December&#160;31, 2021 is 9.75&#160;years. The Company did not grant restricted stock&#160;units during the&#160;years ended December&#160;31, 2020 and 2019. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2009 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 2009 Stock Incentive Plan, as amended and restated (the &#8220;2009 Plan&#8221;), which provided for the grant of incentive and non-qualified stock options and restricted stock awards and restricted stock&#160;units, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to its employees, officers, directors, consultants and advisors. Upon the closing of its IPO in February&#160;2014, the Company ceased granting awards under the 2009 Plan and all shares (i)&#160;available for issuance under the 2009 Plan at such time and (ii)&#160;subject to outstanding awards under the 2009 Plan that expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased without having been fully exercised or resulting in any common stock being issued were carried over to the 2014 Plan. Stock options granted under the 2009 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 0.1&#160;million fully vested stock options outstanding under the 2009 Plan as of December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-of-Plan&#160;Inducement Grants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company has granted equity awards to its newly hired employees, including executives, in accordance with the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) employment inducement grant exemption (Nasdaq Listing Rule&#160;5635(c)(4)). Such grants are made outside of the 2014 Plan and act as an inducement material to the employee&#8217;s acceptance of employment with the Company. There were approximately 2.8&#160;million stock options outstanding which were granted as employment inducement awards outside of the 2014 Plan as of December&#160;31, 2021. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the Company&#8217;s total stock option activity, including awards granted under the 2014 Plan and 2009 Plan and inducement grants made outside of stockholder approved plans, for the&#160;years ended December&#160;31, 2021, 2020 and 2019: </font>
        </div>
        <table style="width:456pt;height:268pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:241.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares under </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Contractual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Life</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,942</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.12</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.14</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">57</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,986</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.02</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(90<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.10</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(1,602<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.78</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,236</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.52</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">8.83</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">358</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,044</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.87</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(12<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.13</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(121<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.04</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,147</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.26</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">8.50</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">3,160</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.32</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(34<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(2,683<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">3.70</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.93</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.03</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">82</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,562</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.65</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.41</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">59</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognized share-based compensation expense of $5.1&#160;million for the year ended 2021. The stock option related expenses were $4.6&#160;million, $1.8&#160;million and $1.2&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. The RSU related expense was $0.5&#160;million for the year ended December&#160;31, 2021. The Company did not record RSU related expenses for the&#160;years ended December&#160;31, 2020 and 2019. As of December&#160;31, 2021, there was $10.4&#160;million of total unrecognized compensation cost related to non-vested stock options which the Company expects to recognize over a weighted-average period of 2.7&#160;years. The weighted-average grant-date fair value of stock options granted during the year ended December&#160;31, 2021, 2020 and 2019 were $2.16, $0.56 and $1.02, respectively. The total intrinsic value of stock options exercised for the&#160;years ended December&#160;31, 2021, 2020 and 2019 was de minimis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the&#160;years ended December&#160;31, 2021, 2020 and 2019, the grant-date fair value of stock options was determined using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model: </font>
        </div>
        <table style="width:456pt;height:112pt;margin-top:9.99999999999994pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:351.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:351.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair market value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.02</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grant exercise price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.02</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">74.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">71.5<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">78.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:0.330000000000041pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.&nbsp;&nbsp;&nbsp;EMPLOYEE BENEFIT PLANS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Employee Stock Purchase Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Employee Stock Purchase Plan (&#8220;2014 ESPP&#8221;) was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 ESPP became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and established an initial reserve of 0.2&#160;million shares of the Company&#8217;s common stock for issuance to participating employees. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 ESPP that increased by 2.3&#160;million the number of shares of common stock reserved for issuance under the 2014 ESPP. The purpose of the 2014 ESPP is to enhance employee interest in the success and progress of the Company by encouraging employee ownership of common stock of the Company. The 2014 ESPP provides employees with the opportunity to purchase shares of common stock at a 15% discount to the market price through payroll deductions or lump sum cash investments. The Company estimates the number of shares to be issued at the end of an offering period and recognizes expense over the requisite service period. Shares of the common stock issued and sold pursuant to the 2014 ESPP are shown on the consolidated statements of changes in stockholders&#8217; equity (deficit). As of December&#160;31, 2021, there were 2.3&#160;million shares of common stock available for sale under the 2014 ESPP. The Company sold a de minimis number of shares under the ESPP for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Defined Contribution Plans</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">United States&#8201;&#8212;&#8201;401(k) Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 401(k) defined contribution retirement plan which covers all of its US employees. Employees are eligible to participate on the first of the month following their date of hire. Under the 401(k) plan, participating employees may defer up to 100% of their pre-tax salary, subject to certain statutory limitations. Employee contributions vest immediately. The plan allows for a discretionary match per participating employee up to a maximum of $4,000 per year. The Company contributed a de minimis amount for each of the three&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Canada&#8201;&#8212;&#8201;Defined Contribution Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a defined contribution plan for its Canadian employees. Participants may contribute a&#160;percentage of their annual compensation to this plan, subject to statutory limitations. The Company contributes up to the first 4% of eligible compensation for its Canadian-based employees to the retirement plan. The Company contributed a de minimis amount for each of the three&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">16.&nbsp;&nbsp;&nbsp;INCOME TAXES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the components of the Company&#8217;s loss before income taxes by country (in thousands): </font>
        </div>
        <table style="width:456pt;height:82.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:306.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Country </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(32,757<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(35,529<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(27,468<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:306.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canada </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">24,148</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">14,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(80,032<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:306.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total Loss Before Income Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s tax benefit (provision) is comprised of the following components (in thousands): </font>
        </div>
        <table style="width:456pt;height:165pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current Tax Provision </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(286<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total current (provision) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(286<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax provision </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,559</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total deferred benefit (provision) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,559</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:336.26pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Tax Benefit (Provision) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not record current or deferred income tax or benefit for the year ended December&#160;31, 2019. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a reconciliation of the statutory United States federal income tax rate to the Company&#8217;s effective income tax rate: </font>
        </div>
        <table style="width:456pt;height:163.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:355.22pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">United States federal statutory income tax rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">21.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">21.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Impact of foreign rate differential </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(15.9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(4.2<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">4.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">State taxes, net of federal benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.3</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">2.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock option cancellations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(1.1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(0.2<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">178.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">14.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(18.0<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General business credits and other credits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">6.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Permanent differences </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(1.4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(13.8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(2.1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(0.5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Foreign taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(3.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(6.9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(72.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(37.7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(7.9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:355.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Effective Income Tax Rate</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">96.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(6.9<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the tax effects of temporary differences that gave rise to significant portions of the Company&#8217;s deferred tax assets and liabilities (in thousands): </font>
        </div>
        <table style="width:456pt;height:178.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">NOL carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">63,381</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">57,935</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">50,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">R&amp;D credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,316</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,787</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accruals and other </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,058</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,811</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Capitalized start-up costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">53</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">70</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">91</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">41</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">57</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Gross deferred tax assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">71,849</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">65,631</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">57,724</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">IPR&amp;D </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Gross deferred tax liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(71,849<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(65,631<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(57,724<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:-0.2pt;">Net Deferred Tax Liability</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In assessing the realizability of the Company&#8217;s deferred tax assets, management considers all relevant positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The realization of deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of the NOL and R&amp;D credit carryforwards. The Company has generated NOLs since its inception, and management believes that it is more likely than not that the Company&#8217;s deferred tax assets will not be realized. As a result, valuation allowances of $71.8&#160;million, $65.6&#160;million and $57.7&#160;million have been established as of December&#160;31, 2021, 2020 and 2019, respectively. The $6.2&#160;million increase in the valuation allowance was attributable to the NOL for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The net deferred tax liability of $4.0&#160;million primarily relates to the potential future impairments or amortization associated with IPR&amp;D intangible assets, which is not deductible for tax purposes and cannot be considered as a source of income to realize deferred tax assets. As a result, the Company recorded the deferred tax liability with an offset to goodwill. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the Company&#8217;s NOL and R&amp;D and other credit carryforwards in the United States and Canada as of December&#160;31, 2021 (in millions): </font>
        </div>
        <table style="width:456pt;height:179.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:322.77pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beginning in </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:28.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Through </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">United States: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:41.34pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.18pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal NOL carryforwards&#8201;&#8211;&#8201;indefinite </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">101.1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">None </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">None </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal NOL carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">118.9</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2038 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State NOL carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">138.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal R&amp;D credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.5</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State R&amp;D credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Canada: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:41.34pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.18pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal non-capital loss carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">31.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:322.77pt;white-space:normal;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Federal scientific research and experimental development expense carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal and provincial investment tax credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Tax Reform Act of 1986 (the &#8220;Act&#8217;), NOL and R&amp;D credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service, and there are similar provisions in certain state and non-US tax laws. NOL and R&amp;D credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interests of significant shareholders over a three-year period in excess of 50&#160;percent, as defined in Sections&#160;382 and 383 of the Internal Revenue Code, respectively. This could limit the amount of tax attributes that can be utilized to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future&#160;years. Management completed a Section&#160;382 study through March&#160;31, 2016 and determined that it is more likely than not that the Company&#8217;s NOL carryforwards are subject to a material limitation. Accordingly, the Company reduced its NOL carryforward by $0.8&#160;million. The Company has continued to raise additional equity capital since March&#160;2016 but has not done any additional analysis to determine whether or not ownership changes, as defined in the Act, have occurred, which would result in additional limitations. There could be additional ownership changes in the future that could further limit the amount of NOL carryforwards that the Company can utilize. The Company has not yet conducted a study of its R&amp;D credit carryforwards. Such a study may result in an adjustment to the Company&#8217;s R&amp;D credit carryforwards; however, until a study is completed and any adjustment is known, no amount is being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s R&amp;D credit carryforwards, and, if an adjustment is required, it would be offset by an adjustment to the valuation allowance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We assess the impact of various tax reform proposals and modifications to existing tax treaties in all jurisdictions where we have operations to determine the potential effect on our business and any assumptions </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">we have made about our future taxable income. We cannot predict whether any specific proposals will be enacted, the terms of any such proposals or what effect, if any, such proposals would have on our business if they were to be enacted. Beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminates the currently available option to deduct research and development expenditures and requires taxpayers to amortize them over five&#160;years. The U.S. Congress is considering legislation that would defer the amortization requirement to future periods, however, we have no assurance that the provision will be repealed or otherwise modified. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the Company had no accrued interest or penalties related to uncertain tax positions and no amounts have been recognized in the Company&#8217;s consolidated statements of operations. Due to NOL and R&amp;D credit carryforwards that remain unutilized, income tax returns filed in the United States, certain states within the United States and Canadian tax jurisdictions from the Company&#8217;s inception through 2020 remain subject to examination by the taxing jurisdictions. There are currently no audits in process in any of the Company&#8217;s tax filing jurisdictions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">17.&nbsp;&nbsp;&nbsp;LICENSE AGREEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Zurich</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with the University of Zurich (&#8220;Zurich&#8221;) which grants the Company exclusive license rights, with the right to sublicense, to make, have made, use and sell under certain patents primarily directed to the Company&#8217;s targeting agent, including an EpCAM chimera and related immunoconjugates and methods of use and manufacture of the same (the &#8220;Zurich License Agreement&#8221;). These patents cover some key aspects of Vicineum. Upon the Company&#8217;s receipt of the CRL regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC, the Company became obligated to pay $0.5&#160;million in a milestone payment to Zurich. The Company is also obligated to pay up to a 4% royalty on the net product sales for products covered by or manufactured using a method covered by a valid claim in the Zurich patent rights. Royalties owed to Zurich will be reduced if the total royalty rate owed by the Company to Zurich and any other third party is 10% or greater, provided that the royalty rate to Zurich may not be less than 2% of net sales. The obligation to pay royalties in a particular country expires upon the expiration or termination of the last of the Zurich patent rights that covers the manufacture, use or sale of a product. There is no obligation to pay royalties in a country if there is no valid claim that covers the product or a method of manufacturing the product. The Company recorded an expense of $0.5&#160;million and $0.3&#160;million related to achievement of a development milestone, (the submission of the Company&#8217;s BLA with the FDA in December&#160;2020), in the year ended December&#160;31, 2021 and 2020, respectively, and a regulatory milestone, (the Company&#8217;s receipt of the CRL from the FDA in August&#160;2021), in the twelve&#160;months ended December&#160;31, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Micromet</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a License Agreement with Micromet AG (&#8220;Micromet&#8221;), now part of Amgen, Inc., which grants it nonexclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products (the &#8220;Micromet License Agreement&#8221;). These patents cover some key aspects of Vicineum. Under the terms of the Micromet License Agreement, as of December&#160;31, 2021, the Company may be obligated to pay up to &euro;2.4&#160;million in milestone payments for the first product candidate that achieves applicable regulatory and sales-based development milestones (approximately $2.7&#160;million at exchange rates in effect on December&#160;31, 2021). The Company is also required to pay up to a 3.5% royalty on the net sales for products covered by the agreement, which includes Vicineum. The royalty rate owed to Micromet in a particular country will be reduced to 1.5% if there are no valid claims covering the product in that country. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. Finally, the Company is required to pay to Micromet an annual license maintenance fee of &euro;50,000 (approximately $56,625 at exchange rates in effect as of December&#160;31, 2021), which can be credited towards any royalty payment the Company owes to Micromet. The Company recorded an expense of &euro;0.7&#160;million ($0.9&#160;million) related to achievement of a development milestone in the three&#160;months ended December&#160;31, 2020, due to the submission of the Company&#8217;s BLA </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for Vicineum with the FDA in December&#160;2020. The Company recorded an expense of &euro;0.5&#160;million ($0.6&#160;million) related to the submission of the MAA to the EMA for Vysyneum&#8482; in the first quarter of 2021. Vysyneum is the proprietary brand name that was conditionally approved by the EMA for oportuzumab monatox in the European Union. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with XOMA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with XOMA Ireland Limited (&#8220;XOMA&#8221;) which grants it non-exclusive rights to certain XOMA patent rights and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems (the &#8220;XOMA License Agreement&#8221;). These patents and related know-how cover some key aspects of Vicineum. Under the terms of the XOMA License Agreement, the Company is required to pay up to $0.25&#160;million in milestone payments for a product candidate that incorporates know-how under the license and achieves applicable clinical development milestones. Based on current clinical status, the Company anticipates that these milestones may be triggered by Vicineum&#8217;s clinical development pathway. The Company is also required to pay a 2.5% royalty on the net sales for products incorporating XOMA&#8217;s technology, which includes Vicineum. The Company has the right to reduce the amount of royalties owed to XOMA on a country-by-country basis by the amount of royalties paid to other third parties, provided that the royalty rate to XOMA may not be less than 1.75% of net sales. In addition, the foregoing royalty rates are reduced by 50% with respect to products that are not covered by a valid patent claim in the country of sale. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Roche License Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, the Company entered into the license agreement with Roche (the &#8220;Roche License Agreement&#8221;), pursuant to which the Company granted Roche an exclusive, worldwide license, including the right to sublicense, to its patent rights and know-how related to the Company&#8217;s monoclonal antibody EBI-031 and all other IL-6 anti-IL-6 antagonist monoclonal antibody technology owned by the Company (collectively, the &#8220;Roche Licensed Intellectual Property&#8221;). Under the Roche License Agreement, Roche is required to continue developing, at its cost, EBI-031 and any other product made from the Roche Licensed Intellectual Property that contains an IL-6 antagonist anti-IL monoclonal antibody (&#8220;Roche Licensed Product&#8221;) and pursue ongoing patent prosecution, at its cost. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financial Terms</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company received from Roche an upfront license fee of $7.5&#160;million in August&#160;2016 upon the effectiveness of the Roche License Agreement following approval by the Company&#8217;s stockholders, and Roche agreed to pay up to an additional $262.5&#160;million upon the achievement of specified regulatory, development and commercialization milestones with respect to up to two unrelated indications. Specifically, an aggregate amount of up to $197.5&#160;million is payable to the Company for the achievement of specified milestones with respect to the first indication, consisting of (i)&#160;$72.5&#160;million in development milestones, the next of which is $30&#160;million for initiation of the first Phase&#160;III clinical trial, (ii)&#160;$50&#160;million in regulatory milestones and (iii)&#160;$75&#160;million in commercialization milestones. Additional amounts of up to $65&#160;million are payable upon the achievement of specified development and regulatory milestones in a second indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, Roche paid the Company the first development milestone of $22.5&#160;million as a result of the Investigational New Drug application for EBI-031 becoming effective on or before September&#160;15, 2016. In December&#160;2021, a $20&#160;million milestone was achieved due to Roche initiating a Phase&#160;II clinical trial. Management evaluated the milestone under ASC 606 and determined it is probable that a significant revenue reversal will not occur in future periods, which was not the case in the previous quarter. Accordingly, the Company invoiced Roche $20&#160;million with payment terms of 30&#160;days following the achievement of the corresponding milestone event, pursuant to the Roche License Agreement and $20&#160;million was recorded as license revenue and accounts receivables in the fourth quarter of 2021. In January&#160;2022, the payment of $20&#160;million was received. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Company is entitled to receive royalty payments in accordance with a tiered royalty rate scale, with rates ranging from 7.5% to 15% of net sales of potential future products containing EBI-031 and up to 50% of these rates for net sales of potential future products containing other IL-6 compounds, with each of the royalties subject to reduction under certain circumstances and to the buy-out options of Roche. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Buy-Out Options</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Roche License Agreement provides for two &#8220;option periods&#8221; during which Roche may elect to make a one-time payment to the Company and, in turn, terminate its diligence, milestone and royalty payment obligations under the Roche License Agreement. Specifically, (i)&#160;Roche may exercise a buy-out option following the first dosing (&#8220;Initiation&#8221;) in the first Phase&#160;2 study for a Roche Licensed Product until the day before Initiation of the first Phase&#160;3 study for a Roche Licensed Product, in which case Roche is required to pay the Company $135&#160;million within 30&#160;days after Roche&#8217;s exercise of such buy-out option and receipt of an invoice from the Company, or (ii)&#160;Roche may exercise a buy-out option following the day after Initiation of the first Phase&#160;3 study for a Roche Licensed Product until the day before the acceptance for review by the FDA or other regulatory authority of a BLA or similar application for marketing approval for a Roche Licensed Product in either the United States or in the EU, in which case Roche is required to pay the Company, within 30&#160;days after Roche&#8217;s exercise of such buy-out option and receipt of an invoice from the Company, $265&#160;million, which amount would be reduced to $220&#160;million if none of the Company&#8217;s patent rights containing a composition of matter claim covering any compound or Roche Licensed Product has issued in the EU. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Either the Company or Roche may each terminate the Roche License Agreement if the other party breaches any of its material obligations under the agreement and does not cure such breach within a specified cure period. Roche may terminate the Roche License Agreement following effectiveness by providing advance written notice to the Company or by providing written notice if the Company is debarred, disqualified, suspended, excluded, or otherwise declared ineligible from certain federal or state agencies or programs. The Company may terminate the Roche License Agreement if, prior to the first filing of a BLA for a Roche Licensed Product, there is a period of twelve&#160;months where Roche is not conducting sufficient development activities with respect to the products made from the Roche Licensed Intellectual Property. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OUS Business Development Partnership Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Qilu License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;30, 2020, the Company and its a wholly-owned subsidiary, Viventia Bio, Inc., entered into an exclusive license agreement with Qilu (the &#8220;Qilu License Agreement&#8221;) pursuant to which the Company granted Qilu an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to develop, manufacture and commercialize Vicineum (the &#8220;Qilu Licensed Product&#8221;) for the treatment of NMIBC and other types of cancer (the &#8220;Field&#8221;) in China, Hong Kong, Macau and Taiwan (&#8220;Greater China&#8221;). The Company also granted Qilu a non-exclusive, sublicensable, royalty-bearing sublicense, under certain other intellectual property licensed by the Company to develop, manufacture and commercialize the Qilu Licensed Product in Greater China. The Company retains (i)&#160;development, and commercialization rights in the rest of the world excluding Greater China, the Middle East and North Africa region (&#8220;MENA&#8221;) and Turkey and (ii)&#160;manufacturing rights with respect to Vicineum in the rest of the world excluding China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In consideration for the rights granted by the Company, Qilu agreed to pay to the Company a one-time upfront cash payment of $12&#160;million, and milestone payments totaling up to $23&#160;million upon the achievement of certain technology transfer, development and regulatory milestones. All payments were to be inclusive of value-added tax (&#8220;VAT&#8221;), which can be withheld by Qilu upon payment, and for which future recovery of such taxes may be available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Qilu also agreed to pay the Company a 12% royalty based upon annual net sales of Qilu Licensed Products in Greater China. The royalties are payable on a Qilu Licensed Product-by-Licensed Product and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">region-by-region basis commencing on the first commercial sale of a Licensed Product in a region and continuing until the latest of (i)&#160;twelve&#160;years after the first commercial sale of such Qilu Licensed Product in such region, (ii)&#160;the expiration of the last valid patent claim covering or claiming the composition of matter, method of treatment, or method of manufacture of such Qilu Licensed Product in such region, and (iii)&#160;the expiration of regulatory or data exclusivity for such Qilu Licensed Product in such region (collectively, the &#8220;Royalty Terms&#8221;). The royalty rate is subject to reduction under certain circumstances, including when there is no valid claim of a licensed patent that covers a Qilu Licensed Product in a particular region or no data or regulatory exclusivity of a Qilu Licensed Product in a particular region. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Qilu is responsible for all costs related to developing, obtaining regulatory approval of and commercializing the Qilu Licensed Products in the Field in Greater China. Qilu is required to use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize at least one Qilu Licensed Product in the Field in Greater China. A joint development committee was established between the Company and Qilu to coordinate and review the development, manufacturing and commercialization plans with respect to the Qilu Licensed Products in Greater China. The Company and Qilu also executed the terms and conditions of a supply agreement and related quality agreement pursuant to which the Company will manufacture or have manufactured and supply Qilu with all quantities of the Qilu Licensed Product necessary for Qilu to develop and commercialize the Qilu Licensed Product in the Field in Greater China until the Company has completed manufacturing technology transfer to Qilu and approval of a Qilu manufactured product by the National Medical Products Administration in China (&#8220;NMPA&#8221;) for the Qilu Licensed Product has been obtained. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement will expire on a Qilu Licensed Product-by-Licensed Product and region-by-region basis on the date of the expiration of all applicable Royalty Terms. Either party may terminate the Qilu License Agreement for the other party&#8217;s material breach following a cure period or upon certain insolvency events. Qilu has the right to receive a refund of all amounts paid to the Company in the event the Qilu License Agreement is terminated under certain circumstances. The Qilu License Agreement includes customary representations and warranties, covenants and indemnification obligations for a transaction of this nature. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement is subject to the provisions of Accounting Standards Codification 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which was adopted effective January&#160;1, 2018. In 2020, the initial transaction price was estimated to be $11.2&#160;million and was based on the up-front fixed consideration of $12&#160;million less amounts withheld for VAT. The Company concluded that its agreements under the Qilu License Agreement represented one bundled performance obligation that had been achieved as of September&#160;30, 2020. As such, $11.2&#160;million of the total $11.2&#160;million transaction price was considered earned and the Company recorded $11.2&#160;million of revenue during the three-month period ended September&#160;30, 2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Investigational New Drug application for Vicineum submitted by Qilu to the Center for Drug Evaluation of the NMPA was accepted for review in January&#160;2021 and approved in March&#160;2021, resulting in a $3&#160;million milestone payment from Qilu, the first milestone payment out of the $23&#160;million in potential milestone payments. The Company recorded $2.8&#160;million (net of VAT) as license revenue during the three-month period ended March&#160;31, 2021. The Company received the payment in 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. An agreement that is designated as a Technology Transfer shall be entitled to a tax incentive of VAT recovery. As such, the Company recorded $0.9&#160;million of revenue during the three&#160;months ended June&#160;30, 2021 for additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen an amount equal to its recovery of VAT. The Company will not be subject to VAT on future potential milestone payments from Qilu. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MENA License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;30, 2020, the Company entered into a license agreement with a third party pursuant to which the Company granted an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to commercialize Vicineum in the MENA region, (&#8220;MENA License Agreement&#8221;). The Company retains development and commercialization rights in the rest </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of the world excluding Greater China, Turkey and MENA. In consideration for the rights granted by the Company, the counterparty to the MENA License Agreement agreed to pay to the Company an upfront payment of $3&#160;million, which would be subject to certain tax withholdings. In addition, the counterparty agreed to pay to the Company milestone payments upon the achievement of certain sales-based milestones as well as a royalty based upon annual net sales in the MENA region for the term of the MENA License Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The MENA License Agreement is subject to the provisions of ASC 606. The initial transaction price was estimated by management as $1.5&#160;million as of December&#160;31, 2020 and was based on 50% of the upfront payment, or the amount not subject to a refund if certain regulatory approvals in MENA are not obtained. The remaining upfront payment ($1.5&#160;million) is subject to a refund if certain regulatory approvals in MENA are not obtained and recorded as long-term deferred revenue as of December&#160;31, 2021. The Company also concluded that its agreements under the MENA License Agreement represented two distinct performance obligations, the first of which is a bundled performance obligation related to the delivery of the license, associated know-how and certain documentation. The second performance obligation relates to the delivery of manufactured product. The first performance obligation (delivery of the license, associated know-how and certain documentation) was achieved during the quarter ended March&#160;31, 2021; as such, revenue of $1.5&#160;million has been recognized. Additional variable consideration, determined to be allocated entirely to the bundled license performance obligation, to be paid to the Company based upon future sales levels will be recognized as revenue when the underlying sales of the licensed product occurs. In addition, variable consideration related to any future delivery of product will be recognized in future periods as the product is delivered. As of December&#160;31, 2021, none of these additional amounts were reasonably certain to be achieved due to the nature and timing of the underlying activities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EIP License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;5, 2021, the Company entered into an exclusive license agreement with E&#304;P Eczac&#305;ba&#351;&#305; &#304;la&#231; Pazarlama A.&#350;., (&#8220;EIP&#8221;) pursuant to which it granted EIP an exclusive license to register and commercialize Vicineum for the treatment of BCG-unresponsive NMIBC in Turkey and Northern Cyprus (the &#8220;EIP License Agreement). Under the terms of the License Agreement, the Company is entitled to receive an upfront payment of $1.5&#160;million. The Company is in the process of amending the license agreement to defer payment of the upfront payment to coincide with the potential FDA approval of Vicineum. The Company is eligible to receive additional regulatory and commercial milestone payments of $2.0&#160;million and is also entitled to receive a 30% royalty on net sales in Turkey and Northern Cyprus. The EIP License Agreement is subject to the provisions of ASC 606 and as of December&#160;31, 2021, none of these amounts have been received by the Company. No initial transaction price was estimated by management as of December&#160;31, 2021, as the upfront payment is subject to a refund if certain regulatory approvals in the US are not obtained. The Company also concluded that its promises under the EIP License Agreement represented two distinct performance obligations, the first of which is a bundled performance obligation related to the delivery of the license and associated know-how. The second performance obligation relates to the delivery of manufactured product. Additional variable consideration, determined to be allocated entirely to the bundled license performance obligation, to be paid to the Company based upon future regulatory milestones will be recognized as achievement of those milestones. In addition, variable consideration related to any future delivery of product will be recognized in future periods as the product is delivered. As of December&#160;31, 2021, none of these additional amounts were reasonably certain to be achieved due to the nature and timing of the underlying activities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">18.&nbsp;&nbsp;&nbsp;RELATED-PARTY TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company leases its facility in Winnipeg, Manitoba from an affiliate of Leslie L. Dan, a director of the Company until his retirement in July&#160;2019. For each of the&#160;years ended December&#160;31, 2021, 2020 and 2019, the Company paid $0.3&#160;million of rent, which includes the related operating expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company pays fees under an intellectual property license agreement to Protoden Technologies Inc. (&#8220;Protoden&#8221;), a company owned by Clairmark, an affiliate of Mr.&#160;Dan. Pursuant to the agreement, the Company has an exclusive, perpetual, irrevocable and non-royalty bearing license, with the right to sublicense, to certain patents and technology to make, use and sell products that utilize such patents and technology. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The annual fee is $0.1&#160;million. Upon expiration of the term on December&#160;31, 2024, the licenses granted to the Company will require no further payments to Protoden. For each of the&#160;years ended December&#160;31, 2021, 2020 and 2019, the Company paid $0.1&#160;million under this license agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Due to his retirement in July&#160;2019, Mr.&#160;Dan was not deemed a related party during the twelve-month period ended December&#160;31, 2020 and 2021; as such, only payments made through the nine month period ended September&#160;30, 2019 are considered payments to a related party. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.&nbsp;&nbsp;&nbsp;RESTRUCTURING AND RELATED ACTIVITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;30, 2021, the Company approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following receipt of the CRL from the FDA regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC (the &#8220;Restructuring Plan&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Restructuring Plan included a reduction in the Company&#8217;s workforce by 18 positions (or approximately 35% of the Company&#8217;s workforce as of the date of the Restructuring Plan), as well as additional cost-saving initiatives intended to preserve capital while the Company continues development of Vicineum. The following is a summary of accrued restructuring costs related to the Restructuring Plan: </font>
        </div>
        <table style="width:416pt;height:122pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:357.69pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:357.69pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Severance and benefits costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,792</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contract termination costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,736</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other restructuring costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total restructuring costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash payments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,031<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,497</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.19pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Restructuring costs related to the Restructuring Plan were recorded in operating expenses in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss in the year ended December&#160;31, 2021. The Company expects that substantially all of the accrued restructuring costs as of December&#160;31, 2021 will be paid in cash by the end of September&#160;2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">20.&nbsp;&nbsp;&nbsp;SUBSEQUENT EVENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;7, 2022, the FDA granted the Company&#8217;s request for a Type C Meeting (&#8220;Type C Meeting&#8221;) to discuss the study protocol for an additional Phase&#160;3 clinical trial that the Company plans to conduct for potential resubmission of a BLA for Vicineum&#8482; for the treatment of BCG-unresponsive NMIBC. The Type C Meeting has been scheduled for March&#160;28, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;24, 2022, the Company received written notice (the &#8220;Notice&#8221;) from Nasdaq indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule&#160;5450(a)(1). The Notice has no effect at this time on the listing of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;), which continues to trade on The Nasdaq Global Market under the symbol &#8220;SESN&#8221;. In accordance with Nasdaq Listing Rule&#160;5810(c)(3)(A), the Company has a period of 180 calendar days, or until July&#160;25, 2022, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company&#8217;s Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this 180-day period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the Company is not in compliance by July&#160;25, 2022, the Company may qualify for a second 180 calendar day compliance period. If the Company does not qualify for, or fail to regain, compliance during the second compliance period, then Nasdaq will notify the Company of its determination to delist the Company&#8217;s common stock, at which point the Company would have an opportunity to appeal the delisting determination to a Nasdaq hearings panel. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:452pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company intends to actively monitor the closing bid price of the Company&#8217;s common stock and may, if appropriate, consider implementing available options to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As previously announced, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) initiated an independent internal review conducted by outside counsel with the assistance of subject matter experts focusing on the conduct of, and data generated from, the clinical trials of Vicineum for the treatment of BCG-unresponsive NMIBC, and the overall safety of Vicineum (the &#8220;Review&#8221;). The Review took place over the course of five&#160;months, involved full cooperation from the Company&#8217;s management team, a review of more than 600,000 documents, and 39 interviews of current and former employees and consultants. It is now complete. As a result of the Review, the Board continues to fully support the Company&#8217;s current management team and believes no changes or amendments relating to the Company&#8217;s prior disclosures to the SEC or the FDA relating to Vicineum, the Phase&#160;3 VISTA trial for Vicineum for the treatment of BCG-unresponsive NMIBC, or the BLA for Vicineum are warranted. The Company intends to work cooperatively with the FDA in preparing for an additional Phase&#160;3 clinical trial for Vicineum.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED BALANCE SHEETS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:577.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">71,107</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">162,636</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Short term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">106,427</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,011</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">14,297</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,482</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">527</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">18,476</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">192,358</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">205,605</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,336</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Goodwill </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Long term prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,192</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,366</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">35,142</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:40pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">199,724</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities and Stockholders&#8217; Equity</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">514</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,853</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">33,800</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">381</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">460</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">34,695</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">11,568</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred tax liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,969</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total non-current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">57,469</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Total Liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">34,695</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">69,037</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Stockholders&#8217; Equity: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Preferred stock, $0.001 par value per share; 5,000,000 shares authorized at September&#160;30, 2022 and December&#160;31, 2021; no shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Common stock, $0.001 par value per share; 400,000,000 shares authorized at </font>
                <br >
                <font style="letter-spacing:0.2pt;">September&#160;30, 2022 and December&#160;31, 2021; 202,757,012 and 199,463,645 </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares issued and outstanding at September&#160;30, 2022 and December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2021, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">493,629</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(328,567<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total Stockholders&#8217; Equity </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">165,029</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Liabilities and Stockholders&#8217; Equity </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">199,724</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:15.5pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:187.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (OPERATIONS)</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:373.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:253.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:253.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,931</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,967</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">37,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">18,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">8,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,699</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">32,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,797</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(1,800<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(114,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,240<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(63,112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">57,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">24,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income (loss) from Operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">19,781</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">63,112</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,052<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,508<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other income (expense), net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(45<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income (loss) Before Taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">63,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Benefit from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">8,561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Income (loss) After Taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:253.84pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201; basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,622</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:253.84pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201; diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,623</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per common share&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average common shares outstanding&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">196,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per common share&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average common shares outstanding&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:484.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:76.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:275.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:275.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unrealized (gain) loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(46<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:275.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total comprehensive income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,503</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,545<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:230pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:31.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:154.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9.00000000000001pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Comprehensive </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Loss </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Investments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:154.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(807<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(807<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">1,894</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at March&#160;31, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">489,662</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(317,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">172,797</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(31,960<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(31,960<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,802</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,802</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized loss of investments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(281<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(281<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at June&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">491,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(281<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(349,024<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">142,358</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net income </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">3,293,367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,165</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,168</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized gain of investments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">46</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">202,757,012</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">493,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(328,567<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">165,029</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:359pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:13.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">140,449,647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">140</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">306,554</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(315,921<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,227<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(55,512<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(55,512<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">958</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">30,610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">39</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">39</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">852,840</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">468</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">469</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:192.64pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $2.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">30,645,702</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">31</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,512</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">72,543</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at March&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">171,978,799</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">172</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">380,531</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(371,433<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">9,270</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(25,442<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(25,442<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,260</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:192.64pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $2.0&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">16,482,152</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">64,245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">64,261</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at June&#160;30, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">188,460,951</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">188</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">446,036</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(396,875<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">49,349</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,168</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,168</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">1,195,219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">656</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">657</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:192.64pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $1.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">9,804,475</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">38,147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">38,157</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">486,010</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(325,201<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">161,008</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:33pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:528pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Operating Activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Adjustments to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,864</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(52,240<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivable (net) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">21,012</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,107<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(10,816<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17,949</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(23,665<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Long term prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Unrealized loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,339<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">807</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">21,497</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,453<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(1,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by (used in) operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">22,214</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(56,278<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Investing Activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Purchase of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(113,763<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Disposal (purchase) of equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(113,733<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(4<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Financing Activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of common stock under ATM Offering, net of</font>
                <br >
                <font style="letter-spacing:0.2pt;">issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">174,961</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">176,129</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net (decrease) increase in cash, cash equivalents and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(91,519<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">119,847</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;beginning of period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">162,656</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">55,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;end of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">71,137</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">175,256</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental cash flow disclosure: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash paid for amounts included in the measurement of lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">127</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tNTCC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.&nbsp;&nbsp;&nbsp;DESCRIPTION OF BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. (&#8220;Sesen Bio&#8221; or the &#8220;Company&#8221;), a Delaware corporation formed in February&#160;2008, is a late-stage clinical company focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The Company&#8217;s most advanced product candidate, Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule (&#8220;EpCAM&#8221;) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive bladder cancer (&#8220;NMIBC&#8221;). On July&#160;15, 2022, the Company made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the United States Food and Drug Administration (&#8220;FDA&#8221;), which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial, which the FDA previously confirmed would be required for a potential resubmission of a biologics license application (&#8220;BLA&#8221;) for Vicineum for the treatment of NMIBC. The Company continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such, intends to seek a partner that can execute further development to realize the full potential of Vicineum. As a result of this decision, the Company has&#160;turned its primary focus to the careful assessment of potential strategic alternatives with the goal of maximizing shareholder value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anticipated Merger with CARISMA Therapeutics Inc.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic transaction, on September&#160;20, 2022, Sesen Bio, Seahawk Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Sesen Bio (&#8220;Merger Sub&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (&#8220;Carisma&#8221;), entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other things, and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma continuing as a wholly-owned subsidiary of Sesen Bio and the surviving corporation of the merger (the &#8220;Merger&#8221;). Sesen Bio&#8217;s board of directors unanimously approved the&#160;Merger Agreement and resolved to recommend that Sesen Bio&#8217;s stockholders approve the proposals described in the Merger Agreement. If the Merger is completed, the business of Carisma will continue as the business of the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future operations are highly dependent on the success of the Merger and there can be no assurances that the Merger will be successfully consummated. In the event that Sesen Bio does not complete the Merger with Carisma, Sesen Bio may continue to review and evaluate a strategic alternatives, including, without limitation, another strategic transaction and/or pursue a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Viventia Acquisition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, the Company entered into a Share Purchase Agreement with Viventia Bio, Inc., a corporation incorporated under the laws of the Province of Ontario, Canada (&#8220;Viventia&#8221;), the shareholders of Viventia named therein (the &#8220;Selling Shareholders&#8221;) and, solely in its capacity as seller representative, Clairmark Investments Ltd., a corporation incorporated under the laws of the Province of Ontario, Canada (the &#8220;Share Purchase Agreement&#8221;), pursuant to which the Company agreed to and simultaneously&#160;completed the acquisition of all of the outstanding capital stock of Viventia from the Selling Shareholders (the &#8220;Viventia Acquisition&#8221;). In connection with the closing of the Viventia Acquisition, the Company issued 4.0&#160;million shares of its common stock to the Selling Shareholders, which at that time represented approximately 19.9% of the voting power of the Company as of immediately prior to the issuance of such shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Share Purchase Agreement, the Company is obligated to pay to the Selling Shareholders certain post-closing contingent cash payments upon the achievement of specified milestones and based upon net sales, in each case subject to the terms and conditions set forth in the Share Purchase </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Agreement, including: (i)&#160;a one-time milestone payment of $12.5&#160;million payable upon the first sale of Vicineum (the &#8220;Purchased Product&#8221;), in the United States; (ii)&#160;a one-time milestone payment of $7.0&#160;million payable upon the first sale of the Purchased Product in any one of certain specified European countries; (iii)&#160;a one-time milestone payment of $3.0&#160;million payable upon the first sale of the Purchased Product in Japan; and (iv)&#160;quarterly earn-out payments equal to 2% of net sales of the Purchased Product during specified earn-out periods. Such earn-out payments are payable with respect to net sales in a country beginning on the date of the first sale in such country and ending on the earlier of (i)&#160;December&#160;31, 2033, and (ii)&#160;fifteen&#160;years after the date of such sale, subject to early termination in certain circumstances if a biosimilar product is on the market in the applicable country. Under the Share Purchase Agreement, the Company, its affiliates, licensees and subcontractors are required to use commercially reasonable efforts, for the first seven&#160;years following the closing of the Viventia Acquisition, to achieve marketing authorizations throughout the world and, during the applicable earn-out period, to commercialize the Purchased Product in the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China and Canada. Certain of these payments are payable to individuals or affiliates of individuals that became employees or members of the Company&#8217;s board of directors. However, as of September&#160;30, 2022, none of these individuals are active employees of the Company or members of the Company&#8217;s board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASUs&#8221;), promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interim Financial Statements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying unaudited interim condensed consolidated financial statements have been prepared from the books and records of the Company in accordance with GAAP for interim financial information and Rule&#160;10-01 of Regulation&#160;S-X promulgated by the United States Securities and Exchange Commission (&#8220;SEC&#8221;), which permit reduced disclosures for interim periods. All adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the accompanying condensed consolidated balance sheets and statements of operations and comprehensive (loss) income, stockholders&#8217; equity (deficit) and cash flows have been made. Although these interim financial statements do not include all of the information and footnotes required for complete annual financial statements, management believes the disclosures are adequate to make the information presented not misleading. These unaudited interim results of operations and cash flows for the nine&#160;months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the full year. These unaudited interim condensed consolidated financial statements and footnotes should be read in conjunction with the Company&#8217;s audited annual consolidated financial statements and footnotes included in its Annual Report on Form 10-K, as filed with the SEC on February&#160;28, 2022, wherein a more complete discussion of significant accounting policies and certain other information can be found. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preparation of financial statements in accordance with GAAP and the rules and regulations of the SEC requires the use of estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company&#8217;s business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">significant estimates and judgments impact the fair value of intangible assets; goodwill and contingent consideration; income taxes (including the valuation allowance for deferred tax assets); and research and development expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principles of Consolidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries Viventia and Seahawk Merger Sub, Inc. and its indirect subsidiary, Viventia Bio USA Inc. All intercompany transactions and balances have been eliminated in consolidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Translation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The functional currency of the Company and each of its subsidiaries is the US dollar. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.&nbsp;&nbsp;&nbsp;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s complete summary of significant accounting policies can be found in &#8220;Item&#160;15.&#160;Exhibits and Financial Statement Schedules&#8201;&#8212;&#8201;Note 3. Summary of Significant Accounting Policies&#8221; in the audited annual consolidated financial statements included in its Annual Report on Form 10-K for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.&nbsp;&nbsp;&nbsp;RECENT ACCOUNTING PRONOUNCEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adopted in 2022</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2020, the FASB issued ASU No. 2020-06, </font><font style="font-style:italic;letter-spacing:0.2pt;">Debt&#8201;&#8212;&#8201;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (&#8220;ASU 2020-06&#8221;). ASU&#160;2020-06 simplifies the complexity associated with applying US GAAP for certain financial instruments with characteristics of both liability and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. The ASU&#160;also amends the diluted earnings per share (&#8220;EPS&#8221;) guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for public companies for fiscal&#160;years, and interim periods within those fiscal&#160;years, beginning after December&#160;15, 2021, and should be applied on a full or modified retrospective basis. The Company adopted this guidance on a modified retrospective basis effective January&#160;1, 2022 and it did not have an impact on the Company&#8217;s financial position, results of operations including per-share amounts, or cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">In May&#160;2021, the FASB issued ASU No. 2021-04, </font><font style="letter-spacing:0.2pt;">Earnings Per Share (Topic 260), Debt&#8201;&#8212;&#8201;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8201;&#8212;&#8201;Stock Compensation (Topic 718), and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</font><font style="font-style:normal;letter-spacing:0.2pt;"> (&#8220;ASU 2021-04&#8221;)</font><font style="letter-spacing:0.2pt;">.</font><font style="font-style:normal;letter-spacing:0.2pt;"> ASU&#160;2021-04 clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. ASU 2021-04 is effective for public companies for fiscal&#160;years, and interim&#160;periods within those fiscal&#160;years, beginning after December&#160;15, 2021, and should be applied on a prospective basis. The Company adopted this guidance effective January&#160;1, 2022 and it did not have an impact on the Company&#8217;s financial position, results of operations including per-share amounts, or cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other recent accounting pronouncements issued, but not yet effective, are not expected to be applicable to the Company or have a material effect on the consolidated financial statements upon future adoption. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.&nbsp;&nbsp;&nbsp;FAIR VALUE MEASUREMENT AND FINANCIAL INSTRUMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying values of cash and cash equivalents, restricted cash, prepaid expenses and other current assets, and accounts payable on the Company&#8217;s condensed consolidated balance sheets approximated their fair values as of September&#160;30, 2022 and December&#160;31, 2021 due to their short-term nature. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain of the Company&#8217;s financial instruments are measured at fair value using a three-level hierarchy that prioritizes the inputs used to measure fair value. This fair value hierarchy prioritizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;1</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for identical instruments in active markets. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;2</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;3</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Inputs are unobservable and reflect the Company&#8217;s own assumptions, based on the best information available, including the Company&#8217;s own data. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following tables set forth the carrying amounts and fair values of the Company&#8217;s financial instruments measured at fair value on a recurring basis as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:161.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.34pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;height:49.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:131.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates transfers between fair value levels at the end of each reporting period. There were no asset or liability transfers between fair value levels during the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2016, the Company acquired Viventia through the issuance of shares of common stock plus contingent consideration, pursuant to the terms of a Share Purchase Agreement. The Company recorded the acquired assets and liabilities based on their estimated fair values as of the acquisition date and finalized its purchase accounting for the Viventia Acquisition during the third quarter of 2017. The contingent consideration relates to amounts potentially payable to the former shareholders of Viventia under the Share Purchase Agreement. Contingent consideration is measured at its estimated fair value at each reporting period, with fluctuations in value resulting in a non-cash charge to earnings (or loss) during </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the period. The estimated fair value measurement is based on significant inputs, including internally developed financial forecasts, probabilities of success, and the timing of certain milestone events and achievements, which are not observable in the market, representing a Level&#160;3 measurement within the fair value hierarchy. The valuation of contingent consideration requires the use of significant assumptions and judgments, which management believes are consistent with those that would be made by a market participant. Management reviews its assumptions and judgments on an ongoing basis as additional market and other data is obtained, and any future changes in the assumptions and judgments utilized by management may cause the estimated fair value of contingent consideration to fluctuate materially, resulting in earnings volatility. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Company made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. The Company continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such intends to seek a partner for the further development of Vicineum. Additionally, during the second quarter of 2022, the Company observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the bacillus Calmette-Gu&#233;rin (&#8220;BCG&#8221;) shortage. Accordingly, during the second quarter of 2022, the Company concluded that it no longer expected to pay related milestone and earnout payments to the former shareholders of Viventia, with the exception of the potential 2% earnout payment related to the Greater China region since those territory rights had been out-licensed pursuant to the exclusive license agreement with Qilu Pharmaceutical Co., Ltd. (&#8220;Qilu&#8221;) (the &#8220;Qilu License Agreement&#8221;) (as further&#160;described in Note 17. &#8220;License Agreements&#8221; below). As of June&#160;30, 2022, Qilu held the exclusive license to develop Vicineum in the Greater China region, and accordingly, the $1.8&#160;million estimated earnout payment in the Greater China region remained as long-term contingent consideration as of June&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company and Qilu are in the process of negotiating a termination of the Qilu License Agreement. Upon the termination of the Qilu License Agreement, the Company will regain the rights to develop, manufacture and commercialize Vicineum in Greater China. However, the Company does not plan to develop or commercialize Vicineum in that region or any other, as it is pursuing the Merger with Carisma. The Company is also seeking to sell or out-license Vicineum and all the related obligations related to Vicineum. The Company expects that any partner who acquires or licenses Vicineum from the Company will be obligated to make any payments, including those related to sales in the Greater China region (if any), that become payable to the former shareholders of Viventia under the Share Purchase Agreement. If a sale or license of Vicineum has not occurred at the time the Merger is completed, Carisma has indicated it may continue to seek a sale or license of Vicineum and has no plans to develop Vicineum. Accordingly, as of September&#160;30, 2022, the Company concluded that it no longer expects to owe any future earnout payments related to the Greater China region and reduced its remaining $1.8&#160;million of contingent consideration liabilities to zero as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The contingent consideration balance as of December&#160;31, 2021 was $52.0&#160;million which was based upon projected world-wide net sales. The estimated fair value of the Company&#8217;s contingent consideration was determined using probabilities of successful achievement of regulatory milestones and commercial sales, the period in which these milestones and sales are expected to be achieved through 2033, the level of commercial sales of Vicineum forecasted for the US, Europe, Japan, China and other potential markets and discount rates ranging from 8.0% to 9.3% as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the change in the fair value of the Company&#8217;s contingent consideration liability, measured on a recurring basis at each reporting period (in thousands). </font>
        </div>
        <table style="width:416pt;height:40.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:367.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the Company&#8217;s contingent consideration was determined based on the present value of projected future cash flows associated with sales-based milestones and earnouts on net sales and is heavily </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">dependent on discount rates to estimate the fair value at each reporting period. Earnouts were determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout was derived from the Company&#8217;s weighted-average cost of capital, which was 9.3% as of December&#160;31, 2021. As of December&#160;31, 2021, the balance also reflected potential milestone payments which constitute debt-like obligations, and therefore a high-yield debt index rate was applied to the milestones in order to determine the estimated fair value. This index rate was 8.0% as of December&#160;31, 2021. The decrease in the fair value of contingent consideration of $52.0&#160;million for the nine&#160;months ended September&#160;30, 2022 was driven by the Company&#8217;s decision to voluntarily pause further development of Vicineum in the United States and seek a partner to acquire or license the asset and assume all associated liabilities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.&nbsp;&nbsp;&nbsp;RECEIVABLES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accounts receivable balance as of December&#160;31, 2021 was $21.0&#160;million, comprised primarily of a $20&#160;million milestone achieved in December&#160;2021 due to F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (collectively, &#8220;Roche&#8221;) initiating a Phase&#160;II clinical trial in the fourth quarter of 2021. In January&#160;2022 the payment of $20&#160;million was received. Additionally, in June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. As such, the Company recorded $0.9&#160;million of revenue and accounts receivable for the additional purchase price resulting from Qilu&#8217;s obligation to pay the Company an amount equal to its recovery of value-added tax (&#8220;VAT&#8221;). The accounts receivable balance as of September&#160;30, 2022 was zero. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The other receivables balance as of September&#160;30, 2022 was $14.3&#160;million compared to $3.5&#160;million as of December&#160;31, 2021. The increase of $10.8&#160;million was primarily driven by expected insurance recovery of $13.4&#160;million related to the preliminary settlements of the Securities Litigation and Derivative Litigation (as defined in Note 10. &#8220;Commitments and Contingencies&#8221; below). This amount was partially offset by the receipt of $2.4&#160;million for German VAT recovery in the first half of 2022, related to drug substance sent to Baxter in 2020 and 2019 and other individually immaterial changes of $0.2&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.&nbsp;&nbsp;&nbsp;PREPAID EXPENSES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The prepaid expenses balance as of September&#160;30, 2022 was $0.5&#160;million compared to $25.7&#160;million as of December&#160;31, 2021. In light of the Company&#8217;s decision to voluntarily pause further development of Vicineum in the United States, the Company evaluated prepaid balances and determined that the prepayments for the manufacturing of Vicineum, including consumables, had no future economic benefit or value. Pursuant to ASC Topic 730, </font><font style="font-style:italic;letter-spacing:0.2pt;">Certain Nonrefundable Advance Payment</font><font style="letter-spacing:0.2pt;">, the Company expensed $25.2&#160;million of prepayments during the second quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.&nbsp;&nbsp;&nbsp;INTANGIBLE ASSETS AND GOODWILL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intangibles</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Intangible assets on the Company&#8217;s condensed consolidated balance sheets are the result of the Viventia Acquisition in September&#160;2016. The following table sets forth the composition of intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:63pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">IPR&amp;D intangible assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vicineum European Union rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">14,700</div>
            </td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total Intangibles</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.1pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the acquired intangible assets for the European Union (&#8220;EU&#8221;) rights of Vicineum is determined using a risk-adjusted discounted cash flow approach, which includes probability adjustments for projected revenues and operating expenses based on the success rates assigned to each stage of development for each geographical region; as well as discount rates applied to the projected cash flows. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, the Company observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage. On July&#160;15, 2022, the Company made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Management updated the discounted cash flow model using the market participant approach and considered preliminary terms of a potential partnering deal to conclude the fair value of the Company&#8217;s intangible asset of Vicineum EU rights. The Company concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum EU rights of $14.7&#160;million was fully impaired and was reduced to zero in the second quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on the Company&#8217;s condensed consolidated balance sheets is the result of the Viventia Acquisition in September&#160;2016. During the second quarter of 2022, the Company observed continued trends in the Company&#8217;s market capitalization as compared to the carrying value of its single reporting unit as well as changes in certain assumptions in the fair value of the business including market share, size, length and cost of a clinical trial, and time to potential market launch. The Company identified these changes as potential impairment indicators and performed a quantitative impairment analysis, in advance of the Company&#8217;s typical annual assessment date of October&#160;1 and concluded that the carrying value of its goodwill of $13.1&#160;million was fully impaired and was reduced to zero in the second quarter of 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the change in goodwill as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands). </font>
        </div>
        <table style="width:416pt;height:40.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:367.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Impairment loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.&nbsp;&nbsp;&nbsp;ACCRUED EXPENSES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the composition of accrued expenses as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:123pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,242</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,841</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payroll-related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,043</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,967</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restructuring charge related </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">6,365</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,497</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">381</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">597</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal expenses, including preliminary litigation settlement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">23,720</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,344</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">49</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:298.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Accrued Expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">33,800</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company may become subject to legal proceedings, claims, and litigation arising in the ordinary course of business. When the Company becomes aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. In accordance with authoritative guidance, the Company records loss contingencies in its financial statements only for matters in which losses are probable and can be reasonably estimated. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum estimated liability. If the loss is not probable or the amount of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the loss cannot be reasonably estimated, the Company discloses the nature of the specific claim if the likelihood of a potential loss is reasonably possible, and the amount involved is material. The Company continuously assesses the potential liability related to the Company&#8217;s pending litigation and revises its estimates when additional information becomes available. The Company is not currently a party to any material legal proceedings, other than as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7, 2021, three substantially identical securities class action lawsuits captioned Bibb v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07025, Cizek v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07309, and Markman v. Sesen Bio, Inc. et al., Case No. 1:21-cv-08308 were filed against the Company and certain of its officers in the US District Court for the Southern District of New York. The three complaints alleged violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints sought compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption In re Sesen Bio, Inc. Securities Litigation, Master File No. 1:21-cv-07025-AKH (the &#8220;Securities Litigation&#8221;), and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj (collectively, the &#8220;Lead Plaintiffs&#8221;) collectively as the lead plaintiffs under the Private Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. On November&#160;24, 2021, defendants filed a motion to transfer venue to the US District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed an amended class action complaint (the &#8220;Amended Complaint&#8221;). The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. The defendants moved to dismiss the Amended Complaint on March&#160;7, 2022, and that motion was fully briefed on May&#160;6, 2022. On June&#160;3, 2022, before the court ruled on the motion to dismiss, the parties requested that the court hold any decision on the motion to dismiss in abeyance to provide the parties with an opportunity to engage in mediation. On June&#160;30, 2022 and July&#160;6, 2022, the Company and the plaintiffs engaged in mediation sessions in an attempt to resolve the Securities Litigation and continued to discuss a potential settlement over the following weeks. On July&#160;19, 2022, the parties reached an agreement in principle to settle the Securities Litigation. Pursuant to that agreement, the Company and the individual defendants will pay or cause to be paid to members of the class who submit timely and valid proofs of claims. In exchange, the Lead Plaintiffs will dismiss the action and all class members who do not timely and validly opt-out of the settlement will provide broad customary releases to the Company and the individual defendants. On August&#160;3, 2022, the parties entered into a Stipulation and Agreement of Settlement to settle the Securities Litigation, which was filed with the court on August&#160;17, 2022. The Stipulation and Agreement of Settlement related to the Securities Litigation provides for a settlement payment of $21.0&#160;million to the class and the dismissal of all claims against the Company and the other defendants. The settlement payment is being funded by the Company and its insurance carriers. On September&#160;1, 2022, the US District Court for the Southern District of New York issued an order denying the motions to appoint a different lead plaintiff. On September&#160;28, 2022, the court issued an order granting preliminary approval of the proposed settlement of the Securities Litigation. The court has set a final settlement approval hearing for January&#160;23, 2023 at 10:00&#160;a.m. local time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2021 and September&#160;24, 2021, two substantially similar derivative lawsuits captioned&#160;Myers v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11538 and D&#8217;Arcy v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11577 were filed against the Company&#8217;s board of directors and certain of its officers in the US District Court for the District of Massachusetts, with the Company named as nominal defendant. On January&#160;12, 2022, a third derivative complaint captioned Tang v. Sesen Bio, Inc., et al., was filed in Superior Court in Massachusetts against the Company&#8217;s board of directors and certain of its officers (the &#8220;State Derivative Litigation&#8221;). The three derivative complaints allege breach of fiduciary duties, waste of corporate assets, and violations of federal securities laws based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The D&#8217;Arcy complaint further alleges unjust enrichment, abuse of control, gross mismanagement and aiding and abetting thereof. The three derivative complaints seek unspecified damages, restitution and disgorgement of profits, benefits and compensation obtained by the defendants and costs and expenses, including attorneys&#8217; fees. On October&#160;18, 2021, the court consolidated the two federal court cases under the caption In re Sesen Bio, Inc. Derivative Litigation, Lead Case No. 1:21-cv-11538 (the &#8220;Federal Derivative Litigation&#8221;). On December&#160;22, 2021, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">court entered a joint stipulation among the parties to stay the Federal Derivative Litigation until after a ruling on any motion to dismiss filed by defendants in the Securities Litigation. On May&#160;1, 2022, the plaintiffs filed a verified consolidated shareholder derivative complaint in the Federal Derivative Litigation. On May&#160;18, 2022, the court entered a joint stipulation among the parties to stay the State Derivative Litigation until after a ruling on any motion to dismiss filed by defendants in the Securities Litigation. On July&#160;6, 2022, the Company and the plaintiffs to the Federal Derivative Litigation and the State Derivative Litigation engaged in mediation in an attempt to resolve the litigation, with settlement discussions continuing over the following days. On July&#160;19, 2002, the parties reached an agreement in principle to settle the Federal Derivative Litigation, the State Derivative Litigation and other potential related derivative claims (collectively, the &#8220;Derivative Litigation&#8221;). Pursuant to that agreement, the individual defendants will cause the Company to adopt certain enhancements to its corporate governance policies and procedures. In exchange, plaintiffs will dismiss the Derivative Litigation and, on behalf of the Company, provide broad customary releases to the individual defendants. On August&#160;22, 2002, the parties entered into a Stipulation of Settlement to settle the Derivative Litigation, which was filed with the court on August&#160;30, 2022. The Stipulation of Settlement related to the Derivative Litigation confirms that the Company previously adopted certain corporate governance enhancements in response to, among other things, the filing of the Derivative Litigation, and that, subject to final court approval, the Company will adopt additional corporate governance enhancements. The Stipulation of Settlement also provides for a $0.6&#160;million payment for plaintiffs&#8217; attorneys fees due to the benefits the corporate governance enhancements are intended to provide to the Company. The payment of plaintiffs&#8217; attorneys fees is being funded by the Company. On September&#160;2, 2022, the court issued an order granting preliminary approval of the Stipulation of Settlement related to the Derivative Litigation. The court has set a final settlement approval hearing for November&#160;8, 2022 at 2:00&#160;p.m. local time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, the Company deemed the settlements of the Securities Litigation and the Derivative Litigation probable and amounts reasonably estimable and recorded $21.6&#160;million to litigation related liability. During the third quarter of 2022, the Company paid $0.6&#160;million to be held in escrow for the plaintiffs&#8217; attorneys fees and $21.0&#160;million remains as a litigation related liability as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company, its board of directors and the individual defendants continue to deny all allegations of any wrongdoing but are seeking to settle the Securities Litigation and the Derivative Litigation to avoid the uncertainty, risk, expense and distraction of protracted litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subsequent to September&#160;30, 2022, on October&#160;21, 2022, the Company received two separate letters and on November&#160;4, 2022, the Company received one letter from purported stockholders demanding that the Company amend the Registration Statement filed with the SEC on October&#160;14, 2022 (the &#8220;Registration Statement&#8221;) to provide additional disclosures that such stockholders allege were improperly omitted from the Registration Statement, including information regarding the financial projections for Carisma, the financial analyses performed by the Company&#8217;s financial advisor in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement. The Company believes that these demands are without merit and intends to vigorously defend against them. See discussion in Note 19. &#8220;Subsequent Events.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Employment Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has entered into employment agreements or offer letters with certain of its key executives, providing for separation payments and benefits in certain circumstances, as defined in the agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination Fees associated with the Anticipated Merger with Carisma</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains certain termination rights of each of the Company and Carisma. Upon termination of the Merger Agreement under specified circumstances, the Company may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay the Company a termination fee of $5.49&#160;million and/or reimburse the Company expenses up to a maximum of $1.75&#160;million. At this time, no assessment can be made as to the likely outcome or whether the outcome will be material to the Company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.&nbsp;&nbsp;&nbsp;LEASES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the third quarter of 2022, the Company entered into a Lease Termination Agreement (the &#8220;Lease Termination Agreement&#8221;) pursuant to which the Company terminated its operating lease agreement for its 31,000 square foot facility in Winnipeg, Manitoba which consists of manufacturing, laboratory, warehouse, and office space and agreed to end the lease by September&#160;30, 2022. As part of the execution of the Lease Termination Agreement, the Company paid the landlord the all-inclusive sum of CAD $1.2&#160;million (USD $0.9&#160;million). Operating lease costs under this lease, including the related operating costs, were $81,000 and $245,000 for the three and nine&#160;months ended September&#160;30, 2022, respectively, and $79,000 and $245,000 for the three and nine&#160;months ended September&#160;30, 2021, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The right of use asset total was zero as of September&#160;30, 2022 and $123,300 as of December&#160;31, 2021. As of December&#160;31, 2021, the asset component of the Company&#8217;s operating leases was recorded as operating lease right-of-use assets and reported within other assets on the Company&#8217;s condensed consolidated&#160;balance sheets. The short-term lease liability was zero as of September&#160;30, 2022 and $123,300 as of December&#160;31, 2021. As of December&#160;31, 2021, the short-term lease liability was recorded in other current liabilities on the Company&#8217;s condensed consolidated balance sheets. There was no long-term operating lease liability as of September&#160;30, 2022 or December&#160;31, 2021. Operating lease cost is recognized on a straight-line basis over the term of the lease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Company has short-term property leases for modular office space for 1) its corporate headquarters in Cambridge, MA and 2) office space in Philadelphia, PA. The Company intends to terminate both leases in connection with the closing of the anticipated Merger with Carisma. The short-term lease in Philadelphia is renewed on a month-to-month basis. The short-term lease in Cambridge ends in June&#160;2023. The minimum monthly rent for these office spaces is $2,500 and $17,200, respectively, which is subject to change if and as the Company adds space to or deducts space from the leases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.&nbsp;&nbsp;&nbsp;STOCKHOLDERS&#8217; EQUITY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Financings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">ATM Offering</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has entered into an Open Market Sale Agreement </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">SM</font><font style="letter-spacing:0.2pt;"> with Jefferies LLC (&#8220;Jefferies&#8221;), dated November&#160;29, 2019, as amended by Amendment No. 1 dated October&#160;30, 2020, Amendment No. 2 dated February&#160;17, 2021 and Amendment No. 3, dated June&#160;1, 2021 (as amended, the &#8220;Sale Agreement&#8221;), under which the Company may issue and sell shares of its common stock, par value $0.001 per share, from time to time through Jefferies (the &#8220;ATM Offering&#8221;). In June and July&#160;2021, the Company filed prospectus supplements with the SEC in connection with the offer and sale of up to an aggregate of $200&#160;million of common stock pursuant to the Sale Agreement of which $97.8&#160;million of common stock remain available for future issuance as of September&#160;30, 2022. Sales of common stock under the Sale Agreement are made by any method that is deemed to be an ATM offering as defined in Rule&#160;415(a)(4) of the Securities Act of 1933, as amended, including but not limited to sales made directly on or through the Nasdaq Stock Market or any other existing trading market for the Company&#8217;s common stock. The Company may sell shares of its common stock efficiently from time to time but has no obligation to sell any of its common stock and may at any time suspend offers under the Sale Agreement or terminate the Sale Agreement. Subject to the terms and conditions of the Sale Agreement, Jefferies will use its commercially reasonable efforts to sell common stock from time to time, as the sales agent, based upon the Company&#8217;s instructions, which include a prohibition on sales below a minimum price set by the Company from time to time. The Company has provided Jefferies with customary indemnification rights, and Jefferies is entitled to a commission at a fixed rate equal to 3.0% of the gross proceeds for each sale of common stock under the Sale Agreement. The Company did not sell any shares of common stock pursuant to the Sale Agreement during the nine&#160;months ended September&#160;30, 2022. The Company raised $175.0&#160;million of net proceeds from the sale of 56.9&#160;million shares of common stock at a weighted-average price of $3.17 per share during the nine&#160;months ended September&#160;30, 2021. The Company raised $38.2&#160;million of net proceeds from the sale of 9.8&#160;million shares of common stock at a weighted-average price of $4.01 per share during the three&#160;months ended September&#160;30, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2021. Share issuance costs, including sales agent commissions, related to the ATM Offering totaled $1.2&#160;million and $5.4&#160;million during the three and nine&#160;months ended September&#160;30, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;), the Company is authorized to issue 5.0&#160;million shares of &#8220;blank check&#8221; preferred stock, $0.001 par value per share, which enables its board of directors, from time to time, to create one or more series of preferred stock. Each series of preferred stock issued shall have the rights, preferences, privileges and restrictions as designated by the board of directors. The issuance of any series of preferred stock could affect, among other things, the dividend, voting and liquidation rights of the Company&#8217;s common stock. The Company had no preferred stock issued and outstanding as of September&#160;30, 2022 and 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following approval by the Company&#8217;s stockholders on May&#160;3, 2021, an amendment became effective to the Certificate of Incorporation that increased the number of authorized shares of common stock from 200&#160;million to 400&#160;million, of which approximately 203&#160;million and 199&#160;million shares were issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021, respectively. In addition, the Company had reserved for issuance the following amounts of shares of its common stock for the purposes described below as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:138pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Shares of common stock issued </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">202,757</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,464</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Shares of common stock reserved for issuance for: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">16,202</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restricted stock&#160;units </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4,695</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,041</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for grant under 2014 Stock Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,725</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">8,933</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for sale under 2014 Employee Stock Purchase Plan </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">2,300</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">2,300</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total shares of common stock issued and reserved for issuance</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">229,878</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">229,640</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.01pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The voting, dividend and liquidation rights of holders of shares of common stock are subject to and qualified by the rights, powers and preferences of holders of shares of preferred stock. Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders; provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#8217;s Certificate of Incorporation that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more such series, to vote thereon. There shall be no cumulative voting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dividends may be declared and paid on the common stock from funds lawfully available thereof as and when determined by the board of directors and subject to any preferential dividend or other rights of any then-outstanding preferred stock. The Company has never declared or paid, and for the foreseeable future does not expect to declare or pay, dividends on its common stock, other than the CVR (as further described in Note 17. &#8220;License Agreements&#8221; below) and any special cash dividend that the Company may pay to its stockholders in connection with the consummation of the Merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the dissolution or liquidation of the Company, whether voluntary or involuntary, holders of common stock will be entitled to receive all assets of the Company available for distribution to its stockholders, subject to any preferential or other rights of any then-outstanding preferred stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">All of the Company&#8217;s outstanding warrants are non-tradeable and equity-classified because they meet the derivative scope exception under ASC Topic 815-40, </font><font style="letter-spacing:0.2pt;">Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:42.72pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Own Equity</font><font style="letter-spacing:0.2pt;">. The following table sets forth the Company&#8217;s warrant activity for the three&#160;months ended September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Exercised) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Cancelled) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mar-2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">Mar-2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2017 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">Nov-2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May-2015 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.83</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">Nov-2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2014 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">11.04</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:30pt; text-align:right; white-space:nowrap;">Nov-2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:112.83pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:6.69pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Exercise price shown (i)&#160;reflects modification and (ii)&#160;is subject to further adjustment based on down round provision added by amendment described in &#8220;Item&#160;15. Exhibits and Financial Statement Schedules&#8201;&#8212;&#8201;Note 12. Stockholders&#8217; Equity (Deficit)&#8221; in the audited annual consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">13.&nbsp;&nbsp;&nbsp;EARNINGS (LOSS) PER SHARE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">A net loss cannot be diluted. Therefore, when the Company is in a net loss position, basic and diluted loss per common share are the same. If the Company achieves profitability, the denominator of a diluted earnings per common share calculation includes both the weighted-average number of shares outstanding and the number of common stock equivalents, if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include warrants, stock options and unvested restricted stock awards and&#160;units using the treasury stock method, along with the effect, if any, from outstanding convertible securities. The majority of the Company&#8217;s outstanding warrants to purchase common stock have participation rights to any dividends that may be declared in the future and are therefore considered to be participating securities. Participating securities have the effect of diluting both basic and diluted earnings per share during periods of income. During periods of loss, no loss is allocated to the participating securities since the holders have no contractual obligation to share in the losses of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, an entity that presents earnings per share shall recognize the value of the effect of an anti-dilution provision in an equity-classified freestanding financial instrument in the period the anti-dilution provision is triggered. That effect shall be treated as a deemed dividend and as a reduction of income available to common stockholders in basic earnings per share. The deemed dividend is added back to income available to common stockholders when applying the treasury stock method for diluted earnings per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For periods with net income, diluted net earnings per share is calculated by either (i)&#160;adjusting the weighted-average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period as determined using the treasury stock method or (ii)&#160;the two-class method considering common stock equivalents, whichever is more dilutive. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. Accordingly, the Company applied the two-class method to calculate basic and diluted net earnings per share of common stock for the three&#160;months ended September&#160;30, 2022 and September&#160;30, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of the diluted net loss per share calculation, common stock equivalents are excluded from the calculation if their effect would be anti-dilutive. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:51.3099999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table illustrates the determination of earnings (loss) per share for each period presented: </font>
        </div>
        <table style="width:456pt;height:402.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:273.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:273.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:273.17pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except per share amounts) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Basic Earnings (Loss) Per Share:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Numerator: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: Income attributable to participating securities&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(15<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:273.17pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201;</font>
                <br >
                <font style="letter-spacing:0.2pt;">basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">71,622</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Denominator: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">200,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">196,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:273.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per share applicable to common stockholders&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Dilutive Earnings (Loss) Per Share:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Numerator: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: Income attributable to participating securities&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(15<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(51<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:273.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201; diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">71,623</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Denominator: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average shares outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">196,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Dilutive impact from: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options and employee stock purchase plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4,239</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restricted stock&#160;units &amp; performance based stock&#160;units </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">200,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.5pt 0pt; width:273.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per share applicable to common stockholders&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:9.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities outstanding as of September&#160;30, 2022 and 2021 have been excluded from the denominator of the diluted loss per share of common stock outstanding calculation (in thousands): </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">55</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">55</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">16,182</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,273</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">16,202</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">15,511</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">RSUs and PSUs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,232</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,695</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:294.84pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,469</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">11,328</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">21,096</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,710</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">14.&nbsp;&nbsp;&nbsp;SHARE-BASED COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the amount of share-based compensation expense recognized by the Company by line item on its Condensed Consolidated Statements of Operations for the three and nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:76.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">863</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">152</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,838</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">536</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,305</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,016</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">4,026</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,849</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:294.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Share Based Compensation</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,168</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,168</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">5,864</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Stock Incentive Plan, as amended (the &#8220;2014 Plan&#8221;), was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 Plan became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and provides for the grant of incentive and non-qualified stock options, restricted stock awards, restricted stock&#160;units (&#8220;RSU&#8221;), stock appreciation rights and other stock-based awards, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to the Company&#8217;s employees, officers, directors, consultants and advisors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the Annual Meeting of the Company&#8217;s stockholders in June&#160;2019, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that (i)&#160;increased by 7.9&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan and (ii)&#160;eliminated the &#8220;evergreen&#8221; or automatic replenishment provision of the 2014 Plan, pursuant to which the number of shares of common stock authorized for issuance under the 2014 Plan was automatically increased on an annual basis. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that increased by 12&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan. There were approximately 3.7&#160;million shares of common stock available for issuance under the 2014 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stock options outstanding under the 2014 Plan generally vest over a four-year period at the rate of 25% of the grant vesting on the first anniversary of the date of grant and 6.25% of the grant vesting at the end of each successive three-month period thereafter. Stock options granted under the 2014 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 13.0&#160;million stock options outstanding under the 2014 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;9, 2021, the Company&#8217;s board of directors and the compensation committee of the board of directors (the &#8220;Compensation Committee&#8221;) approved a retention program for all then-current employees, except for the Chief Executive Officer, pursuant to which the Company will provide certain incentives designed to retain such employees (the &#8220;2021 Retention Program&#8221;). Pursuant to the 2021 Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s non-executive employees received a combination of a cash bonus award and a one-time RSU award which vested in full on September&#160;30, 2022, subject to continued employment through September&#160;30, 2022. Each RSU represents a contingent right to receive one share of the Company&#8217;s common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also pursuant to the 2021 Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s executive officers, except for the Chief Executive Officer, were granted a one-time performance-based restricted stock unit (&#8220;PSU&#8221;) award equal to the value of approximately fifty&#160;percent of then-current base salary. The fair value of PSUs at the grant date was $0.4&#160;million. Each PSU represents a contingent right to receive one share of the Company&#8217;s common stock upon the satisfaction of pre-determined performance criteria. Subject to continued employment, such awards vest on September&#160;30, 2023 upon the determination by the Compensation Committee of the level of achievement of certain key milestones consisting of a clinical trial milestone, an employee retention milestone and cash management milestones. As of September&#160;30, 2022, achievement was deemed probable for only the cash management milestone, representing $87,000, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">20% of the PSU awards. Therefore, $11,000 and $44,000 have been expensed during the three and nine&#160;months ended September&#160;30, 2022, respectively and $43,000 remains measured but unrecognized. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2009 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 2009 Stock Incentive Plan, as amended and restated (the &#8220;2009 Plan&#8221;), which provided for the grant of incentive and non-qualified stock options and restricted stock awards and restricted stock&#160;units, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to its employees, officers, directors, consultants and advisors. Upon the closing of its IPO in February&#160;2014, the Company ceased granting awards under the 2009 Plan and all shares (i)&#160;available for issuance under the 2009 Plan at such time and (ii)&#160;subject to outstanding awards under the 2009 Plan that expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased without having been fully exercised or resulting in any common stock being issued were carried over to the 2014 Plan. Stock options granted under the 2009 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 0.1&#160;million fully vested stock options outstanding under the 2009 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-of-Plan&#160;Inducement Grants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company has granted equity awards to its newly hired employees, including executives, in accordance with Nasdaq employment inducement grant exemption (Nasdaq Listing Rule&#160;5635(c)(4)). Such grants are made outside of the 2014 Plan and act as an inducement material to the employee&#8217;s acceptance of employment with the Company. There were approximately 3.1&#160;million stock options outstanding which were granted as employment inducement awards outside of the 2014 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the Company&#8217;s total stock option activity, including&#160;awards granted under the 2014 Plan and the 2009 Plan and inducement grants made outside of stockholder approved plans, for the nine&#160;months ended September&#160;30, 2022: </font>
        </div>
        <table style="width:456pt;height:146pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:228pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares under</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Contractual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Life</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:228pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.93</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.03</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:12pt; text-align:right; white-space:nowrap;">82</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,510</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:12pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:12pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:228pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(1,011<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">2.10</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:12pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:228pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">16,202</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.81</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.41</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:12pt; text-align:right; white-space:nowrap;">DM</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:228pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,494</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.72</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.94</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:12pt; text-align:right; white-space:nowrap;">DM</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognized share-based compensation expense, related to stock options, of $1.0&#160;million and $3.5&#160;million for the three and nine&#160;months ended September&#160;30, 2022, respectively and $1.2&#160;million and $3.4&#160;million for the three and nine&#160;months ended September&#160;30, 2021, respectively. As of September&#160;30,&#160;2022, there was $6.4&#160;million of total unrecognized compensation cost related to unvested stock options which the Company expects to recognize over a weighted-average period of 2.09&#160;years. The weighted-average grant-date fair value of stock options granted during the nine&#160;months ended September&#160;30, 2022 and 2021 were $0.46 and $2.20, respectively. No stock options were exercised during the nine&#160;months ended September&#160;30, 2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022 and 2021, the grant-date fair value of stock options was determined using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model: </font>
        </div>
        <table style="width:416pt;height:107.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair market value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.40</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grant exercise price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.40</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.0</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.03</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">71.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">74.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Restricted Stock Units and Performance Stock Units</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the Company&#8217;s RSU and PSU activity for the nine&#160;months ended September&#160;30, 2022: </font>
        </div>
        <table style="width:416pt;height:117pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Restricted Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Units</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average Grant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">3,041</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.80</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4,160</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.68</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cancelled RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(217<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.75</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Released RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(3,293<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.76</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted PSU </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,004</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">0.67</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">4,695</div>
            </td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.68</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not grant any RSUs or PSUs during the nine&#160;months ended September&#160;30, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The share-based compensation expense related to RSUs and PSUs for the three and nine&#160;months ended September&#160;30, 2022 was $1.2&#160;million and $2.4&#160;million, respectively. There was no shared-based compensation expense related to RSUs and PSUs for the three and nine&#160;months ended September&#160;30, 2021. As of September&#160;30, 2022, there was $1.8&#160;million of total unrecognized compensation cost related to unvested RSUs and PSUs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.&nbsp;&nbsp;&nbsp;EMPLOYEE BENEFIT PLANS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Employee Stock Purchase Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Employee Stock Purchase Plan (&#8220;2014 ESPP&#8221;) was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 ESPP became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and established an initial reserve of 0.2&#160;million shares of the Company&#8217;s common stock for issuance to participating employees. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 ESPP that increased by 2.3&#160;million the number of shares of common stock reserved for issuance under the 2014 ESPP. The purpose of the 2014 ESPP is to enhance employee interest in the success and progress of the Company by encouraging employee ownership of common stock of the Company. The 2014 ESPP provides employees with the opportunity to purchase shares of common stock at a 15% discount to the market price through payroll deductions or lump sum cash investments. The Company estimates the number of shares to be issued at the end of an offering period and recognizes expense over the requisite service period. Shares of the common stock issued and sold pursuant to the 2014 ESPP are shown on the condensed consolidated statements of changes in stockholders&#8217; equity (deficit). As of September&#160;30, 2022, there were 2.3&#160;million shares of common stock available for sale under the 2014 ESPP. The Company did not sell any shares under the ESPP during the nine&#160;months ended September&#160;30, 2022 and 2021. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Defined Contribution Plans</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">United States&#8201;&#8212;&#8201;401(k) Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 401(k) defined contribution retirement plan which covers all of its US employees. Employees are eligible to participate on the first of the month following their date of hire. Under the 401(k) plan, participating employees may defer up to 100% of their pre-tax salary, subject to certain statutory limitations. Employee contributions vest immediately. The plan allows for a discretionary match per participating employee up to a maximum of $4,000 per year. The expenses incurred for the periods presented were de minimis amount for each of the nine&#160;months ended September&#160;30, 2022 and 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Canada&#8201;&#8212;&#8201;Defined Contribution Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a defined contribution plan for its Canadian employees. Participants may contribute a&#160;percentage of their annual compensation to this plan, subject to statutory limitations. The Company contributes up to the first 4% of eligible compensation for its Canadian-based employees to the retirement plan. The expenses incurred for the periods presented were de minimis amount for each of the nine&#160;months ended September&#160;30, 2022 and 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">16.&nbsp;&nbsp;&nbsp;INCOME TAXES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the components of the Company&#8217;s loss before income taxes by country (in thousands): </font>
        </div>
        <table style="width:456pt;height:91.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Country: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(32,083<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(38,864<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canada </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">21,311</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total loss before income taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s tax benefit (provision) is comprised of the following components (in thousands): </font>
        </div>
        <table style="width:456pt;height:106.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:376.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:376.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:376.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current tax benefit (provision) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8,559</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(286<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total current benefit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s deferred tax liability is comprised of the following: </font>
        </div>
        <table style="width:456pt;height:63pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax liabilities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">IPR&amp;D </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total deferred tax liabilities</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022, the Company recorded a benefit from income taxes of $3.9&#160;million. In the second quarter of 2022, the Company determined that the fair value of the Vicineum EU rights was zero, which resulted in an impairment charge of $14.7&#160;million. In connection with this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">impairment charge, the Company reversed the associated deferred tax liability by $4.0&#160;million as an income tax benefit, partially offset by $0.1&#160;million income tax paid to foreign jurisdictions pursuant to the Qilu License Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2021, the Company recorded a benefit from income&#160;taxes of $8.3&#160;million. In the third quarter of 2021, the Company determined that the fair value of the Vicineum US rights was zero, which resulted in an impairment charge of $31.7&#160;million. In connection with this impairment charge, in the third quarter of 2021, the Company wrote-down the associated deferred tax liability by $8.6&#160;million as a benefit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">17.&nbsp;&nbsp;&nbsp;LICENSE AGREEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Zurich</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with the University of Zurich (&#8220;Zurich&#8221;) which grants the Company exclusive license rights, with the right to sublicense, to make, have made, use and sell under certain patents primarily directed to the Company&#8217;s targeting agent, including an EpCAM chimera and related immunoconjugates and methods of use and manufacture of the same (the &#8220;Zurich License Agreement&#8221;). These patents cover some key aspects of Vicineum. The Company&#8217;s receipt of the Complete Response Letter (&#8220;CRL&#8221;) regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC triggered a $0.5&#160;million milestone payment to Zurich. Under the Zurich License Agreement, as of September&#160;30, 2022, the Company is also obligated to pay up to a 4% royalty on the net product sales for products covered by or manufactured using a method covered by a valid claim in the Zurich patent rights, which includes Vicineum. Royalties owed to Zurich will be reduced if the total royalty rate owed by the Company to Zurich and any other third party is 10% or greater, provided that the royalty rate to Zurich&#160;may not be less than 2% of net sales. The obligation to pay royalties in a particular country expires upon the expiration or termination of the last of the Zurich patent rights that covers the manufacture, use or sale of a product. There is no obligation to pay royalties in a country if there is no valid claim that covers the product or a method of manufacturing the product. The Company recorded an expense of $0.3&#160;million and $0.5&#160;million related to meeting a development milestone, the submission of the Company&#8217;s BLA with the FDA in December&#160;2020, in the fourth quarter of 2020, and a regulatory milestone, the Company&#8217;s receipt of the CRL from the FDA in August&#160;2021, in the third quarter of 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Micromet</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a License Agreement with Micromet AG (&#8220;Micromet&#8221;), now part of Amgen, Inc., which grants it nonexclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products (the &#8220;Micromet License Agreement&#8221;). These patents cover some key aspects of Vicineum. Under the terms of the Micromet License Agreement, as of September&#160;30, 2022, the Company may be obligated to pay up to &euro;2.4&#160;million in milestone payments for the first product candidate that achieves applicable regulatory and sales-based development milestones (approximately $2.4&#160;million at exchange rates in effect on September&#160;30, 2022). The Company is also&#160;required to pay up to a 3.5% royalty on the net sales for products covered by the agreement, which includes Vicineum. The royalty rate owed to Micromet in a particular country will be reduced to 1.5% if there are no valid claims covering the product in that country. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. Finally, the Company is required to pay to&#160;Micromet an annual license maintenance fee of &euro;50,000 (approximately $48,987 at exchange rates in effect as of September&#160;30, 2022), that can be credited towards any royalty payment the Company owes to Micromet. The Company recorded an expense of &euro;0.7&#160;million ($0.9&#160;million) related to achievement of a development milestone in the three&#160;months ended December&#160;31, 2020, due to the submission of the Company&#8217;s BLA for Vicineum with the FDA in December&#160;2020. The Company recorded an expense of &euro;0.5&#160;million ($0.6&#160;million) related to the submission of marketing authorization application (the &#8220;MAA&#8221;) to the European Medicines Agency (the &#8220;EMA&#8221;) for Vysyneum&#8482; in the first quarter of 2021. Vysyneum is the proprietary brand name that was conditionally approved by the EMA for oportuzumab monatox in the EU. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with XOMA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with XOMA Ireland Limited (&#8220;XOMA&#8221;) which grants it non-exclusive rights to certain XOMA patent rights and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems (the &#8220;XOMA License Agreement&#8221;). These patents and related know-how cover some key aspects of Vicineum. Under the terms of the XOMA License Agreement, the Company is required to pay up to $0.25&#160;million in milestone payments for a product candidate that incorporates know-how under the license and achieves applicable clinical development milestones. The Company is also required to pay a 2.5% royalty on the net sales for products incorporating XOMA&#8217;s technology, which includes Vicineum. The Company has the right to reduce the amount of royalties owed to XOMA on a country-by-country basis by the amount of royalties paid to other third parties, provided that the royalty rate to XOMA may not be less than 1.75% of net sales. In addition, the foregoing royalty rates are reduced by 50% with respect to products that are not covered by a valid patent claim in the country of sale. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Roche License Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, the Company entered into the license agreement with Roche (the &#8220;Roche License Agreement&#8221;), pursuant to which the Company granted Roche an exclusive, worldwide license, including the&#160;right to sublicense, to its patent rights and know-how related to the Company&#8217;s monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by the Company (collectively, the &#8220;Roche Licensed Intellectual Property&#8221;). Under the Roche License Agreement, Roche was required to continue developing, at its cost, EBI-031 and any other product made from the Roche Licensed Intellectual Property that contains an IL-6 antagonist monoclonal antibody and pursue ongoing patent prosecution, at its cost. For additional information regarding the Roche License Agreement, see Note 17. &#8220;License Agreements&#8221; in the Notes to Condensed Consolidated Financial Statements in the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Company entered into an asset purchase agreement with Roche (the &#8220;Roche Asset Purchase Agreement&#8221;) pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by the Company for up to $70&#160;million. As a result of the Roche Asset Purchase Agreement, the Roche License Agreement was terminated resulting in no further diligence, milestone or royalty payment obligations under the Roche License Agreement. Pursuant to the Roche Asset Purchase Agreement, Roche made a $40&#160;million payment to the Company upon execution of the Roche Asset Purchase Agreement, which was recorded as license revenue in the third quarter of 2022. The Roche Asset Purchase Agreement also provides that Roche will make an additional $30&#160;million payment to the Company upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a defined indication if initiated prior to December&#160;31, 2026. Pursuant to ASC 606, the variable consideration of $30&#160;million is constrained. Therefore, the amount was not recorded as revenue during the third quarter of 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, at or prior to the effective time of the Merger, the Company will enter into a Contingent Value Rights Agreement (the &#8220;CVR Agreement&#8221;) with a rights agent (&#8220;Rights Agent&#8221;) pursuant to which the Company intends to declare a dividend payable to the Company&#8217;s stockholders of record as of a date agreed to by the Company and Carisma prior to the effective time of the Merger with respect to the receipt of one contingent value right (each, a &#8220;CVR&#8221;) for each outstanding share of the Company&#8217;s common stock held by such stockholders on such date. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by the Company of certain proceeds payable by Roche, if any, pursuant to the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement, subject to certain customary deductions, including for expenses and taxes. The contingent payments under the CVR Agreement, if they become due, will be payable to the Rights Agent for subsequent distribution to the holders of the CVRs. In the event that no such proceeds are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">received, holders of the CVRs will not receive any payment pursuant to the CVR Agreement. There can be no assurance that any cash payment will be made or that any holders of CVRs will receive any amounts with respect thereto. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OUS Business Development Partnership Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Qilu License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;30, 2020, the Company and its wholly-owned subsidiary, Viventia Bio, Inc., entered into the Qilu License Agreement pursuant to which the Company granted Qilu an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to develop, manufacture and commercialize Vicineum (the &#8220;Qilu Licensed Product&#8221;) for the treatment of NMIBC and other types of cancer (the &#8220;Field&#8221;) in China, Hong Kong, Macau and Taiwan (&#8220;Greater China&#8221;). The Company also granted Qilu a non-exclusive, sublicensable, royalty-bearing sublicense, under certain other intellectual property licensed by the Company to develop, manufacture and commercialize the Qilu Licensed Product in Greater China. The Company retains (i)&#160;development, and commercialization rights in the rest of the world, excluding Greater China and (ii)&#160;manufacturing rights with respect to Vicineum in the rest of the world, excluding China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In consideration for the rights granted by the Company, Qilu agreed to pay to the Company a one-time upfront cash payment of $12&#160;million, and milestone payments totaling up to $23&#160;million upon the achievement of certain technology transfer, development and regulatory milestones. All payments were to be inclusive of VAT, which can be withheld by Qilu upon payment, and for which future recovery of such taxes may be available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Qilu also agreed to pay the Company a 12% royalty based upon annual net sales of Qilu Licensed Products in Greater China. The royalties are payable on a Qilu Licensed Product-by-Licensed Product and region-by-region basis commencing on the first commercial sale of a Qilu Licensed Product in a region and continuing until the latest of (i)&#160;twelve&#160;years after the first commercial sale of such Qilu Licensed Product in such region, (ii)&#160;the expiration of the last valid patent claim covering or claiming the composition of matter, method of treatment, or method of manufacture of such Qilu Licensed Product in such region, and (iii)&#160;the expiration of regulatory or data exclusivity for such Qilu Licensed Product in such region (collectively, the &#8220;Royalty Terms&#8221;). The royalty rate is subject to reduction under certain circumstances, including when there is no valid claim of a licensed patent that covers a Qilu Licensed Product in a particular region or no data or regulatory exclusivity of a Qilu Licensed Product in a particular region. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Qilu is responsible for all costs related to developing, obtaining regulatory approval of and commercializing the Qilu Licensed Products in the Field in Greater China. Qilu is required to use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize at least one Qilu Licensed Product in the Field in Greater China. A joint development committee was established between the Company and Qilu to coordinate and review the development, manufacturing and commercialization plans with respect to the Qilu Licensed Products in Greater China. The Company and Qilu also executed the terms and conditions of a supply agreement and related quality agreement pursuant to which the Company will manufacture or have manufactured and supply Qilu with all quantities of the Qilu Licensed Product necessary for Qilu to develop and commercialize the Qilu Licensed Product in the Field in Greater China until the Company has completed manufacturing technology transfer to Qilu and approval of a Qilu manufactured product by the National Medical Products Administration in China (&#8220;NMPA&#8221;) for the Qilu Licensed Product has been obtained. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement will expire on a Qilu Licensed Product-by-Licensed Product and region-by-region basis on the date of the expiration of all applicable Royalty Terms. Either party may terminate the Qilu License Agreement for the other party&#8217;s material breach following a cure period or upon certain insolvency events. Qilu has the right to receive a refund of all amounts paid to the Company in the event the Qilu License Agreement is terminated under certain circumstances. The Qilu License Agreement includes customary representations and warranties, covenants and indemnification obligations for a transaction of this nature. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement is subject to the provisions of ASC Topic 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue</font><font style="letter-spacing:0.2pt;">. In 2020, the initial transaction price was estimated to be $11.2&#160;million and was based on the up-front fixed consideration of $12&#160;million less amounts withheld for VAT. The Company concluded that its agreements under the Qilu License Agreement represented one bundled performance obligation that had been achieved as of September&#160;30, 2020. As such, $11.2&#160;million of the total $11.2&#160;million transaction price was considered earned and the Company recorded $11.2&#160;million of revenue during the three-month period ended September&#160;30, 2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Investigational New Drug application for Vicineum submitted by Qilu to the Center for Drug Evaluation of the NMPA was accepted for review in January&#160;2021 and approved in March&#160;2021, resulting in a $3&#160;million milestone payment from Qilu, the first milestone payment out of the $23&#160;million in potential milestone payments. The Company recorded $2.8&#160;million (net of VAT) as license revenue during the three-month period ended March&#160;31, 2021. The Company received the payment in 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. An agreement that is designated as a Technology Transfer shall be entitled to a tax incentive of VAT recovery. As such, the Company recorded $0.9&#160;million of revenue during the three&#160;months ended June&#160;30, 2021 for additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen Bio an amount equal to its recovery of VAT. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MENA License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;30, 2020, the Company entered into a license agreement with a third party pursuant to which the Company granted an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to commercialize Vicineum in the Middle East and North Africa region (&#8220;MENA&#8221;) (the &#8220;MENA License Agreement&#8221;). In consideration for the rights granted by the Company, the counterparty to the MENA License Agreement agreed to pay to the Company an upfront payment of $3&#160;million, which would be subject to certain tax withholdings. In addition, the counterparty agreed to pay to the Company milestone payments upon the achievement of certain sales-based milestones as well as a royalty based upon annual net sales in the MENA region for the term of the MENA License Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;20, 2022, the Company provided notice of termination of the MENA License Agreement as a result of the Company&#8217;s strategic decision to voluntarily pause further development of Vicineum in the US. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EIP License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;5, 2021, the Company entered into an exclusive license agreement with E&#304;P Eczac&#305;ba&#351;&#305; &#304;la&#231; Pazarlama A.&#350;., (&#8220;EIP&#8221;) pursuant to which it granted EIP an exclusive license to register and commercialize Vicineum for the treatment of BCG-unresponsive NMIBC in Turkey and Northern Cyprus (the &#8220;EIP License Agreement&#8221;). Under the terms of the EIP License Agreement, the Company was entitled to receive an upfront payment of $1.5&#160;million. The Company and EIP have amended the license agreement to defer EIP&#8217;s payment of the upfront payment to coincide with the potential FDA approval of Vicineum. The Company would be eligible to receive additional regulatory and commercial milestone payments of $2.0&#160;million and also to receive a 30% royalty on net sales in Turkey and Northern Cyprus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;20, 2022, the Company provided notice of termination of the EIP License Agreement as a result of the Company&#8217;s strategic decision to voluntarily pause further development of Vicineum in the US. The EIP License Agreement was terminated on October&#160;20, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">18.&nbsp;&nbsp;&nbsp;RESTRUCTURING AND RELATED ACTIVITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Company approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following the decision to voluntarily pause further development of Vicineum in the US (the &#8220;2022 Restructuring Plan&#8221;). Execution of the 2022 Restructuring Plan is expected to be substantially completed in connection with the closing of the Merger with Carisma, which is expected to occur approximately two to three&#160;months from the date of this Form 10-Q filing, November&#160;7, 2022. The 2022 Restructuring Plan includes an incremental reduction in the Company&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:228.5pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">workforce as well as additional cost-saving initiatives intended to preserve capital during the pendency of the Merger with Carisma and while the Company seeks a potential partner for the further development of Vicineum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company also incurred one-time cash costs associated with the termination of certain contracts and all other activities under the 2022 Restructuring Plan. The following is a summary of accrued restructuring costs related to the 2022 Restructuring Plan, (in thousands): </font>
        </div>
        <table style="width:456pt;height:84.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:363.36pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 Restructuring Plan </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Severance and benefits costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,944</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contract termination and other associated costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">4,003</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total restructurings costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash payments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(4,582<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,365</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Restructuring costs related to the Restructuring Plan were recorded in operating expenses in the Company&#8217;s Condensed Consolidated Statements of Income (Operations) and Comprehensive Income (Loss) in the three&#160;months ended September&#160;30, 2022. The Company expects that substantially all of the accrued restructuring costs as of September&#160;30, 2022 will be paid in cash in connection with the closing of the Merger with Carisma, which is expected to occur approximately two to three&#160;months from the date of this Form 10-Q filing, November&#160;7, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.&nbsp;&nbsp;&nbsp;SUBSEQUENT EVENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;21, 2022, the Company received two separate letters and on November&#160;4, 2022, the Company received one letter from purported stockholders demanding that the Company amend the Registration Statement filed with the SEC on October&#160;14, 2022 to provide additional disclosures that such stockholders allege were improperly omitted from the Registration Statement, including information regarding the financial projections for Carisma, the financial analyses performed by the Company&#8217;s financial advisor in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement. The Company believes that these demands are without merit and intends to vigorously defend against them. At this time, no assessment can be made as to the likely outcome or whether the outcome will be material to the Company.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="TOC5">&#8203;</a><a name="fISCS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:351.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO CARISMA&#8217;S CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:239.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:424pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Audited Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tROIR1"><font style="letter-spacing:0.2pt;">Report of Independent Registered Public Accounting Firm </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROIR1">F-71</a></font> <a href="#tROIR1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCBS1"><font style="letter-spacing:0.2pt;">Consolidated Balance Sheets, December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCBS1">F-72</a></font> <a href="#tCBS1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOO1"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations, Years Ended December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOO1">F-73</a></font> <a href="#tCSOO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCSOC2"><font style="letter-spacing:0.2pt;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit, Years ended December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC2">F-74</a></font> <a href="#tCSOC2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOC3"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows, Years ended December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC3">F-75</a></font> <a href="#tCSOC3"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTTC"><font style="letter-spacing:0.2pt;">Notes to Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTTC">F-76</a></font> <a href="#tNTTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Unaudited Interim Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUCBS"><font style="letter-spacing:0.2pt;">Consolidated Balance Sheets, September&#160;30, 2022 and December&#160;31, 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCBS">F-89</a></font> <a href="#tUCBS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tUCSO"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations and Comprehensive Loss, Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCSO">F-90</a></font> <a href="#tUCSO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tUCSO1"><font style="letter-spacing:0.2pt;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit, Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCSO1">F-91</a></font> <a href="#tUCSO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUCSO2"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows, Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCSO2">F-92</a></font> <a href="#tUCSO2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTTI"><font style="letter-spacing:0.2pt;">Notes to Interim Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTTI">F-93</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tROIR1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Report of Independent Registered Public Accounting Firm</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the Stockholders and Board of Directors</font> <br ><font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc.: </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Opinion on the Consolidated Financial Statements </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated balance sheets of CARISMA Therapeutics Inc. and subsidiary (the Company) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations, convertible preferred stock and stockholders&#8217; deficit, and cash flows for the&#160;years then ended, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for the&#160;years then ended, in conformity with U.S. generally accepted accounting principles. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Going Concern </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has incurred losses and negative cash flows from operations since inception that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Basis for Opinion </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Critical Audit Matters </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Critical audit matters are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1)&#160;relate to accounts or disclosures that are material to the consolidated financial statements and (2)&#160;involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ KPMG LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have served as the Company&#8217;s auditor since 2018. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Philadelphia, Pennsylvania</font> <br ><font style="letter-spacing:0.2pt;">October 14, 2022</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCBS1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:6.00999999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidated Balance Sheets </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:569pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">1,235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,277</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,786</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">53,065</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right of use assets&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,579</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,413</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">211</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">58,463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,322</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4,471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,573</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">813</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,679</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">1,734</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">2,632</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">9,425</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,311</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Commitments and Contingencies (Note 6) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Convertible preferred stock, $0.0001 par value: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred stock, 6,138,518 shares authorized; 5,201,017 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">issued and outstanding (liquidation value of $54,091 at December&#160;31, 2021) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Special voting preferred stock, 1 share authorized, issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:358.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B convertible preferred stock, 4,807,541 shares authorized, 3,499,866 and 2,453,170 shares issued and outstanding as of December&#160;31, 2021 and 2020, respectively (liquidation value of $54,598 at December&#160;31, 2021) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B special voting preferred stock, 1 share authorized, issued and </font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">91,631</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Stockholders&#8217; deficit: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Common stock $0.0001 par value, 14,230,158 shares authorized, 1,084,082 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">339</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,213<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total CARISMA Therapeutics Inc. stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(96,179<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(55,874<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Noncontrolling interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(41,479<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total liabilities, convertible preferred stock and stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">58,463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCSOO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:381.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidated Statements of Operations </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:177.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">34,387</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">23,292</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6,407</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,086</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">40,794</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">28,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(40,794<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,378<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">29</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Share information: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share of common stock, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(37.62<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(26.66<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares of common stock outstanding, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,063,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="min-height:579.31pt;page-break-after:always; width:775.7pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCSOC2">&#8203;</a>
      </div>
      <div style="margin-top:61.66pt;margin-left:46.86pt;width:680pt;">
        <div style="width:680pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:115.5pt;margin-left:46.86pt;width:680pt;">
        <div style="margin-top:12pt; text-align:center; width:680pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:680pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:680pt;height:253.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.33pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="46">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="34">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;height:23pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.33pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;A </font>
                <br >
                <font style="letter-spacing:-0.16pt;">convertible </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Special voting </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;B </font>
                <br >
                <font style="letter-spacing:-0.16pt;">convertible </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;B </font>
                <br >
                <font style="letter-spacing:-0.16pt;">special voting </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.16pt;">paid-in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Noncontrolling </font>
                <br >
                <font style="letter-spacing:-0.16pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.33pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Balance, January&#160;1, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,910,151</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">29,752</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,042,187</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">157</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(27,864<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4,250</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(23,457<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Issuance of Series&#160;A convertible preferred stock at $10.40 per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,290,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">23,825</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">5,500</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">5,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Issuance of Series&#160;B convertible preferred stock at $15.60 per share, net of issuance costs of $215 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4,645</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">4,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">41,895</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Balance, December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">339</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(56,213<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(41,479<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Issuance of Series&#160;B convertible preferred stock at $15.60 per share, net of issuance costs of $151 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,046,696</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">16,177</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Balance, December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:1.99999999999997pt;height:12pt;margin-left:46.86pt;width:680pt;">
        <div style="text-align:center; width:680pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to consolidated financial statements</font>
          <br >
        </div>
      </div>
      <div style="margin-top:49.64pt;margin-left:168.89pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCSOC3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:83.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidated Statement of Cash Flows </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:475.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:357.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:357.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash flows from operating activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Adjustment to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Depreciation and amortization expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">682</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">448</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Reduction in the operating right of use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">834</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,179</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">253</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(936<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(974<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,282</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,995</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">353</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(813<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,152<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(37,328<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,012<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash flows from investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Purchases of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(440<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(440<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash flows from financing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the sale of Series&#160;A convertible preferred stock and noncontrolling </font>
                <br >
                <font style="letter-spacing:0.2pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">29,325</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the sale of Series&#160;B convertible preferred stock and noncontrolling </font>
                <br >
                <font style="letter-spacing:0.2pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">16,328</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">42,914</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payment of Series&#160;B offering costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(366<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">72,258</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net (decrease) increase in cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,237<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">44,806</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at beginning of the year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,982</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at end of the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental disclosures of non-cash financing and investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B issuance costs in accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B issuance costs in accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment in accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">121</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the consolidated financial statements</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tNTTC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notes to the Consolidated Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.42pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(1)&nbsp;&nbsp;&nbsp;Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.42pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc., a Delaware Corporation (the Company), is a clinical-stage biopharmaceutical company focused on utilizing the Company&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative therapies to treat cancer and other serious disorders. Cell therapy enables the utilization of reprogrammed living cells to perform complex functions such as clearance of tumor cells or resolution of inflammation. The Company&#8217;s initial focus is its proprietary Chimeric Antigen Receptor Macrophage (CAR-M) platform, which redirects macrophages against specific tumor associate antigens and enables targeted anti-tumor immunity by utilizing genetically modifying myeloid cells (macrophages and monocytes) to express chimeric antigen receptors, or CARs, enabling the innate immune cells to recognize specific tumor associated antigens on the surface of tumor cells. The Company&#8217;s clinical lead product candidate CT-0508 is an ex vivo gene-modified autologous CAR-M cell therapy product intended to treat solid tumors that overexpress HER2. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company received an investigational new drug application, or IND, clearance for CT-0508 for the treatment of HER2-overexpressing solid tumors in July&#160;2020 and dosed the first patient in March&#160;2021. The Food and Drug Administration, or FDA, granted CT-0508 Fast Track Status in September&#160;2021. As of September&#160;1, 2022, enrollment in group 1 of the first in human study has been completed with 9 patients successfully dosed with CT-0508, and group 2 is currently open for enrollment with an additional 9 patients to be dosed in the study. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(2)&nbsp;&nbsp;&nbsp;Development-Stage Risks and Liquidity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.41pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has incurred losses and negative cash flows from operations since inception and has an accumulated deficit of $97.0&#160;million as of December&#160;31, 2021. The Company anticipates incurring additional losses until such time, if ever, that it can generate significant sales from its product candidates currently in development. Management believes that cash and cash equivalents of $28.6&#160;million as of December&#160;31, 2021 and the $80.0&#160;million of cash proceeds received in January&#160;2022 from ModernaTX, Inc. (Moderna) related to the Collaboration and License Agreement and the Convertible Promissory Note (Note 11) are sufficient to sustain planned operations into the second quarter of 2023. As a result, the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the financial statements are issued. The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liability that might result from the outcome of this uncertainty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management is currently evaluating different strategies to obtain the required funding for future operations. These strategies may include but are not limited to private placements of equity and/or debt, licensing and/or marketing arrangements, and public offerings of equity and/or debt securities. There is no assurance that such financing will be available when needed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to those risks associated with any specialty biotechnology company that has substantial expenditures for research and development. There can be no assurance that the Company&#8217;s research and development projects will be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially viable. In addition, the Company operates in an environment of rapid technological change and is largely dependent on the services of its employees and consultants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(3)&nbsp;&nbsp;&nbsp;Summary of Significant Accounting Policies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principles of Consolidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.31pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a majority owned subsidiary in Luxembourg. The functional currency of the majority owned subsidiary is the US dollar. The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All intercompany transactions have been eliminated in consolidation. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from such estimates. Estimates and assumptions are periodically reviewed, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Significant areas that require management&#8217;s estimates include the fair value of the Company&#8217;s common stock and stock-based compensation assumptions, the estimated useful lives of property and equipment and accrued research and development expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value of Financial Instruments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management believes that the carrying amounts of the Company&#8217;s financial instruments, including cash equivalents and accounts payable, approximate fair value due to the short-term nature of those instruments. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value Measurements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Level&#160;1 Inputs:&nbsp;&nbsp;&nbsp;Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Level&#160;2 Inputs:&nbsp;&nbsp;&nbsp;Other than quoted prices included in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Level&#160;3 Inputs:&nbsp;&nbsp;&nbsp;Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cash equivalents of $5.2&#160;million and $0.2&#160;million are classified as Level&#160;1 assets as of December&#160;31, 2021 and 2020, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Concentration of credit risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to significant risk on its cash and cash equivalents. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Segment information</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company views its operations and manages its business in one segment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash and Cash Equivalents</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company considers all highly-liquid investments that have maturities of three&#160;months or less when acquired to be cash equivalents. As of December&#160;31, 2021 and 2020, cash equivalents consisted of investments in a money market account. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets ranging from two to five&#160;years. Leasehold improvements are amortized over the shorter of the life of the lease or the estimated useful life of the assets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Long-lived Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When events indicate a triggering event occurred, the recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, then an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Considerable management judgment is necessary to estimate discounted future cash flows. Accordingly, actual results could vary significantly from such estimates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company did not recognize any impairment of long-lived assets during the&#160;years ended December&#160;31, 2021, or 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-02, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases (ASC 842)</font><font style="letter-spacing:0.2pt;">, which requires lessees to recognize most leases on-balance sheet and disclose key information about leasing arrangements. The Company adopted ASC 842 effective as of January&#160;1, 2019 using the modified retrospective approach. The Company determines whether an arrangement is or contains a lease, its classification, and its term at the lease commencement date. Leases with a term greater than one year will be recognized on the balance sheet as right-of-use (ROU) assets, current lease liabilities, and if applicable, long-term lease liabilities. The Company includes renewal options to extend the lease term where it is reasonably certain that it will exercise these options. Lease liabilities and the corresponding ROU assets are recorded based on the present values of lease payments over the lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rates, which are the rates that would be incurred to borrow on a collateralized basis, over similar terms, amounts equal to the lease payments in a similar economic environment. Payments for non-lease components or that are variable in nature that do not depend on a rate or index are not included in the lease liability and are typically expensed as incurred. If significant events, changes in circumstances, or other events indicate that the lease term or other inputs have changed, the Company would reassess lease classification, remeasure the lease liability using revised inputs as of the reassessment date, and adjust the ROU assets. Lease expense is recognized on a straight-line basis over the expected lease term for operating classified leases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has elected the &#8220;package of 3&#8221; practical expedients permitted under the transition guidance, which eliminated the requirements to reassess prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the Company elected the practical expedient of hindsight in determining the lease term upon adoption of ASC 842. The Company also adopted an accounting policy which provides that leases with an initial term of 12&#160;months or less and without a purchase option that the Company is reasonably certain of exercising will not be included within the lease right-of-use assets and lease liabilities on its consolidated balance sheet. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Noncontrolling Interest</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent that ownership interests in the Company&#8217;s subsidiary are held by entities other than the Company, management reports these as noncontrolling interests on the consolidated balance sheet. At December&#160;31, 2021 and 2020, an investor had outstanding Class&#160;B and Class&#160;B-1 shares in the Company&#8217;s Luxembourg subsidiary related to the sale of the Company&#8217;s Series&#160;A and Series&#160;B convertible preferred stock. The shares are nonvoting shares at the subsidiary entity level and presented as noncontrolling interests in the accompanying consolidated balance sheet. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Earnings or losses are attributed to noncontrolling interests under the hypothetical liquidation at book value (HLBV) method. The HLBV method is a point in time calculation that utilizes inputs to determine the amount that the Company and noncontrolling interest holders would receive upon a hypothetical liquidation at each balance sheet date based on the liquidation provisions of the respective articles of incorporation. Holders of the noncontrolling interests do not share in earnings or losses of the Luxembourg subsidiary. In addition and upon a liquidation event, as described in the Company&#8217;s articles of incorporation, holders of noncontrolling interests will automatically convert into the Company&#8217;s preferred securities for purposes of liquidation. As a result, no earnings or losses at the Company&#8217;s subsidiaries are allocated to noncontrolling interests. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development costs are charged to expense as incurred. Up-front and milestone payments made to third parties who perform research and development services on the Company&#8217;s behalf are expensed as services are rendered. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company measures stock-based awards, including stock options, at their grant-date fair value and records compensation expense over the requisite service period, which is the vesting period of the awards. The Company accounts for forfeitures as they occur. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Estimating the fair value of stock options requires the use of subjective assumptions, including the fair value of the Company&#8217;s common stock, the expected term of the option and expected stock price volatility. The Company uses the Black-Scholes option-pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock options represent management&#8217;s best estimates and involve inherent uncertainties and the application of management&#8217;s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The expected term of stock options for employees is estimated using the &#8220;simplified method,&#8221; as the Company has limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The simplified method is the midpoint between the vesting date and the contractual term of the option. The contractual term is used as the expected term for stock options granted to nonemployees. For stock price volatility, the Company uses comparable public companies as a basis for the expected volatility to calculate the fair value of option grants. The risk-free rate is based on the U.S. Treasury yield curve commensurate with the expected term of the option. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Net Loss per Share Attributable to Common Stockholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Basic net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during each period. Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as convertible preferred stock and stock options, which would result in the issuance of incremental shares of common stock. For diluted net loss per share, the weighted-average number of shares of common stock is the same for basic net loss per share due to the fact that when a net loss exists, potentially dilutive securities are not included in the calculation as their impact is anti-dilutive. The Company&#8217;s convertible preferred stock entitles the holder to participate in dividends and earnings of the Company, and, if the Company were to recognize net income, it would have to use the two-class method to calculate earnings per share. The two-class method is not applicable during periods with a net loss, as the holders of the convertible preferred stock have no obligation to fund losses. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:79.0700000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding, as they would be anti-dilutive: </font>
        </div>
        <table style="width:416pt;height:112.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A Convertible Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Convertible Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B-1 exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">965,912</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:306.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">11,805,586</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,855,364</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accounting guidance not yet adopted</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2020, the FASB issued ASU No. 2020-06, </font><font style="font-style:italic;letter-spacing:0.2pt;">Debt&#8201;&#8212;&#8201;Debt with Conversion and Other Options</font><font style="letter-spacing:0.2pt;"> (Subtopic 470-20) </font><font style="font-style:italic;letter-spacing:0.2pt;">and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (Subtopic 815-40)</font><font style="font-style:italic;letter-spacing:0.2pt;">: Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. This standard is effective for the Company on January&#160;1, 2022, including interim periods within those fiscal&#160;years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company does not expect the adoption of this standard to have a material impact on the consolidated financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(4)&nbsp;&nbsp;&nbsp;Property and Equipment, net</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment, net consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:143pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:333.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:333.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">214</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">108</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lab equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,694</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,821</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Office furniture </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">317</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">317</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Construction in progress </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:333.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">4,505</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,513</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,421<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(739<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:333.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Depreciation and amortization expense was $0.7&#160;million and $0.4&#160;million for the&#160;years ended December&#160;31, 2021, and 2020, respectively. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(5)&nbsp;&nbsp;&nbsp;Accrued Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accrued expenses consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Compensation and related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">985</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,352</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">323</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">233</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,573</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.2pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(6)&nbsp;&nbsp;&nbsp;Commitments and Contingencies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has operating leases for its lab and office space. In April&#160;2019, the Company entered into a lease agreement for its headquarters in Philadelphia, Pennsylvania, which commenced in October&#160;2019 and has a termination date of September&#160;2029. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2018, the Company entered into a lease agreement for lab and office space in Philadelphia, Pennsylvania. This lease agreement commenced the same month and initially had a month-to-month lease term. As of January&#160;2019, upon adoption of ASC 842, the Company was reasonably certain the lease would be renewed for approximately five&#160;years based on certain economic factors at that time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s operating lease ROU assets and the related lease liabilities are initially measured at the present value of future lease payments over the lease term. The Company is responsible for payment of certain real estate taxes, insurance and other expenses on certain of its leases. These amounts are generally considered to be variable and are not included in the measurement of the ROU assets and lease liability. The Company accounts for non-lease components, such as maintenance, separately from lease components. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The elements of the lease costs were as follows (in thousands): </font>
        </div>
        <table style="width:416pt;height:37pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,129</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,129</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:14.19pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease term and discount rate information related to leases was as follows: </font>
        </div>
        <table style="width:416pt;height:82pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.41pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average remaining lease term (in&#160;years) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">4.4</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">4.9</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average discount rate </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:9.19pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Supplemental cash flow information (in thousands): </font>
        </div>
        <table style="width:416pt;height:52pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash paid for amounts included in the measurement of lease liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating cash used in operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,108</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,103</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Future maturities of lease liabilities were as follows as of December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:168.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:370.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Operating </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Fiscal year ending:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,114</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">892</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">219</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">226</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">657</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total future minimum payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,321</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less imputed interest </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(689<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:370.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Present value of lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,632</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Licensing and Sponsored Research Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2017, the Company entered into a license agreement (Penn License Agreement) with The Trustees of the University of Pennsylvania (Penn) for certain intellectual property licenses. The Penn License Agreement specifies the Company will provide $5.5&#160;million of sponsored research as part of the research and development plan within the first three&#160;years of the agreement. The Company is required to make annual payments of $10,000 through 2021 and $25,000 in annual payments thereafter. Penn is eligible to receive up to $10.9&#160;million per product in development upon the achievement of certain clinical, regulatory and commercial milestone events. There are additional milestone payments required to be paid of up to $30.0&#160;million per product in commercial milestones, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. Additionally, the Company is obligated to pay Penn single-digit royalties based on its net sales. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingencies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Liabilities for loss contingencies, arising from claims, assessments, litigation, fines, penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(7)&nbsp;&nbsp;&nbsp;Convertible Preferred Stock, Noncontrolling Interests and Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2020, the Company sold 2,290,866 shares of its Series&#160;A convertible preferred stock (Series&#160;A) and 528,847 shares of Class&#160;B exchangeable shares issued by the Luxembourg subsidiary at an original issuance price of $10.40 per share. One special voting preferred stock share was also issued to the investor in the Luxembourg subsidiary. In December&#160;2020, the Company sold 2,453,170 shares of its Series&#160;B convertible preferred stock (Series&#160;B) and 297,764 shares of Class&#160;B-1 exchangeable shares issued by the Luxembourg subsidiary at an original issuance price of $15.60 per share. One Series&#160;B special voting preferred stock share was also issued to the investor in the Luxembourg subsidiary. The proceeds received associated with Luxembourg subsidiary securities are presented as noncontrolling interests in the Company&#8217;s consolidated financial statements. As of December&#160;31, 2021 and 2020, there were 937,501 and 297,764 Class&#160;B and Class&#160;B-1 exchangeable shares outstanding, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2021, the Company sold an additional 1,046,696 shares of Series&#160;B at an original issuance price of $15.60 per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Class&#160;B and Class&#160;B-1 exchangeable shares (the Exchangeable Shares) are exchangeable into shares of Series&#160;A and Series&#160;B, respectively, on a one for one basis, at the option of the holder, or automatically upon an initial public offering or liquidation event. The Class&#160;B and Class&#160;B-1 exchangeable shares participate as Series&#160;A and Series&#160;B preferred shareholders, respectively, as it pertains to all rights and preferences held by the Company&#8217;s preferred shareholders. In addition, the Class&#160;B and Class&#160;B-1 exchangeable share investor </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">holds a share of special voting preferred stock and Series&#160;B special voting preferred stock that provides the investor with additional control relating voting matters for the Series&#160;A and Series&#160;B preferred shareholders, respectively. The following is a summary of the rights, preferences, and terms of the Series&#160;A and Series&#160;B (collectively, Convertible Preferred Stock): </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of the Convertible Preferred Stock are entitled to receive dividends payable when, as and if declared by the Board of Directors of the Company, with the holders of common stock, paid out of any assets or on the common stock of the Company, on an as-converted or as exchangeable to common stock basis. No dividends on common stock were declared or paid from inception through December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of Convertible Preferred Stock, Special voting preferred stock and Series&#160;B special voting preferred stock are entitled to vote on any matter presented to the stockholders of the Company. Each holder of outstanding shares of Convertible Preferred Stock is entitled to the number of votes equal to the number of shares of common stock into which the shares of Convertible Preferred Stock are convertible or exchangeable. Holders of Series&#160;A and the holder of Special voting preferred stock, exclusively and together as a single class, are entitled to elect three directors of the corporation and Series&#160;B holders and the holder of Series&#160;B special voting preferred stock, exclusively and as a separate class, are entitled to elect one director of the corporation. The holders of record of common stock and Convertible Preferred Stock, together as a separate class, are entitled to elect the balance of the total directors of the corporation and on an as converted or exchangeable basis. As of December&#160;31, 2021, the Company had 7 directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidation Preference</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of any voluntary or involuntary liquidations, dissolution or winding up of the Company, the holders of Series&#160;B shall be entitled to be paid out of the consideration payable to stockholders before any payment shall be made to the holders of Series&#160;A or common stock, an amount equal to the greater of (i)&#160;Series&#160;B original issue price, plus any dividend declared but unpaid, or (ii)&#160;such amount per share as would have been payable had all shares of Series&#160;B been converted into common stock immediately prior to liquidation, dissolution or winding up. The holders of Series&#160;A shall be entitled to be paid out of the consideration payable to stockholders after any payment to the Series&#160;B but before any payment shall be made to the holders common stock, an amount equal to the greater of (i)&#160;Series&#160;A original issue price, plus any dividend declared but unpaid, or (ii)&#160;such amount per share as would have been payable had all shares of Series&#160;A been converted into common stock immediately prior to liquidation, dissolution or winding up. If exchanged as of December&#160;31, 2021, the Class&#160;B and Class&#160;B-1 exchangeable shares have a liquidation value of $9.8&#160;million and $4.6&#160;million, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conversion</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Convertible Preferred Stock is convertible into common stock based on the original issuance price of the security. The Convertible Preferred Stock automatically converts to common stock upon (1)&#160;an initial public offering totaling at least $50.0&#160;million in proceeds, or (2)&#160;the date and time, or the occurrence of an event, specified by vote or written consent of (i)&#160;the holders of a majority of the voting power represented by&#160;the outstanding shares of Series&#160;A, voting together as a single class and (ii)&#160;the holders of at least two-thirds&#160;(2/3) of the voting power represented by the outstanding shares of Series&#160;B, voting together as a single class (the time of such closing or the date and time specified or the time of the event specified in such vote or written consent). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Redemption</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Convertible Preferred Stock is subject to redemption under certain deemed liquidation events not solely within the control of the Company, as defined, and as such is considered contingently redeemable for accounting purposes. Accordingly, the Convertible Preferred Stock is classified outside of permanent stockholders&#8217; deficit. An adjustment of the carrying amount of the Convertible Preferred Stock is not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">necessary until it is probable that the securities will become redeemable. At December&#160;31, 2021, the Company has determined that redemption of the Convertible Preferred Stock is not probable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The holders of the common stock are entitled to one vote for each share of common stock held at all meetings of stockholders. Unless required by law, there shall be no cumulative voting. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, after the payment of all preferential amounts required to be paid to the holders of shares of Convertible Preferred Stock, the remaining funds and assets available for distribution to the stockholders of the Company will be distributed among the holders of shares of common stock, pro&#160;rata based on the number of shares of common stock held by each such holder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(8)&nbsp;&nbsp;&nbsp;Stock-based Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2017, the Company adopted the 2017 Stock Incentive Plan (the Plan) as amended that authorized the Company to grant up to 1,739,936 shares of common stock. In 2021, the Company amended the Plan and increased the total number of shares authorized under the Plan to 1,984,018. As of December&#160;31, 2021, there were 24,242 shares available to be granted. The Company&#8217;s stock options vest based on the terms in the awards agreements and generally vest over four&#160;years. The Company recorded stock-based compensation expense in the following expense categories in its accompanying consolidated statements of operations: </font>
        </div>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">185</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">67</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">294</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">96</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:14.19pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of stock option activity under the Plan: </font>
        </div>
        <table style="width:456pt;height:199.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:236.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">contractual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">term (years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of January&#160;1, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">912,321</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.06</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">134,997</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.28</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(41,895<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.47</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">34</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(16,386<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expired </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(23,125<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.18</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.0000000000001pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">965,912</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.11</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">903,526</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">2.63</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.85</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">8.2</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,693</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable as of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">828,821</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.24</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">7.2</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,270</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vested and expected to vest </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.85</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">8.2</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,693</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The weighted-average grant-date per share fair values of options granted in 2021 and 2020 were $1.43 and $0.66, respectively. The fair values in 2021 and 2020 were estimated using the Black-Scholes option-pricing model based on the following assumptions: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:97pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:307.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:307.43pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:62.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:62.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0.89%&#8201;&#8211;&#8201;1.26%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0.4%&#8201;&#8211;&#8201;1.8%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">53.3%&#8201;&#8211;&#8201;54.2%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">54.1%&#8201;&#8211;&#8201;55.5%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Estimated fair value of the Company&#8217;s common stock per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$2.77</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$1.28</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recorded stock-based compensation expense of $0.5&#160;million and $0.2&#160;million for the&#160;years ended December&#160;31, 2021, and 2020, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Future compensation cost for awards not vested as of December&#160;31, 2021, was $1.2&#160;million and will be expensed over a weighted-average period of 3&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(9)&nbsp;&nbsp;&nbsp;Income Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has incurred losses since inception and has not recorded current or deferred income taxes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A reconciliation of income tax benefit at the statutory federal income tax rate and income taxes as reflected in the consolidated financial statements is as follows: </font>
        </div>
        <table style="width:416pt;height:127.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Federal tax benefit at statutory rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(21.0<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(21.0<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">State tax, net of federal benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(12.6<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(12.6<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Permanent differences </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.2</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.1</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(4.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(4.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">37.1</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">40.3</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Return to provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">0.6</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(2.5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total provision </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.9pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for&#160;years in which differences are expected to reverse. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Significant components of the Company&#8217;s deferred tax assets for federal income taxes consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:173.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Deferred tax assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net operating losses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">25,507</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">14,474</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development credits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,862</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,166</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Start-up costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,133</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,732</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Equity compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">34</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(35,374<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,299<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferred tax assets, net of valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">107</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Deferred tax liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(193<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(107<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net deferred tax assets and liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the Company has net operating loss (NOL) carryforwards for federal income tax purposes of $76.4&#160;million, which are available to offset future federal taxable income. The pre-2018 federal NOL carryforwards of $1.1&#160;million will begin to expire in 2037, if not utilized. The post-2017 federal NOL carryforwards of $75.3&#160;million carry forward indefinitely. The Company also has NOLs for state and local income tax purposes of $76.4&#160;million and $71.2&#160;million, respectively that are available to offset future taxable income. The state NOL carryforwards will begin to expire in 2037 while the local NOLs expire after three&#160;years with $4.1&#160;million expiring in 2021. As of December&#160;31, 2021, the Company also had federal research and development tax credit carryforwards of $3.9&#160;million that will begin to expire in 2038, unless previously utilized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future losses, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, a full valuation allowance has been recorded against all of the Company&#8217;s net deferred tax assets as of December&#160;31, 2021. The valuation allowance increased by $15.1&#160;million and $11.4&#160;million during the&#160;years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The NOL and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. NOL and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50&#160;percent, as defined under Sections&#160;382 and 383 of the Internal Revenue Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future&#160;years. The Company has not done an analysis to determine whether or not ownership changes have occurred since inception. Certain state NOLs may also be limited, including Pennsylvania, which limits NOL utilization as a&#160;percentage of apportioned taxable income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company will recognize interest and penalties related to uncertain tax positions as a component of income tax expense/(benefit). As of December&#160;31, 2021, the Company had no accrued interest or penalties related to uncertain tax positions and no amounts have been recognized in the Company&#8217;s consolidated financial statements. Tax&#160;years from 2018 and after remain subject to examination by all of the taxing jurisdictions. The NOL and credit carryforwards remain subject to review until utilized. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(10)&nbsp;&nbsp;&nbsp;Related Party Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has outstanding licensing and scientific research agreements with Penn, a significant shareholder (Note 6). The Company recognized $0.8&#160;million of research and development expense for each of the&#160;years ended December&#160;31, 2021 and 2020 related to the Penn License Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(11)&nbsp;&nbsp;&nbsp;Subsequent Events</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has evaluated subsequent events from the balance sheet date through October&#160;14, 2022, the issuance date of these consolidated financial statements and has not identified any requiring disclosure except as noted below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Collaboration and License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company entered into a Collaboration and License Agreement with ModernaTX, Inc. (Moderna License Agreement), to develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered chimeric antigen receptor monocyte (CAR-M) therapeutics for different forms of cancer. The Moderna License Agreement allows Moderna to develop and commercialize product candidates for up to twelve research targets. The Company will be responsible for discovering and optimizing development candidates, and Moderna will be responsible for the clinical development thereafter. Pursuant to the Moderna License Agreement, the Company and Moderna will form a joint steering committee, or JSC, that will be responsible for the coordination and oversight of all research activities to which the Company is responsible for providing. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">JSC will be comprised of three representatives each from the Company and Moderna and with Moderna having final decision-making authority, subject to customary exclusions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the research term of the Moderna License Agreement, the Company has granted Moderna an exclusive worldwide royalty free license to the Company&#8217;s intellectual property associated with the product candidates that permits Moderna to conduct its research and development activities. Upon Moderna&#8217;s election of a development target (and payment of a related development target designation milestone) for commencement of pre-clinical development of a product candidate, the Company will grant Moderna an exclusive worldwide, sublicensable royalty bearing license to develop, manufacture and commercialize the product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon execution of the Moderna License Agreement, Moderna made an upfront non-refundable payment of $45.0&#160;million to the Company. Moderna also will reimburse the Company for all costs incurred by the Company in connection with its research and development activities under the Moderna License Agreement plus a reasonable margin for the respective services performed (with a minimum commitment to reimburse $10.0&#160;million in research and development costs over the first three&#160;years from execution of the Moderna License Agreement). In addition, assuming Moderna develops and commercializes 12 products, each directed to a different development target, the Company is eligible to receive up to between $247.0&#160;million and $253.0 million per product in development target designation, development, regulatory and commercial milestone payments. The Company is also eligible to receive tiered mid-to-high single digit royalties of net product sales, subject to adjustment. In addition, Moderna will repay the Company for certain development, regulatory and commercial milestone payments and certain royalty payments pursuant to the Company&#8217;s license agreement with the University of Pennsylvania. The Moderna License Agreement terminates on a product-by-product basis upon the latest of expiration of the applicable product patents, expiration of regulatory exclusivity and the tenth anniversary of first commercial sale, unless terminated earlier by the Company or Moderna. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Convertible Promissory Note</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Concurrent with entering into the Moderna License Agreement, the Company issued and sold to Moderna a convertible promissory note in the aggregate principal amount of $35.0&#160;million (the Note). If not earlier converted or repaid, the Note is payable on demand beginning in July&#160;2023. The Note accrues interest at an annual rate beginning at 0.33% through March&#160;2022 and then increasing by 0.767% each month thereafter capping at an annual rate of 8.0% in January&#160;2023. Upon the completion of a qualified financing event, the outstanding principal and accrued interest under the Note will automatically convert into shares of the Company issued in connection with the qualified financing at a conversion price equal to the lesser of (a)&#160;90% of the purchase price paid by other investors in such qualified financing and (b)&#160;$21.06 per share on an as converted to common stock basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Office and Laboratory Space</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company amended its October&#160;2018 lease to add additional lab and office spaces. The lease for the additional spaces commenced in April&#160;2022 and has a term of 18&#160;months. The total future minimum lease payments for these spaces are $3.6&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2022, the Company entered into another agreement to lease additional office and laboratory space in Philadelphia, Pennsylvania. This lease commenced in March&#160;2022 and has a term of 18&#160;months with an option for the Company to renew the lease for two additional terms of six&#160;months each at the end of lease term. The total future minimum lease payments for the lease are $3.3&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger with Seahawk Merger Sub, Inc.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the Merger Agreement) with Seahawk Merger Sub, Inc. (Merger Sub), a Delaware corporation and wholly-owned subsidiary of Sesen Bio, Inc. (Sesen Bio). The Merger Agreement provides for the merger of the Company with Merger Sub, with the Company as the surviving entity and the Company continuing as a wholly-owned subsidiary of Sesen Bio (the Merger). Subject to the terms and conditions of the Merger Agreement, at the closing of the Merger, (a)&#160;each then outstanding share of the Company&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:444pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">common stock and preferred stock (collectively, the Company&#8217;s capital stock) (including shares of the Company&#8217;s common stock issued in connection with the pre-closing financing transaction described below) will be converted into the right to receive a number of shares of Sesen Bio common stock, and (b)&#160;each then outstanding stock option to purchase the Company&#8217;s common stock will be assumed by Sesen Bio, subject to adjustment as set forth in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the Merger, the shareholders of the Company are expected to hold 58.3% of the combined company, and the shareholders of Sesen Bio are expected to hold 41.7% of the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Concurrently with the execution and delivery of the Merger Agreement, certain parties entered into agreements with the Company to purchase prior to the consummation of the Merger shares of the Company&#8217;s common stock for an aggregate purchase price of $30.6&#160;million (Pre-Closing Financing). Shares of the Company&#8217;s common stock issued pursuant to the Pre-Closing Financing transaction will be converted into shares of Sesen Bio common stock in the Merger. Upon completion of the merger, the outstanding principal and unpaid interest associated with the Notes will automatically convert into the shares of Sesen Bio common stock.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Balance Sheets </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:592pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">28,943</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">41,705</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">2,290</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,235</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">72,938</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">29,786</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">8,677</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Right of use assets&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">6,121</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">2,579</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">87,736</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">4,085</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,322</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">8,997</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">4,471</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,230</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">5,184</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">898</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,006</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">33,175</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">157</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">53,834</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">7,691</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Deferred revenues </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">5,189</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,003</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,734</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">703</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Other long-term liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">307</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:16pt;">
                <font style="letter-spacing:0.16pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">106,036</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">9,425</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Commitments (Note 6) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Convertible preferred stock, $0.0001 par value: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:16pt; text-indent:-8pt;">
                <font style="letter-spacing:0.16pt;">Series&#160;A convertible preferred stock, 6,138,518 shares authorized; 5,201,017 shares issued and outstanding (liquidation value of $54,091 at September&#160;30, 2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Special voting preferred stock, 1 share authorized, issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:16pt; text-indent:-8pt;">
                <font style="letter-spacing:0.16pt;">Series&#160;B convertible preferred stock, 4,807,541 shares authorized, 3,499,866 shares issued and outstanding (liquidation value of $54,598 at September&#160;30, 2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Series&#160;B special voting preferred stock, 1 share authorized, issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Stockholders&#8217; deficit: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:16pt; text-indent:-8pt;">
                <font style="letter-spacing:0.16pt;">Common stock $0.0001 par value, 14,910,158 shares authorized, 1,153,019 and 1,084,082 shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,141</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accumulated other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">(141,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total CARISMA Therapeutics Inc. stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">(140,503<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(96,179<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Noncontrolling interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">(126,108<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total liabilities, convertible preferred stock and stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">87,736</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCSO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:273.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Statements of Operations and Comprehensive Loss</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:285.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6,103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">38,536</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">24,597</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">8,407</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">3,852</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">46,943</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">28,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(40,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,449<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value of derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(1,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(2,278<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.75pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Share information: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share of common stock, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(40.16<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(26.23<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares of common stock outstanding, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,107,792</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Comprehensive loss </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(44,647<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCSO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Statements of Convertible Preferred Equity and Stockholders&#8217; Deficit </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share and share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:350.06pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:227.44pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
          <tr style="line-height:6.2pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:85.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 3.07pt 0pt; width:0pt;" colspan="46">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 3.07pt 0pt; width:0pt;" colspan="40">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.97pt;height:18.27pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:85.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.124pt;">Series&#160;A</font>
                <br >
                <font style="letter-spacing:-0.124pt;">convertible</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center; line-height:6.96pt;">
                <font style="letter-spacing:-0.124pt;">Special voting</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.124pt;">Series&#160;B</font>
                <br >
                <font style="letter-spacing:-0.124pt;">convertible</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.124pt;">Series&#160;B</font>
                <br >
                <font style="letter-spacing:-0.124pt;">special voting</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Common stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.124pt;">paid-in </font>
                <br >
                <font style="letter-spacing:-0.124pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.124pt;">other </font>
                <br >
                <font style="letter-spacing:-0.124pt;">comprehensive</font>
                <br >
                <font style="letter-spacing:-0.124pt;">loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.124pt;">deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Noncontrolling</font>
                <br >
                <font style="letter-spacing:-0.124pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:6.2pt;height:12.84pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:85.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.24pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Balance, January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">68,937</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Unrealized loss on marketable </font>
                <br >
                <font style="letter-spacing:0.13pt;">securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.49pt 0pt 2.75pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.24pt 0pt 3.5pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Balance at September&#160;30, </font>
                <br >
                <font style="letter-spacing:0.13pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,153,019</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">1,141</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(141,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(126,108<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:8.74pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Balance, January&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">339</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(56,213<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(41,479<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Sale of Series&#160;B convertible </font>
                <br >
                <font style="letter-spacing:0.13pt;">preferred stock at $15.60 per </font>
                <br >
                <font style="letter-spacing:0.13pt;">share, net of issuance costs </font>
                <br >
                <font style="letter-spacing:0.13pt;">of $151 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,046,696</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">16,177</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.49pt 0pt 2.75pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.24pt 0pt 3.5pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Balance at September&#160;30, </font>
                <br >
                <font style="letter-spacing:0.13pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">700</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(84,649<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(69,554<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCSO2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Statements of Cash Flows</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:572.38pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:362.1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.467pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.55pt 0pt 1.8pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.55pt 0pt 1.8pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.55pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Cash flows from operating activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Adjustment to reconcile net loss to net cash provided by (used in) operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Depreciation and amortization expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,188</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">475</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Reduction in the operating right of use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,895</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">408</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Amortization of debt discount </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,995</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Change in fair value of derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,369</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Non-cash interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">176</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,055<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(81<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,794</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,526</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">414</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Deferred revenues </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">46,230</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.79pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,882<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(396<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.54pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:38.8pt;">
                <font style="letter-spacing:0.194pt;">Net cash provided by (used in) operating activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">11,984</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,207<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.54pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Cash flows from investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Purchase of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(84,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from the sale of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.79pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Purchases of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(4,341<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,526<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.54pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:38.8pt;">
                <font style="letter-spacing:0.194pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,526<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.54pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Cash flows from financing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from the exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Payment of principal related to the finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(766<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from failed sale-leaseback arrangement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">505</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Payment of finance liability from failed sale-leaseback arrangement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(50<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from the sale of Series&#160;B convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">16,328</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Payment of Series&#160;B issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(366<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.78pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from issuance of convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.53pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:38.8pt;">
                <font style="letter-spacing:0.194pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">34,777</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.53pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.194pt;">Net increase (decrease) in cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">392</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,771<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.78pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.194pt;">Cash and cash equivalents at beginning of the period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.53pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.194pt;">Cash and cash equivalents at end of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,943</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">38,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.70000000000005pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Supplemental disclosures of cash flow information: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Cash paid for interest </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(50<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.70000000000005pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Supplemental disclosures of non-cash financing and investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Property and equipment in accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">90</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">212</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Unrealized loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Allocation of debt proceeds to derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">3,820</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:1.646pt 0pt 2.254pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt; text-indent:-9.7pt; line-height:10.6999999999999pt; margin-bottom:-0.499999999999978pt;">
                <font style="letter-spacing:0.194pt;">Operating lease right of use assets obtained in exchange for operating lease </font>
                <br >
                <font style="letter-spacing:0.194pt;">liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,437</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Operating lease right of use assets obtained in exchange for finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">2,471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:20.62pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tNTTI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notes to the Interim Consolidated Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(1)&nbsp;&nbsp;&nbsp;Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc., a Delaware Corporation (the Company), is a clinical-stage biopharmaceutical company focused on utilizing the Company&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative therapies to treat cancer and other serious disorders. Cell therapy enables the utilization of reprogrammed living cells to perform complex functions such as clearance of tumor cells or resolution of inflammation. The Company&#8217;s initial focus is its proprietary Chimeric Antigen Receptor Macrophage (CAR-M) platform, which redirects macrophages against specific tumor associate antigens and enables targeted anti-tumor immunity by utilizing genetically modifying myeloid cells (macrophages and monocytes) to express chimeric antigen receptors, or CARs, enabling the innate immune cells to recognize specific tumor associated antigens on the surface of tumor cells. The Company&#8217;s clinical lead product candidate CT-0508 is an ex vivo gene-modified autologous CAR-M cell therapy product intended to treat solid tumors that overexpress HER2. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company received an investigational new drug application, or IND, clearance for CT-0508 for the treatment of HER2-overexpressing solid tumors in July&#160;2020 and dosed the first patient in March&#160;2021. The Food and Drug Administration, or FDA, granted CT-0508 Fast Track Status in September&#160;2021. As of September&#160;1, 2022, enrollment in group 1 of the first in human study has been completed with 9 patients successfully dosed with CT-0508, and group 2 is currently open for enrollment with an additional 9 patients to be dosed in the study. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the Merger Agreement) with Seahawk Merger Sub, Inc. (Merger Sub), a Delaware corporation and wholly-owned subsidiary of Sesen Bio, Inc. (Sesen Bio). The Merger Agreement provides for the merger of the Company with Merger Sub, with the Company as the surviving entity and the Company continuing as a wholly-owned subsidiary of Sesen Bio (the Merger). Subject to the terms and conditions of the Merger Agreement, at the closing of the Merger, (a)&#160;each then outstanding share of the Company&#8217;s common stock and preferred stock (collectively, the Company&#8217;s capital stock) (including shares of the Company&#8217;s common stock issued in connection with the pre-closing financing transaction described below) will be converted into the right to receive a number of shares of Sesen Bio common stock, and (b)&#160;each then outstanding stock option to purchase the Company&#8217;s common stock will be assumed by Sesen Bio, subject to adjustment as set forth in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the Merger, the shareholders of the Company are expected to hold 58.3% of the combined company, and the shareholders of Sesen Bio are expected to hold 41.7% of the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Concurrently with the execution and delivery of the Merger Agreement, certain parties entered into agreements with the Company to purchase prior to the consummation of the Merger shares of the Company&#8217;s common stock for an aggregate purchase price of $30.6&#160;million (Pre-Closing Financing). Shares of the Company&#8217;s common stock issued pursuant to the Pre-Closing Financing transaction will be converted into shares of Sesen Bio common stock in the Merger. Upon completion of the Merger, the outstanding principal and unpaid interest associated with the $35.0&#160;million convertible promissory note will automatically convert into the shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(2)&nbsp;&nbsp;&nbsp;Development-Stage Risks and Liquidity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has incurred losses since inception and has an accumulated deficit of $141.5&#160;million as of September&#160;30, 2022. The Company anticipates incurring additional losses until such time, if ever, that it can generate significant sales from its product candidates currently in development. Management believes that cash, cash equivalents and marketable securities of $70.6&#160;million as of September&#160;30, 2022 are sufficient to sustain planned operations into the third quarter of 2023. As a result, the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the unaudited interim consolidated financial statements are issued. The accompanying unaudited interim consolidated financial statements have been prepared on a going-concern basis, which contemplates the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">realization of assets and satisfaction of liabilities in the normal course of business. The unaudited interim consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management is currently evaluating different strategies to obtain the required funding for future operations. These strategies may include but are not limited to private placements of equity and/or debt, licensing and/or marketing arrangements, and public offerings of equity and/or debt securities. There is no assurance that such financing will be available when needed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to those risks associated with any specialty biotechnology company that has substantial expenditures for research and development. There can be no assurance that the Company&#8217;s research and development projects will be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially viable. In addition, the Company operates in an environment of rapid technological change and is largely dependent on the services of its employees and consultants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(3)&nbsp;&nbsp;&nbsp;Summary of Significant Accounting Policies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The summary of significant accounting policies included in the Company&#8217;s annual consolidated financial statements that can be found elsewhere in this registration statement, have not materially changed, except as set forth below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interim Financial Statements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The accompanying unaudited interim consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) for interim financial information. Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) of the Financial Accounting Standards Board (FASB). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the opinion of management, the accompanying interim consolidated financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the consolidated financial statements) considered necessary to present fairly the Company&#8217;s financial position as of September&#160;30, 2022 and its results of operations for the nine&#160;months ended September&#160;30, 2022 and 2021. Operating results for the nine&#160;months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The interim consolidated financial statements, presented herein, do not contain the required disclosures under U.S. GAAP for annual financial statements. The accompanying unaudited interim consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and related notes as of and for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the unaudited interim consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited interim consolidated financial statements in the period they are determined to be necessary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Significant areas that require management&#8217;s estimates include the fair value of the Company&#8217;s common stock, the derivative liability, stock-based compensation assumptions, the estimated useful lives of property and equipment and accrued research and development expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value of Financial Instruments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management believes that the carrying amounts of the Company&#8217;s financial instruments, including cash equivalents and accounts payable approximate fair value due to the short-term nature of those </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">instruments. Due to the related-party relationship of the Convertible Promissory Note (Note 5), it is impractical to determine the fair value of the debt. The derivative liability is recorded at its estimated fair value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Marketable Securities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s marketable securities consist of investments in U.S. Treasuries that are classified as available-for-sale. The securities are carried at fair value with the unrealized gains and losses included in accumulated other comprehensive loss, a component of stockholders&#8217; deficit. Realized gains and losses and declines in value determined to be other than temporary are included in the Company&#8217;s statements of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value Measurements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Level&#160;1 Inputs:&nbsp;&nbsp;&nbsp;Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Level&#160;2 Inputs:&nbsp;&nbsp;&nbsp;Other than quoted prices included in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Level&#160;3 Inputs:&nbsp;&nbsp;&nbsp;Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following fair value hierarchy table presents information about the Company&#8217;s assets and liabilities measured at fair value on a recurring basis: </font>
        </div>
        <table style="width:456pt;height:172pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:329.19pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value measurement at </font>
                <br >
                <font style="letter-spacing:-0.16pt;">reporting date using </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">September&#160;30, 2022:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash equivalents&#8201;&#8211;&#8201;money markets accounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">575</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities&#8201;&#8211;&#8201;U.S. Treasuries </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">41,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Derivative liability&#8201;&#8211;&#8201;redemption feature on convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5,189</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">December&#160;31, 2021:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash equivalents&#8201;&#8211;&#8201;money markets accounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,182</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:7.8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the Company&#8217;s marketable securities as of September&#160;30, 2022. </font>
        </div>
        <table style="width:456pt;height:56.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.06pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amortized </font>
                <br >
                <font style="letter-spacing:-0.16pt;">costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Gross </font>
                <br >
                <font style="letter-spacing:-0.16pt;">unrealized </font>
                <br >
                <font style="letter-spacing:-0.16pt;">loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.06pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Available-for-sale marketable securities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.06pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">U.S. Treasury securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">41,865</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">41,705</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluated a redemption feature within the convertible promissory note issued in January&#160;2022 and determined bifurcation of the redemption feature was required. The redemption feature is </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">classified as a liability on the accompanying consolidated balance sheet and is marked-to-market each reporting period with the changes in fair value recorded in the accompanying statements of operations until it is triggered, terminated, reclassified or otherwise settled. The fair value of the derivative was determined based on an income approach that identified the cash flows using a &#8220;with-and-without&#8221; valuation methodology. The inputs used to determine the estimated fair value of the derivative instrument were based primarily on the probability of an underlying event triggering the embedded derivative occurring and the timing of such event. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, the discount factor used was 12% and a 90% probability of completing a qualified financing prior to the maturity date of the convertible promissory note was assumed. The estimated time of conversion ranged from three to twelve&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table presented below is a summary of the changes in fair value of the Company&#8217;s derivative liability (Level&#160;3 measurement): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:345.03pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at issuance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,820</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,369</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5,189</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022 and 2021, there were no transfers between Level&#160;1, Level&#160;2 and Level&#160;3. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue Recognition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes revenue in accordance with ASC Topic 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue from Contracts with Customers</font><font style="letter-spacing:0.2pt;"> (ASC 606). This standard applies to all contracts with customers, except for contracts that are within the scope of other standards. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company enters into collaboration and licensing agreements with strategic partners, which are within the scope of ASC 606, under which it may exclusively license rights to research, develop, manufacture, and commercialize its product candidates to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: (1)&#160;non-refundable, upfront license fees; (2)&#160;reimbursement of certain costs; (3)&#160;customer option fees for additional goods or services; (4)&#160;development milestone payments, (5)&#160;regulatory and commercial milestone payments; and (6)&#160;royalties on net sales of licensed products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation. As part of the accounting for these arrangements, the Company must use its judgment to determine: (a)&#160;the number of performance obligations based on the determination under step (i)&#160;above; (b)&#160;the transaction price under step (iii)&#160;above; (c)&#160;the stand-alone selling price for each performance obligation identified in the contract for the allocation of transaction price in step (iv)&#160;above; and (d)&#160;the contract term and pattern of satisfaction of the performance obligations under step (v)&#160;above. The Company uses judgment to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price as described further below. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Amounts due to the Company for satisfying the revenue recognition criteria or that are contractually due based upon the terms of the collaboration agreements are recorded as accounts receivable in the Company&#8217;s consolidated balance sheet. Contract liabilities consist of amounts received prior to satisfying the revenue recognition criteria, which are recorded as deferred revenue in the Company&#8217;s consolidated balance sheet. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the changes in deferred revenue (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at the beginning of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferral of revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,333</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Recognition of unearned revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(6,103<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at the end of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">46,230</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:12.1pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There was no deferred revenue as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The current portion of deferred revenue represents advanced payments received from ModernaTX, Inc. (Moderna) for costs expected to be incurred by the Company within the next twelve&#160;months. The noncurrent portion of deferred revenue represents the $45.0&#160;million upfront, non-refundable and non- creditable payment allocated to customer option right which is not expected to be recognized within the next 12&#160;months. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Upfront license fees</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other promises or performance obligations identified in the arrangement, the Company recognizes revenue from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. In assessing whether a promise or performance obligation is distinct from the other promises, the Company considers factors such as the research, manufacturing, and commercialization capabilities of the customer; the retention of any key rights by the Company; and the availability of the associated expertise in the general marketplace. In addition, the Company considers whether the customer can benefit from a promise for its intended purpose without the receipt of the remaining promises, whether the value of the promise is dependent on the unsatisfied promise, whether there are other vendors that could provide the remaining promise and whether it is separately identifiable from the remaining promise. For licenses that are combined with other promises, the Company exercises judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Customer options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates the customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. The Company allocates the transaction price to material rights based on the relative standalone selling price, which is determined based on the identified discount and the probability that the customer will exercise the option. Amounts allocated to a material right are not recognized as revenue until, at the earliest, the option is exercised. If an option is not exercised and the research and development target is terminated, the Company will accelerate and recognize all remaining revenue related to the material right performance obligation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and development services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The promises under the Company&#8217;s collaboration agreements may include research and development services to be performed by the Company for or on behalf of the customer. Payments or reimbursements </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:23pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">resulting from the Company&#8217;s research and development efforts are recognized as the services are performed and presented on a gross basis because the Company is the principal for such efforts. Reimbursements from and payments to the customer that are the result of a collaborative relationship with the customer, instead of a customer relationship, such as co-development activities, are recorded as a reduction to research and development expense. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Milestone payments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The Company evaluates factors such as the scientific, clinical, regulatory, commercial and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. At the end of each subsequent reporting period, the Company reevaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Net Loss per Share Attributable to Common Shareholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding, as they would be anti-dilutive: </font>
        </div>
        <table style="width:456pt;height:114pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:302.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B-1 exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options to purchase common stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,804,246</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Conversion of convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">1,688,301</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:302.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">13,428,695</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">11,805,586</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The above table assumes outstanding principal and interest converted into shares of the Company&#8217;s common stock at $21.06 per share. Conversion of the promissory note and related interest may vary depending on the terms and conditions to upon conversion of the promissory note. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent Accounting Pronouncements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2020, the FASB issued ASU No. 2020-06, </font><font style="font-style:italic;letter-spacing:0.2pt;">Debt&#8201;&#8212;&#8201;Debt with Conversion and Other Options</font><font style="letter-spacing:0.2pt;"> (Subtopic 470-20) </font><font style="font-style:italic;letter-spacing:0.2pt;">and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (Subtopic 815-40)</font><font style="font-style:italic;letter-spacing:0.2pt;">: Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The Company adopted the ASU effective January&#160;1, 2022 using the modified retrospective method of adoption. The Company applied this ASU to the convertible promissory note entered into in January&#160;2022 (see Note&#160;5). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(4)&nbsp;&nbsp;&nbsp;Property and Equipment, net</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:7.12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment, net consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:129.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">917</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">214</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lab equipment</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">9,749</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,694</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Office furniture </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">340</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">317</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Construction in progress </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,286</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">4,505</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(2,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,421<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">8,677</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:6.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Lab equipment includes finance lease right of use (ROU) assets of $2.2&#160;million and are recorded net of accumulated amortization of $83,000 as of September&#160;30, 2022. There were no financial lease ROU assets as of December&#160;31, 2021. Lab equipment includes $0.6&#160;million resulting from a failed sale-leaseback (see Note&#160;6) and is recorded net of accumulated depreciation of $62,000 as of September&#160;30, 2022. There were no assets from failed sale-leasebacks as of December&#160;31, 2021.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation and amortization expense was $1.2&#160;million and $0.5&#160;million for the nine&#160;months ended September&#160;30, 2022 and 2021, respectively. </font>
        </div>
        <div style="margin-top:10.02pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(5)&nbsp;&nbsp;&nbsp;Convertible Promissory Note</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, concurrent with entering into the Moderna Collaboration and License Agreement (Note 8), the Company issued and sold to Moderna a convertible promissory note in the aggregate principal amount of $35.0&#160;million (the Note). If not earlier converted or repaid, the Note is payable on demand beginning in July&#160;2023. The Note accrues interest at an annual rate beginning at 0.33% through March&#160;2022 and then increasing by 0.767% each month thereafter capping at an annual rate of 8.0% in January&#160;2023. Upon the completion of a qualified financing event, the outstanding principal and accrued interest under the Note will automatically convert into shares of the Company issued in connection with the qualified financing at a conversion price equal to the lesser of (a)&#160;90% of the purchase price paid by other investors in such qualified financing and (b)&#160;$21.06 per share on an as converted to common stock basis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.22pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since the Note is convertible into either (i)&#160;a variable number of shares of stock or (ii)&#160;a fixed conversion price, the Company evaluated the conversion provisions as a redemption feature and as a conversion feature, with the redemption feature evaluated as an embedded derivative and bifurcated from the proceeds of the Note due to the substantial premium paid upon redemption. Upon bifurcating the redemption feature, the Company recorded a debt discount of $3.8&#160;million which represents the initial fair value of the derivative liability that will be recognized as interest expense over the term of the Note. For the nine&#160;months ended September&#160;30, 2022, the Company recognized a change in fair value related to the redemption feature of $1.4&#160;million, which was included in the change in fair value of derivative liability on the consolidated statement of operations. For the nine&#160;months ended September&#160;30, 2022, the Company recognized interest expense of $2.6&#160;million of which $2.0&#160;million was related to the amortization of the debt discount. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the carrying value of the Note at September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:416pt;height:40.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Principal amount of the Note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unamortized debt discount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(1,825<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrying value of the Note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,175</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.92pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(6)&nbsp;&nbsp;&nbsp;Commitments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company amended its October&#160;2018 lease to add additional lab and office spaces. The lease for the additional spaces commenced in April&#160;2022 and has a term of 18&#160;months. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2022, the Company entered into another agreement to lease additional office and laboratory space in Philadelphia, Pennsylvania. This lease commenced in March&#160;2022 and has a term of 18&#160;months with an option for the Company to renew the lease for two additional terms of six&#160;months each at the end of lease term. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2022, the Company entered into a purchase and sale agreement under which the Company sold lab equipment for a purchase price of $0.5&#160;million. Concurrent with the sale of the equipment, the Company entered into a three-year lease agreement, whereby the Company will lease back the equipment at an annual rental rate of $0.2&#160;million. The Company was considered to have continuing involvement, and thus, accounted for the transaction as a failed sale-leaseback, with the equipment remaining on the balance sheet and the sale proceeds recorded as a finance liability. No gain or loss was recorded on the failed sale-leaseback. The Company continues to carry the lab equipment as property and equipment, net on the accompanying consolidated balance sheet. The ongoing lease payments are recorded as reductions to the finance liability and interest expense. As of September&#160;30, 2022, the Company had a $0.5&#160;million financing liability recorded in other liabilities and other noncurrent liabilities on the unaudited consolidated balance sheet. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company also has obligations under an arrangement for the use of certain lab equipment that are classified as finance leases that commenced in May&#160;2022 and have an end date of April&#160;2025. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The elements of the lease costs were as follows (in thousands): </font>
        </div>
        <table style="width:416pt;height:122pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,331</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">847</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Finance lease cost: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Amortization of lease assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">264</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest on lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">50</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total finance lease cost </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">314</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,645</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">847</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease term and discount rate information related to leases was as follows: </font>
        </div>
        <table style="width:416pt;height:98.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average remaining lease term (in&#160;years) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.0</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.4</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average discount rate </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Supplemental cash flow information (in thousands): </font>
        </div>
        <table style="width:416pt;height:91pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash paid for amounts included in the measurement of lease liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating cash used in operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,319</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">830</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating cash used for finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">50</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financing cash used in finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">766</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Future maturities of lease liabilities were as follows as of September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:416pt;height:174.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:289.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Fiscal year ending:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2022 (remaining three&#160;months) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">110</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,430</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,137</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,161</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">437</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">216</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">219</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">226</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">233</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">425</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total future minimum payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,900</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6,907</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less imputed interest </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(191<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(720<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:289.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Present value of lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,709</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,187</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(7)&nbsp;&nbsp;&nbsp;Stock-based Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2017, the Company adopted the 2017 Stock Incentive Plan (the Plan) as amended that authorized the Company to grant up to 1,739,936 shares of common stock. In 2022, the Company amended the Plan and increased the total number of shares authorized under the Plan to 2,664,018. As of September&#160;30, 2022, there were 631,560 shares available to be granted. The Company&#8217;s stock options vest based on the terms in the awards agreements and generally vest over four&#160;years. The Company recorded stock-based compensation expense in the following expense categories in its accompanying statements of operations: </font>
        </div>
        <table style="width:416pt;height:76.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.66pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">122</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">135</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">113</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">226</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:337.66pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:12.8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of stock option activity under the Plan: </font>
        </div>
        <table style="width:456pt;height:169pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:236.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">remaining </font>
                <br >
                <font style="letter-spacing:-0.16pt;">contractual </font>
                <br >
                <font style="letter-spacing:-0.16pt;">term (years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.85</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">107,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.67</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(68,937<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.28</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(101,844<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.78</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expired </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(1,411<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.89</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,804,246</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.92</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">7.6</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,441</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable as of September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,039,047</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.51</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">6.9</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,243</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4pt 0pt 2.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vested and expected to vest at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,804,246</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.92</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">7.6</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,441</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The weighted-average grant-date per share fair values of options granted during the nine&#160;months ended September&#160;30, 2022 and 2021 was $1.46 and $1.44, respectively. The fair values during the nine&#160;months ended September&#160;30, 2022 and 2021 were estimated using the Black-Scholes option-pricing model based on the following assumptions: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:97pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:287.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:287.43pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:72.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:72.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">2.40%&#8201;&#8211;&#8201;3.05%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0.98%&#8201;&#8211;&#8201;1.19%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">54.54%&#8201;&#8211;&#8201;56.50%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">53.27%&#8201;&#8211;&#8201;54.22%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Estimated fair value of the Company&#8217;s common stock per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$2.68</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$2.77</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Future compensation cost for awards not vested as of September&#160;30, 2022 was $0.9&#160;million and will be expensed over a weighted-average period of 2.5&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(8)&nbsp;&nbsp;&nbsp;Moderna Collaboration and License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company entered into a Collaboration and License Agreement with Moderna (Moderna License Agreement), to develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered chimeric antigen receptor monocyte (CAR-M) therapeutics for different forms of cancer. The Moderna License Agreement allows Moderna to develop and commercialize product candidates for up to twelve research targets. The Company is responsible for discovering and optimizing development candidates, and Moderna is responsible for the clinical development thereafter. Pursuant to the Moderna License Agreement, the Company and Moderna formed a joint steering committee, or JSC, that is responsible for the coordination and oversight of all research activities to which the Company is responsible for providing. The JSC is comprised of three representatives each from the Company and Moderna and with Moderna having final decision-making authority, subject to customary exclusions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the research term of the Moderna License Agreement, the Company has granted Moderna an exclusive worldwide royalty free license to the Company&#8217;s intellectual property associated with the product candidates that permits Moderna to conduct its research and development activities. Upon Moderna&#8217;s election of a development target (and payment of a related development target designation milestone) for commencement of pre-clinical development of a product candidate, the Company will grant Moderna an exclusive worldwide, sublicensable royalty bearing license to develop, manufacture and commercialize the product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon execution of the Moderna License Agreement, Moderna made an upfront non-refundable payment of $45.0&#160;million to the Company. Moderna also will reimburse the Company for all costs incurred by the Company in connection with its research and development activities under the Moderna License Agreement plus a reasonable margin for the respective services performed (with a minimum commitment to reimburse $10.0&#160;million in research and development costs over the first three&#160;years from execution of the Moderna License Agreement). In addition, assuming Moderna develops and commercializes 12 products, each directed to a different development target, the Company is eligible to receive up to between $247.0&#160;million and $253.0&#160;million per product in development target designation, development, regulatory and commercial milestone payments. The Company is also eligible to receive tiered mid-to-high single digit royalties of net product sales, subject to adjustment. In addition, Moderna will repay the Company for certain development, regulatory and commercial milestone payments and certain royalty payments pursuant to the Company&#8217;s license agreement with the University of Pennsylvania. The Moderna License Agreement terminates on a product-by-product basis upon the latest of expiration of the applicable product patents, expiration of regulatory exclusivity and the tenth anniversary of first commercial sale, unless terminated earlier by the Company or Moderna. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At commencement, the Company identified several potential performance obligations within the Moderna License Agreement, including research and development services on research targets, option rights held by Moderna, a non-exclusive royalty-free license to use the Company&#8217;s intellectual property to conduct research and development activities and participation on the JSC. The Company determined that there were two performance obligations comprised of (1)&#160;research and development services and (2)&#160;option rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the research and development services, the stand-alone selling price was determined considering the expected passthrough costs and cost of the research and development services and a reasonable margin </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:155pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">for the respective services. The material rights from the option rights were valued based on the estimated discount at which the option is priced and the Company&#8217;s estimated probability of the options&#8217; exercise as of the time of the amendment. The transaction price allocated to research and development services is recognized as collaboration revenues as the research and development services are provided, using an input method, in proportion to costs incurred to date for each research development target as compared to total costs incurred and expected to be incurred in the future to satisfy the underlying obligation related to the research and development target. The transfer of control occurs over this period and, in management&#8217;s judgment, is the best measure of progress towards satisfying the performance obligation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transaction price allocated to the options rights, which are considered material rights, will be recognized in the period that Moderna elects to exercise or elects to not exercise its option right to license and commercialize the underlying research and development target. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company included the $45.0&#160;million upfront payment and $73.9&#160;million of variable consideration for expected research and development services to be performed during the five year contract term, inclusive of passthrough costs, in the transaction price as of the outset of the arrangement. During the nine&#160;months ended September&#160;30, 2022, the Company recognized $6.1&#160;million of research and development services as collaboration revenues as the Company is the principal in providing such services. The following table summarizes the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:276.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">allocated </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">unsatisfied </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:276.51pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Performance obligations: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:276.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">73,937</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">67,834</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:276.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Option rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:276.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total performance obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">118,937</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">112,834</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(9)&nbsp;&nbsp;&nbsp;Related Party Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has outstanding licensing and scientific research agreements with the University of Pennsylvania, a significant shareholder. The Company recognized $1.4&#160;million and $1.0&#160;million of research and development expense for the nine&#160;months ended September&#160;30, 2022 and 2021, respectively, related to the license agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(10)&nbsp;&nbsp;&nbsp;Subsequent Events</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has evaluated subsequent events from the balance sheet date through November&#160;21, 2022, the issuance date of these unaudited interim consolidated financial statements and has not identified any requiring disclosure except as noted below.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAAPM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX A-1</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENT AND PLAN OF MERGER</font>
          <br >
          <font style="letter-spacing:-0.2pt;">AND REORGANIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">among:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.,</font>
          <br >
          <font style="letter-spacing:-0.2pt;">a Delaware corporation;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.,</font>
          <br >
          <font style="letter-spacing:-0.2pt;">a Delaware corporation; and</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.,</font>
          <br >
          <font style="letter-spacing:-0.2pt;">a Delaware corporation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dated as of September&#160;20, 2022</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="TOC6">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:620.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS1OT"><font style="letter-spacing:-0.2pt;">Section&#160;1.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS1OT">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">DESCRIPTION OF TRANSACTION</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS1OT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS1OT">A-1-2</a></font> <a href="#tS1OT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1MUT"><font style="letter-spacing:0.2pt;">1.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1MUT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">The Merger</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1MUT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1MUT">A-1-2</a></font> <a href="#t1MUT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OTM"><font style="letter-spacing:0.2pt;">1.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OTM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Effects of the Merger</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OTM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OTM">A-1-2</a></font> <a href="#t1OTM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ETU"><font style="letter-spacing:0.2pt;">1.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ETU">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Closing; Effective Time</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ETU">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ETU">A-1-2</a></font> <a href="#t1ETU"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OIA"><font style="letter-spacing:0.2pt;">1.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OIA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Certificate of Incorporation and Bylaws; Directors and Officers</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OIA">A-1-2</a></font> <a href="#t1OIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OS"><font style="letter-spacing:0.2pt;">1.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Conversion of Shares</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OS">A-1-3</a></font> <a href="#t1OS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OTC"><font style="letter-spacing:0.2pt;">1.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OTC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Closing of the Company&#8217;s Transfer Books</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OTC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OTC">A-1-4</a></font> <a href="#t1OTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OC"><font style="letter-spacing:0.2pt;">1.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Surrender of Certificates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OC">A-1-4</a></font> <a href="#t1OC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t18RI"><font style="letter-spacing:0.2pt;">1.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t18RI">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Appraisal Rights</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t18RI">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t18RI">A-1-5</a></font> <a href="#t18RI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1AIA"><font style="letter-spacing:0.2pt;">1.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1AIA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Further Action</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1AIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1AIA">A-1-5</a></font> <a href="#t1AIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TPA"><font style="letter-spacing:0.2pt;">1.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TPA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Withholding</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TPA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TPA">A-1-6</a></font> <a href="#t1TPA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ONC"><font style="letter-spacing:0.2pt;">1.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ONC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Calculation of Net Cash</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ONC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ONC">A-1-6</a></font> <a href="#t1ONC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS2AW"><font style="letter-spacing:-0.2pt;">Section&#160;2.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS2AW">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS2AW">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS2AW">A-1-7</a></font> <a href="#tS2AW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OS"><font style="letter-spacing:0.2pt;">2.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OS">A-1-7</a></font> <a href="#t2OS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2DTC"><font style="letter-spacing:0.2pt;">2.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2DTC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2DTC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2DTC">A-1-8</a></font> <a href="#t2DTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2BNO"><font style="letter-spacing:0.2pt;">2.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2BNO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2BNO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2BNO">A-1-8</a></font> <a href="#t2BNO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2RTA"><font style="letter-spacing:0.2pt;">2.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2RTA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2RTA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2RTA">A-1-8</a></font> <a href="#t2RTA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2CST"><font style="letter-spacing:0.2pt;">2.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2CST">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2CST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2CST">A-1-8</a></font> <a href="#t2CST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t26C"><font style="letter-spacing:0.2pt;">2.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t26C">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t26C">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t26C">A-1-9</a></font> <a href="#t26C"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t27ST"><font style="letter-spacing:0.2pt;">2.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t27ST">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Financial Statements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t27ST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t27ST">A-1-10</a></font> <a href="#t27ST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OCA"><font style="letter-spacing:0.2pt;">2.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OCA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OCA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OCA">A-1-11</a></font> <a href="#t2OCA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OUL"><font style="letter-spacing:0.2pt;">2.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OUL">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OUL">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OUL">A-1-11</a></font> <a href="#t2OUL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2TAE"><font style="letter-spacing:0.2pt;">2.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2TAE">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2TAE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2TAE">A-1-11</a></font> <a href="#t2TAE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2PLN"><font style="letter-spacing:0.2pt;">2.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2PLN">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2PLN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2PLN">A-1-12</a></font> <a href="#t2PLN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t21PR"><font style="letter-spacing:0.2pt;">2.12</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t21PR">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t21PR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t21PR">A-1-12</a></font> <a href="#t21PR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2CAC"><font style="letter-spacing:0.2pt;">2.13</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2CAC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2CAC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2CAC">A-1-14</a></font> <a href="#t2CAC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2PR"><font style="letter-spacing:0.2pt;">2.14</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2PR">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits; Restrictions</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2PR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2PR">A-1-15</a></font> <a href="#t2PR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2PO"><font style="letter-spacing:0.2pt;">2.15</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2PO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2PO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2PO">A-1-17</a></font> <a href="#t2PO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t21MA"><font style="letter-spacing:0.2pt;">2.16</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t21MA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t21MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t21MA">A-1-18</a></font> <a href="#t21MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2ALM"><font style="letter-spacing:0.2pt;">2.17</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2ALM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2ALM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2ALM">A-1-19</a></font> <a href="#t2ALM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2MSJ"><font style="letter-spacing:0.2pt;">2.18</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2MSJ">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2MSJ">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2MSJ">A-1-22</a></font> <a href="#t2MSJ"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2TCH"><font style="letter-spacing:0.2pt;">2.19</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2TCH">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Insurance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2TCH">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2TCH">A-1-22</a></font> <a href="#t2TCH"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2FAN"><font style="letter-spacing:0.2pt;">2.20</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2FAN">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2FAN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2FAN">A-1-23</a></font> <a href="#t2FAN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2WAS"><font style="letter-spacing:0.2pt;">2.21</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2WAS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2WAS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2WAS">A-1-23</a></font> <a href="#t2WAS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2NOT"><font style="letter-spacing:0.2pt;">2.22</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2NOT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2NOT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2NOT">A-1-23</a></font> <a href="#t2NOT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OOR"><font style="letter-spacing:0.2pt;">2.23</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OOR">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OOR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OOR">A-1-23</a></font> <a href="#t2OOR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS3AW"><font style="letter-spacing:-0.2pt;">Section&#160;3.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS3AW">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS3AW">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS3AW">A-1-23</a></font> <a href="#tS3AW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OS"><font style="letter-spacing:0.2pt;">3.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OS">A-1-23</a></font> <a href="#t3OS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3DPH"><font style="letter-spacing:0.2pt;">3.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3DPH">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3DPH">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3DPH">A-1-24</a></font> <a href="#t3DPH"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3BNO"><font style="letter-spacing:0.2pt;">3.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3BNO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3BNO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3BNO">A-1-24</a></font> <a href="#t3BNO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:647.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3RAT"><font style="letter-spacing:0.2pt;">3.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3RAT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3RAT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3RAT">A-1-25</a></font> <a href="#t3RAT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3CST"><font style="letter-spacing:0.2pt;">3.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3CST">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3CST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3CST">A-1-25</a></font> <a href="#t3CST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t36C"><font style="letter-spacing:0.2pt;">3.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t36C">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t36C">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t36C">A-1-26</a></font> <a href="#t36C"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3FFS"><font style="letter-spacing:0.2pt;">3.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3FFS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">SEC Filings; Financial Statements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3FFS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3FFS">A-1-27</a></font> <a href="#t3FFS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OCA"><font style="letter-spacing:0.2pt;">3.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OCA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OCA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OCA">A-1-29</a></font> <a href="#t3OCA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OUL"><font style="letter-spacing:0.2pt;">3.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OUL">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OUL">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OUL">A-1-29</a></font> <a href="#t3OUL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3TAE"><font style="letter-spacing:0.2pt;">3.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3TAE">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3TAE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3TAE">A-1-29</a></font> <a href="#t3TAE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3PLN"><font style="letter-spacing:0.2pt;">3.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3PLN">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3PLN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3PLN">A-1-29</a></font> <a href="#t3PLN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t31PR"><font style="letter-spacing:0.2pt;">3.12</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t31PR">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t31PR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t31PR">A-1-29</a></font> <a href="#t31PR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3CAC"><font style="letter-spacing:0.2pt;">3.13</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3CAC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3CAC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3CAC">A-1-31</a></font> <a href="#t3CAC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t31PE"><font style="letter-spacing:0.2pt;">3.14</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t31PE">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t31PE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t31PE">A-1-33</a></font> <a href="#t31PE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3PO"><font style="letter-spacing:0.2pt;">3.15</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3PO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3PO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3PO">A-1-35</a></font> <a href="#t3PO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t31MA"><font style="letter-spacing:0.2pt;">3.16</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t31MA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t31MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t31MA">A-1-35</a></font> <a href="#t31MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3ALM"><font style="letter-spacing:0.2pt;">3.17</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3ALM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3ALM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3ALM">A-1-36</a></font> <a href="#t3ALM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3MSJ"><font style="letter-spacing:0.2pt;">3.18</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3MSJ">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3MSJ">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3MSJ">A-1-39</a></font> <a href="#t3MSJ"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3PHM"><font style="letter-spacing:0.2pt;">3.19</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3PHM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Insurance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3PHM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3PHM">A-1-39</a></font> <a href="#t3PHM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3FAO"><font style="letter-spacing:0.2pt;">3.20</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3FAO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3FAO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3FAO">A-1-40</a></font> <a href="#t3FAO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3WAE"><font style="letter-spacing:0.2pt;">3.21</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3WAE">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3WAE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3WAE">A-1-40</a></font> <a href="#t3WAE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3NPN"><font style="letter-spacing:0.2pt;">3.22</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3NPN">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3NPN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3NPN">A-1-40</a></font> <a href="#t3NPN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3ITP"><font style="letter-spacing:0.2pt;">3.23</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3ITP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Valid Issuance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3ITP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3ITP">A-1-40</a></font> <a href="#t3ITP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OFA"><font style="letter-spacing:0.2pt;">3.24</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OFA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Opinion of Financial Advisor</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OFA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OFA">A-1-40</a></font> <a href="#t3OFA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OOR"><font style="letter-spacing:0.2pt;">3.25</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OOR">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OOR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OOR">A-1-40</a></font> <a href="#t3OOR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS4CO"><font style="letter-spacing:-0.2pt;">Section&#160;4.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS4CO">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">CERTAIN COVENANTS OF THE PARTIES</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS4CO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS4CO">A-1-40</a></font> <a href="#tS4CO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4OPB"><font style="letter-spacing:0.2pt;">4.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4OPB">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Operation of Parent&#8217;s Business</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4OPB">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4OPB">A-1-40</a></font> <a href="#t4OPB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4OTC"><font style="letter-spacing:0.2pt;">4.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4OTC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Operation of the Company&#8217;s Business</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4OTC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4OTC">A-1-43</a></font> <a href="#t4OTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4AI"><font style="letter-spacing:0.2pt;">4.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4AI">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Access and Investigation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4AI">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4AI">A-1-44</a></font> <a href="#t4AI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t44NO"><font style="letter-spacing:0.2pt;">4.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t44NO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Non-Solicitation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t44NO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t44NO">A-1-45</a></font> <a href="#t44NO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t45NO"><font style="letter-spacing:0.2pt;">4.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t45NO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Company Non-Solicitation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t45NO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t45NO">A-1-46</a></font> <a href="#t45NO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4OCM"><font style="letter-spacing:0.2pt;">4.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4OCM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Notification of Certain Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4OCM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4OCM">A-1-47</a></font> <a href="#t4OCM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4TA"><font style="letter-spacing:0.2pt;">4.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4TA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="letter-spacing:0.2pt;">. </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4TA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4TA">A-1-48</a></font> <a href="#t4TA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS5AO"><font style="letter-spacing:-0.2pt;">Section&#160;5.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS5AO">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">ADDITIONAL AGREEMENTS OF THE PARTIES.</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS5AO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS5AO">A-1-48</a></font> <a href="#tS5AO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SPS"><font style="letter-spacing:0.2pt;">5.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SPS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Registration Statement; Proxy Statement/Prospectus</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SPS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SPS">A-1-48</a></font> <a href="#t5SPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t52MA"><font style="letter-spacing:0.2pt;">5.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t52MA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Regulatory Matters</font><font style="letter-spacing:0.2pt;">. </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t52MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t52MA">A-1-49</a></font> <a href="#t52MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SM"><font style="letter-spacing:0.2pt;">5.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SM">A-1-50</a></font> <a href="#t5SM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SM1"><font style="letter-spacing:0.2pt;">5.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SM1">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholders&#8217; Meeting</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SM1">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SM1">A-1-51</a></font> <a href="#t5SM1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:12pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OCC"><font style="letter-spacing:0.2pt;">5.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:80pt;">
                <a href="#t5OCC">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Company Options, Company Convertible Note, Parent Warrants, and Parent Equity Awards</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OCC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OCC">A-1-53</a></font> <a href="#t5OCC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OOA"><font style="letter-spacing:0.2pt;">5.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5OOA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Indemnification of Officers and Directors</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OOA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OOA">A-1-54</a></font> <a href="#t5OOA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5AIA"><font style="letter-spacing:0.2pt;">5.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5AIA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Additional Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5AIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5AIA">A-1-56</a></font> <a href="#t5AIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5TIP"><font style="letter-spacing:0.2pt;">5.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5TIP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Disclosure</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5TIP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5TIP">A-1-56</a></font> <a href="#t5TIP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5DTP"><font style="letter-spacing:0.2pt;">5.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5DTP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Listing</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5DTP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5DTP">A-1-56</a></font> <a href="#t5DTP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t51MA"><font style="letter-spacing:0.2pt;">5.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t51MA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t51MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t51MA">A-1-56</a></font> <a href="#t51MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-iii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:647.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5PSB"><font style="letter-spacing:0.2pt;">5.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5PSB">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Legends</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5PSB">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5PSB">A-1-57</a></font> <a href="#t5PSB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5AOP"><font style="letter-spacing:0.2pt;">5.12</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5AOP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Directors and Officers</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5AOP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5AOP">A-1-57</a></font> <a href="#t5AOP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OCA"><font style="letter-spacing:0.2pt;">5.13</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5OCA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Termination of Certain Agreements and Rights</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OCA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OCA">A-1-57</a></font> <a href="#t5OCA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t51MP"><font style="letter-spacing:0.2pt;">5.14</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t51MP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;16 Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t51MP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t51MP">A-1-57</a></font> <a href="#t51MP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5EPS"><font style="letter-spacing:0.2pt;">5.15</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5EPS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Cooperation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5EPS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5EPS">A-1-58</a></font> <a href="#t5EPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t51CE"><font style="letter-spacing:0.2pt;">5.16</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t51CE">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Allocation Certificates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t51CE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t51CE">A-1-58</a></font> <a href="#t51CE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5FST"><font style="letter-spacing:0.2pt;">5.17</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5FST">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Company Financial Statements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5FST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5FST">A-1-58</a></font> <a href="#t5FST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SIA"><font style="letter-spacing:0.2pt;">5.18</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SIA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Takeover Statutes</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SIA">A-1-58</a></font> <a href="#t5SIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5LEP"><font style="letter-spacing:0.2pt;">5.19</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5LEP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Stockholder Litigation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5LEP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5LEP">A-1-58</a></font> <a href="#t5LEP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t52BE"><font style="letter-spacing:0.2pt;">5.20</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t52BE">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Employee Benefits</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t52BE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t52BE">A-1-59</a></font> <a href="#t52BE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5DPT"><font style="letter-spacing:0.2pt;">5.21</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5DPT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5DPT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5DPT">A-1-59</a></font> <a href="#t5DPT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5RSP"><font style="letter-spacing:0.2pt;">5.22</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5RSP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Reverse Split</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5RSP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5RSP">A-1-59</a></font> <a href="#t5RSP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SDF"><font style="letter-spacing:0.2pt;">5.23</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SDF">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Parent SEC Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SDF">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SDF">A-1-59</a></font> <a href="#t5SDF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OMS"><font style="letter-spacing:0.2pt;">5.24</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5OMS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Obligations of Merger Sub</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OMS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OMS">A-1-60</a></font> <a href="#t5OMS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS6PT"><font style="letter-spacing:-0.2pt;">Section&#160;6.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS6PT">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS6PT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS6PT">A-1-60</a></font> <a href="#tS6PT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6RNT"><font style="letter-spacing:0.2pt;">6.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6RNT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">No Restraints</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6RNT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6RNT">A-1-60</a></font> <a href="#t6RNT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6AIP"><font style="letter-spacing:0.2pt;">6.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6AIP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6AIP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6AIP">A-1-60</a></font> <a href="#t6AIP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6TES"><font style="letter-spacing:0.2pt;">6.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6TES">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Listing</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6TES">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6TES">A-1-60</a></font> <a href="#t6TES"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6ORS"><font style="letter-spacing:0.2pt;">6.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6ORS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Effectiveness of Registration Statement</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6ORS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6ORS">A-1-60</a></font> <a href="#t6ORS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:12pt; text-align:left; width:51pt;white-space:nowrap;">
                <a href="#tS7CP"><font style="letter-spacing:-0.2pt;">Section&#160;7.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:51pt;">
                <a href="#tS7CP">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS7CP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:normal;">&#8203;</div>
            </td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:normal;">
                <font style="letter-spacing:0.2pt;"><a href="#tS7CP">A-1-60</a></font> <a href="#tS7CP"></a></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7ORT"><font style="letter-spacing:0.2pt;">7.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7ORT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7ORT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7ORT">A-1-60</a></font> <a href="#t7ORT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7OCT"><font style="letter-spacing:0.2pt;">7.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7OCT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7OCT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7OCT">A-1-61</a></font> <a href="#t7OCT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7CPS"><font style="letter-spacing:0.2pt;">7.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7CPS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Closing Certificate</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7CPS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7CPS">A-1-61</a></font> <a href="#t7CPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7CPS1"><font style="letter-spacing:0.2pt;">7.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7CPS1">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">FIRPTA Certificate</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7CPS1">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7CPS1">A-1-61</a></font> <a href="#t7CPS1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7OIA"><font style="letter-spacing:0.2pt;">7.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7OIA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Termination of Investor Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7OIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7OIA">A-1-61</a></font> <a href="#t7OIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7LAT"><font style="letter-spacing:0.2pt;">7.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7LAT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Company Lock-Up Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7LAT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7LAT">A-1-61</a></font> <a href="#t7LAT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:12pt; text-align:left; width:51pt;white-space:nowrap;">
                <a href="#tS8CP"><font style="letter-spacing:-0.2pt;">Section&#160;8.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:51pt;">
                <a href="#tS8CP">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS8CP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:normal;">&#8203;</div>
            </td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:normal;">
                <font style="letter-spacing:0.2pt;"><a href="#tS8CP">A-1-61</a></font> <a href="#tS8CP"></a></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8ORT"><font style="letter-spacing:0.2pt;">8.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8ORT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8ORT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8ORT">A-1-61</a></font> <a href="#t8ORT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8OCP"><font style="letter-spacing:0.2pt;">8.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8OCP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8OCP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8OCP">A-1-62</a></font> <a href="#t8OCP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8TCS"><font style="letter-spacing:0.2pt;">8.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8TCS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8TCS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8TCS">A-1-62</a></font> <a href="#t8TCS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8LAT"><font style="letter-spacing:0.2pt;">8.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8LAT">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Lock-Up Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8LAT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8LAT">A-1-62</a></font> <a href="#t8LAT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8PFN"><font style="letter-spacing:0.2pt;">8.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8PFN">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Minimum Parent Final Net Cash</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8PFN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8PFN">A-1-62</a></font> <a href="#t8PFN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tSE9T"><font style="letter-spacing:-0.2pt;">Section&#160;9.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tSE9T">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">TERMINATION</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSE9T">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSE9T">A-1-62</a></font> <a href="#tSE9T"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t9TAM"><font style="letter-spacing:0.2pt;">9.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t9TAM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Termination</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t9TAM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t9TAM">A-1-62</a></font> <a href="#t9TAM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t9OTI"><font style="letter-spacing:0.2pt;">9.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t9OTI">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Effect of Termination</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t9OTI">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t9OTI">A-1-63</a></font> <a href="#t9OTI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t9TF"><font style="letter-spacing:0.2pt;">9.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t9TF">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Expenses; Termination Fees</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t9TF">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t9TF">A-1-64</a></font> <a href="#t9TF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS1P"><font style="letter-spacing:-0.2pt;">Section&#160;10.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS1P">
                  <!--blacklining:none;-->
                  <font style="letter-spacing:-0.2pt;">MISCELLANEOUS PROVISIONS</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS1P">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS1P">A-1-65</a></font> <a href="#tS1P"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ORA"><font style="letter-spacing:0.2pt;">10.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ORA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Non-Survival of Representations and Warranties</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ORA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ORA">A-1-65</a></font> <a href="#t1ORA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TAM"><font style="letter-spacing:0.2pt;">10.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TAM">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Amendment</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TAM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TAM">A-1-65</a></font> <a href="#t1TAM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-iv</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:214.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:143.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t103"><font style="letter-spacing:0.2pt;">10.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t103">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Waiver</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t103">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t103">A-1-65</a></font> <a href="#t103"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ACE"><font style="letter-spacing:0.2pt;">10.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ACE">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Entire Agreement; Counterparts; Exchanges by Electronic Transmission</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ACE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ACE">A-1-65</a></font> <a href="#t1ACE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1LJW"><font style="letter-spacing:0.2pt;">10.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1LJW">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Applicable Law; Jurisdiction; Waiver of Jury Trial</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1LJW">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1LJW">A-1-66</a></font> <a href="#t1LJW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TAS"><font style="letter-spacing:0.2pt;">10.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TAS">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Assignability</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TAS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TAS">A-1-66</a></font> <a href="#t1TAS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ANA"><font style="letter-spacing:0.2pt;">10.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ANA">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Notices</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ANA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ANA">A-1-66</a></font> <a href="#t1ANA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ATO"><font style="letter-spacing:0.2pt;">10.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ATO">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Severability</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ATO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ATO">A-1-67</a></font> <a href="#t1ATO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1RSP"><font style="letter-spacing:0.2pt;">10.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1RSP">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Other Remedies; Specific Performance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1RSP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1RSP">A-1-67</a></font> <a href="#t1RSP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TPB"><font style="letter-spacing:0.2pt;">10.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TPB">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">No Third Party Beneficiaries</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TPB">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TPB">A-1-68</a></font> <a href="#t1TPB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t101"><font style="letter-spacing:0.2pt;">10.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t101">
                  <!--blacklining:none;-->
                  <font style="font-weight:bold;letter-spacing:-0.2pt;">Construction</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t101">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t101">A-1-68</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Schedules</font><font style="letter-spacing:0.2pt;">: </font> <br ><font style="letter-spacing:0.2pt;">Company Disclosure Schedule </font> <br ><font style="letter-spacing:0.2pt;">Parent Disclosure Schedule </font> <br ><font style="letter-spacing:0.2pt;">Schedule&#160;5.7&#8201;&#8211;&#8201;Additional Agreements </font> <br ><font style="letter-spacing:0.2pt;">Schedule&#160;5.12&#8201;&#8211;&#8201;Post-Closing Directors and Officers of Parent and the Surviving Corporation </font><br ><font style="letter-spacing:0.2pt;">Schedule&#160;N </font></div>
        <table style="width:456pt;height:160pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:60pt;">
              <font style="letter-spacing:-0.2pt;">Exhibits</font><font style="font-weight:normal;letter-spacing:0.2pt;">: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Definitions </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;B-1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Company Stockholder Support Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;B-2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Parent Stockholder Support Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;C-1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Company Lock-Up Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;C-2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Parent Lock-Up Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;D </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Contingent Value Right Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;E </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Net Cash Illustrative Calculations </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;F </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Certificate of Merger </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;G </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Company Stockholder Written Consent </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;H </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Exchange Ratio Calculation</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-v</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="letter-spacing:0.2pt;"> (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is made and entered into as of September&#160;20, 2022, by and among </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation and wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and </font><font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;). Certain capitalized terms used in this Agreement are defined in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;Parent and the Company intend to effect a merger of Merger Sub with and into the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger</font><font style="letter-spacing:0.2pt;">&#8221;) in accordance with this Agreement and the DGCL. Upon consummation of the Merger, Merger Sub will cease to exist and the Company will become a wholly-owned subsidiary of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;The Parties intend that the Merger qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, and by executing this Agreement, the Parties intend to adopt this Agreement as a plan of reorganization within the meaning of Treasury Regulations&#160;Sections&#160;1.368-2(g) and 1.368-3. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">C.&nbsp;&nbsp;&nbsp;The Parent Board has (i)&#160;determined that the Contemplated Transactions, including the Merger, are fair to, advisable and in the best interests of Parent and its stockholders, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of Parent Common Stock to the stockholders of the Company pursuant to the terms of this Agreement, and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Parent vote to approve the Parent Stockholder Matters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">D.&nbsp;&nbsp;&nbsp;The Merger Sub Board has (i)&#160;determined that the Contemplated Transactions are fair to, advisable, and in the best interests of Merger Sub and its sole stockholder, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub votes to adopt this Agreement and thereby approve the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">E.&nbsp;&nbsp;&nbsp;Parent, as the sole stockholder of Merger Sub, has adopted this Agreement and thereby approved the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">F.&nbsp;&nbsp;&nbsp;The Company Board has (i)&#160;determined that the Contemplated Transactions are fair to, advisable and in the best interests of the Company and its stockholders, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to approve the Company Stockholder Matters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">G.&nbsp;&nbsp;&nbsp;Concurrently with the execution and delivery of this Agreement and as a condition and inducement to Parent&#8217;s willingness to enter into this Agreement, the officers, directors and stockholders of the Company listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;A</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule (solely in their capacity as stockholders of the Company) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Signatories</font><font style="letter-spacing:0.2pt;">&#8221;) are executing (a)&#160;support agreements in favor of Parent in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;B-1</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which the Company Signatories have, subject to the terms and conditions set forth therein, agreed to vote all of their shares of Company Common Stock in favor of the Company Stockholder Matters and against any proposals that compete with the Contemplated Transactions, and (b)&#160;lock-up agreements in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;C-1</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Lock-Up Agreement</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">H.&nbsp;&nbsp;&nbsp;Concurrently with the execution and delivery of this Agreement and as a condition and inducement to the Company&#8217;s willingness to enter into this Agreement, the officers and directors of Parent listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;A</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule (solely in their capacity as stockholders of Parent) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Signatories</font><font style="letter-spacing:0.2pt;">&#8221;) are executing (a)&#160;support agreements in favor of the Company in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;B-2</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which the Parent Signatories have, subject to the terms and conditions set forth therein, agreed to vote all of their shares of capital stock of Parent in favor of the Parent Stockholder Matters and against any proposals that compete with the Contemplated Transactions, and (b)&#160;lock-up agreements in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;C-2</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Lock-Up Agreement</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="tS1OT">&#8203;</a><a name="t1MUT">&#8203;</a><a name="t1OTM">&#8203;</a><a name="t1ETU">&#8203;</a><a name="t1OIA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">I.&nbsp;&nbsp;&nbsp;It is expected that promptly after the Registration Statement is declared effective under the Securities Act (and in any event no later than five Business Days), the holders of shares of Company Capital Stock sufficient to adopt and approve the Company Stockholder Matters as required under the DGCL and the Company&#8217;s certificate of incorporation and bylaws will execute and deliver the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">J.&nbsp;&nbsp;&nbsp;In connection with the execution and delivery of this Agreement, the Company has entered into one or more Subscription Agreements with certain investors, pursuant to which such investors have agreed to purchase immediately prior to the Effective Time certain shares of the Company in connection with the Pre-Closing Financing. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Parties, intending to be legally bound, agree as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;1.&nbsp;&nbsp;&nbsp;DESCRIPTION OF TRANSACTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">The Merger</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the terms and subject to the conditions set forth in this Agreement and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, and the separate existence of Merger Sub shall cease. Following the Effective Time, the Company will continue as the surviving corporation in the Merger (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Surviving Corporation</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Effects of the Merger</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Merger shall have the effects set forth in this Agreement, the Certificate of Merger and the applicable provisions of the DGCL. As a result of the Merger, the Company will become a wholly-owned subsidiary of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Closing; Effective Time</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless this Agreement is earlier terminated pursuant to the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1</font><font style="letter-spacing:0.2pt;">, and subject to the satisfaction or waiver of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">, the consummation of the Merger (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Closing</font><font style="letter-spacing:0.2pt;">&#8221;) shall take place remotely as promptly as practicable (but in no event later than the second Business Day following the satisfaction or waiver (to the extent permitted by applicable Law) of the last to be satisfied or waived of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">, other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of each of such conditions), or at such other time, date and place as Parent and the Company may mutually agree in writing. The date on which the Closing actually takes place is referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Closing Date</font><font style="letter-spacing:0.2pt;">&#8221;. At the Closing, the Parties shall cause the Merger to be consummated by executing and filing with the Secretary of State of the State of Delaware a certificate of merger with respect to the Merger, in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;F</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Certificate of Merger</font><font style="letter-spacing:0.2pt;">&#8221;). The Merger shall become effective at the time of such filing of the Certificate of Merger with the Secretary of State of the State of Delaware or at such later time as may be specified in the Certificate of Merger with the consent of Parent and the Company (the time as of which the Merger becomes effective being referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effective Time</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Certificate of Incorporation and Bylaws; Directors and Officers</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;At the Effective Time: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;the certificate of incorporation of the Surviving Corporation shall be amended and restated in the Merger to read as set forth on Exhibit&#160;A to the Certificate of Merger, until thereafter amended as provided by the DGCL and such certificate of incorporation; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;the certificate of incorporation of Parent shall be identical to the certificate of incorporation of Parent immediately prior to the Effective Time (which shall reflect the Nasdaq Reverse Split, if approved), until thereafter amended as provided by the DGCL and such certificate of incorporation; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that at the Effective Time Parent shall file an amendment to its certificate of incorporation, to change the name of Parent to &#8220;CARISMA Therapeutics Inc.&#8221;; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;the bylaws of the Surviving Corporation shall be amended and restated in their entirety to read identically to the bylaws of Merger Sub as in effect immediately prior to the Effective Time (except that the name of the Surviving Corporation in such bylaws shall reflect the name identified on Exhibit&#160;A to the Certificate of Merger), until thereafter amended as provided by the DGCL and such bylaws; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1OS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;the directors and officers of Parent, each to hold office in accordance with the certificate of incorporation and bylaws of Parent, shall be as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.12</font><font style="letter-spacing:0.2pt;">; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;the directors and officers of the Surviving Corporation, each to hold office in accordance with the certificate of incorporation and bylaws of the Surviving Corporation, shall be the directors and officers of Parent as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.12</font><font style="letter-spacing:0.2pt;"> or such other persons as shall be mutually agreed upon by Parent and the Company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Conversion of Shares</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any stockholder of the Company or Parent: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;any shares of Company Capital Stock held as treasury stock or held or owned by the Company, Merger Sub or any Subsidiary of the Company immediately prior to the Effective Time shall be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(c)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.8</font><font style="letter-spacing:0.2pt;">, each share of Company Capital Stock outstanding immediately prior to the Effective Time (including any shares of Company Capital Stock issued pursuant to the Pre-Closing Financing, and excluding shares to be canceled pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)(i)</font><font style="letter-spacing:0.2pt;"> and Dissenting Shares) shall be automatically converted solely into the right to receive a number of shares of Parent Common Stock equal to the Exchange Ratio (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If any shares of Company Capital Stock outstanding immediately prior to the Effective Time are unvested or are subject to a repurchase option or a risk of forfeiture under any applicable restricted stock purchase agreement or other similar agreement with the Company, then the shares of Parent Common Stock issued in exchange for such shares of Company Capital Stock will to the same extent be unvested and subject to the same repurchase option or risk of forfeiture, and such shares of Parent Common Stock shall accordingly be marked with appropriate legends. The Company shall take all actions that may be necessary to ensure that, from and after the Effective Time, Parent is entitled to exercise any such repurchase option or other right set forth in any such restricted stock purchase agreement or other agreement in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;No fractional shares of Parent Common Stock shall be issued in connection with the Merger or the Conversion, and no certificates or scrip for any such fractional shares shall be issued. Notwithstanding any other provision of this Agreement, any holder of Company Capital Stock or the Company Convertible Note, as applicable, converted in connection with the Merger or the Conversion, as applicable, who would otherwise have been entitled to receive a fraction of a share of Parent Common Stock (after taking into account all Company Stock Certificates delivered or Book-Entry Shares transferred by such holder and the aggregate number of shares of Company Capital Stock represented thereby, as applicable) shall receive, in lieu thereof, cash (without interest and subject to applicable Tax withholding) in an amount equal to such fractional part of a share of Parent Common Stock multiplied by the last reported sale price of Parent Common Stock at the 4:00&#160;p.m., Eastern Time, end of regular trading hours on Nasdaq on the last trading day prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;All Company Options outstanding immediately prior to the Effective Time under the Company Plan shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Company Convertible Note shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(c)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;All Parent Warrants outstanding immediately prior to the Effective Time shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(e)</font><font style="letter-spacing:0.2pt;"> and Parent RSUs and Parent Options outstanding immediately prior to the Effective Time shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(f)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Each share of common stock, $0.0001 par value per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and exchanged for one validly issued, fully paid and nonassessable share of common stock, $0.0001 par value per share, of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1OTC">&#8203;</a><a name="t1OC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Surviving Corporation. Each stock certificate of Merger Sub, if any, evidencing ownership of any such shares shall, as of the Effective Time, evidence ownership of such shares of common stock of the Surviving Corporation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;If, between the date of this Agreement and the Effective Time, any outstanding shares of Company Capital Stock or Parent Common Stock shall have been changed into, or exchanged for, a different number of shares or a different class, by reason of any stock dividend, subdivision, reclassification, recapitalization, split (including the Nasdaq Reverse Split), combination or exchange of shares or other like change, the Exchange Ratio shall, to the extent necessary, be equitably adjusted to reflect such change to provide the holders of Company Capital Stock, Company Options, Parent Common Stock, Parent Options, Parent RSUs and Parent Warrants with the same economic effect as contemplated by this Agreement prior to such stock dividend, subdivision, reclassification, recapitalization, split (including the Nasdaq Reverse Split), combination or exchange of shares or other like change; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that nothing herein will be construed to permit the Company or Parent to take any action with respect to Company Capital Stock or Parent Common Stock, respectively, that is prohibited by the terms of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Closing of the Company&#8217;s Transfer Books</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;At the Effective Time: (a)&#160;all shares of Company Capital Stock outstanding immediately prior to the Effective Time (including any shares of Company Capital Stock issued pursuant to the Pre-Closing Financing) shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)</font><font style="letter-spacing:0.2pt;">, and all holders of (i)&#160;certificates representing shares of Company Capital Stock and (ii)&#160;book-entry shares representing shares of Company Capital Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Book-Entry Shares</font><font style="letter-spacing:0.2pt;">&#8221;), in each case, that were outstanding immediately prior to the Effective Time shall cease to have any rights as stockholders of the Company; and (b)&#160;the stock transfer books of the Company shall be closed with respect to all shares of Company Capital Stock outstanding immediately prior to the Effective Time. No further transfer of any such shares of Company Capital Stock shall be made on such stock transfer books after the Effective Time. If, after the Effective Time, a valid certificate previously representing any shares of Company Capital Stock outstanding immediately prior to the Effective Time (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stock Certificate</font><font style="letter-spacing:0.2pt;">&#8221;) is presented to the Exchange Agent or to the Surviving Corporation, such Company Stock Certificate shall be canceled and shall be exchanged as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;1.5</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.7</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Surrender of Certificates</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Prior to the Closing Date, Parent and the Company shall agree upon and select a reputable bank, transfer agent or trust company to act as exchange agent in the Merger (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Agent</font><font style="letter-spacing:0.2pt;">&#8221;). At the Effective Time, Parent shall deposit with the Exchange Agent: (i)&#160;evidence of book-entry shares representing the Parent Common Stock issuable pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)</font><font style="letter-spacing:0.2pt;"> in exchange for shares of Company Capital Stock and conversion of the Company Convertible Note; and (ii)&#160;cash sufficient to make payments in lieu of fractional shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(c)</font><font style="letter-spacing:0.2pt;">. The Parent Common Stock and cash amounts so deposited with the Exchange Agent, together with any dividends or distributions received by the Exchange Agent with respect to such shares, are referred to collectively as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Fund.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the Effective Time, the Parties shall cause the Exchange Agent to mail to the Persons who were record holders of shares of Company Capital Stock that were converted into the right to receive the Merger Consideration: (i)&#160;a letter of transmittal in customary form and containing such provisions as Parent may reasonably specify (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">LoT</font><font style="letter-spacing:0.2pt;">&#8221;) (including a provision confirming that delivery of Company Stock Certificates or transfer of Book-Entry Shares to the Exchange Agent shall be effected, and risk of loss and title thereto shall pass, only upon proper delivery of such Company Stock Certificates or transfer of the Book-Entry Shares to the Exchange Agent); and (ii)&#160;instructions for effecting the surrender of Company Stock Certificates or transfer of Book-Entry Shares in exchange for shares of Parent Common Stock. Upon surrender of a Company Stock Certificate or transfer of Book-Entry Share to the Exchange Agent for exchange, together with a duly executed LoT and such other documents as may be reasonably required by the Exchange Agent or Parent: (A)&#160;the holder of such Company Stock Certificate or Book-Entry Share shall be entitled to receive in exchange therefor book-entry shares representing the Merger Consideration (in a number of whole shares of Parent Common Stock) that such holder has the right to receive pursuant to the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)</font><font style="letter-spacing:0.2pt;"> (and cash in lieu of any fractional share of Parent Common Stock pursuant to the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(c)</font><font style="letter-spacing:0.2pt;">); </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t18RI">&#8203;</a><a name="t1AIA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and (B)&#160;the Company Stock Certificate or Book-Entry Share so surrendered or transferred, as the case may be, shall be canceled. Until surrendered or transferred as contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.7(b)</font><font style="letter-spacing:0.2pt;">, each Company Stock Certificate or Book-Entry Share shall be deemed, from and after the Effective Time, to represent only the right to receive book-entry shares of Parent Common Stock representing the Merger Consideration (and cash in lieu of any fractional share of Parent Common Stock). If any Company Stock Certificate shall have been lost, stolen or destroyed, Parent may, in its discretion and as a condition precedent to the delivery of any shares of Parent Common Stock, require the owner of such lost, stolen or destroyed Company Stock Certificate to provide an applicable affidavit with respect to such Company Stock Certificate. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;No dividends or other distributions declared or made with respect to Parent Common Stock with a record date on or after the Effective Time shall be paid to the holder of any unsurrendered Company Stock Certificate or Book-Entry Shares with respect to the shares of Parent Common Stock that such holder has the right to receive in the Merger until such holder surrenders such Company Stock Certificate or transfers such Book-Entry Share or provides an affidavit of loss or destruction in lieu thereof in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.7</font><font style="letter-spacing:0.2pt;"> (at which time (or, if later, on the applicable payment date) such holder shall be entitled, subject to the effect of applicable abandoned property, escheat or similar Laws, to receive all such dividends and distributions, without interest). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Any portion of the Exchange Fund that remains unclaimed by holders of shares of Company Common Stock as of the first anniversary of the Closing Date shall be delivered to Parent upon demand, and any holders of Company Stock Certificates or Book-Entry Shares who have not theretofore surrendered their Company Stock Certificates or transferred their Book-Entry Shares in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.7</font><font style="letter-spacing:0.2pt;"> shall thereafter look only to Parent for satisfaction of their claims for Parent Common Stock, cash in lieu of fractional shares of Parent Common Stock and any dividends or distributions with respect to shares of Parent Common Stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;No Party shall be liable to any holder of shares of any Company Capital Stock or to any other Person with respect to any shares of Parent Common Stock (or dividends or distributions with respect thereto) or for any cash amounts delivered to any public official pursuant to any applicable abandoned property Law, escheat Law or similar Law. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Appraisal Rights</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Notwithstanding any provision of this Agreement to the contrary, shares of Company Capital Stock that are outstanding immediately prior to the Effective Time and which are held by stockholders who have exercised and perfected appraisal rights for such shares of Company Capital Stock in accordance with the DGCL (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dissenting Shares</font><font style="letter-spacing:0.2pt;">&#8221;) shall not be converted into or represent the right to receive the Merger Consideration described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5</font><font style="letter-spacing:0.2pt;"> attributable to such Dissenting Shares. Such stockholders shall be entitled to receive payment of the appraised value of such shares of Company Capital Stock held by them in accordance with the DGCL, unless and until such stockholders fail to perfect or effectively withdraw or otherwise lose their appraisal rights under the DGCL. All Dissenting Shares held by stockholders who shall have failed to perfect or who effectively shall have withdrawn or lost their right to appraisal of such shares of Company Capital Stock under the DGCL (whether occurring before, at or after the Effective Time) shall thereupon be deemed to be converted into and to have become exchangeable for, as of the Effective Time, the right to receive the Merger Consideration, without interest, attributable to such Dissenting Shares upon their surrender in the manner provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;1.5</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.7</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company shall give Parent prompt written notice of any demands by dissenting stockholders received by the Company, withdrawals of such demands and any other instruments served on the Company and any material correspondence received by the Company in connection with such demands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Further Action</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, at any time after the Effective Time, any further action is determined by the Surviving Corporation to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to all rights and property of the Company, then the officers and directors of the Surviving Corporation shall be fully authorized, and shall </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1TPA">&#8203;</a><a name="t1ONC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">use their and its commercially reasonable efforts (in the name of the Company, in the name of Merger Sub, in the name of the Surviving Corporation and otherwise) to take such action. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Withholding</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parties and the Exchange Agent and their respective agents shall be entitled to deduct and withhold from any amounts otherwise payable pursuant to this Agreement such amounts as such Party or the Exchange Agent is required to deduct and withhold under the Code or any other Tax Law with respect to the making of such payment and shall be entitled to request any reasonably appropriate Tax forms, including an IRS Form W-9 or the appropriate IRS Form W-8, as applicable, from any recipient of payments hereunder. The payor shall provide commercially reasonable notice to the payee upon becoming aware of any such withholding obligation (other than any withholding on amounts treated as compensation), and the Parties shall cooperate with each other and with such payee to the extent reasonable to obtain reduction of or relief from such withholding. To the extent that amounts are so deducted and withheld and paid to the appropriate taxing authority, such deducted and withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding was made. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Calculation of Net Cash</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Not more than ten nor less than five calendar days prior to the anticipated date for Closing (as mutually agreed in good faith by Parent and the Company) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Anticipated Closing Date</font><font style="letter-spacing:0.2pt;">&#8221;), Parent will deliver to the Company a schedule (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Net Cash Schedule</font><font style="letter-spacing:0.2pt;">&#8221;) setting forth, in reasonable detail, Parent&#8217;s good faith estimated calculation of Net Cash (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Net Cash Calculation</font><font style="letter-spacing:0.2pt;">&#8221; and the date of delivery of such schedule, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Delivery Date</font><font style="letter-spacing:0.2pt;">&#8221;) as of 8:00&#160;p.m. Eastern Time on the last Business Day prior to the Anticipated Closing Date (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cash Determination Time</font><font style="letter-spacing:0.2pt;">&#8221;), prepared and certified by Parent&#8217;s chief executive officer and chief financial officer (or if there is no chief financial officer at such time, the principal financial and accounting officer of Parent). Subject to the terms of the Confidentiality Agreement, Parent shall make available to the Company, its accountants and/or counsel, the work papers and back-up materials used or useful in preparing the Net Cash Schedule, as reasonably requested by the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Within three Business Days following the Delivery Date (the last day of such period, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Response Date</font><font style="letter-spacing:0.2pt;">&#8221;), the Company will have the right to dispute all or any part or parts of the Net Cash Calculation by delivering a written notice to that effect (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dispute Notice</font><font style="letter-spacing:0.2pt;">&#8221;) to Parent. Any Dispute Notice shall identify in reasonable detail to the extent then known the nature and amounts of any proposed revisions to the Net Cash Calculation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;If (i)&#160;the Company notifies Parent in writing on or prior to the Response Date that it has no objections to the Net Cash Calculation or (ii)&#160;the Company has failed to deliver a Dispute Notice as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(b)</font><font style="letter-spacing:0.2pt;"> prior to 8:00&#160;p.m. Eastern Time on the Response Date, then the Net Cash Calculation as set forth in the Net Cash Schedule shall be deemed to have been finally determined for purposes of this Agreement and to represent the Net Cash at the Cash Determination Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Final Net Cash</font><font style="letter-spacing:0.2pt;">&#8221;) for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;If the Company delivers a Dispute Notice prior to 8:00&#160;p.m. Eastern Time on the Response Date, then Representatives of Parent and the Company shall promptly, and in no event later than one calendar day after the Response Date, meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of the Net Cash, which agreed-upon Net Cash shall be deemed to have been finally determined for purposes of this Agreement and to represent the Final Net Cash for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;If Representatives of Parent and the Company are unable to negotiate an agreed-upon determination of Final Net Cash pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(d)</font><font style="letter-spacing:0.2pt;"> within two calendar days after delivery of the Dispute Notice (or such other period as Parent and the Company may mutually agree upon in writing), then any remaining disagreements as to the calculation of Net Cash shall be referred to Deloitte &amp; Touche LLP or another independent auditor of recognized national standing mutually agreed upon by Parent and the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Accounting Firm</font><font style="letter-spacing:0.2pt;">&#8221;). Parent shall promptly deliver to the Accounting Firm all work papers and back-up materials used in preparing the Net Cash Schedule, and Parent and the Company shall use commercially reasonable efforts to cause the Accounting Firm to make its </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="tS2AW">&#8203;</a><a name="t2OS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">determination within five calendar days of accepting its selection. The Company and Parent shall be afforded the opportunity to present to the Accounting Firm any material related to the unresolved disputes and to discuss the issues with the Accounting Firm; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that no such presentation or discussion shall occur without the presence of a Representative of each of the Company and Parent. The determination of the Accounting Firm shall be limited to the disagreements submitted to the Accounting Firm. The determination of the amount of Net Cash made by the Accounting Firm shall be made in writing delivered to each of the Company and Parent, shall be final and binding on the Company and Parent and shall be deemed to have been finally determined for purposes of this Agreement and to represent the Final Net Cash for purposes of this Agreement, absent fraud or manifest error. The Parties shall delay the Closing until the resolution of the matters described in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;">. The fees and expenses of the Accounting Firm shall be allocated between Parent and the Company in the same proportion that the disputed amount of the Net Cash that was unsuccessfully disputed by such Party (as finally determined by the Accounting Firm) bears to the total disputed amount of the Net Cash and such portion of the costs and expenses of the Accounting Firm borne by Parent and any other fees, costs or expenses incurred by Parent following the Delivery Date in connection with the procedures set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;"> shall be deducted from the final determination of the amount of Net Cash. If this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;"> applies as to the determination of the Final Net Cash described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;">, upon resolution of the matter in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;">, the Parties shall not be required to determine the Net Cash again even though the Closing Date may occur later than the Anticipated Closing Date, except that either Party may require a re-determination of Final Net Cash if the Closing Date is more than ten calendar days after the Anticipated Closing Date. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;2.&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.11(m)</font><font style="letter-spacing:0.2pt;">, except as set forth in the written disclosure schedule delivered by the Company to Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Disclosure Schedule</font><font style="letter-spacing:0.2pt;">&#8221;), the Company represents and warrants to Parent and Merger Sub as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware and has all necessary corporate power and authority: (i)&#160;to conduct its business in the manner in which its business is currently being conducted; (ii)&#160;to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii)&#160;to perform its obligations under all material Contracts by which it is bound. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company is duly licensed and qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business requires such licensing or qualification other than in jurisdictions where the failure to be so qualified would not have a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company has no Subsidiaries, except for the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule; and neither the Company nor any of the Company&#8217;s Subsidiaries owns any capital stock of, or any equity, ownership or profit sharing interest of any nature in, or controls, directly or indirectly, any other Entity other than the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. Each of the Company&#8217;s Subsidiaries is a corporation or other legal Entity duly incorporated or otherwise organized, validly existing and, if applicable, in good standing under the Laws of the jurisdiction of its incorporation or organization, as applicable, and has all necessary corporate or similar power and authority to conduct its business in the manner in which its business is currently being conducted and to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used, except where the failure to have such power or authority would not have a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is or has otherwise been a party to, or a member of, any partnership, joint venture or similar business Entity. Neither the Company nor any of its Subsidiaries has agreed or is obligated to make, or is bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any other Entity. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2DTC">&#8203;</a><a name="t2BNO">&#8203;</a><a name="t2RTA">&#8203;</a><a name="t2CST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Neither the Company nor any of its Subsidiaries has, at any time, been a general partner of, or has otherwise been liable for, any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company has made available to Parent accurate and complete copies of the Organizational Documents of the Company and each of its Subsidiaries&#8217; in effect as of the date of this Agreement. Neither the Company nor any of its Subsidiaries is in material breach or violation of its respective Organizational Documents. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and, subject to receipt of the Required Company Stockholder Vote, to consummate the Contemplated Transactions. The Company Board (at a meeting or meetings duly called and held and at which all members were present) has unanimously (i)&#160;determined that the Contemplated Transactions are fair to, advisable and in the best interests of, the Company and its stockholders, (ii)&#160;authorized, approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to approve the Company Stockholder Matters. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;This Agreement has been duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by Parent and Merger Sub, constitutes the valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The affirmative vote (or written consent) of (i)&#160;the holders of a majority of the Company Capital Stock, voting together as a single class, (ii)&#160;the holders of at least two-thirds of the Company Series&#160;A Preferred Stock, Company Special Voting Preferred Stock, Company Series&#160;B Preferred Stock and Company Series&#160;B Special Voting Preferred Stock, voting together as a single class, (iii)&#160;the holders of a majority of the Company Series&#160;A Preferred Stock and Company Special Voting Preferred Stock, voting together as a single class, and (iv)&#160;the holders of at least two-thirds of the Company Series&#160;B Preferred Stock and Company Series&#160;B Special Voting Preferred Stock, voting together as a single class, in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;G</font><font style="letter-spacing:0.2pt;"> (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Written Consent</font><font style="letter-spacing:0.2pt;">&#8221; and such vote thereon, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Required Company Stockholder Vote</font><font style="letter-spacing:0.2pt;">&#8221;), is the only vote (or written consent) of the holders of any class or series of Company Capital Stock necessary to adopt and approve the Company Stockholder Matters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to obtaining the Required Company Stockholder Vote, the filing of the Certificate of Merger with the Secretary of State of the State of Delaware required by the DGCL and clearance of the Merger under any applicable Antitrust Laws, neither (x)&#160;the execution, delivery or performance of this Agreement by the Company, nor (y)&#160;the consummation by the Company of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation of any of the provisions of the Company&#8217;s Organizational Documents; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of, or, to the Knowledge of the Company, give any Governmental Body or other Person the right to successfully challenge the Contemplated Transactions or to successfully exercise any material remedy or obtain any material relief under, any Law or any order, writ, injunction, judgment or decree to which the Company or its Subsidiaries, or any of the assets owned or used by the Company or its Subsidiaries, is subject, except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by the Company or its Subsidiaries, except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any Company Material Contract, or give any Person the right to: (i)&#160;declare a default or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t26C">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">exercise any remedy under any Company Material Contract; (ii)&#160;any material payment, rebate, chargeback, penalty or change in delivery schedule under any Company Material Contract; (iii)&#160;accelerate the maturity or performance of any Company Material Contract; or (iv)&#160;cancel, terminate or modify any term of any Company Material Contract, except in each case under this clause (d), as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;result in the imposition or creation of any material Encumbrance upon or with respect to any material asset owned or used by the Company or its Subsidiaries (except for Permitted Encumbrances). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except for (i)&#160;any Consent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.5</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, (ii)&#160;the Required Company Stockholder Vote, (iii)&#160;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL and the clearance of the Merger under any applicable Antitrust Laws, and (iv)&#160;such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities Laws or, if not given or obtained, as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, or would not reasonably be expected to prevent or materially delay beyond the End Date the ability of the Company to consummate the Contemplated Transactions, neither the Company nor any of its Subsidiaries is or will be required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (A)&#160;the execution, delivery or performance by the Company of this Agreement, or (B)&#160;the consummation by the Company of the Contemplated Transactions. None of the Company nor any of its &#8220;affiliates&#8221; or &#8220;associates&#8221; directly or indirectly &#8220;owns,&#8221; beneficially or otherwise, and at all times during the three-year period prior to the date of this Agreement, none of its &#8220;affiliates&#8221; or &#8220;associates&#8221; directly or indirectly has &#8220;owned,&#8221; beneficially or otherwise, any of the outstanding Parent Common Stock, as those terms are defined in Section&#160;203 of the DGCL. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The authorized Company Capital Stock as of the date of this Agreement consists of (i)&#160;14,910,158 shares of Company Common Stock, par value $0.0001 per share, of which 1,085,436 shares have been issued and are outstanding as of the date of this Agreement, and (ii)&#160;10,946,061 shares of Company Preferred Stock, par value $0.0001 per share, of which (a)&#160;6,138,518 shares have been designated as Company Series&#160;A Preferred Stock, of which 5,201,017 shares are issued and outstanding as of the date of this Agreement, (b)&#160;1 share has been designated as Company Special Voting Preferred Stock, of which 1 share is issued and outstanding as of the date of this Agreement, (c)&#160;4,807,541 shares have been designated as Company Series&#160;B Preferred Stock, of which 3,499,866 shares are issued and outstanding as of the date of this Agreement and (d)&#160;1 share has been designated as Company Series&#160;B Special Voting Preferred Stock, of which 1 share is issued and outstanding as of the date of this Agreement. As of the date of this Agreement, the Company does not hold any shares of its capital stock in treasury. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule lists, as of the date of this Agreement (x)&#160;each record holder of issued and outstanding Company Capital Stock and the number and type of shares of Company Capital Stock held by such holder and (y)(A) the holder of the issued and outstanding convertible promissory note into Company Capital Stock (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Convertible Note</font><font style="letter-spacing:0.2pt;">&#8221;), (B)&#160;the date the Company Convertible Note was issued, (C)&#160;the type of securities subject to the Company Convertible Note, (D)&#160;the underlying principal amount and accrued interest of the Company Convertible Note, and (E)&#160;the maturity date of the Company Convertible Note. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All of the outstanding shares of Company Capital Stock have been duly authorized and validly issued, and are fully paid and nonassessable. None of the outstanding shares of Company Capital Stock are entitled or subject to any preemptive right, right of participation, right of maintenance or any similar right and none of the outstanding shares of Company Capital Stock are subject to any right of first refusal in favor of the Company, in each case under any Company Contract. Except as contemplated herein, there is no Company Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of Company Capital Stock. The Company is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Company Capital Stock or other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t27ST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">securities. None of the outstanding shares of Company Capital Stock held by current or former Company employees or other service providers are subject to any repurchase or forfeiture rights held by the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Except for the Company Plan (and awards granted thereunder), the Company does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person. As of the date of this Agreement, the Company has reserved 2,664,018 shares of Company Common Stock for issuance under the Company Plan, of which 45,436 shares have been issued and are currently outstanding, 1,900,829 shares have been reserved for issuance upon the exercise of Company Options previously granted and are currently outstanding under the Company Plan, and 717,753 shares of Company Common Stock remain available for future issuance pursuant to the Company Plan. Only shares of Company Common Stock are subject to Company Options. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule sets forth the following information with respect to each Company Option outstanding as of the date of this Agreement: (i)&#160;the name of the optionee; (ii)&#160;the number of shares of Company Common Stock subject to such Company Option at the time of grant; (iii)&#160;the number of shares of Company Common Stock subject to such Company Option as of the date of this Agreement; (iv)&#160;the exercise price of such Company Option; (v)&#160;the date on which such Company Option was granted; (vi)&#160;the applicable vesting schedule, including the number of vested and unvested shares as of the date of this Agreement and any acceleration provisions; (vii)&#160;the date on which such Company Option expires; and (viii)&#160;whether such Company Option is intended to constitute an &#8220;incentive stock option&#8221; &#8203;(as defined in the Code) or a non-qualified stock option. The Company has made available to Parent accurate and complete copies of the Company Plan and all forms of stock option and other award agreements evidencing outstanding options granted thereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Except for the Company Convertible Note and the Company Options set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, there is no: (i)&#160;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other securities of the Company or any of its Subsidiaries; or (ii)&#160;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of the Company or any of its Subsidiaries. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to the Company or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All outstanding shares of Company Capital Stock, Company Options, the Company Convertible Note, and other securities of the Company have been issued and granted in material compliance with (i)&#160;the Organizational Documents of the Company in effect as of the relevant time and all applicable securities Laws and other applicable Law, and (ii)&#160;all requirements set forth in applicable Contracts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Financial Statements</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company has made available to Parent true and complete copies of (i)&#160;the Company&#8217;s audited consolidated balance sheets at December&#160;31, 2021 and 2020, together with related audited consolidated statements of income, stockholders&#8217; equity and cash flows, and notes thereto, for the fiscal&#160;years then ended and (ii)&#160;the Company Unaudited Interim Balance Sheet, together with the unaudited consolidated statements of income, stockholders&#8217; equity and cash flows of the Company for the six-month period ended on the date of the Company Unaudited Interim Balance Sheet (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221;). The Company Financial Statements were prepared in accordance with GAAP (except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments that are not reasonably expected to be material) and fairly present, in all material respects, the financial position and operating results of the Company and its consolidated Subsidiaries as of the dates and for the periods indicated therein. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each of the Company and its Subsidiaries maintains a system of internal accounting controls designed to provide reasonable assurance that: (i)&#160;transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii)&#160;transactions are recorded as necessary to permit preparation of the financial statements of the Company and its Subsidiaries in accordance with GAAP </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2OCA">&#8203;</a><a name="t2OUL">&#8203;</a><a name="t2TAE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and to maintain accountability of the Company&#8217;s and its Subsidiaries&#8217; assets; (iii)&#160;access to the Company&#8217;s and its Subsidiaries&#8217; assets is permitted only in accordance with management&#8217;s general or specific authorization; (iv)&#160;the recorded accountability for the Company&#8217;s and its Subsidiaries&#8217; assets is compared with the existing assets at regular intervals and appropriate action is taken with respect to any differences; and (v)&#160;accounts, notes and other receivables are recorded accurately, and proper and adequate procedures are implemented to effect the collection thereof on a current and timely basis. The Company and each of its Subsidiaries maintains internal control over financial reporting that provides reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.7(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule lists, and the Company has made available to Parent accurate and complete copies of the documentation creating or governing, all securitization transactions and &#8220;off-balance sheet arrangements&#8221; &#8203;(as discussed in Item&#160;303 of Regulation&#160;S-K under the Exchange Act) effected by the Company or any of its Subsidiaries since January&#160;1, 2019. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there have been no formal internal investigations regarding financial reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer or general counsel of the Company, the Company Board or any committee thereof. As of the date of this Agreement, the Company nor its independent auditors have identified (i)&#160;any significant deficiency or material weakness in the design or operation of the system of internal accounting controls utilized by the Company and its Subsidiaries, (ii)&#160;any fraud, whether or not material, that involves the Company, any of its Subsidiaries, the Company&#8217;s management or other employees who have a role in the preparation of financial statements or the internal accounting controls utilized by the Company and its Subsidiaries or (iii)&#160;any claim or allegation regarding any of the foregoing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Company Financial Statements will be suitable for inclusion in the Registration Statement and prepared in accordance with GAAP as applied on a consistent basis during the periods involved (except in each case as described in the notes thereto) and on that basis will present fairly, in all material respects, the financial position and the results of operations, changes in stockholders&#8217; equity, and cash flows of the Company as of the dates of and for the periods referred to in the Company Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(a)&#160;Between the date of the Company Unaudited Interim Balance Sheet and the date of this Agreement, (i)&#160;the Company has conducted its business only in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto) and (ii)&#160;the Company has not taken any action that would have required the consent of Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(b)</font><font style="letter-spacing:0.2pt;"> had such action taken place after the execution and delivery of this Agreement; and (b)&#160;since the date of the Company Unaudited Interim Balance Sheet, there has not been any Company Material Adverse Effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has any liability, indebtedness, obligation or expense of any kind, whether accrued, absolute, contingent, matured or unmatured (whether or not required to be reflected in the financial statements in accordance with GAAP) (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Liability</font><font style="letter-spacing:0.2pt;">&#8221;), except for: (a)&#160;Liabilities disclosed, reflected or reserved against in the Company Unaudited Interim Balance Sheet; (b)&#160;Liabilities that have been incurred by the Company or its Subsidiaries since the date of the Company Unaudited Interim Balance Sheet in the Ordinary Course of Business; (c)&#160;Liabilities for performance of obligations of the Company or any of its Subsidiaries under Company Contracts (other than those arising as a result of a breach or default thereunder or as a result of failure to comply with applicable Law); (d)&#160;Liabilities for payment of fees and expenses incurred in connection with the Contemplated Transactions; (e)&#160;Liabilities which would not, individually or in the aggregate, reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; and (f)&#160;Liabilities described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.9</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each of the Company and its Subsidiaries owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or purported to be owned by it, in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2PLN">&#8203;</a><a name="t21PR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">each case that are material to the Company and its Subsidiaries, taken as a whole, including: (a)&#160;all such tangible assets reflected on the Company Unaudited Interim Balance Sheet; and (b)&#160;all other such tangible assets reflected in the books and records of the Company or any of its Subsidiaries as being owned by the Company or such Subsidiary. All of such assets are owned or, in the case of leased assets, leased by the Company or any of its Subsidiaries free and clear of any Encumbrances, other than Permitted Encumbrances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries owns or has ever owned any real property. The Company has made available to Parent (a)&#160;an accurate and complete list of all real properties with respect to which the Company directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the possession of, or occupied or leased by the Company or any of its Subsidiaries, and (b)&#160;copies of all leases under which any such real property is possessed, occupied or leased (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Real Estate Leases</font><font style="letter-spacing:0.2pt;">&#8221;), each of which is in full force and effect, with no existing material default by the Company or any Subsidiary thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule identifies, as of the date of this Agreement, each item of material Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries and that is the subject of a registration or application in any jurisdiction (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Registered IP</font><font style="letter-spacing:0.2pt;">&#8221;), including, with respect to each such patent and patent application: (i)&#160;the name of the applicant/registrant; (ii)&#160;the jurisdiction of application/registration; (iii)&#160;the application or registration number; and (iv)&#160;any other co-owners. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(a)(2)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule identifies, as of the date of this Agreement, each license agreement under which the Company or its Subsidiaries exclusively license material Company IP from a third party. To the Knowledge of the Company, each of the patents and patent applications included in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule properly identifies by name each and every inventor of the inventions claimed therein as determined in accordance with applicable Laws of the United States. To the Knowledge of the Company, as of the date of this Agreement, no cancellation, interference, opposition, reissue, reexamination or other proceeding of any nature (other than office actions or similar communications issued by any Governmental Body in the ordinary course of prosecution of any pending applications for registration) is pending or threatened in writing, in which the scope, validity, enforceability or ownership of any Company IP, other than such items with pending applications, is being or has been contested or challenged. To the Knowledge of the Company, each item of issued Company Registered IP is valid, enforceable and subsisting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except as would not have a Company Material Adverse Effect, the Company and its Subsidiaries collectively exclusively own, are the sole assignees of, or have exclusively licensed all material Company IP, free and clear of all Encumbrances other than Permitted Encumbrances (other than as disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule). The Company IP and the Intellectual Property Rights licensed to the Company pursuant to a valid, enforceable written agreement constitute all Intellectual Property Rights used in, material to and otherwise necessary for the operation of the Company&#8217;s business as currently conducted. Each Company Associate involved in the creation or development of any material Company IP, pursuant to such Company Associate&#8217;s activities on behalf of the Company or its Subsidiaries, has signed a valid and enforceable written agreement containing an assignment of such Company Associate&#8217;s rights in such Company IP to the Company or its applicable Subsidiary. Each Company Associate who has or has had access to the Company&#8217;s trade secrets or confidential information has signed a valid and enforceable written agreement containing confidentiality provisions protecting the Company IP, trade secrets and confidential information. The Company and its Subsidiaries have taken commercially reasonable steps to protect and preserve the confidentiality of its trade secrets and confidential information. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, no funding, facilities or personnel of any Governmental Body or any university, college, research institute or other educational institution has been used to create material Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries, except for any such funding or use of facilities or personnel that does not result in such Governmental Body or institution obtaining ownership rights or a license to such Company IP (excluding confirmatory licenses to inventions made with government funding and for which the Company, its </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subsidiaries or either of their licensors has duly retained title under the Bayh-Dole Act) or the right to receive royalties for the practice of such Company IP. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(d)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule sets forth, as of the date of this Agreement, each license agreement pursuant to which the Company (i)&#160;is granted a license under any material Intellectual Property Right owned by any third party that is used by the Company or its Subsidiaries in its business as currently conducted (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company In-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) or (ii)&#160;grants to any third party a license under any material Company IP or material Intellectual Property Right licensed to the Company or its Subsidiaries under a Company In-bound License (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Out-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) (</font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, Company In-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, agreements with Company Associates, services agreements, commercially available Software-as-a-Service offerings or off-the-shelf software licenses; and Company Out-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, services agreements, or non-exclusive outbound licenses). All Company In-bound Licenses and Company Out-bound Licenses are in full force and effect and are valid, enforceable and binding obligations of the Company or the applicable Subsidiary and, to the Knowledge of Company, each other party to such Company In-bound Licenses or Company Out-bound Licenses. Neither the Company or any of its Subsidiaries, nor to the Knowledge of the Company, any other party to such Company In-bound Licenses or Company Out-bound Licenses, is in material breach under any Company In-bound Licenses or Company Out-bound Licenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;To the Knowledge of the Company: (i)&#160;the operation of the businesses of the Company and its Subsidiaries as currently conducted does not infringe, misappropriate or otherwise violate any Intellectual Property Rights of any other Person; and (ii)&#160;no other Person is infringing, misappropriating or otherwise violating any Company IP. As of the date of this Agreement, no Legal Proceeding is pending (or, to the Knowledge of the Company, is threatened in writing) (A)&#160;against the Company or its Subsidiaries alleging that the operation of the businesses of the Company or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Rights of another Person or (B)&#160;by the Company or its Subsidiaries alleging that another Person has infringed, misappropriated or otherwise violated any of the Company IP or any Intellectual Property Rights exclusively licensed to the Company or its Subsidiaries. Between January&#160;1, 2019 and the date of this Agreement, neither the Company nor its Subsidiaries has received any written notice or other written communication alleging that the operation of the business of the Company or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Right of another Person. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;None of the Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries and, to the Knowledge of the Company, no material Intellectual Property Rights exclusively licensed to the Company or its Subsidiaries is subject to any pending or outstanding injunction, directive, order, judgment or other disposition of dispute that adversely and materially restricts the use, transfer, registration or licensing by the Company or its Subsidiaries of any such Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries or material Intellectual Property Rights exclusively licensed to the Company or its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, the Company, its Subsidiaries and the operation of the Company&#8217;s and its Subsidiaries&#8217; business are in substantial compliance with all Laws pertaining to data privacy and data security of any personally identifiable information or sensitive business information (collectively, &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sensitive Data</font><font style="letter-spacing:0.2pt;">&#8221;). Between January&#160;1, 2019 and the date of this Agreement, there have been (i)&#160;no losses or thefts of data or security breaches relating to Sensitive Data used in the business of the Company or its Subsidiaries, (ii)&#160;no material violations of any security policy of the Company regarding any such Sensitive Data used in the business of the Company or its Subsidiaries and (iii)&#160;no unauthorized access, unauthorized use or unintended or improper disclosure of any Sensitive Data used in the business of the Company or its Subsidiaries, except in each case as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole. The Company has taken commercially reasonable steps and implemented reasonable disaster recovery and security plans and procedures to protect the information technology systems used in, material to and necessary for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2CAC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">operation of the Company&#8217;s business as currently conducted from unauthorized use or access. To the Knowledge of the Company, as of the date of this Agreement, there have been no material malfunctions or unauthorized intrusions or breaches of the information technology systems used in, material to and necessary for the operation of the Company&#8217;s business as currently conducted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.13(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule lists the following Company Contracts in effect as of the date of this Agreement and under which the Company or any of its Subsidiaries has any remaining material rights or obligations (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Material Contract</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Material Contracts</font><font style="letter-spacing:0.2pt;">&#8221;): </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;each Company Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;each Company Contract containing (A)&#160;any covenant limiting the freedom of the Company, its Subsidiaries or the Surviving Corporation to engage in any line of business or compete with any Person, (B)&#160;any most-favored pricing arrangement, (C)&#160;any exclusivity provision, or (D)&#160;any non-solicitation provision, in each case, except for restrictions that would not materially affect the ability of the Company and its Subsidiaries to conduct its business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;each Company Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess of $250,000 pursuant to its express terms and not cancelable without penalty; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;each Company Contract relating to the disposition or acquisition of material assets or any ownership interest in any Entity, in each case, involving payments in excess of $250,000, other than Company Contracts in which the applicable acquisition or disposition has been consummated and there are no material ongoing liabilities or obligations; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;each Company Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements or instruments relating to the borrowing of money or extension of credit in excess of $250,000 or creating any material Encumbrances with respect to any assets of the Company or any of its Subsidiaries or any loans or debt obligations with officers or directors of the Company; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;each Company Contract requiring payment by or to the Company or its Subsidiaries after the date of this Agreement in excess of $250,000 pursuant to its express terms and constituting: (A)&#160;an exclusive distribution agreement; (B)&#160;an agreement involving provision of material services or products with respect to any pre-clinical or clinical development activities of the Company or its Subsidiaries; (C)&#160;a dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or similar agreement currently in force under which the Company or its Subsidiaries has continuing obligations to develop or market any product, technology or service, or an agreement pursuant to which the Company or its Subsidiaries has continuing obligations to develop any Intellectual Property Rights that will not be owned, in whole or in part, by the Company or its Subsidiaries; or (D)&#160;a Contract to license any patent, trademark registration, service mark registration, trade name or copyright registration to or from any third party relating to the manufacture or production of any product, service or technology of the Company or its Subsidiaries or any Contract to sell, distribute or commercialize any products or service of the Company or its Subsidiaries, in each case under clauses (A)&#160;through (D), except for Company Contracts that are entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;each Company Contract with any financial advisor, broker, finder, investment banker or other similar Person, providing advisory services to the Company in connection with the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;each Company Real Estate Lease; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;each Company Contract that would be a material contract as defined in Item&#160;601(b)(10) of Regulation&#160;S-K as promulgated under the Securities Act if the Company were subject to such regulation; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2PR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;each Company Out-bound License and Company In-bound License, and each Company Contract containing a covenant not to sue or otherwise enforce any Intellectual Property Rights; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;each Company Contract containing any royalty, dividend or similar arrangement based on the revenues or profits of the Company or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;each (A)&#160;Company Contract, offer letter, employment agreement or other agreement with any employee that requires payment of base salary and target annual cash bonus in excess of $150,000 in any calendar year that (1)&#160;provides for employment by the Company or any of its Subsidiaries and is not immediately terminable at will by the Company without advance notice, severance, or other similar cost or liability (other than for accrued compensation, vacation or other amounts due upon any termination) or (2)&#160;provides for retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event) and (B)&#160;each Company Contract, independent contractor agreement, or other agreement with any individual consultant or service provider requiring payment of fees in excess of $150,000 in any calendar year that (1)&#160;is not immediately terminable at will by the Company without more than 30&#160;days&#8217; prior notice, severance, or other cost or liability or (2)&#160;provides for retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;each Company Contract under which a third party would be entitled to receive a license or have any other rights in, any material Company IP; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;each Company Contract entered into in settlement of any Legal Proceeding or other dispute; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;any other Company Contract that is not terminable at will (with no penalty or payment) by the Company or its Subsidiaries, as applicable, and (A)&#160;which involves payment or receipt by the Company or its Subsidiaries after the date of this Agreement under any such agreement, Contract or commitment of more than $250,000 in the aggregate, or obligations after the date of this Agreement in excess of $250,000 in the aggregate, or (B)&#160;that is material to the business or operations of the Company and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company has made available to Parent accurate and complete copies of all Company Material Contracts, including all amendments thereto, in each case in effect on the date of this Agreement. There are no Company Material Contracts that are not in written form. Neither the Company nor any of its Subsidiaries has, nor to the Company&#8217;s Knowledge, as of the date of this Agreement, has any other party to a Company Material Contract, breached, violated or defaulted under, or as of the date of this Agreement received notice that it breached, violated or defaulted under, any of the terms or conditions of any Company Material Contract in such manner as would permit any other party to cancel or terminate any such Company Material Contract, or would permit any other party to seek damages which would have a Company Material Adverse Effect. As to the Company and its Subsidiaries, as of the date of this Agreement, each Company Material Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. As of the date of this Agreement, no Person is renegotiating, or has a right pursuant to the terms of any Company Material Contract to change, any material amount paid or payable to the Company under any Company Material Contract or any other material term or provision of any Company Material Contract, and, as of the date of the Agreement, no Person has indicated in writing to the Company that it desires to renegotiate, modify, not renew or cancel any Company Material Contract. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.14&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits; Restrictions</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in compliance in all material respects with all applicable Laws, including the Federal Food, Drug and Cosmetic Act and regulations issued thereunder by the United States Food and Drug Administration (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">FDA</font><font style="letter-spacing:0.2pt;">&#8221;) (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">FDCA</font><font style="letter-spacing:0.2pt;">&#8221;), the Public Health Service Act and its implementing regulations (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">PHSA</font><font style="letter-spacing:0.2pt;">&#8221;) and any other similar Law administered or promulgated by the FDA or other comparable Governmental Body responsible for regulation of the research, development, pre-clinical and clinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">testing, manufacturing, storage, supply, approval, sale, marketing, distribution and importation or exportation of drug and biological products (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Drug Regulatory Agency</font><font style="letter-spacing:0.2pt;">&#8221;), except for any noncompliance, either individually or in the aggregate, which would not be material to the Company and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, no investigation, claim, suit, proceeding, audit or other action by any Governmental Body is pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries. There is no judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries which (i)&#160;has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any acquisition of material property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently conducted, (ii)&#160;is reasonably likely to have an adverse effect on the Company&#8217;s ability to comply with or perform any covenant or obligation under this Agreement, or (iii)&#160;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries hold all required Governmental Authorizations to develop, test manufacture, store, label, package, distribute, import and export the respective current products or product candidates that are material to the operation of the business of the Company and its Subsidiaries as currently conducted (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Permits</font><font style="letter-spacing:0.2pt;">&#8221;). </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.14(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule identifies each Company Permit. Each such Company Permit is valid and in full force and effect, and each of the Company and its Subsidiaries is in material compliance with the terms of the Company Permits. As of the date of this Agreement, no Legal Proceeding is pending or, to the Knowledge of the Company, threatened, which seeks to revoke, limit, suspend, or materially modify any Company Permit. The rights and benefits of each Company Permit will be available to the Surviving Corporation or its Subsidiaries, as applicable, immediately after the Effective Time on terms substantially identical to those enjoyed by the Company and its Subsidiaries as of the date of this Agreement and immediately prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there has not been and is not now any Form FDA-483 observation, civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, or proceeding pending or in effect against the Company or its Subsidiaries or any of their respective officers and employees, and the Company has no liability for failure to comply with the FDCA, PHSA, or other similar Laws. There is no act, omission, event, or circumstance of which the Company has Knowledge that would reasonably be expected to give rise to or form the basis for any civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, proceeding or request for information or any liability (whether actual or contingent) for failure to comply with the FDCA, PHSA or other similar Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All clinical, pre-clinical and other studies and tests conducted by or on behalf of, or sponsored by, the Company or its Subsidiaries, or of their respective current products or product candidates, were and, if still pending, are being conducted in all material respects with applicable regulations of any applicable Drug Regulatory Agency and other applicable Law, including the Good Clinical Practice (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">GCP</font><font style="letter-spacing:0.2pt;">&#8221;) regulations under 21 C.F.R. Parts 50, 54, 56 and 312 and Good Laboratory Practice (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">GLP</font><font style="letter-spacing:0.2pt;">&#8221;) regulations under 21 C.F.R. Part&#160;58. No preclinical study or clinical trial conducted by or on behalf of the Company or any of its Subsidiaries has been terminated or suspended prior to completion for safety or non-compliance reasons. Between January&#160;1, 2019 and the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written notices, correspondence, or other written communications from any Drug Regulatory Agency requiring, or to the Knowledge of the Company, threatening to initiate, the termination or suspension of any clinical studies conducted by or on behalf of, or sponsored by, the Company or any of its Subsidiaries or of their respective current products or product candidates. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, neither the Company nor any of its Subsidiaries is the subject of any pending or, to the Knowledge of the Company, threatened investigation in respect of its business or products or product candidates pursuant to the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy set forth in 56 Fed. Reg. 46191 (September&#160;10, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2PO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1991). To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has committed any acts, made any statement, or failed to make any statement, in each case in respect of its business or products that would violate the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither the Company nor its Subsidiaries, nor any of their respective officers, directors, employees or, to the Knowledge of the Company, agents has been, is, or is in anticipation of being (based on a conviction by the courts or a finding of fault by a regulatory authority): (a)&#160;debarred pursuant to the Generic Drug Enforcement Act of 1992 (21 U.S.C. &#167;&#160;335a), as amended from time to time; (b)&#160;disqualified from participating in clinical trials pursuant to 21 C.F.R. &#167;312.70, as amended from time to time; (c)&#160;disqualified as a testing facility under 21 C.F.R. Part&#160;58, Subpart K, as amended from time to time; (d)&#160;excluded, debarred or suspended from or otherwise ineligible to participate in a &#8220;Federal Health Care Program&#8221; as that term is defined in 42 U.S.C. 1320a-7b(f), including under 42 U.S.C. &#167;&#160;1320a-7 or relevant regulations in 42 C.F.R. Part&#160;1001; (e)&#160;assessed or threatened with assessment of civil money penalties pursuant to 42 C.F.R. Part&#160;1003; or (f)&#160;included on the HHS/OIG List of Excluded Individuals/Entities, the General Services Administration&#8217;s System for Award Management, or the FDA Debarment List or the FDA Disqualified/Restricted List. Neither the Company nor its Subsidiaries, nor any of their respective officers, directors, employees or, to the Knowledge of the Company, agents has engaged in any activities that are prohibited, or are cause for civil penalties, or grounds for mandatory or permissive exclusion, debarment, or suspension pursuant to any of these authorities. Neither the Company nor its Subsidiaries are using, or have ever used, in any capacity any Person that has ever been, or to the Knowledge of Company, is the subject of a proceeding that could lead to the Persons becoming debarred, excluded, disqualified, restricted or suspended pursuant to any of these authorities. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries have materially complied with all applicable Laws relating to patient, medical or individual health information, including the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations promulgated thereunder, all as amended from time to time (collectively &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">HIPAA</font><font style="letter-spacing:0.2pt;">&#8221;), including the standards for the privacy of Individually Identifiable Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the standards for the protection of Electronic Protected Health Information set forth at 45 C.F.R. Part&#160;160 and 45 C.F.R. Part&#160;164, Subpart A and Subpart C, the standards for transactions and code sets used in electronic transactions at 45 C.F.R. Part&#160;160, Subpart A and Part&#160;162, and the standards for Breach Notification for Unsecured Protected Health Information at 45 C.F.R. Part&#160;164, Subpart D, all as amended from time to time. The Company and its Subsidiaries have entered into, where required, and are in compliance in all material respects with the terms of all Business Associate (as defined in HIPAA) agreements (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Associate Agreements</font><font style="letter-spacing:0.2pt;">&#8221;) to which the Company or any Subsidiary is a party or otherwise bound. The Company and its Subsidiaries where required, have (i)&#160;created and maintained written policies and procedures to protect the privacy of Protected Health Information in its possession or control, (ii)&#160;provided training to all employees and agents, and (iii)&#160;implemented security procedures, including physical, technical and administrative safeguards, to protect all Protected Health Information stored or transmitted in electronic form. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written notice from the Office for Civil Rights for the U.S. Department of Health and Human Services or any other Governmental Body alleging a failure to comply with HIPAA or any other federal or state law or regulation applicable to the protection of individually identifiable health information or personally identifiable information. To the Knowledge of the Company, as of the date of this Agreement, there has been no Breach of Unsecured Protected Health Information, unpermitted disclosure of Personal Health Information, or breach of personally identifiable information with respect to information maintained or transmitted to the Company or any of its Subsidiaries that would require notice to a Governmental Body. All capitalized terms in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.14(h)</font><font style="letter-spacing:0.2pt;"> not otherwise defined in this Agreement shall have the meanings set forth under HIPAA. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.15&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there is no material pending Legal Proceeding and, to the Knowledge of the Company, no Person has threatened in writing to commence any Legal Proceeding: (i)&#160;that involves (A)&#160;the Company, (B)&#160;any of its Subsidiaries, (C)&#160;any Company Associate (in his or her </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t21MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">capacity as such) or (D)&#160;any of the material assets owned or used by the Company or any of its Subsidiaries; or (ii)&#160;that challenges, or that would have the effect of preventing, delaying beyond the End Date, or making illegal, the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;There is no order, writ, injunction, judgment or decree to which the Company or any of its Subsidiaries is a party or any of the material assets owned or used by the Company or any of its Subsidiaries is subject. To the Knowledge of the Company, no officer or other Key Employee of the Company or any of its Subsidiaries is subject to any order, writ, injunction, judgment or decree that prohibits such officer or employee from engaging in or continuing any conduct, activity or practice relating to the business of the Company or any of its Subsidiaries or to any material assets owned or used by the Company or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.16&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries has timely filed all income Tax Returns and other material Tax Returns that they were required to file under applicable Law. All such Tax Returns are correct and complete in all material respects and have been prepared in material compliance with all applicable Law. No written claim has ever been made by any Governmental Body in any jurisdiction where the Company or any of its Subsidiaries does not file a particular Tax Return or pay a particular Tax that the Company or such Subsidiary is subject to taxation by that jurisdiction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All income and other material Taxes due and owing by the Company or any of its Subsidiaries (whether or not shown on any Tax Return) have been fully paid. The unpaid Taxes of the Company and its Subsidiaries did not, as of the date of the Company Unaudited Interim Balance Sheet, materially exceed the reserve for Tax liability (excluding any reserve for deferred Taxes established to reflect timing differences between book and Tax items) set forth on the face of the Company Unaudited Interim Balance Sheet. Since the date of the Company Unaudited Interim Balance Sheet, neither the Company nor any of its Subsidiaries has incurred any material Liability for Taxes outside the Ordinary Course of Business. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;All Taxes that the Company or any of its Subsidiaries are or were required by Law to withhold or collect from payments to employees, independent contractors, stockholders, lenders, customers or other third parties have been duly and timely withheld or collected in all material respects and, have been timely paid to the proper Governmental Body or properly set aside in accounts for this purpose. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;There are no Encumbrances for material Taxes (other than Permitted Encumbrances) upon any of the assets of the Company or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;No deficiencies for income or other material Taxes with respect to the Company or any of its Subsidiaries have been claimed, proposed or assessed by any Governmental Body in writing other than any deficiency that has been resolved. There are no pending or ongoing, and to the Knowledge of the Company, threatened audits, assessments or other actions for or relating to any liability in respect of a material amount of Taxes of the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries (or any of their predecessors) has waived any statute of limitations in respect of any income or other material Taxes or agreed to any extension of time with respect to any income or other material Tax assessment or deficiency, which waiver is still in effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has, since January&#160;1, 2019, distributed stock of another Person, or had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section&#160;355 of the Code or Section&#160;361 of the Code (or any similar provisions of state, local or foreign Law). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has participated in or been a party to a transaction that, as of the date of this Agreement, constitutes a &#8220;listed transaction&#8221; that is required to be reported to the IRS pursuant to Section&#160;6011 of the Code and applicable Treasury Regulations thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2ALM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has taken or agreed to take any action or knows of any fact or circumstance that would reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is a party to any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement, or similar agreement or arrangement, other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result of any: (i)&#160;change in method of accounting for Tax purposes filed on or prior to the Closing Date; (ii)&#160;use of an improper method of accounting for a Tax period ending on or prior to the Closing Date; (iii)&#160;&#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any similar provision of state, local or foreign Law) executed on or prior to the Closing Date; (iv)&#160;intercompany transaction or excess loss account described in Treasury Regulations under Section&#160;1502 of the Code (or any similar provision of state, local or foreign Law) as a result of a transaction on or prior to the Closing Date; (v)&#160;installment sale or open transaction disposition made on or prior to the Closing Date; or (vi)&#160;prepaid amount received outside of the Ordinary Course of Business on or prior to the Closing Date. The Company has not made any election under Section&#160;965(h) of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has ever been (i)&#160;a member of a consolidated, combined or unitary Tax group (other than such a group the common parent of which is the Company) or (ii)&#160;a party to any joint venture, partnership, or other arrangement that is treated as a partnership for U.S. federal income Tax purposes. Neither the Company nor any of its Subsidiaries has any Liability for any Taxes of any Person (other than the Company and any of its Subsidiaries) under Treasury Regulations&#160;Section&#160;1.1502-6 (or any similar provision of state, local, or foreign Law), or as a transferee or successor. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries (i)&#160;is a &#8220;controlled foreign corporation&#8221; as defined in Section&#160;957 of the Code; (ii)&#160;is a &#8220;passive foreign investment company&#8221; within the meaning of Section&#160;1297 of the Code; (iii)&#160;has ever had a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise had an office or fixed place of business in a country other than the country in which it is organized; or (iv)&#160;is or was a &#8220;surrogate foreign corporation&#8221; within the meaning of Section&#160;7874(a)(2)(B) or is treated as a U.S. corporation under Section&#160;7874(b) of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.17&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.17(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule is a list as of the date of this Agreement of all Company Benefit Plans, including each Company Benefit Plan that provides for retirement, change in control, stay or retention, deferred compensation, incentive compensation, severance or retiree medical or life insurance benefits. &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Benefit Plan</font><font style="letter-spacing:0.2pt;">&#8221; means each (i)&#160;&#8220;employee benefit plan&#8221; as defined in Section&#160;3(3) of ERISA (whether or not ERISA governs such plan) and (ii)&#160;other pension, retirement, deferred compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based (other than individual Company Options made pursuant to the Company&#8217;s standard forms, in which case only representative standard forms of such stock option agreements shall be scheduled), phantom equity, employment (other than individual employment agreements made pursuant to the Company&#8217;s standard forms, in which case only representative standard forms of such employment agreements shall be scheduled), offer letter (other than individual offer letters made pursuant to the Company&#8217;s standard forms, in which case only representative standard forms of such offers shall be scheduled), consulting, severance, change-of-control, retention, health, life, disability, group insurance, paid-time off, holiday, welfare and fringe benefit plan, program, agreement, Contract, or arrangement (whether written or unwritten, qualified or nonqualified, funded or unfunded and including any that have been frozen or terminated but only if the Company has continuing liabilities with respect thereto), in any case, maintained, contributed to, or required to be contributed to, by the Company or any of its Subsidiaries or Company ERISA Affiliates for the benefit of any current or former employee, director, officer or independent contractor of the Company or any of its Subsidiaries or under which </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the Company or any of its Subsidiaries has any Liability (including as the result of its being treated as a single employer under Code Section&#160;414 with any other person). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As applicable with respect to each Company Benefit Plan, the Company has made available to Parent, true and complete copies of (i)&#160;each Company Benefit Plan, including all amendments thereto, and in the case of an unwritten Company Benefit Plan, a written description thereof, (ii)&#160;all current trust documents, investment management Contracts, custodial agreements, administrative services agreements and insurance and annuity Contracts relating thereto, (iii)&#160;the current summary plan description and each summary of material modifications thereto, (iv)&#160;the most recently filed annual reports with any Governmental Body (e.g., Form 5500 and all schedules thereto), (v)&#160;the most recent IRS determination, opinion or advisory letter, (vi)&#160;the most recent summary annual reports, nondiscrimination testing reports, actuarial reports, financial statements and trustee reports, (vii)&#160;all material records, notices and filings concerning IRS or Department of Labor or other Governmental Body audits or investigations, and (viii)&#160;any written reports constituting a valuation of the Company Common Stock for purposes of Section&#160;409A of the Code, whether prepared internally by the Company or by an outside, third-party valuation firm. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Company Benefit Plan has been maintained, operated and administered in compliance in all material respects with its terms and any related documents or agreements and the applicable provisions of ERISA, the Code and all other Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Company Benefit Plans that are &#8220;employee pension benefit plans&#8221; within the meaning of Section&#160;3(2) of ERISA and which are intended to meet the qualification requirements of Section&#160;401(a) of the Code have received determination, opinion, or advisory letters from the IRS to the effect that such plans are qualified under Section&#160;401(a) of the Code and the related trusts are exempt from federal income Taxes under Section&#160;501(a) of the Code, respectively, and to the Knowledge of the Company, nothing has occurred that would reasonably be expected to adversely affect the qualification of such Company Benefit Plan or the tax exempt status of the related trust. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Since January&#160;1, 2016, neither the Company nor any of its Subsidiaries maintained, contributed to, been required to contribute to, or had any liability with respect to, (i)&#160;any &#8220;employee pension benefit plan&#8221; &#8203;(within the meaning of Section&#160;3(2) of ERISA) that is subject to Title IV or Section&#160;302 of ERISA or Section&#160;412 of the Code, (ii)&#160;any &#8220;multiemployer plan&#8221; &#8203;(within the meaning of Section&#160;3(37) of ERISA), (iii)&#160;any &#8220;multiple employer plan&#8221; &#8203;(within the meaning of Section&#160;413 of the Code) or (iv)&#160;any &#8220;multiple employer welfare arrangement&#8221; &#8203;(within the meaning of Section&#160;3(40) of ERISA). No Company Benefit Plan is sponsored by a professional employer organization. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there are no (i)&#160;pending audits or investigations by any Governmental Body involving any Company Benefit Plan, and (ii)&#160;pending or, to the Knowledge of the Company, threatened claims (except for individual claims for benefits payable in the normal operation of the Company Benefit Plans), suits or proceedings involving any Company Benefit Plan, any fiduciary thereof or service provider thereto. All contributions and premium payments required to have been made under any of the Company Benefit Plans or by applicable Law (without regard to any waivers granted under Section&#160;412 of the Code), have been timely made in all material respects and neither the Company nor any Company ERISA Affiliate has any material liability for any unpaid contributions with respect to any Company Benefit Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither the Company, any of its Subsidiaries nor any Company ERISA Affiliates, nor to the Knowledge of the Company, any fiduciary, trustee or administrator of any Company Benefit Plan, has engaged in, or in connection with the Contemplated Transactions will engage in, any transaction with respect to any Company Benefit Plan which would subject any such Company Benefit Plan, the Company or any of its Subsidiaries or Parent to a material Tax, material penalty or material liability for a &#8220;prohibited transaction&#8221; under Section&#160;406 of ERISA or Section&#160;4975 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;No Company Benefit Plan provides death, medical, dental, vision, life insurance or other welfare benefits beyond termination of service or retirement other than coverage mandated by Law and fully paid by the participant (except in connection with severance), and neither the Company nor any of its Subsidiaries or Company ERISA Affiliates has made a written or oral representation promising the same. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions will either alone or in connection with any other event(s) (i)&#160;result in any payment becoming due to any current or former employee, director, officer, or independent contractor of the Company or any of its Subsidiaries, (ii)&#160;increase any amount of compensation or benefits otherwise payable under any Company Benefit Plan, (iii)&#160;result in the acceleration of the time of payment, funding or vesting of any benefits under any Company Benefit Plan, (iv)&#160;require any contribution or payment to fund any obligation under any Company Benefit Plan or (v)&#160;limit the right to merge, amend or terminate any Company Benefit Plan that is subject to ERISA. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions (either alone or when combined with the occurrence of any other event, including without limitation, a termination of employment) will result in the receipt or retention by any Person who is a &#8220;disqualified individual&#8221; &#8203;(within the meaning of Code Section&#160;280G) with respect to the Company and its Subsidiaries of any payment or benefit under any Company Benefit Plan that is or could reasonably be expected to be characterized as a &#8220;parachute payment&#8221; &#8203;(within the meaning of Code Section&#160;280G). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;The exercise price of each Company Option granted to a U.S. taxpayer is not and never has been less than the fair market value of one share of Company Common Stock, as determined by the Company Board, as of the grant date of such Company Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Each Company Benefit Plan providing for deferred compensation that constitutes a &#8220;nonqualified deferred compensation plan&#8221; &#8203;(as defined in Section&#160;409A(d)(1) of the Code and the regulations promulgated thereunder) is, and has been, established, administered and maintained in material compliance with the requirements of Section&#160;409A of the Code and the regulations promulgated thereunder in all material respects. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;No current or former employee, officer, director or independent contractor of the Company or any of its Subsidiaries has any &#8220;gross up&#8221; agreements with the Company or any of its Subsidiaries or other assurance of reimbursement by the Company or any of its Subsidiaries for any Taxes imposed under Code Section&#160;409A or Code Section&#160;4999. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;No Company Benefit Plan is maintained outside of the United States. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has ever been a party to, bound by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees, and there is no labor union, labor organization, or similar Person representing or, to the Knowledge of the Company, purporting to represent or seeking to represent any employees of the Company or its Subsidiaries, including through the filing of a petition for representation election. There is not and has not been in the past three&#160;years, nor is there or has there been in the past three&#160;years any threat of, any strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, or any similar activity or dispute, or, to the Knowledge of the Company, any union organizing activity, against the Company or any of its Subsidiaries. No event has occurred, and no condition or circumstance exists, that might directly or indirectly be likely to give rise to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, any similar activity or dispute, or, to the Knowledge of the Company, any union organizing activity. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in material compliance with all applicable Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification, discrimination, harassment and retaliation, equal employment opportunities, fair employment practices, meal and rest periods, immigration, employee safety and health, payment of wages (including overtime wages), unemployment and workers&#8217; compensation, leaves of absence, and hours of work. Except as would not be reasonably likely to result in a material liability to the Company or any of its Subsidiaries, with respect to employees of the Company and its Subsidiaries, each of the Company and its Subsidiaries, since January&#160;1, 2019: (i)&#160;has withheld and reported all amounts required by Law or by agreement to be withheld and reported with respect to wages, salaries and other payments, benefits, or compensation to employees; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2MSJ">&#8203;</a><a name="t2TCH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&#160;is not liable for any arrears of wages (including overtime wages), severance pay or any Taxes or any penalty for failure to comply with any of the foregoing; and (iii)&#160;is not liable for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Body, with respect to unemployment compensation benefits, disability, social security or other benefits or obligations for employees (other than routine payments to be made in the Ordinary Course of Business). As of the date of this Agreement, there are no Legal Proceedings, claims, or charges pending or, to the Knowledge of the Company, threatened or reasonably anticipated against the Company or its Subsidiaries relating to any employee, applicant for employment, consultant or employment agreement or otherwise relating to labor, employment, employment practices, or terms and conditions of employment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;Except as would not be reasonably likely to result in a material liability to the Company or any of its Subsidiaries, the Company and each of its Subsidiaries has accurately classified each individual service provider as an employee, independent contractor, or otherwise under all applicable Laws and, for each individual classified as an employee, the Company and each of its Subsidiaries has accurately classified him or her as exempt or non-exempt under all applicable Laws. Neither the Company nor any of its Subsidiaries has any material liability with respect to any misclassification of: (a)&#160;any Person as an independent contractor rather than as an employee; (b)&#160;any employee leased from another employer; or (c)&#160;any employee currently or formerly classified as exempt under all applicable Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(r)&nbsp;&nbsp;&nbsp;Within the preceding five&#160;years, the Company has not implemented any &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; of employees that would reasonably be expected to require notification under the WARN Act or any similar state, local or foreign Law, and no such &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; will be implemented before the Closing Date without advance notification to and approval of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.18&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Since January&#160;1, 2019, the Company and each of its Subsidiaries have complied with all applicable Environmental Laws, which compliance includes the possession by the Company of all permits and other Governmental Authorizations required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in such compliance that would not have a Company Material Adverse Effect. Neither the Company nor any of its Subsidiaries has received between January&#160;1, 2019 and the date of this Agreement any written notice, whether from a Governmental Body or other Person, that alleges that the Company or any of its Subsidiaries is not in compliance with any Environmental Law and, to the Knowledge of the Company, there are no circumstances that would reasonably be expected to prevent or interfere with the Company&#8217;s or any of its Subsidiaries&#8217; compliance in any material respects with any Environmental Law, except where such failure to comply would not have a Company Material Adverse Effect. To the Knowledge of the Company, (i)&#160;no current or prior owner of any property leased or controlled by the Company or any of its Subsidiaries has received, between January&#160;1, 2019 and the date of this Agreement, any written notice relating to property owned or leased at any time by the Company or any of its Subsidiaries, whether from a Governmental Body or other Person, that alleges that such current or prior owner or the Company or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to such property and (ii)&#160;neither the Company nor any of its Subsidiaries has any material liability under any Environmental Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.19&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Insurance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company has made available to Parent accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of the Company and each of its Subsidiaries. Each of such insurance policies is in full force and effect and the Company and each of its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, between January&#160;1, 2019 and the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written notice regarding any actual or possible: (a)&#160;cancellation or invalidation of any insurance policy; or (b)&#160;refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy. The Company and each of its Subsidiaries has provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding that is currently pending against the Company or any of its Subsidiaries for which the Company or such Subsidiary has insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed the Company or any of its Subsidiaries of its intent to do so. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2FAN">&#8203;</a><a name="t2WAS">&#8203;</a><a name="t2NOT">&#8203;</a><a name="t2OOR">&#8203;</a><a name="tS3AW">&#8203;</a><a name="t3OS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.20&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No broker, finder or investment banker is entitled to any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.21</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule describes any material transactions or relationships, between January&#160;1, 2019 and the date of this Agreement, between, on one hand, the Company or any of its Subsidiaries and, on the other hand, any (A)&#160;executive officer or director of the Company or, to the Knowledge of the Company, any of its Subsidiaries or any of such executive officer&#8217;s or director&#8217;s immediate family members, (B)&#160;owner of more than 5% of the voting power of the outstanding Company Capital Stock or (C)&#160;to the Knowledge of the Company, any &#8220;related person&#8221; &#8203;(within the meaning of Item&#160;404 of Regulation&#160;S-K under the Securities Act) of any such officer, director or owner (other than the Company or its Subsidiaries) in the case of each of (A), (B)&#160;or (C)&#160;that is of the type that would be required to be disclosed under Item&#160;404 of Regulation&#160;S-K under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.22&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;None of the Company or any of its Subsidiaries or any of their respective directors, officers, employees or, to the Company&#8217;s Knowledge, agents or any other Person acting on their behalf has, directly or indirectly, made any bribes, rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form of cash, gifts, or otherwise, or taken any other action, in violation of the Foreign Corrupt Practices Act of 1977, or any other applicable anti-bribery or anti-corruption Law (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery Laws</font><font style="letter-spacing:0.2pt;">&#8221;). To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has been the subject of any investigation or inquiry by any Governmental Body with respect to potential violations of Anti-Bribery Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.23&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company acknowledges and agrees that, except for the representations and warranties contained in this Agreement, neither Parent nor any of its Subsidiaries nor any other person on behalf of Parent or its Subsidiaries make any express or implied representation or warranty with respect to Parent or its Subsidiaries or with respect to any other information provided by the Company, any of the Company&#8217;s Subsidiaries or stockholder or any of their respective Affiliates in connection with the Contemplated Transactions, and (subject to the express representation and warranties of Parent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3</font><font style="letter-spacing:0.2pt;"> (in each case qualified and limited by the Parent Disclosure Schedule)), neither the Company, its Subsidiaries nor any of their respective Representatives or stockholders, has relied on such information including the accuracy or completeness thereof. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;3.&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.11(m)</font><font style="letter-spacing:0.2pt;">, except (a)&#160;as set forth in the written disclosure schedule delivered by Parent to the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Disclosure Schedule</font><font style="letter-spacing:0.2pt;">&#8221;) or (b)&#160;as disclosed in the Parent SEC Documents filed with the SEC prior to the date hereof and publicly available on the SEC&#8217;s Electronic Data Gathering Analysis and Retrieval system (but (i)&#160;without giving effect to any amendment thereof filed with, or furnished to the SEC on or after the date hereof and (ii)&#160;excluding any disclosures contained under the heading &#8220;Risk Factors&#8221; and any disclosure of risks included in any &#8220;forward-looking statements&#8221; disclaimer or in any other section to the extent they are forward-looking statements or cautionary, predictive or forward-looking in nature), it being understood and agreed that any matter disclosed in the Parent SEC Documents (x)&#160;shall not be deemed disclosed for purposes of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.5</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;"> and (y)&#160;shall be deemed to be disclosed in a section of the Parent Disclosure Schedule only to the extent to which its relevance is readily apparent from a reading of such Parent SEC Documents, Parent and Merger Sub represent and warrant to the Company as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware, and has all necessary corporate power and authority: (i)&#160;to conduct its business in the manner in which its business is currently being conducted; (ii)&#160;to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii)&#160;to perform its obligations under all material Contracts by which it is bound. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent is duly licensed and qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3DPH">&#8203;</a><a name="t3BNO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">requires such licensing or qualification other than in jurisdictions where the failure to be so qualified would not have a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Other than Merger Sub, Parent has no Subsidiaries, except for the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule; and neither Parent nor any of Parent&#8217;s Subsidiaries owns any capital stock of, or any equity, ownership or profit sharing interest of any nature in, or controls, directly or indirectly, any other Entity other than the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule. Each of Parent&#8217;s Subsidiaries identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule is a corporation or other legal Entity duly incorporated or otherwise organized, validly existing and, if applicable, in good standing under the Laws of the jurisdiction of its incorporation or organization, as applicable, and has all necessary corporate or similar power and authority to conduct its business in the manner in which its business is currently being conducted and to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used, except where the failure to have such power or authority would not have a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Merger Sub is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware. Merger Sub was formed solely for the purpose of engaging in the Contemplated Transactions. All of the issued and outstanding capital stock of Merger Sub, which consists of 100 shares of common stock, $0.0001 par value, is validly issued, fully paid and non-assessable and is owned, beneficially and of record, by Parent, free and clear of any Encumbrances with respect thereto. Except for obligations and liabilities incurred in connection with its incorporation and the Contemplated Transactions, Merger Sub has not, and will not have, incurred, directly or indirectly, any obligations or liabilities or engaged in any business activities or conducted any operations of any type or kind whatsoever or entered into any agreements or arrangements with any Person. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is or has otherwise been a party to, or a member of, any partnership, joint venture or similar business Entity. Neither Parent nor any of its Subsidiaries has agreed or is obligated to make, or is bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any other Entity. Neither Parent nor any of its Subsidiaries has, at any time, been a general partner of, or has otherwise been liable for, any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent has made available to the Company accurate and complete copies of Parent&#8217;s and each of its Subsidiaries Organizational Documents in effect as of the date of this Agreement. Neither Parent nor any of its Subsidiaries is in material breach or violation of its respective Organizational Documents. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Parent Board (at a meeting or meetings duly called and held and at which all members were present) has unanimously: (i)&#160;determined that the Contemplated Transactions are fair to, advisable and in the best interests of Parent and its stockholders; (ii)&#160;authorized, approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of Parent Common Stock to the stockholders of the Company pursuant to the terms of this Agreement; and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Parent vote to approve the Parent Stockholder Matters. The Merger Sub Board (by unanimous written consent) has: (A)&#160;determined that the Contemplated Transactions are fair to, advisable, and in the best interests of Merger Sub and its sole stockholder; (B)&#160;authorized, approved and declared advisable this Agreement and the Contemplated Transactions; and (C)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions. Parent, in its capacity as the sole stockholder of Merger Sub, has by written consent duly approved votes adopting this Agreement and approving the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;This Agreement has been duly executed and delivered by each of Parent and Merger Sub and, assuming the due authorization, execution and delivery by the Company, constitutes the valid and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3RAT">&#8203;</a><a name="t3CST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">binding obligation of Parent and Merger Sub, enforceable against each of Parent and Merger Sub in accordance with its terms, subject to the Enforceability Exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(a)&#160;The affirmative vote of the holders of a majority of the outstanding shares of Parent Common Stock entitled to vote on the record date for the Parent Stockholders&#8217; Meeting is the only vote of the holders of any class or series of Parent&#8217;s capital stock necessary to approve the Nasdaq Reverse Split and (b)&#160;the affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Parent Common Stock present or represented by proxy at the Parent Stockholders&#8217; Meeting and entitled to vote thereon is the only vote of the holders of any class or series of Parent&#8217;s capital stock necessary to approve all other Parent Stockholder Matters (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Required Parent Stockholder Vote</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to obtaining the Required Parent Stockholder Vote, the filing of the Certificate of Merger with the Secretary of State of the State of Delaware required by the DGCL and clearance of the Merger under any applicable Antitrust Laws, neither (x)&#160;the execution, delivery or performance of this Agreement by Parent or Merger Sub, nor (y)&#160;the consummation by Parent and Merger Sub of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation of any of the provisions of the Organizational Documents of Parent or Merger Sub; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of, or, to the Knowledge of Parent, give any Governmental Body or other Person the right to successfully challenge the Contemplated Transactions or to successfully exercise any material remedy or obtain any material relief under, any Law or any order, writ, injunction, judgment or decree to which Parent or its Subsidiaries, or any of the assets owned or used by Parent or its Subsidiaries, is subject, except as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by Parent or its Subsidiaries, except as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any Parent Material Contract, or give any Person the right to: (i)&#160;declare a default or exercise any remedy under any Parent Material Contract; (ii)&#160;any material payment or payments, rebate, chargeback, penalty or change in delivery schedule under any Parent Material Contract; (iii)&#160;accelerate the maturity or performance of any Parent Material Contract; or (iv)&#160;cancel, terminate or modify any term of any Parent Material Contract, except in the case under this clause (d)&#160;as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;result in the imposition or creation of any material Encumbrance upon or with respect to any material asset owned or used by Parent or its Subsidiaries (except for Permitted Encumbrances). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except for (i)&#160;any Consent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.5</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, (ii)&#160;the Required Parent Stockholder Vote, (iii)&#160;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL and the clearance of the Merger under any applicable Antitrust Laws; and (iv)&#160;such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities Laws or, if not given or obtained, as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole, or would not reasonably be expected to prevent or materially delay beyond the End Date the ability of Parent or the Merger Sub to consummate the Contemplated Transactions, neither Parent nor any of its Subsidiaries is or will be required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (A)&#160;the execution, delivery or performance by Parent and the Merger Sub of this Agreement, or (B)&#160;the consummation of the Contemplated Transactions. Assuming the accuracy of the representations and warranties of the Company in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.5</font><font style="letter-spacing:0.2pt;">, the Parent Board and the Merger Sub Board have taken and will take all actions necessary to ensure that the restrictions applicable to business combinations contained in Section&#160;203 of the DGCL are, and will be, inapplicable to the execution, delivery and performance of this Agreement and the Parent Stockholder Support Agreements, and to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t36C">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">consummation of the Contemplated Transactions. No other state Takeover Statute or similar Law applies or purports to apply to the Merger, this Agreement, the Parent Stockholder Support Agreements or any of the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The authorized capital stock of Parent as of the date of this Agreement consists of (i)&#160;400,000,000 shares of Parent Common Stock, par value $0.001 per share, of which 201,701,853 shares have been issued and are outstanding as of the date of this Agreement, and (ii)&#160;5,000,000 shares of preferred stock of Parent, par value $0.001 per share, of which no shares have been issued and are outstanding as of the date of this Agreement. As of the date of this Agreement, Parent does not hold any shares of its capital stock in its treasury. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All of the outstanding shares of Parent Common Stock have been duly authorized and validly issued, and are fully paid and nonassessable. None of the outstanding shares of Parent Common Stock are entitled or subject to any preemptive right, right of participation, right of maintenance or any similar right and none of the outstanding shares of Parent Common Stock are subject to any right of first refusal in favor of Parent, in each case under any Parent Contract. Except as contemplated herein, there is no Parent Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of Parent Common Stock. Parent is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Parent Common Stock or other securities. There are outstanding Parent Warrants to purchase 198,535 shares of Parent Common Stock. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(b)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule accurately and completely lists all repurchase or forfeiture rights held by Parent with respect to shares of Parent Common Stock (including shares issued pursuant to the exercise of stock options) and specifies which of those repurchase rights are currently exercisable and, to the Knowledge of Parent, whether the holder of such shares of Parent Common Stock timely filed an election with the IRS under Section&#160;83(b) of the Code with respect to such shares. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Except for the Parent Stock Plans (and awards granted thereunder) and as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, Parent does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person. As of the date of this Agreement, 13,133,660 shares of Parent Common Stock have been reserved for issuance upon the exercise of Parent Options granted under the Parent Stock Plan that are outstanding as of the date of this Agreement, 3,068,594 shares of Parent Common Stock have been reserved for issuance upon the exercise of Parent Options granted outside of the Parent Stock Plans that are outstanding as of the date of this Agreement, 5,750,166 shares of Parent Common Stock have been reserved for issuance upon the settlement of Parent RSUs granted under the Parent Stock Plans that are outstanding as of the date of this Agreement, 0 shares of Parent Common Stock have been reserved for issuance upon the settlement of Parent RSUs granted outside of the Parent Stock Plans that are outstanding as of the date of this Agreement, 2,300,000 shares of Parent Common Stock have been reserved for issuance under the Parent ESPP, and 3,724,762 shares remain available for future issuance pursuant to the Parent Stock Plans. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule sets forth the following information with respect to each Parent Option and Parent RSU outstanding as of the date of this Agreement: (i)&#160;the name of the holder; (ii)&#160;the number of shares of Parent Common Stock subject to such Parent Option or Parent RSU at the time of grant; (iii)&#160;the number of shares of Parent Common Stock subject to such Parent Option or Parent RSU as of the date of this Agreement; (iv)&#160;the exercise price of such Parent Option; (v)&#160;the date on which such Parent Option or Parent RSU was granted; (vi)&#160;the applicable vesting schedule, including the number of vested and unvested shares as of the date of this Agreement and any acceleration provisions; (vii)&#160;the date on which such Parent Option expires; and (viii)&#160;whether such Parent Option is intended to constitute an &#8220;incentive stock option&#8221; &#8203;(as defined in the Code) or a non-qualified stock option. Parent has made available to the Company accurate and complete copies of the Parent Stock Plans and all forms of the stock option and other award agreements evidencing outstanding awards granted thereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Except for the Parent Warrants, the Parent Options and the Parent RSUs, there is no: (i)&#160;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3FFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">acquire any shares of the capital stock or other securities of Parent or any of its Subsidiaries; or (ii)&#160;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of Parent or any of its Subsidiaries. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All outstanding shares of Parent Common Stock, Parent Options, Parent Warrants, Parent RSUs and other securities of Parent have been issued and granted in material compliance with (i)&#160;the Organizational Documents of Parent in effect as of the relevant time and all applicable securities Laws and other applicable Law, and (ii)&#160;all requirements set forth in applicable Contracts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">SEC Filings; Financial Statements</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent has filed or furnished, as applicable, on a timely basis all forms, statements, certifications, reports and other documents required to be filed or furnished by Parent with the SEC under the Exchange Act or the Securities Act since January&#160;1, 2019 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent SEC Documents</font><font style="letter-spacing:0.2pt;">&#8221;). As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), each of the Parent SEC Documents complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be) and, as of the time they were filed, or if amended or superseded by a filing prior to the date of this Agreement, on the date of the last such amendment or superseding filing prior to the date of this Agreement, none of the Parent SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The certifications and statements required by (i)&#160;Rule&#160;13a-14 or Rule&#160;15d-14(a) under the Exchange Act and (ii)&#160;18 U.S.C. &#167;1350 (Section&#160;906 of the Sarbanes-Oxley Act) relating to the Parent SEC Documents (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Certifications</font><font style="letter-spacing:0.2pt;">&#8221;) are accurate and complete and comply as to form and content with all applicable Laws. Parent meets the registration requirements for the use of Form S-3 under the Securities Act. As used in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.7</font><font style="letter-spacing:0.2pt;">, the term &#8220;file&#8221; and variations thereof shall be broadly construed to include any manner in which a document or information is filed, furnished, supplied or otherwise made available to the SEC. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The financial statements (including any related notes) contained or incorporated by reference in the Parent SEC Documents: (i)&#160;complied as to form in all material respects with the published rules and regulations of the SEC applicable thereto; (ii)&#160;were prepared in accordance with GAAP (except as may be indicated in the notes to such financial statements or, in the case of unaudited financial statements, except as permitted by Form 10-Q of the SEC, and except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments) applied on a consistent basis unless otherwise noted therein throughout the periods indicated; and (iii)&#160;fairly present, in all material respects, the financial position of Parent as of the respective dates thereof and the results of operations and cash flows of Parent for the periods covered thereby. Other than as expressly disclosed in the Parent SEC Documents filed prior to the date hereof or have been permitted or required by any regulatory authority, there has been no material change in Parent&#8217;s accounting methods or principles that would be required to be disclosed in Parent&#8217;s financial statements in accordance with GAAP. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Parent SEC Documents fairly presents the information called for in all material respects and has been prepared in accordance with the SEC&#8217;s rules and guidelines applicable thereto. The books of accounts and other financial records of Parent and each of its Subsidiaries are true and complete in all material respects. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent&#8217;s independent registered accounting firm has at all times since its first date of service to Parent been: (i)&#160;a registered public accounting firm (as defined in Section&#160;2(a)(12) of the Sarbanes-Oxley Act); (ii)&#160;to the Knowledge of Parent, &#8220;independent&#8221; with respect to Parent within the meaning of Regulation&#160;S-X under the Exchange Act; and (iii)&#160;to the Knowledge of Parent, in compliance with subsections (g)&#160;through (l)&#160;of Section&#160;10A of the Exchange Act and the rules and regulations promulgated by the SEC and the Public Company Accounting Oversight Board thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Except as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.7(d)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, Parent has not received any comment letter from the SEC or the staff thereof or any correspondence from officials of Nasdaq or the staff thereof relating to the delisting or maintenance of listing of the Parent Common Stock on Nasdaq that has not been resolved, and Parent has made available to Company all such comments or correspondence (written or oral) with the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Between January&#160;1, 2019 and the date of this Agreement, there have been no formal investigations regarding financial reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer, principal accounting officer or general counsel of Parent, the Parent Board or any committee thereof, other than ordinary course audits or reviews of accounting policies and practices or internal controls required by the Sarbanes-Oxley Act. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Parent is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act and the applicable listing and other rules and regulations of Nasdaq and, except as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.7(f)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, has not received any notice from Nasdaq asserting any noncompliance with such rules and regulations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Parent maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that is sufficient to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance (i)&#160;that Parent maintains records that in reasonable detail accurately and fairly reflect Parent&#8217;s transactions and dispositions of assets, (ii)&#160;that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (iii)&#160;that receipts and expenditures are made only in accordance with authorizations of management and the Parent Board, (iv)&#160;regarding prevention or timely detection of the unauthorized acquisition, use or disposition of Parent&#8217;s assets that could have a material effect on Parent&#8217;s financial statements, and (v)&#160;interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Parent SEC Documents fairly presents the SEC&#8217;s rules and guidelines applicable thereto. Parent has evaluated the effectiveness of Parent&#8217;s internal control over financial reporting and, to the extent required by applicable Law, presented in any applicable Parent SEC Document that is a report on Form 10-K or Form 10-Q (or any amendment thereto) its conclusions about the effectiveness of the internal control over financial reporting as of the end of the period covered by such report or amendment based on such evaluation. Parent has disclosed to Parent&#8217;s auditors and audit committee (and made available to the Company a summary of the significant aspects of such disclosure) (A)&#160;all significant deficiencies and material weaknesses, if any, in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect Parent&#8217;s ability to record, process, summarize and report financial information and (B)&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in Parent&#8217;s or its Subsidiaries&#8217; internal control over financial reporting. Parent has not identified any material weaknesses in the design or operation of Parent&#8217;s internal control over financial reporting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent maintains &#8220;disclosure controls and procedures&#8221; &#8203;(as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) that are reasonably designed to ensure that all information (both financial and non-financial) required to be disclosed by Parent in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods required by the SEC, and that all such information is accumulated and communicated to Parent&#8217;s management as appropriate to allow timely decisions regarding required disclosure and to make the Certifications. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Between January&#160;1, 2019 and the date of this Agreement, (i)&#160;Parent has not received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of Parent&#8217;s internal accounting controls relating to periods after January&#160;1, 2019, including any material complaint, allegation, assertion or claim that Parent has engaged in questionable accounting or auditing practices (except for any of the foregoing after the date of this Agreement which have no reasonable basis), and (ii)&#160;no attorney representing Parent, whether or not employed by Parent, has </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3OCA">&#8203;</a><a name="t3OUL">&#8203;</a><a name="t3TAE">&#8203;</a><a name="t3PLN">&#8203;</a><a name="t31PR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">reported evidence of a material violation of securities Laws, breach of fiduciary duty or similar violation, relating to periods after January&#160;1, 2019, by Parent or agents to the Parent Board or any committee thereof or, to the Knowledge of Parent, to any director or officer of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(a)&#160;Between the date of the Parent Balance Sheet and the date of this Agreement, (i)&#160;Parent has conducted its business only in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto) and (ii)&#160;Parent has not taken any action that would have required the consent of the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1(b)</font><font style="letter-spacing:0.2pt;"> had such action taken place after the execution and delivery of this Agreement; and (b)&#160;since the date of the Parent Balance Sheet, there has not been any Parent Material Adverse Effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has any Liability, except for: (a)&#160;Liabilities disclosed, reflected or reserved against in the Parent Balance Sheet; (b)&#160;Liabilities that have been incurred by Parent or its Subsidiaries since the date of the Parent Balance Sheet in the Ordinary Course of Business; (c)&#160;Liabilities for performance of obligations of Parent or any of its Subsidiaries under Parent Contracts (other than those arising as a result of a breach or default thereunder or as a result of failure to comply with applicable Law); (d)&#160;Liabilities for payment of fees and expenses incurred in connection with the Contemplated Transactions; (e)&#160;Liabilities which would not, individually or in the aggregate, reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; and (f)&#160;Liabilities described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.9</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each of Parent and its Subsidiaries owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or purported to be owned by it, in each case, that are material to Parent and its Subsidiaries, taken as a whole, including: (a)&#160;all such tangible assets reflected on the Parent Balance Sheet; and (b)&#160;all other such tangible assets reflected in the books and records of Parent or any of its Subsidiaries as being owned by Parent or such Subsidiary. All of such assets are owned or, in the case of leased assets, leased by Parent or any of its Subsidiaries free and clear of any Encumbrances, other than Permitted Encumbrances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries owns or has ever owned any real property. Parent has made available to the Company (a)&#160;an accurate and complete list of all real properties with respect to which Parent directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the possession of, or occupied or leased by Parent or any of its Subsidiaries, and (b)&#160;copies of all leases under which any such real property is possessed, occupied or leased (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Real Estate Leases</font><font style="letter-spacing:0.2pt;">&#8221;), each of which is in full force and effect, with no existing material default by Parent or any Subsidiary thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule identifies, as of the date of this Agreement, each item of material Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries and that is the subject of a registration or application in any jurisdiction (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Registered IP</font><font style="letter-spacing:0.2pt;">&#8221;), including, with respect to each such patent and patent application: (i)&#160;the name of the applicant/registrant; (ii)&#160;the jurisdiction of application/registration; (iii)&#160;the application or registration number; and (iv)&#160;any other co-owners. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(a)(2)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule identifies, as of the date of this Agreement, each license agreement under which Parent or its Subsidiaries exclusively licenses material Parent IP from a third party. To the Knowledge of Parent, each of the patents and patent applications included in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule properly identifies by name each and every inventor of the inventions claimed therein as determined in accordance with applicable Laws of the United States. To the Knowledge of Parent, as of the date of this Agreement, no cancellation, interference, opposition, reissue, reexamination or other proceeding of any nature (other than office actions or similar communications issued by any Governmental Body in the ordinary course of prosecution of any pending applications for registration) is pending or threatened in writing, in which the scope, validity, enforceability or ownership of any Parent IP, other than such items with pending applications, is being or has been contested or challenged. To the Knowledge of Parent, each item of issued Parent Registered IP is valid and enforceable and subsisting. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except as would not have a Parent Material Adverse Effect, Parent and its Subsidiaries collectively exclusively own, are the sole assignees of, or have exclusively licensed all material Parent IP, free and clear of all Encumbrances other than Permitted Encumbrances (other than as disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(b)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule). The Parent IP and the Intellectual Property Rights licensed to Parent pursuant to a valid, enforceable written agreement constitute all Intellectual Property Rights used in, material to and otherwise necessary for the operation of Parent&#8217;s business as currently conducted. Each Parent Associate involved in the creation or development of any material Parent IP, pursuant to such Parent Associate&#8217;s activities on behalf of Parent or its Subsidiaries, has signed a valid and enforceable written agreement containing an assignment of such Parent Associate&#8217;s rights in such Parent IP to Parent or its applicable Subsidiary. Each Parent Associate who has or has had access to Parent&#8217;s trade secrets or confidential information has signed a valid and enforceable written agreement containing confidentiality provisions protecting the Parent IP, trade secrets and confidential information. Parent and its Subsidiaries have taken commercially reasonable steps to protect and preserve the confidentiality of its trade secrets and confidential information. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;To the Knowledge of Parent, no funding, facilities or personnel of any Governmental Body or any university, college, research institute or other educational institution has been used to create material Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries, except for any such funding or use of facilities or personnel that does not result in such Governmental Body or institution obtaining ownership rights or a license to such Parent IP (excluding confirmatory licenses to inventions made with government funding and for which Parent, its Subsidiaries or either of their licensor has duly retained title under the Bayh-Dole Act) or the right to receive royalties for the practice of such Parent IP. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(d)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule sets forth, as of the date of this Agreement, each license agreement pursuant to which Parent (i)&#160;is granted a license under any material Intellectual Property Right owned by any third party that is used by Parent or its Subsidiaries in its business as currently conducted (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent In-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) or (ii)&#160;grants to any third party a license under any material Parent IP or material Intellectual Property Right licensed to Parent or its Subsidiaries under a Parent In-bound License (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Out-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) (</font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, Parent In-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, agreements with Parent Associates, services agreements, commercially available Software-as-a-Service offerings or off-the-shelf software licenses; and Parent Out-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, services agreements, or non-exclusive outbound licenses). All Parent In-bound Licenses and Parent Out-bound Licenses are in full force and effect and are valid, enforceable and binding obligations of Parent or the applicable Subsidiary and, to the Knowledge of Parent, each other party to such Parent In-bound Licenses or Parent Out-bound Licenses. Neither Parent or any of its Subsidiaries, nor to the Knowledge of Parent, any other party to such Parent In-bound Licenses or Parent Out-bound Licenses, is in material breach under any Parent In-bound Licenses or Parent Out-bound Licenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;To the Knowledge of Parent: (i)&#160;the operation of the businesses of Parent and its Subsidiaries as currently conducted does not infringe, misappropriate or otherwise violate any Intellectual Property Rights of any other Person; and (ii)&#160;no other Person is infringing, misappropriating or otherwise violating any Parent IP. As of the date of this Agreement, no Legal Proceeding is pending (or, to the Knowledge of Parent, is threatened in writing) (A)&#160;against Parent or its Subsidiaries alleging that the operation of the businesses of Parent or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Rights of another Person or (B)&#160;by Parent or its Subsidiaries alleging that another Person has infringed, misappropriated or otherwise violated any of the Parent IP or any Intellectual Property Rights exclusively licensed to Parent or its Subsidiaries. Between January&#160;1, 2019 and the date of this Agreement, neither Parent nor its Subsidiaries has received any written notice or other written communication alleging that the operation of the business of Parent or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Right of another Person. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;None of the Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries and, to the Knowledge of Parent, no material Intellectual Property Rights exclusively </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3CAC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">licensed to Parent or its Subsidiaries is subject to any pending or outstanding injunction, directive, order, judgment or other disposition of dispute that adversely and materially restricts the use, transfer, registration or licensing by Parent or its Subsidiaries of any such Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries or material Intellectual Property Rights exclusively licensed to Parent or its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;To the Knowledge of Parent, Parent, its Subsidiaries and the operation of Parent&#8217;s and its Subsidiaries&#8217; business are in substantial compliance with all Laws pertaining to data privacy and data security of Sensitive Data. Between January&#160;1, 2019 and the date of this Agreement, there have been (i)&#160;no losses or thefts of data or security breaches relating to Sensitive Data used in the business of Parent, (ii)&#160;no material violations of any security policy of Parent regarding any such Sensitive Data used in the business of Parent or its Subsidiaries, (iii)&#160;no unauthorized access, unauthorized use or unintended or improper disclosure of any Sensitive Data used in the business of Parent or its Subsidiaries, except in each case as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole. Parent has taken commercially reasonable steps and implemented reasonable disaster recovery and security plans and procedures to protect the information technology systems used in, material to and necessary for operation of Parent&#8217;s business as currently conducted from unauthorized use or access. To the Knowledge of Parent, as of the date of this Agreement, there have been no material malfunctions or unauthorized intrusions or breaches of the information technology systems used in, material to and necessary for the operation of Parent&#8217;s business as currently conducted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.13(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule lists the following Parent Contracts in effect as of the date of this Agreement and under which Parent or any of its Subsidiaries has any remaining material rights or obligations (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Material Contract</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Material Contracts</font><font style="letter-spacing:0.2pt;">&#8221;): </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;a material Contract as defined in Item&#160;601(b)(10) of Regulation&#160;S-K as promulgated under the Securities Act; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;each Parent Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;each Parent Contract containing (A)&#160;any covenant limiting the freedom of Parent or its Subsidiaries to engage in any line of business or compete with any Person, (B)&#160;any most-favored pricing arrangement, (C)&#160;any exclusivity provision, or (D)&#160;any non-solicitation provision, in each case, except for restrictions that would not materially affect the ability of Parent and its Subsidiaries to conduct its business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;each Parent Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess of $250,000 pursuant to its express terms and not cancelable without penalty; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;each Parent Contract relating to the disposition or acquisition of material assets or any ownership interest in any Entity, in each case, involving payments in excess of $250,000, other than Parent Contracts in which the applicable acquisition or disposition has been consummated and there are no material ongoing liabilities or obligations; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;each Parent Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements or instruments relating to the borrowing of money or extension of credit in excess of $250,000 or creating any material Encumbrances with respect to any assets of Parent or any of its Subsidiaries or any loans or debt obligations with officers or directors of Parent; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;each Parent Contract requiring payment by or to Parent or its Subsidiaries after the date of this Agreement in excess of $250,000 pursuant to its express terms and constituting: (A)&#160;an exclusive distribution agreement; (B)&#160;an agreement involving provision of material services </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or products with respect to any pre-clinical or clinical development activities of Parent or its Subsidiaries; (C)&#160;a dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or similar agreement currently in force under which Parent or its Subsidiaries has continuing obligations to develop or market any product, technology or service, or an agreement pursuant to which Parent or its Subsidiaries has continuing obligations to develop any Intellectual Property Rights that will not be owned, in whole or in part, by Parent or its Subsidiaries; or (D)&#160;a Parent Contract to license any patent, trademark registration, service mark registration, trade name or copyright registration to or from any third party to the manufacture or produce any product, service or technology of Parent or its Subsidiaries or any Parent Contract to sell, distribute or commercialize any products or service of Parent or its Subsidiaries, in each case under clauses (A)&#160;through (D), except for Parent Contracts that are entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;each Parent Contract with any financial advisor, broker, finder, investment banker or other similar Person, providing advisory services to Parent in connection with the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;each Parent Real Estate Lease; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;each Parent Out-bound License and Parent In-bound License, and each Parent Contract containing a covenant not to sue or otherwise enforce any Intellectual Property Rights; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;each Parent Contract containing any royalty, dividend or similar arrangement based on the revenues or profits of Parent or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;each (A)&#160;Parent Contract, offer letter, employment agreement or other agreement with any employee that requires payment of base salary and target annual cash bonus in excess of $150,000 in any calendar year that (1)&#160;provides for employment by Parent or any of its Subsidiaries and is not immediately terminable at will by Parent without advance notice, severance, or other similar cost or liability (other than for accrued compensation, vacation, or other amounts due upon any termination), or (2)&#160;provides for or otherwise relates to any retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event), and (B)&#160;Parent Contract, independent contractor agreement, or other agreement with any individual consultant or service provider requiring payment of fees in excess of $150,000 in any calendar year that (1)&#160;is not immediately terminable at will by the Company without more than 30&#160;days&#8217; prior notice, severance, or other similar cost or liability (other than for any accrued but unpaid fees) or (2)&#160;provides for retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;each Parent Contract under which a third party would be entitled to receive a license or have any other rights in any material Parent IP; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;each Parent Contract entered into in settlement of any Legal Proceeding or other dispute; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;any other Parent Contract that is not terminable at will (with no penalty or payment) by Parent or any of its Subsidiaries, as applicable and (A)&#160;which involves payment or receipt by Parent or its Subsidiaries after the date of this Agreement under any such agreement, Contract or commitment of more than $250,000 in the aggregate, or obligations after the date of this Agreement in excess of $250,000 in the aggregate, or (B)&#160;that is material to the business or operations of Parent and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent has made available to the Company accurate and complete copies of all Parent Material Contracts, including all amendments thereto, in each case in effect on the date of this Agreement. There are no Parent Material Contracts that are not in written form. Neither Parent nor any of its Subsidiaries has, nor, to Parent&#8217;s Knowledge, as of the date of this Agreement, has any other party to a Parent Material Contract, breached, violated or defaulted under, or as of the date of this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t31PE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Agreement received notice that it breached, violated or defaulted under, any of the terms or conditions of any Parent Material Contract in such manner as would permit any other party to cancel or terminate any such Parent Material Contract, or would permit any other party to seek damages which would have a Parent Material Adverse Effect. As to Parent and its Subsidiaries, as of the date of this Agreement, each Parent Material Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. As of the date of this Agreement, no Person is renegotiating, or has a right pursuant to the terms of any Parent Material Contract to change, any material amount paid or payable to Parent under any Parent Material Contract or any other material term or provision of any Parent Material Contract, and, as of the date of this Agreement, no Person has indicated in writing to Parent that it desires to renegotiate, modify, not renew or cancel any Parent Material Contract. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.14&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in compliance in all material respects with all applicable Laws, including the FDCA, PHSA and any other similar Law administered or promulgated by the FDA or other Drug Regulatory Agency, except for any noncompliance, either individually or in the aggregate, which would not be material to Parent and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, no investigation, claim, suit, proceeding, audit or other action by any Governmental Body is pending or, to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries. There is no judgment, injunction, order or decree binding upon Parent or any of its Subsidiaries which (i)&#160;has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of Parent or any of its Subsidiaries, any acquisition of material property by Parent or any of its Subsidiaries or the conduct of business by Parent or any of its Subsidiaries as currently conducted, (ii)&#160;is reasonably likely to have an adverse effect on Parent&#8217;s ability to comply with or perform any covenant or obligation under this Agreement, or (iii)&#160;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent and its Subsidiaries hold all required Governmental Authorizations to develop, test, manufacture, store, label, package, distribute, import and export the respective current products or product candidates that are material to the operation of the business of Parent and its Subsidiaries as currently conducted (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Permits</font><font style="letter-spacing:0.2pt;">&#8221;). </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.14(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule identifies each Parent Permit. Each such Parent Permit is valid and in full force and effect, and each of Parent and its Subsidiaries is in material compliance with the terms of the Parent Permits. As of the date of this Agreement, no Legal Proceeding is pending or, to the Knowledge of Parent, threatened, which seeks to revoke, limit, suspend, or materially modify any Parent Permit. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there has not been and is not now any Form FDA-483 observation, civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, or proceeding pending or in effect against Parent or its Subsidiaries or any of their respective officers and employees, and Parent has no liability for failure to comply with the FDCA, PHSA, or other similar Laws. There is no act, omission, event, or circumstance of which Parent has Knowledge that would reasonably be expected to give rise to or form the basis for any civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, proceeding or request for information or any liability (whether actual or contingent) for failure to comply with the FDCA, PHSA or other similar Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All clinical, pre-clinical and other studies and tests conducted by or on behalf of, or sponsored by, Parent or its Subsidiaries, or of their respective current products or product candidates, were and, if still pending, are being conducted in all material respects with applicable regulations of any applicable Drug Regulatory Agency and other applicable Law, including the GCP regulations under 21 C.F.R. Parts 50, 54, 56 and 312 and GLP regulations under 21 C.F.R. Part&#160;58. No preclinical study or clinical trial conducted by or on behalf of Parent or any of its Subsidiaries has been terminated or suspended prior to completion for safety or non-compliance reasons. Between January&#160;1, 2019 and the date of this Agreement, neither Parent nor any of its Subsidiaries has received any written notices, correspondence, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or other written communications from any Drug Regulatory Agency requiring, or to the Knowledge of Parent, threatening to initiate, the termination or suspension of any clinical studies conducted by or on behalf of, or sponsored by, Parent any of its Subsidiaries or of their respective current products or product candidates. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, neither Parent nor any of its Subsidiaries is the subject of any pending or, to the Knowledge of Parent, threatened investigation in respect of its business or products or product candidates pursuant to the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy set forth in 56 Fed. Reg. 46191 (September&#160;10, 1991). To the Knowledge of Parent, neither Parent nor any of its Subsidiaries has committed any acts, made any statement, or failed to make any statement, in each case in respect of its business or products that would violate the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither Parent nor its Subsidiaries, nor any of their respective officers, directors, or employees has been, is, or is in anticipation of being (based on a conviction by the courts or a finding of fault by a regulatory authority): (a)&#160;debarred pursuant to the Generic Drug Enforcement Act of 1992 (21 U.S.C. &#167;&#160;335a), as amended from time to time; (b)&#160;disqualified from participating in clinical trials pursuant to 21 C.F.R. &#167;312.70, as amended from time to time; (c)&#160;disqualified as a testing facility under 21 C.F.R. Part&#160;58, Subpart K, as amended from time to time; (d)&#160;excluded, debarred or suspended from or otherwise ineligible to participate in a &#8220;Federal Health Care Program&#8221; as that term is defined in 42 U.S.C. 1320a-7b(f), including under 42 U.S.C. &#167;&#160;1320a-7 or relevant regulations in 42 C.F.R. Part&#160;1001; (e)&#160;assessed or threatened with assessment of civil money penalties pursuant to 42 C.F.R. Part&#160;1003; or (f)&#160;included on the HHS/OIG List of Excluded Individuals/Entities, the General Services Administration&#8217;s System for Award Management, or the FDA Debarment List or the FDA Disqualified/</font>&#8203;<font style="letter-spacing:0.2pt;">Restricted List. Neither Parent nor its Subsidiaries, nor any of their respective officers, directors or employees has engaged in any activities that are prohibited, or are cause for civil penalties, or grounds for mandatory or permissive exclusion, debarment, or suspension pursuant to any of these authorities. Neither Parent nor its Subsidiaries are using, or have ever used, in any capacity any Person that has ever been, or to the Knowledge of Parent, is the subject of a proceeding that could lead to the Persons becoming debarred, excluded, disqualified, restricted or suspended pursuant to any of these authorities. </font></div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent and its Subsidiaries have materially complied with all applicable Laws relating to patient, medical or individual health information, including HIPAA and the standards for the privacy of Individually Identifiable Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the standards for the protection of Electronic Protected Health Information set forth at 45 C.F.R. Part&#160;160 and 45 C.F.R. Part&#160;164, Subpart A and Subpart C, the standards for transactions and code sets used in electronic transactions at 45 C.F.R. Part&#160;160, Subpart A and Part&#160;162, and the standards for Breach Notification for Unsecured Protected Health Information at 45 C.F.R. Part&#160;164, Subpart D, all as amended from time to time. Parent and its Subsidiaries have entered into, where required, and are in compliance in all material respects with the terms of all Business Associate Agreements to which Parent or any Subsidiary is a party or otherwise bound. Parent and its Subsidiaries where required, have (i)&#160;created and maintained written policies and procedures to protect the privacy of Protected Health Information in its possession or control, (ii)&#160;provided training to all employees and agents, and (iii)&#160;implemented security procedures, including physical, technical and administrative safeguards, to protect all Protected Health Information stored or transmitted in electronic form. As of the date of this Agreement, neither Parent nor any of its Subsidiaries has received written notice from the Office for Civil Rights for the U.S. Department of Health and Human Services or any other Governmental Body alleging a failure to comply with HIPAA or any other federal or state law or regulation applicable to the protection of individually identifiable health information or personally identifiable information. To the Knowledge of Parent, as of the date of this Agreement, there has been no Breach of Unsecured Protected Health Information, unpermitted disclosure of Personal Health Information, or breach of personally identifiable information with respect to information maintained or transmitted to Parent or any of its Subsidiaries that would require notice to a Governmental Body. All capitalized terms in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.14(h)</font><font style="letter-spacing:0.2pt;"> not otherwise defined in this Agreement shall have the meanings set forth under HIPAA. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3PO">&#8203;</a><a name="t31MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.15&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there is no material pending Legal Proceeding and, to the Knowledge of Parent, no Person has threatened in writing to commence any Legal Proceeding: (i)&#160;that involves (A)&#160;Parent, (B)&#160;any of its Subsidiaries, (C)&#160;any Parent Associate (in his or her capacity as such) or (D)&#160;any of the material assets owned or used by Parent or any of its Subsidiaries; or (ii)&#160;that challenges, or that would have the effect of preventing, delaying beyond the End Date, or making illegal, the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;There is no order, writ, injunction, judgment or decree to which Parent or any of its Subsidiaries is a party or any of the material assets owned or used by Parent or any of its Subsidiaries is subject. To the Knowledge of Parent, no officer or Key Employee of Parent or any of its Subsidiaries is subject to any order, writ, injunction, judgment or decree that prohibits such officer or employee from engaging in or continuing any conduct, activity or practice relating to the business of Parent or any of its Subsidiaries or to any material assets owned or used by Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.16&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries have timely filed all income Tax Returns and other material Tax Returns that they were required to file under applicable Law. All such Tax Returns are correct and complete in all material respects and have been prepared in material compliance with all applicable Law. No written claim has ever been made by any Governmental Body in any jurisdiction where Parent or its any of its Subsidiaries does not file a particular Tax Return or pay a particular Tax that Parent or such Subsidiary is subject to taxation by that jurisdiction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All income and other material Taxes due and owing by Parent or any of its Subsidiaries (whether or not shown on any Tax Return) have been fully paid. The unpaid Taxes of Parent and its Subsidiaries did not, as of the date of the Parent Balance Sheet, materially exceed the reserve for Tax liability (excluding any reserve for deferred Taxes established to reflect timing differences between book and Tax items) set forth on the face of the Parent Balance Sheet. Since the Parent Balance Sheet Date, neither Parent nor any of its Subsidiaries has incurred any material Liability for Taxes outside the Ordinary Course of Business. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;All Taxes that Parent or any of its Subsidiaries are or were required by Law to withhold or collect from payments to employees, independent contractors, stockholders, lenders, customers or other third parties have been duly and timely withheld or collected in all material respects and, have been timely paid to the proper Governmental Body or properly set aside in accounts for this purpose. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;There are no Encumbrances for material Taxes (other than Permitted Encumbrances) upon any of the assets of Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;No deficiencies for income or other material Taxes with respect to Parent or any of its Subsidiaries have been claimed, proposed or assessed by any Governmental Body in writing other than any deficiency that has been resolved. There are no pending or ongoing, and to the Knowledge of Parent, threatened audits, assessments or other actions for or relating to any liability in respect of a material amount of Taxes of Parent or any of its Subsidiaries. Neither Parent nor any of its Subsidiaries (or any of their predecessors) has waived any statute of limitations in respect of any income or other material Taxes or agreed to any extension of time with respect to any income or other material Tax assessment or deficiency which waiver is still in effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has, since January&#160;1, 2019, distributed stock of another Person, or had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section&#160;355 of the Code or Section&#160;361 of the Code (or any similar provisions of state, local or foreign Law). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has participated in or been a party to a transaction that, as of the date of this Agreement, constitutes a &#8220;listed transaction&#8221; that is required to be reported to the IRS pursuant to Section&#160;6011 of the Code and applicable Treasury Regulations thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3ALM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has taken or agreed to take any action or knows of any fact or circumstance that would reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is a party to any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement, or similar agreement or arrangement, other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result of any: (i)&#160;change in method of accounting for Tax purposes filed on or prior to the Closing Date; (ii)&#160;use of an improper method of accounting for a Tax period ending on or prior to the Closing Date; (iii)&#160;&#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any similar provision of state, local or foreign Law) executed on or prior to the Closing Date; (iv)&#160;intercompany transaction or excess loss account described in Treasury Regulations under Section&#160;1502 of the Code (or any similar provision of state, local or foreign Law) as a result of a transaction on or prior to the Closing Date; (v)&#160;installment sale or open transaction disposition made on or prior to the Closing Date; or (vi)&#160;prepaid amount received outside of the Ordinary Course of Business on or prior to the Closing Date. Parent has not made any election under Section&#160;965(h) of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has ever been (i)&#160;a member of a consolidated, combined or unitary Tax group (other than such a group the common parent of which is Parent) or (ii)&#160;a party to any joint venture, partnership, or other arrangement that is treated as a partnership for U.S. federal income Tax purposes. Neither Parent nor its Subsidiaries has any Liability for any Taxes of any Person (other than Parent and any of its Subsidiaries) under Treasury Regulations&#160;Section&#160;1.1502-6 (or any similar provision of state, local, or foreign Law), or as a transferee or successor. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries (i)&#160;is a &#8220;controlled foreign corporation&#8221; as defined in Section&#160;957 of the Code; (ii)&#160;is a &#8220;passive foreign investment company&#8221; within the meaning of Section&#160;1297 of the Code; (iii)&#160;has ever had a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise had an office or fixed place of business in a country other than the country in which it is organized; or (iv)&#160;is or was a &#8220;surrogate foreign corporation&#8221; within the meaning of Section&#160;7874(a)(2)(B) or is treated as a U.S. corporation under Section&#160;7874(b) of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.17&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule is a list as of the date of this Agreement of all Parent Benefit Plans, including each Parent Benefit Plan that provides for retirement, change in control, stay or retention, deferred compensation, incentive compensation, severance or retiree medical or life insurance benefits. &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Benefit Plan</font><font style="letter-spacing:0.2pt;">&#8221; means each (i)&#160;&#8220;employee benefit plan&#8221; as defined in Section&#160;3(3) of ERISA (whether or not ERISA governs such plan) and (ii)&#160;other pension, retirement, deferred compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based (other than individual Parent Options or Parent RSUs made pursuant to Parent&#8217;s standard forms, in which case only representative standard forms of such stock option agreements and other award agreements shall be scheduled), phantom equity, employment (other than individual employment agreements made pursuant to Parent&#8217;s standard forms, in which case only representative standard forms of such employment agreements shall be scheduled), offer letter (other than individual offer letters made pursuant to Parent&#8217;s standard forms, in which case only representative standard forms of such offers shall be scheduled), consulting, severance, change-of-control, retention, health, life, disability, group insurance, paid-time off, holiday, welfare and fringe benefit plan, program, agreement, Contract, or arrangement (whether written or unwritten, qualified or nonqualified, funded or unfunded and including any that have been frozen or terminated but only if Parent has continuing liabilities with respect thereto), in any case, maintained, contributed to, or required to be contributed to, by Parent, any of its Subsidiaries or Parent ERISA Affiliates for the benefit of any current or former employee, director, officer or independent contractor of Parent or any of its Subsidiaries or under which Parent or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any of its Subsidiaries has any Liability (including as the result of its being treated as a single employer under Code Section&#160;414 with any other person). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As applicable with respect to each Parent Benefit Plan, Parent has made available to the Company, true and complete copies of (i)&#160;each Parent Benefit Plan, including all amendments thereto, and in the case of an unwritten Parent Benefit Plan, a written description thereof, (ii)&#160;all current trust documents, investment management Contracts, custodial agreements, administrative services agreements and insurance and annuity Contracts relating thereto, (iii)&#160;the current summary plan description and each summary of material modifications thereto, (iv)&#160;the most recently filed annual reports with any Governmental Body (e.g., Form 5500 and all schedules thereto), (v)&#160;the most recent IRS determination, opinion or advisory letter, (vi)&#160;the most recent summary annual reports, nondiscrimination testing reports, actuarial reports, financial statements and trustee reports, and (vii)&#160;all material records, notices and filings concerning IRS or Department of Labor or other Governmental Body audits or investigations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Parent Benefit Plan has been maintained, operated and administered in compliance in all material respects with its terms and any related documents or agreements and the applicable provisions of ERISA, the Code and all other Laws, including applicable pension Laws and, if applicable, the Income Tax Act (Canada) and the regulations thereunder. All filings and reports as to each Parent Plan required to have been submitted to the Internal Revenue Service, the Canada Revenue Agency, a Canadian Governmental Entity or to the Department of Labor, in each case to the extent applicable, have been timely submitted. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Parent Benefit Plans that are &#8220;employee pension benefit plans&#8221; within the meaning of Section&#160;3(2) of ERISA and which are intended to meet the qualification requirements of Section&#160;401(a) of the Code have received determination, opinion or advisory letters from the IRS to the effect that such plans are qualified under Section&#160;401(a) of the Code and the related trusts are exempt from federal income Taxes under Section&#160;501(a) of the Code, respectively, and to the Knowledge of Parent, nothing has occurred that would reasonably be expected to adversely affect the qualification of such Parent Benefit Plan or the tax exempt status of the related trust. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Since January&#160;1, 2016, neither Parent nor any of its Subsidiaries nor any Parent ERISA Affiliate has maintained, contributed to, been required to contribute to, or had any liability with respect to, (i)&#160;any &#8220;employee pension benefit plan&#8221; &#8203;(within the meaning of Section&#160;3(2) of ERISA) that is subject to Title IV or Section&#160;302 of ERISA or Section&#160;412 of the Code, (ii)&#160;any &#8220;multiemployer plan&#8221; &#8203;(within the meaning of Section&#160;3(37) of ERISA), or (iii)&#160;any &#8220;multiple employer plan&#8221; &#8203;(within the meaning of Section&#160;413 of the Code). No Parent Benefit Plan is a self-funded group health plan that is a &#8220;multiple employer welfare arrangement&#8221; &#8203;(within the meaning of Section&#160;3(40) of ERISA). No Parent Benefit Plan is sponsored by a professional employer organization. Except as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(e)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, Parent has not maintained any Parent Benefit Plans outside the United States that are defined-benefit type plans. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there are no (i)&#160;pending audits or investigations by any Governmental Body involving any Parent Benefit Plan, and (ii)&#160;pending or, to the Knowledge of Parent, threatened claims (except for individual claims for benefits payable in the normal operation of the Parent Benefit Plans), suits or proceedings involving any Parent Benefit Plan, any fiduciary thereof or service provider thereto. All contributions and premium payments required to have been made under any of the Parent Benefit Plans or by applicable Law (without regard to any waivers granted under Section&#160;412 of the Code), have been timely made in all material respects and neither Parent nor any Parent ERISA Affiliate has any material liability for any unpaid contributions with respect to any Parent Benefit Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither Parent, any of its Subsidiaries nor any Parent ERISA Affiliates, nor to the Knowledge of Parent, any fiduciary, trustee or administrator of any Parent Benefit Plan, has engaged in, or in connection with the Contemplated Transactions will engage in, any transaction with respect to any Parent Benefit Plan which would subject any such Parent Benefit Plan, Parent or any of its Subsidiaries or Parent to a material Tax, material penalty or material liability for a &#8220;prohibited transaction&#8221; under Section&#160;406 of ERISA or Section&#160;4975 of the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;No Parent Benefit Plan provides death, medical, dental, vision, life insurance or other welfare benefits beyond termination of service or retirement other than coverage mandated by Law and fully paid by the participant (except in connection with severance), and neither Parent, any of its Subsidiaries nor any Parent ERISA Affiliates has made a written or oral representation promising the same. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions will either alone or in connection with any other event(s) (i)&#160;result in any payment becoming due to any current or former employee, director, officer, or independent contractor of Parent or any of its Subsidiaries, (ii)&#160;increase any amount of compensation or benefits otherwise payable under any Parent Benefit Plan, (iii)&#160;result in the acceleration of the time of payment, funding or vesting of any benefits under any Parent Benefit Plan, (iv)&#160;require any contribution or payment to fund any obligation under any Parent Benefit Plan or (v)&#160;limit the right to merge, amend or terminate any Parent Benefit Plan that is subject to ERISA. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions (either alone or when combined with the occurrence of any other event, including without limitation, a termination of employment) will result in the receipt or retention by any Person who is a &#8220;disqualified individual&#8221; &#8203;(within the meaning of Code Section&#160;280G) with respect to Parent and its Subsidiaries of any payment or benefit under any Parent Benefit Plan that is or could reasonably be expected to be characterized as a &#8220;parachute payment&#8221; &#8203;(within the meaning of Code Section&#160;280G). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;The exercise price of each Parent Option granted to a U.S. taxpayer is not and never has been less than the fair market value, as determined by the Parent Board, of one share of Parent Common Stock as of the grant date of such Parent Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Each Parent Benefit Plan providing for deferred compensation that constitutes a &#8220;nonqualified deferred compensation plan&#8221; &#8203;(as defined in Section&#160;409A(d)(1) of the Code and the regulations promulgated thereunder) is, and has been, established, administered and maintained in material compliance with the requirements of Section&#160;409A of the Code and the regulations promulgated thereunder in all material respects. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;No current or former employee, officer, director or independent contractor of Parent or any of its Subsidiaries has any &#8220;gross up&#8221; agreements with Parent or any of its Subsidiaries or other assurance of reimbursement by Parent or any of its Subsidiaries for any Taxes imposed under Code Section&#160;409A or Code Section&#160;4999. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;No Parent Benefit Plan is maintained outside of the United States. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;Parent has made available to the Company a true and correct list, as of the date of this Agreement, containing an anonymized list of all full-time, part-time or temporary employees and independent contractors (and indication as such), and, as applicable: (i)&#160;the annual dollar amount of all compensation (including wages, salary or fees, commissions, director&#8217;s fees, fringe benefits, bonuses, profit sharing payments, and other payments or benefits of any type) payable to each person; (ii), dates of employment or service; (iii)&#160;title; (iv)&#160;any eligibility to receive severance, retention payment, change of control payment, or other similar compensation; (v)&#160;visa status, if applicable; (vi)&#160;if any employee is an on approved leave, and the expected date of return, if known; and (vii)&#160;with respect to employees, a designation of whether they are classified as exempt or non-exempt for purposes of the Fair Labor Standards Act and any similar state or foreign law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is and has never been a party to, bound by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees, and there is no labor union, labor organization, or similar Person representing or, to the Knowledge of Parent, purporting to represent or seeking to represent any employees of Parent or its Subsidiaries, including through the filing of a petition for representation election. There is not and has not been in the past three&#160;years, nor is there or has there been in the past three&#160;years any threat of, any strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, or any similar activity or dispute, or, to the Knowledge of Parent, any union organizing activity, against Parent or any of its Subsidiaries. No event has occurred, and no condition or circumstance exists, that might directly or indirectly be likely to give rise </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3MSJ">&#8203;</a><a name="t3PHM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, any similar activity or dispute, or, to the Knowledge of Parent, any union organizing activity. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in material compliance with all applicable Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification, discrimination, harassment and retaliation, equal employment opportunities, fair employment practices, meal and rest periods, immigration, employee safety and health, payment of wages (including overtime wages), unemployment and workers&#8217; compensation, leaves of absence, and hours of work. Except as would not be reasonably likely to result in a material liability to Parent or any of its Subsidiaries, with respect to employees of Parent and its Subsidiaries, each of Parent and its Subsidiaries, since January&#160;1, 2019: (i)&#160;has withheld and reported all amounts required by Law or by agreement to be withheld and reported with respect to wages, salaries and other payments, benefits, or compensation to employees; (ii)&#160;is not liable for any arrears of wages (including overtime wages), severance pay or any Taxes or any penalty for failure to comply with any of the foregoing; and (iii)&#160;is not liable for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Body, with respect to unemployment compensation benefits, disability, social security or other benefits or obligations for employees (other than routine payments to be made in the Ordinary Course of Business). As of the date of this Agreement, there are no Legal Proceedings, claims or charges pending or, to the Knowledge of Parent, threatened or reasonably anticipated against Parent or its Subsidiaries relating to any employee, applicant for employment, consultant, or employment agreement or otherwise relating to labor, employment, employment practices, or terms and conditions of employment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(r)&nbsp;&nbsp;&nbsp;Except as would not be reasonably likely to result in a material liability to Parent or any of its Subsidiaries, Parent and each of its Subsidiaries has accurately classified each individual service provider as an employee, independent contractor, or otherwise under all applicable Laws and, for each individual classified as an employee, Parent and each of its Subsidiaries has accurately classified him or her as exempt or non-exempt under all applicable Laws. Neither Parent nor any of its Subsidiaries has any material liability with respect to any misclassification of: (a)&#160;any Person as an independent contractor rather than as an employee; (b)&#160;any employee leased from another employer; or (c)&#160;any employee currently or formerly classified as exempt under all applicable Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(s)&nbsp;&nbsp;&nbsp;Within the preceding five&#160;years, Parent has not implemented any &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; of employees that would reasonably be expected to require notification under the WARN Act or any similar state, local or foreign Law. No &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; will be implemented before the Closing Date without advance notification to and approval of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.18&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Since January&#160;1, 2019, Parent and each of its Subsidiaries have complied with all applicable Environmental Laws, which compliance includes the possession by Parent of all permits and other Governmental Authorizations required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in such compliance that would not have a Parent Material Adverse Effect. Neither Parent nor any of its Subsidiaries have received between January&#160;1, 2019 and the date of this Agreement any written notice, whether from a Governmental Body or other Person, that alleges that Parent or any of its Subsidiaries is not in compliance with any Environmental Law and, to the Knowledge of Parent, there are no circumstances that would reasonably be expected to prevent or interfere with Parent&#8217;s or any of its Subsidiaries&#8217; compliance in any material respects with any Environmental Law, except where such failure to comply would not have a Parent Material Adverse Effect. To the Knowledge of Parent, (i)&#160;no current or prior owner of any property leased or controlled by Parent or any of its Subsidiaries has received, between January&#160;1, 2019 and the date of this Agreement, any written notice relating to property owned or leased at any time by Parent or any of its Subsidiaries, whether from a Governmental Body or other Person, that alleges that current or prior owners or Parent or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to such property and (ii)&#160;neither Parent nor any of its Subsidiaries has any material liability under any Environmental Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.19&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Insurance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent has made available to the Company accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3FAO">&#8203;</a><a name="t3WAE">&#8203;</a><a name="t3NPN">&#8203;</a><a name="t3ITP">&#8203;</a><a name="t3OFA">&#8203;</a><a name="t3OOR">&#8203;</a><a name="tS4CO">&#8203;</a><a name="t4OPB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">business, assets, liabilities and operations of Parent and each of its Subsidiaries. Each of such insurance policies is in full force and effect and Parent and each of its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, between January&#160;1, 2019 and the date of this Agreement, neither Parent nor any of its Subsidiaries has received any written notice regarding any actual or possible: (a)&#160;cancellation or invalidation of any insurance policy; or (b)&#160;refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy. Parent and each of its Subsidiaries have provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding that is currently pending against Parent or any of its Subsidiaries for which Parent or such Subsidiaries has insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed Parent or any of its Subsidiaries of its intent to do so. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.20&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Other than SVB Securities LLC, no broker, finder or investment banker is entitled to any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of Parent or any of its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as set forth in the Parent SEC Documents filed prior to the date of this Agreement, since December&#160;31, 2021, no event has occurred that would be required to be reported by Parent pursuant to Item&#160;404 of Regulation&#160;S-K. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.22&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries or any of their respective directors, officers, employees or, to Parent&#8217;s Knowledge, agents or any other Person acting on their behalf has, directly or indirectly, made any bribes, rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form of cash, gifts, or otherwise, or taken any other action, in violation of Anti-Bribery Laws. To the Knowledge of Parent, neither Parent nor any of its Subsidiaries is or has been the subject of any investigation or inquiry by any Governmental Body with respect to potential violations of Anti-Bribery Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.23&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Valid Issuance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Common Stock to be issued in the Merger will, when issued in accordance with the provisions of this Agreement, be validly issued, fully paid and nonassessable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.24&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Opinion of Financial Advisor</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Board has received an opinion of SVB Securities LLC to the effect that, as of the date of this Agreement and subject to the assumptions, qualifications, limitations and other matters set forth therein, the Exchange Ratio is fair, from a financial point of view, to Parent. It is agreed and understood that such opinion is for the benefit of the Parent Board and may not be relied upon by the Company or any other party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.25&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent hereby acknowledges and agrees that, except for the representations and warranties contained in this Agreement, neither the Company nor any of its Subsidiaries nor any other person on behalf of the Company or any of its Subsidiaries makes any express or implied representation or warranty with respect to the Company or any of its Subsidiaries or with respect to any other information provided to Parent, Merger Sub or stockholders or any of their respective Affiliates in connection with the Contemplated Transactions, and (subject to the express representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;"> (in each case as qualified and limited by the Company Disclosure Schedule)) neither Parent, its Subsidiaries nor any of their respective Representatives or stockholders, has relied on any such information (including the accuracy or completeness thereof). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;4.&nbsp;&nbsp;&nbsp;CERTAIN COVENANTS OF THE PARTIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Operation of Parent&#8217;s Business</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as expressly permitted by this Agreement, as required by applicable Law, in connection with any COVID-19 Measures or COVID-19 Response or unless the Company shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the period commencing on the date of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9</font><font style="letter-spacing:0.2pt;"> and the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Period</font><font style="letter-spacing:0.2pt;">&#8221;), Parent shall, and shall cause each of its Subsidiaries to, (x)&#160;use commercially reasonable efforts to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">conduct its business and operations in the Ordinary Course of Business and (y)&#160;conduct its business and operations in compliance in all material respects with all applicable Laws, including timely making all filings required by the SEC, and the requirements of all Contracts that constitute Parent Material Contracts. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except (i)&#160;as expressly permitted by this Agreement, (ii)&#160;as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1(b)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, (iii)&#160;as required by applicable Law, (iv)&#160;in connection with an Asset Disposition, on the terms and subject to the limitations set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;">, (v)&#160;in connection with the Pre-Closing Dividend in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.21</font><font style="letter-spacing:0.2pt;">, (vi)&#160;in connection with any COVID-19 Measures or COVID-19 Response, or (vii)&#160;with the prior written consent of the Company (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, Parent shall not, nor shall it cause or permit any of its Subsidiaries to, do any of the following: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with the payment of the exercise price and/or withholding Taxes incurred upon the exercise of any Parent Option or vesting of Parent RSUs in accordance with the terms of such award in effect on the date of this Agreement); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;sell, issue, grant, pledge or otherwise dispose of or encumber or authorize the issuance of: (A)&#160;any capital stock or other security of Parent (except for Parent Common Stock issued upon the valid exercise or settlement of outstanding Parent Options, Parent Warrants or the vesting of Parent RSUs, as applicable, in accordance with their terms as in effect as of the date of this Agreement); (B)&#160;any option, warrant or right to acquire any capital stock or any other security; or (C)&#160;any other instrument convertible into or exchangeable for any capital stock or other security of Parent or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;amend any of its or any of its Subsidiaries&#8217; Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;form any Subsidiary or acquire any equity interest or other interest in any other Entity, or enter into a joint venture with any other Entity; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;(A) lend money to any Person, (B)&#160;incur or guarantee any indebtedness for borrowed money, issue or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities, (C)&#160;guarantee any debt securities of others, or (D)&#160;make any capital expenditure or commitment in excess of $250,000; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;other than as required by applicable Law or by the terms of any Parent Benefit Plan as in effect on the date of this Agreement and disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule: (A)&#160;adopt, terminate, establish or enter into any Parent Benefit Plan; (B)&#160;cause or permit any Parent Benefit Plan to be amended in any material respect; (C)&#160;pay any bonus or make any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, benefits or other compensation or remuneration payable to, any Parent Associate; or (D)&#160;increase or otherwise modify the severance, retention or change of control benefits offered to any current or former or new Parent Associate; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;enter into any Contract with a labor union, labor organization, or similar Person, except as otherwise required by applicable Law; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;(A) hire or engage, or offer to hire, any director, officer, employee or consultant, or (B)&#160;enter into, amend or extend the term of any employment or consulting agreement with any Parent Associate; </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;enter into any material transaction; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any Encumbrance with respect to such assets or properties; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;make, change or revoke any material Tax election, file any material amended Tax Return, settle or compromise any income or other material Tax liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material Taxes (other than pursuant to an extension of time to file any Tax Return granted in the Ordinary Course of Business of not more than six&#160;months), or change any material accounting method in respect of Taxes; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;(A) sell, assign, transfer, allow to lapse or expire, pledge, abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of Parent or any of its Subsidiaries in any material Parent IP, or (B)&#160;license, sublicense or otherwise encumber (other than pursuant to a non-exclusive license granted to contract research organizations, including clinical trial sites and clinical trial services provides, or contract manufacturing organizations, in each case, (x)&#160;with whom Parent or any of its Subsidiaries has previously entered into Contracts prior to the Effective Time and (y)&#160;who are engaged to provide services directly related to clinical studies and manufacturing of any product candidate of Parent, provided that the scope of any such non-exclusive license grant is limited to only the extent necessary for such Persons to perform their obligations under the respective Contracts) any right, title or interest of Parent or any of its Subsidiaries in any material Parent IP; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;enter into, amend or terminate any Parent Material Contract (or any Contract that would have been a Parent Material Contract if in effect on or prior to the date of this Agreement); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;(A) materially change pricing or royalties or other payments set or charged by Parent or any of its Subsidiaries to its customers or licensees or (B)&#160;agree to materially change pricing or royalties or other payments set or charged by persons who have licensed Intellectual Property Rights to Parent or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;make any expenditures, incur any Liabilities or discharge or satisfy any Liabilities, in each case, other than those expenditures or Liabilities that (A)&#160;will not survive the Closing, (B)&#160;are discharged or satisfied prior to the Closing, and/or (C)&#160;are taken into account in the calculation of Net Cash; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xvi)&nbsp;&nbsp;&nbsp;waive, settle or compromise any pending or threatened Legal Proceeding against Parent or any of its Subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any restriction on the operations or business of Parent or its Subsidiaries (nor on the Company or any of its Subsidiaries, from and after the Closing), (2)&#160;involve any equitable relief and (3)&#160;do not involve admission of any wrongdoing by Parent or any of its Subsidiaries; or </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xvii)&nbsp;&nbsp;&nbsp;agree, resolve or commit to do any of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything to the contrary contained herein, nothing herein shall prevent Parent or any of its Subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 Measures or otherwise take any COVID-19 Response and (a)&#160;no such actions or failure to take such actions or COVID-19 Responses shall be deemed to violate or breach this Agreement in any way, (b)&#160;all such actions or failures to take such actions or COVID-19 Responses shall be deemed to constitute an action taken in the Ordinary Course of Business and (c)&#160;no such actions or failures to take such actions or COVID-19 Responses shall serve as a basis for the Company to terminate this Agreement or assert that any of the conditions to the Closing contained herein have not been satisfied. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the generality of the foregoing, nothing set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> shall restrict Parent&#8217;s right to effectuate one or more Asset Dispositions, on the terms and subject to the limitations set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;">, or the Pre-Closing Dividend, on the terms and subject to the limitations set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.21</font><font style="letter-spacing:0.2pt;">, it being understood that </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.21</font><font style="letter-spacing:0.2pt;"> contains the parties&#8217; entire agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4OTC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">pertaining to Parent&#8217;s rights and obligations in connection with the preparation for, and negotiation and execution of, one or more Asset Dispositions prior to the Closing and the Pre-Closing Dividend. Nothing contained in this Agreement shall give the Company, directly or indirectly, the right to control or direct the operations of Parent prior to the Effective Time. Prior to the Effective Time, Parent shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Operation of the Company&#8217;s Business</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, as expressly permitted by this Agreement, as required by applicable Law, in connection with any COVID-19 Measures or COVID-19 Response or unless Parent shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the Pre-Closing Period, each of the Company and its Subsidiaries shall (i)&#160;use commercially reasonable efforts to conduct its respective business and operations in the Ordinary Course of Business and (ii)&#160;conduct its business and operations in compliance in all material respects with all applicable Laws and the requirements of all Contracts that constitute Company Material Contracts. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except (i)&#160;as expressly permitted by this Agreement, (ii)&#160;as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, (iii)&#160;as required by applicable Law, (iv)&#160;in connection with any COVID-19 Measures or COVID-19 Response, or (v)&#160;with the prior written consent of Parent (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, the Company shall not, nor shall it cause or permit any of its Subsidiaries to, do any of the following: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with the payment of the exercise price and/or withholding Taxes incurred upon the exercise of any Company Option in accordance with the terms of such award in effect on the date of this Agreement); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;except as contemplated by the Company Pre-Closing Financing or the Conversion in accordance with the Convertible Note Conversion Agreement, sell, issue, grant, pledge or otherwise dispose of or encumber or authorize the issuance of: (A)&#160;any capital stock or other security of the Company or any of its Subsidiaries (except for shares of outstanding Company Common Stock issued upon the valid exercise or settlement of Company Options in accordance with their terms as in effect as of the date of this Agreement); (B)&#160;any option, warrant or right to acquire any capital stock or any other security, other than options grants to employees and service providers in the Ordinary Course of Business; or (C)&#160;any other instrument convertible into or exchangeable for any capital stock or other security of the Company or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;amend any of its or its Subsidiaries&#8217; Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;form any Subsidiary or acquire any equity interest or other interest in any other Entity, or enter into a joint venture with any other Entity; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;(A) lend money to any Person (except for the advancement of reasonable expenses to employees, directors and consultants in the Ordinary Course of Business), (B)&#160;incur or guarantee any indebtedness for borrowed money, other than in the Ordinary Course of Business, (C)&#160;guarantee any debt securities of others or (D)&#160;except as contemplated by the Company&#8217;s capital expenditure budget and operating budget made available to Parent, make any capital expenditure or commitment in excess of $350,000; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any Encumbrance with respect to such assets or properties, except in the Ordinary Course of Business; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4AI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;sell, assign, license, sublicense, transfer, allow to lapse or expire, pledge, abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of the Company or any of its Subsidiaries in any material Company IP (other than pursuant to a non-exclusive license in the Ordinary Course of Business); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;make, change or revoke any material Tax election file any material amended Tax Return, settle or compromise any income or other material Tax liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material Taxes (other than pursuant to an extension of time to file any Tax Return granted in the Ordinary Course of Business of not more than six&#160;months), or change any material accounting method in respect of Taxes; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;enter into, materially amend or terminate any Company Material Contract (or any Contract that would have been a Company Material Contract if in effect on or prior to the date of this Agreement) other than in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;waive, settle or compromise any pending or threatened Legal Proceeding against the Company or any of its Subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any material restriction on the operations or business of the Company or its Subsidiaries (nor, following the Closing, on Parent or any of its Subsidiaries), (2)&#160;involve any equitable relief and (3)&#160;involve admission of any wrongdoing by the Company or any of its Subsidiaries; or </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;agree, resolve or commit to do any of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything to the contrary contained herein, nothing herein shall prevent the Company or any of its Subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 Measures or otherwise take any COVID-19 Response and (a)&#160;no such actions or failure to take such actions or COVID-19 Responses shall be deemed to violate or breach this Agreement in any way, (b)&#160;all such actions or failures to take such actions or COVID-19 Responses shall be deemed to constitute an action taken in the Ordinary Course of Business and (c)&#160;no such actions or failures to take such actions or COVID-19 Responses shall serve as a basis for Parent to terminate this Agreement or assert that any of the conditions to the Closing contained herein have not been satisfied. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct the operations of the Company prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Access and Investigation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to the terms of the Confidentiality Agreement, which the Parties agree will continue in full force following the date of this Agreement, during the Pre-Closing Period, upon reasonable notice, Parent, on the one hand, and the Company, on the other hand, shall and shall use commercially reasonable efforts to cause such Party&#8217;s Representatives to: (i)&#160;provide the other Party and such other Party&#8217;s Representatives with reasonable access, upon reasonable notice and during normal business hours to such Party&#8217;s Representatives, personnel, property and assets and to all existing books, records, Tax Returns, work papers and other documents and information relating to such Party and its Subsidiaries; (ii)&#160;provide the other Party and such other Party&#8217;s Representatives with such copies of the existing books, records, Tax Returns, work papers, product data, and other documents and information relating to such Party and its Subsidiaries, and with such additional financial, operating and other data and information regarding such Party and its Subsidiaries as the other Party may reasonably request; (iii)&#160;permit the other Party&#8217;s officers and other employees to meet, upon reasonable notice and during normal business hours, with the principal financial officer and other officers and managers of such </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t44NO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Party responsible for such Party&#8217;s financial statements and the internal controls of such Party to discuss such matters as the other Party may deem necessary or appropriate; and (iv)&#160;make available to the other Party copies of unaudited financial statements and any material notice, report or other document filed with or sent to or received from any Governmental Body in connection with the Contemplated Transactions. Any investigation conducted by either Parent or the Company pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.3(a)</font><font style="letter-spacing:0.2pt;"> shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the other Party and to comply with applicable COVID-19 Measures and COVID-19 Responses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, any Party may restrict the foregoing access to the extent that any Law applicable to such Party requires such Party to restrict or prohibit access to any such properties or information or if access would jeopardize protections afforded the Party under the attorney-client privilege or the attorney work product doctrine, violate applicable Law or breach such Party&#8217;s confidentiality obligations to a third party in effect as of the date of this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that such Party shall use commercially reasonable efforts to allow for such access in a manner that does not violate any such applicable Law or jeopardize protections afforded the Party under the attorney-client privilege or the attorney work product doctrine, including by entering into such effective and appropriate joint-defense agreements or other protective arrangements as may be reasonably required by the other Party in order that all such information may be provided to the other Party without causing such violation or waiver. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent Non-Solicitation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as expressly permitted by this Agreement, Parent agrees that, during the Pre-Closing Period, neither it nor any of its Subsidiaries shall, nor shall it or any of its Subsidiaries authorize any of its Representatives to (and shall use reasonable best efforts to cause such Representative not to), directly or indirectly: (i)&#160;solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition Inquiry; (ii)&#160;furnish any non-public information regarding Parent to any Person in connection with or in response to an Acquisition Proposal or Acquisition Inquiry; (iii)&#160;engage in discussions (other than to inform any Person of the existence of the provisions contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">) or negotiations with any Person with respect to any Acquisition Proposal or Acquisition Inquiry; (iv)&#160;approve, endorse or recommend any Acquisition Proposal (subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4</font><font style="letter-spacing:0.2pt;">); (v)&#160;execute or enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction (other than a confidentiality agreement permitted under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4(a)</font><font style="letter-spacing:0.2pt;">); or (vi)&#160;publicly propose to do any of the foregoing; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, notwithstanding anything contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;"> and subject to compliance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">, prior to obtaining the Required Parent Stockholder Vote, Parent may furnish non-public information regarding Parent to, and enter into discussions or negotiations with, any Person in response to a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> written unsolicited Acquisition Proposal by such Person, which the Parent Board determines in good faith, after consultation with Parent&#8217;s outside legal counsel and financial advisers, constitutes, or is reasonably likely to result in, a Superior Offer (and is not withdrawn) if: (A)&#160;neither Parent nor any of its Representatives shall have breached this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;"> in any material respect; (B)&#160;the Parent Board concludes in good faith, after consultation with Parent&#8217;s outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties of the Parent Board under applicable Law; (C)&#160;at least two Business Days prior to initially furnishing any such nonpublic information to, or entering into discussions with, such Person, Parent gives the Company written notice of the identity of such Person and of Parent&#8217;s intention to furnish nonpublic information to, or enter into discussions with, such Person; (D)&#160;Parent receives from such Person an executed confidentiality agreement containing provisions (including nondisclosure provisions, use restrictions, non-solicitation provisions and no hire provisions) at least as favorable to Parent as those contained in the Confidentiality Agreement; and (E)&#160;at least two Business Days prior to furnishing any such nonpublic information to such Person, Parent furnishes such nonpublic information to the Company (to the extent such information has not been previously furnished by Parent to the Company). Without limiting the generality of the foregoing, Parent acknowledges and agrees that, in the event any Representative of Parent (whether or not such Representative is purporting to act on behalf of Parent) takes any action that, if taken by Parent, would constitute a breach of this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t45NO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">, the taking of such action by such Representative shall be deemed to constitute a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;"> by Parent for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If Parent or any Representative of Parent receives an Acquisition Proposal or Acquisition Inquiry at any time during the Pre-Closing Period, then Parent shall promptly (and in no event later than twenty-four hours after Parent becomes aware of such Acquisition Proposal or Acquisition Inquiry) advise the Company in writing of such Acquisition Proposal or Acquisition Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry (subject to any confidentiality restrictions that may be in place between Parent and such Person as of the date of this Agreement), and a copy of the Acquisition Proposal or Acquisition Inquiry, or if the Acquisition Proposal or Acquisition Inquiry is not written, the terms thereof, and the material terms thereof). Parent shall keep the Company reasonably informed with respect to the status and terms of any such Acquisition Proposal or Acquisition Inquiry and any material modification or proposed material modification thereto. In addition to the foregoing, Parent shall provide the Company with reasonable advance (and in any event not less than 24 hours) written notice of a meeting of the Parent Board (or any committee thereof) at which the Parent Board (or any committee thereof) is reasonably expected to consider an Acquisition Proposal or Acquisition Inquiry it has received. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent shall immediately cease and cause to be terminated any existing discussions, negotiations and communications with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any nonpublic information of Parent provided to such Person. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Non-Solicitation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as expressly permitted by this Agreement, the Company agrees that, during the Pre-Closing Period, neither it nor any of its Subsidiaries shall, nor shall it or any of its Subsidiaries authorize any of its Representatives to (and shall use reasonable best efforts to cause each such Representative not to), directly or indirectly: (i)&#160;solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition Inquiry; (ii)&#160;furnish any non-public information regarding the Company or any of its Subsidiaries to any Person in connection with or in response to an Acquisition Proposal or Acquisition Inquiry; (iii)&#160;engage in discussions (other than to inform any Person of the existence of the provisions contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">) or negotiations with any Person with respect to any Acquisition Proposal or Acquisition Inquiry; (iv)&#160;approve, endorse or recommend any Acquisition Proposal (subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3</font><font style="letter-spacing:0.2pt;">); (v)&#160;execute or enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction (other than a confidentiality agreement permitted under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5(a)</font><font style="letter-spacing:0.2pt;">); or (vi)&#160;publicly propose to do any of the foregoing; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, notwithstanding anything contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;"> and subject to compliance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">, prior to obtaining the Required Company Stockholder Vote, the Company may furnish non-public information regarding the Company to, and enter into discussions or negotiations with, any Person in response to a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> written unsolicited Acquisition Proposal by such Person, which the Company Board determines in good faith, after consultation with the Company&#8217;s outside legal counsel and financial advisers, constitutes, or is reasonably likely to result in, a Superior Offer (and is not withdrawn) if: (A)&#160;neither the Company nor any of its Representatives shall have breached this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;"> in any material respect; (B)&#160;the Company Board concludes in good faith, after consultation with the Company&#8217;s outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties of the Company Board under applicable Law; (C)&#160;at least two Business Days prior to initially furnishing any such nonpublic information to, or entering into discussions with, such Person, the Company gives Parent written notice of the identity of such Person and of the Company&#8217;s intention to furnish nonpublic information to, or enter into discussions with, such Person; (D)&#160;the Company receives from such Person an executed confidentiality agreement containing provisions (including nondisclosure provisions, use restrictions, non-solicitation provisions and no hire provisions), at least as favorable to the Company as those contained in the Confidentiality Agreement; and (E)&#160;at least two Business Days prior to furnishing any such nonpublic information to such Person, the Company furnishes such nonpublic information to Parent (to the extent such information has not been previously </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4OCM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">furnished by the Company to Parent). Without limiting the generality of the foregoing, the Company acknowledges and agrees that, in the event any Representative of the Company (whether or not such Representative is purporting to act on behalf of the Company) takes any action that, if taken by the Company, would constitute a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">, the taking of such action by such Representative shall be deemed to constitute a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;"> by the Company for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Company or any Representative of the Company receives an Acquisition Proposal or Acquisition Inquiry at any time during the Pre-Closing Period, then the Company shall promptly (and in no event later than twenty-four hours after the Company becomes aware of such Acquisition Proposal or Acquisition Inquiry) advise Parent in writing of such Acquisition Proposal or Acquisition Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry (subject to any confidentiality restrictions that may be in place between the Company and such Person as of the date of this Agreement), and a copy of the Acquisition Proposal or Acquisition Inquiry, or if the Acquisition Proposal or Acquisition Inquiry is not written, the terms thereof, and the material terms thereof). The Company shall keep Parent reasonably informed with respect to the status and terms of any such Acquisition Proposal or Acquisition Inquiry and any material modification or proposed material modification thereto. In addition to the foregoing, the Company shall provide Parent with reasonable advance (and in any event not less than 24 hours) written notice of a meeting of the Company Board (or any committee thereof) at which the Company Board (or any committee thereof) is reasonably expected to consider an Acquisition Proposal or Acquisition Inquiry it has received. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company shall immediately cease and cause to be terminated any existing discussions, negotiations and communications with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any nonpublic information of the Company or any of its Subsidiaries provided to such Person. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Notification of Certain Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;During the Pre-Closing Period, the Company shall promptly notify Parent (and, if in writing, furnish copies of) if any of the following occurs: (i)&#160;any notice or other communication is received from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions; (ii)&#160;any Legal Proceeding against or involving or otherwise affecting the Company or its Subsidiaries is commenced, or, to the Knowledge of the Company, threatened against the Company or its Subsidiaries or, to the Knowledge of the Company, any director, officer or Key Employee of the Company or its Subsidiaries; (iii)&#160;the Company becomes aware of any inaccuracy in any representation or warranty made by it in this Agreement; or (iv)&#160;the failure of the Company to comply with any covenant or obligation of the Company; in the case of (iii)&#160;and (iv)&#160;that will or could reasonably be expected to result in the failure by the Company to satisfy any of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">. No notification given to Parent pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.6(a)</font><font style="letter-spacing:0.2pt;"> shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations of the Company or any of its Subsidiaries contained in this Agreement or the Company Disclosure Schedule for purposes of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">, as applicable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;During the Pre-Closing Period, Parent shall promptly notify the Company (and, if in writing, furnish copies of) if any of the following occurs: (i)&#160;any notice or other communication is received from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions; (ii)&#160;any Legal Proceeding against or involving or otherwise affecting Parent or its Subsidiaries is commenced, or, to the Knowledge of Parent, threatened against Parent or its Subsidiaries or, to the Knowledge of Parent, any director, officer or Key Employee of Parent or its Subsidiaries; (iii)&#160;Parent becomes aware of any inaccuracy in any representation or warranty made by it in this Agreement; or (iv)&#160;the failure of Parent to comply with any covenant or obligation of Parent or Merger Sub; in the case of (iii)&#160;and (iv)&#160;that will or could reasonably be expected to result in the failure by Parent to satisfy any of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">. No notification given to the Company pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.6(b)</font><font style="letter-spacing:0.2pt;"> shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations of Parent contained in this Agreement or the Parent Disclosure Schedule for purposes of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">, as applicable. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4TA">&#8203;</a><a name="tS5AO">&#8203;</a><a name="t5SPS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent shall be entitled, but under no obligation, to sell, transfer, license, assign or otherwise divest Potentially Transferable Assets in a transaction or series of transactions; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such sale, transfer, license or other disposition must be expressly approved by the Parent Board (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Disposition</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Dispositions</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent shall keep the Company reasonably apprised of any developments related to the Asset Dispositions and any transactions undertaken pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;">. Without limiting the foregoing, Parent shall provide the Company with notice of Parent&#8217;s intention to enter into any definitive written agreement (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sale Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) providing for the consummation of an Asset Disposition (such notice to include copies of the proposed execution form of such agreement) or otherwise to consummate an Asset Disposition, at least ten Business Days prior to the execution of such Sale Agreement or to otherwise consummate an Asset Disposition. Parent shall not enter into a Sale Agreement or otherwise consummate an Asset Disposition that would result in a Material Continuing Obligation without first obtaining the prior written consent of the Company, such consent not to be unreasonably withheld, delayed or conditioned (it being understood that if the Company does not notify Parent by the tenth Business Day following receipt of the applicable notice from Parent that the Company has not consented to the entry into such Sale Agreement, then the Company shall be deemed to have given its consent). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;5.&nbsp;&nbsp;&nbsp;ADDITIONAL AGREEMENTS OF THE PARTIES.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Registration Statement; Proxy Statement/Prospectus</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;As promptly as practicable after the date of this Agreement (but in no event later than 30&#160;days following the date of this Agreement), Parent shall, in cooperation with the Company, prepare and cause to be filed with the SEC, the Registration Statement, in which the Proxy Statement/</font>&#8203;<font style="letter-spacing:0.2pt;">Prospectus will be included, in connection with the registration under the Securities Act of the shares of Parent Common Stock to be issued by virtue of the Merger or the Conversion. Each of Parent and the Company shall use their commercially reasonable efforts to cause the Registration Statement to become effective as promptly as practicable, and shall take all or any action required under any applicable federal, state, securities and other Laws in connection with the issuance of shares of Parent Common Stock pursuant to the Merger or the Conversion. Each of the Parties shall furnish all information concerning itself and their Affiliates, as applicable, to the other Parties as the other Parties may reasonably request in connection with such actions and the preparation of the Registration Statement and the Proxy Statement/Prospectus. </font></div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent covenants and agrees that the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), will comply with applicable U.S. federal securities laws and the DGCL in all material respects, and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances in which they were made, not misleading. The Company covenants and agrees that the information supplied, or to be supplied, by or on behalf of the Company or any of its Subsidiaries to Parent for inclusion in the Registration Statement (including the Company Financial Statements) will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make such information, in light of the circumstances in which they were made, not misleading. Notwithstanding the foregoing, Parent makes no covenant, representation or warranty with respect to statements made in the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), if any, based on information furnished in writing by the Company or any of its Subsidiaries or any of their representations specifically for inclusion therein. The Company and its legal counsel shall be given reasonable opportunity to review and comment on the Registration Statement, including all amendments and supplements thereto, prior to the filing thereof with the SEC, and on the response to any comments of the SEC on the Registration Statement, prior to the filing thereof with the SEC. The Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), including any amendments thereto, shall be subject to the Company&#8217;s advance review and reasonable approval. Each of the Parties shall use commercially reasonable efforts to cause the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t52MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Registration Statement, including the Proxy Statement/Prospectus, to comply with the applicable rules and regulations promulgated by the SEC, to respond promptly to any comments of the SEC or its staff and to have the Registration Statement declared effective under the Securities Act as promptly as practicable after it is filed with the SEC. Each of the Parties shall use commercially reasonable efforts to cause the Proxy Statement/Prospectus to be mailed to holders of Parent Common Stock as promptly as practicable after the Registration Statement is declared effective under the Securities Act. If Parent, Merger Sub or the Company become aware of any event or information that, pursuant to the Securities Act or the Exchange Act, should be disclosed in an amendment or supplement to the Registration Statement or Proxy Statement/Prospectus, as the case may be, then such Party, as the case may be, shall promptly inform the other Parties thereof and shall cooperate with such other Parties in filing such amendment or supplement with the SEC and, if appropriate, in mailing such amendment or supplement to Parent&#8217;s stockholders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company will use commercially reasonable efforts to cause to be delivered to Parent a consent letter of the Company&#8217;s independent accounting firm, dated no more than two Business Days before the date on which the Registration Statement becomes effective, that is customary in scope and substance for consent letters delivered by independent public accountants in connection with registration statements similar to the Registration Statement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Regulatory Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, the Company and Parent shall use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary or desirable under applicable Laws to consummate the Merger as promptly as practicable, including in connection with (i)&#160;preparing and filing as promptly as practicable with any Governmental Body documentation to effect all necessary or desirable filings, notices, petitions, statements, registrations, submissions of information, applications and other documents and (ii)&#160;obtaining and maintaining all approvals, consents, registrations, permits, authorizations and other confirmations required to be obtained from any Governmental Body that are necessary or desirable to consummate the Merger as promptly as practicable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In furtherance and not in limitation of the foregoing, each of the Company and, solely to the extent required under applicable Law as mutually determined by Parent and the Company, Parent shall make, with respect to the Merger: (i)&#160;no later than 10 Business Days after the date hereof, a Notification and Report Form pursuant to the HSR Act, as applicable; and (ii)&#160;as promptly as practicable after the date hereof, all filings required pursuant to applicable Antitrust Laws as described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each of the Company and Parent shall (i)&#160;respond as promptly as practicable to any inquiries or requests received from any Governmental Body, including in connection with any Antitrust Laws applicable to the Contemplated Transactions, (ii)&#160;supply as promptly as practicable any additional information and documentary material that may be requested by a Governmental Body, including pursuant to the HSR Act, as applicable, (iii)&#160;if any request for additional information and documents, including a &#8220;second request&#8221; under the HSR Act, as applicable, is received from any Governmental Body, then substantially comply with any such request at the earliest practicable date, (iv)&#160;not extend any waiting period or agree to refile under the HSR Act, as applicable, or any other Antitrust Law except with the prior consent of the other Party, and (v)&#160;take all other actions necessary or desirable to cause the expiration or termination of the applicable waiting periods under the HSR Act, as applicable, and any other Antitrust Laws, and obtain all other required consents, authorizations, orders and approvals from Governmental Bodies, as promptly as practicable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;If any objections are asserted with respect to the Contemplated Transactions by any Governmental Body, including under the HSR Act, as applicable, or any other applicable Law (including applicable Antitrust Laws), or if any action is instituted or threatened by any Governmental Body or any private party challenging the transaction as violative of the HSR Act, as applicable, or any other applicable Law (including applicable Antitrust Laws), the Parties shall, and shall cause their respective Affiliates to, take any and all actions to resolve such objections as promptly as practicable and in any event prior to the End Date. The Company and Parent shall oppose, fully and vigorously, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5SM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&#160;any administrative or judicial action or proceeding that is initiated or threatened to be initiated challenging this Agreement or the consummation of the Contemplated Transactions and (B)&#160;any request for, the entry of, and seek to have vacated or terminated, any order that could restrain, prevent or delay the consummation of the transaction, including in the case of either (A)&#160;or (B)&#160;by defending through litigation any action asserted by any Person in any court or before any Governmental Body as may be required (x)&#160;by the applicable Governmental Body in order to resolve such objections as such Governmental Body may have to such transactions under the HSR Act, as applicable, or any other applicable Law (including any other applicable Antitrust Law) or (y)&#160;by any domestic or foreign court or other tribunal, in any action challenging the transaction as violative of the HSR Act, as applicable, or any other applicable Law (including other applicable Antitrust Law), in order to avoid the entry of, or to effect the dissolution, vacating, lifting, altering or reversal of, any order that has the effect of restricting, preventing or prohibiting the consummation of the transaction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Subject to applicable Law relating to the sharing of information, each Party shall (i)&#160;furnish the other Party with copies of all documents (except documents or portions thereof for which confidential treatment has been requested or given, which the Party may limit to sharing only with the external legal counsel of the other Party) and correspondence (A)&#160;prepared by or on behalf of such Party for any Governmental Body and affording the other Party the opportunity to comment and participate in responding, where appropriate; or (B)&#160;received by or on behalf of such Party from any Governmental Body, in each case in connection with the consents, authorizations, orders or approvals contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;"> and (ii)&#160;use reasonable best efforts to consult with and keep the other Party informed as to the status of such matters. Further, no Party shall, nor shall it permit any of its Representatives to, meet or engage in substantive conversations with any Governmental Body or representative of such Governmental Body in connection with obtaining any such consent, authorization, order and approval unless it consults with the other Party in advance and, to the extent not precluded by applicable Law, offers the other Party the opportunity to participate in such meeting or conversation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Promptly after the Registration Statement shall have been declared effective under the Securities Act, the Company shall prepare, with the cooperation of Parent, and cause to be mailed to its stockholders an information statement, which shall include a copy of the Proxy Statement/Prospectus, and the Company Stockholder Written Consent, in order to solicit the approval of the Company&#8217;s stockholders, including the Company&#8217;s stockholders sufficient for the Required Company Stockholder Vote in lieu of a meeting pursuant to Section&#160;228 of the DGCL, for purposes of (i)&#160;adopting and approving this Agreement and the Contemplated Transactions, (ii)&#160;acknowledging that the approval given thereby is irrevocable and that such stockholder is aware of its rights to demand appraisal for its shares pursuant to Section&#160;262 of the DGCL, a true and correct copy of which will be attached thereto, and that such stockholder has received and read a copy of Section&#160;262 of the DGCL and (iii)&#160;acknowledging that by its approval of the Merger it is not entitled to appraisal rights with respect to its shares in connection with the Merger and thereby waives any rights to receive payment of the fair value of its capital stock under the DGCL (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Matters</font><font style="letter-spacing:0.2pt;">&#8221;). Promptly following receipt of the duly executed Company Stockholder Written Consent from the stockholders representing the Required Company Stockholder Vote, the Company shall deliver a copy of the duly executed Company Stockholder Written Consent to Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company agrees that, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(c)</font><font style="letter-spacing:0.2pt;">: (i)&#160;the Company Board shall recommend that the Company&#8217;s stockholders vote to approve the Company Stockholder Matters and shall use its reasonable best efforts to solicit such approval from each of the Company stockholders necessary to deliver the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote within the time set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(a)</font><font style="letter-spacing:0.2pt;"> (the recommendation of the Company Board that the Company&#8217;s stockholders vote to adopt and approve this Agreement being referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Board Recommendation</font><font style="letter-spacing:0.2pt;">&#8221;); and (ii)&#160;the Company Board Recommendation shall not be withdrawn or modified (and the Company Board shall not publicly propose to withdraw or modify the Company Board Recommendation) in a manner adverse to Parent, and no resolution by the Company Board or any committee thereof to withdraw or modify the Company Board Recommendation in a manner adverse to Parent or to adopt, approve or recommend (or publicly propose to adopt, approve or recommend) </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5SM1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">any Acquisition Proposal shall be adopted or proposed (the actions set forth in the foregoing clause (ii), collectively, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Board Adverse Recommendation Change</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(b)</font><font style="letter-spacing:0.2pt;"> and subject to compliance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">, if at any time prior to the approval and adoption of this Agreement by the Required Company Stockholder Vote, the Company receives a bona fide written Superior Offer, the Company Board may make a Company Board Adverse Recommendation Change, if, but only if, following the receipt of and on account of such Superior Offer, (i)&#160;the Company Board determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Company Board Recommendation would constitute a violation of the Company Board&#8217;s fiduciary duties under applicable Law; (ii)&#160;the Company has, and has caused its financial advisors and outside legal counsel to, during the Notice Period (as defined below), negotiate with Parent in good faith to make such adjustments to the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a Superior Offer and (iii)&#160;if after Parent shall have delivered to the Company a written offer to alter the terms or conditions of this Agreement during the Notice Period, the Company Board shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Company Board Recommendation would constitute a violation of the Company Board&#8217;s fiduciary duties under applicable Law (after taking into account such alterations of the terms and conditions of this Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (x)&#160;Parent receives written notice from the Company confirming that the Company Board has determined to change its recommendation at least four Business Days in advance of the Company Board Adverse Recommendation Change (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Notice Period</font><font style="letter-spacing:0.2pt;">&#8221;), which notice shall include a description in reasonable detail of the reasons for such Company Board Adverse Recommendation Change, and written copies of any relevant transaction agreements with any party making a potential Superior Offer, (y)&#160;during any Notice Period, Parent shall be entitled to deliver to the Company one or more counterproposals to such Acquisition Proposal and the Company will, and cause its Representatives to, negotiate with Parent in good faith (to the extent Parent desires to negotiate) to make such adjustments in the terms and conditions of this Agreement so that the applicable Acquisition Proposal ceases to constitute a Superior Offer, and (z)&#160;in the event of any material amendment to any Superior Offer (including any revision in the amount, form or mix of consideration the Company&#8217;s stockholders would receive as a result of such potential Superior Offer), the Company shall be required to provide Parent with notice of such material amendment and the Notice Period shall be extended, if applicable, to ensure that at least two Business Days remain in the Notice Period following such notification during which the parties shall comply again with the requirements of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(c)</font><font style="letter-spacing:0.2pt;"> and the Company Board shall not make a Company Board Adverse Recommendation Change prior to the end of such Notice Period as so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Company&#8217;s obligation to solicit the consent of its stockholders to sign the Company Stockholder Written Consent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(b)</font><font style="letter-spacing:0.2pt;"> shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or other Acquisition Proposal or by any withdrawal or modification of the Company Board Recommendation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholders&#8217; Meeting</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Promptly after the Registration Statement has been declared effective by the SEC under the Securities Act, Parent shall take all action necessary under applicable Law to call, give notice of and hold a meeting of the holders of Parent Common Stock for the purpose of seeking approval of this Agreement and the Contemplated Transactions, including: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;the amendment of Parent&#8217;s certificate of incorporation to effect the Nasdaq Reverse Split; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;the issuance of shares of Parent Common Stock to the Company&#8217;s stockholders in connection with the Contemplated Transactions pursuant to the terms of this Agreement; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;the change of control of Parent resulting from the Merger pursuant to Nasdaq rules (the matters contemplated by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;5.4(a)(i)</font><font style="letter-spacing:0.2pt;"> through </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.4(a)(iii)</font><font style="letter-spacing:0.2pt;"> are referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholder Matters,</font><font style="letter-spacing:0.2pt;">&#8221; and such meeting, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholders&#8217; Meeting</font><font style="letter-spacing:0.2pt;">&#8221;); and </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;the approval of the Equity Plan&#160;Amendments. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Parent Stockholders&#8217; Meeting shall be held as promptly as practicable after the Registration Statement is declared effective under the Securities Act, and in any event no later than 45&#160;days after the effective date of the Registration Statement. Parent shall take reasonable measures to ensure that all proxies solicited in connection with the Parent Stockholders&#8217; Meeting are solicited in compliance with all applicable Law. Notwithstanding anything to the contrary contained herein, if on the date of the Parent Stockholders&#8217; Meeting, or a date preceding the date on which the Parent Stockholders&#8217; Meeting is scheduled, Parent reasonably believes that (i)&#160;it will not receive proxies sufficient to obtain the Required Parent Stockholder Vote, whether or not a quorum would be present or (ii)&#160;it will not have sufficient shares of Parent Common Stock represented (whether in person or by proxy) to constitute a quorum necessary to conduct the business of the Parent Stockholders&#8217; Meeting, Parent may (and at the Company&#8217;s request, Parent shall) postpone or adjourn, or make one or more successive postponements or adjournments of, the Parent Stockholders&#8217; Meeting as long as the date of the Parent Stockholders&#8217; Meeting is not postponed or adjourned more than an aggregate of 30 calendar days in connection with any postponements or adjournments in reliance on the preceding sentence. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent agrees that, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(d)</font><font style="letter-spacing:0.2pt;">: (i)&#160;the Parent Board shall recommend that the holders of Parent Common Stock vote to approve the Parent Stockholder Matters and shall use its reasonable best efforts to solicit such approval within the timeframe set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(b)</font><font style="letter-spacing:0.2pt;">; (ii)&#160;the Proxy Statement/Prospectus shall include a statement to the effect that the Parent Board recommends that the holders of Parent Common Stock vote to approve the Parent Stockholder Matters (the recommendation of the Parent Board with respect to the Parent Stockholder Matters being referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Board Recommendation</font><font style="letter-spacing:0.2pt;">&#8221;); and (iii)&#160;the Parent Board Recommendation shall not be withheld, amended, withdrawn or modified (and the Parent Board shall not publicly propose to withhold, amend, withdraw or modify the Parent Board Recommendation) in a manner adverse to the Company, and no resolution by the Parent Board or any committee thereof to withdraw of modify the Parent Board Recommendation in a manner adverse to the Company or to adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any Acquisition Proposal shall be adopted or proposed (the actions set forth in the foregoing clause (iii), collectively, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Board Adverse Recommendation Change</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(c)</font><font style="letter-spacing:0.2pt;"> and subject to compliance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">, if at any time prior to the approval of Parent Stockholder Matters by the Required Parent Stockholder Vote, Parent receives a bona fide written Superior Offer, the Parent Board may make a Parent Board Adverse Recommendation Change, if, but only if, following the receipt of and on account of such Superior Offer, (i)&#160;the Parent Board determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Parent Board Recommendation would constitute a violation of the Parent Board&#8217;s fiduciary duties under applicable Law; (ii)&#160;Parent has, and has caused its financial advisors and outside legal counsel to, during the Notice Period, negotiate with the Company in good faith to make such adjustments to the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a Superior Offer and (iii)&#160;if after the Company shall have delivered to Parent a written offer to alter the terms or conditions of this Agreement during the Notice Period, the Parent Board shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Parent Board Recommendation would constitute a violation of the Parent Board&#8217;s fiduciary duties under applicable Law (after taking into account such alterations of the terms and conditions of this Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that (x)&#160;the Company receives written notice from Parent confirming that the Parent Board has determined to change its recommendation during the Notice Period, which notice shall include a description in reasonable detail of the reasons for such Parent Board Adverse Recommendation Change, and written copies of any relevant transaction with any party making a potential Superior Offer, (y)&#160;during any Notice Period, the Company shall be entitled to deliver to Parent one or more counterproposals to such Acquisition Proposal and Parent will, and will cause </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5OCC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">its Representatives to, negotiate with the Company in good faith (to the extent the Company desires to negotiate) to make such adjustments in the terms and conditions of this Agreement so that the applicable Acquisition Proposal ceases to constitute a Superior Offer, and (z)&#160;in the event of any material amendment to any Superior Offer (including any revision in the amount, form or mix of consideration the Parent&#8217;s stockholders would receive as a result of such potential Superior Offer), Parent shall be required to provide the Company with notice of such material amendment and the Notice Period shall be extended, if applicable, to ensure that at least two Business Days remain in the Notice Period following such notification during which the parties shall comply again with the requirements of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(d)</font><font style="letter-spacing:0.2pt;"> and the Parent Board shall not make a Parent Board Adverse Recommendation Change prior to the end of such Notice Period so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Parent&#8217;s obligation to solicit the consent of its stockholders to approve the Parent Stockholder Matters shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or other Acquisition Proposal or by any withdrawal or modification of the Parent Board Recommendation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Nothing contained in this Agreement shall prohibit Parent or the Parent Board from (i)&#160;complying with Rules 14d-9 and 14e-2(a) under the Exchange Act, (ii)&#160;issuing a &#8220;stop, look and listen&#8221; communication or similar communication of the type contemplated by Rule&#160;14d-9(f) under the Exchange Act or (iii)&#160;otherwise making any disclosure to Parent&#8217;s stockholders if, in the case of the foregoing clause (iii), the Parent Board determines in good faith, after consultation with its outside legal counsel, that failure to make such disclosure would be inconsistent with applicable Law, including its fiduciary duties under applicable Law; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that in no event shall Parent or the Parent Board make a Parent Board Adverse Recommendation Change except in accordance with the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(d)</font><font style="letter-spacing:0.2pt;"> above. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">5.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Options, Company Convertible Note, Parent Warrants, and Parent Equity Awards</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(d)</font><font style="letter-spacing:0.2pt;">, at the Effective Time, each Company Option that is outstanding and unexercised immediately prior to the Effective Time under the Company Plan and that, following assumption by Parent at the Effective Time, will be eligible to be registered on Form S-8, whether or not vested, shall be converted into and become an option to purchase Parent Common Stock, and Parent shall assume the Company Plan and each such Company Option in accordance with the terms (as in effect as of the date of this Agreement) of the Company Plan and the terms of the stock option agreement by which such Company Option is evidenced (but with changes to such documents as Parent and the Company mutually agree are appropriate to reflect the substitution of the Company Options for an option to purchase shares of Parent Common Stock). All other Company Options that are outstanding and unexercised as of immediately prior to the Effective Time shall be canceled immediately prior to the Effective Time. All rights with respect to Company Common Stock subject to Company Options assumed by Parent shall thereupon be converted into rights with respect to Parent Common Stock. Accordingly, from and after the Effective Time: (i)&#160;each Company Option assumed by Parent may be exercised solely for shares of Parent Common Stock; (ii)&#160;the number of shares of Parent Common Stock subject to each Company Option assumed by Parent shall be determined by multiplying (A)&#160;the number of shares of Company Common Stock that were subject to such Company Option, as in effect immediately prior to the Effective Time, by (B)&#160;the Exchange Ratio, and rounding the resulting number down to the nearest whole number of shares of Parent Common Stock; (iii)&#160;the per share exercise price for the Parent Common Stock issuable upon the exercise of each Company Option assumed by Parent shall be determined by dividing (A)&#160;the per share exercise price of Company Common Stock subject to such Company Option, as in effect immediately prior to the Effective Time, by (B)&#160;the Exchange Ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv)&#160;any restriction on the exercise of any Company Option assumed by Parent shall continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Company Option shall otherwise remain unchanged; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that: (x)&#160;to the extent provided under the terms of a Company Option and the Company Plan, such Company Option may be further adjusted as necessary to reflect Parent&#8217;s substitution of the Company Options with options to purchase Parent Common Stock (such as by making any change in control or similar definition relate to Parent and having any provision that </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5OOA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">provides for the adjustment of Company Options upon the occurrence of certain corporate events relate to corporate events that relate to Parent and/or Parent Common Stock); and (y)&#160;the Parent Board or a committee thereof shall succeed to the authority and responsibility of the Company Board or any committee thereof with respect to each Company Option assumed by Parent. Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;">, the conversion of each Company Option (regardless of whether such option qualifies as an &#8220;incentive stock option&#8221; within the meaning of Section&#160;422 of the Code) into an option to purchase shares of Parent Common Stock shall be made in a manner consistent with Treasury Regulation&#160;Section&#160;1.424-1, such that the conversion of a Company Option shall not constitute a &#8220;modification&#8221; of such Company Option for purposes of Section&#160;409A or Section&#160;424 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent shall file with the SEC, promptly after the Effective Time, a registration statement on Form S-8 (or any successor or alternative form), relating to the shares of Parent Common Stock issuable with respect to Company Options assumed by Parent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(d)</font><font style="letter-spacing:0.2pt;">, as of immediately after the Effective Time, the Company Convertible Note shall convert into shares of Parent Common Stock in accordance with the Convertible Note Conversion Agreement, as amended or supplemented. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Prior to the Effective Time, the Company shall take all actions that may be necessary (under the Company Plan and otherwise) to effectuate the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(c)</font><font style="letter-spacing:0.2pt;"> and to ensure that, from and after the Effective Time, holders of Company Options and the Company Convertible Note have no rights with respect thereto other than those specifically provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Prior to the Closing, Parent shall notify the holders of the Parent Warrants of the Contemplated Transactions in accordance with the terms of the applicable Parent Warrants and, at the Effective Time, each Parent Warrant that is outstanding and unexercised immediately prior to the Effective Time, shall survive the Closing and remain outstanding in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Prior to the Effective Time, the Parent Board shall have the right, in its sole discretion, to adopt appropriate resolutions and take all other actions necessary and appropriate to provide that each Parent RSU and/or each Parent Option, to the extent unvested immediately prior to the Effective Time, be accelerated in full effective as of immediately prior to the Effective Time. At the Effective Time, each Parent RSU and/or each Parent Option that is outstanding and unexercised immediately prior to the Effective Time, whether or not vested, shall survive the Closing and remain outstanding in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Indemnification of Officers and Directors</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;From the Effective Time through the sixth anniversary of the date on which the Effective Time occurs, each of Parent and the Surviving Corporation shall, jointly and severally, indemnify and hold harmless each person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Effective Time, a director, officer, fiduciary or agent of Parent or the Company and their respective Subsidiaries, respectively (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">D&amp;O Indemnified Parties</font><font style="letter-spacing:0.2pt;">&#8221;), against all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or completed proceeding arising out of or pertaining to the fact that the D&amp;O Indemnified Party is or was a director, officer, fiduciary or agent of Parent or of the Company or their respective Subsidiaries, whether asserted or claimed prior to, at or after the Effective Time, in each case, to the fullest extent permitted under applicable Law. Each D&amp;O Indemnified Party will be entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation from each of Parent and the Surviving Corporation, jointly and severally, upon receipt by Parent or the Surviving Corporation from the D&amp;O Indemnified Party of a request therefor; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such person to whom expenses are advanced provides an undertaking to Parent, to the extent then required by the DGCL, to repay such advances if it is ultimately determined that such person is not entitled to indemnification. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The provisions of Parent&#8217;s Organizational Documents with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Parent that are presently set forth in the certificate of incorporation and bylaws of Parent shall not be amended, modified or repealed for a period of six&#160;years from the Effective Time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers or directors of Parent, unless such modification is required by applicable Law. The certificate of incorporation and bylaws of the Surviving Corporation shall contain, and Parent shall cause the certificate of incorporation and bylaws of the Surviving Corporation to so contain, provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers as those presently set forth in the certificate of incorporation and bylaws of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;From and after the Effective Time, (i)&#160;the Surviving Corporation shall fulfill and honor, and Parent shall cause the Surviving Corporation to fulfill and honor, in all respects the obligations of the Company to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under the Company&#8217;s Organizational Documents and pursuant to any indemnification agreements between the Company and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time and (ii)&#160;Parent shall fulfill and honor in all respects the obligations of Parent to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under Parent&#8217;s Organizational Documents and pursuant to any indemnification agreements between Parent and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;From and after the Effective Time, Parent shall maintain directors&#8217; and officers&#8217; liability insurance policies, with an effective date as of the Closing Date, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Parent. In addition, prior to the Effective Time, Parent shall purchase a six-year prepaid &#8220;tail policy&#8221; through Parent&#8217;s recognized broker of record for the non-cancellable extension of the directors&#8217; and officers&#8217; liability coverage of Parent&#8217;s existing directors&#8217; and officers&#8217; insurance policies for a claims reporting or discovery period of at least six&#160;years from and after the Effective Time with respect to any claim related to any period of time at or prior to the Effective Time with terms, conditions, and retentions that are no less favorable than the coverage provided under Parent&#8217;s existing policies as of the date of this Agreement and with limits of liability no less than $20,000,000, in each case with respect to any actual or alleged error, misstatement, misleading statement, act, omission, neglect, breach of duty or any matter claimed against a director or officer of Parent by reason of him or her serving in such capacity that existed or occurred at or prior to the Effective Time (including in connection with this Agreement or the Contemplated Transactions) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">D&amp;O Tail Policy</font><font style="letter-spacing:0.2pt;">&#8221;). For clarity, the cost of any such D&amp;O Tail Policy, to the extent unpaid as of the Effective Time, shall reduce the amount of Net Cash. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;From and after the Effective Time, Parent shall pay all expenses, including reasonable attorneys&#8217; fees, that are incurred by the persons referred to in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;"> in connection with their successful enforcement of the rights provided to such persons in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;The provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;"> are intended to be in addition to the rights otherwise available to the current and former officers and directors of Parent and the Company by Law, charter, statute, bylaw or agreement, and shall operate for the benefit of, and shall be enforceable by, each of the D&amp;O Indemnified Parties, their heirs and their Representatives. The obligations set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;"> shall not be terminated, amended or otherwise modified in any manner that adversely affects any D&amp;O Indemnified Party (and their heirs and Representatives) without the prior written consent of such affected D&amp;O Indemnified Party (or their heirs and Representatives), </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;In the event Parent or the Surviving Corporation or any of their respective successors or assigns (i)&#160;consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger, or (ii)&#160;transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Parent or the Surviving Corporation, as the case may be, shall succeed to the obligations set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">. Parent shall cause the Surviving Corporation to perform all of the obligations of the Surviving Corporation under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5AIA">&#8203;</a><a name="t5TIP">&#8203;</a><a name="t5DTP">&#8203;</a><a name="t51MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Additional Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to each Party&#8217;s obligations in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, the Parties shall use commercially reasonable efforts to cause to be taken all actions necessary to consummate the Contemplated Transactions. Without limiting the generality of the foregoing, each Party: (a)&#160;shall make all filings and other submissions (if any) and give all notices (if any) required to be made and given by such Party in connection with the Contemplated Transactions; (b)&#160;shall use commercially reasonable efforts to obtain each Consent (if any) reasonably required to be obtained by such Party in connection with the Contemplated Transactions pursuant to any applicable Law or any Contracts set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.7</font><font style="letter-spacing:0.2pt;">; (c)&#160;shall use reasonable best efforts to lift any injunction prohibiting, or any other legal bar to, the Contemplated Transactions; (d)&#160;in the case of Parent, commercially reasonable efforts to resolve the matters set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;N</font><font style="letter-spacing:0.2pt;">, either without any Material Continuing Obligation, except for obligations which would reduce Net Cash pursuant to the definition thereof; and (e)&#160;shall use commercially reasonable efforts to satisfy the conditions precedent to the consummation of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Disclosure</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The initial press release relating to this Agreement shall be a joint press release issued by, and mutually acceptable to, the Company and Parent and thereafter Parent and the Company shall obtain the consent of the other before issuing any further press release(s) or otherwise making any public statement or making any announcement to Parent Associates or Company Associates (to the extent not previously issued or made in accordance with this Agreement) with respect to the Contemplated Transactions and shall not issue any such press release, public statement or announcement to Parent Associates or Company Associates without the other Party&#8217;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing: (a)&#160;each Party may, without such consultation or consent, make any public statement in response to questions from the press, analysts, investors or those attending industry conferences, make internal announcements to employees and make disclosures in Parent SEC Documents, so long as such statements are consistent with previous press releases, public disclosures or public statements made jointly by the Parties (or individually, if approved by the other Party); (b)&#160;a Party may, without the prior consent of the other Party hereto but subject to giving advance notice to the other Party, issue any such press release or make any such public announcement or statement such Party has determined in good faith, upon the advice of outside legal counsel, is required by applicable Law; and (c)&#160;a Party need not consult with the any other Party in connection with such portion of any press release, public statement or filing to be issued or made pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(e)</font><font style="letter-spacing:0.2pt;"> or with respect to any Acquisition Proposal, Parent Board Adverse Recommendation Change or Company Board Adverse Recommendation Change, as applicable, or with respect to Parent only, pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(f)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Listing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;During the Pre-Closing Period, Parent shall use its commercially reasonable efforts: (a)&#160;to maintain its existing listing on Nasdaq and to obtain approval of the listing of the combined corporation on Nasdaq; (b)&#160;to the extent required by the rules and regulations of Nasdaq, to prepare and submit to Nasdaq a notification form for the listing of the shares of Parent Common Stock to be issued in connection with the Contemplated Transactions; (c)&#160;to prepare and timely submit to Nasdaq a notification form of the Nasdaq Reverse Split and to submit a copy of the amendment to Parent&#8217;s certificate of incorporation to effect the Nasdaq Reverse Split certified by the Secretary of State of the State of Delaware to Nasdaq on the Closing Date; (d)&#160;to the extent required by Nasdaq Listing Rule&#160;5110, to file an initial listing application for the Parent Common Stock on Nasdaq (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Listing Application</font><font style="letter-spacing:0.2pt;">&#8221;) and to cause such Nasdaq Listing Application to be approved; and (e)&#160;in the event of receipt of a Nasdaq delisting determination, Parent will request a hearing to appeal the delisting determination and will pay the appropriate fee to Nasdaq to appeal the delisting determination. Prior to the Effective Time, each Party will promptly inform the other Party of all verbal or written communications between Nasdaq and such Party or its Representatives. The Parties will use commercially reasonable efforts to coordinate with respect to compliance with Nasdaq rules and regulations. The Company will cooperate with Parent as reasonably requested by Parent with respect to the Nasdaq Listing Application and promptly furnish to Parent all information concerning the Company and its stockholders that may be required or reasonably requested in connection with any action contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.9</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For U.S. federal income Tax purposes, (i)&#160;the Parties intend that (A)&#160;the Merger qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, and (B)&#160;the Nasdaq Reverse Split qualify as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(e) of the Code (collectively, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5PSB">&#8203;</a><a name="t5AOP">&#8203;</a><a name="t5OCA">&#8203;</a><a name="t51MP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Intended Tax Treatment</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;this Agreement is intended to be, and is hereby adopted as, a &#8220;plan of reorganization&#8221; for purposes of Section&#160;354 and 361 of the Code and Treasury Regulations&#160;Section&#160;1.368-2(g) and 1.368-3(a), to which Parent, Merger Sub and the Company are parties under Section&#160;368(b) of the Code. The Parties shall treat and shall not take any tax reporting position inconsistent with the Intended Tax Treatment, unless otherwise required pursuant to a &#8220;determination&#8221; within the meaning of Section&#160;1313(a) of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Parties acknowledge and agree that each has relied upon the advice of its own tax advisors in connection with the Merger and the Contemplated Transactions and that none of the Company, on the one hand, and Parent and Merger Sub, on the other hand, makes any representation or warranty as to the Intended Tax Treatment, other than the representations and warranties contained in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;2.16(h)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.16(h)</font><font style="letter-spacing:0.2pt;">, respectively. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Parties shall use their respective commercially reasonable efforts to cause the Merger to qualify, and will not take any action or cause or permit any action to be taken which action would reasonably be expected to prevent the Merger from qualifying, for the Intended Tax Treatment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Parent shall prepare and file, or cause to be prepared and filed, any IRS Forms 8937 that are required to be filed in connection with the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;In the event that the SEC requests or requires a tax opinion in connection with the Contemplated Transactions, each of Parent and the Company shall use its commercially reasonable efforts to deliver a &#8220;Tax Representation Letter,&#8221; signed by an officer of Parent and/or the Company, as applicable, containing customary representations of Parent and Merger Sub or Company, as applicable, in each case, as shall be reasonably necessary or appropriate to enable legal counsel to provide an opinion relating to the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Legends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall be entitled to place appropriate legends on the book entries evidencing any shares of Parent Common Stock to be received in the Merger by equityholders of the Company who may be considered &#8220;affiliates&#8221; of Parent for purposes of Rules 144 and 145 under the Securities Act reflecting the restrictions set forth in Rules 144 and 145 and to issue appropriate stop transfer instructions to the transfer agent for Parent Common Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Directors and Officers</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall cause, effective as of the Effective Time, the Parent Board to be composed of seven members, to serve in the respective director class set forth opposite such member&#8217;s name on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;">, which shall consist of (a)&#160;one such member designated by Parent as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> under the heading &#8220;Directors&#8221; &#8203;(the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Designee</font><font style="letter-spacing:0.2pt;">&#8221;), and (b)&#160;six such members designated by the Company as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> under the heading &#8220;Directors&#8221; &#8203;(the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Designees</font><font style="letter-spacing:0.2pt;">&#8221;). Furthermore, the Parties shall take all necessary action so that the Persons listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> under the headings &#8220;Officers&#8221; or &#8220;Directors&#8221;, as applicable, are elected or appointed, as applicable, to the positions of officers or directors of Parent and the Surviving Corporation, as set forth therein, to serve in such positions effective as of the Effective Time until the earlier of their resignation or removal or until their respective successors are duly elected or appointed and qualified, as the case may be. If any Person named in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> as a director is unable or unwilling to serve as a director of Parent after the Effective Time, as set forth therein, the Party appointing such Person shall designate a successor. Other than with respect to the Parent Designee, prior to the Closing, Parent shall deliver to the Company written resignations, in a form reasonably satisfactory to the Company, of each pre-Closing member of the Parent Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Termination of Certain Agreements and Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company shall cause the Investor Agreements (excluding the Company Stockholder Support Agreements and the Company Lock-Up Agreements) to be terminated, contingent upon, and to take effect as of immediately prior to, the Effective Time, without any liability being imposed on the part of Parent or the Surviving Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.14&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Section&#160;16 Matters</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Prior to the Effective Time, Parent shall take all such steps as may be required to cause any acquisitions of Parent Common Stock (including derivative securities with respect to Parent Common Stock) in connection with the Contemplated Transactions, by each individual who is or is reasonably expected to become, subject to the reporting requirements of Section&#160;16(a) of the Exchange Act with respect to Parent, to be exempt under Rule&#160;16b-3 under the Exchange Act. At least 30 calendar days prior to the Closing Date, the Company shall furnish the following information to Parent for each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5EPS">&#8203;</a><a name="t51CE">&#8203;</a><a name="t5FST">&#8203;</a><a name="t5SIA">&#8203;</a><a name="t5LEP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">individual who, immediately after the Effective Time, will become subject to the reporting requirements of Section&#160;16(a) of the Exchange Act with respect to Parent: (a)&#160;the number of shares of Company Capital Stock owned by such individual and expected to be exchanged for shares of Parent Common Stock pursuant to the Merger; and (b)&#160;the number of other derivative securities (if any) with respect to Company Capital Stock owned by such individual and expected to be converted into shares of Parent Common Stock, restricted stock awards to acquire Parent Common Stock or derivative securities with respect to Parent Common Stock in connection with the Merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.15&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Cooperation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Party shall cooperate reasonably with the other Party and shall provide the other Party with such assistance as may be reasonably requested for the purpose of facilitating the performance by each Party of its respective obligations under this Agreement and to enable the combined entity to continue to meet its obligations following the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.16&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Allocation Certificates</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company will prepare and deliver to Parent at least two Business Days prior to the Closing Date a certificate signed by the Chief Executive Officer or Chief Financial Officer of the Company setting forth, as of immediately prior to the Effective Time, after giving effect to the Pre-Closing Financing: (i)&#160;each holder of Company Capital Stock and Company Options; (ii)&#160;such holder&#8217;s name and address; (iii)&#160;the number and type of Company Capital Stock held and/or underlying the Company Options as of immediately prior to the Effective Time for each such holder and the per share exercise price of each Company Option; and (iv)&#160;the number of shares of Parent Common Stock to be issued to such holder, or to underlie any Parent Option to be issued to such holder, pursuant to this Agreement in respect of the Company Capital Stock or Company Options held by such holder as of immediately prior to the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Allocation Certificate</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent will prepare and deliver to the Company at least two Business Days prior to the Closing Date a certificate signed by the Chief Executive Officer or Chief Financial Officer of Parent, setting forth (as of immediately prior to the Effective Time), the number of Parent Outstanding Shares and each component thereof (broken down by outstanding shares of Parent Common Stock, Parent Options, Parent RSUs and Parent Warrants). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.17&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Financial Statements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company will furnish to Parent Company Financial Statements required to be included in the Registration Statement prior to the initial filing of such Registration Statement and in no event later than 15 calendar days after the date hereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that, for clarity, the final, signed audit opinion with respect to such Company Financial Statements shall not be provided until the date of filing of the Registration Statement. The Company shall also furnish to Parent unaudited interim financial statements for each interim period completed prior to Closing required to be included in the Registration Statement prior to the initial filing of such Registration Statement and in no event later than 15 calendar days after the date hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.18&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Takeover Statutes</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any Takeover Statute is or may become applicable to the Contemplated Transactions, each of the Company, the Company Board, Parent and the Parent Board, as applicable, shall grant such approvals and take such actions as are necessary so that the Contemplated Transactions may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise act to eliminate or minimize the effects of such statute or regulation on the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.19&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Litigation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Party shall give the other Party the opportunity to participate in the settlement or defense of any stockholder litigation brought or threatened against such Party or any of its directors and officers relating to or challenging this Agreement or the consummation of the Contemplated Transactions (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transaction Litigation</font><font style="letter-spacing:0.2pt;">&#8221;), and no such settlement shall be agreed to without the prior written consent of the other Party, which consent shall not be unreasonably withheld, conditioned or delayed. Without limiting in any way the Parties&#8217; obligations under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.19</font><font style="letter-spacing:0.2pt;">, each of Parent and the Company will cooperate, and cause its Subsidiaries to cooperate, and shall use its reasonable best efforts to cause its Representatives to cooperate, in the defense against any Transaction Litigation. All costs and expenses, including attorney&#8217;s fees and settlement costs, incurred in connection with any Transaction Litigation shall be treated in accordance with the definition of Net Cash. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t52BE">&#8203;</a><a name="t5DPT">&#8203;</a><a name="t5RSP">&#8203;</a><a name="t5SDF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.20&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Employee Benefits</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Immediately following the Effective Time, the employment and service, as applicable, of each employee, independent contractor or officer of Parent, subject to the exceptions listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Terminated Parent Associate</font><font style="letter-spacing:0.2pt;">&#8221;) who remains employed or engaged immediately prior to the Effective Time shall automatically terminate. Each such termination shall be deemed to be an involuntary termination without &#8220;cause&#8221; after a &#8220;change in control transaction&#8221; or a &#8220;covered termination&#8221;, as applicable, and Parent shall comply with the terms of any employment, severance, retention, change of control, or similar Contract or Parent Benefit Plan specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that any Terminated Parent Associate who is an employee of Parent as of the Effective Time and is terminated in accordance with the immediately preceding sentence and is not otherwise party to such Contract or subject to such a Parent Benefit Plan, shall be paid severance by Parent equal to two weeks of base salary plus one week of base salary for each full or partial year of employment with Parent, but no less than a minimum of 12 weeks of base salary, subject to such releases of claims against Parent and the Company and their agents, representatives, and other customary releases as the Company shall require. Notwithstanding the forgoing, any severance pay or severance benefits payable, including payments to cover COBRA, to Terminated Parent Associates pursuant to any employment, severance, retention, change of control, or similar Contract or Parent Benefit Plan specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule as a result of the Effective Time, to the maximum extent permitted by Code Section&#160;409A, be paid in lump sum as soon as practicable following the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that the Terminated Parent Associate consents to the lump sum severance payment (to the extent required). From time to time after the date hereof, Parent may update </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule upon the prior written consent of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each Person, other than any Person who has previously entered into a Contract with Parent providing for the payment of severance benefits and/or is a Terminated Parent Associate, who is an employee of Parent as of the Effective Time and who is terminated by Parent following the Effective Time shall be entitled to severance benefits to be paid by Parent pursuant to Parent&#8217;s current severance practice, but in no event shall such severance benefits be less than two weeks of base salary plus one week of base salary for each full or partial year of employment with Parent, but no less than a minimum of 12 weeks of base salary, subject to such releases of claims against Parent and the Company and their agents, representatives, and other customary releasees as the Company shall require. For the avoidance of doubt, all such payments under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(b)</font><font style="letter-spacing:0.2pt;"> shall not be included in the calculation of Parent Transaction Expenses nor in the calculation of Net Cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Prior to the Effective Time, Parent may (a)&#160;declare a dividend (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">&#8221;) to its common stockholders of record consisting of (i)&#160;the right to receive one contingent value right (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR</font><font style="letter-spacing:0.2pt;">&#8221;) for each outstanding share of Parent Common Stock held by such stockholder as of such date, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;D</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) and (ii)&#160;cash in an amount not to exceed $25,000,000 in the aggregate subject to satisfaction of Parent&#8217;s obligation set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.5</font><font style="letter-spacing:0.2pt;"> and (b)&#160;make any necessary equitable adjustment required under the Parent Stock Plans. The record date for the Pre-Closing Dividend shall be a date agreed by Parent and the Company prior to the Effective Time and the payment date for which shall be three Business Days after the Effective Time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the payment of such dividend may be conditioned upon the occurrence of the Effective Time. In connection with the Pre-Closing Dividend, Parent shall cause the CVR Agreement to be duly authorized, executed and delivered by Parent and a rights agent selected by Parent with the Company&#8217;s prior approval (such approval not to be unreasonably withheld, delayed or conditioned). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.22&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Reverse Split</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall submit to Parent&#8217;s stockholders at the Parent Stockholders Meeting a proposal to approve and adopt an amendment to Parent&#8217;s certificate of incorporation to authorize the Parent Board to effect the Nasdaq Reverse Split, and shall take such other actions as shall be reasonably necessary to effectuate the Nasdaq Reverse Split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.23&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent SEC Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;From the date of this Agreement until the Effective Time, Parent shall use commercially reasonable efforts to timely file with the SEC all Parent SEC Documents. As of its filing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5OMS">&#8203;</a><a name="tS6PT">&#8203;</a><a name="t6RNT">&#8203;</a><a name="t6AIP">&#8203;</a><a name="t6TES">&#8203;</a><a name="t6ORS">&#8203;</a><a name="tS7CP">&#8203;</a><a name="t7ORT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">date, or if amended after the date of this Agreement, as of the date of the last such amendment, each Parent SEC Document filed by Parent with the SEC shall comply in all material respects with the applicable requirements of the Exchange Act and the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.24&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Obligations of Merger Sub</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent will take all actions necessary to cause Merger Sub to perform its obligations under this Agreement and to consummate the Merger on the terms and conditions set forth in this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;6.&nbsp;&nbsp;&nbsp;CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The obligations of each Party to effect the Merger and otherwise consummate the Contemplated Transactions to be consummated at the Closing are subject to the satisfaction or, to the extent permitted by applicable Law, the written waiver by each of the Parties, at or prior to the Closing, of each of the following conditions: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Restraints</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No temporary restraining order, preliminary or permanent injunction or other order preventing the consummation of the Contemplated Transactions shall have been issued by any court of competent jurisdiction or other Governmental Body of competent jurisdiction and remain in effect and there shall not be any Law which has the effect of making the consummation of the Contemplated Transactions illegal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(i)&#160;Parent shall have obtained the Required Parent Stockholder Vote and (ii)&#160;the Company shall have obtained the Required Company Stockholder Vote. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Listing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The existing shares of Parent Common Stock shall have been continually listed on Nasdaq as of and from the date of this Agreement through the Closing Date, the approval of the listing of additional shares of Parent Common Stock on Nasdaq shall have been obtained and the shares of Parent Common Stock to be issued in the Merger and the Conversion pursuant to this Agreement shall have been approved for listing on Nasdaq. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Effectiveness of Registration Statement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Registration Statement shall have become effective in accordance with the provisions of the Securities Act, and shall not be subject to any stop order or proceeding (or threatened proceeding by the SEC) seeking a stop order with respect to the Registration Statement that has not been withdrawn. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.</font>
          <br >
        </div>
        <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The obligations of Parent and Merger Sub to effect the Merger and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by Parent, at or prior to the Closing, of each of the following conditions: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company Fundamental Representations shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct in all material respects as of such date). The Company Capitalization Representations shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (x)&#160;for such inaccuracies which are </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis</font><font style="letter-spacing:0.2pt;">, individually or in the aggregate, or (y)&#160;for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications as set forth in the preceding clause (x), as of such particular date). The representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.8(b)</font><font style="letter-spacing:0.2pt;"> shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date. The representations and warranties of the Company contained in this Agreement (other than the Company Fundamental Representations, the Company Capitalization Representations and the representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.8(b)</font><font style="letter-spacing:0.2pt;">) shall be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date, except (a)&#160;in each case, or in the aggregate, where the failure to be true and correct would not have a Company Material Adverse Effect (without giving effect to any references therein to any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t7OCT">&#8203;</a><a name="t7CPS">&#8203;</a><a name="t7CPS1">&#8203;</a><a name="t7OIA">&#8203;</a><a name="t7LAT">&#8203;</a><a name="tS8CP">&#8203;</a><a name="t8ORT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Company Material Adverse Effect or other materiality qualifications), or (b)&#160;for those representations and warranties which address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications as set forth in the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or modification to the Company Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company shall have performed or complied in all material respects with the agreements and covenants required to be performed or complied with by it under this Agreement at or prior to the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Closing Certificate</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall have received a certificate executed by the Chief Executive Officer or Chief Financial Officer of the Company certifying (i)&#160;that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;7.1</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.2</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.5</font><font style="letter-spacing:0.2pt;"> have been duly satisfied and (ii)&#160;that the information set forth in the Allocation Certificate delivered by the Company in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.16</font><font style="letter-spacing:0.2pt;"> is true and accurate in all respects as of the Closing Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">FIRPTA Certificate</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall have received (i)&#160;an original signed statement from the Company that the Company Common Stock is not a &#8220;United States real property interest,&#8221; as defined in Section&#160;897(c) of the Code, conforming to the requirements of Treasury Regulations&#160;Section&#160;1.1445-2(c)(3) and 1.897-2(h), and (ii)&#160;an original signed notice to be delivered to the IRS by Parent in accordance with the provisions of Treasury Regulations&#160;Section&#160;1.897-2(h)(2), together with written authorization for Parent to deliver such notice to the IRS on behalf of the Company following the Closing, each dated as of the Closing Date, duly executed by an authorized officer of the Company, and in form and substance reasonably acceptable to Parent. If Parent does not receive the certification and notice described above on or before the Closing Date, Parent&#8217;s sole remedy shall be to withhold from the payments to be made pursuant to this Agreement any required withholding Tax under Section&#160;1445 of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Termination of Investor Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Investor Agreements shall have been terminated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Lock-Up Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company Lock-Up Agreement will continue to be in full force and effect as of immediately following the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;8.&nbsp;&nbsp;&nbsp;ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The obligations of the Company to effect the Merger and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by the Company, at or prior to the Closing, of each of the following conditions: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Fundamental Representations shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct in all material respects as of such date). The Parent Capitalization Representations shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (x)&#160;for such inaccuracies which are </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis</font><font style="letter-spacing:0.2pt;">, individually or in the aggregate, or (y)&#160;for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications set forth in the preceding clause (x), as of such particular date). The representations and warranties of Parent and Merger Sub set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.8(b)</font><font style="letter-spacing:0.2pt;"> shall be true and correct in all respects as of the Closing Date with the same force and effect as if made on and as of such date. The representations and warranties of Parent and Merger Sub contained in this Agreement (other than the Parent Fundamental Representations, the Parent Capitalization Representations or the representations and warranties of Parent and Merger Sub set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.8(b)</font><font style="letter-spacing:0.2pt;">) shall be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date except (a)&#160;in each case, or in the aggregate, where the failure to be true and correct would not have a Parent Material Adverse Effect (without giving effect to any references therein to any Parent Material Adverse Effect or other materiality qualifications), or (b)&#160;for those representations and warranties which address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications as set </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t8OCP">&#8203;</a><a name="t8TCS">&#8203;</a><a name="t8LAT">&#8203;</a><a name="t8PFN">&#8203;</a><a name="tSE9T">&#8203;</a><a name="t9TAM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">forth in the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or modification to the Parent Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent and Merger Sub shall have performed or complied in all material respects with their agreements and covenants required to be performed or complied with by each of them under this Agreement at or prior to the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company shall have received the following documents, each of which shall be in full force and effect: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;a certificate executed by the Chief Executive Officer of Parent confirming that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;8.1</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">8.2</font><font style="letter-spacing:0.2pt;">, and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">8.5</font><font style="letter-spacing:0.2pt;"> have been duly satisfied; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;a copy of the CVR Agreement, duly executed by Parent and the Rights Agent (as defined therein); and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;a written resignation, in a form reasonably satisfactory to the Company, dated as of the Closing Date and effective as of the Closing, executed by each of the officers and directors, from their positions as such, of Parent who are not to continue as officers or directors (as applicable) of Parent after the Closing pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.12</font><font style="letter-spacing:0.2pt;">, such resignation not effecting such officer&#8217;s or directors&#8217; status as an employee (if applicable), including any characterization of their cessation from employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent Lock-Up Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Lock-Up Agreements will continue to be in full force and effect as of immediately following the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Minimum Parent Final Net Cash</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Final Net Cash shall have been determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> to be greater than or equal to $100,000,000. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;9.&nbsp;&nbsp;&nbsp;TERMINATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement may be terminated prior to the Effective Time (whether before or after adoption of this Agreement by the Company&#8217;s stockholders and whether before or after approval of the Parent Stockholder Matters by Parent&#8217;s stockholders, unless otherwise specified below): </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;by mutual written consent of Parent and the Company; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;by either Parent or the Company if the Contemplated Transactions shall not have been consummated by January&#160;31, 2023 (subject to possible extension as provided in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;">, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">End Date</font><font style="letter-spacing:0.2pt;">&#8221;); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the right to terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;"> shall not be available to the Company, on the one hand, or to Parent, on the other hand, if such Party&#8217;s action or failure to act has been a principal cause of the failure of the Contemplated Transactions to occur on or before the End Date and such action or failure to act constitutes a breach of this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, in the event that a request for additional information has been made by any Governmental Body, or in the event that the SEC has not declared effective under the Securities Act the Registration Statement by the date which is 60&#160;days prior to the End Date, then either the Company or Parent shall be entitled to extend the End Date to the date that is 60&#160;days after the date that the SEC has declared effective the Registration Statement under the Securities Act, but in any event no more than 60&#160;days after the original End Date, by written notice to the other Party; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;by either Parent or the Company if a court of competent jurisdiction or other Governmental Body shall have issued a final and nonappealable order, decree or ruling, or shall have taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;by Parent if the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote shall not have been obtained within ten Business Days of the Registration Statement becoming effective in accordance with the provisions of the Securities Act; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t9OTI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">once the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote has been obtained, Parent may not terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(d)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;by either Parent or the Company if (i)&#160;the Parent Stockholders&#8217; Meeting (including, if applicable, following adjournments or postponements thereof as permitted or required pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(b)</font><font style="letter-spacing:0.2pt;">) shall have been held and completed and Parent&#8217;s stockholders shall have taken a final vote on the Parent Stockholder Matters and (ii)&#160;the Parent Stockholder Matters shall not have been approved at the Parent Stockholders&#8217; Meeting (or at any adjournment or postponement thereof) by the Required Parent Stockholder Vote; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the right to terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(e)</font><font style="letter-spacing:0.2pt;"> shall not be available to Parent if Parent&#8217;s actions or failure to act has been a principal cause of the failure of Parent to obtain the Required Parent Stockholder Vote and such action or failure to act constitutes a breach by Parent of this Agreement; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;by the Company (at any time prior to the approval of the Parent Stockholder Matters by the Required Parent Stockholder Vote) if a Parent Triggering Event shall have occurred; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;by Parent (at any time prior to the Required Company Stockholder Vote being obtained) if a Company Triggering Event shall have occurred; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;by the Company, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by Parent or Merger Sub or if any representation or warranty of Parent or Merger Sub shall have become inaccurate, in either case, such that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.1</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.2</font><font style="letter-spacing:0.2pt;"> would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the Company is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that if such inaccuracy in Parent&#8217;s or Merger Sub&#8217;s representations and warranties or breach by Parent or Merger Sub is curable by the End Date by Parent or Merger Sub, then this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy until the expiration of a 30-day period commencing upon delivery of written notice from the Company to Parent or Merger Sub of such breach or inaccuracy and its intention to terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;"> (it being understood that this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy if such breach by Parent or Merger Sub is cured prior to such termination becoming effective); or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;by Parent, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by the Company or if any representation or warranty of the Company shall have become inaccurate, in either case, such that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;"> would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that Parent is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that if such inaccuracy in the Company&#8217;s representations and warranties or breach by the Company is curable by the End Date by the Company then this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy until the expiration of a 30-day period commencing upon delivery of written notice from Parent to the Company of such breach or inaccuracy and its intention to terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;"> (it being understood that this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy if such breach by the Company is cured prior to such termination becoming effective). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Party desiring to terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1</font><font style="letter-spacing:0.2pt;"> (other than pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(a)</font><font style="letter-spacing:0.2pt;">) shall give notice of such termination to the other Party specifying the provisions hereof pursuant to which such termination is made and the basis therefore described in reasonable detail. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Effect of Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event of the termination of this Agreement as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1</font><font style="letter-spacing:0.2pt;">, this Agreement shall be of no further force or effect; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that (a)&#160;this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.2</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10</font><font style="letter-spacing:0.2pt;"> and the definitions of the defined terms in such Sections shall survive the termination of this Agreement and shall remain in full force and effect, and (b)&#160;the termination of this Agreement and the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> shall not relieve any Party of any liability for fraud or for any willful and material breach of any covenant or other obligation contained in this Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t9TF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Expenses; Termination Fees</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, whether or not the Merger is consummated, (i)&#160;all Parent Transaction Expenses shall be paid by Parent (or on behalf of Parent) at or prior to the Closing and (ii)&#160;all Company Transaction Expenses shall be paid by the Company at or prior to the Closing; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that Parent and the Company shall share equally all fees and expenses, other than attorneys&#8217; and accountants&#8217; fees and expenses, incurred in relation to the filings by the Parties under any filing requirement under any Antitrust Law, to the extent applicable to this Agreement and the transactions contemplated hereby; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that Parent and the Company shall also share equally all fees and expenses incurred in relation to the printing and filing with the SEC of the Registration Statement (including any financial statements and exhibits) and any amendments or supplements thereto and paid to a financial printer or the SEC and the filings with Nasdaq pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;5.9(b)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If (i)&#160;this Agreement is terminated by Parent or the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;"> (and the Required Parent Stockholder Vote has not been obtained by Parent) or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(e)</font><font style="letter-spacing:0.2pt;">, (ii)&#160;at any time after the date of this Agreement and prior to the Parent Stockholder Meeting, an Acquisition Proposal with respect to Parent shall have been publicly announced or disclosed or otherwise communicated to Parent or the Parent Board (and shall not have been withdrawn), and (iii)&#160;within 12&#160;months after the date of such termination, Parent consummates any Subsequent Transaction, then Parent shall pay to the Company, upon consummation of a Subsequent Transaction, a nonrefundable fee in an amount equal to $7,600,000 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Termination Fee</font><font style="letter-spacing:0.2pt;">&#8221;). If this Agreement is terminated by the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(f)</font><font style="letter-spacing:0.2pt;">, then Parent shall pay to the Company the Company Termination Fee within two Business Days of such termination. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;If (i)&#160;this Agreement is terminated by Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;"> (and the Required Company Stockholder Vote has not been obtained by the Company) or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(d)</font><font style="letter-spacing:0.2pt;">, (ii)&#160;at any time after the date of this Agreement and before obtaining the Required Company Stockholder Vote, an Acquisition Proposal with respect to the Company shall have been publicly announced or disclosed or otherwise communicated to the Company or the Company Board (and shall not have been withdrawn), and (iii)&#160;within 12&#160;months after the date of such termination, the Company consummates any Subsequent Transaction, then the Company shall pay to Parent, upon consummation of a Subsequent Transaction, a nonrefundable fee in an amount equal to $5,490,000 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Termination Fee</font><font style="letter-spacing:0.2pt;">&#8221;). If this Agreement is terminated by Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(g)</font><font style="letter-spacing:0.2pt;">, then the Company shall pay to Parent the Parent Termination Fee within two Business Days of such termination. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;If this Agreement is terminated by either the Company or Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(e)</font><font style="letter-spacing:0.2pt;"> or by the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(f)</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;">, then Parent shall reimburse the Company for all reasonable out of pocket fees and expenses incurred by the Company in connection with this Agreement and the Contemplated Transactions, up to a maximum of $1,750,000, by wire transfer of same day funds within five Business Days following the date on which the Company submits to Parent true and correct copies of reasonable documentation supporting such expenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;If this Agreement is terminated by Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(d)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(g)</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;">, then the Company shall reimburse Parent for all reasonable out of pocket fees and expenses incurred by Parent in connection with this Agreement and the Contemplated Transactions, up to a maximum of $1,750,000, by wire transfer of same day funds within five Business Days following the date on which Parent submits to the Company true and correct copies of reasonable documentation supporting such expenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;If a Party fails to pay when due any amount payable by it under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, then (i)&#160;such Party shall reimburse the other Party for reasonable costs and expenses (including reasonable fees and disbursements of counsel) incurred in connection with the collection of such overdue amount and the enforcement by the other Party of its rights under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> and (ii)&#160;such Party shall pay to the other Party interest on such overdue amount (for the period commencing as of the date such overdue amount was originally required to be paid and ending on the date such overdue amount is actually paid to the other Party in full) at a rate per annum equal to the &#8220;prime rate&#8221; &#8203;(as published in </font><font style="font-style:italic;letter-spacing:0.2pt;">The Wall Street Journal</font><font style="letter-spacing:0.2pt;"> or any successor thereto) in effect on the date such overdue amount was originally required to be paid. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="tS1P">&#8203;</a><a name="t1ORA">&#8203;</a><a name="t1TAM">&#8203;</a><a name="t103">&#8203;</a><a name="t1ACE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;The Parties agree that, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.2</font><font style="letter-spacing:0.2pt;">, (i)&#160;payment of the fees and expenses in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> shall, in the circumstances in which they are owed in accordance with the terms of this Agreement, constitute the sole and exclusive remedy of each Party following the termination of this Agreement under the circumstances described in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, it being understood that in no event shall either Parent or the Company be required to pay the individual amounts payable pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> on more than one occasion and (ii)&#160;following the termination of this Agreement under the circumstances described in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> and the payment of the fees and expenses set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> by a Party, (A)&#160;such Party shall have no further liability to the other Party in connection with or arising out of this Agreement or the termination thereof, any breach of this Agreement by the other Party giving rise to such termination, or the failure of the Contemplated Transactions to be consummated, (B)&#160;no other Party or their respective Affiliates shall be entitled to bring or maintain any other claim, action or proceeding against such Party or seek to obtain any recovery, judgment or damages of any kind against such Party (or any partner, member, stockholder, director, officer, employee, Subsidiary, Affiliate, agent or other Representative of such Party) in connection with or arising out of this Agreement or the termination thereof, any breach by any such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated and (C)&#160;all other Parties and their respective Affiliates shall be precluded from any other remedy against such Party and its Affiliates, at law or in equity or otherwise, in connection with or arising out of this Agreement or the termination thereof, any breach by such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Each of the Parties acknowledges that (i)&#160;the agreements contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> are an integral part of the Contemplated Transactions, (ii)&#160;without these agreements, the Parties would not enter into this Agreement and (iii)&#160;any amount payable pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> is not a penalty, but rather is liquidated damages in a reasonable amount that will compensate the Party in the circumstances in which such amount is payable. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;10.&nbsp;&nbsp;&nbsp;MISCELLANEOUS PROVISIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Non-Survival of Representations and Warranties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The representations and warranties of the Company, Parent and Merger Sub contained in this Agreement or any certificate or instrument delivered pursuant to this Agreement shall terminate at the Effective Time, and only the covenants that by their terms survive the Effective Time and this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10</font><font style="letter-spacing:0.2pt;"> shall survive the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Amendment</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement may be amended with the approval of the respective boards of directors of the Company, Merger Sub and Parent at any time (whether before or after the adoption and approval of this Agreement by the Company&#8217;s stockholders or before or after obtaining the Required Parent Stockholder Vote); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that after any such approval of this Agreement by a Party&#8217;s stockholders, no amendment shall be made which by Law requires further approval of such stockholders without the further approval of such stockholders. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Company, Merger Sub and Parent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Waiver</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Any provisions hereof may be waived (or the time for performance extended) by the waiving Party solely on such Party&#8217;s own behalf, without the consent of any other Party. No Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Entire Agreement; Counterparts; Exchanges by Electronic Transmission</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement and the other agreements referred to in this Agreement constitute the entire agreement and supersede all prior </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1LJW">&#8203;</a><a name="t1TAS">&#8203;</a><a name="t1ANA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:24pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">agreements and understandings, both written and oral, among or between any of the Parties with respect to the subject matter hereof and thereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect in accordance with its terms. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all Parties by electronic transmission in PDF format shall be sufficient to bind the Parties to the terms and conditions of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Applicable Law; Jurisdiction; Waiver of Jury Trial</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the Parties arising out of or relating to this Agreement or any of the Contemplated Transactions, each of the Parties: (i)&#160;irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware; (ii)&#160;agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (i)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.5</font><font style="letter-spacing:0.2pt;">; (iii)&#160;waives any objection to laying venue in any such action or proceeding in such courts; (iv)&#160;waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any Party; and (v)&#160;agrees that service of process upon such Party in any such action or proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.7</font><font style="letter-spacing:0.2pt;"> of this Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.5</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any Person to serve legal process in any other manner permitted by law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE CONTEMPLATED TRANSACTIONS, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Assignability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and permitted assigns; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that neither this Agreement nor any of a Party&#8217;s rights or obligations hereunder may be assigned or delegated by such Party without the prior written consent of the other Party, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such Party without the other Party&#8217;s prior written consent shall be void and of no effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Notices</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1ATO">&#8203;</a><a name="t1RSP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">if to Parent or Merger Sub: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA</font> <br ><font style="letter-spacing:0.2pt;">Attention: Chief Executive Officer</font> <br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Hogan Lovells US LLP</font> <br ><font style="letter-spacing:0.2pt;">1735 Market St, 23</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">rd</font><font style="letter-spacing:0.2pt;"> Floor</font> <br ><font style="letter-spacing:0.2pt;">Philadelphia, PA 19103</font> <br ><font style="letter-spacing:0.2pt;">Attention: Steve Abrams; Jessica A. Bisignano</font> <br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com; *****@*****.com </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">if to the Company: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font> <br ><font style="letter-spacing:0.2pt;">Philadelphia, Pennsylvania 19104</font> <br ><font style="letter-spacing:0.2pt;">Attention: President and Chief Executive Officer</font> <br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Wilmer Cutler Pickering Hale and Dorr LLP</font> <br ><font style="letter-spacing:0.2pt;">7 World Trade Center</font> <br ><font style="letter-spacing:0.2pt;">250 Greenwich Street</font> <br ><font style="letter-spacing:0.2pt;">New York, NY 10007</font> <br ><font style="letter-spacing:0.2pt;">Attention: Brian A. Johnson; Hal Leibowitz; Christopher Barnstable-Brown</font><br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com; *****@*****.com; *****@*****.com </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the Parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Other Remedies; Specific Performance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any Party does not perform the provisions of this Agreement (including failing to take such actions as are required of it hereunder to consummate the Contemplated Transactions) in accordance with its specified terms or otherwise breaches such provisions. Accordingly, the Parties acknowledge and agree that the Parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance or other equitable relief on the basis that any other Party has an adequate remedy at law or that any award of specific performance or other equitable relief is not an appropriate remedy for any reason at law or in equity. Any Party seeking an injunction or injunctions to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1TPB">&#8203;</a><a name="t101">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">prevent breaches of this Agreement shall not be required to provide any bond or other security in connection with any such order or injunction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Third Party Beneficiaries</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the Parties and the D&amp;O Indemnified Parties to the extent of their respective rights pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Construction</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;References to &#8220;cash,&#8221; &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;For purposes of this Agreement, whenever the context requires: (i)&#160;the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; (ii)&#160;the feminine gender shall include the masculine and neuter genders; and (iii)&#160;the neuter gender shall include masculine and feminine genders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Parties have participated jointly in the negotiating and drafting of this Agreement and agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting Party shall not be applied in the construction or interpretation of this Agreement, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#8220;hereof&#8221;, &#8220;hereto&#8221;, &#8220;hereby&#8221;, &#8220;herein&#8221; and &#8220;hereunder&#8221; and variations thereof refer to this Agreement as a whole and not to any particular provision of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#8220;date hereof&#8221; refers to the date set forth in the initial caption of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;As used in this Agreement, the word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; means the degree to which a subject or other thing extended, and such phrase does not simply mean &#8220;if&#8221;. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Except as otherwise indicated, all references in this Agreement to an &#8220;Article,&#8221; &#8220;Section,&#8221; &#8220;Recital,&#8221; &#8220;preamble,&#8221; &#8220;Annex,&#8221; &#8220;Exhibit&#8221; and &#8220;Schedule&#8221; are intended to refer to an Article, Section, Recital or preamble of, or an Annex, Exhibit or Schedule to, this Agreement, respectively. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Any reference to a Person is also to its permitted successors and assigns. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Any reference to legislation or to any provision of any legislation shall include any modification, amendment, re-enactment thereof, any legislative provision substituted therefore and all rules, regulations, and statutory instruments issued or related to such legislations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;Any reference to a communication by a regulatory agency include a communication by the staff of such regulatory agency. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;The bold-faced headings and table of contents contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;The Parties agree that each of the Company Disclosure Schedule and the Parent Disclosure Schedule shall be arranged in sections and subsections corresponding to the numbered and lettered sections and subsections contained in this Agreement. The disclosures in any section or subsection of the Company Disclosure Schedule or the Parent Disclosure Schedule shall only qualify other sections and subsections in this Agreement to the extent it is reasonably apparent from a reading of the disclosure that such disclosure is applicable to such other sections and subsections. The inclusion of any information in the Company Disclosure Schedule or the Parent Disclosure Schedule shall not be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:436pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">deemed to be an admission or acknowledgment, in and of itself, that such information is required by the terms hereof to be disclosed, is material, has resulted in or would result in a Company Material Adverse Effect or a Parent Material Adverse Effect or is outside the Ordinary Course of Business. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;Each of &#8220;delivered&#8221; or &#8220;made available&#8221; means, with respect to any documentation, that prior to 11:59&#160;p.m. (New York time) on the date that is one Business Days prior to the date of this Agreement (i)&#160;a copy of such material has been posted to and made available by a Party to the other Party and its Representatives in the electronic data room maintained by such disclosing Party or (ii)&#160;such material is disclosed in the Parent SEC Documents filed with the SEC prior to the date hereof and publicly made available on the SEC&#8217;s Electronic Data Gathering Analysis and Retrieval system. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;Whenever the last day for the exercise of any privilege or the discharge of any duty hereunder shall fall upon a Saturday, Sunday, or any date on which banks in New York, New York are authorized or obligated by Law to be closed, the Party having such privilege or duty may exercise such privilege or discharge such duty on the next succeeding day which is a regular Business Day. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(</font><font style="font-style:italic;letter-spacing:0.2pt;">Remainder of page intentionally left blank</font><font style="letter-spacing:0.2pt;">) </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS WHEREOF</font><font style="letter-spacing:0.2pt;">, the Parties have caused this Agreement to be executed as of the date first above written. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Thomas R. Cannell, D.V.M.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:&nbsp;&nbsp;&nbsp;Thomas R. Cannell, D.V.M. </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;&#8199;&#8201;President &amp; Chief Executive Officer </font>
        </div>
        <div style="margin-left:220pt; margin-top:36pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Mark Sullivan</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:&nbsp;&nbsp;&nbsp;Mark Sullivan </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;&#8199;&#8201;President, Secretary &amp; Treasurer </font>
        </div>
        <div style="margin-left:220pt; margin-top:36pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Steven Kelly</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:&nbsp;&nbsp;&nbsp;Steven Kelly </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;&#8199;&#8201;Chief Executive Officer </font>
        </div>
        <div style="margin-top:144pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to Agreement and Plan of Merger and Reorganization</font><font style="letter-spacing:0.2pt;">]</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT A</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTAIN DEFINITIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For purposes of this Agreement (including this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Inquiry</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a Party, an inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by the Company or any of its Affiliates, on the one hand, or Parent or any of its Affiliates, on the other hand, to the other Party) that could reasonably be expected to lead to an Acquisition Proposal, other than (i)&#160;with respect to Parent, solely with respect to the Asset Dispositions and (ii)&#160;with respect to the Company, solely with respect to the Pre-Closing Financing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Proposal</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a Party, any offer or proposal, whether written or oral (other than an offer or proposal made or submitted by or on behalf of the Company or any of its Affiliates, on the one hand, or by or on behalf of Parent or any of its Affiliates, on the other hand, to the other Party) contemplating or otherwise relating to any Acquisition Transaction with such Party, other than (i)&#160;with respect to Parent, solely with respect to an Asset Disposition and (ii)&#160;with respect to the Company, solely with respect to the Pre-Closing Financing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Transaction</font><font style="letter-spacing:0.2pt;">&#8221; means any transaction or series of related transactions (other than the Asset Dispositions) involving: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;any merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (A)&#160;in which a Party is a constituent Entity; (B)&#160;in which a Person or &#8220;group&#8221; &#8203;(as defined in the Exchange Act and the rules promulgated thereunder) of Persons directly or indirectly acquires beneficial or record ownership of securities representing more than 15% of the outstanding securities of any class of voting securities of a Party or any of its Subsidiaries; or (C)&#160;in which a Party or any of its Subsidiaries issues securities representing more than 15% of the outstanding securities of any class of voting securities of such Party or any of its Subsidiaries; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that in the case of the Company, to the extent the Pre-Closing Financing is effected in accordance with the terms and conditions of this Agreement, the Pre-Closing Financing shall not constitute an Acquisition Transaction; or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or account for 15% or more of the consolidated book value or the fair market value of the assets of a Party and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning given to such term in Rule&#160;145 under the Securities Act. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Antitrust Laws</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal Trade Commission Act, as amended, all applicable foreign anti-trust laws and all other applicable Laws issued by a Governmental Body that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of competition. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day other than a Saturday, Sunday or other day on which banks in New York, New York are authorized or obligated by Law to be closed. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Code</font><font style="letter-spacing:0.2pt;">&#8221; means the Internal Revenue Code of 1986, as amended. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Associate</font><font style="letter-spacing:0.2pt;">&#8221; means any current or former employee, independent contractor, officer or director of the Company or its Subsidiaries. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Capital Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Company Common Stock and the Company Preferred Stock. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Capitalization Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of the Company set forth in the first sentence of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;2.6(a)</font><font style="letter-spacing:0.2pt;"> and in Section </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the common stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Contract</font><font style="letter-spacing:0.2pt;">&#8221; means any Contract: (a)&#160;to which the Company or any of its Subsidiaries is a Party; (b)&#160;by which the Company or any of its Subsidiaries or any Company IP or any other asset of the Company or its Subsidiaries is or may become bound or under which the Company or any of its Subsidiaries has, or may become subject to, any obligation; or (c)&#160;under which the Company or any of its Subsidiaries has or may acquire any right or interest. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Convertible Note</font><font style="letter-spacing:0.2pt;">&#8221; means the outstanding note convertible described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company ERISA Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means any corporation or trade or business (whether or not incorporated) which is (or at any relevant time was) treated with the Company or any of its Subsidiaries as a single employer within the meaning of Section&#160;414 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Fundamental Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;2.1(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.1(b)</font><font style="letter-spacing:0.2pt;"> (Due Organization; Subsidiaries), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.3</font><font style="letter-spacing:0.2pt;"> (Authority; Binding Nature of Agreement), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.4</font><font style="letter-spacing:0.2pt;"> (Vote Required), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.5(a)</font><font style="letter-spacing:0.2pt;"> (Non-Contravention) and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.20</font><font style="letter-spacing:0.2pt;"> (No Financial Advisors). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company IP</font><font style="letter-spacing:0.2pt;">&#8221; means all Intellectual Property Rights that are owned or purported to be owned by, assigned to, or exclusively licensed by, the Company or its Subsidiaries that are necessary for or used in the operation of the business of the Company or its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Material Adverse Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any Effect that, considered together with all other Effects that have occurred prior to the date of determination of the occurrence of a Company Material Adverse Effect, has or would reasonably be expected to have a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that Effects arising or resulting from the following shall not be taken into account in determining whether there has been a Company Material Adverse Effect: (a)&#160;the announcement of this Agreement or the pendency of the Contemplated Transactions; (b)&#160;general business, economic or political conditions or conditions generally affecting the industry in which the Company and its Subsidiaries operate; (c)&#160;hurricane, flood, tornado, earthquake or other natural disaster, changes in weather conditions, epidemic, plague, pandemic (including COVID-19) or any other outbreak of illness or other public health event or any other force majeure event, whether or not cause by any Person, or any national or international calamity or crises, or any law, regulation, statute, directive, pronouncement or guideline issued by a Governmental Body, the World Health Organization or industry group providing for business closures, &#8220;sheltering-in-place,&#8221; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including COVID-19) or any change in such law, regulation, statute, directive, pronouncement or guideline or interpretation thereof or any worsening of such conditions; (d)&#160;any COVID-19 Measures or COVID-19 Responses; (e)&#160;any acts, threats or escalations of war, armed hostilities or terrorism anywhere in the world or any governmental or other response or reaction to any of the foregoing; (f)&#160;any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP); (g)&#160;with respect to any product or product candidate of the Company or any of its Subsidiaries, the request of the FDA to refile, amend, or temporarily delay making any regulatory application or filing related to such product or product candidate or the protocol for any clinical trial relating to such product or product candidate (provided that this clause (g)&#160;shall not apply in the event of repeated or continued adverse decisions with respect to the Company&#8217;s product or product candidates by the FDA); or (h)&#160;resulting from the taking of any action, or the failure to take any action, by the Company that is expressly required to be taken by this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, in the case of clauses (b), (c), (d), (e)&#160;and (f), solely to the extent the impact on the Company and its Subsidiaries, taken as a whole, is disproportionately adverse compared to the impact on similarly situated companies operating in the industries in which the Company and its Subsidiaries operate, the incrementally disproportionate impact </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or impacts shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Options</font><font style="letter-spacing:0.2pt;">&#8221; means options or other rights to purchase shares of Company Common Stock issued by the Company. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Plan</font><font style="letter-spacing:0.2pt;">&#8221; means the 2017 Stock Incentive Plan, as amended from time to time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means, collectively, the Company Series&#160;A Preferred Stock, Company Special Voting Preferred Stock, Company Series&#160;B Preferred Stock and the Company Series&#160;B Special Voting Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Series&#160;A Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Series&#160;A Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Series&#160;B Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Series&#160;B Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Series&#160;B Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Series&#160;B Special Voting Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Special Voting Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Transaction Expenses</font><font style="letter-spacing:0.2pt;">&#8221; means, as of the applicable time of determination and without duplication, the sum of (a)&#160;the cash cost of any accrued and unpaid retention payments or other bonuses, as well as any change of control payments or severance, termination or similar payments that are due or become due to any current or former employee, director or independent contractor of the Company or any of its Subsidiaries at or prior to the Effective Time or otherwise in connection with the Merger or the Contemplated Transactions, and (b)&#160;subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, all costs, fees and expenses incurred by the Company or its Subsidiaries at or prior to the Effective Time in connection with the negotiation, preparation and execution of this Agreement or any agreements, documents, certificate, opinions or other items contemplated hereby and the consummation of the Merger or the Contemplated Transactions and that are unpaid as of the Effective Time, including brokerage fees and commissions, finder&#8217;s fees, legal fees or financial advisory fees payable or otherwise incurred by such person at or prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Triggering Event</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to have occurred if: (a)&#160;the Company shall have made a Company Board Adverse Recommendation Change; (b)&#160;the Company Board or any committee thereof shall have publicly approved, endorsed or recommended any Acquisition Proposal; or (c)&#160;the Company shall have entered into any letter of intent or similar document relating to any Acquisition Proposal. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Unaudited Interim Balance Sheet</font><font style="letter-spacing:0.2pt;">&#8221; means the unaudited consolidated balance sheet of the Company and its consolidated Subsidiaries for the period ended June&#160;30, 2022 provided to Parent prior to the date hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Confidentiality Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Confidentiality Agreement, dated as of June&#160;25, 2022, between the Company and Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Consent</font><font style="letter-spacing:0.2pt;">&#8221; means any approval, consent, ratification, permission, waiver or authorization (including any Governmental Authorization). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Contemplated Transactions</font><font style="letter-spacing:0.2pt;">&#8221; means the Merger, the Nasdaq Reverse Split, and the other transactions and actions contemplated by this Agreement, including the CVR Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Contract</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to any Person, any written or oral agreement, contract, subcontract, lease (whether for real or personal property), mortgage, license, sublicense or other legally binding commitment or undertaking of any nature to which such Person is a party or by which such Person or any of its assets are bound or affected under applicable Law. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Conversion</font><font style="letter-spacing:0.2pt;">&#8221; means the conversion of the Company Convertible Note for shares of Parent Common Stock pursuant to the Convertible Note Conversion Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Convertible Note Conversion Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Conversion Agreement, dated as of September&#160;20, 2022, by and between the Company and the holder of the Company Convertible Note. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">COVID-19</font><font style="letter-spacing:0.2pt;">&#8221; means SARS-CoV-2 or the COVID-19 virus, and any evolutions or mutations thereof and any related or associated epidemics, pandemics or disease outbreaks. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">COVID-19 Measures</font><font style="letter-spacing:0.2pt;">&#8221; means any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; workforce reduction, social distancing, shut down, closure, sequester or any other law, regulation, rule, order, directive, guideline or recommendation of any Governmental Body or industry group in connection with or in response to COVID-19, including the Coronavirus Aid, Relief, and Economic Security Act. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">COVID-19 Responses</font><font style="letter-spacing:0.2pt;">&#8221; means any action or inaction, including the establishment of any policy, procedure or protocol, by a Party or any of its Subsidiaries that such Party or any of its Subsidiaries determines in its reasonable discretion is necessary, advisable or prudent in connection with (a)&#160;mitigating the adverse effects of COVID-19 or applicable COVID-19 Measures, (b)&#160;ensuring compliance by such Party or any of its Subsidiaries with COVID-19 Measures applicable to any of them and/or (c)&#160;in respect of COVID-19, protecting the health and safety of employees or other persons with whom such Party or any of its Subsidiaries and their personnel come into contact with during the course of business operations. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">DGCL</font><font style="letter-spacing:0.2pt;">&#8221; means the General Corporation Law of the State of Delaware. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any effect, change, event, circumstance, or development. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Encumbrance</font><font style="letter-spacing:0.2pt;">&#8221; means any lien, pledge, hypothecation, charge, mortgage, security interest, exclusive license, easement, adverse title or similar restriction or encumbrance of any nature. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Enforceability Exceptions</font><font style="letter-spacing:0.2pt;">&#8221; means the (a)&#160;Laws of general application relating to bankruptcy, insolvency and the relief of debtors; and (b)&#160;rules of law governing specific performance, injunctive relief and other equitable remedies. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Entity</font><font style="letter-spacing:0.2pt;">&#8221; means any corporation (including any non-profit corporation), partnership (including any general partnership, limited partnership or limited liability partnership), joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint stock company), firm, society or other enterprise, association, organization or entity, and each of its successors. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Environmental Law</font><font style="letter-spacing:0.2pt;">&#8221; means any federal, state, local or foreign Law relating to pollution or protection of human health or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any Law or regulation relating to emissions, discharges, releases or threatened releases of Hazardous Materials, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Equity Plan&#160;Amendments</font><font style="letter-spacing:0.2pt;">&#8221; means (a)&#160;an amendment to the Sesen Bio, Inc. 2014 Stock Incentive Plan to provide for (i)&#160;such number of shares of common stock of Parent as mutually agreed by Parent and the Company (such agreement not to be unreasonably withheld, conditioned or delayed), not to exceed 9.5% on a fully diluted basis to be available for grant or issuance thereunder, as calculated to be as of immediately following the Closing, (ii)&#160;an extension of the term of the Sesen Bio, Inc. 2014 Incentive Plan up to, in the Company&#8217;s discretion, the 10th anniversary of the effectiveness of the Equity Plan&#160;Amendments and (iii)&#160;any other amendments deemed necessary and advisable by the Company, and (b)&#160;an amendment to the Parent ESPP to provide for such number of shares of common stock of Parent equal to one&#160;percent (1.0%) on a fully diluted basis to be available for purchase thereunder, as calculated to be as of immediately following the Closing. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">ERISA</font><font style="letter-spacing:0.2pt;">&#8221; means the Employee Retirement Income Security Act of 1974, as amended. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Exchange Act of 1934, as amended. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; means, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(h)</font><font style="letter-spacing:0.2pt;">, the following ratio (rounded to four decimal places): the quotient obtained by dividing (a)&#160;the Company Merger Shares by (b)&#160;the Company Outstanding Shares, in which: </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Aggregate Valuation</font><font style="letter-spacing:0.2pt;">&#8221; means the sum of (i)&#160;the Company Valuation, plus (ii)&#160;the Parent Valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Allocation Percentage</font><font style="letter-spacing:0.2pt;">&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Company Valuation by (ii)&#160;the Aggregate Valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Merger Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the product of (i)&#160;the Post-Closing Parent Shares multiplied by (ii)&#160;the Company Allocation Percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Outstanding Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the total number of shares of Company Capital Stock outstanding immediately prior to the Effective Time expressed on a fully-diluted and as-converted to Company Common Stock basis and assuming, without limitation or duplication, (i)&#160;the exercise of all Company Options outstanding as of immediately prior to the Effective Time, (ii)&#160;the closing of the Pre-Closing Financing, and (iii)&#160;the issuance of shares of Company Common Stock issuable in respect of all other outstanding options, restricted stock awards, warrants or rights to receive such shares, whether conditional or unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation of the Merger. Company Outstanding Shares shall also include all shares of the Company issued in the Pre-Closing Financing prior to the Effective Time and excludes any shares to be issued upon the conversion of the Company Convertible Note. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Valuation</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;$196,000,000, plus (ii)&#160;the amount of gross proceeds from the Pre-Closing Financing prior to the Effective Time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Allocation Percentage</font><font style="letter-spacing:0.2pt;">&#8221; means the quotient (expressed as a&#160;percentage, with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Parent Valuation by (ii)&#160;the Aggregate Valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Outstanding Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the total number of shares of Parent Common Stock outstanding immediately prior to the Effective Time expressed on a fully-diluted and as converted to Parent Common Stock basis, assuming, without limitation or duplication, the issuance of shares of Parent Common Stock in respect of all Parent Options, Parent RSUs, Parent Warrants and other outstanding options, warrants or rights to receive such shares, in each case, outstanding as of immediately prior to the Effective Time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Valuation</font><font style="letter-spacing:0.2pt;">&#8221; means $140,000,000, minus the amount by which Final Net Cash as determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> is less than $125,000,000 (if any), and plus the amount by which Final Net Cash as determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> is greater than $125,000,000. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Post-Closing Parent Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the quotient determined by dividing (i)&#160;the Parent Outstanding Shares by (ii)&#160;the Parent Allocation Percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An example of the calculation of the Exchange Ratio and its components is set forth on </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;H</font><font style="letter-spacing:0.2pt;"> for illustrative purposes only. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">GAAP</font><font style="letter-spacing:0.2pt;">&#8221; means generally accepted accounting principles and practices in effect from time to time within the United States applied consistently throughout the period involved. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Governmental Authorization</font><font style="letter-spacing:0.2pt;">&#8221; means any: (a)&#160;permit, license, certificate, certification, franchise, permission, approval, exemption, variance, exception, order, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any Law; or (b)&#160;right under any Contract with any Governmental Body. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Governmental Body</font><font style="letter-spacing:0.2pt;">&#8221; means any: (a)&#160;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b)&#160;federal, state, local, municipal, foreign or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">other government; (c)&#160;governmental or quasi-governmental authority of any nature (including any governmental division, department, agency, commission, bureau, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any taxing authority); or (d)&#160;self-regulatory organization (including Nasdaq). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Hazardous Materials</font><font style="letter-spacing:0.2pt;">&#8221; means any pollutant, chemical, substance and any toxic, infectious, carcinogenic, reactive, corrosive, ignitable or flammable chemical, or chemical compound, or hazardous substance, material or waste, whether solid, liquid or gas, that is subject to regulation, control or remediation under any Environmental Law, including without limitation, crude oil or any fraction thereof, and petroleum products or by-products. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">HSR Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property Rights</font><font style="letter-spacing:0.2pt;">&#8221; means and includes all intellectual property or other proprietary rights under the laws of any jurisdiction in the world, including, without limitation: (a)&#160;rights associated with works of authorship, including exclusive exploitation rights, copyrights, moral rights, software, databases, and mask works; (b)&#160;trademarks, service marks, trade dress, logos, trade names and other source identifiers, domain names and URLs and similar rights and any and all goodwill associated therewith; (c)&#160;rights associated with trade secrets, know how, inventions, invention disclosures, methods, processes, protocols, specifications, techniques and other forms of technology; (d)&#160;patents and industrial property rights; and (e)&#160;other similar proprietary rights in intellectual property of every kind and nature; (f)&#160;rights of privacy and publicity; and (g)&#160;all registrations, renewals, extensions, statutory invention registrations, provisionals, continuations, continuations-in-part, provisionals, divisions, or reissues of, and applications for, any of the rights referred to in clauses &#8220;(a)&#8221; through &#8220;(f)&#8221; above (whether or not in tangible form and including all tangible embodiments of any of the foregoing, such as samples, studies and summaries), along with all rights to prosecute and perfect the same through administrative prosecution, registration, recordation or other administrative proceeding, and all causes of action and rights to sue or seek other remedies arising from or relating to the foregoing, including for past, present or future infringement of any of the foregoing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Investor Agreements</font><font style="letter-spacing:0.2pt;">&#8221; means each stockholders agreement, voting agreement, registration rights agreement, co-sale agreement or other similar Contract between the Company and any holders of Company Common Stock, including any such Contract granting any Person investor rights, rights of first refusal, rights of first offer, registration rights, director designation rights or similar rights. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">IRS</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Internal Revenue Service. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Key Employee</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to the Company or Parent, an executive officer of such Party or any employee of such Party that reports directly to the board of directors of such Party or to the chief executive officer or chief accounting officer of such party. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Knowledge</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to the Company or the Parent, that an individual identified on Schedule&#160;A of the Company Disclosure Schedule or Schedule&#160;A of the Parent Disclosure Schedule, as applicable, was actually aware on the date of this Agreement of the relevant fact. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Law</font><font style="letter-spacing:0.2pt;">&#8221; means any federal, state, national, foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (including under the authority of Nasdaq or the Financial Industry Regulatory Authority). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Legal Proceeding</font><font style="letter-spacing:0.2pt;">&#8221; means any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Body or any arbitrator or arbitration panel. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Material Continuing Obligation</font><font style="letter-spacing:0.2pt;">&#8221; shall mean (a)&#160;any non-competition obligation affecting any of the assets or business of the Company as they exist as of the date of this Agreement, or (b)&#160;any Liability </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or other obligation which would require Parent, Company or any of their respective Subsidiaries, to, after the Effective Time, make any cash payment or expenditure in excess of $250,000, which would not be offset by the receipt of a future payment or contingent consideration. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Merger Sub. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq</font><font style="letter-spacing:0.2pt;">&#8221; means the Nasdaq Stock Market, LLC, including the Nasdaq Capital Market or such other Nasdaq market on which shares of Parent Common Stock are then listed. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Reverse Split</font><font style="letter-spacing:0.2pt;">&#8221; means a reverse stock split of all outstanding shares of Parent Common Stock at a reverse stock split ratio as mutually agreed to by Parent and the Company that is effected by Parent for the purpose of maintaining compliance with Nasdaq listing standards. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Net Cash</font><font style="letter-spacing:0.2pt;">&#8221; means, as of any applicable time of determination and without duplication, (A)&#160;the sum of (i)&#160;cash and cash equivalents, marketable securities and other short-term investments of Parent and its Subsidiaries, (ii)&#160;accounts receivable (including any Tax refund claims pending as of the date of this Agreement), deposits and interest, (iii)&#160;deposits, prepaid expenses and other prepaid assets which are reflected on the most recent balance sheet and do not constitute restricted cash of Parent and its Subsidiaries, and (iv)&#160;50% of the cost of settling any Transaction Litigation to the extent actually paid in cash by Parent prior to the Closing Date, minus (B)&#160;the sum of (1)&#160;any unpaid Parent Transaction Expenses, (2)&#160;any unpaid indebtedness of Parent and/or its Subsidiaries outstanding as of the Closing Date, (3)&#160;any accounts payable, accrued expenses or short or long term liabilities that are or will become payable in cash, including any such accounts payable, accrued expenses or short or long term liabilities under any Parent Contracts which were in effect prior to the Effective Time or associated with the termination of any Parent Contracts which were in effect prior to the Effective Time, or the termination before, at or after the Effective Time, of all current or former employees of Parent and its Subsidiaries (even if the applicable expenses or amounts are due and payable after the Effective Time) pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> (including, for clarity, any amounts in respect of the matters set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;N</font><font style="letter-spacing:0.2pt;"> if reasonably estimable by Parent in good faith), (4)&#160;any unpaid employer portion of payroll or employment Taxes incurred in connection with the grant, exercise, conversion, settlement or cancellation of Parent RSUs, Parent Options, equity compensation and other change in control or severance payments (including bonuses payable) to be paid pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> or CVRs issued to holders of Parent RSUs or Parent Options or otherwise as compensation (either incurred prior to or at the time of the Merger, and for the avoidance of doubt, not calculated as of the close of business on the Business Day prior to the Closing Date) in each case with respect to this clause (4), incurred in connection with the Merger by Parent at or prior to the Effective Time (even if payable after the Effective Time), (5)&#160;any pre-payment, termination, &#8220;end of term&#8221; or similar fee or charge payable to any lender in connection with the repayment of indebtedness by Parent at or prior to the Effective Time, (6)&#160;the amount of any cash dividend declared (or to be declared) but not yet paid as part of the Pre-Closing Dividend, (7)&#160;to the extent unpaid at Closing, the cost and/or premium of the D&amp;O Tail Policy, and (8)&#160;to the extent unpaid at Closing, (A)&#160;the cost of settling any Legal Proceeding or other dispute existing as of the date of this Agreement, as well as the unpaid deductible amount under the Parent&#8217;s insurance reasonably expected to be payable in connection with Legal Proceedings existing as of the date of this Agreement, and (B)&#160;if reasonably estimable by Parent in good faith as of the Closing Date, 50% of the cost of settling any Transaction Litigation. Each component of Net Cash, to the extent applicable, shall be determined in accordance with GAAP, applied on a basis consistent with the application of GAAP in the preparation of Parent&#8217;s most recent audited or reviewed financial statements. Net Cash shall be calculated excluding the effects of any payments or liabilities (including attorney&#8217;s fees and settlement costs) in respect of Dissenting Shares or any Transaction Litigation (other than as set forth in clause (8)(B)) and any payments which become due and payable after the Effective Time, if any, under that certain Share Purchase Agreement, dated September&#160;20, 2016, by and among Eleven Biotherapeutics, Inc., Viventia Bio Inc. and the other parties thereto. Net Cash shall be increased as necessary to account for any payments made by Parent to cover expenses or fees that are required to be shared pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3(a)</font><font style="letter-spacing:0.2pt;">. A sample calculation of Net Cash and its components is set forth on </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;E</font><font style="letter-spacing:0.2pt;"> for illustrative purposes only. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Ordinary Course of Business</font><font style="letter-spacing:0.2pt;">&#8221; means, in the case of each of the Company and Parent, such actions taken in the ordinary course of its normal operations and consistent in all material respects </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">with its past practices, taking into account any acts or omissions that have been or may be taken to comply with COVID-19 Measures or in good faith response to the COVID-19 pandemic, or otherwise to the extent necessary to avoid, mitigate or remediate a material adverse effect on the Company, Parent or any of their respective Subsidiaries or their respective businesses as may result from the COVID-19 pandemic, and subject to any reasonable changes required to address any then current facts and circumstances (including requirements to comply with applicable Law and guidelines and to reasonably preserve the health and safety of current employees and other service providers of the Company, Parent or any of their respective Subsidiaries); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any actions taken or not taken by the Company, Parent and any of their respective Subsidiaries reasonably and in good faith to respond to any other extraordinary event that was not reasonably foreseeable as of the date of this Agreement and occurring after the date of this Agreement that is outside of the control of the Company, Parent or their respective Affiliates, as applicable, shall be deemed to have been taken or not taken, as applicable, in the &#8220;Ordinary Court of Business.&#8221; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to any Person (other than an individual), (a)&#160;the certificate or articles of association or incorporation or organization or limited partnership or limited liability company, and any joint venture, limited liability company, operating or partnership agreement and other similar documents adopted or filed in connection with the creation, formation or organization of such Person and (b)&#160;all bylaws, regulations and similar documents or agreements relating to the organization or governance of such Person, in each case, as amended or supplemented. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Associate</font><font style="letter-spacing:0.2pt;">&#8221; means any current or former employee, independent contractor, officer or director of Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Balance Sheet</font><font style="letter-spacing:0.2pt;">&#8221; means the unaudited balance sheet of Parent as of June&#160;30, 2022 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Balance Sheet Date</font><font style="letter-spacing:0.2pt;">&#8221;), included in Parent&#8217;s Report on Form 10-Q for the quarterly period ended June&#160;30, 2022, as filed with the SEC. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Capitalization Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of Parent and Merger Sub set forth in the first sentence of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;3.6(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.6(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the common stock, $0.001 par value per share, of Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Contract</font><font style="letter-spacing:0.2pt;">&#8221; means any Contract: (a)&#160;to which Parent or any of its Subsidiaries is a party; (b)&#160;by which Parent, any of its Subsidiaries or any Parent IP or any other asset of Parent or any of its Subsidiaries is or may become bound or under which Parent or any of its Subsidiaries has, or may become subject to, any obligation; or (c)&#160;under which Parent or any of its Subsidiaries has or may acquire any right or interest. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent ERISA Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means any corporation or trade or business (whether or not incorporated) which is (or at any relevant time was) treated with Parent or any of its Subsidiaries as a single employer within the meaning of Section&#160;414 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent ESPP</font><font style="letter-spacing:0.2pt;">&#8221; means the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan, as amended from time to time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Fundamental Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of Parent and Merger Sub set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;3.1</font><font style="letter-spacing:0.2pt;"> (Due Organization; Subsidiaries), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.3</font><font style="letter-spacing:0.2pt;"> (Authority; Binding Nature of Agreement), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.4</font><font style="letter-spacing:0.2pt;"> (Vote Required), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.5(a)</font><font style="letter-spacing:0.2pt;"> (Non-Contravention) and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.20</font><font style="letter-spacing:0.2pt;"> (No Financial Advisors). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent IP</font><font style="letter-spacing:0.2pt;">&#8221; means all Intellectual Property Rights that are owned or purported to be owned by, assigned to, or exclusively licensed by, Parent or its Subsidiaries that are necessary for or used in the operation of the business of Parent and its Subsidiaries as presently conducted. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Material Adverse Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any Effect that, considered together with all other Effects that have occurred prior to the date of determination of the occurrence of a Parent Material Adverse Effect, has or would reasonably be expected to have a material adverse effect on the business, financial condition, assets, liabilities or results of operations of Parent and its Subsidiaries, taken as a whole; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that Effects arising or resulting from the following shall not be taken into account in determining whether there has been a Parent Material Adverse Effect: (a)&#160;the announcement of this Agreement or the pendency of the Contemplated Transactions; (b)&#160;general business, economic or political conditions or conditions generally affecting the industry in which Parent and its Subsidiaries operate; (c)&#160;hurricane, flood, tornado, earthquake or other natural disaster, changes in weather conditions, epidemic, plague, pandemic (including COVID-19) or any other outbreak of illness or other public health event or any other force majeure event, whether or not caused by any Person, or an national or international calamity or crises, or any law, regulation, statute, directive, pronouncement or guideline issued by a Governmental Body, the World Health Organization or industry group providing for business closures, &#8220;sheltering-in-place,&#8221; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including COVID-19) or any change in such law, regulation, statute, directive, pronouncement or guideline or interpretation thereof or any worsening of such conditions; (d)&#160;any COVID-19 Measures or COVID-19 Responses; (e)&#160;any acts, threats or escalations of war, armed hostilities or terrorism anywhere in the world or any governmental or other response or reaction to any of the foregoing; (f)&#160;changes in the trading price or trading volume of Parent Common Stock (it being understood, however, that any Effect causing or contributing to any change in stock price or trading volume of Parent Common Stock may be taken into account in determining whether a Parent Material Adverse Effect has occurred, unless such Effects are otherwise excepted from this definition), or the suspension of trading in or delisting of Parent&#8217;s securities on Nasdaq; (g)&#160;any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP); (h)&#160;with respect to any product or product candidate of Parent or any of its Subsidiaries, the request of the FDA to refile, amend, or temporarily delay making any regulatory application or filing related to such product or product candidate or the protocol for any clinical trial relating to such product or product candidate (provided that this clause (h)&#160;shall not apply in the event of repeated or continued adverse decisions with respect to Parent&#8217;s product or product candidates by the FDA); or (i)&#160;resulting from the taking of any action or the failure to take any action, by Parent that is expressly required to be taken by this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, in the case of clauses (b), (c), (d), (e), and (h), solely to the extent the impact on Parent and its Subsidiaries, taken as a whole, is disproportionately adverse compared to the impact on similarly situated companies operating in the industries in which Parent and its Subsidiaries operate, the incrementally disproportionate impact or impacts shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Options</font><font style="letter-spacing:0.2pt;">&#8221; means options or other rights to purchase shares of Parent Common Stock issued by Parent other than Parent Warrants. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent RSUs</font><font style="letter-spacing:0.2pt;">&#8221; means restricted stock&#160;units issued by Parent, whether time-based or performance based vesting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stock Plans</font><font style="letter-spacing:0.2pt;">&#8221; means the Sesen Bio, Inc. 2014 Stock Incentive Plan and the Sesen Bio, Inc. 2009 Stock Incentive Plan, in each case, as amended from time to time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Transaction Expenses</font><font style="letter-spacing:0.2pt;">&#8221; means as of the applicable time of determination and without duplication, the sum of (a)&#160;the cash cost of any accrued and unpaid retention payments or other bonuses, as well as any change of control payments or severance, termination or similar payments that are due or become due to any current or former employee, director or independent contractor of Parent or any of its Subsidiaries at or prior to the Effective Time otherwise in connection with the Merger or the Contemplated Transactions (and, for the avoidance of doubt, shall exclude any payments under arrangements entered into by Parent after the Effective Time), and (b)&#160;subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, all costs, fees and expenses incurred by Parent or its Subsidiaries at or prior to the Effective Time in connection with the negotiation, preparation and execution of this Agreement or any agreements, documents, certificate, opinions or other items contemplated hereby and the consummation of the Merger or the Contemplated Transactions and that are unpaid as of the Effective Time, including brokerage fees and commissions, finder&#8217;s fees, legal fees or financial advisory fees payable or otherwise incurred by such person at or prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Triggering Event</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to have occurred if: (a)&#160;Parent shall have failed to include in the Proxy Statement/Prospectus the Parent Board Recommendation or shall have made a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parent Board Adverse Recommendation Change; (b)&#160;the Parent Board or any committee thereof shall have publicly approved, endorsed or recommended any Acquisition Proposal; or (c)&#160;Parent shall have entered into any letter of intent or similar document relating to any Acquisition Proposal (other than a confidentiality agreement permitted pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Warrants</font><font style="letter-spacing:0.2pt;">&#8221; means the warrants to purchase capital stock of Parent listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;B</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Party</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parties</font><font style="letter-spacing:0.2pt;">&#8221; means the Company, Merger Sub and Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Encumbrance</font><font style="letter-spacing:0.2pt;">&#8221; means: (a)&#160;any liens for current Taxes not yet due and payable or for Taxes that are being contested in good faith and, in each case, for which adequate reserves have been made on the Company Unaudited Interim Balance Sheet or the Parent Balance Sheet, as applicable; (b)&#160;minor liens that have arisen in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the assets or properties subject thereto or materially impair the use thereof or the operations of the Company or any of its Subsidiaries or Parent, as applicable; (c)&#160;statutory liens to secure obligations to landlords, lessors or renters under leases or rental agreements; (d)&#160;deposits or pledges made in connection with, or to secure payment of, workers&#8217; compensation, unemployment insurance or similar programs mandated by Law in the Ordinary Course of Business; (e)&#160;non-exclusive licenses of Intellectual Property Rights granted by the Company or any of its Subsidiaries or Parent or any of its Subsidiaries, as applicable, in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the Intellectual Property Rights subject thereto; and (f)&#160;statutory liens in favor of carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means any individual, Entity or Governmental Body. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="letter-spacing:0.2pt;">&#8221; means the non-cash assets of Parent existing as of the date of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Financing</font><font style="letter-spacing:0.2pt;">&#8221; means an acquisition of capital stock of the Company to be consummated immediately prior to the Closing pursuant to the Subscription Agreements. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Proxy Statement/Prospectus</font><font style="letter-spacing:0.2pt;">&#8221; means the proxy statement/prospectus, which shall be included in the Registration Statement, to be sent to Parent&#8217;s stockholders in connection with the Parent Stockholders&#8217; Meeting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Registration Statement</font><font style="letter-spacing:0.2pt;">&#8221; means the registration statement on Form S-4 (or any other applicable form under the Securities Act to register Parent Common Stock) to be filed with the SEC by Parent registering the public offering and sale of Parent Common Stock to holders of Company Capital Stock and the Company Convertible Note in the Merger or the Conversion, as applicable, as may be amended prior to the time it is declared effective by the SEC. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Representatives</font><font style="letter-spacing:0.2pt;">&#8221; means directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors and representatives. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sarbanes-Oxley Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Sarbanes-Oxley Act of 2002. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">SEC</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Securities and Exchange Commission. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Act of 1933, as amended. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means any stock purchase agreement, as well as related investment agreements, entered into among the Company and the Person(s) named therein, pursuant to which such Persons have agreed to purchase immediately prior to the Effective Time the number of shares of capital stock of the Company set forth therein in connection with the Pre-Closing Financing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subsequent Transaction</font><font style="letter-spacing:0.2pt;">&#8221; means any Acquisition Transaction (with all references to 15% in the definition of Acquisition Transaction being treated as references to 50% for these purposes). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subsidiary</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a Person, another entity of which such Person directly or indirectly owns or purports to own, beneficially or of record, (a)&#160;an amount of voting securities or other interests that is sufficient to enable such Person to elect at least a majority of the members of such entity&#8217;s board of directors or other governing body, or (b)&#160;at least 50% of the outstanding equity, voting, beneficial or financial interests in such Entity. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Superior Offer</font><font style="letter-spacing:0.2pt;">&#8221; means an unsolicited bona fide written Acquisition Proposal (with all references to 15% in the definition of Acquisition Transaction being treated as references to 70% for these purposes) that: (a)&#160;was not obtained or made as a direct or indirect result of a breach of (or in violation of) this Agreement; (b)&#160;is on terms and conditions that the Parent Board or the Company Board, as applicable, determines in good faith, based on such matters that it deems relevant (including the likelihood of consummation thereof, the financing terms thereof, any termination or break-up fees and conditions to consummation), as well as any written offer by the other Party this Agreement to amend the terms of this Agreement, and following consultation with its outside legal counsel and financial advisors, if any, are more favorable to Parent&#8217;s stockholders or the Company&#8217;s stockholders, as applicable, than the terms of the Contemplated Transactions; (c)&#160;is not subject to any financing conditions (and if financing is required, such financing is then fully committed to the third party); and (d)&#160;is reasonably capable of being completed on the terms proposed without unreasonable delay. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Takeover Statute</font><font style="letter-spacing:0.2pt;">&#8221; means any &#8220;fair price,&#8221; &#8220;moratorium,&#8221; &#8220;control share acquisition&#8221; or other similar anti-takeover Law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tax</font><font style="letter-spacing:0.2pt;">&#8221; means any federal, state, local, foreign or other tax, including any income, capital gain, gross receipts, capital stock, profits, transfer, estimated, registration, stamp, premium, escheat, unclaimed property, customs duty, ad valorem, occupancy, occupation, alternative, add-on, windfall profits, value added, severance, property, business, production, sales, use, license, excise, franchise, employment, payroll, social security, disability, unemployment, workers&#8217; compensation, national health insurance, withholding or other taxes, duties, fees, assessments or governmental charges in the nature of a tax, surtaxes or deficiencies thereof of any kind whatsoever, however denominated, and including any fine, penalty, addition to tax or interest imposed by a Governmental Body with respect thereto. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tax Return</font><font style="letter-spacing:0.2pt;">&#8221; means any return (including any information return), report, statement, declaration, estimate, schedule, notice, notification, form, election, certificate or other document, and any amendment or supplement to any of the foregoing, filed with or submitted to, or required to be filed with or submitted to, any Governmental Body in connection with the determination, assessment, collection or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with any Law relating to any Tax. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Treasury Regulations</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Treasury regulations promulgated under the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">WARN Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar state or local plant closing mass layoff statute, rule or regulation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each of the following terms is defined in the Section set forth opposite such term: </font>
        </div>
        <table style="width:416pt;height:143.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:41pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Section </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting Firm </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(e) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Agreement </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Allocation Certificate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.16(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Anti-Bribery Laws </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.22 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Anticipated Closing Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Asset Disposition </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Asset Dispositions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Book-Entry Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.6 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Business Associate Agreements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(h) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:653.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:41pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Section </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash Determination Time </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Certificate of Merger </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Certifications </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Closing </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Closing Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Company </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Benefit Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.17(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Board Adverse Recommendation Change </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Board Recommendation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Convertible Note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6(a)</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Designees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.12 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Disclosure Schedule </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Section&#160;2 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Financial Statements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company In-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Lock-Up Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Material Contract </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Material Contracts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Out-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Permits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Real Estate Leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.11 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Registered IP </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Signatories </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stock Certificate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.6 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stockholder Matters </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stockholder Support Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stockholder Written Consent </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.4 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Termination Fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">9.3(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">CVR </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.21 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">CVR Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.21 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">D&amp;O Indemnified Parties </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.6(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">D&amp;O Tail Policy </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.6(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Delivery Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dispute Notice </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dissenting Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.8(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Drug Regulatory Agency </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effective Time </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">End Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">9.1(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange Agent </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange Fund </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">FDA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">FDCA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Final Net Cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">GCP </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(e) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:653.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:41pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Section </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">GLP </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(e) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">HIPAA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(h) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Intended Tax Treatment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.10(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Liability </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.9 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">LoT </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.7(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Merger </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Merger Consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.5(a)(ii) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Merger Sub </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nasdaq Listing Application </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.9 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Calculation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Schedule </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Notice Period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Parent </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Benefit Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.17(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Board Adverse Recommendation Change </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Board Recommendation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Designees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.12 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Disclosure Schedule </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Section&#160;3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent In-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Lock-Up Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Material Contract </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Material Contracts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Out-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Permits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.14(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Real Estate Leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.11 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Registered IP </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.12(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent SEC Documents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Signatories </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Stockholder Matters </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(a)(iii) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Stockholder Support Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Stockholders&#8217; Meeting </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(a)(iii) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Termination Fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">9.3(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">PHSA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pre-Closing Dividend </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.21 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pre-Closing Period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.1(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Required Company Stockholder Vote </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.4 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Required Parent Stockholder Vote </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.4 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Response Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sale Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.7(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sensitive Data </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(g) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Surviving Corporation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.1 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Terminated Parent Associate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.20(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Transaction Litigation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.19</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT B-1</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Company Stockholder Support Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT B-2</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Parent Stockholder Support Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT C-1</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Company Lock-Up Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT C-2</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Parent Lock-Up Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT D</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of CVR Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT E</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Net Cash Illustrative Calculations </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT F</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Certificate of Merger </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT G</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Company Stockholder Written Consent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT H</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Exchange Ratio Calculation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Schedule&#160;5.7</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Additional Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">None. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Schedule&#160;5.12</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Post-Closing Directors and Officers of Parent and the Surviving Corporation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Schedule&#160;N</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFAAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX A-2</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FIRST AMENDMENT TO </font>
          <br >
          <font style="letter-spacing:-0.2pt;">AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="letter-spacing:0.2pt;"> (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">First Amendment</font><font style="letter-spacing:0.2pt;">&#8221;) is made and entered into and made as of December&#160;29, 2022, by and among </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation and wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and </font><font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;). Parent, Merger Sub and the Company are sometimes individually referred to herein as a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Party</font><font style="letter-spacing:0.2pt;">&#8221; or collectively referred to herein as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parties</font><font style="letter-spacing:0.2pt;">&#8221;. Unless otherwise defined herein, capitalized terms shall have the meanings set forth in the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;The Parties previously entered into that certain Agreement and Plan of Merger and Reorganization dated as of September&#160;20, 2022 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;Section&#160;10.2 of the Merger Agreement provides that the Merger Agreement may be amended with the approval of the respective boards of directors of the Company, Merger Sub and Parent at any time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C.&nbsp;&nbsp;&nbsp;The Parties desire to amend the Merger Agreement pursuant to the terms and conditions of this First Amendment and the respective boards of directors of the Company, Merger Sub and Parent have each approved this First Amendment to be effective as of the date hereof. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Parties, intending to be legally bound, agree as follows: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;AMENDMENT TO SECTION 3.24 &#8220;Opinion of Financial Advisor&#8221;. Section&#160;3.24 &#8220;Opinion of Financial Advisor&#8221; of the Merger Agreement is hereby deleted in its entirety and replaced with the following: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Opinion of Financial Advisor</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Board has received an opinion of SVB Securities LLC to the effect that, as of the date of this First Amendment and subject to the assumptions, qualifications, limitations and other matters set forth therein, the Exchange Ratio is fair, from a financial point of view, to Parent. It is agreed and understood that such opinion is for the benefit of the Parent Board and may not be relied upon by the Company or any other party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;AMENDMENT TO SECTION 5.21 &#8220;Pre-Closing Dividend&#8221;. Section&#160;5.21 &#8220;Pre-Closing Dividend&#8221; of the Merger Agreement is hereby deleted in its entirety and replaced with the following: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;5.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Prior to the Effective Time, Parent shall (a)&#160;declare a dividend (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">&#8221;) to its common stockholders of record consisting of (i)&#160;the right to receive one contingent value right (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR</font><font style="letter-spacing:0.2pt;">&#8221;) for each outstanding share of Parent Common Stock held by such stockholder as of such date, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;D</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) and (ii)&#160;cash equal to or greater than $70,000,000 in the aggregate, subject to satisfaction of Parent&#8217;s obligation set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.5</font><font style="letter-spacing:0.2pt;"> (and, for clarity, such cash dividend shall be reduced by any excess amount necessary to cause Parent to satisfy its obligation set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.5</font><font style="letter-spacing:0.2pt;">) and (b)&#160;make any necessary equitable adjustment required under the Parent Stock Plans. The record date for the Pre-Closing Dividend shall be a date agreed by Parent and the Company prior to the Effective Time and the payment date for which shall be three Business Days after the Effective Time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the payment of such dividend may be conditioned upon the occurrence of the Effective Time. In connection with the Pre-Closing Dividend, Parent shall cause the CVR Agreement to be duly authorized, executed and delivered by Parent and a rights agent selected by Parent with the Company&#8217;s prior approval (such approval not to be unreasonably withheld, delayed or conditioned).&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:156pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">AMENDMENT TO EXHIBIT D &#8220;Form of Contingent Value Right Agreement&#8221;.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Exhibit&#160;D to the Merger Agreement shall be deleted in its entirety and replaced with the form attached hereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">AMENDMENT TO SECTION 8.5 &#8220;Minimum Parent Final Net Cash&#8221;.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Section&#160;8.5 &#8220;Minimum Parent Final Net Cash&#8221; of the Merger Agreement is hereby deleted in its entirety and replaced with the following: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;8.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Minimum Parent Final Net Cash</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Final Net Cash shall have been determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> to be greater than or equal to $75,000,000.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">APPLICABLE LAW.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This First Amendment shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;HEADINGS.&nbsp;&nbsp;&nbsp;The bold-faced headings contained in this First Amendment are for convenience of reference only, shall not be deemed to be a part of this First Amendment and shall not be referred to in connection with the construction or interpretation of this First Amendment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;ASSIGNABILITY.&nbsp;&nbsp;&nbsp;This First Amendment shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and permitted assigns; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that neither this First Amendment nor any of a Party&#8217;s rights or obligations hereunder may be assigned or delegated by such Party without the prior written consent of the other Party, and any attempted assignment or delegation of this First Amendment or any of such rights or obligations by such Party without the other Party&#8217;s prior written consent shall be void and of no effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.&nbsp;&nbsp;&nbsp;CONSTRUCTION.&nbsp;&nbsp;&nbsp;The terms of this First Amendment amend and modify the Merger Agreement as if fully set forth in the Merger Agreement. Upon the effectiveness of this First Amendment, all references in the Merger Agreement to &#8220;the Agreement&#8221; or &#8220;this Agreement,&#8221; as applicable, shall refer to the Merger Agreement, as modified by this First Amendment. If there is any conflict between the terms, conditions and obligations of this First Amendment and the Merger Agreement, this First Amendment&#8217;s terms, conditions and obligations shall control. All other provisions of the Merger Agreement not specifically modified by this First Amendment are expressly preserved. This First Amendment may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed First Amendment (in counterparts or otherwise) by all Parties by electronic transmission in PDF format shall be sufficient to bind the Parties to the terms and conditions of this First Amendment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.&nbsp;&nbsp;&nbsp;AUTHORITY.&nbsp;&nbsp;&nbsp;By their execution of this First Amendment, the undersigned Parties hereby confirm that they are duly authorized to execute this First Amendment and any necessary requisite approval has been obtained with respect to this First Amendment and all matters set forth herein. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">(Remainder of page intentionally left blank)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS WHEREOF</font><font style="letter-spacing:0.2pt;">, the Parties have caused this First Amendment to be executed as of the date first above written. </font>
        </div>
        <table style="width:456pt;height:233pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1.833pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.167pt 0pt 0.5pt 0pt; width:14.38pt;">
              <font style="letter-spacing:0.2pt;">By:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.167pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Thomas Cannell</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 208.81pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Name:</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Thomas Cannell </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Title:</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:18.5pt 0pt 1.833pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.167pt 0pt 0.5pt 0pt; width:14.38pt;">
              <font style="letter-spacing:0.2pt;">By:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.167pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Mark Sullivan</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 208.81pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Name:</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Mark Sullivan </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Title:</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">President, Secretary &amp; Treasurer </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:18.5pt 0pt 1.833pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.167pt 0pt 0.5pt 0pt; width:14.38pt;">
              <font style="letter-spacing:0.2pt;">By:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.167pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Steven Kelly</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 208.81pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Name:</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Steven Kelly </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
              <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Title:</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Chief Executive Officer</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to First Amendment to Agreement and Plan of Merger and Reorganization</font><font style="letter-spacing:0.2pt;">] </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT D</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of CVR Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONTINGENT VALUE RIGHTS AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [&#8226;], 2023 (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), is entered into by and among Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and Computershare Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221;) and its affiliate, Computershare Trust Company, N.A., together, as the Rights Agent. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, Parent, Seahawk Merger Sub, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), have entered into an Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub will merge with and into the Company, with the Company surviving the Merger as a subsidiary of Parent; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, pursuant to the Merger Agreement, Parent has agreed to provide to the holders of record of Parent&#8217;s common stock, par value $0.001 per share (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), immediately prior to the Effective Time, the right to receive certain contingent cash payments, on the terms and subject to the conditions hereinafter described. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the consummation of the transactions referred to above, Parent and the Rights Agent agree, for the proportionate benefit of all Holders (as hereinafter defined), as follows: </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;DEFINITIONS; CERTAIN RULES OF CONSTRUCTION </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definitions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Capitalized terms used but not otherwise defined herein will have the meanings ascribed to them in the Merger Agreement, unless expressly set forth otherwise herein. As used in this Agreement, the following terms will have the following meanings: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3(d)</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person. The term &#8220;control&#8221; (including the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Disposition Proceeds</font><font style="letter-spacing:0.2pt;">&#8221; means, without duplication, any and all consideration of any kind that is paid to Parent, or is received by, Parent or any of its Affiliates during the period specified in clause (b)&#160;of the definition of CVR Term in respect of an Asset Disposition, if any. The value of any securities (whether debt or equity) or other non-cash property constituting Asset Disposition Proceeds shall be determined as follows: (A)&#160;the value of securities for which there is an established public market shall be equal to the volume weighted average of their closing market prices for the five (5)&#160;trading days ending the day prior to the date of payment to, or receipt by, Parent or its relevant Affiliate, and (B)&#160;the value of securities that have no established public market and the value of consideration that consists of other non-cash property, shall be the fair market value thereof as of the date of payment to, or receipt by, Parent or its relevant Affiliate. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board of Directors</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board Resolution</font><font style="letter-spacing:0.2pt;">&#8221; means a copy of the resolution(s) certified by the secretary or an assistant secretary (or other comparable officer) of Parent that have been duly adopted by the Board of Directors and are in full force and effect on the date of such approval, and delivered to the Rights Agent. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day other than a Saturday, Sunday or other day on which banks in New York, New York are authorized or obligated by Law to be closed. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to each Holder, an amount equal to (a)&#160;(i)&#160;the applicable Total Payment Amount, less (ii)&#160;applicable accrued and documented Permitted Deductions, as calculated in accordance with GAAP, divided by (b)&#160;the total number of CVRs and then multiplied by the total number of CVRs held by such Holder as reflected on the CVR Register (rounded down to the nearest whole cent). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Sale Assets</font><font style="letter-spacing:0.2pt;">&#8221; means any and all assets, tangible and intangible, including, without limitation, patents, patent applications, know-how, trade secrets and other intellectual property rights, data, documentation, agreements and licenses, inventory related to Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, which Parent or any of its subsidiaries owned or had rights to, as of immediately prior to the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Term</font><font style="letter-spacing:0.2pt;">&#8221; means (a)&#160;with respect to any Roche Payment Amount, the period beginning on the date hereof and ending on the earlier of (i)&#160;the CVR Payment being delivered to each Holder in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4</font><font style="letter-spacing:0.2pt;"> of this Agreement, and (ii)&#160;March&#160;31, 2027, and (b)&#160;with respect to any Disposition or Asset Disposition or otherwise in respect of Asset Disposition Proceeds, the period beginning on the date hereof and ending on December&#160;31, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVRs</font><font style="letter-spacing:0.2pt;">&#8221; means the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Disposition</font><font style="letter-spacing:0.2pt;">&#8221; means the sale, license, transfer, disposition or other monetizing event of any CVR Sale Assets, in each case (i)&#160;during the period set forth in clause (b)&#160;of the definition of CVR Term and (ii)&#160;in a transaction identified by Parent&#8217;s financial advisor who was engaged as of the Effective Time for the purpose of identifying and proposing a potential Disposition transaction to Parent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">DTC</font><font style="letter-spacing:0.2pt;">&#8221; means The Depository Trust Company or any successor thereto. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.9</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; means a Person in whose name a CVR is registered in the CVR Register at the applicable time. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Officer&#8217;s Certificate</font><font style="letter-spacing:0.2pt;">&#8221; means a certificate signed by the chief executive officer, president, chief financial officer, any vice president, the controller, the treasurer or the secretary, in each case of Parent, in his or her capacity as such an officer, and delivered to the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Deductions</font><font style="letter-spacing:0.2pt;">&#8221; means the following costs or expenses, without duplication (as approved by the Board of Directors, including, if applicable, the Parent Designee (as defined in the Merger Agreement)): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;any applicable Tax (including any unreimbursed applicable value added or sales tax) imposed on the Total Payment Amount and payable by Parent or any of its Affiliates to any tax authority and, without duplication, any income or other similar Taxes payable by Parent or any of its Affiliates that would not have been incurred by Parent or any of its Affiliates but for the Total Payment Amount; provided that, for purposes of calculating income Taxes incurred by Parent and its Affiliates in respect </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of the Total Payment Amount, any such income Taxes shall be computed after reduction for any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) as of the Closing Date that are available to the maximum extent permitted by law to offset such gain after taking into account any limits on the usability of such attributes, including under Section&#160;382 of the Code, in each case, as reasonably determined by a nationally recognized tax advisor (and for the sake of clarity such income taxes shall be calculated without taking into account any net operating losses or other Tax attributes generated by Parent or its subsidiaries after the Closing Date or any Tax attributes of the Company, whether generated before or after the Closing Date), assuming for this purpose that (i)&#160;the only item of gross income of Parent and its subsidiaries is the Total Payment Amount (for the avoidance of doubt, assuming that the Total Payment Amount is taxable in the hands of Parent or its subsidiaries no later than the taxable year that includes the corresponding CVR Payment), and (ii)&#160;the net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries shall only include any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) existing as of immediately prior to the Merger for U.S. federal income tax purposes and applicable state and local income tax purposes; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;any reasonable and documented out-of-pocket expenses incurred by Parent or any of its Affiliates in respect of its performance of this Agreement following the Effective Time, losses incurred and paid by Parent or any of its Affiliates following the Effective Time arising out of any Legal Proceeding relating to or in connection with (i)&#160;an Asset Disposition, (ii)&#160;Parent&#8217;s, Roche&#8217;s or any of their respective Affiliates&#8217; obligations under the Roche Agreement or (iii)&#160;otherwise with respect to the Total Payment Amount; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;any Liabilities that were ascertainable prior to or at the Effective Time which Parent reasonably and in good faith determines should have been, but were not, deducted from &#8220;Net Cash&#8221; &#8203;(as defined in the Merger Agreement), in connection with the Closing of the Merger, to the extent that deduction of such Liabilities would have resulted in a change in the Exchange Ratio under the Merger Agreement were such amounts properly deducted; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided that no Permitted Deductions shall be deducted to the extent they were otherwise deducted from the calculation of Net Cash (as defined in the Merger Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Transfer</font><font style="letter-spacing:0.2pt;">&#8221; means a transfer of CVRs: (a)&#160;on death of a Holder by will or intestacy; (b)&#160;by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (c)&#160;pursuant to a court order; (d)&#160;made by operation of law (including a consolidation or merger) or without consideration in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; (e)&#160;in the case of CVRs held in book-entry or other similar nominee form, from a nominee to a beneficial owner (through an intermediary if applicable) or from a nominee to another nominee for the same beneficial owner, to the extent allowable by DTC; (f)&#160;a transfer from a participant&#8217;s account in a tax-qualified employee benefit plan to the participant or to such participant&#8217;s account in a different tax-qualified employee benefit plan or to a tax-qualified individual retirement account for the benefit of such participant; (g)&#160;to Parent or its Affiliates for any or no consideration; or (h)&#160;as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means any natural person, corporation, limited liability company, trust, unincorporated association, partnership, joint venture or other entity. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(e)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights Agent</font><font style="letter-spacing:0.2pt;">&#8221; means the Rights Agent named in the Preamble, until a successor Rights Agent will have become such pursuant to the applicable provisions of this Agreement, and thereafter &#8220;Rights Agent&#8221; will mean such successor Rights Agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche</font><font style="letter-spacing:0.2pt;">&#8221; means the collective reference to F. Hoffman-La Roche Ltd and Hoffmann La Roche Inc. or its successors or any of its or their respective Affiliates; provided, that neither Chugai Pharmaceutical Co., Ltd, a Japanese corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Chugai</font><font style="letter-spacing:0.2pt;">&#8221;) nor its subsidiaries (if any) shall be deemed as Affiliates of Roche unless Roche provides written notice to Parent of its desire to include Chugai or its respective subsidiaries (as applicable) as Affiliate(s) of Roche. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">RocheAgreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Asset Purchase Agreement, dated as of July&#160;15, 2022, by and among F. Hoffman-La Roche Ltd, Hoffmann La Roche Inc. and Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means the thirty million dollar ($30,000,000) milestone payment to be made by Roche to Parent upon the initiation of a phase III clinical study in diabetic macular disorder with the compound known as &#8220;EBI-031&#8221; during the CVR Term, as set forth in Section&#160;11.1 of the Roche Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Third Party</font><font style="letter-spacing:0.2pt;">&#8221; means any Person other than Parent, Rights Agent or their respective Affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Total Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, as of any applicable time of determination, any Asset Disposition Proceeds plus any Roche Payment Amounts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Rules of Construction</font><font style="letter-spacing:0.2pt;">. Except as otherwise explicitly specified to the contrary, (a)&#160;whenever the context requires, the singular number shall include the plural, and vice versa; (b)&#160;the masculine gender shall include the feminine gender and neuter genders, the feminine gender shall include the masculine and neuter genders, and the neuter genders shall include masculine and feminine genders; (c)&#160;the word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; means the degree to which a subject or other thing extends, and does not simply mean &#8220;if&#8221;; (d)&#160;the word &#8220;including&#8221; &#8203;(in its various forms) means &#8220;including without limitation&#8221;; (e)&#160;references to a &#8220;Section&#8221; means a Section of this Agreement unless another agreement is specified; (f)&#160;references to a particular statute or regulation include all rules and regulations thereunder and any predecessor or successor statute, rules or regulation, in each case as amended or otherwise modified from time to time; (g)&#160;words in the singular or plural form include the plural and singular form, respectively; (h)&#160;references to a particular Person include such Person&#8217;s successors and assigns to the extent not prohibited by this Agreement; (i)&#160;the word &#8220;or&#8221; shall not be exclusive (i.e., &#8220;or&#8221; shall be deemed to mean &#8220;and/or&#8221;) unless the subject of the conjunction are mutually exclusive; and (j)&#160;all references to dollars or &#8220;$&#8221; refer to United States dollars. For clarity, the parties agree that the phrase &#8220;materially adverse&#8221; when used in this Agreement with respect to the Holders includes any amendment or other action, as applicable, that does or would be reasonably expected to reduce, eliminate, or materially delay the Roche Payment Amount. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;CONTINGENT VALUE RIGHTS </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">CVRs; Appointment of Rights Agent.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each Holder is entitled to one CVR in the form of a dividend for each share of Parent Common Stock held by such Holder as of the Record Time. The CVRs represent the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. The initial Holders will be the holders of Parent Common Stock as of immediately prior to the Effective Time, and a list of the initial Holders shall be furnished to the Rights Agent by or on behalf of Parent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent hereby appoints the Rights Agent to act as rights agent for Parent as contemplated hereby in accordance with the express terms and conditions set forth in this Agreement (and no implied terms or conditions), and the Rights Agent hereby accepts such appointment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent intends to treat the issuance of the CVRs as a distribution of property by Parent to the holders of Parent Common Stock for U.S. federal income tax purposes. Consistent with such intended tax treatment, Parent will timely send Forms 1099-DIV to all Holders notifying them of the portion of the CVR value that is a nondividend distribution (or a dividend to the extent of Parent&#8217;s earnings and profits) for U.S. federal income tax purposes, and take all necessary steps to file its tax returns and any information statements consistent with such tax treatment. Parent will determine, in consultation with and with the consent of the Parent Designee, the fair market value of the CVRs in connection with the issuance and Parent will utilize such fair market value for purposes of all tax reporting (including on Forms 1099-DIV) with respect to the CVR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Nontransferable</font><font style="letter-spacing:0.2pt;">. The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer. Any attempted sale, assignment, transfer, pledge, encumbrance, transfer or disposition, in whole or in part, that is not a Permitted Transfer will be void </font><font style="font-style:italic;letter-spacing:0.2pt;">ab initio</font><font style="letter-spacing:0.2pt;"> and of no effect. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Certificate; Registration; Registration of Transfer; Change of Address</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not be evidenced by a certificate or other instrument. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Rights Agent will create and keep a register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221;) for the purpose of identifying the Holders and registering CVRs and transfers of CVRs as permitted herein. The CVR Register will be created, and CVRs will be distributed, pursuant to written instructions to the Rights Agent from Parent. The CVR Register will initially show one position for Cede &amp; Co. representing all the CVRs provided to the holders of shares of Parent Common Stock held as of immediately prior to the Effective Time. The Rights Agent will have no responsibility whatsoever directly to the street name holders or DTC participants with respect to transfers of CVRs unless and until such CVRs are transferred into the name of such street name holders or DTC participants in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> of this Agreement. With respect to any payments to be made under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> below, the Rights Agent will accomplish the payment to any former street name holders of shares of Parent Common Stock by sending one lump-sum payment to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to such street name holders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to the restrictions on transferability set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer and other reasonably requested documentation in form reasonably satisfactory to the Rights Agent, duly executed by the Holder thereof or the Holder&#8217;s attorney duly authorized in writing, personal representative or survivor and setting forth in reasonable detail the circumstances relating to the transfer. Upon receipt of such written notice, the Rights Agent will, subject to its reasonable determination that the transfer instrument is in proper form, notify Parent that it has received such written notice. Upon receipt of such notice from the Rights Agent, Parent shall determine whether the transfer otherwise complies with the other terms and conditions of this Agreement (including the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">), and if it determines that it does so comply, Parent shall instruct the Rights Agent in writing to register the transfer of the CVRs in the CVR Register and notify Parent of the same. No service charge shall be made for any registration of transfer of a CVR; however Parent and the Rights Agent may require payment of a sum sufficient to cover any stamp or other tax or governmental charge that is imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action under any section of this Agreement that requires the payment by a Holder of applicable taxes or charges unless and until the Rights Agent is satisfied that all such taxes or charges have been paid or will be paid. All duly transferred CVRs registered in the CVR Register will be the valid obligations of Parent and will entitle the transferee to the same benefits and rights under this Agreement as those held immediately prior to the transfer by the transferor. No transfer of a CVR will be valid until registered in the CVR Register. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;A Holder may make a written request to the Rights Agent to change such Holder&#8217;s address of record in the CVR Register. The written request must be duly executed by the Holder. Upon receipt of such written request, the Rights Agent is hereby authorized to promptly record the change of address in the CVR Register. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Parent will provide written instructions to the Rights Agent for the distribution of CVRs to holders of Parent Common Stock as of immediately prior to the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221;). Subject to the terms and conditions of this Agreement and Parent&#8217;s prompt confirmation of the Effective Time, the Rights Agent shall effect the distribution of the CVRs, less any applicable tax withholding, to each holder of Parent Common Stock as of the Record Time by the mailing of a statement of holding reflecting such CVRs. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment Procedures</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Within thirty (30) days after the receipt of any portion of the Total Payment Amount, Parent shall (i)&#160;deliver to the Rights Agent a certificate certifying to and specifying in reasonable detail (A)&#160;the amount of the applicable Total Payment Amount received by Parent or its Affiliates, (B)&#160;a calculation of the CVR Payment Amount and CVR Payment, and (C)&#160;the Permitted Deductions reflected in such CVR Payment Amount, (ii)&#160;deliver to the Rights Agent an amount equal to the aggregate CVR Payment Amount in immediately available funds (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221;) and (iii)&#160;instruct the Rights Agent to deliver the CVR Payment to the Holders. The Rights Agent will promptly, and in any event </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">within ten (10) Business Days after receipt of each applicable CVR Payment, pay to each Holder, by check mailed to the address of each Holder as reflected in the CVR Register as of the close of business on the date of the receipt of the CVR Payment statement, such Holder&#8217;s CVR Payment Amount less any applicable tax withholding. Until such certificate, CVR Payment and instructions are received by the Rights Agent, the Rights Agent may presume conclusively for all purposes that such portion of the Total Payment Amount has not been received. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All payments by Parent to the Rights Agent under this Agreement shall be made in U.S. dollars. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent shall be entitled to deduct or withhold, or cause the Rights Agent to deduct or withhold from any CVR Payment Amount otherwise payable or otherwise deliverable pursuant to this Agreement, in each case directly or through an authorized payroll agent, such amounts as are reasonably determined to be required to be deducted or withheld therefrom under the Code or any other provision of any applicable federal, state, local or non-U.S. Tax Law as may be determined by Parent. To the extent such amounts are so deducted or withheld and paid over or deposited with the relevant Tax authority, such amounts shall be treated for all purposes under this Agreement as having been paid to the Holder(s) to whom such amounts would otherwise have been paid or delivered. Prior to making any such Tax withholdings or causing any such Tax withholdings to be made with respect to any Holder, Parent shall instruct the Rights Agent, to the extent practicable, to provide notice to the Holder of such potential withholding and a reasonable opportunity for the Holder to provide any necessary Tax forms (including an IRS Form W-9 or an applicable IRS Form W-8) in order to avoid or reduce such withholding amounts; provided, that the time period for payment of a CVR Payment Amount by the Rights Agent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> shall be extended by a period equal to any delay caused by the Holder providing such forms; provided, further, that in no event shall such period be extended for more than ten (10) Business Days, unless otherwise requested by the Holder for the purpose of delivering such forms and agreed to by the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Any portion of any CVR Payment that remains undistributed to any Holder six (6)&#160;months after such CVR Payment is received by the Rights Agent from Parent, provided, that the Rights Agent has fully complied with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, will be delivered by the Rights Agent to Parent, upon demand, and such Holder will thereafter look only to Parent for payment of its share of such returned CVR Payment, without interest. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Neither Parent nor the Rights Agent will be liable to any person in respect of any CVR Payment Amount delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If, despite Parent&#8217;s and/or the Rights Agent&#8217;s commercially reasonable efforts to deliver a CVR Payment Amount to the applicable Holder, such CVR Payment Amount has not been paid immediately prior to the date on which such CVR Payment Amount would otherwise escheat to or become the property of any Governmental Body, any such CVR Payment Amount will, to the extent permitted by applicable Law, become the property of Parent, free and clear of all claims or interest of any person previously entitled thereto. In addition to and not in limitation of any other indemnity obligation herein, Parent agrees to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject to in connection with transferring such property to Parent and such indemnification obligation shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Voting, Dividends or Interest; No Equity or Ownership Interest in Parent</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not have any voting or dividend rights, and interest will not accrue on any amounts payable on the CVRs to any Holder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The CVRs will not represent any equity or ownership interest in Parent or in any constituent company to the Merger. The sole right of the Holders to receive property hereunder is the right to receive the CVR Payment in accordance with the terms hereof. It is hereby acknowledged and agreed that a CVR shall not constitute a security of Parent or any constituent company to the Merger. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Holder acknowledges and agrees that such Holder will not challenge or contest any action, inaction, determination or decision of Parent or the Rights Agent, except via written action of the Acting Holders, and will not threaten, bring, commence, institute, maintain, prosecute or voluntarily aid any action, which challenges the validity of or seeks to enjoin the operation of any provision of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ability to Abandon CVR</font><font style="letter-spacing:0.2pt;">. A Holder may at any time, at such Holder&#8217;s option, abandon all of such Holder&#8217;s remaining rights in a CVR by transferring such CVR to Parent without consideration therefor, and such rights will be cancelled, with the Rights Agent being promptly notified in writing by Parent of such transfer and cancellation. Nothing in this Agreement is intended to prohibit Parent from offering to acquire CVRs, in a private transaction or otherwise, for consideration in its sole discretion. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;THE RIGHTS AGENT </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Duties and Responsibilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Rights Agent will be authorized and protected and will not have any liability for or in respect of any actions taken, suffered or omitted to be taken by it in connection with its acceptance and administration of this Agreement and the exercise and performance of its duties hereunder, except to the extent of its own willful misconduct, bad faith or gross negligence (each as determined by a final non-appealable judgment of a court of competent jurisdiction). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Rights of the Rights Agent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied duties, covenants or obligations will be read into this Agreement against the Rights Agent. The Rights Agent shall not assume any obligations or relationship of agency or trust with any Holder. In addition: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;the Rights Agent may rely and will be protected by Parent in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document believed by it in the absence of bad faith to be genuine and to have been signed or presented by the proper party or parties; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;whenever the Rights Agent will deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may request and rely upon an Officer&#8217;s Certificate with respect to such matter, which certificate shall be full authorization and protection to the Rights Agent, and the Rights Agent shall, in the absence of gross negligence, bad faith or willful or intentional misconduct (each as determined by a final non appealable judgment of a court of competent jurisdiction) on its part, incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith under the provisions of this Agreement in reliance upon such certificate; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;in the event the Rights Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document received by the Rights Agent hereunder, the Rights Agent, may, in its sole discretion, refrain from taking any action, and shall be fully protected and shall not be liable in any way to Parent, any Holder or any other person or entity for refraining from taking such action, unless the Rights Agent receives written instructions from the Parent which eliminates such ambiguity or uncertainty to the satisfaction of the Rights Agent; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;the Rights Agent may engage and consult with counsel of its selection (who may be legal counsel for the Rights Agent or the Parent or an employee of the Rights Agent) and the written advice of such counsel or any opinion of counsel will be full and complete authorization and protection to the Rights Agent and the Rights Agent shall be held harmless by Parent and shall incur no liability for or in respect of any action taken, suffered or omitted by it hereunder in the absence of bad faith and in reliance thereon; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;the permissive rights of the Rights Agent to do things enumerated in this Agreement will not be construed as a duty; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;the Rights Agent will not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Parent only and the Rights Agent will have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent), nor shall the Rights Agent be responsible for any breach by Parent of any covenant or condition contained in this Agreement; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, damage, judgment, fine, penalty, settlement, claim, demands, suits, cost or expense (including without limitation, the reasonable and documented fees and expenses of legal counsel) for any action taken, suffered or omitted to be taken by the Rights Agent or arising out of or in connection with the Rights Agent&#8217;s duties under this Agreement, including the reasonable and documented out-of-pocket costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss arising therefrom, directly or indirectly, or enforcement of its rights hereunder, unless such loss has been determined by a final non-appealable judgment of a court of competent jurisdiction to be a result of the Rights Agent&#8217;s gross negligence, bad faith or willful or intentional misconduct; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;anything to the contrary notwithstanding, (i)&#160;any liability of the Rights Agent under this Agreement will be limited to the aggregate amount of the annual fees (but not reimbursed expenses) paid by Parent to the Rights Agent under this Agreement during the twelve&#160;months immediately preceding the event for which recovery is sought, and (ii)&#160;in no event shall the Rights Agent be liable for any special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including but not limited to lost profits) arising out of any action taken, suffered or omitted to be taken by it, even if the Rights Agent has been advised of the likelihood of such loss or damage and regardless of the form of action; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Parent agrees (i)&#160;to pay the fees and expenses of the Rights Agent in connection with the Rights Agent&#8217;s duties under this Agreement as agreed upon in writing by the Rights Agent and Parent on or prior to the date hereof, and (ii)&#160;to reimburse the Rights Agent for all taxes and governmental charges, reasonable and documented out-of-pocket expenses and other charges of any kind and nature incurred by the Rights Agent in the preparation, delivery, amendment and execution of this Agreement and the exercise and performance of its duties hereunder (other than taxes imposed on or measured by the Rights Agent&#8217;s net income and franchise or similar taxes imposed on it (in lieu of net income taxes)). The Rights Agent will also be entitled to reimbursement from Parent for all reasonable and documented out-of-pocket expenses paid or incurred by it in connection with the administration by the Rights Agent of its duties hereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing from the Parent and all notices or other instruments required by this Agreement to be delivered to the Rights Agent must, in order to be effective, be received by the Rights Agent as specified herein, and in the absence of such notice so delivered the Rights Agent may conclusively assume no such event or condition exists; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;the Rights Agent and any shareholder, affiliate, director, officer or employee of the Rights Agent may buy, sell or deal in any securities of the Parent or become peculiarly interested in any transaction in which the Parent may be interested, or contract with or lend money to the Parent or otherwise act as fully and freely as though it were not the Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Parent or for any other Person; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;the Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its attorneys or agents, and the Rights Agent shall not be liable, answerable or accountable for any act, omission, default, neglect or misconduct of any such attorneys or agents or for any loss to the Parent, any Holder or any other person or entity </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct (each as determined by a final non-appealable judgment of a court of competent jurisdiction) in the selection and continued employment thereof; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;no provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by the Parent or its Affiliates, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Parent; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;the Rights Agent shall neither be responsible for, nor chargeable with, knowledge of, nor have any requirements to comply with, the terms and conditions of any other agreement, instrument or document, including, without limitation, the Merger Agreement, nor shall the Rights Agent be required to determine if any person or entity has complied with any such agreements, instruments or documents, nor shall any additional obligations of the Rights Agent be inferred from the terms of such agreements, instruments or documents even though reference thereto may be made in this Agreement. In the event of any conflict between the terms and provisions of this Agreement and those of any other agreement, instrument or document, including but not limited to the Merger Agreement, the terms and conditions of this Agreement shall control as they relate to the Rights Agent; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;The provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;"> and this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;"> shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Resignation and Removal; Appointment of Successor</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Rights Agent may resign at any time by giving written notice thereof to Parent specifying a date when such resignation will take effect, which notice will be sent at least thirty (30) days prior to the date so specified, and such resignation will become effective on the earlier of (i)&#160;the date so specified and (ii)&#160;the appointment of a successor Rights Agent. Parent has the right to remove the Rights Agent at any time by a Board Resolution specifying a date when such removal will take effect (or, if earlier, the appointment of the successor Rights Agent). Notice of such removal will be given by Parent to the Rights Agent, which notice will be sent at least thirty (30) days prior to the date so specified. Notwithstanding anything to the contrary contained herein, such replacement or removal of the Rights Agent shall not affect any of the provisions of this Agreement that expressly survive the termination of this Agreement, or the resignation, replacement or removal of the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Rights Agent provides notice of its intent to resign, is removed or becomes incapable of acting, Parent, by a Board Resolution, will as soon as is reasonably possible appoint a qualified successor Rights Agent, who shall be a stock transfer agent or national reputation or the corporate trust department of a commercial bank. The successor Rights Agent so appointed will, forthwith upon its acceptance of such appointment in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">, become the successor Rights Agent. Notwithstanding the foregoing, if Parent shall fail to make such appointment within a period of thirty (30) days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Rights Agent, then the incumbent Rights Agent may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent will give notice to each Holder of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by delivering a written notice of such event to the Holders as their names and addresses appear in the CVR Register in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;">. Each notice will include the name and address of the successor Rights Agent. If Parent fails to send such notice within ten (10) Business Days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent will cause the notice to be mailed at the expense of Parent. Failure to give </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any notice provided for in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, however, and any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, unless consented to in writing by, at the applicable time of determination, Holders of at least 33% of the then outstanding CVRs, as set forth in the CVR Register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221;), Parent will not appoint as a successor Rights Agent any Person that is not a stock transfer agent of national reputation or the corporate trust department of a commercial bank. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Rights Agent will reasonably cooperate with Parent and any successor Rights Agent in connection with the transition of the duties and responsibilities of the Rights Agent to the successor Rights Agent, including the transfer of all relevant data, including the CVR Register, to the successor Rights Agent, but such predecessor Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acceptance of Appointment by Successor</font><font style="letter-spacing:0.2pt;">. Every successor Rights Agent appointed hereunder will, at or prior to such appointment, execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Rights Agent. On request of Parent or the successor Rights Agent, the retiring Rights Agent will execute and deliver an instrument transferring to the successor Rights Agent all the rights (except such rights of the predecessor Rights Agent which survive pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> of this Agreement), powers and trusts of the retiring Rights Agent. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;COVENANTS </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">List of Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent will furnish or cause to be furnished to the Rights Agent in such form as Parent receives from Parent&#8217;s transfer agent (or other agent performing similar services for Parent), the names and addresses of the Holders within ten (10) Business Days of the Effective Time. Until such initial list of Holders is furnished to the Rights Agent, the Rights Agent shall have no duties, responsibilities or obligations with respect to such Holders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment of CVR Payment Amounts</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If a CVR Payment is due under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, Parent will deposit the CVR Payment with the Rights Agent for payment to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Roche Agreements</font><font style="letter-spacing:0.2pt;">. Without the prior written consent of the Acting Holders, neither Parent nor any of its Affiliates shall (a)&#160;amend, restate, supplement, terminate or otherwise modify the Roche Agreement in a manner materially adversely affecting the Holders&#8217; rights under this Agreement, (b)&#160;in the event that Roche fails to make a payment of a Roche Payment at the time rightfully due and payable, take action with respect to, or unreasonably waive or fail to enforce, the right to receive the applicable payments which are rightfully due and payable under the Roche Agreement, in a manner materially adversely affecting the Holders&#8217; rights under this Agreement or (c)&#160;agree to any of the foregoing. Without limiting the foregoing, Parent and its Affiliates shall pursue their rights under the Roche Agreement in good faith, and not take any action (or fail to take any action) with the intention of avoiding, reducing or materially delaying any payment to the Holders hereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Records</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall, and shall cause its Affiliates to, keep true, complete and accurate records in sufficient detail to enable the Holders and their consultants or professional advisors to confirm (a)&#160;whether the Roche Payment Amount or the Asset Disposition Proceeds have been received by Parent or its successors or Affiliates and (b)&#160;the applicable CVR Payment Amount payable to each Holder hereunder in accordance with the terms specified in this Agreement. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;DISPOSITION </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the period specified in clause (b)&#160;of the definition of &#8220;CVR Term&#8221;, Parent will, and will cause its subsidiaries to, use commercially reasonable efforts to effectuate a Disposition, including the negotiation and execution of a Sale Agreement and completion of the transactions contemplated thereby. Further, Parent will not take any actions for the primary purpose of frustrating the payment of CVR Payments. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Holders acknowledge and agree that, except as expressly set forth in the foregoing Section&#160;5.1, (a)&#160;Parent has a fiduciary obligation to operate its business in the best interests of its stockholders, and any potential obligation to pay any potential Asset Disposition Proceeds or any other amounts will not create any express or implied obligation to operate its business in any particular manner in order to maximize any such CVR Payments, (b)&#160;the Holders are not relying on any representation of Parent or any other Person with regard to any Disposition or other action involving CVR Sale Assets following the Closing, and neither Parent nor any other Person has provided, or can provide, any assurance to the Holders that any potential Asset Disposition Proceeds or any other amounts will in fact be earned and paid, and (c)&#160;none of Parent or any of its Subsidiaries, officers or directors shall have any obligation or liability whatsoever to any Person relating to or in connection with any action, or failure to act, with respect to the sale of CVR Sale Assets. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;AMENDMENTS </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments without Consent of Holders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, at any time and from time to time, and the Rights Agent may enter into one or more amendments hereto, solely to evidence any successor to or permitted Assignee of Parent and the assumption by any such successor or permitted Assignee of the covenants of Parent herein as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, may, with the consent of the Rights Agent, which consent shall not be unreasonably withheld, conditioned or delayed, at any time and from time to time, enter into one or more amendments hereto, solely for any of the following purposes: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to evidence the succession of another Person as a successor Rights Agent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3</font><font style="letter-spacing:0.2pt;"> and the assumption by any successor of the covenants and obligations of the Rights Agent herein; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to add to the covenants of Parent such further covenants, restrictions, conditions or provisions as Parent shall consider to be for the protection of the Holders; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that the CVRs are not subject to registration under the Securities Act or the Exchange Act or any applicable state securities or &#8220;blue sky&#8221; laws; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;to cancel any CVRs (A)&#160;in the event that any Holder has abandoned its rights in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">, or (B)&#160;following a transfer of such CVRs to Parent or its Affiliates in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, unless such addition, elimination or change is adverse to the interests of the Holders; or </font>
        </div>
        <div style="text-indent:60pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that Parent complies with applicable Law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">, Parent will transmit a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments with Consent of Holders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> (which amendments pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> may be made without the consent of the Holders), with the consent of the Acting Holders, whether evidenced in writing or taken </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">at a meeting of such Holders, Parent, when authorized by a Board Resolution, and the Rights Agent may enter into one or more amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interest of the Holders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent, and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2</font><font style="letter-spacing:0.2pt;">, Parent will transmit (or cause the Rights Agent to transmit) a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Execution of Amendments</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In executing any amendment permitted by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, the Rights Agent will be entitled to receive, and will be fully protected in relying upon, an opinion of counsel selected by Parent stating that the execution of such amendment is authorized or permitted by this Agreement. Notwithstanding anything contained herein, the Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent&#8217;s own rights, privileges, covenants or duties under this Agreement or otherwise. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Effect of Amendments</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the execution of any amendment under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, this Agreement will be modified in accordance therewith, such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;OTHER PROVISIONS OF GENERAL APPLICATION </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices to Rights Agent and Parent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed given when delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fee prepared, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to the Rights Agent, to it at: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Computershare Inc. and Computershare Trust Company, N.A. </font> <br ><font style="letter-spacing:0.2pt;">150 Royall Street, 2nd Floor </font> <br ><font style="letter-spacing:0.2pt;">Canton, MA 02021 </font> <br ><font style="letter-spacing:0.2pt;">Attention: Relationship Manager </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to Parent, to it at: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Telephone:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Telephone:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Rights Agent or Parent may specify a different address, email address by giving notice to each other in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> and to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Where this Agreement provides for notice to Holders, such notice will be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid or, if applicable, transmitted through the facilities of DTC in accordance with DTC&#8217;s procedures, to each Holder affected by such event, at the Holder&#8217;s address as it appears in the CVR Register, not later </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">than the latest date, and not earlier than the earliest date, if any, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder will affect the sufficiency of such notice with respect to other Holders. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Parent Successors and Assigns</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent may not assign this Agreement without the prior written consent of the Acting Holders. Notwithstanding the foregoing (i)&#160;Parent may assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations hereunder to one or more direct or indirect wholly-owned subsidiaries of Parent for so long as they remain wholly-owned subsidiaries of Parent (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221;) and the Assignee agrees to assume and be bound by all of the terms of this Agreement; provided, however, that in connection with any assignment to an Assignee, Parent shall, and shall agree to, remain liable for the performance by such Assignee of all obligations of Parent hereunder, with such Assignee substituted for Parent under this Agreement, and (ii)&#160;Parent may assign this Agreement in its entirety without the consent of any other party to its successor in interest in connection with the sale of all or substantially all of its assets or of its stock, or in connection with a merger, acquisition or similar transaction (such successor in interest, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221;, and such transaction, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221;). This Agreement will be binding upon, inure to the benefit of and be enforceable by Parent&#8217;s successors, acquirers and each Assignee. Each reference to &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; in this Agreement shall be deemed to include Parent&#8217;s successors, acquirers and all Assignees. Each of Parent&#8217;s successors, acquirers and assigns shall expressly assume by an instrument supplemental hereto, executed and delivered to the Rights Agent, the due and punctual payment of the CVR Payments and the due and punctual performance and observance of all of the covenants and obligations of this Agreement to be performed or observed by Parent. Notwithstanding anything to the contrary contained herein, no assignment pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;"> shall relieve Parent of its obligations and liabilities to the Rights Agent hereunder, unless specifically agreed to in writing by the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Any Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any Person succeeding to the stock transfer or other shareholder services business of the Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided, that such Person would be eligible for appointment as a successor Rights Agent under the provisions of this Agreement. The purchase of all or substantially all of the Rights Agent&#8217;s assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Benefits of Agreement; Action by Acting Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The holders shall be intended third-party beneficiaries hereof and shall be entitled to, solely by action by the written consent of the Acting Holders, specifically enforce the terms hereof; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that under no circumstances shall the rights of Holders as third-party beneficiaries pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.4</font><font style="letter-spacing:0.2pt;"> be enforceable by such Holders or any other Person acting for or on their behalf other than through the action of the Acting Holders, which Acting Holders shall have the sole power and authority to act on behalf of the Holders in enforcing any of their rights hereunder. Nothing in this Agreement, express or implied, will give to any Person (other than the Rights Agent, Parent, Parent&#8217;s successors and permitted assignees, and the Holders and their respective successors and permitted assignees) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Rights Agent, Parent, Parent&#8217;s successors and permitted Assignees, and the Holders and their respective successors and permitted assignees. The rights of Holders are limited to those expressly provided in this Agreement and the Merger Agreement. Except for the rights of the Rights Agent set forth herein, the Acting Holders will have the sole right, on behalf of all Holders, by virtue of or under any provision of this Agreement, to institute any action or proceeding at law or in equity with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise such rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement, the CVRs and all claims and causes of action based upon, arising out of or in connection herewith shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without regard to Laws that may be applicable under conflicts of laws principles </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In any Legal Proceeding between any of the parties arising out of our relating to this Agreement, each of the parties hereby (i)&#160;irrevocably and unconditionally consent and submits, for itself and its property, to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if such court does not have jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (ii)&#160;agrees that any claim in respect of any such Legal Proceeding shall be heard and determined exclusively in accordance with clause (i)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.5</font><font style="letter-spacing:0.2pt;">, (iii)&#160;waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Legal Proceeding in any such court, (iv)&#160;waives, to the fullest extent permitted by Law, any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (v)&#160;agrees that service of process upon such party in any such Legal Proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> of this Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.5</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any Person to serve legal process in any manner permitted by Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If any term or other provision of this Agreement is determined by a final judgement of a court of competent jurisdiction to be invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provisions, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. Notwithstanding anything to the contrary herein, if any such excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately upon written notice to Parent. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business or other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.7</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Counterparts and Signature</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement may be signed in any number of counterparts, including by electronic transmission, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.8</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement will expire and be of no force or effect, the parties hereto will have no liability hereunder (other than with respect to monies due and owing by Parent to the Rights Agent or any other rights of the Rights Agent which expressly survive the termination of this Agreement), and no additional payments will be required to be made, upon the later of (i)&#160;the conclusion of the CVR Term, and (ii)&#160;the payment of the full amount of all CVR Payments made to Parent on or prior to the end of the applicable CVR Term to the Rights Agent and the payment of the full amount of all CVR Payment Amounts to the Holders by the mailing by the Rights Agent of each applicable CVR Payment Amount to each Holder at the address reflected in the CVR Register; provided that, for clarity, the term &#8220;CVR Term&#8221; as used in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.8</font><font style="letter-spacing:0.2pt;"> shall be deemed to mean clause (a)&#160;of such definition with respect to any Roche Payment Amount, and shall be deemed to mean clause (b)&#160;of such definition with respect to any Asset Disposition Proceeds. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.9</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All funds received by the Rights Agent under this Agreement that are to be distributed or applied by Computershare in the performance of services hereunder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221;) shall be held by Computershare as agent for Parent and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, Computershare will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1&#160;billion or with an average rating above investment grade by S&amp;P (LT Local Issuer Credit Rating), Moody&#8217;s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:256pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">paragraph, including any losses resulting from a default by any bank, financial institution or other Third Party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to Parent, any Holder or any other party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.10</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Entire Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As between Parent and the Holders, this Agreement and the Merger Agreement (including the schedules, annexes and exhibits thereto, the documents and instruments referred to therein and the documents delivered pursuant thereto) constitute the entire agreement of Parent and the Holders and supersede all prior agreements and undertakings, both written and oral, among Parent and the Holders, or any of them, with respect to the subject matter hereof and, except as otherwise expressly provided herein or therein, are not intended to confer upon any other Person any rights or remedies hereunder or thereunder. As between Parent and the Rights Agent, this Agreement (including the documents and instruments referred to herein (other than the Merger Agreement) and the documents delivered pursuant thereto) contains the entire understanding of the parties with reference to the transactions and matters contemplated hereby and thereby and supersedes all prior agreements, written or oral, among the parties with respect thereto. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement will govern and control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.11</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Jury Trial</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Remainder of page intentionally left blank</font><font style="letter-spacing:0.2pt;">] </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written. </font>
        </div>
        <table style="width:456pt;height:207pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">SESEN BIO, INC. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Title: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:15.667pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">COMPUTERSHARE INC. and </font>
              <br >
              <font style="letter-spacing:0.2pt;">COMPUTERSHARE TRUST</font>
              <br >
              <font style="letter-spacing:0.2pt;">COMPANY, N.A., jointly as RIGHTS </font>
              <br >
              <font style="letter-spacing:0.2pt;">AGENT </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Title: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;min-height:690.02pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX B</font>&#8203;</div>
        <div style="position:relative;margin-top:8.71pt; width:456pt;">
          <img src="lg_svbsecurities-4c.jpg" alt="[MISSING IMAGE: lg_svbsecurities-4c.jpg]" height="51" width="224" >
        </div>
        <div style="margin-top:14.81pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">December&#160;29</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">, 2022 </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors </font> <br ><font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font> <br ><font style="letter-spacing:0.2pt;">245 First Street, Suite 1800 </font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA 02142 </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Ladies and Gentlemen: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You have requested our opinion as to the fairness, from a financial point of view, to Sesen Bio, Inc., a Delaware corporation (&#8220;Parent&#8221;), of the Exchange Ratio (as defined below) proposed to be paid by Parent pursuant to the terms of the Agreement and Plan of Merger and Reorganization (the &#8220;Original Merger Agreement&#8221;) dated as of September&#160;20, 2022 by and among Parent, Sesen Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;Merger Sub&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;Company&#8221;), as proposed to be amended by the First Amendment to Agreement and Plan of Merger and Reorganization (the &#8220;First Amendment to Merger Agreement&#8221;) to be entered into by and among Parent, Merger Sub and the Company (the Original Merger Agreement, as proposed to be amended by the First Amendment to Merger Agreement, the &#8220;Amended Merger Agreement&#8221;). The Amended Merger Agreement provides for the acquisition by Parent of the Company through the merger of Merger Sub with and into the Company (the &#8220;Merger&#8221;), with the Company continuing as the surviving entity of the Merger and as a wholly-owned subsidiary of Parent. Capitalized terms used but not defined herein have the meanings set forth in the Amended Merger Agreement. At the effective time of the Merger (the &#8220;Effective Time&#8221;), after giving effect to the Nasdaq Reverse Split, if any, and the declaration of the Pre-Closing Dividend, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any stockholder of the Company or Parent, among other things, each share of Company Capital Stock outstanding immediately prior to the Effective Time (excluding Excluded Shares (as defined below)) shall be converted solely into the right to receive a number of shares of the common stock, $0.001 par value per share, of Parent (the &#8220;Parent Common Stock&#8221;) equal to the Exchange Ratio. As used herein, (i)&#160;the &#8220;Exchange Ratio&#8221; is the number of shares of Parent Common Stock to be received by holders of Company Capital Stock, other than Excluded Shares, in the Merger, which is derived from the agreed relative valuations of the Company and Parent as set forth in the Amended Merger Agreement; and (ii)&#160;&#8220;Excluded Shares&#8221; means (a)&#160;any shares of Company Capital Stock held as treasury stock or held or owned by the Company, Merger Sub or any Subsidiary of the Company immediately prior to the Effective Time (which shares shall be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor); and (b)&#160;any shares of Company Capital Stock that are outstanding immediately prior to the Effective Time and which are held by stockholders who have exercised and perfected appraisal rights for such shares of Company Capital Stock in accordance with the General Corporation Law of the State of Delaware. The Exchange Ratio is subject to certain adjustments set forth in the Amended Merger Agreement; we express no opinion as to any such adjustments. The Merger and the other transactions summarized above are collectively referred to herein as the &#8220;Transaction.&#8221; The terms and conditions of the Transaction are more fully set forth in the Amended Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have been engaged by Parent to act as its financial advisor in connection with the Transaction and we will receive a fee from Parent for providing such services, a portion of which was payable upon delivery of our opinion in connection with the Original Merger Agreement, another portion of which is payable upon delivery of this opinion in connection with the Amended Merger Agreement, and the remaining (and principal) portion of which is contingent upon consummation of the Transaction. In addition, Parent has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may arise, out of our engagement.</font>
        </div>
        <div style="position:relative;margin-top:12.21pt; width:456pt;">
          <img src="ft_svbsecurities-4c.jpg" alt="[MISSING IMAGE: ft_svbsecurities-4c.jpg]" height="42" width="594" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities LLC is a full-service securities firm engaged in securities trading and brokerage activities as well as investment banking and financial advisory services. In the ordinary course of business, we and our affiliates have in the past provided, currently are providing and may in the future provide investment banking and commercial banking services to Parent, the Company or their respective affiliates and have received and would expect to receive customary fees for the rendering of such services. In the ordinary course of our business, we or our affiliates have in the past and may in the future hold positions, for our own account or the accounts of our customers, in equity, debt or other securities of Parent, the Company or their respective affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Consistent with applicable legal and regulatory requirements, we have adopted policies and procedures to establish and maintain the independence of our research department and personnel. As a result, our research analysts may hold views, make statements or investment recommendations and/or publish research reports with respect to Parent, the Company and the Transaction and other participants in the Transaction that differ from the views of our investment banking personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with this opinion, we have reviewed, among other things: (i)&#160;the Original Merger Agreement; (ii)&#160;a draft of the First Amendment to Merger Agreement, dated December&#160;29</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">, 2022; (iii)&#160;a draft of the form of Contingent Value Rights Agreement to be entered into at the closing of the Transaction by Parent and a rights agent (the &#8220;CVR Agreement&#8221;), dated December&#160;29</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">, 2022; (iv)&#160;Parent&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021, as filed by Parent with the Securities and Exchange Commission (the &#8220;SEC&#8221;); (v)&#160;Parent&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods ended March&#160;31, 2022, June&#160;30, 2022, and September&#160;30, 2022 (including any amendments thereto), as filed by Parent with the SEC; (vi)&#160;certain Current Reports on Form 8-K (including any amendments thereto), as filed by Parent with, or furnished by Parent to, the SEC; (vii)&#160;certain internal information, primarily related to expense forecasts, relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of Parent, as furnished to us by the management of Parent; and (viii)&#160;certain internal information relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of the Company, including certain financial forecasts, analyses and projections relating to the Company prepared by management of the Company, as modified by management of Parent and furnished to, and approved for use by, us by Parent for purposes of our analysis (the &#8220;Company Forecast&#8221;) (collectively, the &#8220;Internal Data&#8221;). We have also conducted discussions with members of the senior management of Parent and the Company and their respective advisors and representatives regarding such Internal Data as well as the past and current business, operations, financial condition and prospects of each of Parent and the Company. In addition, we reviewed certain financial data for the Company and compared that data to similar publicly available market, financial and other data for certain other companies, the securities of which are publicly traded, that we believe to be comparable in certain respects to the Company. We also conducted such other financial studies and analyses and took into account such other information as we deemed appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have assumed, without independent verification or any responsibility therefor, the accuracy and completeness of the financial, legal, regulatory, tax, accounting and other information supplied to, discussed with, or reviewed by us for purposes of this opinion and have, with your consent, relied upon such&#160;information as being complete and accurate. In that regard, we have been advised by Parent, and have assumed, at your direction, that the Internal Data (including, without limitation, the Company Forecast) has been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of Parent and the Company as to the matters covered thereby and we have relied, at your direction, on the Internal Data for purposes of our analysis and this opinion. We express no view or opinion as to the Internal Data (including, without limitation, the Company Forecast) or the assumptions on which it is based. As you are aware, Parent&#8217;s management did not provide us with, and we did not otherwise have access to, financial forecasts regarding Parent&#8217;s business, other than the expense forecasts described above. Accordingly, we did not perform a discounted cash flow analysis or any multiples-based analysis with respect to Parent. In addition, at your direction, we have not made any independent evaluation or appraisal of any of the assets or liabilities (contingent, derivative, off-balance-sheet or otherwise) of Parent or the Company, nor have we been furnished with any such evaluation or appraisal, and we have not been asked to conduct, and did not conduct, a physical inspection of the properties or assets of Parent or the Company. Furthermore, at your direction, we have ascribed no value to the contingent value rights issuable pursuant to the CVR Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have assumed, at your direction, that the final executed First Amendment to Merger Agreement will not differ in any respect material to our analysis or this opinion from the last draft of the First Amendment to Merger Agreement reviewed by us. We have also assumed, at your direction, that the representations and warranties made by the Company and Parent and Merger Sub in the Amended Merger Agreement and the related agreements are and will continue to be true and correct in all respects material to our analysis. Furthermore, we have assumed, at your direction, that the Transaction will be consummated on the terms set forth in the Amended Merger Agreement and in accordance with all applicable laws and other relevant documents or requirements, without delay or the waiver, modification or amendment of any term, condition or agreement, the effect of which would be material to our analysis or this opinion and that, in the course of obtaining the necessary governmental, regulatory and other approvals, consents, releases and waivers for the Transaction, no delay, limitation, restriction, condition or other change will be imposed, the effect of which would be material to our analysis or this opinion. We have not evaluated and do not express any opinion as to the solvency or fair value of Parent or the Company, or their respective abilities to pay their obligations when they come due, or as to the impact of the Transaction on such matters, under any state, federal or other laws relating to bankruptcy, insolvency, or similar matters. We are not legal, regulatory, tax or accounting advisors, and we express no opinion as to any legal, regulatory, tax or accounting matters. We express no view or opinion as to the price or range of prices at which the shares of stock or other securities or instruments of Parent or any third party may trade at any time, including subsequent to the announcement or consummation of the Transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We express no view as to, and our opinion does not address, Parent&#8217;s underlying business decision to proceed with or effect the Transaction, or the relative merits of the Transaction as compared to any alternative business strategies or transactions that might be available to Parent or in which Parent might engage. This opinion is limited to and addresses only the fairness, from a financial point of view, as of the date hereof, to Parent of the Exchange Ratio proposed to be paid by Parent pursuant to the terms of the Amended Merger Agreement. We have not been asked to, nor do we express any view on, and our opinion does not address, any other term or aspect of the Amended Merger Agreement or the Transaction, including, without limitation, the structure or form of the Transaction, or any other agreements or arrangements contemplated by the Amended Merger Agreement or entered into in connection with or otherwise contemplated by the Transaction, including, without limitation, the fairness of the Transaction or any other term or aspect of the Transaction to, or any consideration to be received in connection therewith by, or the impact of the Transaction on, the holders of any class of securities, creditors or other constituencies of Parent or any other party. In addition, we express no view or opinion as to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to be paid or payable to any of the officers, directors or employees of Parent or any other party, or class of such persons in connection with the Transaction, whether relative to the Exchange Ratio to be paid by Parent pursuant to the terms of the Amended Merger Agreement or otherwise. Our opinion is necessarily based on financial, economic, monetary, currency, market and other conditions and circumstances as in effect on, and the information made available to us as of, the date hereof, and we do not have any obligation or responsibility to update, revise or reaffirm this opinion based on circumstances, developments or events occurring after the date hereof. Our opinion does not constitute a recommendation to any stockholder of Parent as to whether or how such stockholder should vote with respect to the Merger or otherwise act with respect to the Transaction or any other matter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our financial advisory services and the opinion expressed herein are provided for the information and assistance of the Board of Directors of Parent (in their capacity as directors and not in any other capacity) in connection with and for purposes of its consideration of the Transaction. This opinion has been authorized by our Fairness Opinion Review Committee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based upon and subject to the foregoing, including the various assumptions, qualifications and limitations set forth herein, it is our opinion that, as of the date hereof, the Exchange Ratio proposed to be paid by Parent pursuant to the terms of the Amended Merger Agreement is fair, from a financial point of view, to Parent. </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Very truly yours, </font>
        </div>
        <div style="margin-left:240pt; margin-top:12pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ SVB SECURITIES LLC</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX C</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORM OF COMPANY STOCKHOLDER SUPPORT AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This STOCKHOLDER SUPPORT AGREEMENT (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is entered into as of [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;], 2022, among CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and the undersigned stockholder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder</font><font style="letter-spacing:0.2pt;">&#8221;) of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as of the date hereof, the Stockholder is the sole record owner of and has the sole power to vote (or to direct the voting of) the number of shares of common stock, par value $0.0001 per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), and/or the number of shares of preferred stock, $0.0001 par value per share of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), set forth opposite the Stockholder&#8217;s name on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto (such Common Stock and Preferred Stock, together with any other shares of the Company that are hereafter issued to or otherwise acquired or owned by, including upon exercise of options or securities convertible into or exercisable or exchangeable for Common Stock (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Shares</font><font style="letter-spacing:0.2pt;">&#8221;), the voting power of which is acquired by such Stockholder during the Voting Period (as defined below), are collectively referred to herein as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the Company, Parent, and Seahawk Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), are concurrently entering into an Agreement and Plan of Merger and Reorganization, dated on or about the date hereof (as amended from time to time, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub shall be merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the adoption of the Merger Agreement and the transactions contemplated thereby requires the written consent or affirmative vote of (i)&#160;the holders of a majority of the capital stock of the Company, voting together as a single class, (ii)&#160;the holders of a majority of the Series&#160;A Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Series&#160;A Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), and the Special Voting Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), voting together as a single class, (iii)&#160;the holders of at least two-thirds of the Series&#160;B Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Series&#160;B Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), and the Series&#160;B Special Voting Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Series&#160;B Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), voting together as a single class, and (iv)&#160;the holders of at least two-thirds of the Series&#160;A Preferred Stock, Special Voting Preferred Stock, Series&#160;B Preferred Stock and Series&#160;B Special Voting Preferred Stock, voting together as a single class; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as a condition and inducement to Parent&#8217;s willingness to enter into the Merger Agreement and consummate the transactions contemplated thereby, Parent and the Company have required the Stockholder to, as an inducement and in consideration therefor, and the Stockholder (in the Stockholder&#8217;s capacity as holder of the Subject Shares) has agreed to, enter into this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, the parties agree as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE I</font>
          <br >
          <font style="letter-spacing:-0.2pt;">DEFINITIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Capitalized Terms</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For purposes of this Support Agreement, capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the Merger Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Expiration Time</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the earliest to occur of (i)&#160;the Effective Time, (ii)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the Stockholder in the transaction, (iii)&#160;the date and time of the valid termination of the Merger Agreement in accordance with its terms and (iv)&#160;the End Date (as defined in the Merger Agreement in effect on the date hereof) provided that the Effective Time has not occurred on or before such date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Voting Period</font><font style="letter-spacing:0.2pt;">&#8221; shall mean such period of time between the date hereof and the Expiration Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Recommendation Change Requirement</font><font style="letter-spacing:0.2pt;">&#8221; shall mean, with respect to the Stockholder, 35% of the Subject Shares held by such Stockholder. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE II</font>
          <br >
          <font style="letter-spacing:-0.2pt;">VOTING AGREEMENT AND IRREVOCABLE PROXY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Agreement to Vote.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby agrees that, during the Voting Period, and at any duly called meeting of the stockholders of the Company (or any adjournment or postponement thereof), or in any other circumstances (including action by written consent of stockholders in lieu of a meeting) upon which a vote, adoption or other approval or consent with respect to the adoption of the Merger Agreement or the approval of the Merger and any of the transactions contemplated thereby is sought, the Stockholder: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;if no Company Board Adverse Recommendation Change has occurred in accordance with Section&#160;5.3(c) of the Merger Agreement, shall, if a meeting is held, appear at the meeting, in person or by proxy, and shall provide a written consent (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Written Consent</font><font style="letter-spacing:0.2pt;">&#8221;) or vote (or cause to be voted), in person or by proxy, all of the Subject Shares, in each case (i)&#160;in favor of (A)&#160;any proposal to adopt and approve or reapprove the Merger Agreement and the transactions contemplated thereby, including (1)&#160;adoption and approval of the Merger Agreement and the Contemplated Transactions, (2)&#160;adoption and approval of an amendment of the Company&#8217;s certificate of incorporation to increase the authorized shares of the Common Stock, (3)&#160;acknowledgment that the approval given thereby is irrevocable and that the Stockholder is aware of the Stockholder&#8217;s rights to demand appraisal for its shares pursuant to Section&#160;262 of the DGCL, a true and correct copy of which will be attached thereto, and that the Stockholder has received and read a copy of Section&#160;262 of the DGCL, (4)&#160;acknowledgment that by the Stockholder&#8217;s approval of the Merger the Stockholder is (A)&#160;waiving its appraisal rights with respect to the Subject Shares in connection with the Merger and thereby waives any rights to receive payment of the fair value of the Stockholder&#8217;s capital stock under the DGCL, and (B)&#160;waiving any notice that may have been or may be required relating to the Merger or any of the other Contemplated Transactions (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval Matters</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;against any Acquisition Proposal and any action in furtherance of any such Acquisition Proposal; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;if a Company Board Adverse Recommendation Change has occurred in accordance with Section&#160;5.3(c) of the Merger Agreement, shall, if a meeting is held, appear at the meeting, in person or by proxy, and shall provide a Written Consent or vote (or caused to be voted), in person or by proxy, at least the Recommendation Change Requirement (rounded up to the nearest whole number of Subject Shares) of Subject Shares held by such Stockholder, in each case (i)&#160;in favor of the Stockholder Approval Matters, and (ii)&#160;against any proposals that compete with the Contemplated Transactions, including any Acquisition Proposal and any action in furtherance of any such Acquisition Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Grant of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event and to the extent that the Stockholder fails to vote the Subject Shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;"> at any applicable meeting of the stockholders of the Company or pursuant to any applicable meeting of the stockholders of the Company or pursuant to any applicable written consent of the stockholders of the Company, the Stockholder hereby appoints the Company and any designee of the Company, and each of them individually, as the Stockholder&#8217;s proxy, with full power of substitution and re-substitution, to vote, including by executing written consents, during the Voting Period with respect to any and all of the Subject Shares solely on the matters and in the manner specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, for the avoidance of doubt, if a Company Board Adverse Recommendation Change in accordance with Section&#160;5.3(c) of the Merger Agreement has occurred the Stockholder shall only be deemed to have granted a proxy to the extent of the Recommendation Change Requirement. The Stockholder shall take all further action or execute such other instruments as may be necessary to effectuate the intent of any such proxy. The Stockholder affirms that the irrevocable proxy given by it hereby with respect to the Merger Agreement and the Contemplated Transactions is given to the Company by the Stockholder to secure the performance of the obligations of the Stockholder under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;"> of this Support Agreement. It is agreed that the Company (and its designees) will use the irrevocable proxy that is granted by the Stockholder hereby only in accordance with applicable Laws and that, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to the extent the Company (and its designees) uses such irrevocable proxy, it will only vote (or sign written consents in respect of) the Subject Shares subject to such irrevocable proxy with respect to the matters specified in, and in accordance with the provisions of, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Nature of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The proxy granted pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> to the Company by the Stockholder shall be irrevocable during the term of this Support Agreement, shall be deemed to be coupled with an interest sufficient in law to support an irrevocable proxy and shall revoke any and all prior proxies or powers of attorney granted by the Stockholder and no subsequent proxy or power of attorney shall be given or written consent executed (and if given or executed, shall not be effective) by the Stockholder with respect thereto. The proxy that may be granted hereunder shall terminate automatically, without any further action on the part of the Company, Stockholder or any other Person, upon the Expiration Time, but shall survive the death or incapacity of the Stockholder and any obligation of the Stockholder under this Support Agreement shall be binding upon the heirs, personal representatives and successors of the Stockholder. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE III</font>
          <br >
          <font style="letter-spacing:-0.2pt;">COVENANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subject Shares.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Stockholder agrees that (i)&#160;from the date hereof until the Expiration Time, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, directly or indirectly, whether by merger, consolidation or otherwise, offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign or otherwise dispose of (including by gift or by operation of law) (any of the foregoing, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transfer</font><font style="letter-spacing:0.2pt;">&#8221;), or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to or permit, a Transfer of, any or all of the Subject Shares or any interest therein; and (ii)&#160;during the Voting Period, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, (A)&#160;grant any proxies or powers of attorney with respect to any or all of the Subject Shares or agree to vote (or sign written consents in respect of) the Subject Shares on any matter or divest itself of any voting rights in the Subject Shares that would conflict with the terms of this Support Agreement, or (B)&#160;take any action that would have the effect of preventing or disabling the Stockholder from performing its obligations under this Support Agreement. Notwithstanding the foregoing, the Stockholder may, at any time, Transfer its Subject Shares (1)&#160;by will or other testamentary document or by intestacy, (2)&#160;to any investment fund or other entity controlled or managed by the Stockholder or the investment adviser or general partner of the Stockholder, (3)&#160;to another corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect Affiliate of the Stockholder, including any investment funds or other entities that controls or manages, or is under common control or management with, or is controlled or managed by, the Stockholder, (4)&#160;to any member of the Stockholder&#8217;s immediate family, (5)&#160;to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder or otherwise for estate planning purposes, (6)&#160;to stockholders, current or former partners (general or limited), members or managers of the Stockholder, as applicable, or to the estates of any of the foregoing, or (7)&#160;to the extent required by applicable Law; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the case of clauses (1)-(6), such permitted transferee shall have executed and delivered to Parent and the Company a support agreement substantially identical to this Support Agreement. The Stockholder agrees that any Transfer of Subject Shares not permitted hereby shall be null and void and that any such prohibited Transfer shall be enjoined. If any voluntary or involuntary Transfer of any Subject Shares covered hereby shall occur (including a sale by the Stockholder&#8217;s trustee in bankruptcy, or a sale to a purchaser at any creditor&#8217;s or court sale), the permitted transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Support Agreement, which shall continue in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In the event of a stock dividend or distribution, or any change in the Subject Shares by reason of any stock dividend or distribution, split-up, recapitalization, combination, conversion, exchange of shares or the like, the term &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to refer to and include the Subject Shares as well as all such stock dividends and distributions and any securities into which or for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which any or all of the Subject Shares may be changed or exchanged or which are received in such transaction. The Stockholder further agrees that, in the event the Stockholder purchases or otherwise acquires beneficial or record ownership of or an interest in, or acquires the right to vote or share in the voting of, any additional Shares, in each case after the execution of this Support Agreement and prior to the Expiration Time, the Stockholder shall deliver promptly to the Company and Parent written notice of such event, which notice shall state the number of additional Shares so acquired; provided, that no such notice shall be required with respect to any additional Shares acquired in connection with the Pre-Closing Financing. The Stockholder agrees that any such additional Shares shall constitute Subject Shares for all purposes of this Support Agreement and shall be subject to the terms of this Support Agreement, including all covenants, agreements, obligations, representations and warranties set forth herein as if those additional Shares were owned by the Stockholder on the date of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stockholder&#8217;s Capacity.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All agreements and understandings made herein shall be made solely in the Stockholder&#8217;s capacity as a holder of the Subject Shares and not in any other capacity, including not in the Stockholder&#8217;s capacity as a director or officer of the Company. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director of the Company (including any director who is an Affiliate of the Stockholder) in the taking of any actions (or failure to act) solely in his or her capacity as a director of the Company, or in the exercise of his or her fiduciary duties as a director of the Company, or prevent or be construed to create any obligation on the part of any director of the Company from taking any action in his or her capacity as such director, and no action taken solely in any such capacity as a director of the Company shall be deemed to constitute a breach of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other Offers.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except to the extent the Company is permitted to take such action pursuant to the Merger Agreement, the Stockholder (in the Stockholder&#8217;s capacity as such) shall not, and shall direct its Representatives not to, take any of the following actions: (a)&#160;solicit, initiate, knowingly encourage or knowingly facilitate an Acquisition Proposal; (b)&#160;furnish any non-public information regarding the Company to any Person in connection with or in response to an Acquisition Proposal (except as required by applicable Law, pursuant to applicable rules and regulations of any applicable national securities exchange or pursuant to a request by a Governmental Body); (c)&#160;engage in, enter into, continue or otherwise participate in any discussions or negotiations with any Person with respect to, or otherwise knowingly cooperate in any way with any Person (or any Representative thereof) with respect to, any Acquisition Proposal; (d)&#160;approve, endorse or recommend or publicly propose to approve, endorse or recommend, any Acquisition Proposal; or (e)&#160;enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction or publicly proposing to approve, endorse or recommend, any Acquisition Transaction; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that none of the foregoing restrictions shall apply to the Stockholder&#8217;s and its Representatives&#8217; interactions with Parent, Merger Sub, the Company and their respective subsidiaries and Representatives; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> shall prevent the Stockholder from referring a Person to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> or to the Merger Agreement. Without limiting the foregoing, it is understood that any violation of the foregoing restrictions by any Representatives of the Stockholder shall be deemed to be a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Communications.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the Voting Period, the Stockholder shall not, and shall direct its Representatives not to, make any press release, public announcement or other broad-based public communication that disparages this Support Agreement or the Merger Agreement or the Merger, without the prior written consent of Parent and the Company, except as may be required by applicable Law, including applicable rules and regulations of any national securities exchange applicable to Stockholder, in which circumstance such announcing party shall consult with the Company and Parent to the extent legally permissible prior to any such disclosure; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the foregoing shall not: (x)&#160;limit or affect any actions taken by the Stockholder (or any affiliated officer or director of Stockholder) that would be permitted to be taken by Stockholder pursuant to the Merger Agreement or (y)&#160;prohibit the Stockholder or its Representatives from communicating truthfully with any Governmental Body or from cooperating with any such Governmental Body, or testifying truthfully pursuant to subpoena, as required by valid legal process, in which circumstance such announcing party shall consult with the Company and Parent to the extent legally permissible prior to any such disclosure. The Stockholder hereby: (a)&#160;consents to and authorizes the publication and disclosure in all documents and schedules filed the with SEC, and any press release or other disclosure document that Parent or the Company reasonably determines to be necessary in connection </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">with the Merger or any Contemplated Transaction of (i)&#160;the Stockholder&#8217;s identity, (ii)&#160;the Stockholder&#8217;s ownership of the Subject Shares, (iii)&#160;this Support Agreement and (iv)&#160;the nature of the Stockholder&#8217;s commitments, arrangements and understandings under this Support Agreement; and (b)&#160;agrees as promptly as practicable to notify Parent, Merger Sub and the Company of any required corrections with respect to any written information supplied by the Stockholder specifically for use in any such disclosure document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Trusts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except for this Agreement and the Amended and Restated Voting Agreement of the Company, dated as of December&#160;22, 2020 (the &#8220;Voting Agreement&#8221;), the Stockholder agrees that it will not, nor will it permit any entity under its control to, deposit any of its Subject Shares in a voting trust or subject any of its Subject Shares to any arrangement with respect to the voting of such Subject Shares, in each case to the extent that such action would restrict the Stockholder from performing its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Appraisal Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby irrevocably and unconditionally waives, and agrees not to assert, exercise or perfect (or attempt to exercise, assert or perfect) any rights of appraisal or rights to dissent from the Merger or quasi-appraisal rights that it may at any time have under applicable Laws, including Section&#160;262 of the DGCL. The Stockholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors, directors or officers, (a)&#160;challenging the validity, binding nature or enforceability of, or seeking to enjoin the operation of, this Support Agreement or the Merger Agreement, or (b)&#160;alleging a breach of any fiduciary duty of any Person in connection with the evaluation, negotiation, entry into or consummation of transactions contemplated by the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;the Stockholder may defend against, contest or settle any action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder&#8217;s capacity as a director, officer or securityholder of the Company and (ii)&#160;the foregoing shall not limit or restrict in any manner the Stockholder from enforcing the Stockholder&#8217;s rights under this Support Agreement and the other agreements entered into by the Stockholder in connection herewith, or otherwise in connection with the Merger, including the Stockholder&#8217;s right to receive the Merger Consideration pursuant to the terms of the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE IV</font>
          <br >
          <font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Stockholder hereby represents and warrants to Parent and the Company as follows: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Due Authorization, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder is a natural person, corporation, limited partnership or limited liability company. If the Stockholder is a corporation, limited partnership or limited liability company, the Stockholder is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, organized or constituted. The Stockholder has all necessary power and authority to execute and deliver this Support Agreement, perform the Stockholder&#8217;s obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery by the Stockholder of this Support Agreement, the performance by the Stockholder&#8217;s of its obligations hereunder and the consummation by the Stockholder of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Stockholder and no other proceedings on the part of the Stockholder are necessary to authorize this Support Agreement, or to consummate the transactions contemplated hereby. This Support Agreement has been duly executed and delivered by the Stockholder and (assuming the due authorization, execution and delivery by Parent and the Company) constitutes a valid and binding obligation of the Stockholder, enforceable against the Stockholder in accordance with its terms, except to the extent enforcement is limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar Laws of general applicability relating to or affecting creditors&#8217; rights and by general equitable principles. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ownership of Shares.</font><font style="letter-spacing:0.2pt;"> </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;hereto sets forth opposite the Stockholder&#8217;s name the Shares over which the Stockholder has record ownership as of the date hereof. As of the date hereof, the Stockholder is the lawful record owner of the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, has the power to vote or cause to be voted such Shares and has the power to dispose of, or cause to be disposed, such Shares (other than, if the Stockholder is a partnership or a limited liability company, the rights and interest of Persons that own partnership interests or&#160;units in the Stockholder under </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the partnership agreement or operating agreement governing the Stockholder and applicable partnership or limited liability company law, or if the Stockholder is a married individual and resides in a state with community property laws, the community property interest of his or her spouse to the extent applicable under such community property laws, which spouse hereby consents to this Support Agreement by executing the spousal consent attached hereto as </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">). The Stockholder has, and will at all times up until the Expiration Time have, good and valid title to the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, free and clear of any and all pledges, mortgages, liens, charges, proxies, voting agreements, encumbrances, adverse claims, options, security interests and demands of any nature or kind whatsoever, other than (a)&#160;those created by this Support Agreement, (b)&#160;those created by the Voting Agreement, (c)&#160;those created by the Amended and Restated Investors&#8217; Rights Agreement of the Company, dated as of December&#160;22, 2020, (d)&#160;those existing under applicable securities laws and (e)&#160;those that would not prevent or materially delay the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. Without limiting the generality of the foregoing, no Person has any contractual or other right or obligation to purchase or otherwise acquire any of the Shares denoted as being owned by the Stockholder on Schedule&#160;I hereto, and no such Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such Shares except as provided hereunder and in the Voting Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Conflicts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;(a)&#160;No filing with any Governmental Body, and no authorization, consent or approval of any other Person, is necessary for the execution of this Support Agreement by the Stockholder and (b)&#160;none of the execution and delivery of this Support Agreement by the Stockholder, the performance of the Stockholder&#8217;s obligations hereunder, the consummation by the Stockholder of the transactions contemplated hereby or compliance by the Stockholder with any of the provisions hereof shall (i)&#160;conflict with or result in any breach of the organizational documents of the Stockholder, (ii)&#160;result in, or give rise to, a violation or breach of or a default under any of the terms of any material Contract, understanding, agreement or other instrument or obligation to which the Stockholder is a party or by which the Stockholder or any of the Subject Shares or its assets may be bound or (iii)&#160;violate any applicable order, writ, injunction, decree, judgment, statute, rule or regulation, in each case except for any of the foregoing as would not reasonably be expected to prevent or materially delay the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Finder&#8217;s Fees.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No investment banker, broker, finder or other intermediary is entitled, whether directly or indirectly, to a fee, commission or other benefit from Parent, Merger Sub or the Company in respect of this Support Agreement based upon any Contract made by or on behalf of the Stockholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reliance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder has had the opportunity to review the Merger Agreement and this Support Agreement with counsel of the Stockholder&#8217;s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Parent, the Company or any of their respective Representatives with respect to the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that such Stockholder (and not Parent, the Company or the Surviving Corporation) shall be responsible for such Stockholder&#8217;s tax liability that may arise as a result of the Merger or the Contemplated Transactions. The Stockholder understands and acknowledges that Parent and the Company are entering into the Merger Agreement in reliance upon the Stockholder&#8217;s execution, delivery and performance of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Litigation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of the date of this Support Agreement, there is no Legal Proceeding pending or, to the knowledge of the Stockholder, threatened against the Stockholder that would reasonably be expected to prevent or materially delay the ability of the Stockholder to perform its obligations hereunder or consummate the transactions contemplated hereby. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE V</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TERMINATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement shall automatically terminate, and none of Parent, the Company or the Stockholder shall have any rights or obligations hereunder and this Support Agreement shall become null and void and have no effect upon the earliest to occur of: (a)&#160;the Effective Time; (b)&#160;the valid termination of the Merger Agreement in accordance with its terms; (c)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stockholder in the Contemplated Transactions; (d)&#160;the time this Support Agreement is terminated upon the written agreement of the Stockholder, the Company and Parent; and (e)&#160;the End Date (as defined in the Merger Agreement in effect on the date hereof) provided that the Effective Time has not occurred on or before such date. The parties acknowledge that upon termination of this Support Agreement as permitted under and in accordance with the terms of this Support Agreement, no party to this Support Agreement shall have the right to recover any claim with respect to any losses suffered by such party in connection with such termination, and no party shall have any further obligations or liabilities under this Support Agreement, subject to the following sentence. Notwithstanding anything to the contrary herein, (i)&#160;nothing set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> shall relieve any party from liability for any willful breach of this Support Agreement prior to termination hereof, and (ii)&#160;the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;V</font><font style="letter-spacing:0.2pt;"> and of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;VI</font><font style="letter-spacing:0.2pt;"> (other than </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">) shall survive the termination of this Support Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE VI</font>
          <br >
          <font style="letter-spacing:-0.2pt;">MISCELLANEOUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Further Actions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the terms and conditions set forth in this Support Agreement, the Stockholder agrees to take any and all actions and to do all things reasonably necessary to effectuate this Support Agreement. If the Stockholder is a married individual, his or her spouse shall deliver the spousal consent attached hereto as Exhibit&#160;A unless such Stockholder can demonstrate to Parent&#8217;s and the Company&#8217;s reasonable satisfaction that his or her spouse does not have any community property interests in the Subject Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fees and Expenses.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise specifically provided herein, each party shall bear its own fees and expenses in connection with this Support Agreement and the transactions contemplated hereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments, Waivers, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement may not be amended except by an instrument in writing signed by all the parties hereto and specifically referencing this Support Agreement. No failure on the part of any party to exercise any power, right privilege or remedy under this Support Agreement, and no delay on the part of any party in exercising any power, right, privilege or remedy under this Support Agreement, shall operate as a waiver of such power, right, privilege or remedy, and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. No party shall be deemed to have waived any claim arising out of this Support Agreement, or any power, right, privilege or remedy under this Support Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to the Company, to </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to Parent, to </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If to the Stockholder, to the address or electronic mail address set forth on the signature pages hereto or to such other Person or address as any party shall specify by written notice so given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Interpretation; Construction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Headings of the Articles and Sections of this Support Agreement are for convenience of the parties only, and shall be given no substantive or interpretive effect whatsoever. Except as otherwise indicated, all references in this Support Agreement to &#8220;Exhibits&#8221;, &#8220;Sections&#8221; or &#8220;Schedules&#8221; are intended to refer to Sections of this Support Agreement and the Exhibits or Schedules to this Support Agreement. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Support Agreement. As used in this Support Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; For purposes of this Support Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Any term or provision of this Support Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Support Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Support Agreement is invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Support Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Entire Agreement; Assignment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, between the parties, or any of them, with respect to the subject matter hereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, as between the Company and Parent, to the extent of any conflict between the Merger Agreement and this Support Agreement, the terms of the Merger Agreement shall control and supersede any such conflicting terms. This Support Agreement will be binding upon, inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns, and, in the case of Stockholder, such Persons to which record or beneficial ownership of the Stockholder&#8217;s Subject shares shall pass; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that neither this Support Agreement nor any of the rights, interests or obligations hereunder shall be assigned or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">delegated by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other parties, except that, without consent, each of Parent and the Company may assign all or any of its rights and obligations hereunder to any of its Affiliates that assume the rights and obligations of such party under the Merger Agreement, and any attempted assignment or delegation of this Support Agreement or any of the rights, interests or obligations by any of the parties without the other parties prior written consent shall be void and of no effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;THIS SUPPORT AGREEMENT AND ALL QUESTIONS RELATING TO THE INTERPRETATION OR ENFORCEMENT OF THIS SUPPORT AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES THEREOF TO THE EXTENT THAT SUCH PRINCIPLES WOULD DIRECT A MATTER TO ANOTHER JURISDICTION. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Specific Performance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereto acknowledge that any breach of this Support Agreement would give rise to irreparable harm for which monetary damages, even if applicable, would not be an adequate remedy, and would occur in the event that any party does not perform the provisions of this Support Agreement (including failing to take such actions as are required of it hereunder to consummate the transactions contemplated hereby) in accordance with its specified terms or otherwise breaches such provisions. Accordingly, the parties shall be entitled to a decree of specific performance, an injunction or other equitable relief to prevent breaches or threatened breaches of any of the provisions of this Support Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the parties agrees that it will not oppose the granting of specific performance, an injunction or other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance or other equitable relief is not an appropriate remedy for any reason at law or in equity. Any party seeking an injunction or injunctions to prevent breaches of this Support Agreement shall not be required to provide any bond or other security in connection with any such order or injunction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Submission to Jurisdiction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereby (a)&#160;irrevocably and unconditionally submit to the exclusive personal jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if the Chancery Court declines jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (b)&#160;agree that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, (c)&#160;waive any objection to laying venue in any such action or proceeding in such courts, (d)&#160;waive any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (e)&#160;agree that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.4</font><font style="letter-spacing:0.2pt;"> of this Support Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any person to serve legal process in any other manner permitted by Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Jury Trial.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS SUPPORT AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS SUPPORT AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS SUPPORT AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS SUPPORT AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:548pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Counterparts</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Support Agreement may be executed in two or more counterparts (including by facsimile transmission or other means of electronic transmission, such as by electronic mail in &#8220;pdf&#8221; form), each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each of the parties and delivered (by facsimile or otherwise) to the other parties. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(Signature Page Follows)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">C-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, the Company, Parent and the Stockholder have caused this Support Agreement to be duly executed as of the day and year first above written. </font>
        </div>
        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
        </div>
        <div style="margin-left:240pt; margin-top:3.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
        </div>
        <div style="margin-left:240pt; margin-top:3.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">STOCKHOLDER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
        </div>
        <div style="margin-left:240pt; margin-top:3.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-left:240pt; margin-top:24pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Address: </font>
        </div>
        <div style="margin-left:240pt; margin-top:36pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Electronic Mail Address: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">]</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Exhibit&#160;A</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Form of Spousal Consent</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I acknowledge that I have read the Stockholder Support Agreement (to which this consent is attached) and that I know and understand, and have been fully advised by my attorney with respect to, its contents. As the spouse of the Stockholder, I hereby agree: (i)&#160;that all shares of capital stock, all options, all warrants and all additional securities of the Company held by the Stockholder, and all other rights with respect to the capital stock of the Company held by the Stockholder, and my interest in such shares, options, warrants, additional securities and other rights, if any, are subject to the provisions of the Stockholder Support Agreement and the Merger Agreement (as defined in the Stockholder Support Agreement), which I consent to; and (ii)&#160;that I will take no action at any time to hinder the operation of the Stockholder Support Agreement or the Merger Agreement. </font>
        </div>
        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURE OF SPOUSE:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:26.5pt; width:236pt;">
          <div style="margin-left: 0pt; width: 236pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="border-collapse:collapse;width:236pt;margin-top:19.5pt;margin-left:220pt;white-space:nowrap;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="vertical-align:baseline;">
            <td style="width:287.38pt;">
              <font style="letter-spacing:0.2pt;">Printed Name:&#8199;</font>
            </td>
            <td style="padding-left:0pt;text-align:right;max-width:168.62pt;">
              <div style="margin-left: 0pt; width: 168.62pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
            </td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Schedule&#160;I</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Ownership of Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:32.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Name and Address of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stockholder </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANND">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX D</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This STOCKHOLDER SUPPORT AGREEMENT (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is entered into as of [&#8199;&#8199;&#8199;], 2022, among CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and the undersigned stockholder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder</font><font style="letter-spacing:0.2pt;">&#8221;) of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as of the date hereof, the Stockholder is the sole record owner of and has the sole power to vote (or to direct the voting of) the number of shares of common stock, par value $0.001 per share, of Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), set forth opposite the Stockholder&#8217;s name on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto (such Common Stock, together with any other shares of Parent that are hereafter issued to or otherwise acquired or owned by, including upon exercise of options or securities convertible into or exercisable or exchangeable for Common Stock (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Shares</font><font style="letter-spacing:0.2pt;">&#8221;), the voting power of which is acquired by such Stockholder during the Voting Period (as defined below), are collectively referred to herein as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the Company, Parent, and Seahawk Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), are concurrently entering into an Agreement and Plan of Merger and Reorganization, dated on or about the date hereof (as amended from time to time, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub shall be merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the adoption of the Merger Agreement and the transactions contemplated thereby requires the written consent or affirmative vote of (i)&#160;the holders of a majority of the outstanding shares of Common Stock entitled to vote on the record date for the Parent Stockholders&#8217; Meeting and (ii)&#160;the holders of a majority in voting power of the votes cast by the holders of all shares of Common Stock present or represented by proxy at the Parent Stockholders&#8217; Meeting and entitled to vote thereon; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as a condition and inducement to the Company&#8217;s willingness to enter into the Merger Agreement and consummate the transactions contemplated thereby, Parent and the Company have required the Stockholder to, as an inducement and in consideration therefor, and the Stockholder (in the Stockholder&#8217;s capacity as holder of the Subject Shares) has agreed to, enter into this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, the parties agree as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE I</font>
          <br >
          <font style="letter-spacing:-0.2pt;">DEFINITIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Capitalized Terms</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For purposes of this Support Agreement, capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the Merger Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Expiration Time</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the earliest to occur of (i)&#160;the Effective Time, (ii)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the Stockholder in the transaction or otherwise materially and adversely affects the Stockholder and (iii)&#160;the date and time of the valid termination of the Merger Agreement in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Voting Period</font><font style="letter-spacing:0.2pt;">&#8221; shall mean such period of time between the date hereof and the Expiration Time. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE II</font>
          <br >
          <font style="letter-spacing:-0.2pt;">VOTING AGREEMENT AND IRREVOCABLE PROXY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Agreement to Vote.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby agrees that, during the Voting Period, and at any duly called meeting of the stockholders of Parent (or any adjournment or postponement thereof), or in any other circumstances (including action by written consent of stockholders in lieu of a meeting) upon which a vote, adoption or other approval or consent with respect to the adoption of the Merger Agreement or the approval of the Merger and any of the transactions contemplated thereby is sought, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholder, if a meeting is held, appear at the meeting, in person or by proxy, and shall provide a written consent (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Written Consent</font><font style="letter-spacing:0.2pt;">&#8221;) or vote (or cause to be voted), in person or by proxy, all of the Subject Shares, in each case (i)&#160;in favor of (A)&#160;any proposal to adopt and approve or reapprove the Merger Agreement and the transactions contemplated thereby, including (1)&#160;adoption and approval of the Merger Agreement and the Contemplated Transactions, (2)&#160;the issuance of shares of Common Stock to the Company&#8217;s stockholders in connection with the Contemplated Transactions pursuant to the terms of the Merger Agreement, (3)&#160;the change of control of Parent resulting from the Merger pursuant to Nasdaq rules, (4)&#160;the approval of the Equity Plan&#160;Amendments, and (B)&#160;waiving any notice that may have been or may be required relating to the Merger or any of the other Contemplated Transactions (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval Matters</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;against any Acquisition Proposal and any action in furtherance of any such Acquisition Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Grant of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event and to the extent that the Stockholder fails to vote the Subject Shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;"> at any applicable meeting of the stockholders of Parent or pursuant to any applicable meeting of the stockholders of Parent or pursuant to any applicable written consent of the stockholders of Parent, the Stockholder hereby appoints Parent and any designee of Parent, and each of them individually, as the Stockholder&#8217;s proxy, with full power of substitution and re-substitution, to vote, including by executing written consents, during the Voting Period with respect to any and all of the Subject Shares on the matters and in the manner specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">. The Stockholder shall take all further action or execute such other instruments as may be necessary to effectuate the intent of any such proxy. The Stockholder affirms that the irrevocable proxy given by it hereby with respect to the Merger Agreement and the Contemplated Transactions is given to Parent by the Stockholder to secure the performance of the obligations of the Stockholder under this Support Agreement. It is agreed that Parent (and its designees) will use the irrevocable proxy that is granted by the Stockholder hereby only in accordance with applicable Laws and that, to the extent Parent (and its designees) uses such irrevocable proxy, it will only vote (or sign written consents in respect of) the Subject Shares subject to such irrevocable proxy with respect to the matters specified in, and in accordance with the provisions of, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Nature of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The proxy granted pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> to Parent by the Stockholder shall be irrevocable during the term of this Support Agreement, shall be deemed to be coupled with an interest sufficient in law to support an irrevocable proxy and shall revoke any and all prior proxies or powers of attorney granted by the Stockholder and no subsequent proxy or power of attorney shall be given or written consent executed (and if given or executed, shall not be effective) by the Stockholder with respect thereto. The proxy that may be granted hereunder shall terminate upon the termination of this Support Agreement, but shall survive the death or incapacity of the Stockholder and any obligation of the Stockholder under this Support Agreement shall be binding upon the heirs, personal representatives and successors of the Stockholder. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE III</font>
          <br >
          <font style="letter-spacing:-0.2pt;">COVENANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subject Shares.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Stockholder agrees that (i)&#160;from the date hereof until the Expiration Time, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, directly or indirectly, whether by merger, consolidation or otherwise, offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign or otherwise dispose of (including by gift or by operation of law) (collectively, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transfer</font><font style="letter-spacing:0.2pt;">&#8221;), or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to or permit, a Transfer of, any or all of the Subject Shares or any interest therein; and (ii)&#160;during the Voting Period, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, (A)&#160;grant any proxies or powers of attorney with respect to any or all of the Subject Shares or agree to vote (or sign written consents in respect of) the Subject Shares on any matter or divest itself of any voting rights in the Subject Shares that would conflict with the terms of this Support Agreement, or (B)&#160;take any action that would have the effect of preventing or disabling the Stockholder from performing its obligations under this Support Agreement. Notwithstanding the foregoing, the Stockholder may, at any time, Transfer its Subject Shares (1)&#160;by will or other testamentary document or by intestacy, (2)&#160;to any investment fund or other entity controlled or managed by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholder or the investment adviser or general partner of the Stockholder,, (3)&#160;to any member of the Stockholder&#8217;s immediate family, (4)&#160;to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder or otherwise for estate planning purposes or (5)&#160;to the extent required by applicable Law; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the case of clauses (1)-(4), such permitted transferee shall have executed and delivered to Parent and the Company a support agreement substantially identical to this Support Agreement. The Stockholder agrees that any Transfer of Subject Shares not permitted hereby shall be null and void and that any such prohibited Transfer shall be enjoined. If any voluntary or involuntary Transfer of any Subject Shares covered hereby shall occur (including a sale by the Stockholder&#8217;s trustee in bankruptcy, or a sale to a purchaser at any creditor&#8217;s or court sale), the permitted transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Support Agreement, which shall continue in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In the event of a stock dividend or distribution, or any change in the Subject Shares by reason of any stock dividend or distribution, split-up, recapitalization, combination, conversion, exchange of shares or the like, the term &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to refer to and include the Subject Shares as well as all such stock dividends and distributions and any securities into which or for which any or all of the Subject Shares may be changed or exchanged or which are received in such transaction. The Stockholder further agrees that, in the event the Stockholder purchases or otherwise acquires beneficial or record ownership of or an interest in, or acquires the right to vote or share in the voting of, any additional Shares, in each case after the execution of this Support Agreement and prior to the Expiration Time, the Stockholder shall deliver promptly to the Company and Parent written notice of such event, which notice shall state the number of additional Shares so acquired. The Stockholder agrees that any such additional Shares shall constitute Subject Shares for all purposes of this Support Agreement and shall be subject to the terms of this Support Agreement, including all covenants, agreements, obligations, representations and warranties set forth herein as if those additional Shares were owned by the Stockholder on the date of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stockholder&#8217;s Capacity.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All agreements and understandings made herein shall be made solely in the Stockholder&#8217;s capacity as a holder of the Subject Shares and not in any other capacity, including not in the Stockholder&#8217;s capacity as a director or officer of Parent. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director of Parent (including any director who is an Affiliate of the Stockholder) in the taking of any actions (or failure to act) solely in his or her capacity as a director of Parent, or in the exercise of his or her fiduciary duties as a director of Parent, or prevent or be construed to create any obligation on the part of any director of Parent from taking any action in his or her capacity as such director, and no action taken solely in any such capacity as a director of Parent shall be deemed to constitute a breach of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other Offers.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except to the extent Parent is permitted to take such action pursuant to the Merger Agreement, the Stockholder (in the Stockholder&#8217;s capacity as such) shall not, and shall instruct and cause its Representatives not to, take any of the following actions: (a)&#160;solicit, initiate, knowingly encourage or knowingly facilitate an Acquisition Proposal; (b)&#160;furnish any non-public information regarding Parent to any Person in connection with or in response to an Acquisition Proposal (except as required by applicable Law or pursuant to a request by a Governmental Body); (c)&#160;engage in, enter into, continue or otherwise participate in any discussions or negotiations with any Person with respect to, or otherwise knowingly cooperate in any way with any Person (or any representative thereof) with respect to, any Acquisition Proposal; (d)&#160;approve, endorse or recommend or publicly propose to approve, endorse or recommend, any Acquisition Proposal; or (e)&#160;enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction or publicly proposing to approve, endorse or recommend, any Acquisition Transaction; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that none of the foregoing restrictions shall apply to the Stockholder&#8217;s and its Representatives&#8217; interactions with Parent, Merger Sub, the Company and their respective subsidiaries and Representatives; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> shall prevent the Stockholder from referring a Person to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> or to the Merger Agreement. Without limiting the foregoing, it is understood that any violation of the foregoing restrictions by any Representatives of the Stockholder shall be deemed to be a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Communications.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the Voting Period, the Stockholder shall not, and shall use its reasonable best efforts to cause its Representatives, if any, not to, directly or indirectly, make any press </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">release, public announcement or other public communication that criticizes or disparages this Support Agreement or the Merger Agreement or any of the transactions contemplated hereby and thereby, without the prior written consent of Parent and the Company, except as may be required by applicable Law in which circumstance such announcing party shall consult with the Company and Parent to the extent legally permissible prior to any such disclosure; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the foregoing shall not limit or affect any actions taken by the Stockholder (or any affiliated officer or director of Stockholder) that would be permitted to be taken by Stockholder pursuant to the Merger Agreement. The Stockholder hereby: (a)&#160;consents to and authorizes the publication and disclosure in all documents and schedules filed the with SEC, and any press release or other disclosure document that Parent or the Company reasonably determines to be necessary in connection with the Merger or any Contemplated Transaction of (i)&#160;the Stockholder&#8217;s identity, (ii)&#160;the Stockholder&#8217;s ownership of the Subject Shares, (iii)&#160;this Support Agreement and (iv)&#160;the nature of the Stockholder&#8217;s commitments, arrangements and understandings under this Support Agreement; and (b)&#160;agrees as promptly as practicable to notify Parent, Merger Sub and the Company of any required corrections with respect to any written information supplied by the Stockholder specifically for use in any such disclosure document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Trusts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except for this Agreement, the Stockholder agrees that it will not, nor will it permit any entity under its control to, deposit any of its Subject Shares in a voting trust or subject any of its Subject Shares to any arrangement with respect to the voting of such Subject Shares that would restrict the Stockholder from performing its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Appraisal Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby irrevocably and unconditionally waives, and agrees not to assert, exercise or perfect (or attempt to exercise, assert or perfect) any rights of appraisal or rights to dissent from the Merger or quasi-appraisal rights that it may at any time have under applicable Laws, including Section&#160;262 of the DGCL. The Stockholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors, directors or officers, (a)&#160;challenging the validity, binding nature or enforceability of, or seeking to enjoin the operation of, this Support Agreement or the Merger Agreement, or (b)&#160;alleging a breach of any fiduciary duty of any Person in connection with the evaluation, negotiation, entry into or consummation of the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;the Stockholder may defend against, contest or settle any action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder&#8217;s capacity as a director, officer or securityholder of Parent and (ii)&#160;the foregoing shall not limit or restrict in any manner the Stockholder from enforcing the Stockholder&#8217;s rights under this Support Agreement and the other agreements entered into by the Stockholder in connection herewith, or otherwise in connection with the Merger, including the Stockholder&#8217;s right to receive the Merger Consideration pursuant to the terms of the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE IV</font>
          <br >
          <font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Stockholder hereby represents and warrants to Parent and the Company as follows: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Due Authorization, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder is a natural person, corporation, limited partnership or limited liability company. If the Stockholder is a corporation, limited partnership or limited liability company, Stockholder is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, organized or constituted. The Stockholder has all necessary power and authority to execute and deliver this Support Agreement, perform the Stockholder&#8217;s obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery by the Stockholder of this Support Agreement, the performance by the Stockholder&#8217;s of its obligations hereunder and the consummation by the Stockholder of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Stockholder and no other proceedings on the part of the Stockholder are necessary to authorize this Support Agreement, or to consummate the transactions contemplated hereby. This Support Agreement has been duly executed and delivered by the Stockholder and (assuming the due authorization, execution and delivery by Parent and the Company) constitutes a valid and binding obligation of the Stockholder, enforceable against the Stockholder in accordance with its terms, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">except to the extent enforcement is limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar Laws of general applicability relating to or affecting creditors&#8217; rights and by general equitable principles. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ownership of Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto sets forth opposite the Stockholder&#8217;s name the Shares over which the Stockholder has record ownership as of the date hereof. As of the date hereof, the Stockholder is the lawful record owner of the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, has the power to vote or cause to be voted such Shares and has the power to dispose of, or cause to be disposed, such Shares (other than, if the Stockholder is a partnership or a limited liability company, the rights and interest of Persons that own partnership interests or&#160;units in the Stockholder under the partnership agreement or operating agreement governing the Stockholder and applicable partnership or limited liability company law, or if the Stockholder is a married individual and resides in a state with community property laws, the community property interest of his or her spouse to the extent applicable under such community property laws, which spouse hereby consents to this Support Agreement by executing the spousal consent attached hereto as </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">). The Stockholder has, and will at all times up until the Expiration Time have, good and valid title to the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, free and clear of any and all pledges, mortgages, liens, charges, proxies, voting agreements encumbrances, adverse claims, options, security interests and demands of any nature or kind whatsoever, other than (a)&#160;those created by this Support Agreement, (b)&#160;those existing under applicable securities laws and (c)&#160;those that would not adversely affect the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. Without limiting the generality of the foregoing, no Person has any contractual or other right or obligation to purchase or otherwise acquire any of the Shares, and no Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of the Shares except as provided hereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Conflicts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;(a)&#160;No filing with any Governmental Body, and no authorization, consent or approval of any other Person, is necessary for the execution of this Support Agreement by the Stockholder and (b)&#160;none of the execution and delivery of this Support Agreement by the Stockholder, the performance of the Stockholder&#8217;s obligations hereunder, the consummation by the Stockholder of the transactions contemplated hereby or compliance by the Stockholder with any of the provisions hereof shall (i)&#160;conflict with or result in any breach of the organizational documents of the Stockholder, (ii)&#160;result in, or give rise to, a violation or breach of or a default under any of the terms of any material Contract, understanding, agreement or other instrument or obligation to which the Stockholder is a party or by which the Stockholder or any of the Subject Shares or its assets may be bound or (iii)&#160;violate any applicable order, writ, injunction, decree, judgment, statute, rule or regulation, except for any of the foregoing as would not reasonably be expected to impair the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Finder&#8217;s Fees.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No investment banker, broker, finder or other intermediary is entitled, whether directly or indirectly, to a fee, commission or other benefit from Parent, Merger Sub or the Company in respect of this Support Agreement based upon any Contract made by or on behalf of the Stockholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reliance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder has had the opportunity to review the Merger Agreement and this Support Agreement with counsel of the Stockholder&#8217;s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Parent, the Company or any of their respective Representatives with respect to the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that such Stockholder (and not Parent, the Company or the Surviving Corporation) shall be responsible for such Stockholder&#8217;s tax liability that may arise as a result of the Merger or the Contemplated Transactions. The Stockholder understands and acknowledges that Parent and the Company are entering into the Merger Agreement in reliance upon the Stockholder&#8217;s execution, delivery and performance of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Litigation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of the date of this Support Agreement, there is no Legal Proceeding pending or, to the knowledge of the Stockholder, threatened against the Stockholder that would reasonably be expected to impair the ability of the Stockholder to perform its obligations hereunder or consummate the transactions contemplated hereby. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE V</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TERMINATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement shall automatically terminate, and none of Parent, the Company or the Stockholder shall have any rights or obligations hereunder and this Support Agreement shall become null and void and have no effect upon the earliest to occur of: (a)&#160;the Effective Time; (b)&#160;the valid termination of the Merger Agreement in accordance with its terms; (c)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the Stockholder in the Contemplated Transactions or otherwise materially and adversely affects the Stockholder; and (d)&#160;the time this Support Agreement is terminated upon the written agreement of the Stockholder, the Company and Parent. The parties acknowledge that upon termination of this Support Agreement as permitted under and in accordance with the terms of this Support Agreement, no party to this Support Agreement shall have the right to recover any claim with respect to any losses suffered by such party in connection with such termination, and no party shall have any further obligations or liabilities under this Support Agreement, subject to the following sentence. Notwithstanding anything to the contrary herein, (i)&#160;nothing set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> shall relieve any party from liability for any willful breach of this Support Agreement prior to termination hereof, and (ii)&#160;the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;V</font><font style="letter-spacing:0.2pt;"> and of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;VI</font><font style="letter-spacing:0.2pt;"> shall survive the termination of this Support Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE VI</font>
          <br >
          <font style="letter-spacing:-0.2pt;">MISCELLANEOUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Further Actions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the terms and conditions set forth in this Support Agreement, the Stockholder agrees to take any all actions and to do all things reasonably necessary to effectuate this Support Agreement. If the Stockholder is a married individual, his or her spouse shall deliver the spousal consent attached hereto as Exhibit&#160;A unless such Stockholder can demonstrate to Parent&#8217;s and the Company&#8217;s reasonable satisfaction that his or her spouse does not have any community property interests in the Subject Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fees and Expenses.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise specifically provided herein, each party shall bear its own fees and expenses in connection with this Support Agreement and the transactions contemplated hereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments, Waivers, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement may not be amended except by an instrument in writing signed by all the parties hereto and specifically referencing this Support Agreement. No failure on the part of any party to exercise any power, right privilege or remedy under this Support Agreement, and no delay on the part of any party in exercising any power, right, privilege or remedy under this Support Agreement, shall operate as a waiver of such power, right, privilege or remedy, and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. No party shall be deemed to have waived any claim arising out of this Support Agreement, or any power, right, privilege or remedy under this Support Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to the Company, to </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to Parent, to </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If to the Stockholder, to the address or electronic mail address set forth on the signature pages hereto or to such other Person or address as any party shall specify by written notice so given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Interpretation; Construction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Headings of the Articles and Sections of this Support Agreement are for convenience of the parties only, and shall be given no substantive or interpretive effect whatsoever. Except as otherwise indicated, all references in this Support Agreement to &#8220;Exhibits&#8221;, &#8220;Sections&#8221; or &#8220;Schedules&#8221; are intended to refer to Sections of this Support Agreement and the Exhibits or Schedules to this Support Agreement. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Support Agreement. As used in this Support Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; For purposes of this Support Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Any term of provision of this Support Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Support Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Support Agreement is invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Support Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Entire Agreement; Assignment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, between the parties, or any of them, with respect to the subject matter hereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, as between the Company and Parent, to the extent of any conflict between the Merger Agreement and this Support Agreement, the terms of the Merger Agreement shall control and supersede any such conflicting terms. This </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Support Agreement will be binding upon, inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns, and, in the case of Stockholder, such Persons to which record or beneficial ownership of the Stockholder&#8217;s Subject shares shall pass; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that neither this Support Agreement nor any of the rights, interests or obligations hereunder shall be assigned or delegated by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other parties, except that, without consent, each of Parent and the Company may assign all or any of its rights and obligations hereunder to any of its Affiliates that assume the rights and obligations of such party under the Merger Agreement, and any attempted assignment or delegation of this Support Agreement or any of the rights, interests or obligations by any of the parties without the other parties prior written consent shall be void and of no effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;THIS SUPPORT AGREEMENT AND ALL QUESTIONS RELATING TO THE INTERPRETATION OR ENFORCEMENT OF THIS SUPPORT AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES THEREOF TO THE EXTENT THAT SUCH PRINCIPLES WOULD DIRECT A MATTER TO ANOTHER JURISDICTION. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Specific Performance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereto acknowledge that any breach of this Support Agreement would give rise to irreparable harm for which monetary damages, even if applicable, would not be an adequate remedy, would occur in the event that any party does not perform the provisions of this Support Agreement (including failing to take such actions as are required of it hereunder to consummate the transactions contemplated hereby) in accordance with its specified terms or otherwise breaches such provisions. Accordingly, the parties shall be entitled to a decree of specific performance, an injunction or other equitable relief to prevent breaches or threatened breaches of any of the provisions of this Support Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the parties agrees that it will not oppose the granting of specific performance, an injunction or other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance or other equitable relief is not an appropriate remedy for any reason at law or in equity. Any party seeking an injunction or injunctions to prevent breaches of this Support Agreement shall not be required to provide any bond or other security in connection with any such order or injunction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Submission to Jurisdiction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereby (a)&#160;irrevocably and unconditionally submit to the exclusive personal jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if the Chancery Court declines jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (b)&#160;agree that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, (c)&#160;waive any objection to laying venue in any such action or proceeding in such courts, (d)&#160;waive any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (e)&#160;agree that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.4</font><font style="letter-spacing:0.2pt;"> of this Support Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any person to serve legal process in any other manner permitted by Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Jury Trial.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS SUPPORT AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS SUPPORT AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS SUPPORT AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS SUPPORT AGREEMENT WITH ANY COURT AS </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:516pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Counterparts</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Support Agreement may be executed in two or more counterparts (including by facsimile transmission or other means of electronic transmission, such as by electronic mail in &#8220;pdf&#8221; form), each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each of the parties and delivered (by facsimile or otherwise) to the other parties. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">(Signature Page Follows)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, the Company, Parent and the Stockholder have caused this Support Agreement to be duly executed as of the day and year first above written. </font>
        </div>
        <table style="width:456pt;height:361pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="7">
              <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Title:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:40pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:29.5pt 0pt 1.5pt 0pt; width:0pt;" colspan="7">
              <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Title:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:40pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:29.5pt 0pt 1.5pt 0pt; width:0pt;" colspan="7">
              <font style="letter-spacing:-0.2pt;">STOCKHOLDER </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Title:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:17.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Address:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:39pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:28.5pt 0pt 0.5pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">Electronic Mail Address:</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:255.56pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">] </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Exhibit&#160;A</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Form of Spousal Consent</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I acknowledge that I have read the Stockholder Support Agreement (to which this consent is attached) and that I know and understand, and have been fully advised by my attorney with respect to, its contents. As the spouse of the Stockholder, I hereby agree: (i)&#160;that all shares of capital stock, all options, all warrants and all additional securities of Parent held by the Stockholder, and all other rights with respect to the capital stock of Parent held by the Stockholder, and my interest in such shares, options, warrants, additional securities and other rights, if any, are subject to the provisions of the Stockholder Support Agreement and the Merger Agreement (as defined in the Stockholder Support Agreement), which I consent to; and (ii)&#160;that I&#160;will take no action at any time to hinder the operation of the Stockholder Support Agreement or the Merger Agreement. </font>
        </div>
        <table style="width:459pt;height:83pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:-0.2pt;">SIGNATURE OF SPOUSE: </font>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:17.167pt 0pt 14.833pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 237pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 14.833pt 0pt; width:63pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printed Name: </font>
              </div>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 14.833pt 0pt; width:171pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 171pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Schedule&#160;I</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Ownership of Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:32.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Name and Address of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stockholder </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX E</font>&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc.</font> <br ><font style="letter-spacing:0.2pt;">245 First Cambridge Street, Suite 1800 </font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA 02142 </font></div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-Up Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; &#8199;&#8199;&#8199;&#8199;, 2022 </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is executed in connection with the Agreement and Plan of Merger and Reorganization (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) by and among Sesen Bio, Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), Seahawk Merger Sub, Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and CARISMA Therapeutics Inc. (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), dated as of &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; &#8199;&#8199;&#8199;&#8199;, 2022. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with, and as an inducement to, each of the parties entering into the Merger Agreement and to consummate the transactions contemplated thereby and for other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the undersigned, by executing this Lock-Up Agreement, irrevocably agrees that, without the prior written consent of Parent, during the period commencing at the Effective Time and continuing until the end of the Lock-Up Period (as hereinafter defined), the undersigned will not: (i)&#160;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of or lend, directly or indirectly, any shares of Parent Common Stock or any securities convertible into, exercisable or exchangeable for or that represent the right to receive Parent Common Stock (including without limitation, Parent Common Stock which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the SEC and securities of Parent which may be issued upon exercise of a stock option, restricted stock unit or warrant) whether now owned or hereafter acquired (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Securities</font><font style="letter-spacing:0.2pt;">&#8221;); (ii)&#160;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Parent Securities, whether any such transaction described in clause (i)&#160;or this clause (ii)&#160;is to be settled by delivery of Parent Common Stock or such other securities, in cash or otherwise; (iii)&#160;make any demand for or exercise any right with respect to, the registration of any Parent Common Stock or any security convertible into or exercisable or exchangeable for Parent Common Stock (other than such rights set forth in the Merger Agreement); (iv)&#160;except for any voting agreement entered into as of the date hereof by the undersigned with Parent and the Company, grant any proxies or powers of attorney with respect to any Parent Securities, deposit any Parent Securities into a voting trust or enter into a voting agreement or similar arrangement or commitment with respect to any Parent Securities; or (v)&#160;publicly disclose the intention to do any of the foregoing (each of the foregoing restrictions, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Restrictions</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the terms of the foregoing paragraph, the Lock-Up Restrictions shall automatically terminate and cease to be effective on the date that is one-hundred and eighty (180) days after the Effective Time. The period during which the Lock-Up Restrictions apply to the Parent Securities shall be deemed the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Period</font><font style="letter-spacing:0.2pt;">&#8221; with respect thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned agrees that the Lock-Up Restrictions preclude the undersigned from engaging in any hedging or other transaction with respect to any then-subject Parent Securities which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of such Parent Securities even if such Parent Securities would be disposed of by someone other than the undersigned. Such prohibited hedging or other transactions would include without limitation any short sale or any purchase, sale or grant of any right (including without limitation any put or call option) with respect to such Parent Securities or with respect to any security that includes, relates to, or derives any significant part of its value from such Parent Securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the foregoing, the undersigned may transfer any of the Parent Securities: (i)&#160;if the undersigned is a natural person, (1)&#160;to any person related to the undersigned (or to an ultimate beneficial owner of the undersigned) by blood or adoption who is an immediate family member of the undersigned, or a family member by marriage or domestic partnership (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Family Member</font><font style="letter-spacing:0.2pt;">&#8221;), (2)&#160;as a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> gift or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">charitable contribution, (3)&#160;to any trust for the direct or indirect benefit of the undersigned or any Family Member of the undersigned, (4)&#160;to the undersigned&#8217;s estate, following the death of the undersigned, by will, intestacy or other operation of law, (5)&#160;by operation of law pursuant to a qualified domestic order or in connection with a divorce settlement, or (6)&#160;to any partnership, corporation, limited liability company, investment fund or other entity which is controlled by the undersigned and/or by any Family Member of the undersigned; (ii)&#160;if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (1)&#160;to another corporation, partnership, limited liability company, trust or other business entity that controls, is controlled by or is under common control with the undersigned, or to direct or indirect affiliates (as defined in Rule&#160;405 promulgated under the Securities Act of 1933, as amended) of the undersigned, including any investment funds or other entities that controls or manages, or is under common control or management with, or is controlled or managed by, the undersigned, (2)&#160;to current or former partners (general or limited), members or managers, limited liability company members or stockholders of the undersigned or holders of similar equity interests in the undersigned (including upon the liquidation and dissolution of the undersigned pursuant to a plan of liquidation approved by the undersigned&#8217;s stockholders) or to the estates of any of the foregoing, (3)&#160;as a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> gift, donation or charitable contribution or otherwise to a trust or entity for the direct or indirect benefit of an immediate family member of a beneficial owner (as defined in Rule&#160;405 promulgated under the Securities Act of 1933, as amended) of the undersigned&#8217;s Parent Securities or (4)&#160;transfers of dispositions not involving a change in beneficial ownership; (iii)&#160;if the undersigned is a trust, to any grantors or beneficiaries of such trust; (iv)&#160;to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under above clauses (i)&#160;through (iii); (v)&#160;to Parent in a transaction exempt from Section&#160;16(b) of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221;) upon a vesting event of the Parent Securities or upon the exercise of options or warrants to purchase Parent Common Stock, including on a &#8220;cashless&#8221; or &#8220;net exercise&#8221; basis or to cover tax withholding obligations of the undersigned in connection with such vesting or exercise (but for the avoidance of doubt, excluding all manners of exercise that would involve a sale in the open market of any securities relating to such options or warrants, whether to cover the applicable aggregate exercise price, withholding tax obligations or otherwise); (vi)&#160;to Parent in connection with the termination of employment or other termination of a service provider and pursuant to agreements in effect as of the Effective Time whereby Parent has the option to repurchase such shares or securities; (vii)&#160;acquired by the undersigned in open market transactions or in a public offering by Parent after the Effective Time; (viii)&#160;pursuant to a bona fide third party tender offer, merger, consolidation or other similar transaction made to all holders of Parent&#8217;s capital stock involving a change of control of Parent, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that in the event that such tender offer, merger, consolidation or other such transaction is not completed, the Parent Securities shall remain subject to the restrictions contained in this Lock-Up Agreement; or (ix)&#160;pursuant to an order of a court or regulatory agency; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that in the case of clauses (i)-(iv), that (A)&#160;such transfer shall not involve a disposition for value and (B)&#160;the transferee shall have executed and delivered a Lock-Up Agreement with terms and in a form substantially identical to this Lock-Up Agreement with respect to the Parent Securities so transferred. For purposes of this Agreement, &#8220;change of control&#8221; shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of capital stock if, after such transfer, such person or group of affiliated persons would hold a majority of the outstanding voting securities of Parent (or the surviving entity). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the foregoing restrictions shall not apply to (i)&#160;the exercise of stock options granted pursuant to equity incentive plans existing immediately following the Effective Time, including the &#8220;net&#8221; or cashless exercise of such options in accordance with their terms and any related transfers of Parent Common Stock to Parent for purposes of paying the exercise price of such options or for paying taxes (including estimated taxes and withholding taxes) due as a result of such exercise; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the restrictions set forth in this Lock-Up Agreement shall apply to any of the Parent Securities issued upon such exercise; or (ii)&#160;the establishment of any contract, instruction or plan (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan</font><font style="letter-spacing:0.2pt;">&#8221;) that satisfies the requirements of Rule&#160;10b5-1 under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221;); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that such Plan does not provide for the transfer of Parent Common Stock or any securities convertible into or exercisable or exchangeable for Parent Common Stock during the Lock-Up Period; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, further</font><font style="letter-spacing:0.2pt;">, that with respect to each of clauses (i)&#160;and (ii)&#160;above, no filing by any party under Section&#160;16 of the Exchange Act or other public announcement shall be made voluntarily reporting a reduction in beneficial ownership of shares of Parent Common Stock or any securities convertible into or exercisable or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">exchangeable for Parent Common Stock in connection with such transfer or disposition during the Lock-Up Period (other than any exit filings) and if any filings under Section&#160;16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Parent Common Stock in connection with such transfer or distribution, shall be legally required during the Lock-Up Period, such filing, report or announcement shall clearly indicate in the footnotes therein, in reasonable detail, a description of the circumstances of the transfer and that the shares remain subject to the Lock-Up Agreement, including a statement to the effect that no transfer of Parent Common Stock may be made under such Plan during the Lock-Up Period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any attempted transfer in violation of this Lock-Up Agreement will be of no effect and null and void, regardless of whether the purported transferee has any actual or constructive knowledge of the transfer restrictions set forth in this Lock-Up Agreement, and will not be recorded on the share register of Parent. In furtherance of the foregoing, the undersigned hereby agrees and consents to the entry of &#8220;stop transfer&#8221; instructions with Parent&#8217;s transfer agent and registrar relating to the transfer of the undersigned&#8217;s shares of Parent Common Stock in violation of this Lock-Up Agreement and further agrees that Parent and its transfer agent and registrar are hereby authorized to decline to make any transfer of shares of Parent Common Stock if such transfer would constitute a violation or breach of this Lock-Up Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parent may cause the legend set forth below, or a legend substantially equivalent thereto, to be placed upon any certificate(s) or other documents, ledgers or instruments evidencing the undersigned&#8217;s ownership of Parent Common Stock: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AND MAY ONLY BE TRANSFERRED IN COMPLIANCE WITH A LOCK-UP AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the release of any Parent Common Stock from this Lock-Up Agreement, Parent will cooperate with the undersigned to facilitate the timely preparation and delivery of certificates or the establishment of book entry positions at the Parent&#8217;s transfer agent representing the Parent Common Stock without the restrictive legend above and the withdrawal of any stop transfer instructions at the Parent&#8217;s transfer agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement and that upon request, the undersigned will execute any additional documents reasonably necessary to ensure the validity or enforcement of this Lock-Up Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event that during the Lock-Up Period any holder of Parent Securities that is subject to a substantially similar agreement entered into by such holder (such agreement, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Similar Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), other than the undersigned, is permitted by Parent or otherwise granted a release to sell or otherwise transfer or dispose of shares of Parent Common Stock for value other than as permitted by this or a substantially similar agreement entered into by such holder (whether in one or multiple releases), the same&#160;percentage of shares of Parent Common Stock held by the undersigned on the date of such release or waiver as the&#160;percentage of the total number of outstanding shares of Parent Common Stock held by such holder on the date of such release or waiver that are subject to such release or waiver shall be immediately and fully released on the same terms from any remaining restrictions set forth herein (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pro-Rata Release</font><font style="letter-spacing:0.2pt;">&#8221;). Parent will notify the undersigned of any Pro-Rata Release within ten business days of such release. Upon the release of any Parent Securities from this Lock-Up Agreement, Parent will promptly cooperate with the undersigned to facilitate the timely preparation and delivery of evidence of book-entry shares representing the Parent Securities without the restrictive legend above or the withdrawal of any stop transfer instructions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement shall terminate automatically, and the undersigned shall automatically be released from all restrictions and obligations under this Lock-Up Agreement upon the earlier of (i)&#160;the expiration of the Lock-Up Period, (ii)&#160;if the Merger Agreement is terminated prior to the Effective Time pursuant to its terms, upon the date of such termination and (iii)&#160;the End Date (as defined in the Merger Agreement in effect on the date hereof) provided that the Effective Time has not occurred on or before such date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:456pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement and any claim, controversy or dispute arising under or related to this Lock-Up Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the conflict of laws principles thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement, and any certificates, documents, instruments and writings that are delivered pursuant hereto, constitutes the entire agreement and understanding of Parent, the Company and the undersigned in respect of the subject matter hereof and supersedes all prior understandings, agreements or representations by or among Parent, the Company and the undersigned, written or oral, to the extent they relate in any way to the subject matter hereof. This Lock-Up Agreement may be executed in counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by the undersigned by facsimile or electronic transmission in &#8220;.pdf&#8221; format shall be sufficient to bind the undersigned to the terms and conditions of this Lock-Up Agreement. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page Follows</font><font style="letter-spacing:0.2pt;">) </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The undersigned understands that Parent, Merger Sub and the Company are relying on this Lock-Up Agreement in entering into the Merger Agreement and proceeding toward consummation of the transactions contemplated thereby. The undersigned further understands that this Lock-Up Agreement is irrevocable and shall be binding upon the undersigned and the heirs, personal representatives, successors and assigns of the undersigned. </font>
        </div>
        <table style="width:456pt;height:149pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:228pt;">
              <font style="letter-spacing:0.2pt;">Very truly yours, </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:228pt;white-space:normal;">
              <div style="text-align:justify;">
                <div style="margin-left: 0pt; width: 228pt; margin-top: 17.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Printed Name of Holder </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.667pt 0pt 0.5pt 0pt; width:228pt;white-space:normal;">
              <div style="text-align:justify;">
                <div style="overflow:hidden;">
                  <div style="float:left;">
                    <font style="letter-spacing:0.2pt;">By:&#8199;</font>
                  </div>
                  <div style="overflow:hidden;line-height:10pt;border-bottom:0.5pt #000000 solid;">&#160;</div>
                </div>
              </div>
              <div style="margin-top:1.5pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:228pt;white-space:normal;">
              <div style="text-align:justify;">
                <div style="margin-left: 0pt; width: 228pt; margin-top: 17.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Printed Name of Person Signing</font>
                <br >
                <font style="letter-spacing:0.2pt;">(and indicate capacity of person signing if signing</font>
                <br >
                <font style="letter-spacing:0.2pt;">as custodian, trustee, or on behalf of an entity)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:431.88pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Lock-Up Agreement Signature Page]</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX F</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONTINGENT VALUE RIGHTS AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [&#8226;], 2023 (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), is entered into by and among Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and Computershare Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221;) and its affiliate, Computershare Trust Company, N.A., together, as the Rights Agent. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, Parent, Seahawk Merger Sub, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), have entered into an Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub will merge with and into the Company, with the Company surviving the Merger as a subsidiary of Parent; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, pursuant to the Merger Agreement, Parent has agreed to provide to the holders of record of Parent&#8217;s common stock, par value $0.001 per share (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), immediately prior to the Effective Time, the right to receive certain contingent cash payments, on the terms and subject to the conditions hereinafter described. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the consummation of the transactions referred to above, Parent and the Rights Agent agree, for the proportionate benefit of all Holders (as hereinafter defined), as follows: </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;DEFINITIONS; CERTAIN RULES OF CONSTRUCTION </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Definitions.&nbsp;&nbsp;&nbsp;Capitalized terms used but not otherwise defined herein will have the meanings ascribed to them in the Merger Agreement, unless expressly set forth otherwise herein. As used in this Agreement, the following terms will have the following meanings: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3(d)</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person. The term &#8220;control&#8221; (including the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Disposition Proceeds</font><font style="letter-spacing:0.2pt;">&#8221; means, without duplication, any and all consideration of any kind that is paid to Parent, or is received by, Parent or any of its Affiliates during the period specified in clause (b)&#160;of the definition of CVR Term in respect of an Asset Disposition, if any. The value of any securities (whether debt or equity) or other non-cash property constituting Asset Disposition Proceeds shall be determined as follows: (A)&#160;the value of securities for which there is an established public market shall be equal to the volume weighted average of their closing market prices for the five (5)&#160;trading days ending the day prior to the date of payment to, or receipt by, Parent or its relevant Affiliate, and (B)&#160;the value of securities that have no established public market and the value of consideration that consists of other non-cash property, shall be the fair market value thereof as of the date of payment to, or receipt by, Parent or its relevant Affiliate. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board of Directors</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Parent. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board Resolution</font><font style="letter-spacing:0.2pt;">&#8221; means a copy of the resolution(s) certified by the secretary or an assistant secretary (or other comparable officer) of Parent that have been duly adopted by the Board of Directors and are in full force and effect on the date of such approval, and delivered to the Rights Agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day other than a Saturday, Sunday or other day on which banks in New York, New York are authorized or obligated by Law to be closed. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to each Holder, an amount equal to (a)&#160;(i)&#160;the applicable Total Payment Amount, less (ii)&#160;applicable accrued and documented Permitted Deductions, as calculated in accordance with GAAP, divided by (b)&#160;the total number of CVRs and then multiplied by the total number of CVRs held by such Holder as reflected on the CVR Register (rounded down to the nearest whole cent). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Sale Assets</font><font style="letter-spacing:0.2pt;">&#8221; means any and all assets, tangible and intangible, including, without limitation, patents, patent applications, know-how, trade secrets and other intellectual property rights, data, documentation, agreements and licenses, inventory related to Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, which Parent or any of its subsidiaries owned or had rights to, as of immediately prior to the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Term</font><font style="letter-spacing:0.2pt;">&#8221; means (a)&#160;with respect to any Roche Payment Amount, the period beginning on the date hereof and ending on the earlier of (i)&#160;the CVR Payment being delivered to each Holder in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4</font><font style="letter-spacing:0.2pt;"> of this Agreement, and (ii)&#160;March&#160;31, 2027, and (b)&#160;with respect to any Disposition or Asset Disposition or otherwise in respect of Asset Disposition Proceeds, the period beginning on the date hereof and ending on December&#160;31, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVRs</font><font style="letter-spacing:0.2pt;">&#8221; means the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Disposition</font><font style="letter-spacing:0.2pt;">&#8221; means the sale, license, transfer, disposition or other monetizing event of any CVR Sale Assets, in each case (i)&#160;during the period set forth in clause (b)&#160;of the definition of CVR Term and (ii)&#160;in a transaction identified by Parent&#8217;s financial advisor who was engaged as of the Effective Time for the purpose of identifying and proposing a potential Disposition transaction to Parent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">DTC</font><font style="letter-spacing:0.2pt;">&#8221; means The Depository Trust Company or any successor thereto. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.9</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; means a Person in whose name a CVR is registered in the CVR Register at the applicable time. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Officer&#8217;s Certificate</font><font style="letter-spacing:0.2pt;">&#8221; means a certificate signed by the chief executive officer, president, chief financial officer, any vice president, the controller, the treasurer or the secretary, in each case of Parent, in his or her capacity as such an officer, and delivered to the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Deductions</font><font style="letter-spacing:0.2pt;">&#8221; means the following costs or expenses, without duplication (as approved by the Board of Directors, including, if applicable, the Parent Designee (as defined in the Merger Agreement)): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;any applicable Tax (including any unreimbursed applicable value added or sales tax) imposed on the Total Payment Amount and payable by Parent or any of its Affiliates to any tax authority and, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">without duplication, any income or other similar Taxes payable by Parent or any of its Affiliates that would not have been incurred by Parent or any of its Affiliates but for the Total Payment Amount; provided that, for purposes of calculating income Taxes incurred by Parent and its Affiliates in respect of the Total Payment Amount, any such income Taxes shall be computed after reduction for any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) as of the Closing Date that are available to the maximum extent permitted by law to offset such gain after taking into account any limits on the usability of such attributes, including under Section&#160;382 of the Code, in each case, as reasonably determined by a nationally recognized tax advisor (and for the sake of clarity such income taxes shall be calculated without taking into account any net operating losses or other Tax attributes generated by Parent or its subsidiaries after the Closing Date or any Tax attributes of the Company, whether generated before or after the Closing Date), assuming for this purpose that (i)&#160;the only item of gross income of Parent and its subsidiaries is the Total Payment Amount (for the avoidance of doubt, assuming that the Total Payment Amount is taxable in the hands of Parent or its subsidiaries no later than the taxable year that includes the corresponding CVR Payment), and (ii)&#160;the net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries shall only include any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) existing as of immediately prior to the Merger for U.S. federal income tax purposes and applicable state and local income tax purposes; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;any reasonable and documented out-of-pocket expenses incurred by Parent or any of its Affiliates in respect of its performance of this Agreement following the Effective Time, losses incurred and paid by Parent or any of its Affiliates following the Effective Time arising out of any Legal Proceeding relating to or in connection with (i)&#160;an Asset Disposition, (ii)&#160;Parent&#8217;s, Roche&#8217;s or any of their respective Affiliates&#8217; obligations under the Roche Agreement or (iii)&#160;otherwise with respect to the Total Payment Amount; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;any Liabilities that were ascertainable prior to or at the Effective Time which Parent reasonably and in good faith determines should have been, but were not, deducted from &#8220;Net Cash&#8221; &#8203;(as defined in the Merger Agreement), in connection with the Closing of the Merger, to the extent that deduction of such Liabilities would have resulted in a change in the Exchange Ratio under the Merger Agreement were such amounts properly deducted; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided that no Permitted Deductions shall be deducted to the extent they were otherwise deducted from the calculation of Net Cash (as defined in the Merger Agreement). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Transfer</font><font style="letter-spacing:0.2pt;">&#8221; means a transfer of CVRs: (a)&#160;on death of a Holder by will or intestacy; (b)&#160;by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (c)&#160;pursuant to a court order; (d)&#160;made by operation of law (including a consolidation or merger) or without consideration in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; (e)&#160;in the case of CVRs held in book-entry or other similar nominee form, from a nominee to a beneficial owner (through an intermediary if applicable) or from a nominee to another nominee for the same beneficial owner, to the extent allowable by DTC; (f)&#160;a transfer from a participant&#8217;s account in a tax-qualified employee benefit plan to the participant or to such participant&#8217;s account in a different tax-qualified employee benefit plan or to a tax-qualified individual retirement account for the benefit of such participant; (g)&#160;to Parent or its Affiliates for any or no consideration; or (h)&#160;as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means any natural person, corporation, limited liability company, trust, unincorporated association, partnership, joint venture or other entity. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(e)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights Agent</font><font style="letter-spacing:0.2pt;">&#8221; means the Rights Agent named in the Preamble, until a successor Rights Agent will have become such pursuant to the applicable provisions of this Agreement, and thereafter &#8220;Rights Agent&#8221; will mean such successor Rights Agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche</font><font style="letter-spacing:0.2pt;">&#8221; means the collective reference to F. Hoffman-La Roche Ltd and Hoffmann La Roche Inc. or its successors or any of its or their respective Affiliates; provided, that neither Chugai Pharmaceutical Co., </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Ltd, a Japanese corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Chugai</font><font style="letter-spacing:0.2pt;">&#8221;) nor its subsidiaries (if any) shall be deemed as Affiliates of Roche unless Roche provides written notice to Parent of its desire to include Chugai or its respective subsidiaries (as applicable) as Affiliate(s) of Roche. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">RocheAgreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Asset Purchase Agreement, dated as of July&#160;15, 2022, by and among F. Hoffman-La Roche Ltd, Hoffmann La Roche Inc. and Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means the thirty million dollar ($30,000,000) milestone payment to be made by Roche to Parent upon the initiation of a phase III clinical study in diabetic macular disorder with the compound known as &#8220;EBI-031&#8221; during the CVR Term, as set forth in Section&#160;11.1 of the Roche Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Third Party</font><font style="letter-spacing:0.2pt;">&#8221; means any Person other than Parent, Rights Agent or their respective Affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Total Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, as of any applicable time of determination, any Asset Disposition Proceeds plus any Roche Payment Amounts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Rules of Construction. Except as otherwise explicitly specified to the contrary, (a)&#160;whenever the context requires, the singular number shall include the plural, and vice versa; (b)&#160;the masculine gender shall include the feminine gender and neuter genders, the feminine gender shall include the masculine and neuter genders, and the neuter genders shall include masculine and feminine genders; (c)&#160;the word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; means the degree to which a subject or other thing extends, and does not simply mean &#8220;if&#8221;; (d)&#160;the word &#8220;including&#8221; &#8203;(in its various forms) means &#8220;including without limitation&#8221;; (e)&#160;references to a &#8220;Section&#8221; means a Section of this Agreement unless another agreement is specified; (f)&#160;references to a particular statute or regulation include all rules and regulations thereunder and any predecessor or successor statute, rules or regulation, in each case as amended or otherwise modified from time to time; (g)&#160;words in the singular or plural form include the plural and singular form, respectively; (h)&#160;references to a particular Person include such Person&#8217;s successors and assigns to the extent not prohibited by this Agreement; (i)&#160;the word &#8220;or&#8221; shall not be exclusive (i.e., &#8220;or&#8221; shall be deemed to mean &#8220;and/or&#8221;) unless the subject of the conjunction are mutually exclusive; and (j)&#160;all references to dollars or &#8220;$&#8221; refer to United States dollars. For clarity, the parties agree that the phrase &#8220;materially adverse&#8221; when used in this Agreement with respect to the Holders includes any amendment or other action, as applicable, that does or would be reasonably expected to reduce, eliminate, or materially delay the Roche Payment Amount. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;CONTINGENT VALUE RIGHTS </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CVRs; Appointment of Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each Holder is entitled to one CVR in the form of a dividend for each share of Parent Common Stock held by such Holder as of the Record Time. The CVRs represent the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. The initial Holders will be the holders of Parent Common Stock as of immediately prior to the Effective Time, and a list of the initial Holders shall be furnished to the Rights Agent by or on behalf of Parent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent hereby appoints the Rights Agent to act as rights agent for Parent as contemplated hereby in accordance with the express terms and conditions set forth in this Agreement (and no implied terms or conditions), and the Rights Agent hereby accepts such appointment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent intends to treat the issuance of the CVRs as a distribution of property by Parent to the holders of Parent Common Stock for U.S. federal income tax purposes. Consistent with such intended tax treatment, Parent will timely send Forms 1099-DIV to all Holders notifying them of the portion of the CVR value that is a nondividend distribution (or a dividend to the extent of Parent&#8217;s earnings and profits) for U.S. federal income tax purposes, and take all necessary steps to file its tax returns and any information statements consistent with such tax treatment. Parent will determine, in consultation with and with the consent of the Parent Designee, the fair market value of the CVRs in connection with the issuance and Parent will utilize such fair market value for purposes of all tax reporting (including on Forms 1099-DIV) with respect to the CVR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Nontransferable.&nbsp;&nbsp;&nbsp;The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any attempted sale, assignment, transfer, pledge, encumbrance, transfer or disposition, in whole or in part, that is not a Permitted Transfer will be void </font><font style="font-style:italic;letter-spacing:0.2pt;">ab initio</font><font style="letter-spacing:0.2pt;"> and of no effect. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No Certificate; Registration; Registration of Transfer; Change of Address. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not be evidenced by a certificate or other instrument. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Rights Agent will create and keep a register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221;) for the purpose of identifying the Holders and registering CVRs and transfers of CVRs as permitted herein. The CVR Register will be created, and CVRs will be distributed, pursuant to written instructions to the Rights Agent from Parent. The CVR Register will initially show one position for Cede &amp; Co. representing all the CVRs provided to the holders of shares of Parent Common Stock held as of immediately prior to the Effective Time. The Rights Agent will have no responsibility whatsoever directly to the street name holders or DTC participants with respect to transfers of CVRs unless and until such CVRs are transferred into the name of such street name holders or DTC participants in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> of this Agreement. With respect to any payments to be made under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> below, the Rights Agent will accomplish the payment to any former street name holders of shares of Parent Common Stock by sending one lump-sum payment to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to such street name holders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to the restrictions on transferability set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer and other reasonably requested documentation in form reasonably satisfactory to the Rights Agent, duly executed by the Holder thereof or the Holder&#8217;s attorney duly authorized in writing, personal representative or survivor and setting forth in reasonable detail the circumstances relating to the transfer. Upon receipt of such written notice, the Rights Agent will, subject to its reasonable determination that the transfer instrument is in proper form, notify Parent that it has received such written notice. Upon receipt of such notice from the Rights Agent, Parent shall determine whether the transfer otherwise complies with the other terms and conditions of this Agreement (including the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">), and if it determines that it does so comply, Parent shall instruct the Rights Agent in writing to register the transfer of the CVRs in the CVR Register and notify Parent of the same. No service charge shall be made for any registration of transfer of a CVR; however Parent and the Rights Agent may require payment of a sum sufficient to cover any stamp or other tax or governmental charge that is imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action under any section of this Agreement that requires the payment by a Holder of applicable taxes or charges unless and until the Rights Agent is satisfied that all such taxes or charges have been paid or will be paid. All duly transferred CVRs registered in the CVR Register will be the valid obligations of Parent and will entitle the transferee to the same benefits and rights under this Agreement as those held immediately prior to the transfer by the transferor. No transfer of a CVR will be valid until registered in the CVR Register. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;A Holder may make a written request to the Rights Agent to change such Holder&#8217;s address of record in the CVR Register. The written request must be duly executed by the Holder. Upon receipt of such written request, the Rights Agent is hereby authorized to promptly record the change of address in the CVR Register. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Parent will provide written instructions to the Rights Agent for the distribution of CVRs to holders of Parent Common Stock as of immediately prior to the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221;). Subject to the terms and conditions of this Agreement and Parent&#8217;s prompt confirmation of the Effective Time, the Rights Agent shall effect the distribution of the CVRs, less any applicable tax withholding, to each holder of Parent Common Stock as of the Record Time by the mailing of a statement of holding reflecting such CVRs. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Payment Procedures. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Within thirty (30) days after the receipt of any portion of the Total Payment Amount, Parent shall (i)&#160;deliver to the Rights Agent a certificate certifying to and specifying in reasonable detail (A)&#160;the amount of the applicable Total Payment Amount received by Parent or its Affiliates, (B)&#160;a calculation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of the CVR Payment Amount and CVR Payment, and (C)&#160;the Permitted Deductions reflected in such CVR Payment Amount, (ii)&#160;deliver to the Rights Agent an amount equal to the aggregate CVR Payment Amount in immediately available funds (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221;) and (iii)&#160;instruct the Rights Agent to deliver the CVR Payment to the Holders. The Rights Agent will promptly, and in any event within ten (10) Business Days after receipt of each applicable CVR Payment, pay to each Holder, by check mailed to the address of each Holder as reflected in the CVR Register as of the close of business on the date of the receipt of the CVR Payment statement, such Holder&#8217;s CVR Payment Amount less any applicable tax withholding. Until such certificate, CVR Payment and instructions are received by the Rights Agent, the Rights Agent may presume conclusively for all purposes that such portion of the Total Payment Amount has not been received. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All payments by Parent to the Rights Agent under this Agreement shall be made in U.S. dollars. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent shall be entitled to deduct or withhold, or cause the Rights Agent to deduct or withhold from any CVR Payment Amount otherwise payable or otherwise deliverable pursuant to this Agreement, in each case directly or through an authorized payroll agent, such amounts as are reasonably determined to be required to be deducted or withheld therefrom under the Code or any other provision of any applicable federal, state, local or non-U.S. Tax Law as may be determined by Parent. To the extent such amounts are so deducted or withheld and paid over or deposited with the relevant Tax authority, such amounts shall be treated for all purposes under this Agreement as having been paid to the Holder(s) to whom such amounts would otherwise have been paid or delivered. Prior to making any such Tax withholdings or causing any such Tax withholdings to be made with respect to any Holder, Parent shall instruct the Rights Agent, to the extent practicable, to provide notice to the Holder of such potential withholding and a reasonable opportunity for the Holder to provide any necessary Tax forms (including an IRS Form W-9 or an applicable IRS Form W-8) in order to avoid or reduce such withholding amounts; provided, that the time period for payment of a CVR Payment Amount by the Rights Agent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> shall be extended by a period equal to any delay caused by the Holder providing such forms; provided, further, that in no event shall such period be extended for more than ten (10) Business Days, unless otherwise requested by the Holder for the purpose of delivering such forms and agreed to by the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Any portion of any CVR Payment that remains undistributed to any Holder six (6)&#160;months after such CVR Payment is received by the Rights Agent from Parent, provided, that the Rights Agent has fully complied with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, will be delivered by the Rights Agent to Parent, upon demand, and such Holder will thereafter look only to Parent for payment of its share of such returned CVR Payment, without interest. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Neither Parent nor the Rights Agent will be liable to any person in respect of any CVR Payment Amount delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If, despite Parent&#8217;s and/or the Rights Agent&#8217;s commercially reasonable efforts to deliver a CVR Payment Amount to the applicable Holder, such CVR Payment Amount has not been paid immediately prior to the date on which such CVR Payment Amount would otherwise escheat to or become the property of any Governmental Body, any such CVR Payment Amount will, to the extent permitted by applicable Law, become the property of Parent, free and clear of all claims or interest of any person previously entitled thereto. In addition to and not in limitation of any other indemnity obligation herein, Parent agrees to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject to in connection with transferring such property to Parent and such indemnification obligation shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No Voting, Dividends or Interest; No Equity or Ownership Interest in Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not have any voting or dividend rights, and interest will not accrue on any amounts payable on the CVRs to any Holder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The CVRs will not represent any equity or ownership interest in Parent or in any constituent company to the Merger. The sole right of the Holders to receive property hereunder is the right to receive </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the CVR Payment in accordance with the terms hereof. It is hereby acknowledged and agreed that a CVR shall not constitute a security of Parent or any constituent company to the Merger. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Holder acknowledges and agrees that such Holder will not challenge or contest any action, inaction, determination or decision of Parent or the Rights Agent, except via written action of the Acting Holders, and will not threaten, bring, commence, institute, maintain, prosecute or voluntarily aid any action, which challenges the validity of or seeks to enjoin the operation of any provision of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Ability to Abandon CVR. A Holder may at any time, at such Holder&#8217;s option, abandon all of such Holder&#8217;s remaining rights in a CVR by transferring such CVR to Parent without consideration therefor, and such rights will be cancelled, with the Rights Agent being promptly notified in writing by Parent of such transfer and cancellation. Nothing in this Agreement is intended to prohibit Parent from offering to acquire CVRs, in a private transaction or otherwise, for consideration in its sole discretion. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;THE RIGHTS AGENT </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Certain Duties and Responsibilities.&nbsp;&nbsp;&nbsp;The Rights Agent will be authorized and protected and will not have any liability for or in respect of any actions taken, suffered or omitted to be taken by it in connection with its acceptance and administration of this Agreement and the exercise and performance of its duties hereunder, except to the extent of its own willful misconduct, bad faith or gross negligence (each as determined by a final non-appealable judgment of a court of competent jurisdiction). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Certain Rights of the Rights Agent.&nbsp;&nbsp;&nbsp;The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied duties, covenants or obligations will be read into this Agreement against the Rights Agent. The Rights Agent shall not assume any obligations or relationship of agency or trust with any Holder. In addition: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;the Rights Agent may rely and will be protected by Parent in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document believed by it in the absence of bad faith to be genuine and to have been signed or presented by the proper party or parties; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;whenever the Rights Agent will deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may request and rely upon an Officer&#8217;s Certificate with respect to such matter, which certificate shall be full authorization and protection to the Rights Agent, and the Rights Agent shall, in the absence of gross negligence, bad faith or willful or intentional misconduct (each as determined by a final non appealable judgment of a court of competent jurisdiction) on its part, incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith under the provisions of this Agreement in reliance upon such certificate; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;in the event the Rights Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document received by the Rights Agent hereunder, the Rights Agent, may, in its sole discretion, refrain from taking any action, and shall be fully protected and shall not be liable in any way to Parent, any Holder or any other person or entity for refraining from taking such action, unless the Rights Agent receives written instructions from the Parent which eliminates such ambiguity or uncertainty to the satisfaction of the Rights Agent; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;the Rights Agent may engage and consult with counsel of its selection (who may be legal counsel for the Rights Agent or the Parent or an employee of the Rights Agent) and the written advice of such counsel or any opinion of counsel will be full and complete authorization and protection to the Rights Agent and the Rights Agent shall be held harmless by Parent and shall incur no liability for or in respect of any action taken, suffered or omitted by it hereunder in the absence of bad faith and in reliance thereon; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;the permissive rights of the Rights Agent to do things enumerated in this Agreement will not be construed as a duty; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;the Rights Agent will not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Parent only and the Rights Agent will have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent), nor shall the Rights Agent be responsible for any breach by Parent of any covenant or condition contained in this Agreement; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, damage, judgment, fine, penalty, settlement, claim, demands, suits, cost or expense (including without limitation, the reasonable and documented fees and expenses of legal counsel) for any action taken, suffered or omitted to be taken by the Rights Agent or arising out of or in connection with the Rights Agent&#8217;s duties under this Agreement, including the reasonable and documented out-of-pocket costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss arising therefrom, directly or indirectly, or enforcement of its rights hereunder, unless such loss has been determined by a final non-appealable judgment of a court of competent jurisdiction to be a result of the Rights Agent&#8217;s gross negligence, bad faith or willful or intentional misconduct; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;anything to the contrary notwithstanding, (i)&#160;any liability of the Rights Agent under this Agreement will be limited to the aggregate amount of the annual fees (but not reimbursed expenses) paid by Parent to the Rights Agent under this Agreement during the twelve&#160;months immediately preceding the event for which recovery is sought, and (ii)&#160;in no event shall the Rights Agent be liable for any special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including but not limited to lost profits) arising out of any action taken, suffered or omitted to be taken by it, even if the Rights Agent has been advised of the likelihood of such loss or damage and regardless of the form of action; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Parent agrees (i)&#160;to pay the fees and expenses of the Rights Agent in connection with the Rights Agent&#8217;s duties under this Agreement as agreed upon in writing by the Rights Agent and Parent on or prior to the date hereof, and (ii)&#160;to reimburse the Rights Agent for all taxes and governmental charges, reasonable and documented out-of-pocket expenses and other charges of any kind and nature incurred by the Rights Agent in the preparation, delivery, amendment and execution of this Agreement and the exercise and performance of its duties hereunder (other than taxes imposed on or measured by the Rights Agent&#8217;s net income and franchise or similar taxes imposed on it (in lieu of net income taxes)). The Rights Agent will also be entitled to reimbursement from Parent for all reasonable and documented out-of-pocket expenses paid or incurred by it in connection with the administration by the Rights Agent of its duties hereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing from the Parent and all notices or other instruments required by this Agreement to be delivered to the Rights Agent must, in order to be effective, be received by the Rights Agent as specified herein, and in the absence of such notice so delivered the Rights Agent may conclusively assume no such event or condition exists; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;the Rights Agent and any shareholder, affiliate, director, officer or employee of the Rights Agent may buy, sell or deal in any securities of the Parent or become peculiarly interested in any transaction in which the Parent may be interested, or contract with or lend money to the Parent or otherwise act as fully and freely as though it were not the Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Parent or for any other Person; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;the Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its attorneys or agents, and the Rights Agent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">shall not be liable, answerable or accountable for any act, omission, default, neglect or misconduct of any such attorneys or agents or for any loss to the Parent, any Holder or any other person or entity resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct (each as determined by a final non-appealable judgment of a court of competent jurisdiction) in the selection and continued employment thereof; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;no provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by the Parent or its Affiliates, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Parent; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;the Rights Agent shall neither be responsible for, nor chargeable with, knowledge of, nor have any requirements to comply with, the terms and conditions of any other agreement, instrument or document, including, without limitation, the Merger Agreement, nor shall the Rights Agent be required to determine if any person or entity has complied with any such agreements, instruments or documents, nor shall any additional obligations of the Rights Agent be inferred from the terms of such agreements, instruments or documents even though reference thereto may be made in this Agreement. In the event of any conflict between the terms and provisions of this Agreement and those of any other agreement, instrument or document, including but not limited to the Merger Agreement, the terms and conditions of this Agreement shall control as they relate to the Rights Agent; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;The provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;"> and this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;"> shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Resignation and Removal; Appointment of Successor. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Rights Agent may resign at any time by giving written notice thereof to Parent specifying a date when such resignation will take effect, which notice will be sent at least thirty (30) days prior to the date so specified, and such resignation will become effective on the earlier of (i)&#160;the date so specified and (ii)&#160;the appointment of a successor Rights Agent. Parent has the right to remove the Rights Agent at any time by a Board Resolution specifying a date when such removal will take effect (or, if earlier, the appointment of the successor Rights Agent). Notice of such removal will be given by Parent to the Rights Agent, which notice will be sent at least thirty (30) days prior to the date so specified. Notwithstanding anything to the contrary contained herein, such replacement or removal of the Rights Agent shall not affect any of the provisions of this Agreement that expressly survive the termination of this Agreement, or the resignation, replacement or removal of the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Rights Agent provides notice of its intent to resign, is removed or becomes incapable of acting, Parent, by a Board Resolution, will as soon as is reasonably possible appoint a qualified successor Rights Agent, who shall be a stock transfer agent or national reputation or the corporate trust department of a commercial bank. The successor Rights Agent so appointed will, forthwith upon its acceptance of such appointment in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">, become the successor Rights Agent. Notwithstanding the foregoing, if Parent shall fail to make such appointment within a period of thirty (30) days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Rights Agent, then the incumbent Rights Agent may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent will give notice to each Holder of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by delivering a written notice of such event to the Holders as their names and addresses appear in the CVR Register in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;">. Each notice will include the name and address of the successor Rights Agent. If Parent fails to send such notice within ten (10) Business Days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent will cause the notice to be mailed at the expense of Parent. Failure to give </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any notice provided for in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, however, and any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, unless consented to in writing by, at the applicable time of determination, Holders of at least 33% of the then outstanding CVRs, as set forth in the CVR Register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221;), Parent will not appoint as a successor Rights Agent any Person that is not a stock transfer agent of national reputation or the corporate trust department of a commercial bank. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Rights Agent will reasonably cooperate with Parent and any successor Rights Agent in connection with the transition of the duties and responsibilities of the Rights Agent to the successor Rights Agent, including the transfer of all relevant data, including the CVR Register, to the successor Rights Agent, but such predecessor Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.4</font><font style="letter-spacing:0.2pt;"> Acceptance of Appointment by Successor. Every successor Rights Agent appointed hereunder will, at or prior to such appointment, execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Rights Agent. On request of Parent or the successor Rights Agent, the retiring Rights Agent will execute and deliver an instrument transferring to the successor Rights Agent all the rights (except such rights of the predecessor Rights Agent which survive pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> of this Agreement), powers and trusts of the retiring Rights Agent. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;COVENANTS </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;List of Holders.&nbsp;&nbsp;&nbsp;Parent will furnish or cause to be furnished to the Rights Agent in such form as Parent receives from Parent&#8217;s transfer agent (or other agent performing similar services for Parent), the names and addresses of the Holders within ten (10) Business Days of the Effective Time. Until such initial list of Holders is furnished to the Rights Agent, the Rights Agent shall have no duties, responsibilities or obligations with respect to such Holders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Payment of CVR Payment Amounts. If a CVR Payment is due under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, Parent will deposit the CVR Payment with the Rights Agent for payment to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Roche Agreements.&nbsp;&nbsp;&nbsp;Without the prior written consent of the Acting Holders, neither Parent nor any of its Affiliates shall (a)&#160;amend, restate, supplement, terminate or otherwise modify the Roche Agreement in a manner materially adversely affecting the Holders&#8217; rights under this Agreement, (b)&#160;in the event that Roche fails to make a payment of a Roche Payment at the time rightfully due and payable, take action with respect to, or unreasonably waive or fail to enforce, the right to receive the applicable payments which are rightfully due and payable under the Roche Agreement, in a manner materially adversely affecting the Holders&#8217; rights under this Agreement or (c)&#160;agree to any of the foregoing. Without limiting the foregoing, Parent and its Affiliates shall pursue their rights under the Roche Agreement in good faith, and not take any action (or fail to take any action) with the intention of avoiding, reducing or materially delaying any payment to the Holders hereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Records. Parent shall, and shall cause its Affiliates to, keep true, complete and accurate records in sufficient detail to enable the Holders and their consultants or professional advisors to confirm (a)&#160;whether the Roche Payment Amount or the Asset Disposition Proceeds have been received by Parent or its successors or Affiliates and (b)&#160;the applicable CVR Payment Amount payable to each Holder hereunder in accordance with the terms specified in this Agreement. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;DISPOSITION </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the period specified in clause (b)&#160;of the definition of &#8220;CVR Term&#8221;, Parent will, and will cause its subsidiaries to, use commercially reasonable efforts to effectuate a Disposition, including the negotiation and execution of a Sale Agreement and completion of the transactions contemplated thereby. Further, Parent will not take any actions for the primary purpose of frustrating the payment of CVR Payments. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Holders acknowledge and agree that, except as expressly set forth in the foregoing Section&#160;5.1, (a)&#160;Parent has a fiduciary obligation to operate its business in the best interests of its stockholders, and any potential obligation to pay any potential Asset Disposition Proceeds or any other amounts will not create any express or implied obligation to operate its business in any particular manner in order to maximize any such CVR Payments, (b)&#160;the Holders are not relying on any representation of Parent or any other Person with regard to any Disposition or other action involving CVR Sale Assets following the Closing, and neither Parent nor any other Person has provided, or can provide, any assurance to the Holders that any potential Asset Disposition Proceeds or any other amounts will in fact be earned and paid, and (c)&#160;none of Parent or any of its Subsidiaries, officers or directors shall have any obligation or liability whatsoever to any Person relating to or in connection with any action, or failure to act, with respect to the sale of CVR Sale Assets. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;AMENDMENTS </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Amendments without Consent of Holders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, at any time and from time to time, and the Rights Agent may enter into one or more amendments hereto, solely to evidence any successor to or permitted Assignee of Parent and the assumption by any such successor or permitted Assignee of the covenants of Parent herein as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, may, with the consent of the Rights Agent, which consent shall not be unreasonably withheld, conditioned or delayed, at any time and from time to time, enter into one or more amendments hereto, solely for any of the following purposes: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to evidence the succession of another Person as a successor Rights Agent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3</font><font style="letter-spacing:0.2pt;"> and the assumption by any successor of the covenants and obligations of the Rights Agent herein; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to add to the covenants of Parent such further covenants, restrictions, conditions or provisions as Parent shall consider to be for the protection of the Holders; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that the CVRs are not subject to registration under the Securities Act or the Exchange Act or any applicable state securities or &#8220;blue sky&#8221; laws; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;to cancel any CVRs (A)&#160;in the event that any Holder has abandoned its rights in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">, or (B)&#160;following a transfer of such CVRs to Parent or its Affiliates in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, unless such addition, elimination or change is adverse to the interests of the Holders; or </font>
        </div>
        <div style="text-indent:60pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that Parent complies with applicable Law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">, Parent will transmit a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Amendments with Consent of Holders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> (which amendments pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> may be made without the consent of the Holders), with the consent of the Acting Holders, whether evidenced in writing or taken </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">at a meeting of such Holders, Parent, when authorized by a Board Resolution, and the Rights Agent may enter into one or more amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interest of the Holders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent, and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2</font><font style="letter-spacing:0.2pt;">, Parent will transmit (or cause the Rights Agent to transmit) a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Execution of Amendments.&nbsp;&nbsp;&nbsp;In executing any amendment permitted by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, the Rights Agent will be entitled to receive, and will be fully protected in relying upon, an opinion of counsel selected by Parent stating that the execution of such amendment is authorized or permitted by this Agreement. Notwithstanding anything contained herein, the Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent&#8217;s own rights, privileges, covenants or duties under this Agreement or otherwise. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Effect of Amendments.&nbsp;&nbsp;&nbsp;Upon the execution of any amendment under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, this Agreement will be modified in accordance therewith, such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;OTHER PROVISIONS OF GENERAL APPLICATION </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Notices to Rights Agent and Parent.&nbsp;&nbsp;&nbsp;Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed given when delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fee prepared, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to the Rights Agent, to it at: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Computershare Inc. and Computershare Trust Company, N.A. </font> <br ><font style="letter-spacing:0.2pt;">150 Royall Street, 2nd Floor </font> <br ><font style="letter-spacing:0.2pt;">Canton, MA 02021 </font> <br ><font style="letter-spacing:0.2pt;">Attention: Relationship Manager </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to Parent, to it at: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Telephone:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Telephone:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Email:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Attention:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">[&#8226;] </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Rights Agent or Parent may specify a different address, email address by giving notice to each other in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> and to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Notice to Holders.&nbsp;&nbsp;&nbsp;Where this Agreement provides for notice to Holders, such notice will be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid or, if applicable, transmitted through the facilities of DTC in accordance with DTC&#8217;s procedures, to each Holder affected by such event, at the Holder&#8217;s address as it appears in the CVR Register, not later </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">than the latest date, and not earlier than the earliest date, if any, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder will affect the sufficiency of such notice with respect to other Holders. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Parent Successors and Assigns. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent may not assign this Agreement without the prior written consent of the Acting Holders. Notwithstanding the foregoing (i)&#160;Parent may assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations hereunder to one or more direct or indirect wholly-owned subsidiaries of Parent for so long as they remain wholly-owned subsidiaries of Parent (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221;) and the Assignee agrees to assume and be bound by all of the terms of this Agreement; provided, however, that in connection with any assignment to an Assignee, Parent shall, and shall agree to, remain liable for the performance by such Assignee of all obligations of Parent hereunder, with such Assignee substituted for Parent under this Agreement, and (ii)&#160;Parent may assign this Agreement in its entirety without the consent of any other party to its successor in interest in connection with the sale of all or substantially all of its assets or of its stock, or in connection with a merger, acquisition or similar transaction (such successor in interest, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221;, and such transaction, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221;). This Agreement will be binding upon, inure to the benefit of and be enforceable by Parent&#8217;s successors, acquirers and each Assignee. Each reference to &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; in this Agreement shall be deemed to include Parent&#8217;s successors, acquirers and all Assignees. Each of Parent&#8217;s successors, acquirers and assigns shall expressly assume by an instrument supplemental hereto, executed and delivered to the Rights Agent, the due and punctual payment of the CVR Payments and the due and punctual performance and observance of all of the covenants and obligations of this Agreement to be performed or observed by Parent. Notwithstanding anything to the contrary contained herein, no assignment pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;"> shall relieve Parent of its obligations and liabilities to the Rights Agent hereunder, unless specifically agreed to in writing by the Rights Agent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Any Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any Person succeeding to the stock transfer or other shareholder services business of the Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided, that such Person would be eligible for appointment as a successor Rights Agent under the provisions of this Agreement. The purchase of all or substantially all of the Rights Agent&#8217;s assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Benefits of Agreement;&nbsp;&nbsp;&nbsp;Action by Acting Holders. The holders shall be intended third-party beneficiaries hereof and shall be entitled to, solely by action by the written consent of the Acting Holders, specifically enforce the terms hereof; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that under no circumstances shall the rights of Holders as third-party beneficiaries pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.4</font><font style="letter-spacing:0.2pt;"> be enforceable by such Holders or any other Person acting for or on their behalf other than through the action of the Acting Holders, which Acting Holders shall have the sole power and authority to act on behalf of the Holders in enforcing any of their rights hereunder. Nothing in this Agreement, express or implied, will give to any Person (other than the Rights Agent, Parent, Parent&#8217;s successors and permitted assignees, and the Holders and their respective successors and permitted assignees) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Rights Agent, Parent, Parent&#8217;s successors and permitted Assignees, and the Holders and their respective successors and permitted assignees. The rights of Holders are limited to those expressly provided in this Agreement and the Merger Agreement. Except for the rights of the Rights Agent set forth herein, the Acting Holders will have the sole right, on behalf of all Holders, by virtue of or under any provision of this Agreement, to institute any action or proceeding at law or in equity with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise such rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Governing Law.&nbsp;&nbsp;&nbsp;This Agreement, the CVRs and all claims and causes of action based upon, arising out of or in connection herewith shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without regard to Laws that may be applicable under conflicts of laws principles </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In any Legal Proceeding between any of the parties arising out of our relating to this Agreement, each of the parties hereby (i)&#160;irrevocably and unconditionally consent and submits, for itself and its property, to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if such court does not have jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (ii)&#160;agrees that any claim in respect of any such Legal Proceeding shall be heard and determined exclusively in accordance with clause (i)&#160;of this Section&#160;7.5, (iii)&#160;waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Legal Proceeding in any such court, (iv)&#160;waives, to the fullest extent permitted by Law, any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (v)&#160;agrees that service of process upon such party in any such Legal Proceeding shall be effective if notice is given in accordance with Section&#160;7.1 of this Agreement. Nothing in this Section&#160;7.5, however, shall affect the right of any Person to serve legal process in any manner permitted by Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Severability.&nbsp;&nbsp;&nbsp;Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If any term or other provision of this Agreement is determined by a final judgement of a court of competent jurisdiction to be invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provisions, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. Notwithstanding anything to the contrary herein, if any such excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately upon written notice to Parent. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business or other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.7</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Counterparts and Signature.&nbsp;&nbsp;&nbsp;This Agreement may be signed in any number of counterparts, including by electronic transmission, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.8</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Termination.&nbsp;&nbsp;&nbsp;This Agreement will expire and be of no force or effect, the parties hereto will have no liability hereunder (other than with respect to monies due and owing by Parent to the Rights Agent or any other rights of the Rights Agent which expressly survive the termination of this Agreement), and no additional payments will be required to be made, upon the later of (i)&#160;the conclusion of the CVR Term, and (ii)&#160;the payment of the full amount of all CVR Payments made to Parent on or prior to the end of the applicable CVR Term to the Rights Agent and the payment of the full amount of all CVR Payment Amounts to the Holders by the mailing by the Rights Agent of each applicable CVR Payment Amount to each Holder at the address reflected in the CVR Register; provided that, for clarity, the term &#8220;CVR Term&#8221; as used in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.8</font><font style="letter-spacing:0.2pt;"> shall be deemed to mean clause (a)&#160;of such definition with respect to any Roche Payment Amount, and shall be deemed to mean clause (b)&#160;of such definition with respect to any Asset Disposition Proceeds. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.9</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Funds.&nbsp;&nbsp;&nbsp;All funds received by the Rights Agent under this Agreement that are to be distributed or applied by Computershare in the performance of services hereunder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221;) shall be held by Computershare as agent for Parent and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, Computershare will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1&#160;billion or with an average rating above investment grade by S&amp;P (LT Local Issuer Credit Rating), Moody&#8217;s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:256pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">paragraph, including any losses resulting from a default by any bank, financial institution or other Third Party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to Parent, any Holder or any other party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.10</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Entire Agreement.&nbsp;&nbsp;&nbsp;As between Parent and the Holders, this Agreement and the Merger Agreement (including the schedules, annexes and exhibits thereto, the documents and instruments referred to therein and the documents delivered pursuant thereto) constitute the entire agreement of Parent and the Holders and supersede all prior agreements and undertakings, both written and oral, among Parent and the Holders, or any of them, with respect to the subject matter hereof and, except as otherwise expressly provided herein or therein, are not intended to confer upon any other Person any rights or remedies hereunder or thereunder. As between Parent and the Rights Agent, this Agreement (including the documents and instruments referred to herein (other than the Merger Agreement) and the documents delivered pursuant thereto) contains the entire understanding of the parties with reference to the transactions and matters contemplated hereby and thereby and supersedes all prior agreements, written or oral, among the parties with respect thereto. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement will govern and control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.11</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Waiver of Jury Trial.&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.</font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Remainder of page intentionally left blank</font><font style="letter-spacing:0.2pt;">] </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written. </font>
        </div>
        <table style="width:468pt;height:183pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">SESEN BIO, INC. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Title: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:15.667pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">COMPUTERSHARE INC. and COMPUTERSHARE TRUSTCOMPANY, N.A., jointly as RIGHTS AGENT </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">Title:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify; line-height:0pt;">
                <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="AnnexG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:58pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX G</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORM OF CERTIFICATE OF AMENDMENT </font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO THE RESTATED CERTIFICATE OF INCORPORATION OF </font>
          <br >
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc., a corporation organized and existing under the laws of the State of Delaware (the &#8220;Corporation&#8221;) hereby certifies as follows: </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FIRST:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;That the Board of Directors of the Corporation adopted resolutions setting forth the proposed amendment to the Restated Certificate of Incorporation of the Corporation, declaring said amendment to be advisable and in the best interests of the Corporation and its stockholders in accordance with Section&#160;242 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;). The resolution setting forth the proposed amendment is as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">RESOLVED</font><font style="letter-spacing:0.2pt;">, the first paragraph of Article&#160;FOURTH shall be amended and restated to read in its entirety as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The total number of shares of all classes of stock which the Corporation shall have authority to issue is 105,000,000 shares, consisting of (i)&#160;100,000,000 shares of Common Stock, $0.001 par value per share (&#8220;Common Stock&#8221;), and (ii)&#160;5,000,000 shares of Preferred Stock, $0.001 par value per share (&#8220;Preferred Stock&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the filing and effectiveness (the &#8220;Effective Time&#8221;) of this Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware, every 20&#160;shares of Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without any action on the part of the Corporation or the respective holder thereof, be combined into one validly issued, fully paid and non-assessable share of Common Stock (the &#8220;Reverse Stock Split&#8221;). No fractional shares of Common Stock shall be issued as a result of the Reverse Stock Split and, in lieu thereof, the Corporation shall pay cash equal to such fraction multiplied by the fair market value per share of Common Stock immediately prior to the Effective Time, as determined by the Board of Directors of the Corporation. The Reverse Stock Split shall occur whether or not the certificates representing such shares of Common Stock are surrendered to the Corporation or its transfer agent.&#8221; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SECOND:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Certificate of Amendment to the Restated Certificate of Incorporation has been duly adopted in accordance with the provisions of Section&#160;242 of the DGCL. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THIRD:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;That except as amended hereby, the provisions of the Restated Certificate of Incorporation shall remain in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FOURTH:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Certificate of Amendment shall be effective as of </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;">, </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, I have signed this Certificate this </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;"> day of </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;">, </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="margin-left:220pt; margin-top:2.5pt; width:236pt;">
          <div style="margin-left: 0pt; width: 236pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:220pt; margin-top:2pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
          <br >
          <font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">G-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX H</font>&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;262 of the Delaware General Corporation Law </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#167;&#160;262. Appraisal rights </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a) Any stockholder of a corporation of this State who holds shares of stock on the date of the making of a demand pursuant to subsection (d)&#160;of this section with respect to such shares, who continuously holds such shares through the effective date of the merger, consolidation, or conversion, who has otherwise complied with subsection (d)&#160;of this section and who has neither voted in favor of the merger, consolidation or conversion nor consented thereto in writing pursuant to &#167;&#160;228 of this title shall be entitled to an appraisal by the Court of Chancery of the fair value of the stockholder&#8217;s shares of stock under the circumstances described in subsections (b)&#160;and (c)&#160;of this section. As used in this section, the word &#8220;stockholder&#8221; means a holder of record of stock in a corporation; the words &#8220;stock&#8221; and &#8220;share&#8221; mean and include what is ordinarily meant by those words; the words &#8220;depository receipt&#8221; mean a receipt or other instrument issued by a depository representing an interest in 1 or more shares, or fractions thereof, solely of stock of a corporation, which stock is deposited with the depository; the words &#8220;beneficial owner&#8221; mean a person who is the beneficial owner of shares of stock held either in voting trust or by a nominee on behalf of such person; and the word &#8220;person&#8221; means any individual, corporation, partnership, unincorporated association or other entity. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b) Appraisal rights shall be available for the shares of any class or series of stock of a constituent or converting corporation in a merger, consolidation or conversion to be effected pursuant to &#167;&#160;251 (other than a merger effected pursuant to &#167;&#160;251(g) of this title), &#167;&#160;252, &#167;&#160;254, &#167;&#160;255, &#167;&#160;256, &#167;&#160;257, &#167;&#160;258, &#167;&#160;263, &#167;&#160;264 or &#167;&#160;266 of this title (other than, in each case and solely with respect to a domesticated corporation, a merger, consolidation or conversion authorized pursuant to and in accordance with the provisions of &#167;&#160;388 of this title): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1) Provided, however, that no appraisal rights under this section shall be available for the shares of any class or series of stock, which stock, or depository receipts in respect thereof, at the record date fixed to determine the stockholders entitled to receive notice of the meeting of stockholders, or at the record date fixed to determine the stockholders entitled to consent pursuant to &#167;&#160;228 of this title, to act upon the agreement of merger or consolidation or the resolution providing for conversion (or, in the case of a merger pursuant to &#167;&#160;251(h) of this title, as of immediately prior to the execution of the agreement of merger), were either: (i)&#160;listed on a national securities exchange or (ii)&#160;held of record by more than 2,000 holders; and further provided that no appraisal rights shall be available for any shares of stock of the constituent corporation surviving a merger if the merger did not require for its approval the vote of the stockholders of the surviving corporation as provided in &#167;&#160;251(f) of this title. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2) Notwithstanding paragraph (b)(1) of this section, appraisal rights under this section shall be available for the shares of any class or series of stock of a constituent or converting corporation if the holders thereof are required by the terms of an agreement of merger or consolidation, or by the terms of a resolution providing for conversion, pursuant to &#167;&#8201;251, &#167;&#8201;252, &#167;&#8201;254, &#167;&#8201;255, &#167;&#8201;256, &#167;&#8201;257, &#167;&#8201;258, &#167;&#8201;263, &#167;&#8201;264 or &#167;&#8201;266 of this title to accept for such stock anything except: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a. Shares of stock of the corporation surviving or resulting from such merger or consolidation, or of the converted entity if such entity is a corporation as a result of the conversion, or depository receipts in respect thereof; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">b. Shares of stock of any other corporation, or depository receipts in respect thereof, which shares of stock (or depository receipts in respect thereof) or depository receipts at the effective date of the merger, consolidation or conversion will be either listed on a national securities exchange or held of record by more than 2,000 holders; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">c. Cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a. and b. of this section; or </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">d. Any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a., b. and c. of this section. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3) In the event all of the stock of a subsidiary Delaware corporation party to a merger effected under &#167;&#160;253 or &#167;&#160;267 of this title is not owned by the parent immediately prior to the merger, appraisal rights shall be available for the shares of the subsidiary Delaware corporation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(4) [Repealed.] </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c) Any corporation may provide in its certificate of incorporation that appraisal rights under this section shall be available for the shares of any class or series of its stock as a result of an amendment to its certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation, the sale of all or substantially all of the assets of the corporation or a conversion effected pursuant to &#167;&#160;266 of this title. If the certificate of incorporation contains such a provision, the provisions of this section, including those set forth in subsections (d), (e), and (g)&#160;of this section, shall apply as nearly as is practicable. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d) Appraisal rights shall be perfected as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1) If a proposed merger, consolidation or conversion for which appraisal rights are provided under this section is to be submitted for approval at a meeting of stockholders, the corporation, not less than 20&#160;days prior to the meeting, shall notify each of its stockholders who was such on the record date for notice of such meeting (or such members who received notice in accordance with &#167;&#160;255(c) of this title) with respect to shares for which appraisal rights are available pursuant to subsection (b)&#160;or (c)&#160;of this section that appraisal rights are available for any or all of the shares of the constituent corporations or the converting corporation, and shall include in such notice either a copy of this section (and, if 1 of the constituent corporations or the converting corporation is a nonstock corporation, a copy of &#167;&#160;114 of this title) or information directing the stockholders to a publicly available electronic resource at which this section (and, &#167;&#160;114 of this title, if applicable) may be accessed without subscription or cost. Each stockholder electing to demand the appraisal of such stockholder&#8217;s shares shall deliver to the corporation, before the taking of the vote on the merger, consolidation or conversion, a written demand for appraisal of such stockholder&#8217;s shares; provided that a demand may be delivered to the corporation by electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such stockholder&#8217;s shares. A proxy or vote against the merger, consolidation or conversion shall not constitute such a demand. A stockholder electing to take such action must do so by a separate written demand as herein provided. Within 10&#160;days after the effective date of such merger, consolidation or conversion, the surviving, resulting or converted entity shall notify each stockholder of each constituent or converting corporation who has complied with this subsection and has not voted in favor of or consented to the merger, consolidation or conversion, and any beneficial owner who has demanded appraisal under paragraph (d)(3) of this section, of the date that the merger, consolidation or conversion has become effective; or </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2) If the merger, consolidation or conversion was approved pursuant to &#167;&#160;228, &#167;&#160;251(h), &#167;&#160;253, or &#167;&#160;267 of this title, then either a constituent or converting corporation before the effective date of the merger, consolidation or conversion, or the surviving, resulting or converted entity within 10&#160;days after such effective date, shall notify each stockholder of any class or series of stock of such constituent or converting corporation who is entitled to appraisal rights of the approval of the merger, consolidation or conversion and that appraisal rights are available for any or all shares of such class or series of stock of such constituent or converting corporation, and shall include in such notice either a copy of this section (and, if 1 of the constituent corporations or the converting corporation is a nonstock corporation, a copy of &#167;&#160;114 of this title) or information directing the stockholders to a publicly available electronic resource at which this section (and &#167;&#160;114 of this title, if applicable) may be accessed without subscription or cost. Such notice may, and, if given on or after the effective date of the merger, consolidation or conversion, shall, also notify such stockholders of the effective date of the merger, consolidation or conversion. Any stockholder entitled to appraisal rights may, within 20&#160;days after the date of giving such notice or, in the case of a merger approved pursuant to &#167;&#160;251(h) of this title, within the later of the consummation of the offer contemplated by &#167;&#160;251(h) of this title and 20&#160;days after the date of giving such notice, demand in writing from the surviving or resulting entity the appraisal of such holder&#8217;s shares; provided that a demand may be delivered to such entity by electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">demand will be sufficient if it reasonably informs such entity of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such holder&#8217;s shares. If such notice did not notify stockholders of the effective date of the merger, consolidation or conversion, either (i)&#160;each such constituent corporation or the converting corporation shall send a second notice before the effective date of the merger, consolidation or conversion notifying each of the holders of any class or series of stock of such constituent or converting corporation that are entitled to appraisal rights of the effective date of the merger, consolidation or conversion or (ii)&#160;the surviving, resulting or converted entity shall send such a second notice to all such holders on or within 10&#160;days after such effective date; provided, however, that if such second notice is sent more than 20&#160;days following the sending of the first notice or, in the case of a merger approved pursuant to &#167;&#160;251(h) of this title, later than the later of the consummation of the offer contemplated by &#167;&#160;251(h) of this title and 20&#160;days following the sending of the first notice, such second notice need only be sent to each stockholder who is entitled to appraisal rights and who has demanded appraisal of such holder&#8217;s shares in accordance with this subsection and any beneficial owner who has demanded appraisal under paragraph (d)(3) of this section. An affidavit of the secretary or assistant secretary or of the transfer agent of the corporation or entity that is required to give either notice that such notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein. For purposes of determining the stockholders entitled to receive either notice, each constituent corporation or the converting corporation may fix, in advance, a record date that shall be not more than 10&#160;days prior to the date the notice is given, provided, that if the notice is given on or after the effective date of the merger, consolidation or conversion, the record date shall be such effective date. If no record date is fixed and the notice is given prior to the effective date, the record date shall be the close of business on the day next preceding the day on which the notice is given. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3) Notwithstanding subsection (a)&#160;of this section (but subject to this paragraph (d)(3)), a beneficial owner may, in such person&#8217;s name, demand in writing an appraisal of such beneficial owner&#8217;s shares in accordance with either paragraph (d)(1) or (2)&#160;of this section, as applicable; provided that (i)&#160;such beneficial owner continuously owns such shares through the effective date of the merger, consolidation or conversion and otherwise satisfies the requirements applicable to a stockholder under the first sentence of subsection (a)&#160;of this section and (ii)&#160;the demand made by such beneficial owner reasonably identifies the holder of record of the shares for which the demand is made, is accompanied by documentary evidence of such beneficial owner&#8217;s beneficial ownership of stock and a statement that such documentary evidence is a true and correct copy of what it purports to be, and provides an address at which such beneficial owner consents to receive notices given by the surviving, resulting or converted entity hereunder and to be set forth on the verified list required by subsection (f)&#160;of this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e) Within 120&#160;days after the effective date of the merger, consolidation or conversion, the surviving, resulting or converted entity, or any person who has complied with subsections (a)&#160;and (d)&#160;of this section hereof and who is otherwise entitled to appraisal rights, may commence an appraisal proceeding by filing a petition in the Court of Chancery demanding a determination of the value of the stock of all such stockholders. Notwithstanding the foregoing, at any time within 60&#160;days after the effective date of the merger, consolidation or conversion, any person entitled to appraisal rights who has not commenced an appraisal proceeding or joined that proceeding as a named party shall have the right to withdraw such person&#8217;s demand for appraisal and to accept the terms offered upon the merger, consolidation or conversion. Within 120&#160;days after the effective date of the merger, consolidation or conversion, any person who has complied with the requirements of subsections (a)&#160;and (d)&#160;of this section hereof, upon request given in writing (or by electronic transmission directed to an information processing system (if any) expressly designated for that purpose in the notice of appraisal), shall be entitled to receive from the surviving, resulting or converted entity a statement setting forth the aggregate number of shares not voted in favor of the merger, consolidation or conversion (or, in the case of a merger approved pursuant to &#167;&#160;251(h) of this title, the aggregate number of shares (other than any excluded stock (as defined in &#167;&#160;251(h)(6)d. of this title)) that were the subject of, and were not tendered into, and accepted for purchase or exchange in, the offer referred to in &#167;&#160;251(h)(2) of this title)), and, in either case, with respect to which demands for appraisal have been received and the aggregate number of stockholders or beneficial owners holding or owning such shares (provided that, where a beneficial owner makes a demand pursuant to paragraph (d)(3) of this section, the record holder of such shares shall not be considered a separate stockholder holding such shares for purposes of such aggregate number). Such statement shall be given to the person within 10&#160;days after such person&#8217;s request </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for such a statement is received by the surviving, resulting or converted entity or within 10&#160;days after expiration of the period for delivery of demands for appraisal under subsection (d)&#160;of this section hereof, whichever is later. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f) Upon the filing of any such petition by any person other than the surviving, resulting or converted entity, service of a copy thereof shall be made upon such entity, which shall within 20&#160;days after such service file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all persons who have demanded appraisal for their shares and with whom agreements as to the value of their shares have not been reached by such entity. If the petition shall be filed by the surviving, resulting or converted entity, the petition shall be accompanied by such a duly verified list. The Register in Chancery, if so ordered by the Court, shall give notice of the time and place fixed for the hearing of such petition by registered or certified mail to the surviving, resulting or converted entity and to the persons shown on the list at the addresses therein stated. The forms of the notices by mail and by publication shall be approved by the Court, and the costs thereof shall be borne by the surviving, resulting or converted entity. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g) At the hearing on such petition, the Court shall determine the persons who have complied with this section and who have become entitled to appraisal rights. The Court may require the persons who have demanded an appraisal for their shares and who hold stock represented by certificates to submit their certificates of stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any person fails to comply with such direction, the Court may dismiss the proceedings as to such person. If immediately before the merger, consolidation or conversion the shares of the class or series of stock of the constituent or converting corporation as to which appraisal rights are available were listed on a national securities exchange, the Court shall dismiss the proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1)&#160;the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal, (2)&#160;the value of the consideration provided in the merger, consolidation or conversion for such total number of shares exceeds $1&#160;million, or (3)&#160;the merger was approved pursuant to &#167;&#160;253 or &#167;&#160;267 of this title. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h) After the Court determines the persons entitled to an appraisal, the appraisal proceeding shall be conducted in accordance with the rules of the Court of Chancery, including any rules specifically governing appraisal proceedings. Through such proceeding the Court shall determine the fair value of the shares exclusive of any element of value arising from the accomplishment or expectation of the merger, consolidation or conversion, together with interest, if any, to be paid upon the amount determined to be the fair value. In determining such fair value, the Court shall take into account all relevant factors. Unless the Court in its discretion determines otherwise for good cause shown, and except as provided in this subsection, interest from the effective date of the merger, consolidation or conversion through the date of payment of the judgment shall be compounded quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the effective date of the merger, consolidation or conversion and the date of payment of the judgment. At any time before the entry of judgment in the proceedings, the surviving, resulting or converted entity may pay to each person entitled to appraisal an amount in cash, in which case interest shall accrue thereafter as provided herein only upon the sum of (1)&#160;the difference, if any, between the amount so paid and the fair value of the shares as determined by the Court, and (2)&#160;interest theretofore accrued, unless paid at that time. Upon application by the surviving, resulting or converted entity or by any person entitled to participate in the appraisal proceeding, the Court may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the persons entitled to an appraisal. Any person whose name appears on the list filed by the surviving, resulting or converted entity pursuant to subsection (f)&#160;of this section may participate fully in all proceedings until it is finally determined that such person is not entitled to appraisal rights under this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i) The Court shall direct the payment of the fair value of the shares, together with interest, if any, by the surviving, resulting or converted entity to the persons entitled thereto. Payment shall be so made to each such person upon such terms and conditions as the Court may order. The Court&#8217;s decree may be enforced as other decrees in the Court of Chancery may be enforced, whether such surviving, resulting or converted entity be an entity of this State or of any state. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j) The costs of the proceeding may be determined by the Court and taxed upon the parties as the Court deems equitable in the circumstances. Upon application of a person whose name appears on the list filed by </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:264pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the surviving, resulting or converted entity pursuant to subsection (f)&#160;of this section who participated in the proceeding and incurred expenses in connection therewith, the Court may order all or a portion of such expenses, including, without limitation, reasonable attorney&#8217;s fees and the fees and expenses of experts, to be charged pro&#160;rata against the value of all the shares entitled to an appraisal not dismissed pursuant to subsection (k)&#160;of this section or subject to such an award pursuant to a reservation of jurisdiction under subsection (k)&#160;of this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(k) From and after the effective date of the merger, consolidation or conversion, no person who has demanded appraisal rights with respect to some or all of such person&#8217;s shares as provided in subsection (d)&#160;of this section shall be entitled to vote such shares for any purpose or to receive payment of dividends or other distributions on such shares (except dividends or other distributions payable to stockholders of record at a date which is prior to the effective date of the merger, consolidation or conversion); provided, however, that if no petition for an appraisal is filed within the time provided in subsection (e)&#160;of this section, or if a person who has made a demand for an appraisal in accordance with this section shall deliver to the surviving, resulting or converted entity a written withdrawal of such person&#8217;s demand for an appraisal in respect of some or all of such person&#8217;s shares in accordance with subsection (e)&#160;of this section, then the right of such person to an appraisal of the shares subject to the withdrawal shall cease. Notwithstanding the foregoing, no appraisal proceeding in the Court of Chancery shall be dismissed as to any person without the approval of the Court, and such approval may be conditioned upon such terms as the Court deems just, including without limitation, a reservation of jurisdiction for any application to the Court made under subsection (j)&#160;of this section; provided, however that this provision shall not affect the right of any person who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such person&#8217;s demand for appraisal and to accept the terms offered upon the merger, consolidation or conversion within 60&#160;days after the effective date of the merger, consolidation or conversion, as set forth in subsection (e)&#160;of this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(l) The shares or other equity interests of the surviving, resulting or converted entity to which the shares of stock subject to appraisal under this section would have otherwise converted but for an appraisal demand made in accordance with this section shall have the status of authorized but not outstanding shares of stock or other equity interests of the surviving, resulting or converted entity, unless and until the person that has demanded appraisal is no longer entitled to appraisal pursuant to this section.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAnnexI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX I</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">AMENDED AND RESTATED 2014 STOCK INCENTIVE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Purpose</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The purpose of this Amended and Restated 2014 Stock Incentive Plan (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan</font><font style="letter-spacing:0.2pt;">&#8221;) of Sesen Bio, Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), is to advance the interests of the Company&#8217;s stockholders by enhancing the Company&#8217;s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests of such persons with those of the Company&#8217;s stockholders. The Plan amends and restates the 2014 Stock Incentive Plan (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Original Plan</font><font style="letter-spacing:0.2pt;">&#8221;) that was originally adopted by the board of directors of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board</font><font style="letter-spacing:0.2pt;">&#8221;) in December&#160;2013 and approved by the Company&#8217;s stockholders in January&#160;2014, was amended by the Board on April&#160;19, 2019 and approved by the Company&#8217;s stockholders on June&#160;19, 2019 and was amended by the Board on March&#160;12, 2021 and approved by the Company&#8217;s stockholders on May&#160;3, 2021. Except where the context otherwise requires, the term &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; shall include any of the Company&#8217;s present or future parent or subsidiary corporations as defined in Sections&#160;424(e) or (f)&#160;of the Internal Revenue Code of 1986, as amended, and any regulations thereunder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Code</font><font style="letter-spacing:0.2pt;">&#8221;) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as determined by the Board. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Eligibility</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All of the Company&#8217;s employees, officers and directors, as well as consultants and advisors to the Company (as such terms consultants and advisors are defined and interpreted for purposes of Form S-8 under the Securities Act of 1933, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;">&#8221;) (or any successor form)) are eligible to be granted Awards under the Plan. Each person who is granted an Award under the Plan is deemed a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Participant</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;">&#8221; &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Award</font><font style="letter-spacing:0.2pt;">&#8221; means Options (as defined in Section&#160;5), SARs (as defined in Section&#160;6), Restricted Stock (as defined in Section&#160;7), Restricted Stock Units (as defined in Section&#160;7) and Other Stock-Based Awards (as defined in Section&#160;8). </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Administration and Delegation</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Administration by Board of Directors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable. The Board may construe and interpret the terms of the Plan and any Award agreements entered into under the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient and it shall be the sole and final judge of such expediency. All decisions by the Board shall be made in the Board&#8217;s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Appointment of Committees</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Committee</font><font style="letter-spacing:0.2pt;">&#8221;). All references in the Plan to the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the Board or a Committee of the Board or the Delegated Persons referred to in Section&#160;3(c) to the extent that the Board&#8217;s powers or authority under the Plan have been delegated to such Committee or such Delegated Persons. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delegation to Delegated Persons</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to any requirements of applicable law (including as applicable Sections&#160;152(b) and 157(c) of the General Corporation Law of the State of Delaware), the Board may, by resolution, delegate to one or more persons (including officers of the Company) or bodies (such persons or bodies, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Delegated Persons</font><font style="letter-spacing:0.2pt;">&#8221;) the power to grant Awards (subject to any limitations under the Plan) to eligible service providers of the Company and to exercise such other powers under the Plan as the Board may determine, provided that the Board shall fix: (i)&#160;the maximum number of Awards, and the maximum number of shares issuable upon exercise thereof, that may be issued by such Delegated Persons, (ii)&#160;the time period during which such Awards, and during which the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">shares issuable upon exercise thereof, may be issued, and (iii)&#160;the minimum amount of consideration (if any) for which such Awards may be issued, and a minimum amount of consideration for the shares issuable upon exercise thereof; and provided further, that no Delegated Person shall be authorized to grant Awards to itself; and provided further, that no Delegated Person shall be authorized to grant Awards to any &#8220;executive officer&#8221; of the Company (as defined by Rule&#160;3b-7 under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221;)) or to any &#8220;officer&#8221; of the Company (as defined by Rule&#160;16a-1(f) under the Exchange Act). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Available for Awards</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Number of Shares; Share Counting</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Authorized Number of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to adjustment under Section&#160;9, Awards may be made under the Plan for up to such number of shares of common stock, $0.001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;) as is equal to the sum of: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;an aggregate number of shares of Common Stock equal to 12.79% of the fully-diluted capitalization of the Company as of immediately following the closing of the transactions contemplated by the Agreement and Plan of Merger and Reorganization between the Company, Seahawk Merger Sub Inc. and Carisma Therapeutics Inc. (as it may be amended from time to time, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) minus the number of shares of Common Stock that remain available for the grant of Awards as of the closing of the transactions contemplated by the Merger Agreement; plus </font>
        </div>
        <div style="margin-left:80pt; margin-top:8pt; width:376pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;25,313,283 shares of Common Stock; plus</font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;such additional number of shares of Common Stock as is equal to the sum of (x)&#160;the number of shares of Common Stock reserved for issuance under the Company&#8217;s 2009 Stock Incentive Plan (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Prior Plan</font><font style="letter-spacing:0.2pt;">&#8221;) that remained available for grant under the Prior Plan immediately prior to the closing of the Company&#8217;s initial public offering and (y)&#160;the number of shares of Common Stock (I)&#160;that were subject to awards granted under the Prior Plan and (II)&#160;that are subject to stock options assumed by the Company pursuant to the Merger Agreement, as of the closing of the transactions contemplated by the Merger Agreement (the awards described in the foregoing clauses (I)&#160;and (II)&#160;together, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Outstanding Awards</font><font style="letter-spacing:0.2pt;">&#8221;) in each case which Outstanding Awards expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased by the Company at their original issuance price pursuant to a contractual repurchase right (subject, however, in the case of Incentive Stock Options to any limitations of the Code). </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to adjustment under Section&#160;9, up to 252,000,000 of the shares of Common Stock available for issuance under the Plan may be issued as Incentive Stock Options (as defined in Section&#160;5(b)) under the Plan. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Share Counting</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;For purposes of counting the number of shares available for the grant of Awards under the Plan: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;all shares of Common Stock covered by SARs shall be counted against the number of shares available for the grant of Awards under the Plan; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;SARs that may be settled only in cash shall not be so counted and (ii)&#160;if the Company grants an SAR in tandem with an Option for the same number of shares of Common Stock and provides that only one such Award may be exercised (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tandem SAR</font><font style="letter-spacing:0.2pt;">&#8221;), only the shares covered by the Option, and not the shares covered by the Tandem SAR, shall be so counted, and the expiration of one in connection with the other&#8217;s exercise will not restore shares to the Plan; </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;if any Award (i)&#160;expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right) or (ii)&#160;results in any Common Stock </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">not being issued (including as a result of an SAR that was settleable either in cash or in stock actually being settled in cash), the unused Common Stock covered by such Award shall again be available for the grant of Awards; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that (1)&#160;in the case of Incentive Stock Options, the foregoing shall be subject to any limitations under the Code, (2)&#160;in the case of the exercise of an SAR, the number of shares counted against the shares available under the Plan shall be the full number of shares subject to the SAR multiplied by the&#160;percentage of the SAR actually exercised, regardless of the number of shares actually used to settle such SAR upon exercise and (3)&#160;the shares covered by a Tandem SAR shall not again become available for grant upon the expiration or termination of such Tandem SAR; and </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;shares of Common Stock delivered (either by actual delivery, attestation, or net exercise) to the Company by a Participant to (i)&#160;purchase shares of Common Stock upon the exercise of an Award or (ii)&#160;satisfy tax withholding obligations (including shares retained from the Award creating the tax obligation) shall not be added back to the number of shares available for the future grant of Awards. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Substitute Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof. Substitute Awards may be granted on such terms as the Board deems appropriate in the circumstances, notwithstanding any limitations on Awards contained in the Plan. Substitute Awards shall not count against the overall share limit set forth in Section&#160;4(a), except as may be required by reason of Section&#160;422 and related provisions of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Options</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may grant options to purchase Common Stock (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Option</font><font style="letter-spacing:0.2pt;">&#8221;) and determine the number of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Incentive Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;An Option that the Board intends to be an &#8220;incentive stock option&#8221; as defined in Section&#160;422 of the Code (an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Incentive Stock Option</font><font style="letter-spacing:0.2pt;">&#8221;) shall only be granted to employees of Sesen Bio, Inc., any of Sesen Bio, Inc.&#8217;s present or future parent or subsidiary corporations as defined in Sections&#160;424(e) or (f)&#160;of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently with the requirements of Section&#160;422 of the Code. An Option that is not intended to be an Incentive Stock Option shall be designated a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nonstatutory Stock Option.</font><font style="letter-spacing:0.2pt;">&#8221; The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or if the Company converts an Incentive Stock Option to a Nonstatutory Stock Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exercise Price</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall establish the exercise price of each Option and specify the exercise price in the applicable Option agreement. The exercise price shall be not less than 100% of the fair market value per share of Common Stock, as determined by (or in a manner approved by) the Board (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Fair Market Value</font><font style="letter-spacing:0.2pt;">&#8221;), on the date the Option is granted; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that if the Board approves the grant of an Option with an exercise price to be determined on a future date, the exercise price shall be not less than 100% of the Fair Market Value on such future date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Duration of Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Option shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable option agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that no Option will be granted with a term in excess of 10&#160;years. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exercise of Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Options may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic) approved by the Company, together with payment in full (in a manner specified in Section&#160;5(f)) of the exercise price for the number of shares for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company as soon as practicable following exercise. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment Upon Exercise</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as follows: </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;in cash or by check, payable to the order of the Company; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;except as may otherwise be provided in the applicable Option agreement or approved by the Board, in its sole discretion, by (i)&#160;delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii)&#160;delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;to the extent provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by delivery (either by actual delivery or attestation) of shares of Common Stock owned by the Participant valued at their Fair Market Value, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> (i)&#160;such method of payment is then permitted under applicable law, (ii)&#160;such Common Stock, if acquired directly from the Company, was owned by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii)&#160;such Common Stock is not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(4)&nbsp;&nbsp;&nbsp;to the extent provided for in the applicable Nonstatutory Stock Option agreement or approved by the Board in its sole discretion, by delivery of a notice of &#8220;net exercise&#8221; to the Company, as a result of which the Participant would receive (i)&#160;the number of shares underlying the portion of the Option being exercised, less (ii)&#160;such number of shares as is equal to (A)&#160;the aggregate exercise price for the portion of the Option being exercised divided by (B)&#160;the Fair Market Value on the date of exercise; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(5)&nbsp;&nbsp;&nbsp;to the extent permitted by applicable law and provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by payment of such other lawful consideration as the Board may determine; or </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(6)&nbsp;&nbsp;&nbsp;by any combination of the above permitted forms of payment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Limitation on Repricing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless such action is approved by the Company&#8217;s stockholders, the Company may not (except as provided for under Section&#160;9): (1)&#160;amend any outstanding Option granted under the Plan to provide an exercise price per share that is lower than the then-current exercise price per share of such outstanding Option, (2)&#160;cancel any outstanding option (whether or not granted under the Plan) and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section&#160;4(b)) covering the same or a different number of shares of Common Stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled option, (3)&#160;cancel in exchange for a cash payment any outstanding Option with an exercise price per share above the then-current Fair Market Value, or (4)&#160;take any other action under the Plan that constitutes a &#8220;repricing&#8221; within the meaning of the rules of the Nasdaq Stock Market (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may grant Awards consisting of stock appreciation rights (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">SARs</font><font style="letter-spacing:0.2pt;">&#8221;) entitling the holder, upon exercise, to receive an amount of Common Stock or cash or a combination thereof (such form to be determined by the Board) determined by reference to appreciation, from and after the date of grant, in the Fair Market Value of a share of Common Stock over the measurement price established pursuant to Section&#160;6(b). The date as of which such appreciation is determined shall be the exercise date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Measurement Price</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall establish the measurement price of each SAR and specify it in the applicable SAR agreement. The measurement price shall not be less than 100% of the Fair Market Value on the date the SAR is granted; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that if the Board approves the grant of an SAR effective as of a future date, the measurement price shall be not less than 100% of the Fair Market Value on such future date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Duration of SARs</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each SAR shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable SAR agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that no SAR will be granted with a term in excess of 10&#160;years. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exercise of SARs</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;SARs may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic) approved by the Company, together with any other documents required by the Board. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Limitation on Repricing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless such action is approved by the Company&#8217;s stockholders, the Company may not (except as provided for under Section&#160;9): (1)&#160;amend any outstanding SAR granted under the Plan to provide a measurement price per share that is lower than the then-current measurement price per share of such outstanding SAR, (2)&#160;cancel any outstanding SAR (whether or not granted under the Plan) and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section&#160;4(b)) covering the same or a different number of shares of Common Stock and having an exercise or measurement price per share lower than the then-current measurement price per share of the cancelled SAR, (3)&#160;cancel in exchange for a cash payment any outstanding SAR with a measurement price per share above the then-current Fair Market Value, or (4)&#160;take any other action under the Plan that constitutes a &#8220;repricing&#8221; within the meaning of the rules of Nasdaq. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Restricted Stock; Restricted Stock Units</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may grant Awards entitling recipients to acquire shares of Common Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock</font><font style="letter-spacing:0.2pt;">&#8221;), subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. The Board may also grant Awards entitling the recipient to receive shares of Common Stock or cash to be delivered at the time such Award vests (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Units</font><font style="letter-spacing:0.2pt;">&#8221;) (Restricted Stock and Restricted Stock Units are each referred to herein as a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Award</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Terms and Conditions for All Restricted Stock Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall determine the terms and conditions of a Restricted Stock Award, including the conditions for vesting and repurchase (or forfeiture) and the issue price, if any. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Additional Provisions Relating to Restricted Stock</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless otherwise provided in the applicable Award agreement, any dividends (whether paid in cash, stock or property) declared and paid by the Company with respect to shares of Restricted Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Accrued Dividends</font><font style="letter-spacing:0.2pt;">&#8221;) shall be paid to the Participant only if and when such shares become free from the restrictions on transferability and forfeitability that apply to such shares. Each payment of Accrued Dividends will be made no later than the end of the calendar year in which the dividends are paid to stockholders of that class of stock or, if later, the 15th day of the third month following the lapsing of the restrictions on transferability and the forfeitability provisions applicable to the underlying shares of Restricted Stock. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Certificates</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company may require that any stock certificates issued in respect of shares of Restricted Stock, as well as dividends or distributions paid on such Restricted Stock, shall be deposited in escrow by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to his or her Designated Beneficiary. &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Designated Beneficiary</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant&#8217;s death or (ii)&#160;in the absence of an effective designation by a Participant, the Participant&#8217;s estate. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Additional Provisions Relating to Restricted Stock Units</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Settlement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the vesting of and/or lapsing of any other restrictions (i.e., settlement) with respect to each Restricted Stock Unit, the Participant shall be entitled to receive from the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Company such number of shares of Common Stock or (if so provided in the applicable Award agreement) an amount of cash equal to the Fair Market Value of such number of shares of Common Stock as set forth in the applicable Award agreement. The Board may, in its discretion, provide that settlement of Restricted Stock Units shall be deferred, on a mandatory basis or at the election of the Participant in a manner that complies with Section&#160;409A of the Code. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A Participant shall have no voting rights with respect to any Restricted Stock Units. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Dividend Equivalents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Award agreement for Restricted Stock Units may provide Participants with the right to receive an amount equal to any dividends or other distributions declared and paid on an equal number of outstanding shares of Common Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dividend Equivalents</font><font style="letter-spacing:0.2pt;">&#8221;). Dividend Equivalents may be paid currently or credited to an account for the Participants, may be settled in cash and/or shares of Common Stock and may be subject to the same restrictions on transfer and forfeitability as the Restricted Stock Units with respect to which paid, in each case to the extent provided in the applicable Award agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other Stock-Based Awards</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise based on, shares of Common Stock or other property, may be granted hereunder to Participants (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Stock-Based-Awards</font><font style="letter-spacing:0.2pt;">&#8221;). Such Other Stock-Based Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock-Based Awards may be paid in shares of Common Stock or cash, as the Board shall determine. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Terms and Conditions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the provisions of the Plan, the Board shall determine the terms and conditions of each Other Stock-Based Award, including any purchase price applicable thereto. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adjustments for Changes in Common Stock and Certain Other Events</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Changes in Capitalization</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an ordinary cash dividend, (i)&#160;the number and class of securities available under the Plan and the number and class of securities available for issuance as Incentive Stock Options under the Plan, (ii)&#160;the share counting rules set forth in Section&#160;4(a), (iii)&#160;the number and class of securities and exercise price per share of each outstanding Option, (iv)&#160;the share and per-share provisions and the measurement price of each outstanding SAR, (v)&#160;the number of shares subject to and the repurchase price per share subject to each outstanding Restricted Stock Award and (vi)&#160;the share and per-share-related provisions and the purchase price, if any, of each outstanding Other Stock-Based Award, shall be equitably adjusted by the Company (or substituted Awards may be made, if applicable) in the manner determined by the Board. Without limiting the generality of the foregoing, in the event the Company effects a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to an outstanding Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reorganization Events</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definition</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Reorganization Event</font><font style="letter-spacing:0.2pt;">&#8221; shall mean: (a)&#160;any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b)&#160;any transfer or disposition of all of the Common Stock of the Company for cash, securities or other property pursuant to a share exchange or other transaction or (c)&#160;any liquidation or dissolution of the Company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Consequences of a Reorganization Event on Awards Other than Restricted Stock</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;In connection with a Reorganization Event, the Board may take any one or more of the following actions as to all or any (or any portion of) outstanding Awards other than Restricted Stock on such terms as the Board determines (except to the extent specifically provided otherwise in an applicable Award agreement or another agreement between the Company and the Participant): (i)&#160;provide that such Awards shall be assumed, or substantially equivalent Awards shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii)&#160;upon written notice to a Participant, provide that all of the Participant&#8217;s unvested and/or unexercised Awards will terminate immediately prior to the consummation of such Reorganization Event unless exercised by the Participant (to the extent then exercisable) within a specified period following the date of such notice, (iii)&#160;provide that outstanding Awards shall become exercisable, realizable, or deliverable, or restrictions applicable to an Award shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv)&#160;in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Price</font><font style="letter-spacing:0.2pt;">&#8221;), make or provide for a cash payment to Participants with respect to each Award held by a Participant equal to (A)&#160;the number of shares of Common Stock subject to the vested portion of the Award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such Reorganization Event) multiplied by (B)&#160;the excess, if any, of (I)&#160;the Acquisition Price over (II)&#160;the exercise, measurement or purchase price of such Award and any applicable tax withholdings, in exchange for the termination of such Award, (v)&#160;provide that, in connection with a liquidation or dissolution of the Company, Awards shall convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings) and (vi)&#160;any combination of the foregoing. In taking any of the actions permitted under this Section&#160;9(b)(2), the Board shall not be obligated by the Plan to treat all Awards, all Awards held by a Participant, or all Awards of the same type, identically. </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Notwithstanding the terms of Section&#160;9(b)(2)(i), in the case of outstanding Restricted Stock Units that are subject to Section&#160;409A of the Code: (i)&#160;if the applicable Restricted Stock Unit agreement provides that the Restricted Stock Units shall be settled upon a &#8220;change in control event&#8221; within the meaning of Treasury Regulation&#160;Section&#160;1.409A-3(i)(5)(i), and the Reorganization Event constitutes such a &#8220;change in control event&#8221;, then no assumption or substitution shall be permitted pursuant to Section&#160;9(b)(2)(i)(i) and the Restricted Stock Units shall instead be settled in accordance with the terms of the applicable Restricted Stock Unit agreement; and (ii)&#160;the Board may only undertake the actions set forth in clauses (iii), (iv)&#160;or (v)&#160;of Section&#160;9(b)(2)(i) if the Reorganization Event constitutes a &#8220;change in control event&#8221; as defined under Treasury Regulation&#160;Section&#160;1.409A-3(i)(5)(i) and such action is permitted or required by Section&#160;409A of the Code; if the Reorganization Event is not a &#8220;change in control event&#8221; as so defined or such action is not permitted or required by Section&#160;409A of the Code, and the acquiring or succeeding corporation does not assume or substitute the Restricted Stock Units pursuant to clause (i)&#160;of Section&#160;9(b)(2)(i), then the unvested Restricted Stock Units shall terminate immediately prior to the consummation of the Reorganization Event without any payment in exchange therefor. </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;For purposes of Section&#160;9(b)(2)(i)(i), an Award (other than Restricted Stock) shall be considered assumed if, following consummation of the Reorganization Event, such Award confers the right to purchase or receive pursuant to the terms of such Award, for each share of Common Stock subject to the Award immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise or settlement of the Award to consist solely of such number of shares of common stock of the acquiring or succeeding corporation (or an affiliate thereof) that the Board determined to be equivalent in value (as of the date of such determination or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Consequences of a Reorganization Event on Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the occurrence of a Reorganization Event other than a liquidation or dissolution of the Company, the repurchase and other rights of the Company with respect to outstanding Restricted Stock shall inure to the benefit of the Company&#8217;s successor and shall, unless the Board determines otherwise, apply to the cash, securities or other property which the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to such Restricted Stock; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Board may provide for termination or deemed satisfaction of such repurchase or other rights under the instrument evidencing any Restricted Stock or any other agreement between a Participant and the Company, either initially or by amendment. Upon the occurrence of a Reorganization Event involving the liquidation or dissolution of the Company, except to the extent specifically provided to the contrary in the instrument evidencing any Restricted Stock or any other agreement between a Participant and the Company, all restrictions and conditions on all Restricted Stock then outstanding shall automatically be deemed terminated or satisfied. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General Provisions Applicable to Awards</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transferability of Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an Incentive Stock Option, pursuant to a qualified domestic relations order, and, during the life of the Participant, shall be exercisable only by the Participant; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Board may permit or provide in an Award for the gratuitous transfer of the Award by the Participant to or for the benefit of any immediate family member, family trust or other entity established for the benefit of the Participant and/or an immediate family member thereof if the Company would be eligible to use a Form S-8 under the Securities Act for the registration of the sale of the Common Stock subject to such Award to such proposed transferee; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided further</font><font style="letter-spacing:0.2pt;">, that the Company shall not be required to recognize any such permitted transfer until such time as such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument in form and substance satisfactory to the Company confirming that such transferee shall be bound by all of the terms and conditions of the Award. References to a Participant, to the extent relevant in the context, shall include references to authorized transferees. For the avoidance of doubt, nothing contained in this Section&#160;10(a) shall be deemed to restrict a transfer to the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Documentation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in the Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Board Discretion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination of Status</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall determine the effect on an Award of the disability, death, termination or other cessation of employment, authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, or the Participant&#8217;s legal representative, conservator, guardian or Designated Beneficiary, may exercise rights under the Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Withholding</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Participant must satisfy all applicable federal, state, and local or other income and employment tax withholding obligations before the Company will deliver stock certificates or otherwise recognize ownership of Common Stock under an Award. The Company may decide to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">satisfy the withholding obligations through additional withholding on salary or wages. If the Company elects not to or cannot withhold from other compensation, the Participant must pay the Company the full amount, if any, required for withholding or have a broker tender to the Company cash equal to the withholding obligations. Payment of withholding obligations is due before the Company will issue any shares on exercise, vesting or release from forfeiture of an Award or at the same time as payment of the exercise or purchase price unless the Company determines otherwise. If provided for in an Award or approved by the Board in its sole discretion, a Participant may satisfy such tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, except as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company&#8217;s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income), except that, to the extent that the Company is able to retain shares of Common Stock having a fair market value (determined or approved by the Company) that exceeds the statutory minimum applicable withholding tax without financial accounting implications or the Company is withholding in a jurisdiction that does not have a statutory minimum withholding tax, the Company may retain such number of shares of Common Stock (up to the number of shares having a fair market value equal to the maximum individual statutory rate of tax (determined or approved by, the Company)) as the Company shall determine to be necessary to satisfy the tax liability associated with any Award. Shares used to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendment of Award</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as otherwise provided in Sections&#160;5(g) and 6(e) with respect to repricings and Section&#160;11(d) with respect to actions requiring stockholder approval, the Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option. The Participant&#8217;s consent to such action shall be required unless (i)&#160;the Board determines that the action, taking into account any related action, does not materially and adversely affect the Participant&#8217;s rights under the Plan or (ii)&#160;the change is permitted under Section&#160;9. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conditions on Delivery of Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan or to remove restrictions from shares previously issued or delivered under the Plan until (i)&#160;all conditions of the Award have been met or removed to the satisfaction of the Company, (ii)&#160;in the opinion of the Company&#8217;s counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and regulations and any applicable stock exchange or stock market rules and regulations, and (iii)&#160;the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acceleration</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may at any time provide that any Award shall become immediately exercisable in whole or in part, free of some or all restrictions or conditions, or otherwise realizable in whole or in part, as the case may be. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Miscellaneous</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Right To Employment or Other Status</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No person shall have any claim or right to be granted an Award by virtue of the adoption of the Plan, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Rights As Stockholder; Clawback</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp; Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of such shares. In accepting an Award made under the Plan on and after the Closing Date (as defined in Section&#160;11(c)), the Participant agrees to be bound by any clawback policy that the Company has in effect or may adopt in the future. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Effective Date and Term of Plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Original Plan became effective immediately prior to the closing of the Company&#8217;s initial public stock offering of its Common Stock on a U.S.-based stock exchange whereby the Company&#8217;s shares of Common Stock are offered for sale to the public. The Plan shall become effective on the closing of the transactions contemplated by the Merger Agreement (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Closing Date</font><font style="letter-spacing:0.2pt;">&#8221;). No Awards shall be granted under the Plan after the expiration of 10&#160;years from the Closing Date, but Awards previously granted may extend beyond that date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendment of Plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may amend, suspend or terminate the Plan or any portion thereof at any time provided that (i)&#160;to the extent required by Section&#160;162(m) of the Code, no Award granted to a Participant that is intended to comply with Section&#160;162(m) of the Code after the date of such amendment shall become exercisable, realizable or vested, as applicable to such Award, unless and until the Company&#8217;s stockholders approve such amendment in the manner required by Section&#160;162(m) of the Code; and (ii)&#160;no amendment that would require stockholder approval under the rules of the Nasdaq Stock Market may be made effective unless and until the Company&#8217;s stockholders approve such amendment. In addition, if at any time the approval of the Company&#8217;s stockholders is required as to any other modification or amendment under Section&#160;422 of the Code or any successor provision with respect to Incentive Stock Options, the Board may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Plan adopted in accordance with this Section&#160;11(d) shall apply to, and be binding on the holders of, all Awards outstanding under the Plan at the time the amendment is adopted, provided the Board determines that such amendment, taking into account any related action, does not materially and adversely affect the rights of Participants under the Plan. No Award shall be made that is conditioned upon stockholder approval of any amendment to the Plan unless the Award provides that (i)&#160;it will terminate or be forfeited if stockholder approval of such amendment is not obtained within no more than 12&#160;months from the date of grant and (2)&#160;it may not be exercised or settled (or otherwise result in the issuance of Common Stock) prior to such stockholder approval. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Authorization of Sub-Plans (including Grants to non-U.S. Employees)</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable securities, tax or other laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan containing (i)&#160;such limitations on the Board&#8217;s discretion under the Plan as the Board deems necessary or desirable or (ii)&#160;such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Participants in any jurisdiction which is not the subject of such supplement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-size:9.8pt;">
          <font style="font-size:10pt;letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-size:10pt;letter-spacing:0.2pt;">Compliance with Section&#160;409A of the Code</font><font style="font-size:10pt;letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;</font><font style="font-size:10pt;letter-spacing:0.196pt;">Except as provided in individual Award agreements initially or by amendment, if and to the extent (i)&#160;any portion of any payment, compensation or other benefit provided to a Participant pursuant to the Plan in connection with his or her employment termination constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code and (ii)&#160;the Participant is a specified employee as defined in Section&#160;409A(a)(2)(B)(i) of the Code, in each case as determined by the Company in accordance with its procedures, by which determinations the Participant (through accepting the Award) agrees that he or she is bound, such portion of the payment, compensation or other benefit shall not be paid before the day that is six&#160;months plus one day after the date of &#8220;separation from service&#8221; &#8203;(as determined under Section&#160;409A of the Code) (the &#8220;</font><font style="font-style:italic;font-weight:bold;font-size:10pt;letter-spacing:-0.196pt;">New Payment Date</font><font style="font-size:10pt;letter-spacing:0.196pt;">&#8221;), except as Section&#160;409A of the Code may then permit. The aggregate of any payments that otherwise would have been paid to the Participant during the period between the date of separation from service and the New Payment Date shall be paid to the Participant in a lump sum on such New Payment Date, and any remaining payments will be paid on their original schedule.</font><font style="font-size:10pt;">&#8203;<font style="letter-spacing:0.2pt;"> </font></font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company makes no representations or warranty and shall have no liability to the Participant or any other person if any provisions of or payments, compensation or other benefits under the Plan are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:408pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">determined to constitute nonqualified deferred compensation subject to Section&#160;409A of the Code but do not to satisfy the conditions of that section. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Limitations on Liability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, employee, or agent of the Company will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in connection with the Plan, nor will such individual be personally liable with respect to the Plan because of any contract or other instrument he or she executes in his or her capacity as a director, officer, employee, or agent of the Company. The Company will indemnify and hold harmless each director, officer, employee, or agent of the Company to whom any duty or power relating to the administration or interpretation of the Plan has been or will be delegated, against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of a claim with the Board&#8217;s approval) arising out of any act or omission to act concerning the Plan unless arising out of such person&#8217;s own fraud or bad faith. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than the State of Delaware.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAnnexJ">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:180pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX J</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AMENDMENT NO. 2</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TO</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 EMPLOYEE STOCK PURCHASE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio, Inc. 2014 Employee Stock Purchase Plan, as amended (the &#8220;Plan&#8221;), is hereby amended as follows: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;The second sentence of the first paragraph of the Plan shall be deleted in its entirety and replaced with the following: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Subject to adjustment under Section&#160;15 hereof, the number of shares of Common Stock that have been approved for this purpose is 6,568,655 shares of Common Stock.&#8221; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;The following sentence shall be added to the end of Section&#160;26 of the Plan: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;The first amendment to the Plan took effect on May&#160;3, 2021. The second amendment to the Plan shall take effect as of the effective time of the merger contemplated by the Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022, by and between the Company, Seahawk Merger Sub Inc. and Carisma Therapeutics Inc., subject to approval by the shareholders of the Company as required by Section&#160;423 of the Code, which approval must occur within twelve&#160;months of the second amendment of the Plan by the Board.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as set forth above, the remainder of the Plan remains in full force and effect. For the avoidance of doubt and for purposes of the Plan, the &#8220;Board&#8221; shall mean the Board of Directors of the Company. </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Adopted by the Board of Directors on </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;] </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Approved by the Stockholders on </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;]</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">J-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_sesenbio-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_sesenbio-4c.jpg
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M# P,# P,#/_  !$( 6T": ,!$0 "$0$#$0'_Q #(  $  @(# 0$!
M    " D'"@0%!@(# 0$!  (# 0$               $"! 4& P<0  $# P(#
M! 4%"PD$!P8'  $  @,$!081!R$2"#%!$PE182(R%'&!%5<9D4)28I(C,[34
M=CBAP7(DM=46IG>B0W,WL=&"LE,E->%C9)56%],T1&6&MA@1 0 ! @,$!P<#
M! (!!0$    ! @,1! 4A,=$205%A<9&AL8'A(C)2$Q7PP3-"<A0&\6(CDJ*R
M4S06_]H # ,!  (1 Q$ /P"_Q 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'3WZ_P!EQ>U5=[R&YT]HM-"W
MGJ:ZI>&,;Z .\N)X!HU)/  E7MVJKE44TQC,IB)F<(0'W*ZS;A--46S;"V,H
MJ5NK!DURC$D[R#[\%,=6,'#4&3F)!XL:5TN4T&(C&].,]4?O/!E49;ZD1,BW
M)S_+)I)LAS"[7/Q3J:>2ID; ..OL0,+8VC7N:T+>6LI9M?+3$>S]V1%%,;H>
M(60N]YC>Z&X>(2QRX[F5UMK8CJVE%0^6F)_&IY2^)WSM*QKN3LW?GIB?7QWJ
M544SOA-+:KK'BK)Z>S;I4<5"Z4AD.54+'"$$]GQ5."XM'X\?#\0#4K09S0L(
MYK,X]D_M+&N9?II3MI:JFK::GK**HBJZ2JC;-2U4+VR1R1O',U['M)#FD'4$
M%<Y,3$X3O8K]U (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @ZB]WVU8[0R7&\5C*.E9P!=Q<]W
M<UC1J7$^@!>MJS7=JY:8QEC9O.6LK;FY=JPC];NM&[)=\KO6/D@QJE;:J;L;
M6SM;+4.'I#3K&WY-'?*M[E](HIVW)QGJZ'!Y_P#V^]<F:<O'+'7.VKA'FQ37
M9=E-Q<75N0W"?4Z\AJ)&L'R,:0T?,%LJ,M:HW4QX.<O:GFKL_'<JGVSAX;G"
M9?;W$X/BO%=&\=CVU$H(^<.5ILT3_3'@\HSE^)QBNKQEZNU[HYQ:BWDOLM;&
M/>AK0*@.^5SP7_<<L>YI]BO^G#NV-CE_]ASUG=<F8_[?%Z[?-E['M]Z&=S(,
MEMCJ%[B :^CUDB'K=$[VV@>HN/J6LOZ/5&VW./9/ZX.GR7^XT5;,Q1R]M.V/
M#?ZLY6VZVV\TK*VU5T-?2O[)H7AP!]!TX@CO!XK3W+=5N<*HPEU^7S-O,4\]
MNJ*H['8*CV>4S7,[!@&.7#*,DJ_A;;;V^ZW0RS2N]R&%A(YGO/ #YSH 2/;+
MY>N_7%%$;96IIFJ<(5![M[PY/NW?'5UUE=1V2DD=]!8[&[6&E8> <[@/$D</
M>>1ZAHW0#N,ED:,K3A3OZ9Z_<V%NW%$,2+.>@@(" @EETV[^5. 76GQ#*JU\
MV$7641T\\KM?HN=YT$C2>R%Q]]NNC??'WP=I=6TV+]//1'QQY^_J\&/>M<T8
MQO6G@AP#FD.:X:M<.((*XU@OZ@(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.ER&_4&-6BKO%Q?RT
M]*WV8QISR//!L; >TN/_ %]B];%FJ]7%-.^6)G<Y;REFJ[7NCSGJA"#*\KNF
M7W22XW*3E8-6T=$TGPX(]>#6CT^D]I779;+4V*>6GQZWR34M2NYZ[-RY/='1
M$?KIZ7F%D->(" @(.WLM^N^/5C:ZS5\M#4#3G+#[+P/O7L.K7#U$+RNV:+L8
M5QC#*RF<O96OGM533/KWQTI.X9O+:+NQM'DKX;'<&-U-:]X922Z#4GG<=(SP
M[''3U]RY_-Z77;VV]L>?O?0M(_V>WFIBW>^&O_VU<)[/-75U";R5.ZN6/AM\
MSX\-L$CX+!2ZD"=P/*^LD;^%)I[.ONLT' EVO1Z7D(RUO;\T[^#NK-ODCM1^
M6S>P@(" @(""TOI+W3DS'$)<-O%09;_AC&,II7NU?46UWLPNX\283^;/XO)W
MDKCM;R?VKGW*?EJ]??O\6#F+?+.,=*6ZTC'$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$2=Z\H?=
M+^RP4\A^!L0TF /!]4\:O/\ V&D-'H/,NETG+\EOGG?5Z/FG^V:A-[,?9IGX
M:/\ Y3O\-WBPJMLY00$! 0$!!';J'S=UBQV'%Z"?P[ED@=\66G1T=$TZ/^3Q
M7>SZQS+;:3EON5\\[J?7W-MI67YZ^>=U/K[D3L>RV6AY*.XN=/1^['-VOB'\
M[?\ H_D6US61BOXJ-D^KZ'IFM56<*+NVGKZ8XQ^NQE6*6.:-DL+VRQ2#F9(T
MZ@@]X(6FF)B<)=C17%<1-,XQ+[4+" @(" @RMLIG3MN]R<;R*28Q6PSBBOOH
M-%4Z1RD_T-1(/6T+"U#+?Y%FJGIWQWQ^L'G=IYJ9A=8"" 0=0>PK@&M$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0<:LJHZ*DJJR7]%20OFE_HQM+C_(%:FGFF(CI>=VY%NB:YW1$S
MX*\:RKFKZRKKJAW-45DTD\[O2^1Q<X_=*[>BF*8B(W0^(W;DW:YKJWS,S/M<
M96>8@(" @(/X2&@N<0&@:DGL 05E;DY4[,LSO5Z:\OHW3&GM8]%+#[$7#NY@
M.8^LE=ED['V;44]/3WNPREG[-J*>GI[WA5E,EZ?'<CFL\HAF+I;?(?SD7:6$
M_?,_G'>L/-92+L8Q\S;Z7JE65JY:MM$^7;#,4,T53%'/!()891S1R-X@@K0U
M4S3.$[W<V[E-RF*J9QB7ZJ%Q 0$! 072;#Y6_,MIL,O$\OBUL5$+?<7GWC/0
MN-.YSO6\,#_^TN!U*S]G,5T]&./CM:V[3RU2R\L%YB @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @\AG\
MQI\*R>0:ZNMT\?#T2-Y#_P!Y962C&]1WPUFM5\N2NS_UF/'8@<NQ?'! 0$!
M0$&,MX<A=C>WN05<4GA5=;$+?1.';SU1\-Q:>XM87.!]2S-/M?<O4QT1M\&9
MD+7W+U,=$;?!6XNP=:("#U&.9#):)A#.XOMTI_.L[2PG[]O\X6'F\K%V,8^9
MN-*U2<K5RU;:)\NV/W9CCD9+&R6)XDCD <Q[3J"#V$%:&8F)PEW--451$Q.,
M2^U"P@(.LKKQ;[=J*BH'B#_<,]I_W!V?.O2BU57NAY5WJ:-\O)U692G5M%2-
M8.Z28\Q_);II]TK*IRD=,L2O.S_3#*NW6\VY=HL5;CUFS&OL]MCJS5BEHG-@
MT?,UK7$/8 _CX0X<VGW2L'.Z=8JKBN:8F<,-J^7J^[C-6V7JQNUNH"#_ /<O
M*N'_ .\UW_XRQ?\ "L?_ %T^$<&5]NGJA[BP=3&\^/O;R9A+=X =7TMUBBJP
M[Y9'M\4?,\+'NZ3EKG].'=L]RLV:)Z$J]O.LZPW66"W;B6?_  Y4R'E^G;?S
MST6I[Y(3S31CNX&3UZ!:;-:#73MM3CV3OX>C'KRTQN31MURM]XH:6YVJN@N5
MNK6"2CKZ61LL,K#V.8]A((^0K05T31.%483#'F,'-54" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#QNX<9EP
MC)FM[102/^9GM'^0+*R,X7Z.]JM;IYLE=_ME!%=B^/" @(" @((F]4-X+:?%
M; Q_LRR3W"IC]<8$4)_VY%O=%M[:J_9^O)O-&M[:JO9^O)$%;]O1 0$'NL1R
M TDK;76/_JLSOZM(X\(WG[WY''[A6MSV5YHYZ=\;W1:)J?VJOLUS\,[IZIZN
MZ?5E1:9V+\*FJIZ.%T]3*(HF]KCZ?0!WE6IIFJ<(5JJBF,98\NF4U5470T.M
M)3]GB?[QP^7[WYONK.M9:*=M6V6NNYJ:ME.R'E"2223J3Q)*RF(_B#UV'2\E
MQGB)X2P$@>MKAI_(2L7-Q\,3VLS)S\4QV,D+7MD("#-^S.^&1[27B,1R2W3$
MJR0?3...?[)!X&:GYN$<H'HX.['=Q&OS^G49JGJJZ)X]CRN6HKCM6\8WD5HR
MRQVS([%5MK;3=H&ST=0WT'M:X?>N:06N![""%P]VU5:KFBJ,)AKYB8G"7=KS
M0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(53YJ8=WA3_G6 ?(':+L<G=^Y9IJ[/1\<UG+?X^<N4=&.,=T[8]7D5E-8("
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M;M,54[I=$O5Z"#H;A0O$GC0,+Q(?;8T:D$]^GK4XLW+W.;X>EWMIM@HV>-,
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MGH:%XXM<>8?GI&]H)'*T]@) >N5U#6:KV-%K93U],\(8=V_-6R-R8BT3'$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MGN:QKG#VR^7KOU<M$;29:Y/4QU[[P]0%5<+);+A/MYMG(Y\=/AUJG<R6K@/
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M8P&HMV2>'2[J8+%3P9=#&T,CN$+QRPW.%K0&M\5S2)&-X,?V -<P+C]2R/\
MC5XQ\L[N#TB<4ZEK4B#CU=72T%+4UU=4Q45%11/GK*R=[8XHHHVESY)'N(:U
MK6@DDG0!3$8[(&O+UR]?ETW9K+MM3LW=9[5M7 7TE_R. NAJ<B<#H]K7<'QT
M?#0-X&4<7^R>1=3IVF1:B*[D?%U=7O4F55ZW*H@(.;;K;<;O606ZTT%3<[A4
MNY::AI(GS32.]#(XPYSC\@43,1&,C/MDZ1>IW(:85=MV*S(4[FM?')66N:AY
MVNXAS!5B(N!''4+&JSUBG?7'BG!W=SZ)>JZTLDDJMC<EE;&UKW"BBBK7$.(
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M5SQ_XA/%<SF=4O7NGECJCBO$)OPPPT\,5/3Q,@@@8V.""-H:QC&C1K6M&@
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ML><HFK-0(-D_RN-RY,UZ;FXG6S^+<=KKU56=@<=7F@JM*ZE<3KV!TTL;?0&
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MZ8-D(MU5.&Z.^C[O$X/U<.WEJ((0 ?PG=G?N]#N\MR:.B8]%:FO@NH4$'O\
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MAETU8[TL<]CL7-Y2G,T<L[^B>I,3@VN\!SG&]S,+QK/L0KQ<L;RN@BN%IJN
M=X<HXQR-!/))&X%CVGBUP+3Q"XJ[;JMU335OAZ/-;Z6OZ;V2WBLH89#=\'R&
MBY [E+OB+;41Z<Q[->;M5LM/+=IGMCU):<*[UY" @LWV^\KG=O<; \+W M&X
MN&TULS:QV^^T%)4/KS-#%<*=E0V*7PZ5S>=@?RNT)&H*T]W6;=NN:9IG9.'0
MMRO7_9#;V?67A'Y5R_8U3\[:^F?+B<I]D-O9]9>$?E7+]C3\[:^F?+B<I]D-
MO9]9>$?E7+]C3\[:^F?+B<I]D-O9]9>$?E7+]C3\[:^F?+B<I]D-O9]9>$?E
M7+]C3\[:^F?+B<I]D-O9]9>$?E7+]C3\[:^F?+B<I]D-O9]9>$?E7+]C3\[:
M^F?+B<I]D-O9]9>$?E7+]C3\[:^F?+B<I]D-O9]9>$?E7+]C3\[:^F?+B<I]
MD-O9]9>$?E7+]C3\[:^F?+B<I]D-O9]9>$?E7+]C3\[:^F?+B<J1'2GY<FY6
MPV^V%[KY1G.,WBU8JRY\]NM9K#42/KK=4T+=/'IHV:-^(YC[0[%B9W5:+]J:
M*8F)G#UQ3$+A%HEA 0$&$=T>F[8S>=LCMR-M+-D-=(WD^G!$:2Y-'<!74KHJ
MC0>CGT]2R+.;NV?DJF/3P1@KRW%\HK;>ZNJ*O;#<J]8=.\E\=JO4$5WI >Z-
MDD9I)F-];G2'Y5M;6N5Q\],3W;$<J$^?^5MU-XDV>IQJ#']R:.,%[&6:X"FJ
M^0=O-!<6TK>;\6.1Y/=J>"V%K6;%>_&GO]R.5!G.=L=Q=LZYMMW"P:^8962.
M<V".\4,](V;E[3"^5C6R-];"1ZULK=ZBY&-$Q/<AX9>B! 0$&P#Y;/6'7[C4
M(V&W-N[J_-+#2.FP._U;^:>Z6ZG;K+23/=QDGIF#F:X^T^($GC&YSN8U;(1;
MG[M$;)W]DKTRMQ6C6:_'F]6HP[R[87OP@&W'"S0B;CJXT=QJ92T]WL_%:\/3
MQ[ET^A5?^*J.W]E*E2BWBH@D'TV=.V2=36>7';_%<@M&.72WV.HOGQ5Y=,V&
M6.GJ*:G=%'X$<KB\_$AVFFG*UQ6+F\U3EJ.:J)F,<-B8C%./[(;>SZR\(_*N
M7[&M=^=M?3/EQ3RGV0V]GUEX1^5<OV-/SMKZ9\N)RGV0V]GUEX1^5<OV-/SM
MKZ9\N)RGV0V]GUEX1^5<OV-/SMKZ9\N)RGV0V]GUEX1^5<OV-/SMKZ9\N)RG
MV0V]GUEX1^5<OV-/SMKZ9\N)RGV0V]GUEX1^5<OV-/SMKZ9\N)RGV0V]GUEX
M1^5<OV-/SMKZ9\N)RGV0V]GUEX1^5<OV-/SMKZ9\N)RGV0V]GUEX1^5<OV-/
MSMKZ9\N)RGV0V]GUEX1^5<OV-/SMKZ9\N)RGV0V]GUEX1^5<OV-/SMKZ9\N)
MRK?^D_96[=/NQF);77^ZTEYO=EGN51<KC;S(:5[JVOGJ(Q#XL<;]!$]@/,WW
MN;3AHM%G<Q%^[-<1A$X>BT1@D:L1*.O5S_#!OU^Y%X_5GK*R/\]'?")W-1==
MR\Q 0;N2^>/40$! 0$!!A'J9_AOZ@O\ 37*_['JED9/^>C^Z/5$M/M=V\Q 0
M;N2^>/40$! 0$!!@W=;IKV-WK@F;N/MQ:+Y7RM+6Y#'%\)=(^! Y:^F,<^@U
MUY2\MU[6E9-C-W;/R53'9T>",%1^_P!Y4%]L-'<LEV"RB7*Z6E8^<X%??#CN
M18T:EE)6Q-9#.XGW62,CX??N=V[S*ZW%4X78P[8W*S2IWK*.KMU756^X4LU#
M7T,SZ>MHJACHIH9HG%DD<D;P'-<UP(((U!6]B8F,85<=2""]SRC=W*JYXWN)
MLK=*ITS<8EBR7%(W'4LI:U_@U\3=3P8R<1/  ]Z5Y7-ZY8PJIN1T[)_9>E<A
M44\-73STM0P2T]3&Z*>,Z@.8\%KAPT/$%:")P6:76;XS4X5FF7X;6APK,2O5
MPLU6'C1WBT%3)3OYAPT.K#JOH%NOGIBKKC%YO,*Z!!M*>7;G<&<])^W31/XU
MPPPUF,79G-S>')03N=3LU/\ \)+ =.[7T+C=5M\F8J[=OZ]KTC<F\M<D0$!
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M<4QOZ>]YS.*.:RT""\;R@]M)X:'=;=ZLA+(:Z2FQ.P2D$%PATK:\C7M&KZ<
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M7-=6^7HR6O$$$=>KG^&#?K]R+Q^K/65D?YZ.^$3N:BZ[EYB @W<E\\>H@("
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MLS0<K2ZHB&DW*/=;.V1H_!67E\]>L?+.SJZ$3"JO=/RBLSM\M36[.[CV[)*
M:OAL631OH*UK1V1MJJ9DT,SCZ7,A'\^ZLZY3.RY3AW?KBKRH*9IT6=4N!23M
MO>RF1UL, +G5MB@;>X.0<><OMCJD-;H-3S:$=X"V5O4,O7NKCV[/5&$H\WC&
M<DQYYCO^/W*QR!P88[A234S@X@D-TE8WCP/#U+*IKIJW3B.D5D/46/!\UR<L
M&-X?>\A,@UC%LM]35EPX]G@QOU]T_<5*KE-.^8A*1V%]"G5=G,D0M^S=YLE.
M\CQ*O(_"LC8P?OG1U[X9C\C6$^I8ES4LO1OKB>[;Z&$I][0>475F>DN>^>XL
M+*=CFOFQ+$6N>Z0=O)+<JN-G)Z'!D#N_ED' K67]<Z+=/MGA[UHI6[;7;.[9
M[+X^W&=L<.H,3M1+757PK"ZHJGM&@DJJF0OFG?IPYI'N.G <%H[U^N].-<XR
MM@R6O$$! 0$!!_" X%K@""-"#V$((([Y^7?T][SRUEYHK/)MEF%42]]_QEL<
M-/-(>/-4V]P^'?J22XL$;W'M>5LLMJMZSLF>:.WBB85:;F^55U!XB^>HP&X6
M3=2UL!,+*6=MIN1 /$OI:UXA'#B VI>>[3LUW-G6K-?S8TSXQY<%>5";+NGW
M?+ WRC+]H\ML44)(=75%HJS2GE[2VI9&Z%P'I:\K8V\U:K^6J)]J,&(I(WQ/
M?%*QT<D;BV2-P(<UP.A!!X@@KW0^4'=V3&<DR6H;28YC]RR"J<X,;36VDFJY
M"X]C0V%CCJ=>Q5JKIIWS@E*# .A'JJW#= ^W;2W3'J"4CGN63F.RLC:?OS#6
MNCJ'#^A$XK#NZEE[>^J)[MIA*P[:#RC+?3/I;GOEN(ZY.:0Z7$\2:Z*$D<=)
M+E5,$C@>PAD##Z'^C57]<F=ENGVSP]ZW*M@VQV?VSV9L/^&]L<-MV(VI[@^J
M;2,)GJ7@:"2IJ9"^:=P' .D>X@<!P6EO7Z[TXUSC*V#)*\00$! 0=3?+#9,F
MM5;8LDL]%?[)<HS%<+1<:>.JI9XSVMDAE:YCAZB%:FJ:9QB<)%;&\GE8['9W
M)573;:YU^T=[G+G_  =,TW*SN<>)_J<\C)8]3V".=K6]S.P+;9?6;M&ROXH\
M)5FE6UN'Y8?5!A;IYL?M%GW*ML6KFU%@KV1U C'874M?\*\N_%C\3U$K;6M8
ML5[YFGO]R.641<HV)WKPI\C,LVER_'VQ:\U16V:MC@( )+F3&+PW#@>+7$+/
MHS-JOY:HGVHP8MFAFIY9(*B)\$T3BV6&1I:YKAVAS3H00O9#[IJ6IK)F4U'3
MRU51)KX<$+"][M 2=&M!)T )29P&6<8Z?-]<SDB9B^SV8WEDQ ;5P66M^''-
MV%]0Z(1,'K<X!>%>:M4?-5$>U."7.W?E>=3F8S4\N44-EVSM;W SSWFOCJ:K
MPR1J8Z6W_$ZNTXALCX_60L&[K-BC=C5/9[T\JTO8;RV=B=H)J.^97"_=W,*4
MLDBN%]@9';()6Z'F@M8=)&>/$>.^4C[W0K39G5KMW93\,=F_Q6BE88UK6-:Q
MC0QC &L8T:  <   M4E](" @(" @\1G^VN!;IV"?&-Q,2MN7V.?4_ W&!LOA
MO(T\2&3@^)X'8^-S7#N*]+5ZNU.-$X2*M=VO*0P2]2U=SV;SVMPF>1SI(<9O
ML9N=O!.ND<54US*F)HX<7^,Y;FQKE<;+E./;&S]>2O*KSSWRYNJ_!73218##
MF]OAUUN.+UL-:':?@TTA@JSKW?F?Y5M;6JY>O^K#O_6",)1<R#:/=7$Y7P91
MMGE6.2QNY7LN5GK:7CW?I8FZZ]RS*;]NOY:HGVH8^(+26N!!!T(/:"O5#L[9
M8[U>I/!LUHK;M-S!OA45/).[F=KH-(VN.IT*B:HIWREG+$.DSJ6SJ2*/'-DL
MMDCGT\&MK[?):Z5VITU%5</AX?\ ;6-<SUBC?7'KZ&":6VOE,;U9$ZGJMRLM
ML.W%O?H9J&F+KU<F^EICA=%3#U$5#OD6OO:W:I^2)GRC]>Q/*M#V1Z NG79*
MHH;U28W+G>7T+FRT^4Y2YE8^&5IY@^FI6L931%KN+'",R-T'MZ\5ILQJ=Z]L
MQPCJA:(376O2(" @(,6[W8)<=S]H=R-N[164UON>:8]76>@KJSG\"*6JA=&U
M\OAM<[E!/'0$KVR]R+5RFN>B<25(OV0V]GUEX1^5<OV-=%^=M?3/EQ4Y3[(;
M>SZR\(_*N7[&GYVU],^7$Y3[(;>SZR\(_*N7[&GYVU],^7$Y6P8N77$! 0$!
M 08^W;Q"NW!VIW-P&V5,%%<LWQ.]6"WUE5S>!#/<Z&:ECDEY YW(UT@+M 3I
MV!>MBY%NY35/1,3X2*-/LAM[/K+PC\JY?L:Z/\[:^F?+BIRGV0V]GUEX1^5<
MOV-/SMKZ9\N)RGV0V]GUEX1^5<OV-/SMKZ9\N)RM@Q<NN(" @(" @(" @("
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+! 0$! 0$! 0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lg_carismatherapeutics-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_carismatherapeutics-4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@!303A P$1  (1 0,1 ?_$ .4
M 0 " 04! 0             ("0<! @,%!@0* 0$  04! 0
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M=Y#<%?7&N]7ZB:QPQV,PXL99J'I=/<S,>UE>50V,D]WNJ^D<5F6>"UT<@I4
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @TZ@#2O%-0ZAWH-"]HI4
MTKR5-0ZFU KQ/)5&[F@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("!_6089W
M;V0T7O%81VFI;)T-]9-IB\]:$,NK>M:M#CP<PDDEKN';P/%6S&JZMIA%JU\@
M.G(KV.6\W R5W8AP+[2.RABD<WM'BF1X'KZ5;X$GQ4U=!;?Z6VWT_;Z<TIB8
ML7CH#UOZ?:EFD( =)-(:N>\TXDGU<%?$:(IG5[954$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[2.D[K(68-'Y.4LM;1M/^NG<QA/+@"3Z%6(4FT0E+I?R%ZQOV,EU5K/&Z>J
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MYLG*J@@(" @XI:=%3V?J(*<_-_NO/KC<*XTGC[DG3NAY)++PV./1/? D3R.
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MX_JJ;5C/5S&C>'HY?559E;$*9-9YN\U%JS4.;OGE]Q?W\\A:>36AY#&#T-:
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M6FUR9^VUO#\E8_>B,/Z@N&UB(X/3(UB)B.9[GN),:<N:LZ+#/*%J"[OM*YO
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MT&UY>-<%G+_%*._--BY(!$T!/<%8E7^;+8D87:C;W'L;TB'!V;B.VLD8D/\
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MVW>Y6WUA$Z>[UO@8(P*DOR-M4^H>)Q]2MC;Y+<JS[)79.H;;'&MLE8_Q1];
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M'U458GOG16E)M/V8GV,Y:#\O>XNNGP3-QCL!B'EOB9+(M=#5A-"8XC1[^'H
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M/</\_P#7'Z09/\*D4$LN/NI,^1?Z;;NO^ZV1_"+-751Y>2X-2H! 0$! 0$!
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MVJ*6!_EO#?Q^V^-:K97ROK4S&9*5RQH3Z%2139O=:FSW:U]"YO279>::G/\
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MHH0>5$'P187$03?*8,9:P7%:^/'$QCZG]<T JFBNKL6M:T4:*!54;D! 0$!
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M%54U?> &@ <AR0:H" @(-" X4/)!M$;!R"#K+_ X3*-+<GB++(M<*.;=01S
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MWS) 3T\_3R4;+<J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MR<Z)AZR/5U +T_R'AM3#DM/*9B(^1XM_Y-W%+;G%CC[U:\?EY)G+OGF @("
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M.XBO,$<01P(718\E<D1-9X/,-QMLFWOX,E9K,=_[<63=KM[-7[7W+8K&<Y7
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M3Y7BN?<SGW$Y\D:S-HGUZ3]WV1HE#!YQ]66K(8H-'X6.*W8(XH@ZX#6M:*
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MGWO0NE_TF+^2ONADA1,X0$!!L?R]U!3#N3]*^KOTEG_"0NKP?TL?RO(.H?\
M<[?_ )/IA<ZVGM^OA[P7*0]><@Y!%1!H[D56%)4S2_3$_P#3+_Y\+JX_I_\
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M+&_MF%M?^5;[]HCZFG_-=O%_K;'_ .@Q)_;,)_RK??M$?4U_YKMX_P#6N/\
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D(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_mackenziepartners-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_mackenziepartners-bw.jpg
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M# P,# P,#/_  !$( +("5P,!$0 "$0$#$0'_Q "D   " P$! 0$! 0
M    "0<("@8%! (# 0$! 0$!                  (! Q   0,# P(# P8(
M"@8$# <  0(#! 4&!P 1""$2,1,)02(446$R0B,5<8%25946%QEB<M(S<R24
MU%<8D:'1@D,EP5,TIK&28]-D1=7E)C8X:.&BH[-$5'81 0$  P$! 0
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MK 4A:%I)"DJ!W!'CHYO[: T$09]R?%PSAG(V3)#C:';5HLA^E(=V[':BZ Q
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MG?V?1C'1.QX>B!H/$N2Y*%9] K%TW/5(]$MZWXCLZL5:4KM:CQV4E2UJ/4]
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MTR#*$B@8Q8;M.F=A!29$4J<J*B 2.X2W'&B?D;3^#1TU\4(T:T@^E9B9-DX
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M<G8Z T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
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MD%QP'JAQ!T;-2I6VY4^4AII#LV;-="6VTA3CKKKBM@ !NI2E*/X2=%&7\>>
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M&.-^-5^91PUEO,=LQU2:;B=Z")=,2VI3DYEQ#KM07'4.G=!:#;SB3]11(Z@
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M_K*2.NBK\C6TE*4)2A"0A" $H0D;  =  !HYOUH#0+C]2CCH,Q88<ORWJ?\
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M?9*0E"=SV)2#HRW*9M&#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
MT!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#05$YJ<CH_'##
M-4KE.D-_M NLKHN.X)V6OXUU![YA;(.Z(B#YAW':5^6@_3&C9,J(\'_3XD&5
M3\X\CZ8Y-K$IU%5M/'U2)<6''#YPGUE+FY4ZI1[DL+\#U>!5[B3;L=3HD: T
M!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&
M@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
MT!H#0&@- M3E?_\ 5]PX_P#DS^=K/_SG_P!F^DQ_,?\ I/\ _6_](\O14\,K
IT2- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2227887d8-tbl_pipelin4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d8-tbl_pipelin4c.jpg
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M# P,# P,#/_  !$( R('; ,!$0 "$0$#$0'_Q #^  $   <! 0$
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MJ='^E_+,65&TJK_M(XR:0    !5+?]L-+_;*^@4-5W:=67VI9I'.Z0
M                    69:_\)73]?J^C<&56U"%YC%(
M
M       "S)?MWIGU@K]ET91[*%YC%(                          +NOG
MVQ+^Y]+_  ?'&FS[/GGTRW9CV^#T0M$;FD                         3
M+/TB9^]I^C2(E,)82@
M                                         !=E8]JUG?QA]72-5'MU
M>9NN?9T^?TK3&UI
M%^_ZK_\ 2G_(AH_B_P"7E;OX7GY&GT?Z7\LQ94;2LO\ M(XR:0    !5+?\
M;#2_VROH%#5=VG5E]J6:1SND                          %F6O\ PE=/
MU^KZ-P95;4(7F,4@
M                                       +,E^W>F?6"OV71E'LH7F,
M4@                          NZ^?;$O[GTO\'QQIL^SYY],MV8]O@]$+
M1&YI                         $RS](F?O:?HTB)3"6$H
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M]BISB]#NV"NIUA$YCJ='S^;%9UZMFG+]=I;D3AAOSY6K(L58
M                    NRL>U:SOXP^KI&JCVZO,W7/LZ?/Z5IC:T@
M                                      "_?]5_^E/^1#1_%_R\K=_"
M\_(T^C_2_EF+*C:5E_VD<9-(     JEO^V&E_ME?0*&J[M.K+[4LTCG=(
M                       +,M?^$KI^OU?1N#*K:A"\QBD
M
M          !9DOV[TSZP5^RZ,H]E"\QBD                          %
MW7S[8E_<^E_@^.--GV?//IENS'M\'HA:(W-(
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M'KIJ1;M7Y^N[7-NY'THY'/K'5]NU1%RW.Q/+NM@KG_V;\;[DTC_^88PXK?\
MR/GG_P",NZ__ ,='DI],.28]*\P                                N
MRL>U:SOXP^KI&JCVZO,W7/LZ?/Z5IC:T@
M                 "_?]5_^E/\ D0T?Q?\ +RMW\+S\C3Z/]+^68LJ-I67_
M &D<9-(     JEO^V&E_ME?0*&J[M.K+[4LTCG=(
M      +,M?\ A*Z?K]7T;@RJVH0O,8I
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MG]*TQM:0                                            !?O^J_\
MTI_R(:/XO^7E;OX7GY&GT?Z7\LQ94;2LO^TCC)I     %4M_VPTO]LKZ!0U7
M=IU9?:EFD<[I                          !9EK_PE=/U^KZ-P95;4(7F
M,4@
M                          +,E^W>F?6"OV71E'LH7F,4@
M               NZ^?;$O[GTO\ !\<:;/L^>?3+=F/;X/1"T1N:0
M                 !,L_2)G[VGZ-(B4PEA*
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M\;6IK;(C[#=\G:,J=7T1?Z[&<>+:P85ZQJJL=3A&&$;/D:W#O5X
M                      "[*Q[5K._C#ZND:J/;J\S=<^SI\_I6F-K2
M                                         +]_U7_Z4_Y$-'\7_+RM
MW\+S\C3Z/]+^68LJ-I67_:1QDT@    "J6_[8:7^V5] H:KNTZLOM2S2.=T@
M                          LRU_X2NGZ_5]&X,JMJ$+S&*0
M
M             %F2_;O3/K!7[+HRCV4+S&*0
M  7=?/MB7]SZ7^#XXTV?9\\^F6[,>WP>B%HC<T@
M   "99^D3/WM/T:1$IA+"4
M                                              +LK'M6L[^,/JZ1
MJH]NKS-US[.GS^E:8VM(
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M9?K]*[J'9<W\WB.V9+Y7APGEAY0_[,,OU^E=U#LN;^;Q';,E\KPX3RP\H?\
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M9?K]*[J'9<W\WB.V9+Y7APGEAY0_[,,OU^E=U#LN;^;Q';,E\KPX3RP\H?\
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M9?K]*[J'9<W\WB.V9+Y7APGEAY0_[,,OU^E=U#LN;^;Q';,E\KPX3RP\H?\
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M-(YW2                          "S+7_ (2NGZ_5]&X,JMJ$+S&*0
M
M                    %F2_;O3/K!7[+HRCV4+S&*0
M         7=?/MB7]SZ7^#XXTV?9\\^F6[,>WP>B%HC<T@
M          "99^D3/WM/T:1$IA+"4                           OF]O
MI%D?YLQ/J\@:+/[7E;[_ .S\,+&&]H                         $S&_Y
M1^\K^8(DA+"0                          %V5CVK6=_&'U=(U4>W5YFZ
MY]G3Y_2M,;6D                                             7[_
M *K_ /2G_(AH_B_Y>5N_A>?D:?1_I?RS%E1M*R_[2.,FD     52W_;#2_VR
MOH%#5=VG5E]J6:1SND                          %F6O_"5T_7ZOHW!E
M5M0A>8Q2
M                                LR7[=Z9]8*_9=&4>RA>8Q2
M                    "[KY]L2_N?2_P?'&FS[/GGTRW9CV^#T0M$;FD
M                      3+/TB9^]I^C2(E,)82@
M       %\WM](LC_ #9B?5Y T6?VO*WW_P!GX86,-[0
M        )F-_RC]Y7\P1)"6$@                          +LK'M6L[^
M,/JZ1JH]NKS-US[.GS^E:8VM(
M          OW_5?_ *4_Y$-'\7_+RMW\+S\C3Z/]+^68LJ-I67_:1QDT@
M "J6_P"V&E_ME?0*&J[M.K+[4LTCG=(                          +,M
M?^$KI^OU?1N#*K:A"\QBD
M                                            !9DOV[TSZP5^RZ,H
M]E"\QBD                          %W7S[8E_<^E_@^.--GV?//IENS'
MM\'HA:(W-(                         F6?I$S][3]&D1*82PE
M                    +YO;Z19'^;,3ZO(&BS^UY6^_^S\,+&&]H
M                  $S&_Y1^\K^8(DA+"0
M %V5CVK6=_&'U=(U4>W5YFZY]G3Y_2M,;6D
M                    7[_JO_TI_P B&C^+_EY6[^%Y^1I]'^E_+,65&TK+
M_M(XR:0    !5+?]L-+_ &ROH%#5=VG5E]J6:1SND
M       %F6O_  E=/U^KZ-P95;4(7F,4@
M                                                        +,E^
MW>F?6"OV71E'LH7F,4@                          NZ^?;$O[GTO\'QQ
MIL^SYY],MV8]O@]$+1&YI                         $RS](F?O:?HTB)
M3"6$H                          !?-[?2+(_S9B?5Y T6?VO*WW_ -GX
M86,-[0                         )F-_RC]Y7\P1)"6$@
M              +LK'M6L[^,/JZ1JH]NKS-US[.GS^E:8VM(
M                                 OW_ %7_ .E/^1#1_%_R\K=_"\_(
MT^C_ $OY9BRHVE9?]I'&32     *I;_MAI?[97T"AJN[3JR^U+-(YW2
M                     "S+7_A*Z?K]7T;@RJVH0O,8I
M
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M(
M                        "S)?MWIGU@K]ET91[*%YC%(
M             +NOGVQ+^Y]+_!\<:;/L^>?3+=F/;X/1"T1N:0
M              !,L_2)G[VGZ-(B4PEA*
M7S>WTBR/\V8GU>0-%G]KRM]_]GX86,-[0                         )F
M-_RC]Y7\P1)"6$@                          +LK'M6L[^,/JZ1JH]NK
MS-US[.GS^E:8VM(
MOW_5?_I3_D0T?Q?\O*W?PO/R-/H_TOY9BRHVE9?]I'&32     *I;_MAI?[9
M7T"AJN[3JR^U+-(YW2                          "S+7_A*Z?K]7T;@R
MJVH0O,8I
M                                69+]N],^L%?LNC*/90O,8I
M                    !=U\^V)?W/I?X/CC39]GSSZ9;LQ[?!Z(6B-S2
M                      )EGZ1,_>T_1I$2F$L)0
M       "^;V^D61_FS$^KR!HL_M>5OO_ +/PPL8;V@
M       3,;_E'[ROY@B2$L)                           796/:M9W\8
M?5TC51[=7F;KGV=/G]*TQM:0
M        !?O^J_\ TI_R(:/XO^7E;OX7GY&GT?Z7\LQ94;2LO^TCC)I
M%4M_VPTO]LKZ!0U7=IU9?:EFD<[I                          !9EK_P
ME=/U^KZ-P95;4(7F,4@
M                                          +,E^W>F?6"OV71E'LH
M7F,4@                          NZ^?;$O[GTO\ !\<:;/L^>?3+=F/;
MX/1"T1N:0                        !,L_2)G[VGZ-(B4PEA*
M                   7S>WTBR/\V8GU>0-%G]KRM]_]GX86,-[0
M                 )F-_P H_>5_,$20EA(
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MO/R-/H_TOY9BRHVE9?\ :1QDT@    "J6_[8:7^V5] H:KNTZLOM2S2.=T@
M                         LRU_P"$KI^OU?1N#*K:A"\QBD
M
M             !9DOV[TSZP5^RZ,H]E"\QBD
M  %W7S[8E_<^E_@^.--GV?//IENS'M\'HA:(W-(
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M=R_CHQL1N[C&8Z',     +,M?^$KI^OU?1N#*K:A"\QBD
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M3U/#NU=2?%KIMWZ[!KU/FJ(IZK]J9GT,M<Y6NJKK=C1B(CCYU^<UGYF>'O\
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M>4RX:3Z2-2#T/S!?6ZXKIBJ-J8Q>?NVYMUS3.W$X*$,V
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MU:SOXP^KI&JCVZO,W7/LZ?/Z5IC:T@
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M.3#8-1MM+DN&XI"#5J>A&>S4;[-N+=$41N1@Y[]WK;DUX88RM4;6H
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MI]/CDI,:%$;-1MQV$J-1DDC4:C,SU-1F9[Q;9;+49>C0I_Q4^:S5>8KTJO\
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M;E^<:YQ8_&]H  !9EK_PE=/U^KZ-P95;4(7F,4@
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MM$;FD                         3+/TB9^]I^C2(E,)82@
M               %\WM](LC_ #9B?5Y T6?VO*WW_P!GX86,-[0
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M7F,4@
M                            +,E^W>F?6"OV71E'LH7F,4@
M                 NZ^?;$O[GTO\'QQIL^SYY],MV8]O@]$+1&YI
M                  $RS](F?O:?HTB)3"6$H
M   !?-[?2+(_S9B?5Y T6?VO*WW_ -GX86,-[0
M   )F-_RC]Y7\P1)"6$@                          +LK'M6L[^,/JZ1
MJH]NKS-US[.GS^E:8VM(         Z761=]IQ^0J[+9D7/26+D?14>HM]R:P
MF<OBJ*5IX8QK)P]4EJ6B=PH+UJN<_%6$X;&SAL;3T=BY3&0F,8QPGTRSOR=9
MJLF-@.C4N[[RHM J%G2I].5'J,YB/(<C(7WVTXAIQ9+4DD/\">$MO#H6TAQZ
MTRM?7S--,S$X3L0ZM5YFF<O$53$3&QX>9B?DBRE;KUV\PUV7K=%*MR7>E5I=
M49*JS8\/K5//51YU+1/+02B;ZU)&2?0ZE\@=.MLO5%%NFF)G")C8CR.;5-^F
MJN[55.&,Q.SYV+^2^Y[:M[F(R15:_<-,H=+ET&L-1:E4);,:.ZMRKP5H2AUU
M:4J-24FHB(]I$9CHUI;JJR],1$S.,>B7/JRNF,U7,S&&$^F$]C^Z;8B\^=P7
M-*N.EQK;=JE=6U<#LQE$%278#R6U%)4LFS)2C(B/BVF,;UNJ<A%.$XX1L;NV
MV6;E/;ZIQC#9]"4RGF:CV!SK+R?1YT>YK;AIIS%2>I;[4EM^&_2VHLDFG$*-
M"EMDHU$7$79I(C,AEE\K-W)=7.Q.SM^5AF<U%G.Z<;,81CAY&<\J89QIS$77
M&RO9>?J7;]+K$:*FYX:GD+4DXZ4,I<2A4AA3"S:2E!H=26TB/IT''E\U<RM/
M5UVYF8VG;F,K1FJHN47,(W</\=AJ)S*1^7ZV[IMV@XHD3[HBTU\G[S?35G9<
M!U*5$11HSZ^LU<4GBXG$&:4ZD1:GQ$5GD)S%=,U7,(WMC95FL)R]%5--&,X3
ML[,S'D\K8MO"F%[SH]L75RO9I:Q97VT*36HDVL26)[W%V:2?1WPEYAQGLD]@
MDVUEM(]G$KAG-WK<S3F*-*-S8V/0[HR=FY3%67KT9W=F>/975G[*]L61RVN8
MAK&3XF8,F5R(B%,JT5QM]7"<PI*GY2FUND@F6R)MOC5QK,DJT]$9:\EEJKF9
MZV*-"B/4SSN9IM9>;=56E7,8*3R5719-<P7D/$=6NR#;MPUJ95&R9ENMMN'%
MJL!F,F0PAU;9.\"DJXDI/4M"UTXB&6M;==-^FY$8Q&'%+'5%RBJQ-N9PG9XV
M*<1WE:7*/S 5VTYUX,7G8->IL.'5KQI[:%(:?4E+[;YLQWI!DEE:UMK22E*T
M/B(C,B2?3F;5>>R\513A5$SL.;+7*,A?FB:L:9B,9\;+5S\J> K^O2HY,IN=
MZ53K*K<TZM6Z''?@K(CD+-U]+4Y4I)1TK5Q:$ME1HVET#FMZQOVJ(MS;G2C8
MB=GT8;+IN:LL7:^LBOZ,[,[7I88YSL_6ED!NV,78V?1.LNRW$R9-59(RCR);
M3)QX[<;B[)3<=I:T\>Y1JV;$DI75JK)5VL;ESVI<>ML[1=PMT;,1LX^IE+F;
MO.SZQRD8HH5(NNCU2MP?%GOVCPYT=^4SU-)=0YUC#:U+3P*,DJU+8>PQSZOM
M5TYNN9B8C9W/&Z]8W*9RE,1,8[#[^KZO.S[6MC([-S771[<=EU2"N(U5)T>&
MIU*67"4:">6@U$1GMT#75JNNNG1B9V-R$:DN4TVZL9B-GD8UY)LZ6?8IW7C'
M(DUNEVS>KA2*?5I*^"&S)4T<>0U(7LZM+[9((EF9$DTZ'OU+?K;)UW,+E&S,
M.;5&<HMXVZYPB=F)9.HW*UAJSJS4[KR'GRGU['*&9*Z/2D5$HCZR5JEM2Y,>
M6:G5,Z[":3V:M-A%V!\]6L+UR(IHMX5>3F=E.K[=NJ:J[F-.]CAQXN=.19=H
MS;TK[UAMU!NSTR.KH'A5XWY:V&R)/6.*41&76*(U$D_0D9)/4RU%Y8BN*(T\
M-+=P>?S-5%5R9HQT=S%90W-          OW_ %7_ .E/^1#1_%_R\K=_"\_(
MT^C_ $OY9BRHVE9?]I'&32     *I;_MAI?[97T"AJN[3JR^U+-(YW2
M                     "S+7_A*Z?K]7T;@RJVH0O,8I
M
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M(
M                        "S)?MWIGU@K]ET91[*%YC%(
M             +NOGVQ+^Y]+_!\<:;/L^>?3+=F/;X/1"T1N:0
M              !,L_2)G[VGZ-(B4PEA*
M7S>WTBR/\V8GU>0-%G]KRM]_]GX86,-[0                         )F
M-_RC]Y7\P1)"6$@                          +LK'M6L[^,/JZ1JH]NK
MS-US[.GS^E:8VM(
MOW_5?_I3_D0T?Q?\O*W?PO/R-/H_TOY9BRHVE9?]I'&32     *I;_MAI?[9
M7T"AJN[3JR^U+-(YW2                          "S+7_A*Z?K]7T;@R
MJVH0O,8I
M                                69+]N],^L%?LNC*/90O,8I
M                    !=U\^V)?W/I?X/CC39]GSSZ9;LQ[?!Z(6B-S2
M                      )EGZ1,_>T_1I$2F$L)0
M       "^;V^D61_FS$^KR!HL_M>5OO_ +/PPL8;V@
M       3,;_E'[ROY@B2$L)                           796/:M9W\8
M?5TC51[=7F;KGV=/G]*TQM:0
M        !?O^J_\ TI_R(:/XO^7E;OX7GY&GT?Z7\LQ94;2LO^TCC)I
M%4M_VPTO]LKZ!0U7=IU9?:EFD<[I                          !9EK_P
ME=/U^KZ-P95;4(7F,4@
M                                          +,E^W>F?6"OV71E'LH
M7F,4@                          NZ^?;$O[GTO\ !\<:;/L^>?3+=F/;
MX/1"T1N:0                        !,L_2)G[VGZ-(B4PEA*
M                   7S>WTBR/\V8GU>0-%G]KRM]_]GX86,-[0
M                 )F-_P H_>5_,$20EA(
M "[*Q[5K._C#ZND:J/;J\S=<^SI\_I6F-K2
M                    +]_U7_Z4_P"1#1_%_P O*W?PO/R-/H_TOY9BRHVE
M9?\ :1QDT@    "J6_[8:7^V5] H:KNTZLOM2S2.=T@
M         LRU_P"$KI^OU?1N#*K:A"\QBD
M                                                         !9D
MOV[TSZP5^RZ,H]E"\QBD                          %W7S[8E_<^E_@^
M.--GV?//IENS'M\'HA:(W-(                         F6?I$S][3]&D
M1*82PE                           +YO;Z19'^;,3ZO(&BS^UY6^_P#L
M_#"QAO:                         !,QO^4?O*_F")(2PD
M               !=E8]JUG?QA]72-5'MU>9NN?9T^?TK3&UI
M                                  %^_P"J_P#TI_R(:/XO^7E;OX7G
MY&GT?Z7\LQ94;2LO^TCC)I     %4M_VPTO]LKZ!0U7=IU9?:EFD<[I
M                     !9EK_PE=/U^KZ-P95;4(7F,4@
M
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M^U+-(YW2                          "S+7_A*Z?K]7T;@RJVH0O,8I
M
M                      69+]N],^L%?LNC*/90O,8I
M          !=U\^V)?W/I?X/CC39]GSSZ9;LQ[?!Z(6B-S2
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M%I_#3[G/90._O<X^8[@^\XN<^+3^&GW.>R@=_>YQ\QW!]YQ<Y\6G\-/N<]E
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M_*I,_"%6%SK3[*Q\')"HU9]K>^+EET6%,MP
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M4EJI2#(B^29 +?M6!+IM(1%FM=2^3JU&CB2K89[-J3,@%R
M            "V*Y3IDRJV[)CL]8S ?6N4OB27 DS;T/0S(S]">X!<X
M                      .=/ZNSVO<P'Y5*K]29%SKGVK?P0I]4>S<^*718
M4RX                                             'YU/TQO[U'\X
M1[+\I_*Y'D/S7\WE:!"WA60"4@    #;'D:_.MP[]T9OX-E"NUK^&K\G+#MU
M;^)H\-R7Z=QX9[0                          '.GDD_ICYX_RJ3/PA5A
M<ZT^RL?!R0J-6?:WOBY9=%A3+<
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M\JE5^I,BYUS[5OX(4^J/9N?%+HL*9<
M               #\ZGZ8W]ZC^<(]E^4_E<CR'YK^;RM A;PK(!*0    !MC
MR-?G6X=^Z,W\&RA7:U_#5^3EAVZM_$T>&Y+].X\,]H
M        #G3R2?TQ\\?Y5)GX0JPN=:?96/@Y(5&K/M;WQ<LNBPIEN
M
M                 Y=YS_VB6&_R8/?5J\+BU_Q]?Q_NJJO\?3\'++:Y/2*5
M;0]EO($HI;QDA$3T@A,HW$($9.\@$PD2)I ";1N$)3370)0G$= $)]OY@)E-
M%O!":3N+S@0F $PWTC)"91O(0E,IWA)#V(2 )2?_ .PS?WASZ$P%OV5[7HO[
M=WZ,P%U@                         "RJ][9;7_;N?^:(%ZB0
M                 0G_ *0]^T5^P M2Q_X!;_?G/V2$0+P$@
M              LNY?X<M+ZY<^B:$"]!(                          #
MG3^KL]KW,!^52J_4F1<ZY]JW\$*?5'LW/BET6%,N
M                         !^=3],;^]1_.$>R_*?RN1Y#\U_-Y6@0MX5D
M E(     VQY&OSK<._=&;^#90KM:_AJ_)RP[=6_B:/#<E^G<>&>T
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MU&7$?-K*S13-%=,8:5.,QO.C5UZNJ*Z*IQT:L(G?;H"M60
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M7J.\]?;UC_5ZP[^YYB_[+L/_  'W<.R9'?KXCO37V]8_U>M\\?N>;_X58?\
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M3J^9M5UV)_9PPGR[_C;\"I6H
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MV&2%?L +7LIQQVAMK=6IQ77.%Q*,S/?YIA NT
M   6=<3KB*U:J4.*0ER2X3B4F9$HM6MY=(@7B)
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M6=23'2[PJ(B,G5MGV1'L-/\ P3*XM;&0KQZ48<2HN;.?HPZ,X\;H6*=;@
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MLM.$BY\WFYOS$884T[41N.C*Y2+&,XXU3MS.ZS^.1U@
M                                              .>.'OSH.:3Z^@?
MLNCT68_"V?)/(^=ZJ_Y7/?%3_P!3;WI%=#T\O*OF A\+<)'PP8H:MX,90SW
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MN'?NC-_!LH5VM?PU?DY8=NK?Q-'AN2_3N/#/:
M    YT\DG],?/'^529^$*L+G6GV5CX.2%1JS[6]\7++HL*9;@
M
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M:M_!"GU1[-SXI=%A3+@
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M*$S/CN36S3KQ<4=*S<+30]=4C5-JN(TIB<-_!MBY3,X1,8[V*Y1@S
M         ?G4_3&_O4?SA'LORG\KD>0_-?S>5H$+>%9 )2     -L>1K\ZW#
MOW1F_@V4*[6OX:OR<L.W5OXFCPW)?IW'AGM
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M+:$B3Y0J?)@8"LWOE'5JG.5"6T@]=>K<FO<!F1[N(BXBTZ#()VQLP(
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M$I     &V/(U^=;AW[HS?P;*%=K7\-7Y.6';JW\31X;DOT[CPSV@
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MW#SHI<FM^G^E3??JDK^4 [YI^33X>8_1E?\ 67N'G??ZF=^?VJ;[_P >5_*
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M2/Y0#OV/E4^'F1^@[G]7<X)_>>3Y(;L/?S-WD?\ Y+_\H!W['RH\/,?H*O\
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MP\Q_ZYI_J*OJ_P#V4*H<D%6A5.E4_P OUS.^$E*(WNI<+@X=.COT]=_FA/\
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M/ L=5?\ CO)Y._%RNK3B-G1T8IB9W,=F<8\7#L;#?0B(B(B+0BV$1"@?0GT
M           !"?\ I#W[17[ "U+'_@%O]^<_9(1 O 2
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M'EJ-1ZK5J>FNPMG0*V[7%=4U1&&.Y&XLK5$T4Q3,XX;LKH&MF
M   #\ZGZ8W]ZC^<(]E^4_E<CR'YK^;RM A;PK(!*0    !MCR-?G6X=^Z,W\
M&RA7:U_#5^3EAVZM_$T>&Y+].X\,]H                          #G3R
M2?TQ\\?Y5)GX0JPN=:?96/@Y(5&K/M;WQ<LNBPIEN *#2[9H5%J=?K%+IR(5
M1NA]J37I"%+TD/,MDTAPT&HTI/@(B,TD6O3J8"O
M               HE$MN@6TW/:H%(BTANJS7:C4DQ6TM]?+>))./N:>B6KA+
M4SVGH K8    "$^PQ*8>C2642(TA"FI$=U)+0XA9<*DJ2K4C(R/0R,!BVG8+
MP]2:JU6Z=CB@Q:DPYUL=],1!I;<WDIML]4),CVD9)V= G$97$  H,&V:%3JW
M6+DB4Y#==KR66ZK5%*6XZZW'+A:;(UJ5P(3J>B$Z)UVZ:[0%>
M                    !R[SG_M$L-_DP>^K5X7%K_CZ_C_=55?X^GX.66UR
M>D4JVA[+>0)12WC)"(GI!"91N(0(R=Y )A(D32 $VC<(2FFN@2A.(Z (3[?S
M 3*:+>"$TG<7G A, )AOI&2$RC>0A*93O"2'L0D ?#(E$:5$2DJ+123VD9&
M\-,M,()MAI#+:=S:$DE):_((!$                          $);#+BVW
M7&4+<:^E.*21J3KYAGM(!%                           R(R,C+4CWD
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M\(587.M/LK'P<D*C5GVM[XN67184RW
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M:M_!"GU1[-SXI=%A3+@
M    ?G4_3&_O4?SA'LORG\KD>0_-?S>5H$+>%9 )2     -L>1K\ZW#OW1F_
M@V4*[6OX:OR<L.W5OXFCPW)?IW'AGM                           <Z>
M23^F/GC_ "J3/PA5A<ZT^RL?!R0J-6?:WOBY9=%A3+<
M
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MGH2R,M?/ 4RC4INC0DPFG5/)2M2^-1$1]EYP"J@
M    "D5"D-U"92YBWE-JI;BG&T)(C)1J-)Z'_B@*N
M        #G3^KL]KW,!^52J_4F1<ZY]JW\$*?5'LW/BET6%,N
M                                  !^=3],;^]1_.$>R_*?RN1Y#\U_
M-Y6@0MX5D E(     VQY&OSK<._=&;^#90KM:_AJ_)RP[=6_B:/#<E^G<>&>
MT                          !SIY)/Z8^>/\ *I,_"%6%SK3[*Q\')"HU
M9]K>^+EET6%,MP
M                                     '+O.?\ M$L-_DP>^K5X7%K_
M (^OX_W557^/I^#EEM<GI%*MH>RWD"44MXR0B)Z00F4;B$",G>0"82)$T@!-
MHW"$IIKH$H3B.@"$^W\P$RFBW@A-)W%YP(3 "8;Z1DA,HWD(2F4[PDA[$) $
M&2Z;,>0\DB-33:UI(]QFDC,!2Z!4G:O3&9S[:&W'%+(T(UX>Q49=)GY@"M
M                        "@5*KO0JM1Z>VTA;=14LG5JUXD\.F[0].D!7
MP                         !X<4:&UK+::$F9%YQ *-;U4>K%-3-?;0TX
MIQ:.!&NFB?/,P%<                          % JU6>I]0HD-MI"T5-Y
M3;JE:ZI))H+L=#_X72 KX                           .=/ZNSVO<P'Y
M5*K]29%SKGVK?P0I]4>S<^*7184RX
M              'YU/TQO[U'\X1[+\I_*Y'D/S7\WE:!"WA60"4@    #;'D
M:_.MP[]T9OX-E"NUK^&K\G+#MU;^)H\-R7Z=QX9[0
M       '.GDD_ICYX_RJ3/PA5A<ZT^RL?!R0J-6?:WOBY9=%A3+<
M
M               !R[SG_M$L-_DP>^K5X7%K_CZ_C_=55?X^GX.66UR>D4JV
MA[+>0)12WC)"(GI!"91N(0(R=Y )A(D32 $VC<(2FFN@2A.(Z (3[?S 3*:+
M>"$TG<7G A, )AOI&2$RC>0A*93O"2'L0D 2TQ"G(DIM!<2ULK2A/FF:3(B
M4:U8<F!18\:6T;+Z%.&ILS(S(C69EN,P%Q
M"UJQ ER*[0)3+)N1XBEG)<(RT3KIIKJ>H"Z0
M !#=(U-.I26IJ0HB+Y)D MZTX4JGT=$>8R;#Q.K4;9F1[#/9N,P%R@
M                   "UJ[ ERJM;DB.R;C,)]:Y2R,BX$F;>AGJ?R#W +I
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M#O
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M*/1*2U,_D$ E(,^)4HY2H3O7,&HTDOA4G:6_8HB,!.
M        "2DU&'#?B1I#W5O3U&B*CA4?&HM-2U(C(O1%O 3H
M               .=/ZNSVO<P'Y5*K]29%SKGVK?P0I]4>S<^*7184RX
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M#<\CIU;/5S79F/I4SC,]+'=\K?D5*U
M                                  <<L\9':_KLTR^X%L5FKP,4VVY:
M5=@PF">?=DK547">:))FDFS*:DNS,C[%6S</39?)35D=#2B-.<8Q\WJ>#SG]
MT6[.L:J8LW*^KC1G1B)V=GQ[3(I<UU/+_51>_P!@H[<<7<E7S*.%T_K6W_37
M_J1ZWK^MA3_>HO?[!1VX=R5?,HX3]:V_Z:_]2/6]ES94[WI[W^P4=N)[EJ^9
M1PH_6MO^FO\ U(];T7-G32_U3WO]@H[<.Y:OF4<)^M;?]-?^I'K14\W%,+3_
M .T][[/^9([<.Y*OF4<)^M;?]-?^I'K>RYNZ61Z^2:^/L)';AW)5\RCA1^M;
M?]-?^I'K12YOJ47^J:^/L)';AW)5\RCA/UK;_IK_ -2/6C)YPZ27^J6^?L)O
MMP[DJ^91PGZUM_TU_P"I'K1D\Y%((OZ)+Y^PF^W#N2KYE'"G];6_Z:_]2/6B
MHYS*.G37$=\_83?;AW)5\RCA1^M;?]-?^I'K1RYTJ*7^J*^OL)ON@GN2KYE'
M"?K:W_37_J1ZTPGG8H:=^(;[^PFNZ".Y*OF4<*?UM:_IK_U(]:,7.[0BV^2"
M^_L-KN@GN2KYE'"C]:VOZ:_]2/6BESPT'3^A^^_L-KN@=R5_,HX3]:VOZ:_]
M2/6B?UY:![S]]_8;7= [DK^91PH_6MK^FO\ U(]:*GGIM].O_P!GK\V_\S:[
MH)[EK^91P\Q^M;7]-?\ J1ZT5//;;Z3(_([?FS_F;7=!'<E?S*.'F/UK:_IK
M_P!2/6BESXV\7^IR_/L1GN@=R5_,HX>8_6UK^FO_ %(];[_7SM[WG+\^Q&>Z
M!W)7\RCAYD_K:U_37_J1ZS^OG;OO.7Y]B,]T#N2OYE'#S'ZVM?TU_P"I'K09
M//?;ST=]DL.WVDWFU()1Q&MG$1E__$#N2OYE'#S'ZVM?TU_ZD>M(6_SP6Y2:
M6S!?Q)?CCC:EFI3<%GA[)1F6]TCZ0[CK^91PL9_O>WN9:]]6/6K/]?*UO>AO
M_P"P6.[!W'7\RCA1^MZ/Z:]]7G/Z^=K>]#?_ -@L=V$]QU_,HX3]<4?TU[ZO
M.?U\[6]Z&_\ [!8[L'<=?S*.%'ZXH_IKWU>=\_KZ6K[T5_?83'=@[CK^91PG
MZXM_TU[ZL>L_KZVI[T=_?83'=@[CK^91PGZYM_TU[ZL>M\_K[6G[TE^_83'=
M@[CK^91PH_75K^FO?5CUOG]?>TO>EOW[#C]V#N*OYE/"?KJU_3WOJQZWS^OS
M:'O37Y]AQ^[!W%7TZ>%'Z[M?T][@CUOG]?JS_>GOO[#C]V$]Q5].GA1^O+/]
M/=X(];Y_7[L[WJ+[^Q(_=P[BN=.D_7MG^GN\$>M\_K^6;[U-]?8D?NX=PW.G
M3QH_7UCY%W@CUOG]?ZS/>JOK[$C]W#N&YTZ>,_7UCY%W@CUG]?\ LLO]5=\_
M8L;NX=PW.G3Q^I'Z_P O\B[P1ZWSXP"R?>LOC[%C=W$]PW.G3Q^I'_L#+_(N
M\$>M\^,!LCWK;X^Q8W=P[@N=.GC]1_[!RWR;O!'K>?C [']Z^]_L:-W<.X+O
M3IX_4C_V%EODW."/6^?&"6+[V%[?8T7NX?I^[TZ>/U(_]AY7Y-S@CUOGQ@UB
M>]C>WV/%[N)_3]WIT\?J/_8F5^3<XO6^?&#V&6_&5ZE_T>+W</T_=Z5/'ZD?
M^Q<I\JY_I];Y\838)?ZM+T]0B]W#]/7>E3Q^I'_L;*?*N?Z?6MZI\^EC3*M1
MZ@C'-X(:IREFZA3$;B5Q::<.C^G0'Z>O=*GC]2?_ &/DMVW<_P!/[RO_ !AF
M/O>VO/U&)]L"?T]>Z5/'ZF/_ +(R7RZ_]/K?#_6'8\+?CB\B_P#4Q/M@/T[>
MZ5/'ZD?^R<E\NO\ T^MY^,0QV6_'-XE_ZF)]L!^G;W2CC]2/_961^77_ *?6
MNZQ.>S%%Y752[6J%(K=E*K"^IA5BM(CMP^O/0D-N.-O+-'&9Z$HRX2/34R+:
M-.8U%?M435L3AN1CB[M7?W]D,Y>BUA51CNU888[D3A,X8[^TW8%*]P
M              A/_2'OVBOV %J6/_ +?[\Y^R0B!> D
M         %EW+_#EI?7+GT30@7H)                           <Z?U=
MGM>Y@/RJ57ZDR+G7/M6_@A3ZH]FY\4NBPIEP
M                     /SJ?IC?WJ/YPCV7Y3^5R/(?FOYO*T"%O"L@$I
M   &V/(U^=;AW[HS?P;*%=K7\-7Y.6';JW\31X;DOT[CPSV@
M              .=/))_3'SQ_E4F?A"K"YUI]E8^#DA4:L^UO?%RRZ+"F6X
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M5-V*:*(PHIVM_P LM^4RM5J:JZYQKJV][R0V>'"[@
M                                            '/'#WYT'-)]?0/V7
M1Z+,?A;/DGD?.]5?\KGOBI_ZFWI=(KGIY>%;P0&)1+R8,9000\GO,3"'@2B4
M,^D$/(E$H9] E#PK<#&4(Q*7Q7H1,,4,$2A'O,9(>3!#RKH$L7@$2\J$PQ>!
M,DO"^@(8O!"42AJ$CPK<0(0U= F&,I%SH^6,X:*D@[TC.&BI(.;E#)IE3G>D
M9PT5J<]TC.'/4ISFY7G#9#1*16,FBI(N#.&BM(.;C&RESU*>Y\P90TU)!WI\
MX9PTU*<Y\\,X:*E/=]",X::E/7O,9PT5)%W>8SASU*>Y\\,H:*E/=&<.>I(N
M] RAIK4I[Y@VPY:DDYN/SQ,-->TICFX;8<M2VJY28E9BN19:-2WLNEZ)M70I
M)C*:(KC"6%N_59KTJ6XO*OS42K<ET[#N8:EK$[&+8]\25]B2?0MPYCBC]#N2
MVXH^Q]"KL=#+Q6NM2S3,W+<>6.6.6'W7^Q_[XHNTTY;,U;&U35.Y[M7BZ-7F
MGQ=11Y1]=                  !\,B,C(RU(]AD8"$Q'CQ6^JC,-QVB,S)M
MI)(3J>\]$D1 (P                          @.QHSRV77H[;KL<S4PXM
M!*4@STU-)F6I;BW (X                           .=/ZNSVO<P'Y5*K
M]29%SKGVK?P0I]4>S<^*70.M5BGV]1JM7ZO(*)2J'"?J%3E&1F34>,VIUU9D
M6WL4),Q44TS5,1&W*VJJBF)F=J&C%K9FYO\ ,5OJR;B+'&.Z)C><M]=J4:\I
ME2\/U:+'<6V3S9PU(BL&Z:#)).F1%OXE(T6=I<RV5L5:%RJJ:MW##".'95EO
M,YJ]3IVZ:8IW,<<9X-AD6T>9I=_<N&3\OT>WD6_>^,:1<2;ALRIFI]J%7:%!
M<E''=-LV5N-*,D'L-"M#-.I*(S&FYD>KS%-N9QIJF,)C>F6VWG>LL57(C"JF
M)QCQQ#*V L@5G*F&\>Y#N&-"AUJ[*4B=48M.0XW%0XI:TF32'7'EDG1/SRS\
M\<^;LQ9NU41M1+HREV;MJFN=N86!?6:KIMCF>P?A6! I3UK9+I5;G5V?(:?5
M4&G*;#E2&2C.(?0TE*E,))7&TK4M=#+>6ZUEJ:\O7=G'&F8PWMF8:;N9JHS%
M%J,,*HG'?V(EL\.%W-%HF=>8?,]RWPSRVVC8L6PK"K#]OOWQD%^H\-7J$0D]
M\)@QZ89+0A!J(R4O4E),CU2HS0FTG*V+%-/735I3&.%.&Q'CQ5<9J_?JJZF*
M=&)PQJQV9\6#)&">8*IW_-R18^4+:CX^REB!UHKVI;$CKZ>[$D-J>9J$1U79
M$TM">(R4:N%)H/B[+0M.:RD6XIJMSI4U;6_Y&[*YN;DU4UQHU4[>]Y6(J#GG
MFGS#1ZQDW!6-['/%$25+9M:%=LFHMW!<3,%Q32WH11U-QF.L6VI*4O'H2MG$
MK0S'17E,M9F*+M56GNX884^7=<]&:S-Z)KM4TZ.YCCC/DW&8[8YI+)KG+Q4N
M82? F4>EV[$DE=%L+T5,AU.(X3#E/U42"4M;RD);49)U):342=I%SUY&NF_%
MF-F9VI\6^Z:,]158F].Q$;<>/>8?9RSSNSK+3EZ#BG&R+)>IY5V-CAZ=5#NM
MRF&WUZ='TZ0R=4T?$231Q?.]7Q]B.B<ODXKZN:ZM+:QPC1Q]+FC,9N:.LBFG
M1V\-G2P]#(%P\WUGT[ESMS/M%HLJMNWJZQ2K1LE+A)E2:Z\XXP=/4X25:=6X
MRZ:E$D]4HU2DS4DCU4:NKF_-J9PPV9GQ;[=7K"F+$78C''8B/'O,>71GGFBP
M= HV0<_6%8$G%<Z=&A7&FRI5176J"F8HD-O22F*6Q()"E$DTL&?$K<HB,C&V
MC*9:_,T6:JM+<TL,)X.5IKS68L1%=VFG1W<,<8\/$WZ:=:?::?96EUEY"7&G
M4GJE25%J1D?F&0J5LB -8:SFJZ:=S;6G@5B!2E6?7K <NJ94EM/G4DS$2YC!
M-MND^3)-<,=)Z&T:M3/LMVG=3EJ9RLW=G&*L/%N.&K,U1F8M;&$TX^/=;/#A
M=P P1;-Z98H=JY=NO,MK4BE1K-FUB=9D6@N<3D^WX#"GV'7S7*D$E]PD&1^@
M+_@$.NNU:JJHIMS.SACCN3/FVG+1<NTTUU7(C8QPPW8CE4RD91R+DCESIV5,
M5VI2UY"NBEM5"V+3J\@W()+7*)"FGWR<AFKA9)1Z\2.R_P  FJQ;M7^KN3.C
M$[,QX2QIOW+MCK+<1I3&Q$^$,X6V]79%NT!^Z(L>#<K].BN7%"B'K'9G*92<
MEMDS6YJA+AJ)/9*V=)[QRUZ,53H[6.QY'51C-,:6WALJT,637&9E^Y8_-=2<
M%H@TP[2GXU5>+U14T]X1*<53>A=6ETGB:ZGJVR/0VN+B^>TV#MC+TSEIN[..
MEAXL,,7'.8JC,Q:V,-''Q[>#8X<3L        :XT++]RU3FBOC"<B#3$6K;-
ME0;C@5!MIXJ@N5)?::6AUPWC:-LB6>A$T1Z_/#MKR],9:F[LXS5AXG'1F*IS
M%5K8PBG'QMCAQ.P   !^=3],;^]1_.$>R_*?RN1Y#\U_-Y6@0MX5D E(
M VQY&OSK<._=&;^#90KM:_AJ_)RP[=6_B:/#<E^G<>&>T
M           !SIY)/Z8^>/\ *I,_"%6%SK3[*Q\')"HU9]K>^+EET6%,MP
M
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M1L^.=R'+?OV\K1C.QXHW9:C6YCF_X&&>;WF*RK#*W\F9JL:MRXUKMZ]90Z1
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MB;.,S3,8QCN>)T!%0MGYU/TQO[U'\X1[+\I_*Y'D/S7\WE:!"WA60"4@
M#;'D:_.MP[]T9OX-E"NUK^&K\G+#MU;^)H\-R7Z=QX9[0
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M3I$!=4ITR;&9FNS9#*%K2;!&@R,UK-*"X2XN@@&8A
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M%X3'K^QEB'(U<R#?R+XKU-I\^92*HU3X]-0R1121&8)N,E.IF_MXC\TO, 8
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M/4S,S,>"N7*KE4U53C,OT-E\O;R]NFW;IBFFF,(B-Q6!@W
M  /#BN!M:R+4T),]/.(!1[?JKE9IR9KK265*<4C@29F78^> K8
M                H55J[E/J%&AH92XFJ.J;<6HS(TDDT%J7^, KH
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ME^7MB&J,RH#-K6%67JY7XDA;A27Y#24'"ZA"6E(/@6E7%Q+3L/9J$#-@@
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M2$6RH;8\C7YUN'?NC-_!LH5VM?PU?DY8=NK?Q-'AN2_3N/#/:
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MXNMS11)UW*,R/IU(3B-C$I2A*4(22$((DH0DM"(BV$1$0@>@
M                     !Q_R'.R]C+F]N^T;"ET:/<&9H17+3')J.N8\'1S
MEI0EU1HU;<XHKNPB,O0[1ZBU<L7,G35<QPHV-C?V'S>]JS6=C6=ZK+3;_P"[
MA5]+':C'#:C;VV2BF<ZA[JS9'J9]Q'+VC(;U?$[>P_W!OV/]7J.^N=0_^V+(
M]3/N(=HR&]7Q'8?[@W['^KU/O?/.J?\ VQ9'J9]Q$]HR&]7Q([#_ '!OV/\
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MF9CR-RY5<JFJJ<9E]DR^7MY>W3;MTQ333&$1&XK P;@
M ?#,DD:C/0DEJ9_((!+0YL6H,%(AO$^R9FDG"(RVEOWD0":
M             $I(GQ(KT6/(>)MZ:HT14&1GQJ+34BT+Y);P$V
M                 #G3^KL]KW,!^52J_4F1<ZY]JW\$*?5'LW/BET6%,N
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ME*>(]ID1:ZGJ9U>M;=-O,513&$;'H6>J[E5S+TS5.,[/I;=BO6
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MC)@VQY&OSK<._=&;^#90KM:_AJ_)RP[=6_B:/#<E^G<>&>T
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M4M4E;R-FI<;!\)EKM/03N#/0@
M              '+O.?^T2PW^3![ZM7A<6O^/K^/]U55_CZ?@Y9;7)Z12K:'
MLMY E%+>,D(B>D$)E&XA C)WD F$B1-( 3:-PA*::Z!*$XCH A/M_,!,IHMX
M(32=Q><"$P F&^D9(3*-Y"$IE.\)(>Q"0!*3_P#V&;^\.?0F M^RO:]%_;N_
M1F NL                          657O;+:_[=S_S1 O42
M              "$_P#2'OVBOV %J6/_  "W^_.?LD(@7@)
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M6FTT)\P@W!6\M.%-YC.6BF1B4Y+@'<DZ4DM-$L.0VB)1F?[PKYFT(VAM2(
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MJE5^I,BYUS[5OX(4^J/9N?%+HL*9<
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MWN)+:BWI4I)^A"1M((
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MD*T/Y0"V+,>>?HC;C[JWG.N<+C6HU'H1^:8"ZP
M   !:%POO-5FUFVWEMH>D.$ZA*C(E%JUL41;]_2 N\
M         '.G]79[7N8#\JE5^I,BYUS[5OX(4^J/9N?%+HL*9<
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M]T9OX-E"NUK^&K\G+#MU;^)H\-R7Z=QX9[0
M '.GDD_ICYX_RJ3/PA5A<ZT^RL?!R0J-6?:WOBY9=%A3+<
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MVO<P'Y5*K]29%SKGVK?P0I]4>S<^*7184RX
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M8]$N3@]$\^VQY&OSK<._=&;^#90KM:_AJ_)RP[=6_B:/#<E^G<>&>T
M                    !SIY)/Z8^>/\JDS\(587.M/LK'P<D*C5GVM[XN67
M184RW
M                             <N\Y_[1+#?Y,'OJU>%Q:_X^OX_W557^
M/I^#EEM<GI%*MH>RWD"44MXR0B)Z00F4;B$",G>0"82)$T@!-HW"$IIKH$H3
MB.@"$^W\P$RFBW@A-)W%YP(3 "8;Z1DA,HWD(2F4[PDA[$) $&2Z;$=]XB)1
MLMJ61'N,TD9@*;0:FY5Z8S.=:2RMQ2R-"3,R[%1ET^< K
M            H-1J[D*JTBGH92M%14HEN&9ZIX=-W^$!7@
M           !X<5P-K61:FA)GIYQ */;]5<K-.3-=:2RI3BD<"3,R['SP%;
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M_P!IF(C8IAJ"+)6ML>1K\ZW#OW1F_@V4*[6OX:OR<L.W5OXFCPW)?IW'AGM
M                          <Z>23^F/GC_*I,_"%6%SK3[*Q\')"HU9]K
M>^+EET6%,MP
M                                  '+O.?^T2PW^3![ZM7A<6O^/K^/
M]U55_CZ?@Y9;7)Z12K:'LMY E%+>,D(B>D$)E&XA C)WD F$B1-( 3:-PA*:
M:Z!*$XCH A/M_,!,IHMX(32=Q><"$P F&^D9(3*-Y"$IE.\)(>Q"0!+3$*<A
MRT((U+6RXE*2WF9I,B(!1;4BR(5$CQY3*F'DK<-3:MY$:S,@%Q@
M                "U*Q"E/UZWI++"G&(JEG(=+<C7334!=8
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MJS[6]\7++HL*9;@
M                                      .7><_]HEAO\F#WU:O"XM?\
M?7\?[JJK_'T_!RRVN3TBE6T/9;R!**6\9(1$]((3*-Q"!&3O(!,)$B:0 FT;
MA"4TUT"4)Q'0!"?;^8"931;P0FD[B\X$)@!,-](R0F4;R$)3*=X20]B$@#RM
M:6T+<6?"AM)J6KS"(M3,! AS(T]A,F(Z3S"S,DN$1EKH>A[R(P$R
M                  )1^?$CR(T5YXFY$LS*,V9'JK3?IH6@";
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MA):C(?E.DHVV&U.J22G%$DS));3T/0M@RIHJJVHQ8U5TT[<X*N,60
M  YT\DG],?/'^529^$*L+G6GV5CX.2%1JS[6]\7++HL*9;@
M
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MX"0                         67<O\.6E]<N?1-"!>@D
M             !SI_5V>U[F _*I5?J3(N=<^U;^"%/JCV;GQ2Z+"F7
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MJ\-CQ2T.%NJ6V/(U^=;AW[HS?P;*%=K7\-7Y.6';JW\31X;DOT[CPSV@
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MPB-)FVO8:5I/:E:%$:5I/:E1&1[2%?=M56JIIJVX=]JY3<IBJG:E=0UM@
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M3%7CTL/-M.S+1?C'K9I\6&/GVV<ARNH
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MC+4CV&0"!&BQH;1,Q6$1VB,S)M!:%J>\]" 3
M   EWHD:0XP\^PAUV*9JCN*(C-!GIJ:3Z-Q )@
M     '.G]79[7N8#\JE5^I,BYUS[5OX(4^J/9N?%+HL*9<
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MF2NW*;M=FY.EH[,3XO&WC%6LP
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MVX1:&6P]%$I)?.,]D:\K7HU;6Y.^_3VH=?6-;6.LM[%4>U3NTSRQ.Y/+C#.
MXEX     +1K4F2U<%N,M2'&V7UN$^TA9DE>FFG$1'H?RP%W
M             "&\9DRZ9'H9(49&7G +9LZ1(E45#LE]R0Z;SA&XZHUJT(]A
M:J,S 74                          +1N"3)9K%KM,R'&FI$AQ+[:%FE*
MR(V]"41'H>\]X"[@                           <Z?U=GM>Y@/RJ57ZD
MR+G7/M6_@A3ZH]FY\4NBPIEP
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MV=V=]NR>6KIKJNW,-*K<C<C>;;"O6
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M#YO+].1CALO8)    46?1^_JE2ZCWQU7@U2CZG@XN/BT^>XBTW>88"M
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MGH9)U(U\*.S&-6K8JIFJS7%>&W&U/ RIUC--44WJ)HQVIVXX6\(JUF
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M=_MT Y#1351.,V^^"C\76&WQD:>/ATUV:ZC+0G#2PV-]CIQCHX[.\JHQ9
M          #G3R2?TQ\\?Y5)GX0JPN=:?96/@Y(5&K/M;WQ<LNBPIEN
M
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MZA5U0JG2J>3!.)J2E$ITU:&CATW%IMW@*X
M/#BN!"UZ:\"3/3SB 4F@U559IZ9JF2CFI:D=62N+T/3KH0"L@
M              "AU2KJI\^CPTL$Z54=4VIPU:<'":"U(M#U]$ K@
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MT)Y27):$;=J5)/S2(=/=NCA%=RFFJ=R>6=QS=Y:6,T4554QNQR1NLJ8CYF;
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M@D&^\ADG%DVV;BB3Q+/<DM=YGY@@10$-UYIA/&\ZAE&I)XUJ)):F>A%J?FF
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M>2(W(Y<99P'$O       6G68DIZOV[(:86XQ'6X;[J2,THUTTU/H 78
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MK0:&=J5/(5O27$2S2K.Q=KM=9.AI6\?I1Y]AA?M47.KC3T;F'T9\VRHT&_\
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MJH<?B(].#OY_7AUZ.+BW=.H3MC:$0
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M!5W4.\\M\GCYD?IG6?\ 6_[<>M$+!O,0K])27]@J[L'>F7^3Q\Q^F=9_UO\
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M7GOZJ/J1ZT,^3G-9[^8]9_Q4K[9#ONU\OC1^B,Y_51]2/6AGR:9G/?S&*/\
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M_=& +PIV#'<=T19W9=M_73$JN3:^EYF.1]:\4F5(2<E;?&AI;+9$DBXE'V7
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M*=X20]B$@"4G_P#L,W]X<^A,!;]E>UZ+^W=^C,!=8
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MR2429(:0B6I+G$9K)Y2"5N+AW;0&0P
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MI6E2%D2D+(TJ2>XR/89 (4:-'B-)8BLH893J:6T%H1:[3V (X
M               EW8D5YYF0ZPAQ^,9FPZHB-2-=^A] "8
M            'PR(R,C+4CV&0"!&BQH;1,Q6$1VB,S)M!:%J>\]" 3
M                     EWHD:0XP\^PAUV*9JCN*(C-!GIJ:3Z-Q )@
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MG)P>B>?;8\C7YUN'?NC-_!LH5VM?PU?DY8=NK?Q-'AN2_3N/#/:
M                  YT\DG],?/'^529^$*L+G6GV5CX.2%1JS[6]\7++HL*
M9;@
M                          .7><_]HEAO\F#WU:O"XM?\?7\?[JJK_'T_
M!RRVN3TBE6T/9;R!**6\9(1$]((3*-Q"!&3O(!,)$B:0 FT;A"4TUT"4)Q'0
M!"?;^8"931;P0FD[B\X$)@!,-](R0F4;R$)3*=X20]B$@"6FJ4B'+4E1I4EE
MPTJ(]#(R2>AD8"A6B^_)H<9Z2\Y(=4MPE.N*-:CT69%J9ZF N8
M                6C6I,EJX+<9:D.-LOK<)]I"S)*]--.(B/0_E@+N
M                     $-XS)ETR/0R0HR,O. 6S9TB1*HJ'9+[DATWG"-Q
MU1K5H1["U49F NH                          6C<$F2S6+7:9D.--2)#
MB7VT+-*5D1MZ$HB/0]Y[P%W                            YT_J[/:]S
M ?E4JOU)D7.N?:M_!"GU1[-SXI=%A3+@
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MI,_"%6%SK3[*Q\')"HU9]K>^+EET6%,MP
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M)IU\\@%)H=)\"P$P>^.^>%:E];P<'HNC357[("L
M     "BU*C^$9U(F]\=3X*=4YU?!Q=9Q&@]->(M/0^88"M
M              YT_J[/:]S ?E4JOU)D7.N?:M_!"GU1[-SXI=%A3+@
M                                        ?G4_3&_O4?SA'LORG\KD
M>0_-?S>5H$+>%9 )2     -L>1K\ZW#OW1F_@V4*[6OX:OR<L.W5OXFCPW)?
MIW'AGM                           <Z>23^F/GC_ "J3/PA5A<ZT^RL?
M!R0J-6?:WOBY9=%A3+<
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MP'Y5*K]29%SKGVK?P0I]4>S<^*7184RX
M                 'YU/TQO[U'\X1[+\I_*Y'D/S7\WE:!"WA60"4@    #
M;'D:_.MP[]T9OX-E"NUK^&K\G+#MU;^)H\-R7Z=QX9[0
M          '.GDD_ICYX_P JDS\(587.M/LK'P<D*C5GVM[XN67184RW
M
M                    <N\Y_P"T2PW^3![ZM7A<6O\ CZ_C_=55?X^GX.66
MUR>D4JVA[+>0)12WC)"(GI!"91N(0(R=Y )A(D32 $VC<(2FFN@2A.(Z (3[
M?S 3*:+>"$TG<7G A, )AOI&2$RC>0A*93O"2'L0D 2TU*EPY:$)-2ULN$E)
M;S,TGH0"B6E&D1*'&8DLK8>2MPU-++11:K,RV& N0
M       6G68DIZOV[(:86XQ'6X;[J2,THUTTU/H 78
M        (;Q&IITB+4S0HB+Y0"V[0BR8=&0S*87'=)UPS;66AZ&>P]# 70
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MY5)GX0JPN=:?96/@Y(5&K/M;WQ<LNBPIEN
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M^>/\JDS\(587.M/LK'P<D*C5GVM[XN67184RW
M
M <N\Y_[1+#?Y,'OJU>%Q:_X^OX_W557^/I^#EEM<GI%*MH>RWD"44MXR0B)Z
M00F4;B$",G>0"82)$T@!-HW"$IIKH$H3B.@"$^W\P$RFBW@A-)W%YP(3 "8;
MZ1DA,HWD(2F4[PDA[$) $I/_ /89O[PY]"8"W[*]KT7]N[]&8"ZP
M                 !95>]LMK_MW/_-$"]1(
M (3_ -(>_:*_8 6I8_\  +?[\Y^R0B!> D                         %
MEW+_  Y:7URY]$T(%Z"0                          '.G]79[7N8#\JE
M5^I,BYUS[5OX(4^J/9N?%+HL*9<
M            #\ZGZ8W]ZC^<(]E^4_E<CR'YK^;RM A;PK(!*0    !MCR-?
MG6X=^Z,W\&RA7:U_#5^3EAVZM_$T>&Y+].X\,]H
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M+5/3J9\N=L44TT7;<84UQM;TQMNG)7ZZIKMUSC51.WOQ.TVT%>L
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M                     $J]"BOOQY+S"7'XIF<=T]Z-=^@":
M               'PR)1&DRU(RT,@$O$AQH+),1&4L,D9J)M.[4]X"9
M                     $J_"BR78[[["778BC5&<5O09Z:F7^ @$T
M                     #G3^KL]KW,!^52J_4F1<ZY]JW\$*?5'LW/BET6%
M,N                                             !^=3],;^]1_.$
M>R_*?RN1Y#\U_-Y6@0MX5D E(     VQY&OSK<._=&;^#90KM:_AJ_)RP[=6
M_B:/#<E^G<>&>T                          !SIY)/Z8^>/\JDS\(587
M.M/LK'P<D*C5GVM[XN67184RW8]RW2:C7L4Y-H=()9U:M6G6H%+)M)*6<B3!
M>::X4F1D9\:BT(R&[+U13=IF=J)CTM.8IFJW5$;<Q/H:[\@-7IE5Y4<8MTY:
M#71RJD"IL)(B-J2BI27%$HBV:K2XESSE%KM'9K:F8S-6.[AZ')JFJ)RU.&YC
MZ6PV2<KV#B&D4RNY#KZ;?I=8J;-'IT@V)$E3LV0E:VFDM1FW7#U)M6TDZ%TZ
M$..SEZ[TS%$8S$8NN]?HLQ$USA$S@R(-+<T"_5Q_T'79^4.O?011;:Y^VCX8
MY53J?[&?BGD9'ROS$91Q]>U1M:V.6"\,F4>$U'<CW?2'%)B2%/,I<6A!%$=V
MMJ4:#[+>0TY?)V[E$5578IG>G_%NOYRY;KFFFU-4;\?X,_8XNBL7O9-OW3<-
MG3K!K-5:<=F6A5#-4N"I#KC1)<,T-GJI*2478EL4.2];BW7-,3C$;L.NS7-R
MB*IC"=Z6G7+[^>=SG_Z+?^YJ%CF_PEGS^E793\7>\WH;^:%J1Z%J1:$?3H?_
M . J5LT#Y#OTGORRU_\ _MBVUK_"^"%3JK^+\<MR<C$7D^OP]"U.W:H1GTZ%
M$=_WQ76?;I\L+*][%7DEK3^K\_-$Q)_'WX?J([=;_BJ_-Z(<6J?PM'G],L7V
M#8O-'ROR+@QQBK'M#S-B2=5Y-3LJH3:VQ1YM$1-T6N++2^K5U#:BU_<T*-1F
M:M2XN!&^[=RV;PKN5337AL[&.+1:M9C*XT6Z8JHQV-G#!2>4FAW?%YK^:J?>
M-8A5ZXV(5 3=L^EH<13VZE4FN^SAQ.LU4;4,D*CI-9\2B;XCWF19:PJIG+6H
MIC"-G#';PC=\^VQU?35&9NS5.,[&.&UC.YYMITP%(N@
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M35=65JTJ=FB>+Q2_0O\ :G]UV];6XMW)B+T1YJXZ5/+&YY-K;X5#V0
M             "TZS+E,U^W8[3ZVV)"W"?:29DE>FFFI=("[
M              !#>,TM.F1Z&2%&1_* 6W:$J3,HR'I3ZY#INN$;BSU/0CV%
MJ8"Z                          !:=?ER8]7MEEA];34J0M,AM)F1+(C;
MT)1=.\P%V                            YT_J[/:]S ?E4JOU)D7.N?:
MM_!"GU1[-SXI=%A3+@
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M93*Q8IG9QJF<9G?EG0<KJ
M                         <[\0?G/\TGU] _9='HLQ^%L^2>1\[U5_P K
MGOBI_P"IMZK>0KGIGA6XQ+"4 ]P0A!4,F$H1]/GB42@JW"6,H)[C$PB4%>X9
M0P03Z1+&4/I$L90^D2QE />8RAC*$KI\X2QE*/\ H?E#*&%2CR.D;:7%6H<G
M>8VTN.XH$C>8VTN*XHC^X;8<5:BR>D;J7'<420-D.*M09&XQNI<M:B/]/GC;
M#BK4.1\\-L.&XH<G<-M+CN+?D>A/S_\ ?&ZEP7%C5B!.9GT^Y+=GNT2ZJ(\B
M12:O&6;;B7&SXD]DG:6A[C^8(O9>F]3,3#+):RN9*Y373,QA..,;<3OPZF\L
M',_ S) \4[LZJBY4HK6E0IYZ-MU-MLNRE14[B41;7&RW>B3V'H?GVM-5U96K
M2I]CT>*>27Z0_M/^[+6M[445S$7HCS5QTJ>6-SR;6WXIWLP
M     4.H4A4VITJH$^3:::I1J:-.IKXM-QZ[-P"N
M      #PXGC0M&NG&DRU\\@%)H-*51J>F$IXI!I6I?6$GA]%T::F K(
M                     H=4I"JA/H\Q+Y-%2W5.*;-.O'Q&@]"/4M/0@*X
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M69*X>(B,C2I![4ZGS9W*3EZXC'&F=F)WX=&3S<9BF9PPJC8F-Z6PPXW8
M        _.I^F-_>H_G"/9?E/Y7(\A^:_F\K0(6\*R 2D     ;8\C7YUN'?
MNC-_!LH5VM?PU?DY8=NK?Q-'AN2_3N/#/:
M YT\DG],?/'^529^$*L+G6GV5CX.2%1JS[6]\7++HL*9;@
M
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MC$[.&['E?JG^UM=7=:93K+M$Q5$X3/[-7CIY=R)VO%LJ*YZ4
M     46?6.\:E2Z=WOUOA)2BZ[CX>#AT^=X3UW^:0"M
M         #RM7 A:]->!)JT\X@%)H=6\-0$SN]^]N):D=5Q\?H>G71/[ "L
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MD E(     VQY&OSK<._=&;^#90KM:_AJ_)RP[=6_B:/#<E^G<>&>T
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M4E2K<ORSFZG2Z<^\XXS%J--?6TXF,VH^!LG&"-:^ NR5H9B-P;"B
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MLND1:F:%$1%YP"V;.CR(M%0U)8<CND\X9MNI-"M#/8>BB(P%U
M               "T;@C27JQ:[K,=QUJ/(<4^XA!J2@C-O0U&1:%N/> NX
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M0"4@    #;'D:_.MP[]T9OX-E"NUK^&K\G+#MU;^)H\-R7Z=QX9[0
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M20S*-Z.WQ;-G9D7^$A&X-J1
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MMYF9[3,]IGJ9F9F/"W+E5RJ:JIQF7W_+Y>WE[=-NW3%--,81$;BL#!N
M             !+NRXK+S,=U]#;\DS)AI1D2EZ;]"Z0$P
M           /AF1$9F>A%M,P$"-*C3&B>BOHD-&9D3B#U+4MY:D F
M                   !+O2XT=QAE]]#3LHS3';49$:S+34DET[R 3
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MTU^0&(NBT,?+L*^,Q94NFO0WVKQ<CR&G]%-)IU-IK;A<+JUGH?[F2.(RV=@
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M$1&XK P;@                   %E5[VRVO^W<_\T0+U$@
M            A/\ TA[]HK]@!:EC_P  M_OSG[)"(%X"0
M          67<O\ #EI?7+GT30@7H)                           <Z?
MU=GM>Y@/RJ57ZDR+G7/M6_@A3ZH]FY\4NBPIEP
M                       /SJ?IC?WJ/YPCV7Y3^5R/(?FOYO*T"%O"L@$I
M     &V/(U^=;AW[HS?P;*%=K7\-7Y.6';JW\31X;DOT[CPSV@
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MIWA)#V(2 /*T)<0MM9<2%D:5I/I(]AD @Q8D:$RF/$92PP@S-+:=Q:GJ8"8
M                         $J]"BOOQY+S"7'XIF<=T]Z-=^@":
M                   'PR)1&DRU(RT,@$O$AQH+),1&4L,D9J)M.[4]X"9
M                         $J_"BR78[[["778BC5&<5O09Z:F7^ @$T
M                         #G3^KL]KW,!^52J_4F1<ZY]JW\$*?5'LW/B
MET6%,N                                             !^=3],;^]
M1_.$>R_*?RN1Y#\U_-Y6@0MX5D E(     VQY&OSK<._=&;^#90KM:_AJ_)R
MP[=6_B:/#<E^G<>&>T                          !SIY)/Z8^>/\JDS\
M(587.M/LK'P<D*C5GVM[XN67184RW
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MQZO;++#ZVFI4A:9#:3,B61&WH2BZ=Y@+L
M!SI_5V>U[F _*I5?J3(N=<^U;^"%/JCV;GQ2Z+"F7
M                           _.I^F-_>H_G"/9?E/Y7(\A^:_F\K0(6\*
MR 2D     ;8\C7YUN'?NC-_!LH5VM?PU?DY8=NK?Q-'AN2_3N/#/:
M                    YT\DG],?/'^529^$*L+G6GV5CX.2%1JS[6]\7++H
ML*9;@
M                            .7><_P#:)8;_ "8/?5J\+BU_Q]?Q_NJJ
MO\?3\'++:Y/2*5;0]EO($HI;QDA$3T@A,HW$($9.\@$PD2)I ";1N$)3370)
M0G$= $)]OY@)E-%O!":3N+S@0F $PWTC)"91O(0E,IWA)#V(2 (,AHWX[[)'
MPF\VI!*\SB(RU 4ZATQ5(IK,%;Q/J;4M1N$7"1\2C/=J?F@*N
M               *'4*0J;4Z54"?)M--4HU-&G4U\6FX]=FX!7
M                !X<3QH6C73C29:^>0"DT&E*HU/3"4\4@TK4OK"3P^BZ-
M-3 5D                          4.J4A50GT>8E\FBI;JG%-FG7CXC0>
MA'J6GH0%<                           !SI_5V>U[F _*I5?J3(N=<^U
M;^"%/JCV;GQ2Z+"F7
M   _.I^F-_>H_G"/9?E/Y7(\A^:_F\K0(6\*R 2D     ;8\C7YUN'?NC-_!
MLH5VM?PU?DY8=NK?Q-'AN2_3N/#/:                           YT\D
MG],?/'^529^$*L+G6GV5CX.2%1JS[6]\7++HL*9;@
M
M    .7><_P#:)8;_ "8/?5J\+BU_Q]?Q_NJJO\?3\'++:Y/2*5;0]EO($HI;
MQDA$3T@A,HW$($9.\@$PD2)I ";1N$)3370)0G$= $)]OY@)E-%O!":3N+S@
M0F $PWTC)"91O(0E,IWA)#V(2 (4AWJ&'GN'BZEM2^'737A+734!3J+5/#%/
M:G]1WOUJEIZKBX].%1EOT3YGF *L                          *+/K'>
M-2I=.[WZWPDI1==Q\/!PZ?.\)Z[_ #2 5H
M>5JX$+7IKP)-6GG$ I-#JWAJ F=WOWMQ+4CJN/C]#TZZ)_8 5@
M                46I5CP=.I$+O?KO"KJF^LX^'J^$T%KIPGKZ+S2 5H
M                        '.G]79[7N8#\JE5^I,BYUS[5OX(4^J/9N?%+
MHL*9<                                             #\ZGZ8W]ZC
M^<(]E^4_E<CR'YK^;RM A;PK(!*0    !MCR-?G6X=^Z,W\&RA7:U_#5^3EA
MVZM_$T>&Y+].X\,]H                          #G3R2?TQ\\?Y5)GX0
MJPN=:?96/@Y(5&K/M;WQ<LNBPIEN
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M3-"B(B\X!;-G1Y$6BH:DL.1W2><,VW4FA6AGL/11$8"Z@
M          !:-P1I+U8M=UF.XZU'D.*?<0@U)01FWH:C(M"W'O 7<
M                    #G3^KL]KW,!^52J_4F1<ZY]JW\$*?5'LW/BET6%,
MN                                             !^=3],;^]1_.$>
MR_*?RN1Y#\U_-Y6@0MX5D E(     VQY&OSK<._=&;^#90KM:_AJ_)RP[=6_
MB:/#<E^G<>&>T                          !SIY)/Z8^>/\ *I,_"%6%
MSK3[*Q\')"HU9]K>^+EET6%,MP
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MJW\$*?5'LW/BET6%,N
M   !^=3],;^]1_.$>R_*?RN1Y#\U_-Y6@0MX5D E(     VQY&OSK<._=&;^
M#90KM:_AJ_)RP[=6_B:/#<E^G<>&>T                          !SIY
M)/Z8^>/\JDS\(587.M/LK'P<D*C5GVM[XN67184RW %&K=Q6_;,/PA<E=I]O
MP.+A[^J4IJ(SQ::Z=8\I"=?EC*FBJJ<*8F6-5=-,8U3@^4*Y+=NB&=0MFOTZ
MXH"5]6J=3)3,MDED6O";C*EIUV[M0KHJHG"J)CRE-=-<8TS$I&=>]ETN6] J
M=WT6G3HQD4B%*J$9EULS(E$2D+<)1:D9'M(3%JN8QB)X$3=HB<)F.%*>4?'O
MX^6[ZZ1.ZB>IKZ,\".NHZ4<*[8TF/,CL3(;[<J)*;2]%E,J);;C:R)2%H6DS
M)25$9&1D>T83&&Q+.)Q1%*2A*EK42$((S4HST(B+>9F(2IE*KM$KK;SU$K$&
MLM1U]7(=@R&Y"4+TUX5&TI1$>G08RJHFG;C!C35%6U.*))K%(A.FQ,JD.(^1
M$9LO/MMJT/<?"I1&$4S.U!-41MRA-U^A/.-LLUJ ZZZHD--(DM*4I2CT(B(E
M:F9F&A.\:=.^BU.KTFB1>_:S5(E(A<9-]]S7VX[7&K<GC<4DM3TV%J(IIFJ<
M(C%-544[,S@CPIL.HQ6)U/ELSX4E/'&F1W$NM.)],A:#-)E\DC"8F)PDB8F,
M82=3K]"HJHR*S6H%)7,5P0TS9+4<W5%IL;)Q2>(]I;A--%56U&**JXIVYP58
M8L@
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M@7@)                         !9=R_PY:7URY]$T(%Z"0
M               '.G]79[7N8#\JE5^I,BYUS[5OX(4^J/9N?%+HL*9<
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M@
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M;:RXD.)-*T^:1EH9 ($.'&@,)C1&B9809FELC,]-3U/>9F F0
M              !*/P(DB1&E/,DY(B&9QG#,]4Z[]-#T 38
M             ^&1*(TF6I*+0R^08"6APHM/8*/#9)ADC-1-D9GM/?O,P$T
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M5=
M      .=^'_SH.:3Z]@_LNCT68_"V?)/(^=:K_Y7/?%3_P!3;H_0BO>EJ2RM
MXF&$I5>XQE#"4LO>8R8)5?S!E#"4!6\_.&4-<I=>[Y8RAA*67O,9,%'F;O\
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MD0"XP                         !:E8FRF*];T9E]3;$I2RD-%N7IIIJ
MNL                          0WC-+3JB/0R0HR/Y0"W+1F29U'0_+>4^
M\;KB3<5OT(]@"YP                         !:M>FRHU6MIAA]334N0M
M,EM.Y9$;>A'_ (3 74                           #G3^KL]KW,!^52J
M_4F1<ZY]JW\$*?5'LW/BET6%,N
M           !^=3],;^]1_.$>R_*?RN1Y#\U_-Y6@0MX5D E(     VQY&OS
MK<._=&;^#90KM:_AJ_)RP[=6_B:/#<E^G<>&>T
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MS3HT1A"_AJ;0
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MF _*I5?J3(N=<^U;^"%/JCV;GQ2Z+"F7
M                  _.I^F-_>H_G"/9?E/Y7(\A^:_F\K0(6\*R 2D
M;8\C7YUN'?NC-_!LH5VM?PU?DY8=NK?Q-'AN2_3N/#/:
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METZC%)N2\F-'<ZY'"X\KT+2#UT-1]"2V@)X
M                          '._#_YT'-)]>P?V71Z+,?A;/DGD?.M5_\
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M>,N(F4*7P[M>$M= $A1JFFKP&IR638)TU%U9JXM.$S+?H7F *H
M                *-.JZ851IE/-@W%5(U$ETE:$CATWEIMW@*R
M                 /*U<"%KTUX$F>GG$ I=%JJ:S!3-2R<<E+4CJS5Q>AZ=
M=" 58                          4>HU=-/FTJ&I@W3JCBFTN$K3@X326
MIEH>OH@%8                           !SI_5V>U[F _*I5?J3(N=<^U
M;^"%/JCV;GQ2Z+"F7
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M^+/0V6O8E):2Z1;=NSB&(K
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M1%J9H5H7R@%L68R\Q1&VWVELN=<X? M)I/0S\PP%U@
M       "T+A8>=K-K.-LK<0S(<-U:4F9)+5K:HRW;ND!=X
M             .=/ZNSVO<P'Y5*K]29%SKGVK?P0I]4>S<^*7184RX
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M2I1%\@1&V,[6;2GJ#:%JT.3IWQ1J/!@R.'87''CH:5IOZ4B!<@
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M]S ?E4JOU)D7.N?:M_!"GU1[-SXI=%A3+@
M                   ?G4_3&_O4?SA'LORG\KD>0_-?S>5H$+>%9 )2
M -L>1K\ZW#OW1F_@V4*[6OX:OR<L.W5OXFCPW)?IW'AGM
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M7*/3FR3(QKAB?W]6Y/HFJC<Z2T9B(^=4F$D^)PRW*4;:BV[&T-G1
M                                           #EWG/_:)8;_)@]]6K
MPN+7_'U_'^ZJJ_Q]/P<LMKD](I5M#V6\@2BEO&2$1/2"$RC<0@1D[R 3"1(F
MD )M&X0E--= E"<1T 0GV_F F4T6\$)I.XO.!"8 3#?2,D)E&\A"4RG>$D/8
MA( E)_\ [#-_>'/H3 6_97M>B_MW?HS 76
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M1!I<"/3832EJ;AQ6D,M)-Q1K69(01)(U*49GLVF>H"<
M                                  !R[SG_ +1+#?Y,'OJU>%Q:_P"/
MK^/]U55_CZ?@Y9;7)Z12K:'LMY E%+>,D(B>D$)E&XA C)WD F$B1-( 3:-P
MA*::Z!*$XCH A/M_,!,IHMX(32=Q><"$P F&^D9(3*-Y"$IE.\)(>Q"0!Y6A
M+B%MK+B0XDTK3YI&6AD @0X<: PF-$:)EA!F:6R,STU/4]YF8"9
M                 $H_ B2)$:4\R3DB(9G&<,SU3KOTT/0!-@
M               #X9$HC29:DHM#+Y!@):'"BT]@H\-DF&2,U$V1F>T]^\S
M30                          E)$")*>BR)#)./0E&N*LS,N!1Z:F6A_(
M+> FP                           <Z?U=GM>Y@/RJ57ZDR+G7/M6_@A3
MZH]FY\4NBPIEP                                             /S
MJ?IC?WJ/YPCV7Y3^5R/(?FOYO*T"%O"L@$I     &V/(U^=;AW[HS?P;*%=K
M7\-7Y.6';JW\31X;DOT[CPSV@                          .=/))_3'S
MQ_E4F?A"K"YUI]E8^#DA4:L^UO?%RRZ+"F6X
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MSVO<P'Y5*K]29%SKGVK?P0I]4>S<^*7184RX
M                     'YU/TQO[U'\X1[+\I_*Y'D/S7\WE:!"W5D/H)
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M[BX.IX.RZS7ATVZZ#UNA5V7##9ZK#SX;3RFG3VG''8ZW'S8M&A:*P
M
M
M
M
M
)        !__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2227887d8-tbl_oncolog4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d8-tbl_oncolog4c.jpg
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M# P,# P,#/_  !$(!'0'; ,!$0 "$0$#$0'_Q $#  $  04! 0$
M    ! ,%!@@)!P(! 0$  @,! 0$              04#! 8"!P@0  $# P("
M P8(%! '"@H'"0 ! @,$!081!S$2(1,(08'1(I,443)25746%QAA<<&RTK-4
MI-05-975-I9GAU@)*;%"DB-SH].TQ%9V-W<X2$F1H6(SPS2U<H-TA)1%A<7&
M&8*B0R0E989'5SG"4V/C9.0FMB<H1O!$I:=H$0$  0("! 8-" <'!0 " @,
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M52&7GE(
M                                    &(V'ZNY5^S0?H2'JK5"&7'E(
M                          %:#TTG[&_XU2)%$D
M          9GGGU<H?Y.XY_L2B,5GR>6>_++>\KDCO0PPRL0
M
M              V5_L>?AD_[/E?_ +S_ "_[3?\ ]G_F?V7.:G_S??4NZ-2C
MO^4KGIA       9W@?I;O^R1?H.-:[K;]OR8>A&-D
M     #$,3_Y\]DI?B'JI#+SRD
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M^5_^\_R_[3?_ -G_ )G]ESFI_P#-]]2[HU*._P"4KGIA       9W@?I;O\
MLD7Z#C6NZV_;\F'H1C9                         Q#$_^?/9*7XAZJ0R
M\\I
M                                 Q&P_5W*OV:#]"0]5:H0RX\I
M                       K0>FD_8W_ !JD2*)(
M        S///JY0_R=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
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M&7GE(
M                                  &(V'ZNY5^S0?H2'JK5"&7'E(
M                        %:#TTG[&_P"-4B11)
M         &9YY]7*'^3N.?[$HC%9\GEGORRWO*Y([T,,,K$
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M['>ES!.A<V                                   V5_L>?AD_[/E?\
M[S_+_M-__9_YG]ESFI_\WWU+NC4H[_E*YZ80      &=X'Z6[_LD7Z#C6NZV
M_;\F'H1C9                         Q#$_\ GSV2E^(>JD,O/*0
M
M                        ,1L/U=RK]F@_0D/56J$,N/*0
M              *T'II/V-_QJD2*)(                            S/
M//JY0_R=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
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M$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R
MZ>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ
M7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C
M/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=
M!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>
MGBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[
MJ\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<
MVR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5
MQQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GB
MGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\
M>^R Z>GBGU:O$=!5QQZU/C/<VR+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C/<VR
M+UQQ7[J\>^R Z>GBGU:O$=!5QQZU/C5H=M\A1S__ $CBW3&].C*\?7]*O_K
M=/3Q3ZM7B.@JXX]:GQJ/N;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZX
MXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:G
MQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B
M.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =
M/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK
M]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQG
MN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@
MJXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3
MQ3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U
M>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;
M9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JX
MX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3
MZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/
M?9 =/3Q3ZM7B.@JXX]:GQGN;9%ZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQGN;9%
MZXXK]U>/?9 =/3Q3ZM7B.@JXX]:GQMF[EV.-\,R98<EL-KM%7:;GCE@=1U+;
MM2N:]([321.5KF/<QS>9BZ.:Y6JG2BJBFA3O2Q;QIF9QB9X.W*QG=-ZY$51A
MA,1P]J%L]XCVA_6*T_72G\)ZZXR_'/,CJ7,=KG/>(]H?UBM/UTI_".N,OQSS
M'4N8[7.>\1[0_K%:?KI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2
MYCM<Y[Q'M#^L5I^NE/X1UQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\QU+F.
MUSGO$>T/ZQ6GZZ4_A'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.
M>\1[0_K%:?KI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2YCM<Y[Q
M'M#^L5I^NE/X1UQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\QU+F.USGO$>T
M/ZQ6GZZ4_A'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.>\1[0_K
M%:?KI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2YCM<Y[Q'M#^L5I
M^NE/X1UQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\QU+F.USGO$>T/ZQ6GZZ
M4_A'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.>\1[0_K%:?KI3^
M$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2YCM<Y[Q'M#^L5I^NE/X1U
MQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\QU+F.USGO$>T/ZQ6GZZ4_A'7&7
MXYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.>\1[0_K%:?KI3^$=<9?CG
MF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2YCM<Y[Q'M#^L5I^NE/X1UQE^.>8Z
MES':YSWB/:']8K3]=*?PCKC+\<\QU+F.USGO$>T/ZQ6GZZ4_A'7&7XYYCJ7,
M=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.>\1[0_K%:?KI3^$=<9?CGF.I<QVN
M<]XCVA_6*T_72G\(ZXR_'/,=2YCM<Y[Q'M#^L5I^NE/X1UQE^.>8ZES':YSW
MB/:']8K3]=*?PCKC+\<\QU+F.USGO$>T/ZQ6GZZ4_A'7&7XYYCJ7,=KG/>(]
MH?UBM/UTI_".N,OQSS'4N8[7.>\1[0_K%:?KI3^$=<9?CGF.I<QVN<]XCVA_
M6*T_72G\(ZXR_'/,=2YCM<Y[Q'M#^L5I^NE/X1UQE^.>8ZES':YSWB/:']8K
M3]=*?PCKC+\<\QU+F.USGO$>T/ZQ6GZZ4_A'7&7XYYCJ7,=KG/>(]H?UBM/U
MTI_".N,OQSS'4N8[7.>\1[0_K%:?KI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G
M\(ZXR_'/,=2YCM<Y[Q'M#^L5I^NE/X1UQE^.>8ZES':YSWB/:']8K3]=*?PC
MKC+\<\QU+F.USGO$>T/ZQ6GZZ4_A'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,
MOQSS'4N8[7.>\1[0_K%:?KI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'
M/,=2YCM<Y[Q'M#^L5I^NE/X1UQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\Q
MU+F.USGO$>T/ZQ6GZZ4_A'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N
M8[7.>\1[0_K%:?KI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2YCM
M<Y[Q'M#^L5I^NE/X1UQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\QU+F.USG
MO$>T/ZQ6GZZ4_A'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.>\1
M[0_K%:?KI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2YCM<Y[Q'M#
M^L5I^NE/X1UQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\QU+F.USGO$>T/ZQ
M6GZZ4_A'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.>\1[0_K%:?
MKI3^$=<9?CGF.I<QVN<]XCVA_6*T_72G\(ZXR_'/,=2YCM<Y[Q'M#^L5I^NE
M/X1UQE^.>8ZES':YSWB/:']8K3]=*?PCKC+\<\QU+F.USGO$>T/ZQ6GZZ4_A
M'7&7XYYCJ7,=KG/>(]H?UBM/UTI_".N,OQSS'4N8[7.>\1[0_K%:?KI3^$=<
M9?CGF.I<QVN=ZW[UC=WW /<L^E]K]N'NE_3WS+Z94W)YG](^JUY^;TW-T\NF
MNGC<.DU>L;7VCI-.SL8:NVV>K+OV?H]&.UCKX,'%JG_S??4ZFC4Y._Y2N>F$
M      !G>!^EN_[)%^@XUKNMOV_)AZ$8V0                        ,0
MQ/\ Y\]DI?B'JI#+SRD
M                                                #$;#]7<J_9H/
MT)#U5JA#+CRD                          "M!Z:3]C?\:I$BB2
M                      ,SSSZN4/\ )W'/]B41BL^3RSWY9;WE<D=Z&&&5
MB                           OU/]J]X]E+;\HKC'/EQW)\#W'D3W8\*P
MF1X                           E4/^NT?[/'\<A$ZB-:*2
M                  -E?['GX9/^SY7_ .\_R_[3?_V?^9_9<YJ?_-]]2[HU
M*._Y2N>F$      !G>!^EN_[)%^@XUKNMOV_)AZ$8V0
M       ,0Q/_ )\]DI?B'JI#+SRD
M                                                         #$;
M#]7<J_9H/T)#U5JA#+CRD                          "M!Z:3]C?\:I$
MBB2                            ,SSSZN4/\G<<_V)1&*SY/+/?EEO>5
MR1WH8896(                          "_4_VKWCV4MORBN,<^7'<GP/<
M>1/=CPK"9'@                          "50_P"NT?[/'\<A$ZB-:*2
M                           -E?['GX9/^SY7_P"\_P O^TW_ /9_YG]E
MSFI_\WWU+NC4H[_E*YZ80      &=X'Z6[_LD7Z#C6NZV_;\F'H1C9
M                   Q#$_^?/9*7XAZJ0R\\I
M
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M\F'H1C9                         Q#$_^?/9*7XAZJ0R\\I
M
M                     Q&P_5W*OV:#]"0]5:H0RX\I
M           K0>FD_8W_ !JD2*)(                            S///
MJY0_R=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
M+]3_ &KWCV4MORBN,<^7'<GP/<>1/=CPK"9'@
M   "50_Z[1_L\?QR$3J(UHI(                            V5_L>?AD
M_P"SY7_[S_+_ +3?_P!G_F?V7.:G_P WWU+NC4H[_E*YZ80      &=X'Z6[
M_LD7Z#C6NZV_;\F'H1C9                         Q#$_P#GSV2E^(>J
MD,O/*0
M                                   ,1L/U=RK]F@_0D/56J$,N/*0
M                         *T'II/V-_QJD2*)(
M         S///JY0_P G<<_V)1&*SY/+/?EEO>5R1WH8896(
M              "_4_VKWCV4MORBN,<^7'<GP/<>1/=CPK"9'@
M                "50_Z[1_L\?QR$3J(UHI(
M     V5_L>?AD_[/E?\ [S_+_M-__9_YG]ESFI_\WWU+NC4H[_E*YZ80
M  &=X'Z6[_LD7Z#C6NZV_;\F'H1C9                         Q#$_\
MGSV2E^(>JD,O/*0
M                                            ,1L/U=RK]F@_0D/5
M6J$,N/*0                          *T'II/V-_QJD2*)(
M                  S///JY0_R=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
M                      +]3_:O>/92V_**XQSY<=R? ]QY$]V/"L)D>
M                        )5#_ *[1_L\?QR$3J(UHI(
M              V5_L>?AD_[/E?_ +S_ "_[3?\ ]G_F?V7.:G_S??4NZ-2C
MO^4KGIA       9W@?I;O^R1?H.-:[K;]OR8>A&-D
M     #$,3_Y\]DI?B'JI#+SRD
M                                                      #$;#]7
M<J_9H/T)#U5JA#+CRD                          "M!Z:3]C?\:I$BB2
M                            ,SSSZN4/\G<<_P!B41BL^3RSWY9;WE<D
M=Z&&&5B                           OU/]J]X]E+;\HKC'/EQW)\#W'D
M3W8\*PF1X                           E4/^NT?[/'\<A$ZB-:*2
M                        -E?['GX9/^SY7_[S_+_M-_\ V?\ F?V7.:G_
M ,WWU+NC4H[_ )2N>F$      !G>!^EN_P"R1?H.-:[K;]OR8>A&-D
M                  #$,3_Y\]DI?B'JI#+SRD
M
M       #$;#]7<J_9H/T)#U5JA#+CRD                          "M!
MZ:3]C?\ &J1(HD@                           #,\\^KE#_)W'/]B41B
ML^3RSWY9;WE<D=Z&&&5B                           OU/\ :O>/92V_
M**XQSY<=R? ]QY$]V/"L)D>                           )5#_KM'^SQ
M_'(1.HC6BD@                           #97^QY^&3_ +/E?_O/\O\
MM-__ &?^9_9<YJ?_ #??4NZ-2CO^4KGIA       9W@?I;O^R1?H.-:[K;]O
MR8>A&-D                        #$,3_ .?/9*7XAZJ0R\\I
M
M                      Q&P_5W*OV:#]"0]5:H0RX\I
M            K0>FD_8W_&J1(HD@                           #,\\^
MKE#_ "=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
M +]3_:O>/92V_**XQSY<=R? ]QY$]V/"L)D>
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M?G(_GZOE7GUY>33IUX:: P?LD<D3W1RL=%(Q='QO16N1?@HH)B8T2^"0
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M_P"=7B+=V_-^:9I^9P2]7+.7C+Q535\_1HQY]#7$WU:
M "M!Z:3]C?\ &J1(HD@  WO[*O9SVPW>P+-LOW!N%YMZ8K<'1.FMM1'%&REC
MI6U$CWM=3S.54U5>CN=PIMXYZ[8N4TT8:8X>ZN]V9"U?MS57CHGP/3<8[/G8
MDW"N$6.89N]?)\@K^9EMI75D4$LDC4YN6..KMT76+IT\K>E4UTX+I@N9W.VH
MVJZ(P[GBEL49')79V:*]/=\<-*]^MF+ML7GU3AUPK4NU%-31W"PWEL:Q)54<
MKG,:YS-7<KVO8YKD15Z4UX*A:Y/-1F;>U&CCA3YW*3EKFSKC7$O%S;:@
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M3"E-3SPI+RJC7]*="Z-=RJA/6F8LU1%ZC1/9W'GJK+WJ9FS5I[N,<K7WLI[
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M]V\_Q[ ;+,REJKW,_KZ^5-64U-"QTL\SDU3FY(V*J-U3F71O=,&9OQ8MS7/
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M+VHM6Z:(X(4N9O3>N55\<_\ 1A!F80 !B&)_\^>R4OQ#U4AEYY2
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M4P1+RHY71L93NU1$]'5*B[ELO11,U7,:].K3&/-X5Q;S.8KN1LV\+?;T3W_
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M<Q'JJMTZ%Z7*NSN[:LYFJU$_-TM;>44WLK3=F-.CY>!RN.B<T
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M;:&^;^W>V8U4]_A:7%JJ0 !6@]-)^QO^-4B11)  !U/[$_\ 5WWY_P!W</\
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MC[O/=A;;E^\<DL"[6?\ 6*W2]DXOWK 9MV_=Z.YX6#>GWFOD[T-=C>:
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M%GZ&MUZ5XN75SE55(RV]+5BC9IHGGU_(]9K==S,5[55SN1AJ^5R&.F<L
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M_-]]2[HU*._Y2N>F$      !G>!^EN_[)%^@XUKNMOV_)AZ$8V0
M        -H^SM<NS99_.[QO;3W2IOUFN,-9CE)3,FFHZB)C4=R3Q1)H[ED;K
MHYR-<BZ.U0KL]3F:M%K#"8TK/(596F,;OE1.C6H]J;M ,WZS2WUMHI*JVXAC
M-,^DQZBK%1)GOF<CJBID8QSV,=)RL;HBKXK&ZKJ3N[)?9J)B?*G6\[RSL9FN
M-GR8U-8BP5P   8AB?\ SY[)2_$/52&7GE(
M                           ="L=WE[*>X&V]BQ+>+ '8ME-H@IH*S++!
M;8&35+J2-(TF2JIF]>BS(GZY&]BMU75%71%;25Y7-6KDU6JL8G@F?!*_HSF4
MO6XIO4X3'#AX8THNX7:'V9Q+96\[([ 6>[OHLFDE^G>179%8G)4.9U[F\[ED
MDDDCC2+I8QK6^BI-C(WJ[T7;TQHX(><QG[%NS-JQ$Z?#KUN?Y=*(
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M2[HU*._Y2N>F$      !G>!^EN_[)%^@XUKNMOV_)AZ$8V0
M           ,0Q/_ )\]DI?B'JI#+SRD
M
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MYG]ESFI_\WWU+NC4H[_E*YZ80      &=X'Z6[_LD7Z#C6NZV_;\F'H1C9
M                       Q#$_^?/9*7XAZJ0R\\I
M
M            Q&P_5W*OV:#]"0]5:H0RX\I
M  K0>FD_8W_&J1(HD@                           #,\\^KE#_)W'/\
M8E$8K/D\L]^66]Y7)'>AAAE8@                          +]3_:O>/9
M2V_**XQSY<=R? ]QY$]V/"L)D>                           )5#_KM'
M^SQ_'(1.HC6BD@                           #97^QY^&3_L^5_^\_R_
M[3?_ -G_ )G]ESFI_P#-]]2[HU*._P"4KGIA       9W@?I;O\ LD7Z#C6N
MZV_;\F'H1C9                         Q#$_^?/9*7XAZJ0R\\I
M
M                         Q&P_5W*OV:#]"0]5:H0RX\I
M               K0>FD_8W_ !JD2*)(
MS///JY0_R=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
M    +]3_ &KWCV4MORBN,<^7'<GP/<>1/=CPK"9'@
M       "50_Z[1_L\?QR$3J(UHI(                            V5_L
M>?AD_P"SY7_[S_+_ +3?_P!G_F?V7.:G_P WWU+NC4H[_E*YZ80      &=X
M'Z6[_LD7Z#C6NZV_;\F'H1C9                         Q#$_P#GSV2E
M^(>JD,O/*0
M                                       ,1L/U=RK]F@_0D/56J$,N
M/*0                          *T'II/V-_QJD2*)(
M             S///JY0_P G<<_V)1&*SY/+/?EEO>5R1WH8896(
M                  "_4_VKWCV4MORBN,<^7'<GP/<>1/=CPK"9'@
M                    "50_Z[1_L\?QR$3J(UHI(
M         V5_L>?AD_[/E?\ [S_+_M-__9_YG]ESFI_\WWU+NC4H[_E*YZ80
M      &=X'Z6[_LD7Z#C6NZV_;\F'H1C9                         Q#
M$_\ GSV2E^(>JD,O/*0
M                                                ,1L/U=RK]F@_
M0D/56J$,N/*0                          *T'II/V-_QJD2*)(
M                      S///JY0_R=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
M                          +]3_:O>/92V_**XQSY<=R? ]QY$]V/"L)D
M>                           )5#_ *[1_L\?QR$3J(UHI(
M                  V5_L>?AD_[/E?_ +S_ "_[3?\ ]G_F?V7.:G_S??4N
MZ-2CO^4KGIA       9W@?I;O^R1?H.-:[K;]OR8>A&-D
M         #$,3_Y\]DI?B'JI#+SRD
M                                                          #$
M;#]7<J_9H/T)#U5JA#+CRD                          "M!Z:3]C?\:I
M$BB2                            ,SSSZN4/\G<<_P!B41BL^3RSWY9;
MWE<D=Z&&&5B                           OU/]J]X]E+;\HKC'/EQW)\
M#W'D3W8\*PF1X                           E4/^NT?[/'\<A$ZB-:*2
M                            -E?['GX9/^SY7_[S_+_M-_\ V?\ F?V7
M.:G_ ,WWU+NC4H[_ )2N>F$      !G>!^EN_P"R1?H.-:[K;]OR8>A&-D
M                      #$,3_Y\]DI?B'JI#+SRD
M
M           #$;#]7<J_9H/T)#U5JA#+CRD
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MK;]OR8>A&-D                        #$,3_ .?/9*7XAZJ0R\\I
M
M                          Q&P_5W*OV:#]"0]5:H0RX\I
M                K0>FD_8W_&J1(HD@                           #
M,\\^KE#_ "=QS_8E$8K/D\L]^66]Y7)'>AAAE8@
M     +]3_:O>/92V_**XQSY<=R? ]QY$]V/"L)D>
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M/0N%7 2D      !VM_),?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
M                      Y)=EGZO=I3^E6]_+7&A\9>78_EPNO@G]S?_FSW
MH;=G&.U
M                                     U![-7\_/:\]G[)_UD?39_I^
M5^C/@?*[_P#4LU]*.]+=MO TF9]!*H>D*B<4"%5OID D-X$"HSCWB17:!)9P
M DL^*0F$AOID)$MG<[P0DLXH$PG1^ $I"<4"$AG#OA"NSAWP2JM[I,"4W@WO
M$H5X^*_"(A*NWB)(?9"0 !:;E:VW&:VS+,L7TNJ&U"-1NO.K51=.*:< +L
M                          !:K-:VVBB;1MF6=&O<_K%;R^F^!JH%U
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M/C+R['\N%U\$_N;_ /-GO0V[.,=J
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M760(U9H&HK$>FJ=+D3I3H]$"71RNGI*6=^G/-"Q[].&KFHJZ 20
M                  <!O[S[\(G\&.M_#OJN4_$/K.:!>*B E(      #M;^
M28^U[>WV1L?RFM.7^(/*HY? Z+<.JONQX77LYU?@
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M0.8V6=J(QSU5&IHY%Z=$5>YZ $NCA=3TE+ ]45\$+(WJWAJUJ(NFNGH 2
M                         <!O[S[\(G\&.M_#OJN4_$/K.:!>*B E(
M   #M;^28^U[>WV1L?RFM.7^(/*HY? Z+<.JONQX77LYU?@
M          !R2[+/U>[2G]*M[^6N-#XR\NQ_+A=?!/[F_P#S9[T-NSC':M1^
MV_\ U>\C]DK7^^F'4_!W]1I[E7><M\9_TRYW:?VH;<'+.I:&;>/=B>ZO;,L.
M.5'FEIHZ&"^43*9'1-IKA44,T\KHD33D5))%1=/4IIT(=KGHZ?*9"NY&-4S-
M,X\-,51$8\D?*XS=T]#G<_;HT4QLU1AP533,S\O>6.^[F9_0]F[8R^U&57JU
M6K)ZR*#=#<BCC=6W2BHEED1)&O7F<U7JFG/HJ]"-3CRNS6=WY>K>>8HBBF:J
M8_PZ)T4S.'9H8;^\<Q1NS+7)KJB*L.DKB-JJFGCY9X<'I&SLRU><VNOVU[1<
MNZNW]11U29=BN5W#SN]P2M:BTT]&WS>*1K>=WC\[6(B)IXZKXE?O6-FQ-.8R
MO17<8V:J(PHGCBK3,=S#'DX=_=,[5^*LOFNFM83M4US$UQ/!-.$1/=QP\4+&
MXLW[1.9;FW-VYN28!M[@F15&+XO;,3GCH*BKJ:%&K45-34.CD<YKE<QR-5O!
MVGBZ+S9,Q-C=-BS3T-%R[71%=4UQM1$5:HB-';T]ICR_3[VO7JNFKMVK=<T4
MQ1A$S-.N9F8GDCB1LLR[?7:#;N;%KK>:/)LQRC-*3$=I\PJ%C?62T=PY^KJ:
MVF:Q4=+$D?+JNNKGMYN;3QYRV5R&?S/24TS3;IMS7<IC5C3P4SQ3X-':C-9K
M/[ORW1UU15<KN11;JG7A5JFJ../%CV_S<7!]T=E<*GW4Q[>W*LPO>))%6Y3C
MN1S,J;1<J=TC&5#(*9&(M,B(Y7)HYRHG!6KTDY#.93>-_P"S7,O1137HIJIC
M"JF>#&?UOD,_E,WNZQ.9MYBNNJC3537A-%4<.$1'S>UK9+<,]OMEWLV;RIUV
MN";:;Y8ZVW1V&IG=)34%X?%'54KV1=#6/F:YD?1Q57J:]&2MW,C?M[,=+8KQ
MQB--5&,Q/-IGF;-W.W+6>L7-J>AO4X8<%->&U3/+&A(N.>7BZ;^9E44UXKX=
MN=A<0EK<JMM%,J4]PN]7"^=L4K6*C7]53HJHCM>5[.":GFWDJ*-WVXFF.EOU
MX4S,:::(G#&.[//$O5>=KN;PKPJGHK%&-41^M75IP[>%/RM<<;W0LNX5BJ,R
MW [5EXVZS2[R336?#L?G6GM=HC:YS*>*IITIWK4KHB.=^N-547155>DOLQNZ
MO*7(M6,G3<MQKJJC&JKCF)Q^;VM#G\MO*WF[?37\[-NY5IBBF8BFCBB8F/G=
MO3"]Y+V@,ZR;LN09M;KPZCS?',VIL<NUYM+W4\5Q?3JDB2-2+DT941RQ\S4T
M15UT1$T1,67W'8L[UFS53C;JMS5$5:=G'PQ,3@S7]^W[VZ>FHJ_Q*;D43-.J
MJ8F/DJB89ON#MWO-MIMKD6XD.]F3Y;E6/U%MR*NLKYG0V_J:1[G7*G9$U[D6
M!62<W+HB<L?!>;HT\CG\EG,U38G+T445153$_K8SY,X\?C;N?R6=R65KS$7Z
MZZZ9IKF)T4X4^7'T9C@[3/=Z=R;ED6(;2X[MI>:BU7_?.YVY+3=Z*165%':6
MMCJZVH;)&O,U8V*UKM$]*KS2W1N^FU>OW,Q3$TV(G&)U35Y-,<O!R-S>V\*K
MMFQ;R]6%5^JG"8UQ1Y54\S:R&)(88H6N>]L3&L1\CE>]4:FFKG.U557NJIS,
MSC.+I(C"&BF3.E2[95<-[>U#4[9W9+C,W&,'PR^4]-'0V]OC4SJF%('5$[W<
M7<S&Z^CTZ-[/+X;%%.3R<7*<(VJ[E,SM5<.$X[,<[C<SC%=<YS.=%.,[-%%5
M-.%/!CC&U,\:PXINQFU^[)>\.129E5W6^83=Z^S8YFT.M-63TE/YE)!4.<Q&
MN1[FU"IJOC:>F55U4SYG=EBUO>Q;Z.(IKIBJJC7$3.UC'R,&4WK?O;HS%SI)
MFJW55337JF8C"8GY5TRW%=W;3LS)O<N]V3QYW0VFFR.3'()86X\RF<R.5U'Y
MDL?CJR-=%D>]W,J*JM57:F+*YG)W,[]C^ST='-4T[6GI,=/SMKN\$1H9LYEL
M[;R4YS[17%R*=O9T='AKV=G#&='#,LPS?<+.,^O&QFV&*7^3!Z[<_'F93FV2
M6]$6JI*!M,V98:-ST56.DD1[4?Q3Q>YS(NKD\C8RM&8S-VG;BU5L4TSJFK'#
M&KCPC#0V\[G;^9N9?+6JMB;M.W75&N*8B-%./'.C'@>=[A;?Y3@F]O9NIZS<
M"^9[BE5DTRVMV22QU5RHJM(X4F:M4R.+K(Y6HU6HK?%5J^CJN_D<]:S61S4Q
M:IMUQ1IV-%,QIPT8SA,?*T,[DKV6SV4B;M5RC;G#;PFJ)PXXB,8GN:,'0TX1
MW#43L8_S=9M_+^^?H4YU/Q9]YM_RJ?"YGX5^[W/YM??0>TM3P6W=+LO9/0JV
MFOZYU365U2Q%266WULL+*B-SDTU:C7.31?5KZ*GOX>JFO*9RW5IIZ.:OK1$X
M=G:8?B*(HS63NT^5TL4_5JT5,&S[>&V95O%F>%Y1O57[,X#M^D-#!'9)%H[M
M>+C+&JSR>==3/R10.\733QO%5$U55;NY+=55C)6[UO+Q>N7-/SM--%/!HQC3
M+4SV]:;^=N6;F8FQ;MX1\V8BJNJ8QF<9B<(IU)>U>Y%=E>4;B[%67=NJSVU7
M#&:BZ[<[FK(Z.ZT,SE2%U-4U$;&.>^%\B2->K?2M]!R,3QO+=]-BU:SM=B+<
MQ7$5V_U9C7C$<$3&C#_J][MWC-^]=R5%^;D31-5%S]:G@F)F-<Q.F)P9=A.^
MMQMG9?R#-<IJGR9QMO%78W?/.W-=,^]TCTIZ5)>;I<YZRQ*]5355YE74U<YN
M:FO>M-FW'^'<PKC#5L3IG#FG!LY/?55O=55Z[/\ B6HFFK'SZ=$<LZ.=YSF&
MX>9;>8?L?M7DNYM5B&1YS0S7K<O<RZ.EJJV@IEUF\UIW2<ZME5SE@:J-\7E:
MO1JJF_E<C8S=[,9FW9BNBB8IHMQHBJ=6,]K];MXM'-Y^_E+.6RUV]L5W(FJY
M<G3-,:YB,>&9G9C1H1+;O)8=N]P\ @PC?NZ[Q8CF=W@L66X]DE1Y]6T#JMZ,
M@KZ:H2"!6L8YVCV(WAT=*JWE]W-TW,WEKLWLM39KHIFJFJB,(JPUTS&,\D]D
MXZ-[6\IF+46<U-ZBNJ*:J:IBJJG:U51,1&B)UPRW$\PBV_W'[<.:30MJ4QIE
MAKH:5[N1LTT=#6K#$KNYSR<K=?@FKFLK.:RV[[,:-K;CY:<9YFQE<U&5S>\;
MTQCLQ1/=PIJT+SB6UF[^X&"6S<2[;\Y38,^RJWQWFS6BVRQP8_1-JF-FIJ>:
M@2-5D1&*U'KS(J:JFCNE78<UO+)Y7,38IRU%5NF=F9G37.&B9BK'1VO V,KN
M[.YK+TWZ\S73=JC:B(PZ.G'3$33AI[>EA61;W;C9;V>]M<PL=<N/[B.W!MV.
M7=\"K%3557"^>-6RQL5.:&=48Z2/TO%NFFAN6-SY:QO&[:KC:M=%-4<<1.&K
MMQIPEJW][YJ_NZU=HG9N]+31/%,Q,Q./HSPPRC=*R;D; XK;]W;9NWD^<28Y
M6T7NAX[?ZB*:VW"FK)V4TCJ.F:QB4JI)*U&-:JZ(J=/BKS:V[;V6WI=G*U6*
M*-J)V*J8PJIF(Q^=/ZVB-/9AGWG;S.ZK,9J+]=>S,;=-6$TU1,X3LQA&S.G1
M@NV>UF>YGVCK'M]B.X%UQ'#[UMQ3WV^5-M7]>; VY5+%EI6S-<R&:95AC656
M\S6]'P#'DJ,OE]VU7[MJFNNF[-,8\>S&O#7$:9PXV3.W,QF-Z1E[5V:*)LQ5
M.&ORICYN.B)G1&.&IA]@L^Z,N\^:; 1;T9*["[=;:/)GY14RQSY*R%Z11K10
M5[V*UB/?,CG/ZOH1B<J)S/YMJ_=RD9*WGIR]'23,T;,:+>.GYTT]J(U8\/<:
MUBUF_MMS(_:*^CBF*]J<)N:=&S%6&&F=..'<X60X7G>5[2WWM&XGE>5W+<&Q
M;4V6CR/%[E>9.NN+F55(^?S6:=K45_,_D9JO0FBN\5'*B8,WDK.?MY6[:HBW
M5=JFFJ*=%.B<,8CGEGRF=O9"YFK=VN;E%JF*Z9J\K"8F<)G1CIAXW9=Q+1E>
M+)F.4=KRZXEN?=X5KJ+&[?+U-@MDCM'04D] E-)UJ,1$21>?CKKS:*KK6]D*
M[%WHK>1IKLQHFJ?+JXYBK'1VM'-P5-G>%&8LQ>N9^:+U48[,3&Q3CJIFG"<<
M.'2S;(]]L[S'LZ[6Y]C==](\ZJL[MEDNR4SG1TM34Q/G8Z.1K'>-!/RQN>S7
M3I5O!#4L;ER^7WE>L7(VK<6ZJHQUQ&C_ +HTX2W+V^LQF=V6;]N=FY-RFF>*
M9QF)^K*^[G6/<K8N#!]Q:'>7*<UJ9\DMUKS/'KY+"^UU<-<YS9%IJ9D;4ID1
M4Y41.94U14<G+TX-W7LKO.;EBJQ11&Q,TU4X[433QS^M\GRL^\+.:W;T=^G,
M5U_/IIJIJPV9BJ<-$1$;*V[@X!)=^V+B-$W.\LM*WW%*JZ-J[?7QPS4*0R3,
M\THWK [JZ=_5ZN8J.55<[QDU,F1ST6]S5ST=$[-<1IC1..'SJM.FK3HGN,>=
MR,W-]6_\6N,;<SHF-&$^3&CR9X>^W].(=JYL]F/>GVB;=5UA]R;<?,N7(KI4
M?3G%[#],:!>LD;^MI/U\?CMT\9-.@^@?$.Z/M69BOIK5'S*=%=>S5S83H?/]
MP;Y^RY>;?07J_GU::*-JG7QXP]6P.V9]NMO_ &[>J_X'<ML\5P_')++9;;>T
MZJY7":H695=)!HBL8Q)W+TIT*C=-55W+69VYE\CN^<I1<BY777M3-/DTX8</
M)V<-IDK>8SV\(SE=N;5%%&S$5>55,\<<$1V_^F+7Y[F5627'?#M456W.4NKI
M_I-A6%WR"&FMM(U52G;/2M@=43+P5>9&JNG2JKPVK,8Q13D\G%RC",:KE,S-
M4\.$X[,?*U\Q.%54YS.S:KQG"BBJ(BFG@QC#:GML&EWHW"N'9!OV8KE]749+
MC67Q6:BRRF<M+4U='#44[F.E=%R+J]DO*[NJGIM5U5=R-T9:G?--K8B**K>U
M-,Z8B9B=6/<:56^,Q.Y:[^W,UTU[,51HVHBJ.+CB64;N[19]:]C=PLJSC>C*
M\@N55;*:Z7#%V2-I[;%5.<B34O5+UFM.BRZ(QO)TL:O<T-;=>],O7G[5JS8H
MIB)F(JUU8<$XZ/G:->G7+9WMNO,4;OO7+V8KJF:=J:=$4X\-.&GYNG5VHTI&
M3LSG;C8?8&+ L[OU5D>;9AC$5+57FK2H9"ETM,C&6]K8V1(M%'*QCDA<CN[J
MJGG+38SF?S,W[=,446Z_)C#'9JCYW#\^8Q^<9J<QDLCEHLW:IJKN41C5..&U
M3,;.B(^9$X3A\J_;@63<78JZ;8YG0;PY3G-+?,NMV/YICV0SQ2T51%<5?S24
ML3(VI3Z<BHB)S*BJU471%1<.1O9;>=-ZS58HHFFB:J:J8G&-GCG'YWR-C/6L
MUNVNS=IOUW(JN4TUTU883%6C&,(C90]W=WJ:Y;TW7:Z_[MU6S6#87;Z2IO%T
MM+NHNMTN%9"R>.&&IZJ58HXXI6J[1JHJ]"HNJ<OK=>ZYHR-.9HL1>N5S,1$Z
M:::8G#&8QC&9F.SAQ[SWK37GJLM7?Z&W1$3,QA%55548Q$3,3A$1K2=E=WX*
M;>-=J;3NG4;QX1DEJFN6-9%<G=;=+=6TJ.=-1U,_5Q=<QT3%>CE;T+HB(GC:
MQO?=<SDOM-5F+-RFJ(JICR:HG55$:<-.CLA[W1O2(SOV6F]TUNJG:IJF8FJF
M8UTS,1&,3&F)8YV<K'NSNS;*+.<@WHR.VVG$\FGHZ/'Z:5STN<-+.E1-Y[*]
M^KT>DG4M145&M;T)J9]_7LGD:ILT9>B:JZ(F9G]69C"-F.3'NRP[BM9S/4Q>
MN7ZXIHKF(IC]:(G3M?L]J(XV'V3.'YG<<NIMR>T=E.SV[E-=JREM6'+-]*;!
M1,C?I2MD:^%T<S%T3573-<J>J],[:O9/[/31.7RM%ZQ-,3-6&U7/'PXQ/)^C
M3M9W[177&8S==F_%4Q%&BFB-/S=<85>L].W_ &[A/VD[/+*R^VB[;DOW+QQ*
M/([8G76V>X+%7>9U+$<QB/:J\CG)R(U5UT30K]Q_9HSF:PIJBUT->-,Z*HIQ
MIVH[[>W_ !F/LF4BJJF;O36_G1IIVL*L)[FI(S^R[C[%W/;'-*+>'*,ZI[[E
MMNQ_-L?O\T+Z&HCN*OYY*2!D:)3(G(J(U.9456JBZ-5%\Y&]EMYTWK,V**)I
MHFJB:8G&-GCG'YWR,F>M9K=M=F[3?KN15<IIKIJPPF*M&-,1$;+U:U9%?I>U
M3E6+RW>KDQREV^I+A36-TKEI653ZYK'3-BUY4>K>A5TUT*R[8MQNFBY%,;<W
M9C'APPU8K2WF+D[UKM;4[$6HG#@QVIC%XEL7B6YN\FW\V395O7E]C92UMQMV
M(162L2!_ZS52JZJN$CVO?5*DCNK:Q7-1L;$1%U75MQOG-97=^8BW;R]NK&*9
MJVHQUQ&BGS=&G'CE4;GRV:WAEYN7<Q73IJBG9F(U53IJT3M<41JPCCTO=>S?
MGV39EBF267.*F.MS3;7)*_%,@N,3$8VK?0*U&5*\OBZNU5JZ<5;KHFI3;_R-
MK+WJ*[,86[E$5Q'%M<"WW!GKN9LUT7IQN6JZJ*I\[9X>7OMABA7H
M               U![-7\_/:\]G[)_UD?39_I^5^C/@?*[_]2S7TH[TMVV\#
M29GT$JAZ0J)Q0(56^F0"0W@0*C./>)%=H$EG "2SXI"82&^F0D2V=SO!"2SB
M@3"='X 2D)Q0(2&<.^$*[.'?!*JWNDP)3>#>\2A7CXK\(B$J[>(DA]D)  %H
MN=U^ET]LAZCKOIC4-I^;FY>3F5$YM-%UX\ +N
M     !:;+=/IQ0MK>H\WYGN9U?-S^E[NNC?T +L
M      "TR73DO4-HZC7KJ9:CSCFX:.<G+RZ?Y/'4"[
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MJ1QIHFNCD7NZ>@!.H8WQ4-'%(WEDC@C8]OH*C414 E
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M@                           077&F9<([8JN\ZEAZ]J:>+R:JG'O 3@
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M?^CUE;W36J:^./\ JRDUVP
M                     &H/9J_GY[7GL_9/^LCZ;/\ 3\K]&? ^5W_ZEFOI
M1WI;MMX&DS/H)5#TA43B@0JM],@$AO @5&<>\2*[0)+. $EGQ2$PD-],A(EL
M[G>"$EG% F$Z/P E(3B@0D,X=\(5V<.^"55O=)@2F\&]XE"O'Q7X1$)5V\1)
M#[(2  ,4R2-[ZW&U8QST9<(U>J(JZ)S-Z5"65A
M      #%<-CDBLK&R,=&[KI%Y7(J+Q]!0,J
M  !BL\<BYA1R(QRQI;E:LFB\NO._HU RH
M%BR9CWV*X,8U7N5C=&M355\=O<0"X6Y%;;Z!%145*>)%1>*+R(!-
M                   !P&_O/OPB?P8ZW\.^JY3\0^LYH%XJ("4@      .U
MOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
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M''X&3=5,TY6C'B\+U,T%@
M                    &H/9J_GY[7GL_9/^LCZ;/]/ROT9\#Y7?_J6:^E'>
MENVW@:3,^@E4/2%1.*!"JWTR 2&\"!49Q[Q(KM DLX 26?%(3"0WTR$B6SN=
MX(26<4"83H_ "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\?%?A$0E7;Q$D/L
MA(  H355/3NA9/,R)]0](X&N73G<O!$^"!7
M    H4]33U<:34LS)XE5421BZIJG'I0"N
M"@M33I4-I%F8E2]G6-@U\96]*:Z>AT 5P
M4IIX::)\T\C888^E\CUT1.YTJ!]L>V1C9&.1['HCF.3@J+THJ ?0
M                   . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D      !VM
M_),?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
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MKBFF*8B(U0D'EZ
M             #4'LU?S\]KSV?LG_61]-G^GY7Z,^!\KO_U+-?2CO2W;;P-)
MF?02J'I"HG% A5;Z9 )#>! J,X]XD5V@26< )+/BD)A(;Z9"1+9W.\$)+.*!
M,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E-X-[Q*%>/BOPB(2KMXB2'V0D  8CD
MW^NXS[(Q_'-"67!                            #$L*^H<?[-)^B!EH
M                          ,2G^W2C]C5^/D RT
M         %@RCZ@7'_<-^/:!<K9]3K?_ ,&B^,0":
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MZ(U/,44Q,S$1C.OMI9Y>@
M                     :@]FK^?GM>>S]D_ZR/IL_T_*_1GP/E=_P#J6:^E
M'>ENVW@:3,^@E4/2%1.*!"JWTR 2&\"!49Q[Q(KM DLX 26?%(3"0WTR$B6S
MN=X(26<4"83H_ "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\?%?A$0E7;Q$D
M/LA(  IR0PRK&Z6)DCHG<T3G-15:[T4UX*!4
M     IQ0Q0,ZN&)D+-=>1C4:FJ_ 0"H                           "F
ML,2RI.L3%F:WE;-RIS(WT.;CH!4                           !\21QR
ML='*QLD;O3,>B*B_#10/IK6M:C6HC6M31K4Z$1$X(B ?H
M            . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D      !VM_),?:]O
M;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP                        Y)
M=EGZO=I3^E6]_+7&A\9>78_EPNO@G]S?_FSWH;=G&.U
M
M             U![-7\_/:\]G[)_UD?39_I^5^C/@?*[_P#4LU]*.]+=MO T
MF9]!*H>D*B<4"%5OID D-X$"HSCWB17:!)9P DL^*0F$AOID)$MG<[P0DLXH
M$PG1^ $I"<4"$AG#OA"NSAWP2JM[I,"4W@WO$H5X^*_"(A*NWB)(?9"0 !B.
M3?Z[C/LC'\<T)9<$                            ,2PKZAQ_LTGZ(&6@
M                           Q*?[=*/V-7X^0#+0
M          6#*/J!<?\ <-^/:!<K9]3K?_P:+XQ )H
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M$3S3,2]&8]DC&R1N1\;T1S'M75%1>E%14XHIHS&"]B8F,8U/H)
M"$Z@I75\=R<Q?.XXNI9)JNG)JJZ:<.ZH$T
M $:KI(*ZFEI*EJO@F1$D:BJFNBHO%/A 58HF0Q1PQII'$Q&,3CHC4T0"H
M                        #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I
M   =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
M          .8O8S^JW:=_I:O7RQ3)\2:[/\ +A[^&?W=W^9/@;P',NF
M
M                         Y[]GW^L3VR/Y26;]&Y'9YC[GEOHSX'%4_?<
MQW:>]+<UO K&Z^@E4/2%1.*!"JWTR 2&\"!49Q[Q(KM DLX 26?%(3"0WTR$
MB6SN=X(26<4"83H_ "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\?%?A$0E7;
MQ$D/LA(  QC(*JHIZO'V03/B;45S(YVM541[5<W5%]%.D)9.$
M                 ,9Q*IJ*NSLFJIGSRK*]%D>NJZ(O1TJ!DP
M C5E%1W&EFHKA20U]'4)RU%)41MEB>FNNCF/145-4[J'JFN:9QIG"6.[9HNT
MS173%5,ZXF,8GDEB4NVFW$\;HIMO\;FB?Z>-]JHW-7N]*+%H;$9_,1JN5>M/
MC5E7P_NVJ,)RUJ8_ET^)A]X[/6RU[8]E7MU::?GU7FM\;J!45?06D=%IQ-JU
MOK.6]5R>73W\57FO@;<F9C"K*T1]&-C]B:7DFQMFCP/>W>+;2Q5]<[#K'16N
MLM5IJYW3MAEJH(9I',YN'3,J='2J(G-JJ:ECO:[]IR5F_7$;<S5$S$8:IF/
MYCX/RD;LWYGMWV:JN@HIHJIIJG'":J8JG#UICMQACC@W!.:?4@
MQF:IJ$RNDI$F>E,^@61T&OBJ[G>FNGH] &3
M   LN13S4UEKYH)'0S1L:K)&+HJ>.U.A0)]O>Z2@HI'N5[WT\;GN7I555J*J
MJ!+                           !P&_O/OPB?P8ZW\.^JY3\0^LYH%XJ(
M"4@      .UOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
M                ',7L9_5;M._TM7KY8ID^)-=G^7#W\,_N[O\ ,GP-X#F7
M3
M                               <]^S[_6)[9'\I+-^C<CL\Q]SRWT9\
M#BJ?ON8[M/>EN:W@5C=?02J'I"HG% A5;Z9 )#>! J,X]XD5V@26< )+/BD)
MA(;Z9"1+9W.\$)+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E-X-[Q*%>/BO
MPB(2KMXB2'V0D  6NXVMEQFMTSY71K;IVSL:B(O,K51=%_P 70
M                  "UVBV1VBC;1QRNF:U[G\[D1%\;X0%T
M   U6P'^M3OQ[$6+]Y4AT&<_IF7^E5WY?.-R_P#*]X_0M?L4-J3GWT<
M     +6^V1ON\5V65R214ZTZ0Z)RJBJY==?_  @+H
M        "#<J%ERHJBB>]8VU"(BO:FJIHJ+W?A 2*>%*>G@IT57)!&V-'+Q5
M&HB:_P"("L                           #@-_>??A$_@QUOX=]5RGXA]
M9S0+Q40$I       =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
M                       .8O8S^JW:=_I:O7RQ3)\2:[/\N'OX9_=W?YD^
M!O <RZ8
M                                    #GOV??ZQ/;(_E)9OT;D=GF/N
M>6^C/@<53]]S'=I[TMS6\"L;KZ"50](5$XH$*K?3(!(;P(%1G'O$BNT"2S@!
M)9\4A,)#?3(2);.YW@A)9Q0)A.C\ )2$XH$)#.'?"%=G#O@E5;W28$IO!O>)
M0KQ\5^$1"5=O$20^R$@ #'[U<:FAJ;+%3N:C*ZL9#4(J:ZL<K473T.(&0
M                          6#&[A4W.V-JJI6K,LCVJK4Y4T:O1T 7\
M            #5; ?ZU._'L18OWE2'09S^F9?Z57?E\XW+_RO>/T+7[%#:DY
M]]'          "P2W"I9D=-;$5OFLM&L[DT\;GYG)Q[P%_
M             !:KY634%JK*NG5$FA:U6*Y-4Z7(G#O@3**5\]'232:*^:&-
M[].A-7-15 D@                           X#?WGWX1/X,=;^'?5<I^(
M?6<T"\5$!*0      ':W\DQ]KV]OLC8_E-:<O\0>51R^!T6X=5?=CPNO9SJ_
M                        #F+V,_JMVG?Z6KU\L4R?$FNS_+A[^&?W=W^9
M/@;P',NF
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M%K]BAM2<^^C@         !9)+9*^_P %V21B0Q4BT[H^GF5RN<NO#33Q@+V
M                          "V7BBDN-MJJ*)[623M1&O?KHFCD7ITU] "
M720NIZ6F@<J.=!$R-RIP56M1%T_P 2                            <!
MO[S[\(G\&.M_#OJN4_$/K.:!>*B E(      #M;^28^U[>WV1L?RFM.7^(/*
MHY? Z+<.JONQX77LYU?@                       !S%[&?U6[3O\ 2U>O
MEBF3XDUV?Y</?PS^[N_S)\#> YETP
M                                                          %B
MV(_FZ9[,W?\ ?TQJ_"GW'Z]?[4MOXS_J7^7;_8AZ?4]TO*W/6V-57IC3K;]M
MC]5Q4U+C=ML?J/2J:=;<M+!4]TT[BPMZV'W#],5]Q96F'UO=*^ZM;+#Z]K7L
M>Q[4>QZ*CFJFJ*B\45"LO1C$K6Q,QA,+C@&X4^ UC;/=9)*G#:J3]:>NKWVU
M[UXMXJL2JO2G<XITZHZS^'OB*K==<6;LS-B9[LVY[7H\<<L:==3\3_"].^*)
MOV(B,S$:>"+L1Q^GQ3PZIT833N+2SP54$-333,J*>H:V2">-R.8]CDU:YKDZ
M%14X*?7+==-=,54SC$Z8F-4P^)5VZK=4TU1,51.$Q.N)XI36^F0]O"6SN=X(
M26<4"83H_ "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\?%?A$0E7;Q$D/LA(
M  M%SNOTNGMD/4==],:AM/S<W+R<RHG-IHNO'@!=P
M         +39;I].*%M;U'F_,]S.KYN?TO=UT;^@!=@              -5L
M!_K4[\>Q%B_>5(=!G/Z9E_I5=^7SC<O_ "O>/T+7[%#:DY]]'          "
MTR73DO4-HZC7KJ9:CSCFX:.<G+RZ?Y/'4"[
M   M]TKOI;05-=U77>;M1>JYN775R)QT73CZ $FFF\XIJ>HY>3KXV2<FNNG,
MB+IKT>B!7                           !P&_O/OPB?P8ZW\.^JY3\0^L
MYH%XJ("4@      .UOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
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M$Z'*JN7F=JN3-6XHJC#4Q9.[-RF9G'%[AG^928/8%N]-C-WS"OFG926W'[)
ML]3//(USDU1/2,:C%5[U]*G3HO P6Z-N<,<&>Y7L1CA,]QK'LME6Z.?[^9]4
M[A0I8J? K'3T=+A=#5=?1V^HNSHIX^M?$Y635'4Q/1[EUT75J(WET3:O4446
MHV>&=?<:EBNNN[.UHPC5W6R=SW*QJU;A8YMC4NJ793E%#/<;=''%S0MIZ=LK
MG.EDYDY=>I<B='2IK1:F:9JX(;<W:8KBCAEGYC9'/[:3;M-_';C;CY!G>9VB
M@N&8W.GQ>VV>\24L,=!&K7Q^*K'IT))RIRZ)XO L+USH<*8B-7$K;-KIMJJ9
MG7.&$L[VNDO6$=H#(-I;-G=YW!P:GQ9EWKV7NJ2OJ++<?.$C;3+4Z)IS,7FY
M-&]#TZ-6*Y<=W"NU%<Q$3CSLEG&B[-$3,QAP\"7L3F]&RQ;V;OYCDTM'B]PS
M.X);)+A,]]/26RB5&TZ0LU=HKUF5G+&W5SD1$15707Z)QIHB-."<O<T55U3H
MQ^1G-E[3&VMXN=DM\L=^Q^ER>?S;&<@O5IJ*&VW"55T8VGJI$Y5YNYS:?X3'
M5EJXB=4X,E.:HF8C3&.K&&=[A[KX5MA3V]^4W&5M=>)%BLEBHH)*NOK'IIJD
M-/$BN5$UZ7+HWN:ZJB+CMVJKFIDNWJ;>M!P/>3#MP+M=,<MS;G8\JLT3:BXX
MI?Z&6VW".!VB)+U,R>,W5R(JHJZ:IKIJFLW+-5$8\''"+=^FN<(T3Q3H6#,.
MT3MMAN0U>+U,]SOEXM3.MR""QT$UP;;8]->>K?$FC-$XHFJIW40]49>NJ,>^
M\UYFBB<-<]I@&TN6>Z3O]NOEUCO\UTP:P6&S6BPQ,ED\TE?71LJY)F0KHU'M
M="YJJJ(Y-=%] R7J-BU3$QIQECLU])=JJB=$1#93)\HQ_#+'7Y)E%UALUCMC
M$?6W"=5Y6HJHUJ(UJ*YSG*J(UK4557H1-36IIFJ<(UMJNN*(QG4\?Q3M*;;9
M9D5JQF)+U8:_(-4QJ>]VV:AI[BJ(BHVFE?JCE<B^+S::\$Z5:BYJ\M73&.C0
MP49JBJ<-,8\<+OG&_6!8+?5Q:I6ZY'DT4+:BML./4$MQJ*6%^G*^H2/1L>NJ
M*B*[FT5%TT5-8HR]5<8ZH[;U<S%%$X:Y[6ED>#[JX3N%8;ED&.W1RTMD?)%?
MZ.KB?35=!)$U7O94P2(CF*B(O3THNBZ*NBGBNU51.$O5N]37&,/+9.UCM-](
MZ.^T+KY>8JB!]5745MMLE3/;Z=DCX^MKE8O5P(Y(U>B.?S<FCN714,OV2O'#
M0Q?;+>&.GF>KU&Z>!4F!4^YM7D5/38554K*NGO$B/3G;)T-8V+EZQ9%=XO(C
M>;FU334Q1:JFK9PTLLWJ(HV\=#!L0[1NW689);\4A;><?N]Z8Z3'FWVW2T$=
MQ:UO.OFTC]4=T<-=->YJNADKRU=,8Z)[CQ1FJ*IPTQ,\<+QFF^.#X5?V8E*V
M[9/EJQI/48OC=!-<ZV"%S4>DDS(DT8BM5%T5>;14733I/-%BJN,=4=M-S,4T
M3AIF>*-+),+W,PW/L;J<JQRZ==:[>Z6*[MGC?!/134[>>:*HA>B.8YB=*II\
M%%5#S7:JHG"7NW=IKC&'G./=IG;+*KGBEFL+KO<KGELC604D- ]RT22/>V-U
M<]%5D*/;&LB)S*O)H]41%0R59:NF)F<-#%3FJ*IB(QTM@S7;(
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MI::/K9YFM2-FJ-U5'(O%RHG! )M#&^&BHX9&\LD4$;)&ZHNCFM1%35 )0
M                        . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D
M  !VM_),?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
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M&R53Y%1$55ZQ5:FO2C4:W@U#4O7-NN9;EBW%NB(>I&)F
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MXK\(B$J[>(DA]D)  %OK;E3T$M%%.CU=7S)!!RHBIS.5$37I31.D"X
M                       0+;<J>ZTJ5=*CTB5RM3G31=6\>A%4">
M        !JM@/]:G?CV(L7[RI#H,Y_3,O]*KOR^<;E_Y7O'Z%K]BAM2<^^C@
M         ! =<J=ERCM:H_SF6'KVKIXO+JJ<=>/1Z $\
M           $2NK(;?2S5DZ.6&!$5Z,35>E43H3H]$"M#*V>&*=FO),QLC->
M.CDU34"J                           #@-_>??A$_@QUOX=]5RGXA]9S
M0+Q40$I       =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
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MN?U+56E?UC&O<J.5Z.?XSU<O,Y>E5U/%-ZJ*MKA>ZK%,T[.&AZB8F8
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M2KMXB2'V0D  8KD4,LM9CBQQ/D2.O8Z16M5>5J.;TKIP0)94$
M                 ,6P^&6"S,CFB?"_K9%Y'M5JZ*OH*!E(
M  &JV _UJ=^/8BQ?O*D.@SG],R_TJN_+YQN7_E>\?H6OV*&U)S[Z.
M   &+30RKE]).D3UA;;U:Z;E7E1W._HYN&H&4@
M     L>2QR2V.X1Q,=)(YC>5C$557QV\$0"X6YKFV^A:Y%:YM/$CFKT*BHQ-
M45 )@                           . W]Y]^$3^#'6_AWU7*?B'UG- O%
M1 2D      !VM_),?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
M                  YB]C/ZK=IW^EJ]?+%,GQ)KL_RX>_AG]W=_F3X&\!S+
MI@
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M_P!+=)U_XA6_N!KU[YRL_K3ZM7B;=&X<Y$^3'KT?WF-UF>XM+S=773NUX?\
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MID^)-=G^7#W\,_N[O\R? W@.9=,
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MO\R? W@.9=,
M                                        !SW[/O\ 6)[9'\I+-^C<
MCL\Q]SRWT9\#BJ?ON8[M/>EN:W@5C=?02J'I"HG% A5;Z9 )#>! J,X]XD5V
M@26< )+/BD)A(;Z9"1+9W.\$)+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E
M-X-[Q*%>/BOPB(2KMXB2'V0D  498Z=[HEF9&][':P*]$54=Z+=>[\("L
M                         !1@C@BCY:9D<<6JJC8T1&Z]WH3H K
M         :K8#_6IWX]B+%^\J0Z#.?TS+_2J[\OG&Y?^5[Q^A:_8H;4G/OHX
M          45C@69LBLC6H1O*V143GY?01>.@%8
M      %.5D3XW,G:Q\2^G:]$5J_#1>@#Z:C6M:C$1&(B(Q&\$3N:: ?0
M                       . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D
M !VM_),?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
M         YB]C/ZK=IW^EJ]?+%,GQ)KL_P N'OX9_=W?YD^!O <RZ8
M
M                       #GOV??ZQ/;(_E)9OT;D=GF/N>6^C/@<53]]S'
M=I[TMS6\"L;KZ"50](5$XH$*K?3(!(;P(%1G'O$BNT"2S@!)9\4A,)#?3(2)
M;.YW@A)9Q0)A.C\ )2$XH$)#.'?"%=G#O@E5;W28$IO!O>)0KQ\5^$1"5=O$
M20^R$@ #$<F_UW&?9&/XYH2RX(                            8EA7U#
MC_9I/T0,M               U6P'^M3OQ[$6+]Y4AT&<_IF7^E5WY?.-R_\
M*]X_0M?L4-J3GWT<          ,2G^W2C]C5^/D RT
M         %@RCZ@7'_<-^/:!<K9]3K?_ ,&B^,0":
M        #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I       =K?R3'VO;V^R-
MC^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\                        .8O8S^
MJW:=_I:O7RQ3)\2:[/\ +A[^&?W=W^9/@;P',NF
M
M         Y[]GW^L3VR/Y26;]&Y'9YC[GEOHSX'%4_?<QW:>]+<UO K&Z^@E
M4/2%1.*!"JWTR 2&\"!49Q[Q(KM DLX 26?%(3"0WTR$B6SN=X(26<4"83H_
M "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\?%?A$0E7;Q$D/LA(  B5-!25C
MZ:2IBZQ]'(DM,O,Y.5Z*BHO0J:\.Z!+
MB45#2VZ!*:CBZF%%5R,YG.Z5X]+E50)8              &JV _UJ=^/8BQ?
MO*D.@SG],R_TJN_+YQN7_E>\?H6OV*&U)S[Z.          $1U#2NK67%T6M
M9''U+)N9W0S55TY==.ZO< E@                           CU5+!6T\E
M+4Q];!,B)(S56ZHBZ\6JB\4 JQ1LACCAC;RQQ-1D;=571K4T1-5 ^P
M                     <!O[S[\(G\&.M_#OJN4_$/K.:!>*B E(!NON'V(
M=RL>VYQ/=O '>Z7A&18]07NYMMC.>X6MU12LGJ&2T[%?UT<3E<U9(]531>=C
M--2JL;UMU7)MU_-JB<.U*VO[JKIIBNW\Z,.7]+2E45%5%314Z%12T5+\)  !
MVM_),?:]O;[(V/Y36G+_ !!Y5'+X'1;AU5]V/"Z]G.K\
M        .8O8S^JW:=_I:O7RQ3)\2:[/\N'OX9_=W?YD^!O <RZ8
M
M                     #GOV??ZQ/;(_E)9OT;D=GF/N>6^C/@<53]]S'=I
M[TMS6\"L;KZ"50](5$XH$*K?3(!(;P(%1G'O$BNT"2S@!)9\4A,)#?3(2);.
MYW@A)9Q0)A.C\ )2$XH$)#.'?"%=G#O@E5;W28$IO!O>)0KQ\5^$1"5=O$20
M^R$@ #&,@JJBGJ\?9!,^)M17,CG:U51'M5S=47T4Z0EDX0
M              QG$JFHJ[.R:JF?/*LKT61ZZKHB]'2H&3
M :K8#_6IWX]B+%^\J0Z#.?TS+_2J[\OG&Y?^5[Q^A:_8H;4G/OHX
M  8S-4U"9724B3/2F?0+(Z#7Q5=SO373T>@#)@
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MK?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
M      .8O8S^JW:=_I:O7RQ3)\2:[/\ +A[^&?W=W^9/@;P',NF
M
M                     Y[]GW^L3VR/Y26;]&Y'9YC[GEOHSX'%4_?<QW:>
M]+<UO K&Z^@E4/2%1.*!"JWTR 2&\"!49Q[Q(KM DLX 26?%(3"0WTR$B6SN
M=X(26<4"83H_ "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\?%?A$0E7;Q$D/
MLA(  MEPM<5PFM\TDCV+;YVSQHW3QG-5%T77N= %S
M          MMJMD5HI$HX9'RL:YS^9^FNKOA(@%R               U6P'^
MM3OQ[$6+]Y4AT&<_IF7^E5WY?.-R_P#*]X_0M?L4-J3GWT<          +:^
MV1/NL5V61Z310+3MCZ.56JJKKPUU\8"Y
MA7"BCN-'/12O<R.=$1SV::IHJ+T:Z^@!(IX6T\$,#55S8(VQM<O%4:B(FO\
M@ J@                           X#?WGWX1/X,=;^'?5<I^(?6<T"\5$
M!*0#=C<+,NU%O%L)0Y3<J&HLO9YVTHK3C\-/1.2DHJJ2EZBW0S2M<_KJQ_6*
MU'/5%B8_H:C7=!56+66L7]F--RK&?#R=];7[N8OV=O5;C#EX.7O+EB/Y/#M"
M9MB>,9G94QGZ39=::*]6GSBYOCE\VKX&5$/6,2!>5W)(FJ:KHI%S?-BW5-,X
MXQ.&KB1;W1>KIBJ)C"8QUSP\C3;+,6ON#Y-?L/R:A=;;_C==-;[M1/5%ZN>!
MZL<B.3H<U=-6N3H5-%3H4LK=RFY3%5.J5==MU6ZIIJUPQXR,8!VM_),?:]O;
M[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP                        YB]
MC/ZK=IW^EJ]?+%,GQ)KL_P N'OX9_=W?YD^!O <RZ8
M
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MWJXU-#4V6*G<U&5U8R&H14UU8Y6HNGH<0,@
M    L&-W"IN=L;552M699'M56IRIHU>CH OX              &JV _UJ=^/
M8BQ?O*D.@SG],R_TJN_+YQN7_E>\?H6OV*&U)S[Z.          %@EN%2S(Z
M:V(K?-9:-9W)IXW/S.3CW@+^                           "U7RLFH+5
M65=.J)-"UJL5R:ITN1.'? F44KYZ.DFDT5\T,;WZ=":N:BJ!)
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MEJ]?+%,GQ)KL_P N'OX9_=W?YD^!O <RZ8
M
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M6ZVN2X5%IF9*V-+?5-G>CD55<C51=$T^$!>@
M    +-8;9):+>VCDE;,YKW/YVHJ)XWPP+R              !JM@/]:G?CV(
ML7[RI#H,Y_3,O]*KOR^<;E_Y7O'Z%K]BAM2<^^C@         !9I+9(^^P79
M)6I'%2K3K#HO,JJYRZZ\/TP%Y                           !;;O0ON5
MNJJ)CTC?4-1$>[I1-'(O<^$!*I85IZ6FIW*CE@B9&KDX*K6HFO\ B D
M                       X#?WGWX1/X,=;^'?5<I^(?6<T"\5$!*0#I)LI
MVN=I;KM9:MB^U9@<^<8?C7(S#\DI&++4TD3/%CBEY)H)X^J8JL9+ _FY-(U8
MJ>,4>:W==INS=R]6$SKCL\*[RV\;55N+5^,8C5/9WX>K46__ .3TV2J?;ELS
MM)<<CSZA8KK ZI2X.B@G7H1_7WBJGZA415\>*)SNXAKU9//YCYMVO"GAU>#6
MSTYK)6/G6XQGE[]6IS#W0W(R;=W/<DW$RZH9/?<FJNOJ6Q(K888V-;'#!"U5
M54CBC8UC45571.E5752^R]BFQ1%%.J%'F+]5ZN:ZM<L!,S" =K?R3'VO;V^R
M-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\                        .8O8S
M^JW:=_I:O7RQ3)\2:[/\N'OX9_=W?YD^!O <RZ9 NUTM]CM=RO5VJ6T5KL]+
M-6W*L>BJV*GIV+)+(Y&HJZ-:U571"8B9G"$3,1&,O!O?8=GS_P"(]-_R*X?0
MQG^R7>)K_;+7G,PPG?+:O<:\/L&%9;%?;O%3/K)*.*FJXU;!&YK'/5TT+&HB
M.>U./=/%=BNB,:H>[>8MW)PIG&7K!B9@     +9;[U:;M-<Z>V7&GN$UFJ5H
MKJRGD;)YO4HU'NAD5JJC7M:Y%5J]*:IJG23-,QK>8JB=2O<;C;[10U=TNM;!
M;;;01.GKJ^ID;%##$Q-7/>]ZHUJ(G%541$S.$)F8B,9>7XIOSM!F]Z3'<7SN
MWW.]/YD@M^DL#YE;JJI"L\<:2JB(JZ,5>CIX&6NQ73&,QH8J,Q;KG")TO7#"
MS 'D&<;^;0;<7/Z2YAF]);+NUK736V&&IK9XD>G,WK64<4RQJJ=*(_3H5%X*
MAFHR]=<8Q#!<S-NW.%4LEP7<S!-RZ">XX-DM+D%-2N:VK9%SQS0J]-6];!,U
MDK.;1=%<U-=%TX*>;EJJCRHP>[=VFY&-,XLZ,;(B5]?26N@K;G7SI34%N@DJ
MJVI=JJ1PPM5[WKHBKHC45>@F(QG!$SA&+!W;K[?,QK&\P=D<;<=R^OAMF-W%
M8*C_ ,[JYW2,BB9'U76(KEB=IJU$Z->![Z*K&8PTPQ]-1A%6.B=3T,QLK%X<
MSQFHR^KP.&ZLDRVAMS;M5V=(Y>:.C<]L;95DY.KZ7/1.7FYN[IH>]B=G:X'C
M;IVMGA9#55=+0TU16UU3%1T=)&Z6JJYWMCBCC8FKGO>Y41J(G2JJIYB,7J9P
M4[?7T=UH**Z6ZI966^Y4\=505<2ZLEAF:CXWM7NHYJHJ"8PG"2)QC&$LA(
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M.U%2-5TUU<B<>GT0)5+,M134]0K>59XF2*WCIS-1=/\ &!7
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M#[(2  ,=OE!5UE58Y*:+K&4=:R6I7F:G*Q'-55Z537AW ED00
M                 QW%Z&JMUJ935D74S)(]RLYFNZ%7HZ6JJ 9$
M      !JM@/]:G?CV(L7[RI#H,Y_3,O]*KOR^<;E_P"5[Q^A:_8H;4G/OHX
M         6&6W5#\BI[HG+YK%1K [I\;FYG+P]#I OP
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M*;UZ9IU1&#4XL5> =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
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MB.JK])FR*J="/= KV:)W$^ 17.%GZ4XO5$8WY]&F(;<FFW0
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M5[6(BN7543HU5$[OH@5X)FU$$,[$5&3L;(Q'<=')JFNFOH@50
M                <!O[S[\(G\&.M_#OJN4_$/K.:!>*B E(!?,?R;(\2N45
MYQ7(+EC-W@Z(+K:JN:BJ6=WQ9H',>G#N*>*[=-<851$QVWNBY51.-,S$]K0]
M&J=U-UMT;G8\7SS='+<FLETN-)2U-ON%XJZF%&RS,8KFPS2/BYD1=456KTF#
M[/:LQ-5%$1,1Q-F,Q=OUQ375.$S$:V:]K79K&-AMY[OMUB%?=+E9*"WV^KAJ
MKQ+!-5*^J@21Z.?3P4[-$5>C1G^$Q;NS-68M;=6&.,ZGK>&6IR]S9IQPPQTM
M:#?:(!VM_),?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
M             YB]C/ZK=IW^EJ]?+%,GQ)KL_P N'OX9_=W?YD^!O <RZ8
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M6-8CGKHBN5&HFJKHG23,XHB,$@A(
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M.8WE8Q%55\=O!$ N%N:YMOH6N16N;3Q(YJ]"HJ,35%0"8
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M:O7RQ3)\2:[/\N'OX9_=W?YD^!O <RZ8
M
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MO\R? W@.9=,
M                                        !SW[/O\ 6)[9'\I+-^C<
MCL\Q]SRWT9\#BJ?ON8[M/>EN:W@5C=?02J'I"HG% A5;Z9 )#>! J,X]XD5V
M@26< )+/BD)A(;Z9"1+9W.\$)+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E
M-X-[Q*%>/BOPB(2KMXB2'V0D  8CDW^NXS[(Q_'-"67!
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M$:ZL9,K461K5U75$=JB=)SU<1%4[.K@?2;,US;IFN,*L(QCBGA^5+/+(  -
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M>3;<F  +!E'U N/^X;\>T"Y6SZG6_P#X-%\8@$T
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M
M                             !SW[/O]8GMD?RDLWZ-R.SS'W/+?1GP.
M*I^^YCNT]Z6YK>!6-U]!*H>D*B<4"%5OID D-X$"HSCWB17:!)9P DL^*0F$
MAOID)$MG<[P0DLXH$PG1^ $I"<4"$AG#OA"NSAWP2JM[I,"4W@WO$H5X^*_"
M(A*NWB)(?9"0 !2D;"YT:RM8KFNUBYT35'?Y.O=^$!5
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M  !\2)&YCDE1JQKZ9'Z:=_4#Z:C4:U&Z(U$3E1.&G<T _0
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M-=G^7#W\,_N[O\R? W@.9=,
M                                                    !SW[/O\
M6)[9'\I+-^C<CL\Q]SRWT9\#BJ?ON8[M/>EN:W@5C=?02J'I"HG% A5;Z9 )
M#>! J,X]XD5V@26< )+/BD)A(;Z9"1+9W.\$)+.*!,)T?@!*0G% A(9P[X0K
MLX=\$JK>Z3 E-X-[Q*%>/BOPB(2KMXB2'V0D  8CDW^NXS[(Q_'-"67!
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MPO!A;   L&4?4"X_[AOQ[0+E;/J=;_\ @T7QB 30
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MMVG?Z6KU\L4R?$FNS_+A[^&?W=W^9/@;P',NF
M
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MGP-X#F73
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M4Z%3I GV]SGT%"][E>]]/$Y[W+JJJK$5555 F
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M4XXX0R@\/8!S%[&?U6[3O]+5Z^6*9/B379_EP]_#/[N[_,GP-X#F73
M
M                        :B[2[-9HR_;G[KXE=K(R7=6]NDO-!=TJ7M@D
MM<]5"SS=L#6JU'=:Y5YGO[G#IUT\GOG?.\,M1-OH(HHFJF,8KVM$X:<*L.#@
M6&\=R[BW=FZJ;OVF;E<455;,V]G33CHQIQX>%[._#MYHDZ;AA:_[U<?DSW-W
M?<<.7YKGC8:;/P_/!F>>W_=09,?WAC71:W#5^%%</DS'.:WU'_K\USQLU.3W
M!/!F>>W_ '422W;O1]"U6'K\*&X?NABJS^^8]AS5_P!YEC=NX9_]GGM_W41[
M=VH^E9\173_[&O\ W4QSO7?$>PYJ_P"\RT[GW%/_ +//;_NHCZW=>)=5EQ)=
M/_L:[]U,56^=[QP6.:O^\S4[AW'/#F.>W_=6^;)MTX->;VJKIZ$-=^[&"KX@
MWM'!9YJ_[S/3\,[EJX<QSV_[JVR9YN;!KK'C"_"AK?W<PU?$^]:>"SS5_P!Y
ML4_"&YJOUK_K4?W%OEW7W%HE2>>W8_6PQ.1T]+3QU4<KV(OC-8Y\SD1RIP54
M7X2F"?C'>5N<:J+4Q&N(BJ)F.U,U3IY);%/P+NFY&%-R]3,ZIF:)B)X,8BF)
MPY8[K8'$\IM&7VB&\6>?K(7^)44[^B6"5$\:*5O<<G^/BG0?0-U[TL[QLQ>L
MSHX8X:9XI[;YGO?=&8W7F)L7XPF-4\%4<%5,\,3^B=++&?%+!60D-],A(EL[
MG>"$EG% F$Z/P E(3B@0D,X=\(5V<.^"55O=)@2F\&]XE"O'Q7X1$)5V\1)#
M[(2  +=76R"X2T,TSY&NM\R3PHQ41%<U45$=JB]'1W +B
M             !;K7;(+32)1TSY'Q-<YZ.D5%=J[CP1$_P 0%Q
M     U6P'^M3OQ[$6+]Y4AT&<_IF7^E5WY?.-R_\KWC]"U^Q0VI.??1P
M      MS[9 ^YQ797R><10=0UB*G)RJJKJJ::Z]/H@7$
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MXV;34 .UOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
M             ',7L9_5;M._TM7KY8ID^)-=G^7#W\,_N[O\R? W@.9=,
M
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M  ,>O=PJJ*JLD5.]&,K:QD-0BM1=6*YJ*G3PX@9"
M        !C^,U]5<K6RJJWI),LCVJY$1O0B]'0@&0               :K8#
M_6IWX]B+%^\J0Z#.?TS+_2J[\OG&Y?\ E>\?H6OV*&U)S[Z.          &/
MRU]4W)::VM>B4DE$LSX]$UY^9Z:Z\>X@&0
M  M-]JYZ&TUE73.1D\+6K&Y41=-7(G!?A@3**5\U%232+K)+#&]Z\-5<U%4"
M4                           #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I
M .I6V'9Z[.&RFS^);V=K&IJKW<]PZ9M;A6W-*LZ*M/(ULL:I%321/ED6&1DC
MUDD9%&CD8[5ZIK07\YF,Q=FUE]$4ZY7]C)V+%J+E_7/!^COLZL#_ ,FUO[<Z
M7;FQX==]KLHO\C:7&K[(V:@<ZLD72.*.1M764ZN>O0UL[-'*J-;XRH8:^L,M
M&W,[41KX?T\S-3.1S$[$1A,ZM&'9RN:^^FT5XV,W1RG;2]5+;A+89F.H+K&W
MD95T51&V:FG1NKN571O3F;JO*[F;JNFI>93,QF+45QPJ/-Y:<O<FB>3N/(S9
M:P!VM_),?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
M          YB]C/ZK=IW^EJ]?+%,GQ)KL_RX>_AG]W=_F3X&\!S+I@
M
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MQ\5^$1"5=O$20^R$@ "RW6UR7"HM,S)6QI;ZIL[T<BJKD:J+HFGP@+T
M                       !9K#;)+1;VT<DK9G->Y_.U%1/&^&!>0
M        -5L!_K4[\>Q%B_>5(=!G/Z9E_I5=^7SC<O\ RO>/T+7[%#:DY]]'
M          "S26R1]]@NR2M2.*E6G6'1>955SEUUX?I@+R
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MX(B&CQ:JL [6_DF/M>WM]D;'\IK3E_B#RJ.7P.BW#JK[L>%U[.=7X
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MB>OF%G
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MA79P[X)56]TF!*;P;WB4*\?%?A$0E7;Q$D/LA(  LMUNDEOJ+3"R)LB7"J;
M]7*J*U'*B:II\,"]                             6:PW.2[V]M9)$V%
MSGN9R-553Q?A@7D              #5; ?ZU._'L18OWE2'09S^F9?Z57?E\
MXW+_ ,KWC]"U^Q0VI.??1P          LTESD9?8+2D35CEI5J%FU7F14<Y-
M-.'Z4"\@                           MMWKGVVW55:QB2/IVHJ,=T(NK
MD3N?# E4LRU%+35#D1JSQ,D5J<$5S473_&!(
M   !P&_O/OPB?P8ZW\.^JY3\0^LYH%XJ("4@'M^S_:+WAV*FJUVVR^>ST-Q?
MUEQL<\<=703R:(G6.IIVO8C]$1.=J([3HUT-3,Y*UF/+C3Q\+;RV=NY?R)T<
M7 ]HS'\H+VGLQM-99G9E2XU1U\20U4MAH8:.I5O=Y*E>LFC5=.E8WM7O&K;W
M/EJ)QPQ[LMFYO>_7&&B.Y#2ISG/<Y[W*][U5SWN7555>E555+163.+Y)0 =K
M?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
M     .8O8S^JW:=_I:O7RQ3)\2:[/\N'OX9_=W?YD^!O <RZ8 U%W"URWM7;
M,8LJI-0X'9+CE5?&Q47EEJ.:"'GTX*V2")>GN+\$V[?S;-4\<X-*[\Z_3'%$
MR]8WWR&7'-N+Q/39Y;]MZRN='1T^4U[))5A21=9$IHHD=(Z96([EY6JK>ER<
M-4Q6*=JO5BS9BK9HG3AVVAF<77;3$[!;\CV8RW<&X;DQ7*W1T.6UK;LVBKYY
MY/UUE7Y]%'$_K6\R\B-\9>C16\QOT175.%<1AQ:%?<FBF,;<U;6C3I;';PP9
M-GG:%VRV[QG(JS'*>Q8]<K]DMVMTG+/34M<[S-SH^E6I-^MHR)SD7JUD21$U
M0UK,Q1:JJF,=.#9O[5=VFF)PPB9EB5MP!MWW2OFP&.Y/D5JVUPFGBR+/ZE;A
M(^YW:XW..%T%(ZK3E>R!(U:]6IQ7G5?&5KF^YN841<F(QG1':>(MXUS;B9V8
MTSITSB^*O 9L*[1>U6WV/93>/<\IZ6HS&IQ^OKI*EE#+0QU$>K'R.YDAD>V/
MQ7*J(O,HBYM6JJIC3J)M[%ZFF)G9UL*L&X>W.\5SR#,MZ<LR6&TNN,]/@. V
MJFOK;?26^+Q8ZJ6:UTRI+.YW2J]9T*WI331K?=5NNW$11$=N='A8Z;M%V9JK
MF<."(Q\#([%DWGVR?:)L%UO5^ON#X.O7;>Y-<?/:.OJ*=[%FH:5\TS()E2&H
MAC:OBM71W+Z140\U4X7*)B(QG6]TUXVZXF9F(U/>.S!M;:=O=L\<ND"5"WS,
M+-;[A?%EGDDC8Z5KZEC(HGJK8M$J-'\B)S*FJZZ(8,U=FNN8X(EL92S%NB)X
M9AL)66VW7'S5;A04]<M%.RJHO.(F2]3/$NL<L?.B\KVKTHY.E#7B9C4V9B):
M.9?79[EF]FU>#;W4=#B>'?3:2^X1'8M:J&[76W=,$%94RR(Z+E:_14;'TJ_E
M_3(]F]1%--NJJC3/#CP*^N:JKE--S1&N,.&6V-SV[MEUW"QS<>HO%WCN6,4,
M]#062&H8VV2)4-E8^6:'JE>^32541>L1$T;T>CJ1<F*9IXV[-N)KBK&=',R3
M)KW!C6.9!D=2WFIK!;:NY5#==-64L+IG)K\)IYIIVIB.-ZJJV8F>)H'V=J?M
M(V/;&CK\'QK#+C9<KK:N^MJKU4U;*V::=R1.<]L3FL1%2%.7X'2JF_F.BFOY
MTSC&A79;IHHQIB,)TLJVKR&XMW<W9RW>F)]#NUA.+.DIK%2MC;::7'8M*E[J
M*5LDSGJKW-5SGKJWG5.E5<C?-VF-BF*/)F>7%[LU3TE55SRHCDP8/A-YRS'M
MD=IL,Q6Y/LN>]HO)KG65>1-3QZ&D6=$JZJ'IUZSJ$B5J\4U=HJ.1JGNNFFJY
M55.JF&.W553:IIC1-<RSO>+;.W[#X$S=7 <IR"ES#$:ZADKZJY7:HJVWV.IJ
MHX)H*R"5ZQ.YDD5_B,;T(JZ:Z*F.S=F[5L51&$_(R7[46:-NF9QCMZV7Y&MX
MWRWDR';-+[<\=VVVRH**;,J>TU*TU3=+G<6=;!32SQ*JI%&Q%YFHOIF.[JM5
MOFG"U;BK#&J=3W5C>N31CA3&OMRM+&4>P>^>/XYC]YN+=N<RQF[72^8Q7ULU
M?';I+/!)4^=4JU#WRM1[(N545RZ^-KKHWEG]];F9UQ,?*C]S=B(GYLQ.CN(6
MVVV]?V@+!)N[N7D^0T-?DM54RX+9;/<9:&GL=#%(Z*!\#(M$6558KN=R>,G*
MKD554FY=BS.Q3$:-?;1:M3?C;KF=.K3J77L;V^Z5-@W(S:_7%]WO64Y3+2U%
MUD1.:JBM<38F3*J="\SY)/\ !\$\YR8QBF-40G(Q.%54ZYGO,X[0N79/1OV[
MVSPJYR6#)-V+RZW^V.'HFH;?2)&^MEA5.E)$;*W14Z43714714\9>B)QJJTQ
M$,F9KJC9HIT35*U0]G2JPK),-RC:O,;O0UMOND/MXI+[<ZFJ@O%K<B)4M>WD
M>WKU1J<GBHU%\;H5K2?M.U$Q7'<PX$?9MB8FB9[>,ZX>3YS>=KLHW'S&/<[=
M>ZY32VF:.DQ3;S#8KLL- C'<LJU+Z&%T<E0K]$5>LZ%U;ZEK<U$5TT1LTX<<
MS@PW*J*JYVZIGBB,? D[/[@5M@V^[2-=2WB]U&%[>SU4> ID'6K<:25E-*KJ
M1ZS)UC5;+U36L=Z55Z4154B];QJHT1C.O L7<**YQG"-6*TX]LYU_9LAS'<_
M,<BJ:NUXM67W';53W%]+26Z*2.6MI7(R-=9ZB17H]SI5<NKDC1$1B:S5>_Q=
MFF(UX(IL?X.U7,ZL=:Z-S+<:[;9=F[:VCR*LMV:;OTSI;WES7*M?36*D9YP^
M6.1=7=<^E<U4?KJO*[I17:I&Q1%==>&BG@[:>DKFBBC'35P]IZM0]GJLP7,,
M-RC:[+KI00TE:C,_ME\N5360W6WO1&R*C%:]O7HB*K=>5NNBIRZ&*<QMTS%<
M=QFC+;%431,]O&=;7JV[C[>;Q9'E63;PY;D5/BM'=):+;_ K/37MM"E' G*E
M=436NG=UDTB]/^=U:O,FG+RHFQ-NJW$11$8\,Z/"UHNT79F:YG#@B,? ] VR
MW%JL<PGM#PT5_N]^PC;FC;7[:Y)>H:N&K?'644[VT:/K8H97=1/$V-O,U.E?
M4JTQW;>U51HTSK9+5W9IKTS,1JQ7K8'8^IJL/VOSG/<IO]POEL@BNV.8\RN<
MRW4<$[G5$*21>,Z627K>ME<]VNJI'HC6:+&8OX554TQ&#UEK'S::JIG%N8:3
M>                                                   %BV(_FZ9
M[,W?]_3&K\*?<?KU_M2V_C/^I?Y=O]B'I]3W2\K<];8U5>F-.MOVV/U7%34N
M-VVQ^H]*IIUMRTL%3W33N+"WK8?</TQ7W%E:8?6]TK[JULL1K>"E9=6ME8;;
M8;ME]Z;8+$Q%GT1]QN#TUAHX5_3R*G%R_I6\5,.2W?>WC?BQ9C3^M/!3''/@
MCA9\_O.QNO+3F+\Z/U:?UJZN*.UQSP-S\-Q"SX7:(K1:(ETUYZRL?HLU3,J>
M-)([NJO<3@B="'V3=.Z;.[;,6K4=V>&J>.>S0^$;YWUF-[9B;UZ>U$1JIIXH
M[-+,&^F0M%2EL[G>"$EG% F$Z/P E(3B@0D,X=\(5V<.^"55O=)@2F\&]XE"
MO'Q7X1$)5V\1)#[(2  ,>O=OJJVJLDM.Q'LHJQDU0JN1-&(YJJO3QX 9"
M                         !C^,T%5;;6REJV)',DCW*U%1W0J]'2@&0
M             :K8#_6IWX]B+%^\J0Z#.?TS+_2J[\OG&Y?^5[Q^A:_8H;4G
M/OHX          8_+053LEIKDUB+21T2PODU37GYGKIIQ[J 9
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M;Z5D4348QJ:]Q$1$-69Q;<1@DD)
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M[6(BN7543HU5$[OH@5X)FU$$,[$5&3L;(Q'<=')JFNFOH@50
M               <!O[S[\(G\&.M_#OJN4_$/K.:!>*B E(      #M;^28^
MU[>WV1L?RFM.7^(/*HY? Z+<.JONQX77LYU?@
M!S%[&?U6[3O]+5Z^6*9/B379_EP]_#/[N[_,GP-X#F73      >#Y?V=-O<O
MR.OROKKYB]]O",2^5F/7*6@2NZO1$6H8WF:JZ)HJHB*O%>GI-BC,U4QAHF.V
MUZ\M15.UIB>U+TG!L#Q;;C'Z?&<0M;+7:H7NFD;S.DEGGDTZR>>5ZJZ1[M$U
M55X(B)HB(B8J[DUSC++;MTVXPI9>>'L
M                                                   .>_9]_K$]
MLC^4EF_1N1V>8^YY;Z,^!Q5/WW,=VGO2W-;P*QNOH)5#TA43B@0JM],@$AO
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M>QJ,C8U7.7QVKT(G2!/M[7,H*%CVJQ[*>)KV.3145&(BHJ*!,
M                !P&_O/OPB?P8ZW\.^JY3\0^LYH%XJ("4@      .UOY)
MC[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
M  ',7L9_5;M._P!+5Z^6*9/B379_EP]_#/[N[_,GP-X#F73
M
M                 <]^S[_6)[9'\I+-^C<CL\Q]SRWT9\#BJ?ON8[M/>EN:
MW@5C=?02J'I"HG% A5;Z9 )#>! J,X]XD5V@26< )+/BD)A(;Z9"1+9W.\$)
M+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E-X-[Q*%>/BOPB(2KMXB2'V0D
M 1:BMI:1]/'43)$^KD2*G:J*O,]=$1.A%]$"4
M     !%HZVEKX4J*25)H556H]$5.E./%$ E               :K8#_6IWX]
MB+%^\J0Z#.?TS+_2J[\OG&Y?^5[Q^A:_8H;4G/OHX          175M*VK90
M.E1*N2/K60Z+JK-537733N*!*                           !0J:F"D@
MDJ:F1(H(DUDD75=-5T[FOH@5(Y&2QLEC=S1R-1['>BBIJB@?8
M                . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D      !VM_),
M?:]O;[(V/Y36G+_$'E4<O@=%N'57W8\+KV<ZOP
M  YB]C/ZK=IW^EJ]?+%,GQ)KL_RX>_AG]W=_F3X&\!S+I@
M
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M0VI.??1P          Q*?[=*/V-7X^0#+0
M 6#*/J!<?]PWX]H%RMGU.M__  :+XQ )H
M. W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D      !VM_),?:]O;[(V/Y36G+_$
M'E4<O@=%N'57W8\+KV<ZOP                        YB]C/ZK=IW^EJ]
M?+%,GQ)KL_RX>_AG]W=_F3X&\!S+I@
M                                                           .
M>_9]_K$]LC^4EF_1N1V>8^YY;Z,^!Q5/WW,=VGO2W-;P*QNOH)5#TA43B@0J
MM],@$AO @5&<>\2*[0)+. $EGQ2$PD-],A(EL[G>"$EG% F$Z/P E(3B@0D,
MX=\(5V<.^"55O=)@2F\&]XE"O'Q7X1$)5V\1)#[(2  *4CH6NC25S$<YVD7.
MJ:J[_)U[OP@*H                            %.)T+F:P.8YFO%BHJ:]
MX"H              !JM@/\ 6IWX]B+%^\J0Z#.?TS+_ $JN_+YQN7_E>\?H
M6OV*&U)S[Z.          %-70]:C5<SKE;JUNJ<W+\+CH!4
M              !\2+&UCEE5J1IZ97Z:=_4#Z:K5:U6Z*U43E5.&G<T _0
M                         <!O[S[\(G\&.M_#OJN4_$/K.:!>*B E(
M   #M;^28^U[>WV1L?RFM.7^(/*HY? Z+<.JONQX77LYU?@
M          !S%[&?U6[3O]+5Z^6*9/B379_EP]_#/[N[_,GP-X#F73
M
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M?^5[Q^A:_8H;4G/OHX          8E/]NE'[&K\?(!EH
M           +!E'U N/^X;\>T"Y6SZG6_P#X-%\8@$T
M          ' ;^\^_")_!CK?P[ZKE/Q#ZSF@7BH@)2       [6_DF/M>WM]
MD;'\IK3E_B#RJ.7P.BW#JK[L>%U[.=7X                        <Q>Q
MG]5NT[_2U>OEBF3XDUV?Y</?PS^[N_S)\#> YETP
M
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M5-)(UU371=>YIZ %2.-D4;(HV\L<;48QOH(B:(@'V
M        #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I       =K?R3'VO;V^R-
MC^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\                        .8O8S^
MJW:=_I:O7RQ3)\2:[/\ +A[^&?W=W^9/@;P',NF
M
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M'Z%K]BAM2<^^C@         !BTTTJ9?20)*](76]7.AYEY5=SOZ>7AJ!E(
M                         +'DLDD5CN$D3W1R-8WE>Q514\=O!4 N%N<Y
MUOH7.57.=3Q*YR]*JJL3554"8                           #@-_>??A
M$_@QUOX=]5RGXA]9S0+Q40$I       =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1
M;AU5]V/"Z]G.K\                        .8O8S^JW:=_I:O7RQ3)\2:
M[/\ +A[^&?W=W^9/@;P',NF
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MJ*=SVQ3HB/<Q41R:*B]&J*G<] "O!"VG@A@8JJR!C8V*[CHU-$UTT] "J
M                        #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I
M   =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
M          .8O8S^JW:=_I:O7RQ3)\2:[/\ +A[^&?W=W^9/@;P',NF
M
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M!0)M#(^:BHYI'<TDL$;Y':(FKG-1571 )0
M . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D      !VM_),?:]O;[(V/Y36G+_
M !!Y5'+X'1;AU5]V/"Z]G.K\                        .8O8S^JW:=_I
M:O7RQ3)\2:[/\N'OX9_=W?YD^!O <RZ8
M
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MKIHY%X='H 2J6%:>FIZ=7<RP1,C5W#7E:B:_X@*X
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M*BW=IN1C2SHQL@
M       +%L1_-TSV9N_[^F-7X4^X_7K_ &I;?QG_ %+_ "[?[$/3ZGNEY6YZ
MVQJJ],:=;?ML?JN*FI<;MMC]1Z533K;EI8*GNFG<6%O6P^X?IBON+*TP^M[I
M7W5K98C6\%*RZM;+"J]99)X*.D@?65]=(D-#11)S22R.Z$1$0KJXJKJBBB)F
MJJ<(B-<RM;<TT4377,4T4QC,SJB&U>U6UM/AL/TYO"1UF5UK-)IDT='1L=QA
MA7T>XYW=X)T<?JOPS\,T[NIZ6[A-Z8Y*(\VGPSR1HU_&OBWXMKWK7T-G&G+T
MSHCAKGSJO[-/!KG3J]K;Z9#KG$I;.YW@A)9Q0)A.C\ )2$XH$)#.'?"%=G#O
M@E5;W28$IO!O>)0KQ\5^$1"5=O$20^R$@ "RW6Z26^HM,+(FR)<*IL#U<JHK
M4<J)JFGPP+T                            !9K#<Y+O;VUDD387.>YG(
MU55/%^&!>0              -5L!_K4[\>Q%B_>5(=!G/Z9E_I5=^7SC<O\
MRO>/T+7[%#:DY]]'          "S27.1E]@M*1-6.6E6H6;5>9%1SDTTX?I0
M+R                           "VW>N?;;=55K&)(^G:BHQW0BZN1.Y\,
M"52S+44M-4.1&K/$R16IP17-1=/\8$@                           '
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M5'#.#'-'27::9_5C'E;MQPPPHJ0Q,B1VBN1C4;KHU&IKIZ#6HGPD-%OJ@
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M"5=O$20^R$@ #'[U;JFNJ;++3M:K*&L9-4*JZ:,:K573T> &0
M                  6#&[?4VRV-I:I&I,DCW*C5YDT<O1T@7\
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MET3H<B\>\!,HHGP4=)#)HCX88V/TZ4U:U$4"2
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M1%4U<,L],;(
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MJNJHG1KIZ($BGF;400SM16MGC;(UJ\41R(J:_P"$"J
M         #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I       =K?R3'VO;V^R
M-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\                        .8O8S
M^JW:=_I:O7RQ3)\2:[/\N'OX9_=W?YD^!O <RZ8     "G+#%.SJYXF31ZM=
MU;VHYNK%1S5T7NHJ(J?! J
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M9&Q-57QVKT(!/M['1T%%&]JL>RGC:]J]"HJ-1%10)8
M         . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D      !VM_),?:]O;[(
MV/Y36G+_ !!Y5'+X'1;AU5]V/"Z]G.K\                        .8O8
MS^JW:=_I:O7RQ3)\2:[/\N'OX9_=W?YD^!O <RZ8
M
M         #GOV??ZQ/;(_E)9OT;D=GF/N>6^C/@<53]]S'=I[TMS6\"L;KZ"
M50](5$XH$*K?3(!(;P(%1G'O$BNT"2S@!)9\4A,)#?3(2);.YW@A)9Q0)A.C
M\ )2$XH$)#.'?"%=G#O@E5;W28$IO!O>)0KQ\5^$1"5=O$20^R$@ ")4U])1
MOIHZF7JWUDB14R<KEYGJJ(B="+IQ[H$L
M")15U+<8$J:.7KH556H_E<WI3CT.1% E@
MB.KJ5M:RW.ETK)(^N9#RNZ6:JFO-IIW%[H$L
M   $>JJH**GDJJF3JH(419'Z*[1%73@U%7BH%6*1DT<<T;N:.5J/C=HJ:M<F
MJ+HH'V                           #@-_>??A$_@QUOX=]5RGXA]9S0+
MQ40$I       =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
M                   .8O8S^JW:=_I:O7RQ3)\2:[/\N'OX9_=W?YD^!O <
MRZ8
M                                #GOV??ZQ/;(_E)9OT;D=GF/N>6^C
M/@<53]]S'=I[TMS6\"L;KZ"50](5$XH$*K?3(!(;P(%1G'O$BNT"2S@!)9\4
MA,)#?3(2);.YW@A)9Q0)A.C\ )2$XH$)#.'?"%=G#O@E5;W28$IO!O>)0KQ\
M5^$1"5=O$20^R$@ #$<F_P!=QGV1C^.:$LN"
M    &)85]0X_V:3]$#+0                           8E/\ ;I1^QJ_'
MR 9:                           "P91]0+C_ +AOQ[0+E;/J=;_^#1?&
M(!-                           !P&_O/OPB?P8ZW\.^JY3\0^LYH%XJ(
M"4@      .UOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
M                ',7L9_5;M._TM7KY8ID^)-=G^7#W\,_N[O\ ,GP-X#F7
M3
M                               <]^S[_6)[9'\I+-^C<CL\Q]SRWT9\
M#BJ?ON8[M/>EN:W@5C=?02J'I"HG% A5;Z9 )#>! J,X]XD5V@26< )+/BD)
MA(;Z9"1+9W.\$)+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E-X-[Q*%>/BO
MPB(2KMXB2'V0D  499*=CHDF?&Q[W:0(]415=Z#=>[\("L
M              !1@D@ECYJ9\<D6JHCHU16Z]WI3H K
M           HK) DS8U?&E0K>9L:JG/R^BB<= *P
M       *<KXF1N?.YC(D].YZHC4^&J] 'TU6N:U6*BL5$5BMX*G<TT ^@
M                        <!O[S[\(G\&.M_#OJN4_$/K.:!>*B E(
M  #OM^3-L6W%JV[RRNPK.*C*<BO3;-/N!8YJ">D99JYL53R4\<TK&-J$=J[Q
MF*J)IQZ3D-]UW)N1%5.$1CAVX=3N>FU%$[$S,SACVI=,BD7
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M&?9&/XYH2RX(                            8EA7U#C_ &:3]$#+0
M                        8E/]NE'[&K\?(!EH
M       +!E'U N/^X;\>T"Y6SZG6_P#X-%\8@$T
M      ' ;^\^_")_!CK?P[ZKE/Q#ZSF@7BH@)2       [6_DF/M>WM]D;'\
MIK3E_B#RJ.7P.BW#JK[L>%U[.=7X                        :!=@_P#M
M/?TRW_\ T9;;U_A?0A4[J_B?3EOZ5*V
M
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MV]?X7T(5.ZOXGTY;^E2M@
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MBIX[>"H!<+<YSK?0N<JN<ZGB5SEZ5558FJJH$P
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MB8G&)74\O0     &@78/_M/?TRW_ /T9;;U_A?0A4[J_B?3EOZ5*V
M
M                       Y;;._UG^VC_**P_*[@6V\/NUCN3X%5D?O%_NQ
MX6VC>!3K9]!*H>D*B<4"%5OID D-X$"HSCWB17:!)9P DL^*0F$AOID)$MG<
M[P0DLXH$PG1^ $I"<4"$AG#OA"NSAWP2JM[I,"4W@WO$H5X^*_"(A*NWB)(?
M9"0 !;ZVVT]?+12SJ]'4$R3P<JHB<S514UZ%U3H N
M          $"VVVGM5*E)2J]8D<KDYUU75W'I1$ G@
M         @.MM.^Y1W15?YS%#U#4U\7EU5>&G'I]$">
M          ")74<-PI9J.=7)#.B(]6+HO0J+T+T^@!6AB;!#% S7DA8V-FO'
M1J:)J!5                           !P&_O/OPB?P8ZW\.^JY3\0^LYH
M%XJ("4@      .UOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
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MB5JR      T"[!_]I[^F6_\ ^C+;>O\ "^A"IW5_$^G+?TJ5L
M
M                  !QOV:PG?+-KINANYA.;6"R5^>9$^FRGZ94JR/FGM?/
MU3V1M@DC8U&U"IXNFO=.JSD9:F*+5=,SLQHPGC?,]T9G>N9IKOT7J(VJIC":
M,?)F8X,'N2[?=K-O_O3P_P"MR_0AH[&2\RKG6LW=\Q_&M^I^E2=@O:R;QW2Q
M#ZW+]"$]'DO,JYT3>WS[:WZGZ5)V&]K%O_O1Q'ZW?_E#U%K)^95SO/VG?'MK
M?J?I4UQ/M8-_]Z&)?6[_ /*D]#D_,JYWB<WOCVUOU/TJ3L;[5[.GW4,3Z/\
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M                           #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I
M      =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\    '@>^?9Y
MQG?MN%KD.697B51@5Q?=\?K\4K:>@J65KDC2.=9IJ6H<U\*QZQNC5JM5577A
MIMY7.59?:PB)QC"<=/A:F:RE.8PQF8PG&,-#S'WG'_\ U1VA_NX__)&?K'_]
M5OU?TL/5W_[;GK?H9Q?NS'BV78?@&!YIGF<YIBV"W!;G66^^76*M?D4Z5#JB
M-+[424O75,<2O5K(V/C:C=$T7E;IBHSU5%=5=--,3.C1&KZ.G0R5Y*FNFFBJ
MJJ8CCG7]+C9AD&R.(W[=';_=Z*LN>/Y;MY05%IH$M,E/#2UUMJ$5/,JZ*2"5
M7PQJ]ZQI&YBM5RKKKRZ8Z,U53;JMZ)BK3IX)XX9:\M35<IN:8FG1HXN*7L1K
M-AKYE?9HVXS/>O%M];\ZZ5.38E34L-!84FA^D\L]"ZI?25D].Z!97SP.J55C
MDE1$5K?%X\VY;SMRBS-J,,)X>'N-2YDK==Z+LXXQP<'=9CGFT>-[B95MEEE_
MK;DRIVJNTU[L%KI9(6T=1621MC8^K9)#(]W4\O-'R/9HJKKJ8K68JM4U4QA\
MZ,)9+N7IN54U3C\V<88SOOV=\%[0UKQNTYQ6WF@IL8N$E?2262IBI99DFA=!
M/3S/DAF58I6.T<C.5WH.0R97.5Y:9FG#3QO&:R=&9B(JQT<3URIQG'ZO&IL.
MJ+/228M46UUGEL'5HE*M Z'J%INK31$CZOQ-$[AKQ75%6UCIQQQ[;8FBF:=G
M#1AAAVFJ+.Q;B?TKBPNIW6W)K-I('ZP[227IB6KJ$D61M$^5E.VK?3-5>B-9
MM>AOC=!O]958[6Q3M^=AI[O%BT.K:<-G:JV/-QT=SCP;=6FU6RQ6RWV6RT$%
MJM%IIXZ2V6VEC;%!3P0M1D<4;&HB-:UJ(B(A75535.,Z9E84TQ3&$:H7 A(
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M "=+<[=!74ELGKZ>&Y5[))*&WOE:V>9D*(LCHXU7F<C-4YE1.C5->($T
M
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M *X                           . W]Y]^$3^#'6_AWU7*?B'UG- O%1
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MS45$%$ZW4LC&0M:R-_/-52-5TC^7ECC;R:JYS]$E#=--=$U75>ZJ=!"7Z
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M,:^2!J*UC]=%U<B=.FGH@2Z29U12TT[D1KIXF2.1."*YJ*NG^$"0
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M/1CM7(]-,TY&W-JJ[17C$8:,,)Y6&,]<B[3:KHPF>''&.1E-\[0FX&29_EV
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MTJY&2M:NO3T:=PA+88
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M<U?:JRDIT19IFM1B.71.AR+Q[P$RBB?!1TD,FB/AAC8_3I35K410)(
M                     . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D      !
MVM_),?:]O;[(V/Y36G+_ !!Y5'+X'1;AU5]V/"Z]G.K\  :>]L/=7,-M<>VW
MMV+9)!M_1[AY?28[D^Z%33,J8[!03HJR3HDR+"Q[D1='R=#6M<O0OCML=W9>
MB[55-4;6S&,4\<J[>-^JU33%,[.U.$SQ0T4[3U-MOCMNVZ\T[267[YYA'F5E
MN-TI*N_Q7>T6RVPSN;/5R4=NC;3TRND?&QBOU>JKHWHUTM<C-RJ:L;<41LSP
M83,]V=:KST6Z8I_Q)KG:CAQB([D:FY-K_P#F+9'_ $$L_P!OTI6U?<(_F>"5
MC3]^GZ'AAIC8+)>*WL06C)[5:Y[W3;8[UR9CD-GIV\\E1;;?6R,J&\FBJY&I
M,CW:<$:KEZ$4LJZHC.33,X;5&$=V85U%,SE(JB,=FO&>Y$MQ^TGVBMFLG[.N
M8VW#\XM&<W_<^RR6'",2LU0RLNM96W1$@B8E#$[KXW1+(CGI(QJM5.54YU1J
MUV2R=VB_$U4S$4SC,SJT=M8YW.6JK$Q35$S5&$1&O3VGE-!%[V7>WLZYENO+
M]*,/NFQMJVKK\FG19**SW^UK!4/BFF;S-A9+U:HURKHNLCO2M<J9Y_\ *LW*
M;>F=N:L..):\?^+>MU7-$;$4X\4PG;D[N8-NGVR^R5:MO;O!EU%A]5E/TSR>
MU.\ZMLE15VR.1U+!5QHL4SZ>*!LDG5O<C4D;KHNI%G+UVLI=FN,,<-$Z];U>
MS%%W-6HHG'#'3&K4\UVUPK";'NKV@\!W8WVSO9'+'YY=,GL-':\NDQ>TWFS7
M9R2T]="C](IIM&*DCN97:<K?TCM,]^[75:MUVZ*:XV8B<:=J8F.!@LVJ*;ER
MBY751.U,QA5LQ,3PLGQ>V[65VWW;>RS;*\Y_G<<.W]YL%YW5RZZI=:&^34MF
MJG(V@J'L;--YJB<BO<JM1BLY/%<ACKJN178IKBF/G1.S$83&F-?=9**;<T7J
MJ)JGYLQM3...B=7<;18U'&WL*V-C8VM8[8JG5S$1$15?C35<JI\%555-&O[Y
M/\S^TWJ/N<?0_LM)-P; UNR?Y/\ W&OMWR'&MN\*MS;=G66XO4RTEQM#+Y0T
M45-7-J(&N?$QCZ=6O>C5Z'<B>,]$6SLU_P"-F*(B)JF=$3JG"9T*R[1_@V*Y
MF8IC7,:XQB-+,MPL7[/%7=-M</I]^-V>T#?,UO\ 0NQW"K3G+,@9"L>LC+G5
M,D1\,,4&FJO<J.1O,YO0UZICLW+\155T=%$1&F9IPY&2]18F::=NNN9G1$58
M\KV:HLE;DW:H[46-VV=*:XY!L];+;05*JJ)'-5LGAC>JIHJ:.>BFM%449:U5
M/!7+9FF:LS=ICAHA&[+&_>TN!]G+'\<SW,+5@.5;3TU9:,YP^\5$=)=*6JHZ
MF;FY:-ZMFE6;5'-ZMKE<Y>3I>BH3G\I=N7YJHB:HJTQ,:N=&1S=JW8BFN8B:
M=$Q.OF;7;+[B7/=C;7&-P[IA]3@LN40OJZ3':R?SB=E-UCFP3.?U4/1,QJ2-
M\7TKFKW2OS-F+-R:(G'#A;^6O3>MQ7,88\#U(P,X   :!=@_^T]_3+?_ /1E
MMO7^%]"%3NK^)].6_I4K91EIZ>=T3YH(YGP.YX'O:CE8[U355.A?@H!^-IJ9
ML[ZIM/&VIE:C9*E&(DCFIP17::JG0!7 _'-:]KFN:CFN14<U4U147BBH!9Z#
M',>M=3)66RQ6ZW5<VJ2U5+2Q0R.U75>9[&HJZK\$"\@6=N/6!EQ=>&V.WMN[
MUYGW1*:)*E5TTU67EY]=.CB!<IZ>GJHEAJH(ZF%VBNBE:CVKITIJCD5 *J(B
M(B(FB)T(B ?,D<<L;XI6-DBD:K9(W(BM<U4T5%1>A45 +5;<>L%FDFFM%CM]
MJFJ$Y9Y:.FB@<]$771RQM:JIKZ(%QJ::FK():6LIXJNEG;R3TTS$DC>U>XYK
MD5%3X8%*@MUOM=,VCME#3VZD8JJREI8F0QHJ\51C$1$U^$!^^84/4S4_F4'4
M5+UDJ(>K;R2/735SVZ:*JZ)TJ!5EIZ>:!]+-!'+2R,6.2F>U'1N8J:*U6JFB
MIIT: 1*6T6FABI8:*UTE'#0\ZT44$$<;8>LZ7]6C6HC>;NZ<0+B!"I[;;J2I
MJZREH*:FK+@K75]5%$QDDZM31JR/:B*_1.&J@48++9J62NFIK314\USU^F4L
M4$;'5&NNO6JUJ*_75?3:@2EHZ1?-M:6%?,^BC\1OZUHFGZWT>+T)IT ?;Z>G
MDFBJ'P1OJ(.9()W-17LYDT=RN5-4U3CH =3T[YHZE\$;JB)%;%4*U%>U%XHU
MVFJ(H$.XV>T7AL+;M:J.Z-IG]93MJX(YTC?ZIB2-=HOP4 FOIX)85IY(8Y*=
MS>5T#FHK%:G<Y5Z- /MC&1L;'&U&,8B-8QJ:(B)T(B(G!$ ^@
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MQ$D/LA(  M=QNC+=-;H7Q.D6XSM@8Y%1.57*B:K_ (0+H
M             !:[1<X[O1MK(XG0M<]S.1RHJ^+\("Z
M           M;[G&R[Q6E8G+)+3K4)-JG*B(KDTT_P#! N@
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M)E?H    T"[!_P#:>_IEO_\ HRVWK_"^A"IW5_$^G+?TJ5L
M
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MFJKX[5Z$ GV]CHZ"BC>U6/93QM>U>A45&HBHH$L
M      ' ;^\^_")_!CK?P[ZKE/Q#ZSF@7BH@)2       [6_DF/M>WM]D;'\
MIK3E_B#RJ.7P.BW#JK[L>%U[.=7X                        :!=@_P#M
M/?TRW_\ T9;;U_A?0A4[J_B?3EOZ5*V
M
M Y;;._UG^VC_ "BL/RNX%MO#[M8[D^!59'[Q?[L>%MHW@4ZV?02J'I"HG% A
M5;Z9 )#>! J,X]XD5V@26< )+/BD)A(;Z9"1+9W.\$)+.*!,)T?@!*0G% A(
M9P[X0KLX=\$JK>Z3 E-X-[Q*%>/BOPB(2KMXB2'V0D  0JNX4M%)215#U:^M
ME2&G1$5=7JJ(B+IPX@30                            (5!7TMRITJJ1
MZR0JY6HY45O2G'H4":                           "$ZOI6U\=M<]?.Y
M(NN9'HNG)JJ:Z\.XH$T                           $:KJX*&FEJZERL
M@A1%D<B*NFJHG!/A@58I6311S1KK'*Q'L7AJCDU0"H
M         #@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I       =K?R3'VO;V^R
M-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\                        - NP?
M_:>_IEO_ /HRVWK_  OH0J=U?Q/IRW]*E;
M
M    <MMG?ZS_ &T?Y16'Y7<"VWA]VL=R? JLC]XO]V/"VT;P*=;/H)5#TA43
MB@0JM],@$AO @5&<>\2*[0)+. $EGQ2$PD-],A(EL[G>"$EG% F$Z/P E(3B
M@0D,X=\(5V<.^"55O=)@2F\&]XE"O'Q7X1$)5V\1)#[(2  ,1R;_ %W&?9&/
MXYH2RX(                            8EA7U#C_9I/T0,M
M                 !B4_P!NE'[&K\?(!EH
M  +!E'U N/\ N&_'M N5L^IUO_X-%\8@$T
M ' ;^\^_")_!CK?P[ZKE/Q#ZSF@7BH@)2       [6_DF/M>WM]D;'\IK3E_
MB#RJ.7P.BW#JK[L>%U[.=7X                        :!=@_^T]_3+?_
M /1EMO7^%]"%3NK^)].6_I4K8
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M@%0                           %-9HDE2!96),YO,V'F3F5OH\O'0"H
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M<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\
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M<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\
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M=IBY,3$QIX];WA.R_N^J?UN,W3_>Y?H\KNL;/L*>SD67V*[[:KY'[[U_=_\
M&XS?R<OT>.L;/L*>SD/L5WVU7R/OWKV\'XW6;^3E^CR>L;/L*>SD/L5WVU7R
M/KWKN\'XW><>2F^CQUC9]A3V<B/L5WVM7R/MO9;WA54__B\SA/@]5-]D!UC9
M]A3V<A]BN^UJ^163LL[Q:?UOLY\E-]D!UC9]A3V<A]BN^UJ^1]M[+&\:K_7
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M<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\
MH\=8V?84]G(=7WO;5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'
M\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;
M5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV
M%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*>]"WQ_'<W#\B
M_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0
MM\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?
M>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8
MV?84]G(=7WO;5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S<
M/R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*
M>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R
M'5][VU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*QV7LE;UIDU-2KVTM
MP'3.HE>VM6*3G:WF>G(G_G^FG01UC9]A3V<CU]@NX8=-4R+WH6^/X[FX?D7_
M $>3UC9]A3V<CSU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0
MM\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?
M>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8
MV?84]G(=7WO;5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S<
M/R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*
M>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R
M'5][VU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*>]"WQ_'<W#\B_P"C
MQUC9]A3V<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?Q
MW-P_(O\ H\=8V?84]G(=7WO;5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5
MV<I[T+?'\=S</R+_ */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8V?84
M]G(=7WO;5=G*>]"WQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S</R+_
M */'6-GV%/9R'5][VU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*>]"W
MQ_'<W#\B_P"CQUC9]A3V<AU?>]M5V<I[T+?'\=S</R+_ */'6-GV%/9R'5][
MVU79RGO0M\?QW-P_(O\ H\=8V?84]G(=7WO;5=G*L]^[)&]M/:*V:7MJ[@U4
M;&M5T#X9.5WC(G3I7CK&S["GLY$TY"[$_OJNSE3J'LB;WR45&]O;9W"B:^"-
MS8VPOT:BM141/_/^X.L;/L*>SD1.[[WMJNSE2O>A;X_CN;A^1?\ 1XZQL^PI
M[.0ZOO>VJ[.4]Z%OC^.YN'Y%_P!'CK&S["GLY#J^][:KLY3WH6^/X[FX?D7_
M $>.L;/L*>SD.K[WMJNSE/>A;X_CN;A^1?\ 1XZQL^PI[.0ZOO>VJ[.4]Z%O
MC^.YN'Y%_P!'CK&S["GLY#J^][:KLY3WH6^/X[FX?D7_ $>.L;/L*>SD.K[W
MMJNSE/>A;X_CN;A^1?\ 1XZQL^PI[.0ZOO>VJ[.4]Z%OC^.YN'Y%_P!'CK&S
M["GLY#J^][:KLY3WH6^/X[FX?D7_ $>.L;/L*>SD.K[WMJNSE/>A;X_CN;A^
M1?\ 1XZQL^PI[.0ZOO>VJ[.4]Z%OC^.YN'Y%_P!'CK&S["GLY#J^][:KLY3W
MH6^/X[FX?D7_ $>.L;/L*>SD.K[WMJNSE/>A;X_CN;A^1?\ 1XZQL^PI[.0Z
MOO>VJ[.4]Z%OC^.YN'Y%_P!'CK&S["GLY#J^][:KLY3WH6^/X[FX?D7_ $>.
ML;/L*>SD.K[WMJNSE/>A;X_CN;A^1?\ 1XZQL^PI[.0ZOO>VJ[.4]Z%OC^.Y
MN'Y%_P!'CK&S["GLY#J^][:KLY3WH6^/X[FX?D7_ $>.L;/L*>SD.K[WMJNS
ME/>A;X_CN;A^1?\ 1XZQL^PI[.0ZOO>VJ[.4]Z%OC^.YN'Y%_P!'CK&S["GL
MY#J^][:KLY3WH6^/X[FX?D7_ $>.L;/L*>SD.K[WMJNSE/>A;X_CN;A^1?\
M1XZQL^PI[.0ZOO>VJ[.4]Z%OC^.YN'Y%_P!'CK&S["GLY#J^][:KLY3WH6^/
MX[FX?D7_ $>.L;/L*>SD.K[WMJNSE<H_<XRKW[?N:>ZG>?;9[;OI?[J_*OTT
MZ_J>;SOEZ[7GTZ/\YWR_Z:G['M[,88>3P=Q0]#5]KV-J<<?*X6EY9M" E(
M    #M;^28^U[>WV1L?RFM.7^(/*HY? Z+<.JONQX77LYU?@
M           !H%V#_P"T]_3+?_\ 1EMO7^%]"%3NK^)].6_I4K8
M
M                    #EML[_6?[:/\HK#\KN!;;P^[6.Y/@561^\7^['A;
M:-X%.MGT$JAZ0J)Q0(56^F0"0W@0*C./>)%=H$EG "2SXI"82&^F0D2V=SO!
M"2SB@3"='X 2D)Q0(2&<.^$*[.'?!*JWNDP)3>#>\2A7CXK\(B$J[>(DA]D)
M  %":EIZAT+YX62OIWI) YR:\CDX*GP0*X
M  %"GIJ>DC2&EA9!$BJJ1L31-5X]" 5P                           4
M%IJ=:AM6L+%J6,ZML^GC(WI737T.D"N                           "E
M-!#4Q/AGC;-#)T/C>FJ+W>E /MC&QL;&QJ,8Q$:QJ<$1.A$0#Z
M                 !P&_O/OPB?P8ZW\.^JY3\0^LYH%XJ("4@      .UOY
M)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
M   &@78/_M/?TRW_ /T9;;U_A?0A4[J_B?3EOZ5*V
M
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MR,;HYJZ*GCM[J 7"W*KK?0*JJJK3Q*JKQ5>1 )H
M      . W]Y]^$3^#'6_AWU7*?B'UG- O%1 2D V=W1[)F[.V6%XON2^U^V?
M;[*+);[TS);4UTB4#:^G94=37P]+X59SZ<_3&O1X^J\J5^7WC:NUS1CA5$X8
M3P]Q89C=MRU3M1IIPU\7=:Q%@KP   [6_DF/M>WM]D;'\IK3E_B#RJ.7P.BW
M#JK[L>%U[.=7X                        :!=@_\ M/?TRW__ $9;;U_A
M?0A4[J_B?3EOZ5*V
M                                              Y;;._UG^VC_**P
M_*[@6V\/NUCN3X%5D?O%_NQX6VC>!3K9]!*H>D*B<4"%5OID D-X$"HSCWB1
M7:!)9P DL^*0F$AOID)$MG<[P0DLXH$PG1^ $I"<4"$AG#OA"NSAWP2JM[I,
M"4W@WO$H5X^*_"(A*NWB)(?9"0 ! K+=35TE'+.CE?0RI-!RKHG,BHJ:^CP
MG@                            0;=;J:UTR4M*CDA1RN1'+S+J[CT@3@
M                           076ZF?<([FJ.\ZBAZAJZ^+R:JO#O@3@
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M5B5SK174]:D*R<W(DBP/?R\W*NFO'13'7;KH\J)CNP]T7*:_)F)[C)#P]@
M!:[1>[+D-$ERL%WHKY;G2/B;7V^HCJ85DB<K9&))$YS=6N145->A3U53-,X3
M&#S35%48Q.*Z'EZ         &@78/_M/?TRW_P#T9;;U_A?0A4[J_B?3EOZ5
M*V
M                                XO;89'O!/N%OANSA.TKLMMVZ%_@2
MIB9<(H(Z*:U).U8VO?HZ3F2H1556II\$ZG-Y.Q-%NW7<PFF.+CP?-\A\0Y^Y
M5<O6LKMTU3AY<1Y.,<,/<?='[2+>/9S=]>(/ :/5N6]M_P!LK+\Q[T_]+_\
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M.35M4W**6@;*J4DE"LKX=$T5_,]-==->X@&1@
M    L^05,])9ZZIII%BGB:U8Y$T735R)W=?1 G4,CY:&CED=S2201O>[T55J
M*J@2@                           <!O[S[\(G\&.M_#OJN4_$/K.:!>*
MB E(!O?N%VD^T5N9LE;;3BUCN6%[&;?6BTXQD-ZM39&,KIJ>"&B1E9<=&:I*
MKFZT\6C41R=9S]#BHL9'+VKV-4Q-RJ9F(GGU>%<W\[?NVL:(FFB,(F?DU^)@
M..=AWM1Y;CUARK']L/IA8<FMU+=K)7_3NR1=?1UL39X)>KEKV2,YXWHO*]J.
M3@J(IFKWKEJ*IIFK3$X:I\34HW;F*Z8JBG1.G7'C:Q7JRW7'+Q=,?OMOFM5Z
MLE5-0W:V5+59-3U$#UCEB>U>"M<BHIOT5Q7$51IB6G71-%4TU1A,+6>GD [6
M_DF/M>WM]D;'\IK3E_B#RJ.7P.BW#JK[L>%U[.=7X    -.>WME_M1[+FXRQ
M2I%6Y.VCQZA15T1WG]3&VH;K_P &;*I8[IM[>9I[6GF_2KMZW-C+U=O1S_H>
M68O;?R=%FQK';1<KCM!>+C:K924=PNU2^WR354\$+(Y)Y'NZ7.D<U7*J\54V
M*ZL_55,Q%<1,]M@HIR--,1.Q,X=IZ[=\MVOV'V/OV\O9ZVSQW+<06:*LO\6*
M5$-NBJJ*FF?2U-9'/#35#9UI'<W,U41$1'^,G*J+KTV[F8O1;O53$\&.GDY6
MQ5<MY>S-RS3$QPX:.S!?\K[2UKCONU>';5X^S=+,MU:.GOM#:F5_TOIK;CT\
M:2?3>X5+:>K6*/1R(UO5JYZZHGC<J.\6\E.S55<G9BG1JQQGBC4]7,[&U33;
MC:FK3KPPCCG6V=-%O/$]L=XO=$SC>?!:C'4L%QV@OM-:I)/.UJ5KJ:MA=/35
M?(L$/4]8UJ^)J_\ W1M7\MT=%%>..U&/<[36L9CI*ZZ<,-F<'GER[3]"V?M$
M5=OQ-UPP/8"T3I=<U2Y+ VZ9!% LLEFI(FT[N56+I&^;K=62*U.K5%1QEIR,
M_P"'C/SJYU8:HX_T,-6>C_$PCYM$:\=<\7Z6/;.[H8YAM;V>-F\=VH@V^QO=
MW":S,;!3P766L2W5+FK<JBWJV:E:^9W)-UCI'2-T5>7DT1#WF;%5<7+DU[4T
MU83HU\&.MXR]^FB;=N*=F*J<8TZN'!Z[FF]'M>W<VWV:QS&ERW*,TBJ+KD;T
MK/-(K#8J54;)<:C2"=9%>_6.*/Q$>]-%>W5-=>UEMJU5<JG"(T1VYXFQ<S.S
M=IMTQC,Z9[4<;R^F[3&>Y]<LE?L'L9-NGAF*U<]OJ<\KL@I;!17&MIM$EAM3
M9J>H=4M1=6I*JM9JG'144SSDJ+<1TM>S,\&&.'=XF",[7<F>BHVHCAQPQ[G&
M]IV5W?L6]F$19A9J&KLM32UU39\FQNO1$J[7=:)R-J:.?EZ%<SF:Y%Z-6N:J
MHBKHFMF<O58KV9T\,3QQQMG+9B+]&U&C@F.*>)ZT:[8      T"[!_\ :>_I
MEO\ _HRVWK_"^A"IW5_$^G+?TJ5L\([1F^-+V>MM*K<>LQV7*(*:X4E MJAJ
M6TKE6J<K4?UCHY4\73ARFUD\K.9N;$3@U<YFHRUO;F,7NYJMI@%QS"^46X^.
MX53X1<:_'[U:JNX5^?1JOF-!/3.1(Z29.K5.>9%U;XZ?"4S1;IFW-6U&,3JX
MV*;DQ<BG9G"8U\3/S"R@    TPRSM4YG0;S9]LSM]L%=-SKMM[!;JJ[W&BO=
M'0-6*XT=/5L=U=5$FFBS\G0]>&O1J65O(43:IN5W(IBK'@F=4JVYGZXNU6Z+
M<U33APQPPS?;[>+>G*LOM%ARWLR7G;W'Z_SCZ89A5W^W5L-'U5/)+'S4\#4D
M?UDC&QIIP5VJ]"&*]EK-%,S3=BJ>+"66SF+M=415;FF./&%;+M_KK@^UV\>Y
MN2[876T0;69%66>V6BLJ.H??J""HIJ>"ZTLKH-&0U"U"JSQ7>D7QE%O*1<N4
M44U1.U&/<GB+F;FW;KKJIF-F<.['&]ZQZ[MO]@L=^9 M,R]V^FKVTRNYEC2I
MB;*C%=HFO+S::Z&I73LU3'$VZ*MJF)XUX/+T   &+YK?KEB^(Y'D5GQRKRZZ
M66WSUEOQ>A54J:^6)BN;3PJC7^,]4T3Q5^$>[5$5U13,X1/#Q/%VN:*9F(QF
M.#C7#'KE5WFP6.[U]JFL5==;?35E99*E=9J.6>)LCZ>1=&^-$YRM7H3I3@17
M3%-4Q$XX)HJFJF)F,%X/+T
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M1)#[(2  +1<[5],9[9-U_4_2ZH;4<O+S<_*J+RZZIIPX@7<
M               "TV6U_2>A;1=?YQRO<_K.7D]-W--7?H@78
M                %IDM?/>H;OU^G4TRT_F_+QU<Y>;FU_RN&@%V
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M&%,QXV?)837,V[FU1AJF<9B?$WB*M9@
M                                    !SX[&W\U^0_RSN_QL!T6\_WL
M=R'SWX5^Y?7J[[:F3NFA"_E!DX=Y#U#'*!+W>^9(8I0I/B*>X8JD&7@I[AAJ
MU,*NO!QM6U1F7G%S[IO6W/YEYW=.+C<MJ+,/,K[3P5=/44M5$V>GG:K)H7IJ
MUS5XHJ&[0Y_,S,:86;:3=V[]G^^MM-T?47C::\U&LU.FLDUIFD7IFA3BK?5-
M_3<4\?TU3O;=$9B-NC15'R]J?!+L/@[XSG=]?07IQM3P<-'I4]KSJ>6-.OJG
M9[M;+[;J"\V:NAN5JN4+:B@KZ=R/BEB>FK7-<AP]=$T3--483#[Q:NT7:(KH
MF)IF,8F-4PO;.YWCR]I+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E-X-[Q*
M%>/BOPB(2KMXB2'V0D  6*\7.>WU%GAA9&YMPJVP3*]%54:Y415;HJ=/3W0+
MZ                            !8\>N<]VMK:RI9&R5TCV*V-%1NC>'%5
M7_&!?                            6.2YSLR"GM*,C\WEI%G<]47GYD<
MY-$7733H] "^                            MEYK9;=;*NM@:QTL#45C
M7HJM75R)TZ*B]WT0)=',ZHI*6=Z(CYX62/1O#5S45=-=?1 D
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M,1=V-B(B>+&K'CP= BH6P
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MEG% F$Z/P E(3B@0D,X=\(5V<.^"55O=)@2F\&]XE"O'Q7X1$)5V\1)#[(2
M +#>;;45]39I8.3DH*ML\_,NGBM5JKIT+JO0!?@
M       +%CEMJ+5;6TE4K%E21[EY%U31W#I5$ OH
M       +%+;:A^14]T16>;14:P.37QN;F<O#3AT^B!?0
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M(5.ZOXGTY;^E2M@
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MSB@3"='X 2D)Q0(2&<.^$*[.'?!*JWNDP)3>#>\2A7CXK\(B$J[>(DA]D)
M%IN5T;;IK;"L*R_3&H;3HY':<BN5$UX+KQ NP
M     %JLUT;=Z)M8V%8$<]S.K5W-Z7X.B 74
M   %J?=&LO$-HZE5=-3K4=?S="(BN3333_)]$"Z@
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M^T]_3+?_ /1EMO7^%]"%3NK^)].6_I4K8
M
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M:U&1MXKH]J@3J!CXJ&BCD:K7QP1M>U>**C414 E@
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MFY2+L   - NP?_:>_IEO_P#HRVWK_"^A"IW5_$^G+?TJ5L
M
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MLCD15TU5$X)\,"K%*R:*.:-=8Y6(]B\-4<FJ 5
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M0V6-)N@        #0+L'_P!I[^F6_P#^C+;>O\+Z$*G=7\3Z<M_2I6P
M
M                        '+;9W^L_VT?Y16'Y7<"VWA]VL=R? JLC]XO]
MV/"VT;P*=;/H)5#TA43B@0JM],@$AO @5&<>\2*[0)+. $EGQ2$PD-],A(EL
M[G>"$EG% F$Z/P E(3B@0D,X=\(5V<.^"55O=)@2F\&]XE"O'Q7X1$)5V\1)
M#[(2  ,2R5KG5N-:-5=+A&JZ)P3F:$LM"
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MN::]<,/,K" =K?R3'VO;V^R-C^4UIR_Q!Y5'+X'1;AU5]V/"Z]G.K\
M                  - NP?_ &GOZ9;_ /Z,MMZ_POH0J=U?Q/IRW]*E;
M
M                           <MMG?ZS_;1_E%8?E=P+;>'W:QW)\"JR/W
MB_W8\+;1O IUL^@E4/2%1.*!"JWTR 2&\"!49Q[Q(KM DLX 26?%(3"0WTR$
MB6SN=X(26<4"83H_ "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\?%?A$0E7;
MQ$D/LA(  HRU$$#HFS3QPNG=R0M>Y&J]R\$:BKTK\! *P
M             %&"H@J8^MIIXZB)55$DC<CVZIQ35%5 *P
M             **U$"3-IEGC2H<WG;3JY.=6\.9&ZZZ='$"L
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M?TJ5L
M                                  !RVV=_K/\ ;1_E%8?E=P+;>'W:
MQW)\"JR/WB_W8\+;1O IUL^@E4/2%1.*!"JWTR 2&\"!49Q[Q(KM DLX 26?
M%(3"0WTR$B6SN=X(26<4"83H_ "4A.*!"0SAWPA79P[X)56]TF!*;P;WB4*\
M?%?A$0E7;Q$D/LA(  Q')O\ 7<9]D8_CFA++@@
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ML'_VGOZ9;_\ Z,MMZ_POH0J=U?Q/IRW]*E;
M
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MZ*>)DT3^A\;VHYJ]WI1>@#Z:UK&M8QJ,8Q$:QC4T1$3H1$1 /H
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M;^28^U[>WV1L?RFM.7^(/*HY? Z+<.JONQX77LYU?@
M     !H%V#_[3W],M_\ ]&6V]?X7T(5.ZOXGTY;^E2M@
M
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MV]?X7T(5.ZOXGTY;^E2M@
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M ! K+=35TE'+.CE?0RI-!RKHG,BHJ:^CP G@
M    0;=;J:UTR4M*CDA1RN1'+S+J[CT@3@
M 076ZF?<([FJ.\ZBAZAJZ^+R:JO#O@3@                           1
M:VCAKZ66DJ$589D1'HU=%Z%1>/> K0Q,@BBACUY(6-8S7I71J:(!4
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M_P#M/?TRW_\ T9;;U_A?0A4[J_B?3EOZ5*V
M
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M8(                            8WBE74UMH9/53.GF65Z+([CHB] &2
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MZ]G''1B\;-IJ ':W\DQ]KV]OLC8_E-:<O\0>51R^!T6X=5?=CPNO9SJ_
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MJBB>O/!*B:]7-$]&R1N5%U1'M35.E.@B]8N69PKC"7JS?HO1C1.,,^,+*
M
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MKIHJ+PZ/0 DTT*4]/!3H[F2"-L:.X:\J(FO^("L
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M5.*NUP7[MJ<M%%.U.%6B9C5VL6:Q;N1F9KJV8QC3$3K[>#?PJ5L
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MC5Y&HO!.G1$1(S&<JNTQ1$133'!"<OE*;54US,U53PRV"-1M@
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MJK='<.*(O^("^                            L<ELG?D%/=D?'YO%2+
MYBJO/S*YRZHFFFG3Z(%\                           !;+S12W&V5=%
MYC99VHC'/54:FCD7IT15[GH 2Z.%U/24L#U17P0LC>K>&K6HBZ:Z>@!(
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MNW%5R,*IX'J9@9P   T"[!_]I[^F6_\ ^C+;>O\ "^A"IW5_$^G+?TJ5L
M
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MB!)IIDJ*>"H1O*D\;9$;QTYD1=/\8%8                           '
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M_A?0A4[J_B?3EOZ5*V
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MRM:D<::)KHY%[NGH 3J&-\5#1Q2-Y9(X(V/;Z"HU$5 )0
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M[^F6_P#^C+;>O\+Z$*G=7\3Z<M_2I6P
M
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MJO2J)P[X%:&5D\44T>O),QKV:]"Z.35 *@
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M:C"G!XP;;4 .UOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^
M                  &@78/_ +3W],M__P!&6V]?X7T(5.ZOXGTY;^E2M@
M
M                           .6VSO]9_MH_RBL/RNX%MO#[M8[D^!59'[
MQ?[L>%MHW@4ZV?02J'I"HG% A5;Z9 )#>! J,X]XD5V@26< )+/BD)A(;Z9"
M1+9W.\$)+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E-X-[Q*%>/BOPB(2KM
MXB2'V0D  8EDK7.K<:T:JZ7"-5T3@G,T)9:$
M    ,4PQKFV1B.:K5ZZ3H5-.Z!E8                           ,4G:[
MVY4;N5>5+<J<VG1KSO[H&5@                           L.3HKK#<4:
MBJJL;HB?[MH%QMJ*ENH$7H5*:+5/_ 0":
M#@-_>??A$_@QUOX=]5RGXA]9S0+Q40$I .P-CK]E>PILWMED][V]I=S-^MU;
M1'?6.K%C1M!3S,9*UK9I8IO-HXDE:S];9SS/1^KD:C>3FJHO;QNU4Q5LVZ9P
M[./P.DIFUN^U3,TXUU=FO@A,QG\H)MIOC?;9MWO]L=9TQ7)JF.W,ORU"5[*!
M]2O5MD?'- R1C>=S=9(I&NC35R(JH1<W/<R],UV:YQCD+6]K=^J*+E&B=''X
M&@':NV8H]AM[<IP*T32U&.HV"YXS).O-*VAK6=8R)[OTRQ.YH^;]-R\W=+C=
M^:G,68KG7JE4;PRT9>[-,:M<-<3>:0!VM_),?:]O;[(V/Y36G+_$'E4<O@=%
MN'57W8\+KV<ZOP                        T"[!_]I[^F6_\ ^C+;>O\
M"^A"IW5_$^G+?TJ5L
M                                              !RVV=_K/\ ;1_E
M%8?E=P+;>'W:QW)\"JR/WB_W8\+;1O IUL^@E4/2%1.*!"JWTR 2&\"!49Q[
MQ(KM DLX 26?%(3"0WTR$B6SN=X(26<4"83H_ "4A.*!"0SAWPA79P[X)56]
MTF!*;P;WB4*\?%?A$0E7;Q$D/LA(  H355/3NA9/,R)]0](X&N73G<O!$^"!
M7                             H4]33U<:34LS)XE5421BZIJG'I0"N
M                          "@M33I4-I%F8E2]G6-@U\96]*:Z>AT 5P
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M*V
M                                Y;;._P!9_MH_RBL/RNX%MO#[M8[D
M^!59'[Q?[L>%MHW@4ZV?02J'I"HG% A5;Z9 )#>! J,X]XD5V@26< )+/BD)
MA(;Z9"1+9W.\$)+.*!,)T?@!*0G% A(9P[X0KLX=\$JK>Z3 E-X-[Q*%>/BO
MPB(2KMXB2'V0D  8CDW^NXS[(Q_'-"67!
M #$L*^H<?[-)^B!EH                           ,2G^W2C]C5^/D RT
M                           %@RCZ@7'_ '#?CV@7*V?4ZW_\&B^,0":
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M]_3+?_\ 1EMO7^%]"%3NK^)].6_I4K8
M
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MFB?T/C>U'-7N]*+T ?36M8UK&-1C&(C6,:FB(B="(B(!]
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M7\3Z<M_2I6P
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M &:3]$#+0                           8E/]NE'[&K\?(!EH
M                   +!E'U N/^X;\>T"Y6SZG6_P#X-%\8@$T
M                  ' ;^\^_")_!CK?P[ZKE/Q#ZSF@7BH@)2 ;CV#M[=I[
M&;%9<;LV=4=-:,?H*:VVJF=9K9(L=-21-AA8KWTRN=RL8B:JJJO=*RO=&6JF
M:IB<9[<K2G>]^F,-',NW_>)=K#_X@47UCM7T*>>I<MYL\\IZXS':YFLNY^Z6
M:;Q9;59QG]SCN^25D$%-45L5/#2M='3LY(TZJ!C&)HU--40WLOEZ+%.Q1J:.
M8S%=^K:KUO/#.P ':W\DQ]KV]OLC8_E-:<O\0>51R^!T6X=5?=CPNO9SJ_
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MJJ3?SE5VF*,(IIC@C46,I3:JFO&:JIX9UO>C4;0      #0+L'_VGOZ9;_\
MZ,MMZ_POH0J=U?Q/IRW]*E;
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M2TE2U7P3(B2-1537147BGP@*L43(8HX8TTCB8C&)QT1J:(!4
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MWT$,E37U]3(V*&"&)JODDDD>J-8UC45555T1.E28B9G"$3,1&,O(_?&=GO\
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MU5)JIFF<)C"44U15&,3C"YGEZ
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MR+%-&UJLD;Q35[4 G4#WRT-%)(Y7/D@C<]R\556HJJ!+
M           !P&_O/OPB?P8ZW\.^JY3\0^LYH%XJ("4@      .UOY)C[7M[
M?9&Q_*:TY?X@\JCE\#HMPZJ^['A=>SG5^TU_*!_U1-V_^@?]OVXLMT?>J.7O
M2KM[?=:^3OPV7VX_F]P/^3MK_>D1HWO+J[LMVSY%/<ASX[?6 W3<_=?LH8/8
MKR_'K]>9<U?8+TQSF+3U]'26VKI'\[/&:G70M17-Z6ITITH7&Z;T6K5VJ8QB
M-G'N8RJ-ZVINW+5,3A,[6'=T/;=HM[JW=_8;<BVYA3?2;=S;>T77'MT\=D1L
M<L5P@I9F-JDC;II'4I&YR:)HCT>UNJ-15U<QE8LWJ9ITT53$TSVOT-G+YF;U
MFJ*M%=,3%4=O]+1ZZ?\ RE\<]D7_ /[8U1:4_P!3GN?V85E7],CN_P!J6_F1
M;?=B&&RW!U]Q39NU6IT+FUE<RFL="]C-.E65,"12QN]!6.1WH%31>SF.B:\>
M65M79RF&F*,.1Y[^3REKW[.9=!32UE1M]19[>X-IJFOY^M?86K$L7)SHGB=:
MLG<]/SIW#-OC#I8\[9C:[K#NC'HI\W:G9[CVCM89/7XUL-G,%E55R;,X8,/Q
M6G:NCY:_(9V6V-&+W%8V=TFO^3T=/0:N[Z(JO4XZHTSW(TMG/US39JPUSHCN
MSH>RX5BU!@^'8KAEK1$MV*6BBM%$NB)K'10,A:Y43NJC-5^":UVY-RN:IUS.
M+9M6XMT13&J(P:R9/VD<]CWHSW8S;O:-,WRS%Z&TW*W7":Z,MUO;1UM,LU5/
M7SR1/ZKJI'PQQ1L1SI>9R^*C%-ZC)4=%3=KKPB<>#&>1HUYROI:K5%&,QAPX
M1RL3Q?M5;MYI<,GVVQ[8!TF]N"U\E-G%HJKU%!C]OI.5KJ:L^F*Q*^5:KF7J
MH61ZJB.?S\J&2YD+5$17-SYDZM&F>UAVN-XMY^[7,T1;^?&O3HCE[;(+/O?5
M[S;$=HNGR##I<"SG;FV9+C>:8N^J;6QQ54-MF<DD%2QK&R1OZ=.CBBZ*YO*Y
M?%65BQ>MX3C35,3$\KU3FIOV;F,854Q,3'(U\[-]X[#L&QFVD.XL.S[LWCL[
M$R1;[0V:2X^<\[]?.7U$3I%?IIZ9=3<SM.<Z:K8V]G'1AC@U,G5D^AIV]C:P
MTXQ&*\]G9F!U_;%W#O/9OHFTNR,6%14>=U5JB?#C\^2>=M?"E$S1D2*V'TO(
MW1/UU6^*_5?.<VXRM,7O+VM&.O9[?9Q/63V)S54V?(V=.&K:[79QM=,+O.9[
M);R]H#M+65U3=]O;5O5DV(;SXO U7.9:*FX=;37*-O!SZ>:9>.BZJUNJ-DD5
M-R[31?M6[$Z*MB)IGMX:FG;JKL7;EZ--.W,51VL=;;7M?7:V7_+>PY?++70W
M.SWG=O'ZVUW&G<CXIZ>HJ*.2*6-R="M>UR*BE?NZF::;\3KBB?"L-X51559F
M-4UQX'J?;4S.ZV/9UV!XK)_^NM[;K28%BD#55'*MU>D=6]=$54:E/SL5W1RJ
M]JZFONRW%5W;J\FB-J>1GWE<FFUL4^57.S'*\QV M%/V;^T9FW9RCF6+"-P[
M%0YKM@DB\K5KJ.G;17>%K=5_7)5IW3*W7Q61HO=,^;J^U6*;WZU,X5=^&#*4
M_9K]5G]6J,8[TNA)4+<  :!=@_\ M/?TRW__ $9;;U_A?0A4[J_B?3EOZ5*V
M:-_E%_ZJ6<>R-D_VE 6FYOO-/<GO*O?'W:KNQWT/LN9AD.UV7W_LA;GW!]9?
M<)A=<-G\FJ/%^GF+N5RQ,9S<9*5$5JM15T:U[$Z(559SUNF[1&8MZI\J.*K]
M/9K1D;E5JJ<O7KCR9XZ?T=FI8>RQ=K=8=V^WC?;Q5QV^T67.%K[K7RZI'!34
MWTQEEE>J:]#&-55/>?IFJU8B-<T^)YR-44W;\SJBKQLMM_:5WTR_'JG<[;OL
MW/OVT[4FJ;-/77Z.BR"[4$#M'5E+;4IY4;S-1RQQJ]72:)RJO,FN.<E9HJV*
M[F%?<T1/%BR1G;U=.W1;QH[NF8[C+<O[5EAHML]D]TL%M3<JL.\>;6?$H8ZJ
M9:26A2Y>=-G?(UC9466FDIG1N9KHJZZ.TT5<=O(53<KMUSA--,SW<,.^]W,_
M3%NBY1&,551'/CWF=]H3>6IV0Q3&,DI;!%D3\ARVU8T^DEJ'4R1,N2R(LZ.;
M')JK.K]+IT^B8LGENGJFG'#")GF9LWF>@IBK#'&8CG>5;L]I[-\-WGEV-V]V
MC?N3F5QQJFOF-0QW*.AC?))-,E1YW+.UL4,,,4"NYEDU>]6L33FU3/E\C17:
MZ6NO9C'"=&+7S&>KHN]%11M3AC&E,R'M)9[:Z[;_ &UM&S;K[V@LOLJW[(-O
M([S"VVX]0,D=$ZHK[LD3F:*YNC6L8NJ^+S*JLZR*,E1,55S7A;B<(G#3,]J$
MUYVN)IHBC&Y,8S&.B.[*];<]H'*ZO<NGV8WJVW3;'<"[VV6ZX=5T5Q9=;1?*
M>F;S5+:6=K(W1S1(CG+$Y%7E:KE5-6H[S>RE,6^EM5;5,3A.C"8>[.;JFYT=
MVG9JF,8TXQ+&H^TCNEGF19E#L/LI!N'A6WUWFL=ZRNYWZ&S_ $SN%(G_ )U3
MVN.2&1')'JB)(]W*[5."+J>_L5NW3'2U[-548X1&.$=MC^V7+E4]%1M4TSAC
MCAC/:>1=D#<_';'AG:[W=RB.KQG'(=U<CR*YT=?%RUM)%,V.=*:6%JK^OHKT
MCY$5=7^*AL;QL555VK=.F=B(:^[[]--%VY5HC;F7HLG:8WWI<33=VN[-$D&T
M"4R76=67^%^2PV5?&^F#[;U"-Z(OUYT76:M;Q=HBN,/V*S-71Q<^?JU?-QXL
M6;[;>BGI)M_,UZ_G8<>#T3<CM-6FP63:[W,,=EW9S7>Z/K]L<6HZAE$RHI6P
MMGFK*RHF14IXH6/3GYFZZZHO+RO<W#9R,U35MSLTT:Y\$<;->SL4Q3L1M37J
MCPO-;AVIMV<*W&VHVPW1V.I\9O&Y]^I[;09!07I+A:GTDKF1S20R-@:[KX'O
M;S0O3TKFNYNE#/&0M7+===NO&*8U883V=MAG/7:+E-%=&$U3KQQAG^8]H#-*
MW<C(=I]B]LXMRLDPBF@GS^_7*YMM-GM4M8SK*6DZ[JI73SO;XRL;IRZ*FJJU
M_)AMY2B+<7+M6S$ZHPQF66YFZYN3;M4[4QKG'"(3]ONT159-2[H8]F&$2X#N
MUM);Y+ADF"U%6VJ@J:7J'S4U;05K&,2:GFY-%5&:L541VNJ*L7LG%$TS35C1
M5JGP3'&]6<YM15%5.%=.N/#$\3QVQ=K#?#-]MH-W,![.$=YP6WVWS^]UE=D,
M=%55DE*Q5N4=JIEIGODCIGM>Q)')^N*UR,8JIH;%>0LV[G1UW,*L>+FQ[K6H
MS]ZY;Z2BWC3AQ\^'<>MWOM5X=;]E,"W>M-BN>0UNZ4M+;=O\ I4;],KA>*M7
ML2AU3F:WJY(WM?)HK4TZ$<KFM=KTY"N;U5N9B-G7/!$<;8JS],6J;D1,[6J.
M&9XF-^^+W3P"_8I#V@=FZ3;_  W-KE#9K;F]EOL=YI[9<:G1*>"Z,2"+JV2N
MU3KFKRM5.G5/&3)]CMW*9Z&O:F(QPF,,8[3Q]LN6ZHZ:C")G#&)QPGMK5G_:
MDW%M>\^;;%;8;+.W)S7'J"V7.U:76&WT[J*IIDFK*BKEJ6LCB2%\L4;&\_ZX
MY_%%3E=-G(VYM4W;E>S3.,:L>Y@\W<]<B[5:HHVJHPG7AW6791OYN71WW"]M
M\.V6=DF[=]Q>#*<RLM3>(Z.S8[!(J1OAFN:P.2HD2;FC1L;$[CNEICHREN::
MJZJ\*(G"-&F>3@9*\W<B::*:,:YC&=.B.5'VY[06X5WW(R#9/<[:RFPC="AQ
M5V5XSYC=F7"U7>D;(E,G+,D;7P*L^K='([H:[7@G--[*6XMQ=HJQIQPG1A,(
MLYNN;DVJZ<*L,8TXQ+6OLK95N<ZX=KBHRK [75XT[.<PK<YF?>7324MSIZ?1
MUHAC6'6:G1K$C2;5NC>#.C0W<_;MX6MFJ<=FG#1P<?=:>0N7,;NU3&&U5CIX
M>+N/<;'VB\0VY[-&S^96?;R2"OS^*EM.VFSU@EZV2HKZF1Z14<,TC-6QHJ:N
MD5BZ:HB-<Y41=6K)U7<Q73-7DZ9JGBXVS3G*;67HJBG7HBF./B2)>TCNOMU>
M\5;V@ME*; L*S.XP6BBSBR7V*\06NNJNB""YQ-BC5C7+T+*UW*FGZ8C[%:NQ
M/0UXU1&.$QAC':3]MN6YCIJ,*9G#&)QPGMKWN)VCLOQO>BJV.P7:I^X.75.-
MT=^LBMN+:"G:R>>>*IFKYY8GL@@ITB9HJ<SI'O:QK4UU/-G)4U6>EKJV8QPU
M8\SU>SE5-WHJ*=J<,=>'.NNSV_N4Y=N5E>RVZ6W+=NMRL7L\.0P0T5Q;=+=<
MK5+*R%:F"=(XE;RR2M;RJCN[THK5:><SE*:+<7;=6U3,X:L)B7K+YNJNY-NY
M3LU1&.O&)AM$:+>
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MJ*HHGO6-M0B(KVIJJ:*B]WX0$BGA2GIX*=%5R01MC1R\51J(FO\ B K
M                       X#?WGWX1/X,=;^'?5<I^(?6<T"\5$!*0
M ':W\DQ]KV]OLC8_E-:<O\0>51R^!T6X=5?=CPNO9SJ_::_E _ZHF[?_ $#_
M +?MQ9;H^]4<O>E7;V^ZU\G?AD."=I_L[4&#X;0UN].(4M916*W05=-)=:=K
MXY8Z:-KV.17]"M5%14/%W(WYKF8HG7/ ]6L]8BB(FN-4<+S'>^]VC).TOV"[
M_8+E3WBRWBIS2KM=TI'I+!402VRA<R2-[=4<UR+JBH9\K3-.7OQ,83&SWY8<
MU5%68L3$XQ.UWH8]VOL$R/:V\W'M1[7T3JJ2>RSXUOEBT70RYV2JA6GCN&B=
M/6TB\BJY$]*UCET8R3F][NNTW8Z"YQXTSQ3Q<KQO"U5:GIZ.+"J.../D:TW3
M_P"4OCGLB_\ _;&J-VG^ISW/[,-*K^F1W?[4NCD'8][,5--'/'LIC3GQ.YFM
MEIW2L54]4R1[FN3X"H4T[QS$_KRN(W=EX_4AL+;K;;K/04EKM-!3VNV6^)L%
M!;J2)D$$$3$T9'%%&C6L:U.A$1-$-.JJ:IQG6W(IBF,(U-6MWT3.NT-V=]L&
M)U]!B4UQW3RN#_ZMMHC\PL[^ZBZUM4J_^!T=/#?R_P#AV+E?'A3'+IGY(:.8
M_P 2_;HXL:IY-$?++;(KV^TQVOCC7MI]J*98VK*S&\*8R543F1KZ.17-1>*(
MJM35/@(65_[I:[M7?5MC[W=[E*T]G;^M;VX_9'!_]FUQZSGW:QW*N_#SD_O-
M_NT]Z6&8?_F?RCGLC=?_ -GY#+<_V_<COL=O_<=V>\R;LV[$;-[B=E7:ZGS#
M;/'+Q-?<<;],+L^W4[+@LCWRLZYE:QC9V2HB]#VO1R>B8\[F[MK,U;-4QA/'
MHYGO)96U<RU.U3$XQQ:>=;^S/F&0[-[E7[L?[FUGGDMIA?=]CLNF8UC[W8G+
M(]T$JM1$=- UCEUZ5\25NO+&SF]9VW3?MQF*.'15'%/9X$9*Y59N3EZ^#33/
M'"5V3+-:LBJ>VA8+Y0Q7.S7K>S+Z&ZVZ=.:*>GJ']7+&]/0<URHI&\*IIZ&8
MUQ12G(4Q5-Z)U374TGSC'<WV6WS[-W9UOJSWG;['=W[%DVS>55"ZR?2BON=.
MR>W2.X.=2S=_QE=HC'QHEG:KHOV;EZ-%4T3%4=N(U\JLNT5V+UNS.FF*XFF>
MU,ZN1M9G&.W/M.=KNX6"SYE=\,QCLR6&-(\FL;875#,GO;FND;&^HCEB32G9
MR+JQ7-=$NG'5-"U7&5RN,Q$S<G5/FQ^GOM^[1.:S6$3,1;C7'G3V?(Q;M,;*
M9UM!9\/[2-OW<S#=*_['WVCN3K5D3J-S4M-7/'!<(XG4M-"].L_6VOU542/G
M7HXGO)9FB],V9HBF*XX,=? QYW+5V8B]%<U31/#AJX73+&\@M.68]8\IL54V
MMLF1T%-<[36-X2TU5&V6)_P-6N0I*Z)HJFF=<+NBN*Z8JC5*]'EZ - NP?\
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M/[*?]]_E_P!IN65JQ
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M^R$@ "PWFY5%!4V:*#DY*^K;!/S)KXKE:BZ=*:+T@7X
M           "Q8Y<JBZVUM75(Q)5D>U>1-$T;PZ%50+Z
M           "Q2W*H9D5/:T1GFTM&L[ET\;FYG)QUX='H 7T
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MWTUJME#&D5%;J.)D$$,:<&1Q1HUK43T$05535.,Z9*:8IC"-2:0D T"[!_\
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M\R^EOT]ZB/SSS/K.N\V\XY>LZKK/'Y.;EYNG34;4X;..CB-F,<<-*YGEZ
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M3VLDG:B->_71-'(O3IKZ $NDA=3TM- Y4<Z")D;E3@JM:B+I_@ D
M                    X#?WGWX1/X,=;^'?5<I^(?6<T"\5$!*0      ':
MW\DQ]KV]OLC8_E-:<O\ $'E4<O@=%N'57W8\+KV<ZOP
M       T"[!_]I[^F6__ .C+;>O\+Z$*G=7\3Z<M_2I6P
M
M              '&+:NW[Z6W.MZ]H\ W/HL7H=L<@B?<72VNEJXZNHNJ3.ZR
M)9Z>61NC:9$5%=IZ'=.IS>:R\46[E=N9FJ./#5@^:[OW!O*W5<LVLS%%-,X^
M1%7E8SPZ7N?M5[6#N._5I^L-!]!FCUAE/93ZTK+\O[WG_>1_ITOA</[5J\=^
M;3]8:'Z$)ZQRGLI]:4?EW>W_ +D?Z=+Y7">U4[COO:5_Z"H?H0GK'*^RGUI1
M^7-[?^Y'^G2^5P/M3KQWVM/UBHOH0GK+*^RGUI>?RWO7_P!R/].E^>YYVI7K
MHN^MHZ?_ %'1?0A/6>6]E/.B?AG>D_[N/].$67:CM,SZ];OA:':\?_0M*GZ%
M*>HWOEX_A3SL-7PCO&K7FX]2%ODV/[1,_P#G-Z;0[_H>G3]"G,D;[LQ_#GG:
M]7P1G:M>9CU/TK;/V7MULE?3V[--VJ2MQN6:-UWI:"@93SRPM75S&/9&Q-5_
MRM4[JHNFA-6_Z(B=FC3P8R\6_P#Y]=JKCI;^-..F(IPF8[4XZ&[>.X_9L6LU
MOQ_'[?%:[/:X6PT-#"FC6-3_ !JJKJJJO2JZJJZG.7+E5RJ:JIQF7TC+Y>W8
MMQ;MQ%--,81$,B9\4QL\)#?3(2);.YW@A)9Q0)A.C\ )2$XH$)#.'?"%=G#O
M@E5;W28$IO!O>)0KQ\5^$1"5=O$20^R$@ "T7.Z_2Z>V0]1UWTQJ&T_-S<O)
MS*B<VFBZ\> %W                             M-ENGTXH6UO4>;\SW,
MZOFY_2]W71OZ %V                           !:9+IR7J&T=1KUU,M1
MYQS<-'.3EY=/\GCJ!=@                           6^Z5WTMH*FNZKK
MO-VHO5<W+KJY$XZ+IQ] "333><4U/4<O)U\;).3773F1%TUZ/1 K@
M                    X#?WGWX1/X,=;^'?5<I^(?6<T"\5$!*0      ':
MW\DQ]KV]OLC8_E-:<O\ $'E4<O@=%N'57W8\+KV<ZOP
M       T"[!_]I[^F6__ .C+;>O\+Z$*G=7\3Z<M_2I6P
M
M              '+;9W^L_VT?Y16'Y7<"VWA]VL=R? JLC]XO]V/"VT;P*=;
M/H)5#TA43B@0JM],@$AO @5&<>\2*[0)+. $EGQ2$PD-],A(EL[G>"$EG% F
M$Z/P E(3B@0D,X=\(5V<.^"55O=)@2F\&]XE"O'Q7X1$)5V\1)#[(2  ,;OU
M%55=787T\*RLI:UDM0Y%3Q6(YJJJZK\ )9($
M    ,<Q:BJJ"TLIZN)89DE>Y6*J+T*O1P50,C
M    !CDU%5.RBEKVQ*M)'0K$^;5-$?S/73377NH!D8
M         +/D%-/5V>NIJ:-99Y6M2.--$UT<B]W3T )U#&^*AHXI&\LD<$;'
MM]!4:B*@$H                           ' ;^\^_")_!CK?P[ZKE/Q#Z
MSF@7BH@)2       [6_DF/M>WM]D;'\IK3E_B#RJ.7P.BW#JK[L>%U[.=7X
M                       :!=@_^T]_3+?_ /1EMO7^%]"%3NK^)].6_I4K
M8
M                              #EML[_ %G^VC_**P_*[@6V\/NUCN3X
M%5D?O%_NQX6VC>!3K9]!*H>D*B<4"%5OID D-X$"HSCWB17:!)9P DL^*0F$
MAOID)$MG<[P0DLXH$PG1^ $I"<4"$AG#OA"NSAWP2JM[I,"4W@WO$H5X^*_"
M(A*NWB)(?9"0 !;ZVY4]!+113H]75\R00<J(J<SE1$UZ4T3I N
M                   $"VW*GNM*E72H](E<K4YTT75O'H15 G@
M                  @.N5.RY1VM4?YS+#U[5T\7EU5..O'H] ">
M                   ")75D-OI9JR='+# B*]&)JO2J)T)T>B!6AE;/#%.S
M7DF8V1FO'1R:IJ!5                           !P&_O/OPB?P8ZW\.^
MJY3\0^LYH%XJ("4@      .UOY)C[7M[?9&Q_*:TY?X@\JCE\#HMPZJ^['A=
M>SG5^                        &@78/\ [3W],M__ -&6V]?X7T(5.ZOX
MGTY;^E2M@
M                                      .6VSO]9_MH_P HK#\KN!;;
MP^[6.Y/@561^\7^['A;:-X%.MGT$JAZ0J)Q0(56^F0"0W@0*C./>)%=H$EG
M"2SXI"82&^F0D2V=SO!"2SB@3"='X 2D)Q0(2&<.^$*[.'?!*JWNDP)3>#>\
M2A7CXK\(B$J[>(DA]D)  &*9)&]];C:L8YZ,N$:O5$5=$YF]*A+*P@
M                     !BN&QR165C9&.C=UTB\KD5%X^@H&5
M                  Q6>.1<PHY$8Y8TMRM631>77G?T:@94
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MO<P]W>B>\NW_ -K[_.0_?,_\8>[O1/>7;_[7VG_>2=SW3?\ QA[N]$]Y=O\
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@TY_R/II]-.3]1S\A8_X/0\'1X<F"O_QNFX>DQY<7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2227887d8-fc_problem4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d8-fc_problem4c.jpg
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M(#P_>'!A8VME="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T
M!UAWZ__N  Y!9&]B90!DP     '_VP"$  (" @(" @(" @(# @(" P0# @(#
M! 4$! 0$! 4&!04%!04%!@8'!P@'!P8)"0H*"0D,# P,# P,# P,# P,# P!
M P,#!00%"08&"0T+"0L-#PX.#@X/#PP,# P,#P\,# P,# P/# P,# P,# P,
M# P,# P,# P,# P,# P,# P,#/_  !$(!'D'2P,!$0 "$0$#$0'_Q #N  $
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% ?AJ"LC]J2PH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!^4!^5!
MB/T4+Q/VI+"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'X:@K(_:DL* 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% ?E ?E08C]%"\3]J2PH!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4!^&H*R/VI+"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'Y0'Y4&(_10O$_:DL*
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% ?AJ"LC]J2PH!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M7::>>#(<O8A"CV^(J+;UZMIQ46J*G'89KBT+N-2K6KKMI6ID/4[F,?Z9N/\
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M+^4KBLYK"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'X:@K(_:DL* 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M(_YW)?B-<_Z_:_IEYN\W_H4_ZUV#^ZIYK_K TC_G<E^(T^OVOZ9>;O'T*?\
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M.W!SS)T536/@3@K;?4-O9T+3Y4+'SFL=(RDW)Y$NB+'CQRA!4X66W5#N6XA
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M:EOZGT')UNENV*>)*M:[V]G7UFKM;YH'M+EO^R5:_:4+_P"W1JO,0_Y/RO\
M\3TUW_CO(O2BXO3+O*>./03Q/M[KYC1,?L,:-E) _40LAOQA2U?H,/KK6UUK
MQ=;./1Z(5,^@N>'I(/IIVRH4SLO ZG/O-M:E(AJ;P&698Y*6XA/>E"X#*VU*
M)]A5DHR2;^'>#[16S#5__P#.:W^[V_P,,]+77J6ZF;LP]-"[/47OJ^0_2;ZK
M,FE]+T#![@]KN*"%=S:6</DL7$44'K<+=;<<Z=+JZ=*U=':\/4VEQ5>U-FWJ
MYJ>GN-=*[,")>D_>SQGZ$L3O"G"W%P.V-N9-0-C\D]LD5B8 3[V'%BLG,;7B
MZUQXK_ZF+EL\FDB_QM(!RKP1]H_>3\<2FXB#@]N;@[W//82RES!-K#[:Q:Q+
MCL%HJ]A+HOXFLVGU=.7R6]>SV_ZOL,-[2UUT94P:KV?A&PG/^]JWSTU>L-U#
MA7!U/9)6L8Y!/=V#%M8AJ0D?091>5;Z:T]):\/46>E5[:^HW=5/-8N=":\QK
M_P"B#_81]2/[=W'_ .U>!6YS7_,M]4?_ "9H\H_QI];]"/)KB7\ZG&?\J\-_
MGS->AU'PI=3]!P-+\:']R])Z*?>N?G1XP_DL]_GKE<7[?^'/K]1V.>^]#R^H
M]0MAV30)^,XOX(Y C(>A<Y:=DHF/\X@-O.8R) +D9-TGM=6W+4XTNX[5-=/C
M*:X4(33E=A_(UYZ]QVYS@VK<OYD_-3O//?T3</9W@KUJ<K\<YSN>&+T+(/83
M)D )G8U_+8I462FW3XT=% ?56%)_4UV.9ZE:C1PFOZE7H=&<?E^F>GU<H/\
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M>+JI78*D,?/N-CF4_#TJMS=9.GFVLP7)7_99Z%_P<3_&[E6L?\E+R^@KJ/\
MCUU1]*,TG,R?3Q]VS@,YH;AP^U\A-QER]ABDHD)DYM]2G7PN]TK;B-^2A2;=
MMDJ'47JN3YGF#4\4MW5_$MF^6T*E#:TNV1Y2<5\Q[UQ#O^*Y#U;,2/M:#+3(
MR<5]YQ3&2:[OUZ/, 4"XAU)(-S<7[DD* (]!J--"]!PDL/1U' T^KN69YTWT
M]/693G?G'9_4%O'Y?;=B,+A\O\BSCO(PD=UAE3,<K+:G/.>?6M=EV*BKP
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M9+[I+_V@/_13_P"K%>:^X?\ U_\ =ZCT/(?Y_)ZS7YCT&>L5_87IL6$UK_\
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MJE)(ZUYQV_J&KE_2DUZEY\3T2FM!IH\:JOEQ?FP*8^\SX[QV4<XS]16J($K
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M YCMBQK.3P;3P[F8\J2VY%=D].H4T\U$<38'JF_X=[G'^S=MWEM7X[S2Y/\
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M?[+7J6_X64_B2N/SC_)M^3TG8Y-\"76_0CQJKTQYD]E?O!?]EKTT_P#"Q?\
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M-T-(93J2$,-QO+;D"4E)*&PL_KP[S=74^-ZQ+26E<\3+[7$S/677;\/-[/#
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MT[GB9?:X^8V5J[JM^&G[/# K7&9*=ALEC\OC)"HF2Q4EJ9CY20"II]A8<;6
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MB3>YOUZUOT5*&DI-.N\L#DCESD?EW(8[*\D;5*VO(8F.J)CI4I#25-,J65E
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MZJ'I?I9M2YIJ6J9_,NXU74I2U*6M16M9*EK4;DD]2236^:#=24Z5N^U<=;)
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% ?AJ"LC]J2PH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!^4!^5!B/T4+Q/VI+"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0'X:@K(_:DL* 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% ?E ?E08C]%"\3]J2PH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!^&H*R/V
MI+"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0'Y0'Y4&(_10O$_:DL* 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% ?AJ"LC]J2PH!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!^4!^
M5!B%"R=#]O0G,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,
MR%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@
MS(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z
M#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7
MH,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A
M>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R
M%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S
M(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A>@S(7H,R%Z#
M,A>@S(7H,R%Z#,A>@S(7H,R%Z#,A0AL7H3F0O09D+T&9"]!F0O09D+T&9"]!
MF0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T
M&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O
M09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"
M]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D
M+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F
M0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&
M9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O0
M9D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D+T&9"]!F0O09D?E"AZM
M?=L<=<?;UBN7'-WT77MQ<QLO"IQSF<QD3(F.'43"X&C):<[ KM3?MM>POX5Y
M/[EU-VU*WDDXU3V-KAP/6_;FFM7;<W."EBMJ3W=)Z=?V?.!/ZD- _FUB_P 6
MKS'U#4_JS_,^\])]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0
M_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J
M?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX
M?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3
M^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.
M!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\
MS[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD
M- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]
M/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _F
MUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ
M4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q
M:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RK
MN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#
M4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']G
MS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS
M_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^
MI#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\
M?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/
MYM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-
M^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O
M\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\
MJ[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]
M0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_
M9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/Z
ML_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$
M_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/
MO'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T
M#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_
M3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6
M+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0
M_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J
M?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX
M?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3
M^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.
M!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\
MS[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD
M- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]
M/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _F
MUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ
M4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q
M:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RK
MN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#
M4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']G
MS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS
M_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^
MI#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\
M?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/
MYM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-
M^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O
M\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\
MJ[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]
M0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_
M9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/Z
ML_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$
M_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/
MO'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T
M#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_
M3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6
M+_%J?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0
M_*NX?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J
M?4-3^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX
M?V?.!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3
M^K/\S[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.
M!/ZD- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\
MS[Q]/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD
M- _FUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]
M/TWZ4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _F
MUB_Q:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ
M4/RKN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q
M:GU#4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RK
MN']GS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#
M4_JS_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN']G
MS@3^I#0/YM8O\6I]0U/ZL_S/O'T_3?I0_*NX?V?.!/ZD- _FUB_Q:GU#4_JS
M_,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\S[Q]/TWZ4/RKN/*3UX:#
MHNG\V<+XK4M*P.KXO*Q&%9/&XC&Q84>2HY+RR7FF&T)62GX?B!Z=*]7R'47+
MFGN.<FVN+;W'FN=::U;U%E1BDF\:)*N*VGJW_9\X$_J0T#^;6+_%J\I]0U/Z
ML_S/O/2_3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9
M\X$_J0T#^;6+_%J?4-3^K/\ ,^\?3]-^E#\J[A_9\X$_J0T#^;6+_%J?4-3^
MK/\ ,^\?3]-^E#\J[BO>7.">$,;Q1R=D<=PWHT#(0-3S4F!/C:]C6GF'FH+R
MVW&W$1PI"D* ((-P>HK8TFOU$KT$[DFG)?S/CUF'4:#3JW)JW'8_Y5PZC^:V
MOI9\T/8O[J[_ $/S5^W,%^QSJ\;]U>];ZGZCVGVO\.?6O0>L]>3/4"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0'CG]XE^?O@C]I1_P"-*]C]N_XUW\;CRO/O\FQU
M^M'L97CCU0H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!6?-/YG.6?Y&9[^+WZV=%\
M>W_<O28=3\*74_0?RLU]5/E)[%_=7?Z'YJ_;F"_8YU>-^ZO>M]3]1[3[7^'/
MK7H/6>O)GJ!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#QS^\2_/WP1^TH_\ &E>Q
M^W?\:[^-QY7GW^38Z_6CV,KQQZH4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MK:<&C>H+ASDG9\AIFE;S$S>SXMIYZ;ATLR6'$HCN):=*3(9;2OL4H A)/O\
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MV/$NBM(VQ0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0'CG]XE^?O@C]I1_XTKV/V[_C7?QN/*\^_P FQU^M'L97
MCCU0H!0"@-5?6Y_LM\M?M/'_ ,9Q*ZO)/\RWUOT,YW-O\6YU%:?=P_[.#/\
M*;*?[S-;/W)_E_\ :C7Y!_B1ZWZ357G?_M'N-OWZT_\ Y35=70?\3/JD<[6_
M\I;\GK/0#E#TM<";<O<MZV+CR-D]LR$.1-F9A<R<A2WV8Y"%EMN0EL6"$] F
MW2N!I>::FWEMQG2*>RBX]1W+_+M/<;G*";>\\T?N]^$>+>9/Z7?Z2M29VG\G
M/L#[%\V1*8\CYS[2\^WRSS5^_P A'UK^'3VUZ;[AUU[3>'X4J5S5V;J<3S/V
M_I+6H\3Q(ITI3SFP/K_X_P!/XQ],.D:CHN%;U_78?(D5Z-C&W7GDI<?QN6<<
M5WOK<6>Y1OU57/\ M_47+^LE.XZO(_3$W^?V86=)&,%19_5(C'.O_9Q\/_\
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M]B-?-M[7YC?7<?09Z=-AU*9@,'IB=0S CJ3A]HA2I;DF/("?@<=#SRTOIO\
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MH6]7)05*I/RO\5.OR6[.YI8N3J\5V,W'KC'4% * 4 H!0"@% * 4 H!0"@%
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M3W)SBVW/;7KJ?GJ)]*^A^HT:[(V2=.U_-:V76XN<Q@9\YV*]U5&=\U"@I(6
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MQH3Y)"=J-ISEEBW39O\ (;T:Y@,;JFO8/6,,R6,3KL"-C<8R;72Q%:2TV"0
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MP)K8T6JEI;RNQ56J^=->LPZO31U-IVY-I.FSH=2HI?I,TN=Z=<9Z<Y.>RCN
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MIY960+LWL":[,/N>]&*62.'6<JY]NV9R<G*6+KN[CH?W7?%W]8^T_P#-PO\
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M>-^ZO>M]3]1[3[7^'/K7H/6>O)GJ!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#QS
M^\2_/WP1^TH_\:5['[=_QKOXW'E>??Y-CK]:/8RO''JA0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MEI4:6T;+05/MI)%_H)%9;*3FDS'>;4&T8R<K-9/6>.ID?;F=>DO*QLG*/27
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MTXN(L@H92LKOV6]]A6:[%*$68K<FYR1==:YG% * 4 H!0"@% * 4 H!0"@%
M5GS3^9SEG^1F>_B]^MG1?'M_W+TF'4_"EU/T'\K-?53Y2>Q?W5W^A^:OVY@O
MV.=7C?NKWK?4_4>T^U_ASZUZ#UGKR9Z@4 H!0'3R/^CY_P"UW?\ D&ICM(>P
MHGTU?F[?_?B3^QLUL:OW_(8-+[GE.YRS_KKPQ^_Z_P#E1ZBS[LNH7O>CUG<]
M07YK\S^V(?\ G"*:7WT3J?<(7RO#7DL3PMC6Y+D->2R4*();*BAQOSVFFRI"
MAX$!70U>RZ.;*7E511U^:=#U;4-)@9K5\2U@\MA<C%^3R44J2_[1\;E^Y1N
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MLW&XRKC0B[;2E&F%3M<PZ3K&GX/6<_JV(9P66QF<AMQYD2Z5E)"U66;GN-T
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M_+C3'4Y+*NKP[<U)/FH93)D(LD^(/E,]@/L]G6U95!.\^TQ.;5E!A7"+6NC
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MSKJE()1VLH2CN[.UIOM2D6Z6O6._=EF<=QDLVHT3WE]UK&P* 4 H!0"@% *
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M.)B4HN3<L3,:]EL-C^5L!(X^P^3Q6 V%I</9\6[#>CQ0Y91:>0E7PI(-O#P
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MM ;4GXEEP7/^+6Q?NRA1+@8+-I2JWQ)WKC:&N?-W::0$-MZ]"0VA(L D",
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MU*O14\%AL#M2<,7CM.[(Y"Y*D8ES%1N+\I%VUULQQ.44?9S;I%B\ETFQ /4
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MM5MR49)LM<58M(IS"8#.[QQ;.X]SVM2]4G8.'$CXO(S.K<E]@E25H 2+)NV
MJU^BNE[5GE)0N9DZU,,8N<,K5*&2QV]\D8C$-8+(\89+);) :3%9R,9:%8^2
MI">U+RW1T1>UR ?T4^ AVX-U4L"5<FE3+B2GBC2\GJ.&R4G8'FW]DV:>YD\T
M6CW);6YU#84.BB"221TN2!<"YI>N*;PV(O9@XK':RRY32GXLEA) 4\TMM)/@
M"I) O6%;3*S7CBUC;<1JF9X^S.G3<<O'P<@Y&S:E!4>2Z\H]C+=A8D]Y((4?
M"MJ\XN2DF:UK,HN+187#N(R6"XXUW%9B&YC\C%^<^8B.BRT=\Q]Q-P+^*5 U
MBOR4IMHR64U!)D;TS4,@K+\SQ<Y >AXO;I[C<-]0 \Z.\F0A:VSU]BQ5[DU2
M--Q6W!UE7>835LKOO&6,.H9;1\CM<+%J<&!SF'[7$O,J4I:4NH))18GV]0.E
MC:YM.,+CS)TZRL'*VLK52>\?-\@2Y&;S^[._9S&4<3]B:FGRUB$TGIW+<2+E
M2@!TO[R0";#'=R*BCVF2WG=7+L*\U34]CA<.;W@9>(D,9C)/Y-4''J \QT/-
MH#92+_JB#:LDYQ=Q.N&!BA!JVU3$N'CZ#,QFCZKCLA'7%FPL9'9E1G.BD+2@
M!23](-8+K3DVC/;5(I,F%4+B@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MVF&-N6:LG6A<58#,* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M\.LI=4O$6/4;-0DRD0XB)SJ'YJ&6TS'FT]J%NA("U)3[ 57(%:;VX&VMAV:
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MWU?39:M;Z%-36B>XGVR[AM6B:YBX>1,3:-ZV*>8.!9C-EB.M2RD)*TD@V1W
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/'/[Q+\_?!'[2C_QI7L?
MMW_&N_C<>5Y]_DV.OUH]C*\<>J% * 4!7'+WYM-Q_:"O^6FLMCWT8KWN,K/;
M9,>?Z;66X,AJ8Y%P6"1)0PM+A;4VY$*TK"2>TI[3<'PM66"I>\K,<W6SY$6
M]MNN,\7IR:LO&5&<P(:9"7$E;CRH_8EE*+W*RKX>WQO6/)+/2F\R9UDK7<5!
MK?\ LR9C_P !._SHUGG\=&"/P677@/S183^1\;_,$UKR^(^OUF>/PUU>HQ'
MWYJ-5_\ G[_/I%3J?B/\;B-/[B*/Q^*F9?A/E6/!;4](C[;*E^2@7*FV#$<<
MM^! *OT*V7*EV/48$JVY=9LKIVVZ_E-,Q6:9RD5J#%@,C(+6ZA BK;; 6AVY
M^ I(/C^'PK4N0:DU0V833C4H?42K*:SZA]OCH6G#[*WDOLA:TE/F(8CRU%P
M@>(>3?Z;CV5LSPE".]4,$,5.6YEU<0_FTT[]H)_Y:JU[_OLS6?<154/4...3
MLAF<_KDS*Z/M$*8\WE&67D1Y"7A]=UQ@+78*5?JA0N0;];UF<YVTD\48E"%Q
MMK!DBXBSVQN;#NNH97/_ )88W6%LB!LI%U%3E[M+6"KN/0^*B04JZD>%;\8T
M4DJ5W%K,G5Q;K0N7%9S#YQ,E>'R4?)(A/&/+5'6%AMU/4H5;P(]U:\HN.TSJ
M2>PR:T)<0IM:0I"P4K2? @]"*@DUHXFS,'CK*[-QCL\IO%/L9%<W7YLHAIJ5
M'>2E([7%63<A (N>I)3XIM6W>B[B4T:MF2@W!EG<A<DX33<!-DM9*-)SC[*D
M83&-K2ZXX^L6;46TF_8DD%1/LZ>)%8;5IS?09;EU1720#==XWK \<:C(GN1L
M'M&TS&HF2R0:[6X#3W>L$H65]K@0$]U_#XK $"V6W;A*;IBD8[ER2@N+,7O&
MBX' :AE<QM?(.?V26N$Y]EQ9>1*8\F2MLAE+3";D@K(-@H@#KX7J;=QRE2,4
MB+EM*-6VR/Y8A7I=Q9201W-"X]XR*@1^@:O'X[_&XJ_@_CB;,Y'_ %/G?O,[
M_FYK47O>4VG[OD*+T_+Z_AO3UAI.TXF1FL"\94?(0HZ$K-G,B^$*5W+;[0%V
M^(&X-K=:V)Q;O.CQ_@:\))6E79_$QV9X]Q&HZW.W;CKDB=@83$9<R-&,I+\.
M20GO0RD#MN5]  H+-_94QNN4LLXU(E;45FC*A];AF\EL>E\)YO+LAG(Y'8\>
M[)"4]H4;K <"?8'$@+Z=.O3I2W%1E-+@)R<HQ;XD^]07YK\S^V(?^<(K'I??
M1DU/N$BW_P#-7LO[P._L-4M_$766N>X^HJ3+[;FM;XKXIQ^$G(PS^SMPH$C/
MN)"DPVBA'<OXN@/Q7O[@;6-B,Z@I7)-[C"YN,(I;SYY"T? :YI^6RFS;[G]D
MR;\-:,/$G9(^2])6DADM1T@E24K5W$7(L*6KCE)))(7+:C&K;9;O$!"N--/*
M2"/D0+CWA:@1^@:P7_?9FL^XCH<S;?EM+TMS)80I:R$R8U!:FK2%IC!U*U%W
MM((N BPN#U(Z&IL04Y48OS<(U1!,YHN$QFL2=BW3DK/;(U\HMUIE62\F%*<*
M+H;893W$]YL $JK+&XW*D8I&*5M*-92;('$Q<K+^F528*2\[C9KLQ]E'51;:
MEJ+G0?X*5=Y^@5D<J7\2B5;)LOB]XUEW3(NUG*1VL0U#0Y(<[TW;6E'Q,E-[
M]X(*>WQ)K4E;EFR[S95R.6IK%@,?+SOIWW%,!E3CR,T[.$9 [B6V5QG7 +?X
M* 5?H5MR>6\J\#5BJVGUFS>G;;K^4TS%9IG*16H,6 R,@M;J$"*MML!:';GX
M"D@^/X?"M2Y!J35#:A-.-2A]1*LIK/J'V^.A:</LK>2^R%K24^8AB/+47 "!
MXAY-_IN/96S/"4([U0P0Q4Y;F6IP]LV#G<;8)2)\:.<%#$;+MN.(08ZF24E3
MER.T* [@3[ZPWX-3?29;,TX+H(_PTK[7V/E/<(B2,+G\NTSB7K%(>$7SNYP
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MJV^TQ._0\9!XMXMCX:/.B8L[+CG8,?)=@E);>1*='FA!*;GNOT]E6M-NY*O
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M\*7D$_BQ*[Q.L8B3ROR)@]CS^7US(Y.8,C@S!FF$B8PZIQPB_;990%CM%_\
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M!_*S7U4^4GL7]U=_H?FK]N8+]CG5XW[J]ZWU/U'M/M?X<^M>@]9Z\F>H% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MV$"XK)*_.2HV4C9@G5(E>"UK!ZS <Q>#QZ(&/==6\N(E2UH[W  JP6I5@;>
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MMN/ML%7C_P"3H<2U;Z.VU75^:5*E'8@W6A,LIK6 S6(^P<GB(TK#I2E#>/*
MEML(%D>6$6["D= 4VM[*HIM.J>)=Q35'L(MB.)..L$X\[C=6C(=?;6RMQ];T
ME00XDH6$%]QPINDD$IM5Y7YRVLJK,%L1EW=#U)[76=2=PZ'-=C+\QC&*==*4
MJ[RNX5W]_P!91-KU7Q)5S5Q)\.-*4P,IE-=PV9F8B?DX*9<O!/F3B7E*6"RZ
M>T]P"5 'ZH\;U"DTFEO)<4Z-[BH^6]U:<AY;C?%8:=E=IV!A$:&RE@*C^7([
M>Y[S+FW8">MNA%S8=:S6+>R;>",-ZYMBEBRT]0UYC4]9PNNQR%(Q<9+3CB?!
M;I^)U8_X:U*5^C6&<LTFS-".6*1(ZJ6(SLNF:ON##4?9,,QE$1[_ "[B^Y#K
M?=]8(=;4E:0;"X!J\+DH;&5E",MJ.EK/'FF:<Z[(US L8^2\GL7**G'WNT^*
M0X\MQ0!]H!M2=V4]K(C;C'8C,MZ[AFL\_L[<%*<[*BB$_D.Y?<I@*2H([>[M
MM= /A>HS.E-Q;*JUWC*:[ALS,Q$_)P4RY>"?,G$O*4L%ET]I[@$J /U1XWHI
M-)I;R'%.C>XJ?DC.,0L[&QF\::WG>/)<;OCYIB,Y(>BS+V(<*5$H! Z%(!-Q
M8FQK-:C55BZ2,5V5'22JBN68&L[IG--PO&&L/8_6\/EF<UL>Q+C+8;6(Y!0V
MEUZZUJL5  ^%Q86[B,M903<WC2B,5(S:4%@;//Z[AI.<A;(_!2YF\<PN-"GE
M2PIMI?=W)"0KM-^X^(K44G2FXVLJK7>(.NX7'97*YR%!2QE<WY?VK,"EDO>4
M+(N"HI%A[@*.;:IN044G42M=PTS-8W8I,%+N9P[;C6-G%2PII#R5(6 D*"3<
M*(ZBBDTJ;B7%-UWG0V;2=5W%MEO9,*QE/E[_ "[JBMMU /B$NM*0L ^T VJ8
M7)0V,B5N,MJ.#6- T[35/.:W@F,<\^.UV3W.//%/CV^:\I:PGZ ;4G=E/:R(
M6XQV([6RZ9J^X,-1]DPS&41'O\NXON0ZWW?6"'6U)6D&PN :0N2AL9,H1EM1
MTM9X\TS3G79&N8%C'R7D]BY14X^]VGQ2''EN* /M -J3NRGM9$;<8[$9G\G<
M+]O?E/\ (I^W?E?DOM#N7W>1W=W9V]W;:_7PO49W2FXG*JUWG=R.-Q^7A2,=
ME(3.0@2D]LB(^@+;4/$72?<>H/L-0FTZHEI-49 ,;PYQIB9[62A:JPF6ROS&
ME/.R)"$J!N"&WG5H!!\/AZ>RLCOS:I4QJQ!.M"?Y'&P,O"D8[*0V9\&4GLD1
M'T!:%CQZ@^X]1[JQIM.J,C2:HR 0N'.-,?\ .?*ZJPDSFE,R"X](=/8OZP07
M'5=E_"Z;=.GA61WYO>8U8@MQ84&%%QD&'C8+(CPL>PW&AL DA#320A"02239
M( ZFL3=75F5*BH=J@% * 4 H!0"@% * 4 H!0%9\T_F<Y9_D9GOXO?K9T7Q[
M?]R])AU/PI=3]!_*S7U4^4GL7]U=_H?FK]N8+]CG5XW[J]ZWU/U'M/M?X<^M
M>@]9Z\F>H% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@$@D>%(69255L(G=C%T>TY=1Y*U'=WI$/!Y!1R$1)7(QLEI;#X0"$E82H64
M2+V)M[;7I.U*&T0NQGL,OK6VX3;&\BYAI"W3B9:X60:=;6TXT\@ J24K /MM
M?\-1.#CM+1FI;#Z?VO",;-#U!<E:L].BJF-14-K4E+">[XUK [4W*"!<_P"_
M49'ES;AG6;+O(UL?+&EZSDEX:9.>FY9D=TG'X]AR2XRD"]W.P=J;#Q%[CW5>
M%F4E7<4E>C%T)'J^WZ[N4%60UW)(R##2@B0@!2'6ED7[7&U@*2?=<6/LO5)P
M<'1EX34E5$EJI8U@QFY:_IG*G+4W/33'3)<QK4*,VA3KS[GDD]K;: 2;>T^
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MBE3B$D$B_7MO[O&K+3S:*._!%FQ,KC9V-:S$2<R_BGV?F&\@E8\KRK7*RHV
M  ZW\/;6)Q:=-YE3352KW>=..6I"VADY3T-IP,O9=J&^N(E9]A<"+G\(!O[.
ME9OEYF+YB!:<7(09L%K)Q)C,C'/M>>S-;6%-*;(OWA8-K6K"TTZ&5--5*P_I
MQXY,\PDYAU3*7@PO+B.[\DEPFUB]VVM?]5]7VWMUK+\O.FPQ?,0J1?TX$*T_
M8U)(4E6S3"E0Z@@QXW45?5>\NHKI?=?6;!UK&P5/QTYI>%UW;)VM9&;-Q,3,
M3YF<?F(^-J2VRTI]#:4M-W2E"4D=#^$UFNYG))[:&&UE2=-E3BF\X\=PFHCH
MRC\PRF!)+46,XXMEI7@IX6 1<"]B;VZVM:I6GFP]1!%A:]LF%VO&-9C 3T9#
M'NJ* \@*24K3;N0M"@%)4+CH16*4'%T9DC)2549NJEA0"@% * 4 H!0"@*SY
MI_,YRS_(S/?Q>_6SHOCV_P"Y>DPZGX4NI^@_E9KZJ?*3V+^ZN_T/S5^W,%^Q
MSJ\;]U>];ZGZCVGVO\.?6O0>L]>3/4"@% * 4 H!0"@% * 4 H!0"@% * 4
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MQ&5=S47:)K32CUNE#$9(/Z0K-JG62ZC%IL(OK+_K6-@UEXS_ #8<N?OOG_\
M,FJV[WOQZD:MKW)>4F_!.+@0N,<"ZQ&;2]E1(?R+O:.YY9?<0.\^VR $CZ*Q
MZB3<V9-.DH(PW"3#4+*<KX^*@,PH.URFHD9/1#:$K<0 E/@/A2!^A5M0ZJ+Z
M"MA4<ETE^5K&P* 4 H!0"@% * 4!6?-/YG.6?Y&9[^+WZV=%\>W_ '+TF'4_
M"EU/T'\K-?53Y2>Q?W5W^A^:OVY@OV.=7C?NKWK?4_4>T^U_ASZUZ#UGKR9Z
M@4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M45@B]NVXMMO%G8XPTW)Z5B\_"RK\60[E<[*R<=412UI2R^AI*4J*T((4"@W
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M_8YU>-^ZO>M]3]1[3[7^'/K7H/6>O)GJ!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M4 H#!;/GX^KX#*[!+9<DQ\4PI]QAJW>NU@ .X@=2:M".9I%9RRJIS:]E?MW
M8/.>1\M]LX^-.^6[N_R_F&DN]G=87[>ZU["HE'*VB8NJ3,O4$B@% * 4 H!0
M"@% * 4 H!0%2:ER%D]AU#=]BDPHK,K6)N2BQ&&N_P MQ,*.AY!7W*)N2JQL
M16:=I1DEQH887'*+? E7'^QRMNT_";'-8:C2LFVXMYACN\M)0ZML=O<2?!/M
M-4NPRR:+VY9HIDQJA<4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% 5GS3^9SEG^1F>_B]^MG1?'M_W+TF'4_"EU/T'\K-?53Y2>Q?W
M5W^A^:OVY@OV.=7C?NKWK?4_4>T^U_ASZUZ#UGKR9Z@4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MTZ]/U7;UJ)1NUP>!,96J8K$M;B.\C79&5&FP]+8RDE3D&#%06U/1T@!MYU)
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MFGI_R\2+DRPE+KQE+:*E=]U(!-TGN-_&M7)GFU$V,^2*<BS:Q&44 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0%9\T_F<Y9_D9GOXO?K9T
M7Q[?]R])AU/PI=3]!_*S7U4^4GL7]U=_H?FK]N8+]CG5XW[J]ZWU/U'M/M?X
M<^M>@]9Z\F>H% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/'/[Q+\_?!'[2C_ ,:5
M['[=_P :[^-QY7GW^38Z_6CV,KQQZH4 H!0"@.FUCL>RAYMF#':;D*[Y"$-(
M2%J\;J '4_AJ:LBB.V$I">P) 2!8)MTM[K5!)\MM-,H#;+:6D#P0@!(Z_0*
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M2I00D)!)\2;>V@.L[C,:_(3+?Q\9Z4BW9)<:0IP6\+*(OTJ:LBB.XI*5)*5
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'CG]XE^?O@C]I1
M_P"-*]C]N_XUW\;CRO/O\FQU^M'L97CCU0H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H#QS^\2_/WP1^TH_\ &E>Q^W?\:[^-QY7GW^38Z_6CV,KQQZH4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * K/FG\SG+/\C,]_%[];.B^/;_ +EZ3#J?A2ZGZ#^5
MFOJI\I/8O[J[_0_-7[<P7['.KQOW5[UOJ?J/:?:_PY]:]!ZSUY,]0* 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% >.?WB7Y^^"/VE'_C2O8_;O^-=_&X\KS[_)L=?K
M1[&5XX]4* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M?!N?C<<;F7QK77ZT>P]>>.R* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M9V[FKUM^EK9-;E\M9F-M^LYMY9;AO"%(B3DQRGSVD2F&&Y$=P)6"F]AUOVK
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MX1U#6SU6\WS> N))NY8>"S/V')3V,)KK<D$QVY<E#KOG/)205);;96H)!%U
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M)2<>IT5BY8=VSA3\/:9+&JO0O>%=QKO/6BN =<4 H!0"@% * 4 H!0"@% *
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MH[-NRY0C1U.?H-3=N7<LWA2N[H/KE#ECU.[-ZM-MX3XIY*?PWGY%UG7,8_\
M+-1641L8)SJ2ZJ.ZH?"VLB]^O2EC3Z>.E5VY&O'MH1>OWWJ';A*G9PKP)_\
MT5?>2_UO8O\ ^CH__P!;ZQ>/R_\ H?X\IE\+6_UK\>0MWU)[GS'Q!Z3]6RS^
MW+@\J0I>(@;-L</RG?.><2[\QVE;000HI'4(%:VBMVKVI:I[.-$;&JN7+6GK
M7VE3'TG#Z%?4WDN9==R^D[[EOM'D;5>Z8WD7$H0YDL6ZNP=*6TI3WQW%!M=@
M/A+9ZGN-3S70JQ)2@O9?F93E^K=Z-)>\O.8:7S!R4W]X3B^)4;9*3QT]&4MW
M5NQGR%*&LO3;]WE^9_ETA?UO'Z*LM/;^1=RGM<?^ZA$K\UJE"OLTV>1D-YFU
MCUWZYD.5]]PG*4/'\<X&1G<_B(#<F.7V,)%6_*9:2VJ$3WHCI "2OQZ7]M9=
M-/124(./M.B\O;Q*7XZJ.:2DLJJ_)V%&<*[%ZZ^>\)E\_H?+J/D,).&/FC(N
MQ8Z_.+:71VI$-=QVJ'6];6JAHM/)*<-OXXFOIYZN_'-&:VTQIW'KSQ-CM[Q/
M'.J8[DW)MYG?(D,HV7)M+2M#S_F+(4%)0V#\!2.B17GM0X.XW!4CN.S;4E%9
MMM,2Q*PF04 H!0"@% * 4 H!0"@% * 4 H"M.:/S.\L?R-SO\7OUFT_Q8]:]
M)2Y[KZC^6&O=GASV'^ZR_P!#\T?MS!?L<ZO.<]]Z'E]1Z+DWN2ZSUBK@G9%
M* 4!XR\H?]IAJ_[\ZW_%L>O1V/\ CWU/TG'N?YL>KU,X/4)@H>T_>!:WK.1!
M./V)K$8N<!U/DRX*F7+ _P"*LU.DDX:%R6ZOI)OJNLBNCO*&U?E>;QQZ:O4+
MP9DW/E\])VN! @1R;+27UK:RH \>U*,8E!'A=R_OOMW-.KNHMW5LI_IZ34A>
M\*Q<MO:G3MV^ADLQFE?D%SIZ&,*XREF9-US5<SD0!91>RVPY.<0O_&0EY*#_
M ,&U8Y7?$L7WTM=B2+QM^'?M1_Z5ZRW/4_BX6;]?/%&%R+7GX_+C6H4]C_#9
MD2WFW$_HI416MH9..BFUNJ9]3_F0ZN\H/4>39W#?"OJIX(R;[K&<D9AC%XEC
MN[1YKDA>.S!*?\:/'2.GC6Y<L*_>M75LI7UKSFM;N>#:NV^#].!V<9I/Y#<F
M>@Z&ZQY$_/C6=AR!/UEJRFT.R&2H>PB.II/Z%0[OB6[[X579$.WD=A=3[74N
MO[RG\\'$'[S?_5!5:O)?A3Z_4;/,OB6^OUH]>ML_U5V7]ZIG[ NO/6_>76==
MGE7]U=_Z]O\ T7_^JU=_GW\GE]1Q>3_S^3UFMNA<&IYXW[U3Z]!2!MN"?R68
MTQTJ"$JFL99Q)CK4?U+[:E(\0 HI4>B:W+NJ^7A:;V.B?88K>F5^5U;ZX=K.
M'+\[2=L](V4X4V]QUK=.-=AQHQ*9(*7G\0VMUKREA74+AN*#1!M\!;'BE1I'
M2J&J5V/NR3[?XD/4.>FE"7O1IV5]1L+ZAW):/N]/3^F-W>2]-P",A8]/)&.R
M"A?Z/,2BM31T^>N>7THV-6W\I"G17L[S>;T7HA(],7$WR"6TM+QTE3I;\"^9
MTCSB?I\SNO\ 37*YE7YB=>/J.AHZ>#&G UR^\^;Q!XEX_=>#?V\C;@G&DCX_
ME%0)1E]IMX>8EB_7W5N\CKXLN%/6OXFGS?X2Z_4S/.<,:YSMZ..%,!N^RQ].
MV#&:[ FZALDMU/:R41PTA#B'E-%QIR.4!0!';\*DDA([J?,RT^KFXJJJZHR_
M+J_IXQEP7H-7VN+/7_Z<(A1I.8G[/J>&N&(6&E-9N&EKQ[6<7.07T@CQ#3 L
M>M_;6\[^AU+]I4;XX>=&FK.KL+V75=OIQ[#=KT=^JJ3ZAL5GL+M.+C8C?-1;
M8>GF$%IBSXKQ4@2&VUE1;4A:>UQ)41\22GH2E/,YCH/EFG%UBS>T6K\=.JHU
MM-._NUOSP<O_ +S?_5!-='G7PH=?J-7EOQ+G7ZV69]Z/_J?Q-^_.2_S=JL/(
MO?GU(MS?X:Z_4S(^K+_8/XM_:6F_Q<*KR_\ S)?]WI,FN_QNSU%%<(\^^K?4
M^']4U;C3@?\ *;5,?%E-Z_MGV-E)GG!V4\XMP+8?0TLH<6I/06Z6-^M;6JTF
MEG=<IW*/>JHU[&HU"M)1A54P9>7HM]-_*.#Y(VCGOF:"O#9_.MSE8S$R2@37
MIF4?\V9-D-MDAD?62E"K*/>39(">[6YEK;<K:M6\4J>;8C+H=+.$Y7+F#>[K
M-/,'N_)G'_K%YOS_ !/I/Y?[7^4^WQOL'Y:3+_Z,YEG"Z[Y<5:'/A*4];VZU
MT9VK=S205R654CCY#1M7)PU,W"-75^DLWD;6O6/ZP=CU+ [CQ;_1[K^!=66Y
M,B#(QD&-\QVAZ4^N:ZX\\H)2 $-7Z>";DJ."S/2:*+<99F_*9[UO4ZIJ,HY8
MEB_>+ZW$TWB+T_:ACW%.P-54YAX3JQ92F8,"/';40/ E*!6'DTW.[<D]^/G,
MO-(J-F*6Q/U,K3.^H;UM<0<8\?S<IK>+UK0Y&(QT34ME:@Q)R78ORB?DP\XB
M1)2VXME(4$N)0HV/3H16:&CT=ZY))MRJZK9U[C%/5:JU!.453\=)L/Z%N#@_
MD\IZF-FWS&[[LVY)F"+]F+<6(DJ:Z'9[DTN-L%,DD]I;" E*5$CN[DD:G--5
M@K$8N*7'S4Z#9T&GI6ZY5<N'X_T-3>1F.49/KYVYCA>:SC^2UY63^3<R0(RF
MT6PA,KN$QMUGK&#H'<D]?#K8UT++MK1+Q?=ICV]YHWE-ZQJ#I+^!LS]A?>A_
M]<\-_P UK7XA6CGY=_2__EWFWX>M_K7F[C;OF[B7#<Q\)8_2>4MCCZYG&X\*
M>G9UK80B+G(T927'P@J:;6@^8ZE204CL4>TIZ$<[2ZAV+V:"JN'0;VHL1O0R
MR_#/.&/PAZ\/3PPK^C'8Y6T:G!/GQ8VOS6LE#4ASXB6\3D$]UU7^(-,JZ]03
MXUV7JM%J?B*CZ</.CEK3ZNQ[CJOQQ]1N!Z.?5GFN=96P:%OV%9Q?(.K0S/7,
MAMJ99F16G41GBY'6267FG7$!0![3W= GMM7/YCR]:=*<'6+-S1:QWJQDJ211
M?,OHQVZ7R9L'*7IDY"A0L[+EN93+ZS&R9@3H$J:M9<,25'44I;>6'"$.%L"R
MD@J L-K3<R@K:MWXX;*TJ8;^@EG<[4J-_C\(K^#ZH_5SZ:MAPV(]0.O2=CUB
M6M321DV8WGNM-E)=5!RL+];><;"@2'%.=" >VX(S/0Z751;LNC_&U,P_.:C3
MM>*JK\<,"8?>8YB!L.G\ 9_%/?,8O.#+9#&R+%/?'DQ\>ZTJQZBZ5 V-8N21
M<9W$]JIZS)S9UMQZR]?4_P 9_P!(GHTP,R)'#V:X_P!>PVS8Y24!3A9BP4(F
MH"O$)^66M9 \2A/3PMJZ&_X6J?!MKSX><VM=:\2R^*Q[#5C"^HT1?N^<SK)G
MVVV)D5<=QD>9=XP)X5+#BDGKV?(^='%O:D5ORT==<GN][\>7$THZK_\ 3Z?=
M_'D-V/0;QG_1[Z?L!D)D<L9KD)YS9,B'$=BTL/A+<)%SU*3';0X/#JL_A/,Y
MK?\ %OM;HX=_G-[E]GP[*XO'\>0\I_3/"]1,W?\ ?D^G/+1,3L"(ZSL#DM./
M4E</YKX0G[09>1?S+?5 /Z%=[6NPK<?&55NV^HY.FC>=R?A-+'&O6^AGH%HN
M%^\;:W?3G=XVW$R=*;SF/5N$=MO7@MS%B2V9J$EF$ARY9[@.Q05_@D&N1=GH
M,CRQ>:CIMV[MYT+=O5J2S25*X]78>DM<8Z92?J"XNTWF'C/*Z3NN8;UR'*=;
MDXC8G%H08.08"E,O)2XM"5V3WI4@D=R"H I-E#9TE^=FXI15>CH,-^S&[!QE
MO/+J+P+ZY_3['4[Q+M3VTZC'/SD1C79[4V&M#MCYB<3D  I2P1W>4TN_C<@7
MKNO5Z/4_$5'TKUHY*TVJL?#E5?C<_4;8^CWU<;%S-F\WQCR9A6<3R%KT1R6W
M/CM*BIEMQ74,26I$99NS(;4L$A/0_%\*.VQY_,>7QL)3@ZQ?X[#;T6M=YN,E
M22-5/NTRE_FCD^1E$I5GSKCJU*<ZN@KR#'S)!Z_J^WN_0K?YUA:A397U&KRO
M&Y-RV_QQ/9/86\0[@,XUGPV<"YCY*<V'1='RA:4'^\6-QY=[]*\Y"M53:=IG
MD1]ULY/&R<P--]WV6K&XA<OJKM\\/20STMVW[2YU)O[K];>AY[3+#C5^HXO)
M_P"?R>LX_NM_]:N7?WJQ7[/(ISWW8=;(Y/\ S^3UGLG7G#N'C+Q?_P!IAM'[
M\[)_%LBO1W_^/74O2<>W_FRZO4CGV7_M1HW[ZXG_ .U>/2'_ !WD?_D8W_G_
M (_I/2KU'M07O3_S4C(!HL#2<XML/$!/GH@NKCD7M\7FA/;_ (UJXNBKX\*?
MU+TG5U7PI]3]!I5]UZ[./'')C#@/V:WLD=R(?9YZX: _;KX]J6[]*Z?/*>)'
MJ]9H\H^$^OU(]/JX9U3R=^],_P!$<+_MS._L<&N_R+WI^3UG(YO[D>L]*N,O
MS;<>_P FL3_F;5<2][\NMG66P\G>+_\ M,-H_?G9/XMD5W[_ /QZZEZ3D6_\
MV75ZD;@_>#_[,NT?OKA_\\17/Y1_D+J?H-KF7P)>3THHK4_^R\E?O-FO_MEE
M5M7/^1\J_P#%&O8_PGU2]+-"8<*9H_%GI\YVQ#:C-UK>,G"DN ?"5X^1%R4)
MLD]#W_KX(/0C]&NJVKEVY:>^*[NXT?<M6KG!OTU[R^MLR,3GKU&>I??8*D3=
M8XZXQVQS#ND]S:DP\&[BV5)^E;S[CZ?=;Z*U;:>GL6H/;*4?34SW7XMZY+=&
M+]'^IF.-7);7W:_-BH7<'CM24+[38^2N7A4O>[IY95>J7J?4(5X>IEK3?R3I
MT^G'S&VOW;B(2?3S*7%2V)"]KR7VBI'UBZ&8O;W_ $AOLM]%:'.:^/Y$;?+*
M> J<62S[P%O$+],&YJR0;^<:R&&5@.\7/S9R#"5=G0V/RY>_0O6/E%?F8TZ:
M]A;F7P)>3THTA<<GN?=D-"9W>0UM'9BRHJ/ZQ]LDFW<  /-+G07'Z-P.GA]1
MPX>HT?\ ^#^/ZB)\;\O>L/BOTZ:YG-*U3'#AK&?/'%;;\K&G2&TJR<@R5OM)
MDK=0@25.([G& FWM\%5EOZ?2WK[4F\^&'DZN'28[%_46[*<8K*M_EZ_46IZ2
M.-LQZB^5SZFN2>0\5L>7UF<P\[JL!):G,3H[?EP/FV0RRVPRA+?>WY97YA1U
M-PN^OS"\M-:\"$6D]_I,^CMN_/QIR3?!;CV'KSIV10"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#QX
M^\/_ #]<$_M*/_&E>AY1\&Y^-QQN9?&M=?K1[#UYX[(H!0"@-%OO$W93?IMR
M2(ZW$M/[!BD3@B]E-!Q:P%V]GF)0>OMM74Y/_D+J9H<R^!+R>DF7H61CT>EO
MC(P V/,3E535(MW&1]JRPOO]O<+ =?9;V6K'S2OS,J]'H1?04\"-#99_*ZI%
MV.-CY.2Q,;;9T,?*077F$9%Z('#;L;40ZIOO!\!V]U_;6BHR<:XT\QMU531/
M[QOE+\D.'X&@0)7E9CDN:&92$GXAB\>I#\@].H[W2TCZ4E8]]=7DUC/=SO9'
MTLYW,[V2UE6V7X9HKR.QP2OT@<:ZWKN^XB?ROI\TY[+8MDO^>^[FRD9","ML
M(*V4A@&R@"&.ER>O4L.]\U*3B\CP[-GXZ32OQM?+**DLRQV\=OXZ#TN]+_*@
MY6]+4>=+?\[/ZGAYNM;%?ZQ?Q\;M9</4DEV.II:B;?$5>ZN+KK'@ZFFYNJ\I
MU-'>\6TGOV,\L/2/L?J6UN+R9,]/.I0=J9",2YNJ)28[KK(;^=^2##+LJ.XX
M5W>N&TK/0>'2_>YC#3R<?&=-M/-7<<303O1S>$D]E:^7I1)]8E<J>NGD;!:-
MRER5A];&HJD.M8!V)\E.<02/GA"CML!#KZ4,CN2ZX.Q(*@FP76.:M\OMN=N+
M==^[HJ9HN>MEEFTJ;M_X]' ]8N6N=N,?2SKVB8G9<?F#AYT9>*UN/B6&Y1:9
MQ3+#82X7GV;60M !N;]:X&GTMS5RDXTKM=>D[%[40L)9MAK'S'ZE>/O4/Z7?
M4%^0D7,QOR0AX'[5^UXS4?N^T,FCR?*\I][NM\LONO:W3QK=T^BN:;46\],:
M[.A&K=U4+]F>7<CSWQ[;_&^F>E/GF$UYGV3G\I#R2$@@*3B,Q\ZAM9'CYS<A
MU'OL*[$O]V=VT]Z7G5#FQ_VX6KO!M/M_U+2W*4US5SAZM>3&7D2\%H&FYQG!
M2VOC96&6$82,IL^YUHO.@UKVUX%FU#?*2KZ>XSS_ -V[=ENC%KS4[S?#[N7_
M &<F?Y2Y3_>9KE\Y_P CR(WN6_ CY?2;XURC?/"W,\IZ'REZY4;QR!M43$<9
M<?9'R\',F%Q;#K.![OE$M)"5$ID3;OD=OU5*O7J(V)VM'E@JREZ_X8'"=V%S
M5UDTHQX]'\3K:?R=HO$7K?D[1H&S1,QQ9OV35%R$V'W-QVHN>*%O(4E0!2F)
M-(6!;ZB!;QJ;EB=[1Y9JDHKT=Z(A=C:U=8M.,N'3_'S$\^\<4VYSUQ%'R:S]
MBC!13(2N_E!*\H^'S^BA*;_1:L7)O@SIMKZC+S+XMNNS^*/9Y*4I2$I 2E(L
ME(Z  >  KS9V3 8/*ZK->R\/6\EB9<B!.?1GHN->8<6S-[R'Q)0R24N]X/?W
MCNOX]:M*,E2M2$T:C?>#_P"S+M'[ZX?_ #Q%='E'^0NI^@TN9? EY/2C/^A'
M_93XK_\ /G\>9"J<U_R9>3T(<N^!'R^EFDWJ=_[03A']]='_ (XKIZ'_  9]
M4O0:.M_RX?\ ;Z2P?O->.%R,#H/+V-06YNO2U8#-2&^C@CR>Z1#<[A8@-/(<
M'X716'DEZDI6WOQ[S-S6TW%36U/\><J[U<\_.\K<!>GG6\.X9N>Y':;S6S0V
M %.&7CN['>2 GV.S2]V@"_ZV/#PK/R_2>#?N2>R."\N/H,>NU'B68*.V7XIV
M^@]0^.-9PW _"6O8'(2$1<5QWK:I.Q3QU1WL-+EY&0 /8ITN+M]-<.]-ZB\V
MMLGAZCJVX*U!+<D>/OINY$XOVKG[E+F;GG9L?A8^:BY%O$XO(J>5YJLWWQ5M
M(\I*SY;$'O8()'1:;>%>BUMFY"Q"U:3=*>;^.)QM'=A.].Y-I<*_CA@2ST(\
M@XKC;U"[EQ/#S[.;TW>G9,/7,VTJS,F5C%NNP) [PDCSXY<3:P/<4#V5CYK9
M=VQ&XU22V^7;YRW+[BMWI6TZI[/QU'MM7F3N'C9]UO\ ZU<N_O5BOV>17H^>
M^[#K9P^3_P _D]9NSZ[O]E/E3_S'_'F/KF<J_P F/E]#-[F/P)>3TH\\_3?B
MO7)*XJQ+W!FRXW&\>*ES1CHDEO"J<2^'U"029L5U[JY<]56]U=?6RT:NOQ4\
MWE]3.?I(:IVUX<DH_P >HW]]..-]84/;,VYZB<_ RVJ*Q"DX5B(C$I6G(>>R
M4J)Q\9ERWE!P?$>WZ+VKDZR6E<5X*:=>G9Y6=+31OIOQ6GPI_HC<FN<;A!^3
M?S;<A?R:RW^9NUDL^_'K1#V'FK]UG_HCFC]N8+]CG5V^>^]#R^HY/*/<EUDL
M^] _-?QS_*ES_,GJQ\C^)+J]9;F_PEU^IE9\<87[QMWCS0W='VW$QM*<UW%J
MT^.XWKQ6WBS$:,)"B]"6Y<,]H/>HJ_PB36:]/0>)+-%YJNNW;OWF*S;U;A'+
M)4HJ=785MZ1FMP9]<&9:Y!D-R]Y;7LB=MDM!H(<R 0OYE20PE#5BN_U$A/N%
MJS\PR?)K)[N%.HIHE-:J6?%TQ\QTN?V>0Y'W@.PL\42VH/(;DO#C5Y;XCEM#
M_P"3D,J*A*0XS_D^X?&DBITCMK0KQ/=QK^9F.^IO6/(Z2W?E-BOL+[T/_KGA
MO^:UK\0K3S\N_I?_ ,N\V_#UO]:\W<>EFH(V%O4]7;VUU#^UMXB$G9GVPV$+
MR 80)2DAI*6[%WN([0$^X6KB7,N9Y=E<.HZD:TQ)%52QXV>IW_M!.$?WUT?^
M.*]'H?\ !GU2]!P];_EP_P"WTGLG7G#N'C9]UO\ ZU<N_O5BOV>17H^>^[#K
M9P^3_P _D]9,?O3/]$<+_MS._L<&L?(O>GY/69>;^Y'K,IZZO]CWA#]^=:_^
MU^?5>5?Y4^I^E$\U^"NM>AE :9E(? 'J-].>]9"T+5>1>+M5>RRT'M0$S,"U
MCG2?9=,J,AY0]M_9>];=V+U%BY!;8S?IKZ#!:?A7K<MTHKT?P113^/F[GQ!S
M_P YYAM9G[/O6+@QGSU'F3'I62G(O_BE4>P'@/T*VJJ%VW:6Z+[EZS![]F[<
MXM>FOK-HO4F[D4>@[TRM,A0QCLG%?/K'_P JG&3"PD^VQ'>;>%P/HK1T5/G;
MO''THV=97Y2'D]!Z+>DE,!'IMX>&.#8CG7VE.!KZOGJ<69%_I\XK[OIO7'YA
M7YB=>)T])\&'4C4#[T5&-.C\5..A'VNG.SDP21\?RRHR#(L?=WAJ_P"A71Y%
M7/+A0T>;T\-=?J93OK'7-<]+/I 7D0!,5@81=^)2B?\ Z3P^TJ*@D]Q38J'L
M-QU\:V.6T^9NTXOTF+7U^6MUVX>@QV=]0WK:X@XQX_FY36\7K6AR,1CHFI;*
MU!B3DNQ?E$_)AYQ$B2EMQ;*0H)<2A1L>G0BIAH]'>N22;<JNJV=>XB>JU5J"
M<HJGXZ38?T+<'!_)Y3U,;-OF-WW9MR3,$7[,6XL1)4UT.SW)I<;8*9))[2V$
M!*4J)'=W)(U.::K!6(Q<4N/FIT&SH-/2MURJY</Q_H>FM<0Z9X8;KI8Y$]<G
M,NE!GSY&PXK88^.;_P#YP:VM<57_ !7DH/Z%>HMW?#T<)<&O_(X;AGU<X\5Z
MD5$OFQU?HW8X3\YTY=.^*2F)<_Z'"/M#L[/&YG+O;W_36Q\M_P#M^+NR^?9Z
M#7\;_P#5R;\U/7Z38+BS3$\=^OKB;20T&7M;U6)$GH!O>6G2G52E]/\ ">*U
M?HUJ7[GB:*<N+_\ L;,89-7"/"/J9D.4/^TPU?\ ?G6_XMCU6Q_Q[ZGZ2]S_
M #8]7J9Q),>5]Y^!LBRIEO.J$7YB_1QK7B<>$BW_ ,H&NW]"IV<NPX?_ &Q,
M?_\ /_'])[+RU1419*YRFD04-+5,6^4AH-!)*RX5?#V]M[WZ6KS:K7 [9#IF
M2U[*Z!FI>JY#'9+!_8\Q$&3BG67HG8(ZK!M3!*+ $>%9$I*:S;:[R*IK \(/
M2/L?J6UN+R9,]/.I0=J9",2YNJ)28[KK(;^=^2##+LJ.XX5W>N&TK/0>'2_J
M^8PT\G'QG3;3S5W'F]!.]'-X23V5KY>E$GUB5RIZZ>1L%HW*7)6'UL:BJ0ZU
M@'8GR4YQ!(^>$*.VP$.OI0R.Y+K@[$@J";!=8YJWR^VYVXMUW[NBIFBYZV66
M;2INW_CT<"]_O,\6WKNK>GS6\.TJ/KF&:S,*-'[BH(3#8QK,5))-R0WW@$UJ
M\DEFE<D]KIZS/S>JC%+9^*>L]-N(40F^)^,48U+:<>-4PWR0:^IY1@LE';]%
MJX>HKXDJ\7Z3K0IE5-E#RX^])1B4[!PV\QV#/J@9E.14D6<^42[$,2YMX>8I
M^W7WUWN15RSX8>O^!QN<;8>7U$;^\A7.==X!<REQDW-7E*R(45*/GDQ2Y<K"
M5$]U_$ U?DM/]RFRO>.;_P GE]1</V%]Z'_USPW_ #6M?B%:V?EW]+_^7>9O
M#UO]:\W<;+8F+S3$]+O*K7/>1CY3?OR=V=2Y49,-*/DSCG/(3:"TRU<?%^IO
M[ZT9.T]1'PE2-5Z>DW8*XK5+CK*C/(C3.")FY>EG/<SZBT\-RXRW>?\ :HC=
MWFO89O'XQ\NH*>H5"<4IX$6^!3A\0FO17=4H:E6I>[**[:OTG"M:=SL.<?>C
M+S47HVDP]0_/,?GK0O3)F)KR/RTUV9G<7O$1(2DF4E6'\N4E"3T1)0.\=  K
MO2/JUBT>D^7G=6YT:\_H,NHU"OJU+?5UZ\#TV]=O&?\ 2)Z?=CF1(X>S7'[B
M-FQRDH"G"S%2I$U 5XA/RRUK('B4)Z>%N)RJ_P"%?7!X=WG.IK[7B67Q6/8:
M0X7U&B+]WSF=9,^VVQ,BKCN,CS+O&!/"I8<4D]>SY'SHXM[4BNI+1UUR>[WO
MQY<31CJO_P!/I]W\>0VY]'/&?]'OI5>R$R.6,UR% R&R9$.([%I8?CEN$BYZ
ME)CMH<'AU6?PGG<RO^+J:;HT7?YS=T%GP[*XO'\>0UY^ZN_]>W_HO_\ 5:MW
MGW\GE]1I<G_G\GK-4?3'FO4#@M[Y&F>GW68.SYM,)U6Q1IORY\N$B5W!32'Y
M,;O45@#M1W*/L%;VMC8E"/C.BW?BA@TTKT;D_"2>.-?+THEB-FYJ]9?(.&X<
MY3Y PNCN8#(O.# Y"$8#QEM]S4AMAAMJ[TII'<E+;KJ/U5NO=5,EG0P=RW%N
MJV[?PBV:YJY^'-J-'LWFR?WAVM-:%P5P?H>O!Y&IZWDDP&TN*N5+A8\LQEND
M6"EJ0723;Q*O?6ER>?B7IS>UKUFSS2*C9C%;$UZ&;Z>FE&,;]/G"Z<0&DQ3I
MN'4Z&?J_-*B-JED_XQ?*^[_&O7)UM?'G7^I^DZ&E^%#J7H-#_O2F\=]B<.O+
M2V,L9V91'7;]<,<-Q"Z+V\ LH_3KJ\BKFGPHCG\WIDCQJ5IZYURG."?2"Y.O
M\ZYK15,N2H^:<7BBNY4 3\5_$5GY53QKM./K93F=?"A7;_ ;%"R/H/\ 5/#V
M/&QWSPSR(7.Z.VDJ2,:\ZDRHJ ; NX]U25M];ELH!5\:J0:YAILK]^/I_B1)
M?)WZKW)?CS>@GOHUGPLKZS?4WD\;*;G8[(N;+*@365!;;S+VQ-+;<0H="E22
M"#[JP\R36DM)]'H+Z#X]WK?I9KAF-,._>H[U?:XVCS)2\9N61@(M<JDXS(,S
MV4I^E2V G]&MV-WP]/9ETQ\ZH8';\2_=C_TOU$;V+EZ7N7I1X7X0@+3(SL7=
M,C$D1TJ)><8C=CD +'^"M>5*$V_^1^@U>&G5O4SNO9E7\?1YS'*\[FGA;6UN
MG9L]*-CN"];BZ;]X)D]1A$*AZMA7,3%6!V]S<+!QF$FWTA%ZT]5-ST*D][KY
MV;=B*CK));H^I%5<C,<HR?7SMS'"\UG'\EKRLG\FYD@1E-HMA"97<)C;K/6,
M'0.Y)Z^'6QK8LNVM$O%]VF/;WFM>4WK&H.DOX&S/V%]Z'_USPW_-:U^(5HY^
M7?TO_P"7>;?AZW^M>;N+$]>Z<PCTHXA&Q.)>V!&5P*<XZCL"53 RX)"AY82B
MQ<N?A 'NK#RFGS.&RC,_,?@/R>DT-S.E;+Z=L1Z</5+QXVK[-S>(QQV6(.[R
M49$1^Q]E[MM9G(,!5^M^\.&Z245U8W8ZEW+$]J;IU?P.=*V].K=Z&RBKV>OT
MESZ5O>!Y-^\8T+?-9?+^%V;#B7%[K=[2CJ$A+K+@%P%M.)4VL#]4DUK7+4K6
M@E"6U/\ ^R,RFIZR$EL:]3/3CU _F&YM_D#LO\5R:XFD^-#^Y>DZ>I^%/^U^
M@TF^Z_\ S7\C?RI;_P R9KI\\^)'J]9H\H^$^OU(]-JXAU10"@% * 4 H!0"
M@% * 4 H!0"@% 5IS1^9WEC^1N=_B]^LVG^+'K7I*7/=?4?RPU[L\.>P_P!U
ME_H?FC]N8+]CG5YSGOO0\OJ/1<F]R76>L5<$[(H!0"@/*+D3BSDC(?>!:[OL
M'1<Y+TJ/EL Z_M;4)Y<!"&,>PVZI4@)[ $*20>O0UWK-^VM"X.2S8X>4Y=RS
M-ZN,Z84V^1F1Y1XPY%R?KYT;>\=I&:FZ7"EX)<S:683RX#26&.UTKD!/8.P]
M#<]*K8OVUHI0<EFQP+7;,WJHS2P2V]IK[Z@?2MR1L?JJSZ-=TC-3]'WC8X$U
M_;(\)U4&.C*EE<]QU]"2A(9=6Z5&_@+UN:37VXZ95DLR3PZMAJ:G13GJ*I>R
MVOXFS?J!XPW?*^L_T\;1K.D9:?I.KP=;CY+.083KD""F)F9SBT./(24(\MI:
M5$$]$D&M'27X+27(RDLS;P\B-J_9F]3"26"7>8KG3C'D3-^N7B7=L/I.:R>G
MXJ1K2LGLT:$\Y!8$:8XMXN/I24)\M)NJYZ"K:6_;CHYP<E5UP%ZS.6JC-+!+
M;VFO_JF]+_)FR>IS/RM-T7-9/5-ZGXV6K8HD-QV'&=FH::F+=?2GL1V/!;BN
MX]$FY]];>@U]N&G2E)55</0:NLT4YWZI8.GDW&QOJ,XGW*=ZJ?3!EM.T?+Y+
M2=).KQLAEX,1UZ' CP,XIQ0>>2DI0&F0%'N/1/6M/1:B"TUU2DLSKY<#:U=F
M<KUMQ6">/:3+UX^G#;^8,3JN[\=Q3D]KTA$B/,P;:DMR)<)Y2'4JCJ44@N,+
M02$7NH*/;\0 5CY5K866XSV,MS#2RO).&U&O^1]2/KCR^ER>/WN ,TWGI^/5
MBI6XIUO,(E*;6CR%R0" PEQ5R?,'P ]0D=*VUHM&IY_$5-M*HUWJ]2XY?#=>
M-'^/.;1^A7T][1P=HVRY'>(Z,=M>^RHC\G"I6AU4.'!;<$9#RT$I\PJ?<4I(
M)"18?6N!H\UUD=1-*.Q&UR_2NQ#VMK*M]&W&O(.G^H+GW/[5IF9U["9U<\X7
M*Y"&['CRO,RRG4^2XM(2NZ/B%CX=:S\QOPG8MJ+3:V]A31V9PNW')43>':RI
M_7/Z3=KF;^SR;Q/J.0V6/NRUG;<)B(SDEZ-DT"ZI7E-@D(DIZJ-NC@43U6*V
M.5\PBH9+CI397@:_,-%*<L\%6NWO-TM<X01R3Z0--X?W>)*UO)O:O 97\RP4
MRL9D8O:XRXIE?:JZ%I 4FXNDJ3<7KF3U7A:IW(8JK\J-^-C/85N7!&C.@3_6
MCZ03E-%A<5RN2=($AZ5!^3@R\K";*_K2(LF!=QA*^WN4V\D>T]J5*)/4O+2:
MVD\^679Z3GVWJ-)[.7-'H_'J/V5Q/ZI?6=R)@LMS#K4KC'C[7EE'RLN([C4Q
M(SJDJ?1"ARR9#K[X; +BQVBPN0 E!+4:;0VVK;S2?E[=U [-_5S3N++%?CM-
MHO69Z5<ERCH>DR>+(;2=CXKB''8C7/,#1F8KL:0F.RZXH)#C'DI* H@$%0OW
M=H.CRW7JS.7B;);^DV]=I'>BLNV.PHB#ZG/71B]78U%WT]YB?LL:'\BSNC^N
M9AUY:DI#:93B0#'<<%PHJ/P%752;7%;3T.C<LWB*G"J-=:O4I97;>;CC3\>4
MN?T'>F_=N)(VW;]R1%5A]GW-IF)C]>4M"G8\1"R\X[)#94E+CJRFR+W0$GNZ
MJLG7YKK(7FH0Q2WF?E^FG:3E/:S6J9Q=ZDO2)S=L^Y\0:)+Y&T[952FXK,*!
M(R;+T"2\'T1Y3$/]?9=CK[>U8L#:XNE2DUNJ_I]994;DLLEY/2:LK5[3793@
MLT68OD#$>K3UH[1IV%V3BF5QOJN"6M;<R=CYF-@L)E%'G2W79]ER%!" $(:!
M^A/52JFS+3:&+<9YF^FODP*W8W]8TG'+%<3=7UG\:9_*>F?$:!Q[KN2V>5@<
MAA(L#%XZ.N3)^4@,K9"RVTDFR4@7(%JYG+;\8ZC/-I5KYSH:ZVYV7&*J\/26
MMZ1M=SVI^G7C37MFP\O 9W&Q9J<AB)[2F)#*EY"4XD.-K 4FZ5 BX\#6#F$X
MSOR<75?P,NEBXVHI[4C8^M,V#RH]//%W(^O^MWE[=,YHV;Q.HY;);@YC-EEP
MGFH4A$O*>;'4T^I(0H.(^)-CU'45WM9J+<M'"*DFUEP\AR=+8G'4SDU@Z^D]
M5ZX)UCSB^\6X\WOD+5N,XNBZAE]ND8W*SW<@QB8CLM;*'&&TH4X&DJ*02" 3
M78Y/>A:E)S:6&\YW,K4[EM**JZFUN%XVQ6[>GK5.,M]Q#@B9'2L1B\WC7T>7
M(BR&H+*>X!0NAYAU 4DD72M-:$KSMWW.#_F;\YN>&IPRR6%#SY]+6H<[>F;G
M/8./<QH^Q;#Q3LD_[/F[1C\?(?QR'1_Y!E6W$I*4I*5!#_7X4D]URT!77U]V
MSJK*FI)36[?TKN_B<W1VKNGN.#58/?\ CSD*Y,U?U :%ZR-MYHX\X=S>WMX[
M)/.820K%S9&.E(EXKY%Q7?'["H)#JK=JOK#]"LMBY8N:16IS2\N.VICO6KT=
M2[D8U7\*%M_VIO7+_P#HM_\ YBS?XS6M\CH_U?.C8^:U/Z?G+!Y]X8Y%]4_I
MYX_V2?@&]7YEUQ,C)'3WDN0VU"22W)A 25%32UAEI:"XJUQ8V"NY.+2:FWI+
M\DG6#PKZR^JT\M1:6Z6W^!1NK^HOUP:)J..T"1Z=\OL&4U^$G&8W9Y&OY=]Q
M3;"0TTMY4;]9?+:;#O20%6!5<DJ.U/1Z.Y)S\1)/=5&O'5:F$<KMMOCC^/.6
MIZ&_3IR/I>R;QS)RW!5AL]NL%_'Q-?DAOYAUN=*;F3),IE'PM=[C* ALB_UK
MI2.V^#FFLMSC&W;Q2W^9&70:6<)2N7/>91$;B_U+>C/EC9<WQ%H\SDW0-C[F
M6(T.)(R2)$+S"Y';E,0SY[4B-W%(<MVFZB+I44C;=_3ZZTE<EEDO)^$S75F]
MI+CE".:+_'7@8SD3%>K?UG;'J. V+B61QMK&"=4XB9D,=+QL2/\ ,=B7I;ST
M^SKY"0 E#(_XI-U5-F6ET,6U/,WTU]!%U7]8TG'+%<2[?7GPSNF8T;@34N-M
M1S>Z1M&C3L:\K'1'9;K3#,: PPM_R4GM*PR?PD&M7E6IA&<Y3:5?XFQS&Q*<
M(J"K1GHEI.(__MMJ.!S< @_DU @9?&24$$?]#;:>9=0>H]J5 UQ[DO\ <;7$
MZ:V'@V[Z.N7T<QO<=,Z;L8X_=VU,'\L_DWSCSBQ)*$3U/=OEDICK*KWZ$E->
MK^I6O"SU6:FS?7AVGG?I]SQ<M/8KYO\ 0_H1@08>+@PL9CXZ(D#',-Q8,1L6
M0TRRD(;0D>P)2 !7D6VW5GHCP?X4A^JGT][AN&R:AP!G,Z]LC2X3R<IA<DMI
M+0D><E;?D%HW) \21:O4ZEZ;4PC&5Q*G2CAV8W[$Y-0K5FS?]J;UR_\ Z+?_
M .8LW^,UH_(Z/]7SHVOFM3^GYSU0KAG3-1?63Z?,ES_QM$A:RXRC=-1F+R6N
ML2%AMJ6EQLMR(A<59*"X DI4KIW) 40DE0Z'+=8M/<K+8\&:>MTWCVZ+:L4:
M9Z7Z@?6YQEJ&+XZD>G?+[/+UJ(,=B,_)P.7DN>1' ;9#KD,^2_Y2>U(4E0N
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MA/<0+FJ<GO0MW).;2PW]9;F5J=RVE%5=?4S;GA'&9#"\,<18?+PGL;E<3I6
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \>/O#_S]<$_M*/_ !I7
MH>4?!N?C<<;F7QK77ZT>P]>>.R* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M=OST_');:!Z>)2ZI1\?8#2HR,N''Y"%E8,7)8Z2B7!FM)>BR6S=*T*%P1_\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MXA"@? V4"1[";4(DZLLVI(-&, DZZW#Y&:':G []/Q^:<'_Y#,982HJ^A/Q
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M)+3*5VYAAYC!S#4*^XVK>+J3/US:8KCOTP^GO1G5I=DZM+BXZ:Z@W2N0SC'
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MOFVHI3-YD:BY?8K7+YV;98/!8;6<1C\!KV+BX7"8ID,8W%0FDLL,MI\$H;0
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H#QX^\/\ S]<$_M*/_&E>AY1\&Y^-QQN9?&M=?K1[#UYX
M[(H!0"@% 5KL'$7'VRS7,EDM?0)[ZNZ1)C.NQRX3XE:6E)22?$DB_P!-02I-
M&9U;0-1TL.G7<,U"??':],4I3KZD^/;YKA4H)Z#H"!]% Y-G%M''>H[B_'EY
MW%!^=%3V,3V7'&'@CJ>TK:4DD"YL#>WLH%)HQ[7$O'S6/1C4Z\CR4RFYI?\
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M7'B,I"6T)]P2.GX:DH5Q/X6XWR,UZ:]KX97)4%R8\:0_'8<(-^K32TI'7_!
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MKW9X<]A_NLO]#\T?MS!?L<ZO.<]]Z'E]1Z+DWN2ZSUBK@G9% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@/'C[P_\ /UP3^TH_\:5Z'E'P;GXW'&YE\:UU^M'L/7GC
MLB@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M2HI/PK"5"Q!%B*DJU0ZD#:<#E,KF<+ R D9'7B@9ED-N!#!<!*075)#9/0]
MHVL;^%!0@T[F_C2!)=C+V'YE3"NUYZ+'?>:2;V_RB&RE0^E)(J*ELC)'.WW5
MF=3?VYG-M+PG;V-9%I#CH2ZL]B$J;0A2PKN(!"D]/;0BCK0K+B3>H&TZ9/Q6
M;V!^9LC4>?+SKBT.EQJ,MQ0#B5]G8>U*AVI0>G@!THBTE1EB<=_DYC]$Q2L%
MFW<IKL5$IQG-S@6E*0)#JG5.>8ELI"%=PN0.@_1H5E6IA5<W\9)F&&=C!LYY
M1EB/(,?N_P#"AOMM]/A]-J5)R,GV2V+"XC".['.GH;PC+2'UY!L*>06W"E*%
M)#065 E0M8&I*T(/DN:.-\5-3 E;$DOD)+A98?=0WW@$!:D((!%^H\1[0#4%
MLC+'@3X65A1LCCI3<V#,0'(TII04A:3[014E3LK6AM"W'%AMML%2UJ-@D#J2
M2? "@*I<YOXT:E*C'82I*'/*7-1&D+CA?N\U+9!'TCI]-JBI;(S[Y/WO'Z]H
M\G)8_-)C3LW&4G69K""\'7" JZ%I2M ^$W!58?HT$8U9V^-MTPFP:9C9*,S\
MW(P6-B,[+,D^8WY4E$=)>+CKZ4A74$E0)'MO0B2HS&/<Z<8LOED[ IQ*5A"Y
M+<22MH$_XX:Z^'LO2I.1F6W;?<+AM#F[)"S;:$Y2(^QK&280I]+DY;#JHZ1V
MH6 >YLW[Q8$65:A"CB8WA[<L?M&I0HXR[F4SF'CM?E$MY+O>AU]3A25..) 7
M?L/5)-K4)DJ,Y9O-7&T":Y!=V)+JV%^6_(CL/OL(5>W5UM"DGP\4DB@R,LF!
M/A92''R&.EM3H,I'?&E,J"VUI]X4.GT5)4[= * K7.\O<?Z[/>QF0SR7)\8E
M,J/%9=D>44_6"U-(4D$>T7N/;4$J+9)=8V_7-QAN3M<RC>1994$2$@*0XTHB
MX"VUA*DWL;$BQ]E20TT1B?S!QWCHAF2-B1V?,NQ RAA\O%U@@.#R_+"NU-_K
M6[3["34$Y62;5]QUO<HCDW7,HWD6F"E,E 2I#C2E D!;:PE0O8V-K&W2I(::
M,%LG*FBZI/\ LK,YM+>12 IZ(PT[(4T"+_KGE)4$].MCUMUM4$J+96VG9R%G
MN=]FR&)R*<AB96L-N176E$MGXH0/PGP(-P01<&X-"S5(FQE24()LW)>F:E-;
MQN:R_EY)Q(6,>PT[(="5"X*DM)5VW'47ZU!*BV936-RUK<HKLO7,JWD6XY"9
M+82MMQLJ%P%MN!*A?K8VL?94AIHQ.R\G:3J4P8[,YE*,B0%*@1VW)#J 1<%:
M6DJ[>G6RK&W7PJ HMF;UO;->V^$J?KN4:R4=LA+P1=+C:CX!QM82M)-NEQU]
ME20U0PVS\E:9J$MO'YO,):R+B0H8]AMR0\$GJ"I+25=MQU'=:_LJ"5%LRNN[
MCK6UXY[*8'*MSXD;_P J[0I+C1MW6<;4 M/0=+CK[*$--$5<YFXX1]D]NPAX
M9H$PO+C2%*L'5,W6CR^Y%UI( 4+GQ\.M*ELC,_M._P"I::6&]@RZ(DF2.Z/!
M0E;SZQ>W<&VDJ4!?P) %20HMGWJV]ZKN:7SKV6;FO1NLF&I*VGVQ>UU-.!*K
M7Z7 M]-0&FBFH_+N%/+DYJ3LSOY*HQ7V?CHWD2/*^TE2&0H%M+7<5?"H!:A8
M#H#8T+9<"Y=IWO5=,2P=ARS<)Z3UC0TI6Z^X+VNEIL*5:_2Y%OIH52;/C5M_
MU+<B^WK^71+DQAW2(*TK9?0+V[BVZE*B+^) (J0XM$QH01+-[WJ>N3G,;G,R
MWCIC4#[26TZAVWRWF%H+"P@I)*QVA(/<?8*@E)LQFN<HZ1M,_P"RL3F+Y)2>
MYF%):=C+=3:]VPZE/?T%[#K;K:@<6C+9W=M7UF6S!SN61CI+\9V8TAQMTI++
M(/>KO2@I!Z6 O<GH 34A)LZN!Y"U'9,1D,[C<LD8K%*[,C,DH7&0T;!7Q%U*
M1X$>%0'%HCD;F[C.5-1"1L8;4XLMM2GH[[3"E"W3S5MA(\?%1 ^FE2<C+62I
M*DA22%)4+I4.H(/M%25/V@% * 4 H!0"@% * 4 H!0"@*TYH_,[RQ_(W._Q>
M_6;3_%CUKTE+GNOJ/Y8:]V>'/8?[K+_0_-'[<P7['.KSG/?>AY?4>BY-[DNL
M]8JX)V10"@% 4!&_VB\C_)I/^^U4%_Y2_P"I*&JCN3S#O-FW9./I[NYOZZQ'
MB8N*)#3(@I4A!\U/FW!*CW$$>'<:@R?RG>VAO?-FV+4,_"XSE:_EL!D&W'\J
M9D9PNQ5$!QISL[21:_M/0J'MH0J+>2K_ -H7_P!$O_'TWD?RG3YD_P!;N%_Y
M3-?YQ%H3'8R-<G3-HA\Q8?\ (Z )^P2M5^7A!5NUGS)$KN>/=9/P $CN-KV\
M? B8TIB2_@=&"=UR=/82ZO;G9;C>YOS#W2_F0I1 45 $((Z@>^][J!HBL]IT
M>)HS.:W/D_:<FVF3F&,TYCH;CH*E1H[*EI"$%0Z72$IZ?X/L]HF6Q'SR1&8P
M/)W%>PXIH1LGG,DK&9930[?F&%K9:)< ^L4I=5U/T>X4$<4SEX^C1\YRKREG
MLFA$G)8*8QCL05_$8[/ZZ@E /U2H-#J/\;WF@E@D6@_IV!<W&%N*2Y%S\>*N
M,4LK2A$AI0()>1VW61W=#?V#W"I*UPH59HDF/Q_NG(NFSG!&PP0K9\(2+(1&
M4F\@)Z?J!VIM_B&H+/%)G:XDAR)VO[?OF1;*,AO,J3*;2?%$1GO0R@?0"56^
MBU")<#!<?Y&5B?3WD<C"4IN7%AY5<9U/UD+\QP!8\.J2;T)E[QU.,<OLFOZ;
MC8V(XGD91C(-&3*S")T9'SJG23YBPL%5NT]H!\!022;VF7X]UC:$3.2H,S7G
M]-U[;&%N8J&IYIY,60\A;;A;\H@#ZU_ = D>R@DU@87!Y3>.,L"-2V7C3\H=
M<BAYMS*XFSR7F7%%2UO-!*PJX41=81T\??0ET>-2W>*Y6F2M39_(9#T?#M2'
M4NPI*UJ>8?-E+0L+6NQL0;)-NM_?0I*M<2QZD@_"+@BY%Q:X\1^"@-7=>_I!
MX@BS<$_H8W#7ERG7DYG%F\AQ#GB76TI<4JP'@I(MX=Q%J@R.DC.X7(:+/XOY
M.7I$)_$A6/RCV:PTDJ#D>0Y$<'^3*UI2DA-D]G3I;Q%J$.M54L#B/\VVH?M
M?\M5"LMI37'F0DXKCOF3(PEEN7#R.3<C.CQ0L,#M4/I2>M"\MJ+6X;PF,QO'
M6 5%CM%S,11+RC_:"I]QTDD.'V]H/;8^P4*R>)%M\U'":AQ7R%&P*WA$R4A,
MQV&MP+:8=7(9"D-)2!V)  %C<]!UH2G5HGFD:Q@V>/,)ADXYGY#*8F.O)-%
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MKSQV10"@% 5SRY^;;;_V@?\ EIJ"8[2N]V_V;H7[P:_^R0Z%E[Q;7_\ 0/\
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M(6HJ#;H3VA0!)-@?T0+) EM,D>H\?Y>%B]H7MF?=R.?W)*TY)^(XM#,1*TJ
M3%OVV*>^]P!X 6Z=1#EP(_B,?S7JF.3KT)K [+#B=S>+SDMYYMY+14>WSD="
MHI!\!?\ "JA+RLEFA://TG6,I#,YJ;L>7?D9"9,0GM8$MU%D)0DCZB2!XIZ]
M>GLH5;JSGXNS&?SFL.2]DELS\DQD9D0S8Z4I9=1&=+04WV)2%)NDV-NM!)8E
MA.MI>:<:7?L=24*[24FRA8V(ZBI(*)P^#Y=T9J3A,&<3MV"\YUW$2\D^ZU*8
M2XHJ['? *%R3T)]O4> @NVF9G4>-IL+%;R=GGLOYSD7SAG%P 4L,(=0Z@(:[
MP"2GSE&Y'N\;7(AR(YKV YJUG%,Z=CGM?<Q40K9@;,\75/,L+457#-[*4FY[
M04D7L"2.M"6XO$D?'''$G5<)N&O9QUO)0,[D))9<"BI;T-YL-7>Z"RU)![@+
M^/C0B4JF#P^O\M:'#<UK6QAMDP#*G#@YN0<<9D1D.**NQU*;!0223T_W!\($
MMIGV>*<LQQ]N.'5D&,GN.Z/IF9;(K);84]YR7.Q)[2>U([K'M\3X =*#-B7%
MK\%[&8'"8V24F1CX$:,^4&Z>]II*%=IL+BXZ5)1D*XEU+*Z3J#6#S*F%342W
MWB8ZRM':X04]2E)OT]U03)U9(MWUI.X:KF=;,DPSDV4I:D@$]CC:TNH) (N.
MY N/=4A.C*WPT/FF#AX&KIC:[ :Q\9$%G9O,==4EEI(;0M$< 76$@6[@$W\1
M4$O*?>A\99;7L'O6KY;(]\'/RG5XS,1G%"44.H+9<6+#M6.U*K GK>@<JG7Q
M4+F[6\8UKD5G7\\Q"0&,9L$EYY"TM#HCSF^A44)L.GZ:O&@]EDWXUTE6AZW]
MDOS$S\A,E.S\I);!2VI]X)20VDVLD)0D> OXV%[4(DZLL"I(*EY$TG,[1L_&
MN8QBHZ8FIY0S,H'EE"RV7XKGZV E7<;,J\2/94%HNB9;525% 45&U#?M!RN8
M7H*<9F=9SDI<U6#R"UL.1'UCXBTM-DE)L!^  6Z=Q@M5/:9/5N.\D].VC9-_
MD1LAG-LAJQLB%#[OEXL%:0E3*%*ZDJ %S[+>)N30.7 PV&P'+6@Q7->UP8;:
M=>94X<)(R#KC$F,A:BH-NA/:% $DV!_1 LD"6TR5:1I6=P<38LALF:^V-FV<
MJ<F>6I7RC'17:VRE0%A=74]H]@ Z7(JW4CV(X[S\'AR?HCRHAS<EN2AM27%%
MB[KY<3=?8#X'K\-"<V-3OYK0=DE:?HD7"9E&)VK28L,,DK68;[C#+2'&W0D?
M$GN;NDE)]UNM I*I@]@UWE;D& UK6R1<%KN#=>:<RTZ&XX^^XEI84 RA5PGJ
M >I_1]E"4TB5;]/V/6F](;UB6Q$QJLI$Q>2BNI2X\^T\XTTTAD+2HDA/<200
M;=:$+$M6I*E/;WIFS2MMUW?M/=AOYG!1UPWL5D"I++S"_,!*%)^JJSJ@?#V=
M>EC!9-4HR,;IIG*?(V"?AYA_#X!N*M#V/P<1;COS#Z5!)5)?((2E*"HI"0>O
MC[*$II$NVW3L]L*^,'VOE6WM5RL*?FT*<(':SY1<#1"3W&Z3:]J$)TJ37;]7
M@[EKN1UW(+4TQ/0.R0@ J:<0H+;< /CVJ Z>T=*DJG0JR+$YTQ.*3KD8:_D3
M':$:#M+SSJ74M@=J5N-D'N6D6Z]I^GN]L%_9+$T'4G--UYG%2<H]F9[CBI.0
MR#RE*[G5@ I;"B2$)"0 +^\^VI*R=3.Y_"0MCPN2P61250LHPIAXI-E)[O!2
M3[TFQ'TBA"="G<3BN:-2QB-8Q0P&?Q\% 8PN<EK=9=:9'1"76AX]@Z "]O>J
MH+MQ9+-%T%[4L/G!-R'VOLFS..2LYD[%*5O+"K)3?KVI*B;GQ)/0>%"K=3]X
MEU+*Z3J#6#S*F%342WWB8ZRM':X04]2E)OT]U!)U9$N.]%W'6H>6T?8&<5D-
M%EM3$HFLJ<^;<,FR.U0) "2B]QVW!/11%"TFGB?.&P'+6@Q7->UP8;:=>94X
M<)(R#KC$F,A:BH-NA/:% $DV!_1 LD VF2K2-*SN#B;%D-DS7VQLVSE3DSRU
M*^48Z*[6V4J L+JZGM'L '2Y%6ZG=XKU;)Z;IF/P&7+*IT5V0MPQUE;=G75+
M391"3X'W40DZLZ^F:EE<#M_(V<G*8,+:I<1[&!I94L)8#P5Y@*0$G]<%K$T#
M=4BS*D@U2U1C=VM_Y4RNFN09?D9M3&3P604MMN0E:W2AQMQ/U5MD'QZ$$U!D
M=**I9VKZ7LTO;E;_ +Y)A_:\>,J'@<+CRI3$)I?<%**U=5+(4H=+^)Z^ 2*M
MJE$9/3-2RN!V_D;.3E,&%M4N(]C TLJ6$L!X*\P%("3^N"UB:$-U2.EN^C9N
M;L&*WG2I[$':<4U\J_&F=WRLR,23Y;G8"0?B/^YU! -"4]S,!.UGE#?)F*B[
M8] U37,<^F3-CXB0XN5+6D6"?,O\*;$CQZ7O91M835+86;N^M-[;J>;UY78E
M<^,4PUJ^JA]%ELJ-O8%I%[>RI*IT9%N*-'R6FXG)N9^0U,V/.S#)R<II9<24
M(':TCN4E)-A<^'ZJH)DZF-V'2=JQ6WR-[X^E0S-RC*6=AP&1*DQY/8 E"T*1
MX*L!XVZ];]2*!-4HSBAZMR#M&TXC/[O+B8/$Z\KS<=KV)><67WKA7=(6; IN
MD7%S<"W:+DD*I+ S\/4LJQROEMT6IC['FX%.-92%GSO.#K*^J.VW;9L];T(K
MA0;SJ.5V+8N/<ICU,"-J^45,R0=64J+9+1_6P$FY^ ^)% G2IB.0]3V^9M&J
M[KI9Q\C*:ZU)85C\B5I;6F0DH[@4E-_A6JX[D^RUZ$Q:I1GQLND;6]FL+O\
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MP4I^($DD4#E5U.MI^E[6[IN3X^WR/C1@40TP\3,QRUJ?5\2EE:ROX;H/:4?
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M2E$V]GA4E&ZDAH!0"@% * 4 H!0"@% * 4 H"M.:/S.\L?R-SO\ %[]9M/\
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M9""XM9/7_OB; #KUZBA*5284(% * PNQYV+K.#R>?FMNO1<6PI]YID N* Z
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M7D')Y4KS$*29 [0GPM^LC].H)IA4L>I(% * 4 H!0"@% * 4 H!0'CQ]X?\
MGZX)_:4?^-*]#RCX-S\;CC<R^-:Z_6CV'KSQV10"@% 1S;<EFL3K^0R&O8G[
M<S$?ROD\7<CS>]U"%]1U^%!*OT*!&:ANOO0XCTEGY>2ZRVN0Q_@+4D%2?T#T
MH#LT!!.1MT3H6L/YT0_GY)>;BP8A44I6\[>W<0";  GIX^%"8JK()D]_Y#U;
M#8_);9KF*BR,KFH.,B18SRU=K<AMY;JUD+7\22VD  VZFH)44]A>U25% * 4
M H!0"@% * 4!#]ZW&'HFNR=@FQ79J&5H99BLE*5+<<-D@J5T2/>;'\!J"4JD
MPJ2!0"@% * 4!U,A-9QL"=D9%_EX$=V2_P!O4]C22M5OT!0%3<?;IONZO0\U
M(UW&XS2YQD?+R0\I<PAKO0GX>ZQ_7$V)[1]'OJ"TDD7)4E10"@,!M.Q1-3U_
M)[#.:=?BXQL..,L@%Q14I*$@=Q ZJ4/;0)5.]B,@,MB<7E0UY R<1B4&">[L
M\YM*^WNL+VO:]J!F1H!0"@% * 4!"-1W>)N>N2MDQT-V+%;>DM1FI!'>L,#H
MI03<)[O<";>^H):H<?&^VR=WU.#L4N(U!?ENOH5&945( :<4@6*NO6U!)49.
MZD@4 H"'ZGN,/;G-B3"B.QFM?R;F,6X\4]SKC0'>H)3>PN;#KU\>GA4$M4)A
M4D"@% * 4 H!0"@% * 4 H"'[UN,/1-=D[!-BNS4,K0RS%9*4J6XX;)!4KHD
M>\V/X#4$I5)A4D"@% * 4 H!0"@% * 4 H!0"@.EDGY4;'9"3!C_ #DV/&=<
MAQ/#S74()0C_ (R@!0&.U>?E\I@<=/SN,^QLM(0HS,9<GRE!:D@7/7JD _HT
M#,]0"@% * 4 H!0"@% * 4 H"'P-QAY'<L]IK$5U,K7HK$B;,64A"E2$I6E#
M8%R;)6"2;=>EO;0FF%284((?/W*'!W+!:5\J\[/S45Z8)5TAIIII+A^DJ42V
M1:P]]_90FF%3'2]RE1^2\9HJ832HD["JRBYQ4KS$K#CJ.P)\+?K8J!3"I8-2
M0* 4!#]BW&'KV:U/!/179,S;93L>(M!2EMI+(07%K)Z_]\38 =>O44)2J3"A
M!$]JRVPXK[$^P,)]M?/9%J-E.I'RT9=^]_H?U-02D2RI(% * 4 H!0"@% *
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M6(+"%)/G%T!224]3;\ \2!08TQ);D_\ :%U[^22_V>30JO='-W_JW_E;!_\
MC48AO(GR-B,'A>4H&T;IATY+2\_CTP),U:%N-Q)B" A:PCJ/A2/T"JU[4)B\
M,#J9Y[B!,K#XC1M,Q>[9[+2$H$&,IQ+33)![G''D]P38VN+=!<JM;J)5=Y)^
M79L+ [AP]E\@OY/$8N;.$N4$J6AH%,8)![03X)/L]E"([&?>UY"'E>4.%LGC
MWTRH,]J>_$D)! 6VMD%*@" 1<>\4"V,R'/61RT#5<<F%(E0<1,R;+&S9&&"7
MFH:@;CIX!1\>HN;)\%6HR(;2O<U#X/Q6M9!C48$39]ER$)YG$,-%Z?)\YQL@
M/+2LJ2WY=^]1(3:WOH66:N)F\5_TKTT.IC@O*1BI86E()(\J6X5W'T $_@H1
M_,=#/[+A,]Z=Y43%3TRY."Q6"AY9D)6E3+R'HJ"D]P%^J#U%Q0E*DC-\F_Z
MX;_?W$?L0HR([66+RY^;;;_V@?\ EIH5CM*IV2!D8VD\)[SCX;N1;T>'CY&3
M@L"[JHC\:-YJDCZ U8^Z]_ &A9;6C([[S%J68TK-XW5Y;^:RN7QS[2HC,=Y)
MCL+;(?=?*T )2A!-[$]?HZT"BZEH\8_F]TS]Z(O[&*(K+:9K;&W'M5V9EE"G
M77<5-0TVD74I2F%@  >))J2%M->-6V3"9'@7-8&'/2]E\-@)IR<'M6%-!QQT
MI-RD)(((\":@R->T7;QC^;W3/WHB_L8HBDMI1VF8"5L_$_*F$@I"YLS9,@J(
MV3;O<93%>0B_@.XHMUH7;HT<&HO\&.:W%&U8G'8?8L2P(^>@34.HD&0P.QQ2
M4>*BLB]D]1>UJ!YJX%G\/+QDV!F\QAM*:U'$3Y26\8^E2O,GL,E?8ZM"A\(
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M'C>-%;$5Z05*:$]2FR4LJ4$W 'F D#J.V]^A(2V8[3K<3;OK>CXS9-8V[(#
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MPV2=:D9'$0I[[/1EZ3';=6CK?X5+22.ONH*G<1%BMO*DHC-(D*0&U2$H2%E
M\$E0%[#W4!^,1(L7S?EHS4;SEEQ[RD)1WK/BI7:!<GWF@#<2*T\]):C--2)%
MOF'T(2E;EO#N4!<V^F@'RD7YGYSY9KYOL\OYKL3YG9X]O?:]OHO0'#/Q>,RC
M:&LGCHN1:;/<AN4RAY*3[P%@@4!S18D2"PB+"BM0XS?1N.PA+:$_@2D "@/U
MJ+%8=??9C-,O2B#)>0A*5.%-[%9 NJUSXT!ST!UY42).87%FQ6ID9SHY'?0E
MQ"OPI4"#0'"WB\8TW$::QT5MJ ;P6DLH"63XW; %D_H4%3ZFX^!DFOE\C!CS
MV+W\F2TAU%_?VK!% (.-QV,:+&-@1\>P3W%F,TAI%S[>U  O0'%/P^(ROE_:
MF+AY+RO\E\TPV]V_@[TFU!4[4:+&A,HC0X[42.T+-L,H2VA(^A*0 * Z<O"8
M;(2&Y<_$0ILIFWDR9$=MQQ%C<=JE))%C[J"IW$18S;SDEN.TB0ZD(=?2A(6I
M*? %0%R![* ZL_#XG*AL93%Q,D&KEH2F&WNV_CV]Z3:@J=J-&C0V41HD=J+'
M:%FV&4!"$CW!*0 * C&+UA4/:]@VB0\RM[*,QX4&.PWY8;CLW<473<][BW%F
MY]P%":X4)=0@X&HL5AU]]F,TR]*(,EY"$I4X4WL5D"ZK7/C0'4GX;$97RSE,
M5#R1:_R1E,-O=OX.])M05.ZQ'8BLMQXS+<:.T.UIAI(0A(]R4I  H#'2,!@I
M<H3I>%@2IHM:8[&:6[T\/C4DJZ?AH*G>^3B&2)IBLF8$]@E]B?-"?\'OM>WT
M7H#KS\1BLJEM.4QD3)):-VDRF6W@DGV@+!M05.5N!!9=0^U"8:?;;#+;R&TI
M6EL>" H"X3]% ?;<2(RI];,5II<H]TI:$)27#UZK('Q'K[: _8\:-#:#$2.U
M%8224LLH"$ GJ;)2 .M <*X+(1.,1#<&7.00[-:;2'"NQ"5J-OB*;W%Z HR%
ML'(^%:3CMPXY=W;+PGEC'[)"^6\MY!)4@D);_6K>%[ ^%Q?Q@O1;F2;C/5L_
MCINU;=M;3<//;A);=7BVEAP16&>X-ME:20395C8GH![;T(D]R+:J2IT)&*Q<
MN2Q,E8V+)F1B#&E.LH6XV1U!0M0)3^@: _9^+QF4;0UD\=%R+39[D-RF4/)2
M?> L$"@.:+$B06$1845J'&;Z-QV$);0G\"4@ 4!V* X$Q8J)#DM$9I,IU(0[
M)"$AQ21X JM<@6H#\8B18OF_+1FHWG++CWE(2CO6?%2NT"Y/O- &XD5IYZ2U
M&::D2+?,/H0E*W+>'<H"YM]- /E(OS/SGRS7S?9Y?S78GS.SQ[>^U[?1>@/U
MF+%CK>=8C-,N25=\AQM"4J<5[UD $GK[: )BQ42'):(S293J0AV2$)#BDCP!
M5:Y M0!46*N0W+7&:5*:24-22A)<2D^("K7 -Z Z\_%8O*H0WE,;%R3;1*FV
MY3*'DI)\2 L&U!4Y&\? :,534&.VJ"DHA%+2 64D6*6[#X01TL* Y$18K;[L
MIN,TB4^ 'Y*4)#BPD6 4H"YL!TO0'XY$BNO,R78S3LB/?Y=]:$J6W?Q[5$7%
M_HH#\EPX<]A<6=%9FQG/\I'?0EQ"K>]*@0: XX.,QN+;4SC,?&QS*CW*:C-(
M923[R$ "@.7Y2+\S\Y\LU\WV>7\UV)\SL\>WOM>WT7H#AGXO&91M#63QT7(M
M-GN0W*90\E)]X"P0* YHL2)!81%A16H<9OHW'80EM"?P)2 !0%+Y/(\A:_F\
MXSF=37R)JDZ09&OKBIC^;#0I2E>0MHH[E=MP I5_#ZQ\!!;!G[JN V?8=[1R
M#LV&3J\/%8XXW6\ 7$N/!"N[N<<[+!/1:A:P/ATL+D&TE0NA$6*V^[*;C-(E
M/@!^2E"0XL)%@%* N; =+U)4ZL_#XC*^6,IBX>2\F_E?-,-O=M_'M[TFU!4[
MK++4=IMAAI#++20EIEM(2E*1X  6 % 8UO 8)F8<BUA8#60*BLSD1FDO%1\3
MY@3W7_1H*G<1!A-N2'40V$.RQ:4ZEM(4Z/\ '(%U?HT!\_9V/^4^0^1C_(__
M )%Y2/)^MW_4MV_6Z^'C0$0W;8-DUV)#3J^H.[._+2ZT RZ&D15I"0TI:>PW
M2;GP(M;Z;B"4DSK<8:C)T_5VXN3*7,[E'W,CGG4D*O)?()3W#H>Q(">G2]R/
M&@DZLL2I(/AQMMYM;3K:76G 4N-K 4E0/B"#T(H#H0,-A\47#B\3#QI= #IB
ML-L]UO#N[$B]!4[,N'#GL+BSHK,V,Y_E([Z$N(5;WI4"#0''!QF-Q;:F<9CX
MV.94>Y349I#*2?>0@ 4!S&+%5)3,5&:,M"/+1**$^8$7)[0NU[=3TO0'!/QF
M-RC:6<GCXV1:0>Y#4II#R0?> L$ T!]-8['L*CK9@1V5Q4>5%6AI"2VCK\*"
M!\(Z^ H#N4 H!0"@% * 4 H!0"@% * \>/O#_P _7!/[2C_QI7H>4?!N?C<<
M;F7QK77ZT>P]>>.R* 4 H#AD1X\ME<>4PW)8<MYC+J0M"K$$72H$&Q%Z ^'(
M<-[Y?S8C+ORB@N+WMI5Y2D^!1<?"1;I:@.1]AB2TMB2RB0PX+.,N)"T*%[]4
MFX- <3T&#)81%D0V'XS=O+CN-I4VGM%DV200+#PH#[D18LM*$2HS4E#:PXVE
MU"5A*Q>R@% V(OXT!Q3<=C\FS\ODH,?(1[A7D26D.HN/ ]JP1>@.)O#XEJ']
MGM8N(U *N[Y%##:6>[W^6$]M^GNH*G85"AK<CO*B,J>B"T5TMI*F@18A!M=/
M3W4!^OQ(LKROF8S4GR5AQGS4)7V+'@I/<#8CWB@/V1&C3&BQ+CM2F%$%3+R
MM!(ZBZ5 CI0'XY$B/*86]%:=7%/=%6M"5%L].J"1\)Z>R@/V1%BRT!J7&:E-
MI4%I;>0E:0H>! 4"+B@/I]AB2TMB2RB0PX+.,N)"T*%[]4FX- <3T*%)BF%(
MB,R(2DA!B.-I6T4CH$]A!38>ZU =>+A</"CO1(6)AQ(LCI(C,L-MMN?\)*4@
M'Q]M!4[0AQ!&^2$5D0^WL^4[$^5VG]3V6M;Z+4!QPL=C\<Q\KCX,>!%N5?+1
MVD--W5XGM0 +F@.K&P&"AR3-B86!%F*)*I;,9I#I*O'XTI!Z_AH*G?D18LM
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M""#X@T!UC @&)\@83!@V ^3+:?*L#W#X+=OCU\/&@.TE*4)2A"0E"0 E(%@
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M#P(/4&@/J@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MX ;=ZK_53<'KU\#8=#80HU,-BN4N[-P-?VW5LAI<_+J[,0]+4EZ-(7TLV'D
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M:B0D6)N#>W2XG(?D+FV!D&'H<75LN_N,>0N,]IS;?<^A38NMQ;E@E+:3T*B
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MC]A<H%[S-KJDQE&<W?\ JW_E;!_^-4,M#>=3D4(<Y<XB:R%CC N6J,%V[3*
M!3^CWAO_ '*$QV,L3DY,-7'NYB=V>0,1**._P\X-DL?H^9VV^FA6.TZ?$9E'
MC;4#,[O-^0 1W>/E!:@S^AY?;:@EM(=ZAD)=TC'-K'<AS.PTK3X7!0Z#X49,
M-I*>8?.8XPVM,%/EJ3#;1V(Z ,EUM+@  \/+O0B.TA6EP>6AJ.M?867U-.'.
M-C''I6Q*+GEEL$>84].__"_QKT+.E3]T;6&($3E1K:-JP4V#L+BAGFL7("&L
M>XZ)")/FARWDD]XMW']3]% WLH8[%8'E[3\9%1IN<P^^:FAH+Q4*2 AQ4=?Q
M)"%@I!!!Z?KI'T6Z4%4]IT-DVK'[;P%M$Z!A6]>5"E1H,_$LI2EMJ0W-BJ5V
M=J4="%I/AT\/9>A*5)&PVOMX]&MX5J$&_LP8V.(P%O++'E)[?HL4U)C9I>XJ
M0."]@3$*_L=6YJ2P4^'R78V4VO;X?, M]-09?YC>*$B(B%$;@I1\@EAM,-*.
MJ/)"0$!/T=MK5)B-4-0L.+^;40[?8B9V3&)*/\GV^5U[/H[.RH,CVHOOBQEI
MCCK3D-(#:58MAPI'^$X.]9_14HFB*2VFNV-3(1P=RVF"DI6G9I [6Q:S(<@A
MWH/8&^Z_T4,C]Y&SNCIB?D5J:8808GV/"#03:Q'D(O>WMOX_34F-[2K.!$Q4
M0M\1![?DD[/*$/L^KY02GL[?H[;6J$3/<7[4E2AN)O-^V.9O(ZO_ )53O)'3
MZ_F/=OCT\:@O+</3J(_Y O.(L9KN5E*R:C]<O61;N]M^SMHA/:<.8"4^H?4C
M MYKF ?^V_+_ /DPB3Y9<M[>X(\?H^B@7NE_U)0HS1/SO<O?^;?V(U!9[$<7
MIZ:;1I^9=2@!Q[/S"ZOVJ[4- ?I"B$]I^<3,LIWCF9Y+:0Z<ZE)6!UMWR%$?
MHDW-!+8CDP  Y]WJPM? Q"?IZ1J!^Z?'"#+27N2Y 0 \[M4MMQSVE*#=(_0*
MS^G1">X_-#89_ICY;>\M(=;3 0A8'4!QL*6/^,4@F@>Q'* !ZA20+7U*Y^G]
M?M0?RCA[_6#E_P#E;+_97:"6XZ4125>HS)A*@HHUM*5@&]C^M&Q]W0@T)_E.
MSQFRTKD[F>04 O-38+;;GM"5A\J'Z)0/TJ"6Q'WGDI'/^CJ[1W' 2@56ZD 2
M;"_T7-"%[I!=)8WR1N_*[NKS\)%FC.N(R2,JV\X[Y0>?\CRBV!\%KCK[A0LZ
M41)9VM[G+WO1,MMNU:M#GXJ2M6/AQ%.QY4ME12'FD)=OYG3H /\ "-"*JF!L
M54E"C,G_ +0NO?R27^SR:@LO=.* TTYZA\VMQ 6J/JB'&5']2HNQT7'_ !5$
M?HT)_E/KE="?RVX97VCO&=6D+MUL51S:_P"A0B.QD4R;6UR>>L\-=EXN+DX^
M#9^SSET.N-F.4L^9Y(;%POO*OT.[Z:$X93L[_K/(N;QN.8VW;M.PT>/D&G\;
M/)?BK$I"5]B4..@BY%S;VVH(M+89_8V6GN?="\U 7Y6#E.-@];* DV/Z%^E"
M%[K))RELF.P4?7HJ]:C[5L.7R"6M6QTE*"E$E*D?KO>L$H[2I(Z6\?$"YH(J
MI -\3RY(TK9)>S3];PF&3!694""T\^^X%6"6BMWN2DJ)">Y)\>HH2J5,5NOE
MGT]:@'B0R6\3YI'B$VZV_0H2O>-E9+>+3A9#+J6AA4PEH<0FWE"*&R"![.WL
M_P!RI,9I\W\Q_9ED>=W>6,H/E+^'E_.IO;Z._NJ#+_,3?D=&9?Y"XD8Q;\*-
M(^3=7B7LDE:XHE!-_B2@7N>U 3;]5:A6.QF;W+ \I9;6LIC]GV+386#DH0F=
M,<1)92V/,24*\QRZ4D+M8F@353LYW3XV8U?CC&IW>'C=QP;#*M5R[+R'$3%M
MM("BTDE*G$J"$GN /T@WH$\68',[/R7H[,21R5@<-N.L,RVPYF(J4>:RX20E
MT-J2E(4 3;];'7IW"] DGL-E6W$.MMNMGN;<2%H5X7!%P>M24/N@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \>/O#_P _
M7!/[2C_QI7H>4?!N?C<<;F7QK77ZT>P]>>.R* 4 H"B_4.71Q[9*EIC+RD09
M#R[7+/QGK?\ QPFWTVJ&6AM+E6C'?9:FUI:.)^5*5(L/*^7[+$6\.WL_W*DJ
M:V9A_5IV_<+?8"8HTWS)YQ2([?E1_FPJY[4$)^+S0B_3Q^FH,BK1ET<G)AJX
M]W,3NSR!B)11W^'G!LEC]'S.VWTT*1VFOFR-O2.$N)&<B@K\[.8]M2%WZL%$
MM+8_ 6^VWT4+KWF; \GH0>.]R24@I&)DD)(Z I02/TB*,I':4+G@#JGIV$S_
M $*9^/\ M(J_R5[,]O??V=O?^A>A=;67]R8B*OCW<Q,[?)&'EJ1W^'FI;)9_
M1\P)M]-"D=IK]MO^S=K'X8?[(Y0NO>-B>05H3H.ZJ4M*4JP.1 42 "51G D7
M^DFPH4CM-:L\71Z;M3"5+3&7-:&0\NURS\S(/6_^.$V^FU"Z]XVV6C'?9:FU
MI:.)^5*5(L/*^7[+$6\.WL_W*DQFN_(,C696!XK=T\1DZ_\ E=%$),1ORF@>
M]?F=J"E-CWWOT\:AEU7&I(>7&E:YG-'Y+CI-L!.3C\XI/4F#*NDD_P#![E@?
M2H4(CC@,!V[IS%L&PFSV(T&*G#XA?BDS'>[SUCQ!*;K2;>SMH'@B$ZNSO,GD
MKE=W6)V%BY!&10W+&7;><<,8+=#'D^6!9/:!W?\ %H6=*(S^8UO=Y^WZ#D-N
MVO5(,K$9)+V-C1E.QI,MLN->>RT'0?,*D@  >_Z:$)JCH;&U)0HS>_SO<0_^
M<OV(5!9;&=1T(<]14<9"Q\G62<&%V^MW*[BCZ;%W_=H3_*9;G],,\8YDR>SS
MT2(9QW=X^=\P@'M^GRRO]"]&1#:6AKQE*P&#5.[OG3CXQF=WUO-\I/??Z>Z]
M2593W+K+4C<.&VGD!QM6?)4A74&RXY%Q[>HJ"T=C.7U$*D#CIP-=P87DH@G=
MO_R5U$7O_CA-&(;2ZH2(B(41N"E'R"6&TPTHZH\D) 0$_1VVM4E3437K#BGF
MI$.WV(G+2AB2C_)]MV[]GT=G94&1[4;+<?(B-Z+IZ8/;\M]CPB@I]I4RDJ)M
M[2HF_P!-24EM->M;#:= Y[3!O]C(R64&+ MV=H0KZMNGU.RH+O:B^>,B/Z/-
M--Q88B-<_@;%$4EM*5XCAX3+<4;W!SV0:QV%GYV8U)R3CJ&D-!QB*&W/,60@
M644VOT)H7EM1DXV+YET[$MLXB?A^0]48B@1(<A/8\J&$=$I^KW H\ 5KZ= /
M90BJ9V-BV;&[;P'F\OB\:C#1RRAES%-A(;8<;E-A:4=J4@I)Z@@#Q]] E21<
M^G?ZHZM^]$'_ #=%24>TZF]YK#:_J>9RV?@-Y3%QFDA[&.H0XF0I:TH;;*7
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MAND/O-K4IP?2>OM!!ZT)S4V(NB-'8AQV(D5E$>-%;2S'8;':A#: $I2D#P
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M$YV'5I.;S&JY.-GI6(8UN0M^1CH_<&IJ5%HAMVRTBR?+(%P?$T(3)C4D"@%
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M)\ORP0J][T(<JNI&F.*MOA8_[ @<KY&/K8066\>J"RY(0P;CRTRRL+2+&PL
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MN2ZSUBK@G9% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MK77ZT>P]>>.R* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * B>3T74LUFXNQ97!L3\O"0E$:4\5J 2@E2;M]WEJL22"4F
MH)JR65) H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@*TYH_,[RQ_(W._Q>_6;3_%CUKTE+GN
MOJ/Y8:]V>'/8?[K+_0_-'[<P7['.KSG/?>AY?4>BY-[DNL]8JX)V10"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * K3FC\SO+'\C<[_%[]9M/\6/6O24N>
MZ^H_EAKW9X<]A_NLO]#\T?MS!?L<ZO.<]]Z'E]1Z+DWN2ZSUBK@G9% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@/'C[P_\_7!/[2C_P :5Z'E'P;GXW'&YE\:UU^M
M'L/7GCLB@% * J3FK9,IKFE'[%=5'R><G,XF+*;N%ME]*U*4@CJ%%+9 (ZB]
MQUJ"T%5G03P-H9P8Q[D-U684U=S9/.=,KYFUR^+K[?K=>VUO]^E!G974*3^6
MG"VU-;6C[5S&AN38\.>XI7?YD=F[3I*2.Y0"RGXKWM<]:%MDC+-:]AL/Z?\
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@*TYH_,[RQ_(W._P 7OUFT_P 6/6O24N>Z^H_EAKW9X<]A_NLO]#\T
M?MS!?L<ZO.<]]Z'E]1Z+DWN2ZSUBK@G9% * 4 H!0"@% * 4 H!0"@% * 4
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M\OJ/1<F]R76>L5<$[(H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!X\?>'_GZX)_:4
M?^-*]#RCX-S\;CC<R^-:Z_6CV'KSQV10"@% * 4 H!0"@% * 4 H!0"@% *
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MRF+R,;,8S'9:&5&'E(K,N(5CM46WT!Q%Q[#90Z4#.]0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MJW@>HO<4&7&A&3MW,R,&C;AK&NR<*N.F<,*P])5D?EE(#G<%]Q;)[3>P%_\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M*,VW_9NUC\,/]D<H77O%Y<M)2GC7;DI 2E, A*1T  4GH*%([3]U\ <1X4
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M% * \>/O#_S]<$_M*/\ QI7H>4?!N?C<<;F7QK77ZT>P]>>.R* 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MI*U*_P =PAH^/=2XL9#),L!7R4&;*4['CJ4" IMNP%T@]";V\?&H+9V8GE7
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M?54GQ]EB"" 00;@]1UH$Z%5HX,TM*41G96:DXEM86G NY!PP^AN!V"RK=/\
M"J*%L[,SR5JS&9T.5KN.Q#DI2$LLX3'Q%)90RZ"&V5JN0 VU?N4/\$4(B\2?
M8V*J!CH$%2PXJ'&:84X!8*+: FX'TVJ2&=V@% * 4 H!0"@% * \>/O#_P _
M7!/[2C_QI7H>4?!N?C<<;F7QK77ZT>P]>>.R* 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MDAQ )L"IM82H ^PD4(::.38-LUO56&Y&PYB-BT/$AE+ROC<MX]C:;K5;VV%
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M0'CQ]X?^?K@G]I1_XTKT/*/@W/QN.-S+XUKK]:/8>O/'9% * 4 H!0"@% *
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M\*UJ=+99V":VIJ&2 U"$IU*'4L=J0I(+?P]3[![?$2G5XG0U[(8G$ZO#U_\
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M6CV'KSQV10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MX62E))3;O'C0-U2&6U?,R^6M6VMB.E6$Q>)D1)DDN("DNN![M 03W&_>.H%
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M!TJ+(CJ,EQ[(-SGY2D#O;9:\D!+86L *4L]!>@5$=;9-&VO+\,8+46<<@;#
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * K3FC\SO+'\C<[_%[]9M
M/\6/6O24N>Z^H_EAKW9X<]A_NLO]#\T?MS!?L<ZO.<]]Z'E]1Z+DWN2ZSUBK
M@G9% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0%:<T?F=Y8_D;G?XO?K-I_BQZUZ2ESW7U
M'\L->[/#GL/]UE_H?FC]N8+]CG5YSGOO0\OJ/1<F]R76>L5<$[(H!0"@% *
M4 H!0"@% 07?MT_(?'X>=]F_:GVMEX^*\KSO(\OST.*\R_8Y>WE^%AX^-03%
M5)U4D"@(MLFW8S6']?BST/.R-ER3&,QS;*0?UQY:4=RR2 $I[KGV^X4)2J2F
MA H!0"@% * C&X9W(ZW@I.6Q6OR=GFL+:2WAXG>'7 M82HCL;=5\(-S\-0$J
MDC96IUEIQ;9:6XA*E-'Q22+D'P\*D')0"@% * 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0%:<T?F=Y8_D;G?XO?K-I
M_BQZUZ2ESW7U'\L->[/#GL/]UE_H?FC]N8+]CG5YSGOO0\OJ/1<F]R76>L5<
M$[(H!0"@-<L]EN0LYRCL6BZUL P\!,"-*7.6TEPPV@VV5EH  E3CBTCJKH+V
MJ"Z2I4[^>SF\:\UIW'&-SK68WO8E2%2=DDM)"6(K:EJ#@;[;$A"3]8*^JKQ)
M% DGB<.RL<B<9XT;:C=G=QQD!QK[?PN0C-M][3BPV5LK25*005#H/#Q-P+4"
MH\#/[[O>4#&GX31G&AGM_"7,9D'TA2(T0H2X7BD]PO95Q<$6"NA-J$)<2(;M
M#Y2X]UF?GH6_.;&PE"6\HU+B-H<CEQ00A^.H%=NU2@"D]+=>OL$JC9GMPVK8
M,=K?$\V%DEL2M@R.*9S#P2@E]N0R%.I(*2!W'KTM1D)8LF_*67R.!T'8\MB9
M2H61ALM*C2DA*B@J?;22 H$>!(ZBA$55E3\DS962XQXDR,YXR)L_*X&3,?(
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MA%"4J2/WD#_U"?O[BO\ Q%!'>=W<]HS4_D1G1&-N:T'%-8Y$U>54ALO3'5J
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M:BV4J'4$%^-U% _=(!BQA-]VK=1R;M3^-5ALBY%QFK.SA CHC(4I(58E/?X
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * K
M3FC\SO+'\C<[_%[]9M/\6/6O24N>Z^H_EAKW9X<]A_NLO]#\T?MS!?L<ZO.<
M]]Z'E]1Z+DWN2ZSUBK@G9% * 4!T6\7C&L@_EFL=%;RDIL-2<DAE"9#C:;60
MMT#N4!VBP)]E <\J+&FQW8DR.U+BOI['XSR$N-K2?8I*@01^&@(_C-*U#"RQ
M/Q.LXW'S4@A$IB,VAQ(/CVJ";IO]%035F Y#E[ECFL1D-8Q;>P8QAY:=HU_L
M0MZ3&7V6+7<";ILH6%[]W@0*"-"H<ZX_N6(EZAHG%,[47<\XRWG<W/QK.,9:
M:;<2ZNZD?Y0W2.GC;P%Z%UABV;'Q</"8PL3!/,MSH$:(U"4R^@+0XVT@( 6A
M5P;@=0:DQU,9!TG3\8B8W UC%Q6\@T69R$16K.M*\6UCMZI/M!Z5!-691_!X
M65$A8^5AX4F!C5-KQT)V.VMF.IE/8V6FU)*4%"39/:!8>%214^,Q@,'L#"(^
M<Q$3+,M*[FFY;*'0A1\2GN![2;>R@3H=1G4-4CXYW$,ZUBT8M]:7'\=\HR67
M%I-TJ6@I(41[":@59D,AAL1EH/V9E,9%R&/';VPI#*'&AVBR2$*! *1X$>'L
MJ14_&<)AV,6G",XJ(WADH+8Q091\OV$]Q!:MVFY-STZGK05,;BM-U/!R#,P^
MMXW&RR+?-1XS:' #X@+";@'Z#0-MF7F8O&9%R&[D,=%G.X]X2,>[(90ZIAY)
M!#C16"4*! L1UH*G1V3,NZ_AI>79Q,S.*B%LJQL!'F2%I6M*"4(_5=O=W'Z
M:!*I6/'&(R^6V;9^2MBP[N#EYM+<'!8J2GM?8AM)2"IP$ @K*$^(OT/L(J"T
MGA0NJI*G2R&-QV6BK@Y6!&R<)PI+D.6TAYI12;I)0L%)L1<=* ^).)Q4QV"]
M,QD24]BU^9C'7F4+5'7T^)DJ!*#T'5-O"@J?60Q>,R[*(V5QT7)QT.)=1'EL
MH>0'$W[5A+@(!%S8T!R38,+)17H.1AL3X4@ /PY+:76E@$$!2%@I-B >HH#K
M2,+AI;,&/*Q,*3'Q:T.8UAUAM:(ZVA9M3*5)(04CH"FUJ"IS9#&X[+15P<K
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MRUK6Z6H"-0]$TO'3$Y"#JF*B34*[FI+41I*D*O>Z+)^$_2*@FK)74D"@% *
M4 H#QX^\/_/UP3^TH_\ &E>AY1\&Y^-QQN9?&M=?K1[#UYX[(H!0"@% * 4
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MI4)#B5.M!8!25H![D@@@BXH#MT H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0'CQ]X?^?K@G]I1_XTKT/*/@W/QN.-S+XUKK]:/8>O/'9%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M>#+2YL^/2A-W7G>ZSI<"4%1*@J]QT]YO>A$E0MNI*B@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4!X\?>'_GZX)_:4?^-*]#RCX-S\;CC<R^-:Z_6C
MV'KSQV10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"M.:/S.\L?R-SO\7OUFT_Q8]:
M])2Y[KZC^6&O=GASV'^ZR_T/S1^W,%^QSJ\YSWWH>7U'HN3>Y+K/6*N"=D4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \>/O#_S]<$_M*/_ !I7H>4?
M!N?C<<;F7QK77ZT>P]>>.R* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 5IS1^9WEC
M^1N=_B]^LVG^+'K7I*7/=?4?RPU[L\.>P_W67^A^:/VY@OV.=7G.>^]#R^H]
M%R;W)=9ZQ5P3LB@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'CQ]X?^?K@G]I1_P"-
M*]#RCX-S\;CC<R^-:Z_6CV'KSQV10"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"M.:
M/S.\L?R-SO\ %[]9M/\ %CUKTE+GNOJ/Y8:]V>'/8?[K+_0_-'[<P7['.KSG
M/?>AY?4>BY-[DNL]8JX)V10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#QX^\/_/UP
M3^TH_P#&E>AY1\&Y^-QQN9?&M=?K1[#UYX[(H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M'W']*GCPXCY>YP%C[C^E3QX<1\O<X"Q]Q_2IX\.(^7N<!8^X_I4\>'$?+W.
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M>T^U_ASZUZ#UGKR9Z@4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \<_O$OS]\$?M*
M/_&E>Q^W?\:[^-QY7GW^38Z_6CV,KQQZH4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* K/FG\SG+/\C,]_%[];.B^/;_N7I,.I^%+J?H/Y6:^JGRD]B_NKO]#\U?MS
M!?L<ZO&_=7O6^I^H]I]K_#GUKT'K/7DSU H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4!XY_>)?G[X(_:4?^-*]C]N_P"-=_&X\KS[_)L=?K1[&5XX]4* 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% 5GS3^9SEG^1F>_B]^MG1?'M_W+TF'4_"EU/T'\K-?
M53Y2>Q?W5W^A^:OVY@OV.=7C?NKWK?4_4>T^U_ASZUZ#UGKR9Z@4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * \<_O$OS]\$?M*/\ QI7L?MW_ !KOXW'E>??Y-CK]
M:/8RO''JA0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MP(#D:*[*4IX-J=(*6@2!VI/4U@T>ANZN3C;56E7;0RZK66M-%2N.B;IQ-?\
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MT62E=IL_4+/C>#7V^%'PKMV;"_GWV8S+TF2\B/'CH4Z^^ZH(0A"!=2E*-@
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M\B,AP1FE/N@..)";AM"E6^BM[5<GU.FMNY-*BZ4:FGYKI]1/)"57U-%@\O\
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M?LTK58FM?]X7Z8_^M&6_@>9_W%=/]NZS^E=J.=]=TG]7F?<2'4O7'Z>MVV?
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MM?9M6HW9/V94I@]ZJO,3[0M\U;DW4L/N^F9-.6UW.-%R#+"%-JNA1;<;<;6
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M0"@% * K/FG\SG+/\C,]_%[];.B^/;_N7I,.I^%+J?H/Y6:^JGRD]B_NKO\
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MC@?%8$[W@\;(R(D0<'/QS[$(J;B/K2]+BL(ZF2E!2%7(5X6O;@:^WS"W;_\
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M;@%7U05.UFY]HXW[:U5K'CU<?)L?\#'R34RL7'I;NW=^.G:C,^ES_M /4O\
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MG8S7ZU&;==5W.NI3\*3:]STN:]-#3SO\I5NVJR:7_E7>>9NWX6.:N<W2*_\
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M[I;;G\Q3=2JKQKN9Z(:AMOW<VR[5KN U+#:Q*VC,9&-$UZ.C6<JPI<QQQ*6
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MH4 H!0"@/![D+"9WUH^J#E6/K<MR1@]#P&5:UEQLA2%M89I;,)MOO(^&9D7
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ME,#3=[R-DI3=IE.+V95A;I8-Q9GZ%FOTLG^?ROC**\\>]>DQ?X7,_P#IG_\
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M;=A2]FRIUQ6'#ATG;T]G2VY5M**;X4J>9^6T/5.3?O'\]H^\8K[;U?-Y:?\
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MWER?\<QJ])]Q?XEKK7_BS@<C_P J]Y?2;5?>/?[.#W\IL7_O/5ROMO\ R_\
MM9T>?_XDNM>DLOT1_P"RWQ+^T\A_&<NM;G?^9<ZUZ$;'*?\ %M]1M'*BQIT:
M1"FQVID.8TMB7$?0EQIUIQ)2M"T*!"DJ!(((L17+3:=4=%JIXI_=X83$H]2?
M* &/9/Y/X3*#"*4GN,7_ .F<>/=HFY2?*447\;$CVU[7[BG+Y2WCM:KV,\ER
M*W%:J[1;*T[3VSKQ)ZTP^PY[&:M@<ULN:D")A]?@R,CE))Z^7'BMJ=<5;VV2
MD]*O;MNY)1CM;H5G-0BY/8C^?[B9'J7Y8YBW7U \-:G'S^SQ<K)?E3)KV.0Q
M!5E$.H:9:3D9#"5EN."V.WN[4VO:XO\ 0-7\II[$=/>E2--U<:=2>\\/I7J[
M]^6HLQ3=7MIA7K:W'QSWA_51I>]ZKS]S'JD?6=B8R,!G%9^ ]C5M/3,;=^.E
MY&.DOV5Y;?;=0'<E-NMC4\OGHKMJ6GLRJJ.J==CZTB-<M9;NQU%Z*336RF['
M<V;-_>&;GBN1.&/3WO.$4#C-J>E9&,CN[BWYT1E2VE&P^)M5T*Z>(-<O[=LR
MLZB[;EM6'G.G]P75=TUN<=C=?,2WUL\&3LAH&B^H70T.PMPX_P 5C/RF?A?K
M;ZX##:%QYR5)LKS(;EKJ%SY9N2$M"L/)-<HW9:>Y[LFZ=?#R^GK,W.M&Y0CJ
M+>$H>C^'H*E^[ZVS([WZJ>4=SS"6T9;:-0RV3R89':W\Q)R^+<=*$^P%1) ]
ME;GW#95G10@MBDEYI&CR.^[^MG<>UQ?IB<6D9W":W]Y%M^7V+,0<#B8V;V),
MC*9&0W%CMES'OH0%NO*2@=RB +GJ>E+]N4^4Q44VZ1V=9DLS4>:S;=-OH1M7
MZU_4/Q.C@G<--U_><'M>T[FTQC\=BL/-9GJ;;^8:=>>?,9:PTE+:%=O>1=5@
M+]:Y7).77WJ8SE%J,<:M4])T><:^U'3RBI)RDJ43KM)/]WOH^5TOTZXZ3EXJ
MX3^[YF9LD6.Z"E?RK[4>+'60? .-Q0XGWI4#[:Q?<-^-W5-+^5)>EOTE^16'
M:TJJJ.3;[O,C>&N&=@\F?O4/]#\*_MS._L<&O6_:OO7.I>L\S]S?#AUOT'I=
MQA^;7CS^3.)_S-JO,ZGXL_[GZ3T=KW%U(\>96G:SO_WD^:U'<<.SGM<RV6R/
MVCB9!4&W?(UQV0UW=BDJ^%QM*A8^(KV*O3L\I4X.C26/_<>1E:C=YLXS54]W
M_8;0>K#TS\$:+Z?.2-KU+C7&8/8L1%AKQN584^7&5.3XS2RGO=4.J%J'4>VN
M5RGF>INZJ$)S;3KAY&=7F?+]/;TTY1@DTN!57!7_ &<?,'_ V/\ 8V:V]=_R
MUO\ [35T7_%RZI>LA7HCT;TP[-Q3L$_FI&H*VEG;)<> =@RC4*3]GI@P%-]C
M:Y#)+?FK=LJWCW"_2L_/+^LMWTK&;+E6Q5QJ^CJ,'([&FG8;NJ+>9[:;*(]
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MZ6WI]'"2E!03W4H:N^KW_;>]*G[<U7_[97*ZO)_^.O\ 5+_Q.5S?_-L=:_\
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MQE!#R8\]A<=TMJ4E0"@A9L2D]?8:R6;KM3C-;8M/LQ*7;:N0<'L::[2LN#>
M=(]/V#S.OZ-)RLF#G)PR$U66?:D.!T-): 0IIED!/:D="#6UKN87-9)2N4JE
M3 U]'HK>EBXVZT;KB1;D?TI<9\K<FX/E/<YN>GYG7OD4X[#)ELIQ@9@/%]#*
MF#'4LH<<4HN#S.O<>HK+IN:WM/9=J%$G7&F./E*7^76K]U79U;5*8X88FR]<
MPWC639/2?QELG,D+G5<W/8?>H4R#/"L;*8:B.OP$(;076EQW"H+;;"'!W?$+
M^^NG;YM>AIW8P<:-8[<?*:$^6VI7U?Q4UP.YQ?Z7.-^(^2-JY1U:7FWMDV^/
M.C95F?*9=BI1D)C4U[RFT,-J20XRD)NLV%QU\:C5<TO:FU&U.F6-*4Z%3B3I
M^76K%V5V-<TJUQXNI/>8.'M*YPTU_2-YBONXQ<EF9%F0UI:EQ9#!^%UAQ:'
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MVG&86,RQC<Q,=MDVG6&0R)293800ZL"ZR $J/BDCI6&QKKMBX[EMT;W;NJG
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MVEX/M)#J/W?'!>E[7K&XXC);8YEM3RT+,XQ$G(15LJD0'T2&@XE,-)*2M N
MH=/:*QWON'4W82@U&DDUL>_#B7M<BTUN:FJU33V\"W=B],/'.S<T8?G?(R\V
MC=,(Y#=AQV9+*8!5!1V-=[)84L]/&S@K3M\TNV].["IE=>O'RFW/06IWU>=<
MR,-NGI#XEWSEV'S1GCF%;7%F8R<N$S)93CWW<4&DL><RIA2U I90E8[Q<#V5
M>QSB_9L.Q&F6C73CY2EWEEF[>5Z2>94\VPDV\^G#0.0>6M*YFSLK,-;;H3<%
MK",1)#3<)2<?+>FL^<TIA:U7<?5W66+BWAXUBL<RNV;$K,:995KQQ5/49+N@
MMW+T;SKFCL\_>7[6@;@H!0"@% * 4 H!0"@% * 4 H"L^:?S.<L_R,SW\7OU
MLZ+X]O\ N7I,.I^%+J?H/Y6:^JGRD]B_NKO]#\U?MS!?L<ZO&_=7O6^I^H]I
M]K_#GUKT'K/7DSU H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!XY_>)?G[X(_:4?^
M-*]C]N_XUW\;CRO/O\FQU^M'L97CCU0H!0"@% * 4 H!0"@% * 4 H!0"@%
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M3Z7YC4QB]BQ?4OXT1U.::KY?3RDMNQ=;_%3R6X9WST]8'TQ\M<<;OG947?\
MDU:WT%K'27VHR\8D+PZ5.MH*2$R IQ1!^JLI]]>NUNGU4]9;NP7L0Z5O][S>
M@\OHK^EAI)VYRI*?0\*>[WFVGW8_*IR6M;CP]D9'?)UI[\H-:;425?(RUI:F
M-IZV"6GRA=K>+QKD?<^DRSC>6_!]:V>;T'3^V]5FMRM/;'%=3_CZ2@-%X:Q/
M.OJ,]96AY#L9R#LG:INKY-?_ /!Y1C8T_+O=/U)[BVL>U"E =;&NAJ-;+2:7
M37%L]FO2LN)I:;21U6HU-M\73H>9T95$CE[.8;TY\G>F#D)IV#L6F9V(_K#4
MDGS&PQD4)GXXDD@^6LEUNWBDN=;!-;:T<9:N&JM[))U[,'ZC6>KE'27--<PE
M%JG:JKR;N@VFY2:E.?=I<9+CH<4TP_C')Q1?M2T9LE *[>SS%('7VVKE:1KZ
MO/R^A'4U?_%1ZH^DW)]"<R!*]+7&+<!Q"S!&5CS6TGJW(^U);BTJ'L)[PK\!
M!]M<;GR:UDZ]'H1U.3-/20IP?I=2^M@Y6XVU/9\;INT;OA]<V;,14S,7BLG*
M1%5(96XIE);6Z4H45+0I(2%=Q(Z"M"WI+MR#G"+<5M:Q-V>HMPDHRDDWL39Y
M,_>;MNN\K\4-,.>2^[@%H9=ZCM6J<L)5T]QKUOVPZ6+E>/J/,_<:;NVDMN/I
M1:7]E?UT?_I3?_GW-_BU:GU7EWZ'FCWFW].U_P"OZ3?'@?3N1-#XXQNN<I;C
M^7>X1I4MV9L7S$B5YC3KJELH\V4A#A[$$#J.GLK@Z^]:O77*U'+'##_0[&DM
M7+=M1N2S2XEQUIFR* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M!&LIM)K=7%FU6;;QG'G%.7<TUM#$:!C%.8V4T?,4MQ\!*9*EI![U$J"N[P_
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MK6M";V"E7 OX]*F_<E%12X$6;:DY-\3:-MMMEMMEI ;::2$-MI%@E*18 #W
M5IFV:_[[%:VWE_1]+RX\_78>->S<K'%1")#W<\A 6!]8)+0Z'V%0]IK9MO+;
M<EMV&O<6:XHO9M)SLG%VNYMW"3<:TWJ^4P,QJ5#R>,8::<[6[_K2@  4DV\?
M=])K'"\XUKC4O*TG2F%"CY>;A9+E_;\CL>GYS=HNK^5C\)C<7 ^?8B&Q[G'F
MEJ0 5E*E))N";D> (V%%JVDFE4P.5;C;3=#GR,QV1OFE[)I7&>TZQ+9G)C;*
MX_AU1(TB$^M"5ESR2M-TCN)4H#V$GX18E[#4I)\,0W[2<8M>0GG_ +1'_HC_
M ./K'_Z?*9/_ &^0_>)O]=>9_P!_T?\ *D5%[W8]0L^]+K+PDQHTQAV+,CMR
MHSP[7H[R MM8]RDJ!!'X:UTZ&PU4U\X'PN(D8+<G7L7%<>_*7)0@^64>8(RF
M6 60NW<$$*/P@VZUM:F3374C6T\51]9]<4Y5&DQN0=*S;Q0UH$E_(1'%]%*Q
MSJ2Z% ?H=W_'%+T<^62WBR\E8O<1_ 8Z4YP[R5NN41VY;?&<ADG;^*8X"TLH
M%P.ERHI_Q2*M)_[D8K8BL5_MRD]Y8'%_'NKL<?8/Y[#0\I)V'',3,I*E-)><
M<$AL+0CN6"0EM"@E('A:_CUK%>NRSNCV&2U;CD55M*XU7-9#2].YJPF/D.+9
MT>?(;UUY14M3*9*G&T6-OU!2%^ZY)/2LLXJ<H-[S'"3A&26XZV@9#5L1J4&-
M-X@VK8IN48$C+9DX-$U$Q3P[^YMYQRZFR".VP MU\234W5)RPDEY2+;BH^ZW
MY#MZ3A=HG:WROJ6+PV9UO#9!*G]+8S,=R(ML2"YYD<*7<6("4FRC:]SU-1<E
M%2C)M-[Z$PC)J44FEN,-#V'4,'K+.D\E<72]:[8R8C^=9AH<2XZ$]AE)>*0K
MO)Z]R"OK]%6<9.6:$JE5**664:&S&BMX-C4L&QK>5=S6#8C^7CLB^L+<6VE1
M%ED(;L4?5MVBUK$=*U+E<SK@S:MTRJFP^>0?]0MW_>#)?YJY2U[ZZT+GNOJ,
M/Q#^;33OV@G_ ):JM?\ ?96S[B*NX:APY^L\EQYT1F;'.?F*+#[:7$%26TE)
M[5 BX(N*S7W24>HQ6%6,NL[7#D" WPW)R+<)A&0D1,JV_.2VD/+0E;MDJ< [
MB!8=":B^WXE.HFREX=>LB/\ [*/_ +OW=J__ /(_' I_Z/QQ);R#_P"H']_L
M5_XBJ6OY^IE[G\G6BU=T5I&!QD_:-IQ&-D)CH 4^_%9=?>7:S;2"M)*E&U@+
M]![@#6&WFDZ)F6>5*K16G&&BKRN85R?L>&BXB3,2#JFN1F4--0HI!['5I0E/
M<XI*NA(N+W\2 G+>N461/K,5JW5YVNH@>,ST"=R5OV?V32,_N[N*R"\5@D8[
M'?/QX;,9QQ![VW%)"%J"01<=+J]]97%J"2:1C4DYMM-F6CR'E<H:EL&F\=;+
MJL26I<#;D2\2J'$<9=*0ATAHK0"DDJ43;ZJ?'K56O8:E)/AB6_G3C%KC@9W1
ML7C]VY+Y-V#9(K66=US(C#X2+*2EUJ.TRMULJ2VJZ;GRP0;>)4?$FJW).$(I
M;\2UM*<Y-[CH;%J>&USG'CB;A836-:S8EJE0XZ VUYK+2P7$H38)*@L7L/9?
MQ-3";E:E7<1*"C<C0V=K4-HHC_VB/_1'_P ?6S_Z?*:__M\A'-*U7"[#RURM
M.S4%K)IPLV.(4.2D.LI<DAR[A;5=)4 S8$CI>K7)N-N*6\K;@I3E4R"\-C=:
MY_UQO Q&L3&SN!DKR<.,D-LN*1YQOV)  N6T$V'B+^-ZC,Y6G7<R<JC=5.!L
M56J;)KMH(#'.'*T>6+3G6&'HQ4>ORY\L]/HLMNMJ[\*)K6_B2-B:U39,7"SF
M&R*L@B!E8DQ>)<4SE$,O(6J,X@J"DO $E!!2?'W&I<6MJ(4DS4W2^3]99WC=
M]YSR9[K^8<3"U\1XJW@W :-NI'0%00W<#V@^^MVY9EE44:<+L<SDS+<5;AB(
M_*>TX7$*>:U[<U*R.)9DM*84B8A)<=0$*\ 05@?\%-1>@W;3>U%K,UG:6QG=
MY%C;)+YUU9C4\A&Q>;5K9,:;+1YC24AR:5@I[5^*;@=*K:<5:>;97N%U-W53
M;3O.EO&1YPT^''EYW;8OY/2G4Q\CFL1!9=>A^8;!2FUMLFQ\ 4J\?:#:\VU:
MF\%B+CN1VO NSC+4\!JNMM'!9!>:1FR,A*SSINN6MU((7_BBW@GQ'6_6]8+T
MW*6.%#/:@HK GTA[Y>.^^4]P8;4YV^%^T$V_W*Q+$R,UZX0UW%;#@<CO.PP8
MV;V'9LA*5)ERVTOEMM"NP-(2L$(%P?#V6'@ *VM1-Q>58)&M8BI+,]K,AL^M
MM<6ZOR7LNK37H;.98:5&PS:0&(3[BDL%YCMN0?UPJ\ !T]B140GXDHIDSCX<
M9-$(TB?J6'U''8Z5PWM><D38J'<OE%8%$I,IUU(4M:'EN7+=S\'ATL?&]9+B
MDY5S)>4I;<5&F5OR&>XM1F8.M\FX>3A,QA-<B&1)U2/F8SD=Y,>4V^5-#ON#
MV=B2>U1ZJO[:K>HY1=4WOH3:JHR5'3<1?_V4?_=^[M6__D?C@5_]'XXFTFN_
MZOX+][XO[$FM2>UFW'8BEO4# @N8C4)CD)A<Q>SX^*N4IM)<+!;DJ+161<H)
MZ]M[7K/IFZOJ,&I2HNLZ'-V!QTA7%NNQX[>.QL_9&X99B(2TEM$E:$K*$H
M/QD]/;4Z>3]I]!%^*]E=)D.8=#U#'\99A_&Z_!QLG"H8<QTJ,RAMU!\YM!!<
M [E=R5$'N)OX^-18N2<U5[2;UN*@Z(BG*N:E3<!P_@IC.1RD#9D,3-BA8Y"G
M)<Q$=J,HM-@6[U*+JC:_B ?=5[,:.3X%+LJJ*XGSMTK6,]JTS"8OA7;<7/:C
MG["G-Z^EDL2$"[1+K;A6$E0 7XW%^A-(*495<UVB;BXT47V''R2O-Y?A_C5.
M?;E8[.2<[ C3_F$*:D)<2S*9#BTJ"5!2@ OP]M3:HKDJ;*"[5VXUVU+GEZ%I
M.OZYFVX#3.H1Y&-5#R6?C=K;Z(P [RIU=[D@=2>OZ-:ZNRE)5Q,SMQBG3 J/
M!Y_BV-@V-=UGCK*;VTTT&7LDQAD."2YU"G77G;*22;F]OA\!8"L\HW*U<J>4
MPQE"E%&OD.OQHIP<'<IQE)<9:A+S[$:*ZKN4R@8]"O+O]"E&_P!-Z7?BQ\GI
M%KX<O+Z">\1:#K+/'V'D3\1$RDW88B9.3E2VDO*6AT?K;0+@)"4(LD =/;6.
M_=EG='L,EFVLF*VD:X[P3,I',G%;KBUX''S/*Q <*EEA$X/6 )_P"VE0]ZKG
MWU>[*F6>\I:C7-#<<^C[X]KW$.?.5(;SO':I&(=C+/7SD*[(B2"/#N4$?\4U
M%RWFN*FQDV[F6VZ[46#P_K;FM:'B&I25?:>6!RF56OZY>E66 N_6Z4=J3?VB
ML5^>:;,EF.6)9U8C*=/(_P"CY_[7=_Y!J8[2'L-=. ](UF;HC69RN'B9>=DW
MY#2G)K*'_+9:<4@--AP*"4D@J-O$GK6UJ;DE.B9K:>VG&K1U.$]*UV5)WA_(
M8YG*HPV<DXO#QIR!(;C,-J*E>6ARZ05]P[C:_3Z34ZBXU2G BQ!.M>)G^,(,
M7"\E<NX7%H3 Q4=R"]'A-]&FE.(6HE"?!(!4>@]G3V56\ZPBWM+6E2<DB-8/
M,<4ZO(S&.QV)R?*.<DS'7<EEF,8C(/...&Q;#BPA)%[]4=#U/6K2C<E1URKK
M*QE"-5M?4=OAQ;;7)7(\:%@I.J8]^-#DIUN0D(6PI02H$MIZ(OYA4$CZH5:H
MO^Y'&O238]]X4.]PGA,7MF/SV_[% CYC/9_*R$^=+0E\,,(">UIM*P0FUR.G
MZGM'@*C42<6HK8D38BI)R>UDY:X_QNI?E[F,+)<B8_8,<Z7->;0E,5EUME7Z
MXV!U!/Q=!TZ_0*Q^*Y94]Q?PU&K6\@G!>@ZM+T;![)DL1'R68ERG9+,Z0GO<
M9,22III+9/U0DM=UA[^M9-1=DI-)X%-/;BXIO:?G#^'QNZR]RW[9(3&9RLO-
MO0H(F(0^F*PPA"D);2H$)L' GPO9(]_5?DX4BL%068J=9/B?>5QT+0>9]-=U
MQA.,Q^[LOQ,WB8X"(ZUM#X' V+)2>Y23T'L/^$;HMSM.NX-*%Q4WG'K.I8G8
M.:>3,IEXK<]K N0/E83X[VO/D,?"ZI!NE10EM0%_#NOX^$SFXVXI;R(04KDF
M]QV=RQ<+3>5.-<]KT5O&*V>4]B<Y$C)#;3Z%%M*5*0@6)'F7)]Z4GV5%N3G;
MDGN)FE"<6MYT8&K8;9.?]^=S<-O(L8B'CWXT%](6R7EQ(R M:#T5VB]@01UO
M[*ES<;*H0H*5UU.YL6$Q>M\U\:2L#!9Q!S3$YC),1&TLM.I;:58J;0 F_P ?
M4V]@]U1"3E:E7<3**C<C0[.\/\;87D!&;VN3)V?.N04Q\=J"(PG(C(Z$.):M
MVA2OB("S^J[@/ U%M3<*1P7$7'!3J\7P(!E\ICI_)/%^8P>BY+2"]E?EWY\R
M&B 9R'%-I4/*03W=H4H%5^H5;\&6*:A)-UP,<FG.+2H3B'CH6\<V[6-B8;R4
M#2849G"8F19;*5OI0I;I:/11N5>(]J?<*QMN%I4WF1)3N.NXZ'*&G8+#[KQ5
MG\/ CXN1-VB!$R#$9*6D/6?;6VX6TV3W)LH%0%S?K[*FS<;C)/@1=@E*+7$Q
M6[9:-D.:%P\_K68V_":CC&W(.!Q,0S!\R^&W/.>9*D)*+.6)N1=*0?;4VXTM
M8-)LB<JW,4VD8_=\A\_*U_/Z-Q1MFO[3@I[;XEG!F,T]& (<:<\@K*K] +I\
M.X>VK6U2JE)-/I(N.M'&+3703'DK%9O&<@XK>%::K?\ 7(^,^27BD)#RXCW>
MI1=2SVKOT-P>TCQN19)K':DG#+6C+W4U/-2J/G3<YQ7L^^X_,XAJ=J&Y1V'8
M[F <:;B-2^Y![PXA"5)6H#J/B2HV!(Z=%R-R,*/%"$H2E58,V/K5-D4 H!0"
M@*SYI_,YRS_(S/?Q>_6SHOCV_P"Y>DPZGX4NI^@_E9KZJ?*3V+^ZN_T/S5^W
M,%^QSJ\;]U>];ZGZCVGVO\.?6O0>L]>3/4"@% * \R.6?3US!LWK7TCES":A
M\[Q[B,GK<C([!]H8]ORVX!;,E7RSLE$A79VGHELD_J;UZ;2<QL6^7RLRE[;4
ML*/?LQI0X&JT5Z>OA=4?85*NJZ>FIMKZEN"L5S]QCE-3?#,;8X/=/TS,N)ZQ
M<@VD]J5*'4-/#];<'7H>ZQ4E-<GEFOEH[RGNV-='\#I<PT4=7:<'MW/@S7/T
M@:-ZC>.^/]TXGY5T5['Z\F!+D:%EE97&2PP_)2I+V/*(\QY:4.+7YJ#VA*3Y
MG<?B372YQ?TEZ[&]:E5U694:\N*\G8:'*+6ILVW:NQHEL=4_)@S4KAGA7U]\
M"?E)_1SQW#@?E7\G]L?-Y'7I7?\ (^?Y';YD\]MOF%WMX_H5U];K>6:S+XDW
MA6F$EMIT=!R-%I.8Z3-X<%C2M7'=7IZ38'#YS[S=66Q:<OIN'1BE2V!DUI=U
MNXCEQ/FD=DXJZ(OX"_NKG3M\HRO+)UIA[W<=*W=YHY+-"-*X[-GYB0^KSTG\
M@;QOF#YQX.F-L\@XD1/M#$F0W$>=?QYO$F19#ZDM!Q 2E"DN*2DA*3?Q!Q\G
MYM:M6G8OKV'7';MVIEN:\LNW;BOV'2:]6RG\2D=R3]XUS#K<GC7/Z0SB,+F4
M"-GI[2<=CS)938J2_(,E0"%6^(- =W5-B+IK>L_2M-/Q8RJULVOU>DU+WU34
M0\.44D]KP[WYC:;6O3)G^,_1_O\ PY@U-[/ONWX[(S)R([J&8[^5FLM,AIAR
M26DI0AMEM 4LIN05'MO8<J[S2-_7PO2PA%KL74=*URYV-%*S'&33\K:(AZ;/
M2[M<?TN<G\(\R89>HS=WV*7,BAN3#GK:;^3QORDL&(^ZV2W)B=W85@GMZV!!
MK-S/FD'K(7[+S**7%;W58K@S!RWELUI)V;RIF;X/<J/"N]&OVCZ#Z]_3"WE=
M-X]UJ#N6H2YKLF$ZV8DZ&73VI4^RAQ]B2P5I";I6 GQ-B0370OZCEFOI.Y)Q
ME3I3]#3-.Q8YCHJPMI2CN_%4T3O@OTO<\[OSIC_4#ZD'$8N7AI+62@8A3T=<
MN3)CH[8:$M0U+:CL,$)44DA1( [?B4H:^OYIIK6F>GTV*>%=W3MVMF?1<NU%
MS4?,:C!K8O\ 38CTEY/P^2V+C3D/7\/&^<R^=UG+8_%1.]#?FR94-UIE'>XI
M*$]RU 740![2!7F]+-0NPD]BDF^T]!>BY0DEM:9IUZ!^$N3N%=:Y$Q_)FL_D
MU+SN3@R,4U\["F>:VRRXA:KPGWPFQ4!91!KL\_UUG53@[4JI)UP:]*1R.1Z.
M[IK<HW%1M\4]W013UN\+<[\];IQYK6D:F7^.=>;\W*;$YD,='0F;/>#;[I8=
ME)?6F,PVDBS=R5+"0KI67D>MTVCMSE.7MO8J/8O)3%F+G.COZN<(07L+:ZK?
MY:X(VAA>DWTYPH42'_1#KDOY1EMGYN3#0X\[Y:0GO=78=RE6NHVZFN7+FVK;
MKXDNTZ:Y;IDOAQ[$:8M^F+E;A[U>XSDOAG0D3N)'YD=60C1<AC8R8L&>R(^3
MC(C29,=:O*)4\T FWU!<D&NT^:6=3H7:O3_W.I[5L=4GU,Y"Y==T^N5RS'_;
M>VC2I7!X5\I97IQX,Y3T+U3^H#D?;-7^RM,W>3GW-8S/SL%_YI,W.(F1SY#$
MAQYOO9!5^N(3;P-CTK5YEKK-[1VK<)5E'+54>Z-.%-IGY=H[MK57KDU2,FZ8
MKC4@_K@]'>V<H;-B.2N'\ UE]ER*$P-UPB9,6$7O)0?EYX<EO,ME02 TL!5R
M @@'XC6QR/G,-/!VKSI%8IXOR8=I@YURF>HDKEI5EL:P7EQ-HN+.%7)OI7US
MA+E7#J@2).ONXO8\:V^R\Y&=4^XZTXV\RIUHK:5V.((*@% 7OX5RM5K::V5^
MTZXU1U=/I:Z6-FXOY:,T0U_A_P!</I7R>:P/#S,;?]"RDI<B+V&*_&6XI/:E
MY<.2\T]'>[$I"^PE!( [EV%=ZYK.7<P2E>]F:Z_2L&CB6])K]"W&S2<'^.*[
MB5<0^D_G#E#F.!S?ZH7D11B9,>=$UQUV.[(EN13WQ&/)BJ6S&C-+ 4I!/<KJ
M"GXE*K%K.;:?3Z=V-+OPKU[=N+9DTG++]Z^K^IW;%U;.I(E'KL]/?-'+^_Z!
ML'%^GC9(6OX9<>;).0QT,-R/FE.I2439+"E="#=((^FL7(>8:?36IQNRI5\&
M]W0F9>=Z*_?G"5J-<M=Z7#BT8O[=^]'_ .I>&_YW6?Q^K>'R;^I__+N*>-S;
M^B/F_P#R-QO3;,]1,W6]@7ZC<3$Q.QHR:4X!J(K'J2N%Y*+J/V>\\B_F=WUB
M#^A7&YE'2J:^6=53';M\M#K:"6IE!_,)*5<*4V>1LV-KG&\* 4 H!0"@% *
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MY;>11DHXX&*>9RCFPQ+,W'5-JQ>Z1>2-%C,96>N(,?L.NON!CYM@$$*;=40
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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ME)F9PT')S\0_@I<M*E/8F2;NLD+4D!5TI\0+^'MK#)).B=3-%U56J&:JI84
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M'M*PRVI?:#8VO:UZF*JZ$2=%4Q.F[*C<-9Q6R-Q%0$91M:TQ%+#A1V.*;L5
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MZ,UQ6K;I0Q6W<N*M2:R]AW3?-QSVKZ9F6M7P.I*3'S>P&.B3)>E$D%IM"_A
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MD6XJC1&:5MI-U3.;)_[1&N_R17_G$JH7P7UA_%74.,/SE<V_OACO^3*I>]R
MM>_(O:M<V#53/X/<7N=8<6)O/R61F81^5BLI]F1W/DX2I$CLA>4I7:[VV/ZX
MKXC>MR,H^%LW\34E&7B[=Q/=GVG;<_O+G'6C3F<&YC(B9FR[(\RF0IA+@24-
MLMJ^$DA:?'KUZ6[23CA",8YY8\$9)SE*66)B)^<WWBS,8-S:]B;W/3<[+1 ?
MR"XK<23"?<N4JLW?N38$]2;@'ZIM>5&%U.BHT5<I6VJNJ-A:UC9*PY/W3):K
M!PV.UZ,W+VC:IR<?@VWNK:%$@+=4/:$E21UZ=;GH+5ELVU)MO8C%=FXI);61
M')XOF;4X+6PQMN&]28ZVSE=4^SFVDO(6H!8CK:'?=-_8!TZV_4UD4K<G2E.D
MHU<BJUKT&4W/=MED9S6=&TMMO&;'L,09'(3YS87]G1;$F[9NDN72H$$'PM;X
MKBMNW&CE+8B9W'51CM9@L_D.1.*D0-AS&UIWK5ER68V=C/0FXLB.EWX?.94T
M57Z^PGQL+=>X7BH7<$J,K)SMXMU1W-Y<0]RYPVZTH+:=3D5MK'@4J9!!'X14
M6_AR)N?$B<F,_P!HC8OY(H_SB+4/X*ZPOBOJ+VK7-@4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@/'/[Q+\_?!'[2C_P :5['[=_QKOXW'E>??Y-CK
M]:/8RO''JA0"@% 1C<LKF<+KF2GZ]B%YS--H"<=CD)*@I:E =R@D@E*!=1 /
M6UO;5[<4Y4;HBLVTL-I5$O6N9&L([GGN3VH^79C&6YA/LV,F*A24E19\X^-O
M#N*/_NUF4[=:9<#"XW*5S8GTOD;.Y/@Z7O45Q&,V%EGL4^TVA;8=;EI84M*'
M0M-E)ZV(Z7IX25W+N'BMV\V\Y=.7R=D%8K?-EVF+!U23"5.F:VVP@J3%\@J:
M47/+^LJR7%$$>T"W@%S(O92QXB&=^TW@8_79?)G*4:3M&.VM.B:V\\ZWKL!B
M$U+>>0TM2"X^IQ0M\2;&QM<&P'B9DH6L&JLB+G<QK1$KX]V_/RL[L>A[D6'M
MEUH(?;R<9'EMS8CO:4N]@L$J'>F]@!UM:X-\=V"24H[&7MS;;C+:BW*PF8UG
MU7,<I;_D]LQ<?:$8##Z_FI;)SB(;#LE:0OM9B-H[4)[6P@J4L_$>X"Y%;<XV
M[:3I5M&K"4YMJM$F2W3MHVK$[O,XVW><SF92H0R.N["VTEA<E@$A27&T_#<=
MJO ?J57)Z&J7(1<<\2\)R4LLB&Q\WRONFU[WK.O;''PT#6\JX!E7H[2EH:*E
M(8BH"6NM^Q2BI5ST'7WWRVX13:VHHI3G)I/82++[+O<[8</QAKF6CL[%#Q;4
MS=-Q<CH6EHE*.XL,6" 5%0L"G]4GZMB:K&$$G-K#<BSE)M06W>SI9?-<@<43
ML/D=FV9&ZZ9DY:(>3DN1&XLF$MP$AQ/E]W<+ GJ3X6Z$@U,8PNII*C(E*5MI
MMU1&^3,7M:>5]"\C<?)=RLB4-==^SF%?9:"$)6FQ-I%[^*[6JUEQ\-X?Q*W5
M+.L?X$\VK9]QAY75>--;R<>9N&2AB3FMKDQT(0RPWW!3R8Z>Y 4LH4>WJ!T%
MOBN,<(1:<WLX&2<Y)J*V\3$Y_(<B<5(@;#F-K3O6K+DLQL[&>A-Q9$=+OP^<
MRIHJOU]A/C86Z]PM%0NX)4963G;Q;JC*<A[GFD[5JVE8#8(>IL[%$7,D;5*;
M0\ CXPAIE+MD=RNWVD$DIL0?&MJVLKDU6FXM<F\RBG2N\[^)B<IZ[M&)BR\P
MG?M0RJ5B;D%LQXC\!0 *5_"H=Z3?I8JN+] ;7B3MRB\*,E*<9+&J(_E-EVC:
M^1<[I6*W&-HD'74,=A+#3\S(..H"U%L/$ )3W?J3X6/6_2RA&,%)JM2CG*4W
M%.E"9Z6.2,;G<K@MO=;V'!LL)>P^WH;9C+6JX'DNL(5>]B3>QM;JH]PJES(T
MG'!\#)#.G26*XF#T_?,BK^EW(;).,O&Z7F9S4!I+32%-Q8RG2&D]B4=YL@ %
M1))]M6G;7LI;T5A<?M-[F8;7VN6>0L6C;$;JSI,+(=[F!P4: U*'E!1"%O..
MD*/=V_3TZV'U:M+P[;RTJ5CXDU6M"1:#O.=RJ=LUC:FF6-PTX$2I,<6:DMJ2
MHMOH3:P\ 2+6((-A<@4N6TJ-;&6MW&ZI[4070YO+?)FLQLG^6K.L1HBWF!/;
M@,OR)[R7%*[UI :0VA"5! [?$I)(-9+BMVY4I4I;=RXJUH3OBK;=ER[VWZUM
MRVI>;TN8W'?R<= 0)#;WF=BNQ( O^M$]$BX(Z7K'>A%4<=C,EF;=5+:C$P(/
M+^ZKR&3E[*KC;'IDN-8K!(Q[4B06T]$N/+<4#UO[%6/6P2+5+=N&%*E4KD\:
MT.[QGM.U/[+M^B;=.CYG(:OY+D;-L-I:+K3HO9Q* $W 4GP%P>X$GQI>A'*I
M1PJ3:G*KC+<=3@'_ %?W+^5V1_8H]-3M741I]CZR]JUS8**BQ.7-UEY::[L*
MN-L/'E+8P^*&/;D27FTCX7G5.J! /</ V)N+"P-;#=N%,*LUTKD]]$<_'.S[
M8G<-JX^V[(Q\]*P##4J#G&&DLJ<:7V?"XE%A>SB?9<$*N5=#2[".52CA4FU.
M69Q>-"*ZQF>4]_G;=B86TL:_CL!FY;!SWR3+\E3?=VLQ6V@&T]K805*63W'N
M'4VJ\XV[:3I6J*0E.;:K2C)-H>Q;G'W/9>-]MR;.8F8W'C(XG86V4M*4RI3:
M!WMILDG]=3T]X()5T-4N1CE4XHO;E+,XLA/'V%VY/+.]MN;MYK^+>QZ]BD?9
ML=/VHV47#?:%6CV3TNB_OK)=E'PUAY]ACMQEXCQ_B6!J6\9)S*<O/;#/,C$:
M7.7\@V&FD%F,T'U*2"A*2LV;%NXDUBG;5(TVLR0N.LJ[$1_71RUR%CORPC;D
MQIL":M:]>U]N"U)2IE"RE*GW%V5\7;[C?Q 'A5Y>';>6E>)6/B36:M#)<8;M
MM65RW)3&\/LL#4%1$*BLMH2S'*42!(6A02%J2OR0L=Q/3PJMZW%*.7>3:N2;
MEFW&.UV7R9RE&D[1CMK3HFMO/.MZ[ 8A-2WGD-+4@N/J<4+?$FQL;7!L!XFT
ME"U@U5D1<[F-:(E?'NWY^5G=CT/<BP]LNM!#[>3C(\MN;$=[2EWL%@E0[TWL
M .MK7!OCNP22E'8R]N;;<9;45_IV7Y6Y&1GHT;;6-=Q^$RLB,O-B$R_)>-P4
M,(; ;0E+:0"57[CW>)]F6Y&W;IA6J,<)3G7&A,>.MFVU.V[3Q]N4QG,S\ PS
M+@9MII+)>8<[>BTI %[.)]EP>X$GQJEV$<JE'>7M3EF<9;BZZUS.:[3]AY'S
MG*6W:'KN99Q>)A-07SE78S3JH#"HS2W0TDI!<6ZXZ+=ZC8 VM[-I1A&VI-8F
MLY3<W%,[\?/;IH&ZZ]K6VYU&UZ[N"U1\5F5QT1I,>6.T!M26_A*2I21UOXW%
MK$&'&,XMQ5&B5*4))-U3.AM.R<BSN3\AH6I99B!'D8IF0F4^RTH0@+*=>2?+
M*U*5T0 20.[POU$PA!0S26\B<IN>5'<SNR;YJ.+U72T9.+LG(NU2GVH^6=:2
MB/'C(7T=4A*4W*4$>*3X*^M87B,(3;E2D43*4HI1VR9P;"GE3CK%G;7=T:W;
M'X]3:\_@Y,!J+=I2PE2V'&B5#M[OH \2#]6D?#N/+2A$L\%6M3(\A<B3X\70
M8VLY.-@F]_/F(V><A*VX<?L:6#VKNCN5YH^MT%OIN(M6EC7&FXM<N/"F%=YR
M,0>6-;RV!DQ=E1R1KN1D(9S,=R/&B.QVU>,AIQ*[* %S;N^BW6X-VY)X48I.
M+6-4=K>-MV:1MF*XYT=YB#F9T8SLSG9#8=3"B@D H;5<*6;>T>U(]MTQ;A'*
MYRV"Y-YLL=I'\WE>0.*7<5F<_M2-WU&9+;AYD/0VXLF(71T=;+15W =IZ$_X
MMKGNJT5"[5)4963G;Q;JC(<B;=NF,WS3]:U&3'(V2&^GY>2A"F0[<@2%K["Y
M9I(*^U)ZV\#X5%J$7!N6XF[.2DE'>8'9,AR=Q>_@\]E]R:W/ Y'(LPLSCW(+
M4531=[E79+9)\$JL;@7M=)'A:"A<JDJ,K)SMT;=4=;F/%[&[OG'#D;:?E&<C
ME@U@8_R++GV:^D,!;W<HW?[E$*[5]!X5-AQR2PW=HOIYHXDUV?/;3K>S<0:]
M]N_.C./2H^RROE6&_G2PF/9?9VJ\KJM1L@CQK'",91DZ;-A><I1<57:878-G
MY"E\J3]$U;)QH<5_%,R42I+#;B8(%E.OI'9W.*/1"4J)3=7A[1:,(*WF?$B4
MYN>5'$G+<@\?;MJ.$V/9V]SU_<7UQ&Y*XC<5]A\=J00$%72ZTGJH@CNZ ]:F
MD+D6TJ-$5G"23=4S+;-LNW;)O+O'FCY)G7TXB*B7L^R.,ID+:\T)*&F6U_"3
M9:?<3UZI[3>L(1C'-+'@BTY2E++' C&<S/*>C;+HN R.S,Y["['GHC'VV(;+
M,A32GD(?BO([5I 4EP%*DGNZ'K[KQC;G%M*C2*2E.#2;JFS9>M0VBJ^3MTRV
MN-X#!:PPS(VK;I?R>),CJTRE/:''ECV]O>GQZ>)ZVL<UFVI5;V(Q79N-$MK(
MOE,?S'IT:-L$;:CR"6G6QF=7^SFV5.(<6 HQE,W7=/=[ +#XB+#MJZ=N>%*=
M)1JY'&M>@R>Y[CLT[9\+Q_HZF\9F<E#&1S.9F-!PP(I\ &C=)<Z=0;^*1[;B
M+=N*BY2V$SFW)1CM,'F\KR!Q2[BLSG]J1N^HS);</,AZ&W%DQ"Z.CK9:*NX#
MM/0G_%M<]U3%0NU25&5DYV\6ZH[VU$*YVXK4D@I..R9!'@1\M(J(?"EY"9_%
MB-5-N=>5#8FV.QAL/$_]&CTG\*/E$/BR([J.8WOE-G(9O'\CQM2+<AUJ!JL:
M&Q)<90@W0J072%GN'ML0?9;ZM7G&%O!QKTE8.5S%2IT%P:!+W61B'V-[Q[<3
M,P)3D=$UA39;FLIMVOI0@_#<W%B![["]A@NJ-?9V&:VY4]K:3FL9D.K/FQ\;
M!F9&6ORXL!AR3)<_P6VDE:C^@!1*KH&Z*I0.N.<I<F0'=KB[@WHV%EN.C7L0
MQ":E+4VVLH\Q];ECU*;?3X@ >.U+P[;RTJS6CGN*M:(DN(VGD6-J&S',ZL[D
M-OUU]43&EEE2(^4NKL1(;2.VZ1U4KMM<>%B;"DH0<E1X/S%U.>5U6*\YASK'
M,TC#_;;_ "8UCLR8_P T,",;'$5I7:5^2MT]>G@5%!_1\:MGMUIEP*Y;E*YL
M3L87D/-Y[AC+[EW-P=@Q\*:DR6FTEOSXP/:ZEM?>GJ+$@BU[]+5$K2C=4=Q,
M;C=MRWF*UF/R]O.MX[9E;NUJ[C\5LXK&MP&74R"VD),B2I21V^>I)5VI24I2
M>@]E6F[<)4I4K!7)JM:$HT;D',Y[5=D=R.)^8W+3WI$'(XB*+"1)9!#?8+GM
M[U I/L!!(Z52Y:49*CP9>W<;BZ[483'Z_P R[#BV\WDN04ZGD):2\QKC.,94
MU&23=*'7%GOO;QN%$>\U9RMQ=%&O34JHW)*K=!J>XYG;N,]]&P^2O,X!K)XR
M9+C@);?\J*2' $]+DD@V 'M I.VH35-CH(3<H.NU5(=Q=@^3L_HF(>QFY-:=
MAX;;K6"B-0FY+DDI=65.OK<-T@K)2 /8+V]][TH1FZJK*6HSE%4=$65H.YYC
M8<;N&O[0VRWM6GN.P\HY'':T^A25AMY(Z?6*%7L+>!L+VK%<MJ+36QF6W-R3
M3VH@_'&VQ](X&:V-]KYE4-Z6F)%O;S7W)2D-I)]@N;D^X&LEV&>[0QVIY+52
M00L!S3E,4UL3F_QL7F930DQM73CV50T)4DE+"W574"01<V58^T^-5<K2=,N'
M$LHW&JUQX$YXSW5>]:RC)RHR8.6A2'(&:AHOVHDLV*NT$D@*"@;$]/"YM>L5
MVWDE3<9+4\ZJ2[-Y:+@</D\U-O\ *8J*[*D!/UBEI)40F]NIM8?35(QS.A>4
MLJJ4;K[7+/(6+1MB-U9TF%D.]S X*- :E#R@HA"WG'2%'N[?IZ=;#ZM;,O#M
MO+2IKQ\2:K6AE]/VK;=HB[9I&5R#.N;_ *RMMI>=CQT26G&UJNE]##G:@W2+
M$&PLH* '@*W(1C22QBRT)RE6+P:(/P!CME4_L$D;5VX3'YZ8C+8+Y%D_.R%L
MA/G_ #%^]JRNU7:GI\-O::R:EQPPQH8].GCCA4VFK3-LUSXKS$37L-R[G)U_
ME,5LN2DOI3]90;2%=J;^U1Z#Z:VKT<SBEP-:S+*I/I.SK\?EK?<4WMOY;,Z;
M'R(+^!P,: U*0&;W;4^XX0H]X'T].MA]6HD[<'EI415R:K6A*./][S&9@[5B
M]A@I=VW1WEQ\G'A"R9E@LM+92? N%LCW>!Z7L*7;:336QE[=QM-/:B/XO"\R
M;9!7FLINHT1Z2MSY+6H^-:>\A"5=J?-<<4%DJ[;VN>A!_P 6KN5N+HE7I*J-
MR2JW0R/&>]YG(8[=8NYR(\F?H4MUF?EXJ$I;?9;2X2YVHLFX\I1Z)3TMTO>J
MW;:367>3:N-IYMQ'];?Y5Y*@N;?!V]G2<1(==&NX9N"U+\QMI91W/K<L>I21
M[?:0D#H;S\.V\M*O>5CGN+-6AT.%EYASD/E16P-,LYH.14Y%$>_DEU*G4E3=
M[GM5;N%_8:G44R1IL(L5SRKM,IJ^\[3D>)-VV>9E/.SF(>R2,=.\AA/EB.VA
M38\M+80KM)/UDF_MJL[<5<2W$PN2=MO><. 8YAWK6<9LK6\1]84]#;..QK<%
MI[YI;:>U3\ET@!!>6DJ[4H*4@^%3)VX2I2HBKDU6M#-Z?RE+D<9YW;MGCH^T
MM4D2(&10R A,A]D-^78=0DK+J4FW2]R!;I59V?;45O+0N^PY/<8W"X[F?9,/
M&V\;O$PTO(-)F8K4_D&UQ?)<'<VV\Z?C25)(ZV41[[^$R=N+RT\I$5<DLU?(
M9[AO;MDV^!M4K9E@2X&;>BL0DMH;$5M*4J\@%"4E7821=1*O>:K?A&#5.!:Q
M-RK7B6SD&9<F!.CP)OV;.?CNMPLCY:7OEW5((0[Y:K)7V*(5VGH;6K"MN)F>
MPUHX:QNQL;5R#,D[>%X_$[#-;V2&8+*1DGQYR?F"X#>/9?Q]J+CV>%;5]K+'
M#=AT&K83S/'>9K Y3D7E@Y'.X/:$Z)J3$ER-A6VX3<J3*\OIYKI<4.T=? *M
M>XMT[JB2A:P:JR8N=S%.B)!H^W;/%V[)\<[TZQ/S$6-\]AL]'0&DS8UP/C;2
M $J'CT \%#V7-+D(N.>.PM;G)2RRVET5@,XH!0"@% * 4 H"L^:?S.<L_P C
M,]_%[];.B^/;_N7I,.I^%+J?H/Y6:^JGRD]B_NKO]#\U?MS!?L<ZO&_=7O6^
MI^H]I]K_  Y]:]!ZSUY,]0* 4 H#6B=F\1@/4)D)^;R4?%PSKB&A)DK#:.]1
M;(3<^TV-;:BY6:+B:KDHW<>!;G]*''?_ %TQ'_T4W_\ =K!X,^#,WBPXF5D?
M86]ZSD(L2<SD\-FH[\-4R.H.(^(%"BE0Z70?]T5"K"72BSI./0:K:F]E=PR6
MA<6Y1I91Q[D)DG:0JY2M&/<[(J3_ (H[O*_ :W)T@G-;]AJ0K)J#W;2=\[XF
M']NZ!L6=CR)&J0I+T+8'6%.)+"7RCRW+MD* O<W'NM[0*QZ:6$DMI?41Q3>P
MQ>U:[P7KVOKS!DKS8?"4P,9#S#SKLHK(%DI2ZKH!U)(L/PV%3"=V3IL\A$XV
MHJOK.[R!#C0-6X8BP\:]AXK>Q8U3.*DK*WHX6"ORW%&Y*DWL;U%IUE+J)N*D
M8]9LL^PS)9>C2&TO,2$*;?:4+I4A8LI)'N(-:B=#:-)TLY/N_L_DNE(VOO+U
MC_H6WS?C;Q/^5_#70P^+T><T,?A]/F-V6FFV&FF&4!IEE"6VFTBP2E(L ![@
M*YYOE+<^XZ=+TB+D(,<RE:WEXN6DL %1++*7&UFP]@\P$_0":V-,TI4XHP:A
M-QZF2B=RGI<;5G]HCYV%*8$8NQ88>1Y[CO;W)8+0)4%DV!!'3VU1699J4+N[
M'+6I46Z[QL69B\8P9\E[CC%[N7'L[D67B'&FTJ2&VQ(*6RWWH4%&XZ=PN2 ;
MY[=N*S/;0P7+C>7=4BW*>K\7ZWJTPP,F]LFWS.Q.+=D9%<U]M(6E3SRT-J"$
MI#:5"ZDVO5K,[DI8X(K=A",<,62_?5)7IW!*T*"D+RN"4E0\"#'20:I:]Z?E
M+W/=AY"U>7OS:;C^T%?\M-8;'OHRWO<94.Z1Y4?C'AC:F8ZI474!@Y^390GN
M(8$=DE9'N"D@'\-9[;]N4>-3#<7L1?"A;FQ<IZCAM6D[)#S4#*DLE6*@LR$E
MR2\1\#?:+K3U^M=/PB]ZP0LR<J4,TKT5&M2DN1X\?);-QCN>]XF1BM<S&-^2
MS3#3[MX#[GF.->8Z@-J3_E05= ;)4.MJV+6$91B\3!=Q<926!VMQUWA#6\2U
M*2']DE3W&VL=A8&7>?=DE:@+I"'5] .MR+$V'B146Y79/AY"9QMQ7'RD@WN(
MS S/I_@QXBX#$/(LL,075=ZV$-HC)2VI5SW%(%B?;5;;JIEKBHX&QE:ILD$Y
M0_-WNG[T2OV,UDL^^NLQW?<95[F<US#\1\=1]NP"LUKF9C08>0D6NW#[FQ9Y
M=OC! N04=>G0WK-ED[DLKHS%F2MQS+ @FZZWJ&@8=6U\:;](QN44\R8.$B3T
M2F9?<M*2$H3=2@E)*CWE2>EJR6YRF\LXF.<8P58LVVQ+TR1BL8_D6?EL@_$9
M<GQP+>6\I +B;=?!1(K2E2N!N+9B4?S#,CXC=>'LWD%&/B<?DYJ)TY0_6VB\
M(P25GV"R5'\ /NK8L*L9);3!>=)1;,'Z@MPUS(:4G#8O+Q<O/DRV)"FH+J9
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M,6<1G<L)+DI+C[O:EIHNJ4I'<D)-PBWUO?X73F[<G(JU%3BHEK?^T1_Z(_\
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M;+4F,Z I#B%"Q2H'Q!HG3%!JN#.K]BX@XI."5C(R\,ED1QBUM)5'\I/@CRU
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M +K*7 4K"%>("@H@U52:5-Q;*JU&5PV)SD=$3,8]C)16W4OML2$!:0XB_:L
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MJ4+@!LJ[KG\%3E=*T(S*M*F4J"10"@% * X$2XKDAV(W):7*8 +\9*TEQ 4
M05)!N+@]+TH*G/0"@% * 4!UY,R)"0ER9*9B-K6&T+>6EL%9N0D%1%R;'I1)
ML-T.Q0"@% * 4 H#@5+BHD-Q%R6DRW4E;44K2'%)%[E*+W(%O=2@J<] * 4
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MDN):;!/@.Y9 N:E)O80VEM.TE25)"DD*2H72H=00? @U!)^T H!0"@% * 4
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MAX/S$5E0\>YQ2V^@]X!'N-8%IY;Z+K,SOQW59.]=W# ;7A3GL%-$V"V%^>D
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M$I6.Z_?W=WL]U8EF\-\*F5Y<ZXT.UL_*.MZQE$8(L9'/Y]20M>$PT8RI"$$
MA2QW(2+@WMW7^BHA9E)5V+I)G=473:SLZAR3K>YR)>/@&5CLQ '=+P>29^7E
MH3_A=EU @7ZV)MTOXBHG:E#%[!"ZIX+:8O+\OZEALGFL+)3/?S&&?8C#%QF
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M)5BR6M\ZZ=\Y$8FP,WB8$]81!S\Z"68+O=:RDK*ROM-_$HZ>)L*I\M*FXO\
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MRYD?%8O.[0QCU%$_)X>#\Q%94/'N<4MOH/> 1[C61:>6^BZRCOQW59.]=W#
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M$7(O8FUQ?Q%1.TX8O8(75+K,1E^7]2PV3S6%DIGOYC#/L1ABXS =?E.2$*<
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MEP;VZ=O;5I9?"]G94K&OBX\#:&M,VRB/_:(_]$?_ !];/_I\IK_^WR'[C/\
M:(V+^2*/\XBU#^"NL+XKZCI\N$?TB<'B_49B3<?_ (R'4V/<GU=XO>_'K[CZ
MD0XTKU%Q')#2750=7^8C=P![7 XIL*%_: LT3I9\H:K>\A\\CP(DSE_B%,EA
M#H6J8I84 ;F. ZU>_P#@KZBIM.EN1%U5N1.SSBA'F<9N]H\U&VPDH<]H"C<@
M'Z2D?I5&F_FZB=1_+UG6C-HR7J,R0R0#OV%K:',$A8Z(4LLA2DW]OZ\YX?\
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MD" U@7&$1NT=O8(Q%K#I6JF\]>DV6O8IT&K>0><'IRT&.IU;<*=GC'RJQ?\
M\F^;FKZ]1T"D)/Z5;:^,^KN-1_!77WFWF3Q6)<U^=AY,9EK"F"Y&=C! \M#
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M29.ZQF04 H!0"@% * 4 H!0"@% * 4 H!0%9\T_F<Y9_D9GOXO?K9T7Q[?\
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M4(M5;4\DDR]R&>+1B=LXXC;5KN#QJ\@O&9S6DLN83/1Q=;#[24I*@FZ24J*
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MI]HL0:FU=RU354R+EO-1K!HB4_CS?MT<QL+D'9L8[KN/D-RG\5B(ZT*EN-W
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M67(+V%^A]HK 9BLMZX^>V3(8G9L!F%:YN&!2I&.RH0'&W&E$DLO(/BGXE?\
MPC<&]9;=W*FFJIF*Y;S.J=&B+R^-]UW25CF^2-G@RL!C'DR/L'#LK:1*<0+
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MKZJ?*3V+^ZN_T/S5^W,%^QSJ\;]U>];ZGZCVGVO\.?6O0>L]>3/4"@% * 4
MH!0"@% * 4 H!0"@,;F,/C,_CI6)S,)O(8Z8GMD170>U0!N#<6(((N"#<'PJ
M8R<75$2BI*C*N9X)T!MUHO,9&;"CJ"H^(DSGEQ4$$D (N"1U\"3_ +]9OF9F
M+Y>)<#333#3;##:6664A#+* $I0E(LE*4CH !T %8#,?= * 4 H!0"@% 1[:
M-8QFWX=_!Y;SA#?4A97'7Y;J5-J[DE*K&U6A-P=45G!25&?.K:G@]-Q2,-@(
M?RD-*RZY=16MQQ0 4MQ9ZDD #\'0=*3FYNK$(**HB1U4L* 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * K/FG\SG+/\
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M':U1N+W2RON4\Y(!4;)L D 6'MK)*WEBI<3'&Y637 GM8S(* 4 H!0"@% *
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M22[BLC\V^9* 5EM ?[5BQ4D.E0OX$"WMJ\)JY%YEL*3@X265[3L<@Z:CC!C
M;GK.P9E663F(T;)F;+4^F8VZ%*7YHL+]Q18CPL3T\*BU<\2L6E2A-R'ATDF]
MIM56F;8H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MDAI2RD!;G<19/Q>RL4+>>O099SRTZ28U0N* 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!6?-/YG.6?Y&9[^+WZV=%\
M>W_<O28=3\*74_0?RLU]5/E)[%_=7?Z'YJ_;F"_8YU>-^ZO>M]3]1[3[7^'/
MK7H/6>O)GJ!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M[J[_ $/S5^W,%^QSJ\;]U>];ZGZCVGVO\.?6O0>L]>3/4"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H#QS^\2_/WP1^TH_\ &E>Q^W?\:[^-
MQY7GW^38Z_6CV,KQQZH4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * K/FG\SG+/\C,
M]_%[];.B^/;_ +EZ3#J?A2ZGZ#^5FOJI\I/8O[J[_0_-7[<P7['.KQOW5[UO
MJ?J/:?:_PY]:]!ZSUY,]0* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% >.?WB7Y^^"
M/VE'_C2O8_;O^-=_&X\KS[_)L=?K1[&5XX]4* 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% 5GS3^9SEG^1F>_B]^MG1?'M_P!R])AU/PI=3]!_*S7U4^4GL7]U=_H?
MFK]N8+]CG5XW[J]ZWU/U'M/M?X<^M>@]9Z\F>H% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@/'/[Q+\_?!'[2C_QI7L?MW_&N_C<>5Y]_DV.OUH]C*\<>J% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4!XY_>)?G[X(_:4?^-*]C]N_XUW\;CRO/O\
M)L=?K1[&5XX]4* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 5GS3^9SEG^1F>_B]^M
MG1?'M_W+TF'4_"EU/T'\K-?53Y2>Q?W5W^A^:OVY@OV.=7C?NKWK?4_4>T^U
M_ASZUZ#UGKR9Z@4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M-_7E2G4,MI_"M9 'Z=$F]@;2VG!C,WA<VVM[#9>%EVFSVN.PI#<A*3[B6U*
MHXM;4%)/8S)U!(H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"L^:?S.<L_R,
MSW\7OULZ+X]O^Y>DPZGX4NI^@_E9KZJ?*3V+^ZN_T/S5^W,%^QSJ\;]U>];Z
MGZCVGVO\.?6O0>L]>3/4"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M#.W)PCALW&:V'.[QNNLY/6M=X\GZXF;#<8G3LL6X[;;/9\;4=I-U.*<%T)Z
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4!XY_>)?G[X(_:4?^-*]C]N_XUW\;CRO/O\ )L=?K1[&5XX]4* 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@*SYI_,YRS_ ",SW\7OULZ+
MX]O^Y>DPZGX4NI^@_E9KZJ?*3V+^ZN_T/S5^W,%^QSJ\;]U>];ZGZCVGVO\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MF\X;C#"_L3,J=CXM\@A+_D-OE2Q<#V*2?^-6:[@H1WF&WCFEN)]P-^:C5?\
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * \<_O$OS]\$?M*/_&E>Q^W?\:[^-QY7GW^38Z_6CV,KQQZ
MH4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% 5GS3^9SEG^1F>_B]^MG1?'M_W+TF'
M4_"EU/T'\K-?53Y2>Q?W5W^A^:OVY@OV.=7C?NKWK?4_4>T^U_ASZUZ#UGKR
M9Z@4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M^HO",L^:E$;"UK&R* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H"L^:?S.<L_R,SW\7OULZ+X]O\ N7I,.I^%+J?H/Y6:^JGRD]B_NKO]
M#\U?MS!?L<ZO&_=7O6^I^H]I]K_#GUKT'K/7DSU H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H"L^:?S.<L_P C,]_%[];.B^/;_N7I,.I^
M%+J?H/Y6:^JGRD]B_NKO]#\U?MS!?L<ZO&_=7O6^I^H]I]K_  Y]:]!ZSUY,
M]0* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% >.?WB7Y^^"/VE'_C2O8_;O^-=_&X\
MKS[_ ";'7ZT>QE>./5"@% * 4 H!0"@% * 4 H#Y6A#B%MN(2XVXDI6A0N%
M]""#X@T!32^$, RY(1A=EV76L9,<+DO"8O(EJ(HJO>R%(4?TR>G2L_S#WI,P
M> MS:+%U?5<'IV*;PV AB)#0HN.$DK<==5;N<<6>JE&P_0Z"P %8IS<W5F6$
M%%41(JJ6% 5!-X8P"Y\V?@\]L&H?:;A<R,+"3C'CNJ5U62@I5:_N!L/8*SK4
M.E&D^LPNPJX-KJ)GJ.E8#28+T+!QUI5+<\[(3Y"R[(DN=?C=</C:YL  /'IU
M-8YW'-XEX6U!8$LJA<4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * \<_O$OS]\$?M*/_ !I7L?MW_&N_C<>5Y]_DV.OUH]C*\<>J
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@*SYI_,YRS_(S/?Q>_6SHOCV_P"Y>DPZ
MGX4NI^@_E9KZJ?*3V+^ZN_T/S5^W,%^QSJ\;]U>];ZGZCVGVO\.?6O0>L]>3
M/4"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0'CG]XE^?O@C]I1_XTKV/V[_C7?QN/
M*\^_R;'7ZT>QE>./5"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MXQ[7W#]Q:3B^P?WEOIZ_<K<_X-B?CU/VUJN,>U]P_<6DXOL']Y;Z>OW*W/\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
:4 H!0"@% * 4 H!0"@% * 4 H!0"@% ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2227887d1-pht_tumor4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_tumor4c.jpg
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M# P,# P,# P,# P,# P,# P,#/_  !$( OX'; ,!$0 "$0$#$0'_Q #Y  $
M @(# 0$!            !@<%" ,$"0$""@$!  $% 0$!              4"
M P0&!P$("1   00! @,$!04+!P8("0(7 @ ! P0%$08A$@<Q02(346$R% AQ
M0A57&(%2DM(C4]/4E1:6D:'!8C-U-[%R0R2&2(*S-'24M!<)T:*R<Y,E-;5W
M./#A8\0V9O'"@T2%)G:C5(1%92<H6%5&5A$  @$" P0$!PT%!@8! P$)  $"
M$0,A! 4Q05$287$3!O"!D:&Q(C+!T>%"4F*2TE,45!46<B.3!Q?QPC-S-#6"
MLH.$14:B0[,DPW0V"&-$)63BQ/_:  P# 0 "$0,1 #\ ]_$ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $!7N_^I>SNF6+@RV\<LV-K6IO(IQB!33S'IJ_EPQL1DPMQ=V;
M1N]9>3R-[-RY;4:M$1K.NY/2+2NYJ:A%NBP;;?0E5^3QDCV[G\9NG!XG<6&E
M*QBLQ6CN8Z8XRB(H96U%W V8A?3NT5B]9E9FX2VIT?69V3S=O.6(7[3K":4D
M]E4\5@\3/JV9(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!ALSFL1M[&V\QF\E7Q.+H#YEN]:D
M&..,6])%Z>S3O5RW:E<DHQ3;>RA8S.:M9:V[MV2C%8MMT276S7X/BVZ&GD?H
M[]Y[ CYC1MD"H6&K:\VG,Y^7JS=^KCIHI?\ 3N=Y>;D\554TQ?S(T-W.3MGM
MI7EER\-M-G3LWFQ./R%'+4:F3QEV+(8^_$%BE=KFQQRQR-J)"0ZL[.W>RAIP
ME"3C)4:VI[C=+-^W>A&Y;DI1DDTTZII[&FMQD527@@" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @,%G,_AML8NSFMP92OA\31;F
MLW[<C1Q@S]G%^UW[&9NU7+5J=V2C!5;W(QLUF[.4MN[>FHP6UMT1K_'\770R
M2][A^\EJ,?,Y!O'0LM!J[Z<SER<S-WZNRF'W=SJ5>1>5&FQ_F3H;GR=L]NWD
ME3RT\YL7C<E0S./J93%7(<CC,A"-BG>@)CBEBD;42$FX.SLH6<)0DXR5&MQN
MUB_"_;C<MR4HR54TZII[&GP,DJ2Z$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M[.0_66C?BK?E/GVB^B'UDXG\.3\5>_D^<^SEY!^L=&_%6_I'W[1G1'ZR</\
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M!^LM&_%6_I'BBNJGQ^$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M*R9O+7LL8\C6Y&>$/O 'P@/\@K8K-M6X*/ YGGLP\S>E=IM?DW+S(PRO&"$
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! >CWP(?^Q>I'_/\=_Q,RT7O;_B6^I^E'T%_)S_ $F8_;7H9L[U\_P7ZF?W
M!;_XM06D_P"KM?M+TG0N]O\ M&:_RI^AGB(NKGQV$ 0! $ 0! $ 0! $ 0!
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MZ?@1HO>SO#"S;EE;,JW)82:^(OK/8EPQX&E6:RL&!Q5K)RLW+5#2&'[^1^
MWRO_ #+:;5MW)*/$Y1FLQ'+6G<>[=Q>Q+RFIEB>2U//9F+6>Q(<LI>DC?F=;
M'&/*DD<PN7'.3D]K;?E.%5%H( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ]H_AE_P+Z=_\RG_ZW.N6:Y_K;G7[B/KKN-_L
MF5_8]UFL_P >/;TQ_P#QM_\ 4BGNZ.V[_P /NG._YR^QE>N?]T\]%NIPD( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#ECED@FBGB)XY(2&2(O00O
MS"J6JJA=C-QDI+"F*]*-K\!F8-P8FKDXM!>8>6U%]Y,/MC_2WJ=:[>M.U-Q\
M*'3,EFXYNRKBW[5P>]>]T,W2Z*=3JMNA4V9GK(U\G1%H<':E+1K4+>S%J_\
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M;\[9KQOG>K9YQQF,<PQ,;\TLQ>$K)-[+N/#01[F^ZIK*97L_6EM]!HNLZO\
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MVK4JQ/V_?2'_ %G_ )F4YE<NK2Z=YH6K:E+-SPJH+8O37I?HZR&K+(4( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#VC^
M&3_ KIY_S*?_ *W.N5ZY_K+G7[A]==QO]DRW['NLUH^/#VNF7_XV_P#J53W=
M#;=_X?=.>_SE]C*]<_[IYYK=C@X0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M$^NC:<3/3VB?O]#<%-Y?+JU&FU[S0M1U.>;N5I2*V+TM\7QX+#I(>LLA0@"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M (CPX+!;MWNNI'5D$:$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0'H]\"'_L;J-_>&._XF9:+WM_Q+?4_2CZ"_
MDY_I,Q^VO0;/=??\%^IG]PV_^+4%I/\ J[7[2.A=[?\ :,U_E3]#/$-=7/CL
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M]??\%^IG]PV__(4%I/\ J[7[2.A=[?\ :,U_E3]#/$-=7/CL( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" (#VC^&7_ OIW_ ,RG_P"MSKEFN?ZVYU^XCZZ[C?[)E?V/=9K1\>/;TR^7
M+?\ U*I[NCMN_P##[ISS^<O^'E>N?]T\\UNIP@( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MHIU22]9RX4]:Q,;=^#C?^0/:%7;=S9<MM_)Q.ZY3DJ 4FG,VDIV)1!W=N'G
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ML[GWV_EYE5E'?T^WRSMJLHJKYX[<$ZOF6[EI556.!47P\=-MC;TZ<=5\YN;
MQ9?*;>AD/"W))9@*$FI2RL[-'((OXQ9^+.I'6\]?L9BU&W*BEMV<36^X.@9#
M4-.S=W,6U.<*\K=:KU6^A;<=YIV+D8"3N[N[-J_I=UM!R.56V?5Z4! $ 0!
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MD:T>">#GMI7"*H3[HYT1WOMK9G4;8/4:WC,I@=YB<M2:G/)+)'9M1D%DB&0
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M5RIS-8T<J);?%AM1@5D$6;1_!W_C=B_[IR/_ !8K7>\_^C?6CIO\I_\ >?\
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M1N=F?0M."V_(YEYBQ"XU1M5.*Z_I<--U"]E82YHPE1-[7LZE5)T>XVXZU_\
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M)AYZD.1I03%YAUQL,?Y!R?B3 XORN_'1^]UL.C9Z><RZG/VJTZ^GPP.:]]]
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MCV^?'I)#/:%;TG1=1C9:=NXIW(I?%4H)<O2JI\O0TMU7Y+KI!\PGU#P( @"
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MY7-&RMW+PM*2N[6ZJF'+A2M>)2T;O&\4C>+RB%QYN_E?A_D4MT&EIM/F\/#
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MXAKJY\=A $ 0! $ 0!$ @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" (#VB^&/\ P+Z>?\RG_P"MSKEFN?ZVYU^X?77<
M;_9,M^Q[K-9_CQ]KIE_^-O\ ZE4]W1VW?^'W3GG\Y?8RO7/^Z>>JW4X0$ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! >C_P !_P#[&ZD?\_Q__%2K1>]W^);ZGZ3Z"_DY_H\Q^VO0;.]??\%^
MIG]PV_\ R%!:3_J[7[2.A=[?]HS7^5/T,\0UU<^.P@" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @/:/
MX9?\"^G?_,I_^MSKEFN?ZVYU^XCZZ[C?[)E?V/=9K1\>/;TR^7+?_4JGNZ.V
M[_P^Z<\_G+_AY7KG_=//-;J<(" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" V0VO\+?5/>&W<1N?"1X8\5GJK6\>\UQXY?+/LYP>(F%_4S_=4!?[Q
M9:S<=N7-6+H\,/2=(T_^6>IYW+PS%IV^2Y'F56TZ/97U73Q/QF<^QIUI_-8+
M]H%^A5O]493YWD^$R?Z2:Q\JU])_5'V-.M/YK!?M OT*?JC*?.\GPC^DFL?*
MM?2?U1]C3K3^:P7[0+]"GZHRGSO)\(_I)K'RK7TG]4^_8TZU?FL#^T'_ $*\
M_5&4^=Y/A'])-8^5:^D_JGS[&G6G\U@OV@7Z%>_JC*?.\GPC^DFL?*M?2?U1
M]C3K3^:P7[0+]"GZHRGSO)\(_I)K'RK7TG]4^_8SZT_F<%^T"_0I^J,I\[R?
M"/Z2:O\ *M?2?U3Y]C3K3^:P7[0+]"GZHRGSO)\(_I)K'RK7TG]4^_8TZU?F
ML#^T'_0KS]493YWD^$?TDUCY5KZ3^J?/L9]:?S6"_P"GE^A7OZIRGSO)\(_I
M)J_RK7TG]4?8TZT_FL%^T"_0I^J,I\[R?"/Z2:Q\JU])_5'V-.M/YK!?M OT
M*?JC*?.\GPC^DFL?*M?2?U1]C3K3^:P7[0+]"GZHRGSO)\(_I)K'RK7TG]4^
M_8SZT_FL%_T\OT*?JC*?.\GPGG])-7^5:^D_JGS[&G6G\U@OV@7Z%/U1E/G>
M3X3W^DFL?*M?2?U3[]C/K3^:P7_3R_0I^J,I\[R?">?TDU?Y5KZ3^J?/L:=:
M?S6"_:!?H4_5&4^=Y/A/?Z2:Q\JU])_5'V-.M/YK!?M OT*?JC*?.\GPC^DF
ML?*M?2?U1]C3K3^:P7[0+]"GZHRGSO)\(_I)K'RK7TG]4?8TZT_FL%^T"_0I
M^J,I\[R?"/Z2:Q\JU])_5/OV,^M/YK!?]/+]"GZHRGSO)\)Y_235_E6OI/ZI
M\^QIUI_-8+]H%^A3]493YWD^$]_I)K'RK7TG]4?8TZT_FL%^T"_0I^J,I\[R
M?"/Z2:Q\JU])_5'V-.M/YK!?M OT*?JC*?.\GPC^DFL?*M?2?U1]C3K3^:P7
M[0+]"GZHRGSO)\(_I)K'RK7TG]4^_8SZT_FL%^T"_0I^J,I\[R?"/Z2:O\JU
M])_5'V,^M/YK!?\ 3R_0I^J,I\[R?">?TDU?Y5KZ3^J?/L:=:?S6"_:!?H4_
M5&4^=Y/A/?Z2:Q\JU])_5/OV-.M7YK _M!_T*\_5&4^=Y/A'])-8^5:^D_JG
MS[&G6G\U@OV@7Z%>_JC*?.\GPC^DFL?*M?2?U1]C3K3^:P7[0+]"GZHRGSO)
M\(_I)K'RK7TG]4?8TZT_FL%^T"_0I^J,I\[R?"/Z2:Q\JU])_5/OV,^M/YK!
M?]/+]"GZHRGSO)\)Y_235_E6OI/ZI\^QIUI_-8+]H%^A3]493YWD^$]_I)K'
MRK7TG]4?8TZT_FL%^T"_0I^J,I\[R?"/Z2:Q\JU])_5/OV,^M/YK!?\ 3R_0
MI^J,I\[R?">?TDU?Y5KZ3^J?/L:=:?S6"_:!?H4_5&4^=Y/A/?Z2:Q\JU])_
M5'V-.M/YK _M%_T*?JC*?.\GPC^DFL?*M?2?U1]C3K3^:P7[0+]"GZHRGSO)
M\(_I)K'RK7TG]4?8TZT_FL%^T"_0I^J,I\[R?"/Z2:Q\JU])_5'V-.M/YK!?
MM OT*?JC*?.\GPC^DFL?*M?2?U1]C3K3^:P7[0+]"GZHRGSO)\(_I)K'RK7T
MG]4?8TZT_FL%^T"_0I^J,I\[R?"/Z2:Q\JU])_5/OV,^M/YK!?\ 3R_0I^J,
MI\[R?">?TDU?Y5KZ3^J?/L:=:?S6"_:!?H4_5&4^=Y/A/?Z2:Q\JU])_5/OV
M,^M/YK!?]/+]"GZHRGSO)\)Y_235_E6OI/ZH^QGUI_-8']H%^A3]493YWD^$
M]_I)K'RK7TG]4^?8TZT_FL%^T"_0I^J,I\[R?"/Z2:Q\JU])_5/OV-.M7YK
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M_I)K'RK7TG]4?8TZT_FL%^T"_0I^J,I\[R?"/Z2:Q\JU])_5'V-.M/YK!?M
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MDU?Y5KZ3^J?/L:=:?S6"_:!?H4_5&4^=Y/A'])-8^5:^D_JGW[&?6G\U@O\
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ML']*T+5_]7=_:9]"]T?]GRO^5'T%RJ.-C" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" TX_WU_]B%L7_B/^I[ASK_V__MO[Q<7P]_X*=-/[D@_I4=J_^KN_M,V+
MNA_L^5_RX^@N51QL80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M_P"V_O%Q?#W_ (*=-/[D@_I4=J_^KN_M,V+NA_L^5_RH^@N51QL80! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0&G/\ OK?[$+8O_$?]0YS_ .X?]M_>+A^'O_!3
MII_<D']*CM7_ -7=_:9L?=#_ &?*_P"5'T%RJ.-C" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" TXU__K7T_P#L(6Q?^(_ZASK_ -O_ .V_O%Q?#W_@ITT_N2#^
ME1VK_P"KN_M,V+NA_L^5_P J/H+E4<;&$ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!#=X[MI;/QH6[ /8N7)/(Q
MU(7T>6737B_<(MQ=UDY7+._*BP2VOH(S4]2AD;:E+&3=(KB_@WG+M#<P;JQ3
M7V@]UFBD*&Q!S<S,8LSZB6C:L^OH3-9?L9TK5%6FY]9RUSTHZT:Z26K&)$(
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" TY_P!]?_8=;%_XC_J'.O\ V_\ [;^\7#\/?^"G33^Y
M(/Z5':O_ *N[^TS8NZ'^SY7_ "X^@N51QL80! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MX<7T=)-8)HK,$-F$FDAL ,D)-\X3;5G^ZSK$:HZ$M"2E%26QG97A6$ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M'5\A5?6.=NSO$F[6?Y'4?=MNW+E9LF6S$;]M3CL9EE;,@( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MQ)SCCGY6,9(9'9G*.47YAUXMQ%^++HVB:O'4K'.L&MJ]WQ^:F_:^.=\>Z\M
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M;/J"-^" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MSEJN#QE[*WC8*U*(I9-7[=&X"WK)^#*[9M.[-0CM9C9K,PRUJ5R;PBJFF]3
M1;SWE@I<C0ADS&:O_2M^R8"4D%:)V-@8G9W9N5F%;%>L9>W&5WLX.4%RQDXQ
M<J]$J5\YH65SF=S-R&6[6Y&-Z?:3@IR4.58T<4^5K!+%&[ZU@Z,$ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!IQI_P#UKZ__ &$+8O\ Q'_4.=?^
MW_\ ;?WBXOA[_P %.FG]R0?TJ.U?_5W?VF;%W0_V?*_Y<?07*HXV,( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M=K;FZ<=NB"6SC1E>")]/,,>5G?U*F]8E:=);2YDL_;S<7*WL).K)G! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0'5MV0J5;-J37RZT1S'IVZ
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M(;O+Z"[E#FVA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M;@_G21J'=/U;UR/&$'Z4;&J -Z" ( @" ( @" ( @" ( @" ( @" ( @" (
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MO"H( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M'*[M'9FDL01OV")OQ9O4L36KBN9AOA@37<G*O+Z;"+V-MKQEW*(-O" ( @"
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M>Y^1Y"]*U:S<N5P;]22I63XTY4ZQC3FWE<CNF#;-R?&1P2>XS2C!2IN;>>Y
M[CS-%%J1$7>9>UW:+/[MZO'6\G',RJN9O#:E3:D\*[=OB-5[[]W;W=;4YY*W
M&,G"*K*K]>OL/&M.6C2B3W";;@IY;,[SS>3;$W-RXX<+4CBB<9!A>1BB\UR;
MFCY7;7MXJ>NNW.:Y-NS#<N!IN4^\V,O-7ME>;'XTG@Y4W*B5*8T6)F=M2/C)
M,CM'<VX!*Y.)OB6RH$PRDW$"#0A8W$M'86+BL>[E53E;]7=X;B2R6KR5SG@J
M32QKO\6],S8]--ZUS_>NW='J7CLK#/!D<.-TL))"8CQ."(9/*,1]IF[U@=MR
M5@O5:?#F_L-@^[SO<M]OM(R5*5Y.O"M'3I,7CL5G<1@);<-O(X_(5IQBQ-#)
MUAMTK,7AYXPN1F?*8ZL_'AZ55&]-2I-IKH]YEF>2L2M<UE2A)-8O&M-W-'AN
MJRNL]MN/,[AI;BFPUW;.ZJL')9JX2YY%;*-$[NQ2U %XI"T9VU9A(N]]5H'>
M?O3=TK-_<\@IQOS4>62]GFF\%R4QX)UPEN9UWN%W)M]X=.>H:N[-S)V)R5R$
ME6[&,%[?/N5<:->M'8R;;%Q^U]W8_(Y/#[JFV9D:;#-$<\4AX^T)FX/$7:0F
MY=VO!;3W>U/5LQE(??H5NUDGARS:C\9K=PV8T-![Y]VN[>1U&[+3,Q3+TC*+
MJY6ZSV05?:H]B3PKU$MM9W/X[%UJTMVE$U\WCGJSL^FD.K/,)B).Q-VZ/VLI
M?/\ >S2]&[*&;G).:?+2+=,:>OP5<,*OH,?NEW+UOO%9S<,I:A<5MIRCS)53
M6#AQD\)4=.%3I;?ZE=<^G>3EL4&G?;LH:UK$#>?!S]S\KEIH3-JVFBQUG,OG
M5&4\>;?Q3V<K,.&0U/2.:.6DURU5'\5[&I1;W=%"W:WQ$]2<Q!!,^ZY8;TK\
MTD<4;11L/H:/CQ4K;T?*RA6,,.+-9O\ ??5[5U6[UVES%\J5%3=AB\3-;;W1
M0STERSE[=S,Y(I?%<"0WD&0N[3773T:+V[9G:I"-$NHR-.U*UF^:=URG.NVK
MJGPIZ"]]N=1]T;9$81M3W<:+:!C\W%*+@WH"QIJS-Z'45F-/M7L:)/C%KSHW
M/(:]FLGA5N'"XFJ=4_?+IQ76#%6HQ+)XFY09V;6Q78;D'R\T+N3-\K*(NZ5.
M+]62?7@_.;;EN\]J:K<A*/2O7C_\<?,3G'[SVME-&I9VH9/VQG(T9Z^CE/E+
M7[BPKF4NPVQ9+V-4RM[V+D?+3TT9) DCD%BC,9!?L<79V_F6.S.33V'TS &U
M(F%O6^B'K=#],[.VK<6=>@_2\/0@" ( @" ( @" ( @" ( @" ( @" ( @"
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MB]LWQ?1Z3=  ",1 !80%F$!9M&9F[&9EJIU=*ARH5! $ 0! $ 0! $ 0! $
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M@N/Z75DRSMA99^]!B=D)=>U&CU,YF?54E1]0! $ 0! $ 0! $ 0! $ 0! $
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M-;8\'%\5_::^[EZ=X7"G5W+'?ES$5R>0FS?O0U+#6/\ 15FB;E;E%FXN/:M
M[ZZ9JEWL;&FVZ68JG);6$<:U>-?&]]6SKG\N.\_=RW/-9W79<]Z;KSS=6Z+U
MHI<7Z,-QV-[W<6$=<()#S56S%+!DX#FY1>W687*+0>+Z<W!]>Y;CH^5O1R]O
MMY?O%&*F^,J8]?2<Q[PZG9G?FLO!=G*4I0C2O+"OJI\*+%(XX,(]_;T&/O\
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M#_@BH^YG;DU2M%P6'PD_E]'R]F7.TYRXR?-3JW+Q(G*Q"6" ( @" ( @" (
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M0YK.'F\,PMWNS=I,WJ6GY[3;N5?K;.)UG0>]&3UB-;+I);8O:6XL V,( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#SP^*?>.3S&^:O
M3X)C@P&#J5[MVF):!;M6=3 Y&;VFC!FY6?71]77'OYA:M=[;[NG2$4GUR:K7
MR-)>/B=S_EQI5JQD7GFJW)R<4]\8QP:7[3VOA1&O%O#QQ51D86$F9BC-N!"[
M=CB[<6=GXL[+E=G-R4\&;W;S+<J'H_\ #OO3*;VZ;4;>;G*WEL1:FQ5R\;ZG
M8]WY2CE-^\BC,=7[W;5?1G='4IY_(*5QUE%N+?&E&O,Z'!._6DVM.U.4;*I"
M<5-+='FK5+HJG3H+W6TFF! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!IS_OK
M_P"PZV+_ ,1_U#G7_M__ &W]XN'X>_\ !3II_<D']*CM7_U=W]IFQ=T/]GRO
M^7'T%RJ.-C" ( @" ( @" ( @" ( @" KGJM_P#6+FO_ #E'_KM=:KWU_P!I
MN_M6_P#[D#.TW_41\?H98RVHP0@" ( @" ( @" ("MY>J6TZV7M8:]8LT+%*
M1XK,UB QB$F])-KHS]SNS,I!:9>E!3BDT^D@I=XLI"]*U-N+C@ZIT\ON[#O9
MC:6VMWQADHG&*X8ZU,_CC$9=.[QCJ)MZBU5NUFKN7]5[-\67LUIF6SR5Q82W
M3B\?+L:ZZE,9[:&>VQ8+)2QS6(8.,>ZL,SPVHV;OLP#[3>EVU92UC-6[RY8M
M+YDL4_V6:KG-,OY27:23:7_U+>$E^W'?UJJ,IA>JN8Q<<19L(]R85]&;-4F8
M; -Z98NPG;OTT5N[IL+CI#U)?)>SQ,R,KWBO6$G=I<M_+C[2_:CO\Q9>8W5@
MLML7<.;QM^.Y0#'6&,Q?1Q)XW;E,7T<7U?31V4=;RURWF(PDJ.J)_,ZE8OY&
MY>MR4H\K]&_@S6SH4%R6[NF6KS/9K[?,8B'M\Z1]8V^75N"V/77%1@G\KS'/
MNY*G*=YQVJUYWL.6SUX#<6T)MN96.7#[IDY8#LPERQ3.!:'QU8HR=FXBZH_(
MW9O*Y%\T-OAQZSW]<1SF3>7NUA?>&&QM/'J?0S7O/;CR67N25<QE)K=7%1-%
MC2>5_P G&?<SN^G'O?M4K:LP@JQ5&WCTFE9[/W<Q<<;TW*,52..Q/PV[39_H
MIU5VUAL%3V;F[M?%?1]<Y<=>ED?RY0=R(XY.;A&8/KHW8[=B@-6R%RY<=V"K
M5XKAT]*\YT/N?WBRN6R\,G=DH<L?5;>#6]/Y,EPV4V&DF5M5<GELH]C(QM4O
M7+1GJ7-RB4QE&8OZQ=EL=M)45=R]".77JW9S<UMG)KJYFT_&J$-S$\$0/D(L
M=+$U.,@FMV&&O% (^$"YW<G-S[F!M53<E5TW%^QEXQCZNWPZ<")8[?U&Q(>!
MQMH),QR>\6*4GFF(!Z9'(-!U;CQX^A6I7E#&;]7<]]>KA0REI5V2YH1>+WT4
M:>ENOF\1/ZMC+%#7N6L[C6J60<*[4)7&>-P;5^8O"POW/\OH5Z%UUYH\#%G:
M5NB;HZX\>GS5_L*QRN2Q&,KV<WDMI3W9H"82R/)-9D\LNV5@CYB<6^>0B[>I
M8=N5VY65U).NPFG:MRE&WEY536UT5'PQXDJJ922O5QUG%2XF**RT5R&$[#3Y
M.:FXZSQ1PLPGV.SLSBQ#WJ]"YRR3;P3V>X8D\JG%\T,=C:V5Z63C"=3LN=O)
M8O863@BP66C:/*8Y[8M")L7*;R0-^4B(>Q^#*Y?Y,Q*#Y5S+>+%R_D83A&4H
M0GMCMB^GQ]!DJ6[;^"R-3)V9J-MJTX^64\+20,7S"=FXD+<O#7M5<X<U82;2
MZ"/MYFY8N1N0Y9.+KZRJO)OH7YC?BUW32GCBR..Q^:J ^AVH-(')OZHZ\%$7
MM!L/V),W'+?S#SMN25ZW&2XK VLZ?]:=F=06BJT+94<P8LYXJR/*3%IQ8"]D
M_N*!S>F7LOBU6/%'0=&[U9+4VH0ERW/DO!^+CXBWR(1TYG9M7T'5^]1YLC:1
M^UX>A $ 0! $ 0! $ 0! $ 0! $ 0'&8L3.SLW%M.+:KT\:J>7'4Q[=/>>Y\
M3<KR5LA5L><;$W)YT!D[Q&&G!V<5O&62G8A*.*H?/^L2E;U"]:N*DDZX_&3K
M1K<5!E<J%?&VQR ^95YM='\)$WWK$LJW%19$7F[N'#TE'YS('E]R83'QX[GP
MUF>.WN3,$YQ1PT(GT&('(M3ED;06;3@VKK&CZM8RDG*KV88;O,3EBW!VY7FI
M*B2A%^M*4OC/@HK%X[\"95<O)?RDN2&K&^*IM)3PM28=8A.1N09?*^<X#V,Z
MR(R3V$5*V[>#7K/;X>4ZCY.:OD:-#$.18R632>K$8E8R-G_2^<0Z-IK]P652
M>)1**<&WMIY/)3?3W3/[MQ5R_%0DP5BM](5?R4WGD_*\!-S"X\GM.'8O7B6<
MO.,&^>M.CP\765!7MD=Z6K^], F%F(;8N!>48L_+(_*7WG%45)%PHJ\GP>#W
M[#DDW=F,C+EMN],SG@I99GB_>GD8?*#FY2("?YQ^+31>IT+D+$;34[V[;&N+
M\GG.DUC/X'&3T-O2UXZ=,/,N;DNQ#&<Q<W+(,LA<2+T:+RI2E;N33FGT);EN
MILIU;S%7NH>*RU+R<5;M9&QCQ8"*"$H1FG'VO;Y=5Y+ O1R$X2]=))]-?14X
M,]D)G*[=!I8O?*<<WN_-R\IE[0Z_*K,V5Y>WLC78^'AAP-<+-&Y'E;F5R.1L
MWS.0BHU'(CA@.3Q:"/-IP[%CRD;,KL96XVXQ4:;7\9EBU(K5>C!<N7)0,X0:
M:IV"W-X=']!=Z(C).+DTO#PV-LZV2Q5G.51I5LM/B;$!<T8CROYW)Q9R/773
MTJN#H7+-Z-F7,X*2?'=7#=O-F^F6"KXX(KF<DK/D+E8=";FY.(^U'%[(NLJV
M:SG[O.Z0K1/H+JV_@L#5M26*CE>N.12QV['B>+F^;$W8/^57DC E=;P,C?MY
M6O99X@=X?9EY^_Y1?M518JT\6T_#RE-;NQ>2Q>3JEMFU+6')593J1S&1102E
M)SR-S%V_U [F=6VJ$C9G":]9<.OP\-YB,A?^F]NY#"WKY5L]-'H)RQD5:O8C
M+F&0G[-?0R]KAB>VX]G=4DO5\[Z/[3%T-J7GH5CW=EJ4-=C8H<I#^1DF+^I'
M\W7TI0N7<Q%R?9)]3QIX]_BQH6=6I5<K#?@Q(PV7EIA!#YK\\(#&7A*3U>E>
MK$P6Y1:YJK&O2='(P9.B6,VI@H(Y(L@W/F\MY?*,HCP(1(> " ^E>-%V$HRK
M)^+W#,T<EC-T//B<&(V,5MJ1BGL6A(8)YX_")R:#KHWS&;Y5Z>3MRMJKP3QZ
M?)P\$<6?",?<*.4:[D6O1RS5LE3C_P!4#RGY2CT'V/"_8_;IKVHRB$6ES1HJ
M?V>2ODP9^-J1YNO%+<STD,$F+A=JM>"4R.$9'T$2?V90(?$VK<PNB%]PV0\N
MSP>[SF:QE>UF,B$A6"EB=^8B=_9'O=O4R]+;C\5;?#%]1C=Q;D9\Q9Q(R'CL
M75CBCISQMRO8YAYC9R]+/Q^1>5XEWLTXIQ6&RGP=.T[F+OU,4]<I6*W+8)VB
MC<OFEX2D543'FG79@2.LTWN^1AD/R(O.%CLE[+_.Y?P5=QYE0Q8I=FT]E?"I
M8NW<;E+5BA7H"X4K&DD4Q.X5W!G\4LA/HSLWH=8]ZY!)M[5Y>I$OIV5ORG&,
M/9>-=D:;Y2>_J/1OI_A:.(P47NUN#(3V=#MW:[L0$3-P$7;N'N6B9RZ[EQU5
M.".^Z/E86+"Y6I-[6B>K%)<( @" ( @" ( @" ( @" ( @" BFY=H8;=5< R
M$+QVH6_U+)0OR6("](&W=Z6?@ZR<OFYV'ZKPWK<_$1V?TRSG8TN+%;)+"4>I
M^YL->,MA\]L#+!/+>DQ[V#8:.Z:8\L-A^Z.Y!Q%W].K?(IVU=MYJ%$JTVQ>U
M?LO::1F<K?TR]5R<:O"Y%82Z+D=E?!%D;?ZMTADBQF\VBPM\F9JV4!W>E9;N
M=BX^63^A^'K6!>TMM<]GUEO7QE[Y.Y/O-",E;S=(2W2^)+Q[GUX=)F-V=/,)
MO"/Z7Q-@,7G) YJ^:J:/'.VG 9V'PRB_I[?6K.5S\\OZDE6/![NK@S*U/0[.
M?7:VGRW-TH['T2W27G-#=[6[F"S5["9:N6.OTB$<M"#ZQ3N_&,FTX$+MQ9UN
M&62N6U.#JMW%'%=9S$\OF)6+L>6<:<U-DN#Z5O1)]K=3<CM_;=W";:D#'9#*
M3%-;R/ IR\/* QL_A'1N]UC9C(QO75.YBDMA)Z;WAN93*RLY>D9R=7+XW13=
MXV4MNBK::8+,K2SVIN:7(A.8'YFK\9.;TL_:ZSH4IAL1KF8BU+UJN3Q=<<:[
M??(=*)N Q1$4?O5#EE,3YN7R^;E$2[W519W]1@L???/P5O<!L:9?&QRQW=-(
MQEJR%#RR%S<'+E5*Q+UR'9/UJ8.GE(9/C),38Y,VY/9N$<-;'4S(Y?+;VI2(
M1_LQ[R9G9^QE30R>9RPCT[?#R[NJJ)7BX):X'6KWIZN,CC(<;<KQ-4%R^]'W
MWQFW^8VK]R]+4DI.KQ?AX=6RNT_%BK4BIC?R$\NX:X ?OU.:4+!/$/A(A$NX
M2[6;BE-Y1&;K1>J^./AX4,3!CGWG&;X&ARUJ,)QT*?/)7D"1FTYHR]D>'9Q[
M5X\2_"MN5'C)X\?-_8=7;,.X=N!:Q-F.6S5CL>>5RSD(I+ \HB)Q1S,,(DWA
M]GCH^K:KVK*LS.W>I)))\(JBZZ5V^&XR9;AM[<+WB]6D:"03D@L7*T<)3.?M
M (N6NOHT?1>;"B-OGP6WPX_ ?NEN?'SVJEPIL=CH;QL,61GE<N4B;E]U*"+5
MP<^[4=->]>%2M22Y7X<,>+^ D&X#JQM-1DL%;F&K^7/PB(E&7F:>C3Y./#AQ
M5<Z)41CVTW)-T\%N\V)$:MC%G"$E>J1P3Z">2<><1(OFCW::]C*RVV9?9J."
M6/N? =I\M+A8_I>-O>:U=V:S:J<T4D0??E%Z&]++Q.47@>RMV[F#5-ZXKJ99
M^!W?E7R->S8SQW&C )HWGD(Y8OG@+:O_ )%>[.VXM4IT<3"^]9FW=4G-R2>#
M=:JFZCZ>!:53JIN>]DFM/E[<?*3>4$9.$8LW<P-PT6']PM*%%!4\_E)K]39R
M=[FE=DGT.B\A?V"ZVO7J V4@:W, Z&0/Y9%ZW;V7^5E%W-$4WZCHC=<GWX<+
M=+RYFO$_>.S<^(B_&+MB=L1 _P V:Y.6GR\H:?Y5DV>[*?MW/(BQF?YB7%_A
M6%URE[Q@:V]^LO4.?W3!S25XC?1RQ\7N\$;/]_8+5]/NK*GD-.R*K<Q?2ZM_
M\)&6M:U[6)<MC!?-7+%=<V;3=/\ ;>4VUA!J9O,39K*SF\UN>0RD$7=O9!RX
MZ-Z5JF?S$+]QRMQY8[CINB9"]D\NH7KCG-XMMU\A/5A$R$ 0! $ 0! $ 0!
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M'.O_ &__ +;^\7#\/?\ @ITT_N6#^E1VK_ZN[^TS8NZ/^SY7_*CZ"Y5'&QA
M$ 0! $ 0! $ 0! $ 0! 5SU6_P#K%S7_ )RC_P!=KK5>^O\ M-W]JW_]R!G:
M;_J(^/T,L9;48(0! $ 0! $ 0! $!!]U;%Q&ZA::9BHY6$=*V7@9FE'T";=A
MCZ6)9>5SL[&"QCP>S^WJ(G4=(LYW%^K-;)+;X^*Z&4)+#NCIWE6@]Z;#R63=
MZMJ(7/%WW;NDA?@!OWZ:.IM2M9N%:<R6U?'CU/>C390S.E7>6O(V\&O\*?7'
MXLO(RW]M=3\9DY0Q6>$-OYPF\$4IM[M8]<$K\'U]#\?E47F--E%<]OUH>==:
M-FR'>"W=EV5_]W<X/V9?LOW'CUG7W9TPHY=Y<MMN4,'FS9RD\MO]4M<.R:-N
M&K_?#_.JLMJ4H>I=7-'SKJ]XHU+N_"^W=R[[.YT>S+]I>ZO.:9;MR]W 7<GM
M^=IL)<DT#<V*YM(9!9]8W]!"6FHNW:MKR]I7(QN*DDO9>_P7 Y)JV>EE;D\O
M*MN3_P 2.YK<^I[4R7]/NHL6S\#F&P=>*QG\M,+^]6?[.*.,7:,1!O$;N[OH
MS<%AY[)_>KD>=^JE_:2^A:['3\M/L4G<F]KV)+V53:WU8% [T]^LW7RUT9)[
MV1L%8R<)0M&3&[ZO)&P=FCJ3LT45&+P6'$T[44YW>TNKUYNKJJ8\40LRL,,(
M122^=<I'%X]"*-XB+E(O7W*M.N!BRC1MKP1':^8#*QU0J6RDM9G'DT!L!<I3
MTI2C/F(O9<NSBJ6ZLO=G**JUOQ\*U]XA$M:]C);-G.3SXJK',]: &)GE*61M
M>4 YON]NG+VK"=N5VDO9DB:C.%E2MJDXO;NZ=O EV#*[H>(KY"*S4I1O)!;C
MY\D(EIKRF7,,3.W>^O#NU635D?*$:U>'F\.EC(5;$U1KNY+LN1HAX;D(Q\O(
M#=X\A"^C<W;W=RMW+/.TWLX%RQF^SJH+UGL=?-T<:$<*K4W%##0VO'8MX[&@
M;PQP2,TS2L/ N69WY]6'5^'%+EMR7*MF\O6+KM3Y[B]?=@<6SPS^%L6<9D<;
M=OWPD":OEGIUX)Z\?+X@Y(R)G;OU?1V5R"4<"C.SC=?-"D>*JWXZNE/09BIE
MJ.,S)YBQ0K6KPM*99<8)8I'C/PE'YQ<I,7J[UY3$MIRY5%5IP\,#M5;.)NY.
M'-5<9%YV4?E@RE@XH:\@_P"DA.0_G^'5M7;CV(TDPE-QY&_%\&SQF:S\4<<+
M4+,H/))3+_5X!YN1A+S!\+?Y=>':KDDHK!F)"LI5:HJ^&PA<!8GE&(9BE.9O
M:=_R0/\ >^'M^756N9U,IVJ+89>OGKFV_*R\=B6K%7D#6]0E(A G]ER9^(NW
MI7G-QQ7I*NRJURMQDL4UA),NJEU8WWE\AC9\KN>UDH8!"6D4LO+Y?+XA?D!F
M[1;M?M7D,G847RQ2KM*KVNZ@[D'<NRE1JF.&'5LV;7M+C'XB-\97*A)#E0I0
M1.+14X8@>-V9OG.3.1:]^KK!_*+$8^S7IJ; ^^V?N7D^=16Z*6'PFPFW>OF-
MFH 6X*W+:!ORDU7L)_3R%Q;[CJ+NZ+)R_=O#I-TR/?2U*W6^L>CWC\Y+XD-N
MUV(<9@,AD)&X,1/'"'\KN3Z?<5ZUW:O2]J446,S_ #"RMO"W;G)^)+SE?V.N
MG47<UML;M?"5Z<TK\L458"MV'U]+EX!^712*T#*9>/->FVO(O?9 S[[ZGGI]
MGE;23?#UY>/XJ-C^GE'>-/"O+O;(O<RUH_,]W\#M &GLZ@S,[^G1:SJ$[$KG
M[A4BO.=$T*SG;=BN<E6X\:8>KT8%A+!)L( @" ( @" ( @" ( @/-?X@LU7F
MZFYFL]F.%ZE6*%[$G'DY!U=G6]:+:7W55WU9PCOG=[;5YQ7Q8I5]PTUS.2;.
M9#$PSVO)V^TWFV9"8O[,?%R-_6+EX+(FVL"'M6HJM5CP]WW2 96Z-C<L5B"_
M&6"AG.2*J+\Q'$(^4+?U2YNQ8G91YJDI"_-6>6G4_#;\)UX=Z04LK/B*-D=3
MKD4)D_/I8]HB(O7[*NJ26",>>5E.//+P_L.Z,=34++&6.KD)%?I _)S23>UR
MEVB!>I55+>-.+W;_  IN/V^?J268L16L%!<PXB->$2+R^7YH_P!8Q7O/N/.P
M:7.U@]OATD<LW<-G;AW"H2N]0)H,C3JB(SM+W^AG\SO7G-4O*W.VJ56-&O#<
M?+NYJ6&Q6,J/1#$ /*,&-A?EE+[G]5D<A#+2N3;K7B]WE]!AMUT3W#1BALT[
M]+&6V%@RYB0$+>US.!/Q;^KRIS-.I?RL^QE54;7Q?<V53\^X@MCW2O6BQ.WL
MI8R!1\S_ $C:?F*0VX>$M/#Q5$I)LS5S2DYW$H]"V>DQ][&;BRMFW+>FE+$A
M4;S&8B 8I&;Q:=BM29=MSMPBE%+FJ8/!7ZU&22F$/N\K0:8Z*4O-,S!_RALY
M?U5:4C(OP<O6V\?'L.]E;C6;..KPR')-;%FK1<V@>:3Z&9Z(V46H4BV]B\/#
MI,'D<E!@I<?+*\]^G?EGJ6+-5N66.4!8V\)<.1V52+UFP[RE1I.*KCO^'H\9
M;NU.L!8RM5K6:<60IUHHVH3N1$?*1<H\Y#X?"LB$V1&:TKF>#HZ^'AO+WN;Q
MR^0QDT,&0CPK3P>\4/<6U*1A'FY2+VB9Q5[FJ0RL*$N/&OA[A",5UYVR^.I5
MK^<L$1D0TLA/&;R:"^A1S:<=.;L=7$F9][N_FU.5(>RO6Q7"N&/F+3S.?JY3
M:\%F  S%NO,$ITHC;F>#EY9"C+YKZ=B5JB'MV7"Y1X=>[P]#*4LYO&;)RQ^_
M9JUF([4T.1$+0\T<T<S<L)>$?F=C^MN*4;V$I&Q/,1]6*6[#S^;>\7@7#(..
MW#CPO#1;(2GXIZ,Y<O@^<8MW_<0C%S6Y4K01W+5/!3TL55]PD.PT<M:'PEY9
M#X2CD+VV[_3W(*)S3DZKCX=!E ?)R;3W)6CF*OEHJP TA\W,\1$)&/RD/!-Q
M2G%7$]QANFF0?(3[GH>5,%"[B0L5J_.(PQ\DG)(P:>R3<R(R,S#D73[SK5DX
M+*G@L!BW(1.$;ONID3\W@E N4OPA7M:&'R*[5<,3(7XY+&-*;'2#R"/*<OSQ
M$N4N4A[^4NSU.O66H8.C\/#<1MLXU''E0K"4$]6QY&= FY)>P2Y(_47;ZUY4
MO]F]KWK#T4(;G<S9@W$4KO#)5ROD%AXK3<U60F#RY!\/LD+>(5Y7$OVK:=OI
M5:\>A]702RA1LP32#?R5:$P%O(*(/-YA+_1CZ-%72ABS:EL\/#>2K(W*TF+J
MT DYH@D=YO,]HG?3Q*]:E5[:,PLU;Y8<M*QQP\GF/03"W-BYKIEMH<'7&QCL
M?'%5CA>/D*6U&7Y2/3M)N?7BM2O0OVLQ+G>+Q\1V?(W\AFM,M=@JPC2*5*5E
M%XKRFP&TL06*QK>9$,$UMQED@#@P/RZ,VG8H;,7.>1N>G9?L;>*HWC0EJQR0
M" ("OM]]1=L]/:$%S/W0AFO&T&.HL;>=8D?N!O0W>ZS,IDKN:DU!;-O!$5JF
ML9?3H*5Z27,Z);Y/H,OM3<U/=F*CRE.,X@)]"B-V=V[V?5N#LZM7[$K,N5F3
MD\Y#-6^>.PE2L&8$ 0! $ 0! $ 0! $ 0&-R6-HY>C8QV1KA;IV@<)H3;5G9
M^_U.W:SLKENY*$E*+HT6+]B%^#A-5B]II?O; 2X.QF-J62>Q%4#WO"VI/:>%
MVU9G?U<6=;9D[ZN<MY8-X272<IU?).P[F5EBDN:#? K_ &]U"W!@CK5L7E;6
M)K'XK4,!-)"Y1\6D>,F?E]!LVC.L[,Y&W=3<DF_?\,#7].U_,99QA;FX+>EB
ML-]-WSN)6?5C>4VYMQ_3LT$7G%7"+)C6'F&0X_",HZZ\-&[.Y5Y.S]WM<BV;
MB+U[/_F6;[:22=$G38VMZ?A0KRIN*:H!G#6KWJLK:^6Q.W'N=G;O5YLP814>
MFOAATD$O9^SD\F5^\+/%C*Y!8K2&[PR0%[3/XN7AW,J*X]!E*WZNUMOS=1V8
M-RP'!7DR$@U+4+:\A^$1C+Q#R^OE[5[4MNPZNF*\/[3&PU*^,VK3KYO/3T@"
MW8LX^>#Q.,,Y^8(3^5V^+71F;L3K+LY=I<;A%5HE3S5Q?FWF:I[ORU&>M9IP
M8R_7C@TAR58S>8P'V1DYO9;U?S)4HC;Y=C:?F.Y9?#[KJ%GX;1392J<D+>,6
MDCL!XO=^>3F &YBX%H_#@E*E/-*$J2K1X_#[E#APT34:[C)[O:MN9V*\3!R@
M,A#^5C(A\1<W>_>Z(IN8OS>&WW=I\R^-P1Q1V[%:2 3%BAJTC>"*N8C[4?*7
MA/TNCH50N3;=/01S<C4<K3K238\<H$D>GFV9B&U&(>$3C+V3Y?DU5+9>L\T6
M\:>+!]'AL(0V3VWAK%.#>KY>?'D)#&Y/)::2,O9%Q8'\MO\ ,T=E2FMYF1MW
M)U=JE?H^[YBQ]DPX 2?<.'IVH*4\0MCX<G+!:BLQ-^4CLQ'RM+$T;C\_1U5$
MQ\S*4?5WK;MP]%3*#DJ>N1SE+R;!9R\9U[IMS\XCRQ?.YN5G+5VX-P[548K4
MJJ+K5;?'X?V'++9:O_K\F.K03$#^;8-V&+F+YQ?,)_0_<O*'B>-*OJ.K0LY&
MV=BS'-![J!O%YL["0ER^T(^7S,;?S+RA7)I*CV]'AZ3'7JY1SGDX!AC =1L0
M5RY?R8_.$2[F[O0JDZ%+BG@WU>'@B8[4W;2NR1@U<BJ>7R^^$3D<<S>$AD#T
M*Y7FV&.K;LNDU6F_KX;:HMVO-"#BUFN,U?[YGT?3U.K?K)X;3,A.*]M)Q+/Q
M&[NF^%"&0=F'>MQLSG+9E:0>;TMS\/YE@W<MGK]5VM%T*AL^4U?1LFD_NW-+
MC)IKSDIL?$1F8XQJX+$8[&UPX1Q:>9RMZA;E'^96K?=R.VY*39F7_P"8EVG+
ME[<(KR^;!'1AZ@]7MTD04[V6T)]&AQE)@UU_K\G#Y=5D?EV1L8R4?^*7N5,:
M&O:UGG2$I]4(4\[1;'3;8/4N'/T]R;FW#>HX^'F*7$6+16)K#.W 9!9W &UX
MNVKNHK4\_DW:=JU!-_*2HE[K-F[O:'JL<S',9F])07Q'+F<NOXJ7G-FUK1T4
M( @" ( @" ( @" ( @" (#B, E!PD%I -M" FU9V];.O:E+2:HRJ]U](=L[B
M8[-6)\+E.T+E;PL[_P!8.Q_N*2RVJW;2Y9>M'@S7=2[L97-^M%<D^,?>-:MS
M]-MT;7G*6WBWRE0?[+,8]W$]/Z[#Q9_E93F7S=J\J0GROY,O<-"U#0LUDY5G
M;YX_+A@_'0C%#;&:W/,]/%;:OY"<]!.U9(Q"+7O<RT9M/E64[D;'K7+D4N"W
MD;;R%[//DM69R;WR;27C9)KOPY;HQ%-LO'(&3MR/K;Q-*1V<!T[6<V9C?TLR
M\AWCLW)<K]5;FUX4+]S^7>9RT>V3YI/;&+]_:4UF,0T5>>2M;*-P=XRKV=&%
MB9^(N_9V\%+6[SVO%=!JF=R'JODE1[*2V5X/T&MM\]\XO<E67&"X6;=@88_+
M;S!?G?3E+ARN/I61=S%MKH2-9R>0S5N?,O\ $;VKT8X=9;7T%-D[-^K1GI8^
MW$/^ORU2'WJ>73Q!V>%M>#-JL*#4US78MK<MR1..S-3E;RMV$9+VVEZSEP5=
MBX%5OMPOIC&ULQFIZ5[) \E:J<;&T;"_+R2O]\2N9AP];LU3P]!AY%7T[;S,
M\=NQ88[-FTM/;NS=NT*]DYBI39.$7]_:>?S)!9VX,;/QU?UJ,=EW**XJUW4]
M7R;&;5"_;L\SL344GBV_7_XGM3Z*E-;NIM@X[=[IW2H@.=M@&Z8;4DLH&,+/
MY1A&[F(CJ_LBW:HOO!H6:N0@\M>["*?K<N&/1184X*G2S/[K=\[':7+=ZPLV
MW%J'/*O+MK/YU?BU;HUL([D#J8B*',9K&GE,^T#2A@;#^Z5F\/MS!JSQQ^AG
M<5(W)]HURX)))O?)I8R;Z=K2,;*6/N]NEVMR3;HI-\L4ZM)0XK962KU'W/[N
MOY_:$-ZY2QLT5$7GH6J=>$ IN? AHR2#J):<&D[?0K3L=K.K56O&97WQY>VU
M"7(I<*1\*E'[9VEN+=66N5*FW,7@]N4XQLA/;<IY9Y3+B<LS\SN?8_!5I\KQ
MV>&TM7$YV_4=9\-BIT>[Z#;7&;>KRUMNW\Q=Y\D,;P261K/.]@*I"PA*0EHP
MEV>EV4A;ES1<HI/"E>O@:QF+3LSMPNSE%5JHXTPHZ2>S$R6>BBBN8AZQE*=4
MI&&.$/(CC>0W,G$&[!;71N*R<G"-NW*$]Y&ZYFIW\U;NV:53>S<M[Z%3>5[>
MMU<3N0LK[M%=#.'-D'O6)>6*$1;DD&,>SF$N/'TK%S"FJP4L-E"7TQV9<EZ4
M/6HY<^RB;]/0]E36?,=1]B[8W+G,CCMKV,R5VW#7'+9.1RK/?T\/N\9>*41?
MMX*%OVH7H\EZ"E&NQK?NH;QE%.U)7,M-QGRO&+=5%[>>E-NW$NN;+CDZ[5<<
M1EEA.%K=L1%X0$WU(=!T&/FU=Q'B[,S]ZC.\>L_D^2EF'1R;I%/Y6VKXT2Q7
M'#8;-_+KN9#O?K4<A*4HV5%W+LU@^S6'+&GLN<FHQ;KAP=&3NE@LI5A"W7M>
M6XDTWDO#$\+E_6 HRYM>]GU=<!_J)JL<QVD<Q-2Z).G5RUY:?\-#[#G_ "L[
MFO+_ '.>EV)0XN-9UV<W:5Y^;IJ8'<FXY]QY$"W90ISC&+01P586C@&.)Q$M
M(1=^5Q8Q/7T/Q[-5WGNCK?YOD>WV7(NDNE[5+QK"B^,F?('\V^YT>ZVM?=(U
MEE;D%<LMTK&%>65MTIC;E\:F,>E,C<)[DZ;/?PF!H5<MMFWK>PUFY*8^ZG(_
M,X0L_:)/QT=;E9N\J3<4]K\.@X[G;%N].Y#M&I/E77PPV.6[9CO,EC.H^X</
M1\L=OS%E-/?;,$W-)%,!>V3,WB 2[6)GX.KE[5K$LJLS*<.R^7S+EJW14EU^
MK0Q,CW>S=O-3R\(7'-*O)R2YN5+'F@\?G<R^ GMCJ+C<G!4W92@DR%:&$8,S
M%$^LT+$W]G*#>V'<Q=_RKRY*-V/-%T:W&5&-ZQ=Y+L4X37M>Y\Y>&TS-S%;8
MW;MN.SM-YJEU]6BF!_.&"0NSF&1]1'U-V*Q*].:VU==GPF3;R.7L/%.*>_%K
MAA%]&[<8C8VY/B#VF(;1Q60Q><V^5ERLY.$QJ7,5KQ\R1[ \ACKKX69]5'9F
MS+,7'*2:EQ-ATS,VLAEU"Q.L%5\NS;P>U+?B7"U<<U+2S6[(,-F-\[>R!VL;
MN_"5#Q!^5RZ"-SD/E,A?CKP%_0KF5RDXU4I57"F!YJ>L6;W*[5M*:QYD_$ZM
M4^$B.X<E1ZA!#BX[<66QM"VUG<V0A(QK\L;Z>[<X&)E(;\1)O#PXZJ0NW6HN
M,'2N#Z5O70_00^6E+G4[M6Z-K<J\6OC+KP=.@P]R?:5DSPEG"0'2M \#L!$)
M&+_-)Q?37[BP[V7<$N;Q? 7LKJ4;SGV=.,L%39M:ZO,8*#9E#QU*EJE'CXHM
M*E^RYC/7Y7Y@B>/Q>8S]W]"HOV>1J47B]I=R6H=O&5N<4HQ:HUAU[O)2N&&!
MVWQ\EHQKV;,.3@ N:M?KE_K%8^YW9^+MZ59I4S7)16[E\E.K@8K;F8RWGY&K
M>G^B,QA+GDQY".5X7EUXQ<KMHY-(+?\ A4EDO5PDJP>U<.G'@:SK2C=:N6I*
M%Y>S*M.;YKI1X\#=#HOU9N[2*:_N8[=VM:JO&==I?,<I1+POXWT;APU6/JVF
M0N)0@U5/;T,V#N?WINY6MS,*335*5KBF;J;&ZG;=WX,D6->6G?@'GDQUIF&3
ME^^%V=V)F[]'6K9S3[F6HY4:XHZUH_>'+:FFK=5)?%>WX2R5@$\$ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $!Y![MREG/=0]Z9/).3V[&9M 0R/Q (9'B
MCC^0 %A9O0OF;O'F+E_-W9RVN3]-*>)8>(^H]+RT<KIUBW;]E6X^.JJWXVZG
M#=Q\#U^8='=VUX+6[=UJ1<M7I<Q8O0+JA/TWR^Y<78AGR6$RM1K=;&1DPC'>
MB)A8]2X Q@^A.S=S<'T70.[_ 'N6BVYRN1<XR6$4U[>[J5*IM5>S!T-<[\=W
MXZK8M7(M1N1ERN3WP>[IH]GC+$W)U8WKNMRCDOOB,:3_ /LV@[QL[>B23VRU
M[^+-ZEK6O=_M2U*L>?LX/XL/5\K]I^6G0:[D.[F3R>*CSRXRQ\BV+TG%"X31
MA(#LXFVJYA.33H2;=#\G7DM$-6$.>29]!'^EW[F95\](GDIJ"JS-1[-N>4QC
M8B>5FU\O0F^XQ*Q*9@/4H5HTZ&);&O7DE!X1AD8G:9F%A)W;[YV;C]U6Y7>-
M<.)E]ISI.M4<S5-.UE0[YY4RD!G + 0OH/!GTT5F=);2U**D<D]ARC(09]2;
MM]"IA&,75='FQ\J/(VZ,[L.YMQ/0;$SY>U)1 F((R-^;A\WG]IQ]3NMJS'?+
M5[N364>9GV:==KYNKG]KE^;6AB?E655UW5;7-U8>397I)7M;>F3P4\ G:DLX
MQR9K-.0G-A%^TH]>QV4IW2_F%J.A7XNY<E=R[?KPG)R:B]LH.6*E';39+9TD
M;JFB6LS!\J49[FE3Q,V>BFBGBCGA)CBE$3C-N\2XLZ^P+-Z%ZW&Y!UC))I\4
MU5/QHYM*+BVGM1V%>* @" ( @" ( @" ( @" ( @" (#3G_?7_V'6Q?^(_ZA
MSK_V_P#[;^\7#\/?^"G33^Y(/Z5':O\ ZN[^TS8NZ'^SY7_+CZ"Y5'&QA $
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M.]8JIRQE7P>&TKFQGKIYIK;8VO+-4;FE&7D<Q,?:(7]KE?L^52\;%J<*NN/
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M7+HV\= 1<W-5Y-!Y3$BX:]RMODN/U=Q=<;V7CZ^]5IYZ+HW;.DY+MN3+[=/
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MZRDOD[Y/JWX;.%,3MG<WOIEKF5ADLW+DG#U82?LRC\5/A);.#PQJ:T139.R
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MQT7*0<U.EJ"JG5/#CT;#D^J.N:N84]9X>,E"V8P @" ( @" ( @" ( @" (
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MH,J]::23HTMDFJIK@^"I7;2GDK9NW^K.(VY+6VCOC9E_+6Y#\RGN*I?DJC+
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M4$)AO-:Q@#SQ3V#*25BU['=FU9M.]UZIE%S+1DZ4];HP].!FVW;/.\$<9^3
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MGJ7XQ:,;]9GY2(@;@,@.[<S#P=GUT;BND]S^]#U2+LWG^\BJU^4M_C71M6[
MY?WV[I6]+Y<QEJ]C)T:V\DMV/R7NKCA3@;2+>3G@0! $ 0! $ 0! $ 0! $
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MPRM+[I0UR[*5RZXQALY:5==]>!L']GJ])%RXV;'[BC+5XSR1'%9T]#R-J/\
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MV8SFE1MM*/-*F%%OZW0D=.T7O7<S$'*Z[=M-5YIIOE3Q2BD]JPK4WTB PBB
MS>0P$6,W[2=FXO\ =6G-G9XII*ISKPK" ( @" ( @" ( @*'WW\.W2+J-8:]
MN7:%6:]S\Q7H@&.1ST]LG9]%?MYF=O8S!S.FV+_M1.IL#X:.CW3>T5_;VTJS
MY!_8M6 &5P^1G;@ES,W)[6>6--L6?9BBY;&V]O6R*2U@<?8,VT,I*L1/I\I"
MK*DS,=N+VI')7V_@JG&IA:%?_P U6B#_ ,D4<FSU0BMR.A-D-L2R-2.>G*<W
M-$T;")-Z"'F9G98-S4LM:GV<[L%+@Y)/R5+O82DJJ+:ZC1V+HGC_ (?<#U?Z
M@X2;'[DW-NBV-FI++#'*="M+(PN3"^NC@QZLZQ>]6KW<ID)7+6$E1)\*NE>N
MA)]R=!R^:U.%F^ZPDVWTT5:>-E$#E\WRQY:3-/=MD0D]>8(SC-W=O"\?+IH_
M9HN"6^]^IPO<RO3P?%_V'?+W=K2KJ=J65@HTI5*C\I-MS_#WMZ7KOLSK+CY*
ME*K%C(I=S[$AA9JTEHHF+N;@)$_'E==.[P?S<R.B6K=F<97;TH1DU!JD:\9-
MTKP1\]Q[DO,9N=RW2,(R:5=]'P-TBZ<]%MV8.',9[8FW(X)=1FDLP0@#&W!V
MY](_N+;.[_>2SK.2AG+#:A+<\'%[T^DQ,YI4<O==N<57J(/FOA:^&S(8>UE;
M&RL<&*@A.:2S4+P"$;:NXNS$IZ&;F]DJD;<TS+XMQ/!GXH,E\/F.WF./Z'PS
MR8>H)AEIS=]0M 6CB(OVCJIBQ*=/7-6U#+6XR79+#W3#]'_AZZO]<L7+N#IO
MBJV2Q=6Q[O=>208YHR9^5]1[E7/,PMOUBQ:TR[>7J8TZ2>[N^!SXA-G//=GV
MC+G3EC;FGJ:R::<6$F;AX5Y#-VY;RN[IF9AARX=!K=E>EG4[#V;G[R;(RV$@
M%F;S7C,1YQ]GF)G^ZLN%V+V,M7K;L)56/2JKX3L;<)L818ZWE[EJ:0W>:* 6
M9A8QY'#F/F(N#Z<%=YB*S'[SUE%*G]O]A*X:^ H0R"-8:\=:<7@BY]8II7UY
M.35W=B'3Q=RN*1B2E=N/B^KJ\JZ>*,#6R.YZLF:,X+#U)W AKQ:>(>?V8^5_
M#X>U7XN-$9<[.7FH)22>-:UILW\<>&[ GNY*ES=>&Q,>,GE]^AC&0<=.7EE)
M$0Z$.I=I#ZU<A.CQ([)7;>5NR=Q8;*K=+:GU<7P9P%%6R^T\?N:;FJ6]OM[G
M<9O#YA5RY>3_ (7A5Q.CIQ/)*5C,.TL5+%;_ &E7S>6AFL5;RH6L5GCK,P0P
M2#;J^UH_#V?E;@Z\PV&-=C;I*VGOP\7O.A-MNY#*3[HHQ1W^?;..CL6CI\PE
M)#))'^1X^TX<?N+U-4,6];M++RJGVK<:/=3XW0G@F6[D96L8/$V*EX*=C*Y&
M*()A/0I/)$I"Y?3V<4W$3"+4VFJT7AU;S\4HLE4L93)M&4QYZ." XX?$'-&3
MZR%R]_+P7HDXM1C\FK\VSX#);NCJ9PCVV$0^XX6:&6V,C/S26)AX31D7M#'V
M+ULIR[=M*>]^#."LUB2Q;:<2YWJE&0%\[P<H_A+P2I3#B5MTVQLD%HZ]T;%6
MS9C*.Y5D'E+FA+R1+Q=Y#HJEBS-U*:>S%+8_#PQ)KB=SU"S4V#)BBL2R20UI
MY"80D>%M78A[EA6\_&=[LZ4KL9=S&CW+66[>J:5&UU^FA.L+2Q-O)##)1&">
M4QB-F?2(_,?1B]3ZK/N\UM<RW&%E8PO^I)4K39T_";IXKX-+Q15LA^]T4/O4
M;2G0D@(^3F;7EYA[=/D4)<[R1>'9[-Z9O64_E[<AZW;[<:->[T$QJ?!GMN0@
M+,[CLS-P\V.G$T6OJ8BUT^716/U)=7LQ\I*KN%EW[<WXE3SFQNP.D^P^F=1Z
MVT\%'3GD_P"49.5_.M2_Y\Q\?Y%#9S4;^;E6Y*O1N\AL^DZ#D]+ARY>"CQ>V
M3ZY;RS&;181,'U $ 0! $ 0! $ 0'QVUX.@.C)C,;*^LN.K2/Z3B O\ *RK5
MR2V-EF5BW+;%>1$:S=K:V(BDAM2X;'3D+O'%<CC82^4>#NWR*_:C>N/U>9]1
M@YJYE;"I)PB_G)&E6[;P%G+4E#&8MHC-R"QBK!/!)KWL!OP?T\%N.3L_NUSR
ME7A+;Y3D>K9C_P#(;MPA3C"6#\3(A)/'(Y%-4FBYO[728&C=_6RRN1+!,BI7
M>;&46O&J$%R<9F14ZU<&K6G=XI&87&.P/B V9N.C]CNKJ;V[UZ"&O03?(EZL
MNK"6U-=>QE<RY6K:G&GD<+/6RCD8VK$+\D;"+>*4V+AR^E^]>2EAT%N%M-UI
MBM]=O6O2R&V9HC)L3AYY9I1D(3O2>$P\S[TO9$59D9MO!5>PBFZ\3=P6/LA<
MJPY6.U:KRCY#%&431CQE,)/#RB7B?E[>_@K;CRJFTS+-Z-Z55ZN'B?@N)2FY
ML^#,&WC&*:.9BE\Z8>:?SR'F,_%_9L %_.K$Y[B5RN7>-Q84X<.'C>..&PU[
MM7XL;;M3VYB.S*PE4C[(X1$= :,&?01=EARF;!&VYQ26S?TD8R6Y[ET'$7\D
M7]IV=W_DU[%:<VS+M96,,2*22ZZFY\^OSWXJVV9<%78="6=M'=WX-W:JVV9$
M8F)FN:.^CZ-_/]U6I3,B%ILQ<MX6?MX^CTJT[AE*PCJOD6U=F)N9OFZ\51VC
M+JLH_0Y$7=V=]7;VF]"]5PI=@[T-YM6Y2T?T.ZK5PM2L&5ALB7+QT?N=N"O1
MG4Q9VW$M7IQTQZB=5\C+BMA;5M[BFJ\OOUN)ACJ5G+V?.LR.,8.[=C.6OJ4+
MKW>G3-!M*[G[\;:>Q/VI?LQ592\2+V2TC-9^7+8@Y-;>"ZV\"SNH?PO=:>E^
M"DW)N?;,,N"K,+Y#(8NT%UJK.^G-. LQB+/VEHXMZ5!=WOYG:!KN866RM]]H
M_9C.,K?-T1<DDWT5KT&?J7=34,A:[6Y!."VN+KR]+6WQ[%Q*!U^<S\6[V70#
M6F; ]/\ -9Z&KC)*L9N<,<\4$@CSGH3\Y.&O!^#<5EV9.AKVH6;3DZ^'%/K=
M'UFR6Q]SU,,53"[F(JE>P_O&"LGJ,;E)XN4O1V_<6=;?$UW.V.>L[>.Y^&]\
M277[.-K922Y>H$,7F<_GQ$)^24GSN7YS/V\%68D8MQHG\)DK4M8XH)K$HR 8
MZT<J'$>7YORZ>A^Q>U+7*=?9&^,OT_WE8,9XY("CB*:J1>">J7B86'^KVB_;
MJL7,6(WERS)C3\]=R,NUL;=Z>];T^K<S=G#?$]1L5F?;^WI)>30>:[(,8N7>
MS#&[ZLL:WW:YES2N8=")?,_S0<)]G;R[KQD\'U4K@2JK\3V[87'EVMCYA;N
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M>G'19=Q/E<6Z=)C97E4U<BDZ.M-E=GC/5'IY\0>!W3@)CR$E##Y[':ZX<Y7
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MM_*SEZRI3H95F)MY.2]D<3ELK%E':OYE.J,@/*1 7]D)>@F5NI6X554GX>'
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MM61S';14E[2P:XG(N\6E2R5QI>PW6+X/=CT&P/1_J;'O#'#ALO.,6ZL7&S6
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M[<I4K1-^0O6;?:7(QXM+RL\?&N7-Y9?);ESUDK>6S4QV;<TCZ\O,_AC'7V1
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M)_9$G^^;L6F:SDX0N.4/&N!UONMJ5V[84+N/R9<4;:*"-N" ( @" ( @" (
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M98V?U3,YYUO2K38MB)/0NZ^G:+%K)VE&NUU<I/QMMT+04<;"$ 0! $ 0! $
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MI+MP^_-G;@$/HC<E"X9LVD(3"Q\?ZA.SJ+N9:Y;]J+7B)>UF[5SV9)DQ5DR
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MN5Z^%NUW&IL^S!"]II'?5I2\IA:OR_>ZD[]^BA-9NZ<H]GEH>LG[573S[>O
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MWF(PV/N9D,F>+8XZE>Y6JYJ5F[!?YQ?\%N"\H7;LU;IS8NCH7+)]%YN>66Q
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MI795K<>@$9A( 21DQA(S$!"^K.S\6=G]#K1F=M3354<R\*@@" ( @" ( @"
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M0QTT4D&6'F%GD=O%RMQUU61#!XF%<G:[1=K'FBTZQKC3'?N>-=QN5LSJ%@;
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MBF=QJU..+G+=3=AAT[^C'H.O=/(7-QY>[F_,8ZY26;Y^$@<7#5M/ZL<?L_\
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M<\?]7P'6@;3T"WW5K\N\&1L+ELY=-=*27H;-YAW2U/--2S.;DG\UNOF<8_\
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M.:9Q]D2[=69>&=/+1Y.:KVTIX<7N1B<GE[GO,3WIY+%:Y:U@\7A8/+YO"/\
MG=Z)EV-F+C6*V+P\7F.Q#=JWXJ[#>"<ZEEI*_*)%YD4C<I"9?+Q6?E+*O-KH
M+%RW.">%&]GAMQQKT/H)A4S\D>/^CSY2MUY2]T/L&0/:]KN<5D=@U!);5Z#
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MC)2@Y;E7CQJ7>X&1OYK5[<[5Y6Y+UI)-U:6V+BL,:[-BW'L"N/GU6$ 0! $
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MY2M^3PJZ.L>?%2]9;L*8[E7DWCMJH\UK<$&>FL;F"_6R%>U<C&.J4E1^$'F
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M#6KU?[6W)Q =>_7O?U,MYRO=J6N02MQY(4]KP]!J^>URUDXNKJ^&\V=QW3S
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M1T\1+*_*67Y)MSBG5<<,%LW+:>@.1Q=&[:QN=FA&(I,5%D;I]OB>%CDX>O\
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M_"_>,_2^,GHO;=VFNY6AIIXK&/E9OYE9EW3ST=BB^IHR+??_ $J>V4EUP:+
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MI9ZIY2]>9III9F<@CB?B(QAW:>E94)1M-)+#C2I!YF-W-0E)RI+'#FY5Z=O
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ML6O=)@GC-V?D8 ,XV\+CKIWKGW>+OU?S<Y6<NHJTFJ-I\TN5UQV43X4\9O\
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M_,O'J/B?FB@=W;Q,W'3^15YN_;N33C&M"WI.1S5B$X7)\JEPZ\72KW8+C0H
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M9]F_;O04[<E*+V---/J:,:Y:E;DXR336YX,B>^-D8O?6'?%Y"26K+&[R4<A
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MEN3=GI^ZJX8GF9<I1P.3,A5FLB=<!9W'\KRLVCOKPUT[UY-T/,JY1C1G)#=
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MO%P_#W_@ITT_N2#^E1VK_P"KN_M,V/NA_L^5_P N/H+E4<;&$ 0! $ 0! $
M0! $ 0! $ 0! 5/T/_PQV[_YS(_^\+*U?N;_ +5:ZY__ ')&S=\/]TN]4/\
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MHR)_\UB4#G-&S>45;MMI<=J\J-BR>M93.-*U<3?#8_(\2\5%DH$ 0! $ 0!
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MV]X+B:E<E!]%N7FP:*ZR&].I.3\T;N[,];Y^!LX2LS_<T92-O)9.'LP@O&B
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M5K4'_+2=O,CD'L*-RY7/^3UJKE=53?[A[;LJ4)5PHTO+L\.)(:T[WHO.CI"
M1:.TQPAXBB]KF\7:I&U8G)5BMU2%S$[5MTN2:QY<-^RE*56W!K;7AM-7.H&)
MM;CS=@L5RW(:L9<[3-J\A"?,]>"(W((0?YQMQ<EAW<A*X_5I3_FQV8TPZ39,
MAK,+-M*YS)TI^RJ>U55J^AX4WF<VCLV7Z*I6+E2:F1"[RUW'4A,2U=M>]7%E
M9PG&JH_09+S,)VY..*XTIS<&ENZ"=_N)4Q30VBO28^*Q+YHTP9M F(?;D?O^
M3N4M9R-F4W)/%*O1X>0@KV=S=FW%322;Y5OECLJ]BIXS!XZF>1MO2>=[/NS%
M7KQ5XC=W/Q.W(S"3OZ7]2JE)I8I)=?G,C+Y:,IIU<I;L-G1TTKB>CWP ]3[E
M;+9GI)?.22E:@ERV&B(>$$T3LUEM>X9&=BX]_9WK5^]VG15N.86W8^E;O)L-
MX[AZI+M)Y63JL9+H?QO$\)8\<-AZJN+$VCMJS]SK0CII%<KL;9F>B.+-;4P^
M5CE9V/WJC!+KKZR%U=AF+D,8R:\;+<[%N>$HI^)% ;K^#'X>]U";_N2VW;!Z
M\UK"3R5#X^D6<@_\52^6[R9^QLG5?.Q(?,=VLA?Q=M)_-]5^8URM?]W-4Q67
MAS.PNKF7VY9KR^;4F.N+6(78M1Y+,!QEJWK%32[YRG#ENV8R7F?B=2$?<JW;
MGSV;THOQ57C6/EV[ST8VYC+V'P.(Q62RTV=R%"I'#<S-EF:6S( L)2FS<-26
MFWIJ<W)))-[.'0;I:@X046ZM+;QZ20JT7 @" ( @" ( @" ( @" ( @-+_B]
MZ4[5W1L;([VGM187<>VJI'3MZ-_KC$[.U8VXN3D_8[<5.Z+FKBN=DE52\W2:
M'WWTG+SR_P!\E+DG;6WY2^3[U,>!XR7]M7IXV"-RBLB7G.$@\/ZP\JVF=EJ6
M*.:6,XI0HG7T^^F33;5@:N&L5\BT=:&K*W/=E)@;W:,>;F<_ZI<VJ]<.54>"
M+?,KLU."JWNVNOBW])%?IRIF,WEI9&BM4)87^C7GT\@H/9%XI8R]KYS=[+&Y
MG+9L)/[O&U%5?K;UO3ZO# [M41"E-7]S'(/1DUJ-)+YA1QOQB<9/G,*NVIJ-
M:JI9NVVY[:5\*=9^-Q8^[%'C<Q%YL,TD/E6(XI"&(W'YI#[+^%4MNE3VTHMN
MVWTKCT_"0PK%>P'G8ZNUNU1_MXF(A(G[V,?9YE2L3(<6L).E?1T<>H[4.<KR
M5P*6E8B,!_Y*3B[B_HYN]>>,\<'N]#]W8*>1.R=J4\*T,0B)<\DG]KJ_B'PC
MHKG*XK$MRCS.B>/HV/#?3=@=:Y-8JVQGQ(^3<GCX8Z;_ )-,WSQ'YO,O'4N6
MU%IJ:V>&'6]Y-\9MW$W(FG>L,(6 UFB+7E<C;Q>M7G&F"(^-V3K)NE*KIPXG
M2W'A!P%%\IBQD\CGCKV!Y.=JSE[),)?-+V51.%-U#(RUYW=]5Q]SPW%<W<A?
MR,S2V<S9(8(G\N)C&%I)7]AC'N%O0HK4+>9ER]@UMQJZ>,V#2YY2'.K\'BO5
MHJUZ.)T<C3R$1-=R\M6;,\!*>M"/Y$2;@/F\NK?<4A&/E,7M5&-%50Z7AT'>
MJ#N*W8%FCDCJ0Q#)"4(#'S'V<CE\U7[67G.5%Z3$O7K$()NM6^#]'FVX'>N9
MK,.,.,DG(8;9%%-/YG+YCC\WE]"J49<U'@V8[MVU!R6*B_-OX[%CT<3-8W;<
M=N+2W7"6O/X#B/L=G[5Y&#3Q,EW$UZKX.O#>2:SA*&)Q46*IQ')#%'^3[N7Q
M>RIF,+<[-$L4\>HAKL)V\PI-^TNNLMSKNX/S%@_#H CU>V'6FFY*CY>%P(GT
M[7X,_P!U1>IV^3+3IP-@T%J><M\VWFQZ^/C/Z$G?7V>UG\2YH=J-)?CRK13=
M%(9RKM-8BS=2.O,+>,/-$V?E^713_=R2CF<=E&:YWIMN>4HMO,J'D3THZBY#
MI'U%PFZHJL5Q\-8;WNC8'F&2 O#,W'BQ<NNC]JW#/959B$K3>$L4_0:/IF9E
MEIQNTQAA)>G;C[I[!U,=B]C;IPG7GIU$\_3'J/#')OG'UG\%,K?*PWXXF]D7
M/3S1;V2;F[W6DN<KUMY>[[</9\6[WNC WZ%J-BZLS9_P[GM);J_&7][IQXFH
MGQG])9MB[UEZDX,2_<OJ1*$EZS7'4,=FQ9B";G;@PV&9B9_OM66PZ!G5F+*L
M2]NWLK\:&]>+T&N=X,B\KF.WC_AW:5I\6YNEPI+97CUF^?PL=6FZL]*L/=NR
ML6YMNLV+W%%KXGFA;09?DD#BRU?5\E]US#BO9>*ZC;='SWWK+IOVE@^LV948
M2@0! $!@\]G<5M?"Y;<6=NAC\/AJTMS(W97Y1"*$7(GX]KZ-HS-VOHRL7[T;
M,'.;HDJ^'7N7$S,ED[N=OPL68\TYM1BEO;\/$41CM_=>-WX]]T;.Z:X#%;9M
M UG 8_<^4L5LO?K.W,$A0UZ\L59Y6XBTA.[,[<VBAH9W/WX]I:MQ4-J4GZTE
MT4=,>FBZ6L3<[^BZ!D+GW;-9J[*ZL)NU",K4);US2DI3Y=[BNHMG9>\)]S8;
M&7<W@+FR,]>\X)MIY8HVMB=8N61X^4ORL?SF,6XCQX*2RF<[:"<XN$G7U7MP
MVTV-KIH:SJVEQR=Z<+-R-ZW&G[R%>7UME?DRW.+V/#$E-S)8['-$]^_6H^?S
M>3[Q*$?-RMS'R\SMKHW%]%DW+L+?M22ZV1UK+W+M>2+E3@F^HA?3KJ1@^I6&
MFR^()H"@O7:4V/DEBDG%J=J6JTSC&1:!*\3F#OVB[.L/(:A;SD.:+5>%4V2V
MO:!?TB\K5W&L8R3HTO7BITQ2QC6DN#)37W%@+62GPM;.8^SF*K:V<5%9B.S&
MS=YPL3F/W663'-6I3<(SBY+:JJOD(V>1S$+2NRMR4'LDXM1?4Z4(=9WO;@ZM
MXGIT./A.CDMKV\_)E'D+SAEK7(:S1,&G+RNTG,[ZZ\%BO.26<5BF#AS5W[:$
MK;TB$M(GG^9\T;T;?+3"DHN5:[:X4)!N7/3XW#[ADP7T?D]R8BA);KX2W<CJ
M Y\KO%[Q(6ODQD[>T3:*]F<QV<)\E'.*K2J7EQ5/'3K,'3\E&]>M*]S1M3DD
MY*+DZ;^5?&DN"Q,C4RT+4L;)E;%/'Y"Y2:S-3:P!"+A&,D_EF^G.$>O$F;33
M1U7"^N6+FTFU6E>BKIQ2XEB[E9<\U:4I14J)T?%J-5N;X<<#DQ.<PF>K%;P6
M8I9JJ!O&=FC8CLQL;=HN49$VK>C556<Q;O+FMR4EQ33]!3F<G?RLN6]"4'MI
M).+IXTCCL[BP%3)U\+:SF/K9FV/-5Q,MF(+4C>D(2)C)OD9>2S5J,U;<TI/=
M55\A5;R&8G:=V-N3@MLE%N*ZW2B,XL@PP@" A6^>H&T>F^!FW+O3,Q8;$12#
M"$IB1G-*3.XPQ1 Q'(9,SZ"+.ZQ<SF[>6ASW'1$OH^B9S5\PLOE+;G-JO!)<
M6W1)+BV87IOU=V!U8I7;FR,Z.2+&F(9*A+%)6M5W+7E>2"81-A+1]'TT?TJU
MDM1LYR-;4JT\/"AEZ]W8U#0YQAG+?+S>RTU*,NJ2;55O6TGN3GI5L==L9$HP
MQ\,)G;*73D:,1=RUUX::*1@G*22VFL7I0C"3G[*3K7@>-^Z(:\>5S%B2,#K7
MIY)FJN_8$KNP@7^<RZEEG6RUP1\Q:A9Y<VI;ISKXG6A:O0_X?K74G;VXLED;
M98"G%8>MA9QB:3SC8-2[7;PCJS.S* U34XY:4(Q572K-Z[M=U[FHPNW+CY8I
MTCTX5\BK3Q%&=4.G]KI_G\GMJ:X&4DQK@QVQB*&(F<6)^4"U?1NS759N7S/;
M6XW*4KN(G/:6\I?GEW*O+3&E%QP_M*:A"Q $DQ.1T18HZE<_$!\W?Q]"O7+4
M8SP,:S=G<M>LL4VJ[W3!>#(;FK5<+YXP*]FF)1#9ANP@4D 2#P9B[>4_1X?E
M5%R/+U&3E?WB;PJG2F]^CJX]!CSK96M5CJXNW8L.PBU]I9-9[)$6OG<P\O*0
M\W+\B*TV53S,.:LE3=AL6Q>3T;BP*Y96G%@X+#^Z35'\R>(A;\L.FGB'ULJN
MS<41T[MNY)M4\/"NPY\ENG*MDFPX-7I8Z-^:.N,9$4X\OB+SN7E!]>#+UQ91
M;C;<:O%[.IX^YOV;B [@W!;C"*")[4.+J2<LD12>\$?]8O9_X/*J'%I$AE[<
M)/%*N[X-WE9%Y;-/*5I[-:I':&N?-=L<OER1E\T9!?E1*JJ9:MRMRP>#V8^&
M-<-IU82A"LUFSC">(2X66KQO#''Z7YRYB)_5P5#D7XV-E)8^'#<MFW'@3C;4
M-3'9F&^,-V&G?A>O/++'R10C(XZ'H^@\?ZJ)X["U>L.Y!JM>KC[_ )"Q]Y[=
ML4J^.S>-D@ER&)!Y*X.WF!-6D?QN/SG]#MW+-[-.W6+V;?@(6W.<,QR7%A+V
M<:8KBNGR8=)Q[>VUU)ZR6I]N;"V_[]/B1CLY2K',,0A$9<C222D[,/#@S?=6
M#F<W'+PK*5*O#I-AR&DSSE[EMP3Y5ZRV)5\U5Y?*=7J5T0ZI].I(Y-R[4GQS
M0:&,]'6Q3>/O9K "S.WIU['5W(YVSF$G&2JMQ7J.CYG*MQG!TIM6.'7Z=E"#
MT<G*,<TDD/O5D/RH,\A!JS>UR_-UT4]<B[D<=JV>\0F47W>=8I4>U8I;W6*Z
M?=+X^&W:VT^L/5>#:/4*:Q%C'Q]BQA,56LO ,]N!F?EE)N):#Q86?BZAM6O7
MLKE>TM;4U7"M$S9M%R]C/9WL;WLM-K&E6J;:<.%3U$Z"_#7M_H-=W/=P^?NY
MN7<C1 XV8PB:$(7)V%N7VW=R[26FZMK4]045**7+P-_T3N_;TMS<).7-QIAY
M-O6\38>#%XVG8DM5:%:O9F;EEL0Q !DW;H3LVKJ(<Y/!LG5"*Q2,HJ2H( @"
M _!B)BXE[+KU8 _:\ 0! $ 0! $ 0! $ 0! =>6"*5V>2$)';YQ"S_Y5ZF4N
M*>XQ-W;F%R/_ "S%UIW;L(HAU_R*N-V4=C9:GEK<_:BGXC!2]-]F3ZM+A('U
M^;HS?Y%=6;NK9)F.]-R\ML$?FITTV)2-I(-K4/-9]6*6)I'_ /'U7LL[>EMF
MSR&E96&*MQKU(S.9R6)VAM_+9RZ,=#$8*G-=MO&P@ Q0 YEHVHMJ[-HS:\76
M!F<Q&U;E<GL2J_$3.0R,\U>AE[*]:<E%+IDZ'E/N/X@^M/4#(GF,9N>ULG#C
M,\V(P&*&,/+A^8%F8P,YB=F9R[!U?1FT7'=5[YYEWGRR<4MB3IZ*5_XJ\:+8
M?2^0[C:)I=KLKEE7YTI*<ZNKWN*32BN&^FTK7=>]MT;ZO41W1%3.]B0:*>_3
M@"O[T-B9F\Z6*/0/,9WY2<6XZL_I7:?Y7][/S2,\M>=;J7.G\J,=J=,*JJ:H
MEA7>L?EO_P#B _E[:T:.7U+(565N2[*<&ZNU<G[$HMXRA-<T<<4Z;JT@.6G.
M'*>YU@UBA$WEB^^U]'R,NN6;';66Y;6?.>9S7W3-PA;V*M5Q6Q>1%:W\?$<U
MZU:(W"FWO=<A^^$D45V/)OKL/+CE][=VGJ<M:]6SW3DK8"?(S8UHG:LUAVLS
M::<K/(_,3\OH%N*MJW*$')8)8>/X3)E)7II;6TF^K<\>&TDCX#Z-EL5&HTH+
MTLAR4+D4C'+)!XN9S'N=V?L67*=N5ER<>&/204\O?MYN%J$VTW)TK@H8T5*[
MZX=)Q?NS;S.WKM.%X^2Q&3F9.[#H'!^;YWM=RM.W"#ES/:J>4\M]O?C;Y4JJ
M3E2M/9JGMQK78BO89K. J7)Z?NU3*0!&%NQ0'2'DE\(Z >KMKR_RJU/**/*F
MZ]6\D,MG)W%.<4U6BJU2F[X:E;Y7.209R6YD_.R,P1EYUV(N:3E+YLD3Z_DV
M[?"RCLY#EG2-/0;+I#4K;[6M'A7;[BP9S9&P$U,>>J,^-ML$]/*$#<YC][S>
MTS>I7I3YK:<]J\/(6XY9VK\N3!/'#WMS:>XQM3&8V_#(4L=:OXOR4 3L-F4.
MXHP$W?MX+$E>M235*&?]SS,*2YJUW/'JKL5=]%@=A\-G=MVJMW$6LW#</2,/
M]:+46<NPN;77[J\[#FPCCULI>8<%6Y6,L=BKY*;.A,V#@DRQ[B/&WLE)8&EA
MZMBWJ ^7YYN7G&S..C=G:WH5=F%)J"V8,C\_<=VU*[+&2<E79A18<*;^@P&$
MNA9AOY7'C9.*<B@N5;P,PR.!: X"'=Z'[5DJU*Y.4DL7+ PY9B%G+V[;?J*V
ME+?5O"F!/M+[53:Z$M2.*.$@%V$XQ%G_ +,H_0I3L[JK*&*:_M-3NRRTG&%Z
ML'%X5Z*\JWO9T8E!=4]R-4<Z-*W%SV@>)Z5.M[_,\4(\SG'S:- 3.^FFK:J&
MU'&56GS<%C7P\YN7=NMNSRP:Y'2LI.G+5T5:[NA+U7UE);8&]3N%:C"2S(\D
M=JI8F)V.'30M) =WU+MU[F6%9M.E9;'X4)S-W4WRPVQVTQ\:PV>=EQ;JWG9W
M++!';IG6:?0/+$F:)B'B['ZR_D67"W&$:0V/T^\15USNW%*\ZRBMBP5-B?[6
MY]&P^8K;M!W>:.@3WBA8><Q88R%R[A'P\/D6;?RT+=J,X+UGM=2QELW*_?<)
MOU%BHOVMRV=#Q19N'VW@H0<[5"*8B9G=]/!S>M592Y*M&D^OB4:AE8.+E%RC
M3@Z85Q1@<EBH8IZEJD$=#(#.Q$\3<?40J]G;-N3B[=%+?3 PM-O7[49QO.3A
MNJZU]W';CL:J2F,\QA\@-MZ(T,RT+235#9G"U!(VK^S[).S=BR\O3DK@XO#J
M9:OPY;OR+E*T?QEN\W#;O)G]*06*5B]CISCK7H""U'KH<$PC[!?(LJW!2Q>W
MTHPLQ<E!MQKRM/KC)*M'T4/5&7H96W9\*N$Z=PA&V:@PD61P=MM/#D^5YP+F
M]!N7(7J=US%ZN[.J2O\ Q>9I_L[#MD>[T;^A0RGQE!-/Y^VOEP?0:<?"IT3V
MOU3Q_4? ;O@NX3=6VK-:"A9B,HKM A9]>WM89!TTU_D6R=X-5N9.5J=NCC)/
MI4C4>Z.A6,_;OV[R<9QDEM:E'#WUYJX'J';Z=X;<6Q(]A;^ -\8YZH5KMC(1
MMSSO&V@3.[<1E;MYA?FUXK0HYV=J_P!M9]1UKAZ.KH.ISTZW?R_87UVD:8UW
M\'T/?4\_-\_]W>=7('DNE6]I*M,N=VV[F1\SDU[ CL [,0^HV^ZMKRO>Y-4O
MV\>,?>]XTK-=QY0ES9:[ACA+'J553#K7C*KH8[XG?A>M/=KU;3;=C+_6:L.M
M_#S#]\43>*%W](J2G/3M65&US=/JR\N_QF!:LZIHSYDO46Y>M#R;8OJJN@VP
MZ9_')L7<;5L?U"HEL?)R.T;Y(7*QC9"[/[1FYH_D)EK^>[K7[579?.N&R7PF
MRY#O;E[J2OKD;W[8>7=U.C-V\7E,;F:4&2Q%^#)8^T+%6NU9!EB-G[V(7=G6
MLSA*#Y9*CZ3;(3C-<T75&45!4$ 0! ?@A$A(2'5G]H52U4]3H53^YN;VE:M7
M^GM^)L=;E*>YL3(N38]S)]3>C,+$=,B?5^5A*+5_8%:_^57<C)SR+2BW5VI8
M0;WN$EC!OJ<7PX3KU*UG8J.;3YDJ*['VZ?/C@KE.-8RIO9E\;O\ Q4]V+#YR
M"QM'<$GACQ65Y0&9^S_5K N\,[:]G(7-Z199F7U>U.79W4[5Q_%GA7]F2]62
MKLY77H1BW]+N1CVEIJY;^5'&G[4?:C_Q*G!LL)2Q%A :0?%H>S\#1V]:K_1^
M/WE:NO*4$->/WBS2Y#&2670>(B>FG-VOKIKHN7_S!T_)RMQ<5%7FZNBI*4:/
M%M4W[*]/ ZY_+.WF\S<NQDI2L*-*MOEC.JHECM:KLW&FFW<+?WCDH*V,\4UV
MR->JSMIYL\K]C-P86;75W?@RTC3^[^;SEJ4K,4U&BQ9UG/YRWI]MRN;$JOH2
M\/&3;(4,MLS)7-M9F 8<AC^49/+)C @,6("$F[6<7U9_0M<S^2GE[TK=U4E%
MXK;T[L*-4:IM(JQ?LZA:CF+3K&7]C\YT:[A8.4CE$#[7'5GY69M>*PKCY47Y
MUBE@2ZOBLW5LV,5/1&G<@J%>DAM2QPZ0M$TS.SF[,Y$#L0BW$M>#*\\A=[25
MN2Y9*/,U)J/J\O-A6F+CL6UU(R>9L3BKBE6+ERX)O&O+NW)X-[$=>.(&C8^?
M5W;5W;L]:BIO>7')UH?DW!R%F(6YNS5V;7Y%2F>JIURIVI*EW(15RDHT)(HK
MMMM.2(YW)HA+CVFX/I\BS[67N3MRN*+Y8TJ^'-6GEHRM78J<8-^M)-I;VEM\
ME<3&#![R1",C _H?M?[BI<U!59?<^7<2[%9/%5:3PW(H6,&Y'\P1[6^5==[L
MZ[IUG)\MV,6Z;TO=(C-9:]<N5@WXJE<;CQ$F#W13DOXZ"3&W1HYCZ/:9_+L8
M^UI*S:Q.SB\@,^K,[.RU//PA8S:G./J2I-);XRHUL>%5U-$]D,PLSE9*$GSQ
MYH5IC&<<-^VCW[SUFV;N#;FY=MXO*[3GBEP)PC%1:(>1H1A;D\EXWT<"CTY7
M9V_F7>M.S=C-9>,\NUR4HJ;J84INH?-&JY',Y/,SMYE-7*U=<:UQYJ[T]M26
M*0(PZ%[(4L94L7LC:AHTZH\]BU.;1@ ^DB?1F6-F<S:RUMW;LE&"VMX(OV;$
M[\U"W%RD]B2JR#8GJQT_SN0'&8S<E>S:D)AA;E,!,BX,(&0LSNM8R_?O1[]]
M6(WJ2;HN:,HQ;;HDI226+V$SF>[&HY:WVERTTEMV.G6D60MP-?" ( @/)?J%
MA<EMGJCO&GN&,VM7LG8R-2U+V6:UJ1Y(Y0)^!,POROI[+MIW+YO[VY._8SMQ
M7*U<FZ\4VVGX_@/IK0LW:SFEV)V&J1@HM+XLHJC3X8X]*=2'9LHYFBBH"17)
MC".C'#J\A3D3-&T>G%RYM--.]:_I\+CN)*M25RJ<:N?LK;793?7HIM/7W;PY
M$,!A S!.66"A6'*D3ZN]EHA\Y]6[?'JOJ7)JXK$%<]OE7-^U15\Y\N9YVWF+
MCM>QS2Y?V:OE\QCLMLS;.;G][OXJ,[??:#6.0M/OG'37[JIOZ?8ORYIQQXGM
MC4+]A<L)8</>J=G&;6P6&/S*-  E;V9C=S)OD<M=/N*JQDK-G&,<3R]GKUY4
ME+#R$D66880! $ 0! $ 0! $ 0! $ 0! $ 0! $!IQ_OK_[$+8O_ !'_ %/<
M.=?^W_\ ;?WBXOA[_P %.FG]RP?TJ.U?_5W?VF;%W1_V?*_Y4?07*HXV,( @
M" ( @" ( @" ( @" ( @->NLV:Q%W-;%Z>Y7+U,5B\U?;,;HGNV K1/CL:[2
M!"1R$(OY\S"+-KW.M+[T9JU<O6,G<FHPG+GFY-17)#&CJU[36'2C>>Z>4O6[
M&8SUN$I3A'DMJ*<GVES!NB3?J1J_&=; [HV[C.M61I8+<&-S&&ZEX\;A!0MP
MV&@R^.'D/F:,RY?.@T?5]-7'3N5O)ZCE[6L2C9NQG"_&OJR4J7(;L&Z<T<=U
M7U%S.Z=F;VB1G>M3A<RTN7UHN-;5S%;4J\L_(F=P\;D]V=6-^X&YNG,8_;F.
MQF&F?#X^R5?S))AFU=I1\<8OR^)@=N9]-7T95SRUS/:IF+,KLXVXQ@^6+Y:U
M3W[4MM>6G-A5X%N.8M9'2,M?A9MRNRG<7-)<U$J;MC?!RK3&BQ,9@\;=EJ=9
M-@6]QYJSB=KS02X2\=P_?HH;5/WAZ[V?;(&)G;1WXB[LL3*V93MY[)2N7'"U
M1Q?,^>DHN7+S;>7=3A4R,YF(1GD<[&U;4[J:DN5<C<9\O-R[$^K>JD<Q5>WM
MCX:+6=Q&<RM?(Y#"5;4,Q6S?W0FD$>6FW#R1T=^ K%L6I9+NY*];N3YI13]I
M^KZU/4^2NHS\S<AG>\\;-VW!QC<DO97K8/V_E/I98&[)LONK>NU.G<&<O8'$
M28*3/[BN8Z7R;=L0D&"*L,[-S +DY$?+Q=E,:A<NYW.6<BKDH0=OM)N+I*6/
M*HJ6[';Q(/386<CDKV?=N,YJXK<%)5C'#F<N78W2BC4ZPXS);3ZK; P5/=&8
MR&W<CC<S*V'R%DK')) $.CO*7CD%N;PL;OROKH^CJB.6N9'5,O9C=G*W*,WR
MRES4HEOVM;*5KRXTVEQYFUGM)S-Z5FW&[&=M<T8\N#;W;$^+C2N%5@1%]SX[
M=^=W7;W5E]VUJ&(RUG$;>PFWJ^2"M"%(N0K,T]*)_-FDD9RT(O"VC<JBYZA:
MS]^[+,ROJ,)N$(VE/E7+AS-P6,F^+P]$HM.N9"Q9CEH6'*<%.<KKMN3<\>6,
M9OU8)46"]9XU.[)NC<?_ &2]5XI+^8.7:L%@-L;LOUYJ%ZU5.%I(C+S(XB>2
M(N8"-F;FT8NUUDPS^8EI>:BY3?9UY+DE*$Y1>S;1\RQ3>&YEE:;EOS?)M1MT
MNM=I;BU.$9)T:5')<LL&HUPQ6P_>]]O9;;>Q8NHM?>V?L;MQ(8^Z=B2V0TYQ
MDEA"2N5(/R+1D)NVFFO>Y.K>JY*[DLA]_5^Y*]%1E5R]5U:3CR+U:8[..VIY
MI&?LYO/O(2R]I69\\:<OKJB;4N=^MS575T&S<9<T8%IIS,SZ?*NA1=4F<\DJ
M-HY%44A =.Y!5LUIZ]Z*.6I*#C/'*S.#AIQYM>&B]BVG5;2W<C&<6I*J?$\=
M]\TZ8;DW)*(">(OVIBAA?OBYG'3Y';L74L@ZV$G[2C[A\R:U:<,ZY)^I*>'5
M7T,SO1CH=E>IU?<IT3AQ-7$\D-:[9$B\PS9W:%M/ZK,Y.H?4\_#*\F]O%FW=
MWM O:F[V-(QHDWQX>3:5AU'Z?9GI[EK6W\O+7L7J8Q$;4C(@!C;5FYW9GU9N
MWT+(R^8C>@KB6#KM,'.:1/*7I6)-.2ILZ?#Q%.A8NF5@;)G9Q]?5N65^9Y'D
M[!YO0/I5^YEE":Y7@U6A1E,X[UJ2G!<T)4K3:EL\?3XR"9^WC*MB/!#.="2P
M/OM.O*)'6:2/1R\>G*+\?N]BM7X\E$\4\3/R35[FFE24:+;Q]/73:80FRV(J
MQR4''(6I/RN2N-!'"8N9.X'681T'E;PNVGB5%O*3E%NM3)O:E9C<46N6N&]I
M>/I>'6651R6;?&X$)B=I8IF*Y[RQ$,@=[<LGB'F;T=ZO0M2MPI3:1&<OPOW4
MZ[.''?7Q;-YD<MO0ZF0';]#$4ZT!F!23VY!:Q8!VU+R![V'U]ZNTN1P3W5\Q
MAJ.6N+F:HZT?&M:8O'K5:%?;EW=/2@^CJLT_T<,O+D[-F)F*9R[OR?,X^LBU
MU5J4)PCS+>9]B-B[<Y)+9@G[OPD)*;&6H99\?5:P#R.5B[4<F&/3YLD?S>;T
MJF-)QK2C1G3L7+<TJUB]]:^"]!CF/%VX".]5Y^23\CK!-*'+PUDDD'PC\BM.
MXODF7#*227[S%^7PXX+;0FNSJ>)QFXJERK8<J5N*6J\,=<QCC>5M&,G8=='[
MN9>P<:[_ '#S,9:<X--KW:]>SQ%L[VVO>Q]7&9ZM#':N[?YIXX)#X303\O,8
M$/<W>I%65V2E%U:VUW+W36H7YQS3MW(M1:HFJ4DUCUQ=?$SI5I-X[\ =L[ V
MM>R5]A]YLT:4;36&CUT=V$?"(^+B3]JQKV<=F#<ITQI7C[_42]K2HYJ[",;3
M=%S-8-JN'BKC5X8$?WSTUWST_FACW'M._M6T.CM#8CYWD!_%XIHM8_%V\'X/
MP=5Y+,QS$4X27';Y2YJ&G3RLG&Y!I[,5NW;,.CH9U<;F)" SL>?*4;-)%'&_
M+X6^]8N'L]RF;U;JQ>*]'OD5D:V&L&X;*8X/'V:_%X+=4N3H9M;&=;^J&-V!
MN'+W-O8*>I/<TJD V+<M9N9H.<F=AU;5]='?N[U$:EF;F3RKNP2;3W].\V/3
M,O;U#/*Q.L8M5JM[7Q?#JWGI)\.WPJMT0W)NS.WL_5W%'G(6K8V(:W(=<6D<
MW,B/7Q.+L+\OK6HZQKOWZ$(J/+3%X[3>= [M_EERY-S4N;9A2BJ]O32B>PV9
MQ.Q-FX/*'F<-MK'8O*R 43W:U< D\HWYB%G9FT9W[690MS-7;D>64FUUFQ6\
MK:MRYHQ2?0B9JP7P@" (#\$/,+B_?Z%Z@?IFT9> ^H @" ( @" ( @" ( @"
M (#1SXTZM^7 ;7DAEE]T&T8>[Q\S_E2;1BT'M?1]&6Y=T(VYSN1EMH<A_FP[
M\+-B=MNBD\%Q:HL./#I/-O.4PHV(QEY7L0Q>/E?V2?Q%XEM>::5*;*',]*L-
MN3D_63QZ-Y7EVQ';IG1DA]YBGE=QJD.H.)>I8MZ*G!)HDLO&5J]*Y!O'ANIO
M7N$)R.VPA,GL'[K!&S#5HPC^1'T: RQ>Q<GR)8DJLPH15QO;PV]-=^)R0Y&7
M%!3KR SC7;EJ0^PY^9_65NYE)VGC@R1Y^9)-53V5ZO#$L+%YR2U0:GEH(JQS
M?DY*1.S-+']]'KWBKJM2BZ3(^ZHKV-JW/=Q^!$,GFAHG*3<H5Z\AC"P<OF3%
M]\7I=U8E%/!&3;<EC+?X>)+<C$V,C#0IMEY6;RSYN:N+#S2$/'E%WX*UR/:9
M7.FJ;6]CX>+;XB)!U&R\%G$37\7C9,'-+[O>FJE)'9B C\$CL;<IL/>VNOH6
M3<S3<%'E7+O:VGL-/LOFY9-75BD\5)+=54>W9YRS-Z8R'+86"2O:KV69XYPD
M%B'\E(_()Q&Q"W-KP5-^,5;JNC$Q]/=Q7_6PP:I3?PQ\>XR?3VR]L2P^0>>"
MQ4TEA>P'+(<78Y?.X*[D_P!YMVF/JEGLFTO9>WH^"A8^3#'5<%E/I5@R-&Q)
M'#(#EXG*0^9G$A[.73@LC,Q3V\# TN#BI8MT>WHVE!9+#?0YWZ&0L5<N&8-I
ML;''3!F&!N @ .YZ$S^V;OVJ*=B2E27K5V&VK,V^3F@N116+KX_1N)/B]G/:
MB.QE<B-F:+ED]R9]7#E'E'G9O0REWD^PM\9>'E-9AGOOMZJPMKC1NO3\E/@S
MGGQM>H9@<YL$P%S0OV$S?>K&L6Y<^#WDGF;D8V_66-,"*Y;%QW;-*"C5ALE(
M\<,%DI/#7(.YA_\ NEEW<K*_=7+O>TP;6:CE;#<]M-G'KW4;PW%R8O&8YX*_
MF&5R[5C9I7?P1\PMXCY5(WX.*HE2N_B86F6(2;E.7-)8<NZ/]A&LUD*U$9(X
M"&Q:M3 QPB^NH,7B^3@L2S)PE4G,Y9A.U2.VJ\.KB8FM--C;=?+86YY5FG*,
MU2<'Y)(I!?5G65.W&:<7BC%MN=J2G'!K>O#X3V+^$CXA+G5O"Y#;NZI@/>>V
MQ$CEX"]JJ_A:5V^^%^#KG6O:2LI-3A[$O,SJO=O699RV[=WVX^=<3N?&Y@<G
MG>AN3DQA\HX3(5,E=$?:\J(G;F9_4[LZM=W[T;6:];>FB_WDR\KV5]5^S)/R
M'AAN.S9LWI;UQ_,O@P6#/33S8]&YG^7O_G6]Q@I6^6.[%>\:+-\ESM&MN$O-
MB>Y?P>5,R'1O%8?-QE<V]=J#=VZ5H>#5+;%YM<F+M83U=O4ZT#691EF')82W
M]:.A:-%QRZB_9W=3-D\QLG;NX=K7ME9W'1Y3;=ZN]63'SMS#Y3]@LY=CAPY'
M[E&V[\[<U<BZ23VDE=R\+MMVYJL6J494'0SX=\)T,O[NLX',6K5/<TH..-E+
M6.&.%W\MV?MYF9W9UFZAJ<\ZH\Z55O,'3M+ADN;D;H]QLFHPE @" (#7_P")
MO#9;.=%]W5\15EOSTO<\E:QD+.1VJE&U%9LPB#<2<HHRX=Z@^\-F=W)S4>A^
M)>]M\1NW\O<W9RVM6976HJ7-%2>R,IQ<8R;W4DUB6WM;<V"W=M[$[DVW>AO8
M/*UH[-"S$3<OED.O*^GLD'80O[+MH[*3R^8MWK:G!^J_-T/@UO6XUG4=/OY#
M,3R^8BXW(MII\?=3W/?M*.ZP9'&YC:>#ZQ;%OUMQW.D.9/+-8QLGGM/0B=ZV
M<I\T3NSZUW)W;[X!U[%#ZI.-RU'-67S.U*N&]?&74U1OHZS<.ZUBYE\W<TK.
M1=N.;MJ%)*E)OUK$\?GT2Z),XL(.(ZP]8,WN:08,]L/ISAQP6WHY1\VG<R>9
MACLY&;DD9P+RZ[Q0OP[2)G946>SU+-RN82M6X\JWIN2];S8237 JSCO:!H]O
M+JL,QF+G:3IA*%NTW&VJK%<T^:?BB5%MN,=G?"YU.W9L^C7P>Y1N;CJRYVA7
M ;<=.OF[-?FYQ;F=JU=R>/CX&;AHHZQ#[OI=RY8BE-X56#IS);=N"KU;3:-0
M?YAWIRF6S4G.URV7R2;Y7.5F,MFSUYTYOE5Q)GU7Z=],MF="+>Y-FXZCALQM
M/'5\ML7>U(&')RY%W ZTOO8_E9SMF3,3$1<_.^K.LS/Y'*6<EVENB:47&:PD
M\53'I\BVJE%2)[M:[JFH:\LOFY2G"[)PNVI?X:MXJ2Y/9@K:551+EY3&]2=P
M=1,;U9V?<V9M1L]U#RO2W(15<?-($%6E9*Y6EFGLN;MJ,;BXB#/J9N(\&U5C
M-W\Q'-PE"%;CLK#Y+JV\'AA3CMIU&1H&1TZ]I-^&;O<F6CG(-M)N4X\LE&,:
M;W6KE\6*;Q.8*6T#^%GJEN';UZQG,SNG;67L;ZW#DQ;Z5L9>.J<=F*\.C/$5
M<M0&%F88Q9F%M.+W[,;7Y=<N0=92CZS?M<V]/A3<NFM76KH=[.+O5D[%^*A"
MU=MJU"'^'&TY)Q=OY2FO6<]LGB\=F0SNW\1N3J'\,F)SE(,CC#VEF9YJ$NOE
M2O'2H.(3"+LT@:OJX'J):-S,^BLW+$+]W)0FJIP>&["*?N>YL+&3SM[)Z=JU
MVS+EGV]M)K:JSN8K@^$EZRW-&>Q6&H;-Z^[YJ;-Q%;%0Y7IW7RDV%HPC!6GR
M%>[+!#+Y,;,/.X^!W9N+*[&"RVHW(68I)V>:B6',I46'AMZ3#S.:N:AW?R\L
MW-R<<TX<TG62A*"E)<SQI7$JCIIMNYO?I-3OWNC^$WI>WC6EN[DWO?SD,>5F
MR1D332'(50IJTE>1N4 $V\KD9FTT6!E+$[^6K]WC<YJUFYKF;KM]FJ\OI9LG
M>#/PT[5Y0AGKEF-EJ,+4;3=M6UL27.HSC..+DX^OS5>TV_Z:U-TT-A;5H;UM
MQW]TT<?%7S-Z*5IAGDC;E:5Y&8.<C!A)WT;5W=;7IT;L<O!7?:2QW]6/50Y=
MK]W*W=0O3RD7&S*3<4U2B>ZF-$G5)<"=K.(8(#3GXO.E&\>HV!VAE]F5#SEW
M9U^>6[M<91C>U!;C:-YHF-V$I(7#@SNVHD6G%:OWGTR[G;"[.M57#KICYCJG
M\K^\N2TG,7[6;?)&]%)7*5Y7%UHZ8J,J[>*C4HOH%B;71/<NZ>HO5@8]@U;6
M)'$8G;,\T1Y&V;S#*<QP0F;#&/)H/,^KN[NJ.X_=7/PDVXO8UY:>BGO'G\X/
MYC:':R%K*QS$9M3YW);%ARJ*JDW)UQW41]ZF_$=E.H?F8O!P/@=I@>IV+#Z'
M9Y7U9R'YS=[-V?+VKM>G=WEEO6F^:?!;CX\USOO/4ER6ER6>+^-[ZWT])4>P
M]G;BZO[KKX?;56:?$5; OGMQ3,[001L_$B)N#F_S1;Q?(RD]1S5K(6*2:YGL
M2VOX#7]!T^_K>=3MQ;A%T<GLCT],N"VTX*E?6S ;?H[3V]4V_@X&BKX^NX51
MTT<STXF?K(N+NN97;KNS<Y;6?0V6RT<M:5JVJ)+#WV><7Q28+>46Y,%EMQTH
M2"_CGKQST.:0".N;D;$[MJY\KZK<-#NV96W"+V/?TG+N^&6S,+T;LUBXM88[
M,:<:T-3<I$U3W2*,1FK66YHR[GYO9(?0[J<MV.UK%X-&I7+SRT8SCC&7O>9U
M(3-B'@GL>#FE?F:M([^*,R]D/D=)PI'EEMW'EN-9N</9>U=.[WS)8?&PC9I6
MKE4A.:J[%&3.#<S:@3=S]O?Z50X)+#;7S>^5I.;QV->?&J>S#9CQ/QD;U3'V
M@K15';'5XV:.?F(Y0(?%[1=K>EG5WDE**>\P'"$+DHO"+IT4ILINIQ\YDLC+
M8S.,:E P0-RO-6M0_P!G9C(>4AYOFEZG[%0H\VS!^&!6H]FZS2:Z-W2O=7 H
M_<=&:]C BGJV;47F#%=E -9'^:#6.7PORC_*KF9RZ[*L4Z[UPXLEM+N\TN=X
M=*QQW;-E5C1[W@1&G@HZ<EF&& H88F<AE$"T,&X>)FU?APT91DI.$6^7QDY"
M'WB=')^CSO''HH9^CA[,M&RY8V&M#"PF%?5QGLCQUU&1W<6;U,LG*Y-W(<\Z
MI=7GJ>9_FM1_=M2?6?6PLN1LQO3Q+9N8Q9JVKEYD QMP!GY]!$5=EE(1]9K#
MIW>_4BX9V[)=G%XXNB2QW/?@UA6M>HM/W3>^W<"6-S=>;&>]0!<QAR2#*PUY
M.UXW=RT;L=+3A<CRP=<<:5*[F5G;ESW4UOBW1^1].WH-SO@'W-M_#;FW%M+(
MU]-R;NKC+C,NQ<)0HLYR5W=^]V+G9^_L4+WGRMSLH3W1JFNO>;-W)S5F.8NV
MUBYI23W884]VN]MGJO/2@MPR5;4$=BM-P."86DC,'[1(#U9UI:;6*.E.*>#Q
M/$CXD.C>:V5UKEQ&W\",>&ZAV>;9,$+M'!)+8=A.LQ/H,9";]CNWI72=&U*%
MW)N4GC!>MQZ^DY-KFDSL:@HQC2-R7J\&WNZ&NM5KT%-YSISUDZ2;@K7K&V<W
MMG.[>M#8QN9J0G*$<L;ZC)'/$Q 3>O71V5ZSF[&83Y9QE&2Q3>[I3+E[3K]A
MJL)0E%U4HJM'Q3H_1LP9M?LG_O&-XX,8,;U,V!!N HA8)<OB)?<;9>DY*TPO
M&[^H7%0V9[L6I^M:DX]:YEY5B3^5[S9B'JW8J?4^67T7AYS=?IA\7_0WJK:K
MXG%;I; ;BL<(=OYV-Z4\AZ=D3DY0R/Z.4]5K^;T/-9=.7+S16^./EWHV'*ZW
MEK[4:\LGNDN5OJW/Q&U"AR7" ( @" ( @" ( @" ( @" ( @" ( @" ("F>K
MMK#Y7%Q=-LQ(T$'4>"UARLOKI&\T)#&[::.[\[MHM [V]X_NF;RVGI*E]^O)
M_$A7EBUCM=QK;A2+-K[KVKUFZ]0M8O+.,Z<:.K\QY693 ;SZ9WY]M;NV]=IY
M*L3PA9CKR25;3=@RUI0%P,3;1V9GU;71]'7.-8T"]9O.,XTQ\*/?UGTAEL]D
MM8MK,96[%Q>-&TI1Z))XIKR/:L"R-C]$-W[DBDS6:P=S#?3,U2+;=2R!0S20
M0V(Y[,\H%H0"3 (@Q,SOQ?LT77?Y8Z5/3)SSEWU?4E%)[^;?3;1<=[>!P3^>
M>K9?5,G8T;*R5R7:PNW)1QC'LWZL4]CEMK3!;-I6&[=FVJ&Z2K5A9RR5IL=7
M-V\/FR3>4#E\CEQ7T-IF=C*PT]RYO$E5GQQW@TJ=K-QN1>VD%^U*7+'TXFW-
M+X%<18&V.?W?.\<U,(:T=*)@Y)C;\H<CD_B%G]EF6ER[T3KS**K6N/F1TJ'<
M6UR<DKC24:*G'>RD^IWPP[OZ<3Y'.8>-\_M.A /+E8]//B@869_/A;BVCMQ(
M>&BE\EK5G-+DEZLF]G3T,@]1[LYC(R[2"YX)4YNCYRZ]M,.@TGS5FW/D6NQV
M=+-8_P @ >'E>/V=/E6UV[47:Y5LIZ3FN:O2CFNTDL:[MW+N^'<2NA8DM!#,
M$[P4LG!(.2@$N3R;0^$W;E^^<M58MS<?5EBEA_PLKS>65R7:V\&\<-TX\'L]
M\JF[']'6,O9: VGKA+7F(0>5I(=1TD=O9\+\=>Y9EBQ"W;Y9*M/# D<EFOO,
MYR>":3IMI)88[J+>4GD<)0R!ULC,7O$UHR#FE9_.87?1M>QV8UJ5RW&4^><'
M2O7XJF[6I<L>SM7%6G5NVT=>&XS/NMJK!6I6\C+3HQ$?E%(Q211LS\&XMH[?
M(J[U^$HJ$*T3P3QHBJWE;[ES7:/#=O9EK<#6:T,<,-.W)%RS%E8ZWDZB3\S_
M )3P\=%YV%V:JEYBQ<NV+$N63QV+$SOTQCJC5PADSL%6$QE@MS58[%>0V=F<
M/,YF/1O2ZM-<LEZLJ<:%V/K0=91KPJ]GUJ%[TIL/E=RVIH9?]7R6VJ<4G(7A
M>8Y)M68A_P U3.FTG=DJ;8[>'2:5WHM2MY>W)2I2Y6E6E/#V7Y'XR![<SL^V
MVR5*Y2*Y3"U(=,0\+QMV$+L7:WK6.TZI*6-<>@E(<BMR<K244DUQ=>'%K@?C
M)[MR&X+=BG)/%B81$1:!R?G)F;41#F_M"5S[])/LT\,3!CHEN[^_DO6372Z<
M,=FW=CQ(3%!3"T524GGCF'PZCRZM]\Y++LR3:AQ7E,7-9=PB[BW-KJIPX[%0
MS&"Z<X_#5[<5:RUJ.6PY@QNY&+-QY7UU=F]2MYK(1L)1COQ)7)YV>87:-K&*
MV*G&M5QXG?O[#++T)6K4CB:(QD;SGY ,A+A_,KT,C&5IQ<DF\41M[/WEF(W%
M;DXJJ;HL4]]'XC&0MD\2Q4K4->N4AB]$(W_)L/\ I"$E<LY2Y97+)IUV%J]G
MK-]\T4TT\5XO=6*>PZ]J-I)I0:\<S"1$+"9:$PI<LJ*V49=RMSG=.:M*X/&J
MW5,E#'2%QCF$#FUYG\9-)&7H'TNKRM1MK!+QF-'FOR?-)II[%A3;@L,:[R;V
ML^V8GHM>/6V-9Z5B9^#S1]L9MZV=M%58A&,9<N&/-3TF3FXRG.WVF-5R<V_C
M%OIW(R ;3W5:V?=WM4QLUG"8:P]#/Y"KXQ@E?@/O -Q'F%VT)VT=4PS%J-]6
MFZ2DJI>\7KF4O7,H[SC50E2;7D]==3VTIA78>MWPA=8"ZA;%?:V9>,=U;#BK
MU;7)X?>:)AI6L<OI9FY"];>M<[[T:5]TOJY'V+E7U2WKW4=8[FZS]]RSLSIV
MEJBZXOV9>X^E&T];"XBG?NY6IBZU?(Y+E:_>AB&.:?E[/,)F9R6M.Y.246\%
MLZ#;8VH1DY))-[7QZS-*@N! =6:&*Q$44\0S0R,X20F+$!,_<[/P=EZG0\I@
M:N]2OA%Z4]0#GR-&C)LS/3:N60Q3",,CO^>K/^3+[FBG,EW@S.6I%OGCP?N/
M:0.>[N97,MR2Y)<8^ZMC*EZ6] .N'13?N#EVUN&CGMA2V?*W/1:R=>*2G)JS
MF%2341F!]"9P?CQ92.?U?)Y^Q)7(M7*>JZ5QZ^'61F0T;/:?F(NU*+M5I)8K
M#BHXI.O3Q/09:B;D$ 0! $ 0&-OX['Y6M+2R=*#(4YN$U:P RQO\HDSLK-[+
MV[\.2Y%2B]S547K-^=F7-;DXOBG0A3;'N8@2_<_<U[!!X?+Q5G_UA0%A[!"&
M=^>-O5'*+>I1?Y5.S_IKLH+Y+]>'527K)?LR1(_F<+W^HM1F_E+U)^-K"3ZX
MLZ,N8ZJ8F/2UL_%[K;G=WLXC(/2-HV;AK7N _B]7G/JK=S-:E9VV8W.F$N7_
M .,_<D78973KWLWI6^B<>;_Y0^J>9'Q$9S)YWJAN.WE,=<Q$X#5@@Q%YP\^O
M"$ N(NT1F#,3DY-ROH_-KWKE/>#,W,QJ%R=R,H[*1EM2HJ<5TX/>?1/<3*6\
MMI5J-N49)\S<H[&VW7:D\-F*W4)ST,PIXS#[NW6^4H49\52>A@;.5L#4JCE<
ME&4;.,KL[\T<'.?#OT=5:%?OJUF+D9JW#EY8\SY8N<\*X[XQ4FEQI7 B^^&:
M5Z]8RW)*2E+FFH+FEV5MI[.$I\JZJDKSNWH,]4Z69?+9G%6PAOUMG;TRF&NA
M:@B@:9BI3'*VCB;UR('<F^8SZ\=%;SNEPO6\K*<XM*4;5R46GZM?5DWQY*K_
M ("-R>>EEIYRU:MS58ROVHSBXMNGKQ2WKG2>'RFC$;GW9F*>0W/@&VKB<7CM
MO6RCHU Q4328X*LVD1O/R<Y>:S#S/*1"?-V<64/K&<O=K<R_8P4(2P7(JP49
M8>M2KKLESN2E7I,O3M-LSMVK_;3E*Y&K?:.EQR6*Y:T7+C102<:%G;CR7T[U
M%S%#)U:<T%+8EFU5!JT(:2EA(K#'J(-S$!OJ#O['8.C,IK46LWJ-U78Q:CEF
MUZL5CV"E7!+%/V?DX4HC7LA8^[:;"=MR3EF4GZS>';.-,7L:]KY6\Q&-J4LP
MVV.H4M.!MM83$RR;TI!&(@62Q B$,),S:,UUSA?33CX^WBL#*Z?E<P[6HR@N
MSMP_>1IZKN6J**:6'[VMO=1UEP9E9B[<L=KD5)]K.:[)UQ[.[5RE_P!*D_\
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M5VI-I/K29.9?OGJ=FW&"G&3@J0E*$)S@MRC.47))?%Q]7XM"V:E2M1JUJ5.
M*U6G$$%6K&+"$<<8L( (MP819F9F;L4I""A%1BJ)8&M7;LKLW.;JVVVWM;>U
M];.XKA9.I9D.*O/+'&\YQ 1!"/:3LVK"WK?L7JVE,G1-FBN^-Q_%!O7+7L1M
M7"3[>P $P>]4!& S9V?MMSN[L_IY16XY.QI66@I7I<T^#^JO=9RG5\YWES]Z
M5K*P[.UQ5$_I2KYH^,KW$_"3U(SME[NY\G7IRR\9;%F8KMKF?M?G-^77[BSK
MO>K+VERVH-KZ*\A#9;^6F>S$^TS-U)\76<^NK=/_ (EY[8^#[9- XIMT7;&X
M7C+F>KS$$9O_ %GUUT]3:*'S/>K,W%2W2/5X>^;=D?Y<9"RU*]6XUQ\-G0J(
MVFP.WL'MG&08?;V+K87%U1Y8*52,8HQ];L/:_I=UKEV].[+FFVV][-[RV5M9
M:VK=J*C%;$E1&<86;CWJW4OT(SN/:N)W1%2ARM<)QH6&LU^<&-F)N'8_I;@Z
MNVKTK3?+O5#'S&5AF$E-;'4T0ZB?#M5Q^'W=F*]4\;BJV5.>A4E+S'AK6'=Y
M.4^\!/B/WK/HMJR6MR[2VJUE15?%K9YO*:#J'=2V[-Y-4@Y-I5V*6WSXKANV
M'?\ A+V7L_.EO4\[@:F>RFULQ2EQ>9L1L;!SU]1Y![&=G9W[%7WHO7(NU*+Y
M>>+JEUEGN+D[,GF(3BINW<CRR:^8O/MW;S<[/].MB;IBKP[@VGB\F%7F]W>6
MN#$'/Q/E(69VX\>#]JU6UF[UK&$FO&;_ )C3<KF52[;C+K2/)'XJ>E6%Z8;^
MJT]O',V&W!3^D*U*9W+W9Q-XRB$GXD.K:MKQT^1;WH6H3S%JL]J=.LY/WKT*
MSEK_ "VUZLE6GR=WCX]'$H_&;/W7E<5E<MA:4LVWL=R_3%WFY8JTKMP\?BT=
MV'L]7%9V9OVX7%!NC>Q$5D-/N7;#N158JO,WNW=+KUO<0F>A<"0S\^*$IG?G
MY92Y#YO9+M]I9D,PMR;,)Z;*/QU&M>.-=E=F*.[A8L\&1=L%!9OY5H2>O4I1
M^\SL[=_DL#N0>GAHK5Z<';I)>K7&N"\O$R;&5O6[S=N5)\KIR5D^OE:QCQHJ
M5-U^OO0+>F5Z4;&ZB8[9='&;PJ48[O4:A1$(Y8?+B$@E8 TUT;C(+>R[OVK6
M-,U&U#,SLN;=MMJ%:\?"AO>L:5F;V2M7^S2NI)S2W8;J/RJO$UP^'VKM"YU=
MPM7>-^+&X*0)XY E+RXYII8W&.-Y.P6=R?B_#5E-ZHKL<I)VE5X>))\#7M'5
MB>H05YI1QIP;:I2N[;+P1OE\7G2FI#T^Q&X=I8:N6,PE2'&90ZX<YQTM6]VF
M%Q[18GY7?^LM8[OYYQS%)RQ;JNO?X=!NO>?2XSRR<(IQ247^SN\GNGED1;_V
MAC\!OBG4O8&J.0GBP.Z*XE&!6*[ZR!!*WSA[V6YW[]J]+D;YJ+UHO@S0\ID[
M^6M\\5V?,_5DNBNSIZ/&;L=*_CTW?AXL-3ZBTZN\L5:E>*UF*C>[Y2F NP\T
ML3-R2\'U9V9G?TK7,[W<M3YG:?*]JWQE[QMV0[SWXJ*N+G5:2W3B\-JW^;H-
MZ.HVW-K?$QTF_P#R+W#3GM-8KY+:&YXWYBHWZTHR,YLS<X.S<#'@_'U,M?R.
M8N:9F:SBZ4:DN*9LNH96UJN6I"2JFI1E\F2Q1L'5AE"C4KW9!N3QP %J7EX2
M&PLQEI_6?BHIM5="82=*,@NZ^D73+>]2:GNG8V'RL<K:%*=2,9V];2QB,C/\
MA+)L9V_8=83:\9CWLG9O*DXI^(\T/B#_ .[^DH4[>Z.BTEC*A5UEL[*M%SV@
M8>+E3G?1S=NX"\7WKNMJT[O(IM0S&#^6L/*O=-<SW=_E7-9Q7R7CY&4_\.OQ
MI[VZ-Y*ML7JK+=W+L*"9ZDLUMB/+89Q;E=@(O%+&#]L9\6;V7;L6;J>B6\VN
M>%(W-S7LRZ^GI1C9'5+F4PDW*&]/VH]7%+@_@/;/:^Z=O[SP6-W-M;+ULY@L
MQ"T^.R-4N<) ?Y>+.S]K/Q9^#\5HE^Q<L3<+BI);4;C:O0O04X.L7L9)U9+@
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $!J1\6..R=/;&"WUA[!06]I9"(Y-'[!D
M,7 VTX^$QT?U.N9?S"T=7NRS:VQK!\:2QBUU2\[.G?RSOVIYFYD[JJKL7YEB
MO&GAU$'QWQC6,SAZU'"[%LW-WS"T)L)^96:5VT:3EC%R)G?BPJ/??S/6\NK;
MMP=ZE.>KI+I[.E>;HYJ5V88$Q>_E7#+WG.[F$K"QV4E3A5X>,OS8;[BP6S,U
MO'J39(<MD&/(6H)=&]UBC#\G&(ZNP$_;RMV<&?BMH[AZ;GXV[E_.2D[M^2=)
M;5%*D:KXNU^K1<JI@L4N=][<WD8W5;RJ2M6DU5?&>]UW]>_$TBZ3X._U>ZS8
MVY:@+]VMLW9=P9 7]AN21_=(G?O<Y'9_D9UWC/9B.GY&48^W-*'UGY/2<#RF
M1GJ^JVW)?NK4G<?"J]A>7'JCTGJ@N>'6B-[IN4:&VL_=R4034*N/LR7(3XA)
M&,;N0/\ YW8KMF,I3BH[:JA8S,HPM3E+8DZ]1_//D/)NY>[<AA&"!YY#BA'P
ML$9F[L+?(*[#E'R1Q\*>^SYVU.TKLU)*F.'0I/\ NK:<][:>Z</5LR6,79JX
M^\0V:AE^3(N9M6)F/BXFW>RQ(YJW>E2J\/=1)RTN[EK;Y8MIXI/TX[F0PWNU
MIIY6>> ;3.-D-'(79^UG]+*5MYBVW2J\9!1RN<RM903C6J=*;'MHCHQXZED;
M$4%JLTHEXS\GE\43<2'^18\K%J*;<:=-<.ORF1:SV8G.*4^;>X\JYJ+%QKTK
MQ%U9;H#5EZ?4.J6 NCG,);,QM4[<SQM5:%^5V(=>5^/A6K95V;.==N_%J:=8
MTQ71[YTZ.8E>R2S%F2=MK8Z57%=>XHFWR6YZN2HU6AKR1'"]87T >3AHWJ]"
MVKMDI-<,:F@ZA'[PW>@L)55.%.GK,AANG>]LL4 8&LT]6_*X4*Y&',?#5W;G
M]'>L',7+=BJ<J;]FRI7D[%_-J,E"NV-&Z5I[O$Y,<6?VGD\[CYJ[U<I'3@@G
MA-F-_#(3^'N^ZRLQFI7:Q>V*Q6'$R)91JQRW(M-3V2];##97 V;^$[I#!UAZ
MCU;NZYP+%;6,<ID,4?9<(= CB<>SEYG9W]2CM:S7W3*TC[4G2I+]W].>H9].
MX_4A&M'YL-GC]X]6M_\ P^=,=]8#)8J3:F*Q5ZX'-3S56G'%8@F#V)&(&;@W
M>RTG*ZA=L7%.K=-QTO/:-E\U:=MQ2KL:6Q[CQ1ZV=%-U=(-V>XYZ%BJ3\[XS
M)1L_DV(_OM?2W>RZ1I6?M9N-8;5MXHX]K^CWLE)J>Q^1]+(3CK]6I7A*XQCS
M&PE:'L$A'0>;E[B4G>C6VJ;41V2:A>ES*JG1U6YK#=Q)?4S<N8(\3A,3D-QW
MI8WY*V/B*25A^^819WT98T+L;2YI-*F]["4S$>W;A!2E54I';XBO,K'E[N2J
M8!\81Y #<?<3A=IPE+AY;CVL3>CTK/NW^VBIR=%Q6SK(#+Y'[K-V[<>9O=)8
MUW+H>->LX\CAPQ4-**6K:KS-,[R!:A*"3UB(&+/IKWJFRE=5*U6.S$R,Q;[!
M1DDXMTVJCZDFEO/73H%T.Z1]5OA_VQ)N78N/'-VZL]2YN"N/)=\Z,R ; S#Q
MY]'%^*Y_K6HYG*9^:A-\J:=-U.%#J'=_1\GGM,MN[;7,U1R^-7Y5>)H/UT^&
MGJ+T4M6[YT9=Q[+KR$^.W=3!W8(R?@UJ,>9XC;OU\+OQ9;5I.M9?.4H^6YOB
M_<XKSFGZWW>S61KS+GM[I+:NO@UY*XJAT?AXZ\T^F^[3^GHVR.R-W1CB]_8.
M4&DBDK%X0N-&_!RBU\3:\1U99.KZ7]]M?N\+D/6B]]?D]3,;0=9^XW_WN-N?
MJS6YK8IOI6Q\5U(]<^C70'I]TSSN9WUL'*6;>.WC3C:E5*5IJ\521VE 83[2
M#7Q-KQT7/-5UO,YVW&S?2K![=[>S'I.GZ)W=RFG7)W\LWRW$L*^JEMPZ.LV4
M4$;($ 0! $ 0! $ 0! $!UYIHZ\4D\\@PPP@1RR&^@B(MJ[N_H96;UZ%F$KE
MQI1BFVW@DEM;Z*%R$'-J,55LK ^M73&.\V/FW95AF<F!I9!D&)R=]-/,<>5O
MNOHM2M=_M'NW>SC=?[7++D^E3S[.DV)=T-4=OG5EM<,*^2I9\,L4\030F,L,
MHL44H.SB8NVK$+MP=G9;?;G&<5*+33Q36*:XIFNSBXNC5&MQ^Y#"(".0A",&
MU,B?E$69)SC"+E)T2WO84Q3DZ+:>9_QA3[/S^X]O7=K7Z4N=K0SP;KOUR8PD
MC#E]UC(AU$C%W+CW-PU]').]VJZ?F+\?N[YYI-2<<8[J8['OV5W<#Z"_E;#.
M97+789F,E;;3MI[4W[;Z$\.MXFJT>X,XV,AVY/D92P]><KD..Y_]7]X,6!YV
M#O-Q;EU?NX+4IS<K7(F^2M:;N:E*TXTWG1I9*QVKOJ*YVN5R^-RK'EKPKB23
M$Y?(5Z%W$U;TL.,RYPEE,>):0SE 7-"4@][@3ZL_<L"=^Y"W*VI-1E2JX\NS
MR&#F<M;G<C=E%.<*\KWQKMIU[RT;N[-R9+!?0V3W??NX^  9\=8GYHS&+B 2
M=Y,&GA8G=F6'?UO/7X*S.<G##"KW;.NF[AN-?LZ9EK-_M;=F*DZXI8X[6N%=
M]*' &Z]T7X:$7T[<L1XRG-C\?^4U\JI./ERUQ+37D(6879W[."\O:MFJ1C*Y
M*D8N*QV1DJ-=36%.!6]-RMMR?9Q3E)2>&V2=5+K3QZSJQ97(UZ5K"!?FK8V[
M*$UW&L?+#))%[!F'>X:<%AQS5Z-F5J,GR2:;5<&ULP+DLM;G-7G%.<4TI4Q2
M>U)])(:>X=S8C&?1^(W';ITGD\\:L9,PA*_:<1:.0.7>XNVO>J\MK6;L6^RA
M.2C6M$]CXKAXJ&#>R&5OW>>[:BY4I5\.#X^,PD&Z]R8Z?+W*F<M59\Z)AG)A
M-O\ 6FD=W/S=6T=W=W?7^19<=7SG/.?:2<KBI+%^LN#X^X94],RUV,(2MQ:A
M3D5/9ILH=W![OW54H2XBANF_0QT?.T5**9_R;2^WY1/J4;'QUY7;5>1UO.Y:
MTK5NY)1QV/97;3A7?2E=Y:S>E92=Q79V8RDZ8M;:;*[G3=6I&ZN\MS[,>Y%M
MO/V\1#>T]ZCKR:";C[).+L[.0Z^%]-6]*R-,U',Y=/LIRC7:D\'\/3NW&?=T
MK*ZARO,6XS<=E5LX^)[UL('D\QD,]:&]G;]C,70CC@CN6Y'DD&*'5HPYGXZ#
MJ^FJRK^8NWFG.3;2IBZX>,F,OE;>6CR68J$:MT2HJO:^MGH9\-VP=H9SIMB]
MP9O9E";)VK-H(\A8B\Q[$$4I#'(PF[B/8X^%F;@NE]T^[>1S.25W,65*3;QE
M5U2?!NFVJP6-#AW?W6\YEM2G8LWY*"4<$Z<K:Q6&+XX\3:6MA,-2 0IXFG4$
M6T$88(P;_P 466]Y?3<KEXJ-JU"*7"*7H1SFYG;]QUG.3ZVV:J=:^A=RWGZ/
M4KIS&.-W%1D&:]5K"P>9+'Q"P CHSD[<#;O;[JYKWZ[NSM1>;RMMRCMG&"]9
M4Q[2"6/2^7&M)+>=)[H]\H0R\LAGWS6I8)O@]L77_P"/#R%Z].]ZV=UXJ&/,
M8R?#[AJ!RY*G(!,#F/!SC)VT=GUU9NY2O<KOO#6?_P :ZFLQ"-6Z/EG%47,L
M*1ECZT'CPJC3=>T>.1NMVIJ=I^RZX]3]\LQ=$->" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @-.?]]?\ V(6Q?^(_ZASK_P!O_P"V_O%P_#W_
M (*=-?[E@_I4=J_^KN_M,V+NC_L^5_RH^@N51QL80! $ 0! $ 0! $ 0! $
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M#'8 XI0&2(Q<)(S;F$A)M'9V?M9V2H:J8?![6VWMF*:';F!H8.&R7//'1@"
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MYBY*^V[CD^:ORJX^<SZRC!" ^:,VNC::]JH44MB/3ZJSP( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" TY_P!]?_8=;%_XC_J'.O\ V_\ [;^\
M7#\/?^"G33^Y(/Z5':O_ *N[^TS8NZ'^SY7_ "H^@N51QL80! $ 0! $ 0!
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MF_W=U=1SKOS:YKV7:VKF\E-GEH>?_0/&1[AZ[]+<(<?-6FSE=[0=[A&7FO\
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MA-+[P7(1FKEZ34%@HKVIUW=7N'G?O_KGO;?<53;6//\ =?9=#2M@ME8=GB@
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M1U?0Y*,LYEKJOV6ZRDL)Q;^TAMCU^STHNQ;&:L$ 0! $ 0! $ 0! $ 0! $
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M?3O[^]797IRBH-NBV+@6XV81FYI)2>UDL5HN! $ 0! $ 0! $ 0! $ 0! $
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MA+V7[CZ3<-)U19V#4E2Y'VE[JZ&;0J')<( @" (#\<P\VGSEZ>'[7AZ$ 0!
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MF[MRVK4I5C'8N!C6\G:MW978Q2E+:^)9JQC)" ( @" ( @" ( @" ( @" (
M@" ( @" ( @(9OO>6(Z?[6R^[,Y)R4,1 4I W$Y#[ B#OYC+1F63D\I/-78V
MH;7X>8P=2U"WD,O._=?JQ5>O@NMO8>2=R]U%^(3J%9NT\;)G]Q6?_9^+YN3'
MX>F[^$)97\(<.)._$G[ETV,<MI6646^6*VOXTY="]&Y'$^?.ZYG7-1Y[CV+_
M .G:AP;W-[][=,**IN-TX^#O;F*EK9OJ9D_WTS \AQX<!>+&0&W'1@]J73^L
MM4S_ 'HN7$X6%R1X_&^#Q'0-+[D6;35S-R[6:W;(+Q;_ !U-RZM2K0K0TZ-:
M.I5K@T<-:$6",!;L8 '1F;Y%JTI.3JWB;Q&*BDHJB.\J2H( @(#U(WKC^G6R
MMP;OR4@A!AZIR0L?#S)7;2,&]/,2RLGEI9F[&W'>S%SN:CE;,KLMD4>*?3S8
M.>^(/J6]*W(;196V>9W9?U=_*B,]1C8O27LKI&<S4-.R]5N7+%'+<EDKFJ9G
ME>]\\WX\%XZ>%3V]V=M+";&V]CMM;>IQT<9C@TBBC9FU+YQEZ7)^UUS/,7Y7
MYN<W5LZKELO#+VU;@J)$M5DOA $ 0'F!_P!Y;EJS;3Z9[?$];L^:LW_*;NAA
MAY>;^4M%NW<VU)SNR6RB7G-%[[SBX68OY3?B29?/P-[0_=3H!MR>:)AM[FLV
M,I,3CH7+(?+'K\C H?O+>[3.R2V1P)ONS8[+(P;VRQ\IN,H$GP@" AV_-OQ[
MKV3NS;4@<[9W$7*(CIS>*>$A;A\KLLC*7NRO0GP:99S-KM+4H<4T?S3]+=PW
M>G'4_;.6(BKV=J9Z)K@FSL[#%/Y4S$W=PUU74,W95ZW<M_*55Z4<^R=QVW;D
MWC%T?BP9_3Y5LP7:M:Y6,9JUJ()JYMV.!CS"_P!UG7*'A@SHRQ53NKP]" (
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MNB:HM0RRN;U@_3X=-5C0X%WS[N+0M0=B#<K<DI0;V\KW/=6+3BZ<"ZU-&HA
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MS]+"N%=AL@021BWA(7X^MO3JI'(Z-9O0E*<E5>%#!O9RLO5V''3V/D;7-)7
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MN1>^.U?M1>*)BIDB@@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M;]^'"6W=+';9*F2)" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M<;SR6IS?@4TQ,4CCZF=UAY[-O-7G<>\S<ADUE+,;:W%OK$,P( @" ( @" (
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M<EH\''+0I*7M2>,Y?M2X8X)4BL:)''=3U;,ZC<Y[\J\%L2ZD2M3Q%A $ 0!
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M_P!;_FAJ.IY.65Y+=M35)R@GS26]8MJ*>^FW9L-LELIS,( @" ( @" ( @"
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M_P#N65ZKOHB;3I?^SY[KL_\ -(N!3YJP0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M &KG]TUG(/\ _O.;_P NS_\ J%T*%-F" ( @" ( @" ( @" ( @" ( @" (
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MAD(BVO:ZQLSF(Y>V[D]B_L\[)32-*OZIF[>4L*MRXZ+<N+;?!)-OH1K+TO\
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M&3NY3)PMW7ZV/BKN/ECOGJF7U+5;M_+KU'1)TIS423E3YU.OB7(ILU4( @"
M( @" ( @" UEPG_RN=_?_#3 ?^\KZS)?Z:/[3]"(VW_KI_L0],S9I89)! $
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M[.VJJ=Y+F7Q:UJVM]9/&6-*JJVLDLQJ=Z_E[=B;K&W6G'J\6XE"V C0@" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#3G_?7_ -AU
ML7_B/^H<Z_\ ;_\ MO[Q</P]_P""G33^Y(/Z5':O_J[O[3-B[H?[/E?\N/H+
ME4<;&$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$!A&J8:AD+62:"I5RF6&*&U>80">PT#.T0F7 B8.9]&=^&JN\\YQ4:MQC6BW
M*NWJJ6.SM6[CG2*G*B;P3ER[%7:Z5=.%7Q,PYB(NY.S,WM._!E;H7JT/VO#T
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MWM9-)V^SDG#<W)M*'+':Y*3JD^6KP+X4&;0$ 0! $ 0! $ 0! $ 0! $ 0!
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MK_ZN[^TS8NZ'^SY7_+CZ"Y5'&QA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MKY-*&.&'F?5^6,6%M7].C+HUN"A%16Q*A\YWKCNSE-[9-M^,[JN%D( @" (
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M'.VEF869NZYJ,X<TIVW&*C.,G*/JJG+1*2B]YWK^TK]GI?U^O;:WS5Z@97>
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MO=CMP/8Y_-Z9=L0EF(9FS<G&$5RI7H\VR58/EG&.V3Y5ZN.[':Y0)OP0! $
M0! $!IS_ +ZW^Q"V+_Q'_4.<_P#N'_;?WBX?A[_P4Z:?W)!_2H[5_P#5W?VF
M;'W0_P!GRO\ E1]!<JCC8P@" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M3Z=3]+P]" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M%PE%>O5-UVU=?C5/7'H_A]Q[>Z7;#PF[IRFW)B\-5KY8I)'E,91#A&1OKS$
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MW &E:FV-R8B5 CN3QP"5MG;3R0>1B/AV*5T7*O,YN$%)QVNL?:P3?J_.=,"
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MRP]%W=^UW>"/5UKF<_QY_M/TLWC(NN7MOYL?0B4+&,L( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M 0! $ 0! :RX3_Y7._O_ (:8#_WE?69+_31_:?H1&V_]=/\ 8AZ9FS2PR2"
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M^DPK>?M3S,\LJ\\(QD^%)-I?\K):L4S0@" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#JVVE*K8:
MN^EAXC:%^SQ\K\O\ZHE6CH7+32FN;97'J*&IUK7O5>*"&8<R,PZZL32";%Q(
MG[=->UW[EKT(W.TZ3=;MR'(VVN2GBH;!-KHVO:MD-&/J ( @" ( @" ( @"
M( @" I7K5T6P'6K;]#%Y3(3X3*X6T]O ;AJ ,DM:0QY)!<)/"82#IS#JW8SL
M[:*)U72K>H6^2>#6Q^_LP?6MB-M[I=[,QW=S$KEN*G":I.#P4DL5BMC3V/I:
MIB1WHA\.^"Z,V,SF&SES=>YLU$-2?-VXPKM%3C)C:".")W%M3;F(G=W=V;L9
MECZ-H5K34^5U;Z**G55^G=A0SN]_?F_W@C;M=G&U:@^913<JS>',Y/'9@EA2
MKVFQBGC1 @" X3,8Q<S=@$&<B(GT9F;O=4-I*K*TFW1'GQ\2&_L4.[=@;YZ<
M[FJ93.8"2:"R]$QFY/+)G%I1'VA/G(>/!^Q<A[V9^Q//6LUE;L7)1I5;I0=8
MOIK5K@TJ;#N'<+1;OW/,Y//VI1MW*-<V%:\.#5$SJ9OK_O?<UNM=K7Y-I5J\
M ,V-H&SB4S-J<AD8ZNSOV#V,W#B^KK7-8[\:EFKBE9GV:26$7@WO?CX/8N.U
MWLGW)R.3@X2BKK;?K26[<E3T[WP.*[ULZL;C@>*+/08J.D;FTU*)H)9N&C"3
MOSMIW\&9,QWWU7,P4>TY:;XJC?656>Z&DY257;<F]TGS)=6PL?I_\3?N6+BQ
M>^:5[)Y*O*X_3588O' []L@,X.Y!WZ-Q;UK9=&_F(K%B,,XI3E6G,J>STK#%
M>?K(#6_Y>]I==S)RC&#7LNOM=#QP?F-R,?D*>4I5<C0L!:I78QFJV8WU$P)M
M6=G76+%^%^W&Y;=8R54^@Y3?L3L3=N:I*+HUP9WE?+)3>RM]Y3>V_=]T:ODU
MMJ['L-B.5F8IK=[B\AN3\1$-'9F;M6FZ5JN;U'5+RC)1R]I<O+15E*K2DY/%
M>S+!45*;3;-7T:SIVGY><JN]?7/T1AN72V7(MR-3" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#67"_\
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MU<LTFVOD\TG+EW^S6FU[-I;RCS8@@" ( @" (#3G_?7_ -AUL7_B/^H<Z_\
M;_\ MO[Q</P]_P""G33^Y8/Z5':O_J[O[3-B[H_[/E?\J/H+E4<;&$ 0! $
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M3=:+"D?8CM^)%=-66DHPF0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MV2?)NKM\=#)J5,<( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ("I*/3V6GUAW#U0+*A)7SFUL?MT,-Y3M)&=
M&U8L%.\FO%G:9FY=.Y7G=K:4*;&WY:&-'+TORNUVQ2IU-^FI;:LF2$ 0! $
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M!_2H[5_]7=_:9L7=#_9\K_EQ]!<JCC8P@" ( @" ( @" ( @" ( @" ( @"
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M_M,V+NA_L^5_RX^@N51QL80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M-Q:CRM;*46_=3?P,;2<S8MY>5N32E&4N=/;S-MUIM?-M7%-%.5X;H?#%\/\
MEHYH<;L[ [T>_NN>W2DMUJ=(<CD K6+=07C=X:TY1$8N3<NFK^RL^J^_7H[9
MN%%1T;=%5)\6J\:D?)4R.7DJ*W&:<JK!1J^6L>$9<O#EI5THR])Z5K>.]>ES
MY7K?L_-Y?!Y?Z;V]3P6/ ;]F&*$_>X(Y0OS\L,T#D,CN.C\%&J2M6KG+:DDU
M1U>"QPW+%,E)1=V[;YKL&T^946.S'>\*,S_1&"O_ -HWQ+6QAB][_?N&"2RP
M"\KQCAZ1#&Y=O*Q$3LWI=U1J#?8Y=?,_O,]TQ?O\R_\ ^8O^2!S?"ZT0=.LY
M%7Y1KU]Y[GB@BCTY8V')3>$1;@S-Z%YK%>V5?D0_Y4>Z'3L)4^TN?\[-F%%$
MP$ 0! $ 0! $ 0! $ 0$$ZA[*I]0-HY?:UJU)1>^T<E/(Q:.=:U7D&:O,(N[
M,7)(#.[/VMJRR<GFGEKJN)5INXIK%>0C-9TN.I96>7DVJT::^+*+4HRZ:22=
M-CV%?T*_6^5Z.*OX/9-7W>2(<CO$)K$[SP@3>8<..]WCY))!;31YN47?AS++
MF\FJR4IOA&BP_P"*KP7[.)$V5K3<;<X6$E2MSFDZI;6K7+&C:W.Y2+>UTHY)
MN/9F5RO5#IIO&F54,1L^IFH,I$9D,[OD((XX?)%A<79G!]=296;.:C#+7;3K
M63BUP]6NTRLYI=V]J>6S46N2U&XFJX_O%&E,*?%=<5XSDK;/RT76#+[[.2N^
M$O;5IX2"-C+WAK$%R6P3N'+R\O+(VC\VOJ7DLS%Y56MZFY=%&DO<*K>FW8ZM
M/-X<DK,84KZW-&4I/"E*4DM]>@BN*Z1S7=H=6=G;IL1#2Z@[DR^4IST9",X:
M]UH7KF[&(LTD9Q<SCQ;UK(N:CRW;5VVL81BL>*K7Q=.TP+'=QSRF;RN8:Y;]
MRY).+K2,Z<KQ7M)JM,5TL_.'@^("K'A]MWOW4D@HR0Q7M_\ FV)+%FI 3,[O
MC'B%AGE!M"_+<C.[NWH2Z\C)RG'GQ^)A1/\ :KL6[U:^D\RD->A&%BYV+4:)
MW:RYI16_LJ)<\EM]?E3;:X'Z/:F^]H=0-Y[IV?BL/NC'=07J3Y ,E=/'VJ-F
ME U<6:0:]CS8'%F=FT9Q=WT17[-^Q"W=<HN%:47,FFZ[*JC].!Z]/SN1SU_,
M96%NY&_RN7/)PE&4(\J]91GS0P6&#BVZ5J8_;/1S(3;9ZO[8WK/0\CJ9F[F0
M&3#<X!#':AB838)6\)A(',S:DS]_;HJ[^I15RS<M5_=Q2];H;\U#'R'=BX\M
MG;&:<:9FY*7[NJHI1BJT?QE*-?C)[7M:.WB*OQ 4*N(VM:+:DU;'E!!8Z@/)
M9*>:G 3,[OB_*$6GD!M'_+\FNKMZ%3<ED9-W%SU=?4PI7]JNQ/HKZ2]E;>NV
MX0L3[%J-$[M9<THK?V5**;6#]?EKBN!%_B5QEV0-@Y3:F4'&=0;F5EVW@6$>
M<[-3-0O7N@[-W0CI-S%P#EUX:K(T2Y%.Y&XJVZ<SZ'!U7EV=-2/[\Y>XUE[F
M6GR9ES=N.#?-&ZN6:IPCA.KJH\NZIL/M;;E#:6W,'MG% PX_!4H:547[7"$&
M'F?MXD[:OZU#W[TKUR4Y;9-LW+(9*&3R]NQ;]F$5%>)4*YZB[.W%D-S[&W_M
M.''Y/-[&>_$VW\I*4$%JOD8PCE**<0D\F8/+\)<KZL[LZR\GF;<;<[-QM1G3
M%8M..RJPJO@(;6M+OW<S8SF749W+/,E";I&2FDFU)*3A+#!T=4VF8S$;.WU?
MZM8KJ3N2GA,54K[;M88\50L36;$<DED)8WDG.&,9.#/V,/+V-S>TKES,V(Y5
MV(.3?,I5=$ME-E7\/08^7TS/7-5AGKZMQBK4H<L6Y2JY*2K)J/,J+@N5X+FV
MDFZ5;-RVR\9NFIESK22YO=>7S50JQD;-6O3^9"Q\PCH;-VLW\JL9_,QORBXU
MPA%>-*C)#0-,NY"U=A<:;E=N35,?5G)R6Y8TV^EE=4>BF:DZ42[*O9>OB]ST
MMR6MR;<S53FGAKVPOR7*AFQ#&Y<"Y39NS5]-=%F3U."S/:I-Q<5%I[UR\K^
MAK7=>[+3)96<U&XKLKL)+%1EVCN0K5+JEXZ,ZF]=J=<NI6U7VYFJ6T]N!6O8
M^W:*I;M6OI%ZMF*8F#G@#W8- <N+&3NS#X6U)59;,9/*W.>+G+!K%)<M4UQQ
M\U.LMZEI^M:IEU9O1LVZ3A)TE*7/R24G3U5R;*_&;?JX+$VF4&;T41'TZS\;
M=>&>:E__ #+E<]O:2%X6?%A3_P!8\'@_*"[\.;@I1YR'[C;^[V_2YL/$:O\
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M @" ( @" ( @" ( @" ( @" ("!6=CUIK<TT5Z2M5G-SDIB OIJ^I,)=S/\
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M>SO]9-5IP7'C0UW^9VKQRFGPR4$V[NV6Q14&G3K>'B/31=>/GP( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M$(,+<Q%Q)^])2<L6ZB,5'!*AE52>A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$!"PV%L\-VS[Z;;]1]W3QM">?(7*?D8&CT!R=V#P-RZBW8LC[W=[+LN9\G#<
M1JTG*+-/-]E'MFJ<]/6V4P>[## E[&+DX<S.8Z.XZ\6U[-65BA(5.5>%00!
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M:O\ ZN[^TS8NZ'^SY7_+CZ"Y5'&QA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $!@+FX]OX[)XW"Y#.4*.8S#E]$XF>S%'8M<GM>3$
M1,1Z?U65Q6Y--I.BWEV%BY.#G&+<8[73!=? SZMEH( @" ( @" \I/B1Z.;I
MVYO#<._7Q)7ML9J^4PY2H3%Y,U@M1:6(?&'B?37EY=?E7->^.C3[3[Q97JR]
MKKX^,^DNX/>K*YO)VLES\MV$:<KWJ/!['U5K3J-4[$<=^,?I(-#8N7S!\$L1
M::.[NW9P[6?5ONJ)[K=[L]W;ON64=8/VK<L83IZ)<)1HUTK ][__ ,LM([YY
M=6LU%JY!/L[L,+D*[D_C1>^$O5>W;B8F]M6U 4917:5Z(Q9@-^83?5M'<A;G
M;LX<77?<A_./0K\8N^KEJ356N7G2?!25'_\ $^1=5_\ X;N\^5N..3G:S$-E
M6W:EPK*,ZQV8839Q5]M7#E$)+-:M$WM2OS2'\K-RB+O]UEYJ/\Y="R\*V%=O
M2X*/9KQN3JO$I%.E?_PW]Z<S<4<R[-B"VR<^UEUJ,$DVOG2CXR88ZO5V_$=N
MN'O!.SQE=D=G+B^NC>@==.#<.SM7!>^/?C/]Z;BA>I;LIUC:C7E3XR^7+I>S
M8DCZD_E[_*;2NZ4/W-;F:DJ3O32YVJUY8;H0V/E6VBYFSCBM7<L0T*$!2V)I
M&>,P;5^;77@S<?\ Z"U?+Y!RE@=9E;A87/-T21Z+]+_AQR6'Q>T][87=>3VQ
MN>6L$N8Q1#I7FYGUY=&=BC$AT?1V)O3Z%O5CN5<AV=^S><9JCHU272E.+6#Z
M8RZ3A?>'O[:OW;V4O687+56HR^,O<;3WX$\ZD]6^H.V-X;:Z9;5VW5RFY-U5
M_-I[@R+^75B;F<3T"/@?)H[N^K?YJS]7U_.Y*Y'*VTI79\O+)I+&;Y4E1J+Q
M7M8+YI#:!W8T[.Y.[J&9NN-JTZ.$<9/>L7LKLICUEO;$H]2J,$T?4#-XG.2$
MVL,^.@. A+7L?P@+MI_5U]:E="L:U;N2^_W+<X-84]M2PWJ,(\NW=6N^AJ^M
M7M+NM/(VYPXJ337I;KXRQ5M! ! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! :M-UGL[IZW_ /9WM'>&V,9M
M_;L563+'99[M[,W)3F\^A189XAB*O'#K(6ANSE[*EON"M97M9PDY.M-RBL*2
M>&-:X;"&_,97<WV5N<%&-*UQ<GC6,<53EICMV[$791ZA;'R>1QF(QV[<7?RV
M:"T>+QU>S')/-'2,H[)!&+ZNT9BXD^G!VT[5@2RUV*<G%I*E73CL\I)1S5J4
ME%27,ZT5<7RX/R,QL'5OIC8W&&T*V_<)/N6:1X(<1'=B*4YF?E\D="Y7DUX<
MFO-ZE6\E?4.=P?+QH4??K#N=FIQYN%<20;IWEM;9.-^E]V[@I;;QSR-&%R_,
M$0G(_8 ,3^(G]#<5:LV+EZ7+"+;Z"[?S%NQ'FN245Q;H<6$WOM'<TM:OM[<V
M-S-BW2?(UX:=F.8BJM+Y+S,(N_A:3P._<_#M2Y8N6UZT6L:8K>+=^W<]F2>%
M<'N([)UAZ6P6\+0EZA8(;FX)?+PM?WV'FL%SE'RCQX:F)"VO:[.S<5=61OM-
MJ$J+;@699_+QE&+N1K+9CM\*&4I]2=@9'=-G9./WAB;F[:C2/8P,-J,K+>5_
M:,P"^KO'\X6XMWJF65O1AVCB^7C3 KCG+$KG9*:Y^%<<.CTG+NWJ#L;8S5?W
MPW3C=O%=?2G'=G".27BPNX@[N3LSOQ=FT;O7EC+7;WL1;IP/;^:M6*=I)1KQ
M9E9-T[;BV^^ZCSM#]V6@:S]/M8C>GY+OHQM,Q<CMKWZJCL9N?)1\W#>5]M!0
MY^9<O&N'E([!U3Z<6]S!LJMO;#S[ID9VBP@7(WF,FXN(BSZ.3-QY6XZ=RNO)
MWE#M'!\O&A:6=L.YV2G'GX5Q(A'USV@75VUTH?(8\9X,=%*&2>['J>5.R5=\
M6,.FOG"+,>C/KQ[%>>GW/NZO4=*[*?%I7FZBPM1M/,.S55HM_P :K]6G'?XR
M5Y3JSTSP6>_=C,[\PF-SK<K28VS;BCDC(M.49=7T!RU;1B?5^Y689*].'/&#
M<>-"]//6(3Y)32EPJBR&=G;5N+.L<R3]+P]" ( @" ( @" ( @" ( @" ( @
M" ( @*6P^1P0]6^I\57;KUL_C<'AI\KG_>I#]]CD&R\,+0/X(O*:-VU'B6O'
ML4C=C/[K:K+U7*5%39LQKOK7>:WE;ME:KFE&W2Y&W;<I\S?,GS\JY=D>6FU8
MNN.PK>#K]O.WL.EU0K]*RBV57C"?/V;.2C"UY/F-%--2@:-WECC[=3<'+3@V
MG%9TM'LQONP[OK[J+#H4G7!OHK3S$!9[YYV[D(Z@LG2PE6?--*5*TE*W&CYH
MK&CER.5,(TQ)/;ZP;JQ>1VID,ST\/%=/]XY6KB,7FY;XED(CO/I5L6:0 XQ!
M(_S?,<A^=H_A5B.FVIQE&%RMR*;:IZN&U*6]KJIXB1N=Y<U9N6IWLMRY>[.,
M(R<JW%SX0E."5(QD_G.2JJI/U5EMP]4-S5NH&1Z<[5V,6XLO6P]7*Q9*:Z%2
MG$$\LD9^]2.!$##R-R\@D1/PT9FU5NSD+3L*_<N<JYFJ4JW1+9\-*=.POY[O
M!FH:A+(Y;+]I-0C/F<E&"JVGSNC:V>KRJ3D\*12<B/8;J_U#W-4S-#;W2P9=
MV[3NV:&[:MO*!%0@G@T*..M9:,SL',#\S,P,PMIS%Q9E>N:=E[33G=]223C2
M.+KQ5<*=?B,3+=Y-1S<)PLY1.];E*-Q.XE;BUL494;FY)II<J26V6Q/,2];J
MQ=)L#U1HX&24<O>IT9L)/,T<D$T]UJ,PD; 7]D;$[<&UX=G=:6EM9J5B4MB;
MKQPYEY?"IDR[U0>EV]0A;;4Y1CRMT<7*:MRJZ/V77=C3<3GJ%O8MC4=O7!QW
MTE]/;CQN!(/-\ORFR,WE/-KH6O)VZ<-?2RQ<GE?O$I*M.6+EY%4E=9U1Z=;M
MS4>;GN0AMI3GDHUV/96M-_%$1W#U2W!1Z@W^G&V=BR;ERT.$KY>K?>X%:H'G
M3%$7O<AB[QB+#J/(QD3\.5NU9-G(6Y9=7[ESE7,U2E7LKAQZ:TIQW$9G>\.8
MMZC+(9?+NY-6U-2YE&"JVO7;7JK##E4Y2?Q4DV9+8/47)[AR.\-M[PP,>TMT
M;)>M)EZT=EK-26I<C*2&Q!.X1ORNT9:L[<%;S>2C;C"Y;ES0G6F%'5;4T96C
MZU<S-R]8S-M6KUFCDD^:#C*KC*,J*J='7#"A&*G5;?NXZ$NZ]E]+GSFQXS,J
M%NUD@IY3)P1D[%9I4WA(>4M'>-I#$CX:,VJORT^Q:EV=V[2YOHJQB^#E7RT3
MH1UKO%G\W;^\Y7*<^7K@Y3Y+ER*>,[<.5JF^*E*+EALJF7'M;<F)W?M_%;FP
M<Q38O,P-/5<Q<#'7@0&+\1("9Q)NYV4;?LRLS=N>U&SY'.VL[8A?M.L)JJW>
M)\&G@UN:*ZW?U-S>$W[C>GVW=F2;GR^7P4F7J6&N!5AA>.=X7]Y(Q?DC;35R
M'4M786%]>&;ELC"Y8=Z<^5*5-E:X;NGK\I":GKU[+Y^&2L6'<G.VYI\RBE1T
M]>JPCTKF=:)1>Z+87J[U SUC<.U,;TQ M_;2MM!N&"7)C'B((I8VFKR!<>-S
MD*87\(#'PTU)V97[NG6+:C<E=_=R6'J^MP?JUHJ/?7'=4C\KWDS^9E=RT,JO
MO%ITG6=+232E%\].9N2>$5"JIZSCA64;<ZQX?(],KO4;<6/GVV&"FM4]P8EW
M:Q+#>J3>['7A<-/-(Y'88VX:N3,K%_391S*LP?-6C3V8-5KT46TD<CWEM7--
M>>OQ=OE;4XX2:G&7(XKY3<L(\6U@86?JKOW;U.ON?>G2_P"A-D3G'[]<JY,+
M>0Q<$I,PV+U5H@'RQYF>3RS)XV[6?175D+%U]G:NUN;DU2,GPBZ[>%4JF)/O
M!J&5@K^:RG)8;57&?/<MIO"=R%(KE6V?+*7*N*3,[O'J;E\!O/ ;*V[M"3=>
M1W)B+>3H2PVHZ\<95Y(P'SS-G88M)-2-M7[&82YE9RV1A=M2NSGRJ+2>%=M=
MG3T8=9F:GKE[+9NWE;%AW97(2DJ244N5Q7K-K"&.,E5[$HRJ17%=7-_Y7([A
MV76Z91GU#VU/$64JODQ##QT[,?F06??2C\PGD]D8QB=^&NK,SZ9$].L0C&Z[
MO[N2PP]:JVJE:8<:^4CLOWCS]ZY<RL<JOO-MKF7/2TH258SYVN9UV)*#=5C1
M5:D^UNL&,R?3[/[YW/0/:Y;-M7J.[<:\C6?(M8X^26.(Q9O,YG=N3@VKOHK%
M_3I0OQM0?-SI.+V54MG5T\"0T_O+:O9"YF[Z[/LG*-Q5YN65O"236WHPQJ1:
M?K%O_#XJ+>NY>DT^(Z?FPSW+461BGR]&F>G+:M46!FY='8C$#<P;M['60M-L
M3EV4+U;G52+?!2]&"3(V7>;/V+2S>8R;AEMK?.I780^7.W393%Q4G**VK!DO
MWQU3+:V3V%CL/MVSO$]^C=?$CCI8V,RKUAL0NW/H'))S-S&1,P#XG6+E,AVT
M;DI24>2E:]+H_&N&-=A*:MK_ -SN9>%NT[O;<W+RM5K&/-';14>^3:45BS]X
M'J%FI-Y8O9&\=M0[;R^9P#YK'25[C6X9)H9GBMT^;RPU*$7 M6[6)_0E[)P[
M%W;<N9*7*\*;L'X\?!E63UF\\Y'*9FTK<YV^>-)<R;3I.&Q8Q7*Z[TWA@9>#
M?97>IUWIYCL7[S!@L+%E-Q9SS68:LUJ5QJU6BY=2.0!*1WUX-Z5;>4Y<LKTG
M2LJ)<:+%UZ-A?CJ[N:E+)0A50MJ<YU7JN3I"'+M;:3E78DEMJ64L,F@@" (
M@" ( @" ( @" ( @" (#3G_?6_V(6Q?^(_ZASG_W#_MO[Q</P]_X*=-/[D@_
MI4=J_P#J[O[3-C[H?[/E?\J/H+E4<;&$ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! 1RMN7;MS-WMNU,[0M9_'1C-D<)%8C*W!&6CL4D
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MZJ@$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MT^W%NOHIU)V[5HV:N=DWQF,MAZ%KS*CV_=LJUJ,&,N1V:<0=@-GT9]"U6?\
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M;35W?BZQ=&NRNY*U.3JW%-M\:&9WCLV[&I9BW;BHQC<DDEL23V(L)2A!A $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MRD6)SF>LRRQ7FQD\_FE7EM%,T<8-QC=].(/R:CP=0>:R%MN=^%>=*J6ZO&A
M:QH%N$KF=BGVC7-%+%<U-M*5?'SGLS[U0@Q_OK3PQ8R&OYXVA(6@"  YN=C;
MPL##QU[-%IU&W3><MI)RIC6OCJ1K8>]L-U%VO0WAMUYCPV4DLACYIPY#D&M9
MDK/(PZOX2*)W;TMHZNW[,K,W"6U>]4NYK+2R]QVY[53SJI-U8,<( @*[WOL:
M'>UW9YVYVBI;9RPY::/CSRG$#M&#=VCN_%_Y%K'>#0KFJ7<OZR5NW/FG\ITI
M2,=V+5&V\%LJ3VCZR]-A?4565R'(N"KM?O%B+9R!" (#![G_ /K:W#_=EO\
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M>+A^'O\ P4Z:?W+!_2H[5_\ 5W?VF;%W1_V?*_Y4?07*HXV,( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MI2YKX0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! :<_P"^O_L.MB_\1_U#G7_M_P#VW]XN'X>_\%.FG]R0
M?TJ.U?\ U=W]IFQ=T/\ 9\K_ )4?07*HXV,( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M;[TC ?O?D5V*A*O9NC>YD7*[<A']]&N-:QQ7C6W#=@=NY/6,1DCL#8@D'7S
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M44E7J,G4\\\]FKF8:2=R3E1;%7&A)5ED>$ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&G/^^O_L.MB_\
M$?\ 4.=?^W_]M_>+A^'O_!3II_<D']*CM7_U=W]IFQ=T/]GRO^7'T%RJ.-C"
M ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M ( @" ( @-4_B-ESUO<?0O:>)W?GMFTMY;JGQV<O[>N/2MR0!1EF86D82;VA
M;M%_D4MIJBH79N*DXQJJJJVI$UI"@H7KDHQDXQJE)56WPX$>WIM;J;T&P>4Z
MF;1ZI[DZBX';,;7MV["WM8BR#V<='H]F2G=&.&2":(-3%N(EIH^NC"]RQ=LY
MR2M3A&+>"E'#'=58IHO9>_8S\U9G:C"4L%*%5ZVZJJ]I>>Y.L6T-M;;VKN2;
MW_*EOD8'V9M[%U2MY/*'8A:<8ZU>-^+C&_,;D3"+>T3<-<"UD[ER4HJBY=K;
MHEUD;9T^Y<N2A@N7VFW2,:.F+\&S\;%ZN87>F;R.U;&#SFS-YXRH&1M;0W'5
M&K;*E(?E#:@*,Y89HO,;D<HY"T+@3,Z]OY25J*FFI1;I5/"O#BGUH]S6GSL0
M5Q24X-TYHNJKP>QI]#16OVK=FW<'9W)M[9F]MU8+#RV@W5DL;B.:'%-4D,)7
ML')+&)Z"'F:0O([!Q+E[%D_E5Q2Y92BFZ4J]M?#?0S/R*ZIJ$YPBVE1-^U7@
MO-C3'86;NOK)L3:>S,%ORW?GR>&W9[D.T*F,@.S=RT^0!CJP5*XLQG)(+Z\K
MZ:-VZ+&M9*[<N.VE1QK6N"5-M685C3[UZ[*TE1QKS5P4:;6WT%(Y+K)?W-UC
MZ [=JX_=73^WD,AGCW3LK/5BI'<IAAYI:TSO$4E>>,91X<LCN!^TS/HLV&34
M+%V3<942HUC1\R\:PZ"26FQM96_-N,TE&DHNM'S*JW-.G1BN@M*CUXVIE=[9
M#8&#PNX\YN'"YY\%G_<\<4E7'\L8&]ZU:8_+CKOS\HN[\Y$SZ!P=UBRR$XVU
M<DTDU58XOH2XF#+2[D;/:RE%1<>95>+^:EMKOX);RC=[=:<IL'HIU"W/LO);
MJWCFJN\<SC*VX,KCX;4.'GK7QCEBL,),(4P9GCA)VU<G'@W8V=9R2O9B$)J,
M5RIT3]K#=\[>R3R>FQS.;MPN*,8N"=$Z.2:PI\[>^HMF]OVMG<YT*MV[>\MB
M7-TY3)0U-ISU(JK7SK4I)"#*1D1D$3"'F1\COKJW9VMB1L.,;J2C*B6-=F/Q
M?0S CE7;C>2Y)J*6-:TQ^*^..)EMU=>,!@-RY/9^!VINCJ3N/ 1Q3;GH;4Q[
M7!Q@SCSQC:FDEAC:0@;48Q)S=OFJBUD)3@IRE&*>SF=*]6WR["C+Z7.Y;5R4
MXPB]G,Z<W5@\.G86AM+=.*WKMS$[IP3SOBLS%YM4;4$E:<=#>,QEAF83 A('
M%V=ODU98MZT[4W"6U>,PK]B5F;A+:O&:\;PW!O?JIU8S?1W8^Z+>P=L;"Q].
M]U+W?C@!\I-9R+>;4QV/F-B"OK$SF<NG-\UN&NLC9MV\O85ZY'FE)M13V46U
MOCCL1+9>S:RN6CF+L%.4VU"+]FBVN2W\"1X#I!OW8NZ\'D]J]8MQ[DVK,<D>
M\]L[XLEF"EB<7<9:%A@CD@E8NUM7!^W3@S*W<SEJ[!J=N*EN<?5\JW^DLWM0
MM9BVXSM1C+XK@N7Q26QKI]^IF]R]<L)A=QY/:N VGNCJ+F=NM$6ZH=JT!M1X
MMIA\P L2RS0 \I!XABC<I-/FJBWD92@IRE&*>SF>WT^786K&F2N04YSC!/9S
M.G-U43PZ71$%ZP=3X<YT4Q6^NG.X[=6'([GV]3&_5>6I:C8\S7K6ZLX&PG&3
M>*.0"9N]GX/QOY/*\F8=N['9&3X_%;37I1D9').&:[.['9&72O9;3Z>*:,Z&
MZ,M5^)O<6#N9RQ!M+']+ZN8/%22N-.&PV5ECEM.#\!+RPY7+T,K;M1>4C)+U
MG-JN_8L#QV(O3XS4?6=UQKOIRK#RG/@?B)V_N&UB)JFQMZP[2W#<CI;?Z@R8
M<BQ-LYC\N*1O+D.Q'%(3LPR20B#ZL^NB\N:=*":<H\RVQKBO<KT)U*+ND3MI
MUG#F2JXU]9<>BO0FS8A1Q%! $ 0$?W%@XMR8+*X"Q>NXR#,59*D]['3E6MQC
M*W(10S"SN!:=A=RN6Y\DE)*M.)=L77:FII)T=:-57C6\KD=N=-.D/3R_MK'9
M/&]/<)-3L1?3%NT$$QV; .#VYIYB8YIR)V?F)W)WX-Z%D.[=S-WF:<GP]SH1
MF1N9C.7U)Q<Y56"5<%NIL2/YZ\OB[&T<QE,'DP:Q9JRNT.2B8W@LQ:NP6(#,
M1(@ETYF)V;5NWBNC1EV\5..SA[CZCJF7S<$GAM\W1MIAUGX"Y_J\S]K@#ZOZ
MWX-_.K<K>),Y2_62Z,?)B?J_-#6Q+-&['+#&&K%WR.3-HVGW>Q>6H.5S'85Y
MK.N-N4T_6?GK3 YX\A8JA!Y<D)3QMKI:$I $N[71QYM/ZW:Z=G&3=:TZ#"S%
MZ[R<L7&M-KK[A&<F<!RRV*VL$LAMSD+> _OG,!]+^CL65:BTJ,B[\^GUM[2H
MGXO!])Z,_!))N_8S[EV]'>P^T]Y[\K8W,;3V[N^G:A#,X]AFY;-&U"0<S-SN
MW(+$_%WY>"UO7^SO<L\90C5-Q:]5\&O=-.UEVKM*\S4*U<6G39NWKR4WGH]:
MWKU/PSNV2Z0RYFM"#%-<VUF:EMR]/)!>:A*3^KBM85FS+9<IUI^Y4UZ.6LS:
M4;J5?E)JG6US&2V;U#N;PR=VC+TXW?M"M1K^=]*[CJ5JD,Q\[!Y,+1V9I"+1
M^;7E8>':J;V75I)\\95X-OW"B]E5;CS<\6ZTHFZ]>Q*GCJ6BL4Q @" ( @"
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M8IHL=2Y ! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! :<_P"^O_L.MB_\1_U#G7_M_P#VW]XN'X>_\%.FG]RP?TJ.U?\
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M.D;M7ZZ[.LDN5>MS1HMQM0MR.;A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M%M&X,R]&T^<HN_,[-S-PYEY05/VO3P(#\"(CKRLS:OJ6GI7B14VV?M>E(0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&G
M/^^O_L.MB_\ $?\ 4.=?^W_]M_>+A^'O_!3II_<L']*CM7_U=W]IFQ=T?]GR
MO^5'T%RJ.-C" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MG ;:&!10"+@[>D7;11M^7-<D^+9&9NYVMZ<^+;\Y,59,<( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" (#3G_ 'U_]AUL7_B/^H<Z_P#;_P#MO[Q</P]_X*=-/[D@
M_I4=J_\ J[O[3-B[H?[/E?\ *CZ"Y5'&QA $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0%<[CZ8;(W1#MFIEL'![EM'-AN##48&\B
M ;P^;XY(PT$V)YB(A)N)<763:S-RWS-/VE1]1EVL_>M\_+)^M'E>]TPW[MB\
M18RQC$" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#3C_?5_V'6Q?^)_ZASG_V
M_P#[;^\7%\/?^"G33^Y(/Z5':O\ ZN[^TS8^Z'^SY7_+CZ"Y5'&QA $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! :<_[Z_\ L.MB_P#$?]0YU_[?_P!M_>+A^'O_
M  4Z:?W)!_2H[5_]7=_:9L7=#_9\K_E1]!<JCC8P@" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M<;&$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!IQ_OK_P"Q"V+_ ,1_U/<.=?\
MM_\ VW]XN+X>_P#!3II_<D']*CM7_P!7=_:9L7=#_9\K_EQ]!<JCC8P@" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M:3[SE/L7]-^\/R[5OQD?X*^N/W+ZT?7;4_A:K^M)]YRGV+^F_>'Y=JWXR/\
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0V=CZO95VTKRUK\^O10__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2227887d1-lc_human4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_human4c.jpg
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M0S2E4V-4-H:V)Z*RPH.CPV1%)G=S1(1EY:9H$0 " 0," @0'# <%!P,# P4
M 0(1 P0A!3$205$3!F%Q@9&QT2+PH<$RDM*3%%0551;A0E)R,S0'\;(C4[-B
M@J*#-3870W/3PJ,DXL-$=/*4U"7_V@ , P$  A$#$0 _ -_@
M
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M2N$_+3,4ZHH[3_,):6FJ%^=I2GD&7G83Q9J+=:JIB8.:LJ+DE2CH2:&"9P
M    &NG?+W@MMV6W=R?:4]I[AE<_&S@E[3BW-#/B#FP(\XM+'A75%H)_2?>.
MM*C<XNT._:5SGI7P>&G6:?*W=6+KM\C=/#X*]1CRW^]0Q)FZ0XN7[,Y'C5MD
M&7-G-3&93R$U(C6F.ZS%UD7EHL7I;#*GLS3?N\996^QK[4&E[O$;/<9R6QYE
MCUERO&K@W=L?R*$S<+/<6JDEZ.^@EH511$I)T/BE1$9'P,B,AHYP<).,M&C>
M0FIQ4HZIE<$"0    !%KJEZG8/3'8,5OL[$'\O1D]P>@-QF)B89LFRUS=9J4
MR[JKV4H0S\#!>5)I.E# SLY8L4VJU)&X]=DW^P6.^H8.,B]6^-/3&-6HVRDM
M)=)!JH5=.JE:#"G'EDUU&;"7-%/K*P(D@   H63Y-8<,Q^[Y5E%S9LV/6&,N
M7=KH_7ELLM_&49)(S/S$1$9F? BJ)PA*<E&*JV0G.,(N4G1(L?9W>'$]\<2>
MSC""F*QSVG*ML*5-:Y#D@XAI2IY+1F:DH49]TE453M2D^!7<G&ECRY9<:%K&
MR8WX\T>%3"_2IU9V[JB^?G@,)D8=\QO9?-\1.1-\3[3\733I99T:/"'7MKJ\
ME!DY^WO$Y:RK6O1U4]9C8&X++YJ1I2GOU]1+T:XV(
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MI]\JU\@6=O=RQ*]S<*Z4ZA>W!6[\;/+QIKXR7HUQL0
M
M
MC?U>Y3<\-Z:=X+[9WEQ[BBQ*@L26ZDMLKD\U!6M!I(S2I*'S,C+L/C4J5&;M
MUM3R()\*^C4PMQN.&/-KJ].A%_W7^!X_:=DKOGK4%I>499?9<2;=E((WD0H)
M-(:C(72I(UZG#(NTSX_%*F=OMV3O*'0D8.QVHJRY]+9*'=OI2V9WLS#'LWSN
MQRW[YCS"HR7;=+<M_BVR6EQDI3L;0\HV3(^6:7$F6I7;PI@X^?=L0<8/1^4S
MLC M7YJ4UJO(53J:W61LKL=GN=LODS=X5O.#C!&9&I5SG&4:(9$KXW+6OFJ+
M\E"C$<''[>]&'1T^(EG9'8693Z>CQFCACI?DO]$\KJ!.,X>5%E'M)"S-1K/&
MD*.VK/29D>KQ9F]JX_FRKV<1U#SO_P SL>BG_%Q]!RZP?_Q.VZ:_\/#TFYOI
MQW;+>GIFL>829)2+_'LDJSY8=2-?M.WLFR\M=.PWDDE^GF<(<WFX_89#CT5J
MO$_=0Z3#R.WQU+II1^->ZII[Z&^JG;WIF^M#Y^6;(KM\]O8GLKV#'B/\OV;X
M_G<[Q4N+2OBD:=.KL56G"O1;I@7,KEY&E2O'PT\#ZCG=KSX8O-SINM.'@KX5
MUF0>IO>@NNBZ;=X9L5M/DT^XX_-D*E7JXQ&$.H*:EI!-N+C.R&F&"-!K6MUT
MD\"/A06L'&^[U*5V:HR]G9/U]QC:@]#=-BS5HVNV_P $Q;)<EM\1>.6.W63V
MG-D-QD2G8$1MA:T&\I-=6C53M',W*W9RE%<6WYSI;=+4(QD^"2\Q'CK.R7'+
M_P!*F]*+%D%MO2XUM@')3 ELR3;)5RBZ3632E::T.E1F;;"4<F%4UJ_0S#W*
M<98TZ-/1>E&GG89P]FMQ.D;>!*SAV;.)ERM-^E'4D&:;K*M<U:O.EN+,853S
MIKYAT>7_ (]N[;Z51KS)KWTSG<3_  +EJYT.J?G:?O-&3NJ=9[U=3'4-=#I+
ML.QF#RX\<CXH2Y;TM0S09]FI%PGN+21?D^@Q8P/\#'MKIG+TZ^A%_/\ \?(N
M/HA'T:>EFP?W:O\ 5@M7ZQ7?]\0-/O?\P_$C;[+_ "Z\;).]0&47+"]C]V<J
MLSJF+Q8\4NLFU245U,R2C+)ETJ$?Q%F2ON#!Q+:G>A%\&T9V7-PLSDN*3-?G
MNJ<%L"=OMPMS7(33^4SLD7CC=Q<02G6(4.'%EFAI9E5!.N3*KH?>T(K\4AM]
M^NRYXPZ*5]]^HU&PVH\DI]-:>\O63;WJZ7-H-_KKC5YW&LDB9.QA#S,9^#(.
M&N3'>-*O#R76B)U;:%$:D$2RTFI5#[QUUF-G7<=-0?$V>3@VLAIS7 B?UE;T
M;T=-&X&S-\Q+)WRV6N:8\+(,4=A0IBEN6M]"I3*I\F.Y+(Y,1:229O:M2%J(
MQL-MQK.5":DO;Z'KT^#AHS W+)NXLX.+]CI6G1X>.J+\Z[.I/(=F=L,)D[5Y
M U S'<.YH58;LVQ&F_\ =<=DGI#S34IIYM>M3K"",T=BS,J'06=JPHW[DNT6
MD5KX_=4N[KFRL6X]F]9/3Q>ZAKEZ][-OW;6-CIN]6:P\KCW6Q2'+'";B1HDR
M!<RC6U=\3)1%A14:5/N-I:[Z^ZBM$&9ZMUM,K#YU:C2CU\*UY>EFFW:-Y<CN
MRK5>9Z<W0C9'EF\&\72KTX7C+=_LBL>YNZTN^+MV&*M:$L0'E2FDJC-/DS"M
MQZ62:>=<HW51$2261J(TZ6WC6LO(4;*<84UKQ]+\!NKF1=Q,=RO-2G72G#T(
MC!85>\HSK;UO?:S;C6R%;Y\)5XL. ICPD3)=O-).H6Q#.WN,*)Q!$IHG7N8I
M)^=1:LZ?W?;N=DXOJ;UX^.OP&##[PN0[5276EIP\5#-.WW4XOJ4Z.^HB7>X3
M%MSS"\#R&%EL:)4H[Z9-GF*BS&4&:C0EXFED:3,Z*0JG=,ABWL'ZKE6Z?%<E
M3SK0R;.=]:Q;E?C*+KYGJ08Z?.JY.P72WDN(X6A-SWCS;/)YXQ )HI!0([EM
MM3)3G63(^8I2TJ0P@R,EK(S,C2@TJVN9M_UC)4I?$457PZO3UFKP\_ZOC.,?
MCN3IX-%KZC:CM^UU%87T_9_F>]>XAW[<SYLW.\6NV-6ZU,1["N-!>>8:K$B-
M)D/$LB4X:]3=2)"2,B-2]#>["Y?C&U&D:I<7KKX7H;VSV\+$I795E1O@M-/$
M8.Z2^H'=W<WIKWVS_-\M]MY=AGM?YMW;P$"-X;PMF1*9_,QHS32]+IFKOH57
ML.I<!E;AAVK61;A%43I75]9B[?EW;N/.<G5JM-%U&"^G[=KKGZHL-R.T8CN+
M8\?7C5R-R\;D76%%C2'TRF&RC6N*U"MZVTDT;3CJW.7K_.)+61$25967CX>)
M-.46ZK@O3JS%Q,C,RX-1DE1\7Z-$9FZ'>HS>7,]S]SMA]ZK@UD.0X''G26KY
MR66I##UKN#5NFQ'%QT-H>3S'DJ0HTZBHJJE$:23C;IA6H6XW;6B?PJJ,G:\R
M[.Y*U=U:^!T99=UWWZE^J+?'-ML^F_+;;MM@NWIR&YV2R6VU+F%'>\,4AQU3
M$EW\\Z2N4AI*2T<7#J+L<3'Q+,9WDY2ET%N65D9=Z4++48QZ3)73=U#;QV7?
MK(.E?J,G0<AS"(RZ_BF9064->+-J,F<32N4TPAQM<34ZA9MI6DTJ0NJC[MC-
MP[4K"OV=%TKWO27L+,NQO.Q>U?0_?]!LG&E-T:(=WL]QG;#WFUUSS,9CEOQK
M'9EJ>NLQIER0M"',3BLI,FFDJ6JJW$EP(=7CVI7=N4(\77^\SE<B[&UN#G+@
MJ?W47+UN=8>Q>]^US& X%;KAD^2*O$:7;K_,@'%:MZ&3/FK84\9/*6\D^5I)
M!$:34:CJ22.WM>W7K%SGFZ*G"O$GN>XV;]ODAJZ\:<#,5XR#=WIC]WAMQ,LU
MT>Q'<*W28_.<D18\IZ/&O%RES$1W&)K3Z$J2R\A)D::I,J<*#'C"UE9TDU6/
MJ2709,IW<7!BTZ2];;Z3GT_W_KDWOO.TV[5QS"WXWL^^Y$C7RUH1!*1=(EO1
MRKA,7&\(=#G/L+(C2I!MZZM)2@B4*9<,.PIVTFY]''2O!<>C^T8D\R^X7&Z0
M\FM.+X=/]A:MRZA^IOJIWCRW;KIAOMNP+ \-4\B7ETI#=9##;AL)E/R5L2G$
M^(6DS8;8;)6GBL^"C3<CAX^):4[Z<I/H]U/+4MRS,C+NN%AI173[J^2A7ML^
MI+J%V1W]L6P751.@Y3"S-R,QC>:0VV6^6N<ZIB&^VZRQ&)Z.X^DVE\UM+B#[
MU=*=)POX5B_8=ZQI3BO%QZ]2=C-OV+ZM7]:\'X^'D*KU/]2>]EYW_L?2[TXS
MH]BR=TV$7_(W&V7'#D/QO'+;2X^V\AIB/%HZZI*#<,R-*?BT7'!PK,;#OWM5
MT+WO?9+.S;TKZL6='TOW_>1#KK?B=3&(X[M_@V_N16?/[:Y.EW7$<[M;7*=-
MQ#2&94&21,1B,T$M"TF;=3)7QU4-*-EM;QYRE.RG%\&GZ37;HLB$8QNM27%-
M>@F%UC[\[K[&;2=.4O:S*_FO(R.U&U>7/ P9O.1&@05-%2='D$G2;BOBTK7B
M-=MN):R+MSM%6CZWUOJ-CN.7=Q[5OLW2J\'4NLE)U4;DYIMOTM9=N-A=Z]C9
MG:X5A=@WGPT:1H7-N<".^?(DM.LGK;>6GB@Z5J5#(C&!@687<E0DJK7T,SL^
M].UC.<71Z>E&+]NNIZ_X]T-VGJ'W*F%EV7^'NB/W)B%X^=[;EVZ R;<5IIM"
M2)+9+-"*Z$J50U=M^]@QEF.S#1:>14398LYTHX:O3U>OE=6D1CPZ[>\3WFV[
MF[^8MN5:[+:'$S)N*X#&AQTOSF83BTN-Q8IP9!+)2VE(:*0Z:W*<3TFE2LZY
M' L7.QE%M]+ZO?\ 08-N6??M]K&22Z%U^]Z2]=XLOZF-TNBF^WC*[%]561X\
M\ZWNI;+S 5#5?K"EHM#D)AZ,^IEQ;JT:DZFC(T*,E)2I*1:QK>/:RTHOF3^+
M1\'X?<R[DW,B[B-R7*U\:JXKP>Y'#W9MDWM3B4>_2,PM"]AUJNT>#A26D>TT
M7GG,UDJ<\"2N70E\/%&7'XGFKO<K/-2C[337HIY_@&R1O<M:KL]=.FOF^$NK
MW?O4CNCO! WNNF\V;(OUOP2/8Y4"6Y @040V9"+FN8M7@8S&LC3&09ZM5-/"
ME3K;W?"MV7!6HTK7I;ZJ<2>T9MR\INY*M*="\->!BC'-[>L3K&S3,%[ Y';-
MI]ML2?2W'E3T-H-9.FKPQ2)'A9KSC[B4&M2&DDV@N"J]U2\B>+BX4%VR<I/W
M=:T+$,K*S9OL6HQ7NZGJ90Z=NIW>C&=]973#U.G&N64R#-K&,QCMLM<Q[D')
M9;<5';::>9D,E^:<)"5DON.$:E'HL9F#9G9[>QPZ5[NHOX>==A>["_QZ'[NL
ML/.^I;JB3UBYKL3MC>[?=8LYXK7AMANL*$B%;G'+:S+=G/2&HIRG$QTDZ[I4
MXHOVJR+0=VUA8WU2-VXFNEM5UUI3C34M7<W)^M2M0=>A)TTTX\*Z% O6]/5Y
MTP;^;?8IO)N%;MS<7SZ3#5*8CQF$QUQ94E,1]3!IBQ'6'F#[R4I_-GPJ1U,B
MG'&Q<NQ*5N+BX_V];(2R<K$OQC<DI)^[J1N<'-'2
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MFI^4:[=+$+-[E@J*B]VIL-KOSO6>:;JZOW:$O1KC8@
M
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MN07LQZ?%ZV7/AO\ >LY5_P#UW_V.($+G_35[OUBY;_ZD_=^J?/>-?UA.FO\
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MM1I>)*TD9E4M14)1)3IMSPXXUWEB]&JFXVS,EDVN:2U3H2_&N-B
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MD+[M7^K!:OUBN_[X@8>]_P P_$C,V7^77C9/P:DVP
M
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MB)19.%R'9#2UMT61*[IEQXA"]<@FHR:3ZF)V83:<HIM=:+R%LN
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M)%##,P
M
M
M
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M.A+;##:20A"$%1*4I*A$1$5"(A:;J74J':
M
M                                        /AGI(S/R #H<E,M)-;JR
M;07:M2DD7K,Q&4XQ56Z(JDWP.3;[;I)-LR4E952HC(R,O09&*J2DJHHU0[A4
M             !U>(8YO(YS?/[>3J+7V5^+V]@AVD>;EJJ]725Y72O0=HF4
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M(5 YR?,?WOPA4#G)\Q_>_"%0.<GS'][\(5 YR?,?WOPA4')*R56GD^ 5!S
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M!KNZ[TNK_;^!&:M;?Y!>L_P#4'5C6W^07K/\  :V_P @O6?X  UM_D%ZS_
M&MO\@O6?X  UM_D%ZS_  &MO\@O6?X  UM_D%ZS_   !K;_(+UG^  -;?Y!>
ML_P !K;_ ""]9_@ #6W^07K/\  :V_R"]9_@ #6W^07K/\  :V_R"]9_@ #6
MW^07K/\   &MO\@O6?X  UM_D%ZS_  &MO\ (+UG^  =C1I,STI(O@ '<*@
M
M
M
M
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M^07J "I_D%Z@ J?Y!>H *G^07J ')->-4T^X .8J
M
M
M
M
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MN)_=,9GU5RM<ZZ#16]WC'.>-+R>\90:)1-HH52I7M\_W1@IU-Y2AV=_S??\
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M [_F^_\ L@!W_-]_]D ._P";[_[( Y)U>4J"H.0
M
M                                    # V\W4#C>S4_#L>D8OD^X&:9
M\Y,3BV#8?!1/N;[5O;2[+D*0X\PA#325)U*-5>/ C)*C2*I&,7^M_:5W;_#,
MUQZRY7E=ZW O,W'<8VPMMM2K)%W6W$1S8S\5;R6VCC$M"G#YID25I-.JH"AF
MS9?>?$]\L3E95BL:YVE=INLRPY+C5[CE$NEJNL!1%(AS6$K<2AQ!*2JA+/@H
MO+4B!HRV!0
M
M
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MORB]1 !0ORB]1 !0ORB]1 !0ORB]1 !0ORB]1 #DDO21_ *@Y
M
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MX?*3JUMDE9+)94[*'Q -*ANE B
M                                                 %+OEZM>-V6[
MY%?)B+=9;!"D7&\7!PC-#$6*VIYYU1)(SHA"3,Z%4 8-VWZKNGS=W)FL-VYW
M*A91DS\=Z6U:F(LUI9LL$1N+U/QVT=TC_* K0D,!0 #P1+K;)ZW&H-QBS7&2
MJZVP\AQ22K3O$DS,N( ]X
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MLM!K(EJ2E1IJ0#E)]@4
M                                               #HDQ8TQE<:9':
ME1W*<R.\A+B%4,C*J5$9'0R(P <BQGHZHCT=IV*I)(5&6A*FS278DTF5*>@
M=C;:&D(::0EMMM));;21$E*2*A$1%P(B( <P!H*V'_O7\^_67-OX++ F^!OU
M @
M                         &"^II%OD=/V[T"[9-&PRUWC&)UKN.43&)$B
M/"8N#?A''76HJ''5))+ID>E/I/A4"J(:;#97G&V^_P#M1LFYNCC.^&#9OMTN
M\P+O9[#;[6]8$0&3*.3;T#4MR.\AM*$JDJ-:C,N)&7>%6;(<I3>5XQD:,=J6
M0*M<PK$:30D_&&ROP]#=H@OSFGXW#S\ (FD3YO>^,_\ I%S_ (SPG_KP)Z'@
M]T:4PMVM\2N-?:!6.,4^II,^=X]7,XI[OQJ]G !(WT 0
M
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M?_"S(]KW64E;;.10#@-K(B9N3)FIE?I/B9E48=S;V_X>OC-WC=XDJ1R(\O\
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M.+XZ!!N%OM*5NQ]:F^8DDQ5<-:%%]P"M$?IT M@
M
M          :"MA_[U_/OUES;^"RP)O@;]0(
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M[U99B'TK5&G6Z>T1)<:>Y3E"XFG3Q,Z@4:H2J H
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MDN$EQ.@FRUI)2B50@',3Y H?GN][[_+;MG^HZ?TE, G$_0B!
M
M                    #05L/_>OY]^LN;?P66!-\#?J!
M
M                T3>ZA_EMZ@_]F-_I)P"<C>R! I%ZQ^PY)%;@Y%9(%^A-
M.D^U#N,9J4TEU*5))Q*'DJ22B2HR(Z5H9^<7+5Z=IUA)I^!T(R@I:-5+)NVS
M&T]XM=RM$K;K'68UUBO0Y#L6V1&'TH?0;:E-.MM$MM9$KNJ29&1\2XC*M[ED
MPDI*Y*J==6V6Y8]MJG*O,:OKQ[N[=%K)G(5BR>P3,6<>,XU\F.OLR&V-78]&
M0RO\X1>1"S2?Y2:\.YM]\<9VZSC)2ZE2GD=>!I9;3<YJ)JAL8VWZ=]L=O\*L
M6)O8K9LHEVMDRGY#=+9%>DRY#BC<=<4;B'%)2:E&2$ZCTIHFITJ.-S=XR,F]
M*XIRBGP2;HD;:SB6[<%&B?AH93LF'XEC3K[^.8M:,??DH)N2];8,>(MQ!'4D
MK4RA)J(CXT,8%W)NW52<G+QMOTE^-N,>"2,$[V[&9OGF6XAN3M9O!/VFS[$(
M<FW)6N$B\6>X0I53-J5;GG&V]:#4HTN<3*O94DFFR7$S"3O0_>LDQ#?I.X>\
M:\HW7Z@(=IMV09^W8F(L*WQ+.\RXPS&M;$AHEU2RE*U&ZFM$G0CU:PJ9$SSI
M/._93LGN1@>?%MWNCL["BV=W*T6KQ\>]VAACDK@3892XIZ%U50^:>E*UIXGI
M4@*E'R[I=W(M&YN9[H].V]Q;07#<Y++NXV.3[''OMNFSV"42)\=$APN0X>H]
M1454U*.M.Z J9/V&Z<\?V5PK*<<N%\E;BY%N+<9EXW.S*\-I2]>IDY)H>-;)
M*<T-Z3,B1K5Q4HS49J, V65TR=(=@Z<<?W)L999*S1W<66AMZ[.1U0)$6SQ8
MRHT&WDM,A]2CCI<<HZE2/C<$)T\0;J8^QKHSSYF^[20-P=_9.X&UVQF2)RG
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MLKN!3[K<H=IBV2!&;01\F'"A1:DAIK6JAK6I1UKP[ *-F>0*
M                                   ?#K0Z=H X=_S??_9% ._YOO\
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MGYOOG^$6C./I:C*I%]\_P@#[W_-]_P#9% ._YOO_ +( Y)U>4J"H.0
M                       /SW>]]_EMVS_4=/Z2F 3B?H1 @
M
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ME>'Y:5F*1X"%;_#H*W1'W&.7!CQTJT.NK+4I.H_1V$*,G<!0
M
M -$WNH?Y;>H/_9C?Z2< G(WL@0
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M45MZ;)N"R8>-"B6>MOO$HS/CW?)ZPX%Q-E$N]T)@BB3)C1.K-:68ID:B4NO
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MBA])%"(M1G0"B/NG]L?K J-/[8_6 /I%3RF?P@#Z
M         #\]WO??Y;=L_P!1T_I*8!.)^A$"    8ZW@NMQL6TNZ-[M$MR!=
MK-B-[G6N<UP6S(CP'G6G$&=>*5I(R&9MUN-S*M1DJISBFO VBU?DXVY-<4GZ
M#0W_ $J.H;^=B^?Y1O\ Q!ZM]PX/^5$YKZ[>_:8_I4=0W\[%\_RC?^('W#@_
MY41]=O?M,?TJ.H;^=B^?Y1O_ ! ^X<'_ "HCZ[>_:8_I4=0W\[%\_P HW_B!
M]PX/^5$?7;W[3-M?1+G67;A;-RK]FM^E9'>$9'.BIN$LR4X3+;,92$5(BX$:
MS/[H\_[SXMK&RU"U%17*G1>-F\V^Y*Y;K)U=27PYTSB+FXO4Y%QW/I>T>V6W
M&0;V[I6R,Q+R''K"J-$@6=J2G4Q[4NDQ:&(RG4F2D).IZ>)TX5%:'S;+J:1E
M6X?U.[E[:WS93=>1 =NEDQN]/19T.[1&#5SEVVY0UJ9D*:))J6DB*A$9EJTJ
MTA0E(!0   ,<;=[IXKN@[N WBCDEYO;;+KAA&0OR&392=VM;;"YB624=5-MF
M^2"69%J42M)&G2I0&1P  &'L WAMN?;B;R;>0[-)M\W9RX6NWW.XO.(4U-5=
M(ART*92GBDD$6D]7E K0S"!0
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MBX95C#<%U3AHM\EEEMM+Z5-H)"R-LZI*I%YP*-DE *
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MDXA36JFH@#-E $0      -$WNH?Y;>H/_9C?Z2< G(WL@0
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MHCT>L4 HCT>L *(]'K "B/1ZP!](DEV"H.0
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M&[Z-91CF>V'(\BEW<^=#MGB8EQANR5*7'D$ZJJW$&1T(B3IJJH<3 NU>+2\
MV.]X9G&-Y[FL:_XAG6Y>.V9YS(9ZVR.$W!>;NKB.86JY&I!$J8?YTRJ1JX@.
MHNZ^6G<;:K9C:7/;+O3F]^WEZK[CAV"3;[>KFJ9:+(_E:2F.3+=;5DEMIR.T
MR;#3AF:B(S46E2C, 9!WMP&\=)N,8GO5MQNKGMY>QO(K/;MP<<RW()E]A9);
MKG+1#?-YF6M3;4E)O:D.-$@D][A4 M3)/3A_6:ZY/UEQ+]"J H^!-\"@
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MT*:4:32M1&1*+O &;)@(@      :)O=0_P MO4'_ +,;_23@$Y&]D"
M                                                      !:.:8%
MAVXEKCV3-\?BY):HLI$Z/!ED:D(D(0MM+A:3+B2'5%]T9&-EW<:7-:DXNE-.
MHMW+4;BI)51KYVMV4VJO/4_OYA]TP>VS<8QF);EV&S.)4;,53K;)K-LB41]X
MU'7B.OS]SR8;=8N1FU*3=7U\356<:V\B<7'14-DMJM=OL=KMMDM$1$"U6>*S
M!MD%K@AF/'03;3::UX)0DB(<7<N2N2<I.K;J_&S<1BHJBX(]X@5
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MP!F58N17QBVK=)S.WM3;1><<CE)-Q3L:XMO&:%4/XIU2=3^Z*)%V<H2^*5J
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M\I7!1K,]1:?( J9] H
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MLCVKVWW'EP(-AW(7=85VA(=NC?-A*DM1TH<:;<3Q-1\2+\4Z&0%*$_P*
M                   !2,@9O,FPWN/CDQFWY"_;Y+=AGR4ZV6)JFE%'=<3I
M5J2APTF94.I>0Q;O*;A)0=)4='X>@RL&=F&1;E?BY6E*+FEHW"JYDGIJU5+4
MBY\SNLG^=S#?XL+Y$-%]6W7_ #8>;]!Z)]Z]S/L5_P"7_P#K+CQ'%^J.'DMG
ME9EN7B]WQ=F02KU;8< FGWF:'5+:_"(H=:?C$+V/8W&-Q.Y<BX]*2U]!@[GN
M/=:YC3CBXEZ%YKV92G6*?A7._027&[//P
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MTV]S;YS+5B\;.,HNMED6ZU62)9XJ&YDER2^1$JBB/30N]2A56:$J#@;I (@
M                     !"_?W >I3)<Y9N.TV62++BR;7'9<AM794))RTK=
M-Q7*+SI-/$<UNV)N%V]S8\Z1HOUJ:ZGK'<K>N[6'@NWN=E3O<[=7;Y_9HJ*O
MCKH1=W Q[K VSQ>;E^4[CW1JS0'&6I"XU]<><)3[B6D401D9]Y1#1Y=G=,6V
M[ERXZ+_:ZST39,[N=O&5'%QL6#N23:K:27LJKU\1W8'B_6)N/BEJS/&=Q[F[
M9+SS_!.2+ZXRX?AWW([FI!F9EWVE4] KB6-UR;2N0N/E?^UU.A#>=Q[F[3ES
MQ,C%@KD*5I:37M14EKXFB6'3O@_4-BV3WN9O!E#]]L<BUFS;([MT5.)$OG-J
MUD@_B]PE%4;_ &?%SK5R3R)5C336NM3S7OSO'=W-Q;<=KLJ%Q3K)J')[-'I7
MQTT)>#H3S                                    UZ=?#V!6UC9J_9G
MN=G.U=PL]ZN)XA?\%MZI<M<Y^.TTII;J%(4T:FU*2E)'^<(UI,C(@)(PUTX]
M3FT&#YK,MN4]1V[&X'SED1<?C)W"M$EBVVNX..5;);U7"86X9DDS61$1<5&2
M:F0-&W ")9>XN>X]M=@N4[A95(.-8,2M[MPN"D4-Q9-E1#+23,M3CJS2VA/E
M4HB\H UQ]*^4[H7#K"W)9W/S*3,N&6[<Q,I+!2GN.VVQ/W"9'<:MD6.I9MDY
M#BDEIQ24ZE+)Q1UJ9F)/@;4 (FJ"X>]QV5MT^;;W=M<V6Y!D.1W%I3;=)J:4
M:#,JRR.AF0$N4CS[I*8BX[O;ZW!I*D-SK+'D-H53427;@M9$=*E4B,"LC?*!
M LO.MO,,W+M$>Q9S8FL@M,28B?'A/..MI3(;;<:2Y5E:%5)#JRI6G$0N6XW%
M22J86=M]C.@K=^/-%.M->.JZ*=;(Z;C])&T;N!9>W@FV<0LS7:I)8P:)DA"O
M&FV?)HJ1))HN]3BLZ><8MW#M\KY8Z]!SVX]T\)XUQ6+*[3E?+J_C='%T\YKC
M_H:=27\W'_QBS_+1K?J5[]GWUZSSK\G;K_D_\4/G$Y]@^D3$(VWL9K>C;2,K
M."G2C?-V<IU7AC47([T&4IKLKV'7SC/Q\./)[<=3N-A[I6(XJ6;97:5?3T='
MQ70E-@>S6V>V,N?/P3%&,>EW1E,>>\R](<-QM"M24F3SKA%0^/ 9=NQ"W\54
M.HP-GQ,&3E8@HMZ/5_"V8&ZB-D-U,EW/VDWXV1O&/L[@[5LW*WNXUE1R46NY
MV^YMFTX@W8A*<0M!+73A0S-)U+115TVB8Z==C]T<8W.W?WXWMNN/O;B;L-VR
M"WCN*JE+M=LM]K9)EM!.2R2M:UI;;K0J$:5'4]=$@V75LCLME.VNZ_4GG5]G
MVJ7:-X\CM]WQF/ =?<DL,1&'FEIF)=8:0A9FX5";6LO20!LA]B'2]UM8CM5E
M.PUDS;:&P;=YG.NJKQE+'MV9D3$.].'XM#!.1F8IJ4THT%W4F53TN)511"M4
M;']K-N[)M)MUANVV.FMRSX;:V+=%D.T)Q]395=?<(N!+=<-3BJ<*J.G ")?X
M                                       -4>_&V.[6S<'!YD;J;W O
MQY?DD:P.-NW&?'Y"9"5J-XC3.7J,M/9P^$=]M6=BYLIIXUM<L7+@G6G^Z:/*
MLW+*3[23JZ<7ZR=>S&TV4;7?.3YR[NY%NI[<\'X+V^Z^YX#PO/U\CG29%.=S
M4ZJ4^(GM\G*[EN%O+Y>2S&W2OQ::UIQHEPI[YL\>Q*U7FFY5ZR+'7IFF-9'C
M-@V?Q^=)O^Y#F0Q+DWBUG95+>)"(\AHFY"6JFE2^>2D((C6="/22>(WW=3&N
M6KDLF:2M\K7,].E</-QX&#NER,HJVM95X(U<8GMSFV;Y0SAN-XW.GY"X\3+\
M#DK0<;CI4N2:B(F4(_&4NA$.ZR,RS8M]I.24>OK\76:6W9G.7*EJ?I!Q6SN8
M]B^-V!Z1XMZQVN';W99F9\U49A#1KJ?'O&FH\8OW.TN2FM*MOSLZ^$>6*74B
MO"T2            '7R=H X]_P!  =_T !W_ $ !W_0 /+(=2R2W'5I0E)54
MHZ4(B])BSD9-NQ!SN.B1*,7+1<3'%ZW&L=O8E%'<.9(01I2VV1D2C[."J4'G
MF\?U*VW$YH1FG+5<5XC=X7=_(O--JB(T-RW[G>;M(49I7+<:4HJ\2[ICYCW?
M+>XW(W)]+9WN-C1QUH70_8V>0;O,4:B+@1]@UEU>UIP+<<N7::ENJBH4DT.)
M)95XI47 QB=O*$M#:0NM*IP:A,-$?+:0V9_DI(A.YDSD]0[_ #'<B*XL]+=2
M\]!!7&]"/.HZLITXI,92VW#,TK*BTUX4])=@V>'F7;,)0MW:>4G:A:NNM#->
MTDZ'"B7:1)E-Q68Z2YA+-*$H*I4/R#Z)_I3FS6++MKM4ETM?[)P?>+'DYJ,(
MMZ^LRO:<EQ_*&W6;7/:GH29MNI3Y_*/7<;/M7W_AR3:ZF<UD;==M0_Q(M)]:
M+6NNUF/W1];M%PS5Y65*(O4:AMK>X7(JC.9R.[V->=>#\']I;Q[)66JC*[22
M(BX%4C_YQDQW2:->^ZF.W\=E(N&TF.P6%OOY ^PI*3/4HBH7#RT,%O$W*E"W
M?[J8MN+?:/WO68!O$:#"G.1V[XU,:2HR)QM9I.GI*HZ:Q)78)O1G 9MN%FXX
MJXFBBR8B'DJ2V2);:RX=\B47WQ?24>DP;EOGT6J\99TV*413[4F0LXLI1:4E
MQ)ERA$6E1=A5%Z#KP-/D6NS;4F^5^\_ RUGGER5/VWVHEF?%_-K;>H@G2\BN
M%.(N*/+K30P)NX].>C6FO!EDW.VW9*V([T(I,12-$IPU$:$TJ9F9EZ.(LWJ=
M!?L.XH4D6#(.';GY*H#',<?(TN3DI,R222X)(B["](M*39FJ$5!5ZSR2''CM
MUE.-(3)C+C$Z<0BU'K711$G5Y#IQX"I54Z#G?W:P&6H-[7#ND",I,ZW,-(6T
ME3S9I2A1K)1T1J-1I+T<> C-Z%^RX*6JU+)P9-UES[D:R=;M;!I0HY:N8<QL
MB,C[GQ2IZ"%+<BN3R4TXF?H*K8S$<5$6SRDDK0K6I9U,B[ND^Z5.P7C3W9.I
M95XN#<8T1X\UMEXJ./LNZ::5<-!D?G\P%^U:G%<U.)BC+'+5 41MNJB76:Y1
M#*SYC:.%"TF7Q2.@H;:WPU.F9BEWN=MCOOJ4^@TIU*<J9(21F2M*JD9'YA40
MR(0E0]F/,/8C%:2VPR^<=XE$XHD$\XG57\XLR.M"[!0ADWHW%1%UY?E$&3 3
M:+<E-UN>1R$E:+:E1&HUD9NN.*H7!+:2,S,P98Q,33FEH6$_@-OC/-/W),-$
MB[&:W9;=5DEU-"--5F9TJ=. &6LR:?+'@BWTR\<Q"3,-V%/<NT%Q3*X3+BUD
M9$JAN-HHHB+_  @3Y9W/C,J;N<WV*AN3)MCC%HYA&F0JJ%FA5*&94(B.JNR@
MJ4>'%JCXE;3E$FX7)R)<XZDP4$V4*>:'#0IU15Y:S(J$=!0@L>$"N6&V^U;S
M%CNV1Q%O=<-T[E&UDWRD%4]9^DRH!AWVH<#*=SEVVW3$0W8\5]B='-M=O-LM
M'?/XU"[#2GS"IC1G.M8EGN8AB%NE,716+V.$Y(490[@ZXXVIT^T^',(C/[@H
M97;WIKEJ5_YQ6FT1%/&ZPFU.&E#K,!HU(865"YKBCJ8-)HPY8][FU*<]=,&;
MR1]]UI-Q3<;7K63"S[ZW3IK;4GL-!D2AC2L)FTQ7<@M>!>>W%Y8OMD79TH8.
MZ15J*63R2,W6%$G2I:3[>'=,9MJCCRFOR;<HRYHJFO$MK(\"B0+XI-D>3"2\
MM+K*$+(DH47><;22CX%Y:"XVHQ43'FKDY:/0KTZR1YJ&&)A<FZ0M*V9O9S"/
MM2KST%MZD'"XD69<IA8Q-@ON,$J1#D-NQWU%W-9+YB5D?E(M-*#'R[*=LRL2
M>1"["2X)FW/:#>;&=Q,5A25S&8ERBM):NT)U22T+I0U$:J%0R'&9&'-2JD>\
M[3OEB_92DTI):EZW+/-M8)DU,OEL)789&M#AU+X-0I##R9?%3+E_>]OBZ3N6
M_/$HZ,_VFDN(;1<+2\I1\*I1_P Y"<L/-AK)2H8\=\VIOV9VV_'$O:W+Q2X-
MDY:V($BOQ5-H0?\ @&-=[:'&IMK$\:\JV^3WBX(T9IHCTLH;4?XJ4T+U$+*N
M-K7B94;*3J>RA_F^SM$>DE+B=_?] D4/I:O+3[@ ^@              L3%-
MN<8Q&Z9!D,*.NXY9E4A;^19A<30_<Y2-9J9C*?)"=$>.DR0RR@DMH27!.HU*
M4!?8 B%MKNKLOUL8[EC,#%+W'9V[O;<-JY7EF-"N4"YH(W&IUIEPI4AUAQLT
M52XE:%>0R-)F0%>!(G-9&5V3;O+96%Q3R;.+1CD]W$X4OED=PNL>(XJ&V]IY
M+9<Y]*2530GC^*0%#\\.Y5FZAMM]K,-M.Y6P$JTY#D>\MMS'(=U+C>H<J;DV
M1FU</"P'&F-7)0IMUPTGJ-*3)1]KA@3)F9MF5YQKKMZ3=X-[+''VJB9=MS-L
MUY9N<UIR'9[HGVRA4;QI)2T?>F1R-1JX<VIF1 4Z#!DBT7#=VT>]"W'PE;MW
MQ6YOP8UANEN<YT2Y(LUQ.?*=8-*5$Z28L4G-2?Q'>Z?>U$*]14-T,]Q;>/83
MW>NT. 7Z#>,W7=\<AW:QVJ6A4^V.6B(W;'W)+:2-4?OJ4X2G"+@DUEJ21J =
M9>>Z_NJ]P-P]TMRL_A;K8_;H><Y5><@B6]Z%+6ZPU<YSTM#2U).AJ03A$9EP
MJ 4C6SU3=,-^Z6<PQ[#[_E$#*I.0V<KPS,M[+K*&T'(=C\M1.\3.K1G4O.!5
M.I^MP"V   %A[IWJY8WMCN/D5ED^#O%AQ>\7&TS-"'.5)BPGGF7-#B5(5I6D
MCHHC(_*1D,?,N2MV)RCQ46UXTC<]W,2UE[IBV+JK"=ZW&2JU6,II2551JJ?%
M-/J-+?\ 3-ZE/YR/_@]G^0CA/OS,_;]Z/J/K+_Q1W:^R_P#W+OSQ_3-ZE/YR
M/_@]G^0A]^9G[?O1]0_\4=VOLO\ ]R[\\?TS>I3^<C_X/9_D(??F9^W[T?4/
M_%'=K[+_ /<N_/'],WJ4_G(_^#V?Y"'WYF?M^]'U#_Q1W:^R_P#W+OSS9WTA
M;CYGNCM1(R7.KS[<O;=^F0D3?#QXU&&FF%(1HBM-(X&M7'37TCK-ERKF18Y[
MCJZM="ZNH^>OZH;#A;+NRQ\.');[.,J5E+5N576;D^A=)*4;<\Y,,[6[UV#=
M;)-VL9LUJN%NE[09,YB][D3>5RY,ELE&;L?EK6>CN_C$1^@"M#V9)N_9,9W<
MVUV>EVR=(OFYL"\W"TW-GE>$CHLK27GDOZEDNJR71.E)^F@"A'FT=9\O*[CF
M43!.G+<K.H&$9+<<5N]\M#5L5%.X6U:4O(2;DU"OBK0LJEV*(!0ROB^_-YNV
M-[A91EFR6;[:6_;^R/WM99$W!0JXMQV7GW6HGAY3Q&M*6>.LTEWBX]H"AB7%
M^LO(<UQVU9;BG2KNM?<<O<<I5INT5BTJ:D,F9D2T5GD9E4C\@"AEC;?JAVQW
M%P?/,X4JZX,UM4J0WN;CF4PS@W6QJBM*>7XJ,A3M24A"C0:#5J,C27?(TD%#
M&S76QC4:UV?-<FV?W(PS:&_R&&+;NY>+9%1:T-RUI1&F2V&9CLJ/%>-1:'EM
M4,C3P[W *$T6W$.H0ZTM+C;B24VXDR-*DF52,C+@9&0%#F
M     ")>V']:[J>_T+$?T6V--B?SU_Q0]!Z9WB_[3VG][(_U&2T&Y/,P
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M:[U[S:WC<[N7:AR1GRTCIIRPC'HTU<:F3QG'/
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MT@B2E*4W%9$E)%P(B+L("4C>Z!
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M,O&Q(V=>,NEF(]FOZX?4S_H-J_>HXV&Y?]*QO'+X2QC_ ,U<\A.,<N;(
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MIEY!/5YA,&DJ,DLC,E$V22,N!@5J9A H?GN][[_+;MG^HZ?TE, G$_0B!
M ,7[W_R+;O?J5?\ ]'/C$S_Y:Y^Y+T,Z+NA_UK"__J+7^I$_.>/,3[L
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MI4B):P9L> B      !HF]U#_ "V]0?\ LQO]). 3D;V0(
M                                     1XWAP/?3*[Y;)FUF[<?;ZSQ
MH/)N-L>A(DF_)YJU<XE*:73N&E-*^0;C;LO#LP:OVN=UT=::=1B9%J]-IPE1
M$5>G"1U/;R6>U[@.;XHC8[;\@*'=L?DV^.IV2Q$4RZ^@G&V"(N8APTEQX#?;
MTMNPINSV'M.-4ZO2M:=/086&\B\E/GTKPH36W9WNV\V7LYW3-+REF6\@U6O'
MHVEVX3#*I?F6*EW:E0UJ-*"\JJCF=OVN_G3Y;2TZ6^"\;^#B;&_DPLJLGY.D
M_/7?\8R:RN0Y=[L%VM;-^04RSR+E&=:5+9>,S0ZA2TI)S53M+M'K]J_;G51D
MG31T? Y24)1XIZFW_H)VTRS!MOLEO>4V^19OGI/C2+/:I:5-O%&C-*24A32B
M(T$Z;G=KQ-*25V&0\[[V9MK(OQC;=>1.K76^CR&_VNS*$&Y:5)-[OWK=>PXU
M!F;.X= S?)G+FTS.M5QDMQ6FX!LO*<?2MV3%(U)=2VDBU&=%'PX5+1[=:QKE
MQK)FX1IHTJZU6G!]%3,R)7(Q_P -5=2"N+63K-Q3<_/MTX>R%DDWC<%F,S<[
M<]>+?X9@HR4)2;.FZ$OCH*NI1CJK]W:;V/;L._*D*T?*ZZ]?LFLA'*A<E-05
M7X5ZS9'C$F^S,:QZ9E%O:M&32K9$>R*U,+)QJ+/6RA4EAM:5N$I+;IJ21DI1
M&1=I]HXN_&$;DE;=8INCZU71^8W$&W%<W&FI7!:)            ?#I3CV #
MC1'H]8H!1'H]8 I%^AJGVF="962')3+C1*K^4DR%C*MRN6I1CQ:9>QY\ER,N
MIHU1WC&KEAUXGVB_6QY+Q.+)B3RS-#I*.I&E5*'P,A\T[YMF1B7FKNGE_2?1
M^!NEK,L1E;GZ2_<&M[\6$M2FS:2\[J0V?FJ?;0<#O-R-Z:3?!&NW*=MW6^+T
M]!FJR/-Q2TJI57'6?DX#0RNQ2Y(G,YD7-Z'G6OQ-YO1LI)=?#<2]#9C87<;(
MNVX_5U7C[N@PL>$H:L]:([BST:>]VF0Y^5B5F3Y_C&6[Z7$[S86R:34G@7:,
M=3]H@Y\W K#$IHFJ4+B-A&\E&G28D[4N8HTTTN+-2>SRC'G.O S+.G$\#+:>
M>UK*J2452&;MUZ$KM+ADW'6.A>5]QJU7:S]Q+27CH9$=.VGP#VK(V;#GM_/:
MTG7Q:4?@.?LY\[%]<S=*]!B[$+I-PN;(7!)#2"<43K9)+O&7#M,ASW=KO!G[
M=??86W/W>-&YWN-C+@N>Y3QU,Q6;>27SFX]TAMFEU=">*B3)%/0=#'K^R]]L
M_)NJ&1CN*Z]/6SB,[;<6RJJ_'W_49@9R>PR&4OHN;!:RK3FI*GH[1Z?:L]M%
M2A5'*W,VQ%TYDSP7')L.0V9W"Y6]:4^1\T+]5:C-LX]Y:*IAW\["2K.47XS#
MV7;D8R[%<M^,6F-*EN$:5RR83R4D?"M3251M,;"O.7M/WSE=TW[$<'"Q!-]=
M-/01QMN'Y'EE]7!MIH><<4:W])I)MLJUXJ5P2.K^N6<:S[?0>:VMFR]QR>6T
M^/'J17LDVSO&,0RE7FW))@ST&^AY"J\.VB#,85G=H772+-EN'=B[APYKL=.N
MI%[-;!'D1)%SLMH3=UM*(UI;<_.\#K^YE11T,9UR;DCE?J=E^U'H9=>.O(N+
MI<YZ7:[FF V90EMN)CJ2E)%4EF6G5Y#(6X7.0RG;5UMJ33H6_=)MQMTU:SDK
MCDM-5<JGXOG,_.,AW(R6AJ>RNQ;U+7NTDFT09U'G;;?U+:/61&2'"(SJHSIV
MF7:*7HTB9>(O:U,9Q;Y(8N3L?Q:FYJU+)#"TF1$ACB1UIIH2:>48$6VS=W,>
M$HIGCPVW7+/<DEW^1/4O'HI+0Q'0DDK6Z1J06DZ<*F0RX4H6\E1M027$N9,6
MV8_,O./P97,CR)"W)##BS4Z:229F1$7F/MX"*+$K;<><KCN2'$;BPV&F4HTI
M,B.M=/F(DEK,SIV5%2Q&TKJK)EJ9-/L^0VZ3"?A/QVS(W'&GF]!-*(OW1&M(
M$\:Z[,O9,*VW&O\ O"5<KLY'FL6^.E=D@(:2E-?_ )0TD14,Z5%.:AOOK:FJ
MOB9+Q1;K5E7D=^8;\,ZXXW;(:4FE;RDG1)$DJGIX4KY3%.8U.7<ES%\RX^5^
M%1<+5:7;C<YR22RV5$(BLF79WC*ATX"1C1N1K5EMQ]N;O9?:E^N;["?%=^7#
M:49O-F\DDK,W"X&H_P!J8H9$\I222Z"CN-8Q<ER"9?E)D.))I:];K*5I30N-
M#+C4NT"Y&.E3%^00Y<9,N"]8RF0B[[$V*E+RFRU<5:S,U5\@&?C7E'XW J^#
MW16/SELPV7$E.2@I=M(JDRE/$E/GV$I9&!;SHQNJL3+DTH4MGPSQ,RH3NA45
M2B(U,FKCJ0H^-"5Y!4U=BXXZ,M-LI%I?F>#>=C/0Y"%34F1\M:#(SUD79V&*
M&0Z,N&),A7-E2+O;X<Y+J"\/*(TDI1&794C)0J65;FGKP+:M[&-Y%(<C6QQ^
MQWZS235"-2E*03B"-.DR74S29>8Q;N1T,NS*=I\U/9*W .2AV7;Y$'Q4XG-<
MAU:C-!NII53:2.G'R"-N.A:R<AWI*G N./,N<=M;7*6RA5#-KCIX%0BIYO0!
M3LH%FY/D=SB7-B2AAV1X5I"69#2E=U!\-)H+A0A57.3CTDHX\9<"\\8;.^/2
M3EH;Y*4)=-]1&9F?E(J]AD0DX<RJBW*XH.C/EWM<.*_&7;WS>:)P^4GMHKM-
M/E[1.+2C1F(F^T<EP+7?M#:KBF=):D&TTDS)!:>30N.GAQH(-J3IUFP[7V'K
MK0OK$+5N%D<L[9CL">\>DW41X^I*$H+R\.%/A&9.Y:Q[?M,U,,/-RKC[*L_=
MXR_7L$SJW*7[9M=W;,OW5)QG%$9^A1$JHR\;.P[L:2:]WD-9G[3NUM.MEJO@
M\/C)!;+[+S<SBW*5>(]SQ^.V>F'*69LZ^"3^(HJF7'M&HW;>+>)2-JC.W[F]
MS;V98D\E.+Z-? O'X3,[/3O>(;+L.VWV"XRZ9ZG)$9*G2K^W/B-*M^BU[2.P
MM]Q)V%RPDFO#2OG,^;=X?\R+!"LCES?N#S+AFM]U1G76HS,B\Q%7@-#FW^VG
MS):':[7A+$M<C;;,ET1Z/6,0V9](DEV"H.0              (%[F]"G1W(F
MYUNQN1C[UM*Y3+ADN9Y#*OT^)%0[+>7)E/*(I"4(2:UF9)27EH1=A 5JR#CE
MF]SHVM;:LGN)J;4:5&E.:+34CIP4F*9&7I(P):FPCHQB]*47&,T3TI7&1<<?
M5=(YY8N0F[I-,SDGRB+VNTTO]S_((R\_$"+J3/ H        'Y[O>^_RV[9_
MJ.G])3 )Q/T(@0   #%^]_\ (MN]^I5__1SXQ,_^6N?N2]#.B[H?]:PO_P"H
MM?ZD3\YX\Q/NP     W2= ?\ADO]:+A^\11W?=S^5_WG\!\G?UK_ .NQ_P#9
MAZ9DW!OCR(C5L1LI?]J<TZ@\FO-UM]QB;OYN]E%D8A<WF1HSA*(FI',0@M?>
M_%,R](%6RHYKM!>\FZA]D]X8ES@Q['ME:<DM]VMCW-\7(7>H[;+*F-*#11!H
MJK4HO14!4C'@FP/6/L]/W-B;79WM4C%\_P [O6:I8O\ #NTF8T[=5-I)M2V4
MMH(DM,MD9$1][5Q,@*U1FJRX5U59+C.YN*;RY7MQ<+7EF(72RXXK%X=RC.L7
M*<RIAMV2J3J(V4I6JI)+56@%-#*73]MM<]H]EMN]LK[-B72Z8?:$6Z?.A:SC
M/+2M:C-OFI0K317E20!D9[;TR;S;6P.H7$-ALZL.,X%NL1W+;JWW!4MJ1B=W
MFN--W+PGAV%I2RJ.;G)TGJ;6EGAP6HPJ6EM-L/UJ;)X7;\$V_P FV/MEEA*4
M](?<MM\=ES93M.=+F/F9*=><,BU*/R42DDI2E)"M4;&[8FXHMMO3=W&';LF,
MT5T=BDI+"I!(+FJ:)7>)!KKI(^- (GN                $7^LW^K7N1_N?
M],01J=\_DY^3^\CT3^E'_<N+_P S_2F:'QYX?90   ?ILL?^I;/_ *%'_>TC
MU:W\5>(_/G,_CS_>?I*H)F.                                    !
MH*V'_O7\^_67-OX++ F^!OU @
M   &/,@VEVRRNZ/7O)<$LE\N\E*$/W*;#:>>6EM)(02EJ(S/2DB(AAWMOQ[T
MN:<(M];1O,'O-NF#:5G'R+D(*M(QDTM=7H<+#M#M=B]VBWW'<!L=EO,'F>#N
M<.&TT\US6U-+T+21&6I"U)/T&%K;L:U)3A;BFNE(EF]Z-TS;3LW\FY.$J5C*
M3:=&FJKP-)F1AF&A                                   (%Y'T*VG(
M-RI^1%NK?X.U=_SEO<C*=E4L-.0)N2(42W)!2U+UMMO**KC>@ZUH2DZ4:16I
MG#;+896#[I[K;P9'G$_/<PW(D'%MCDN.B*Q8\?9DNR(=HBH0M>I+7,2E3AF6
MLT)5H29JU!4D(!0      #1-[J'^6WJ#_P!F-_I)P"<C>R!
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M8KTJWWI8ON/Y6[TLL6]BP,7!E&5%;[=<;<DYAM5:U(N++*E'R_*DC("+J2K
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M_P#0H_[VD>K6_BKQ'Y\YG\>?[S])5!,QP
M  "-^^60=02<AV_PC8BQ6B,>4'<7LPW,R*,]+MEC8B,I7';)AAQM2WI*S4E-
M:I*A5+O52*HAIB_6=O7N; VUVLQ&WXC:]ZLTSO+,,NN;*;D2\?3$Q"&Q-DW6
M#&YI+63[<@B1J<4FK:^'>2216A+KI;WDR[=6Q;BV3<6);8NXFT&;73"LJ?M#
M;K,&<J I/)G1V7U+<0AY)G0C/CI-14(])"C1E3*=ZMF\&NR[#FV[6&8??6VD
M/.66]WZW6^6EIPJH6;$E]M9)478=*&!2AI&Z<+Q:,@]Z7EU\L%TAWRRW6_9G
M*M=XM[[<F+)8<B2U(=9>:4I"T*(ZDI)F1@3? _0,!
M
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M9SEO<)!RX)N*6KE+KIXK5WDJH= *-4).@4
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MUJ]H]ZO+_)X 1=258%         _/=[WW^6W;/\ 4=/Z2F 3B?H1 @
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M4.OHB093:7%I1W2-1%4R("KX'Z,@(
M                                               !IKS[$NDB^_TE
M=X-R>G1V\W; =V58?=Y$#*+VT]=I,Z3&;.>IM,QAEBJY6HVT)H1%P EJ;%]G
MNE[8O8.Y7B[[2X/\T[C?XS<.[R/:=SG\YEI?,0C3/ER$IHKC5)$8%&ZF?0*
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M^) *LDSL]L%M+L';;Q:-I<3^:=NO\EN9=X_CY\_G/-(Y:%ZI\B0I-$\*),B
M-U,P@4        #\]WO??Y;=L_U'3^DI@$XGZ$0(
M                         $7^LW^K7N1_N?\ 3$$:G?/Y.?D_O(]$_I1_
MW+B_\S_2F:'QYX?90   ?ILL?^I;/_H4?][2/5K?Q5XC\^<S^//]Y^DJ@F8X
M                        !"3K$W#V=>P[--IL[S^X;?Y'9<?LVXL?(8-J
M?N2K:Q'R*) M\TFD(-M__O$VVU,ZM6DS5P+O$*H@OTV7[8S)=V]FL7M_43/S
M_("S/(-Q,B@.8I+MCF19K<HSQ)EJDN(TQF6(R3,T:S):R/NIUT2),WA@0
M    T%;#_P!Z_GWZRYM_!98$WP-^H$
M                                                 T];W=.^WQY/
MO]"NW6-.PNRW&XKW2W-VT@63VDFV(7*84Q)D(C/+=-2%J9T%I):BTJT:>($D
MS/\ T8YQC^7Y#F96+JXR+J23$MS!O6J\8Y.LK-M,W?W9MZ4RVEQ2_BFDCJ1<
M0*,V# 4       T3>ZA_EMZ@_P#9C?Z2< G(WL@0
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M.%'AH0U%;2RRTVEMIE!$E*4IX$1$7F(<RY2DZMUJ=HHQC%12I0]H
M        PI?]I'8%ZN&;[37=O;_-;DX<B^PC:4_C]_<))%_WM;D+07-,B(BE
MQS;D%PU*=;+E&*U+MP7+[SDC=RM^48;.PK*;"IE%XMSJO%V]XGB4;<BVW)"4
M-RF5Z%4JE#J*4>9:,TD8H7O*3(7&D)ANH9EJ:645YU!N(0X:3T*4@E)-1$=#
M,B,J^<@!H0ZA]N+SL+>\,./U"9CF_7#FN31;G8UQ9#L2U.6>;*D1F#=1)3X=
MEK6QH-M3YI[4FWR"J0FM25G5#(R3>3JNZ>NE&[9)=,>P*\XU)R_<E&.RCB.3
MGFVK@;;#CA'JY:5V_2DC+AS==#-*32*+A4PWM]O;GW3W@?7;M2WE<[(2Z?W4
M'M!>+R\F5.AL7>6Y;V=2W#,EDPIR.ZE--.LU=TB5H K2I82;'E/3)B_1UU-V
M?<7*;ID&\ESMI;RP[Y<ERH5TB7YI$Y*5-K4=-$=;A$I9J/5I<[BBXAQ)[YA[
MR#IEP;+<IPF_73(&[[A]WG62]-LVAQQI,NWR%QGR0LET4DEMG0_*0$>5FG'W
M@W4-MQU&[EX7E&VDF?*M5CQDK5/7<(JHBRD%,D/T2A1G4M#B>($TJ'Z@@+8
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MK6@ST%I JT;C (@      :"MA_[U_/OUES;^"RP)O@;]0(
M
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M%]\:2[?N77639TEG%M6E2*2\A<!()-"+@GS<!9:;>ID)*)W)(B/@?DH)D3D
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MKRR69*2*\3:4!$      #05L/_>OY]^LN;?P66!-\#?J!
M
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MW\SG> L<:/SJ:=?*GJ1JTU.E:5I4"LC?.!
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M',?Q6S-J9L^,VV):K4RH]2D1H3*6&4F9$53)""+L B5L       !^>[WOO\
M+;MG^HZ?TE, G$_0B!
M    B_UF_P!6O<C_ '/^F((U.^?R<_)_>1Z)_2C_ +EQ?^9_I3-#X\\/LH
M /TV6/\ U+9_]"C_ +VD>K6_BKQ'Y\YG\>?[S])5!,QP
M        "$/6INMF^#X8O&+#T^*WGQO,&8D/(9TRK]J8*5<8\4X;\1K0\MU]
M"S)E:'$\MPT.'4D&1BJ(V]-6W4K#-Z<2GX)T*3]F8DZ3-+,=QLMO;][7;;8J
M&_1FU)??1R'7'C;;-9)6HVU*29:3-215FW "(      &@K8?^]?S[]9<V_@L
ML";X&_4"
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M_P MNV?ZCI_24P"<3]"($
M      "+_6;_ %:]R/\ <_Z8@C4[Y_)S\G]Y'HG]*/\ N7%_YG^E,T/CSP^R
M@   _398_P#4MG_T*/\ O:1ZM;^*O$?GSF?QY_O/TE4$S'
M           ,!=4*-OW-B\Z;W1Q2_9OA+A6U-TQ;%TNKN\MX[G%*$4-+#S"S
M6F5RE_'(J$>JJ:D8JC7EM1B?7A;KG[1V4C9#@.U,:,M^VX=OS>H]\D25(15N
M,S'C0T7& @S(DDV;B:=NOR 5=#:-M+D^4YIMMAV49OBCV#Y=>;<V_D6*/I<0
MN%+(S2XWI=(ED1FG4DE<:&53/M BS(@      T%;#_WK^??K+FW\%E@3? WZ
M@0
M                    #75[P*7!L$;9K-(N[-\VRSC%KK=G,*BXGC3.27ZZ
M*?B-HFICLNS8"4,,L)-3^MSEJ)2=9&9( E$J/1GF>79)D640\RZBKWNQ<?FG
MC&0P\/ON+0L><B0LDM\>ZQIT=^',E)DI)$@H[I$9$AU*BXEI4H&;! (@
M  :)O=0_RV]0?^S&_P!). 3D;V0(
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MCAN0+M%;DQ5&5#T.))15+S\1SUR#A)QZCHK5Q7(J765\0+@
M8+ZD]N,MW@V0SW;?!,ABXSDF61XL.+>IBG"CH81.8<FM.\E#BC2]';=:,B2=
M=5#X5 JC5O:/=[]:^/XO\R;%U31[/B.A32<<A7R_L0TM+KK;0RVR24H54]24
MD23\I 2YD>_#^@GK?V_L4;&,'ZHK;B6/1%N.1K-:KC>(L="W5&MQ9-MQ4EJ4
MHZF?:8%*HW$87;KQ:,.Q.TY#="O>06NS0(E\O1+4X4R8Q'0W(D:UD2E<QQ)J
MJHJG7B!$N4       !^>[WOO\MNV?ZCI_24P"<3]"($
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M"MA_[U_/OUES;^"RP)O@;]0(
M                                          !K5ZO\HVVRZ_XK<,*Z
MC]N,$WAV@<R.R.6'+[@@H#L;(HB;==8LPF=;[+J$M)-"DH.AD9&7&I"2'0UC
MT-S(IF29!O5M[N?F^([>8_MUCUCV]EN2HMKQFRJ,VG9;CR6W'7Y#M#4HVR(C
M(R2>E1)2#-E0$0      -$WNH?Y;>H/_ &8W^DG )R-[($
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M=TZDJ#0E?%BQH4:/"A1VHD.(TAF)$90EMIIIM))0A"$D1)2DB(B(BH1 4.\
M      !^>[WOO\MNV?ZCI_24P"<3]"($
M                 "+_ %F_U:]R/]S_ *8@C4[Y_)S\G]Y'HG]*/^Y<7_F?
MZ4S0^//#[*   #]-EC_U+9_]"C_O:1ZM;^*O$?GSF?QY_O/TE4$S'
M                  (N=9N;YAM[T[YQD^$7=_'+RP]:HDC*8S'B7K5!FW&-
M&FS4-$1F9M,.+.I%5/QBH95 JN)##;N\8[MIOUL-8MC^K'*>HMK="7-B[F89
M>K^UDL9F"B"Y(7="-A!%!<:<;)6EP^:9<#4:=1&*FW("(      &@K8?^]?S
M[]9<V_@LL";X&_4"
M                                   :YNL':^+#SS8[<?&-E,9W4B6:
M_7J=N-M@TS;8MWR54F&AN-+2EYO7/."XI;JFJ.:E*0:DTJI(DF53I5Q++I6\
MVZ&[:=A$=-VW.38[;;- P>0U%8FW*ZQ)#CKMS5%CMM^%+E+Y:DDE*7#TK[ZB
M49 S8*!$      #1-[J'^6WJ#_V8W^DG )R-[($
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M0HS17)3/[F;^@N::.SNZJT&R5::GH5KFY%S_ !J*OCZ3W"I,
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M=JOEFXVHT5,^[3O*^,8HS,(%     #05L/\ WK^??K+FW\%E@3? WZ@0
M
M              " G7%:K(Y*V4RN3OW8>GS)\*N]SGXAEEWMGM&0Z\XPPT\W
M&JHDDC0?YU"R4A9&FJ>Z0%45#I)S[)<PR++HU]ZO;!U)-0[<PZQ9+/CT*RKM
MJE/4.0XY%:;-PEEW"(SH7: 9.L"@      &B;W4/\MO4'_LQO]). 3D;V0(
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M4],[D8+Q87DYPE5Q^))3Z^-.!/$; [H
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MRC"J;)>'B=E"_(_P"B5"53[V=B3^\*E!4_,?W@ J?F/[P ?<H /H
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M;CUH*SQHUG)\FEM$^[(UK\0ZZK5J=,N!TH!5*A^N@"V
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M%XY9,2Q:ULV7',<A,V^RVIBO+8CL()#:"-1FI5"+BI1F9GQ,S,S,"!7@
M !H*V'_O7\^_67-OX++ F^!OU @
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MOFVLJD1'4R.A&*M$OP*  :)O=0_RV]0?^S&_TDX!.1O9 @
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MA;^*J&TV[:,7;U)8\.7FI75OA^\V9*%TV0
M             !\X^8O6 ''S%ZP X^8O6 ''S%ZP X^8O6 ''S%ZP X^8O6
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MAQ&B7 Z!Z,<Q2>SL K0[$ND9$9F1'\(J4.WCYB]8 <?,7K #CY0!]
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ME*EMQVTM)-7M*653)!$1G0@)Q/T. 0
M               (O]9O]6O<C_<_Z8@C4[Y_)S\G]Y'HG]*/^Y<7_F?Z4S0^
M//#[*   #]-EC_U+9_\ 0H_[VD>K6_BKQ'Y\YG\>?[S])5!,QP
M              "-'5_=-O;7T^YTO<[&+CF>,3?9\%&+V=:FKA+N$F<PW;TQ
M7D\6UIDFVLE<::?BK^(H51!_:#;^ZWKJ.PO.K]TN;L8%$*=[1?=O&4QY6,PK
MLS;512O4BWIA-NKE.I;2A2B>))J54T>0"K-NX$0      -!6P_\ >OY]^LN;
M?P66!-\#?J!
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MUMUBY&Y"TE*+JG5Z/SF=1D&\
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M%4N(M4.CEE6]*GCND2_QFY;#;LNR/LL=YM1D\PDS[W JF9IX]M!%DXN$Y57
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MUNH6R\1ZZD9ZT&1^<"C)^ 4       T%;#_WK^??K+FW\%E@3? WZ@0
M
M             #".0[)=.%SR#Q>5[1[;7#*LKD/R/%7:P6=VX7*05%ON:WV#
M=?66HE+/B?&I@5J7?AVU&UNWDF9-P#;7%<&F7%I+-PEX_9H-L=?:0K4E#JXC
M+9K21\2(SI4"E2_P       &B;W4/\MO4'_LQO\ 23@$Y&]D"
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M7T'H6Q[?+ PX6)--QKP\,G+J77U&61>-L
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M_P!6O<C_ '/^F((U.^?R<_)_>1Z)_2C_ +EQ?^9_I3-#X\\/LH   /TV6/\
MU+9_]"C_ +VD>K6_BKQ'Y\YG\>?[S])5!,QP
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M .M7WA_UD^R?8/SXDY5>?8O/\5X7Q<"4YRN?RV>9IK35H37S$!5\#]'8$
M
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M6[MY+EY6M'75M>HV/#9GHH
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MR*Z=25VO<V]Y'<696+VW(IRY=QB04,Z5$\VLU''UK.O+4>LOQDI,"#H3K H
M       'Y[O>^_RV[9_J.G])3 )Q/T(@0
M                  (O]9O]6O<C_<_Z8@C4[Y_)S\G]Y'HG]*/^Y<7_ )G^
ME,T/CSP^R@   _398_\ 4MG_ -"C_O:1ZM;^*O$?GSF?QY_O/TE4$S'
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M1,BS5J+#CH2TTTA,2624H0@B2DB+L(B F^!O^ @
M                                                         $)N
MK?%,XBY)LAOM@V/X_F\O9&?>SGX)D-QCVEJ>U?HS$=+T:;+,F&Y$=3!*;U<:
MJ[M3*ABJ+9Z9(N<;A[Y[D=0F<X]C&VTJ_8M;\7M>W%COD*^SELQI2I*[E=)$
M$^6;AG1ILS2E6CNFE.DC6#)_@4       T3>ZA_EMZ@_]F-_I)P"<C>R!
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M9)0@B(N)U[!U$$E%)'TCB6XV[,8P2226BT1<(D9
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MFG\:Y)_K^"/5^EG6YKM;!@W,*,E/)O45QK6-N*_4KTRZ_P!"K(L=F<&
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MD?X >H'#\G_ (\J%3[7]J?WA("I^8_O !4_,?W@ ^Y0 ?0
M?FXZRNO'>#</+\WVGQV6K;?;W'KO<+!<X=H=-4^ZIAON175RYE&U\MS09\EO
M0FAZ7#<X&!-([>F[JPZ4>FV+'GV+8K)<ISXVM$[<*\2X"YE5%WTPVZ&B(@ZF
M5&^\9<%K6 :;-R_2KU58_P!5./Y7D&/XI<,49Q2X,V^1'N#S3RG5/-<TE)-K
M@1$7#B!%JA*L"@        ?GN][[_+;MG^HZ?TE, G$_0B!
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MR8P%       -!6P_]Z_GWZRYM_!98$WP-^H$
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MY0A+:4H0DD(01)0A)4(B+@1$1"X9R5#D
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M1D7D,CX#K]EW"*JGHO[3S?O/L]V<N:&ON1$R\0WFXI+:0IIQESER&S+BAQ'
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MV?ZCI_24P"<3]"($
M "+_ %F_U:]R/]S_ *8@C4[Y_)S\G]Y'HG]*/^Y<7_F?Z4S0^//#[*   #]-
MEC_U+9_]"C_O:1ZM;^*O$?GSF?QY_O/TE4$S'
M  *3=;#8[Z41-[LL&\E >*3!*=&:D$R\GXKC?-2K2HO(9<0!5@         :
M"MA_[U_/OUES;^"RP)O@;]0(
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MMKEF2S?CQS(Z]E",9^)CRLIITU.V[J['?VJU<A=<6Y--<K;Z/"D2M&6=4
M
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M187,@O[>0OE;^>X@B;D-S)A-HYJ5]S47&ITXU JC]>8%L
M                              B_UF_U:]R/]S_IB"-3OG\G/R?WD>B?
MTH_[EQ?^9_I3-#X\\/LH   /TV6/_4MG_P!"C_O:1ZM;^*O$?GSF?QY_O/TE
M4$S'                                     T%;#_WK^??K+FW\%E@3
M? WZ@0
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MQ55N.*H55K,S/SCHH6XP5(K0]_PL&SAVE:LQ48KW5?6_"R[!,RP
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MFT!0_/=[WW^6W;/]1T_I*8!.)^A$"
M              !%_K-_JU[D?[G_ $Q!&IWS^3GY/[R/1/Z4?]RXO_,_TIFA
M\>>'V4   'Z;+'_J6S_Z%'_>TCU:W\5>(_/G,_CS_>?I*H)F.
M                         !H*V'_O7\^_67-OX++ F^!OU @
M
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M2\<=9+)!K*0HTUI2M#%;>WJ$E+FX# [C0Q,B%Y7F^22=.7C3RD^QL#O0
M
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M)G(D$DB(B)!>0B%566K"27 [2+CV^3L$ZAG("@
M              'Y[O>^_P MNV?ZCI_24P"<3]"($
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MV<>:,6UUT+4\FU"7+*23ZJF3!8+X
M                           !'K:'9"5MCN5O[GS^1-7AG>F_0;S%MC<9
M3*K>F(RZT;:W#<63IJYE:D2:4[ *MDA0*$8.I_8.Z[^6#&+-:K]$L+EAGO3'
M7I;3CA+)QKED22;[#+TC*P<^_A7HW;+6FC3X23Z/5X33;M@7\KLW9DH\K=:U
MHT^C0_/-L=A5RR6X[U7&$VX_%PYZ/.NY--\Q:8[DR1'YNG47=2M:=7F(Z]A&
M,3)W[(VFQ=NV(U<E1NOQ4_UEIQ]'$Z;"[JW>\EZ.#9OPL7)5Y933DFTOBJE/
M::K2O53C0_2K@./;8YIM_AUYBXY8<CMLVU1%,SY%MC.&XXTT3*S63B%&2TJ2
MI*B,ZD9&0QL:=J_:C.-&FC!W#NVMMO2P\JU'M+?LNL4ZM+XRJN$EJGTIFL;=
M7I$WMNVY.<7/#=MF$8I/O4M_'DQ;A:(C)1%N&;7+85*;-M.GL2:2IYAKKV'<
M<VXQTKX#QS=>Z6X7,N[*S97(Y-QI*"5*Z:<RIYC,727TT;BX)N1=[UNKM]#C
MV!S'),6W/3)%LN*"G+EQ%(TM,OOJ2HVD.=[214J5>-#O8>+.$VYK2G@-QW3[
MM96)ERGE6DH\C2JXR]JL>A-]%=2=&ZVUMNW-VUR#;=N8G&(5^\(9SHD9"^5X
M26Q**C)*;2>KD$GM+M] V%ZTKD''A4[C==KCG8D\9/D4J:I<*-2X:=1"C^SE
MLO\ .K-_BEOY4,'[M7[7O'%_^.[?^>_DKUDZ-J\!9VOV_P ;P-BYKO#..LNL
MHN3C1,J=YCSCU3;)2R33F4[3&?:M]G%1ZCN-KP%@XT+"ES<JX\.EOX3((N&P
M
M                                                    ^&52,O.
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MC)#:2)"2H7 8L8I(R6SG0O,)412I]%0   'RA"E$!0B\@4 H7F%0?12@ J
M                                   /SW>]]_EMVS_4=/Z2F 3B?H1
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M+EOQ72E^O3P?&7^RY*OL$\AU9XR
M
M                            !QJ?_(A'4J?2J*JH/HJ4,#;[[2ENO8(T
M%BX,VZ?:G_$QWY"#6V7=IY.)=@S,/)[&53"S<57XZ]!QV,VAMNT6.RH93$7*
M\WI],F[W5**<U=*)2FI5TD7944SLQY+KU%,'#6-'QF>2*GD^\,)&>?2$@?0*
M     'P_@J*-5!\H1]I>L5I0'(BIP
M                      ?GN][[_+;MG^HZ?TE, G$_0B!
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M2>6TJ1*DK6LR:1W4(31""X)27$6KU^5VE>"X):)%VS8C:K3B^+>K9D,62\
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M<>AM4?FU.F@Y->UQ*V+1(
M    -$WNH?Y;>H/_ &8W^DG )R-L/4-M$G=S WX-O,HV88\L[GAEQ)7+6B6V
M539YA&1I2\1::UX*TK_%&JWC;_KEFB^/'6+\/5Y?TG8=QN\[V+/4YZV+GL78
M\:Q?33I<>/A58])X^G#=QS=/!R:OFJ-GF'K*U9K;W4FVZ4AO4A$A2#(C3SB0
M9J*A462TTH1".S;A];L^U_$CI)>'K\OIJ7>_G=A;+G5LZX][V[36JY7JXU_V
M:Z=<7%])(0;<X<
M
M                   Q?O%+FV_;;-)D"4]!EM6M\V)C"U-NMJ)!F2D+09*2
M?I(QF;?!3R()\*KTFOW>Z[6'=G'BHOT,N?&5JD6"Q*>4IQQ4*,IQQ1F:E*Y:
M>)F?$S,8V3!0N22_:?I,C"F[F/!O]F/H+I$#(
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M6'O5G*N=G!23\-/6S0=Y?Z8[EL&&\O(N6I034:0E-RK+A\:$5[Y*4;<\Y
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M5_.AV=%&/2ET^-EK&P(67S<62S'/F<
M               :)O=0_P MO4'_ +,;_23@$Y&]D"!K'ZKT7+9#<>!N1MKD
M98W>=R(4B/DEICTUK<C.,K5*)%#21.GIU&=#UDHRKJ53B-_4L#(5ZQ+E<TZK
MQ4U\OI\I]!_TU=OO'MLL#<+7:0QY)PD^A232A7C[.M.CE:6E(UGCM3N19MU,
M'L676I]@WI\5L[O;6G"4N',(M+S"TU-2=*TJTZB+4FBNPQU>!FPR[,;D>E:K
MJ?2CQKO)L-[9<ZYBW$Z1;Y9-?'C^K)='"E:<'5=!D<9AH0
M
M                                                 Q+O<9EM=G!>
M1=K?IZ.Y3_G&=M?\W;77)>E&JWO3"N_NOT,O'%TD6.8XKRJM\4__ ,D@8V;&
MM^<?]I^DS,'V<>'[J]!=(M&2
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MR8[_ ./VW_M3/^,'WKA_YT/E1]8^JWOV)>9CYR8[_P"/VW_M3/\ C!]ZX?\
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MJE^TC,XV1R@
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MQMU"'6EI=;<(E(<09*2HC[#(RX&*)U*RBXNCT9S%2@
M
M                                    !B;>ZOU7YKYO9;__ -Z,[:OY
MRU^\O2C5;Y_)7?W7Z&7EC-/FUC9?_P!OB_O2!8R_YB?C?I,O#_EX>)>@N<6#
M*
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M?EP#F']CGC?\_%S_ (@9^7 .8?V.>-_S\7/^(&?EP#F']CGC?\_%S_B!GY<
MYA_8YXW_ #\7/^(&?EP#F+3S[W3&/89@N:9@UO;<;@YB=AN-Y;@*L;3:7U0(
MKD@FS64U1I)9HI6AT\P%>8A_T4]'-MZL_K+]H9Y)PGY@>QN3X> B=XKVKX[5
MJUOLZ.7X,J4K75Y*<15NA.S^QSQO^?BY_P 0,_+@(\P_L<\;_GXN?\0,_+@'
M,/['/&_Y^+G_ ! S\N <P_L<\;_GXN?\0,_+@',3XZ3>EZ!TK89DF'V_,9&9
MMY%>CO*Y\B$F$II1QV8_+)"'GB45&JUJ7;V 4;J2J H
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ME*^ RT->7P
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M<71Z,YBI0
M                                          +/SO%W<PQ2^XXU,3!<
MO$5<=$I:#6EO65*FDC*OK%_$O=A>5RE:.IB;ABO*QYV4Z.2:KU5352JVBU.V
MVW08#DGG^"8992LB,B_-)))F1&9TK06[T^TFY=;J7\>WV4(Q>M(I>94J5L0+
M@
M  %CVC;+;;'\BGYA8=OL:LF6W77[3RB!:8<:XR>9\?G2VFDNKU>74HZ@"^
M        :QO>4]/.\&_]DVEA[28A\[9&,SKN]?&_:%O@<A$IJ*EDZSY,<EZC
M;5\0SI3C3@!*+H3EV+QN]8=LEL[B&20O9V18K@^/6>_6_F-O<B;!ML>/(:YC
M*EMKT.(4G4A1I/M(S+B!%F5                !I=_HF]0/]H/]>/S _P#M
M7?/CVQ\Z/:MJ_P#<N1HYOA/&>*^-PT\K5Z )5T-T0$0              "P-
MU[)<\EVMW*QRR1O&WF_XK>;;:(>M#?.E2X+S++>MQ24)U+4154HB+RF1 #7A
M[M#IPWGZ?OKJ^MW#?FE\[?FW\WO^\;=/\1X#VIXG_P!PDR=&CQ+?Q]-=7=K0
MZ"4G4VG 1                                      #'.Z.[.WNS&+J
MS'<K)&<:L/B6H4=];;TAZ1*?KRX\>/'0X\\XHDF>E"#.A&HZ)(S(*'7M9N]M
MYO3C;N5[;9$C(;/%F.VZX&;#\61$FL$E3L:3&DMM/-.)):3HI)5(R,JD9& H
M9* &@K8?^]?S[]9<V_@LL";X&_4"!P==;9:<>=42&FDFMQ9]A)253,_@(4;I
MJ5C%R:2XLPE_24V)*IGN=9B(N)GK7_B# M[KBW9*$)IR>B2JVWX$=5>[C[U9
M@[ES&G&,55MT22ZVVZ)'2WU-[!O&HFMT[(X:>TDNK/\ _ &TS[-S @KF1&4(
MOI:=//31^!ZFCVK;,C=+CM8D5<FOU8N+EITI5JUX55'=_23V)_G-LW_37_B#
M4+><-_\ J(W[[A;ZE5XD_>]9UHZFM@E\^FZ^/I\.C6X2Y.@Z$=*))1$:C]":
MF.DM[3F7(J4;4J/AHUZ>'E..O7;=F<H2E&L71T:?H;KY#)V*9GB>=6PKSAV1
M6_);7K-M<RWOH?2APN)H7I,S0HB.NE1$8Q<C&NX\N6Y%Q?A0A<C-5BZHN86"
M8    !3[K:+5?;?)M-\MD2\VJ:DDS+9.9;D1W4I42B)QITE)41*(CXEVB%RW
M&Y%QDDT^AZHOXV5=QKBNV9RA-<)1;C)>)K5%@/;)[-OLNL.;48@2'D*;6:+)
M!;5114/2M#)*2?'@9'4A9LX=BS-3MVXQDM4U%)KWC9Y'>3=,BV[=W*O2A)4:
M=R;37A3=#7ID7NXKNYDCZL6W"@Q\2??4IE-RC.KGQFE<211JC;QI[*ZD5\Q#
MT>SWSBK?^);?/X'H_5[YQ,]H?-[,M#,$7W?6V\>,PP>:Y(M3:"):T^$22E=J
MC(C8495.ITJ8\LWS:UN^7/*O3ES2Z%2B25$EIT+S\3V3NS_4G)V# MX6-8M\
MD*ZOFYI2;K*3]KI?F5%T&=]L.FK;?;2T7"TG;6,R\?,\7X[((<.4^U^;2WRV
MU<DJ([M:><S%<3:;5B/++V_#*C:\"\!JM][\9^YW8W(/L**C5IRA&6K?,TGK
M+7B9GLV,8UCGB?F]CULL/C-'C/9T1F+S>7JT<SE(3JTZCI7LJ?G&?;L6[5>2
M*5>I)',9>X9.73M[LYTX<TG*E>-*MTK1%<%TPP
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M_P#3E_P_../NX%J#TOVY>)7/_JMQ,';Q^\PVPO$W!5[69)<(46Q79-UR,KA
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M6IM9$I)J;<(S)1$9=AC>' %?
M
M                                           !%OJ&ZL]NNGI=HL=R
MB7'-]Q<C-'S>VUQQLI-T?;4:BY[B*_FVZI,DF9&I1\$)511I%4JEG=/W7)MG
MOGE<S;>?9+SM9NE#)9E@^3MI9=DFV6MQ$9SNFIQ">\IM:$+TU4E*DI49 T35
M H               :T.M/K9S[ILW,VVQ#%]NO;-DN#!WW)KK-)1HND%LW&Y
M$&WK:-7*6PDN:XXLC-)Z*HY==8DE4G!L_O!@F^>"6G<+;V[)N=DN:=#["Z)E
M0I22(W8DMHC,VW6S,JE6AE1234A25&(M&3P               !J&POWF4IC
MJ'S/!=XL+5M[MDU>#QVSW.0A7C+#/C..-&=Y6E2FS3(-"C5HX,TX&M!*< ER
MFW1A]B4PS)C/(DQI*$NQY#2B6AQ"RU)4E2:D9&1U(R B=H
M                         ( =9LF/:=U>BW(L@D-0<'M&YJBOEREJ)N''
MG.QT';G'G%42C2I#ADI1D14,_(!5'WI$E1KSOQUO9)CTEJ=A%SSBSQK//C+2
M]&>N,2$\5T4T\A2D*JMQLSH?E("K,<]=K'6HK/\ #7NFA64?-%6/FB^E8'(Q
M-^T4RWC/FH=5K)7*4W0Z4,NSB1B48.7"GG2])!SC'C7S-^@U?6CI]Z_[#N%,
MW7L^W^96_<6>_*DS,N:.*4MQV:E29*U*-PRJX2S(^'E$NREX/.O6.VCX?,_4
M9=Y/O8O/N/\ Y2%^$.REX/.O64[:'A\S]1U2&O>MDP^<D]Q/#$VHY',7"-.B
MAZM1&=*4[125ITUI3QKUD[=U.2Y:UKIH^/F(8RIF_263\4F1R3,B5^8@&7HK
MI0,/8<>Q+)KM_+VR3^*US4X.FOAZ#L^]%WO#:P__ /JN_P!@Y)/GYG!RXQKY
MJJO3X3P,S=Z^:WR$O$Z9T1I8@UJ?_J#K,_&W66/-9->RY7S<SCR\O374X;:\
MFW'*MO#JK_,N3D4N;F;HN6BK4J;TS?Y+3ANID<NG?HQ;SX>7L14<1M>-@SR8
M+%Y'=K[-&JU6NE7QZCTC>KG>JUAW)9KR%8I2?-S<O*]/:IT=?1UE'\;O-^0[
M_P!G@_X@]"[#?>N?REZSRGM\#J7R7ZC,>S<WK4>NUWA[)+R5%U=BH>O;5A1$
M:-4=M>E"GC(DIH2E]VO'B=/*-;N6/N/*GE5I73F:X^#4OX]_&J^SX^!/U$A.
M3[V+S[C_ .4A?A&G[*7@\Z]9E=M#P^9^H<GWL7GW'_RD+\(=E+P>=>L=M#P^
M9^H<GWL7GW'_ ,I"_"'92\'G7K';0\/F?J')][%Y]Q_\I"_"'92\'G7K';0\
M/F?J')][%Y]Q_P#*0OPAV4O!YUZQVT/#YGZAR?>Q>?<?_*0OPAV4O!YUZQVT
M/#YGZAR?>Q>?<?\ RD+\(=E+P>=>L=M#P^9^H<GWL7GW'_RD+\(=E+P>=>L=
MM#P^9^H<GWL7GW'_ ,I"_"'92\'G7K';0\/F?J')][%Y]Q_\I"_"'92\'G7K
M';0\/F?J')][%Y]Q_P#*0OPAV4O!YUZQVT/#YGZAR?>Q>?<?_*0OPAV4O!YU
MZQVT/#YGZAR?>Q>?<?\ RD+\(=E+P>=>L=M#P^9^H<GWL7GW'_RD+\(=E+P>
M=>L=M#P^9^H<GWL7GW'_ ,I"_"'92\'G7K';0\/F?J')][%Y]Q_\I"_"'92\
M'G7K';0\/F?J')][%Y]Q_P#*0OPAV4O!YUZQVT/#YGZAR?>Q>?<?_*0OPAV4
MO!YUZQVT/#YGZAR?>Q>?<?\ RD+\(=E+P>=>L=M#P^9^H<GWL7GW'_RD+\(=
ME+P>=>L=M#P^9^H<GWL7GW'_ ,I"_"'92\'G7K';0\/F?J-UG2^[NF[L/MZK
M>LIQ;GIC2V\I]IH:1+UMSI"(YNDR1(,SCDWQ+XW:9F9F874DZ+J7GIK[X@ZJ
MOC])GP6R0                                  !%;K>MUXNO2AOC$L3
M3KT\L=5(6VR1FLXL9]I^7P21G0H[;AGZ *KB10PG*<2W"ZH^BAW;"\V^^1<+
MV?N;V;*M3S<A,*"];4Q(D22EM9DPMN49$:%$2B,R(RI0"O0;6 (FL+>#W8F"
M;P;FYGN;<MT+]9YV97!5PDVR-#BN-,J4E*=*%+/49=WR@24C5AT;=)6,=2^X
M6XN(Y'E=TQR!@L=$EJ1;6F5O22.6J.I*C>)24=U-2.A\?(8$FZ&R+^R"V2_G
M,SC_ *5M^1@1YA_9!;)?SF9Q_P!*V_(P',/[(+9+^<S./^E;?D8#F']D%LE_
M.9G'_2MOR,!S#^R"V2_G,SC_ *5M^1@.8?V06R7\YF<?]*V_(P',/[(+9+^<
MS./^E;?D8#F.QGW0FQB76SD;DYVZP2BYK;;EL0M2?*25'!61'Z=)@.8K']D5
MTW?\;;E?QE9__)@',Q_9%=-W_&VY7\96?_R8!S,?V173=_QMN5_&5G_\F <S
M']D5TW?\;;E?QE9__)@',S%&">[$V$RC/-[L7N&79^S;]M<CM=HL3T>?:TO.
ML3<>MEV<5)4NU+2I9/35I2:$I+022,C,C48<QE?^R*Z;O^-MROXRL_\ Y, Y
MF/[(KIN_XVW*_C*S_P#DP#F9VL>Z.Z:VG6W',OW'E(0=51W;G:B0OT&;=H0K
MU&0#F95_[*#I>_\ $,X_C:+\A <S']E!TO?^(9Q_&T7Y" YF/[*#I>_\0SC^
M-HOR$!S,HUQ]TST_.O(5:LDRF#')!$MJ5(:DK-=3JHEH0P1%2G#3]WS6;D;C
M?LR27BK\*,O'O8\8_P"+"4G7BI*.GBY9>D\K'NE=BDOLJDY9D;T=*TF^RVI#
M:U(KWDI69K))F789I.GF,1C"ZGK)4\7Z2[/(Q'%J-J2=-'SIZ^+D5?.BX5>Z
M@Z832HD7'-TK,CT*5=8QD1^0S(H15]8R#7J6NIC3^R*P'^<Z1_%+O_F@U_8Y
M?^;'Y#^>=%]=V;[+>_\ \B'_ /KEX8K[IO8BWF\O,,COV3+UD<5NWK.U-$BA
MDI+J5.3%K.M#(TK13TC)L0NQ3[22EXER_#(UF??Q+C7U:W."Z>>:N5\5+=NG
MOG/./=6[(2[?$;V\3+M%R*1JG2KW<9<ILV"29:&T,FV9*-1D=3/L+LXBWEPO
MRBE9DHNNM54R-GO;?;N2>="Y.%-%;DHNO6W)/2G01XQ;W;..Y1E.Y&+Q;I;F
M)6V5XA6>Z/O*N/*DN3;3"NZ%LZ9&K23<U*#K0]1'3A08'8;C_FP^2SH/KO=G
M[/D?20^82Y:]UMTJ<IOG6?(R>TES21>GC22J<=)F@CI7L&Y7A.)E)5=.!AO)
M?=1X7)OD][%+G#MF/*6GV9"N#]QD2D())$?-=0XA*C-53X)*G8-9?M9TIMVY
MP4>A-59U>WY6P0L1639ORN_K.,XQCQZ$XM\/"5/"O=3[;1+LXO/I3=YLBXZT
MML6>7/B24/ZDFA>MU;B330E$94KQ(Z\*'/%MY<9_XTXRC3H5'4Q]WR=FN64L
M*U>A<KQG*,H\O2J))UX:E^9![K+IN=LMQ;Q>!>(E_<9--KE7&[278K;IF1:W
M6VB2I1$53(B,N(S+RFX-6VE+HKP-+@W+$;\7D*3MU]I1:4FNI-U2,*?V3EM_
MXBL_KN?_ %PU78;C_FP^2==]=[L?9\GZ2'S3->'>ZWZ<H5IMWSUM%PO5_9)P
MKDN!=IK$%ZJE$VI+9J)U%$FFI:_C%YCH-ICJXH)7&G+I:X'*;C<QI7Y/%4HV
MNA3:<EIK5JB>M::<"WMQ/=;;0727;?JUMT7%X+#2_:972?=ICK[JE%ITGXG2
ME*4EY.)F9U\@Q,VUES:[":BNFJK4VVQY>T683^\+-R[)M<O))027PM_ 6GCW
MNJL0AWRUR<BD6>\V%F0@[O;&9%WCNO1ZT<2VZF3W54XI/LKV\!C6,?<(S3G=
MC*-=5RTJO,;/.W#NW<L3C8Q;T+C3Y9.XI)2Z*KI77X"0/]F9T@?\ W/^/KI\
MH&Z.(YF1KD^ZDLKLA]UBYV**PXXM;,5+EW63:#,S2@E*DF9Z2X5/B-%+%W)M
MM7HK_=_0=_;W/NM&*4L2^VEJ^T6OA,I;>>Z[V+ML"X,;E6-O)9RWTKMDVU7.
M[0]#1I(E-N(.30Z**I&7'B=?(-AA6\B$6K\U)UT:5#G-\R=MO7(O;[4[<:>T
MIR4JOK3])5,U]U[TYW*S)BX+8G,9O1R$*<ND^X72>@F")6M"&?&-%J4K3Q,S
MH5>%:&5S+MWIPI:DHRKQ:KIXC'VG(P[-[FS+<KENC]F,N1\W0VZ/3CIUTU(T
M8W[MC!\CS3<?"V;S%BR=N9%KCRYRV;@I$D[G!1.0:$E<:IT$O2=>TQK?JFX?
M:%\A'2_>W=S[!=^G_P#T&YG"<7@X1AF(X7;&T,VW$++ LEO:0;BDI8M\=N,V
ME)NK<<,B2V5-:E*\YF?$;F-:*O$XFZXN;<$U&KI75TZ*O37R%SB1;
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MMK4OX8)M
M            C3OYU/X9L3/PW%W;5<<\W&SRXQHF-;;X^2';H_'=>)MV6:%'
M1"$%JT:J<Q9:2,DDXML52J:X'59)T+]5MXW4WNM3VZ.W.]$@V+?OE,CE)O5A
M<<U&<=?*JVTIML^6ZTRE).,H)3'!M3 $N*,F>\IMVV%TVXVPWMP^_1&=YF[S
M:U[/7ZQ+2].OD9;J7B0QR=1O-L&M+[:Z'H71!&7-HH4B;4K ]=)%ALC]\83%
MO;\",Y>(R/BMRE-)-Y":&?!*S,BX@1*N             @5[P;,.HS!MH(V1
M;#%X*WVR9XO<3((!<V\08+!H<:<CLJ0I/(U$?B%E524TX<LW%$*Q-:VZO4O?
M=YMB\=:WRL:;7EEAEIOFQO4MBS"G+4_>X!)6Y;[@TTG7#?=2G2XA)%I<Y3JF
M$MI2LQ*ADCIJM^XZ)N&=1_2+;H=QLN<72/CG4CT_N24PK?;;HE1<Z=%U:B9B
MK2YXADT$I4<EZ$I<:-QI /PF]8"              :9>KOJ#ZP-E.I:PO6VY
M6;&=K+FUX3 (L])+QV\D9)4\W=9;B4*8E&Y1)J-;264Z3UDTIQU0DDJ$5=\]
MXMLLDWBM>9;F;8W7;^]96RSBW4WM!/862GX^@O"9)9):4$2G8Z4I6VI1(49H
M;)/.:==48JD;.>C7$=_=H[[>MIK[.B[E=.$6T,7S9W=OQ22=\'-42HL%IHC6
MI:3;,UF@Z):H1H6:'&T@49L+ B
M    %MY9AV)YW9)6-YKC5LRS'YAD<FS7>*U,C+4GBE1M/)4G4D^*5$52/B1U
M 'S$<,Q' ;'&QG",9MF)8]#4M<:RVB*U#C(6X>I:R;92E.I1\5*I4SXF +E
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M5,FXZ^^I!&2.=(?6XZYIJ>DE+,BJ=.TQA9F??RY<UZ3DU[N"T%JQ"TJ05#(
MQ"Z
M              !P<;0ZA;3J$N-N)-+C:B(TJ294,C(^!D9 "S\4VXV\P-ZY
MR,'P/'<,?O2R<O#]BM<2W+EK29F2GU1FFS<,C49U57M, 7F   H-IQ;&+"_(
MDV+'+799,LM,N1 ALQENE751:FD)-7'CQ %>                   !YF8<
M2.]+D1XK+$B>M+LY]M"4K>6A"6DJ<41$:C)"$I(S\A$780 ](
M        /,S#B1WI<B/%98D3UI=G/MH2E;RT(2TE3BB(C49(0E)&?D(B[" '
MI                   !YFH<1A^5*8BLLRIQH5-DH0E+CQMIT(-Q1%56E)4
M*O87  >D
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M^P8?[V0T^\?SEW]]^DZ/NY_TS'_]N/H1D\:TW0
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MN
M         !2K[)NL*RW:78K6B]WN+#>=M%G=D%$1*DH09M,JD*2LFB6HB2:S
M2>GMH8 B=M]UA66Z[AQ]F]Y<"N^P6[$^A62Q7YYJ7:KL:EFA";7=V20U(-2B
M,D]Q)*5W4&I?= K0F,!0           "@Y1;[W=L=O5LQO(3Q._3X;K%HR9,
M5J<<!]:3)$@HS_YMTT'Q)*^Z?EX "!S/4/O=TXYK8<.ZLX=GR';?*YB+=BW4
M3CD9<**U+<UFVS>X?%#"ED5:MDE*2(U%S$DM2!*E>!L.(R41*29&1E4C+L,@
M(GT                                              8=ZALLN^";$
M[PYCC[JH]]QS#[Q.LTI/:Q*:AN&R\52,CY:Z+I3C2@%4:T-JL2A;*Y[[O[-<
M,N5U7D'4GCL]S>I,NY3)JK^[-LL*XHE/,R'UI(XCTC5J01<"16OE%6;D0(@
M               :Y^M#!=J/;![D[];@W:Z8PG&G,>VJV+LRYD69+RAQ\W6K
MC#\#+0Y*D&:D-DE3/+1W3<494("2(N;2;99IO=N%C.RO5;.O,I>U.R)7B-8Y
M5UEQCC7:X7=2H5RF.1WFU*D18+C+2B<4JBFRU=XE5%7X"?G07FV2;@=*.U&0
MY9,DW.]ICW"V/W:6I2W935MN4J''<4XHU*69-,H0I2CJ:DJ,P(OB2_ H
M           :OO> ;I>VK/F6Q]FS.-AK6,8;*SC/KBN8U#ESW&TK]A6& 3BT
MK=7)DM^(?)LJDVTE%?SAD!)&)=N++C74_N3T[[.YY=962[8X3TPV')U6*WW:
M0RR]DO-AVY^1(<A/-JY\8U:=*E&:'&SJ7%1 .!,GW?V89%F72_A,G*+J]?[C
M89EUL3.0/K-U4V+;YKK49PG5*4:TI:TMDKS(\O:8H^)-("@
M !J7ZL'\EW/ZKK;LZK:Z[;W8?BFUSN4,;6V_)/FS&=NDBX&PJZ2Y=4ZC8:)#
M;"**,G5),J)4L"2X&)-D8VWW5ANAMAL_>;UG.3;-[?;.7"_QL8RF\N%=D9"G
M(3@+.=*MI0B=.&AQ*(QFG@VA%2+4I(%7H3Q]W]F&19ETOX3)RBZO7^XV&9=;
M$SD#ZS=5-BV^:ZU&<)U2E&M*6M+9*\R/+VF(OB32 H
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MX6#*
M    (]=2O4%;^FS 8FX%WPV]9A:G+Q#MMR39TITP6)"Z.2I+J^ZA*4D9((Z$
MMPT-ZD:M9"J53"F^^Q&U_7!M?C6YFV>2QH.<08R9^UVZ,!2VG$.-+-PH4TVR
M)Y*$O$9&1ES8[M5)*NM"P3H4_HUZE<XS6[91T\[]VIVQ;_;51]5S==222O-O
M:4VV4RJ"Y?,+G-&HT'I=2M+K?=-1)!HS=CG2QMCA^_5YZ@<51<,=R7(K8]"O
MN.VZ0<>SS),A9*>FOQ6R+6XNA&:3/EZ_SNCF]\!4DD!0           ")'6Q
MBN^.8["Y-9MB+J4+(72-606MA*DW&YVDD*\3#M\@E%RW5\*II5Q-6TJ(U44*
MHU5VS<Z%N_TT6?H_Z5]@9*=Q[U$\3O'$FE%;3#5:WV>?/7/F+82X_)?0V1+>
M-/)*C*"KR](ETU);[4[S=5>(N;;;(9KT0RIN/8^U:;%CU\C3S=@VYJT-MMQ)
MDN>IF=$U,)92KF<U!ZBJCOZ4F*-(VIE6A:B(CIQ(CJ5?AX 1/H
M  #3][P>VY]8=UMJ]T-SK&]N?TCXM<(J[W@-I-4;P<Y1&VM^Z)U**1K6HC:4
MHTMF7^;*Y9N&MT2B8WR[--Z^HG>#;[J%Z;NG9&4[0]/Y2[/MX],=AV=5SD);
MY:G?#JDQY"X\=>GDLLD9)TF2C(UK;2*\"?O3=O3O1NKE&0,;I=+DW9R998+4
M>X9W/>6VB<1+4MB)%;D1&W7DI4MQ=4.K;14ZF2E$2A%HF8!0
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MUHAFIF*9NJ2DUK\.EO6?'OZN*OC&*,S(!0
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M??>6DDD:W77%+50B(C.B2))$0%&9(
M
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M16VWE>5QG+P49HKJY"2M$94G07.-A+BE+)!KKI)1F=*5,S @>X
M  !J%ZS<MZH,4ZK]H;-MQNV6W^+[@VM5NP II$FQN7I*C2_"N+1LR$/./NG'
M0A;C:M'-22=):U 25*'#^T"NV 7V[[%];^SL:V7%Z&F)?[GCRF+G;Y4*8@TD
MN5;E//%RW6SU*Y;JC,C_ '%/Q0%.HO'I)VDO&#;L2<RZ9=SK7F71KN$U,G7B
MRS77W)-JNC*4I;B1V'20\A\C6BCCA$?)(T/I4XAI2P;-I@$0
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M#)W)SZ9)DW3(;V\229CO35\Y4*&:4(4<=A1FEO479P2E#>AM HS,X%
M   BWU']3%MV2:L6)8Q8G-QM[<^<*+MYMA!7^?D+69I\7+4FILQFS(S-1TUT
M,B,DI<<;%4B-&Q5TS7?'J+G6KJ7PZV6G>/I8:*Y8Q?,+GO-6Q363,()<6:A#
M[YN*0A*307-(C(UI<0HJZA5Z&%M@LPW]7U"]1&S^S./Q++!=WYR'+-S=R;W&
M5(@P;&<\T-P&HYZ-3LU+2M&E9*-)U0:")3J 9ND B
M
M
M
M
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M,S.A<3.O:!$K(
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M;CSRR0DC4H^PB2FB$I20@7D
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MV7H,VRWIU4XR2:S/Q"$DU\5)]Y="%&B>0%
M
M
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MX_8+0UR+99[>RB/&8;J9Z6VVR))5,S,^'$S,SXF!$K(
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M,Q&4,-F\^Z:EN+T((C4HZF! KP
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MYFVM(\0^:DTYSAZM/ Z\* V2Y H
M
M
M                       ! #J6;W]WQW#:Z9=N;3<]N-L95NCW'=K>QYNC
M<NVRC-)VVUK2KO*7I4AQ-26HR,E$A@E*=%48I]V);V\,=ZI=IVW%N)VZW&7$
M2;VGG&DCD0$FYIIQ/V?QX$5:T\H%9&S6#>\6RHK_ &RVW6V9$FRRW+1DT".\
MS+*-*)"5N1)3:342%DA9&I"RK0^) 1.&/8?B6(MR6L4Q:T8PU-7S9C5I@QX2
M75_E.$PA!*/TF +C                %!R'%<7RZ&FW97C=KR>WH63B(-VA
ML362678HFWT+21^F@ JD&#!MD./;[;#8M\"&@FHD&,VEIEI">Q*&T$24D7D(
MB 'J                                                   %"OF3
M8_C=DO\ DE\NT:W6/%8K\W(KBXNK<-B*SSWE.Z:F6EOO4I6E.'$@!I_Z@^IJ
MS=6V'2]C\(Q6_8;F%VD6W,=J;?F##<*WY[;X$ATRB-:G4Z?%<M3D<EGI>4WH
MUI69$!)*AG79+*=[-S-YMK9-@V4R?IEV5V\L]W=W,P>Z6]NS6J[WFXL.M,(@
M1TQH[D@FWEI>YAIT]TZI2K]T!FR@"(           $(NLFQ9MCA;8=2.VMF7
MD>3[!W.9(R/%V4J-RZ8M=FD,7AA)))1J4A#:5IJE6@M;A%5-%"J(MX7M3%8W
M9P?JVZ%&L?RO#\\E(M&ZNV$U;$7V,U<5MKFK94LE.0N69$I;;9&I"B(VT.L+
M-M(KX&;4+-M]@^.Y/D^:V/%;9:LLS3D?.K((T=#<J?X9.EKG.$55:2]?:=3
MB7B           -.-^P#$,NSW=?HRWZG.V7(+ODMTSWI.W3EJ-4A",@?<EKA
M,REJU.&B3K2MM2OSRB<(C2M+)@2\)D3I5V,=NNT.Z'23O]L0U9[?B%S-QW<.
M"C3#R%^9J<8N,68X?-5+91I-+J",DMZ6W$MF1MJ!OI-E&(XK8\&Q?'\-QJ*J
M#C^+V^/;+-#4XMY3<:,@FVTFXZI2U&24EQ49F!$N(
M
M
M
M
M            1KZA>J7;CIR8QF/E"9V095F$^/$Q_!K&VF3=9#+KR6G9*6-1
M=Q%3))&=7%T;1QU&D52J:GO;^_V&]5_55LUL!C$B#F/4#>8-V:RN:VN(5BM;
MOB)KUT4E3)<OA<E$3JN*%5(DK?-!$)=!MIZ:.FW$.FO!UXY8GG+WD]^<1.S[
M-I9'XN[SR)57%U-1H:;-:B;;J>DC,S-2U+4H1;J2, H
M                                                     1%WPZU-
MD-A-P<=VSW N=TB7;((OB[C=($-4B/9XSQFAA^6:3UGS#2JA,H<41)JI)$::
MBJ533=B^3YQL=N=OG9;A?E;^;&Y@RY>=SK.BX*DN9/AMY6;*LDM\IIQ.J3')
MPD2%-K)25U2KNMK<9$B3&$])MUZ@LV<OAQ\5N'37?<I;RK"MVK',6C(VL=M<
M!=NL>*0D5YD)N"DT-NH6VDTK:,S4I24$!2M#=/;H$>UV^#;(AO'%MT=J+&.0
M^[)>Y;*"0GF/OK<=<50N*UJ4I1\5&9\0(GL         !8^XFY.#;38K/S;<
M7)(N*XQ;30F3=)6M55N'1#;3325N.K5Y$-I4H^-"X #35UNYA-W0.'O4Q'RO
M<'I3/!9*=M[]BLAVTP[9F:IIQ&+A=V)32']*)&ALM;95[I-GJ)Q*A-$S^E_?
M#=Z'F]HZ7^H'"TVG/['M_!R*P9G&N;=S3>;?'4B"X],6DU4?4X1U42CU*2O5
M^*I8BT9@;Z1]I;/N5&W5P,[[M7DJIC4O(H>&W%5MM=[)ISFFQ<K?H<8<;69G
MK)"4&=3.NKB J2> H        &&MU][\-VEGX+CU_EJ;RC=*XNV3;^ ;:O#R
M;BE">6B1(X-LH4ZZTW51UJLJ$9$HTBM#63B]SZV]K,HVJWBRBW;F[MW+.+5E
MEWWBV34ZRQ9[5'BJ)JUMP&DKD,QG#YK;W+2VEXR2;9),S61"NA-ANP;&]?FQ
MF'YA?,>F)MMR)]^PW!*RB7NPW%AU4>24:4@E$1I=9\I*;<(D*4@^%!3@9<V7
MVUS;:^S7+'\KW@O&[EM2\V6*2K_$CMW"WQ$),C9D363US%*,R/F.$1E2A$ 9
MF<"@
M
M
M
M                                6*C<[;Y619-B2\OM<;(\/7;D9):)
M,E##T4[N3?@-1.FFI2%.I0@RK59DCXW  :F^JF[;N;EY%O3+O>6YMM;C&VE]
MM6%=.V"8ZAV"YF>77+5R7SDU04A)&1+[BOS;2BTFE>KF"2,A=+NZ5LS7>F!M
M/U.X$Q<.K79)J=;,:W%:@^,3*MI-H=-U^3&)2$.I0K4AYQ*4&E=4J2ZZM*P:
M-J108*9SES3#83<GF$17;@3:2?4PVI2T-*<IJ-"5+49)K0C,S\I@1/4
M
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M.A$14("C,C
M
M
M
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M):&6UFE.I9M-);CMI0WK,BTU\H%&S.X%
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M/&XKKK[5K@H-*#=>5J<<6I1J6M2CX:E&9T(B["(B$2]0
M
M
M
M
M             <4J2JNE1*TGI50ZT,NTC &F'<CJPZ@\R>W)S?:K=:Q;>V;"
ML]<V]VUV838V;OD68W&.IHEJ<2\R\\WS"<JGEDE*>*%&2DDM0E0NZ\;19)OC
M>K9OKL7DN.[==9.U<Z%:-\;79GGE8Y)N2TDF7$DO&VI+CK+=4ODCFH.BF%+<
M4A+@"M#:!CV#8Q9+G,RMK%,=M^>9!&9;S#++3;&8DJXNH2DU<U\B4^M&LJI2
MXXLR*G$S*H$2\@
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M0
M
M
M
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MF339'72FI\34KM4!1NI(,"@
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M<-RPVOJ Q"(U$3F-C@:-;3C?+9:</0HTH>-K]R6E#K;G>("C=#<<!$
M
M
M
M
M                         "/74ETVX%U,8$_B&7L%"NL(G'\0R]AM*IEJ
MF*21<QNIEK:70B=:,R)9%^*M*%I%4Z&L"%NAUO6&#<^A*5B:;_N?<&O9^/[R
M27''([>'NI4P_/<>6V:7$(09(1(4?,34VU-JD$D"6G$VR[#;/6/83:?$-J[!
M*<N,3&8SA2KJ\G0Y,F275R)4@T55I);KBC2FIZ4T34Z 1;J9? H
M
M                   $:^I[ICP7J=P-S&,F05LR.UDZ_A69,MDN3;)2R*O"
MI<QAW2DG6C,B41$9&E:4*2*IT-+FVO2=N=<MQ&ML,:R29M9OUL5=X^1O6RY%
M,DXI<H3DEIM.16>0VVLF%N)0T3K"T:7R3W5(TJ9:$JF^K;+:';[:*#?(F!8O
M;\9^=-S<O62(MK:V6'Y[R4I<6TTMQWDMEI[C25:$%P27;40,F@
M  ,";V=,VS74,>/+W6Q=W('<64][&>9GS82FT2-/.;/PKS1*2LVTF=2J5.!E
MQJ*IT,K8?A^+X!C5HP_#+'%QS&;"P4>TV>$C0TR@C,S\YJ4I1FI2E&:E*,U*
M,S,S H7*
M
M
M
M                                          #H/PWB45Y7C.4KEUT\
MWE:DZJ>736E?)6@ [P
M                                                  '47(Y[FG1X
MG0CFTIKT55HU>6E=5/N^D =H
M
M
)        /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2227887d4-lc_contrl4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_contrl4c.jpg
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M# P,# P,#/_  !$( PH'.P,!$0 "$0$#$0'_Q #Y  $  @,! 0$! 0
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M#(UE1$G_ $&CZ'QI(UZ)ZW4WJ7PZ?$M,8+$0J
M
M                         %>?=9WW5W;5M;&-56S34^S+EE5AHKQ;YZ6\
MNH9WSUU=5T,='%2LMM:Z1ZNI45JH[EROZ4;X<J6B,7$+I\Z!L3&:9MUS+LQR
MS%<?9*R.LO-;=*N&./K7A$1U18H(U<ON(KTY^B#961Z3W-A>_-=679>"3U#K
M+=UDBEHJQC8JNCJH'=$U-4L:Y[6O8O\ 4N5JHJ.:JM5%")C!U@(
M
M
M                         5,?.M;4K:' L$T+C+I*K(MJW6*KNMMIN72R
MT%#*Q*6!6)Z?:*UT:L^G"J!:E%7?6J)>PO;W:KM[$X%6V45IH+;G<E+STUET
MMT;8+TO/*=/MU+4NZ$7W6N7W F)Q?Z [9<J"]6VWWBU53*ZV7:FBK+=6Q+RR
M:"=B212-7Z#FN14"CW
M
M      %"GSC.25V&]]';WE]LL,^57+%;#B=XM^,4KG,GN4]#DUSJ(Z.)S(YG
M(^=S$C:J1O7E?!KO0%Z=3+=PW?QNG-]09QAM9VDWS7-IRNUSVF\97?G5];3T
MU/5-\N1[6R6FA8V1&J[H<Y_JNX=QZH(A-_YMRR8-8>V&PTV%YG39K-772LN&
M855-') VCNU0V+S*)89V,E:L,+(F\N3U_P"N-]1S0K5K3V"
M
M
M                     '^>:OP5_P XCWN;0@7(:JS:XPB@GHJ#(:*)D_1;
MK5*E'2-@5R]"^V54DE0WJ7ZA7\>CP+ZH=.V[\U!8,,UCG.7X5LB^9'DV+VBH
MNMLL-71T[(ZOV-OG2PHL2]76Z)KD8B>EW2@(J2U^;)W+\9G;M1XC<:GSLCU!
M4IC]4UR\O=;)$6:V2+XKPU(^J!O_ .1"*H6+!4
M
M                         4(_./9C3:\[X^W_ #^MHY;C1X-C^*9!5V^%
MS62SQ6S)KG5OB8YW@CGI&J(J^'(7IU.@YM\[)AN68?E.+6'2=ZK+ODEJK+70
MT]?64TE,KZR%T*K-'''(Z1K4>JJQ&^MQT\MYY0C9=J^:TTQGVK]4YGDF=6JJ
MQU-CW.CJ\>L%<Q\-4VCHH9&)520O1'1I.Z7U4<B*K6([ZES5452M#"H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M[5
M                                                           _
M+G-8USWN1C&(KGO<O"(B>*JJJ!^()X*J*.HIIF5$$J=44T3D>QR?11R<HH'U
M ^3)X)))H8YF22TRM;41-<BNC5R(YJ.1/%.47E.?< +/ V9E,Z9C:B5KGQP*
MY$>YK>$<Y&^E43E.5 ^H
M
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MIB)T:HCOH=]_3'?6?S'2++6[M^Y71/C,8JKJJB<+5<Z8F<->EMO9E^K7K?\
MOQ]^*X]MQ_4Z.S\Z6L_JO_N7-?N_Y5"4!MGSL
M
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MZ/:)F1.D:Q]E9U]'6BJB*G[J V5R@5
M
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M.S\Z3^J_^Y<U^[_E4)0&V?.P
M
M                #!7_ "C&L4I&U^49%;,;H'N5K:VZU<-'"KD3E422=[&\
M\>/I \F.9OA>8)*N)9?9,I2!.J=;1<*:NZ$YXY=Y$C^/'P\0-H U//L:?F>"
MYIA\56VWR998;C9HZ]S%D; ZOI9*=)%8BM5R,5_/'*<_1 CU3]ME^I.U[&]
M6C:]YPW)<6MD%-:]E8T^>WS)4T\CI&K)!%.UTD$B.5DD2R^LGNHJ(J$XZ6DX
MEVEY9D>897L3N4V73[/RC(,'K-=6^BLEM;:*&ALMP;(VKD1$<[KJ)DF?X]"(
MWJ7ZKU>@8M7U-V6YUBF;:CN&RMQ19]@?;PRXLTYC%/:VT50UU=ZK);C.DCNM
M8&-8C&IS]0WA43J1Y,RPF8]AN57V\[$Q&P[B2P=O&WLQAS?/M>>]K9;E[<DK
M*BIIZ.MZT:R*:6-BHJMY8C(TZ7]"]8Q624]/!24\%)31-AIJ6-L5/"WP:QC$
M1K6HGT$1. JI_P#G1OSD]F'Y2WG[,Q\+4KA@J
M      >2LN%!;F-EN%;3T,;W=+)*B1L35=QSPBO5$5>$ \M-?;)63,IJ.\T-
M542<^73PU$4CW<(JKPUKE5>$15 RH
M P./93CF6TM978S>Z._4=OKZFUUU312MF9%6T<BQ5%.]6JJ(^)Z*US?2B@+5
ME..7VY9!9K/>Z.YW7%*F*CR6WT\K9)J&HFB;/'%4,1>6.=&Y'(B^XO(&> \5
M#<K==(YI;97TUQBIJB6EJ)::5DS8YX'K'+$Y6*J(]CD5KFKXHO@H'M   /%;
M[E;KM3>VVJOIKG1^;-![722LFB\VFE=!-'UL54ZHY6.8Y.>6N16KXHH'M P.
M0Y3CF)4M'79->Z.PT=PKZ:UT-36RMA9+6UDB14].Q7*B*^5ZHUK?2J@9X
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MC^IT=GYTG]5_]RYK]W_*H2@-L^=@
M
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M32-Z^3
M                                                        X;W,
MQ9K/V_;@BUW[6N928M<$LC;?S[6KO*7S$IN/6\U8^I&=/K=7'3ZW 3"%N/\
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M   #1]F_FVV#^35V^PY0(>?-F?J@8#]T[]]]*@)JUI]A
M  <KWI^9+<7Y#Y#][:@\[WDZNM+7;X^I7_[NOYLHL?-S_F2RG\N*[[VVPQLA
MY.>OS.=Z#?4J_P"\GYM*?9FNS (Z=V_ZMNX/N!)_9(S<;@^OVOC,?->2JZSG
M78!^K#AGW0O/WPG,SI9]X5]:GN0\\CY*.RF@<VS     5?\ S;O_ &S?YN_]
M9G)]%_VOR?UGZ'_KU_H?WW^4M .L?G@
M
M                     "%>Q,\WW<]U7O3';M:<%Q9F-X_19;FV79C3UCFU
M51>*B>&&.C@H5;UJOL[EDE<B\N16\M5J=9+*ZVQ#N\M.?4][V!>].38S=ITD
MSF3&;1<J6\U[8:98:=4J)O5>Z-6QM19%7AB=*>X#0E^$       *>?G1OSD]
MF'Y2WG[,Q\+4KA@J                              (Z=JOYGF_EQL+_
M %TO83*180 1TU!^>'NP_+C'_P#4NP!,I%A
M                 "EW9G_BW:J^YE']YJ\+<"Z(*@'.LPV]JK7[JN+.-D8S
MB=101T\U91W6Z4M+/''5K(VG<Z&21LG$JPR="]/K=#N/J5X&#U3;1UM3X2FR
M9L^Q]FOG1><S-5N5-[UN8K_+3IJTD\I55_J(B.YZO5^J\ /M@^R-?[,ML]XU
MYFEES6V4LOD5=99:V&L9#+Z?+E\ESE8Y4\41W"JGCZ -U
M  (A[Y[NK)VZYW:+#GNMLMJL!NUE@N*[5LM&M9;J6LEJJB"2BJ6JD;6K$R)D
MBJR1S^)&_P 7Z%4F(Q=<U;O[36Z:5*G6.Q;/E<J,\V:U03>3<8F<(O5-05"1
MU,:>/I=&B P=@"     :/LW\VVP?R:NWV'*!#SYLS]4# ?NG?OOI4!-6M/L(
M                 #E>]/S);B_(?(?O;4'G>\G5UI:[?'U*_P#W=?S918^;
MG_,EE/Y<5WWMMAC9#R<]?F<[T&^I5_WD_-I3[,UV8!'3NW_5MW!]P)/[)&;C
M<'U^U\9CYKR576<Z[ /U8<,^Z%Y^^$YF=+/O"OK4]R'GD?)1V4T#FV8    "
MK_YMW_MF_P W?^LSD^B_[7Y/ZS]#_P!>O]#^^_REH!UC\\
M
M                                     5V[:PO,]L]W\&,V7:%7HR7"
MM<05UBOUAIH??K(X;E7S,JX73RN1):6B?"Q?*5KD9(_KX17HY"T:G9, [>]H
M8?F%DR2^]T^=9[:;7+))68C=8*)E'6M?$^-&2NB8CT1KG(]./=1 C%*X(
M    4\_.C?G)[,/REO/V9CX6I7#!4                              1
MT[5?S/-_+C87^NE["92+" ".FH/SP]V'Y<8__J78 F4BP@
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M6?H?^O7^A_??Y2T ZQ^>
M
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M(*VG=4NIFVZVI44U(ZLD<R*7GF:K8QB+PCEY\? $1BF$$
M                                                        %=^S
M<KV-C'=U=7=N^LV;,R^LU_;F[HMERKZ6TVV"FCJZA;)-#73.ZV57K3-DCZ'-
M?%T*C45KG-+<#L6 ;%[L;SF%DMFP.W&Q89AU7+(V^9/29?27&:DC2)[F.92Q
MQ-=)U2(UO"+X<\^X$:$K@@      !3S\Z-^<GLP_*6\_9F/A:E<,%0
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M5:KEB]''-T27&DH<6M%#4RTB2(SSDCGI96KT<^#5=]1ZP3,)S!
M            !&/)^S?MOS+(;UE>2:Y]\K_D-9+7WBO]][Q#YU1,Y7R/\N&M
M9&WE5]#6HGT$-W8Z19^S1%NBYA33&$1LTZNS#&JREJJ<9C3/5E6GN?YIC*;W
ML>ZWO3N;8[:,#OM6^L=9,AEKTK+9YSNJ2&!\4%5[4QJJY6+(]CN.&N5RHKUT
M]RN;E4U5:YG&>RRZ9B(P3?U_\WCVW8GA>-XWD>*S9M?;32)%=LJGN5TH75M0
MY[I)94I:6M9%$U7/5&L:B\-X17.=RY=IE-^YS*6XMVJ\*8X,*9U]>)EC7<M;
MN5;54:>RF#A>%XUKS%[3AF'VWWGQJQ1OBM5M\Z:H\IDDCI7)YM0^21W+WJOK
M.7]XU^9S-S,W)N7)QJG7.B.YH>M%$41A&IM!X+*\-<9]>>URZ;8U[L+5N>WR
MSWK8-\RG7F9XE8:B_4%PMM^F]K93R/HT<Z&IA>KFO9(UO/I;RWQ"VMUOM7Q?
M,(W[GVOF^-U^&7+=>:R7ZR8E=4:VXT5EI:2&CMZ5T355(9WMC<YT?I8G2BKS
MX(1+TZ(QW(+/N?NTNEVL5PM=LR3,;-58[<:NEE@@KX(K'3122TLLC6MF8V1J
ML5S%5$<BHOB"7'L6V'<=,;P[IJK(=0[1R*AS3)[5<\8NF+X?=+O1UD%-9::"
M3RJJ&+R57S&JWZKCE/%4X"68P_6N<;VVCM#>&76_+]"6^_8;;]=:OCIYX+=E
MT-JI[C[[UMPG:B53*1\U2B1L8]'.\OJY1/5<XC4\>U]&9-B%BTI;;+F.R=U2
M1;ZP*_7:LRBI2^5-JM]#5/\ :9T=1T<"04T;5ZY7O3I;Z5<@(EX,0UAGE'W&
MSZRJ\:KX=&X/FEWW/C>3/BE;;:BMO-(R*ELL,G1Y?727*LKJORT=ZJ-C=QZ$
M">!V3LVQW(,7TP^UY-8KACMS7,<MJDMUSI9:2?R*F^5DL$OE3-8[HDC<CV.X
MX<U45/!0B4JP@ T[8ESRBR:_SF\X/:HK[FEIQ^YUN(6.9CI(JRZ4])))14[V
M,DB<YLLS6L5&O:JHO@Y/2!55^DS\Z#_W5<:^"+G_ (]"V$.=['[\N_K4-KH;
MWLO0F%X=:;G5>PT%=<+5=6LEJ.ATGEMZ;V[QZ&.7^@$X0NGP^[U.08EBU^K6
M115E[M%#<*N.%'-B;+4T[)7HQ'.<J-17+QRJKQ[H4;&
M   #4\^="S!<T?4X[+F%.VPW%9\2@:YTMT8E+)U4,;6->Y75"?Q:(C57EW@B
M@4V7?.,8OU/8:2\?-1Y]<*;%[<EHQ^&6W794I*%*B>K2"/BUIPWSJF5_C[KE
M"_9=Z[4*_$:C;M''9NP/)NWBM6UURMV1=:.X04\348WJIE?4T,#.9O0GK\^
M1*T4*@    T?9OYMM@_DU=OL.4"'GS9GZH& _=._??2H":M:?80
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MC3P76^MJZ-W6R2UX]<5GN-5"Y/5<RIN55(U'(OBD+?Z(A<B%0
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M;SRG/CXA#/@      IY^=&_.3V8?E+>?LS'PM2N&"H
M        $=.ZK\SSORXU[_KI9 F&][DV;;-0:YR3.KET2OM=.K+10/7CVNOE
M]6F@3CQX<_CJ5/0U'.]P\[MR+=,U-=O3>%.1RU5ZK@C1''5P1^7 AQV+ZSNE
M>W)^X7.%?7Y/G=3416"KJ4_C/(=*KJRK3GT>?*G0WCT-8O'JO,3)VYG&Y.N7
M+=$-WU5;>>O::ZYG#'BQ]]/9G1UHZJQ<SW<@$-^_ZR9#D':9MF@QJL;25C*:
M@JJQKIDI_/HZ:X4\M3 DCE1.7QM5$;SZ_P!1_3<'I:M5W:HIHB9F>"#:BG3+
M_/SVC:IVIEW<)JE^'X[=X'8[D]KN][OB02P4]!04=4R6JEGG<C6M18V/:C57
MEZ^HB*J\%*J9IG"8PEZ3,8/]9Q#S
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M:&U"3R*D[W/7KD<CE7UN4"<7:0@
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M6NJ<>MQ1V(T,ZU;BW3%,<#?C$>@
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MJ    #1]F_FVV#^35V^PY0(>?-F?J@8#]T[]]]*@)JUI]A
M      &$O>,XWDT4$&28_;<@@I7K)30W*DAJV1O5.%<QLS'HU53PY0B:8JUP
M\;V7MWHPN4Q5AQQ$]UKGQ4:M^3;%?@:A^LE?%4<4<CP]6Y7S5'@QS.&]RVN=
M>VK0^S[C:\#QVVW"DLSY*2NI;720S1/ZV>LR1D2.:OTT4\,Q;IBW.$0U&_\
M(Y>C(7:J;=,3%.N*8Q[CQ]C'ZN&(_P!O7;[/F&3\E"O1#[MHZ]7SI1)^=/\
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M8>S6@
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M*T"Z]X;4Y/:\QH9:>2MN%KJ&1)"ZVRQL@;*R19&K(D?F*UO'4C?2"5M 5
M !H^S?S;;!_)J[?8<H$//FS/U0,!^Z=^^^E0$U:T^P@
M     X#W2_J][7^X<G]D8>&9\G5UFEZ1?=][XK0>QC]7#$?[>NWV?,4R?DH8
M?1#[MHZ]7SI1)^=/_P"PG_.?_JD^D]!OV_R/UFQWG^;V?<6Y' -J
M  $7,Q[/],9UD]ZR^_T5VDO-_J%JK@^"O?%&LBHB+TL1J\)X&HO[DRUZN:ZH
MG&>J^B[J_JCOK=N5MY6Q51L6XPC&B)G#KM:_02T#_)][^$W_ ,$\O9[*\4\K
M8?C)T@[ZWX$<Y^@EH'^3[W\)O_@CV>RO%/*?C)T@[ZWX$<Y^@EH'^3[W\)O_
M ((]GLKQ3RGXR=(.^M^!'.?H):!_D^]_";_X(]GLKQ3RGXR=(.^M^!'.?H):
M!_D^]_";_P""/9[*\4\I^,G2#OK?@1SGZ"6@?Y/O?PF_^"/9[*\4\I^,G2#O
MK?@1SGZ"6@?Y/O?PF_\ @CV>RO%/*?C)T@[ZWX$<Y^@EH'^3[W\)O_@CV>RO
M%/*?C)T@[ZWX$<Y^@EH'^3[W\)O_ ((]GLKQ3RGXR=(.^M^!'.?H):!_D^]_
M";_X(]GLKQ3RGXR=(.^M^!'.[AJC2^$:8M]VMF$05D%+>JAE57)65#JARR1L
MZ&]*N1.$X-AD\C:RD3%O'2X_I+TLSW2&Y1<SDTS-$3$;,;.B9Q=8,QS0
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M!L#-H)*G%\8<R9\]5#$DBN>CF1N8Q/XE_"O<WGI7@&#HX
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M]A]E=0LF@5?Z2IN#ZR7P3Q16^GW!P+APJ
M                                            5M=PN,:[R?N4IK9W
M.9_5XEJ&LPF"74U'+?YL?L4]XIZN7WX]KJ630L2KCC? K.M[4?&Y$;U*Q40M
M#8-0:F[%<?V/B]XU5M"Q7W8%#/*[&[32;"6\332N@D9(C*'WPF\[B)7KQT+Q
MQU>X"9E8*%0      %//SHWYR>S#\I;S]F8^%J5PP5
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M\]4$QK=3QC_)O'ON92?V%@0S@
M                    ,1D-]MN+V"^9->9G4]HQVWU-SNM0UCI',IJ2)TTS
MD8Q%<Y48Q5X1.5 H_P!N=SO9SM+NGP#9&>5E5L?5%JP6IQ]<>J;37>3:[XE>
MZH9<*BCJ&1MJ(I:>=T:HQ'N1S&N5J]+0O$3@Z'V[95VUYSWPV.[]M,+,"Q^U
MX)<:;(;/3T%5;X,BJGOY1(*5&+%$RF8C)'NE\I7O:WI8]45P1.."Y0*@
MT?9OYMM@_DU=OL.4"'GS9GZH& _=._??2H":M:?80
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MD_@]>J6CLO;5%6Q5]/+"_P ZZ+5VQE"Z5BM7AKWRM=*]7>E7*#%+@(
M
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MSZ>%^@!P^!43NUNZJO")J*WJJK]WJT)X$*.5[P^Z]$\;CI_5?C[OD5%-3O\
MZ'/M]2WZ3EA;]%AK/K%[_MC\NV^;??V]>.Q:Y)B/IU?H]9;$B(B(B)PB>"(A
MLWTA_0 %->XMO28AVHV[5UAED?E.U,]V%33P4_*RLM4&;WA9T1&\KS42*R%$
MX]9JR)[AUO1'=_CLQ-^OX-OYW!R:^1@[PN[-.S&N5C?;5J*'2>GL5PIS&^_2
MQ+<LKG;Q_&72L1KYTY3TI$B-A:ONM8TT^^=X3GLU5=X-5/Q8U<NOLO?+VO%4
M1'"[R:I[@        #B'<U^K=W!_[M<L^\]4$QK=3QC_ ";Q[[F4G]A8$,X
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M2_54U9_?S[^7 =*/O*[\GYM)DO(T]GNRER<^R@
M
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M6>KSTI[JJONA#>0.(=S7ZMW<'_NURS[SU03&MU/&/\F\>^YE)_86!#.
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M&V;^;;8/Y-7;[#E"J'GS9GZH& _=._??2H":M:?80
M     %6/SE__ &*_YR?]5FMWA^;V?<?.^GW[#Y?ZJTXV3Z(B-WV_JJ;3_O']
M_+>=!T7^\K7ROFU,7.^1J['=@[$OU5-6?W\^_EP'2C[RN_)^;29+R-/9[LI<
MG/LH
M                                                       !A<BR
M.PXC9+EDN47>EL./V>%:BZWBNE;#3T\2*B*^21RHC4Y5/%0(';-WGAV69&RZ
M:\^<,Q35%@;1Q0/Q>"VXW>6.J&.>KZCVFX=4J*]'-3IYZ4Z?#TJ%L.HUW6%+
MK;.MT:^R'..^&@[B,IQ2HJJC7. TL5FM5,VXRTLD3ZE:.VKQ/)'#U.9ZJ*U4
MZN?2@%EH5       4\_.C?G)[,/REO/V9CX6I7#!4
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M .(=S7ZMW<'_ +M<L^\]4$QK=3QC_)O'ON92?V%@0S@
M                                       %9G>SJC*:K9&&;SM7<EB_
M;O1XI8%L5MNUT8RFN-15RSU4M2R*JC1)JF-\,K$2G57M:K7O:Q%<Y5+1+.=I
M:;GR?,'Y5>.\G&.X' K923T]WQ:QTU-'/#53M_Z-),D<,<L7"HJHCN.KZ? )
M6+A4    &C[-_-ML'\FKM]AR@0\^;,_5 P'[IW[[Z5 35K3["
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MM775%52VW-+)%;J::5[XZ=C[#2O<V)KE5&(KE551O'CXA$I;A
M
M  \M=0T-SI)Z"Y4<%PH:IO14T53&V6*1O]2]CT5KD^DJ 04VO!D.3;8^(OM_
MP/7&/76PV"FR/8VQ<CLE-6Q6V"X32PT-'1T43&^942^0^15D]1&<>A50)>#"
MH]H:*VOKC%MRVG7F;XSLVOJ;+AVTL8Q^"Q72V7R.DEJHJ:LIHVJQ8ZJ*&1K'
M1>*.YZEZ0:U@@0       IY^=&_.3V8?E+>?LS'PM2N&"H
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M9)W.2YKC]]PZV8Q#KVV6GV.HH)YIG5'M*SQ+YB2IPG"0(OA]$$Q@L6"H
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M8%ENN7LK):/\'\SH(K=<G)$UCO/2&&>I;Y3NOAKNOQ5'>'@%70P
M
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M&C6-3Q]"(!D    !H^S?S;;!_)J[?8<H$//FS/U0,!^Z=^^^E0$U:T^P@
M                     *L?G+_^Q7_.3_JLUN\/S>S[CYWT^_8?+_56G&R?
M1       &H[ _P @LV^X%R^Q9#(RGEJ/C1W5+GP9ZR 'S8?YI<__ "N7[ I3
MJ^FWUFW\3W98.[?@3UUEIQC8@
M
M         /Q+%%/%)#-&V:&9JLEB>B.:YKDX5KD7P5%3TH!"7<?;?VN8XZ?9
M-;?V=L^2M1[H]C8C>FXI.YS>'N;Y*.2EJ%>O'4U87/?SQZ5"8F7+^W??>Z<D
MV;8\&Q^^3]RFE9EJ8[KO>IQ6JQ=]M\B)RQQK52.925Z];$CYCB1[N>M7!,PL
MM"H   ?)D\$DDT,<S)):96MJ(FN171JY$<U'(GBG*+RG/N %G@;,RF=,QM1*
MUSXX%<B/<UO".<C?2J)RG*@?4"GGYT;\Y/9A^4MY^S,?"U*X8*@
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M/IIUF>O@B)_&<^+E<IF9K>%_-13%VJ:MF,(Q_+3/5>5-FBW,[,88K63#6
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M^J,WK?H&YX\3EJ8V=JF-FJJ.*B(^!1^E/#LZ83T1$1$1$X1/!$0Z)\8?T
M                                                     #!918V9
M/C.18U+6U-MCR&V5=LDN-&Y&5-.VKA?"LL+E141[$?U-7CTH!3IN'MG[:M!5
M%FH]L]Y>U<4K<@CDFM-"E945\\D42HUTBQ4%!4/8SJ7A'/1$5>4155%"T3,M
MS[0(NUZEWC:8]1]S.QMOY7-:+EQCE_BKH[:R!L;5DFE6MH:1%<U..CI5?'W
M3BMU"H    -'V;^;;8/Y-7;[#E AY\V9^J!@/W3OWWTJ FK6GV$
M               !5C\Y?_V*_P"<G_59K=X?F]GW'SOI]^P^7^JW[]H]JW\1
MLJ_>H?MDOZ?1Q2S?;K*^;K[7.?M'M6_B-E7[U#]LCT^CBD]NLKYNOM<Z9FJ-
MCVO;F 6#85EH:JVVS(/:O9J*MZ//9[)534CNORW/;XNA54X7T*AEVKD7*8JA
MU.[<_1GLO3?HB8BK'1.O1,Q[CHAZ,X   -1V!_D%FWW N7V+(9&4\M1\:.ZI
M<^#/60 ^;#_-+G_Y7+]@4IU?3;ZS;^)[LL'=OP)ZZRTXQL0
M
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MPQZBTYN]%GQ$5SXN9VMG'WLU888S'#.&KB6^GHQ0
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ME/+4?&CNJ7/@SUD /FP_S2Y_^5R_8%*=7TV^LV_B>[+!W;\">NLM.,;$
M
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MFI8VQ4\+?!K&,1&M:B?01$X"JG_YT;\Y/9A^4MY^S,?"U*X8*@
M     #1L[UQA^R[=1VK,K=47*AH*GVNEBIZ^MH'-FZ'1]2R44\#W)TN7P553
MZ7($7NV#3N PPY+F26^XS9'BVR\\M%BKZB]7:H;!16V_W"WTD/D35;X7I%3,
M:Q.MBKX<JJN\0F90J^<Z[I[MBV::WU3KB])1WO [G19OE%P@5'>5<J9W7:J1
MZ>[T-ZII&.Y1R/B^@I!3&,-STKVBV'NAUS2;>V1MV_7Z/9-%(^-UEFB6NIOX
MQT-1!55=P@JFK)&YKX7L;%TM5%Z'JG"F%:RDQ5M5SC+D-V=&*K&:G,YBY-RJ
M)G9]R9F>'#@U1+KN ?-AZ/UGFN+Y_B>P-DT>18C<8+G:IGW&T.C62!R.\N5K
M;0U71R)RQ[>?6:JI[IG.PVECX5 *W]C]UVG-<]Q&=9'#EULRRXV+6%-9:7'K
M35,GEJ;U!>JJ5]O\R/K8Q\;9$=+SRK&]2JBJG29F[\G.;OTVHJBG:G7/Y:9X
MHX5+M?BZ)JPQP<V[8M)95W$YY4=T._8UN-MJ*GSL(QJ=J^S5*P.5(GI!)U=-
M'3KRD3%_KCT5SN4Y\SLM][SM[ML^@Y31.'OIX8[/?3PSP1VM=EK,WJO&W.Q^
M7$MI.!;0        B]E7<'F^*938L4J>V_,JRJRZ[UMGPRK@O&*I%=):&EJ:
M][X^N\M="UU+222IYZ1KPG3]6J-"<'?L2O%XOV/V^[7_ !.NP>[5?F^UXM<J
MBBJJJE\N5\;/,FMU154SO,8U)$Z)7<(Y$=PY%1"$2^[KN!J, M$.M,$GDJ-E
MYDQL#5H^7SV^EJ'>6US$9R[SYU7IB1/%/%_@O1U:'?6\IL4^*M_#JXN".>>!
M];_IAT(IWI>G>&<B(REG3[[5753ITXZ-BC77.K\WOL-Q[6>WZFTKB'MUYACG
MV%E$3)<DK$5'^RQ_5LH8G^*<1JO,BI]4_P!U6M8>^Z-VQE+>-7PYU]3J<_5:
MK^HW3>KI%G-BU,QEK4S%$:MJ=4W)CJ_FX_!IXIFI*8V[YR
M                                              " /=_KZ.BR"V;Q
MLG==-VUYE9K''9J>GN%5$MEN]/1SU-7'%+0*]CYY%DJ7<^I.G"-XAY3E28<\
M[*^\+<FZ\YNFN<TQ>VYQCMDIZI6[XQFCN-!:YWTW3Y;9XJREB;US]7JITP.3
MC^M+XJ$S&"T$*@    T?9OYMM@_DU=OL.4"'GS9GZH& _=._??2H":M:?80
M                         !%CO6_5EV7_ 'F^_5"8V;\E/8[KG>EGW9=^
M3\^D[*?U9=:?WY^_5<,IY*.SW3HG]V6OE?/J2G,ET0   :CL#_(+-ON!<OL6
M0R,IY:CXT=U2Y\&>L@!\V'^:7/\ \KE^P*4ZOIM]9M_$]V6#NWX$]=9:<8V(
M
M                                             !#S:N=;KS7;\NB=
M#W^R8#-C./TF2;'V7>*%MUEHVW*:6&@H:"@>]L;Y7I ^1ZRIT]/3PJ+X.)8/
M'LG[B=([.USAF[,_LFY\ VU<)\?L6=TEFBQ^[6N^1TDM930U-'2.?3R05+('
MM16\N1_BJM:G#@F^$       *>?G1OSD]F'Y2WG[,Q\+4KA@J
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MKO*6NM-IHJ.L6!J-B\V"!D;_ "VM1J(WJ:O"(B)Q[A%54U3C.F9>>&#82
M      CIM_\ /#VG_EQD'^I=_"8;#OC<]ETC@M7DU>D=9>:OJI<7L;G<.K*Q
M6\ISQXI'&GK2.3T)X?5.:8&\<]3E+4USKX(XY_+6ZSH9T3O](\_3EZ,8MQIN
M5][1]*=5,<>G5$HK=I.F+WDMZK.Y';*ONF3Y+,^LQ&"K;ZS$E16NN#H^$1O+
M>&4[43AC$ZFI]1TZC<V1JN53FKVFJ=7/S=3L/H_]3>E=C)V*=P;L][9MQ%-R
M8ZG[/'ATZ;DZZJM$S\+&Q,Z9\+
M                          !@LHN]58,:R*_4-HJ<AK;);*NOH[!1HYU3
M72TT+Y64T*-:]ROE<U&-X:J\KZ% J5W5DUNS;.]:[@SKYOS96U<GN>"TL:6.
M:&Y34%C6GO%U:E%644=K<R2H5/XYR3HJ>7+'Q&GU3BT==*?M\[D\YV!EUMUW
M<.T+-]&XM3V^HEI<@NU#4T=JIO9VHYE,QC[;21-615X:B.3]Q0B83@"
M:/LW\VVP?R:NWV'*!#SYLS]4# ?NG?OOI4!-6M/L(
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M9X\E@
M                                                (*]S-NH\!SZR
M;GP_N$Q'1>RKA9DQZZ6;-7P26?)K733OJ(&34[I&3L?3RR.XGA17(UW1RB>D
MF'.-0Y#:]L[CP/(MR=T^M=EY/B$M7+JS4^ /;#0-ND]-)%+<)EG>ZHJ964_7
MT-5.&+RYJ^E%)E9B%0      %//SHWYR>S#\I;S]F8^%J5PP5
M     &M9EEMBP+$\CS7)JQ*#'\5MU3=+Q5KPJLIZ6-TC^E.4ZG*C>&M3Q<O"
M)XJ!1GVCTDG>1MJ^7++9(J7$,/OU[RVZX8LR*BLR*\5-T;30L\'.9)/4.9+)
MPJ]$:-5R*Z,P[N7FY=B9^"Y;>NX*\]O"W<N3C9IITQU8G5\KAGBC#B7W1QLB
M8R*)C8XHVHV.-J(C6M1.$1$3P1$0S'41&#7\MR:DP['[AD==;KO=J6W>5YMO
ML-MJ[Q<)/.E9"GDT-#%-/+PKT5W0Q>EJ*Y>&M50EQ*P]T>O\DOL^.6K%=DRW
M6AN%-;+Q#)@>21-MU35QQ31-KWOH$;2HL4\<O,JM1(W(_P"I7D)P5?\ SGO=
M)LNPYT_0&)5[<>Q!;)15^55$4<;ZJYRU3W2LB65[7+%%$D;.$9PKG=74JMX0
M+4PP?9+BE?WM9QEN>;_R:XYC)J]EI@GMLZ)'!<VUK:E*:-SH5C;$R+V1SI&1
ML;YBN:Y5Y<_JZ+)](KN4RDV+=,15C\+AP]V>KQ,.]DZ:[FU,Z.)?)24E+04M
M/0T--%145)&V&DHX&-CBBC8G2UC&-1&M:U$X1$3P.>JJFJ<9G&99,1@]!
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MF*MJUN...&..&&-L44349%$Q$:UK6IPB(B>"(B'6Q&#\^5535,S,XS+]A
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M'+C/:1@ENUCWN;&P&TUE3<+;BUCNM%1UE7T>?(QLM"[JD\MK6\^M[B(;+?\
MFJLUNBW=JB(FJJ)T=EXY6B*+\TQP0N3/G3;@
M
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MOOI4%WA5K3["H
M               "JONBL&D;YWJ:RH^XR@IDUU<-<M;9K[?+^ZTV.FNE'<+E
M,^.>-J,1SY6.C3F2>-CD\/75.D+1J3YUQD.BJ*"DPC4E_P &A@IXWR4F*XI6
M6WP8Q/7D;2T3^5X]+G=/[JA5UL     -'V;^;;8/Y-7;[#E AY\V9^J!@/W3
MOWWTJ FK6GV$                           18[UOU9=E_P!YOOU0F-F_
M)3V.ZYWI9]V7?D_/I.RG]676G]^?OU7#*>2CL]TZ)_=EKY7SZDIS)=$
M  JDTE_XB^[?[0N_]DH#N]Y?<5GKT_K-79^LU=GW%K9PC:
M
M                              0(VA-NC6/<W<=FZLT'<]N6',,*M]CR
M^:.YV^W)%46^JJ):9U%-42.D14;*K9HW1=+O4<U_4BH$\#I. ;PWSE.862P9
M9VFWW7V/7&61ESS&KR.UUL-"UL3WM>^G@:DC^IS49PWZ/(,$K@@      !3S
M\Z-^<GLP_*6\_9F/A:E<,%0              " NX,MWGJ7(L8I[QOZUQ8W?
M[7DEVK:]<-I/-I6V2&FEAIXF+7HDKZAU0D;>7-];CZ)6NN*(F9>&;S5O*V:K
MM?P:8Q_+JSJA'3MRK:RXY;?^Z_<=KR3+'>VOMF//Q_'[A>W^WI3+Y]6ZFML$
M[H(*6G:D3'.:C$<[A%1S#!RU/C*YN3V'%='<OZQSES>-=.$8X4Q,XZ<(B9QT
M:N#1P]1/?6W=+K';5VAM.#4&973S*N:AJ+Q)B=[I[92U-.CUDBJZ^6D;3P.:
ML:M5)'M];U?3X&P=[@C;W.]SM\T5G%!89>XO![--?;O0M?A51A%QNM?9++5N
MZ9:ZLJJ*[\2+"WUVQK%$^5%3H3CQ"8C%%W:FX-J=W-%4]LN U-LVE:[O7,JK
MSLJWV22Q4TU-3/BEIY603UU?[-3P2L\Q9G2H^;U8VL;]3+UV6W%EJ,C.9S-R
M(VH][AIPG]:K@F.#3CQQKZ\U7XV***=6MC=&_-4;&QK:^.9+M/,,:EPK$;K3
MW1*.QS5=15W-U)(V:&%6STU.V&-[FHDB]2NXY1J>*/3D6QFI>H%      -&S
MO,;EAENHZ^V:]R;8LU54^SR6O%VVUU3 WH<[SI??.OM\?1RWI]5[G<JGJ\<J
M@<QU;W!2;7J[?[TZ6V'8+!75ETM\N8WJ*PQVVFJ;1-4TM5',E+>:FIY2II7P
M(K(7(K^/Z3UT)P2'"$"/G!]ROUUH+*J?"MA_@KLQ*JU26V"U5WDW6.G=7P-G
M=TQ.\QC'1N5%5>$5/ \9S%N*XM[4;4\'"V%&ZLU5EYS7BJO$Q,1->$[&,ZHV
MM4SU(4/ZO[@^XBX[,LE!;=QY7#<MBY1:(;_/[[5,?M]1(ZFMT3ZI[7<NX@CC
MBY7T,:B>X,Q355;JBC15,3AU\-"N2KMV[]NN[&-$54S5&&.-,3&,8<.C@7X:
MD[(<0QFJCR?:MP^,K+I9/:)Z:=7NM<<RKU*YS9/XRJ=SSRLWJKSXQ\^)I<EN
M"W;G;O3MU=K^WL\CZGTF_J]G,Y1.7W;3Z-8B,(F,/&3'4F-%N.I1ICOTL7:T
MUP]SGOP#&WO>JN>]UJHU557Q5558C?Q&#X_-4S.,MFMEIM=DHX[=9K;2VBWQ
M*YT5#10LIX6J]>IRMCC1K4Y5>5\"4,@
M                                  !5IWNU?;13[6Q]FY>VC.MRY0N)
MTBT&3XQ-<HZ2"@]NK_+HWI1W"D9YC)?,D7EBKTO;ZW'"(6C%JG9M>^TNNWJV
MU:>[9<YU9L"@LE9/4Y#?ZNXS4]+1RM1',FBJ;G5-;Y_H8KH_%4\%!.*W8*@
M   T?9OYMM@_DU=OL.4"'GS9GZH& _=._??2H":M:?80
M          !%CO6_5EV7_>;[]4)C9OR4]CNN=Z6?=EWY/SZ3LI_5EUI_?G[]
M5PRGDH[/=.B?W9:^5\^I*<R71       *I-)?^(ONW^T+O\ V2@.[WE]Q6>O
M3^LU=GZS5V?<6MG"-H
M
M !&W;';A\:V41Y/\?6X=;>70Q4/X/8+E/O/:W>4Y[O/=3>S3<ROZ^'.ZO%$;
MX> 3$HT5.KKWV\]P/;[/-W$;:V7BNQ;U<,??A>6974U[V5K;?-/#6/A;Y4-3
M3,5JME8^)%8YT;T?X=*DZUE(5       4\_.C?G)[,/REO/V9CX6I7#!4
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MQV'/<L6NM'=[?!57"TN@?/0SLJ(VRM9:6.5BN8B.1'(O'H5/2;Q\PVEEX5
M
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M<WAGL]EZKE=6U,53&JF.")X(CC;U[V_.D_C!;_\ F8G]K'0;?1WO9_Q.=O\
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MPIPT_"U_*9>6\;A/C/<]Q)@TK)
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M$1$1$X1/!$0L\']
M                       #0MJ9?-K[5^R,^IJ9M9481BUXO\%&_P"IE?;*
M*:J;&[A4\'+'POB!3ODFX^X_&.U#7U;4[<JLCW'W@9A3)AU71N6&HL5IG:R.
M2FH'Q.Z8GND= U?)C8L2RN1%ZVHX+X:7<](T&U.VKNZQOMYR3<UZW+AFT<(G
MR"G??Y)I*BW7"B\]7/A2>>H6-C_99$X:_AR/3J171HY2)TPM2"H    -'V;^
M;;8/Y-7;[#E AY\V9^J!@/W3OWWTJ FK6GV$
M              !RO>GYDMQ?D/D/WMJ#SO>3JZTM=OCZE?\ [NOYLHL?-S_F
M2RG\N*[[VVPQLAY.>OS.=Z#?4J_[R?FTI]F:[,
M
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M3.+O00
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MZ_,YWH-]2K_O)^;2GV9KLP
M
M !\IX(*J*2GJ865$$J=,L,K4>QR?05J\HH'T1$:B-:B(B)PB)Z$0#^@
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MZ2A&+J@
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MZ@B8P=@"
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M?$[CJBJ+2DK5Z5Y3E'W!4\%\3(IMTT_!B(:>O,5W/A3,]><6)_8YXW\O%S^
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M..$"T3B_TJXQ_DWCWW,I/["P/-G
M                    !RC>6JZ#=NI,[U9<:U;;#F-L=2P7)&>9[-51O;/2
MSK'RWK2.>-CE;RG4B<<ISR$PAIJ'M?WW/M/2^9]P&0X;4V'MNQV;'];V[%/;
M'SW.5U/[&RMN"U4<:,<D2,<O1Z7L3U&IU=1,RGUG%LK+WA>7V:W1I+<+O9+A
M14,3G(Q'35%-)'&U7.5$3ESD\5"J.?9%JG-M*]NV)Z]V%;HK5E-JK;K-6T4-
M1%5,:RJKIIXE26!SV+RQZ+X+X!,I:!           0WTQI_/,.[H^Z39U_MD
M-+AVS_P?_ ZX,J899*CWOI715'7"QZR1]+EX3K1.?<"9G0F0$          !
M#?<^G\\S'NC[6]G6"V0U6':P_"#\,;@^IABDI_?"E;%3]$+WI))U.3A>A%X]
MT)B="9 0          $2^]W5.;;J[=LLU[KVW177*;K6VJ:BHIJB*E8YE+70
MSRJLL[F,3AC%7Q7Q"82@L=+-166ST50U&5%)14\,[$5%1'QQM:Y.4\%\4"&4
M          ,7?*6:MLMXHJ=J/J*NBJ(8&*J(BODC<UJ<KX)XJ!$OL2T_GFC=
M V_ MC6R&T9-3WNYULM'!4PU;$AJ9&NC=YL#WL\43T<A,RF0$
M
M                            'P6EIEJ&UBT\2U;&+$VJ5C?,1BKRK4?Q
MSQSX\<@?<"&'=;VI7#N1R?2.046:4^)LU'=*ZX5%+/0OJUKDJYK=*C&.;-%Y
M?3["J<JCN>KZ7B3$X)GA       "&&:=J5PRSN[U[W.1YI3T5#A%KCM\N(.H
M7OEJ%9%71];:I)FM;S[6B\>6OU/TPG'0F>$       (8:N[4KAKONKVUW'S9
MI3W6BV7:ZRWP8HRA?%+2+555!4H]U2LSFOZ4HE3A&)]5]+Q)QT)GA
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M630]/'IYY4)B<$P+51K;K9;K>Z1)5H*6&G65$X1RQ,1G/'CQSP$/>
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M(Y3@5R2U9O@N24K:2Z6RH>CUB\V-CY&],GEO1J]7/+7(J)P"8P=\"
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M>0
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MF?[/*V9['*_I8WU6J].CP:XG!:4%0
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M&R5[7-@KKO>ZBTHY%3_HWMTD?*<HG@LK)%"*M:P((
M
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MIY[35%;@V94=)C46:5-79+A!#A\]7[!'=724[VI0OJ^A_DI4<^7U]*]///N
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MT-L=U_VI>KA;WPVFCMMLKJBI;+#7.YBD]HBGXCX\'/1$:KD<U5)7J!0
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MM^+Y#>(WPU=U9-554K8I'(Y\4'M<TR0,<J)RV)&M7A/#P0)F7? @
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M04\$34:R.-C41$1$0(9<
M
M
M
M
M
M                                                        :KE^
M=81KZVP7G/<QL>$6>IJ6T5-=;_<*:VTTE2]CY&P,FJI(V.>YD;W(U%Y5&N7C
MA% P6)[CU%GMQ?9\&VIA^:7:.)9I+78KY07&I;$WTO6*EGD>C4]U>. 8.C@
M
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M0UT]LNEJN]-[)7T-;3]*R05$2.>WJ1'M7ECW-\>.>45$$Q@["$
M
M
M                   "LCYU2&*HT9JVGGC;+!/MJR1S1.3EKF.MEW1S53W4
M5%"U+GG?YH_5NB]8X?N_3>*6K5NQ,"S&V/L]SL,24*5+9DE5T,L42L;)PYC7
M\JG/2US?J7.!$NX=QV\=QX=E-HI;-M/5&CL+GQR&Z0U^83.N%\N5PE^K@AM<
M2K.D+.>E'LB=XHO*JKFL01#CU#WO[DE[:]-]Q=59K#[RQ9W^"V\*2&DF7JMO
MGM8VX4/,W,#E:BL<B^8GF/:K6HWEH,-*0-W[DMA7+N)VM@NN;+;\JU[H_6\N
M393%31/GKKKD$]*^JM]LHZJ-ZQL\]DD?"=#EY9)X\^"$8(OZ,[TMO[)R7 9:
MC<6I:FX9'>4H<RTO>:"X8U6VV"21S>FWW.I\V.JGX:B,8BOY<Y&JCEYZ29A<
M4%0
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MA][KO<[1&U46>>G<KG]#E1JL<]SW<J]O6]K44(E/((
M
M
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M-?T\H]W3TL=P]6\*,5JX5
M
M        &.N]%-<K3<[=3U\UJJ+A234T%TIE1)J9\L;F-FC5?#J8J]3?IH!%
MC0?:=0:<SK,-L93L6^;>VOFE'';;EFE\9'"Z*AC6-4AAA8Z3IZO)B155ZITL
M:UJ-3GDF92X"
M
M                                               #&72R6:^100WJ
MT45WAI9FU%-%6T\=0V.9J*C9&)(UR-<B*O"IX@9,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                  "ICO$[H]Q7?=EA[1>V2I2UYW='
M4\6597&K$J(IJJG6J]E@E>QZ01P4JI/-,U%>B>JSI5CNLM$<+CVR.WWOW[=<
M7?N'&^YF_P"S:ZQ.AJ<HQ9M==+BJH][(E?'17!U1#6L9ZJ.ZHVN1GH;P@3C$
MK5NW'9&8[6T_B>8[!PFXZ_S6KB?!D>/7&BJ*!?:('JSVFGAJFMD\FH;TR,YY
MXZNGJ=T]2E9=R"
M                             5#_ #JNWMH:J^(?XML^OF#^_P!^%'OU
M[S5DM)[5[+[T>1YOEJG5Y?G/Z>?1U+]$+4PQ.3]K?SBN(VRKR+$NZZJS>XV>
M!]5%CLEQKV353HT5?)ABJXYJ>1[D^I256M5?=!C"1O8)W9WKN2PO(K)G\<,6
MT->2P17ZI@A2FCN%)4]:05?DM1&QRH^)[)6L1&HO2Y$:C^EI$Q@L!"
M
M                         %(?=KG&_+WWPV#1VLMSW_7-NRZ@L]/0Q4E=
M4Q4-//40R/?,Z&!R<]71X\!>-3J7Z&W?3_WW;G_=5V^N!&,+)M38SEF&ZXQ#
M%\ZRE^;Y=9:!M/?LLE=(Y]=.CG*LRNE57KRBHGK*%9=$
M
M                HJU)+[P_.S[!I,I>V.XW6X9 RQOF:C/_ 'JV^U4:-YZ>
M%=2>#5_IN?=Y"_ NKS?-L7USBE\SC-+LRQXMCE/[5>KK(R21L,74C>KHB:][
MU57(B-8U7*O@B*O@%'GP/8>$;0QVGRW7V3T&6XY5/=%%=;?*DD:2Q\=<;T\'
M,>WE.6N1')SXH!N0
M                               4A?/*?_ZX_P"=_P#U(%Z5WBJC45SE
M1$1.55?0B!11C\V4Z*[=TG<KD-B@5,6GH[@ZDEC>KX6-K+VDM&SJ7Q=S%&_I
M5?<10O5J7GA0
M                                          !_GY[S<3RG.OG$L5Q'
M"<KGP?*[];[%2V/+::6>"6@G6GE5)F2TSF2M5$14Y8J*%XU) ?H*][7_ 'Y<
ME^'<D^VPC&%L.&6FZ6'#\4L5\NK[]>[+9Z&@O%\E>^1];54U.R*:I<^55>Y9
M7M5ZJY55>?'Q"K90
M                                               *\>\3LAJM[9#8
MMN:IRIFOMUXPVG93W65\T%-7-HWK)2O?/3-=+3U$#E]29C7*K41CDX1KFEHG
M!%G*>U3YQC?E%;M?[NW!8:;7E-4Q35TB/I%\Q(53I>Z"V45-)5O;THYK:B1$
MZO6ZFN\08Q"V33.I<7T=K3%M88?&_P!Y\9IEC6LFX6>KJ97K+4U4RIX=<TKW
M/5$\&\]+>&HB(5F74
M                                 K;^<)[4-H=S_P 47Q;5%C@_ ?W_
M /?KWYJY:7GWS][?(\KRX)NK_P!T?U<\<>'IY"U,X.(7'MV^="S*AJL8R;N'
MQ^BQ^\QK37>>"N6GD]G?X2-:^AM,<WK-Y3AKVH[T*J(J@QA.WM.[6L8[6,!J
M\9M5R=D>39%4LK<QRM\*4ZU<L359#%%%U/Z(8&N=T-5RKRY[E7UN$(F<4I@@
M
M                              !4EW4=GO<EL/N:I=[Z5O\ CF/S6>WV
MV.Q7*X5CXJN"KHXWL>](5HZB-4];PYY_<"T3H8;XG?G7_E[QK^Z*7_$P,868
MZ0M.S;'JS$+5N2]T^1[+HZ>9N5WJD<UT,\KJF5T;F*R&!J\1*QOA&WT?T0B7
M50@
M
M
M
M             #4LWSW"];8]597GV3V[$<=HE1L]VN<[((NMR*K8V*Y>7O=P
MO2QJ*YWN(H'.-==R^C-KWQ^,8'L2AO&1I"ZIBL,\-5;ZR:%BN1\L$%=#3OF:
MWH55=&CD1/'T>(3@W79&TM?ZAQUN6;)RBEQ+'7UD- RYU:2.:ZIGZECB:V)C
MW*JHQR^">"(JKX(H0SV2Y7CV'XQ>,RR.Z16W&+!0R7*[7=4=)'#20LZWR\1-
M>YR(U.?51?I 1DIN_3M$JYXZ>+=UH9)*O#734UPAC3W?6DEI6L;_ $5"<)2K
MM-WM5_M=OO=CN5+>;-=:>.JM=UHIF3TU1!*U'1RQ2QJYKVN1>45%X4(:+?MP
MZUQC8.+:KO\ EE-;,_S6!U3B^.2QS>961M65.62MC6)/&%Z(CGHJJG">E.1@
MS6?; P[5^*73.,^OT&-8K9?)]\[Q4-D>R):B9D$2=,37O<KI)&M1&M7T@9^S
M7BVY#9[5?[-5-KK1?*."X6JM:CFMFIJF-LL,B(]&N1',<B\*B*!D@
M
M
M
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MF*]BB<9ZTM/OS^G^^-RY:<SF[<4VXF(QBJFK3.K1$S+OAL7%@
M
M
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M;GTCXD-+?)#A7P!;OK ] RWFZ/!CF/:_?7VW,?Q;GTCXD-+?)#A7P!;OK ]
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MZ V+MZNJNNJJG&JJ9JJGW]4:9G&96?'6/SR
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MB:>M3CKX6?5:HP[&*R]GU+?W$-)#7OT2
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MTI)&0WP
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M_M*H^]M*<KE_O:OK>Y#[_O?_ (\RWQH_F5K+#JGP
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MJWGV3\./P3]EY]I_^B>G_I?H\WCP\_\ I@M@O/"@
M#Y3<>6O)$D(U=NMZN.5T>P:N_P $#JNU9K=X**5D36N8CG-=(B+XKZ55/ S<
M[1%$TQ3PTPR;],4X8<4),HG"(GT##8S^@
M                              -1SRFS:KQ*\P:XN=KL^;+'&_'JZ]P2
M5-N2:.5CW1U44+FR+'(QKF*K%ZF]74WQ0"O'N&VAD69ZDR;2/<!C"=ON89')
M0-L.P*Q\USUU>JBAK8*MM+/>*1J2TD55Y"M>RH;&Z-KN5<_CI4M#;.U[M[SG
M&-I-W#?<7U3KC'G8C/8K58M4.K7T]Z]NJ:>J2MK9)G>2YL20<1*SE7=2\KPU
MO(F5B 5    !#SO]_5 W9]S*'[Z483&MU3ME_5N[?/\ =KB?WGI03K=O"
M                5W_./?FMP;\JD^P:DP,_\".NXCIU]5M_']R7?NT+]7#5
MW]HU?V?4GOE?)0W/1C[ML]:?G2DD9#?
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MI^UY?%K^Y;1Q6@SB:1L,>)U%WHX[AYKT161+3NE1Z/>BHK6JG4[W$4(P=-
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M,;-^2GL=USO2S[LN_)^?2=E/ZLNM/[\_?JN&4\E'9[IT3^[+7ROGU)3F2Z(
M  *T\(_\0?/?[2J/O;2G*Y?[VKZWN0^_[W_X\RWQH_F5K+#JGP
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M+V6N6M-4:&]'FQP
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M9OYMM@_DU=OL.4"'GS9GZH& _=._??2H":M:?80
MBQWK?JR[+_O-]^J$QLWY*>QW7.]+/NR[\GY])V4_JRZT_OS]^JX93R4=GNG1
M/[LM?*^?4E.9+H@   K3PC_Q!\]_M*H^]M*<KE_O:OK>Y#[_ +W_ ./,M\:/
MYE:RPZI\
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MCV.]+7)X*GT%1431W;4VJL)<YF<M59JPG5P2Z >;&
M                                     :=G^%6_8N'WS#+I<KK9J.^0
MLC==['5OH+C2R12,FBGI:EB*L<D<C&N:O"IX<*BIR@$&[EJ3YP/ %?0ZQ[B<
M6V=C<'"6^'8%M2"[1Q\M1&/JJ:FG6H<U/2^25%=XKPB\(%M#TV?27?'L-[*7
M=?<M;,"Q65$]\+'J^B9!<ZAJIPK$NL]+!+2N\5]:-9$^EZ%08PGCC5@HL4QS
M'\7MLE3-;L;MM):K?+63/J*ET%'"V"-TTTBJZ1ZM8G4YR\N7Q4*LV    (>=
M_OZH&[/N90_?2C"8UNJ=LOZMW;Y_NUQ/[STH)UNWA
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M<O\ >U?6]R'W_>__ !YEOC1_,K66'5/@
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MRU=:;6Z[46T,1K,PLV7QS]$+:2FZ'1M]G='U.\ULB.1>I./=0&#O00
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M!,1B[IK'>NH-RT?MNL=AV;+D:SS)Z"EGZ*Z%O]5/13)'4Q)_Z<: P=8"
M 0\[_?U0-V?<RA^^E&$QK=4[9?U;NWS_ ':XG]YZ4$ZW;P@
M     %=_SCWYK<&_*I/L&I,#/_ CKN(Z=?5;?Q_<EW[M"_5PU=_:-7]GU)[Y
M7R4-ST8^[;/6GYTI)&0WP
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M1JF,7M)7 *T\(_\ $'SW^TJC[VTIRN7^]J^M[D/O^]_^/,M\:/YE:RPZI\
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M0-/G+LU5[/!#F-YWIFO8X([J1AB-8
M                          0.W==N[//ML7?3^D,BP'7^'4-GI*R^9=>'
MT]??'QU:=-0V.V/=5.\M$>C6N?2L:Y5X\[GT$Q@BS=_FXL MUIS&CQ7=5PR7
MNUH+>F3V1E%<;?9)(:A)$\N=+9 JST\$TCNCSG2\(JM5JIXM<3M+:\!@RBEP
M7"Z7.)XJK-::PVZ++ZF!W7%)=&4L;:U\;N$Y:Z9'*B\>@*ML    $/._W]4#
M=GW,H?OI1A,:W5.V7]6[M\_W:XG]YZ4$ZW;P@                  $,^];
M5&?[<P+%++KVP?A!<[;?TK:VF]JI:3H@]EGCZ^JKFA:OK/1.$55^D8F;M57*
M8BF.%RO2S=N8SV7HHL4[4Q5C.F(T83QS""]GT'WX8];:6S6!V66.T4+5;16J
MWYG24U-"USE>J1PQ71K&HKG*J\)Z5,.+&8B,(QY?[7(6MS;]M4Q11MTTQJB+
MD1')%3)?$[\X1_*^<?SZ@_QL3XK,=7E_M>GJOI!WUS^+'TSXG?G"/Y7SC^?4
M'^-AXK,=7E_M/5?2#OKG\6/IGQ._.$?ROG'\^H/\;#Q68ZO+_:>J^D'?7/XL
M?3;/V0;%V;DF\+A8<RS[)<CHJ7'KB^2U7:[5==3MJ(9Z=B/2.:61G4WE41R)
M[J\%LG<JFYA,S.AD=$<]F;V>FB[<KJB*9T35,QCC''*WLVCZ:
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M:UZL1.41?$PL[;IIB,(P<9TRW?E\M9MS:MTTS-4XX1AP+-L%_P B,.^X=O\
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M$2LP"H    (>=_OZH&[/N90_?2C"8UNJ=LOZMW;Y_NUQ/[STH)UNWA
M                   4N]BOZRF2?<.\_9E.:G)>5GK2^5=#_O*KXM7=A=$;
M9]5
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MVKZWN0^_[W_X\RWQH_F5K+#JGP
M                        _BJB(JKZ$ ^;IHF(KGO1K4]+E7A$_HD8CRT]
MTMM8]\=)74]4^/ZMD,C'JG[J-52(JB=4IFF8X'N1R.]'N%D/Z     '\5J.]
M*<\ ?-T$+G(YT3'.3T.5J*J?T08ODQ]'4N>C%BG="]S'\=+E:]OU35]/"ISZ
M 8O0C6HO*-1%^B!^@              /RKVIRBKZ /%476VTCFMJJ^GIG/\
M!C996,5?W$<J%9KB.%,4S+V-D8]&JUR.1R<M5/'E"<4/V2 '-\VU?BN?7K#[
MUDUO6YS815UE99J9[_\ H[GU]#/;JAL\2HK9&NAJ'IPJ>GQ]P#AM)V7Z=M[\
M0EH8;Y32X52);K9(VZS*Z6WQUCJ^&BG<Y'*^**5Z]'BCD:O1U=/@1@MM,O!V
MF:O@JJV5JY EOJ+I#=[?CJWBI=;;=41WJ#('^QTJN\N-LE=3MD?X*O'+6JUJ
MJA*,7/-F]IO;I--4U^9U%YL\FP+W6TM2VFN<S'W&NR2JBJ'TD<;&O54=/"V1
MK6)ZJ-57+T(XC!,3B\MPT[VE7NCI[U>,@M]VM&P8\MN-NJ)[ZWV6Y,N$=+4W
MR>F>V1J/2F;:V2JYB_Q70YR\ QEIN/4W8W9[<VY4^]K!<Z:RTUWLLMXJ\NI)
MDC9D]$RCG@D>V1K4<^GHOXOT<=+G>+NI1@8N591I_3]!G>I;_3;AU]B6B)KK
M8KY8(ZK*9)Y,EJ,:MT=F2-M'(YM"]SF(V.6JCF5W"(UT?4JN4)\:>T/KS2T5
MS9AC;FRCN<4,$%/75LE7'2TT#I%B@IT<B=+465?%55R^"*Y>$X(F6E6;L]T/
MC]91UUIQJ:FJ[=;<@ME-,M9(KDI\D=)[6J\^"NC9*^.%?_5L<K4"<7KH^U/5
M-NNUMNM$EY@6V/Q2>&W-N,BTTE3A?EML]3+$J>M)$R)K'+SPYJNY3E5)1B_>
M3:^T+C.J;]J[*[S3VK"&7!;O=5J[GY5715E[N\E;35+9VN;+"KJ^1?(<G'BG
M'BB*0,G2=M^MVX/E^"ULEZO=)GURI+KE]ZN=RFJ;E755'+3S4[I*EZ]348M*
MQ$:UJ-Z45/="<6%RG4FK\SWG19!6YCDMKVM06&*IM5MH+K/1L;:(YUCD=31*
MQ8^ETJ=,_ENZO6;YG".;R1J;-AW;/K7"\P;E]NI;A524C;JVQ6*X5TM5:[4E
M\G94W'V&CDY9%[1(Q%=Z>/0WA 8O;G?;EK#8>51Y?D5B=-=H,6N&'0>1*Z&)
M+7<V/CG:D;.&H]&R/1C_ $MZEX!B^N,]O^"XC==777'X[A;)]2V*KQK&V15C
M_+FME:D2RPUK%Y\_F2%DJ*O"]:([Z0,7=24      ?E7(WTK_0 \]174=(SS
M*JJBIH__ +Y*]K&^GCTN5")JB$Q$R_L%92U4:2TM1'4Q+Z)8GM>U?Z**J"*H
MG43$P]/I\24       .5[NE\C4^=3?%M\<'EVQZ_%E_+/KM_Z+_6:CT^G^MN
M]'H!"K"][ OV2RVZ:_\ S255>);1;J2T6R2K>Z58*"@B2&EIHU=CZ],<4;4:
MQJ>")X!;LI-]H-Q]LS?)H_T&?T6>BQJ[\,../?'_ *3"GL'_ -&4/_Y3ZM?J
M/J?=02L("H    (>=_OZH&[/N90_?2C"8UNJ=LOZMW;Y_NUQ/[STH)UNWA
M                       4N]BOZRF2?<.\_9E.:G)>5GK2^5=#_O*KXM7=
MA=$;9]5
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M5'WMI3E<O][5];W(??\ >_\ QYEOC1_,K66'5/@
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M1R<.Z>5\/=X])ZS?PT\#!\1P3K=CB>V2-DC7(]KT16N3Q147T+X&1#'?L
M :-LS'LHRO \HQS"\L?@N57>B=!9,NBB\Y]!.KFJDR1]3>KA$5..4 KT[@\4
MVQ@BX9<<B[_:73M(W&[39IZ.OI&^;=[I;J5D-PN<<25"2.]HE_C'HUJHSJ1%
M=XH%H=4[/;+G=37W[,[IW?T?<QB%10>]U-;:*%C&VZO66.5)9>F>1S'^6US>
MA[6KP[D(E/ (    !#SO]_5 W9]S*'[Z483&MU3ME_5N[?/]VN)_>>E!.MV\
M(                        "EWL5_64R3[AWG[,IS4Y+RL]:7RKH?]Y5?%
MJ[L+HC;/JH
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MJL4]LOOK+W[D6Z9G&>HUF^/Z8[YW5E*\WF*:(MT1$SA5$SIF(U=>4G#;/GH
M                                           TS,\F;CUNYA5'W"K5
M8Z.)R>"*B<N>OTFHO[_!YW*]F'I;HVI1;VS6U<-KL]$LSWMN4DLUQF7TROC1
MBIU+[O*O5>/I)] I"TH[5EPI(4=$^=6R+SZK/!W_ "B9B"(Q=7T6EWEOF15:
M02QV*6EB;/*_EK'UC7IT*Q%1.I?+5W4J?^:B^X5IUK2DR70X5LNW3PW=EQ8Q
MZT]73,9+,UJN2.5JO1%=QZ$5O'"^CP_<YP<S3..+?[IS%.QL3.F)Q>O4MO1:
M2ZS)(B1,K6KT1N5>7^2Q'HO4WA4<B^/"^/TN!DZ=$]=Y;[N8W*8ZGNRD)BU?
M!9)'4#(F04%9,LCNA$:D<S^$5?1]2[P_<_H^&=3[WK-)7[YU5KFN3EJ\H>SQ
M?T    1?[>6.LV3]QF,W#B"[Q[1N=\6DYY5:&]4M)444R<>Y(UKD^DK7)[A"
MTI0)X^/T250 !_%5&HJKZ$]('EIZZCJT<M+4QU+6O?$YT3D>B/C<K'M54Y1%
M:Y%14]Q0/6      #\N>UB*YZ]+43E57T(B </JLA?DESJI(I'>]5"J-H(?1
MUN7GF9R?15/1SZ$^@O)C[6U.+WV=F'Z+#^@ ->RNA?<<>NE)&G,LD2.B;]%\
M;DD:G]%S4/.[3M4S#(RMWQ5VFJ>"4:*2FE?D%D3CRJJ&X4J00S=3'-D9-SPJ
M(BKP_A&JIK(CW\=>'4W;L38KPTQLSVX2KI:.&CEH:J)/,J[:]9*&IEX<YBJB
MITHJ(GJ\*J<?0_H&UV>TX_%V:T72*Z4J2L162-7HFA7TM<B)RGT%^BBGM3.+
MQJC!EBRH!XZRWT-P8V*OI(JR)CV2-BF8CVH^)R/8[I=RG+7-1R+[BIR@'W2"
M)/0SCPX\.?0!^EB8OI;Z/0!_$BC;RJ-\5]*KX^C]T!Y4?HZ?#T\<J!^7T\,C
M'1R1I)&YJM<QWBBHOI147Z(&*L^-8[CM,ZBQ^QT%CHWR.E=26^GCIHED?]4]
M61-:G4ONKQR!EO)BY5>CQ7T^D#S3ST%,L25,S('3/\N!)'=/6_A51K>?2O#5
M5$^D!\X:"ULKI+G#1PLN-1"RGFKVQHDSXHU<]D;I..5:U7N5$5>$55^B!D@
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M0J    "'G?[^J!NS[F4/WTHPF-;JG;+^K=V^?[M<3^\]*"=;MX0
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M3J6A!4    &C[-_-ML'\FKM]AR@0\^;,_5 P'[IW[[Z5 35K3["
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M-3QK$^-_#V\2*WU5]*"5BX5    !#SO]_5 W9]S*'[Z483&MU3ME_5N[?/\
M=KB?WGI03K=O"                         I=[%?UE,D^X=Y^S*<U.2\K
M/6E\JZ'_ 'E5\6KNPNB-L^J@
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MO3V/FOT/N_\ XZN_*_G0M .L?G@
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M_5 W9]S*'[Z483&MU3ME_5N[?/\ =KB?WGI03K=O"
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M'P:HB8ZTQC#,$O4
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MU%])=Y/ZB(B<(!_0            X)GUOAR3:>O<<NB\V."GKKK-2N_K=3/
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MS:6?)T]:'TO<_P!2L?W='S8=4/1L0
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M$L>_^$^\;SD[WWO3V/FOT/N__CJ[\K^="T ZQ^>
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MJ^!\<SJ9+=$KDD<QK43S$XZO2O (A9+VR_JW=OG^[7$_O/2A$ZW;P@
M                       JQ^<O_P"Q7_.3_JLUN\/S>S[CYWT^_8?+_53Z
MT7^9+3OY#X]][:<SK/DZ>M#L]S_4K']W1\V'5#T;$
M                                :KF^$XQL;$[[@^9VSWYQ;):9:.]V
MOSIJ?SX7*CE9YM/)%*WQ1/%KD4"H/N$TYV5Z<S&R:MP3M*O^\-M7JA]]W818
M,BR:/V2W=:L2HJ9XZNK<WJ5J\(D3N$3J>K$5G46B9=F[%(^VUN>YK189H&]]
MNN_<>LSJ3*\)O]TO%PG=9:JHII72P+<I4:YGG1P=3E@8Y.6=*JQZ\B<5H 5
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MOT/N_P#XZN_*_G0M .L?G@
M  #D>^-:OW#J/.-91W5MCDS&@6A9=G0^T) JO:_J6+KCZOJ>..I F$0*#L>K
MY(JZDN.PJ+'K/D.262_9+CF"V5N/T'3C\,S:-M'"^JJ_)FDGD9++*O5U+&U$
M:G!"<6<L?:7GFO[MC%RUOM:BIXL'N^65F*PY39Y;JL5%EK:!]52RK35U%UN9
M44LLK7ITI_&JG3ZO*C%\J#LWO4VW(-H7[.+"^LDR^BS2XUUJQ]:2]25=+1QT
MTM!'<Y*Z;RZ&=S%<^'RW+PO'4OBH1C#<LN[3[;1UUHN&E[K;==55-;K_ &6[
MTMUMCLCHJBDR1M$E7.RFK:CI2=BT,?3U]<3DY;)&YJ\*P,6>V1VZ2YY<;+6L
MRIE"VTZTR77W0Z@B_C%R"DAIDK$9 Z")B1>5U>5&QK5YX;T(@,7.'=H5_M>5
MV[8&*["H:+,<?6RI8&W*TNK+=Y=OQ=,9JVU-.RJA>]98_P"-C<R1OEKZOKIR
MHP3,M+A[#KC:*>R6.Q;/BCQRGJ,/N-_@KK2LM74UV)U<]4Q::=E7&R&*?VEZ
M*Q6/5OJHCN$7E@8OO+V(UM78\@LTVQXZ.G=<;9=<0M]MHZVFH(*RUUU35I/4
MP>^;G,6=*E8Y(Z!]+$WI21C&R>L#%V:M[9(JKMTK-)T5^I<>O$]:V\T.76R&
MK>RBNT=T;=HZN"*OK:NH56S,1/7J'*[Q7E.> C%H>+]DEEPU4I[%E<D%NIMC
M63,K512TJ2+26JR1U#H;1&])$\/:*VHD21?0C^.E>.5)Q:E0=BUXI\=O6/UN
MR:2:&KUO6:YM%1':7QOBII[^V^0U4W56/221O2L;D;THOI3CCQ0C%9-"Q8XH
MV.]+6HB_T"4/J          ?"2IABEBA?(ULLR*L4:JB*[I]/"<\KQ[H'V14
M7T* =QPO/H5 (;T_;IFEKON1VVP[8DQ_5>4YC<,UO.,4-N:R[SU%UZG5ML=<
MEF='[#)*YTBHE/YGCT^9PA"<7**?LFN-*N'UE_V?1SKKJ7$J'&)*>T-I&+9,
M4NC[FR*M_P"E/\VIF<Y&.E:K&M1.?+\5"<6K[D[-LHEUU7/Q&])DV16BWYS'
M:\>BI8J9U=)F600W=K4EFJ&L9[*UJL7J7U_2G3Z 8MCK^QBMS"YNR;--B,?=
M;\N6/RF&U6U:*'C)<?BL,+:1CJN=8UI60MD=UN?YCN47A 8L_CW9E7V&VXZZ
M/+[4S)K/E5+?+I=X*.YOCN%'3VB6S+#*VNN]9(V98)WO;(R1K&.X:D?0U&@Q
M;EV\]J<.B[C>+@^^T>0U$F/_ (+6*Z)!<(Z]+:VH6=$JG5-SJZ=7<]*=-/!"
MSEO*-3J<$3+F]S[%(*W#=18]%F5+4UNN\9K<3O?MM'7-H;G0U\R32R+!;[E0
M2ME:YO@CYGQO3ZMCN$"<6E;@[-,TI\5VU78'>H;M-DU'6^]&#6VFEHW7"HN-
M?1R]56M7<9*%'4S('=,D$$$DG/\ '/>OI8&+?:SLSRNIO>0[ 9M&VLV7EURO
M]1?JWWB<ME]BR"V0VB>&FMZUR2,ECA@:]DCIW<OY1Z.:,#$INQ6AI+6W'H<[
MG6QLRS&+^B/I.:I:7'K!-9%IEF\[CS)FS+(DG3PU?#I48&+"5?8MD-ZMUNI\
MBVC0U%PQ2QXQ8\,GM]GGM\38L4GF?1NKT@N22R.FBG<V1T$L+D=PYBM5 8MN
MQ[LQH+-;<FMS;]:&?A)K^KPVKI8K5-44D536WFLN\M8D5PKZV5S7+5>6YCIN
MI>%>DC7+ZI"0>@-17;4>-WFU7G*4R.HNUV?<::")M7[-00K#%"VEIWW&LN%8
M]B>7U<RU#U17*B<-1$!,N]^8SK6/J3K1O5T\^/'HY)0_7*?1 ^4-1#.CUAE;
M*V-[HWN8J*B/:JM<WE/=145%3Z('V                      QE-9K71W"
MNNM-;Z:"Y7-&)<:^.%C9YTB3B-)9$1'/1J>"<KX>X!DP        %8F\-;X[
MO/NQK,/PS,,Q[?=\X1AE/<Z7:]F<WV*^6666-/95IV5='/*Z&296]3'=*M:]
MDG/0Q$+1HA([MP[5;/H*NRW+;IG5\VOL_.FPQ91L/(GJ^IE@I_ZW!$U\DSV-
M]"NZY7JO2WQ1&HB$3.*5H0 1:W;VZ9!L;.,7VGK;<5WTQLO%[=-9HKW2T,%Y
MM]5;YWN>Z.HME5)'$][5>[I?S[J<HO2SI)B6BL[%=<R:$R[2MTR*[W>[9O?'
MY;D.SJCR_?27(W/1[:]&)ZB-3A6>7SXM<_UNMRO!BVO1/;!<-79]EFW-B;5N
M.Y]JY5:Z>P+EE;;H+5'2VFF6-S:>*E@DF3J>Z&-7OZ_65J+THY7JX3+P=_OZ
MH&[/N90_?2C!&MU3ME_5N[?/]VN)_>>E!.MV\(
M       *L?G+_P#L5_SD_P"JS6[P_-[/N/G?3[]A\O\ 53ZT7^9+3OY#X]][
M:<SK/DZ>M#L]S_4K']W1\V'5#T;$
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ME8^JCI)%;,Z5S>I7HK45%Y]P(B7)/FS/U0,!^Z=^^^E0"K6GV$
M                JQ[I/UVNW3_-'_62K-;F?+T]CNOG?2'[[RW[O^9*TXV3
MZ(          %7^3_P#B)8]_\)]XWG)WOO>GL?-?H?=__'5WY7\Z%H!UC\\
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M],V)*:SUU+A>3U%NC:J4]/?K[9WRW9L;>?45[8J>5[?3U/ZU\7A$IC$J@
M                           !4#W\8IV=TNS;3EF]=G['H<^KK;3MM>%8
M344,JTE'"KF-J_*JJ*5*?S'(OBZ9%>J<M:O2O!:,70?F_P#'>UV2[Y?F.A=H
M9]E=^][&6S(\1SJJI5J**FEG9-'4,IX*.!'=3H>GS&2/:G/2[ARH"<5GH5
M  !#SO\ ?U0-V?<RA^^E&$QK=4[9?U;NWS_=KB?WGI03K=O"
M                 "%W=[VYYOO_ .+W\#KI8[;^"7OM[X^_,]3#U^W^Q>5Y
M7L]-4<\>SNZNKCTIQSX\8F:L57<,,-#E.D^XK^\_%>*FF-G:QVIF/A;.K")X
MD+OV<^[?QIP?^[KE_BPQ/0+G''Y=AROL-G>_M\M7T7.-K]FVSM/83<<\R:^X
MO76BV2T\-136RJK9:E75,K86*ULU%"Q41SDYY>G@>=W*5VZ=J9A@;RZ+9K(6
M)O7*J)IC#5,XZ9PX:86!_-\?F&J_RJN/]@I3.R/D^R[7H3]0GX\]R$YC,=>
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M[_\ CJ[\K^="T ZQ^>
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M]#[O_P".KOROYT+0#K'YX
M
M                     ,5>[[9,9M-=?LDO-#C]BM<2S7.]7*HBI*2GB141
M7S3S.8QC>5]+E1 .2_I-=MW_ '@]:_SLL_VT$X2VW#]N:IV%755LP'9V)YQ<
MJ*#VJLM^/WJAN<\,'4C/-DCI9I'-9U.1.I4XY5$",'0@     AYW^_J@;L^Y
ME#]]*,)C6ZIVR_JW=OG^[7$_O/2@G6[>$
M    !$/OG_5PR[^WK3]GPF+G/)2YGI?]VU]>GYT-5^;X_,-5_E5<?[!2E<CY
M/LL;H3]0GX\]R$YC,=>
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M^]Z>Q\U^A]W_ /'5WY7\Z%H!UC\\
M
M                            &M9AB&-Y]C-YPW+[6R]XSD-.M)>;5*^2
M-D\*JBJQ71.8]/%$]#D IW[C*#L,[?<SJ\$7M6N.P+S9+5!><MJ+-67!E)::
M6K>C(%J9GUCNE7JYOBK4:G6Q.KJ=P%HQEW#L@R'2]VVCGUIUAVM7O1%[L..P
MKE5XO=36+.K*NIB?2T3J6I5W1YR,=*URJB\,\$5%Y!*ST*@    AYW^_J@;L
M^YE#]]*,)C6ZIVR_JW=OG^[7$_O/2@G6[>$
M      !$/OG_ %<,N_MZT_9\)BYSR4N9Z7_=M?7I^=#5?F^/S#5?Y57'^P4I
M7(^3[+&Z$_4)^//<A.8S'7@
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MO'9QF)QV<-KX,SJVHY71C*:$
M
M                     "M7:>L<4R[N5W+C$.Y,7L4V[]9,QO-->75?*O++
MDRG6.R5UN29&MJ(V^#WMB=U(K>%1>KEA;@;5VR:3[DK+N*][>[B;]CM1<+=@
M=+KC'*#'7O>VNI*2LCK&W&J56,17]37<*Y.I?,=ZL;41JD3,+  @    $/._
MW]4#=GW,H?OI1A,:W5.V7]6[M\_W:XG]YZ4$ZW;P@
M            (A]\_P"KAEW]O6G[/A,7.>2ES/2_[MKZ]/SH:K\WQ^8:K_*J
MX_V"E*Y'R?98W0GZA/QY[D)S&8Z\
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M7^':^@B_\V[_ -LW^;O_ %F:GHO^U^3^L^A_UZ_T/[[_ "EH!UC\\
M
M                                                   55=[=U[><
MLSN35UP[<,EWCOI;535-)48E"^WU-+2S<^0M5=8$D>K&HG@DD$T;45>>D+0Z
M!V+:A[I-9+D$VZ<IJHM?5]$L>%:SN]X;?KI:I?/8Z-TE8R+RV-;"CF=$4B-5
M5Y6-JH"9A8J%0    0\[_?U0-V?<RA^^E&$QK=4[9?U;NWS_ ':XG]YZ4$ZW
M;P@                               (A]\_ZN&7?V]:?L^$Q<YY*7,]+
M_NVOKT_.AJOS?'YAJO\ *JX_V"E*Y'R?98W0GZA/QY[D)S&8Z\
M                                        A)O2Z=Y&";#ESO4F,8IM
MS545# DVO*Z2.CO=%-&Q4JYZ2J<V#CS4X7A9)O!%1(D\.28P>/M/[I]-[JR/
M*\+Q36M1J;:5%337G.\6DM]-"V9::>*FFF6MI6,2H<R6J:WF9C'KU*J-XY4$
MPG.$     T?9OYMM@_DU=OL.4"'GS9GZH& _=._??2H":M:?80
M               "K'ND_7:[=/\ -'_62K-;F?+T]CNOG?2'[[RW[O\ F2M.
M-D^B              *O_FW?^V;_ #=_ZS.3Z+_M?D_K/T/_ %Z_T/[[_*6@
M'6/SP
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MOI1A,:W5.V7]6[M\_P!VN)_>>E!.MV\(
M   "(??/^KAEW]O6G[/A,7.>2ES/2_[MKZ]/SH0Q[6N[C6^D=:3X;E=DR6X7
M26]55Q;/:::CEI_*GCA8UJNGK('=2+&O*=/'H\3$RV:IMTX3BY3H[TFRV[LM
M-JY37,[4SHB,-.'',<21_P"T8TE^*V<?W#;?\9F1Z?;XI_+LM][<Y+O+G)3]
M)V;2G=-K[?%_NN.XA9\AMU;9[?[XU,MXIZ2&)T22LAZ6+3U=0Y7=4B>"M1./
M=/6SF:;LX1BVNZ>D67WE<FW:IJB8C'WT1QX<$RDJ9#?
M                              U7-\VQC7.)WW.,SN?O-BV-4RUE[NGD
MS5'D0M5&J_RJ>.65WBJ>#6JH%3O<UF';GLK9EKJ=Q=WN48KJ6_8O9+YCNG\>
MM-]CAKZ*Y4R54-;5SQT,T2)4,>B^6^%9&M7A71N\ M"3W:/F78Y+=:_ ^UAU
ML?DU'9Y;C>:AEGN\%RFM\51!%(^HN=UI(Y)6I--%_%^:OBO+6(C? B<4[@@
M   &C[-_-ML'\FKM]AR@0\^;,_5 P'[IW[[Z5 35K3["
M          58]TGZ[7;I_FC_ *R59K<SY>GL=U\[Z0_?>6_=_P R5IQLGT0
M            !5_\V[_VS?YN_P#69R?1?]K\G]9^A_Z]?Z']]_E+0#K'YX
M
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MJ_I(4_-P_G2SG\E5^SJ8Q,A\.>LY/H+]:N?$]V%QIM7U$
M                               &/NMIM=]M]7:+W;:6\6FO9Y5=;*Z%
ME13S,7QZ9(I$<QR>'H5 *]^X"IS_ %KL-MXI>S;$]ZZ0I+1;Z.EK;/:J*;([
M8E+'Y3H64ZQ5#WP1-1/+8V!&M:BIYC4]!:'3.V3=?:WM6\72ET]B-MP+8]MM
MLDF2XE-CL%DO5+1-F@9,V5]/%Y<D:3.B1R,E=P[IZD3P")B4S @    &C[-_
M-ML'\FKM]AR@0\^;,_5 P'[IW[[Z5 35K3["
M  50]W5UM]B[QM#7N[U;*"TV>EQ>NN==+X,AIZ?(:R261W'/@UC55369J8B]
M3,]3NOG'2:Y3;WQEZZIPB(HF9XHBNK%.#]*7M[^5>Q_^TD_@&9Z3;[Z'6^T6
M[_/4MHQ'>6I,]O+,>P[/+9D%ZDBDG9;J5[UD6.).7NX5J)PB*6HO453A$LC+
M;WRF9KV+5R*JN*'5CU;(           %7_S;O_;-_F[_ -9G)]%_VOR?UGZ'
M_KU_H?WW^4M .L?G@
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M!NS[F4/WTHPF-;JG;+^K=V^?[M<3^\]*"=;MX0
M           !BK[_ /0=Y_M&H_L3B*M3SO? JZTJA_FX?SI9S^2J_9U,:O(?
M#GK/F707ZU<^)[L+C3:OJ(
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M,Q,1J<[NC*V\KOVNU;C"FF)PX>")6QFS?2            5?_-N_]LW^;O\
MUF<GT7_:_)_6?H?^O7^A_??Y2T ZQ^>
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M32-EAEC<G+7LD8JM<BIZ%12T3BRZ*Z:XBJF<8GAAZB5@
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MY/HO^U^3^L_0_P#7K_0_OO\ *6@'6/SP
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M;;_8&FUL>3IZSZEN+ZA9^)3W':3V;4
M          "LWNEV7V'8OMBLM/<%K_\ "+8K+912U-R]ZIZOFD>U5IV^;'*Q
M/53GPX\ M&+EG9A>=)WWN[SJ[=L.O:RSZIGUO%3Y->:ZGEC2CO/OE&_RJ5\\
MDKHXJF)L?,2N]9\3GM:C6*JB=2X4*@    T?9OYMM@_DU=OL.4"'GS9GZH&
M_=._??2H":M:?80                            K%P7_ ,1/8']HU/WM
MI#74?69_+@?/\G_N*YUI^;"SHV+Z            "K_YMW_MF_S=_P"LSD^B
M_P"U^3^L_0_]>O\ 0_OO\I: =8_/
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MO7^A_??Y2T ZQ^>
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M                           !6+@O_B)[ _M&I^]M(:ZCZS/Y<#Y_D_\
M<5SK3\V%G1L7T            %7_ ,V[_P!LW^;O_69R?1?]K\G]9^A_Z]?Z
M']]_E+0#K'YX
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M6]Q/DQQUE?CW1TH]])YKEEZO,Z5:GU/5XA.+7:KM9WUD=@K9\GQ+'_?2V6C
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M2!,0Z;_Q0?\ 8A_A,&@_XH/^Q#_"8-!_Q0?]B'^$P:#_ (H/^Q#_  F#0?\
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M0,E:LUPV^U:4%DRVRWBN<USVT5#7T]1*K6_5.1D<CG<)[J\ ;,
M
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M?'+G77BS8I[=['<KEY2U4GMU=45[_,\ED;/5?4.:G#4\$3W0F9Q=:"
M     X'H3M\QKM]H,YM^-7JYWJ//,FJLHN+[FL*NAJ:IK&.BB\F.-.A$8G'5
MROTPF9Q=\"           X=@NB,=P+;FW=PVV\7&LOFX?>WW\ME2L/LE+[V1
M+#'[-T1M?ZR+R[K<[Z03B[B$          !PZY:(QVY]P5@[B9;Q<8\GQ[$G
MX?361BP^P/I7U%34+,_F-9?,ZJER>#^.$3P"<7<0@
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MSSR>+8VIQU<>'@GI"<="W\*@
M
M                     07[FMO;5@W)I#MLTKD]OP++]K1W.ZWG/:Z@ANCK
M=;K;3S3HV"CJ.J)[I4IYOJT]+6HBIRY4)B&S]GFZ<YVICVS,6VD^BJ]CZ7S6
MY89DMYMT"4]-</8G=$=4D;5Z&O<]DC7(Q$;PU%1$ZN$$PF"$         "M#
M$^ZC<6>]X^M]>2XA==7:@R*Q7RMM^/7^CIH[K?6T4-4D=QG1S'S4L?G0<1,8
M].IJ=;E>U[>"V&A\=P;L[A\TWKN;6.B,WL^OK3V\8='DE^GK+73767(+C)2L
MK&T"OJ4<E/$K94C5[$1S7-<JJY%1&B(3 [9]MU&]=%:YVI6T<5ON64V^3WXI
M(&N;"VNH:F:AJUA:YSG)&Z>G>YB*Y51JIRJ^D(F,'=0@        K WUG7>U
MAELW/NM^68[I_6NKKDC,#U[6V^V7A^4VWVAE/'4U=<R::6E=4*]JLC:YC^IW
M0K6\(]Q:,&7V#W#;HV+F/;#IK4=\M^G\RW9@<&PLSRBMM\5XEM-+/0OJ64=/
M1U:=#E\R"9CE>WE51O"LX=R,';^S?=F9;EU_ED&R&4?QAZPR^YX9EE;;XO)I
M:R:WJQS*F-B*K6]22=+D;PG4U51K45$")A+D(        *\>Z[-^YS"*W.<V
MQ_9^(Z/U!@5B95XG5W:FH+G6YE>T@DJ'VKHJN7T[GK&Z.-(F];N$<WJY=Y9:
M,&#V7W/[FEU-VGVG&*&@USNKNAKJ.WS7*XTB5$%GB3R&U5;#15'7SYBU,,D;
M94?TQN5J\OX<@P=3[5=O;.R'.-ZZ,W'>:++,WTC=*".FSB@H8[<V[6VYQ/D@
MEFI8%6**5$C1SD8B(G6C?%6JY2)A-<(        (\=S.\H]%:WJ+U;*!<@V!
MDU0VQ:QQ&-.N:XWFJ14A3RT5'+%#_795\/53IY1SFA,1BA+8^\?9N-?-\TV_
MLEN=-E6U+U=ZRPV6XU=)34U/[3)<IX(9'TU)'!&[R*>)SD:C?65J=7**Y0G#
M2Z]I;:.^L)[D7]MN_P#,[7LJJR7!8\VQ3+K=:X+7+3RI4/@J*&2*E1D;HVK#
M,C7JWJ7H:J_5\-(E8&$
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M!FP
M
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MCBL&N+UKVV99'BE+*]U-25]-);Z;ED;U<K'/]KE>OCZ')[G2B"=2SH*@
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ML]76Z+&\$V'J6.Z7G%Z6:1].RNHZN>.*H<R1SN)4;2K[OHD<[^F4(UPM("H
M
M
M
M                                1K[H] 2]PF!6FQVG)EPW,\,OU'E.
M"9/Y2SQTUSH4>D:31HYJJQZ2*BJGBU>EW#NGI4F)P:AV]=N^<X-L?9&\MSYI
M:\WVYL>EH[3--8Z1]);;?;*)D;6P0-D1KG+)Y,2NY:GU"+ZRN<H)E,,(
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M"RNDS3:^X[S'>,UO-NIEI:&%L"2>STE(Q_K=$:S2+U*C>45$Z?5Y4B92K"
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MTLKF<KPQ$;U/\51R(TB935"
M
M                                           '$=J]QVE-(W"U6K:>
M>TN(7"^4[ZNU4U13U<RS0QOZ'/1::"5$X=X>*H$X/OK'N(TEN6IJ:'66RK+E
MERI(?:*BT4\KHJUL/5TK+[+.V.96(O"*Y&\)RG/I3D8.SA
M
M
M
M
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M!.M1.[A&1-D>U>M4ZD7T*)A=L%0
M                                                       >&YUO
MO;;;A</+\[V"FEJ/)YZ>ORF*_IZN%XYXXYX JXP3YQ#<6Q<:J<WQ'LKR+)L,
MM\\U/<;Y9,B]O=')3L:^5C(&VACY'-:]JJB>XH6V4Z= ;ZP;N,UW1;$P66>.
MD?.^AO-FK$:VKMU?"UKI*:=&*YJKTO:]KFJJ.:YJ^"\HA$Q@[)#5TM2^>.GJ
M8IY*5_EU+(WM<L;_ .I>B*O2OTE"'H _$DC(F/EE>V..-JNDD<J(UK43E555
M\$1$ _D,T-1%'/3RLG@E:CHIHW(YCFKZ%:Y.45% ^@
M
M
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M=7.E@ZT2FJ:YZ\,1['JU5\QZ\HU[O,5OB,5K(5
M
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M=;WM<U[D:]6L:C2)6OA4
M
M
M       !@[SC&-Y&M$N0X];+\MLE6:W+<:2&J]GE5.%?%YK'=#E3PY;PH&<
M
M                               \U92Q5U)5450BK!60O@F1J\+T2-5K
MN%]SP4"O6+YKGM.CECD?8\CG:QR.="^]3HUZ(O*M<K&M=POH7A47Z86VI2>O
M/;9I>\Z<DT*["J:W:R6)&TMCH7R1/IYFR><VIBJ%<Z7STE]=9'.<KEYZ^I%5
M%(Q<DQKL.T5C-XP3)F39;?,JUS<J6XXQDUYOM16543:%S7TU&K7HD*4T:M\(
MV1M3A5!BC3N#5FPN[+NNU=%?]&W/!-9:0NM>S+,\O3F+!D=%35K)J>&D:J-\
MV"=U/PSI151LSW.Z>E F-$)Z;M[=M8[_ *&Q09[;JQEUQ2I=68EE=HJY+?=;
M9._H5[Z:IB]'4L;55KD<WEK7<=345"(G!B-,=K^K]'7J_P"5XU[]Y%F^40-I
M+YG647*6ZW::E8YCFT_GR(U&LYC8JHUJ*O2WJ5>EO F4B0@
M
M
M
M
M
&     /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2227887d4-lc_reprogra4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_reprogra4c.jpg
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M# P,# P,#/_  !$(!&D&$0,!$0 "$0$#$0'_Q #H  $  @,! 0$! 0
M    !@<%" D$ P(!"@$!  ,! 0$! 0            $" P0%!@<($  ! P,#
M P$$ P@+"@D( !<" 0,$  4&$1('(1,(,4$B%!51,@EATB/5%A=7&'&!0I34
ME:5VEE@94C.STR2T5C=W.)%B576U-M:7.:&QDR7%MDA9P7*20U,T)H:G@F/1
MX:(ULG-D1>6F)V@1 0 " @ $ @<&! 8! @4!"0 ! A$#(3$2!$%1H=$B4A,%
M%6%Q,I(4!O"!D5.QP>%"(P<S\7)BTG,T5()T-1:3HK+"0R3_V@ , P$  A$#
M$0 _ ._E H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MQ/BGG[",L<6$/$TQW+I$9Y='6XCD5P)X(BKT1DX"*7T$Y]VB+0Y(Y'9KGF.
MY[SY?4(KAD_)3-N!_55$Y,^+<;I<D55]50BCJG[-%G?W,^0)/%OV;6"9W#QG
M'\QD6+C7COMXYE4(KA:9/Q7R>*OQ,87&E/8CJF'OIH8B7732BOBEOAMSE!S'
MQ@F<NYACV)\9V>Q3+W(O<+%+>=MM,:);4[CLA(RNOEO4$525"52]B41,<6G#
M7GUY9<[Y'D@>*W!4*XX=C9IW9UTC.3)O;)"[7Q+R3(L5LW4%21D-Y>Q"/352
M<1'-LEX;><TWR R?(.*.4,0CX%RWCK4A]8<1'F8DP8;B,S&$CRR-Z/(CDOO-
M$9JJ(2ZIL5*$QAK/DWVE?-ECYIYGXCM?&=@RZX6"_7O%>);;:(%Q.X2[G"O(
MPXI3D&:[WA^$!XS!EH%-Q 1% 570=+:OAORAY7L? O)W,7EQAT?CQ,#N:P+5
M9XUNEVVY7%4;:(02+->-")YZ0#3)"HBNA*6@BI4)CR:AV_SY\VN7%O&7<&>/
M%OG<?6.28+I;+C>'2V(CA,.RFI,47G$#15".T))N3Z16B<0W%\-/.2R^3973
M#<FL36$<K8_'67*LK3A'"N,4"0'7X7=_" 31JB.,FI***)"9IOV%9C"I/(#S
MWY#C\QR?'WQ8X\B\BYW:I)P;Y>9C;TMGXQ@565'BQF'8Z(D;31U]UU $D--N
M@[U)B'PX;\\N5[-S+:.!_+CC2'QUDV3'%CXW?[<V[':1^:7;BI);<D2FW&I#
MFK:/LN;0--I#]<@$QY)9YT>:/)'B[G''-@PVQ8S=K/E5M>GWMZ]Q9LB2WV9*
M-*D=8TZ**>XJKH0EUH1&5%\G^=?F=:K SS+C'CW Q+@9\V';1=\BB2)DN1$D
MF(1WYA,36"9!]5'80LB'OBB..:BJC$-K+3Y:9IR?X<9)Y$<1XO:FL]P]F0>0
M8?>@D380N6HFW+D+11WXCI)\(??;7=KZ J*O6B,<4G\'O**Y^47&-YR'*85J
MM.;XO>7+=?[79FWF8J,.@+T-]MN0_(<%'!4@75Q=2 M-$Z4)C"E,>\TN5N1_
M-6X^//&U@Q25QECEUD1LDRF9$G/W$(EH:1+HZ#S4]IA-TH289+LDFI 1(2:T
M3C@BF(>2-TN?VB4OA$^*>-HEO;O=\B)R#%L1MY4J1+'*EHXMQ^*45-Q6^V:]
MKJVI#TUUH8X/5Y1_: 9YXZ^1H\;ABE@OO'L.TP[C/4F)?SIYR3'<-&69 S!8
M#<Z(BA$P6U%5="H1&5A^*WD5Y1\@93GLOR)XQM_%7&F-XT61LWN7:;E:76D<
M<W- CLUXP<:%AMXW%44(=J:Z:Z4)B&N-W^T6\A^8\UO>-^)/";.1V&QZFY=K
ME"E7":ZPA*+<EX&7XS$,7=%V@XIDNG0M=10=/FMSQF^T)OV:<GCP3Y%X(SQG
MR7+EI;K/,CM2(<9R>J:A!EPYIN.QW7>G:)'"%PB040=1W":OMYF>=/('C)SM
M@N!6?'L=NV"7?'[7?\HE38DM^["W(NDZ++"&;4^,RBHQ%16T,%]]5W*H]$$1
ME2_*/G7YN81;[9RI+\>;3A'#EXDM#94OD65*E&Q(U)E)K[4QDV3<%/<(F&QU
MTZ%[1B&W>6^8LZ5X17'RKXYL,!B_1FH )C-]1Z7$CS#O<:TS675CNQ7'!'N&
M39"0:^X2IZA1&.+5+&//7RZYBXVB73A3@*VY)D>.,RSY/RIJ)**TL/@^\Y'B
MVR*Y.1QQU(:-&XBO.FI$J"VB;=2<0^?&/VG/+/)V+IA6(\',YEY#S97;LL*U
MH\-@<@BV1N39#9OJ\TK2H@D"O""[MW=#ZE#I2W@/SWYJ<\@K?X\>2_'EJQ?(
M+S-"UQY=M9>AR8,^0RC\09#3DB2T\U(0@0";4?KB6I#0F%W^8_G"?CW?+!Q?
MQOBC7(',64-LNQ+2_P!YR+!&4XK,076(RB](>D.)H#(&"Z>\I)J"$(C+6V/Y
MZ^4_!N38HSY;<(0K%@V7&O8O5IC.QIK()L1PVU29*8=)E"0B8)&W-%^LG2AB
M/!M5YL^5>5^/?$_'W(_%<3'<G#-[RQ%9D7IF5)B.0)$!Z8T\PD65$+4M@JBJ
M2IHOI1$1EJC<O.KS'SSC>'R9PWX^PTP:P69E[-\XG0WY+4FX16!^;.6V*DUL
MTB,/HX*:*^2".IF*H0H3B%_^//FQFGD+P+S#D^-X)#+G#BNVJ\QBD-J3*MUT
MD2F7W+>3#".C(T=<CN 32.J2;45#][H)C#CGP%RCY#8=Y'YYG'%W&,?+^7;Q
M\]_*?"7;9/EMQ/BYX/3](L:4R^'9?1 3<XNW70M5ZT6EVT\S?)#G#@3&>++I
MQ7@-MRVZY>4P<IAW"UW*X#$6.S&,$ ($J.3>INFB[U+TZ>BT4B,MR>/KY=,F
MP+",DOD0+?>\AL%MN5X@--FT#$J7%;>>;%MTC,$ S5$0B54]%55HA2/F7R;<
M^(O&?E?-K%*.%?X]L;MEBF-$@/,2KM):MX/M*O[MGXA74_\ I:)CFYW_ &5?
MCWQ]D&#97S7F..6_*<D<R!VQ8R-T8;EM6^/$CL///LMNH0HZ\<E14U3<(AH*
MHAGJ3:6XWE)X(\:^1[>/3;><+C+++3.WW/++7:VG7I]O,#[D5]H'(R&7<V$#
MADJA[R(BH2I1$3A'_*/ /S5_9\9UQR.0SLJ:P[&[;;(M]N2-C)>89ND5&1-&
MD041MO:V/MVBFJJNJJ(YJ=^S!XSXWR[QNG77*^/\:R>Z#F5T8&Y7:TPYLA&@
MC0U%M'7VC+:BDJHFNG5:)MS:^_:A^/& \5_FYY?XPL$3!)5YNCUIO]OLC8PH
MQ2VV_BX<QAEG8++J=MQ#4$37W5Z$BJ1-9;#>3EIY(\IOL^.+LQQN&_><MC!8
M\NRVT0Q7O7%(D&5"N"L,AINT>>^(0.ONAH**2)1$<):DRO*7QD+P2:X/CX::
M\J?(V[45H*T@(C>4= G+Q\<B;>IHKJ+N[BE[BB@]:)Q.733[.SB[->*/&FQV
MC/(;UJO&0W:=D$6QR.C\&',1H6&G1Z["-&E>4?4=^A(A;D0K;FW=G08-T@S+
M9<X;%QMMQ8<BW"WRFQ>8?8>%0<:=;-%$P,55"%4T5.BT0YI?:+<6<8XOXI9Q
M><9XXQ?';O'N-D&/=;99X422 N7)@#07F60-$(55%T7JE%J\V&^S5XOXTROQ
M@M5WRCCS&<DNIY%=VCN=UM$.9(4 =! %77VC/0?8FO2A;FZ@6JTVNQ6^):+)
M;8MGM, .U!MD%D(\=D$Z[6VFT$!3KZ(E%51^07.N)>.G&5WY+R]MZ9&ANM0K
M/98RB,BX7"1N[,9HB]T=4$C(E^J D6BZ:*3$9<J&/.CSRRG%;ES-A_ 5A_,_
M;$??*8=NG206)&(T>=5[X]EY\6MI(;K+2-CM75$T*BV(;]>-_F7@G.G#.4<J
M7EH,'D\;-.GR7:77>^W"!E@I"2F#04(V7FP)011W;A(-"VH1%9C#2&%YY^7W
M.M_R.=XO\"V^YX'BSRBZ_=([LR4Z.JJ"2'TFPV!<<!$+L,[C'7ZYIH5$XAMS
MX:>:$;R6'(<.R[&QP?EW# )Z^X^UW$C28P.HPX_'!]5>9)ETD;=:<4E%5%=Q
M;E0")C#GQQ]_XOL_^<N3_P#NQ/HMX'E?_P"*#PG_ #EXY_Z38H1R=]:*.7_V
MD7D#<N"_S,_+^,^/N1?RI_*+O?EW9CN_P?P/RS;\'LDQ^UW?B%[FNN[:'IMZ
MEJQE-O+;RHSWQVX'X@Y#P3'\9E77,Y%NA3[9=(DHX$=E^UN2U&*U%EQB#:0(
M(HIDB#TT]M"(RUGROST\N[]QZQR]Q1P+;HW$UAA,'D^=7>))D-S);""U/>BL
M!.9<"&$A3#44=44'4W15#$1B&8QS[1#G?G#$K98_'?@%,BY9@Q2D<B3)"D]8
M[:&]08*+K(CD12$$B$7G1V*FU$>T4D'2M#PK\Y\SYRY!R3ACF'#[?B_(-BBR
MI,29;&WXK;AV]T6)D.3$D./&V^VI*6J'M7:2;144W"8PKG.?M%>4L$\EN1>&
M@XUM&;VFQSW[+@=DLL::%\N=T<1H83+KZRGFD%3<534(VNB:"FM#IX(5/^T0
M\G^$N3[+8_)[AFSXYBU^!N8Y;+4P\U<&8!F37Q$.04^4P\H**J;9]55--S>M
M#IA]N2O/GS$QZU6_F6T\ 6S%^ [Q):'&YV0QI,B5,BR=RQGI+K$UDFN^"(39
M(TC>JIH3J*BD,0WAD>53^1>&EW\G\%LL2+>(M@DSV<<NRN2HT>X0I2PY$=Y6
M#CFX". 2BJ$"D.TNFNE$8XOQX+>1F;^3G$F19[GMKL=HO%HRZ78(T:P,28\8
MHT>! E"9C*DRC4U.4:*J&B:(/NZZJHF,*7Q;S2Y2O?G=*\7Y=AQ5O 6;O>+>
M%W:BSDO':M]GDW!I5>*<3&Y7610OP&FW5$1%ZT3C@C/E'Y_Y_P"._DE#XT:Q
M6P7OCJ-#M<^]'\++<OKC<L2)]N*ZDYJ.AKIH"DRJ(OKK0B,PJCE#SN\W^*I%
MESO./'NRX/QCD$M&;+;+I&EG(,3$G0CR9@3$)F2K:*J;V&_JK^"]TJ)Q#IQC
MWD;@%V\>8'DE<W7;#@[U@6]W%E[1Q^.;1*P[#'3:CKOQ JR&FF\M---:*X<P
MHOV@7F'S3<[[<_'+Q^AS\)Q][8ZX];YMWD]$W"W(DM2(K/<,="[30;TU^L70
ME+8AM)X>>><;R!R&?Q9R/B[7'_+]M"0;-N8[H0KC\'K\4TTS)57F)#&A*;)D
M:[1(D+W2$2)C#G'Y)YXUQC]IY?,]=LLW)%QJ[XW*CX_;1W2YSZXS;VV(S*:+
M[SCAB*:(J]>B$O128Y+]Y!\]?-;A:]V3).7O'VQXOQ_DCRC:[,\U);?-M-'.
MS\Q"6^+<E&_5'&4]J]I-.@Q#>CR.YTA0_#.\\\XMC-CS"WW:SXW>;3C.7P5G
MVUYF[7*WMH$V(#K6XF1D;D1#3:X*+UTZE8CBK'Q_\J;;;/"[(?(?,<'QS$X6
M,3[@VN(X/ 6U07W_ (EF+%;;9<=?V&^\\ F:DJ)KNTZ:43,<6ON.>6GVBG*^
M,O<L\5<!XI,XR19+MM#:DA^0U!=<!X1;=NT>5*-";)M>PP.Y4T =U#$-J?&G
MR\R_R%X>Y'R(.-'\?Y/P2T/RK9:QCRGK3>I!17G810E+MN%O>:V&RCA$B**H
MXN_W2)C#B1Q_RCY#6;R[R'DG%N,8]XYYFW2^R+KQR=LGO-,RI;3PSVTA-2@D
MCV1(U1%>51T]Y5HOX.Y/D+YE0_&WA_CW)<SQI+GRUGUHC/1>/F3*$#$WX5IR
M>Y(5SO.,L1W7$#:NXR)4!%Z$8E(C+1>1YY^>&.8_$Y;RGQ\M#7$TU&'_ (PK
M+=8K"1'R%&G1E%-<-I'>FQUP%;)231%W"E%L0ZA>/_DOQ_Y!<4KRG8WEL$:T
MB\WFUEGN@KMFDQ6^Z^+S@Z";7;_" ZB(A NJH)(0"5F,.=<[[07R0YOSC(,<
M\0N%XF1XWCBH;U[N\9Z3*=9531M][_*HD:(+VPNVV:D9;>BZZBA/3YKL\2?.
M_(N6N2+GP1SCA$;C_EJ$LL+?\$#\>/*?@"1RH3L24XZZP^VV!.)^$(3$2^IH
M*&)ASHRCDE_B/[3'-<^A8M<,WN=HR6]QK+B-K12E7"?<K)(M\*.&@DJ(;\D$
M)1$E0=5$2705)\&R&8>?_F)P9F-B?Y^X&L>/X;DSAN6^SL-/L2#C,D".C%N"
M39;2O-B8J8N!ZDGN@A)0Q$ND/.WE%@G!W"D/F:<V[?8F21X98)86B1A^ZR;@
MQ\3&;W$A=H.TBN.&HKM%%T0BVB16(<V&_.?SQ_)%WG%> + 7"J+\1\6L":.D
M'N(*/B[\?WU'_P#+]E6O4M-/0MB'07%O*JR\G^*V>^0O'<)MB[8?BU_N,G&+
MKN?"%>K-;G)BPY*LDR3K2D@$A 0*;9(ON$N@E<<6AG%WVAGE/S7B=RL7%_!=
MDS/EN#<'GKE.M\>4Q8;;92992*3P2;@JE)=?[^FZ0 [0'0#7=1/3#X<:?:@\
MJRER;CK..%/RBYO:F?*<'L&/,R(@2;F+_8?B7*,\Z^\T;*H1*K?KM4"%OZ]#
MI>^S?:#>2?%O-&.<=^4O$]DQ:U91(B$X-O9>BRX4.>^K#4QAU9DQF0RT:$A#
M]9=I)O0DTH=,+X^T=YYN/!MEXIE6_CC N1%R.;=FG6<ZLYW=N*D9N*2%%$)$
M?MD?<T->NN@_10K"P.;/+J!X]>-/%W)3V*P[GE>?V6T-XOA\'6%;69$BW-RG
MET3N$W&C"N@@*J2^X&J:J8D1&9:DW?RN^T@Q##6.8\HX$Q).,GF8\YTF65-P
M(<I1[3BL,7AZ:T*H2>^XUH.J*2:43B&R>>>2O)'(WAG<.6^*.*IB9A>4<L^2
M8-=X,R64**X!MSY+*LE$-UH&21UM[ZNB^\.J$*#'%RT^S@Y&YSPOD2=8>*>/
M&,RPW.<CQ&!R]?7;?-F%9+8DN2TDD'HTAEMA>S(D'N>$Q_!ZZ:"2*39O!Y ?
M:)<D<'^4.:\1#A-@R3!L;CQPM;3$::E\ESKAC[,V&TKXS%902N$@ +;&4NUJ
M@HIZ+1$5S"(S/,CS^Q?C;D/DC,>%L5Q>W8'/L_Q\7(L?OD%\XEZ-YD#C"MQ:
M[@,.@V)JO5.XFJ]-$&(=&/%3G;]83@O%>4;DS"M=[DI*AY= A[PBQ9\%TFW4
M!'7'2 #! =%",E033556B)C#5?Q'\R^7?)WG/D'&VL:Q:V\-X<U.FQ[S&B3O
MFIL.2E8M+#CYSC8[KH(3AJC"(J-GM0=4HF8PZ<45*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0<7?M,<^N6;\A\7>.N)[ILX'X]PN4!LNC
MUVNQI$MD==?0@;(B^C1Y/HKZ7Y)JC7KMNM_$1QG^/L?-?.]L[-E=-?XF>$?Q
M]J'^>/ P\$0/'SD3C]2@)A]O@XI.O# ]LDNEH3XRWSBTU_"OJ+Q$O_$2M?E7
M=_J)V4OXYG^4\)C_  9_->T_3QKO3PQ'\XXQ/^+L5P_R+;^6^,,'Y'MFP6,L
MM3,R1';55%B4B*W+CZKK_>7P-M?_ *6OF^YTSIV6I/A+Z/M]T;M=;QXPLBL6
MQ0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*#B[]L9_U;X'_YSO\ _@8-%JNF?C+_ +MWCY_LUQ/_ *'BT1/-QT^RN?:8
M\G.:(3SB-2WL9N*M1C]TR[5YB(YHB_W.Y-:+6Y/#]J;=X4SREXFM4=X7I5GQ
MBUK<$ A+M'(NTLP;-$742V(AZ+^Y(5]M"O)+_MC/^LG _P#S9?\ _#0:%6['
MGC&CQ_ ?.X[# -,0[5B(16A%$%L1O5J 4!/9H/3I[**QS87[+)EEKQ2MQMM
MV<C*+RY(,11%<-#:!")4]5VBB:K[$1/91-N;27['O_63S%_-J!_GBT39@?LQ
MGHUE\M^3+1GCK3>?2+%>H,0IO1]RZ,W..=P;;W]>ZHMN$O[K:)^S6A;DV'^V
M#N6.IQ]Q!9WG8Q9:>0S)EO8Z+)"W#$5N42>T0)TF47V$H_\ %Z$55SYAQ+Y
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MQH[<8\9]O:$CX%C=HT^>H[M%54Z:[:(B81GSVQ2X8+X0^,&'7+(K?EDC&[K
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MAMNNEIO,NWB3<6<#EM-YB2+1*2M&J*0F**HZCN'1"V"1,8EJS]C7_P#$=_\
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M=OB:[8\>$_Y-?D7<9BVJ?#C'^;KS7SKZ$H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H%!I=YC>(7ZV=MP.W_G"_(#\B9,
M^1WOE/S7XKXX& V[?C8?;V=G774M=?9IU)B<-F>,L-_-SQMQ]Q[\R^<_D)C5
MIQWYOV?A_BOE<-J)W^SO=[?<[6[;O+;KIN7UHAS0Y.^S+NLWEVY\K\&<W3N)
M9E_N4FY38S+,@)-N>G$1RBM\V%)CN(!J9:-*@[47;O5.B%NIYLE^RELU[G8I
M?(_.=X<RJWO%.SC*;[:RN\R^SB=;-'5,KBPK "(;1%5=+JJD94.IL'YC>%/Z
MV=RP.X?G+_(#\B8T^/V?DWS7XKXXV#W;OCH?;V=G330M=?9IU(B<+PY[X-_/
MAP-D7"/Y4?DQ\_C6F/\ E/\ !?&]KY7.B3=WPOQ#&[N?"[=.ZFW=KUTT41+P
M^+7 /ZM7$\3B_P#*S\M/A;G-N/SSX#Y=N^,)"[?8^(E:;=/7N=?H2A,Y4?X>
M^#GZI^29CD/YT/R^_*RV,6[X/Y)\J^'[#RN]S?\ 'S-^OIIHG[-"9RB_DC]G
M)A?,^;R.4L"S29Q+R%/DC.O,N-&^+A2Y8:*DH6@>C.1WU5-Q. XJ$7O*&]2)
M28LKOB_[+Z*SFT'/?(;EB=S)-MIM.,6 P?[#Y,%N;&;,EOO//M)_]B001?12
M4545'4V^\N/&4?*;C2Q<=!F:8"%DR2+D 70;;\S0TC0YD1(Z,)*B;=?B]V[>
MNFW3;UU0B)PN/B' /S5<7X#QM\V^??D/8X=F^==CX7XKX1I&^[V.X]V]VFNW
M>6GTK1$K&H-!.5_!S\Y_E#A/DC^=#Y'^1USQRX_D9\D^)^)_)^4W)[?QWQ[6
MSO;-NO9+;KKH7I1.>#">6_V?EO\ *+D.T<AQ^3/S>SH-C9LMQAI9/FB2_AWW
MG6GU/X^'M)!>V*FA=!3K1,3A87DGX<6_GSB#C3B"TYO^;^U\:/PBML[Y7\S[
ML>#;SM[3/927$V>Z2+KN7TTT]M$1.$MY!\:/R[\3X'C!^6ORKX'&L8QW\N/E
MO?W?DX[ =[_P'Q3>G?\ @M-O?]S=]8MO49XO?XV^-\#@+A9SAFZY"UR):Y4J
MY.W*:_;D@M28]S]UV.Y%61*11VZBNI^\B^B4)G+1'*OLL+I9LNN5^X#YYNG&
M=EO3I#(L+C<KO1(SA;B9;G1)31OMCKH .@BZ(FYPEU*B>IM)XE>#N%>+LB[Y
M.>0R,]Y%OL;X*7E$F.,1F-%(A<<9B1T-XA[ABBF9N$I;1TV)N0B)G+R<.^%/
MYIO)GDGR+_.7\_\ SA2<AD?D=\F^%^#^?7$9^WXWXY[N=G;LU[([O7W?2A,\
M&W?(7'^)\I89D& 9Q:0O6+Y-&6+=;>:J*JB$A@8&*H0&V8B8$*ZB2(J=4HAR
M4N?V4^7V"?=XG$WDG=,9P^_FH7&RRXTAM]8^A(C<@X,MEJ6J(NGO--IU7I])
M;J;P^*OAOQWXL6RY.V*;(RO.,@9"/D&;SFA9<-@"0TC18X$:1V5-$-1WF1$B
M;C+:""1,Y4QY'?9Y6?E?D0N9>*^1)W#G)K[PS+G-B-..1I,UL4$9;1QWX[\1
M]4^N;9$A::[$-2,B8LCO#7V<"X_R=:N8.>^7;ES;EMCD,3;7#FC(-I9<718[
MLN7,D2'Y(LFB$ : .HINW#J%";+*\PO!S];#),.R'\Z'Y _DG;'[=\'\D^:_
M$=]Y'>YO^/A[-/331?V:(B<-I^;N,_SR<3YUQ?\ ._R<_+2V';OGGPWQGPVX
MA+N=CNL=SZOIW!_9HB%6>(OC1^JMQM>^/?RU_+OYSDLG(OF_RWY7V_B(<.)V
M.S\5+W;?A-V[>FN[3;TU4F9RJGS \#[/Y5Y-B>8,9\O'E^QZVO6FYRDM"75)
M\7N]Z**I\9#5M63<>ZZEN0_W.WJ(G#</C' +/Q7QYAG'-@U*TX9:(MJC/D*
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MB"*"(H@BE$3.5OT0H+R:X-_6+X@O_%/Y4?D=\\DP)'S[X+YAVO@I3<G;\/\
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M-_\ Q=3Z1W7N>F/6?5^U]_T3ZC^T"\1?TM_R#?\ \74^D=U[GICUGU?M??\
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M]7[7W_1/J/[0+Q%_2W_(-_\ Q=3Z1W7N>F/6?5^U]_T3ZC^T"\1?TM_R#?\
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M-_\ Q=3Z1W7N>F/6?5^U]_T3ZC^T"\1?TM_R#?\ \74^D=U[GICUGU?M??\
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M]7[7W_1/J/[0+Q%_2W_(-_\ Q=3Z1W7N>F/6?5^U]_T3ZC^T"\1?TM_R#?\
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M-_\ Q=3Z1W7N>F/6?5^U]_T3ZC^T"\1?TM_R#?\ \74^D=U[GICUGU?M??\
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M]7[7W_1/J/[0+Q%_2W_(-_\ Q=3Z1W7N>F/6?5^U]_T3ZC^T"\1?TM_R#?\
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M-_\ Q=3Z1W7N>F/6?5^U]_T3ZC^T"\1?TM_R#?\ \74^D=U[GICUGU?M??\
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M&_\ XNI]([KW/3'K/J_:^_Z)]1_:!>(OZ6_Y!O\ ^+J?2.Z]STQZSZOVOO\
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M^K]K[_HGU']H%XB_I;_D&_\ XNI]([KW/3'K/J_:^_Z)]1_:!>(OZ6_Y!O\
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MR1[R=MT.T)>)^(R8[#BD,7;*1S>J"I#KHRA!N71$W"B]?2I_03[RN6.MWE9
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M"0&V.ON[=JH*JFE1\"=,6C[DVVQ?DS&137KA.A+!;8?.)\2L"X-F2*P3/4=
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M89\]S,Q'6-"(R5"@(38=L4,D[B#N15UU44JW<=Q>]8B:XCS<]M,TATPKA9%
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MN7)F_P .(+T98HJ;C($\A)KHT.T=?J].E3\6/)::+TQW((-QGRXL=UJ%\S_
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M(2$M4+=KM0=/>5=-%UH>+DFQD?(6,_9^\,X?;Y-PAV/F+E&Z0980'AB2)MF
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M*CM3:HEJ2C*6<+^)V&\09I>N39N89=RKR;?(?RU[.<VN/S&9'A;D58\;0&T
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MQG$HLZZR&&X,Z VRC2.NAJ126'34G-BBWTZ]?II7MIKQRCJSP0]BWW2U7,)
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MH[]K>U-JZHI?17G=OIO39,6GV79;?%XXPD&:V/D3();4#",[<X_8B7-NYWJ
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MK,W6"LNU+;<9O*C\FA/-3;?&E-A*)WW!5QP21=Z%MT+<*=%]*I2;8F;(2;#
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MJ*B^FE8:=DTS$PKB& O5BQ+/+?'BY9)8L%QQZX_^NWH(]I2D/ F[8XX!$H.
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MCAW5WJ)[E-= 75$3WM46L-FZ;6BN.;HU4C&68R]W/;X\TS$;D);K<+5QAK:
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M]W W8\RT-@R9.&T#+8$;SBZ"JH2*@B/W-:];5FVJ(KS33A/%AT^40;9<I$*
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M@Q7GV$6+'<0546M-44%%$Z5KPTS$J6;X\"("<3XH+:OJ ?'@"2$5'109\A$
MD75?=TTZ_17F=[;JVS/W?X0FO)<%<J2@4"@4&@W,..S[YGF6OL92L>2RV*6V
MT-[A./H "1N(A:J#FG141-%Z]:[^WM,0UC&%86ZV7.WPX48+C N!-W!8SDDG
M^Z(N&B]]YI4 =AB7HFB^B+6^R(F.KR4XS*?0K5<,>O-YB'=KG<[;<&15FY]M
MLVV'"%1W*:N(OHG5431?;I4:MO5"]HPC H_=,MN\!)\=E6;>4.'( 3C;$-=2
M-XVR(%74E5%3_@J+S.OC$95I:)GBPXR+_;\>M=LF?$NBQ)FMSA@NHY&?V@B=
MLP=,5>)0]_HNJ+HO732MM5?B\^"M_L1^QN7]6;E)QZ\/A;8;;"*W-16]C"N;
M1)L=RAJ6I:HNWT]%5>F]M4:YQG*M,]/%(<>'(7Y\;)[;;2%B*[(=>LS(*LJ*
MJ.>_'878PA-B"[DW)[/3VUS[^1KYLYB-QN$:)=[H].>>:RB4PU;)"-. XWL0
MP_#-"NH$N]17151?ITK/N*Q:L=/DM*4Y@5QRBWVC&K'";*V1KCW9-P/N=H'X
MNY"9>]S<&NNHKK[*IHK%8G/,0*XQ(UO4)]R2,]+GSWXD:ROLBQ[@"B;VCW+O
M%477KIU^FNJG+B/FYC^72+=C[)-&]:F3]Q\B;C#&;[Q$J(@JK:DFG1=>J=*B
MLTBQC+/6ABR0+PS;KM=!N$EPWBN$AW6,O;5O;M7?O':B%UT5-5]$6J[^,<%*
M<)8FY<+QXUT/-<;RJYQ'6$ ;C!:)7V9+ "+0(TB *Z *Z:5Y^GKB^'7UQ,)*
M$<KY#>L%IG0+M;S!M;I DMFW)VJ@IJX([=3)>JDJ(FO71*[=7L7S+FO:<\&/
MM>+!"C2KHEWG8Y8B?%6;=,9%M&B:U91#U=1-I[M5)/6M[[HMX)0BU6F\VR*A
MW&!#=LD2>Y\&*H!F^^Z""3S1$O371%1?96M=L8Q@3/'ABM8:&*7R*1PI,:;(
MF&KS;K32&ZCK7=<Z(V2[A(0ZHB^VN39$S/!;@DYWM9<%ZQ66YPFKK9&P^.AF
M&A%$9119:4]5VH2(.JJM(I,1Q1./!X,D-S\CRBS$CQ/BG7&HT9M5DR#'X<G6
M>WUT1=PKKKIJG1*OV_5U>UR0K#$+E;F8]U>RMPI,4XS;3#[+2/[7=I #ZMHH
MD&Q!45Z:^G5/2NG=6O5FH^]ARG)[ACD*TE+9B-,RWXT)]\.XLDAU<4355]J;
M=/=3_P G7/IBPPKG'-UOMW>R0;W-C):^XMW@6=1,?B59 6@$445(VR3WA0DV
M]42L^K!U93 ;-;LD:2%G'(+T:7DB(QWK9)=A$AB/:>&,^JBNB]%$B1"%53VU
MCNO-Z36/%>D<<HA8\-BOR[WB$*Z29TNUQP&_2E,'79;#8J(;72-$<-%5%/4D
MT]*VF)KK]I79:,\%CSL6<^:,6NWXY!M-B^6@%\R8A!M]]%!"-IX@37J((G75
M4TZ+6=JUZ."T3,QQ06-:\*MF3+:)UU1>RPT;SY(JQW((BJ1T%[555T-FNJZZ
MHJ)KKK6W;5]B6=F4MEZQN# N4=+ZY)@VF.<N-<7V&7!$G5U!4;$T3NMH.B(B
M^\G5414)*1JSQ(G@]++%COF-OR;=>WK/+>V.W2Y.,*TY,4FVT-X6T7;VS4MR
MZET5:=.$]3!M6*^AG$+*K?ELO++(EA.WW2QR)#007VR1&))""&X0N"B:IHBZ
MKJG2N:W'8VC_ ,9(M]@S?#X6+,/,#"&XNR\GQN\/;S<CBB#HVZ*=4;Z$@JB?
M3[*WW:8F8SR9:+=.9?UARQ7*?-C6ZQNK'!EEAMU@PBF)151'(Y(VKBJV8KJB
M;EZ)T]*TKKI2."FR9M.681Z589$-RTVEB[V&)<78]\EB6Y].SM_!.=[H2$*H
MFFGH-4KLSE,YGFC"W:XL/WJ\6:/:[MC\^434XGC)?AVW20XPNBXH]O1M4'<B
M*FJ*JJB=*Z*[%>E]3>-A]^(S(;D,R/F5PAP[B:&Y%%IMUTG&2;4T45 =J(G3
M1=?8BK6T9G*T<F"?)B'E5J?A&,B[FTY,R)'']JJ)LDJMHJ(6U43W5-!^A-/;
M5XK5*<0,2G7&TM2W+Z33,<#=E6Y[;)=$66R-HQ/>NI:*A#JO3JGMZ4OO^Q6J
M13'+\Q/B.V*6S=X$F=;FT1YQ=T8HJEJXX8*J"IJ0":::^U4KFB_5.,+SR?;B
M60;_ #798[]W9B,-W61+B66#'567'#9DB7<>7HA#KJJ)K_P5?N(QJEG#I97A
MK% H%!5W,5R2TX)<9?;1XE?C,@TJ(JDKSHMZ"BJB:Z%T^[5]<9M":UZIPY>W
M[+8^/Y)'"!'EW;$'";DW^UVR,X\ZT;JBC<A(ZHI'M)4U][1$UKI[KAAWUT1C
MFNJPW>TY3D5FR2&;=C=*.\Q\JEM=I]YH5)S<H:;15"+547K^TG6+1.RG3X.>
M\32<0J[E*Q3<@M-VN5^BS)>,V\&WR*RDL-TY'Q*-_6#0OHZZKZ5CLZ8U]%5Z
MVE.[S"DW-UK,)MU:MMK#X08S+,=7I3$AT6M&G%%M?0ST)47[M9QMG56(F.4+
M4UYGFJ[,<H9B99>N/ :NEJO$,8]QD28_;=9=:<%7=[A@HZ+UTU0=->GK73H[
MKKX3"-G;>.5Q/W^VY.&.GC>(.39-SG[,@O"DD<8@Q-$><<[I)O55+5$#7714
MK+N+UZL04K,0^E[G'C=\)V3'8'X]LIMXG,/?A&6Q71E&V15=44DZHNE=?;Z(
MM&98VVS640Y#P[-<TAV:]XWD\4 N=ODQY468 L@K<EP7'G64;$='10%34Q+[
MFE>3WW;WOLB,\'5I[B*\9AAL!MA8-QN_C<NXNXW8VI0I&NSV\G'C<70Q,10E
M #%-=41:]#5VWP8BO\U>XW1LGJAD[G9H60):YQ6P8%@P593+=RN8&V1,O O=
M<$]%5=235%1/W25MLITL]-^I^<5"2W;+Q*QZ#%:<V.!"O!*;CDAI%$2:-%7W
ME(41-5'5-$T5-5ILK\.T%O:2O#GXUG&_,O0PCQ+NS'^*MB.FLAKO-N(NB(FO
M4DU33JE:;*]<Q9CRG#%62%CT*T7![+L9C6NTV1U0CR)#3SLH@(C5LVR5=ZD:
MKZCHB_0B=*Y+YZN+;JF(Q"*Y>D:;<7H;/_JYV[1GWMS<=Q7.['1Q4<;;U%%3
M1$1$U3[FE=EJ=>O@IJM-+3-O%##XVP^!@<"X_-)UR0Y(K>QO\8G');ZH2D8
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MZ:)^Q5>[ZK3BK*OO>:H,NND.:[.R^Q6N;=;T3$AABW-HD)Z8ZSM;%L%-51H
M155PU7IZ[5K>NF-=./-K&RLRP/&EO_)^QVV\7.S7'%X>11W+5;K8X[J8RY#N
MANKL(DT'0RW:HJ_17';37.<2WS]JV;7:W[# NLU8S-TNL-AP+DZLI9#RF+@
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M['D,@V).0S0_PGX)=31Q=41/72LXK.9E7=MS3I\G4:K.(H% H% H% H% H%
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MV=="6LM&J=4V^W#79L^+$9\$OA9:;DQ0"\2I+]O?;>N^/1&O=EM*N[WD)5$
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M-55"%=477I4=Q?PAC%>+5+EGE_+W;Q+P._\ %/SC&;)>&HT=^ VVZXL9Q7$
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MET';KZUE35%+\VDVFT<G]#&8EVB3+O>HS.4R<4G.0+&EOEZ;XK#C+C(NDFB
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M! 5?>5!5>J5K6=F?L1,88R1>LWL]ML'Q#)1[/';8)RVM,J3AM-I^&A I)N5
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M7K5-VJM>,21$L=DL<,<9QQH":OMKB3VI"-QF VOHYHK8$X&XA7:*H*HNA?\
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MO\E%MO()1+KZZ(T7IZ43/W.J5%2@4"@4&@GB?_O%^=?\^++_ )I*HF6_=$%
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M9MMPU&E0^.,?BSISMREL.3P?G/ H&XJ3I'5455_81=>OK7!NG-Y4GFL^LD%
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M5_873U6K:YF].FW#[U-NSV\UXOG*;R&Z2'+1=G4E1P868U?X3BE*E$2[A 6
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MN?A7FL<G3ITQ>O5XO7;<SO%]BXA=KK=W<$^8PG+I.>.(#HW(9!$+8+JWW5;
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M))PW&7HE]88N<V2!N"^2J8 L<-$]!147V=4J8BHG&.95;6KM;[2MNBVF )?
M+&<;(B91Q$)DQ77HKBDBKU7KZUGW?;=41,2/[!8;GW&X2<>L[]O*Q3WV68S.
MJM7)YT"!3<WJNU$U4UZZ:>E1:/AUB)E-:YE*[/"/#+/?9MKB1[D\R RP:BJ3
MK_?<04=5PBT71-J*FGHB5SUB-D\VFRO1".S+#+E1H%WES'+?E.17!EP&H:D:
MR(J*C@@Z(^Z&U2T)572MMD8C$>#'.7AN80[F-TNTZX-6^9;'9C$"!'4/PLAG
M4]VT>BFA+NZ)N33UZU2E;?R3#/8[<+;:XL>-#MD^\OS(H2YM^!=S@ Z6_:FY
M=V@KTT]5ILM$<(7>_D:V.78+;C_X,<HC1R>:D%'<^&5IX"!QL57W4Z(J:&OW
M%J_:5XSE66,LU\R&T2<?QZSVZ"M@@ W"OG8,79#$@QWD7;W&B:KK]SI6NRD5
MXH8)C#LNL#LJ3>!3*!$D=MMP8?1N7JXZO:BFJJA:"GO%HFFA:)Z52=]>E:&9
MR,6+3<[?*OKA,2[\"-"XC:/PX5P:1$'W]%1.OM)*SIQG@/7:K[;TG/7V)MNF
M5V>,L6YVY4;![>X*F  JH(KN$%551>B5;=2544RRVWV8D_)V,48^<3!283#D
MS>3,=M%!7%$G5$21!]E:=K$1;VN1G#-V_-;1:PB6N/ ?O-P;@DZ]<(@*I(HM
M]P&NXFN[=Z:Z?<K#;HF;YCDCJ;R<.'*<XXQUV;'*+)>6:Z<8Q42!#F/D(JB_
M0*I7%W/_ ))_CP%FU@% H% H-%^7W[RF99*\D80MEGGQ)4=]8X'W$5AM'4$B
M1>NJ::III[5KT^TB(K"\(*U&.5=;F3ER?MMPF?\ K)B'(!45R,^(J\C1@.U4
M0B1--?9]%:[(C,2E%YD'(<:CW1^0]=V#!LX424]J;3K0DAHXH$B*NHZIJ*::
M5/"Z'D9OMA6T1(\>-)9OL9B2#LJ06H;$5"1$0/=)"3=HNFJ4^!T\8$A'$I1V
MI<@LLAJ#'EL-G.BNR#9.0&W41W.:)T55Z^W72LYVS$X'OCW"Y6.Q25L$QB%/
MQI6UO-N,5^'[SZHO;(Q%!-0%5W:+T7UJO1\6V)2SMVFCR4=NM=HDJPTP@29+
MT<S0VRV;FP<0@3<W[PJH]55:O?3^FC,"'2HF6L1[%:I44;E>#=24Q'E,M)(5
M!+=N1&U]U&E3ZR=$3JO36KZ^XZE+ZL<7XLS%JB7YV9<KXISP;=9OKC: $8WV
MB3M@4@M-JZ%KM54%=*SWTS$ROKM,0^SN1N)=WXTXV@QPGV69K<II=)7US!X-
MPFJ$0Z;E30>E:]KV\8SXHO.7@''9MMQ*^9/#A@P\^Y("P.7$N\H#V]&]$9)2
M/WT]W?Z+]SK4[^YM;V(\%='LV>C@67DS6$SIF:L26)B3)3UD*YOIWGN^JNN-
M&;ANMIW'C<V(6N@*(JB>B>137/7F7;;$PRT$+?=+A<PF7-^VKC[KKEW*^&JM
MN,NJNX=3505$373]K3U2O1G9T.;'@Q N6R%?8L*USP^ DD<F6[)%0MTICWE)
MM531MM%1-!-$37^[6M:6B[.].E[9%ZOV,PV+;"M\A8\CN,1K8Z/?B$*] )ES
M>J^X)KH0JFNJ:KZ5AG-\^2T(-=;9?(-BML*WVF3=YHW-MR)<GV5$ "8ZF_M.
M/$FAB*(NJ]$772M>[_Y*]5><+TCBLN;%MMDCN0K(;$NY6]&?F\J]&;@-L[.Z
MB 2%H1(*Z(@>U-*R[>^V8XLM\8E!FK@PU<[4AW 66Y%P8E-MPA[6V."HK(.:
MB.FH$J*A;E5:Z;6O'-37[7-8)6BW+?;M-=;D)'E* 2XJ"R+#WQ&[0T=U%3<0
M55"%/>^A*I\6S3X<,#-QVXQ[S+5Z';KM:\?@N-,03/M)VE%76P,U]=7!1!)5
M]JZ]*3W$Q7"U:1(S9L9NV*XTQE]J<8N%CN#5T3%HTKN$TY++X=LW"9<]X052
M31"TZ=4ZUQ7TQNGBTZIHE<O(+-;[Y-@1L72.]/9@Q1O[:;F)+1$!DBJTJ"B[
MC77VZHJ+[:Z+U82C[]TRBR2+O&M$8K!96XBMVIZ*RA,GHF\9""ZG4U3T%4Z_
M1I5Z5X+ZXS:(4I@5[OF:R,HO^38W)P>+ EO,0YK@R&79&QU6C=90QWZ"I;E3
MT_N4T2H[:T3;#2\=*U9"*Y#MEJC7AUZ9#G.O32:DF(1H:=#<)?0E503W455T
MUT3K6W12MK3/BPZLK$OMODOO8_<X]SCL0G5/YK !51B4Z^+8@X"HJBNT@1-5
M^ZB=:PSKR*\9>O5RCW.TO9<VF3L716IT-&G"&,SVD)&V5V=5]U53]G377I6E
M-43;JCD/ECEVOEF*\SHT#YS"?N+HQ76'$':\+NXU>:]6_3WM>FOIZI5MU(D?
M29:)]_*,['DQL8=>E*YDL-DR;>T^JB/-#[QHZ&J:$G3]GK37.Q'1A]KA*G6"
M#<Y^#QUE6ZV-:2V&P:66<EM\5)M6Y&PS51Z"@KZ:I]RJ[)OGBB(S.&*6U17U
M HF,%&S*5)9D.V%U54_A9+JEWR!5VBK>NJHI)L]%J\;YBN%_APM=M+5Q];H%
MH:@1I=QN0C\8Y')&W9# ?A'3;#=KJFO7MZUS:]?Q9F91TX53=LZRV[7F4[@T
MVX1TEMMB4*64<H^T%)%(4D*@-)JBCJJ_=W)6]]/3 ^F>9I LSMWRMZ_R)D2
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M6QL=B*2]5UT]B5MWG<=.*PGM=&:YE(VKK+"R83?<LG'"2Z, DO$K:9-+&E@
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MDEVPWJYJZX9*HH#B,M11)10EV^\I(G375*Z=G<Q2(B/$IV\VXOGD.$P,TO\
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MKWN(*:*B[=?9K6.WLJ[*_P#'P::^XM%L7G*V+=:DQ'#&X5IR6XGBEG(8=OM
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MXTZZ=B[265I)!(4G:XJN(8?NMB[5+Z=:U^-B9F?%G6F)RD\Z0W=+WCL*;%*
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M*#83:<7LC5MD3#BS9ER<DP;??()H:"PX1N !*6I&:(2:ZBM=.[JQS5I.>;\
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M'^!5!U4B1!:$D33W?9ZUMH]J>,Y^]6U<0RN+HQ @W6+*AV>%DIMG,?AVTBE
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M)#;A=3!M5!4T]=R]46M*\:\U<RS.2ONSL=)+8Q$NUP0VG;G;==G>9? B1K0
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M?T/[FM6W7RK:LL?9.2HEY?ND')+,<<+?#^9N1_ABV^\K38MJUIH9^_JB^O\
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M7'C_  :-JZFA"*DOO:Z"B5UZZ_$M&O["+126+M6,X- '(KE-'Y[D4^[@[9I
MQXJ,Q7C?5SM0Y;<<71;+ZS@DI+U5=^I%7/3M;:-^)Y*7[B+/<M_O&,VRXSBM
M[,C*FX<N\6F(1HU%F2)*%M;)!%P7>FJZH7W-NE>AWT]=<5\&6JFN9R\6/9;E
MEP?E7/*+;94@R;<UMN3ADTPS.3M*K#0FN[5 5S0D55U%/K>E</9^S/3;Q=.R
ME(B9A[[9DWX!NZ.V]/A[RQ*C6)J&!@??;(&^[(-5,3!$Z*1(BHNFG2NZ*VUV
MGI<-;9E&<1FW7L9I<\F!N_W6S2&6OP;(MM);21>V)29 DV]HH*I; ]5'4E0D
MTYHV;MVV:VY1'^;KVST4B68S_+,GBD<W!+''F VW#?M!P-4_ N:"OQ!"38D+
M:[EVH0ZIJN]/6K[M5HA2EHE+K?>,HO&"FSG<1^YW9F,Q\;D>./[1^(/;O;CH
MVUM(47KNW:*GLTZKCHCICJE-J9MF$4P;+G<UR KK:,-O6/ K)?EC N\07.['
M$@:$VW=C)*J::J.G33VZK6OZR+<*IV:IPA]YN6*83<<2<A6>XS+/<I+]MN=O
M::?-7$%U3!U/PYM$*(6WT3TZ::5;;NG"FNJTHW%$2X-8^]$O5QD,JY+>O<)A
M299?AR=B(#T=MUQ"T0"#>6NJ>FE86VQ-)B5L8M#TN9,]Q]=9F(XQ#")8HYLN
M.,_#D+<4Y2HZ?:)#(=!'1538FI:U;1KUS"^RSTC?KPC\]VX/2%BL7)MR\65Z
MW \[/5\$,Q;1QPS$"71?N*M:VU4B8PY_:F)PP.38_C/*5^AVB:DRXV2QQ4<E
M/ (QHL%\%1QMMOM"JBXI)L<%-/=5>E9[NRK:T2W[?NKUI,2@D"QQ;%C,5J)!
M"XLV^1(BSHHBV<F.W(+5MQ>X;KJLB0IZ"/W4ZUW],:Z],.7KF]NJ62OMG?8?
MP^\'?(R87(N3>^R6Z(VZ^JIUV(\8(;:*2DGNZ)U^K7#MT6M+LU[:PSD\,GPM
MMJY#:DNT1YZ0\Q"ERBD!"8)4#3MMB*D1"NWHNB:>E=NO9IO&*\W++,0\ NMW
MQ=N7"F]^?=7%F.PB7X*.T'=%29[:[B110577T5*QM:];\?PF,LKD6/%91DW?
MY%;!^)M3<%Z)'D-%+,B47#5",204'8G[E=?33K5)VQE/1*M[S@GSR'\#.9NE
MAQ"X U.D?#2U;5LHRDB;E9:'WB77W4).FO5*O;VXX>"])Z.?BSMUS?$+CD-M
ML;]T2-<+9:V>U:[C$1UEOMJHH\CNY37W5$D E5-=5W+KHG/KOBV)7M3/%F;S
MQIA]Y<B)>V)<UF^S&+D-^@A(8=;;0$4%^*:42%2ZZ]$3Z.FE1W7_ "^S"E;]
M/-]YV,\3XCCTW$H-AN"WV-%.7 4)QOD*.EO @DOHYKHJZINUTJO::YT<UK[8
MLK>_XEA&4VVS-Y%:"&98R5\9MSN -/$0IO!"<%E>Z*;M4 41->M=%M6O8SU;
M=D+#QF\W6YK;8S=RN#]WO#B1W9#:HA18XH7:..!"]]8"77H/71:K?1357J@M
MOO:<3R>V]1661O-AN-V@WZV6B1V+=)!$F/Q)3H[A-X 4$1$35?V=?HIK[F,8
M7C7F,O+9F&,<AV6T_%MWFUSW)#WS=QAH5[[JZMJI"2.J*.+HB"NJ)T]*FT=4
MQ,*O2U%R.T7[+&H-M>OD:YQAM\R6#HQ?@D-O:FU\@/?M0R4/V-%K?$8XB)VJ
M2]#-['K<7Y(LS%6WQK^T\*278[3X[B$G8Y"JN*OII[:SW:(FF85K,Q9\+/8/
MR1S7,+IC#$UE^[25FWN<[*<DI(<91$)L0!.V"EM3111%]GI7/J[:8B9:VW<<
M/ YREB%YR*X7^SOR;3D#_P ,=QBE!WB(1C6,!+*(F%<14#<B*VG["Z:US_+J
M=>ZS?92T,M=\IM,>V2&K=:K_ "Y#+K[D">@Z&VZ^2$R<<!- (21-Z#HB]?6O
M1[>OPZ6_CS<D>U.'IQ&X7QJW9#,N4%]L(D!6OB)A"C@NNJ@"X;(ZEN55ZKOU
MTU]ZL]6V,RO\*7[M4PL,MUOBO)'MMFE _<;U;YL?XY^>IDH@#;;IJ0(0#T)/
M5>NOLK&(ILF<\UHUX8')[G,S'(H<1J7'M< F$*U1^V\B,=L4W_%,@YL1"%%T
M]?1*VUZK4_"K,X;%^,]PN!YE#M[UG*7:V;?)2Q9(#*-1VXP(B$VTIZF6]Q%]
MNB)]VJ=U:9IB>;'$YRW\KS0H% H% H% H% H% H% H% H% H% H% H.3'EQ@
MG ."<FY#D?(_DUD?&%@YK;@2>3>%K&P].<R%JW ,9MW6*CCD1HQ:42)QM4-4
M- +7W4+0PWBEBW'/+O(V&2F?+RZ<X8WP/NG<8<17:T'9ID'LM#&C2Y2OJ)3$
MB 8B#@ NA;=2!%)HA+L!155/+'#F)<RPL+@Y<Y<&V,#RVVYG9%M[P,DMRM8O
M"PCRFVYN:5'RW"FBKT]Y*)B7VN?$N-WGDK\YMRG7:5<#Q1W#I.,'*UL;\!Y]
MR0XX[!4%0GB5U04U+ZGNZ41E37$WA?Q!PYG$#.L<FY3=Y>.QYL3 [%?KN<^V
M8TQ<E)9;=H8(!)E'=YH2F9JNXNNJZT3,MM:(:">)_P#O%^=?\^++_FDJB9;]
MT04"@4"@4"@4"@4"@4"@4"@4"@4'-#*_M4O'O#\IR7$;GAW(;]RQ:ZS+1<'X
MMOM),&_!?..X31'=@)04@51511=/5$]*+=+ ?VNOC=_H3R5_%MG_ !S0Z95_
MR']H5POSE#QBR8GC&:VZ7A^3VG+KFY=X5N9;<@VQ]$>;95BY2%5TN\.U"017
MKJ25Y'SB?8U__4K_ )OO_P#KV\:^X[N9_P#P]_\ _;G_ "6!_:Z^-W^A/)7\
M6V?\<UZ[X#ID_M=?&[_0GDK^+;/^.:'3+;'QK\K^._*:#EL_CZS9'9V<-?AQ
M[H.0QXD<G"FBZ;:LI$F2T5$1DMVY1]FFM$3&&SM$% H% H% H% H% H% H%
MH% H('R;#M]PP:_P;JRLB!+;9:?93U)2?;0?8O[K3U33Z:TTSBT3 T+N]LF6
M^!/ND>;(EQGI[3MSB&*(8Q8K9@K>U$V]5+[B5ZG:6XS,I?=;8D:VXY='(\BX
M6O*9K,I]^4ZK2162-$V((;-$%M=1ZKKI6D7K>T_8K+%6<[E ENGCMWDN6_&I
M:DC0!H_,'51<:U5$W*AJ6HKTTZ^RK;(C"'QRC/'I]V=CY-;5BXG;'WF"ND?N
M[@'1D0%PF@WH1.N*NT"'5!375-:K/;Q%(MYD6>Z=$>MEBMMAQ@OF%[21$F9)
M9QCJ<>YN2U;)Q$4DT$$0U4NJ>B:>E<^(G+:+9>'(+397\S;C/J]+@O3%*=:H
MRFBMS6VVT$VM434A#1"_<HFNG6KZ[],(Z7MN[MDQ:Y0Y-L;?O0.L'\QQIEON
M+*<U46WW7#ZIVS:0>GHM16(M:<HG,%LG93;;5%R*[6XI%DG38I6_'IB+)D6V
M-&W+)-'BU)Q74%2#=N5-WLTINM%8X&NG5/%$[UFMAS_%[3EV+*Y=+:[=U"X6
M&8.SL&\>IMOHJKHV#;9$2=4%%UUKFT6ZI;;M>(X)F[#RO+I@Q(GPT*V6V*PQ
M-CJ0[8I/ 9..,.HI;B[)"B:]-/N]:]2MJTCBY:U>'%+'!6RS;;DN+N2OF=V;
M.T7!HR<"8Z8J0O*K9$*"*"IDOI[%]:RFWMC)LB=LQ7)K5=T2,<:[+&LLX'FP
M)TU0S5PQ94DZJ _63V5GNM,WC"8YL==+CF<O+;);;-+5IFU69HF3+H$XWD5%
M)4V"*J)@J=$3IUK2.G''FL^]J"=:XUNM^(3V!R&-/_\ 6]LFJ)*:.HB/ T;J
M?51==-%J.K%9ZC#9#)KC9K9B*WN:DB._:G&1VMMNR#!7'58T)I@7544WHFNF
MGK7CVO-;9A>M5 Y"Y9[[:KO'G%<+/+PZ;\*X_$!1WD9"I$  J(J>S6O4I?-8
ME6>;.W)V%9_ATO=N2!98QLCC4V*)FH.2$44W"*JO0B3JJ56;90JV]!.Q^6Y:
MI1L7B[7IIN//BF)$LJ02F49PC)0010 7J/775/;77KM%:\!=6/Q\I2UVX#F0
MK+(B@V_)LD=IG8:. JDVCB">WJNNY%3U7U2N*9F;\1 .-'LAC#=\BNLZ7<&9
MDEV/)LKR[HT814B(F4547ZP"(IIUUK3?3-H'B>&+F-LN;[TF3E<:RW=V3.MZ
M*4<T-&@[8-[%%5041$_;K2:=(R1W& 5]M=X^2M6MZY+;BO[<Z,Z^J.=H'&6V
M=F\4)M$124DU1==:CIZA@[]+F!<[=$NCS%FNOQTF5;)*D4AR3;VQU)0/80]$
M7<2$NO3I5Z5K11CO@;WDLVV6F^8FY"LJ/K!;CJ\SWUAL**%)$B(G$^N/W"^C
MI5[S&.!*[[&ENM]Y&V0+ _;VG)I@3QNBH.JWM;%SWS77</7:/_DKAV4F>*U4
M8RK);ICUUPY]UR-8H]TD/,2_B&U<<;BJ0[!!&]P@2DNNJ_0E3JU3LK+3D]ET
M*%^4<_';6RBA<$>O5TO7N$D=Q% 2)0=_<)VQ75.FM4KHM2<Q*>OJ?.]WFW8^
M\=X@ #4J7OA6 Y.Y6KE<)*;B-H4%=J$NQ-ZJ@:)IK6V.KA+/#QV_'[9E%QOD
M;++ +%W;"VRIL,GW??7M*"FUL<$134G!44^E%J)GHC@/U<<72T66WK;'8>+E
M$4VQ@S'NX'PK3I H;T+55+HNY=51%]:M6UKQQ$]LEU.5;)4"VVJ5CTFR%V'(
MCRLOJZ@ I;6WP(T+T3KK7-?3B<IA"@QO'QL-_?N]H(OF[PR+V0*ZV1HIJHD>
M\P0$15ZJG3Z:Z(OTPGHR^..0[5:[SD#=F=:^"ELMA&!LU/LH@;O?$_=+MH77
M3V:4K'5[7FK^'@CMD?Q7&B<FN7Y;I- %;W,(1BO?)$0U%$3ZJJ*]/9K4]'4=
M22.Q,EB7YT(938M@C11)UEM&!%QQC4O=4E(T$D7K6O@HDX72U9)9'!0FY-R)
ML9<>-)9!W0S]ULA4DVJ@EKIHJK]*5QVV32V2(5OB&/8]<X=QA7*(X[?X[KL:
M;/5" $??]T@CHJHN@HG54Z=46NC;LSB96Z6ZW",67"XQQN).8*/)C'/:-HBW
M*@C/D("ZZKZCHM>=W-NK9,Q]G^ M:L H% H%!HKRS-&U\DWJ?/E/H$#X=;;&
MAJG=%) (AN$.G71=:]#M],7K&4Q;"MYH0L@S"X6V\&TS:K/%W6W:6TR[B @J
M;G[I21S54T_8KJZ.B/93U<6=MEKL<ZS/W%)['RJTR'0 9 ]D6G'-!$D^D-=/
M7JJUR;.J9YIZX?*+&M$FQW^8TLV-$F@)-7A\B,7'M"#W$14TT777JOLJ+1,1
M'WK1.>2(R\VQ#CH,=@WP9=O<R6:ZT,B4I$@H)-ZF"M@"=IPS%%ZJHKI]-8=U
MMZ,-NWU=43E<6566XJ-DN4-N(W?30HIR/=0P8?TU%HR07$1"0=40NOM2FJ.N
M<QR9YF,Q/F@$C';)GMD9P[+[5*@V^_(4>ZV5QQ0DN(3BIO:,4W#M378OKTZ]
M*OW6BMHXPTINM3\,X>F!BF+<=)9K-$5]+ K0P[?#>5QY$=W[A=-5)=Q*1J6O
MW:K39%8B$6S;BEK,(72A1RDQ;6^W).4Z^2;B?;5%4D '%3WW-$UT]*M-K3&8
MECTS$HJK(79O)[5CTU6)"F+BN26ACQ1)LAZ(C6BK[NJ_^>IUYGFFTI!@L>-*
MNU[NC3TF64<O@VG3;0F$2.#2$3.W7J1*JHB5MOM%:PI")#C-KR@;QD5TEG,9
MG7&8@M'J!G!%U=['K[BH8D**OT5.G;.,0EXWP:%&F7XAQ[I9E;9D0(7=!0BJ
MYN9>,B7T!--W_#6D1[2EHX@,1GY"Y&,]V_,V7=\:XT6LIE=?P0HBJHJB=PBW
M>JC6E[8A:*O'&@6^%>OD^7V5V4W=GBE%.%XA;-P7$5L@;T'JB+U7=^U4S,S'
M-3$I8%T9QB9D#)6,I<-2%J#*WBZ\\#S>_P!5%5TUU32LXB<\T3$H)"5J*^5T
MDN-1?E_P\\(O809" ZHN-@B:HA*FNBCHGKZUI:MY\41-8\%LC>POJWB:-C8N
M$IF0<9JUMR4V.^T7'4'5-VY/9U3Z:Y-E;4\6E)RA.17^\3Y%SN=WB286-M-I
M#<LD=%07UD*BZ$73;LZKO]NB)6VOARYEI>O'+I+L^/WI+Y;4M^$,(#>.6%U%
MDS78_:=<E*^I$FA&1(@)IIT]%UUKFVSLZ\Y;:[5Z>,<7MBSL7MLG&K99; ;2
MY2BW%N \*D^K:,HKBHJ]62:$TU1%^Y[4J?C3/XD3KSR8"^R[;;;R_;K-99MQ
MD,VN(VX,D]X-H!"8JZ*:%J*KHO7T2NW73IIFTY9=,PQS"VIU9%OFV0K6_&=6
M<H0_PC7?)L=Y.*)[D7N%T1%3T2J4TS.;YX0B?)C\<N$^V7+XIB(QE#[[J2+B
M_'W*YL][>>@(&BD*(G4/IZ>VK8\58B7NQ^\# N=XO;^..NRKB:M_ -%W")N2
M\BIW7#'4437JB?\ DJ;6FT?<O6<<WL3&;E/[Q0G8MBGA)T"Z"V@! 9:574;$
M_K(AH:Z]=%ZUC-\(KU3/"6:O/*=IPZ,VTZRLN(U$D2(TIE>TV+C0(JM+NZZ&
MYJJ$*IIN1-%TUKFVUF?:CFUB./%&;-(NF;V5[([W:IC5TOMJ5&[? 817D9DO
M[63:?)P4)!;VKU"K=O:WBM>T0_>08@U$LLX;B^<UY@A;C7.$8M$+0&S''O*.
MNXC5=-%U_9KIV;8CDRC+*G<[%'L6(7AR-)D%)480MO(( ;!M&R)/#ZD@IU1=
M?5:K%K6X+3C"!W['9$//;1ED^Y7*X8NP[(:D8\6U11'E$6U(!U'1=45%5/W*
M::>W.==\\)7BU,<F7@2XT3)'HE@R!H$=D#;6[?*:06V((D*&WNUU,C35$'^Z
M5:TFMN#/,2^G(+%C:-RWG<_R1ML1@HEQD39;,9B1IN,"B@:B6I.N$.FO7T3K
M6E-]:\SX4VY,J](2QXC8;C%@RCN^-2&8K;+:(CBHB?7D-MJ>H*B*J+KKZ(M4
MBT;KS$(F)KPEX9&:)D#42Y72PK<NXBM)=8[&Y2A"1/&PHDJZ%[B)Z]%2FV)T
MH9!RV0YUIEWB"CEIO+KPS&'2-6P1\E-546MZ?5;1%UU]?V*RZ;Q/,5E>X[US
ML]UOK$@GF9MS-J?%?>1'!2. BZC);214,W!)%T31%TZZ+7H=M:N>,<5;US"X
M."8WS+DC"9#+RM1K"RX@Q"/O*3CD54><55]%0R455%ZZ>E8]]->F45K,.D=>
M(L4"@4%(>1#R1N++S+1I]YV)*@/,)&!#>$@E-KN;W*B"J)K[WL]:VT16;Q%N
M1F8Y.;.57O(;V%M=L@3\3QY9R7._7.Y-R)4F6;;:@+(O;Q3;U,1!$]Y4U]!K
MNMHZ>,3EO2V(Y/?+L%DL\@)4C(V8]LR*"T[(MX,%\<>B@Z+CFHN;"5U"7:@H
MBJG_ !.N4:MFVWQ(S68X<."U>YK6,36)_DR]BQ.U6K)[HD4[\Y&OD>/,"YO.
M. XZ]V]6&HS?X-AM%Z(2:=5UZ5>;S6<WG,_;Q4F\6Y5C^CUN9!D]B@N@Q)^%
MG0H:.MQ9B+);97<BDH P&T4#=I[PBOK[=:ZJ8F,SXLHCCR0G'F<*SB_7F(H3
MEO$2&3S\QTU&WML[A1]8SA*1;^XFN@HGNZJOO=*X;?\ FK,><.G$3#)XA,BP
M+8ZX_(D2%2YA$C6QYU/AQ!2(A=1AT-51!'J6U$^[7=NSU<)PPBL&13+)%67+
MO]T^9V$T%V&^Y([RO/.N;18$4U1H4)=B"IZ*OH*>M3&*XF9+UF\88+*69]X_
M)-+FL*U6>-.<A7MK1Q'E#148!C8G;1&01!)=!T_<:>S'N.J9CIG,%<43ZWVZ
M_3;+DUM@W!JX9I<(B#;84IM]YEME&R;:9EJWT @-%5=N[1=>I5GW&NT5CP:?
M%SR>0KW?[%B$5UF&MNR^.XW!N-K@JK4.:2JF\ ,]$%-RHXYT5-/NKI5:]%*9
MQ&?N6Z;6\7[:<E8Y<G;;?KVV3.3/D^&%JXB,P@?! %J*L5G:+9F(F)KM5252
M7KUJG;=M:TYF<HV;8CA",2,TM&*PGKQE=S<Q&-CJ-Q73M) A-1W%<-&U;0R)
MUQPT5/=7=ZJOK71W%*ZZS.(-7M2@>.95@09JSGEOR3)<]NV5N),:N\AL)KUC
M@*ZXX,06E>/X4=JJB^ZF[3U75:\K7W$3;@ZKZ>"UG[^[!E7BT-7AB=#O1?%Q
M9UP=>%V6&Y/[TX.B(2H*+VTZ]-*]GKI6L3,0X*ZK=4XG#R1LIMDPYW&IW=N?
MD5_;64[9FF64;EOBK:(+JB)N"ONH1JYN7I]*)65NYK+>>WF(2>^6%SC>QOYK
M+:@V.1;XAW"Z28:.NJ,A%5 :!M %"1%754W::ZZZ)6&SN_!77JB$0CYBTYB+
M>=#8+D^>0V\9@7QYU8;<F69J8(K8&NB(2=00EU2IU7M;QE&W7$/-$R7/7X-D
MR2?D;K87*, /V15,2<5PS;<<9!5 5ZHBBI:=>NE>IVVFE(_#']'//-(F+1+2
MY7N;+S.\6:U8M;98O6ZW269$]X3:4.ZJ$'NHOHJ+KUT1?=ZUP=Y%MMNBLS&?
M)V:;5I'5,9:S7K#^0TS:#?\ '<VN+ULO"_&/1[G,DNOMP#)/P+L>/[A'[NGL
MUU371:\ZO9;==LS:9_F[)[K5:N(K']&WF)VUFY6*)'D91LRJW35D0HC$A7OA
M67"1%;>C;M04M5%$45Z+UKTI[B*UP\VU)M;+]0>-F+E?+W>W8UQD7NX@(F]<
M6 6&+0.; !E&NTXJAM]W3W4KD^-$3ET].(4SRUF-TPKYCQOQT,R5F2M1GKN$
M5N0KKI.EO,5+WA0@ E4D!=5U][Z*Q[GNLXBO"?-MVVBLYM:,K?L]HM[V%<;7
MF^8]/<OSUDCM7IA):Q8N\V0'=,<;U(2$]5+W=!+5$W+6\1;;2.,Y<UYKKV3P
MC'W(DEAE9AD-F9N]FDV"5CD_;8HJ7V3>[>\R8EO?W&W'(4V#N151-?14KGO.
MS/#@M>T1RAD>2^1 XT=E7*V)>);EU<;9A0K;;!E&H+[JD;CB(IJFGJ:[=.B5
MU]5_A\8RQUWCJXPSG&G'LSC_ !IF/9YY2TR&"AOOM14-_NN(;HNO.D0H"-]X
M]&D7;]S1>N.B^9]J,-9]J># 7G$<BMMLN&1\:Y7'S[)@ELQX12Y(/LP-A#O%
ML&AW$HH6NADNS7W=-*I3N(^)TQ.5[:HI#[N72;CN+Y+>KYCDFXR[?%B2[I?+
M?%^,D/OM/-MR2:;>-MI3 C)07<BH(J754KT>XO.JG4Y=>J;61[!^3K?E=QEY
M1<IL*Y0F]T6WV@8Y-W%]MI$VM*,LQ I ()$:"X@=-41:QU=Q&ZD<<-MO;3X)
M9>ALER')V9T*<V[;!9=M$:"TT3,4C1=J 3(()&2_3NT371:O;9&J)]ISTU]%
MHZE$8=D-_P +/(&.1,&O.31LNO<5O'\Y.,L_:?: 5*2TXX!&FB(B(*;=HZ*E
M>)IW[*;>'![.W%H;.W/);9C PK[#E?&RT6,=PF3Y"M+'9,50@:BD8*VHHF@"
MNY!'HE>UMB^VO3'#QX/'CV-F53Y,_CN,PW0B.WB[6_+69-LM=NO$B9*<?:FM
MDU)?5Q773450]O5$]>E5TZ^CA+2UIEG[#9+M<L4O.+-S5C0HUM;E@%P)P6%<
M/1%,'"5QP$%.G1M.FNY5UK6U:5M$^/DRFTRAUTL,>8]$/&\FB!.=B1HTA^*V
MK2-$PJ-JVVXYMT(RZ:[1117WEZUIMV7O7'X8\XX--7&>+9CQPSK(,CY8"VRK
M@Q+M,"!.C/1XG:?:CRXR ':.0T*(I[-%71=/9[*Y-]:QKCCF?/S1MB8F>'!T
M0KA8E H% H% H% H% H% H% H% H% H% H%!QV;Y8\9N./,[RMR3R0O%O^>K
M(QNU<>#=K).O21835J%9OPZ18DMMK<JLHNJ"71=%7<=%L3AX\CYF\9N1O++Q
M%O?CA<K8N2Q,@NEMS:9:+',LANVZ9$%IEJ0LF'$%]%17A33<HHJ^FM#$X=E:
M*E H% H-!/$__>+\Z_Y\67_-)5$RW[H@H% H% H% H% H% H% H% H% H.//
MV?&,8WD?-OG/^4./6R_?!YQ#^#^8Q&97:[ERR'?V^Z!;=VU-=/71/HHM9U._
M-EQM^C[&OXIA_P"*HJUP\E\)PRS8_P :/6C$;+:GI7).-1I+L.!'8)QAQ\U-
MHU;;%2 M$U%>BZ5Y'SC\&O\ ^I5^A_\ 7,1/<]YG_P##W_X0V/\ S9<;?H^Q
MK^*8?^*KUWYX?FRXV_1]C7\4P_\ %4'+#[)<1 ?)< %  ,DM0@ IHB(GS!$1
M$2BUG8>BI0*!0*!0*!0*!0*!0*!0*!0*" \GD(X-?-\U;<)?#"LP?4-TEH>G
M[.NE:Z?QP-)+P3<TF1O.1I95^,V2VFE_"G":=)0VM@FNI+IN+1>B?\/HUBU>
M2,I;D>0XUD>/LI&>;O=@=18[T5L2-QQ61!-&T11/IMUZ*E8TT369F,\4(C%^
M,DHR61"=HMURMT(K1';;)F0U+>:)QSHV+AMEVT)#5SHB]-:Z,VP*@OI1[QD5
MPFVZVWI+E)89&VV]\![+SC,E6U<CO/BZVCI""*@]LO=Z^M=E9ZZ16>&%9AXV
M^1[_ &EE'8UVN=_GR\H@6J!<!9;:6*U),^X4H 1$5H ZIZ]!]$773@VZ9I:,
M.C76)C*WG&)<^RWN1'F0;NS;U[<2)'(0FN.-D*BX;RB+@J1;45-$U%--:PV=
M43P3U/'E^33(D^/;X;L 9]LLDB5D=MBQQF[W3: HZ/B/O-=MTS+:J^\BZ]:Z
M(U^SF46OAF<8<SZ[6[$'$FQBLC01)%WD]CL2C'M*IBC>U6Q:1%T7W45:KMUT
MQSE%;8E",LMEEX_R2-(>M%NDL9*Z^=MAH#3#83.SM=0@^JI. >U21$UUZ:>U
MVVFO3GBO?9,LM<;I,?MH7RT2H6+-L.,MW951AP9;8LB:MM,[41U>VNB=>G6F
MZO4RA^8,G()N'7_'AN#\&VV>7%9L"0([+4@H9$) RC8:*#9*0Z$OJB:>]Z5O
M>*Q.816N61N%WM;-HQ^RSI7Q$C=\-=;@#;;JQ9D@!V$X'L1-2ZIHJ:>M1KB9
MOU(GA+[V%N\V$FFKA?H+S$1 A8M(?1%.4XX(DA)M77U$Q_X:ILU1-^K,F7]Q
M6R.OP+Y>+%%9G9*U).3;V+D1BD<]^KC+BMD/L1=%7HBIZ4[B\6F.KA&/!I3B
MDE@R/D8,BNDV]72P2N/EB 5VMC6[YA:YC0"AMF:*0N@9(1BNW</L5$Z5PQIC
MCU?R:1.$#Y5Y1QO';4WE-N57CE%_DLR,@*PZ@.;E$S<40%54215+TT5=*WI?
MHB(NB*1:4NB9S%*%D-TO=U9[$B/&N%KMKK0I(C-.MHXP)L&G1U$(=PIKHNO6
MM::_B3'3R9WCI8(\JC26,.R7(+;.5Z6U<&'2::UW.1T4V"<:Z?WQ-VWIIZU>
M*S%^F%,L"])0G2S:TFXS=(ZFVY;FV7P<FCH@MJH[SZ!TU04'71?;6DZXZN)E
M(;?;[OD<B--=O%O?A%+1ZX.-N=J0V[&5'6FWD'H2M:*!H@I]-4V6@ZF!.U7S
M"KV5\.<3EL;CN/W:*ULV/'[VC:,BFF\M^O5-=$^Y6W7%Z9GFKU2DF06]KY-$
MODV=#L-HG6Y1N3[I/"^U%DH!H+;6_MD^(EMU)-5^FLZ3,3P7CB6"%C5JLLJ^
M6QF7D#D V8<&WR5%0=6636U6T-23<@.*O1?J[NFO5,KVM9&'OR&W76\R36%=
MG\7NUI5 OEW-":7X74C1IIQM=J@)+ZHG[/I4TMCFG"%62Y,X[?X2SX\C(_D+
M;<F;=5D*?9[BJK#S8:"A=T50M-?5:Z)M$U3'!-[#?WI+LK'KQ;7([<6')NA7
MF]2!>;!I7M&=Y(#8[5T1=-?6N:*^4IF<O=CL*X-&=XOY+D-KN,!UA^Y$T (T
MTCW1&NG5LU]-5ZI46SYJUKCB^5T8"3<,:GMX>+K3-R8ALL2DWC"88+<,@611
M$;Z;E0EU]M8TZLRMF$AML3#7KWFL^V3G@O;P_P#W1?&/*(Q]H&JJQN5-FY=-
MR#]"5%HV=4<.")F%,6FZ06[?9HF0HUE_QUSD#;(P/F;W9,NWN[CQ#NT,%]U!
M3U3UKT+?\=,HB5P,V.;B\>; Q:=+=F79"F.SYJHZXUL3J(H@*&XM-JIKUU73
M2N:NVM^-O0M*'.6"^77';S&NTN7>)^8QUA.QO@B-6VE5$4WA7LLM$JKHB$:;
MT3W=5%:SWVUQ'#+75.9XHA@JYRK03KMAUMLIK<'H]VLI;26/$:%!62ZI/N+J
MZVFBJBH*H*=$+6K=OLGX<>7'_%3=6.N64?3%&K[;;8SC/>LSG^6R+^VXC(@$
M<2_!I[%%4U$EKJUSG\++I8%VY.V68Q=YD!Z58=9 6MN5(< W)$M!$F-0'10Z
M*J:ATT]:V]G'!"=Y/.S[&,'8+"<-9O$MN.TPW:HKXMSFC?<)PG/B'E1%;:%$
M7JBD6NFJ>M>;W''DM2,RRD>]8\Q=F\@[[MRRF3#6(XP#JA%5Q@04T%-ZH*DJ
MIKIZ+TJ9K-ZXEI;@W.XSENSL'L4MYE([CPOJ3(EO0?\ *'$1-WMZ)7!LKTVP
MS3NJ!0*!0*#4;/,>C9#F^1"RXK#S"=B?)W$V>TV4)MM#]$%25/3K75KW6I'V
M-:TB80NVV"T6+&TC1;=&NM[CM$P3Q(A=XVU(_>).JBFNM5GN+VM'#@F:0PV'
ML(^MS<R2R0@539-(C30M-?#M*AM"(!H*[2%$'7T3HM7MMS*OPV,MS,2? N*2
M'Y3]L8D/-1K:#:=ML.T1*J>S02T7ITJ;;>$?>F*]**S,6QB_/V.1G]IMF4Y#
M8)#IX*W,%'@9%5#=^Y7:BH (@].HC5.ZT3>(F(X-NWV=,3E,<VNC#MWM 3&%
MC*TB*".N$>YYU5=4=414T71/_-75VM8KKX.:9F9E)L+M 7.!%F3 *)>H<HPB
M2NA.L[%T5L%)$5!6N?;LF28F$/Y=MN:7>-'@!<W,;MUODN%*D0)+@N=%;=95
MI&512Z@HDA+Z+]4QW)6.W7,QFL.OMICQ5GAL^WWNW7F;+DOVVYVN<$=VWRC/
MXB0X+B*V\PX2"3X:":B9"*H7UA2FFUHX3#7?2,9A;<VVV:Y2K?<66KC.-X7(
M[Y$0JY'UC_4%$5/7W=4].M=5:RXK,1\?/M+D"TXXCKWR=OXUNV._@WGMC8MM
M"HB>I A[A7[JZ>M3U4F>FTQ"(I.,XX/6;ETGW%BU9 +=ON652&5?AMMHZV@B
MVWO!W4M4_":Z*O5?5:M[%>4C$!=QLEZS*8X^)VLI#D9RR 0OFX9-Z(B!JJB/
MHJHGK[:TI/5Q1A],5O=[9C1;C:+5"DMW::L>X3--KB-JBZ"X"]1%!1$1:QWY
M\&E9AGEM\G(;A%G7O(83?:9=&+&9+N.">FCB-%^YT$50MOLTUK.N_P %)A'R
MMTF/$"^01=FG=WC;?$M?\GMZF*B+VI@H&C>NTA5>FVM+[_9G'--8C/%]X-N;
ME3'H]H [E.MDD7+:=R=[JOQ72U?:37150==0WJO2M-.^V.+'9K]K@R3^.LXY
M,AN8@,67'FW(F;F?Q HXVJ^STV^ZGNH@KZU6;]4^UP;],17@P=[LUTQ_*(GP
MN1/PH\]O;)^9$J1!5'-3;)?15+IL33UK35S93$SR9S'>PZ^^<N[.7.U/QICA
M%/8+OC*9?[;B]Q445%!5$1=WIIZ4VSFTQ!%)AYH$B-\6YE$L'[398[3S[<Q'
MG.TA278XFO;!21%3X8$Z?N51%]*YIIF<>+2M\/ ]>;U9@E/VEN-?W&2<6;,<
M97>X#^B,L@2(HGL%=IHB:JO6NGX46I[4XE2EIGFK#C9WD&9E.?W*<@V.9:;L
MW&QQB6#;(O12VKWB0=2/<" N[1/;7)I^)2>GP;S6D5SE94AAW$Y3SH?!*^]L
M.<EL%1>2,!B $*:HBKO5%%?W.E>C_M8<$ABE;;C=,1E1)4B4<6/<(K02"W(D
MDA;<!'R!55$--RIKZ=/IKABUZS;@F*1*'7;*PR&RR'[?&.'%??=;N5FN*$DM
M945_8VVWTVD/X,UTU]H_35=,6O;BVM'3'!%^3\CF<=\4W*]V[$%NKWX.-9X,
MA4%6I#Q&IZFWN+\*2IHB=>NFJ5AW.VU-TTCE&/\ "&NJL37,ISB+-UR+"[=>
M\BTLU[O-H8LUVLAJ+;82G&P:>,$35?=4E$5UKHUSPXL=U(GDD./E:UCQ[/B)
M%-M&019LL,@;<[@HBZAHVZGNHJJF[W?W0U6LQ:>:MH0TCR!R1'0[+/F2L<0X
MULO#W1 0G4 77!1-"ZZ(BIU377V5Z,12*<)XJ1$S.$=EVUE_X.^PVG;5'O[!
M]Q0WC+D/L%^ :0/8*$*_M$B5:+1A2U.+'Y'+-^_M7EVPHL"W/QW)[4=' %HV
MVM744$Z+HI[D5?:M6TVK-;9E>:X>;D_CW%>8;3CN%M9,U"AM7!B=>8+C:R$E
MPF5$R84U74%5%]W3IN5?2O)VZK6MPAO3;%4KN<JTRFKO,C09C]INBF"]M5.>
MVL22#C2*"D:*HJ6B**]4Z5UZJQKKF.;/9FTYPR]LM\NYRK:_@LN W>XY S>W
M0)",(:DIO" )J@+O0%73KT76KVO&S\?!D\V6LNP+C$L#9_/%965!5MY\GY39
M36P(7%%40D::U74?^,E7IQCB/K9&;("6W'KA; EE,@%/N\O5WL@:F#8;%,E4
M54F5U%/1.M4O$U]J%J\TXX#F68,NQZ&+4%^Y-RY*6Y8HD*LQ'63/<2DJ;E(D
M+V5ANS:DS*;RZ#UYS,H% H*:Y[FRK?QI=IL%329'DPCB[3[8JY\0&SNET_!Z
MZ;T]HZI[:TU:_B6PM3&>+GS:\0R#%K'D$O/,OA93E5ZD0V(TA6B=@P$)F0XO
M;V-&Z)&)^KB[?=1!5%]=M5]VNV,9C[_]75,5F.#%,62-?HDE^1E$)FSXY\*T
M0M"\R1JB+M:$#U05/NKU3KKI]'3U9W3:8K6..&$1T^#$W&R7W(K'8P@9[=\7
MPF#(<*Z.MR2CD^$<OP<9MQCMIHKPZ*NU54>BJGMXMNNUK=..+2N_RADK84:U
M$W>A^;NN2&VQ8B-R 5MV29*Z2N"I*2 HBFXC35/HKHO>-=8B><0RXS.5D6&)
MC5@EV:-*@M!\U6>9WM@XS+41'(SC[Y(XVJ/;C,4%51$7JNM<&>J>J/!O'&,/
MS+M6'W^Q2W+;:VARJ,^Q\V..+DE]E%1QMHB[VJJBAUT1="73UKKI:TLII,<T
M#;NS""["@,3+F49]R$%OF!%!HA%-.ZXU(38JBXNHBFBBJ:Z>E;3VT[\1;A$<
M5.N*O6V&136F,F>A/3+Y#N2VFT')BF8-L:*6Z2VNJ%N'30]JZ?MU7N=VO1,1
M$YE::S,926U3+=:'W(D8'785S8DR6)T-AMB0G;U%T1+<#F]#50;1%4==.JIU
MK'?NOOB)PMJBN./-5TG'_GV2X]?KD*XG.AW,[7&GMFT\DA@MZ/.28^PFE,R5
M#3>/_P!,FNU4SG3::8PO;9%7WSK*&(N26RY76:-Y;BRVV+8=K;()[NY1$10=
MFI[#VJ?7H/0:Z+;H[?V;\)Q_')CKTVVSP4I=N7+HUR>]9K1@#?*EK*V&KMC:
M8%]X'2$R)R62H8(XBH9;3'1 4=53TKQ]O>?'M-:SF/%Z-='PJYGP6GF-\PG#
MLKXPPR!:Y/&]^R-HKC=)N+QHUNA3!0%5N+,8CL?Y8HZET5?=7KU]:SIV]NK,
M03MBT<$VR*R8%=[<Q>[I/N-\&WFZ_:&7N^X:S?KHC0=P6T141!1")1U7UKU9
MI-J1'DXXO-+9E&L"CP+U%+(1P27;+S=KJ]);:D_@+HY#!L4(R)C0M751=!(M
M=/N:537KBRVW=,QP7,F4V6_L%CMS.18I=R48K5@G XZCL-M--%U$M%)-4_"%
MKUU3I47[7JG,.6FZ><LM;[IQ_;,5?L%HMT.]6+%F'W+M;IB-..LN(G7:KHIN
MW%IH2+IIJB+6^G5-4WV3?DH:&&/2';:S=5M^.QI[;\FTVV9_ELJ4V&O>6.>C
MI-"FB:=!UU3:BUVW[BD1C**TF_)G[QBTS'K>U(^.+#,=GL.G='C:^+<.UHT:
MC%!&2VD9Z **O73=NZ)7F]=HO%X=$5C'39AN,<GDW^Y6VTV]\G+1?67692SQ
M%9+8Q0,Q!L@ ACIL:34=.OO?2E=MML7KQ<WPYK;['KEVJ[VR5E3W%V-LV',;
MPW%AVNZQ6FXD1V+[KLLV@-M $A5!ZG[=VWVUX^REIM]COKMUQB,\59<?<ZY-
M;KN/'V:2F7,FNTPVV\AMA&3G98<5-'C9(MB(VNXA1!545%)/J*O-?929Z8GB
MZKTS7,-K[>Q@?&+4/*<=?">.;REEY#D\PSW//N.*KR[2Z(.]33TZ:=57U7HU
M=K-<S=QSMOPK5JSQ[D\_+>6,RMTJ-)GXG<[E=;ICB(O;9F@;[K[;'Q0&FH-K
MH0*.B*.J*I"E5T7O39/DZ=^JLZXSS68]E\&5R0!S'BL6.8LTXP&[XB0*RVE#
M>,>,B[-B)W!][HJZ>[I7=IG9LY5_P<^VL5YIZD9_-[-?3M.0P;I EO@EMDW"
M,*25: DT!%$1VCN0MO3U2NRFRU)]J'+-<\GA@YK?83=CL?Q$67C^\H5QB-1Y
M3DM\$<74A5H$(5V^XB]%]WTK.-5=N<\&-=LUMA[<FXWD+=1?P6\GQ-9;_)&5
MF'P!&4JX/M,]MK:RJFW&(41"/:([U^OJM>//9QKV=59R]";S-?:>I[C%J58&
ML)OLRZ.VB)&EI'NL:0\S(4WU4QE?$QS%Q3!4%=#0@5475%35%]";1MKTV<M+
MVI*F2M5LO6&Y.Q9,?DW?.;7"*+B9*^X+B"TAH),(1-(;BGZH1)N]NOI5-WR^
M=>N+4=.GN/;GJY++X+M.>XIQPW8\QQ]ZT76[*2GD+DEMXV5)3T)]]UWND*::
M *D2HJKZ:UAHUQ,_\D\3N<7XU9'/+3-<Q^7;6Y$.[N*YW+Y=I+XB*/+U:5E%
M)7!,6433HJ?MUUS$1LSAG6]\9E"[+A%T^7]^!CO>L5X1UEZX@J$;':4>U)+X
MHQ=+JBJJ(FU4]:Z[]WKK.(Y_<PXWG*.I-ND;(?R,E8R.18Y;6WRC7IF1\ ;[
MC ;B:;1EQIY=A*N[>">GJJ:UY%XWVOU1'#[X];NI\/IQGBF-JO$P(F26I1NM
M\MK8.PIEGG&R3<$7]FTB41#46T%40152_=5U12+WC9GC$8QZ6-ZQ5@$LUHDP
MAC!;9=DAM=J)*G00DN?'":;=JF+@HGU=R:Z:=*[]^VVZG3,8_HQK.);2>.%E
MLV+9##LEEM4NQQ0:EM)9A36*RHBCBFI'N-#,B553<OKUKR+:NBO-:][3&)C@
MWCK%B4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&@MNR.Q<O^6V?\=P. L(R' >
M-(;3/*?*%XM,.1<WKY+C(Y#89-X-3$$!6RU$U]U5W".U")\&,N>2VSAWRRP[
M LA\=\$L'&7)+S4+AWE6S6N"Q<F+TS$ WV91-AJ"N/DK;:"@%HHDA&FY )\'
M0VBI0*!0*#03Q/\ ]XOSK_GQ9?\ -)5$RW[H@H% H% H% H% H% H% H% H%
M H.2OV;_ /KM\\/Y\0/^DLBHM9UJHJU?\J?^K7%O^U#&/\,Y7D_-_P &O_ZE
M7Z)_UQ_]SWG_ .Q[_P#"&T%>L_.R@X\_9-?_ !,_SEM?_M"BUG8:BI0*!0*!
M0*!0*!0*!0*!0*!0*"ON56C>X^R9MJ.4IY8X*Q'!-2)P70(-$_\ ID1:V[><
M;(1+06TLS_GN0.9=$=E%8[-![LQQD>RU)?\ > 6G45-41153UUT6O7ZD,'8\
M9F0+QAYWTK@#DIV3)=V:FQM>,E0% &]-AAU54)-!TZU:)CID2&^1KG<+-D.8
MOH6.K%D-,V:U2-6'4CM*C>D@G2$??=5%U04Z=-*QU;(FV!#\@R9V_P ZRV\X
M@3V++)D,OY:3I Q G/\ 9(60,-PZ+N!&R)%W$JH/U2KJBN)RB\<$>@S95HAC
M/O W"ZVN->FKC OL&,I-RY*OJ78$5$=1T0]53V_^5>8P:[RN6? N@9PUD6*3
MH5WD7JVRFKI:ICHQT@QFFO<? %-#->^ "NO1-=?2N2)B5LJ^QJZ7&!.O=SG1
M8[<^S1FTN%UM6TSN ]Y0 $^L*J2@NU4]-OO:UI;VHPB9RM&UQ9S3.59$RX["
M>O<Z)+<AEW1=:%R,R(@IFB@I"X9)[B;5KS[Q,SA>KRY':;KD3^'1I!.VPWKN
MT]'N(Q0E.QF&VR-[>C@$"?$:(*ZHFS36MM<S6,)EZ<M^"O61V&UMV>0,2R=Z
M9(?CB+L>-M0@9[K0CH6\1W;4ZZ+TJ_-#Z8N%L?M$C)<C:.UJW+)P4F@EO1_9
M^#9=4=H:)HNJ;JS[B9K*=:'7G',.8NT%MRX2X+^2.E)(Q)) "WW1?,E-$T3W
M4]5]$KKT7S16W-.<?MUE;D2\>=FQKHK?9NF-1275]J,B;D<0NO13->NGTUC>
M9RH@L#(+SC]VO.4Y7"."J:LR;; ;)6C<=D["<Z*2*A(6J=:M;5&^.C^:]4B@
M7;+(LV\75ZWVUO&;Z*G:E<;$''W#$5:1[J*].NY5_8K#9'7B(_V?Q_DME+KW
M:^/;A;F\,SVU6M(<TV5BV\Q[3,M\"%T5:VKJ*"6WT7K_ ,-</<VG=Q;4E$,S
MM#E\RSXJ#:(MWMX1WBGPC$A=??V=LD5U%1$(?NI7J]C?X=,2RV<V8O4T(.'.
M0\G HLZ>ZY%B_"L]T(W3\![=-43H77UZ5%-N=C)44"XKV7;LY!GR<FFPUBQY
M3:-I^&B[6VU:9$-/>0]R]/5*ZMO&> D4$VH&-OQY[,VSP+-=NS/><$7I5Q=>
M C)4<;$1ZE[13ZJ+KUK'X61DKI<X$F3<AQ5ANV,2Y#$D9MP E<E21#1\(C:I
MJ>@%HHHBZ+K]RK4UX5GF^V+0)>4-WR=F*27,9BSS6U02CFP*M*:[B=0A12;T
M1$UUZ+[:C9?H:0PE^NS.6RCLL6Q2K3CUG"%<DN#(+'!N1KH)HX0;2#WNB)ZU
MMKUQCBEG<>A6NVPQE7.6,>VV(@"4\1E)FNSB5"("#1-XKO5>B:)Z+7%NC%L"
M;.QKK)GI!ORQ[;:KLUH,R)M;5[O(798;+1?>$-%T^C5?95HC@/E+M%MOEHOE
MIN%I?L,8&6K9%O1O"^\XP)[T,0)$10WJB:Z==?7I6/7-!)8-DCL8PS:&Y#]^
M@+&;A1A3M(+;;6FH]QI$U+W-WO%[>E9VWHRC]OBSGKK-NES4<7MMHDC;@E.*
M8I*C-)[HDKJJB[E5$14K;KZ:Q)\/*+91QC/.]7*YVAIV='G&[.:7OHBE*<1$
M1LD':O;0D1=?H0JUU]S$\$31],-M35MO=T.?E47XNS"AOPHQ1U;!I/=5!1%4
MFQ0EU)=$ZK5^[OU4X$/9(F9/C4ZR6G'(TO)+%&=C*=S!T'>XDPS[BN&B$2]K
MW371/;[*Q[?56*YE>T\F!B<@1&+O=H]W>:<O+D*04AB(#K+LAP) @#$<BT1S
M:B:="(ET1=*B:4M.%I]F'@N7>MZR'HHSFY5RVW&UV-27:*J*;VS:(MYHG[K7
MT76MZUB8^''@SBW5Q9*%"LN<0DA7%R$S<;:9P\G>W$PY"0E531LB)455-%!=
M>GT52W__ #\DI!>;M:&)+N,76VQIN/6VW+)LLU#[CSRM )$0$WH(: FB=55:
M4C*C(,OX(MALK<Z<S%:OKO<M$2=(,%?>4?<9U<+7ZB#JGW:K-,3E->$OS9+#
M*AK(6"]";.UNR'"L#.U[:\Z*D(O&VJ+I[?JU$;.."UFU/#$V7<.-L=ESI+4N
M4X4X79#*;079.?!$1-$]$%$KA[G_ ,D_QX$<EH5@DH% H%!J%R'<[U:<VNC$
M:&RY"O,EMLICB]6MC8ZK]9/36NGG2(:ZT&NDC&TNEBO%F*3+"&^Y'G-QT)!$
M2ZDZ8N(BZ(GMJ^OA&$[)1%ZX.6V+:;G9+DY.A7&81#"+3<!N*JJ9$J]$T31$
MUKIU]O6S+JE\K++?MJFT^S)-R0DWY@XTJFK+8MJJ.*B:HBKZ)39IKC"U;3,O
M5C<&U2;+>)DN%+DR+41/QG%38XB&**3@]4557;UUU]GI7'\:V>GP7??#YD/*
MYET<ND!+C"9)J="26J"8NZI[FHJ/[")5MEYU>S'WD1F7WM%OEPKZLAZ2H6*
M\#EI "59:$)H)]UM%+V#^Q6>N>IILKP3G\NK1D%GE7&WN2&D8E-N219;$W=0
M33:8JBJ*+U37337U6IKKO,LZ\%/6RQ6R^9'-Y)>_]0$_ :MEO@F\)]Q&'G)+
MQ(V2DJ$:]L?=Z:"GW=:VTWK:+3X-K7]F89_(;<CP6<(B')N%_=62$9HT!([
M%UWKKZ_AM-4_8]E;]MW$3;$L[ZYZ,O'BCV&6F_VVUI<"M6>OK\MB&L5'I<R*
MP\[,?:;[HD",JI*1'TT71-==$JG<Q2+Y6I:>C#-WB"_%R"XR\=>!IV2:/S+T
M\HGN,7!38 *JD.J*J+M3HJ>RNBEZ8Y,[,78;!;4=FW:]O% F/S7)]L@MIHI)
MH2$I*:*JKM+737V5$7S;$*S^%BIDC)W6YEMX]DPKC=XO?G1.\VK;1 J(C/=,
MD73:6J%I[%J.XM-85U\WRM$;([4Q&<RYQJ3<'HFF1/Q1;)N"\2*.@(+0D2&'
MM+=HOT5?.N(AI9Z\?&[@W$:M]_:69+MFZW1D0%=?BIN8<*1O3;M$P_9TK2>B
M:S,0S9!V/FEK21=+7:X\6Y/VX#=O+>BM&\RNS\$ [OK BJB(-8U686_1GAMO
MQEO$":1U;K--#17N^!;3=:%%U]Y/9IZHM=.JU*_B5M,QR>3X2\7*RWQV1<I,
MVY($:5;GYH--1S3=[B +NB*X(EJHKZZ:UEMI-_P)TVX\6#QA.0H6$7F#>[@[
MDLAZ[@PXHQU;5&I &BB1( IIJ@JJBNB5EJK;3;VN;HV_8F WLH,65CM^MTY(
M]X(6'#>:7X4)"L"2-MH*(NQ$Z:IKNJUXQ/6Y*\W]Q)]BSQGFY$2<:OR)*7$
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MU":00)!-7"14+=U42W)MKDIV]HMU0ZI[G->G"?W6QS\@E8KGS6.MOW:SPI[
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M:6Y91%ND6=#MIQ[MD45CL.-.]R,ZHHHH3(M[A+<.A>J(G5.NE3KK79JG[_\
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M?W[^W-_R3YKLU[9K,;,[*S2.BO3>9X13,]'3.8Z<SB,<7/3[)K_XF?YRVO\
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M(5+:J?NOW2)NKS)F9F)\W5OK$4='ZEP% H% H% H% H% H% H% H% H% H%
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M0!%J66Q2,D1!1%443JI5W6UYA3JEA(=R:>DY!DKMH^72+FD1+=';,V5&432
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MQM\EG4@$5->X!&\@$1(FBJH)U32M>V^9_!S28\4Z^TZHSYH].Y"!9F(6&VY
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MG"R&X%;L4S9_%)$B*_'GVF HR&5-\>V!(^2F DBKKN3J/LT6N:_;3.J8\?\
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M+.).VN[W*U6Y9-RD+"FLF4U'B'8K8.&"$AHFI*J]--:WFUYF.E68B4<>RN3
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M73:G371*B:1:<M,81V=>G&KM=&(,NZ-8]+EH1C 98^#:<=:0Q5LC:]Q-135
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M<=;; ]^T]B)Z:)KIJJUS[HGHG/FF\\&]=<3(H% H% H% H% H% H% H% H%
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MUUX5:C$X2FGU%+>B+UZ(72NC1KF-BL[>K@U/NG($"1EEOP/.L/D9/&G6MZ)
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MHJZKHNU$1%ZUT3NUZ\1X2RF;9X,;=\?OT/X+\G[^WCN-L28Q7R?!A/R!G01
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M% H% H% H% H% H%!4.6\?W;(IMS>;?@?#R1W0Q?5Q#%Q!1$W;07IJGTU/\
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M^B5:F^M;1,Q*8OC+'-^/N<%96[=,N5ADR1CBW\0+LD.T0KIMCHL<A:;VHG1
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M?W?_ #'VK)"G#W'(*2(99BBB.O542WRM5T^YJE/D'_EM_P"W_.#Y]_XJ_?\
MY2\?FS,S:1Y/>,F*8;FERPN1E:?+'+G >(>PDR>,9R0C6NPW&VS)0W)]9$ZI
MZU/RR*1V^VUJQ../H1\SF\]QJK6TQGUHY+P6Z^,GFKP;CN#<@99><7Y6CN)E
MD+)+F5P*6\12&7E>VBT)^C;@*0J0FBKKI[M:1MCNNTO-ZQ$UY8C"DZI[7NZ1
M2TS%N>9RKGA[@&P3?/KE+!CS/+VH/'<%O)[==VKBT-PG/QY5G>&-/>6.HNQR
M622$ @*J@@F[IUV[GN[1V5;],>UPY<(Y\OMX,>W[2L][:F9]GCSX^'/['MQ3
MBS(O(KRH\HN/;SRGE.+838;U-N+MOM$PD5V2U.-F$V@N[P%IM''"443JNWVH
MBI&S?7MNVU7BL3:8\?NXIUZ+=SW.VDVF*Q/A]_!B>6<UL^:>1V0<.\FY3R'$
MX5X8LT:RV''<-&1,G3IT-B*S\5/5L7=RF1.$KKB$2(@@FBD2K/;ZIU]O&RD5
MZ[SF9GECCR5[C;%]\Z[S;HK&(B//[5]>'7(^9LL\^\<7/+\DA\>8E;)-XXIY
M,SF \,JU0!1UMQR7\7V@<".BM.JVIB*;3TVB7N\OS+33_CO$1U3.+16><_ZN
MOY=NO_R4F9Z8C-9M'*&E'(S>!VCC[(,]P#ECF?ESE.R7-MZ3S;&B3;;BS/<G
M TJ//2")]I5%U %4=+<\2:: 6E>GIZ[7BEZ4K68_#PFW+^/Y/,W=$4F]+WM:
M)_%QBO/^/YK.\O<;>S3'?"WDW(<CO4C)>5L?L,')0&0V$5LRC0'W)L1H6OP3
M[IS#4BU5.@:"FWKA\NOT6W4B(Q69QZ>'W<&_S&G773>9G-HC/HX_?Q6'Y67Q
M_C+*N"?$Z+G6<Q>+6[1\ZSJ_P'5GY+=HDJ?-1(Y'&:;5U0^&<1$[>SWA(Q+M
MUCV%/BUV=QTUZLXB.58X0V[^WPK4[?JMTXS,\[3QEDO&/-)F#>35GX]XQG\B
MWW@+.K2^,F-G,&6"VB[L,2) DR;C0"*$3 AN1!0D=T-"(!*J]]JC9V\WOTQL
MB?\ ;XQ_'^">QVSK[B*4ZIUS'^[PG^/\6)\;./K]YHW/DSG#D'EC,\>NEIOS
MENX^@8[<%AMV75H9 $T*BXB"V+C8H ;=VA$9$1:I;O=U>QBNJE*S$QQS'-7L
MM-N^FVV][1,3PQ/)._LPF)\9[R0C766D^YQ\EM[=RG)Z/O@L]'7$TT^L2*M9
M?/)B?AXY8G_)K\CB8^)GGF/\W5RO >^4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@Y;?:#D(<P^%!F2  9C.4B5=$1$N%@U55KW?E'_BW?\ M_RL
M\+YO_P"73]_^=5R?:,$(^*>;(1(BG<K(@(J^J_,6%T3]I%6N;Y-_]S7[I_P=
M/SG_ .VM]\?XM@/'/_=[X(_V>8O_ -$QJY.\_P#/L_\ =/\ BZ^S_P#!3_VQ
M_@T<^S>_ZP^5'\\H_P#A;C7J?.OPZO\ V^IY?R;\6W_W>LYM_P#$P\;/YFM_
MX3(:=K_^[]G_ +O_ )3NO_WAK_\ ;_\ ,D?VH[-M/Q[Q]^4#*W!G-( VMT]$
M=13AS>Z+:^NBBFI)Z=$5?1*I\BF?CS_[9_QA?Y[$? C_ -T?X2G&9>9N!^.N
M,\18YRC8\LN^49'@UHO$J19XT*0"&;*,NH\4F=&+N=ULE7053[M9:_EM^YM>
MVN8B(M,<<^IKL^94[:M*[(F9FL3PQZVJOD?<L<\D>:O$F7:XTN#C?+6+W:+$
M9N;;8266I_Q$="=%EQX1(%7<FTUTZ*BZUW]E6W:Z=N>=9CE]C@[VU>ZW:ICE
M:)Y_:H3!\OF\OX/XJ^*$]MPIN/<G7(,XMKJ:N!;K<Z$@-R(JHJ"Q-F!HOIVO
MVZZ]NN--]O<1XUC'WS_Z1_5R:MD[J:NWGPM.?NC_ -9_HWC^S)_U>\Q_[0Y?
M^:1Z\OYY_P"2G_M_S>I\D_!?_P!SI?7B/;*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0<I<>5J7]JAFB9+L)^WXR"82#A*2"?R2"J]G<B=
M5:<DD2)Z*I]5]:]^_#Y;7I\^/]9_T>#3C\RMU>7#^D?ZN@/*TGA.,SBY<U+B
M0PCN>S%3RX8A1AN"M&NK*S$5L3V(NB]/V==*\CMXW3GX6>7'&>7\GK=Q.F,?
M%QSX9\_YM&/M..56+%QEB7$MON+<25R7<0E7IY%4@:L]L-MS5P6T(]KD@FR'
M:BZHV:(BUZGR/M^K9.R8_#'IG_1Y?SO?TZXUQ_NGT0U-<YBX%XC\G>#>0>"L
MS"]X.S8+=AW)P+ G6Y1CQV@MIS'TFQH^_<PC3_NJ2]QE5)4W)KZ'Z;?N[>]-
MM<6S,QQB?MQP_I_-Y_ZG3I[BE]4YKB(GA,?9GC_7^2\?+25G\3SXX+E\5P+3
M=\];P:.6-0+V1C;W7%DW[>CY-.LEIVE)4T-.NE<OR^*3V5_B9BO5QQS_ -KJ
M^83>.]I\/$VZ>&>7^Y66=9+SKY5<N8[XO^1-QQ3A!;+=F;HMI@PI:O7.2C#H
MM?!/F_.9<<*.\YV]7VVUU_=N(@5OJII[35._3$WS&/N^_E_@PVWW=WMC1NF*
M8G/W_=S_ ,70[G#RYXG\6;KBV Y5CV47 Y=D9EVA;%&A2&6XC1G% #*5-C%N
M3LKZ"J::=:\?M?E^WNXF]9CGXY]4O8[KYAJ[28I:)Y>&/7#2CR/N6.>2/-7B
M3+M<:7!QOEK%[M%B,W-ML)++4_XB.A.BRX\(D"KN3::Z=%1=:]/LJV[73MSS
MK,<OL>9WMJ]UNU3'*T3S^U0F#Y?-Y?P?Q5\4)[;A3<>Y.N09Q;74U<"W6YT)
M ;D1514%B;,#1?3M?MUU[=<:;[>XCQK&/OG_ -(_JY-6R=U-7;SX6G/W1_ZS
M_1O']F3_ *O>8_\ :'+_ ,TCUY?SS_R4_P#;_F]3Y)^"_P#[G2^O$>V4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@Y(<1<S6'P@O7/7%O-]CR6$62<AW?,^-,B@VQ^=
M'R.)=66098C/-IL[^D4=R$J"ADHD2;5HM,9;>QLVY Y.\1,[S#D+C\N.<IR+
M!\E=#$.ZX^^$<H,D8SCC;C39M&\&A=I=Q"BIJNY5$2/%K;@$"<'V5<^ <-\9
MR\;Y*"0E;)'=Q2IV@[--VJZ^FE$^+6'*N '>+N)/%SG6]KF/-'#OR7%IG,O#
M-\NLZ3&MISX,=69MNB,FT*-1G75;%AQ"%/<!?<,E$G+82[\\<=<4><F=\DY;
M-N/Y%YGQ38H^.7NV6N;<&Y)ONL2F]!C,F0HK0JNI(GT+UHC'!T1XGY<PKFK%
MW,PP*5-EV-J<[;C=GP9-O=[[ @9IV93;9Z:.#H6FB_M45F%FT&A7GO OD''.
M".3;=C\_)+)PSRSCV89I!M;2OS&[5!,R>?!I/K(*H(JNO3<BK[J$J$PI_&>2
ML:\J?-[@_DOAYF[WO N'<5OR9AE<FVR(<-N5=(DJ(Q$0Y MJKFZ0*Z(BZHBJ
M.J"1"3RA8^50Y9?:;\:3ABO%"#A-]HYB 2M(?S.ZKM4]-J+HJ=-:'@@&6\Q8
M7P5Y\\FY;R(=T@V"]\9V>U6Z= M<RXH<I)#+R@J1&G%3W&R75>E#&8>W@;%^
M9N1+KY=\Z\>/2>'KGS9?;!'XDG97;"55M]@)0?GR+<\);DDQS4&U5/=)3T]-
M:$JNY\XBY3S/.L7P+E6^Q.0\ZG<*Y\JY):[>D&$[.9D),M+:,@ B!"XTTB]-
M55-:$2H7B6U9IEEW\<.<<UM\IS+^4.?K<ETDDRXA+;<>MT6WQ7'-R:BB.=].
MO2B7^@NBCGCY:P[[QUSSXV>4 8[=LJP/C!;Y9N0XMGCG+DVV+>(;D5JX=AO4
MB;#OFKB^S8">I)1:$NX_\S;?RGEN9W3!<)N5P\?\ Q"1?<DY>G,28&ZXQD-X
MX,&*ZTI2E[0^GN$*H2]4[>\C#G7 X$\M.8^!>4.26K-QY%A<TY _RF871R]!
MF\:1:77C@1K<K3/P8(K0&$<7-?<>74@W)L+9A;%UT\N>8_#.]76Z93ARY-QO
MD"97><9DN6FY0;O %YN6V$A&R[0G(9+1"'WVR3IH5$<DW\8,4OW$/*?D/P7?
ME<;\A[U99,OBWR%O13+E\^M2LDEN5\9;CS:%#<0'#:;^N@&!;NSN(2S',V \
MSJGC-CW/>96SE2;=><;8"S;+:AM[#%I?MS[+K+S;;8HNI*:J2IZ%I0AS>NN
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M-NLM-(V2.=5)%;UU2L/F'>1W-JS$8Q&&_8=G/;5M$SG,Y;55P.\H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H%!ISY'^)S7,>1XURA@F9R>+
M^8\. 6[/EL4%-J2TVI&VU)$" T4%,D%P57W"(#!P=J#Z79?,/@5G7>O52?!Y
MW>_+_CVB])Z;QXJ8M'A3RUR-G6+9?Y5<TL\EVO"'0=LF(6R-VXKZB0&HOJK,
M9L!<5L4=VLJ;B)HKB5TV^9ZM5)KV].F9\9_B7-7Y9MVWBV^_5$>"VK[XJ3,[
M\IF^=N1KQ:,FPJQVGY9BG'[\0I MH,<FA^)1]"9,4=??>T0>AJ/T:UST[^-?
M;?"I$Q:9S,_Q_*&]^PG9W/Q;S$UB.$?Q_.6>\@/$CCKESC*[X?BN+XS@63N/
MQI=BR>%:8T<F'F'44Q<6,V#A XTI@J(OJJ+[*IVGS#9IV1:TS,>,97[OY?KW
M:YK6(B?"<*ZLOB;R"G,?CSRSE&>VFZRN&L.C8K?&6F)'>N10UN;;4D#/T4FI
MC>_=U4A)?:E;6^8:_A;-=:S'5;,?9R]3&OR^_P 77LM:/9C'W\_6FOE?XIM>
M0C6(9#C-_;PCD[!Y@'9,N4'%UB(?=[)JRHFA-O(CK1(ON%NT^NJUG\O[_P#3
M9BT9K/@U[_L/U.)K.+1XMI,2CY)$QFPQ,QG0[GE,6"RS?[G  FHTF4V""X\T
MV?4$<5-VW]SKIUK@V36;3T\O!W:XM%8ZN?BUVY6\>[SR%S_PES%#R&%;K;Q7
MW?F%F>:<)^7W'"-.T8^Z.FOMKL[?O(UZ+ZYCC9Q]QV<[-]-D3PJK7C+PN3C_
M ,I\O\@#R&#,L=W?O%PQW&VF' D0YMY+\,1&J[-@B\^*(/L(:WW_ #/XG;1I
MQQC&9^[^(8:/EOP^YG=GA.<1]_\ $K*\4?'N\^/&-9Q8KSD,+(G<KR9Z^QWX
M33C0M-NLM-(V2.=5)%;UU2L/F'>1W-JS$8Q&&_8=G/;5M$SG,Y;55P.\H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H/+)FPH2-E,ELQ$>-&V5><%M#-?01W*FJ_<2@
M]5 H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M/M(VJI]507K1/4WEY^\=,9YWXA:X<>N;V%X[$D6]RWN6IAHOAVK:FUEAMH]
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M!]4U>5ORR?KR<1?Z,\A_T4G_ 'M/I>WSK^:#ZIJ\K?ED_7DXB_T9Y#_HI/\
MO:?2]OG7\T'U35Y6_+)^O)Q%_HSR'_12?][3Z7M\Z_F@^J:O*WY9/UY.(O\
M1GD/^BD_[VGTO;YU_-!]4U>5ORR?KR<1?Z,\A_T4G_>T^E[?.OYH/JFKRM^6
M3]>3B+_1GD/^BD_[VGTO;YU_-!]4U>5ORR?KR<1?Z,\A_P!%)_WM/I>WSK^:
M#ZIJ\K?ED_7DXB_T9Y#_ **3_O:?2]OG7\T'U35Y6_+)^O)Q%_HSR'_12?\
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MO?9,36\U^Y5OZLW+O]<'D/\ >T#[RM_UVK^S7TL/T.W^];T'ZLW+O]<'D/\
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M9KZ3]#M_O6]!^K-R[_7!Y#_>T#[RGZ[5_9KZ3]#M_O6]!^K-R[_7!Y#_ 'M
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MP%@.?<?<>6NV\H\B7/DOD"<(2\GO<YW?'8D&":Q((((:,M=40B3<XNIEM11
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M>I$KGN[$K]KN)M7*43;*2#12(FQ5(Z:ET5M4]E$S#I514H% H% H% H% H%
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M#BF1MQ,4Y;M5I"TM9,3I2?BWC (\;ND';:<5PVT<7O>^JEUH64_YW%FWD)Y
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M95BDC!\@.WMA<<6E26)CT0FM6Q0WHQ$T2F H>@K[N[:O5%HJG5 H% H% H%
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M4J!.N-HA3YMJ/NVN9)CMNNQC547<R9BI NJ)U%4]*#[C;K> RP"#' +@I%/
M6@1'U/5"5U$3W]VJZZ^M!XXV.X_"M;ECAV*WQ+(\AB[9V8K3<4D<ZFA,B* N
M[V].M!][7:+38X@6^RVR):(#9$00H3+<=D2)=25&VQ$455ZKTH/<XV#H&TZ
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M_,Q:=<W[@DA$3LB(2D1O8JZ[E]?HH<&S-$% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!
M6O*W)_'7$V)NY'RADS>)XQ.D#:OFK@/N?AY+;B@V/P[;AH2B!*BZ=-*#BYQM
M!X+=N%HQ!?*[%<CE7S(,&Q:SLQ<?NT60F(XO/*?&@QB)C:W.N%Q&*3KBF@#H
MX6I;MM%W>VBA0*!0*!0*!0*!0*!0*!0*!0*!0*#\.[NTYLW;MJ[=FW=KITV[
M_=U^C7I0<).,(/E:'EK;QR'\X/RQF%CIY'%6?8CRP,4^<24M7SA\6D9>;22A
M%+ /?5A50UT3H7X8?OFR#Y5EY5P1LGY?C9'9&7N81&"?8TRD\=^*BK?5L;W:
M4&6B10^"!W5Q 30>J]1&,)=YHP_* ^=,*+CTLI9L$C*;4. ?.I=C[3F3_(G4
M/Y$*-K\."1T=1U7E5M9*J0IZ:$1AYO+^)Y(K9^%BQ%<\B6,8.!M3W,[EV1]I
M,H6;I:4)MII36XC(U68X7N*FWN)ILHF'4[QZ;S!GAW"FL_#)F\S"/(3) R]^
M))NR2_BGNYW'H*"R;6O]X44_O.S7KK165T404"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4',_P D> ."\^\C<8#)>>,OX[Y9Y4MS5ML6)XS)
M;8[\6V,O."Z\:1S5L2[1"*N&B&?N@BKKH6B58,>)/CMB_/> \99+Y-\@W7DR
MUR+;FF+X7?IC3\66<20X;(BX<56>ZOPY_@T-'%!=131:&77^BI0*#$9"5]"P
M7P\7;ANY*-ODKCK5QW_!E.1HOADD]M4/M*YMW[51=NNG6@Y$Y(USOY$9_P $
ML2/&:[<*\VX#F<>\\I<Y# ^ M"6R"BL.,0+DI.'.!]I!3M$X?U!!%)LB(2W)
MC>1<,YMXHOOF?Q;C7">5<CVORJN)73CO+K#&^)M,-^\F_P#,4N;ZDB15;^))
M$5Q43<VB_P![)#0+ RCB3DCQMY#\3N8;'@5_Y=M'&7&3?&O)EEPZ.LZZ"XS'
M?)N1'B)M)QHI$HR31.B!H9(JBJC.53N>,7-\SQKF\C-81+B<M2><BYHB<8J2
M!/;MVBM)"0%])&J][:OO[$0-O<U%2<\6S? .+YGR_P"3',?D=FG%N0\8X/D&
M#Q>/\>Q/,(BP+I/;<*,].=>B$JF "491$NB$)IIJJ%M(GDJCSZ\8> >,_&3,
MLOP+BRR8ODT"?9VH=YA-N"\V#]P8:=05(R3W@)47I0B>+IWQE_JVX^_FU:?\
MS:HJG% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H%!XX]QM\Q^;%B3H\J5;3%JXQF70-
MR.9"AB+HBJJ"J*HJ(6G3K0>R@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@JG
MF/"<ZS[$F['QYR0SQ;?PN#,H\F?Q^#D@%';!P3C_  5P(6D4U(5WZ[AVZ)ZK
M1,.:6!9S=I_(=HMGZ^D'([?;<JLEF>3\SMF@6^[R[A*E S!B7,.NV05O?922
MWJVA:*!JNE$NP=%2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'++D;-,(\<O.G(>6N<[;(
MB81R+A=OM_&_(:P'KE&M,Z"@-S(VC(.NLFXC9$JM JZ&G[DS5"W.$2\@>9>(
MO*ODGQ\P'QY(\YY0Q_/K5D,WD2#;),=NP66 2NS"=ER663(%50<VCJ&H(BKW
M-@J(C#KU14H% H% H% H%!H)]IG_ +H&??\ .=A_Z4CT37FW#XR_U;<??S:M
M/^9M40G% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MN>.Y%S1B%EOMEDN0[M:9EUCM2(TAI=KC3K9$BB0JFBHM$X8G];OQ>_3W@_\
M'$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\
M'$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\
M'$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\
M'$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\
M'$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\ '$7[^AB3];OQ>_3W@_\
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M&T)H^GU26@U,\>_"4N$<1SNRP.3,@L%PSR%=K=,9QZ>2P8BORS*V7.*,EE'
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MM693K/RM:I-SC6\S(F6G)$8!,MPCT4NE$Q#LA14H% H% H% H% H% H% H%
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M$$/5.NB4&<H% H% H%!H)]IG_N@9]_SG8?\ I2/1->;</C+_ %;<??S:M/\
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M61NO\>-/Q<YCX?X>OIQC/3CAU=6?]W+V73*OJG\_% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H->/(7
ME3!L M..X_F''%TY<D9S*D#:L M-KC79V0U:F?C9DIQB8;;.R,V*'U7<I;4%
M/:A,-<_#K,^*,.;PWB7"^,<DQJSY9:)\SC/F+(+= BNYO#MKY2'7'3BH#XD
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M.(OW]$XD_6[\7OT]X/\ QQ%^_H8E7',7E5XW7CB/E.T6KG##;A=+KB%\AVV
MQ=HQNOR'X#S;338H>I$9$B(B>JT(B3AWRJ\;K/Q'Q9:+KSAAMONEJQ"QP[E
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M)K%QG;<,\XI608EA/R:Q9%Q!?)^17V)$,(TW(+EE427(61+VJ)2'412VD6Y
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M)MYHDU$@)-"%4]J*BT0YVXK]G?Q'CG,.=7V9A&,9-P_EL%B39<4N8R#N-CO
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MYUDF9\OR^,>9FL X\\B"AN<P8E)M(SWE=C$JNO6]]7!4%?WGO%5'ZY:D0[$
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M;7\(.A(B$3]SI714H% H%!S-^T0_ZR>'?^UVV_X:-1:KIE14H% H% H% H%
MH% H% H% H% H% H% H% H,?=K;'O-KN5HEF^U%NL5Z')<BO.1WQ;?!6R5IY
MI1-LT0O=(5117JBZT&M'ZH'%O^DO)7]/LF_&%$Y>)WPMX<?FQ;D_=>07KC"$
MPAW \YR,GV1<Z&+;BSMPH7M1%ZU6:5F<S$9:1NO%9K$STSSCP_H]OZH'%O\
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M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H*7YXEX
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M?# B.%O^LBZ)UHG"_?UC_)K^HWDO]+;+][1&(/UC_)K^HWDO]+;+][0Q"?\
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M_#EOQVJ$EG^,8)V$4CXA+@KGPZF"DA]K=MZ[=>E"(;@>$?\ NG\%_P VFO\
M"N41/-M/1!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#5CEG_ 'FO$K_[_?\
MH5FB8Y-IZ(*!0*!0*!0*!0*!0*!0*#6KRBXRS+D?"\/G\=M6Z?G/%6;6?/\
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MX)P"MN7Y7<K[! 7'6G>ZW&F.F NHK2"AHFY!4A]"6AE=%$% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M^2&!N\-RWW2#?PPF/,0,>.]6R MMA70H/;54D,1E0!4#$.B$H*76AE_?+O\
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M&BV/^/\ GCSW'^8W#BR=B7EGDO+,J_Y)R!+RIJ9)MF-L7!)#LAYJ/*5B1%*
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M=&GQ'(K4&Y.,H;,:4(F3T&1HYTZJ2>]1,SP=G**E H% H.9OVB'_ %D\._\
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M+K):AVV Q=HQNOR'S1MIIL4/4B,B1$1/5:&)7]1!0*!0*!0*#G']IVXXO!6
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M/G#G,&9>)MMXRY!M693K/RM:I-SC6\S(F6G)$8!,MPCT4NE$Q#LA14H% H%
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M&UVEBWY177XW?MW]OM?6W[?>V?6TZZ:5U_H.X^%\;HMT>]B<,_BTZNG/%/\
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M:YVRZCKZ4(Y-6^<N-N;...;?'CCNV>7')TNV\\7J]P[E*<G*!VUNWI#<;^'
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MX'Y,B3H<I_RMY&N#$9]MUZ ]#QQ&GP D(FC4+2)()HFB[51=/1:@RV=H@H%
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M7X^H9CR/U)_*'_YA.<?Q1*_'U#,>1^I/Y0__ #"<X_BB5^/J&8\C]2?RA_\
MF$YQ_%$K\?4,QY'ZD_E#_P#,)SC^*)7X^H9CR/U)_*'_ .83G'\42OQ]0S'D
MUFS#C'RAQ3R=XG\</UV,XG_G0L=PO/Y9=B4U\#\#'GO]KX+YJ?=W_ Z;N\&F
M[71=O4GAALS^I/Y0_P#S"<X_BB5^/J(S'D?J3^4/_P PG./XHE?CZAF/(_4G
M\H?_ )A.<?Q1*_'U#,>1^I/Y0_\ S"<X_BB5^/J&8\C]2?RA_P#F$YQ_%$K\
M?4,QY'ZD_E#_ /,)SC^*)7X^H9CR;,^.G"?*'#OY8_G)\A+YSQ^47R_Y+\YB
M.Q?E7P?Q/?[7<GS=WQ'?#=IMT[:?6UZ$3+9FB"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4%*\VR<_>QN1C.#X->\G#*;5>8UUO^/9! Q^XVAQJ$3D/
MX5^;KH[+>T9!P$5&27N'[J43#6GQKQLN.\[A6&X^);7#]WR>#.D/\FWW-K)D
M^0W,XJ-D^A$+[T]Y"5P5<[:]L-1U$4VT)= *(*!0<RK[R[R>USA/R5G,KO'L
MMDY_QOAZ+QJVC"V=^QW:U@<J4ZUV4>*3WGOB$=[GN".W391;#Q>37DAR7E.)
M<W<)V/Q&Y<N:W./>\3M6;P[',D6R4B$[%;GL$U%+N,.HB. HJNHJFBT(A#>
M_*'E;A_ASC[C*Y>%G-%XG8;:@M\FYQL?G-M/$)D6X!.)N1/>]M"86]^O5R3_
M %&N;_XBF?P2A@_7JY)_J-<W_P 13/X)0P?KU<D_U&N;_P"(IG\$H8/UZN2?
MZC7-_P#$4S^"4,(O;_+.[6F^3LGM?V=G*MMR2YH27+(8N).,SI"&J*2/20@(
MX>Y415W$NNE5BE8G,1Q<].ST4O.RM*Q:><Q$9G[YYOKBWVC5[SFTA?L)\0^6
M,PL3CILMWJR0';A$)UM=#!'XT=P%(5]4UU2K.CI2/]>KDG^HUS?_ !%,_@E#
M!^O5R3_4:YO_ (BF?P2A@_7JY)_J-<W_ ,13/X)0P?KU<D_U&N;_ .(IG\$H
M8/UZN2?ZC7-_\13/X)0P?KU<D_U&N;_XBF?P2A@_7JY)_J-<W_Q%,_@E#!^O
M5R3_ %&N;_XBF?P2AA'+;]HU>[S?+YC%H\0^6+KDN,=G\I<>AP'7YUN^('<S
M\7&;CDXSW!ZCO%-4]*'2D?Z]7)/]1KF_^(IG\$H8/UZN2?ZC7-_\13/X)0P?
MKU<D_P!1KF_^(IG\$H8/UZN2?ZC7-_\ $4S^"4,'Z]7)/]1KF_\ B*9_!*&#
M]>KDG^HUS?\ Q%,_@E#!^O5R3_4:YO\ XBF?P2A@_7JY)_J-<W_Q%,_@E#".
M7+[1J]V:^6/&+OXA\L6K)<G[WY-8],@.L3KC\..Y[X2,Y'%Q[MCU+8*Z)ZT.
ME(_UZN2?ZC7-_P#$4S^"4,'Z]7)/]1KF_P#B*9_!*&#]>KDG^HUS?_$4S^"4
M,'Z]7)/]1KF_^(IG\$H8/UZN2?ZC7-_\13/X)0P]$/SBY'E2XL4_"'FR*$EX
M&CDNV.8@-H9(*F2K$Z(.NJT,.AU%2@4"@4"@4"@JGF/ LPY%Q)O'\(Y1N?$5
MY"X,RRRJTQFY4@F&P<$XRMN&VFTU-%5=?W*43#4U_P +^6+]<L5=SSR\RK.K
M#C.0VO(EQJX6:,+$A^U20DM"1!*U'50TUT737T6B<NA%%2@4"@4"@4"@P.3Y
M3CF%6&XY1EU[AXYCMH 7+G>K@Z+$9@#,6Q)QPU1!13)!37VK0?*3E^+P\GMF
M%R[_  8^6WF&]<+3CKCPC,D18ZHCSS32KN( 5="5$Z4$B54%%(E1$1-55?1$
MH/-!G0;G$8GVV8Q<(,H=\:;&<%UIP?[H#!5$D^ZBT%4V'@[ \<YBS?G2V1YH
MY]R#;HMJR.0Y)(XI1X;45EI&V%30%VQ&]51>O7Z:)RMXB$!(S)  $4C,ET1$
M3JJJJT0\\*;#N4.)<;=+9N%ON#+<F!/C."ZR^RZ*&VXVX"J)B8JBB2+HJ=4H
M,?D61V'$;)<LERB[Q;#C]G961=;Q.=%F/':1413<<)404U5.JT&69>:D,M2&
M'!=8? 7&71742 DU$D7VHJ+0?2@4"@KY>6.-$Q2W9RN=65,.N\_Y7:\F^+;^
M"D35DG#^';>UVD??;)O:BZ[D5/6@@5R\JO&ZSW&?:+KSAAMONEJDNP[E ?NT
M8'6)#!JVZTX*GJ) 0JBHOHM$XE6A/^)3?DV_R*_RG8(W/$:*6(O6*1D$=E1(
M?P"Q?@G#'\-K[J)]95]$H<<-K\BR.PXC9+EDN47>+8<?L[*R+K>)SHLQX[2*
MB*;CA*B"FJIU6B$/F<R<4V^W89=YW(=@BVSD5UMC YSDYD6KNXZH( 0B4M'5
M)3%$VZ^J4,+*H% H% H*R;YIXA>S8^-FN3<8<S]MTHYX<-TBK<4?%-Q,_#]S
M?W$3JH:;ON4,)'=\XPZP9#C6)7O)[9:<FS)9 XK894EMJ5<%B"AOI&:)4)S8
M)(JZ)0:X<I2/%K&^?L#Y0Y1Y)LV(<N8)9GHN,0KI>FH() N(3(Y..Q7%1"0D
MDO(A*OK^Q1/%M/9[S9\BM<&^8_=8=]LMS:1^VW>WOMRHLAHOJN,O-$0&*^Q1
M54HA747G7AJ;A%QY*B<G8W(P"T3!M]SS!NX,%;V)1$T(L./H6T357F_=5=?>
M3Z:)PLJVW*!>+= N]JF-7"UW6,U,ML]@D-I^.^".-.MDG0A,2145/5*(>V@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@I?F/-^8,*C6%WB3@
M[\]DBX.R!OD7\IK?C?R\&Q!63WSVS1[NJ1)H'U=O7U2B8:]8D]Y&\F^0G$^<
M<F>.?YFL6XWL>5PW;I^5]HR+XIZ_-V\6@[4+M.M[%A>NTD7=UVZ=0WMH@H%!
M3TO@+B:=R8QR])Q,3SR.^U,^9)+F#&<F1XQ0V)KMO%](CDEI@R:!XFE<$5T0
MN@Z$Y7#1!0*!0*!0*#5'PQX*RWQUX1@\;9M<;1=+[%N]PN#DNR/2'XBM2S$@
M1#DQXQ[D1.ON:?=6B9G+:ZB"@4"@4"@4"@U1XEX*RW _([R.Y?N]QM$G&N7_
M )'^34&&](.<Q\LCJR]\6VY';;#<2^[L</5/72B9EM=1!0*!0*!0*!0:H\M<
M%9;GGD=XX\OVBXVB-C7$'SS\I8,QZ0$Y_P"9QT99^$;;CN-GM)/>WN!HGIK1
M,2VNH@H% H% H% H% H% H% H*1YWXEOG+>.XS#Q7D*3QAEV%Y+%RC%LOCV]
MBZHQ,C1Y,7:["D&VV\!-RS11)=-=%Z^E$Q+FCP#GF86?*N/N&'OM"84RZ62Z
M,V:3A<; &KA:I\B+(UD6B)E=P:8<D&ZFH"\NA*I>YN7;J3/W.SE%2@4"@4"@
M4"@U+\Z[7<;QXE<V0;5!>N,SY,Q(^%C@KCG:BSHTA\]HZKH#39&7T(BK1,<V
MMV2<LXARYY/XUG'#65Q\K@X+PAEMPO-[M:D8VQZ6B+#%\U':V\IZ?@U]]-/>
M%*)QP0K$,BY2G6OBIB^\O9=E;'D)P#D]ZRR!<'HQ-Q+A;H,9R,]:P9C-HP>U
M]0-50E<^L>XUW4&(\>WLES4_$_BO#^=LHM.%2^*YM_S4+#<8OQ#=PMDF&"6T
M'OAG4:%AQP6R;TWHWO!2U6A++<9\Z<L3>;/C<CY,1F\_EKE=JS3AN5=/BGFK
M%:6Y!,-0,9CVKNQ766VFW@E.2]K_ +R$2ZJ*#"M\,Y=RSD*3R!8(W+N19/B/
M(O!V8Y ];KCD=NO%Q9N$/8;".0X,%IBT/*T9@<-MUU>VNI;5VT3A^W>4\FL'
M&'C%BN/<URL5X]/A@[VF:.9+%LK199 ",RY9CN/RV>CPVQ%41MX@AGIL(C(4
M$@P?-7*>9YSQYSS;N8.:9>,Y=9<!P\^/>-[+LAVG*HUUMC$R[7$8,N(V_,%U
M[N$I"(%%$5UVH*T(AW QC_JWCW_-D3_ A11G*!0*#AG'S?%I_BOQ'X[1[NVO
M-UGYJ"!<^,R$QNS+J9=.G$1QU'<+8L/"2N+[B>FNJ:47\6\>585AK_G%QQ$>
MQ*RO1;AQ7DDV?&.!')M^3\UA?AW15O0S]Y?>7KU7K17P:>Y3E7!,;COSTPK-
MRL=RY8R7E3,6>.<96.W+R&1-DP[>U:#A- !R-HS@U11Z(HE]VB5]^2M_YR@>
M,&;X1E7%#9XK"XP@!D?+3V2QG92W5N!&*2V=H1A727XM":4T>T7Z_ITH1S:$
M_*<AD9-A&!7>.\F-^)6?X_C^+/.JOX0\US +E#>3JJKI;(S8(BKT_81%4E_H
MFHH4"@4&/NP3W+5<F[4Z+%S<BO#;7C3<(/J"HT1)JFJ(6BKUH.3' V;^,UGX
M<X4XLS_#$R;GB!FS4&]8#&A(>6Q,N"Y/..7649N,.]MI41TWR=44:Z>]MV(6
MG*"\_2>4>6>5>9.<>..-;ME<+QPN%MLW%V=Q+E;XL&VS,/D_-<E)Z#)DLR9B
M/J9L?Y.![A%!]]?<HF$WS:YYWRYSMEO)? EOQ#)9,[@G&<EMV.9?9_FZSH\B
M7.=&)$1'6Q9D]5#WD5%+W%V^M$+S\7,DOV+\!\"V7@? 3Y;PFX%-#/LENU]B
M8[-QV:_<B=N#)6HV9.Y6''WMK+1BFT!T(NXAJ)<C<1M.0EPFYPXW'>'#>0,*
MNO.<F8"JK32XM9<A@/,GJJ_WZ? A'T]%1/8J(I9_HFX+_P!27#O\Q\>_Z-CT
M9RM.@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@ICR&Y7B\(\+<A
M\G2%!9&,VET[*PYIM>N4A4CP&E3Z#D. A=%T'5?91,.(OB3YZ\YR>?./K#S-
MR)*R/ <VD+9)#,V)"8;9?G*K$*4+C,=I40)0B!ENVH*GKZ46F'^B&BCSRI<6
M$R4B;):B1P5$-]XQ;!%5=$U(E1.JT'U:=:?:;>9<%YEX4-IT%0A(235"%4Z*
MBIZ+0<Y.9?-#)\6\M>-_&+$L<B1(MSR#'X^99?-)7WGHUT5IXH\)A-H-?@S0
M2<-27JJ"(JB'1:(X+I\OK3Y-W?",98\7+G\KR]J^(>0O=ZWL;K;\,\BCNN*$
M"_AE!=!][]K6B(PN_B&-GD3B_ 8O*#_Q7(L>QPPS61N9/?<D:1)!;HZ(TNIZ
M]0]WZ*(E8U H/',N-OMP@=PG1X(.+M;.0Z#2$J==$4U36@]0D)B)@2&!HA 8
MKJBHO5%14H.<?,OFAD^+>6O&_C%B6.1(D6YY!C\?,LOFDK[ST:Z*T\4>$PFT
M&OP9H).&I+U5!$51#HM$<'1ZBKRMSH+TEZ$U,8=F1TW2(@."3H(NG4@1=4]4
M]4H/50><Y<5J0Q$=DM-RI2$L:,1BCCB FI;!5=2T3JNE!R _6.YK_M*OS)_E
M[*_-;\]^$_)'X>)V>S\A^+V=WL=[^_>_]?\ \G2BV.#L/15RC^T[Y^Y?X-_,
MA^:G-I.'?E1^4OS[X=B*]\3\%\J^'W?$LNZ;/B'--NGUNOLHM6%$0;+]KI.L
MD')+7E3MQA3H;-Q@-MR\75QUET$=;T;= >JBJ>Z7[%$\%T^%GG=GN>\C2/'_
M ,B;<S;>1$*3&L60+$2VOO3H2$<BWW&(B VV_M E FQ!%V[%#<J*I$PV!\W_
M #$B^+F)VJ!CT&-?.4<S%U<9MLO<42'&841=G2P A,AW%L;!%'>6[KH!)1$1
MES_LV#_:J<JV!GE*/GUTL#5S9&XV/&7+M%LKTEAU$-M6[<R ,MHJ+T&1L+3U
M3KJI;@N[PB\W^3,KY.D^./D4P/Y<,E,A6+(GHX0IWS&VH:R+=<6FT!I3V-'L
M,1%5(=I;R-"0B8=>Z*M!/,*P>:]XR3#G/%F]?*[ S;'QRIOXFTL;YBO(K2Z7
M$2)?P?\ <]*)C#?NB'EE384$ =G2V8;;AHVVX^X+8D:HJH**2HBJJ(O2@]5!
MP?Y#YE\J_(WS$S3@3A_EA>-++B%VNUNM81'S@1FVK'N:DORGXS3DE\W76U1
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M&!(BZ="%51>J4'VH% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H%!K%Y,Y+Y&8=9+7DO &)0<\*!"O 9/C$@Q&2KKC#:VV7';4=\A&'
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M239;$"><4B)5)Q4W+JJ]5]:*.1WV:?)?'."\=\UL9MGV.8@^?(4Z6#%ZND2
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MJ.X1<3715374?K"2(0F- H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H*/\ )0\#
M#@KDPN3&KB_A7R<TNS5G5!N1.*X"14@D7NI(^)[?:4O=0]N[W=:)AJSP-QQ;
M.+>?K':,[R7D#+<XRC"[KDG'MTRTH26Z,Y<YL>3DL-IN*B%\P%PHY/.%T(%5
M$TT34F71:BI0*!0*!0*!0*!0*!0*!0*!0*!0*"A^=O'/C3R$L*VK.K2AW.)
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M6P4'KQMT%V5O4AU]Y=HIN<-5]TB9RVEH@H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H(KG&%XYR+B.0X-EUO2Z8UE$)R!=X*D3:FTXGJ#@*A 8JB$)"J*)(BIU2
M@I+A[QPP/C/)Y^:0L[S+E+*68;MCMMZS;(#OSMF@.. Z[ @ZB L 1-ANU13T
M%$W:*6I,RV7H@H% H% H% H% H*JY5/F\+?:EX0BX-*NJR#^>#G+]R8CI'V>
MXL9;:R\2GN]=Z(FE!2/Q'G__ ,D^/O\ &&5?P*B>!\1Y_P#_ "3X^_QAE7\"
MH<#XCS__ .2?'W^,,J_@5#@?$>?_ /R3X^_QAE7\"H<#XCS_ /\ DGQ]_C#*
MOX%0X'Q'G_\ \D^/O\895_ J' ^(\_\ _DGQ]_C#*OX%0X'Q'G__ ,D^/O\
M&&5?P*AP/B//_P#Y)\??XPRK^!4.!\1Y_P#_ "3X^_QAE7\"H<#XCS__ .2?
M'W^,,J_@5#@?$>?_ /R3X^_QAE7\"H<#XCS_ /\ DGQ]_C#*OX%0X'Q'G_\
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M_OB!^FRV?O&Z?P.AB4EP_P S?&3/LFLV&XARQ O>39#(2)9K4U#N &^\J*J
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M;7^+*&(/SP>7_P#4TMG_ 'FVO\64,0?G@\O_ .II;/\ O-M?XLH8@_/!Y?\
M]32V?]YMK_%E#$'YX/+_ /J:6S_O-M?XLH8@_/!Y?_U-+9_WFVO\64,0?G@\
MO_ZFEL_[S;7^+*&(/SP>7_\ 4TMG_>;:_P 64,0O3BS)^3<IL]QF<H\61^*+
MO'F=FWV:/?X^0C)C=L"^(61'CQQ;7>I#L457IKKUHA9] H% H% H% H% H%
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M+6O'T1]S[;YI_P!A?.?F781V._;$Z^$3B(BUXKRBUO'E$^&9YY; UZ3XDH%
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M6,/9)#3;HJDFBKT&6\V-V"W8ICM@Q:S@35IQJW1;5:VS7<0QH;(L-(1:)JJ
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MG<?LWCWR!R/";CLOCDV.M6\X)$ZBJ32+)ELGN#30O=THG#3KRMYIY Y,X#Y
MX]3QHY#PZ3ET>+"A7V_K:(L!MUN6S)T<<^/5=2%DD1$15UJE]E:1FTQ$?:Z>
MT[/=W5^C32U[<\5B;3C[HB9; QO*K.IL9B9#\1^6)<24V+L:4RW9G&W&S343
M QN*H2*BZHJ+5HM$QF.3'9JMKM-;QBT3B8GA,3Y3"[^*.2[_ ,CQ[T_?N)<L
MXJ.TN,!&CY2$0#FH\AJ1,?"R'T5&]B(6[3U32I4E;=$% H% H% H% H% H%
MH% H% H% H% H% H% H%!CKN;S=IN;D>VI>7VXCY,6=2 $EFC9*+&YSW$[B^
M[J73KUZ4'"B_<XXC9L>YHNG'O@=9^/,EC6U<&Y."9=F821+7D$Z)#EQ)5F@'
M;)8#*[@M-/LH&TR$A/:)"I?#LWPTP47B_#(9<;IQ"D*#\*UQNC[,KY4VPX;;
M;2O1_<<4A%#4DZKN]Y5+5:*2U?Y^\L+]Q9S)QI@%GXVSVZVF3>GH^72[?BS\
M]F^1CM*S&F<?D"2))>9<,>\@=00'$7ZJT3$-U<=O(Y%C]BR +;<+,-]M\6X#
M9[O'*)<(B2FA=1B7&/4F7F]VUP%ZB2*GLHAF*#5_R=XRS#DO]7K\D(#4_P#-
M_P UXGF>4=U]ICLV>U?%?%O#W2'N$/='0!U)?8E$PI;R7XVYPS.[\LXGB7 _
M'N;XUR_CD"R6?D]7HEIO-C>:!0==O;DGNOSA9->[&^&%.WH*;5+<5$PJS/\
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MZ5W_ !=#$ME[3=;??;7;;W:)83[3>(K,ZV3FNH/1Y (XTX.NG0@)%2B&0H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M[ZNB;OH?G?[;GY=JKMB_5&<3PQQ_K/!Q]MWGQK37&&\]?+NTH% H% H% H%
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M$1_*(B/M36MWDE H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H%!I]Y(Y+E\OD'A/BGC&PX?(Y)R=V]9%:
M,XS&&Y-CXW&LL=H'I4-EM$-93WQ>P%0M$1"0TT)%0F& XCF<HX;Y#2L,YO@8
M1E&8Y[A3]VQWEO%[<Y GO0[),89?M4X'5+W 68+C:@J(O[K5=-HEO!1!0*!0
M<Z?!7_63YR_[;[[_ )Y+HM+HM14H% H% H% H% H% H% H% H% H% H% H%
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MIS6%^5Y3<H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH%!RN\ML.QEGE>Y9WR-@_+^#8*S%MQW#G'B2\M%&DA"950/(+6+3SS"0B-T
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M8I%XMT:<<)Y=-7(Q2&S5HEVIU#1>E!*Z#F;:?_%0R?\ V1-_X6)1;P=,J*E
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M7R_ONT^=Z9FVN)Z9XQ:(G$^<??ZVR,2)%@18\*#&:A0HC8LQ(C "VTTV";1
M %$$1%$T1$31*Z(C#W:UBL1$1B(>BBQ0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#P76Z6^R6RXWJ[2VX%JM$5Z;
M<YSRZ-L1XX*XZX:^P1$55:#4W*\S\*.;7&+IEEQX_P"4'<5N-LM$.XOL,W4F
M95Z<92'&:=!MSN ZX^ F(J38FJB[M(21">+;B'#B6Z)%M]OBLP8$%D(\*%'
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MMF8V())PSNUID!*CI(:02-I7&U5-PH8JJ?=2B$PH% H% H% H% H% H% H%
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M<+[5#]!?$7[\=_[0T.!^<+[5#]!?$7[\=_[0T.!^<+[5#]!?$7[\=_[0T."
M<H>1WVD'#N"WSD?/>&^)[7B>.?#?-9S+DF28?&2FH;.C3-_,RU=?!.B=-=?1
M*&(2^T\J_:B7NUVV\V[@_B-VWW>*S-@NE*>!29D CC9*)9 BIJ))T6AP9#\X
M7VJ'Z"^(OWX[_P!H:' _.%]JA^@OB+]^._\ :&AP/SA?:H?H+XB_?CO_ &AH
M<#\X7VJ'Z"^(OWX[_P!H:' _.%]JA^@OB+]^._\ :&AP/SA?:H?H+XB_?CO_
M &AH<#\X7VJ'Z"^(OWX[_P!H:' _.%]JA^@OB+]^._\ :&AP53RKY5_:'\+1
M<7F\@\0<4VJ/F-Z8Q^PFRLN4KL^0)$VV2,7XU!%05]XM$^[0B(6M^<+[5#]!
M?$7[\=_[0T.!^<+[5#]!?$7[\=_[0T.!^<+[5#]!?$7[\=_[0T.!^<+[5#]!
M?$7[\=_[0T.!^<+[5#]!?$7[\=_[0T.!^<+[5#]!?$7[\=_[0T.#8;QZR7R]
MOMYR)KR2X^PO#;(Q":/&I.+O&Z\]+5S1P'D*Y3M!0.J>Z/7VT1.&UE$% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MF0S9=54%7-'7M40E]2Z43G@WF_4C\3_T%XU_Z)W_ !E$9D_4C\3_ -!>-?\
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M1Q]R4Y..U0!(6ED.B FYH1$NI( HO7V40G- H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H-?.6_&#A_FV^6[(\[LDUV\0H*VF;+MEQEVTKC:U=[
MZVZX?"N-_$1^ZF] +T7714U74F)7S!@P[7!AVVW16H5OMS#<:#"9% :999%
M;; 4Z((BB(B)[*(>J@4"@4"@4$'Y-PW\XW&W(/'OS+Y-^7>-7;'?F_9^(^%^
M:0W8G?[.]KN=ON[MN\=VFFY/6@BW /$_YC>(,)XI^?\ Y4?D=&?C_/OA?@OB
M>]*>D[OA^](V:=W;IW"]-?N43,KAH@H% H% H% H*0\C^&OU@>&,RXB_*/\
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M+A(BB*="7Z5H,Q9+!8<9M[5HQNR0,?M3"J3%LML9J)'!2ZDHM,B )K[=$H/
M6%8:<SY@>)64IZ7-+TDY8$=7OF0AVDF]SM[N^@)M[FN_3IKI09:UVFUV."Q:
M[+;8MGMD7=\-;H3(1V&]Y*9;&FT$1W$2DNB=555H,A0*!0*")M8#@K%^G92Q
MA=A9R>Z-FS<\C;MT49\AMQ$$P>DHWW3$D314(EU2@]+F'XD[CHX@[BUH=Q(
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'"@4"@4'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2227887d1-pht_macrop4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_macrop4clr.jpg
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M# P,# P,# P,# P,# P,# P,#/_  !$(! X'; ,!$0 "$0$#$0'_Q #_  $
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MTD-S-#47)%0V8X,EXI-$L\-T)O*C16331O_:  P# 0 "$0,1 #\ [^
M
M
M
M
M                                            AJ6VC:HR2%"C:1".
M4V708GP,AXB("I2B/81)%> B[AX\4[UD7P!P1*>(SQXASUQ7@B4XV..[ZYBG
M!$<<CT4MWUB/X X8CQ)$5,LS/ R(. DKA$*6V?>(TBC@25Q$PAQ*^Z>(BU0F
MI)GL4*@
M
M
M
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M;PRICT\+6VGD>^E#9P:@[$
M                  " X^AORF)*-2+E0E%ONJV$64O()\*1:<VR6/;O$B
M             !'0\ZCREZIB+C4DIM$XB0E>P^R8@XT+L9U)@1)@
M &OE>O[5ZFUZMP*)I"NM4B+)-JG5?WBTUXEO(E1+RGM+:HR^ 348O>6I3FGL
M*;^,K7/^@L_]JL"O##I*<<^@^_C+UU_H,5_M5@.&'2..?01;4U:O*IZ@4NP[
MNT_1:4FIP)%00X<U+[AM,JP2I)(++@9XEOQ%'!4JA&Y)NC1L>(%X
M
M
M
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M3GH_,<LG"7%"4I6WV1]EOKP7I1<.I_\ 7CM[^';8_<\<6,E_LL^R?K,O6_\
MS*W]NUZHE4Y_O_,6G7\%U+[]'#E+V+G:O4R_[V_VV7^S+UHZ 6G3*?+LFUV9
M<&/):=HM/2XVZTE:5%X='>(RRJ''YB<E=ECO?K/8,A:A+*VTTGW8[NI',?FG
ML*G:/:CVS==@H*WVJNTJKT^#%,FTPJC37"4XM@B[B',R#-"=F.;#?@7;:!F9
M9W+2M7<:8=JD>'\^:5:T/4+&8R?W?%BDJ4C*#W+='O1[NSVMN"75*VJO[]MR
MA5LT<$ZW3HLXF_4*2REW#]$.%NP\.XX=#:\Q[OE+_CV(7=G%%/SJOQEQB!D
M                                                   0G'D-EVC%
M5&I%R2)%R2:]VPO5%Q1H67.I+B1$ "&XXRRC,ZLF4^L9X!0-I;<"F.UN&W\T
M2I9_)+ OC,25MLQY9F"V8DB[6Y*B]E&0CSF:_L":M=);EFGN1*G4ZBLMDI*?
MM4D0JK:+;S%Q[R%XV:>TYC_P&)<$2'BSZ6/&S2/_ "V1\8<$1XL^ED3WG4$_
M]*,_M\#%/#B368N+>32*S+1\ZEA?QI^R(NVMQ..9FMM"?;K,9?SR%1_E=XOJ
M"+MLNK,Q>W J33K3Y9F7DK+R&(--%^,E+8R*!4 ".B0;?F]44<:DE.A/-NMK
M[I[?5%IJA>4DR,*$@           -;J[_6BL;^1L_P"_."Y\TL?XGD-D1;+X
M
M
M
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M[?B-9SE_L^8^S\:-0>6:QV-1N7_5^SGS(G*O55)ISJ][<MJ(P['7AT97"3\
MZ'7<T\MGK-Q;EZ*NIYSR)I:U/0<UEI?.EA]I1BXOLJD:\Z&675-1=5++LRL\
M9VD6E(?FU6FNF:DQ8T1XGY+&4]Q/R3)"BZS,;?5LU#+9:=V'M3V4WUP]"./Y
M3TN[J>I6<M=KP66W*+V1475K\^3H^TR[K?\ URZ#_#=I?78&#I?^U2[)G0<T
M?^66O\RS_9.KHX(][.2>O46.GFZIC/AFN#+JML'+9R%E=4X;)&;B=RC/IQWC
MO=)=-+F_J3^,\!YK@ES3;HO:N6:]#]E8]9UL'!'OQR-YCG:<QS4LR*UX=-$8
MDVV[6/$I-31PV^&;W$068S3DQS%AN'?:+QO39*&WOT[:'S]SE*VN9(N[3@4K
M7%79P]VM>JFTVN^G'):1X\.Q/]BH_>PY_P##:K_ZGG?RG>_Q'E'HR_\ ]M?W
M2:U+JE@5CEEU&EZ9G3E6DBFRVHJ*7&\+&2ZA\C>2ELD-D1DH]O9WB&0A>AJ$
M%>KQUW[=AEZU>R=[EZ^\EP^%PNG"J1VJM%1&O7*7J_IMIM:-U4V][G:H,ZI5
ME,F&RZU(>XC?AFV\^9AE9%VD&6T;KF+3[^:O0=J%8J'4M[Z3B?=WS+I^EY.Y
M;S-U1D[E:4<MR^BGT&VZM1=*M>:%=VG5IW:S6)U7H<M$MIMF4T<=IQ/"2[F=
M901Y''$;",<X\GF=/G"]<A1)K>NWIZCT5:SIO,%J[D[%Y2E.#KA)-)T5<4MC
M:-#- =47^76_+KLW4>&_!ILYY$6X%MH):X,R*:DM24(269;+B%'M3CBG*M.)
M#KM8R"U.S"]8IU===JZF>2\I:]_+&>O93.IJ,FDZ)OAE'8^N+4MJZJ*E&;N7
M7S7:,4"C/5*G70Q=504V:J?1*:2EOONY<229J2:6BZS7AAU&8Y>QH&<N2HX-
M+>WL/4\_SWI.6M.<;JF]T8XMOXO*:C\K=KW!J3K15M7JXP14ZCS)U0G2B1D;
M<JM129-L-=?!2Z:C+T>SCWAT6O9BWD\HLK!XNB\BZ>UGGO(F0OZIJT]2NKNI
MRDW3!SFO973PJ6/T<.DC:G?UX[?_ (>MG[PP(9+_ &6?9/UD-;_\RM_;M?JQ
M*GS^DH[ETZ26U2J34\O[,P'*/L7>U>IEWWN?M\MV2]:-C+?YH=#:3:=#C2;[
M;.93J1$;D0FX4U:^*TPA*T%ECX&>)888_"-%<T/-SNND-LGO7RG<93GO1K.6
M@G?55!+V9[4EAL-(M2[IK7-;J]0Z':=*>BTMEHJ=1FWR]LS"6O-+J,LDJ4E'
MD3CT)3M4H=1D,O'1LK*Y=?>>WK>Z*/,-:SM[G#586LM%J$5W6ULC7O3EMI\?
M=WX/KM1Z8Q2*93Z3%(_!TJ,S$BX[\C+9-I^H0\^N2<Y.3VMU/H++V8V;<;<=
MD4DNQ*A610O
M $L\^3?93M5]82C&I;G.A3U*-9X]X_6%PLMU/(J"7D2&(S>=]XDI/N]9^8A1
M8["DIJ"JV4%^L/.=F*GPJ?75M5\6XA>C:IM,.>:;]G LFZ*[[@I$JL/DJ:ZT
M:6XT<S/VKZU94)S=72>'FWB4I*"(6[;NRVEI'>%Q41V$Y>EOQXM,G*)"*G!7
MG2RM18I)UO,HT]G:9;#WF6.& AXC7M(O.S&?L.KZ#*"4FHRR]K-AEPZ<=V'G
M%ZIB49H!JKS-W*B]ZM:MAR&*52;>EK@RZLMEMZ1-DLGD?X9OI6AII"TFDL$F
MI6&;-M(BZ+)Z-;\)7+JJVDTMT5N\O3C0W&6RENG>Q;,IZ+:S5RXZO%M6[>'.
M>JB'%TBMMM)CNFXRG.;$I#>5OM-I-3:DD6.!D:=I&,+/Y"%J+G;P2VK=VKL^
M,GG<C&W#CATK:;78)&IJ:6@V>J%4*'S*8<0H,@J4H>4I-)D98D9;<2V& 2*F
MQ5Y+'LWOPI'EV.?'TBV[:>POPS$HX/'UE=C2V)9>P/M%WD'L47P"S)-&7"<9
M[": F?2/  3K$C$TMN=[UA:<:%V,Z[2=$2Z          :W5W^M%8W\C9_WY
MP7/F%C_$\ALB+9?
M
M
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M!XDZ1F1EN,CP,A4CUE9B57+@W,V%Z,SH^Z+\T6)6Z;#,M9C=+SE?\I;E"!D
M"I.L/X>S<^Y4+<HER$]S)X0+P        :W5W^M%8W\C:A]^<%SYA8_Q?(;(
MBV7P
M
M
M
M
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M_K16-_(VH??G!<^86/\ %\ALB+9?
M
M
M
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M8U[Q%:@X\%*UI\ZO1V&Q U1U8
M                     $%U?#0:NGH\XJE4C)T13%*-1[=Y]X73';/(J"UJ
ME/XZC8:/\%(]I_KAET>8OJB["%,6868O<3I'9ZRG;]NX73&(F44;)I$9*"Z1
M$E0M'41.&GU_?R8J_P"XGA>RS^^M_:7ZR+UE=Y'%.Q=LB-L/N)/S;"'H6<V,
MW.4HTCHCRV,<.]:PK?\ ^'4_NIL<AJSK;7VOB9<U/]E$V-T_3A=&I:#W)KK9
MY?MB<'/])J6L$<=;C/)J=?!JPV7+5"R]'^6.CTZW^PA]E>HS;+Q9M]H<XE=Z
MV*DE$9>]#Z#Q[,*4.<U%4MW/L_&C89IIV'Y/6=&N&.7.<H.&8"AY-LA44/)H
M\FT"E#S@0%"&9"M64H>3(^L53(M$/*1[P6PHR&I/2*E&B9@3/"J4D]L0]JT]
M7E+\T4E'B)VKG!AN+H2I*DI4E68E;4J+I%@SCZ*@JK3I.$?67>%J2H7XRJ1A
M$F     :W5W^M%8W\C9_WYP7/F%C_$\ALB+9?  LJ];PHEB6S6+LN"442ET1
MDWI)I(C4LS/*VVA);36XLR2@NDS%W+V)W[BA!8LP]1S]K(9>=^\Z0BJOY.UO
M!=9RDOGFMU>OFI&S;M1?LFDN/9*70J,DG)RDF>""=D$E2UN92Q,D94]1=([[
M+<O93+K[SO/I>SR+H/G_ %3WAZIJ%ZF6EX<*]V,%63QWO;7S)]!;\/7KF"L.
MK,G4KJKGB6TI=51;E86ZV\WN[2'VT.FE6[,VI/VV(R)Z/DLS'NQCVP?R/X=!
MBV^<-=TVY][.==O#<54ULQJJT;V4:I])G4+1/5VDZR6:U<D*.J!58#YP;CI&
M;B>'F-I2LR0H^\A:3):#\N&\C'!ZCIT\C>X);\4^H]VY:Y@MZUE%?BJ26$H[
M:2ZGO3VI_&:2<S/,!?%*U3GVS8=VRZ!2K6B-1*DF'PL)$]PN,ZH^(A?<2I*,
M/DJ'4:%H]F[E?$NPJVW2O1L/,.>><LYEM2EE\K<<86XI.E,9/%[GTI4[3URP
MZ^WS5M4H=LW]=\VX*;=4-V+3"F\+*Q-;]NSAD;;VNH0M'PD*:]H]FWEO$M0X
M6FJTZ"O(G.&<S&H*QG+CFKB:C7=+:OTDGZ#<[F'N"LVOHO?-?MNI/42LTV/&
M7#GL92<:4N4RE64E$HL32K+N',Z19C>S<(354_D9Z5S?G;N3TJ]>LRX9Q2H^
MCO17Y#E]3-;N8NM2%0:-?5R5>625.KC08[<A[(C>KAMQS5@728[V>EZ?:CQ2
MA%+K_I/!LOS5S!F9\%J[<D]M(QJZ=."*K%YB^8:RJVW[XN:HNNM*)4FWKB@H
M0AYO=VVU,M.((_60HC%IZ+D;\*12[4_D;]*,F/.VNZ==3O7)/IC.-*KRQ35>
MIUJ=4]+=0:=J?85 O: PJ(FJ-J3*@F9J5'DL+4V\T:CPS95I/ ^DL#' YW*2
MREZ5J6[X\3W_ $/5X:KDX9JVJ*>[H:=&O.O,7:W=%N/2?",U^FN3,V3P:93*
MG<WJY"<QS"SX,Z5X73L,Q9RPY<*N1XNBJKZRY1;,D
M
M
M
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MWU\17D+NB]%4,>;JR *D2C5>82$G$9/M*^<,NA/5\(G"%<3'S%VBX46ZE.S
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M==W,S;AP=5*>?K/I'E?+?A].M0\;QL,9\7$F^B+^C'V5V&;1@F^
M
M
M
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MQ$_='[>;[+?]LZ4CBSVH
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M*C:WL]N]V^GYG)Z:_P 0G'BDY1B]JC1*N.RK5?3O-RAH3T
M
M
M
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MWPIREXE*UI\VO1]HV,&J.L
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M5>;$\,P\@SKI4^G,ZZ5.L_*,V1Z0IVXG[ZJ/WPAZOR?CIL.U^L^5/>WCK?\
M[4/4S9DT?$.I/+Z$%:<=@F1:("DX 1:(*DX[@(D+*+A;/<-WPLDE&?8D]E?P
M[C^ Q&:J2M2X)=I= M&<1&U&AXC$9*I*+HRKBT9    :W5W^M%8W\C:A]^<%
MSYA8_P 7R&R(ME\   *7.I5/J;!Q:G C3XY[51Y3*'F_SJR,OJ"JDUBL"U=L
MPNKAG%270U5>DD:5;=N40UKHU!I]&<<+!:H<5J.9EY>&E(G.[<N>U)OM=2W9
MR=BQ^SA&/8DO43$NC4J:M#TRF1)KJ$Y&W'V$.J)/JDI1'L$(S:V,N7+-N?M1
M3[54F8E/A06^%!B,PVU&:N$PA+98GO/!)%M%*M[2L(0@J122ZL#Y-I\*>TEF
M;$9F-$9+2T^A*RQ+IP41[03:Q16=N,U223[20;M^AMD\E%$@H3)1D=),=LB6
MC''!6S:6.W Q+Q)=++:RUE;(+';@B8BT:DPG.-#I<.&_ER\9AEMM>7JS)(C%
M')O:R<+%N'LQ2[$D?)-&I$Y?&ETJ)+?RY>*^RVM6'5BHC/ %)K8R,[%N;K*"
M;ZTB+'IL*%&.)$A1XL16)JC--)0A6._%*2(MO3L%*MNI*%J$%2*270D49JS+
M/CRDS6+4I#4Y)YRFH@1TNDKUN(2,<?A%UYBZU3C?G9CQT_+1GQJW#BZ>%5\]
M"[A:,P
M
M
M
M
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MU1,"), #6ZN_UHK&_D;4/OS@N?,+'^+Y#9$6R^
M
M
M
M
M
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MMSXI4HGP[J]#-:S_ +0*ED>"M,)233WD^]FOWL-Y_*-Q?XJ\WY3AO^7+3_\
MQI?I_P#TF:-#.9:+K;<-<H4:TW+=*BP$SERG)B)1K2ISAY"0EEO##'''$:G5
M=&>0A&3G6KZ*?&=5RMSI'7KL[<;+APQK7BXMZ5-BZ2Z-7>82Q='DLP:LMVL7
M'*:)UBVJ?@<@FSV$[(69DEE&_ UX&?HI/ Q9T[2+V>QCA!;9/9^4S^8N;\EH
M:X;KXKCV0CM[7T+X),U;;Y_7_&^VTR;]W*4HDDBK>UPQZ#5%))GY!T#Y1?#A
M=Q[/RGG\?>[6>.5[OV\?U3<32?6&S]8*._4K7ENM2H"D-5B@S$$W+B.++82T
MDHTJ2K*>52#-)^0R40YG/Z?>R4^&XNQ[F>EZ%S%E-9M.=ANJIQ1>$HM]/RK#
MRU1JW4^>R#2:E5J8]II)<729\F$I\JHVDE^&=4WC_DYX8X8X#?V^593A&7BK
M%5V?E."S7O5MY>[.V\LVXMJO&MS^R2#O]H)3$-J5^*^3V",R_P!;-]!?Z,)/
ME&?[U>;\I97O;M-T_#2_3_\ I-AM5M>4:66-9M[.6RY76KL>C-IIZ)26%,>)
MC+D_.*0YGPRX;O*-/I^DO.7IVE.G!7&E:T=#L^8>:XZ1D;6:=MR\2G=K2G%'
MBVT?9L-?%?V@-,2>'XL)23ZE55L__9QN%RC/]ZOT?RG&+WNV7_\ C2_37]TS
M9H_S0V5JW5"MTH,NU;E6VX[ IDY3;K,IMM.991GT;%.((\QI4DCR[4XECAJ]
M2T*]DH\3::V56U=J.KY<YXR>LW/!47"YNBZ-.GT6MKZL/*8JN;GDIMM7+<%M
M.:?/37*!4Y=-5**JMMFZN*\IGB</PZL,V3' E;!G9?E>=ZW"?B+%)[.GRF@S
M_O1M93,7+/X>3X)2BWQ)>RZ5V;RE'S_4Y&7/IA*3FV)_UHT7_LXO_P HW/WJ
M_1?RF"O>[9?_ .-+]-?W39/1#6N)K):U:NOW,=LQ:/4%07F9$I$E.5##3YN*
M=R-I21)7MQ+X1HM4TR61NJWQ5JD]G])W?+',T-;RT[_!X:A)QQ==B4JUHNDP
MA?G/%9M"G/4^RK=D7@F,LVG:R[(3"A+42MI,=AUQPO+E3CY2VC:9/E>]>CQ7
M'P]5*LY75_>CE<K/P\K;=VFV5>&/YN#<O04BT>>VWJA-;AWI9TFWHRE97*M3
MY)3D,XGWG65-M.9.LT9C^2+N9Y4N15;4^+J:I\J,73/>OE[TU',V7;7THOB7
ME5%Z*]AO/2JY3:Y2(5:HLUFHTJ>R4F!.CJ2IIULTXI4E6[ RVXCE9PE;DXSP
M:VGJV7S%O,6U<M-2@U5-;&C0U[GZ@,+>0YIA)+AN+;,_>K6]M2D_YM\D=8N4
MYO\ Q%YORGDT_>S:C+A>6>#I[:_NDY1>?2U9TYIJMV)4J135*+Q%1BRVYJF<
MVXU,FTPHR^U49X=![A"]RG>BNY--]%*5]9?RGO7RUR=+UB4(]*?'3T1-S9-\
MVI$M!=]NUV(5JH@%4_?N)FR<<RQ2XDD]HU*(\"219C/L[]@YJ-BY*YX2CWZT
MIUGI<M0R\<O^)<UX7#Q<6ZGPW;=QH]7N?>(U-=9MG3Q^=36E8HG5&<49YU&;
MO$PVR]D(T[L5GY2'5V.4I-?>7$I="1Y3G?>Y;A<I8R[E'IE+A;\B4J>=F4M)
MN;ZR]2*W3[9JM)EVE<%9=*/24J7XV')>49DE"76R(T*5\I)%\H:[4>7KV4@Y
MIIQ6W<T=%R_[PLIJ=Z.7G!V[DMGSHOJJMGE7E-R!H#T
M
M
M
M
M                                       ILE7MB3ZI"Y L7'B2PF0+
M:JKF>9E_6DD7PGM,7;?LF'F)5F2J$8%B0DBU0C$6(@V32(Y%CL F3*4X%L$9
M$TB9;0(DTB92DQ0F6CJ2G_Z;ZB]7T8J_[B>&3E/VUO[4?6B[!8G"FR")3L9*
MMJ$I3YT]0](S>QF5E<:4.E7*NR2+WKJSQQ<MLD]KR2FQQFLNMI?:^(S,YA!)
M])O@2#,:"IJZ'H1J5H1"1CTBE2M#0'^T'+#36QE$K+ENI)YO_49(YGFAUR\?
MM?$SV[W&_P"YYE?^C_;B<WK<=)*FTI+>72/)\]&M3WW/QK4ZZZ41RG<K%-:P
MQST*I*[/4W+DFK]*/8>6L-.M=C];/DCW@*FO9GMC^I$QKS3+5/Y3J7,;+,3+
MM#<?46U+9)=)DS/R9E$0ES!CE)=J]9O_ '.R4>8()[[<TOT:_$<K*;))HRPP
M222Z3WCRR_;J?5.8MU.P_)BM3FBD)Q1&@E5VJ*)1EAB27<N/U!Z9RM'AR,>U
MGRA[W8TUUI?NX>HVP7N'3(\L9++Z 9%D!:=FP5J1:)51=8JF6VB56C#:6X2(
M-$!1=0J1/L5?#EQ3/I7D^!1!+&)2VZ31<HMF:1F%8/)\NP1D2@\2JBT9  &M
MU=_K16-_(V?]^<%SYA8_Q/(;(BV7P ,"<SO\Q&I7\&(_=#(VFB?ZVUVG+\Z_
M[-F/L_&C4+E*OO2NU;,N>'?M=H=*J,FN<:$S4^&3BF/"QTYDYDF>7,E6WUL1
MT',.4S-V]!V5)KAHZ=K///=SJNG97)7(YJ=N,G.JXJ5IPK\OE,0\T]RZ97C>
MU+=TM98FO^!.+7*I2V3:8F2W%$41MM*$IXKB,%%F).W,E.)X;,_0,OF+-B?C
MU6])[EO[#0\^Y[3L]G8?@DI/AI)P6$I/V5@L6EU8X+<; <YC,Z-I/I)'J1G[
MR8J#+504H\5<=%-63F977FQ&JY:<7F[SCLHZ>='5^\Q3AI>54_:4E6O3PXU\
MI3],^9K16T=/[3MJX;:J<NN4.FMQ*C)9I<5YIQY'>-+KCJ5+QZS(A7.Z!FKM
M^<X-*+=5B_D+6C<]:1DLA:LWK<G.$5&5(0:XEM5:HV/THUTTOU(GW$Q9E#J%
M*?H-/*94W)$"-$);.9192-EQ9JP-.X]@TFH:5F,HH^*TTWA1U.UY>YJT_593
M66A*+@JNL4OU6S0[0JU6>836RN5^^#54("3?N"N0<YY9)&ZEF%$S)/'A((T]
MGU49>DAUNJ9B6G9*-NU@\(]F%6^T\HY6R4>9=8G?S6,:.<D]^-(P?U5W<-Z5
M-E#JO,LRT9M$5;DRV:9(H:FN![H.,T3"4&G+E2V18)PZ,NT<$K]Q2XE)UZ3W
MFYI^6N6O!E;BX4IPT5*=AB_2[E\T]TCJ,^L6XQ-?K4\G&#JD^0IY3<5QPG$Q
M4(3E1E3E3M,C4>&U0SL_K&8SJ49THNA;^GI-+H/*.0T:;N6(OCE55;Q46Z\*
MW4\C>&+.;6F%_6KIMK;=UQWE"D5.C+EUR)X2+&;E.<9R<9MGD=4A/HGB>8=K
MG<G=S>1A"U@\'MIA3$\4T/6,MI.M7[V93<7XD:)<4JMK<Z+<;<KYPN7<D.*.
MS:PHDDI2_P#4T']\#G_Y;SWTUYW\AZ O>1HC_P *?Z$/[Q3>=B7%GZ5:>SHC
M9MPYU=CR&&C21*2VY ?<0G NR64E;A<Y4BXYFXG]!^M%CWJ3C<TNQ..QW$_(
MXLK6AFI^AU"TBL>EW5<MMQ*_!IO#JD.6EHY#;ANK4:5DI"CQP,8^J9#-7,U.
M4(2:K@9_*^NZ/9TRQ"]=M*2C1ITKM>TU1I3]#NCFKH$[2> <2WY%U0Y=/1':
M-ILFF$H5.?;9P+(RLDNGE,MA'N+<.BFIV=+:S&WA:QVU^;Y3SRQ/+YOFB$].
MCW'=BU147#&G&TL*1:XG\*'5.ZZ%0RMVYI!T: ;YTV8M;JHS1K4YP%GF,\-I
MC@+$Y<<55[4>]Y_+6?P]U\"KPRW+H9SJY$H,.HW%?+50BL3&VZ+35-ID-(>2
ME7'7W<Y'@.QYL;5JU3I?Q'CONHA&YF,RII/!;57>S/\ SCUWZ':2LT*@QVJ5
M]-*LB#4G(Z":2<1#:WGD*X:4_.Y$H/Y.)#5<MV%?S7%/'A3:KT[CK?>3GWD=
M+5NUW?%EPO=W:.36'32GG('*-I#;%+T_I6H-1IL:I75=*7'X\Z0V3ZHD$G%-
ML,,$HE$C,E&=9IVGCAC@D@YAU&[<S#M)M1CA0C[O>7+&7R$,U<BI7;BK5X\,
M<:)5V=+IY=A?W,3HW:]_6!<-4128T2Z[=@/U*BUIAHD/*5%:-U3#RT)Q6VZE
M.4TGN/ RVD,31]2NY6]%*3X6Z-=IM>=.7<MJ60N3<4KD(N49)8]U5X>Q]'E,
M(\B5XS)M#O.R9$A;L.BKCU6BH6K,EE$[B$^V6[!/$;S8;L3,;;FO+1C.%U?.
MJGY*4]!RWNIU*=RQ>RCQ5MIQZE*M5YUYV8 Y7+FLRU-3;GJ%^5.FTND/467'
MBO58DDTN0J>PHB(UD:<^1*C\PVVO6+E[*P5J+<JK9T49R7(6=RN4U.[+-3C&
M#A))RZ>->GVO@C)G-??^BEUVK1(-D2*56KL8J*'F:I26B0F+"-"B>0[()*24
M3BL,J>LLVS#;@\NY/.6KLG.JA38^GL-W[P]7TC-Y6$,LXSO*6$HKV53&K\V'
MEW%?IUEWC</)+ I<"+*DSR?56:?24YC>?IS50<?2AM!;59D'Q4(WJV8;3%J>
M<LV]9XW3AV-]=*5\YG9?2\UF.3XVHQK+VE'Z4./B_P#J6_88KY?N8ZU-)*!*
MM>XK&5.8D3G'Y-P4\FE2UYMAMRF7S0:N'EP3@O=LRX[\[5]$O9R:N6Y[E@]G
MD9SW*7.N5T2P\M?LUJVW*/M/<^*,J?K5I\U&X6E5=Y;[_OA=Z6%#@0=02ANL
M*@.QU091M'ESO)BG@VI>&PW6^UE/!2L#'.9^UG\M9\*ZV[==SJO.>DZ#FM U
M'-_BLHHJ_2E*<,J;VH[*TVRCC3!NAMF-(=P
M
M
M
M
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M;+\P68:7-R@IPHUCM?>2?SH[:M[L*T.UX\T/I8
M
M
M
M        ^9BZPH!F+K"@/H
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M3]&EXEF+=S9Q2=7Y*42\U38L:LZL
M
M
M                                                \J4E/>/ 52J4
M;H2YRVRW$9BO"0\1$ Y9X;"))B2@1=P\'(=/?]02X4B/&R&;CA[S"A&K(>(K
M4#$*@];!4'G$4J#UF,O2,,!4B>(=]<1<42XV1_%&G?M#A)>(R*F4V>_8(<!)
M7$1D+0ONJQ$:$TTR(!4
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M HBM"R90 &MU=_K16-_(VH??G!<^86/\7R&R(ME\
M
M
M
M                                         "5<DI1L3M,34"W*Y0E5
MR'3\A>054:$'-L@F>82('P5                   >LQ@",B0ZG?M\XBXID
MXR9,(E(/O;#$> GXB)HC(]I")-'T4*@
M                                   %)>+VJ_.+RV&-+:0A4H6FZG)*
MEIZGS^KM%V'LF!-4D^T]EMVBC=221'+K%"1-ET"C+B)U!;=HB7$3;210FD3!
M%M%&219.I2W$:<WRZRLV7F+;JRV5H/ T+1#=-)DHMQD+N4BG>@G]*/K+T7BC
MA38TV7'P1'?<CHDL$Q)-OTVE88MJQZ#'I&=M0G[23HZJNYK?VHOY;%8G1+E*
M2IN_KD(S/(Y;31J/'8>241%CUX9CPZL?*.2URCM1^U\1E9KV5VG0P<T8
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MDC N6YVW22H^LWV7S-K,05RU)2B]C3JO.BO")>
M
M
M
M "5=DDGN[1-1+<IT))QU2]YX":5"TY-D,5*       ?22:MP ^&G+M/9YQ0;
M""I]E/>?27G40K1E')+>>/'P2WRV"^Z(5X9$?$ATH\^\(?1+8/[H@X6/$ATH
MBD^P>Z6V?W1"E&5XH])&+;N[7F D?<#+>*U!\%       !Z2LT;25@*%4Z$X
MW)+#!W8?K"#@7(W.DG"/':0@73Z
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M2'#PK'>Z]O1U'7\H<H/0G=;NN7&Z)?-X5O:^F_1NVX;8C2';
M
M
M
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MLW&+3C0O1G4CB),
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ML6R]#RI_$_E/.L_[J+D:RR=^KZ)JC_25?4CQRBZIWPQ?<W2>YZC)J]-1&F>
M;FO'*=ITNGJP=0V^9J4;2MJ<#,R(R++O/&O,6GV78_$VU1U5:853ZNDG[N]>
MSOXR6G9AN44I4KBX2B]E:^S3R5V4.FXXL]H
M
M
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M/[#^#H,691DC,MWH3?1U,GS+#88$P    "=9?,BP=/[H6W$NQGTD\(%T
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M>+Q;>\W(&@/0
M
M
M                             *<_)S=AO=Z2A-1+,IUV$J+A;   "$\\
MS':XSRB0GUCZ?,72*)5V%)2455ENR:Q(?[,,O"H]<^\?V!>5OI,*>9<O9P*2
M1;S/>?>5TF+ICGH"@ 'W 5*T/1%B*%3U@7_ @*C$R/RBC95'U)[4EYA%L(UI
M8D$_K$ZZUZ5<4A'W*,ICH*4R=.H\^A/BUIM?O/B-ER2?P#0\1Z#PGK*85%"&
MHC+>'$*'T4XBE!B?4*\2!\/*8J!E '@TX 1H>%)298'N 4)Z+4I$;!*OPB/Z
MBCVD7D/[(MRMIE^%^4.M%R19D>6WG:5BHN\T>PR\Y"TXRCM,V$U-51-"A(
M ([3_#W]I/UA&4:DHSH5)*B46);A;:H7TZGH4*@
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M(2H>P*@ :W5W^M%8O\C:A]^<%WYA8_Q?(;(BT7P
M
M
M
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M   (C3O!\WI)$&B494*JE25)Q+<+9?3J>@*@
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MVMY4!;+P   :W5W^M%8W\C9_WYP7/F%G_$\ALB+9>
M
M
M
M                             "G2'LW81N]+RBXE0LSE7!$J)EL   +?
MGU4C,V(9]&"WBZ^I/V1<C;WLQ+N8W1*&18"\89] 'LBQ D?2/#8*5*T/:$8^
M81))$4DX;0)'H ?<I@#ZDL3P &MMT:WOT2XSAI@)CT:"Z3<M#VU]]*%8*4CU
M/)B-S9TJ-RW5O%[&MQPVH<X3R^:\.,.XG1I^U+LZ#'=>NBLWS4TO.N*>:->-
M,I+2L6F"/=CAZ769C96<O;RJP\K.<SNI7]4N5>/T8K8ORFR^G5M-6_0,#++/
MG]J>\>S N@B\A#GL]F/%N=2/1=!T]93+T^=+:9!P&'QFYX3Z18AQCA/JT*1W
MR#C#C3:0\/N0XRE#Z23/Y02D542W:W<]!MPL*Q46(CBCP1%(\75)]?AEM%^W
M8N7?953"S>H9;*?M9I=6_P Q5(<N+4(C$V(X4J-,9)V.\G<IL]QBU*+@VGM6
MTRK5R-Z"G'&,E5/I1-&1&*E3RI!*\XH4H>%)P%449!%4R+1]-.S#T3[R14H5
M"#4U1,&I)FJ)N2>\V_LD+5RW7$R+-_@PEL]1<R5$9),C(R/:E1;C%DS$ST*E
M0 (K#W#W]T^\(-5)1E0JPMF0
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M_P F9W5<U8F\_"E'2+:X9NGM5CLHGOPKB;2C3G9@
M           4NHSHE-@RITM?"C06%OONX&9I;:2:E'@6W81!%5=$0N7(VX.4
MO92J^Q& 4\VW+XM!*+4!."TYL/=]2QPZO\F&Y_E_/?N_3'Y3C_\ D'0_W_\
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M+S;[+3S18H=22T>8RQ(:>E,#LDZJI,@5
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MS++$>.4=A@B9889(B)!%N(B&L=7BSI8I12C%42P21%,A+C(\)YR^42* RP%
M>#3B H0C3AYC%40:(0JF4:)Z)-5!/*K%<-1[4]+7RR_-(0N6ZEZS=\/L]1=*
M%$LDNDHE)/:E1;C(6#-3KB>A4J !-,.Y.RKN^CYQ"2+D)4*B+9>
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M:C<Y:Z=:^REM7-7(C3;>UM,53,E3[9=24+2>'F+J'?YWOZ0G<]KAB_3@?/\
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M\-=MRC*'!=BDVEBFGOCY=JW=)M(-.=F
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MCTS_ &F79,\XYH_\LA_F6?5 ZRC@3Z .39_UZ2_E=_[$.^__ ++^;_:/ _\
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M>D?RGRHW[5O_ .]_]1NK':;89:9:^;;0E#?VI$.;;KB>F)45":%"H
M
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MZ_-UB$X5Q+UF]P8/9ZBYQ9,X   *E'=SEE5WDBW*-"_"529$"8
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MC(IU\:YZ/D-\R+ L!RQZDD?0*@
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MP6S*  ]I<-!EAO('B53H55"B6DE"RU0R$ZGL4*@
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M5Q'6FDI<<ZS26!F.+D\3V6":BD3X$@
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MX !-Q7-O"^$0FBY;>XJ MEX
M                   "FO1S1M:+$OK"Y&18E"FPEA,@ !(.PBQ-R.KPR^H^
MZ?V/@%5(MRM;U@2*E.,GD?2;?J])'YCW"M2VZQP9&(Q2A6I$0LR\PH23(J5Y
MO.!6I%S 2/A*ZPH4J:(<_9XZ;V67_P T-_N.2.6YK_T\/M?$SW'W$_[IF/\
M)_MQ.>%N.MI3M/!/I;.GS#R3/1;/H//Q=3LCRY9?Q*6+A^L2>C_TMX>R\L+_
M .-LUZ'^M(^0?>)_OV:^U']2)FM2^H;\XALA\4]V %.(@&Z1J-+9')5U)_-/
M<7PB5"->C$C(B&YMEF6/^;I/9\)[S%'(FK?TO,5$BP)*2[)%L2DMA")< J".
MRPI[,:^[]<0<J$XPJ5%"2065*<"%LO)4/8%0        UNKO]:*QOY&U#[\X
M+GS"Q_B^0V1%LO@
M                                                %* !0 5
M         !2@ J                          *4 %0     !2@ 4 %0
M
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M9EIZTG]@4<:HK"?!*OG+O/R"R9X 'U)Y-PH-A5FU9TDH6FJ&1%U1$%"0
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MM)(0DD)+H+80$SZ /J2-6PMI^J )QF-MSN[_ %1:<B[&'23PB70
M  -;J[_6BL;^1M0^_."Y\TL?XOD-D1;+X
M
M
M
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MXJS"E)84\O;UE,JM38HS:&)R"C)J$@T-29*&W$4QQ:%8.^T2K,>97946\MI
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MT7;;W$^(%T
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M_."Y\TL?XOD-D1;+X
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M;LQS,X\<SVJR)^L+!E$R
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MDI%W"T9X 'U.*5I46])BC52J>)6A9,D
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M31)E+4J+4&):2)Q2EMJ-*3SXJ-1EL+ 5=%&B$5-SJS:T6R^
M                                                          !2
MJW_V15/]$?\ O2P#,(\L?\S5N_X6=^Z7!.YM+-CV#8,0+P
M
M         :Y\T7\TTO\ A:E_NI N6?:+-_V5VHV#C_Y/'_P2/THMLO$R
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M^#JB8%"8
M              'S*74%0,I=0K4I092Z@J*#*74*5*GT
M
M                       %*K?_ &15/]#?^]+ ,PCRP_S/6Y_AIO[I6)W-
MI9L>P;!B!>
M                                 #7'FA_FEF?PO2_W4@7;/M%B_P"S
MY4;"Q_\ )X_^"1^E%IE\F0
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MJ3AN%2)",L=@$2&9?5%P@>#Z *$W25\.5(8_SA'%3YT[_J"$U@7LO+O-=)<
MMF4 !.1%;32(S1<MLGQ:+P
M
M
M               4VI,*E4^=%:R\61'<;02N[BM!I( 8WT=LNK:?V#2;7KCD
M634:>[)4XN&:U,F3KRUIRJ<2@]Q[=@E-U9"U%QC1F6A$F
M
M        &'M9['J^H5D2;<H;\2-47)\.23TY:TM98[J7%?-I</' MFP2A*C(
M7(\2H9:90;;3:%;TH2DQ$F1P
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M9,]GD 1&3R+2KH$7L)1=&5<6C(
M
M
M
M
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M0LNG 7$RW)5+J863S+;Q>FDC^,ACM49L(NJJ10*@ 5HCQ+$6#)3/H%0
M
M
M
M
M
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M3)L.L$3XH70 *LR?LD'Y!99DQV$44*@
M
M
M
M
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MXQG$^JXKZN!BD]I?L>R541+P %4CGBV0M3VE^&PCB),
M
M
M
M
M
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M$N
M
M
M
M   4J#YF+K%: ^@         "E0 J *@
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M)Q_WPOTI"EPN9??VE6$3(/A @5*/\TG[86Y[2];V$T(%P
M
M
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M<M-NF@32,V:Q2I:)3"E%VC2:VE&25)QVI/:D]AD--=M3LRX9II]9=33V%\B
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M*ZY_A'#[PT5R7%)NB5=R5#/BN%4V]I6!0J
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M(A:F7[&Q]I5A0O  5.,7LS+RF+<]I?M["8$"8
M
M
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M27$D4MQ98K;+O*:/VC18YC6GMGQ6J:/<R;XEWH=/1V_+ZMAEVKREVF] U!=
M       #5773F.HVF+3]NV^3-?OQU.V&I1JC4]*RV.3%([1GTDT7:/>>5.&/
M1Z+R]/.TN7*QM^F79U=?KW<[K&O0RB=NU25S]7MZ7U>5TPKS.N*Z+@O*LNU^
MZJQ(KM5DF?X1(5B3:?49:+L-HZDH(B'I&6RMK+0X+45&*Z/AMZV>=9G-7<Q+
MCN-MOX?T)41-2+<KT.T47L[3%-4!Z6<"G5%SLID220I9DTG>M"22>*^Z1[",
MS$H9FV[O@I]]*K70OR]&TQ[N7N*"NM/@;X:]?;MPWM8;MIN-R!S9-0M?5!^4
M^IU\KE8PZ"0GP36"4]1%AN'#<ZK[ZU]GXSTGE:W&&7?"J8G0L<6=,<(;)V\Q
M>E'9_P#]W@?N@Q[-J_\ H;WV)>H\EY6PNP\GK1TVUQY8K(U@C2:M%8:MF^DM
MGX:Z(K99))IV$B<VG+QBP+#-WT]"MF4_-M)U^_D&HNLK?T>C[+W>KL/1L]I5
MO,]Y82Z>GM7Q^LY'7MI7>FG=5JM%N^DG2I=,+%#QEGCS6U8FAV*[ERK;5E[V
MPTGV5$2NR/3LCG+.<MJY:E6+\ZZFNDX/4+DLI<\*<>^\4JT]/673H]S%7AHF
MM,N#4"J-DJ7GJUI3W%>%6DS]HJ.>TV'NHT=DS[R5# U70[&H*DE2>Z2V^7I7
M4_0;33]0NV&E&K3^;\/AVE YBN<V^-<'YEO6VY)LC3$RX:Z''?)$VHH/8:J@
M\T98H/H91V/6SJ+$4T;EJSI_?GW[O33!?9^7;V&TS>I.^J1PC\/AL^4UGM.V
MK@O"MTVV;5H\FNUZJ+*/2Z;$3G==5O,^C*E)=I2E&24IVJ/ ;S,7[=B#N7&E
M%;6S!A"4VDL6SM=RW<E=KZ7M4^[-0DQ[PU"227F65(XM-I*MY%&:4GVKR3_5
MEEL/YM*<,RO,=:YGN9MNW9[EOI^=+MZ%U;>GH.CRFFQM4E/%^C^GT>LY<?VC
MY$>N.J)]/AX6/^R8XZG2?]G7V7ZV:_'\9+M^)'>K0W'\2NC^._Z$V_A_LYD>
M:YW]M/[3]9OK'[./8O496&.70
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M5E_+JD?.5(1+H %48+*T@A99D1V$<4)
M
M
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M8_9Q[%ZC+8QRZ
M              !1EE@LRZC%Y&*SR*@=:>O8 +.:["3;/>V9I^+8+YKELH3
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MC!6&RP:27D%IF3'81!0J
M
M
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MM>'F>F*ELDI2E*4)3L0?HI&[XSQ#QG6NTR9I71FG=5])*?5X#4VG5ZYJ>P_
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M;18>6AE-IQ#J$N-J2MM:24A:=QD8P&9Y'
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M1FGP >VRS.I+K,4>!58LK LF2
M
M
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MJ,^]M@L[QYEJ?^KNKZ\O6STG)XV(?97J1DD89D
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M/&(S>\B1";)VUB506R^
M
M
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MRA1*Q<U9I]NV] 75:W5G>% @->EUJ4>Y+:2VJ4>Q);1EV<E*])1BJM_#X>G
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M_4B=4=(/YI=+OY(T3]PL#S/4_P#5WOMR];/2,I^PA]F/J1D@89D
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MQL(</W5-M/K^2AN>7O'6>E^$H[G&OQ2E[,76GW/57Q.G'A2[AT8'*'K(
M    2\A!+;/Y.T5CM(3544P7BP !(SVC>B+27>1@^CSE_P 0K%T9;O1XH^DH
M*5DHB4G<8N2,2+(Q;=HH3(I;P*DR1"+1-$5L\#$2:)A.\"2(R3PWBA(CH,RW
M 513)% H4Y1+E4J-)61XIS%LQ\PJKLUL9:GD[,WWH)EMWO8M(NVU*E;JHC,9
M,M&>$:6DHX3J>T1I,BV"YE\S.U<4ZF/J6EVLYEI6>%*NS!8,Y W3%J5LU"?2
M'FW(4AF0N*F.X7>6V79S)Z<4CNH34HQ:WG@%W+.S=E;N>TI49:<@G:I2'4/$
MBG3)*76(\ME!I2E1%V594]W$2*]V+Z"F4N)*=I#5/JTM3]0:P4;KJ\Q95=U*
M5*V[!0E=E'BK#823DZ?3Y;M#=F)D1*A'X"_12I2O2;4K8A?Q8]8%Q04H\706
MLS<-0H:G8<=3D>D/N.,2H-/;0I2)!?JC+;^;AFKI22]O0!?674NBO6^%-]'Y
M"]Z4EZ<R\C&)4X*HW$9=J<=,<GLZDYDNP>^E;2D]Y!F@*&-=X;?LU3ZG6G8^
M@M*KT^LE48!4NG-S:9"=<\!3XC2VW(KTI&5UY."DH6WEZRV;RVBADV;L."49
MR?$Z5;WT*S;\JZJ.B4ZW!;=JKSZ6VE)>><:7&2KM*FI<3E3Y%=[J%:%F]X<L
M8N7#\-GPJ6;<U]5:?5YC1S6V&6S[+!QW,$?+96I67)Z.">CI!F99R<.'BX:E
MIP9T6E5EVYESV&:RI"R5*XKC69AU/#..A3.9226GH]81,RZYSM^'5\/1Z,?A
MM,J,7!0KKI]-ID)Q254_C277I!29$A:LGM$MN/=A)>4MI$*FLE9NV6V]W11>
MH]MK.#+1$9=;0U/CI<1#=6I+RN$KYQM7:RY?2V@0:XHUZ"YGI<E--<J4Y7AV
MDLFXE.*<V'=4A*5)^$OJB1C))RHC76=:\NKS)$ZG*:0IUY/"I+A96<BLO$7F
MV*>=5EQ2O81=W# $MQO;>=C;A1U[5T_1CU&3X5LQTK0T\AMU#O9>)2]B6U)[
M7VPI0P;E]RQB0ZO3*=14+3&7):D)4AUIU2\RG$]WM9MV7H$N$C"<YR[YD"S;
M3U"MMVT-2:=8];F4F).;D0ZH4?%J0DNWBR:2)1DE*>]NQV#'N3LSXK3FE*FP
MV^5RN:LRAF(6IN%<*)?#XCN+9USM7C:]"NF*R["8K<)#Z(\M!LN(-6PR,C[2
M=HX2[;\.;AT'L^5O^/:C<6%5O+N4X>&.8Q$NMEF5ZS+-NEEQJX[4I5?0\G*I
M4Z&PZH_NC+'ZHO6K]R'LR:\I8NY:U=PN03[4C6NZ>2?0&Y'_ !+=M3+8>,\R
MSHLMQ#2OMF'.(CZ@V^7YBSMI4XZ]J-+F.6<A=?L4[/D-A[,M&EV);D"UJ$IY
M5,I3?#B>(62U9>G=^8-9F<Q/,3=R?M,VMC+QR\."&Q%S8X[1:)D!9]KX!1E&
M0C_-$D09+*WF)(@R=IB,4.2NF2K OM4[/KB,WB7K,<.+I*H(ET "?B)[*CZQ
M";+MM$X+9=
M
M
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M,M=Q)$21:,M))41[%2H %8061*2]4A99DI41[%"H
M
M
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M)?XW7+X=9L]$<XYR+LP5V<KGWL'@LI]6&VOSU6.S@5MXXG1D<H>L
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MR^
M
M
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M'%1=6'Y2?AQ-RFFFV&T-,I2TVTE));0G*E*4[B2GH& 2)L
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M/?.B@Y8]6          /"TYTFD53H4:JBDJ3E%XQJ'D ?%$2B4E2<4JV&GR
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M2?1M976&$QV$L)VD1;5=9])B&TR(QX50B@2  J4=&1)GTJ%J3Q+\%1$R(DP
M
M       AFZA.]9"7"R/$D0_$-]8<#*<:'B&^L.!CC1[)UL^ZHA1Q97B1$(R/
M<*$CZ
M
M
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MGLQ/-TJ^'H$9NF"\I*S&KXO,5<4+P $5AO.YY-ZA&3H2A&K*L+1D
M                                                       !"6\A
MOO&)*+9%R2("Y.'=3\8DH$'<)53[JMF;XA+A1;<VR$>W>*E         B)==
M3Z1X"/#4JI-$PF6?I%F\PHX$U<)A#[:]A+V]1B+BT34TR.(DP
M
M
M
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MO!U,&.4>JO5BV:8Z156]ZP3J=!;FB0%<&R8B([:VJ?56VR/!UEI22RN(<-K
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M3
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M*_+0JJLH83D8(S/LY\YXX8$>& H[=(U*QNIRH9]%LN@
M
M
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M$9.A<MJI/BT7@
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MKO\ 6BL;^1M0^_."Y\PL?XOD-D1;+X
M
M
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M%N%DR$J'L"H
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MM
M
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M?C&A%$20
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M/&,NC8M^W$W"&A.\
M
M                                         ,?UJYWV)S=(MJ-%N*XH
M\B NL4,YS49^)393RFUS5)4E1F2$DHTIP+/EPQ%ZW94EQ3K&.-'1M-I;/*8.
M9SDH2\.S%3N)QXH\2BXPD\9>3HWF+B>IOT=BQ57U-*P<C+T76WW]%]X/SSK"
MR.DK=X.UO-[+-NP]GAF+$9W#+C;X%Q_N^%TIP^UMV[_2<_&=OP%'QI?AZ)K,
M>)'C<O$?W3=/9V1KT=W:A49]=749$]%+2WJ%$IDYFB:'JKT1-.JD!-1;2FK+
M(FL"<R'CBHNSCD/ ]HK"$.&E>Y55N<+K%T]G;L_I)WKV84O$4/OTI*.7\2*A
M./&OO7A2M,?ZKQJ2T:G2;@*OVO;EQU:XJ)6Y]P-7'J9$K,=55M*H&IE?NJ"1
M-*6E*3V$DNX6_>0I.2A2=Q*,DHTAPNDU])]92W9=YSLV;DKD)2N<=U37'8E@
M_#CA6G4MGE1G^FTZ/38Q,->U=-*?%2UDGBR'"02>(Z9$6=1D6TQK)R;9U%JT
MK:HO*][?2^LK8H7                              "$ZV3A8&*IT(RC4
MI:T&@\JA=3J6&J'D5*  0G667VC9>(C2>](+ C**DJ,H;S+T0\7<9$7T9?27
MVWV1).ICS@X;<5TGU"NDOSPJ43(Y'T"C1-,T1UP<2GFST*Q6DE8TC%)G_P#$
M'QU6F+_XR_Y?4>6<SO\ _B;)?^W^NS$]UZ1U,^81W1F&X]'LJ\:\Q=ON\NRR
MF!D>4X]E+# V2-YA*O*7D&9E]0@\C^)?MQCP>7=Y\#1ZARY>>N_PZ+:R]R:N
MTW<.-7N<:+C@NPRQ;2F$<]=SL=GA-4^2VB.6!$E"*5&2E.'024IP&!>J]&CV
M_P!IG09))<Y7?LT__IK#S%HV5<LCE0U6O&V[YIDPK#O)\GZ578S?$(VVG''(
MC[98ISX)<4AY!'G2>W:6T\C,VEK.7A.U)>+':J^=?)TFOTS-OE#4[UG,QDLO
M=QC))M43;BUYVI+:O(7!KMS$4'5"W4Z4Z31YUTU:\)+#,YQ,9;>9MMTG"CLM
MKP69K<(C4HRR)3CM%C2](GD[GXC,4C&.S'?_ $&9S3SA9U;+_@-.4ISNM)OA
M:P3K15Z7MW<-2U^9>T'-/=#=#+/J#J'IM%?FHJ+R3P0<IUCC/DVKI)+CAD1]
M. R-#S<<QG+]U;'2G94P>>-,_AVBY++-8P;K]IJK\E69BYC=+*E(I="UIL W
M(5\V/!B/U-43Y^5"80E1/(PWKC))68O2;S)Z"(:S1=0A%O*WOV4GA7<^CRG2
M<Y:%<E:AJ>3=,Q9C%NGSHKYW;'TQP=<$8?Y8[6+472?F"M1J6B/,N8H*(TK'
M!M,E3;[K)GE+8@W$ECY!L==S'X?,V+CW5\V'Q'-\A9!ZEIF>L-TE/A57LXN\
MUZ=I<6@VO]%TDH4C2;5R%4+2J=M39*XDA4=;Q)2\LW5L/(1G66"U&IM:2-"T
MF6W9MM:OI%S.W/Q&7:DI4KB9W*?-EG1+#R&H1=N5N3HZ.6UUHTL5U/%-;RB:
MB7:YS:ZD6?9=@4Z7]#K6?.15Z_);-DTMO+04B0XD\>$A+361I"NTM1[B(7,G
M9_@UB=V\UQR5$O5Z=IB:SG7SEG[65RD7X-MUE-X8.G%+9A1*D:XM^4N?6F/7
MM#]?:=KO"HKU:LNM(;B5@FR[#9G'*&^PM7=;,TH0ZR:NRI1&G$6-,<,]DGE'
M)1FL57MJOC3WFQYCC?T+6HZK&''8G2,NK#A:ZL$G'<R_[KYT]-X- ;E60W/N
M>YYQH3"H4F,Y$0VHSQ44AT\<QET$T:C,\.C:,;+\LYB4Z7:1@MKJGYC9Y[WE
MZ?"S7+*5RXZ4BTU3[3_NMFTEK5*;=%L4BI7#;KUN2ZY$S5*V)RD/J9)Y)DII
MY1)P5F1O2I.S'M$1[!H;T%;FU%UH\&CO,E?GFK$)W8<#DL8/&E=S\F[SHT>Y
M)(%-]_:T28\5HY<&3"@P7\-K45;TLS92?0@S:0>'3E\@ZCF>;<+*ZGYZ(\M]
MV%J$;^=:2JG%+JBW/Y%YCH"\>9MPC_6G?O:QRBVKM/64\'\-S-%>1923M_5(
MR42O]=P^Z>_V+HZCFC]I:^Q\9Y7[K5_TV8^VO4RP.9V=:D/F1LJ1>[12;49H
MM/7<<;*MWB12>E8HR-F2U;<NX9>BQNSTZ:M>WQ.GH-7SQ=RUOF&P\U&MI0CQ
MX/IET;2^;1O3DT.Z[:3:MMKBW.JI1T6Y*;A3\437'"1',C6Z9%VE%O+ 8>9R
M^K>%+CE6%'556PW.G:ERK^)A^'MTN\2X:1G[5<-_P1O8XHR,R/O8]H<T>E-D
MOB6\Q0B0D<:4HT1L-FQ<LR[*?LF+E:$56>SSE4CQVHI&3..8]JUGO4?E$&ZE
MZ,%#81P)  >D%B>S> 14F6B;+RF+4I5+\(T(XB3
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M+T8T)@1)@
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MN/I^4?RM:^G+T#\A;3_^.-Q_]3_>X?SC?_=Q]/RC^5K/TY>@?D+6!_'&X_\
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M6,:E0::)HL"VF?I"TW4OQC0C")(
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MGS2Q_B>0V1%LO@
M
M
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MR_")9$7J1RP_1'M$>+H)*VWM?F)MF,S&VLI(C5O5O,_.9[11NI<4%'81P*@
M   $TTQGVJ[)"+E0G&%2?0@D%@0M%Y*AZ J
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MD-YI\B\_#,Q6=N4/:37:4LYFU>5;<U+L:?J*Z(EX
M
M
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MO:?:/J%MR+L84)H1+@
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MI[);BXQ2;JTMO3UE9 D
M
M                                          $!YI#S9MN=I*BP/:9?
M6 HU4I+[>9Y+CA)5);XGNW W,NU'ZKEV?\-FT"+CC5[5L(2&C4\^EM*.,ZM)
M5LE&[AM9REP<=G5NZ-^T5J02QP_.V]&XJD:.B-':CQTF33"$H;(U&K8DL"VG
MB9_"*5J7$N%41/ 2
M      )9<5H]I)RGY!)2H0<$R5-A2-Z<?,+BE4MN#1+BI
M           CMM*7N+X3%&Z$HQ;)M$9"2Q46)BVY%U02)D1)@
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MIIY*%*-"]NXQ9G9G"G%%JN*KO,JQF[-]R5N:EPNDJ-.CZ'T,N81+X
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MZ@E&@SV8Y%8ECAM'!9BT[%R4'M3H>]:9GHY[*V\Q%44XJ5.BJV>387L+)G
M
M
M                       $%UM+B%(5CE41EL/#>%2C1Z0DDH)!='6*E2(*
M                                                        A*:;
M7L,A5-HBXIDNJ(7HG\8FID';("H[J?1Q\PEQ)D'!H@&1EO(5(GS * ^@
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MB+<[ZD,(21*5\I6&)CB<Q>E>N.<MK=3V[(9.WD[$+%OV8145V)%VBT98
M
M
M                    !#6M*"-2E8)3O 'I*B46*=P ]
M                                                (2F6U]Y(K4BX
MID+PC701D)<;(^&CX<1!^D8<8\-'CPG4OZ@KQE/#/7A2Z_J!QCPS[X1'K&*<
M97PT??"LETG\8IQ,>&B*3+9= <3)<"(A$1")(^@
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MBL;^1L_[\X+GS"S_ (GD-D1;+P      'PRQ+ 4:J#Z*@
M
M
M                                    #R:DH3B?9( 4B0XI2E&XW@3/
M$3X7LGX@N'C@6(%N4GZ\.G A(=?0M)\)Q92#21LEPR\(DFL>UMV[17:43=>W
M^K@5IM:'$DM!YB5Z0H7"(!4
M
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MS(@!]              !\S%UA0'T  !\S%UA0'T
M
M
M4F>D^$M2T'(9)M?&A);):GMFXL3^ITBJVD)[,<5T=)(RD.<5!+(EONJ>]W3/
M#DHH>+6';/'I/X]PJ6Y+''KHZ>S@2Z$+4IXD-J0IA2#J<E45O_6)>'W-[?,7
MZ$.W^@CC7#=2KHN_AN)9F5(A-PGV84I4&HE&8@T=J,AM=/2:#S&_@O8DMA'Z
MN[:*N*>&]5QKM["D9N"32?"Z)1HNYA\[JZ>@O-*B5M(0,JIZ
M
M                            /R "@)D2E*IQ*FQ%D\E7'-"#Q=5AB2F.
MWN+>KO!6A:4G58KY>SXR0.;4"8B**K4MMUVJ&R\^I)Y%L\59>';]K\_E(BWG
MMQ[/5)TJ6N.=%WH^U3M57@L?:^%"3J-0JC<6OK9KE&B.Q9+2:>_*09LPTGP<
MR)F#Z<RSQ,TX&C8I.\327=P?7U]F!;NW+BA<I."HU1O9'9[6.UXTV;4>YLVJ
M(EU]MJLT>,U&I2'X,:2@^+$?]MFDR\'DYF%8%@1)3W5]OJ0BL*I[=V_J762N
MW;BG-*<%2%4GMB\>]+'V=G1L>)+0ZA65U:VV7KAHC\:71W7ZC$9;,I$R0G@9
M94+VR\(Q9E8D9+[R.WUUE&*C*BEMPZEC@\-I&W<N.Y;3N0:<*M+;)X=Z./L^
M?:L2A4ZL7*Y3[&<D7=:DI^H3'T5F1&;4EBI,D3V1JE9I*L'$&2<V*E]U6PNB
M]*W"LZ0ELP^KURP,.QF+[MV7*]:;;?$ULFL<+?>>*WXO8RFR:W=3=*JK[=\V
M<Q*:O H,6H.H449BG>(;3[N?_""QG<,S3OPS&78(55J'&EP3]BO6W3VMGLEN
M6:S"MS?C6:^-PI[E"J^[>/[7^BB(=P5NZ6&M550K[LRF>Z(T)=MKG)Q*B<1G
M,^NM8O;G5;6]B>SUBMNS;:M5A/&M?K8_,PW;]HS.:O1_$TO65PJ/#7_#K[7B
MX_.^;@O*3KU:N<KAGQ6KYM%N$BSCG,TMS;,9J!J,O>:T\;'P'_X9ND44+? G
MP2]NE=U/H[/:$\SF/&<5>LT\'BI\Y3_>4K^R^%=Y;]$N2\Y,W2)J9J19%09K
M-/FN70S ,B=KCK369IZC=M6+;9X&OR8^8KMZS;BKS\.:HU3ZO5+M+&7SF8G<
MRJ>8LM34G))XW*;';Z4L*TI\2MV!=6H*J%9+[^KNG4F94+V>I]7GL[8DZ EU
M22IL'MGC-(DX&GHZ]F*[TK%GCFE9N44*I;T_I2^J8=K/9QV;+>:L-N[PR:]F
M4?H0^OU=:[V'>DKANS4:/1]4Y$76#3NFOTBZ8T6WILSLM4>&:RSPJF:B412%
MI,B3L/:2MI>A6S9L2G:3M7'6+K3YSIMC]4AF\_G86LS)9JQ'ANI1;>$(U]B>
M#I/SU:>*KW:A<EU7Y#KFK3$'5.Q*7$H=L195!ILK9+H\Q;;9N3*CF2>5AS!6
M7'/WF^SZ\+%BR[=INU<=98O=)8X1Z_RE[-YW.1O9F,,S94803BG[4)85E<6-
M(O&FWVHX?2@1;KOYVXK*C*U9L)R%-L%ZIU6GI-)NS:B3:U)JL8LJ#\*E1)7C
MF3BE+G8Z4UE:L*U-^'<JKE$]RC]%_6+,,_G97[*_%6*.PY26^4Z/[R.SN5QK
M581GW?HVY;U[:CRXNABIFM&GU1=KU3GLW2J*M*SKK+3N5$>G>Q3F<0C%*LI-
M8.&GO]-Z[E;"=]*S/!*E?F]<L=C+&5U'/RCDV\U8?%*2G3'Q$I+NPP]I+!^S
M236$BW7[]U6^ALV:G7?3E%4/40J8BM9T>%3 PP]W'[ _:9NWA@:LF/MA>65R
MWBT\&Y3PZTW\7TMNSX4,">I:G^%<EG<NI^/P\7S>&GL>SMKC]G'Q":NB]]3H
MS>O:H>M5C4\K>ETU%KI<4V2J,VZ]D=:EYHZ\CCB/9ECQ?:8]T4L9;+MY>MF;
MJGQ?7^SCL+^<U'/Q6>IG+*X7'@V?=XXJ6#QW?/K+Z)%G7IJ:5R7)&;UJL%$:
M+INU48<<G&T^'J*H[:CJ64VEY6C4HW$F:E%PU(]D$,K8\.'W%ROBT[57V=NW
M=V[R%S4=0\>['\98PRZ:2IA/A7?V/"M9;^ZX]S$I]N7SJG(N#1B-*UKL6>Q6
MJ#.?KD="T&=1?0<CAO),FD9\F1"<4FT6+;O94)7LKEE&]3+W,)*GU=F#]/26
M\IJ.HRO912SEE\5N3DL.^^]1[,:*BPX,8R['9,*Z]1:U0M(IU:U?TVKM1*^I
M+2JA*1&D9VFS8)#4=:HJ<JTYU=TFU%Q&>WLV9,K%BW.[P6;JCX:Z>O%X[/D9
MK89W.YB&5=W-Y>;\=[5%NG=HH]W;&K]E1=)0[RW6_<=4NM-N:MH1J3I61?3M
MA22>BPC)/;?PXN:$I/$Q2@R-:7%=ASM[\;UB-OCLOPKO[)[WC@L5CLZNS P<
M]+,^#FE^(RV-^+]F.&,J5[KJ\%1R4GW)=[IKETU*[4U_7=/XQ-,R25 @)-I4
M6(;A))<;$G,T9PS/*:B+.;A9U-X)+!.6.7A:X,O]W=]I[&^O9CAZ,*F1J%S,
M^-GE^(RN-N.U1>^&WNX[]O%WI1ZN$W5KK;NJTG"U*TO9>3I2M7$-B+ES%$=6
M2T_@F)-XF2\I'DR)7[+#%)QX+;M2^ZN_M>E]/;M^/>3\?,1S-M_B<LO^F>Z/
MT6_H^6FSA3[FYS%@WIJ#38V@5.C:O6'#IE3J,Y%?I<1+#*9<=,A)):-+45LL
M^7%"<O"]H:3,U;Q'-Y:S-WV[-QR25&]W7MV><GI>HYVW')1CF["C*4N)*BXE
MQ;***QI5+V<6JUVF\UF:@6;?\>?+LZX85PQZ7*.%4'8IFKAO%VC2>))/:DRR
MJ[I]!F.8OY2[EZ*Y%JN*J>FZ?JV5U"+GEIJ:3HZ=/PV/8]Q?PLF>     4EW
MYT_.+L=ACRVD(MY"K(EG8>VD_P"&7]<QD&NWOM)@MXC,E$YO\\MTRY5<L>P6
MG"3"@Q'*]4&$GB3DAU:XT?,76VE#IEUYAP?..;HX6^JK\N"]3\Y]+^XK2HV\
MOF<_+VG)6H]224Y_I-PKV&H5.B$I&4B+X/J#S&_<HSVB_<HR\&*<9H(S29$?
M7^:-9._B:N=_$I\V$A*-VW;Y_,+UJZVR_:NMLLB1+F42=#K5,>7%J=)DMSZ?
M-:,R4U(C*)UI:3+I):<2\N\;_(W91FFG1IFUC:AF;<K5Q5A).+3WQE@UYF?H
M!LRO-W3:=L7.PE+;%P4J%46VRW%XQA+V3[G/@/:+%[Q;<9]*3\Y\.ZID7D<Y
M=RS_ ,.<H?HMHNHD]8R:FNH3*"V8BU(N1/9^3>!4X3<QUWR;ZUTON<\ZIV';
M\U5 I"#/%#<>G&;;A)QW9GC<</SCRSF#-.[F9=3HO(Z?#M/L7D'3(Z;H.7BE
M25R/BRZ6[F*\T>&/D+(ID E$C*1[.CIP(<=F+U#=9B]0N%-/Q2:S21EC\(P7
M>QH83O8T*!4(9$1XEM29EL^/8,VQ=J9EBZ7]RX75)L?7BPI;"U-0KBE%;]60
MD\"=9J)DA!*ZR2\3:R\P['ES-.WF8X[73SX>OU&CY^TR.I:!F(R]JVO%CU.W
MB_/'BCY3N@6TMH]5/CP&6(H5)998&K$7$6V0E8;A4B0\N!@19*K3@6(JR#)=
M6\5(LDU$*HMLEU)Z2W"1!HDGR]DX7D,2C[1:G[)=B?FDF?JE]863/W!'?( B
MM"R90 &MU=_K16-_(V?]^<%SYA8_Q/(;(BV7P *%5ZG3Z%3*A6*I+;@4ZEL.
MRJA/>,DH:99+.XXHSV$E*4[16W;<Y*,<6\$6\Q?A9MRN7'2,55OH2VG-ZZ.:
M_5?42YG;:T.H#T:,I2_ .HA)FU24RE64Y+B7B-F,WTEF2>7I5CL+LK'+^7RM
MOQ,W+TT2\N\\8SW/^I:IF/ TJ%%C3#BG)?2QK&,?/3"KQ*/-UIYK=()4.=J+
M3G*A1Y;I))NK0XQ,.F99N&B=3LO#7@9X$L_+E,7X:9IF>PL.CINK7]%^DQY\
MS<RZ*U//0XH/Z2C3L4[>%>WM-H+MUV<K7+E6]7=.I*J74V$1T-,RXZ7U1)?C
M&&)+*DJ(TN8$X9$HL2/O$.?RNE)9]9>]BL=F]),[S4^:?$T*>H9-T:4=JKPR
M<DFL51[=NPJO*SJ'=FIVG]1N&\J@S4:K&KLB$R^U';C$3#3+)I3E:2DM[A[<
M!37LE:RF84+6"HGMKTD^1-:S.K9!W\PTYJ;C@DL$H]':RM<R-\7-IUI34KIM
M26B!7(DZ"RU)=:;?3D?D(0LLBR4GM$?4+6BY2WFLS&W<V4?5L1E<Z:K?TS3)
MYBPZ33C1M)[6D\&6MHEJ9>=Z:#5^^;CJ34RYH'OHXLU$=MI!>"0:F?9-I2@\
MIE\(O:ID;>7SBM07=[N_I,'E;6\UG]%EF[S3N)3HZ)>RJK!8&G]G<P'-??Q2
MVK.=3<C],::<J"8M+@YF2>S9%+SDC#/PU89>HQTN:T?3,M3CPK6E9,\YTOG#
MF74G-99<?#2M(QPKLW=3,BTR\N=YRK4E-1MV8FFKG1D5)7NJFI(F%/))XS-+
MF)'EQVE]0:^[E]'4)<,N]1TQ>TWV5U'FYW8>);?#55[D=F\OKFMUJU$TNN6T
M*99=98IT.K4Z2_.:>B,2#4XT\V@E9G$+,MA] Q]!TNQG+<Y757A:WT^,V'/_
M #1GM&O689:22G%MU2EBG3H9>7*OK56M5:#<D*\)C,RZK>F(=-]II$?C0)2?
M8F3;9)+%*T+2?W(Q=?TJ&2N)V_8?EHT;+D'FB]K5BXLPT[L&MB2K&2PP76G7
MR5Q)'FKUQK^ED2U:/9=09AW-7G7)DQ];#<@VZ='[!8)=S)]HZLB)6&Y*A+0=
M*AG')W%W%AT=[\A:Y_YKO:-"U#+M*Y)MNJ3I!8;'O;>'V64KE-UCU"U4J=\L
MWO5F*BBB,0%TU#41F*;:WUR"<QX24XX\(MXO<PZ98R<;;M)JM:XUZ#%]WO,V
M>UB5]9J2EP*-,%';6NSL(>OO-<[8%9E6+8,&/5[LC<-%5JLDE.QH3SO=C-,H
M-"GGBQ29D9DE.)$>96*2:/H"S,%=O.D-R6U]?4B7-_/KTVZ\KE(J=Y4JWBHM
M_-23JY>A=;P,,KO+GCBQCNM^GU<Z9E-Y4(Z73E&EO+CVX*$^((LOW0V?X;1V
M_#4EQ=K]9S#U#G*"_$-2X>C@AL^QP\7Q]9GSE\YHF=3YR;.O"!'H]Y&VM=.D
MP\R8=1)I.=Q*$+4:FWD)/,I!J,C+$R,L,!I]8T3\(O%M.L.O:OE76==RASU'
M5I_ALQ%0O4=*>S.FVE<5*F/#ZMA:'-9KEJ3I9=UN4JR:TQ38-1HJYDMIV&Q)
M-3R9"D9B4ZA1I[/00R.7]*L9RU.5Q-M.FVFXUWO YKSVC9FU;RTDE*-76*>-
M6M_D,]:QZSTW233^+6YAHJ%RUEA#5M4<SRE)DJ;)2G7"3@:6FLQ*<\Y)(\5$
M-7I^FRSF8X%A%/%]"^7H.MYCYEM:+DE=GC<FJ0C]*5/U57O>1;T8OY:;IUUU
M(S7E?5Q--6,V2V:/ ;IT5AZIO;CD$XE&8F6E;$FGOJV>B8S=<LY/+?=68UGO
M=6U'J[32<E9[6-37XK-S4;.*C'A2<WTUI[*Z?G,LN%KMJ<_S1*TR=K;"K.3<
M;\#W?X*/Q/#MQ7'4IX^3/WDEMQQ&5+2;"TW\13O\-:UZZ;#50YLS[YD_ <:\
M'C:IPK92NW:>.:3774_3/4*G6]9=<CTZES;?8GNMNPF)*C>=DR&S5G=2H\"2
MA.S[(KR_I.6S=ASNQ;=:;6MR(<^<W:AI&?A9RTDH.W&3K%/%RE':^I(V1T(U
M?@ZO65'JY\.)<M,R0KKI*"/%J42"]JA'>)IXCSM_"G$S28TNJ:=+)WN'YKQB
M^K\AVW*W,,-9RBN;+D:*<>B73]F6U>:N!K?KMKIJ98^N%&LBVZU'AVY+*C>(
MA.0X[RS\;)-M_P!JXC,68BZ-W0-QI6D9?,9.5V:?%WM_0CC>:>;,_I^LV\K9
MFE;EP57"G[6#QI4OWFTU8OK2F+8LBQJLU355R1.;J9O1FY)&EA#"D9>*E>&&
M<]Q#%Y?TZSG)35U5HE3&FUFR]X/,6<T>W8EEI*/&Y)U2ELX>FO3T&!Z=J/SN
MUB! JM-H4B?3JC&:ET^:W2:>:76'4$XA:<RDJ,E)41EL&UGDM'A)IR[RP?>9
MR]G6>;[UN-RW;K&233X(XIXI[#8_0"XM?:E/NI6ME-?I=-A0XSU%6_$AQDDO
M.]Q\#C&9GE01;QIM7L9&'!^%=7OQ;]9VG*><UJY*Y_%(\*23B^%1Z:[.HUZK
MW,IK7JK=T^W-"J4J-28_%5#D-1V7YKS#9\/Q<ER5[%A*S,LI8%AB18F8W%G1
M,ID[2GG'B^MT75ABV<=G.==8U?-2R^DP[JV2HG)Q3IQOB[L4_P FTD/QZ<U&
ME57ID;4*V7*Y%J4M$6+"G06F_&.N*(B:C2Z>DT<51[$DHE;?1$WI6FYN,G9G
M1I5P?K4BTN:>9=)NQCG+?&FZ)./M-O9"<,*OKKV,Z6TJ1)F4Z!+G0%TR9(CL
MNS*<M2%KCN+22EM&MO$E&@\2,R'$R23:3KU])[7:G*4(N4:-I56VCZ*[,.HK
MPH7                        I,Z;'I\63-DJX<>&TIZ4Z?H-MEF4>SJ(L
M16,:NBWD+EQ6XN<L$DVWU(P6GFMT 4E*BU(CX*+-_D<[][#:_P !SO[M^=?*
M<H^>]%_[A?HR_NE8MWF#T:NNJ,T>A7_3I-3DKR183Q/13=4O:2&U2&VR6HSW
M$1XBQ>TG-68\4X-+S^HS,GS=I6<N*W:OQ<GL6,:_I)>8O2];[M'3JE-UZ\ZP
MBB4AZ2B$W4'4//8OK2I26\K2%J[1(4>[H&-E\M<S$^"U&KVFRU+5<MIMKQ<S
M/@A6E<7CY$WN,:ES4:!?TDQ?VG/_ 'N-A_ L[^[?G7RFB_GO1/\ N%YI?W2_
M[-U/L'4),ARSKK@U]41*52HT=1ID-)5W5K8<2EPB/K,L!AYG)7\M^T@X_#IV
M&ZT[6LGJ,6\M<C.FVFWS/'T%]/R&8[3K[SR6F&4FM]U:B22$D692E*/81$0Q
M4JFS;HC7ZL\U6A5$E+@.WTU-?:,TO.4V-)G,D9=3S#2FU? HQM[>@YRXJJ%.
MUI>ALY#-<^:-8GP2OIOZJ<H_I)</I,@V1JMIWJ,V^=F75"K#D5&:1!0:FY+2
M3Z5L/)0XDCZ\!A9K(7\M^U@U7S>=8&YTO7<CJ4:Y:ZI]2V_HO'T%:NZ\K;L.
MA2KDNRIE2:%#4TW*J2DNNDE3RTMH(TM)6O:I1%N%NQE[F8GP6U6709.H:C8T
M^R[V8EPP5*O%[>RK,6_E3Z!?TDQ?VI._>XV'\"SO[I^=?*<]_/>B?]PO-+^Z
M7G9>KFG&H+[D6S[OI]<F,H-;L)"E-2"26S-P7DH<4DNE1%@,3-:??R_[6#1M
M]-Y@R&I-K+7HR:W+!^9T9+WOK)IIIS4(-*O6YF:'-J#)R8:'([[N=HE<,UYF
M&G"+%6!;0RVG7\RJVHU2[/C:(ZIS%D-,DHYFXH-JJP;P\B9:?Y5&@/\ 23%_
M:D_][C*>A9U?X;\Z^4U7\^:)_P!POT9?W3+-MW?;-YTE%;M>NPZW2G3-"9T)
MTG&\Z>\A6!XI,L-I'@-=?R]RS+AN)J70=)DL]8SEOQ;,U.'2G\,2S%ZVZ8(O
M1.G!W6W]-CF%3TT/PTK/X@V^)DXG"X?=VXY\!D?PW,NSX_!W-M:HUO\ ,NG_
M (S\'XOWU:<-);>VE/21;VUDTTTYJ42DWM=#5"GSH_BH;"V9+O$9)7#->++2
MTD69)EMVBF5T^_FHMVH52["6J<Q9#2YJ&9NJ#:JL&ZKR)EJ?E4: _P!)4;]J
M3_WN,O\ @6=_=OSKY36?SWHG_<+]&7]TK<'7G2>I6S7+SA7@P];%MO-1ZU5_
M#2DH8=D*)+232MHG#S&X1=E)[QCSTO-0NJTX/C>Q8&=:YHTV[EIYJ-Y.U!TD
MZ2P;V84KCV%&_*IT _I(B_M6=^]AD?P/._NWYU\IK_Y\T7_N%^C/^Z>#YJ]
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MQ1;>+:W+9M2IBVS)0L&R
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MKPUW^7V:&:QA&_
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M++Y..<MOCN7%1NE.'Z4$NW?\[::Y2/Z]#?\ +%'[B&YC_LOYOQG%S_\ -/\
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M*8W7-F8:<+2V4JUUU.*]U.GVI1O9IKOU48_536/E>&.]'24<<>R
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M;.IV,K:E?C-/*QXN*<G)R5SCX:)->S5X4PZ,#/R5DHB,NDL1KSI$SV!4
M
M                                                   ^92Z@J#Z
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MY%$8ULDXNC.EA)32E'8\45("0
M
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M\ALB+9?
M
M
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MB%)V&2BVD8U4HN+H\&CIK-V%Z"N0:<9)--8II[TRL@7
M
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MY-SZ=M:;C88:LZH
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M<>F+3]1<8MF2
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M1IY*471X/H.NLW87H*<&I1>*:=4^QE: F
M
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MG?\ *>A\NZ1HL+T\YI]&Y*F#JH=-(O&/%OKY*(VB&I.Q
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MTC4?'5]NVEA1N+DW7"XMCBMJZZ&\HYP]*
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MI&NOV96I.+V;GN?6NHZ#(YZWG+4;D>A53IQ0;5>&5*TDMZ+S%LS
M                            (:G&T=XR284*-I$)4II/3F$N!D7<1#.6
M700EP$?$(1RG3ZB!01%W&>/$.^L)<**<;''<]8_C"B'&SYQE]9BM$4XV??$.
M^L*<**\;/OB7_(*.!7Q&14RCZ2Q%. JKA$*6VK>1D(\#)>(B82XA6XQ1IHFI
M)GL4*@
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M)J-V0<E:<K_C%GB:WDK0:%FH]Z<"[.4APNJ3S#S$U?=9IT\FZG4>Z<K0R/\
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MM/HNOQGFW+/_ ,?S'"QE+OB6W)QJOGPQQ>-'1;_J\1V4'G9]&@
M                                            '+[G_P#_ #!I[_ U
M2^^M#M^4?8N]J/$/>W^VRO9+UQ*-K5#GZ5:GZ0:TTQI;L:M4RE2JBA/9-V5
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M73876JTBL/+UGSCJFF/4^9[N6C/@E*;I*E:4BWL\AFHN0NYNR9:J1?/[N?\
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M+C)\7#Q<*C*,ME.]NV[TI8'6(<(>]
M                           !JKJ%8-.M.-<M<IM/B)TRN JM6-<+99C2
M)M3KKC["4H\(9.>R42RQ/(:"+$U;1M\IF97G&+;\6/"K;P48T>_R=IR&JZ9#
M**=V"7X>?'._%)N=QR6'#T8XX."56S'DQF.3MBG4J<U+14I+2>5Y#%*E$=HF
M=,0IKW\GB$99<S)F2\_<4ONEV<Q-]_AELKXV*^\[WS/3T&ENP7%8XXIUI^$I
M%_<=Q->-C]AT?'[#GLPC3X4:IG7KE8AG&;ON(Q3%<P]S.4J0Y3[HIW@G35%H
MJ<V4W%MEE,FT-9C[2=V42N2C*,?H.OA1JJP==L]]-ZQ9;MQN>-=4:>,E'\3)
MQ?#>APUX;*Z7'#"-OB?>3H5BPK^:T\H]OU^D0)K&AMR-4^DZ>Z<PZ8X[7J3.
ME2'2D2J@I2E*X3KJ'5$OBKSYDY"V=J&9RBS,Y0DUXT:N4V^[)4P4>O9N1D:7
MJG\/A"[;3_!3I&W:46[L)N3XI3;?LMJ;KQ2XJQX4J/BW7C28\II+S#B'VUXD
M3C9DI/9V'M(<]1K:>B*2DJHGA0J:::Y+IAZF6W&MB NBZW+MZ6[96I$UE3E&
MI\=IQSCHE+4:F\YMJ=2E2VU$@W$XEVB&^TU2_#S<W6SQ+B@O:D]U-^VGF9P7
M,KM/4+<;,7'.>&_#NO\ 9Q5752VK9QKV9<+FJ[48FMFZ';*J=QWC9+*Z#1;1
MJ<IW7*D/05G,NBJ--=MVCMNN.X-<0U+)!+1PDKSN$:320S[^75Z,;=W&4U]W
MCA;CT2^#KN-!D]0ED9SS%CNPMR?XE-=Z]<2Q=I-R[M75+BCP1?%*JI$WKLV[
MZ=>MOTJXJ>3D1%1BL2GZ;*R^*BG(0E:6I+:5*R+))]/1Y!R^8L2L3<'N>W<^
MP]0T_/PSMB-Z&'$DW%^U&NYK<7R+1F
M'A2TH+%1@4K0EG))%W2^,7% MNX2JGWG-ZLOF%5$@YMD(2(@
M     !%2ZXC81BCC4JI-$=$L\/:%M\@AP%Q7.DFTN)7N,1:H34DR(*$@
M
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MXI;ET16[U]9LJ-2=<
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M6P
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MA[2^J(N!<C,FVW4N%L[P@U0N1E4BB)(
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MKO\ 6BL;^1M0^_."Y\TL?XOD-D1;+X
M
M
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MA\Y^>%'"NPN1N=)/$9'M(6RZCZ*%0
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MHY;-?L;L)_9DGZF7<+1F
M
M
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M4L5B114   !$;<-LR,OSO0*-5*QE0J+3I.%U*+T1::H7XRJ1A0D
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M5[946U];WEP"A=
M
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M_"=28$28
M           <M.?JSY,6OV#J,Q'-4"3"=M^H/H+LMO-N+E1B6?\ ?$K=P^T'
M$\UY9RX;NYJGFJ_C?F/H?W*:K">7S&0D^\I*Y%=*:4)4^S2-?M&E-,E94D1'
MAF/KQQ'F^8MU/7\Q;+T8GH)&&)X&6T:J=EU-5.RZE-GS4J29*,L,<4[!D6;6
M)?LVBRG(<ZNU&GT>EM*DU6MR6H%-AH+,IV5)<X3:4EUFI1?7&_R-B4YJ$55M
MFT5ZWE;4KUUTA!.4GT1BJOT([S6S:J+5MBV[;@+2MN@TR+3B)>Y116$M&HC[
MQ9U(Q'MF6CX-J%OH27F1\+ZOF99_.7LSON3E.C^LVRKFM36Q]!M=&8]I?&6P
M9-345IM(R3(]I&*4)5/:5F7F%"29[XO6 XCV3I8 5J:W\P>@]-UIH41^#(;H
M]\4))G;]:=2I2'&UEBY$E8=HVE*[1&6UM7:3Z25:76=(CGK?1);'\3^&!Z)R
M#SY<Y;S#C<3GE[GMP^<GNG"N'&ME-DHX/<UR:NNU+QTXJ*J3>]OS+>E(Q2VM
M].:/((CP-<:0G,TZDODF?EPP'E^=TN[EY\$XT?P^&!]5:5JV1UJUXV2NQN1Z
MO:CU2CA*+[2@JK2";,U.H(D^D:BP^ :Y95UV&Q64==AD#3S2J_\ 5V<U%M.C
M.>[#62)]T3$*9IL;#O+-_#VBBWDVWF/R=(W>F:)?S4Z06&][E\.K$YWF'FK3
M>7;3GFKBXZ5C;33N2ZN'YJ^M*B.N^DVF= TFM*+:MMH=G/FM4FM5<D>TGS%D
MDEO/&GLH+LX)02L$$1%M/$U>IY#3[>2M*W'RO>V?(O-7-.:YBSKS-W#="*]F
M$%LC7IWR>]U?4971$><3[9[AE^MLGB?Y[[ SN)G.>&][\Q/-MH91D;02"\@H
M32X=A$ J>DI-9X$G,*-T*I5*BW'0C:98J%MRJ7HP2)@1)@         &MU=_
MK16-_(VH??G!<^86/\7R&R(ME\ # ?,[_,/J3_!J/W2T-IHG^MM=IR_.O^S9
MG[/QHYR:(L<R;UO59>B;KJ* =1_UPAM=-;_#>"W_ )[@O#A9.[L'9ZF].C=7
MXKVJ8;=GD/%>5H<PRRTOX77@X^]C;7>HOWF[AX=GD,FTSEGUTU5O&%6M;*GX
M*G,DANJ2I$N-)E+C-KS*C0V(AK:9)6W::B(L35@HQK[FN9')V96\I'%[,'MZ
MZ[3H\OR1K.L9J-[59TBMM9)RIT14.XJ]/YU*X%Q\^,=F'%TGBQVR1&AIJ[;,
M='=2A#<0B(OM4D+7*+<G>?9ZV9'O:MTCE(QV+CP[% MBW^4?56MT.AU>%JI'
MA1*Q C3(D4Y-1Q::?:)Q+6#:B3V2/ \-G4+M[F++PG*#M5HVMQBY/W>ZG>L0
MG'-T4HII5EA55IY.PVJY=]&;QTA^EQ79=S5TG<*X1P%MNR738\*3Y+_RDU89
M^,GN]6WH&AUC4[6=</#AP\->C?0[WD_EK-:/XWCWE<X^&E*X</%7;TU]!S<T
MH:U8<U KZ=&UJ1=ILSSE<)41"S@>*1Q,%33X1EQ<GRNH=KGI919>'XKV,*;=
MM.H\2Y?AJKSUS^&?MN&5<8KN\2_>=UJM.O;U&<:WHUS=:KR(%/U"EI:I<)\E
M(?J$Z"41E1YDJ=\-3LW$61&>!FG'H(RQ&JAJ6E9.LK.WJ3]<CK+W+7-.L.,,
M[*D$_G2AP]O#:VM;MYT,TRL*EZ:610;,I*UOQZ0R:7I:R)*Y$AY1N/NJ2G=G
M69F1=&[H''YW-3S5YW9;_@CV+1M*MZ7E(96WBHK;TMXM^5G._G<_GFM+^3T'
M_O%\=ERQ_I)_:?J1XU[SO]VL_P"7']>1U8+<.#9[PCE5>/\ 7LI_\IJ)_P!W
MQQWV6_V5_9E^LSP//?\ FO\ [EO]2!/\_?\ YLL/^!*A^Z$"SRC^SN=J]1E>
M]S_4Y;[+]9THM;_RU;?\&0_O"1QM_P#:R[7ZSVC)_L+?V5ZCE_SRUBF5K4*V
MJ%3.',J] I#C%62UVE(<FOI7'CJR^GE(UX?*+K';<KVW;R\Y3P3=57H6UGB/
MO2S%O,9^S9MXS@J2I]9]V/;O\I?'.?"?I^G^B4"69>.@I=C3#W^U:A1TN?5(
M8_*\^+,7I1^&+-A[T;<K>GY2$MJJGVJ,2Q[+Y5=4+KM&W+FI6IS%+IM?IL>?
M!IZGZ@2F&WF\Z6U$VK(1D2LNP\.H7LUK^6M77!VJM.E<,:>0U^E\@ZEFLG:O
M0S5%.$9)5E@FJTZ#;/EXT0O/2.7=<BZ[Q:NANNHAIIZ&W93IM'%4\;G^4F>&
M;B%W>K:-#J^J6<XH*W#AI7HQKV'H/*'+.:T9W7F+RN<?#2E<.&M=O34Q7J'R
M86Y==3JE<TZN=JWW)4IY<RAR&BEP$2LY\9+*VU)6R1.;T'FRGB18%L&;D^9;
MEJ"A>AQ+<]DJ?&:+6?=IELY<G=REQ0;;K%I2BGO2>V..Y\36Q45$:Y5^A\P_
M+)*IE2.XWF:)+?)B#(BS53:3(<;3G-EZ+(P-.9M)X8H3L(\JL2/#>6;V0U92
MCP=ZG122Z\#B,[E]?Y4N0NNZW;;HJ2<K;>WA<7U+;PKZKHCJ%I;>9:@Z?VO>
MJHA0EW##1(E04F9DT\2C;>0DSVJ2E2#P'"9[+?AKT[6VC/>-%U):CDK692IQ
MJM.A['Z3)@QC9@
M
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MVN@W&D2X<W;;M^/62I#_ ++ZN_AHOLU\/Z9TH'(GKH
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M^@]Y?9&/*/"9]NXIK FP)@ ?2[!X](H-A4&7N)V5=[ZXMRC0O1E4FA$N
M                                                          8[
MU"L.@:F6A6+-N6.IZEU=O*IQ."78[R-K+[*L#RK:61*2>&'0K$L4C&S66AF+
M;MSQ3^%3;:)K.8T?.6\WEW2<'7'9);XRZ5)8/XF<4M5-'K[T3J;L&ZH2IE!=
M>--'N^&A1PI:/1S*3CP7/6;69'CW34G!0\QU31+V5GBL-SW?#X=;^N.6N:]/
MYCLJ>6E2XEWK;]N+W_:CT2CY:2P,=M59)(29*S$KNJ(]XT$LLZG02RSJ>/&R
M:C(CP8#+TV?*<)$*G,(5(D.J7W4MH01J69]!$1B_8R<I.B5:] \*-J+G-J,4
ML9-\,53I;P1T?Y6^6:IVK46-3=2(11;A2THK6MAPTK5 XJ<GBI>7'\(-!Y4M
MD?LTF>;MG@GT70-">77BW5WMRZ.OY/A3Y[]Y7O%M9ZV].T^5;3_:7%LG1^Q#
M?P5QD_G-*G=]K?X=B>%@ 2JH45>WPV17K)/+]8$VB#MQ>XAG!7^IRS+[8B/Z
MV KQ%':Z&0SCRR/8<<_A,OLA6)3@GU'GA2O\W1^R%]D5XH] X)] X4KHB)_/
ME]@*H<$^@D)E&;JC#D*IT^GSXK^QZ),04AM1?+0:<BOB%J<83C22JNO%&1E[
MU^Q/CM2X9=*;4O/&A9\?1O3*,^<E%@VNW*,]K[%'AI47VJC:/+\ Q(Z?E(NJ
MLPK]E?(;J?,VLSCP2SMYKH\2?RE_L4Z"PVTTRQ@TVA)-(P)*$I3Z)(3E2DO,
M0S4VL$:2:4I<4JMO&K=?.5,MB2(NR1>B6PA4B?0!])./F $TW',]I]@A%S+B
M@3J4)06"2P%MNI=22/8H5            UNKO]:*QOY&S_OS@N?,+'^)Y#9$
M6R^ !A77JWJS=.D%[V];T!=3K=5A(9IT%M24+<63Z%92-Q22+LD>\QG:7>A9
MS4+DG1)XFAYHREW-Z9?LV56<HT2Z<5TF*.473Z\=.[0N:F7K07:#/J%=.7$9
M<=9>SM'$91Q"4RXXG>DRV[1G\Q9RSFKT':E6*5-E-[Z3G?=WHV;TS)W(9J'!
M*5RJ54\.%8X-FX(T1Z :.<X.EM^:E%8+=E6Z[7TTDZE[TX;T=@VRD>')O'Q#
MK>.)I5N'2\N9^QE>/Q72M*8/=V'F7O&T#.ZKX'X6WQ\/'7%*E>'A]IKH,.0(
M?/13(<"G4YB;$@4Z.U%B14'0EDAII!(;2:EK49X$DBVGB-G*>BR<FZ5>/SSF
M[5OG2U",()QC%)*GA;%@MORFS_+LK7[/=JM<"E9,(?T:XQ0/[_XG#P2C^1WQ
MH=9_ ]S\)UUV^3VO*=SR:]<^^_BM?F\'L_6XO8_-VF#.6+1_4JQ-7*[<-W6H
M_1:+.I50CQIRGXJR6\]*9=0DB9>6HL4D9[AL]<U/+YC*0MVY5DFJJCW)HYCD
M?EK4-/U6Y?OVG&#A))U3VR36QMK!;#HT.2/7P .=7-/H[J5?^IUMU^S[6>K=
M'@TB'&DS6Y$9I*'6IKSBTFEYU"MB5)/80ZW0-3R^6R\X794;;=*/H1Y#SYRU
MJ.HZG:O9:UQ0C"*;JE1J4F]K3V-'1%)XMD?D'([3UXYY71I%J1-YL(>HD2U'
MW;.:K]*E*KB7XR6TL1XC+3J^&IWBGE-)^AT;!UUC4\M'3'9<N_1JE'O?3L/(
MLYRUJ$^9UG8VON>.#XJK8HI2PK7:NC<5#F\TDU$U'N2SI=EVR[7(=/IDJ/4'
M42([61;KR%I2KQ#K:NT2>@0Y<U'+Y6$U>G2K5,'T=1>]X_+VH:I>LO*6W-1B
MT\4J.J^DT8[32N>J9&8HY*J<"*32&&GFWJ-&-#3992(Y#:C6G NG'$9LIZ+!
M\6#?9)FEC9YUFO"58QI3;:6S#VE1^DR)HIRE5&B7+$OW5>H,5>LPI'C8-":<
M7)+QN8E%)G2'-KJD*[1)(L,V!FH\,!A:KS"KMKP,NN&-*-[,.A+H-[RQ[OIY
M;,+.9^7'<3JHUXN]]*<GM:>*78VWL+LYO].;XU'IEB1K(M]VX'J3.F.5%+3K
M#7!2ZRVE&/'<;S8J2>X6.7,[9RLYN[*E4J;>OH,SWC:)G-4LV8Y6#DXRE6C2
MI5);VC U'I'/!;E)IE!HD.;3Z31X[4.GPVUT-PFF6DY6TDIU:E'@GI,QMKD]
M%N-SFZR>+]HY/+Y?G/+6XVK47&$4HQ7W3P6"VFPNAS',G-EWG$U>GRZ5$E4E
M#-L5):*4I<>:KB)4ZVW&S9C26"L%]D\!I=5EIR4'EE7'%=[%>7XCM>5HZ_-W
MHZC)Q3C2#^[PETTAO6W' US1H_S5:,5BIOV!5)-QP*I(7+F3H#[,A$UP^TM^
M3!GJ,R>5F[2B)7VQD-RM0TW/02OQX6E3H\S1Q;Y>YET2])Y*;N1DZMQ:?$^F
M4+C?>ZZ;MK)2L::<UFN]1ID74".NBT>FNFIN54O#1(D4S[+CQ1(RN(\X9;"Q
M+R9DD9B=K/Z9IT9.QC)[L6WY7N+69T'F7F&Y&&=7!;6^7"HQ_-C2LGTTZ<4F
M=*;&M2FV-:EO6?23-VGV[";A,..&1N+-!%F<69;#-:B-1^<<3F+\K]R5R>UN
MI[9IV1MY'+0R]OV8))?+Y=I>XM&8
M
M
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M_P +JE\-U#9:#;NSSJ5B?A.-S[Z;V9I],*]-&Z+=/Q-ITE')'KH
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MK")>  =W;TD *HR[Q"V[Q:E&A?A*I'$28
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ME4N**1%$20              !K=7?ZT5C?R-G_?G!<^86/\ $\ALB+9?
M     *4 %0            %$J "H  ^"-$#Z)
M
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M]I[6S$O/E_)-6*P_8?L\7W=G7CL6WH,P##-R               >%K)"<3W
M4;H4IQQ3BL>@N[YA>2H6)2;9X%2( %.J%01#1@G!<I9=A'YI^05C'B+=V[X?
M:6JI2EN&ZZ9K6K>L^D9"5#7-U=6"(5*4(I%@!4^I(]Q"C9)(B)1@(DJ!;1.)
M)H^OLEY0#5<#3#4^M5*QK_K<^VZZAOWYE>E1V72425X8*:?QV8]0Z?(PC?RZ
M\2.S \GY@S-W3=3G++7*>)BZ8TW/B1A*IW$Q451GELJCO,R&O&DOT#>S?FC8
MJ,56AR]^_P"-1M49-4^\Y%"E'4(#RH]2I\IE+4A"L5,.*/*C/AO29;#2+<[4
M)JDE6I=RN;O9>:N0;C)4:?9\1YU7UF^EU3ILBITQF(Y3(3L22EDS6@W,^*SR
MGN[NPA9RF4CEHRBI5J;/6-6NZS.W<G!1<8TP=<:F/(]U1JG*A4Z-+53G4,+7
M@F+XAM6)>GBGLFGT=N'4,HT_A2C1N/I^'PV%K5N#5(BWY=)JE(:<CLF4-VO3
M7^+(4KO*=-I*LF7;@G+\(%ZV[;KXB?7@L.SX>4A499JG0(UQT!-=5*1C.J"$
M/M0\&\J?8J)2C3@7HK[1BC5=Y5.,9)K9N4FF_P A+5Z[J"K"DJE)MQEN2YPG
M#>892:O12E,AQG.749'V1(6LO<<J\-53X;"<*DW'3ZP=5E5="Z43!)GVJ^?!
MGNJ4G*;C<V.X9$2U=_BM^1)BCJ2A.SP*+C6>'>V*F^L:4XO+Y'L*K"B7!$@S
MJY0;:C6[.;4<-RAR)3DHYL=*4FC/+9(R95@KLDA!D73B%",[D*\/&W'96CP>
M^O3Z/*3-MH9>AN3)=&>:J)N9%%)EIDI92H\R72464EXETFC:%&6KKX6XQ:IU
M+83\BO2Z#(2J$V1QW%.,NH(U)4VXWWE?%T] J^LC;XMTJ%1I6H]T078\J!5Z
MJT:5D1JXBEH^)6PR%F5B#5'$S;6>S-EUA<E4VOTWYD(\QQ--OI],9S# J@EI
M2#(_[X1]'E(:G-Z2Z5M>8['1^=&I>'GL/KK9Y>@S2QK!8<^L1J/3*F=1.4M+
M2)K*5< G#W)49C >G7XPXI1V'31YGR$KZLPEQ<6QT=*EZG<=N^.]V^^X)S<<
MO@R>2:\W5YQB^#<:KPNAM/QV7X_#\2/%T5*WAM%LR2&I&8*%&0C3@?D!,BT?
M#(E8>?'X1,H7!3:B;YDQ*,N+T'ZW_&+$X4Q1F6;W%A(JQB#,@^@#ZE9H/9L,
M4"956G"60MR5#(C*I%$20
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MS6E7$(C0G'-@1&?0*O"-",6Y3K0W!%HR
M
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M.2/7@
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M?SWF$6JDHNA5"/':0M&0?0
M
M
M
M                                    <C.<ZJ29VM'@5JS,4*@P68R?
M5XQOR%G]UBGXAWO+<(QRM>F3]!X![RK\IZHH+YL(KT2F:I#H#@  *E2ZC(I%
M4I%7BJ4S*ID^+,8?1LP6P^3B?JBW.''&47O31E9:]*S=MW$N\I0:\C3];9^@
M5A]+S#+Q;"=22OC+$>3-'UFG55)D"H
M                                      2LEWAIP+>8E%$)RH4X72P
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MEIZC&.U0V$)\:J3($P )R*X7S1[]Z1;E$NVY;B?$"Z
M
M
M
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MO.D
M          ^&>&TP!2%JXCBC%]*ABMU9X ##$ 6I59?BGS80?X-'/\\KI/S$
M+UJ-#!S%WC=-R)$BQ%PL'M*<=PHV52(R4"),B%@!4QGJ[5'J18U1D,*R+<41
M)<^$9NG6_$OQB:#F?,RR^GSE'::,QZCQ$-S&TE.;0^;TMHMJC+S#K9(\8A<:
MHZ5QJS'M<E28Y+F2:4[*@R4K:ETQKO%V\R%(5Y"Z11E81J^ALM%4>!.BO>"<
M3*6IIQUFC2O8*BHRYE.K<WG@GKPQ OI<.WS_ "$:WIE+K=-H=20R3Y5%:GJA
M/FMNQFO",%L[*T]U'>2E2"XFSH%$3OVW:DXX88-IEWUZD4BZ:(Y*=JI.94MM
MJK40R4K(E6;(II.&!X;CV&*(MPG*T^)JM/AL,?L4H[4G*.CP6YE(FQWW7ZPE
MA2HL1E.&4YBG%;,B<=B-YGL$JE_&ZGC5^GR?#L/-(A):4Y*I#+E9J$]+CU-*
M+B:8,)!>R.7F)2L5[RZB%*D9IRBHT=-M7N[2S*[(BLONLPZZW-N"X'$FF+"1
M(2XPUAVF77$),DY\N.)"AD6[=8\35(+IKB^WTX>LN^5(K4^>Q#9I#,Q<MM=.
MJ<8LSY&_E2IM1*2K%23_ %3:6 K4QXP2JTZ/9'XSR=7K4$VHK%HTY,")V:O%
MI[JTOJ4W^KLI66*C1NP6>T@)\,+D<9-2>RNSTE/>O*JJ5,5"950XSS;/A7)+
MR?%(1FRY^$79QZ\,=G0#$<O%8O'U$!-;J%2DJ179#\*9#5A!K<-)I4XGT5/,
M'CF2?P'Y!0JX)8QV]#V>0O-55FDNFDY-B2IT23@1-.DT;L-Q&5_B(5E2EQ)*
M(RZ3%:F*XIU[K4?C(BE$;B8K[:9$:"^B4TEWYM64_9YLW=[0J.PJ$VLMG2ZA
M!J*G7(]0;>2O@KX:V\R<REI5WL$](4*05&FMQBBCU&-(D26$TUQI^F(XLN(V
MEM;#JF5=E+CGSG:5@LL<1%&9>M47$Y=U^0O"AU][@%+K[3,*LRW%HC4IY>7C
MH+NN.)5VDDG<9[NH5J6+EE\5(XKI107*W4&G:@],F3(#\-IV.A[)[!MQS]14
MA6Q.'ZFLNRHCP/*>T49=C;C%Q[M:^?\ 2*DMR:5,I%4J4--3]\)_":G#Q2R:
M"[."EKRN)V;T'VDGBG$]AAMP#23K'=L6\NRV[_U/LZ=#IELW"FHV:E?%I\<T
M-/-,F>W@I6^V;BT^4C&//*0XJ3C4V-C5[UFW'AFXN.U43]>\WWM7F4MNH>%@
M5FD5&'46LK4N:9M&@E=)Y6RV$-3=T._'BFO9.ORG/>5<HVKL9*7TL*>@V2BR
MHLZ*S+AR"DQGRQ1)2>S QII0<<&=Q;N1N14HNJ>\BGL$>(4 D4("T8^<"C1[
MC2C@O$^>Q![)B?)U_ #58E83X)5\Y=V)'M+:7HJ%@V  'I*LNTMY $RK)5G)
M*B^$66J&2G4]BA4
M
M
M
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M;D+>0RT,O:]F"I^7RO$O46C-
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MV)4\Y7HT:.S I**2R4&/++@-J=:R/NFDD\>+,3T&OO)6>U)X8;,0(R;VO?\
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M<5>W+T*$9HN6V5 6B\
M
M
M
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MTZ'&'M(
M               4EQ7$<,_B%Z.PQI8LA"I0 "SYTCQ4I3I=PBRQ/,73\)C(
MMQHC77I\<J^8@$728D6R*A/28@7$B8+9N J?2+$P;*I&OVI^KT"AMO4>CND[
M)S$U/G)VDP:O6]7SC;Z?IKN-2GL.+YCYHAED[5IUEO?0:=5&7%8G/24Y?&K=
M(G%8FI>=7:[1]720Z2%8QHCRF]W[CFMM3&U6K%8CSGYB%KJ=,=;<5,3W76W2
M[G"5NV])'L$%@92MQN)UV_#:6_&*1[TI\J>;%-J,E*WN+P^TPG)F85(;2I1)
MV[3^/R"E:EV*PHL=Q(.T]BX:G.JLR:=,8:BK;CU*":'765JRI>>;4Z2DJ6OM
MXJ7W<2Z2P!8HNPD[4DE&LJ[";*]K?3.8CQ7#.DH;9>HM0AFM]YLI;6&,UU!$
MDF^R72:L-^)&*HMRR]QXI.NS':_+0K5/9KE8J4F5,<4;,U@H]7BQC4['F-EV
M6'XZ^ZTZ6;''R"I:N/ABTORKJ/57B-N1FV)\EIE^FK0A,\U?.M8Y4MNK]+'U
MMZ0(PE*N!B2\JA4GS8IQ$5"G0G&CJ=61'))E'/-PV(TC^^)+:M)XX>4*FQR<
M81Q??KL77TM%$MVMTZP8U#F.+G7;+I3SLVH2&LJ4)SYE&EEMP\59.@SV].\1
M9E782S,YT2C[*1F6+=[VHC\4W*2U M:<VE^,U)DH7-=;2A3BE*0UBE&U*<B3
MQ]8]HJ:V_9C9E2M7LV;/*4>]:M/I<*GOPB=.'/)U4]#&52DM1DYFXK)*4E/;
MWGMV[S%"N3MQN-I[?AB8;1>UP%.B2CM$XD-+BE-16W^.^IONDK@LY24LLV;#
M$R,52ZS:7,C:BJ<?>\R*][K;NJ+ DE+>H$:-.7,I'BF3XS+BOGF^"YV<J^DM
MZ3W8D8;#%\7P927==51T?PQ?H*ZJRK3?BNQ6G6&'%^UJ#3+26&GG,>\UP\N)
M]8H0><O*=77XR.ZAAN-%1!I$]N5!2IN),:E*6G@I[V9M2NP?49>8""C)REQM
M%7H='N%^%%?CUI]J)4)2#HGC#)LVW35ERM]Y:$.J298[C/R 1NRM\336W;0M
M6LIU@^E$WQEH.5>GR9!->]65H<R(RY>T2%)P(NUN[/D%:85,ZW')RM)J[22V
MK_ZOZ#8*W9THH1MW)2FD5*-%2U&82ZCB/1THP-7"VY<A;RZ0H:6[&'$Y)U5/
MAYC%2Z35XU9J3:8:HITJ.Y/=K%.92EYR 1GD7P]J731F(U;.O 155(S5X;M*
MBVXR77\-I<K5 O4J7&K%/J$2>XMO/%@'BVN27HNM+5L2H]^'3T"M2SPP;<6F
MJ['O[>PI,"=2JC4TK?IRJ94WT\)BH*;X+^=OO9LN4NR?DQ%2,EP/Z43VW#*G
M39K%2IJ42T.(<5(0V3?$XO92XE*>R>/D$7$0NUP;^#-P.3Y7%N2Z&'4>'D08
MC;C4?,E27DK4HEY5;^R9;1I]8?#:BJ';\CPB\U<:E7#8;^Y<-@YY'I-#P9?$
M*[2.PAF6&TA5,HT>3+J%2)")2HZTOIWM'CAUETE\)"C52B?#B78A:'&B=3M2
MLB,E>0Q8V&Q6*J1!4'I*LIX@$Z%72HE$2BZ19:H9*=3T*%0
M
M
M
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M@JTJGU+YK/5O=IK5FQ.YE+K493:<>ANG>C]JKW[=QT['&GM
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M^*K$E)/H$)HNVV3@MET
M
M
M
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MDHN+H\#V:U>A=CQ0DFGO6**P!,
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MC(
M
M
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M#3':
M      4IT\75'Y1?6PQY;2"!$&>0C,^@L5?  V%ANN8E(E9#6:S->1.\_,,F
M*W&JE+;(EX52ARLQ-FM"R[R'FC;7]45E;:(V[\)[*^7 K"1 OGLMNT0VDU@1
M2+K J14;\10DC737Z@T1%$A59DT4VK&ZXPVF&VTAR2I9DK:>S:G#8-UH]Z?$
MX[4</SODK'@1NI\,ZM*E*RJ:43J9!FI8J+U.;J\ZGNI7"42?#RD%W5<7+ORJ
MV](Z$\PC*JP?Q,\TNJ-K8?HGAGXD&,K+"=?6M]!Y^^G.YF,B2>[H+<*O;4IQ
MU5-U3%%QW4JV;@B'0HS5Q.POPFH-I>RL-LO9F<#<22LRU>J18=8/$R\MEW-5
MDZ4V='PZBAUVF.-Q5G&8?2AU:GZ!%CYFY2'I7SC>/RE+W>04H1L7*/U^0G:+
M9<R)=%(KU>FMIC4&DMPE4UU?$/BH=SJ>[O;<6K O(0D3GFHNS*W&-*RK7J(-
M]UBYJO<]!@6LT<BGP9;35=0A!KDK0\7&<<0I792>XCZ<!0GEH6H6YNYA)^SV
MI_.*36JY3Z1(6Y69QTZATZ:TQ5*@VA2EQ5R7-G%V9DEFP+$B/*6T"N5RL[ZX
M;>-QJJ73OP+CF4"+X=#T5J12)U19XL"I/253*6[F[JN+W6G%)VH-79 M0N-T
MK1I;5L+;8LJLSVZC2F4+9<D&Q%9*2TI*&W$EVWWW.Z^I6;'L[ :)1S<8RB_+
M^2N\O)%L04*I=OL/X6O:32,D4G/;RI"5?//J]+-M5Y-A BU/,-MS>V7H15KA
MKFG-J>Z+ANR%#AUB>>:F2%0U3'D<-*DI41XX-ET$:\"Q"C9/*9:]=35NM-^.
M'KQ,'7WJK3;ED3$TUTHQ49A*DJ??R.DVI>;!UYO,G,?J),\NPA!SBN(VF6TN
M[%1<H^U\-J,4U/6.V\C, X\BH1%J2B0FH$@LR5=Y*'$JS*]4CPV;QCO-QW&Z
MRW+M[;.:782E"N6P)33KS\6H4&H.HX7B*4;2FG6N)FRI4O:T;A=E?K=8G',I
MES,Z1FN*D)*4>B2W^0V)M8J"J"2*-/6FAE$)]A"EH23:6LY*RLJXBU&1[%&O
M+CT"^G$Y+-1NPGPW(]^M/AO\Y0(59\;"MN?/@J\>N9*BLDUFRICJ2?SW:^'#
MK N7+7#)I2Z//\/25*DL//29D5F6EE$)]3\.:\E#B7(RDI4WPU=D\4+Q29;R
M$:T$Y1HF]_K_ "%+@2Y-,K+]P4]4@GI;V6HQ$+_!TK;5E4KAJ[IK3VL>H2+\
MUXEN,7Y&7!5JG!I=QQ4IAH5]((QS8I+2KAN9=CS?$+NK](BZ>@"Q;M2G;D_H
M8,^G5EI0IUNGQV(S"5.2'4+6O*UAV5>3#I M^%]8M";*81=-,2[27U-U%E,^
M+6HJB5[1SL\)3:?G"-.TC($9D(2\)RXN\L*?&9/I=WVZ=+9B1[DB4U+<M+29
MCQ.I[2E97&\N7OYMFT5XD:R>7OM^R>YS]-3(>),J.\4ATUQXQ]KV:D]Y7D7O
MP(&BU!MX4]D\6_%I<VXJ%3JJPQ'IKTMF/-=S*-,5"W$]I!=*\?@%$Y*,BY*-
MNY*,92<>]&KIU_&=NZ73X%-I5.IU+;)-.@Q4-P$D>Y!)V'\(X:<G)U?M'OUF
MU"%N,(>RE@3BBVF8H59#46(%&0C+I%8D60'$<1!IZ3(2(-5+GAN\>+&>Z5((
MU>?<8L-4,^W+BBF3($@ *T1XEB+!DIGT"H
M
M
M
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MV6K<]N#X9=?1+RHS@, Z
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M<9>9HO)L%J6TOP>!,"),
M
M
M
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M-'*'47)55U'9S>P-%.?47]\]N6;XAK^8(45M]IO^0;[E<S"W=U^LWG'-'I(
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M9=TFUU%P"V90 $]$/$E)%N9=MDZ(%T
M
M
M                                         #YF+K"@/H
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M<_ZG,1>W@@_3+\AT4')GK@
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M"T9H $Y$/M'YA"9<MD^+9>
M
M
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M7THR$^O(A6;)G4.OX8GD"N2#DB2XA+2WG'4)[B%&I204$'<D2XD6P
M C-/NL9C:<<;S]_AJRB,HDXW)1(GBI9$I/B%Y5=[M*!02).Y,VUY**KX#5VJ
M4Y>Q-?MV2A'^$C/LN?'EQ'/<RVZY:,OHOUGH'NTONWJ<K?T[;\\7'^R=81PI
M[R
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M"8<ENN.1515.%D2ZAU<4O9YG#S&L^]CN(Q5EBS?X+E-E7YD6);,VH7$]#BW
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M^@"/&^?^ 0D3M[2J"V7P
M
M
M                *=+J$2"G&4\E!X=A'I*\R0!:TNZ'U9DPH^3#>\[VOT*0
M!8E5N>(R:DU.J')=3_T4E<17[&GLI^$"I9DJ]E'F13X24I_79)YE?G4_9% 6
M[)N*MRLR7*@XVA7H,>S3^AV@"C+-;AXN.*</UEFI7Z8 >2+  ??, 'D%"I]
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M>;SZLYNU9^E6OE]CTG4:7R^\YI69SCCWK3CP]L*.[Z&L.HPGFQVD-H<P? *
M      9NTKTEF:A6SJM7FFE/+LJA\:A(Q(L]24?B,N/IGP&5)\ZTC4ZCJ4<O
M<M1^F\?L_P!/J.KT'EV6HY?-7<7X5ON;/;]KRTC&E7TF$$*-QMIQ.YPDJ27R
M5#;-)'*1XG&IEW06O_176/3VJ..)98<JA4N4M7=X<]M4<\WW3F(UVK6?&RDU
MU5\V)T?*6:_!ZMEYMX<? ^R<:>CB;\IW$'F9]-@
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M\
M
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M?6 &2Z=7I,1#)MNE+A*[I&K,E2?[VY^8#90OV!58E0(C87@X7?CK[*T_<BM
M50         $G*BM2HTB,YW)"#0OX2%4Z.I"<>--=)@MUAR(\['>3D<CK4V?
MP=/P[QM%+BC4YF491EPO<>14B8;UFTO9U.ME$>(34:ZJ$:Y-LS%GE)2C+%V*
MZHNZA[#8?HJP/K&?I^=_"SK\U[?E-!S)H4=6R_"L+L,8/UQ?5+T,YH2XDNGR
MI5-J$5V!.@N*CSZ>\DFWFG6RRFE769_5WEL':QE&:XEBF>(7+,[+E;FJ-=UI
MJE'2B:?TNLE!,M   !\-"#;X1H3P_4R]G\Z!3ZID>W;]*GVE6["N2DE<]H3&
MW9-%@J>)J31:H:#-$R$Z:%FA*C^=:[JRQPWJS8%_)\5V-VW*D]_UEO3^)_!;
MS)ZOP96YE+\..RXMQ5:2LSVJ<=]/I1QXL:57M9DY=M(GZY-B:@7-#PMVFKXM
MNPWD8>\IK9['\I_J#)XJ(_37NV$-?K.H*VO!A+O/;U'2\G<NROR6<OQ[D?97
MTY_2^S'&G2;[8&9[=JU#ESU-XG,;7^X2N#5BYU,GC$H? HT1PMJ3\&V?$4GS
MO&H_@':Z39\/+1KO[WG/$N;LY^(U2[3V8<,5^;6OFDF_(884HB2H\JG%>@TG
MO*5ZJ?E*&R.:PI\/A4[7Z/Z:Q;.T?H=BU..DWIU.=.YT&67B2*@DW)*3^UXF
M3S$/,M0SKO9J5Y;GAY-A].<O:-')Z7;RLUBX=_K<EWO70XP52E.T2K5F@OXJ
M70:A)IRS/_T9U;1J^$MH])MW..$9]*3\Z/FK,6)6;MRR\5!N'IDGZ&>8D-V4
M:LNQ">^\?=3_ /F"<Z$;-J4RJE2&"RD;SJE^9*4J%OQ3)_"QX3P=&8R]AYQM
M?RBS)_NA+Q2/X.-"E2HCD0\'2[*^ZZGNJ^U$X3XC'NVI0VDH)EHZW<GUL-T7
M12E3UI;5)NZ;+JTQ6&U25N<!HE%TEPFD[/*//>8[WB9R2^C1?'\9]#>[S(_A
M](A+YUQRF_*Z+T(YMZPV0K3K4N[K20@RA1)BI5%4>!8PIIFZSMZ202C0?E)0
M[33,S^)L0N=6/:L#Q7F73'IN?O6/FIUA]F>Q]D:I/RF.$N+CY9,=PDR(;J)+
M#J=Q.M'Q$*^,B&:\<'OP\^!I[<^#O1>,>\J=*[QWKL:Y(]Y6=:MU1U)6W7Z;
M&FX)+LI4\VE:RP\BL2'E&9LNS=E;>YM'U;IN<6;RUJ^MDXI^=5+R%HS0
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MM+J5\X+)G/:?!4$>)\Z7VHC+V2=O:506B^
M
M
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M>=IAYR?1YP*NE]-;O>[);!Y45.X:F\P?JI.4\K-^=,>J6%P68+H@O4?*>?\
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M3V_:1[K[MM8CF,F\I)]^TW3[#>#78\/,;RCG#TD
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M"V;18,IDL9 1(+FXO.)D&05$>TA5$&>6BQF1"_OI'\1&8J]Y2/M1[2Y!:,T
M"8B%[;'R"$R=O:5,6R^
M                         !YS)ZP!YXK?2L@*<2&='KI_/ *H]D9'N )G
MT"H
M                                     !2ZE4&Z=&4\OMK5V66_65U
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MN3B]JP/J+*YF&8M1NVW6$DFGU/$N$1+X
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M6 !.Q"P-9BW,NVR>$"Z
M                 'E2B26)[A5*I1NA 5*;3N/,*J)%W$B75*5NP)(GP(MN
MXR$J0[TXBM$B/&SSG5TBM!4AF#*'T  !Z2K L.@$#Z2UETA0K5D0GW$EAT"G
M"F54VB,B4?I%F\PCP$U<(R)#2^G*?E$.%DE-,F!0F
M
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M\6?"<4E#A)>87Z25)]%7E3N,4!EFF3TU"&W)3V5=UY'JK3WB%2A4P
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MX>8C=7LS7I6#^(]V]VFI^/D)99OO6I8?8EBO3Q&[(YP](
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M;P1.PL6_(5D1,@ "H1494J/UC%J9>MK FQ$N
M                               $%;R&]BCVBJ52+DD2RY1X;.R)J*+;
MN$JI1JVF9GYQ,MMGD   P,]P           ^J2:-F&'G% T?!4  >TN.I+!*
ML!%QJ2XF32)?0X7PD(N!-7.DFTJ)18D>8A"E"XG4]@5
M
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M,Y1^)IBU=G_*8N;\ZXGZQC3G7F9+9E\*8N+^IR49D%\M']TD"AD(5
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MF4K:611%]L-)K]IW<LW]!I_$SN.0LQ^#U)0^;=BUY=L/0FCK$.%/=P
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M/J"-QU9>L*D>TJ(B70 *JQL:00LLR([",*$@
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M3-=YB&6M/;GJ#U6;E+)5I5&:^MQUM2MJX2W3,S4E6]HS/?F06](Q>6M<:O\
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M>)*P,4"="=:E$?8=V*];H$'$NQG7!DZ(%T
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MJ64AF;7LS6SZ+WQ?6G@;"T]U3$Z"YZKZ,?NE9?\ E"P9YET5
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M<7N/><IF89FS"[#V9)/SES"V9
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MDREWG.RGSF*K MRV%RMH0A)-IW-$1%\ M5J9J5,.@]"H/:"S&DO6,&RL54K
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MJA>C*I$%"0
M                          &/+I4DZDRDN\49.<OMEJ%"IJQS%7$[:]EO
M5..K)-FLKIE-47?)Z2>12T_:HQ,;/2,K^)S,(/8L7Y/RG,<XZN],TN[<AA.7
M<CVRP]&)S))*4I0@NZC</2N*I\SJ-(HC1V')#[<=OYQ]Q+:!23H554\#)[#"
M([;3#"<&VDDVA'_#UE"PV6S*E,@HI\-#!)]J?;D*]9:OL;A@W9<;.CRUE6H4
MW[_AZ"?$2\6/>]T*H41,*"YEK%00?#5_F[1]E3OG/<GXQ?R]KCQ9B9S,>&N&
M+[S]'68 WECZRLR\_:[0V1I"OVW07;BJC< G%,QTI-VH/I/M-M)W9?*I6PA:
MNW?#52[9LRO24%@GMZEV=9L; @0J7&1"IL=$6,C<A'3\I9^D?E&LE+BVF_M6
MXVUPQ5%\-I-BA(I%0KL*GJ4UMD2DE\PCH^V5W2\V\3A:;,6_G86L-K^'F[-I
M:,NX*A*)2>*F&UVMC>SXU[S&1&TD:N[GKES?1&0K1T7O*[&F:B\EF@TU].+4
MJ:E;DATE=UQ#"2)6"N@UJ(868U2S:[J[S^'PH=5HW(6H:C%79TLVGBG.O&UT
MJ"HZ=;:9=-SZ4Z;6!3&:C>U^U2G-27BC1#9BH6IU_#.I#31)=4>4BQ/,>PAI
ML[S/#*KCN)1BW1;?[*/2M ]Q<]9N2LY6]<G-1XI4X(QBME7*>YO!;^HL*XK
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M,=Q2F9$=2\@E%N2>7<:>DC'/7;,[4N&::9Z'E,Y9S<%<L34XO>G4ND0,@
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MY)_J,1.;_G#V$*2%M5EU(KPB9( $S%3[52NH0F3MK$J0ME\
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M42AFK>*\2,?FW%1J[:>":XH5@\-].7S6=R_X2[8N)Y"KLID;B,R58)\?';/
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M +$DXF9;N*>PG@+@ 'I"S0>);Q0JG0J33Q.EU*+>D6FJ%^,JD<4)
M
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MB^[/)SN:G*ZO9M0E7KX\$O[1T,J4GPS$0R5VY,V+&3\K.\G-^A'"'O+,\"H
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M9N[#UNS*<K<7-)2HJI8T>]5ZBO"A<
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MR+4.%=I.BA<  JC!8-EY=HM2VE^"P(XB3
M                     "0D/'\VWO\ 2,3C$M3EN1)BX6@ (3SS4=DWWU$E
M)>D?UB%$JE)2455EKRZB_+Q2C%J)ZA;U>?[ R(VZ&!=ON>S84])$G<>P3+*(
MA$9@5/6&&\ ?2+':*<16A[X>(B2H1"3U 2,=:B:7VAJ?0T4.[:<M]EE1OTZ?
M',FI,1XRP-;#J2,TF:2(C(R-*BWD>!#"SN0LYR'AW55;GO78=)RUS3G^7LQX
M^3EPMJDHM5A-=$H[Z;J=Y;F2MG:0V39=F2["I4%<J@UCB^_6I[AR'9BI"20X
MI]PDEZ)$DL"(DD6S:+&4TG+Y6R[4%6,O:KCQ84\GH,C6N<M1U74(:A=FHWH<
M/!P+A4.%\2X5COVUKOJ<Q],I#UK:Z6C%C/+0S2[P70EYU9C-A;SD)1*/TLR%
M%B/+](A^%U6$=ZG3SOA?K9]3\TVXZCRWF)22?'EO$_.45<7F>PR)S#,0[FU1
MO9NHME);I\QJG0UEL4VAEEM)$GX5&?G&TUK.7(9^<HOR;L%3XC\W.9+-O-YV
M[Q[8M136U8+^]7M.AU*L6U:-8U/TZ:H;!VK3J>S32HIXDVM">TM1J3VC4IS%
M>?>:CS#T;\);=CP98JF/6>F+*6E95AQ3BDHT?IKUUQ/5G6!9FG\*5"M&BMT=
MNI+2[49"G7)#\A1;6R<>>4M9DGT2QV= CE<E:RR^[C2OPWEO):?E\E!PL1X4
M]N-6^UMU+VP\HS*&0>#2 /"D8[@:*4/.4R$DR+1Y,L=@<12AX,MV'9,MQEO(
M5*%9AU8TX-33V;BF8?IOLBS*WO1E6\QNEYRX/+T'W<!;,L #ZE1H/'I(4"="
MI,/$ZG;WBWD+35"_&548$KV@-!N2N5:X)=X79"D5B3XEV%"J:F8[:LJ4Y66S
M1V2V;A.-QHB[,6ZLIGY,]K?QUO7_ &TK^X%?&D4\&/7YS[^3/:_\>+W_ -LJ
M_N \:0\"/7YRS*!9S.GO,#:MOTVX*Y5J?,MJ?/?159[LCVG$-K=BE&!$G9LQ
MQ%7+B@1C'AG1=!N0+)D
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M2E"2]EMK!QZI+N_:1TF'(GL
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MWTXJWUU/0>2<I-2G>V1I3MQ.D+,2'$291([<<C[R6T$C'XB&@Q9W]$MA'6K
M2(MDN8JR)#5O!E" 9](J4)8U;10@0UGB1D)HBR"TWXE]#.'8C^W<\W07PF*2
M[I2"XY4Z,2OGM+$]X@9(%016D9W2(Q1NB*Q565863)
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MY&S_ +\X+GS"Q_B>0V1%LO@
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MWI-^T^BNXL&FF1U6F8YE*548RLQ][M/)&(G4V[5&;K"I$
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M^ CQG!^;XN4L^3R9L<!R4J5PV'K-OBX%Q>U3&G3O*H!,
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M]D;3[EQW"&TE2A$(O(*$CZ214'K*0%:'U!8&C9TD 1QJ4>.OTL^]GU7_ /\
M-),>/[=:7^;_ &S[02__ (7BO_\  _\ V!D?5+LZI7X9^A=[I_\ 6D&,C4<-
M0GVR];/S=U?_ %5[_.7KB=5)!8R'\.L_KCU=;#U6?M,A&DR\XJ0H><I *'G)
MY10I0^*+;M%6#S@0K4I0\Y2%>)$:'DRP%2AX-/6 (!EDW@F0:)N%-.&[E5MA
MJ/:DO1\I?FD*7(<1<M7>!]1=>Q9$XV9&1EBE1=1BP9^W% 5!&9<-!XBCQ)1=
M"II42TYBW"R7TZGH"IK=7?ZT5C?R-J'WYP7/F%C_ !?(;(BV7P
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MDBS*Q/ B&-*3DDF]FSJ-C"S"VVXQ2;=714J^E]97 )@
M                                       4Q]DD;2W*%V#+$XT)<2(
M 4FH1U*(I;!8J26$A)>DDOS2%8O<6KT*]Y>4IZ3+UL2/NBY(QXD0A$D31;11
MHFB(E6 BB29,I/J FB*D]N(%2+B%2I%2KH,4)$7'XQ1HDF>MA[#(OB#:5(A.
M'T9?B%*%:GS-CO%:"I2ZI2Z96X"Z;58#-3A2OG8<E*5(5ANV*Z2$82E!\471
MD;MJ%V/!-5B]S+&3HWIDC-A9L%.?O]D9/XR]](P/X/D_W:/7XG-,TI2E-H0#
M)/=/(*_C+W25>DY7Z"*U2-/K)H+A2*/;<&&^7=>0TDU"U<S%R:HV7[.GY>RZ
MQ@B^DKQ%BAFU+!K.G-B5^=[RK=K4^I5)6Q4MQDC<,NLSQ%V&8N15$S#OZ?EK
MTJS@F^PN*D4>DT&&4"CTQBE04=QB.@FT_$(2E*3JR]:M0M1I!415DJR"K52:
M=#PI6(JD4J>,0J4/AGT@RA\/:!1LA+/$A4HR"9X;@J4(2E=)@19#6HMXJ4;)
M0]H(@>#$D19]@M$\YXESYMLS)KRGTJ^P$G0K;C5U96!$O@ 1&V\[F'4*-T*Q
M565<63)                                               ^&>  I
M3RS6>)_<B\L#&DZD(5*'EUUIAHWGCP0DL5*%"C:2JRS)4ER6\;SFPMR$>J7V
M>L9,(<)KKMUW'5D,BQ$B![(L=V(HV22)A*<!$F>R+I 'HDX"+9)1(B2%$R5#
M[E K0B$G, /1-D*%>$BY0)4&7 D>?8*U*4.,-%(I>O$/#VAR=5"5_P#Q@S_Y
M(\>A66M1_P Q?K'VCGGX?+D^K(__ +$R9K*9,ZI:C8_J5R+<_/*;<_-&1JR<
M<_)]OQGYMZW)+-YCJNK^RSJLX6+AK+I'J]3U:6+J>,""I&A\RGT"H(?" C0^
M&CJ,!0AFD^D5*4(9I%"AY,A6K*4(9EUB=:D*4/BD]0 A&E0%&B=ILSPY^&</
M",L_9'ZJC_,/ZXA*-<2]8N\/=>PN46S+  FHSN!\)>[T1;DBY"6XJ(@7C6ZN
M_P!:*QOY&U#[\X+GS"Q_B^0V1%LO@
M                                   :Y:P)45Q4Y7K4S*C[EU?]T -?
MKA+"1$_P:OKC<Z9[+[3@.<_VUK[#]9C>Z;<;N"%@A*2GQB4<12L,KA*[S2O/
MZ/48W>3S4K$OJL\ZU73(YVW3YRV=?5\G0R>TWUQK-GFS;EWLRJS0(BO#LO*[
M=0@(3V<"Q^?;+U3/$O1ZA74=$MYI^)8PEZ'\AD\L<_9C3/\ IL]&5RRL$_\
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MDB2F)0*8UCY$Q6AY5G)<5Z;^L_6?5FCV_#R5F/1;C^JB_1CFQ
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M8J5/A @55AO(GRF+4G4OPC0CB),
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MX:5*[2$&>X6K&4N9B7#;C5K$R=0U;*Y"TKM^:C!T2>._'<BPORH] _Z3*?\
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MB055"[Z,WEQ3'>.6Y]JP6/Z; <XCUIFVXJ4
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MW1(C#!_\VT1?F#R*3JVSZYR\."W"/0DO,BL"A?
M                                             E)#68LQ;_2%R#+<
MX[RGB99  \J03A*0XDE)46"DGTB@:K@RWGV3AN<)9XMK_P D6?Z4_+U"ZGQ&
M)*/ Z;MQZ+>0 C(5\8H23.7W,%:DR^.8Z[K<II8SWZ F9!CX9C=7!I1R2:+_
M  A-F1>7 =OI.8CE\A"X_I4\\J?&>'<XZ=//Z_<M6_:<$UU\%OBIY4J5+INC
M6B;>?+58=F4UXYE[WG,CVG56B,S=4W 6V6<TXXEXDE,%CTYE=0QLOID;&H7+
MC]BVG->7Y#:Y_F66>T"QE;>-^[)6FJX]RC_K)P\C94N4FA+M?6W5>V''_%KM
MZDO4QY\RQ)Q<:>RV9EYS2>41YAN^+D[4^EI^>(]WF3_!ZOF\O6O!&4?T9Q7]
M!7;L@1]?N:EJRI#:IUC::4Y^/6VT&:6UNI1C(Q4GNGXE;;?_ #9C'L2>GZ?X
MJPG<>'9_09^H6H<P\QK*RQLY>+XNM_._K-+\TJ_*5<$JTI^INBUQJ5[PLF=(
MJ=+;5V5.-(5P92$X]!J)MXL/US$6^8K2O1MYJ&R:H_AZ/(97N_S4LE/,Z9>?
M?M2<H]<=DO)L?EJ6)RT6=2-:[TU"U3U&BMW-.AU!E,6DR2XD=+\DEJ);J%8$
M:66DI;;2?9+ 96MYFYD;5O+V'1-8M8/R/UFIY(TZUKN<S.?SD5<?$J1:P[U7
MBM_"EPJNSL2-JKJY;=*+JKU"N-5"^C\VC2">4B@9:<F8;6!M&\3))P-I22,E
MMY5]&. T-G6LU8MNVI53P[V-#O\ .\F:;F[]N_P<$HOYG<XNBM.C<XT:Z35'
M5.NV3;/-Y.K.H<1N?:,:E145&,]&\<A3KM-RM&<<TJ-6"S(\<-@Z#3[-Z[I7
M#9]OB>-:;SSW7LWDLMS0[F=2=I054UQ8N%%AOQ986JM8TXU,OK3>G\O]IJIU
MP(EM^)GP:>=.;=<XS:V#2RA!8&QD6XMTR(DIZ3+=EZ?:S&5LW'G)]UK!-U[?
MZ#5:[F=/U3.Y:WH]OAG7%QCP+:J8);8XMRPP,L7W2BUGYNXFG]SR7EVG9\8B
M32R4I"74-1&Y<@BRFG!3[KB$K-/:R)PQV#7Y27X'2W>A[<WMZ,:'0ZI86N<S
MK)WW6S97L]-(J3_2=*]2[*[/:@: :7W19M1HD>S:309,6&[[DK%-BM17HCS;
M9&VKBH21K+,7;)>)*+?UC1Y35\S9O*?&WCBFVZ^0[?5N4M-S>5E:5F$73NRB
ME%Q:6&*VKIJ:3V%=-2K?*!K!0*@^J0Q:#\)FE.N'BI$>4^PYP2^2AS/EZL<!
MTV:R\+6JV9KYZQ[4F>::5J%R_P J9NU-_LFDNI-QP\]2<TVU/Y9J#I/2*!?U
MJ1JY>$:%+:JY%2$JD/N.OO+90B:I*<IY%)(EYRR^3 4S^0U&>9E*S*D'2G>Z
MEN):#K7+MG2X6LW:C.\DZ]Q-NK=._3Z-,:X%M6#1JY&Y4-=:I,8>8M^M3Z6N
M@J>,S0ZIB2RB2Z@NDCP0DU%L,T]. O9N];EJEA)IR5:T[,/C,+2LIF(<L9V<
MTU"<H.-=_#-<3]2J9%TEYJZ38&G-J6=*T_N.LO4.*MEVIP^$<=W,\XO,WC@>
M':RC#U'0)YC,SGXL55['V(W/+O/MG(:?9L/+W)<*I54H\6\/42.B-VQ[[YMZ
MW=\>G2*.Q7*3/>13)V7CLY(\=M1.$1F6.+>._<8EJV6EEM,C:;K1K%=K+'*^
MHQU#FB[F(P<5*+PEM5(I8E\:U*/63F+T\T?:PE6]:2DU&[6VS/+F612)25*+
M=A')MKSNF,;3%^"T^[F7A*6$?AVX^0V_,U-;UVQINV%JDKB[>\_ZJBNV741.
M720YIAK;JAH94L6*?.E.52U$*/ CX?M$$C_"17$_"V8CK/\ U>4M9I>UL?Y?
M*4Y.D]*U?-:5/V6^.'Q+RP:?D+*TMMFGZ^\PFIMRZ@-%6:?:KZTT^WWS,V%(
M3*7%ALK+':RRAE2S26Q2SQ/I(9>?ORT_(6XV94XM_DJWVNM#7:%D(:_KV:O9
MOOQM-I0>S"3C%/ZL8KO+8WB]]9_4*^>3JXZHJDUVV9L&?:LYV-*50J44+C>&
M<4V['=5'-/$:49=9'TDHA:RF5U:VN*VZJ:WNOEQ,G5]3Y7OW/#O6FG;>V$%&
MO#A1N+Q7F[2D\VE7HDZHZ"7!"BKEV_(I?CXT!U!I>=A&_$>2RI"U*/,ML\ID
M>.W>+_+UN<8YB+=)UI7KQ^,U_O"S-B=W3[T8N5IQJEO<6XM=.-.TKC.N>@4J
M="CM<N,EEV1*98:=72()$VIUQ)$I6WLY35B+#TO.J+?XG=])F?;YGT65R*_A
MS3KM<('01_%!FUOPV?$.56)ZK+# E<< 1 ES-QUWP[)]O#%;F\D%U_;]1"Y[
M)'VI47P_*5IEIF.R3+/=+XS/K/RBU6ID1BHJB(HJ5  G6&>WQ#W%W1;DR[".
M\GA N@                                              >5*))&I6
MXA5*I1NA1U*SYC/>8N[C&;J?!4%-J4KPT?!'^4N8I1^:?P$*PC5EJ]<X(]9:
MR$D192&4:Y(BD6.[$1;)I$PE)$(DSV18A6@VGM)= @F3H1"(A0J120>_8*DJ
M$9)8"/$22/:2ZA2I)(B$WB*4*T(R&\-I 52/64Q4K0^DDC/$]R2,_B%*E:'#
MKE_7[WUZTX;S8\:YI,OX$)D._P#)'END1X]1C+I=?C/M;GJ/@\O9O_)4?/PH
MR]S1N)CZO:D-DK#CQ:?*3YWJ<R?UR&PU:W7/MKZ2_5B_C/S YSN\&>S,7OA%
M^>-/B.IUOK)ZWK=D=#M,A+^..T.[RTJV8/J1[-9QMP?4O4BMX$+Q,\93Z!6I
M2AY-.(J*$-3>(H4:(2DX;PJ1:/)IZOC$N(I0A*1U[14BT014B0S0*%*'@RZA
M-2(M'@RQ%2)#S*CNI?:[[1XY>LNDOA(4EB@GPNJ+L;6AYI#R%8I>+%/F%C8;
M!.JKTD05!%97PWMO=5L$)(E!T9@2O?UH+&_D9/\ O[@+V"3_ &OD-D1;+P
M <JM>)[VMO,I;VF5,?7[GHDIJANNLY5&VXH_$522A)^DVA.7SMCNM*C'3]/E
MF'[3Q7JBO+M/"N;+DM?U^WD(/N0:@]F_O7)+L2IU<).<K]7E:6:]7CI+57EM
MQJT])IK)J,^W.IJG'HKQX=DN-&-6[>>46]>A'-Y.&9CM2J^Q[5Y'\9=Y%ORT
M?6;VFS;X9.457Z4&W%]"XH\7;@;=<UQD>@&H!E^L0?W='&@T'_76^U^IGH'/
MO^R9CLC^M$Y>:3WS=&CUQT'42'!DJM^I//4^HL)(DM5.-&-!RXY'W>*UQ$K1
MCN5AT&>/<ZEE;6>MNRY=]8KJKL\FX\,Y:U7-:)?MYM1?A2K&71-1IQ+[2VJM
M-U=]=^>:ZO4FZN76/<=#E(J=(J]2H\NGRDJRDIMQX\"+J,MQET'LZ!R'+]N=
MO/\ !+"23/7N?LW;S.A>-;=82E%I]7PV]!3N72PJ!J7RS1;1N5#ZZ/4*Q-=D
M-QW39=]C-XJ,%E\I.T7-:S4\KJ'';]I)>E&/R;I5C4^78Y>]7PY2EL>.$ZK'
MR&!>:/0RPM(:%:,^T&YS+];J#\6H*F2E2$\-MKB)P2O<>8;G0=6S&=N35RF"
MK@J;SD.?N5<AH^7M3R_%%RDTZMRPI789ATCY4]);TTSLBZZS'JSM7KM+8FSU
M,SUMMJ=7M5@@T'@6)[AJ]0Y@S=G,3MQ:HFUL.FY?Y TK.9"S?N1EQRBFZ2PK
MV8HQ=SXH)%^V4VGN)MI:?SLMT;#E/]C/M^)'-^]O#.6*?0_M,S5SJEAHM9W\
M.4_]Q2!J^5_]9/[+^(ZCWGK_ .&M?YD/U9&-=%M#] KMTRM:XKTK"(]S51N2
M[46E5OPF4T27FD$;/$3DP0E/0,W4]6SUK,SA:CW5L[M=QJ>6.5M$S6FV;V9F
ME<:EQ?></SFME<.[1&$*O;]#LWF-MJAZ-U9VN,1*U2_=4ME[Q2VWE+(Y<8WV
M\"=;2G,2SW934E1[!M+-V=_3ISS*IW77#S8=)R^8R-C)<P6K>F2XXJ<&G%UH
MZ]Z/%';OK7&E4]C-HN=?5:K6] H^FM!D.Q%W)%<J%R26#-+IPB6;+,9*T]HD
MO+)6?#:9)).Y1C1<LZ>KTI7Y/"+HNWI\AW?O-U^YE;<,E9;4KBXI-;>&M(KL
M;K7J5-Y$TLY,;*.UJ=4=2"FU:X*E&;D.4N-(<B1H!.I-262X1I6MQ&/:4H\,
MVXL"Q..?YFO.Y)6>[%;VDV^O$EH/NTR:RT99U.=V2JU5QX:X\.&+:Z7V)41A
M#F T'?T'G6_J%IY69L6CG4$M,.J7FFTN;@M;2D2-AK:<)*BP5T]E1J)0VND:
MJM04K%]5E1]C7RG+<V\I_P O3AG<E.2AQI?6MRW8[X45.]3HKB;(WA?R]3N3
MRX[O?0VW4IE'3'JR&\<J)L68VT^9$>XE&C,DNHQH\OD_PFJ*T]B>'8TSMM2U
M;^+<K7,QO<*2^U&24O(VJKJ,$\K^@>GFK5GURNW<S47JA3JVN!'5#EJCH)E$
M=EU&*2WGBL]HW6O:OF,G>4+=.%JN*KO9Q_(?*6GZQDYWLQ&7%&;BJ2:PX8RP
M\Y+:^<LJ-(J:WJ/IW7*B=+H\IKWC&?=(IE.4ZM*&I3$ILD*-!.FE*L>T6)'B
M98BFDZ[^,EX&8BG5/L?4T.;.1OX-;_'9&<J1DJIO&-712C)4I1X8^<V1L74V
M7JERR7I5JJX3EPT:@5FE7 XG!/%?9AJ4V^24[C<;6A1[BS8X;!H\UD5D]1A!
M>RY1:[*_*=OI.NRU;EZ]=G^TC;N1EUM1?>\U/+5&*?[/[YK5;_"43ZTT;7F[
M;:_.^(Y;W0;,U_[?]LU]LBUK.O3F(NFW[[?3&MM^K7$])>5)\$9.,R'%-%QC
M4G#:6[':-GF<S?R^0A*UMI'=4Y73,AE,]K]ZSFW2VYW:OBX:M-TJWV&X*N6G
ME3-*L]>:PRX*+Z2H[O[*.>_CNI=']3\AZ-_)/+>WC7_W5\I9G.4Z_;6F.EUG
MVX^ZFSG'4P7E)<4X3[=.B-^!:==QQ61IQ5M[QI(^@7^64KV9N7+GM[?*WC0P
M/>3*62TS+9:Q^Q]EX[H17 F]ZW[=U2SM']-N56];-HT>MW0?T[E14'7FYM45
M3I3,L\W$;CLJ4EE2$J[AEFS)P,]N)#(U//:GE[TFH]RN'=3376S6<MZ+RQGL
ME;5ZXO'DEQ<<^"7%O44Z)I;J5P-D-%.6BC:17?7[KBW%)K[4^,B);*%>Q-B(
MY@MXY!MGPWUJ42<BL"(DD9X8F-+JFMW,];C!Q2IMZ^SH.VY7Y)L:)F+E^%QR
M4E2.ZD=KK3"3Z'\%MH-*=P                    6O=M$37Z!/II9>.M'$
MA*5Z+Z.TV?Q@#3:I0UR(S\1:%-R65'@VKO)=;[Q*^$L!>R]WPKD7Y/.:S6,C
M^-RL[:V^U'[4=WEQ18F\=(>0  4^J4BG5I@XT^-QDEM9>+8XW]HKH\PNV;T[
M4JP+&:REK-1X;BK38]Z[.@Q+6;+JE+XLB$:JM$3VDJ27M4?;-[C\Y#;V,_;N
M=U]U^@Y'/:%?L=ZWWX_UO,6S2ZC4Z),*HT*JRZ/.S;9,%TV59OEX$9J^$9ER
MU"['AG%2CUFIRN:O9.[XF7N.W/IBZ>?!U\IG*WN8R^J6;3%=AP;JB$>4GUEX
M67Y3-UHC;7\*!H\QR[E;GL2</4>@:;[S]3RSIF80O1Z<87/.NZ_,JF8X.O\
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M=[R?DJ*>9>_N1]<F;/Z1T,X\29<$A&5=0_!H&;]80KM*^[7]8:L[4S2*@
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MBNVU]*<?6C]!Q;-@\G/K4^@
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M6VZF3&"A@OZ28%0 !'9:XGF](4DZ$HQJ5,B(BP(63(/H
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M(6+:M0V)41MS'C,Q([$2,VEJ/'0EMAI/=2A*<J4B)=)P
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M#8F_J/U&9IN53SMCAWW+?ZR.[X\P/J,
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MGK,0VE^,5%41&%2H $5IHW#P_/"C="L8U*HE))+ MPM-U,A*AZ%"H
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M?(GBMW3L>ZF2N7S3JN:6:;P;1N%V'(J42;-?4]"6XMC(^\M:,IN(0>.!EB>
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M:J/28 JO*3K1],KENFW+HHU%<J=5J,N#-CU"9'E(9EON+R*4S'Q3BE>"B)6
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MA51N8- >A                      2KS+4EIQE]"76'4FAUM18I4E6PR,
M:Q7S8B[>4]+C-G*MV1L7MSJBYO07\CU5? ?EJG)2JB-VW"]!PFJIJC1@JH4U
MR LUE@N*HR)AWU3]5?7B-[E<TKV#V]!Y=K.B7-/EQ1QM/V9?$^LIXS30 4 %
M0  5@O,A9$IL]Z3+$OB%%AL*MUVEOS;4MZ<>9VF):7^N1L6E?H=GU!D6\U=M
M[)&!?TK*WO:AYL"W)&G-.<+\$J4J+\APD._7(C&5#4Y[XHUMWEJQ)=R4H^GU
ME&?TZJJ=D>I19)?*2MI7UU"\M3M[XLP'RU>BL+B?H]13G;'N1ONPF'?\&^@_
MTQ)%V.?LOI,:>A9Q?-B_*22[1N9!'A1GC\C:FU_740FL[8E\XLO1LW%?L_-^
M6AY^BUR%L5197YU/]V*_B[7TB/\ "\U^Z9]3:=RJ+_L22G[<T%]90?B[7TBL
M-(S;_P .7EH3+=DW(OO0$-?X1Y!?FJ$99ZPOG%V&B9Q_-IY43[&GU<7\_*A1
MR\BEN?I2,6WJ5I;(LOPY=S3]J4%YW\;*Q&TY9P_#:NXKY,=HD_56:OK"Q+4^
MB)FV^68_/N/R*GI*_%LFW(V5:HCDM:?2E.J<+XBRD,>>?NRZC86="R=KYKE]
MIMERQH\:$CA0V&XK?JLI))?4&(Y2>TVL(1M^PJ=A'%"H%: "@  BQV'93R6&
M$9EGTGZ*/6\N(MW+BMJK,W)Y2[F[JMVE5OT(R;:EJS*I)32J6CBO.8.3II_-
MMD?I+5U=1;QS^8ON\ZOV>@]3TK3+>GVN".+?M2Z7\G0;:VY;\*VZ>U @IS8]
MN5*47M'G5=Y:OS"Z"V"R;(N4                             '.KG%A'
M(O.Q5IWJHTM'Q2$?9'6<NRI:GVKU'DOO#M<6;L_Y<O6C5;Z/OY<_#5@-]XYP
M_P"!E[1=>D] ]XZLZ=07&\[/OUB0ZA7I%%S2/KH%C/WN'+3?U7Z<#.T+*<>I
MY>$OWB?Z'?\ B.R8\\/H0 #GQSHT8EUO3NN)3_E46H4YQ7D0MIU'Z8QU/+=S
MN378SRGWCY;BO9>YTJ<?4S4./0W'DYB;-0Z%WJ'!6\HIQ+JT_I*VM2=/24E6
M)7)35;O5?;&-G+E<O=^R_49^E9:4<_E_\R/K1V9'GQ]"
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MC&I4T()!8%N%INID)4/8H5
M          "$\K*TI7D%8K$C)X%)%XQP +9J[O%DH9Z(Z<RO.K_B%ZVMYAYJ
M59</02!)VX$)2+"1,)(B2!-$0BZ1!LDD14D1;A0DB,A.(H22(Z2__*(MDTB.
MA.W$]X$DB*2>@4)4(R4B))$38)%2*2"%"M"S]0:A+I%CW54H#WAYT2FON19"
M>\VLTX9D_*3CL$9%V)I/8KBZ%=5N5AJ2N.3,^.BH2,RNVP^O(ZEU722LV)X^
M<01<9T/4DMW00N%BA:-Q-(J-4MJA.ISQ)CSTZHM'W7&H2,R$*3Z23=<09EY!
M N)5(-;C,T:;3+@@-HC**8Q J[+24I1(C2EDRG.DN\IM:B-![]Y;C JC434Q
MQ=P:BW,I]U4N/3I"8,-)G[-I#"$DI*/5[>..'2*5*HVJTKFRJCI[;K\Y]<F0
MAMZ.I]U69Q:6'W&D9E=)Y4D0JB,D9$$ZEL8"I0\*3B!1HA&@Q4I0@J+I%*%"
M$:2,5J1(*DX^<"C1+X?&*ID*$-:<=V\2(M$L98[!4@>#\H591HA&6SR"9 K-
M*7FB\(]\4S3\&\A9DJ,R[$JQIT%3%"Z8 JQX<SMCF?\ %"?]^6*2V"+[YLT+
M)E
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MI[,
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M-S;N(1<J$XPJ5%""06!;A:+R5#T!4
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M6I692E*ZS/:8$C:W1S;IU1/\+,_=3HE$A(R7E/J$ZEL\J3T'N 'P510\F1_
M*5*4(:D_&)%"74D\10B0S+$$4)9Q.&TA4@T03+':)(BR6-)]0J6Z$%1 4(9^
M023(-$U37,DIQOHDMYOA2?\ QBEQ%W+OO4Z2X!;,HUZK1_\ W,61_(Z=]]<#
MYI3YQLXVK.V2NDR%EF4G5$04*@ !2H J       /AG@ /H
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MM75LE",O.B]!9,X
M                              DW8Q++%L\#]7H$E+ MRA4DC2X@\#+
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M<W^J+;F78V^DGA N@
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M(R,MY&,(W*=2< J
M      !:E;L^WJ^2E5"G).0K_IC7LWB^[3M/[H4*HQ'7-%B?)2Z9/;EI/M)C
M32)*_N7F_P U(O6[]RW[,FO48.;TW+9M??6U)].Q^=&(ZQI?<5(,U.0)3;2=
MO%0GQ3)_=-9E?&0SK>I->TJG,YGDZW+&S<<>J6*\_P#26.[29S2LB6TK/];:
M7VOSJNU]49D,_9EOIVF@S'+6?L[(<:^HZ^C:2*VW6CRNM/-GUJ2K#Z@R5<B]
MC--=R]RTZ3@UVIHAYD]8G0L51]%     5 % #/#?O"I4^I(U=U"U%UH(S%&Z
M;2Y"$I^RF^PFVX$QW_HQM(Q^<</A)^KC]88\\W9CM?F-IEM!SU_&-II=,NZO
M27+2K&K=8-/AH<B2D^F,TI22_P"<7E1]48D]27S57MP-[E>3KCQO7$NJ.+\[
MP,KT316IJ-#M0<C4ULN^;A^*>+S$6#:?C&%<S=V>UT[#H\GH&3RV,8<36^?>
M_J[#+M'TTMFDDVZ_&55I;?:0_*VI2KY+1=A/Q#&-SNH9!0VAM*4(02$(+!"$
M@",                                    .%U<K?OVY;HK+;W&54:S4
M)"O73Q)+AIS)^U,>FV;7!;A'J7J/F/,YOQ;]V?3<D_.W\I*^+?PPRJ_.B7!$
MAX\C-'+<^?X\++0MQ*3<3/P94KM*_!'O1&LUI?\ 1S\GK1TO)TZZO9_._5D=
M<QP9[T !HWSL.)10M/&TK2A2JQ)-*%'EQRQ?1'2<M*MR?8O6>:^\J5+.7^V_
M4:"IEO-IVI4GSCK&CRKQI(A/25FG.XKAH]-:^RD24:D9W*[3JURP5=%7T2LI
M:#4M5,;DTQ:E]/A);C:?T!)'!:W;X,W-]-'Z#W7D?,^-H]E_1K']&37J-B1J
MCK
M                   /"T$LL#%4Z%&JD@\P:"Q3VR^J+BD690H2QE@)$
M  #Z1Y10$)QMMW8ZRF07RRQ#8*)[54E3IT/'%!&@_P"\*,A/C9;\&/\ 00S@
M&1>SF*_YXB,.,CX/0_.0O S2W2V#\[1_F&*<0\.72O,??"S>@XZB^Z"L>LIP
M3ZC[X6;TG'3^>"L>L<$^H^>'G?K[!>9I1_\ *%*HEX<NE>9D4H+BN]-/#Y+1
M$*\0\*N_T'SW;'47;4^Y]NX>'Q%@'$RO@QZ_.3J666?F8R4^8OS11MLG&"6Q
M$8U9A0K4^"H     )E#!KV[B\HHY4)J%2<0RA!["V^L+3=2ZHI$84)
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M8CA]3NW+V8G*Y'AET=![ERYD\OE,A;MY>?'"F$J[:^5T[-QFD8)NP
M                                                 *-/H=(JA&51
MID:7FZ76TFK\]O%* M*9I?:$O:F Y$^3&>4A/YTS,@6&PDW7;CVX^LM:7HE0
MWC]C49#*<.XZVR[]9*#^J+L;UR.R3,&[IV5NOOVXOR+^DMV3H.C_ */5HJOM
MF%M_I'#%U9R\MYA3Y=T^?^&EV-_*4Q6@=0P]G.A_:<1]'YBA-:A>ZO,8\N5=
M/>Q27YS)?\0M7_SJ#^SO?XH26H7NKS%O^4\C];SGLM ZDHB-<R&1=&#KRO\
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MTM?:FIM1_5,QP7,B_P"K_-1[[[M95TA+HG+XC< : ]
M
M   (3C25[]_K"2E0C**9**BF6[M":F6W;)9233O$BVT>0
M         3*8RE[]A>41<J$U!LG$L(1T9C\H@Y5+J@D1A$D
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M4DS+R8'T@#'ES:!6I7*A*JL"9,MV5-=4[+9BFA<<UJ[2EI:61Y3-6T\%$7D
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MM@-&=R
M
M  ! =90\VMIQ.*%D:3+R&"91JJH?GWJ]/.E5NMTMQ.4Z74I<-:?5./(6@OK#
MUFS/CMQETI'R3FK"LWYP>Q3DO+%_E*<+A8-].1>W%.UK4"[EEB4")&H\)2D[
MUO*5(=R_ EOXQR7--ZD+5OI[WQ+XSUKW69+[S,9C<DHKR]Y_$=+!QY[( !KS
MS/6V=S:*7NPRV;DRDL-5B(A/>SP'">/XT$LAM-%NJWFX5V-T?EP.3YWR3S>D
M7HKVHI27YKKZJG&5*DK3F;[JNX8]*:Q/FR,N)8 4*G8#E%IATW0ZUG5=A59D
MU"H&76EZ2ZE"OSJ"'G>OSXL[-=%%Z#Z*Y L>'H]I_2<I>>3IZ$;0#3':
M
M                   !Y4E*MY8BJ="C29+JBD?=5@)*9!VR75$5YQ7B1%VV
M05(-&\C(3J6VJ'@          ^SO   >B0H^@*BA&*.\K?V1!R)\#)E$8BWJ
M^(4<R:MD9#:$=TL!"I-)(B 5
M                          H[OSB_.+RV&-+:>!4H4>M_-1O])_,,3MF/
MF=B[2D$6 N&.12+;B(R)1(R=FT4J22)EL4)HBEO%LF3:"P%2:(Z!1$D32"P!
MDD1"%*DDCT*E2*(,DB9(L"P$":1] J             'PRQ $%S>)Q(2("MY
MB2('@R!E#PKH%41)59=(,BR KK%419+.%@?D BR$9"9 E5;C @R7=+%L\?5,
M27M$'L+BC?Y-&_P*?THM/:9T?8788%K']9BR/Y%5#[XX*?-*+V_(;'1-Y^;\
MT4F7;9/BT7@ (1H0LLJR)1>7: (H  "&A"$XFDLIGWC $0    ##I    !"R
M(S9LO;P[W2*@BB@
M
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M)1CRS4+OBYB<^EL^J.7LM^&T[+VWNMQ\],?290&(;@
M
M            AFVT>])"M64HCR;#?J"O$R/ B&<9KJ4'&RGAH'$;Z#,5XV/#
M0\(UY13C'AH^^$:\OQAQ,KX:/I1FRZ!7C8\-$3A-EM)!"-27"B(*%0
M
M  H[WSB_.+VXQI;3P*E"DUG F(JNJ07U2,3M[2QF5W5VE((7#&1$2(-\1-*A
M&270*$D33992 FL"8:W_  B!.),%N4#)HC(+ L11%432>D&2/:2P(41,B$72
M8-E2.E(@V22(PB3                 \*WBJ*,E5= N(ML\"I0\'MV"B9%H
M@+3@*D6B7/<"(DJ[T"I&1 ,S$DRVR646 D09+/\ 99,_(8JR$MA<K'^3QBZF
MT?6,6MYG1]A& ZS_ %F+(_D54/OC@H_9$?;\AL;#WJ$9ERT3XMEX
M
M
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MBDDDMQ. 2
M
M
M  "F2/GA=B8\]I+B1$IM53C",S]!23^J)VWB6,PNX407*&-4BD+9<1&+>*E2
M;$6R:1':WB).),X;!1DR.WL+X 1)$PG<*2)(]D")'M/2#*HF&]QBU(N(B@5
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M3KP
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M,
M
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M^4>NG9A@9Y&O.C
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M8XCE#U@
M
M
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M:IW<U3PE=N5JN+I2PQW]1N&?,#RC88<.DY?Y,N_O,<W_  34^O\ 27RGHO\
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M\L7K5MS<U@F]CW>0R<E[S<IFKT+,;,TYR45LVR:7QF]8YH],
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MO!^C$W;BR8\Z-&DQ742(TII+K#R59B6A98DHODJ(<ZU3!GHL9*236*95 *@
M
M
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MS&HS&9NYB7'<DV^L['(:=E\A;\++P4(="^/>WVU+U%DS0
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M9Z)HG.&@YW,1M^!&U-ONN4(>UVK&+Z&]^\WQ',GIX
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M Y#U^5Q_@;F-$W"7U?HOLW>8WQ'-GI@
M                                                 67?$.MU"T+K
M@6V^<2X)=)F,4*4ES@*:F.,K)A9/;<AI7@K-@+N7<(W(N?LU5>S>86IV[US*
MW8V'2XX247LI)KNX[L>TYC7U0.;+3:V';JNK4FJ,TF(XPQ)7%KKK[O$D+)M&
M5&5.;!1[=H[G)WM+S5SP[=O'KBMQX=K&1YGTO+RS%[,RX$TL+C;Q=%\*GFP*
M%S7ZG6ZBZK1U)JKE*<D/1$JF5MQASBLJP<Q;)*MAGN%<Y=TS*3\.Y:5<'[/2
M4T?*<S:M868R^9EP5:QN23JMN!F3F)K^IFG>C6D+2[LJE)O(GVX=TU6).4;L
MF0F$M3AN/E@;A9BQQ&IT2SELUF[M8)PHVDULQ.IYVSF?TS1\M6[*-ZJ4Y1DZ
MM\+K5K;B;.Z U2I5S1S3ZL5JH/U:K3Z2AV;492S<?>6I1XFIQ6U1GL+:-)JE
MJ-O-3A%429V_*^8N9C3+%VY)RG*-6WBWBS6SG6O>\[/78!VG=-4MGQZ*IXY5
M-DN,&\;7AS;SY-^&8\,>L;OEK*V;_'XD%*E*5ZSB?>;JV:R/X?\ #W)6^+CK
MPMJM.&E:%YZL77=-)Y4Z%=-,N"HP+E=H]N2';@:?4W,<<DJC\92G4X'F62CS
M><8^GY6U/5)6Y13C66%,,*FRU_4,S9Y8AF(W)*Z[=IN2=)5EP\6/74P5RP\Q
M]<:NU-EZE7%)K-/N=]":#7*F\;KL2H'@E+)N+(S-N1N+;V5X>L8VNO:)!6O%
ML1I3:EL:Z?(<GR%SM>>9_"9RXY*?LRDVVI8=VKW2W8[>TV1YN[EN&U-*H]5M
MBOS;<J1U^"PNHP'5,.DTXAXU)S)(MAFDL2&EY>L6[V9<;D4UPMT9VWO"SU_)
M:8KEB;A+CBJIT='7H+CY7J[6KBT7M>M7#5Y5:J\IV>4J?-<4Z\LD37D-YE*[
M2LJ4D1>06-=LPLYR<+:I%4P78C,Y&S=[-:19NWY.4WQ5;=7[4J>@PGSA:L7'
M;LZS+$L:N3*'7*BKWI5I-,=-I]32C./$CFI."BXKAJ/#IRD-GRYI]N]&=VZD
MXK#'97:_,CF/>/S#F,I*SE,K-QNR?$^%X_1BL/I.OF3*'RI:JWJ[J%=VF6I5
M;J54K#B%+@-U9Y3ST6;3EJ1+CDHS,^T@\Q'CA[,S%WF#3[$;$+]A)+?3926Q
M_#I,7D#7\[+.WLAGIRE-5IQ.K4H>U&M>BKZ.[4VLUYJ=1HFCVHE8HU0D4RIT
M^C..P:A&6;3["B41DI"T[2/S#G],MJYFH1DJIO>>A<SWYY?3+]R#:DHMIK!K
ML9SMTSC<T&K-.JE3M#4^IJB4B44264^M/,*-XT$[@E))<Q+ ]^P=KGWIN3E&
M$[:Q5<(IGB^A0YDUF$[F7S<N&+X7Q3>VE<-I,73=W,]H%7Z-)NZ\)E3:GDIZ
M&S+EG4J;+0QAQF%<5*5)423+'#*K:2DJ$+&7TW4825N%.Q<+71\.HNY_4N8N
M6[\)9J\Y1ELJ^.$J;5WL4^RFU8X&UG,3J'6E\O="ORSZO/MB7<$BC2V)$)Y3
M3Z&IR2<6TIQ/068R5YAS^CY*'XV=JXE)14MJZ&=_S?K%W^!PSF7F[;GP/!T=
M)JM*EY<J]>K=SZ,T*L7%69=?JLB94$.SYSBG7E);DN-MDI:B-6Q*<"Q(8^NV
M+=G-2C"-%18+L,[D/.7LWI%NY>FYS;EBW5X2:6)G&Z''&K;KTAE9M2&*;+<;
M>2>"D+2RHR,CZR/<-792<XI]*]9U6;;C8FU@^%^HY&Z657F1U=E5&!:&J-9.
M71(S,J:<^KO1TFAY2D(R*)*\3Q2K$>AY^WI^2C%W+:Q=,(IGSWH&8Y@UN4XY
M;,R3@JOBF\:O<9LCZ0<YC4V Y+U)><BHD,KE-?2&0HE-DM.=.7A%M,L1JKFH
MZ3P2I;[V[NK:=19Y<YKC.+EF7PIK_$D=+!QQ[(
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M5A[9LT+1D@
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MESXC@+O#XDN#95T[*GT%DO$_#V_%]OAC7[5,?27.+9E
M                  %CWK9-O:@T"5;-S0O&4N6I*L"4:'6GF^TAYEQ)D:%H
M5N,A>L7YV)\<'BC!U'3;&H696+\:Q?G3W-/<UN-4ZSR76X<2:NW+SK,.>I.-
M+*H$S)CMN%W2=)MMMQ1'NQ)6/3MW#>6^9)I]^$6M]*U]9P>8]VN7<9>%?N*5
M,.*C5>NBBWY_.9-T%T.7I+!K<RLU"/6;GKYH;FS(R'"88C,X\-AKBF:\%*4:
MU&>&)X=0PM5U3\8XJ*I!>>O2S><J\K_P>$Y7)*5V>UJM%%?-5?.;+C5'7
M  %C7W9U-ORTZU:=5SMQ*S'-DY#.4W&'$K);+R#5TH61*(7LM?E8N*Y':C U
M/3[>H9:>7N>S-4KO70UV&FUM\ESRTSE7E?"LV))IB:&P3:30E7SCYR$K/,?J
M)V%UJ'1W^9/W4/TOR'G63]VWM?B;SKL7!T=+XJX]GI-C],-"[)TJ<D3Z$W*G
M5F8V3$JN5!WBOFR1D9H024H2@C,B,\$XGTC39[4[N;PG11Z%L.RT/E?*:0W*
MU5S:HY2=73=U&<QKSH@
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M<JJ]V.RN/H.D(Y$]<
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MVTVORF=HON\R&G75>DW<FL5Q44:]/"OC=$;BC0'?
M
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M1S#1RY6MQBWXWH_*=U9]ZF8N3C#\)2KI[3_NG2L<<>R@
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M,-^']!Z#D^0=)>;MYO*SK:BZ\"EQQ<E[-)5K@\6N]6B-X1SAZ2
M
M
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MA'Q$%6*(F10J
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MQ5!0OGHBS "?C-Y$YCWF+<F7K<:&O%=_K16-_(V?]^<%?F$?\3R&R(MEX #
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MGO&.EM9>Q?O1SEO>J=O;UH\VSFI9O)96[I.8C[-Q-+Z+5=G3%K9LW4]HZ/\
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MG!3N4HW3!U.;T3FW(:Q=E:RTI-Q7$ZJF%4OC+FU.U3M72>CQ*]=B9_NN;,*
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M2=<
M                                 4Z1(8@L/2)+B(T:.VI;SRU94(0@
ML3,SZ"(@2K@BCDHJKP2*?1ZU2[@ID"LTB:S4J74XZ)5-J#!D;3[#A9D*0K=@
M9"LH.#H]I"Q?A?@KEMUBU5-;T7"*%P                "VHU?H\RL5.A1*
ME&D5BAHC+K%.;42G8Z91&IA3B=Y)625&1^02=J22DU@]C["S;S5N=R5I23G&
MG$MZXJ\->VCH7*(EX
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M::-#?W(TNL9S\5F926Q8+L1VG)>D+3-+M6Z4G)<<OM2^14CY#8,:LZH
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MV9R@]J=/,?162S<,W8A?A[,XJ2\J+K$#)
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M^86/\7R&R(ME\
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MJ6Y2\3]+"XNOYW8F2&">8WFG2ME12[6.I(=-P\23[DHR4J+8K:1/J^^"3_\
MC--H\)T_K2^3XBPO_P"*.9>)=ZTI8='AV_[WKD=?R(B'GQ]"GT
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MIU7V)X^B5?.C>L<R>H
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M"2_3"UH*KF:=,9>IE_GEN.F2FO:C.VUV\:7J9L^-.MAUX%0
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MJ3J7X1H3 B3  UNKO]:*QOY&U#[\X+GS"Q_B^0V1%LO@
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MFK[4A>UC6?QZC%1X8K';6K,3E#DQ:#.Y<E<5R<TE6G#1+%[WMP_1-KAI#N
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M4J\6U/AW;C=<<Z>B@
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MG2*6O$O/YD'3[4L$:[FVM_\ #92.V[>C5?\ IP[TWY%0V>&H.O
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M[.0LRN\?U!:<JEZ$*$V(EP   -;J[_6BL;^1M0^_."Y\PL?XOD-D1;+X
M
M
M
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MCIE<^\W.5:04(+Z-76;ZW+#'"B5,:F6ABFU
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MY5+\8T)P1)@    &MU=_K16-_(V?]^<%SYI8_P 3R&R(ME\
M
M   "QKVOBW=/K>EW1=<TZ?1X"V6I,MMAQ\TJ?<)MOV;1*7M4HN@7LMEIYB:A
M;56S U34\OIMAW\Q+A@J5=&]KHL%5[3"9\Y'+^1X'>CA'_!D[_$C:_R[G?H>
ME?*<O_R+HO[U_H3_ +I>VGNO.F&J55GT.R:\[5ZE38A39;)PY$?!DEDV1XNM
MMDKM*+80Q,YI69R<5.[&B;IM6TW&D<SY#592AEIN3BJONR6'E2*Q8VK=CZAU
M&O4:VZFXY6;8?-BN4:7&>AR6%DI31DIM]MM1X.$9&98X'OZ!:S.0O9:,9SC1
M2V/:GY3(TS7<GJ,YPLSK.VZ2BTXR6[9)+L[3(TB0Q$CN2)#B(S$="G'GG%$A
M"$)+$U*,]A)(MYC$2J;9M)5>",?6!JI9FI[%3G65.>JL&CR"B29RXLF.RIW#
M,:6G'FT$Y@G SR[B,NL9.;R-[*-*[&C:K3"M#5Z7K>5U.,I9>7%&+HW1I5ZF
MUCY"/J!J7:6E])8KMYS7Z?2I$E$,IK<1^0E+JTFI)*)AM:B)64R(SV8[!3*Y
M.[FI\%I5=*DM5UC+:7:\7,2:A6E:-X^1,OB'*C3XL2=$=2_%EM(>8?1W5H<3
MBE2?(9'B,>46G1[C90FII2CL>**9<-?I5KT6JW#6Y10Z318KDRHR\#5PV6BQ
M4>5)*,S/<1$6)B5JU*[-0@JR>"+.:S5O*VI7KKI"*;;Z$BP%ZV:?,Z<EJJNJ
M2F+')SAHJJX4A+BC-_PV8F5-\4TJ<V8Y/+N&7_#<P[_@)=_HJNBNW8:O^8\C
M^!_'<;\'Z5'T\.RE=I,71K)8=FPK1J5QU-V! O532:!-\+(6TLW4H4GB*;;5
MPL4N$KM8;,>HQ&SI]Z\YJ"KP;<5\'Y"N=YAR62A:N7ITC=IPNCIC3;AAMWT,
MNC$-T63>%Y6]8-OU"Z;HG'3*)2\AS)&13ID;KA-H(D-DM:C4HR(B(A>R^6GF
M)JW!5;W&%J.HV-/L2OWY<,([7MVNBP6.TF;<N6D79;U,N6DNN*H]9BHF0'GV
M51UJ95VB6:'4I41*+M%B1;!"[:E9FX2]I.GE\A/)YRUFK$;]OV)*JJJ8=./G
M,)7+S7Z(VU47:0NZ':S,9-29'N6*[,;;-)Y58/-IX9GCTI48VEC0<Y>AQ\%%
MUNAS.=Y[TC*W';=WB:V\"<DOSEW?27MI_K?IIJ@I<6S[H;E5-DC6[1I"5QI:
M23@2E$TZ234DL=IIS$0QLWIM_*8W(X=*Q7G-GI/,NGZKAEKB<EMBZQEYG1OM
M549D&";T                                 ,;6WJ9:=V7%==J4.H.2
MJS9CZ8MQ1%,.LDPXLUDDDJ6DB<,\A]PS&3>R=RS"%R2I&>Q])K,GK&6S=^[8
MM2K.TZ25&J;>G;LW%.@ZNV#4-0)VET>N87I34J-^D.LNMYC2VEU1-.J03:S)
MM6;!*L<,?*)3R%^-E7G%\#WEJUK^2NYV61C/[Z.V-&MU<&U1X8X/89:&(;@Q
MQ1=2;3N"]+EL6F5!U^Y;0;:<KL)4=UM#27<#1@ZM*4+Q)9=TS&1=R=VW:C=D
MN[+8S6Y;6,MF,S<RUN7WEJG$J/"O7L?D,CC'-D8NIFJ5EU:^ZQIQ#J;A7E06
M#DSJ.]&>9P9(FU9VG5H)#B<'4&60SV&,J>3NPLJ\UW'O-78UK*WLY/)QE][!
M5<6FL,-C>#V[C*(Q3:&+;IU2LRT+FMFSJW47$7/>2^'0*6Q'?DK=/.EO$^$A
M24))1EM69%L,^@95C)7;UN=V,>[':S59W6LKE+]K+W)?>7/923=<:8TV+K?7
MT$TC4JT%ZANZ9)GN'>+5/]Y.T_P[V1,?!*LW'R</TL<,PI^#NJSX].Y6E>LE
M_%\M^-_!<7WW#Q4H_9[=GI)2T]4[-O2X+HM2A5)QZX+*>X-P4N1&>CN-*)Q;
M69'&0E*R-2=Z<=Y=9!?R-VS",Y+NRV.J(Y#6\KG;UVQ:D^.TZ23BTUBUO6.S
M=U=*,IC&-J8MG:IV5 OZFZ9OU1U=Y51CQ,:F,QGGB)HR6K.Z\ALVD%E:,^V?
M5Y!DQR-Z5EWU'N)TK@:J[K64MYR.2E/[Z2JDDWACM:5%LWT*S=U]VG8-)76K
MQKT6@T\CR-R)*L#=<P[C2$XK<5AT)29B%C+7,Q/@MQ;?47]0U/+:?:\7,34(
M]+W]BVOR(P-'YR]"GY#<=RN5")&=7PRJ4BF2BC_;8DVH\/N1MI<N9U?-795'
M*P]XFC2E3Q&D][C*GJ-CZ!7Z)<]+BUJWJG'K%+GI(XE0BN$XTLNHE)W&721[
M2&EN6IVIN$TTUM3.QRV9M9FVKEJ:E%[&G5%QB)?
M
M
M                                       )1UC9BWL/U1-2+4H=!(*3
MEV&+A:/@  "$_'8?VOIQ,NZLMAE\(5H1E!2VE-7$E,GBV924^7LJ^P8JI%MV
MI;L2!XC*K(\1Q5=2BP_XA,M\73@3!>41:)I@L#$01$K,"53$.O-\5?3W2&^+
MPM]32:Y1XK)4IYU!+;:=E2F8W&X:LR3-!.YR)193,MN)#,TW+QS&9MVY^S)X
M]=$W^0R;*4I49S7Y;M3+[F:X6FJIW95:NBZJBJ+<+$R4Z\W+2\TM)*<0I1IS
M(,DFDR+LX$1;-@ZC5\I:CEI4BEPJJHJ4[#J;V6M2R<G184IT[<>KM+5U/U<U
M+IVKMW7!3KUJM/J%%KU0CT<FI+AL1H\:0IMMA+*\6U-Y6R)2%(P5MS$9B_DL
MC8E9C"4$U15Z6Z;:[:B67MQRD&DL8IUIU;>@Z]::W-+N[3VRKJJ2&FI]PT.'
M.J#+*<K7'?80MPVRVX%BH\"'%9JRK-^=M.J3:5=M$<K>I&3IL+YXI"R6*GA3
MAGLZ *5/"EY"Q=/ B](]@4*-])")U;I8LLG(^66Q/QGL$J4VE(MR]E5(Z(+B
M_P#*7=F'S"-A?"O>?U!&I-6Z[7Y"HH0TV61DB0DO1+8")I);#T!4 "*EMQ9X
M%M!NA5)LGF6":+;VE=8M.52]&%"8$28 &OMP<O5E7+7*I<50J5P-3JU(.3,:
MB5%;3*5FVE!Y&\.RG MPFIM%J5F,G4I?Y,&GO_O6ZO\ :R_L!XDB'X>/6>OR
M7]/O_>ET_P"UG/[D/$D/P\>LN*S]"[,LBXF+HI,NLR:K$8=8:*?..0V2'RRJ
M[*DYO-M!S;5"Y&THXHSD(%P
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MS;?)/R2<0>7R#49[+_A[\[70SK-#U'^(Y&SF6J.<4VNO8_2G0R8,8VH
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MU$
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MNL9+S/>GUI[35%',7J OF2_%%X&B_1?W^JFE*\._XW@)C*=QXGB,F./3DW=
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M60G&*GQ*2KT-=OR[ST+E#FIZ]9G)VI0<*)O;!M]#PQZ5N36.)LN-0=@
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M6!;A;>)>2H>P*@
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M-;*^K N<H9&>3TFQ:G@^%MKHXFY4\G$9V&N.D
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M$EJ',N5L6\? BYSI\W?1_P!7],WN',GI@
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M1HZRC11:<M[2P?%TXU[4S.HP#H@
M                         E'(S:NZG _J"2D6W;3)9;!H_NB%Q2J6W&A
M%2(      &M_-W_5RU'ZN#3O^]8@VFAK_K;?E_59>L[?.<N^6-S#7#3%/K5E
MK](H=5K4?^FN=C.H5Q+*3CTKY"Q-6UDK434$O5N.K)_ZVZ,O3E2U#L7J&;N*
M5B"Z(H[;Z$?S*:3%_P#*E+_<R1P.I?ZN[]I^LY:]M1E@8A:     /64_A $5
M,5U?>/*0@YDU;;)Y#*&]Q;?6$'*I=C%(C"A(
M
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M$]LG[3,C+\GW\UF8YG5+_C.+K&"5+:?9OW845=]=AN*-$=Z
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M*V16Q'0<O<MV-&MR4&YW)NLYR]J3^)>5];9G88!T(
M                                        !R@U3/#G<I1__,MJ_58B
M#O<BO_B)?8GZSP+7O_,(?YMCU0.KXX(]].0%]/U;E^YGYEY/TMR53Y-8EUFG
M)+$D3:=4D+*6AI:MG$;4\HO(9%CV3V^@Y3@U+3?"37%1)]3CL\^!\]:L[G+7
M,<LVX-PE)S7UHSKQT?2JOLWX&U=P<Z>EL2WWYMNG4JQ<2V3*GV^]"7&2E\T]
MDI#KG82A)][(I1]6(T%CEC-2FE.BCO=:X=1W^<]Y^EV[$I67*=RF$>%K'ZS>
M"731LPCR26A6*C>-SZD3&W"I<>(]3H]061$U)GS'D.O$WT*)M+1&K#<:B&SY
MHS$8689=;=K70DJ*IR_NNTR]=S5W/33I1Q3>QSDZRITT25=V/84'5@__ +V:
M$?\ \S6G^EC#)TY?_#R[)_&:WF/_ ,OM_P";8_\ V9M7S1:(EJC:BJY1(7&O
MFU67':8V1%C-B'VG82\-IF?>;^7LW*4.=T+5/P=WAE[$MO;TGHO/7*ZU?*^+
M;7WUM-Q^LM\>W?'KP^<SGIR^RY4S7K361,>>DR553ANN2#4MW!F*ZVDC4KM=
M@DX8=&&'0.RUB,5D;BCT?&F>-<FW+D]<R[N5K7?]6+1F;G!NN=?>JM TTH32
MY_T<2S#8A-&2B=K%46V>3:6]".&6W<9J&KY:L++9>68FZ5W]"C\IU'O)S]S4
M-2M9"PJ\#2_]RY_]-%VME3IFG'.W0Z? H])J3U.IE,91&IL!FJTTD-M-IRMH
M+IP)(A<S>CSDYRC63VX2+^6TCG'+0C;M2<81227%;HDMBVF+=)IUPZ!Z^T6F
MWE%]T2I3J:3<\8G$+:*+5LJFG<Z#4DT(=4TX>4]F51#/U&W#4LC*=K&BJL-\
M30\O3O<N:Y;AFEPRE2$U54I.F-5A2M)/[+P+SYS'6HVO-O27MK$6ATMV067-
MV$37UK[/I;$[A9Y;CQ9&4>ER]2,_WDW(PURS*7LJ$&_TI&RDSFYY>W8[Z5Q)
MTQMQ!I<CG1<R7B]3MGE[7RM@Y^/+N?70O*=W/WAZ&XO"3ZN#Y35[E.*34^8:
M=6;;I[M+MM$:KOU* WB;,2#+5FA1G%%V>ROAY2+U3PV$-]S#2WD(PG*LL*5W
MM;6<%[O(2O:Y.]8CPVJ3;5-D)>S'S\/;0E-3KA@VAS>U"ZJL3Z:50*_3)LS@
M%G<)IJ QF-"#,B498[L1=R5B5_2E;A[3BUZ2SKF>MY'FN68NUX(3BW15=.&-
M:;L-YMT?.[HHE)JRW'@7:P]VE_C1SG\L9WH7G/15[S]'V5G^BOE,+<^,E,]C
M2:2SCDDL55QK'LJP=;BJ+-U#:<I1<7>3W</K9S'O:FIQRDEL?'Z> OVS.:?0
MVA6A:=$J34SWA1J/ @S\M*4O\(8C-MN$E1%@>U![1A9G0,]<N3G'V6VUCNJ;
MK3>?-$R^5M6KC?%"$8ON/:DD]QL!I3K#I[JL]6V;&3)2JBHCJJA/PCB%A)S\
M+*?I?-J\WPC4ZAIN8RG"[V^M,:]IUV@<QY#5W-92O<IQ5CP[:T]3,X#7'1'(
M>E4"D71SDU:AU^ 50I,F[ZN]+A+(C0Z<9IQYHG$]*,Z4F9;CW'L'H%RY.UI"
ME'!\$:>?Y#Y]R^3M9KFV5N_'B7C7'3L3DJ]7K*EJ_8]Q\LNJ-(U*L$N#:M4F
M+536C(UL,K<]I(I$@D[VG$XFT>_ MG:;)0MZ;F8:MEGE[OMI>K9)=:WE_F73
M;_*FHQS^3PM3>"^:M\K3^J_F]"V8KB6\GXPZ#JEH9=MW6^[BQ,MJK,S(+BDF
M[$E-Q%\6.Z:?23CC\HL%%L,<NLG/*9Z%NYNDO*JK$]3_ (Q8U;1KN8L^S*U.
MJ>V+X76+[#5S^S^^<U0_P=$_]K&_YN_POSO[)Y][H-N:_,_MEAZ%8_EBW$9;
ME5>[/T\@9>K+_P"*C]F'Q&KY3_\ ++WV[WKD9>YP-%GYL8M8;296S6:$EL[L
M;C&:'7H[&'"GHR;>)&P/,9;<FWT-NJY=U*,)?A[OLOV>WH['ZSI_>/RS*_#^
M(9==^%.-+:XK9)?6CT_1^R81Y*''']:ZA(=<-YV1;D]UYU1XJ6M<F.:E*/TE
M&K;B-SS0N')Q7UEZF<A[KI2EJ\I2^=:F_P"M$@:TUNF6YS>OW#6$J.D42K4&
M;5,B.+[%B)&4LR;+O[B[/2*:;9G>TG@AM:DEVU="O,V;LY3FOQKOL1E;<L*[
M(QW>0VS_ "O.7WU9W^Q3'/\ \NY_Z/I/0?\ D+0NE_\ VW\AL'I[>EM:@6K3
MKJM-+J*+43?1$)YCPZ\8[BFU^S+##M)/HVC39S*W,M<=NY[6_>=CI&I9?4<M
M&_EOV;K3"FQT>':<]N?K;>EBX?Q?E?NHAV7*?[&?VEZCQWWM?ZK+_9?K.F5!
M_P"Q*+_H,;[TD<1=]N7:SVW*_LH?97J.6W,'_6]MW^$+4^_LCNM)_P!KEV3/
M"N<?_*;/V[7K1F?G4TFJMT4ZCZBT"([4)%L1785Q4]E!N.%3U+XK<A#9;5<%
M>?/AMRJS;DF-5RQJ4+$Y6I_.Q7;LIY3JO>9R[<SEJ&<M)N5I-22V\&+K^:]O
M4^HE=(.<JTDVQ3*-J6<RFURC,-QRKL9A<J//::3E2ZHF#4I#JDEVDFDR,]I'
MT)GJ/*]Y7*V,4]S=&OE+'+GO*RCRT;>>K"<$DY4XHRHMN&*EACAM\Q)5GG(N
M"O:@V_;VD-G'<U)F.>&53Z@E;,VHO+-/;9R*,H[;1),S4M)EAF-24D0K#EJ-
MO+RN9B?#)=&*7;TUZB-_WD7<SGH6=.L^)!X4E52DWT4KPQ72ZX5JJ*ID76CF
M<?TCOFVK9=M)ZH0'8IR[ED.&;3BDN%@A%-=/!IPVE8FZ9[-R>R>(PM+T+\=:
MG*,\4\/R_$;OFCG=Z+FK=J5EN+59/%;=B@]F&^NW9M+5O?F(Y8KXM>H'<-$=
MN6=(C+*/2I%(4U4.*:5$G+*RY6C(_22YL\HR,KH^I6)K@?"NFN'FW^8UVJ<Y
M<N9[+R=^#FZ;'#O5^K*E(OK4C&'(G1*L]=UY7,VT\5#C4INE29.TFGICCZ7D
MI)1]Y32$JQPW9BQPS$-AS9=@K=NW\ZM?)2GI9H?=3E+KS%Z_CX:BH]3E)J7G
MBJUIT_6.HPX@]O
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M\HCQDU!LCIBI+:I6)"/&25LF$I)&Q*?A$6ZEQ*A$%"H
M
M
M
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M?R[XR_'\/B<*IQ<=>''AV>7K,=)_('Q+#Z/9NC_M09O_ ,S];T&C_P#X,_\
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M8FM?RS^+G^-X/&PXJ\5=BILP]FGQED__ &#_ /R__P#Q(9/_ ,S];^J:O_\
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M1&G'ULVT=)D?XMP?=5X>NG]H\RUO^4O%?XK@X]_!Q[>OPM_:98T1_)TX<_\
M$M[D\7D_UAP.+[RX6)8<3Q?X5EQW>C\(P-4_'5_ZJOQ>C W_ "Q_ N%_PS@K
M3&E?$IU\??I7I+^U._%5]'5?C8]Q?1S-[+WUP\.)CM\/F[>?_!]H8>4\?C^X
MKQ=1N=9_A_@?]=P>']>E*]5=_9B::-HY _')63T;YSYI?T@\+CCTYDY,,>M6
M7X!T_P#\WP[_ .I4\Q7\D>)A2O%_ZU*^JG]4WILKZ$_1FF?B^]U_1/A_ZL]R
M\+P>7IR\'9CCWNG'>.5S7C<;\:O'];;Z3U73?PO@1_"<'A;N"G#Z"]19,X
M
M      )=7 Z<!-5(/A(9^$Z</JAWB/</)^#_ .&(KB4[A]_ _)]44[Q7N'K\
M$PZ,/A#O#N$5/!Z,!1U)+A(PB3
M                                                          __
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2227887d1-tbl_exvivo4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-tbl_exvivo4c.jpg
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M-4-S@R3B5+,EH\,V_]H # ,!  (1 Q$ /P#W\0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0',FY_%ETNVGN',[9RE?..R."MRTKKH*D3XC+"XM=R.
M,[21J.'!7UCJ[DWK<;D7&DE5;?X'SW4/U,TK!R+F/<5SBA)Q=(JE5S><:+]M
M/H_^+;A__,H?RA;?A?+YX]U^0A_NUHW-=]E?2+<Z6=:=G]7_ ,^_V3BR,?\
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M!RELLFIU6O/TB]A14KE*-TV/^!+ZN]<L'7;D[>,IU@DWQ)+8W3D;+G56=8$
M0! $ 0'Y<YK&N>]P8Q@)<XG0 #M)*'C:2JSEG>'B_P"D^U\A-C*+LCNVQ7>6
M3VL1'$ZH'-X$-GFEC#_06!S3YUT&-U;RKT>)TCV=_<2\)\YU3]4=(PKCMPXK
MK6]P2X?:DU7LQJNDV&PO%=TKWUDZ^%?/>VME+;Q%2CS$<<<,\CCHUC)XI)&
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M6P0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MSPV.X[(2AK@=1HV<TQ&3J#Y/0K;X5@_-5[SNQXJG'/\ 5W(25QX35M\O&_\
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M!X/)WLI7RE[VZ::]W?.U_=LBY6]TQ@TT8#Q"I]2U*>=-3FDFE38=OU8ZL6-
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MUK#"(QVGNK/-([ZY3]5TSWV?:E39+?\ Y=K[JV'.]4.M7X+J[F6W*D[7H?\
MY?-C3^F=9/LEC>"+8_L&VMQ[_MP:6=P6!C,3(X<14J'FF<PZ=DDQY3Q[8U!Z
MU9?%<C96Z*J^R]W>\)??I#H_NL:[FR6VX^"/],=[79EL_P AW2N3/L80! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M! :?/?\ =LWNM^BL[>\U7O1*\4D@! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! 2;;'X59_HO\H+5=W$G'WLFJT$L( @-'F_YN#W7?24/+W(
MFX>]D<4$GA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! ;_!?]:_D?Y2FX?+VB#F\G;\1
M(%-((0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M $ 0! $ 0&_P7_6OY'^4IN'R]H@YO)V_$2!32"$ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M6@:DDZ!4:3>Q%J<_6O%MX<*F2.)FZMX4VFO+#)$9YJ^H.GX3'$Z'3T\^BEK
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MK/\ 1?Y06J[N)./O9-5H)80! :/-_P W![KOI*'E[D3</>R.*"3P@" ( @"
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M;A:G8S&U:=6NBA/NJ_5?9_1C9UK?&][4];"UK$%1K*L7?6)IK#^5C(H]6\Q
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MAZ/YWR7E.8? -U'L].>N-O8&;<^CC^H$3\/;JRDM$.7HN>^ISCZHGO80/JI
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M_P! 2^>'?A $ 0! $ 0! ;_!?]:_D?Y2FX?+VB#F\G;\1(%-((0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M^2CN+K#G*=F+EO.G5")(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M9JL&KBER-%ZT>EG[O^UTS;U)ERD<,$>,;<N;=.XYADX[1CYC2]D,O?&7G!8
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M["W]_P !ZR+D#K0@" ( @" ( @-_@O\ K7\C_*4W#Y>T0<WD[?B) II!" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MEZ:8O9.X\#D-TW\SNS<$=>&'><E6*-N/CAM0V7>QTN=X:^40F-SW2./*X@:
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M88FAK&-'F "II2<G5[V6J22HC:+P! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M>"YNQ?G9EQ0=&7EVU&['ADJHX6E_=E=.G9)TL/4C<<6(,A+:+H*C[ C\C?:
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M6T[JK3=M:\!<6V=O8S:.V]O[4PD3X,-MC&U,3B(9'F1[*M*%D$+7/=J7$,8
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MD7?Y>^6RH9*" ( @" ( @" W^"_ZU_(_RE-P^7M$'-Y.WXB0*:00@" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MUH  5/*3DZO>6:22HC/7@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M4$GA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M#XUZU^O/[&'W8_7[XI_ZURW]WJ7Y"GY/IG,O;?TA\:]:_7G]C#[L?K]\4_\
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MZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q(_C>6^0:OY&GY9IO\
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MZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q(_C>6^0:OY&GY9IO\
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MZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q(_C>6^0:OY&GY9IO\
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MZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q(_C>6^0:OY&GY9IO\
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MZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q(_C>6^0:OY&GY9IO\
M+[;^D/BCK9_R?8Q^['ZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q
M(_C>6^0:OY&GY9IO\OMOZ0^*.MG_ "?8Q^['ZX?$C^-Y;Y!J_D:?EFF_R^V_
MI#XHZV?\GV,?NQ^N'Q(_C>6^0:OY&GY9IO\ +[;^D/BCK9_R?8Q^['ZX?$C^
M-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q(_C>6^0:OY&GY9IO\OMOZ0^*
M.MG_ "?8Q^['ZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV?\GV,?NQ^N'Q(_C>6^
M0:OY&GY9IO\ +[;^D/BCK9_R?8Q^['ZX?$C^-Y;Y!J_D:?EFF_R^V_I#XHZV
M?\GV,?NS*J];?$U3>Y]:_EHW/'*X_F"H[A[](KQZ5IDN2/MOZ0^+>M=O;6XO
M_P ,?NS-_7[XI_ZURW]WJ7Y"O/R?3.9>V_I#XUZU^O/[&'W8_7[XI_ZURW]W
MJ7Y"GY/IG,O;?TA\:]:_7G]C#[L?K]\4_P#6N6_N]2_(4_)],YE[;^D/C7K7
MZ\_L8?=GQFZY^*&R )LCEY SB!_9^F--?<HA:[FB:5+THQ]M_2-MGKMUNKYD
M[E?_ +,'_P#ZS'_7/XFOQW+_ "!4_(EK_(=']6/MR^D2/C;KGZUW["'W8_7/
MXFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8
M^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US
M^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^
MW+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<
M_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/
MMR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_
MB:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C
M[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/
MXFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8
M^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US
M^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^
MW+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<
M_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/
MMR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_
MB:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C
M[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/
MXFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8
M^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US
M^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^
MW+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<
M_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/
MMR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_
MB:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C
M[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/
MXFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8
M^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US
M^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^
MW+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<
M_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/
MMR^D/C;KGZUW["'W8_7/XFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_
MB:_'<O\ (%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C
M[<OI#XVZY^M=^PA]V/US^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W8_7/
MXFOQW+_(%3\B3\AT?U8^W+Z0^-NN?K7?L(?=C]<_B:_'<O\ (%3\B3\AT?U8
M^W+Z0^-NN?K7?L(?=C]<_B:_'<O\@5/R)/R'1_5C[<OI#XVZY^M=^PA]V/US
M^)K\=R_R!4_(D_(=']6/MR^D/C;KGZUW["'W9]X.N7B@J\W<Y'+Q\^G-_P#:
M_3.NG9VT3YULMZ)I,?14?;?TC1>Z[=;]G'*YV[,%_P#ZS[_K]\4_]:Y;^[U+
M\A6S\GTSF7MOZ1I^->M?KS^QA]V/U^^*?^M<M_=ZE^0I^3Z9S+VW](?&O6OU
MY_8P^['Z_?%/_6N6_N]2_(4_)],YE[;^D/C7K7Z\_L8?=C]?OBG_ *URW]WJ
M7Y"GY/IG,O;?TA\:]:_7G]C#[L?K]\4_]:Y;^[U+\A3\GTSF7MOZ0^->M?KS
M^QA]V/U^^*?^M<M_=ZE^0I^3Z9S+VW](?&O6OUY_8P^['Z_?%/\ UKEO[O4O
MR%/R?3.9>V_I#XUZU^O/[&'W8_7[XI_ZURW]WJ7Y"GY/IG,O;?TA\:]:_7G]
MC#[L?K]\4_\ 6N6_N]2_(4_)],YE[;^D/C7K7Z\_L8?=EB_KF\1'ZI?S_P#G
M')?VI_M=^;^]_,E3O/S?[!WO+W/L?+R][\;EU\FOD4+\LP/Q7!1<'!7TGZ5>
M>O,7OQ7UB_*/?\4_?>_X?[4:\'!7T>"E.+EI7DJ>E:X8^_A $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&-<_!IOK5ZMYC/<1E;2.$ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!L<7^$/_HS]$+&6XV6
M]YOEK-P0! ?&?X'OA8RW&<-YAK VA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 9-?X_
MO?36437<,E9FL( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" (#&N?@TWUJ]6\QGN(RMI'" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @" V.+_"'_P!&?HA8RW&RWO-\M9N" (#XS_ ]
M\+&6XSAO,-8&T( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MA8RW&RWO-\M9N" (#XS_  /?"QEN,X;S#6!M" ( @" ( @" ( @" ( @" (
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MT2QY+=M)EO/A+TMA+X+$%J,2UIF3Q.[)(W!P^:%H::WDV,E)53/LO#T( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M @,FO\?WOIK*)KN&2LS6$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $!C7/P:;ZU>K>8SW$96TCA $ 0! $ 0! $
M0! :K)YK'XEG-;F D(U979ZTCO<;],\%G"VY;C5=OPMKSF5ME-Y9&[S14_\
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M(PZA1FFMY8QDI*J/NO#T( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M?(S:*210@" ( @" ( @" ( @" ( @" (#)K_ !_>^FLHFNX9*S-80! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M\MA]IZN]1--T9*4(<=WUYT;_ ,JW1W\FVF]LZ"5.=F$ 0! $ 0! $ 0! $!
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M<3+IYLMW(RSE#+0_J ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M.R\Z]E2K<DWX%V$?:](T'"TJW[O%MJ"Y7\Y]F3VOND^40MP@" ( @" ( @"
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MP3 >4?QO./?"Z?3]05Y<$_2\/\3E]1TYV7QP]'P?P)BK4J0@" ( @" ( @"
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MX_O?36437<,E9FL( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M:X\ANU9V0Y7ZW\/"?2>HO4&.F)9F8N+(>U)[5;KX9\[Y-RYWV:N9/J00! $
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M<0%;-VL"T[MU[?EL72<%/\7UDS%AX:\RNU\E/6E_*N1<O9I3U7Z1='=L=(L
MS'8B%MO,VV,_/NX9& 3VI&\=/+R1M)/*P'AY=3J5P.HZE=S;G%/=R+D7\>D_
M0?5KJQBZ%CJU959.G%/YTWT]"Y%R=G:6VJ\Z,( @" ( @" ( @" ( @" ( @
M" (#C'Q&>&BMO..[OK859E'>%>-T^3P\+0V/*<G$N9RZ<MC37C\<\#H?673:
M+KCQVK5[;![GZO\ #P'RWKUU!CJ2>9AKAR%M:6Q7*>"?,^7<^=<.[5W/+9><
M-F Z')UR8V.E!:YY9P+'@Z$/&G'S^ZNER\51\^'HOY=P^;Z%K<KS_#Y&R['9
MMV5IO3_F7*6O@\W;P-YERJ>9I]6S7)T;(SR@_2/D57=M*XJ,[+$RI8\^*/;7
M.='XW(U<K2@O4W\\$[=1KVM/E:X>0@\"J:<'!T9VEF]&]!3CN9(,3DY\3=CM
MP\0/5FBUX/8>UI^DM,X*:H2K-UVY51>=6U#=K0VJ[N>&=H<QWTCZ1V%5TDTZ
M,OH24DFMQD+PR" ( @" ( @-CB_PA_\ 1GZ(6,MQLM[S?+6;@@" ^,_P/?"Q
MEN,X;S#6!M" ( @" ( @" ( @" (#\22,AC?+*X,CC:72//8 !J25C*2BJO<
MC*,7)T6]E'[@S,F9NNEU+:L.K*D1\C?*X^EWE7(9N6\B=>1;CL<'$6/;IRO>
M1NS9@IUYK5F00UX&E\LCNP *#.:A%REL2)]NW*Y)1BJMG.VYMQ6-P7C(>:.E
M 2VG6U[!]4X=G,?+\Q<EFY<LB=>1;D=UI^!'%A3YSWOY<A5N8RMFS9CPN'CD
MLW;+VP:0-+Y'2//*(HVMU)<2=.'N*DOWI2E[NWM;V;/ CHL7'C"+NW6E%*NW
M=3G?0=S]"^@=38L$&Y]U00WMX6&!]: @/CQK7#7E9J-#-QT<\=GP6\-2[ZIU
M6ZIQP$K^0D[SW+DA_P#Q<[Y-RYW\<ZY==9ZE)X^,W&PM[W.YV?Y>9<N]\RZ=
M7<'SP( @" ( @" ( @" ( @" ( @" ("G^KG1_!]4<0YLC8\?N:G&1ALZ&^L
MW34B&;3BZ)Q/9VM/%OE!YWK#U=LZK:V^;=7HR\3YX^#>NGJ>K'6F_HM[965I
MOSH?^T>:7AW/G7F]-7S>Q,Y<VKNFI)1GI2<DD;^/)KQ;)&X<'1O'$$<-.(7Q
M>=N]@7G8OJC3^37.F??(7+&IV(Y.-)237=Z'S21.,9D[6+MP7Z,O++&=1Y6O
M:>UK@.T%6-F]*U)3B]I49&/&]!PFMC.C\'FJN=H1W:QY2?5L0$ZNC>.UI^D5
MU^-DQOPXEV^@X+,Q)XUQPEVGSHD=&[/C[4-NL[EEA=J/,1Y6GT$<%-LW96IJ
M4=Z(-ZU&[!QEN9>V,R,&5I0W(#HV0:/9Y6/'PFGW%V./?C>@IHXO)L2L3<)&
M>MYH" ( @" ( @" ( @" (#)K_'][Z:RB:[ADK,UA $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 8US\&F^M7JWF,
M]Q&5M(X0! $ 0$9W1F/S50+(G:7+>K(-.UH^,_WO)Z5MLV^)]!%R[WNX[-[*
M85@4A7&_MR''UOS13DTNW&:V)&GC'$>&GH+OH>\IN)9XGQ/<BFU;-]U'W<?2
M>_H7\3F+=FXFX2H(H' Y&T"(!V\C>PR'Z2O\3&][*KW(^<:]K"P;5(_W);NC
M^9^+G?;.M/"KT"&+KT^J>]J9DS=]O?[6QMD:FM%)Q%R0.U^V2 ZLU^"/6^$?
M5H^L&K\;>/:?FK>UR]'81V/Z<]2_PT5J.9&MZ6V"?S4_G/\ GEW4NEL[L7*'
MUX( @" ( @" ( @" ( @" ( @" ( @" IKK9T=P_6#:TF,L\E+<&.#YMMYK0
MDP3$<8WZ?"CDTT</)\(<0K+2]2G@W>);8O>N=>4YCK7U8L:]B.U/9..V$O5E
MXXO<UV]Z1Y6XB?+;/SU_8VZH'T+V.L.K=U+VQ3 _ U\K7Z@M/I&G KO+\(9%
MM7[6U-5^78Y3X'I.7>TW)EIV7LE%T5>1\W8EOCV>DM&A>LXVY!>J/[N>NX.8
M?(?.#YP1P*JIP4E1G;6;LK4U..]'2F%RU?-XZ#(5^ D&DT6NICD'PFGW/H<5
M2W;;MRHSML;(C?MJ<?\ !DFQ>1FQ=Z&Y#Q,9TD9Y'L/PFGW5IG!25"99NNW)
M21>U:Q%;@ALP.YX9V!\;O056M4=&=!&2DDT?=>'H0! $ 0! $ 0! $ 0! $
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M==XGLBMRYEY3[YU4ZL6-!Q%:AMG+;.7K2\45N2[;VMERJM.G" ( @" ( @"
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MA"AEPG0O/ Y,9;&PV21WS?M=EH\DC>WYO:JZ[#@E0O\ 'N^\@GRFY6LW! $
M0! $!L<7^$/_ *,_1"QEN-EO>;Y:S<$ 0'QG^![X6,MQG#>8:P-H0! $ 0!
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MD>O2YTZ$( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MN>QE5J6/[ZRZ;UM1=BZXX\( @" ( @" ( @" (#)K_'][Z:RB:[ADK,UA $
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MM3O*KJXP?2]LY>"*?]2/1M<6?<@@" ( @" ( @" ( @" ( @" ( @" ( @"
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M3J"H;52Y3HZHO^C:9>IUK;.#;$;7Z>8D<1[QX*KE'A=#HK<^.*?.9:\,@@"
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M2>ZS3RKC>NVE+,PG=BO/M>=_E^<NYYW:.[_3[6G@Z@K4GYEZD7_5\Q]WS?\
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MW=CB>^6WM<GRZ3T#506X0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! 8US\&F^M7JWF,]Q&5M(X0! 8MVRVG4LV
MG?!KQ.DT/EY1J![Z]BJNAC.7#%OF.?GO=(]\CSS/D<7/<?*2=25:(YQNKJ5E
MU+R/<XVIC6.T=>E[R4?]'%H=#[KB#[RG84*R<N8I-;O<-M07*^\OXG)?4*\\
MQ4,1 '/EMO[V2-O%S@#RL: .)U<3\Q=+IT%5S?(?)^MN2^"&/#:Y.M%T;$NV
M_ >NW279473WIWM7:C6-99Q])C\HYH Y[D_VVPX^?[8X@:^0 +Y[J&4\F_.Y
MSO9V.3O'Z(ZNZ5'2]/LXJWPBJ],GMD^W)LL50RZ" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" (#QOZC;8'2[KAN' 11]QA\A:[[%M'P?9+^DL+6Z>2-Y[
MOC]25](Q+WXS!C/YR6WLQ\JVGYEU3#_(^L5RTE2W<=8_TW-J]F?F]HD#'NC>
MV1CBU["',<.T$<00H353JDVG5'4>)O-R>-HWV\/:H6O<!Y'$>L/>.H5%<CPR
M:.[L7?>VXSYT3G9]SV7-0L)TCN-="_W3ZS?G@!1K\:Q+'"GPW*<Y<J@%T$ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0$(WS<[G&P5&G1UR75P\[
M(^)_PBU2,:-95YB#GSI!+G*H4TJ#GC?&1_.&X;8:[6*CI5B_^KUY_P##)5QB
MPX;:Z=IQVJWO>7WS+9Y>^5ETYVP.J/7#;V!EC[_#T+7?Y1I^#[)0UEF:[7R2
M/'=\/J@K7+O?@\&4_G-;.S+R+:<+I>'^>=8K=I[;=MUE_3;VO?ZT_-[9[(KY
MN?IH( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @*ZZM;*BZA=.]U;4<QK
M[.0I/?BW. /)<@^VUW#S?;&@'3R$A3-/RGC7X7.9[>QR]XI>L6E1U33[V*]\
MXNG1);8OM22/(KI[=D$-_$3AS):DG>LC=P+0X\KVZ'B-'#YZ^A:C!54URGYW
MZI9,N">//8XNM'R5WKM/PE[;'R/YOW#4#G:17M:LO\OX'^& J3*AQ6WT;3Z%
MI5[W=]<SV>3OG0ZISL2V-C7.^QDU1QU=3E]4>9DG$?/#E"R8TE7G+? G6%.8
MFRCDX( @" (#8XO\(?\ T9^B%C+<;+>\WRUFX( @/C/\#WPL9;C.&\PU@;0@
M" ( @" ( @" (",;ON>R82PUIT?;<V!ON.XN_P $$*NU2[P6'T["RTJU[R^N
MC;\NV4LN3.M*,ZC9$V<S'1:[6+'1 $:\.\ET<X_,Y0N9U>]Q7>'DBN^SL=!L
M<%ESY9/O+9Y2B]R&>]=QN%IL,UFS(T1P-[7R2N[N-H]))/S5S676<XVX[6_"
M]B.PP.&W"5V6Q);^A;6>L.RMLU]G;3P&V*O*8\-3C@DD;P$DNG--)V#X<A<[
ML\J^_:9@QPL6W8C\U)=E\K[;JS\T:OJ$M0R[F1+Y\F^POFKM*B)0IY7$&ZD8
M*CN#9N<K7GVH12K29"I/2M35)H[%1CI8GME@>QW!P[-=%)P[KMW8M4YMJ3V/
MH96ZMB0R<:<)N2HJUC*4&G':O.BT]_2<]X:W5Z/]',/U?JX#*=0M\[MP^'FS
MN4N6Y[-MXNP1S<KYY._='!&X]C1Q/+KY-+F[%YN7+&<E"$92HDDEL?,J5;.)
MPKL=%T6&IQM3R,BY;MN3<I3G+B2?I2XG&";W)4Z"ZYMT08S8;^J=;I_=ESF1
MQ5.]?V]3K-.7D$HC^TR.# ]_<AVIU'!K3P'8JM6'*][AW%PIM5;\WL]LZR>H
M*U@_CUCS<W",G!1_W=M/-:WMQKNZ#"W_ +L@V)LJ]U0I;"?D]QRU*HGHL@9%
M>:+'(T1VIF,?(&Q$@.''LT](RP\?\1>5AW*1J]O)LYNR:M:U'\NPIYT+#G<H
MO-2\_;14DTFZ1Y=]*%*]3,)B]P;+VSUCQV.S6P]U[IM8*MN"KCKMBE8LT[]J
M.O)6L=R8N<\DAY7EH<1I[@L\&[*W=EC-QG"*FU5)I-)NJK7F.8UW$M96):U*
M$;EB]<E94U&4H2<9SC%PGPN-6E)I-JIUKA,-0V]B,=@\7&^+'8JNRM2BEEDF
M>V.,:-!DE<Y[M!Y25S]RY*Y)REO;KS> ^@XV/#'M1M0KPQ22JVW1=+;;[;*2
MZS[5W1'F]B]6=BXXYO<G3N:RS);:8>67*8BZP,M00N.H[U@'-&-.TGM<&M.*
M-Y@2^)C;,]-L.$V7O+,;OEYHXMD_F2W!;9.-!R3RO9W,;03ZS@YW* 21V:J'
MI&.L=7=-BUT&ZD[BV#8SF*V;8MW>H6RL7_\ $Y*DUVK$(9VQAK>^]CD8YQ(&
M@([=#S(CP_74KKCAMX].M[[?Z?[6W-O'(YC;62@MR1XJU2K4(YZDC)7V)KD4
M0+HVDD,C#R\Z-;VZ@D#Y]3,5E+/AKZ>4*^-M6+U9FS?:*4<+WRQ]W)4:_G8
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M^)'NITVZ>;8Z4['V[T_V=2-';^VJHK4V.(=)(XDOEGF< .:2:1SI'G0:N)T
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MQQ?X0_\ HS]$+&6XV6]YOEK-P0! ?&?X'OA8RW&<-YAK VA $ 0! $ 0! $
M0%9[_LZS8^F#P8QTSQ]<>5O^*5SVM7/.C'HJ=%HEOS93Z:?+NE=D@ DG0#B2
M?(J,O3EC)W'9#(W;KNVU.^0 ^0.<2![PX+B+USWDW+G9]'Q[7NK<8<R2,CH9
MA?[6=:L3+(WO*F"DERDWET%(!L!]'VXQK=U6Q?Q>K0;W0;E[.[_50U=<<O\
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MB2N1DU*$I<:HN&CEZ<>';L<O/K5UE.6XU>R>G%S%1;>N[CW!D\E:V]/<M8C
M2.IBA1GM=_"9(O9JT4LA[B=[1WTK].9VG%;,G,4^)0BDFDF]M72CVU;6]5V)
M$?3]&E:<)WKDYN#<HQ?!P0<N*-8\,(R?FR<?/E+8WR[36Y#;.YH-\[ASE7$9
M.]0R=NC8J24,\['0D5ZL,+Q/6! D]:,]HXC@O8WH.U&+:32>^-=[>YB>'>CE
M3N*,FI.+5)N*V12VQY=J[:)7N:EN.CNK";LP&(;N&*MC+V*RF'%B.M/I9FK3
MPS0OF(8>4P.:YI(X.!'9H=-F4)6Y6Y.FU-/>ME4UWR5F6[\,B%^U'C2C*+C5
M)^<XM--[-G"TT^>JW4>?T_P%[;VWY8,HV*/*9;+97-Y&O"\R1PRY6]/=[EKR
M!S=TV4,+M.)!([5CEWE=G6.Y*,5_E2C7MTJ>Z1A3Q+#C.G%*=R;IR.Y.5SAZ
M>'BX:\M*CIU@LAMO:..P^48QEVM/=?*V-P>W2>Y-,S1P_BO"\R[JN7'*.[9X
M$C;IF//'QU;GO3EWY-^!D+DV5N.OL;IS5J05[.X-@WZ>3DQ$D_=P6S#!/7E@
M[X-< >6P7L)&G.UNO!25DP=VXWZ,TU7E6U.O>H^BI6W-.O+&QU&CG9E&7#6B
ME2,H--T?))RC_,HDO>_<>Y-O;HIYG9M.K'>J34\?@+^0:_VUDL3F2,MR5HYF
MPL?S<NK#(=-20%H7!:G%QF]CK5+=V*M5?<)USWV38NPN68TE%I1E+9*JHU-Q
M4E%/=LXMG)R&EZ=X?=>)NY=F3CR-#;9JU(\/B<OE&Y>U%98Z7VAS+'K/[DL[
ML-$DCG$@G1OEV9=RW-*E'*KJTN%4V4V;J[]R7;-&E8^19G)2XE:I%14I^\DI
M*O%YVU\-.&G%*3>W9'EM502Z" YH\5N&&1Z7')!FLFW\I5M&33B(YN:LX:^0
M%TK?F!<3U]QO>:=Q\L)I]I^;X6CZ!^FN7[K5?=\ER$EVUYW@BSB7;TW?8BJ3
MVQAT9_DD@?.T7R_%E6VCZ]FQX;K.C^F]GOL%+ 3QJ6GM:/XKPUX^>2NOT>=;
M+7,SA->M\-]2YU_ LFG/[-;JV =.XE9)K]:X'Z2N;4^":ES-%!=AQP<>=-'0
MZ[DX,( @" ( @" ( @" R:_Q_>^FLHFNX9*S-80! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&-<_!IOK5ZMYC/<1
ME;2.$ 0%2[YDYLO"SR15F CTESC_  *;C+S>V5&>_P#<78(!?F->A=L Z&""
M20$?Q6D_24J"K)(K;LN&#?,F<?YZ4P87*R-.CFU9>4^8EI ^BNDL*MR*Z4?,
M]3FX8MV2WJ$O =6>!K'B/86\,KH-;N?%0GRZ5JL+Q_IU3]:YUR(1YHU[K?D.
ME_1^TEIMZ?/=:[D8O_V.W%RQ]:" AV6ZA;'P<&>LY;=6-HQ[8?''GVR3L[RJ
M^5C7QL?&"7\SPX<H )<> XJ1;Q+UQQ48M\6[9O*[(U?#QXW)7;L(JW3CJUYK
M:32?2ZJBY:[#EW.]5Y<KG\]E\]BMXX+HAO#;OYBBW+/4EBCJ72^3FNLKL[R1
ML4L;@WO'-&NFG+HI^;H4,O"GBJ<??.M5%[>&2I2NZJYCE\#KM=P-5CJ$[-U8
M24>&4X/A5R$G+B<%6:A*-%QR2HUTU-)A-Y#;]38^(Z21[NWYT_V5DK&3WWN7
M&U)&LLQ3"0"G7BD[GOFL>>=[6:Z::\25#ZO]5X:1AO&NS7&Z\/&U5-NM=E>%
M<U>DL.M?Z@W>L&HV\S"M3G8@ZW96HOA<5%Q48\7"[KXO.EP5HDET'4F!ZO=.
M=PX./<%+=5*"BZU%0FBN2"M8AN3.Y&5Y89>5[9"[L&G'B1P&JRNZ??M3X'!U
MI79M5.=-<A/P^L.!E6??0NQX>)1=7PM3;HH2C*C4J\C52RE"+H(#G_/]<;<N
M[<GL;I?L*YU/W#MYW)NB:*Y#C,;CY/N,EV=KVF7@X%H;V@C74.#?: _N%ZS[
MBK[KPVT>IG2S)=/;6YI16VWEX+D6:QMBP6EP@DLUHV=T\@< 6^<G0<4H#>[X
MZI9C ;CK[,V;TZR^_P#=,U5EZ=D3V8_&UJ[W.8UT^1L-,;7$M.C0T_-X+P$7
M?UNW3MC/[?Q?57I;+L3#;GN1XW%;LJY>#+TFW9AK%#8,<,+H>?0@$CR$_!!(
M]H";]6NI]3I1@L)GKV.&0JY;/4<+.Y]@565F6^<OLO>8Y 1$V,DC0:^<=J\!
M&MM=6-[;SRV/GVST@R#NGUZS&QF^,MDH,;(^JYVAN08V2-\TD9;ZS-2TN&G9
MKP]!*]]=1V;)W)TWV\_$'(_K"R\F)%P3]U[(61AXDY.[?WFI(&G,WSZ^1> D
M&^=ZX'IWM7+[PW)-)#B,/&U\XA;WDTCY'MCCBB9J.9[WN#1J0./$@:E 4NSJ
MKURFI,S]?P[S.P4D/?18^3<%6/+&,^L)#5,/JGE_S7P]?F+T$WGZN4CTCR_5
M>EM_(LBQ./M6Y=M91CL?;;-4<YDD$O,V3D/.TCF </+Z%X"O</UUZ@;]Q-;,
M=+>C%K<&*EAB,V<RV5@Q54V.4&>&JV:/O+#8W<T?> -;S#L\B]H!3\3F+AAS
M6&W1L?-8#J=B+<%"#IE#RWKE^:TUSX74IF-8R6,AI<Z30!K=#QU;JH#\9CK;
MU:VC3GW+O3H%9QFRZW=R9#(8_.U,A=I0'X<TM6.,%P ()T+0SCS.\J4!?$N]
M, S9CM^U[$N1VY^:_P [P6*43YY9JQC[UO=Q-',7$?%TX'MTXKP%/T^J_6+-
M4WYC;_AZMR864=YC3F-P5,7D+$1['&D^"4QDCCRO>%Z"PNE_4O&]3L'<R5;'
MVL%E\+?FQ6YMM7P!:Q]ZOIWD4FFFHX\':#7S @@>,%DH""]4,6W-=-]_8HC4
MWMOY**(]NDAK2=V[35NNCM#IJI6#<]WD6Y<TEX2JUW%_%:?D6?6MS7=BSQ_Z
M<2@T<E!KQCG:_3Z]NG^2OHFI+SD^@_.?4ZXG8N1YI5[J_@7SL*;NMST6ZZ"=
MDT9_]VYP^>%29:K;9]"TF5,B/37P'0BISL"X]F2<^"B;K_,RR,'OGF_RE R%
MYY=83K:1*UI)80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0'.TTG>
MS2RGMD>YY]\ZJU2HCFY.K;*RZFS%N'HP@Z=[;#C[C&._]I3<%>>WT%)KDJ6H
MKG?B9R5U(ETHXV#4?;)WOT\OJ-T_RETVFKSF^@^3]<;E+%N//*O<7\3V Z88
ML83IOL+$@:.H;?QT4I\\@K1]X[M=VNU/:OG>=<]YD7)<\GX3]&:%B_A=/Q[/
MJ6X+N12?.3I12U,:Y<JXZG;R%Z=E6E1ADL7+4AY61Q1-+WO<?(&M!)7L8N32
M6]F%RY&W%RDZ)*K?,EO*TW3UCV3MJ'%B"Y+NK+9^,2[?V]MYGYPNW6.!Y7QL
MB.@82-.=Q#?2IMC3KUUO9PJ.]R\U+^/1O*74.L>)B*%&[DYJL(6UQSFN=)?-
M_F;4>DY2FW%@LIM[:.V^O6<W1L7>6QK\]VG/;K3SR9BO-*)('MDA9,UTS6\K
M.!U:0[E&A]6)UFZFQUNY;N6)^9!U\QI4>RJ:=*;O-ER)F/4G]3I=6<:YCZE!
MQO3BXUNQ<G.-7P.,H<492:DE."=7);%1%E[;ZVW,'N;=.X>I&#W1M?8N\;E1
MVQ<KD:;W8ZE6AB$ $_(Y[JS[+_MFCFZ<===.*O;VEJY;C"Q*$KD4^))^<W6N
MSUN%;-AS>'UJGC9%V[GV[MK'NR7NI2C_ +<8I1CY]*NVYRK+STM^UG2]#=6V
MLID!B<9GJ&0R3J3,D*-:Q'++['(X-9/RL)/(XD 'RJDE8N1CQ.+2K2M.7F.Y
MMYMB[<]W"<7+A4J)IOA>Z5.9\C-^M1*-5G,YB=M8C(Y[.WXL7A\3 ZQD+\YT
M9'&P<2=-22>P #4G@ 24!S[C.MG4O=U9V:Z?]!,AG-JS<<3FLOFZ>%EN1Z:B
M6*K-'*>1WQ7%VA'OZ>T!8W3/J?7ZB1YNG8VYE-G[HVM-#!N7;.5BY9*[K#7.
MB?'*!RRQO#'<KAH>&N@!:3X"#4^L?4+=,EFYT]Z(9'-[:A>^.KG\]E(-OFTZ
M/@705IX9I7,)!T<X#TZ'4#V@)3TVZM?VVR^X-H[@VO;V)O[:X9+E]K6YF6FF
MM+H&6:UJ-K631DD#F ':/.@(_O3K_B]E;ZR>Q+6V[V7RD>,I6MNU<:_O[F4N
MWI)&-J15N0!@8V,O=(7Z :\-=-5 3W8&Y-^[CCR<N]^G Z>M@[@XB,Y>OE)+
M0D[SO.=M>-@A,?*S@2=>;^*O 8VS>HXW=O/J9M$8<X_]75VC3.0-CO?;/;(7
M2\W=]VSN^3ETTYG:]O#L0&JZB]63L[.X'9>W-JW-][^W+#);QNVZL\=2..K$
M2UUBU:E#FPLU! /*=2#V<-?01)O6+J/MJ_C(>IG1>]A,+E;4=1FY\!D(LW#7
MEG>&QBS7AC9)&T%P!?QU/P0>Q* D?5;K7B^DV>V'B<OA;>3J[V_.C6V:),EB
M*7'PQ/AAAJAA,[[,LS(FCG8 3J3HE 0_(=7^M>,IR[DM>'BTW:M>$S68F9VK
M)EF0AP)F-)D3CJ&<3$-7#RN&B4!F,\0T6[F48.C.R<AU/R-BG%<RGV^/%T<8
M)@2V"Y<L!S&S\#]K:#KIP<E 9.V.MN>9O+$=/^JO3V?ISN#<43G;9R#+T61Q
MN0EC&KX63Q-:(Y-.QA)\@)!<WF4!/.HO4678S<+2QFT<QO;<FY998<'@\5&.
M5Q@##*^S9?\ :X(VAX]9WS- XCP%:9KK7U(V53ASW4+H?/@MH1OC;FL[B\]6
MS$M!LC@T22U8J\3BQNOK.:[0>ZO: Z,I7:N2I5,C1G;9I7X8[%.RSX,D4K0]
MCV^AS2"%X#*0'$7CEQXDV'L[*Z<:6?-0.]%FK*__ /<+J>JDZ9$X\\:]QKRG
MR3]8;2>FV9\UU+NQD_\ U.5,#*9\+BI''5SJL0<?.0T _05Q?5+DETLYO3)N
M>+:D][A'P'0G3*;FP]V$G4Q6RX>X]C/I@JFSEYZ?0=MH<JVFN9^)%F02=U-#
M*.!C>UX/N'50FJHNXNC3.B55'2! $ 0! ;'%_A#_ .C/T0L9;C9;WF^6LW!
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M^GQ%TKHCDB^\&XNPV+)\E6(?,:!])=IANMF'81Q6:J7Y]EFU4DBA $ 0! $
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M>SQL].KUX @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M-2!J5[7:"Q<;UZS_ .;:]2_T$ZB5MS11B*?&5<0'8X3M]72*^^1D?=:]CB.
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M0@" (#8XO\(?_1GZ(6,MQLM[S?+6;@@" ^,_P/?"QEN,X;S#6!M" ( @" (
M@" ( @.>+GX9:_IG_P",5PUWTWV6=W:]!=A%9]3/^X:G_;X_]%*J76?[*_J\
M3.AZO_WY?TOPHYNW-_W1/]='_C!<AF?VV=Y@?WEVSOWPT3B;HWM>/EY?99<A
M$3K\+6[/)K_AZ+ZYU)GQ:5;7,Y+_ %-^,^)?J!#AUJ\^=0?^B*\1?*ZLXP(
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M_#SL/(1;BW/D=R17\XR@]L\=#EBDKQ]^]G,&N;'/+(\:^HQO,[0$(@S<^+H
M>(SP> #0#==4 #_Q?&(@=W;YW)9V?L[<VZZF%GW%/MS'6,B,)6>&366UF&1\
M<9+7>L6M.@T)/8!JO#TXWVOMOPK>+/:8WQE-HX? ;KNR2MW#4J7O8LI3M->Y
MH?.Z UQ/SMT<U\D;FD'ZIIT]W'A5OADHLZ=^*;?72GI?O*]O+I'3PS[F2[Z9
MEFM6MAM<APEAY83*R5YB+V-&H):X$LU!@]1%X>A $ 0! $ 0! $ 0! $ 0!
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MG2VSZ%I<:Y,>WX&=%JF.R+>V0SEPI=I_.6)'?.:WZ2@Y'I%S@JEOMDP6@F!
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MN'H(.JTM-.CWDN$E-*2VIGW7AD<6>.'(]STXVOC&O+77]Q,F< 2.9E>K8!!
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M7WI8N>6Q9<S7E,]F9SY9.7F/*'.(;J>71> L- $ 0! $ 0! $ 0! $ 0! $
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M*^[G:X8T;;J[G%6E*1VT;2);OW&7\E-L-U&K):;C=UTKMXL&O=5XX;#72.]
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M'SH@=!KP! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MN[BS]?;>XL3=V=DL@0,6W)P25&S:D :.LB/7R]FO8L;>="<N%IQ?\RI4SRM
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M.;F;XD>E&Q;<\?4V$;NX]2-J5\P8Q<;TO=CJG=\O+S>RNM^REPD\FG?<NO\
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MW/ 77Z2ZTY6KNG7'YT&Y17\K?G+M2V_YCOM<B?90@" ( @" ( @" ( @" (
M@" ( @" ( @" ( @*AZY]0F=-.FNX=PQR!F6FB]@V^S71SKMD%D;AQ&O=C60
M^AI5CI6'^+R(V^3>^PO+N[9S?6W6UH^FW<A>G3AA_7+9'N>D^A,\I^G^->RK
M:R\^KIKSBR)[N)+&G5SM3]4[Z"[S4+M9*"W(^"=4\-QM2R)^E-[.PM[[;\!;
MVW<8<OF:-'EUB?('6/1$SUG_ #0-%4WI\$&SN,*Q[Z[&/)R]@Z;  &@X =@5
M&=P6)L.EJ^[D7#@T""$^DZ.?])1<F6Y%EI]O?+M%E*(680! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! :3<5'V_#W(6C61C.]A^NC];0>Z!HMEJ7
M#),T9-OCMM%&*Q*$J#J9BRV6CEXV^K(/9K)'U3=7,/OC4>\K'!GL<3G-<L;8
MW%V'XCF7J!C7OJU<O!JV:BX,E>W@0QQU:[4?4N^BNAT^[23@]S/F76S#<K4<
MB'I0>WL/<^T_">K70[J$SJ7TVV_N&29LF6BB%'<# >+;M8!LA(\G>#20>ARX
M+5,/\)D2AR;UV'N\A]\ZIZVM8TVUD5\ZE)]$X[)=W>NAHMQ5YT80! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0' GC9Z@]W3V_TPQLO-9R#V9;.L9H3W3"Y
ME6$_7/#GD?Q6GRKK^JV'64LB6Y;%V>5]SPGQK]6M:X;5K3K;\Z;4I+^5.D5V
MY;?\ISE@\:W$XJG1&G/$S68CRR.]9Q^:597[OO)N12Z;AK$QX6ER+;V7M??+
MLZ9XSFDO9>1O",>S5B?.='//O#0>^JK.GNB==H=C;*X^PO&6^JXZ(O3;U'\W
MXBG YO+(YG>S>?FD]8@^YKHJZ[+BDV7^/;X+:1NEK-P0! $ 0&QQ?X0_^C/T
M0L9;C9;WF^6LW! $!\9_@>^%C+<9PWF&L#:$ 0! $ 0! $ 0! 861J-OT+=-
MW_6(G-:3Y':>J?>.A6F_:][;E'G1NQ[ONKD9\S.?GL=&]S'@M>PEKFGM!' A
M<2U1T9W"::JBLNI6,[^A5RD;=7TG]U.1]SD["?<=H/?5+K%GB@IKD\#.AT#(
MX;CMOYVU=E?P\!0&:I>WXZ>)HUE8.\A^N;Y/?&H7+9%OC@URG:XEWW=Q/DW,
MZN\)>^OSGMW);%N2ZW-NO=<Q33VNI6'_ &QH_HY7:_RQYE] _3_5/>V)8LGM
MAMC_ $M[>Y+_ ,CYI^INC^YR89D%YMSS9?UQ6SNQ_P#%G7R^B'RX( @.$_"/
ML3;]S]8^[KV-K7[YW;E<?&^S$R7D:UM675G.#H=7GL\ZI])MKAE*FWB?B.WZ
MYY]R[/'MU\V-F"IV'+;V2 ;BV/@<AXO*..?CJ[,2V*&[-C&Q,%>1S;5:/1T6
MG(1RDC0A)V(2S*-?-KVZF^QJ%RWU<DEZ7OTD^51]W)T3WI5V]DMGQ;X#"8G8
M^!R>+Q-/'WL;F<>*=JM!'%)&!,':-<QH(XM'85NU&*4(OFDBGZLWI^_N1JZ2
MMS3Z:JA7'4M\^^=S]#-D9BR^/"NPU.].7./)-(:%:<B0:^MJYGE\ZTY4??7+
M4);G6O:29-TF?X3'R[]OTXN*3YE*3B^\=ULV%LN/&LQ']EL2Z@QH8*[J5<M(
M;IIJ.[T\@\BM?=QIPT5.8Y+\1<XN/B?%SU=>Z>?'33*Y#IYF?$#M+;]J5V(V
MQALED,2"XNY)H'T8F:'7S./8J?$D[+NQCN3=#L]82S88MVYLE))2?K5<GQ/P
M%T^$G8&V9>G\6\\A1K9C/;DEL.NVKD3)WQ^SW;4+6L,@<6@M8W70\= M^EV8
MJTI[Y.NWML@=;,ZY<RW:7FVX*-(K<JQBWLW;75]LB_C$Z>;7KX3;>Z\?CZN*
MR=#(Q,<*L,</?B6U4;Z_=AO-R@'MU[3YUKU:Q!P4Z;4UWR=U)U.]9R9VM\)6
MY['M^9+=S;RE.MF5W!F,GT@V;CZ+\K6&)IVXL5WK(6S/?#,7-+I2UG^;!XK7
MJ#E*<()5Z.<E=5[=BWCY5ZY/@DHJDJ-\+XES;=S:+3.Y^L[JGL#NAF$=C^SV
M(MP?=:?T>O+\Y2?>7Z4]SL[,2F6)@*7%^,\[GX+E>Z0WIYM+?VT.GG72/<^(
M_-& R.V\C+1J>UUK(CF;1LD-#:\LG)JY[C\$*+8LW+5J[Q*BX=BJGR.NXM]0
MS<3*R\+W,^.XIKCE1KB\^/#Z26Z.S>SHGPA[6P,/23%9C\U5),E?LVN_N/AC
M=*>[GDY?7+>;ASGRJ9I=M1LJG*4G6O+N7\Z?$VZ42[2IXBG.ENT\)N7Q5]4+
MN9H0Y%N&NY1]:K8C9+"7NN7(R71O!:>$FHX=H!\BCV;:EF2;6Y>,M,[/N6]"
MLV(NB<VW3IC'9WB5^,_%X["X/8>?Q-&OCLI%FS$RY6B9%(&-KS. YV '34Z]
MJSU14X)<J9#ZK3<O?VWZ,H;5VT1KJ5&[??7WICM'.6"W 8RKB;/L4A+HK3BZ
MG*YKF?!)=WSF^L#\Q89$?>Y,(2W4K3IJ2=-G^$TO(OV_3<^"O*HRC*M.XCN#
M(; V;?PEG!3[;Q@H3UGUN7V2 <@<SEYV^IP<.T$>7BK9VXM<+6PX^%^Y"?&I
M/BYZG$'A<VUB,3UEZY[8BK1VL3C;5ZM!7G:)&F.#*.:P$.!!T#0JC3X*-^XE
MNJ_"=KUISKF7AXLY[U""[-([^R^<]#8HHH(HX((VPPPM#(86 -:QK1H&M X
M <  KHX0^B ("D^OV^F['Z=9:2O,(\QGVG%X=H/K!TX(EE'E'=Q\Q!^JY?.N
M8ZVZHL' E1^?/S8]O>^TJ]NAUW4G1WJ6I04EYEOSY=K<NW*G:J>=>U:7<4WV
MWC1]L^I]8W@/FG5?&\*W2/%SGW?4;O%/A7)X2[.G.,-O+R9![=8<;'JTD<.]
MD!:WY@U/S%T>D6>.[QO='PLY+7<C@LJ"WR?>7R1>2Z8XXN;9U$T\-%(X:277
M&=WUIX,^<-??75Z59]W93>^6WR')ZK>]Y?:6Z.SRDJ5D5@0! $ 0! $ 0! $
M!DU_C^]]-91-=PR5F:P@" ( @" ( @" ( @" X"WAX*9\WO;(9?"[PKXW;68
MNR7+-2Q ^6U6[Y_/)'%H0V0 D\I<YI T!U[3V&-UI5NRHS@W)*F_8_(?%-4_
M2263G2NV;ZC:G)R::;E&KJTN2715KIKO.YMOX2CMG!8;;N,:YF.P5&O0HM>=
M7=U7C;&SF/E)#>)\I7)WKLKLY3EODVWVS[#@X=O#Q[=BWZ,(J*[$51&W6LE!
M $ 0'F5XP*E3(>)[PL4+]:*[1NY?&07*<[&R13129JNU\<C' M<US2001H0O
M4>'>GZI>E?\ ]S/:GR-1^\KRIZ>>?C?VEM7:V^/#3_9G;.)V[[=G<A[;^;*4
M%3ONZLXCN^\[EC.;EYW::]FI\ZR1XS:>.:CF;76+PUBKGF[7ALY"2##;EDA$
M\>/R'MU(^TOC?HQPC)B<03IH#KP7B#+B_4AXK_\ ^;#_ /QRK_[2'I^?"YTG
MAZ?[ZZM9L]:L'U1SVY+ &]<=BXX(K-3)QVK#I)+<44\IB<Z1\HY2UO'7S(SP
MK[]W@Q@PW6>0- >[=4;7/TXD-CD(!/HU*,(_77S_ )W/#7_V&+_:KB+<#H'Q
MA_\ +9U3_P"PU/\ ;ZR(]9Q/XC8<A)X&?#S+7U=0KRX)V1:T$D<V*MMB<X@<
M&AQ(.I[2U>K>>'0F$Z,^)VYA<1<POBR8_#VZ5>;$OCVY4+#6DC:Z$M]8\"PC
M1>'IK^E717*[:\1\N]-X^(;![]ZBUL9+5W#M)E:O3RTU62I&V%[Z\<Y<UC&F
M)W-W7$ <4J>'?:\/3SG\;W_%3PC?[UV_]NPB]1X;OKPUO23Q1=$.M,7^KX/>
MQ?LW>TO$1CGTBAFE/H9,U_#[AV><@;CI.W]:_BOZP]4IA[3M_I76CV+LR5QY
MXQ:!<+TD+NS5KFR\1\68=O:@(9X1/^8SQA?[UVO_ #?)HP?;$=;_ !$>(S=&
M[JGA]=MS9'3_ &G;%+^V.<C-BQ;>XGE<QICL-U>UI>U@BT:TCF?J0E <Z^,C
MI]U>VKL;:N9ZL=:G=1+F2SKH*.VX*,5"G6(K2O?98V(L#W#@S^:;RAW;Q7J!
MT)^\F_X5[$_WK'^PV5X@Q^\F_P"%>Q/]ZQ_L-E$&?;Q3NBQ_B=\*&7S+2S #
M+-ABL2.Y8&6A>KZ.)(+6EKI(G$^8<2--00/1%SFL:YSG!K6@ESB=  .TDKP]
M//CP#6L=>K]=[N(T&)N;U?/C WB/9Y!(Z+3@.'(1Y O6>(UO[O!C!ANL\@:
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M $ 0&QQ?X0_^C/T0L9;C9;WF^6LW! $!\9_@>^%C+<9PWF&L#:$ 0! $ 0!
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M#DY6O BYR,K!UF*N7I>[OK8VZ*$J;([?.ELBH\BY2)=2]K^(WK;'C\UF=J#
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M<7:UGNGM/S/(JC*O<<J+<CK=+P_<0XI>D^\N;RD\8Q\CV1QM+WR.#6,':2>
M 45["U2JZ(O+!8MN(QT-;0&=WKVGCRO/;[P[ JVY/CE4O\>U[N"7+RFY6!N"
M ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" _+FM>US'M#F/!#
MFGB"#V@H-Y1N>Q3L1D):^A-=_P!LJO/E8?)[H["K&U/CC4H<BS[J=.3D(ODL
M?7RM&Q0M-YH;#.4GRM/:'#T@\0M\)N#31#O68W8.$MS.:,KC+&)O6,?;;]LA
M=H':<'M/P7#T$*[MS4XU1Q&18E9FX2Y"KZ>4SO23>>+WSM1_=LKS$FN=>Z>Q
M_"6M*T=L<C>SS>3BT%6O##.LNS<W_*C72<)==_JYGPSL7T*[5R;?2@_Y7R<S
MZ4CUUZ;=1,!U/VK0W3M^7[58;R7\>\@S5++1]L@E'#BT]ATT<-'#@5\\S<.Y
MB77;GO7?7.?H_0];Q]8Q(Y-A[);URQERQ?2N_O6QD]40MP@" ( @" ( @" (
M @" ( @" ( @" (#D[Q.=>8NG&$EVGMFXQV^<Y#RF2,AQQM60:.G=H>$CAPC
M!^O\@#N@T+2'ES]Y-?[:_P!3YNQS]P^<_J!UR6C8_N+$E^(FMG\D?6?3ZO3M
MVI4? 6S=O24HW9?(!SLC=!<P2<71L=Q)=KQYG=I__"NKS<A3?!'T4?+.KNDR
ML1>1>_N3Y]Z3Y_YGR_XEFXG&6<Q?KX^J/MD[O6?IJ&-'PGN] "K;DU"-6==C
MV)7YJ$>4Z7QU"OBZ5>A5;RPUF<K?.3VEQ])/$JDG-S=6=O9M1M04([D2C 8I
MV7R$5<@BO']LM/'D8/)[I[%HNSX(U)F/9][.G)REXM:UC6M: UK0 UHX  =@
M5<7Q^D 0! $ 0! ;'%_A#_Z,_1"QEN-EO>;Y:S<$ 0'QG^![X6,MQG#>8:P-
MH0! $ 0! $ 0! $ 0! 4QNO#_FS(NEB9I3NDR0Z=C7?&9[Q.H]"Y/4L7W-RJ
M]%[O&CKM,RO?6Z/TH['XF1&Q!#:@FK6&"2"=ACEC/86N&A"K)Q4TT]S+2$W"
M2E'8T<V;APDV!R4U.35T)]>I.?CQGL]\=A]*X_+QG8N.+W<G8.^P<N.3:4UO
MY5S,K7/XV:.6/,XYSX;=5S9'OB):\%AU;(TCB"TCR*GRK33]Y#8U\JE]A7XM
M.U/;%[-O3R=L]!.@_6.MU(P@Q>6F9#O+#1-&0A)#?:XAP%F(?.>!V.]#@OKW
M53K''4[/N[CI>BMO\R]9?^W,^R?$.N?566D7_>6E6Q-[/Y7ZK_\ 7G72F= +
MKCB @" ( @" ( @" ( @" ( @" ( @" ("NNIW4?#],MM3YS).;/<EYH<+B@
M[22U8TU#1Y0UO:]WD'I(!IM<UFUI>.[L]LGLC'UGY%ROD[-"]ZO:#>UC*5FW
MLBMLI<D8^5\BY>Q5GF&;66WON'(;NW'.;=F].9IGN'JO?V-8QO'1D8  'D
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M6'3EA[,PA>_\[V6>HS44F'RGL+_>[ HN1<^:BRP;'SWVBRU$+,( @" ( @"
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MSSZ.9;Y/8ME6O-C"XW*[ERUK>6[;,V1R.1F-HRV3S/FD=Q[U^O8!\4 :>;@
MNSR+T+,%9M*B6S9X/*?%M(TV]FWGGYK<IR?$J\K]9]'JK<N390L>.-\KV11,
M=))(X-CC:-2XG@  %6-T.S2;=%O.@]G[9;@*1EG:'9.V ;+^!Y&]HC:?1Y?.
M?>51D7_>/9N1V&G8*QX5?I/?Y"9L8^1[(XVE\DA#6, U))X  *,]A8I5=$7;
MM[#MP]!L3M#:FT?;>/JO(T>AJKKMSC?07V-9]U&G+RF^6LWA $ 0! $ 0&QQ
M?X0_^C/T0L9;C9;WF^6LW! $!\9_@>^%C+<9PWF&L#:$ 0! $ 0! $ 0! $
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M_P#:/1X.7D;^#]:NJE[1;U565F7HR_\ 67-+O2WKE2NA=,<D$ 0! $ 0! $
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MUA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! 8US\&F^M7JWF,]Q&5M(X0! $ 0! :?-XB',TG5WZ,F9ZU:;ZE_\
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MQ'Q&^CSGZ:AY&0K:HMY=:=I[R'Q2]!=_H+\BBCACCAA8V.*)H9'&T:!K0-
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M1K<_(^@^_=6^M>%KMKBL2I->E!^E'RK^9;.WL+A5:=,$ 0! $ 0! $ 0! $
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M%_A#_P"C/T0L9;C9;WF^6LW! $!\9_@>^%C+<9PWF&L#:$ 0! $ 0! $ 0!
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M<3OCN'QSZ!Y/2KK2\'C?O)K8MW3TE)JN=P+W4'M>_HZ"T5T9S80! $ 0! $
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MJ$:(S%B9A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M8QY77LW<Y<N/Q]7&5F5:D89&WBYWQG.\KG'RDJ!*3DZLN[=N-M41G+$S" (
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M 0! $!L<7^$/_HS]$+&6XV6]YOEK-P0! ?&?X'OA8RW&<-YAK VA $ 0! $
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M^Z\/0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M" ( @" ( @" ( @" (#)K_'][Z:RB:[ADK,UA $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MU[62M:26$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M=%BZM"YLGYK[W\"&.:YKBUP+7-.CFG@0?2JIJA;IU/F^-DK'1R,;)&\:.8X
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M$ 0! $ 0! $ 0! $ 0! $ 0! $!DU_C^]]-91-=PR5F:P@" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M2H?M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MQQ?X0_\ HS]$+&6XV6]YOEK-P0! ?&?X'OA8RW&<-YAK VA $ 0! $ 0! $
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MF,VKB<;RO[GVNPWCW\^CM#_%;V!7./IMJUMI5\[*3(U*]>V5HN9$D5@5X0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $!DU_C^]]-91-=PR5F:P@" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M7/87,: X^Z[M*U2FY;V286XPW*AFK$S" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @/E+##.PQS
MQ,FC/:Q[0X?,*)T/&D]Y'K6TL':)(K&L\]KH'%O^"=6_.6V-^:(\\.W+DIV#
M0S[!C.IJY%S1Y&2QAW^$TCZ"VK)YT1Y:>N1FJEV+EF:]W/6E'D]9S3\PMT^>
MLUDQ-+P)K<T83MG9YNNE5C]/J96<?FD++W\#!X5WF/G_ &2W#_5__P"-B_\
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MRF7YIC>MWGY#Z-V=GW::U&,U^JE9P^8XK):7D/YO?1X]5QU\[O,S(MBYA_\
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M;S&>XC*VD<( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#8XO
M\(?_ $9^B%C+<;+>\WRUFX( @/C/\#WPL9;C.&\PU@;0@" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @,FO\?WOIK*)KN&2LS6$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!C7/P:;ZU>K>8SW$96TCA $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! ;'%_A#_ .C/T0L9;C9;
MWF^6LW! $!\9_@>^%C+<9PWF&L#:$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MQEN,X;S#6!M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" R:_P ?WOIK*)KN&2LS6$ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $!C7/P:;ZU>K>8SW$96TCA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! ;'%_A#_P"C/T0L9;C9;WF^6LW! $!\9_@>^%C+<9PWF&L#:$ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $!DU_C^]]-91-=PR5F:P@" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @,:Y^#3?6KU;S
M&>XC*VD<( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (#8XO\
M"'_T9^B%C+<;+>\WRUFX( @/C/\  ]\+&6XSAO,-8&T( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @,FO\?WOIK*)KN&2LS6$ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$!C7/P:;ZU>K>8SW$96TCA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! ;'%_A#_Z,_1"QEN-EO>;Y:S<$ 0'QG^![X6,MQG#>8:P-H0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0&37^/[WTUE$UW#)69K" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" QKGX--]:O5O,9[B
M,K:1P@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @-CB_PA_\
M1GZ(6,MQLM[S?+6;@@" ^,_P/?"QEN,X;S#6!M" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M#)K_ !_>^FLHFNX9*S-80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MV2-:^-P>QXU:]IU!!\H(48L4ZGZ0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M&FG1GJ::JC+7AZ$ 0! $ 0! $!J<WG\%MK'R9;<>:H8#%PD";)9*S%5KL)[
MZ69S6C73RE91A*3I%59C*<8JLG1%=T>OO0K*6X:&-ZU;#R-ZRX,KTZVX\9-+
M(X]@8QE@N)]P+<\2\E5PEW&:5EV6Z*<>ZBV&N:]K7L<'L> 6N!U!![""HY(/
MT@" ( @" ( @" (#4Y;/X+ 1PS9W-4,+%8<602W[,59KW :D-,KF@D#S+*,)
M2W*IC*<8[W0RZ-^CE*D-_&78,C1L FO=JR-FBD ):2U["6G0@C@5XTTZ,]33
M549:\/0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MV-Q5B;!8FP( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M.$H.DDT^D0G&:K%IKH-RL3(( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MN1]%=RO2=(0PPUXHX*\3(((6AD4,;0UC6C@ UHT  5*W7:SN4DE1;CZ+P]"
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MK":$\DS-!8KD^LQWTP?(57W+;@R[L7XW8U1N%@;@@" ( @" ( @" ( @" (
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M 0! $ 0! $!L<7^$/_HS]$+&6XV6]YOEK-P0! ?&?X'OA8RW&<-YAK VA $
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M9PW/:O&OER%\?O!NJ6W>L_1CPU]1MLR#V#<,V:DL4B\.DIVV14FV:DNGQX9
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M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!C7/P:;ZU>K>8SW$96TCA $ 0!
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MYC+\9F\?)6O:6[Q'^@Q<@=<$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! 8US\&F^M7JWF,]Q&5M(X0! $ 0! 1K<F=;AZG+$0Z]8!%=O
M;RCRO(]'D]*VV;?&^@C961[J.S>RF7O?(]TDCB][R7/>3J23Q))5@4;==K(E
MNK<T.WJ@Y.67(6 ?9*Y[!Y"]VGD'SU(L6'<?00,_.6-#GD]R\9S=F\VV%MK+
M9:T7.<>:21W%SW'L:T?. 'T%=6;+DU&*.'SLZ-F,KUZ7RYEXD:+IYTYWCU^W
M,:= '%[8Q;VNRN6D!,%6-QX-'W2=XUY6_-T;Q4W+S+.EVZO;-[ES^1'+:3I.
M;UORJ+S,>#VOD78]:XUVET+?ZL=/.FVT^F&!AP.UL<VM'H'7\@\!UFW*!QEG
MD[7$^0=C>QH 7 9F;=RY\=QU\"[!^B-%T+$T?'5C&APKE?SI/GD^5]Y;E1;"
M>J(6X0! $ 0! $ 0! $ 0! $ 0! 8>0Q]'*TK6-R=2&_C[L;H;=.=@DCD8X:
M%KFNU!!64)N#3BZ-&N[:A=@X32<6J-/:FCS/Z]>&O*=/+-C?W31DUG;,1=/D
M\2P\\^,;\9S=23+!VZ\-6#MU;ZP[C2=<AE+W.1Z7(_6\C\)\%ZX=0[^E7'GZ
M97W:JY06^'.UZT.=;X]*]&H-M;FKYZ$QN @R$+09Z_D<.SG9Z-?F*9DXKLOH
M(.C:U;U"--UQ;UXUT>#N%F;;W'9V]<$K.:6G,0+E77@X?5#S.'D^8JZ_95Q=
M)U&%FRQIUWQ>]?+E.B:5RMD*L-RI*)J]AO-&\?/!\Q!X$*GE%Q=&=C;N1N14
MHNJ9OL/E9\1<99B)<P^K8AUX/9Y1[OF*U7(*:H2;%YVI51>-6U!=KQ6J[^\A
MF;S,=](^D=A5=)-.C+Z$U)56XR%X9! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! 5;N_/\ M,CL54?_ *O"[2W(/CO'Q1Z&_1]Q3+%J
MGG,JLW(XGP1W<I U)*\I_>^\#(Z7"XJ;2)NK,A:8?A'RQM/F\Y\O9[MCBX_S
MI=HYW5-1K6U;?9?B\I0.Y=SU\%"(V 3Y"9I,-?R-'U;_ $:_-5UC8KO/H.$U
MG6K>GQION/<O&^CPEO\ 07PU93J%9K[^ZELGK;9E+9\9B7GDGR8[6N=H08H.
MS3AJ\=FC='&'JVN0QE[G']+E?J^5^ G=3^H=[5;BS]3K[M[8P>^?,WZL.9;Y
M=$?2],,?CZ.*I5<;C*D-#'THVPU*<#!''&QHT#6M;H  N'G-S;<G5L^]6K4+
M4%""2BE1);$D9BQ-@0! $ 0! $ 0! $ 0! $ 0! 0'J)TUVIU/P,V!W3CVV(
M]"ZAD& -LU)?))!)IJT^<=CAP<"%+P\V[B7..VZ>!]DJ-;T+$UC'=C)C5<C^
M=%\\7R/P[G5'E/U#Z=;QZ [E%2^TY/;.4>YV*RK 1!:C:>P]HCF:W3F;]%J[
M_$R[.J6ZK9-;US>5'YWU;2<WJCE4EY^/-['R/L^K-+N]/)ML?D*N4JQW*<@D
MAD'OM/E:X>0A1+EN5N7#+>=-BY5O*MJY;=4_E1])<FQ]WF,Q87*S:QNT9C[3
MS\$^2-Q/D^I/O>Y696/\Z/;.HTO4:4M7'V'XO(6^JXZ(GNT,_P"SR-Q5Q_\
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M@15*,)<(8(]6C4,9HT:\3Y505E<GM>UOPE_2-N&Q;$O >*^>Z5^#'Q7=3_\
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M! $ 0! 8US\&F^M7JWF,]Q&5M(X0! $ 0&+<MPT:TUNP[EA@;S./E/F ])/
M+V,7)T1C.:@FWN1162R$^3N37)SZTA]1GD8T=C1[BLH1451%!=N.Y)R9&\UE
MZV$Q\U^R=1&-(H@=#(\_!:/=^AQ6ZU;=R5$0\G(C8@YR_P 3F;.9I]F6YF,I
M.&C0OE>?@L:.QK1YAV *\LVJ4C%'#9N8O.O771+:^A$3Z=]/]R=?=YMQM(OQ
MNVL61)E\H6\S*D#B=.'8Z:7E(:W7_!!*GY>7;TNS5[9O<N=^1''Z3I>5UOSN
M%5ACP])^JO'.7)R+L+;ZW[.V=M[86WJ&V-L4&X_%8]NC6CC)+(?ARRO[7O>>
M))^AH%\\R<FYD7'<N.K9^D=,TS'T['CCX\5&$5L7C?.WRLE"T$\( @" ( @"
M ( @" ( @" ( @" (#\N:U[7,>T/8\%KV.&H(/ @@H-YYG>)3P_S;$N2=3.G
ME5T&WW2]YGL7 .&.E>=.]C:/\P\G0CXA_BGU>YT/5UD1_#WWYW(^?H[/-S]G
M?\%Z^]39Z9<_,]/5()UG%?,?K)>H_G+YO]->&H-NYZ#/4A*W2.U#HVW7U^"X
M]A'H/D4O)QW9E3DY"'I&JPS[7$MDEZ2YOX/D+6V9N=V$N"K:>?S7;<!+K_FG
MG@)!Z/JO1[BK<FQ[Q56]'4Z9G>XEPR]%][I\I?X((!!U!X@CRJH.M)KL_-^Q
M6?S=8?\ ZK;=]J)[&2G@/>=V>[HH]^W551/PK_"^%[GX2V5"+<( @" ( @"
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M'O6[L$_44L@@" ( @" ( @" ( @" R:_Q_>^FLHFNX9*S-80! $ 0! $ 0!
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M8V0UJT30QD<; &M8UHX  #0 +YXVVZO>?I&$%!*,51+8D?9>&00! $ 0! $
M0! $ 0! $ 0! $ 0! $!7W4WIS@NJ6TK^ULXSD$X[W&Y%@!EJ6F@]W,SSZ'@
MX?&;J%,P<V>)=5R';7.N8IM>T2QK&)+&OK8]SY8RY)+L=];&>1L=/-]--W93
M86[(35FJ63%S'C&'.T,<L;CVQRM((/I'9Q7T*XX9EE7[7-\EV4?G/!E?T/.G
MI^7LV['R;=TE_+/O/?3:634MST;,%RK(8K%=X?$\>0CZ1\JJY14E1G;V[DK<
ME*.]'2^#R\&;QM>_#HTR#EGB^HD'PF_P>A4EVV[<J,[?%R%?MJ:^3)1B<C)B
MK\%R/4AATE8/C,/PF_,[%IG#B5"99NNW)2+WAFCL113PN#XIFA\;QY0X:@JL
M:IL.@3354?5#T( @" ( @-CB_P (?_1GZ(6,MQLM[S?+6;@@" ^,_P #WPL9
M;C.&\PU@;0@" ( @" ( @" ( @/X2&@N<0UK1JYQX  ("A-R9AV9R<L[2?98
M?M51O\0'X7NN/%6MFWP1IRG-Y=_WLZ\G(1/(WZ^,I6;]IW)!687O\Y\@:/23
MP"D0@YM)$&]=C:@YRW(YBR^4LYB_9R-MWVR=VH9KZK&#X+1Z %>V[:A%11PN
M3D2OS<Y<O>*KQ^&SG6'?6,V-MG^8?*>]MD$Q11,_GK4NGQ6 \//P XN5OQPT
M^P[US?S>!' W87^LNHQP<9^8GM?(DO2F^A;H\[[)Z][$V1@NG>U\9M3;U?N:
M&.9Z\KM.\GF=_.3RD=KWGB?F#@ OG>5E3R;CN3>U_*A^D=)TJQIF-#&L*D(K
MMM\K?2][)@HY8A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&#DL;0S./NXG*TXK^
M-R,+Z]ZE.T/CEBD'*YCFGM!!64)RA)2BZ-;C5?L0OVY6[D5*,DTT]J:>],\A
M^KG3?)]!-_\ ^IMFM[.S9=+A;+CKSP<WKUY'=G>PZCCY1H?*0OHNGYD=3QZ2
MV7([_+V&?FOK!H]WJEJ2G;3>-<W=CE@_YH\C>]?YC=4KC)HZU^E-JUX;-6G8
M="/*TCS$*#.#3<6=98OQN1C<@]CHTSIG:F?9N#%LL.(%VOI%>C'#1^G!P'F<
M.(]\>14619]W*G)R'=8&6LFW7E6_Y=),*5N:A:@N5W<LU=X>P^0Z=H/H(X%1
MY14E1EA;FX24EO1T+C[T.2I5[L!^UV&!W+VEI\K3Z0>"J)Q<71G46KBN14ER
MF8L3,( @" ( @" ( @" (#)K_'][Z:RB:[ADK,UA $ 0! $ 0! $ 0! $ 0!
M $ 0! $!"][]1=D=-L?4RN^MR4]LXZ_8]DIV[CG-9)-R.?R#E!X\K2?>0$PA
MECGBBGA>)(9F-DBD'8YKAJ"/=" ^B A>R.HNR.I./MY78NY*>YL=0L>R7+=-
MSG,CFY&OY#S <>5P/OH":( @" ( @" ("NM\]6NF_3.7'0;\W?0VO-EV228V
M.ZYS3,V$M$A;RM=\$O&ONH"!_M5>'?\ ^ZS@O_>2?^PO:"I--D=9>EW4G(6\
M5L7>N.W-D:%?VNY4IN<Y\</.UG.>9HX<S@/?7@-SM'J+LC?LN;@V=N2GN";;
ME@5,Y'5<XFM,XO 9)J!Q)C=\Q -H]1=D;]ES<&SMR4]P3;<L"IG(ZKG$UIG%
MX#)-0.),;OF(":( @" ( @" (")[SWUM#IYB&Y_>N?J[<P[[#*C<A;);&9I
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M<'R[46HH)<! $ 0! $ 0! $ 0! 9-?X_O?36437<,E9FL( @" ( @" ( @"
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M^:5X#FJ/Q[]&^>">YMS?&,P-F01P;KM8>,8YVOE:^.R^0CMX"/7AV+VAY4[
MVWN3!;PP6+W-MG*09G YF 6,9DZYUCEC.H\H!!!!#FD M(((!!"\/3>( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @,:Y^#3?6KU;S
M&>XC*VD<( @" K/?>0YY:V,8[U8AWTX_C.U#1[PU/OJ7C1Y2KU"YM4>V5Z2
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M)4[?^W'NIR?/1KE/6U?/3]'A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M><'C,Z<287-X7JO@X.YCR,C*.X7Q-TY+D0YJUAV@_P XQI82?*QOE<NUZLYJ
MN0EC3[*['*O'W3X7^JNARQKUO5;"HZJ,Z>LO0D]G*O-;;Y(KE*DQ&1BRV-J7
MXM-+# 7M^I>.#F^\05OO6W;FXOD/,#+CEV(W8[I+N/E7:9TQL/,?G3!Q12OY
MK6-(KS:]I:!]K=]CP]Y467;X)]#.]TK)]]92>^.SR$^IVI:-NO;A.DE>1LC?
M3H>P^[V*)*/$J,M;<W"2DN0Z,K3QVJ\%F(ZQ6(VR1GT.&H5.U1T.JA)22:Y3
M[+P]" ( @" ( @" ( @,FO\ '][Z:RB:[ADK,UA $ 0! $ 0! $ 0! $!Y2^
M+O:.]3U:NYR?&WK^W\O5I1;;MPQOFA8V*!D<M<%H(8[O@]_+VGFU\J^A=6\F
MS^%4$TI)NO=W]RA^;/U/TS._-Y7G"4K4U%0:3:5(I./0^+B=.FO*=N^&; [I
MVYT@V_C=VPSU+XELS4L=:#FSUJDLA=%'(UW%I[7!ITT! T&BY77;UJ[ERE;V
MK9M7*SZ]^GV%EXFCVK>4FI5DU%[XQ;V)\W/3D3H7ZJ<[4( @" \Y_P!Y-_PK
MV)_O6/\ 8;*]1XST#P/_ ''AO^PU_P#1-7AZ;5 >;W[N:G5R/1[J-C[T#+5*
M_N66O<K2#5DD4N/KL>QP\H<TD%>L\1N/!M:M=-=_=;/#=F)WN?M+*OSNT^]^
M%-0F+(GR=G .C=6D ![7N]*,(_G0&/\ 7/XGNL/7:<>T;<V4[^R6PIB-6.<&
MF%\T+AJ/YECGGC_UCYA@Y\VGU7I5_%-UHZF;GZ:[HZI7\!E;&'V@S!4/;QB(
MJUB6K!*]A.D3S#7T81Y3(>WBO03KQ&]8:G7/IQ?VO%X=^I-/<]:6&UM7/W,$
M[_4IV2L,GKQESPV2(.8X '74'34 CQ RO$IE]Q9SP/\ 2[([MK7*NY79+$09
MJ*_"^"T9ZT%RNY\L<@:X.?W?,=1QUU\J]6\'<_1KIWM#:/3/IYC<5@,?&ZAB
M*%OVX58A-)=EK-,UIS^4N[R1SG$NUUXZ:Z+%GI<2 \Q_'/B\GG.L7ACPN%R\
MFWLSF,L^EB<_$'&2C:L9#'QPV6!KFG6)[@\:$'AVA>H\9-OV7O$Q_P#S>9W_
M -U<_+4J#J'HGL/?/3O:N0PO4#J-;ZGYFUEI;M;/W&RMDAJO@@C;6 EEE.C7
MQO?VZ>OV+P].2/ 3_P!^>(__ 'K@_P!+?7K/$:3P*[(P-O?'73?]VE%;SV+W
M)-B<+9E8'.J1RRSRV'1$]CI=6-)'$ $:Z.=J81*/W@F IXO9NQ.K6'C9C=\[
M/W12@Q^=B:&S]P^.:=C'/&A=W<T+'LU^#ZVGPBB#(+XXH*^_<SX2:UP.KU-Z
M7;D5IK?A1QY&3"M>!Q[0)#Y409W;OBIA>F?3'>^Y-H[=QF(N[)VAE[."%6K%
M"(FU*;[#(FEC00POA:2!P.@7AZ<V> 39>&H='1U!?7CN;MWUE,A+EL]-I);,
M-:PZNR RDN=RET;I"#H2YVIUX%>L\1"/'OAJFR7]*^NNVX8\9O?;^YH*,F1@
MTCDM1B*2W")].+Q&:SF\?BO+3J" B#-[XH]H=3\#UJZ8>(;8VQSU+Q6Q\7[!
MD]J,8Z:6*1LEIW?B!@=)J66]621QN[M\;7.&@"($3SOBD\.'7K&0=/.NFU,Y
ML*:"_!.YMYCG15;3-1H+=<">($$M>70L'*>) XA0$N\=]?&5/#+MBKA;(NX:
MMG,+%B;@F]I$M9E.RV&03ZN[SF8 >?4\W;JB#-SXENE6].JGAVZ;UMBT6YK+
M[6.'S,NW7.:/;8(\>Z%[6->YK7N;WH=RD^L.8#UM 2! !XU-E7L->Z:>(+H]
MGNG[<I0?B\M095,E7NG,[MQ%:=M>>%H'P0ULA:=-#Y4H*G8O07%]+L1TTPM7
MHYE?SOL-[YI\99-F6RX22NYIFN[_ $DB=SDET;FM+7$^J%XSTN1 $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!C7/P:;ZU>K>8SW$9
M6TCA $!_"0T%Q.@ U)/F0% Y2X<AD+=P]D\A+-?(P<&CW@ K.$>%)'/79\<W
M(@F]LF<9M^T6.Y9[NE6$CM^V \Q^Q!4K%AQ371M*O4[_ +JPZ;WL[O\  Y*W
MGDCCL'.UCM)[Q]GB] </7/V(*Z3"M<=Q<RVGS#K'F_AL.5/2EYJ[>_O5[9WE
MX0^G[-I],8MQ6H S,;YD%^60CUVTH]65&:Z=A'-(/KUS'6/,]_DN"]&&SM\O
MD[1])_3+1%@:5&])?[E_SW_3\Q=BGG=F3.K%SY]%" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" CN[=M8_>.V<[M;*MYJ&=IRU)W::EG>-T;(WB/68[1P]
M(6['ORL7(W([TZD/4,&WG8]S'N+S9Q<7VT>-&VJ]_:VZ-P[+RS>ZNXZU/7FB
M/8+%5YCDY?.' :@^8+Z1EN-ZU&]'<TNXS\S: KF!FWL"[OBW[471T_J6U="+
M9P^0?BLG2R#-?]6E:YX'E8>#Q[[20JFY#CBT=WC7G9N1GS/_ !.H6/;(QDC'
M!S'@.8X=A!X@JC>P[I.JJB?[$N]W;M4''U;#!+$/XS.!'O@_.47)CL3+'3YT
MDX\Y:*AEJ$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0$=W3=]AP
MMIS3I)9 KQ>[)V_X(*VV8\4D1\NYP6WT["DU8%$4MU*R7?9"KBV.^UTH^]F'
M_22=@/N- ^:K/"A2+ESG,ZW?XIJVN3;VW\N^<V;EKW]T[HV]LO$M[V[D;4%>
M&(=AL6GB./F\P:#J3YBN@Q'&S:E>EN2?<1\OU]7,_-LX%K?)KVI.BK_2MKZ&
M>S&T]M8_9VV<%M;%MTH8*E%3@<1H7]VT!SW<3Q>[5Q])7S?(O2O7)7);VZGZ
M9T_"MX6/;Q[?HPBHKM*A(5I)@0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0'*/B^V W=G3)^XZL'/E]C2F\Q[0"YU*31EIFNFN@ ;(?K%T'5S,]QD\#W3V
M=OD\G;/G/ZFZ(L_2G>BO/L>>OZ?GKL4\[_*C@_9F3.1PD#9'<T]$^SRGRD-'
MJ'[$A=/FVN"X^9[3YOU=S?Q.)&OI1\U]K=WJ=LOCIKD^YOVL6]WJ76=[ /\
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MDMS52P-@V^YR\M4GU;L+@!YWQ^L/G<RB9<:QKS%GILZ7&N=%QJN+T( @" (
M@" ( @" R:_Q_>^FLHFNX9*S-80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $!_&M:T:-:&@DG0#3B3J3[Y0']0! $ 0! $ 0! ?QK6L:UK6AK6@!K0-
M  .P (#^H @/XYK7M<US0YK@0YI&H(/:"$!_4 0'\#6@N(: 7G5Q [3H!J?>
M" _J (#^<K>;FY1S::<VG'3S:H#^H @" ( @" ( @" ( @" ( @" ( @" (
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M! $ 0! $!DU_C^]]-91-=PR5F:P@" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MK1KY2> " ^<UNI7E@@GM10S6B6U89'M:Z0C34,:2"[34=B K_>O3/:^^-P[
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M#7$N!U<"3VHP8%3PS]':-&6UO#&R[SR\WVS-;OW)>GFMV)7<"]\AE8U@U/
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M]4?$%U J4-HXO*OQVP^F%O-1XR*.%K6R<[V=_%(&B-[&E\?*9).<EWJ\J]W
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M$Y =,^*+?.YNG/0S?6[-H%T6?I05J].\Q@>:@MVHJTE@-((UC9(2TD:!VA/
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M.R=(JE.T+:V*TC#S$_&MO(^P8/I*%D^EVBXP%_MOL^0FBCDT( @" ( @" (
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M]IT7M06SN[86"WKLV?8N7=99A+#:3'FM(&3Z49XK$6CW-</A0MUX<1JO 35
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MY!]]]1<9N#JEL3=^T<-D]^;4Z3OR(WKE<;6-FC7.2C9 R6JX$=_+!RE[^0.
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M/CNG)[@R&[\+L? 9K^S M8NWF<MG(X8;%LQ02PUXX*K++)(07.E+GN>QV@
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MQK6M:&M: &M T  [  O ?U $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M>V[K[\I#].PS2$@>0<%LEDS=Q3>])+N+A7>(]K3;-NP[$4^%RE+?RSD[DO\
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M7KR)N:F]ZIWMQA'!M0LRLQ5(2XJK^NKE3FVMLD->!E:""M%KW=>-L<>O$\K
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MND6RZM1XII<[.CU3G5! $ 0! $ 0! $ 0&37^/[WTUE$UW#)69K" ( @" (
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MX@(#9H @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" QKGX--]:O5O,9[B,K:1P@" C&[ZOM.#L. U
M=5<R9H^M.A_P7%;K#I,BYD.*V^C:4PIY2%#]1:)K9X6@W1F0A9)KY.=GJ.'S
M #[ZML.584YCE-9M<-[B]9?P**K9Q^P.JVTMZ,U;7J7JUNV0"=8FN$5EH X\
M8B>SSJ[5K\5B3M<M&EX5WSYQDY/Y1K=C-W1JG+L>C/\ T,]IHI8YXHYX7MEA
MF8'Q2M.K7-<-00?*"%\T:H?J!--51]%X>A $ 0! $ 0! $ 0! $ 0! $ 0!
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M4C3G+#!AQ7*\Q;Z@ER$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M+:D76F6Z1<N<L50RT" ( @" ( @" ( @,FO\?WOIK*)KN&2LS6$ 0! $ 0!
M$ 0! $ 0'$W7GPK9CJ5O67>VTL]0H6LO'!'G:.4,S6!]>)D#)8'PQRZZQL:"
MPM'$:\W'0=3I'6"&)9]U<BVE6C5.7;MK3E/D?7/]-[VL9KR\:Y&+FEQJ=?FI
M13BXJ7S4ME%NK7;LZ,Z0]-JO2G8V-VA7NG)3P/ELY+(\G=B:S.[F>YK-3HT
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MTYN/E0>DZ\/0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" (#&N?@TWUJ]6\QGN(RMI'" ( @*AWI0]EROM36Z17V<X/DYVZ-</H'W
MU.QY5C3F*?.M\,Z\Y![=:*[5L5)QS0V8W12#T.&A4F,G%U17W(*<7%[FCEK*
M8YU2S>QEM@<8G/@F:>QS>SYA"O;<ZI21P618X7*W-5WI_+I/KX:M\GI9U9DV
MWEK'<[>W>68ZQ-(>5C)B>:E8)) 'K.Y''L <?,M^MXOXW$5R*\Z.WZ2\90]1
M-3>@ZS+#NO\ VKOFU?/_ /3EVZ\+Z7T'K*OGQ^C0@" ( @" ( @" ( @" (
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MES]'.D/+RE4'<"\/0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MRGN >\N/'DB;\+CZ>P>ZJJ_<]W%L[3!QG?NJ/)R]@Z6:UK&M8QH:Q@#6M'
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M)QLO%^WY9MB1NM?':2O)[#)_FQ\WC[RBY,^&-.<L=/L\=RKW+Y(NM5I?A $
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M3W%=^4F9I+:')6U[1&#Q/\HCYWI4/(G5\);8-GA7&^4GBC$\( @" ( @" (
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M" ( @" ( @" ( @" (#)K_'][Z:RB:[ADK,UA $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MCAPM1?#=7FQF]BF^:?JSY*O9)]._O $$ @Z@\00N3/L!_4 0! $ 0! $ 0!
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M5N1DKPR" ( @" ( @" ( @" (#)K_'][Z:RB:[ADK,UA $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M V.+_"'_ -&?HA8RW&RWO-\M9N" (#XS_ ]\+&6XSAO,-8&T( @" ( @" (
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M)KN&2LS6$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M=6=99L0LQX8*B-O5JV+MB*K5B,T\QT8P?^G !:Y2455DB$'-T6\N[;FW(<'
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MXGTN/:??4"=R4W63J=3CXMK'CPVXJ*Z#?XO#9+,S=SCZKIR".\D[&,U^J<>
M6B=R,%5LGV,:Y?=(*O@+CV]L*ABRRUD2W(WFZ%K2/M,9_BM/PB/.?F*MO9<I
M[%L1TF'I,+/G3\Z7>1/U$+<W.'P=S,S<D#>2!A^W6G#U6^CTGT+7<N*"VF^S
MCRNO9NYRXL7B:F(KB"JSB=#-,?AO/G)^@%!G-S=67-JS&VJ(V:P-H0! $ 0!
M $ 0! $!L<7^$/\ Z,_1"QEN-EO>;Y:S<$ 0'QG^![X6,MQG#>8:P-H0! $
M0! $ 0! $ 0! $ 0! 860QU3*5GU;D0EB=Q!['-/D<T^0A90FX.J-=VU&Y'A
MDBE<]MJ[A)'/T-BBX_:K31V:]@>/(596KZGV2@R<25EUWKG(VMQ$(5N+9.-S
MG/8ATH9$\388/5D/_2-X:^Z./NJ59RI6]CVHK<S2[>1M6R7/Y2E,QMW+8*0L
MOUB(B=([;/6B?[CO)[AT*M+5Z-S<SE\G"NX[\];.?D(GD,5C\K%W-^I'9;IH
MUSAZS?K7#0CWBI-N[.VZQ="KR\&SE1X;L5)?+<]Z[1 ;.P;5&RS(;:RTM*W
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M1Q$7=U8]9'#[;8=Q>_W3YO0%"G<<WM+BU8C:5$;98&T( @" ( @" ( @" (
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M<MA8F*V;CZ1;+</M]@<='#2('T-\OO\ S%%GD.6[865K"A#:]K)@    - .
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M8XO\(?\ T9^B%C+<;+>\WRUFX( @/C/\#WPL9;C.&\PU@;0@" ( @" ( @"
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MM]XE=';>"QI:ZIBX(WM^#*YO>/'N/?S'YZCSOSEO986L*S:]&*\?=9O%J)(
M)( &I/  (>DJQ>S\ODN5\D7L-9W'OIP0XC^*SM/OZ+1/(C'I)EG!N7-^Q=)9
MV'VMB\1RR,C]IMCC[5+H2#_%'8WZ/I4*Y?E/L%O8PX6MJVOG)&M)*" ( @"
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MZ&CF518E'^>G]<_,^"/>"T2O2D3+>+;AR5[)O^S@.Q:B0?U $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M5Y]UQU)^:M$IN6]DVW:A#T4;!8FP( @" ( @" ( @" ( @" ( @-CB_PA_\
M1GZ(6,MQLM[S?+6;@@" ^,_P/?"QEN,X;S#6!M" ( @" ( @" ( @" ( @"
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M $9^B%C+<;+>\WRUFX( @/C/\#WPL9;C.&\PU@;0@" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" P9<9C9_P">Q]:;7ROB8[Z(62G);FS7*S"6^*[A@/VS
M@'Z\V+@&HT]4%OT"%E[Z?.:WB6G\U'R_LGM[^K&?9R?^TO??SYS'\%9]7PGT
M9M?;[--,7$=#KZW,[Z)*>_GSGJP[*^:C-BP^)@T[K&56$?&$3-?FZ:K%W)/E
M9LC8MQW17<-@UK6 -:T-:.QH&@"P-J5#^H @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @,FO\ '][Z:RB:[ADK,UA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 8US\&F^M7JWF,]Q&5M(X0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&QQ?X0_\ HS]$+&6X
MV6]YOEK-P0! ?&?X'OA8RW&<-YAK VA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 9-?
MX_O?36437<,E9FL( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" (#&N?@TWUJ]6\QGN(RMI'" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" V.+_  A_]&?HA8RW&RWO-\M9N" (#XS_
M  /?"QEN,X;S#6!M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M%_U[?],? C\XZ]_\CD?_ '9_^3(:I15! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
&0! $!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2227887d4-tbl_pipelin4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-tbl_pipelin4c.jpg
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M/O_M $A0:&]T;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (
M @ X0DE-!"4      !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3
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MMR'A_P![S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7
M[;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX'
M;<AX?][S>L\!_;3TCUP.VY#P_P"]YO6> _MIZ1ZX';<AX?\ >\WK/ ?VT](]
M<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K
M@=MR'A_WO-ZSP']M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<
M#MN0\/\ O>;UG@/[:>D>N!VW(>'_ 'O-ZSP']M/2/7 [;D/#_O>;UG@/[:>D
M>N!VW(>'_>\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TC
MUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_ +WF]9X#^VGI
M'K@=MR'A_P![S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/
M2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/^]YO6> _MIZ
M1ZX';<AX?][S>L\!_;3TCUP.VY#P_P"]YO6> _MIZ1ZX';<AX?\ >\WK/ ?V
MT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^V
MGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_O>;UJ%2:#[*2)K';70=IF1<7!Q<6I
MF6[B+3<,ZJ]%KV<MVDS&.&"N^ _MIZ1ZX,.VY&QX?][S>L\!_;3TCUP.VY#P
M_P"]YO6> _MIZ1ZX';<AX?\ >\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX';<
MAX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7 [;D
M/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/\ O>;UG@/[:>D>N!VW
M(>'_ 'O-ZSP']M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#M
MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=M
MR'A_WO-ZSP']M/2/7 [;D/#_ +WF]9X#^VGI'K@=MR'A_P![S>L\!_;3TCUP
M.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_O>;UG@/[:>D>N!
MVW(>'_>\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.
MVY#P_P"]YO6> _MIZ1ZX';<AX?\ >\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1Z
MX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7
M [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/\ O>;UG@/[:>D>
MN!VW(>'_ 'O-ZSP']M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](
M]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'
MK@=MR'A_WO-ZSP']M/2/7 [;D/#_ +WF]9X#^VGI'K@=MR'A_P![S>L\!_;3
MTCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_O>;UG@/[:>
MD>N!VW(>'_>\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3T
MCUP.VY#P_P"]YO6> _MIZ1ZX';<AX?\ >\WK/ ?VT](]<#MN0\/^]YO6> _M
MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M
M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/\ O>;UG@/[
M:>D>N!VW(>'_ 'O-ZSP']M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?
MVT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^
MVGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_ +WF]9X#^VGI'K@=MR'A_P![S>L\
M!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_O>;UG@
M/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!
M_;3TCUP.VY#P_P"]YO6> _MIZ1ZX';<AX?\ >\WK/ ?VT](]<#MN0\/^]YO6
M> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZS
MP']M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/\ O>;U
MG@/[:>D>N!VW(>'_ 'O-ZSP']M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\W
MK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]
M9X#^VGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_ +WF]9X#^VGI'K@=MR'A_P![
MS>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_WO-ZSP']M/2/7 [;D/#_O>
M;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/^]YO6> _MIZ1ZX';<AX?][S
M>L\!_;3TCUP.VY#P_P"]YO6> _MIZ1ZX';<AX?\ >\WK/ ?VT](]<#MN0\/^
M]YO6> _MIZ1ZX';<AX?][S>L\!_;3TCUP.VY#P_[WF]9X#^VGI'K@=MR'A_W
MO-ZSP']M/2/7 [;D/#_O>;UG@/[:>D>N!VW(>'_>\WK/ ?VT](]<#MN0\/\
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M/H4N#L\*>"X   !'3^DZ?^&:^[(1.]*N?>4\\=;,0U'M
M     "D5[]#U#\$?[9#.CVH4YCW=7,B6K^A8WVSGW9B;GM,,G[J%Q"ML@
M
M       L:T_\OK7VY?=K%UW>AH9/VZ_+C7R*6^
M
M
M                  ^H"P_X#V;[A4[_ %9L<3=]N>>70T>S',^1:!N<\TOW
M1]"EP5GA3P7    (Z?TG3_PS7W9")WI5S[RGGCK9B&H]H
M      4BO?H>H?@C_;(9T>U"G,>[JYD2U?T+&^V<^[,3<]IAD_=0N(5MD
M
M       %C6G_ )?6OMR^[6+KN]#0R?MU^7&OD4M\
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MN$32W774K-/1K0>TDEO&CM6_7:BG0G#'%LY*W35CC&.\T&'JM$
M                                                         !]0
M%A_P'LWW"IW^K-CB;OMSSRZ&CV8YGR+0-SGFE^Z/H4N"L\*>"X   !'3^DZ?
M^&:^[(1.]*N?>4\\=;,0U'M                     "D5[]#U#\$?[9#.C
MVH4YCW=7,B6K^A8WVSGW9B;GM,,G[J%Q"ML@
M                                              L:T_\ +ZU]N7W:
MQ==WH:&3]NORXU\BEO@
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MH
M        !]0%A_P'LWW"IW^K-CB;OMSSRZ&CV8YGR+0-SGFE^Z/H4N"L\*>"
MX   !'3^DZ?^&:^[(1.]*N?>4\\=;,0U'M                     "D5[]
M#U#\$?[9#.CVH4YCW=7,B6K^A8WVSGW9B;GM,,G[J%Q"ML@
M                                                         L:T
M_P#+ZU]N7W:Q==WH:&3]NORXU\BEO@
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M=%,88QOL;-^BBNJ9WI:##U6@
M                                ^H"P_P" ]F^X5._U9L<3=]N>>70T
M>S',^1:!N<\TOW1]"EP5GA3P7    (Z?TG3_ ,,U]V0B=Z5<^\IYXZV8AJ/:
M                     %(KWZ'J'X(_VR&='M0IS'NZN9$M7]"QOMG/NS$W
M/:89/W4+B%;9
M                      !8UI_Y?6OMR^[6+KN]#0R?MU^7&OD4M\
M
M
M                                 !]0%A_P'LWW"IW^K-CB;OMSSRZ&
MCV8YGR+0-SGFE^Z/H4N"L\*>"X   !'3^DZ?^&:^[(1.]*N?>4\\=;,0U'M
M                    "D5[]#U#\$?[9#.CVH4YCW=7,B6K^A8WVSGW9B;G
MM,,G[J%Q"ML@
M                      L:T_\ +ZU]N7W:Q==WH:&3]NORXU\BEO@
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M[9S[LQ-SVF&3]U"XA6V0
M                              6-:?\ E]:^W+[M8NN[T-#)^W7Y<:^1
M2WP
M
M                                          'U 6'_  'LWW"IW^K-
MCB;OMSSRZ&CV8YGR+0-SGFE^Z/H4N"L\*>"X   !'3^DZ?\ AFONR$3O2KGW
ME//'6S$-1[0                     I%>_0]0_!'^V0SH]J%.8]W5S(EJ_
MH6-]LY]V8FY[3#)^ZA<0K;(
M                                 +&M/_+ZU]N7W:Q==WH:&3]NORXU
M\BEO@
M
M                                            /J L/^ ]F^X5._U9
ML<3=]N>>70T>S',^1:!N<\TOW1]"EP5GA3P7    (Z?TG3_PS7W9")WI5S[R
MGGCK9B&H]H                     4BO?H>H?@C_;(9T>U"G,>[JYD2U?T
M+&^V<^[,3<]IAD_=0N(5MD
M                                %C6G_E]:^W+[M8NN[T-#)^W7Y<:^
M12WP
M
M                                           'U 6'_ >S?<*G?ZLV
M.)N^W//+H:/9CF?(M W.>:7[H^A2X*SPIX+@   $=/Z3I_X9K[LA$[TJY]Y3
MSQULQ#4>T                     *17OT/4/P1_MD,Z/:A3F/=U<R):OZ%
MC?;.?=F)N>TPR?NH7$*VR
M                               "QK3_ ,OK7VY?=K%UW>AH9/VZ_+C7
MR*6^
M
M                                            ^H"P_P" ]F^X5._U
M9L<3=]N>>70T>S',^1:!N<\TOW1]"EP5GA3P7    (Z?TG3_ ,,U]V0B=Z5<
M^\IYXZV8AJ/:                     %(KWZ'J'X(_VR&='M0IS'NZN9$M
M7]"QOMG/NS$W/:89/W4+B%;9
M                                  !8UI_Y?6OMR^[6+KN]#0R?MU^7
M&OD4M\
M
M                                             !]0%A_P'LWW"IW^
MK-CB;OMSSRZ&CV8YGR+0-SGFE^Z/H4N"L\*>"X   !'3^DZ?^&:^[(1.]*N?
M>4\\=;,0U'M                     "D5[]#U#\$?[9#.CVH4YCW=7,B6K
M^A8WVSGW9B;GM,,G[J%Q"ML@
M                                  L:T_\ +ZU]N7W:Q==WH:&3]NOR
MXU\BEO@
M
M                                              /J L/^ ]F^X5._
MU9L<3=]N>>70T>S',^1:!N<\TOW1]"EP5GA3P7    (Z?TG3_P ,U]V0B=Z5
M<^\IYXZV8AJ/:                     %(KWZ'J'X(_P!LAG1[4*<Q[NKF
M1+5_0L;[9S[LQ-SVF&3]U"XA6V0
M                                     6-:?^7UK[<ONUBZ[O0T,G[=
M?EQKY%+?
M
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M[4*<Q[NKF1+5_0L;[9S[LQ-SVF&3]U"XA6V0
M                                              6-:?\ E]:^W+[M
M8NN[T-#)^W7Y<:^12WP
M
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M&UE=HQ>KT*HT:E-[*31&E$XPTT'HM,
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MS.'(U+&^U     !(B,=M2HT;BX.V'4-<>FNG&HDZZ;-=-0F<(3$8S@],:O\
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M'LQS/D6@;G/-+]T?0I<%9X4\%P   ".G])T_\,U]V0B=Z5<^\IYXZV8AJ/:
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MWZ'J'X(_VR&='M0IS'NZN9$M7]"QOMG/NS$W/:89/W4+B%;9
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M@;G/-+]T?0I<%9X4\%P   ".G])T_P##-?=D(G>E7/O*>>.MF(:CV@
M          !OO@C//+AA"V8=SQ,?U^L9I*EN0ITU:D=HFZI:M39<=DKZ%+B2
M3QJ2R:MZ2+A-1'Y6:RM^_5HZ411BW[-ZU;C&(G2:4W;<]5O6Z+@NZN.D]5[D
MJ$BHU!:2T1TLA9K-*"ZB4ZZ)+J$1$/2MT113%,;T-.NN:ZIF>%;PS8*17OT/
M4/P1_MD,Z/:A3F/=U<R):OZ%C?;.?=F)N>TPR?NH7$*VR
M                           #-F!<J43$UZ.5JY[*@7];-3A.4^LT&<TR
MZ9(6M#B'V"?0X@G$*06\MJ34G4M=2ULW8F]1A3.$K[%V+=6[&,-N*/G;DMLB
M\9.5+,Q9=OAJE<B51Z2ZF/&IT65)2I*S;:3-<:9+1:B+A0M*-?O:"T+3SZLK
MFZZ>SJJC1\_4VHO6*9THB<6B>2K\JN3K[N>_:TVABH7--5*<BM&I2&6R23;+
M*35M,FVT)01GY ]2S:BU1%$<#2N5S75-4\*QQ:K
M !8UI_Y?6OMR^[6+KN]#0R?MU^7&OD4M\                  &7;OSWF._
M:,=O7=D2L5JB+X.GI;CI-LO<!DI/3):2CI=#(C+CUV[=XU[>4M6YQIIB)75W
MZZHPF6(AL*0
M                                                          'T
M%8[N]-NV!RF4*2MLJ??EJTZC2&W2(T&XBWD2V=_54;!H(NKQ:#DKUO2KNSQ3
M,^?![ENK"BB..(ZFI/+M92<$USFYO^8V3*,7QYU#MMUQ.B7FR-R<A/FN$U$T
M+_ECT,Y=^8BU1'VMV>KTM>Q1V<UU<7_'T*1](F^]*M[EUDR'#>D2*=6W7W5;
MU+6U2%*4?EF9C+8\857/H_JPS_V?I_HQISC8;LC#UX8O@V5'G,,5MN0_/*;-
M>F&:V9#*4<)O*5PEHH]PNV=F*[U%4U<",U;BBJG!E/GWM>IWOF_#-GT9*#JM
MS4U%-@&X>C:7),]39*69$>B4ZZJ/R"%&RKD6[5=4[T>AGG*)KJIB.%!O''O)
M9A"XJ+B:_P"B7)=MUS(\=5PWRW*?9;IJI9$2'5,LR66R3MZ3A)ITTH,M36K8
M<V[V;OTS<HF(C@CC15;L6YBFJ-UBBZ^49FW^9VT,+HN%Y%GWPE53HU>?)/;2
M8#+<AY^.LR239R$]K*;29)X3-2%&DM326Q;VAI9>;F&['6JJRL1=BG@EFR\,
M><HV/+JD6!?6%;YM>F,ZQF\PRGZBJ"ZHD$LI#:FI"VEI,^QU2P>W>@MNFK;O
M9JY3ITUTS.KN8KJK5FF<)IGGW<&#N6Z+A>A\T<:G1JI4[TMXJ@AO$]P,LNQ5
MG/6ZVMAR8T[T"N%#9N(49H[)1$HD$1[-K.3=JR^.$1/VH]"K+Q1%W<W>)E3G
M&MJQ,@YVI-@V72ZDC-5P5:E0KCJDE1^QBH;T%LF%-D3JM.B0:%.'T9;$JW]6
MC9U==NS-=4QH1$X<>^LS5%-=<4Q[7]$N\; Y), U2#CC)%)N:_+P=C,O5JX8
MKTA"(/3I[%;C4:9%0@C+LTH2AY1)TUUU+6+=W-YB-.B8B.+RB?Z%=NQ:F*:L
M9EA'F$Y:Z+BB[<>56U*L[<6+LE28Y4:2\LEOL\9LJ6TIYM*"6AQMTEM+(B/3
M4CVIXE;.4SLWJ:HJC"JE5>RT451AO3+/N9<1\G?+Y=]$.]*%=%QM5ZG(.%8]
M.E.*;92A]Q#U0DR52HSQ\9*2EMM#A%JVK4CXM4ZN6S&:S%,Z,Q&'#_3>77;5
MFU,8Q.ZPOS<X L7'7\W-XXF*2FU,E,J[2HKKKD@FG30R]'4PM\U/&EYMXNQ6
M9FDRW]EH6SL_-UW-*FYOTJLUEZ:<)IX63;GQ'RM\M%#LVCYOH-=R1D&ZHB9=
M6;I<IYAB @CX75LI9DPTFA*]4(XU+4LTFKL"/A*BC,9G-3,VIBFF/+E9U6K5
MF(TXQF6 N:+ MO8FD67=^/JI)K&-<EP/9"W'99\3\=71M/=&I?"CB0MMY"VS
M41*TXDJU-/$K;R.;JO8TUQA53OJ<S8BC":=Z6IPWVH        ^H"P_X#V;[
MA4[_ %9L<3=]N>>70T>S',^1:!N<\TOW1]"EP5GA3P7    (Z?TG3_PS7W9"
M)WI5S[RGGCK9B&H]H                     4BO?H>H?@C_;(9T>U"G,>[
MJYD2U?T+&^V<^[,3<]IAD_=0N(5MD
M                                       %C6G_ )?6OMR^[6+KN]#0
MR?MU^7&OD4M\
M
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MD6@;G/-+]T?0I<%9X4\%P   ".G])T_\,U]V0B=Z5<^\IYXZV8AJ/:
M               %(KWZ'J'X(_VR&='M0IS'NZN9$M7]"QOMG/NS$W/:89/W
M4+B%;9
M                !8UI_P"7UK[<ONUBZ[O0T,G[=?EQKY%+?
M
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MX*SPIX+@   $=/Z3I_X9K[LA$[TJY]Y3SQULQ#4>T
M  *17OT/4/P1_MD,Z/:A3F/=U<R):OZ%C?;.?=F)N>TPR?NH7$*VR
M
M   "QK3_ ,OK7VY?=K%UW>AH9/VZ_+C7R*6^
M
M
M                ^H"P_P" ]F^X5._U9L<3=]N>>70T>S',^1:!N<\TOW1]
M"EP5GA3P7    (Z?TG3_ ,,U]V0B=Z5<^\IYXZV8AJ/:
M     %(KWZ'J'X(_VR&='M0IS'NZN9$M7]"QOMG/NS$W/:89/W4+B%;9
M
M      !8UI_Y?6OMR^[6+KN]#0R?MU^7&OD4M\
M
M
M                 !]0%A_P'LWW"IW^K-CB;OMSSRZ&CV8YGR+0-SGFE^Z/
MH4N"L\*>"X   !'3^DZ?^&:^[(1.]*N?>4\\=;,0U'M
M    "D5[]#U#\$?[9#.CVH4YCW=7,B6K^A8WVSGW9B;GM,,G[J%Q"ML@
M
M      L:T_\ +ZU]N7W:Q==WH:&3]NORXU\BEO@
M
M
M                  /J L/^ ]F^X5._U9L<3=]N>>70T>S',^1:!N<\TOW1
M]"EP5GA3P7    (Z?TG3_P ,U]V0B=Z5<^\IYXZV8AJ/:
M      %(KWZ'J'X(_P!LAG1[4*<Q[NKF1+5_0L;[9S[LQ-SVF&3]U"XA6V0
M
M         6-:?^7UK[<ONUBZ[O0T,G[=?EQKY%+?
M
M
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M?>Q_T(?.6=>.D["YJR?)PSWXH+K[V/\ H0^<LZ\=)V%S5D^3AGOQ077WL?\
M0A\Y9UXZ3L+FK)\G#/?B@NOO8_Z$/G+.O'2=A<U9/DX9[\4%U]['_0A\Y9UX
MZ3L+FK)\G#/?B@NOO8_Z$/G+.O'2=A<U9/DX9[\4%U]['_0A\Y9UXZ3L+FK)
M\G#/?B@NOO8_Z$/G+.O'2=A<U9/DX9[\4%U]['_0A\Y9UXZ3L+FK)\G#/?B@
MNOO8_P"A#YRSKQTG87-63Y.&>_%!=?>Q_P!"'SEG7CI.PN:LK4OC!>9+<M*O
M5RO8RN.D4>F13>J%3EP'FF66R,B-2UJ21$6I]466LU:JKB(JB9YU&9LUQ:JF
M8G>4G&&&,L7E9U/K]JX[K]PT64[(1'JD""Z\PM33JD+)*T),C-*B,C\L99C,
MVJ*YBJJ(E7D;5=5J)B)X60?DX9[\4%U]['_0BGYRSKQTMOL+FK)\G#/?B@NO
MO8_Z$/G+.O'2=A<U9/DX9[\4%U]['_0A\Y9UXZ3L+FK)\G#/?B@NOO8_Z$/G
M+.O'2=A<U9/DX9[\4%U]['_0A\Y9UXZ3L+FK)\G#/?B@NOO8_P"A#YRSKQTG
M87-63Y.&>_%!=?>Q_P!"'SEG7CI.PN:LGR<,]^*"Z^]C_H0^<LZ\=)V%S5D^
M3AGOQ077WL?]"'SEG7CI.PN:LGR<,]^*"Z^]C_H0^<LZ\=)V%S5D^3AGOQ07
M7WL?]"'SEG7CI.PN:LGR<,]^*"Z^]C_H0^<LZ\=)V%S5D^3AGOQ077WL?]"'
MSEG7CI.PN:LGR<,]^*"Z^]C_ *$/G+.O'2=A<U9/DX9[\4%U]['_ $(?.6=>
M.D["YJR?)PSWXH+K[V/^A#YRSKQTG87-63Y.&>_%!=?>Q_T(?.6=>.D["YJR
M?)PSWXH+K[V/^A#YRSKQTG87-63Y.&>_%!=?>Q_T(?.6=>.D["YJR?)PSWXH
M+K[V/^A#YRSKQTG87-63Y.&>_%!=?>Q_T(?.6=>.D["YJR?)PSWXH+K[V/\
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M+K[V/^A#YRSKQTG87-63Y.&>_%!=?>Q_T(?.6=>.D["YJR?)PSWXH+K[V/\
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M
M          #PXY)/CEYCO= _?&8.AVU[FUY<$/ V+[R[SQUR]-T;B'.N@A,:
M"1(+>7FA"$@@(2$"$I3?4$B06\O- 24@A)3N$D)21"4E&XA([B!"06\A D)\
MZ)1+FG>,H1*4U]B F-[S&$IA8\[^&U._!I^Y6)C>2OX
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M=4=HY"E^@R    9*PO\ ''B;X94'WP8%&:]U7^&>I98][1SQUOK:'SYWH
M                  UHYQ_FP9I^#KOJK8W=F]XHYVEM'N]?,QG]'3\U.Q_=
M&M^^3XOVSWFKFCJ4;'[M3SSUMXQY;U
M                                         >''))\<O,=[H'[XS!T.
MVO<VO+@AX&Q?>7>>.N7INC<0YUT$)C02)!;R\T(0D$!"0@0E*;Z@D2"WEYH"
M2D$)*=PDA*2(2DHW$)'<0(2"WD($A/G1*)<T[QE")2FOL0$QO>8PE,+?D2Z8
MBXHL9R":ZBM!&U,V:)+16S?Y!'U A*YA(                     +>N.53
M8D5A=3AG-:4[HVV6FQ7">W:9=02*\V9&A!I+1)I(TEY!:"!S
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MH[1R%+]!D    R5A?XX\3?#*@^^# HS7NJ_PSU++'O:.>.M];0^?.]
M               &M'./\V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?FIV/[HUO
MWR?%^V>\U<T=2C8_=J>>>MO&/+>H .B/*C2TJ7%D-24(6;:UM+2LB6G>DS29
MZ&75(3,3"(G%WB$@
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M_DX@=)<_38\OM.<M_J4^7 ]DQS;HP
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ML2430RKB_P!C<^9B,,/J[WM<&&'!Y<;&B;/:V_EIG''ZV_[/#CB]DAS;H0
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M]3GZR#Q*CX<=/J1_%<U_EU=$_P![\/DDKA?TX3>];GZR#Q*CX<=/J/XKFO\
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M<3]EC.SZ_BSY?^IT'A2N$>G\Y$[N=W\[$Z4:JN<E7\6?+Z70O#5;1_2-./\
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M2%I/0TK2>PTGN,<1>L5V:IIKWWW7)9VUG+47+4XTS"\D[B_=%3;?H
M "G5:4["ILR6SPFZPWQ(XBU+77JEL =5"FO5&E19D@DD\]Q\? 6A=BM22T+4
M^H0"K                      "V+;J\NJ]O]M$V7:SB4M\!&6P^+?J9^0
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M[2VCW>OF8S^CI^:G8_NC6_?)\7[9[S5S1U*-C]VIYYZWS>EU1VCD*7Z#(
M!DK"_P <>)OAE0??!@49KW5?X9ZEECWM'/'6^MH?/G>@
M    #6CG'^;!FGX.N^JMC=V;WBCG:6T>[U\S&?T=/S4[']T:W[Y/B_;/>:N:
M.I1L?NU///6WC'EO4><5\U*=RH\SMYYKK5OU.IX/S9283%W5VD1U2U4.M4Y"
M6VWI32>R2TM)*5KU3<5PZFCA/VK5,9S+TVHF-.B=R)X8EX]VJ<IF)N3$Z%4;
MN'!,)U]\W\K+C]MX]Y-9<J[KXK55CG7;S?HLEJCT.F-F:I#DLZE':VJV$6B=
MW$25=(:$G%K9T6<:\SN4Q&Y&.[,_0F[M";V%&7W:IG?PW(CZ6>>;V/)>Y8,Q
M1FTKF2EVXM!$V@S6XOI&]3)"==_D$-39T_\ V:.=M;0C_P"O7S+APC2'*IRS
M8BH+TR?1':CC&@0':A <.-.B*>HS#1NL.&DS;>;,]4JT[%1$>@PS56&8KG?^
MM/-OL\M3CEZ(WOJQU+'M_E58H#]3?DY[S!>\:I4BI4F1;UWW.56I+J*C%<BJ
M6]$.,T2S;)SB1V6Q1$8MKS^EA_VZ(W8G&(PG<Y<5=&1T<?KUSN3&$SC&ZU:Q
M'S&6[@;!%2P%E&+4J9G''+-4H%'L9J!+E.UU<IY]=,<ISC+:FW&G>E2@E<9;
M$\1%H:==[,9*K,7HO6\-"K"<<8W./%HY?.4Y>SV5>.G3C&&&_P 6"O6,N[.4
MG ?+BJ[\9HN6WX<R?+RQ5^TU3*I:9U5]4MAYEELEJ239.$A\R+8I&FNJTZ8W
M='.7[FC5A.YH\56&Y_P96M+*6;>E3C'VN.G'RW4RZ[ZM7FGY@N7A>$FG[IH^
M(*R_<E^9.1"D18$&,:6U(IB7I#;2W'9"FRU0DMFJ3[(B<X(MVJLI8N=KN35&
M$4\,\OT)N7:<U>M]ENQ3.,S_ $0,-YALOE%5E[#^;)$VTWZ=>%6N3'$HH$I^
M-7:+4B0XPFG+9;6A3B5)X5I,TD2E\.NJ5Z3F<M7G="Y:W=R(G=WICC1E\Q1D
M].W=W-V9C<WXGB8?GXGR67*H5VW!9E3E4R\,X'EK)&+8J%E47;4D\*'(JV2/
MB4K[RA[@/:23)2M%-F0V8S%OYG1BJ,8HT(JX-)KS8N?+:4Q.$UZ4QPZ*Z\TW
MUB+/;^&+4Y4Z0W4\K4*[:75HE=HE$>I2;;I<8G3?.;)7'82T@E<)FWV23-.[
MBX"57EK5W+Z=68GZDQ,83..E/(LS-VUF-"FQ'UHF)W(PT8Y7K8.>>\
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M8S^CI^:G8_NC6_?)\7[9[S5S1U*-C]VIYYZV\8\MZ@
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M6XRV@.BV7GI%#A.ONK>=7TG&ZXHU*/1U9%J9ZGN(!7@
M    !9=GRI4GV5[9DNR.C=03?2K4OA(^+86IGH"(7H"0
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M/C=]B6Q6YM$778$M:&RB/L-O] XTVLG#6;J#T4:301<.TC 7J
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M674<+DA6A$DO)/4R(!U46,Q#ID:-&E)F,M\?!)09&2M5J,]-#,MAGIO 50
M                    6Y;]/AP.WNU*BW/Z9:5.\!I/@,M=A\*C\D!<8
M                   \;+-_K6;J_+OY.('27/TV/+[3G+?ZE/EP/9,<VZ,
M                6W=EX6M8E$DW)>5P0;8H$-;;<JL5%Y,>.VIY9-MDIQ9D
M1&I2B(O+&=NW5<G1IC&6%RY3;C2JG"%R#!F .B-*C3&NGB2&I3'&MOIF5I6C
MC;6;:T\23,M4J2:3+J&1D)F)C?1$XN\0D             :T<X_S8,T_!UWU
M5L;NS>\4<[2VCW>OF8S^CI^:G8_NC6_?)\7[9[S5S1U*-C]VIYYZWS>EU1VC
MD*7Z#(   !DK"_QQXF^&5!]\&!1FO=5_AGJ66/>T<\=;ZVA\^=Z
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MDG<\>823U4J-VDUH2D_VI<2S(]-^WJ"(WAM&(
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MEOHDM$D6[9N'B.X<@        %%N+]"5+\"?[9 (]I_P?@?WWU582+B
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M=%J7$M+C*)B";?1V*B)25I(MBB,B/:6A[0%>
M      %OT*U;>MERLO4&DL4QVX9[M4K;C)'K)F/GJX\X9F>JE'O 7    #\,
MB,C(RU(]AD8#$:<"8814_9=.-:"4XGCD$KM5)M](9ZZ]"?WO?MTX=!.(RX1$
M1$1%H1;"(A A5.FPZQ3IU)J#:GH%28<C364N+:-;3J32M/&VI*RU(S+4C(P'
M31:+2;<I,"A4*GLTJD4ME+$"GQTDAMIM/4(O+WF9[3/:>T!5
M              !X<<DGQR\QWN@?OC,'0[:]S:\N"'@;%]Y=YXZY>FZ-Q#G7
M00F-!(D%O+S0A"00$)"!"4IOJ"1(+>7F@)*00DIW"2$I(A*2C<0D=Q A(+>0
M@2$^=$HES3O&4(E*:^Q 3&]YC"4PL>=_#:G?@T_<K$QO)7\
M         +'OK]'0_P#2/[A0F$2O1G]Y:^T3^T(2[
M  %%N+]"5+\"?[9 (]I_P?@?WWU582+B                      %B61_V
MO^&1_="91"^Q"0                    !XV6;_ %K-U?EW\G$#I+GZ;'E]
MISEO]2GRX'LF.;=&              #&-D8EM:P+KR5>5"<G+J^5*C'JESIE
M/)<92_&0MM!1TI;2:$Z+/4C-0ONYBJY333.]3&$*+5BFW555&_5.,LG"A>
M                  UHYQ_FP9I^#KOJK8W=F]XHYVEM'N]?,QG]'3\U.Q_=
M&M^^3XOVSWFKFCJ4;'[M3SSUOF]+JCM'(4OT&0   #)6%_CCQ-\,J#[X,"C-
M>ZK_  SU++'O:.>.M];0^?.]                     &M'./\ -@S3\'7?
M56QN[-[Q1SM+:/=Z^9C/Z.GYJ=C^Z-;]\GQ?MGO-7-'4HV/W:GGGK;QCRWJ
M
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M?EZ .JBSW*G3(TYU"6W'^/B0C70N%:D[-=?( 50
M 6Y;]9?J_;W3M-M=JK2A'!KMUUWZF?D +C                      'C99
MO]:S=7Y=_)Q Z2Y^FQY?:<Y;_4I\N![)CFW1@
M             #6CG'^;!FGX.N^JMC=V;WBCG:6T>[U\S&?T=/S4[']T:W[Y
M/B_;/>:N:.I1L?NU///6^;TNJ.T<A2_09    ,E87^./$WPRH/O@P*,U[JO\
M,]2RQ[VCGCK?6T/GSO0                    !K1SC_-@S3\'7?56QN[-[
MQ1SM+:/=Z^9C/Z.GYJ=C^Z-;]\GQ?MGO-7-'4HV/W:GGGK;QCRWJ
M
M   \..23XY>8[W0/WQF#H=M>YM>7!#P-B^\N\\=<O3=&XASKH(3&@D2"WEYH
M0A(("$A A*4WU!(D%O+S0$E((24[A)"4D0E)1N(2.X@0D%O(0)"?.B42YIWC
M*$2E-?8@)C>\QA*86M*I<YVZ8510QQ0FD$3CW$DM#X5%YTSUZOD"82N\
M                  6K=E-FU.'&:@L].XV]QK3Q)3H7"9:]D9>2)@7.T1I;
M;2>PTI(C+RR(0.8                    "F5F.]+I<V-'1TCSS9I;1J1:G
MJ75,R(!T6]$D0:/#BRF^B?:Z3I&]25IQ.*46U)F6XP%:
M      %I6M3)U.]DNW6.A[8<2IKLDJU(N+7SIGIO!"[02
M      /&RS?ZUFZOR[^3B!TES]-CR^TYRW^I3Y<#V3'-NC
M                       &M'./\V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?
MFIV/[HUOWR?%^V>\U<T=2C8_=J>>>M\WI=4=HY"E^@R    9*PO\<>)OAE0?
M?!@49KW5?X9ZEECWM'/'6^MH?/G>@                    #6CG'^;!FGX
M.N^JMC=V;WBCG:6T>[U\S&?T=/S4[']T:W[Y/B_;/>:N:.I1L?NU///6WC'E
MO4
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M$GH9'J6XP'1;3[TFB0GY#JGGE])QN+/4ST<41:GYA *Z
M      +-M&;+E^RG;4AR1T3J2;XU&?"1\6[7S 1"\@2
M    /&RS?ZUFZOR[^3B!TES]-CR^TYRW^I3Y<#V3'-NC
M                     &M'./\ -@S3\'7?56QN[-[Q1SM+:/=Z^9C/Z.GY
MJ=C^Z-;]\GQ?MGO-7-'4HV/W:GGGK?-Z75':.0I?H,@   &2L+_''B;X94'W
MP8%&:]U7^&>I98][1SQUOK:'SYWH                     UHYQ_FP9I^#
MKOJK8W=F]XHYVEM'N]?,QG]'3\U.Q_=&M^^3XOVSWFKFCJ4;'[M3SSUMXQY;
MU
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MD^6>T@'51894^F1HB7TR2:X]'T>=5Q+4K9M/=KH J@
M    MRWZ4FF=O<,QN7VPXE1\!:<.FNP]I^2 N,
M>-EF_P!:S=7Y=_)Q Z2Y^FQY?:<Y;_4I\N![)CFW1@
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M[G^+3T4?V!4WG[ZE9A?^[;WX@1V6S=6>FKTFE^Y_C4]%']CF4#G^3NK4(O\
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MM+7L\,<3M_VI^\?G9C+YJ8BYP5;T5=&Y$\ST';6:R/4M#+J#P'T+%V
M          HMQ?H2I?@3_;(!'M/^#\#^^^JK"1<0
M  L2R/\ M?\ #(_NA,HA?8A(                     \;+-_K6;J_+OY.(
M'27/TV/+[3G+?ZE/EP/9,<VZ,
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MQY<*_,V+>4T+EKVL8CCQB?+@>M0YY[P
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MF[;]GACB?9OVA^[8SL4Y;,3_ -R-Z=>/[O\ B]$T'KKMUT/]PAX#Z"Y@
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MI?H,@   &2L+_''B;X94'WP8%&:]U7^&>I98][1SQUOK:'SYWH
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MG'295HHRU;))Z;-PONY^_=IT:JIF%-K(V;=6E33$2SX-1M
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MX             HMQ?H2I?@3_;(!'M/^#\#^^^JK"1<0
M      L2R/\ M?\ #(_NA,HA?8A(                     \;+-_K6;J_+
MOY.('27/TV/+[3G+?ZE/EP/6N]KB>M"SKINF/1IMQ2;=I4NHQJ!3FU/2YKD9
ME3B(["$)4HUN*222T+JCG[5&G7%..&,[[H+E>A3-6&.$;S1!ZZN=6EX@G<PM
M:NZS*:B!17;JEX1ET!UE#-*:0<M3+E04^F4B24<C^]J+8KL3/B'JQ;R<W>QB
M*M_#2QX>;>PQ>7-S-Q:[:9C>QT<.#GW\5]U?F%NFM7SR2N6NM-$M/F @5NI7
M=0WFFI#O#'ID.7'92^I'$GHG'ED:D</%U153DZ::+^ENS1AA/TRMJS=55=G1
MW(KQQZ(9OYD+TN''6#,F7O:DM$&XK;HZYE)EN-(?0VZE:$D9MN$I*MAGL,AJ
MY*U3=O4TU;TRV<Y<JMV:JJ=^(7)AJXZM>&(,4W=7GTRJY=-G4*KUF2A"6DN2
MYU/8D/K2V@B2DE+69D1%H74&&9HBB[73&]%4QYV>7KFNU35._,1/F8#NZX^9
M#(>9[LQQBVH0\26'C^GT]RK9'K5!<J;U6GU%OIDM4UN0MEAUII)&A:DGJE1'
MJ9\22&W;HR]JS%=R-*JK'<B<,(CC:MRN_<NS11]6F,-V8QQQXE L7F6NZV&N
M9&V<WQJ34KFY;H,:JR;@MXEQXU;A3XBY41!,.&YT#ZM$(/17#Q+TT+@,U9W<
MC17V=5K'"YN83P8;_P!#"UG:J>TINX8T;N,<+'+N4><"C8?I_-!4ZO:%3M-^
M&Q<E3PHS2W&G6;<E*0XAUFJDXITY!1W"<,EEPI(M3XC(T"[L,K5=["(G'>TL
M?M<W%BI[?-4VNWF8PW]'#@Y^-F._\IYCON[<6V/@**Q;E!R!::;TJ^9*Q2W:
MC A0)*3.+%C)2:8ZY*MBE(6L^Q4@]--3&M9L6K=-5=[=FF<-&)PG'T-B[?NW
M*J:;6Y$QCI3&,?\ %T8]RGERS\]GR]YCJU%OYRLVHY=EG7[1()TR4MMAY;#L
M:=3R<=0E2NB6I*FSTV::JXC)N;V7M5V.VMQ-.$X3$SCT26K]VB]V5R8G&,8F
M-SIACVI7ESH5*PK\SH<^VL3T2UVJG5*#AFXZ,IV4_2J42U+749RGFW&'G$-+
M-))[%6P]4)42BNIM92*Z;6[5,X1-43PSQ0IFYFIHJN[E,1CA3,<$<<ME;-Y@
M+.JF'\7Y6OB?%L6/DIJ!&A19;BE-G59C:U%$961&:N(V7#09D6J2U/0]@T;F
M3KB[5;HW=''H;MO-TS:IN5;FEUL]C4;33_%V9+LKG,1S061=588\!L4LT61;
MS/:[31Q&I,13\I;CR$$MPNQU[(STZ@]&_EJ:;%JJF/K58XO/L9BJJ_<IJGZM
M.&"]W^;7EKBO49B1F:VFEU]LG:<HY78$@S4DE/KX>&.1FD]#>-&I:'N,A5&S
M\Q./U)W%LY^Q&'UXW50ON[ZM&R;@6GV_DFWJ';=XN5ERJVS+03\RY66HL=V-
M[%O(:=21,<9N+/I$$I*DZ&H1:MQ-NY,TS,QANZO.F[<F+E$15$1..YK<S!>,
M^;ZBY:JF?K<IMWVW0)MI^R?\U5223SB9%.@PW'%5B3QDX2VT+(EJ)*"(DEIP
MJ/:>U?V=-F+=4Q,XX:7/,[S5L[0B]-<1,1ACH\W&SS9>3J-0,)VE?^4\GVW/
MCR(#:JID)EQ$*E3WUJ62514N(9UX^'1*"02CT/1(U+MB:KTT6Z9YN&&U;OQ3
M:BNNJ.?@5#'?,)A7+%0>I&/<CT>Y:NPA;JZ0RZIJ6;;9D2W$1WTMN+0G4M5)
M29>6(O9.]9C&NF8AE9S=J[.%%43+'_+7D^\<CUCF'AW94&IS&/LJUZUK72W'
M:8-FF07"2PTHVTI-PTEO4K51]4Q=G;%%J+<T_:HB9YY4Y._5<FYI<%4Q',SY
M>%ZVCC^A2KFO>XZ?:U AFE+]5J3Z&&B6KSK:369<2U:=BE.JCZA&-2W:JN5:
M-,8RV[ERFW&E5.$+0QMG/$>7U3V\;7[2[KDTQ/25"#&6I$EILU<).*CO);=X
M#5LX^'AUZHLOY6[9]NF85V<S:O>Q5$K9JO--R[T.Z5V95<O6Y"N)EXXTB(N5
MJTR\1\*FWI*2-AM23V&2W",CWC.G(7ZJ=**)P859ZQ35HS7&*_KORKCBP'Z)
M&O6\Z5;#ER,3I5#549"66Y+--93(EK0XKL-&FUI4>I]4M-3%5O+W+F.C3,X8
M8_3O+;E^W;PTIB,?Z+ IG--R\5BWZ[=$#+MO.42VEMHK4MR0;*V5.J4EHNA=
M2AU?2&@R1P)/BT['46U9"_35%,T3C*JG/6)IFJ*XPA%N#.UI73@?+>3L-7I3
MKC?LVU:[/@5&*1.]J5"#3GI+!/QGTDI)DI*5<+B.R+R2$T92JB_11=IF,9CH
MF45YJFNS77;G'")Z<%A8:YN<35ZS,7TR_<N6XSE&Y+?ITNO07'FHR2GR64*6
MTXM!)CLN*4K8T:DJZA)%V9V==IKJFBB=&)G#FZU67S]NJBF*JXTIB&R5]9%L
M7&5$5<>0+JIUI44G"91-J+R6B==,C,FV4>?<69$9\*",]",]-",:5JS7=G1H
MB9EN7;U%J,:YPA0L;9JQ5E]B8_C:^:7=GL<23GQHCAIDL)4>B5.QW4H=0E1E
MH2C3H?4&5_*W;/MTS#"SF;=[V*HECCG'^;!FGX.N^JMB[9O>*.=3M'N]?,QG
M]'3\U.Q_=&M^^3XOVSWFKFCJ4;'[M3SSUOF]+JCM'(4OT&0   #)6%_CCQ-\
M,J#[X,"C->ZK_#/4LL>]HYXZWUM#Y\[T                     :T<X_S8
M,T_!UWU5L;NS>\4<[2VCW>OF8S^CI^:G8_NC6_?)\7[9[S5S1U*-C]VIYYZV
M\8\MZC\,R(C,ST(MIF8"W8]XVC,B4N?$NFD2H-<D'%HLUF='6U,?)?1FU'6E
M9I=7Q]CPI,SUV *\^^Q%8>DR7D1XT="G9$AU1(0VA!<2E*4K0B(B+4S,!1'[
MLM:+2HU=DW+2H]$FKZ.'6'9C"(KJ^R[%M\UDA1]@K81]0_( 4G^<O''C MOO
MK#_&@*M,NVU:=!@U2H7-28-,J9$JFU&1-8:8D$9<1&TXM9)7LV]B9@(<*_;&
MJ4EN'3KSH50EO&26HL:HQG7%&9D1$E"'#,]IZ;" 7',FPZ?&>FU"6S!AQRXG
MY<AQ+32"UTU4M9D1%J?5,!%I5;HU>C',H=7A5F(E1H.5!D-R&R46]/&TI1:E
MY&H"I@+;K]Y6?:G0E=%UT>VSD%K'*JSH\/C+=JGIUHUW=0!6(%1I]5B,SZ7.
MCU*#(+BCS8KJ'F7"(]-4K09I/;Y!@(]6KE%H$9$VNU>%18;CA,HESY#<9HW%
M$:B02W5)(U&23/37J& J25)6E*T*):%D2D+2>I&1[2,C(!9BLDXZ0I2%W];B
M%H,TK0JJQ",C+89&1N@+GIU4IE8BHG4FHQJI"<V-S(CR'VE;"/8MLU)/8?D@
M)P"E4NNT2ME).BUF#5RA.=#,.%(:D=$Y_:.=&I7"KRC ?M6KE$H$=$RNUB#1
M8CCA--RI\AN,VIPR,R02W5)(S,B,]->H J:5$HB4DR4E1:I46TC(^J0#]
M    ! EU6EP)$&'.J46%+JBU-4R*^\AMR0M)$:DLH49&LR(RU))& G@
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M'(4OT&0   #)6%_CCQ-\,J#[X,"C->ZK_#/4LL>]HYXZWUM#Y\[T
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M8N?X%[Y4ONPHU-9B4*SX+\V+<ZY.O;B8<AN+)<2V:"232'361+)9EHDCZHG
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MM&G<HCS\K[G^U_VM1LNW%RYA-Z=^=7[L?UXVYZ2(MI=4>0[!R
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MH[1R%+]!D    R5A?XX\3?#*@^^# HS7NJ_PSU++'O:.>.M];0^?.]
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M/K;39]BV?:Q))*J!1X4%_33LG664I=6>FS52R,S\LQ O
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MBGIK]#B?(YS%'OS7!/\ XE5_Q0>.Y?4GS(_@>TO\BGIK]#B?(SS#GOS3 /\
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MI=4=HY"E^@R    9*PO\<>)OAE0??!@49KW5?X9ZEECWM'/'6^MH?/G>@
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MO,82F% D460]<,6KI=;)AA!)4V>O&>A*+9LTZODA$I7*)
M      !;UQT=^LQ6&&'4-*:=Z0S<UT,N$RZA'Y("O-I-"$)/::4D1GYA .8
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M(6I+NAEPEN+4N+4:6T\O19O84QA$Q$X<3<V;?JO6L:IQF)F,>-MV/.;X
M         UHYQ_FP9I^#KOJK8W=F]XHYVEM'N]?,QG]'3\U.Q_=&M^^3XOVS
MWFKFCJ4;'[M3SSUOF]+JCM'(4OT&0   #)6%_CCQ-\,J#[X,"C->ZK_#/4LL
M>]HYXZWUM#Y\[T                     :T<X_S8,T_!UWU5L;NS>\4<[2
MVCW>OF8S^CI^:G8_NC6_?)\7[9[S5S1U*-C]VIYYZV\8\MZC73.^2[RLZKXO
MM#'Z::=SY%K+D%MVJ-./1V8[1-I<<4EI25$25/)49EKL)6P3 LF^KLYFL76U
M-ONOS,?W%0*"MERLTJ&Q/8DN,.NH9/HEK42241N%O/\ 85YTVX-C:AD.S:%1
M*/7KFN.G6O"K<=J1 *JRF8REDXA+G @EK+C4DE%J2=1 KD*XJ!4J-X14^N0)
MUO\ 0KD'7(\EIR&331&;CAOI4:.%/"?$>NA:;0%O%D[&ZIM*IR+^MYR=720=
M&BHJ<52Y1.;&S9)+A\7&9Z)T\\>[4!*9R!8LFX56E'O*BOW0@U)7;[<YA4PE
MHU-2#9)9JXDD1F:=-2+;IH Q)7<TM4'-TJRJO6J-;]C4&UFZG<-6J:TL.>R4
ME\TQXS;RW$I[)I25DGA,ST5Y G 9O:N6W7J&=SM5^G.6V3"I2K@3*:.$3"=J
MG3D<71DDM-I\6A"!3J??ED5:IO46E7?1JE5HT0I[].BSF'GD15$1D\I"%F9(
MT4D]=VAD>XR 1*+DO'=R55RAV_?-!K58;U,Z9"J$=]Y1)(S4:$(69JX=.RX=
M=.J L:M9%K3.=K4QI2^T_83P;FW%>C[K9J=:92I;$7@=):4M_?2(U<1'L,MV
MNHD=]H9*C0[><KN3+^L>%&KM7G^!M1I]4CHA/TUA2&T(3(==)+SS:R43IH/0
MCT+0!>]$R+CZY9R:7;E]V]<%36A3B:=3:I$EOFA&U2B:9=4K0NJ>@@5>E7-;
M=<I:ZY1+@IM8HK72=+6(,MF1%3T1:N:O-K4@N O/;=G5 0RO:S3B4>H%=M%.
M!<3ILV_-*?'Z&<XDS(T17.DX75$9&1D@S,! @9*QW56ZN]3;[H$YF@%Q5MYF
MHQEHB)U)/&\HG-$)-1Z<1[-=FNH"JVY=MKWA$=GVK<5.N.$PZ;+\FFR6I*&W
M"^P6;:E<)Z;2(^IMW *$[E7&3%9.WGL@VZU6R<Z%5+54HQ/)=UX>B4DW-B]=
MG"?9>4& LK-V2JKC]./(5"=@1ZA>-TQ:9,EU).L>-3>%2YLE1\;?#T2>$S,S
MT(M3,3 R7;5[6?>3<IVTKHI=R(A*)$PZ;+:D]$9Z\/&3:E&G70]-=_4$"PL5
MWW5[DKN4[2N)QIZLX_N1<2.\TWT724N8CIH"W$ELX^$E$HRV'IJ)&91
M                                     /#CDD^.7F.]T#]\9@Z';7N;
M7EP0\#8OO+O/'7+TW1N(<ZZ"$QH)$@MY>:$(2" A(0(2E-]02)!;R\T!)2"$
ME.X20E)$)24;B$CN($)!;R$"0GSHE$N:=XRA$I37V("8WO,82F%CSOX;4[\&
MG[E8F-Y*_@                     !8]]?HZ'_ *1_<*$PB5Z,_O+7VB?V
MA"78                     HMQ?H2I?@3_ &R 1[3_ (/P/[[ZJL)%Q
M                   "Q+(_[7_#(_NA,HA?8A(
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M.T<A2_09    ,E87^./$WPRH/O@P*,U[JO\ #/4LL>]HYXZWUM#Y\[T
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M?4/1P"M80<;J&:.9ZLQ%$[3WJW1::V^6XY%.CR6I*-=W8+,B"1M.(
M                                  !X<<DGQR\QWN@?OC,'0[:]S:\N
M"'@;%]Y=YXZY>FZ-Q#G700F-!(D%O+S0A"00$)"!"4IOJ"1(+>7F@)*00DIW
M"2$I(A*2C<0D=Q A(+>0@2$^=$HES3O&4(E*:^Q 3&]YC"4PH$AJC'<,5QZ0
MXFK$@N@8(E<!EHK>?"9;M>J$)7*)                     !;UQMTAR*P5
M8?6PP3NK2FR49FOA/9V*5=0!7F^'@1P'JGA+A/RM-@#F
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MZ75':.0I?H,@   &2L+_ !QXF^&5!]\&!1FO=5_AGJ66/>T<\=;ZVA\^=Z
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MK2]>.=49&AOOJXC,]ID24Z[>$BUU/4Q$C)@
M                 \..23XY>8[W0/WQF#H=M>YM>7!#P-B^\N\\=<O3=&XA
MSKH(3&@D2"WEYH0A(("$A A*4WU!(D%O+S0$E((24[A)"4D0E)1N(2.X@0D%
MO(0)"?.B42YIWC*$2E-?8@)C>\QA*86/._AM3OP:?N5B8WDK^
M           %CWU^CH?^D?W"A,(E>C/[RU]HG]H0EV
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M[']T:W[Y/B_;/>:N:.I1L?NU///6WC'EO4
M                                            !X<<DGQR\QWN@?OC
M,'0[:]S:\N"'@;%]Y=YXZY>FZ-Q#G700F-!(D%O+S0A"00$)"!"4IOJ"1(+>
M7F@)*00DIW"2$I(A*2C<0D=Q A(+>0@2$^=$HES3O&4(E*:^Q 3&]YC"4PH$
MBJ1VKABTY5.;<?=01IGF9<:=24>A%PF?4\D(2N42
M "WKCJ3%,BL.OP$5!+CO 3;AD1)/A,]=J5>0 KS9DI"%$7"2DD9)\C4@',
M                  ! JDA$2GRI+C"9*&4<2F%:$2B\@]2/]H!U466W.ID:
M4U&3#;=X^&.@R,D\*U)V:$G?IKN 50                      6Y;]38J7
M;W04]N!VNM*5\!D?'KKM/1*?( 7&                      /&RS?ZUFZO
MR[^3B!TES]-CR^TYRW^I3Y<#V3'-NC
M       &M'./\V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?FIV/[HUOWR?%^V>\
MU<T=2C8_=J>>>M\WI=4=HY"E^@R    9*PO\<>)OAE0??!@49KW5?X9ZEECW
MM'/'6^MH?/G>@                    #6CG'^;!FGX.N^JMC=V;WBCG:6T
M>[U\S&?T=/S4[']T:W[Y/B_;/>:N:.I1L?NU///6WC'EO4
M                                                        !X<<
MDGQR\QWN@?OC,'0[:]S:\N"'@;%]Y=YXZY>FZ-Q#G700F-!(D%O+S0A"00$)
M"!"4IOJ"1(+>7F@)*00DIW"2$I(A*2C<0D=Q A(+>0@2$^=$HES3O&4(E*:^
MQ 3&]YC"4PL^9$E*O"!)3&=5&0V1+D$A1H(^%>]6FG5$QO)7L
M           +.O.+)E08J(L=V2M+^JDM(4LR+A5M,DD8F$2NUHC)IHC+0R0D
MC(_,$)=@                    "D5YMQZCSVF6U.N+:,D-H(U*,]2W$6T!
MT6RR]'H<)I]I;+J.DXVG$FE1:NK,M2/0]Q@*\                      +
M+L^+*C>RO;,9V/TCJ#;Z5"D<1%Q;2U(M01"] 2                     /
M&RS?ZUFZOR[^3B!TES]-CR^TYRW^I3Y<#V3'-NC
M                &M'./\V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?FIV/[HU
MOWR?%^V>\U<T=2C8_=J>>>M\WI=4=HY"E^@R    9*PO\<>)OAE0??!@49KW
M5?X9ZEECWM'/'6^MH?/G>@                    #6CG'^;!FGX.N^JMC=
MV;WBCG:6T>[U\S&?T=/S4[']T:W[Y/B_;/>:N:.I1L?NU///6WC'EO4
M
M    &+LXN+:PKE]UI:FW&[)N!3;B3,E)45-?,C(RVD9&-G)>_M_BCKAY>W)F
M-GYB8^%7_P!,O'O G*W*R[9LJ]8F1W;1<74WX#\)FG')4OH$MKZ13J9L<SU-
MW<:=GD[1UF=VC39N]G-&.YQ^I\EV'^W+V>RW;TYBJC&9C"(F=[ETHZF;CY$:
ML7].DWO.Y^M!J^+6_A1T^I['\0S'^95T3_>X?(3J_4SI,[T.?K,/%K?PHZ?4
MC^(YC_,JZ)_O<#Y%JRG?G.9WI<_68GQ6W\..GU(G]HYC_,JZ)_O?GR%ZQX\I
MG>ES]9B?%;?PXZ?4C^)9C_,JZ)_O<3Y&JT7].,WO2Y^LQ/BEOX<>7T$_M/,?
MYE71/][C\ARLE_3C-[TN?K,/%+?PX\OH8_Q3,?Y=71/][B?(]62_IPFGYE)<
M_68>*6_AQT^I'\5S'^75T3_>ZSY(JT7]-T[O2Y^LP\3M_#CR^@_BN8_RZNB?
M[WX?))6RW9NG?LTIPO\ ]R&4;2MS_IQY?0C^+9C_ "ZNB?[W$^2:ME_3=-[U
MN?K(3.T;?PX\OH/XOF/\NKHG^]P/DHK9?TW3>];GZR$>)6_AQY?0C^+YC_+J
MZ)_O#Y*:V1:_SVSN];GZR#Q&G@M1Y?0C^,9C_+JZ)_O</D65SQV3N];GZR#Q
M&GX4=,>AC_&LQ_EU=$_WGR+:WX[9O>MW]8B?$*?A1YO0C^-YC_+JZ)_O<#Y+
MZV7]-D_O6[^LA/S]/PH\WH1_&\Q_EU=$_P!Z.ODWK:-V:IY_\,=+_P#<1/SU
M/PH\WH1_'<Q_EU=$_P!R(YR@UQ&[,TX_^&NE_P#N GYVGX4>;T(_CV8_RZNB
M?[D-SE,KB/Z8IRB]SW?U@,HSE/PX\OH55_M_,3&$YFN8YI_O1%\JM<1J99=G
MF1>U[I?_ *\9_.QJ>70UY_;ER/\ 7JZ)_N1%\K];01_^+<X_R%TO_P!<)^<C
M4\NAA/[>N1_K5=$_W(B^6FN)_I8FG^1N_GHRC-1/V/+H8SL"[\:KHG^Y%7RY
M5Q']*DX_R-S\]$_,QJ>70KG8=V-^]5T3_<BKY>ZVC^E&<?Y([^>C*+\:GET,
M9V-7\:>B?[D=6 ZVG77)\[N5W\\$]M&HKG95<?ZT]$_W(B\&UM.O_B7./\F=
M_.QG3<IG[,0JJV=7'^K/1/I1585KB2U_G'G'^3N_G0RTJ>*/+Z%<Y&Y'^I/G
M]*&O$%;1_2)./^\._G0F)IXH5596[&]<GR^E#<Q77&ST_G G*_O3OYR,XBF>
M"%-5N]'VYZ?64BNY/P3<,"]+6NF74H[!I;J;*UO)9>:-1&IB4R;BB-M6A:'K
ML/;L/059C*6[].C53&'&V,CM/-;/NQ=M5SC&_&,[L<4O9?!^<[8S=:K->HCI
M0ZI&)+=?H#BR4]$?ZI:;-4JTU2HMY>61D7$Y[(UY6O"=V.!]QV'MVSM6SVE&
MY5&_3Q,ZEN(]=1HO<?H    "U[JJ<REPX[T-PFW''N!9FDE;.$SZOF"8%RMJ
M-3;:CWJ21G^R0@<P                    %-K$EV'3)LEA1)>9;-3:C(CT
M/4NH8#HH$Q^?2(DN2HEON])QJ(B(CX7%)+87E$ K(
M   M2V*K-J?LCVXX3G:[B4M:)).A'Q:[B\H$+K!(
M \;+-_K6;J_+OY.('27/TV/+[3G+?ZE/EP/9,<VZ,
M                  :T<X_S8,T_!UWU5L;NS>\4<[2VCW>OF8S^CI^:G8_N
MC6_?)\7[9[S5S1U*-C]VIYYZWS>EU1VCD*7Z#(   !DK"_QQXF^&5!]\&!1F
MO=5_AGJ66/>T<\=;ZVA\^=Z                     -:.<?YL&:?@Z[ZJV
M-W9O>*.=I;1[O7S,9_1T_-3L?W1K?OD^+]L]YJYHZE&Q^[4\\];>,>6]0
M
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MFL16&(JVFUM.](HW341:<)ELX4J\D2+@;2:&T)/>E)$>GE$(',
M          !3ZK$<G4Z7$94E+C[?"A2S,DD>O5T(S =5$@O4VEQ83ZD+=9X^
M-39F:>R6I1:&9$>X_( 54                      6U;M&E4CM_MEQI?;3
MB5-]$:CT(N+?JE/D@+E                      'C99O\ 6LW5^7?R<0.D
MN?IL>7VG.6_U*?+@>R8YMT8
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M?1A@ML7:[F.G1H_3BR^-9L
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M9&?'M-'!I&=M6YM47J(T=+'&.6.).3N7(N5V:YTM'#">2>-NL/,>D
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M?+:EO&Q&6C1YXOL2\GJ@.JBLQ(],C,P7SDQ4<?1/G]EJM1GN(MQF9 *H
M                  +<M^)3(O;WL=-.9TCB3?UT[ RUT+81>6 N,
M               >-EF_UK-U?EW\G$#I+GZ;'E]ISEO]2GRX'LF.;=&
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M$A"3/34]NG"2:LUFIO81$:--.]'$LRV6BSC,SC55ORSN-1M
M                                        #%>=/B2S'\![A][9 VLE
MWBW^*GKAY6W?T_,?^*O_ *9:#<FV0[ M?$4BFW-?-OV[455^8\FGU.IQ8CYM
MJ:CDE?1O.(5PF:3T/338/?VK8N5W<::9F,(WHEP?[3VCE;&0BFY=HIJQG<FJ
M(G?XIEMBK,V'_&M9W?VG_CQYWRE[4JZ)=%XQDOCV_P ]/I=1YEQ!L_\ %:SN
M_M/_ !XR^5O:E71+#Q?)?'M_GI]+K7F3$)D>F5;/[^4_\>'RM[4JZ)1.U\E\
M:W^>GTNG^>/$7C4L_OY _'B?E;VI5T2Q\7R7QK?YZ?2X*S%B+3XT[0[^0/QX
MF,K>U*NB43M;)?&M_GI]+K/,.(_&G:'?R!^.#Y6[J5=$L9VMD_C6_P U/I<%
M9AQ)I\:5H=^X'XX3&5NZE71)&ULG\:W^:GTN@\P8E\:-H]^X'XX3\M=U*NB2
M=K9/XUO\U/I=:LOXF\:%H]^X'XX3&6NZE71+&=JY/XUO\U/I</YWL3>-"TM_
M^^X'XX3\M=U*NB6$;5R?QJ/S4^EU%EW$_C/M+OU _'!\M=U)Z)15M7)X^^H_
M-3Z7XK+N)]/C/M+OU _'"8RUW5GHECXIE/C4?FI]+J7ES%!D7_B=:??J#^.&
M49>[JST2B=J93XU'YJ?2X_SN8IV?^)UI]^H/XX3\O=U9Z)8SM3*?&H_-3Z72
MO+6*C_I-M3OU!_'"?E[NK/1)XIE/C4?FI]*"[EC%A[LE6J?F5F#^.&?R]S5G
MHEC5M/*?%H_-3Z5.?RIC ]V1[7/S*Q"_'">PN:L]$JZMIY7XM'YH]*E.Y0QF
M>[(EL'_Q>%^-&?87-6>B5-6T<K\6C\T>E3'LF8W,STR#;1^95H?XT9=C<U9Z
M%<[0RV/O:/S1Z5+=R1CL]U^VX?\ Q2)^-&<6:]6>A5.T,M\2C\T>E37<BX^,
M]E]6\?\ Q2)^-&46J^*>A3.>R_Q*?S1Z5-=R#81F>E[T _,J47\8+(MU\4]"
MFK.V/B4],>E3G;^L4]=+TH)_\2B_C!E%NKBE5.<L:]/3"GN7W8YD?_UE0_V*
MC&_&#*+=7%*FK-V=>GIA3';WLL]=+OHI_E\;\8+*:*N)KU9JUKT],*<[>EG&
M1Z791C_+X_HQG%,\2FK,6M:.F%.>O"TC+9=-(/9U)T?T8SIIEK7+UN?M1TJ,
M_==K*,]+EI9^9,8]&+*8EJ5W*>.&.KRR%!IT4HE ELU.J3-C;L=:7FV2W:F:
M3,C5KN3_ &?+SG?Y&I<F.#=F6[7*+RIO4E<'+V4(;CUQR=95LV_*(S5%X]=)
M4DE;W5:ZI2?G-Y]EYWEMK[5TL;5N=SAGC?5/V=^U8LQ&;S,?7GV:9X.6>5Z6
MI+1)$1::%N'./I#D     L>^OT=#_P!(_N%"81*]&?WEK[1/[0A+L
M              46XOT)4OP)_MD CVG_  ?@?WWU582+B
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M
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MHDBU,]I=0!'M9"VZ#!0XDT++I=4J+0R^^KZAA(N
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M.=I;1[O7S,9_1T_-3L?W1K?OD^+]L]YJYHZE&Q^[4\\];YO2ZH[1R%+]!D
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MI5(B1WHA(-;KW KI",RTX3/J&7D"8%Q-J-3:%'O4DC/]DA Y@
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M-[S&$IA;4FDS';FAU1"4]J,H)*U&HM=22HMW[(F)2NL
M     6S=%*EU:)'9ADE2VWN-1*5P[.$R_=$P+C;2:6VTGO2DB/\ 8(0.8
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MWS>EU1VCD*7Z#(   !DK"_QQXF^&5!]\&!1FO=5_AGJ66/>T<\=;ZVA\^=Z
M                    -:.<?YL&:?@Z[ZJV-W9O>*.=I;1[O7S,9_1T_-3L
M?W1K?OD^+]L]YJYHZE&Q^[4\\];>,>6]0
M                                           'AQR2?'+S'>Z!^^,P
M=#MKW-KRX(>!L7WEWGCKEZ;HW$.==!"8T$B06\O-"$)! 0D($)2F^H)$@MY>
M: DI!"2G<)(2DB$I*-Q"1W$"$@MY"!(3YT2B7-.\90B4IK[$!,;WF,)3"S)K
M[Z;RI[*7EDRILN)HE'PGV*]Y;A,;R5\@                     "S+U??C
MP(BF'ELJ5(T-3:C29EPJV;!,(E=[)F;31F>IFA.I_L"$NP
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M+]!D    R5A?XX\3?#*@^^# HS7NJ_PSU++'O:.>.M];0^?.]
M          &M'./\V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?FIV/[HUOWR?%^
MV>\U<T=2C8_=J>>>MO&/+>H
M                                 #PXY)/CEYCO= _?&8.AVU[FUY<$
M/ V+[R[SQUR]-T;B'.N@A,:"1(+>7FA"$@@(2$"$I3?4$B06\O- 24@A)3N$
MD)21"4E&XA([B!"06\A D)\Z)1+FG>,H1*4U]B F-[S&$IA09%/@N5^+.74$
M-S6D$3<$U)XE%HHM=#/7J^0$)7()                     !0+A@09\9AN
M=.3 ;0[Q(<4I*24KA,M.R,@%=01)0A*3XB))$1^26@#D
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MC^Z-;]\GQ?MGO-7-'4HV/W:GGGK;QCRWJ
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MPD7$                      +$LC_M?\,C^Z$RB%]B$@
M      #QLLW^M9NK\N_DX@=)<_38\OM.<M_J4^7 ]DQS;HP
M                       !K1SC_-@S3\'7?56QN[-[Q1SM+:/=Z^9C/Z.G
MYJ=C^Z-;]\GQ?MGO-7-'4HV/W:GGGK?-Z75':.0I?H,@   &2L+_ !QXF^&5
M!]\&!1FO=5_AGJ66/>T<\=;ZVA\^=Z                     -:.<?YL&:
M?@Z[ZJV-W9O>*.=I;1[O7S,9_1T_-3L?W1K?OD^+]L]YJYHZE&Q^[4\\];>,
M>6]0
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ML!U45V$]3(SE.95'AJX^A97O+1:B5KM5O/4]X"J
M "W+?D4E_M[V*B.1>!:2D\?V2MNAEV2O+ 7&                      /&
MRS?ZUFZOR[^3B!TES]-CR^TYRW^I3Y<#V3'-NC
M               &M'./\V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?FIV/[HUO
MWR?%^V>\U<T=2C8_=J>>>M\WI=4=HY"E^@R    9*PO\<>)OAE0??!@49KW5
M?X9ZEECWM'/'6^MH?/G>@                    #6CG'^;!FGX.N^JMC=V
M;WBCG:6T>[U\S&?T=/S4[']T:W[Y/B_;/>:N:.I1L?NU///6WC'EO4
M
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MK>E1;_*/4BXC.Y&O*UX3O<$ON&Q-N6-J68KMSA5PT\,2SN1D>X]1I/;?H
M            +)OE"ET^(24FHRD;2(M?L%"81*\F?WEK[1/[0A+L
M             4:X2-5%J)$1F9M'H1>:0"/:J330(!*(TF72ZD>P_P!]6$BX
M0                     !8ME(4GV7XDFG5Y&FI:?VPE$+Z$)
M           'C99O]:S=7Y=_)Q Z2Y^FQY?:<Y;_ %*?+@>R8YMT8
M                              UHYQ_FP9I^#KOJK8W=F]XHYVEM'N]?
M,QG]'3\U.Q_=&M^^3XOVSWFKFCJ4;'[M3SSUOF]+JCM'(4OT&0   #)6%_CC
MQ-\,J#[X,"C->ZK_  SU++'O:.>.M];0^?.]                     &M'
M./\ -@S3\'7?56QN[-[Q1SM+:/=Z^9C/Z.GYJ=C^Z-;]\GQ?MGO-7-'4HV/W
M:GGGK;QCRWJ
M                    #%>=/B2S'\![A][9 VLEWBW^*GKAY6W?T_,?^*O_
M *9:<<C'Q)ROA+.]1C#VML>^^B'(?LS]-C\4];<A0\QTSI7N$JW2)0Z5C*&$
MN@Q+&4=>[]D2Q="MPF$2CJWE^R,D.![C_8$PK=*MXF$0Z5;U>8,XWF-2"[YY
M/[(SA75O*'+WK&4->I09?G19"BI;\O>0LH:]2B/>=,6**E$?&:BM19&]?F"V
MAJ5*&_YS]D74-6M1Y&X_,%E.^U*UK366I$=V.^VAYA]*FW6ED2DJ2HC(R,CW
MZBYH76#H<V[L#WC"OVPIJVHC2R)]A1FILVU&7'&DIU[-M74/>1Z;>(B,\,QE
MZ<Q1HUQN*=G[1O;-O1>LSAQQQQQ/:# V=;5SA:S=:H[J(5;B)2W<-O.+(WHC
MQ^5H7$A6AFE1%H?E&1D7#Y[(UY6O"=[@E]VV'MRSM6S%=$X5<-/#$L\#2>V
M             "W+EJ\FCQ6'XJ&G%NN]&HG249:<)GLX5)\@2+@;4:VT*/>I
M)&>GED(',                    !3ZK+<@TZ7+92E3C#?$A*R,TF>O5T,C
M =5$G/5*EQ9KZ4(=>X^-+9&2>Q6I):$9F>XO) 54
M  6U;M9E5?M_MEMI':KB4M]$2BU(^+?JI7D +E
M'C99O]:S=7Y=_)Q Z2Y^FQY?:<Y;_4I\N![)CFW1@
M                 #6CG'^;!FGX.N^JMC=V;WBCG:6T>[U\S&?T=/S4[']T
M:W[Y/B_;/>:N:.I1L?NU///6^;TNJ.T<A2_09    ,E87^./$WPRH/O@P*,U
M[JO\,]2RQ[VCGCK?6T/GSO0                    !K1SC_-@S3\'7?56Q
MN[-[Q1SM+:/=Z^9C/Z.GYJ=C^Z-;]\GQ?MGO-7-'4HV/W:GGGK;QCRWJ-/\
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MJ<,8QW)Y6]0\IZ8
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M-2+4]2ZIF1 .BWHDB#1X<64WT3[72=(WJ2M.)Q2BVI,RW& K0
M           M*UJ9.IWLEVZQT/;#B5-=DE6I%Q:^=,]-X(7:"0
M          !XV6;_ %K-U?EW\G$#I+GZ;'E]ISEO]2GRX'LF.;=&
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MGH9'J6XP'1;3[TFB0GY#JGGE])QN+/4ST<41:GYA *Z
M     +-M&;+E^RG;4AR1T3J2;XU&?"1\6[7S 1"\@2
M   /&RS?ZUFZOR[^3B!TES]-CR^TYRW^I3Y<#V3'-NC
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M8WM*<<.9M"-%N@
M      #%>=/B2S'\![A][9 VLEWBW^*GKAY6W?T_,?\ BK_Z9>?7)]E3'%FX
MDD4BZKUI% JBZ_,D)@39*&G3:6TP25\*CUT,TF.@VIE[ER]C33,QA' X+]I[
M3RMC(11<NTTU8SN35$3O\LMISY@,)G_2A;O=S?7'G_)WM2>AT/C.1^-;_-'I
M=2L_85TV9/MT_P N:ZXGY.]J3T,/&<E\:C\T>ETGGW"WC.MWNYKKB?D[VI/0
MCQG)?&H_-'I=2\^87,OC-M[NUOKB?D[VI/0PG;&2^-1^:/2Z3SWACQF6_P!V
MM]<3\I>U)Z$3MC)?&H_-'I="\\X9/=DNW^[6^N,OE+VK/0Q\7R7QJ/S1Z74K
M.^&]/C*M\_RUOKA&4O:L]")VODOC4?FCTND\ZX<,R_\ $JW]G_SK?7$_*W=6
M>A'B^2^-1^:/2X'G3#NA_P#B3;Y_EK?7&496[JST,?%LG\:C\T>EU'G/#VOQ
MD4#NUOKB8RMW5GH8^*Y/XU'YH]+J5G'#YF?_ (CT#:7^>M]<91EKNK/0B=JY
M/XU'YH]*(YF[$1F1ED:@[/\ YQOKC.,M<U9Z%=6U<I\6C\T*1)S1B=7%PY"H
M2M?(F-]<3&7N:L]"FK:64^+1^:%&DYAQ:M/8W]1#/R"F-]<61E[FK*BK:65^
M+1^:%$DY9QFLR--]44_RMOKC.FQ<U94U;0RWQ*?S0I+N4\<&1Z7M1S_*F^N,
M^RKU94SGLO\ $IZ84E[)N/3W7G2#\R4WUQEV5?%*BO.Y?XE/3"DO9'L)1JTN
M^E;2_P Y1UQ93;JC@EK59RSKT],*0]D*QC1H5V4LSUZDA'7%M--7%+7JS-K7
MIZ84I^_;+41\-T4T]G^<(ZXLIB<=Z6K7?MS]J.F&';INVJ7A58=A8[8=K%1K
M#J8W30RXE/*<_P":9,MR=//KW::[=-3%M5441I5;D0T*M/,7(M68TJIXO+S\
M#U.Y8N6"DX4I**S5R9JM_P!68(JG4M-6XB%;3C1N(M=",BXE;#4?E:$7&;3V
ME5F:M&G<IA]D_;'[9M[+HTZOK79C=GBY(;>(1PCRG6.8               +
M>N.FL5.*PT_/13TMN\9..$1DH^$RTVJ3Y("O-D24(21\1)21$KR=" <P
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M^@R    9*PO\<>)OAE0??!@49KW5?X9ZEECWM'/'6^MH?/G>@
M         #6CG'^;!FGX.N^JMC=V;WBCG:6T>[U\S&?T=/S4[']T:W[Y/B_;
M/>:N:.I1L?NU///6WC'EO4
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M!'M/^#\#^^^JK"1<0                      L2R/^U_PR/[H3*(7V(2
M                   /&RS?ZUFZOR[^3B!TES]-CR^TYRW^I3Y<#V3'-NC
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M%D9$9I)6>SK%67TKUR)IB*9PQW,9EAG[U-_1LVYQF9C'#@B'I:/$>R
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MNX*8A2C4EIRM0TORD)U/L4\9),DELW_LQ(V4$
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MW1(I1W'T&?GDKU09&7E_L)&TX@
M!X<<DGQR\QWN@?OC,'0[:]S:\N"'@;%]Y=YXZY>FZ-Q#G700F-!(D%O+S0A"
M00$)"!"4IOJ"1(+>7F@)*00DIW"2$I(A*2C<0D=Q A(+>0@2$^=$HES3O&4(
ME*:^Q 3&]YC"4PL>=_#:G?@T_<K$QO)7\                      +'OK]
M'0_](_N%"81*]&?WEK[1/[0A+L                     46XOT)4OP)_MD
M CVG_!^!_??55A(N(                      6)9'_ &O^&1_="91"^Q"0
M                    !XV6;_6LW5^7?R<0.DN?IL>7VG.6_P!2GRX'LF.;
M=&                                     -:.<?YL&:?@Z[ZJV-W9O>
M*.=I;1[O7S,9_1T_-3L?W1K?OD^+]L]YJYHZE&Q^[4\\];YO2ZH[1R%+]!D
M   R5A?XX\3?#*@^^# HS7NJ_P ,]2RQ[VCGCK?6T/GSO0
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MCJRJ1%8>3';DFZ[P<+FXNQ,]?_0)%>;5Q(0K33B21Z>:0@<P
M        $"J2CA4^7+)M+IL(XB;5N/RC =5%FG4:9&F*:2R;W'JTCSI<*U)V
M?V %4                      %N6_5U57M[BC-Q^UG$I+@^RUUVG_8 7&
M                     /&RS?ZUFZOR[^3B!TES]-CR^TYRW^I3Y<#V3'-N
MC                                     &M'./\V#-/P==]5;&[LWO%
M'.TMH]WKYF,_HZ?FIV/[HUOWR?%^V>\U<T=2C8_=J>>>M\WI=4=HY"E^@R
M  9*PO\ ''B;X94'WP8%&:]U7^&>I98][1SQUOK:'SYWH
M      UHYQ_FP9I^#KOJK8W=F]XHYVEM'N]?,QG]'3\U.Q_=&M^^3XOVSWFK
MFCJ4;'[M3SSUMXQY;U
M                             >''))\<O,=[H'[XS!T.VO<VO+@AX&Q?
M>7>>.N7INC<0YUT$)C02)!;R\T(0D$!"0@0E*;Z@D2"WEYH"2D$)*=PDA*2(
M2DHW$)'<0(2"WD($A/G1*)<T[QE")2FOL0$QO>8PE,+4ETZ:Y=<*>B.I41ML
MB6_J6A'PK+R=>J)C>2O$                      6G=U/F5&%&:AL&^XA_
MB6DC(M"X3+7:9"8)72T1I:;29:&E)$9>80@<P                    %+K
M3#TJE3H["#<>=;-+:"T+4]2\D!T6[%?AT:'&DMFT^WTG&V9D9EJXHRW:]0P%
M;                      %H6I3IL#V2[<8-CIW4J:U,CU(N+7<9^2"(7>"
M0                    !XV6;_6LW5^7?R<0.DN?IL>7VG.6_U*?+@>R8YM
MT8                                     UHYQ_FP9I^#KOJK8W=F]X
MHYVEM'N]?,QG]'3\U.Q_=&M^^3XOVSWFKFCJ4;'[M3SSUOF]+JCM'(4OT&0
M  #)6%_CCQ-\,J#[X,"C->ZK_#/4LL>]HYXZWUM#Y\[T
M     :T<X_S8,T_!UWU5L;NS>\4<[2VCW>OF8S^CI^:G8_NC6_?)\7[9[S5S
M1U*-C]VIYYZV\8\MZ@
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M\90B4IK[$!,;WF,)3"U)=1FMW7"@(D*3$<;(UL:%H9\*S\C7J"8WDKQ
M                 %IW=4)E.A1G8;YL.+?X5J(B/4N$STVD8F"5TM&:FFU&
M>IJ21F?FD(',                    !2ZT^]%I4Z0PLVWFFS4VLM#T/4O)
M =%NRGYE&AR9+ANON=)QN&1$9Z.*(MVG4(!6P                     !:
M%J5&;/\ 9+MQ\W^@=2EK4B+0CXM=Q%Y (A=X)                     'C
M99O]:S=7Y=_)Q Z2Y^FQY?:<Y;_4I\N![)CFW1@
M               #6CG'^;!FGX.N^JMC=V;WBCG:6T>[U\S&?T=/S4[']T:W
M[Y/B_;/>:N:.I1L?NU///6^;TNJ.T<A2_09    ,E87^./$WPRH/O@P*,U[J
MO\,]2RQ[VCGCK?6T/GSO0                    !K1SC_-@S3\'7?56QN[
M-[Q1SM+:/=Z^9C/Z.GYJ=C^Z-;]\GQ?MGO-7-'4HV/W:GGGK;QCRWJ
M
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M_DX@=)<_38\OM.<M_J4^7 ]DQS;HP
M     !K1SC_-@S3\'7?56QN[-[Q1SM+:/=Z^9C/Z.GYJ=C^Z-;]\GQ?MGO-7
M-'4HV/W:GGGK?-Z75':.0I?H,@   &2L+_''B;X94'WP8%&:]U7^&>I98][1
MSQUOK:'SYWH                     UHYQ_FP9I^#KOJK8W=F]XHYVEM'N
M]?,QG]'3\U.Q_=&M^^3XOVSWFKFCJ4;'[M3SSUMXQY;U
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MJ6\-ZY$1C'+Z&RB=X\^'2RE-?8@)C>\QA*86/._AM3OP:?N5B8WDK^
M                %CWU^CH?^D?W"A,(E>C/[RU]HG]H0EV
M        *+<7Z$J7X$_VR 1[3_@_ _OOJJPD7$
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M\U.Q_=&M^^3XOVSWFKFCJ4;'[M3SSUMXQY;U
M                                             !BO.GQ)9C^ ]P^]
ML@;62[Q;_%3UP\K;OZ?F/_%7_P!,M->1KXE)7PCG>I1A[6V/??1#COV;^FQ^
M*>MN$X/-ATB*KJC)6BN#*&$H:A9P,:MY'7O,32J1%>?&<L*MY39.X]3,O($P
MPJWEJ3_/+T48OI:M:T)I;#U4>\7TM2XM2;IV79"Z&E<6K+W'V0OI>?<6E.W*
M[(QL4O-O;RRZEP<!DI6J3U(R/JD-FAXF9WF!;-?NN#F*B*P8J2N[%2N"G-12
M)3*EJUZ="B5V!Q^#7I./L2+4]Q$8HSL69M5=K[/#ZEVP9SE.=HG*>]QW.+#A
MTONX;_I?0!23J:J93CK28R*R<5DZLB&:SC%*X"Z8F3<T4:"7KP\6W3>/GTX8
MSAO/T73I:,:6&/#AO8\BLM?8B&28WO,82F%OR"HWA%%-Y;OLMP%T"2UX--%:
M:[--VH0E<PD                     %O7&5(.*Q[,*<2QTOWHV^+7CX3_M
M2/J"17F^'@1P>=X2X?,TV"!S                     0*H40Z?+*<:DQ.#
M[^:==>'RM-H#JHI02ID8J::E0NSZ$UZ\7GU<6NNA^>U 50
M        6Y;Y4<NWO8E;BM7$]M<?%Y[;IIJ1>6 N,
M   >-EF_UK-U?EW\G$#I+GZ;'E]ISEO]2GRX'LF.;=&
M                    -:.<?YL&:?@Z[ZJV-W9O>*.=I;1[O7S,9_1T_-3L
M?W1K?OD^+]L]YJYHZE&Q^[4\\];YO2ZH[1R%+]!D    R5A?XX\3?#*@^^#
MHS7NJ_PSU++'O:.>.M];0^?.]                     &M'./\V#-/P==]
M5;&[LWO%'.TMH]WKYF,_HZ?FIV/[HUOWR?%^V>\U<T=2C8_=J>>>MO&/+>H
M
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M                      %CWU^CH?\ I']PH3")7HS^\M?:)_:$)=@
M               "BW%^A*E^!/\ ;(!'M/\ @_ _OOJJPD7$
M          +$LC_M?\,C^Z$RB%]B$@                    #QLLW^M9NK
M\N_DX@=)<_38\OM.<M_J4^7 ]DQS;HP
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M=JNY31JFN:J9G"8GEX8>B \=ZX
M                   Q7G3XDLQ_ >X?>V0-K)=XM_BIZX>5MW]/S'_BK_Z9
M>4O+AS0V!A_'CUI7+2+@G5%RK29Z7J9'BNL=&\AI*2-3TME7%JV>O8Z>6.JS
M^SKE^YI4S&&YOX^A\JV!^Z,ML_*19N4US5C,[D1AN\]4,\KY\L0JW6Y>'<=/
M_6 U/!KW'3Y_0]?^<9+4N=%/]SI/GNQ$>O\ ].7?M_\ DX'ZP$^#WN.GS^AA
M_-LEJ7.BG^YT+YZ<2*W6[=W<D#\_$^$7>.GS^AC/[TR>I<Z*?[G0?/+B8_\
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M,BL.OP$5!+CO 3;AD1)/A,]=J5>0 KS9DI"%$7"2DD9)\C4@',
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M/%&.]S1R-/-V:JM"B;FG5,QA&YN1QSAO\[V?'-.B
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M#E3(,5$2.N0M#_$I+9&HR+A,M=@F$2NMHC)ILC+0R21&7[ A+L
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MYO2ZH[1R%+]!D    R5A?XX\3?#*@^^# HS7NJ_PSU++'O:.>.M];0^?.]
M                   &M'./\V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?FIV/
M[HUOWR?%^V>\U<T=2C8_=J>>>MO&/+>HM>[K(LZ_Z2N@WO:U*NVC+63GL;5H
MC4ME+A$9$XA+J5<*RU/12=#+J&++=VNW.-,S$\C"Y:IN1A5$3'*LJP\"88QC
M47*Q86-:#;-8<0IOV7BQ$G*2A1:*0A]?$XA*BWDE1$?5%EW-WKL85U3,*K65
MM6IQHIB)9%K]OT2ZJ-4+=N2E1JY0JLT;%3I,QM+K#[1F1FAQ"M246I;C%-%<
MT3I4SA,+JZ(KC"J,82*32J;0:53*'1H+-,H]&B,P:538R";9CQHZ":99;06Q
M*4(222(MQ$(JJFJ9F=^4TTQ3$1&]"H"$L-7#R[X-NRZ?#6Y,56W6KH4XAY^K
MRH+:UO.-^=6^DRX'5%H6U:3ZGD#9HSEZBG1IKF(YVO7E+-=6E53$RR3<5M6_
M=U#GVU<]'B5VWZHVEJHT::TEV.\A*DK2E;:B,C(E)(]/*%%%=5$Z5,X2NKHI
MKC1JC&%3A0HE-AQ*= C-PX$!EN-"ALI)#;3+220VVA);"2E)$1$0B9F9QE,1
M$1A#!1\JW+<HS,\(6:9F>IF=)CZF?_N#:^?S&O5TM;Y&QJ1T+]H.)\96Q:]5
MLFW["H5*L^NNN/UJV&(+)0);CS;;3BGXYI-"S4AI"3XBW)+R!57F+E=4535,
MS'#CNK:;%NFF:8IC">!2K"P;B#%\^95<?XYH=J52>@VI53@Q4)D&T9D9M)>5
MQ+2@S(C-*3))Z%LV$,KV:NW8PKJF88VLM:M3C13$2RL-=>
M                                        #PXY)/CEYCO= _?&8.AV
MU[FUY<$/ V+[R[SQUR]-T;B'.N@A,:"1(+>7FA"$@@(2$"$I3?4$B06\O- 2
M4@A)3N$D)21"4E&XA([B!"06\A D)\Z)1+FG>,H1*4U]B F-[S&$IA:TJJ3F
MKIA4Y#_#"=01N,\*3U/A4?GC+7J>2)A*[P                     !:MV5
M*;3(<9V"]T#CCW M7"E6I<)GIV1'Y F!<[1FIMM1[34DC,_+,A Y@
M             *969#T2ES9,=?1O,MFIM>A'H>I=0R,@'1;TN1.H\.5*<Z5]
MWI.D<T).O"XI);$D1;B 5H                      6E:U3G5'V2[=?Z;M
M=Q*6NQ2G0CXM?.D6NX$+M!(                     \;+-_K6;J_+OY.('
M27/TV/+[3G+?ZE/EP/9,<VZ,
M :T<X_S8,T_!UWU5L;NS>\4<[2VCW>OF8S^CI^:G8_NC6_?)\7[9[S5S1U*-
MC]VIYYZWS>EU1VCD*7Z#(   !DK"_P <>)OAE0??!@49KW5?X9ZEECWM'/'6
M^MH?/G>@                    #6CG'^;!FGX.N^JMC=V;WBCG:6T>[U\S
M&?T=/S4[']T:W[Y/B_;/>:N:.I1L?NU///6WC'EO4<5K0VA;CBTMMMI-3CBC
MT))%M,S,]Q$ LU[(^/XU&IMQ3+WH4&@UE2T4BL2ZA'CQI2FS-*R9==6E*]#2
M>O"9@.NEY.QM7)K-,HF0K:K%1D'PQZ?!JT.0^X>NFB6VW5*/?U" 5ZO7';]K
M0%52Y:Y H%-2HD'.J,AN,UQF1F226ZI)&H]#T(MI@*;;-^63>A/^"5V4FXU1
M2(Y35.EM2%M$9Z$:T(4:DD9[C,@$]VZ+98KT:UGKBIC-SS&C?B6XN6RF>ZT2
M5*-:(QKZ5222A1ZDG30C\@P%7DR8\.._+EOMQ8D5M3TJ4\HD-MMH(U+6M:C(
MDI21:F9[@%.HEP4&Y8*:I;E;@7!3%K4VFHTV2U+8-:-BDDZRI2=2ZI:@.J-<
M]M3:W.MJ'<-,EW'3&NFJ5OLRV7)T=L^#LW8Z5FXA/WQ.U22+LB\D@%< 4FM5
MZAVW <JEPUF#0J8THDN5"H2&XS"5*W$;CJDIU/J%J HELY"L2\W'6;3O"CW%
M(83Q/QH$QE]U"=A<2FT*-1%MWF6@"ZY,F/#CORY;[<6)%;4]*E/*)#;;:"-2
MUK6HR)*4D6IF>X!3Z+7Z%<L!%4MRM0*_3'%J;14:;):E,*6@]%))UE2DF9'O
M+4!0:SDC'=N5!VDW#?MN4*J,)2I^FU&JQ(LA!+22D&IIUU*B)1&1EJ6T@$J@
MWU9%TON1K8O&AW'):2:W8]+J,:8M*2T(U*2RXLR(M2V^6 NH!1&[EMQZN/VP
MU7Z:[<L5DI,FWD2F53FV3))DZN,2ND2GLT]D:=-I>2 G5&I4ZCP953J\^-2Z
M;"0;LVH3'4,,,H+>IQQPTI21>29@*/#O.TJD_18U.N6F5!VXV7Y%OE%E-/)F
MM13T?7'4VI27";/SW"9Z=4!<H
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M2S,DD>O5T(S =5$@O4VEQ83ZD+=9X^-39F:>R6I1:&9$>X_( 54
M             6U;M&E4CM_MEQI?;3B5-]$:CT(N+?JE/D@+E
M           'C99O]:S=7Y=_)Q Z2Y^FQY?:<Y;_ %*?+@>R8YMT8
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M"-'WELR3]GM\Z9"1Z'#$:5V90H/,+E;(-XWTPFN65C2KNVU8EIR.S@&^P?\
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MJL=+-0+=KV9Z[/[(@;MB
M   'AQR2?'+S'>Z!^^,P=#MKW-KRX(>!L7WEWGCKEZ;HW$.==!"8T$B06\O-
M"$)! 0D($)2F^H)$@MY>: DI!"2G<)(2DB$I*-Q"1W$"$@MY"!(3YT2B7-.\
M90B4IK[$!,;WF,)3"R9JE%>M/22CX3;+5.NSSJQ,;R5^
M      "R;Y6I%/B&E1I,Y&TR/3[!0F$2O)G]Y:^T3^T(2[
M       %&N$S31:B9&9&31Z&7FD CVJHU4" :C-1GTNIGM/]]6$BX0
M               !8ME+4KV7XE&K1Y&FIZ_VPE$+Z$)
M    'C99O]:S=7Y=_)Q Z2Y^FQY?:<Y;_4I\N![)CFW1@
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MHS2G"H]':6;L:*L]#-#<;@:U(]Q[#,^ @Q&2JQC*HYIRH_"O"B5.@X@Q7$3
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M9'\XN?,96!3&>VZ=B^1X97Q-+:B-))'^S&#/<3AKT7IU4J(R\ZH!M2(
M                                      >''))\<O,=[H'[XS!T.VO<
MVO+@AX&Q?>7>>.N7INC<0YUT$)C02)!;R\T(0D$!"0@0E*;Z@D2"WEYH"2D$
M)*=PDA*2(2DHW$)'<0(2"WD($A/G1*)<T[QE")2FOL0$QO>8PE,*!(CTA5PQ
M7W9;B*JE!$S%+SBBT5O[ ^IK]D$)7*)                     !;UQQZ5(
MBL)JTI<1E+NK:V]YJX3V>=5U %>;))(023U222X3\K38 Y@
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M;TNJ.T<A2_09    ,E87^./$WPRH/O@P*,U[JO\ #/4LL>]HYXZWUM#Y\[T
M                    :T<X_P V#-/P==]5;&[LWO%'.TMH]WKYF,_HZ?FI
MV/[HUOWR?%^V>\U<T=2C8_=J>>>MO&/+>HL*IV%"GY"MC(K4YZ#5;?ITVDRX
M[:4FW.AR]%I:=4?9%T3J>D3IU==0%^@                     #@ZE:FW$
MMN=$XI)DV[H2N%1EL/0]^@"Q["Q_2;!@U-F%(D56K5^>]5+DN.<:%3)\MY1F
M:W30E"2)!=BA"4DE);BU,S,+[
M        !X<<DGQR\QWN@?OC,'0[:]S:\N"'@;%]Y=YXZY>FZ-Q#G700F-!(
MD%O+S0A"00$)"!"4IOJ"1(+>7F@)*00DIW"2$I(A*2C<0D=Q A(+>0@2$^=$
MHES3O&4(E*:^Q 3&]YC"4PL>=_#:G?@T_<K$QO)7\
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M37%W;$ZP> 5Z\'CU&I)]:_CWQ37%W;$ZP> 5Z\'CU&I)]:_CWQ37%W;$ZP>
M5Z\'CU&I)]:_CWQ37%W;$ZP> 5Z\'CU&I)]:_CWQ37%W;$ZP> 5Z\'CU&I)]
M:_CWQ37%W;$ZP> 5Z\'CU&I)]:_CWQ37%W;$ZP> 5Z\'CU&I)]:_CWQ37%W;
M$ZP> 5Z\'CU&I+%6</I';*ROB:^\=4_&];I,V[J8N!&J,B7&6TRI2TJXEI07
M$9=CU!L978U=F[37-43A+7S6V:+UJJB*9C&%J<L?/Y:&!L/4#&E7Q_6*_.H\
MF>^[4X<F.TTLIDIR0DB2X7$7"2]#&>>V37F+LUQ5$8X,,CM:G+VHHFF9PQ;
M?6OX]\4UQ=VQ.L-3P"O7AM^/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-
M<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7
MKP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK
M^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3
MK!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4
M:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-
M<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7
MKP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK
M^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3
MK!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4
M:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-
M<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7
MKP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK
M^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3
MK!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4
M:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-
M<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7
MKP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK
M^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3
MK!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4
M:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-
M<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DGUK^/?%-<7=L3K!X!7
MKP>/4:DGUK^/?%-<7=L3K!X!7KP>/4:DO/S _,U1L/WQD^[)UK3:VQ?TDWXD
M-A]MI<<NV7W]%J4E1*/1TBV>0/3S^SJLS113$Q&B\[(;1HR]==543.EQ?3Z6
MU1?216D6G_AC5^[V/Q8\S^/UZ\=#T_'K6K5YO2[T?246DG^B^KG^7Q_Q8?Q^
MO7CH/'K6K5YO2["^DKM$C+_PNJ_?"/\ BP_C]>O'0>/6M6?-Z787TE]H^*VK
M]\(_XL/X_7KQT$;>M:M7F]+M+Z3*T2_HLK'?"/\ B@_C]>O'0GQZUJU>;TNU
M/TF]H)_HKK'?"/\ B@_C]>O'0CQZUJU>;TNPOI.K0(]?YJJQWQC_ (H/X_7K
MQT'CUK5J\WI=I?2?6>7]%%8[XQ_Q0?Q^O7CH/'K6K5YO2[2^E"L\OZ)ZSWQC
M_BA/@%>O'0>/6M6KS>EW%]*/9Q?T35GOE'_%"/X_7KQT'CUK5J\WI=B?I2[.
M(OBEK/?*/^*$^ 5Z\=!X]:U:O-Z787TIMFE_1)6>^4?\4'@%>O'0>/6M6KS>
MEV%]*C9I'\4=9[Y1_P 4(_C]>O'0>/6M6KS>EV%]*K9I%I_-%6>^<?\ $B?
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;2HM=Y&6TC'F;8G_[-7T=3T]CQ_\ 6I^GK?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2227887d1-pht_key4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_key4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    4   _^$#,&AT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-BXP+6,P,#4@-SDN,38T-3DP+" R,#(P+S$R+S Y+3$Q.C4W.C0T
M(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N
M;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"\B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UP.D-R96%T;W)4;V]L
M/2)!9&]B92!);&QU<W1R871O<B R-2XT("A-86-I;G1O<V@I(B!X;7!-33I)
M;G-T86YC94E$/2)X;7 N:6ED.D4P,C$U,30U.3<S03$Q141!-SA"03@U-#@P
M0T9$14-"(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.D4P,C$U,30V.3<S
M03$Q141!-SA"03@U-#@P0T9$14-"(CX@/'AM<$U-.D1E<FEV961&<F]M('-T
M4F5F.FEN<W1A;F-E240](GAM<"YI:60Z13 R,34Q-#,Y-S-!,3%%1$$W.$)!
M.#4T.#!#1D1%0T(B('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z13 R,34Q
M-#0Y-S-!,3%%1$$W.$)!.#4T.#!#1D1%0T(B+SX@/"]R9&8Z1&5S8W)I<'1I
M;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B
M/S[_[@ .061O8F4 9,     !_]L A  " @(" @(" @(" P(" @,$ P(" P0%
M! 0$! 0%!@4%!04%!08&!P<(!P<&"0D*"@D)# P,# P,# P,# P,# P, 0,#
M P4$!0D&!@D-"PD+#0\.#@X.#P\,# P,# \/# P,# P,#PP,# P,# P,# P,
M# P,# P,# P,# P,# P,# S_P  1" &L V$# 1$  A$! Q$!_\0 V  !   '
M 0$!              $" P0%!@<("0H! 0 " P$! 0             ! @,$
M!08'"!   0,# P($ P4#!@8*#P@# 0 " Q$$!2$2!C$'05$B$V$4"'&!,B,5
MD4(6H;'!4C,DT6)RM"47X4-3-(24E78W&/#Q@I*BLL)CLT2D=86U.-+RTU2E
M5E<H@\-T$0 " 0,# @0$ P4%!@4$ P$  0(1 P0A$@4Q05%A$P9Q@2(RD;$4
MH=%"4C3!8G(C%?"2,R06!^'QHG-4@L)#-K+2-9/_V@ , P$  A$#$0 _ /OX
M@" ( @" ( @" ( @" ( @" ( @" (#5\US;A_'+AMIG>38S$W;V[Q:W-S''+
MM/1Q87;@#X&BYV7S&'B2VWKT(2\'))_@='$XC,RX[K-J<X^*BVOQ,B_D. CQ
M/Z])G,?'@@&DYIUS$+2CGB-I]\NV:N(:->NBSO.QU9]=W(^G_-N6WK3[JTZZ
M=>I@6#D.]Z"MR]3^7:]W2OVTKTUZ=#!?ZR.W?_[]XY_RI:?_ (JT_P#7^-_^
M3:__ .D?WFY_H'(__&N_[DOW&R8S+8K-VHOL-D[3+63G%C;RRFCN(BYOXFA\
M9<VH\15;^/E6<F&^U.,X^,6I+\4:&1BW<:>R["4)>$DXO\&4\MG,+@;=MUG,
MO98:V>[8RXOKB.W8YU*[0Z1S03\%7)S+&+'=>G&"\9-17[2V-AW\J6VS"4WX
M13D_V%S97]CD[6*^QMY!D+*X%8+RVD;+$\ TJU["6G7R*R6;UN]!3MR4HOHT
MZI_-&.]9N69N%R+C)=4U1KY,PCN:<.:XM=RS#-<TT<TW]N""/ ^M:CY?"7_Y
MK?\ OQ_>;:XG-?\ ^&Y_N2_<9/(9O#8FR;DLKEK/&X]^W9?74\<,)W"K:2/<
M&FHZ:K8OYEBQ#U+LXQCXMI+\7H:]C#O7Y^G;A*4O!)M_@M2KCLGC<O:LOL3D
M+;*64I(CO+25D\3B.M'QES33[5:QD6LB&^U)2B^\6FOQ16_CW;$]EV+C)=I)
MI_@S%?QAQ(9,87^*,1^L&3V1BOG8/F?<Z;/:W[]WPI5:W^JX?J^CZT-]:;=T
M=U?"E:U\C9_TK,]+UO1GLI7=MEMIXUI2GF;&M\T @" ( @" ( @" ( @" PO
M(\_C>+8/)\ARTIBQ^*@=/<.;JYU-&L:#2KGN(:T>9"U,_.M85B=^ZZ1@JO\
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M@%5Y2?OEQY7]+MCZ&_9OUK7IUZ4W?^G4]5#V,I<5^JW2]?9OV:4IUZ=:[?\
MU:'1>\_<+)]M>+V&=Q5E:W]Q=Y2*P?#=[]@9)!/*7#VW--:Q =5WO=O.W>'Q
M8WK45)N:C25:4:D^S7\IPO:?!VN8RI6;LG%*#E]-*U3BNZ?\QSC)=R^_6"Q4
MW(,QVRQ3,)9Q"XO)X;MCWMA-/5MCNI7@ &I.PT&IT7 R/<'N#&M._=Q(>FE5
MM23T^4Y/]FAWL?V_[?R;JL6LN?J-T2<6M?G"*_;J=ZX5RJTYMQ;#<HLH76T&
M6A<\VSSN,<D;W12LW4&[:]CA6@KU7M>(Y*')8EO)@J*:Z>#3::^33U[GB^7X
MV?'9=S&FZN#Z^*:33^::T[&I]T.YT/;ZUQ=K9XQ^>Y-R&8V^"PD1(+W5:W>_
M:'.IN<  !5Q-!XD<SW'[BCQ481A#U+UQTA%=_-_-I4ZM_-KI>W?;TN5E.4Y^
MG:MJLY/MY+Y)NO1+Y)\OO^[7=[A$F-R?<?@>.@XU?SL@DN,5(73PN?J [^\3
MM+@ : AH-*!R\[>]S\QQKA<S\:"M2=*P?U*O_P!4M?+2OB>CL^V.'Y)3MX&3
M-W8JM)KZ73_Z8Z>>M/ ]-?/V8LFY%]S'%8OB;,+J5PC8(W@%KB7TH"#XKZ%Z
MT-GJ-I1I6KT5/F?/?1GO]-)N5:46KK\B6QR./R</S&-O[?(6]:>_;2LE97RW
M,)"6<BW>CNMR4EXIIK]@O8]RS+;<BXOP::?[2A)G,+%%<32Y>RBAM'^W=2ON
M(VMB>:^EY+J-.AT*QRS+$4VYQ26CU6C\_ R1P[\FDH2;>JT>OP\2I<9;%6L=
MM+=9.TMHKP@6<LLT;&RDT(]LN(#NO@K3RK,$G*<4GTJTJ_#Q*PQ;LVU&$FUU
MHFZ?'P*\][9VIA%U=PVQN7!EN)9&L]QQZ-;N(J?@%>=Z$*;I)5Z5=*_ I"S.
M==L6Z=:+I\2E;Y3&7=S<6=KD;:YN[3_?5K%,Q\D7AZV-)+?O"K#)M7).$9)R
M75)IM?%=BT\>[;BIRBU%]&TTG\'W(WV2QV+A^9R=_;8ZWKM]^ZE9"ROEN>0$
MO9%NQ'=<DHKQ;27[19Q[EZ6VW%R?@DV_V%:*ZMIH!=0W$4MJYI>VY8\.C+1U
M(<#2@HKQN1E'<FFO'M^)25N49;6FGX=_P+&3.X2&&"YES-C%;W3S';3ON(FL
MD>#0M8XNHX@^ 6&6;8C%2=R*3Z.JH_AJ9HX5^4G%6Y-KJJ.J^)DW/8QCI'O:
MR-C2YTA(#0T"I)/DMAM)5?0UTFW1=2SL<IC<HR23&9&VR,<3MDK[:9DP:[R)
M830Z+%9R+5Y-VY*27@T_R,M['NV6E<BXM^*:_,DDR^)B;>/EREI&S'D"_>Z>
M," DD 2DN]%2#U42RK,5)N<?IZZK3X^'S)CBWI.*4)?5TT>OP\?D6.8Y+B,-
MQ[(<FGNH[C%V%I-=^[!)&_WFPL<\LA)<&N<[:0T5U*PY7(6<?&ED2DG",7+1
MK6BK2.M&W337J9L7C[V1D1QTFIRDHZIZ5=*O2J2KKIT,'V\YQ:<]XM9\DCCB
ML'W+K@SX[WFROMV1W$L49E( H7MCW:C[%I\%S,.4Q(Y"2C6M8UJXI2:5?BE4
MW.=X>?%Y<L=MRI2DJ44FXINGP;H;/8YS"Y.66#&YBRR$T-?>AMKB.9S*&AW-
M8XD4/FNA9S+%YM6YQDUU2:?Y'/O8=^RD[D)13Z-IK\S*+9-8( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" (#7.89E_'>*<DST0#I\1C+J[MVN%09(H
MG.8"/(N "T.5RWB8EV\NL(2DOBDZ?M-_BL19>7:LOI.<8OX-JO[#SAV4[7<5
MY=P[^,^98_\ B7-\HNKN6:[O)'N+61S/A.W:X4<YS"XNZ^6B\#[0]N8F?A?J
M\N/J7+LI-N3?9N/CUJFZ]3WWN[W'EX&;^DQ)>G;M**2BEW2EX=*-*G0Z5Q/L
MI@^-XSE/'+S(3Y_B?);IEPSCMR',BMO:E]R,->R3<YWI8'.TW;14+T'&>T;&
M':O8\Y.Y9N-/8]%&CJM4ZUZ5>E=J//\ )^[K^9=LWX15N];36]:N551Z-4IU
MHM:;F<3R';;A$/U 8/B,> B;QRZPC[JXQ?N3;'3".X(?NW[^K!X^"\A?]OX,
M?<-O%5I>D[=7&KZTEKUKV7<]=8]P9TO;US*=Q^JKE%*BZ5CITIW?8]48FPX?
MP2PBP>-=9<?LMSYXK&2X#:EY]3A[SRXU(\U])Q;&'QEM6;>VW'K1OQ[_ %.I
M\WRK^9R=QWKFZY+I5+P[?2J'G3/VV,[@?458X'.L9E^.X;"^[8V6_=;R&2#W
MMYV$5JZ0'0Z[6^&B\'FV[7*^Y(V;WUVH6ZI5^EU6ZNGF_P!B/>85R[Q7MR5Z
MS]%V=RC=/J5'MIKY+]K).T^2?PW,=]>-8\R28SB\MUD<%8@.D,?LF=NQH]1<
M7-;&WS)"K[9R'Q][D<>%=EIRE!=:4W:>?\*\Z$^YL=<A9X[(G3?=48S?2M=N
MOE_$_*IQOB=APS"<<QV2[C]ILW?V5W>21W?,OF+N"-NYY:UH@9)&"&TZD@DU
M J0O*<98PL;&C<S\*Y*+DT[M9177^5-=/'OKUH>KY._FY.3*W@9MN,E%-6J1
MD^G\S3_#MITJ=BYG!B>8][^U_#KEK;_A<&$^;L;(2.=%*#;W$['UK4AS8(AJ
M=0/BO5<M"SR'.X>)+ZL=6]R5='],I)_-1C\EYGE>)G>X_@LO+C]-]W-K=-5]
M48M?)RE\WY%7MQ:GC_='O'V\P-R<9C)<?)?8IFYWMVDM(FM>TDFFSYD#[&CR
M5N M_I>5SL&R]L'%RCX1>FORW_L7@5Y^Y^JXK!SKRW34E&7C):U7SV?M?B>>
MC/Q)G YN+OXZ7<Y.<]D<^$K#C])M3\YO_#LTI3;3UUJO#.>&N/>,[7_,>I3U
MJKT^O\]>E.U*?Q5/<J&8\]9"N_\ +^G7T:/?T_DIUKWK7^&A]*L-%/!B,5!=
M7C<A<PV<#+B_::MG>V-H=*#Y/.J_0.)&4;,%*6YJ*J_YG3K\^I^?\N497IN,
M=J<G1>"KT^70R2V#7" ( @" ( @" ( @" X?]15K>77:C/?*!SFV\UI/>1M%
M2Z%D[-WW-)#C\ O'>_+<Y\1<V]G%OX;E^6C^1[#V)<A#EK>[NI)?':_SZ?,V
MSMQF<1)VQXGE(;F&#&6."M6W<I?Z(#:P-9.U[C_N;F.!)\EU. R[+XNS<32A
M&W&OA':J2K\&G4YG/8EY<I>MM-SE<E3QEN=8T^*:H:WD>\/&[CMER+G/&YY'
M18QC[*RCG@=$6WSVM;#'M<*. ,C2=I(HN??]U8TN+NYF.W2-8JJI]>FU>?5-
MTKH;]CVKDQY2UAY"594DZ.OT:[GY=&E6FIXP%]8/[4S<<DXKGI.3393]='(C
M;5M]_P#9ZRD[RPP5-:?BU^*^2J];?$O'=FX[SGZF_;]/AUZTV?\ JU/K+LW%
MRRR%>M^DH>GLW?5X].E=_P#Z=#K'=CEPYMV X/G))!)?G.6UKEO,75O:7;)"
M?\N@>/@X+TWN;E/]2]O8]YOZO4BI?XHQFG^/7YGFO;/%_P"G>X<BRE]/IR<?
M\,I0:_#I\BT[EQ]V./XO!6G..<2Y#@'(!%:92]Q5E Q\#" _VI&-CA+JM%1Z
M_51P/D<7N"/+XMJW',R'+&N44G",4UWHU2-=.FNM'\\OM^7$95VY+#QU')MU
M<5.4FGVJG65-?+2J^7L'A&*P.%XE@,;QB;YG P6C'8V[W!YFCEK)[I< T$R%
MQ<: :GH%]4X?&Q\;#MV\=UMJ*VOQ3UK\ZU/EG,9.1D9ERYD*EQR>Y>#6E/E2
MAY[[KRLQ7??M/F<LX1X-T+;>*:0[8V7 FE#G%WAM,T1-=//1>&]S25CG\*]=
M_P"'2E7T4JO6OENB>X]M1=_@,VU:_P")6M%U<:+2GGMD=\YKSCC? \;;97DM
MRZ"UGN66]N(V>[(9' FK6#4AH!)(Z+VW+\QC<7:5W(=$W1:5=?AY=SQ7$</D
M\G==K'56E5ZT5/CY]C@7=&2#G'=GMGP;*7L\?"<QCQE9;=I? +F9XN71M>#M
M<"X0L8 :.;O-*$KQ'N.4>2Y?$P[DG^GG'?36.YO=2O1_PI>*W/HSVWMR,N-X
MC+S+<5^HA+9726U+;6G5?Q-^#VKJBSO,+C^V'?+@^-X,R2PQW++?V\]@&3/D
MB+"Z1GND2.<= -XJ="TTZD+%=Q+?"\]CV\.L8W52<*MJFJKJ_G\M/ RVLNYS
M7!9%S,I*5IUA.B3KHZ:+Y?/7Q-6[:\'XWS7D?>S^)+-^0CQ&1E=CX/>ECCCD
MN)KW=+MC<T%X$0 )Z:KF^W^'QN1R>0_41<E";VJK23DYZZ/K]*H='W!S&3QV
M-Q_Z>2BYP571-M14--5T^IU,#PK@N!S_ &,YARK,1S9#,X5MY'@9Y)Y=ME%;
M,9.(X8P_8 Z1[W.TUK^W2XCAL?*X&_DW4Y7(;E!MOZ%%*5(JM-6VW\3>Y?F<
MC%YZQC6FHVY[7-)+ZW)N-9.E=$DE\"ZYK=SW_9[L9->W\D$GS[H79'>0^*.%
M[HF/#CT+&-%#\%DY>[*[PW'.<FGNIN[I)T3KY)&+B;4;7,\@H13^FNWLVU5J
MGFV;5W0X9Q_M9G^V&=X)#+BLM/E!:SQ-N))'7<8,>XO$CR3NWEKJ4!#J'P73
M]Q\3C\)D8E["3C-SH]6]RTZU?>M'V=3F^W>6R.;Q\NSFM2@H56B6UZ]*+M2J
M[JAE;?"XWN=WVYIB^;.DR.-XG:AN"P#I7QQ;?RVN?1CFN.KMQH=2X5T "V88
MEKFN?R+>964+4?HA5I=M=/C5^+:[*AK3R[O#<#CW,.D9W9?7.B;[Z:_"B\$G
MW=2TX9&>)=Q.[_;O!3S3</M,%<7]M:/E,K;6?V("0TN)Z&=S#^\=HK^%8N)C
M^@Y+.P++;L*VY)5KME2/_P#9Q?=T5>AEY:7Z_CL'/O)*^[BBW2FZ-9?_ -5)
M=E5TZFI<$[=<:SW8KE/*,Q;2WV9QMIE9<-=.FE M&V<3IF1Q1AP8 Z3<YVFN
MXKF<+P.+E<#>R;J<KD8W'%U?T[%N22K3656]-:G3YGGLK%YZSC6FHVY2MJ2H
MOJWO:VW2ND:):Z4+'D6>S4W8GM%B/?N)K3/7]W:Y,1R>VZ:&SNY(H+<R.](;
MM(INT](\EAS\V_+@,*U5N-R4E+6E5"348UZ4IXZ:+P,V#A6(\]FW:)2MQBXZ
M5HYQ3E*G6M?#75^)N&!X[R# ]R^&Y/C';BYX!CW'Y/D=C)E8+IMU:RO#'2F-
MTN\[-U32NH:0*C7JX6!D8O*6+F/BNQ'[9KU%+=%NE:5KIU[ZI=SE9N?CY7&7
M[>1E*_+[H/TW';)*M*TIKT[:-]BKPCA.!YKW:[Q6W);9^1QEADS*S%F:6.%\
M[YIFLE>(GLW.8W>&UZ;BK</Q&/R/+YT<A;H1G7;5I5K*C=&JM*J7^)E>8Y?(
MX[B,&6.]LY0INHFZ4C5*J=$W1O\ PHP/"L%CKGM_W_XW>,DN\3Q2XO+S"6[Y
M7CV;BTANO:EJQS:D&%A(.AIJ"M+B,*W/CN2QYU<+3E*"J])14Z/3_"O)]S=Y
M?-N0Y#C<B%%.ZHQFZ+6,G"JU_P 3\UV,CQ7@4.1^G6:YX[/;X;D/+';LU>7-
MTZ&*]987]RR* ND?[<?HJ!0 ._>\UGXWA%>]MN5AJ%V[]S<FE-0G)*.KVQT\
M*5[^)@Y+FG:]QJ-].=JU]J4:N#G"+<M%NEK\:=O P.(FP_#^3<.FYOVNR' ;
MVPN8X+/DV&NI&VMQ*=K:S!_N-E;2I=LF)+2:APT6EBSL\?E6'F8<K$HM)7+<
MGMD]/NK527C2?1NJ9NY4+V?BWUAYD;\9)MPG%;HK7[:4<7X5AU2HT>]%]J/B
MP0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0&.S&+MLWB<IAKRORF6
MM)K.ZV]?;G88W4KXT<M?*QXY-F=J?VSBXOX25&9\7(EC7H78?="2DOC%U/*G
M%,GW0[+V-YPN?MW>\XQ<-Q--@,SBO<+"V4UVR".*8M:75=ZJ.:2?Q"A7S7C,
MCE?;MN6)+%E?@FW"4*TU\:*5%776C6O54/I7)8_%>XKD<N.5&Q-I*<9TKIX5
M<:NFFE4].CJ=5[0X_N1[6>S_ '"OIHI,]<F?%<9D?O%C&7.<:5W%@-0&LW>D
M#74Z>E]K6.3I<OYTFG<=8VW_  +7\/!1KHEKJ>:]T7^-K;L8,4U!4E-?QO3\
M?%RIJWIH8/(\>SDGU%8'D4>*NGX*#!/@FRXC<;=LICN0&&2E :N&GQ6G?P;[
M]R6[Z@_35MIRI]-:2TK\S<L9UA>V[EAS7J.XFHU^JE8ZT^1NW-^TG#^X.0M,
MGR.&ZENK*W^5@,$YB;[>]S]0 :FKBNQS'MC"Y6Y&YD*3<514=-*U_M.1P_N?
M-XJW*W8<4I.KJJZTI_8<=Y#PW-=K^X7'.;\2XQ?\KXW;8AF(O<99;IKR(Q1&
M!AVAKG$;0PU#::$&E03Y3.XF_P +R-K,Q;,KMI04'&.LU1;5XOI36G9UIU/5
M8/*V.:XZ[AY5Z-JZYN:E+2#J]S\%UKI7NJ5Z&8[6<3YU!;]S>;W5C'QWE?.)
MY)^/XV_:7?+D.EE9[S: AI=(&ZC=1M2U;7MOC,^,<O,E%6[U]MPC+^'JUN7A
M5TUUTK0U?<G)X$I8F'&3N6;"2G*/\71/;YT5=--:5-2Y+G.[7/\ B$G;;*=M
MK^VY%D+F&/)\D?&8<:(H;ALPD;)M+ ?2T':\U%2*]%S.0S.7Y3#?'W,22NR:
MW3I2W12W5K2G9=&^]/ Z?'X?$<7F+D+>5%VHI[85K<JX[:4K7N^J7:OB9CEW
M".2<%Y3VRYUQW"W/+[?AV%M\#E\=9-+KEX@MY+<3,C <3N9*?PC0M%>M5M<I
MP^3QF7B9MBV[RLVU;E&/W:1<=R6O52[+2GF:O%\QC<GB9>'?N*R[UQW(RE]N
MLE+:WIT<>[UKY%7@W".5\FON[7,\[BY>*7G/<;<XK 6%V"V>&.>,L$DK:!S=
MNV,:@$D$T&E;\-P^7FW,W+O0=J5^$H04ON2DJ5?=4I'SZZ%>8Y?$P[>%B69J
M[&Q.,YN/VMQ=:+LZUEY=-3G[+?N';]L9>R[NU63DRK[DQMY &;K':^\^9]TS
MAOM;A^ 'W* 4-=*+AJ'(PXM\1^CFYUIOI]'W[J[J;:]J[NFOD=MSXZ?*+EOU
MD-E*[*_7]FVFVNZG>FWKIYGL7B&&N./<5XY@;J<75UA\;:V=Q."2USX8FL<6
MD@';4:5\%]5XO$EB8EJS)U<(1BWYI4_#P\CY7RF7'+R[MZ*HISE)+R;K^/CY
MFQ+?- ( @" ( @" ( @" ("C<VUO>6\]I=PLN;6ZC=%<6\C0YCV/%'-<TZ$$
M&A"I<MQN1<9*J:HT^C1>W<E;DI1=&G5-=4SSU>?3-P>>YG^3R^=Q6*NY/<N<
M';73/ER0:@#W(WNH-/Q$GXKPUW_M[@RD]L[D8-U<%);?VI_MJ>YM?]PLZ,5N
MA;E-*BFXO=^QK]E#=<_V<XCGN+8;A@=>X7CV%N!<P66.DC8990US=TSY8I7/
M)WN)-0234^"Z^=[4P\K$MXGU0M0=4HM*K_O-J3?5G(PO=69BY=S+^F=V:HW)
M-T7]U)Q2Z(Z?';6\5LRSCA8VTCB$++>@V",#:&4Z4II1>BC;C&.Q+Z4J4[4\
M#SLKDI2WM_56M?/Q.%N^G?A;N/7G%QE\['A[O+1YD0-GMJPW$<,L%(R;8T:Y
MDM#6I]+=>M?&OV)A/&EC;[FQS4Z5CI))QT^GHU+6M7HM?'V2]]YJR8Y.RWO4
M'"M):Q;4M?JZIK2E%J]/#K.?XMB.3<<N^+Y>%UQC+RW%N_4"1NP#9(QU" ]A
M <#3J.B]-F\;9S,:6-=58-4\_)KS75>9YG"Y&]AY,<FTZ33KY>:?D^C\BSX1
MPZRX)@8>.XW)9#)8^VD>^T.1DBDDB;(=QC8Z**(;=U2 0=2=::+%P_%0XS'5
MBW.4HINFYIM5[*BCI77YF7E^5GR>0[]R$8R:5=J:3IW=7+6FGR)N8\)X[SO$
MNPW([+YJV#Q);S,=LF@D&@?$\:M--#X'Q!4\KQ&-R=GTLB-5U3Z-/Q3_ -O,
MCBN7R>,O>KCRH^C75->#7^WD<LPGTY\*QF4L\EDLCEN3-QI!Q^/RDT<ENP--
M6AS&QMW $#2NT^+2O-X?L+!LW8W+DIW=O2,VG%?))5^'3Q1Z3+]^9UZU*W;C
M"WNZN":D_FVZ?'KX,W_GG;7CG<.WLF9D7%K?XQYDQ>8LI/:N;=Q()VN(<""6
M@T(^RA7;YKV_C<M&*NU4H_;*+I*/^W_D</A?<&3Q4I.U1QE]T9*L9?[?^9B.
M%=G^.<-RTW(C>Y'D?(Y6&)F:R\_ORQ1D;2V.C6@5;H2:FF@(!(6KQ'M7&X^\
M[^Z=RZ]-TWN:7E^_5]NAM\O[IR>0LJQMA;M+7;!;4WY_NT7?J9/BG;/ \/O>
M87V,N[^>7FLPGRK;J2)S8W!TSJ0AD3"!6=WXB[P^_8XSV]C\?._.W*3=YUE5
MK3[G]-$OYGUKV-;D_<.1R$+$+D8I652-$]?M7U5;_E72G<M<'VHX[Q_@^8X!
M9WN1EP^;^8^;N9I(77+?F6-C?L<V%K!0-%*L*QX?MG&Q<"Y@PE-VYUJVUN^I
M4='1+MX&3,]RY.5G0S9Q@IPI1)/;]+JJJK??Q.,=W^WK<7Q;M=Q#!6&1S>)Q
M.8='<$L,\H@E=N>9G0,8 /616@7DO=7!>CB8>+9C.<(7*/2KVOKNVI>/D>M]
MK<YZV7F95Z4(3G;JM:+<NE-S?AYG2<'V)XKA^0V'(;C*9G/OPI!P&/RET)X+
M+::L$8V!U&&FP$T'74ZKT&'[,Q,?)C?E.Y<V?9&<MT8>%-.W;P\V>?S/>>7D
M8TK$86[>_P"^4([93\:Z]^_CY(RG->SW'.99>+D8OLEQSD<;!$_-8B?V)96-
M&T"2K7 T;I44--"2!1;/+^U<;D+RO[IV[JTW0=&UY_+OH_D:_$>ZLGC[+L;8
M7+3UVS54GY?/MJOF7_$.U?%^&8G+XW&?-7%SGXWLS6;NI!)>3[PX$E^T-%-Y
M( ;UU-2LW%^V\7CK,[=NK=Q/=)NLY5KWI3OX?&I@Y3W)E<A>A<N42MM;8I4A
M&E.W7MX_"A5P/;/ \=X/D^ V5W?RX?*PWD%Q<SR1.N6MOF&.0L<V)K 0#Z:L
M/QJK87M['Q,">#"4G;DI)MM;OK5'1T2^&A7-]PY&7G0S9QBIQ<6DD]OT.JJJ
MM_'4L'=GN'S<!L>W5VV[OL+C9))K"\FD9\Y%+)+)*9&R,C:VH,K@/12FA!6%
M^U<.7'QP);I6XMM-M;TVVZU22_B:Z=.M3.O=69'D)9\=L;DDDTD]C225*-M_
MPI]>O2A8<7[+X'CV>M.27^;S/+<OC(O9P\V:N1<-M& $#VF[1J 32IH.H .J
MP<=[2Q\3(CD3N7+LXJD7<ENVKRT_#LNRJ9N1]VY&7CRQX6[=J$G62MQV[GYZ
M_CW?=T-HXWV^PW%N1<JY-C[F]FO^7S"?)0W#XW0L<'O?2$,C8X"KS^)SETN/
MX.QA9-[(@Y.5YUE5JBU;^FB3[]VSG<ASE_-QK./-14;*I&B=7HE]56UV[)%C
M@>UO&\!%S:W@FO;VWY]),_.PW4D;F@3B4/9%[<<9:")G#4D]-5APO;F-BK(C
M%R:OM[TVOXJU2HE3[GUJ9LWW'DY3QY244["6QI/M2C=6Z_:NE#5L1V#XEC<#
MF>-7>3R^;PV6,1ALKRX;MLW0O>]DEL(V-#'[I'5/0^(U->;B^R<.SCW,>4[D
M[<Z:2?V4;:<:)4>KJ^_AU.CE>]<R]D6\B,(0N0KK%??5)-2JW5:*B[>/0EQO
M8; 6^0Q-YFN3<BY9:X&1LF&P^7O?>M8',ILI&&#0;1H*--*$$:*,?V7CPN0G
M>O7;JMNL8SE6*ITTI\--%XJA.1[TR)VYPLVK5IW%24H1I)UZZU^.NK\'4[FO
M9'C@@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" DEECAC?+,]L44;2Z21QHUK0
M*DDGH $!RV?O+P6"Y?;_ #]Q*R-Y8^[BMI'PU!H:/ U'Q" Z#B,WB<]:-OL/
M?PY"V=_MD+PZA\G :@_ H#*("'10#S=WA^I3B':J[.!;&[D'*WL#QB+=X8R
M.KM-Q+ZMG3H 3\%U^/XB[E+=]L?']Q=17<X3B?K&Y3+=-DR/#,=)8.)+H+:[
ME9.UOAM=(PM)^! 72N>W[:5%-U^!D]/N>P^WG<WC7<G&R7^!N'":U<V/(XN<
M!MS;/<-!(P$Z.Z@@D%>?R\2YC2I-:>)24*'1*ZEOB!5:U=:&,BI 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0$CWLC8Z
M1[@QC 7.<>@ ZE :MB^<<6S5])C<;EXKB]C)'LT<TNIUVEP =]RA@RN;S>,X
M]BK_ #.7O8[#&XR(SWMW*:-8QHJ25-N$KDE""JR4JG&N+?4?VRYAEHL-BLK/
M'<W$@BM)KF!T44KW'0-<:T)\*T72O\3D68[I)%_3;6AWQ<TQA $ 0! $ 0!
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MXLI:0N/R5E7<>:?957R_\#)-*A]4&#JX]2O%1KW-1JA45B @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M_P!^1KE9+_RI_P"&7Y&S<6A]:&FM3\5X>)H,F5B @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ("1SVMZE2D0V6\EQ31@^]642DIEJ][I!1SC]B
MM1&-RJ4PT U\DH03U4@@A 0! 2EP!IJHJ"4D$MIYJK>J+(^2GU@/V=_XB=!^
MB8[7_NI%[S@5_P E\V7A]R.^?2Y'7D4[Z B3#3"HI762%<?FM;=//]YO9/\
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MY,VKB^D^KC.A^U>)B<YDRL0$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M)F[<^P^J+?'[5XR/?_;L<LF5@$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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ME$!F8)W#<(=PWD>>WJMC?&NVNO@:^R5*TT\2JK%0@" ( @" ( @" ( @" (
M@($TU/1 6,T^X[6FC?YUDBC#.1;JQC" ("WEGC@!?(X-;YE%'4B4DEJ:]=YB
M23<RW!C9_7_>^Y95&AJW,AOH8@.<\N<\5)/4ZG]JDUZM]2H&H23(";52!0J!
M0JZ>2%QIY("-!Y("1S:G3R4^ ?0^77U4.<WOK!M<6N&'QU' T(JZ1>TX-?\
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MJZ/J< X7>\4X[W XN,WP'/\ :K.SR"QLG6US*['7SY'-92=MTPO+"7!I+'N
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MB!YH2D3 "J$T)]H\D) :#X(":GW(!1 3 :=%!(+>A2O0=CY6_5E((N^4;W4
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M-]BTZ=*ING[3=,CV3X_E.+\>P%UF,J<CQ:6:;"<K$P&0C?-,Z<[G[:$!Q%-
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M=XO)CD6J-JJH^C35*.GX_$K<.XIC>$\<QO&L27OL\<UP$TNWW)'R/+WO>6@
MDEQ\/@K\5QEKC<:&/:^V/=]75U;97E>3N\EDSR+OW2[+HJ*B2-G71.<$ 0!
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M=H.,2UKN?>$'[;N9>%YC3*DOA^2,=SJ8?ZA;1Y@XS?L%=K[NU<3X>XQDC?\
MT:YYB.Z8"YCRN"P]\'%S;VQ@FJ.AWQ@E5<2:GS9^H_Z-N07_ "')\[[36T>0
MBR\\MUF>*/>V*1EQ(YSY)+5SBUKFN)KL)!!Z5\/;</[BA&VK61I312\O,PSL
M[G5=3Q9C^S?=V[Y'%Q-G!LE!G9I/:%K<L; T.V&3U2/<&CT"M:]%Z"?*XBCO
M]2+7D5C;G7H?5#Z9/IG/:2.?E'+;B#(\XOXO9CC@]4&/A-=S(GN%7/>*;G4'
MD/CX?F>96:_3MU4$_FW^XV>B/8M-:KA4*D5(" ( @" @!2NM:H !1 10! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M5O/=7,4U/3[4$/RD9K_C$Z*U**D:)? @]6(@%(" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MV! 5D 0! $ 0! $! FG5 *U0$4 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 6L\M!M'4]5:*,<Y
M%E6NJR&$("5]&L<]QVAHJ24I4/0TZZN'7,Q>?P"OM#_%_P!E9DJ(T;DVV4NJ
M&,F HA8J=4)*@"$D]$)2)QT(\4)-$YUSNPX5CVW,U)9[C<RW8-?4!76AT6QC
MX[NOR.=R')1Q(>;/)>6[E9SD%^3-<,B@E.UD!<=@KTT!7<M6(6J:'A<WDKV0
M^IKV>S=GC;"[N+EDOS6RI8PU+ATJ!4!9Y]=#EQAKKU.<VMY:W!=<0Q&VM[J
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M" ( @" ( @" ( @" ( @" ( @" (#&R.J]WVFBS+H8)=2D4*D>C:H# Y2\W
M6P)&[66GEY*T#7NW*:&$(J:C3P60U7J3-ZA"45:5*$DX&J$DZ$EGDLC%B;*:
M^G-(XA4CQ5[5J4Y4,>1?5B&YGG[+]Z;B6MO8VORT<I<T7+M=/,TZ+JV^/HZL
M\=E>Z&_I@M/$\Y\]Y5<Y@.=>3O#&2=:[MCR-'#X+?C:C!:' O9,[\MTG4Y0Z
M_:&.=<R#:"=L[7$%Q'P5RK5487,&[N9&AMP^0%@>6RO)] UZ(98Q2ZEA<.N\
M?*,@UDEK;V[6FP8\$;S)HXM;Y4\_-"_TD,=E<?R*]^7OHFFWQ\GO.B#@XOD'
M1H&I-/,(-GIZF1R.>GO;M\$^.M;BV>7@'>Z"< =0UH%*CXH44/I,7<3NXZV*
M>SEGCGF<)+>Q<XO<2>@)/F=%!,8;X_ Z/?Y*+(8S'07D1M+C(1M=="W<*-<T
MU=&9!U:7:40P)-/0UZPY#BKF9N"@:ZW=*YS&1-A<UHE;4Z$:"M/%2_X5YEY1
M=&WX&B\HR1AY]9W-G(Z)]O;VP8\=0X%VOVU7:QX)XR3\_P V?0O:-5B)KS.@
M2V@G%I/.^9OOMD?\W$\L<""PU/F/4M"Y+Z)+S7]I?WG%*Q:EW)<CBL]910Y+
MCN2AGORZHCD>]S 6Z^16HCYTI)_=T-@P&4Y;?/=?\LO[?8]SHH,3:$/M9P!0
MO>V9FYI:>@!5BMQ0?VDAS RF?OL;'"XLPL9<+EP_'<2^DTKT J=I"H'#;'<8
MWV_E'7$V2N/D-'4WO :X#IM'4G[$)KOZ&LF\9D[N*QLVS2,NFA_SK]OM>W'^
M(N:3N'D*(74'%:FP.AL86,CMK=TA=0";<ZIIIYJ2KF8C)V]_9R>_AHWLGU,D
M1.X'8 Z@/@7:H3&2;U-BXGR=D=LZ>\F=[$TI;-;S$[XWB@-*Z]4JEU,-VVZ_
M0JGI/@L=W;9S$WS(;AMK<.:6R[';2'$>-%KY4XNVTCH<9&["_%N-$>W0:[3U
M!;4?>O-O[CZ=6H+04*EN58J4SXH"0A0593(HA!-!.;:9LH/P>/-OBC+0GM9M
MS'!\;7M-0[4+$S=6J(H @,C [<P>8ZK'(V(="LJE@@)'?]I4EU)1\3_J]NYY
M/J%YC'-*Y[+2#&0V[2=&L^1@?M'PW/)^TKZ3[?BEA0IY_FS!<?U&C<$Y/?X.
M*]@MFM>W(Q&&5KA4@.TK59,[$A><9/\ A=49[>JH= L6F2.1Y:-Q:3MZ5J/M
M6O,W8'U!^GF5\G9_AX>=(([F"(?U8XKJ5C&CX-: !\%XSE4EDS^*_(U+G4[6
MM H$ 0! $ 0! 8^[EF97VA4_95725#%-M=#5[W)Y>(.]J,N<.GY9/]"RQC$U
M)W;IIU[RCET K;6SR/+Y5Y6>-JTS1N9>5'[8FFWW-NXL9<(<;(0.A^1D*V(X
M^._XC1GR>=2FQ_[IY\Y/=9&XR5S>9"V&/R$KVRRQ,B,!WUW!VRFA)UJNICPB
MX;5JCR^;<N^KOFJ2_ ]@=H<WR?-\<AGY#:T;'1MCD'G\RYC&F]S#J#TU\5P,
MRW&$VD>\X7(OW;"=WJ=>6F=@\E_3C8V7);OGO-LW:QWW(;W+&,RW+ ^2!CP9
M'!@<#MW%VTT\&@=%\Q]@V89D\G,O)2NN=-55Q3U=*]*UI\J'TWW[>GAPQL.R
MW&TH5T=%)K15IUI2OSJ=VQG;;B.'Y??<UQ=DZQS=]$8;ID$ACMRUX:''V&4;
M5Q:'&O5WJZZKV>/P&'CYDLNW';<DJ.CI'S^E::TK\=>IXS(Y_,R,..)<ENMQ
M=555EY?4]=*T^&G0X-]-&*Q>0L.=NO\ &VM\YF9#6.N(62D L=4#>#0+Q7_;
M[&M7;>1OA&7^9W2?;S/:_P#<')NVKF/LFX_Y?9M=_(<7M;+B7U'<LP.'#,7@
M<IB#/>6,1]J&(F"*<N: 0&;7%Q']4.(% IXZU# ]RWK-KZ;<H5:6B7TJ5?*C
MK3PJZ#D;D\[VU9O7?JN1G1-ZM_4X_.JI7QHJG&K6\S.-[9\YXY@.-MY#P6;+
MGW>X7L&-[8XWQ4?[!]3MH:"#6C=VJ\G;NWK/%Y&/8M>ICNY_QJ4=$UKMZNGC
MVJ>KN6K-[E,>_?N^GD*'_!K55:>F[HJUZ=Z'N[@+,9%PGBD.&R)RV+M\7:PV
M61<"TS,CC:P.+3JTZ?A/X>G@OL_"*U'!LJU+?!0BE+Q25.G;X=NA\9YMW99U
MYW8[)N<FX^#;KU[_ ![]3S!S?,9?!?4?;9+!\=EY3D8<0QL.%AF$#Y ^VD:Y
MP>624V@UZ+YUS&5>Q?<JN6;3NS4/M3I7Z7WH^G7H?1.'Q;.3[:=N]=5J#G]S
M5:?4NU5UZ=3!]R^5\IY/S/M)_$O [GA/R.:_N7S%T+GYKW;BSW[:11;?;V-K
MUKN6G[AY/+S<W"_48SL[;FE9;MU90KVC2E%^)N>W^-Q,/"S?T^2KVZWK2.W;
M2,Z=Y5K5_@=KQ_),O+]0N=XR^:$X>WP;+B*$6MN)1(8[<U-P(Q,1ZCH7T^&@
M7KK'(7I>X[F.VO35M.FV-:TC_%3=WZ5H>1O\?9C[=MY"3WNXU7=*E*R_AKM[
M=:5.=<+Y-WI[AX#E-QCN8VF*_AV^N/9OI+&!TUR1&',M?3$(V,9MJ7[2X[]=
M N#Q'(<WRV/>E;OQCZ<GJXQK+32'2B2IUHW]7@=[EN/X3B<BS&Y8E+U(K12E
M2.NL^M6W7I5+Z?$R]EWOS\78^;FMY%!<\G9D'86WN/;#8GS&CVSOC;05$9)H
M* N'0 K:L^\,A<$\N:3O;O33II7KN:^'RJO U;WL_'?.K$@VK.WU&JZI=-J?
MQ^='XF&YMGN^?;[A-CR2_P":V>2.:EMV3M;86[9["69AE#6$Q[)&D-+759H:
M;?%:G+YO/<5@QR)Y$9;VJ_1&L&U6BTHUV>FFE#;XC"X'E<Z6/#'E'8G3ZY4F
MDZ5>M4^ZUUUJ;9W/[GYS'<AXIP?"\@L>)39>P9?YWEU^R-[+>-[7[6M;(-@)
M]MWAJ2T MU*ZGN+W%?LY-G#LW8VG.*E.Y)*D4Z]*Z=G\VDFCF>W?;MB]C7LR
M]:E=4).,+<6ZR:IUIKW7R3;3+OM-W*R^4YAG. YWD=AS/Y&T%]AN6V#&1LG8
M/;#XGMB ;5ON?<0ZI.BR^V?<%Z]F7,*]=C>VQW1N126Y:53IIW_8]7H8O<WM
M^S9P[>;9M2L[I;96Y5>UZT:KKV_:M%J>CE[T\$$ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! 49W%K*#J5:/4K-T1CCU*R&N$!3FE;!$^
M9^C6"I0-T533)'NED?,XU,AK_@69'.DZNI%G6OP0(JC5"Q.T:H23H25 H).,
M][<I)C>-PF-Y87R /H? U70X_P"\\][DN;;*1Y,@R#Q';W-L&W,<8=[K#XU!
M%5WF?/H0H<XR\]]9DW4EBZ]9*S9>V8(H*$D.T_H56;,%0UN06=Q!<&W_ +9T
M;WNQ]P*,MVTU?6@J1\2H,L>I/QJ\@RF-LYOEB)9;C\Z[O(71@11BH!;0.#?$
M5%"H%VJ9O<\6%Y)B[F$7XOXX&%K;D:2Q!W]5I\-/)#72E"53G+^/C#W%C?<5
MM'9(.>QL\+&1L?&QC=7O>\Z@]2AL*2EU+>TBMLAD9,E#3+W3]L-OCXF&-TES
M6DDPVUT;T\BI+R^A4,1R&:PLI)+G,Y%T>4L]\,."$4DSRYW1P+*TVH6M)KJ6
MV-DRT&"CLX]@O)MUS:%^DH(<"XR,<2X C2J%I0C6IG)KCDV+B+H[2SL[C*1M
MEBGDA#9HQ3\3G#4U(TKX*8_<B8QC*2.<96ZR$W*89<K;,M+R..!LPC/H=2OK
M;Y ^2[>*O^6C\_S9[KVHE''_ /JD=*Y!FKJ/%8(XMS9*.D;?1O:'-,6UFATK
MU\ESKD*1E7Q7]IL^[:2QK:?B4<1?0VIDN;._?C6@M^:L[@N? =WDXZZK4/F]
MR#Z(RL%Z;F*Y^6N(YXK>=TMB6/#BUKOQ-(J2T@^:&/9*/8RMO=&,O<*1R7!;
M*]U?60!1NH\$(-:YIFHI8;:Z%FVYNK!Q8Z8G\45/70ZT(.J&6U"*T-;@RN3?
MC([W$6<AN+IXC>U[FO 8P^HC3H2AEE'L;3)GH7XZ6QQLS9;\1UNQ$:[#^^V,
MTH33R*&%VJ,TY^1FAMF.;>2XRZN[B+\Z0.,<@::5<PFHH.HZ^+2JLSJE#:[^
M,6MS:6N3MF_)7$3-]^^A82_J10EQ\QXJ*)]3'K70SO$^3=P^.Y>WM;7DM[=8
M..1IL[=UP]H]L'5NQQ-!15E;BU1&TLV4%770]O<:^HBVNFVUK?X22$-<(WR^
M[OZ=2?2M&YQ,ON.Q9]TVU2,D>D<3EK#-6T=Y8S-EBD (H>E? KD7+<K<CU.-
MD0OQW1>AE"*JIG*#AJ?M4E64CU*D@D(KHA5E)S>I4$4,SBKC>PP/.L>L9\VE
M5DC9LSJJ&95#,0/1 5H'4</(]561>!D1T"QF<B@(%58/B%]76GU$\YUKZ<9I
M_P##[9?2O;_]##Y_FS!=^XYCQQI<6N!H?,!;E\SVCMF)A!;"74(!%&E<JXSH
MVT?33Z>_^BGC(I2C[T$>7]\F7C>5_J9?+\D:EWJ=L6D80@" ( @" ( @(4'D
M@%!Y!!0PN;CRLV-F9A#%%D'@M@EN*AC*@^J@!K3R5XTW:F&ZIN#4-&<*PO9;
M(76>=E^:9*/+1%YEEMV%Y,TA-1O)#:-'D/YEOSSZ0VQ//8_M^4KKNY$MW<]$
MVT4<$+(HHQ%'&-K& 4  \@N<VWU/3122HE1%=02>9+KMWW)[>\ISO(.T\F-R
M>'Y-+[^0XUDR6"*8N<ZK#OB!:TN=M(>#0[2'4JOGES@N3XK+N7^,<)0NNLH3
M[/7IJM%5T^I/6C3I4^AV^=XSE<2W8Y-3C.TJ*<.ZTZZ2U=%7Z6M*IJM#.]N.
MW7,(.7Y7N1W$R,,G(LC!\M:8BQ<?8@CH&^JGI.UHVM:"1J7$EQTW. X'-CF3
MY#/DO5DJ*,?MBO/X+1+7NVVS2Y_G<.6'# P(OTHNKE+[I/R^+U;T[))(YSPW
M@_?GM_\ K4'&[' 26V8O#=2F\F]QU14-IM<RFA7!XGA_<'%>I''C:I.5?J=?
M[4=[E>8X#E?3ED2NUA&GTJG]C.D=O>U&:Q^5Y3R_G^5ARO+.66K[*?Y.OM6]
MO( UP:YS6U=M8QHHVC0VE35=_@_;-^U=O96=-3O74XO;TC%]>RUHDNFB5-:G
M YSW-8NVK.+@P<;-IJ2W=9273N]*MOKJWVH<ZMNW/>GCW%\SVQPT&#R/%\Q+
M,UG(Y93'-%!<$"0%FZH) U]#J5-"=*<&WP'-XF+<XZTK<K,V_K;HU&772O\
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M=N.I66AK-U(J2 2 TN/@B)[&E7$AN+B28^)HW[!T65*ASYRW.I,"3]RD$X"
MG HA)68T$5/@H99$YV1L=+(X,C:-SG'0 #XJ8IRT)>BJ^AYY[B=S;1QEP6,F
M]4C"'S TJ!UVFJZV#@NNZ1Y#FN;5';ML\KSW<5G.^:!P;._<YLI=4GK4E=>>
MAY!_6ZMG-,AR+(V,]VR[A-S9[-\<[&DD$G\)9XC[%B<FS-&",%;-D?>V]U)'
M%:WTS7S10O)#"Y@JS<' TKX**F95I0L+S&NY'F;FY?.<?\O;GY:ZD'NADI ;
MO().X]:#[%*9._:9EW(<%B;FTQPNA#91B*;'Y4;!+(\_E4<UI< #M-30*Q65
MMO4N&WV:O\K"\-9"QH,-[;2&L-S%2H>PBOJ'FA1I)>9?9+'>[:7%A='=+$TF
MSO91Z]O4"305;0TH5!6+9S3E=^RTQC\4;""2]:UQQ(N 7M<[;I,:&A:#KHI-
MNROJU.=8<9&S.6RO(N0/O?=CCBM+*W]4E6 %QI^Z.H '@AMW6ND3NF/[LXC,
M8NUQ/',1=74MLQD%]NB]J&WVMK4N<:DFF@'WJ#GW<25=U3(W$#,5CKR>&)QD
M@@-W>0$AYD<X;@ROB >JENJH8XRW246<#R_<*1DKK=^*OLED0W?<S0Q;88@1
MN#0YVAH/)2H[CHPQ:NI7Q/+K;*BTM8M]GE8PYDEJXD!S7:/]QU*$.Z?!0X;4
M)6E#4FQO;C'ND<_,R6$T#9W3XZX+"9[<N.X-)KKKY:*?4KH4EE]J&SV_&\=@
M,F<B^>XGDN &[+20#<*=:D$5HH(G==Q%!\\XG99X._O+1KYJVGOL)>Z8GI0"
MA/W(1%)_<;3?OYQC,5DKVVM#>S-MRVXMF1U<)7"H?MUVEW@1HA2"@Y4?0T'@
MW+>1SY:%MUQ6^L[BP>'^U/!(UKJ@@[:@BIKU"&Q>LQ4=&>D,NVTR'&7&/&/_
M %*X9[\-M=-!#9&>KVW &H)1]#F6UMN:LXYB9,FRWF?8?Z,BDG]H0/:_V7W!
MU<T$DEI(Z:K'&3[FY<<4;A?Q\LP4$5]D;-EUC)FM]_VJODA8\>HO;UVT\5D:
MT,$=LF8[&0XF^?>.Q4/RE[< N$)T9(TZ:QFHH?@JT+-R7P+:PM+. 2B6T?;7
M-N\M$;00 7>%"JN(C<U/6GTKV7ZER+*7.YUM-BHF&2)PHYXD+J?:!1:G(WMM
MNC.Y[>QG*^Y'O\BJ\^>Z*1ZE711DI'B@*3FUU*DJT6Q'4*2I2>VNG0>*$&?Q
MDONVX:XU= =OW>"Q2-JU*J,DH,@0%W:/)#FDZ#H%22H9;;J7BH924GK\%3NR
M3XA?5_1OU$<XJ*5CQ?\ \OMU],]OK_D8?/\ -FM>?U'*.,O#96DD#77[-%NW
MUH9[+U/0_'KB/;!N=6AJ#4="N+?3.I9:/I+V .[M?@C_ .?OJ?\ '9EY#E/Z
ME_+\D:5[[CM2TC"$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M?5;Z=)1-VGXY(-?<EO37_A<Q7A^75,E_+\D8;CJSN:T#$$ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MUQ4V>S]NQDT&3RDIE]N0M_%'$*1M-3H:$KFYO.Y62G%M*/@B\:1Z'J%K0T
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M,J.HJ*@^((- O9<'RT.4Q(9$53=U7@UHU^[RH>.YOB9\7ESQY.NWH_%/5/\
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M#--S/*,DS.T>9F6^UU'S5KOE+R[=0ZT6_<Y#Z=L=#@8GM]0NN[>>YG?X6AK
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MB($-&CPU7,N,Z%L^G7T\5':;C (I1UZ*?\,F7C>5_J9?+\D:EWJ=N6@8@@"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MWSJ6CZ1=@A3MA@FCH)[_ $_X9,O(\I_4/Y?DC3O+4[0M(P! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M+C<4_P#;O\SE9&+?L3?IIRA+JO#X&D_Q9P7B;<)?/N[7D5]C./QXR?&68=)
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M]8?G'P9C /NQ]NOI7M[^AA\_S9K7ON..X*38]M"!0[B>II\%T+R,UMG>N/9
M?D.T):6^FO@N/?@=.S+4^GGT^O$G:[ /'1T]\177K>3+QO*:9+^"_)&K>>IV
MQ:)@" ( @" ( @" ( @)&NK_ (4>@3J35_V%"=00:=PJK-"M290 @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MJTO([CV;JUD;+:WL+J%KVG0@I1/J1N:Z'UC^E/G&<YKQW(2<ADM[^YLGTAR
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M,[$O9$KR@K<J.JTVJFZ76NB;HJ:NB[DG#N[&<R?.)^W_ #/A_P#"N<=;.N[
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M# THX?*70UUUW,5XS?9I ]$V&WY6SZ;O993_ +T*D5KKU)9?K(5" ( @" (
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MB!-*DJK='J#Q?]2WU-O[77D7"^)P0W?,+JW%Q=WDYK%CXI/[-QCIZWOH: D
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MC;N#OQ5_+"X-O@H0Y.6?N>Z4=NWMV_<=VYSLY\;' VK;&6[=W[_O.B+O'""
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M! $ 0! $ 0! $ 0! $ 0! $!97#:.!\PKQ,4T6JN8B" Q.5@+F,N!_M6C_\
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MJI0$&GBMG&S)6Y:O0TN0XZW?@]J^H\&S?1]W,<(H&NMPTR5=)N;H#H>J[/\
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MKD>C,DG4Z>M8J$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 2N:' @C
MJI3(:J8R8>T_:?*H62I@DJ,D!JA4@ZM-$9)9W5J)XZCTS,_LW?T%3%T*3C5&
M(:7;BQXVR,-'L69:FO2A<5JJDE0.&BK1EJE5I'5263*@-=55DD'-:ZE17::C
M[5#)*T?4HR45P? BH.A0LF<)[D=C,'S>YAR-F6XN_P!6W4D8 ;(T^8 ZA;F/
MFSMZ'&Y#AK>0ZK1G*K?Z1\8S>V7,/<U_6G_W5M?ZFSF_],K^8WK#_2OVRL'2
M27UO=91[]I FEHUI;0G:&!O4^:UI<A<9T;/ 8\.IK7*/I+XS>,R-QQC*76,N
M9M[[6RF+9( XU.VNW?3[UDL\E./W&OD^VK4JN$M6>4;[Z9>X[+R6"3&MD;$\
MCW8]U#3I0T707(P>M3B/@[T'2E2Z;]/7<YK2QV.#I6T:)"''<SP#O3KIHI_U
M"'B5_P!$O/\ A,8WZ7^XMR]UN[%Q&WE<"=[34'[:=%#Y"'B9%PM_2B_:=IX'
M]%=KN9>\OE8YU1_=8W&E/&M0M2[R-/M.KC< ZUFS:.X7T=<<.$=+P02X_+01
MD1P!](Y''Q-&U46.2DG270SYG!J4:PZGFO&_2;W-N+^W;=6$=O&]X^8D=NVT
M'4_A\5O/D84ZG(7!WF^G[3WWQCZ=^$X;!28R^L1=S7;(C<DD4#F"GIT%*E<>
M[G3<JH]+C\1;A;I+J:7??21P&YSC,I$^>""H=)9APH2/+TK+#DKFVC-67 6=
M^Y,]-X+$67'L18X7',,=ECXA%;L.M&MT"Y\FY.K[G:M6U;BH+HC)'4U_D5=I
M>I"M>K0E!4@2 -%8J4B::E002%X(('4J2*E$@CJIH5)7.UZJ047/:*DFE.J%
M6Q;0FYD$TG^]QK&S^L?,_#R1O0F$:NKZ&7H!TZ*IE(H"!&FO11(E%_;QAK=W
MB>BHV9H(N54N$ 0! $!:W=K#>1/MKJWCNK69CF3V\K0]CVNZM<UU00?BJ_4I
M*2[?B2G0XKD_IK['9F\DO\AVSPQN)=9'11&$$]:[8G,;_(NC#ELV&BNRIX$-
M)]4C>^)=MN#<%88^(\4QF :1M?):6[&2.'^-)3>?O*UK^7?ONMR3?Q)KH;N!
M30:46NHTT0)E8@( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ("A-$V
M0'3U :%2F5E&IC:$.<""**Z,#1&HZ5U5B H9)8W=I[H$D9VS,_"?/X'X*\9&
M.<*F-8_5S7@QO9^)CM"K&'H55(*C3H%1]2Z*K3\4+(GJH9)4C.IKY*"45:CS
M4$D0[R* J U4DDZDD55&34D/N5]-***,4)FM#A^8!7P^Q2DQ0B&L\DHQH56O
MH:>'@IH6W$2\'_ @J0JWR"BC%4-WQ0BI1JFI%2-0!J:%61!*2.H/V(02;BH!
M*A!(_P#"I0*'BI*DCW[-7&C1U=Y*2"FYX W;A3SJE&0W0DAA==OW/!;;@U;_
M (_^PH$5N,PUH:-H  '0!09:4)D Z==$)+B&+<:D&BK)Z%X*I?  "@Z!8S,1
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M7D,!)J_0#P5=S,D8%ZUH:*#HJMU,J5"* ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MA 2&-AK5O5""D;6W=HZ)A^X*4VB-J\"D['VCC7V&?L3<R-B(?IUI_N(_:?\
M"E6-B Q]H#7V6I4;$51:6S:4A8*=/2$W,;(^!5$48Z, ^P**DT1/]P5:,M5$
M/7YA*,5(BOCU5B"* (21H@H1:QSC1HJ5#="8QJR[;;=-SJ^857(R*!<M:&B@
M% J&1(B@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ("A) U]"!M/F%*964:EJ^![=1J%9,Q
MR@47>GKHK*52C5"%5) T\U%2:$:*0$(" ( @" ( @" EJ$H"9 1H2A-"=L4C
MNC?O45H646RYCMZ'UZJKD7C#Q+@-:.@HJU+T)E!(0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $!*6-<*%H*FI#52B^V8X$-])/BFXJX(MODG#]ZJFI7TV2F*0=6'^
M=7JBNUE(FE:U%.NB516A#</-201K5 *U0$4!"H'B@(;@HJB2H(WGHP_L3<B=
MK*P@<>K:)N1;8RJ+84%7$?!4<BR@5FQ,;T%3YE0Y,NHI%102$ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $!2.VIJ!U\D&A(6L/[H_8IJ11$-D9_='
M[%.YD;8D!%&/#^1-S&V)'VX_ZO\ (4W,;8D=L?\ 4'[%%632), S3T@?<H&A
M60D( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @+?\WXJ2!^;\4 _-^* ?F_% /S?B@'YOQ0#\WXH!
M^;\4 _-^* ?F_% /S?B@'YOQ0#\WXH!^;\4 _-^* ?F_% /S?B@'YOQ0#\WX
MH!^;\4 _-^* ?F_% /S?B@'YOQ0#\WXH!^;\4 _-^* ?F_% /S?B@'YOQ0#\
MWXH!^;\4 _-^* ?F_% /S?B@'YOQ0#\WXH!^;\4 _-^* ?F_% /S?B@'YOQ0
M#\WXH!^;\4 _-^* ?F_% /S?B@'YOQ0#\WXH!^;\4 _-^* ?F_% /S?B@'YO
MQ0#\WXH!^;\4 _-^* ?F_% /S?B@'YOQ0#\WXH!^;\4 _-^* KCH*]?%0210
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
-! $ 0! $ 0! $!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm2227887d1-org_clinic4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-org_clinic4c.jpg
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M0]-/>#X-CWF3WQBGPOB<\NE> ?-K6>:UYK](>FGO!\&Q[S)[XQ3X7Q.>72O
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MAZ:>\'P;'O,GOC%/A?$YY=*\ ^;6L\UKS7Z0]-/>#X-CWF3WQBGPOB<\NE>
M?-K6>:UYK](>FGO!\&Q[S)[XQ3X7Q.>72O /FUK/-:\U^D/33W@^#8]YD]\8
MI\+XG/+I7@'S:UGFM>:_2'II[P?!L>\R>^,4^%\3GETKP#YM:SS6O-?I#TT]
MX/@V/>9/?&*?"^)SRZ5X!\VM9YK7FOTAZ:>\'P;'O,GOC%/A?$YY=*\ ^;6L
M\UKS7Z0]-/>#X-CWF3WQBGPOB<\NE> ?-K6>:UYK](>FGO!\&Q[S)[XQ3X7Q
M.>72O /FUK/-:\U^D/33W@^#8]YD]\8I\+XG/+I7@'S:UGFM>:_2'II[P?!L
M>\R>^,4^%\3GETKP#YM:SS6O-?I#TT]X/@V/>9/?&*?"^)SRZ5X!\VM9YK7F
MOTAZ:>\'P;'O,GOC%/A?$YY=*\ ^;6L\UKS7Z0]-/>#X-CWF3WQBGPOB<\NE
M> ?-K6>:UYK](>FGO!\&Q[S)[XQ3X7Q.>72O /FUK/-:\U^D/33W@^#8]YD]
M\8I\+XG/+I7@'S:UGFM>:_2'II[P?!L>\R>^,4^%\3GETKP#YM:SS6O-?I#T
MT]X/@V/>9/?&*?"^)SRZ5X!\VM9YK7FOTAZ:>\'P;'O,GOC%/A?$YY=*\ ^;
M6L\UKS7Z0]-/>#X-CWF3WQBGPOB<\NE> ?-K6>:UYK](>FGO!\&Q[S)[XQ3X
M7Q.>72O /FUK/-:\U^D/33W@^#8]YD]\8I\+XG/+I7@'S:UGFM>:_2'II[P?
M!L>\R>^,4^%\3GETKP#YM:SS6O-?I#TT]X/@V/>9/?&*?"^)SRZ5X!\VM9YK
M7FOTAZ:>\'P;'O,GOC%/A?$YY=*\ ^;6L\UKS7Z0]-/>#X-CWF3WQBGPOB<\
MNE> ?-K6>:UYK](>FGO!\&Q[S)[XQ3X7Q.>72O /FUK/-:\U^D/33W@^#8]Y
MD]\8I\+XG/+I7@'S:UGFM>:_2'II[P?!L>\R>^,4^%\3GETKP#YM:SS6O-?I
M#TT]X/@V/>9/?&*?"^)SRZ5X!\VM9YK7FOTAZ:>\'P;'O,GOC%/A?$YY=*\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M0/$$'M%?2::JC5.$H2<9)IIT:>]/F9S0X,VXR&XEOB/SI;O!J+';4ZXK^2A
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M7OYH3HSL<J_D]ZE.M?-N_;N_<DGVFF;LK3<K$IZ^U.%=W%%Q^E(P];3B% *
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MN1FJQ::[&TTY&+=QI\%V$H2YI)Q?0SI5]F@V5>&9@U#^4',4O#<#EYO+E09
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M[A&M<MUEQLN^52UMMLMH8YN]65+=0GQ4GBH>OIB]GV;-Q6YRI)ION+L[N1]
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MLK5;<8-*7!P\.W=Q-\,I<RYC2<!V9W'W,;>E8ACCDZWQEEM^Z/.-1HR5@:E
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MQ=DEOYZ*KV'9SW8/=#;>VB\Y+CP39^9*';G#?:DM-*5H '>[45(U)T!4-">
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MI)((]<5U)U(>47%M/D[O?6QESLY_^Y5TQ8;A*=(^1;IROEJ_('B."(GD>"5
M'7L[A''MT5Z]5;$_^;J4[O[MM47;W>DSU_6E^0]5K.'NNY+XI\CILDZ]I<$'
MSJO:*75:CQXN[TW_ .!O4G_8$K_EDVJGK?\ OL;^9?WD>Q]0_P#U[4_Y)_\
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M%H]CMQKOU"X]GVWFZC42]LQ[:F5%OI8:CJ:*BIOG6&DI;2MM7*M"D@$:'MJ
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M4=:4[I-=OZ:MXKCD=SQAO%PS<+.RT_<)#LI@14)?',T._2M2%*4./*"5#M(
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MHRHJ,W%2V-2V.O-V4UW.:ARVK;S+;WA]_P \MML2_C&,O(8O$\OLH4VM?)H
MTI8<5IWB==$^'UCIB[G6K=Z-F3\:6Y49]XG5_,RL*[FVXIVK3I)U5>1O96KI
M5=.RNTD[96];P0<?W)A[9Q8<NT_)@E9<J5Y/SLL);>2%L]\X@E11S\ %=G9K
MIK'ZM:Q)7+3OMIUI&E=N[?WBS=2\S6K>/E0TZ,904>*?%39L:\6K6UI/G6SG
MWPA9;)=\CND.RV&VR+M=9ZPW$@1D%QQ:O#H!V #B2> '$\*E[MZ%J+G-I)<K
M*3A8-_-NQLV(.<Y;DE5_].=O8M[)JOW3%O/CMC7?YN*A^+':+TV+"DL29+"
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M<FJ[J\$*=&\IA>LPRO(Q(1?LDN=X:E2O+GX\N4ZZTJ3HI(=[M2B@* 6H @<
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M !7_ .3C]1]:%_[A_P#Y%WZ9G;ZEMR\TG[K9!9$7R3;+1B4PQ[+ @.KC-H4
ME:GU<BAS.J4HDJ/'U-*^="P+*Q8S<4W);6]O<[1]_J%UCSY:M<L1NRA"TTHJ
M+<=Z3<G1[95>_DY.4GG>K<_+[;L!M=>($\0[]GEMBQ<AO[*>2:ME,8.K2AX'
MF1WBSJK3U]--:B-+P+4\^["2K&#;2Y-]"Z];NL698ZNXM^W+AN7XP4Y+9*CA
MQ/A?)5_90TGIMOUTR7;7?C%+_,>O%GBX^Y,AL2W5NEEQV/*#G(5$E();0KAV
M$:CC75KMF%G(L7())\7)V&O"1/Z>9U[/T[4,;(DYP4*KB;;7%&:DJM[O%3V;
MGM,1T?6R!%D[G[A2(K<R=@5C2Y:VG 3RN26Y+BU)[-"4Q2C7MT4?5K;UFN2:
MM64Z*<MO<IX3A_2?'MQGEYDE65F"X?[7$W_<IW65EG[B9S<L@=RB5E5S-\=D
M>4B<B2XA2%ZZ@-A*@$I3V!(X <.RIZ&!8A;]6H+AI3<>?7^LFI7LAY#OSXVZ
M[)-)=I5HEV-U"UO4FZC,MG]E=T)[#:,EN;"8-UDMI"2]WC!<42!X XTI21X.
M<U7="7J,N_CK[JVKN.GT,]+_ %":S]%P=0FEZV22;7+Q1<GW.*.SFJ;'NAN%
MD>%=-VS%MQN6JUR,KL[,:?=F2426XS,=I2VFECBCO"H<Q!UT&GAK1I^%;R-1
MO.XJJ,FZ<E:\I(=8]<R=-ZLX,<>7#*[;A%R7WE%03?"^1OGWTW<Y0VYWF[WI
MUAZ\769=GHK(CQG9C[CZFV4J4L-H+BE%*0I:CH.&I)\-7"W:A;5()+M*AXCE
M9E_*DI7IRFTJ)R;DTM]%6NRK>SLF-K8<Q?\ ZS]P<IL^36?!K-<5VBR7"SLW
M>Z^1DLO2WW'Y$<)><005(0B.G1/LZZ#2F]6,&U<MRO359*5%7<MB?UGN'ZK=
M8<S%R(85F;A"4%.3CLE)N4HT;7(E'=R\IC]AKW<=PMD-[\&RB:]=(6.VD3;$
M_*47UQU.L274)25<>5IV*E:1S>$Z:5]:Q9CBYEB];5')[:;*T:^E.A\=2,Z]
MK&BY^%DR<E"%8REXS7%&5-_DRAQ+;RTV4*V[71-WLB%YPW:]VYB/=^Y>R%F"
MZ(K7(WS);4_))1R)\90TYQS=FBM*G=0EB6N&[D)56ZNWH7[4//\ JS#6LM7,
M337-1E1SX6HI<B;GL:[2?C*NQT+@].FU.YVW6X0D7_)+4+3-C2FKOCS-V$E]
MUQ2>\0YY,G4%27!J5:Z@<W@)JLZUJ.-E6*0@^)-4?#3N5/5^HW5C5M(SG+(O
M0=N49)P4W)N3V\7#2E:[WOVOG*R8-'9B=3=IBQFPS'C9XZTPRGL2A$U:4I'K
M #2I[+;>F-OV:^A'GFC04.MBC%42R)I>=(WOJBW7S5S=*ZXO:[U,L%FQ!UI%
MOC6U]R.5ONM-ON2'%-%!4LJ7PU[/!Q))Y- TVS[LKDHJ4I<ZKLK2A+?J-UHS
MUJD\6U<E;A:I3@;BVY14G)M4?+1<W=-MZ-[O=9MPW,:F7.7+;8L7>LMO/..)
M0XMU:EK2%*(!43J2.TUS=9[4(QM426WF[1+_ *3YM^_/*5RY*248M5;=&W*K
M5>?EYRF_WX9;^%-W\^D?5U9_=+/D1Z$>2_GFH?\ D7?/EX2U75^M2U;0+6HK
M6O%4J6M1U))[LDDFJ[U9_P#K?S>$]-_5EU]R;]G+_M-@ZF+Q<MO,&VGVPQ68
M[9K(JS^5W8Q%J:5+<0&TCO%)(405J6M0)T*B"?:BM.@VHY5Z[?N*LJ[*\E:_
M8CN_47,O:/@X>!BR<+?"Z\+:;X>%+:MM&VV^=T*BO;A9G*Q9_"YF0RYV-2)3
M4PVV4OOPAUD$)[M3G,I XZD)(!-658-F-U75%*25*K8>57.L6?<Q)8<[LI6I
M-.DGQ;5S-U:7+1<W;K9G='_*=L?_ &F[^U-J!T[_ )2_VOK1Z+UH_P#4<#^9
M?W9FTX?F5[P7I!<ON.NMQ+Q\OR(D2X*0%N1A)<[M;K.O!+G(2 KP:FN?)QH9
M&K<$]L>%.G/1?02>E:K?TSJ9Z^PTKBG))TKP\4W%M=FCV$2]->XN6V_>+&HC
MU]G7"#E,I4*]Q)4AUY#_ 'K:^1Q7.5>.A>B@KM[1KH34EKN#9>)*2BDX[514
MY2K?I]U@SEK-JW.[*<+K:DI2<J[&T]M=J?*87<V+>,,ZALH8V\#\2]LWLNV!
MJ"WSNI>GM)<4VRWHH=KRD@:=G9I6S E"_I\7?VQX=M>:+^PY.L5O(T_K-=6G
MU5WCK#A57Q7(INB=?*?82YC=H^Q?4(+K"RZ\Y+&QK(''!)CW*]7Y+<M*R0X"
MHI4Z>)3[7UN(X5R2U;3^%VHP<H\RCL^HF[74SK,[L<JY?5N[O3G=?$N6FSB5
M-GW=VS:C,=;$9"<\PZ:MMH3IF--"<^U[5Q3<A[0CP'3F.A]33U!7QU5D_4S7
M(I?4;?U?M16;CSIXSMT;YZ2=/I9MV^.?Y/B&QNP5CQRX+M#>6XI$%XGQB6Y2
MFH4& 4,H=20I*%%\E6G;H!V:@\^E85J_FY$[BKPS=$]VUR\!(];M>RM.T'3K
M./+@];9CQ26R5(0M[$^2O%MY=G;,1TW7^Z9-MGOOB60S'KS9H>/KEP6);BW>
MX6Y'E!8;*B2D$MH4-#P4-1Q-?>NV86<BQ<MJDG+D[#7A-?Z>Y][4--S\7)DY
MP4*KB;;7%&::3>Y>*FJ;GMY2/^D&?.1O)8[<B:^BWO1;BZ[!#B@RIP15 +4W
MKRD\!QTKMZRPC[HY45:K;R[R!_2K(NK5U:4GP.,WPU?#6BVTW5[)&.\=\O<C
M<K<RVR+Q.?MS>5W=#<!R0XIA*6YSW( V5%("=!IPX5WZ99MK'M2457@CMHJ[
MD5KK7J.3/4LNU*[-P5ZXN%R;C13=-E:;.3F+20;5#WYV)P+",$RZ%8\KPIHH
MO.&S'C'\M4E)27"E&I4%$<Z5<JAJLA12JJ].X]-SKEV]!RA/=);:?MN/3;./
M#K1U?Q\3"OQMW;22G;;IQ47#M2VT;\9.C6W;MW5(W#Q_<?$9D#%]PF[E'5:T
M.JLD>:\J0PEIP@+5$<YEH*%% UY#IKVZ&K)@WL:\G<L4V[Z*C[IY9UAPM5P9
MPQ]0X_%KP<3XHT=*\$JO9L6Q;N5)LT6#-DVV;#N,-PLRX#[<F*\.U#C2@M"A
M] @&NR<%.+B]S5"#Q[\\>[&[!TE%J2[:=47-ZJ+2G-#M)N?8HZ5IW!M,> XT
M@GA*/*ZRA7#VWU]2/_8]:JOU>N^[^NL3_<;?<W/Z%TGKWZDX/YE[EGV%_GQ4
M.[+QH+\4EW"PN=0+1?L!W!V!M;#;MQVUPRSSK;R<%NR8R%/$)X]I2TT-3V]Z
M=3QJ%Q)SM7[>9)[)SDGVG_U?07O6<:QEZ?DZ+:596+%MQ7/)5<5V_$C6OE;6
M5RV9<_)WT];O;E+_ .'N>2%./8Z\?;ZE/==XWX/%7(4KC[G4WJB]ZU"S8WJ/
MC/Z?H7?*#U1?Y1U<S=0>R=SQ(/\ #%KM3F_-YBN^T6%+W!W'Q/%>[4N)/FH<
MNI2->6''U>D$GL&K:"!KX2*F]3RO=L:=SE2V=M[$4#JGI'YKJEG':K%RK+^2
M/C2KVTN'MM$A=46:(R_=J\QH;@5:,10BQ6QM!^M@Q2?*"E(X#Z\I:>':$BN/
MJ_B^HQ4WOGXS[N[O?23OZDZO[_J\X1?B65ZM;=E5MGLY'Q-Q?\J*ZU-E +Z]
M)TNUP-K-^)U[@&ZV6% +]WM:5<IDQ6X,M3S(5J-.= *==?#5/ZQ1E+*L*#I)
MO8^9U5&>W_II=M6M&SYWH\5N*;E'RHJ#<H]U;#1_RK=,/Y@Y/GRO?JZ?RW4_
M_(7[=PB_BGJK_P#LY_A](E#>&ZXQ>^DW%+IAE@5B^-RK^/DVQ+67%,<DF<AW
M59*M>=Q*E]OAKATVW=MZI*-V7%)1VOGV+ZB?ZT96)E=487<2WZNTYKACS4G)
M/E>^2;[IBNF";9K;LGO3/R&UJO5BAJ+MVM*5<ADL)B$K:"@1IS#AVULU^$YY
MMF,'23W/F=3G_3B]9LZ#FW+\>.W%R<H^5%055W41M=-S^FR3;+C&@;%R8LZ1
M%>;ARO+UCNW5H(0O4.DCE40>RNVWI^HJ2;OJE>;[""R.LW5:=N48Z>TVFEN6
MVG.I57;1HO31_CEM]_YR1_5'Z[=>_P!E<[2^E%?_ $[_ .>QNW+^Y(M1E<KI
M9N.\UZLF:XU>F\J>NH:N=XEO.(M3DI00$Z]Q+Y@@ZCM;"?XW"J]CQU.&&IVI
M+@IL2IQ4[J^NIZ9J5SJM?UR=C+LS]>Y*LI-^KE*BHO%GVM\%'G[,*]6MSSIK
M-(&*9!%AVS$K+%2YA%OMJ%)BJBD=UWA*@/KB>3D*1H$  )&AU5*=6[=AV7<@
MVYM^,WOKX/I*C^J65GK,AC7E&-B*K:45XK6ZK_B6ZBV15.>KJDPP_*?9BQ65
MR9,E:6H\=I)6MQ:SRI2E*=222= !5CE)157L2/+[=N5R2A!-R;HDMK;>Y)<K
M9>)Q+'3+LU<K7+=3^5[=>,$OP4%)7:X)2I YR-="VE:AZ[BN&J6R:J2KJ^8I
M+_)M_B?V_1VSVA\/4O1)0D__ )N2MRI6VJ4_!5\]9O96*J47JW'BA(FTN.0L
MNW+PC';B.>W7.[1T3VC_ .\80KO'&_\ VTI*?V:X=2ORL8UR<=Z6SZ"P]5-/
MMY^JX]BY]V4U5<ZCXS7=I0FGJIW R*9NE=L4B7*3;,<P]N-"M=IBN*99"E1V
MW7'"ALI!)*^4:]B0 -*BNKV%;6,KC2<I5;;V\M"W_J3K^6]5GBVYRA;M**48
MMQ3;BI-NE.>BYDMF]DB[)WB?N?L-O/A&5RW;PWB4 3[#-F'OG(ZG&)#S*4K4
M2K1MV+J/" HI!TX#BU6U'#S;-ZVJ<3HTME:-)]*9/=3LRYKFA9N%E2<W;C6,
MI>,UQ*3CM>U\,H-JNZM$Z;L;LV4[I=/&Y.U+Q#UZQ+FO6+M<>?11,A*$=NNK
MR'$G_O*^]4_^'J%O(_=ELE]#[U.@T=4::WU<RM,>V=JLH=WQX_C4D^PS$]*L
M*)BULW,WGNS05%PJTKB6GGUT7*>3WBTC33CH&T?_ !*V=8IN].UBQWR=7VMR
M^OH.7],K$,.SEZM=7BVH.*[=.*7_ &KNFU]*ULGW.T;R[DQGX9SMUEV)9+I<
M5!MB-*E(=D./NK4%:)4X4%7K)(\-<_6&<83LV'7U:HVEO:6SZ*])*?IMCW,B
MSG:C%Q]YDVHN7W8R:<VV]_"Y.->Q$UK'-F]X+#F<'-6]S,65>&YS<J?-5?RM
M<A(7S.(=!1XZ5@D%)X$&MU_5,.Y9=KU4J4HO%W=\Y=.ZHZ[C9\<QY=IRXDY/
MUDGQ*NU-<-&J5V;NT83J>8QY._%KGX]+ART7F+;)EU<A.(<0)??K95SELD!9
M;:0H_1U\-;M"E-X$E.NQR2KS4K]+9'_J!;L1ZQV9VFGQJVY4\KC<=M.7AC$D
M7K'W-RNV97;<$LER?LEH;@,W2>Y"=4R]*D.K<;3WBT<JN5"6QHG7MXGL&G'U
M9P+4[;O37$ZT5=RW>$F?U4ZR9F-DPPK$W;CPJ;<6U*3;:2JMM%P]WEW'[TO6
MV\S\)W=W"AW)A[<&8#:;1D5ZD*(CK+(67G7W><\5.(.IUUY .RL=8)PA>LV6
MO\-;6HKL\B[G?-GZ;V+][ S,Z,T\J3<(SN-NC44TY2=72LE7^5&MX9LYNUBN
M<VO-$;DXL9S=P9D7F2;^7%RV0L=\V\%('>!:-1HH^Q6[*U3$O6':]5*E'3Q=
MSY*;=AQZ1U0UO"U"&8\NTWQ)S_Q)-SC7QDZQ\;Q:I5W<E#5>HJ\Q<.Z@3F&!
M7**)Z&H-V7)AN)=:3-Y2AQ*^11'UQ* 5CPA1U[:Z=$M/(P/57DZ5:V\WV/<1
M'7W+6F=8HY>')<?#&;IM7%MBT]O[T4JK95/LU+8)QO;[+'K#U6R;9(:1;<=>
MNMSQU#!4I^X0D\C3Y !YE-<BDA6FAY6UZ@ U77?R+*EIZ:VRHG7D?)W?"CTV
M.GZ=FSM]8W!KAM.;C3:Y16R5.644FD^7Q7R(\\I69W?<#=BWY;>W.:==[]#<
M[D$E##0?0EIEO7^"V@!(^AKVU=%BPQ<1VX;E%]W9O/"_SB]JVMV\J]OE=A1<
MD8\2I%=A+IW\I8_K$W"RN/G8PBWW1RU8]%AQIS\6$I3"I4A])!<DK007.5*4
MI2#P '9K4)U:PK4K/K9*LJM;=M$N8O?ZJ:_F6<V.):FX6U%2?"W%RDZKQFMZ
M26Q;N]3O;?WJX;A]+.[-FRJ4Y=U87_Q5DG25*<>:2RVF0T@+4==$*;4!Q]JH
MI]KPK7F6HXNIV96U3CWI=ET9TZ'F7-8ZJ9EO*;F[7$XMU;\6*G';V&NC8]A^
M=+&0OXGM3OGD\6.W*EV%AB=$8>]H7F(\A;95V\ H UGK!95[+L6VZ*6SI:,?
MIMFO!T;/R(JKM^,D^5Q@VBKC.49AN+E,"TY'E5SGL9;>HC=R8=DNF.5O/I0E
M7<!7=CDYSR@)\7P5/RQ[.):<K<$G"+ILV[N?>><6M5S=9S86<F].4;UR*DN)
M\/C22^[7AV5V;-A>+J'VNS7,+E9<7QC)<;QW \;ML>/ QN;<_(U%U.NKKC/(
MKFT2$I3J?!J.)-5/1=0L8\97+D92N2;VI5[]>D]DZ\]6]1U.=O'QKMJWC0BE
MP2DXUESM).J2IP]TPSF,7&Q=-^XF(;E9A8;\_;1\HX9Y/<TS'6%-!"T-(4KD
M5Q<!"4@'VZAV'2MJR(7-1MW+$)13V2V4[?>^@YIZ7?Q>K65C:E>A<<4Y6VI\
M35$G%5=']];%MWTW;#3=F)=CS[8V_;-6S+H^$YU)NIFQUREEA%Q;4IM81SH(
M4L$(Y%)&JAH#RD<*ZM5C/&S8Y4H<=NE.U^V\A^J%ZQJN@STJU?5G)XF]NSC5
M5+91IM-+AE3:N9JE:_[CX!NMMC"8QG,VYK.,ORTR+;W<A4BUNR6D+2E;1!*$
MN!#BQH0E6A/#2IG!S,7+D[EJG'3;LI*G9YUNYRB=8=$UC1K2Q\OB]2Y)QI)R
MM\23^[Y+HY;&HM[=C2++V"!;]\-@L/VYPK+X>.9CB+CBKKBDQTQTW$CO/&T1
MQ6%=X%A7*H!1(5H>-0-Z<M/SYW[L'*$MTEMIN_Z<AZ+A6K?67J]9P<.^K=ZU
M]Z#=..B:VTVN,J\7%22KL:KNJCN+C6Y6%OVW%-P6[C'9MO?N6"/*?,B($.\B
M75Q' I:.57=HY@D\-!S &K'@W\:^G<L4VTK14?8KWSS#K#@:KI\H8V?Q4C7@
MJ^*-'1/@>W9LC5<FRJ52P>\W^6G8#_XG]$JH72O^2R/VY2^=</\ U;3O[/\
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MU?*\);OU7DI>Y4?_ --_]I(N1XY!ZJ=O,$NV(WZWP=Q,0A^07S'ISW=EP%*
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M[9LV;#+8)E#N%9EC.6--%\V"XL3'(X.A<;;6"XV#PTYD:BM>9C^\69V_*5/
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M.8GC6O3,+W3'C;Y5O[;.KK7KOYUJ-S*2:BZ**>]12HMU>RWM>UD:5WE<% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4!;7IS6G'.IDV9_1*G)5\M7,K0:+90^L<=0!J6=!IKQ.E5S6UZW3N-
M?POZ/">H=0)K#ZS2LRWMW8=V-9?]AZQ5YX?I,4 H"BN\\)S=+J1VYVLGJ7]Z
MUEA_*EUB<_*ETE+DA[4>'G;90T/".96FFI-6K3)^Z:?=R(_?;X5WO"WW$>2=
M:K#UGK'B:=.OJ81]9)5V/>]JY?NQCSTE*E-Y>5AAF,RS&C,HCQXZ$M1X[20A
M"$(&B4I2-   - !56;;=6>M1BHI)*B1RU@R* 4 H#Y4E*TJ0M(6A8*5H4-00
M>!!!H-Y37(.EN^V3)9N3[)9\[M^JZ**IMC474QDZG7E;6UKJ@$DA"T*"? =.
M LMK7H7+:MY5OUE-SY?V[)Y?E_I[>QLJ61I&2\?C^]"E8=SL;Z1:=*^+1;#L
M8ITO76=E,7,=YLZ?W"N%N4E=OM.KABA2#JGO%.G4H!X]VA"1KVZC45\Y&NQC
M:=K&MJVGO?+^W9VFW3NH%V>7'+U3)>1..V,:4@GW7NW/A2BJ[ZEPR 001J#P
M(-5P]+(QQ#9_!L$RG(LMQBW.6VX9,V&YT5#A\D;3SAQ7<LZ (YE#4CL'\'0<
M*[LC4;V1;C;N.JCNY^ZR"TWJYA:=DW<G'APSN_>H_%Y]D=RJR3ZX2=% * 4
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M"$<Q'AK1F:KCXCI<EMYEM?[=LD=#ZGZGK$>/'M>)6G')J,>E[7S>*GM-YO\
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M'3_MJ=Q<J&3;5R#V,\[UC2,C2LJ6-D*DX\VYI[FGRI_MM-7KH(PN9U6_],[
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M;]KV),V7(>GBWR<6O&9;4[B0-RK7CZ5.WRW-,*BSH[24E:EAHK65Z)!/$)U
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MVXA20MMQM1 U2M"@H?1X\:GL3*ADVE<AN9YUK.D7]*RYXM]>-%]QI[4UV&O
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MP_F^H]*_1S_=Y'\D?[Q2*K8>."@% 7=R3_)#M_\ V^]_S&Y54[/_ #4_Y?\
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MGJMU4R->NR4)*%N"K.<MT>94Y7W4J+:ULK8S:+#-CL=W2Q$V'>*=E.4Q9H3
MC1;0]&B//%M:%H+RN8<JDD\0HC3AJ:@]2RLV[C3X[*C!K;5IM;>;[#T+JKI&
M@8>JV?49LKM]-T2@U"3X77QJ-4I7][L59$>ZN22<-ZE,DRJ$PW)DX_DK4]J*
MYJ$.EGNUE"B.("@"-14EIUA9&FQMO=*+7TE6ZSZE+3>M%W*@JNW<C*G/XL:K
MNKE)HON*[-]3%YD9'AN:.85N3>$-JG8M>4:M27FFTMCNR"-20D#5I2NS4M@Z
MU%V<C,TF"A=AQVEN:Y/V[*[I;,S2]$ZY7GD8M]VLJ2583Y6DEN[2I6$FN5QJ
M0GM?/O.Q6^]L@9.@6]VWSOD?)6PH*;\EFA*>]"M0"@!:'@?4 X>"I74(0U'!
M<K>VJXEVUR=O>BG]6KM[JSU@C:R-C4O5SIM7#.E)5YONSYZ<E=A-#^RNG5VU
M:/(TC&Y$G[] C0\GDP/>J1H1IR^6#N]!PT/[%1:U3_\ %-:^-]S]O[);I=4O
M_P"L5'A_PF_>.7=__=Y-W"^X0-NYF_W_ .]]SOK3I=MK-W8MUF.NJ?)(;B64
M*3ZSA27/_:J6T[%]VP5%[W%M]MKZMW<*=UDU?\SZQ.ZG6$;D81_EA)+9V&ZR
M[I)_6M<)SVZEMMKLMURWPK%&=B0BHEIMQYU[O%I3V JY$ZGPZ"N+JM"*QI2I
MM<GM[B)S]7<BX]3MVG)\"M)I<B;E*KISNBZ#9K3=;E!Z);JN'.?BK-X7#YVE
ME)\G?GMAUH$'VJPM6H\.I]6N:Y;C+6555V5[JB2N+DW;/4:4H2:?$U5<TKM&
MNZFZ]LT/HU>=:WF:0VX4(DV6>V^D=BD#NU@'UN9(/[%=O6=)XG]I?60/Z32:
MUETY;4OIB8C9<!/4]9DI  &174 #L [N57WJ?_&/^6/U&GJM_P"VK_5N_1,T
MOJ G39^\FX2YLMV6J->)$6,75E?=LLJY&VTZ]B4@: "NO18*.';HJ552&Z^W
MIW=;R>-MTE15Y$DJ)<R)ZOCSETZ*<9>N7U]ZTW_NK4\YH5)0B5(;2$GMX(6I
M/T/6J'M+@UF2CRQV]"?T[2[YDGD=1K4KFUQFE%ODI<<53M1K'M'[C?\ DAW
M_M]G_F-MI>_YJ'\O_;(^,3_T6_\ SK_[6!#73)!B7'?3;^/-2%LMR94E .G\
M]%A2'V3Q]1QM)J5UZ3CA7&N9=]I%1_3NW&YKV,I;JR?=C"37?2,=U#7"=<=Z
M-PG9[JW'(]T7$CA6OBL1TI::2D'L'(D?MU]:)",<.W3FKW6:^O\ >G=US)XW
MNDDNPDE2GT]\GG9R0[<^EG?"U7-?>VNUJ>?MJ7/:H>[AIX)23P_G6T* ]4^J
M:A]42AJ=B4=[I7I:^@N_5*;O=4\^W<VQCQ\->3Q%+9_:V]MG5V@G3;;TK[W2
M[?+=A2D7%*$26%E"TI=;B-K 4G0CF2H@^L:^M3@IZG84E54^MFOJC>G9ZJ9\
M[;<9*4J-;']V'*1ITH/.M;\X2AMQ2$2$7-M](.@6@6V4L)/JCF2#^Q4AUBBG
M@S[%/[R*O^FER4=>L)/9)33[*]7)_2D^X:MU 3IL_>3<)<V6[+5&O$B+&+JR
MONV65<C;:=>Q*0- !6_18*.';HJ553BZ^WIW=;R>-MTE15Y$DJ)<R)LZGGG9
M>V/3'-D+[V5+Q9QR2^=.9:E0K4HDGZ))J+T&*CDY26Y3^N1:OU%NRNZ9I-R;
MK*5EMOG;A:;-'QW8&VQ\.M.?;K9_%VXL%^'/8X1BN3I\ILIYDK#+9!2%)\8<
MH6=--0G45U7]9D[SLXUMW)+>ZT2_;N$9I_46U#"AG:IDK'MSVQC3BG)4JNZ]
M]$I.F^CW3OC5LV_M?3CO9%V^RV?EMO+(<N+\Z&N&&I'=H'UMM8'!24@Z^L.-
M0]^YD3U"P[\%%UV4==E2\:=CZ;8ZMY\<"]*["DFW*+C27"MR:7)3PFG]#7_7
MF8_V /ZTU75UL_R8?S?40GZ.?[O(_DC_ 'BD56P\<+F=5O\ TSL#_=3_ .0P
MZJW5S_,R/YOKD>O_ *I?[?3O].7T6S(]8BUV^'L]CL-2F;';["M<2(G@WSA+
M+0) X$I0@ >IJ?5KXZL+B=Z;^\Y+ZS?^K3=J&%8ALMJ$J+DV<*70MW-5\Y29
M+SJ6G&4NK2RZ4J=:"B$J*->4J'82-3I]&K715J>.*Y)1<4W1TJN1TW5[7(<=
M9/@O7NLRJ_=(VT-XMJ4NQ+#)BLW+D.O)R-R(:E'@-/KR0D^N:J&G/U6JWHRW
MRK3I4OH/:^L\/>NI^'=M[8V^#B[%(RMO\>QE%*MYXH2'M%_BOMA_>VR_UYFN
M+4O]K=_DE]#)SJQ_RV)_KV_[\2P^_N97+;_J@5E]J.LJRMVQU;&I2EYDQ4)>
M941X'&R4GZ-0>CXL<K37:ERM]QUV,]"Z[:O<TGK1'*M[X1A5>5%IJ4>ZO"3V
MG#[5*ZA=H-Y\2 >QG<6/<')[K?%+<_Y'ED%0'!)<0-%#^.A>O$U$+*DL"]BW
M/O0:IVN)?0^\RYSTBU/K#A:MC;;5]2XFO*]5/A?8XH['V8\[*);Z_P",6Y/]
MOS/Z0U;M'_V=K^5'C/7C_F\K^=_0B3=M>JK-</AQ\<RJ,QGF(H0F,N#/ ,IN
M,-$EMMX@A:0G71+J5>IJD5P9W5VS?;G;?!/L;J]KD[G06#J_^IF=@15G*2OV
M=VW[ZCNV2W2V<DDV_*2,OU*[;X/;;)A>Z^W486K',Z2GOK*E/=MMN.L]^TXT
MUJ>[U2%)6@>*"!R]IK7H6=>G.>/>=90Y>TZ/;R]AG7^H75_!LX]C4\%<%N]2
ML4J+QH\49*/[NQ-26[=1;ZU#JRGE)=C<FX3HG2-LY%BRW8\:Y3UM7!EM12EY
MM"I;B4. >V 4D*T/A JIX$(RU6\VMJ6SO'LO63(N6NI^%&$FE)Q4J<JI-T?8
MJD^X=GHIDOL7/<_N75-@6)EX!)X=XVMSD5IZJ>8Z?1K'6I)QM=M_4?7Z/R:G
MET\F'_<5/Q2Y7"1GV,W=^8\_<W;_  I3L]Q96ZIXRD++BEG4E7-QU-6+)MQC
MCSBELX6J=P\RTC)N7=4L79R;F[T&V][?&MI:O?Z!"N75;A]NN"$J@7&9C<>X
M)5H IIV2AMSF)X>U.G&J]H\G'2[C6]*=.@]+Z[6HW.MF+"2\63LI]ISHS<^H
MVT;,7G<N6O/]R+W8KW$@Q&&[/$MJY+#+!1WB.1P(4#S%94?7-<NB7<RWC_X%
MJ,HMO:W1UZ27Z]XNA9&H_P#S\JY;N*"2C&+E%1VOR9;]M=IHLC-]D<5V/SS;
M7&LRNV6R,B=$NUQYUN=9#4D*8(Y2I"4) +(63KKKZ]=<<3-O9MN_<@H\.QT:
MW;>SV:$/<UG0,'0LC3\?(G=<ZN*E"6R6RE*Q44DX\7;J]YV.F_\ P-ZD_P"P
M)7_+)M8UO_?8W\R_O(QU#_\ 7M3_ ))__92*5PX<FX2XL"$PJ3,G/(CQ(R!J
MIQUU00A"1ZI) %6J<U"+D]B6T\AL69W[D;<%64FDESMNB726CN>P6 [?,PV=
MW=WF,=R*8PB0<7M%O=N+S2%^!;K9(!.A&I0$ZC@5"J]#6<C*;]VL\45^\W3]
MND]+O]1],TF,5JN:H7))/@A%R:[JXG3DKPI57*2#O['L$;IOVA8Q>[2+[8&+
MLMNU7:6T67G6@W*'C-J *=".4#U *X]&=QZC>=Q)2IM2[:)WKW#'AU:PXX\W
M.TII1DU1N/#.E5L^@UG$-P-I]R=L<;VEW6G3,/N.*N*&-Y9&3S1M#S! >X+"
M?%5RJYD\IT!"TFM^3A96)DRR<=*2EOCR_MS4Z"/TK7=(UK2K6EZG)V9VJ<$U
M]W95+;M2\79+B5.5-/=$^\&R%WVI^2KFB\1,IQ'("KY"R:$0$.D)YPE: I82
M2GB"E2DD:Z'A4EIFK0S:QX7&<=Z95NMG4R]H7!=4U=L3^[-=*357O6U--I[2
M;LD_R0[?_P!OO?\ ,;E439_YJ?\ +_VQ+?E_^BV/YW_]K,JUMWM_D&YN4P<3
MQMMLSI84Z])?44LQV&].\>=4 3RIU'8"22 !J:L.=FV\2T[D]WTOF/-M T+(
MUK+CC6*5>UM[HQ6^3_;>T3XSM?L;AV10;?>M\I$_);;.;2]%LMH>6TU*;=&B
M!(!<0>50T.BM=?4J%EJ&=?M.4+"4&N67)3FV?07VQU;T#3LN%N]GRE?C-;(0
M=.-2V*J4UL>Q^-7M'?ZP9KULWPM5RC!/E,"S6V2QSC5)6U(?6GF'#4:I%?/5
MJ"GA2B]SDUWD9_5+(ECZ[:NQ^]&W"2KNK&<FJFXWQ6S'5%.M]T^^I_;?=%V(
MW"<MMP2%PI;C>O(E"E%*5'4\J>5Q*R.ULFN6U[YHZ<>!7+5:U6]>#NJG9)C,
M_(^NTX7%>=C+X>'AENES+;LERTX9*5'MB5EN6 9!MGNM9,3R1MM,^)=K>ZU(
M85SLOL./H+;K:B =%:>$ @@@]E3T,VWEXDKD-W"^XZ;CSV>A9&BZU9QK]*JY
M;::W2BY*C7[;T3#U6W1^Q]0$:]14I7*M$2TS8R5C5)<CJ+B0H#P:IXU&]7K:
MN8#@]S<ETHM'ZEY4L3K#;OQ57"-N2[<9-_4;S?XFS/5%<X]YMN6O[>;H38[4
M5ZQW5(7&EN- );2VK5*5D@<J2A85IH2WK7'9EF:/%QE!3M5K5<G@[J[I,YMK
M1.NUR-VW?=C+:4>&6Z5-RIL4N6G!*M-LH\A3O/,'OVW647'$\C90W<K<4GO&
ME<[3S3B0IMUM6@U2I)UXC4=AT(JSX>7#*M*Y#<^\>3ZYHN1H^7+&OTXEMJMT
MD]S7[=@PEC_];L__ )Z/_2)K;?\ \N7:?T'-I?\ N[/\\?[R+7=:UPG/;J6V
MVNRW7+?"L49V)"*B6FW'G7N\6E/8"KD3J?#H*KW5:$5C2E3:Y/;W$>D_J[D7
M'J=NTY/@5I-+D3<I5=.=T709KI\=7-Z?NHJV327+;"M4F7#:61R)D&WOJU2#
MX>9EL_L"M.LI1U#'DM[:7XEX6=W4>;GU;U*$ML5&;7;]6_K2-AV4M^*L]+&X
MLO(+S*QZVWF\JBY%?8+)DR&F>:&RAI+2024J[PI(TX!:CV5HU6=UZG;4(J32
M\5/8N5_MVCOZGV,2'53(E?N2A"<VKDHKBDEXL*))-T:[#IQ-[B.\0B=-F'93
MCV50-V\B<EX_<(\]I@V=U"7>Y6%J:44MZA+@!2K3P$UVY,M2OVI6Y68TDJ?>
M7A(/2[7573LJWDV\Z[Q6Y*2\1[:;T_$W-;'V&8N_Y;C&<]56)Y3B*G'+/=,K
MQHI?=:+)<=:=B-.+#:M" 2CP@$G4^&MMC&NX^F3MW=ZA/Z&<.HZGB:EUKL9&
M(VX2O6=K356G%-I/;R);EMKVSH]6]WN,_>_)K?+EN/PK$Q;XUIC*)Y&&W8+$
MAP)'8.9QU2B:V=7+48X49);95;Z6OH1S_J?F7;VMW;<Y5C;4%%<B3A&3Z7)U
M[G,;WTD2I$*Q[ZS8CRXTN)C*'HLALE*VW&VIBD+21Q!! (-<766*E.PGN<G_
M -I8/TJG*%G4)1=&K<6GV:7"N^T4N5^5[;:5Y0X9+^66D/OE1*U]]-:2YS*/
M$\P40=>W6IO4H+W2ZJ;."7>6P\_ZKW[GYSBSXGQ.]"KY7Q22E7MINO;):ZPI
MTV3O1<XDB6Z]%MUO@H@1EK)0REQA+BPVD\$\RE$G3M-1O5F"6(FEM;=2T_JM
M>G+6.!MN,81HN15WT79Y3:<\>=E=&.T#TA?>NHRAYE#BM-0VTN\-H2#Z@2A(
M_8K1AQ4=8O)>1Z!W:W=E=ZEX,I.K]<UW(^NBEW$DCBPK_)9N[_>V-_366OK*
M_P"8L_R/Z)FO2?\ TG-_UX_38,CT??\ IF]O]WF?]R76GK/]ZQ_,_J)#])?\
MO._DA_WE.K'_ .MV?_ST?^D35GO_ .7+M/Z#RC2_]W9_GC_>1;3K@_Q7Q[^Z
M43^O3ZKW53_:R_G?T1/1_P!7_P#EK7^A'^_<-UV4M^*L]+&XLO(+S*QZVWF\
MJBY%?8+)DR&F>:&RAI+2024J[PI(TX!:CV5Q:K.Z]3MJ$5)I>*GL7*_V[1/]
M3[&)#JID2OW)0A.;5R45Q22\6%$DFZ-=ATXF]Q'>(1.FS#LIQ[*H&[>1.2\?
MN$>>TP;.ZA+O<K"U-**6]0EP I5IX":[<F6I7[4K<K,:25/O+PD'I=KJKIV5
M;R;>==XK<E)>(]M-Z?B;FMC[#-OQ&_X=N1UCV[)\<67++*2Y*CE]DLF1*BVE
M2"I+:B%)(6CGXC4E).G'6N?)LWL72';N;]W:3E^W226F9N#J_7*.3CR\3A;V
MJG'.-MQV)T:IOW?NO9RE;]]KA.N6\6X[]P*^^9OTR(T%DDAB*X6&--?!W:$D
M5.:1",,2VH^2GW7M??//NNU^Y>UK*=S8U<<5_+'Q8],4GW2?\DN$ZY=%V).S
MY;LQUC)!&9<>45J2RR[+0V@$\=$)  '@'"H6Q",-8FHJGB_2D7S/R+E_J1:E
M<DY/CI5\T9R27<2H4GJV'C0H!0"@% * 4 H!0"@/;S?+ /RD[99)CC#0<NJ6
M?+K!P!/EL75QI*2>SO!JV3X HUY5I.9[KDQF]VY]I^#?W#]>=<-$_-],NV$J
MSIQ0_GCM7G;8]IE+NBW<;Y&R"\[979TLQ[^I4ZQH=/+R3V$:/M:$C0N-)![.
MU&GAJS]:,+CA'(CR;'VN1]/TGE?Z2Z]ZF]<TZZZ<?C0KY27C1[J5:?PL]+*H
MY[V* KYU![,KW7QZ%*L<A-NS;%UJE8Y.YN[[S70JCJ<&A1S%*5(5_!4/ ":F
M-'U/W.XU)5A+9)?7^W(4SKIU6_.\:+M2X+]I\5N6[;Y-=ZK1--;FD^<A_$NK
M"5B24XGOEBUUL636U(:=NS$<$2 G0!QUDE!!/;S-\R5=HTJ1R.KRO?XF)-2B
M^2N[]NS1E9T_]1W@_P#QM9LSM7H_O)5C+LT7/_#Q1[6XWWTQ-E?G"Z_:]S]V
MN3X;S?)72B8^9^A>UEYDO 5"V\WSMNS6>7"'C%XGY;M/>Y'?R(4UM34R*73X
MSB O@74?PB.#@TUT5[6QYFD3SK"=R*C>BJ;-S^SZ.T>9Z-USL:!J$K>/<E>P
MKCJ^)/C@V]K7%O:Y?*7\1;WJ6W5G8QMG9EX9+6BZ;B.M1K-<6B6W4176@ZMU
MK7E4E:DJ0D'M3S:\"*KFAX$;V0_6KQ8*K797(>G=?.L%W!TV#Q'_ (E]J$&M
MC2DJU79IL7,W4QN$](&V=OL$9.<0'\JR>4V';K/5-E1VVWEC5264QW6]0DG3
M5?,3V^'2MF3UDR93?JGPQY%1/9W4<FF?IAI5NPO>XN[=>V4G*2\9[Z*,EL[=
M6R+VK/<.E[>W$;38[I+F;:;H24Q7;9)/>*:=4ZAA1X  JCJ>;4%@<Q02DZGB
M>]W8ZOASE-)7;:K5<JW]^CV<^T@(8L^INMV+-B<GB94J<+VN,JJ/X7*'C;W&
MJ=6DST(JG'M(H!0"@% * 4 H#QTZH-R$;A;G3VX#P=L.)I5:+4M)U2ZMI9,E
MX?RW-0".U*4FO2M P?=L9-_>GM?U+H^D_+GZCZ^M4U24(/\ P[-8+LRKX\O.
M\7F:BFMY7.IP\_% * 4!;K:C</;B\;17W93<F[R<4CS)WEUGR5AE;S85SH>"
M7$H2L@I<;\(T*3IJDBJSJ.%D6\N.587%14:[WT'J_5?7M,R='GH^H3=I-UC-
M+9OX]]'1J2Y=C7+4W?:7)NG;9#*&W8^;R\PNMSCNQ[CF7D$F/!@1^3O VU&;
M0\XXMUQ*02.8 ?PAH0KEU&QJ&H6]MM1BGLC55;[+V;EVB7ZM9_5KJUD>+D.[
M<DJ2N<,N",=](J*E7B=/*IRM4HZFXKE[6)[E6C-&FUS(MHO@N!9;)0IU@/%2
MDIUTT*D$@:_LU8LC%=[%=I[&XT[M#S/3]8A@ZQ'-2<HQNN6S8W%MUI6G[KY>
MZ6)WN'3_ )PYDVYMBW'EJR>[Q6G(F()AO([R:VA#("U.,^(.5&JN.FO%*M"*
MA-*>?C\./*VN!/[U>3?SE\ZWQZN:FKNHVLI^NE'9;2>V:7"JIQJELV[ERI[2
MF]6D\A++8QN#B-NZ8=Q=NYEV[K,+]D3$ZU6CN'U=['0Y;%*7WR6RRG01G."E
M@\.SB-8*_AW9:E;O)>)&+3=5O\;DW\JY#T#3M;P[75?*P9SI?G=4HQI+;%.U
MMXJ<*^Y+>Z[.T<FR&[>)V#&\JVMW.B29>W^7J[XRXJ2MV%)(0%.<J3S<I[M"
M@4@E*D@\IU-?.K:;=N7(9&._\2/?7[5W\AOZF=:</%Q;NFZBF\:[MJJOA;6W
M=MIL37"JJ6VFW9EE[;],4%0GR=]+A<;>E04+9$M;HE+2>(0%EI0!T[24#]BM
M2S]3EXJL)/G;V?3]9VRZN]5+/^)+4)2CY*7C/L;(M]Y=PU3:C<S$=K-YI636
MN)/>P-]4NW,)>"536X#Z@6W5)!T4I)0DJ&O9KIQKIU# O9F&H2:]8J/L5YB*
MZM]8L'1=<E?M1E[M*L%7;)0;5)4Y=L5LWT[.PWJ\X_TQ0L@N.=O[E7#+;9+E
M.7&-M[%@.M27G75*=\G=E.! 2WS$ ZI20.',37':O:E*VK*M*+2IQM[*;JTY
M^GM$YEX/5:WDSSYY4KL92<U947Q.3K+A;HO%[$E&FYR=37^H;<?!]RMS,*R6
MW27+ICT>QVV+DL=EM]EQM:)LEZ5'07VV2I26W0 M(Y3KP-=&C85_%QIP:I+B
M;CNYDD]E>5$7UXU[3]7U;'OPDYV5""N44D]DY2G%<2BZ\,MZZ3+C .EN3,;O
MD3>BY6VR!??NXW(MSRIR4I(464O);''0$ A"O!Q/ATO-U-+@=E.7/79V]_UD
MA'0NJ<IK(AG2C;3KP-/BV.M$^'B["V-\S?+H74/NO!W:SM%WLS#[%AL\)%MM
M/E*0EUU*'%N+>4D%1'.I? $ZZ :Z'6NW1=.EA6.&?WFZOP%?Z^=9K>NYRG9K
MZJ$>&-=C>UMRY]NRB?(MR=2?LWR?8'?.U8ADN8[A3\-R&P6SR2]VA$5U]YT@
M!:DH46EI4>?F*5 G4'Q@#4+B6,_3ISMVK:G&3V.NSZ2^:QJ'5WK-9LY&5DRL
MSMQI**7C;:-K;%\6W<XUK7G*$5<CPPL)T_;PP-K[Q>[;D\%RZ81F49,+(8K8
MYUMZ!24NI02 I/*XM*T]I!X<4@&$UK3)9D(RMNDX;5X/ 7WJ)ULMZ+>N6\E.
M6/=24J;>%[N*G*J-J2WM4INHY!1@O2;$N8R!S=NXSK A?E",33"D>4J!5JEA
M3O<!>G\$^*#I_"';7$\S591X/4I2W<55T[Z?MN+ M$ZH6KGO#S)2MUKZNC;_
M )?N\=.3=6F]\I%.^V[:-V,HB2;9;S:,6QV-\GXS;5:!2601S.+2GQ4E>@\4
M<$I"1J=-:D='TWW*TU)UG)U;^HJW7;K2M=RHNU'ALVUPP7+V9/FK1;.1)&U=
M06X6(9Q8]H86+W;Y3D8MC_D5]1Y/(9[B1W49/)J^VV%\6U<4:CUZY]%PKV/.
M\[D:<4JK:G7?S/LDGU^U_"U2SAQQKG&[<&I;)1HVH>4E7[KW5/C8_<'$</V^
MWZL617;Y.NF:XZ(.,QNX?>\ID")<&N3G9;6E'C/H&JRD<>W@:^M5P[M^_CS@
MJJ$JRVK8JQY^T]QHZGZWAX&G:C9OSX9WK7#!4D^*7#<5*Q32VRC]ZBVG0V$W
M=LVWK^2XSFEO<NN 9Q$\DOT9I(6XTKE4@.I3JDE)0M25 $'L4.*=#]:QIL\E
M1N6G2Y![/V^@QU'ZU6-*=W&S(\6->5);*T=*5IRIITER[J&U2=M^F K=N;.^
MDYFU+5WK5J%J?<EI0KL;YNZU*AKIJ6_H^K7-'.U/[OJ%7GKL^GZR6N]7NJFV
MZM0DH/;PI5DD^3[O%TQ[?.5ZS@8<G*;JC %3EXBA32+0Y<M/*EA+* ZMSE '
MC.A93P'BZ<!4WA^N]4O74X^6F[?L[QY_K?N2S)K!XO4;.'B^]N7$WVY5IV#4
MZZ2*++91N#B-QZ8MN=NX=V[[,+%D+\^[6CN'T]S'6[<U)7WRFPTK426^"5D\
M?6.D%CX=V.I7+S7B2BDG5;_%Y-_(ST#4=;P[O5?%P83K?A=<I1I+9&MW;Q4X
M7]^.YM[>V=_I4W(PW;7+<ENF:7<V>#/L_DT1X1Y$CG>#[:^3ECMN*'BI)U(
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M<2H#L%?<+DH.L6UVC5>L6[RI<BI+LI/Z3 +P#!4H6I&#6!Q822A'R=%',=.
MU+?#6MOO5[RY=+.5Z9B>QAYL? 4PV^Z>LCW"SVX9_O#C,/%K-!D!-IP2&TRR
MR\&CJA"D,>+W"->))YG3KKXO;9\O6+>+85G%DY-[YNOU\OT=L\JTCJ5E:MJ,
ML_5K4;<(ND+*X:.F[BX=CBNF;K6D=CE_JEVVN^9;?VV;B<7O;U@TQ-PA6YA
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MP/&O/KEN5N3C)4:Y#]'8V3:R;<;MJ2E"2JFMJ:,I7P;Q0"@% * 4 H!0"@%
M* T[.L\QG;K'Y6293<$PH,<$,-:@O2'="4LL(U!6M6G ?LG0:FNG%Q+F3<4+
M:JWWNRR-U;5L;2\>61D248KI;YHKE;YCQ^WGWGR'>'(3.G%5OQ^WJ4G'\?2K
M5MAL\.\<TX+=6/;*_8'"O2=+TNW@VZ+;)[W^W(?ESK=UNR-?R.*58V8OQ(<W
M\4N>3[VY=F&JE"HB@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@*C]4G_JVQ/\ ?B)_2-58] ^Y?_TW]9YC^HO^=IW_ .L1
M^E%N*KAZ<* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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ME%* ?*<SW0?2BE /E.9[H/I12@'RG,]T'THI0#Y3F>Z#Z44H!\IS/=!]**4
M^4YGN@^E%* ?*<SW0?2BE /E.9[H/I12@'RG,]T'THI0#Y3F>Z#Z44H!\IS/
M=!]**4 ^4YGN@^E%* ?*<SW0?2BE /E.9[H/I12@'RG,]T'THI0#Y3F>Z#Z4
M4H!\IS/=!]**4 ^4YGN@^E%* ?*<SW0?2BE /E.9[H/I12@'RG,]T'THI0#Y
M3F>Z#Z44H!\IS/=!]**4 ^4YGN@^E%* ?*<SW0?2BE /E.9[H/I12@'RG,]T
M'THI0#Y3F>Z#Z44H!\IS/=!]**4 ^4YGN@^E%* ?*<SW0?2BE /E.9[H/I12
M@'RG,]T'THI0'(U<I:G6TE8T4H ^*.PFE ;)6 * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * Y6/Y]G^6G]N@-SK % * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 8"\
M?SK/\D_MUE PU * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * WBL 4
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MU NDVRN^3WF'$DM/NQ'25#NY"&U*4VK5"AHH \#ZE 9:@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H# 7C^=9_DG]NLH&&H"!NIS<O(-H-C<YW$Q9J(]?\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% ;Q6 * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0%6.K+_I/;?_ />'9_Z"95@ZN_YMW_3E]*/./U+_ -IB_P#Z
MU;_NS+3U7ST<4 H!0"@% * 4 H!0"@% * 4 H!0&N7?_ ,2C_NA_O*K*!BJ
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M:RGE0E#:M210&D6CJ:Q2;D=GQ^^8KDV%MY*M*,;O%]@B-&E]XH(00><D)45
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MG!A7*&YWL.X,-R8CNA3S-NI"T'0Z$:@CMH#M4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * Y6/Y]G^6G]N@-SK % * 4 H!0"@% * 4 H!0"@%
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M>=@H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@-XK % * 4 H!0"@% *
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ML&2WU#!!.XV[<[',PLNWF$XHG,-P;Y#7+:8=D(BQHD4%9[Q]T@D_S2CR:IX
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M/.7II_SL=5__ ,3^NM5-9W^SLD9B_P"ZO=SZ"YW4%_@+O=_<')?^5R:C,/\
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M6/JS_N)_Z;^F)YC^JO\ QUC_ /6(?W9EN*KAZ<* 4 H!0"@% * 4 H!0"@%
M* 4 H#7+O_XE'_=#_>564#%4 H!0"@*^;E[!PLRR-C/,4R69@&X$5"4B^P4\
MS<CD3RI[]L*;)/+XA4%<4\%)4-!0&C7?9/?3-[<O&\]WKC2,7D! G18%J92Z
M^&UA:0LH1')XI':H]FNAK(+1XW8XV,X[8<;ANN/0\?MT6VQ'GB"XMN(REE"E
ME( YB$ G05@&9H"J=SZ>,CQO);GE&R>X+FWZ[VKO+GCK\=,J IPDDJ0E86D
M:DI2IM7+J>521P &W81M/FT/*;?FVY6Y\W-+S:&WD6FTQF40K:PJ0T67%EE
M"5DI4="$(]4ZT!J3.T&^N,(7:,(WR*L;T*8<>^0&I<N*WKHE"'W$/%7*G@-"
MD>HD4!).TFT$+;%J]SY5ZD95EV4OB1DF32T\JWEI*E!*$E2RE/,LDZJ)4>WL
M2!D'QM+M7(VTF9]*?O+=V&97MRZL(;9+)80I3B@A6JU\Q\?P5@$RT!J.?XR[
MF>%Y-BC,M,!V_P!O>A-S%H*TM%U.G,4@@G3U-: Z^V^(N8'@V-X@[-3<7;%$
M\G<G(06TN*YE+)""5$#QO5H#4]C]KI.T6'2<6E7AJ]N/7-^X)F-,EA(2ZVT@
M(Y5*7Q'=ZZZ^&L@^,$VKDX?N)N5G+UY:G-9X^T['MR&2A4<-J6HA3A60KVP[
M *P#0IVQ698ME-^R?9C<!O#FLJ=+]]QV?#1+B%XJ4LK9YDK"?&4=!R:IU("N
M7Q:R#:MNMF9F.Y1.W$SO*G<YW!GQS%3<E,ICQH;!X%N,RG@.'#4!(T) 2-3K
M@&MY=T_7;(=RK_N99L]D8I?I,>&,;DPV2I49Z,RAEP2$J6$O-.I204\.WCS#
M5)R#[QW9#+[EG-DS[=[.V\SN&*DJQFS0XJ8T-AW@0\H)" 5!0"N" 2I*25$
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M1!B,1WYBR2IU;3:4*<45$DE1&IU- 9"@% * 4 H!0"@% * 4 H!0"@% * 4
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MUL9S;,](FW&SN3JSQN[7[.,\4TZRUE&12P^XPAX*0ON4-H0 5-JY25E9[="
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MR=1N7H\%%&/,A8PH6I<57*7.W5EI*X#L% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4!O%8 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 50ZP6 ]MSB
M[A5R^2YE;'0-/;:LRF]/_J]:L/5ITR)]F#^E'FOZI0XM-LOFOP?>FOK+7U7C
MTH4 H!0"@% * 4 H!0"@% * 4 H!0&N7?_Q*/^Z'^\JLH&*H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@-XK % * 4 H!0"@%
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MNYR_ML/1NK7ZGX>IW58R(>IN2V)UXH2?-6BX6^1-4_BJ6ZJN'IXH!0"@% *
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M H!0"@% * 4 H!0"@% * 4 H!0&\5@"@% * 4 H!0"@% * 4 H!0"@% * 4
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MREI7 '31?'P4!+M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M#<ZP!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0& O'\ZS_)/[=90,-0"@%
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M\J%D"5ESNN7GU*@GD!Y?&T*M=..E ;;0"@% * 4 H!0"@% * 4 H!0"@% *
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MG6T\B2V-.7EY>!3V=FFA (P"+)>Q&Y5YMQQ[(^H2]73&'DEF=;F;8S&E/L*
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M2>GFX7#*,4S?+=SKIE>58S=6)_E4B(TQ%4PPH+$:/$:<"(X4H:J4"K7U!QU
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M'MK$-Y8YUL%A844J9YN4E7:?&[#0R2YTQ91DF00L_A7'(IN98QCU\,'#LNN
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M7&]5(!< )0MM7(H\ !PH"1MR8&Q6/Y!%SW=!-J^6EQ$0;=\J<\O5EE2UZLP
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M6,XS>F%W'*DQG(T%,AY"D,Q6@XA"BHI"U'@/:\-1QHC):+JH_P !L[_^5?\
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M 5@$FT H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@-XK % * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"K'
M6-_@M._M:!_OJJP=6?\ >+M,\X_53_A)?SP^DLM:/_2;7_Y1C^C34%<^\^V>
M@8O^5#^5?09&O@WB@% * 4 H!0"@% * 4 H!0"@% :Y=_P#Q*/\ NA_O*K*!
MBJ 4 H!0$=7?=W;&PW*79[SG5FMUS@+[N9!>E(2XTO0'E4->!T/$4!LV/97C
M.6Q5SL8O]OO\5I02\] D-OAM1XA*^0DI)]16AH#/T H!0"@% * CG MTL7W$
MQZ\9193*AVFQ39$"XNW!M+2D+BM-O.+T0MP<@0X#KKZO"@-@Q+,L9SJT"^XG
M=F[S:B\N/Y6VE:-'6].9!2XE"@1J#Q'AH#9J 4 H!0"@% * 4 H!0"@.&3)8
MA1I$R4ZEB+$:6])?5P2AML%2E'U@!K0&OXEF6,YU:!?<3NS=YM1>7'\K;2M&
MCK>G,@I<2A0(U!XCPT!LU * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H#E8_GV?Y:?VZ W.L 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!@+
MQ_.L_P D_MUE PU * 4 H!0"@% * Q=QL5DNZFUW:SP;FMD:-*EQVWBD'M"2
MXE6E =Z/&CPV&XT1AN+&9'*S'92$(0/42E(  ^A0'%.M\"YQS$N4&/<(JB%*
MC26D.MDIX@E*P1J* XF[1:F8C4!JV1&H+*N9F$AEM+2%<>*4 <H/'P"@.V^P
MQ):4Q)9;D,KTYV74A:3H=1JDZ@Z$:T!]MMH:0AII"6VFTA+;:0 E*0-  !P
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ME<<A-=ZLAQ+:!JX !J4\/7K -4MO4Q>,LM;$W;S:&\9H_&CA[(T-2A'C0G%
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M<69=/O'>QRQ,@IB7=<]F6EY]"^5Q@MH0VM"DCQO&'9IZHUP"<* 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% <K'\^S_+3^W0&YU@"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@,!>/YUG^2?VZR@8:@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0&\5@"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M^_7BXR+Q>41SS,M/R4MH[I"M!KRH:3J0-.;734:$@356 * 4 H!0"@% * 4
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M 4 H!0"@% * 4 H#>*P!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M=[M!2=5#5\C4^H* T2\=/I9R:ZY5MQN!>-M)V0/>47Z!!0F3!D.ZE1<$=:D
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MEVP8M<3;WS*4@]Z?&T6GD)T]J>!H#DS[=6UX!DNW6-3[9*G2-QKFJV09,=2
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MM*XZ=NG[ '3W&WJQK;'(L6L>21WVXV2MR757A!1W,5$;EYBXDD*5KKV)U/J
MF@-6VXZAX6Y&6MX]!PF]6JV3V9$BRY),2 Q);C\22D)T3J/XJU<>%!0_,LZB
M[7;,EG8=@^'WG<W(K3S"[L65'-'C*3P4E;R4NGF2KQ5:(T!X:\W"L@SVVN^N
M.[A7BX8K)M-RPW-+8E3DG%[RUW3ZD)T*E-D@:E(4"4J"5:<0"D$C )NH#S\Z
MRL^5.MJ=OAC5XB"S7R#-5D[S/+;905 >5W3+NOC*!?XCU4*]2LH%G=LMV8N=
M*ND+[R+]A,6P16G0_>HPC1U-<4\J%$Z#D"=?H5@&A2^IN/<;C<8NW.VV2[E6
M^SN]S<K[:V%>2\XUU[DH;=*]0-4ZA/-X.'$Y!)VUV\&*[KP9SMC\IM]VM"PW
M>\?GH[N5%4HJ2"H E*DDI(U!]90!X5@&J9IU VG',GFX3C6'Y!N#EEL#9N5N
MLT8K:C]XD+ <= 4K710)T04CPJ!&E =? NHFRY9E:,$R'%KQM_E\A)5"M5X;
MY4O$(*^1*E!M040"4\R %> Z\*R#>MT-V,:VIM<&;?&Y4^?>'E1K%8X#8<E2
MWDZ:A"24@)25)YB3X1H"2 < T?$]^95YR>SXOE&UV48)(R%:FK)/N4=7D[KB
M4+<Y%J4AHI)2@\ %<>W3MH#L[EY)M]9MS=J[9DN%(OV37^6EG&\@+;2E6]:7
MT!M1*R%'E<<"AI[7BH<: BKK%=:8:VF??<2TRSD2W'G5G1*4I#1*B3V "AE&
M=O'5C:8BI-SL.W62Y)A,%XLS,X9CJ8A:@\I4T5ME)!UX=XI!]85DP6)PC-L?
MW"QR#E.,RS*MDX* "T\CK3B#HMIU''E6D]HUT\()!!K (NV3R3;Z^W7<F%A&
M%(Q&38KNB+D#Z&VD":X%/I0X.[).B5(7HD]G-P[30,BW9?\ S+;]_L_UA%#)
M*5MR3;Y74!?L5C84B/GK-H1+F9F&VM7FRTRKN]=><'NW$I*M-3IH>%#!5K?C
M=61,WBVX=;Q?(K>UM_D*D+AO,EM5V\GGL$F"D'1P.AK1/J\R?5K(+,-=0C:\
M'RW.']N<EMD;$5PTR;?<641G'T2W.[[QHK.A#9T*^' $&L F/"\LMF<XK8\M
MLX6FWWV,F0RT[IWC9U*5MKY21S(6DI.A[10&E1-WK5/W;G[20+1-EW"TP?+;
MK>VRV8L?ZVVX$K&O-_[U"=?XR@-/#0$N4 H!0"@% * 4!O%8 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M)['A6Z>\FXV],E*GK-:'#C^$+6DA(0!HIQ'J*#(!4./\\: ZG2?_ -==0_\
M;L7^M72@)0R[?FR8[F$_"L+PNY;@YJ@AV^P[.VE#;2D(2G_B)'*LE2$\J2>4
MA/!)4#PK *YYSD^5Y/OQL7<,HVZ?V\EM76/'A]_-;ENS&/*VU<>[;;Y @K(Y
M3K[8UD$B]:C:'<1P1IP<S;N2)0M/9J%1W 1PH@6U:QRR1\?^]6+;6(N/B$JW
MIM;2 EI,9:"VIL)[-"DG77M\-8!5CHE4I6U-^"E$A&5RP@$]@\B@G0?LDFLL
M'2Z/R-=WTZCF&2))'AT/?:?M5@RSM]27^*O2_P#WL5_7K363!MG5Q_@E??\
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M\\W?O;>MVW N[Z8BU#VL9IQ2W2V>SE4\LHTTX=V* N'6 * 4 H!0"@% ;Q6
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M0"@% * 4 H!0"@% * Y6/Y]G^6G]N@-SK % * 4 H!0"@% * 4 H!0"@% *
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MZ&EY2I"Y"&RX%J:[OE21(<*M>;L0GZ% 64H!0"@% * 4 H!0&\5@"@% * 4
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ME)4E12H%*DG123P(([0151:H7E.I^4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0%F^DW_%*1_8<O^E8J[=0/^1?\DOI1Y[^IG_%+_4C
M]$CTIKVD\!,!>/YUG^2?VZR@8:@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0&\5@"@% 0-O)OG9ML8RK9"2W>,PDM\T:U:GNXZ5 \KLDI
MX@>$(!YE>L.-53K'UHM:5'@C25YK9'D79EX-[["VESZJ]3KVLR]9.L+">V7+
M+L1^M[EV7L*;XG@&Y'4%D#V17JX/)M?>=W.R68#W+:0=2Q#9'*%%.OM4:)'\
M(@GCYQ@:3G]8K[O7)/AKMF]R_A@OJ5$N5H]6U/6M-ZK8ZL6HKCILA'>_XIRY
M*\[JWR)TV7ZP#:K#=MX89Q^VI5/6@)F7R2 Y,>]75S0<J3_%0 GUJ]8TC0,3
M3(TM1\;ED]LGW>3M*B/%-;ZR9NKSK?GXO)!;(KN<K[+JR1ZFB!% * 4 H!0"
M@% * A+<W8C#=QVWYBHXL63*!+5_B( *U?\ X2T-$N@^J=%>HKP56-;ZJXFI
M)RIP7/*7+_,OWOI[);^KW7/-TEJ%>.UY$N3^5_N_1V#SCS_;C*=M[L;7D<+D
M0[J;?=&=5Q92!_":60.(\*2 H>$=E>-ZMHV3IEWU=Z/::^[+M/ZMZ/>-%U[%
MU>SZRQ+=OB_O1?97UK8^<T2HLF10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M<>??@LN..+4>U2E*))KDR$HW));JOZ3KMNL4^P;]6D^Q0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M (-RBGS+FG_9Y>Q4\K""DD$$$'0@]H->$GZ0% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M2"5F-W.;2V157_-^WT'KO5<)T4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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ML'.<HJD+GC+M_O+IV]IH_174+67J&G*$W6=KQ'V5^X^C9V7%E?JJ9=A0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#-8[CUWRN\P+!8H:
MIUTN+G=QHZ= /5*E*.@2E(!))X 5TX>)=R[L;5I5E)[$<F=G6<&S*_>EPPBJ
MM_MO;Y$6*F[2[.X'RV_<W<B8_DA2#*LV.M!7DRB->5Q:V7_!_&""===-*M]S
M0-+T_P 3.R&[G+&VON]MM2[_  OL%%M=9M9U/Q]/Q8JUR2NO[W:2<>]Q+LF
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M;0[&E6Y6[+DXMUI)\5-E/%YC1:C"8% * [$-R.U+BNRV3(BMO(5)C@\I6V%
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M=W_*BZ-\B=? Z\_B]@B3!MN-S&\TL+D/#;S&E6BZ19#TA^*ZPTSW+R5<RW7
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M?[T:UV=_9S/9M,G:=MMHK+?K7-F;R,WUD38R[7:+3!4J5(6IT=VA:PMQ+9U
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!0/*T?E
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MN6M7QUX]EI37E0>S;TN+[$NP;)U)VN58]NMD[+.2$SK/;C"F)2=0'8\2(VL
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MF]FQU[E&<N*VJ=M%L9N%=\H879[YN(VFU62S2 6Y);+3C(66SHI! ?<7H0"
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MC>^UU_"FJ>PETKPG%\:Z/_Y$>B7@'Y =X/P(E_9HWOM/A35/82Z5X1\:Z/\
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M=9S<^5VS+BC2.W;R+LT*UU)T[(P--C9R(\,^*3IL>]]ALA.JT6T4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@*&=)W^*3W]B2_Z1FO%.H/_)?V)?4>_P#ZE_\
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M;0A('\9:@-3P':2 ":R#.;1X5-WKOS6^^YCT:Y1BZMK!<196EV+":CNJ"5/
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M,.+1KRE3:BDD:@'3457+D';FXO>FUT%KLW5=A&:W-)])U:^#8* 4 H!0"@%
M* 4 H!0"@% 6;Z3?\4I']AR_Z5BKMU _Y%_R2^E'GOZF?\4O]2/T2/2FO:3P
M$P%X_G6?Y)_;K*!AJ 4 H!0"@% * 4!Y[7"7=>F#>W(,DFVF3/VQW%=<<<DQ
M4ZAA;KI?Y4C@GO(ZU+"4$CF;5J./9D$]W+JOV2@VU4^+DK]XD%.K-IB090D+
M5_%^OMM-I/\ *6!0&A;Y6V_[T; 6?+H>*S++>;=,-[&-/%3DH0D%^.H@<B.8
MK:4A\#EUY> U\(&5P[>SIWOF.6V??6<?QV]EA*;O:)=L0E;4A(T<Y"E@I6DD
M:I(/9IJ =0,&29-L,WVZS5F_.[<QFD6^U2FXTZ9'@^1,ON%'.DH!0A2@D'35
M21[!H8(-Z;?\5>J#^]B?Z]=JR#K;7_YL]ZO[*3_OP: N;6 4SS^)%N'6'M=
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M)2?"G5=D@NKVNPUG&]XA!Q7$XT;KNIM[YO4G';&GIRM^2IM4<7]>5*BKNX0
M^6>[<^ME?:4\!PJ4GAV?R*-_A7K/6TXN6E'L[1#V\Z^^LDL?C?J_4UX?W:U6
MVG.0!54+J* 4 H!0"@% * 4 H#(V>X&TW:V701F9OR;*9E>1R$)<:=[I87R.
M)4""E6FA!%;<>[ZFY&=$^%IT>U.CW/L&C*L>OM3MU:XDU5;&JJE4^=$M;\8Q
M;;'F,>\8_&3&QK-K=&OME::0$--IDI^N-I"> T4.;0< % 5/]:<*W8RE<M*E
MN[%3CS+BWKIVTY$T5GJ9J%W)PG:ONMVS.5N5=[X7L;[FRO*TR%*K9;10"@%
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M]Z5^Y*Y+?)MOMMU+WC8\<>U"U#[L8J*KM=(JBVF/K4;A0"@% * 4 H!0"@%
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M;CI<<(T*UAM*0I6GA- =>]XQC63--,9'CULR!EDZLLW*(S+2@GPI2\A0'[%
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M'DC3<:UBFU=HO/4!><(DLDXU9+C.E/P^<@KAL*YF6>8'FT)6A*B#KIKV&N+
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MZ G4#F"].%7[]0G_ /*M)_>]7MZ7]IYG^EZ?N=YK[OK-GFKZJ&D=,G^,./\
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MRDH5RH)T!820015JT;K%9P\.>)>L^LA.7%][AY%LW?PHI>O]5K^?G6\W'O\
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MQV+HVKOX*EA:X[[2BVZTLC34I4G@=!J-#IQH#=Z 4 H!0"@% * 4 H!0"@%
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MK4LSUUI/AX4MNQ[*]EE5ZG:+?TG!]1?:<N)OQ754=.PN8ARJZ6H4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#9<,NT6P9AB
M=]G!Q4*RWF!/F!H!3A:C2$.KY 2 3RI.@UKMTW(CCY5J[+[L)QDZ;Z1:;.#5
ML6>5AWK,*<4[<HJNZLHM*O29G=+)[=F6?9)DUI0\W;KL^AR*F0D(=Y4-(;\9
M*5* XI/AKHUS-AFYMR_;KPR=57?N2.3J[I]S3]/M8]VG%!-.F[>WV.<T&HHF
MB9X>?6&R;,7'!K.W+&495<TR,FFK;2AE,1E6K;3;@65*U[M&HY1[98U]6QV]
M5LV-*EBVT_6W)5FZ;.%;DG6O(N1;V52[HM_(UJ.9=<?4VH4@JNO$][:I1;WR
MO=$BFSJM:+M;%WM+Z[,B4RJZMQ0E3ZHX6"ZEL*4A/,4Z@:J'&H+'=M7(^MKP
M57%3?2NVF[;0LF4KKLS5FG'1\-=W%396B>RN_8;GNIG7Y0\SN.0LQUPK9R-Q
M+) 6 %,0V!RMI*4E202=5$ D DZ<*D==U3\QRY7DJ1V**YHK=X>VR)ZN:/\
ME6%&PW6>V4GSSEO?U*NVB([J()T4 H!0"@% 3YF&;8S==C]N,/@7(OY'89SS
MUVM_<O)[I"C(Y3WBD!M6O>)]JHU:M1U/'NZ1C8\)5N0DW)4>S[W+2CW\C*7I
M>D95C7<K*G&EJY%*+JMK\7DK5;GO2(#JJET% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4!9OI-_Q2D?V'+_I6*NW4#_D7_)+Z4>>_J9_
MQ2_U(_1(]*:]I/ 3 7C^=9_DG]NLH&&H!0"@% 5UN/4O@L"^N6E$2X38##I9
M?OC"4%GF!T*FT%04M ]7V :HU_K]@V[[MJ,G%.CDJ4[:5:M?LD>AX_Z;:C=Q
ME=<H1DU50=:]INE$^QTM%@H<N-/B19T-Y,F'-90_$D(.J7&W$A2%)/J$$$5=
MK5V-V"G!UBTFGSI[44"]:G9G*$U246TUS-;&CL5]FL4!Y_1+6>IC??*VLBE2
M'MM]M%KBPK5'<4AI]:75,HU4G33RA3;CBE#QN1(0#PU&06IG[%;/W&U.6AW;
MNQL1UH[L28L-N/*3PT"A*:"7M1ZO-6 5GV(?NVT^^&7[%R[@]<,<E(=FXZ'3
MS<C@:1*;6. "2N.HAS0:%:160?>_%KMU[ZF=G+3=X35QMD^#&9FP7TA;;K:I
M<K5*DGM!H#8^HG9;:JS;6Y#DEKQR#C%YLB67+7.A L<[BWVT=RM"2$KYPH@:
MC4'B/#0$T[ 7F\7_ &=P2Z7YQQ^YO07&G9#Q*G'6X[[K++BU'BHK:0E1)[==
M: F&L IAMVXK/.JG<W*)22Y$V]AKL=I3KP9>2OR4Z:_QN20?_:K(.KUP_P#0
MN'?VZK^JNT!,65; ;+3<>N[<K$+7C[+<5YU5\B-^3N1.[0I7?\Z"G4-^V(5X
MITXBL C/HMO5[N6V]YM]Q4X_;+)>%1[)(<4I7*AQEMUV.C7@$H4KF '\<UD&
MA8!B.,9CU/;T6_*;'#OT*,W)D1XTUL.H0Z),= 6 >P\JB/V:&2V]MV=VML]P
MAW6UX%98-QM[J7X,QJ*A+C3J#JE:#IP(/$&L&"N'4C?[[FN>X3L#C=P7;F<D
M+4K*9+>IYFEJ4I*%@:$I:;:6\I.NBO%]2L@G2S=/NSUELR+*C!+7<F^["'KA
M<6$2ICA':LR%CG2HGB>0I'J "@,KMUM+BNULG)EXEY7&@9*^P^Y:'G2\S%4P
ME:=&"H%>BN?CS*4> XU@%=>A[_H7,?[=3_56JR#2-B[;AN9;Q;L_E5@PKQFZ
MKDZ+/:+TA#K12AY]$E#3#W,A:FP&TI202E(\7@": N+9MH-O,;RQO,\<QN-C
M]Y1%=AK3;QY/&6V\4DZQT:-@CEX%('KZU@&&OVRNTWR;>9HV]L8E>32'P\(C
M8(<Y%*YAH.''C0%:>DC;? LPVXO=SRG$[;?K@QDDF*S,F,)=<2RF'#6EL$^
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M5?\ 3X7L16+$+7K+<^&<IM5C'B7C.W+[MO@6^3V\2JZ;$>8ZI<L9KR,FY?\
M578<5N-N+2E/@?BJY'[USUC6R*V<+HJ[61]9HV42CF%BM>%3=SL'OU_=?BY
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MGX;HX$2WP$, 'U2$J ]<U-=4_P#!GD9+_P#I6I-?S/9'ZRO]=O\ 'AC8B_\
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MSC8VY9=<8Q*6[_CH=4P^D'@M28[$E&JAQX%/\@4!BL4PW<C>#=^Q[L[A8LO
M\<Q!"!CU@D$B6XMA2W60I*TI7P<<YUK4A.N@2D=I %R+PTX_:+HPR@N.O0WT
M--CM4I3:@ /HFL K5TBXOD>)[;7NW9/9)M@GOY+)DLPY[*V'%,JAPT!P)6 >
M4J0H:^L:RP6FK ,?=YC]NM-SN$6 [=94"(](C6QG@[)<:;4M+*.!\99'*.':
M: \\M]K_ +I[R6&S65C8O*,?5:;@9ID.-/20L%I;?+RB,WI[;776L@MGMONA
ME^;7N7:\@VDO> PX\%<IJ[W)2RTZZEQM 83S1VO&4%E0X]B3PH##N9;NZ-_F
M,53C2QM0J*2N_B&XILJ\A+W.9>O*E?E([KD]3P:G6@-RW,SW),&9M#N.[<W7
M<)=R6\F4U:U*28H:""DN<K+Q\?F.G =AH"F6+W_=/'=YLSW75L7E$MG*[>N$
MBR!IY"F"M<17,7O)E!7_ (;LY1V^M0%\\)O]SRC&+7?;QC<O$+C/#WE..SB3
M(C]V\MI/.2AL^.E 6/%'!0K *I].:/OKWDWRW):5WEN=FN6JTR3XW>M.2"M)
M2>/8W&:)'^T*R"ZU8 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@-XK
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M _Y%_P DOI1Y[^IG_%+_ %(_1(]*:]I/ 3 7C^=9_DG]NLH&&H!0"@% * 4
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M1(?45O/NJ*UK4>)4I1U))]4U2)2<FVW5L]"A",$HQ5$MR1Q5@^A0"@% * 4
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M'I37M)X"8"\?SK/\D_MUE PU * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MU.NG#_P6G"OO\_ZQ?Q__ 'I>@?/PUU6_I_\ WZ7IG"<AZI<C]HC+@ETG1UB
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * K'U%?^I;-_P![XW^^W5(ZX_YF'_K+
MZ4>A=1/\K._T)?0RSE7<\]% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MUQ_S,/\ UE]*/0NHG^5G?Z$OH99RKN>>B@% * 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0%8^HK_P!2V;_O?&_WVZI'7'_,P_\ 67TH]"ZB?Y6=_H2^AEG*NYYZ
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M^]\;_?;JD=<?\S#_ -9?2CT+J)_E9W^A+Z&6<J[GGHH!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% 8"\?SK/\D_MUE PU * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@-XK % * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!\J2E:5(6D
M+0L%*T*&H(/ @@UAJNQF4VG5'DGO1@*MN\]NMH9:*+/,/E]A7X/)7B2$ _\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MZD?SWYE]MI/U=9]PQ_(CT'S[]?\ +?2/2IZD?SWYE]MI/U=/<,?R(] ]^O\
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MG ]\E7NO:NC82'T![EG.]@[789[Q5?=M)3F.SFED]YY*@!V"HI/8D-*[H?\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MR%<RNM&'C9?ND^+UE8K=LK*C6VO91H=:2QB@% * 4 H!0"@% * 4 H!0"@%
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MIZ;ZO_$MKQ>5<WV?1VMWFE4X0@H!0"@% * 4 H!0"@% * 4!8?83_P#RO_\
M$?\ [(KNPOWNY]9Y=^I/_P##?V_^PB'./^L,F_M*1_OFN6]]]]LO/5[_ (['
M_P!./T&K5K)@4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!8[8;_ ,+DO_>Q
M?]UVN_"Y3RK]2/OV.U+_ +2$\O\ ^K,H_M>;_3KKCN_??;9Z#H?_ !^/_I0_
MNHUVO@E!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#,8[_P!06+^T(O\ 2IKZ
MA]Y'%J7^UN_R2^AD_P"^W_I=@_\ -._[@KMS=R/-/TX_SKW\L?I96BN ]8%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@+88;_@\?[-NO\ 2R*D
M[7^3W']9XMKO_L?_ .4M?1 J?48>TB@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0$V[(Q(LN[7M,J,U)2B(@H2ZA*P#WG: H&NO$
M2<G7F*!^H%^Y:QK3A)Q?&]S:Y.P:1N.TTQFU_:8:0RTAYL(:0D)2/K2.P#@*
MTWU2;+!U7G*>FV92;;<=[[;-)K43XH!0"@% * 4 H!0"@% * 4 H!0"@% *
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M)6*FM7SO4Q]5#8VMO87[=XBM)PO6/UT]W)V7S_MRGO#54+** 4 H!0"@% *
M4 H!0"@% * Z-SMENO5NG6B[P6+G:KFPY%N-NE-I=9?9=24.-N-K!2I*DD@@
MBLIN+JMYAJNQG\U/65TS2^G7<92+0T](VVR]3LS"K@O5?< $%ZWNK))*X_,.
M4D^.@I5KS<P%VTW.63;V_>6_PE0U+"]WG6/W7N['8*?5)$:* 4 H!0"@% *
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MLL(B,*0EQ3;R5JU6H)' >N:^)V)P56=VG=:<'/O*S9DW)U>U-;C1*U%B% *
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MA*&0XI)<4 02$@FMEJS.ZZ03;[!\3N1MJLFDNR0>>M3I:!(.\MEU'#@B4?\
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M]V79)KT%<E4(6T,!U;"D*4E'?K\4GE.O$5):'CV[O'QQ3I3?V:D;K.1<M<'
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MYV_[ OWRGO<Q\ Z;_'YWV#\M68^YV_[ OWRGO<Q\ Z;_ !^=]@_+5F/N=O\
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MS'P#IO\ 'YWV#\M68^YV_P"P+]\I[W,? .F_Q^=]@_+5F/N=O^P+]\I[W,?
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M,? .F_Q^=]@_+5F/N=O^P+]\I[W,? .F_P ?G?8/RU9C[G;_ + OWRGO<Q\
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M]V7(!"HEK=)/:MET$?2O)K*S)]@US_3[3I;I7%VFOKBSD_+CEGS?:/L+_O\
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M3<DFO&:IM[441Q6@M0H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MJ)$C(+DB4\M+;;:$\2I:U$  >J30$7QM]-GY<]%L8W#LRY;CG=MZR EI2M=
M \H!LZGL\;C0$K@A0"DD$$:@CL(H"*E;Y;/H4I*MQ[#JDD'28V1J/7!H#9L9
MS_"LS=EL8IE%NO[T%"5S&83Z75-I62$J4D'70D::T!G+Q>[/CUO?NM]ND6SV
MV,-7YTQU#+2?4!6L@:GP#PT!HU@WEVMR>Y-6BQ9S:IUSD*"(T+O>[<=43H$M
MAP)YU'U$ZF@),H"+KSO9M/8)[MKNN>VB//8442(R'N^+:@="E9:"PE0/:"=1
M0&^66^V7)+>S=L?NL2]6R1_,SH3R'FB1VCF02 1X0>(\- 96@-,R7<7!,.EL
M0,IRRV6&;)9\H8B3)"&W%-%12%A).O*5)(!]4'U* X[#N7M[E$E,+'LVLMWG
M.**6X$>:RJ0H@:GE9YN<C3P@:4!F,KR2#A^-WO*+FV^];[#$=FS&HR4J>4AH
M<Q#:5J0DJ/@U4!Z] =+!LQM>X&*6C,+,Q*C6R](<<BL3$H0^D-NK94%I;6XD
M>,@]BCPH#;* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * JE^D'W;7MET]WJTVZ2&,AW,>^]FWA)\=,1]"EW!P#U/)TEK7P%Q)J
M4T?'];?3>Z.WP$9JU_U5EI;Y;/"5X_1;;.,VW%\LWNNL4&XY&^O'\4<6.+<"
M*I*YCJ#V://A+?JCNCZM=>O9-9*TMRVOM\G[=DYM%Q^&#N/>]B[2^WZ#ULJO
MDX* Q&07F+CEAO>0S@HPK# DW&8$<5%J*TIU?+Z_*DZ5]0BY-)<IANB/Y]=H
M=KL\_2![S9OF.=Y7(LV/6;NY%XF-)+YB,REN"#;+<TL]V@!+:N)[ DJ4%*5Q
MMV1?AIMF,8*K?[-LJ]BS+4;LIS=(K]DE]9?/]5=T^?ACN']L+3_^2:BOSZ_S
M1Z'X20_([//+I7@)!ZI=O\>VKZ%\[V^Q1#Z,?Q:T6V);O*G.^?6#=XCBW'5Z
M)!4M:E*.@ U/  :"M&#=E=S(SEO;?T'5F6U;Q916Y1-)_1YX[:LOZ0[YB=]8
M5)LF47?(;3>(R5%"G(LV.TP\@+3H4DH61J.RMVL3<,I26]),U:7%2Q4GN=?I
M.JK]%?T]E1(R_<)()U"1<;5H/6&MI)K/Y]?YH]#\)K>B6.>72O ?GZJ[I\_#
M'</[86G_ /)-/SZ_S1Z'X3'Y'9YY=*\!SQ?T6?3PQ)8?=R?/IK3+B5N0WKC;
M0VZE)U*%EJUMK 5V'E4#ZA%'KU]K='H?A,K1+">^3[J\!"'Z6EM#3?3VTV.5
MMI.5(0GMT"19@!QKJZO?_4_L_6<VO?\ T^[]1>3)NGO ^HW83:7$\\>NL*+:
M+-9;E;;E9I#<>4R\+<AI0!?9?:4E:5D$*;/K:&HFWF3QKTI0IM;6WMDM?Q89
M%M1E7D>PK^[^BMV +3@8S3<%MXI(9<7.M2TI5IP*DBU)) /: 1]$5V_GU_R8
M]#\)P_D=GGETKP%*,89SGH(ZM;)ACF0.7G"<H?MR+GHE3;-TL5S?5'1*7&YR
M$R(KB7.4A7MT$:\BU R5QPU'%<J4DJ]QKZF<-M2P,E0K6,J=#V=*/Z":J)9Q
M0"@/ K])ILTSA6ZUHW/L\4,67=".OY62V $HO,$(2^K0: =^RIM?JJ6'%5;=
M#R>.V[;WQ^AE8UK'X9JXMSW]O_I]!YGU.$(* 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0'K!^B@_Q"W8_N["_K9JO]8/\N';)W0OOR[1[BU5BRF
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M ]M9!F>H'83;JP;<W?,L/M"<3R#%"Q-B2X3SJ$N#OVT*0L*6H:CFYD*3HH*
MXZ<* VMW)[GF/21<LBO+O?W2=BDU$V2>UU<=3D<N*[/&7W?,?7-8!'^U?4)@
MNW.T>!X[*:N61Y&U"E/3+-9F$ON1FU3'U!3ZEK0E&J3S::DZ:$@ @UD%G-L=
MWL,W:M\R=BLE]+UM4A-RM4UM+4ICO 2A2TI4M)2KE.A2HC@1VU@'UN1NYA>U
MD6&[DTMYR=<E<MKL<!OOYLD@@$MM\R0 "=-5*2-> .O"@(]QSJ>P.[WV%CM\
MM-^P2XW-?);5Y!#3&8=*E<K8[Q+B^4JU'%0"=>'-0$P9[FMIV[Q.[9C?6I3]
MJL_<>5-0T(<?/E#[<='(E:VTGQW!KJH<* A3(>J_;*R+BM08]YRAY<1B;<46
MB,VZ(+3R4KY9"W'6T!:4J\9*20%>*H@UD$N[=[E8INA8OE_%)BWX[3I8FPWT
M=U)C.@!7(ZWJ0-0=002D^ ]M8!K^Y6]^![6N1(602I,Z]S@%Q,=M;0D35MJ)
M 64J4A"02-!S+!/\'70Z9!H>,]5>W5\O,.PWB#>L*GSUA$-V^1D,QUE2N5 +
MJ'%\G-ZJDA(_C4!DNH_<V!@F$7&SK%U9O67VR?'L5PMS9Y([K2$)*G7@M!;_
M )T:%.I[:P"*>GCJ"L"<6P3;Z]MY%=,LERGH2[PXSY1'4N3->4R525O%92A"
MTI)Y?%TT[!606,PG=W%L[R7+L1MC%P@7W"Y"V+I$N#*&N\[MU3*W&2AQSF2%
MIT/-RGBGAQK ._N9N9CFU..HR7)DRG8;TMN%'C04(<?<><2I8"4N.-IX)0HG
M57@H#JY/NMC>()P15[C7",-P9L>#:P6FT^3.2 V09G>.H[M*.\'/IS:<>'"@
M(DO75WME:IS[,.W7_(+5#>[B9D=NB-F$E78.1;SS15Q]8>JGFK(+#8KE5AS6
MQ0,DQJX(N=HN*"J/)0"""DZ*0M*@%)4DC0I(U%8!&FX._>$;?7=K&GFKEDV5
M/(Y_O<L4<2I#84GF1WNJT)3S#CH"5:>-RZ$:@<>WV_\ @VX-Z<QAEJYXSE3:
M=1CM\CB-(<*4E;@:Y5N))2!KH2%:<>7370"<* 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MLUH"3.K#'+7>MF[_ '.9'0JXXRY%FVB9R@K:6Y):8=2%=O*MM9! /:$G^"*
MQ3UWF7WI$D7.X.%Z8]A3C3[RCS*66&RR%J)[2H(U/KU@R;/TK_X#8)_\M/\
MFDNLF"(L\3^27J@P[-VSY+CNYS'R9?%CQ6^_5R1W.;3L"5^3O$GM/-0':WB;
M_*CU!;:[5HT?LF*H^7,I:X\AUT>4VX #VM-H0#_\]H#YZRXK,Z)M7"D J8F7
M]QA\ Z$H<2TE6A\' U@RBVT3$\:@XXG$(EDB,XRF*87R*EL=P6%#125).O-S
M:ZDGB3Q)UXT,%2.C1U^'%W4QE+Q<MMBOK2H22>;13H>96K4?QDQT5D$1=/\
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MND6BYW&TRT\DNURGHDI'J.,++:Q[*:]%C+B2:Y2@W(<$G%\CH="OH^!0"@%
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M?NEF3R/O';N" H1#(=6W!;94I)+7UMI<EQ:-%J3X@4.%5O*G/,RO41=(K?\
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M_)U]ZT!N=][][\LNO>/M,]VR>[\8=XI/-[4\!J:&465H8% * 4 H!0"@% *
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M4N(]2H_25==MJW.,=NYK;NWG9J*M<2=R$I;-C7_4B*%OJK?7K0Z7[RO;R\X
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MP"5 #B>%>A8T."U&/,E]!1<N7%>F_P")_21S6\YQ0"@% * 4 H!0"@% * 4
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M'*MHR&T=ZE*AP/(I.HX'4<*Y;6DX]N7$HU:YV==W5K\XTJEVBGU21&"@% *
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MN/!/)&;;23SNJ.I&M=>-BV\>+C!43./)R[F0TY\A%%=)S"@% * 4 H!0"@%
M* 4 H!0"@% 3KL]U);P[#1;Y"VRR=NQP\C=8?NL9Z%$FI6Y'2M+:TB4TYR'1
M9!Y=->&O8*Y,G!M9#3FJT.S&SKN.FH;F:-!W,S:W;CIW:BWM:<_3>W,B-^4T
MTLJN+KRGW'5-*06B%+4=4\O+H=--*VNQ!V_5T\6E*=@U1R)QN>LKXU:FW[Q=
M0V[._3E@<W/R5%^&,)D)LK+4.+#;9,LME]7+&:;"BOND#56O9P\-:\;#M8]>
M!4J;,G-N9%./D-DVAZLM]=C[.[CF!9CY/CCCJGV[#<(K$Z,RZLE2U,!]"E-<
MQ)*@A0"CQ()XUKR=/LY#XIK;SGWC:C>L1X8O9S,PF\W4AN[OXJTIW+R1N[0[
M"IQRSVV-#C1&&%O )<6 PVE2E*"0-5J/K:5]XV%:QZ\"WGSDYUW(V3>Q<A)&
M!=='4IMWC=OQ.S9PW<++:6D1[2U=X,:<['8;3RH90^XCO"A( "0I1Y0 $Z#A
M6B]I6/=EQ.-&^8W6M6OVX\-4^V1Q>NI3>7(=UK'O5><L$_<+&FT,6&[+AQ S
M%8;#H0RW%2R&>4=^X="@ZE14=3QK?'!M1M.TEXKWFF6==E=5UOQEN_;NG6MO
M41NY:-VY^^%LRGR/<>ZETW*\-Q8W<OI>9#"T.1"T6%)*$C@4<% *'C &LRPK
M4K7JFO%1A9MU77=3\9D?9QFE_P!Q,LOF;92^Q*R+(Y'E=WE1HS,1MUXI"5.=
MS'0VV"KEU40GQE:J/$DUNM6HVH*$=R--Z]*[-SEO9JE;#43#E>_.Z&:[:XEM
M'D60-S,"PAUA['+,B'%94RY&9=CM*4^VTEUSE;>6/&4>WCQKFMXENW<=R*\9
M[SJNYERY;5M[EN[FPAZNDY10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M 6,SSJPWWW+P!C;+,LS%UP]E,-*X(@PV77A Y>X[Z0TREU>BDI4=5<5 $UQ6
M=/LVI\<5M[?.=U[4;UZ'!)[.T8_9_J;WGV)MEXLVV>4MV2V7R4B;<(;T&),2
MI]".[#B?*67"DE( .AXZ#U*SDX-G(:<U5KLGSC9]W'3C"E&1"O*,A7D[F9_+
M$EK*G;FJ\JOS*RS)$];QD&0A;?+RK[P\P*=-#V5T^KCP\%-E*4[!S^MEQ\=?
M&K6O9+@1?TB'55$MC5N&<P9#C+0:1='[/ <DGE&@4I19Y%*]=23KX=:C7HV,
MW6CZ62*UG(2IL[="M-FW>W)Q[<23NO9LNFV_<&;-D7"=D;7(''WY:BN1WK?+
MW2T.%1YD%'(>SEKNEC6Y6_5M>+S'%'*N1N>L3\8L7?\ ]('U0Y%8YMADYM"A
M1KBPJ--E0K3!:D+:<24.)#G=*Y.8'B4@$> BN*&CXT76CZ6=D]8R)*FQ=P@;
M$M[]R<'V_P SVOQN]M0<+S_F^^BV*B1GEO\ .VEE7*^XVIQO5"0/$4*Z[F+;
MN7(W)+QH[CEM9=RW;E;CN>\R&/=0FZ^,[6W[9BV9$TO;C(R^JXX]+A1)829/
M)WA9>?:6ZUXR L<BARK\=.BB2<3P[4[JNM>,N4S;S;L+3M)^*_K(:CR'XC[$
MJ*^Y&E1G$NQI+2BAQMQ!"DK0I)!!!&H(KI:KL9RIM.J+K6O](;U46NU1[6,Z
MAW#R5D,-7*=:H+THI2D)2I;A:'>* &I4L$J/%1)J+EHV,W7A[[)2.L9"5-C[
MA5'.,\R_<K);AF&=7^5DN270I,RZ2R.8A Y4(0A 2AM"1P2A"0D#L J0M686
MH\,%1$?>O3NRXINK-2K::A0"@% * 4 H!0"@% * 4 H!0"@% * 4!)6UN\&X
M^RN02<HVRR9S&+W,A+M\N6F/&E(=C.+0XIM;,MIYH^,VD@E.HTX&M%_&MWX\
M-Q57[<QOL9-RPZP=&8S/MQ\UW0R^?GF=7UR^99<^X\LN_=,QB?)FD,L\C<9M
MIM'*A"0.1(]7MU-?5FQ"U#@@J(Q=OSNRXY.K)%W-ZH-]MXL;A8AN1GSV28[
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M(N+DUD)+P0%**=4M<P )T\% 2=+LO5C-BR84B^;;*8EM+9>3R7'BAQ)2H?\
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M9FLWV)W5VXP_$\\S;%?D#%\Y2VO%IKTZ"X]*0ZSY0A0B-2%R$#NR"2XVG34
MZ$@'XM9=J[-P@ZM;]_T[C[NXEVU%2FJ)]HB.NDYA0"@% * 4 H!0"@% * 4
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M6E?/IH#V ^$5V9F?*&,KMOEIO[)QXF#%Y,K5S;1/ZO"2=F6,_HX\)R?*L.O
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M5RM"T@?Q.\5P/*3-:/A>MGZR7W8]]_816JYGJ;?#'[TN\N<_G_JWE2% * 4
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MW<O\,G56Z_3X=I-:CD*U8<H[Y[.]X#P8JVE2% * 4 H!0"@% * 4 H!0"@%
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M@U,:3B^ILU?WI;7]1#ZMD^MN\*W1V=WE*4U*$6* 4 H!0"@% * 4 H!0"@%
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M>3%6(K8H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M1Y#8)+;K9\5:3V'U1H33[UF=F;A-4:+7:NQNQ4HNJ9O5:C8* 4 H!0"@% *
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M)6+LYMIJ7AJ=>=GPOVHP2::\!3&I0BA0"@% * 4 H!0"@% * 4 H!0"@% *
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M2&T,)<=*$I0D-M-I0VVD$)'-XRN;AOP,#W:LI.LI;V:<_/\ >*1BJ11E-O\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MZ&%$MQ8K9)Y4)UU)/C*5JI1*B35TQ<6&/#AC_P!2GY65/(GQ2[BYB):Z3F%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4!D$7>ZM(0VW<Y;;;:0EMM+S@2E(&@
M  5P KYX(\QL5Z:V*3Z3'DDDDG4GB2:^C6<[LN4^VTT_)=>:8'*PTM:E)0--
M-$@G0<!X*PDD?3G)JC9S0+E<;4_Y3;+A)MLGE*?*(KJV5\I[1S((.E8E%2WJ
MHA.4'6+:[0GW*XW5_P IN=PDW*3RA/E$IU;R^4=@YEDG2D8J.Y4$YRFZR;?;
M.%B7*C!P1I+L<.CE=#:U(YAZBM"->VLM)[Q&<H[G0X*R?)W[?=;I:75/VJY2
MK8^M/(MZ(\ME93VZ%2""17S**EO53[A<E#[K:[1UY,J3-D.RYDAV7*?5S/R7
MEJ<<6KU5*422?HUE)+8CYE)R=6ZL,RI,=+J8\AUA+R>5Y+:U)"T^HK0C4<?#
M1I,S&;CN9P5D^10"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M*;,=4^;(<66>\0E:RE*$G56B]2E!XZF@(@QO:W?+<2PP,SR7?*\8E<;\PB=
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MG<?"M8_W([>?EZ2%R,V[?^\]G-R?MVR$ZZCD% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4!ZP?HH/\ $+=C^[L+^MFJ_P!8/\N';)W0
MOOR[1[BU5BRF O'\ZS_)/[=90,-0"@% * B*X[&;:W2^N7^78U&3(>+\J(V\
MXB,ZZ3J5*:20.)XD#0'PCMJLW^I^FWK[O2M[6ZM)M1;[7@V%MQ^O&JV,=8\+
MNQ*B;2<DN:OT-[42VVVVTVAII"6FFDA#;: $I2E(T  '  "K+&*BDDJ)%3E)
MR;;=6SZK)@4!2;;/_.'O#_83W]+:ZR"[-8!2CJZFQ;;?=C;C-=#$*!?WY,M\
M@D(::=A+6HA().@!/ 5D%P7[]9X]C=R5RY1S8689N"KJEQ*F#&".\[T+!T*2
MGB"#6 5#Z+(<A6+9W?2SW,"\7\(@@]I[EH*7H"2=!WP&NO;KZE98/OH__P#V
MO?WE'_R:L&6=;;H>2]8^[;,DI9=D6%980H@%?.;6ZGEX\24>-IZE9,&P]:,"
M5,VC@R([96U:\CARIRAV(:4Q)CA1_P#B/('[-$"QF"7FWY#A>+7JU/(?@7"U
MQG&%H((&C:4J0=.Q2% I4/ 016 5)LCC66]9MWNMD<1,MV(VE;-TFMGF;[U$
M,1%HYAPYDNO<A'^RJL@72\VNR]:$9Z[3FK>S,LC4..\^KE0I]^+RM-\QX K5
MP&O:>'::P9)JZE[O;[1LKFOE[R&U7..U;X#2CHIV0^ZCE2@:@DA(4OZ"2>P4
M,%9\\QR[-=&6")7'6E5KD1+M,0 =4Q9CTDM+/K$2FS^S6025@>PF*Y;AF,Y%
M;MU]P51KK;H[Q1%O;26FG"V XRE/DRN7NU@H*2>&FE8!+.VNQ6)[89!>,DM-
MZOM[O5ZB^2SI5ZE-25=V7$N%6K;#1)4I XJ)[.'AK()LK ,9;[O9KVB:+9<H
MEU1"D.P;BF.ZAX-/M**'670DGE4D@@I/&@* =26+8_@.Y6U^0[<Q&K)FEWN'
M>OVFW@(0XMMYE$=T1T:!)=4M:%  !>AX:\Q.02!U37*#9MP^F^\7.0F);;5D
M4B9<):@2EIAB7:W'%D)!.B4I)X"@+<73(;/:+!,RB7.:^0X,)5P<N"%I4VJ.
ME'>!:%Z\JN8>UT/'4:5@%4.B>W28^W&17)UH-1[ID#OD:>/C)9CLI4H:Z\.8
ME(X]H-9!Q]%__2N?_P!YE_T#=&# ]7UM:^^S9B\W29+MN.)N+L.[W>"KNY$-
M!?BN*=:<((2X&PM2#IVHU\% 2@UTS8\^TV^QNQN.\R\@+9>1?6E)6E0U2I*A
M%T((X@BL V&RX9C/3EMIF]PQ<W"\LP695Z=3<7FW''7V6 A#?,RVRE*-4#71
M.HX]O90$/[78;GN]V+L;@YGO'D]JBW]Z4W'QS&I(MS+3##JXY2L)"D<2@\"@
MGET)))K(,1TU6Z#:-\MX[7;+O)O\&WL>3Q[Q,D)E/R W)2DK<>0$I6K4$$@5
M@R9#8^4S9.I3?2P71:6;I>YDJ;:PZ0E;C0EJD!" >W5E]*] ?:IUT]3)@V'K
M.OUGB[9Q<??GM(O5UND:1 MNNKJV6.?O'.4=B4Z@:GAKPH#<]T_\L=V_NG;_
M /<8K!GE.A@/^5!O^Y-V_H9-9!R=(_\ @E8O_/7'^LKK!@TC_P"_4_\ T:_^
MQ*&34]TWKI=>II"<,R"SX%E6(XZTY\N7Q_NXMQ6OE7Y.1RK'%F21IRDZ)4?
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M][VEW7X"7[?^B6N3D5"[KOM&A3"?KD>)CBY30'@T<<N3!/T@KG?6%5V6^_\
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M_3_%]@_(?X^]]H_5)?Z@/Q4^[%/B'^G^+[!^0_Q][[1^J2_U ?BI]V*?$/\
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M/85-J(\))XT!9C%L7L>%V&W8UCD%-OM%K;[N+'!*CQ)4I2U*U*E*4223VFL
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MFBBHJ5IV* )! F_(\"MV2;?RMO)$V1'MLJVLVPSF^0OAM@("5<4\O,>0:\*
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% 8"\?SK/\ )/[=90,-0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
*"@% * 4 H#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm2227887d4-bc_adverse4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-bc_adverse4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@#3 =L P$1  (1 0,1 ?_$ .T
M 0 !! ,! 0             % 00'" ,&"0(* 0$!  (# 0$
M 00% @,&!P@0   % P(!! </#P<*!0 "$P ! @,$!08'$1(((3$3%"(R4F*R
M%95!46%QL7*24W/3-%075QG!T4+2(S.3LW24U!96& GP@9&BPE58H8)C)#5U
M=I8W.$-DM"6U-N-$1=7A\>*#929FAB>CA*2EPX5'$0$  0$#!P@'!08& 04!
M     0(1 P0Q49$24A05(4%A<:$34P7P@;'1,@86X2*2,S3!8G)4!Q?Q0H*B
M(R0ULM+BDQAS_]H # ,!  (1 Q$ /P#W\
M                    !T"?>U(I]\6_CZ0F2==N:F5"K4Y2&M\<HU-7&:?Z
M1PS[%6LM&WD[+E\X"QW\    !:N2&VUL(</13ZMK?8GRGIK_ #?S@+H    !
M;.O-LD@UGMWJ)M')KV2N8!<@    +9]YMAI3KA[4)[<]IJ]0!<@    .%QQ+
M2%N+Y$H2:E^D0"K;B7&T.([5:=Q .4    !;,O-O;]BMW1+4VODT[-/. N0
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MTE:M%/*VMEIKV0"Y
M                 :XW5_W18A_X&N__ -71A!L<*    (J5KUFF:\_3+_%*
M[XO4,!*@    (JI:D43\K9\+UR?Y>8 E0    $553VT^29]R6OLO7)\(!*@
M   +&;KU*5[DO7V/II]4"7W%UZI%]S1X/\X(NP4   !%4[7;,T^-NZ^R]<KZ
MGI )4    !%1->N5+S^D;U_!([X_!(!*@    (I!_P#NSQ>;U5KPU=]_9_G
M2H    "+6:O&D8M?_ >\)OOO[("4     1<LSZU3"/GZ57XM7?%ZA@)0
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M$              8]L?[Y4O<H_XR0"SE9"!
M   $?5/]G3OR9WP#!6$.%@M.';#7_"T+P"!&?P           6%0UZC+]Q7X
M/KD^$(.6/\&8]S1Z@L+*Z!           6LCX,_[FOU E8<,#7J4/W)&GL?7
M*]4P1(            C:H9E3I9_Z(]?Y;D^$ D4\Q!(J           ",J>O
M5>7FZ5C7\*GOD^J DP            $55C,H#QGWFOLT]\GP@$J
M    BZCKLAZ\_6V=/9>N3]7T@64H"            (JIF9,-F?M[/XU/?) 2
MH            "+G??:?YW6D^ OOD_5](!*
M                                    -<+I_P"Z3$'_  +>'_JZ0)(V
M/%    $9*W=:I^W7;TJ]_;>UJ\[ZH"3     1M1TV1.?X4US:]UZ "2
M1=4W=0DZ;MVTM-N[7MN][(!*     +29\%E>Y+\_N?0 E]1?@T7W)'@@+D
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M[8:_X6A> 0J,_@           L9WP.3IKKT2^Z[GO>4!S1_@T?UB?4 7
M        +>1\&D>L5Z@#@@? XNNOWI'==SWW* OP           1U3UZA*V[
MMW1'VN[=_5Y0$@GF()%0           1E1UZKV.[=TK6FFOMB>Y E)@
M       (NJ;NHO::[NPTV[N[3W/9 )0            !%U'M(NFOPIKFW=UW
MH"4             1M2UZ!K37[^QS:^V)\X!)             (N?NWP-.;K
M"=>V[E7<_5"1*
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M:*Q4)RWJ=2([B4%).FP]=C"Y!-D;BRU-6GF"4?=B;.?+[NI:_O6='I:S:*@
M             ,>V/]\J7N4?\9(!9RLA @
M #$&2\J6GCR(TS<3=:?=J\=_JJ:11JC5]J6RU4IU4&.\3?(KDWJ+7S '6>%A
M25<.>&7"Y.DM:"LC5SZ*;W<H#84           %E.^ R]>;J[G@@.2-\'C^L
M1Z@*N00          %M)^#R/6+]0%<-/^ Q-.;H4<^WN>]Y 1?@
M  C*H1>+I>X^3HCUUV_VDJ3_ %0$B7,D64A]"*          ")JI)ZL1J-.T
MGF>VV^VI[I*@$L             B*KIU![=VO8<^WND]T2B 2X
M  "*J9%MB:Z:=:9Y].Z]$C 2H            "*J>G5F]VW[^QVVGMJ?/)00
M2E0            $3.3N<@:Z=C*+GV]PKNOJ )8
M   !K-Q;9#NO$W#OD[(ED3&H%UVK 8D4:7)81(:0M<N.T9+:7HE1;'#Y% .\
M7CDJ)CK$4_*MQTZH5>#;=!:K=;B4=E+LHVDLMN2'&F5*;2K:DU*/0RT21@.G
MU7B2L*!7H]OQ&*I7'Y&.I64GY]/80[&CV_'(C;==6;B#2Y(Y2:1]EH>ID P]
M2>/K%5<=HD>E6#DF34+QH9U_'U-1;3IOW*PWITZ:6E+OW0V>4UJ624:$9DH^
M346NVSN,S$T6P\39$AT^YZW1\R59ZB6G2Z;2U2*FFIQTO$Y$?B;TK)PG&3;T
M(U=EWO* Q)F;C-).!ZIDC%JJC:=S6;D*B6E?]LW+2#15*4<B6VB9'D0%&X6]
M;)[FE(,]=>Q/4!G&VN+3%E;IV6JC7XUQ8W7A5AB=?5,NZF+ILR/"EMJ>BRVX
M^KBE)D)2>PNV,].Q(ST ?./N+7&U]UR9;U3H=U8QJS5O.7=38]\4E5'.IT%@
MMSU0AFI;B5MMD6Y9&HEIU(U)T 0MH<9=@WP[**BV)D)J'(MZI7-9M:G4!V-"
MN.GTMLUOG3'S6HE*6E/W(G>CZ3DTYP5VB/Q38[JK.(#MF!7KJF9LMZI7-9]+
MI<5#LI$"EQ$R'U2D*=3T2MZDLI+4]73V>B",#X:XXD5C"]-R#E&R;CC73<%U
M2K<L^V*'2E.NU^2I]_J\:CL&^M3QQF&MLA:U))*TJU/F ;;XAS#:>:+>GW%:
MS51IKM&JDJBW-;E:BG!JE*J4,R)^+,C&I1H6G<E7(9I/=N)7* Q/.XP\:Q+\
MEV9"MR\Z_3*7<K=GUK(U)HDB;;L"NO&DBA.RVS-PE-FK:XI+9H1YJ@%I>G&C
MB>RKKNJW9E(NRKT7'D^/3LDY$H]&=FV_;LN1LVHJ$Q"]4F@UETNQ"MFO9: .
M\U+B0L.GW?DJSNAJ4N=C&QF,@UJ;':;7%D4E]#CC9Q7"<^Z+4EL^0R(CY.4!
MT>J\9./*?"Q)(AVO>5R5#-MM/738-O46D]=J$F.TVV\MA3+;QDAW:O4M3VD1
M'V0#%F0N-]I%O\.MWXELNNW5;F7[P<H]?C^+-U399@=,W+IC48W4DF>IQO1*
M3/;L2LR/F ;:Y7S!:.&+!>R%>I3F:8EZ'$A4J%&7(J4N9/63<>%&CH5JMYQ:
MM"(E<_F@-3;,XP5S,O9[DWTW5L>8DQ-8E$N"7;ERT8X%9I\V4MTI!/I2IQ;O
M2:(2T2#4E1GHD_,,,Q69Q=XPN:+>TFOP;DQ?*Q]0$W9<-&O6EKIDLZ \2ME2
M902GB<94:=#T[(E:),B,] %C;'&'8MQTN\ZO(L7(%J,6K:+U]L)N&@N0?&M!
M92:CD0'%.FTLU;>1MQ25\O-IKH%E&XTL>2K%HE^M67?:(=Z5.+2,84,Z)I5;
MIDRXW6=U)B$\9NM(01FMU9H26AGKH9:AW2B<35E718)7O:UM7=7YJ+B7:-0Q
M]&I*RKT&MM*T>A3HJS2B-T1%O4ZXX39)T/?RD ZL[QEXN3C]J]DTJYY$YV]7
M<=,V%'IZ':XNYV=QKIR64O=">B2W&X3VPTESZ\@#L,WB?LVAXPD9/NVT;WLU
MA%9;MR%959H;T:X)]6?6EMB+!A:J3)-]1_<S2LTGHKLBT,!!(XR<2L8]O*_*
MU$N:VI6/ZW$MZY[ J=+<9N-FKSR;ZC"1 )2B<7)Z1)LFE1I46O+S@.L80XB;
MLRSQ(Y5L9^CU>U+.M2SJ%4X%G7+2BIE9@5*8\X4CK&JE*6A:"0:32:D^<8#A
MXC7'&\X8<-IY;7_Z+7>9F2E%_P"-2M==/3'S#^K5=5'DT33,Q_RTY)>H^48B
MK&3$\OW?VPZYUJ7\:>_"+^N/S1OM]XE6F?>^I=U=[$:(5ZW)^-/?A%_;!OE]
MXE6F?>=S=[$:(4ZU*^-/?A%_;!OM]XE6F?>=S=[$:(.MROC3WX5?UPWV^\2K
M3/O.YN]B-$'6IOQM_P#"+^N+OE]XE6F?>=U=[$:(.M2OC;WX1?UQ-]O?$J_%
M/O.ZN]B-$*]:E?&GOPB_KAOM]XE6F?>=U=[$:(4ZU*^-/?A%_7#?;WQ*M,^\
M[J[V(T0=;E?&G_PB_M@WR^\2K3/O.YN]B-$*=:E?&GOPB_M@WR^\2K3/O.YN
M]B-$'6I7QI[\(O[8-\OO$JTS[SN;O8C1"O6I7QI[\(O[8-]OO$JTS[SN;O8C
M1!UJ5\:>_"+^V#?+[Q*OQ?:=S=[$:(.M2OC3_P"$7]<-]OO$JTS[SN;O8C1!
MUJ9\;?\ PB_KAOE]XE6F?>=S=[$:(4ZU+^-O?A%_;!OM]XE6F?>=S=[$:(5Z
MU*^-/?A5_7#?+[Q*M,^\[F[V(T0=:E?&GOPB_M@WV^\2K3/O.YN]B-$'6I7Q
MI[\*OZX;Y?>)5IGWG<W>Q&B%.M2OC3WX1?VP;Y?>)5IGWG<W>Q&B#K4SXV_^
M$<^N&^7WB5:9]YW5WL1HA7K4KXT]^$7]L&^WWB5:9]YW-WL1H@ZW*^-/?A%_
M;!OM]XE6F?>=S=[$:(.M2_C3WX1?UPWR^\2K3/O.YN]B-$/DY,HB^%/?A%_;
M!&-O_$J_%/O(N;O8C1".O^5+*JT<BFR&R\04U1FEU:3[17HC]8_*E4U>3829
MF?RZ>=^5OGRN:?.K^(FR+>9TGK4WX[*_.%_7&_M>.[VO/.E3K4SX[*_.%_7$
MM.]JSSI5ZU-^.ROSA?UPM.]JSSI.M3?CLK\X7]<6U.]JSSI:$\>-4JL6KX01
M'K%0BH<M*I&LF);[6I^-WN4S;61J/T_K#V7R[3$W,VYWN_*JYG!T3,Y_;+0O
MQY<'[1UGRA+]]'H-2,S*MJS'CRX?VBK'E&7[Z&I&9=:K,>/+@_:*L>4)?OH:
MD9DUJLQX]N#]HJSY0E^^AJ1F-:K,KX_N#F_6&K>49?OH=W&:'+6GH?/CRX/V
MCK/E"7[Z&I&9-:K,KX\N#]HZSY0E^^AJ1F-:K,>/+@_:*L^4)?OH:D9DMJS'
MCRX/VCK/E"7[Z&I&8MJS*^/KA_:*K>4)?OH=W&:%UIZ%/'EP?M%6?*,OWT-2
M,R:U68\>7!^T=9\H2_?0U(S&M5F/'EP?M#6?*$OWT-2,QK59E/'EP?M%6?*$
MOWT-2,RZU69NS_#OJU5D\7&.69-:J<UA<"M&IA^8^XE1IISVW<A:U$8U_FE,
M1AYLZ&3A_C?H"SS,O^GX8R?/Q;'7(R'%MV>[:+32-[ISDLJ-OHFS,R4LM=4)
M/[+0>3;)XD87R_1;"RAPM53&>0,F5ZZL@5=FV>)J@WDY/73UU"I(2V3:"F)Z
M-M]J0I:TDV>I(21GIJ9 /T0
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MV1/RMKPO7)^KZ0"4             1=2,R9;]W8_&)[Y/\O, 2@
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MU<BCY//"C[\S3&6(ME:HU:=:<EMC.H(         ,>V/]\J7N4?\9(!9RLA
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M&[]L'"+_ *-)O5!]*5PK?'[L\AN_;!PB_P"C2;U0?2D\*_QZ[/(3OVP<(O\
MHTF]49SZ4KA6^/W9Y#=^V#A%_P!&DWJ@^E)X5_CUV>0W?M@X1?\ 1I-ZHSGT
MI7"M\?NSR&[]L'"+_HTF]4'TI/"O\>NSR&[]L'"+_HTF]49SZ4GA7^/79Y#=
M^V#A%_T:3>J,ZWD_Q0>%:1'=8.HW<WTJ5))7B-WD_K"\(O\ HTKO-&=<%_%)
MX5_C]V>0W?M@X1?]&E-YHSGTI7"M\?NSR&[]L)PB_P"C2;U0?2E<*WQ^[/(;
MOVP<(O\ HTF]4'TI/"O\>NSR&[]L'"+_ *-)O5&<^E*X5OC]V>0W?M@X1?\
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M;IQ-S+2EN&>QJ.2S2VV@B2E/(.&#JLO*Z8R=W,]N67/$_?IUYRZT/7<$
M     &/+'^^5'W&/^,D"+.5D,5                            %E.^!S
M/<7/!$YA^+J3\,J/Y;,_'K'ML%^11U-1>_%/6X?3&2Z51    6 $ 6 $
M 4!          !;0$         44U(!40   %%/2 5$           !0"P!
M  %/0%%0 0      4!  !0$               !0$      % 0     'K)_"
M._ZM99_X0B?_ ""1I?//@HZ_V,_!\_IF>^8\XSD=.V[H.OQA/G=RKSP$B
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M+$Q15:=0B>NC%&5;WN;]2J=6X]-E2Z/<;[W0/4^HJ;>CLOMH4E24K3S&I/(
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M;!R/9M/HUHKQ'A*WE5)-X6C4[JBW91C@ND:HK%O-JC-S81])HM72.$E)=CH
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M9^/6/;8'\BCJ:B]^.>MQ#+=( KR@B@*
M "O,"* H         KH"6J H  *^D"', H"J^D"* H  *D"2H"@    "O,"'
MH * H KZ0(:"%J@J@!Z0( H           "N@)::Z@* JO,"* H
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M$9"U)0A;JDI)2E<R>R\T2T7HH +,I,8GRBJ?;2^M)J;8-:=ZD]T2>?0!>
M       #'MC_ 'RI>Y1_QD@%G*R$"                            +*=
M\"E^X.>"(/Q=2/AE1_+IGX]8]M@OR*.IJ+WXIZW&,MT@           *F"0H
M"@   '," *J8)"@*         *^D"* JOH@B@*        >D" *KZ0(H"J^@
M"* H          *Z EJ@*          "I DJ H      !<X( IZ((KZ "@*
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MW+9RIH1R        8\L?[Y4?<H_XR0"SE9#!
M    %E-^!2_<5^").0?BZD_#*C^6S/QZQ[; _D4=347OQ3UN,9;I   /G! %
M      !7F!#F 4!0 T,$ 4 5] $# A0%    /2! % %?1!% 54@23F 4!0
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MG];MIKU8MF;8[7A.IQ;RW7W2T<D.K>=2GS%+4:U%_6'IFMEZQ?PC?^K>6O\
MA"+_ .O(:/SWX*.O]C/P7/Z9GOF/.LU'S->DA:\W6"\%7?)^KZ0"0
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M\]^"GK_8V&#Y_3,]\QYUFH^7V\/37X07==RKSOJ@)
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MK_\ N"I_B1]&_I;_ .;N_P""O_TR\3_4+_PE_P"IAY'(2/6C]*/RESJ"N(
M+RG?[2IWY9&_&D%/Q.ZY^.GKCVO50;=]?>+G&?Q!83R3:EW0HEYU^VLQX+NA
MMBWL$UZ-T<*ZJPS,9Z%4JD;7.OLN:'T2MZ=O;:<I:B7KI9TZK52TK7J=>IOB
M2M5.D0959HI:?ZG+>82X^QZ/1.&:/Y@+7;P%G-^"3/<7/! ?47X+%T]J1X("
MZ     1-,+L)9)T^%.\VG=>@E("6     1$5*>N533MND;U[7VI/H>J EP
M  $2A)>-GNUW=6;/['7ME=[N_K )8    !$K+_W6/R\O0/=SW3?>Z_Y0$L
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MD;C0KT4\QB2/QB2/AE1_+IGX]8]M@OR*.IJ+[XIZW&,MT@!Z0( JI<H(H"@
M KS@AH!:H"JZ EIJ!8H"@"OF B@*      !Z0( H       "O*"* H KZ (>
MF H"@      J0)*G.  JOH B@*KS@B@*        KZ((H"J^@"* H   "OH
MAJ!8IS  *KZ0(H"@    "IB)"@J@  %S@@"@        #UC_ (1O_5O+7_"$
M7_UY#1>>?!1U_L;#!\_IF>^8\XS4;-V[H6O/U@MOL5>@8"2
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MXZG'Y.QZ!WS^Z;[W3^L E     $7)W=:IOG](O\ %J[T_5(!*
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M:FTZ-49"9=08BM(GRDEHEQY""):]OV.X]3';5,3,V9'71;%,1.6Q,B.0
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M>PN37NT]RE7@@J5!            $54==D;G^%-:::]UZ"5 0E0
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M#:TJ4VON5[>U5Z!@B^  $>Y+C1WHS#TIME^2I28K"U)2IU1)W*)"3Y5;4]R
MD  !82I<:+T)29#4?K"R99Z5Q*#6M7:H3N[92O. 48F192GVX[[4A45:F9#;
M3B5]&M/.A>WM5>@8"0     ?*E)06Y7( Z'>V/K(R/3&*-?MITJ[J5'?3*8I
MU6BMRV$/)2:4NI0ZE:==JC+7T0'7Z#CJQ['HM?MC$]'H.-ZE.C..:T>GQ4]!
M(<;4EB4]&1MZ78?*1+Y#Y@'4<$X'@X8MJZZ;4JZY?UU9$KTRY<BW;-B,1#J<
M^HD273.&T1MMM(0DD);(S+;KYYD [C:^&,5V-.J]5L7'UO656:TVMJ;6:)38
ML*29+\PG&6RVEN[+0RTU\P!K#;7!4JGY-M:_KKR)%N*)9MP+NJF4FF6I2*#*
MGU8VG&6956J$$DKE&V3AGH2$$I6BC ;4+Q!BQR\F\AO8ZMYR^DF2D7:Y3HQU
M)*RUT44GH^D-1:F>[=KZ("RKN$\0W/6:C7[CQI;%8KM80VW5:U+I<9Z4\F.M
M*VR<>6WTBB3M2?;<AD0#EN#"^)+KN2/>%RXSMBO73$4A46X9U*B/S$K;/1LS
M><;4I6WS-VNGF )6H8XL"K52X*M5;,HU3J5V4YJD7-,E0VG5U"GLJ-34:1TA
M&;C:%*/1*N3E 1=K8ZQG8M0FOV)9=O4"O-TU$1Q-+CL19#D5LU*::>6VDCV[
M^8U:Z /.CB;LM>:\H8GMWB3ME=C6]3Z)<L^WG+(KA5*8_)0Y3D*0^<B$P32$
MMJ^Q2K<?FD.VYQ=6%G7CJ8/F.)NL-=:UY;9;9R,8?N5\&G]^94_#P/T<97U%
M>9HT?:T''L%^_H@_<LX-/[\RI^'@_HP?45YLQH^TX]@OW]$'[EG!I_?F5/P\
M']'#ZBO,T:/M./8+]_1'O4_<LX-/[\RI^'@_HP?45YLQH^TX]@OW]$.M7CPH
M<%EE6?<5]5>L9:=H=IM1GJPW%?@*DJ1*D)BM]$A;)$9](LM>7F'?A?.;_$WF
MI3$6]+.P?F&&Q=4TW>MR1;RQ#6_HOX:_QG/7L*8-O_W/W.UFVW7I8J;7\-?X
MSGKV%,#_ +G[G:EMUZ6*=%_#7^,YZ]A3 _[G[G:MMUZ6'1_PU_C.>O84P/\
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M&;F93'HVM   $L 4                8[L?MZC[E'_&/B+.5D05
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MKM[M-O3Q^?;[:GNP@2@            ",F[>D@Z\_6"T[7N5=U]0"$F
M                \M^,V\_W?,W6#GMM;C+-R8YNZQ99M;RZ2I-L(J-%0I/.
M9JD$9$ TQI-G5G'=+A\$E8J,R94,TWICF[FSD*5N<A5)I,RY4[M$[D-2(.T_
M,],P&<KLO?,.+LL<?V4,5UFW*=3<<S;4K-T4FN07Y;U2:C4S1,.,IMUM$=)M
M&LC7H9[MI$6@#+66+XN*X\H938M>+0K8K50X7'+IIUZ'!4]56.FDN+>BIDI>
M;,VNCUVIVZI<,E^9H QK9&;<YVAC[A@PO:MQ0#N&[\9%?:[R5;$ZNO,4II#3
M-/I2:=$=Z5]PC7_K$I:N;LMI:@/1_!5\7MD3$5LW3D:SI%B7S.BOHN2VWVG&
M2:?C.N,*=:;>/>2'DD3B25RD2M#Y@'EWPWY+S3A7"F);TB56U:OAZY,L3K.J
M5C'&>\>:URNR6.N)J'3&WTK3VIDT;>G1\YZ]J'=*'EF[,2U?B;:L)BFJO3*7
M$\S8UM52N=(JF4UZIP6".;+)M25*)I*%;6R,MRM"U 9)N#BNR[A:F<15HY)9
MM[(E^X<I-MU:UKHI+#U+ILYNZ9)08K=3C$MTXYQWE[E;%]DWREH?* ["UG[.
M&&;RNFR<U5"V,FNEBNN9/MJJVK!>IRV%T+:3]/DL*=?-33IJ+H7BT/GU+D(!
MA"#7\UWEF+@$OS+=RVE6(>0)]<N&VZ5;L1^(]2TSZ%TI1'36\\F4TEI2"Z3L
M3WD9&7*0#<WB+RKD2V+NPIB3%\BCT"[\TU>I1F[UKT9R;#ID2DQ#E/\ 1Q4.
M-=.^Z2B0VDUER<I@,+Y+SKQ"8ZH&'<<U>JVC)RUDVZ:Q19.0;;I,^MP(U.H[
M73]*BD-K0\N8ZG0ELDHTHY_6AC+(5^9,R#CCAUG99MAZVKOM_B4MRB]:.#(I
M358B1G7%1ZG'B25*=:2^A1&:%&>U6I -A.#(M+SXS"\SY=:_^)C@.N65ESB0
MRS=-VWK9%?L&W,76/DN78<JP[C8DHJ$R)3'6V)<Q=2;</H9#IKU89)HTGR$9
M\H#I5\\2W$ MKB+RO8TRSJ1C#AFN.30*E8-9BO.U6OE2TM.3WG)Z7DIAJ=)[
M2,E+:M=.73< [S4.)B_7<BYYIM,=IT"V;(P33LCVA"EQB4_&J,^.^_\ ZVK>
MDEH0;:2V\@6#J,+/_$+>\SA)M6SJ_;%"N'/&-)]RW17*K2W),>)/AQXT@Y$:
M,V\V>I]*I)-*5IH?*?( PG<F5\UYRLC@XN1B[Z79]V2\S5&UZZJ- ==ITBL4
MDYK,:H'&Z=/2,;&5&;"CTWJ2K<6T!OQQ3Y<O'#6+J-4K/:I\B][PNBA671:K
M54+53H<RMO\ 5^N/LMJ(S0UH9D@E%J>A:@-%I62LFX S+QBY(ON50K^OZQ<4
MV>J+*I+#]/@3%/S'&(BY$=3KQM&3CNKJ4+T-)$9::@,LT'B=SWCZU,Q7)E&V
M#OJBV3C]-Z6Q>[%N5"U83U1W$AVC/-3#<4LDJ<2XAU';(W .^0K[XH+.QAD/
M(&0+VQ]<\7Y+9EZVFU1H+\*H4VK(C*D)85&6\ZB7#))E]U-25[N30!B^H<1?
M$5;^+,"U&K5ZWYE^<3E2B*MZ=3;=E38ULTSQ8B;)),%B0IZHRE?8EV)%JKD,
MB =[IW$/F!O%$9N_G8F-\COY _4NW[@E6W4GG[G@;.F9F4*W=_3JDO(Y.B=7
MT;9I6I1Z$1 .IT7B.XE+MPC<E8M:VDU*^+-RQ.L>Z:\W0'I-1@6_#VN'55VX
MU*U<E(WI;7';>/3MB(P')6N+*_;8P0BK4R\K;R+DZJ9&@8^168MNU*E%17JE
M]T2=6H$ASK/6FFDF9,H,B<,TZ>B%I5N*'B(LO%]YQ[EMF,N^6;[MRR,;Y+JU
M"G4&DU-JY'":34)%,DN=*A<-1J0M!*(E&2?,/E#L'#]"R#3N-G/,')M?I%TW
M9&QO:B'J[0HKL&-(8ZS(6VIR*XZ[T+O;:DE>FFTRYP'9>+'_ *SX4_X<NO\
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MG)#9T5R         &/+&^^5+W*/^,?!9RLA@@
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MSVN[VQ/<J2 DP            $?,[:&9?&"\%?HD"2D 4
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M9V.9][S[4IZX,S(UP2;HNQ;CZW>LU*4E*7G4I<-6PE;2+1/( Q96N$7 =Q9
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M!'"1@]NTJU9,>WJA#M^LW'^M[C<>L5%J2U7%H0@YT>4W))Y#B]NJONFAGRZ
M+V)PIX)B8_KV-%V0F=;=U5%-9N.1-ERI-2EU-K3H:B]45NJD]9:VIZ-PED:=
M.0!R0>%S"T/'ES8ND6Q)KMJWC)3.N1NM5&?4Y<J6C:;4GKDE];[;C1I2:%-J
M29&7( N\9\.F*\+UJMW78- F,W+6Z8S3:S4)=1DSI50;B+6ZUT[DQYTU+U5M
M)1F7)H7, U,R]>$:JYHQ<]GZF-</M#C6W="*)7*M7*9-9J$EQ^F$4=)QU&32
MTMIW]D?+YG,&[3?_ ':;9ZFO\RP=&+NHHKFSEM2/CWA(_P 4=N?G\+[8.$7^
MS5H:#Z8N?&GL4\?<)'^**W/SZ%]<.$7^:K0?2]SXL]BOCWA'_P 45N?GT'ZX
MG";_ &:M!],7'BSV*>/N$C_%';GY]"^V#@]]LU:#Z8N?&GL=0OMKA(O>Q+LL
M&5Q3T"!"O)B)'F5)N?!4\P4*4W+2IM*M4&:E-$D]_G^>,K!X*_PMY%Y%$S9G
MAL/+_*+G!U35%Y;;%G,U0_<_X'O\;D3\XI/UQO=]Q7A>UL>YNLY^Y_P/_P"-
MR'^<4GZX;[BO"]IW%T?N?\#W^-N)^<4GZX;[BO"]J=Q=>G^)^Y_P/_XW(?YQ
M2?KAON*\+VKW%TOJ/P5<&]Q5BD6_0.,ENL5RN3&X%)I,5VENOR'G3VH:;;22
ME*6H^8AUU>8XBF+:KOVD7-W/.V2H7\)?#L9R2JX,C7A7&W$I3%:CG"@&TO[)
M2E)9<WD?G<@Q:_.KR<D1#LW2G.@4?P_."5R[56$WFBKN7JE6S]5DW-2U3]_M
M?5NK])O[S;_,)QF_S1H^U=UI]+';JQ_":P;)A&U1+\O6BS]Z3.:_(AS6]B>V
M3T*HS9=EY^[D%I\ZO>>(2<)0ZW]$/CKYYKH_,H/VHY<;KV8[7'=*?3_$B?PH
M<>42=3*RG+USON4:;%G-QU0H.BU1WTN$E6Q!GSIT/02KSJN8LU8[7*G"4YWK
MZ-,RFLMS<(_#?=^0D90N7$E#JM\E):EOU9UMPD/R&2U;>D1]Z6'E)V]LM!Z^
M;J V72E*$[4\A$ ^P%E.UZG)T]J5KZ6WUJO! (FO4XWN:=/8^DGU %Z
MBJ?KLF^?UMWPO6I^KZ8"5     1<;7KM2/\ TK6OX-/>I\(_J )0    !&((
M_&D@_P#0->$KO?[0"3     1;A*\:1S/XN]X3?>_5 E*     (J7KUJF>?TJ
M]/P:N]5ZI )4                !CK)D>I3<=WY#HVOC>9;]2:INSME/*BK
M)"4^BH^8=&(BJ;N;,MDLWRRJBG%7<U_#%5-O5:\(Z>:.H0C;[%/5VR0CSB).
MTD_S#Y?5,Q/*_9EW,619DLBQ>J4A*5+<4E+:4FIQ2NUVI[8<'8]C>&:)5(>
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M*I<JA2ZK"9EOT>:E*9$5Q]M*U,O)2>F]K=M5Z)!,6384S;%N1V8%
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M&=.EEYG1*_EVJO! 2!<R192'T(H          (NI:]5]#I6/QJ>]5Z@"4
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M7^9I@U$?-R:F ]NT)-*4)-9K41??// <P")JNA4Z02NUVEKKIW7?*3X0"6
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M8R3UI5&M3-,Y)RPR.*H         QY8_WRH^Y1_QD@%G*R&"
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MVG]I2?" 2:>8A92%1%          !$U0T]5(EDG0WF>VV^VI[HT@)8
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MMW;MI:;=VO;=[V0"4     64S7JDC3GZ)?G]SWO* ^XOP6-[BCP0.==
M(NG]I+[;X4[S[NZ[X()2@    "+C;NLU#MMF]O9VWM:>;=V/] "4     1B-
M?&3_ &VWJ[>G;;>V5_, DP    $8O7QG'[;9U=W7MM.V3_, DP    $9*W=:
M@::[>E7N[;VM7<\GL@$F
M   #'EC??*E[E'_&/@LY60P0                           !85'_ &?.
M_)G?!,%AXUXC_P"F%B_[K1X2AJKSXI?*_-?U-?\ %/M9&'!@*"HJ(KYT%<;'
MT(Y   H*!\P)*HB@      ^!7!FWA]_ZD-?[KE?V!WX;XGH?EG]9_IEOF-@^
MB   MY'P:1ZQ7J .&#\"B\_WI/G]SWW* O@           1M3UZA*V[MW1*T
MV[M?ZO* D4\Q!(J           "-JF[JO8[MW2M:;=WMB>Y 20
M  "+JFO47=N[=V':[M>V3W/* E             $74>TBZ:_"FN;=W7>@)0
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MEXTC'KR] ]W/=->AK_E 2H    "*EZ]:INO/TJ]/P:N],!*@
M                               Q[8_WRI>Y1_QD@%G*R$"
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M[#MM.[3YZ5>H()84            1%3TZ.)NT^$M=MIW7HI4!"7
M    154(C8;UVZ=.SVVGMB?/2H!*@            (R9KOA?E!>"KO3 28
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M7*492J<7FJ>7I^#5WR?4,!*
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M/W)'@^N5ZI@+X           $;5#,J=+/_1'K_+<GP@$BGF(64A410
M    1=3,RBZGS=*Q^-3WR?5^L E             $55=>HO>=V&OLD]\GP@$
MJ             BZAKLB:_&VO"]<GZOI J4!            $74E&EAO7V]C
M\8GOD_R\P^8($H             CY>N^%^4%X*N^3]7T@$@
M                                    \X;GSAQ=W%FG-N/L'6?CFMT/
M#CM(;>:N63.BSYBJI!1+2TVIEPVM=246I[=.34!VVQ^+)>1;;X=;C8<IEA3\
MHW=.M*[K/J\:9-D%4J2A],R# ?CFEIIQ+C9JZ1\MIHY.V 9GH_$MB*LWK2K$
MB7#):J]Q5"?2;7J,FFS8U*JL^FZ]=B0*@ZREB0ZR:#(R2OET/;J!,NK1.,K
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M)\6)5&DR#7T2?NBO]69=TV[BY] '5N%=27.'/#2T?=$KM6"M'H[V]Q& V&
M         !93=W4Y>GM+FOL?YP')&^#Q_6(]0%7((          "WD?!I'K%
M>H X8.[J</7VI'@_S>H O@           1E2-1T^5H1DHVCYMW]E*E?U0$DG
MF(64A410          1E2-1Q="+35UKS_;$]RE0$I,            !%534H
M3FF[=V!=CN[I/<I5X("5             151UZ.+YO\ K36G/W7H)4 E0
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M 2P    ")3M\:O=KNZLUW.[MU?S@)8    !%+V>-8W:[NK/:]KKKN;_S@$J
M    B96WK=,W::]*YMW;?:E<VO+_ $ )8
M                &/+'^^5'W*/^,D LY60P0
M    !85(]*?/47.B,[X!@,'\+'_;OAO_ (6A> 0#/X           +&=\"F:
M\W0N>=W/H\@#D8^#1_<D>"(JZ%0          %M)^#OZ^UK]0%<-.V]2B;==
M.A1IVO<][R B_           !&57;XNF:[=O1'VVW3^MV("1+F2+*0^A%
M       !%57;U7ETTZ5G3=M]M3W8"5             1-7T\7O;M--$=MM[M
M/==B E@            $55-NV'NT^%-<^WNN^ 2H            "+JFSJ[>
M[33K$?GV^VI[H!*             (V;IOA:_&"[GN5=U]0"$D
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MSI[[;_5 2@    "+E;^M4[3FZ5>_\&KOB 2@
M                   ,>6/]\J/N4?\ &2 6<K(8(
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MJ6AG]]9YMWMB>Y-("4             154UZB[IKKV':Z]VGSE)\(!*@
M        (JHZ[(W/\*:TTU[KT%) 2H            ",J6[H&]O-T[/-K[8G
MSE) 28            "-F;M\/W<OZ=JN^3]4!)
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MC.GR?6EK[+UJO! 2@    "QFZ]3D^Y*U]CZU7@@*Q->J1O<TZ>Q])/J +T
M  !%4_79-\_K;OA>M3]7TP$J     BXVO7:E[HUK^#3WJ?",!*     (M!'X
MTD'_ *!KPE=[_: 2@    "+<(_&D8S]H=\)'>_V@)2@    "*E:]:IOG],O3
M\&KO5>J0"5                                           !CVQ_OE
M2]RC_C) +.5D($                            6<[X),]Q<\$2<@_%S)
M^%U'\NF?CUCV^"_(HZFHO?BGK<8RG2        KS B@* *D"2>@ H"@ 7."
M*      !Z0(KH!:H"@   *^B"'H * JOH B@*    ^=1"U[U_P ([_I'E/\
MXS1_\?''F?//S(ZFRPN2?4];1IF6     (FI$9QCU+>72L_C$]ZKU/K@2E@
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M]K[4KT?4 2H                                           ,>V/\
M?*E[E'_&2 6<K(0(                            LYWP29[BYX(DY!^+
MF3\+J/Y=,_'K'ML#^11U-1>_'/6XQEND        U,$ 4]$$ 4   !7T@10%
M  !7T010%             %?3!% 4    /F$27O1_"-_Z1Y3_P",T?\ Q\<>
M9\\^.GJ;3"Y)]7L>MPTS*     $355$49.NW0WV>VV^VI[I20$L
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MU^$M]UW7>@)0            !&5'7H6]-WW]CFW<W2)[@!)@
M(Z7V\/G^$%W7<J[GZH"1
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M,\[H7/!_G]05')$^"Q-/:6_!$5=     (FG=K,TT^%N\VG=>M3]7TP$L
M BHFO7*EW72-Z_@D=Z7A& E0    $4C7QJ]^3-G]CW:N]W?UOY@$J     BE
MITJD=7_EGC^Q[IOO=?ZP"5     14K7K=,UY^E<_%*[T_5(!*@
M                                 Q[8_P!\J7N4?\9(!9RLA @
M                      "RG? 9GN*_!$D?BZD_#*C^6S/QZQ[; _D4=347
MOQ3UOCD&6Z% 4           !7T 10%     %>8$4!0   %?1!% 4\T$ 4
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M7737K+//IW7HI4!"7             1=4(^KMZG_ ..R7V/MB>Z2H!*
M        (V9NWPM?C!:>Q5WI@)(
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M2 E*@    (M!GXU>+S>K-^$KOO[("4     1;AGXSC%_H'O":[[^R E
M$7*,^M4S7GZ5?XM7?)]0P$H
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MI7-J0#N5YY2LJQ,<U#+5PU0VK%I5,:J\JL,,K?UAO$A2'4MMI-2B43A'R>>
MU<C?Q&N%V7(BL1KCK[JYS[3,996Y5>C4;ZR0WHKJY%RF9<O, WHF<L.7[BOP
M1)'XN9'PRH_ETS\>L>VP7Y%'4T][\4];X]$93I4%4  %= 2U0%         %
M?3!% 57T 10%                  N<$ 4  %2($4/F$)>]/\([_I'E/_C-
M'_Q\<>9\\_,CJ;/"Y)]3UM&F98     C*EKU;EYNE9_&I[Y/J@),
M    !%54S* \?K-?9)[Y/A )4            !%U#4D1/RMKPO7)^KZ0"4
M           152,R829\W3L_C$]\G^7F )4            !'S=>DA?E"?Z=
MJN^3]7T@$@
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M=E[6KO?5 2@                                           ,>V/\
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M>?F1U-GA<D^IZVC3,L     1=2UZL6F[4W6>UW>V)[DE!!*4
M 154W=1>(M=W8<V[NB[E*C_J@)4            !%U'79&Y_A+6FFO=>@E0$
M)0            !&5$S-A&F[[ZSVN[VQ/<I4 DP            $?,[:'^4)
M\_N5><$(D 4
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M\8'X=P_^E<7@0QMO)/SIZI8N,^".MXQ#U%C6 6 %@:>8 " +8 6 %@:>A_D
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M E@    $6[T?C2+VN[J[VO:Z]LW_ #@)0    !%2]O7*7KKNZ5S9VOM2O/\
MJ )4                                           &/;'^^5+W*/\
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M/FN(HOKR)HFVR&;AZ)ICE>D8UKO     $55=G5NRVZ]*SINV^VI[H!*@
M        (FK[.H/;M-.PTW::=NGNN0%2P(            B:IMZ.'KS=:9Y]
MO==\ E@            $55-O5V]VFG6&.VV^VI[L!*@            (V9LW
MP=VWX2G3F[E0"2
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M34H+AENU[#M=>[3YRD^$ E0            $7.W;8OY4UI[+UR?Y>88"4
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M22] M?9>M7X("5     6,W=U*3I[4KP?6J\$!6)KU2-KS]&GU/23Z@"]
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M$53U!45$4  %/1%1410!MEPQ_ KR_*XGXM0S,+DE[3Y3^"\ZX;5C,>N
M%I)UZL_[FOU/YP'' UZG#]R1I['UJ?!(!?@           C:GKXOEZ^U'_+M
M5>" D4\Q!(J           "*J)&<8]>;I6?QB>]5ZGUP$J             B
MJH6L%XN?M-?9)[U7@@)4            !%U#79$U^-M>%ZU7U/3!4H"
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M8\C0F=O6);]Q);::W'M2:U*CDDMQ\@L>;W-7)%L^IV1=1/)$TSU2BOW <O\
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M     15-/DF<A?"G>;3NO0,PDA*@    (F,:>N54R[;I&]_:^U)]'U0$L
M  B$FGQJ[VN[JS1?8Z]LKOMW]4!+@    (M9EXSCEV.[H'NYW=LWZ.O^0!*
M    (J49]:I>I']]7R=C[4KT?4 2H
M            ,>6/]\J/N,?\9($6<K(8J
MQW<V.;0O&X;+N>Y:2FJUG'4YZJ6:XZZYT4*9(:5'5)2T2DH6XEM1DE2TGMU,
MT\O* [K4/@$[\F=\$P6'C7B/_IC8W^ZF_"4-5>?%+Y7YI^IK_BGVLC#@P
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M$UV_"FNVT[KT3(!*@            (FJ&1,-F>GW]GMM/;$^>I("6
M      1TWGA>?U@O.[E7G@)$
M               'D7Q%<1F4;5XBLE6!3^)RT<!6G:EMT2JV\Q<]$8J1U&7.
M86N0TTX9&[V)I2HRY3[(MI -A>&OBNEY"MG"-+RE1)% OS*MJUFX*?76HY1Z
M3/10I)-OJ;2XO>TMV.92$H,M.CY==.0!>R^-VQ6+5Q5=D*P+SKC.:ZQ7*5C:
MC4V$Q(GU%RC*-*74-=801-R=IJ9,U=KV2MI +NZ>-;'EHUZJTJKV=>2Z99GB
MMG+%X0Z>U)I5I3*PAM3$.J/)>(^D1TJ"=Z)*TIUY3 2.2.,.P<77=6;#N:W+
ME<NQ$6DR<>TB!$1(5=Z:N^4=M%$63NUQ;#G(\EPT;$]ERER@.0\X+H^;LLVW
M4IUS5>-8E@T6Y7L<4^B1Y2F'9SJFS*%(C.*DRGW%)V&THB06FI*YS =XQ7GV
MAY+O.\\>NVQ6K*ORP8L"=7;;K!1EK3"J9+7&>0_#>DLF>B5$I!J)2#Y-.4!@
M'BR(U9DPND^R05MW6O0_1=IA#'Q/P>MY[YGC_JQ_%^QB3HF^X3_0,!\\.B;]
MK3[$1;#HF_:T^Q%+%.C;]K3[$$8EXA&6E<-^;R4A!D=.HVJ2(C(__>8HW'D?
MZJ/6]'\M_F5?PQ[7B]U6/\71[%(]]8]/WDJ]4B_%VO8$(FO*G5(WQ=KV"0Y#
M7DZI%^+->P(+(-><[/G"O'81Q,X#-+#:33?-*VJ2DM?OQ#%QT?\ #5U2[KF9
MUH?K3DMN/1Y#3#RHKSJ%(:D)(C4VHRT2LDJ[$]O./%-L\/,V<.U@XXNW&N-,
M/W#<N0>-:ZKVBW3+R0[-><J5/HW6NFERJOT+A1V(R6M2;2:"-7*?-SU'N<@E
M$E!+/56G9* <H"*JN[J$GNM$]KN[KO>R 2H    "QF?!9.NOWI?-N[GO>4!R
MQ?@T7W)'@@+D    !%P.TEZZ_"G>Z[KO@)2@    "*B[NN5'7=MWMZ=M[6GS
M^3V("5     1B-WC-[7=MZNWW6G;*_S0$F     C%Z^,H_;Z= [W6WMD_P P
M"3     1DK=UNG[==O3+W=M[6KSOJ@),
M               &/+'^^5'W*/\ C) +.5D,$
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MI.[=VO8:;=VO;)[GL@$H             BZCKMC::_"F]>V[KO0$H
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M>"*    BZ=KMF:?&WM?9>M3]7TQ%2@J    (J+KURI^Z-_BT]Z7A& E0
M$6@C\:O'YO5F_#5WO]K^8!*     (M9'XUC'_P"7>T]DWWO]H!*     (J5K
MUFF:\_2K_%*[T_5(!*@
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MU(T]CZU/J$"+\           $95"UITPE<W1'_+M5>" D2YDBRD/H10
M     1=4UZKR\W2L:_A4]ZKU $H             B:J1J@.^FC7F[M/=)5Z@
M*E@0           !%U#79#UY^MM>%ZU7U/3$5*"H            BZIKU=&O
MM['XU/>J 2@            "/FZ[X7Y0G^G:KO5?4],"$@
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MWJ[VA?YS???4 2@    "+E&?6J9KS]*O\6KOB]0P$H
M                         #'EC_?*C[C'_&2!%G*R&*@
M              "PJ'P"=^3N^"8+#QKQ'_TPL7_=:/"4-5>?%+Y7YK^IK_BG
MVLC#@P   ? K@^C!RE410  4](5%1%    ?(KBVSX8_@-Y_E<3\6H9>%R2]M
M\I_!>=<-K!F/7     "UD?!G_<U^H$K#B@:]2A^Y(T]CZY7A&"+\
M   $;5-?%LO7VH]?Y;D^$ D"YDBRD/H10          1=3,RB\O-TK&OX5/?
M)]4"$H             B:N>D!X_6:^S3WR?5!4L"            (NHZ[(>O
M/UMCPO7)^KZ0*E 0           !%U/7H$>[L_C$]^G^7F )0
M !'S==\+\H3_ $[5=\GZOI 0D
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M/! 70    ")IVNR69[OA3G==UWQ$ E@    $7&W=<J>NNW>WIVWM:?Y<@"4
M    1:#5XT>[;:;#?=:<ZN]V_P!8!*     (M9GXRC]MM)AWNMO.CO=O]8!*
M     (N3NZU3]NNWI5[^V]K5YWU0$H
M             #'MC_?*E[E'_&2 6<K(0(
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MZ\_0H\_N?1 A>@           C*ENZA*V[MW1*[7=N_JDHP)22>8@D5
M      !&5(U=71IOW=*SVN[VQ/<DH!)@            (JIDOJ3NAGKV!=CN
M[HNY)2@$J             BZD9[8O(?PAKFW=UWI&$"4             1=2
M,^A;V[B^[LGV.[VQ/<I4 E             %A+[>%^4EY_<K 7X
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M >AX  BZBI241]%;-\EE/F=WZ("4     1-6T\72=VFFU/;;>?=WW8@)8
M !9S?@DS7FZ%SP0'W%^#1/<D:^Q 7(    "*IVFR9I\;=YMOG][_ /A"!*@
M   (J)IURI:=MTC>_M?:D^=V7L@$J     B4;/&SO:[NJH[G7MU?S@)8
M!%N='XTB]KNZ!_7M=>V;_G 2@    "*E[>N4S77[ZYM[7VI7G_4 2H
M                                     ,>V/]\J7N4?\9(!9RLA @
M                         "/JG^SIWY,[X!@K!_"S_P!NV&_^%H7@"I+8
M 0          !8S_ (%,]P<\[N?1Y!!R,?!H_N2/!!5T*@          +:3\
M'?U]K7Z@*X8&G48FFNWH4>=W/>\@(OP           1E5V^+IFNW;T1]MMT_
MK=B DD\Q"RD*B*          "*JNWJO+IITK.F[;[:GNP$J
MBJKMZ@_NTT[#MMNG;%W78@)4            !%5/;MB:_&F===O==\ E0
M         $74]O5V]VFWIX^FNWVU/=@)0            !&S-FZ#KMUZR6WF
M[E0"2                                                 ?GTOC!
M]1EWKQ(%=G"SF2^J]=M[UR98EUVM.73:.J%))*8:GF>F2AS[IJM2EI42DF1>
M8 V5NNT.(I5IX>M:^\>KK%6^1FI4:X[XMBW:=6JOX^?^YMT$URON%.85')!N
MOH;T4XDTDI.A .N6UBJ^[3MC@MN_(N#*]E.S\:8^K%LWKBUJ"U5*C2:Y*,BC
M3#I<MQ*'4[&S9W)U4@C(^8!RY7X>+\R[#X5;2Q_C2N<,UNLTJ^H]7@05(FIM
MAFH,).-%G/QU[6TU TZ+22M4DI2><@'H;PS2*RK"=B4NX,='BROVU!30JU9B
M8R8D:-)IQE'6["2G5*X[^WI6E$7*2N7EY@\C<.V#5,@6?:%MV)@Z<Q?$?B!G
MW+(XA8[$5$.'2J97'53^DJ27"D(<2TDXY1]-%=L6NI@,M9;LK,]U7Q/<>Q!6
M*2]1,_4FXHT*V+<AG3YMOPY"$M7!+KAFJ7+E.M\BVVS239$9*1M(!=YKPKDZ
MX*%QSPJ;C>M51>0,EV/4+588B*4JKP8:8B9K\;DT6AM*5$H^330P&TN(<4R,
M>\7F;*G;6/RLW&=>L.U6:3+IT%N%2I-3B.2$2$M$TE+9NI;,B7R:^: TR_B_
MFE,O *E*VEK<1;C]SAC;>2?G3U2QL9RT1UO&'I6O;$?TD/4VM;JR=*W[:C^D
M@-63IFO;4?TD!J2ITS7MJ?Z2"TU);J?P\G&SXOL5$2DJ,V:T1\OF>+9(UWFO
MZ>KU>UD8>)UX],[]/SK;;[:VG6TN,NI-*T*+5*DJYR,AY%LWG;1J/46?XEMT
MU%%)EL4-&%X,9BIIC.IB]*B?][2]MZ+<1&78D>H#T;  $74=21&Y_A36FGKO
M7) 2@    "*JAJ* ^9=MM1K[+UR?" 2H    "QFZE"DG_HE^#Z:?5 ?<77JD
M;W)/@_S@B[!0   $93]=DO3GZT[K[+UROJ>D DP    $7&W=;J?G](W^+3WQ
M^H0"4     1B#/QF\7F]7;\)7??V0$F     C%Z^,XQ?Z!WPD]]_9 28
M",D:];I^OMR_ 5WR?!,!)@
M     Q[8_P!\J7N4?\9(!9RLA @                           #$62<E
MT3'\1MBJT.YJNJJQY70JM^B3ZQT26T]DIY45IQ+9&2N3>HM0'5N%A1+X=<-+
MY='+6@+3O3L5V3>[^GSR ;#            L)^O4IGG]$O7V/KD^$0#GC_!H
M_K$^H N            6K_P:1[DOP1%<4$S.%$,_:DZ>Q]<KPA47X
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M<C6C2L@6[C";6#;OBZJ;-J]&H:4+,UP:<;:9#QN;"024FZE/9'J?F%R&"LD
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MA> 0#/X           +"?KU*9[DO7V/K5>H8#GC_  :/ZQ/J +@
M  %K(^#/^YK]0)6''!UZG#]R1X/K4^"0(O@           1U2U\7RR/VH_Y=
MJKP0$B             C*ERQ>7FZ5K7\(GO5>H!"3             154UZ@
M]YW8:^R+O5>" E0            $74==D37XVSI[+UJOJ>F"I0$
M   1E2UZ%/N[/XQ/>*_EYH"3             1\S7?#_ "@M/8J[U7U/3 2
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MW&L__'2!@>:_IZO5[63A?C].E^H0>1;0   !$U0RZ.*9Z?"6>?;W7?&0"6
M   1-6-)4Z3NTV[2[;;S[N^[$!+     +.=\#F>XN>" ^HGP2)YW0H\$!=
M   (BF=I,Y_A3NNFWNN],P$N     B8FWKE4TUUZ5O=VOM2?.^J E@    $4
MWM\:O:[=W56^YW=LK_. 2H    "+<V>-(_-NZL]W.O;-_P"< E     $5+T*
M92]?;7.Y]J5Y_P!0!*@
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M=W&G:>SMMO=I[HTI E+@            (NI[=D373X4SSZ=UZ("4
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M]MIVS?\ F@)(    !&2=W6J?IKITJ]>V]K5YWU0$F
M                        #'EC_?*C[E'_ !D@%G*R&"
M              +.=\$F>XN>").0?BYD?#*A^6R_QZQ[;!?D4=347OQ3UN,9
M;I %>8$4!0      4'  %1S     !4@23F /2 4!0   'Z3/X8?_ &G6]_Q#
M7?\ UBAY'S;]1/5#;8;X'H4-:[P       $;4]?%\O9NW=$>FW=N_J]D D4\
MQ!(J           ",J6[JW)NW]*UIMW>V)[D!)@            (NI[NHO::
M[NP[7=W1=SHH!*             (NH]I%TU^%-<V[NN] 2@            "
M-J6[H$;-=>E9YM_MB>Y 20            "/E]O#Y_A!=UW*O.^J D
M        !T:I9$L&BS7J;6;ZM^D5%CD?@S*G$8?;]%2'%I-/I&0D3:2[+"G1
M*I$CSZ?)9FPI2$NQ)<=:7&G$FG<2D+3N2I)^>0MEBI0$
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M     BY>O6J;[LO3\&K7[%7JD!"4
M           !CRQ_OM2]RC_C'P6<K(8(
MLYWP29[BYX(DY!^+F3\,J/Y;,_'K'ML%^11U-1>_%/6XQEND 5YP10%-#!%?
M3 4!0!7F!% 4/G! %    5YP10%  !4@25 4  'Z3/X8?_:=;W_$-=_]8H>1
M\V_43U0VV&^!Z%#6N\       !&U0C.G2R_T1Z_RVJ\$02!<R1RE(?0B@
M       BZH1G%Y>;I6-?PJ>]5Z@"4             1-6(S@/$KO/#3WJO!!
M4L"            (NHZFB'KS];9T]EZU7U/3!4H"            (JID9L-Z
M^WL_C$]ZK^7F@)4            !'3-=\'7XPG3V*N]5]3TP$B
M   "3(\*<?T+',^C5V4[P(7%Q+)=N:X%-YN6S$W7&CQE(,I&DYU+B=GWK;VO
M8:IYQQNH_P".CDL^['^/KRN5[/\ R5<_+HZ/4]D,9L1H^/K+9@V<[CZ&S18B
M(MBO$A*Z0VEI.V$KHS4C<SVO8JTY!W7W+7/+;TN%.1D8<%
M            !9R)#$5ER1)=1'892I;S[BDH0A*>=2E*Y$D MJ=5:;5V"ETF
MH1JG#69I3+B.H>:-2>V+>VI20@2H   (N;4:?3V),NH5"/"B0D;YDE]U+2&4
MJYE.*4I*4EZ8"Y:=:D-H=:6EQEU*5MK0K<E25<J5)47F& Z/0\:X[MFL3KCM
MVQ+?H%?J/+.KE.IL:+*=W<YK>;;0H]VO+V7+YH#CDX[QY)B5VE2K+H;]/N^H
ME4[BI[L&.IJHSDFE?6)+:BVO.$;1'N/4^3T '"[9F-+M7<DQRW;>N$[E911K
MND]6C2NNM1%&:(<Q6U?2$RKF0OD+7F 7SF/;$<=J,IRS*(_(K%-CT>K.N0(Z
MSE4^-RL1']S9](RV9ZI;/L2\X#*X[9L"R\?P9T/']G4*T"GJ-UZ/2H;$!IY]
M)'L4\4=M.NFA:^<7, \Z<_Y"+%66L5W)Q8/4-^V95OW+"MI%AP:FM\IBWJ<I
M76DONK-2>B2>PT:=EKJ7*0[+K"3B9U8ZV)C;BZO[O5OLEMOK=<_?)X"O:[P\
MFS?MQW_3]YFC2TW!O+]F=,^]]?OD<!7<W=Y,G?;A]/WF:-)P;R_9G3/O/WR.
M KN;O\F3?MPX!>9HTKP;R_9G3/O/WR. KSKO\F3?MQ> 7F:-*<%\OV9TS[V3
M\'<2?";?^4[7M+&"+D_76IIF'3"GT^4S'T8CN.N;ENKT+L$JTY#'7>>3UW$:
M\QDZ67A/+<)<WD5W=,ZT9.5Z5C';EUOQ!0TUMRXTT>"BXG8Y17:\F.WUQ4="
MMR65/D72F@U'VFN@#L@  BJAKMB:_&V-/9>N3_+S $J     BJJ9E3Y.O<EK
M[+UR?" 2H    "PG;NJ2C_T2_!]-/JD ^HFO5(WN:=/8^FKU0%Z     BZ=K
MI,_*W?"]<KZGI )0    !%Q=>N5+U[>OX-/?'X) )0    !%-_[5D>?U9KPE
M=]_9 2H    "+<-7C2.6O_V.]X3???V0$H     BY6O6J9Y_2K_%J[Y/J& E
M                                            8\L?[Y4?<H_XR0"S
ME9#!                            %E.^!S/<7/!$YA^+J3\,J'Y;,_'K
M'ML%^11U-1??%/6XQEND          %?3!% 4T,$ 4 5] $4!5?2!% 4
M  'Z3/X87_:?;W_$->_]8H>0\V_43U0VV&^!EKB?XE:9P]6HM<2WZC>>1*[
MJ$BR+4I\5Y]#G4&ND?ES76R,F8L9*DK=4:M=.1/*?)KG>M,=<1L5?"I9O$3E
MAQ, JG0(U3KK-#BOOFIZ2]T#34*,DW'%FZX:$I29GJ9Z&>@#K'"%Q)7MQ#5#
M-SEW6<BQ8]B7/'I=NVX^VI%3C1'F%NDW4MRE$;_(1F22+3< WB     1E4U\
M72]?:CU_EN3X0"23S$+*0J(H          (NIF912U]M9_&I[Y/J@)0
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M6?,N8/RQ<M"O1VU*!0[JH=?I%,.E$VBK*>;<AK:-Y[<EM;9&A:CW&7. T?\
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M^W7;TJ]==WM:O.^J DP
M  8\L?[Y4?<H_P",D LY60P0                           !93O@<SW%
MSP1.8?BZD_"ZC^73/QZQ[; _D4=347OQ3UOCU!ENA0%      !7F!% 4
M  #G! %5YP10%5+S@0Y@% 4 5YP1^DO^&%_VGV]_Q#7?_6*'D/-_U$]4-OAO
M@;,\045<G!^9>J0U2JD[8UP,1D1VEN/K)V \1-)V)6I9FK3D+G&N=[&O!139
M,3A,P13:O3G84R';$3K%/ELK:=9>0XLRW-.)2M)D9:EJ Q9P;4VJP<P\<,BH
MTV; 8JF5CD4]^4PXRA]KH%(Z1E2DI2LO13R?T /0X    !&U+7Q?+V[M>B5V
MN[7^KV0"13S$$BH           (RI:]6Y-^_I6M-N[VQ/<@),
M !%5/=U%TN=?8<J=W=I[G50"5             1E1[6)S_"FN;7NO0 28
M         "-J.[H$;==W3,\V[VQ/<@)(            !83.>%S_  @M=->Y
M5YP"_             44>A"3-@\5[538MZUC(%TU3A]P;3;.E65>%V6!"G4-
M"YT>3;M75!4=PS%:)2;ZS-2D-I(T:\YF.$3-%U-4Y8BFJ,UE7-TS^UWUTS-[
M$6Y:JJ9GGMB,O5^QZEX5J].N'$>-*Y1;=:M2DUBVJ7.IUL1VB:8I[3\5#B([
M*.Q)*$:Z)T+F&3?TZMY5%MK%NJM:F)9>'4Y@
M  QGDC%]@Y>MB59F2K7A7;;<MQ+CM-FMFHDK1RH=:6G1;;B>0R6@R/4!TS%W
M#7A/#=%N&@8^Q]3J-3[N;-JZDN])->J+:D*1T<IV4IU2T;5&6TU&GE/D 66,
MN&#!^(;AD738%A1Z+7EQ5P(DYR1)EG!B+7O5&@IDO.IC-&HBU2R22,_, <T#
MAHP[3+=LZU(=J='0; NL[VM:%UN291JZ;[LCK1&;FY>KSRSVK,T^@ BF^$S
M:+Y3D$[$:>N JN=?3'?FSGZ<FK=)O.<5/<D+BD_KV1*Z/4CYA!>7%POX2NFL
M9*KE7L\E5#+M+\39#6U,F,M5&,A3:B4ZTVZELG=6DEO2DEZ%INTUUHPQ7N"F
MSKXSC>M[Y ID"X<<U6RZ#;-L6RU*G1IL1='-9.DZ]'6UN9?;VI4A2U$O311
MK.5U<-6%KPET:96;):2Y0*!^J<1N!)E4]M=",B)-*>1$>92_'+D-*%ZD"+=[
MADPM(IN*Z2[9YDQA-TG,:NMS)C3]-22TN&R3[;J5N-J-M.K;AJ2>FTR L5E\
M,.$:E:%;L.HV(Q+MBN7+)O"1"<>D=,U79KG3.SXTA#A/,.[S-1*:66G-S<@#
MA;X6L&,8XG8E8L1ANR*G4V*Q68!/R>LSJC'=1(;E2IAN*?><);:=36HS_FY
M5D*%CBRZ+?MQY7@4-W]>;BHT6D5NJ(=4I<B%3C6Y&8)E3G1D9&L]%)(M=>4P
M1YD\65KP.)?(N(K5RDY4>&*D42D7'4:;<]VN4AUJHODN T49GHIZD)4E)[CW
MJ(].8C&9@;^NYO-:F+>3(ZKVB*HLF;&!_H^N'W_&[;']%)_^Z(W/$K[PI[?<
MQ-WHVO32^OH^>'S_ !O6S_12/_NB'$[[PI[?<=Q1M*?1]</G^-VV/_[1_P#=
M$.)WWA3V^X[BC:/H^N'W_&[;'_\ :/\ [HAQ*^\*>WW'<4;3.G#+P@8>Q7G&
MR;YM;BCH>1:[2_&"8EG0_%W6)1/PW&5J3T$UY2MA*WGHCS.0QB8S'7EY=335
M=S%O/RNVYN:8FVVU[$#2LMU_QY1RK7ZO>-H/CXX_7?$O3M]<ZKKT?3=7W;^C
MUY-VFFO( [   (JIZ='%U^-,]MM[KT0$J     B:MIXND;]--I=MM[HNZU2
ME@    %E-^!S-?:7/!]$!]1-.JQ=.;H4>" NP    $73M-)NW3X6[IIIW0"4
M     1,7;URJ:=MTC>O:^U)_ER@)8    !%-[/&KVNW7JS>G:[NV5_G )4
M  !%.;/&L?M=W5WM>UW<[?\ G )4    !$R]O6Z9NY^E7T>NWVI7G_4 2P
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M(_%S)^&5#\MF?CUCVV"_(HZFHO?BGK<8RW2J?*"* H7." *>B" *
M   7." *        _29_##_[3K>_XAKO_K%#R/FWZB>J&VPWP/0H:UW@
M   (NJ[?%TS=IMZ)7;;?[7( DT\Q"RD*B*          "*JI(ZKV6W3I6=-V
MWVU/= )4            !#U?3J#NXDZ%L[;;W:>Z)1 J8!            $5
M4R+9$UT^%,\^G=>B1A E0            $55-.K(UT^_L=MI[:GSR,!*@
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M]IT/A/J5H6'&H4_*%YIB7-:95^!**8I#+SC%+34V4.L]!(2E3RGD<VPD&79
M.[7AQB*M.VN)VXE6 J8OANKE(H[\$JDDO&JZFF(I2TK-DR9Z,Y.T^16[;YFH
M#LQ<1UY5G/=0PA:6*%5QNAT:AW'<]YO5AN)&@4VLI7O4<=3*W'7&].P;0?9\
MJM4Z -6>'3BPRA:^.K$J65+-KUVV#=60ZG9Z\W3JM'?D(ES:N]'IJ3INSISC
M(426.DW<FG(1^:&QV0>+63C7)=&M*X['A,4.MWE3[-@/-W'#=K[RJ@6B*L5$
M:2M2(9.'LU<>2YH6[9H Z;D'C;N*S*MF\X.#)ER6=P^W! IN0[P:K<:-LA3V
MF'$R(\1UKI''&S>U6V1Z$DM=W+H0=[OCBANN+D"N8_P[A6I9CJ=D6_3;FOU<
M>JQJ5U:+5DF]#CPT/H<.3(=:0:B01I+F+=R@.JY<XW&\<735[6HN,G;AFV1:
M\"[,F1:I7(%#F4V-/:-]$*(Q)-SKTU#25+4VV>GF;N;5 V)NK(M)K6 ;ARI;
M\F>Y0ZC8\NXZ0]">.%4"8<IYRFC;>-*S8=)/*1F1[5>88#56W.*V[X%'P99-
MCXIK64KGR#B1B_H3U8N*.S+0A@VFW45*<['23J]#UZ0D:K49%M3KJ0;:8(RY
M3,Z8HM'*E+I3]$CW/'==?HDA:'GHDAAY<=YDUHTW$AQI1:EIJ1'R%S ,"4CB
M[EOYDLS$MPV)"I,_(3U9CV\S!N.'5*E ?HZ''FT5J+%;4B(4M"=6]KSAI[59
M<X#3J=Q-\5J< 99O!RC,PJK3\P?JU$NA%5AJ7 8\;M1':3'C]7).UH]L<G]-
M3)Q3OV(#8[(?';,Q[6Z_1)^*FI\C%E(I=2S>35RT]AREOU!OK#D.D-/I)54<
MC-=FYT9(\Y/* [=D#B[N&CWQ6+*QEAR5DU^FX[A9+1545B/2F/$TG>:S63[:
MCW[$)Z-"-34H].334!T*H\2^5;VS)PA2,8VR3V,\R6O4+CJ5#EU"/$?DZ-,'
M**2:FG%$=+;7TB$-J^[FK;R;0'-9?%4=NV=*CT2V[GR1D.^,PW18^/K1K-:8
M=>DO4QTW'WNO.,H1#@L-(-9)4A1H(R3J?.0=JK7&NY:^,\GW1=&**A1LA87N
M6D6]?V-BJ+#^Q=:=:3%D0J@AOHGT/-N[VSVIY>Q/3G 91PYGVX,@Y&R%BF^L
M7RL8WM8D*FUM$!=3C51J72JL:B8=Z6.E*4N)-M1.-\I%YA@/.[^, AMR7P_D
MM"5E_P#I%V!EK_X4,;;R3\Z>J6-C)LICK_9+Q=ZK%^+-^P(>HL:S6DZM%^*M
M^P(+"V<YU>+\7;]B06%LG5HWQ5OV)!9!;.=NM_#P891Q?8K-#2$&3%:/4DDG
MD\6R?.&O\U_3SZO:R</5;7'IG?ILK"*H[2JDW1'V(M8<B.E2)<A)N,-REH5T
M2W"+E-"5Z&9%Y@\BV>5Y/X'L:[[#_B'7; R%D"5DV^JIB5BK7+=DAA$1KIY,
MU"51849&J68C!-D3:?YSY3 >OH  BYYF2(VOQIKPO7)_EY@'.E     $553,
MH$D^]+7V7KD^$ E0    %E-UZG)T]J5KZ6WUR?" (FO5(WG]&GU/35ZH"]
M   1=/UV3-.?K;OA>N5]3T@5* @   "*B[NN5/S][?XM/?'ZA )4    !%H,
M_&D@O-Z!KPE=]_9 2@    ",6:_&D8OL>@>\)OOO[("3     1<K7K5-\_I5
M_BU=\GU# 2@                                           ,>V/\
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M( JI@D* JOH B@*_29_##_[3K>_XAKO_ *Q0\AYM^HGJAML-\#T*&N=X
M   ".J>OB^7K[4?\NV3X0"_+F2+*0^A%          !&5,S**6OFNLZ_A$]\
MGU0$F             BZIKU%W_,U]FGOD^$ E             $74-=D3\K:
MT]EZY/\ +S 5* @           "+J6O0-^[L?C$]\G^7F )0
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M[J$@B[;:6OLO6J\$!*@    +&:1G#D^Y+U]CZ2O4 E]Q=>J1O<D^#_,"+L%
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MFF;8LAL;BF::;);TC!=H       ".J1&<"61^U'_ "[57@@+\N9(LI#Z$4
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MZ0#V7](#C=+[FOTA4F'J=1?]D4G\BC_BR&VC(^OW'P4]4>Q*BNX
M %M)^#R/6+]0%<,#7J,/3FZ!OP?0!%^           ",JFWQ=+W::=$?;[?[
M78@)$N9(LI#Z$4          $95-O5#W::=*QVVGMJ// 28            "
M)JVG4'MVFWL.VV]VGNN0!+             (NJ;=L3=I\*9Y]O==\ E
M        $75-G0-[M-.L1^?;[:GN@$H             C9FW?"W;?A!<^G<J
M 20             )(\3*?Q+SJ)>&3ZEEC/DBW;NFV==T5>/7XL=EZT[A@U8
MHU%B4B&I@W'GW8VCB5JW]+N-6N@ZZ)MNIU>69BF8G]Z?BILYHC)VNZNFF+R-
M;DC6F)_@LY*NOGAZR8FJETUK&6.ZO>\7J%WU2WJ=*N>":-AMS78K9OI-O['1
MPSU+S#Y!DWU---<Q3D8MS,S1$RR>.MV
M#1G.N$<^7!G.S\V8-O&T+;J=O6?+M67'NJ)+F(<1+F=;-;3<8TI+7:2===0&
M)KOP9%Q+PZ\1=8SO=D[(N0L\2D3;JKULT:0YLJS+9-T-BG0(R7'4HC.MHVJ/
M3EY]I .YX?P-D-?"2JWKAC6]*S-EA\[MR2B^Z8JI4Z14ZDXTXN/-BLN-K2II
MAMMLC2K5M:>0C,!AC(O#WE#%_"SQ7KK]>C5*/>EOQV[6Q!:!U2=1Z,<=2$NN
M02JBWY1N2#T-22T06TM" 9BL;AZR]=]5IF1\I7Q0)LVD8GE6/C:ETBGR81EX
M\BMD_-K'6%+T>[%*#0SV!:&9<O( D;)X4KTMFF\&4&==%'E-\-T&M0KN2UU@
MO&)52G=1(H>J4[3(SY>DTY.0@'4Z)P<Y8C46Q<)5K)=O3.'3'%X,W918\:G/
M(NJ8U"GN5&'2Y#YK.,A#<A6JGD%O47)HD!.7=PD7Q<-H\9=M0[HHD>5Q)7'#
MK5JR'2D='3V8R(J5)FDE&XS/H3(B1J7] "YOSA3R7<EUYNN>U,C1K)F9,QK;
M=ET"JP^LE,ARJ+(-V2;JVC;-+,EO5HS0O>25'IR@.R</W#E<^(<M9%R76CL^
MBT*][9H],1;-L]=Z.#(I2G#6ZX].^Z/$Z3AK4XLR5KSI\T!HG_$PJM/S36\)
MTS#LYG*E4HC5PR*O3;065:?BM&4)"7'VX1NJ0A2N351#:>4511?3,S9R,?%4
MS-'K>9?R$YR^9N^/(-0]Y'I=XN]J-+7]U)\A6<?F9OCR%4/>0WB[SQI3NYS>
MU3Y"LY?,Q?'D*H>\AO%WGC2=U.8^0K./S,WQY"J'O(;Q=YXTG=SF]K;O@1Q3
ME.V>*G&=8N7&ET6_1HK-71*JE2H\J+&0I=/>2@ENO-I2G<9Z$,#S.^HJP]41
M,<WM9&'HF*[+/3E?I)'E6Q    152UV1=-=.L-=KN[KO3(($J     BJGNZB
M\9$K7:7:[NZ[TTJ 2H    "TF?!97N2_/[GT %8OP6-KS]"CP0%T     C*=
MVLO77X4[SZ]UZ)F!"3     1<;7K=1W;M-[?-N]K3_+D 2@    "+01^-'NV
MTZ!ONMO.KOM/ZH"4     1:]?&3';:= Z?V6WG1WVG]4!*     (R3NZU3]-
MVSI5Z]M[6KSOJ@),                                           &
M/+'^^5'W*/\ C) +.5D,$                >/9XTS-PZ0\WX8<P#5N(SAY
MS!6ZC7*&]:E5:@5>%XW,E2X<Y)J0XDB-);7$'YG(HM320=?QCPO97LW /&2X
M6,9%DGF&B]!C##[56.O56*S&8=;)IV0M2DFM:G"T+=KSZZ<F@;&W';G$7:O
MGC6V<,TJ=0\MT*WK<C5ZBL%';J[$1A""J<>$;^K292229),_1TY= &!\38:R
M)-XHZ;>\O'>3;8L>[<85RVY%XY JJ*U6D5%_D4Y.<0\]U+=S--ER*TW:)W:
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MNUZ)7:[M?ZII4 DD\Q!(J           "+J1*ZN1I-6I.M=KN]L3W*D@)0
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M    !%2M>MTW7VYS3V"N]5X1 )4
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MT-FW$[=MJT"YGJ'4;8>KT%F<_;U8;ZO.AJ>3N)B0WR[5IUY2(!W(
M!;2?@\CUB_4!7# UZE#]R1I['UJ?4$%^*@          (VJ:^+I>OM2OY=JK
MP0$@7,D64A]"*          ",J>IQ?0Z5C7\*GO5>H DP            $35
MB,X#Q>LU]FGO5>" E@            $74==D37XVSI[+UJOJ>F"I0$
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M,S)A'G=.S^-3WR0$H             CY>N^%K\8+3V*N^3]7T@$@
M     P_?V7['QG7+"HUZU+Q(K(E0E4RBU=_8U3VY,2,J4I,J4XIM+72-D9(U
M[97(0XV15.KT3.C+[2>2-;IB-.1YB4C'<NIOL53#G%W8MK8BK%(KMOT>+7HL
M5-R4:B5RIG,J$6-TLAM"U)>2OHG'DDI*#+D/D,2FBV-2OEB8ICDRS3&2)]DN
MV\O*K;8RQ5-71%4\DS&BVQZM8ZMZW;1L2S[8M*0B;:]NT>'3[?EH=2\ER&PT
MAMISI4ZDO<225J7(.Z\KFNJ9ET44ZL6,@C@Y
M #7'B(SLS@"U;=N-=F57($RZ+C@VQ1K;HJV$RY$V>ESHTIZ=24GJI&A$6G*9
M *8BS9<F0H5UU&^\,W/@BGVPEAQ,R\UQ6FI;;I.*=<:<;<4DB9Z/LS49%V1
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MRNKZNJNR6U\G\WQ-_BJ*+RNV)M]C=@9SW    ",J7:1>V^$M=KKW7H ),
M !%U77J,C9NW:)TV[MW;=[R@)0    !8S=>J2--=>B5W7<][R@.2+\%BZ^U(
M\$!=     (NG]K+Y_A3O==UWP02E     $9&UZU4->UWM[=-WM:?/Y/8@),
M   !&(U\9O=MMZNUIVVWME?S ),    !&+U\9Q^VV=7=U[;3MD_S ),    !
M%RMW6J?INV=*O=VWM:NY^J E
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M[NJ]CNW](UIMW>V)[D"4D             BZINZB]IKKV':[N?>GN>R 2@
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MJMN4V7;]!:02$08CT9"V8Z4)Y/N:5;.3SAW7T3%Y,3-K'NZM:FW(RP.MS
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MC6/RIW&P]R]CN[9OO=?\H"7     1,HD]<I1*/LNE<V'V/M2O0]0!+
M                                      QY8_WRH^Y1_P 9(!9RLA@@
M                           "PJ/^SYWY,[X)@L/&O$G_ $QL7_=2/"4-
M5>?%+Y7YK^IK_BGVLB^B.+7@*J(   IR$*BHB@  XG/O2P2<CU-HO^QJ5^0Q
M_P 60V\9'UZX_+IZH]B5%=H          +:3\'D>L7Z@*X:?\!B::_>4=SW/
M>\@(OP           1=53K3I9*TTZ(^?;_:2HOZH"33S$+*0J(H
M (FJ$GJI;MO(\SVVWVU/=$H!+             (BK:*@O$HB(NP/LMO=I[HE
M)!4N"            (JII)2(FNGPIHN73NO1(P$J             BZH23CH
MW;?O[/;:>VI\\C 2@            "/FZ;H6OQ@O.[E7G@)
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MVRXB$RXVDG(^BM$O:Z*,CV\G*"M[ 0 1=0,R:BZ\_6FM/9>N3]7T@@E*
M (JJGI3Y*N]+7V7KD^$ E0    %C.,RAR3_T2O!]<GP@%8FO5(WN:=/8^FKU
M0%Z     BZ?KLE_E;NOLO7*^IZ0*E 0   !%QMW7:EY_2-:_@T]\KP2 2@
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MJ1F3"?=V?QB>^2 E             $=,U)<+7XPGP5=\GZOI )$
M   !JMQ.7U?-J6_8=JXWJL:V[TRW>=/LRFW;,C%,12FYB'GWYA1CT)YQ#;"B
M01]B2C+4<8BJNN*8Z9GJIBUV4T6T35FL[9="PL[D6T<U7A@G*E[1<Q-P[1I]
MZ6O>\FC1*;44M2)CT&3"EHC%T3NUQ!*0HN70^7F'939-%4Y-68CKB8F>RQUU
MT51JSEB8GU3%GMM;O--MLMI;:0EMI!;4(2G:E)>D.(N
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MW^,X_(>TF'2^R[I'>Z?U@$H     BY>_K5-T]N7^+5WJO5(!*
M                                 QY8_P!\J/N4?\9(!9RLA@@
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M35/@+Q%KN[#M=>Z3W*5>" E@            $74-=D;\J:T]/=ZU020E
M         $74C7T+>FOW]GE+=[8GN4J_EYH"4             1\S=TD/3FZ
MP7@K[U7U/3 2             #".9L&V#GF@4NV<@QILNET>HMU:F%3IK]/D
M-RVFUMI<2_&6A9=BX?,..KRVN<5S$3&?]C7,_P"'/PU](N6<6\>MK1T*YOZU
M5?K!L:Z]&;O6-^W=RZ:Z#DX-S+7MBFV9;5!M.AID>*+>@1Z?3"E/.27^@CH2
MA&]YU2G%GM3RJ4>HY5US7-LI33JQ9#MPXJ
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MOW\#WS=7GY/+]/&7]/WG1I:GA?E_A]OVJ_OW\#OS=WGY/+_[H"?3]YT:3A>
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MVR40#80           %A.TZC+UUV]"OSNY[[D <L?X,Q[FCU A970(
M    "VD_!Y'K%^H"N&G:=1B;>UZ%'<]SWO((B_%           1E4V^+IG:Z
M=$?;;=O];L0$B7,D64A]"*          "*JNWJI;M-.F9TW;?;4]V E0
M        $35M.H/;M-O8=MM[M/==B E@            $54]NV%NV_"V>VT[
MKT0$J             BZILZNWN[7K#'/M]M3W8@E!0           !&3=N^%
MKS]8+3M>Y5W7U (28
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M8Q--?A37-KW7H&0"4             1E1W$PC3?]^9[77VQ/G*2!*3
M       6$SMH7Y07G]ROS@@E?@
M          (M-2IYQG)Z)T=4%G7II1.HZ)&SGW+W;4[?- 7Z5)<22T&2T++L
M5 .4  =/H-IVS:\BO2K>H$*C2;GJ*ZM<,B(TEE4V>Z1)<D/J1IO<42=#,_0
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M)=-_%$T_>SM,ODYX"O\ $K?_ /RE_P#5#>]YB]BG2Q=2ZZ%?DYX"?\2]_?\
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M)OO?J@2E     $7*UZU3->?IE_BU=ZKU2 2@
M                   ,>6/]\J/N,?\ &2!%G*R&*@
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M#YNE8U_"I[U7J?7 2@            "*JI&=/>+UFOLD]ZKP0$J
M    BZANV1-?C;.GLO6J^IZ8*E 0           !%U+7J[>OM['XQ/>J_EYI
M )0            !'3",UP]>;K!>"KO5?4],!(@
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M36MA3^(3<=CVBNHS(A8@CU.K5FKRW)]2J-1E5!/6IDN2YJ;CCFA:Z<G)R$1
M/70  1-1UV1MVW3K37/IW7HJ3_+S $L     B:MM*G2-VAEM+E5IW7?*3X0"
M6     6,W7J4KW)>OL?33ZH$N6)\%B>YH\$!<@    (FG=K,T^-N^=W7KE?4
M](!+     (J+KURI^?O;_%I[X_4(!*@    (E*B\:O%]EU9LOL>[5WV[^J E
M@    $4M1>-(Q:<O0/=SW37HZ_Y $J     BI6O6Z9KS]*O\4KOB]0P$J
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M"23S)](64A]"*          "*JGP0M=/OK.N[3VU/GJ3ZH"5
M 1%6Y(#Q'R]IR\G=)[I2?" 2X            ")J.NR'KYLMK3F[KT5)^KZ0
M$I8            !%5,R)A&I$9=.R?9;?;$]TI("5             1\WMX7
MY07].U7?)^KZ0"0
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MNIBJ[LCDY;7;<W=,56Q-KWA&@9K"[&%;&CYFJ&>FV9AY"J-OM6O(DJD.=5.
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M5[VVPWPO3<:IW@       +&=\"DZ:_>E^?W/>\H#FC?!H^O<)]0!<
M     MY/P:1ZQ7J .&#KU*-KS]$CS^Y[[E 7P           (VIZ]0E;=^[H
MCTV[MW]7E 2*>8@D5           !&5+=U8MF[?TK.FW=[8GN0$F
M     BZGNZB]IKOU1VN[GW)[GL@$H             BZCKMC::_"6M>V[KO0
M$H             C:ENZ!&W=NZ5GFW^V)[D!)             (Z9V\/373I
MT]UW*NY^J D0                                           >;7$1
MF2[,3<76(':1;EY9%H4['E=5.QQ:1]9<E22FLI:FN1%.-MKZ$N0C/FW=B QI
MCGBAON@TCBJS-4;3N%RAV[D^W6JU8-U2%L3[:MZ5#BQY[C3">F2A3)N=8Z-/
M8FG4]2YP&?L@<6U:MJG<4-S6W9T&X[0X=X-';A5A<UQ!U>M3T-2)<-!H0HD(
MCLOM'N(]34KFT <E#XLKIM^Z+EMW.V,F<?)B8_EY/M692:HFL=8HU/4DI4:4
M1,M=%*:-9:D6J#(^17( ML>\5>1*G=.'V<J8@C6!9?$&AQ>):Y"K":G+;>ZH
M<^+&J[!--$RY(C%N2;:E)(]4F P9P-<2EV7I,I>$H;CUZ7!0*I=-<RO>5QSW
M3>I]-.K/M4R' 2K>N6XHEH(^4D-(TU/4R2 S9$XP:O'S?86,:];ML.P,B7#4
M[=@1Z!7RJU6H[L%#CC#U6Z)GJ:2D$T9]$V\;C>I;B,RY QSA+--\6MC;+M<E
M5JFUV:K/ETV]$K-\UU4"!2H#2VU(22W"=D/)1MV-1HZ#4HU>81& GF>/$Y6%
M[;OMFS*:=\75D";CFBTF15%0Z$NH0#4;U3=J#[*7&X:6TDYV36_EV[3,P'RK
MCIKZL>PJY QG J]^0LK4W%U?MN%5R72Y,BILN/1IU+JALI0XPXE)$2EH+;V6
M[FY0@:EQR9>H%*R75J]@BD-1\"W3#H69YT2Y#4RTU4'&4M*I251B<D.(0^2W
M-Y((O,U\P,H3,Q.T/B+SY%I-&D5239^+Z#<,(JE<ZH5(E=9?=2VCJ\K2) ,N
MV<?UU47F'R$ [5P^<3$W+V0,CXWJM-H+M4L&GTJJLW3:<^1/H\YBII<T:;7)
M88=W,N-F6]*5(5SI\T%:(_Q@/AN #+_]8R_J0AM_))_YIZI8F,^#UO&,>I:P
M   !NC_#P_[OL4>X5K_XU\:WS3\BKU>UD87X_3I?J%'D6U    1-2(^CC:_&
M6>?3N_12K^7F@0E@    $35B(J?)WF1I))=MM[KODJ3_ %0$L     LYOP*9
M[DOP0'U$^"Q/<T>" N@    $13"["7MT^%.\VG=>@E("7     149.LRID1_
M^(WR]C[6GT/5 2H    ")1M\:O=KNZLV?V.O;*[W7^L E@    $4LB\:1^UW
M= ]YI:]LWWNO^4!*@    (J21]:IA:\O2K[GVI7H>H E0
M                            8]L?[Y4O<H_XR0"SE9"!
M                %E.^!S/<7/!$YA^+J3\+J/Y=,_'K'M\%^11U-1>_'/6X
MQE.E^A_^%)_VU5C_ ([J_P#Z>(/*>=_G1U>]ML-\+:3B(S[3L"VK%GIMRK7K
M>ER]<C6-9U)BNR79\N*R;ZS>4A.UEAE);W%J,M$\VHU3O6?"/EBZ,W</U@90
MO)N Q<-SMRW9[5-;6W%W-2G64;$K-2NU07F@-GP     !8S_ (%,UY^@<\$!
MRQO@\?UB/4!5R"           M9'P9_W-?J!*PXH.O5(7G= WK['^;U 1?@
M          C*H7_MTK<?_A'KKM_M)4G^J D2YDBRD/H10          154+_
M %4M=/OK/;:>VI\\E )4            !$58DJ@/;M-I;.VT[I/=)5Z@"7
M           1-3TV1"/3X4SSZ=UZ*5 )8            !$U,B.,WNV_?V.V
MT]M3YY* 2P            "-G%V4+\H+SNY5YY& D@
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M5*"H    BHV[KM2]T:U_!I[Y7@E]4!*@    (M&OC227F] UX2N^_L@)0
M !%N:^-(WN#VGLF^^_L@2E     $7)UZW3M?;EZ>P5WR?!,!*
M                                 QY8WWRI>Y1_QCX+.5D,$
M                     64[X',]Q<\$3F'XNI'PRH?ELO\ 'K'M\%^11U-1
M>_%/7+C&4Z7Z'_X4?_;56/\ CNK_ /IX@\IYU^?'5[VUPWPM^,CQR?L2]2;8
M-^4=NU9$9*4;W"4N*M.UO;RZJY.0N<:ID-7/X>%+JE#X0\0TNM4Z;1JG$BS4
M2Z=.CKC.MGUZ09$MMY*5%R?S@-X@     !83M>IR_<EZ^Q]<GU2 <D;7JS'N
M:/4_G 78           +23KU9_W-?J?S ..!KU.'[DC3V/KE>$8"_
M    !&50S*GRC_T1Z_RW)\(!))YB%E(5$4          $74S,HOG%TK'XU/?
M)]7ZP"4             156,R@O'ZS7V:>^3X0"5             1=0UV1-
M>?K;6GLO7)^KZ0BI05            $54=>@1K\89\-/?)_EY@"5
M     6$S7?#_ "A/@J[Y/U?2!5^"
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MK[4C3V/I)]00A?B@          (VJ;^H2M.?HE:\_P!1*O4 2!<R192'T(H
M         (RJ;CC$1%SNM=U[8GN4J 28            "*JN[J+I=EN[#E3K
MW:>Y2KP0$J             BJENV1#+XTUIS]UZ"5 )4            !&5,
MU="@BW_?6>UW>V)[E*@$F             C9F_?#T]O+^G:KO5?4 20
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M8^FW=U9[N===S?\ G )4    !$R]O7*7KKNZ5S9VOM2O/^H E@
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MMZKV6FG3L\^WVU/= )4            !%5;;U![=MT[#MMNG;I[KL0$J
M         BJGMV1-=/A3.NNWNN^ 2H            "+JFSH&MVGW]CGV^V)
M[L!*             (V;ITD'7XP7<]RKNOJ )(
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M)'[9U'^E/V@PN^JSO%<9QOB2?*CDC]LZC_2G[07OJLYQG&^))\J61_VSJ/\
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MHJI'+4]IL.=UW2>^T_J@)0    !%24JZS3R(S/[HOE[+VM7?%_E 2H
M                                     ,=V/V]1]RC_ (Q\19RLB"H
M    -)[NX"N&J]KLN:^*]:54=N.\)[E3K\R)6ZC$2])=+LE=$S(;21D9<Q)
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M'W9B>IZ C!9(       "RG:]5F>=T+G@_P WJ@.2-\'C^L1Z@*N00
M   %M)^#R/6+]0%<4/X%$]R1X/\ ."+X           $94]2I\HR,]2:5VN[
M^RI)_P!8%28(            BZG\'(TZZ=*UKMU]L3YRD@)0
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M     1=/UV3/RMW7V7K4_5],14H*@   "+C;NN5+S^E:U_!I[U/A& E
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M>H"KD$          !:R/@S_N:_4"5AQ0=>J1/.Z)&GL?6I\$@1?@
M   C:H1G3I9'[4K^7:J\$!(%S)%E(?0B@          BZCKU;0^;IF/QJ.]5
MZGUP$H             BJJ1G >+UFOLD]ZKP0$J             BZAKLB:_
M&VO"]:KZGI@J4!            $54]>A;\[IV?QB>]5Z@(E04
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MBP%,MWO(>FLH123DI2MDINX_N.]*]4[]-2 8V9SY2EYWK6&7J84:'0[ 8O\
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M-]]N_P @"6     1,I1=9IG)HKI5]&78^:TKOB_R:@)8
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M3=-:F5^L6Q=E:9K=13+E;24^N3',T)-XT$HT\Y'KKR@-2^)K@IR754<1.5+
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M_/ZH(OP           1=447BZ6:BT2;1Z]K_ &E)3_6 21<R192'T(H
M     (JIJ(HJ=VWE=9[;;[:GNC2 E0            $15=I0'=VFA[.VV]TG
MNE)\(!+@            (FI\B(IJT^$LZ:Z=UZ*D@)8            !%5)2
M2CM[M/O[)]EM]L3W1I 2H            "/F=M#_ "@O!7Z) 2D
M                            'G)Q4X2NK+V<<>-P;:E3K43C2^Z15[B;
M211XE1G16O%J%++E2M;R4FG3S@&%L"X8S=$R/PK95R/9U48O"KU"_P"MYBE.
M-)(J4_-A-0:6F69N'MZ1J.DDD6O. ZG:6,,Y4B-A7%,S!]P1F,8\1#]Z5Z_=
MT-VDN4N5.EOLR8>QTW5HV2-RSV%LTY>?0@[V>.LCV=G!].)L%UZ1%JN3EW#7
M57Y1K?J=NMQ9DA2ZA6:9<+;GC2*ZI*C6RRK>I)\FGF )/Y-KDM')>9Z'>'"<
M]GZ=D[)\:[K*R.MR 4"/2G#8ZNB949*C>B+II(/:VE)DK['D,!T[/N.<UQY_
M')9EN84K]\1N(=-O5&T;MI9Q.H(8IT=EF4U();R72>0I*MC9(,U<G,7* R%D
M?'&:&<IY0NNR\6M7>[,X<:5;5 A5YI#E'J%8;J'22*>ZA;A)=<2QN5T2]$K,
MB29\H#'U#Q5EZI7!Q25M^Q+ODLY!P"W0+9G5BET^E.3JQ%:=;53F*?!VM,$2
MG-&4++=MU/<?( ]"N&.P(^.<$8LMM-J,V?68MLTI-S4Q+#3#WC!$5I+_ %C9
MKN<Z0CU4HS/T0'F=>O#+FZ-?V4(EL6E-79^ JK4,G<,:XID3-1K]<J,2I/4]
MOE[+H29>;TY-#7_. [#6^'?+5$L3AEON;9=6N6KT>O73>6;;0I<*G52HM5N[
MRZPF:W3ZH?592XG+',EZJ0GE2 [G1,99(QUCS!=-M'&MU0;9FWK<E?O(YU*H
M=:NZTDU-I1Q6Z1!0I4*(U(=4O4TI4IA*M-" 8E@<-N9:]P\82QD];5UV)78>
M>*M/N"K1VV#J5#I$]V8HJNE3*DL[2;D%V;?8[C/0@&1JQAS(U2X9<78,J>(7
M'ZCB7-5!@UUNGQ&TP*];T&8\M5?(B5HM$AE9'(-79=)OW<X"PR;PVY,K"N-V
MW<>V"Y0[>NRX,?5^S:'%;CP8%P,4=OI*O%BD9I9-2R2DC2LB0I1$E7(8"9H>
M#$W98/$A6:WA_)[3>0X5O1)>/G&+;MJ757J+(2^S,IL" KJS3T=7(HWRVOI2
M1:*Y@'U:N.<D7GCGB'M.^\(5J=C>O46DIM_92+?LR_JY/B/(<<86FG.=2<;C
M]&E:%O$6_E3M,CT 9GX0Z;E>GWI?Y7'C=RV,?KI-.;H=W7';E&MJZY]196I+
MD:4Q1%FS(CLM]JZI*5:\Q<I@-2?XP"T(EX -:B06MQ]D?,780QMO)?SIZI8V
M+C[GK>+W66/;T_TD/46M9JR=88]N3_206P:DYE.L1_;D?TD%IJSF5Z=CVY']
M)!;!JSF;I_P\'V5<7V*B2ZA1G'K78D?_ .;9(UWFGZ>KU>UDX6+*WZBAY)LV
M@--LJ\F?XB5SW\NUJFU9$G$<*EQ[L..KJ#DU$[I#BD_VN\D^9]4%;_ @ C*E
MVD7MOA36NF[FW>@ DP    $74]>H2-N[=M3IMW;NV[WL@$H     L9NO59&F
MNO1+[KN>]Y0')&^"QM?:D>" N@    $73^TE\_PIWGW=UWP02E     $9&UZ
MU4->UWM[=-WM:?/Y/8@),    !&(U\9O=MMZNUIVVWME?S ),    !&+W>,H
M_;;>@=U[;3MD_P": DP    $7)W=:I^G:]*O?VWM:O.Y/9 )0
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M-JFO5>QW;^E:TV[O;$]R D@            $74]W4GM-=W8=KN[I/<]D E
M           $74==L;37X2UKVW==Z E             $94MW0(VZZ],SVN_
MVQ/<@2DP            $=+[>'S_  @NZ[E7<_5 2(
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MN]U_R@)4    !%3->N4SS^E<T_!*[T_"(!*@
M                   QY8_WRI>Y1_QD@19RLABH
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MVG47==-"V=MIW:>Z2KU $N             B*GKLBD>GPEGGT[KT4J 2X
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MJ4%0   !%QMW7:E[JUK^#3WRO!+ZH"4     1:#/QJ\7_EF_"5W_ /9 2@
M  "*6H_&D8O] [X2.^_LF E0    $7)UZW3=?;EZ>P5WR?!,!*
M                                  QY8_WRH^XQ_P 9($6<K(8J
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M/UMKPO7)^KZ0BI05            $54S,HZ?=V?QB>^3_+S $J
M   CYFO2PM>;K"?!5WR?J^D D
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M*JF[J$C34E&DNUW=UWJ5'_5 2H    "TF?!)>GM*_! ?47X-%]R1X("Y
M 15.UV2N?X4[SZ]UZ*4@)4    !%1C7UJIZ\V]O0N7VM/>^H9@)4    !%H-
M7C1[MMO0-]UMYU=[M_K )0    !%K-?C./R*VDP[W6G.WWNW^L E     $7)
M4OK%/,BT(G%Z]M[6KO3_ ,H"4
M        !CRQ_OE1]QC_ (R0(LY60Q4                            6
M%0^ 3OR=WP3!8>-F(_\ IA8W^ZV_"4-5>?%+Y7YK^IK_ (I]K(A<PXM?#=OA
MO_\ H++_ -[R? ;&=A?A?0/EC])_JEL&,EZ,       !8SMW5)GN+G@_S^H
MYH_P:/ZQ/J +@           %O(^#2/6*]0!Q0_@437VI'@_S +T
M   $;4C6<"5H6BC:/FW?V4J5_5 2*>8@D5           !%U(SZL1%NY76NU
MW>V)[E*@64H"            (JJ:G!=(M2,]G:[N[3W*5'_5 M2H
M    "*J.[9&TU^$M<VO=>@E0$)4            !%U$SZ!O3=]_9[7=[8GN2
M4 E             $?-WZP]/C!>"KT# 2
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M-/:4>=W/>\@(D            1E5V^+YFNW;T1]MMV_UN0!(ES)%E(?0B@
M        BJKLZIV6GWUC3=I[:GSP$J             B:KIU![7O.VV]VGNN
MQ 2P            "*J>SHXF[33K3/;;>;=WP"5             1=4V= WN
MTTZPQS[?;4]T E             $;-TW0M=/A)<^G<J 20
M                            L&YL)Y71LS&'72^P0XE2OZ",!RH>:6MQ
MM+B5.-:;T)5V2=>Z+S %T Z54;)M.L7-;UZ5.WH<VZ[3;EL6W7W6R5*@-SD$
MW)2RYR;.E3R*(O. 75S6U;]W4>H6Y=%%@W!0:LV;%3I%2CMR(S[:CVFA;3B5
M),N7G\SS0@8XAX"PC1;/?L*!C.VZ79U0J$>?,MYJ(TS'D38SI/1W72).KCC:
MTIVJ-1JY '=JM8MGUVXJ3==7MN!4KCH4.93Z/69#1+?C1IZ21+90I7+M>26B
MD^< Z9;V <*V94X-=MG&EO6]5:6B6B!4XL1##T=F8@VY*$.)YFU(49;.1)%Y
MA )AO%^,$V$QBMJT:&>.9++C#-E*8:73W&E.'(4E+"B4E23=6:CT+D/E 4I.
M'L74%_K%$L2CTUY=N-V>:X\<DGXA;5N33RTT/H4J7J2>8!RT7$F-+>FV=4*%
M9%*I4S'U,?HME2V(Z4+ID"02>FC1C+38VHB+4B 6TK$6*:M"ON!*L:@U"!DJ
M:F7?\9R*T\W5);:203TM"MZ5K022T4?*6A +5G!F(([,^*UC:W2BU:A1+8JL
M54%IQJ31X![HE/<;<2I*F63U-*=.?E(@(7EBXAQIBB'4H^,+"H5H'4SWRT4R
M,W$.2M.XFR>>0A2S).O8\^WS@&@V>,9.YGRYBRU^*6#1Z1;4.WKFJ=MJL:JU
M!3ZI2'J<VHI:Y,5K:1-*Y-A<IZZ\Q# \Q^9,/Y#=[SB*M6B9U;;)JY9YN1DX
M;RZ\QU7=W=-LY<R$_<1X'_[SO'RI*]X&A_O-Y1X_^RKW-A]&8WP_]T>\_<2X
M'?[QO+RI)]Y#^\OE'C_[*O<?1F-\/_='O/W$N!W^\KR\JR?>0_O-Y1XW^ROW
M'T;C?#_W1[S]Q'@<_O*\O*LG]'#^\OE'C?[*O<GT;C?#_P!T>]E+"G"CPM8S
MR?;%Z8VE7*[=])ZTFF)J$^0\R2'HRVG=R7&DEVJCTY1EX+^I?EWG%]&$N;W6
MKJR1JS&3ERS#IQ/RUBL'1WMY193'/;#T<'HFM=-*S;4;NIZ^&;=IJ+Q?A(IC
M]U%%;.>N&@]Z8RI.W?T>XB/;KIJ [D  (JHD>R-S_"6BY-W=>@I("5     1
M54U.!(,N?:7-KW7>J3X0"5     6<O7JDK3GZ)?@_P PH^XOP:+[DCP1!<@
M   (NG[MDO7XT[KS]UZ*E?4](!*     (N/OZW4=>;>C;[!/?'ZA )0    !
M%HW>,WC\SH&S^R[I7?:?U0L$H     BUDHJI'+7L38<[KST]]M_J@)0    !
M%RM_6J?IS]*O\6KOB 2@
M   ,>V/]\J7N4?\ &2 6<K(0(                            CZI_LZ?
M^3/> 8BL(<+'_;MAK_A:%X!"HS^           "PG;NI2].?HEZ^Q]-/J@.:
M/\%C^L3Z@"Y           !;R/@TCUBO4 <$'4H47W).GL?35ZH"_
M    !&5+=U"5IYC2O/\ [*D^J"I,$            1=2+2,6FO(ZUVN[VQ/<
MFD()2@            "*J>[J+IEKN[#M=>Z+N5)\(!*@            (NI;
MMD;0_P#[);+S>?=Z"D@)0            !%U$CZ!OMM>G9[7=[8GN32"RE 0
M           !'R]W20_.ZPG3V*^^3]7T@$@
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MRU\T@$-Q)_\ 7+#7_"MV_C:4/EG]7_\ PL?_ -:7JOD_];/\/[8=3'Y@?5@
M  '?\5?_ $\H?K9'XI0]_P#TT_\ /W'^K_TU//?-/_C[SU>V&ZH_6;Y
MC*AJ;477GZTUI[+UJOJ>F(),4    155U.GR?6EK[+UJO! 2H    "RFZ]3D
MZ>U*U]+;ZU7@@$37JD;7VM.GL?23Z@"]     1=/UV2_RMWPO6I^KZ8"4
M  1<?7KM2]U:U_!I[U/A']0!*     (I"3\:O'_Y9OPE=[_: 2H    "+61^
M-(Q_Z!SPD=[_ &B](!*     (N7KUJF^?TR]/P:N]5ZI )0
M                              &/;'^^5+W*/^,D LY60@0
M                  !B')F1HEB1&&'[/NVZ%U5B01+MFBOU8HZ4([9]31:(
MUW=CJ?+R@.J<+!DKAVPTO0T]):\%6U1;%%N;)>BB[HM.4@&Q(
M+"=J<*67^B7X/K5>" Y8WP>/[DCP0%T           "TD:]5?]R5X/\ . XX
M&O4X?N2/!]:GU" 7X           (VID9T^67^B/^7:J\$!(%S)%E(?0B@
M        C*D1G%,CYNE8_&I[U7J?7 28            "+JNO47M>\U]FGO5
M>" E             $74==L+7XVSX7K5?4],!*             (NI:] GW=
MG\8GO5?R\T!*             (^7KTD/\H+P5=ZKZGI@)
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M>JYB[LMLY;;<DMI!]=>01QSH93/%QRV>OJ:Z8H.\NFZ/7;TG1]MMW<FN@"1
M $14C^YQM=/A+7/M[KT5) 2X    ")JJB*G2#46A&DM=VWNN^4E/]8!+
M +*=\#F>XN>" ^XOP2+[BCP0DA=     (BF=I+TT^%/<A:=UZ"E 2EP    $
M3&-/7*H9%V72-[NU]J3Z/J@)8    !$H,O&SW(G=U9ON=>=7?;OZH"6
M1:S1XSC%HG=T#_<[NV:]'7_(!:E     $3*/_7*49E_XKG<^U*]'U $L
M                                       #'=C??:G[E'_&2 6<K(@(
M                            CZG_ +-G?DSO@&"L(<+'_;MAO_A:%X!
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M^8]#N5>>9 )(
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M=UQ<M7TG(=]U3$C-4K-3B1UQ*?".3/;2F#3F-RC;89Z/1*C[)6IK5S@6/7H
M 1E1[2+S_"F^;=W7>@),    !%U/=U%_;KOVEVN[NN][(!*     +&9\%D\^
MO1+YMW<][R@.2)\%B>YI\$!=     (NF]K+UU^%.\^[NN^ 2@    ",C;NM5
M#77;O;V]M[6GS^3V("3     1B-?&;W;;.@;T[;3ME?S ),    !&+U\9QNV
MV=7=U[;3MD_S ),    !&2=W6J=IKMZ5>[MO:U>=R>R 28
M                             ,>6/]\J/N,?\9($6<K(8J
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M.24.+5&DM2TG&?6PO>VVMPBU4VK3LAK+^XFYKU*LL.ZFN*HMAF(=;D
M  MI/P=_3VM?J KBA:]3C;N?HD^?W/?<H(O@           1M3U\7RMN_=T1
MZ;=V[^KR@)%/,02*@           C:IKU7L=V_I6M-N[VQ/<@)(
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M?AE2_+9?X]8]M@OR*.II[[XYZWP,MU "O,"* H         KJ"6/TW_PX?\
MM!Q?[K6/_DY(\=YI^HGU>QM\-^7#>88#O        6K_ ,&D>Y+\$17%!W=1
MB^Y(T]CZ2?4!%^*           BZF?\ [=+W<QMJY#T_M)5X("2+F2+*0^A%
M          !%55!G&(S/L2=9U[7VU/=)4 E0            $552W0'25WFN
MNG=I\]*O4 2H            ")J234B(1_&F?.[KT4J A+             (
MFJ:]7;UTTZ=CMM/;$^>E0"6             1LTCWPOR@OZ=JN]5]0!)
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MN]X3???4 E*     (N7KUJF:\_2K_%*U^R+U# 2@
M                       ,>V/]\J7N4?\ &2 6<K(0(
M             LIWP&9[BOP1)'XNI/PRH?ETS\>L>VP7Y%'4U%[\<];C&6Z0
M  5] $4!0!7T@10%  !7T 10%?IQ_AQ?]H6,/=*O_P#)R1X[S7]1/J]C;X?X
M(;RC =P       "TD:]5?]R5X/\ , ^(.O4HGN2-/8^N5X0"^
M!&U37Q;+U]J/7^6Y/A ) N9(LI#Z$4          $34M>KIUYNF8_&)[Y/J_
M6 2P            "*JOP![_ #-?9)[Y/A )4            !%U#79$UY^M
MLZ>R]<GZOI J4!            $54S,F$>[L?C$]^G^7F! E0
M $?,UWPM?C"=/8J[Y/U?2 2
M#!7$1C&J9GPCDC%U'JL>AU.]J2Y3H56F-K6RPM2T*):R09F9<FFA .RX^QG:
M6/:-285$MBBTBJL4Z-!JM3I,!B([*6RVE*C6XVVEQ1&9:]D8#1*A\%N7:'-Q
M_;_RHVY-Q?C7+;F2Z%1_%,AJJ2$2Y,B4ZQ)ED\IK>VIY1-[4:*UU6?,0#ME;
MX/+OJLR]Y35XTAA-TY\HV7HS:F9!FU3J8VEM<%6W35Y>TS)1=C_2 Y[\X1+M
MNRUN+VA1;QI4.1Q(7#1JO;CSS$A3=.;II14K1+)/9.&YU=6FP_-+^8)B\>&S
M+\"_+XO7"^3;?M=W,-MTNWLEPKAI3\]+3]*B=08J5+-E]O:Z3)J+HW=4&>A^
M8!D3-G\*:[!OSAGJ]L7&T]:. K,K5JR8DU"^OU%=6::24E*DGT2>S(UJ(_/T
M+FY0Q31>"_(-"LG&-M(O6W[A18M[W3<]PV;56)WZNUUBX'G'(R9K3#C;JW8/
M2[T$O<VI6NJ?- 7]E\&EYVK9&$+3?O&AR7\2YBD9&ESHD%Z.U+I\AY]TH;#!
M$KHG$JD;2Y3022YP'6^(#&A9CXPL76U;U*K[-*I]/87Q%U Z<^S0YU$I<I%8
MHL-4Y:$MONKFGIM09F2==W(6@#>_+F-Z3F#&E\8PKDB1$I5\TA^DS9D0D]*Q
MTQ:)=02]2,T*(CT,N730!JW:_"]E&O7-9E5SUDRBW=1L56Q5;8L*F6S37:8N
M3XXAE39-2J3CSCWW?JI$DD-=AN[+T 5"8(X.+BQ?6[9AW1-L"Y;-L6GSJ=;5
M=BT"2U=,A,II;#;TB:[+<9CN(96I"U,-]GKRZ CKM(X.,UTBFX<QZ67+=GXD
MP5D"!=EE4MRD/M5>7"A2UR419TDG5-FIE+BD(-M!$K759\F@"6H/!16;6R54
M)<*78%?Q=5;W?O5YBXJ#)G7%&5+D=:7 C/IF(BDA#_9M/&WTB/.,P%[=W![>
M%?M7.UO,WE26).6,P4[(U)D+8?-$2'#?A/+BOZ:F;JBC'H9=CRES@.SY$X7;
MVO"Z>)^X:%D9NSW\ZV[;-&MZI04/HFTQRA)^[ID+;4V9M2R/HCZ)1*V*/S0%
M_@+AON3$.6,@Y(JDFT*=2;WMJC4ANUK4BRHD: _23<U=Z22I:GNF)9J6XM1+
MW<_)R@(#,-3I5_YWQ3$L6K4Z[WZ;:=V+J$>D3&)9L)6_2DI4[T3BMA&?(6O.
M?(/GW]2O*L5YEY53=8:[FNOO(FR++;+.EZ'Y9Q5UAL7-5[5%,:MEL]<)CY.K
MY_9F9_4^N/S_ /0/GG\K7V>]]$^H?+_&CM/D[OG]F9G]3[8/H+SW^5K[/>?4
M'E_BQVGR=WS^S,S^I]L'T%Y[_*U]GO/J#R_Q8[3Y.[Y_9F9_4^V#Z"\]_E:^
MSWGU!Y?XL=KN6/+.NBDWC2)U3H4B)$;)XE25DG:6YM24[MJC'LOD3Y2\UP'G
M%S?W]Q53=QK6S-ED6TS&=I//_.,+B,%71=WD3,V<G+G;9#]'OFH   "*J1GL
MBZ:_"6N;7NO0(Q($J*    (JJFHX,C0C)1I3VN[NN]2I7]4!*@    +69KU2
M5IS]"OP0%8OP:-K[4CP0%R     BJ:>J9?;?"7>VW=UWQ$ E0    $3'-12J
MF9IU2:V]"[+VM/>^H"I8$    1:#5XS>[;;T#?=:<ZN]V_U@$H     BUFKQ
MDR?9:= [W6WG3WNG]8!*     (R2:CDTY1<B>D7O+LO:U>AZH"3
M                                  !CRR/OE1]RC_C'P6<K(8(
M                       LYWP29[BYX(DY!^+F3\,J)?\ G9GX]8]M@OR*
M.IJ+WXIZW&,MTGI@@"@       *^B"* H _3E_#C_P"T+&'NE7_^3DCQWFOZ
MB?5[&WP_P0ZSQ09[R11LN8_P!B>[+8QI5;CH,^Z[VRI=#:)$&C4N&9MM-H:=
M4VR:W5I/12SY.333E& [V?.&FX<PW'C*)-S6U07KM:GRX\6Y;9EQY-.K5.;4
M11:BUU9QQ+72EJ1M[N3;S%KH"-C@     !;R/@TCUBO4 <4'7J</=S]"CP0%
MZ           "-J>[J$K37<;2N;=_92H_P#( D4\Q!(J           "+J1J
M.,1%KRNM=KN]L3W)* E*             (JJ;NI.Z:FH]G:[NZ+N248"5
M          1E2[6+IK\):YM>Z] C"!)@            (NI:FP@D[OOS/:[O
M;$^<E0*E 0           !'S-=T+\H+S^Y7YPJ2D!%
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MJ^SQ=)W;=-I:;MNG;=]R J6!    %E.^!S-?:7/! ?433JL73FZ%'@@+L
M !%TS3;,T^-.\VWNN]$$H*    (F'MZY4]-N[I6^DTV^U)\[LO9 )8    !$
MIV^-7NUW=5:[G=VZOYP$L     BG-GC6/VN[J[W<Z]LW_G )4    !%2M.N4
MW=I]]<V]K[4KS_J )4
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MVJ-P8_Q9+D$^];])DFDF8KFBE)0:C2:B1NY.<^50#?L      6LCX,_[FOU
ME8<,#3J,3;[0WS:=SWO(")            $95=OBZ9KM^]'INVZ?UN0!(ES)
M%E(?0B@          BJKMZH>[3[ZQINT]M3YX"5             156TZ@]N
MYNP[;;W:>Z[$!*@            (RI;=D3=I\*:Y].Z]$!)@
M(JJ[.KM[MNG6&.VV^VI[H!*@            (V9MWPMW/U@M.U[E7G_4 20
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M?RO7;%X\:) H-.DU?/%W4ZK8V-R7'04J+%*(1JD.'J;)MFTO:2^7SN<!MAQ
MX\NK('#/D?&EM16)EWW'9SE'ID5YY+;3DQ;"4$E3Z^Q(M2UU,!@:C\/F2(F4
MKGNF;1H*J14^'.!CF ^J6RM?C]C[ZQL+E)O3[/M3 8"Q/:%1M[/O")ANM2X7
MZ^8EPC<E)R12X,A,OQ4[.2RW&2ZMK5O[H2M4'J6I<P"5QCPV\2UOS>$RSKCL
MZVXUF\-EYU:?4+JAUDGI-5AS4229EMQ#;2;:2)TDF@U&O7SB 9@L;"T''W#+
MQ'V?GZ51[-MV_KKO*K5*NORVG(T>F5N0?B^6\^1EM6A6PR(^R(R(N4R <O\
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M3I[4O7V/II]4!]1N6+&]R1X/\XHO!    !%T_7;,T^-NZ^R]<KZGI J4!
M $5%W=<J6OMC>OX-/?'X) )4    !&(U\9OEYO0-^$KOO[("3     12S454
MCEJ>TV'#T[+ND]]M_J@)4    !%RM>M4S7GZ9?XM7?)]0P$H
M                               #'=C]O4?<H_XQ\19RLB"H      #S
M*XM[?A7/Q8<%E%K-(36;>K$RZ(->ANL*<C+CR*=T9H?4DC(MV[DU47H -5\,
MX^R'AWCQQ%A.Z.MU>R<74RZ2Q)<KK+JNEMVK,.R6([CW::QUZMZ:ZD9&7-H
M[#:E=L'$5M\86-^(:R:C4\PW_=%PS*(I^@2JJY=L&I-[*0=+D)CNH<2WN26W
M<GHN?DTY M[PMBZ,28O_ (:E1S53I;"\;W*9Y-JDB*[454J$IE;D9F:IEMY?
M8-J).PR/11;2Y2 >D'$]E]&*N'2^,B6^T_-J+](3$L=B.RZMV1/JJ4L0>C:0
M@E)T-TEF1I+M?3 >45Z\.?%[9'"W:-.?MVPT43"$IO(](J%(<GKNQ5296J;)
M<6:D]$IQ?2J)U)<Y)T+F(!ES,>5;&O'B)X#<Q75;DBN6=6;+K%:JE*3!<F+@
MO+;;-4E<-+:W5IA/ZFHB09D2=VG( BDMQ;K/^(OEW'-%ETC!]VV(S3[?J!PG
M*=!JU<AP7"FSXL9U+9K(CYW21R[@&/7JA8V2.';@_P /XAL:;"SU2;EMBL.1
MV*-(C2:9&AJ4[4JL]4^B2@F)"?NG2DX9++T2T 9RJ<60K,G\3U28$@VY5@4X
MHB^A7HZHJ2]N)L]G9]D?F>D QU0(:K1M7^&OE7(M"G5+"5D6G-A76KJ,B;&H
MM8G1=L*H3(J&UJ0E)IT)9I/;H S/>F4,=M\/_$9?V!.&4JW1JC=D)JX)-PV^
M\JA7*MQU*9%?;IJONLEB+KN/[F@C/0^;4!BK"-357>.3'EQQ[R5D2F5/%M9I
M\2[X=HJM*C*?8^Z.4ZGQTMETR&$Z&:G#-1'V.O8@,$XTNC&$+@:S!BBN8\J$
MG,F0ZS7&+*@G;LF1+KTN1+Z*G/0Y1,*3I$66U6JT]'H9Z=GRAMZBU[UH/%'P
M-T&M=8:NZB8.KU,JM16E;Q1JFFFJ:)+CI;RU2[R:F?* T_QW8OC3'%-P+DS*
MZL57[#R"J9*LOY.9M3N1NN,U+IV*FBMQNR=;=/0^FUT)![3/0!^AY3;S=*4U
M(>Z>0W%V/O&6WI%I1HI6W['<KE$'XQ9/+,J'Y;,_'K'ML%^11U-1>_%/6XQE
MNE4P2% 4     5($E0%5Y@10%.8$?IQ_AQ_]H6,/=*Q_\G)'CO-?U$^KV-QA
M_@AO*,!W        +61\&?\ <U^H$K#C@:]2B:^U)T]CZY7A B^
M  !'5,S*GRS/VH]?Y;D^$ ORYDBRD/H10          1=2,^JZEJ7W5K4^7V
MQ/<J3ZH6%J4             154W=1<TUW=AVNO=)\Y2?" 2H
M "*J&[;$TY^M,Z>R]<G^7F )4            !%U'<3#>A_^.SREN]L3W*D_
MR\P+"U*             (^9NWP]/C!>"OOD_5](!(
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MW#J]/FRJL_4.CVKZNVXE<3H^D4M:'NR)M*EZ: ._Q\GVU=MTW1:E1AT&HV!
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MM2M?2V^M5X(!$UZI&]S3I_1Z2?4 7H    "+I^NR9IS];=\+UJ?J^F(J4%0
M  !%QM>N5+W5K7\&GO4^$?U $H     C$$?C1\_-ZNWX2N\_M ),    !%N:
M^-(Q^;T#OA)[W^T E     $7*UZU3O/Z9?XM7>J]4@$H
M                           #'EC_ 'VI>Y1_QCX+.5D,$ $!5;DMZA=
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MD+7XPG3V*N]5]3TP$@
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MI0   "*J:MJ(FOQIH_,[KT3(($J     B*MH5.DDK3;M+GV]UWQI2 EP
M%G.^!S-?:7/! ?4/X+$]Q;\$!=     (FF'JB9R?_93O-M[KO3,!+     (J
M+MZY5-.VZ1O?S>U)_ER@)4    !$),O&SW:Z]6:+['=VRN^W?U0$N     B5
M[/&L;M=28?[G7MF_1U_R )8    !$RMO7*7KVW2.;>U]J5_+D 2P
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MSWWB)MU3:%*T2LMW8\XT>+Q%&(O9KHR2WF$O*;R[BJF;8SPVX&.R
M%M)^#R/6+]0%<%/T.#$TYNA1W/<][R B0           !%U0R.GRMQ))/1'V
MVW3^LI*?ZP"2+F2+*0^A%          !$U,T]5+=IM-YGMB3[:GNC2 E@
M         $35=.H/$HRV]@79;>Z3W1I2 E@            $14S3LB:Z?"6N
M?;W7HF0@EQ0           !%5-1%&;W;?O[';:>VI\\T@2E0
M$=-TW0M=/A!<^G<J 2(
M   #"F9,TVK@RV(=V7? KU0ILVH-TQEJWZ6_57TO.(<<2I;3*=R4:-GJL_0
M8WP?Q<XIX@[@DT&P(EU=+$@.U!54J]$D08"VV7$L+2W)<+HUKW*/L2/DY?.
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MO#Y_A!=UW*NY^J D0
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M>_V@$F     BY6O6J9KS],O\6KO5>J0"4
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M<D:>Q]:GU!$7XH          "-JA&=.ED?M1Z_RVJ\$!(IYB%E(5$4
M    $74RUB]E[:SK^%3WJO4 2@            "*JW+ >U[S7V:>]5X("5
M           1=0(]D37GZVSI[+UJOJ>F"I0$            153(U,(+S.G8
M_&I[U0"5             1TPCZ2%K\83X*N]5]3TP$B
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MZ     BJ=KLF:<_6W]?9>N5]3T@$J     BXNO7*EZ]O7\&GOC\$@$H
MBD*/QJ\7_EF_"5WW]D!*@    (MPS\:1B_\ +O:>R1WW]D!*     (N69]:I
MGG]*O\4K7[(O4,!*
MQY8_WRH^Y1_QD@%G*R&"       Q-G0TIPME[<?)^IM<+_\ H7@'C-1H-5L[
M ?\ #;XC'*+/K^/\,=<^49NFL+EOP(=2=-M,XF6RU4AHVSW&1<G)R\H#?FA\
M;-GY8S%CO&G#Y1SR_3JJ3\[(]]-E(AP;<IZ$)-#G2O1R-;KBM$]&6G+H6NO,
M&J+-;S;FWBASIF3#^*K=RU9%JPY.&Z,=Q5KQ7&:8:VJJRXFB3Z7K"UK)9^8D
MR(!CRP[HKMK\$/&7PS7ZTBD7M@*)/0U1TOF_T-)JJDRF":>Y2<;:<-:267.2
MB 8MXFL=W%AO %O9)L&*E&*^)/'5LT/,%$0E700Z_!88E0*L24]B@Y'1J0??
M:D?;$ W.XGYW#[+MSASMSB#MVZ[3H\FU8<JT>(JWENLMT&>41HE0GY$9+CK9
M.[$+VFE23YRT/4P'WP1Y)O&H9MOG&EG9FKO$;P]T*W&9L#)%PPW67*?5U/$A
M-.;F.D2I!='NUTY.34B+0]0R7_$+B..T3 \ZYX$VJ8,I62:?+SQ B-NNLG2$
MI/HG9S;6IG&0Z>KA::<VX!B6VYF.[HXQY%P\,:*:K%\/$U6BYOJUIM)CT&1-
M6A9TII?1$B.[(06BNP+<2>V 9 _A<V'9D#AGM:]85O4[];:[4:R=0N@HK77E
M-E+6TEHI&W>39):2G:2MO. Y.-(JECG.7"[Q*5&B3ZSC3&%0JE-R%+ID=<I^
ME,51E#;4Y;+:5&;:5:D9D>I:%YY ,C6MQGVMEW-EDXVP!1#RM;;L:7.R5D=L
MI$2!;T9*"Z!#:GF2Z1UU1[31R<Y>CI+%:14+AVK>=LM<>LJS,EW1CV_+8OKH
M;511*DN%39;[T5QQ"*DTUMWD9IV$HC(T:F?+S"H[_P ,M\XKIW"%FJV9>"9M
M:O:PI$N%Q'8ACO+FUJKR5*Z)^?NF*Z1PEM)4X1:]@:%$CF29AK1&R#86+'[#
MJ? YQ&7W<5RW'7J;&_=<K$>958QL2'4E+9?)YHNK$PE1EKJ?GDO0M0'Z#Y2E
MJI4I3S:4O*C.&ZUNW$D]G9)W!"O'+$?_ $QL7_=2/"4-5>?%+Y7YK^IK_BGV
MLACBUH ^@<GR#B^Q', 4%1410   'P*X/0'!7_3&@>NE?^H<&PP_POI7R]^A
MH]?MEBG/O$RK$-S63C:T,>U;+>7,B-2I=MV+2GFHNV#"(^GE2I+_ &#;:=="
M/34]#YM!WMV[GP^9OC9[L$[P;M2KV-58%2ET:Y;4K39(E0JA"61.MI7HA+B=
M%%HLBT/F/F,16P0J     "UD?!G_ '-?J!*PXH&O4H?N2/!]<KU01?@
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M$NEVFHT[R+EYM>0!Z!      "WD?!I'K%>H XH/P.)K[4CS^Y]$)(7H
M      (RI;O%\LB[?HE=KN_LZJ 2)<R192'T(H          (RI;CC:)(]QN
MM<V[VQ/<DH!)@            (JJ;^HN$1F9]ARIW=VGN24H!*@
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MU7)Y@"\?M*UILVW:C+MRGO3[0-PK6F.16EN4[I6^@=ZHK9]RW(22#-'V/)S
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M[X;?B]]_G+'VH<%P7[VG[#_]!8_9I_!_\CY.^&WXO??YRQ]J'!<%^]I^P_\
MT%C]FG\'_P CY.^&WXO??YRQ]J'!<%^]I^P__06/V:?P?_)D?#UEX5IF2+<G
MV>S=C=P,=:ZHJIR&51-%1UDYO2DB/M2Y-#YQEX/RS"W-[%=&M;&>6-C/ZP8O
MS^ZG WE-,4UV9*;)^[RY;9>@ WS1-=J#Q'XPNC-U=P%;E5=K5[VS2#K%?D0T
M)>I\4DNMMJB+E)<^_IWD:FR3V)&6X]>0!L2  (JIZ='%UV_"V==VG=^B E0
M   $35M/%TC?IIM+MMO=%W6J0$L     LYNG4Y6OM*]/8@*Q=.J1=.;H4:>Q
M 78    "*INW;,VZ?"W>;3N@$J     B8>G7:GIKNZ5K=VOM2?.[+V0"6
M  12-GC9[M=W56^YU[97\X"5     13FSQK&[7=U=[7M=>V;_P X!*@    (
MF7MZY2]>?I7-O:^U*\_Z@"6
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M][R B_           !&U39XNE:[?O2NVVZ?UN002!<R1RE(?0B@
M BJKLZKV6W[\SINV^VI[H!*@            (FK:=0>W<W8=MM[M/==B E@
M           $54]NR)KIIUIGGV]UWP"5             1=4V=7;W:;>G8[;
M;[:GNP$H             CINFZ%KI\(+GT[E7G@)$
M                    '7;I0IRV;B;0GI%N4R6E"$\ZE*95V(#Q@9KUN)_A
M16?1O'$'QDJ13:6FF$^E3W7DW0E2HO1;M_2)+E4G373EY@&Z%%R!FZ[>+S(>
M):/>5)MW&.+:1:U<J%.<HZ9=1G)J<573PFI"W$$TE2T[S69*47(22 :O8RS;
MEU%D<+]JXQ=L^PIF9;ZR)1:VIJA).GQFZ7(><8E-1&G$?=DD1K/51$XL^SY
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M?V0$F     BY6O6J;Y_2K_%J[Y/J& E
M               8\L?[[4O<H_XQ\%G*R&"
M   +"H_[/G?DSO@F"P\:L1_],;&_W4CPE#57GQ2^5^:?J:_XI]K(@XM:KZ8+
MUJ^D"JB*      #Y],5QZWT(Y #?W!7_ $RM_P!=)_\ 4.#8X?X7T?Y>_0T>
MOVRS .]NP       %M(^"R/6*]0!PP->I0_<D^#ZY7A"*OQ4          !'
M5(S*!+,_:C_EVR?" 2">8@D5           !&5(S**7F?=6/QB>^3ZH"3
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MM )0    !&+(_&D8_,ZN[X2.]_M ),    !%R=>MT[W9S3V"N]5X1 )0
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M3T^V68AVMR        MI'P61ZQ7J .&!KU*)K[4G3V/K4^"(+\4
M !&U+4X$LC]J5_+M5>" D"YDBRD/H10          151)2HQZ\W2L_C$]ZKU
M/K@)4            !%U37J#W^9K[)/>J\$!*             (NH:[(FO/U
MMG3V7K5?4],%2@(            BZB1FP@B]O9_&)[U7\O- 2@
M  "/F??(>O-UA/@J[U7U/3 2
M             #'F1K6=OFP;QLYBIRJ-)N2CRZ?%JT)]R-(BO/LJ0T^VZV:%
MH4A>AEH?( \L;6RU>V;L<\)G#ZNXJG3\D2+OF4_.M2ARGF)[-,QXZI$Y3KS:
MDJ(IRTL),S/L]Q@,\7;QA9'A*RW?]DXIIMQ8*P/7W[=R!7Y%67%KTQZ ILJF
M_3(70FV;<4W"[%U:=^AZ +'*G&5DRV;HS0Q8>-:!<UE89MBW;TK-?J=4D0I+
M])K$0Y3C+,9++A*?TY4:F22TT7RF0#NEC<3%^7/D"K8YR!CFG6?$NO&+N2<>
MNT^L+FR3IBE&TJ-4#0RTEJ1JK4S:-1%YYGR@-8<2Y<S57[DX%(]A1X=,L>^+
M;N:H3[6K%P5*H*D*ARE,U!<Z6^VX^^J,RK?%-1JU6HTJT)(#OMK\3=R6994!
MVR,?(K]5OWB&N'',6DUFX)KQ*7TCQM24RIB7%,H4MLMS24]&VG<2"Y@5W,^-
M*^:#8.3U7?C&F)S!8&1*;C2G6S2ZFXY1ZC5:YT:Z>\F:^REQMK:X9KW(\SDY
MP1EO#F<<I77FV_<*92L2AVI6["M:D5R34:'47I[$QVINN(W,+=99T9(D:$2D
MDHE$>OHAH5_& T5-P"KS-+B+^I#&V\DG_FGJEBXSX(>,6TO.2/4V-9:;2[E(
M%IM+SD_T!86J[2\Y/] %K=+^'@DBXO\ %.B?_ K/_P ;(&N\T_3U>KVLG"S]
M_P!.E^H4>1;0   !%5';LB[M/A;';:=V E0    $35=/%TDE\VTM=VWNN^T2
M E@    %G.^!S?<7/! ?4/X+$]Q;\$!=     (JFZ;)FGQMWFV^?WH02E0
M  $3$V]=JFFN[I6M>U]J3YW+[(!+     (IO9XU?UVZ]6;T[7=VROYP$J
M  BG-GC6/VN[J[W<Z]LW_G )4    !%2]O7*9KS]*YIVOM2O/^H E0
M                                     8\L?[Y4?<H_XR0"SE9#!
M                         $?5/]G3OR9WP#!6$.%C_MVPW_PM"\ @<6?P
M4          %A.TZE,W:_>E\^G<]]R!(YHY:1H^GM:?!$%R*           M
M9'P9_P!S7Z@2L.*!IU&)IKIT*/.[GO>0(1?@           C*KM\72]VW3HC
M[;33^MR ))/,0LI"HB@          BJKLZIV6FG2LZ;MOMJ>Z 2H
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MO: :-E@   (RI=I%[;X4UVNO=>@ DP    $54]W4'^?=H7:[NZ[W10"5
M 6LOX)+TY^A7I[$ C?!8NO-T2/! 70    "+IO:R^?X2[S[NZ[X!*     (R
M-NZU4=W:](C;VWM:?Y<@"3     1B=?&CW;;.KMZ=MM[97^: DP    $8O7Q
MG&TW;>@=U[;;VR?Y@$F     C)6[K5.TYNE7KVWM:O.^J DP
M                               8]L?[Y4O<H_XR0"SE9"!
M                   &'LEY4M+',1IBY3JYNUF-)ZHW2J-4JKH31:J-:H$=
MXF^178[B+4!UKA74A?#GAI9$6QVUX*V_,YVR60#88           %C.UZE)T
MY^B7Y_<][R@.6-\'C^L1Z@*N00          %O(^#2/6*]0!P0->IQ]==>B1
MW7<]]R@+\           $;4MWB^69:[NB5VN[^SH8$)%/,02*@
M C:G\&['=NZ5K3;N]L3W("2             1=4W=1=TUW=AIMW<^Y/<\H"4
M             1M0[2+IK\*:YM>Z] !)             (RI;N@;VZZ],SS;
MO;$]R DP            $?-/0X9_^8+S^Y7YP$I
M                                        !K?=*C/B@Q 6_D.R+P/9
MZ4JD -D     $7+UZS3->?IE_BE=Z?JD E     $54-=L37XVQI[+UJOY>:
ME0    $352UITDN]+7V7K5>" E@    %A/W=2E:>U+\'UJO! ?437JD;W-.G
ML?23Z@"]     15/UV3?/ZV[X7K4_5],!*@    (J+KURI'YO2-_BT]Z7A&
ME0    $6@C\:/&7Q9OPE=[_: 2@    "+<W>-(WN#WA-][]4!*     (N5KU
MJF>?TJ]/P2N]/U2 2@
M ,>V/]\J7N4?\9(!9RLA @                           "/J1J*GSE)/
M:I##ID?^88#!W"S_ -NN&_\ A:%X #8$           %A/UZC,]R7K['UJO4
M$'+'^#,>YH]06%E= @          +61\&?\ <U^H$K#B@:]2A^Y(T]CZU/@@
MB_           !&U0C.G2R_T1Z_RVJ\$!(IYB"14           $75",XO+S
M=*QK^%3WJO4 2@            ")JQ&<!XN?M-?9I[U7@@)8
M!%U'79#UY^MLZ>R]:KZGI@J4!            $74R,V&]?;V/QB>\4 E
M         $7-UZ6GZ_&B\!7>*^IZ8"4
M                                :X73_P!T6(/^!;O_ /64<0C*V/%
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MZ7N]J/\ EVR?" 2)<R192'T(H          (NJ&11=3]M9U_"I[Y/J@0E
M          $55C,H#W^9K[-/?)\(!*@            (JHZ[(>O/UMC3V7KD
M_5](!*@            (JI_>$:^WL_C$]\G^7F )4            !%S=>DI
M_P"5)\!7?)^KZ0"4
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MK<(]4*YCY7P$A\LN(OG5M#RY3_?@#Y9<0_.K:'ERG^_ 'RRXA^=6T/+E/]^
M5^63$/SJVAY<I_OP6".9R]B9N1,=7E*TNB?6VI@SKD+E)*$I/3[MYX"1^6;$
M'SJ6?Y<I_OX"GRRXA^=6T/+E/]^ /EEQ%\ZMH>7*?[\ ?++B+YU;0\N4_P!^
M 6",N8F*:])/*=I= IE"$*\>0MNY*E;N3IM $A\LV(/G4L_RY3_?P#Y9,0_.
MK:'ERG^_!8'RS8@^=2S_ "Y3_?P%/EEQ#\ZMH>7*?[\ L%Y<Q,J:Q(+*=I=
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M/SJVAY<I_OP#@+,&)U.)2WE"TW775)2TVFMP5J4I7:I0@W^0S 92
M                   !CRQ_OM2]RC_C'P6<K(8(
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MEQ%\ZMH>7*?[\ K\LV(/G4L_RY3_ '\!3Y9<0_.K:'ERG^_ *_+-B#YU+/\
M+E/]_ 4^67$7SJVAY<I_OP"ORS8@^=2S_+E/]_ 4^67$/SJVAY<I_OP"QFY>
MQ,]$DM-92M);SB%)0VBMP=-?\U[4!??++B'YU;/\N0/?P+#Y9,1?.K:'ENG^
M_!8'RRXA^=6T/+E/]^ /EEQ#\ZMH>7*?[\ K\LV(/G4L_P N4_W\!3Y9<1?.
MK:'ERG^_ 'RR8B^=6T/+=/\ ?@L%?EDQ#\ZMH>7*?[\%@I\LN(?G5M#RY3_?
M@%?EDQ#\ZMH>7*?[\%@LIF7<3OQ^C8RC:*E=(T?)7(1=BEQ*E<SW<@+SY9,1
M?.K:'ENG^_!8'RRXB^=6T/+E/]^ /EEQ#\ZMH>7*?[\ ?++B'YU;0\N4_P!^
M /EEQ%\ZMH>7*?[\ ?++B'YU;0\N4_WX ^67$/SJVAY<I_OP"ORS8A^=6S_+
ME/\ ?P#Y9L0?.I9_ERG^_@*?++B'YU;0\N4_WX!'SLO8FD1'66<HVBMT]NUM
M-<A:\BB/G2]J D?EDQ#\ZMH>7*?[\%@?+-B#YU+/\N4_W\!3Y9<0_.K:'ERG
M^_ 'RRXA^=6T/+E/]^ /EEQ#\ZMH>7*?[\ ?++B'YU;0\N4_WX ^67$7SJVA
MY<I_OP!\LF(OG5M#RW3_ 'X+!7Y9L0?.I9_ERG^_@'RR8A^=6T/+E/\ ?@L%
MC*R[B9]#'192M%>R0VM>E<@EV*5<O,\ O?EEQ%\ZMH>7*?[\ ?++B'YU;0\N
M4_WX ^67$/SJVAY<I_OP"ORR8A^=6T/+E/\ ?@L#Y9,0_.K:'ERG^_!8'RS8
MA^=6S_+E/]_ 4^67$/SJVAY<I_OP!\LN(?G5M#RY3_?@#Y9<0_.K:'ERG^_
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M>N,=0V:[>DZSNZ'3=R:Z\_( [4
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M$( <@                          Q[8_WRI>Y1_QD@%G*R$"
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MUW;.K:=%MW<NW3GY0':0
M       ?"EDA!J5S)YP'@?6;XS)6L/9,XYXF:KJIMS63DJ32K:QO'DG^K*:!
M!JC4#J+L#;M6IU#BC4LSU_G/4![M4*I%6:)1JN371>-8,>8EKN>G;2YM_FW
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M/0J8./N6;JE\_HJU ?H2L^N_K/:=K7*3)L%<5)A5,V/-1UMA+Y)+TM= ':P
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MWKY1:Y#CMR^MPE&DNB0I2MFPO,_F >M@
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MRN)/B,1:]OW-2[5_4RS+(M-]Z3':C./]/*ER)#VAJ4M6[:DM2+4^;0@E&_X
M  ,#<1.'8V?,-7]B>542I2[NI_14VK;"6468RLGH[RDGRF27$%KIR[==.4!I
MMBGAPXAZQE_"-\YPB6+:5&X<J/+H]J)LI3SDFOJ?8*(V]+4XVVEEI*")?1EY
MNNA=D8#U"     :;<(F'[YQ91<LU?)4:&W?64<A5BYZC)B2BEDN$\I*(25.$
MDN5MM.W30!N2   "$K5-\<46J4DI;L%53B/Q.O,'M=9Z9LV^D;,N9:=VI>B
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MM.0N4!Z2@
M
M                                                      #'EC_?
M*C[E'_&2 6<K(8(
M
M
M
M
M                             #'EC_?*C[E'_&2 6<K(8(
M
M
M
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M$F.^D^;:XTI1&1%RF+,3&58F)R.V"*
M                                                  QY8_WRH^Y1
M_P 9(!9RLA@@
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MWD9I(F#7OW*2>I),M3\P@C[V3F)Y,K*8
M
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MCN(N42?@HYN3)FY?VN7^:>?)RY_\&ZHXN0
M                                                     #'EC_?*
MC[E'_&2 6<K(8(
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M2@DFV9%KM/AA>74C-,]$T9;9G/\ MB7*_P#\\YXCJJ]SVJ%0
M
M
M
M                      &/+(^^5+W*/^-?!9RLA@@
M
M              #"&:,.T3.5H?J+<=?KM%MN3,0]<$*A3$PSJ<9&XE092]KB
ME,.\F]*329Z<AES#AJ_>B<W-[-#E%7)/2RY3X,6EP85,@LI8A0&&X\*.GM4-
MMI)"$I])*1SJG6FV>=QB+(LA)@
M
M
M
M     Z]1_$>^1XGZ/78CK'1Z]KN<V\_?;@'80
M
M
0                 '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tm2227887d4-lc_rapidly4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_rapidly4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@"+P=L P$1  (1 0,1 ?_$ .\
M 0 !!0$! 0$            ( 04&!PD"! ,* 0$  @,! 0$!
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M3SFVX@U$8-4(5&7L
M
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M4*%@
M
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M6'>%I/O/4N6MQDVY#1M/,/LG]:TZC'!*BQQ(R,R[XK.#C@R8R3Q1LD5)
M
M
M                       T[KC8S^I&E5ZV=#2GM"JP%*I>;VEA1/LI/N$I
M:"3CWQ2==.S$O!T9S<X1M>;=T7>O"P]2U2;?BS9Q2&IBV7%%$FM)W+[#Z$)4
MM..4L#PP+ >N?\2":>)@INS>QF><1O&&=2=MZ@Z"71-ZTF2IRK5J+%,B?-:2
M;9BQT2&\RC-1F9F2>Y@,5NVY3QT%YS48/:3YTEBWA$TXM-&H$YVHWDY 2]<,
MIXDI<ZP\9N;M1-D1$:$J))X%S"+E-YTT$0JXJIS%X]?_ *VVO_\ +\/_ ,V\
M+9'^>_\ :,U_)7,_4=>:5_1=/_X5G_,(4GI)CH1K2X-%-)KMJ\NX+EL&C5FL
M3LIRZG)CDMQTD%E2:E9B+818"$Z:"7B?A)TALVDV)?%H63;E/MAN[J9+C26H
M;1-(<D.QU--+4>)^*9BMYRG%HO::A/>.:'"!JI;FBEV7[:>I4M5K(J1,LN3)
M+:\K$VGJ<0XR]D2I:,Q+/ QZY24[<:'G<'"XZ\Q;;VK$3B,XKZ![DD[4:(<R
MFQFZD3:DYHE./>RI1I5TB1L5ACALP[HKE5N-S>&OV$YF6]%17EM)@\3_ ! Z
ME:'7);1T.V:35;0KD4_^9S$2#64QIW!^.:FW$H(S1E,L>Z8PVEO3W7Y(RR7N
M;QANO?%/I)=VAM>HUM5OM.X[QA-1&J";#K;T-2UI6ZJ0:DDDB023PP4>)B+E
MMUHMI%N:6+,-X;=*Z]</"SJ[#..MIW4(GW+7CK+ W^I-%NU)(^4G74&DC[PS
M9RB4::5CY=!7*M;]6L-!A_!EK;9&EL:]K3U$JWNPJ9-:G09<IEQ39/,MJ8?9
M<W:5*0M)DDR(RV[><7FMZ":U>LI%.,VGY4,<MR6G7OC*C7/;3#SUO1:PQ5%R
MU(-)II]);2E+R_F[U2")./.9"F7B[<&WM;726OM2:2V)>T]\6)2+7XI*9<UT
MP'*A;*CHU0AQUIQ;?@Q,A/LMDK8>5:%8E\8KE<'*NFN'5I+9A5C&FS'K-M<6
M?$!H[J#I.Q;MI5INY*Y4)T29";0RZV=/0R:C<6ZIY*<JC2>3 N[W!10?:1?*
M64TH2V4-^<$M-K-+T%HQU=MUE$^HSIM':<Q)10G5I)LTD?(E2DJ,N\>(RYBE
M4MBH8;6M[69SQ0VO/N_0R_Z32V%2*DS"1.BQT%BIPXCJ'UI27.9H;5@/--:'
ML:9Z;>EK:FB%/!KQ!:=Z=V7<-H7W6T6VZFIN5:FSGFG'&I#;S2$+:Q:2HTK0
MILC(CY<1[+SWXQ:YO.>:"W9-/7B:IT]NBF7KQFTR[:*IPZ17[LDRZ:X\@FW%
MLJ:625F@^0U$6(K:5(-<C0O>\USH^7B5M6-9G$C5*G?-(E5*RKJJ#-8<3'4;
M*Y4)Y*$R4,.\RVU$98=T4RC5'%[7Y]!ES#WJ-;$O4;!N.E<!=#MY-:I<NM7)
M/=2A3%O09<M$K%7C$X;J4(:R_*S&?>Q![Z>Z0E%JIO36ZW[0IG!J3&FK4I=E
MI.GU.E'*4XX\F/(EI<6IW>8&727AMY!7,N7:14]*:IT%K"BHNFAIEHX'M1+(
M3I\O2V;7D1;SJU8J;T.B&VYO'F'6&U;Q*R3D,B2A6)&?,,V8CVB5/E]?[3!:
MENMO:_5^PA';MK6)9&L-;LO7VEU!J@PI$J'(E0UN-+C.FYFCRS2V1J<96CG+
MF/,7)@%F:G"JTKRZR]V&[/:F2#K5$X$J=6+?HU,D5RXNWYK<21.ITN6IB"V[
MT4NO&M*5+Q49%E0DU? (MNXY56E";A&-7H9\G&G9TFQM3K O"%$==MI5,IT2
M"\K%1;VCK+*PM7=4T23+'E^X(RUS<NN4M;_8RU_W[2C'4F2COKC;TLHMF1:[
M9\I-VW-.-LV;663T9;!+_+=:<-LTHR)Q(L#/$^39M&.4&G01DFJEJU,OBX-6
M>#F[KWJUKE;,BJL-R(E,0ZIXSA,36\CV*T)/!1$:N3DVBF9CN-).M&O26L2W
MDV]CH:^X$-2[)HUNU'3^J5QN%=U=N!;]%H[B'#.2E<=OI-J2G*1D3:L<5$/9
M?]Z*:Y:]9@A2,G76_4:JL/\ _'TJ?>O&NG_W4@8,C_(D^1^DR9CXTN5>H^/5
MA<K1'C!:ORN0GW*%-K+=P1I#:,3>A2D&W)-K'8:VU*5L[HG*MJ,H;6R<PJN,
MUJ2-K<7'$=IC?&F+%G6-<"+CGUJ9%E35LM.MHBQXQFM6]-Q*>FI6!$DMO+B,
M:LO?7(Z^:A??2@WM5#!KLLVJ6;P,V^Q66%Q9]>NJ-6NINEE<;9EFYN<2YC4A
M)*^Z,M]IW8I:E3S&&U50==?M)<<$I8\/E&Q/'&H5/_>J%,UBNCVDV-/3["&_
M _\ _C!W*?<I56_\V@9?_CZ$5G_-Z6=BQYS*<=;H_P#Q^*?_ /.=+_W+8S9'
M1/\ W>@KFOP_[?2?CQA&1\3]"[AL4'$NY@^8CAZ_BRY__:6S?\N/-ZR8/'=_
M]!I'/_SZF_=+,L>9_''G]3+?AES>M'Z<#)8Z!TP\,3[:J7+_ +1(]F:TQ_TH
MQ0U\_J)3W,PY)MRXF&2WCTBFRVFDESJ6RHB'CN_ ^9F>RU&Y%\J..?!EJ+9N
MF>HETR;YK:+>BU2D%3X<EYMQ:%2D2D'NU$VE1D9D1X8CVJL[*BM+:\R/.\+F
M/+Z2]<2JR<XP:6X6Q*YEKF1][!K 5R*I<DN5_P#I+YMUM0?)_P"YDN>/G']A
MT/9_^T]/_P!W('D_^2/3Z#(O@ES>LCM'LVKWEP&TM-%C.39EMUF36WH;2<SB
MV(\EY+N4N?*A9K/P#UYW"Y%\BZ,"F6EI1J'0JF\*M?MZ1%UDE3;?NN&\XI-2
M5*DMQ)D91D;9H-A*R0M&U*DF18\I=Z]QM^]'7Y5,,$E[K)5\-M,X8:AJQ5#T
MHA5Q-QVE%<<I53FOO*C38[R39?<:;7@:<IKP+>8&?*1#&]_=KJ+>[6AT9&!&
M0PO4/_T#>W_R_4?_ "S@I=^%EX?$CF-_=V?^N[__ /E^/_YDA[[WPOG7H9Y8
M_&N9^E'0OB _^BVJ/_RW-_W9CP7O@9[+/QHY^<"]OP[OM37.TJDA*J?7X$&)
M()7R=^U(;S_O>4>W,QWK*7*_4>2U*EUOD7K(F4BV[RK%UTGA_?><2S&O!UA=
M-5L2S*4:8TE\_ TUB)LR4]V3V>;2^G86O5@I):W1<I)[C\IL2B5S2NA4]LF:
M?2+8>BPF/F-LNI;01_O4D,%F3=YO6TO2S-)4LQ6R7J1LGBV+#A@T7[ZZ*9'X
M:88B[CF$N5D6G2T^CTGX\./%'I'IKI#;=FW759\:MTU<LY;+,)UY"4OR%N)R
MK22DGL4,U]N<JK8CSV$HQH]K)6:=\3&D^JERMVI:%2G2ZTY'=E);D0W&4;MC
M U&:E%A\H87!Z3-O(QO3_BNL/474R9IG2*=5(M0:7*;IM6?0A,>8N&2C?(DI
M4I:-B3-.;''O"(1WH;ZT$S>[+=>DE>(!@5_6'0-2;5J-G74R\_1*MNBEM,.K
M9=^J<2XG!Q!$9;2+F$-)XDIT+'I;I'9FCU)J-#LB+*CP:G+ZY*1*D+DJWN4D
M&9*7M+81;!:4FUB544G4VR(),4NJT[<O6A3K<NBCQZY19Z,LJG2$XI-7R5$?
MC)47,9;2YA%"4R)SG 7H<NHG,WEQ-QB5F.E)GHW&'S<RFC=P_?#(KC11Q3)"
M-Z16#&T^J&F%/H3='LZI15Q)L""I33BDN8&XM3V!J4I1EM6H\12;W_B+0]W0
M?-I5HK8NCD*K0+(B2XK%=?;?J")DE<E1N,I-*,IKV)P(Q>5R4E1ZB%%+06?5
M3A]TYUCGTNIWM"FR9-&CN18)Q9CD9*6W5$LR42.4\Q&*0>Y+>6DLW5;KT:2)
MO'_!C4NP-*:9$Q3$IU1D1HR5'F,FVHJ4((U'RX)2)A)RN5>M>LAJD:>6L^O3
M'A%TBU.TPTXO"KL52D5FHT9E=672I:6&Y2TJ4G.M#B'<%&1;33@,LYN,L#'!
M5CB34L[3&SK"M)5D6I2$TRA/,NMRF4J,W7E/IR..NNF6*W#+G,QAFW-49DBM
MUU1AVE_#MIMH[5:C7+*ASXL^JQ4Q)BY4Q<E.Z2X3G12KD/$B%M]TH0XJM3Y[
MZX;],-0[SC7]<T&H/W)$**33C,UQEK"&HEM?5IV'@>P\#VB(R<=&LEJN#-EW
MK8=J:A4&3;5Y45BMTJ3TE1GBP4EQ.Q#K3B<IMK+F,C(Q6FLE8$6V> K0YFHE
M-6[<,B.2LW9;E0(F3+YIJ2T3F'[\9%<:*.*)#5?2*P:OI[)TK[$32K+?:;:7
M2*<HXQI)MPG4Y5IQ,U&I!&9F>)\XI)N3JR\'N+W3WI?I3:&D%#EVY9<:3'IT
MN6J>^W+D+D+-Y9(2HR4O:7126P6E-R2KJ*Q@EH,7U9X>=--9U1I=V4V0S5X2
M-S$KM.=*-+)KT:C-*DK21GR++$N856#JBVG UM3^"'0B%1%T9VD5*>Z[)1(=
MK<B:OKG1)22:)31-H2CI;2).)\XO*XV444;,G</NG52TQIND4YFH/V729*9=
M/C'-<ZPA2'%N)+?>-E(UJV"LVY24GI7^'H+0]U-+09IISIQ;.EEL,VE:4=^/
M1HS[S[3<IXWW26^K,I6\69\I]X3.;E2I"BEH,AN*@T^YZ'6;<JK:W:97(CL"
MHMM+-M1LOIW;A),MI;#Y2%'&I9.A&5W@HT(<MV3;[=%J#"'I*9;561-6J<RI
M",AI;=<2M.11<J3298[>47=R3(229FFDO#5IAHY,>JMLT^7-KTAHV#KM4>*3
M):;7M4VV24H2V2BY326)]T'<;5-1&XDZG[7YPX:7ZCW=$OFYH4]^OP416X[L
M>:XRSA%<WC?U9;#VGMV[1%MNVZQTDR2FJ/0;-O.Q+7U!H4RVKNI#-9HTP\78
MKR33D6GQ76U)VH<+F41D*LE,BY&X#=#(]33.=5<,R.2B6FDNST[@TERH4:&B
M<,O L9%<:36TJXIDN*!;]%M>CP*#;],8I%(IC6XA4^*C=M--EM,B(MIGW3Y3
M/:(E)R=6PE141&R_N#C1>_ZS*K[]/J%N5*H.*>GJHKZ8[3[BO&<4RIMU!&?.
M:4D0B,G'!:"6JZ38&E7#]IIHXF0[:-%<55IB-W+N">YUJ8MLN5!.&24H1WDI
M+'GQ%I7')4U%5%(^_5?1'3[62GQ(5YTQQZ13LW9E9BN''F1L_CDAXB5T3,MI
M*29#&E2I>IJ*D<$^A=,H51H[M*J=554UM*?J\N6?74DR>8D,*:0VE"3/EP29
MF,CN296,4M!(73^P;=TSM6G6?:K#T>B4I3JHK4AU3SN+RS=5BXO SVF(G-R>
M(44M!GN"?HBJ1)&?4SA3TBU2JC]?K-(DT>X)>"JA5J,^49V0KG4ZE2%MK5WS
M01]\(O=T!XZ2V6#P?Z*V!58]<BTJ7<-5A+2[!EUR0F2EAQ.TEH92AMLU%S9D
M'@+]HR-U$JR))<GRA0DC]J?PYZ8ZO5V!<5Z0Y\BI4Z&F#'7%FN1T$RA:G,,B
M>4\RN4A,'N.JTDR=4D]!O6)%:A1(L..65F&TAEHL<>@A.5)? (>+J52H?<!)
M0]NP 1?U.X4-(M5*R]<=9ITRC5V81'4*G1WRC*DJY$K=;6EU"C/YV7'NF)@]
MRM"))2TZR_Z3\..F&CSTFH6I2WI%;D-*8<KU1>ZU+W1^,V@TH2AM)\^1.)\X
ML[C:IJ&ZJUUFQ;WL&T-1:'(MJ\J*S6Z6_BM++I8*;=+D<9<3E4VLN8TF0QTQ
M+)D8(? ?H9$J13GBN"H1R63A4B1.+JYI)6.11MM(<,C_  _",JNR2*;BI0E]
M1:'2;;I<*BT.GL4ND4YI+-.IT=)-M,MHY"(B[XQMMNK+)4(UZA\'6C6H=;E7
M#,@5"WZM4'-]47:)(2PW(<6?2<6RM#J"4?.:2(@BW'!"6.+-A:5:":<Z,LRS
MLVE.%4IZ4HG5R:[OYCJ$GBE&\,B)*3,L<J2(A:5QRP>@A12QUEYU+TAL+5RD
MLTF]Z(FH=4,UT^>THV9<9:MJE,O-X&1*YR,L#YR%5@ZHM7"A'VD<".AM,J+<
MZ0BO5QEI9*[,G3DG'7E/'*YN&6EX=XU"ZN,IN(F!3*93Z+ ATJE0V:;3:>PE
MB'!8;)MIII!8$E*2V$1"CDVZLLE3 UCQ"8_L3U1YO_AV;_NS&.YH7.O29;'Q
MHYI\)&AM@ZV6MJ##O.')ZQ1ZA3CI=6@/$Q)82ZR\;J$FHE)4E1I+8I)CVW/=
MC%K:_4>2#K)\R]9T0TCX=-,]&W94ZU($F56IS6YD5ZINE)E$R9XFTV:4I2DC
MPVY"V\XPN;:IJ,B@D>+AX;=,+GU%:U1JL&>Y=T:5$FM/M37&V=]!)*6?JBZ)
M89"Q[HK"3AH+32G@\3,=4-*;1U?H<6V[TCRI5,AS$SHZ(LA491.MI4A)FM'=
M)P]@K3%/663P:/E@:,Z?0=-V-)G*+VC9+;2VBILQ:GUY5NFZ:R?Q)9&2U8DK
M'$A:<G)IO45BE'0:0HG UH71JVU5WHE8K;3:C6U1ZC,)R(1]PR;;0XHB[BE&
M0MVC]1&XF;,TTX<=-=)JO5*S9D6HQ)E8AJA3FWYKLAM3*EDLBW:]F*3+8>(A
MS;CNO0-U)U6D]Z:<.>F>DUP5"Z+.A3H]6J<9<26Y)FN2&S:<=2ZHB2K86)I+
ME$*34=U:"6DWO/3[3(M5-'++UBIM,I-[1Y4J)2))RH119"XZB=4V;9FHT<NS
MF%4J.I-<&MI=Z+IS;% T^:TSI[$A-K,TU^E-L./+6Z4>1G)9;[EQP6>W 3<>
M^\2(+<T&*:4Z"Z>Z+NUEZR(DR(Y76V6YW7);DG%+!F;9))7)RGR"SFWI(W4M
M!:I_#;IA5-26M6)D&H+N]J?'J2'DS7"9.1&))-'NBQ3ERI+8(A)PP1,DI:3]
MM6^'/3365R-.NNG2(]:B-&S'KM->*/+W9GB32S4E27$]PEELYL!"=-!-=IKF
M#P1Z#Q*&JC.T:I35G*3)=KCTY:)JLB%))LEM)0@F]N.4D[3Y3%Y7&RJ23J;\
MM[3.S[=L./IJS 54;0CQG(79M34<LEL.K-9M.*<(S,B4H\.X*7/?^(F/NZ"-
MLW@0T,F50Y[*;@@1C6:U4F//2<8BQQR)-QI3J2\*Q=7)(B44R4UEV1:^GMOP
M[9M"BLT6CP\5-16"QS+473<<6K%2U'SF>TQ63<M(22T$>[[X--%KZK$FNKIT
M^VZC.<-^<5$D)8CNNJQ-2U-+:<0G,?+D(A:,W'02\=)LG2K0/331UN2NS:,O
MM.:@D2Z]-<W\QU!8?5[PR(DH,^9!$(E-M4U%5%(MMU<-^F-Y:@1]3*W!GNW3
M&=AOMO,S'&F<\'*3/U2>CL)!8[=HB$G#03)*2Q,HU1T@L?6"E0J/>U-7-C4Z
M5UJGOQW51WVE&611(<09'E41;2PPY!"P==9:N#6IF$R.&/2Z9I[!TNELU:3:
M5+JAU6G1%U!TW67LIDI+;A](FRS&>0MF)B9-R:D]*(BE%-+0S(7M"=/G=+&M
M'5PIIV2QER1RE+ZST7SD%]=XVU9A-N;3>E:!#W$TM?K,@TSTOM/2.WUVM9L>
M2Q279CD\VY3RY#AO.Y"</.L^3!!;!,IN6G40H*-::S"[0X;],;(OR1J1;\*>
MU<\M<Q;S[TU;S)'.,]\>Z5@6W'9CR"L6XQW5H+2>_+>>DO6J6AFF^L$>,B]*
M)UB="(T0*S%<./-92K:I*7DD9F1<R5$9 L'5#2J,U%:G!%H?:U4:JSL&J7.[
M$63T>)6927HI*3R&IIIMDG,.<EGAWAD5R2T%'%$C;PL6U[[MB?9MS4MJ?;\]
MLFG8)8M[O)@;:FU((C;-L]J3+D&)XXET\*&E]+N%7332*Z'[LMF36Y54<B/0
M4)J$MMYIME[#,24H9;Z6PMJC%W-N.[J*[JJF9!IKPY:9:4W)/NNTH4^/6*G'
M=B3'),UR0WNWW$N*)*%;"/,DB$J;4=Q:/8))2EO/2SWJMPZ:8:Q/M3[LI#S-
M:C-[IFOTUXH\PVB\5M:L%I<21["SD9ES"D7NZ"VDQS33A*TATNK$>X:33YE;
MKD)1KIM2K+Y2#C+YE,MH2VVE7<,TXES#([K:H4W54S_5'133O5^#&B7M1>NO
MP2/L^L1UJ9F1R6>U+;J",S2?.2B-/>&)8.I>N%#25M<#.AMOU)BIOQ:O<6X<
M);=.JTQ*XV);2);;++)K+O*V=X95=DN<HH(D+?NF-F:DVN=FW72$2Z$E33D=
MADSC''<9+*TIE36&[-"3RD1<VP8M==:+IM*FT^ZP["M?36VH5JVA3"I=$@&I
M:&<RG%*<<,C6\XM9F:EJ,L3,S%Y3<G5Z2L8I:#/14D
M
M
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MMN@;I5'I;CSZ$L]6;)EO!33J5]%)X;3!MN6]K"P5-1KG^R'PYX?_ $QBX_\
M&U#^<"RFT5HC*K*T T?TZKJ+DLNS(]!KK;*XR)[<B6ZHFG=BTY7GW$XF2>X#
MG)H;JKH+K0-&]+[7NNHWQ;]EP*5=56S]=J[!+)?UZL7<C9J-#><]BMV18BJ;
MC'=6@E^\ZO2;8        !#0 D   !@-XZ>61J&Q#B7I;4*YH].<4[!CS4;P
MFG%D25*(\2P/ A%*$E^H="HUL4F!0Z#3V:51Z:T3-/@,XI::01FHDH(\3(L3
M$MU9"5#(
M     $4 $@        +'6*/2[@IDZBUF$U4:35&5QY\%_$T.M++!;9D6!F1D
M0AI,E-IU1C5EZ;6'IZU/:LBUX-LMU5:%5%N$C(EY39*2@U'B>.!*,6;;TE:)
M8HV"()                                                 (H )
M$4 $@
M
M
M
M                                                /P==;9;4XZM+
M;:-JUJY" '[@
M
M
M
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MMO/NU^3Y/E$(!0JM!,_RJL%<^[7SY?)\HA(H"JL$\N#BNEAA]6OY67R?*(0
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M *E581GL=5AW=VOR?)\H@J*'INIQ'EI0VXI1J\7H*+YO=3Y0D4+F!
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MT.H?V6M#?U*:]>_YX??,[^8Q_8W!O^M ?V6M#OU):]<]YX??,[^8Q_8_!O\
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M'%2CCF23D:?.=HY/E8.JR;SX"P%?PEM9+BX?Z'J'^R_QB(Z07L0
M   (2\<F/[-[:P(S_P"?%R%C_P"&?%H+$/02HT__ /05E?\ R]3/_*MB@,R$
M@   +?(D,0F'I$E],>,P1NO2'5$E*$I\8U*5L21 #7C&LFD\JH=DQ]2;<?J1
M8%U5%1CFHU'R))6\P 4-HI5FVEXH ]
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M6<_8C?L2WH2T/RV&=I/$L1C9[$ST()
M  B+QI?_ $::_P#F&G_YCPM'2#<^BW_TETW_ .@0?]T0AZ26;3$$
M
M
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MC/NCA/%=J/:0FM+1^@?T@S=V>5O6W\$9)KI6*Y-IT:3R#DC[">A(
M                   H9X P:W;U4TQ?JSE ;U%MERNLO&P_0TUB$<M#J.B;
M:HY/9\Q'RIRBJ=2:&?-/-2&VW6EDZTYM;=0>8A8BAIG7BL:<46R$S-4Z$[<=
ML'4H[::>RWO5%),E[M>!.-<A9OE"8H5,ZL*10)MEVS,MB$JGV[*IL9=$@++*
MMJ,:2W*#+,K# N^(!FX               AL *@"0
M
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M1RUKDND]_65'(ARIY)RG*ZJZ;27\"V&:B+!1ESB;\%"2IK745M2WEB2*&$R
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MGJ7I]48ZG*7>,E3354IRB3G0U++$NLH=+Q5IZ1?*V"U:Z2,"0 $
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M2?7M:J;7&65]FV9#E3*E+Q,FT+E,+BQVC[IK-9GE[B1CD$=EQ0D
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MT]V6C4]II,Q8=F6ZS<(\=3SE18
M
M                          $%^/\ P+12EXEL.Z81J+O;B2*K^;#G?H,L
M/Y4^9>DTI8^B/%'>>F]LMP-;(=)L.OTAE,2B[Z23C,!UO F%):CER(Z)D3G>
MQ'INT4VI8[3S6V]W D;1N'ZTM'M![_MU3;5SU*32*C5:M5Y\9"MY,8B.$TME
MM68FTLD9D@R/,6)GCM&#,7'..&%%@9;$5&=7C5FM?[OZE4MS3>O5ARF1%UAB
MX'F&:NIEM4E#2HS)FVA[+O"+O8CTW_AA39ZS!;7O27*=#R/$L1Y3,5$@
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MU\R2(2XM*H3/OU*UOM;36J4:W)5.J]T7?7FEO4RU+?B*FS5M-^.\IO,DD)+
M\#,SY H"Y:<ZPV;J=0JI7J+)D4XK=><CW+2ZJUU693G6DFIQ,EM9F2"P(SQQ
MPP"C0J:JC<7>FLB9#<72;EB6E4*AV73M1)-+4W179.?(DB?SFHD&>TE&C[@G
M<8J;,U.UFM72XJ)&JC-1KE=N=Q3-N6Q1&#ESIBFRQ4I#:33T",R(U&>T0D#U
MIGK+:FJ#-<31VYU%K%KO%'N2VJU'ZI.A+PS)-UI6)9%8&1*(]@4H#6+W%]IF
MS*?=32[F>M"/4.RI.HC5,4NB(DY\AX2,V;)C\K)]P3N,(VIJ1K%9^F%(HU5K
M+DJJ.7*^B+;5'I#)S)E0><(E$F.VG8HL#(\<<!%*BI\&FFMEK:F5"LT&% JU
MMW5;R6W*O:==B=2G-M.>*Z39J4E2#QVF1D#5 ;3N#^AI_P#LB_=! O8@
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M,>8LHK,E$_A4D
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MF4NP56L#>A'B6)#Q'F*@
M                        \9BS9?EX #V
M                     -":^Z,IURLN+9[EP+MIN-4V:D511'*4:C90ZC=;
MLW&N7><N(K2DE+8R\94BUM,_T_M3W'LJU[/*:=2]VJ<Q3^T#;)HWMRG*3F1*
ME88]S$99S<Y.6TQ1CNX&0U:F1ZU2ZA1Y[>_@U:*]"GLD>7.R\A33A%WS2H8I
MQJGS%TZ-$3-'^$UG1R_"NNC:C56I4-I$A#5I/,DVTK?)-"5/+2X:7%-D>)'N
MR&57'N[K11Q]ZI,TBP+ 4+E0(                  "">I'!S)OW4RNZD4[
M5.=:,VM+;6TQ#@YG8^1DF5)2\F2TK:2-OA$PDX)I:Q/WFGL1DFE/!_9NGER-
M7I<5<J&H=W0UI=@5&IEE98>(NBXEK,XI2T\RE*/#PB[N.E$5<$])>=;^&*A:
MOURDW=%N6=9-YTEIMIJO06R=)QM"L[69)*;5G;Q/*HED?,,<&X-N.LO)*2I)
M:#7-+X+.RKVLZ_RU5J]9N"W9K%0JTFK12E+GOL.YBZ:GR4RDT8)(NEARXC)&
MZH-T6#]FDQRAO))NM#6_'?=%B7)#MBSZ346ZIJ90ZWN"H\5)J<CLRFB);;QX
M88K4;>0B[XI8BY7531KY"]QTMNNG43IT>L=K3G36S[/0E*7:/3V4U##E7+<(
MW)"C[N+JC%[L]Z3IHU<Q2W&D54R:\+3H=]6Y5K3N6(F=0ZVPJ-/CF>51I/:2
MT*3R*2HB,CYC(8FDS*FT07<X!X:=[3(>L5P1K/D/;Y=MFPA9'@>.U1/):-6!
M>,;8RJYA1JI3=Q)HZ=6!;>F-K4NS[6B+C4>FDHT;Q6\><=69&X\\X6PUJ,\3
M/X-@K.3DZL1BHZ#8HJ2           !38>) "&^J_"52=4]5*?J5(NMVDH:*
M 54H*8:'BD]061X&Z;J<N=!93V&+6I]F\%R^HBXM])/5_B9YQ :"P==[?HE%
M>K:[9E4&<J7%JK49,H\JFS;6SNC<:V*Q(^7F%(NDE+G+:MWF\QGFF.GL'333
MZW; 9?*J1:#$.-(F.-$CK*G%J4XM36*BZ9K,L,1>Y)S>/,4A'<1%JXN!VC+N
M&H5O3S4:MZ;1JLM2IM&@IWS19SS*0VM+["R1B>Q*C5AS!&=%1EI*KKK-[:<<
M/]F:>6!6]/E.3+IIET*=7<[E7<-?6W'DY%F2$X$V1E\TS/';CB*S>]J$5ND=
M7^ Z'%ES6+7U@N.W;5J+AKDV\A&=1H5L-"G$NMI7LV8J;Q[HOVE4JD2CC58&
MTK\X5Z)=&C]KZ/T.YIE I%L3TSF*E*;[1D+-*'B4E1*=:(L5.F98;"Y"(4G-
MSN1GHI4M'W8N)[U+X7*'J5I[8MGRZ^Y2J[I_%CPZ3>+44EO+9:;2VXA;.]2>
M59I)1%GZ!ELY1:5QN[VA5+W'#4S?]E4:MVY:U%H-?N$[IJ])CE'DU]QDHRY1
M-]%"W&R4X1J).&)X[3VB)O>=1%45#-A!)%>V.'--L:[W'K8B[79CEQ=<([;.
M(AM+76TH1MD;U1JRY<?$%K<]R#CIK[:BY[[3V>RA*<N046@%1(
M  _%24N)4E2<Z#Z*T& -$7EP[:77C).J=A*MFX2/,BXK><.G2R7\[ZK!"OWQ
M"*%E)FHJ;I=KQH[5Z_7]/Z_3M5(=Q.LOU^F7#FBU)]4=&[0I,K.2%&E&);5%
MC\T3%Z(O14F33=29<-UYV+'<D,=7?<;0N1'S8[M:D]).//@>P"A]X  "U384
M.HQ)$&=%:GPI32FI,1]LG6G$*V&2B5L,CYR, 0\H$:-"XUKAB0V&X<:/IU';
M8BM)2E"$I>:Z*4IZ)"[^$C6?;220[QMW2IXLZHVG<;J)+^3C(9SY/A/' '\(
M-/R5R(MX\=**;G9970&W5;GEWZHB\Q]'Y1DI6(G81M+S>$:FE_=_TTFB:4TS
M;5+=C'CXK_6FU&:>_F,P7QAOW3(J69R>)O0-4PS<>1I(IZ.;O)OE(,E+3W\,
M<1&IDZRUU1<B/Q)\3A024VAS29#SQMEA_&$Q6]VK9\O#' 3J06D^"AQZ>?\
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MORY']/:U'B&S<VF-TT>:BH,.&DTNPU,E'<;>+E3T=AERD0R3ISE(IIXX,NO
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M97OSBNDPRHZW::T\S+WC3-4GE;AM+>/X23A]\>^UP'.7/P4Y\#5W_$F1M?\
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M0M#)$:5$:<2,C2>P0](-DG58)'^47ZMSO^3Y(@8@ZK"(_P HOP[ISO\ D^2
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MH!F+NA0#,7="@&8NZ% ,Q=T* 9B[H4 S%W0H!F+NA0#,7="@&8NZ% ,Q=T*
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M9Y1^6ULQ[J3&HFL37HE(*D@
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MZ;#M&XJINBJ-:I<6;-)DLJ#<=;)1FE)YL"S&(>D&?
M    -=:G6>=^6!=EHIRI>K=-?CQ%.X&A,C+G949]PEI+$9<I=[&]&YL>/,9;
M5S<DF<,JC3JA2*A-I-6B.0*I37EQJC">2:'&7T'@M"DG][XA]"A.,TI1T,ZF
M,MY)K$^(SY3-1$22Q49\V'.+5+4.L7!W850M'3:36:Q%<ASKVF]HL174FA:8
M:&R;CK6D]I&LLRL#^2I(XSC68C=O[J_"J'/<0N[]RBU$O1J3P
M
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MYY][>+'T%C? _P">'=N%_P!3S>PK]Q\5[,K^_P"TK[W<6/H+&^![SP[MPO\
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MV,V;(M2>DG]Z8%3[@                   66X/Z'G_ .S_ ,8E$,O0@D
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M\8$CP+-6&/S5CCI8G.H[ BA(
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MH]YS.SL=F"'F([BD8ERY5&?*/G7B&6_FFWL/HG +#L996WI3=>?6="AI#=
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M&6YGKDU2M%R$G"(DH(D["&M/$>Q(
M
M      #![T\6F?AN_P":0].5^)FLXEHCTF"%S> >Q:#4,J)(
M
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M$XJC1JRT3D=[$D+(RZ*VW4<J7&U=%23YQ4DS4
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M'@(BL14VII54ZA6--;'JM4EKG5*HT2)(GS73Q6XZXT1J4HRYS,'I)-E""
M
M
M      P>]/$IGX;O^:0].5^)FLXEHCTF"%\GP#V+0:AE1)          !IK5
M#7"Q=)E0XUROS9%7J3!R:;1X+!NNNH(\N8W%Y4)+$C+E^X,4KJ3W=9Z[66E<
M55H+-HEK5^V1%VRV;?*@P:!*BQXC:WM\\\F0VM2C=-*4D1EDY"(7B_=WB+]G
MLG0W]R;!8\P @                        $@"        $@"
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MJ85*IV.'5D_X9?-(:M'D*E2:>1[(Z/!]'S2%B 5*IY'@4='P_@^:D":GDJ3
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MSTE.R:=[,CX0H*E>R*=[,D .R*?[.D .R:?[*CX3 5'9-.]G2%!4=D4_V=(
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MZ*E4Y)X%'3_AAYI "K5-@LK0MN.E*D>(?P>:0@%R$@
M                    ,'O3Q:9^&[_FD/3E?B9K.):(])@B>0A[$:@J)(
M        ,3KENV_/.16YU#@3JQ"I[[$.IR8Z'G6D$E2B2VM9*RD2MNP8;J]U
M\S/58FU.*Y40\X'OZ.U,_P"H0_\ ,=%K7\E&?B'\WH]9.\9&:X 2 (
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M9#IM"G+:/'D<-DTM_C*(*581P2H3.=IZ:X1+>=4IIM7.E"3Z7)R9C(S,?2>
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MX;>K'!%J=0(\9PT3ZW;*X]QQ"2V7UKJ282V9)PVIP5M[HK@52;)7:&:ZV;Q
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M<]"S*=NY)1K1JN!.EMU#J4+:<2XA98I6D\2,N\9;!PSTTUGT!--56@^@26
M
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M                           !@]Z>+3/PW?\ -(>G*_$S6<2T1Z3!"YO
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M$P8S*UG+2<AQM:3<2:4I+ D'CM&.PMV+3UGMS%Y3C&FE:236)GRC(>( 0
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MG6E/25EYLQ[0*GW                    LE?\ Z'G_ .R+]T2@R]B
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M,5FC5)!.0YK)XI-)<J5$>U)IYR5M(^4:0WQE@D@
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M>Y?=EUFO>5XIPMUCO;O)[T>K'#J,[MOB5DMFW&NRADYEV.5"G'E61]U3"_\
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ML!RTH.#<9*C6D["$U-*475,N8JBP$@
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M\GP#V+0:AE1)           Y2PYCP/[I 2,RL>4S,^Z(%0)(
M                                               !(!D
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ME%/0VEUE7[Z>VC?4B;<&44V%%F$A31RV4.[H_&3O$$K*?@Q%VJ-K88XNJJ7
M02     8'>&HMC6!#3.O.ZJ;;C!IS(*6^E+JR_U36!K<+\%)@E4%UMZXZ1=-
M IEST::F31:Q%1-@SE)-LELK(U)6:5933@1<X4!IV)Q/Z(S[C;M:->S"YTB7
MU"/,4T^B"[*,\FY1+4WN5'CLVJP[XG=8J9YJ#JI8NEM.B5*]JZW2FY[AL4V-
MD6_(DNERH:9:2M:C+GP+8"50>]/M3[(U0I<BIV57FJPS!>*/46LCC+\=T]I(
M>9=22T'W#,MH-- U_(XG]#HUQN6N]?+"9S$PX#DTF7U0$22/+NCEI;W.;'9L
M5AWPW6*FQ;ZU'LS36BHN"\ZZS1J<\X34-:R4XN0ZYTDH9:0E3BS/G)) DV"W
M:=ZNV!JFS.=LJX$U1VEJ2FITYUMV/*CFK81N,/$A9$?(1DG 0U0DSNO_ -#S
M_P#9%^Z)15E[$$@     0P1&UOUNT'=3>F@MU:]4O2:_:K1]R\\^^U&E0&IS
M9*;>;7,;*.LU(,NB:CQ(\,!245<31>+<6F1*TUT#XHM.[<A6_P ,_&]:.H-F
M4<EE3Z!<M)BSF6"6HUHCHD0G9:VVS-1F1$9$6/1+ 993D\7B5HN8F=H!+XJ5
M.7+2^)&E6.VFG(BIM>Y[-=D&FHN*SE(4^Q(,]WEZ.&"4X]\2Z4Y2N->0P3CF
M-!:;VUB9)/MXL<?^%?$V\&'H)3Z>_P#H"RL/U?IO_E6Q0EF:   .?7'U6]Q:
M=AV\ES^E*O(G/H\F&P24F?[YX7AM(9R[@)-"9"5E@Z<APWMN![,N'WL!I.(6
MY0O.,M.H^$^*]^'%+O:::X:GNT5?4?=@7,/&GJ9SS-O\/U\1M/\ 6FQJ[4'5
MMTM]R53:J9'L0Q*:W9.J[J4KRF?>&TX/EKF8NN$%H3?0EB;WPUQ>WPW/1NW7
M2$EN/8MYI1ERJNO8=TV5I61*2X3B%$1I41D9&1\AD9=T>\^]5KB?2#1)QKU2
MI,GAUXCFJ_3X>:WI<OMF#",OJY%.FFI$Z'@>PRVK1@?>&2-7@MH2]Y<YH&IR
MX53J]8K$"$W3XM9F/2XL%HL&V&75FIII!'M)*$F1$0^B6TXQ46ZM(ZZ-5%5T
MGR?=P\ N2G1D\."&^I,>LW1I]+GI*F/14UBCQGG"(D2"=2R^AHC/\X2DJ-)<
MY8]T<WQ_+JD;J6-:/U=1JN)V,%-:3HQ-GPZ7#E3Y\MN#"@M*>F3'C)"&VT%F
M4HU'L(B(<PL7@:4Y':TZKW3Q+7]3-/M/H[SUL,R]U0J>G%LIKJ/RE0E=QM"=
MJ<?%3MY3,9(JFDBIT6T4T;H.C5H-T2GF4RL3B2_<==-."Y4DBV$7.2$<B"_Q
MF8JW4DV+<5H6M=D9,6Y:'#K+36UDY#9&MOOMK+II_>F,EG,7++K"31AOY6U?
MC2Y%27*JF/V]I3IS:TM$^B6G!BSFSQ:F.$N0ZV?^K6^I9I_>C+>XAF;RI.;:
MYS!E^&Y6PZVX)/F,SJM'I5;B.0*M 9J,1[\HQ(02T^$L>0^^0P6;T[4MZVVG
MR'HO6(7H[LTI)ZF1BO3AR0M+TVR)A,J49GV%,5]69?-:>/$R\"OA'5Y#Q.U[
MN86'S+UHXOB7@].L\JZ/Y6\.AZC0UHSKHT2NB2;5.D4AF>LE5VUWB-$29AL-
MYHMJ4N$7(M!_A8D-G?X5E.(1[2TTGM7K1JLOQO.\+GV5Z+:V2]$9:V3=L_5>
MT+S:RPIZ851)&+]*F&3;Q8%B>7$\%D7=28Y'/<(S&4?O*L=36C]AVW#N.Y7/
M80E26N+P?[3 ;CXD+.I,MZ%184Z[%QEFB1+@DVW$S)/!1(?=4DG,#V&:2,N^
M/5E?#V9O0WFE&NW2>7.>)\IEYN";DUII[3([(UQLV]*@S1RZS0*U(QZK3JDE
M*"D'SDP\@S0M1?-QQ[P\^>X-F,HMZ23CM1ZN'\=RV=ENP=);&;L&I3-P!(
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M9R+FP+G,?.?&G'Z?_3LO%_&__;[>H^K_ *?>%E-KB&87NKX$]#IIF^1?AZS
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M\368V\PI+\2J^<^F>$\Q*[E6G^&5/,2A(\1SQU!4
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MFH_M9>(OF+%01+X-J/5J)I14H=;I4RCRG+KJ[J8DYEQAQ3:W$9%Y'$I/ S+
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MNGXX_,N5+KYS;?$Q<RCIMNVG$DH.)7W'Y=:;0K\K'AY-VTKR3<41J+GRX#]
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MB^X0^>2FYO>EBV?4804(J,51(^SM"![9']8D06*]H0O;6/6) #M*G^VL>L2
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M$I0E)$22(:-MMU9WT(1A'=BJ):"[@6
M B@ D
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MW7@OCBXMPZ$Y/^)#W9\ZT/I]I3CG#WD\S*/X7C'F-*\0^B#=WPWKRM:*7O5
M9,ZE!;(B*?'26)E_M4%XI\Y;!X_%GAGOL7F+"_B)8KYTO_=Z=&DZWP1XN?#Y
MK*YE_P &3P;_  /_ ([=FDBM O.HWE;U$M>JYY=R6>MTK?6LOKID%U))>A*Q
MVJ>:RI4V1^,1&GQL!L?TO\9QLWNY9N5-[W8R>W5%^KJ-;^L/@"5[+OB&1CO)
M>]."V/3*/(]+ZSXFG6GD$ME1.)QP/+RD?<4GE(RYR,?HI.N@_++K#"6%-1BU
MWUZ/1Z1+22R7-DMJ8CMEMRJ6G S5AR8%R$8JYJ*JV;7@_"KW$LS&U:6'XGJ4
M=9U$TBJ<.OZ96'566&T-R:'#3D2DLJ5--DVX1?ODF/E.=@XWYI_,S[#<L*Q+
MLUHC@;(W#/H4?0(>8H-PSZ%'T" #<,^A1] @!$CC00TWHTR:4);QN"G\A9?D
M/BT=(-SZ+-,KTFTX4;:5?\@@[<O^I%7I!M#<,^A1] @ W#/H4?0( -PQZ%'T
M  W#/H4?0( -PQZ%'T )*;ECT+?T" @&RP7YE'T!%01&X@KY2_(9L*C))9I6
MARNJ9(C4IPS^JC%ARGMQ,N[@.S\-<.W4\S<_V\VN1P?BSBCDUE;?^[GU1];Z
M#<6DFG[5EVRAJ:T@ZY5,LBKJ,B4:3,NBR1]Q!;#[XT?&>(]\OMQ^"."]O2;_
M (!PKN.72E\<L9>SH])MC<,^A1A^ 0U"5#?#<,^A1] A-"!N&?0H^@0 ;AGT
M*/H$% -PSZ%'T""@&Y:]"CZ! #Y)5,@SF#BS8<>9%/\ *17FD+:5^\61D)BW
M'0R)14M)!N7"AZ>Z\-]4B,4VGKJK3A-LM);;3%G))*B(B(BP(UF.^MOOO"J5
MJ]U]<3YG>_\ H<9JE1;R^F>'I)VE'9PPW*,?G94CY^?3L#UN&>=E!_O"$T(&
MX8]"CZ  ;AGT*/H$% -PSZ)/T2 DIN6/0M_0(""NX8]"CZ $C<,^A1] @(&X
M9]"CZ!!0#<,^A1] @H!N&?0H^@0 ;AGT2?HD!(W#/H4?0(""NX9]$CZ  IN&
M?0H^@0 ;AGT*/H$ &X9]"CZ!!0#<M>A1] @ W+/H4?0( -PSZ%'T" #<,>A1
M] "1N&?0H^@0$#<,^A1] @ W#/HD_0( -PSZ%'T" #<,E^91] @ W#/H4?0(
M -PQZ%'T  W#/H4?0( -PSZ%'T" #<,^A1] @ W#/H4?0( -PSZ%'T" #<,^
MA1] @ W#'H4?0 D;AGT*/H$!!5++*=J6D$9^2 /W$,'YN&1(Q/D"HH1"U XO
MK&M6J3+>M>CS=0JK <4U/>IRVVX++J=BDE*61I6:3V=%)^$<UQ'Q3E,G*C>\
M^>GEZ#LN$^",]GH*;6Y%Z*Z^CVF-VWQKVL_.9BWM954LN*^HDE6DN-SXS9J/
M\Z;24*07=,B,>;)^,LIF)4=5Y_-1>L]>?_3[.Y:&]"2GYO23+@52'5:?$J5,
MDLSZ?.92_"F,*);3S2BQ(T+3LY!UD9QDDTZIG"W(2@W&2HUJ+T+E
M                                     #4FI6LFGVDM/C3KXK[=).=F
M.GP&TJ>F2#0>!FAIO$U)+G,SP[XA8X$\IB6FG$OI)JO4NP[4N!2:\I*EL4>H
ML+B//(272-HEYDJ,N<B5CSX#([<ECJ*[R)$#&G4D"0
M         $ "0                           $-@"0
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M+>J-<DM&VBL3G'=]O&C_ #B&T)VJ^X$/Q/4WAT$36$>9DG!8J
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M4WQ6>-/2&/:,^O429*GW"C*W3+-DM*C2GWE<B369+02$^,I1*,R+[@KNLFI
MRX^*K7*X:BN:B\W+=CDX2H])H[+3##22Y$$;B%K61=U1F+[I%206@_&)<+]P
M4ZT=6'V*C3ZR\B)3[N0VF.[&?</*VB4A'U:FUJZ.<B(TGM4>&TJN)-3IV*@
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MZB58ND=0@L2%?AJ068ON'B.0S5EV;LX/4VCN<GF%?LPN+1))F1CSGJ
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M.<I52=<2262D*P/,M)XFCS1:6*!.04
M       $4+OX9*5?FM--U6NJXEUBETQMAJ-8DB(A<7(PVHDDIPW,#2;JMX99
M,#/$CV";4MS>VL7/>22T(B7=M+MN[.,ZQZ9H]38L)-IOPW;OFTEE#41#L%Q3
MDIPDMDELB0V9-*/9BK9M&7*MK?D_AIUE<PDU%+XJ^8ZQC F6 D
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MU-NNU*@54H-52M=/J"4N-DZ2%J;4>5U*5>,DRVD,4HN+HRR:EBC,!!(
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MAG&\KQ'"S*LJ5W=:/Z)[/.>NU+655"/M(Z5".J9_&ZQN$;W']^)J;@RD
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M_4S-X5S"N9)1^1M>M&]1SZ.D D
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M/+C+J4U"5.////O$1)218Y$F>PMA;3"56";8J
M              .>O&%Q)2[%)W2NRY"Z?=-8BH<K]P*Q1U"'(Q)*6#Y=ZX6.
M*B\1/)TCV+<.TDU703)[D=XQ7AXU1X8-&:&S2H=YKK-Z7$XRFX;B.G2DF^^M
M6"&&E*1BEE"U=W%7C*[WHE&4L(JB1ABTG5O%G3,CQ(><RE0
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M/0J8E2:?36%*W;25J4XHB-9F9F:E&8Q2DY.K)44L$94()
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M6$DEIIM'(E)<V [&%N-N*C%42T(X"Y=E=DY3=6\6]=2_#(8@
M                                # :WIQ8%R5!55N*R:%7:JXV2'9U0
M@1Y+IMHV$G>.MF>">8-!-2UHT>TG;<:<9TTM=IQEPEM.II,1)DI)XI,CW7*1
MB5)[2&C:0@                            !0\>80@5$@
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MS7I>\N*SV$II+SIXKETPL$-X&?*M@\$'Y.7N&-\X[N!]\@E%)+0D3G$%@
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M?$X_PAF.]<(MQEBXIP^G0=IV74/M-O-JWC3I$MM9<Z5%B1CYPE1LQM4/I$D
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MG</GR1], D
M          $/=4>,_233FK2[;AN5"^KD@KR3J?06TNLQW$^,V])6HFTJ+G)!
MF9<^ ),51B%G<>^D]=GQZ7=E(KFGBY:R1'J%3:;?@$I7B[V0P:\GA-.'=,3N
ML5)N1)<6H1F)<*0W*B2FTNQI3*B=;=;<+,2D&G89&DMAB 74      !%0!(
M                     IB0 9B[H4 S%W0H!F+NA0#,7="@*@"F8NZ% 5 %
M,Q=T* 9B[H4!4    %,Q=T* J   IF+NA0#,7="@&8NZ% ,Q=T* J *9B[H4
M!4 4S%W0H"H IF+NA0%0  %,Q=T* 9B[H4!4 4S%W0H!F+NA0%0  %,Q=T*
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MXS4DI)U3Q1U:L.]:-J':E$N^@N9Z=66">2@SQ4TX71<8<[BVU8E]P4H9#.P
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MZ-:FKD%):&JGVBA<
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MJF#=>LZSP_F.VR-N3=6E1]!M<:@W0$@
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MZ;H<Y06BKZ5M2&*:]6R7E:5%1(P5F))]+ ^[S8"TFZ8Z2-9T&%
M            !@]Z>+3/PW?\TAZ<K\3-9Q+1'I,$+F\ ]BT&H9420
M   >>4C[A<O> LD"/,G,DR6GDS%M+$-(:H>@*@
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MM"7$J0M!+2OHK2KG 'YL,LQVTM,(2TVCQ4)3E2 /I
M    8/>GB4W\-W_-(>G*_$S6<2T1Z3!"YO /8M!J"HD@          BGK#I5
MJCJG>M,IR;E;MW2F(AOKC<20I,IQS*:GG5L$1)6O-T49CP(N88>S<I-R=$;&
MS?A"%$JR-#0J;5-".("R[,LF[Y]ST6YE16ZU0WG,YI1)<4TXVZA)Y"4A*=XE
M6!&1<H66W-QU)>JIEO)3LJ=*.ITE/89X;2&5&J8$D
M      %,BS29I0:B(E'L(SQP(5FZ)O89(1JTMI'30/6*LZOJO1%3H46D%:\M
MB.P<-;KF]WV^VKS^+ADYA6T]^WO<IGS%I6IJ*QP)&'RX#(])Y0!
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MM5YB,9)\Q-V J2Y#BN2FR:DK9;5):+D2YEZ:?N*$M)-I:"B>&)<0
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M#Z#JG;[D9MINGW!$3FI%10G+TT)P)*SYR/D'CW;N5S"SF7_F)4E'0KL?E?\
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MZ\1E9VUCU.J)O%2Z;[&ULV<@X+2?22O95.]C:^B *=E4XL/XFUT>\ '95/\
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MK1X+M-I%)IK\DY;]/AQXKLT]AO&PVE"EGFS'BHTX[1GEI-36I=P,8
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M74                   %DN#^AI_P#LB_=$H%[$            "$O')_\
M3:VL?U@+#]&?%X:2'H)3Z>_^@;*_^7Z;_P"50,9)HSC!K78^A-TLH,DO5]^'
M2T8<OUSZ%J_%08M&.\TMH:JJ''F21-QLN."%9&LQ<N/C&?WB&\\3W.RR4;:T
MMI=6)HOU.S2R_"K>77_R32?-!5_]5":.B-.*DZ7D^997[GJ1N&9%@>YC;?\
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MG<0CWR4J[RWE-I' </@[E]W&?6O$-V.5R:LQUT2YEI)RC?(^? 2
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MLK:UQ:/G5ZX\KGXW-DD^NGJJ=M$&E224D\4K+$E>$?+]&!]93KB?H!(
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M[-1M78>I-1DM/PV*;/IMKN*+<TMN>2WFV4$23-)DTI!*QYQ>26HA:2=(H2
M                   !@]Z>)3?PW/W"'IROQ,UG$M$>DP,N1/@'L1J#T)(
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MM0*+"158[4&7UR%-AN&19F%X9L4F>)D9G]X''6#?EP?T-/\ ]E_C$(@O8@D
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M056K!\2^KA5Q=M+DI*G?M)ZGUC+AU=75>S\^WN;S>?<"25%0A:3HL*$@
M                 8/>GBTS\-W_ #2'IROQ,UG$M$>DP1/(0]BT&H*B2
M       "F/, *@2 (                            2 H !
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MEOR@FWKH8!?%DHKD=VI17WCJD9C!*'75/;Q#98DDE+,S2:2VIVC3<6X9#/\
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MD,F713"IY$M#7@-6[2."R2=Z^YOEJ?I7CDXY/(*S'"J4?:3?&_/GH$@
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MXDI)X$72'1IZS5GL2
M
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M[PG5J36I7$= U?H$-EV-*HE/@0&R:D*461Q;L9PUI(LIGAS@Z; 2E$
M                               #%;HN>D6?;]8N>X)28-(H45<NH2%<
MI(01*P(MG249X$7.>P0W1%DFW0YSZ#<36IVJG$)#HM3JB(=CUDJG(@VP46.G
M<L-,+<C)-_=[U2BR$9GCM\ ]$+-+;<M/EZC#.X]^BT5]7M.H0\Z,@$@
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MR)//U\L/ ,BP=2C=2441CJT:.PIU<@V&D-[YS:I>5.7,KRE<X%3[@
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M"VW*O=L&'1*2XZ25MI>JR-VZLT*Z*C2WO#(E?*(<Q8R;>;[+123\QV5S-_\
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M)+4)^@$DJ8<A2U=6+!OZK/CDY-GWQ?\ #B1K.@XQD@
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M3K(MV6U(5+N)[K&1I3+9J;1]8VE/341)Y1DW8TTE&W703 %"P
M               $>=?*MK=2:+07-$:-$K56>G+366I;;2R;CY#R&6]=;VY\
M 6,E703A1[3F#8E9XA8VO-]5.T:##E:N2$2O>REN-L*8:2IQHWC02G2073RE
ML5SCT0IV>&C7UF.?QXZ=74==-)Y=^S[ M^7J=#;IU\O(=.O0XZ4);0LGUDW@
M2%+270RGRC%<45+W=!,6VL3: H6               (^7QPZ6!?-<?NE;E8M
MBXYB"34*Q;\U<%<G*6"3>0DC)9ESGAB*;M$TM;J74S1MMZ#:?W+>E^V//N._
M:@W8JZ<F<B;73.-.*>RI[#(VV1D2<,#Q/:+1Q5>5HF=8M<JJ3/MRW*):5%@4
M"WJ<S2J12VB:@062-*$(QQ/$SQQ,^4S/E%C&9,(!'/4K08M1KNIUVJU#N.V)
MM'C[FDLTEUMM$<U8[QQM1I,TJ<+8K;@>!"J35>4OO*B5-!C_ /9PN(C2?]H7
M40SS8Y3J"<?W!9:2K>%"3\9E4:/&84\N2;+2&S><\=>5.&97E*YP(H?:
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ML$CJ>%V=Z3N/4J(]?BO.)1A8CSOU>TD:GD(;TX@J
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M:]*:T-G:Y*QV-F,'IUDFAYCT@
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M$:O2;EC6[3HUQ2FC:E5YN,TF8XV9;4K>).\,CR\IF%076?3H%6A/T^IPV*C
ME(W<J)*:2\RZ7<4VLE$9 "VV]:MN6G%7$MFW:?;T1T]X\Q3HS49"E%R&I+22
M-1A4&4                                      -=5;3'3RO5"15J[9
M%"J]4DY2D3Y<%AYYS*G*C,XXDS,R+8"P5$34A]3>%ZJQ^)N5?,FT;?/2)Q#O
M5*7BTIM"SA$AL^IY,I8/%CC]T9+4]V$D]+T<A2['>E&FA:>4Z!)02$DE/(18
M$,98_0                            $4 $@
M      (H"-UG</E*L_62[]8X]QS)=0NU,HI%%<:;2PSUE;:U$APL5JR[OG(7
MC+=CNB2K*NPD@?(8J@RH                U-I?J _?\2[Y#]+13/=NYI]
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M^:@Y"$$H^X18F,E_AF8LJLX/GT^@M<RMV&E$@<1X*GF*BP
M                                 " !(
M                                                         .?&
MF&F=[7B]J74[=UCK=@P6[[K,==#IK*7&5.I<)2GL5+2>*L2+[@I;B^QMOD]9
MEN2_B2YS;/[ ]5O_ /IN[?T9O^&%BN\MANG3NUJ[9]!51[AO6??M0.4](37:
MBA*'LBR226L$J6G!&&);><2RM38H$$>M1*[KFY<BK:TPM:DQ:3U1IV5?M;D*
M-EIQ:E8H:CH/,LT$G;L46T556W7!+SF2D4D]+]!KR/PQQ;TJ3=RZRWS)U'K#
M/)"IZ&J?!9\@MR6\,OWR1*45BD5<G2C,VTZT^N[3;4.IT:CU"?4M(9M)1(A1
MZG,ZVY3JH3I$<>.I1F[NS;V[2P[H*3=:]!#IA0DD)(
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M9ESEBEC[#[CQ::X=P^-F&#:W5S4]YDVFRP0DC[@WZY3YZ>Q(
M           #R9X",&#^>GBHIL_AMXU(6HM&95&IM2JL*]Z;@6"%I>7DJ3.!
M?)4M+I&7<4.NR$EFLIV;U8'-YVN7S&^M&G]GEM._U*JD&M4NG5FG/E*IU5C,
M3:=(26!.,R$DXTHB[Y*(<DX[KH]*.D335=I>@!17(8 USJ+;/O#;[YLH(ZA3
M,9,$^Z:2Z2/ I/WQX<]E^VMZ,5H]AN^!9_NF8Q^&6#]3Z"!>J].[9M.GU$T9
MIEJN&PL\.DJ!)5B:? TZ>)=Y0^;>*\J[UB-Y?%##_:_8_2?8O#E[NV=E#\%U
M5Y-^.CZEZ"5W#3>IW5IQ#@2GMY5;47V;,(SZ9M)(E,+/PHV?<'8^%.)]^R,&
MW[T/=ET:'U8'RSQEPA<-XE.,52$_?C_NTKH9(T=,<J   'Y&D\N7OB-8P(BW
M7%>T^U#:JL5O+$=>*?'2GD-IP\'VOW1^=N/V)^&?$$<Q97N2EOK_ $R?OQ/I
M?#;BXIPYVI?%3=?(XZ'SDL(4IF9%CRHZR<CRFTNQW"Y#0LLQ&/T'8OPOVXW(
M.L9*J?.JGS>Y!PDXRP:PZC6.K>D]MZO6E.M>XF$%CB[2JB2,ST22E)Y7&\3V
M=Q1?*(>RS>[)XI.+P:>AKRZBDH6[D';N14H2PE%Z&CC;5]-?V=7\FT]2E52+
M2HD@BJ3L#=J==AJ/!,F(MU/2(BZ1%]SE&TEX=RF:M]I8;3Y\*[&:>[^FW"LS
M[]O>2>I/7ZN389]<]M5+AKU%MB_M.ZHNNVE74)J%J7 XYO2J$-22.13Y;B3(
ML<"V["PY<"P')7[5S*W*.N'E3RY&?,>-93->&>(1O6?@T16U)>]"6/)O*7D^
MB]R2*)KOI##O"TS*2\PV=0I[6S?-/-EA+B.%S*(L2P[Q#J?#_$%8OIU]V6#Y
M-CZSO.)=EQCAROV<6EO+;A\4>1[5M-$</]W)M+495#D.$W1-1FTM((]B6JS%
M1BT?>W[6*<.=24C<^)\BU)7XK3A+U'C\'\1K&65D\8XQYGI.AY'CS8#D$SMC
MT)!"OB,TSOF]=1=,JU:] 75:905-]KRDO,H)G"8V[@9+6DSZ!&>P63P((=<7
M=:;JVM-RMMK)14UB'3T)^:;31+7]]9C9\5F[/![5M_\ R7&_]J\D?GOQC>CF
M/$-U_EP4>FE?6?)PV6YU2G7C>[K.,BX9R*?34F6*NJ4].[3E/G);JU'X1QV=
MN/LK-C8J_P"YO&I^C_T?X9')\&>9G@[LG+_9'"./*L3KK9=#*WK9HU)41$\S
M'2N49>G<Z;A_24-Q:AN12*YJ^[]V5Q_B;9EXR'G
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M,AS/$<SWC,SN;7AS:#K>%93NN5MVM:6//K,['B-B
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M8[2YC')S@X2<7I1TD)J:4EH9E8H6
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M+WJUV$WX+CS\.&[*9ZO(=9;6\QR95J21J3^]/8+/2RBT%P
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MT^T\'"<S2MJ3Q.T1&1CG*F]H5$D
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M*1HDN(FT9EG2'M0(%&>)^FM/DLSBJ4I"EMDX9DCD/9\(/X<23H(,8
M               P>]/$IOX;G[A#TY7XF:SB6B/28(7-X![5H-05 @
M    ;1"Q)H!( $
M         #OB&Z$C;B6SE$@"*B@(L<>]RA4# \,1(H!%0!)         >VOR
MT?\ #3^Z0K+0S);^*/.;O&K.G  A#0KZIW#Y>%_6OJ/"FTVU;NN"3<-IWLW'
M6_#64TDF]'D+;)2DK:,B+87^(5C)*"B_P^<O.+E)R6NG09Q5^+31B)$WE!N"
M1>-67T85O4F')7(?>/Q$I-UEM)8GLQ#'4JD4IBS*>'BU*]:^GRE7/"[,KES5
M>?<$VD<IPSJ#I.(841\AH3@9EW<1*AN1C'3NJA#=6WM9OT$B"(^OM@:8N56%
MJ%J+J97[)5$C]2HS=/FE'(G"Q-75FDM.NFI9'TLG>Q%?AEIQ9D3WDE30:)M6
MS>'[4NK0:!!UPOR16=^3U(I=8G*8<4\WM0N.4A@DFLN;*>;N":5Z!O-=)+C3
MK16%I_7'*['OR[;D-Z*N*4"N5'K45.=259TH-*<5%EV'W!:M2C-[ 0
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M.'76L.[N?P?*_"  F:IC@<UK#G/<_@^5^$ &YJF.'76L.[N?P?*_" #<U/'
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MH7E^)=3UKK/@O%.'RR&:N9>6F$FN=:NM&?I8J?/.:]1_I#8&N&XJOM[7J?\
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MP^5X! *&Q5,=DUKU)=_RO ) W51Q,BG->'<_A>5X !4V:IC_ "YKU/A\KP"
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MLH/*N239M(R*4HCV&I)\G,/9P[+]YS4(TPKCS(U?%<UW;*7)ZZ8<[P-8\.%
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M^2!)^:'6G#-+3S;QH\8FU)5AX<HBI9Q:=&?J)*@"
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MA[*C<3J#/;U*"9ERI+I/*_S4BO"[*QG31H/OOBS.5<;">CWGZO6R0XW1Q8
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M":#;U)I>&5UF.DY!X<KR^FX?PJ,='9AV<%'8;3.YAYB]*X_Q/R\QE8R'E
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M<9S/;YJ<EH3HNC W_ LIW;)PB]+6\^=FTAK3;@
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M7,?T+M.-NH0MMQ*T.$2D+0>)*(]I&1]\<AB=+@SZ1)(
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M1$S,2?\ LG%)5@,L);MZ4-36'ESF22[>PI:UY>@Z<F6!F7+AW!D-24 @
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MJ0U0J)3Z4@B_BK*2=/YSBMJS^ZK$=#EK2M6U%&7/9EYF_*X];\VHR09SR
M                          $5!RY_O/\ 3,[BTIMK4J#&WDZP*IU:INI3
MTBIU3P;,U=PFWD-E^^&\X'?W+C@_Q>HU/%[._!36E>7I1MO^[YU-+4/ATMZF
M3)!NUK3N2Y;M0Q/,XIEG!V&L\>8V5I1^]'GXM8[*^WJ>)EX9>[2RN3 G6-8;
M$   ,5NRWFKEHDVF.;''49X;OS'4>(KX>48,S95VVXGNX=G)92_&XM&OFUD
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M2\F]53ZRLG'@? [>4AI4%#I_$3N'2G%
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MM<:EIG>E2M2N4NUZ.52NJ=08DAKJ[TDL(<8G'U)/>*Q)1EAXHEQ5*@F8*@
M                   #![T\6F?AN_YI#TY7XF:SB6B/28(7-X![%H-0RHD@
M          BIK=?VKFF=UT"Y:'3_ '@TO<0VFX*9&B)<?:<0HR=2I_*I;>\3
M@:5<F.P8=]QN.NAZ#86;5NY"B=)&@J]6JMQ/ZKV&Y:UJU*C6U:6[54ZK.3AN
MFR?)]Y2EIP1CT20A)&9F86HUNN7-YC--JU9W'KKYSI2H\QFKYPS-UQ-44 @
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M?>F%JUI]:BJ3<8H%7)9&2BE0_JEF9G\XB2K[H]4W5IK6:NY'=DT;>$&$
M  #TU^6C_AI_=(5EH9DM_%'G-X#5G3@       !%S4:B:@6?J5%U=L"W$WNQ
M*HJ:%=MJ)>2Q,4RT\;S+\5:R,C41F9&G 4C[N]RT\QD<MZ*6SUF$77<&KFN5
M(=T_C:2U#3FWJTZRW=%SU]]!FS#:=2XZB.RDDJ6M1IP+#$32K3>BM>HCX:T>
M.CK)EPH[4.)'B,F>ZBM(:9S<N5"<J?O$)K5ME-&!]XD
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MU$B-DB#>415FW;E+H]93GD4E]1ERF:MXT9GS*20T7'HSMQRV=A_,REZ%S_\
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M8_- BI[ D      #QG29Y246/< BI[ D      #P2D*V$HC\ $)H]@2
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M? 0@FM3T)( $
M     !Y-)'L-*5)+F41'^Z%"R="I8<Q8$7<V8"$VPRT5:CTRO4ZH4BK0FIM/
MJC*H]0C*V;YI9]-"E(RJP/GVBKC549=3:=4>*#0J/;-)A4.WX+5*I%-;-J!3
MF,=VTC-F,B)6/*:L1<B3;=67@D))6))0DSY5)21&8$5J>C+'8>!E\TRQ("-!
MY2DDEE2E*2[B2(OW! ;J>Q)4      #VS_*(W^T3^Z*RT,R6_BCSF[QJSIP
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M*/4Z%6HB)M+JT=<:?&<\5;2RP,N]WC[HR6[DK<E.+HTZHQ7;4+L'":K%JC(
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M^N1/]S\/^1_2BO[(;_\ ;(_Z8X'_ (YX_P#GKZY#^Z.'_(_IB4_9'?WM4?\
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MGO #T5.7C_2$K'\)/>\GO" 5;A*;4A779#F4O$6I.!\GD]X2*ES 'A6Q'+E
M&&73?=G67$*7=MT4RV8[A8M*J$EIA2BY.@E9XJ^X*RE&.EF*]F+=E5G)17*R
MU6GJQIK?;O5[/ONC7!)]CARVEOF7=)LU$O#[@1G&6AE+.;LWOY<U+F9LL6/0
M                               !3 @!4
M
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MMYMA#VY?*1L8Z6:#B/%KN=PEA'82*'J1J0)
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M]1ZWI'JI;%,M^\X%-16J?,HCSC\&7#6LDF22=P6E9'M(U'W0<<*DDH14
M                                 ?!(D,1&7),AU,>/')3CKKBB2E*4
M^,I2E<B2 DP2V]4=/+QK<^V[6O"EW%6:4R<B?#A/)?W;1*W9K,T$:3+,K#Q@
MHZ5(JJT-E
M                                                        (H@
M:!X-*3+ ^<2&>Q% 6.X<"HT\SY-U_C$QT@N!3(GMC/K$@!UV'[5']8D,10==
MA^U1_6)#$4'78?M4?UB0Q%!UV'[5']8D,10==A^U1_6)#$4*]>B>U,>L2 *=
M>A>U,>L2% 1'XO;<KUYV'0*?:=(?N.=&K*7Y$2GD3JT-]6>+,9$>.&)D0M -
M$B[(-$*S;0A3%HBRXE%I[$N,XM)*;<;CH2M*N^2BP,5H#+>NP_:H_K$AB*#K
ML/VJ/ZQ(8BA7KT3VICUB0!3KT/VJ/ZQ(8B@Z[#]J8]8D* ==A^VM?32% .NP
M_:H_K$AB*#KL/VJ/ZQ(8B@Z[#]JC^L2&(H.O0O:F/6)$T!7KL3VQCUB1!)3K
ML/VJ/ZQ(8D4'78?M4?UB0Q%!UV'[5']8D,10==A^U1_6)#$4'7H7M3'K$B:
MKUV'[4QZQ(B@*==A^U1_6)#$4'78?M4?UB0Q%!UV'[5']8D,10=>A>U,>L2%
M 4Z[#]K8]8D* KUZ%[4QZQ(4!3KT+VICUB0H"O78?M4?UB0Q%"O7HGM3'K$@
M"G7H7M3'K$A0%.NP_:V/6)"@*]>A>U,>L2)H"O7HGM3'K$B 4Z[#]JC^L2&(
MH.NP_:H_K$AB*#KL/EZVQZQ(F@'78?M3/K$A0%.N0^>6S]-(4!7KT+VICUB0
MH!UV'[5']8D1B*#KL/VJ/ZQ(8BA3KT+VICUB0H#GYQ8K2_JQHTI@]^A"F\ZD
M%F21]H-<IIY!>.A@Z"]=B>UL>L2*4!3KL/VJ/ZQ(8B@Z[#]JC^L2&(H.NP_:
MH_K$AB*%>O1/:V/6) #KD7VMGUB1%"2G7H7M4?UB1.)%!UV'[5']8D,10==A
M^U1_6)#$4'78?M4?UB0Q%!UZ%[4QZQ(F@*]=B>UL>L2(H"G78?M4?UB0Q%!U
MV'[5']8D,10KUZ)[4QZQ( IUV'[5']8D,10=<A^UL>L2% .NPO:H_K$A04'7
M8?M4?UB0Q%!UV'[5']8D,10==A^U1_6)#$4'78?M4?UB0Q%"O78GMC'K$@24
MZ["]JC^L2%"*#KL/VJ/ZQ(8BA7KT3VICUB0!3KT+VICUB1.(!S81[#EL>L2*
MT!$OC-?:?T>:0PM+R^WH!Y6SS'XCO*E(O%8AFX]&I+#>E&G;:Y#;2T4& 2DJ
M4E*BQ9(0]))M+KT3VICUB1!!3KL/VJ/ZQ(8BA7KT3VICUB0!3KL/VJ/ZQ(8B
M@Z[#]L9^FD*"HZ]"]L9^FD* ==A^U1_6)#$4'78?M4?UB0Q%!UV'[5']8D,1
M0KUV'[4QZQ(4!3KD/VMCUB0 Z[#]JC^L2&(H.NP_:H_K$AB*#KL/VJ/ZQ(8B
M@Z[#]JC^L2&(H5Z[$]L8]8D"1UZ)[4QZQ($%.NP_:H_K$AB*#KL/VJ/ZQ(8B
M@Z[#]JC^L2&(H.O0O:F/6)$T Z[#/_Q;'K$@!UZ%[4QZQ(4!7KL3VMCUB1 *
M==A^U1_6)#$4'78?M4?UB0Q%!UV$?_BV/6)"@*=<A>V,^L2% 5ZW#]K8]8@3
M0#KL/VJ/ZQ(C$4'78?M4?UB0Q%!UV'[5']8D,10=<A^UL>L2 H.MPBY)C/K$
M@!UZ%[4QZQ(F@'7H7M3'K$A0#KL/VJ/ZQ(C$4'7H7M3'K$B<0.NP^:4Q]-(4
M ZW#/EEL^L2(H!UV'R];8]8D3B!UV'[5']8D1B*#KL/VJ/ZQ(8B@Z[#]JC^L
M2&(H4Z]"]K8]8D3B"O7(7M;/TTB* =>A>U,>L2)H!UZ%[4QZQ(8@==A^U1_6
M)$8B@Z[#]JC^L2&(H.NP_:H_K$AB*#KL/VJ/ZQ(8B@Z[#]JC^L2&(H5*9$49
M)3)94I7(DEI"@/K '/\ _O!:;->TKM*KLD:J90[MAO5@B\5*'6W&D+5Y*5&1
M8]\>3.1;A@<AXULRN9![NJ2KS5.8I\IF7(-*?%I%/"((6!-/@$ILV5J?JA6F
M4J*E4^WX-+E.%XBICLC?MI\)(08VN0UOR\L#Z=^GEJ25V;T42Z<7ZS=6M#%[
MR>+#2]C3JH4NEW6JRYQP9M:9<>B);)R1OB4VV>?$T8X=\;6--T^DZS9-IZ(7
MU5=1H6IVMUUTJZ*K0:<_3;;MZC0E,4YEN2E27G'M_P!)9F2S/*9?N8"KEA1%
MJ&'\'],IC4O6V0W38C<V'?4^+'=0RVEQJ.?YE*LN9+?<26P3/40C[.+!U%9J
M^BMB15-4.O71<N^H=_..*2NB.14MK-Q@TJ22G',Q))*CP"& D6'2^GU+3[BA
MK]HW5</[3;GNJUVY\>_GR)N=!8C+,C@O1T*-IM"S+,1)P,^CARX!+&(6DGN*
M$@                                    <O^-G4N1,O.UM&G+B=MFT%
MM,U*^JDT2G%*0\L\B#0GI.$A"#42/E+-./(+6(J<FWH0N/<CRLR+AGU!X5Z-
M=35LZ>T:KV[=U99[-C5VX4JSU0LQ.):-27EMH6I22,DY$X\F/,+O?E'#0BGN
MIU>DZ/#"BX$@                         PBX+VM"V'D1KCNRC6]+?94]
M%C5.:Q%<<))X9FTO.),RQ+#8*RK1T)1"KA9XB:C<[VI'[7-1:4RW3)D9-LG4
MWH=/Q:4J1O=T?0WA$1(QY<!GW:VXNF+*3?\ $:6C]I/N-(CS([,J*\F3&DI2
MZR\VHE)4A99DJ2I.PTF7(,5"U2X@                           *&>&T
MP!40@!(                                               _!QM#J
M%-N)2XVHLKB%%BDP!\G8]*^S8GJ6_-"H'8]*^S8GJ6_-"K ['I7V;$]2WYH5
M8'8]*^S8GJ6_-"K ['I7V;$]2WYH58'8]*^S8GJ6_-"K ['I7V;$]2WYH58'
M8]*^S(OJ6_-"K!;W:%!7-C2$0XB&&6W$NL[I/24O+E/D^3E$UP!]_9%*^S8G
MJ6_-$58*]CTK[-B>I;\T*L#L>E?9L3U+?FA5@=CTK[-B>I;\T*L%#I-)3M53
M8A?^Q;\T*@^!%"@IGO23AQ%,.M-H0SND[%)4K%6&&&W,)J#[^R*5]EQ/4H\T
M17E!7L>E?9L3U+?FA5@=CTK[-B>I;\T*L#L>E?9L3U+?FA5@H=)I)<M.B>I;
M\T*L'P0J% CIDD]"B/[Z2XZU]4GHH4KHIVI^2);8+AV/2OLV)ZEOS1%6!V/2
MOLV)ZEOS0JP.QZ5]FQ/4M^:%6!V/2OLV)ZEOS0JP?@]2*8XTZVB!$0XI"DE]
M4C9C^]"K!^<2B0&(L=EZ!$=<9:0AQW<HZ2DIVJ\42V#Z^QZ5]FQ/4M^:(JP.
MQZ5]FQ/4M^:%6!V12OLR)ZEOS0JP.QZ5]FQ/4M^:%6#X)]#@2X<B/&A1&7W$
MY4.[E'1^!(FK0/O['I7V;$]2WYHBK ['I7V;$]2WYH58'8]*^S8GJ6_-"K [
M'I7V;$]2WYH58'8]*^S8GJ6_-"K!;YM#@R$Q]Q"B-;F2VZ[@TGI(2?23L3SB
M4V"X=CTK[-B>I;\T15@=CTK[-B>I;\T*L#L>E?9L3U+?FA5@=CTK[-B>I;\T
M*L%.R*47+38GJ6_-"K!\"J' 7.9DHAQ-PAA;:VMTGI*4I)DKDPV91-6#[^R*
M5]EQ/4H\T17E!7L>E?9L3U+?FA5@=CTK[-B>I;\T*L#LBE?9D3U+?FA5@=CT
MK[-B>I;\T*@MC5OTTI<N0]3H;S;YME'0;*%9,J<#Y4]T35@N79%*^S8GJ6_-
M$58*]CTK[-B>I;\T*L#L>E?9L3U+?FA5@=CTK[-B>I;\T*L'DZ522Y:;$]2W
MYHG$'Q0J%!83))Z%$>-U]QQ'U2>BE:L4IVE\D*L'W]CTK[-B>I;\T15@=D4K
M[,B>I;\T*L#LBE?9D3U+?FA5@=CTK[-B>I;\T*L'@Z52#Z/9T3,?^I;\T3B#
MY(%#@QH4=B1!B//,H)*WMTGI*+PI"H/N['I7V;$]2WYHBK ['I7V;$]2WYH5
M8'8]*^S8GJ6_-"K ['I7V;$]2WYH58+?4*% EQ'H\>%$:>5ER.;I/1Z6/R2$
MI@N'8]*^S8GJ6_-$58'8]*^S8GJ6_-"K ['I7V;$]2WYH58'8]*^S8GJ6_-"
MK ['I7V;$]2WYH58+=)H<%]Z$XS"B(1'=4IY!-)Z2<JDY=A=TQ-07'L>E?9L
M3U+?FB*L#L>E?9L3U+?FA5@=CTK[-B>I;\T*L#L>E?9L3U+?FA5@=CTK[-B>
MI;\T*@MSEOT]R<W(5!AJBI86VMA3*#Q6I25$K#+ALRA5@^\J/24)P*F1$I3S
M[EOS0JP>NQZ5]FQ/4M^:%6!V/2OLV)ZEOS0JP.QZ5]FQ/4M^:%6"ATFDIVJI
ML0O_ &+?FA5@^%JA06YLQ]4**IJ2EI+3>Z3T<F;-S<^(FH/N[(I7V7$]2CS1
M *]CTK[-B>I;\T*L#L>E?9L3U+?FA5@=CTK[-B>I;\T*L'GLFD\]-B>I;\T3
MB#X8-!@1T/$]"B.FM]U;?U2>BE:\R4[2^2#8+AV/2OLV)ZEOS1%6!V/2OLV)
MZEOS0JP.QZ5]FQ/4M^:%6!V/2OLV)ZEOS0JP?+*H].>CR&6H$1MUQM:4+W2.
MB:D\OBB:@K&HM.:CL-.T^(XXTVA*U[E'24E/+XH5!]/8]*^S8GJ6_-$58'9%
M*^S(GJ6_-"K ['I7V;$]2WYH58'9%*^S(GJ6_-"K!;Y]#@2HKS$>%$:=6ILL
M^Y1LRK2KF(35@N'8]*^S8GJ6_-$58'8]*^S8GJ6_-"K [(I7V9$]2WYH58'8
M]*^S8GJ6_-"K [(I7V9$]2WYH58+/5:;3DJI62GQD9Y[:5Y6D>+D7Y(LF"\=
MCTK[-B>I;\T5JP.QZ5]FQ/4M^:%6!V/2OLV)ZEOS0JP.QZ5]FQ/4M^:%6!V1
M2OLR)ZEOS0JP6=5,IW;K2.H1LG45JW>Z1EQWJ=OBB:@O'8]*^S8GJ6_-$58'
M8]*^S8GJ6_-"K ['I7V;$]2WYH58'8]*^S8GJ6_-"K!3LFE<U+B>I1YH L]/
MIM/7,K*50(RDHDH2A!M(V?5([PLV"\]D4K[,B>I;\T5JP.QZ5]FQ/4M^:%6!
MV/2OLV)ZEOS0JP.QZ5]FQ/4M^:%6!V/2OLV)ZEOS0JP6:B4VG.1'3<I\9P^M
M2"Z32#V$XK#Y(LV"\]D4K[,B>I;\T5JP.R*5]F1/4M^:%6!V/2OLV)ZEOS0J
MP.R*5]F1/4M^:%6!V/2OLV)ZEOS0JP.QZ5]FQ/4M^:%6!V/2OLV)ZEOS0JP4
M33*:E25)IT9*DGBE:6D8D?T0J"Y@##KRM"A7W;%<L^Y8A3Z'<$5R+4(RCP,T
M+VDI)\RD'@I)]T1*.\J,PW[$+]N5N:K&2Q./^H7"+K1IW4'V;8H:]4;12L^R
MJE3E(34FVL>BW(C+,LRDIV9DXD-7=R4JUB?*N+^"<Q;N.>72G%ZM$OVX8&-V
MKPT\0-ZSVJ?'T^DV/#6HDR[AN0TQFX[>/26AE*C6X?<(B&.UDY-XGCR/@O.W
MI>^MQ<OJW6=9]$M'+>T3LB):5%6N=*<=.9<-;=227ZA-<PSO+[B=F"4_)3L[
MHVMNVH*B/J_#>'6\A95JWSOE>MF43=.K4GW_ $?4J7"=7=E IS]+ILTGG";3
M&?)PUI4T9Y#,R4>TQDJ;"F)L8 :@H>C.G]M7]5]2:'1U4VZ:ZEU%4?:D/%'<
M4\9&XM+!+W>=2BVGAB);= 7R_M.+-U-HY4*]:&U6J>TO?1MX:FW&'4EL<9>0
MI*T*+G,CP$)M"E2PZ<Z):<:5.3I-GT+JE0J1)1.J\EYV7*6A)XI0IY]2U$GO
M$);;!N$0                                     .5G$C&IEH<66G5]
MWQ!0_8=51 5(DR6M]'(XF=ITG$D2B5NS-+AI[G,,F4:4IIZ6L.JGJ)ONL8[%
M[:F,\25;L;476G2.)HW(A5JX^L1VIU2HJ,$&KK+;D=*EH(B6II*5*-7R4\I[
M!?+)J;;^&B_:8[[K;2UU.O(P%P                          ([:P<.>G
M.LU5IM;O--4Z[1(3D2%U"23*#:-:GCS)4A>8\W<"+<*R6DG!T3T'.[A:X>+#
MUD>U'9O>/56D6O,C1Z3U5Y48]V\I\EYLS:LY_5D,\9N-N,M=3%-5NRCJH=@*
M)2XM"I-*HL(U'"I$5B#%)9XKR,-I;1F/G/*G:8PR>\V]I>*W4EL+T()
M                    +)6:8W5Z14Z2M]<9%3B/Q7)+6QUM+Z%(S)V<I9M@
MAJI-:$,K6X(K9M6X[?N2/J-<\]ZWY\>>S$?=1NGC842R0OEV'AM&2-QQ*2CO
M$Z!CH6 D
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M !72:U26*SHK;U.H\B8RU5IS570MQB,IQ*7G$(-T\32G$R+ &HT&-278J
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M-TBFV?)3+@HE:S%2:U!JAH\8H<EI\T^'(9A&49:&6G:G#XHM=!?BPYA8QE0
M                                            !A%X6):.H%)70KRM
M^)<%*6O>%&E)-61:?EH6G!2%'W241B":F'V%H1I/IE->JEE69$I%4<;-LZGF
M=??2VKQD(=?4XI!&7+E,7<VRNZC<Q;-@J25
M %#+$&#Y&HL=G,;#+;!K\=324IQ^  ?8(2 $@
M
M        #&+FK=)MNWJU7[@<0Q0Z/">DU1;B<Q$PVVI3A9?E8ELPYP!S4N"C
M\-JH%G7O$T#N&IW!J+(FSJ+IK#>>96Y!A*-3DYR*APTH:6G!9)3L^X,JWMI!
MT+TRNBV;SL6V[BL]@H-MSX:2IL FTM*C)9/=J84VGHH-I1&@T]X8FJ$FQP
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M+HWIO'LJLUF:SK-6]3E3(:&%4VJ3FI;<7*X2M^A*%'@9X8$??%&^0DD@(
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M=#X=/KM%J">*"Z:R<*='D)I#U7CK1*-MQ*MPMLEF9DYR&6 ERPT!(FX*$@
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MGLR$S(DN"\9)W\=])%F,C,B46T2U3022.%0
M
M
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MB-^6-9%N:<VQ3K0M2&NGT.E$[U*&MU;RDJ><-P_K'#-1])9\IBC=23.0
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M6L4VH4J<DWH53C.Q9C9*4G%E])H4G,6TL4F (PEP2\/*"P*TYF7D_I*9S?\
MM!?M&11'VT?@\T&H58I5;IEKRF9](EM38#QU&6K(]'<2XWT3<,CP-/.(<VT3
M1$JA4   !@5^6%;.I5M3;2NV&N?0YZFERHB'5LJ-;+A.(^L;,E;%)/G$UH#0
M_P#8EX><,ONG,P_ZE+\\6[21%%L,MT_X9](=,KECW99] D4^NQV'H[,I<Y]\
MMW(+*X61U:D[23W!$IMDDB!4   !JG4W26R-7:;3:5?5,74X-+D];B--2'8^
M#QH4V9XMJ09[#(2FT#3W]B7AXV).U)AG_P!2E_PHMVC(I0V3IEH+IKI!/JE4
ML2BO4J766&XT];TI^3G;:4I22RN+41=)1<@AR;TDT-W"H     +)5_RE&_ZB
MW_FK$H%[$       "R*_]1,_].<_WJ )+V!       %CI?\ +JY_Q+?^Y0)8
M+X(       %BH7\C=_XN1_OE"9!%]$              (S\2K;ONU:,U1FJG
M0;EBKJ!_)2E:5H0:N\2C&NXE%NU@=)X8FHYNCUHT[MVX;3Q'.TUGT4IL DS7
M05IU[4R]Y<;$X46C0XLQ?R>L*<SH2??)!#=<*3Q.*\6R5+:UXF#ZTNWPQQ8:
M8NZ<QJ3,NM-F3NIQZVIU,(T;R1OLYL&2\V7'#OC>1^$XEZ3.;=T<U'O74RG:
MF:Z2[;<*WJ;)IE!LRAH==BFF4DT/+E+DXJ61I6?1Q/'P<L5PHB3%>#RW*!'G
M:RU*/1(,>?3+VJ%-ILQMA"7F(98&49M9EBEO9XI";C81M+7;3*]+EK6G>HFF
M[D)R]=-ISS\6C5)1M1YT64DD/,*=3@2#))8$>/)SA&26#(:-+Z92+ZNWBUJU
M<N]FD1JE:MF%$K%.H3JY,2 <ETC:B/2CPWCVTUJPV%R<PF5-TE'048P
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M?2#L8;!WR[M/3=:JBGF$JGO&E3B24G$NZ*RLQHR\,W=<DJZS;H\!O@
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MB+J!5R+C1.+BU*Y6:316=.[\AOUF8S#:F2*/D9;4^XE"7'%DYB2"QZ1ES"'
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M?B9K.):(])@A<W@'L6@U!420          5RJ(B49'@?> FA3 SY",_N& H
M(                           "*D@R,N42 !
M            "0!         >VORT?\ #3^Z0K+0S);^./.;O&K.G
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M_P 7(_WRA,@B^B                4P+''G 'DT8ER[0![
M                    8/>GBTS\-W_-(>G*_$S6<2T1Z3!"^3X![%H-0RHD
M@          BSJ%HKJI==W5BOVUK)/M2C33:ZG;S*Y)(CDAM*5$1-N)3TC3C
ML(8.SEM-C;S%I+&-2-KU'U9I&M=L:51=9:Y<DQQV/+KTEF3);:B,E]<ZA:5N
M*S8,EB?A(@L2<IO89[VYV.]1*ITY/:9X;"[@SFH* 0
M       >#4E*34H]A$9]_DQ%9NBJ7BJNAI32'6JEZNJN=-/H4NBE:[[4=Y4M
MU#I.F\;F!IR>*19.<1"3G#?U&;,6>RENUQI4W<+GF
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M,-T!,)@Z&F*1I9*(;:38W:2^3N\,!0L9$!
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MR@2P7P0       +%0?Y&[_Q<C_?*%F"^BH
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MX*=)+WJ'5.D-5"/2*5'JKQ2:HS#814I!'L<D);23JB/H\JL3&=Z34,NX&,
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MU(=6B8UGVXQ:-IVW:T9Y4EFW:9%IS<ESQG"BM$T2C\)D*,DRP
M                                         !;9DN-3HLB9.E-PXD9)
MN2);ZTH::2GE-2E;"(N^ (WZ#.4*AQ]3)9WQ;M<B7'?T^HP9=-J#<AI!5/=]
M6CN+/*2759?$+'DV"6"40@     $!Z%1^)'0=JL6?8NGM%U+LQ^KRZC;]45.
M*)-;;FNF\;<EI:D&9I,_&P^Z+^Z](9<'*%Q"ZWUFRX6I=DT;3BQK4K\:XJ@J
M/,*7/FOP3-3++61:R0DS7@:CV8=WD$8+0,63H%0
M              18M5VWO[0&I]ZQ;[MNHTV7:]/C.T^-4FW943LY9E(>E(+H
MM-IQ+I8_ +:@288D-RFVI$=Q+D=U*5LNH5F)1*+,E25)\8C(5!]X    (7W/
M:^N.EVI5^7WI/:]*U H&I'4I59HLZ7U69$FPFC9)3:E*02T+)1[",Q94>DBA
MC%S2>*[6&W:KIW5]+:#I_1;E;*%6[CDU I!LQ'%?6;EE"UFI>!;,",Q*W4'B
M38H%&:M^@T2@1W#>C42!&@1W'=AJ;C-):)2NX9DD4)+^
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M-J4"U*:DNJT.(B*ETBPWCA%F=</OK69J&:<MYU/,WC5F6<@@H (
M                /"B(TN%SJ(B(5DJHLG3$UCIWI-:.EJJ\JTVY;9W"\V]4
M52Y!O]-O-E)&*4X>.8A+=CNK:9KUV5V2E+32AM$Q<P "
M            $@"            /;/Y>/_M$_ND*RT,R6_B7.;O&K.G
M                                          U=J_ N>JZ7WY3;-4IJ
MZ)E$E-4?=['-ZIM1Y$&7RE;4EWP0.8EGZAZ#6+=-O26:!)ID5O3>H4&_;9=A
MO=?GUU]QM#D=XE$HUJ=RJP7L21=SD&5Q;(P1T&X8Z)<-OZ(V)3+G8>AU-N,Z
MXS!?(R>C177W'(S#F8L2R-FDONX"DM(1(85)
M                                      B7Q;T^?.L"WWG(,VLV72;F
MITW4FC4XEG)E45HU$^221M-)'@:B[Y"T0R#CUX::5FA:QZ<Z9TEVHU._KLH\
MC22B4R(Z@XBX[;)%+/,239W1YTGCB>WN;1:CTLBJ.O\ 26IC%-IK%1>ZQ4&H
MK2)\DOENI0DEJQ\I0QEF7@"
M     --ZZ4VZJKI#J'2[*4[[RS*.\BFI9/!U9[#=;;,OEN-YB27=,3&E<0<W
M+<U'T!L^X9IT:WWX5(JFE+MMUVT>HO'-FU]V4G>1WR42C4M:2Q-SQ1D:;*X'
M13AXHUQ6]HKIW1[K2XQ785)0F7'?,S=90XXI3#3A'R*;:4E!^ 8WI+&\Q
M                                         "RUCQZ1_P!0;_S%B8@O
M0@       617_J)G_ISG^]0!)>P(       L=+_EU<_XEO\ W*!+!?!
M   L5!_D;O\ Q<C_ 'RA,@B^B
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MB@P/N!44&!]P*B@P/N!44&!]P*BA[9(]^SL_.)_=(1+X67M_$N<W>-6=.
M                                           !JG6"KU2A:77Q5J1/
METFJP*4^[3I\&-UN0T\DB)M3;'2S8GS<Q"5I!#JTN*FR6Z+;LR^M(KFJE_0H
M;+=9N%FWF'E.R6DX&ZAX]VOIF6/(6 NK;(WD35TXONGZE6G N^F4NHT:%45/
M);I]78*/+2;*S;/.WF41$K)L[PQM4+&Q@(
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M:-'O"GTVH4F'6T.+CP*FSU>6V273:P<;)2B(^CCX!C:H69GP$
M                                !9*O^4HW_46_\U8E O8@       6
M17_J)G_ISG^]0!)>P(       L=+_EU<_P");_W*!+!?!        L5!_D;O
M_%R/]\H68+Z*@
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M<N!^$5>9;PH6CPY1:>\9T7<YR'G-D5$
M                 BAK-?6I[^H%JZ.:0R:=1+GK]+?KU:NFI(W[<& RM3*2
M;:-*R-2E)VX)/FP[HLJ:6&?1HA?>I3EX7SI+JW(@56Z[+CPZC"N6F()IN;!F
MXI2LVB)&"B/89Y2/NA*FE!$IQ4
M                             !!ZX+PU^U1U%OVV]&Z[1;,MS2^2W39]
M1JC'6'ZE4<AN*:(EH<-""QR\A=TSVBZ26+&)NC0+4:L:F6#VK<T%J#=5$J<N
M@W-'CJ^J.93UDA:VRVY4KV&9?XA5J@-\B
M                 $2-7;YU6JVI-)T7T=GTZWJTJC*K]S794FR?*)$-S<-H
M::-*R-2E8;229[>;:+)+2PR\:%WYJ+4J]?NF.JRX$V]=/G(CG;E/3NVJA!G-
MJ6RYN\$DE6"=IX%L/D"26H$GQ4
M           %DK'CT?\ ZBW_ )JQ*"+V(       %D5_ZB9_Z<Y_O4 27L"
M      +'2_Y=7/\ B6_]R@2P7P0       +%0?Y$Y_Q4C_>F)D"^B
M
M
M
M          !#_5W3O6Z3K#1]3M(WZ V[ M<Z!*[;4:C(UREOKP;0GN*+;B+)
MJF))JZ'IOQA4^_ZWJ3'E6.FY;@I;%'GF:EFP<6*K.@FV\NP\>4\1>L*4*XDS
MM.$Z@IM.G%J>[37;RS/=HG22PB9-X>[R<^.3#'#G&)T)-A@
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M:BN0';SR+[=<IA&F)GWBLNZY_P EEY.<8V29V
M                     "R5?\I1O^HM_P":L2@7L0       +(K_P!1,_\
M3G/]Z@"2]@0      !8Z7_+JY_Q+?^Y0)8+X(       %BH/\C>_XN1_OE"7
MI!?1
M            A[Q#<1\_2BMV[8EEVP5VZ@W0A#D2 \I>Y:2ZX;31;MLR6MQQ
M>.!$9<F)\H0BYRHM0E2,:O68)8'%)J%$U-HNENN>GT>SZO<:FVZ+4(>="26_
MBEG>(6MTE(6HLN9*MBN4ADC;4ZT>**2DXTKH9/PMA#$BY42
M            #\UJ2A)J5R)$-T1)K^S=2K"U$55&[+N:)<*Z(XAJKIBYOJ%N
M9B0E>9"<25E,2DZ;VID-XTUFPR/$ 5
M
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M;8GZ.?\ "!5 =7KWML3]'/\ A J@.KU[VV)^CG_"!5 KN*][?$_1U?P@BJV
MIN*][=$_1U?P@FJ W%>]MB?HY_P@50'5Z][;$_1S_A J@.KU[VV)^CG_  @5
M0'5Z][;$_1S_ (0*H#J]>]MB?HY_P@50'5Z][;$_1S_A J@.KU[VV)^CG_"!
M5 =7KWML3]'/^$"J ZO7O;8GZ.?\(%4!U>O>VQ/T<_X0*H%8\:I)EH?ES&W6
MDMJ2F.RVILC4I2>DK%2N00Z O8@       6%<2JI??7'GM;AY>9#3S2EFC%.
M7*DTK3LYP0/75Z][;$_1S_A!:J ZO7O;8GZ.?\(%4!U>O>VQ/T<_X0*H#J]>
M]MB?HY_P@50'5Z][;$_1S_A J@-Q7O;8GZ.?\(%4!U>O>VQ/T<_X0*H#J]>]
MMB?HY_P@50*[BO>WQ/T=7\((JM@*=7KWML3]'/\ A!-4#PMJOI0M2)T1:LIY
M4;A6U7TQ& /+3=PK;0IR7$:<6E)K1N5*RJ[GY03@#]>KU[VV)^CG_"!5 =7K
MWML3]'/^$"J W%>]NB?HZOX0*H#J]>]MB?HY_P (%4!U>O>VQ/T<_P"$"J Z
MO7O;8GZ.?\(%4!U>O>VQ/T<_X0*H#J]>]MB?HY_P@50'5Z][;$_1S_A J@.K
MU[VV)^CG_"!5 HS&JARH[\J>VIADE?4,MJ1G4HOE9E*\40Z OH@       6:
M7&J"Y*'X<U#*-WNW([J#<3CFS9DX*3TA*8/'5Z][;$_1S_A P ZO7O;8GZ.?
M\()J@.KU[VV)^CG_  @50'5Z][;$_1S_ (0*H#J]>]MB?HY_P@50'5Z][;$_
M1S_A J@5W%>]OB?HZOX015; 4ZO7O;8GZ.?\()J@5W%>]OB?HZOX015; 4ZO
M7O;8GZ.?\()J@5W%>]OB?HZOX015 ^9I%Q+2LW94-HR6HD$EE2LR2/HJ_*?*
M# 'T=7KWML3]'/\ A!-4!U>O>VQ/T<_X0*H#J]>]MB?HY_P@50'5Z][;$_1S
M_A J@.KU[VV)^CG_  @50'5Z][;$_1S_ (0*H#J]>]MB?HY_P@50'5Z][;$_
M1S_A J@.KU[VV)^CG_"!5 =7KWML3]'/^$"J!^2HE9<4T3M182TEQ"W-RRI*
ME)2K'+F-:O&$51)D(@@      "TU*.Z^NG*:1FZO+0\X?DI2HO\ \H2F"["
M      !:3CN=LHDY?J2B*:S^4;B5 "[        +1"CNLRZHXM/1D2$N-'W4
M[I*?W2 %W        6BE1G8T=QMXLJU2'E_O5K4I/[HF3JP7<0
M                                                         .7W
M&(N) UFTMK5A2)4_6:&<?JELL1M^VXVV\I<5:^D6"U*-19<-J=IX8"UAM3=-
M#T^7,+JWH*O08+$K5S7CQ2Z>U'B3ISE@5.$F+[HTF/&-,-YYIU2HJ%O+<<,D
M+?,S4K%72Z'1YLME*.\X:3'<;:BGH\O)G7KP\H\RY3(5%@
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M[$!J9(::)IHWUDA+CF4^1..)C)&VY(I.6Z3D&)%BHL
M
M           QNX*RU;]#JU=>BOSFJ/#?F.0HJ24\X3"%.*)M*C+%1D6P@)(E
M1N-_3F:PW)AV3>\N,\G%#[%*WC:O M+JB4+[C*[QG>GO$Y:6HUUT^T:5:5UT
MN;4&WW43:I33CQ4DPV;BLSF?!)GEV=\5<:$IDGA
M                                P;4.[XU@V/=EZ2F.LLVS37YQQR/:
MX;2#-"#[QJ/ $-1"F5K!Q0VE1+;N:Y:1:M9@ZLJBTZQ8$12FG*14:HG>0>M&
M98NMFC',68SQ+:8R;J9%6;2T]O;6.UM5Z=I5K+4Z+<KUW4>36+7K]%9.-D<A
MF1OQW6S2C$LIF9&9<HJZ4P"Y27HJ2
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M1F:NYW#$-1:&AD[!4D
M                        #GSQ#Z-:J,ZN6[KSI)!9N.KT=F.BHT%U:-Z2
MXJ5-I6E#BD[Q#C:\JB2>8MIBUF79N6R0N?Q(Q6N+,"1IGQ \0VK%G7EJG9\;
M3JVK-<85N"5D6MMEXGS2RA2W7%+=418K/HI(7MN%MN6MHI/>FE'1B=0QB+@
M                         ?@XE2VUDD\JU(%9*J:)1%/AMT"KNAS]_.5F
MOPJXF[9D>1%*&AQO=$RI\S)S>'MQWG,,F]_#4-:*M5N.6TED18"I)4
M                    4,B/E 'X$PSS-(^@ /H
M
M          'XK0EU*D+0E2%)RK0K:1D -:Z::<T[2VWI-L4.=,F4A52F5"FL
MS#)74D3'%.JCM94EBVA2CRD?.85J#:
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MZ*<=@.510ET*@
M                      B@ D
M
M
M $8-0=3-:K!O&>N%H^[J#ILIEA4.H4)\NU&E[LM^2X_3-1)7CA@DMG.+12:T
M@_:T.*O1R[)2:5*N%RS:^ES<OV]<K?9SR'/E-YW<6C,C[JR!P:&\B1[3K;[:
M'6EI<:<2E3:TJS)4E7(I)BI)]0$
M                   1=OW4_6NPKPJ*H^CKM_Z;965TVK4!_&I(/=IW^^C9
MG,Y)7FRX$6SG%DD]>(/KL_BHT;N^6FEO7&=H5Y+F[=M^Y&^SI*'>=&+N+)J(
M^XLA#BR%),D<VXA]"7&U)6VM)*0M)YDJ2KG(02?2
M                       C]JS>.L=G52C3[!TYCZB6J<=?O'!9E%'J;;Q*
M3DZN6."R-..)$E0E) Q.W>+G3"7/*A7RW5=*[E21$_2+HBKC$E:N9+Y$:,OE
M*RB7!TJ155)*TVITZKPF*A2I\>IT^6C>1ID1TGFEI+G2Z@U)/[@J27@
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MGL)O>_5DI%*@PLY&\F.XK*3KIIQ))\F/BDH2X456*DMA4
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MV,QWVUM])4KCI"C2E,HC4H\"Z*BVGX2#LI$K-VFZ)E]+ ]HQGI*@
M
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M#26PINF5AT2R)=Q/W0=#WS4:J2$&A6Z4Z:FFB3F<V-I,D%M%&ZDFU0
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MJ;;;4$D'56HCB2GM1NL8.<B<#,N3E";KJ"5#H^,2) D
M                                 &#WGL;IW^T</X$D/3E7[QK.):(\
MY@NPRQREMV\@]BQ-34IL^:7P!05*[/FE\ 4%1L^:7P!05/./>^\%"2NSYI?
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M(BP+D&K.G*@
M                          "!6JNE5;N/5[4=,FSCN*-J382X%CW8IM#S
M-&J-.86I48U.;&52%$619=W\(73P(,>T4.HW/K59=7H.D<W36-95IR*-J9+F
MP$16I4[(A#),FE*<RR<(SSETC29X[ ;PT@Z+"A(
M                                0"U6TIKMQZJZMM/V:JX$:E60AJP[
MP6VAYFE3:4R>\A&I>QE4A:2RK+#E[YBZ=$"W:(NS[KUMMVX;>TEG:9TNU;0=
MHVHSLZ B&W*J)Y=REC(E.925$?3+I*1RB9:-)"TZ#H<,9(
M                             1+ULLZ=4M6]%+LFV@N_+,ITB91*[2-T
MF0W3WZCD0Q4G65DHE);PZ1F6"<,>X+1?*&1@MNWZ[$N3272NG:/2Z3J!II>*
MY=<U%7"05/DT,I#RU.JDI3]:EUI:"+'D,BR[1:N%:A'5,8D )
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M[3R\)MQW%=)Q5,Q:92G)+[AL$\9EB3[:DXI+GP(L1,MI!UL&,D
M                                         #![T\6F?AN_YI#TY7XF
M:SB6B/28(6&!> >Q&H*B2          #7]\ZDV9IO3VZG>-;:I+4DS3 8))O
M2)*D[%);:;VJR\YGL(4G<C%T>D]%JQ*YBM!9M/=:=.=3GGXMI5SK%2CI-UZD
MRFEQY61/*XE"]BB+GP,\.<6B][01<LRMZ3;)X8[.0280!
M                                                           >
MV?Y1'_VJ?W2%9?"^8R6_B7.;O&K.G
M                                            ,<N.O0+6M^M7)5E[
MFFT&$_/FN)+I);80IQ9%WS).P2@0WHDCBRU>I\>^:%=E TIM2N).7;%OOPBF
M2SA+/%EV2XIM9$I:<%8$?/XHM[JP(Q,XTMU#U0HVH9Z.ZVM4Z=<4ZGN5>SKS
MI2#;CU..P9I>:6S@DD.((S/D2>!;2Y#!I4JB268H
M                                ,7NNY*?:-MUZZ*NYDIUO0)$^::?&
M4VP@UJ2GOF98$%*@AY1%<6^K%-C7O2;OM[2JVZVV4RV[:=A%-E=3=VLKDN*;
M6HU+1@98'MQY"%UNK21B]!GFE.HNIE.O]_1[6EBG2KH<IRZQ:=WTDMW'JD1I
M9H>2;1D1)=:49XE@G81[.[#2:JB25XJ
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M$-N/)DK7(=8AR8Z6$I)),FT>8B+;CM$N()\B@
M                             P>]/%IGX;O^:0].5^)FLXEHCTF"%R%X
M![%H-05$D          '.O6==*5Q56@C48TG93,6G]7*5_)39-"L<^/1R=8_
M*??&"RUVLJFXBF\NMW26S5&I69;_ !%Z95?3*32FWC=@MU]NA*:ZIO'9!M9#
MW'U>+C*RS$G[NT39DU>:6AI><;LG8;GIQ\QTG/89D,QJ !
M           !;ILZ#3(KLZI38].B1RS/RY+B666RY.DXY@21#:6DR*+>@M,&
M[K3JTI$"E712*I-<29HA0Y[#SJDD6*LJ&W%&> )U)=MK2C)Q)C8 @
M                  ^9UUIEI3KSA,LLD:G'%GE2E*=JE*5S$051=*IC4>][
M*F/MQ8EY4*3)D+)N,PS4HKCCBU;$DA"',3-7,1"$ZZ"[MR6E&7&7=!&)@20
M         >VORT?\-/[I"LM#,EOXX\YN\:LZ<
M                                                    UEJO:M1O
MC3:\[1I3C+-3N*C2H,5V0LTLDZZC*1.*22CPV]P2G1@B[0+/XU;<HE'MZF7-
M8:*?1(3$& VXPM:R98;2VC%1MXF>5/*+5BRN)>+/TPX@JCK%8^HVK-7M>H4^
MSX53B,-4=*VG23.94@B-!MI)72PYP;5*(E$UQ0D
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ML!^4HUNR$-L..)-Q2E&K$C+;M$2DV2B:(H@!(
M                           ,'O3Q*9^&[_FD/3E?B9K.):(])@A<A> >
MQ&H*B2          #0VO$;1]JV(-6U@IAS:6Q**)3)C#;ARFGW4J6:&UL&E1
M$O+MQZ(PSW4\=9[LL[GX60_TQLN@ZHZP4*LZ=V8]:NE5A+:D/3)!*4[+>84;
MJ3=<4HR6Z\YAT4J/(DA:Q!IN3/1F9J-O<KCKV8G3DSQ/'NC(:H 0
M                 8Q=EJT>]K=JEK7"RY(HM8;2U4([:S;4:4+2M.52<3+I
M)%)QWE1F:W<=MU1K*RN'C2[3ZX8ETVO29<6LPFG6X\AZ6MU))>2;;AY3P(^B
M8M%;IDNYB5Q49O39S"3S, 0                         ?!.AQZC!F4Z6
M1KBU!AV/+0G8I33R5(6G'FV*%914L&982<75&@J+PLZ.6]6*77*719K50HLE
MJ93W5SG%I)YE9+2:DF6W RY C'==49[N:E<5&2,,\QFH^56T6KM/( (
M     /;7Y:/^&G]TA66AF2W\4><W>-6=.
M
M
M
M              ! '52I:=5SB<AT;66KP8MD63:351M^DU5XFX+]5FR.FMUO
M#!:DMXF1'RY2%U5+ @N&I,C@]NRS*[26:M9$&>F ^=&G4SJ\66S)0A2F%,N,
MI2HS)S LI\H*I+-\<.5R52[=#]-J]6WCE56524MRI*CQ4X<9Q;"5JQYU$UF/
MOBLM(6@WL(    <XM9.(2S'KPJVG\S16D5&IQ)SU/.Y;WW%/IRU-*R;U+RVE
M+-!X=%1++$AD4,*D;VHQZT^$U^^ZG&NN%?EIV)#)272@Z9.ORD\I'@J2[(RD
M9>21EW@WR-VCJ=,X[.Y889SJ<W+:49U^,K*G#,KOC&6/K   ?@Z]NVEN&1KR
M)-65/+L '+J\=?;)U(KCMJ,Z(6G2J@XXI"JYJ0ZS2T%MR^,AI#A[>8W#Q&7=
MIK*U3U&;Z4\)TR-=5%U&3J)2:1&@369K5MV&;RJ6[NE$YNEONOKS(7A@K%/(
M(E.N!*B=%1C)
M    P>]/%IGX;O\ FD/3E?B9K.):(])@G,0]BT&H9420          6.L4&B
M7#%1"KU)A5B&VZE]F-/81);0ZGQ5D3A&68NZ*N*=#+&;CH=#[X<2)3XS<.#&
M8@1&2P9B1VB::(N\E!)20LRM6])]H(J (
M                                              #VU^6C_AI_=(5E
MH9DM_%'G-WC5G3@
M
M
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MTJ^:I?\  M/J,YF9(M2S8S\> ^EE9+4PO>NH+(O# ^B8F=Q-$)49T'&,L
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M1%SBL\M=W7[KT;"]KB65<U2[#3\R),I4E98I41ER[!I#LS] )
M
M
M
M
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MPAMROUP_Y'GW4X-_:].OZYB?SD.WXMLN_2_8.Y>$-N5^N'_(K[J\&_M.G?\
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/:-UUG?K0J:/4?8()/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tm2227887d1-bc_single4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_single4clr.jpg
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M=39VEC<)@4)TM5(S@Z'!)*4X.6*"XD-CHT2D);;A9(0FAGC"1=5F=RA8$0$
M 0(# P<(!P<# P(& P   1$"(1(#,5$306'14P0%%I&A(E*2TE07<3)RTQ05
M!H&QP;)S- ="8J(SHS7P(^'Q@L*3)$-C)?_:  P# 0 "$0,1 #\ ]_
M                        !K;@7BCQ_P 1-;R=0;*H]P4N9BB=%I]Q.5N/
M$8:>=ENS&D'%.-+DFI)'"7KOD@]#3L/4]"S%&R0(
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M%*30F(KZFWTI)>\^4F5%)*-%=%)J/[ +$5;$ @
M
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M3"8SDHTJ>.43^_N-&6A,::Z;=-H+1L0"
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M;J5&E"S29 M'IM'D,2X[$N*\B1%E-I>C2&S)2%MK(E)4E1;#(R/4C!ES
M
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M39FDM5:Z@DQ1N,"
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M%?\ INO;_P#R54O]GHP%VUZG R\L>-'_ -8O 9_$K_\ N%.!J-A<?_\ K_\
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M<J%:?0G=-V6FK2XF\OIF:6H[;>I]))=(&;MK9ZJXWQ14<GV_DBL6]2'\JT6
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MWHG<+DS+1.A;O0T+0&61@
M                             /"W,V,;MRY_<LN^SK)RK5\-5UZU8,IN
M]J(4@Y;;3%(BFM@BC3(*]UTCT/\ &Z?8,&XV-@7/[>^<ZFA<*YN/G)-=HSZ3
M3+IBD5,DN),M#(^6K[Z-#(S+:@P3,VZX;N%3&'##0ZG3[':F5.N7 IM5R7?5
MEH=G2^2UW&BY-"$-M(-2C)"4]$]5&H]#!)FK4ZX^)>R+,SSD:TN%3AED9BS#
M)?6UEB[*0LJ=$*2T^KEBD229?WS0^HT.+7R2.4V$M>@+1JUQVW?QAWA@^'+S
M=BFT,78\:N6G+B08=0[X5IRH*8DDSJMB7(92WN&X:B-"5%L+7HD"Q1L_Q^?^
M@>U/_P!C_P @D$C:V+N?_P! %P__ +OLO_\ %58)RO.R@U>J4;^S_77J4I;3
MDRH/P)LEL]#;BR[J;9?(]AZDXA1M']A8-<JUN'*Y>.ZT\&8NHV+\!8YJ=A)H
M$69;=5D5E#<B6Q.3SLY,A!5%&ZZZITUN)W2,E&9&1:: DT<U.Q+QFWQQ;X=X
M@L@XFMBR&K/)JC7+)MVLQCY:EN');>=>0J6^XZM+4M:="Z*2)/2+05BCZBTV
M%/\ [NE5?EQTONTFT43*>I1:\F_WA88WR^SN.J+_ ! Y&S']Q]*5<&68C4DE
M&@[>4@S+70_*&FEJ7J;#,@2W:JZXU*7_ &L(YK4:C+$-*21F>NQ+4<B+_ BT
M!>5=W %_Z0,)_LR=_NDP$G:W#! !Y*X]_P#=NSI_ \/_ &:W@:Y'K4#( \A_
M[/\ 3836),KU=N.E-1G7<S#E2B+LEL18#3C*#/U$*D.&7W1@U<D\UT2FU?\
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MU&*XN]^\43GQ3+@YSS??T5R?*;VYKMW=-0+DUP;?^NGC=_:<K_=G )V%6_\
M=NMC^!W/]FE@<CYX5&&+A_N$\8MRUXDS+BH)O4VANOIU<:AE,:BD;>O0W6(K
M+>\6W=/0MBC G8WOXJ:'1+AX;,Z4ZX$-'36['K<XW76^5)E^#"=EQWR1T34T
M\TA:=-NI;-H)&UY91ZC.J']G&L\^?7(YC)8B0UKVF3#5[QMQ&O3).ID7J$6G
M2!KE>F/!G385*X5\$1:?'3&8=M&!,<;06A&_,2<E]?VUNNJ4?V3!F=K2[ GX
MO^Z;Q2-H[!M=E.+4VG8DU<K;A[QD6S7LCV_9,%G8]:@9
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MG'^9L(:-Y1%L(W#2:C(MA:Z$#+.@
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M&P9
M
M                                     !HEPA<.&0<'9(XG;KO1ZD.T
MO+]RQ:M:B:;)<?=3'9F5=]124K9;)"MV<WH1&K;O;=FTLRWM!       :/\
M%?PS7UE*Z,<9FPK=\.S<SXG-U-%=J2%*A5&*M9.%&>6E+NYNF;A$1MJ2LG%)
M7H6BB+$J3NRV_P"Y;FJWZKC"ZXF,,46M<#)T^Y+RH[LER8_ =3N26VDE+G*_
M&H,TF1-M&>NF^A)F8+@WQP7AVV\"8NM;%MK.NRZ=;C*^<5.01$],ER'%/R9+
MA%J1&XXM1DG4]U.Z@CT20),U6V"
M
M           *=SJYFIC'TR3@%BBS,BQI<9R'3Z_H4.1&WC3(;,S4V1*W3WDF
M:T]#H](RPUOX3>'+)]FWOD3B XB*W K^;<DM-4\F:<:5QZ52F>3_ /#I4A"&
M]Y?(M)W4$:4H;3V:E*6!,M\@0
M
M
M
M
M
M
M
M
M
M
M
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MU@P,3F]R?+8G:*ZP8&)S>Y/EL3M%=8,#$YO<GRV)VBNL&!B<WN3Y;$[176#
MQ.;W)\MB=HKK!@8G-[D^6Q.T5U@P,3F]R?+8G:*ZP8&)S>Y/EL3M%=8,#$YO
M<GRV)VBNL&!B<WN3Y;$[176# Q.;W)\MB=HKK!@8G-[D^6Q.T5U@P,3F]R?+
M8G:*ZP8&)S>Y/EL3M%=8,#$YO<GRV)VBNL&!B<WN3Y;$[176# Q.;W)\MB=H
MKK!@8G-[D^6Q.T5U@P,3F]R?+8G:*ZP8&)S>Y/EL3M%=8,#$YO<GRV)VBNL&
M!B<WN3Y;$[176# Q.;W)\MB=HKK!@8G-[D^6Q.T5U@P,3F]R?+8G:*ZP8&)S
M>Y/EL3M%=8,#$YO<GRV)VBNL&!B<WN3Y;$[176# Q.;W)\MB=HKK!@8G-[D^
M6Q.T5U@P,3F]R?+8G:*ZP8&)S>Y/EL3M%=8,#$YO<GRV)VBNL&!B<WN3Y;$[
M176# Q.;W)\MB=HKK!@8G-[D^6Q.T5U@P,3F]R?+8G:*ZP8&)S>Y/EL3M%=8
M,#$YO<GRV)VBNL&!B<WN3Y;$[176# Q.;W)\MB=HKK!@8G-[D^6Q.T5U@P,3
MF]R?+8G:*ZP8&)S>Y/EL3M%=8,#$YO<GRV)VBNL&!B<WN3Y;$[176# Q.;W)
M\MB=HKK!@8G-[D^6Q.T5U@P,3F]R?+8G:*ZP8&)S>Y/EL3M%=8,#$YO<GRV)
MVBNL&!B<WN3Y;$[176# Q.;W)\MB=HKK!@8G-[D^6Q.T5U@P,3F]R?+8G:*Z
MP8&)S>Y/EL3M%=8,#$YO<GRV)VBNL&!B<WN3Y;$[176# Q.;W)\MB=HKK!@8
MOAQJXT-K6<V(9(2:C[!72+4,#%"T^;7IT-B7WQ:;Y9.NYR.NFTRZ.]]@68A*
MNYO5[PHU\#_\X3!3>KWA1KX'_P"<& ;U>\*-? __ #@P$I0)4N4S.*:ZEYV+
M+4PEQ*=TC22$*+9J?348DP0GA%
M
M
M                      =25 @S=SGL-B7R6O)\LVES=WM-=-XCTUT(6HP^
MW&6H]T7G'CM(88:D1B:9;224)(X<=1DE):$6IF9C5VR&8VRSL8:
M
M                                                           <
M,CXN_P"]J]8P&$6_\SP/N#_",;G:S"8$   ?5N>QK'[1<_)-!<L,C&5
M
M
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M:"Y89&,J
M
M                                             .C.JE,IB4KJ51BT
M]"]B5R7D-$?VC69"Q%2KL,2(\II+\9]N2RO:AYI1+2?VC29D(.8        !
M^&9$1F9Z$6TS,!P19D2<RF3"E,S(ZC,DOL+2X@S(]#(E),RV!2@[     #RO
MXP?ZG*]X;_1XX^G_ *&_MM3[7\'\Z?YH_ONS_P!.?YFIP]W?&0
M
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M2\3[;"]5$>U)D>T_8D72$NV+9MEN7;GL:Q^T7/R30Q<Z0R,94
M
M
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MB8THVT'-T>5_&#_4Y7O#?Z/''T_]#?VVI]K^#^=/\T?WW9_Z<_S-3A[N^,@
M
M                       #T;X'OW=OW]HP_P BL?-?UW_U=+[,_OA_0_\
MA;^T[3]NW^5O,/0WVH                                       !PR
M/B[_ +VKUC 81;_S/ ^X/\(QN=K,-=^):D8&K-,H;&9KB<MJ0PMU=!J$#>54
M"2K=)TD(;CRE*;,R+75LRU^R+;5F^G*KJP\D\(MDVG4,?VI>LAF-<J5QJC/<
MIU35.DKD(Y$E+>5 ).I$K1/8[I>H+C,LQ-L11M)C7&UH8OMQJW[.AK8@.*YP
M_*?5RDB2XHB_&/+W4ZGI]@B+I$0S,U;B(A8=N>QK'[1<_)-"7-0R,94
M
M
M                                :2O9-Q'E&YKSQUGVRJ):E=M*6IJE
M.51[?5(C])YF9R3*FMXC2HDDO:1Z[=!URS&QRS1.$JTX?YQ1<W9*L#%EPS[@
MQ&FCO+8.0\Z['B2E-D2#8-?0U=4I)&6F\DM=N@MVRLI;MI&Q.<+>3K%Q;CR\
M;,O^LL6[<UIUVH/UJ),U2]*2HDD2T),M5J/<-.Z6I] ^F)?;,EET1&*'S5=-
MGWIPLOW%8UDIL>WYUVPRCP41(T-,E:'E)7))N+V)[YEIJ>T]!;8I)=,3;@V
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M
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M)-!<L,C&5
M
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MU.5[PW^CQQ]/_0W]MJ?:_@_G3_-']]V?^G/\S4X>[OC(
M
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MCTAB8ANVZ9Y&P=N>QK'[1<_)-#-S<,C&5
M
M
M                              'E?Q@_U.5[PW^CQQ]/_0W]MJ?:_@_G
M3_-']]V?^G/\S4X>[OC(
M                                             ]&^![]W;]_:,/\
M(K'S7]=_]72^S/[X?T/_ (6_M.T_;M_E;S#T-]J
M                   <,CXN_P"]J]8P& TB5&AT*"]+D-1623NFZ\M*$ZFH
M]"U49%M&YVLPUAS)%O\ LC+5L9EM6U'[]H<:B.T>M4:(H^<L)-9K);:2)1Z*
MWM2-*3VD>O1+75N,48NK$U5[>-[9(XB_)VQZ!B:M692F:U"J5:N.N$IDF41%
M;_8;S;?0UUV&9GT"(:B(MQ9F9NPHW\:0;;;;9J-1H2234?1/0M-1R=7+;GL:
MQ^T7/R307+#(QE0
M
M
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M1]X===YN@\!]Q?"V>?I/1YPO]7U.ZKW= \1]X===YN@\!]Q?"V>?I/1YPO\
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M'77>;H/ ?<7PMGGZ6<6E8=H6(Q,C6C0H]"8J#B79C<??T<6@C2DSWU*Z!&/
M[9V_7[7,3K7S=,;*OVNZ^Y>Q=UVW6=ETK=.+IK-.667#PWZ@
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MA!F8L:<\J3?N6-].F._"COP#GM1.'*YX/ITQWX4=^ <]J'#DSP?3ICOPH[\
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M_'?:E,,26%DXS(;2ZRLN@:5D2DG_ (D8PVY@
M                     !&5*FG4DM([XS8!-&9F<-PFC7K_ ,1[IGL]06)H
MDPQ.UH_-+CN^)R[LGF[\<N<R%;[J]Z(PO5:M"U,M[0OL$1#5TUB$C;+/QAH
M
M
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M1EH     1-:^)?\ 51ZXL"6$            $-6OB['OZ!824NGV*?M$(KZ
M          !#U+XS3O?3]86!,"            "&J/QZF>^D+ F1
M    !#O_ #O ^X<_!,7D$P(            (H_GA'O!^N+R"5$
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MVKM:EC;D
M
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M1EH     1-:^)?\ 51ZXL"6$            $-6OB['OZ!824NGV*?M$(KZ
M          !#U+XS3O?3]86!,"            "&J/QZF>^D+ F1
M    !#O_ #O ^X<_!,7D$P(            (H_GA'O!^N+R"5$
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M!_J47O2?T:,/*T_JO&U=K4L;<@
M
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M#(QE0                      5%C?][LW?QA'_ -BI8U=LAFW;*W1EH
M  1-:^)?]5'KBP)80            0U:^+L>_H%A)2Z?8I^T0BOH
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MK3^J\;5VM2QMR
M
M                 9ICG]_[*_;E/_2&PG8U;M>Y@\)Y@ X9'Q=_WM7K& PB
MW_F>!]P?X1C<[68?*K<H*ZZW="J1%5<344X3=:-M/.4QS/>-HG.CNZGKH%>0
MHY:W0J-<E/<I->ID>KTUU;3KD&4@G&U+96EQM1I/9JE:247V2$B:$Q5*)2E"
M4I21)2DB)*2Z!$70(!]VY[&L?M%S\DT%RPR,94
M%18W_>[-W\81_P#8J6-7;(9MVRMT9:     $36OB7_51ZXL"6$
M  $-6OB['OZ!824NGV*?M$(KZ           !#U+XS3O?3]86!,"
M    "&J/QZF>^D+ F1            !#O_.\#[AS\$Q>03 @
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MVY#8>]IN[V]L]4:S849RXU6D,M/+/C!_J47O2?T:,/*T_JO&U=K4L;<@
M
M                                                           &
M:8Y_?^ROVY3_ -(;"=C5NU[F#PGF #AD?%W_ 'M7K& PBW_F>!]P?X1C<[68
M8S<^4L=67/12[KO*ET"HN-$^W#FOI:<-M1F1*(CZ1F1A%LRDW1#%W\_X8<8>
M;9RG;[#RVU):>YTA6XHRT)6A[#T/;H+EE,T,?X<\JS,G6Q74UFH1:G<%JUB1
M3JA.ADDF9#.\HXTALD[-U:2/0RV'H%\4++JMB+<]C6/VBY^2:&;FX9&,J
M              (*Y[DI=H6_5[GK;CK5(H<9<NI/,M+?6AEO:M1-MDI2M"VG
MH70%B*BA4\6.)9-/54*:Y<%096TMR*\U0*HIEPTD>FCA1C3IJ6FHUDE,S)\-
MYSM_+U-@'"@SZ;7E4IJHU:"]#E(B,FLTI4AF8\RVV]HI>PTGM+;T!+K:$35>
M RJHL;_O=F[^,(_^Q4L:NV0S;ME;HRT     (FM?$O\ JH]<6!+"
M    "&K7Q=CW] L)*73[%/VB$5]            AZE\9IWOI^L+ F!
M      !#5'X]3/?2%@3(@            AW_ )W@?<.?@F+R"8$
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M7:U+&W(
M
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M3 @            AJC\>IGOI"P)D0            0[_ ,[P/N'/P3%Y!,"
M           "*/YX1[P?KB\@E1            !$-_/4G_3(_"%Y!+B
M KW+7]+\A?P]4?T=8U;MAF[9+*+;_=V@?LV+^12)=M6-B:$4
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M%?0           (>I?&:=[Z?K"P)@0            0U1^/4SWTA8$R(
M        (=_YW@?<.?@F+R"8$            $4?SPCW@_7%Y!*B
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MUP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N
M<[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<
M3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*
MFNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UV
MZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3U
MP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <
M[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3
MY4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*F
MNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ
M>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP
M#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[
MB?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y4UVZ>N <[B?*FNW3UP#G<3Y
M4UVZ>N X9$N*;#Q%):,S;5H6^GU#^R*,+H+["*1!2MYM*B0>J341'[(QJ=K,
M);G4;Y0UVY=<0.=1OE#7;EUP#G4;Y0UVY=<!SVTI*D5A25$I)U%S11'J1_BF
M@N6&2C*@                "%N*%6:C1*E"MZMIMRMR6313JXN*B:F,YJ6C
MAQEJ0ES9TC400-$<^6U-C4*);^<.*6A1X4MU$VEP7+(8=G)<95HF0PB'+<D)
M(CU2:B+0RU2>I&9#K;.Z&9YVQ^)3NA-<N:E5S-M.R9Y*DFEU*VXM CT9^FR^
MQ4A;IM/N*-*D)42>QW#VZ'V)D,7?0L+Y&55%C?\ >[-W\81_]BI8U=LAFW;*
MW1EH     :_WGG['M)J<VV(KU3N6M4MU)52+0H#TY,923U-#KB"W"4733O:C
MQ]?MFCV>?_<OBUVTNS:NM]2V99K866['R0N;&MNIN%5:9IWRH,YER).8(^@I
M;#I$K=/U2U+[(Z:6K9JVYK)B8YF-33NTYRW125ECHP         /PS(B,S/0
MBVF8#!JY<],,D1V>5E+:>2I:FDD:2)/1VJ,AXVMV[0T)IJ71$NEFC?J16V)E
MD=+K4"JH,HCIFMLBWVEENJ+_  ';3U;=2W-;,3',Q=;-LTF*2EQM
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MR1J15VGLVK$9LLT;#TBKTNOTR#6J+.9J=*J327X,^.HEM.MJZ"DJ(>6XI(
M  !7N6OZ7Y"_AZH_HZQJW;#-VR646W^[M _9L7\BD2[:L;$T(H   # <IOW)
M%QW>$BTBE>4#5-=5 5 ;)Z:DMG*KB-&2B6^EO>-E)D9*<))&1BVTKBEU:8*?
MQ5,AKR"<:PJO=5:L15M*>NEVX53WX[-;.0T3"6WZB7*)E*:Y7G#*%;J-$&:4
MJ/;N[9BQ;MP;/#FZ("Z:1+K]MURBP*M*H,ZIPGH\.M0EFW(BNK09(>:6DR,E
M(5H9#-^:GH[>1JR8B8KC#SHO#-V4;KMUJZ[=DRZ&BB3K:L"]X*JF=#A1JQ-?
M7(KRWZ@<:6F*;9(BQDR.24;7++TT5H9>9-MDS6V/0ONK;6:3EMMF8BO^Z^[)
M,;9NT\L3$O#LNOBL73Z6G;2ZD5C-==%M9C"F6RWB1R1;J1=-LQ#\5=N7'K7>
MISM^V_#I<&\FHT*CM9&D/R:A&52E.OTD[S*EQS9=9=W92"4DUJ29LJ7IH,S%
MM+)G&?2YL(I28]:8G-$QA%(BLS,7-6S=%VI'^FELQ.,TNG-FB</1MNB+:369
MK,X1$V-VL%W0Q=V,Z'5F)%8E\E(J%/?D5V5%GS%/09K\9TCFPB)B2VE39I;=
M1KOH)*C,U:F?/5VQ.^(G93DVS'),[<,/5PHWHUI,3MB9Y:\NR)Y8C9%<>2[T
MJK='-U                              !%5675(J&3I=([[.+4?*I.0B
M.E"2+HZJ)6IGZA$+$0DL'H4-NL7!=+E;IR&I:7V.4@FYRI,GS5@B(G$[I*U3
MHKH;-=.D-S-(BB1M9AY,T'P:WU5=<9S2M#R9H/@UOJJZX9I*'DS0?!K?55UP
MS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,
MTE#R9H/@UOJJZX9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-
M)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX9I*'DS0?!K?55UPS2
M4/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE
M#R9H/@UOJJZX9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0
M\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX9I*'DS0?!K?55UPS24/
M)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R
M9H/@UOJJZX9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F
M:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX9I*'DS0?!K?55UPS24/)F
M@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H
M/@UOJJZX9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#
MX-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX9I*'DS0?!K?55UPS24/)F@^
M#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@
MUOJJZX9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-
M;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX9I*'DS0?!K?55UPS24/)F@^#6
M^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UO
MJJZX9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;Z
MJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX9I*'DS0?!K?55UPS24/)F@^#6^J
MKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJ
MZX9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJN
MN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX9I*'DS0?!K?55UPS24/)F@^#6^JKK
MAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&:2AY,T'P:WU5=<,TE#R9H/@UOJJZX
M9I*'DS0?!K?55UPS24/)F@^#6^JKKAFDH>3-!\&M]577#-)0\F:#X-;ZJNN&
M:2AY,T'P:WU5=<,TE'$];5"2R\I-.;)24*,CU5T2+[89I*,8H=/@.TJ$X[!C
MNN+09J<6VE2C[(^B9D+,XLPEN]=,\'1?@4=82JT.]=,\'1?@4=8*E#O73/!T
M7X%'6"I1W;8;;::J[;2$MMHJ*R2A)$1$7)-= B"Y89,,J
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MXR/@SZX4#OW%]QD?!GUPH'?N+[C(^#/KA0._<7W&1\&?7"@=^XON,CX,^N%
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MF+9IENNY;HVT7D/P'O(
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M"_AZH_HZQJW;#-VR646W^[M _9L7\BD2[:L;$T(H
M                          /*_C!_J<KWAO\ 1XX^G_H;^VU/M?P?SI_F
MC^^[/_3G^9J</=WQD
M        !N)P3_U.N+^%Y'Z;#'IOZX_LK/ZD?RW/K'^&_P#S.I_0N_GTGIZ/
ME;^F0
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M@           A:VE)QV#-)&?+HVF7V1824P@B)"2(M"T+8(KZ
M!!59AER535.,H<43IZ&I)&?0^R+ G"(B+0BT(N@0@_0           0U1^/4
MSWTA8$R(            (:0E)UB#JDCU0YKL_P#A,7D1,B*            B
MC^>$>\'ZXO()40            0K3;??V2O<3O\ -D=GH6OLO5%Y!-"
M KW+7]+\A?P]4?T=8U;MAF[9+*+;_=V@?LV+^12)=M6-B:$4
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MNS_TY_F:G#W=\9
M      ;B<$_]3KB_A>1^FPQZ;^N/[*S^I'\MSZQ_AO\ \SJ?T+OY])Z>CY6_
MID
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M(17T           "'J7QFG>^GZPL"8$            $-4?CU,]](6!,B
M         "'?^=X'W#GX)B\@F!            !%'\\(]X/UQ>02H@
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M_P#3G^9J</=WQD
M     !N)P3_U.N+^%Y'Z;#'IOZX_LK/ZD?RW/K'^&_\ S.I_0N_GTGIZ/E;^
MF0
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MM$(KZ           !#U+XS3O?3]86!,"            "&J/QZF>^D+ F1
M          !#O_.\#[AS\$Q>03 @            BC^>$>\'ZXO()40
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MMJ?:_@_G3_-']]V?^G/\S4X>[OC(
M                   #<3@G_J=<7\+R/TV&/3?UQ_96?U(_EN?6/\-_^9U/
MZ%W\^D]/1\K?TR
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MWE?Q@_U.5[PW^CQQ]/\ T-_;:GVOX/YT_P T?WW9_P"G/\S4X>[OC(
M                                             #<3@G_J=<7\+R/T
MV&/3?UQ_96?U(_EN?6/\-_\ F=3^A=_/I/3T?*W],@
M                                                      #AD?%W
M_>U>L8#"+?\ F>!]P?X1C<[68:=YDMFH9!X@+7L:E7S6+/0_;CM0J[D-]2$*
M2TM1-)8:(TD:SVFHS/H#=LTASNBMU%:YBPG7,6T&BW$WF>ZJE#EUN%3*C%=D
M&V]R4M1I-;&BS(U)TUT/I"VW59NMHVCQ5@^5CNN+N%W)=P7>U*AJ813:JK5I
M/*&E1.$6^KLBT&;KJNEMM&PMN>QK'[1<_)-#%S<,C&5
M     !46-_WNS=_&$?\ V*EC5VR&;=LK=&6@    !$UKXE_U4>N+ EA
M       !#5KXNQ[^@6$E+I]BG[1"*^@           0]2^,T[WT_6%@3 @
M          AJC\>IGOI"P)D0            0[_SO ^X<_!,7D$P(
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MX6-W8/$W=W6QY+N@^7/?_P +/M6>\>CGFOS G?"QN[!XF[NZV/)=T'RY[_\
MA9]JSWCT<\U^8$[X6-W8/$W=W6QY+N@^7/?_ ,+/M6>\>CGFOS G?"QN[!XF
M[NZV/)=T'RY[_P#A9]JSWCT<\U^8$[X6-W8/$W=W6QY+N@^7/?\ \+/M6>\>
MCGFOS G?"QN[!XF[NZV/)=T'RY[_ /A9]JSWCT<\U^8$[X6-W8/$W=W6QY+N
M@^7/?_PL^U9[QZ.>:_,"=\+&[L'B;N[K8\EW0?+GO_X6?:L]X]'/-?F!.^%C
M=V#Q-W=UL>2[H/ESW_\ "S[5GO'HYYK\P)WPL;NP>)N[NMCR7=!\N>__ (6?
M:L]X]'/-?F!.^%C=V#Q-W=UL>2[H/ESW_P#"S[5GO'HYYK\P)WPL;NP>)N[N
MMCR7=!\N>_\ X6?:L]X]'/-?F!.^%C=V#Q-W=UL>2[H/ESW_ /"S[5GO'HYY
MK\P)WPL;NP>)N[NMCR7=!\N>_P#X6?:L]X]'/-?F!.^%C=V#Q-W=UL>2[H/E
MSW_\+/M6>\>CGFOS G?"QN[!XF[NZV/)=T'RY[_^%GVK/>/1SS7Y@3OA8W=@
M\3=W=;'DNZ#Y<]__  L^U9[QZ.>:_,"=\+&[L'B;N[K8\EW0?+GO_P"%GVK/
M>/1SS7Y@3OA8W=@\3=W=;'DNZ#Y<]_\ PL^U9[QZ.>:_,"=\+&[L'B;N[K8\
MEW0?+GO_ .%GVK/>/1SS7Y@3OA8W=@\3=W=;'DNZ#Y<]_P#PL^U9[QZ.>:_,
M"=\+&[L'B;N[K8\EW0?+GO\ ^%GVK/>/1SS7Y@3OA8W=@\3=W=;'DNZ#Y<]_
M_"S[5GO'HYYK\P)WPL;NP>)N[NMCR7=!\N>__A9]JSWCT<\U^8$[X6-W8/$W
M=W6QY+N@^7/?_P +/M6>\V;X5,49"L2_JW5KMMB11*=)H#T1B4\ME1*>5*BN
M$@B;6H]32VH^ATAZQ^K.^.R=L[+;9HWQ==%\32D[*71RQSP^B_XQ_27>G=/>
M=^MVO1FRR=&ZV)F;9]*;[)B/1F9V6SY&_0^>ONP
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M$            $._\[P/N'/P3%Y!,"            "*/YX1[P?KB\@E1
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M"X(U AX;N>V>65^/K5T4R71:>PG0S-:WYC+9*TTZ""4K[&TA(AJ;Z/Z5^&?
MM$X<,1V_C6DRN^DV,;DZYJZ:-PYU3DZ&^\2-3W4)T2VV71)"4ZZJU,[+"_A
M                   !&5*L4^D):7/=6T3YF31(:==,]WH[&DJ,NCTQ8BJ5
M8G:TIF=<=WS8RE+C2GXZF5J2I"C),1A!ZH625%V23Z)?9Z U=%(A(VRS\8:
M
M
M       <,CXN_P"]J]8P%;1Z/2J_:K=(K=/8JE+G,*;EP9*"<;<2:CV&DQN9
MI+'(U1RQ8?"IB:/!>N+';<RK5QQ94:WZ<Y-<DR#29;YI0F024I(U$6O^!$-1
M,RQ=%L*VQU5>$2[[AIE'=Q9*M"I5"43-"EU)R9S9Z2V>QLGDR#2E>\6A$HM-
M=FNNP:FL)&66^U*L>TZ)<-:NNE41B%<-PMM-5JJ(-9N2$,$26R41J-):$1=
MBUTVCG,RZTAEMN>QK'[1<_)-"7+#(QE0                      5%C?\
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MJG70S,=>TZD:M\WQ_JQF-W-SL:%DV6Y9Y-D[XW\RV1X[N
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MIX10
M       '#(^+O^]J]8P&$6_\SP/N#_",;G:S#7B[:!4(_$I9-S3K>D5R@U*V
MY=+IU2:8-]JFS6E*=-3IZ&3>\A6Q1Z=$].@8U$^BQ,>DU&MR;5;XM:!A>W[%
MJ4NX8M^/UB9>#D<TQ*;%*<IXW">TU2:DZEM,M>@6IZ#I.$U<XQBCU5;2:&VT
M*4:U(2236?1,R+34<'=RVY[&L?M%S\DT%RPR,94
M %18W_>[-W\81_\ 8J6-7;(9MVRMT9:     $36OB7_51ZXL"6$
M   $-6OB['OZ!824NGV*?M$(KZ           !#U+XS3O?3]86!,"
M     "&J/QZF>^D+ F1            !#O\ SO ^X<_!,7D$P(
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MJ47O2?T:,/*T_JO&U=K4L;<@
M                        !Z'\#?S9D;_54S\"2..MR.^CRM\1P=P
M                                                          '#
M(^+O^]J]8P&$6_\ ,\#[@_PC&YVLPH?+V3<@P+NH.+\14:!4KTK,)RI5&IU0
MS*)3X:%;B5F6\G51F1^KIL[%6NS5L12LLW736D*X^D/B0Q/-HE2S%"M^X[&J
ME19IU3JU(T3*@KE+W6EZ))HC3J>FU!_=$?1M(G8S6Z-K=9*DK2E:3WDJ(C29
M=,CZ YNC[MSV-8_:+GY)H+EAD8RH                      *BQO\ O=F[
M^,(_^Q4L:NV0S;ME;HRT     (FM?$O^JCUQ8$L(            (:M?%V/?
MT"PDI=/L4_:(17T           "'J7QFG>^GZPL"8$            $-4?CU
M,]](6!,B            "'?^=X'W#GX)B\@F!            !%'\\(]X/UQ
M>02H@            B&_GJ3_ *9'X0O()<0     %>Y:_I?D+^'JC^CK&K=L
M,W;)91;?[NT#]FQ?R*1+MJQL30B@       ,?NRV*1>MLUVTJ_'.51;BA/0*
MFP1Z&IE])H5H?2/0]AC-T5C<U9?-LUA5-KX=KU!DUNOU7*-5NN^)=&.W[;NZ
M? @-JI, E\J2&HK#2&75J=)*G%N$9KW4D>PAY'&PI3;,3=_NRUI'-%+KHPW_
M $4\6>SQ,Q-<;8NBW_;FRU^U-;;9QW?37CNG![]T52L&YD6N0+0O V7+]LAE
MN,N-4GF&6F-YI]QM3T-+B6$$ZAE1)7H?0-2C/%MT12L5B)K$;IK7]L5QIO=;
MK9G9-)F*3.^*3'EQI7=3="^$(2VA#:$DE#:22A)= B(M"(8EN(H^C(C(R,M2
M/HD UZM# 2;3J](<3?E6JEHV<Y*?QU8\B/#1&HS\M#K:E\NVTEZ1R:7EI:)U
M1D@CTV[!N+YBW_=ERUYL.3?Z,8LW6Q==7DS9ICGQ_;MF9IO3%P8GN*L2J=5Z
M?E2M6[<"J4S1;MJD.)"<;J\1E;CA&<5]MQJ,[JZO1QDB41'IM(DZ9PK,3'HS
MMC]E-NV.??AN/2I%)]*-D_33DY=F&['?*T;9MVD6A;M#M6@12A42W8+%.I40
MC-7)QXS9-MI-1[3,DI+4SZ(UJ:DZETW3ME-.R++8MCD\O[>=.##;7VH8$;G7
M;*JB;\K$6R*E<46[:MC=MF)S-^LQ'&74/%*Y+G*&E.1T+6T2]U2M3Z9D.EE^
M6(K%<M<O-6L_MQNF8W2Q=969F)IFIFYZ1$<NRL1$33D9C=N.)%\6O/M:Y;HD
M38DRX859;>1%8:4W%I]08J#-/T;(B6C5@D&M79&1GJ&EJ<.ZRZF-OGG&D_LK
M'LFK9GMNMK2+L/HC"+H_^K'Z,V&R%HCFV      "%N*X*3:E$J-Q5V64&CTE
MKEZA,41FEMLC(C49%J>A:[18BJ3-'4B7A;LZU6[VBU-IVV'H)U%NJE_RSC$D
MU&Y]K0@I-:%<*N*W[VMBZ+93>%#JS4^W%-//=\T:[A(C[W*&>NTMW=,)MF)H
M1,3%7Q9=\VOD*C>4%HU1%8I'+KC%-;(R2;K9)-:2WB+H;Q!,4(F)9:(H  *W
MQKE*V<J0:[4+9*43%O55ZCS^=-<D?.&4H6K=+4]4Z++:-76T9MNJL@9: &#1
M<DV5-O:;CN)7H\B\*<P<B;1FSWG&VR2A9FHRV%H2TZEKTQ<LTJF:*T9R(KRS
MXP?ZE%[TG]&C#RM/ZKQM7:U+&W(
M                            >A_ W\V9&_U5,_ DCCK<COH\K?$<'<
M
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M6OB['OZ!824NGV*?M$(KZ           !#U+XS3O?3]86!,"
M"&J/QZF>^D+ F1            !#O_.\#[AS\$Q>03 @            BC^>
M$>\'ZXO()40            1#?SU)_TR/PA>02X@     *]RU_2_(7\/5']'
M6-6[89NV2RBV_P!W:!^S8OY%(EVU8V)H10
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MW4NO)3ILT1J2?\-1TNV.=D4N>F8XNSRSXP?ZE%[TG]&C#RM/ZKQM7:U+&W(
M
M>A_ W\V9&_U5,_ DCCK<COH\K?$<'<
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M+B      KW+7]+\A?P]4?T=8U;MAF[9+*+;_ '=H'[-B_D4B7;5C8FA%
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MG]5XVKM:EC;D
M             /0_@;^;,C?ZJF?@21QUN1WT>5OB.#N
M                                               X9'Q=_P![5ZQ@
M,(M_YG@?<'^$8W.UF$:_>]J1;JC63)K<9BZ9L;G<2CN*-+KK6WLD:EH?0/81
MZA2:5*Q6B9J]6@4&EU"LU6046FTMA<F=),C,D--EO*49$1GL(A(BI*/M>[+<
MO2D,5VUJO'K5*D&9-RXRMXB4712HMAI473(R%F*$35D=N>QK'[1<_)-"7+#(
MQE0                  :Y93?O:\;\I.(K7J=&MJF3+=?N.N5RL4ENM\X2S
M+;BHBL0Y"T,GNJ62UFHS,M4Z:?YMVTB*I+OV!BB_;2G(8K61Z'7[.<2]WRLZ
M!9M/HS,E;B#2E:G([Z]-U6BC[ ]=-!)NB2(7Z1$1$1%H1;"(AE51XW_>[-W\
M81_]BI8U=LAFW;*W1EH     1-:^)?\ 51ZXL"6$            $-6OB['O
MZ!824NGV*?M$(KZ           !#U+XS3O?3]86!,"            "&J/QZ
MF>^D+ F1            !#O_ #O ^X<_!,7D$P(            (H_GA'O!^
MN+R"5$            $0W\]2?],C\(7D$N(     "O<M?TOR%_#U1_1UC5NV
M&;MDLHMO]W:!^S8OY%(EVU8V)H10
M              >6?&#_ %*+WI/Z-&'E:?U7C:NUJ6-N0
M                                              ]#^!OYLR-_JJ9^
M!)''6Y'?1Y6^(X.X
M                   #AD?%W_>U>L8#"+?^9X'W!_A&-SM9AI9EG&L7*/$6
MJB.5250ZG!LI%0MZLPUFAR+.9D'R+AZ=%)&>TBT/U#(QN)I:Y716Y/6WGERT
M'9>+>)>$W1:LPRJ/&NA;"WZ968AEHEQSDTN$1K3[(]-W78>ZK4A)MY86+J82
M^>&65;D_(^<9N.&E-8S?D4M5+)+:VHRINZ^3RHR%DDTI/3:6G0W>EH%VQ;-L
MT;HVY[&L?M%S\DT,7.D,C&5                 '6F240HDJ8XAQUN(RMY;
M;*#<<43:349(06U2CTV$71 :@9CD8\O*1CZ[J\UEBERT4^1)MSR3A3F'HB7G
M"2Z<E#3*UL/*W"+0S(S21=(=+:QN9E]8@D6LY?=,12[DSC49ALR>3B7LY4U4
M91<BK>-\I+:6]XBVHU/V6F@7;.0AN,.;2HL;_O=F[^,(_P#L5+&KMD,V[96Z
M,M     ")K7Q+_JH]<6!+"            "&K7Q=CW] L)*73[%/VB$5]
M         AZE\9IWOI^L+ F!            !#5'X]3/?2%@3(@
M   AW_G>!]PY^"8O()@0            11_/"/>#]<7D$J(            (
MAOYZD_Z9'X0O()<0     %>Y:_I?D+^'JC^CK&K=L,W;)91;?[NT#]FQ?R*1
M+MJQL30B@                                              \L^,'
M^I1>])_1HP\K3^J\;5VM2QMR
M                         'H?P-_-F1O]53/P)(XZW([Z/*WQ'!W
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MLCV$:C(O7 83;ZDKNR]EH42DJDQ=U1'J1_\ @HQ;#&YV0S&V6<C#0
M
M
M#AD?%W_>U>L8#"+?^9X'W!_A&-SM9A,"   /JW/8UC]HN?DF@N6&1C*@
M              U)XDX&.I55M:3<5-O&Y;SID&?-MR@V?+<COL1&-PY<Y]9+
M0AEM.J4FX9ZG[%)*VZ;LJS+HXA8L.)>EE.QIV0HE7NVU6+EM-%Q5F5/I,]B;
M$0[)CMFMQ3:WXJ7B-:326FQ21;JT(;B#FTJ+&_[W9N_C"/\ [%2QJ[9#-NV5
MNC+0     AJZXVW"(W%I01NHT-1D73^R+"2F$J2HB4E1*2>TE$>I&(K]
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M!2-Y4[]U3S;E?"("D;RIW[JGFW*^$0%(WE3OW5/-N5\(@*1O*G?NJ>;<KX1
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M+-6LY[H_9%MD_P#W3SL773&MEY,EMW[9NU+?W6QAR,&R#?V36YN;+IMB[XU
MMW!KL&/Y+NTQB4BKK*G1:K/5*D+/ED$;,M+;7(FC=6G>5OD>Z)9=9;;;==%:
MWT^BVL6U^U7-S;,%U+;IF8MFE+,U=N/I84W4MCGQG&&VD22B9$BS&MC<II#S
M9'_PK22B_P"PQ+K<LS$\A9=%T1,<KL#+0
M   (RI4Q-32TA<V;#)HS/6&^I@U:_P#$:-IZ"Q-$HQ.UHY0[CN^(EUV0F._'
M23\A9NNKWHC"]5K5M49;VA:](B+I#5VR$C;+/QAH
M
M                                               !PR/B[_O:O6,!
MA%O_ #/ ^X/\(QN=K,)@0  !]6Y[&L?M%S\DT%RPR,94
M  &G'$2FW*K>=.MW)=2.#8CEEUB?:\*1*<A0)]R,K224/N(6VEQ;+.BFFUGI
MJH]-3/0=+-F#,L=Q--H?E;PWJLFKE-K]1QQ%BY;IL*4;[#5/@T=CF#DQE*U(
M9>;EFEM&PE&2ED87;)(;TCFTJ+&_[W9N_C"/_L5+&KMD,V[96Z,M     "&K
MC:%PB):$K(G4:;Q$?3^R+"2F"(DD1)(DD70(MA"*_0           0U:^+L>
M_H%A)2Z?8I^T0BOH           $+5$I5)INJ2/1T]-2^P+ FA
M  !B-8H=(E5.G/R*<RZ\ITM]PT[3^WZHW%TQ#G=I67368BK*VVVVD);:0EMM
M!:)0DB(B+[!$,.C[           !#24I56(!FDC,D.:&9?\ PF+R(F1%
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M;EYN7&(W^E/+NVT;'M-H9:;9;+=;:22$)]0DEH1#$S5J(I@^Q%
M                      >>O$3EK(..,C3XMF7!WF8J*&79C?-(DC?6F-'2
M1ZR673+9Z@]\_2O<W9.W:%]VO9FF+J1C,<G-,/BW^3OU9WGW-VO1T^QZN2VZ
MR9GT;+JS6G^JVY1'I29V\^O_ "RE_J@]I\*=V=5_RO\ >?,_F;^H?B?^WI>X
M>E)G;SZ_\LI?ZH'A3NSJO^5_O'S-_4/Q/_;TO</2DSMY]?\ EE+_ %0/"G=G
M5?\ *_WCYF_J'XG_ +>E[AZ4F=O/K_RRE_J@>%.[.J_Y7^\?,W]0_$_]O2]P
M]*3.WGU_Y92_U0/"G=G5?\K_ 'CYF_J'XG_MZ7N'I29V\^O_ "RE_J@>%.[.
MJ_Y7^\?,W]0_$_\ ;TO</2DSMY]?^64O]4#PIW9U7_*_WCYF_J'XG_MZ7N'I
M29V\^O\ RRE_J@>%.[.J_P"5_O'S-_4/Q/\ V]+W#TI,[>?7_EE+_5 \*=V=
M5_RO]X^9OZA^)_[>E[AZ4F=O/K_RRE_J@>%.[.J_Y7^\?,W]0_$_]O2]QZ@X
MJK=4N3'%EUZM2N>U:K4F/)J$O<0WRCKB=5*W&TI06I](B(A\J[UT+-#M>KIV
M12VVZ8B.:O._IK]-=LU>V=V=GU]:<U]^G;==-(BLS$3,TBD1^R%@#\]^V
M
M                                                  .&1\7?][5Z
MQ@,(M_YG@?<'^$8W.UF$C)E1H;*Y,R0U$CM%JY(>6EM"2^RI1D1"#EWT;G*;
MZ>3TWN4U+=TZ.NOJ /TC)1$I)D9&6I&70,@'W;GL:Q^T7/R307+#(QE0
M              :KYKN;O#?]MPKMM2I9$Q97*%(8JUH0*"=83'J:)"51Z@[O
M,+3H3>\WNI=2LC,E$E1#=L8<Z2G,3WIBM%51:F/\85JQE54G'GY#EK/4B*X;
M*%+U?D&V@C5IJ2=XS]0@NB>4AL8,*J+&_P"]V;OXPC_[%2QJ[9#-NV5NC+0
M    B:U\2_ZJ/7%@2P@            AJU\78]_0+"2ET^Q3]HA%?0
M     (>I?&:=[Z?K"P)@0            0U1^/4SWTA8$R(            (
M=_YW@?<.?@F+R"8$            $4?SPCW@_7%Y!*B            "(;^>
MI/\ ID?A"\@EQ      5[EK^E^0OX>J/Z.L:MVPS=LEE%M_N[0/V;%_(I$NV
MK&Q-"*  #4KC*C%+QA0FS3O;MT15:?:A32_[Q^;WIJ9-*)Y_X2]W_07]]?\
MTY_FM>:7>9/N0_"_%/K=3O,GW(/Q1596&Z4EG*V/'>3TW*_!/7[3R1W[+VC-
MJVQSP_([^G__ #]?[%W[GLP/:'P0
M     >5_&#_4Y7O#?Z/''T_]#?VVI]K^#^=/\T?WW9_Z<_S-3A[N^,@
M      /:S!W](,<_L*)^ 0^'=^?WVM]N[][^S?T=_P"%[)_1L_EA:H_*>R
M
M                                                   #AD?%W_>U
M>L8#"+?^9X'W!_A&-SM9AJGEZDN94SI96)ZO4Y=.LVF45^X*G"B.&TJ=(W]Q
M"5GT#)!)V>IJKU1NW"*N=V,T063D3\T9FIN!Z17YM&L>RZ6F??,JGN&3CLC<
M)3,<S+L3-)*;Z.NAFK9JD(PBI.,T93PZ%5;0OC+F'GJ]+N2W[)>@2K;FS%\H
M]':FH<4Y'4>TBTT3H1:%J2CT+70I=C%5LPF8;=6Y[&L?M%S\DT,7.D,C&5
M                !K[>==DJSE8-JU6[I-HVPU1)-?IT5AY$5NN56/)0TJ$^
MZLOQC;+"N4-E.FN]O'[$M-1&"<KKU.IO4/B#M.!0;PFU9%^1:CY;6*[*3)B4
MQFF04<VJ##.AJBFMYM+*RUT<->NFJ3%Y#E;%#"JBQO\ O=F[^,(_^Q4L:NV0
MS;ME;HRT     (FM?$O^JCUQ8$L(            (:M?%V/?T"PDI=/L4_:(
M17T           "'J7QFG>^GZPL"8$            $-4?CU,]](6!,B
M        "'?^=X'W#GX)B\@F!            !%'\\(]X/UQ>02H@
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M+"U1^4]D
M
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M+0     B:U\2_P"JCUQ8$L(            (:M?%V/?T"PDI=/L4_:(17T
M         "'J7QFG>^GZPL"8$            $-4?CU,]](6!,B
M   "'?\ G>!]PY^"8O()@0            11_/"/>#]<7D$J(
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M:WAB2&9<6-+CJ-;$II#K"SZ)H6DE)/;]@QFZV;9F)VPU9=%UL3&R78&6@
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M;N_>_LW]'?\ A>R?T;/Y86J/RGL@
M
M                     X9'Q=_WM7K& PBW_F>!]P?X1C<[68::YQMNW+QX
M@+#MO)5<5#L:5;\EVF0BF%&:5.:<U6ETS,MTUD:=I^R(B(CV#=NQSNQNQ3T;
MARX7V),=^/.A\X9=0XQI7$'V:3(T[.4V[0K=N,MK<%M*$-MH;_Y:$DE&W781
M;-HYNCEMSV-8_:+GY)H+EAD8RH                 @[FHJ;CMNX;>6\<=%
M>ILNG+D)+4VRE,K9-1$?J;VHL8#32E6QE6\Z7AG#MT8Y?MBWL65"E2;UNUR6
MP] J<>WF>3ALPR0K?<3+-*%+U21H_P !NL1665I\G<N1L[6S6E6A5;8L["YU
MUENN5ADHYUFI5!KF!'!;WC4N,EHE+2[IHK4MG0$V1]*\K908546-_P![LW?Q
MA'_V*EC5VR&;=LK=&6@    !$UKXE_U4>N+ EA            !#5KXNQ[^@
M6$E+I]BG[1"*^@           0]2^,T[WT_6%@3 @            AJC\>IG
MOI"P)D0            0[_SO ^X<_!,7D$P(            (H_GA'O!^N+R
M"5$            $0W\]2?\ 3(_"%Y!+B      KW+7]+\A?P]4?T=8U;MAF
M[9+*+;_=V@?LV+^12)=M6-B:$4  %2YEC)DVQ ;46I%5&E?_ &#Y?]X]8_5?
M]K;]N/W7/8_TQ?D[3=/^R?WVM:>]#/\ P#Y_B][_ !,'>AG_ ( Q/Q,,DLZF
M-M77;KB4Z&BH1S(__ED/T>Z:_B]+[4/ [TUXGLNI'^V6X%1I\.K0)M+J,=,J
M!46'(TV,LM4N-.I-*TG]@R/0?5+[(OB;9V2^96W3;,3&V%)6M@*DVHJH2F+_
M +SK%8519%O6M7ZK-AR95O4Z1N&;-+TA);U)3;:M^2AY9FA)+4I):#O.O=-:
MXS,Q,SRW4K2O-C.RE:X\E.%FC99-M(PMB8B*S2*TKS\D;9PIA2LU[%PX'M^X
MJY+J[UUW13H5>0PF^[7@2X[5-N-4=A$9IRI(5%6Z2B;;0E1QG&=\DDE>\GL1
MFV^D[(I6L1R1.&,<O)&$S,<S4V5Y9K3+7EF,<-W^J<8B)QV[*7>A"6T(;0DD
M(01)0DN@1%L(B&&XP?0            "@;WX:\:7Q<4B[GD56V;FFIW9]:MZ
M<N ](+9KRNZ2DJ,]TM3TU/IC<7S#$V1+(<98.Q[B5=0E6G37U56K$2:E7*@^
MJ5,>(CWM#=7IH1F>IDDBU/HB3=,K;;$,)NCA3Q3=->JEP+16:"_75;]?@46H
M+AQ)IGT>692E1'O;3/=,A8U)2=.)997<"8[KF.(6*TP9-%M&!)9EL,4UTFWN
M594:B4IQQ#F\:C/51F6IB1?-:K-D4HM%5$ICM$*W9<9,ZDG#* ]$D$2TNL$@
MF]U9::'JDMNP2N-5HUN;X/,.M3%+0FO%1E2>=JM'OH[WJ-S>WML?34RU+H&K
MH;!KB2QPX7!?>)K#R/;<:U+HH;<BDP-TZ63!FR[$-"=U)L.(VHV;/4/IB1=,
M-3;$L'L;ALQO8M?B71&.L7%7J<G<I52K\]<Y41.AEHPDTH2G8?J"S?,I%D0S
M.U<4VQ:%Z7I?E*=G+K=^.)=K:)#J%L)4@]2Y%!-I-/\ BHQ)NK%%BV(FJ*M/
M"%FV9<&1[EI#U254<HO/OW(F0^A;:5R'7GE\W232306\^K34U;- S$6Q"%:X
M<K 9Q-)PRB15_)&7+*:ZZ<EOGG*%(1)T)WD=W3?07^3H!GFM4R12C([OPW:5
MZXY@XOK#U03;=/1#0PY&>0B490M.2WG%-J2?0V]B&;&JS;$Q16/$12<?4^Q+
M.H5\V=6[FM.#):A'7:0DW)=&;98)"9:E-EO;221'HG0_4Z!#5E9F6;Z4Q:K6
M19MI7IG7'$K#\2Y*S;5GK.I7=?MQG(-QWD]C;"5R4M[$[$I22"VF9Z:$9C<S
M2,6(B)G!ZGC@[O*_C!_J<KWAO]'CCZ?^AO[;4^U_!_.G^:/[[L_].?YFIP]W
M?&0           'M9@[^D&.?V%$_ (?#N_/[[6^W=^]_9OZ._P#"]D_HV?RP
MM4?E/9
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MI7440\_NN/\ ]K3^U#Q>VZU="^.:6R0^HO2@
M        !\J2E:5(6DEH46BDJ+4C+U#(P'&S'8CIW([#;"-==QM))+7[1$0#
MF >5_&#_ %.5[PW^CQQ]/_0W]MJ?:_@_G3_-']]V?^G/\S4X>[OC(
M    #VLP=_2#'/["B?@$/AW?G]]K?;N_>_LW]'?^%[)_1L_EA:H_*>R
M
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MB'F]VZ-.TZ<_[H<>T:U=.Z.9;H^BO7@
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M.9FW3MBV)G;2V*8TB(K^R&0#QWG
M
M                    #AD?%W_>U>L8#6C*E#O^OXEYIC2H+I]V1G6)<0FW
MBCJ?;9<4;C!.&:2+?+U3(OLD.L327.8F8P4K(R[Q(281TNJ\-*:JP2":EMON
MF\T\:2T,S2HEI41F6O3%I#.:[<Z]O9&S?1);:*1PIP;=9ENH1,D0$)CGN&HB
M4I7)(3KH6W:+2)Y?.1,QR-HK;N6^*E>]VT.MV9WFM2DL17+=N?EB5SYQU)&Z
MC<UV;IF9?8TV]$AB8BC<3-5E6Y[&L?M%S\DT,W-0R,94
M      %18W_>[-W\81_]BI8U=LAFW;*W1EH     1-:^)?\ 51ZXL"6$
M        $-6OB['OZ!824NGV*?M$(KZ           !#U+XS3O?3]86!,"
M          "&J/QZF>^D+ F1            !#O_ #O ^X<_!,7D$P(
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MNT:NV0S&V6?C#0
M
M                     #AD?%W_ 'M7K& PBW_F>!]P?X1C<[68:YYDN[)=
M8OV@8@Q558]L5*=3':S<MU2&TNJCQ$KW$H92I*^R/0]I%KM+0RVF-6QA66+I
MFM(:^V)D/.MGV_3,G5^]T7O8;ESKMVXZ%.;24MHDR3BID,.[NI:JT/3>T]4C
MZ(U-L3@Q%TQB])$+2XA#B3U2M)*2?V#+4AR=G);GL:Q^T7/R307+#(QE0
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M?V[_ *>=+]*V^V+;HK$13]F[Z.9;8PZ
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MIS<Q;RD\W96Z1$@VDD>N[IT1F[3B(JU;J5FC<8<78
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M;=Q2[>Z\FS>)N4A*'<L6;HE1++2VGRVE_P#IHM;2EV]SE:W% 1$7TLV9L_\
M[:?_ %T2MNXI=O?ODMQ0?6S9G\M/_KH5MW%+MYY+<4'ULV9_+3_ZZ%;=Q2[>
M>2W%!];-F?RT_P#KH5MW%+MYY+<4'ULV9_+3_P"NA6W<4NWGDMQ0?6S9G\M/
M_KH5MW%+MYY+<4'ULV9_+3_ZZ%;=Q2[>>2W%!];-F?RT_P#KH5MW%+MYY+<4
M'ULV9_+3_P"NA6W<4NWGDMQ0?6S9G\M/_KH5MW%+M[KO6;Q-OK96O+%F[S"M
MY&EM/]'\]%K;N*7;W8\EN*#ZV;,_EI_]=$K;N*7;SR6XH/K9LS^6G_UT*V[B
MEV\\EN*#ZV;,_EI_]="MNXI=O/);B@^MFS/Y:?\ UT*V[BEV\\EN*#ZV;,_E
MI_\ 70K;N*7;SR6XH/K9LS^6G_UT*V[BEV\\EN*#ZV;,_EI_]="MNXI=O/);
MB@^MFS/Y:?\ UT*V[BEV\\EN*#ZV;,_EI_\ 70K;N*7;SR6XH/K9LS^6G_UT
M*V[BEV]UG;-XFWG&75Y8LW?85O(TMI_H_GHM;=Q2[>[/DMQ0?6S9G\M/_KHE
M;=Q2[>>2W%!];-F?RT_^NA6W<4NWGDMQ0?6S9G\M/_KH5MW%+MYY+<4'ULV9
M_+3_ .NA6W<4NWGDMQ0?6S9G\M/_ *Z%;=Q2[>>2W%!];-F?RT_^NA6W<4NW
MGDMQ0?6S9G\M/_KH5MW%+MYY+<4'ULV9_+3_ .NA6W<4NWGDMQ0?6S9G\M/_
M *Z%;=Q2[>>2W%!];-F?RT_^NA6W<4NWNNJSN)Q;[4D\L6;RC)&2#\FG].R+
M0_\ [M%K;N*7;W8\EN*#ZV;,_EI_]=$K;N*7;SR6XH/K9LS^6G_UT*V[BEV\
M\EN*#ZV;,_EI_P#70K;N*7;SR6XH/K9LS^6G_P!="MNXI=O/);B@^MFS/Y:?
M_70K;N*7;SR6XH/K9LS^6G_UT*V[BEV\\EN*#ZV;,_EI_P#70K;N*7;SR6XH
M/K9LS^6G_P!="MNXI=O/);B@^MFS/Y:?_70K;N*7;SR6XH/K9LS^6G_UT*V[
MBEV]P>1W$YS@I/TL6;RA)W"__5I_33\]%K;N*7;W/Y+<4'ULV9_+3_ZZ)6W<
M4NWGDMQ0?6S9G\M/_KH5MW%+MYY+<4'ULV9_+3_ZZ%;=Q2[>>2W%!];-F?RT
M_P#KH5MW%+MYY+<4'ULV9_+3_P"NA6W<4NWGDMQ0?6S9G\M/_KH5MW%+MYY+
M<4'ULV9_+3_ZZ%;=Q2[>>2W%!];-F?RT_P#KH5MW%+MYY+<4'ULV9_+3_P"N
MA6W<4NWGDMQ0?6S9G\M/_KH5MW%+M[KE9W$XF0N466+-Y5:";4?DT_IH1Z]#
MGHM;=Q2[>['DMQ0?6S9G\M/_ *Z)6W<4NWGDMQ0?6S9G\M/_ *Z%;=Q2[>>2
MW%!];-F?RT_^NA6W<4NWGDMQ0?6S9G\M/_KH5MW%+MYY+<4'ULV9_+3_ .NA
M6W<4NWHFO8]XE+BHE6H%0RS9_,:S$>A2^3MM]*^3?0:%;I\]V'H8L76DVW3R
MME:7#.GTVG0%+)U4&,S'4X1:$HVD$C73I:Z#$S66X=X0  !AE\R"C4F.L^G+
M0G_[-P_^X?B]^Z>?0B/]T?NDF_+BJKOJGU2ZH]4_"RGX@[ZI]4NJ'X63\0E*
M)4B=K%,;U+LY+1??$/+[!V>;>T63SP<>N"]![TH
M                \L^,'^I1>])_1HP\K3^J\;5VM2QMR
M                                      &Q_"A_6ZVO]+4?T-T8U/JR
MZ:?UGKB/%>4
M                       X9'Q=_P![5ZQ@,(M_YG@?<'^$8W.UF&HN9J50
M;[S[8=@Y(J+L2PU41V;2:5SA41BHU-;W)\FMU!I4:M"21$2B/I)TWMNXV.=V
M-U)89F;%^+,*O67<.+^4M+(Y5R BE4>/4)4IR=&>>Y-XELR7GE;FFI:EH1]
M]0LF92Z(C8] FC6IIM3B=U:DD:T^H9EM(<W5RVY[&L?M%S\DT%RPR,94
M
M
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M=94HE'RJMB=FT^@)IQQ+LMN,[N5J^)LMS781OY,-JUA$
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M3T-FNNHZ392'.V^LMRQS='EGQ@_U*+WI/Z-&'E:?U7C:NUJ6-N0
M                                            V/X4/ZW6U_I:C^AN
MC&I]6733^L]<1XKR@
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MK:_TM1_0W1C4^K+II_6>N(\5Y0
M                                     #AD?%W_ 'M7K& PBW_F>!]P
M?X1C<[688A4\56=6;[C9"JL%50K<6FG2VXLDFWH9LFHU;QLN(5V9:[#(_P#
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MO:U:%%A5^U)27(M0CO16TH>(X[Z6UJ)!]%22-/V1F^)K58ELN,*
M,(R5:DB^<?WC9T26W!DW-295.8F/)-3;2I#9H):B3M,BUZ0L324EKA5,/\0M
M738*9=^V018WFL3[>Y.E32WG8\9<5'+ZR#WRW%GJ1:;1O-:E)7A8M/S/$JTA
MS(MR6M6*(J(M,6-1*?*B2$RC<;-"U+>?<2:"02R,B+74RV[!F:<BQ5:PRH
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MR8U;.D1)(DI(DI26B4EL(B+I$.;;RTXP?ZE%[TG]&C#RM/ZKQM7:U+&W(
M                                                  ;'\*'];K:_
MTM1_0W1C4^K+II_6>N(\5Y0
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MBVX5H7)#B-U5PGT&F$_3V7E-/)?/\6:$-DI6\9:ZZ#5;J8I@VU&&@
M   :.S;JX$F9DMJ="LY$UIYQ$Q+E$?WR=2HR62O_  O1WM=1TI>S@R.Q;FX-
MI=W4"-84:U$7B]*)-OJA4EYB04C0].3<5'023TUVF9!,74Q(HV_'-H
M    $%6;6MBXN3.X+<I==-DM&CJ$-F5NEM/1/*H5IT>D+45)<]4DV7E#!-EV
MFU$M^U[PEW$BXJ-"AQFFI!0*2J1'T,FMYO<<21]@:=>@>I;!8QB47P,J
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M;,N.[R'*_#29:>JX0_+[[[%;9V'6NILME[/^C.T:MW?/9HNG#/#V]'QE_5H
M                                    \L^,'^I1>])_1HP\K3^J\;5V
MM2QMR                                                     &Q
M_"A_6ZVO]+4?T-T8U/JRZ:?UGKB/%>4
M                                           X9'Q=_P![5ZQ@,(M_
MYG@?<'^$8W.UF&K_ !*V[G:L4RY'+&N2''L%5O2&Z];!QF'I<SL'.70TI49Q
MW5Q!DE.ZX6WH:#5M&+ZJ=HN+>*^XL>T2AN7I;Z;3E4QA$:VZI38+BV6-PMQI
MPG:>M>\DMFIJU^R+6(EF(NHO#AIQ)D[$S=P4R\[BC56@2VV%4.F1GENMQGDJ
M7RIH2M"=PE),BT3LV= 2Z8EJRV8;66Y[&L?M%S\DT,7.D,C&5
M                   !&2*+1I=3@5J5284FL4I+B*95G6&UR8R7DFEPF7E)
M-:"6DS)6Z9:ET0%*\3\J/3L&WW57Z/3:VNEQX[\6%5HJ)<;E%2FFM\VU[-Y*
M5GH9:&1[2,:LVI.Q?HRH          *$I%_,W+>E]H9LRGLXZQ\J9!N6_9JF
M^5?J\-*'9++$?<,S;829DXXH]JMA%L,:I2$JJ.CY=OU%%M[+=Q8[M*G8:N2K
M1XK#<<GBK]-@S9118=2E*41QUH-:DFI*")6BDZ?8UEC9RI5NN.;0
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M+\R5>M&54EVI0KB.2Y%WGZ>^B6>KM)C$G1@E*_YJ=3271Z!RZL1L6*-\AR:
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M^K5^CSX-/9E-NQHAR#=4;["VDF7*-)3L-6I[1F_4B8HU9IS$U;N#@[
M
M      .&1\7?][5ZQ@,(M_YG@?<'^$8W.UF$P(   ^K<]C6/VBY^2:"Y89&,
MJ                              #6^]*+6)>0F*'$XCZE9]8NHER+>L&
M+#IC[B68[)J=4V3K*W=S1I:MY9Z:ZD1[-!N)PV(K6^,=G7*BC#M]<4E9=J%X
M0D2&+5F4ZFL'.8)\R03;B6$$:C<9/1"5[QZ=#06)Y8A)ANT.;0
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MZ<T>2:[V_#*%-M--J5OJ0A*5+/IF1:&?^(X3-9>3$4AR"*
M               (RI3)\1+1P*2Y55K,R<2VZTUN$70,S=4G77[ L0C$[6=>
M?N.[WY,94*2Z_'-Z$I25J:,HC"2(UH,TGJDB5L/IZ=$:NV0D;99^,-
M
M
M  .&1\7?][5ZQ@,(M_YG@?<'^$8W.UF$P(   ^K<]C6/VBY^2:"Y89&,J
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M"(B+H$0#Z
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MAY-1/EU0_.G.N&8HDZ=38],:=:CJ<63SIO.+=6:U&HR))F9GMZ"2"9JM'?$
M                              :RY#I^*LKY,I^-ZO9U4N&Z+<C<YJ=\
M4GE8B;=0\TM^.T_4&7&UDM_=[!K11=EO;-HW%8BJ3BPY^TL0X!OZV*M5[&KM
M18JA-1868*M+=JT:E39#JF6X[Y/.'S4E$9:/$C_,1:Z;QE:S="80W+'-H
M       &O-RXIOND777+VPS>T*UYMUK0_=EHUN&J91YLQM!-IF(Y-27([JDI
M)+AH(R7T5;2V[BZ-DI1'P<29+O*LT.J9MORG5JCVW.9J=,L.VX2X=.=G1CWF
M'YC[RC>>)M79$V?8[W1V;#9HC84;+#"@
M                        #I5)B7*IT^+3YYTN?)C.M0JFEM#QQGEH-+;Q
M-N=BO<49*W5;#TT,!JG>].R5CFB/7#>7%L]1::V>XTIVTJ&IU]S34FF&4MFM
MU9])*",_\!TBD\C,X<K[P*GB*KM>DW3D*[I9XY6RM-OV_6J13:=6)N^1<G)?
M9A,D<5);3)"G#4?3+3:)=EY"*MMAAH
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MM"8F-I$U147(=BS;C>M")=U*DW/'U)ZA-RFU24FGHD;9'KJ7J!EDS0S(10
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MG>U-6NNFSHF5MMF)K),U;?1F3CQH\<W%/&PVALWE[5+W2(MX_LGIJ.;3G
M
M    !'5<ZHFDU15$3'76BB/G2$2S44<Y7)JY$G33V6YOZ;VFW0!HW;F+.(N#
M=CU_WE;ME9'O8G%'2*O6:Q+*/2VCTT:IT)N&3+&FGLB(U_\ Q;3UZS=;L9I+
M9:S*EG&56VVK]M>TJ5;YLN&Y+H]2ER91.D7XLB;>8;3NF?1/48FG(N*WQE0
M
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M%DQWE-O/3GI+TFF44GFE$HN;LNH-XM=FZ2>B6RW88I;6<-S?D<78
M                                          '2J%-IU6B.P*K C5."
M_H3T*6TAYI>FTMY"R-)_XD Z='MVW[>:6Q0*%3Z&PZ>KC-/BM1D*/;M-+24D
M?1"HF0
M
M                              'F[AW*EK\-CV5\<Y-5-H]4AW!*J%LN
M)AR'T51EU.C7)*90I)&LDI,C4:4]ET=2,=KHS4<;;LM8E:G!5;=7@65>EWU>
M"_3/+VY)%0IL*0@T+YJ@M$N;JB(RWEK61>J1$9;#&=26M*,$KDFUKYO>NWY=
MLRF3*? Q72I;>**6DB4N?578RE.U1*4FK>-!:(9+37>Z1'J1VV8BA=$RJ/#+
MMJ-7_@=>,:@N75:Q0J@]FEIE]U[528:]URII69[CQ2]"1O:*/9_E,6[9-6;:
M5BCT5'%V        :49R_P#5!PR>^5'_ /A'6W9+E?\ 6AEW&%:M9N/$ASZ%
M#<J4RT*O#KCU.:(U..QV#4AW=(MIF@E[QZ=(C&=.<5U(K#7#.V9;9S_9%D8P
MQDU.K5VURHP7*M3E0I#7>XVT;JDO..(2@]%JVF@U)T(SU&[;:59NNS1$0] [
MFE5FT[$GO6Q1WKFKE&IJ&:-26MW?D/(2EIO74TEH1]DK[!'IM'.,9=9PAI'<
MF/*+8UQXFI^69Y2+3O>15*QE>LSGEM4^7<+T<ULMR7=4DEII1[K25F22+4_5
M'3-6)HY3;28JO_A;D39&/JWO/2I-N,775F;#D2S6I:Z(A391C2ISLC02^4)!
MG_ET&-3:WI[&R0PV         /.7B0SY1*_>Z\'NW2NQ[*B/$UDN[.;R7GW2
M1HM4&,W'9>7MV$:C3NF?3T+;UMMIBXWW5FC8O#>3,!5Z"QBS$5?1)[UTMQQ%
M.13Y\97-V]QIQ];LJ,TE:S4XG4S5J9F,S7;+=LQLAK)A#,MJ\/%E7CBO)J)U
M'NZW*S.<I4)$.0\52;?2@FS96VA2"U-)GJM22W3+0]1JZVLPQ;=EBDKYX.K8
MK%%Q?.KE;A.TV3>];F5J+ >+=6B,XHD-*4DR(RW]TU%K_ET/IB:DXM:<8,9R
MI;F1[K9RMDB9 F4CZ/J//IN(Z @M9!N&W_XZL$E!JU6MO5+)EM(BV;>C;9B,
M$NB9K+'L++M*/EG'S&(YQS*/4;(?E96;BON/L)G:-\DY+WC/<E&]L,E:*TUV
M"W;)JENV*-^!Q=@        !5N9+NNZQ+!JUU67;C5U5:D*;=?I#O*'O1=='
MEI)KLC-!=EH72U&K8B9Q9NF8C!H=FC*F"LHV"Q"L"VR=S)69<1Z!#IU%>C5&
M+/4ZA3IN24,H)P]=2+=6HS/:.EL3$N5TQ,8;5I<0U'NJWK<X?\DU2#)K;^,Y
M\15[L,%RKR4NMM<H]LZ.BVC29^J9=+:);,5EJ^)I$L=R7DBV.)#(>$+1Q<[+
MKT6@W&U7KJJQPY$9N%'84TI25'(;1V1()>W3=UW2(SU"V,L2ETYIBC=#*-4N
M^EV;43L2C.UFZ:@MJGTI*-W<BKE+)LY;VJB/DV2/>/=U/H=+4RQ;2N+I=6F#
M26O6-85BWW%LK*U0W;+@6*_4;?J-1?<99FW*Z\2YTQ*TFDERE*WC06U7L4IZ
M0ZYJQ@Y4B)I+:KANDW3,PY9\B[SDKJKC"^0<FZ\X7#)9E%4[O;=XVMTSU'._
M:Z65HO,8;        <,A+RX[Z([A-/K;43#IEJ25F1[JC+IZ& T"9P-G^P*)
MD6I4S*]O*:N9N=4[J<<I7+29FK*S6GEG4*4G5.I)(CT+4=LT3+CENBJ'X:;-
MOVZ>'"]Z.JX(DBU[HHE8IMJT!$=*)$>H.I6@W'7]W5:5F9%IKL$NF*P61,Q*
M LKB&M.S>'RJXNN*+4*=DRDPIM"B6FJ%(4Y)<<(VT.)<2@VTD6\>\2E$>P]"
M/8+,>E5(OB+:-Q.&JT*I9&%;(HE:87%JJXBILV&YL6RJ6M3R6U%TE)2HB41]
M ]2'.^:RZV12&N&6J#>\^TKWR_=$&?0ZE/J]/H,2CMFKEZ5:#4Y*9*CY$U&E
M<E1[SJD'[#[ ZVS$31SNB:59G@L[:BYOOJF8HEE+Q,U;,1YPH;RI%,;JZW6M
MTHZS-2=]39N&X1'T>B,W[,5L^M--C=(<G4         :^9MS%5\/U"S*C*M)
M5;L*K2'8]SU^.2W'Z:XDB-I1-)(R,ED9Z&?_  F71,B/=MM6+KLK6ZY+VH'$
M#Q#83D8H.55X-C/+J-RW7S1^*TRPEQ+ILF<AMM1^P-.TM#4O0M=HU$4C%B9S
M711VW;E@</W%%D2ZLAMRJ;962Z>E=)N=N,](9;>;-E1MK2PAQ9Z&E1'HDS+L
M>EJ83C:5RW8LGX?)+F2<XY;S13(4F/9L]B/1Z!-D-*9YVII*-5I2LB/0DH(S
M]34M=H7811;,;IE=&3K9N')-VVQ84BFO1<:P]VO7E5S,B;J*X[FD:EHT,ST4
MO\8X1EM21?XYMF(BO*U=%9IR-)8#]*3;U.J[,YTN)TLC<S=AD^Z54-CGYI)E
M<<SUYGR&FTD[FFNWHCKR\SER<[U4'CO(         %-\05F5#(.&[\M.E-<O
M4ZC!;>I\<CT-QZ%(:EMH+[*E,D1#5NUF^*PT>?SI8Q\,B<,RJ742R;'I2+=.
MRSITCE>=-N;I/DLF]S:9;VFN_O'IITQTIZ57+-&6C,\M8YNZV.'S"%1?ISU0
MJN))U-JMRTQK\8XAELU+<(]W7_EFHB49;"^T$3BMT3%L.KEK*-L<2=<P_8.+
MSFUF1'N2-7+EDJAOQTT]F.@TK0XIY"2U2EQ6IEJG4BV[1+8RXEUV:D0WCR15
M;HH]G5B39=%<KUT/(3%HL1&FZV_(432'W=5)_%M&K?7ITB_Q&+8BN+K=6F#2
M.I6%8UBY&M"R\QU(EX_<M*?4UU6IO.,P9]UORT.29#[I&E)N<D;G)DH]FB4I
MVZ$?3-,Q@Y4B)I+9/AAE5R7B*C.UIR6^T4R:BWI$TU&^Y2D/J*&I9KVGV'0/
MU-!C4VMZ>QL$,-@
M
M
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M .MW=[_M%K*422DI6E2%I):%D:5H46I&1[#(R,14; H=%I3CSM+H\*FNR/\
MGN18[;*E[=>R-"2,_P#$69F4HE!%="H4NF59I+%5IT6I,(42T,RF4/()1=!1
M)61D1_9%B:%*NXVVVTVAII"6FFDDAMM!$E*4I+0B(BV$1$(/L
M
M
M
M
M
M
M
M
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M@EH,R/:6I&6P28HKN
M
M
M
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M0JA*C::<F\^RE;J"UZ25F9$.,Q27:)K#-!%
M
M
M
M                       :V<55@7;DG&$>W;+I/?FL(K].FJA\O'C:,,*6
M;B]^2XTC9J6S77U"&[)I+%\3,8-AZ<TXQ3X+#J=QUF.TAQ.I'HI*"(RU+9T1
MF6VOMJ6%=E-XE\IY!FTKD;0N.W:5 HU7Y=A7+2(R&2=1R*7#>3NF@]JD$1](
MQJ9C+1B(G-575QV5F>Q,W7ODFP[!I>4:;?D:"VVJ?/C0I5*<B,H:W$JDN(,V
MCW-=$;>H+$Q2B3$Q-8<V)\8Y2E71Q!/Y>H,.GP,R4BGQE3*;)8=83NQI<9Z*
MA"75.ZMMR=#6I)$HRU(+ICD+8G&O*C;=B<5..[1:Q50+"I%R0J.RY3;9R2NK
M1HZ6H9FHF''XBW2>-;2#(M$I/H=,/1F:I&:(HR?*V)<DU;$%@TJDU)5^Y#L2
MM4VO2WJA(0R=3D173=<03KRTH06IZ)(U$6Z01=%5NMFCNWG;64LAKX?[@JED
MMT.KVO>;-7O&CM3XCR8$-I6G*<KRVCNPM=&S4?V B8BI,3-'7NJRLL8[RI<>
M3L0V_#OBG9!C16[TL^7-:@.E)@I-#$EAY]:&S[!2B,C/I]/I(F)C$F)B:PD,
M96#D>O9/GYJR[38=MUMBDE0+1L^%(;EIA0U+-UUQU]I2D*6M2CZ!GLZ?2$F8
MI2%MB9FLICA@L2Z\=XXF4&\:5WGJSMP5&<W$Y=B1JP^:.37OQW'$;=#V:Z^J
M07S$R61,1BX^%FPKLQQBT[<O.E=YJSW\J4SF?+L2/Q,APE-KWX[CJ.R+I;VI
M=,+YK)9$Q&+XS/CJ]Y5V69ES%C<2;?-FH>@R:!.<2PQ4J=)(^59Y51I2A9'T
M#,].H%MT4I)=;-:PPR-:.:LP7_8=P96M*!CBSL;5%%<IMO1Y[%1E3ZHUH;#C
MCD=QQ"4-F6I%KKU=EK$1@E)F<6=0K$NMGBHK&2'*5NV7*QRF@L5GEV#WJ@51
M8?-GD"<Y8OQ:#/>-&[TM=1F9P6GI5;"R4*<CR&T%JM;:TI+U3,C(AEM0G#59
M%T8_QN]0+NIG>FK*K]6FIB<LP_\ B)4E3C*]^.XXCLDGKIKJ73(AN^8F6+(I
M",X;K NZP<35.V;MI/>FMR*Q6)3,+EX[^K,I>K*N48<<06\72-6I=/0+IB9+
M(F(450N'K)DCAGN/'<ZGLT2\57B]<-,I$F3'>CS6&WFG&V7G([KC9)=))[#/
M89%J0UFBK$63EHCLH6GQ0Y0LZA4!>(*):M/MBIP)IT6'5:>M^<Y'5H:F5<X2
MRTVDB,S)2MX]A$01=$8ET73&Q>^3K#R-1LH4C-6)J1$N.L+H_>&[;.FR6XG/
M(R5J<9=:?=6E"'$&K0]I$9$7V1F)BE);NB:UA,8VAYSN&^)5Z9/9;L6WX=/5
M"HF.8$UJ:VZ\XHC5*ENLK6A2DEJE)$?V0F8I@16M9?G#CCJOV?@RC6'?E(*F
M55*9[53IAO,2"2W(><,OQD=QUL]4JUV*"Z<:P612*2JVUJ+Q*83H\O&UD6%2
MLAVE D23LFZ)%4C0EPX\EU3Q-RF'G4.+)M;BO8D>SJ"SEEF,UN$,8R7C&H8L
MX2KQH]5J**I=-?K35?NFI(+\6Y4ITMCE#06SL2)"2+U=!8FMQ-M+4G<])XE\
MK652L5U&Q:1;%L5=F$S<.0X]3COI=IZ"2H^0A\J3R5+(BU)2?L!Z,24NF*+6
MN'%M;CY?P!5+8HYN6/C:B5&DSYRI#"3BMFPRS$0;:W$N.&:6]-4(/[.@S%V$
MM3;C#[OC'UWUCB:PID*G4CG%H6C2JU&N&K\XCHYN[+ARFF4\BMQ+R]Y;B2U0
MA1%KMT+42OHT)B<T2JZBV;Q 8GO3)7D5CNAWY OVORJU3;ZG5"-&D0^=K-7)
MRD..)>6EO>V$@CUT^SH-UB=K-+HG!\8UP7>KN$<X8TRI#8M^1>EQS*U!K;<B
M.ZPX;C<5;<@DLNN&VA#T1*MU>ZK029BM2+9I,2P_)%;XEX^"[EM:\;&H-,H5
M(H11*K?_ 'TCO]\(K*4H2N/%9=4LG'2))]DDB^P-12J3-U&>3,5W5<V,>'[(
M%B,Q)-^8XHT5RGT*J;J8M0B3(R$28SBG-$IWD= S_P"SHB9J3*Y9F(F%@60O
M.5>NRC.W/B6V,8VO3C6]6'N7AU*;,423)#<?FKBB:+>/>WC/79H),Q3:L5KL
M8[6X?$;;-;NRDMV-3,[6779[L^WGZK/@Q'J:V\1%S1;<E3>\VC3L=TC/;T0K
M!Z7TL_X;L97#C&R*A!N<HT*K7!6)58>M^"OE(=-3(,MV,PHC,C(B+4S+9KU1
M+YJMEM(??$KCZX\@XX-BR8W.;XMRJ0JU:A<JTPHI45TC[%QY:&R[$S/LCTV"
M630OBL*NR#@F[/1SL:S[&A\KD:P51JA2C2^PTX<Q]+J:@7+O.(;_ !AR7%'J
MK0S(OL#478I-OHLIN##]<@<)\C$5LTTJA=";9C0R@)=89Y:>IQMZ3^-<6AHM
M7-\]37I]D3-Z52;?1H^,X8NO>\,.XZI-J0&)=X6!5*%6TT.0^TTF0Y3HKD=V
M.3REDV1ZO&9'O:'IT0B8S5+K9F'+7[8R=>]Y\-%[5BS44.5:,ZNRK]IS<Z(\
MFF%*CI9C$2R>_';^X7_*W].GH$3$56DS1+99L&[;FR[@:Z*'2>>T*RZI,DW+
M.Y=AOFS3K6ZA7)NN(6O4^DA*C"V8B"Z)F8;"U&*J=3Y\%#ZXJYD=UA$EO8ML
MW$&DEI^RG74AF&Y: 698_$OC^PZMB&@XUMQ<20B;&;R8JH14\NQ)WM5N1>5)
MY3ID>Z6\G0C,M3V:CI6VKC$71%*,C/$62W\ 8$LERUS:NBQ;TH]1N.F<]A&3
M,&%)E+=?)TG^37HAQ)[J%&K;L2)FBM5RSEB%G\2F/KOO^+C9NTJ1WV70+ICU
M*K)YQ'8Y*,A)DIS_ ,0XWO:>HG4_L!9=$;6KXF:-F1S;:DXJPW7F+;X@[7OV
MB)@T[)5SU:32B4_'?Y:#,82VV^7(..;ADHM2)6BB,M=!TFZ,'.VW":HCAQPO
M?EE4>_ZSD9HW[VK45%OT5:WX[RN]%.CDQ$(ELN+0DG-",R,R5LU5M";HP++9
MC:S[A4L*[,;8>I5K7K2N\M>C3ICST'EV).ZAU9&@^4C..MGJ7J*&;IJMD3$.
M2%8EUL\5%8R0Y2MVRY6.4T%BL\NP>]4"J+#YL\@3G+%^+09[QHW>EKJ$S@4]
M*K8L9;>>M,J^4:'Q(9VGXVM&#>YDFG(J]"DS6X#YI-O\6XR\\I+>P]2,E&0[
M33+BXXYIHMW%&-\AKKF4<JY.I\:DWQ?L J52+7AR&WVJ? 80K<:4\A:T+4M6
M[J>]H6GV=F9NC"(:MMG&92^%\?W=:?#DQ8=P4GO?=:*15(JJ5SB.[H[()[DD
M\LTXMKLMXMN_H73$F8S1*VQ,6T5G%X?KSJ?#=BVU7F6+=RGC*6JLT>-*<9DQ
M^=(DR%<V?4TMQI2'4.)U,C/39]DA8NQ9R3EYV76RYQ!5ZOV]%K>';3QW1H4E
M#MR5U<B%45R6D$>\W$9CN*4@U'IHI6F[_P!@5C>L9MS-++LBYZ3Q YHO>H4S
MF]KW;3;>CV_4^687SAR#%-N0GDD.&ZC<5LU6DM>EJ,S.%%B/2F6)6GB>Y#S%
MGRKW+1CCV7D:F)IU-J!2(ZSDMNM):>(FFW%.HV&?LTD-3=%(2+<987;-.XI<
M3VT>+K3L6CWI1Z/RT6SK^D5.+&Y"(XM2VN=1'7$N*-K>TT2D]A:;0G+*1FC!
ME$3AUJ- X:[RQ13:DBJWA=423,GU-T^3;D5)Y:7MS4ST2DS02-3^V&;%<GHT
M6#8%)O2ZL2S;.R[9\:T9/>PZ$N(W,8F(>BHC$R4DUQW'$IU,M=TU:EH),Q6L
M+$32DJ0X(K/G0K>NZ]*S*54YL^8U;5#J"C)1=Z:"2F&4MGK[$U'ZFW=(74GD
M9TXY5>X;KV8K?NW/TC&UAT^_J:_>\M$^GOU!FG26))$>XXE<A:$+0:3VEKKL
MV=$:NIRI;,UFBZ[#P#7*U8^7BRRXU$O#.4M,NXXL%:76J>B,:CA,MK2I25\B
M9Z[#/7H:],9FZ*Q1J+,)KRL3M^E<3%JV_#L!C$%I5UZDLII]+R9(F028..WV
M#3S\-2^74M*"+4B3M%S17:D1=&%&[%&C2H=(I<6<J.J='B,MSEQ6^184\E!$
MXIIO4]Q)JU,BUV$.<[76$D(
M
M
M
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MT-#6XE/8_=:F+==5(MHM(9:
M
M
M
M
M
M
M
G                                                '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tm2227887d4-bc_mostpreva4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-bc_mostpreva4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@#E <: P$1  (1 0,1 ?_$ /0
M 0  !@,!               ! @8'" D#! 4* 0$!  ,! 0$!
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M7-R<\=)GRSZ73S<8X8CJCT/H_P"0:YW2\<INCUQO%QJKM73VJ42W&LFDJ)I
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M,Y=]?*WY+TZU IJV]ECI8LOU['4->^-A#7/9!,&N(!< <.RL^"=YGH90B5F
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M3QXO.\="3J1N9<$]*W.E'/QRO:U7=N7<FZALAO-0_JJ*VWFGEMDM2_#'" 5
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M@&F;3.<QK,"(9Y-N[%;-"U=*^;=37;VXV,U?/*,-/H5II"\X]7F4M)'2103
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M:?BZ4=<?\5M/-3\RU/I[J/5Z)YEN+H,N:DOA&7'R._BX+NWCX8QL/V\.P';
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M+36>UJ=\\1MYEK-A_JI0^VD7G:/>:G;'_&'?J=U3S^EL,\S6,>6[-?ZXU/\
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MQ&+0N[3I\2)B-\1GY'+>>'$^7#=?YPD\7)WK;@-@M=%B=W_2-*O%YV<UK/\
MJKZ8>GX?LUO^VW_&7S8>;YV\X6AS>GR@9][>O:Y3_/\ 5EYFKT=L/JUYA]:+
M+H1I'G34J[M;.<OT$C[90.<T>,UCV\-/%ZX$AS]IPV\(."\O7U>'%8WR[-'3
MXIST1O?(7F3,NL/-KK)#)75M7G#/&<[AXM:**5_#'$)7?Q<,+0 R*.-NS
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M8X023Q-KS4-B<0 YS&NCX@-W$.RNN^/@^7B]4.3$_%B?)+&7SPQQYE;*3O\
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MHZW=TAL@\SI9K:.6W,UUCH:>*YU^=JZ&ON#8VB>6&GHZ0PQR/PXBUA>_A!.
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M D] 7)>W#+HK7BW+2\OG,ADWF>RQFK,N3:.HI[)8KS561DU4,'U3(6@BH:W
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MDO>\T^A\C/+,UC.831A[23QYOM6/XPQ>URT?QJ>68</,S_"MV2^V^!Q<QC2
M &-P])<L];97=A\I'G9<&\WV9<=[;/:"/Q1BT:.^_:[N8V:>GV>MN%\TOC_5
M+MK>AN9[L!V\#"O6YZ<QI^2L1Z7EZ'O7\MO5#9VN%T.*5Y8PD#$[@%)'S?\
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M'[7ATX\.U<NO$T\O9Y6[1]N7R:Z\ZE5.M6KV>-1IX!$_-MSEJ:>(EW@0C".
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MM7Y5N;#R0\[&8*[Y.DTMSC:C*,&SW5\M/3=C;(YQ"V5Q:&,9AMO\W5R,ZO\
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MY&];-/AK.6FTS:LPWY<QNE5[U-Y;,_:.Y4E@^6;YEZ.T6B>M>8XB^/JRTR/
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M:$;FD=O$I%8B<KQ2F-/$<<6[QAZ2D5B)R3.41#&"2 ?"&!&)[)/TUEA'&:2
M@C@P![!*QFL3CR&4[:>)@(:#@>VK@SLPBZ&-V]OI;$P9<3H6-:0UN\;SM3?*
MP^8CSQ#6GFCRV'[AI[;!W<*^Y=W%:M",:FI'EC_C#=?;I4\_I;"?-"M;_5US
M'P8$,S+(!OQPZF/Z87H\Y;BIH]GKEYO+9B^K/E_^F&VF*G9PQ #9@21W1M7)
MOETQLC#L>+0XAW#M&XXJ8VY9YV83NB8X<)&Q7IRD[4HIXAB W#'M[NXI,1*Y
M1ZF/8,-@VX8J<,&4HIH0<0WI)W]E68R@:>(X8MQPZ,2J!IH78<3>+#=B4')U
M;>$-PV#<D;"8RXW4\3G<1;X1(<2#TC<D[5RB:>(C#AP!4FN3*5E-%&<6@[\<
M"21Z2L[4C8B:>)QXBW:=A./0$QMR(L@B826MP)Z<5C%8B9GK7*9T3'AK7#8T
M@CNA6(PB3Q:'>68I,9.G*'BT)#<6^MW''L*DSE'Q>+H!'</8V()A#&,1P[]Z
MF! P1'#%N[HQ[*8'(&@)%8@<8@B&S X=C$JS&0%/$"#P[0,!MW#<@G=&Q_KA
MBI@2&"(_6I@1$,8! ;@#O"J3&4Q8TG'IPP4F,JE,,9WC'$88%42BFA:, TX=
MT[RA&Q-U,>&'#L[""!IXCO;B0<<2>V#])3 G+&D8>@F!(*>('$-]#'8F#*+8
M8V.+FMP)_P#)WDQMR.54$!!QOB8\@N&T=*" AC&X8##  '9L3 Y  !@-P010
M0P 4P!:""",0=A3 XNHBQQX?HJD;#Q>+]YT8>@I,9C F9%&S$-;OV%7 @88R
M TMV#<I$8C "&,###';CB3MQ5 PQD8$>CT^FF!)XM"'<0;@>T5)C(F\7BPX<
M-A[?828R(>+P[/!];NV[L51 4L(^M/;Q)V]U)VB>.&.(DL:&XH.5! M#MZDQ
MF,#B=3Q.&#FX@@@[=X/928R(]1'^][?HJ@88SO'T>RL8K$+E*::$N#N' @8#
M JX,@IHA];L&X8G ),92)<I:TM+2,6D8$%(K$1@2"%@[)V8;24P(-IXFAP )
M#M^)/T%9C)&Q#Q:+##A(V8;^A28R IHAM#2#CB#B<4FN5R"FBPX2TD8XX$DJ
MHY!&T-X0-AWJ1&"=J4P1.<7%N)( )[FY42FGB)QX2.X2$')U;<6G#UNY(V$Q
MEQBFA:2X,VG>4B!/U3.'AX=B"!AC..S?LWH)FQL:00-H'"#VD L:X@G>$,I7
MP1R$%P)PW;2F"-B7Q>(G'AV]G$H(>*P^%L/A'$[3O4QMRL3@-+"2#PG$##'$
M]*J=&',UC6X8##!3 XO%XB22"2=^)*HF;!&UW& 0X[]O8W*3 Y51 @'#'H.(
M02OC:\<+AL4F,B7J8QQ8-PXM^!5$OB\>S83AVU)C,D)NICV;/6[MJ8V8$W W
M ##8W<K&PG:D$$0/%P[=_H[TZ<AXO%Q!P:00<0 3@G1@3&-KL<1O&!2-B82L
MIX6;&,#0I$864QB8<,6^MW*B4T\9;PD'#H.)Q""=L;&DD-P+CBX]E!QRN>U\
M88< X[4PDSN:K/.\ESN5JJC</ ;?[8?^.:<5YVK6?M.GC=BSII/\*WF]+5+Y
MI-Q=S:TX_>Y1NV& V[):3N]E>SI3G3U(GZ'_ -4/.YB/;T\?3]4OJKC@8"'<
M Q('%ANQ7-6/9PZ9WHFE@+@\LQ(]7%,#FX&D$8;#O4X8QA<NL^BIWMX"T\..
M. )&!V;O2666.-F'(VFA:00TXCIQ*1L6=J)IXCABW8-RD1@R=1'M.&TG$[2D
M1B<D[470QN(+AQ$##:4B,!U,?[W'HVE,;<B8,:""!A@,!W%4PXC2PEQ>6GB)
M!)Q/1M"F&64_5,;M#=HV[]ZJ/EE\[<XCFH>7$'BRS:P>'9MXJCM'Z*Y.5VVO
M]:79K3_"HV8^9R:).5V_->P%ISU<P<<=PI*$@#TUZO-1Q:6EGZ,_\K/)T-FK
MJ3Y8]$-L[::%I+FMP+A@3B5RNG"=D3(P0T88[]JQBL,IG*3Q:+''A..WI/2K
MA,INHCV>#AAN]%43<#< W# #<D;"=J'51XX\.![*"7J(]N#<,220#@#CO4P(
M>+Q8$<.PXX[3TI$87* I80&CA.#/6C$K++&8RY'1,=ZX8^BHJ4T\1;PX$###
M $I.T1$$8;PAN#<<< 4$PC:,=^WIQ*F!'A"HXW01.<7%NT[SCO[23M(V'41=
M@]K:=FS!2*Q"Y0-/$<,6^MVC;V01WBI6L09!3Q !O#L PWJQ&(PD@IH@,.$X
M=C$I-8F,+E,R&-AXFMP=TE7".5!(^-L@ <,<-VW!!Q"EA:, W =W<I,;<B;Q
M>+][NW;4PN3J(OWNWLX_N["L;$2NI8'.#BS$@ #:>@XA#HPBZFA<,"S9LQ'<
M.(^BA,Y!30@X\&WLXJ8'(6-(+2,01@0J(=3'^]QVX[4$I@B..+=Z9$/%XL,.
M'$=C'T5,"<1,:, #AW524KH(W.XB#CAAO*F!'J8\<>'#LX*B4TT1=QENW##?
MV\4$/%H<0>':-VW<I,9C"Y3NA8[BQ!\+?@58C" AC&X(!AC)QX=O93HP=*3Q
M:'#A+<1TXD]U287*>.&.+'@;ACO53+E0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'')N;LQ&.U23+%K
M-?)ERN9ZS/<,W9IT9L5YS'=)W5-RNLIJ&/EE<<2]S8YF-Q)[2PT]/ASU2M[3
M;$2R)RUE?+V4+-19?RQ9Z6QV6WLX**V4<;8H8QM)X6MV;2<2>E;/B3;>QX</
M?  V!%10$! 0$! 0$!!QD^&6G=AL5Z$Z5B]5.6G0G6NXT-WU6TTM.=+E:H/%
MJ&NK1*V6.$N+N#BADC) +B0#CAB<%A%(BTSULN*>&(5MIUI=D#2C+S,J:=Y7
MHLJ9>B>Y\5KHFN#.)YQ))>YSG$]DE9S>9Q'4PC3BN?*K]H  P&  P 6&>EEA
M.L@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$$"T$@D;1N0PH?/^G.1M4<OU64M0,MT>:<NUQ:ZJM58'&-Q80YIQ
M:6N!!'05JMIQ-HMU+%L1A;C3+E;T T9NU5?=+M+[1DV[UT7B]7<:,3.E=#B'
M%@=-))P@D G#!;8MB.UC:,S$]3(!%$! 0$! 0$! 0$$#M!':06#U0Y8M ]9[
ME1WC5+3"T9QNM%%U%+7U8E9*V/'$-+H9(RX#HQQP6N*Q7.&?%,QB5?:=Z9Y#
MTHR_3Y3T[RQ193RY3R/E@M5"UP8'OPXGDN+G.)P Q)*SB]K1$3NAKX8B9GK5
M^JH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @((<+=IP&)WH(H" @(" @(" @("!@.P@@0#O&*!@.P@B@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(& WX;>R@(" @(" @(" @(" @((8#L;MR8# =A!% 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$#$=E Q" @(" @AB.R@B@AB.R@B@(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((8CLH
M(H&(00Q'9010$! 0$! 00Q'90100Q'9010$! 0$! 0$! 0$! 0,1V4! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0,1V4! 00Q'90100Q'9010$!!#$=
ME!'$=E 0$! Q""&([*"* @("!B.R@(" @(" @8CLH" @(" @(" @(" @(" @
M(" @(" @(""&([*".([*"&([*"* @(" @(" @(" @(" @AB.R@B@(" @(" @
M(" @(" @((8CLH(H" @(" @(""&([(010$! 0$! 0$! 0$! 0$! 0$! 0$!!
MT[A6,M]'45LC7/CIV\3FMWD8X;$%/>5&(!%GKB",1X+=Q]% \J/S+7>P;[I
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M3YP\5=7MMSY)R&NX"\1OG!V.X=_@[UE%H1>CDWU8S3GRP9CR[FZKEN=QRG-
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MIP'N8"_;@W'#:L)WB[)4D% 0%04! 01'9[&/>*H\'+WX'4?'*CVY45[J(("
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MEW+[ZLVYD,_!,/%GCJ^-_">+M[%MM;80V_6^A@M=#1VZE!%-0PL@@#CB>!@
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M:21M&#OKAALQ[2P1,@* @(" @(&/[O0*H\++_P"!U'QRH]N5%E[J((" @("
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MM+>-3=?,VZQOMLE!E_\ PAU),1@U\DG#''&TGUV# 2<$E6S5:YDP(&* @("
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MJ "1L,$@Q'2F3#L95J&5,E[ECQX9JPR,X@6DAP.T@H*QQ'T<%,"*H(" @("
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M@C%!1MVBB&9<OM$;0UW6\3<!@=B"L@UH :  !L 01P'80100  W!!%!# =A
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M% 0-Z#BDBB?B7QM<1N) *"E,K1LX[P>!N+:QP:<-VTH*P0,!V$$,!V$# =A
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M\I*P]) 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%)U'Z84/Q!_?<B=*K$40$!
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M$! 0$! 0$!!X.9_F"Z? _3"L;TG<[EG^;:+X%G>25AZ2@(" @(" @(" @("
M@(" @(" @(" @(""DZG],*#X@_ON1.E5B*(" @(" @(" @(" @(" @(" @("
M @("#IW'\ K/@7]XH/'RG\R4O\+VQ05(@(" @(" @(" @(" @(" @(" @("
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M(" @(" @(" @(" @(" @((%!3%G^=K_\,SO%!5" @(" @(" @(" @(" @("
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M=WU%1.H" @(" @(" @(" @(" @(" @(" @(""!04S9_G>_\ PS.\5!4ZH("
M@(" @(" @(" @(" @(" @(" @\',_P P73X'Z85C>D[G<M'S;1? L[R2L/24
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04G4_IA0_$']]R2D;U6(H@(" @(" @
M(" @(" @(" @(" @(" @(.G<?P"L^!?WB@\;*?S)2_PO;%05*J" @(" @("
M@(" @(" @(" @(" @(" @H^[_I-EW^5]J@K! 0$! 0$! 045J(/^Y69?YOF]
MJMFE[T-6M[LL#.@+VIW/$_S"Q!4$! 07JT+_ $OJC_[B[VS5Q\W[L.WDO>EE
MZ-R\YZ:*D J" @(" @XIOM,OV)[R"F<G_-<GQF7OH*K0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$!!2>8OG#+7Q]O?:@JQ 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M5B @(" @(" @(" @(" @(" @(" @(" @(*3S%^'Y:^/M[[4%6(" @(" @("
M@(" @(" @(" @(" @(" @@=Q[B"DLJ^OO7QQW?*LBKE 0$! 0$! 0$! 0$!
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M04GE7UUZ^.O[Y5D5:H" @(" @(" @(" @(" @(" @(" @(" @I'-P_P6@/\
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M$! 0$! 0$! 0$! 0$! 0$! 0$%)YB^<,M?'V]]J"K$! 0$! 0$! 0$! 0$!
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MM234HB)F@93\+B.+<'<1P6<3'4D[E8V?YMHO@6=Y8RL/24! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 04G4?IA0_$']]R)TJL11 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0=.X_@%9\"_O%!XV4_F2E_A>V*D"I500$! 0$! 0$! 0$! 0$! 0$!
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M 0$! 0$! 0$! 0$%)U/Z84/Q!_?<B1O58BB @(" @(" @(" @(" @(" @("
M@(" @Z=Q_ *SX%_>*#QLI_,M+_"]L5(%2J@@(" @(" @(" @(" @(" @(" @
M(" @(*/N_P"DV7?Y7O(*P0$! 0$! 0$%$ZB?H7F7^;YO:E;-+WH:M;W98'=
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M(" @(" @Z=Q_ *SX%_>*#QLI_,M+_"]L5!4JH(" @(" @(" @(" @(" @("
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M5Y=DRGISDK+DK0RIL]FH:6K^&B@8R7_SP5LUK\5Y:=*G!2(Z>E<8;EJ;44!
M0$! 0$! 0$! 0$'@YG^8+I\#],*QO2=SN6CYMH?@6=Y)5Z2@(" @(" @(" @
M(" @(" @(" @(" @(""DZG],*#X@_ON1.E5B*(" @(" @(" @(" @(" @("
M@(" @("#IW'\ K/@7]XH/&RG\RTO\+VQ4@5*J" @(" @(" @(" @(" @(" @
M(" @(" @H^[_ *3Y>_E?:H*P0$! 0$! 0$%$ZB?H7F7^;YO:E;=+WH:M7W98
M&C<O9Z'B?YA0$! 01[*"].A7Z7U7Q%_MFKCYSW8=G)>]++T;@O.>HBI *@@(
M" @(.*;[3+]B>\@IG)_S5)\9E[Z"JT! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M" @\',_S!=/@?IA6-Z3N=RT?-E%\"SO)*P])0$! 0$! 0$! 0$! 0$! 0$!
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MH" @(" @(" @(" @(" @(" @(" @(" @I.I_3"@^(/[[D3I58BB @(" @("
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MI9>C<O.>FBI *@@(" @(.*;[3+]B>\@IG)WS7+\9D[Z"JT! 0$! 0$! 0$!
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M! 04?=_TFR[_ "OM4%8(" @(" @(""B-12/(O,H.S_ )L/8E;-'/%#5K>[+
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MW86GUKAN0<J#P<S_ #!=/@?IA6-Z3N=VT_-M#\"SO*2KT4! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 04G4_IA0_$']]R)&]5B*(" @(" @(" @(" @(" @(" @
M(" @("#IW'\ K/@7]XH/&RG\RTO\+VQ4%2J@@(" @(" @(" @(" @(" @("
M@(" @(*/N_Z3Y>_E?:H*P0$! 0$! 0$%G-=LY4>0-*M0,WW"T/OE%8+-/63V
MQDO5&=L;<3'Q_6K=RNG:^K$0TZ]ZTI,RT]#G[R$0#^PVJV]/RR[W"^D_";S_
M )G@_B5(G9'[?*?U_M/_ /8;5_Z9=[A9?A-OI3\W[F$^*:?T)^2?WG]?_3__
M &&5?^F'>X3\)M].?F_<GXII?0GY)_>?U_\ 3_\ V&5?^F'>X3\)M].?F_<?
MBFG]"?DG]Z']?_3_ /V&5G^F7>X3\)M].?F_<?BFG]"?DG]Y_7_T^_V&5G^F
M7>X3\)M].?F_<?BFG]"?DG][*CE&YI<KZQ:E5V6;'IK/E*J@M,M8^XRUYJ@]
MD;V!T886C:X'>O-\2Y*="L3,S.7H>'\W76M/#7&&SN%Q<''9ACLP^BO$B7L.
M94$! 0$! 0<4WVF7[$]Y!3&3OFR7XS)WT%6(" @(" @(" @(" @(" @(" @(
M" @(" @I/,7SAEKX^WOM058@(" @(" @(" @(" @(" @(" @(" @(""5VX]P
M]Y!2F5?77KXZ_OE615J@(" @(" @(" @(" @(" @(" @(" @(""D<W?@M!\<
MB[ZL$JL VCT^\H)D! 0$! 0$! 0$! 0$! 0$! 0$! 0$!! ]'[NA!3-H/^=[
M_P##,]J5!4ZH()7$AI(&)Z @QNYH]3+GIGI)>+U9)1%>+A/#:[=4#?#)5!YZ
MQN..UC(W$+3?-L1'2VZ?#&9MNAC)RX\HV4<R9;H,^ZJPU68KCF&,UE-999YH
M(F,>[P7SNC>U\KG <6#CP[=H*[M2/@^S7HWN6)G4VRRTKN6;06KI&T,VF-E9
M"&.C:8(W4\O"=^$T+F28]OBQ[:T3:9;8C# S7W0UW+E=;!JSI/<ZRWT-)<@R
M6WR2ND-)(_#AC$KB721O&+2'XG#>2LM#5M.I&G;=9=32BU)M7WH;.<@9C&;L
MEY5S-'PM%_M5'<'-&T--1 R1S?X))":U)I>8:].W%6)5HM<,Q4$!!*\\+7$;
MP-F*#$OF?Y@Z[1ZT6BTY9IH:_.6:7.;;()FE[(8&>"Z8L&/&>(AK6])6=*Q,
M[1C3<Y.>"Q97GU(JLUE])1TYK[C8604#I(J5HXW<4#:?BP:T8D \6'2K$1,X
M1EGRSZW5.M&2Y[C<Z:*DS#89F4=\;#CU<KG,+F2L;L#>, GAVX+&\8E88Z:H
M:\:T9YU=N>D>A]0RUOL4\M'<;I%'#)(Z:G<1,]TD['MC8TCA&S:LHK&,IE3%
M3K#S(<ON;[!1:Q5\>;,K7MX#)RRFV-)'%U4]/%&6O;M):['8K6D6@SB6=^IF
MI]#I[IQ>,_NC95045$V:UPE_")YYQA#'Q;0.)Q"UQ&W"RP%RKF/G-U@MM9GG
M+.9V6&Q%TC[11-AHH8I#'BWAB$T+WN&S#B<XXE;+5K"1,ROIRP\PF;,]WG,&
MG>I,,4><\O@EE:(FP.F$3RR6.2-@#0]I'UH6-Z8VPL2SB6 \',_S!=/@?IA6
M-Z3N=RT?-M%\"SO)*P])0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!2=3^F%#\
M0?WW(D;U6(H@(" @(" @(" @(" @(" @(" @(" @(.G<?P"L^!?WB@\;*?S+
M2_PO;%2!4JH(" @(" @(" @(" @(" @(" @(" @(""C[O^D^7OY7VJ"L$! 0
M$! 0$!!C+SB1-=RSZTO./%Y+U@':\'ZJZ^0[^O:Y.>[FW9+Y<,"#P\;L .RO
MO7Q,1B3$_OCZ:J9GKDV]D^FAF>N4<7?OCZ:&9ZY,3^^/IH9GKE';V3Z:+Q6Z
MY;&O-B .U_NK'8EKLLU0(Q[,D8W+PO'8_A5GRO:\%F9U)B>I] \8X=WUVTX[
M5\C&[+Z>=[F5@%00$! 0$'%-]IE^Q/>04QD[YLE^,2=]!5B @(" @(" @("
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MEC*P]) 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%)U'Z84/Q!_?<B=*K$40$!
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M$! 0$! 0$! 0$! 0$! 0$%)YB^<,M?'V]]J"K$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @(" @(" @(" @(" @(" @(" @I.H_3"A^(/[[D3I58BB @(" @("
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M 0$! 0$! 0$! 0>#F?Y@NGP/_I!6-Z3N=RT?-M%\"SO)*P])0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$!!2=3^F%!\0?WW(G2JQ%$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!!T[C^ 5GP+^\4'C93^9*7^%[8J0*E5! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 04?=_P!)LN_RO>05@@(" @(" @(,:N</^S)K5^K%9[4+LY#OZ=KD
MY[N;=DOEL^O=W"OO>E\5)T%&*""._NH(((CI[B#8[YL/^T#=/U:J?OL:\/QW
MN8[7M>"]Y/8^@9N\+Y"ONOJ)WN56-P*@@(" @(.*;[3+]B>\@IC)WS9+\8D[
MZ"K$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04GF+\/RW\?;WVH*L0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$!!!VXH*3RMZZ]?'7]\JBK5 0$! 0$! 0$! 0$!
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M 0$! 0$'@YG^8+I\#],*QO2=SNVGYMH?@6=Y25>B@(" @(" @(" @(" @("
M@(" @(" @(""DZG],*'X@_ON1(WJL11 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0=.X_@%9\"_O%!X^4_F2E_A>V*"I$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M4?=_TFR[_*]Y!6" @(" @(" @QIYP_[,NM/ZL5GM0NSD._KVN3GNYMV2^6WZ
M\]Q?>SO?%((Q$! PP01'3W$&QSS8G]H"Z?JU4_?8EX7CO=1VO:\%[R>Q] P/
M"&X[<!N"^1CW7U$[W4;=K81CX_3CNR-]59Q64XH1^5;9^4*;[JWU4X93B@^5
M;9^4*;[JWU4X9.*#Y5MGY0I_NK?53ADXH/E6V?E"G^ZM]5.&3B@^5;9^4*?[
MJWU4X97B@;=;<][8V5L+WN(:QC9&DDG< ,4FLQ&4BT3+M2N!BEP_>'O+'+-3
M63_FJ3XS+WU456@(" @(" @(" @(" @(" @(" @(" @(""D\Q?A^6OC[>^U!
M5B @(" @(" @(" @(" @(" @(" @(" @()7; >X4%)Y5]?>OCKN^515R@("
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M! 0$! 0$! 0$! 0$! 0$! 02NVM/<*"D\J^OO7QUW?*LBKE 0$! 0$! 0$!
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MS89;,%J'@YG^8+I\#],*QO2=SNVGYMH?@6=Y25>B@(" @(" @(" @(" @("
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M6=([OJ*B=0$! 0$! 0<,_P!JD^P=WE)W+7WH6/)VGN_27GSO?1=,)5&8@("
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M(" @(" @(" @(" @(" @(" @(" @(""DZC],*'X@_ON1.E5B*(" @(" @("
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M @(" @(" @(" @(" @(" @("#IW'\ K/@7]XH/'RG\RTO\+VQ05(@(" @("
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MU5/^TS?8_27P</N%.Y/^:I/C,O?515: @(" @(" @(" @(" @(" @(" @("
M@(*3S%^'Y;^/M[X4%6*@@(" @(" @(" @(" @(" @(" @(" @()7;B@I3*OK
MKU\=?WRK(JU0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!2.;OP6@^.1=]()57T
MCN^HJ)U 0$! 0$!!PS?:I/L'=Y8S[JU]Z%CW;W=U<$[WT73"51F(" @(/:R]
M\[T7V1]J5GI>\Y^:[N5V3ZYG<*[W@2Y440$! 0$!! [QW?I(*9M'SQ?_ (5G
M>*BJE]59,4RBI.)IV8XX]"DCHW.@H[K05=NKZ2.NHZV)T-523,XV/C>,'-<T
M@@XA8WKQ0L3AK/SUR6Y^RM?ZO-&AF:Y[?UKBZEMC:N2WU=.QV!=&RJC>T/;B
M-@.![JST[8KPR3$3M6<L6@?-M8;Y=JVPMNMDNU\</EB^4]QZB2HQ)=Q/J&NX
MCM))./;73%J3#5,6RR,T7Y-KA9\QTV?M7[G'?[U'-XXRQN/C;35'%W6U50\G
MK7-=@X8;SM)6'Q(KGA6U>+&>AL1IV\,>'"&[=P[@P[F&Y:6;G0$! 0$! 0$!
M 0$! 0$'@YG^8+I\#],*QO2=SN6CYLH?@6]Y2=ZP]) 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$%)U'Z84/Q!_?<B=*K$40$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>@RED[+65Z=P?!EZVTMMBD&YPI8FQ<7\(MQ6.K?CM,IIUX:Q"K5@S$! 0$!
M0$! 0$! 0$'@YG^8+I\#],*QO2=SN6CYMHNW"SO*2L/20$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!2=1^F%#\0?WW(G2JQ%$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!!T[C^ 5GP+^\4'C93^9*7^%[8H*E0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @(" @(" @(" @(" @(*3J/TPH?B#^^Y$Z56(H@(" @(" @(" @("
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M5P3O?1=,)5&8@(" @]K+WSO1?9'VI6S2]YS\UW<KLGUS.X5W/ E:&^_.]?\
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M>B^S/M2MFE[SGYKNY79/KF=PKN>!*T-]^=Z_X5RX-3WI?0\OW=>R'E+!N$!
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M'E+!N$! 0 A.Z>QRQ^N;W1WPG2Q7QZ/37HU?-J9L_P [W[X9GM2@JA4$$KB
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M 0$! 0$! 0$! 0$! 0$! 0$! 04GF+YPRU\?;WVJ0JK%4$! 0$! 0$! 0$!
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M\DK#TE 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%)U'Z84/Q!_?<B=*K$40$!
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M@(" @(" @(" @(" @\',_P P73X'Z85C>D[G<M'S90_ L[RD[U>D@(" @("
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M$! 0$'@YG^8+I\#],*QO2=SN6CYMHO@6=Y25AZ2 @(" @(" @(" @(" @("
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M G#:-J9$4R"9!,@F0Q3(*@@(" @(" @Z=Q_ *SX%_>*#Q\I_,E(?LO;%!4B
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M_P!IF^Q^DO@X?<*<R=\V2_&).^JBK$! 0$! 0$$KMQ06$Y@9JBGRQ97T]1)
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M?WRK(JU0$! 0$! 0$&(?.N/_ (*59_/%N^_+CYN?8?(_G>/_ /F7V]-?3#4
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MCFN=U-2NM,3$1F-D1MS'4_.OS_X#RGAM-*VA68FTS$^U,^F99EK]"?F8@("
M@(" @Z=Q_ *SX%_>*#QLI_,M+_"]L5(%2J@@(" @(""!W%!8+7+[7EG[.L[T
M*V::2Q]6]J$! 0$!!E;H_P#H?%\<G[[5SZF]MKN73*UV45! 0$! 0$%'W?\
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M@DX\)."QK,<3*=JV/+OS2Z<9.TGMV5<WUL]IO658I8:> 0OE%6SK72-$9:"
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M!WX-;@.ZID5$@\',_P P73X'Z85C>D[G=M/S;0_ L[RDJ]% 0$! 0$! 0$!
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MXE[\=CS.<]Y?]>9#D160(" @(" @I/,7X?EKX^WOM058@(" @(" @(" @("
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M*3J/TPH?B#^^Y1.E5BJB @(" @("#'SF;_HHNOQF#OE?)_G3^G7[8?8_D/\
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MD$ BB(("HD.Y3IA(WRS)Y-OTESM_-E+]^>OTO^WG>ZO9ZX?D?]TN[T>V?0V
MK]4?C8@(" @(" @Z=Q_ *SX%_>*#QLI_,M+_  O;%05*J" @(" @(!V@CLH-
M</G!/P32CX:]>TH5G3>-:ZS05! 0$!!N'Y(_Z$(OY]N'>C6F=ZJVUO\ PRR?
M R=\K9I,++$+<P$! 11$0'KAW0E=XR\TK_0.R_95?^4RKFOOEMAZMV_27+G<
ME]JL55@@(" @(" @(,:></\ LRZT_JQ6>U"[.0[^O:Y.>[FW9+Y;?KSW%][T
MOBCNHQ00.A 03=M$;&O-B_T_77]6JG[[&O"\=[NO:]SP7W[/H(F^UO[;2ODX
M?36W/C@J/M\WV;N^OT;3]V.Q\#J;W'WUFUH(H@CT(B 4)7VY7_[16B/ZYVC_
M "N-<7B/W>W8[/#^_IVOJI=]IF^P^DO@H?<*=R</\URGLU,G?62*L0$! 0$!
M 00=N*#'_F'_ $5L?\\-_P GG7H^&=[/U?7#KY/WI8C+VGJ6WB((" @(,NN7
MO]&[K\='M5XOB7OQV/,YSWE_UYD.1![@QI<=P60X'54;07'%K1O+MG=WJ3Y"
M%D<_<Q>D&08I1>LW4E36QM)%JM[Q55+CN#>"(NPV]E8XST+N8NCFMU7U2NU7
ME?0S3%D-;3L$E5=[X\2/AA?@ \Q8PQ18D@@O<X=I;JZ<XS,L;6B)PRUT:L6I
M5@RU4LU3S+!F;,]RN,M8ZIIL>J@A>Q@;3M'"QH#2TG!C>';L5F(F-C',Q*\8
MW+5&YFBJ*3S%MK\M_'V]]J@JQ4$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!*X8
MM/<*"D\J^OO7QUW?*LBKE 0$! 0$! 08A\ZY_P#@I5_SO;C_ ,:N/G/<?)?G
M;^F7[:^F&G\[?07BP_%<H8*H(H@(B(WCNJ3N6&QSD!__ *F__NO_ /:%ZO([
MGZG_ &\^[ZGUETN> 8Z24_\ .]+[9;>>[OSO3_//]-MVQZ8:DMV(_=N"\5^,
M50""!5#!!'<H(]/H(=#9CR"_,&?OYR@^\-7J\ANE^L?V^^[:GUO5#-O-WX-0
M_'8N^O2A^@2JP#:/3[R@G0$! 0$! 0=6L_!:CX&3VI6&I[L]C/2]^O;# Y_K
MG_9?37R$;G[/""BB @(@BJWTY_32P?"R?>GKIY/OJ]KQ_'?N6IV1Z89A#ZWN
M+ZF.E^62PUSY^EM^^.R=]?+<WWMNU^K^#?=-/ZL*0.X+EAZ8JH@( ]<WNJPC
MFI_PB'X5GM@E=]>UCJ>[/9+/)NYGH=Y?9/QB5-VCYXO_ ,,SO%050J@@(" @
M(" @(" @(" @(" @(" @("#P<S_,%T^!^F%8WI.YW+1\VT7;A9WE)6'I(" @
M(" @("#'O5UI;=K22<0:1Y _AKT.2E\]XS[U?*M*NZT[7B5B-J*QVF*]2";3
M%>I%-IBHFTQ4/1Z*;3%>IE)I[LRC:3_<.]LY>3K^_+Z[P[N*]B@]3+W=K9=J
M2"@KY:6*6F+WLC. )XEOY;2B^]P^*<S?2F(K.%N?*[,OY9J?9+J^!7J>7]OU
MOI'E=F7\LU/LD^!7J/M^M](\KLR_EFI]DGP*]1]OUOI'E=F7\LU/LD^!7J/M
M^M](\KLR_EFI]DGP*]1]OUOI(>5V9<1_GJJZ1Z[L^@I/+UP1S^MGWF263JFI
MJLMV>JJYG5$]3 '22N]<3B1B5YFM$1:8?3<GJ3J:5;3TPDJ-F;Z#X@_ON6#I
MC>JU%$! 0$! 0$&/O,W_ $477XS3]\KY/\Z?TZ_F?8_D/^JZ?G:NE^&0_I 1
M1$$!42="=,)&^69/)L/^\N=?YLI?OSU^E?V\[W5[/7#\C_NEW>CVSZ&P%?JC
M\;$! 0$! 0$'3N/X!6? O[Q0>/E/YDI?X7MB@J1 0$! 0$! 0:X?."?@FE'P
MMZ]I0K.N\:UUL00$! 0$&X?DB/\ \$8QV+[<#]"-:;;U5KK?^&63X)X^BMFF
MQLL3@>PMS'!@43""+A%#""&#';Z2L1TIAEWI4?\ N)9NT^K_ ,HE*Y;[VR'J
MW;])<N=R7VJQ56* @(" @(" @QJYP_[,FM7ZL5GM0NSD._IVN3GNYMV2^6SZ
M\]Q?>]+XH*,4$! 01Q[R(V-^;&_I^NGZM5/WV->#X[W=>U[G@OOV?03*,8W]
MPKY2'TUMSXX*C[?-]F[OK]&T_=CL? ZF]PK-@("")"(@%"5]N5_^T5HC^N=H
M_P KC7%XC]WOV.SP_OZ]KZJG?:9OL?I+X*'W"G<G_-4GQF7OK)%5H" @(" @
M()7G!I*DS@8_\PIXLJV/H_SPP^G3SKT?#9_B3]7UP[.3CVI8C]I>V].=L9$8
MB*AL011$,0BLN>7UW#EN[;-U=MQ^Q7B^(SF\=CS>=C%V0 .U>9&]QN*HQZIV
M!P.S!62&N_FARYS$W;,DU1EYMWO&DW50F>S9=J88JMH#&=:'QD=:XEX)!#7@
M#L)I1'%[6YE?;&S9*E-&[_R?VBJACN]FJLM9S@=PRS9VBEF+I<,'.;(#)3@8
M_OPWN+?>9QL::VQ.U<S1*IMU9S-:X55GF@J+9-243J.:E+3$Z(M@P+.'P<.Q
M@M>C$QIV[?4NO'\2O8SMI\"S8!@"2,#L[2U5S#9.UV <1CAAVEFB*"D\P_A^
M6_C[>^%%E5BJ" @(" @("#CZP>%_<G!2=DID$K".('8%<29A-Q-[(13B;^^'
MIH9.)O[X>FADXV]D('$WLA#*!D;B&@XD[<$VF8 _$D<)P'2I,XA(E,#B,551
M0$! 0$!!!VX]Q!2>5O77KXZ[OE615J@(" @(" @@=Q08B<ZX_P#@I6?SO;OO
MJX^<]Q\E^=OZ9?MKZ8:?^RO%?B@51! P01Q0 -H4G<-C?($</VF#MVL?0J%Z
MO([GZI_;S9H:OUET^> __"6G_G>E]L5MY[N_.]/\\SCPVW;7TPU)'I/[MR\9
M^,0AN000,4!!-ZB'0V8\@OS!G[^<H/O#5ZG(;I?K']OONVI];U0S;S=^#4/Q
MR+OKTH?H$JL!VCTN\H)T! 0$! 0$'5K/P6H^!D]J5AJ>[/8STO?KVPP.?ZY_
MV7TU\A&Y^SP@HH@(@BB"M].?TTL'PLGWIZZ>3[ZO:\?QW[EJ=D>F&80^M7U$
M;Y?EL[V&F?/TNOWQV3OKY?F^]MVOU;P;[GI_5A2/0%RP],540$ >N;W5827-
M3?A,/PK/;!*[Z]K'4]V>R6>3?6L[@[R^R?C$J;L_SQF#M3,[Q414^/?P5$4!
M 0$! 0$! 0$! 0$! 0$!!Y-WO-#8J&NNMUJ(Z*V6V!]36UDAP;''&TN<XGM
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MX1N)[73ATK)'69'Q.Q.QS1X)'H8[\-V"DQG8* SMI'IUJ'#+'F[*=ONL\C.
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MA3>3OFN7XS)WUDBK$! 0$! 0$$KMRDD,)>>5H;IME,CIS1'L_P"15:]_\O\
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MD>F&80^M7U'6_+9WL-<^?I;?OCLG?7R_-][;M?JW@WW33^K"D.A<L/3%5$!
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MO_VBM$?USL_^5QKA\1^[V['7X?W]7U5O^TR_8E?!0^X4YD_YJD^,R]]9(JM
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MWU[6.I[L]DL\FG%C.X.\OLGXQ*F[/\[W_P"%9WBB0J7U543J*(" @(" @("
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MJVS6RKE=UE,&\+N*![F@@M/:6'/<II\U3X5ZYALY#GK\E?XNG:8O"@1RO9+
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M3Z4W^[FT$_(L_P"-2*_B^N?AFDA_NYM!?R+/^-/3\7UU_#-)'_=RZ"?D:?\
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M1WF_?+5KGN49BI'FFJ&]7AQ\3<>SLV$K7I6^%:+1O;[TC5K-9C8H(<OE@PV
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M_P 3/W1R?9-'J7])^'_0CY \FVFY_P#8S]T<GV32ZC])^'_0CY$/ZF^G _\
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M"SI,1O)G,*L#@T; </J8K A3>5&/CMDC)6&-WC4Y#7 @X&1Q!V]I92*H6'F
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M:3.'):&EMKMD;@6/931!S'# @M8 1@>V@]/'!!+Q-.P'$C>$ O:W><,=FU!
M2,(!XM_T^T@F!#AB#B.R@B@\',L;YK%=8HF.ED? X,C:,22>@ *TG%MH]2A!
M%#1@@@B",$'81X(2=XIZS,>V^9D>Z-S62S1&)Y! < P X$[U9G8*IQ/86(@2
M0,7#8@EZQF(&S$_N^DF41XV]( PWXIE4ID:#ATX8X;U,B=C@X8A6)R(N&(.Q
M!2-ABGBNF92Z-T;):UIC<]I <"W#$'IVA97F)B$X9CI5<,>QAAN6O$LDI<P$
M OP)W E9(AQQXAO&<3N&U! R1@X%YQ[&U3(F:YCC@UY)PQP[2HGP[900X=N.
M_9O2=V#"E7Q2C-<$IC=U?B;P9,#PXX]G<KT83$Q.<JI:WP1M*Q4):#AQ''L>
MEZJHCL_?%#"4N8/KR@B"';G%01((W8GM),9''(''=BD3CH)C*E6PS#-XE+#U
M0MP;UN!X<>,G#'N++$8V;S:[6;&/ER]<F1,=(][&!K&@DGPVG<$@5*#CM&XJ
M"*"1SFMQ)<1@@AQ,Q(X]H0.)N&/&IDP!["[A#\2#AAVQO3(Y%12F<XI)K%+'
M$QTCS-%X#02?7CH"RK.$E4D(\$8C X# +&2'(2 <"=^Y8XPIQMQPQV]A3S*E
MZV/$#B&)&(0.MCWEP&S';LV>BB.3T$\P>@K Z%P#G4-:QL1+G02!N'9+2MGG
M3S.EEQKX[':HY&.CD93,:]C@000,#B#W%A?;+++VR0W:5CYD0#VNW;>XGF O
M:W?L5\PAUC-NW'#8<!CVD\PF!!&(W)Y@(*9\@\RZ,D=;[@W8XNII&M &\EI
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MD\J;5,(WF(4DS7R8$M#G.;@"=PQP6<3LDPJL$''#H6(B@(" @(" @(" @("
M@(" @(" @(" @@X8@@()0T@XGT>V@G0$&*W-IF_/61L@T&8<AYCCL%RAN$5/
M(PQQRRU77D-9%$R6.1I..W<LJX26/U#:>?*NHJ6M9G"CA961-F$$L=N#QQCB
MP<T4N <,<#MWK+-3"@<N:C\Y-?=LZ4%'F6GN=XR \',66JBDM_721M'%Q1L%
M,"YI&SB:0=H&*O#&,C.OE]U;&KV18+[5THH;[;JB2@S#0-&#8ZB/?@"20'#
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M=KCAL"RCA10&6-;N:NFRA!JM-=Z+.V1:.H?'>J(4U$9X!&X-E$O40Q2QG##
M\6&!!Z5,0-G^1<T4>=<G9:S;;R31YBM\%?"#O F:'%IP[!)"PF,*JM0</ >Q
MAMZ=O3MV8X;D',=QPW]""RNO^:+[DK27-^9LLUHMU[ME)UEOK.!DG ['9X$C
M7M/HA6L9%O+_ *R7;)_+3:-3[D^.[9FK;-021OE8V..:MK.!H>YC&M;L+B<
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M +02T,&+<3O6,]1"\7*II_F')>1;I<,UT[J"_P"<+O/=ZZUR-##2A[N!L9
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M76%5MH#I_5Z8Z797R?<)!+=*%D]1=I&CP34UDSZB1K2-A#3)P^@D[Q>E0$!
M0=&KHHZR.:&>..:"=O!+#(T.:YI&!!!!!Q!08@9^Y89K5=9,^Z#WU^GN<H.L
MEJ;2P&2VW!SSX39(GD\!(+MW@G'=L"SBQA8#+.;<_9LYLM&SJ+E.7+F9LLVV
MY6FYRM:X05G!0W)XJ8O!X0UYDPP&/="N-DC:((G<7$2  1AAVO06L=A 0$!
M0$%IM:LF56H&FV<,J4$O45MSH7BC=B '3- <QI[1(P2-XP9R-S.Y^TBR[0Y
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M/:0=*2T4,U5#7R4L#ZZG!$%8Z)KI6!PP(:\[1L)"#MMJ.-P 9L)PQQ^H@[*
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MOE?:9"2, :N+?[)3$CW+'?[+??&7V:ZTMT93EK)G4LK90PD8X.X=Q0>^@("
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MC:%98-]:,1ALW+$3(" @E<T.!:=R#K^)4O6MJ# QU0T<+:@M!>!V [#%!V0
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M6Z07"^T5')-;* MXA+*W<WA&TX]I6!AKEOG8BMDL-KU=R'>,E7+P!/5BG<8
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MT!03H" @(+6:Q:G6W2/)=1G&Z6^INL,-3#2PV^DX>MEEFXN!H+M@];O5B,C
M?,N=M8^8IOB&4=!;9:K1*'L%_OD'72!LFSC94RMIXXW ;=@<L\Q"8R[N4.1+
M-EIA%SJ=5GY<S* 74HLM/(6QN.W!\PEB..\'A&'85XTX60G*[G74>\TV>\DZ
MD337&Z:=7A]KI,S20F$UT,;Y83B>%H?PNA):\#:UPQQ.TX6G:RB,,MH\> 8D
MN[!.]8CD0$$#N..P=E!:76S)$^H>F6:LJT4G5UU?2EU#B=G71XN:#W3L2-XU
M=9XUNN_DGICI]G3(UPR]?M-+]1UE=4.9P15,%!@T-9&\->'D=LCM[ELPC(O2
MN[9JU_Y@+7J]-EJKRKDC(ELJ*:T1U3,754U1&^%HX\ "X]<7GAQ #0-Y)6,Q
MB%;#X<=H)QP&'J+$<R @(" @@XX-<>P#VT&L;+VIFEVD/,MK+)F2LCK*"_S]
M9!>! 931UG$UU52N'"3Z\':-FP+9B9A(9#2<W'+R6._S^P;-_B3O<+'@E<LE
M<MWJV9BM%MOEFDZZUW2F944,O"6@Q.]:<#AACW%B/?0$! 0$&$>J_-++EK-]
MWT\ROI=79YS!;I13S.<<:;K'X<(X8XI9'=S8LXCI1C@[EHUGUKNL5]S1EW+V
ME-O>[B$--2&GG+7>$>* .>\OV[W\([2RXTX53YGTVU6Y5J/+F:<AZB7/.-E\
M?@H;OE62D>87B7$N+8A).&M):<2W CL]"QFV86*ME]LJIJREHJJ5IB-5"R8P
MD[6E[>(M(QZ"L%>J@(" @P-UZES5I%K;8M<[-EF?-N7*ZR_(V9:.F:XRTW5N
M]>'!K@WB;P\)=LQ!&S>LZSF,(Q1R;S 5=JDUDI\KY-N5US%JE7<=GHP./Q1L
MC!&XRM8'%SAMP V+*:Y,MC?+9D.ZZ=Z3Y?L5\.%YG+Z^Y0D<+H7U)#G1.Z.)
MO2M:LA5 0$! 0$&*7.-16NOT9O<=SN;;5U$\$]!+("633L+BV'  ^O&(659G
M.Q%"Z><UF@=OR1EBAN%0RRUU%010U-L\2<[J7QCA(!#""-F(64TF3*]&0->]
M*-2,P^3F2KHVKO!I9:LPBF,/\3$YC7^$YHZ7A83&!?YOK6[,-@V**B@(" @H
M#4_/=OTTR3>\[72EFKJ*Q1-EEI*?#K9"][8VM83L!)?TJP-?>8M6]5M>HC:<
MBZ T;*"8\(OM_I_&FMQ&/$7N9#%&<-QXW+9&(3&7#D[D1S9'C>+[J0,L7IW%
M+!3V:G=(Z&1YQVRB6$# X^MQV=*DW3A7YY;<U:HTF;=1=(]0ZZHS$S(;HC9L
MW2Q%O7QR$XQ]86MZP $$..)&[;O6-MNUEC#,V,DL:2<21M*Q$Z @(*.U"R])
MFS(^:LM0RB&:^6RIHH92< U\T9:TDG'I(5B<#3_GS4+,.6M':7E^SCDFNM-X
MRQ=X9:2^EO#3ST\,LDNUKP"2>LV$8@]I;8V[6,LA<H9KS'S*:V:<9DH,JUF7
M<A:7M?527"J;CXR]\1#1Q 88O(V $X#>L-S*&R:'UN_$].W%8$N9 0$! 022
M$!CB=P&*#6C?\^Z<Z3<VF:[]F2KCKZ.^VR"&MF;"Z5]KK T!S7M<T[)&!N!;
MN"SB)F&,[U^OZVW+WM'R^QVS ?X#)M(W[>#8DTEEED5DG,]BSEEZWYERU4"I
MLETCZRAE:PL!:"03PD##:.PL!5J @(" @P^UIYF6:<YE\A;3IW7YZS ^E95"
M*-W!3@2N+6M<&QS/)Q'0%E6,[48L7#0W6[F ND=VO>2,O:46F603B84I@JW
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MFM+L.AQ6S@3*X&E?--GC474BAR)<-+_)T<#YKU4/?4234\(;QM>Z(Q,X 20
M7;-J6I$0L,Z(8HFMXQ&T/?Z]X: 3W2M8[  &P; @(" @\N]W.BLMHN-XN4W4
M6^UT\E56S88\,432]YPZ=@Z$&LK//-5GF_T3\W671^T5>FM)<&VVBS-F"D-6
M9I'.<!P\1C )X7;&@X=+MX6V*P997R:L#*.K.3-*ZW*5/9,O9SMYDRY?*9[
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M9JWRRU#I(*4\?'-U;H(S@ -Y.&Q6=.,;QG[%''@V3JV]86C&3 %Q]'>M2N=
M0$!!TKA.RFI9*B5P9%""^9[C@ QH)<2<#T?NQ0:U-1>:G-^8:;,-ZR-I/;LP
MZ<Y4J/%J[--^IG5,;I.,,!:TEC6 DC >$[IV+.(3*_U5K8,@7#1RVW')5';,
MI:FVVDDFS#0%D$5/<JJ&.5L#*9K<>'B?O[>/94QE999TX(CP.&()!(_<%B.=
M 0$! 0<4PQ8>Z.^@Q7UXKN7?)SXLRZL99MU]OUSCZNUTGB3:JX5;(L&\,8=P
MM 8'#;(YH[>. .5<]!*U.2[[RHYRR7G+/3-(*:SV+(SF_+!K+7"Z9P<UKAU<
M=/)*=O$!MP[>Q)B8&86E\>1QDRTU.G5#1T&4[@PU=M@H8^JCPE.+B68#A=Q8
M@CLK$7!0$! 00=ZT]Q!BWKOK3E?1ZIL4YR@,XYZOX,5CHHF,CFZN,C$F?@E>
MT8N&#6M.)["L1DW,=/Z[VH3OE0-T3DX;,_@NA%54EU*X#BX9O\'\ AIQVK9&
MFF65O+WJI?=9,J5^:+_E5F6H'U1AM4#3))'40-:,9 ^4-XO"V; L+5PK(%K6
ML :QH:T;@!@%B)D! 0$&/^NFL]'HY8**JCM3\PYEO]4VBRQEZ,N::J5Y#<7%
MK7D-:7#8!B[<%8@8]Z-ZGYVS=JK>\J9]TERWER^4-DDO-+31T+8JTR<3.J#I
MGOF(X@\8](*SE,LA-"-87ZMV>\27"S>3>:,L7*6W9FR^9.M\7E:YS6X2 8';
M&YIP)VM/00L)C"L@% 0$! 0$'@WNWVZZ6^NM]WIHJVU54;XZ^EJ!C&^)P\)K
MN(8$$;T5KMS-JER99=O3[+1:4T^:3!-U-1<K9:X!2MD#N$-#ZB6%Q./2&X=@
MG<L\2F60=KL?+=8]5+7DFVY*M%JS]24S;K;9&V\1AN.T=5.=A> ['8-RQB)P
MK*U1! 0$!!Y5T%,Z"H;6M8ZB,+Q5-E&,9CP(>']D$8XA%:\+USIQ6*>ZTVG&
MDIN.3K'6&A;?W/?2022<0:"V&.F+8^(X<(<[B(PQVG!9\&4F7+:^<O4BZ9GR
M]E=VC9MM?F&HA93QR35+Y'0.>&/E9'U+"X-&)QQP&&U.!,MC3(V'@D=$T2AH
M\+ 8CLC%8*Y4! 0$'6J2UK ]SN%K#BX]H;T&N_5#F>S-=;EFZTZ<:94.=,K9
M&<XYFS'>(GU%*WJQPR%L1ZMK0'; <7%V&."SK&$E7K==YLBY!T.SA-D2V4EC
MU*AI3FRY6P,I(:&:H:S#@@:TEV)<3M/0IA<LU*25L]-!,P\4<K ^-W9:X8M/
MHA8CL(" @(""23UNXGM!!CCKM+H-ENBI\UZPV*VW.<,-):F5-+XW5SD8NZF!
MNWM[7%K1TN5J2L%IYF7E2U%BS?5T.CD%GHLD6M]YO-1<+7!^"Q'PBQE/).]S
M@-N 'HK*4AECHV=-*S)5#?M*K51VK+-_<:OQ6EIQ3N$Y :]LT8];(WAX7#;N
MWD;5C(NVW##9VU%3(" @D?ZQV.U!CMKSJQD_2*UVS,5XR\S,^9*N;Q7*EM$;
M.O=(X NX9GM>8V@ DD#$[@LJQF1BVWG8U&GK*ZC@T0F?4T$;)*RB%34OD@C>
M"]CY&MI00'-.S$#%9_#A&2W+CK/F+6NV9AO-YRA'EJV4-0RGMCV/DE94>#C)
MX<C& \+MAP"QM7A5DPQC(QPL8UC?WK0 /H+ 3(" @(+*:UZM6;1K)T^:KG3/
MN57+,VEL=FB<8W556YKG-87\+^!N )<[A/<VI&T8L:;ZM9^S9K-8<KZC:09>
MRQY1T-7=;?)/0 7 LAB,D3G22.>\$D>%Q#B[06>-AF61FB>LD^H]TSSEB]V!
MN5LTY#NU10UMF9*)V^*AY;!+Q@ 8G @CM+ 9#(" @(" @(" @(" @(" @("
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M6;6L+CL&."L;R6L+-^O%!6Y-TNR)F>P5N6\SZ:9BH*F\4[HBQKZ2CQ:YS&.
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MTEJ5WT! 0$!!*['9AV4&O[F2EL5DU[T6S%J/!UNG<3)X'32QE]-%6@\372@
MXAIX'.&!Q:#L64)*E,E:FZ9Y1UTUWS=7WNAARC-9:0T'BN$D=7X,6,%/&P>&
MYV'#AAOWJS$B[G(Y;KC3:376X5-))16V^9AJZRQ4[SB!3%D;,6[=P<TM[>&*
MQLL,T1N4$4! 02N&+2.R@P>YLJ"\6*[Z8ZKTMFEOUET_NA??J&,<09#*?!>Y
MN!W.V8]"M11-^U>MNCFMM[U S19JMV2-8\JV:LME=#'UCHYZ* -9#LV$X%W$
M.VT[EG$925;<D[KK<[3J-FHT3[?E7,U_DJ\LTSCX' =DAC'8XL=O96-EAG&L
M00$!!+Q,/UP..S?V$&(/-OE#,EZREEC.&5+:;U<]-;U%?IK-PEYFIX2'OPC&
M!?@Z-N+1M+<<%:S!+$6Y<TV3:W7'*&JM7:ZZBI[!8*RWW2TEH,K:R5CV-C:7
M8;,3@21L6R(V)EDKRF6W-.9LRZEZV9CM$EBI-0:P-L%OD:YA=31DO$C0X EO
MA<()W[QL6-L*SE6 (" @(" @(" @(" @(" @(" @(" @(" @(" @(""E,Z39
M<I\NW63-[Z./+0IGMO+J\M%.87^"6OXMFW' =..[:D;QK?RYDSDUU+SZS+.6
M*>ZNN5PDFD9!$ZHAI']5B]X:YS@6M[&S=N6SBMAC&]F]H[/I9%8KC8=*331V
MG+-?+072G@XN-M4P#B+R_P )Y/[X^@L)V[V2];/6-[B@F0$!!(_#A.*#%K6?
MFCR+I/<3EUU/4YFS2&!TEFH US8,1BT3.)\$G9L&)&(5BN3+'&GYYK8]K:"\
MZ05$-AE<?'(V<+P6':X]6]C6$]DDK+@(EFEH]G;3W/F5HKUIY#3TEN>_AK;=
M#"R&6GJ, 2R:-@]<,>SMZ%C,8%X(R"#AT$CTEC$Y'(J" @@1B".R$&N^OYLM
M2LC7B\46?=)Z^6T4MRJ(*.[4L;XP^G8\B)S0X$.):,<<5GP[!4=MYJ^7+/%3
M&W-ED-FN)D#&_+=NCD./9,D8DP&T^N2*V3+*O)6<M.[_ $[(LD7ZS5M*UN#*
M2VR1 -_DX\,,.G8L9B57!#FN]:<5!,@(" @((.]:>X@PRYE:KEO#Z*#6$1RW
M_@!M[*+C%>V,X\()A(/ <,<'[%E292RWNFN4^4[+=KR]JG01SMIKI=ODK+U9
M>7S/+:V.7J\1"2X#!PQXB-BLS98W-@E*X. <PAT1:#&6D<.!PPPPZ%@.X@("
M @IW,F8K/E6S7/,%]K66^TVF(S5U9(< QF('1O))  [*8& F8N>S+IN&&6=.
MZ_,M'23.-/<ZD"/%PQ''& ).'$=PK/@3+W,A<V.E>H&9;7;<\Y(;EB_U4@CM
MUUKX(YH _'!@,KP'@D[L1AVU9JK/2&1D@B=&6F-P!C<T>"6GL=K<M:NZB" @
M(+!Z_9XS]D#+EKO>0,LNS56NN,<-SML<3I7"E+'%SPUFT>$ ,58C(QMHN>"P
M,XK7J1IK>+//B(JN-D3)H0T[,9&REFS:<0 5E-=IE=W(FL_++>ZIE7E^XV"Q
MW:5W"#64L=%,''H!D8,?0*DQ)EE)15]%74L550U<592R-!CJ(7A['#M.:2"L
M1W4! 0$! 0>)>GVZ*CJY;JZ!EN9 \U[Z@@1"$ \9DXMF "FW(UERV+DKSKJ%
M1Y=L=/<1=+_<(Z*".WF=E"ZHE?U;1&7.P#<>EHPZ5LXK81FGH_1Z29;&8LAZ
M7^+PU&4ZMD.9Z5G$Z;KI8W.8Y\C_  GX#B&.X8$+&9D7[:,&@'> HJ* @()'
MD- ))&WH08ZZU\Q^1M'#36ZYBHO68:YI=36*@#72ANSPI"2 P$^B>@*Q7(Q5
MBYZ*82R0U6D51':JN3CKRTAQ>T[W.88PUQ( WE9<&"9Q++S1#433'4?+\UUT
M^HJ:TO81\L67J(Z>KIWNVX2MCQQ!P]<"0I(OQ'ZP=O;]%8B= 0$''*"8W@;R
M$&!.<>9[4[3K.F:K=F'2NKN>4K;<'Q6B]4T4C ^E&&#^(@M<<"LHK$JY*#FW
MY?,ZS,ASQEZ>S5;"&12WBWQSCPOWKX^-P&/9 5X<,64>0L\:5WRG;39$O]CG
MC<&EM#;WQ,>"=P,3<#CAVEBJZ+'M>,6G$*"9 0$! 02OV,<>P%)&+',I4Z!Q
M6FW0ZTB&1\O6&S1PAYK\#@'&(Q>&&XX D[%G69)6!T\R3RC4^7*S5^FI:N2R
M99N$=(ZHNSIG,94R%K6 08GCVN'I8JS,D-B=IJ:2KI(*F@EBGHJB*.6CFA(X
M'Q.&+'-PZ"-RP'J(" @(.A<+I;[51U5PN57'0T-%&Z6KJICPLC8W>YSCN0:_
M<V\\^465KZ/*61J_-]%1S'"X3-$<+GL)\./ //<Q *V10E)ECG TRSK?+=;M
M1L@'+\TTS8K?>:V".I@B)( XWO:US1CV <.E3@PD6; J!U,Z&G?1F-U)(QKJ
M<QG%A86@@MP&&&"P5Z2 @(""S6MV;,[9,R;57[(=B\HKW2SQ 6QL;I7/B<?#
MP:W;C@K$9&*=%SOP6][[=J1I?>;/4@<-0R&(2-+3Z[B9,6 #$;EEP&5SLFZY
M<KN8:EE9;ZJRV.ZEV(^4J2.D>UQ .Q[V\)V]@[U-L&65MMN=MNM/'5VJN@N%
M*_#@GIY&R,]DW$;BL1ZR @(" @(//K'P,CJ7U3HV4K(W&I=)AP< ;B[BQV88
M=E8[<JUD9TIN2W,&>W6QD58;Y<:_Q2J?9^N91NJ99. 8'$-VN/KF[%NS;#%E
MUI/8M&-/;]?--]/&P4N9+;''57RG>Y\M06OPX<9),>+#L#<L9S*LC5B" @((
M%P;O_=@@L1K)K]D71JEIGW^>6X76M!%'8:'A?4O'[YP<YH8W'I)V]"L5R,0O
MZ]K#4U'%I%4NHZN3_#)2_!\D>XEXZO!QPZ"5GP)EDYH5JMI5JA35]1DFUPY?
MOD!#[U9I((H*MK<< _%GKFG 8D'NK&8PK)=GK6].S>L1,@("#CEV,/H=]!@[
MJ3S$ZI:99\S#05.F%3F#)=#(PV^\4T<C<8R!Q$R %I./8641DEY5+SC:$YNX
M*7/66*VT2;")KI01U,8/3P<!>_#9V%>&8(EDQD'4#1Z\0LILB7ZP_P < 304
M;HH)!MV<4?@NQQ[*QG(O P@C$'':=J@G0$! 0$''+ZSN$(,>N8*JT4BR@QFM
M#J9]IEE<+;&X.-691@TFG$?A@@.'$1L&.U95ST$L4=/=/N4"]67,6HE%35TM
M@R/(UUV-U?/U3"0'M!BXCU@V@<)]%96F8(;%\KU]HNEBMEQL$T4]EK*:*2V2
M0 !AA+1PX ;L!LP6L5 @(" @Z\]1!%%+)+*V**-CG22N.#6M:,223L& 3&1@
M/GSG@R5;KC567*N4JS/$=!*8JBNX6MI9"PX Q>O+AB-A('9"SX"94[9^<[3W
M-%PH[=J3IK+9Z1\K8Z2Y31,J8H >EXD:UP&/8!3A3.6P7+U7;+A;*"NLTD4U
MJJZ9DMNE@P$1A< 6<    P*QE7NJ @(""UVK5_S9E?(U]OF2K4+UF*A:U]!;
MBPR=;B[!PX6[3LQ08>T'.U6V1PH=2]*;U:9RS^.=3QXES7;'8QR\  ]%9<)E
M<3*FOO*YFFMBJ6_(]BNS@'N^5:".F+7=@R%I83W"DY,LL+)>;->J>*JLESI+
MG1O:US):25DL?"1BW M)&Y8CWT! 0$! 0=21T>+^L. &W#L]OT$P9:T]7IN3
M.X9TK([RV9V8GRF.YSV 2BG,KC@XNZLB,NQ.TM6RL61DMI?E'0O2G.<V0LF1
MPTF=ZFA;6U4<KWRU+Z8ENP/DQ[1X0L)F99,H5$$! 00Q&.'2@L_J[K-D_1ZS
MPW;-%4]TM871VNTTPXZFID;O#&$@8#$8DG!6(RK"^?GQ8VLJ)Z+22KE@F(!J
MY'%LLC!CAQX,..PGI6? Q9":%:U:4:J5UP.6K)%EC.4<1EN5JG@BAJ96; Z2
M-[/7C$[=N/96,Q,#*P;ACM.&W!8JB@("#CEQX=@Q.\>AM08;ZR:YZG:6YYFH
M[7IU49JR4+?#.;C3QR<3)3Q&1KI0"-G#V%:QDE1%'SGZ-9F$=!G[*%QM#7-\
M-UPHF55.UQV8-P)?L^Q67"C(O3_4G1&ZL9%D;,%@I)*H!WB4'54LY!];Q,(:
M[IZ5C-9A5\X=L8((())!!Q!&)PVJ#E0$! 0$$"<-Z"S.N57I3!D:L.KCZ/R8
M>\<,53B9'SAI+.H#?#ZP#$CAV[%8&$FG>0.3O.U7F*Z66FN;Z#)E&Z[W5MQE
MGCIXZ:-PQ<<7$O&S:"-JSS,(V&Z>WC*U\R9E^Z9+?3G*M31Q&R1TS.KCC@#0
M&Q]7@. MW%IV@[UK56@((Q&XH(H" @XI'-$;G<0:,,>([ !OQ08.ZG\Z.1\L
M7:YY6RWE^ISW66^1\%SE@#?$Q*UW"^/C\(N(PVD##MK.*$SA;:AYV,EWM\-L
MU TJGHK"Z1C893&RJ9$XD-XBR1K, !OX=JO#ACQM@N3+KEV]V"W7;*LU+/8:
MZ!LEMDHPUL7 <<0&MP P..(Z"M<QA<Y56BB @(*.SM7WFTY4S'<\OTGC][H+
M?4U%IH<"X2SQ1N,;"!OQ=@$&#%MYU<S9=\7I=4-)[O:*AS<7U%+$YI<X;RV.
M7#9Z*SX.I,J]RSS%<L&<ZR*IK8;=E^]3 22_+%!'$YCSZX/F <S$'IQ3$C+3
M+>8,MW^DAJ,M76@NE &X0/H)8Y&!@&S#@)P"QF,*J=0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$!!A?SO/K1IK8XW/GCRW-?J1N:G0$AWBW&,-H&(Z3
MOWX+.AG"TD/[)\O:^:'5N1*BR6[*L66*M]9<*.:)K 6F8%U5+Q'"0 #BXSCV
M5E,S,,8WJIY=+C;[WS%ZYWO)C"_(]330!M3 !XI)7"5N+H\ &XEH)':[JQMN
M90V ,PX1@<1V5@)D! 0>3?:M]!9;K71@&2BI)JA@(Q!=&PN&/I(,&>3?*-EO
M\6<]5;W21W;.-YOE5"VYU;0^2GBB>"!$2/!./2-N&S'!9VDV,YJZAI:VEFHZ
MVFAK*2I:8ZBFG8V6*1KMA#F/!#@>P5@, M-;52:<\W>;LCY::*+*V8;3\I3V
MANR**1[7/X8P3X+6D;.ZMD[8&PZ+8W#=@=RUCE0$!!!WK3W$&#^=N=?(EAN]
M9EO+67+GFR]TE6^BEAC#::-TS'%KPQQXB[ [-RRBLIE;&^6+6O7)LC8M",J9
M,H:P\$E[O=+&^M,3AZYLN$4A.W$8$K9%^$5EH?R;U&F6=K%G^\YN@KKE8_&'
MQVJCI'"(^,0208=:]P<. 28[&G<L+6XEB&>=-A@2!X) X7_OAV<>E8#M(" @
M(""5_K'[<-AV[D&L6WT>0Z_7_F#=JXZ@FS/#&]F3([R]C8#3-IP(1")2&.>(
MNKX1M^N(&*VYG#%;>GS%DZGY-7Y<N-9239EN%_KSENS1O8:H2"M);*V,8N:-
MN_#;N4Q.64;FSO2..XQ:<9)CNXD^4F6:E%7UHPDXQ&W'C[>Y83!*Y*@(" @P
M<YT'U%XI-*\ANJ'TUGSAFJ*.\D>MD9"PAC'#I <\/P[("SJ;&7.6<I6#)]FH
MK#EJUT]IM5%$R*"EA:&XAK0W%^SPG'#:3O6$S)L8\<U^G^6<RZ29MO5PMT)O
M>7:05MINT<8;4QNC>#P]8/"X7 G9BLJ957G+A?;AF/1/36[727KZ^>SQ13S8
M8<74.=$W8.GA8,5+QM1?50$! 06LU7U6RKI'88\Q9L?4-HZB84M,RECZV1\K
M@7 - (PV-.U6(R,1*GFDONJ_C5GTVT,FSO1QN$4LUV+)J8<6XRQ&-X [I6<5
MQO3>H"JY2=3M4[C%=LU6[*.F,/&7"ALU(6OX#T&.%XC)[K0K-H,,Z-%]+:?1
M[)-+DRGNQO#*>:2=]>Z(0.)F(Q;PAS]W9Q6J57E0$! 0$!!BCSD&\LT4S ;0
MZ9K'2TPN_4<0?XIQ_P 9@6G$8G#$JUG$DL6+U!I!:;_REUVGTEFBHV7]DF8:
M^*2$U+7-DI'.\>>3QM+3Q>NPV;MBVSF88QO76TWO-LS)SCZA7G(]0*S+/DN(
M<P7&C?Q44U6'4@8<6^"3Q-?@<=I#B-Y6$Q,0N&?K?6MV8;!L6"ID! 0=:K=P
M02/P)X03L[0)0:_>6G+-JSUJUK+J+F2CBNU]M=]?1V9]4T2-I8P^1N$8=BW$
M!H#=G@]"SG9!EGS+2"2-\4O#-#*TLDBD'&QS7;P6'81MVA89&OJ&Q6W3'G/M
M5LRC116FT9VLKI[K9Z=C64S7N:2[JHP.%@,D8?@!L).& 6>^!L3B.,;3CCCT
M]E8#D0$!!*_UKNX@PTU*YQ\@9%OUURE16:Y9FS#::CQ2II(6MBA,^S^+;([B
M!.W]ZLXI."9B%I+U-K)KFUSK7R_Y9R_15P:(\QYAIXIJET1WN9*61.V?W+E<
MX1Z&E')17Y/SKE_/=_S;1NKLOW%EQAL]LI7&,O <.K,DCP0!Q;-ZQM.5QAL2
MAPP=M)VXX]'H+$<R @(" @DDPX'8[L.A!K;O5+DFOYM,\Q:Q&E-)#9:4Y"AN
MSVLH<71XEN$F#,>P.EVW>MD3.-B96ZREF')%EY<]>;1>JRAC^5LP7"*P69LD
M;9:B0.9U#J>,DD\#L#Q 8-[(Z4Q,R0STY9H[C%HAIXRZ<8JFVJ,L$F/'U+G.
M,6./]P1AVL%KE5^$! 0$&%7.[=:VGTLH,OTL[X(<W7VDH;A(SWD2MXFGL@X@
MGN*UC(R-T]R-EO(F6K79,LV>GME+!31]8^-H$DKP!B^5V]SCOVE)F11?,+I_
MES.FEV<W7RW05=39K-67"UUQ;C-!-20/E;P2;P'<.!&.!!W)6<"FN3Z]U]]T
M&R3-<9/&*BWFOM[9W;7&&EJY(X02=NQ@ ]!)C:1+*%0$! 06^U&U$RYICERL
MS1F>6:.V4KFAPIVE\CGNP #6@C%6L9D8:U7-S5ZBRUN7]--&*O/8X/#%PX'0
M$$X8O@ZM^ Z3B5GPX3*WMRY7]5=6ZEMQS#EO)FE=(7!T-+;*413"/>6N9 0W
M';AM8-J<4&&9F@.B=)H=E>OR[37LWU]RN)N$U4:=L(C>8V1E@:USL?68X[UA
M,Y5D"H" @(" @L1S(/O;-&]076%SVU@M,H>8QB[J.$]=AV#PX[1M5KO,M?-[
MH=(Z/3'0.MR/\DC,+\PVU^;*MDL;K@V;^+,WC!),C6\0.PX-6W,I"^;[YE[,
MO.QD^KR34072GH,OUD.:KA0.;+3/?U%2&M>Z/82TE@QQ.W#I"PW0-A2P40$!
M!PRGAX3VT&O+3#+]GU*YG=7,SYMI(KO)E*6.CL=%5M$L,/!PL#PP["0&[B.G
M'>MFZ!L#ZALD09@W@W.8<,, ,,,.Q@M72,"=3LL6G3#FCT3S)DZECLLN?GUM
M%F.WTK1'3RM@ZJ,O#&X .D;4G'MM!WK9$YA&P*(81L'8 6"N1 0$$CR TD[@
M@Q,U6YMM/=,+U7Y7DM]RON8K?AUUOIF!D0<X; 978X';T!9129)E9*[YIU@U
MQB<[+W+ME^BI*U@\6S'F6"&H=P^N\&1[&$;!T.66RN]-[RLG\B=T9?:#,N:<
MW6VVR4=;!<!:+32&1C'PRMDX Z1^P$MPV$I-H6&S* 8,..&/$2<-VW:/H+6.
M9 0$! 0<<OVMR#7CJW3Y5K^;+*--JY) ,DLRXYV66U[A'0FK)_\ 7.<6MP+P
M\G$[2&AVS +.LR2I;2O,&G65LO<S,=^K+52Y=J[I-3VZVAT0CJ0ZGX8HZ>,8
MAWA88<(V;UE:)G R2Y,HKC#H)E9MQ9+&'35;Z%DV/$*=TSC'@3O&&Y86WC*E
M8@@(!PPV[NE!BGS@9AKLO:&9D-LE=3SW>:GMLDT9P<(9G%T@W?7-9PGM%94V
MRJX.B6G^6L@:?96MF7[=!3355LI)[M<&- FJZB2)KY)9GG%QQ<20"<!N"EYG
M*/?U-R%EK/N3[U9LRVV"MADI9?%YW,:98'@<37Q/.UIXAT)69)8[<CMYN%=I
MK>[-5U+JBERM>ZFWVOBVN9 #B&D]W$JV1FJL5$! 049G7.EDR%EVY9IS%))#
M:;4TOJ7QLZQV_  -[)Q2-HPOK^<JESM5S9;TVTGN&?:JH80R*LX&L=COXX>"
M0X8=M9\&$RMQ>>7C5W661LUXR)DO2BWOX9(?$Z5L56W#9@_J"S''IXFJ\408
M98<O'+]#H11WVGCS$;_4YBDII*PB 0,B=3"1N#<'NXL>/>0%A,Y5DTH" @("
M @MQJB^[1Y!SD^Q%PN[;75&A=&#QB3JW8<.&W'9LP2!JIDH=*6<KMOKK.ZV2
M:C>4-"[,<L\C'75CS*X.PXSUK8\,,"-F/;"W5RC(C5#,%@S)S,:*4V1:V&Z7
MZTR89FJ[;(V4,I^%V,<SH\1X((QQ.S<L(C8K8KW5@" @(.-[@'#'?ACZ2#7N
MZPV[5+G$S!29P@%VM.0;;$;/:)QQT_6'PN)S#L.+B"000<-JSW0K/V&F9'3Q
MPPQ,;"QO!%&T<+6MW<(&[##9@L,HU\<SF7K7IWJMHQJ3E*FAL^8;U??DR\/I
MHVLBJ& L)?(P8!SW=86DG?L["SK.4;%&'%C"-Q:#M[BP5,@("#CD=PM!QPVH
M,9]8>9[(6CUV%AN]-<;EF%U*VIBM]*S!A9)CP<4CC@"2.PK$3.Y)G#'RXZE:
MIZYTH.5>7:TS6^L8?%,QYFCBJHVD^#B'/C8T'N."SC9O%*V?D1S%>;F+YG#,
MUHRV^66.HGM%EI'/9&\$.(:'R!K0<,-CE9O'0L-G=LI116ZBHP2X4L+(FN/2
M& -&S$X;MRU#O(" @(""23'AV>B@U_\ ,K#8:G7O1FFU,D#-,C#.Z0SO='2^
M.XG#KW@M :3P!V)];CT8K*"5.:<WO3+*&N&OM34UEDMV0/)^FC9$Q\)HYH'M
MBZR.%C3P2\;<?!;CBLYB2%S^1B.X#2:[S3Q5$%HJ<Q5DF7XYR3A3]7$"6DX8
MCB!&SIQ6%X(9K 8# #!8P(H""!W' X'#84%D>8F_5V7-&<_72VS.@KF6N:*"
MI8<',ZX%G$T]D JP*1Y7-/LLY0TKRA<K7;8/EG,5NCN5YNY:#42RU XN#C.U
MK6[ &C9TX;5;3(OAF[*N7\XV2JL>9;53W>VUC7,?!4L#^$N! <PD8M<,=A&U
M8[2&'W)#<*VFH-3<ENJ))K/E+,$D-ECDQ+HXWXEPQ)Z3B=BSL,[E@" @(/!O
M]XM^7+-=;_=9.JMMFI9JVOF#>)PBA87O( PVX#!!A!<.=>S7^O\ )[3;3BZY
MYKJL.9!#+PP-<2,&XQ<+\03L6SAF$SE;B^Z*:QZVXNN.F63-*[;.>-U0VE#*
MYKG'$%W4]6XDX[>)I2+1!ADGRY<M3=#*V]76?,@OMPOM+'3U,;*?J8XS$[BQ
M:_C+G;\/":%C:V3&&6*Q40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&
M/O,;G_).0\C.=J#EFHS5EJ^RBBJ[9 UI!(P>"XN<S @C$$'$$;%8R+#,Y%M)
M,P>)WZUYBS/9+9=(8JJ*SQU%+(V*.9HDZMCY:9[@,#]<7=U7C3#*W3O2_)VE
MEA\G,F6T4%&7"6IE+GRS3S  =9+)(YQ<2.X!T!29RJY<?K&]Q03H" @\V\4#
MKI:KE;6RB W"FEIA,1Q!G6L+.+#$8X8]E!KCD\WW>#--)!K1XLR:5\@B99)0
M&\9QZ+D ?2"V<:)?]WW?]XUQ>#_,LO\ VF5)L+KZ)\HEPTBSW#G6IU';FAT5
M'+2^(.MCJ4GK6D8]:ZLGV#'=PJ38AFM&S@;P]A8JG0$!! C$$=D8(,1=2-$^
M5^JDK;CFBDMF5[G,]TM5<*&X/HJCK)"2^0QQR<)).TES"LHF4PPXO]UR9I4X
MR:/\TM[@,8<ZGR]4T;[C#*_ZUID;U<7:\*(K/>B\'+AS)ZR9]SS9<EYJLU/>
MK'4BI\=S7%0R4DT1C@?+&]SF!L.#G-#<.K&_>I:(B-A$S.]L:@QQ?CL.S$=@
MK6R=A 0$! 00=ZT]Q!@9F7+VBW,IJGG#(5TL-XR]GO)43A6YPHY(X7S14TC(
M0P!W6,>"906ES,<-Q643,&%59%Y)]*,EWB"^UE;=\WU= ]DMMI[K+&*>&1AX
MA)U=/%%QNXMOA$CM*38B&7U,W@/ -C&-X6AOK1A@%!W$! 0$&-7,/R^U.NU-
MEJG@S>S*;\NU,M2VH-":UTG6L#<!A44_!AAOQ*RBV$PQE_W?E^_VX/\ ]"S?
M]IJ\9B4CO-[WI\;H7:W.=$_U\9LDA:>G M-RP.U(OA6=&DVG\NF.0,L9&DNK
M;T<N4Y@^5&PFFZ[%[GX]5QR</KOWQ6-IS(N4H" @(*"S]E+)&<+8RWY\M5!=
M;1$_KF1W AL;'@$<;7$MP(!.XJP,%<_Z1\J>79VU=AU/J],[S3ATE.+/<9*U
MA>-SC%*)G;#T-D:L\RBQ7]8S4O(%P@HLA:R3:O6J$EKZ&ZV:3$@[@YSR^<@=
MELH645B6$S+9=H=G?-.HF0+;F?.%DBR]>:M[V/H8621QEC=C7L9*Y[V\0..U
MQ6F=[9T+W(" @(" @LYK?GK+.GN1KE?<WV.?,%@EX:.OMD#6O,C)\00X.(&'
M03BD1E6*]LY--&]1;5:,\9;NN9LI6G,-+%74MAAJ()64XE:'<,;IX9GM.'9>
M[:MDWF$PRJTNT>R/H]::BTY.H'PFL+)+G<ZJ0RU52]@/"Z5^ ;LQ. :T#M+"
M9%X&^M;W H(H" @X*B+KXGQXX<0(Q[HP3.!KIOG(3=;M?KY>J;6+Y-;>:Z>M
M-+'99#P=<\O#2YMQ9Q<..&. [BV?$CJ3#S/]WY?O]N#_ /0LW_::QXX,2N#I
M1R8W'374"R9ZJ=4&YA-GZP>(.M+X7/$C"W[:ZNFPPQ_>K*=6)A6=D;>%C6]C
MT5K$Z @(..7'JWX' X?NWXH,7M2M&N6^]U5QO.>K;:;5>*MSIJV[0UTE#5F3
M# R.$4S.([/KFG=N646DPPLS"[372][ZK2/FDOMDE8XN%F=3R7*"1^W!A=&(
M6@#^[8]9[]Z2K30CF=UNS/GO+N3[U0TV<K'<*SJ*W,WR=)33QP%KB)@^'JXL
M/!^N85+Q$;BLS+9[!ZUV.&..\+6KG0$! 0$$DGK'(,)-1Z?1W775FKT:S1EJ
MZTN<<MT+Y:/-]*]D#XXG,;-A&\EP<#OP?&1W%E$R81RKR-:2Y?NT%VN5SOF;
M!3O$E/:[E-"VE+QM+I&T\43W88#9Q@'I!3BE,,SZ"GAI(F4U-"RGIJ=C8J>"
M,8-8Q@P:T ;  -BP5WE00$!!C]S :'S:XY:MN7HLT-RN;=7"L%8ZC-:7X##A
MX1/3\.X;BLJWQ),,4?\ =^WX# :X2##=_F:7=N_*785M>)1*[S?5\<US7:WN
M<UP(+399<"#T'_.:5U(@9H:'Z5R:.Y M61I+ZW,+K;/5S_*C*8T@?XU.^;AZ
MDRSX<(?ACQ[<.C<L9MF57A4! 0$%'9QRWE;--IJK5G"VTESLDA#ZFGK@.IQ
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M)W2?0?(&C=/4MRK1SS7"M#16Y@N$@FJYL#ZTEK6,:,=N#6CMXK',RRPOJH"
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M-=;=>[+=ZG6(7%EGK8:QM+)99!Q&)[7\(<;D[AXN'#$#TTXS#8^T<+6M)Q(
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M(M7J1F=HM0:CVS(])2:JUT%QS@V>9U94T\HFC,;GDQ /#68D-W[%A.!=I11
M0$! 0$! 0$! 06[U,R)+J'DZ\Y3COM1E\W<-:;K3,XY8@UV)X1Q,QQW;U8G
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MHCG&JS_I?D_-U>UK;A>;?')<. 8-,["62. Z.(MQP4D774! 0$! 0$! 0$!
M00P^@@B@(" @(" @(""T6M^<:O(.F6<<UT 'RA:Z"0T#B,0V=PX6.(&\ E6-
MHM+RNY"S-8\LUN=\V9GGS%=]1J>ENDL3W\3*5KVES6M<3AM#]O85M*+>9+=F
M[2?F7ATXJ<PRYARGJ335MZI&SGB=2S1Q3S%K&XD@#J<#T8%7? SZ6"B @("
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M0(R]KI9/#=BV>-S>(X@<2EL3MA6=8V@'M+$10$! 0$! 0$! 0$! 0$! 0$!
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MEW.55&V*NK6/AN+6#!IG@<8WN [>&*PF-JKSK&)!4$! 0$! 0$! 0$! 0$!
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M]7=Z6_55GHZB]4<?54=SEA:^:-F..#'D8@=Q3(]]H Q[*"= 0$! 0$! 0$!
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M]=1/O5GI+M\G2]?0"JA9-U4N&'&P/!P.&Q!Z\('  &AK1ZUF&& [&& P0<J
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MR_=+O6W$7.EHQ#621/BX)N/$D,8T] 7/]HQJ5KC?/R-DTQIVF/VVLT>48 Z
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M2M9<'TU ^-CR&N+8)ZALN /]U(S%=TQCE:Q'7ZFK4V\U:T],>MM >YO"?"&
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MU[<4TEN58X%Y .. V]KM+FG=#/I<ZJB @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,T212-(]:YC@00>D$*36-V-C*)E2%FTSR%EVL;<LO9#R[8+E@6FNMMMI:6?
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M&WL)T0=+G5! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+4204%7'4/CC,M"!B0PAH) Q17T3C8 .PB(H" @(" @(" @(" @(""1[2YN
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J$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tm2227887d4-bc_frequen4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-bc_frequen4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@$1P@T P$1  (1 0,1 ?_$ .4
M 0$  P$  P$!           !!P@)!@(%"@,$ 0$!  (# 0$
M 0(' P4&! @0  $" P,%!@L0#P0(! 8" P ! @,$!1$&!R$Q01((47'1$Q8V
M88&1DK*3LQ05576AL2(R4G)3<U1TE+16=C<)\,%"@L+2(S/3-)475Q@XX6+#
M-4-C@R34)289\45&)Z)$9(1E1Z.%*)9F$0$  0(" PH,!@$$ P " P   1$"
M,0,2! 4A05%QL<$R<C,'@9'14I(34Q0T%34&88*R<U06(J%"8A?PX2/Q),+B
M1/_:  P# 0 "$0,1 #\ [^
M
M
M
M
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M;R_57@)0.5EW/&\#JKP%H'*R[GC>!U5X!0.5EW/&\#JKP"@<K+N>-X'57@%
MY67<\;P.JO *"<K+N>-X'57@)07E9=SQO ZJ\ H'*R[GC>!U5X"T#E7=SQO
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M#E9=SQO ZJ\ H'*R[GC>!U5X"4#E9=SQO ZJ\!:!RLNYXW@=5> 4#E9=SQO
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MO *#_?(5>FU-8C9"<9-+"1%B:EN1%S9T(/L@
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MR7ZP5$6BT?Q9+=#T/]HJB^!*/XLED^\%53P+1U_\LE][4_M%0\"TCQ9+]#T
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MGGF*G10!T,W0 9]]>H W<F<!GM1 )]G1"+G5+<J!2Q.IH ?9T0+DTY@)Y^@
MEENXH"VU,N8(:+<J+NA2SJ 3[/\ Q"*%.C: S](!NZ=Q0%J[W0 H$T?:  /L
MM 9TR;@!<B9-(#/EMT6@-&[: MW% =("+ETV;J%K P#C?M"7<P+==YE>N_4Z
MXMXUC)++3EA)Q7$I:[7XQ4SVZ"VVU8L!N^L+PU151;C7A1R9T6++)^&<GJ9-
M*'L+H[<N#=Y9J%*U6'4;H<=$2&DQ/ZD5B*N1+5@:]B=$EV50JV_D9^1JLG+5
M.ESL*HTZ=AI%DYZ7>CX45BID<US55-\XIW&3^4Y6*/37LAU&LR%.BQ4]!"FI
MF%!>J;J->YJJF\2-V!_O:]CV,>QS7L>B.8]JHJ*BZ45,Z%1\K?-"EFG< ^+W
MPV-<^(]&0H;7/BQ%6QK6-2USEWDRJ)&G2[:V'D6_T"X5/NU6:H^:J[:/+5Z7
M? [UB/>_42*U-;6U+>@9SES#&K<A6JU;%RYLNCH^>8RJ9<J]0@OGA4\VS-:
MRV=$ JY$^Q0%N[U0&;H=  N3);TP%OF9P&CH;@'QMR]"TB/EOKT"J?9: 3S-
MT!FL BVV9,P02U<O4 MF@*9DLZ(#(!;=S,@#,F33F0";B:$ EB;@1?L5 ID2
MQ/- 9= %M0"*JIES@-X!]H!U% -],W?3)OJ$>;NOSBO5[:TLJ]\0
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M!338 \T!]FX S /LZ(#_ , +N6@2S0 T]!,X#H)F 9L@!0&=>CH MH$R)OH
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MHZ %EMJV[W]@!/3-MZ%G5(/-W7YQ7J]N:92/?$
M          \!.9+]RJ__ $#O.<6!Z7[9$/MA3[,X"W<7>4!;PH \Y0)YJVA%
MWK<@4R9510+;D^V!\?-L"+]BA2WJ;H#2O1T@-[(@"WS %F?S@&=%7.B 3[+
MB]%4Z05=RS)T (F_TP&_FS@-W=4!N $5;='3 =,!I5;,FE A;N!3+EL\P!F
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M+F3HZ5 GF .AEWP&G? :?M@$\S0 3/D4 GIFINJGGD'F[L<X[U>W-,I'OB
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M+IR90"+Z)GKD\\@\W=CG%>KVUIE(]\0
M  #P$[DOU*^\'?A%@>E3)E3(07HK9O@1,W]@#<1=.0!O9=P"]#-;D F;)U0%
MO5T 3)N6A#)GZJ 7[+ HF[9DT 70OF ?'=W,H14Z 4S9-P EFG-: ML3= J@
M3)]F8!EZ00^V%,@!0'G@70O1W (N33U0":+0*F]8!,B]!,P#?T@.BEEH!415
MZ 0R9L]@5=P")NYDT[@0Z>3[04LR)EW@&3H(GFA$S_: O1W<X4LS^< L1+-'
M1"(MJV[NX 2W*05?["J;N4!TDMT=("Z>@!,UNZ@%2SHY )N -S)T@%F4!;:M
MFX R=("Y^C98!+>CE 9TL7I@%S ,F3,BA!/,W IYX#IY-P!HWUR(!<@$Z-H%
M F[O $3HY=T"HEB?9]L"Z=Q )D =,"9DZ($Z.?=0(=/*F0BO)RO/>=W.\$[$
MRNP@AZW)D6W01#)_;8%,^C3E =+/N@7S+-" 3-G3@ 6Y,X#[+ &0!HWLEJ 5
M; /CYP1\L^[D"I]O1O@%S 4"*FYU0%OF@.CGMSJ@"S0F0!;U% >?H0!DMSY0
M&2W+YH#1FR[P!--BV %Z5H#1DL =!=(#S0&5>@ 10&_DW0)N9+0&3<"+YH4W
MTSY@*N;*!\4L3S BHEJ;X4Z%G2"&32B9@IDR9+;0"@,FG2 M72G1 =   W@%
MJ9P*J=7H 1=\!DWP&A<F^ Z/V* \\!F7)F 6(J]#0H05=S0%55MMWMX"9+-Q
M-Q0%BV>8N^!5R(EJ[X$R)GR6;@$TA%R=4*69M\!I0"+ERD0;;847="G3T@.I
M;GR 73F FBSI 6VU%S@32F^!Y.F<[KP)G_(L^T92CUEF53%1%MSYD ?9:!>C
MT<X$MZ.4!GLZ !<R>8 R6^>!;>CO 1-'F@$W<]F@!ZG*!<B<($Z.?= H$T+T
M %G1R@5$LL >< 4":%RV@%\_. S+NH 3)HLRA$S69LVD"V69<VD*;GV@%N\
MM5<^6Q<J= ()DRIG ?\ B@4R ,BKO@,F^H#)D3S &5>@ \[< 9%Z(1,EBHF1
M%7,%7,!+-*=) B]5-(45$SY%Z(!5MRVV[J@.EO +0&;)GT9 +;N9MP">8 ZB
M .J Z'5M 6@/M($5<ND*F?I $W,R $R:4 =%0*OV(!-'0 O3R 3)I5$Z(#<M
M7, W\NA.@ _\0(MF1 BY JKT@)T\J 32BZ<X155=X*=0!T4L4!]BH!.GU CY
M)9K-L7+;]L1BKS5U^<5ZO;FVF5P]\8@
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M '><I[E@]8W@ =YRGN6#UC> !WG)^Y(/:V\ #O.3]R0>UMX '><I[E@]8W@
M=YR?N2#VMO  [RD_<D'M;> 5#O*3]R0>UMX '><G[E@]8W@ =YR?N2#VMO
M[SD_<L'K&\ #O.3]RP>L;P .\I/W)![6W@%0[RD_<D'M;> !WE)^Y(/:V\ J
M'><I[E@]8W@ =YR?N6#VMO  [SE/<L'K&\ #O*3]R0>UMX!4.\I/W)![6W@
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MCO.3]RP>L;P$#O*3]R0>UMX '>4G[D@]K;P"H=YRGN6#UC> !WG*>Y8/6-X
M'><G[D@]K;P .\I/W)![6W@%0[RD_<D'M;> !WG)^Y8/6-X '><G[E@]8W@
M=YR?N2#VMO  [SE/<L'K&\ #O*3]R0>UMX '><G[E@]8W@ =YRGN6#UC> !W
MG)^Y8/6-X '><G[D@]K;P .\I/W)![6W@%0[RD_<D'M;> !WG)^Y(/:V\ #O
M.4]RP>L;P .\I/W)![6W@%0[SD_<D'M;> !WG)^Y(/:V\ #O*3]R0>UMX!4.
M\Y/W)![6W@ =YR?N2#VMO  [RD_<D'M;> 5#O*3]R0>UMX!4.\Y/W+!ZQO
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M0NH*CRU*@09:]]1A0(:0H;8*:K&YD$R/>D
M      QQ5.?M,][L[)3.,$9',%
M                                                      !CN?Y\
MR'K&]B6!D0@
M                                       #'"*J7\5$]3^ 941D<Q4
M
M                           'AY#GE4_:$ ]P
M            ,;U/G]3/>[.R4SC!-]D@P4
M
M  &.I_GU(>L;V)8&12
M                                               ,<)S[7UOX)EO)
M+(YBH
M                                 /#R//*I>T(6,![@@
M                    &-ZGS]I?O=G9*9;R,D&*@
M
M         QU/\^9#H,;V)81D4B@
M                                                       QNG/Q
M=Y>Q,MYBR08L@
M                                         >'D>>52]H0N\/<$
M                            QO4^?M,][L[)3+>3?9(,5
M
M                 !CJ?Y\R/K6]B6"612
M
M   ,;HEE_%];^ 9;R2R08J
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MFJ?.P\K(L&*U',>F;.BG'2BOL@ &-ZIS]I?O=G9*9Q@F^R08*
M
M                 #'4_P ^9#UC.Q+"2R*10
M
M     8X3GX[H-3L#))9',5
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M5\-\=Q_'SG>G'6ZW>O&KQ-ENC5S&-^+*,&U!BH!C>J<_:7[W9V2F48(R08J
M
M                           #'50Y]2'K&><6"612
M
M             ,;IS[7UOX)EO(R08J
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MWQILXV4CR:)#:Q(,PW5?D5<MA9MF(1EXXU
M
M  !CN?R7YD.BQG8EA)9$(H
M                                                  ,<)S[=ZW\
MRWF+(YBR                                              !YV]W-
M2\WDF=[@\MN*78/Q\)G=Z]_9*;&MP>#UCI>"%,G"N8H  (   4"  *0  $*
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MY<J6&&9BRMP;J&*I8N3*21CBI\_J8NY+L[)3/>&2#$
M
M          !CNH<^:?ZQOG%A&1"*
M                                                        #&Z<
M^U3^[;_\!EO(R08J
M  #SM[N:EYO),[W!Y;<4NP?CX;G=Z]_9*;&MP>#S^EX(Y'R,G"A0 I! J^8$
M !0((44@A12  *(  H   (!0((44@ 0HJ9P.Y?U4'T9XJ_.F7^*-/);?[6.+
MGEZK8_0GP<CJVFC>.AMP=S*E    \1(<\JI[0TN\/;D
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MI%*@LEJ=(0$LAPH3$L:UJ9^J83NJ^T  8WJG/VE^]V=DIG& R08
M
M                    ,=3_ #YD$_NL[$L$LBD
M
M        8X_]=V_W?P3+>1D<Q4
M            'G;W<U+S>29WN#RVXI=@_'PW._U[^R4V-;@\'K'2\$<CY&3A
M0HH$  ""@ (4" 44" 4@A10  @A10! *(!0!!"BD!,Z;Y1W+^J@^C/%7YTR_
MQ1IY+;_:QQ<\O5['Z$^#D=6TT;QT-N#N)4H   'B)'GE4NC 0N\/;D
M                          QQ4^?M+][L[)3+>1D<Q4
M
M              &.I_GS(>L;V)81D4B@
M
MQPG/M?6_@&6\DLCF*@
M    \[>_FI>;R3._%WEC%+L'X^4^[]>_LE-C6X/!ZQTO!'(&3A"B@ ! *(10
M(  *40@!5"!1 *0"@!"*%12"%     7< [E_50?1GBI\Z8'Q1IY';W;1Q<\O
M5['Z$^#D=6TT;QT5N#N)4H   'AY'GE4_:$*/<$
M           QQ4^?M,][L[)3+>3?9',5
M
M!CJ?Y\R'K&=B6"612
M                                              ,;IS[7>_ ,MY)9
M(,5                                              !YV]_-2\WDF
M=^+O+;BEV#\?"9W^O?V2FQK,'@]8Z7@CD4R<(!2@! ! **10( 0HH @% @A0
M(M (% BJ$0HH @GV6E "D#2@'<OZJ#Z,\5?G3 ^)M/);?[6WBYY>KV/T)\'(
MZMIF0Z*W!W"E    \/(\\JE[0A1[@@
M &-ZGS]IGO=G9*9Q@F^R08*
M                                                   #'50Y]2"_
MW&]B6!D4@
M                                     #'"+_UVOK?P#+>1D<Q4
M                                          'G+W<U;S]"DSOQ=YE&
M+&[!^/EOW?KW]DIL6S!X36.EX(Y'R,G$A44@%$ I   0HH$ H " 4@  !1"
M4 * ((44@ 0HNYO@=ROJH/HSQ5^=,O\ %&GDMO\ :QQ<\O5['Z$^#D=7$T;Q
MT-N#N)4H   'AY#GE4_:&EWA[@@                               &.
M*GS]IOO=G9*9;R;[(YBH
M                                                ,=5#GS(>M;V)
M82612*
M                                  #'"<^_O?P3+>261S%0
M                                      >=O=S4O/Y)G?B[RVXI=@_'
MPW.[U[^R4V-;T7@]8Z7BY'R,G"%$(H5% $$**0 (44@ 0HI  A0 H$(JA "%
M "D   *&E-\#N7]5!]&>*GSIE_BC3R6W^UCBYY>KV/T)\'(ZMIHWCH;<'<2I
M0   /#R'/*I^T-*/<$                                QO5.?M+]H9
MV2F<8)OLD&"@
M                                        QU4.?,AZUG8EA)9%(H
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MT)\'(ZMIHWCH;<'<2I0   /#R//*I>T(4>X(
M       !C>J<_:9[W9V2F6\F^R08J
M                                                         #'4
M_P ^9#UC>Q+!+(I
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M-WE;.U?4[]7C(LBVL75I$1O_ (-RS8#60    ,<9[^?>_@F6\C(YBH
M                                        /.WNYJ7F\DSO<'EMQ2[!
M^/AOW?KW]DIL:W!X/6.EX(Y'R,G"A12 %0J*0  5"HH @A10(!0!!"BD$*
M@H   *(!0"9T [E_50?1GBK\Z9?XHT\EM_M8XN>7J]C]"?!R.K::-XZ&W!W$
MJ4   #P\CSRJ7M"%'N"                                8WJ?/VE^]
MV=DIG&";[)!@H
M                                         ,=5#GU3_6-[$L#(I
M                                            &L&UQ]$KO+,CY[CQ
MOWU]._/')<V!W:?5X_;NYG-A<Z:<AI+>\+?\8(&0
M          :'%G!)Q;S[&?ZO?[WS)=S>;6[N^SSN..=IGO6[75^K=RPW@-D-
M2@    QNG/S[W\$RWD9(,5
M        !YV]W-2\WDF=[@\MN*78/Q\-SN]>_LE-C6X/!ZQTO%R*9.%2B$%"
MH5%( $ H H@%  " ! !12   @50@4 (  MI TH!W+^J@^C/%7YTR_P 4:>2V
M]VL<7/+U>Q^A/@Y'5M-&\=%;@[B5*   !X>0YY5/H0$ ]P
M                  ,;U/G]2_>[.R4SC!-]D@P4
M
M        &.I_GS(>M;V)8)9%(
M            U@VN/HE7RS(^>\\;]]?3OSQR7-@=VGU>/V[N9S87.F\:2WO"
M_0$8(%                         !2B$   W2S@DXPWGV-/U>_P![YDNY
MO-K=W?9YW''.TSWK=KJ_5NY6\!LAJ4    &.$Y^+T&_@&6\DLCF*@
M                                       \[>[FI>;R3.]P>6W%+L'X
M^&YW^O?V2FQK<'@]8Z7BY'R,G"A12" "BD HA * % $   *!  %$  4" 4@A
M10   FC? [E_50?1GBI\Z9?XHT\CM[MHXN>7J]C]"?!R.K::-XZ*W!W$J4
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M?9(,%
M                                 !CJH<^9#UC/.+",BD4
M                                     &L&UQ]$KO+,AV3CQOWU]._/
M')<V!W:?5X_;NYG-C2F\:2C">-^@(0*
M )I4LX).,-Z-C3]7O][YDNYO-K=W?9YW''.TSWK=KJ_5NY6\!LAJ4    &-T
MY^+ZW\ RWD9(,5
M!YV]W-2\WDF=[@\MN*78/Q\-^Z]>_LE-C68/!ZQTO%R/D9.$ A0(JA$**00"
ME @%$ I  A12"% @ 4 4 (  I  @54SH5'<OZJ#Z,L5?G3 ^)M/);?[:WBYY
M>KV/T+O!R.K2?:.AMP=Q+Y%    \/(\\JG[0EA=X>X(
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M8?1O..8W7Z&;N<WZ'[PE^YM/FG%RONB !C>J<_:9[W9V2F>\;[)!@
M
M                      QU4.?,AZQGG%A)9%(H
M                          -8-KCZ)7>69'SW'C?OKZ=^>.2YL#NT^KQ^
MW=S.;&YO&DM[PM_Q@@9                              !N[EN4LX).+
M>?8T_5[_ 'OF2[F\VMW=]GG<<<[3/>MVNK]6[EAO ;(:E    !CA.??WOX)E
MO)+(YBH                                              /.WNYJ7
MF\DSO<'EMQ2[!^/AN=_KW]DIL:W!X/6.EXN1\C)PH44" 4 ! *00 %4(% @
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M14T+E+HR/#3<U*SE^*9&E)B',PN(8W7AN1R6ZRY+4,J309/,
M
M                 &.JASYD/6,\XL)+(I%
M                     !K!M<?1*[RS(^>X\;]]?3OSQR7-@=VGU>/V[N9S
M8TIO&DM[PM_VX(&0                              NAPG!)Q;S;&?ZM
M?[WS)=SB&U^[OL\[CCG:9[UNUU?JW<K> V0U*    #'"<^_O?P3+>261S%0
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M1I-]:=*TZ69*RRPFQ%A,MLUE5;5RJ)NNF!E8XX H
M
M       &.I_GU(>L;V)8)9%(
M           U@VN/HE=Y9D?/<>-^^OIWYXY+FP.[3ZO'[=W,YL:>ED-);WA?
MH",$"@                  "0$          )]TA9P2<6\^QIEEK_>^9'N<
M0VMW=]GG<<<[3/>MVNK]6[EAO ;(:E    !CAO/MWK?P3+>1D<Q4
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M'VA  QO4^?U+][L[)3.,$WV2#!0
M                                                       8ZG^?
M,AZUO8E@ED4@                                              #6
M#:X^B5WEF1\]YXW[Z^G?GCDN; [M/J\?MW<SFQI3>-);T\;?\8(&0
M                       :'=(LX).+>?8T_5K^^^)+N<0VMW=]GG<<<[3/
M>MVNK]6[E;P&R&I0    8W3GXOK?P#+>262#%0
M                        >=O=S4O-Y)G>X/+;BEV#\?"?=>O?V2FQK,'@
M]8Z7@YE,G"%%(H$ !0()H**00H 4@A0      !2  *(    *0-*%'<OZJ#Z,
M\5?G3 ^*-/([>[6WBYY>KV/T)\'(ZMIHWCHK<'<2I0   /#R//.I>T(4>X(
M    _F_5R(JK;;F),T*5:(XQ;:E-N=>::N+AI=5V(EY9&,LO/S2.B))PYAF1
M\&$R Q\6,K%R.5MC4LSJ99>5.;&E&'"9DQESHSC3!_JV;]HG$K%K$:]-R[]W
M8IMVUH%*[_6GP8,>#,P(_'0F(R*D9[ELU7VY4MS'+ZJWU6G;NQ,T<<YDVYDY
M<XQ#(T7:,DJ;CU'P4O1=N;NW"GX4!+HWIFG)Q51F(C55$1J6HD.(MK(;D6W6
M16N1JKDXLFV;XNGS>1GF3ZN;:;L3&[/!/ V=1^JB(J+D;:IC7>7%_4H
M              !CBJ<_*9[W9V2F<8)OLCF"@
M
M     QU4.?,AZQGG%A)9%(H
M         -8-KCZ)5\LR'GN/&_?7T[\\<ES8'=I]7C]N[F<V-S>-);T\;?\
M;@@9                       *!  % @  FE2S@DXPWHV-/U>_WOB2[G$-
MK=W?9YW''.TSWK=KJ_5NY6\!LAJ4    &.$RW[=ZU.P,D9',5
M                                   !YR]W-6\_DF=^+O,HQ8W8/Q\M
M^[]>_LE-BVX/":QTO!S*9N%2"%  !0!  %$ I   0HI     $**0 (4  %((
M473TP.Y?U4'T9XJ_.F7^*-/([?[:.+GEZO8_0GP<CJVFC>.BMP=Q*E    \/
M(\\JE[0A1[@@    #S-[8\]+7<O),TQ'>$9:DSL6GHWTRQV0'NAZO1UD2PX,
M^FA=Q2SR^E#1CZOJD7;?<2]EYT@P9F^TQ7XLI69UZ-?,P99L-CX$-'+:YK7J
MY[EL7T2Y\Q]^=N69<6X:-9ZSYLO2FZZ;L:_Z+@@JKMG;0UJV*LE$Z7Y63RYS
M')NF=4BOG3SF;%-:GJQR0^IV[(LDV\N L.G*U;Y,KCHDHD)/]X27=,2R-5;,
MJ-6(BZO1ML,=2W=:MB>CHS5R:S\/=._6*.CJ*ZUJ+8MJ>B7HG#./A9Q@_J9(
M                   !CBII_P!>TOVAG9*9;R,CF*@
M
M           QU/\ /F0]8WL2P2R*0
M               !K!M<?1*[RS(^>X\;]]?3OSQR7-@=VGU>/V[N9S8TIO&D
MM[POT!;@@4               "H              >JZ19P2<6\^QG^K7^]\
MR7<XAM;N[[/.XXYVF>];M=7ZMW+#> V0U*    #'"9+]N3^[;_\  9;S%D<Q
M9                                               \[>[FI>;R3.]
MP>6W%+L'X^$^[]>_LE-C68/!ZQTO_.!\C)Q!4"   A0(JA$**0 !0(   !
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M)3.,$9',%
M                                     !CJ?Y\R'18WL2PDLBD4
M                                          &L.UQ]$KO+,CV3CQOW
MU]._/')<V!W:?5X_;NYG-?2F\:2WIXV_[<$#(               "@
M        >J+."3C#>?8S_5K_ 'OF1[G$-K=W?9YW''.TSWK=KJ_5NY8;P&R&
MI0    8X3GVOK?P3+>1D<Q4
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MIG&";[(Y@H
M                                      ,=5#GS(>M9V)81D4B@
M                                          U@VN/HE7RS(^>X\;]]
M?3OSQR7-@=VGU>/V[N9S87.F\:1C#PM_VX(5D
M       )I4LX).,-Z=C3]6O][YDNYQ#:W=WV>=QQSM,]ZW:ZOU;N5N^;(:E
M   !C=.?B^M_ ,MY)9(,5
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M2F<8)OLCF"@
M                                       QU/\ /F0]:SL2PDLBD4
M                                            &L.UQ]$J^6I#SWGC
M?OKZ=^>.2YL#NT^KQ^W=S.:^E-XTEO>%^@(P0*              $4*@
M       H$ 'JBS@DXMY]C/\ 5K_>^9'N<0VMW=]GG<<<[3/>MVNK]6[EAO ;
M(:E    !C=O/MWK?P3+>262#%0
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M2W55$WT,*[K)_0H                   !C>J<_:7[0SLE,XP3?9(,%
M
M                        !CN?Y\R'K&=B6$ED0B@
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M
M                            8ZG[>7,AZQG8EA)9%(H
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M5.?U,][L[)3.,$WV2#!0
M                                                8[G^?,AZQO8J
M6$ED0B@                                              UAVN/HE
M=Y9D//>>-^^OIWYXY+FP.[3ZO'[=W,YKZ4WC26]X6_XP0,@ )4"
M                  /5=(LX).+>?8T_5K_>^)+N<0VMW=]GG<<<[37>MVNK
M]6[E;P&R&I     8X1/^NU];^"9;R2R.8J
M                    #SE[N:MY_),[\7>90QNP?CY;G?Z]_9*;%LP>$UCI
M>".1\C)P@$* %(!0((4 * (  "!5"(4 *0  $*     $ *J9T*CN7]5!]&>*
MOSI@?%&GD=O=K'%SR]7L?H3X.1U:31O'16X.X?(H   'B)'GE4_:&EWA[<@
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MV>_4JA+3GM$5D3L54%7^X   QQ4^?M,][L[)3/>1D<P4
M
M            &.I_GU(>M;V)8)9%(
M                U@VN/HE7RS(^>\\;]]?3OSQR7-@=VGU>/V[N9S87.F\:
M2WIXWZ MP0*                              "9G)O%G!)Q;S[&?ZO?[
MWS)=SB&UN[OL\[CCG:9[UNUU?JW<L-X#9#4H    ,<?^N_O?P3)&1S%0
M                                          >=O=S4O-Y)G>X/+;BE
MV#\?"9W>O?V2FQK<'@]8Z7BY'R,G"% @A0 $%*!!  50B%%(   !"@!?LL(
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MI&1J:$UDR'%,4E898(H!C>J<_:9[W9V2F6\;[)!B
M
M         QU/\^9#UK>Q+!+(I
M            &L&UQ]$J^69#SWGC?OKZ=^>.2YL#NT^KQ^W=S.;"YTWC26]/
M&W_;@@9                               B>F6TLX).,-Y]C3]6O][YD
M>YQ#:W=WV>=QQSM,]ZW:ZOU;N5O ;(:E    !CC_ ->?>_@F2,CF*@
M                                        \[>[FI>;R3.]P>6W%+L'
MX^&YW>O?V2FQK<'@]8Z7B?(R<*%%   (!0(0"@!2"%% @    I * $ I   0
M"@ "9T*.Y7U4'T9XJ_.F7^*-/);?[6WBYY>KV/T)\'(ZN)HWCH;<'<2I0
M/#R'/*I^T(7>'N"     /YN9:MJ+E7[,AC=65AA'%K&?"G"RG=Y8BU:7BNJ<
M)5A77; 2>FYN%K66K*6*FIDSOL:MBV6J@I-TUC!-RV-UIY VM]E'PGJOP69
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MU576;ZH+\4M;PF#)+0,<5-?^O:7DLMEV=DIG& R08
M
M          ,=3_/F0]8SL2PDLBD4
M              &L&UQ]$KO+,AY[SQOWU]._/')<V!W:?5X_;NYG-C2F\:2W
MIXWZ C! H                              >JZ19P2<6\^QI^KW^]\R7
M<XAM;N[[/.XXYVF>];M=7ZMW+#> V0U*    #'&>_B]!J=@9;R;[(YBH
M                                          /.WOYJ7F\DSO<'EC%+
ML'X^&YW>O?V2FQK>B\'G]+Q/D9.$  0*H1"B@" 40 !2   A12 !"BD5"H
M* (   4$T$'<KZJ#Z,\5?G3+_%&GDMO=K'%SR]7L?H3X.1U<31O'16X.XE2@
M   >(D.>53]H0N\/;D     ?45RIPJ+2*O6H[=:!1Y./.16VYVP(3HCDZ:-.
M.^^+;9NX&5ENE=$.8&S7@]2MHJK7NQOQ@?$O.VH5F+*TRA/BN;+Q7PD1SEC(
MU4=Q4)KFLAPT5&V)E/JBR<C)MMG&[=<,W1FYMW!;N-^9G K!F/2_!$7"^[+I
M)6ZO%I3H#'V666<:UJ1,W]XX9NG><E(:!XL8?RFRCC)ACB)AK'F)*Z=[*BM.
MK5V71G1&,A*^&V8@(]ZJYT)\.):Q'*JL<W)H.75+IS<[U,_[HF8\#CUFVF7Z
MR-Z8_P!75'C$:FKT,G130<$;M8<G _T&0         /Y1GMAPGQ(D1(4.&BN
MB17*B-:U$M555<B(B:0.4NT=C?>'':\\+ [""'-3E+6=XBKS<NJM2HQ8;M5S
M'V?_ "[%RK;D=8BG+;&BXYFK=?9WP&HV"%TFR2,AS=[*NUD2\U::B:SWIE2
MQUEO%L7,87W5EE;%'U6V(U7;/-_]5JN1D&7<]42W53CV9;!9B7X,0_5]1&+A
ME>&$CVK$95W*^&BY4147*IEF)8R3ML1H</9\O7"<[5B3$>4;!;NJD5'+YB$R
M\64O&[ T&*S!N<C.8J0XU7C\4]<SM55MZEHS,4M;PQ$>L.(D-R,B*U4AO5+4
M1RID54TY3!D\"^ZUXXCWO=?&:17N5RM:VQJ6Z$2W(AGI1P#Z*#3YVG7PIDM.
MU&)5(RPVN;-14L5&VKZ'I%F8H,O'&
M                                                          QU
M/\^9'UK.Q+!+(I
M &L&UQ]$J^69#SWGC?OKZ=^>.2YL#NS^KQ^W=S.;&FVW(J&DM[PM_P 8(&0
M                             >J+."3C#>C8T_5K_>^9+N<0VMW=]GG<
M<<[3/>MVNK]6[EAN^;(:E    !CAO/MWK?P#+>261S%0
M                              >=O=S4O-Y)G>X/+;BEV#\?*9W>O?V2
MFQK,'@]8Z7@A3)PH44B@0*!!"BD "%% @    $ *I40BJ5  0 (44 00HJ:
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M^TSWNSLE,XP-]D@P
M    /AKIT0&NFXH*&NFXH*&NG1!NFNFXH#73<4%#73<4%#70%#C$Z(#73<4!
MKIN* UTW% :Z;B@-=.B#=-=-Q0&NFXH*&NFXH#73<4!KIN* UTW% :Z;B@H:
MZ;B@H:Z;B@H:Z;B@-=-Q04-=-Q04-=-Q0&NFXH#73<6S= _FNHJI:W3;E)$U
M*<+^OW2*B)99D72!\B@   8ZJ'/F0]8SSBPDLBD4
M                          &L.UQ]$KO+,CY[SQOWU]._/')<V!W:?5X_
M;NYG-=<Z;QI*,)XWZ A H                              :'=(LX).+
M>?8T_5K_ 'OF1[G$-K=W?9YW''.TSWK=KJ_5NY6\!LAJ4    &./_7BV>I3L
M#+>1D<Q4                                              'G;W<U
M+S>29WN#RVXI=@_'PGW7KW]DIL:W!X/6.EXN13)Q 10!1 !  % "@0 !2 !
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M&W?U$0M4H^W0BJ  QQ4^?M+]H9V2F<8)OLCF"@
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MA_6M4_$_[5VQ_P /1GRG\W&.7C^0^ 0B?UK5/Q/^U=L?\/1GRG\W..7C^0^
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M6IVVS9OS+8_=Y]VZ[MS,SK=8T?\ "(G<BF,S^/X-W$ULEJI99EWSS+:;Y
M #'-0Y]2'K6=B6!D8@
M    #6':X^B5WEF1\]YXW[Z^G?GCDN; [M/J\?MW<SFOI3>-);T\;?\ ;@@9
M                              !ZKI%G!)Q;S[&GZM?[WQ)=SB&UN[OL
M\[CCG:9[UNUU?JW<K> V0U*    #'"<^W;WX!EO)+(YBH
M                               /.WNYJ7F\DSO<'EMQ2[!^/AN=_KW]
MDIL:W!X/6.EXN13)Q*$0"@0HN<@  (44 0"B$%   (44 ! *0   "%%( !,Z
M%'<OZJ#Z,\5?G3+_ !1IY';_ &L<7/+U>Q^A/@Y'5M-&\=%;@[B5*   !X>1
MYY5/VAI=X>X(     _R18+9F',0(K?R49%AOL6Q5:YMBV+TS"^V+XHMMTQ-7
M*VI4_$G8?OS$K5%29OC@;>B=MG95Z_FGQ%UM2)H@S+$MU(EFK%1+%RY$^K)N
MMS:9=^Y3"6&9;,5S+<9QADK%;;9ITQ)4^Z^ LE-7KOA>:%"2!47RD1W>4682
MQ($*65-:/--5;%3TC5LM5V8X/5W7W:$;D</D_P#;.VZW?Q_\Q?WP-V2:EX<@
M8J8]S\:\M^XLRVHR= C1UCMEHZ>CAQ9V,B_E8C5L5(;?R;;$]-F3Z)S+<JW1
ML\,^1P1I7S_EX/\ VZ$-]$Q+=*'RQNS5S/Z&0                   !C>I
M\_:7[0SLE,XP3?9(,%
M   "*!$],[>0#@??OGU?3R[4/C#S;VH_#Y?5MY(?C#;OU#6/W;_U2\MI0^IU
M*D  !// H$ %%(  " 4   @ HI!   "@0H$%  0"@;V["7.G$+R7)=V>>0^[
MNAE\<MU]S7;:SU;.6YTM/#M]     QU/\^9#UK.Q+!+(I
M                                &L&UQ]$KO+,CY[CQOWU]._/')<V!
MW:?5X_;NYG-A<Z;QI+>GC?H",$"@                             !H=
MTBS@DXPWGV-/U:_OOF1[F\VMW=]GG<<<[3/>MVNK]6[E;P&R&I0    8X3)?
MM>BW\$RWDED<Q4
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M*5D8LYQTVO%,F(K8;GJBP41=5%MRF%N5$UW5G,ETL;D;O6H<$N5\@
M             8WJ?/VF>]V=DIGO)OLD&"@
M                   !% B>F=O(!P/OWS[OIY=J'QAYM[4?A\OJV\D/QAMW
MZAK'[M_ZI>6TH?4ZE2 ! *! *!   HI!"@0 *! +O@0"@0  *!!0(44@ 0#>
MW82YU8A>2Y+NSSR'W=T,OCGD;L[FNVUGJV<MSI<>';Y    !CJ?Y\R/K6=B6
M"612                                               -8-KCZ)7>
M69#SW'C?OKZ=^>.2YL#NT^KQ^W=S.;&E-XTEO3QM_P!N"!D
M                 'JND6<$G&&\^QI^K7^]\R/<XAM;N[[/.XXYVF>];M=7
MZMW*W@-D-2@    QNWGXOK?P3+>1D@Q4
M                  'G;W<U+S>29WN#RVXI=@_'PF=WKW]DIL:W!X/6.EX.
M9\C)P@ HA%4( 0H$4*@15" $*  "D$"J"4*B@ (  I  F^44@)H*.Y?U4'T9
MXJ_.F!\4:>1V_P!K'%SR]7L?H3X.1U;31O'16X.XE2@   >'D>>53]H0H]P0
M   DB*B.2Q4M1<Z*)'^6,Z7EX<:-$AMU(+'/B6-15U6MUE\Q!4HU#=MQ[/".
M<Q:E6+6N5KO^33-EK5L7[GH&46S.!,Q&+X_SR;/*V?\ ,JQES)X&F?Q2^JNG
M>8Z=L/\ ;3-M+ 2M56F4B0J-66>J\U!DI%(E(F&-6-'>C&(YRMR):J6KH+;E
M7732,4NS+;8W9;<HJ-;8N2PXZ[K-\R@                   &-ZHME_:7[
MW9V2F<8)OLD&"@                                            !%
M B>F=O(!P/OWSZOKY=J%GPAYM[4?A\OJV\D/QAMWZAK'[M_ZY>6W#ZG4J00"
M@  $ N<"   % A0(*!"BD$   *!   H "   WNV$N=.(/DN2[L\\C]W=#+XY
M;K[FNVUGJV<MSI:>&;Z    !CJ?Y\R'K6=B6"612
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M7T\NU#XP\V]J/P^7U;>2'XPV[]0UC]V_]4O+:4/J=2I!-(% @     4
M(44@ 0 4 !  %  0 *! -[=A+G3B%Y+DN[//(?=W0R^.6[.YKMM9ZMG+<Z7'
MAV^0    8ZG^?,AZUG8EA)9%(H
M            -8-KCZ)7>6I#SWGC?OKZ=^>.2YL#NT^KQ^W=S.;&E-XTEO>%
MO^W! R                              #U2[A9P2<6]&QI^K7^]\R7<X
MAM;N[[/.XXYVF>];M=7ZMW*W?-D-2@    QQ_P"O/O?P3+>1D<Q4
M                                      'G;W<U+S>29WN#RVXI=@_'
MPGW7KW]DIL:W!X/6.EX(Y'R,G"A12  * $   *00HH @    H@%(   4"
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M_0                    &-ZIS]IGO=G9*9[R;[)!@H
M                             10(GIG;R <#[]\^[Z>7:A\8>;>U'X?+
MZMO)#\8;=^H:Q^[?^J7EM*'U.I4@@   **00 !0 $ H " 4"% @H$*!!0(
M  *! -[MA+G3B%Y+DN[//(_=W0R^.6Z^YKMM9ZMG+<Z6GAF^@    8ZJ'/F0
M]8SSBPDLBD4                                              &L&
MUQ]$J^69'SW'C?OKZ=^>.2YL#NT^KQ^W=S.;&E.@AI+>\+] 1@@4
M                      $S.Z19P2<6\^QI^KW^]\R7<XAM;N[[/.XXYVF>
M];M=7ZMW+#> V0U*    #'"<^U];^ 9;R2R.8J
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M$4'S*                    8WJ?/ZF>]V=DIG&";[)!@H
M                                10(GIG;R <#[]\^[Z>7:A\8>;>U'
MX?+ZMO)#\8;=^H:Q^[?^J7E=*'U.J4B*!       4"  * M @% @ "@0
M      WNV$N=.(7DN2[L\\C]W=#+XYY&[.YKMM9ZMG+<Z6GAF^0    8ZJ'/
MF0]:SL2PDLBD4                                              &
ML&UQ]$J^69'SWGC?OKZ=^>.2YL#NT^KQ^W=S.;&GI&DM[POT!&"!0  "@0
M                       #=W"S@DXPWGV-/U>_WOF1[F\VMW=]GG<<<[3/
M>MVNK]6[E;P&R&I0    8X3)?M?6_@&6\C(YBH
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M76SS.76.QF_S9C_5T?2QR,<MJ(J6V+H13BNW)HL<+^Q0
M   #&]4Y^TSWNSLE,MY-]D@Q4
M          (H$3TSMY .!]^^?5]/+M0^,/-O:C\/E]6WDA^,-N_4-8_=O_5+
MRVD^IU(0-T!Y@% @  !0(  ><!0(  H$  4"?9:!0(     % @&]NPCSIQ"\
MER7=GGD/N[H9?'+=G<UVVL]6SEN=+CP[?(    ,=S_/F0]8WL2PDLB$4
M                                          &L&UQ]$J^6I#SWGC?O
MKZ=^>.2YL#NT^KQ^W=S.;&E-XTEO3QM_VX(&0
M       69\A9P8SBWHV-/U:_OOF2[F\VMW=]GG<<<[37>MVNK]6[E;OFR&I0
M    8W3GVN]^"9;S%D@Q9
M        \[>[FI>;R3.]P>6W%+L'X^$SN]>_LE-C6X/!ZQTO!'(IDX5 %$ H
M @% @@65*@!  % $ H@ "@ ! *(15"   4$SH!W+^J@^C+%7YTP/BC3R.WNU
MCBYY>KV/T)\'(ZMIHWCHK<'<2I0   /#R//*I^T(7>'N"     /\LU*PIR#&
MEX\-L6!,PW09B$[*CH;T5'-7H*BV&%]D71,3O[BQ-)JY5/F<5]B.^%XH5+NV
M^_&#%Y9WOR!&]&C(*K;8U9B&U_>\=C$U':[58]$1=RSGLS-*R+;^E&Y'$QOL
M_P YNLW(WX_%BBXFU)1;G8U8F8OQ;IS,_+W[E%@R= 9.0F.@.<^ ]=>.K%1;
M.*5,C=S(<F7;HY$9>_6O*X<S=SIOWJ1#+]PJ/B;M<XM7=Q-O[1>3>&%QHS(]
M(IVI$9+QE@O2*R6EUB6.CNB/1JQHR)JHB:K;/0H3+B,K2NG&E(9YE_K+8LC#
M&75)NMJHN=;,MO3/FW9AR/ZF0          $5; "+:!0 $MWP"+:!0 &-ZIS
M]IGO=G9*9[R;[)!@H
M  10(GIG;R <#[]\^[Z>7:A\8>;>U'X?+ZMO)#\8;=^H:Q^[?^J7EM*'U.I"
M      % @% @% @% @% @% @ HI! *! *   0#>[82YTXA>2Y+NSSR'W=T,O
MCENON:[;6>K9RW.EIX=OH    &.Y_GS(>L9V)8261"*
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MU-6RQZY-*I:6:0D5=(DT] XV2@ ,;U3G[2_>[.R4SC!-]D@P4
M                                  (H$3TSMY .!]^^?=]/+M0^,/-O
M:C\/E]6WDA^,-N_'ZQ^[?^J7EMP^IU*D$      !0(!0(!0)8!0  "  *! *
M  @  !0 &]FPESIQ"\ER7=GGD/N[H9?'+=G<UVVL]6SEN=+CP[?(    ,=3_
M #ZD/6M[$L$LBD
M :P;7'T2N\LR'GO/&_?7T[\\<ES8'=I]7C]N[F<V-*;QI+>\+] 1@@4
M                         -TLX).,-Z-C3]6O][YDNYO-K=W?9YW''.TS
MWK=KJ_5NY6[YLAJ4    &-TY^+ZW\$RWD9(,5
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MJG/RF+N2[.R4RB=P9(,0
M     (H$3TSMY .!]^^?=]/+M0^,/-O:C\/E]6WDA^,-N_'ZQ^[?^J7EMP^I
MU(0  % @  !0  "=(  *!!0(   4"=#=     H$  !O=L)<Z<0O)<EW9YY'[
MNZ&7QRW7W-=MK/5LY;G2T\,WT    #'4_P ^9#UK.Q+"2R*10
M                                   :P[7'T2N\LR'9./&_?7T[\\<E
MS8'=I]7C]N[F<UUS](TEO>%^@+<$"@             H$
M"6^B+."3BWGV,_U:_P![YD>YQ#:W=WV>=QQSM,]ZW:ZOU;N6&\!LAJ4    &
M-TY^+ZW\ RWD9(,5
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MA'TD&:J<Y?&FQ:M(MITTC&M;+-=K)J6K8ZTQNMB(W$9<3J'%"J4
M                                   $4")Z9V\@' ^_?/J^GEVH?&'F
MWM1^'R^K;R0_&&W?J&L?NW_JEY;</J=2?9:0      H  ! *! *!    !0
M"       H&]NPESIQ"\ER7=GGD/N[H9?'+=?<UVVL]6SEN=+3P[?0    ,=3
M_/F1]:SL2P2R*0
M!K#M<?1*[RS(^>X\;]]?3OSQR7-@=VGU>/V[N9S76RU+-PTEO3QOT!;@@4
M                            /5=(LX).+>?8T_5[_>^)+N;S:W=WV>=Q
MQSM-=ZW:ZOU;N5O ;(:D    !CA.?:^M_!,MY)9',5
M                            !YV]W-2\WDF=[@\MN*78/Q\MSN]>_LE-
MC6]%X//Z7BY R<2A$ I0(  H@%(!0((4 *0"@00H 4 00*?8I44@   $*+N
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M-=MK/5LY;G2T\,WT    #'4_SYD/6L[$L$LBD
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M]Y:;+3#I2/.TZ.V/#9':B*Z&YS<FLB*BV";9B(GA6)BLQP/6D4 $KN@4
M      ##6,&"%T\:J?3:;>R+-,EZ7%6-+I*N1JZRI9EM13*V[128>[N1=&FW
M"NG0[GT=\1],H$LV5DG1E17ZC554M5+-TDS58>J(,)8G[/F%^+2I,WJN_"6K
MPVJR#6Y?\G,-1<^LJ>A?]\BEMNH2\#<K8WP3N;4H-6;0G5V?E8J1I*+4':S8
M3VID5&,U47+ERF4WU8Z+:EC&L:UC6HUK41&M1+$1$S(B= P9/D  QO5.?M+]
MH9V2F6\;[)!B                                             !%
MB>F=O(!P/OWSZOIY=J'QAYM[4?A\OJV\D/QAMWZAK'[M_P"J7EM*'U.I" !0
M(   -\"@ (  H$ % @H  !  % @     4#>W82YTXA>2Y+NSSR'W=T,OCGD;
MK[FNVUGJV<MSI:>';Z    !CJH<^9#UK.Q+"2R*10
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M]BRZ)Z%%MRJ6,JK&^_1BKIDCE1%MSI;EWEL0X:;KD?T*
M    8WJ?/ZF>]V=DIG&";[)!@H
M           10(GIG;R <#[]\^KZ>7:A\8>;>U'X?+ZMO)#\8;=^H:Q^[?\
MJEY;2A]3J5((!0(!0  "  *! *!   HI!   HI! *! *! !0(-[=A+G3B%Y+
MDN[//(?=W0R^.6[.YKMM9ZMG+<Z7'AV^0    8ZJ'/F0]8SL2PC(I%
M                                        !K!M<?1*OEF1\]YXW[Z^
MG?GCDN; [M/J\?MW<SFPN=-XTE&'A?H",$"@                    H$
M      'JBS@DXPWGV-/U:_WOF2[F\VMW=]GG<<<[3/>MVNK]6[E;P&R&I0
M  8X3GV[UOX!EO)+(YBH
M      /.7NYJWG\DSOQ=YE&+&[!^/E/NO7O[)38MG1>$UCI>#F4R<*@"@0
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MR.8J                                             $4")Z9V\@'
M^_?/N^GEVH?&'FWM1^'R^K;R0_&&W?C]8_=O_5+RVE#ZG4J00H$ HI  B@ *
M  A12"  *  @  !0(!0  "  !1O;L(\Z<0O)<EW9YX_[NZ&7QRW9W-=MK/5L
MY;G2X\.WR    #'50Y\R'K66=:6"612
M                  -8=KCZ)7>69#SWGC?OKZ=^>.2YL#NT^KQ^W=S.:^YO
M&DMZ>-O^W! R   *!                          /5%G!)QAO/L:6)+7^
M]\R/<WFUN[OL\[CCG:9[UNUU?JW<L-X#9#4H    ,;IS[7UOX)EO(R08J
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MNC.F<O\ W8QQ,,ZWU5L9D='">&LX.K#5L357*J9%7?."KE?,H
M        !C>J<_:9[W9V2F<8)OLD&"@
M               !% B>F=O(!P/OWSZOIY=J'QAYM[4?A\OJV\D/QAMWZAK'
M[M_ZI>6TH?4ZD $  44@@ "@ (!0 $    %    $  4 ! &Z!0-[=A+G3B%Y
M+DN[//(?=W0R^.6Z^YKMM9ZMG+<Z6GAV^@    8ZG^?,AZUO8EA)9%(H
M                                          -8-KCZ)7>69'SWGC?O
MKZ=^>.2YL#NS^KQ^W=S.;"YTWC26]/&W_&"!D
M       'JBS@DXPWGV-/U>_WOF2[F\VMW=]GG<<<[3/>MVNK]6[E;P&R&I0
M   8X3GVO1;^ 9;R,CF*@
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M55N9$6U#EU29MSHS9PMB8\;#/I.5-F_,Q_HZA-L5+?N=%O0TG#3=9;S^AD
M                  8WJG/ZF>]V=DIG&";[)!@H
M                         10(GIG;R <#[]\^KZ>7:A\8>;>U'X?+ZMO)
M#\8;=^H:Q^[?^J7EMP^IU(0         % @    H$**00   H$ H$  "BD&]
MNPESIQ"\ER7=GGD/N[H9?'+=?<UVVL]6SEN=+3P[?0    ,=3_/F0]:SL2PD
MLBD4                                              &L&UQ]$J^6
M9'SWGC?OKZ=^>.2YL#NS^KQ^W=S.;"YTWC26]/&_0$8(%
M               $3.XLX).,-Z=C3]6O][XDNYO-K=W?9YW''.TSWK=KJ_5N
MY6[YLAJ4    &.$Y^+T&_@&6\C(YBH
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M(4.W+JL1+?NE<+\V;HIO$616N^SOJ-S6:+#BHS?,
M&-ZIS]I?O=G9*9Q@F^R08*
M       $4")Z9V\@' ^_?/N^GEVH?&'FWM2^'R^K;R0_&&W?C]8_=O\ U2\M
MI0^IU*D$    % @%   (     % @% A0(   !0(44@@&]VPESIQ"\ER7=GGD
M/N[H9?'+=?<UVVL]6SEN=+3P[?0    ,=3_/F0]:SL2PC(I%
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M0GP<CJVFC>.AMP=Q*E    \1(\\JG[0TH]N0     M GH5W"2&1>C847)H
M                     8WJG/VF>]V=DIEO&^R08@
M                           10(GIG;R <#[]\^[Z>7:A\8>;>U'X?+ZM
MO)#\8;=^/UC]V_\ 5+RVE#ZG4A  H$ %  0"BD "   "SI@4" 4" 4" %* %
M((!0(  WNV$N=.(7DN2[L\\A]W=#+XY;K[FNVUGJV<MSI:>';Z    !CN?Y\
MR'K&=B6"61"                                               -8
M-KCZ)5\M2'GO/&_?7T[\\<ES8'=I]7C]N[F<V%R*F\:2WIXV_P"W! R
M   H$   *!                 ]46<$G%O/L9_JU_??,CW-YM;N[[/.XXYV
MFN];M=7ZMW*W@-D-2     QPG/M?6_@F6\DLCF*@
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M7S                    !CBIV<O:7[0SLE,MY&1S%0
M                             B@1/3.WD X'W[Y]7T\NU#XP\V]J/P^7
MU;>2'XPV[]0UC]V_]4O*Z4/J=4I$ *  ;X    @ "@0HI!   "@0HI! *!"B
MD$ H$ H&]NPESIQ"7_\ %R7=GGD?N[H9?'+=G<UVVL]6SEN=+3PS?(    ,=
MS_/F0]8SL2PDLB$4
M  &L.UQ]$KO+,CV3CQOWU]._/')<V!W:?5X_;NYG-=<Z;EAI+>GC;_C! R
M                            !/NND6<$G%O/L:?J]_O?,CW.(;6[N^SS
MN..=IGO6[75^K=RPW@-D-2@    QPG/Q?6_@&6\C(YBH
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M<Z6GAF^0    8ZJ'/JGK_<;V)82612*
M                 #6#:X^B5WEF0\]QXW[Z^G?GCDN; [M/J\?MW<SFQILZ
M!I+>\+?]N"!D                              &AQ9P2<6\^QG^K7^]\
MR7<XAM;N[[/.XXYVFN];M=7ZMW+#> V0U(    #'"<^U7^[^ 9;R,CF*@
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MO]0 #'%3Y^TOVAG9*9Q@F^R.8*
M           $4")Z9V\@' ^_?/N^GEVH?&'FWM1^'R^K;R0_&&W?C]8_=O\
MU2\MN'U.I""@/. @% @ "@0"@ (!0(!0 $ H$   *!  %   -[=A+G3B%Y+D
MN[//(?=W0R^.6Z^YKMM9ZMG+<Z6GAV^@    8ZG^?,AZQO8E@ED4@
M                                       #6#:X^B5WEF1\]YXW[Z^G
M?GCDN; [M/J\?MW<SFQIZ1I+>\+] 1@@4                          *
M!   T.+."3C#>?8T_5K_ 'OF2[F\VMW=]GG<<<[3/>MVNK]6[E;P&R&I0
M 8W3GVOK?P3+>1D@Q4
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MO/JU\YEWJ9QF*Q/%O,-8BEOK8WII,<;JCJL6S637L3(JY;4.&M:PR_%_H*
M       #6K:%P#F\=X=UJ8M[YJZU'H\6/&J?>S>,='XQB-8U8;E1KK.B96W:
M,U&@6U3L]W!P0N1=2-=:',S%:GYE9>J5>/$5%CM:Q;;(26M:JV:#DR[])A=%
M'1O9C^@/"]%RJE%A9=WT3CCOQ6W!]3M22-_*OA#7[OX>T:>K-;K[H<I&A4]Z
M,CPY=7:[W-<KFV6V(BV+F4D3263#&Q_L\2]T[ISMX\2;B,DKZSL]$@R].J\&
M%'=+2L"Q(<2&Q==C5B6JMJ93.^^L[C&(>,V\\.+F4^ZMW[Y4ZDRE&KO?ZR<S
M$E(3(+9N"YBKJ1&M1$547+;9:,N:RES/&Q75JG5]GZZ\:JS#YF-*S<])RSGH
MJ:L"!'<R$QJ+H:W(ACFXLK<&UYBH!C>J<_:9[W9V2F>\F^R08*
M                                   $4")Z9V\@' ^_?/N^GEVH?&'F
MWM1^'R^K;R0_&&W?J&L?NW_JEY;2A]3J5()]L"@  $ H$    %  0     *!
M *! '0 H    WLV$>=.(7DN2[L\\A]W=#+XY;L[FNVUGJV<MSI<>';Y    !
MCJH<^9#=U6=B6"612
M    -8=KCZ)7>69'SW'C?OKZ=^>.2YL#NT^KQ^W=S.:ZYTWC26]/&W_;@@9
M                             !NEG!)Q;S[&GZM?WWS)=S>;6[N^SSN.
M.=IGO6[75^K=RMX#9#4H    ,;MY^.];^ 9;R,D&*@
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M7#S+*O(UJ^=-G:?$=%ETA-AJYS5:NLBJJY%RB;9B$9;.-0
M                               B@1/3.WD X'W[Y]7T\NU#XP\V]J/P
M^7U;>2'XPV[]0UC]V_\ 7+RVE#ZG4J0 (     %    $ %%((!0(!0(!0 $
M  !0 $&]NPESIQ"\ER7=GGD/N[H9?'+=G<UVVL]6SEN=+CP[?(    ,=3_/J
M0]8WL2PC(I%                                              !K!
MM<?1*[RS(^>X\;]]?3OSQR7-@=VGU>/V[N9S8TIO&DM[PM_VX(&0
M                      :'%G!)Q;S[&GZM?WWQ)=S>;6[N^SSN..=IGO6[
M75^K=RMX#9#4H    ,<)S\7UOX!EO(R.8J
M                    #SM[^:EYO),[\7>6W%C=@_'PF=_KW]DIL:S!X36.
MEXN13)P@ H$ H$% A0(&D*%12"  *!"@  $%  "@0"@00"@$SH4=R_JH/HSQ
M5^=,#XFT\CM_M;>+GEZO8_0GP<CJVF9#HK<'<*4   #Q$ASRJ?M#2[P]N0
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M5:QJ-2VU<MB6%K-!DPQ
M     B@1/3.WD X'W[Y]7T\NU#XP\V]J/P^7U;>2'XPV[]0UC]V_]4O+;A]3
MJ0@   %  0   H " 4" 4 ! *!        'VRBD&]FPCSIQ"\ER7=GGD/N[H
M9?'+=G<UVVL]6SEN=+CP[?(    ,=3_/F0]:WL2PDLBD4
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MM0^,O-O:C\/E]6WDA^,-N_4-8_=O_7+RQ]3J0@H "% @ 4" 7? @     4"
M4"  *!  %*(!2 ! -[MA+G3B#Y+DN[//(?=W0R^.6Z^YKMM9ZMG+<Z6GAV^@
M    8ZG^?4AZUO8E@9%(
M       U@VN/HE=Y:D//>>-^^OIWYXY+FP.[3ZO'[=W,YL;F\:2WIXWZ MP0
M*                              &A2S@DXMY]C/]6O\ >^9'N<0VMW=]
MGG<<<[3/>MVNK]6[EAO ;(:E    !C=.?:^M_!,MY&2#%0
M                                ><O=S5O/Y)G?B[S*,6-V#\?3<[O7
MO[)38MO1>$UCI>+D#-P@%((44@%$(H$4 %0(H$**!   BJ$0H$%*!   0HI
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MR^.6[.YKMM9ZMG+<Z7'AV^0    8ZG^?,AZUG8E@ED4@
M                              #6#:X^B5WEF1\]QXW[Z^G?GCDN; [M
M/J\?MW<SFQN;QI+>GC;_ +<$#(                 H$        H " #U6
MX6<$G&&]&QI^K7^]\R7<WFUN[OL\[CCG::[UNUU?JW<K=\V0U(    #'"<^U
MT>A_ ,MYBR.8L@    2U++;4LW25%M3=*
M      EJ+F6T"@    !YR]W-6\_DF=^+O,HQ8W82_'RW._U[^R4V+9@\)K'2
M\7(IDX5   (4 *0 ( "@0**  $  40  (JA$*! * %( !"CN5]5!]&>*OSIE
M_BC3R.W^UMXN>7J]C]"?!R.KB:-XZ*W!W$J4   #P\ASRJ?M#2Q@/<$
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MF=[LT]O]I=&_CYFA>^3MM6ZMW+:T4X#V$[S2UV,\8&(44@ 0"@   "?98
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M]$KO+,CY[CQOWU]._/')<V!W:?5X_;NYG-C2F\:2WIXV_P"W! R
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M1X=%O73H-3I;9J'Q4=($PU'L2(RU=5;%RI:=9F9=V7?-D[S[,O,C,MBZ-][
MQ9@    \[>_FI>;R3._%WEC%+L'X^&YW>O?V2FQK<'@]8Z7@CD?(R<0$0H
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M\%(I2C/6;Z9,9GF[E.&LND;5L:B-36:F1%Z!QQ-9EF_J4
M     QQ5.?E,][L[)3+>3?9',5    !S0V[>=F'WDF=[LT]O]I=&_CYFA>^7
MMM6ZMW+:T4X#V,[S2MV,\81$*!!0(   4"  !0(  "@ (  H$**00     *
MM]&G2$8>-9P=A-D7Z![I^WU'XY%-:_<?QEW%;R0_4W=E]"RNM?\ KN;+'1/?
M   !% B>F=O(!P/OWS[OIY=J'QAYM[4?A\OJV\D/QAMWZAK'[M_ZI>6TH?4Z
MI2( 0"@   "          %   (4""@0  ^RT   WNV$N=.(7DN2[L\\A]W=#
M+XY;K[FNVUGJV<MSI:>';Z    !CJH<^I#UC/.+!+(I
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M:C\/E]6WDA^,-N_4-8_=O_5+RNE#ZG5*1%S@ (      "@   " 4 !"@0,@
M"@0      &]VPESIQ"\ER7=GGD/N[H9?'+=?<UVVL]6SEN=+3P[?0    ,=3
M_/F0]:SL2PDLBD4
M &L.UQ]$KO+,CY[CQOWU]._/')<V!W:?5X_;NYG-=<Z;QI*,/"_0$8(%
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M*OSI@?$VGD=O]K'%SR]7L?H3X.1U;3,AT5N#N%*   !X>1YY5/VAI1[@@
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MYTN/#M\@    QU/\^9'UK.Q+!+(I
M               &L.UQ]$KO+,CY[CQOWU]._/')<V!W:?5X_;NYG-?2F\:2
MWO"W_;@@9                               GW19P2<8;T;&EG>U_O?,
MC9VMYM;N[[/.XXYVF>];M=7ZMW*W?-D-2@    QO_P"NUMW/P#+>262#%0
M  ?G6^LP_J?J'S6I'^,>QV)\/X9>1VQVU_%')+0%/2MWCN'5?[80H  *0"@0
M0"E @ "@0"@0"@00HH " " % *$ (4 /YQOS"_?=BIA=T7/D=*.-^K#99_IQ
MP3^9]+[@T\+M'XB_C>NV;\-9Q,^'Q/N    !YV]W-2\WDF=^+O+;BEV#\?#<
M[_7O[)38UN#P>L=+P1R/D9.) B@ (44" 4@% @ 0HI  A12 !"BD$"J5$  4
M"  * TIOD'<OZJ#Z,\5?G3 ^*-/);>[6.+GEZO8_0GP<CJVFC>.BMP=Q*E
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MSQOWU]._/')<V!W:?5X_;NYG-A<Z;QI*,/"_0%N"!0
M           !-TLX).+>C8T_5[_>^)+N;S:W=WV>=QQSM,]ZW:ZOU;N5O ;(
M:E    !CA.?:^M_ ,MY)9',5    !^=;ZS#^I^?^:U(_QCV.Q/A_#+R.V.VO
MXHY): IZ5N\=PZK_ &V\2%%  0"D$* %(    *(  H$ H$ I *(15"!0( $*
M '\XWYA?ONQ4PNZ+GR.E'&_5ALL_TXX)_,^E]P:>%VC\1?QO7[-^&LXF?#XG
MV@    \Y>[FK>?R3._%WF48L;L'X^4SN]>_LE-BV8/":QTO!S*9.)0@40B@
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MYM[4?A\OJV\D/QAMWZAK'[M_ZI>6TH?4ZE2    1  % @    H$  4   @%
M@%S@0"@0 !0 &]NPESIQ"\ER7=GGD/N[H9?'+=?<UVVL]6SEN=+3P[?0
M,=5#GU(>L9YQ82612*
M    #6#:X^B5?+,CY[SQOWU]._/')<V!W:?5X_;NYG-C2F\:2WIXWZ A H
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M^7U;>2'XPV[]0UC]V_\ 5+RVE#ZG4KOD$ H$  "@0   "@0 !0(    *  @
M"@  $  ;W;"7.G$'R7)=V>>0^[NAE\<MU]S7;:UU;.6YTM/#M]     QU/\
M/F0]8WL2PDLBD4
M&L&UQ]$KO+4AY[SQOWU]._/')<V!W:?5X_;NYG-A<Z;QI*,/"W_;@@9
M                         !ZI=XLX).,-Y]C3]6O][YD>YQ#:W=WV>=QQ
MSM,]ZW:ZOU;N6&\!LAJ4    &-TY]KZW\$RWDED@Q4    'YUOK,/ZGZA\UJ
M1YT8]CL3X?PR\CMCMK^*.26@*>E;O'<.JCHVH4 !  % "D$ H$** (  "%%
MA  H "%%(!1 * ( '\HWYA?ONQ4QGHN?)Z4<;]6&RS_3C@G\SZ7W!IX7:/Q%
M_&]=LWX:SB9\/B?<    #SM[N:MY^A29WXN\RC%C=@_'PF=WKW]DIL6S!X36
M.EX(Y'R,G"% @A12 4" ! !12"%% $     0HH @  !1 *00"IG"NY7U4'T9
MXJ_.F7^*-/);>[6.+GEZK8_0GP<CJVFC>.BMP=P^10   /#R//*I>T(4>X(
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MYTM/#M]     QU4.?,AZQGG%A)9%(H
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M?Q\S0O?+VVK=6[EM:*)U,B'L9WFE;L5(B 4"   % @  !0(!0  "  *! *
M@  !0 $ OW29<O\ X",/&N\[";(OT#W3]OJ/QR*:U^X_C+N*WDA^IN[+Z%E=
M:_\ 7<V6.B>^   "*!$],[>0#@??OGU?3R[4/C#S;VH_#Y?5MY(?C#;OU#6/
MW;_U2\MI0^IU*D$ %%((!0 $     HI!"@0 !0(*!"@0       ;W;"7.G$+
MR7)=V>>1^[NAE\<MU]S7;:SU;.6YTM/#-]     QU/\ /F0]:SL2P,BD
M                                           :P[7'T2N\LR/GN/&_
M?7T[\\<ES8'=I]7C]N[F<UUSIO&DHPGC;_C! R        H$
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MOM1\.%.1.-AM<BY45&JF0PNQ6&RABH!C>IK_ ->TSH2[,GWRF48%&2#$
M!S/V[>=F'WDF=[LT]O\ :71OX^9H7OE[;5NK=RVM%. ]A.\TK=C($ !0( %
M@ "@0"@0 !0(!0(  H    @  !0(!?NTZ0C#QF\[";(OT$72]OJ/QR*:U^Y/
MC9XK>2'ZG[LOH65UK_UW-ECHGO@   B@1/3.WD X'W[Y]WT\NU#XP\V]J/P^
M7U;>2'XPV[]0UC]V_P#5+RVX?4ZH(@!0(  H$   *! *!    4"!D H$  4
M!  % @&]VPESIQ"\ER7=GGD/N[H9?'+=?<UVVL]6SEN=+3P[?0    ,=3_/J
M0]8WL2P2R*0                                              !K!
MM<?1*[RS(^>X\;]]?3OSQR7-@=VGU>/V[N9S8TIGS&DM[PM_VX(&0
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MQX=OD    &.I_GS(>L;V)8)9%(
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MM3B;<_UWFQ,>--9FF3H1C=,?Z.HJL1WHFKZ&S)O'!$Q%9<E-V'^DR
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MM.D(P\9O.PFR+] ]TO;ZC\<C&M?N/XR[BMY(?J?NS^A9/6O_ %W-ECHGO@
M B@1/3.WD X'W[Y]7T\NU#XP\V]J/P^7U;>2'XPV[]0UC]V_]4O+:4/J=2$
M"@-T"       %%\T@@% @  !0(   4HA    *!O9L(\ZL0O)<EW9YY#[NZ&7
MQRW9W-=MK/5LY;G2X\.WR    #'4_P ^9'UK>Q+!+(I
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MYO),[W!Y;<4NP?CX3[KU[^R4V-9@\'K'2\7(IDX5 A0 I!"@!0  @%$ I *
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M%1<V)-/AHMJPH>JU&PH:KEU6IER:RK82[.F=PT(9];;8C52Q+#AIO,GS,@
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M>>0^[NAE\<\C=G<UVVL]6SEN=+CPS?(    ,=3Z?]=2'K&]B6$9%(H
M                                        -8-KCZ)7>69#SW'C?OKZ
M=^>.2YL#NT^KQ^W=S.;&E-.3.:2WIXV_[<$#(
M       32I9P2<8;T;&GZM?[WS(]S>;6[N^SSN..=IGO6[75^K=RMX#9#4H
M   ,<6_]=KZW\ RWD9',5    !^=;ZR_^I^H?-:D>=&/8[$^'\,O([8[:_BC
MDEH"GI6[QW#JHZ, $*!% @44 ! *0 H5$ $% A0 I! H5%(( **0"@!"*H1_
M*-^8=]]D^]4QGHN?)Z4<;]6&RS_3C@G\SZ7W!IX7:/Q%_&]=LWX:SB9\/B?<
M    #SM[N:EYO),[W!Y;<4NP?CX;G=Z]_9*;&MZ+P>L=+Q<BF3A4 !  52H
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M9A2DC+]X3[=>-&<C(;=9TNB):Y42U5'JY2;XALBBVHBV6;J'',;K)\B@
M               &.*GS]I?O=G9*9Q@F^R.8*    #F?MV\[,/O),[W9I[?[
M2Z-_'S-"]\G;:MU;N6UHKP'L)WFE;L90J!!0 $ H  !  % @  !0(     %
M 0"@0!84 +]VG2)O>-9P=A-D7Z![I^WU'XY%-:_<?QEW%;R0_4W=E]"RNM?^
MNYLL=$]\   $4")Z9V\@' ^_?/J^GEVH?&'FWM1^'R^K;R0_&&W?J&L?NW_J
MEY;</J=2$  !0(!0(!0(  9P*!          "@ (4 !!0-[=A+G3B%Y+DN[/
M/(?=W0R^.6[.YKMM9ZMG+<Z6GAV^0    8[G^?,AZQG8EA)9$(H
M                                     -8-KCZ)7>69'SWGC?OKZ=^>
M.2YL#NT^KQ^W=S.;&E-XTEO>%^@+<$"@               4
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M^\DSO=FGM_M+HW\?,T+WR]MJW5NY;6BNYO'L9WFE;L90B       *  @%
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MY[SQOWU]._/')<V!W:?5X_;NYG-C2F\:2WO"W_&"!D
M            +H<)P2<6\VQI^K7^]\R/<XAM?N[[/.XXYVF>];M=7ZMW*W@-
MD-2@    QNU?^NW;WX!EO(R08J    #\ZWUF']3]0^:U(\Z,>QV)\/X9>2VQ
MVU_%')+0'[EN\=PZG_;:%$ H @ "@00HH @ 0H 4 0   H@%((44@    H$'
M\XWZNOWW8J8ST7/D]*.-^J_99_IQP3^9]+[@T\+M'XB_C>NV;\-9Q,^'Q/N
M   !YV]W-2\WDF=[@\MN*78/Q\)G=Z]_9*;&MP>#UCI>"'R,G$!$*     I
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M5MY(?C#;OU#6/W;_ -4O+:4/J=2I! &8 !0(  H$  "@04"  *!  % @ "@
M(!0(  WMV$>=.(7DN2[L\\A]W=#+XY;L[FNVUGJV<MSI<>';Y    !CJH<^J
M?ZQO8EA&12*                                              #6#
M:X^B5WEF1\]YXW[Z^G?GCDN; [M/J\?MW<SFQI3>-);T\;?]N"!D
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MS4]"B*G05#CW:LWS*                    8WJG/VE^]V=DIG&";[)!@H
M   .9^W;SLP^\DSO=FGM_M+HW\?,T+WR=MJW5NY;6BG >PG>:5NQ @  H "
M7[% @   *!  :0*   0"@0 !0 $  4" 7[M.D(P\9O.PFR+] ]T_;ZC\<BFM
M?N3XR>*WDA^I^[+Z%E=:_P#7<V6.B>^   "*!$],[>0#@??SGW?7R[4/C+S;
MVH_#Y?5MY(?C#;OU#6/W;_U2\MN'U.I4@@%\\"% @H$ H$  4" /, H$ = "
M@0"@0H$% A12" 4";Q1O=L)<Z<0O)<EW9YX_[NZ&7QRW9W-=MK75LY;G2T\.
MWR    #'4_SYD/6L[$L#(I
M         &L.UQ]$KO+,CY[CQOWU]._/')<V!W:?5X_;NYG-?2F\:2WO"W_&
M"!D                              "9G=(LX).,-Z-C3]6O][XDNYO-K
M=W?9YW''.TUWK=KJ_5NY6[YLAJ0    &-TY]KO?@&6\DLD&*@    _.M]9A_
M4_4/FM2/.C'L=B?#^&7DML=M?Q1R2T!3TK=X[AU,=& " 4  * $ I *!!"@
M H @A12"% @%%((!2@14"*  _G&_,+]]V*F,]%SY/2CC?JOV6?Z<<$_F?2^X
M-/"[1^(OXWK]F_#6<3/A\3[0    >=O=S4O-Y)G>X/+;BEV#\?#<[O7O[)38
MUN#P>?TO$^1DX0"%50B$4"*!"BD ">:!0!1" 44@  (44@A12"% "@0 !=*
M=R_JH/HSQ5^=,O\ %&GDMO\ :V\7/+U>Q^A=X.1U;31O'0VX.XE2@   >'D;
M>652]H0H]P0   DC_+,RZ3,&- ?8Z%,-5D5JZ6N2Q4Z:$OMTK9AE9=-LQ+7=
M=D79U=:YV&4BKW*KG+WQ-YU6U<T9$\PY9S+I<>BO\HFSID_]L)#H_P"\3F7_
M /G)-]W"M($V1-G/^&$A\(G/TY?67%(?ZI#92V?Z54)&J4_#>2EI^FS$.:D9
MAL>:58<:"Y'L>B.C*EJ*EN5!ZRY)LB<6PJ(J(B9]U3!D^0
M      ,<5/G[3/:&=DIE&";[(YBH    .9^W;SLP^\DSO=FGM_M+HW\?,T+W
MR=MJW5NY8:*\!["=YI:[&>- Q !12 !  % @%  0"@0 !0(!0 $ H    @%
M@%^[3I#>\9O.PFR+] ]TO;ZC\<BFM?N/XR>*WDA^I^[+Z%E=:_\ 7<V6.B>^
M   "*!$],[>0#@??OGW?7R[4/C#S;VH_#Y?5MY(?C#;OU#6/W;_U2\MI0^IU
M( SD#.!0(  %  04   @%   (4""@0!TR@04"   % WLV$>=.(7DN2[L\\A]
MW=#+XY;L[FNVUGJV<MSI<>';Y    !CJ?Y\R'K6=B6!D4@
M                                #6':X^B5WEF0\]YXW[Z^G?GCDN;
M[M/J\?MW<SFNN=-XTE&'A;_MP0,@                              T.
M+."3BWGV,_U>_P![YDNYQ#:W=WV>=QQSM,]ZW:ZOU;N6&\!LAJ4    &-TY]
MKO?@F6\DLD&*@    _.M]9?_ %/S_P UJ1_C'L=B?#^&7D=L=M?Q1R2T!3TK
M=X[AU7^V.)"BVD "%% $ "%%  "   A0 I   0HI    (   4#^4;\POWW8J
M8W=%SY/2CC?JPV6?Z<<$_F?2^X-/"[1^(OXWK]F_#6<3/A\3[0    >=O=S4
MO-Y)G>X/+;BEV#\?"9W>O?V2FQK,'@]8Z7BY'R,G"@ *%0 I! !12 4""%%
M$    %$ I  A12    0HJ9T [E_50?1GBK\Z9?XHT\CM[M8XN>7J]C]"?!R.
MK::-XZ*W!W"E    \1()_P!95/VAI=X>W(
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MENSN:[;6>K9RW.EQX=OD    &.I_GU(>L9V)8)9%(
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MTT;QT5N#N%*   !XB07_ *RJ?M#2CVY
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M]\R/<XAM;N[[/.XXYVF>];M=7ZMW*W@-D-2@    QNG/Q?6IV!EO(R08J
M #\ZWUF']3]0^:U(_P 8]CL3X?PR\CMCMK^*.26@/W+=X[AU?^V$*BD$**!
M*0"B  *0  $"J$0HI    !0(!0( 4"( */A&_,.^^[%3">BY\GI1QOU7[+/]
M.."?S/I?<&GA=H_$7\;UVS?AK.)GP^)]P    /.WOYJ7F\DSOQ=Y8Q2[!^/A
MOW7KW]DIL:W!X//Z7BY%,G"%% $$*&4     !%4(=$ !"@!2"% "D *@12@0
M (44@)G0H[E?50?1GBK\Z9?XHT\CM_MHXN>7J]C]"?!R.KB:-XZ*W!W$J4
M #P\CSRJ?M#0/<                           ML EJ+F H  !CBJ<_*9
M[0SLE,MY-]D<Q4    ',_;MYVX?>29WNS3V_VET;^/F:%[Y>VU;JW<L-%> ]
MC.\TK=BA$4"%%((!0(  H$ H " 4" "@0 *!  % @%   (!?NT&]XS>=A-D7
MZ![I>WU'XY%-:_<?QEW%;^F'ZG[LOH63UK_UW-ECHGO@   B@1/3.WD X'W[
MY]7T\NU#XP\V]J/P^7U;>2'XPV[]0UC]V_\ 5+RVE#ZG4J00"@ (!0(4"
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MM]9A_4_4/FK2/.C'L=B?#^&7D=L=M?Q1R2T!3TK=X[AU7^V     0H "*%0
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MS;VI?#Y?5MY(?C#;OU#6/W;_ -4O+:4/J=2$%   (!;0(!0( * #*0 !12"
M"@0 *! *! *!  % WLV$>=.(7DN2[L\\A]W=#+XY;L[FNVUGJV<MSI<>';Y
M   !CJ?Y\R'K6=B6$ED4B@  !_-_IF=,EV YS;7WTBW?\A_X[C47>!\79U?*
MWIW7? YO7YFJIKYLT             % @ (H5             /?X4?2EAWY
M>E?/4[W[:^HY'7MY8>?^Z_I.M?MW.PZ:3]!/R\H     :P;7'T2KY9D//<>-
M^^OIWYXY+FP.[3ZO'[=W,YL+G3>-)1AX6_[<$#(
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MR.WNUCBYY>KV/T)\'(ZMIHWCHK<'<2I0   /#R'/*I^T-+& ]P0
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MM[4?A\OJV\D/QAMWZAK'[M_ZI>6TH?4ZD( %  0H ""@0   H$   *! *
M0    4" 4#>W82YTX@^2Y+NSSR/W=T,OCENON:[;6>K9RW.EIX9OH    &.I
M]/\ KF0]:SL2PDLBD4   /YO],SIDNP'.;:^^D:[_D/_ !W&HN\#XNSJ^5O3
MNN^!S>OS-537S9H                               >_PH^E+#KR]*^>
MIWOVS]1R>O;RP\_]V?2=:_;N=ATTGZ"?EY0     U@VN/HE=Y:D//>>-^^OI
MWYXY+FP.[3ZO'[=W,YL:4WC26]X6_P"W! R
M     #0HG!)Q;S[&GZM?WWS)=S>;7[N^SSN..=IGO6[75^K=RMX#9#4H
M,<)S[7HI^"9;R2R.8J    #\ZWUF']3\_P#-:D?XQ['8GP_AEY';';7\4<DM
M 4]*W>.X=5'1@ A0 H$(  H 4@%  0 !0  0"@"*!  4 !    /Y1?U=?ONQ
M4QGHN?)Z4<;]6&RS_3C@G\SZ7W!IX7:/Q%_&]?LWX:SB9\/B?:    #SM[N:
MEYO),[W!Y;<4NP?CX;G=Z]_9*;&MP>#S^EX(Y'R,G" 0H "*I40BJ$  $* %
M(   4 (!2"!0"A$**0 (!0":-\H[E?50?1GBK\Z9?XHT\EM_M8XN>7J]C]"?
M!R.KB:-XZ&W!W$J4   #P\ASRJ?M#2Q@/<$
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M[;5NK=RVM%4T;Q["=YI6[$"(!0 $   *!   H$% @% @    H$ H$ H$ H$
MOW:=(;WC-YV$V1?H(NE[?4?CD4UK]Q_&7<5O)#]3]V7T+)ZU_P"NYLL=$]\
M  $4")Z9V\@' ^_G/N^OEZH?&'FWM2^'R^K;R0_&&W?J&L?NW_JEY;+D/J=2
M$  !0&8   @  4""@0 !0)8!0 #[%  0H$ H ""@ -[-A+G3B#Y+DN[//(?=
MW0R^.6[.YKMM:ZMG+<Z7'AV^0    8ZJ'/F0]8SSBPDLBD4   /YO],SIDNP
M'.;:]^D:@>0_\=QJ+O ^+LZOE;T[KO@<WK\S54U\V:
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MS-"]\O;:MU;N6UHFF;I(>QG>:5NQ"(OVP  " 4 !   "@0 !0(4 *00"@3*
M   !0(  "_=ITA&'C-YV$V1?H'NE[?4?CD8UK]Q_&7<5O)#]3]V?T+)ZU_Z[
MFRQT3WP   10(GIG;R <#[]\^KZ^7:A\8>;>U'X?+ZMO)#\8;=^H:Q^[?^N7
MEESGU.I""@1 !12 !   "@0   H$ % @ ,H       %  ;V["7.G$'R7)=V>
M>0^[NAE\<MV=S7;:UU;.6YTM/#M\@    QU/\^I#UK>Q+ R*0   #X.SLWR7
M8&^YR[7WTBW?\A_X[C47>!\79U?*WIW7? YO7YFJIKYLT
M      "@0        ]]A1]*>'?EZ5\]3OOMGZCD]>WEAY_[K^DZU^W<[$)I/
MT"_+R@    !K!M<?1([RU(>>\\;]]?3OSQR7-@=VGU>/V[N9S87.F\:2WIXV
M_P"W! R   *!        *  @               T.Z19P2<6\^QG^K7^]\R7
M<XAM;N[[/.XXYVF>];M=7ZMW+#> V0U*    #&Z<_%];^ 9;R2R08J    #\
MZWUF']3]0^:U(_QCV.Q/A_#+R.V.VOXHY): IZ5N\=PZK>CB"@!   @H$**
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MO=FGM_M+HW\?,T+WR=MJW5NY8:*)98EFXEA[&=YI6<0B*!  % @ H$  !0
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M-&\=%;@[B5*   !X>1YY5+VA"[P]P0
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M!SEVOOI&N_Y#_P =QJ+O ^+LZOE;T[KO@<WK\S54U\V:
M               'OL*%LQ2PZ\O2OGJ=]]M?4<GKV\L//_=GTG6OV[G8A-)^
M@7Y>4     -8-KCZ)7>69'SW'C?OKZ=^>.2YL#NT^KQ^W=S.;&YO9#26]X7Z
M C! H              )        "E$(     :'%G!)Q;S[&?ZM?[WS(]S>;
M6[N^SSN..=IGO6[75^K=RPW@-D-2@    QNG/O[W\$RWDED@Q4    'YUOK,
M/ZGZA\UJ1_C'L=B?#^&7D=L=M?Q1R2T!3TK=X[AU7^VWB3< H$* %((44 0
M(4"*H1 !12  *!!"@15"   4""%%(/Y1OU=?ONQ,;NBY\CI1QOU8;+/].."?
MS/I?<&GA=H_$7\;UVS?AK.)GP^)]P    /.WNYJ7F\DSO<'EMQ2[!^/AN=_K
MW]DIL:W!X/6.EXN13)PJ40@%%(   40BT4J(15"!1 *! *00HH$ I * $  7
M[+2" 5- '<OZJ#Z,\5?G3+_%&GD]O]K;Q<\O5['Z$^#D=6TT;QT-N#N)4H
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MW[Z^G?GCDN; [M/J\?MW<SFQI3>-);T\;?\ ;@@9
M  4 !      'JND6<$G%O/L:?JU_O?,CW.(;6[N^SSN..=IGO6[75^K=RMX#
M9#4H    ,;_^O%]:GFM,D9(,5    !^=;ZS#^IZH?-6D>=&/8[$^'\,O([8[
M:_BCDEH"GI6[QW#JO]MO$   4"(44@A0 H BU0"A$*! * %((44@@50@!"BD
M  40#^<;\POWW8J87=%SY'2CC?JPV6?Z<<$_F?2^X-/"[1^(OXWKMF_#6<3/
MA\3[@    >=O=S4O-Y)G>X/+;BEV#\?#<[O7O[)38UO1>#UCI>+D4R<*A0(
M   "% BJ$"@00 %4J!    !0('V*  A0  4@)G0H[E?50?1GBI\Z8'Q1IY+;
M_:V\7/+U>Q^A/@Y'5Q-&\=#;@[B5*   !X>1YY5+VA"[P]P0
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M:-XZ*W!W$J4   #P\CSSJ?M"%'N"
M8WJG/VE^T,[)3.,$WV2#!0    <S]NWG9A]Y)G>[-/;_ &ET;^/F:%[Y.VU;
MJW<MK15,V7)D0]C.\TK=BA$4"%%\T@@  !0 $   *    )I      4""@
M!]VG2$8>,WG839%^@>Z?M]1^.136OW'\9=Q6\D/U/W9?0LGK7_KN;+'1/?
M !% B>F=O(!P/OWSZOIY=J'QAYM[4?A\OJV\D/QAMWZAK'[M_P"N7EMP^IU(
M0    !0 $ H$ % @H$     "@0"@  $ %  0;V["/.G$+R7)=V>>0^[NAE\<
MMV=S7;:SU;.6YTN/#M\@    QU/\^9#UK.Q+!+(I    /@[TS-\EV YR[7OT
MBW?\A_X[S47>!\79U?*WIW7? YO7YFJIKYLT
M       /?X4?2CAWY>E?/4[W[:^I9'7MY8>?^[/I&M?MW.PZ:3]!/R\H
M :P;7'T2KY9D?/>>-^^OIWYXY+FP.[3ZO'[=W,YL:4WC26]X6_[<$#(
M                         -U2S@DXMZ-C3]6O]T)F2[G$-K=W?9YW''.T
MSWK=KJ_5NY6[YLAJ4    &-TY^+ZW\ RWDED@Q4    'YUOK,/ZGY_YK4CSH
MQ['8GP_AEY';';7\4<DM 4]*W>.X=5_MMX@ 4"!]B%$ I   "B$% ?8H H$
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M   'P=Z9F^2[ <Y=K[Z1;O\ D/\ QW&HN\#XNSJ^5O3NN^!S>OS-537S9H
M                             >_PH^E'#OR]*^>IWOVU]2R.O;RP\_\
M=?TG6OV[G8=-)^@GY>4     -8-KCZ)5\M2'GN/&_?7T[\\<ES8'=I]7C]N[
MF<V-*;QI+>\+?]N"!D                              &AV^6<$G%O1L
M9_JU_O?,CW.(;6[N^SSN..=IGO6[75^K=RPW?-D-2@    QNG/Q?6_@&6\C)
M!BH    /SK?68?U/U#YJTC_&/8[$^'\,O([8[:_BCDEH"F9N\=PZK_;;Q(4
M*0"@00HI  % @  !0((%4(@ "@"@!  % $  !_*-^87[[L5,;NBY\CI1QOU8
M;+/].."?S/I?<&GA=H_$7\;UVS?AK.)GP^)]P    /.7NYJWG\DSOQ=YE#&<
M'X^FYW>O?V2FQ;<'A-8Z7BY%,G$@12B$4*@!0 $ $ HH @     H "!5"(4
M %(   F@H[E_50?1GBK\Z9?XHT\CM[M8XN>7J]C]"?!R.K::-XZ*W!W$J4
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M[>=F'_DF=[LT]O\ :71OX^9H7OD[;5NK=RPT5T=)#V,[S2MV*$10(4""@0
M  4 !"@0  %^V  @ HI! *!   "@ +]TF7((P\:[SL'LB_0/=/V^H_'(IK7[
MC^,NXK?TP_4W=E]"R>M?^NYLL=$]\   $4")Z9V\@' ^_?/J^GEVH?&'FWM1
M^'R^K;R0_&&W?J&L?NW_ *I>6TH?4ZD(*!  %    $   *!  %  0H$ HI
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M0GP<CJVFC>.BMP=Q*E    \/(<\JG[0A1[@@
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M3]0^:U(_QCV.Q/A_#+R.V.VOXHY): ?<MWCN'51T;>(*  BJ5$( %*(!2 4
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M]VG2&]XS>=A-D7Z"+I>WU#XY%-:_<?QMW%;R0_4_=E]"R>M?^NYLL=$]\
M$4")Z9V\@' ^_B?]=7U\NU#XP\V]J/P^7U;>2'XPV[]0UC]V_P#7+RQ]3J0@
MH "        4"=      +YX$ H$  4"    "@;V;"7.G$+R7)=V>>0^[NAE\
M<MV=S7;:SU;.6YTN/#M\@    QU/\^9'UK>Q+"2R*10   ^#L[-\EV!ON<NU
M]](UW_(?^.XU%W@?%V=7RMZ=UWP.;U^9JJ:^;-
M         #W^%'TI8=>7I7SU.^^VOJ.3U[>6'G_NOZ1K7[=SL.FD_0+\O*
M   &L&UQ]$KO+,CV3CQOWU]._/')<V!W:?5X_;NYG-C2F\:1C">-^@(P0J@
M                        $4*@  66V] LX).+>?8T_5[_ 'OF2[G$-K=W
M?9YW''.TSWK=KJ_5NY8;P&R&I0    8X3GXJ_P!W\ RWDED<Q4    'YUOK,
M/ZGZA\UJ1_C'L-B?#^&7DML=M?Q1R2T!3TK=X[EU,=&WB (44"$%  0HI!"B
MD "% "@" ! *  % ";P% @ "D H_E&_,+]]V*F$]%SY/2CCA^K#99_IQP3^9
M]+[@T\+M'XB_C>NV;\-9Q,^'Q/N    !YV]W-2\WDF=[@\MN*78/Q\)G=Z]_
M9*;&MP>#UCI>".13)PJ *!!"B@0"@0 !0!!"@!0!  @50@4""%%((4 ! "JF
M="H[E_50?1GBK\Z8'Q1IY';W:QQ<\O5['Z$^#D=6TT;QT5N#N)4H   'AY'G
ME4_:$ ]P                          $U4T9 "HB@5$LS   &-ZGS]IGO
M=G9*9Q@F^R08*    #F?MV\[,/O),[W9I[?[2Z-_'S-"]\G;:MU;N6UHHF9-
MX]C.\TK=BI$ (!0  "  *  A12"  * WP(   4   A0( #0  OW:=(;WC-YV
M$V1?H'NE[?4?CD4UK]Q_&7<5OZ8?J?NR^A9/6O\ UW-ECHGO@   B@1/3.WD
M X'W\Y]7T\NU#XP\V]J/P^7U;>2'XPV[]0UC]V_]4O+;A]3J0@ 7= @%  0
M!0(   6P     (!0(44@@% @%  0#>[82YTXA>2Y+NSSR'W=T,OCENON:[;6
M>K9RW.EIX=OH    &.I[GU(^L;V)8&12    ?!V=F^2[ WW.7:]^D6@>0_\
M'<:B[P/B[.KY6].Z[X'-Z_,U5-?MF@    $ H     *@             5
M  $'O\*/I2PZ\O2OGJ=]]L_4<CKV\L//_=?TG6OV[G8=-)^@7Y>4     -8=
MKCZ)7>69'LG'C?OKZ=^>.2YL#NT^KQ^W=S.:ZYT7H&DM[POT!&"%4 "H
M@%  *@ %0        "H   J! *  !H=TA."3BWHV,_U:_P#[YD;.UQ#:W=WV
M>=QQSM-=ZW:ZOU;N6&[YLAJ0    &.$Y]KZW\$RWDED<Q4    'YUOK,/ZGZ
MA\UJ1_C'L=B?#^&7DMK]O?Q1R2T!T-WCN'5S%(MX@,4!6 %8 5A050%0%87*
M#<  *@J5 5 (!0 *@*@  "H"L *@*@*@#*! /A&_,+]]V*F-W1<^3THXWZK]
MEG^G'!/YGTON#3PNT?B+^-Z[9OPUG$SX?$^X    'G;W<U+S>29WN#RVXI=@
M_'PW.[H/?V2FQK<'A,_I>)\C)PUB@$J K  !4!4!4!4L45  #< 5@R@J E 5
M 54%0%4!4  4%80%8 54%80%0%5T@J[E_50?1GBK\Z8'Q1IY+;W:QQ<\O5['
MZ$^#D=6DT;QT5N#N'R*   !X>1YY5+VA"CW!
M       ?X'52F-<K75&6:YJJCFK%8BHJ9T7*9:,\ Q_49N5??:G3+)F$^79
M8CX[7M5B+K+G<BV%I-$9 \*4SQC+=M9PF-)6IX4IGC&6[:SA%)*GA2F>,9;M
MK.$4D7PI3/&,MVYG"*2'A.F^,9;MS.$4D<Z]M>EU*OWIN'%H<A,5B% I<XR-
M%DH;H[6.6,U41SF(J(JHFD]C]L:QEY-M_K+HMK._N;S2?>OLW6==SM7]WR[K
M]&VZNC$S3=C&F#2M+F7NL1.2U42Q$M_W6+^*>IG:.K;G_P!+?'#4D_;6T_X^
M9Z,G(V]WR7JOP2+^*7YAJWM+?'#'^M;3_CYGHSY$Y&WM^2]5^"1?Q1\PU;VE
MOC@_K6T_X^9Z,^0Y&WMR_P#2]5^"1?Q1\PU;VEOC@_K6T_X^9Z,^1\N1E[OD
MO5/@L7\4?,=6]I;XU_K.T_X^9Z,OCR-O=\EZK\$B_BCYAJWM+?'#'^M[3_CY
MGHSY#D;>[Y+U7X+%_%'S#5O:6^.%_K6T_P"/F>C/D.1M[ODO5?@D7\4?,-6]
MI;XX/ZUM/^/F>C/D.1M[ODO5?@D7\4?,-6]I;XX/ZUM/^/F>C/D.1M[ODO5?
M@D7\4?,-6]I;XX/ZUM/^/F>C/D.1M[ODO5?@D7\4?,-6]I;XX/ZUM/\ CYGH
MSY#D9>[Y+U7X)%_%'S#5O:6^.#^M;3_CYGHSY%Y&WN^2]5^"1?Q1\PU;VEOC
M@_K6T_X^9Z,^1.1M[ODO5?@D7\4?,-6]I;XX/ZUM/^/F>C/D.1M[ODO5?@L7
M\4?,-6]I;XX/ZUM/^/F>C)R-O=\EZK\$B_BCYAJWM+?'!_6MI_Q\ST9\CY+<
MR]WR7JGP6)^*3YCJWM+?&O\ 6=I_Q\ST9?'D;>WY+U7X)%_%+\PU;VEOCAC_
M %K:?\?,]&?(O(V]WR7JOP2+^*/F&K>TM\<+_6MI_P ?,]&?(G(R]V;DO5?@
MD7\4?,-6]I;XS^M;3_CYGHSY#D;>[Y+U7X)%_%'S#5O:6^.#^M;3_CYGHSY%
MY&WN^2]4^"Q?Q1\PU;VEOC@_K6T_X^9Z,G(R]WR7JGP6)^*3YCJWM+?&O]9V
MG_'S/1E%N;>[Y+U7X+%_%'S#5O:6^-/ZUM/^/F>C)R-O=\EZK\$B_BCYAJWM
M+?'!_6MI_P ?,]&?(<C;W?)>J_!8OXI?F&K>TM\<']:VG_'S/1GR'(V]R_\
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MC/D3YYL_^1E^E!R=O)\G:G\%B\ ^2:][&_T9\B_/-G_R,OTH.3MX_D]4D_\
MM8O /DFO^QO]&?(GSS9_M\OTH.3EXUM_Z=J6;W-$X!\EU[V-_HW>0^>;/]OE
M^E#W6%U"KLKB7<":FJ)/RLK+UR6?,3,67B,APV(JVN<Y41$1-U3N?M[96N96
MOY-U^5?$1?;NS;/#'X.C^Y]KZEF[+UFRS.LFZ<NZD1=%9XG67PI3<_A&6S^R
MLX3>E)?F]?"E,\8RO;F<(I(GA6F)_P"8RW;F<(I)5?"E,\8RW;6<(I)4\*4S
MQC+=N9PB@>%*;XQENW,X121K=M46U?"U96DIX4FO#$B_O:4LC1-5JNUG:K+5
ML32>2^\]6S<_4=#+MFZ=.-R(F9PG@>Y[O-:R=6VIIYU\66Z%T5NFD5W-RLN>
M*W<O)G6[U2S>YHG :@^1Z_3L,ST9\C>,;>V=_(R_2A.3MY/D[4O@L7@)\DU[
MV-_HSY&?SS9_\C+]*#D[>3Y.U+X+%X!\DU[V-_HSY$^>;/\ Y&7Z4')V\GR=
MJ?P6)P#Y)KWL;_1GR+\\V?\ R,OTH.3EY/D]4_@L7@'R37O8W^C/D3YYL_V^
M7Z4')V\?R>J7P6+P#Y)KWL;_ $9\A\\V?[?+]*#D[>3Y.U+X+%X!\DU[V-_H
MSY#YYL_^1E^E!R=O)\G:E\%B\ ^2:][&_P!&?(?/-G_R,OTH.3EY/D[4_@L3
M@'R37O8W^C/D7YYL_P!OE^E!R<O)\G:E\%B\ ^2:][&_T9\B?/-G^WR_2@Y.
MWD^3M3^"Q> ?)->]C?Z,^0^>;/\ Y&7Z4')V\GR=J?P6+P#Y)KWL;_1GR+\\
MV?\ R,OTH.3MY/D[4O@L7@'R37O8W^C/D3YYL_\ D9?I0<G+R?)VI?!8O /D
MFO>QO]&?(OSS9_M\OTH.3MY/D[4O@T7@'R37O8W^C/D3YYL_^1E^E!R=O)\G
M:E\%B\ ^2:][&_T9\A\\V?\ R,OTH.3MX_D[4O@L7@'R37O8W^C/D/GFS_Y&
M7Z4')R\GR>J7P6+P#Y)KWL;_ $9\A\\V?[?+]*#D[>/Y/5/X+%X!\DU[V-_H
MSY#YYL_V^7Z4')V\GR=J7P6+P#Y)KWL;_1GR'SS9_P#(R_2A>3EX_D]4_@L3
M@'R37_8W^C/D/GFS_;Y?I0G)R\GR=J7P6+P#Y)KWL;_1GR'SS9_\C+]*#D[>
M3Y/5/X+%X!\DU[V-_HSY%^>;/]OE^E"\G+R?)ZI?!8O /DFO>QO]&?(GSS9_
M\C+]*$Y.7D^3U2^"Q> ?)->]C?Z,^1?GFS_;Y?I0<G+R?)VI_!8O /DFO>QO
M]&?(?/-G^WR_2@Y.7C^3U2^"Q. ?)-?]C?Z,^1/GFS_;Y?I0<G+Q_)VI_!8O
M /DFO^QO]&?(?/-G^WR_2@Y.7DL7_IVI_!HG 9?)->IV-_HW>1C.WMG5^(R_
M2ANILB2\S1I:_7AB7BTGCYB26 DZWB-=$8]%5NO9;9:;+^Q-2S]7LS8S;+K:
MS%*Q,</"U-WF:]J^M9F1.1F6WQ%MU=&8FF[OT;F>%*9XQENW,X38%):N/"E-
M\8RW;F<(I(GA2F>,9;MK.$4E*KX4IOC&6[:SA%)4\*4WQA+=M9PBDC'W?4JE
M]N^.^87$:OY_734]+9Z:VPRI-&+(/A2F^,);MK.$QI+)/"E,3_S&5[<SA%)%
M\*4Q,BU&6M]M9PBDAX4IGC&6[<SA%)#PG3?&$MVUG"*2. _UBMS[W7DVDIZI
M7=NK5Z_3779I4-M0ITE&FH"O9QNLU(D)KFVI:EJ6GJ]D9UF7D4NF(G=QEY?:
M>3??G73;%8I&]/!Q-%_W88EZK?\ V[O-D3Q5-?HSM?>\KSH\<.O]TS*1_C/B
MGR)^[#$S^'=YOV5-?HQ[UE>='C@]SS."?%/D7]U^)G\.KS?LJ:_1CWK*\Z/'
M![GF<$^*?(?NPQ-_AU>;]E37Z,>]9/G1XX/<\S@GQ3Y!<+\3-.'5YD__ *J:
M_1CWK*\Z/'![GF<$^*?(G[L,2_X=7F_94U^C'O65YT>.#W/,X)\4^1?W7XFK
M_P#KJ\R__P!5-?HQ[UE>='C@]SS."?%/D3]V&)G\.KS?LJ:_1CWK*\Z/'![G
MF<$^*?(?NPQ,_AU>;]E37Z,>]Y7G1XX/<\S@GQ3Y%_=?B9_#J\W[*FOT8]ZR
MO.CQP>YYG!/BGR'[L,3/X=7F_94U^C'O65YT>.#W/,X)\4^0_=AB9_#N\W[+
MFOT8]ZRO.CQP>YYG!/BGR'[K\3?X=7F_94U^C'O65YT>.#W/,X)\4^0_=AB9
M_#J\W[*FOT8]ZRO.CQP>YYG!/BGR)^[#$S^'5YOV5-?HQ[WE>='C@]SS."?%
M/D7]V&)G\.KS?LJ:_1CWK*\Z/'![GF<$^*?(?NPQ,_AU>;]E37Z,>]97G1XX
M/<\S@GQ3Y#]V&)G\.[S?LJ:_1CWK*\Z/'![GF<$^*?(G[L,3/X=WF_94U^C'
MO65YT>.#W/,X)\4^1?W7XF_PZO-^RIK]&/>\KSH\<'N>9P3XI\A^Z_$S^'5Y
MOV5-?HQ[WD^?'C@]SS."?%/D/W88F+_^NKS?LJ:_1CWK)\Z/'![GF<$^*?(?
MNOQ,_AU>;]E37Z,>]97G1XX3W/,X)\4^1/W88F?P[O-^RIK]&/>LKSH\<+[G
MF<$^*?(?NQQ,_AW>;]E37Z,>]9/G1XX/<\S@GQ3Y#]V&)G\.[S?LJ:_1CWO)
M\Z/'![GF<$^*?(O[L,3-&'5YOV5-?HQ[UD^='C@]SS."?%/D/W88F_PZO-^R
MIK]&/>LKSH\<'N>9P3XI\C^<;##$SB'?^W=YEL1R_P"536XO^K).M95.E'CA
MGDZKF1='^,X\$^1^G+9GB,I>S_@[3JH]M-J,E=.F09R1FE2#&A1&0&HYD2&^
MQS51<Z*AXS7_ /+/OF,)EZG9]LVZO9$XQ#.7A2F>,9;MS.$^.DOL3PI3/&,K
MVYG"*2'A2F>,9;MK.$4#PI3$_P#,9;MS.$4DJ>%*9XQENW,X122KZ"]<_(Q[
ML7C@P)R!&C1*7.MAPF1&N<Y5@/1$1$7*MJEB)8S@_)XW#'$M=?\ ]N[S>G?_
M .537JE_U9[VW6LJG2CQP\=G:I?=.$^*?(^?[L,3/X=7F_94U^C,O>LKSH\<
M.+W/,\V?%/D3]U^)G\.[S?LJ:_1CWK*\Z/'![GF<$^*?(O[L,3/X=7F_94U^
MC'O65YT>.#W/,X)\4^0_=?B;_#J\W[*FOT8]ZRO.CQP>YYG!/BGR'[L,3/X=
MWF_94U^C'O65YT>.#W/,X)\4^0_=?B;_  ZO-^RIK]&/>\KSH\<'N>9P3XI\
MB?NPQ,_AW>;]E37Z,>]97G1XX/<\S@GQ3Y%_=AB9_#N\W[*FOT8]ZRO.CQP>
MYYG!/BGR'[K\3/X=7F_94U^C'O65YT>.#W/,X)\4^0_=?B;_  ZO-^RIK]&/
M>LKSH\<'N>9P3XI\A^Z_$S^'5YOV5-?HQ[UE>='C@]SS."?%/D/W7XF_PZO-
M^RIK]&/>LKSH\<'N>9P3XI\A^[#$S)_[=WF_94U^C'O65YT>.#W/,X)\4^0_
M=AB8O_ZZO,O_ /537Z,>]97G1XX/<\S@GQ3Y#]U^)O\ #J\W[*FOT8]ZRO.C
MQP>YYG!/BGR'[L,3/X=WF_94U^C'O65YT>.#W/,X)\4^1/W88F?PZO-^RIK]
M&/>LKSH\<'N>9P3XI\B_NPQ,_AU>;]E37Z,>]97G1XX/<\S@GQ3Y#]V&)B9\
M.KS?LJ:_1CWK*\Z/'![GF<$^*?(G[L,3/X=WF_94U^C'O65YT>.#W/,X)\4^
M1?W7XF_PZO-^RIK]&/>LKSH\<'N>9P3XI\B?NOQ,_AU>9/\ ^JFOT8]ZRO.C
MQP>YYG!/BGR+^Z_$Q?\ ]=7F_94U^C'O65YT>.#W/,X)\4^0_=AB9_#N\W[*
MFOT8]ZRO.CQP>YYG!/BGR)^[#$S^'=YOV5-?HQ[UE>='C@]SS."?%/D/W88F
M+_\ KN\W[*FOT8]ZRO.CQP>YYG!/BGR*N&&)B9%PZO-^RIK]&/>LKSH\<'N>
M9P3XI\B?NPQ,_AW>;]E37Z,>]97G1XX/<\S@GQ3Y':/ZK^DU:ZN'&)TO>FE3
M=VIB9O/ B2\"J07RCXC$E&MUF-C(U52U++4/+[:S+<S-B;9B8IO;KT6RK)LL
MF+OPY'3Q*G3<G_,9;-[*SA.FB)H[9\O"E,\8RO;F<):2)X4IGC&6[:SA%)%\
M*4SQC+=N9PB@>%*;XPENVLX121Y*F184:]]1B08K(T-8*6/8J.3JH![L@
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M@!$7=M 6+;GR;@%  8]O;:MX+F^_7?:.7+C<E)9".)0 !+ %@"P!8 L 6 +
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M#B*J+0(70GY>WJJ9Y,[LI+W,#\S!]8WSC"<5?U
M               ?Y9Z5;/2<U)O<K&3,)T-SFYT1R66H!_GI%-ATBG2E-@Q'
M184HS49$?9K*EJK:MF^69K-1]D0
M      !]%5*' JD]29Z+'B0HE*BK%@L998Y<F1;=XRBZ@^],0
M                            'UM7IL*KTV:IT:(Z#"FF:CXC++4RHN2W
M>+&X/]$E*MD9.6DV/5[9:&V&U[LZHU+$ML)(_P!0  !]?5*?#JM.FZ=%>Z'"
MFV+#>]OID3H6B)H/G3I)E.D961AO=$ARD-(;'NSJC<RK8)W1_M
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MY2 Z R EFHJ.MRKIMRETJ10??$
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M[3YE96HTU\3CF-=E5KH<6Q-9%3/DR"Z*#/%J+F4@H    6@
M  (ZVQ=6Q5LR(N:T#1RYNV,EX,97X25:Y+:'_P XF:)+5E)Y(JOF8,348B0^
M+;Z:RW.9SE_XU2K>!;$2RVQ$3T6@XX5HS=3;1E;R8R0L+7W+63D9JM1J+*WD
M[]1UL2"YS4>Z#J)8BZNZ<DV)5O2F9+<^DP5HW=+; FKY8S2^%5*P_5\E$JLS
M3H]XN_K4ALEE>CXKH20[<[+,YGZND52K>1++5Z!@J@+4   %J;N;.!AW'R^-
M=N!A!?R^5VHD&#7;OR#9BF19B&D:$UZQH;%UH:JFMZ%RY"Q&ZDSN,+[(6-%_
M,8J->B=OS-2,S&I4>$R3=)2S99$:]':VLB*MN8SS+8C B=QN5:FZ<:@  !C3
M%O$RB837&K%\JU^69(LU)&0:Y&OF9E^2%"1<MEKK+5LR)E+$5&OFSQM73>.E
M[ZG=69N*EV4IU(6IK.-GDF=9R16PEAZG%ML]-GM,KK:)$U;FMS9<Y@J@
M               7,!K9C-M08<8-3+:/58\>L7EB,5[*)((CUAI9:G'O15XN
MW1D4RBR98S=1JK*?6+-?/PH4YA=%@4Q8JI'G63JOB-A6^G1BP4M6S1:9>K-.
M&Z6$&.^'^-DC-S5T)Z-#GJ>]&U&B3S$@S<+<>C+5UF.T.3S#";:+$U9K(H
M6H!+4W0*           -4]HO:;DL!IB@4]+MOO+4JWKQ705C][0X4%EGHM=6
MNM<NX91;4; 7*O3)7VNM0+UT]D2#*UR59,PX,5NJ]FMD<U47<=:A)B@]80
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M;'2Y]3O5'NYR9=3ZM&IK9%)COG72$QC^,UD:VRW7S6"ZVDK6K/QB
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M_<-U=74%UM$B6TZ+:B+FZ!BJ@
M                 ".1%147-I XE[6D_-UG:1J-+O/-QX%WZ9'ILK)K$UN+
MA2<9D-8RL3-8Y56U<Z'T68..:U=>+JW)P_H]WJ73[JW>I')Z'+,\&O@084:'
M$@N2UKDBJCM='(MMMJG!-TU<D4:)[0^R->6M7]IE\\%J5(TEKH39FI2S(J2R
M,J,*)K,BPTUFZJ*U$M1,F<Y+;^%C,.@MT4KS+KW>9>G46\K:?+I7G0U16K-I
M#1(JM5,EFO;8<-636[%K;%PLPMJ$U14='O;7I!Z,G*;37-1L-RYVK&B>@54T
MHBF<63*3=$/-X>[=6$U\ZE+TNJRL]<R-.1FP).-/.9&@NB/S(Y\&U&;ZET)(
MF);@U2K0*;1:A7&M[\EI"3BSMD%R+QL.&Q8GH%S943(8*T[NIMS88UR#>B/7
M:34+G0+MP'QH;IU\.,LXK7:O%P4A9=955,YGZN4FZ(9&P"VE;N8^S5ZI:@W?
MGJ*VZR2RQHTY%A1$CMF=;55B0\UFHN<QFV8Q(FK[_%[:(PUP:AI O-5%CUR-
M"6+)W?E4UX\1$7)KJGH8:+HUE0MMDW8$W4:]W8^L(PLK4^DK7*!5KJRKE2VH
M1W0YEJ(NE60+7&4Y5T)IPWFH];I5X*7(UJC3L*HTJI06S$C/07(Z'$ANS.14
M\TXYW&3Q6)6+5P\)Z0RL7WKD*EPHSM62E418DQ'<GL<)EKE3=7,A;;9G!)FC
M4*6^L/PUCUE*?'NE6):G<9J+65BP',U4^Z6$U5?TC/U5R:4-T+AXAW0Q*N]!
MO+<RL0JQ2HJJQSF>AB0GIG9%AK8YCN@J&$VT6)JPAC/M14'!B]]&NC5+J5*L
MQZQ"AQFS\K&@PX,)'N5OHDB9<EEJF5MDW8$S$/)XB[<6$UQ9]*3(0IJ^%4AP
MX3YZ6ISX;60'16->C.-B>@>J(N7554'JY*PR+@KM-X?XUQHM+HW?%&O) A+'
MB7>GK%C+"1+5>Q[?0NLTV$NLF(K)%T2^^VA+T71NAA9>"MWWNJZ^EVX;H,&?
MN^Q6HZ-QKT:ECG*EFJNXHLB9G<)W'G-F*]MPKX8==]8<W(?<&[TG.Q8+:+$<
MUZ\9;Z)^LCG*MO1471,8D35Y28VO;HT_%ZKX2U*[4]3GT2=BR<[>J/,0&234
M@L1ZOU7*CK%ML1,Y8RYF";HAX:]7U@6%E"K42E4"AU2^$M >L*+5)1\* S78
MZQR-9&L<MGFCU<E6S^%&,UQ\8Z)&K%SJ@L=TB](53IL5-2/+Q%2U$<U="Y;%
M3(I+K9C$B:O7WOOE=NXE!GKRWKJD*D4:0;;,345<MJY$:QJ>B<Y="(A(BJRT
MCG_K"\,I6M)(0+JUB<I2Q6L2NI$A0X?%JOYSBG^BL3<,O5RFE#U-Z]N/#2AU
M&ZLK=ZD5"^DA>J5AS$&J2+V06RSXL=8/$QH<:QR/2RU>@/5RFE#="0FFSTC)
MSK6N8V<@PX[6.SM2(U'(B[UI@R?ZP              .,6T7+LPNVKZ?>M)=
M).EMG:=6I>.Q+$=%<ML9;$THY3GMFMM&$XNJN)-Z8-WL,;U7GXU(7$T./&DX
MMMB<=&@JD%;?7.0X8Q93@X)TIE[;OONQBKQ&I!FJPR-+U)5]"LUQOY1MF>U4
MM/INF)BC"DN^]<O=+R>&U6OK*QM>#+7?CU6!'3=;+K$;T[3YJ;M'(YC;!M#B
MWDQ9OG?B8@<9)R\C%CPHSL[9N;F$?EZ.HY3EOK$48PZO5VO4>[=*G:W7:A"I
M=+I\)8LW.1W(UC6HEO37)D1,IQ1%631N\WU@^%M%JSY"BW?JMZ)%BZJUB7?"
MEX;EMLR,C6/\PS]7<QTH;$X0[0F'&,[)F7NK4UA5F2A-C3U"FD5D=C'?=,5;
M&O1-*MS&$Q,+$Q+-T:-"@PHD:-$;!@PFJ^+&>J-:UC4M<Y7*MB(B9U4BM*L0
MMNO"2YE0BTRC09V^\Q+1709Q].<R#!8YJJBZL2-8CTZ+<AG&7,L=.'LL)-KK
M"K%>>E*) F8MV;Q3Z*LK1ZDK4UU]0V,W\FKET);:N@DV3!%T2]!M7K__ ([8
MJ^2F6_"()+-V:+=@UF^KQYNWYTVS4O99O..3-E+6:,8=KVY&$MZ(=T&42?OE
M64:BS\"E/AM26BQ%L9">K\[W;B&$6R:45;'7)O#/WJNS2[P5*[LU=69J<)(Z
M42><QTQ!8Y+6\9J9$54T&,LGJP/BYS6M5SU1K6I:YRK8B(F=54#D-CM>>N;3
MF+LS<2Y<?_H_#R4G9MT[:KH#W2T-7S$PJML2R(C=6'K:4.:V-'%C6N#^6P*Q
ML/&B]T-CM9L*[<6&URVY4;-PT1<N[87-2W%V .!F                   !
M_FG7162<T^"U71F07NA-3.KD:JM1.F!PWP&DZ!B!M&2CL5HK)UM0G9^/%EJH
MY6,F)N%K][->YRI98]$U6VY5R'T7=&*,7:2>N1=&HTZ/29V[-,C4^8A+!C2J
MRL)K=14LL16M14R:4/GTI6CGE=G9=Q9PQQ\@7RP_ARDO<:#6;(4/OA$>E&CN
M1(T)\-76O<C+;+3DF^)AC%LU=+IZH25-E)F?J$S#DY&4AK%F9N*Y&PV,:EJN
M<Y<EAQQNLVCE\]OW"J[=3=3Z'1ZG?"##>Z'&J$H^'+PVN;D6SCK%5-Q3DC+N
MECIPROA!M588XP3L.BTR9C42\D5FO"H<_8CGIN0XB>@<O00QFR86+HED/&#$
M^0P@N3-WVJ5(FJU*RD>'!=(RCVLBJL76L6U^3)82V-+ F:-=7[=>%D&XLO>Z
M<IM0EJO-S3I66N:KX:SBZB(Y8BQ/2-;8N2U3/U5R1=#8K!O%.G8Q7 I6(%,I
MDQ1Y*K/F(<*0F7LB1&=[Q70G*KF>ARJEIA,49,,8K;9V%&&4_,4:7?'OE7)*
M+Q4_3Z8YC6053(ML>)^37>:JF49<RQFZ(?XL--MK";$&IR=$GTFKFU2HQ4@4
M^%4E;$A1(BYFK&A6M9;HUK"SES!I0W&UV[YQLFON+VTSAC@[%?3:[4G5&\;8
M7&LN])>CC6+F2(_TD-5W'+;T#*VR9P2;HAA&Y_U@&%%X:@DI7:/5+H2ZJUK*
MA,NAS,-5<MB:R0+51.BJ%G+F$TH;R4VIT^L2$G4Z7.09^GS\)L:2G8#TB0XL
M-R6HYKDR*8,FJ$MM@7,=BG4<,ZI=Z=HO@R8C2\W>F<F(#9-J0;;766ZUBZN8
MSBR9BJ:4/!5[ZP?"NFU9:?0Z!5;T23(BPUJTL^%!8MBZJJD.+8Y4M&A)5M?A
M;BS<[%Z[B7CNA/+,P(;TA3\I$16Q9:,J6ZD1%LZ2F,VT(FK7C:TQ#PEN8^Z$
MEBAA;%Q&;4ECQZ2Z$]D-9986KK6NUFN6VW-;8961,X$S1LI=Z\M+B8=2-[*5
M2GT^CP:*L_*T=-5KH<&#"5Z0DLR6V-LM,)K5:M:K@[;N&M[Z;>*K5RESEQJ=
M=V V,^)48L*(^85<S(,.%Z)RY-RPS]7-*L8NAY"6^L+PQF*WW@ZZM8AT5(JM
MY1)$@OA\6F7C.):NOTLXC+E:PWANK>J@WTH%.O+=JH0ZG1:I#2)*3D/,J+G1
M47*BHN147,IC,4FBO#8K8UW P>IL"=OC54EYB>1W@VE045\Q,.9ZEK;=5-&L
MN06VS,5A):PW;^L$PKK-<92:Y0JI=61COXME9FGPXT/6<[5;;#@VO1%T[AEZ
MN4BZ)>]NGM=W2O?BU&PKH]V:C&<DY&E92]#8\%\I';!1%2,QJ>BU7(N039,0
MM=UMVA@J@             ^OJU-EZQ3*A2IN&V)*U&7B2T=CDM161&JU;4TY
MQ$T''O90J+[@[3=5NM4(:R<S7(E0H\*7LM2R%$?&AMM3-Z%B*<UT_P"+&,6X
M.W3>V)0,&EI$I,)"GKS5.7E70U7*Z6:J\<EFXMJ&.7;62Z:-'MF6+7L*]H&Y
M],KD)*9*WHDXD&/KK^<EXL)5@.3H:ZHEAG=&E&X6SNT;_P"VI>CDW@56H".5
MJWEFY>CN1,FLR.CG*F]Z X\N*R731XK8'NQ$HV$E0KDW 1DQ>"L1GRT9/NI6
M&QB,L^^52YLUE8;3XBXI7)PLHJUR^E:ATJ4<NI+P<KX\9UEMD.$VUR]%;+$T
MF%MLR3-&G,'ZQ##6)5W2$2Z%9A4_C=1*PL6 K',T/2%;KY=PSC+F4TH;G8>X
MDW.Q1N]!O-<JKLJ],B.6'$L16Q841,[(L-?1-7?SZ#"Z)MQ6)J^ZO/>J[]S:
M+/7AO-5(-'H].9KS4[,.U6IGL:U,[G+9D:VU5T"(F29HT?K_ -89A=2ZLZ1I
M-VZO>"GHY$2KPGP8#%15L5>*C6/Z.8S]7<FG#9S"?'C#K&25F7W0JR/J,BUK
MJA18Z<7,PD<GID:MFNU,RN:8W63;BL35J%]8UENKA:J9+:S/?%F&67"78-EM
ME^/"EL!;FQYB*V! @RL:)%C/5&M8UL1RJYRKF1$,;L64,8IMJW:J>('[O[F7
M!KE])V-.]YR52D(L%L&.K51KHK4?E1C<ZJHFR8W4B:MU8#HCX,)\6&L&*]C7
M1(*N1VHY4M5NLF1;,UJ&*OZ@>;O;>BD7,NY6+S5R8;*TVCRSYB8B/5&ZVJGH
M6(JZ7NL:G14L14<.K\MO?C:S$7'VK/65N_3)Z#3Z=!B:UNI$1W$0H7W/Y-K;
M'V="T^BVD11A-6_7U?2VX0WB7=O1-KDZ,&"<.9$U6W!O>8,@
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MS4L=/#B9@
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MR%%=,-:K8=MJHW)F.6V:PPF*2[1W?_R*B^\9?N;3AG%R0^W(
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M)9NW5B&KNP0B_OJOHN5=6[L957?G695,\YC&+KZBV] X&:@
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MX=V:<KW4^[]5GY&26(MKUAPE1&VKNG-=.XQC%VQ.!F              BYE
MXXXTLC83[84A>_BN)DZC4I*>D&PTLL;':R7B*B>N<IS1%;7'=.ZR!MG3K<0,
M;,+,*)6,YL5(D&%&2&MMJU1S58[<S,%FY"WOX[:5TW7&OG@WB%*QW2TM3F25
M*BMA(C4UZ=$2.Z)K)ERL2Q267$Q2:OZ;=]^XE=H6$5*DWM6E7JD/#SM55R+$
M2&D%R(NCT:BR*2715OI@5=6+<O"&X5VYEMDW(4N$LV_51%=$BJKU5>C8XX[I
MK+*(<I<9[Y4W&':393+V7D91L/Z34DI"3T9ZI+R$"6M[X556RQ7O9GLSJ<L1
M2&-:RW<FJGL13=VHMU4K%R8,C%E5E&SD)(:3K;4LXQ)G4XS7RVZRJ8?Y+N-3
M=C>]C+F8ZU6YLA5F35W+TK,R5/2'$<^#,K <Y\&,RW*K^+8B6J9YENX1+[[;
MUOU4:SB!0L,(4SWI2:%*P9^;UWJD")&G+%:^,F7\TUMJ*F8F7&X3+8"X4[L7
M71NA3;O1[P7*J\PV69X4J-0;#F)B+%>VUZ\9$8KFY56RQ4LWR3I5-QIC3JW=
M/"[:GI%3PLO#+S]R9BH2S73\H]8D%TG.K;,2B.6Q;&K8BF=)FW=3?;-?6+*D
M2Z>%:LRM?6)Y66;BRS+#'+6[!J]>;:,GW8-7/P:N2Z8IS$A++WPK"^A6,L:+
M^3EY=4RHU=9-9UMIEH[Z5HZ&[+FSC2\': E>J[9>HX@7@@-=4*E"]'"E9=R(
MK9>75=_T3T]-O''==7<6(HVV1+$L,&1:!R]VM,0:UBU?^A;.N'[GS#5FFI>*
M/ 5SM>9R*L-Z)D5D%BZ^72AR6Q2*L9ED[:(P^I&&.RA#N;1F-XFE3$FDW,-:
MJ<?,O1RQH[DT:[LHMFLKO/Z?5]6IA!>+);_U3-HO:8)<W%+,&^*93B9
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M.7FRI'C74VH):@TZ8B,IDU$J<A-0K?SK(;'<2D2S/JKE0YK\&%N+:?ZPY/\
MVPNA\X6]Q<89.+*[!F_9(^@>Y*_ZAWGH3,Z4K#EIA#<"@8E[1,Y=>\\.)'HD
M2\54CSLI#<K%C\5'BN:Q7M5%1+4RV9\QRWRXZ;KIMCY@UA<W!N_,Q*7'H],F
MZ%1IB=I<[(2D*6CPXTM#5T-5BPVM<Y+4RVJMIQ673I.28W&J_P!7;7YIU8Q
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MFXY<[%+'3Y,R:.@<3,
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M9T6%L[K('UB_^8886Y^)GK>JTPR=];L&[=T,FSY(_-"/\5B&$XK#G7]7TO\
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M[-F,KZ;["VKNY3&33*;3V3SM>=9+0FSCU6VV*C$1ZVIG]%:<#E?[@
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M1I^G56DQ9&6@TYT=8K8KYAL5%<CV-;9JHN9<YE-U4B*-\FYDR6= P5\@
M               ^+LUB*J6[@&EN,^QG<[$BKQKV7:J$2Y=YH[^/F^]F6RTS
M'2S5>J9X2HJ6VL3.<EN91)MJUV;L7[1<Q'24J.+D&+18D163,/PG47N6"O\
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M_6$0PWL[TBG2FU9+4B[371*/2IV?;2VN6U>]8"(NLJI;T3.^:PQC%VR/G<@
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M*?2JY*2L"9C*BQ(\PV&O'O=8JI:KT5;$,M+2BK&E)=TTS'SN0
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M+;]<KZE2JDMYHDBZ0\%K&=J)+MB(_C%BM;G5Z6%NNJQB*-S$S(8LE
M
M              &M&U!A'?+%ZXDG1;EWA\#5&E3S9]\BYW%PY_BT_)PG1$5-
M35=Z)%7):AE;-)26F;<5]N2Y;(=SHUR)JN1J=#27;7'4J+/.>EMB/6:8J->M
MFE4.28L8UEZ# K92Q!K]_H.*6.2<8K9E*FE/G(G'S4]-9X;HZ9%AI#6Q41<N
M0771$4A8=0FHJ)ESG"R4
M                                             !HAM,8.8VUR_E Q
M8PIO+%=-W8DT@2EW&QE@.EU156*^$N5(B1D6QS;+5.3+FW?2:M?JMBEMNW]D
M9RY3[CS]$2JM=)QZQ*TJ+)1=6VQ^K,.5S6HY,BK8EJ&5+*U2=ULALI;+\[A&
MZ;OE?=LM&OK/0EEY&4@.2*V0@/MXU$BHOHG1+4M,+[ZK$-WVVHB6Y])@J@
M
M                       -.MJK!G$_$EET+P8:7D=(52Y<5\Q+T)(O>_&3
M"JCF3,.+;8CX:)8B6&=ET1N2DM7YG&';C=#F+GNN+.PYC461=>&#2(W&HNKJ
M\:R:MU-;3KV9\IG2Q*RRALO[*5Y;IWI_>?BJV'$O#!5T>BTUT5)B*R9C973<
M>(BY'V*N3HDONBE(6'11J6(B*<2J
M
M                             EG4W ")8*"@
M
M      $U4WMX":O14"HE@%
M                                                 (J*J66], B6
M:<P%
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M               "6IEZ&<E1\5=E1$5"@KT1=._8H2IKMMLMLR9U)$J_FL1R
M(KK4<B:$0H_LBHMF?+T &6W/D H
M  $<JHBJB6KN ?'6R9%S9\A-V#%%>J.U4:JKNE-Q%<K4M5;>@B&,W?C ^=MN
M;S"Q,3A(CGZJHEEJJHP!RKDL5$WTM%LU**U55J*J6*4?(
M                    #XZR(NKI4"K;H5.H015=H2U1$@FMIR= #Y" *
M
M
M
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MS2R[HGP[OAA[A+-!Q/J-9-U,@%SY@
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MVK9F1=-N9$Q/X[C[IJM1J+;8W=7^TYI<,/E:FZ15
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M<+G
M
M
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M3 RP0
M
M
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M\1,PFNL>U6>ERIF5,IR3$70QC<EW9IE];N3]W:#>6/5I*F2%?EH<Q)OFX\.
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M=+5L[SE-_P!.N3I&.:RMW-QU0.&&0
M
M
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MT9?1EQW8NJ^SG]!V&?D6%V3CANQ9PS2J>88JX5[8<W(36.U[72,2'$ART&#
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M(^6W_<Y/+]\I,TM=4#A9@
M
M
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M$BNM/OV9VT/AVCV4\</SIT9J)!=9I6WI69#V>1@\GG128C\'VRG.^>9J%0(
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MKJ?:F:TX&0
M
M
M                 'UE:D_"-(J=/\82L>61;+<L6&YGVS*R=&^V>"6&9;I6
M3'#$OS>3M-==2_\ 7*%&;Q3J;4YJG*Q4LR,BJB9-RQ#9>H9T5B[>E^5MN:K=
M;ZVRE*73N>%[Q<BJ=U.YB\-"=%,O1"S$P!%  2Q;;-(G<5Y^\\=)>E18>18D
MPY(;&9[;>AI.#6+XC+G\=QV.RLN;\^)X'0CZNJ[;X%W+^WN>U4;59N#3(#U3
MTW>[==;%W+7G@-OYL3-MF_&+]$=W&KS&1G9E-R9I_HZ80[=1MN=,BGGFRV,L
M:_HDQ$L\0SG<U+;BDX.'>"%P*7BAB7=RY%:G)J0IU9=%;&FI)6MCLXN&KTU5
M<CDSIN'T7S2*N.V*NB__ &],+E7GC>GM\NO^$<49DL]"'K[H;#6#=V9U)RI,
MJ-\48Y'0I6KQ6K#1R+:BJD%&*O5).9)HPV_IU-D:3)2M.IDE!D)"38V%*RD!
MJ,AL8U+$1K4R&$[K)K1MDY,!;S^WRO9F5F*2T<V ELQ:KEN?P!$[HTY<UA;B
M[$HMIP.0  1= '#/;*M_?]?#VJ3[@P^G*P<=[K=@#]#&&_D27\Y3Y[L99Q@R
M^10               !S!V^;IQ(55NA?27A.=+S$.+3ZI&LR->S56"EO]ZU3
MQ'W5D3IVYD1N4IX?_P -E_8>M?XWY5?QAJQ=J=2=I$JY5_*P4XJ*G10U+K^3
M.7G7<$[K=&S\W3R8F7WQ\3[@@   '\XT5L"%$CO])":KG+O(966Z5T1PN/,N
MI;)LXW:C7ZQQNPCH2QI&1F8E2J3T2W4A0458:KN(KD1#9&P=5TM8R[*;D-:_
M=6NQE:EFW3/2BD?B[C(JJ],F2PVI,Q@T8_J4</MM);,?+RZ/]TDLO^P;:<^7
M@X[XW72; +#RX%4P9P[GZE<>@3\],TB&^9G(]-EHD6([6<FL][X:N55Z*G'=
M=-641#,4+#+#B ]D6!<&[L&+#RLB-I<JCD7H*D,QTI6D/:PH3(,-D*$QL*%"
M:C8<-B:K6M1+$1$3(B(17] /S[8^M5N-E_VN:K7>'8F1>C&/HC=M<<QNN\ES
ME1+I77:N?P3)9/\ 8,/GNG=<D/2@ /%7_OU=[#>Z]2O=>::;*TRG,UE2U.,B
MO^XAPT7.Y=P1NCBK?.]V(>U;BK*R%-EXD?OJ,^%=NB-M2!(2EMBQHJID2Q,K
MG'T6VQ;&ZPW:NN6!N"EWL%+J2]%IK&SE:G$2+>&NN:B19B.J6JUNXQJY$3IG
M#==6640S9:FZ8JMMN;*                UEVPKAQ,1=G/$Z@2\)T:>EJ3&
MJ5-@-2U7S$DU8K&HG1LR'U:C?ZO.ME\FOV:>3=#\J%&B18+5@S#59$;:R(U<
MZ/;D<B]%%2P]ID7;FZ\EGVS%M9>B5%2RW2EJ'UOFH(EH2DH5 "D#TV;[G.,6
M415YZLQEB1(<O!17QG6-APT3*KW9&ITU/ES[HJ^K)I&+]4^QI<1^'>S?AA0I
MB$Z!/35*AU.I2[DL6''G&I$>U4SY+4/%Z]?I9TO6:CEZ&3$-H3Y*OK:3;>7T
M,2_EN6[%YG9BQNP:J;$6'MR,0:]?F6OK=B0O- D)"7B24.>A\8D)SHFJJM30
MJH9YETI$0Z*+LUX#?PIN]9I_W5.$X].65(9!NO<&YER8+I:Z5V:==^"]45[9
M."UBK9T;+23,RKUR6V9<BD'-SZPY%6BX>JB6IWU-);O)#.7*8WQ5]S]7HO\
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M
M
M
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M0 (H'#/;*^GZ^'0@R=OP=A].5@PO=;L ?H8PV\B2_G*?/=BRC!E\B@
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M;%*C7)KLE18--J$"-%BQ)2&]L6V&B*EBN>J:3CNMB%B9=*&V69-"V''#)\@
M             /YQ60XL*)#BL;$A1&JV)#<EK7-7(J*BY[16FZ3%=Q^6';.P
M"G]GG&JM2<M*NAW(OA,1:Q<N>M5R+#CO5T:"]UEFLV(KK$30>LV?K49ED<,/
M+Z_D39=-LX2UREYEDPQ'(N;(J;AW5M^E#IKK9C<?Z'>AS&4[B3N(9( 4BO\
M/,S#)6'KN6QRYMU3"^_1AE%LW;D-B=C3 &H[0V.%&DIB3>^Y=TH\*L7UGLK4
M;"A.1T&"UUEFN^(C<FX=+K^LQEV36=V7;ZCJ\YE\13<A^J"%!9 9#A08;84&
M$U&0X;$L1K6Y$1$W+#R4S,S5ZB(B(I#^PHK23;T>UN"\!7O:Q/#DJFLY41,K
M7[IR68L;L& _J[HD-]YL1-2(UZI3)6U&JB_Z8RO+<'5<XF0  TIVWL/:S?+#
M&5K%"E8D]-73FEFIF2A-UG++OL2(]$1%5=35T&>7.ZDX.=6">TM>O :5KDA0
MJ13ZY)UF(D>-3JF^)!6%&3(CDXNQUMF144Y;LNKCB9=M<.;RS-\[C77O7.RL
M*1G*_3H,Y,2<%56'#=$2W5:KLJHG1."8HY7MB#XJF:SIH!\@-,MNJ(D/!*+K
MO1C'527UM9;$7T+[+3.S%+HJUY^KOB,?7<2&PXJ._P!RDU>QBHJ>F6S(BF>:
MEKJBC<V7+NG"R?(
M
M
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M ?576PXN'<>)-QKGW2IEVHL^C6SD2GR[(#HJ-]*CE:F6S069F1[4@
M
M
M
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MOHWKZJ+$=:][EW7*IU.;G79TUNQ=KE9-N5%(>_1K<F3HG%@Y7R*
M
M
M
M                     /XO@0XJVQ(4-Z;KFHJ^:@'\VR<JU55LM";T4AM3
M[0I!$4?Z6HB)8B6)N 4
M
M
M
M
M
M
M
?                                     !__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tm2227887d4-tbl_selct4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-tbl_selct4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@"J0BT P$1  (1 0,1 ?_$ .L
M 0 !! ,! 0             ( 08'"0(#!00* 0$!  ,! 0$
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MG'WX\8]V-^@A@^%9TX^_'C'NQOT$,*_"KZ<O?DQCW8WZ"&'$]5O3> 2=Y,8
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M]%]ZH*#Y.#9+ORW,?M]%]ZH*_P"'!LC_ %NS+[?1?>R"G^'!LD/_ .[<Q/\
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MSPTVIVW&F@&,6H#W)$D+/-DA$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:]OE-_BNW+^TEH^JE0>)TB?%RVO
M_)\_W5,HJ1B((!X(HB&A0$ >/L0"@***HKH$51$$! 1335$.Q 11$$! 0$!
M0$!!Q/;ZB#5CUTC_ -_G3S])3_\ %6*K#?!2_P %IOL3/J0B/H0:B=A?C3]6
MGY4@_P#0464WD00$!!4D$^)!1%$13F \?ATXZ>591A(G(7 :]Y\ XZJ3[&5>
M/,U![#J.\J<?$GV*H@@(*:@<-=->"9)B9A4%I(',..GS3X59G'+D8Z^-?>IJ
MW70NXGL"D_+Q@ZHER[/*/"LICAF%%A$Y%%4$%%,XXDJ@C3RK/IQ7AS.KIF;^
M8? L8XQGS*QBN#7N[SV(!X>H.*M^&N9CFL<)ZO)0.U[.XZ'52>-8F4ISF5?^
MA5GF"@(HB"*KW%$4'! 0$%1IW]B"B#DSM]5!K%V-_P"9S?OILC^X)%8&]!!#
M[KQ^*UNA_%8/W=J",_0?\6?$_P K7C[J*@F"@( T^@@=J @(&I0$! 0.U T*
M @(" @IS#PC4<"%<P8D#FGOT\J6S'(C$\SF:=!KQ/$!(XQQ7DJHAW@>'@K$^
M'F<0<#IV'MT*DS-8Z5KBQWK*M<XK\4B<3D+@.!\BFNV-N9Y)TST](./9_P!.
MY28B*X\67&34<1X.TK+&:\$S'*0$'B#KX"%A$S'"66(F. LK5Z6$3U"BB @(
MHB" @:(" @)$9X+!KZA[PKG-IB6-IXSCQ_934:Z=ZG'E/@SF(QF%48B @:<-
M441#0H" @J=.[U4%$41 (!0$!!#;KY/_ ,,&9CO_  C:/NMB0-EFW7] L&_L
M]:_N2)55YN]B[R%$:-M]/^9UC7TE@_X<Y!LV?[)WTQ]<J#@@(" @(" @(" @
M(" @( 5@4YNX\#W#P^128\*\DSPS/-5%5[M/"5E7FDQF% =2=#XM5ARG$?%8
MXYSXX_(X]ZL_+.?,Y\U'.#>WP*XQQCFE.,XGDKS-U/'LU!/=P6.?+Q4U![#X
MBLIK$<54+AQUX:?]."F8B./B8F9C'ADYAV=IT[$F)F/9!$Q'QA70H@@(" @!
M%@1! 0$41! \* @#QH" @("*#M0$1&+K&^+?N/\ 8J3[KC161_DX_BM8E^4K
MI^[JPB=;_8E!K(Z^O[T.CC^VM9_]S0A*$^SD^F/KJ*J/&B'=Y$! 0$!!34#B
M3H.\IC*3.(5!\[E[TBV>#**\,G,W4C7B.T),)%N&0=NG8[73E/ IQ7$&J)S$
M! 0$#1 [$! 04) [3HGACS/8IS=VAU\BM^%HF/!E/"W'SRY \ 1PU2>>?-)C
M!Y.Q1%-0/HI?Y(X>,89ZHS%K6\.0'C4-[_!Y.])C%8B.;53Z)B?%5&0@("BB
MJ" @(""NNG9ZJ"B"A[#Y$&L7Y2C^C^U?Y7J_W-JHW&[/_P!U.V_]F;5]R1H2
MR,@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @U[?*;_%=N7]I+1]5*@\/I$^+EMA^3ZC[IF45(U$$%=>X(*:=Z
M0'%)X!HL<\<+@T6R:X0[%B" @>5 0$41!,<P2L=5L$<LG;IXU8C-<IGC@T6,
M<64P*H(" .] 0$! 0$%._P!1!JQZZO[_ #IY^QT__%F(L-\%+_!:;[$SZD*H
M[T&HG87XT_5I^5(/_0464WD00$! 0$#N5\".,X1?WZW^K-N:^Q8'@./NS?=C
M+9-+)CD?&."'1W-/4D$<K0&GO[2%IT5MW&R==.<1F9GESQ^+=>(T4Z[\LXX<
M^6?P8:DQ3Y09DW\Z&[DX8ZC;_M;MOF4[C(]HX^UA*:3M[O9^JMU)^U:8MQQY
M?MR:O]:,TX1[?XEFSIXZ@/SNTEYL>369V*;CXG.:7),<D &C@ ?21\Q)+>.G
M@73-:[=4;:<I_&/9+1:9T[/MWY_DD-<+W9;0UCKO>;?:&R?6S754-,'?2^E>
MW7U%R9CS]C?$3C.)P^BDKZ&X0,JK=6T]PI7\(ZJEFCGB<=-= ^-S@3ZJSZ)C
M.>'O_9CU1G$<?<^6XWRQV<,=>+U;[0)#RQ^WJN"EYCX&F9[ ?46OJC.(F)98
MF.,Q+NI[C;:VG]NTMQI:JA:WG=603Q21<HXD^D:XMTTXZZJ[LZ]<VF.$1S\#
M5/5>,3X\8\40]INH6NSO>O</$+K>+/1XYCDII;%!%4P U+@/9L>7 O)_S=5L
M[&/N]O-YC$QX3]7X,?4LZ-NN*<K1/P]_DR_A]-N3'N9G=1D6X%@OV#SN:<5Q
M"@DC?<;8"?.]M-8P.&OC<4[?%=%NOSGCX>[/G[&7>8ZJ33^['X^?N92&28\*
M::J.06KVI2N]%55@K:?T,3QIJU\GI.5K@""03JL*SBD3/#.<,HUVSTSSA]--
M>+374OMZ@NE%74(!_P!NIZF&6#AKKK*UY8-/&5+?)$=7#W\&NL]<XKQGRCFX
M4-\L=U=(RU7NW75T1TF915<%0YA'ZIL;W$>J%ETSB9QPB,KF(Y\'8VZVMU9)
M;F7.D?<86\\MN;/&ZH:P]CC"'%^GCT2E9O3KCDFR>C&?%6LNEMM[8G7"X4MO
M;.\1P&JGB@#W]S&F1S03X@I2?FCA,\>4<V>,<9Y1&44=X]T,VQ3?S9+"K!>1
M28SEYG.04'HHW^G#.0M >YI<--?TI4]*BU^YW:[^$1C\)EJ]0M&KL]>SSG'X
MS"655745OC?-75<%!31:^DJ:F5D,;=-3Q>\M:.'C2LUQ$9C,SAMK6UJYB,Q#
MX:#(L>N\AAM&06N[RC36*AK:>I<->SA%(XK.M+6G$1,^WP8UFLQ/S1&/.>*+
M74[OS=MJZK"+/B]QMD-;D=TAIKG/--$Z:FA<X DQN)T!'>X:>-<_:[(V]W6D
M?3TS,^S'A/M9]S6VKMK;)B>$Q'+C.?+V)4VNZ4-PMM+<*2NIJZD?"USJVFFC
MEAUY=7'TC'%G;KKH>"Z]\17;B9Q'AG@PT_/2(KSQGW>]TTN2XS7U'M.@R6T5
M]8"0:.FKJ>64:>&-CR[]!:Z5FWN\_!(F,XGA[WWUEPH+=":BX5M/;Z8$--35
M31P1ZG@T<\CFMU)X :ZK',=73X^'M]WFL<>,<O/P_%\8R+'S4BB%_MAKBPR"
MA]N0>FY .8O]'S\W*&@DG3L3/"9QPKS]GO6_RQF9?91W"@N,#:FW5U/<*9Y+
M655+*R:)Q':!)&7-X>59S28F(\TGA.'"2ZVN"K@M\]THX*^I;S4U#+41,GD'
M^9&YP<[M[@5C3YK3$>"S&*]3[OT#X$8Q.5440$! 0<F=OJHK6+L;_P SF_?3
M9']P2*HWH((?=>/Q6MT/XK!^[L21&;H/^+/B?Y6O'W45!,) 0$!!73_*@H@(
M" @(""O!!1 0$'$O:T.+_-:SB7'LT\.JEOIFWDRI'5;"#68;\[I[DYW?-L.F
M^T4;Y,=+H,FW'NFOM&DJ X@1QZ!_.=01[ K#7JOMU?=B<1[>;/=LIHG%N,XS
MP65=;MUQ;'6^JS/.L@QW>7%Z'EEO%JL\)AJ:>F!T?(W]@I]=.WM6Z-]-<Q%_
M&<9\/Q8SV]KUS68]WBFI@&Z.&[AX;CV;V2]4D=HR1@_!QJJB*%SI@>4P 2/&
MKP\$:=JW;]>+8CG^ON<VJ^:S,^'/V>]D8N: 7%PY1KYVO#0#4GR+FGA$SY-\
M1F<(^]06\M+MGM)F&:8Q>;-<;]98FMM](:R&36=TC8W#D8\DN8':\NGJ=JU;
M+XM2(\9^&./'W.CM=<7ZLXC$>/GY>_V+EV,SI^?[7X;D=PO%'=+Y<[735-[;
M32Q.,4TK XMD9$?,/B("]#NM71:OC$^,<OQ>?HO-[XY<<8GA/!D.JR?&:&J]
MHU^26F@KCII0U%?313'7@ (WR!W'R+EI,S:8CC[F[;2:URM/=N_7+&]K\YR6
MPU0I;K9[+5UMKKN5L@9+%$YS'AK@6NXCO"T=W?[=(\)R[>TI&[96(\6-^E'/
M\IW'V0Q/+\SN/X7R"Y>G-;7>CCBYN2>6-I+8PUHX- X!>IWFNE(AYW7:=UXC
ME$PRKD]SEO.,Y)3X-E]EHLDIX7QTUTDJZ>:"AG/Z:H#3)R :'V07F[J7BD6B
M8BL^/FZ=45B_S<^>/'\'F;>U5_M&"6F7<K-;)D-\B9I<\KHZB&&VS$]A;*[T
M<?'U%T]U-8BE8^J8CA\'/VT6BUIGZ<S\./*?:O2IR7&Z%\$==D5JH):D!U-'
M4UU-"Z1KNPL#Y 7 ]VBPSU?+XQX>+9$1$1;PEZS9&/8)(W-D80"U[""#J-1H
M0=#ZBEOEF8G^/9[TK,6C,3#RJ_(L?M4K(+M?K9:9I/81UM93T[CY!(]I*E;5
MM$8F./M96B8C.'IQ3PU$;9J>5E1#( 8IHGM>QX/86O:2TCU5ELK.N.,)&)QB
M8F9\/&/?#S*_(L>M,C8KM?[7:97^PBKJVGIGN\C9I&N/9VZ*5Q:<1,9\F73,
M<9C@]&FJJ:MA944=1'5T\@UBJ('B6-P\(<PD$):MJ\XG\&,369^J/Q=Y( XG
M0C@1V\>[LU[4X^2VC'M>9<+W9;0&NN]YM]H;("8S7U<%+S:?J?3/9KP.JQZH
MQ[?+Q7IMQX<OP_CWNZ@NELND7I[7<J2ZT^@/MBBJ(JB/C_GQ.</T5MMKM7ZH
MQ[V.8GE,2ZOPW9!-4TQO- RJHF\];3.J8A+ S]5*SFYF#QD+#AC.>"Q$RXVZ
M_6*\.D;9[Y;KNZ$:RB@JH:GEU_5>A<[3U5G&N9C,<F,SB8B>;[9ZJGI8I)JJ
MHBI8(P3)/-(R-C0.\N<0 /*M,WB*S,\/>SIG/",HT]2^Z=RP_9Z^99MME5!^
M%Z.IIX6W&AEI:]K ]Y#FNY3*P$@Z:'BM>_JKLU<,9F>/QAT]C2LS-;3$SB99
MJVZNM??<%Q*\W2<5-RNEII*FNG #>>22)KG.T: !J2O0[VL1NM$<HX/.[>9F
MD3/CQ^"]%S-XB""O9Q[T%.TH" @(" @("*(@@(J&O7S\6+,_RA:/NMB0-ENW
M7] L&_L]:_N2)47F[V+O(41HUWT_YG6-?26#_ASD5LW?VN^F/KE0<$00$ ]J
M @(" @(" @(" @JS3FT/8KY^XF.4(5;?[LY]?.JS.=M;G>_;.&66V.J;=:O0
MQ-,<G*XZ^D:SG/$=Y4](C[O8;;6^J+?NQ]3^3O\ 56OTS7]DP/PW9?2U4'X9
MH/34(YJZ'VU#SP#PRMY]6#QN 4S&,^'GX?BVUI,S$>,J6^^62\"3\$7J@NK8
MCI*^@JH:GD)[.;T3W:>JLIK/1U^#7GC,>,(M3;HYK#U<0[9B]<F#NQWV\^TF
M*$ 3:.)>9"WG_P#G+#TV8M_43?PZ,?A.5]0K-?L17G;J_+"4E%?K#<:B2EMU
M\MUQJH#^S4E)5P3RLT)!YF1/<YNG?J%G2)F)MSC/AY+LF)MCEP\>#%>X=/N7
M49?@$F&9_8,5QV&KURRPW:2)E5=(]23%2!['$N\A"=M'_,9GC7'*.?*66V8G
MM^FL8MYSR\&(+SNMG5#U:V;;*"]B+!JBP>W:JV&*%H,P;&2\S.',/9'],GI\
MQL^]:>$5MPS[E[NOVM.JWG'''GE+*AOMAN$LE-;+[;;I40:F:GHZR">1@U\W
MG8QY<#HKB;1%HY2U3'3;IMS8NW4I]R:BZ8,_ <_L.%4#+D3E-'>'QLEN=-HT
M>@I0]CM7@]PT4[?_ %\WC-8B>$?5QCR;-\?Y/R\^''PY_NQ!OGU 7+ =V=HM
MO;'<[33V_*JF7^=5?+40E],V-A(;+S.(C!(';HL>RM]WN)B?HBD_CG]67<ZY
MIV?7'U=7Y8E+Z&MHZB%M5!5P3T9:7-JXY6/A( U)$H<6$:=^NBRM&)^;Y??P
M:*6ZL17YO;'&'FT>38U<:AU);LCM-QJV^RI*6NIIY0._]CCD<[]!(K-J]4<8
M]C.T=-IK,XQYONK;C;[:QLEQKZ:WQ.?Z-LU5-'"PN)T #I'-!)[ECGC$>,\H
M\9(C,QY>?A[\OB?DN-Q5$E++D=JAJH6F2>EDKJ=LK&::\SF&0. TXZZ=BOAF
M.,1SQX>]/")GAG.,^QZ--64E;!'5455!6TTPYH:FGE9+&\']2]CB#ZA5Z9SB
M>!F/!U?A2V-K!;3<J3\)/;S-MOIX_;);X?0<WI-/'RZ*5^:9B/!;QT8SXOL!
MU[B/!KWJ9'+3AJJ@@(" @(" @(" @(" @C%UC?%OW'^Q4GW7&BLC_)Q_%:Q+
M\I73]W5A$ZY/8%!K'Z^O[T.CG^VM9_\ =$$HC[.3Z8^NHJJ(KW:(*(" @(*'
ML/'1!$_>+!>KF_Y;)7[+;LXSA>'NIXFLL]UIS-/Z<- D>7>U91H2.'G+3JU6
MBV9=%]E9KB$.;9D?7=<]Y;KLC!OEC<>2VFW&Y375]!'[2=$.75H(HR_F\[O;
MIXUNT3_4TMMIRI;IG////A['-N_R+:Z6Y[.,8_?^)32V6L_4+B5]NL&_N\>)
M9C3U-+SVBT6UT5-4PE@)?*]CX*=Q: -=>(X+?;;2L3'/&,S'*,L8U7G$\HG]
MDDZ"]6:[,DDM-WH;K'3DMGEHZF&H:PC74/=&]P:?*M-JS7C/+S\/Q6)X],1F
M7PNRW$VU/M)V5V1M;S<GM,W&E$O,>P<GI>;4^#1*1U_3Q96^7&?%ZT];1TE.
M^KJZN"DI(VA\E7/(R.)K3V%SW$-'JE86MTQF8GW>/X,JUZIQ7C[GFSY/C-+%
M!/59):*6"J;S4L\]?31LE![/1N=( _7MX+9-<6Z?%CX9]N'K0U$%3&V6GE9/
M"\<T<T;@]C@>PM<W4$'Q%+TFO-*S%N3RJK*,7H*D45?DUHH:PD 4=174\,VI
M[!Z-[VNX^1:ZVZOIX^[BRM$UC,\/>]=DT<C&R0N$T;QS,?&0\.'A!;JMDUF.
M'C^GO8]4<,<<_E[WEUV0X_:YF4UTR"UVRHDXQT]96T].]P)(X-ED:3Q"PK:+
M<*SF?8RFLQG,<OP?8^OH8J1U=+6T\=$QO.ZL?-&(@W]5Z0NY=/5673,3B>'O
MX%8ZHS7CQ\.+SI,DQQLE)$<DM+)*_P#@,7MZGYJD'L]"/2>?S=W+JE8ZL]/&
M8\/%/#]_#+&&)T^Y;-S\QJ,@W"L%YP26,'&L/HGQFXV]W#SJEK6!P!T/:3VA
M.VF*TGKX^V.4>_R7;;JO28CE'+QGW>;*#,EQQU-/5LR.U24M*_T=34MK:<Q1
M/[>220/Y6.\(<1IWK',1SF,>$^$^Y>F<S^+[:2ZVNX4XK+?<Z.X41&HK:2HB
MGAX<7?LD;G-X=_%6\33/5$QCS2,3PB<SY1S_  0]L'437WCJJRK:RJOEGM^"
MXYCXJJ2J-53M;4UCY8QKZ9SM.9H<6\H*W=C$;NWO:?JZIZ8]F.!W^=?16/9G
MV>R?:S/:Z?<@;QWBIKL]L-;MJZT:6W X)(C=J>K!!-3* WF,9 (UYCVA8=K$
MQ2W5QM[.4>].XQ::6KPCV^./)EJONUHM,0J+M=J*TP$\K9JVHCIV$^ &5S1K
MXEKZHQ[?+QCWQX,JTF8S')6BNELN</MBV7.CN=/WU%'415$8_P!.)SA^BLXI
M,\^'O:^N)G$<?=Q<7W>T1U9H)+M0QU[6>E=0OJ86SAGZHQ%X>!XR%A68M$SR
MQYLK<.G_ (N4>+IH,@Q^Z324]LOUMN=1""9::CJX:B1NG \S(GN<-/&%E6LV
MC,1P8WMTWBD\)EZP.O?ZB169Q[65N H*H"!H@("*H>P^1$:Q?E*/Q!M7^5ZO
M]S:BMQNS_P#=3MM_9FU?<D:I+(R((" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @U[?*;_%=N7]I+1]5*H/$Z1/B
MY;7_ )/J/NF9%2,1! 10G0$:<5,)G"@+B >4Z$:^HL^G$9%0= "XZ<-3KJ-/
M+JI6>.9\$Y3[P$D$D<HX]JFO,WZO!;?*'NXZZA3QE9C J@@(HB" @*>,,J^)
MKH=--=>X=JV6O%)F6GHM-<0HTZ@^$'0CR=JQUUFL166[9:LS:T?QP"3J .)/
M<.)^8.*6F,XAA2)GB>OX EJS7A*Q.55 0-?40$#3YO@0$! 15#V^HB-6/75_
M?[T\_8X/^+,18;X*7^"TWV)GU(51WH-16POQI^K3\J0?^@HLINHAIH4%1X>W
MQ(*$Z]VB @('8?4X_-2)Z8M;V+$]/#S:_P#:0QY'UI;U7>Z0ODK;#9V4EI$Q
M)$# *75S = W74K+TS_+['9MCZIOT_#&?V8^IS/W]6N?IZ<^^8G_ &I_<@\/
MD&G@4M/VXI'YLK1U6G'*<1CW+#J,:PS$9<ASZEQZBI;V^FEGNEYBBY:F9K6D
M\KWCMX^-:-]Y[?3:*<O"/;X3\&S5$;^XK%^<?QAK[VLV/I.KBEOV[.]=\NMR
MLURNU53XMB=)5/IX:6G@?R,>"WMX Z\%TSV?]/IIGZKUBV?;:,M-N\C=W%^G
M_3I,QCW3A[^/V>Y]*F_F&;>63(ZZ[;4[E4SX[?9[C*9305D7-HR-SR2>8EH[
MEGVV^>Y^YHM]5:YK^$RG<:/L:M>^OTVM,3'QA'^H.TVY&]>Y-EZM\LN-@DH[
MD8</M-162T5&Q@:UK"PM:02X$@<._M7-Z937?MZ\?G\?S=??7M_416(_R^G/
MQRG5LKL#BV(1Y)!AVY]9EFU^44?M.GQ%TPG92M>"WF94AY<#RG3V(71MUWVZ
M+:K>/BXJVI39%OYHGE[$*^G#IQVNK>HC<&U5%#7.HMNKCZ7&&MK)&N8Y@X>D
M=VOUU[UK]-V6V]A?=CYXF(PV>IQ]ON==/#$Y2&V.B;'U:]2O*XZ-C8 -3V-X
M=Q\:U]O$?]+V6GC\]OQ=/J/37N]-8Y?;JP)TU;"6_>R3=BDS6]W./ J/)JCE
MQZWSNI_;%8X-#WRRM))'+RZ-TX>JMFBLV['7:_&<VQ^3/U*_VO4+ZXY1%?SA
M]V![67&S[^YKTO6#-KI;-IA3-N5;112D57H^5CQ#'-KS-!=VD)V%OZ_7LC9_
M)./T<O>5GLK:MFKC-Z\8^/\ L7#D&U]OZ6^H#9QNU-TN%#8=P*XTN36FNJ75
M0F<#KS.+_*>Y;/3-_P!SNK=O;C&(8^HZ8CLYW>,<99.Q!C?AV9J-2'?S=:-=
M3V<I3TG_ #.QW3_Q1AM]5K%-FB(\8E]W7,T&V[4$'1PRNG]B2WAH\]WE7-V5
MY_ZGKK'&,1^.6/=5QV&R_CB8?'OR3\)SIDU/*!'-II]+%Q71Z3./5.YSXQ^T
MN3U&+6]-TY\)C]8?5U(XM;[[GL-PWPW7H,%V$I*01PV2"O--4UE4\:#TI9YP
M!)*X>RZ*6V3?C:)Q$/0[CJFE8T<*SQE!C+KYL'M-EF WCI@RJ]QW!U[A@OTC
MJB:>AFI72-9HXN '$$\%Z7IUKU[NM;3\EFG=JT[--YB/FB&>.N':7![OE^VF
M934E2;MG-72T5\D;.X1O@[-&,_2G0]JX>TUSK[^-,>-;6G\5W]SLV>F_=GPM
M$?C*_-UK#58A)M'TJ[/W:NQ.R9&XUE[N8G=+4LIWAKGM#W:'CS^%=6K'=]Y>
M-G"NNOZ2T7BO;=G6].-[R]3-.B#!\ Q.[9KM7?[]CVX./TDEP;>#6R2"LE@9
MSN:]A( #M._5<O=]Q_2Q$QQK,QF/BZ^UU4VVZ;\.'[+&W@W*O.Y_0]0Y17R
M913W6WT=QE9IQJ8*P-#^&G$@ E=?>:O^<[:U>$7F,?QXL/3JTG3W.NW*D8B?
M/AEG[8_I7P2W4N(;IWZHN=[W NMC;^$*^JJGF LKJ0QOC$&N@ 9(0.*W=Y3H
MO?5KXUM/S3[8G/ZN'M+1MK$[N$0\/I,J[C@&9[G[$WN7D_ MTENN+PGS3[2J
MCS^;WD#RK5VNZ-W95VVYTX6]\S+K[GJIW,1_)?C'PX.O%86;K]8&59(6B?'M
MHK9%;*%XXM%?*Q@DXCAJUT;EK]-I,=OMVVYVF:Q^+'U*W3?7JCV7GXIYG4\2
M5CGA#+&+6^ B" @:<-4!!R9V^J$5K&V-_P"9S?OILC^X)%4;ST$/NO'XK6Y_
M\5@_=VH(S=!_Q:,4'@NUX^ZBH)A(" @(*DH*(HB" @(" @(" @LO<2X36K!,
MNN%,UTE12VNH?$QO;S%O+P\@.JXO4K33MYQXNOLZ=>VOLF)^'%%_H6MU+#LV
M;JQA-QOEUJJJYU#SJ^20NUU<3Q.A<O;[RD:M&NM>4TK/QF(R\O5:=N[?:W]Z
M:Q\)E,BMH:>OI*JBKX6U%'61OBJX7#4/8\:$$>,+S[:(O'3/X.O3%JQ:<\D0
MNIO:.V6[9.JEV\L5+C]?MW7?SELM'11<C&OI2^64M:TC7F[>Q:NYWVU;]>V>
M-:STS[H;>WUQMB]8YWKCXS.5Y1[PTE1TTOW7?4,=-)CLQ:20-:UC'P<O9VF5
MG9HM_KO^3:NJO\TQ_P"K_>U^G5^[-9GG7JS_ .'_ '(%[@;!XTSHRJMQ,FHI
MQFGG9-33LE=&ULEPJ&:>D9^F'+*=%GWNJ.W[CM]?AF*2S["]>YMMM;E,S>OZ
M,EXQ2XWTQ=(1W/P2&>GS#/K50N=45,[IHOPA4M:UKF,<"& <Q("OK-[QLIVF
MKC6T\9:O3ZQ:EM]N-JS/]B[<1Z$\%R[&;;EFY^1Y!D.XMWI6U4V0"NDB-/(\
M%S&M8UQUY3XPG?4GM?EU<9C#'MMUNXK&V_*5G8CEF78_A_4ST^YI?I\FJMO+
M#736.^57U^6D?%YK'=NO*'>%<WJ'3W7I\;8^J+XG\';V6N>W[ZO5/RVC-?CR
M8GVDWYJ8=EMKM@=M[S36S/LP=5TMPO<[@([=#+4R@M&HXREKCH/&%Z7=5_K]
MU::N%:Q'5[>'P_=QUO7LK;=NSC-ICI_--*Z;)8OLQTY[C6NS UEZN=H=/DM_
ME+C-6U1+3(\DDZ#F<2%YOJU^K76*<*UF(Q^/%M]/K,;)V6XS:./LRC'F37#Y
M.NC]&XA_)!R.!()<98@#P/<MOJL]/==M2/JFD3_Z6GTN>K3W-I^FM[?E9D?%
M.B?#,^VWQ_*-PLDOUUSNIM+:NAN@K'Q1T!+"YC(X6G31NFG A;?5/\BUII]<
M<9GX-?ILQNI2+?3/#\W/IPWCR6P]-.XMZR>XOOERVQJ;A16ZNJ':OE%,/V(.
M.G=JM?J>^O\ 2:KUCY[5K/\ XIC,NGLNUK7U#9HM/RUC,?CR1YP^AZ3]SK+'
MF?4;U 0W7<"\22U+[6;E-2BU#G+61AC X:AH:>[M6R_;Z=4=-)S;AQ^&6FNZ
M^RTVF,5SPCW3^[/'3%NO:[;N'G&S>'[AP[G8=36Q]QV_N[IG2OC=&"!2\SM2
M0&\>WN"PB^W;V.[;:/GUS_YHCQ9WC5I[S3>)S6_U?\,RCQB%#L%NOFV>4_51
MF=RMN=Q7ZKIK#;JRMEHHFT[97>C9  -"->PZ#RK#M]5-G;TM2?GGG[&?<VV1
MW%^J/\OP]W\>QLDV VDI=K*.]06#<NIS?$+G(V2P6JH+)FV]@&I;','O+@1X
M0%V;;WV:XUVX3'BXIC5$YI/P2&F$I9*VG#72%NL0/87.!+==.("X;[+]$QCY
ML8C^UVTUUK,3GEQ_V-5&;8)M'59-E==UB[PTLN0U5:Y^+8):;I(T4M(  T!D
M;2.8Z'AIJI2E:Z^BOS;/&?C^T>UEMO:=EKSPU\,1Y\./Y^Q:O39G>(8GU2VS
M;O9J_P!VJ-K,CH)XY+==I'R-]+!%)(UU.9.) (''@O2]-I;?IWQMX]/*?<X/
M4)II^U;5RM/%[?YLY]UNLW=;%ZF^W&RXP^ACDR..WRNAEJH@"!"9 06C73L7
M#Z7JC9V5MFV>$6G'XNWU69U;M4:HYQG\LO3S_:.S])>YVU5^VBNMSMMDRNZ-
MMU_Q^IJ73LG+@X\SG.\31PT6STW?GNOLW^B:6M^$X:^_T9[6=U?JBT0RIOK6
MWS>?J!L73G07ZJL.)T5 R]9E)0O,<E3$]C7>AYV\I:-':<%K[33]^^S;?Z*9
MC\&>[;]GM=?1]5\9^,986ZH.F"R[);5U%XVHO=WH+%/7T\>58[6U+ZN&I#GM
M#91SGS2#J> 6B-DSOI&SC7/!U]MJCYYI]6.$_#BV6[3:#;+ =.(-AH=/)Z%F
MB]/O9SNOCEU/'[.,:XZN?[,A+C=0@("*! 1! 0$! 0$! 0$$->OGXL.9_E&T
M?=;$&RW;K^@6#?V>M?W)$JJ\W^Q=Y"B-&N^G_,ZQK['8/^'.16S=_:_Z;YY4
M'!$.W5 UX?/0$#3P\$! 0$#YR*(@@(" @JWV8]17PGW+_-\&N3:CX\^YWY$=
M^YO3T+__ )VZ?^*?U8>K?_\ 1T>[]F++1M+)NWU9[TX_7Y!<;/BK2),AI;=,
MZ&2J ;'R1F0'4#4K7Z1KZ^SO>_TYX?FZ_5MG1NT17AFLYG\'JY;MA;>DW>W9
MQVU%TN=)C>?W;VA>L<JZITT3BYS&N>2[M.C_  +I]*V?>WWU7C->F,>SFYN]
MU37M_N5X6B9S[7O[I8S>LSZUZ/&K/>)\?ANV,B.[W.E^O,IO.=RL=J""[EY2
M=>]<WIFF+7[N-D_+$T_<]0VQ]GM;5^K%OV6SOUL-8^E\87NQM%?KQ:KO+D$-
M'D<-55OJ&US9]2YTA>=!J?$MG:;9U=YKU_\ QVX?BV6[7^IT7MRM6.K/N94Z
MG)Q6;T=+-4\:&HN<<CXVN/+YY=J%O[/5]OU797^7'#\VN^SJ]*M?QB8_6%@[
MX85?=P.LFR8S9+_/CCZW'6?A.Z4OUT4G)'Z5K#J.4G7M"Y_2J_=ONFW"D3Q]
M^.#=ZALBG9:/&T_VR^G>#IPLW3ACHWDV8R"]6F\X[415>1TE9625#+G"#S/$
MG,3IV'N/:M?]5_3[J3,9UV\#5VW]3KM6TXO$9R]?J/R=N:T_2;EC &B]WTU)
MC;P#7\D;7@:?YP*]#LZ?_MIUSRZ9F/C7+56W7Z;-Y\\3_P"&V&+NJ[8C;ZKZ
ME=HX9Z2K=%NG/*_+6BH=^R.CC=R^B/Z3V/<O/].C/>6UQRK6;?GC]V?<;)CL
M(O/.;]/PQ+,6\M!<V9EM5TF[97JNQ'&[M3>FO]WBE,E6RD87ZQB34./,&#O6
MW3_S_<[-E_II$</QAA-OZ#M:17ZKVG^UU9YT2X=MSB=TS?9[(+[C.?V"F-;^
M$G5KYFU?HR"Z-[20!S=I[5IW=S]CYZ_1F.#+1H^]FNSZIB5@;[;FW/=GHYV_
MS=Y#,AK+K1QU\D?$"MB>]KR.SLTUT79W&JW_ %#1-.5XB8]F88]E:+]MNI;^
M3-9_\,SQ9_V\Z0]O19Z3-KY+=+YN!D=B=#=[M5U3S$\U<'H]! 3H.5KAIH>U
M8=WCMZ[-6OC'"9]\<?U:^SM/<?;V7]L1^CET;Y#<J"TY]M'D;C#<=K+Q)244
M4AT?[1D<2QYUXZ=BVWVTW=I3='.L?-[\,=FNVCN;:_"\YC]'D[#T\>Z74'N?
MO)+S26_'G?S<L#M/V/S 0]S>P$ZZ]RT^EQ.KLHV;/JM:WX9X-_J>+[JZZSPB
M(_C\D\&M(!U[3V]RG5%Y2:]$0KW:+'&$B<B @(" BB((HB" @( XH"",76-\
M6_<<]_HJ3[KC161ODXC_ /"WB0__ #*Z?NZJ)V2>P*#6/U]?WH='/]M:S_[H
M@E%^GD^F/KJ*JB"*(@@(" @#B1KQ65>:PUW8@W7K_P S;PXXD_\ [I/0HSVG
M<?\ ]L_I#'U?AN[6?*(_5:/43BE?FW6!MOBE)=*FTTM\L#Z>]5%*XME-"]L@
MJ8V.!'*7LU',.Q<OH\3NMOB>417/XSAT>IQ]OM==Z^-I_9F/*^G4;4;6WK%]
MA<@9@S;[6LERG)+W7N=)'2\?3.BD>.!<-3HMG=7B9I$S_EQ/X_Q[F.N/JFD?
M/C'P\4+<YQ3H=LMANMPLNY%URS<RCHWOBOUKN$\[G7.-IT+FD#_K!KV]B=U>
M:Q-],8CP]WY,=>9Z8VXX<V<<0SV^;A] ^6W/([BZZ72WTU10&JE.DKX8*IK(
M@[LXA@'%;_\ N'JK]JU/YYKG\F?H]:QW>S7'*L</C7+YMBNCS#]V=F\3R7=.
M]WR]7&II!_-ZDAJWT]-04P8/1!L;=0X\>WQ+=ZEJ^W&8^K_ZG)V^WJV3'AUR
M]'IXR3/<;POJ2P"AN]5DMPVSBK78?53O+YN?D+(XP.)T&@(7-W>R]_3JWB.,
MVQ/N=^K135W_ -N9^6:YCWXE@/97#NF#=^V15.]&X-RIM[:B:;VS#77.2EEB
ME;(X1B-A_4\"-2%O^U6M8CMY]_O</W+VM:-T<,XAL(M=#7].FQ675\^X%1N/
M362BJ:O&;C5M8'0M$;C# '-?)S@'3BN?O^ZM6(Q&)QTS/G,<Y='8=O2^S,3P
M\?8C7M+TI6+?_"Z7=C>V_P![ON693+/5VD4]7)#';XG2.,38VM.A#001V+;N
M[..TI]ND_/$1,SY]41+3I[J>ZO:T\*9Q'_AX2O&KVZW.VNZ>M[<5SC((,EQR
ME9+)@E89C+5QT9( CF)&O#AWKF]0W3N[>G#IM%H_27;Z;HKI[V.G_3F,^YX/
M2_TPXIF6&;>;J9_<+K>LJLD[)\6Y:E\5/2PT[N:)OHFDAWG=I[UZNWH[796:
M\;=/ZP\JEK]Q:\3PIUS$?"?W7#LRQOPO^H#0\NE$SE=X@(EY'9_/Z9OM/C_9
M+U^]CI[CMYKXQ,_AA&OI?V#.]-7NK#EV05\&W%)DU;Z;':"9T#ZNJ=(_F,DC
M3KIRZ: KK[;MZ_T&N]^<1&/PCBY?4MTT[J:TX=41^LLTQ8?/TL[U8=@>/WZX
M5^S6Z-/+;ZC'JZ9TIHYGMD $<A)/G%@=J-.U.SW6[F;]MNYS&8GW1,_[$]0T
M5[?77NM<\:S&8\\S$,-8CTU;67SK2W!V]KZ"X/QJQV=E^H(65<@F%9)+"XET
MO:6^>>"V^C_Y?:S?^:MNF/A&?W/5K6F:1RZ^,^S*2V)^AH>NO<%^I$%OP /X
MDDAD7*=!J? %S^F;>KL^XO/U<?U/4M?1?1$?3G]5B8EMV.L;-L^R?<S(+E-M
MK8KB^WXUB5%,Z"-SH?-](YS>\<>Y8]KVWVNUIOMQOLB<^SP;.[O,;OZ?7PBO
M-V7_  RJZ/-T=LY<!O\ <Y]L<\N0M-TQ6OG=/%3.+F#G8YY)_P"L[@%N['=%
MML]O?C,QP:>ZTY[>=FGA-,S/M_CXO)W:P:Y;E=:MMQJBOM98;7=,<;^'*RA>
M8YW4P,CPUK@1IS:!I(6GTO1U_P!3]V>%+1#'U+9&NNB:1BTQ/QSQG]7E[\[$
MV+I7_F3NELU>KO:*^KR&"W7^DJZM\[*MDH<]SG%WA('<L^T[B8[NNK'R3'YS
M+HOV_P![5-_YJQG/_##:O;YWU=%1U3]&F>&-_(#J!S-!/Z*V=Q;_ #,1X3+D
MT5FT0^U:<8;8G," BFOJH@@(*'L/D0:Q?E*/Q!M7^5ZO]S:D*W&;/G_W4[;^
M/&;7^A2QJDLCH@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @("#7M\IO\5RX_VDM'U4B@\3I$X=.6U_Y/J/NF9%2,
M1!0"=-3X%G-<8]K*8X</+*+'4/OA?L%J\;VXVWM<=\W5SEY;9Z.70Q4D7 &I
MFU&FC>8'M"TZJV[G;;57E'&9_3\6V.G5H^]?QY1YL/2=/'5I=W-R2KZJ+I9;
MMPJ7XC1Q3"W>E: 1"0)M.4G@5M_T:S.>K#1%XOB9X1/Q9 Z=]Z<VNN7Y#LWO
M%0,I=P,8<UU->*=A%/<(22/2!VA .@U]DL[S7=VLWKPEKV5GM]U:S.8MRE;G
M3UNK=GY3U!U>XN<5$V/8KE$]/;9+K5%T%%3 G2.(.UT:/ $U7K7L:6M]5N4?
M'#I]2U3K[G[,?BEKAVX^"[A4LU;@V4V[)J6!SF2OH9>;E<--06D!P[? D:IF
M.#1%OFZ9\GHY/F.+X5:Y+UEM]H\>M<0//65D@8T=_9Q)]0+GG;6L?-S]G%MI
M2;5F7DX9N;@.XD,]1@^66[)X:;Z^^BEYBTZ@'5K@UW?X%OC5>:]41\K5-ZQ$
M3/C.'UW3/L,LE_MV+7?)*&VY%=XW2VVTSR<LLL;!J][>'+H/*M<3G....?LR
MVWI-:1;SX0\.Q;R;69/?Y\6QW.K5>,CI2]M19Z>;69I9KS#B #IIW%9Q6;5F
MU>,1S8;)BG">$^4ETWCVMLF118C=\[M%!DL[N6&SRS:2N)[!V<NO=H2L-7^;
M]'%G>O17JMP9%?40QPFH?*QD 89#*YP#>4=^O9IXU;8I.)8ZHG97JCV_DQ33
M;][-5E_&*TNY%DFR,S>UQ:6SDR>EUTY->7EUX^%35G9&8\\?[6.R8K%<SQG"
MT^J?)+YB^Q.<Y#BUZJK%>J"B=+;[O02F.:)W*[1S'MXCR@KC]2SKBD>&?['?
MV$1NF\Q'*.7XO=V/RBKKMD,&RK++R^KJYK+%5WJ^5\A+B0P.?)+([M\I7M^L
M=/;;K9\)B(>)Z56^_MJ6\^?XK;W'SG$]PMJ\@N.#[W4V"4=-4,IY=Q*)TI91
MR-/G-!;R.).NAT7!]N:6I:W\W*/[/-Z5=D3U:Z\9K_;CCY+]HLUQ7!L*Q"IR
M_<"EK8+C%345'E=<]S1<JF1H$;P2''670D:KHW3$[NF>$X_1SZZS.N;5XQ$N
M%?OEM!:LAAQ.X[B66DR2HDCBAM#I]97.E&K!JT%NIU'>M&F/N\OXAMM'3&9\
MF4631RL#XI&R,<-6O:06D::Z@C@LK5FGU<&%;1;C#%=\WUV>QB]MQS(=Q++:
M;Z]P8VV3S_LG,7<H!T! .O#B5A2>OES97CI]S*%-5P5D$57231U-+.P205,;
M@YCFN[""-1W+.:S'/AY)28M&8G^W\&+\CWWV>Q*[-L62[B6:SWEY ;033$OU
M)T_2-<!QX<2L-4UV<I9368B?8R7;[C0W:D@K[95PU]%4MYX*N!X>QP/@(65J
M6I]488:[1LX5?<IPGC')9B8G$@X(*'MU\2#5CUT_W^]//V.#_BS$5O@I>%-3
MC_LF>L%4=Z#45L*/_BGZL_RI!_Z"BRFZB!0.THHH"J"!Z_<KB9]T'".;7CNO
M47/IOZ@Y-]YK94W7;3/*-EIS:2F'.:"71G)*Y@!)!,0XZ=ZP[#97539HMRO.
M8GR;N_I]V*;(YUC'O9\DZNNG6.U/NQW/M;^2'TPMH,AJW<->01\GLCX-4W?)
M3'U8:=<3,QGA^S#6SF2[E]062[B9I/57:Q[0W.@EM>*6"J<\15#RP\M0R+AR
M$DC7@LM_;S3L;]?UVG,><1'@V6WQ/=U^U'#Q]JT.F/>_"]F[)D.RV[5SBP7(
ML0N]7Z*IN'.V"I@DD+F/8]K#J2#KHNC9W->XT:K1/TTK68\?EAS?TG]/W-Z>
M%K3?/A\W''N==\RNR]3/4SMV=OV&_8?M9"ZOOF2-:6T[ZAQ=Z.-CG :C5HXK
M5Z=2^J^SNL8Q&(B?YN$Q+9ZI:NW57MXMF)M''PCCF7LY)NGTY[GY1EF#]2&!
M6?!,EQ>I,5%<+NWTKYH.!;+%4-B&A+'=@UX+1HIKV:IV:YZ9GG[&_=:\;(US
M&:Q'/W,4[!V?#L8ZGHK9TZ9+<+[MI40&7-RY[WT3 YW!L3G-8#H"=."[?3[W
M^UL^Y'*/EGQGX>#C[V*7MJFGU3;$^R%Y[*Y1C6 =4^\5OS.^4E@KL@K ++3U
M3BSVR9->7T? ZZZ+C]*G'96T_P TSG\'1ZO'_,Z[<XZ97;L<YIZM>I9X=S-?
M&WA^CJL^VC'I>SSZ[<&[U3IMOT8G_P"*C[NA$M_ F\'+H[3-*OG'@\R/YBW:
MK8[#5YS-OV/4[9]0O?GFM?RAXF&%HZ_]PAV__IUAY0?\V(+3Z'7_ "=V.'SS
M'Y1+5ZS;[<]O;_@Q^<O3ZK3KOCTS ?\ XVX#CQ/9V:K'T6(CU2WNB,IZI68]
M,GQ_=:&09I9=G.MJXY!G]0+'C63V%D5!?I.8T[7<CAY[F@Z=BV>D[8IVFVD\
M)F8][/U6DVG3LCE'[K5ZLM[\,W)NNV%DP&X#)+9;\B@EN60TK3[39)HX-C$C
M@-7%:_2]5_\ J=+3&.$?JQ[^]9[#96)\)95WZ(^$YTQ\W ED^H.O'01^0K9Z
M3.._[BL\YCA^$N7U7JMZ?I\LQGW9AC#,9ML9NL/-!U,14$F)PVF-N!LOT3I;
M;PY"3R^<-0.;3QK#TJM::-D[/]2+_EAZ/J^)KJC3PK-8S[UA]6NX>TF36;;[
M&-F+725MGQZ_T<MTO5GIC'0T[/21LCC,A:W7@%AIB9[REK_+&6/737V>RL<9
MF&:.L]T5NLFQ%]K9&T]JH;A0^W*U_L8P=#S.('9HNB;_ &_6>NT\.BT.+56U
M_1YUQQF;1P^+IWTRJV67.]FNI#')FY=M[1M_!=\NMOYI&1:!K2\ #F.G(=>"
MPT3_ $_=;?N1BNRG"??+9:E=_9TI3Z]4Y]_#&/S9=W5ZNMDAMS?&8QF-+E&0
M9#;Y*.TX]0MD=4.J9V<C&R-+!R\7 $K1W>B=OR5B)G,<?>W=I>E<6V<,1/Q1
MIS;![A@70Q;Z6^48H;M>+[;[I7TCNUCIZT%C3_HZ%=VZ>GO^TUS.?MS%?SSE
MCVL=6KNMGA;./A$-F^W6GYO<& ]E^ ;=H?'[78MOJ5XIW5HKRZK?'BX^SB)U
M1,\?]B$W5%55.S&Z6&]05%&[\%FWU%DR*&)O%SW1R&)[M-=?.+1V+S--HU;-
MO:VY;8F8]DXQ'O>G?7_4ZJ6CA&N8_")S,?%E/HUQ"JLFTT677F+DR/<FNJ,A
MN<AXO='62.FA#B>)T#UZO=5C3IU:?[D1GVS$<9>9JM.[=L[B?.:Q'_#$\$M_
M6\*\^)C$.J>:BJ" @:\-$!!R9V^J$&L;8S_F=7WQNR+[@D5&\]!#[KQ^*UN?
M_%8/W=J",O0=\6G%?RK>/NHJ"8: @(" @(""NG#75!1 0$! 0$!!Y]WMT5VM
M=QM<YTAN5-)32]XY9&EOS]5I[C5]W5:(YXPW]O?HVUMY3'Q:X=F]T*/I;R3)
M=D]X'S6+'YKE4UV"Y;4-<^DEIG.)Y7%@=RCV*[-?<1OTUK;ZZQ$8]S1W.GIV
MVVUY6G./]K-NY76=LUC6.5DV'Y73YQD]8PT]CLUG]))*^I?YL8<2P<HUXZKE
MV4V;+=&OZI_F\O[6S3-:5Z]D\/)=_3M8-Q9-FX*7>6Z5=\R')6U,EPI+@\S2
MT]-4.?R4[B2==&D:+K]2[>LZHT4XSTQ$S[?/XN?L]LUVS?\ ESP:[*Z7)K9>
MST=:2NYLZ954LHU]&ZSRAE:X-'9H'N<#Q4]/O'?3IO;GJB_7_P#3^C?W_P#R
M6S?MK.?N]'1$>&(Q;C[>K*>?5W8O0=+.>V2U0'VO:K11PT\#&]D4,\#1RM'@
M 7-WFV+=UJM?E.S.?QXMWI>NNNDT\>CA^2.5VI[1O5T26C%=O[S3Y%E."6JV
MU=PLU(XF6.>E#287@@<2 >S5;?5+WU[Z]SKC-*\&CTJ/MZMFFWUVM/\ :SEM
MKUB;'5VWUHK,DS&DQ>_6NC;#=,=KO2-J1-"WE<&-Y/.U[ MWJ-NJ)G3/5,_Q
M[7+V6JVN(U[.4</Q\4:<0IZG<JEZJ^H6&@GM^+Y58*^@Q8U3"R26..( R:'0
MZ'E/<N'N:?TOID4GZ[7S,?!ZU-L=QZAJB(^356(SYXX/EV@Z=\<SWI#L^0XU
M9Z6W[ET,]3?;5D$3 VHEK*29Y8UTG Z%L30.*]'U&?Z7;39KCZ8XQ_BB,O/[
M68V;]]-GTS,8GRGCC\4BK;NY%NQTL9W/6OY,KQBT.M684<COV2.J@+8W.=KH
M?.+-5YWK=,UU[:?1:8GXXG@V^G3.O=]FW./T\V ,O=I\G;;3J.(IM"3_ -O"
MMWJ<9[_M,<8Z8^'!K]/IGMNZSPG[E\?BV0[?<=L\6T[!88R-/L+O!VK=ZW,1
M;9CC&/V:?0HGHTYX9_M:W]@\,N&XG3GU!XG://N=QOUW%OCUU:^9G8SU5S=W
M7'8:-N.$16?R>CG_ /9;;<IGA^;YMA*[HQ&"4F.;R8%AV-[CXJY]#DWX>H-)
MJB5KW.$C7<I#_-+1JNSNK:[S79JCA,<O+$?QP<&O7;7::7\9X3^S/FPU\V8R
M#.\RK-C=AK+9;7B5&]M%N-00BD-;4GLIXAR#S7CCKKW+1KM>O;WV3SC.(_O-
MFVM)W12(^7QG^[[O-9-?N'TI;T5E_H=_<1LNW>?X_63VZK-T ]M%C"6M?%5-
MB&NI)(X>JM.O56^J)UST]7./*?%NM:]+]%N-8Y>Z5M=(MNM6/[[YM8=E[]<<
M@V1IK:7U%36/<^'\(%[=/1DAH/#LT"[^UGJ[>\;>$UGA[7+WWVZ[*QKX6ELO
MOKJQEFNWX/89*SVG*:-A[3(6'3]%>7W=]M=%IK]6/P=>FL3LQ^/M:G^FN[=-
M5NH\MO&_\=C9O#3Y'4RU]3E,#I:MK6 &(0$L/ : C1>G6*:]-*Z?JF)ZI\?P
M]KE[C[ENXFU_IG'#RQ$0XVO-,>SWKJVIO6(6EUNQ**WU])9*WT7HH*QC8)?V
M6%I \TZK'T")K_4<>=9F(_!L]8Z/MZHK'#QGVXEG/:0Z=;6]C1V"U1EP\''O
M':M?IF/^GVC_ (IG_P!2>I=7W].)X]/#_P O]CZ.MCD-^V(<1VY1&>S4:\D@
M*T>GXGU&(_\ X[?K'!GWF?\ I]YKSF\?I+R]WKA'L7U7V/>O)HY_YAY=:(;%
M<+G'&7MHYVQL#72::D#@>[N6[LMTZ[;M%N$3:TQ/OE-E(V=IJM'U5Q^48>!U
MA=1NV&7[43XI@5]BS6ON57325<]N#W14<;7 ZS/<T $@\!XER[:1?=JQ&(SQ
M]O)V]GLBD6MXQ$XCWPGCM-_=C@('9^ :'M[](&!>GZAB-]HCEG+Q^UB9I6?8
MR&N-UB((" BB((" @(" @(" @AMU\C_X8,T/_P"8VC[K8D#99MU_0+!O[/6O
M[DB55>;O8N\A1&C;?3_F=8U])8/^'.16S9_LG?3'URH."((" @KKZJ"B @(*
MDZH*(H@(@@(.31Q!\B6G$</'@OCEKAVJ.G7-N?IQ/X%.K>_V#A\]7T3Y?3]M
M9YS,_JU>JSU=_IM'A'[/9V%<!U;]0A'LFMC(U/#_ *I9>E<.PQ/]Z/W=GJN)
M[C5CC$5G]G1UD$#=GI@X!W_ZIT!/BD@3TR8CN[SR^6/UEJ[JT_T=IGCF>$>7
M)Z<I_P#CWI.'_P#:?-J3H3QDUX>KHL?3(Q;O(GCF:?NYN^KC7VD1Y7_9Z'7Z
MX?FEQ?4Z#^=5%Q\@)6NO#OM6>7^UZFBTSV_<3$XQKM\5I=2)/YW^E('V7M^#
M0GAV\VG!=O8</5+Q/'A^TO.[G$^BVM'#C7_W0M7>;<FW;6]9]BR:\4\\UH;C
MS*>Y20-+G00RLB!F< ">5NBY_2+9OW&F>$3.<^&8AT>K4F_:Z.CG&,+HZG.H
M' MRL#9M7M-D$.;97G=1%0QP6X/<(8G^8XRDM ;[):(T3N[G5B>$<_+\6R.Y
MKKU7V6CYL8QXR\/J%QY^'6[I$Q>8!DMGO?H)6@@@/]'$YXU'^<2O1[+9&SU>
M;5Y168_]+DK3'I-Z9X]43_ZHEZ?5]7T..;Z]-F7WZKBMF-VRIJ([C=IB?10D
MQO(YR =.U</IUXU>I[(G_P"W,1_YH;^X_P STNL1S^YG\I4WWR:@P;>S:;J1
MH6G(]LS2FWWJ\4 =(V%LI>1*  26Z.&O!;.UI;M^[V4M\O7$<9X8QF6CN8KW
M/9:KUXVUVY1QRR/O%U=;,0[<7JFQ/+*3+\DOU(:2TV"WMDDF,TPT!>.3S0.]
M<W?:)[BL:ZQXQFT.K1MKJM%[?+,1R\T9]RL N.V/1CMOCUZA]HWF:^4E==:<
M]L<T\A)8>/<"%Z6VW3WW:XGA3%?_ "QS:.PK->V[K;/*\VG'OF9PVF8D0<3Q
MHG77\&4O'3M'HF\5CW,17;LQRER:N.JLQRC/P:^.HZ]573SNY6;G6R%_X)W9
ML%18JYD&HTN8'I(7D#7CHT=R\SMJ3/7V<<]N;1^48>SW5HO73W$<?M8B?='B
ME#TLX(_ MG[!25+=+I?2Z\W)SFZ.,E7H_P [Q@+V.^VQ:8I$<*UB/C'-XW;Q
M-K6VS_-,_AG@D6N*,1R=,Q,BC*9$011$$41! 0$! 0$ <$!,JC%UC?%OW'^Q
M4GW7&@R-\G$/_A;Q(_\ YE=/W=5$['^Q*#6/U]?WH='/]M:S_P"Z()1'ZY+]
M,?7*BJH@@(" @(&B1&4F<'81XSHK$XF/;E9G&6N[#GAWR@.:#L__ $C)RZ]_
MUI9>BUZ>WW1G_P"7/Y,O5_\ 4[>/^#]WH[@'_P"._:ENN@..5!]'W_6Y=/F+
M'T?'7W,8Q$Q7X\9;._G'9:J_\=OV<^OV:XLP?!8I6SG"9<C@&<.B!(%)KP#P
M.X\5SZ(I_5].R/DBLX\LY;J6FFC9TSBV?9G&'D7S</I PS;B_6K:.V8[<<DO
MMHEI*"T8_1:UDE1+ 8VOD/H^!!/$ZK/U.UIU3%(S&?PAR^ETI7$WCYH\_%A[
M9H2-Z"=THZAIII8ZJM;-3OTUC?[;',UW@T(T6WUB)^UVN)SQX_\ F_9M]+M_
M^PW3:.<?_3&$]NE[3\P.VG;J+-#RGQ\C>Y=7JW^K-8_NYS[<X<'9<+3&/YY_
M9%7I[O5PQ_/>K*_6>S_SAN=IJY*NFL39!%[9=&7'T0<0=-1XERUV37TRDQ&<
M[)S^3T._U]?J5(SB.B/TEY-1E'1'OW89KYN=;[/MMG%0)H+W2G6&Y0RL)9YD
MWHB'G0 @Z+#=HKKM:-=OEY\OR85V3LMT;(CA,<5H]/V&7S+]K>HC!L/N-QO.
MU[X9H=MJJNYBZ9[&/T;%S:<'*=_&S9V%>&+1;./^%AV<UU^HXCC68Q\?/XLT
M=-74MM;C.U5NPG<?):;!LKP5\]LNMHN(>U\AA>0'1:-(<-  O0[S=KWS&ZDY
MB:QB/;$1'ZN;MNWMJM?7/*+3,3_BG/Y.>4;]?GOV?WUGLF*36["L?HY*.S9?
M--JVY/8[B8XBQI:W3CKJO,[K5:W:Q?9SZ^$?!ZG9;(KW$5CC7IS,^UGCI0=_
M[AL (XCVGKX>UVGSUZG?XC%N>*1^CRNWZIZX\.N?U1_V:=_\8'4&T:.<*$:-
MX Z\L7<O'[>O_P"KVYX>S\7I[_\ \CM?=,?C,,+]'>_6";:73=+&,\N;<:H;
MEE%956^_U37>U72-D>UT3GM:="!H5Z7;W^[V6J,XF*Q'OC$.;U"O1W<VQF)K
M$>Z<\V3\@RJR]2W4GMQ2[=R27S#MM8WU>29-#J*4S-YRUD>K6\WLV\0M7IVJ
M?N6[BW"*QC'OS_O8^J6K]F-43U=4Q.?+$Y>3;\JQG;GKVW#NN;7JFQJWW;%Z
M>GME=6ES8YY7/@#(V. .I/*5M](O$]ILU9^>=TS'NZ89>MTM-M%XXQ%8RO7&
M61UW73N1"QX,=;@ B;*.SEE+&@_HKE],U]7IW<U\<SQ]TLO4YC[W;QGA,Y_"
M%G;#;GXQTYYSN3M)NG6-Q.)]TFNMBOU8'B"JBG(>-'-:[3@>"V=GMC;V.NF>
M-8XQX\Y\%]1I:W=VW8^6_P"7##CO+N#C74CNWM'M_M;4C*K=BEW%UR?(:9CO
M:L<+7L.@>X-U)#"5>PTVGN9[C'36L1$9\<,=_<17MKZHG,7C'N]J_&-9#UW4
M5(T "'$@UH![FF0++TN>'>=7'JM66KU'YY[:OLGX8B/U?=\H$0W:K#2X:C^=
M]'K]K>N;1&._T^43'ZR[M%L]OO\ \%H39L>OX'M>O$BDB&OBY1P79W%HC;?W
MO.[7-(IX_P"YZA7//.6V.0@KKPT040$!1<J'L/D51K%^4H_$&U?Y7J_W-J0K
M<7L]_=3MN?!C5K^Y8U262$00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!KV^4W^*[<O[26CZJ50>'TB?%QVP_)
M]1]U3(J1VOB"(IIX4@QD[1H=/5^>GU?#D7MTQP\N+7]8C-=NO[(?PK2!_P"!
M\)C;:7/XF-CW/YGL'=KRCL3T.<=GW.RWU3-(_.4]8G9_4=MKK$=&+3^B?VF@
M)!))X-U.NA.O'CWE->NL5G$YF?-G,?YD4CP?'!;;7'7&X,H:=M?(X&6K]$PS
MD?9""_3Q Z+&>JFN:Q$<?XXEZTO?YI\OXAJXV!VAQW='=W?HYO"^]XM:,LJW
M'%I7D4=14.<X!TK6Z.=H.[F6SL-'_):]E^-O"/#G*^L;I_K.CPQS7'=MOL8V
M(ZNMKJ3:^C&+V+.K?+#><>IG/%&&MEY2YD9<=">4:\2MGI6SYM\7XQ%)M\<\
MF/J6C.C7LKPGJB/?P\6(=PMW-DLPZD,TEZAKK<JO#L$#;5BF%T\,]1;JB9KW
MBHDJ(XAH?8CM7'Z;>E='W;1U7M,QB<8B,X=7J<]&Z-=.$1&96WF6\73%B.88
M'FO3+)78AD=#>J.FOF/4M#4TUNJ[=-(T5!D8\'4AH\*[.SC9/=16)_RYQ68G
MVSSCP</<TC;VUL<+Q\T?"&:>H_'X=S>I382U^W*FWV_)+3'-7S4CC%(ZEE:Q
M\L.IUT#VNT/#7QJ>EZ(KWW=4YQ'3S^+;WFWH]+U7_FS/X\,OGZN=D=O-G+=@
M&7[26K\WV3NO4-MFO5J>^.69DSFQNDEYB[F=HXG7]!<VC=:.[KJB<1;.8\/P
M;XTQL[:]KQQIQBT\9S'&./O9"W;Z8-IJ/8*Z9/'86OW!I[3#=9<_E>\W.2LE
M8)GO,NNG$NUX-"GJ=_Z6\QJ^6*SX<&'I5([KI^Y,VFT9G/'&8\,Y8XS+.<JR
MC8'IZVW9>JFEN.Z=R@MEYO3)"*A]OCTCDC,G$^=S D]J]#N],=SWU-<<(Z<S
M^&7-V6R>W[';LGC,6Q'QG"2-VZ)M@78+56BBPV&WY$RWO;39Q"7-NOMD,)$I
MG!TUYM/TJX>\W3JK-J?RS_&6WL]<3-:[./5^7N1<H,ZO>2]&6[V+9%6R7*X;
M>S3V6*NG?S22T\/I&L+SWG1O:M?J\_=UZML?S<,>V,9PZ.QB=?<WT>7'/G$Y
MQE:F#[I,WUMNU/3A:\CJ,.Q".U01Y+>6!\4ESEA;SOI(WZ:<NC=.SO7J;M<=
MYW^S=?C2.5?ASF)X<'EZ)MVG8TU1/S<IMY<?Q2PZL,,QK NE6]XMBUL@M5GM
M3:6&"GB8UI>6.#722$#SGN.I)/A7!W%[;>XU<>'5_P"7A/"'I>G4C139U<YC
MG\?%A;JDH)+GTN; T$#W0S5MYL4+)8CRN8'0RC5I[B.;4+K[C3][U;72)X=,
M\O'$9XN3T[9CT[;&..69,KZ/-CZ?9V\2/Q.*3,:*Q/K6YX^21UT%2R+T@?Z8
MG374=S5Q>J;?Z?-]?*)\.6/*>3;Z5KZHB-DYS_:Q;:]Y,BPKH8ER!MUE=?:>
M"2PV:Z/<3/'S!\;)N8DDN9H"MGJW5;[&/IO6,X]V>#+TF:Q.[/.MYB/=$L,X
M%F'R?5!AM#0YW25^9YC64S9;WE=SME9/7"JF:'2&*;AH&N)TX%;>[K%XFNOY
M8S&):-4]-NNW'V>#+/2QN2^^6??+:_;2_P!QOV/V2FJZ_;"ON;)15Q4\T;?V
M'F>&D!KY"&@^!:^]INW=C%IX=%L<.<UB/%L[>NG5ZA7&9BU8G'A$SGP\F%MC
MKITJV^TSX9U+821NQ4U]3[?OU]IJB:5HE/FN;." P-.I"VS&C=7&F<8QGW_!
M-E]NO9;9>(FL\H\/P;-NGK"]ML,Q&>GVLS"NRW%+C4R55*:NK;5LIG/<2Z*+
M1K2T G30D]RSW;IK7IO&?:T:Z1-NNDXEGU<T3$QPY.B<S/'F(CB>WU$&K+KJ
M_O\ .G@_]G3_ /%F*JWPTW\'I_L;/6"([D&HK83XT_5G^5(/_0464W4005TX
M:H*(" @KZ_<G5,3[)6:1,>U\-?;;==::6BNE#3W&BFT$]'4QMDB?IW.:X$%8
M_P!/69GV+79,1AA;X,'3L+L+_P#F<QS\-"?VR;C[7=S^EUUYM.?E[?$LZYK>
M(KQCQ2TQ?YK\(9KI:&BM]-'24%)#14D#>6*E@C;'&T>)K  /45G9.Z^?U:XI
M-*<><^7-C_-]F]J=RY(9,]V]LN5RPZ&*>MI@7Z@:<7,+2?56G7KI7-HYYX^3
MHZK=.+SPY>U<.*X1A^#6]EJP[&[?C=M;IK24$(B'#PGV1]4E=-MMIK7KY>&.
M3GUZ:1F*QF%NYQLUM1N287Y]M_9LL?3OYXI*ZG\\'EY=2]A:7</"2M$:8MLF
M(X>,1RB6Z=T[*^V'M8AM]@V T+K7A.+6_&;>[3]@H(1$".X%WLCIXRNB][3\
M/!A373JK/F\:_;-;5Y3DE#E^18):KOE%M(=;[[-$?;$+AKH6O:6ZD:]^JTTI
M]J9O'BE_\R8B?",/9M6WF$6+(+UEEEQFBMN2Y$T-O][A:X5%6T=TA+B#ZBM8
MBM>B.4SG\2<VO$S_ "QT_@[,4P'#,%9<HL.QVCQV.\53JVYMHVN;Z>H> '2/
MYB?..BF)Z*U\*Y_.66R9OLF_GAU4NW6#467UF?TF,T<&:W"$4];DS [VU)$-
M/,<>;ETX#N5KF(F*<..66R8MCKXXY.R_[?X7E-TLE\R3&Z.]7?&IC/8+C4M<
MZ2DD/Z:(AP [.\*Z[179U5X6\TOFU)K;C7R=&9;;8#N+1"W9WB-LRNC'_57"
M$//;KH'C1P&O<"M5M-<S:/'Q9QNFT3JG^5X$>Q>SL5EM6.P[<62&R62H;56F
MW,@+603-UTD!#N8GB>TE;_ZB\7C9'.N,?#\W/.F,329X2N2[;?83?[Y8\EO6
M-4=SR#&018+O,'&:D! !]%HX <!X%A2?MWF]?JLRV1-Z12WTP^'.-JMMMRZ>
M*ES_  FU9=# 08&W"+F+2.('.TM=IXM5K^UT6]L\V^)ZHQ/*.3X7;+;3'&78
M7^;ZRMQ9SF.=9&4X9$3$06$EI#B1IPU*W7M]Z:SSZ>312G3%HGQ>[D&WV$9;
MCK<1R;&:&^8S'&R*.QU3"Z%K(] P#0APT '$'586QNW?<MSY>Y=-IU5C57DX
MV3;O!L;QB+"K#BMNMN)0AXCQ^.$.IASGSO,?S=OE4WV^[;%N.(PNJL:[VFL8
MSS6=C_3SL9BMX??\=VKQZT7E[N=]PAI=7\VI.NCW.';XEG%K:HFOCP87K79,
M6\%]Y5A.)9S9W8]F%AI<BL;I(Y3:ZP$Q<\+N:,\K2WV)[%C/S;(V?S1.?X\6
M?5.NTTCZ97!14-);J.CMM! VEHJ**.GHZ:/@V.*(!K&MU[@  LYGJO:9X^/X
ML::XM:NO7RF9YM;V_>[V-]05PM>P.W%OK+S>)+Y''EE744<L<%%%22A\A#W@
M \P81J%K['5'<[:[;_13CGQX<71W6V>TK;7/U6C'LXQ\&Q>SVFCL-IMEFM[!
M#0VJFBI*6)H :&0MY  -/$MO<;+;-EI\)F9CW.3MJ16E*^/3&??CB](]WB4M
M6(XME9^6!8 #H@$ZH" @Y,]EZJ#6+L9_S.;Z? [(_N"156]!$0^Z\?BM;G_Q
M6#]W:@C+T'_%IQ3\K7C[J*@F&BG8B2(" @(" @(" @ :H&H/8=?$@>H4#Q]R
M .;1KCP\!X_.2\XF$V1TXF%I97@N&YS0RVW,<8MV26^6,L?2U\+96EA[1S:%
MP!T\*E]$1;[GZ<VR-\]/)9.+=/6QF#5YNN(;5X_8+C_XNGI]7\.SZXYZV5V3
MB8KPQ^+3LI,6Z9XPN?<+</%]KL7K,RS"IJ*:QT#F-JIJ6%\[QSCS#R1@DZ@>
M#@M&S?.G&>/5PRW4U=49KX(;;&"/?3J!RWJ"AL4E%AMGHH;1@U;50>AEJ9 .
M>6H(D'-VN+> '8NGL]<]IV][S]6S&(\.'#]VKO+_ 'KZZUXQ3.?_ !<?R3ZK
MK?176DJ+=<J2.OH*MACJJ*9H='(P]K7 ]H6F^FNV,VC,Q'YLHVSIXT\>/Q67
MA6U.V^VYN?\ ,+#+=BGX:D]+=#0L<WVP\<.9X>YX[.X<%GFU]?3-OD\OXX,;
MTGJ^Y$_-'%;-YZ=MB<DOC,EONU..W&_1EKF7*2EY7!S3J#RL<UG:?U*QUV^W
M3$0V[9^[FOBR-58MCE58JC%Y[/2NQRL@?2U5D;&(Z9\,@T>PQLY1H[7CHKLQ
MNC%V&J\]OPCFZL6P_%\'LE+C>(62FQ^Q4(<*2U4@(ACYR7.T:XN[2XDZJWO:
MU+3;C+*E8Z^KRY^UX-+M)MG1/RA]'A=MI3FH(RP1,<UM?J029FAW+J2.T +&
M:?Y,4MQKX>QC&?N1N\8_]JE1M1MM58<W;RHPRVSX.P 18P]C_:K2T@CS [4Z
M$#M*MIZ]E+S_ "PRB>BDQ'\TS/X\5[45OH[?00VNBIF4ENIHO04U'&3RQQ::
M!H!XZ>4K&_SWM:W*?]S7JB:4K6O.L_[5OXE@&$X'3UE)A>,T.-T]RJ7UEPAH
MV.#9IY#J^1P>YW$GBLL]6J-4_1'+^.7Y%[VMLS'/QE:&7[";+Y_<&W/--LK%
MDERCU(KJNGTEU)'$^C<PGL[2L8U12,UY0W;;1.(GFR!8,9Q[%+=!:,9LU)8;
M;3M#8*.AB;"UH:- .'$\.\DK=NM]R*1^'L::UZ,S/C*P\SV(V:W$K&W#.=M;
M'DU:W@*FK@(=VZ\3&YFOE*T4U]/&.>9;;;)V1B?']N2\\9PS$\*M\5GQ+'Z+
M';5"T-CHJ&,1L '9J>T^J5MMNG9^LM=-%)K-K3PA<>@/C).I"PK?,\?I6MIQ
MU>/[,2Y'L#LIF%\CR?*=L;#?,BA<QS+Q4T_[-S1NYFD\KF@GRA-6O[.9CQ6^
MZ=E<3'%<-3M?MS5W7'[Y/A5K==\4:YF-W!D1BDHFN:6.$/HW- !!T.H5UWG5
M,[(\?E^#":=>OIGE#Z;=M[A-IRFYYM;<:HJ++KTQL=UO\37-J)V-/ /.O+^@
MKK_RJ]'\L\?Q96_S(C/U1R_1RR?;_"\TFM-1EF.4=_FL,XJ;-)6-<\TTPUT?
M'Q&AXI2OVMG77ZHB8+WS/VOY9F)_9ZF08QCV5VR:S9-9J2^VF=O)+;ZR)LL1
M;IRZ:$>!:[5G9'W)^IGJF-<SKCDQM0=.^QMJLMQQRV[66&AL-VE;-<K;% 1'
M,]O%I<>?FX'B.*W<.FOC,?DPUS-;3/A,3C]V5[=;:&T45);;93,HK?01-@HJ
M2/4,CC8 &M:->X#139>;S,SQ:Z4Z8B(\(P^Y8-AJ@<3Q0$! 0$! 0$!115!
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M[5SI^S_)P_6)]WAY.BY[8;>7O(CEMXP^VW/)74IH3>*F'TDIIW  Q:.);RD
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M(*'L/D0:Q?E*/Q!M7^5ZO]S:BMQFS_#:K;<?_P",VO[EB5261T! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&O
M;Y3?XKER_M):/JI$'A](OQ<MK_';ZC[JF45(U$5U*G-84/85G;,Q&/!,1&?;
MS07ZD,4R_;[<C$NI? ;0^_U./TQM6>8_$3Z::VN+7&2%H[7- /;X5AV.[^FV
M6S]-XXQ[L]/YM_=TCN]-*3/&GTSY<L^_D^N+Y03IY--I<+E=[9?.3F?C4E!(
M:D3::B'4<-2[AZJMISF:QF?#^,--:S:?GYQXO&V%FW#WJWEN^^-[H*_$<"H8
MF4.'6*H+FR53.9P])/$=0>T$=BW:=,ZM&R;3F;QQC'E\6O=L^_LUTKPBLY=7
M1V0=Q^I1O=_/*?F!/$<3Y=5EV,Q_0:J3X9_673ZC_P#G3;V3^CJWZ(;U>=/;
M7'0FCGTYNT_L_'1:O2*S.[N,^.N<?C#7W\_\A3'U?<S^4L8W">T=*O4!GM\W
M(Q4WS:[=,-N=/D_M,5;:"K:]YEC>US7: !X\JU]AOK3M[:=D?-6?E^+?ZC6V
MW;3=2>48F%_5'4W@VX628EBG3CMK9\TN%TN4+;_?KI9_04%#0<S6SR:M =Z1
MH(T[0MW:Z[;;S,_+&')MF*:YF>-O#\';N[S1]9.P\4[6MG%M>UPC\U@< T.#
M01KIKV>)7T;%=_=5CG-:XG\6WO\ _P# TYYS-IE]OR@!:,+V^:[0'^=E)KKP
M[)HQH%PZJ_\ [#7?V2[*6_Y';'C,?LSKO+H.F^^GL#\8@(T^PMXZJ>N7^N?^
M*?U:/1XZ?MXX3-8S^"$]RQ+(*OIFV*W1Q&WOO5YVMN<=SEMC0XF6C;ROG+6M
M&I(Y0 /&O3[^W]/ZA3;SK-(_3#G[./N]MNTQPGJS^$Y9HKNOK9JIQ:JI[5#>
M:_<&6C=%#A3:)_IA6.9RACG::$<Q\2Y>\U6W1:M)XVCFO9V^W-+7\)B?P8=E
MVZOF$=&&ZU\R> T5\SPSWFIH7<# R<2/9&_P$<W$+F];B-==&FO.O&??,1G]
M'7V&_P"[W>S9:.$\(]T9PO>IV7CR_I3VWR7#:.&WY[A5L@O=CJXF%KYY(>62
M5CC&-7<[6D +U/6+3VO?_<IRKBL^V)YO+](K][L_M;.,WF9^,<G1O%NW1;O]
M%UUR%NE/>J$TUMRF@?P?3U],X1S!PU)XN:2->XA:>\TUKW.B\?3>V8]F8F7;
MZ;?,7TW_ )/SB)P\[J+</@W]-NNO*<@L'*.P:^B?Y=5T6OGU>D^$5G])<O9V
MF/3KUGG-OW3WSCE&UF4 Z#3&ISQX?[OW>$ZKRO6J36MNGQS+=Z5'3LI,^$?N
MU[X;M97[P]$]=B]D<'WVGJI[A98>Z:>E+GLC/;[(\%U]_6:?TVW^[6.'PAEZ
M;MB=N^EN5KV_67O[?]6_3]CN'6?'=U<19BV?V6D9172RRV1DLE1- WT9?$_D
M&H>YO;Q67=[HW1U:X^#5HU6U7Z;SP9IV:W#W$W!QS<'-L;VQQ_#+/$^5FVM/
M44+Z>MN$<0U:^L$;F#E<[7ETTX:+7W%-FKMJVCC;AP]F&>F^N_=6B?IQB)^/
M\>+!3^J/I]S*P5-CZG,)9C&?QF:ENUF;;)'BH =H'02\W/RDC@22INTZ9K/V
MYS,_E,?[66J^W1BM^43^4R]_H;QN6DR7='(\4M-?CNT=VJ S$+5<.9KW%A&K
MV,=IH-0?FKMILO7LZTVS$WF>>'-W.O7/<Q.N,5QQ]^6QS0_07'/R_+Y.B_/V
M'#N6*.![?451JQZZ?[_.GC['3_\ %F*C?#2\::G/_9,^I"#O0:B=A?C3]6?Y
M5@_]!193>4!5#Q(" @("3.8QX&..13'"(\ER*Y2WS5Z9Y&O>>SO675,VSXK6
M<-9G6CO!O1@VX&-V#:W*:BT15%O-;66Z-K2V41LYG=K2>*X^UWS/=6K?Z*QF
M8=.S16>VI,?5:\Q^2<FSN>0[C[<8OET+_2ON-(P5C^ /IV:MDYO'J%ZO=Z(U
M[9BO*,3'X/*[+;:^N8GZHGC^/!#+KCWWW)P"2TXSM5?IK#=[;2_AK)KA &N(
MHG.,#6'F!TUD<TKS-&RVSN?N6^BORS_BY_H]FE(KIKCZ[3_Z>/'\4Q-CLAN^
M5;38#D%^K'W"\7:S4M1<:YX:'2ROB:Y[B!H.)*]3N]-==\5X1,9_'B\?L\VS
M6>,]=H_"5U#/<)=</P0W,+*;L7^C%N%7%Z;F_4^CY]=5PZ\[8S3C$.NT1%,3
MP_V,7]3.79%A.S&5Y+BMS?:;U0QM=17"(!Q9KKV!P(X^,+F[K;;5-)CAQXNK
MMM<7S%N/#*]-HKY<LAVTQ"]WJM-;=:^W,FKJR4 >D?IQ)T(T7K]Y77IV3%?I
MF(G\GE^F3L[C7QGE-ORG@]X9UACKD+*S+;2Z[N=R?@QM9#Z?G[>41\Q.JXM5
M9V1UQQGR=5K_ &HQ;Q\5V D\IX<?_E5M'5\O+',KCJX>7"?]BUKCFV(6BN9;
M;IE5HMUPDX14535Q12NU_P QQ!4K\TQT_-,?!ERFUK_+GXO6KKS:K;0FYW"Y
MTM%;FM#W7">5D<'*X:@B0DCBKLF(F(GA.>37KB;9F.,1XOIIJRGK((ZNDJ8J
MJDF;Z2"IC=SQO9W.#@="L]L36?FYPD6C;6.GG,K&RO+:%V%YI<<9OE+57*QV
MZJ>)J25DSJ:HC82.8-UY2.W0KC[R]M>G[U>7/X._3JI?NJ:;\V(^DS.<MW"V
MEH\@S&\RWR\R5]1"ZLE#6N+&/( X #AY%Z?<4KJTZ[>=<_C#SYB;[ME?"EIC
M\YC]F<[AG.'6FL;;[IEMGMMP<=&T535Q12$DZ#S7.U_07)2T;<<.+;LFVG7T
MSQGQE<T<C9F,EBD;+%*T.BD:06N!X@M(UU!6<3-)F)\?XRQUS69B*^*UZW/,
M)ME<;7<<QL]%<@0T4,U7#%+S.]B"USM3KY%(F)B(IQF%F.B?GC@NF*:*>*.:
M*5DL4K0^.:,\S7#Q'O\ FK*T8CCS8Q,6G,<8=NIX=Q"UXX893QMGR>?3VFTT
ME1+5TEJHZ2KG.L]5# QDDA\+WM )]5*_+7ICD1.)SXO0[M.T>-93.<>Q/YNK
MQ%C@%00$! 0<F=OJH-8NQH__ 'G-^^FR/[@D5&]!!#[KQ^*UNA_%8/W=B",W
M0=\6C%?RM>/NHJ"80_\ D0#^B@(" @("*(@@***HH>P^,'UE)X1GR95CJF*Q
MXM=W4UF^]TN_.";5;4[C' V91;/3/FDB$D E8YY+G  N[&CL6'8]7<[ME<\*
MQPCX9;>\Z-';UOCC,Q'XSA]9V)ZZ@YP^%99>!(_@53\^);8C,]+3&)GV,Z;9
M6[=/:/%,IN._>[5KSJH#O;%HN0#J6*&..(ZPDS!FI<[QJ]UNU4UQ%>%^/QQR
M8ZM>RVR<_3&/S1%VWW5WGW:S.XYS5=0.-;=X!9[R^G_F+-(UD]520EP/HW.+
MQYW*.)/>M>F+:M%=FWYIFN?+CY-F^8V[IU:OEQX\_P!<?JY6+='?;?C=3*J'
M#=\,?VTQ7&+O^#[99W'GGNL7.YH,&ADYG:-UX<.*Z.RTXBO<W^:+3/R\L?'_
M &,>YV1U_9IPF(XVY\?\/^ULFNF5XWC45)%D636VT2R1@!U=4QP.D(X$MYB.
M!/B6J-E9VVF..? U5M2F/!]S9++?Z!LC/:5[M52T&/A'/!(P^JYKO%HGV)I6
M*7X3/$KMQQCC,/DKKMB^(4D/X2N5MQFWMU$+9W14L7D8TN [U;W_ ))GC^O]
MB:M.:S:GQ]CLBR6PU-JFO=)>Z"KM,##))<HJACH&MT/%TC3H/FK5W-ITQ%IC
MGQ9:+Q>T4B/9,^Q$7IYZAJ_<G<?=:R91DUHBH[/>S;L-M\,K6":&/F ?#S.)
MD+@!J1\Q=>K3%NSZ_P">9GAY1X)WLQHWQKC_ $YCC/Z?FE]><BL6.P,J[_>:
M&R4TCN1D]=4,@:7>#F?P/J+FF]8G'BL:[6IU1^+G:;[9K_2^W[#=*2\47-R^
MV:29DT?#@?.;P[5MVTFN)F/EG\F%;Q:8Z9^:>'Q=-5DU@HJJHH:R^4%+6T4(
MGK*62=C)8XN^1["=6M [RM4;*U^:DY\&R-<\IC'[NVSW^S9!3.K+%=Z.\TC7
M<CJFBF;/&'=NA>WL.@/!;)US2N?"9S+77;%IFB-/67GV8[;[*77(\(O,E@OT
M=5!%#<(0"X"1[6D><#VZKSNYW7KNI6OTVY_"';V^BMZ6F>=5J]%V[F:[A8QD
M6/[G7.2[YMC5=K/72M#7OI96M]&0 !KH=>Y>[W&JD:J6K\7D:=LSLG/*W&/A
MP92ZG-R+QMOM5<+CC52:7+;U+':\<D8 71U52UW(X @Z\I"\7N+VG;%*_P 0
M]7M<179:T<(KF/?P_9AGH3W-W*W*PW-ZC<O(YLAO-DOGM**68-'HV-B:2T<H
M;KQ*]K9KI_3ZKUYVZL_"8B/W>=,SJ[B^NW*,3^64Q;QF>)X[*RGO^46NRU,O
MUJ&NJHX7._T7$'1>?6<S-:\9\G5&NUHZYX5>LRNIZRW27&@JHJNG?!))2UD+
M@^,Z,)#F.&H(\:=Q>=4<.%OT8Z+Q:\3'&.*)W2;N5F>X%#N5-F%[EO4ECR.H
MH;8Z4-'HX&:<K&\H'A[UGJM$]EJOC%[1.9^/DU;:?\WLUQ/")CA\(2?O67XO
MCKHH[_D5MLCY>$+:ZIC@<X>$!Y&OJ)%X_P!/.>#HBEN?*(X/7HZ^DN--#64%
M9#6TE1J:>J@>'Q/;X01KKZA6==%M.,SX3GV^33&^-LS:(^6.'O?!=\DL./1M
MFO\ >J&R0N(#)JVH9 UVO#@7D!<\3'1QGCG$?A_'%LZ;<+5X_L^FWWBU7BC%
MPM-SI;E0N:2*VFF9+$>4:G]D;P[%MVQ.ND=<8K/Y,8M'7\O&T<W5:[[:+XRI
MDLUSI+I'2R.AJ9*2=DPCD':QQ:- 1KV)'_W(Y6AC-NFW1XQ^2KK]9X[M%8Y;
MM1QWF1@E;:O3,%06</.$9(<0>U8S;[O"/Y8RNR)U?/;^;Q1*VGW)S?(.I[?7
M!;Q?Y:S%L5CH38;2YK.2G,O/SZ$ $ZZ#M*S]/K]_LYWWYYX_C+?ZE7[.W32G
M"LQ;A^'C\4K[UDN/XY%'-?KY0V:&34,EKIXX&N.N@T+G!:*;8O;I_#W>3"VN
M:Y]^(_M?1;+Q:KW2LKK-=*6Z4;^#*NED;-&[0>%IT_16^U>B<3&9EKB8M$XX
M3#Y;QDM@QZ..:_7VWV6&4\L4U=4,@:X^ %^G8L(B)MS^#.(GR=]IO]GO]-[=
ML-UH[S1:Z>V:.9LS-?!SM)"MJS$_Q^K#'M>L"2-3VI:,2JJ@(" @(" @(" @
M=RBH;]?/Q8,S_*-H^[&JHV5[=?T"P;^SUK^Y(E57H[V+O(41HUWT_P"9WC7T
ME@_X>Y%;-G]K_ICZY41P05'>@H@KW<?4040$%="@:>'M0444500$!)Y!V'U?
MH);A&658XM8N=9-U([@=4>9[1;7[NMP*V66V1W"F95PF6$-Y8N9K?1-<[B7]
MZG9:;]QIOLF?IOCEX8;.^OK[:-<37C:/-=DNR77A3QOJ8>J.S5\T +F4?M*H
M;Z0CCRZF/AKX5GU36T1AJB(Z>;+W3'OGDNYU/D^([A4%-;=Q,"J#2WZ.D#A"
M]NH#7@N<22=1XEMO6FW33N*\K1^[3LK?5W%^WOQ\<^W$8GX)'WK*\:QD0G(L
MAMUC].-817U,=/SZ?J><\5SSLB]^B.4>/M='3;/56>41F?;XO2H+C1W2DCKK
M;6P7&CF ,-53/;)&\>$/!T*SFLXK,\N+728B)Z9Q,NBZ7RT6*E=7WRZTEHH6
M:<]552MA8->SSWD!:YM6..>$>"YMCA7G_&779\@LF0TQJ[!>*2]4NO+[9HIF
M3Q@^ N82-?$MEN,1F,9Y21'"8K/%6[Y!8[!3^V[[>:*RTKG<C)ZZ9D#"? '/
M("PO\N.J<Q/@RUYF/ECD[+3?+/?J85UANM)>*)QY?;5',R:/F^F9J%LMKOB(
MB,1'BQBU*3&9S,OE=E&/"MK[:;];O;]J9Z2YT/MEGIJ=O ETK==6MT(.I'>L
M8M2T3:)X1XFNMH^6U>/O+-E.-Y$*@X_?Z"]^U#RU'M&HCGY''N?R$\JSBMK5
MG'A'%AGAQGC,\$1^HCJ$NFWVY6UN$6"_VFAM^05W+EM4^1OIZ>(<WFO\_1@.
M@.I6OTR\;.ZZ+?Z>)_3^UO[[3:G:VO'^KPQY<X_;*8U'=K=<:)MRM]QIJVVO
M8)&5\,K'PEO>0\$@A6UHBTS;A7]6K3:-G&D<?+_:\.VYWAEXKC;;5EMHN-QU
MT-!35D<LH([1R-.O!9:Z6OC'+//V&RL5M\TXGQCG_8]FZW>UV>E=57BXTMLH
MN81NJ:N5L4?.\Z-:7NT''N6O-8F*VYV_;V,[7FT]58R\"W7; J2[.M5HK[%3
M7RN'I'VZB?3QU4W, >9S&$.?J..JRT]5IM_P\_\ <U[JUMBV><\'=<<YPNSU
MHMUVRZS6NO<1I15-7%'*3KIIR.<#Q[%-=IV_QS;]];1/LPN>":*HB9-!*V>&
M1H=',P@AP/>""05;UFO@TUV5G@[M5%B1%$011$$! [4! 0$! 0$$8NL;XM^Y
M'V*D^ZXT5D?Y./XK>)?E*Z?NZJ)UO]B4&L?KZ_O0Z.?[:UG_ -S02B/UR3Z8
M^N5!7M0"@(" @KZW<BN*(J@)/$CA&!+3U8SX$<)RJ$M,X)YJ D21CN<X J_3
M2T1[UCA,M6U+<.JG=_>3=O&MN]\X,%LF$7/VM3T%?3NE:6N:' 1^C;V:$=O>
MM7INN^WM*[K3QMG\IF&?J6RE.Y^UCAB/TB60HMCNN=DK#+U56>6)KV.D8**H
MX@$ZCZV[M'8MM+UI/3,9B&N:VM29B4XHKC'C=AH9<OO]'%-20-%PO%3(VGBD
MD:WSG O/#4JWO7KM$<.$>UCIK;HQ;CSXEES#%\ADDCL.1VR]/BXR,H:F.<M'
MC#"2%=5)Q&R(Y\V75,TQGE,>Q[DU1'2Q23U4T<$-.TNFGD<&,: .+G$\ !Y5
MK^_6/JY9Q\&5*=5L1SAX5IS+$[_5345CR6UWBKAYO2TU'5QS2-T[=6M[%:ZY
MQ%J\<<Y:XMTYZO&>"(N]G47<L0WUVCVYLV16FAQJ]RR29E6F1IFA$3N3T4K^
M;EB!#M3J-> 67I4?U/<[)F<4K6<?XL_V.KOJ?8U1:/JM^B9\%VMM30-NU-<8
M)[6]GI6W%CV.@,>FO,) =-/&L=O^5>;VX1XQ_&&C7;JX5X\/Q>+:LWPV_5AH
M+)E=IN]<WV='1U<<LH [?,:2EJYIU1'#FD;:TF,\)SR?3+-C.+1F65ULQV&N
MFY7./HJ1LTSCH [L!<2LJ[8B8KCG],>2[-=JS-YGEQS[%:?+<8JKH;'39);:
MF], ,EJCJ(W3@!H/&,.YNSCY%-?"EIGC'C*;JXM&>$_J^*NSW";96FV7'+[-
M0W%I#7T,]9#',">P<CG:J1$;)Q6<RRV3,\+QC"Z(YFRQ"1CVR,<.9DC"""/"
M#WK9BT9GDPFT6G,2[M5A$X)K$Y]HL9C+.)Q&!6>,1GP8Q&,^T3PP>.5%(X"J
MH(" HJH&JJ*:E!0]A\A0:Q?E*/Q!M7^5ZO\ <VHK<;M!_=3MM_9FU_<L:$LC
M*H(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @U[?*;_ !7+C_:2T?52*#P^D0?_  Y;7_D^?[JF14C$15 "L3@Q
ME3E:006@AP(<'#4$'M!4M2+'5,3P694[<;>U=<ZY56#V*HN+I!*ZOEM\+I2\
M=CN<MUU"SF(I:)USB65KVOPOR7C&R*%C(H8VQQQ@-B8P:-:!W !2][7OB8YM
M<1TS$U>;;;%9+3-6U%JM%);:BY2&:XS4T#(G3RG]/(6@<Q\95U?)KZ?)E>)V
M7^Y*E58;)7W"DNU;:*.KNEO!%#<IH6/G@!.I$<A&K=?$L:?+RYS'-;VB\1$\
MHY>]W7.SVJ]4DEOO%LI;K0S?7:2KB;-&[RL<"%)I39LZK<)B&<;+YC'TXXOA
MLF*XSC;'Q8[CUNL,<G&6.@I8Z<./C$8"R^[,UZ?R:.B;S\WF^BIL-AJ[C2W>
MKL]'4W:@:6T5RE@8ZHB!X$,D(Y@IKM,S,U^7/#/+DSM:;1&?IK,JW;'[)?8X
MH+W9Z.\102"6&*KA;,UCP=0YH<#H01VK&(Q:NSR9QL^6=?\ >?546^AK*.2W
M5=%!4T,C/1OHI&!\3F=G*6'AHLME*[=D]7*6%+32(B.&.#C0VVW6RDCH+=00
M4-!".6&BIXVQQ-'@#6Z ++/W.%^/\<$KG7/5RGP_=X$&"8-37,WJFPZS4]Y+
MBXW1E%$VHYCVGTH;S?HK7IM;77IKQXXRRW9M,9_B'O7*UVZ\451;[O04]RH*
MEO+44E3&V6)[=--',=J"EZ5F,W\?%E2T:;9CD[*.AHK?20T%#1PT=#3L#*>E
M@C#(F-'8UK!P 66RUKS/5QM_'%KU5BDXCESAX;<)P]E'7VYF*6H4%UF]L7.B
M%'$(JB8G4R2M T<[QE9TF+=%><5Q\)CA^C*F;6MCQYOKK,:QRXT=%;ZZPT-;
M0VY['T%#/3L?%"^+4,=$TC1I;KP(6'5Q^Y'U1_N8UGY)I'B]66F@GADIYX(Y
M:>5O))3R .8YI&G*6]FFG<L+5FWU\F6O_+G/D^2V6BU62F;0V>W4MLHVG5M)
M21"*,$]IY6@!9WO-Z?-X<O<QBD3/R<\Y_%XURP+![Q7LNMWP^S7.YL(++C4T
M<,LPT.HT>YI/:L8K]NL7K/&65MO7QMRY+GBAB@C9#!$R**(<L,48Y6M;X !V
M+;.RW5U3/.,2UUKBO3%>&5L7;!<*OE6ROO>(VB[5\6GHZRLHHII6Z'7@][2>
MU:*5KJB(K&);K3,S,=757A\%RT]-3T<$5-2P1TU/$-(H8FAC&CP!HX+;MO:T
MQ,_!JQ6M8\YG#N)*DQY\V<YB<2HHCCW\? @U9==7]_G3Q]C@_P"*QHL-\%+_
M  :G^Q,]8*H[T&HG87XT_5G^5(/_ $%%3>1! 0$! 0$! 044SCB-<G4'205W
M5CM%15#!)3UE&Z&>,]CFOC#2%S]AH^]W.^OGJS^;;W^Z=/:ZK1X;/VE?/295
MOP:Z;P;+729S)<$O+[I;C(-&BWU3?-+2= 0'-=Q7=_5?=[*-L\ZYB?QQ#'?H
MC1WW37Z=D1CWQS_5&'<YDN>;<=5>\U3&7TM:ZCQ_%Y3V>U:>LI?2<O=ISQ'L
M\*YJZ_L=OHBW/9MB\_A-7;IGK[JU/_MZIK\<Q+(V<9SDUBZ7MAL%Q&ODM5\W
M*I;?9S<XR&OAIWP,](6$@Z'35=O=ZI[KU+7V\SB,1GV\'E]IN_INTV;L<8FW
M'RXLIS]!.RK<;DBAHZ]F=0TVK<W%74>VC4M;S>DY3)IQ\BY.YVSII-]/RQ6)
MGAXX_%M[6/O6BFWC,\./M8%;G5^OW21NOA.67 W7(=L[I/9)K@YVKY:>%Y;"
MYQ.A)T[2L/4[1OT=MW$1B+]/_FQQ9]I'V.ZWZ)G/169]W'"Z-YMTJG .F/9Z
MPTU^?C/YP&PV^X7]@U-+11F,U+] "[V$FOFC5=OJ=HGU&-,<NF)G\'+Z'6T=
MC?=']Z8_%BB6W?)WLQISJ3=1T>XC*;GBSAINGMIU6!KSAIC(XD:<0N?N+3KF
M;:N&(_-T=K$3C[G',\?9#+>WW4_<8.D_</)8;NZ_W[;T/M%HO7*0^>-Y,5-,
M_F \XL'-Q5]6I.S5JQ\MMO#XQC*>EXC9NK?C2DY^$S.'L;4=%NW.<;:6G+MS
MO;N3Y]EM&+D,EGK)F/I'U#>9@C <UNC3XET=]V\]O:=6GA:/'X-7:[XW8V;N
M-9\/B^7<O;3/MJND[.\.S?*Z/+J.BK"<8K:<RNEAHW/=Z.&9TC!S%HX<%Y_?
M;:S.GJ^OJC,_"77V>J:WV]/T3$XCXIF;+AOYG<*X</P(P:?Z'^5>EZW'1;;,
M?W8_1YGHV?MTO/\ >_\ J0AZ:VAN'=5'*WE_\PN).GV)>;WD]7I&J?.(A[E:
MY]=KY0^;;#<BHVIZ)\ERNAE]!=(IZR"V2G]))-*8_2:=OF<W-P"Z/5]F-/;Z
MO&U8Q\(AS=KKSWG<6GZ8M.?_ #2Q)AM+T!UV,T-9NKNE_.O<6OA;47:_5!N8
MEIJF5H+VQMC8!HQVNF@6WN(K29C7SB.$N7MKVM$6V1GSAD[8C=JYW#$M]-M-
MM,L?G5)A]'/4[97M[)/3R4DCG:QZ2-#_ -C;H&ZC5:>[C9W'91>?EO$XGVUC
MQ=':4TT]1I7.:6CEPQ$L3;*63HWS;'J6V[Q5M5;=ZG^F;=*R^SUE+4,G+G!K
MF.);& W@6ZKHM35B)[>?PQ^SFFVR;V^_RSP]S:!L;@ELV[PB&QV/.:C/;(ZH
M?-:KI/-#4MBC=J?0M? ]X(!\)5V?1_F1BWG_ +TK'3;.OC'E_N9I''M7+#;G
M(J" @(" @>- 0<F=OJ_00:QMC?\ F<W[Z;(_N"14;ST$/NO'XK6Z'\5@_=V(
M(S=!_P 6C%/RM>/NDJ"82 @(" @>! 0$! 0$ ]A4EE7.>'/P:L.K"[9O8^JO
M:VY;<XW%EV74]F/X+L4SQ&R;5TNH+B]FF@\:U>G6M_5;>CR_9T]Y%9[2.KEF
M,?BR&[>?KY)=KTN6CBYQT]MQZ^R[=/;I71USXPY(K6<1+,=/8\HWMV9O]#U(
M;9P8Q<FLJ9H\;IIW\G+%&7,DYV2N /!ITYEI[[1KU:J[*SU6Q;X+V6[;?=;5
M:,4S7BA]TK=*NQ.Y.$Y1=\QPMMVN%MO-5244_MJ>+EAC?(&MY6/&N@ U)6S9
M/1V%-LS\TUSCV\64T_\ V-]<<:5X?Q+S>F;:3:*RY#O;GMTQELM3L[>I9L2G
M$\H%(V)\K&#3FT?V#V2MN\GL?3J]S$?/,SG\O<U?TM>[[^>VM/R3'Q\?[%B[
M>Y/TF[CT]VS+JBW)%\S*\5TKX<=J/;[8;?#KHUK33LY->WL*L]O31IBFN>JT
M\[<_SC]V=^XONW6K]-(Y0RYL#NOMQA>_E1M]M%GTF7[2Y-;7U=%02^G(M]5$
MT/+(C.T/(.GA/:LZ[=FSMMD;8^:D3,3Y\OXX&S3KSKFLQ6TVXP^O:';FV=7N
M=[H[A;NS55\Q&S7;\"XSB(G?#!$V)NCGD1$=I;JFGM(U]GKOLG.RV?AQX'=;
MXOW%ZZN%:Q'Z<6<<-Z2ZC ,SRBBL5\II]A\LMCJ6Z[=UDU4ZJCE:6N;Z!Y&@
M T/Z=<L[]D]MNU;8XQF:V\L>V?[&4Q$WU;-?+'S(Z=(6R6U\F[&[UWJ<=#JK
M;#)*C^9\PFE_V-D(D &@=Y_9PUU7=HV3I],^_'&\\,^[#7ZCKB>YBG\DQ'ZK
MGVMVVM75SFFX>X.[%14W[$K-=I+/C&)LG?#3QM@#7<SA&YNI'.>.JY^WU5KV
MM=MX^?9S]G&8;N]M.KN9TUX5IPQ[^+[,NV_HNDG=S:^_;:5E9;\!SFZ1V.\X
MA),Z6GA](1^R,](>'S5L].V9VVT;9B8F/EAAWFK.C[FJ,32<S^#R=SL"AW/Z
MUX<5K*J>/&;GC<#LE@IY/1FII0Y[FQ%S2' :CCH>]:/2=,6GN9M'"O3P_'BG
MJ.Z:U[7IGYK=7'RY?AG/BV#;:[48)M'8Y<=P&R_@2S32B=]-Z5\I,@UXATI)
M[_"M^V^9K'AC\8\FFM8BMYCA.9_\2-/R@&HZ>[G^4J0\?LK=%Y7<?/OTUCPM
M+U>RMTUV5\ZPQ_C3CM;OQM3?6M=!8-UL0I[=4D-/H_;[" PN/9J1J5]%JB+]
MQO[7QS%J^Z*QGV\Y\G@5B;>GZ.YC^7-9^,K\W9F_.3U&83MU'^SVC;VBDR:^
MM;Q8)0S6G#M.&NO#0KQ.WF;UW[I_EKB/?$P]?N_DU4UQSO/Y3#!O2ME[\#V?
MZE,M@8346B^W&>A8 #K,(1Z/77NY@NONMF/3='''5.(_\R[8BWJFS,?3$3_Z
M8_L77LETIX-N_A-)N;O9'5YSDV:\]RIQ/531LH62N+@R(,<T+?N[>.UFM8^K
M'&?:X=.^_<WO:?IB>%?-Z&TD%SV(Z@[_ +%P7FHN.!Y-:9KCBM'4O,LE+((Y
M (FEVIT 9IVK3VN[^I[;=2T?YE..?.)Y?IY.C=7[.W3MI]-YZ<>,8CR<.DS(
MH<4P3?S(Y@TQV7(:^HU)&FK1YIXGPZ+1LVX])[>/'$_K)736WJ6V?+'Z0C%M
MSDO21N/;ZW-^J#<IM[SN_P!5+._'9_P@R*VQ\VC&-$$;6ZAH[EOKJUTU5BL_
M-B)S[?)ANOLO>_\ =CA$>UEWI]W<VYPC?:Y[<[39_)FNT>46MU?;J:5M03;J
MRG9*]\,+JAC7$%H'?WJZ+7MVVVVSZJ8Z9]^<L>YK6/M_;X5F>,?&.;[-GMM+
M7U;9EN=N#O!)4Y!C-HO$MIQO%!4/A@C:UQY26Q.;Q&GA4KV7V>TU[+?-LV?-
M[H;>[W]7=3KU?+6M>/MX_']DA=L^F_(-EMP,AN>%9/3P[.W6W3AV#5,M1-50
M3^C=YT1<US0!YNFKUA;N+?TVRN[C,_3[$^W$[*;*QB..5J="4;&X_NGHP<<N
MK7'QG4+HU_\ X/;^<Q/ZRY]N?Z[=/GB/RA\F0LC^'UC?F@Z8NT$^(1,7-Z3\
MUNYF>73;]7H>HQ6>TTQ/*-F/RE\&T%;%;>KSJCKY-!%1T-%.]Q[-&-E=X1X%
MAV>RU?3+6CPGA[?FE>_I-^[T9Y8M^D(PX[G?37NSE^=99U1;C&>8W2:DQK!I
M/;C8*6DB>YH>?:[-"00.\KHUZM4:(_O7C,^R7+NO>-]H_EB97SM?NALUMMU!
MX7C6PN?F^[:9PR2EOV-2BJ]%15 9(8S$:E@=Q(:.!71Z9U[)OHO'&(^6?X_L
M<OJ<UT]O7N*3\T3Q]TX>9N57[9574CF5NZLFW&+#A#%'B,DHJF6UNCARNU@T
M)=IS:Z+R_2=.NVBWW)_SL\^&?X^#TO4]FRMZ3KKG7CCPG]8X);;$;0;*XWF)
MS?8W<9TV.5="8S@=-71U%. [0^F,4KS*TZCP+TZ;+TI-;Q,^V>3SKUIMMFLI
MG#B =-->Y<<1,<)=#DJ""NG=WA!1 0$41! 11$$$-^OKXK^9_E"T?=C45LKV
MZ_H%@W]GK7]R1*B]#V%$:--\S_\ O.L:^DL/_#W(K9N_M?\ 3'URHC@@(" @
M("!J?"@(""O#N040$%/ D\A4]OJ_02_TLZ\VH/+LFW:Q?K=W$KMGL%@W!R62
MQQQ5-HJ9&PLCIG-A)E#C)%KH0!VJ>E;+5[?;6(X3LG]&_P!6BEHU3:W*L>2Z
M\HZL^K;&;Y:L-RK9?'<'NV3D06NZ5TSO:\;G:@/=.*B2(:'N*NG7]^?MQ.+?
MQ[W/;.JO7:."1^PNT5RV.QG.=QL_N]+?<[R:.6[9+<*,_L 8WSFM;JUHX#19
M]WNKVO:QV]/IK$Q$^WC,,>VK;N>ZC;;A6>"!V"YCTJ[IR7[.>J;<9MTRR\7"
M8TF*R"O;#;J:-Q8P-]KL#-7-:#P)6&BE=6BL1]4UB9]\QQ-TV^_>L<*Q,Q[X
MB>?Q95V(W1VMP?J(MVWVR6X,F5[69_1/>;3,VI+;570->YK8G5+&NT<T>,+H
M[39LV=OMB\?3B:\_;,_HP[[7JK.K96?&8MR\9B(>UCF*4O5SOQN?-N!75E?M
MMMO4.L]OQ*.5T$4LVO%TGHR-02P\2>U<W8::_P!+;N;\;VMPCV3Q=7J&^]-V
MO36.'3F?;C@S?AO2U7[0;LVS,-I,@I<>VO93/;E&%5L]1,Z4!KB74VH>W4\.
MUP6S3OFD6KNC-9CA+FWZJ[)I.OA:)XH<3;A=/.ZVZ.?WKJ6W%]JV>W5SZ'%L
M%D]N-A;#"0&RO-,WEUT'ZI<_94I_25V3QO;\G1W]KZ^YG77Z:\)]K[\?W.V(
MVIWLV\9TU[@FYX9F-:VTY7A_^UNIZ</<UL<K#4QCB2YQX'N7H=I]R\SJM.:N
M7O*ZJ:HV4X3$O7;M2=WNMC>BS3W>>W8K!#15&54U*]T<E;3NAC]%$',&H'.
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M1I/@73W/<4[BOW-?&9CC'^]PZ].S1MFE^4<I_P!SJVON#M^NI>\;SVFVU$.
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M1%:Q?E*/Q!M7^5ZO]S:@W&[0?W4[;?V9M?W+&A+(RJ" @(" @(" @(" @("
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M*<3W'YB 01W%%!J>X_,1%=#X"@:'P% T/@*!H? 4%-#X$%=#X"@IH? @KH?
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MV_/?Y-E_>4#\ZW6]^WY[_)LO[R@I^=;K=[Y\]'_\MD_>450;L=;9>6"JSPO
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M=O+M]<FI+-'O$_('4M+4EUE_#=*ZF:)7 !_HN9C=3R]O%$?J V>_NHVU'_\
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M[J=MO%C-K_1I8T)9'1! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M 0$! 06+<?QOKX)&^N$/!?(^>4%4! 0$! 0$'C7_ /%LOTS/70=UG'_E]/\
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M5MQXL:M?W+&B2R0@(" @(""FJ"J @(" @(" I(*@@(" @*9!4$! 0$! 0$!
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M/_WJF&>7'_\ ALB#=BSO\OSD'- 0$'E7@_[!4>3YX0=%@_@+?IG(KW$00$!
M0$!!0]R"QZ/\<#[*_P">@O@=@050$! 0$! 06QD?92^4_.07%!]9B^E"#M0$
M! 0$! 0?!=/X!5'_ #/GA!X>->RJ_P#1]<H+K0$! 0$! 0/ @M*3^D#/4^I1
M5VH@@(""&_7U\5;=#^+T?W9"DBU_DXQKTN8EXKE="/MZ*G:_V)1&M;KE_OCZ
M*?[>5/KT:#91'['U4'8@("#X+E_ JGQ,/K(/ QS@^?U/T4%W(" @(" @(.+N
M_P B"QX?QV/XP?715](@@(" @(" @MS(_P"#0_9/G%!]5E_%\7TSOJD'LH"
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MC>V6CK88YZ25O$/C>-6N]4<5+4FMIK/@QI>+TBT>+V@=1JL(9JJ@@(" @("
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M,S:D97XCE]GR>DX:S6JLAJ@->(#O1/=IP[D%Y@Z@'PA!5 0:=?E9_P 1;/\
MY6J_W(**VA[/@#:G;C3^K5K^Y(U4ED= 0$! 0$&I'(&Z_*:V<$<?YKZD>I$5
M/0HB([R/^*/_ &PS];CJU]K_ !XRM-M1#AWRH,E;DLQHZ'*+$:>R5-1I&R60
MPS#DC<[0$C730>%/0..CN-,_7,Y^&<KZQPKHVS],</=.&WFNJ(*:CJ:F<-BI
MXHC(^1QY0&@'4DD@ :!:M\Q37:<^$\V.G-KQ&&D?IFI9=QMU^N#*L2B]-8;W
M;JR@LU:P%L4M0]^H:QPX$@<2!XEKO%M?_;T]5>,WSCX.R-U*^KTKGC7C/Z)+
M_)@7JUU.QU=C;9F1WO'+U5TUYI=6^F$AF<=2SV6FI[2%['<USV^F\3F.GQ\'
MCQP[O=68Q,SE\7RIN26:V;)V:RU#HC=;[?(8[7"2WGUC<USG<FO-IV#5>)J^
M;O\ M^F.5H_6'L]O:::-TSRFLPEYM5E>/X5T\;<9#DMW@LEFLV'6F>OKZJ01
MQ,C%''QYG<#KH  %Z_K>_P"WW&V]O[T\/B\3T33.WMM=*\9Z8_1KWS'<[<[K
M]R&KVZV6IZ_$>GZU57H,VW*JV.@DN7HW<W)2#3F(> .&G?J[1<>GLHO-=W<?
M3SBOF]'9WD:HG7IXWY3/E_'M;/-H]HL.V:PNUX5A- VAM-!&!)H0Z2:7E:'3
M2N &KCRKH[CN;;K9MPB.$1Y.77IBO&.<\VL?JPMMON/7_P!.%!<J&GN-!54?
M+4T-5&V6&0!M20'L>"#Q [0N7_MZD7[[N8GPI'_M=_K=YIZ5JF)_FG_W0VEC
M:/:AP8_\VF+^=I__  BC_>E>F:SP<W7F.+W[1B&+XQ35$6,8[;L?CET,T5MI
M8J8/+=="X1-:"1J>U9VFTSB>37B.?BT_7RJI^F[Y1B&_WUPM>(;Q4#_17E^C
M86UE0U[7B1YT#='Z:^5:_P#M^T:]6[M)YS.8_'+H]8K.R-7<\YK&/V;EZ:JC
MJ88Y62-<V5@,;@[5K@>(T<.!'D6<UG/M:8M\J*O5MU,4_3?M]2Y#;XJ2]Y7<
M[G26^QXJ]^D]9Z>5K)3'&'<_FM<3KHN7[MK;]>FD=4VF<XS/3'PY?%U:M,12
MVR_"M8_%GG;;);[F."XUDV164X_=KW1PU5592XN,'I6AP:2?$05Z'==O6FV:
M5G,0\[M]]ME(M,8RR)&  X Z@.^9XEJC#H=B @(" @(" @(" @(" @(" @("
M @(" @(" @(" @UY_*=?%;N?]I+/]7(BLH]"GQ5=IOXA4?=4R0DI=H+'SK.<
M?VZQ:]Y?EEUCM5AL=.ZHK*^5P : /-:-=-7.)T [R@UIVZV[W]==T-]N]UN.
MT735!.]EDL\//373(X6'1E0^0:.;%(TZ@M=IV: H)S;4].&S&T%!!08/@5JM
MLD3>22Z2PLJ+A+R]OI*F0&1VA\)09R?0T;F%AI(7,((<TL:=01H1V(0CKNUT
MJ;&[P4;XLIP:WP7,GGI\DMD;:*X0R-XM>VI@#7:M/'0E!#>BRW>;H;OM#9MR
M+Q6[H=.%PJF4UKS)P])7V$2NY(F5CSIJP:M',YQ0;1K!>+?D%GMU[M-7'7VN
MZP1U=OK8G![)89FA['M()X$$%![" @(-:&[V_>Z&\VY-QZ>.F*I]IS6USJ;<
MC=EK/2TMI[3)!!(&O:92.' =IX(,Q[+=%VT&U[F7Z[V@;A[@UW+-><UR,>WY
MY)QQ=)"VHYQ$"[73E03%A@AIXV001,BBC&C8V- :.[L"#P,HQ7&<KMD]LRBP
M6^_VVH:65%%7T\=1&]K@006R-<#J@UW;A='61;57"JW2Z0L@GPO)Z.5]PN6V
MYF=):+SRGTAIF0NYVQ%^A:WE:.+NY!(OIFZE;3OS8*REKZ*3$]R\5E-!GF"5
MAY*FBK(^#W-C.KG1D]A02GA]AKS<Q)/$H.U 0$$&-Z^KMV+9:-H]F<7JMVMW
MJENDEMMW[)06PZD<]PF8=&:::EH.J*QG%L-UF[IQ5%PW-ZB&[<1W%PF@Q;%:
M2*9E(QP'[$99&1N<1H==25!W0]'/4#C/I;AB?5YDDMU;&?:T-QM].ZG>X=@<
M-7\/#P/!!\$/4)U)=-=924?5!BK,SV[>]E-)O!B\1D92/>=&R5T(:P-;IP.C
M?55&Q+#<NQ[.;#;\HQ:\TU]L5W@944%QI)&RQ/8\:\"TG0CO!XHBZD!!I1^4
MI^,7TW?Q>+_BT2+#=/2_P6F^Q,^I"([T&LSI&^-CU?\ Y2IO^[2%ELS1'5-K
MZ-P!T)&@/8@A=U'=4,NW%QMVU.U=FEW&WWRAH-DP^B(E=0TY'G5M=H?,C;P'
M'MY@@Q)AW0_=]PZY^;=5N=7'<C(+B]E2W"Z2IEI[+0N]EZ(11&-LH' '5O=W
MH):6WICZ>[=3-IH=E\,<Q@ #IK+1S/U'#4N?$XGRZH+.S;HTZ;,SI7TU7M99
M[)*?/BN%B@;:ZB-X'!S)*81D$=NB"*57BG4-T4U3;[B-]N>]>P43G2Y)C%:Y
MU1>+/ #K+40R/U>]C&#7B[P\$5L,VOW0Q3=S#;3G&%75ESLMWCYHGM/G1/!Y
M712M_2N:XZ$%$9.;Q (["." [V)\G_3L0:YNKK=/,LLRBP=*>S=QEI<_SI@J
MLOO-.'._!ED(/I'N> [D+P1H>!X*+"5>Q.R&$;"81;\%PBVLI*.+6HNE6073
M5E6X 25$LCN+B>[4\%49NT';H-4%= @(*:#770:^%!\E33T]1#/35$+)8)XW
M1RP/;JQ[7#BTM[^&J#5EN!C]QZ(]YZ'>'$V3GIZW(KVV[<S&X-?:]CJZKS8:
M^)AT:QCIN0'3]4>"*VCVRY4-YMU%=+95QUMMN-.RIH:R%W-')#*T.8]KAV@M
M((*(]) 0?'<*RFMU%4UU;4QT=)2,,M352N#(XXV#5SG.<0  .TE! ',^NJV5
M^0W#!^GO;Z^[[97;>85M59(Q^#('L[0^J>6L=QT'FE%6B[,_E";I&;]'M%@]
MO+P)8+#4UE1[9 /%L;RW4<W'0Z'M0>W:.N>[8'64%GZG-HLAV@-2?1RYD8O;
M-D+SYH<)8R]S&.=V%R#8%CM^M&36>BOM@N4%XLUSB9/;KC32-EBEB>T$.:YI
M([T1[: @("#S+Q=;=9+96W:[5T-LMM!"^>LKZAXCCBC8-7.<]Q   0:X+MU.
M;V]05RNF/=).,"GQFAD=2UF\^01F.VF0<"ZA;RN])RD'75NB*XNZ*MWL^]%4
M[N]4F479DK6ON-EL;6V^#TH[.2>!T;P ?$-5!UCI!ZBMN:69VR_5'>7.I3K:
M;!DT+*NG !UY)9Y!-(X>,A4>WA/5UGFW^66[;+JOP_\ F'=[G,*?'MR*34V"
MX//!K72G3D<XCP#M1&Q6ED;-"R6-XDCD'-'(TAS7-/86D:Z@CB$'T("#2/M7
M_P U'*_L^1?<$B$MW""'W7A\5K=#^*P?N[4D69\FQ\5##_RM>ONZ103T5'3.
M7AH+/9<=$$!][^IS,:W+G;']-5JBS/=!S ;]?W$26NPL.OG5,K.8!X UY=#W
M(KP\4Z#K=D3V9+U&9Y>]VLLJ]);A1NK)Z6UQ2$\61TT3FL<UO9Q:$&>J?H]Z
M:(J!U"-F\<="2-9'T41DX  :/(U[/ 5!@W-?D_=OH)#D&QN0WO9;,Z6<5E#4
MVFNG_![Y6\ V2C+_ $9:=>/ ^15'D[:=26YVT.=V;9'JR9'1UM]D]J8/NY T
M1VRZ/;J&QSOT:V.5Q+0/-[3Q0;(HY!(&.:X.:[B'#B"$'<@(.J4D-!!TT/D[
MD$0.I?J<&T%/;L)P"QR[B[YY@UT>#;>40,DKR- :BI#3JR%FNI/>@PI@_1=D
M.Y5PCW"ZN,RJL^R6K#718-15,L%DHHQY[(WPQ^C9(6D\2YOJE%37QK9':'$Z
M/VECVVF-VF#].VGME.PN([WN$8+CXR@\?-.GC9#/:6:DRK:_'+FV2)T#*IUO
M@9/'&X<0R=C ]O$]Q00FRKIQW:Z8:BIS_I/R&MNF-TSVS9#LI>IY:R"II8_9
M,H'R<Y8\>R#6ENHU4$M^GGJ%Q/J%Q&6\65\MJR&S/%)F&*U1]'5VRK;P>R6/
M4D#F:="? KS$DD00$'SU+^2/FYPP!P+G$Z  <4&N_<_JCW$S?.*_9GI3Q]F5
MY3;7F#*]Q*L%UDM!&HD;Z9H<'RM.G#33YJ*^&P=#%\S$B^=0N\V49]D,S-9J
M&TUT]KH(7G35L;:<QZCCVEJ(N>?Y.SIYB8YMG9EEEJW Z5U-D-P:\'3@3^R^
M$Z]B#&];L[U7=-$45XV8W%JMXL&MA?+7;<9*3)6^UAJ][::H<'R2/U+B-7CP
M(J673WU&XCU 6"KJ[3Z:R978)!29GA5PTAKK;4@$.:^,G7E)!T<$1)1NO*W7
MMT&J"J @XNXCP>%!B+>7>?!=CL+N&:YY>&6RVTA;%34X.M165#W!K(*:+V3W
MN)X >5!!JAR/K0ZFI67G#I(^GO:NJ=S6JNN,+9;Y6TD@U9(8GL>UG,".\%%>
MB/D^JJ]&6Y9MU#Y_D.12@@W*EK9:", >P IX)0SS3W]_>AET_F!ZQ=FJ1ESV
MLW]=N?#;R9)\0RRG;&*AC07"-DK&O<''0 ><.U!F/83JTH=Q[]5;8[E8_6;4
M;U64!MRPR\-,+:SB?V:WO<?V5A'Z(1$THB3&PEW.=.+O"@[$! 0$!!Y=Y!-O
MG &O </]((//QQI$$[B/-<_S7=QT\""Y$! 0$!!URG2-QUT\800AWXZLFX?D
MS-G-G[-)N=OC<XAZ/'Z+]DIK6V4:137"1I_8V]I(]EP**Q-0=)>_F[LU)?>H
MK?B[TU+.3-)@6)R&BI8.?BV(U,7H7GD)T[]41?$GR>.R)@+::[YK35SAHVX-
MR.X%P=WNT]*@Q]6[!=5W3Y"VZ;"[L5&Y>+4)?-5;>96YTU1)'[+T=/4O$CW.
M/=J\(J273OU1XYOA#7X]76^KP3=3&"(\PVYNX$=;2N).DC&D^?&X<01W:*(E
M="=8VG7F[>.NO>J.Q! 'Y2_XH^=_E.R_=\:*F3MU_0+!O[/6O[DB07H>P^1$
M:3=TO^:IA7EQ_P#X;*@W7Q]A\J$//O-RHK/;JNZW*LCM]NMT,E1<*V9P9'%#
M$TO>][B0   @U5T5'F?7[FE;=*^Y5^.=*F/53HK=:V$T\V15%.[T<DGI(]"8
M20[CS:**V<8-@^)[>X]1XOAF/T6-V*W@LI;=0PMBC\;B&@:EQXDGM[547?H/
M $#0> (+?R#'+#E=IKK#D5II+[9KBST5=;*V)D\$C2>Q['@@_,0:L\NPS-^A
M#*W[C;7LK,@Z<KG4-9F> A[ZA]D$K@Y]9 ':EL;2"3H>&O%%;0,/RNQ9OC]D
MRO&;E'=K!?J9E9:Z^!_.R2*1O,#J"?)HB+M0$!!B[=?=K =F\<FRS<+(Z;'[
M1!YL1F?I+/)H2(X8QJY[CIV-!00=H^H#JVWW+JW8S::';["YV_\ E^59T'T\
MU0T\!)'"P/(&H)T+>Q%=;MLOE#J">FOM'O'A]TK)W.=78W44@921- X>AE;3
M<Y+N_5$??3=5^]6RU9%0=4VUDUJQI\HA9N?C37U5KCU[7U0/GM'$:D-T&J"?
M>*Y=CV;6.@R/%+S37VQW%@EHKE22"2.1I'-V@\"/ @NU 0$'7+[$:'3CV^IX
MD$8.HKJ9Q;8BTT5$^DJLHW"R76+"\!MH])7W"8ZANC-?-8#Q)/<@B[9NFG?_
M *A):7*NIW<JXXI9IG&:DVGQF=]''3,[F5%3%Z-Y<!VC5W:BL_8]T+],&/TW
MHHMKJ&[R2#2>LNSI*ZHD/:7.EG+G$\>U$6/EOR>^QUP]/5;?_AC:G(R ZFN^
M.W"H@C9("7![Z=L@8_MTXCLX=B#&%'NMU#=(%XH[7O[-+NGL=/(REHMUZ"(>
MVK2.$<7X28UK=&NU&IX\>]16S"PY!:,FL]OOUAKX[I:;I RHH*^!W-'*R1O,
MT@^-5'O("#KE=RL)UT\:""74CU!Y939);M@M@HV7[>G)8S+6UHTEI+!0-/*^
MJK':.#'><.4$(KU-A^C+ =M9V9AF_P#[SMV*F3VU<<RO9-8Z*9XXMI63<PC:
M"3IR@*";$8:T%C0T!F@:T#@T:<!ZBJ.S0> <>U!A7=[8C:[>NU3VG<#%:*[.
M( I;J(PRNIG :AT-2P"1A!X\'(((63)-QNA;+[7BNX5\K,WZ:<EJQ18[FM23
M+4X]4/.D--62NXEC@= 7./ (K:90UM+<:2FK:&ICJJ2KC;+354+N=DC' %I:
MX<""#J"B<GW(.$G!CNY!#GJGZC)]H+9:<-P>B.2;T;@GVO@.+1#G>X\P9)4R
M-[F1#4D^)%6GTX=)%/BU?+NUO9.W</>W(VBJN-RN6M33VLR.](:>BBD!;'R$
MZ:M:.Q!/",#LX   <H[D1V:#P! (!U! (/:@A?U'=)V-[K5(SK"WLP+>BQ!L
MV-YQ;AZ"1SV<1'5"/02->-6ZN!0>=TK=0>19M4Y+LONS$^R[W[9AL%\II6B-
MMTIVDL%=2CASL<1QT'>$)3A'8/(@AOU]?%6W0_B]']V0H0MGY.+XK>)?E*Z?
MNX03L?[$H-:W7+_?'T4?V]J?7HT(YME,?L4'-!\LSW->>):"!RZ=I/J\$$%=
MZNL-]CRNKV>V'QV7=S>2(,;5T%%J^W6LO =_MU0P\K3R>=H#WH+#IMC.M/<^
M*>X;F]0,.W,5?YU/C6+4<4[:>.0:\CI961N+F]G:5%=D?2)U)XE#-68+U;WN
MKNK6<]/3W>W0&!T@[GD"30>HJ/BMO4[OQL#>:2R]5^%"KQ&=[*6GWBQQCI;>
MV4Z>=5M ;Z,$:ZGET"@V-6&^6W([9;KY9+A%<K1=88ZBWUT#P^*6*0 M+2.W
M4%5'OH" @Z92> [CVGP>,^1!#_J&ZK+-M'74& XC;*C<#>7(XG,QO!+8!+*V
M4\&2U8:?V./F(UU**P);^FSJ>WS]!?\ J#WHK<,L]<YLWYM,1<:=L,#V\WH)
MJI@CD#VN[2"5!D./Y._8[T#>:[9J^MY?.J_YQW#G+^]Q_9=-54616=*^_NR4
ME5D'3IO5<KQ20O$\^W>7ROKJ>I#1S.9%52^DD!=H ---$5F'IYZK6;E7RHVP
MW/QVIVQWKLK2;IB-P_8XZMH<-)J%Q/[(QP((&I.B(FH@(" @^>9Q;QYM!H>/
M<#W$H(1;P]:N-85E$FV.VF,W3>+=?]DADQC'V>FCHYQ[%M9-J&LX]VO<H,;N
M'RB^=TE/<8Z? =O8IP)X[/5/FEJ(VO&H9)K%(.8:Z'0]JHZJC+_E =IX:.LR
M# \8W?LD+BZYP8W)+'<!$3S.]'&YD+2YNB*D3L3U5;>;ZSUUBMSZO%,^L@UO
MNWU[9[7N5/Q#2\,=IZ1NI[6ZHF$J4! 0$%FY_FF.;>8G><SRRZ16?'[!3OJ[
ME7RN#0UD8U &NFKB= !WH-:=-6;_ /7)5U%;9[W<MF>FV=SHJ2>)I@O%\C8>
M5[F2 <S&.XZ.:\=RBI28-T3=.&$TK6-VWM^2U[N5U7=LC;^%JF:30:O>^K])
MQ)XE5&1)>FKI\JJ>6";9;"A'*.1Y98Z)C_*'-A!"8,HN9[T'6"TU[LRZ<<IN
M>S6<T4KZJGIJ.IE?:*B0-/F2T;BZ)H/#71I\BAE[?3SU/9579C)L%U#6P8=O
M7;F&:V3Z>CHK]3,<UHFI''35QXD@#154_D00:=?E:/Q%M!^5ZO\ <E%;0]H/
M[JMM_P"S-K^Y8E4ED= 0$! 04/84$$KCTY9C7=8-OW_%TMW\TJ6T"W2VYSI/
M;I?HP:AH;RD>;X5K].G^EC?U?_)/#\(_L9>H?\S&F*_R<_Q7!U/=*F.]1-MM
M-QCNU1B6?XO(9<9S&C);/ X\I(/*1S-.BU1KMIV?<I.)GFS^Y&S7]J_&(E%:
M7IGZ^,FII,%S3J,M+=MIV&CJ)[?3%MT?1LX1@O\ 0L/,1IS'F6^U=>W$[8X1
M+7U6U_0F]LGL;@'3;MW)B^..+*"(S5U^NU0"^6HGY&B:9YXGB&=@6SO^\B]<
MVQ&NL<OW8=MV\]>>=Y\4 J#9*HS;+\KWFZ!=\*''*JY5CZ#+K!503?@T5(/[
M*X131'1Q(UX-]5:^WU[].B,SG7;C7/'@V;MNO?LF9_U(YH\]9&PNXV,[>6+<
M/J%W4.?;IU]ZIK?C]!1$PV^G;S D10@,#BX :ZM31>*=[HUZXXVM$S^,?NVQ
M,V[?=:\XK2DS\<?V934Z@>FO=_?/IOV?VRP#(;=CD%KLMM;DD-R?+%Z=T%-$
M&,_8FN)#2TZ@K;ZMK^YW^S9SB+3P]N7)Z+NG1V5:Q&)FL1\&+,#Z9OE%MN,9
MMF(X1O-@-@QZTQ-BI:&GMS6]G O>[VMJ]SM.+CJ3WE7=OMMM$VC^PUZHI$XY
MSQ9ZVCV[Z][-G]BK-UMY<7R/!8'.=?+104H9/*W30!I$#2./C5U;-<3:+<?)
M-];6B(IP\WN[O],N;[A=4>T6]=KNULBQK (?1W>W5#I?;DCBV8?L0:TM/UP=
MI"Y_3I_I^ZV[?[\8_)T>I7GN>QIV\<ZVS^>4_?V,:-UT+> "RF.#7!(&F,@G
M0.T^;JL>K'&5F,HX]0W3IM_U$8D['<OI#'70#FL>04X#:RBD#@0Z*0:'0ENI
M&O%:KZIBT7I.)AOU[>F.BW&)0?@Z:NOK;V*GQC:;J.M%?A]#"UM%)D5-Z:K8
MX<"WG=$\EH X><5T3MV;(^?FT]-(G,+XVPZ&K_69W:=U^I;<";=G-+6YM3:[
M9Y[+9254;@621L'(#H #IR?-6[3LU]O$VUU^>><M6Z-FZ.F\_+Y-E5-R01N
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M2O?Z*T7A\C6FC8.+6-D=*T-'#@$&U.$C1W$'0\#XNX>H@[D&E#Y2GXQG3?\
MQ>+_ (M&BPW3TG\%IOL3/6"(^A!K,Z1OC8]7_P"4J;UXTA9;,T1B?>_<NAVD
MVLS'/ZQT;C8+?+-0T\CN43U1:1!%J-3Y[]!P017Z(=GZ^CM-VZA]Q8/;F[^\
MC75ETK:EI=/16TO:::C9([SN3DC8=. X#AP0E/YO@0<D!!YU;2Q5<4]//#Z:
M"=ACEB<.9KV.&A!'@([4&L.Q6^LZ1NK2AQ:C,D6R74;+-%C] P&*CLN0QQFH
M>T#4L_9602'0<NO-WH-I;= UHU[@ @\R\7.DL]IN%UK)&Q4MOIY)YGD@ -C:
M7'4GAW(-?G0M9JO.JW=#J>R6F>V^;L9!6TV,^F\]T-AHY?1TS(W.XAI<P\!P
M16QA$$! 0$!!BO>/;JU[L;<9GM]>J6*IMN36Z2EECGC$C0\#GC> >]KPTCR(
M(J] F;U]TVPO6UF0U\E9E.R-XGQ>M;-JV2.EIW/BH]1W>9'P\2$I_(.N7A&_
MR(-8^^-^R_J?WNDZ7=N[_56/;W"Z>.LWTR:A<\/E9.]S1:6/:6Z%PB(=Q/LN
M(03SVOVPPK:3&;?A^"8[2X]9;="&-BIHVL,K@>,DS@ 7O/>2@R2@MC+<4Q_-
M+-68YE%EH[_8[E&8JZV5T+)X)&G]4QX<.'<@UCV6&_\ 0OO+:\8FNE56],VZ
M5>^FQNDK)#Z'&KE.X/9 PN):V(DNT TX (-K%,]LD$4C7<[9!S-=KKJ#Q!U\
MB#O0$%'>Q.G@[D&K[J'KLCZE]^+;TK8O<:JU8)BT,-\WDO5$]P$C'M9)!;W%
MF@(D#SYI/:$&Q/"\/L&!X_:\3Q6T4]DQZQPBFMUMI8VPQ1L:/TK& #CVGRH+
MO0$&)]Y-IL.WIPNZ8+FUICN5JN41]#,YC72TTX(,<T+G \CV. .H\B"'?1_N
M)F.'99F729NO<9KGF>V0-3A-^G<]S[ECSW:TKBYQ.IBB?&WM/J:)A6Q>$ 1,
M#0  . '9^@B.U!I'VK_YJ.5_9\B^X)$&[A!#[KQ^*UNA_%8/W=J2+,^38^*A
MA_Y6O7W;(@GH@B+UE[TW3:':6:+#W>FW*SVLAQK;VCC.LIN%P>(&3M8/.+8B
M\.<1V>$(/8Z6NGZT[";<T5I<?PIFE\(N><Y/(P"HK;A..=_._B=&:\@'B02@
M8=1W]N@U\7!!R0$&$-]=D\2WYP"]X%E]!'-#71N=:+J8@ZHH*MOG15,#CQ:]
MA&NH(01[Z(]U\GR/'<EV@W,K/;&Y^S5R=9;O/(\NFK*-H:ZGJ2'<?8N#=?$@
MGF@(+'W)S.U[>8+D^;7F9L%LQJADK:I[R&C1HT:-3V:N("""G1/MG4Y?7Y)U
M:9_ :[.]U97S8G-5M+I;59'.>V*"G<X<S YI .FG !"6QV$$ ZMY=>[O]4]Z
M#N0$!!JXZB;)%TL[Y8GU28K$ZUX/E]SBL&^%MA!BI71U;N6*XO:P:<S"22X]
MZ#9W2U,57!3U4#FR0U3&RPO;V%KQJ#^B@^Q!P?H6GCY4$#>MG=;);+9,1V.V
MSF='NCOE7BSV.IB<0^BH6!TE75^:-0 QCF:GAJY%A(;8#9C%MB=O[7@V-0M=
M)3QMGOMV+=)J^ND:/3U,SOTSGN&NI1&;T!!30'7AXB@UG]7&WMWV6RZV=86T
M=***]XY-%3;NV.FYHX[Y9ZAXA,D_)[)\+G-=J0>#>Y%; L+RJS9UB>/9E8:E
MM79LBH(+A;JC74.BG9S@\>_0D%$7>@(/.NU?26NVU]QKYF4]%00/J*N:0@-9
M'&"YQ<3IH  @U=[)8M6]7^]%YZA]QZ6:JVPV\KZBT[+X35M,E"Z5CW1R7-T;
M_,<\<I#2&ZC4:'@BMI5)'Z)AC#/1L9HUK=-!H!IV#R(CZT!!#CJ[Z>8=XL4&
M3XS*+#NYM\UUSV_RNF;RU3)Z?EF%,Z1I:XLD+=-->\H+@Z4=[?SV[3V^]7)W
M)EF/'\"YK1N=J^.X4@]'*YP.A'.YI<-4$IFC1H'@""J @ZY=/1N)[D$5.I'J
M/M6R%KM5GM%I?F6Z&8O--@V TCN:IK)/TTCVM#G-C8W4DZ=WS!"-UJZ:.IW>
MEE/E.^'4!D.WU/6.].W;/#)IJ*.FCD\YD4U5!.SG<T'3BQ17T7;I!W_VV?-?
MMB>IK*JJIA;S-PW+IYKG253PX'3TLT^D?FC3V':JC,?3=U-U>Z-WR#;#<C&7
M8!O+A0+;UB\TA='4PL>6^VJ1SVM+HW<#P'84$T8=/1M([T'8@(*'L.O9IQ01
M7ZL-YJK93:BXW>QPMJ\VR.9EBP>WDGFFN56"R/3E!/F<7<!W(/%Z1.GBBV;Q
M!V2Y%&V\[O;A:77<7,*AH=5SU,VKQ!Z4ZN+(@= -4$PT!!U2:DM &O:01W%!
MKJZT=GKG:7VSJ=VK;+9MS-KM+C?10-Y7WRUP<KI::IY.7G#6-)'-KPU03"V2
MW.MF\.UN&;CVIICILHMT=4ZF<X.,4I);)&X@#BUP(/!!E<=@00#^4P^*-G7Y
M3LWW=$BID;=?T"P;^SUK^Y(D%YN]B[R%$:3MT_\ FJX7_P#Z_P#\-D0;KM=!
MVZ>=\[N0:\.NC)K[EYVRZ7L/DFANF^UV;2Y374KBYU/CU*]CKB'M!'"2%SAZ
MB*G%@&'6+;_$;%AN-6^*V6/'J.*CH*.%@8P-C: 7:#O<[5Q/A*(O) 0$!!XM
M\LELR.S7.PWJABN=IO%/+27&WSM#XYH96ECV/:1H0X$@A0:\NCU]9LMNMNQT
MGW*NEJ;#A\\60;7/F.C6VJX@SRP1-.H CEF(&A[E1LG0$'CWRZV^QVVKO%UJ
MHZ.VVV&2HKJF5P:QD4;>9SG$\-."#5MLAMU5=8VX%1U*;LP5%=MK::N2':#;
MNX,,M&T4SQ'[?=&\%A+G1GCR]JBMK%)'Z*!D88(VQCE8P#0  :: #@ %4?2@
MMZ^6.V9%;;C9+W;X;I:KE&Z&OH:F-LL,D3AQ:YK@0?5[T&L&Q6BOZ'-^K'CU
MOJY6]-^\=P]KT=+.XBFL%YGU$;&$GD:Q_+V<-45M<9(QX!:X$. +="#J#V$(
MCF@:CPH+1SO*+=A6(W_++M*V*W8_1RUM8YS@WS8VD@:GL)=H @U[]'6W]XW5
MR6[]7&Z=*^LR;*9GP;;6^K:7&T6=I'(Z$/)Y3)J>+0%%;+X&EH<#WGP:*H[T
M!!:V48U9LNLMUQK(;;#=K)>HG07*WU,8EBEC.AT+2./$:^5#+71TRW"^].V^
M>1])>372IN]@N]//DVTUXJ"6M91DD/HF-)/ULM( !TX=B#: @(,4[W[CT6TN
MU6:;A5O(^/&K>^IBB>X-:^74-C83XW$!!%_H4VNKK5B%\WPS-IJ]RM\IOPY>
M[C,.::*BF=Z6DIVO/'DY' D>1()3U&O>@J@("#&VZ&W&.;KX3D> Y9;HKG9<
MAI9(*B&>)LC6N<TACP' CF83J"@AUT,9=DMIM>;]/V?5;Y\MV=NS[?;YIY#)
M)-:7AKJ9PYN.C1YH[D);#D'PW.LAM]NKJ^HD$5/10/GGD/8UD;2YQ]0!!K8Z
M3;(=^]X=S>K+*(364$-UJ<5V;I*J,N]J6JB:ULE3$7\-972N9JT#L/:@V8LU
M!TTTX?H=R#L0$! 0:U.N['*_;RX[>]5F!4DE/F&V=U909C)1Q:R5V/5A:)V3
MN&FK(N4GCKIS(-A&,9!;\IQVR9';9F2V^]T$%=2O!U!CGC#QKY 4$6^OKXJF
MZ'V"C^[(4E86M\G%\5S$_P I7/\ =D24[7^Q*#6OUR@G>3HIT_K[4>O1I)#9
M1'[$(.:"$?6EO/?L"QBP;<;?/?\ G/WAJ38,4F@=^RT7IBV.6KY6^=HP/X'4
M:%!D+IKZ>\=V"P*CM-)3QW',[R/;>>9J^,>WKK7R$N?+42G5[]#P <3H@DPP
M<K&CMT':4')!;V0X[9<KLUPQ_(K537JSW2%\%?;JR-LL4D;P6N#FN!!X'3L0
M:U=G*Z^=)?4 [I_R"YU%7L]N5.^HV;FJY'\MMFYCS6V,.):&CG :T:=@X**V
MD-(=QU!\#AWJHYH"#!_4/N]:]CMJ\IW%N7+(^TTCV6>D<2/;-?*US:6#AJ?/
MDT'8@CIT<["56/6:IWTW*A-WWIW;8R\WJYU;/22V^GJ 98:.![]7-:QCP#V=
MG8@GO%J(QKKW]OE0=B"A["@A'U?[ 7#<K$:;/\ <ZR;R[6O-^PF^4C.6>I?1
MM,IH)2SE<YDQ:&Z$G1!DSI=WK@WWVEQG-9*<4-^]&:+*[27ATM)<*8F*9D@'
M$<SF%VA'8@DB@(.+R!IJ=!KV((,=86\&965N';*;/5+F;L[MU[;71W*F=K)9
MJ"7S)[BX-\YHB#@0>'>4&8-@^GO"]B,5@M=@H6UV1U[6RY9E]0T/N%TK'#FD
MEJ)W:O=YSCIS$E!(9FO(W7M X]R#F@@_U5].3LYH&[M;92NP_?7;X?A+'LJM
M[#'45\5*'2.M]2]G*7QR^ GM 09 Z5M\AOSM?:LJK:1MKRF@EDMF968Z\U+<
M*9Y9(WB ='  ]G>A*4" @Z9CHT<-=3IH@UC[V4=QZINIC']@(JZ6GVIVICIL
MJW1@9J8;M4M?I3V^0@Z%KFR:D'7L[$&RBRVZAM%NI;7;***W6Z@B;#0T,# R
M**)@T:UC1H  / @]9 0$$,NL#82'=K QE>/NDLNZFULIR3;_ ">F;RU3*FB:
MZ3VJ7CSS'*-1R@Z<VBBKUZ5=YV[Y[/8QFE2QM/D##);<KH=.7T%RI'<D[2-
M02>.GC51)<D>%!IV^5H_$6T'Y7J_W)/%6T39_P#NIVW_ +,VO[DC1)9&0$!
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M,\XCFD?DJTL.A#AQ.C_$1VK'%OE91CCAS8Z,O 8=.)U'A6<>21'C#Z%00$!
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MV^6&V_AK&O0@>F96T;VO8Z)PT+2!KQ!09>V-W(H,YVCV\RUU09WWNRT\\DK
M7->]@,3]#XG,(097_G!;_P#/_P!4H'X?H.[TG^J4$'OE#LS91=,65VREFEAE
MRJX6NS\S002V:OIR]NH[BT$'RH)E[?XU0X?B&/XU;*=E)066@@I*6FC #&L8
MP   (+S0$! 0:W^M2"WX5N9TO;QQPF&\VC.H;%/6Q:^D?0U<<SW0'E[6%W'0
MH-@?X=HO\_L!]CX4 WZBT]D__53(@7\H+=H[SM!CV)QO<*+*LOLM%<VD$"2#
MVW&7QN'>UW>%%A.S%+11V"PV2R6^G;3T-IMU/24<+!RLCBAB8QC6@=@T"J+E
M0$! 0$&LZ[RTN#?*1V**E)IH-Q=O'U%SBBUY9YXJBH8'O [P(QH?$HK8I^'Z
M#_M/]4JIA@#JJST8QTY;QWZVM>^NM^-U0@ U80Z72+7F\7/JA#Y^C''8\5Z:
M-H;,UT<LL5D$]34,8&^DDJ)I)7.X <3S:'7P()2(" @("##V^V,4>:;1[B8Q
M6MYH+S8ZRG([/.]&>4@D<"".U!'[H6S>IO/35@AOM09[A:_;%MDD:P\8Z24Q
M, /?HT(._KNNM+5]+&Z,<7.7^UZ(#F;IK_M<*BO+^3B^*YB?Y2N?[NJDIV/]
MB4&M3KHD$6\'19(>QF=U3CPUX T90CFV("^T,9<T\XT.F@:>Y!1U_H#IHYX/
MTJ#7A!)1;H?*!3OJ(&UU)LYBW+3R. /M6LK7->PAKM1S$#7L16RJ$$1M!&AX
MZCU?&B.Q 04=[$^1!KV^4%QR)VW6%;CTQ=2W[;;*[=<+?<(^$K!+411R!KNW
M0@()HX[E%#762RW#]D K:.*<MT/:^-IU0>[_ #@H/\__ %2@I^'Z ]\G^J4&
MN[KHJ)<]RGIMVFI971VG+<T977P'ASQVP-F8P@\""20045LDHXXX:=D4,;8H
M8ARPQL'*UK1V!K>X < $1]2 @(.+_8.[^!X(-8?1_54>&=1G6%MW;Z?VMC]J
MRR"XT4,9T:Q]1$Y[P&CAQ+B3H$5LB_G!0?\ :?ZI40_G!0?Y_P#JE4=<E^H7
M  <Y.H\T@CMX#]$A!KAVA93[D=?>^.85E,+C3;<6"CLN/U3M71TE4\PMF8SF
M]BXC74!%;.8?8#MT[B23J.X\=41VH""CFAS7-<-6N!!![P4&LK8F1FW/6OU$
M;?4/-!C5WME!DL=O;QCAJZGT1D<QK=&MYN8]@45L:_G!0?\ :?ZI50_#]!_G
M_P"J4'SU614$=/-+YY]"QTFG*?TH)00 ^3TH1>K?O?N56225MVRK/;C2S5TS
MR^3T%'R".,%W%K6AW8BRV0MU[_4"(Y(" @Z7QLDC?&]GI&2 MD:[O!&FB#6Q
MTF5!P/?SJ<VPYWLL5!>8K_:J5AU9&ZXZ2R !N@';V(K8A^'Z <?V0:=_*41J
M%^5<K(:RP[0OAUT%WJ]=1I_U016U#9_^ZK;?^S-K^Y(D261T! 0$!!34:Z=Z
M!S#PI@RX"6,G0/!)[/5XH.>H\*9'6]P(&G'CQ4S!Q<0X<6Z'RJ3..,&/!0EG
M,.''4 +&TSB,'BY-T.NG$:D:K*>9R<F:-'+KQ!/KZK)(=B*\NHJFTL4TSP6P
MP,,DAT[ .)*T[;Q6LV\F=*9F(CQ:E:FKZC>M#-LZI=O=U+EL)M7@5R=;;;>+
M1'/'77.I9JV5SW,EB=R@M.G$#BLM&B9TUWVS$VSB/9YL^YM6NW[-(S%>,S[?
M)Z^VF?[[]-6^^%;&;S[@S;MXEN+#-_-3,ZYCW7(31,+BV9[GN<0>'!VOE77V
MDQW?W*3&+4C/OC/!R=QIMV]8W9S69QCREM;A/,YKNS7B1IQXA<WBW>$/L62"
M @(" @(" @^>I=RL!TU\[@/'H=%)Y&6!+3O9@^6;BW_:!ULKH[]9HW&NBN5/
M![2JH]&EPB_97.?P>.#F^5-=8V5ZO(V3.J8KYK>S[I:V7SADKGXU'CMSD#GQ
M72QAM*_TIX\[F!I8X ]Q;\Q/N32.J)\&58B9X\F!>E#*,KI[MNULW<;O49#0
M88ZLAQZZ2O=+Z/VM.ZD+&/).C'N < .PZZ+/='W.TC9C$YPU5GH[KH_EQG\W
MU=!E124]GW0L\P$=[IK_ !R5D9/[)Z-T99'J.WS7L?\ -6[;\W;ZHSRRUUF?
MOWS[,)EYQD&!XU9XZ[<"NME'9YZAD$,ET;&Z$U+PXL:ULC2"[1ITTX]JY8^:
MT1'/P=$_+$S/+Q0IZZ9:.?%]HJBW.C=;Y[A*^A=$!Z-T3HZ<QE@'Z4M(T6?;
M1,=W$3S+3%NUO,<L0V&0C_8F:<-(CZRU[YF(M,>4L-/*&H/8+;?-,XS#=.V6
M#>2Y[67VUW:7\)45NBDD=6:3S-<]_)54Q_8G>:=0?9=RW:>/;4MS\_>QV7C^
MILD/DO2'N-E5N=:<LZG+S?;09!*^@N%MEG@]*P^8XLDN9;J-3H5*;*TM$S&9
M\&<YGAX2QKU>XI78SCVP=AEO1%OLT\EK=D;(3&(Y 80)_0\YT(8"0.?N4Z^K
MO/N3PS#+[=8[;HCPG]F7Z;IMWBJJ:&:GZN<F?33L:Z.2.CJ>5S'@%I:1=? 1
MWK.]XCG#"O&."]-E.G>Y[2YGDV87+<J3/;CDL!ANKZB@=2S&8O\ 2F665U94
MESG'B=0M4WBNB:Q!TYV1+%?1CPW&Z@]. %[?IX?X94+JUY_HM>?[T_HPV?\
MY$_X?W7-UYC_ -W^ D  G,*;4]_\&J.Q<>O_ /(I\79'^AL]T?N]7JPU^"N_
M7M_\B_=HECWOU1_BA/3_ *+?X)?'EA'P(91W_P SJ#ZJG6SU/_4G^/)K]-YU
M][*'2EJ=@MO!H"#1R@CRU4RZN]_U9^'Z0Y.V^A@6]?'MLWFZ:8[#P[N$$FG8
MM?I\_P"7N][=W7U:_P"/&7GY'+3VSKOQ^IN^C(;A8X66Q[P.7GDI9H8^4GPR
M-('CU6KLYB(V5_FX?NS[GYJT]B<N9U$3L)S)W,.46.X:.[M/:\BT[(GHPW=O
MC[E9]L?JB5T!\-K+W^6)/J0NRW^CK]SFM_K;/>G<M$,T8^H+I2VUZD:K'*K/
MZF^T[\8BFCMQLU9'2:B<@O$G/%+KV<--%1K,ZR.B+9W8'92OW"PJKR6>^PW:
M@H(H[I<8ZFG]%5%XD)8VFC)) '>@V =#UJIZSI:VFEFY^;VA4#S7:#3VW,?
MBREB,?H>&HD=X07\#^@B( ]#4U1CV6]4&UUP:YL^*[EW*X6\/=P?2725\\?*
MSM'*- 3WJ#8XJ" @(.#I&M(#CH7=B#6OU+029QUE=+&%V_E:_%XZG+[K4]I;
M#2RF+T):.(+N;75%;"X\?HG-YG&4N)))YM-?4T1'/^;]#X9?]?\ R(-<_4%3
MT>']:_2=D=;.8Z"\NN]G@#CQ$[HX0SB=!J2\:(K9BV5CP"T\"= ?#Y$1V("
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M-H-N,2DI_:SK-98(GP1GE:US]97=W \SB@S!_-Z@_P"U_P!?_(@#'Z$=\O\
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MRND2AI<OZDNL?/:"H;/8:W*Z>W4DT9U#W01%KM'#APY>*BMCO\WZ'PR_Z_\
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M(KYYB?RS#'O^*98^&FRMV:>\_AJF^]EI_P"J5\OX_!V__P"$S_\ =_\ 3_\
M['^*79?>8N_\MTWWJG_5*^7\?@O_ /A/_P#+_P"G_P#V/\4RR^\Q=_Y;IOO5
M/^J1Y?Q^!_\ X3__ "_^G_\ V<H?E1<?GJ:9E1L[=Z6G?*QE15_AB"3T49<
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MO^K3WP_+/!1.]$S@5\GTP_<)P[O:9T[#XU8B(7JX*>TO\U9=4IF5/:7^8/\
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MBZ4N'Z70P :D\.U$8JOF_?4MU&@6/I^VLNFV.*W3GAKMS\QA]JO%.[6-TE)
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M693AKXWTT\;.!D+)2"''M( "#NJ.M#>#)J2:CV_Z2,[ENY:&T[KHZGBA$CN
M,FC@=$%O0=.O4;U)72@N?4_ED&*8#$YM0S:;'GO8)'M( 95S@-)&FNHYSY$&
MR3'<9L^*VBV6&PT$%LLUG@CIK;;J=@9'%%&T-:&@> !$7"@("#JD87Z:'0:<
M0@AGU#]*-%N9=:/<G;^]/V^WJQV/TEAS&E):R=[.,<58P<)&<P \X$Z(,263
MJFWSV;:S'^I+9:^W1M UD3MRL3IS6V^J:T<HF,,8YPYW:[S1QU09#;\HATYB
M(<];D;*KE'/1FP7#G:_O8?V'MU08XOO6!N_NNYV/]->Q>25$L\S:=^X&34QH
M+91LDX.G,<O*]P9J#[$^1%9.Z=^E&JP?(JO=W>')3N3O7>@[VQ?I=74M TD?
ML=%&= P  <0T)A$W&Q%K@01XSIQ\B#N0$!!TS1&0  @>4:H(*;Q=%5KR/+9M
MT]F\KK=GMTBYU34W:UDBBKI^UIJZ;4QNXCB>0]J*L"6]_*,8-3T]!)8\"W#,
M36P_ADR3PODY1IZ1[6,C +M-2-$'7+;?E"MU:&&AK[OANSEMJI#'7U]M])45
M@B["(A-&]NI'8=0H)![!])6#[)U59E4U;5YON5>8^2\Y[>'NFJG D.+(0YSA
M$W4:Z-02M#-#KKQ\0^:JCL0$'%P)' Z'5!8^X> XYN5B%[PG++='=;#?Z9]-
M7TCV@GE<- YI[0YIT((X\$&M:TUF^O0[6/LE3C]WWHZ<(I7/M5RMC#476R1N
M/,62,/GO8SCPXHJ86 =8?3QGU&V6V;G66UU8 ]M6J]U4=KJH'Z<6/BJS&1H>
M&J(R?6[W;/VZF965^Z6(TE/+%Z>"62^4#1)'KIS,)F\X:@CAWH(E;A]>>$OK
M:C#]@['=-[MP)974D$%@IGRVVGG+=6NGK"!&6CMX'3QIDPZNGGIGS.HSB7J$
MZD+A3Y)NY4M]'CUHB//0V"!SFEK(&\&B0<6EP'?VH-A 81IQ0=B#3K\K1^(=
MH/RO5_N2*VB;/_W4[;_V9M7W)&B2R,@(" @(+'W'X[?YT/#8+F/_ +)*M>SZ
M9]TM_;?ZM??'ZOS&Q4A$;!H3X5\L_;>IV^U!^H*'4>U/\TJG6>U-/TI0ZSVJ
M?U)4.L]J?YI5.L]J?YJAU-I/R:T?H7;KG335]M^HE^BO5]+_ )_A^[X;_O/C
M]KX_LVMMX- \ 7KQR?"/DJ*2*JAF@G8R:"H:YD\3VAS7L<-"T@\"#WZK&U8M
M$Q/)8G$YAB]^Q.S,SGRR;3X:Z25Q=)(ZQ4!<XN.I+B8=22>]6M>F.GP)M,\7
MVVW9G:BS5U+<[3MIBEKN-&[GI:^CLU%#-&_33F9(R(.!\A677->23$3S9*9&
M&<N@  UTT3([4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$#N(\*"@&@ [
M=%!5, D0"HUZ?*=?%:N7]I;/]7(@RAT*?%6VG_B%1]U3)!*7:"A&H(/81H=4
M'PSV^GJH)::JC94P3L,<\$K0]CVGM:YKM=1XB@B'FW0AT]Y9=SD=JQN?;K(@
MUX_#&&S&RR/+^),@I P.]5!BR#H/L<EXEHY]\=T9[9REK;:[)*\-'#B=?3=X
M09FVXZ).GO;FZ.R"FPV+*\GYV2MR7)R+O5LE;V/CDJ@\M.O%!*Z*DCA8(X]&
M1M :QC1R@ #0  :#@@[V-Y 1KJ->"#F@("#Y_:[-0[],/T^@U\/:@CQNWTG[
M&[TR_A#-,*I/YP,<)(LKMS&4=U:]NNA%7&WTG?X4$9+QT',MLS&6+J.W7L=M
M<#Z&V0Y'<#''R]FFE0T=GB0>[9OD]MO;I#3NW+W(SW=2CU$AM607VLJ*5^AX
M-DAEED#F^$%!-#"-LL&VVLL6/X#B]KQ*TPM:T4ELI(J9KN3L<_T;6\SO&>*"
M^8XA&#IQ+NT]_!!V(" @(.LLU_3$<-."#YYH=() 7$\K7%!XE@#I8JD/>XAK
MP!J2>XH+C;'RGFUU=IH3H@[$! 0:4/E*>/49TW^*GB_XM%]%"&ZBEX4U./\
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MT(UY@[1PUT/C/>@L^[RSQUW(R9S6AK>#21W^75!>#H6N[2?5XG]%!VM'* /
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M^@D*NEO:[RHCD@(" @(""A[#Y$%J9'[*F\ #^'JH/=MAUHJ<_P"8@^] 0$!
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M;'_K]5Y&^N@NM 0$! 0$!!3P(+(O?XQ/D:BKW'>B*H" @(" @(/*O7XNJ/\
M1]<(/.QKZS4?3#YZ"YD! 0$! 0$'%WL7>0H+)M7XX_TI/6**O<?."(J@(""
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M=ZOU202NM 0$ ]B#3M\K1^(=G_RM5_N2GBK:'L__ '4[;_V9M7W)&JDLC("
M@(""V<Q&N)94.W_RFM_<'K#9],MNCZZ^]I'CHM8V>9W+YE^J]3L%%IQT 1>I
M4TGC"83J<?:JN#J5%+Y$P=2OM7Q!,'4>U?(I@ZDY^B^(1.STGL)HNSR/7I^F
M\Y?(?]SSFU/C^R=T9U!/A)7J1R?*.Q6 5'6[3F:>;33N6/.3 US7=A["J<W8
MJ" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @UZ?*=?%:N?\ :2S_
M %<B*RAT*?%5VF_B%1]U3)"2EV@(""A[$%J4WX_E\K_615U-[7>5$<D! 0$!
M 04/8?(@M3(_94WD?ZZ#W+9_ :?Z0?/0>@@(" @(" @ZI_K$WTCO606_C?UJ
MK^R#UB@N5 0$!!I0^4H^,9TW_8(O^*Q(L-U--_!Z?[&SU@B.Y!K,Z1OC8]7_
M .4J;_NTA9;,T00$!!:V2?[MZJ#V+3^+J7Z3YY0>B@(" @(" @\Z[?BZJ^D^
M>@\;'/857E"*ND(BJ @(" @(""Q;C^-__6-]<(>"^1W_ /3O050$! 0$! 0>
M-?OQ9-],SZH(.VS?B^#R%!ZB @("#2/M7_S4<J^SY%]P2(K=PB(?=>'Q6MT/
MXK!^[M219GR;'Q4,/_*UZ^[I%!/14$! 06I4?TAB^FC^I""ZT! 0$! 0$!!;
MF1_6*;[+_P"B4'WV7\64OD=]64'J(" @(" @(*'M""UL?^OU?D:BKI'8$15
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MG(/ QOV<WTH07<@(" @(" @XGO\ (@LB'\=C^,'UT5?*((" @(" @(+<R/\
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MU<B#*'0I\57:;^(5'W5,D$I=H" @H>PH+4IOQ_+Y7^LBKJ;VN\J(Y(" @("
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M T-:!V +W.ZO.SMNVF?_ +5?T>=OI6G>;XCPO/ZRV0=X7F^+)59 @(" @("
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MS0$!!Y5X_@%1Y/GA!T6'^ CZ9R#W$! 0$! 0$%#W>5!9%%^.&^*5_P ]!?"
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M+E0$! 0:4?E*OC%]-W\7B_XM&BPW3TO\%IOL3/J0B.]!K+Z1_C8]7_Y2IO\
MNTA9;-$00$!!:V2'A3?Z7SD'LVG\74OTGSR@]! 0$!!Q<X-:7'70=N@U]9!\
M=7<J*@@DJJVICI*2%I=-53.$<;&CB2YSB !IQU*"%>YG7CL_BU95XUM_%<]Z
M\W@=R1X]AM++<X>?B"V:KI62QQZ'@23P6.645RQ8=[.NS.J5L^(]-EGQ"@KF
M L=D5ZI730M=[%\D!D@>=/!RIEE&N710YC\HKBKWRUNUV#9U2.'I)/P;7T]#
M(P-]DT-DJGEQ/=H$RO1+V+?UVWC!ZIMOZB]B,KVKIPX,?E-%3SWBUEY/%SIZ
M:$M8._B[@D2PM7"<N";H;?[EV2&_X'EELRFUR^RJ+;4Q5!C<0'<DC8W%S':'
ML(U5RQPOUK@X!PX@JCD@(" @(+%N'XX_]8WUPAX+X'?_ -.\H.2 @(" @("#
MQK]^+9?IF^N@[K./_+X/(@]- 0$!!I&VK_YJ.5?9\B^X)$&[E!#[KQ^*UNA_
M%8/W=J"S/DV/BH8?^5KU]W2*">BH(""A(':@M.H</YPQ\-=7,T/^B$%V Z\4
M%4! 0$! 04) [4%N9&0:>G'?Z0G] H/OLSA^#*4=^CN'^D4'JH" @(" @(*'
MY_\ E06M8.,]7_HCYAT074@(" @(" @(+&O7XP/TK$5?'A1%4! 0$! 0$'E7
MK\75'^C]4$'G8U]9J/IA\]!<R @(" @("#B[V+O(@LFU?CC7_.D^>BKX"(("
M @@%\IA\4;._RG9ON^)%3(VZ_H%@W]GK7]R1(+T/8?(B-)NZ7_-5POZ;'_\
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M @^"X_P.I^D=ZR$O QOV<_J?.07<@(" @(" @XN[_(@LB$?^=C^,$**OE5!
M0$! 0$!!;N1_P6'[)\Y!]-D_%\7TSO70>R@(" @(" @X/[D%K6(_[36\#QUX
M_P"DA*[$! 0$&G7Y6C\0[/\ Y7JOW)16T39_^ZG;?^S-K^Y(U4ED9 0$! 0>
M-D YK)>@.^AJ!_\ 1/6&SDV:OJCWM;K:4:#S>Y>+A]WU'M4?J4P=:OM4?J2K
M@ZU/:H_4E,'6K[5'ZE3!UGM4?J5<'6>U1^I4P=22_3Q#Z(900--74X_0<N_L
MWS_KD_3*4:[G@"#S+U;8;S:+I:*DN;372DGI*AS#HX,GC=&XM)!XZ.X+7MU1
MLK-9Y3P;-6R==XO'.)B?P8<V,V*QO8/$W8?B=775MO?75%>Z>X2-DEYZEW,X
M:M:P::]G!;IW3:E-?A2L5CX,+_->VR>=IF?QG+.+=>8</*5KCP':LD$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!KU^4Z^*U<O[2VCZN1!D_H4^
M*MM,/_8*C[JF4@E+M44)T!/@XH,9;E[P;>[1X]/DNX.1TF/6V$D-%1(ULLS@
M->2&,D.D=XFH80;DZXMQ]RJFJI=@.GW(LFML3@R+*+P66^GE>>/FQ2Z.+0-#
MKKQ6.6<4F7Q,S?Y0NFJS>Y=L\,J:7V;[-%.14EO:6->3R\W#PJ=2_;EZ%'U\
MWK ;I!:>H?9/)-NH9M [*:9C*Z@;H='F0PZEH;KKKJK%DFDPGWA>X.([B8]1
M93A=\H\AL=?&V2"NI)F2-', >5_*3RN&O$'BLF"\(Y!(TN TT)''Q(.Q 0$%
ME9ON#B.W>.7'*LTO5+CUBML3I*JMK)&1C0?I6AQ',X]@:.)/!3*Q&6N&^]<>
MYFZE;-;.E_:V>[VV&3T9S_(FBFMTK/U4,9\]P[P>*PMMB'1J[:;K2KJ/Y0/(
M7MKI=XL-QS77EMK:-[PP^#F$!]=:_P"HCR=']!;SA]=-EW7_ +?0>VI;QA^Z
M<-, Z:@CB=3S21@ZN;&XQQ\=!H-2K&^)2W8VB/!GC9SKQPC+LAH]O=T+#7;1
M[B5#VTM-;[URQT57-KRD057!GLCP!*VQ:)<=]4U3UBJ63,$C!S,(#@\$%I!&
MH(/>#X5DUNYKM=>&FG#]#7@@Y(" @Z_2<-=.Q!\U34-93RNDTC9R.\YS@!P!
M\)3(MO%[A13Q5?M>JBJ?V4 B)X<0=#P(""ZQ,"= -2H.T'4:Z:*BJ @TH_*5
M?&+Z;OXO%_Q:-%ANGI?X+3?8F?4A$=Z#69TC?&QZO_RE3?\ =I"RV9HBA.@U
M0<'2!HUT)01MW>ZM=DME9&4.6Y4RIO\ ,[T<.,V@"NN!DTU#74\1+FZ^$HN$
M5[AU]W7)91483TQ9_E%F@)8+K.R.WETG:6MBF;S$:$<5)DP]ZP?**X#:'0VK
M=';+-=KZB$ 5-17T#ZFDA+C^FJ(FANG?JF3"<^$[D87N/98L@P?(:+);5+H#
M54,S)0PD \K^4DM=H>PI$I*]VNYFAP&FO<51R04) !)[ -2@M7+LOL.&XY=<
MGR2MCMEDM%.ZIKZR4@!D;!J3H=-3W:(8:KV5^ZW7S>IZRDNM?MCTRV:K-.:>
M/6&YY(YIU>[F8 6Q:  'F'?ZN$V;:4XIV[9[+;9[/6B&S;>XE16**,'TM8UG
MI*J4NXN+ZA_-(=3QXN6.71$1#)^C]23(2"=0#QT29RO Y7$\7DCM[3JHF'P7
M&TVZ\TLM#>+?2W6AF:6RT59"R>(@^%D@+3\Q7)A /<OI1R+;6[5>['23=3@V
M74P]M7O B]S[3>1$3(^,0R<[8WO:.7S0!V*Y:[4RDOTP]3MGWVLE?:+G1.QG
M=/#M*?.\*J-&3TLK'!AD8W75T;B1H=.&NG:MD.>T8E+('4 CO"(J@(.+G<HU
MT)XZ:#QH.OTS== .8\-=.[7PA!9=>)'75T@C<0V1O-P[M==0>PIA5ZB3B &G
MSAJ#Y2B.;7!X)'<="@Y(" @(*.<&M+CV#MT0=)G:"1H=1]#5!;F176WP43HJ
MJMIZ1[RTL;-*UA(!&N@.A0?38;G155!$*6JAJ_1@"0PR-?RZGAKH>"#W1(.\
M$(.8.O=H@J@(-(VU?_-1RO[/D7W!(BRW<HB'W7A\5K=#^*P?N[4D69\FQ\5#
M#_RM>ONZ103T5'6]_)R\-0XZ:Z]G@0>5=K]:K%;ZJ[7FM@M=LHF&2JN%5(V&
M&-@[2][R&CU2DD-?^=?*0[5VNZ5%@VQQ7(=X;S!+[7>ZQP<M$)?XTX%I'C'!
M83?#.NN;3ACIW63U!U-<+W#TRW,6YI#A ^MI_3<K1H>_37@L/O0Z([6R]<5^
M4BP:&Z_@/=_;K)]I:QKV1FX5\ JJ$NDX-_VB(!H'9KX-5G%XEJV:;4G#8!B^
M9XWF=EHLAQ>\4E]LU?&V2EN%%,R:-P<!IQ83H>/85FTXF%TH" @H3H@X/E#-
M->.J"*F\O61LOLQ5_@:[W>;(\K?'SPXI8&"OK3Q/!S(B>0\.P\46*RC<.L'?
M7.Z=E?AO2MD,=J<>>FEN=93Q2OC/L3Z-W*6ZCCH0L9LR^W+Z?AN;I;>1TOYT
M>F/*+=9 \-J;O:98:SVNPNU+W0Q@N=IKW%3J.B4LMF^I[:#?.GD_F/D<;[O3
M!WMW&:[EI+E#RG0EU+(0\MU[P-%DQF)9^],.77D=PXZ=ZJ0[T! 04)TT\:#J
M=.UHU(\/Z';Q*F1CK,MX-L< /)FF=6+&IN)937"X4\$K@ >+8Y'M<?F*X&'L
M8ZJNGBHKI:9F[F-1RU'&/TUPIXF\'=G.]X;W^%7"I(6G([)?J..X6*ZT=YM\
M@!BKJ&>.>%VO9H^,N'Z*B/::[F .A&HUXH.2 @("#@]_( ="[4Z:!!CS.=V=
MO-M:,UV=9;:\8AY>>-E?510R2#_,8]P+CY%)M$$1,H8W[Y0SI;9<I&QYC<:Q
ML8 =/26NHFBX=NCV\#ZBG4SZ)2 VWZN>G[=9U-#B&XMLFKJP:P6NMF9153CK
MIRMAG<QQ=X@KU0G3*1;*ECQS#0C374$%5B^@'4 ^%!5 0$! 0>5>M!;:DDZ:
M ?5!!YV-\(J@=OG@?H(+F0$! 0$%''E!.FNG<@^66LAA8Z25PC8QI<Y[R&@
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M[Y#?K+6C3TD3AZ2)_?'-'KJQP[P>*QPC).I\"@J@("#@]_)IYI.O@0=9F!)
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M24[_ $?MR>,Z,>'<KM-6]ZW5HRALGHZ*EH:.GH**DBH*"D8V.DM\#&QPPL:
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MS&N@U[=.*K! /Y3#XHV=_E.S?=\2*F1MU_0+!O[/6O[DB07H>P^1$:3=T_\
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M856VL^V4>*-GKZ2XMNS+M[<T]JN=HWT?M:+M)T]D@VJ]$5W-'TN[3PB#TO\
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MSV15$@:22#V KKAX\I<G)7:_P0#Q%_\ D5%/YR/_ /"M_P!?_(@J<DU!#J8
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M7C^HQ$<6V(9&=-/:S2W3M](./C[%T\I>5C,*_P Y'_\ A!_K_P"15#^<C_\
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M&]75)TS.&.;V;:W+>/";>YD%#N?CS'NJG4[#RF6J@:QY+M-#X49Q9EZEZ_\
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M!2RQM@E' QF<L8TZ'AJL.ATUW1*_;EUA].%MI_;$NZ-JJP]GI(Z>DE;42.\
M#(R3KXE/MMD[H87N_59N5NG7RXATS[27N^5E0SS]Q+O!+26RD:[ASM#XQS$
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M'T4_V\J/7HTDALIC]B@YH" @\RY1L=2U!<P.(82"0T^IQ!4'AV!K'R3DL:=
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MGTWH_O6Q^D_LV?TP8UL303JU@;Q\0'T$GC,M%>4/L11 0$! 0$! 0$! 0$!
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M5^J2"5UH" @'L0:=?E:/Q%M!^5ZO]R16T/9\_P#NIVW_ +,VO[EC1)9'0$!
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M1D+!)#*+CQUT+.'J%</=<)8RR..  7+"*H" @(" @(" @(" @(" @(" @("
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M]V0H1S6Q\G%\5S$SX;E=/T)T$['^Q*#6MUR_WQ]%']O*GUZ-"&REGL0@YH"
M@^"X_P #J3_V;OG(/ QSZY/Y @NY 0$! 0$!!P=W^1!9,/X['\8/KHJ^400$
M! 0$! 06WDG\&A^R#UB@^NR?BZ'Z8^N@]E 0$! 0$!!P=VCU4%KV+^$UWJ_5
M)!*ZT! 0#V(-.ORM'XBV@_*]7^Y(K:'L^--J=M_[,VO[EC1)9'0$! 0$'F78
MZ6RYZ=U),?\ YA5IS@0S%:=!YQ7TO2R5]O?YRG2*^W_(G0'M_P B= >W_(G0
M'M\^).@/;Y\2= S9L_-Z;\.'7B##\]>7ZE&,(SAX%YD^"*K($! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:]/E.OBM7/\ M+:/JI$&4.A3
MXJVTW\0J/NJ92"4NU00$ ]A06I3?C^7RO15TM[7>5$<D! 0$! 04/8?(@M3(
M_94WD?ZZ#W+7_ *;Z5!Z" @(" @("#JG^L3?2'UD%OXW]:J_L@]8H+E0$! 0
M:4/E*3_\1G3?XH(O^*Q(0W44W\&I_L3/6"#O0:R^D?XV'5_^4Z;UXU(66S15
M! 0$%JY+_NO^D@]JT_BZE^D^>4'H(" @(" @(/.NWXNJOI$'C8Y["J\H15TA
M$50$! 0$! 06+</QQ_ZQOKH+Y'9ZI]=(%4! 0$! 0$'C7_\ %LGTS?70=UG_
M !?!Y$'IH" @(-(^U?\ S4<J^SY%]P2(2W<((?=>/Q6MT/XK!^[M25A9GR;'
MQ4,/_*UZ^[I%$3T5! 0$%J5'](8OIH_J0@NM 0$! 0$! 06YD?UBF^RGZDH/
MOLOXLI?([ZHH/40$! 0$! 04/:/^G>@M7'_K]7Y&HJZQV!$$! 0$! 0$%C7K
M\8?Z+45?*((" @(" @(/*O7XNG_T?J@@\_&_K-1],/GH+E0$! 0$! 0<7>Q=
MY"@LBU?CG_2D]8HJ^!V!$50$!! 'Y2_XH^=_E.R_=\:*F3MU_0+!O[/6O[DB
M07H>P^1$:3-T_P#FJX7Y<?\ ^&RH-V+._P OSD'- 0$'E7C^ 5'D^>$'18?X
M /*Y('N(" @(" @(.+N[RA!9%%^.!]E?\]#P7P.P(*H" @(" @(+8R/_ '3R
MGYR"XH/K,7TH0=J @(" @("#X+G_  "I^D^>$'AXU[*K_P!'UR@NM 0$! 0$
M! 06E)_2"/U/J45=J((" @AOU]?%6W0_B]']V0H0M?Y.(_\ PN8G^4KG^C.@
MG:_V)0:UNN7^^/HH_M[4^O1H1S;*8SYOD*#F@("#X+E_ JCQL*#P,;XR3^0(
M+N0$! 0$! 0<7=_D*"QX?QV/XP?715](@@(" @(" @MS)!_LT/V3YQ0?59/Q
M=#],[UT'LH" @(" @(.+N[R%!:UA_A-=ZOU202NM 0$!!IU^5H_$6S_Y6J_W
M((K:)L__ '4[;_V9M7W)&B2R,@(" @(/)O)TM-W/>*.?]S<5E3ZH$#6UG =O
M8OJNEGP5]M^,_H)TH>V_&Y7I%/;?C<G2*^V_&4Z13VWXRG2<#VV?"4Z3@D%L
M9-Z09#QU+70:>J'+QO58^GXI*0J\E%5D" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(->GRG7Q6[E_:2S_5R(,H="GQ5MI_XA4?=4R02EV@
M(""A["@M2F_'\OE?ZR*NIO:[RHCD@(" @(""A[#Y$%J9'[*F\C_70>[;/X#3
M?2?/0?>@(" @(" @ZI_K$WTA]9!;^-_6:K[(/6*"Y4! 0$&E'Y2KXQ?3=_%X
MO^+1HL-T]+_!J;[$SZD(CO0:R^D?XV/5_P#E*F_[M2%ELT500$!!:V2=E-_I
M(/8M/XNI?I?GE!Z* @(" @("#S+Q(QENJN=[6 L.A<=!VCO*#Q,=EB(J V>(
MN+@.5KVNX>H4%VCLT\""J @(" @(!["@L6X_C<_9&^N@OD?]/FJ1R%500$!
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M+9^3A^*WBGY2N?[N@G8_V)0:UNN7^^/HH_M[4^O1H1S;*8_8H.: @(/@N/\
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MG31,KTI6X5N-@6X5&^X8/F-HRNDBT$\]KJX:EK">P/\ 1.=R^JC&5]<[1VN
MT[>*#D@("!J!VH/)O-VM=DMU5=[O<*>VVNW1NEKJ^IE;%%$QHU+GO>0T>J4(
MC+71FO7[%<+U/C/3_MO==W*V%YCFR2GYH;6PMX'2;D<UP![='+7;9%>;=31:
MW*)6)/N+UY9/I7OH<-Q2)Q+H+1)'+/)&T]@>]K^)6$[XAV1V4X?3'U+=8^VL
M9GSK:2U[C6*GT+ZS&Y'0U :/9?L;A(3IKW!(VQ+5?L[1RA*C8GJWVRWRD-EH
MJM^*9W3MUK<&O!%/7L<!YPCCDY72::'BT+=6<N:^J:I:!S  .8:@>'BJUN:
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M'KT:#92SV(0<T%"YH[7 >4H(][V=2>T>P]*Z?/LGIZ.YRL$E!CT+VR7"I#@
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M&[3;M;S5+LLW7OY,[I:DA\%L@DXLIJ>+V #0>W1>=MW9?5]CZ?6M<VYI'-!
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M<UU%<&M_96 'CH2#IQ[%Z46R^3V:IUSB4GFG1H\0&JREK<D!!\U5(QD$CGN
M:T<SR=. '$]J&<-/G5K\HG6XK?+AM=T]PT5[R:C])!?LYJ6F2FMLK'AI;3M!
M#)) 1H2X.;IV<5IV[XUQF7I]AZ7N[R_3KC/G[FJ;)<XW=SVNGNN?;K7^]UM8
M=:N"&9M-3\3S$-CA$;1Q\ 7F;/4+1/RON.T_[-T].=T\?9P_9\5DR+<C$JN&
MY8=NCD=@KZ5W/3NCJ!+&'?YS)@YKAXB"L=?J-IGYC?\ ]HZ+_+JF<^W$_LV1
M=-'RE.7VZ^V7;WJ1935]/<)VTMMW.IHO1.?-(\-;[;BAY8P./:Q@7IZNXC9R
M?%^I^C[>PMTWCX_Q#>!;:ZDK:&EJZ2=D]+4QME@FC<'-<Q_G-(<"0=0NAY#[
MP00".(/84%4%#V%!'CJ/WXL>P&VEVS6Y@5ES>'4>+V4$F2LN$@=Z&$-'<2.*
MG)E6O5.(:G,*VYRO=7(';U]0]4[(\NNS_;&-XC*>6@L=,3JR*.%O!SM-->8D
M^->;W&_^6'TOI_I_37JMS2?@BC@8R&&-L,3&Z,B8 UK0.P #L7+G+VJ5Z8=R
M8PN'QU]!17*FEH[A2QUM),TMFIIF!['M/ @@COU[DK;$I>M;QB48)J?,.DK*
MF[J[-23?FXGJ1-N9MTX^EI33\_-)/3,=YS3Q<[S2N_3OR\'U'TZ*QFG)NOVO
MW%QK=+ <:S_%JP5=CR2D;54DO$$<Q/,QP[06G4$+MB<OG9C$X9!!!&H["JB
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M:]CM.5P.HU&G@6YY[F@(/'OESM]EM]7=[K4QT=MMD$E56U4IT9%%$.9SW'N
M )18:C*FX[A]=&879TETK,.Z7<7N#Z>V14!]!5908WECC++ISB,\GZ4MX+5>
M^'3JT9XIM8-MO@VW%JI[/A.,T./4-,T-8:>,&5X TU?(XN>XGM))7-,Y>A%>
MF,+[YSWN\O\ TT45968X%AVX-JJK)FF-4616NLC='+#51 N&H(YF2-Y7-(UX
M$%6ML,9KE!NHILTZ$<BI<NQ&Y5^3=,]UK61YCB%63538]'*X>DK*:1W[*6,
M<=.8KHKL<.W3AMDQ/*+-F=@LF48]6QW"S7ZDAK;961'5KX9F!P\'A6YRXPNM
M$$%"X-XDZ(,2[S[M8ELO@MWS[+ZX4]LM,3C#3,U,U54<I='!"T<2]Y;H%)G"
MQ&6N.UXIOWUC2#,-V,FN>U6R5:]L^,[764LIZVOI2?-DKZ@\\S2]NFH:\:^
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M?\TD=BRCFQM7*,705D%UP^\[K]--[K)*MNT5VY\2GF\USK35.<]C TZ\&.<
M.*Z:R\S=7$MF*V- @Z9NQO ]O<@U3[E5<O4GUAT^UU86U&VFPT%-?KK0#5\-
M==G^C=''.TZ-(8YW8=>"UWEOTZYF4]H(XX8F11-$<430R.,<&M:T:  #N X+
M1EWXB';Y3JAB#54B<+<RO%K-FN.WG%,BH(KC9K]22T==23,#V.;*WEUT=KIR
MZZ@CCJA:M910Z(<BO.W^>;G=*^15DM;'MQ,+GA-=-)SEUJJI&N;$.;SAR\_
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M11>B]);[A>J*.Z3!I'HV-GC<TG7PE:MDSANTQ$RAC0,CCH:..+1\;(&-8X<
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M6+7;UM5=9=]P.F&R7-QCQRXY@7W60-Y='T[0^G',1PU> L;<F5><)_.TYG:
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M)?)L]D])F.UNWN2T$HEI+G8:(Q2 ]OHHFPN!'A#HSJN*\8?0:?FIEDI899^
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MZ2I:00X/C&HX'M!U!"Y9C$O6I;@NP$'L1F("(*3.")1_ZG]S:?:38S<',I)
MVMH[>ZGM$)(!EJZAP9'&.;3B=2LJQEA>_2RAT>[=5.V/3SMGBUS@$-WCMHJK
MLSP35,CI=#KX X+J>1,I0>C;X!\Q$=<D0+':@(<FDO;.D.UW4EU";,UWI(S=
M+F,MQAT@TBFIJ@E\PA<?9<KIQKHN'NM<XR]WTK;SK\4JAQ&NG#PKB>YA55%$
M%5!\-?74ULHJVXU<K8Z:@ADGJ)''0-9&TN))/B!645REYBL9EX/R==LK,AIM
MYMXZJ,&CS_*IX\=F>SV5%1Z-8YITXM<#P7JZJXK#Y'NMG7>9]K9SZ,:ZZ#3R
M+/#F5<QA!\T?,"HU8_*88[7T%AVBW?H8N>/;7(C^'96MU=[3KO0Q'7AP#>)*
MU;:YKAU=IM^WLB5@V^NI[I;Z*Y4;Q)27"&.IIWM["R5O,W] KP[UZ9?H5;1-
M(N^X?HK'VKSCJ\U4%#P*L0<@DC3AV]B3P2.,<&'\7L;]W.LC9O#Z1OMNS;7L
MK<ERR9O$0.D@?% PZ=YD#.U>CV=,<?-\MZSW$6GI\F]T,:0"6@D@<=%Z+YQ7
MT;/U(^8$'&1K0QYY6C0$ZZ(-5GRI^U-XR[:'$MP;+32U];M1=)J^II8&$N]I
MUAB;.\GP,;$2=5KVUZHP[.PW_8V5MY3$M*5%50U]'!60.#FSL#]/&1J5\[?7
M-;3$OV[LM\=UIC97\'T@Z_06J9;YB8 EN$%HPX3314T,L\KM&0M+Y#V  >7@
MLM=9M.&ON=D:M,WG@VK?)/[5UHI]T-];I2%M'EU13VG$C,"UXAH!)Z>1H(XM
M>96@'_-7T7;Z^BD0_%O5^\_J>XO?PF?TB(;HF,UC8>5NI:"=0M[RW;R,_4CY
MB#@YC UQ+6Z '7@%!I3W1IG;7]<N7T55&:2P;R66CK[+.X_7*VCABCF;ZKW'
M1<G=US#V_1MT4O,3XLU \=._BO/G@^GY1GS54PL5SXJJ(HBXAQ<X-',XAK6\
M9'']3VE.<X29Q$RQ[T46BHW'ZI]\-W_9V+"Z*@Q3'IW#1DDKXI6U1B[B 8QJ
M?&O5[>N(?'^H[>K9+<,QC.1OFM[/ %TO-0$^4P:/@CYR1PTN=F\7^_1CYZ"9
M6W7] L&_L]:_N2)%7H>P^1$:3-T^/RJ>% CL-A_1MLGT$5NJ<T\NN@)!X\!Q
M.A)1&J&WL9MIUZ[BXQ5$TM'N[CE-=[/S#2*2HI_323\I/Z?S0- M&ZN7=VNS
M$ILM=KVC0K3G+T\>+FHQB1,,E%!598684[NS7Q+&91!G>& [D]6O3?MS1Q25
M#\*JYLIO<H;YD$9Y&LU(X@N]'V+?JC@\_NK\6VJ* ,#00TZ#0C3RKH><[C&P
M_I1\Q!!GY0G +WF'3M>;UBL?-E>V=QH\RL$<;.>226U.,AC:T ZEP<>"QM&6
M5)Q*X-H-P[5NIMQB>=6:3TM-?:*(R-.G.R9@]%(UX&NA#FG@N6U</8I,3&63
M&G4 ^'N6&5<D13CQT3"PBIUB;C5&!;*9#160NFS/."W'<.H(FA\LM=5N:&Z-
M[P "LZ<6K9;"6O3QML-I]FMOMO7\KY\;M;(:J7O?+(]TSR?])Y78\J99O]&S
M]2/F!$<7,'*=0/4"#7%\I!BURCVSP3=RTL!J-E<LH[_< !J74,S)*.4=G#E,
M[7>0+"_)MU6Z;1+)./7NW9+9;7D%HJ&U5LN]-'54<[="',>->T+@Z</I*6Z\
M2]E%\1 0$CBB$'62^7.Z7;KIZQ^I8,LW5R&C;[7TYC'04THGEE<T?I=83VK;
MIJXN^V=,8;C;=;:>VT5)04T;8Z>CB9%"P#L:P<H_07;C#PYG+[G,9RGS6CU$
M&OGY1&P5+=F[3N#0TTD]1MID-LO,[802]M,RIC$SF@=I 4M'@L3XI*85DE'F
M6(XUE=!*)J3(+725\4G81[8B;)RG34:C7CXUIG@[JSU0N@*+,^"J,1!3B@X<
MVATY2[4Z<./A^@JL3A *PP1;H?*(0WZC::FU[*X<ZW3U7;$RLJ7S'D;IJ.;2
M;RA9UC#GVMI1C'<!\Q;(:$7.LK!:G.NFW=2ST$8DN,-FEK:",#BZ6F(ET&@[
MPTZ*894G$L6=-N:09_LAMUDT)TEJ+4VFKH203'/3O=$YAT/: P?-7'>O3+V=
M%\U9R6/BR%D" @KKPT4G@,=;JY?1X!MUF68US_1P6*U5%02"-7/Y3RM&O>=-
M K6.IC:W2\3Y/O#JS%>G''JFYT7M*XY7755\J(7=O+5/#F'U6:%=D/&M/%[G
M7PT-Z5MT. _@]'Q_^N0JL86U\G&?_A=Q/QW.Z?NX14[9/8%)1K6ZYAKO'T4C
MN.>5(/S:-!LG:QAU=RCB>S0(/EK::&HBEIYF!U/4QNBGB[.9KQRD?,*2- >V
MU-4[>[L[X[-7E@I:JR916W7'H-2 ^W5T\LT9&O$\K2T+R^\USU9?6>B=S$U^
MWXY2"!U'-I[+BN%]%:>F<*:'M/!040/^G#M1)F/BQOO#E#,1VWRRYEY;5R4$
MU);F-T,CYZACHX@P=YYB."W::3:\0Y.[WQKU6F?)L1Z&=O*K;CIHVVL5R@$5
MTKJ::\W-KM2\5%QE=.[FUX@^<O<K&(P^!VSFTREZ(FCM /J!5J<O1M[FM^8$
M5K.Z_P"DNF#WS8W?:U4HEI,'R-M#E$@X<E%< (N<GP-XZK"\9;=-NF4LZ*LI
MKG14ERHI!-1W"&.IHY01HZ.5H>P@CPM(*Y9C$O6BV8?41P4%.[R(*>/57!$Y
M<'21L8Z261L,3!S/E>=&M:.)<3V !2.9:<<4,>C&FGW-Z@NH3?U_/)CTU<S%
M<,D>S1DE+3/<^1[.YWGMTYEU4C#RM]^JS:/R,_4CY@6QI"QO<T?,0=$S- W0
M-'@U [1Q];5"&JFR";9#KBS[';D'4N+[[4,=RQFI=]:?=8Q&)(P3V.<1H .U
M:[PZM&R(3] ))UX'MX^/CW+3TX=F#U5#$ 0B'3//%303U-0]L,-/&^69[CH&
MLC',YQ/9P 5PD\$&.E"'\\'5%O5U 4ND^*T$$6)8S5G1S97T9C;*YG;I[$@Z
M+HB,.#;;JG+:;Z-G#S6_,"R:5>1GZD?,087ZA<(&X&S>>XHU@=)<[7/Z%FFO
M-(QA<P:>,A265>;4KTQ94_(]IK-3543J>YXN^2RW&DDX/CDI3RD'Q<>"\K?7
M%GVGI^R-FN(CP2$UXGQ=JT.N)SD11!5% 3J &ZZZ#4>-(8VS-9ABW8*CFW&Z
MX75]*ST]BVFQQ[:BJ(U:*VI?"6,!'>#KVKTNUIB'S'J^Z+WX>$8;GN1FGL1\
MQ=;Q6G?Y6<:6+:#0 ?\ FU7V?8D5M%V?_NIVW_LS:ON2-$ED9 0$! 06KFQT
MPW+C^ILUP/S*9ZST?ZE8]L#0;'4_L;?/[E^IS4RYBK_SRG295]MC]4G2*>V_
M\Y,' ]M_YR8.![;_ ,Y.DX'MO_.3I.#81T)3>F.XH!UY7T/Z+7KY/_N>,3K^
M*MB X+Y.."*K($! 0$! 0$! 0$! 0$! 0$! 0%)C(Q===F]O;WFUJW%N=A;5
M9C9&L9;;NZ>H'(&!P&L+91"\CF.A>PGQJTF:1."T=7-DST32""=0[N'#3P:>
M12>,#&='LWMY09]4;GT]A#,XJXY(ZB]>V*D\PD8V-Q] 93""6MTU#-5:VZ(Q
M'BEHZN;);X@\:!W+QXZ 'UU)6)8FSK8?:C<JKBN&9X=27>X1#E_"3'STE2YH
MT :^>EEBD<!IP#B=.Y95F:QA)C+[<&V8VUVU$W\Q\4H[#)4 ">K;Z6>H>!Q#
M75%1))*6CP<VB1),97M>,>M.04%5:;[007BUUT?HJRWU<8FAD;X'1OU:>(U[
M%ACCE<^#!U)TF=/U#<H[M3[<T?MN)_I(V35-;/3@]W^S35#X2!W LT[EGF<Y
M28C#,EPQ*S7.PW#&:NB8;'<:*6W5=NAYH(W4LT9B?&/1.:YHY7$:-(T[EA?Y
MIX^"TCI>7A&WF,;>6*#&\1H/P19*65\D-%Z6:?0R>SUDGDD>==.]RROLFW-C
M6,3GVO%N>R>W%XS:@W&KK ?YZVWD]K7ZGJZNF>1'KR^DC@FCCDX.(/.TZCAV
M)KM-8P6K%IRRMHC)5!9>>[?XIN7C[\7S.V&[V26>.HDHA//3DR1:EA])3R1/
M&A/ZI8S&<>]8MC/M>Q8+!;L;M-!8[3$::U6NGCI+=2%SY/1Q1-Y6-YY'.<[0
M <7$GQK.TYG+"L8C#VP-!HL62JHUZ?*=?%:N?]I;1]5(@RAT*?%6VG_B%1]U
M3)!*4U;;:>YT=70US!4T==')!5T[QJU\<C2Q[3Y6DA2%B7YWMP<)J^F/?3(]
MM+JU\&W^;W"IO6WMTD!9!!'4R/=[3YCJ/,(Y1Q]1>=WNB+<8?4^@>H]$S2_*
M5Y:]_<>PCO\ (O)FN'V\5K->J)"K"1/!1 "J3&1[V1L?)(YK&,'-(]QT  [=
M? L:1U3AE>:ZJ9E\_3?MO/U/[]T%VDII9-HMGJ@5%7<',+J>XW2-WFP-/ '0
M%P[3V+V>TT=$/@/6^_C;?IKR_=^@2D:UD#&- #6ZAK0--!W!=[YR'<6:D\=
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M-X[%NY836T<9MF2VX^ULEQ>?S:NCJF#21CV'0Z<W '1>5MU367T_:=Y6]68
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MF(-U=UZ# **GMEN@=?LVOKS2XWC%*?25$T[]&,/HVAQTYCX%MT=O,SQ</?\
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M#/-;40RO#6-Y@ 2 2-5KM7B[=>R,<4Z;==+?=Z:&MM%=37.AG =#64TK98W
M\1HYI.JU35NB8>7D66XUB%OFNN4WZWX_;H6ESZROJ&0Q^;W<SR!JI%)/N1"
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MW!X4Z3J;&.@*;TC]RCVZ.H/J9%\?_P!T\)U_']F43P;)/ ODI%500$! 0$!
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M^BBB:UL<;0 UK6@    :#0:+:Y'V(*$:@CLU\"#Y9J*FG@EIYHQ)!.TLEB<
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M/8[4CM/+J/(NBM(>9MW39M?H[?26^"GI:.)M/2TD;8J6F8 UD;&C1K6M
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MQD]*[='CKR.MVA\K9%\;_P!V1B=?Q_9G$\&SA?'2HJ" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(->GRG7Q6KEXLEM'U<B#*'0I\5;:?\
MB%1]U3)!*7:"G*$'C7FP66_V^>UWJU4MVMU0.6HH*N)LT3QV:.8\$'YB&9CD
MA3N#\G?TV9O55-VI<7GP^\5!/^VV&HDI&#4Z_6HGQMT'@6$UB6[7OM5A2'Y,
M/:)]P?1G.LMY&M.H-;,-=/\ U_85A]BK;/=V]OXI"[:=!/39MU4"OAPF/)KK
MRM]-<,@>;@7$=X9,7M"V12(:;;9MS3'H;9;[930T=OHXJ*CIV!E/2P-#(V-
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MO='Q4L'[NQ)%F?)L?%0P_P#*UZ^[I%!/14$'!T;'$.<T$M["@Z):*EGC=#-
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M>B9KJ!WZGB@MK(6-8*7E'>>WCX$XBX((HS#$=./(.*#N]$P=@TU[?&@[ -.
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MFDCVDQ&*6F\Z&5EHI&N:==-01&A$S#.%OLMJM=/'2VRWP6^FB^MT].QL3&\
M.#6@#L"J3Q>@(F   =FG?X.*#L0$&G7Y6?\ $6S_ .5JK]R"*VA;/?W5;;?V
M9MGW+$A+)"((" @(++W#.F YPX=HL%S_ $*259]M_JT_Q1^JOS30U8]&SB.(
M7[--7-$NWVV/U2=*Y5]M#PA3I3*GML?J@G29/;8\(5Z3)[;'ZH*=)D]M#]4$
MZ3+9]\G!,)';K<=='VWZF1?%_P#=\<=7Q_9MI/!M*7Q3,5! 0$! 0$! 0$!
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MBF^RGZDH/OLOXLI?([ZLH/40$! 0$! 04/:$%JX_]?J_(WUP@NM 0$! 0$!
M06->OQC_ *+%8E5\J((" @(" @(/*O7XNG_T?J@@\[&_K-1],/GH+F0$! 0$
M! 0<7>Q=Y"@LBU?CG_2D]8H0O@=@050$!! +Y2_XHV=_E.S?=\2*F1MU_0+!
MO[/6O[DB07H>P^1$:3=T_P#FJ89Y<?\ ^&R(-V#._P OSD'- 04T&NNG'PH/
M*O  H:@@<=!Q^8@Z+"UIH6ZC],[UT'N<H\'=H@J@(" @("#B[N\H0611?C<?
M97_/0\%\#L""J @(" @(""V,C_W3RGYR"XH/K,7TH]9!VH" @(" @(/@N?\
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M" @(" @XGV0\GST%JX_]?J_(U(%V(" @(" @(*>!!9%Y_&/^BU%7PB" @("
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MU;MWWKVOYS+S].O[=(KY+M6IM$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MF/\ U^K\C$@78@(" @(" @IX$%CWK\8'Z5J*OCPHBJ @(" @("#RKU^+I_\
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M)W3M^09-=XJ5MLM,-/6QOE+*F-[@'2T[&#1K2>)"#,OR<<C/@N8EH\'6Z7,
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M5Q'_ (.Y?>B#Q;9US=)M'/4RS[S6R-LNO(31W'CQU_\ "^!21[8Z]^D, ?\
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M[8;I<J^R,EK+A4T4+Y9G^D?Y[WN;J3H-.*F%XI!?F"V1(U_-;C@[.R@A[_\
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M.>X(?UJF$RK\'W9+WKL;]P0_K4PN5/@^[)>]=CGN"']:F$R?!]V2]Z[&S_\
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M1H#?.[TKQ26^>+879%T;"_;#&W.(!U%! ?T0-#ZB*[V[ ;(N (VMQW0ZZ?\
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M.EACIJ.EB;#2TT0T9&Q@#6M:.X  :(/N0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MNWNZ]746S%*V>JKJ&!DU6R2$Q- <!KH3X#P71;1C,SYX<M=G+VL],<'M#@-
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MB>+FV[(Z,Z^,I\T7IO:=)[8(-1Z&/TY;P!?RCFT\6J6QF<<F=9F8C/-]*BB
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M">WN7+MI;9-8K$QQCBZ.VV5I?JGPXX\V5^F_$[QB.T6)V"]-?!<J>A8ZIIG
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M[AJ/+X%C?A7)7GAJYW<WEW3DW,N^&YED=RV?VWBJO0T&1T%O<75;2!J#5$@
M=O'CV+7VM>O,VG'L;NY^3'3&?:X[@[+[!VW8W,,SPNII\[O[81(S,*NK]N5;
M93(W4M=J TZGLT5VVZ=FNT1X_CQA-%9MU5M..$_HG9LA"QNTV"$$ FT4[W-
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M/3<_FO;Y@#@X>$%I"[.UU?:[/ISPZI_7+7WMHG=KCQQ+93&=6-/A"T0KFJ"
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MVJ;C1VZ5I:YD$O*6. .F@.G@7J]YPBM9G-HB'+6T;-MKUC$3X)FKD;1 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M5U9C]L==*9W-#6QPL;(QW<>9NBRI$U2\]7->\#&L:X-["XGYO%2+=1C#N5!
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M:L6P0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:&^EC?"QY//IVKKV7INS>L\9YQ[7-&NVKY?Y7WY?UG8??*!]GV4MUPW&R:[
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M*IH;*UNI&C@"=.*W6U33&?)KZL3:/*9C\V1H0 P-!UT[5A$Y,8=JH(" @XD
M \.XJ2+0N6%8W=;[:\CKK5#->[.TLH+ER_LD37$DM#M.SBI2TZ_I\>9:.KFN
M>0,]$[5H+1V:^NI$=)G+#UEW?Q^Z[K7S:6&CJF7VPT#+A55C@SVJZ.0Q\K6.
M#B21Z0=RRT5G;KML\*VZ?CC)NM]JU*^-HRS+$YA<YK>[M5P.Y 0$! 0$! 0$
M! 0$! 0$! 0<'C5IXZ:<5)%O7^^VG'[7->+[7Q6RV4FAJJR<Z1LU< TD]VKB
M I:8S%5B)M&8>!'C6'Y1=K/FC:*"NKZ2$26B\M;HXQ3 .'*=.((6=.K5,^WG
M"6F+Q$3X+Z9Z,CF80X Z @Z^HL:QYI/!W\H.A(554 #L&B"J @(" @(" @("
M @("#@]H+'#NT2(24#^I\!N]G3(.\W^H^KI5CZ9..[V1_P /[2W=S/\ R5L_
MWJ_K"ZNMYC3L1<F@<!=K9IZL[=5CI_\ R],?\<?JW]M3JU;?9KF?PPDEMWRG
M"L7[R+31#U/0,79W<1&Z\>V?U>;V\S-(E>P '8%SMRJ @(" @(" @(.+F-<?
M.&OB1,/AK(*2:*6*JBBE@>-'LE +>SO!\2QG@RCBA+OGA'2A0!ERS6X4&(74
M<[J.JLLACJC* -/,IFO\XGN*UQ:T3,TYMO.(BT</:B]M[EF\E/FE!1=/M9E6
M<[<QUC&W>KR."..-L1/'T<DA8[0<=- NSM(BT_YO"//Q<O=ST5_RN,_DW!49
MF-)2FH;R3F%AG8.Y_*.8?-6N^.J<<F5,],9YOI6+(0$!!0]BDC7SUH7RTXWF
M6QE[OE?';;5;;[Z>OK9-2V.-CFDN(&I_06'8WZ>__P#!9V7KGL;_ .*%G=4/
M4QL1G6S]YQS$-R[9?+W-/3.@MT#:@.?Z-WGG5\0!T\JQQ_G:[>$6_:6';WZ,
MS/DR]M]U=]-MDPS&+5<]VK525]%;H(:NE='5$QO:P M.D![#X%U]Q.=GO<.F
MO36*^*26!;GX7N?;'WS \CI\DLK)#$:^G$C6!X.FA](QIU]18?;FL9GQ9?<B
M9PR.TZM'D6$2S55! 0"I/(<2T.[1JL9C/-5M9%:,>NM*ZGR*WT=?;W-_98JU
MC'1^KZ3S5)Z9CC*Q-HG@UP[RX]TF8M<Z^6TYC7XIFHU+*'$'R32<PU( BCC,
M8XZ?IE(M;^3/X<&R.F?KQ^[W^ES*NHF[92*7(:&Z5VTQA<+3>[S'%#5D-#BT
MO =SZD]VG8NW1%9U[)VXB\8Z<.'?:?N4C7QKQRV/Q@\->SE'#L7-'+VNB>;N
M'8%15 0$' \I< 1J1Q'K?/4F1\U3%$YH88P_GU'(1J"._@>"DYCDL1E$W>S!
M^F62BDN.Y'X(QYP=SNNE*X0U0=H=#K 'O)U\(6GIC.8Y^QMZYF,3G""U#DN:
MVG*(J+I3OV8YS1"6/VY37:G_ -@9"2.81R5 C)'C73VLS.S.S/3CQ:-T5Z9C
M7C./!M_Q26]U&-66;(8/:M\? UUTI]0>28^R;PU"RW1'5\O)JT=71'7S70L&
MX0$!28'%W9P.A[BJ,-;R;DW+;7'Z:\6W%:S,)IYQ'^#:)O-(!P\X\1XUKM;C
MALK7,(F7CJ6KLB9Z"^]-UTO$.G&*KI&3#M\#BY(UUK.:QP\V-;^%GA'JNMVW
M%%)<1L!5X?;P>5]4VFBIV#OT&A;J>'<L]NWIQ%9S[/%C35:UI2@Z>M_*7?>R
M7&\T=@K+'3T$H9&:AKFMFUUU+2>WL6W;KZ-<7\_!IU[HM>:^22<0T8T:DZ:\
M3V]JU5Y<&YV*@@("#Q<BIWU=BNU-$2)*BEEC81VZN80%S]U2;ZYB&W3.+QGS
M0LZ++M2TEBSK JOEI\DQ3(:H72C?P?RO>[D?H=-0>4\0O1V[8W:--J\JTBOQ
MAS[8BG=;*S_-:9CW)4UF"8S4Y919S+;F/R6W0&EHK@0>9L+P06CAX'E<D7MJ
MI:(_FQGX2V6^>(KX1^Z)._-52YCOULS@EK<)KG9:A]WNLD7$P0@%K0\]@U([
MUGZ;%J=S?='TQ2:_&<2P]1B;=K&OQF\3^">=-];X=A)(T[-#Q&BF63O0$! 0
M$! 0$'!Y(]CV^!!$_J[Q2_9/MJ:K'Z1]RJ\8JX;M-:XAJ9XZ=P>]NG?P'8N/
M9-M>_5NC^2<RZ]%HG5LU_P!^,/CQBZX5U0;-U>/P&JMP,=/27ZF= Z&>CJ8W
M<P#1*W0C]C[0N[N]$7F-DSPF<Q/NEP]KN^WU:XYQ&)^+)EWR+$=A=M:"IR6\
M/AL6.4L%N@JY(G.?,YC QC0R-I\YW+PX+3WG<S:\S/U6GA'G+;VO;XKTUY5C
M\(8"Z1K7>;O<=SMTJ^U3V2V9_=73V*CJ&EDCH6'7TA8>(UYEUUC[7:TTVYQ:
M9_'#7MV?=[F=L<NF(_#*=K&\HT7-7DR<UD" @*2/#R!O_D]R(UXTTGU)*Y>]
MXZ;>Z6_M>&VL^V&HCI]Z9;ONKB%?DU!NYDF&Q2WJOC-HMT@9 .6ID\X-/%=_
M1T]MIC_^.GZ0Y.OJ[C=/_P#)?_W2SR.A7(] 3U$YD->XSA:Z\(;9XRO#;_I#
MOF#9I8<KJ=[LJR*"QU!FDLU9+S05#2PM+7C3B!KJLJVC#&83H;[%NHT.@U"Q
M5R0$!!0G1!UO<0W@="==/F*5)0%ZEW7/<W=7 MDXKE-;\<K6.N64"G)9)- S
M0<G-X/.[-%CV-:;MU^KE6)EEW=YU:*S$?5:(_5(_'M@=HL>M<-NI, L\T5,P
M1M=4TL<\AT[W/>W4E91>;9B>66&,<4?>HSI[PBAQ6Y[B8/;8\0S/#HQ7VRKM
MFD$9$7*Z1KV, '%NO>M-]U^WF+QQS,1^,X=&NL;IFL\\2D9LCF$^<;8X;DU2
M_FJ:^@@]NNX@&9K 'GCXP5W]YJBNS\W!VU^JN/:S,N=T" @("")G6IZ4;#9,
M^*GFJC#+1S.IX&.DD<(JJ%Y#6M!).@7)MX=QIMX1,S+HU8^WLCQQP1QMG7/@
M=%@U-C,FW^:OJXK7[2=.+:X,,ACY"[CQTU\2Z_4(^_-K5\7)Z?6=%*YYU_WL
M>]/'5WB.T6VMOPV^X+EU=<:6IFG-116YSHR)"-/..G@\"V]QNBU-45YQ2M9]
M\0FK7,[=DV_FO:WXRG/LEU*8WOE6WBAL&,Y!8'6:-DDSKO2&F;('\ (SKQ.O
M;P2VB:4ZIGX+.R)MTPDS&=8V'PCO6FLYAFYJ@@("#B[7AH=#J@\>[WJUV:ED
MK;K7PVZCA:7RU-1(V-H:WM/%83?#**Y0LW1ZW-J\=IJZCQ>GJ=PJN+FBG=14
M\IH8W=FDLKV :<V@X%87Q/3[9B/Q6(Q$S/A&5K8GC74SNR[';_>:^U[7X#5.
MBN%)CEGT]/+%(1(-2TNX.'A7;6GV-_5LXX\&C;M^_KB-7"//Q;"J"-T-'3Q/
M=S/B;R.<3J20="3Y5IGFV1&(?8H" @(" @(""A&JQL(J=8TC(MBLTDD?R1Q,
MIG2//8T">/7Z*XN[O]NU)]L?JZ^UKUQ>/^&6*\7ZK>GNBVDLN.U6Z=KAO5-C
ML=)44!94%[9Q &EG"(CM&G:N_P!:I]^=L1XQ,N'TJ?MUU^R8ACOI6ZD]C-OM
MLC8LPW(MU@NS[E4SB@G;.7F.1P+7#DB<.*W]SL^[KI,>%8C\&GMJQ$W_ ,4K
MAV*S?%L_ZLMT,GPV]0W^PUUEI_:]QIP_D?RF!ITYVM/:%AV6O';;/\<?H[^^
MV=7V?\,_JV0DG4>5:X:')%$!!0]BEA\54X\6CM#=6Z=^FOK+'9'R3)$\6N[I
MWQK'\ZW7WYON=T%/>LJMN2/H+;25T393'0L#FQF-D@/#E XA;.VBL]E2]/JG
MJZI]UIQ^3;WMI_J;4MRKT]/QK$S^<O?WBV.NNW5U9O1L51BWY':CS9'B-.YK
M*.OI&^<_2,: .;PX \5KIW-]4_/QK/"8\O:OVZ[JXGA:.3%^].Z^.[OV;I_R
M.QS_ .T-S2CAO%L>>6>EJ6.!D8^-WG#3PK=V^KI]2TS'*>K\JRY^XV=7IW<1
MXUZ/_?&6S^A(%/2MUXF)AT]18W^K)3Z8CV/149" @("#$6\ECV]OV'7:FW,D
M@AQ>.$R5E7,[D]  #Y[7#4AP[M N?=6)M$^,<O/+=IBTS-:\<\X1?P[:/ICQ
M[!KAN4;L;UB-THI:=E_NLSIF1TP>Z-S8 ]C7 AS2!PU71W,QII]NW#./?GP:
MM.=]HFO\N>'@BG;K9TN7'(V4+]Z<RIL-FE#*/'ZIDT5J?Y_FL;*8NSCH-4U4
MM>.G;]><<>:;+<9MK^G''')MTP^RX[8L?M5MQB&&&R0PM;;3!H8RSE\TAPX'
M59[IM-L6YPU:8K%?EY2O58-H@(" @\JZ4E-70RTM7$VHIYX71S4[QS->UW @
MM[UCLI%ZXF&5+36T6B>+7MN-M'E'3[6W7=C9*[,H[1 ^2LRC![A)RT<K ?2/
M]#J6:$C4::K57N+=OBEYS3PCQAG;37?,VK&+^,^:PG=3^X?4G5T&W&T%#%B$
M]QHVORO(:^1K)(0-3+[7'.-6Z#0.T)73/:_=FV9^2N/?QC+57N(TUX_7/+RC
MWIA;)=/&(;0TDER9Z2_Y;<FB2[Y/6D2322D#4,/*.4:\?"LIVQ%(UZXZ:?G\
M6J-=K6^YLG-DF&^Q;W<!P6MM50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!)'R5D3)Z::)^O),Q
MS' >!PT/8M=I_-80BNO0?L#>[E67:LH+J:FY3NFJ7-N,[6\[B==!KP4UU^S$
M1SQ^[*]_N3F>&?V?"[Y/CIX:USA0W=H;KS%URF 'C)+NQ;(F:>Z6%IZ_@]K%
M>B+8G%;[:<GLE)<S<[/41U-#*ZX2RQMDC<'-X<QUT(6==TZ+=<1\6O;3[U.B
MR:,+!P=S:C3NU6N9\&S&>+ZAV+(50$!!0\ 2>Y0?%/6TE.\,GJXH'.X\LCVM
MU'D<0L8Q*NK\)VK_ /$*3[;'^N6?/FC%V]MQMTNTNXC&5],][L>N(#1+&2=:
M:3@-#JN;NJ]5,1YNKLK=.^LSYPLOI)8Q^P^!DM!_V'L([?.=Q7H]SG-?\%?T
M<%?KV>V]OUE)5C0T:!<[:YH" @HL>8^:6:.)H=-((V-]F]QT;\TJS,1"Q&7S
M_A6U'_\ B5*?_6Q_13".#[I:^4C\(TOVZ,?^DK,F$'<'EBFZV-R7Q2LFC.+T
MVCV.#AV4W>."S].B8[7;[=N?_2P]2O$[M'LIC\Y3S8 "[0+7$LW8J" @(" @
M("#JFUY0 =-3H[CIPT/8I;E)'-'S?+>^BV@H;73PVRIR3+,GE-+C..4Q\^IF
M[N8ZCE:"1J5S_<M:W33PYML:_DM>>4, 'K"R7$8ZVW[J[;5V*9/50^DQ>VQ.
M]+'7N=P:P.+M6G4<5OV1FL12<WS$8_=A,=-NK^3$S^'@Z*W>OJ<Q>V1;@9/M
MY12X9*!4U-HI92ZMI:9^C^=VH'%K>WBG577:*;)XSPS_ +C3'W^-8QXX\TV-
MOLUM.X&*VG*;+*9K?=HO2P%WLAQT+7>,'@5T;]%M-NFW-SZ=T;(S"]EI;A 0
M$!21%GK+;KT\9]]+1?=D*TUC_F-7_P#9'[NOM8^O_#*[, D?#L'C<T+G1RQX
ME YD@.A:X40((/B[5N];OT_<M'!Q=A'&N?-C?HIN]WONS<==>KI476L-XK&&
MIJ9#(_E:6Z#4]PU77W-(B*?X88\?N[/\7[0F TZZ^(KDAL<E00$! 4F,CIE.
ML;M-01X."<CFC+N?U(XMMSEEBP6*BN&1Y;>9F1LM=O;Z0P,?_P!9.=1R@!8=
MO,[MLUCE'-=M8UTZI\GH[R;]6/9O&+5<[K2U-QO%^Y([)CU-YTTT[@-&G4@@
M:G3M2V;;XUZ^,YEEKCJU3LOPB(AB;;WJRN=SRNV8;NE@%PVRNU^YOYOR51YZ
M>=NGF@OYCH3IP6_3$;(X3Q\FG;;[<>Q-NED$L37\VO.T.:=>X]GZ"PQC@SB<
MP^T=BD J" @ZI.+' $DZ<%,\1%7J(Z?+GO;689<+3FLV&7##Y*B:FN%.SFDY
MY_1Z.:[@6EOHUJKJFNSKB<-WW8^U-,<YA'Z]]$>Y>249M-^ZBKY>+:][9'T5
M6USXRYAYFN+2=-0>(6V9CACG''W,.J8MF)]D^V'WT_1WN_110P0=3.204\#6
MQPPLYFM:QO  #7@ %8GYH\9\6,8B_5X>28&R^!Y'MWB#,?R;-*W.[BR9TAOE
M<29"T]C>/@6>W=&V:XC&(:=>N:YX\Y9A6N(PVBH(" @(" @(/GF<\<&<#H3J
ML;3B/:L-/.\&2]3E]W(R*U5=HR>JP"BJG-MM-9&MIO30]W-*QP)!'A7/VU9M
M2;7GYO!T[)Q;%(\'9AUPIL,G974?21=KM=6N$CKM=I'5D_.#J'!TKCIQ\"[)
MV<<1$9]SEBF<1F<>](FR]4&Z4U9;[=\'F[6NBDD;$^I&@9"PG0NTU[&@K+73
MJG$RPO/3$S"?-'(Z:DI97L,;Y86/?&>UI<T$@^186C$K6<Q$OH49" @(.N0\
M-.\]BPM&>'F<N+%NZ6/[876S_A3="UVJMLME:9C475@?'".\C7CQT6&8I>+1
M]6&RLSC'A/@BWB5=T69M?(\=QW'\6JKI([2EA?2-9Z?0Z'T9(XZKHIIFTYCG
M'&6K9?IQ6W",X^+*>4[3=-F#V>JOV48)B]IME*WFEFGIF :?J1PXDZ<-%SWV
M=%?/C\6RM)O?J\7M]/F4[;99BU=6[78T,<QBFK9(H8Q3MIFRO:2'/:T$\#W%
M=6R+16,M-9B;3C\4BF>Q'C"ULW) 0$%"-=$R+&W&KK];L,R.LQAKGWZEH9'V
MIC6B1QF \W1A!U*X^_G973,Z_JX?JZ>TK2VV(ORX_HTTBLW]S&MGJMX<&S3+
MZ61SA'9J&4T-*6@G0EL3FCB%V5K6L1GC+GOF9^6>#.>$;AUFWK8CB?1_64$\
M30&USFB2I(''SI7.U/%99\F'3YI.;6[][A9]E<-AR+9VY89;9V.>^\5)'HVE
MH) [5G6D6K-L\F%MDUM$>$I=-UY&G74\.*U-G@[T40$%"I,X'6_AH0=#K\WQ
M+'Q5JNZG<HZEJC<ROQS%J.^OVYB9$626:)C)7ZC5[1,"'\3XUJ[?%L]<^/!T
M[HFNNLTC.>;&^+"'':@7*NZ5K]EU[=QFNE]G=6%SO"&O>0%U=<^$1^#DZ8GC
M,S^,I$T/4[NA;XH**W]-5UH*-A:QD4(#(VCLX 'NU66,SQE/=">F,W*HN]@M
M-TJZ)]NJ:ZG]-/0/]E$YQXL/D4M7IF88TMU1$K@;V!8-BJ @("#HG:WE;V-'
M-Q/9W%8VB%A$_>GJCQ+;.I&,6""3,<^K3Z*WX[;ASELFO 3.!'*#IIP6J)OL
MMT:XXMO1%8ZK\F&\6Z?-R-[[G39IU'WI[K3PFM&WU(]T<<0UYF^G# T:@'0A
M=-*Z]7AFW\<FBVRVSC$XC^.:?F.8]9<9M-+9[%;*>UVVC;R4])3L#&-;X  L
M;7M;ZDK2*\H>\--.' *1.62JH(" @^:K<QE/(YY#6@<2>Q2TQ',0ZW1Z;X<P
MO\>XVU^5S8#G,@YJJZT;B:>MY3_UK&\._P "UUZNWF>GZ?&/[&RUHV1$S]4<
MI8Y&W77)4S36ZMW3QN"QEO(*Z&$>V_1Z]OU@>=ZJSQ&SGPB6$ST\89GVDV<Q
M;962HO>29&[(L^R67T57DUR<?32\Q!]#$'>Q&HUX+?-YF/MZXQ'.?.6J:?SW
MG^R$IX-.30$$ D:CLX+3&.38[E00$! 0$! 0<3RCB1XE4Y+.S'([/A]GN&17
MZL916BUPNJ*F=_<&@DZ>,]RT;=U:?5X\FS52;6X,"[-[T6C<Z',[WC.%5EBL
M-$XOM]WJ(6PBYF%CBY_FGN=PU6_=K^UV\7F<S&>'DU4X[8B(YSS]R,5QZI-V
MLUAO[+=T]19IBEFN$T4EP+Q+$'TKG-Y^5Q[6C4]BT4M/339>.<1,>QTVKT[+
M:HF8F)F)36V-W/LFZ^"VW);13B@+B8*ZW#3_ &>=FG-'Y&\%U[M>/F\^+DU3
M$3-?)G(>R*U>#8Y(" @)(\:\QQ/HZEE0]T=.Z!_IY >QNAU.GJKGWUB==HMR
M;-<_-&$,]K=X>EW9ZP5>*6?=*WF%M?53S"5\KW,EDF<7MU<WN<=%U5V_<U:_
M**5B/=AIC5T6MGG-IED\=7?3L.'YT;4=.WB_]:L6;T\?ZE]DLMOMOQW'MPK;
M=+O=I3#06^-S@^5_*7D %H[E:Z^O./!C:V&?F.#FCNX+'.)PO.':J" @XN[6
M^7YQ4D=;@2&:=H(]<*\IPC69U!;DV7:7J9Q?-,BMURK[33V5\#F6ZG,TO-)R
MZ<"0.[PK1V%HUVV1/BW=W\^JD>U=C?E%=GFLT&)YH"==2+8SM[_^N\*SSPEK
ME8VY/7;M9F6$9/C=NQ;+X;A>J"6DI9IK:UK Z1I:.8B5QTU\2PW:^JL>^/UA
MLT7Z;_"?T2GZ2HW-V&PGF88W>U^#7@@CB>T'CJO1[WCLS[(<':3\L^^4GAV#
MR+EQAU*H" @(/"R&OM]JME7<[K,RGM]OADGK*B73D9&P:N)U6O;:*UFT^#*E
M;6M%:\Y1ZVCWVQ/>3(<AM.+6&K%GL;2(L@G@:R&I=J&GT9U)(XKHU:I^Q]R?
M&>35?;T;OM^SF]G?'<JX[2V.WWZUX)49?1F8"\>U6-YJ:G;ISR:<.8Z:\%QS
MLBNR*VX5GQ;XIFDSXPNG:;<[$=V,6ILHQ*3_ &.9QBJJ=[0R>"9O;%*T$Z$:
M^%=F_5.K'',>;GI:)M-?&.;+S.+6]W#L6ML<D! 0$'S57,8QR.Y#KQ/J%8WB
M9C@L<VJK=C;?=&U[B5V7[F8Y7;M[<>V'3TEEMM;)RTL#>.KZ<^C8[3APU6KM
M>G5]43,^?-N[G_-C%>'Y._<?>;8S(>GS*\8P*DAPV[EM.TXE4TS:2J)9.SF/
M*WF#O+JL]FN;;M7'AUUGAP\4TSTTO'/Y+?HV$;2>C=MC@/*&N/X"MXU!U'\'
MC[%V=[P[C9C^]/ZN#M(C[-(]D,F1MY6!O@U]=<\.ES0$! 0$! 0$''4<VFO'
MP+'Q&.MS*K!J+%KQ4;D&A_FA&QKKF*]I?!RD@#G&A[PM>RM;?5&6=)M')$)N
M4] 36-+F86.'9[4.GU"W\9XL,17@?SLZ ..C<)X]I]JN_6+&;3$8\%BK,&S%
MZZ:KA?*^/9D8\;TVF#KC^"(?1R>@#P-7ZM' NT6RL6BN/!A:>,1/@E%IKH?
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M[Y6[U=/362.8'W>0>:2..L7@^>IZ=B.ZVS/+HC]93O;3';TBO.;+^ZK\BO\
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MR,3"?;/8MXZ\!Q1@Y(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MLN/*6QU4C#""YA(&H_8CW+?VM)T=I>MN=[YB/9ACW.V-FVE8_EKQ]^>38+$
M"[0>4K3'-E,Y=RR00$! 0$! 0=%2"Z,@:]O=Y#VI"3R:_>I*:EQ??78S-\I@
M]+A5OGEIJJNF!=#2U#Y&%CY  ?!VZ+7V$9[G;6W.U8Z?;S_V-G=9MVU9K'T3
M/5\<?QXI5Y)C&$[R8?+;J^.BR&P72'2*L:&2Z.(X21/[B#V:%8[M%HSX6B>"
MZ-W3B><>,(%W'+LBV!L>=['[F5,]9B57:JL;;9A*'/:^.1I,=)*0'D<O$#7U
ME=O<?U&J*S&-L</\7MY1$?BV]OI_IM\;:<=7C']V?'VS^"2W1)_<!AOC]LZ
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MCH'B.KE;3U$!8XZZ#2>*,GL[EIOJM2L6F.$ME=M;3B)XLJ@@C4=A6ML50$!
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M:V7:V7*DAK+96PU]',-8:B!P>QX\1"UVK.>/!8F,<'LM(+00=01J"D1A54!
M0$'SU.OHCH>4]Q]0K&W)80,R3:?JVO>1WFMQ3J%M]HL<TY=0VEU(YSJ>,G@Q
MQ#3V+5V]^&;<FS?->4<WD#8[K>U('4K;P!_[&_\ 6K=XRU\,0\.[=+G5)EMP
MQY^?[V6K*[/8[C#<!;WTTC"71.!/*=  >"STS&O=39Y2PWQ-]-Z1SF.#9)0P
MNIZ.E@?ISPQ-8[3P@:*6G,S*Q&(?4HH@(" @(" @:J9&)=XMN*+=C"+]@M?<
M)K937N-C)*R!H<YG(YKAIKIQX+3LU=<LZWZ4#ZGH^PK:VFB94=1%TPN&3ZV
MZ.F,F@XZ!KP7+97;TQ$92:3:TR^>S[(X+D=4RCL_5Y>ZVLD<&14S:IS'N)[
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MN_SWM,Q[IB&7?ST]Q&F.73$S\<L@]1N%5^0[B[#QTE@_#%FMEV+[S&(A)!'
MYS!^R-.HY=&G@M/;Z_\ FXM;EB?QPSW6B.TM6O/JC]86;U1X19=MJS:_=_#[
M126&YXM?X:&MAH8FP13PUO:V01@ ^PX++L=MJ^H16?HO'3\9F&O?3[O:6G^:
MGS_"(EL'M=0:RVVZK/;54T,Q_P!-@=\];MM>F\QY3+7KMU4B?.(?<L&8@("#
M@_7E)':$)01ZMB9<^Z?J=^KX7Y&USH=-02',TU5]/K6W?1%N7V[3\77>/^1O
M,><)";QTM/5[29E'/$)V-L50>5P);S"(\=#X"%Y_J4S-9F.<3E?3*Q]VD6Y3
MPE;G2A4NFV V]DD<7D4M0P%W Z-J9M.WQ:+W_5>/<</*O_MAX_I]9C5Q\[?K
M*1+)F%O'4:=O!>?C#KB7?VHH@("#B\$CAV]RDC&^Z&428A@&4Y.UH+K-033^
M=X6@ >/O7)WEIC3;'/\ VNOL-,;ML5GQ_L1<Z1-J;12XG1[K7N/\+YMF0=75
M5XJ3SO9%*[1L;-1P #=5ZV[5/;5KJCG$<7G?<CN+S:>6>#IQ[;B6\=4^YUWR
M;$8;EC]5;*>.W5MPIV2P/D#F ^CYVD:Z!<G95K3M[Q,?-.RT_"75WU^O9KFO
M**QEX5EM5)L[U?R6&P01T./;I645TMJB 9%#/3AS"8VC0#7T?@5])M;;IWZ[
M_P#Q]./_ !=4M?J58I]G;7QZHG\L-@4;FD-<->4\/T5(B9A9G#[E4$!!0G0:
MI(^:J>UK"' D <W#Q+7,_-A<9:[<GQRFWTZJJK$LJ+JS#MNK:R:*T!Q$4]2_
MF<#*TZZ\7!7L-.:;.YGE,Q6OLQ,Y;.[O7[=-4<YS,KWZOL%N5TVQP^P8E87U
MT-OR&A=^#:2,%L=/&UX)Y1^E' *:Z_<[REK<O%GHMTZ[_P"&?T>;U3;5XU;M
MJH,RQBQT&/9!A-13W6GKJ&GC@?I#Q<UQ8 2#VK';W,=OW-+_ ,O5B6OMM?W-
M%JSSZ."7&V%^FRG ,4R"< 376WQS/T[.;3E)]4A=O>:OM;IK_'FX^TW?>U1;
M^.$X7\.P+1#H50$!!Q?P:4&%MY<RVDPS'X+EN]/10X_).&PFOIW5,?IN'#E:
MQ^G=W+GO>L3&6ZE+6Y(PCJ$Z#M7:W#&-#W?@B7A_] M_5F&G$Q*KNH+H.YM6
MW'&.730?^4RC0^$_L"3.*YE:YF>"1>RF=[*YM;[C/LY46Z>W4\K1<76^E=2C
MG/9S-<QFJW;-=J4BUN4M.O96;S$<V>V:\O'MU/KK4VN2 @("#HJ TQ.#_8G3
M4'30^(ZJ3&18%\IL(L%OJKQ>Z&V6ZW4C3)6UM1#&Q@&OA<T:GR+5>U:1F_!G
M2+;)Z:H&Y-O%D>]-YJL'Z;\,H7VQLCJ:[[C5M(R." -)U-.7ANO ::@'Q++[
M.S9&9X4E?OZ]4XB<WCEY,[[']*6&;32G(J]QR7-JO]DK;S4AI#'O(<\0MY?-
MT/?VKJC;&NO13A#D^U.R_7?C*7<&@9RC31I(U"T0WNY4$! 0$! 0$'!_L>"L
M1E)E'WJ*J]V*3!YY-GZ,UF2 CTS6&,2-ATXE@E<UI/JKDVVF+8AOU1$QF4#-
MK9-AK[?8&[XWK('[H>V-)+7EK9(Z/TX/$0\C#$6Z:::E=U:UCZ<9\?-RWFW3
M,VY99KVQHK%0=7N;TV,P4=-:(L7I_:T-N]&(M"UA);Z/4)V6R;=INB8G/W<<
M>'#"=[,5[C3%?&F9QY\6P-LC"W0$  <?%]!:HB8AM?4J" @(*'L4F,CXZES6
MZ/<[E:UI)U[ .\D]RF8KS3$S*-6[&V^PV[IADRB]VB"ZT6HH[O37"G@JHG^-
MP=KP(["M<5B>,-LVFO"81UIND7:=M:Z2X=05UN=I>?.LLEYIO1:?J==>Q;ZS
MAKGBEMMIC^TFWMLI<5P2YVB%LKA^PPUD$D]2_0Z%[@[5[NTJWZML9\(\DQ$2
MSFT</$0M.,RRRYK8@@(""A("D3D8>WCWAQ#9W'FW_*JAX]*_T-LMT+7/J*J<
M@D1Q,:#J3HM.RW5/3'&>;=KUS,=4\(\T)+QN'U%;@U3;[BO2A9+Q8Z@>DH:R
M^FG;5/:>(<X2S,()\BVQJG5Q\9:YW1;-8Y+UPSJ5O.!W*V8MOAM-^:B2\2B&
MCN5 P/MK7ZZ-#WQND YB0!Q[5MK_ )ML1/)KBO3/L3VHZVGK*6*HIIF5$-0Q
MKX)&'5KF. +2/$05JM6:\/%:SU1GP>B.P>19*J@(" @Z9O1^:9.&FI:5C.#&
M5DY5G>'X71SW+*<BH[-10,+IGU,@#@!Q)#!JX_,6-KUSB)X^3*M;8Y<$$=QM
MX\*WQ]N8OMAM#-NQ75,;F19'44CJ2B:'ZM#VU,PB=IWZ@K">WVVMB8Z8\^3.
M-U(X9S[.;)/2EL-GFT\>0W',;HR..^B,6_%Z:=TT%"QIU+6EQ<->)["NZ^R(
MI%,YQXN7HF;]4<(3=AT]$S0ZC1:&UV(" @(/DK=/0'7LUX_,*QO.(RL(+],.
M44]-EN],=^R*.)L>1/%-#7U36\K0W]()'#AY$[2\7[2L^/59N]2B*]UF.715
M,UF7XIYVN3VG3NUK8/UZRSESPYC,,5<YK&9);)'O(#&,JX7%Q/< '\58C),X
M7!&]LC&O;Q:[L*BN: @(" @(" @X.<&Z$K&8S(Q-O+GL.W&W^39;R"2HMM-S
M4L!X>DED+8V#YK@N?=>9Q2O.9;^WI%K<>6,HD;4=,%MW1M])NGO?4UF37_*
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MT&,85N#27^^U+#)#;X8*ECW-;[(@R1,'#RK9]F9C+7.R(9_!U (["-0L6:J
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,8CC9_!N4Y8X_P"TUHB_21.XDG0:=H71:E.XQOV1PGPC@UUM?M;3ICC:/%L
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M YKO'J%NM$UG$\VN)R]F&GBIV\D4;8VZEP#&AHU/B"UVF95]"R! 0$! 0$!
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M',>'$:++37[^O,<9CG'D;X^SLQ_+/*4KHB3&TEH:3KYH.H[?"JCL0$! 0$!
M0$' C5W'L'84SA,<7A7VZ6NT4E177BKAH:"$ 3U$[PR, \ '$^$G1:[S'*?%
ME$3SCP1*S7I/PS*[G-GNV^55^W60WG]FJKS99G-II^?SO2&)I#23KKJF=FJ.
MF9QQ\5BU;_-$<?/,K(M'1S?<B+:?=#?B_P"Y..<X+K4R9T44C6'7D<0]^HU[
M0MM8I68M->,>_P 6%YM,8K./P2HP&7;7%JUVUV&UENHZS&X&OFQFF>/301.(
M(>]IUXDN[?&L;;)V1,QR@KH^UQGQ9@YP'#CKS< I$>*S+L60(""A\"GB/DEB
M#FN.I!T(.BPW<*SA:RUH=->[.V^W62;[4.;9K;,9JJW.:V6DIKA/Z-TL8>]I
M+0[7@#X%OU[HGLM,3S^;_P!TL^\U=/>7\OE_]L)<LZI.GGE#3N]C;=!WU8^@
MM5>;"8?5;^IK8BZUU);+9NC8*ZX5\K8**DBJVN?*]QT:UHTXD]P658F6,SAG
M)DS9 US.+7<0?""EHP1.7<BB @(""&75UA^]F=6>SX[M/>:6UT5<98LDCFJQ
M2R2QO #6,=H2=>(("Y-FKKV?-R\G3JV12O#A/FBQM?LWUE[0T$U!@MDP.B-5
M)SUETECCEK)WZ<?23%G,_P!5=]MGRQ&.#BK3-IMXLJ^E^418UQ<<%:R/B7NC
MCX:\3Q+.X+3-\1,SX-N,QB/-*38JY;F7'#_2[KU=FK<I]M3<TUC+#3&(<O*/
M, ;S#CJNC=$1$8\H88F+S66>UI9" @("#Y*REBK(G03L;+#("V6)PU#FGM!\
M6BPO2+0L3A\]';:6WP14=% RFI83^QP1@-:T>   !9S:9GBF/'QSEZ+0 T =
M@3.3&') 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! /8@\6[-?+;+@(B1,8)&Q'37SBTZ?HKGW
MS\DSY0ST_5&?-";HI93T]MW*H:[T;<L@RJM_#L<FGI^75H8YVO'3V077KM%N
MTUS7EQ_'*=W$_P!9>9\8C'X)RR]@U)+6G4GNX?06J(S.6.4!NJD6^HW3Z?*6
MUEIRF/(VOE,9!E%&)(>?FTU(;VIZ7&>[F8X1'/\ -EWMHKV=XMSX=/OS&4]8
M>;0<>5Y (C'8.'S5ECC.6'/\'H,UT.O:3JI"N2H("#YW/=H&C37O"QB.$F4=
M=\M\[-LQ;:*7\#RY)E%\>8+#C=&=*BH>=>)(:X\H(XG1:ZS-[]&OFW5U_+-[
M<F0=M\@R'*L0M=[RK'SC5[KF&2>T.+BZ'4CEU[.)77W&NM+_ "\7'IM:U?F1
MTW1WZW%VESN7^>>W\=?L[7R0TT&2T6KI:8OT$CZCV0+>)X:#RKD[>T6GHV1B
M<_*Z]U,5BVOC&/FS^R5V(3V6LLEOKL>;"+-70MJ*(T^@C,<GG M X#M6_;6:
MS,6XS[7-KM%XBT+K9QU/A*QCAP;'-4$!!U%[M6C0><583*WK]=*"QVNONUXE
MB@MEMIWU-9/(/-8V,%SCQ/=HM-]D5KF6RE+7OTU\4;=G=_[UO)F%ZAL>#U%M
MV^M3)([9E]47<E=,R0#6+5K1RZ:_173JUS]J;;.%IY1[&K=:O7T4XS$XED+>
MO(]S<9Q@7;;+'*7*+K23"2X6^I)#C3-!<?1@:$N.G#1<M[]-JSC,>+HU4K,6
MB9XXX+8V(W@Q[>1E3<A8VXYG=A8ZER"RU(UJ:?5VA',0TEI.A'!=5Z1T]>N<
MUG]?:Y:6F+=-_JQE)6#7SM7<Q/;Y5IB//FV0^A9 @(" @(" @ZY 2!VGCV#R
M%8V6&,=QMS,2VKQ^KR;+KC'04,.K(QVRS2?J8V#0N<? %JMLK79%8XS98K::
M3:.4.>VN?T6YF+466VV@J+91UX<8*6L:YLFC>QQY@TZ'QA=>W5.N<2U5O%IG
M'*&'LXZG,?V^W*&#9AC=PLUIF;&*'-I6N]H2SO(\SV #=/#S+1VO^?::1.+9
MQ'M;MM+5KU8X8RD]:ZJEKZ&GK*.:.>GJ&A\,\1#FN:>(((X'7Q+9:)CA+568
MM&:O1"Q9*J@@(*'7N08NW@S:T[>8%?,MO]O%TM-J]":JAT!]())6Q@:.#@="
MX=H6J8Z[4K/.;1#;IIU3/LB9=./08;D&*VS*H[#04MONM%'<&.?31?L<4D8D
M\X\O<#VK9W$?:F<^#5KO.R'=B;-N<UMC[SC=%9[O;/2OB95TT44C.=OLF\P'
M<LME)C$KGC,>,+XH,?LUM+I*"VT]#)(-'O@C:PD>/0*1:9ACB,Y>PUO*- 2?
M*I$*Y*@@(*'L\'C0?#51O]%(&GB6D<>*UW^:LUDCA:)0,V.K:'#.HG>/$,BF
M9;[OD,S;G8IZC]C]MPD1^;&7>RY0#V++LK1/:?;\8MGX87O*3/=1LCZ9IC\T
M[8^37G'G,/G-TX>KJ.WYJMO:D(,]:=]M5QLN(;=VY\=QRN_WJCDH;=&6OGC9
M#*U[I"UNI&@:1V+#12;]U2T3PCFW3>-7;[)YS,8Q*:N.T;J2PV:"9[O2T])
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MSAKGPTS6\.4.[.T\0IV6K[7:1:)SFULS\6[U&O1W6/\ AC$>'+BGKZ+]('
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M3F$Q$QA)G#<+L. X_;L7QJC]HV:U1&*AI>;F+0?&5+6F>:5K$<EXCL440$!
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+ 0$! 0$! 0$'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tm2227887d4-lc_pt4comp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_pt4comp4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@"#0=L P$1  (1 0,1 ?_$ /(
M 0 " @,! 0$            '" 4& 0($ PD* 0$  P$! 0$!
M 0(#! 4&!P@0   & 0,!! 0##1$*# ("$P ! @,$!081$@<A,2(3"$%1,A1A
M0A5Q@5+2([1U%G87-S@)D6*R,Y.STS245;4VEE=W&%BAL=%RDD,D)E89P8)3
M<Z-TU#5EE<5(HD0EA_#AA/%41F8H.<*#9*5'XF.D)V<1  (! @0#!08#!@0#
M!P0" P ! A$#(3$2!$%1!6%Q@2(3\)&AL<$RT4(&X5)B<B,4\8*2,[(5!Z+"
M0U-S)#328R46XK.3HT3_V@ , P$  A$#$0 _ /W\
M
M
M
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M-3+:KXW0-*TQG%UC-57=5K'MP(=5*4'G'!TRQ2?U)@
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MF=N6I5HT^*>:H;N(+
M
M
M
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MBS&]&EFW-/"V]-/X9OZ2I4_1(8@
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MYZ*/!]CEB19BX*Y;E_X<)I\JM9I\J4\1@]5Q;9\V^90\^YML^*IC>0U;<*!
MS#[6TRF_D\B-:F3<1XII,B+?Z-?A&=N*_MWC5N[>PK7\W+A]3.[)J5MM42LV
M\?!\>/T+0^3Q%[%PO-J:3+D7&&4&96</C#))B3.995!*):9#SNU*GS-:ED3I
M]5?.&E7+;V935)N/F5*4HZ+#@Z</Q,I)1OW%%UC58YXM5ECRJ7-&9<
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M2BHYZ57L?$K!MN6-4G@^PLN.<N
M                               5!\P/G-X4\M6589A_)4VV;N<V:]XK
MDUD1,EN-'\=,8GI:C=:\-!K/0C+4]"5ZA6'FEI699JD=7 M<Q(8F,,R([J7X
M[Z4NQWFU;DJ0HM4J)7J,A:E,"J9!4GS%\?Q/,!7>6MY%H?(UE1+R.*Z43_Z,
M*$VE:C)4DW=WB;4'J6S0A6V]>JGY<_A^*)DM-*\?VG.(^8C <TYMY#X$IT6R
M<XXP@L6.3+DQ4H@J9D^$IOW=\G36LR\9.I&@3!ZHN2R3IX^R$EI=&6$$D
M    !%0!(      BH D'"NPP!76;YC^.Z[S"T_EK?:MCY&NJ5>00WD12.M*(
ME+BC)<DW-Q+T:/4MFA"MOSU2X9DS6A)OCD6+%B    BCF+E;&>$..,GY2S-$
MY>,8>PV_:%6,ID2MCSS;"?#;4XVE1[G$]#4*3FHTKQ="\(.;HN5?<9W LRJ>
M1<*Q3.Z%$A-'E]9&M:DI39-2? E-I<1XC9:D2M#[Q$-90<&T\T9*2DJHWH5+
M  1'S/RYBW!?'.2<I9HB>O&<5:9<M$5K*9$DTO/(83X32W&TJ[SA=JA64E&E
M>+H7C!RRY&UX9E-;F^*8SF5*4CY)RNJAW%64ELFGO F-I?:)Q)&9)5L66XB&
MDX.+:? SC+4JHW$5)
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M>,)M>4V,WQ[EBWM8-_$D8_#KW&FX,1+Z#:=C*-6Y2EEJ?P"!F7P$D
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M/[2"OY(5?[( P.?O<<\?VD%_R/J_V00!][CGC^T@O^1]7^R !][CGC^T@O\
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M<BY;SEP_R=Y>*.PY8CYM2<JYH6/W\!_'X4%3<4F#=-33L=6Y*E*+0 7U @
M                                              .BE)0G<H]I>D5;
M2562?@O4\8N>?;DKSQ<INM>^8]643G'/"LE:3,BF5ZTR&WF#5T+>N,1J,O\
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MT34'(
M    *(^97\9[R2?=)D7\'H DO<!         4YY,IH"\CY CR^&WK3(<M@-1
M<*SN!%78*<DE'\)"I#QZE!5'<,B)1&6I$,HQDXZ8^66JOA58U[5FC=N*E&4O
M-&E&LZ9X4[>9YN4?+;6<B\?XS.S[,<P@Y-@6(O191X]=.U\:7(;CDMQ<E*",
MGC-3>FXSZD8Z;\HRFW')O Y+*E&"4LS[^0;KY2^'_P ["G:?.L)1#,T+D
M        #$RFK%<R$N+);:B-J5[TRI/>5Z]H RP
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MY?81[3(VF"3:3XZ=K3CFO0R+3U"+:DDJYDWY0E-N"HC<!<R
M         HAY2?PP^=C^E,_K4"2]X$       ?-?L*TT[!263)11?[5G9K]%
MC6,<2O<;\@566-6MQE$2,I4$Z]N4MU]16RBU>\=L^K1GIJ>F@TV]%.$ORQ3U
M++@Z+^+'B-RJJXLW+[7XK'LIR,+YG_*_A5]2\K<N3,PSN+>E3/6":*'?NLU!
MNPHY$V@X1$:-BMGU1.O>ZBH+PXHLUXQCJU;=ZZN(ON=GZ0D20;*
M  -/APLH;R>SES+)A[&GV&RKH!-Z.H=3VJ4?J%?-7L-I.&BB6)N L8@
M                42\VOX8/)+_2B?UH!)>T"
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MM2=Q*T,AK!J55DRDJI5X'[ "E <B0
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MF9;2'F_$271*MJ^\1"[6EXE4ZHV@
M                      %$?,K^,]Y)/NDR+^#T 27N @          U3-?
MXG9=]A9WUNH">)6/R!?BD\0?]4G_ ,(2@(+C@          #&6%A K&/>K&6
MS!CI4E)OO*)*34KHDMRA#:1:,7+!(Q55E-7=6%G6P'DO.UAEXZT*2HCW"(R3
MR)E;E'-&T"Q0                    I[Y^?Q2.9?L;#_A&* +*8+_$O$?L
M'7_6R0)-N @          KO=_C0X#_1_>?7\(03P+$"2            ->L,
MA@0?!(E>]&X]X"TM*)6U7YX ;"                       HCY2?PP>=?^
ME,_K4"2]P$          $*^8K\!?+/W,V'ZR )%Q'^*>-?8B%^LI!!YFR@
M        #P2IT6(DO>'DMF:5*2A2N\K;Z@)/'27+%Y$.9&2I""<4WHK\Z :H
M9L"                    "B7FT_"_Y)?Z4E?6@,E%[0(
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M;=?44RUJ/5V/'0H]5$1F:="3H?7J>AE:+2K3-\2KJS]#D]A"* ["0
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M7H>I0&2U,=%W[WWG+;^U$L"A<
M                  *(^97\9[R2?=)D7\'H DO<!          !JF:_Q.R[
M["SOK=0$\2L7D%/3RC\0GZH<_P#A"4!!;2MLF;-E;[*'$)2XIO1Q.T]4@#*
M         UO(L9I\I@?)UU%.7$\5#R6B4I.BT>R>J1623P9K:NRMNL68_&\*
MI\9E6<NM92T[9J3N-)::-I]E(1@HY"=Z4U1LW06,@             A'DSEU
MCCVRIZ[Y$?M/?U$J7(29H0T@U:)2E6U6Y:O5ZAA=O:&L#NV>R>X4FGD2?1W<
M:]B>\QT*:4G0G6E^TG<6Y(WJ<5*,SX$  4]\_/XI',OV-A_PC% %E,(_B7A_
MV#KOK9L"3;@(          *[W?XT. _T?7GU_"$$\"<W;-EJPCUJD.>-)0:D
M+)/=[OYX2094           :A(Q. N1'>8,XY-O&\^T7>)P^WXP V\
M        &K9;D36*8Y;9 ]&=GHK&%O%"9+5QPR[$$0I.6F+?(ULV]<U&M*L@
M'C?S.8QG%K5T$Z%\AW-JZJ/&B^*;I&^?LIUVIZ*]'PCGM;J,W3)GJ;SH]RPG
M+-)5+3CK/&   "B'E)_##YV/Z4S^M0)+W@0          0KYBOP%\L_<S8?K
M( WC'Y;<#"J&6ZA2T,4T-2T(+<K])2 9L\9]$J.S(0E2$/)2I"5%HKJ /6
M       ##6E+"MDI]Z;U=0E26G?2G<(9*/G14S-%7MP6%;B0I2UKTTW*4"5!
M*3D9T20             $>SLV*+.>89A^\L1SV.NDK:O<7:>WU 6H;?6V,6U
MA,V$-?B1Y"=R5?W#(_\ % 25#)@5  HEYM/PO^27^E)7UH#)1>T"
M                                       ,376!S7+%OPO"]PDJC>UN
MW;4I5N_^(&J RP              .#[#U$/ %=,V\MG'^?<T\:<[W<JX;S?B
MF.[$Q=B))0W 6V]XF[WEDVEJ6?U4^Q21%O\ IRE)9R5&2\4D^!8P6(
M
M                 "NOFX_%EYS^XVT_63 &S>7O\!/#/W%4?UBP())D$D
M8:;8U]<494^P9@%*?1%B>,ZAKQ7W3T0TCQ#[RE?%2&>!)ES^#M%6011@7%6-
M\=WG(U_C[LUR;RCD!Y)DB);Q.H1,4RAG2.DFVS;;VM%T/=U$Q=(J/!5:\0UY
MF^+I\"60J#KN+U@#L)!QN+U@#D14'S69EM^$PJA0I98>2+B6PLK-'VP9[$P&
M]M56]_PM%R.2QB$R4X^4EPW*Y!:[7'2)Q2$.$C4O9(CZ1'RI4X?#_ LY-MOB
MRXT2,U#9:BQVD,QHR$ML,MEM2A*4[4I2E/LD1=A"U6W5YE:<C(@
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M];) DVX"          "NMU^-#@']'][]?0A!/ L1M3NW?&$D'8
M         &MN7CB;AJI;KW5DH]'9'Q4I^B^8 -D      'EDQVY4=V.\DE-O
M)-*TGZC$$GY-<ZX)8XEGMU=XE7NT2Z5QF9%D$6C<HC/>I]K3V"0?M$/(W5JD
MM44?;=)W<;EA6KCU)X=Q^B?#G(#')F!TN2ZH3/4W[K<M(,B\*8T1>-V>A7M%
M\!CTK%WU(5/E>H;1[6\X<,UW$N#8X@ *(>4G\,/G8_I3/ZU DO>!
M  !"OF*_ 7RS]S-A^L@"0\2+=B6.)5V?)$+]92 -G
M!A+JR5507)2(ZY:TZDAM/T1_1? ()2Q53XX]9RK:I@SYU>Y62I*-[\-P]QH4
M2MI?.5VD"=2TXJ+HC81)0     A'E&MCUD5>5-O.PU1]??'&2-1Z;?:V]BB&
M=SRK5R.G;UG)0I6IB>(;N"TU[C'?D2(EXLYD)YW=T?-/U1.T_9W;==.S45M/
MXFN[B]5'FL"P@V.$ "B7FT_#!Y)?Z4E?6@,E%[0(
M                           UG'_VSD/V4=_0(%I< ;,*@
M
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M>Y/H4:5ZGH+RAH;7(SC)254;0()
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ME<(_B7A_V#KOK9L"3;@(          *[77XT& ?T?7GU_"$,G@6)$D
M              '&GITZ@#D       !!/,](3V,7EL<5$])5ZXKS;J=Q()9:
M;C_.=>HRO4T,Z]DVKL<:8E=?*#D4&IN<LX[0XVDU:V,9"%IVH=95X3R3]:E$
M9'J7J''LIT;@>[^H++E&%[P_ _0 >B?+@ 41\I/X8/.Q_2F?UJ!)>X"
M     "%?,5^ OEG[F;#]9 $BXC_%/&OL1"_64@@\S90
M  <&1*+0P!R        T?/L9DYABEMCT6R74/3V]K<ULB/:I)[M#+Z%788I<
MCKBT;[>[&U<4FJI<"NLVJRC&[S$F&+%WW&E<9*XCI0EM3YM[>JE%T[Q?F#&4
M9+2JY'9"[:G&XYKS/(MRP^W(9:?:4E2'4I4A2?H5#I/,/2 *)>;3\+_DE_I2
M5]: R47M @                                              #6L?
M_;.1?91S] @6? DV45(
M  #1<^S6@XXP[)<YRB4<6@Q> [863R2W*V-D1DA">Q2UJ,DI(_29"T(.Y)16
M;*SFK<7)Y(_GIY>\^'/O)%[,DT.73^-<<4X?R+CN//%&>9:(^X<F8E/BNN&G
MV^J4$?870?7;;HUF$?.JL^5O=6O3E6+HOF2#Y=_R@O)^!Y/6U?*U_*Y X_G/
MML6TNP-*[6N2X:4G+8E$25.I09ZK;<U[NNTR,8[[H\'%RM8-<#79]6G&25UU
M3>?(_?R'+BS8T:=#?;DQ);27XLAL]R7&EIU2HC]1EU'RM.9]/4R8
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MAI2TQVTM$LVVT(0@SVZZ)21>H2WJ;918(V@
M                               41\ROXSWDD^Z3(OX/0!)>X"
M    #5,U_B=EWV%G?6Z@)XE9/('^*5Q!_P!4G_PA) @N,
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M$0\S:-QNT/L.MQC/:.G!U/UO'LGP@ %$?*3^&#SK_P!*9_6H$E[@(
M   (5\Q7X"^6?N9L/UD 2+B/\4\:^Q$+]92"#S-E
M           $ YO[H5Y/5.>\!I!;R-2]J=I((E*49]-$BLJ+,VMUR1*N)3$3
M<>JWFUI6CPMB#1U(R;[O0R$X<"DDTZ,VD24*)>;7\,'DE_I1/ZT DO:!
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M2OA(TZ#\]NM.;:YGWEI4@D^1*@S-
M                  "NOFX_%EYS^XVT_63 &S>7O\!'#?W&47UBP!),@$
M       $5!JUYCF.Y(Q%8R/'ZV^CP)+<Z#&LHK4I#,ID_J3S:74+VK3Z%)ZD
M!)Z[6FJ;Z%(J[JLBW-5*+2763F$2([J25O[S+J%H7U!XA&8:0EI)(3T271*
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M+6I730 :9]N\7WWPO=E>Y;MOO6O>_P ;;]" -SCR&);27V'$O-+]A:0!Z0
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MMF:CVH4G\]ZU:CH@DE1'FWI2E-N69)PN9%$O-K^&#R2_THG]: 27M @
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MAC+>=7N7UI2HC7:=*A8>IO4S]*?3\X>2D>J<@
M                           "NOFX_%EYS^XVT_63 &S>7S\!/#?W&47U
MBP())D$D  8*PR"CJI$6):7$.!*F'MBQWWD-J6K\Z2C(S%XVIR54FT8W-Q:M
MM*<DF^;H9LCW=2[!0V.P A7E#FO!>(5T$?+7;1R=DSKS-'6T];*LY3QL(\1P
MR:B-N&24ITUU(44DYZ5FEJ\,OJ6<6HZG@JT\36X/F8XAFXX_E+E\_51X=I"I
MYE;:PY$"QC2K%WPHJ'X<A"'4$ZH]4KTT].O0QI"W*3BE^9M+O6+]PIC)<4JO
MN^I-]C:UM17RK6SFLP:V TI^;.>6E#;;22WJ6I1]-"&<YJ";8C!R:2S,-A&;
M8UR'C-7F&'V2+?'+E'B5EJVE24/(2:D*6@E$E7:DR&LX.#H^5?>43JVN3:]Q
MO J2                                              !\UJVI6OZ$
MNP@!^>W-G-G)V#YY#>@WU-#HY6GR'ARW"3/G(1^G&M'MJ-)^G7YA&/HNE[39
M[FUHDGK?'@C\[_5/4.N].O\ ]QMXPEMXI>7'7+][W>R983$N7G,ZQ2OR&L:.
MLCS&U(D^.1$XEU!Z.'KV::]ACQ]YLY;6Z[;=:?$^MZ+UBUU79QW5M:8R5:/A
MP:)GH;ANVB),U'[PR24R$F7QM/:+X%#E/7-B      %$?,K^,]Y)/NDR+^#T
M 27N @@_FSEJ%PYAQY*]23,IN+.QC4N)XM T2_9VDY1HCQT+46U!*,CU4>NA
M%ZQGB[D81592R^;;[C6$$XRE)TC%5?<1;@WF6LIU[9<?<M\;3>)>3VJN1;X[
M02I;4Z!=1HS9N*.NGMH2EQQ.WO(TW$+7I1C8N78.KMJLH\>=>V+YE;<&[D(R
MPC.5%+A7D^3Y? E7@GE)SF;BW%^1GJ?Y 7D;<A?R23OC^$;$AUC3?HG=N\/U
M#>_:]*27\*?O2?U,83U.2_=E*/\ I;C4FPCU(C&1<Y %$LEC8_)M_-XYDR(C
MD^/40?D]R<E/B-QRKE&R;/B=4EXNW33XV@Q?_P 6.G[O5=>?WK3_ -GX'2VO
M7CJ^WT_"E'J_:>S-I?F71Q3@GWJJ[#9U*]@B%9P]ECTQN8EQ4-/[7)@]I_4]
MVN_T_.'=N_\ >E3FS@VU?3CW&7\@WXI?$.W_ / 9WYORA*U_NCG-F7*    !
MCIUC#K4-N3'4LI=62$&?T1@#W)4E2247LJ '"T)66BD$M/P@#Z ##05V2??%
MVO@MM(<4<<T'_F_SP ];<V,^P3\9U+Z%)4:"2?M;?4 ,+69&B?+=AR(KD%U*
M/$0ESXR2[0!G6I<:0A+C+Z'&W/TM1*]H ?%ZSKV'? >EM-/?0*,@!A(F2-/V
M=C"=)#+$7534C=T4E/M&(!H^1W";66TJ,IQ,>,DTH7[.Y7T6@ UB0<A:-6G4
MDZG3OO;EIV)]H@+1H8^O:;2Y)F-V+D],]S?',SW(0E/=VM[>G055.9I<=4E2
ME"1*')Y$1Y,>P>4_$7W4N*]IOX?A(6,244+0XA"T*):%=4+3V"0?8 5^YNQ>
M9ED2%$@292)T1MU^!&CD7U5[Z'YJD]!C?MN<<#NV.X5F?F6#-,X8KKNJFU,B
MZ/8Z<4XQ-D_^E*,SW-N(]9?WQ6Q"5*R->H7K<FU!<2V@Z#S"G?GZ_%*YB^Q\
M3^$(H LM@O\ $O$?L'7_ %LD"3;3/0M3] JVDJL@H(]YQ[EN5<9E%X1OK+R_
M4EJ_4V'+<62V[(0<5WP9$PJLD^,<5MPC2;A*]&N@M:Q4'<\FO[:_#5RU<#2[
M;:FX6_-*/W)=U:1_>:69-]'SI R7F6)QG1P6;2BL\)9S.HS2/(WLRFI,CPD-
M-MI3U2:>]NW=O:+0MR?K*2H[<HQ?^95*7-,869IU5S5X:*?CX%C14@ "M'F*
M)ER'Q8W8);<IG,_ID6Z7OTA:#-S:3N[H:#5Z^@G:T_N8ZLM,_P#4EY31_P"Q
M<IGA[JJOP-2H4W\+D/S*,\5L5+EPB#3N4$.8:D59W*HSA&3ZF.J?1OV]>P6M
MI_VRK^_.G=@9W:>K%KC#'OJZ? TOC21S_)\R&/GSW7X;7S$8+;_:ZG$'I3J5
M)]_A&_[Q[UWD^C9I\(S)+\"2    Z*4E"34?LD()/# L8=DAQR&\EU+:S09E
MZ#("#(GU$@\;$>.QXALMH9\59K>V)).Y:NU2M/2!+DWF>68=H4R"4-#1PS4?
MON_VM-?B@0>GWR+[P<3QT>\(1XALZ][;ZP!A+7(2JI#:#A.O1U)2M<I/L%N4
M ,TF;%6M*"DM[UM>*2-W79]$ .[TN-&:\9]]#31]BU*Z #7;?)(\!J([%-N8
M3[NUW17LI[?0%0>7(\@BM0W(<=1KDRVNNWXB5?1 ",MZ]NSQ%&GZ#<>@@'7;
M\( ]\"TG5J]T1Y2$ZZK95["O^* )=J+>/;Q4O-=QTOTZ/KWDJ$@S0 U?+9CD
M#&KB8WN-3$92C)LM5&GXVWYPK)T52\(ZI)<S\\;*LJ<=NJZMDM6#4#/[-$VF
MLF8A*<>/78YN4DR-)(,_^$><XJ+4:9L^FC.4[;DJ5@J4KP/T9H5(53UR4*-1
M-,);):E[U?4RV]Y7K'ITH?+MMO' SH$%$?*3^&#SL?TIG]:@"]JBU+00\B45
MCYJYRO./,@Q/C_CWCV5RCR9E[+\^NQQ$Q%?&CU\,R)Z3)ENI42$[CV)+:>IG
MVD*0<ISE&*JHQK)_)=[-'!1MZY.E7I7;*E?=0CR7YPJV/Q5GF8KPN=3<C<9R
MH,/-^)KEU,:="=FR6V$.>*25$ZPKQ-6W$EH>FG347N:5Z<H.L9S4*_NMYJ7\
M2(L6Y3E*$U22C*2[5%5JNPN953/E"NKIIH\(YL9J1X>NNWQ4$O3YVHTN0].<
MH<FU[CGM3UP4N:3,H*&A\']W@.^'[>Q7AZ?1:=!E=P@Z<B\*:E7F?G#4QZI/
M#W%$^*B,G,E\H-[GTDGWY<E5H\EXC,N^9^'[6OHT';9BE?L4P7INM,OMQKX_
M$KN'Y-QJS;PKSJJ4\#8O,Y*\UQ4?*[./5/';W#?R,\ER=8/S47?N9,%[VK8@
MR:\0CW>'Z.P<Y!=_%=GVKX[X6OA_)439O[=G@I &R     QKMG"9F,U[CR4R
MI"=66_6 ,D /F:$*-*E(+<CV! /C*\;P'O==OO.T_ W^SN$@\,>6Y$KVW[I;
M49\B+QUI/N[@!]9L_P!UANRF653#;2E1,M=5*W #'UE_$G1I+[Q%"5%7L?;=
M/V?H0!G4N(<Z(6A6GJ, 8Y=Q7$3R4RV7'64]]K>GMT[ !A:[*(LFOD39I)CG
M'7M4VGJ9_0[?A $=65@N?/D3$&MM+JOJ:-WLI(0#!)BK*>].5,><2\T3?NJC
M^II,OC%\)B%%K$OK\NFGB>]MQQEQ+K2U-.)]AQ/11"2A(F-Y0MY7N-FXGQ#_
M $B4KN[OSJOA $@"0 !6;-)[<K)K]J'!<MK6H2TZZAU@U)8C)(C4MOUD1*[!
MC.6.1WV;<Z)UHF;WQ?;Q[*.^Y%0J/'>0E3+#A;--BMJMJ1I"6I9'+>MN$FGB
M2\+&11+S:?A?\DO]*2OK0&2B]H$
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M7U#7O?%3[7K]  [FFY-?Z=%\/Q%?YM>[P_"[OQNWQ.OS!)!PA%WJWO?A[?\
M1_$VMK]'Z?M[WQOB^KTB"3Y[+_P]"D0O$V>UX;FWQ/$_QO9\/I\T20?12+K5
M>QZ)IJ_X6YM?89?4->]\4_:]?H DY)%QO3N>B&WXJ-_U->[9X?>^-V[^I? !
M!\D(O=J27(A[MK._1MSVB5]6T[W8I/L@#E2+W:O:_"\38[LU;<TW[_J7QO9)
M';\( [&BYWJVOQ-AK<V=Q>NSP_J?QNTE]OP  EN[W(WOQ#3N8\3:VKV23]6T
M[WQE>S_= '0D7VPM9$+Q/#3N^IN;?$W][XWL^'T^: .ZTWFCFQ^'KH_X>YM?
MI_2->]\7XWK]  [[;GQ-?&B>'XG9X:]WA^%_C=N_K\P =4(O-4;Y$/0RC^+H
MVYZ/T_;WOC?%]7I$$GS-%_L,O>(1.>&K3ZFYM\3?W?C>SL[?A $(\J\VL\<S
M(6+5<0\[Y.R)3WVI<;5#9KG2$&6C;\IS=LC1VSU-UYSII[.IZCJL;65RLGY8
M+-^V;.7<;I6Z17FF\DO;!(U3">$,JO<GK>5.>K6OS//HCJ7,>Q9E#AX_B[:R
MZIKF%JT=E$?;)<(S^AT[1I>W2C'T[2TQXOB^_L[#.UMFY:[K3EP7!=W;PKQ[
M"S26[W:C=(AFYL;WZ(<TW;_JOQO9-'9\(X3M"DWII43<B&:M'MFY#GM;OJ7Q
MNQ*?:^$ ?0T7'B*VO0R;\1?AZMKW;/#[GQNW?U5\ DDX2W=DI&]Z&I.K/B[6
MU^A/U?3O?&/V?[H$'SV9!X>GO$+Q/#_Y-S;XGB?XWL^'T^: /HM-W]4V/0]/
MJ_A[FW/3^D:][XOQO7Z!!)R2+G?J3T3P_$3_ )M>[P_#[WQNW?\ W/A$@Z(1
M>:-DN1#UVL[C2VOVDJ^KZ=[XR?9_N@0<&B^V*)+\,E^&YM^IN;=^_P"I_&]G
MP^WX0!Z6$V).K-]U@V?$<V$A*B5X?=V:]?:]K4 94
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M4][.G8/0W;K*/\L?D5OI*_=IEKD6K'*4
M                    "I'F1X D<I0&,FPCY)I.5L?:5]J^6V+)N^ 2E'XR
M$D6XB6I)Z),R[ICLV>Z]&5)5T\ES.7=[:-Z-.//DGG\".F^$9D+B1G"(^1RF
MK"6XA^VN$;DHES6R)3Z4([4(69=-"^:.]=8<MTK\X)TP22X9? ^5N_HV,>E3
MZ?M[LXZI:JIXR=:M5X)\CZ\(\VS&[V5Q]E,5FCO:=2(,.,\\:W):6M2-"E'K
MJZ1)W:^DAOU;I'IP6YM/5"6+PR/-_2?ZO_N+\NG;N*MW[=(QJZN=,U_-Q[B]
M[+S;[276EDIMU.Y"R'SI^CT/0!    41\ROXSWDD^Z3(OX/0!)>X""&>9>**
MOF+#WL3L;*;03(\R/9XYDU:K296V4,]T>2QOT2I2#UU(_1KV#.DE<C.+I*+P
M^37<S2,THRBU525'[<&:SR+P/2\L\=56$YU=3YV1T;3;U1R5")$*WB6+:-GO
MT<VB,FU++VF_9,NA^@1NK:O2<H^5T:PY/[D^:?(;>;M+2_,L\>QU3[USYFI<
M11FN")W%_ED9<>R-MO&K2W5E[Q(9<6<:6D]BV2,RU7X^NXC] [[EQ[K7<I30
MH*GA3Z%8;7TK/J-U<KC^-9%N1R)%0)!&N2\6<>9A;0[S)L0KKFX@$E$>;*;-
M3FU"MR241'WM#+4MVHK!:):HYDR>J.EY?CF9K,D);PO+4-D24II9Q$DBT(B*
M,O0B(7*K K1Y _Q2N(/^J3_X0DB"Q<<"    UE%=8N-3_E!QBQW.^+7-.)[J
M=/9 ':CDW3J'D6\5+)LGM:>3W=__ !0!L@  #!WLI,2JE.FM#2MFQ!K3N3N5
MZ- !XJRFB&S53"5]5BM=PF5;6U&OXVT :S:1[E]Z5</1FJY$4E-]Y7><;(__
M -8A (SAN9 FZL7Y#["*<MJZEEG<2VU=JB,5BI:F;W/3]-)?=Q,S(=7)?>DO
M:&Z\K>Y\T6,,#YZZ="Z?%4 ,99NV;#<<ZN&U+=6Z27R=7L)+?QC+UF(FY<$:
MVU%UU8&1,B4DTJ(C)2=%(/J6A]I"3.M'@>>-$C0V6XT2.B*PSJ33+9;4IW=Y
M6T$DL$3*3DVV>C5.XTDHMY%N-&O7025H;-1Y(_4$MAU"I,/_ #;6[O(5^=^
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MJZU)N%C(HEYM?PP>27^E$_K0"2]H$
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M7F16CZI4Z2:>J26\L^A)/KH0.50L":! -9Q_]LY#]E'?T"!:7 &S"H
M                               ZF9$6OH^B @J+E',N5<B7\_C;RXMQ
MK6PK73CYIR]-03M!0.=BVXYI+2?,]32-4)^.?;IWPVL;45.]ARCQ?X(XI[F5
MR3A:5><N"_'V[*RAQ3PQC'%4>?+A.2LDS'(%>/F/(-POQ[>T?/JHWGE&9H:(
M_8;0>Q/H(^T8;C=2O=D5DEDOVF]C;1M+FWFWFR;!SFX
M                                         5U\W'XLO.?W&VGZR8 V
M;R^?@(X;^XRB^L6!!),@D@ #QO,,NN,K<:0M31F;1J21FD_6D_0)*M)\#V""
MP &->B177F9#T9I<F/N-A]:$J6WNZ*-"CZIW? (=:AT/C,KXEG#<A6$5J?#D
M(\-^');2ZTXD^I[T+[IB-*XXDIM98'I8CL16D,-,):CMIV--(224)273:22Z
M$0EXYXD)4R.(42+"CICPXS42.T6C<=A*6T)_Q4IZ":DF0 @
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MHI3YM/PP>27^E$_K0"2]H$
M         :SC_P"V<A^RCOZ! M+@#9A4
M       &HY9EN-8-0V63Y=>1<?H*EHW)]K-<V--I+T&HR,S4?824]XSZ$1F+
M0MRFU&*JV5N7(VXUDZ)<2JVSD7S1:>*BVXG\OKZ>C9;XF39>T?K^-7P5EZ/T
MUQ/J+V?0?I[/E*Y[XQ_%G#2YNN<;?NE+\%\2U6+8IC>$T=?C6)TL6@H*AHF:
MZJAMDTTVE)]3Z'WC/M-1]5'U/J//G.4Y.4G5G=;A&W%1BJ)&VBI8
M                                                    KKYN/Q9>
M<_N-M/UDP!LWE[_ 1PW]QE%]8L" 3()   0 "8 D   !UW%ZQ .PD
M             &*FP8MG$DP)\5F=!EM&Q+B/H2XTZVLMII4E6I&1EVD%6G5$
M4K@Q!@PJR)&@5\1F#!BM$S%AQT);9:;26TDI06A$1>HA+=<62E18&5$
M                      #7;ZL190G$[#.0P6^.:3T/>1=A?  J0=1\7T^'
MMVM]4(>9F9=,]YMFYDM3A)<UT2ELE=$]3,_@[.PAU;G>W+\8J25(Y'E=-Z+M
M^GW;MVUJ3N2U2J]6/M[LLD5ZYKPV/CJ)/*6+U3A9Q72(Z3>93O:;T5HJ4IDB
M+59%TW?FCV>C;QW7_:WI?TFJYX]U>1\3^M>CPV49=6VEK_W46L5CADY.*XTX
MEJ."^4('+/']?DD6/.AOQ'G*VS3/:-HURHI))Y;6NI+;,S[JB^9Z!XV]V_\
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M78?I'!4[CL)
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MWXUYZ:^35PK0H]#NR=O[<.YR_-I["WPS)
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M]F9P6YN]2X\*55%EGQYY%R!RFX    !7>[_&AP'[@+SZ^A""2Q D@
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M=(
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M@')<;5 7;LPF/<VVTF@F64PV6$["^9\P:.>I=O/F54:994R):%20
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MBLCR=[;C;N/2ZUQ)V&IQE$O-I^&#R2_TI*^M 9*+V@0
M                             !K./_MG(?LH[^@0+2X V85
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M#7D?@0HR?:6?13SBSU4XM9^TM9[E#S[MV5R6J3JSNM6XVXZ8JB-\%2X
M
M %=?-Q^++SG]QMI^LF -E\OGX"N&?N*H_K%@0"91(       X,R+M '(BH.-
M2UT"J!R)
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M:!8S*)>;7\,'DE_I1/ZT DO:!
M            &LX_^V<A^RCOZ! M+@#9A4                         $
M<\JV=I2<9\BW-&E1W53C-M,J306JBE,0W5L[2]>\B,7M).:3RJ4N-J+:/Y(W
M'7GUD\^:U/O()Q]2U&M6]SZHLS,^TS49F8_0[:2BDN1\%6K;SJSYIU)23TUZ
ME_?T%RI_25^3_N;VZ\KV"JO4N*56R;&MJW73-9JKXTMQ#!ZG[1)+H1^HA\+U
M."CN))'V?3)N6WBV7<' =X
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M(VW6KE!2?*KX(JWYYQ5:)T5?F6,&(
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M1MQC'$DLG$HJXA>(G3OZ,I%@S90(/!&L(<I^3'8>2MV(K:^@OBF />
M     (SO[3,HM=;284=B.<<R*,MPMVTMW57PEM]8JZ\#2VE7'(TF==V%FU'D
M62VGDMMIT<9T)LMWM*Z@F'%:G0E?$5,KI(KC#JWT.;E*4O7VO3MU^*+%&;6!
M /X !"5Y)=7+D(FLQF)?C:+<;/0S+XJ=?2?]T0VBR3>1A")1$9&>O4"ICK=V
M8Q7R'("5'+3M\/:DE:=[O'M/MZ")-I51K947+S9&I6.74E(X[#LH,FF0ZPEQ
MZ<ALB(W%]A)T]H]?2,G<4,'Q.N&UG<\T76CP[C"R;:JJ*2)"R+(%RGKJ3OI'
MG"4E3^\M4I)2?^$4UJ,<6;>E.[<K;C2BQ_$\[%?$OIU'&@8\F332+6,4V4G<
MLFUDO1:24GV2(A2E:47$VBW;JY2\U,B\2$)0E"$)T2GHGY@[3Q#[ 042\VOX
M8/)-_2B?UH!)>T"                         "+LOY9XZP2]I<>S+*8F.
M660M+>J2F[FVG4M*)*OJRB\-)[E%[1D"QP#YF^P9\*RBLS:V8Q/AOIUCRXSA
M.-++UDI!FDP:H%B90                 !K./\ [9R'[*._H$"TN -F%0
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M5;@H145DC>Q4L
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M-%K$J]Q3J45!+F6R'4>0 !1+S:?A?\DO]*2OK0&2B]H$
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M())"-UN'>N.62X+DAMMNK,-.;XOFR:!SG0
M       '7<7K$ [ V )                                  5U\W'XL
MO.?W&VGZR8 V;R]_@(X;^XRB^L6 ))D @
M                /,\\TPVIUU1-H;2:EF?T*0!K\/+*B5O);_NJDG_G>[J
M-B:=;>0EQM27&U]4+3U( ?<                   &$MDV1IC*KY+4=*'25
M+6[_ ,F *O\ (F7\36UBNOS&VJ[BVP:S:6F4X2B.(^^9>$A.WHO0]-WH(>IM
M=OO8*MI/3-/Q/ENJ;_HUZ[IW4H.5B47CG&<OMI\"8<)>;59+42C6F3'U8<3W
MDJ+VM=?4:>P>6ZK!YGU*::JG4EH 41\ROXSWDD^Z3(OX/0!)>X"
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MRAF%%2:E;4)ZF>Y756NHB,=*HB;MQW).4GBS8EI0ONJ3J+&9W
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M:NP]"5K\_0=5BWHC0\KJ.Z>XNN62)V&QP  42\VOX8/)+_2B?UH!)>T"
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M5V""#HF\@J2E:3?VK0TZ7U%WV7E^&GXOT7;ZA(.57D!"5K43^UM+RU_47?\
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M[WJ$ [@#4K_+,9Q=MEW([^#1-REI;C%-?;:4ZMQ1))*$J,U*,S5IT!)@VT
M                 '!F1 #X^,UO\+Q$^)V[->\(6(R*]^;?\67G+[C+3]9,
M2#9_+Y^ CAS[C*+ZQ8 DF0"
M/'*EQH2$.2G4LI4HD(6KZ)0 ]>XO6% =4*2KJD]0!J]GD\")'>5'44N0AQ37
M@E]'^>_.@"-;"UF6;_O#Z]JO#\+PT&K;M]/^4(),8)(-CI,A=ITO-$S[PPX>
MXD:Z;5?G1!)(%-?QK=&T]K$M/M1S5\7UD)(-E                  :[D91
MW*F6B2[X22+NJ_/_ !1#R"*FQ>-VW,HS"[R),&ZHLG7%=@U2XJ$J:D1M-'%.
M$7>46A%U[>T>M/J,O2MPA535<:\#Y:Q^FH2WE^]?TSLW'%J&E>6<>+EFW@NX
MLAA=4Y';.P-:4L/MDW'927:A/3YVFFA$/*S/J,B1 )*(^97\9[R2?=)D7\'H
M DO<!          !JF:_Q.R[["SOK=0$\2L?D"_%)X@_ZI/_ (0E 07'
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M]'UY]?PA!/ L0)(     ,390Y,M#*8TU<)33J7%J07M)3\4 98
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M.2FG4&4B5M5H:B62MA%IM(NP=VRLO&<LSP_U#U*,H1L6J:<WQ/TF'I'R(
M41\I/X8/.Q_2F?UJ +W           "%?,5^ OEG[F;#]9 $BXC_ !3QK[$0
MOUE((/,V4    'S46Y!DD]OYX 8ZMAR8D?P94Q<UPUJ5XR_H5?% &5
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MZ3/4QR7)RG)R>;.NW;C;BHK)&XBI8
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MD^=1OE*VM9BY.UIQWQ2990>B$(+4B+0NPAK!YE9<#]1!D6
M    #HHR+M[ H^!#/SBDU;"\"N>:-[Y<E0N0UI;OBD.DZ3#<U$<H*4[MI,^&
M9ELT_N!MI)?VJ>.M*O;746W/_P#TI8::T[*::?,S'G5Y2Y&J./.5L%J.#+S*
M,.M<+E?*7*,:;':A0/'9<)WQ([B3=5X*2U/0^HCL(1:+R^]."^&R(]2+#*/0
M_7_H+ D$S     Q-E9MUK;3CC+KQ.NI:^I)W:;@!E2/4@!R
M          \DB4Q%1XDAQ++>XD[U'IU, >L    &C9+(JYS9PWK+W1R&\7BH
M2G=U, 1\Y+EM.DA$]QQ,=2DL/)6K;M_.B ?6%9S*]27H<AUMSKXZ5*W-J]7=
M 'A=><>6MQQ6Y3JU.+_QE"0?(    '9)J0>J%&E7K3T$ ST#([* A+:7/%:\
M7Q'?$[RC+TI^  ;W1Y(5N_*96R4?PBWLGNU[OY[X1(-L(]W4NP <@
M     (SS$G'K"+%8\1Q9LF?NZ%=-3/0E:>O0,,!QQ]F:AC7%D3!J&]1'OI\X
M[JR5;.?*[N],92RT-IOZ$O68Z]UNWN'&J4=*I@>/TCH\>FJXHW)3]2>JLG73
M7A'L)7QEN0U41FY"4%L-1-&A6XE-_%,S^$<A[#H;( *'>9;\9WR3?='D7U@@
M"2^($          &J9K_ !.R[["SOK=0$\2L?D#_ !2N(/\ JD_^$)( N.!
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MXC]@Z_ZV2))-N @          KM=_C18#_1_>_7T(0R2Q(D@
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M1UPAI5&>1N;T;DVXJBX+D20-#G   "B7FU_#!Y)?Z43^M )+V@0   %?^?\
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M!(              !K./_MG(?LH[^@0+2X V85
M&L9)D=/B&/7649!-164=!#>L+2P<,MC3#*#6M:B])Z%T+TGV"]N#N248XME)
MW%"+E)T2*Z^7;'KC(9&1^83-X;D++>64MEC54^7U2FQ5@S.MAD1Z;5O$92'C
M]*E%KU(=>]N1BHV8?;'-\Y<?=DCDVD7)RO26,LERCP_%EL1PG<
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MO#=-:&%)W>*I/^  9>@M/E6 A\V_#<;T;<1\7<GZ$ 9E2T)4A!K(E+_2R]8
MU*TOK"NL%Q"@I=:<:W0^]M4I1 #2ILY$J8_.6PEU;O=7"<3^E[2]K5/:(!@U
M&DU*-"/#2?LHW;M !\Q(.>T <   .WP_W! ..WL$@Y[?@T$ ^S,F0PEXF75-
MI?1X;VWXR0!O6,Y$E"8M3))6\S-$>1Z"^A28DFA(25I6C<A>]/T20(/H
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M<)M"&T$AMLD(;(DI21:$1%V$1>H>>ST$C[B"0
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M0('8E$?8(J#4\U_B=EVG[RSOK=8D<2LOD"_%)X@_ZI/_ (0E "XX
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MXXAYA]M<:PJ9+::28^MW(&W$]5MZ=W0]OY@I;C*M32_.UHTM/4LF6Q'4>6
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M5R,<VD:1MREDFSWH<0XA+B%)<0LM4+(]2,63311JF9]M>N@D@Y
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MFR]JOP.Z3/<IIC$TF%+G0S;\7P%'M)6AZ;O4*EN!< "
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MU22OATU'3Z4>1YCW5VE-3-Q:0AI"&VD$VVV6TD$6A$7P$+TH85J>@20
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MI_<WN-1]>SH//EU&;>%#ZZS^CMFHTG*39AS_ "B_F5-*DZ8IJHN[K6+,B/\
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M05G)R?P78$J$F""0              #6<?\ VSD/V4=_0(%I< ;,*@
M            .%=A@"F6-F7/G.LG-W4^\\5<#S'ZC!4%U8MLL-)(L+(O0M$)
M)^ T?T9J4GTCT;G_ +:SH_-/%]D>"\3S[?\ [B]K_+#!=LN+\,O?@7.'G'H
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M%@023()(       Q=G61;1E#$HU$VA:7.ZK;U2(!D$$E""2GV4=!(/H
M .-="Z@#0[6.[!B*KF[%]Z1;R3\-2BW;2/XNOQ1%:DT-'>AS&S7XT%:41#2V
M^A.[3_[% 0?%Y+RGG3<;=;?2E/U%23[J"( >3V@!U$@[:>KM$ X[>O\ < '
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M# \4>KZ6WN(3,EYE,:*>JFE.(-2-RT$K0NP;7I^I-RYNIS6H:(J)HGD%/_\
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M%CSL2Y*AR+)PV*YI_&'VG'W=#^I,$:TJ6KX"ZB6#(_[P/B'_ &!Y4_DE,^F
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M2)D:)BG)4N37K)NRBL8O(6Y'6>JDI>2E9J0:BT,DGH(),E_O!.(>G^H/*?\
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M?XI2^W_*"H.?]X)Q#_L#RI_)*9],))'^\$XB_P!@>5/Y)3/IQ!!S_O!.(?\
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ML>*DG326FJB[I]HVM1<H:I<4GAVY5\";R4)Z5W>*S2[F7&&:S*G(L
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MY8U+28BC2ZBDA*&T-MK(D$6U*4DG0DI3Z!QG32A,@ H=YEOQG?)-]T>1?6"
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MD516WU-,1.J;>.B57S4%T<966XC(OGB\X.$J/,I&2DJHSP@D
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MH,B-[[#O;>J<APGVS-.WP7EJ,CW$K4BTZEU&C@TG7!K@\RK:KACVK(EP5
M <&>@ I$U;<;0?,[8\K+OL@]YG4C/&KLCY,,\>1.1+][2GY0)6OC*<[NS3;\
M(6OZE*<<OXN[F3-:&T^&?\/>7=(]1!!R)    >";,8@194V4OPX\1I3SZ_H4
M-EN4?Y@I.2BJO(M&+DZ(J1Y9(5!CCF?1\=A9K,@<EY3:9TW>W]+\GP$G9FCZ
MA'>)9DOH@C29Z&HAMI=&WA3@\RK\KI6I<0C29:EV"@.P  #@ST+4P!!/+=QA
M>1P)?"-MD2ZR]Y:JK&CKRAMD_(80]%<)QU2?91M0HS(EF6O8%M.XVH\%7P)D
MM*J^XTG!N1>/>(Z+%.(#GW=O P!BOQ"1GJZY1U2)C+266FI$E'<;<4>A&DM=
M#Z:B+;]6E..7;3.G/B3-:*]BJ^Q/F6K(]0*G82     #\W//IDTK'5\9G%I*
M&X]\59;_ ):KFK'P_#2R6C7BF6S77J1#S>H3<=-*>*/K_P!+;=7?4JVLLG3G
MF?EU=S';VR?M'X%=7.ODE*HE7&1#B)V%IJAAONEKZ1Y,G5UP]Q]Q9MJU'2FW
MWU9BCAD9&G334M-2[14UJ2S1\B6;,V@B%AV$K0W,A,^.YC\9;QI)UM&]3A]=
MWY[UC>%Z55@CS+NQAID]4\G^; _H-F(>=@OML(2Z\ZRI+*7=?#,U)Z$O3KM]
M8]^XFXM)8T9^4PHI)]I0>IPF]R"\XUQ:IX15Q'DW'65(N<PS*MAMQZ.7":2^
M3C4"P2XIZ5X_BI,VW"Z:GZAMMZ*<;E6HQ@XN+XMI+3W)\2+[\MR&;D_++EYJ
MU?)M<#]#$EH74414[B0        %$^<\2P_E#S$\2<=9M#;;JF\?L;7WE+JF
M7Y[B7-B("5[C)*"-!K41=X_7V";.<WR2^9,_MBNWZ?4V^Q\F/EW.#,(\455E
MX+FMBBPDI-C0OTU*G'5)[O;WBT]82FR$B%_+1Y?N%L]P&+D]SB2)]U17\ZN8
MO6I4AIN:5?(^H2R:)W;WRTUT+3H8UE-K3)9M)F>A5::R9^DHQ-    \3TN+&
M-M#\EIE3G1I#BTIW?XNH!GM   ?#Q4>)LWI\3;N\/XVT =77FF&U.O.)9;1[
M3BU;4E\\P :>:D-H=9=2ZVKV%H5N2?SR D]($&LX_P#MG(?LH[^@0+2X V85
M                $-@IQSC*D<P9YC_EKI'7$T4AMG).<;!E6TV*)EPE1JLS
M+L<L'D$1]-?")1^R8]+:Q]&#OONCW\_ \[=/UYJPN^7=R?\ ,6SB1(U?&BPH
M<=,:+$;2S$BM)T0VVDMJ$H2GH1)26A#SFVW5GHI4P1E
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M2SSQS-FQ)DEW+#IN-I\-"]$*/O*]'= @F 2"B/F5_&>\DGW29%_!Z )+W 0
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M[I#-Q2^\9;=229]33H.F;;C!RIKHM5.?XTS[3.2CZD]'V5\ON5?^U6A.XS
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MQWR9&<DX-ET#(4Q_VU'C+T?:/UN,+VN)^>0B@)*
M &P0URQS5Q]PK3P+C/+9Z-\KR2A4E3"C.S)\V3H2C;CQ64FXX9%H9F1:%Z1F
M[JU:<W2O@N/<7C;>ERX+CWY(R/&7*N$<OXTWE6"VQV=8IY<20V\VN/)BR6BT
M6Q)8=22VG$[O9,NSX!M.W**3X/%/F91DFVN*S[#IC_'[E)R7GO(!V926LSAU
MD5%839D<<Z]+B34:]W7=O[/0(M/1:=OG-R]]%]"LH:KOJ?PJ/N;?U)7$&@
M 5U\W'XLO.?W&VGZR8 V;R^?@)X:^XNB^L6!!),@D@
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M#]'='&F>MGD2T)!1'S*_C/>23[I,B_@] $E[@(                  #S>
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M1LXD@     ^2D)6DTJ22B/MU% ?)QAAXD$ZTAW9U02DDK06IQ"/21:"0<@
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MO0--G#UH79RP2C%QYM-T;?+C0MN8^DH)?<Y8]BI@N_F7)(]14H=@
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M+W&3^0XNSPO&E:>$37Z>O=M)SQ?HO:W>GU=!4V/HNEC*\35Z5]5]XW;7U_\
MS/M:=[XOQ?5Z!) *H8)>_P :3N)Q+OZ<O3<EKPNS7LV_W>H@'5-+%0ELB>E?
M4DLI+=(<_P PK<G7O?&^-Z_2)!U.DCFA39OR]JFW&_T]>NUQSQ#^-[6[L/T%
MT$$GK9@MM.J>2XZI3CBW%$IQ2DZKV_%/T=WH ,H)(  _(#S@\V6N:YM;\6TD
MYV#@^(.E&R)J.M39V=D1$IQMXT]K3'1.WL4K4S["%XHAE.FT(92E#2$MMI+:
MA"4DE.GS"%R#WTUM<XQ=0<HQ2S=H,EJG"<K[:,K8HC^@=(NBVU>RI*NAD(:J
M2C]R>!>4V>8.-*#,O=T0K-TG(610$&9I9GQ5$A]"2]78I/P&0R:H2:#YB^7\
MYXPF<;U&"5E/9VN=VKE6VBW\4F4K[A,D2FUH)/>5U,Q:,:YAFA7O./F XD55
MWW,W'V-NX-/FM09]KC4IU3\)3BC2E:T/*/<70]"TZ^L6TIY$5H3'D_F!Q#&,
M^P;!'%(E_;JTM\[Q,R.VQ 0E&]'O1.*)1;TF1EJ9"NATJ37$GCWAE3'O*'$K
M84GQ$.([R5)TW;D[>WH*@I-]_+G_ #%O)LKXUXOJ$\?XQ)DLZY"\_&L;%,0M
M[RX[?<(B474NGSS,7HB,2Q?#W)5=R[@-+G,"(Y7%/WLSZY:MQQY+*B0ZC=TW
M$2DZD?J%6J,FN!+0@        !PKL %#?,U>6F"\T^7[DE/'64<BT.*,Y"U9
MQ<6@E82HS\V,EIASPC4@B[Q=N[7H*[:[Z=ZZFONMQ2\)-RQ[FC2]%2L0[)U?
M^FB?O(.XC\P]K@V?\U7\ORV\PE5<F9-&MJ.-%QU)^&CP29=5(03Z20LU]5=N
MOK%MMY+$;4J54YNO)2::]Q7=R4[SN++1"/C!.OOJ?JC7S"GP8D[P'8OO;*'C
MCOIV.M>(G=L6GT*+L,A:4=,FN1G"6J*=,S)BI8   *Z>;?\ %DYR^XVT_63
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M^I&,4J4,;=G1*4JYEJ1S)FQ1'S*_C/>23[I,B_@] DDO<!
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MRD]$D1?#Z1MLG_O=EN'CYG4UW-/[>#_^[_W67T29'U(9(R.PD
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M7 RH@L   %=?-Q^++SG]QMI^LF -E\OGX">&?N+H_K%@ 3*
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M6[E;<XTHIQ<7S6.9/"2[J2/U=16I4[@2
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M9$6U)JVD+.;<(0_<CI7<B]UZ[D[CSDZ_!+Z$P"I4
M                #1\ZPN@Y"Q6YP[)XAS:.[9)J;';4:72-)DM*VUEJ:5)4
M1*2>G:1"LHUHTZ-.J?:C2%QP=5RI[U0@U'E[NKF370^2.6;KD3"Z&;$GT.'S
M(,2&2)$%:51E3)<9/BRR3IU)P^\9ZGU&EN[2?J-5FFVGE1OBE\C*<5H=N.$6
MJ-5K5<J_,R<KRZ8W/MN<[.=;V+R.=(L.+=1")MM,+W-A3#:XBTD9[BW;B,R[
M2&,8Z;*M)Y3=Q/BG)U9JY)WE=:6$%"G!I5S]YXLN\MU;D]=Q;#B9C;4,SBEJ
M4W26["&'GGW9</W-3[WB%U61=_7TJ[?6+S_J7)7&L90<&NQE=N_1M^FLM2EX
MIU^9+N(X!087@51QU7QO&QVJK?DM3#B2/QVUI43RG"3T,W#,S/YHG<O^X<M6
M":IAAA2E/<19;M-2B\4ZU[:UK[R&L,\L])AU_P 47[&5VU@KB"'=5N/1)3;.
MCL6W49DT\M):G[OJ:4F7_&&BO24YS>+G"$'_ )&VGXU)N/7%12HE-S2Y.2HU
M[<2;LYR]W",?>OV\5R#,3CNMM%1XU$*=8*WJ,MQ-&XV6B=.\>HYW*CR)A#5Q
M2[R&8?F0DS942(7E]Y@C*E/H;*5*QQIIAG>9%O<<]]/HG74ST&T(ZI*.5>+^
MIG)T5<R0+GBNOON5L'Y7?M)4>TPJKL*R)5H0V<=]%CX1K4X9EN(T;.FA^D19
MD[3F_P!])/P;+SGKMQAP4M7PI\F3"7I+T:"J*G<2               "@?G9
M:\5?'1D>[:=C^A:'F]0X'U7Z:=/4\"B?NA_0D0\T^I]0>['Z@H1J9ZZZ+I9U
M73_YZ+T]?U9(F/W(B<GI?<S]V=Q)/0?1)X'Y<?/QFS6M!+2:T)U<1KU(@)/L
ME:5=AZB2#L        B#ESE*OXBQ^IR"RK7[&-:7<&E-+#C;7@G-4I*7EFX1
MD2$$G43%:I*/,2=(N7(BGFWC_BCE;D+ ,*S:9D;60SJ^?,QI-._X,(V(IH<=
M6ZK8LB61&6TR"VG5M<%CXL2>"3YF'_J-<2_[0YK_ .<G^Q"=;(H6)X\P"DXS
MQ2%A]!(GRZFO<=<8>LWSD2E*=<4XK5S1)GU/IH(E)R82HB1!!(
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M>@18MU%4BW4I=FB&PFP4O::C>V%XNII[I]>TR"ZXZWIR*6E)02EGQ,^*%P
M KKYN/Q9><_N-M/UDP!LWE\_ 3PS]Q=%]8L""29!)
M          8NT@*L(I1T27(BB6E7BM^UW0!X;2D38E!44E3+T)9*)X^\I2/C
M?F@# OT4.RDR8+$)RL5!ZMS2+NN;O0 ,9+@5T&MD0(R4V-LVX@I&U/>2:E>@
MA -RJ8TZ$EY4V0U[IX:38CMIVI:)*>\)!AEQ)-O829U=+24&1'-@Y"5;OJB?
M6@ 9657V2*5N+%G+5.CI2?CEVN;?B@#'L6\RP@RH;Z4U5DKZ@PMWV5K-/7:
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MW1Y#]8( DO@!
M
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M@8?6VEC=1*Y;JVI]J][Q*6;JS<5O<VI+NF>A")/5B$J$CBI(
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MV@#GQ$::Z]!#!SN+342*G"EI3VF%0<ZI+TA4'8
M                   ! /F:TD9"0<[T;==>@(')*29:EV"*@XWI]8BJ8./$
M0?I$U!SXB>S4*@X)Q)[3(_:$U!]
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M9C4L7V+V\:]II:EIC6<-:5MK4V>U24J+0^AIT/4&G',E-/(VH0
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M2))?#H-)17HV9+.4$WWU9KN(:-Q<@LHM+X)EI1DC,"0
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M62.>U+76:;TRR3_=X>+S+*C U
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M/Q.UG.^),LJB')ENZ:;G'64*4>TNA=3&VZMJ%V<5DFT<>WFY6XMYM&W# V
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M+'>DN;C;92I2]I:JZ #&NWD-FNCV7ANJCR5$E*$H[W>]:0!FTKW))1>D =P
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MS_Z0_3<NC[:MV3E?N>:XVZK4^19(>0CZXHCYE?QGO))]TF1?P>@227N @
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M ?*U7^^47]51],!(^5JS]](GZLCZ<"!\K5?[Y1?U5'TP$CY6J_WRB_JJ/I@
M^5JO]\HOZJCZ8 >IE]E])J8=0\CZ)"B47]P"#T@         XU(1J0.1(
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M;SZ"-9KD.F9EN[I:]!UV+DM7KRKC!QA'FGAJ?\*_+Q*[BFB5O"LI5GV4=?\
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M*I*DZD#!_0)QM>S<EX^PC(+(C397=#7S9J#[?%?CMK<_NK&1<WX"
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M<:X?II#CMQ8[,=LM$M)VH,A\RC]'/6)!1'S*_C/>23[I,B_@] $E[@(
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M-?[()%3G^K%P'_-;2?J;G[((%3C^K'P'_-92_J:_V0!4?U8N _YK*7]37^R
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MK$T%6/ZJO G\WS/[OL?^UA058_JJ\!_S?M?N^Q_[4%!4?U5>!/YOF?W?8_\
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MX<!U%:Q%?<=0RG527TJ^+J(!N4"\FR&:PWJQ>Z<M6]U'LI2GXWSQ(-K
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MW=-'5&B(2\I+)I5V&IOL,R&;M)R4F=,=U*-J5M9,D :',
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M4FOC.2R4S%7X:O'4V;FY&A;3UZ"*%43!@I_ZDX@KM65%7?6K8DEFX 0
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M"UDT7SDZ#"IW$LT^/8_0,%'HJ2#2QT%W6H<5N,D_G(2DP(,^
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MI[RT*-)F25_ 8--9DIU)%QV5$?JX[4:1XRHR$H<]9*^> J;$
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M%KD)7L6E.J4[?H@!\<:L9=G 5(F)2;GBJ2@TEIW0!L@
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M6IGT(>EM]O%1]:]]BR7[SY+LYL\SJO4[L[JV&RIZ[592SC:A^_+^)_DCQ?\
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MM:4H*4)9L8$  :]87]%6/L1+*[@UTN7TC19,AME;GQ>XE2DJ/KZ@H#80
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M8M9X\B/(5)3,T4TOXI-]J1PG6;.!              :[:WJ:J7#9>CJ]W?\
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M^R!!D@         =%)2KHKJ /'%@Q8/BE%82P3RS6[M+VE& />
M    "O?+.1YE3OF[3RW:^O@QEON*C$A;B]/C*2HNS^\,+SDLCOV4+4Y4GFS)
M<*<B2,ZQUQ%LLCNZM9(D*/HMUE7L.FGL+7L/0+%W7'$MU#:?V\\,F3D-SS@
M*-_E#OQ:KG[I,<_A..!)=J)^U8O_ #+?Z$&0>H           5[_ /=7_P#5
M/_ZX!)*CCN6?;:PTU&C?:B<-2GI!G]7*1]"2?FBM77L-4H:'7[C<!8Q
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M0GV24!![          ?!UIMY*FG4I<0M)I<0KU& /G$AQX#"8\9HF64>RE(
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MFKM]28%W$8EPMA^)(UZJ4E7=Z #;$)0VDDH3L2CHE) #Z
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M>C=?G<')/^))/3[GF5O6W%7)1^VW*C7-5TZO ORVHS)1'VI&)0^HD
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MV'[X8S?Q,GQVBR*&DBB7T"-81R/T-R6B<(>[%U29^]V[BG!2635?>;&)+@
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MA)S%OA>H+,/?6S*9*/&VK'=[RBJ-7^C$KQ.]U+7;NZ::#.=*B.1:H5)
M               *Z^;C\67G/[C;3]9, ;-Y>_P$<._<;1?6# @DF020
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M^G,=-WKZI&.WEBT=O4K?E4BV@ZSQP **^2_^,_FY_IFN?UML"67J @
M    B/GG\"W+'W*6_P!9N PLS;L"_B5AWV"KOK5H"6;<!
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M+;:4H0A))0A);4I2GT$!!BYM'2V3S<FQIX=A)8_:TB3&:<6WZ>ZI234D 9T
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MRRTDM"2A):)[?41#YMRJZ\S],C%122R6"[C)B"P   4/\ROXS_DD^Z/(?K!
M$E\ (          ,5;?]UV?_ %21^@4()(;\L7X ^+/L*W^C<$AD\@0
M      !Y94N-";4_*>2RTGM6H ?9"TN(2M![TKZI40 ^@              *
M@>8VBMYLR':G7G)QEJM6Q8S4'HIIS?N22R+0RU-1=?G#CW46\>![G2;D4M-?
M-6J-]\N\M*\ 8KTL^[IKWG$-$>NJT*_SG>[=3]0UVWV(X^J*E^18(;GGE&_R
MAWXM5S]TF.?PG' DNU$_:L3_ )EO]"!!Z@          !7O_ -U?_P!4_P#Z
MX!)80"              \3$V+)6\TP\AUR,K:\A)^RH >T
M&'O(SDVIG16D)<<?:-*6U=B@)3*P8[CY4N<IOI+#=>S'L"9DQ]5$:-2VZDE/
M33<.>-NDJGHW-SJM*&;+;CH/-  HKY+_ .,_FY_IFN?UML"67J @
M  B/GG\"W+'W*6_UFX#"S-NP+^)6'?8*N^M6@)9MP$            >-Z5&B
M^'X[R&?&5L:W*TW* 'L                $&YM&EP[.79NK<9@O[-"))+)1
M;=O=^A,4D;6W7 WCC^8W-Q:O-#BG2C&MA2E^WW%*+O"8.J*W521O0L9E$O-C
M^&[R1_TER?K$@!>T
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M\_ 3PS]Q=%]8L""29!)
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MQ_#=Y(_Z2Y/UB0$E[@(
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MV4J8'M D                     #C7KH(X XW%KM]( ["0
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MEYS^XVT_63 &S>7S\!/#7W%T?UBP )D
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M+QR,;DJO!DMBQF43\V/X;O)%_25)^L@)+V 0
M                      !K./\ [9R'[*._H$"TN -F%0           !U-
M1$6I]@($;<@\I81QC5E:9A=MUQ.%I#@((W9<E7H0RPC5:C,^G9H*3N1CF<6]
MZA9VD=5R7<EC)_RQ6+[B#'L5SWS#LLRLX.;QQQ4ZI+D'!F'/#M[AOVDKLGB_
M2$*+J32>NG:,FIW,\$>8K.ZZBJW6[-K]U/SS7\3_ "K^&./-YHLABN'XWA-0
MQ28K2Q*6KC$DVXD5!(W*+XRU'U4H_2HS,:Q@EDCV-MM;6V@H6HJ,>PVX7.@
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M.)4ALM?H=ZB%+BQ)CD7%%"0                   "NOFX_%EYS^XVT_63
M&S>7S\!/#7W%T7UBP())D$D
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M%ZJHVA*"@TUCS)Z2M+B$K2>]*^J5$-#$HKYL?PW>2/\ I+D_6) 27N @
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M6!F<B0 !BK?_ +KL_P#JDC] H020WY8OP!\6?85O]&X)#)Y @
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MC,TLMI02O7M+03*56V<\(Z4ER1ZQ!<   *]_^ZO_ .J?_P!< DL(!
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MD=S/6<B01'V[%*Z((_SI$-[6VA:R6)P[SJFXW?\ N2PY<"3AT'G
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M7K"6ILYK6]*UMJ1K\9IOQ%)[/BHZB@.$7%8LVR3-:4IQ3*4=?:.0G<U_EEV
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ME#CBU:_%;7X:E?\ %7T 'I:G1'W5,-2$..MK6VM!*ZDI&W<G_B[B$ R(D
M                                     %=?-Q^++SG]QMI^LF -F\OG
MX">&?N+HOK%@023()(                                      #SO.
MH89<==_2VT&I?S" &C2)$VZ1M;7#D193J508C_==\-'MJ 'CNZBPAQT,03>F
M1GC4M_H2E)3]"7QMH TM#:E>-JHFO"29J)7P=B?FF(YA-'QUZ%\_TZ%U_P
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M)   #%6W_==G_P!4D?H%""2&_+%^ +BO["M_HW #)Y$D
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ME[NCBM>W0AZ&\PN2BL(5PIEV4_$\VQ1Q3?W4XYY^V!;(<IN     5[_]U?\
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ML_\ ))_R !V)IM/4D)2H ?4
M    5U\W'XLO.?W&VGZR8 V;R^?@)X:^XNB^L6!!),@D@
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M_6DM37Y7@?8?HN/2KVQ_]C!^G&359KS-YUJ\\RUK9:((AY%#[0^@
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MI"9#9*C.;R6X2/95\X 8[+(U4IMI;VYNP4E28JVTZ[MOQ5 "-3+\WXP@'42
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M5+   !$?//X%N6/N4M_K-P&%F;=@7\2L.^P5=]:M 2S;@(
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M*,M_?5R22R2)U&YP%$_-C^&[R1?TE2?K(0R2]@D@
M                          #6<?Z2<A^RCA__  )%I9(5-F%0      !P
MKL,$#XJ;2M*DJ+4EEM,E",\ >")55T$W%0X$6&MW].7';0WN^;M(5C",<4D6
M<Y2S=3*$1%T(6Q*G82
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M?#@2-:*)=18K3V'#D&G_ "%":4(1#WEB_ 'Q9]A6_P!&X!+)Y @
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MZ+5E:$K5_P#1/=3N_P ^)P!XZZ;D]C"CS6DU334I&]"%>/N(&D@>_P#UM_\
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M\%A-R>MA2)KJ:MQJ*@UK0GQMRB+U"4DP>Q"\K<;0LODKO%N_SXC 'T_UL_\
M"?\ IPP!U_UN_P#"?^G# ';_ %L_\)_Z<, =/];/_"/^F$X=H.W^MO\ X5_T
MXC #_6W_ ,*_Z<, ?2+]L7BM^]_)WN_^<\#Q=_\ Q=W=!T!GQ
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MQUSW-ZW9>W:25:Y8GD+I.VN;Z._3;GH<,'Y:5KD247YI>LO27K'&^?,]@X
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MC>2GJDG.N\D&KH9$O705+LL$!!B4S)1V;D,X2DQ4M)6B=\52OH0!E@
M    !I\VBDOS9D[Y3<[S2BBL;MJ4ZI^-I\4 0M<VS=3 <DRIS3!13T0;RSVG
MWN\E'K-7P"DYJ*-;-IW942;KR)&XLNX^0T#UI"9)->Y)6W$DJ(TK>)'=7N)2
M4Z$1]""$]2J6W%CT9:'F2F+F  %7LO=K<1RC*LCF6=F<6R]W:ELO*-;'B>AM
ME!>A)=>O8,'2#<F=\==^$;<:8&L9GD,RBIU9!3UIVCI0W%QU%T2I2D]W>GU>
MD1>N.,:HMM-NKMSTYNE'0K^XK/LN:QH\GH':RZ\(Y*\CALGJM+QZ,*4VD]-6
MST[.N@Y&YW*:D]7,]N$=OMM6B55Q1@*+-_DZQ<B7:G;V^IYNQ=E):\-MYQ*M
MI^.1][:7HU&<+M).O Z+NT<[>J/EC+@;)?&C),KII<JXCX]6L.E(=>;+Q$&Z
MKODI2/01]FOJ%I>>2KD86OZ%EQ4=3,R<!5^[4L-7;<MZ;8DQ7Q66OJ<AE:BU
M41;>B4_"+:=5,<S-7?23PP2/T>B,^!%C,&1%X+2&U$GL[J=!Z26!\NW5U/8)
M(*-_E#OQ:KG[I,<_A..!)=J)^U8O_,M_H09!U?;-YEQM#BFEK0I*7T^TG=\8
MAG)-II8/F63I0HV_Y3N6WY$EYOSI\IQVWW7'$1TE"-+:5K-6PNYKHGL%HJBH
M\1)UE5*BY&4X'R/DC%.8^0_+[G^=O\HQL:I*_),7S6<RTQ9%'EK\)R)-\'1L
MU)7WD*[3+\P:6I*]9E*E)0GI?)U6I>*(N6G:E%ZJJ:;IQ33H_!EW!4@T3,F\
M\=A12P"521+#QR]]7>-/O,FUMZD@HKC:MV[UF(XDX$"\B0+AZHQ:-S7E+='&
M5D\=ROO<*;D0F&%)9=T.PDRG'%,-F9G]429:'H"4=<>>/=_B*R].2X8=^9\,
M8O\ D\Z#E^%QC(B9^>./Q&N)KG)IKC\2<MQI"Y34BP:/>\AM1KT61GUZ:BT:
MRLQE+"3;7@G@R)T5QJ.*HGXO-&G<.6'.$_S'6SG.=!B^.WC7&R$TD?%I3\ME
MV(=N6\WU2#W)7XG1))] @DO:!!C+.4_#B*>C1%3'4FG:RD >MI2G&FUJ1X:E
M)(S0?Q0!Z          86YKW[.*4=B8J&>XC6I/8I/T( C?(HCU9+9:*6MYM
M3!(0HUJW[4]#W" >;&VW7+F"3;2'MIJ4LE^RE.G57S2]  FL2  -0R\THK"=
M.0XTIEU*FT-_&5Z-P BEQQ;JU.N*4M;BMRUJ]( XV_"(J#J?P"0>"R7/]RD?
M)!-.6*"2;+;QFE)EN[R35Z.Z*NM,#2VHU\^1\YU6S:1T(E&MEQ)H=:4RHTJ:
M=27Q5)]KKZQ#CJ1:W=T/#$DKC!B4U43%RE+<-4E2&WW"[RR;Z;B^ ()HB]1R
MJN)*(N9  45\F'\9_-S_ $S7/ZVV()9>D_@$D%>>8^*N0N2':1S!^=,@X<34
MI>*>U2Q(LI,_Q--IN^/IM-!)Z:>L9*#UN5<*4IV\S34M%*8US*N<B81YCO+O
MB%OR_$\T5SR9&PTV)=QA.45,)J'/AG(0V\TA]HR6VYL69I-)=I:#2-^-N<%)
M54I*+YK4Z)KQ8AMY7ZQC*C2;7+RIO'W'Z%8_;HOJ2DO&V5L-W4&/.:966BD%
M(:0XE)EZT[]!I>AZ=R4.3:]S,+4]<(RYI,V 9LN0JV7/GRJ7CJP J+WOZH:"
MMO?/=M_33KX?BZ=OHU"-/S?#,2KPS[2MT2P8Q:.W?<<<B7V0Y;8YJJ)88%:N
MI:2IJ5/-N7NJB+<GPT]4O:^SU&FW6-N&#BUB^6#?^7$MN*MW)O"2I2F7"*[\
M#Z>9C%/-)*J>4[C%.5L2I^)DX])4]B4VE7(LCC-0U>^M>]]2W.GOV'KTU(9D
M%Q\'-*L+Q VT[&RI8!-H5]![LV)(9N  Q,2;(D2IK#L-<=J.HDL/J]ESY@ R
MP           CVTHYS$6TF*M5NFZ6OA*5L3L2>NG^-Z@!&AON/+5O<6HT(VZ
M*[RD^H]3 L3+B;<AFA@HE(;2\:-5+06FXOBJ5^>,!)HV@"H $&6KJBE2XR9C
MLMEM]:O$</XWI$ UR;-17--+4R\^@UDA?@I-2T)/IO,B[2$-T-(0U-]A@VV/
MEFZ7)E1Y,9JI[C#+FA,NDHNTT^D_@%*:F;REZ%ND<6SM9JB3W_D13KL)\GD*
M;<9[R-$%JDM2Z)/X!$G54%O5!*5*IK$T_(T).4B4[9E(D1HJV74JZ(423[R>
M[TWFD9W,T=FV=533FSXXA!/*LIQ=46Y]ZAP9:'E5&\]C?NY[MRC3ZT^@Q2'G
M>9M=_HQDM.+XEY2+0=IX1R *(^;#\-WDC_I*D_6)""2]PD@
M                                             (KS7E[C+C^8Q4YI
MF-?CT^;&*1&C2E+(ULZ[26G:A70SZ"4F*FI4?F$X%5\GTE7R=3NN+,H\!MQ\
MT$:C]E.]Q"4D?S3$N+Y"I/R5)4G<GO)4*@[@          #YK6AM"E*5L2CJ
MI1@"(RYDXCLX>2H9Y#HWH] PXK(5MS&S.,R9>&HS,U=2-1Z:EKUZ=HG2ZY R
MO'G(N <AU)R^/\EBY+75AIAO.QS7XC*DI[J74.)2LB,NPS+KZ!#3!)8
M       #'RYD:"P[*FR&HL5M.KK[RDMH27YY2NA #2L@S;!8]';R+')ZTZ^-
M$>?L"8F-*<\)I.]9-I2K<I6B>A%VB4F#*8IEN.9C3P;;&[-BR@S8C$J.A"TF
MZEIYO<V3K?:A6GH,12@-Q
M              5U\W'XLO.?W&VGZR8 V;R]_@)X=^XVB^L&!!),@D@
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M$JNM%DCV=AM/[3;V[.J4],4M4L9/M;XD[,[B9;\3],VIW_-&1UGW
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M3"ZYRER"1+4B_MI*RT<5NT03AI]!?#VF,9O6>E9B]O*3KJBLHDHY'3XG1X_
MQQ4[WVTDMM,6&2,GOC[2/=LW=A?,^ ;W(1C'34\W;7KUR[*XU1<(FU>7%/OF
M:%1&^=O&Q-N2]'OV6S2DT+T0VRZ9]/C'V>H3M,94Y%>KU5O7EJX'Z#CT3Y@
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MGB  40\V/X:_)%_21)^L1!)>\20
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M>/-TU_D]!6/9-)(W?$?D&RE2E+2XK1*M5'T(B%)2;9:A8T5
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M=Z]]3^JXJ->Q<N3)5H\4.OD>]S'$2'6OVLA.NU)^L]>T_4.0]9O$WD20
M         %$?,K^,]Y)/NDR+^#T 27N @          Q5O\ ]UV?_5)'Z!0@
MDAORQ?@#XL^PK?Z-P2&3J;:35NT+=IIN].@@5=#Z"2    \C4AA]3J&7DN+9
M5M=0E6NU7P@#U@              JUYB<>/.:I.+1C<BSXD-=FU+4XIIDU(5
MM;:<62NA*-)_,[1S[B&N.E'I],OQV]Q7&JUPIV%*ZNHRAYRF7FQ.3J>(E<*W
MI*F3I'CEK]3>6LM2->O74]1Y\5+*678?27)VO,K32EFG)8OLH9>VL5,5Z(,'
MZK(C.K<9GRE*6IQE1;4-)/7J22ZA*6!6U;K)2E6G%=IQ0VD>'@.78_DM.\F7
MD!I156"&TZH<]"U*5[)-GU(^P3;DE;DI9\"M^S*>XMW+3PCBT=8%A&J<0C0K
M2P0[0,FEM$(]IJ\37J\H^TS,S[3%8RI&C+W+;G=K%>9U+P^7N@JZ_!D7,*(E
MAW('UR)"R;V+-+:C0A*OHB[3(RZ=1Z&VBE# ^<ZI=E*[IDZT+"#I/,  HW^4
M/_%JN?NDQS^$XX$EVHG[5B_\RW^A!D'J           %>O\ W5?_ %4?^N@2
M6% @     \CLAB.;9/.I:-Y6QK<K3<H >L              &-M76V:V:XX6
M]"65;R_XH @HNA" 8:RE7#$ZI;KX#<J%(=--E(6K:;2=.FA?_9ZA63=53(VM
M0A*+;S2P,T?:9"QBSYI/OJ[I>CO^L \3/8[!9LK>,RZKN,?Z0MOZ+;[.O_&
M$V"0   %%?)A_&?S<_TS7/ZVV()+U"2          "(^>?P+<L?<I;_6;@,+
M,V[ OXE8=]@J[ZU: EFW:>D"     #S,/L2$;V'4NIUV[DJW=@ ](
M       (,Y#AP[&XC//&\@ZI*7%>$9D:E=NFB?:%))-FMJXXY&B-4++DQZ<;
M[JT2'2?:B.*VFA1=JC+VA7TU4VEN&HZ:'7)TQ7CKFB,CM&9!/5J>NFXNW4O9
M/=\(FXL4AM:Q4GPIB8NXM*RZBJB%9MQY<"0VF<\E*E;3,]'$HZ==>S7T"DIJ
M>'(TM6Y6G6E4\C0[.0_<73E <Y,MN,^I,)N2G8HDD7=4A1=[_".>592TU/2M
MQ5N.NF9<; <=C8SC%;7Q][JW4%)DNK3M4MUU.Y2E)^+]".R$5%41XE^\[LW)
MF]"YB !1'S8_AN\D?])<GZQ("2]P$
M                           !4OF*[Y2L^2\9XVP/-:[C:!/H)-U)R:;$
M;E*F/QWR:.&UXADG5)+WF7;IU%D0S-<78IS'3Y24O-^<*_/J/W5U"J"-7L1G
M?&5IL=\1!J/N=N@-KD$BS0J2             $.7G-O&.+YBK!,HRB-CN1%'
M:D--V)*C,.H>(S3X<A9$UKW>I&K031L$IQ9D2;%;DPI#<R,\G<W(963C:D_1
M)4GNF(!D               :K69/07-I>4M99QY=KCCZ(][7H6?BQ5N()QOQ
M$&6J24@]2/L,&B3%TF?XED>09!BM%<L6USBZ&E7\>*HW$QE.[O#;6ZGNFLC3
MU3KJ7I!IH@WX
M    !73S:_BQ\Z?<;9_K!@#9_+W^ CAO[C*+ZQ8$ F02
M                     -;REI+M),W;OJ1$LMOK28 ATC,NI=OH](BG-##E
M[?4XZGZO\(FH9&-KQ5C%QR;C?+,I^Q+)\6@NU]?':DJ1"6TZ9GN<9+VC(C/H
M7=/TD-H[B4;3M*E'[S)V4YJ>-5[>W/W$G::C%YFIP   ^K33KRR;:;4ZXKXB
M2U4(!G48M<N> ?NQM^\?1'^E_P",)!)5=1P:]A*41T+=V;7GU)U4H 9P ?/:
MC?NT[^GM #Z                  *(^97\9[R2?=)D7\'H DO<!
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MNTFTSDO[IJ+BE2+R1;H=9Y    41\V'X;O)'_25)^L2$$E[A)
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MR,G7'7="6I1'U(U'Z>@I)XED6I%0
M              !U,]! (NG<HXG7YW0\<KF.R<GOD/K:8C-[VHY1VR<44APS
MVMJ-)D9)+KZ=-!-O^HVH\%4F:T1U/FEXLTYWS!8HS>N5ATM]\A,7?VNN9R45
M)U)6>NWW?Q"<\37<>TU>'MU](BS_ %=-/S9=OMP%S^GJK^7/V\<3S^;8]?+-
MSF9?[&VGZR8D@VCR^?@)X9^XNB^L6!!),@D@
M            #7;R!*GMMMIEIC02W>_(-.NY.@ AQ9)2I24JWI2HTH67QB]8
M@'02#D^T >AN)(=8>DMM&J/'VD^YZ$[A .JV5-.&T[M2I.F_:K=[0 S::=,T
MEJJ69,EMIQ"5ON;4I<2KVE)^88D&^UV+U\!]B6@W5O-)U02E=-?6 -I
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MI/"N"Y$LC8XP   HW^4._%JN?NDQS^$XX$EVHG[5B_\ ,M_H0(/4
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M)<KZQ(027N$D
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M')'-MEC5U*R'CA<ZK70V3KBW(Q6)QM+!$(W.OAI42>B>Z73UD*M8!%JQ4
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MVJ)/M>%\X2"5&&&H[;;++:6FFT[4(3Z !Z
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M^U8O_,M_H0(/4           *]_^ZO\ ^J?_ -<$$EA!)
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MKJ-C@.0    40\V/X:_)%_21)^L1!)>\20
M                                %#O-+6\;6.34B+GCR]Y(SJ-12[%F
MKJ+)VO9B5$4S4]*D.EHE!$L]"T+<K\P7A4,^W!N)\08KR+BR\;Q6XH,DRS!T
M9#439=H].B.L2%(3+C$A:C/>SN29&:2UU$2J0DB]8J2           !KN07L
M#&:*WR.U=\&MHXCT^<ZDMRDM,-J=622]*C)/02@5(J,C\U?)L*/FN+1<2P'%
M[0O?,6JKEMZ78/1'#^I+?4@C)LW2T5H6G0_4+4BA5DB\,<A9'97F3\;<B8M
MQ/D3&FVK&6=.7_T?:0I)F2)L=1=?;(TJ(^I&?P")+B$RR@J
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M(W\MNM:.+^$#0XI)*RBQ2>TS(C+W,O070<S_ -Y?ROYHV7V/O7U/TH\G)_\
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M[>]B0P_MW&W*C.$EQ#FWUEU+J0M*.DHI5+,$>H@L<@
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MT(ED'J       14'S)PC]!Z_,$50.361'IH)3#*_?^ZO_P"J?_UP226$ @
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M O<
M  "G?F4QB)&5#Y!KN3JCC+(55$O%YKU\:7(-G63>\['4WH:]Z5'N2I"3TZ=@
MO#,'DX#X[LJ[(:C)\SY%J,SR&DQ*+6X524J2;8@T3YI4B2I)[7%K>-)%N-)%
M_<$-A%SQ4            :!R-C,K,\"R[$X3[<6;D-7)@1Y#Y'L0I]*D)-6W
MO:%KZ!*896.EXX\X=#3U5%7<NX4U7TT-F%!:73N+-#,="6T)-1LF:NZ7:+5B
M^!"J;IQ7Q=RY3\EV_(?*V8464S9= U10_DB,Y$V(:DG(3O2:$I5H9GU[1#:H
M$6G%20           -*S;+(6"XM;Y98PYMC!IFDNRHE:R<F6I&]*-6FR,E+4
M6[7J8+$%"<[M/+_S3<S[6BYJG<295D#42+E%?/87&9G%$4E<;WJ-)\-!NM&D
MM%$L:1;B5P9;/ACCO&L,@75G4Y>_R'>Y5);E9+F\J4W*>ENMH-#2=S2C2VA!
M:DE)'J0HVV62H3P(
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M$E[@(
M   "C7F9QNU;RR!G<S 9/)6*HQ&TQU$"*R4MZGLY:S4S8E',CW$:>X:BZI^;
MH+P#,=Y?HF39;G6%Y@K"[3#\=P+ &L5F65JT<=ZWF&MM7U)K0E*:9VF9&KL!
MX$(OL*$@                             &E9O:Y'1XO<VN(X^G*\CA,[
MJC'E/DQ[RO<DC1XA]U.B=5:? "[0S\Z+W-\LSR=+J^>6X/"4)]TT^&O"U69N
MD2M-Z;*2EY*#(NN\N@UCY<45S+3>7+C7B+!*VWF\6YBK,#N4M?*\XIS<E)&U
MN-.UAHDI:]H^TB%)-LE*A:85)
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M4=HE)BI3[7>^B^8!!NX           HIY,/XS^;G^F:X_6VQ")+UB2
M - L\&K+7-,:S>1)DHL\8CRX\*.A2296F6DDK-PMNXS21'IU$16F4I?O1T^%
M:B?FC%/)/5XTH1<SY>Z*-<1G_MFNGL3@WBLA@\?K<:.N:L5*\3>1DWXQI)TS
M62-^W46M2<'%MU<4TGR]E@3=_J5X5>/:;GSMO+A7EC7M^U2X[/\ J;H@A&W8
M'_$K#OL%7?6K0#B;>                     /@XVVYH2TI623W))1>D@!I
M^0XR=BMJ1 2TS(UVR-W=):5?&Z>D ;5"C)AQ8T4NJ6&TIW?XH ]H
M *(^:_\ #=Y)/Z2I/UF()+W"2
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M:64M];\A_P (S-&IF1)+3<?81"KDV2E0F@0
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M^&/W3:B2![]^43_V?X8_=-J!)Q[]^43_ -G^&/W3:@0/?ORB?^S_  Q^Z;4
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M^$2"*>6^://'PSC$'+,RH>)':JQNH%''1"<M''/>;-WP6343BT%L(S[W7L$
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M]RERMP/DG*N*8!08SQ/E1WLE_'K*4[)<0XR;2TFT^2DJT+LTT 'Z2@0
M                                                     %*N<K2E
MQ?FWC'+>2VK$^,J2MDKI)L5#[L.'D:7R4EV6VP9J_22[IF1D9Z>C47BJHAGP
MXWR3'\[\QMUF?%7RA)P^9C:F.1+M;;[%?,LD*0F#X*9!$2G$-)42MI?"?I$2
M5$2F7<%0
M                                    $=\@765TE(AW#,</);^9,8A1
M(SBML>.3ZMJY,HR,E>$T74]O44=7)16"?'E[<"\4J-O@O>^1$O"4XJ7)>2>.
MY>)T&/WE5/:O[^UQ9MUNNL)%N@W''G&WC4M#^J"\34^O:0TC2=OU%PDX^Y5K
M7Y\BLZQFHOC'4O?3_#F:^OG*_LN3;K$*O(,/IJFGN6:MMNWC63DN0:"0;YE)
M9,HK:]YFE"5&74OF"-O2Y%2SK7+/!T+7UZ;<<FDJ\L57W4+=(5KKK[6HA%#Z
M"0     <&9%U,2051R_E_D6+9\BV&(4M%)Q#BIUAC(6IZY!6$]9I\20413:O
M#;)I/T9'J8SC-**N3^URTX9X-+YLV]/5/TT\=.KLQ3:^",MD]SC_ !S0*S_C
M[$:MK,>9[2H8][61M-S9LY!-QWYRVSU633:NNFAGZ!I.W+UU9XMNKY*.;_88
MVYJ5GU7DDG[Z8&S\<YUE5KDV8X%G42J8R?$$PI2Y]*;Q0Y<2>E1H4AM\S<2I
M"DZ'J?S @E.UK7[SBUVK\1.L9Z7DU5>^GP)R$$@      =3+TEV@"N?(>=<L
M4$C++/&L8IXN(X-7IL)]G?+?2JU)+2G7FH'@*(FS0E.S<X750SUJ*U2RK2BS
MX>;XY&FC4U&.;5:\.X\=_DF)8I@UUYC*S%8-9F62X]7>^64QLRDO-+-!1HTI
M;?>4AI2^A$1:^@:;F+M35NOYJ(IMJ75J>23;[D;!P[GU]FR+1^YR3&+Q,4T(
M9C4,:PAOLJTU7X[5CHX:3^*HBT/UB[BM-2B;JB>A0L      !UU+=IZ08*H\
MF<VV^-\AG@]'<XQ0E#K8TR?/R"+8RS-V4XM+;:?D\C2T24IU-3AD77M%+59M
MTI1.G;V]G<7N)0C'FTW^'O\ H;)FDV@XOQ[).8*[&*BQY!RB-65T^ZA$;:;)
MXUHC1"<>ZJ-ILU[B/M-/I%IJ3NQMQ7W.BKPXD64I0<I/!*KH9#!<[S=><6_'
M'(D&G;OXE.Q>U]E0^.F-(C/.^"XVIN0:W"6VYZ==#+U"\4I0E)?EDHOQ54RD
MJQ<:Y23IX9D]D>HH2<B0      !7?F?,N1L!K+#*:*9BB,=A,-MLUUO'G/3Y
M,YY6QMAGW=Q*3-Q1DE):?-&=9:DEFW1>WQ-8QBUCP3;.DXF,5Q25SEF^*4D+
ME:IQ%UFWLXA+U:9U-],%+KAJ7X?B&1G^>U&FY:MND7FTNRKP^9GM8^HUKP^B
M_P #Y<,\F9)G[TQVXR'%+%AF*V]\ETL2SB2V%NZ'WRL-I+06NAJ26FOI&DH:
M5C[>W S4JM<BQY:'U&=2YR      .#/0M1#"*RJYPM&,BY(BVF+.T]'A..(O
M:M4I>R?-,UJ1HXUWDM)4:>[J6OI&<KE+,Y\8R22_FY^V1I"VY7H6UE)-U_E:
M^AJ^$WETWRKBF0YYA.*0<GY4QE2*3+*-$A,YJ+&VRRK9BY"E$O0E[B4@B3N+
MU#J]-*<X<8*OA73\_@<^NMN-Q?;)T^#DOA\6;9FO)'('VZY-BO'=71OIPBC9
MN\B?NSD;I)O[U-Q8J65)V*-+9F:UZ]1RZVK<[K^V,E'M?&3KV'2[:K&"^^2J
MN6=%7CBR7N/LLCYSA>-9?&CG$:R""U,**I6XVEN=%HW>G11&6HZKUOTYN)SV
MYN4:O/\ # WD9%P               (J#2<QQ/%LVHI5#F='"R''EJ;DRZR<
MVEY@UQE)?;6:5?0K21EU%9RTIRY(M&+;2*\<7\V9!GV5M0RO\/AT:YLMF-0(
MBV2;)R*PXIMDF93IIBN.&24J-*->GHZ#6W%.&K/RI]U<?@1<\LG'*C:]WX\"
MWA:Z=11$'(D   !2SD;*[F=F.49G0X1BUTCR]DHRMKI,@[?Q9<<G)R*UQI9(
M9+P=",UD>HI:FM*N3^QRTJF:HZ5?CP-W:;FK<?N<=3Y8UHOAB6VH+AB^HZ>\
MC$:6+>(Q,90?4R2\@EZ?.)6@VNP=N3B^&!RVYZXI\S.BA<   /DMQ#:5+5T)
M):F*2=$V2E5E(^+>0(N4\IY!?U)X%1S,KL%PKAQN#8MWEE"K#6S#2<]:DQ7'
M23U)*=3+KTZ#2U'5!2SK&N';[8B]Y)N*X.F/M[B\(JB )    0%S'R?><>1:
MM=/C'RRJ59U\6QL92U-PHK$Z03!GN29&XZ>NJ4%\TQ.W7JWH6WE*OR;7R+R6
MFW*?)-^ZA&DF]NN/IN=8=PGA>+4N*\6Q/ES):Z4B0T<R3.0J<\W#2PHD-K4@
MC5N61][091G6+NS^U2T]N&<OV%O3K*-M?=)5[,Z?,LWB&11\MQ;'LFC-&U'O
MH+$UII2MRFS>02C0I7I,C/0=%V&B3B<]N6I5-M&9<
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MI\ 6'KT:L-?V_M+W8..M+."J^[#+WEXT.DX1*+JDR(R/YHL\#-.J3/J()
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MUMT^-*]]"UV&G6E^55?N3P\"YC:R625)/5"DDI*O7J)::;J91=3Z@6
M                                                    #$6UDS3U
M-E;/I-4>LBO2W4EV[64*<5I\Y(+$%,4<T\B0N%+GE7+H-/9R,_FPXW$F$QV3
M4329CBF8S<MQ7Z<HS+Q%:&>FFGI%Z*M"*X&U\89+RQB?),/BOE2517'VR4#E
M_C]C11"AIBN1G2;DQ7&T$E*B+=W5:>H1*F9*J6Z%0
M
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M5[46;);U)"G2U4X:#/T$:CT'5?FIS;67X8'/;BTL<\_>ZDC#$N
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M'CBL1PO%\8<?3)=HJV/#=D(]E:VF]%J+7T&>N@Z[T]<W)'';CIC3VYFZC(T
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MM97)+\\:>]49==EHF6FVD]2:0E!*/U$6@LW5U.=*BIR/0(+
M                                             !X)46/,BR(DAM+L
M>8A33[9^RI"T[5)^>0 JCBWE9@X_D^/2['/[O)<)PF>Y8X1Q].))PZZ0M1J;
M,UZGXA-;C-&I$+.1"1).*<53:[DS*N3\HRAW)K>R;<KL3B&VEF/35"W#=*.V
M2?;6I1ZJ49=>WM$5PH23H(
M
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MCR<E'Q9.">PA!0Y            0 )             10 2
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MZ$?4_00FS%W;BA'.C?9Y<RTHM6Y7'E&GQ="<1%2H$@
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M/$KV^\6J2ZEZ=!:U%W')+\J3?<W14+SCH@IO)RT^-&R:-Q"$4.0    !#0
M"0
M
M
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M;7O3N%#$^@
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MJC&VRK6^N5N%/]3-MQ_\>#_^[_W67;+J9&7J&2,#Z"20
M
M
M
M/%)\#8OWCP_!VGXWB;=FW3O;MWHT%)TIB2BL. ?U3OODW?WN/M'^^=WOE3Y,
M\'WS=O[VW;W>WZ ;6M>CR5T^U?J5GIJJTKP)(/[T/B\F[?M9\?8C[[6O@:[?
M=SV_*?P>#I[?30<]O3Z:TTT:GW:ZX^-?B;/7ZBSUT5.>G'+LS/#EGWD/=L5^
MW7[5_=ODZ;]I7RC[OL]R]U+WOW+7IX?N_M[/B_ +2^^5?NIC7]VO'LK\2L*Z
M5I^W4J4RU?E\<Z$CX_\ (?R#5?:O[M]K_NC7R%\G[?=O=MA>%X'A]WP]O8-9
MZM3UY\:F<:4\I&>,_>'^V:H^U'[4_MMW6?R#\F^[>]Z>*GY3\#9WM/$_3=OI
M%+>7E_=7^BKIX5^):Y7\_P"]Q_?T_/3\#;N0FN07<;?1QI-JX&4^*WX$BXBK
MEQO"U+?N:*1&/7MVZK%9:JJF7$F-,:D'5L+SA%95IVF2X*Y6%);.P;9HWT+-
MC?WR0KY65H>GLGH?S!K&E?-D5>3IF3O<_:']MV(?+_R5]O7AS?M,]Y\+W_9L
M1[[[EO[^FS;OV>CM%8YRTYTQIR_Q)=="U95_[1("=-.G8(1!V$@
M                                              ^"M._M[?C"O#$@
MJJC^J7]]Y&S[0_OQ:GXG[7]_W:'N[.YN[=?3J+[6NF7HY<:$[G)>KRXDT._>
MZ^W]OQ/D3[YGR(?A[O#^5ODCQ"W;?\YX/B?\749Q^V?+#7RR=*\,LBTJ^2O;
MH^&JGPJ:W:?>.^T>'\L?:I][WY5;]P\;W;Y+^4?&^I>%K]3\7Q>S3KOU%OSP
MYT\GNX>!*U>:G;J^M3<,$^TO[6:[[WOR;]J&KOR?\C[/<_;/Q-GA]-=^N[7T
MBUS57S=E.XSPJ^?'O-%G?>)^6G/??M0^7/MLB^)XGN_C_;-X1^[:^GWO;KI\
M<5MUJM&?GI\/4I\-7@7N5QU<HU_EQT5[,Z=I)N3(R-=!;HQ1^-'R0XRBI9$Q
MI3T=,G3NJ=;2XTHR^ UD7PBLJTP$:5QR*Q^X^=;;_&C >P]VM"YV_P#G NLR
M)4)NMBQI,'!2Y070/7Y3XQ4+DI#32#O=B]IP$O*<,G?;V$E1GIVF)P]7R9T=
M.=./@(ZO3>K+"O+/ E@00                                    !P?
M88AY$H@CFO[Q'VNH^_K]K7VN>/\ Z-]L>S9XNO7P]_>]6NG09>74N?MR^I95
MI[>WN.\/[QOWIC]R^U7[S?NB?'V^[_(_NNXM/%U[NFNW7=U[!M?KJ7JYZE2O
M[U<*=M<NTBQ6K]+.CK3E1ZOA\#<8_P!H'RYCGNOR-\N?)/\ JEX?@^]?)>TO
MVMKWO!VZ>SW0E75.N>&KGG^;Q**FB/[OY>67#PH:7AWWB/MTG_:']JGV[^+8
M_*/R7X'OV_Q4>_\ B>'W]?$V^+Z==-1-O5H\OVT7NX>%<B]W[O/]U>/.GSTF
MZ93]HGB8S]N/R5X_RLU]J?RIX?B_*6BO#]U\3KXNFNFWT:C/\V&='[J>;_LY
MDXZ'^[A7EGY:_P";(<??:#]KR?O9?)'VK^^2]OR'X7N?OGC*]XT\+N;_ !-V
M_P!.OSAH]5(URHJ?R\*=G(H_NE7.KK_-Q\2+,\B^9QW*IZ^/;[$(6+&VW[A'
MLZER5*2K;]4WNILH^O>UV]PAG&M,2\M-%0VKBYCFYERY^^[:X_9,*2CY'*DK
MW())/_.>*9S)>[X.P6EIT8^R*8ZL,C;N/_M#^UR/][CY+^U;WB3[M\B^%[GX
MWBJ]XV^%TW>)NW?GM1+U4C7*BIW$R^Z5<ZX]YOX$
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L<JX<M5"2B[?@VBJ*'<22                                   ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tm2227887d1-lc_asses4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_asses4c.jpg
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MX7(34S05%@?!T2(RDK+2,Y,4-1="8J)S\((C=,)CLU3QXD.C)#:#1&33_]H
M# ,!  (1 Q$ /P"_P
M                               0DROQ#>+&%93DN&Y#FUPI+_B5UK++
M?*5EEN,K8JR@G?3SL;(R!6N1LD:HBM547RH$[,L?^DSX@?U^N?Q#=/>X-F3Z
M3/B!_7ZY_$-T][@V93DQZ^VW*+!8\FLTSJBT9%;Z:YVJH<QT;GTU7$V:%RL>
MB.:JL>BZ*FJ!#UP              (C[I<X>.^S.;77;W<+)[G9<HLS8)*RC
M;9KA/&K*F%D\3XYHH71R-5CT[6JNBZM7M14":)0V"^VK*+#9,FL-8VX6/(J"
MFN=FKV(J-GI*N)LT$K4<B*B/8]%35 A\^5Y/9,)QC(<QR2L2W8_BUNJ;K>ZY
M6J[NJ6CB=-*]&M17.5&M71$355[$[0(Y;1<TN/\ OEF,.![;9-<+UDD]+/6I
M2R6FNIHVP4R(LCWS30L8U$U1$U7M543RJ$S"5@0  (ETW-WCM5[K.V5@RRM=
MN"S)9<2=:EM5<D7PK!4NHWQ>L+#W72DK%3KZNGSZZ!-$M @
M
M
M
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M>Z.LM44SW=C6-J:N&.#J<JZ-:LB.<O8B*"DIB!
M
M
M
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M><3ILG@O#KE1U<K*9TL,,E1-.DL4CV/7H7IZ.M5;V(J$1,I[>&3O/?-U>/\
M+8LIKYKI?]KKJMACN-0JOEFMCX63T*R2*OI.C1SX4_X$;==555"+H6,!4
M
M
M
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M>WM1-=>P(E.X(
M
M
M
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M;S^:OYN^L]'P?'3L[KUOX3BUZ_5]>KNDTU\BZ=I,7+"-S<-_6-MMN#M[\)?
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MRXSCL'<T-(U>I[G.57R332+VR22O57O<O:JJ%&<@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZR6)SFN_L*!Z(
M
M
M
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MB-[W6^LMU8D3HKI%%)T],C()65$;O1=I_-N7I<Y 3IAT\!Q@
M
M
M
M
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MR-8JIK5JFJ(H-ET !0
M
M
M
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MKY/233S!:W4Z8<>L<-EQ>QXU+TU<%IM=-;).\1'ME9! V%>I%1$5'(WM[/[
M<;Q?U9;;>S[&OBFC^Y /U9;;>S[&OBFC^Y <[OB'6>T6+F324%DM='9Z%MOQ
MQ[:*A@CIXD<Y?2<C(VM;JOG70+VZG2T%
M
M
M
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M]2E_%F-?W0O;J=)(4
M
M
M
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M=3I)"@
M
M
M
M          ",G+S?N7CCL?D>X=OHF7'(Y)H+/B5),BK MQK5<D<DVG:K(6,?
M*K?X73T:IU:H3$54<6C*O$CK,6DY/6[)\^KL%I72W>6XOND3[8ZGIWKWTR8Z
MZ?I=2MZ557-I.Z1J*[7I15"^ADE7:>3WB=Y?=;_8YK=B^#831V^D;;;M7U-/
M8:.X.IF^L) R""HDFGGE223J6-SF1N8Q[T3HU(T0^3!;OR \-_??$\6W!N3*
MC;K*IH9;_;:"LDJK%<;;-*D%16TG?,A6.HI57KU5D;^QK7_S;^T:W22%
M                     YMO$B^>I2_BS&O[H7MU.DD*
M
M
M
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MGJ4OXLQK^Z%[=3I)"@
M
M
M
M                       !\%/:K92UU=<Z6W4M-<KHV)MSN$4+&3U#8.I(
MDFD:B.>D?6[IZE735=/*!]X&!20[9;/XY>[XZFQO;3%:=[[AD%RCBI+31)+*
M_P!*:=[&Q,5[WO\ *[TG.7SJH$9ZSQ$N&U#424L^\\+Y(ET<ZGLE]J(U_P"Y
MEAM[V._L*$[,OE^D=X8^V3_J]D7^; ;,MJ;1<LN/V^^25V(;4Y_^=616ZV2W
MBMM_P5=:'HHH9H:=\O>5U'3QKI)41MZ4=U=NNFB*J"8HD6$
M        .;;Q(OGJ4OXLQK^Z%[=3I)"@
M              !5QR*P?>_ <XVG;8N5.=0V[>G<V#&9;6V*C;%:*.Y=_.B4
MOH*KNY1J,:C_ #>4+0GGM%@&3[<XW763*]T+YNS<:JYRUT.1W^.&.IAA?##$
MVD8D"(WH:Z)STU[=7N"LMJ
M
M
M                                             H<\7W<#(79GM=M=
M%65%/B]/8Y,FK*)BO;#55M3534D;I?X#W0,IG='G;WCOXR!>UJ' _"HW^S'%
M;)E%PR?$<2^'J."NI;'<)ZV2M@BJ&)(QM2V&D?&Q^BIJUKW:>1=%[ ;3,/H@
MM[?:9@_V5R]Y@VDQN$7!'<3C!NMD&?9=F&.9!;;OB=7C\%':%JUG;/45U!5-
MD=ZQ!$WH1M(Y%T7754[/*$3-5I85                     <VWB1?/4I?Q
M9C7]T+VZG22%                                          '@Y/49
M#2V*XU&*6^ENN0QL:MMM];*L$$CE>U'(^1$56HC=5_=./%F^+9FR*W<E7=W?
M9E[\>VW,W3;A3\Z;8K=&CDCETT5P<G;SO3593Q:?E&&8_;*RFW>M4N,0T=R?
M,VIKTI:KNX9U5OH,<NFKD\AU</$S4Q.U9;&C1IY6=SN4W)9?AQE\?%NMFZ(O
MVK(C9LY9MTZ9ZB;^&WG>FMO<<&<898+)85AD=)7VZXOJ9TE1/YMJ1N:B:*OE
M4G Q,S-U,2VV(ZDU4WKE=RX>!7)X^+?B5C1=9%L4Y=+;QW6L
M
M
M
M          57^*;LCC.9;4VS=RHR:V8ME.VZR4M&RY2]TV]4M8O6MM@\JNJ6
MNC62%J(NJ=XCM$])I:V6KMC?%@P&VX/C>-[RX?D4646*@@M]5DM@BI:RDKDI
MHNA*F6*:HII(9)$:G4UB/;U*JHK6KHT3:W?]*_Q>_P";\X^*:7W\#9EO/C_S
M;V;Y)YE<\&V\I<C@O5JLLU]JGW>AAIH/58*BGIGHU\=3,JOZZIFB:>37M")B
MB7X0                     YMO$B^>I2_BS&O[H7MU.DD*
M                              /AN5SMMFH:BYWBX4UJMM(B.JKA62L@
M@B151J*^216M:BJJ)VJ6LLNOG9MB9F>2$3,1%90!Y8Y]@EWR_B/-:LUL-SAM
M.\]GK+K+27*EF;34[*:I5TTRQR*D;&HG:YVB(<U^4QK)B+K+HKHBL3IGJ(MQ
M;)K28[:<%GSW!LAK6VZP9I8KY<',=(V@M]QI:F96,[7.2.*1SM$\ZZ#$RF-A
MQM7V71'/,3"+<6RZ:1,3V66'77
M
M
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MD7SU*7\68U_="]NITDA0
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ML:BZ.\YPX^\<SCV[.)B771S3*;,OAV36VV(ELDZ3F
M
M
M
M   IU\6ZLVJ=B^W5KR:DO=/N;I<:W +Y;:6FGHG4T;J>.MHKB^6J@D8R17QO
M8YD<BM<U>S1SM2UK46R_BS5V(X78,3W0VSGRJXX]0P4$>6VFX,@EK(Z=B1QO
MJ*6:%6I(K6IUO;)HY=5Z&^0)FUN'Z83;;V.Y+]_T?[P1LI)<7.>>)<H]P+Q@
M%AP*[XM66?'ZC()+A<*FGFB?%3U=)2+$C8DU1RK5HNODT10B8HGH$
M              .;;Q(OGJ4OXLQK^Z%[=3I)"@
M                  &*9=@N&Y[14UMS7&;=E%!1S^LTE'<J=E1''-TJSO&M
M>BHB]+E37ZIV,OFL7+S-V%=-LSS313$P[<2*715"_)ME-HZ7E!MCB]/MQC\.
M.W3#[U67&RLH8DIIJB&5B1ROCZ=%<U%[%4V3 WGFIW=BWSB7;47VQ$UTT8^_
M+X<8]MNS%*2\3DEMKM_M_FW$=^$8=:<5?==[K VY/ME+'3K.D-/5K&DBL1->
MGK=IK[IKN8SN/F*>5OFZFJLU9#"P;,.NS$0L6.JN
M
M
M
M   A_P H>&N"\J:_#KAF&47['9,,IZVGH&69:5&RMK70O>LGK$,JZM6%---/
M*H3$T15^B"V2]IF<?96WWF$[1]$%LE[3,X^RMOO,&TD1QHX([=\8,[NV?8CF
M&1Y!<KO89\?GH[NM(L#8*BJI:ITC?5X(G=:.I&HFJZ:*O9Y B9JG$$
M               .;;Q(OGJ4OXLQK^Z%[=3I)"@
M                    "*F6_.^VB_0:_P#VUAGLO^EXOCVNE?Z3;XLL+Y@_
MTSX<?[;[+^#5)@7>A-\(
M
M
M                                           5#^*)R<SO:^FP_:#;
MJ]5.+5V96^:\99D-"]T%<E"V9:>GIJ:H8Y'1)*^.595;HY4:UJ.Z7/12UL*;
M['Q^Y%;C6^'++'M+G&66RZ-26ER)EJK9XJMB^1\50]BI*W_A-54"U7L?)$Y0
M^P3./B>J_D K"QKPQ-BMY-L=^\NO^X>V61X79:O *^WTMTN]!-2P254ETM4K
M(6OD:B*]61/<B>XU?<"+I7K!0                    !S;>)%\]2E_%F-?
MW0O;J=)(4                                          14RWYWVT7
MZ#7_ .VL,]E_TO%\>UTK_2;?%EA?,'^F?#C_ &WV7\&J3 N]";X0
M
M
M
M               ID\6+8')<GH\1WWQ>VRW:EP^V26/.X:>/KEI;>D[ZFEK%
M1OI+%')-*V1?X'4UWUO4J%K93+X\\Q..N?;:86R+<7&<&OM!9Z.ANF#WJOI[
M5/15%+3MCDAIV53XDFB;T*K'Q:IT::]*ZM0B8;]_7ILE[8L'_P"D-M]\!%'O
MXYN1MWF%=+;,1SW',IN4$#JJ>WVBZTE=.R!KFL=*Z.GE>Y&(Y[45RIIJJ)YT
M S0                     #FV\2+YZE+^+,:_NA>W4Z20H
M                              BIEOSOMHOT&O\ ]M89[+_I>+X]KI7^
MDV^++"^8/],^''^V^R_@U28%WH3?"
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M"')J^U,DH*9M+%ZO3P4TC$[MJJFNLKM5"9BB:80
M
M             %)OBU;Y999*G"-B\?NE19['D%H?D>9^JR.C?<(I*B6DI*65
M6:*L+702O>Q55KW="JGH(%[85W8=P2Y8Y[CEKRS&=GZR>Q7J%E3:ZJNN5JMD
MDT$C4?'*VGKZRGFZ'M<CFN5FCD[4U":PR?Z.+F=[&_\ K#CO^<P;4)]>'/Q-
MY [$;VY3E^ZV ?FKCMQP>NL]%</A6U5W76S7*V5#(N[H:RHD36.GD=U*WI[-
M-=51%*W35=$%0                    '-MXD7SU*7\68U_="]NITDA0
M                                      !%3+?G?;1?H-?_ +:PSV7_
M $O%\>UTK_2;?%EA?,'^F?#C_;?9?P:I,"[T)OA
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MUE()I&='>/:BH^-FNOH2.<G0HI#<?A0?->N'Z<7;\%H07:UF05
M
M                        "FGQ:MKK%>[-@>YM/EECM>7XW35-OJL2N5RI
M*.ONEI=(V1)K?3SRLDJ'4LSU1[(VN<K9=?X.BEK4AMC/$2XVY5@&+Q9AFU/M
MWF%OME+2W_'[K3U,<+*B&)(Y'4U4R)\,D3G-56>FCD33J:B@FV6Z?EN<3_;I
MC7^-E^YA%)9_MSR)V1W<O=5C>VNY%HS"^T5"^Y5=LM[WNECI(Y8H7S*CF-3I
M1\S&_NN0%&Z @                    !S;>)%\]2E_%F-?W0O;J=)(4
M                                       14RWYWVT7Z#7_ .VL,]E_
MTO%\>UTK_2;?%EA?,'^F?#C_ &WV7\&J3 N]";X0
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MW<C:21\,S6KV=44C6R-]QS44(A"CPH/FO7#].+M^"T(3=K69!4
M
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MUAGLO^EXOCVNE?Z3;XLL+Y@_TSX<?[;[+^#5)@7>A-\(
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M:&JIG^NU4SJV"!5='3J]=$32/M?(YJ,5%(B&4^%!\UZX?IQ=OP6A!=K69!4
M
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MYWVT7Z#7_P"VL,]E_P!+Q?'M=*_TFWQ987S!_IGPX_VWV7\&J3 N]";X0
M
M                  # <UVJVRW(9%'N#M[CF;)3M5M*^^6NEKGPHJ*G\T^>
M-[HU[5[6J@&/XCQ_V-P*X1W;#-H</QJ[PN1\%WH+-1Q5<:IHJ=%0D7>-[41=
M$<G;VA-6W@AC$^$X959%3YA4XC9:C+:1J-I<HEH*=]QB:UJL1&5;HUE:B-<K
M>QWD54 R<#&+#A.&8M57&NQC$;+CE;>'(Z[UEKH*>CEJG(YSD6=\,;'2*CG.
M7TE7M5?= \S,-KML]PWT<N?[=8QG,EO:K:"3(+117-T#7+JJ1+512*Q%7RZ
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MJQ3';9C%K=*Z=UMM-)#14ZRO1$=(L4#&-ZE1J(JZ:]B >Z
M
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M+1,!VWP/:VP0XOMWB=LP^PP+U?!]M@;$DC]-%DF>GIRO5$[7O5SE\ZA5FP
M                  .;;Q(OGJ4OXLQK^Z%[=3I)"@
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M]?*8T8,V3;,\_6JR6\N!/RN[+]XX6:P\7#MI\VNG:NBVG4F-K3$Z4N3+//P
M
M
M
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MD7SU*7\68U_="]NITDA0
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M+$SW;99G=^\<7!RF:R\3\C$LMK'5MQ+)B[KZ[?\ -UG0J=EA@
M
M
M
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MC9LMMOMOF*:YF[9BL\FB.>MI9RL&
M
M
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MQNNJG6FWNME#+)+$C:21&M<CI/2U=KVA,11URAQ@
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MBY6;;;9TXW)3DM_FZ_)'9Z^+W5;B5F?X/AZBV@T!G
M
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MCUPN,$%6Q:EC9(4=$]R.3K8]KF]G:BH$T;A"
M
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M[W:O<D4#6,U=YUT[0Y(U.F,.,
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M,:G8B(AV<3$NQ+IOOFLSKE@+;8MBD:GIE$@
M                                           8EG>4_F5B=YRCU'X3
M^"(V2>H][W/>=<K(].\Z).G3JU^M4Q>^=Y>KLGB9G9VMB(FE:5K,1KI//S,I
MN;=OK'-X>6VMG;F=-*TI$SJK'-SHN_*\_P#M>_\ I;_^C/.?W1__ )?_ '/_
M "/1?VN__I_]O_SGRO/_ +7O_I;_ /HQ^Z/_ /+_ .Y_Y#]KO_Z?_;_\Z1&U
MNX'ZRL:DR+X(^!>BMEH_4_6/6=>Z:QW5U]W%Y>OR:&]\.;\]<96<?8V/E3;2
MNUJIIK2WGYFB\1[C]3YJ,#;V_DQ=6FSKKHI6[FYVQS/L     #'<AR_$\291
MRY7E%HQB.XR]Q;Y+M6P439Y=->[B6=[$>[3S)V@8AG.]VSVV=9!;=P=S\8PZ
MY5+$D@MEVN=-35+HU\DB0/>DG3V?7=.GU049C8,LQ;*K'#DV,9+:\BQRH8Z2
M"_VRLAJZ)[&?7N2HA>Z-4;Y^WL\X&M;=R1X_7>_LQ:U[UX17Y!+-ZO!:H+Y0
MOEEFU1.ZCTET>_5=.EJJNOF[ FC<L\\%+!-4U,S*:FIF.EJ*B5R,9&QB=3G.
M<[1$1$3554(>%C>7XGF-+/78AE%HRJBI9>XJ:RSUL%=%'+TH[NWOIWO:UW2Y
M%T5==% ^B_Y)CN*6]UWRB_V[&[4Q[8GW.ZU4-'3H]_8QJRSN8S5WF37M UQO
M%<K=>-@]U[K:*^FNMKN&!7^>@N5'*R>GGB?;)U;)%+&KFO:Y.U%1=%"85[>$
M%^Q+<S].'?DVC";EM054A<VO]Y'Q&_T!_P!<*X+QJ6'[Z\,=D>166V[-MR:&
M[U5]M=HALE));[@^DB2D@J*BI8BL:U45W74O[?<T]P*Q-%6/B <,=D>.NS>-
M9MMM0W>EOMTS.CLE7)<+@^KB6DGMUQJ7HC'-1$=UTS.WW-?="T35)G97PW^,
MN<[-[2YM?K7D$E]S##+#>[U)#=Y(XG5=PMT%3.K&(S1K5?(NB>9 B;I24RW8
M[ ^/O#OD1@FW5/6TV/S8-F=U?'7U+JJ7UBHLDT;U[QR(NFD3=$"*UE6EX?\
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MVF[VF_6VCO%BN=)>K1<(TFH+K031U--/&OD?%-$YS'M7W44(>B
M
M                 1^Y)<=,*Y,;=5."9:Y]MJZ>9*[%LIIHVOJK77-16I*Q
MKE:DC'M5621JJ(]J^5KT8]I,310'N+X:7*C"+E50V3$:7<:R1*Y::^X_74R*
M]B(KDZJ2KD@J&OT3M1K')KV(YW9J7VH>)A7AS\M,QKJ>GFVW;AU!*Y$GO615
M])2PPHKE;JZ&.2:I=Y%7T(7=G[J:C:A?%Q&XFXMQ7PJLM='7)D>;Y.Z&?-,L
M=%W23/A1>ZIJ:-55600];NG55<YRJYVFJ-:4F:I;!     ,7SBV5E[PO+[-;
MHTEN%WLEPHJ&)SD8CIJBFDCC:KG*B)JYR=J@5!\ ^&N_NPV^=7F^Y>+T=GQV
M7%[A;&5<%SHJQZU-1/2OC;W=/*]^BI$[MTT"TS5<_/!!5034U3"RIIJECHJB
MGE:CV2,>G2YKFNU145%T5%"J@?>'P[^0>SFZ#]P^*=7576RLJI*S'4MMSBMU
M\LJ3=39*5RU$L+9XD:]6(YCW*]BJV1GE5Q>+N=\NU/AZ<C]Z]THL^Y35-59K
M%+5QU.3U-SN<%?>[M'!HUM+ VEEF2!CD8D?4]S.AG][8OH@VH7WW"P66Z6"M
MQ:X6RGJL=N-ODM5;9G,3N)**:)8)*=6)HG0Z-5;HGF"B@7/_  _>4VP6Y=3F
M'&"Y5^06/O)?S?O-IN=/;[U1TLZIK25T51+3MF1/K56/K8]$1[F,^M:7K$LF
MV \.[?'</=>GW3Y4N?;[3%<&7>]6VXW"&Y7B_5,3FNCAF=!),R*!>E$DZGH_
MH3H8Q$7J8)N7?9]@^.[EX7D^ Y92+78YEMNGMMV@:J-?W4[5;UQN5%Z9&+H]
MCM/1<B.\P44#7;@US7XXYY=+IQ\N5??K17)+24>58U<Z:WU,U$]>ID-PHJJ>
M)>I-$5=$DC1R(J/UT"]8ENWA_P"'EN?1;IVW>[DDK:*KL-Q2^VK%YJZ.Y7*X
M7A).^CK+C/"^:-K8Y5273O'/?(GIHU$5'B;EW04  '-MXD7SU*7\68U_="]N
MITDA0                                       $5.'W[,,A_3G)/PU
MQGN(O2+?$L[SI9#[N?&GOH=>)1EWK&1[;8)%)HEKM]7?*Z-%['.K94IH-?JM
M2FDT_P"Z-CX+R],/$Q>>8M[6F>_#H;WQ/E6V]EL.CLOZJL<VIMSF]Q5VC93(
MZVHC_BU]?$ZKE;VZ_P#Z1.J:GF?%.;\KO+$Q?Y;Z=C1'>A[1P#D_*[GC!Y\W
M@5[=9^%5MPBMJWGGUB3VM?ZO1W[*;A,YKFM5K8;?<71ZZZZHLBL143MT7^RG
M)EK=G"LCFMCO-&WMCSCYO&Q)UW7W3V[IET['.Q@
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M
M                         !7YSQYD5G&''<?L&%V^EN>Y><,GFMDM<U9*
M2V4-.YK)*N6)KFK(][G*R)NO3JUSG:HWH>6B*J5*SQ!^85;425,F\]9"Z1?[
MU3VRT0QM1/(C61T343_\=0M2'R_+]Y?^VRY_>-K]Y@I"P7PW.3V^^]6^658M
MNAN'69;8*#!:ZZT=MJ*:CA:RLBN=L@9*CJ>")VJ1SR-T5=.WR>0(NA=F%
M                  '-MXD7SU*7\68U_="]NITDA0
M                     $5.'W[,,A_3G)/PUQGN(O2+?$L[SI9#[N?&GOJU
MMZ7.WLYHU&,-<M3;ILIMV*]#>U(Z6@='3UJI]1KFS/7^R;INW_X.Z=OEV9N[
M,Z8^!B,Q_K9JG5B/C3%YE7)MHR.TMCTC?78?64%.Q-$32:X4[7HG_P"31WD/
M"-^WTQ(YYMF.W,/I+W78479/$NN^;9C6WSUK<.Z>_16#X7%'+D'+2>]31-=-
M;,7O=VE5D74UCIY(*95155>[36JTU^KT_P (V2(H\5OFNETFDN,
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MOXR017JIW&BITJ)ZF&DC?;(T]06Y*R2I;,KV.;!HJ]4:)U.:U%55":)(!
M
M                        H;\7_ K^S--K-SV02SXO5V23&)JAJ:Q4U?35
M,]8QKUT]%T\=0[I[>WNG>X%[5H_'W;?CS6;.;>7+;C!\5N&,7"Q4,M-<DMU%
M45,\B0M25:R98W/?4(_J27K57(_J1W:@5EN7]66VWL^QKXIH_N00]6T8?B6/
MU+ZVPXM:+)62Q+#)5V^AIZ:5T3G-<K%?$QJJU5:BZ:Z:H@&1@
M          <VWB1?/4I?Q9C7]T+VZG22%
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M=GE4V5XO<Z#@H
M                       _&>G@JH7T]5!'4P2)I)!*U'L<B+KVM<BHO:5O
MLMOC9NB)B>2=*UE]UD[5LS$QRP\O\V\=_P"8;=]ZP_R3K>K\MYNSZ,?$[/Y_
M,^<O^E/QGYMX[_S#;OO6'^2/5^6\W9]&/B/S^9\Y?]*?C>C2T='0Q=S14L-'
M"KE<L4$;8V]2^5=&HB:]ASX>%9A12RV(CJ11P8F+?BS6^9F>K-7TG(XP
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MZ*F942I/414\DZ]Y*Z:1&NDE>UKET1J-:FO41,U3H"
M
M        !4UXIW(=<%P2U;&VFT4%RNNZ%'+69!6W&G94LH;7!*C(W4T<B*U*
MB69J]$OEB[M5;H]S'L+6PHQP?,]W<2CFGVVRO,,9A?*OK$V-5U?1-67IT7J=
M1O8BNZ7:=O;HH7;#_7IRV]L6[O\ TAOWO@(I"QKPQ-R-\LPW[RZV;F9[G64V
M&# *^JI+?D]UN==2,JVW2U,9*R.ME?&DB1O>B.1.KI5R>15"+EZP4
M              <VWB1?/4I?Q9C7]T+VZG22%
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M;''C5#3O[.ERO6Y2RI[NK>EG]L[C"W+PPH
M
M
M                                                         H[\
M7?:2_5-PVZWMMU&^LL%#;G8GDT\;=?4GMJ9*JA?)IVHR9U1*SJTT1R-15U>T
M+VRM1XXY?M?F&SF!56TU3:_S6H[)0P,LUM=&CK=(V%J/I:F%B]4<K'HY'(]-
M55%=VZZJ5EO,(                       '-MXD7SU*7\68U_="]NITDA0
M                                  !"#?;YYW W_P"ZC_J[3A,:DWP@
M  4 [TY<J;78G@<,O8[.LQO]R@U]RM]5I':?V9T/6=V9?_Y-^+/F[+8[59^!
MK&8Q/].+?YIE8+AV?)Q>XU;*H[$_S@JLHI75M=3NK/47QRW!%N"J]W<3]2HV
M9&::)IH>6<7;W\EF[[Z;4;6SKI\W1S3S/3^ .#O7^UA>5\GL6Q=79VZ[4^-;
M15YSHWQEW:R"UY(W'VXXE'A5=98K<^J6M1ZS72A=)+WB0P:*K)=$3I[%;KJN
MNA@LEG9SGRMFD1//7DGK,IQ3PS'#F)&!Y7RDWX>U79V?XHBE*W=&9K7EU<\A
M?"0RFTV''=T[;='4ELCN]QAJ?ARKJ&0-5U##"QM/_.(B.5?6G/3TNS1>SMU3
MGQ]YX&!C>2Q;[;?D[7RKHCEIRM>P=RXN8R4YG#B;IC$V-FVV9GYNUM5CL1JY
M=:YRAR7'+I4)26R_VVXU2M5R4U+50S2*UOE7I8Y5T0Y,'>&6QKMG#Q;+IYHN
MB9[42Z&-N_,X-NUB85]L<\VS$=N8>V=QTP
M
M
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MINN5W+DLK?Y3!P;++N>(B)>69K?6=S5GD\;&ONMYIF9AEIDV,
M
M
M
M           AARMYG8QQ2N&%V_(,+NF6/S2GKJBEDM]1# D"43X6.1_>IV]7
M?)II[@3$51(^F$VV]CN2_?\ 1_O!.R?3";;>QW)?O^C_ '@;*27%SGGB7*/<
M"\8!8<"N^+5EGQ^HR"2X7"IIYHGQ4]724BQ(V)-4<JU:+KY-$4(F*)Z!
M                 #FV\2+YZE+^+,:_NA>W4Z20H
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MQ;]LQ=Q9C=\63$V8>)?-U=$UT4I3JQRKI#>GEH
M
M                                   'DQ7ZQSUKK;!>J":XM71U RIB
M=,BZN3MC1W5_ =YO,ON >L
M                                             "'_ "AX:X+RIK\.
MN&891?L=DPRGK:>@99EI4;*VM="]ZR>L0RKJU84TTT\JA,31%7Z(+9+VF9Q]
ME;?>83M, W&\(3'H<:NE7M7N?=ZC*J2G?-;+/D4-*^FK96(Y4@6HIVP+!U]B
M(]6O1%\J:+J@VGD>$[;]I5R;.*B*CO%BWVQVR3VJ_6ZJJVR6^NLT]=3ODJ:>
MF6%LD,L$]/%%*UTBHG4BM^O5L9-R\ *                     .;;Q(OGJ
M4OXLQK^Z%[=3I)"@                                 &";AY]0[<6!
MF07"PWW(H'U<=(EOQVA=<:Q'2->Y'K"QS5Z$Z-%=KV:I[IVLGE)S-^Q%UMNB
MM;II';<>+BQAQ68F>MI5M[P<A[#>.4W#O*HMOMP*.FP[]8/K=KJ[!+#7UGPA
M8X8&>HTZO59^Z5O5+HJ=#>T[F)N>^S$LP_*8<S=73%VB*17Y4\E>3G<5N:B;
M+KMF[13DY^9/K;;>NT;FW6OM-NPO,\:EH*3UM]7DEFDMM/(WK;'T1R/>Y'/U
M=KT^YJIQYW=EV5MBZ;[+JS3Y-VU*<',1B32(F.O%&Y3&NPIF\0K;2SXUG-EW
M I<EFJKIGK9&5V,5DCYY*=*%D;._IWN5>B!>I&]VNFCM>C5NJ,](X0SM^+@W
M8,VZ+-4QRUY)ZO5[?5P&],&+;XNKIGD14V0V0R_?3+X<;QN'U6WTO1+DF22L
M5U-;Z9RZ=;]-.J1VBI'&BZN7W&HYS<]O3>F%D,+;OU\D<LS_ (USR.EE\O=C
MW4CLSS)M<GZZGL51@.Q6.5]?=[3MI:X()I:N9U355%=4L;W:2+V]2LAZ>A$1
M$;UJQJ(U$0^<^*-X79O-3%(C368C56?!WWU?[H=QVY+=]^<OUXFBV9Y,.S7-
M>K=6OBPA3XDF"Q[<.XZ8GT-;64.'5LMX>WMZZVHK4EJ5ZO.B2.5K5_BHAF\E
ME_R^#;9RQ&GK\KQ[B;?$[VWEC9G^&ZZEOB6Z+>Y%9ZLRLXV%M:6CC7PMI$:U
MG?55IK=&:HG_ !YD]5KV^=>]U7ZIKO$_WV2_W%O>EV^&ONL[_M[N_"P@VUJ0
M
M         #\IYX*6&6IJ9HZ>G@:KYIY7(QC&IY5<YVB(B?5(F8B*RM99=?=%
MML3,SJB-;POSOQ+^M%H^_8/Y9Q^7P^E';AW/5>;\S?\ 1N^)^L&48S5314U-
MD5LJ*B=R,A@BJX7O>Y>Q&M:UZJJK[B$QC63-(NCMJW[NS-ELW785\1&N9MFG
M>>Z<CI@      .<#EXN2<L-^^1%ZQ&5];BW&;$7LH.ZUDAFBM%?#'<E16JJ=
M3GS5DS7M3THX6]NG:%XT+F^&>\_Z]>/.!YC65*U.26^F^ ,R<Y>IZW2V(V*6
M5^G\*H9T5&GF21 K,42D"  !HWDOGV0;6["[I;@8H^GBR/%K'-5V>:JB[Z)D
M_4UC7NC541W3U:HB]FOE14[ F&NN"V:Y5N+Q;VTS;-[Y4Y)E60S7^>\7NL<C
MIIGLOUQBCUZ41J-9&QK&-:B-:UJ-:B-1$!.MC&W/$6XX+RSW&Y*RYQ37*ASJ
MEKJ>+$F4#XI:9:QU*Y%=4K.YK^GU?_!IKK]0%=";P0 4A<6_]Z#R+_TN_*=(
M%YU+O0HJ5\7W]B6V?Z<-_)M8%K4P_P#W)?\ [B'_ .S81RJ1.&O!2T\J<%RC
M,+AN/5X9)CM^6S,H*>VQUK96I2PU'>*]]1"K5UETTT7R>4+3-$P/H<\;]O%S
M^((??P1M).\4.!%HXL[B7G<&@W+K,RFO&.5&/.M=1;(Z)L;:BKHZM9DD94S*
MJHM(C>GI_A:Z]@1,U0B\3O&X,RY5<?,/J:E]%3979[79ZBLB1'/B977R>G=(
MU'=BJU'ZHBA:W4VY]#WMM[8LE^\*/]\(VFNMW_#RW&V"P:[;J;#;\9+47/;^
MAENM=8'.DMU2ZBI&NFJ)*.HI)T:KHXVJ[N71^FB*B.UT8XF+JIZ<#.15XY&;
M(17K+9(YL[PZXR6#*JN-B1)6.CBCFIZWNV^BU9HI$1Z)HG>->J-:U41"LQ1!
MF\7O>#Q">16X6VV*;BU^VW'K:FH?2W62U/D:^O9',^GCEDCC?%ZQ+620R/B2
M54CAB;KTK(BI(6U,@W-\-RLV3P^\;G\:=X\QLV=85;Y+O/05U7%$MP911K+-
M'!44$5*L;E8C^ADC9&O7T'*B.5P1M)H<%>1EWY([(P9'E4<3<VQ.XR8]E=5"
MQL<=;-##%-%6MC:B-9WT<R=;6Z)WC7]*-:K6H1,43-"     >)DN16;$,=ON
M5Y%6LMM@QJWU-TO5PDUZ8:6DB=--(J)JJ]+&JNB=H%(-JN_(WQ+LXRF*Q9=6
M[.\;<:JDHYZ>F614J$<B.;#.R%\/KU4]FDCV/?W4**W3M5.\+ZF[J_PA-F%L
M_=V7=#-[=DK6HL5WJEMU31MD371WJ<=+3R:(NBZ)4)^Z$;37_'7?#>CBSR+I
MN)G(G(ILMQ7(ZBGI,%R^NFEG= ZM5S;=-35$^LCZ6I>G<.C>J]S(FC5:C'HX
M3%=*ZL*J1^?,]^Y+\F]N^*>#576_$K/<;O>%8NL;;Q46^6N8R=->G2*F@B1J
MKHNL[F^54"T:(JD;X7V\,V=[%5>VU[D>F4[,5_P3+!-V2_!56LDM"KVKHJ+&
MYLT'3IV-C;YU!="RL*N:/9WC#8>4W*KD;A]_RBOQ6FQZ\9%>(:RWPQ3/D>E\
M6G[MR2]B)I*JZI[@7F:0FU%X0&W<$L<T.\V3PS0N1\4K**D:YKFKJCFJBZHJ
M+Y%"-I'3=?#>0?ANYMA&<8CNM<=P]K<AKG4]3:;@^:*EFEB3O):"NH7S31(Z
M2)7+%/&J.U1ZZ,5/2)UK[\5R.VYCB^-Y=9GNEL^56NCO%JD<FCG4U= RHA54
M37158] H]X"DSQA:.6X5W&6@A<ULU=/E=/$YZJC4=*ZQL17*B*NFJ]O8%K6W
M?"JW KI]M=PMC\BZJ;(]G\BF6*W2KH^&CN4DBR1(B^58JV&H5VGDZV^[VBY:
ML%7+GXA&X=PW;Y%;A7RA8^?#]KJNDP"@K6KK&VHITJI94U3L59*F*J5JIY6M
M0.2'1SL7^Q+9W]!\>_)M.''+:8
M                               !$[DIS&VRXLUV)4&X-BR>\39E!65%
MK=CU+15#8VT3HF2),M76TBHJK,WIZ4=Y]= F(JC%]+KQN_J3N5\6V?\ SR$[
M,L+ROQ?MLHK3=?S'VMR>OOO=2-LGPXZBI*3O5:J1OJ/5JFI?THNBN:WM5.Q'
M)Y0;*(7A=LR/)N6=WRE4DG8S'+U<,KK6(K(]:V:%K4=TZ-U?/(U4;]151/1U
M0F[4Z/PH                     YMO$B^>I2_BS&O[H7MU.DD*
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MUJ0
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M2-B5&0TU9?;I.U-%EGKJR9S7.[$U5D21Q_N-0(NUII!##;QMW@&0Y#;\LO\
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M6\A4
M   (8<K>&.,<K;AA=PR#-+IB;\+IZZGI8[?3PSI.E:^%[E?WJ]G3W*::>Z$Q
M-$2/H>]MO;%DOWA1_OA.T_6'P?-L6RQK4;OY1+ CD[V..CHF/<WSHURH]$7Z
MO2H-I81L%QNVJXVXW68[MI:)H'W:2.;(,AN$J5-RN,D*.;$M1,C6-Z8T<O2R
M-C&-U<J-ZG.52)FK?(0                     YMO$B^>I2_BS&O[H7MU.
MDD*                                   (0;[?/.X&__=1_U=IPF-2;
MX0@ISRWA_,/;!N"VFJ[K)-R>\I)NAVCX;3'IZX]=/)WW4V%-?*US].UIM/"N
M[OS&8\K='R</3_FY.UK[3&[SQ]C#V8UW=YAWA\;,NQO$KGN[>Z5&7?-6+18R
MUZ>G#:H9/YR3M1%3UB9B+_W,;7)V..SQ=O+RN+&7MG19IGQO!'=F7'NO+[-O
ME)USJZS7>>Y_\";$38)13HVOS'-K[/<F-7TFT%'6=>BHG:G>3=&B^=&N0\;S
M.9V,KY.-=U]W:B?C?56Y=R_F=_1G+X^3@Y?"BWQ[[*=RVO;ME*OAU@/YJ;8?
MG)60=W=<[G]><JIH]*&'JCI&K]1=7RI]1Z&8W'EO)8&W.N[3V.3X^R\W]Z>^
MOSV]/R]L_(P(V?\ /.F_X+>O:IL\4VZ)E/)RDAL[TO$6-X?;+/4/HF]\V*H;
M5UU2^![H^I.MJU*:IY4UT,T\VM7H;AT$-J?L?:Z=S706W*;92P.:U&M5D-.]
MC51J=B)HGD0U+B?[[)?[BWO2VKAC[G._[>[OPWP;:U(
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M5TDOH-;KJKNQ$!1LT
M                H?YF\YN1^SO)3<C;C LNH;7B>.? _P %4,UIH*E[/7+/
M0UDVLLT+WNUEG>O:O9KIY$"\1H1?^DSY?_U^MGQ#:_>X3LP?29\O_P"OUL^(
M;7[W!LP?29\O_P"OUL^(;7[W!LPGAX>?,#??D#O3D^&[H9-1WJP6S"JV]4=+
M3VRCHW-K(;C;:=CUDIXF.5$CJ9$T5=.W7S(%;HHN0"H
M   #FV\2+YZE+^+,:_NA>W4Z20H
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M:CQ/'^MDI_\ Z+>]+;>&)_T<[_M[N_"ZLVQJ8
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M2.=&R2=(8J=TCI6,=*Z5TR];^G31PF>9:R%0
M                                 !JO)-B]DLQO5;DF7[.X/E617'N_
MA"_7C'K;75L_<QMAC[VHJ*=\C^B-C6-ZG=C41$[$0%7B?)EXW?\ 9\VU_P"B
M=G]ZA-90_P!TMU/#0VDO%3CN0X#MA=\AH7K%7V?'\+MMT?3O:O2]DTU/1K Q
M[%[',=)UIY%:$Z7E;?;W>&%N)=J>Q4.!;:8Y=JR1(J*GR/![?;(I7.[$1*N6
MB6F:JJJ(B/E:JKY$4%)3^P_:#:/ +C->\!VNQ#"KM5TKJ.HN^/V2@MM3+2R/
M9(Z%TU+#&]T;GQL<K5715:U?*B!6K8P                     '-MXD7SU
M*7\68U_="]NITDA0                                  !"#?;YYW W
M_P"ZC_J[3A,:GQ\\MX?S#VP;@MIJNZR3<GO*2;H=H^&TQZ>N/73R=]U-A37R
MM<_3M:;3PKN[\QF/*W1\G#T_YN3M:^TQF\\?8P]F-=W>8KX?&SWYLX5<]U[Q
M2]%YSC6DQ_K;H^*TT\GI/37M3UB9NOU6L8Y/*=CB[>/E<:,O;.BS3/C3\4=^
M5-UX&S;MSKGO(L<A_P!MFX_XW?\ _(8>'[S])OZ[[/X&_1,KXD=^6F3HMK6,
M7O;?%]S>",%ORNY)8Z3&++7Y117]6H]*&HM,M9-WRM56HYKHN\C<FOUKETT7
M13?-T^BV=;X9?)GO!_7LSXT?5M4Q;*8[N_O@V\[9[0S7B\VV1D5TR?%H[BM#
M;$:R1D<=15QSS14[W-<J=.O4[L]%%T,E5ITQ1</LQQH7CCCNVM)>:ZGNF<Y?
MG=MJ\IK*3J6GB;3PSMIJ2%[VM<]L22/<KE:FKGN[-$0U'B?[[)?[BWO2VOAC
M[G._[>[OPL@-M:F
M
M
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M<3_?9+_<6]Z6U<,?<YW_ &]W?AN@VUJ8
M
M
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M10O=J=)X4                     <VWB1?/4I?Q9C7]T+VZG22%
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MP
M
M
M                      (Q<L.-%@Y/[83X;7U;++DUHF6XX3DSH^\2CK4:
MK59*U/2=#,U>B1$_X+T17,1 F)HYQLZXP\H]@\@JF5F"Y3;W4[EB@S'%F557
M03QJ[1KHZZA14:C^Q49)T/\ XS$7L"]8EYM@V(Y3;YWRF@I\#SG+ZY[U9\.7
MV*L92P=X_5RRW"XJR&/5=57JD15[?*"L.A'A/Q'H>+>"5S;O64][W*S-8)\R
MN].FM/ V%'=S04CG-:Y8HE>Y7.5$61RZZ(B-1I29JFN$
M     .;;Q(OGJ4OXLQK^Z%[=3I)"@
M  $7^8F"MSS8+.*:HRA,8MV-T<N1W5\S>JDJJ>U1/J7P5.C72(WT>MJL[4D:
MQ=%TT.[D<;!P[Y\M9M6S$QU8_FMZL=5Q8MEUT1LS28GM]27,EBM6_*I:B&EI
MGTSJ5C732/7JC17KHQB.:FJJ[15^M\B*<F[=VXN?Q)LPZ1,173J1F,:W MBZ
M[GHE?P[Y07'C#O+E6.[D6.LMF.Y!3R6B_P!C>QL%30W6C5SJ*2?O&HNG6KHG
M:JB,;)WGD:J.Q^+?.'9=%*S&GJZ.2)ZKO9; MQL6RVZZ+8NF(FZ=5L3/SIZV
MM.+9O#+QR)WEN63Y:UU5:*:J^&<NDT58G(KM*:@;KKHU_2C$37LC8[3M1#2,
MC@79[,S??JK6?@C_ !R/I;BG>^!PKN6S RLTOFW8P^?5\K$[%=JO+?='.MZ:
MUK&M8QJ,8Q$1K431$1/(B(;L^8IF9FLH*\%;C0V?8?.KM<ZEE%;;7N%FM7<*
MR3L9%!!7/DDD=IYFM:JJ"50G%J@KN4O/2FSR]1OEHF9%7[AW:)R=7<4UNF2:
MWP*GDZ&3NIH>W^#[OG+SHA;]RU_I%B/XNG^W'C7O.])P/$GOO8/=CZ-C^/'>
M;&M^7;.X;C>W]KRVQT#+I<<5M5QDJ_@J.H1[9H$:KI'MC<Y7*Z-RKJGU3/8&
M]-S;ORV6P\UAV[=V#AW5\G%VNW7,TF:UB6!Q]U[YWAF<SB97$NV+<;$MIY2;
M=5VJ(K$4I,- <CJ*U46?4;;-04]OH9[+23L@IH&T[%61\J]2QM:W153375-3
M2./<'"P]X6QA6Q;;.';-(C9US/)H;MP%C8N)N^Z<6Z;KHQ+HK,[6J(Y=*R(]
M^>!@
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M>VU\AMK+)NG9K'58[;[W45M/%:JV1DLS%HJF2F<KGQ^BO4L>J!,Q1NX(
M
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MZL\[K[HW1@[KP9P<&9FV9F[Y4UFLTZD<RV\^GWS$
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M5FU/D(
M                        --[G\>MD]YHWMW,VTLF553V=VEWF@[BXL8B(
MWI9<*98JIB:(G8V1/(GN!-5<6ZGA%[>WCUFOV@W!N>&5CD5\5AOL:72@5WF8
MR=G<U$3=/.[OE_\ B)VE;>YW 3E1M%.^X+@=1F%LH7]Y!DF%R.NB(L2]22)3
MQ-96Q]/8[J= U$]WL4+5A].V'/GE1LO4LM%1F-1F%LMKTBJ<6S:*2X.C[OT>
M[]8D='6Q=*=B-29&I_%!2%RW#OGG:>4V173 ZW *O#<SLMDFOM3/#5QUMLGI
M:>HIJ63HD<V&:.19*IBHQ8W)THO\YKHBE)BBP8(
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M^32!%_\ QT/!\+_YO$]?^?,_AS_Y7N^+_P##X8ISX,?^Y'_F6*GO#P@
M
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MVAM&Z&X.\FZ=%:=SMQKPUDT%735M14-H:?JG?.Z2"F>U'5-34/<Y.K_P;%[
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M;ME&,6ZLO4K&JUKJ[N6LJW-:J)HBS->J)_=\H1+<00
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M[Q&IL-#C[ZQE1=.^JJZ@JVR21TZ21,8C*1R*CI>M%5J='ET*W2N)"H
M              #FV\2+YZE+^+,:_NA>W4Z20H
M         &(W;<# [!726R^YM8++<H4:Z:WU]RI::=B/1'-5T<LC7(BHNJ:H
M=C#RF-B1M6673'/$3*EV+9;-)F([*"?$3=#;K%Z#ES<;]G%BMM,_D%GUWI>^
MN%,U]10JVC>R>!BR(LK'HQ>E6(J.T[-2(RN-,3,674BM=$Z*:Z\U.5-V);HB
ML:5#+,AN6\&]F6[B7=G>5N17BOO\T#T5R-DJYU]7A8NOH]TLC>A/,C#);@P+
M<3-VW7_-LB;[NM;I[]%<S%]UD8=D5NOF+8CGF[0FM2T[:6FIZ9GUE/&V-O\
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M
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MKY0K+:H
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M)RNTZNAR$3%71T%  !S;>)%\]2E_%F-?W0O;J=)(4
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MQ.:VV/I3,_\ "V#WG8],# P^>ZZ?HQ$?\2<I[&\=
M
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MSS'-:9%]0R?)IHJJ2B<]-'NI(888(8G+Y.M6.D1-41^BKJ1,U34"
M
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M7SI30,=V?V9E,C[LL#9R>+B=*^GT8C[3'^\S'VLYA8?1LK]*9^RE8>E/-0
M
M
M
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M]ZUIO'N/Y3>V)'1BVW^F+N_<WH;DTT
M
M
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MIRGI7#D68.[LOAUBNQ;HK&N8K/=EYMQ'-^-O',8E)IMW::3JB:1W(;&,\P(
M
M
M
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M3/?6@'T6^=0
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M>7-U=9ZYRP5E'.C8ZR@K(VM=+1UD37.2.6-'(JHBJBHK7-<YCFN4K,4;8"
M                   '-MXD7SU*7\68U_="]NITDA0
M          !"#F#_ $SX<?[;[+^#5(3"0F^.\^'[![:Y!N7FE2C+?9X^[MUL
M8]K:BXU\J+ZO14R+Y9)7)[FC6HY[O0:Y4$15SM[1[>;G>(=R3O.4YI63PX\V
MHBN&?WJGU;3VFTM<K:2UT'5JUKWM8L4*+JO8^9_6K7JXO.B$C^8=IL.&;K7S
M!\6ME/9+!9Z>S4UKM-*WIBIZ6FM%&R*-J=J_V575535555,_P+NS;WCF,W=J
MMB++>O=$3=VHB/I-IXMWY&'PMN_=]LZ;[L3$N\6W$OMM^E=,S_D:9Q7'XJ2"
M&YU"=Y5SL1\"*G9$UR=FGU53SF!X]XNQ,UC7Y' G9PK)I=,?QW1KCQ8GDY9T
MSR/2?=1[O<'(Y?#WIF8VL?$MBZR)C1AVW1HGQ[HY>2)I'*O-XH?L!P+_ ,Z_
ME6L,7N;T2SL]^6A>\G_[!F?\G_3L9#F_[8-C_P#2;\GQF%WQ^L[O_P#S_4AT
MMS_HV\/_ ,/UY;H-M:FUONOE-DQ?!\@DO%:VG?<Z"JHK;3)HLL\\T3F-;&S7
M5=%<BJOD1.U3 <3;RP,ED,6<6ZFU;=;;'+=,Q2D1V=/,S_#6[L?.Y["C"MKL
MW6W73R6Q$UK,]C1SJJ3YJ?2;/I[]@+\;2UTVW]1#D#8>G\Z'WF61SI5757NI
M4@;%IYD:FG9Y55>TS=^=W?.6\G;EIC%I]YY29T\^QLQ;V-'7G6PEF2WA&9\I
M=F8G"K]WY.(T<VWM3=V=/6C4P:"-LLT,3Y$A9(]K7RN\C45=%<O:GD,-9;%U
MT1,TJS-]TVVS,15)*V;0XK9\CL5RCWCPVYVRW7*EJ:V.6N@IY7P0S->]&M22
M9O4K471%737SGH&7X6RF7S.'B1GL"ZRV^V9K=;;,VQ,3---T5IU:- S'%&;S
M&6Q,.<CCVWW671%+9NB+IB8BNBV:5ZE7FNK:*Y<DJ6NMU7#7T53E-,^FK*:1
MLL4C>IGI,>Q5:Y/JHIUYQK,;B:+\.Z+K9QK:3$UB=,:IAV(P;\'AF;,2V;;H
MP;JQ,4F-$ZXE8R>]/!@
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MJ>U9'Z_$^"KFIW*R6*FZ%<Z9['(J.;&CE3W FCQMN.4W'O=N\)CVWVZUDO\
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M3MZNWZT)N=% 4                     <VWB1?/4I?Q9C7]T+VZG22%
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M$TK'62Z/47EX
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M1R0SSQQOZ5\B]+G(NG8%'YT]^L=7,RGI;U05-1*ND<$53$][E1->QK7*J]B
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MN=!(4                     <VWB1?/4I?Q9C7]T+VZG22%
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MCW8V-=6Z>U$<T<T0R [SH@
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MXPO:;#[/@> 6*#'L8L<7=T5!#JJN<[M?++(Y5?))([TGO>JN<OE4*,X
M                 YMO$B^>I2_BS&O[H7MU.DD*
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M5HBR)[M:\\NID_S7J._\W7RNQBS=77IF^8[E*<T+-CZ'?/0
M
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M/*C=_>Z]-D1<CJ6O]7M_?L2*5T#IW/EEE=&G=I([H1L:]VR-J:JI$RGV$
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M7FU)1<O6"@                    #FV\2+YZE+^+,:_NA>W4Z20H
M                   "#_'%4;R9YRN<J(B9+B2JJ^1$^!7!,ZE0',G>'(N8
MO):R[8[8J^]8Q8;C^:VWM'$_6GKJZ:5&5MT<K45$C>YO8_M1((VO]'5P6B*0
MZ ]BMGL=V'VLQ/;'&D22EQZE1+C<NCH?75\OIU=7(FJZ++(JJB:KTMT:G8U
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MHK%.BE@>F/,P
M
M
M                                         %)7BW[*9)=)<%WULE!-
M<K+8K8N,YB^%KGK0QI4R5-#42(U%TC>^HEC<]51$=W:?PPM;*Q7C?O\ [);C
M;5X&F$998;6^WV.AH*C!W5<%-6VJ2EIFQOI'TCW->C8N[5&N1O2YJ=355O:$
M3"0GYSXW_6&V??</\L(?71WBT7"5T-!=*.NF:U7NBIYXY7(U%1%<J,<JZ:JG
M:!Z(                     '-MXD7SU*7\68U_="]NITDA0
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MU[N]:FX>P/(0
M
M
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MGF2#-Y:.
M
M
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MEF>K/^-#PW>>\L;>.8NQ\::W73V(CDB.I'^-+(SON@
M
M
M
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MSS4\OXJXBOWOF:VUC"MT61_Q3U;NY%(YZ[>-I:N
M
M
M
M              !7-SKYE9UQ6NVW%OP_%[#D4>9TERJ*]]Y2J5T3J*2G8Q(_
M5YHDT<DRZZZ^1 M$50'^E]WM]F>#_8W+WX$[)]+[O;[,\'^QN7OP&RF-PBYW
M;B<G]UL@P'+L/QS'[;:,3J\@@K+0E6D[IZ>NH*5L;O6)Y6]"MJW*NB:ZHG;Y
M0B8HM+"H                    #FV\2+YZE+^+,:_NA>W4Z20H
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M;-X]OR[ODVXM]L:)YHNB-4=Q])9'AK=V9P<+:RN%==L1KP[)G57ECKRUVR;
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MIUJTZ\2N:/J5\L
M
M
M                                                   -$[Q\9]DM
M_P"IL-9NWA7YVU&,Q5$-CD^$KE0=PRJ<QTR:4%53H_J6-OUZ+IIV:=H3$T:6
M^CBX8^QO_K#D7^<P;4L!W&\+WC%DV-72AP3'Z_;C)W4[_@6^4MUN%?#'4HCE
MC]8@N$]4CXU<J(]&JUVGUKFKVA.U*+_A6Y9A=%FF=[77W![19MX,9MM7%0YM
M1Q=%5<+5%6PMKZ&K>UW=O?#.V%S'-;J]B+K]9JXFY=Z%
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M7B[&U.Q6G5ULA.-Q@
M
M
M                                                " G-+FE<^)]S
MV_M]OV_I<U3-:6X5$LM1<'T*TZT+X&(B(R";JZN^^IIH$Q%4(?IC,D]@]L^/
MYO>(6V6%Y7XNV[UUM-UH,6VWQO%*^MBDBH+U)/4W"6CZVJU)61O[J-\C-=6J
M]JMU3TF.3L!LL=\*?#LER;D9?]PEBFGLN)X_7+?KU+U.:^MNKVQP0J_SR2(D
MLG;YF.7RZ N=%X4                     <VWB1?/4I?Q9C7]T+VZG22%
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M5.GZNIC<SBX%\1Y.R;9Z]70Q\3!NC_3LFV>O5MHZ;J@
M
M
M
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M7>^H^L]/\YZOW_\ .=WU?6]?;IY3#8FSM3L5V>2NOLL7B;.U.S6G)76]@HH
M
M
M
M                       <L?B._/.WD_T>_P!7;8');J=3@<8
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M>**7X5]GSHF.O#WCC4
M
M
M                                        Y8_$=^>=O)_H]_J[; Y+
M=32'ZS>2/M!W*^-KQ]U!H/UF\D?:#N5\;7C[J#0?K-Y(^T'<KXVO'W4&A9)X
M7.8;MY!O_E]%GN4Y=>[/%M]<)J:DO]=7U-,VI;=;2UKV,JGN8CT8YZ(J)KHK
MO-J$7+YPH                     YMO$B^>I2_BS&O[H7MU.DD*
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M!CY[&Q[=G$NK'8<.-G,7&C9ONK'8;'K[=;[K2R4-TH*>Y44W9+1U43)HG?\
M=,>BM7^T=:VZ;9K$TEU[;IMFL313=S+?MS;=QJ;$L!Q6U6&HL%-UY76VR!M.
MV:LJD;(R#NX](T[J/155J(O4]47ZTW7<GEKL';Q+IFNJO-#;=T>5G"VK[IFN
MJO,A^BJBHJ+HJ=J*AF652'L&^^=V&ALMEW&L5-N?A;$;66>P9A3NGZ6:.C;-
M15<C5D3LU:BJKV(FJ(TQN)N_"OF;L*=B[EFWX8="_)8=TS.'.S=RS;\,,O\
MUL;+7O>7 ;S#M)9\<VZBI66W*[)4TL#V+-5N<V6L=W:=#FTZN8K55O4K6N[$
M5R(G#^3S%F7OM\I,WZXFO-R=EQ?E<>W NC;F;]<3UN3LK<\3V]P/"75<^&8I
M:L<=<V1MK9;;3QP=\V/58^I6(G4B=2Z?NFG8V9Q<7Y]TS3G:MBX^)B_/NF:<
M[-#@<(
M
M
M                           '+'XCOSSMY/\ 1[_5VV!R6ZG4X'&
M                    #FV\2+YZE+^+,:_NA>W4Z20H     !_$DC(F/EE>
MV..-JNDD<J(UK435555[$1$ T-F_*7CKMUWC,NWEQ6W54**Z6V05\==6M1/=
MI*-9YT^IZ';Y@FB(.;^*]QNQU9H,3MN4[@U+4_F*FCH66^B>O_"DKY(9V_XA
M0G9E$+-O& W(KUFBV]VGQ_&8EU;%57RKJ;O+IK]>C8$H&-54\R]2)_P@G90Q
MR_=W>S>^MN68;CP5=5:ZA\59'74UJ]4MK)%:V!KDECB1%ZFJU$ZGK]3RF+P,
MMDLOFK[[=F,;%I7Y7RKMF.2V9Y(YHZK)X^8SF/E;++MJ<'"K31\FW:GGB.6>
M>>HDO4;[;(2\2H=G&;5I'NJR=JKEB4U*D?>I6>L.N'KO5ZRLCH4[E8U;IIZ/
M5T(B&68A]/&^W5E)A]SK:B)8J>YW%SZ%7)IULCC:QST^IU(J?V%/%?>;F<._
M-86%;/RK;9KU-J=$=?17K3#VCW9Y;$LRN+BW1\FZZ(CJ[,36>MIIV);<OU%E
MU6_2P7JCM46FG5+3]])Y$[=7:M\NOF,-PWGN'LM;7>66Q<>[^6_8MY=&B8F=
M%.6--6V[]RN\\>VV,AC6X4Z=J;K=NO--NC13J[5>H_7&K5>;7!4?#=Y?>JNH
M<URSNU:QNFNJ,9V-:G;YD.#BS?.[MXXMGY#+1E\*V)C9B(VIU:;KZS=?/7G1
MR<LSS;DW?CY/ V<SC78N+.FZZ9T=:RRD19$=N=<\D1(JT;"[E7VU6Z\VRU4U
M1;[I3QU5',M7 Q71RM1S=6O<BHO;YT,CD/=YG<YE[,>S%PHMOMBZ(F;ZZ>>F
M',5ZTRP6=X\W?E,>_!OC$VK)F)I$4K'-\IZ/R;]V/^9*;[^IOY9W/VPWAY[!
M[>)__FZO[C[LZ.)]&/M,HGV.WLMFUN<8KCE-;(KON%+04=?U5S6/IK=2^LK4
MHYW2K%6?O&,1&N7T%?KHNAZ)[O.';^'\?%OS=]ET7;.SL;4Z;=K7M6V]+0U+
MB7BC([TQ<&ZR+XC#VOG1&F;MFE*3.K9GFY$7_D/[[_\ -]F^,F?R3U[U]E>>
M>TP_KG+\\]I,'BUL[NCM*F4V3/+#:J_&KG&EPM2P5$-3-%7QHC',:UZ-T;/'
MIJJKHBL;[JJ8;>V=P<SLW8<S%T:)ZW@8K>6;PL?9NLF:QH['@16SGBUR/SK+
M\ARZX8C;X*F_5LE3ZK%<Z%(X(U]&*%FDJ>C'&C6)]1#+9?>V4P<.+(NG1'-+
M)X.\LKA619%TZ.I+U]J^-W)+:_/L;S:W8K2R+9JIKJZD;=:)/6*21.[J8%UF
MT].-SD15\CM%\Q3-[SR>8PKL.;M?4G7R*9G>&5Q\.;)NU]2=:W(TYJP
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M15EOJXUU;+!.Q)(WM^HYJHIIE]DV73;.N&JW6S;,Q.N'WE50
M
M
M
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MRRVZ,QY#$LONG9BZL4IIKSS',V_<?!N9WME_+X=]EL;4VTFM=%.:)YU-/*W
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M1!B=D8[1%[4:D]8E=.S3W6R(OU3DPL'$Q9I9;,SU(KWD73;;%9FC!DV?YO\
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M/1LE1)%$^:1L;5[7*V-CG+IY$0M%DS$S$:(UK1;,Q,QR/N*J@
M
M
M
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M)V?\3O!-X-S<,VRMNU]^L]=F5P;;Z:YU-92R10N<USNI[6)U*GH^8$VK/0J
M
M
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MRJO9VJ%YU.GT.,
M
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MJ:H3A\.[MP[HNMR^'$Q-8G9C1,*8G$6\<2V;;L?$F)BDQM3IB6=F988
M                   .9OPMOG86C]&KU]J8')=J=,@<8
M         0$\3/YH&??C.P_E2G";=;5GA%?-NS;_ &E7+\CV8)NUK3@J
M                    %!7C"?M)V=_1JO\ PQ O:NBV+_8EL[^@^/?DVG"D
MMI@                        #F;V^_P!Z#7_[;\G_ "G7AR<CID#C
M
M
M                                        "K;E'P S#?\ WWBW<L^X
M%GQ^W1TMJIUM%92U$LZK;U])>N->GTO,%HFBTD*@
M     JFXC>'IF7'#>.BW-O>X=ER2AI;57V]ULH:6HBE5U6QK6N1TB].C=.T+
M3=5:R%0                        CERMV2NG(;93(]K+-?*7';A>ZJW5$
M5UK8WRPL2BJXJER.9'Z2]21Z($Q-&(<+>-M[XN[6W[ +]DM#E-9>,JJL@CN%
MOBEAB9%44-#2)$K9>U7(M(JZ^314!,U2\"                         K
MEYM<)<IY4Y3A&08_F]JQ2'%+546^HI[A3SS.E=-.DJ.:L2Z(B)V=H6B:)U[?
M8W/AN!81A]34LK:G%+!;;/45D2*UDKZ&ECIW2-1W:B.5FJ(H59>
M                *IL:\/3,K%RUJ>1DNX=EGLL^?W;,4QQE+4)5)!<:NHJ&
M0=XJ]'6U)D15\G8%MK0M9"H
M
M
M
M
M
M
M                                           #&LPS#&< QB]YGF5Y
MI\>QC':9U7>;Q5*J1PQ-T3R-17.<YRHUK6HKG.5&M17*B 5=WKQ>-EZ*\RT=
MEVXRZ]V:&1&)>7K1TCY&HNCGQT[IGKTZ=K>MS57SHT+;*>^PW(K:[D=BLN4[
M:7F2I;02-@OM@KHTI[E;9GHKF,JH$<]$1Z(JM>QSF.T5&N56N1")BC>00
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M/UZNB>]$6.>EJ&(G>4U5"_1\4K-4U:Y.U%1S55KFN4K1LD
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M4UZ'HQZ]O2UR(NA$Q1.@(
M
M
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MC9P
M
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MO]I5R_(]F!=K5F^)G\[_ #[\66'\ETX6MU.F3&/Z-X]^+*3[2P.-[@
M             4U>)URBJZ6&'B]MO4RU.0Y*E.[<>>BU=,RGJ%:ZEM$?1Z2O
MJ=6OE1/_  :L9VI(Y$+6PQW/=@<7XZ^&YNK89;E;*_<[,TQFZ9_54U1!-)ZR
ME_MJQ4$2QN<KHJ-CG-31517K)(FB/T0FM9?1X/MRMU#CV^45;7TU')47.P)3
MQSRLC<]>ZK4]%'*BKVJGD"+D-?$Y]9^5WFG?][W7P18O4N\ZNGNO@^+7N]>S
MIZ^KR=G5KY]0M;J=$N,?L2Q[]!Z3\FL"CG3\,SYW^ _BR_?DNH"]VIU !Q@
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MX-?_ +QW^B'_ *[";FJ_%]_;;MG^@[?RE6 M7#<1/FO;"?H/9_P5@5G6D6$
M
M
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M2QTR.17=JZ]WKV]H<;,P
M
M
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MI-%5J/1KG(HF:II!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                       #GWY]<GM_ML^3>98A@6Z=
M[Q?&:"@L\M'9J*2-L,;Y[?!+*K4<QR^D]RJO:%XC0C!0\G>==SI(*^VY]N'<
M*&J;UTU;344LL4C?XS'LIE:Y/JHH32'L6+G_ ,RMN;O##>L]J[HM&Y'56-Y7
M:J:1)6]2NZ97.@AJFHNJIJR5JZ=FO8@*0O#X>\Q<5Y48U71K0QXMN3C$;'95
MB'>K(QT+UZ&5U$]R(Y\#G=CD5.J)RHURJCF/>4F*)F!
M
M
M
M
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M J
M
M
M
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MQ2>LL6AH7U/JCVP*FK?5T?T(GI+V!$U6KA4
M
M
M
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M'8[;C;5(V-K\?M$;K_(S14DNE6JU->Y'(B=3?6)7HU5_@HB>8*3-4"=]^?\
MQ?NF07;9S<_9._Y=#8;Y)9\E9D=OM[:6@F@E[B>HIU2IJ)]8]%5'1M8Y43T%
M[4"8B7LY/X8W%+<FT09=MGDEXPVTW:F2LM5QLESCNMGDA>WJ25OKJ3R.;Y_1
MJ$1.U/W!M2HHN=NNFU&]=7:MO,H9DUZP'+G4V&Y;:$U975-OK.BDJ:=K'R(O
M>N8U41KG(NNB.<G:I=V2!Q
M
M
M
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M&7V"9E7CEFHJ=T-JH*N/M94N=*JR5,D;M'1JK6-8[TNESD:J$3<M."H
M
M
M
M
M                       UIO-0Y5<MHMSZ'!:NMH<WJ,5N[<.JK=*L-4VZ
MI1RK1=U(G:URS(U-4[00YP\QV7\0G>^OMUBW!Q'<?+4MLR_!T&0/?#;8)>R)
M96/J7Q4K7*BZ+(BZJFJZJFH<E87.\%.),O&# [O-E4])<-S,YEAGR:HHU[R"
MBIJ9')34$,KD17]*O<^1R(B.<[3M1C7*4F:IU!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\BHUSH)^AW3U(CFN:YBZ]*/<5F*):!
M
M                    /QJ*B"DIYZJIE;!34T;I:B=ZZ-8QB*YSG*OD1$35
M28B9FD)B*S2&&XON9M]FU946_$,RM.25M)#ZQ4TMOJHYWQQ=2,ZW-8JJB=3D
M34YL7*XN%%;[9B.K#EQ<OB845OMF.NS@X'"
M
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MK:#3VK@
M
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M=#N^ ^CRLWM2K?BJ/WR/:2[S<=OP'KZ[H=WP'T>5F]J5;\51^^1[27>;CM^
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M=#N^ ^CRLWM2K?BJ/WR/:2[S<=OP'KZ[H=WP'T>5F]J5;\51^^1[27>;CM^
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M94PRS=\V*16N>JM9V(B=7F0Q&>S]^:NK.B.:NAB\YG;\S=6=$<W(W<=!TP
M
M
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M')KT(Z"..-Z=COYQ/,$72NR"H  YMO"@^=#</T'NWX50A>[4Z20H
M                  !4KXOO[$ML_P!.&_DVL"UJ1?AQ?,QV;_TA_P!8KF$7
M:TWPA!;EK_2+$?Q=/]N/&O>=Z3@>)/?>R>['T;'\>.\F%A/]#,1_$M!^#QGJ
MFZ/0L#^W9]6'EF]_3<?^Y?\ 6E3-XAO[>Z/]%+=]OJSV#A#T*?'GO0TS>OWW
M8AZ?*GYX+/\ +<9^U4I\\[V]/[-OP/MCW;__ $[_ "XW?N76F[ODD
M
M
M
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MY<;OW+K3=WR2
M
M
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M:;N^20
M
M
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MY)
M
M
M                                       0SYS<=,MY-;.VO!L)NUKM
M-^L634N10?"[I8Z>H;345;2N@[R&.5S'.6K1456JG9HNFNJ$Q-% -^VPY;</
MK^Z_OM>6;:R0O:U<NLDSY;34M1=6,EJZ1TE-(UVFO=3+K_&8%]$IE;,^+5N'
MC_JEJWKP^DSZW,5K)<GLO1;;JUO\)\E/IZK.[W$:D'U5")M6T;*\OM@-^W4M
M#@>=TS<FJ6=287=T^#[MJC5>]L=/*NDZL:BJY8'2-1/.%9BB3 0
M       .;;PH/G0W#]![M^%4(7NU.DD*                           5
M*^+[^Q+;/].&_DVL"UJ1?AQ?,QV;_P!(?]8KF$7:TWPA!;EK_2+$?Q=/]N/&
MO>=Z3@>)/?>R>['T;'\>.\F%A/\ 0S$?Q+0?@\9ZINCT+ _MV?5AY9O?TW'_
M +E_UI4S>(;^WNC_ $4MWV^K/8.$/0I\>>]#3-Z_?=B'I\J?G@L_RW&?M5*?
M/.]O3^S;\#[8]V__ -._RXW?N76F[ODD
M
M
M
M        !^<TT-/#+45$K(((&.DGGD<C6,8U-7.<Y=$1$1-550(4;Q<_>+NU
MD5?:Z_,XMP[RUKX:C%\4C9=>O^ ^.6IZV4;=.U'-=-U>7T5\@3$2H*Y);][8
M[SW:>LP+CMC&TJOJ%E??K?-4?"-0FNKEDAI74MO3O5])^M,]Z+Y)/*KB\0D+
MX>_'+>NIWYVRW:EV]NEJV[QRIJ:RNRBYQI0PR13T-1#&M*VH5DE0CGR-36)K
MD3SJ@1=+I+"@                YMO"@^=#</T'NWX50A>[4Z20H
M                   !4KXOO[$ML_TX;^3:P+6I%^'%\S'9O_2'_6*YA%VM
M-\(06Y:_TBQ'\73_ &X\:]YWI.!XD]][)[L?1L?QX[R86$_T,Q'\2T'X/&>J
M;H]"P/[=GU8>6;W]-Q_[E_UI4S>(;^WNC_12W?;ZL]@X0]"GQY[T-,WK]]V(
M>GRI^>"S_+<9^U4I\\[V]/[-OP/MCW;_ /T[_+C=^Y=:;N^20
M
M
M
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M1&FKO253([JXNR&\L?R&!-VU29TQ34QN]>$L]NW \MC1;LUB-$UUMLFSM9
M
M
M
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M[E;Q\WA=J[[9\E+;O_GG(_OBD]Z#]M-V^<Q>W;]@_<K>/F\+M7?;/DI;=_\
M/.1_?%)[T'[:;M\YB]NW[!^Y6\?-X7:N^VT+QQB;3[N) Q55D-'7QL5WET:B
M(FOD]PTK@*V+=\;,<EM[=./;INW/6>6ZQ8J>\/"
M
M
M
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M^37$\)X$_6IZU[W7CK]&CKV+$#W9X4
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M*HI8IXHYH9&S0S-1\4K%1S7-<FJ.:J=BHJ>10/[
M
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M[L\*
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M"UJV'&/Z-X]^+*3[2P*O<
M                                                         #SK
MO>+18+=5WB^W2CLMIH&++772OGCIJ:%B>5TDLKFL:B>ZJ@0!W<\33C9MOZU0
M8U=:S=B_P*YC:3&XT]021%T_G+E/T1.:J>1T"2A:+94A<C.3'RCKVL]%LIA6
M SU=6DD-=8J!9+]5O>[L95W!J1>LN<JZ=D#54+1%$K. _$'?^W[W;<[Q9)@E
M3AN#8Q45%945=_7U&KJ63T51 Q*>B>BU"ZNE:O4]C6*G:CE")ET0!0
M          <VWA0?.AN'Z#W;\*H0O=J=)(4
M         YMN<W^\'C_&>&?:*(+QJ=)(4   "N_CQ^V.7_)KB>$\"?K4]:][
MKQU^C1U[%B![L\*
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M;;;?;A?!OP-^?>-6G(O@COO6/5?A2CBJ^X[[HB[SN^]Z>KH;U::]*>0*,X
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M7?J*!S&O8]R)U-FIYGHU5]/T'(]SM&:$Q-711C']&\>_%E)]I8%'N
M
M                             !6#XK]LJ;UL#MW:*)]-'67'="U04[ZR
MJIZ*G:Y]IN[$66IJI(H8F(KDU?(]K4\ZH%K42]B/"@N^5T-KRC=[<J@MEBKV
MMG@L.&RQ7*HFB5=%1US<CJ6->SRQ,G:O\;S!,W+<-G>+6Q.Q,,3MNMOK?;[N
MUB-ERFL1:Z[2+IHY?7*A7R1H[756Q*QG_!\@5F:I!!
M<VWA0?.AN'Z#W;\*H0O=J=)(4                                  Y
MMN<W^\'C_&>&?:*(+QJ=)(4   "N_CQ^V.7_ ":XGA/ GZU/6O>Z\=?HT=>Q
M8@>[/"@
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M'OQ92?:6!5[@
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MPS[11!>-3I)"@   5W\>/VQR_P"37$\)X$_6IZU[W7CK]&CKV+$#W9X4
M
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MS5 H](
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MVH%]"=?!WY;OZ^;?^O?]9OY@? UR]8_.GUWX/]:Z&]QU=_Z'7KKTA6:+I0J
M .;;PH/G0W#]![M^%4(7NU.DD*
M<VW.;_>#Q_C/#/M%$%XU.DD*   !7?QX_;'+_DUQ/">!/UJ>M>]UXZ_1HZ]B
MQ ]V>%
M
M
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MF;\O?,3=9.F8U:HGEZ[)3(,>
M
M
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M(O\ .83M2?1Q<,?8W_UAR+_.8-J52OA0?.AN'Z#W;\*H0M=J=)(4
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MVL
M
M
M                       T9R Y"8'QLPVV9SN'#=9[+=;U#8J5EHIXZF?U
MJ>GJ*EBN9)+"B,Z*5^JZ^73L"8BJ('TK_%[_ )OSCXII??P3LR\6Z>+AQRI&
MS-MN'[@7:=K.JG5*"VP0/?YFN>^Y=;?JKW:_V0;*L+9?</*-^_$ P+<N&V?!
M]VRS.Z:ZS6JD<KTI;;1L_G8UDT9UI%10*CW:)U:*NG;H%IT0ZB0XP     ,)
MW+J[Q0;<Y_78]25%??Z+&[K/8Z&DB?/435D='*Z".&*-KWO>Z1$1K6M557L1
M%4"E#PO-C-S<)WURS*=Q=L,KPJCH\+JJ6S5V062OMD#ZNIKJ+5(I:J*)KGI$
MQ_HIKV*J^8+W2OE"BK7Q&.&V4[]08[NAM911W3/\4H'VJ]8ZZ5D,ESM;9'SP
M^K.D5L??0222>BY4ZVOT1>IC6N+6S17YB_*+GYMI@<&R%#A600S6NE;:K#<;
MABM?+D%OI6M6.*GIGN8C7(QO9&LD3W-1&HUVB($TA*CP].#F;X?F--O]O;:I
MK#=K=%.N"X=<$UKTJ:N-8Y+C7L<JK$K8WO;'&].\ZW=;D8K&]1%TKI0J  .;
M;PH/G0W#]![M^%4(7NU.DD*                                  4<\
MN:FGH^8,M95S,IZ6EJL:FJ:B1>EC(XX*9SG.5?(B(FJGJ'#]LW;KI&N8O[\M
M<STTS/:6M_*/V$]KV*?&<'\HT+U-G?,W]J6;_-X/2CMJ [[E.-R^)7!F4=\H
MI,43<ZW71<A;,Q:3U)BPRNJ.^UZ>A&(JJNOD.E^7Q(Q/);,[=:4Y:\SL[=NQ
MM5T4UK_/E'[">U[%/C.#^4=WU-G?,W]J76_-X/2CMGRC]A/:]BGQG!_*'J;.
M^9O[4GYO!Z4=L^4?L)[7L4^,X/Y0]39WS-_:D_-X/2CMGRC]A/:]BGQG!_*'
MJ;.^9O[4GYO!Z4=MEF([J[;9[6U-MPK.+-E%?1P>LU=';:N.HDCAZD9WCFL5
M51.IR)K]4Z^8R&8R\1=BV76Q//%%\/'LQ)I;,2S\ZCE    !$KEK_1W$?QC/
M]I0\P]YWHV!X\]YZ=[L?2<?Q([[;6Q7[)L-_R:?\)E-HX,_2,#K3]:6L<9_J
M^/UX^K#;9L[6
M
M
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M'\2.^VUL5^R;#?\ )I_PF4VC@S](P.M/UI:QQG^KX_7CZL-MFSM8
M
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MKJ$S%$I @
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MKFM;T."LQ19X%0               !S;>%!\Z&X?H/=OPJA"]VITDA0
M                               YMLA_WJ%/_M=MGVV +\CI)"@  Q3.
M_P"@^9?B.X_@TASY7[ZSQH[ZF+\R>M*I7PW/VIYU^BB_AU,>@<9^C6>/\$L'
MNG[R[K?"N5/.&?    !$KEK_ $=Q'\8S_:4/,/>=Z-@>//>>G>['TG'\2.^V
MUL5^R;#?\FG_  F4VC@S](P.M/UI:QQG^KX_7CZL-MFSM8
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M-OU3<M^MVL;GFAN.SN>4%;-+$G_B\-QN=?$RJUT718ZJ&G:FO9Z8<CJFVEW
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M45%1=45 A^H
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M<&Q>BK).]Q?<NIPZ6J<Y$=+"^JGL\R.5J:+WC'N1=.SM"\ZG50'&
M        .;;PH/G0W#]![M^%4(7NU.DD*
M         '-MD/\ O4*?_:[;/ML 7Y'22%  !BF=_P!!\R_$=Q_!I#GROWUG
MC1WU,7YD]:52OAN?M3SK]%%_#J8] XS]&L\?X)8/=/WEW6^%<J><,^    ")
M7+7^CN(_C&?[2AYA[SO1L#QY[ST[W8^DX_B1WVVMBOV38;_DT_X3*;1P9^D8
M'6GZTM8XS_5\?KQ]6&VS9VL
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ME;&YE&Z2K@@>[NI>\Z/1T1BM:FB-0$RE2$
M
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MM^%4(7NU.DD*                                    '-MD/^]0I_\
M:[;/ML 7Y'22%  !BF=_T'S+\1W'\&D.?*_?6>-'?4Q?F3UI5*^&Y^U/.OT4
M7\.ICT#C/T:SQ_@E@]T_>7=;X5RIYPSX    (E<M?Z.XC^,9_M*'F'O.]&P/
M'GO/3O=CZ3C^)'?;:V*_9-AO^33_ (3*;1P9^D8'6GZTM8XS_5\?KQ]6&VS9
MVL
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MAE2"G56Q]ZUNJL_^- F8HE2$
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M>['TG'\2.^VUL5^R;#?\FG_"93:.#/TC ZT_6EK'&?ZOC]>/JPVV;.U@
M
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M!2M])[E55?)-,_1%?+*]5>]R]KG*JA5G(
M
M                       <VWA0?.AN'Z#W;\*H0O=J=)(4
M                        .6SD)GTVUG/O.MQZ>V,O,^$9_#>8K3)*L#*A
MU)W,B1ND1KU:CM-->E?W Y(U)=?3&9)[![9\?S>\0C9/IC,D]@]L^/YO>(-E
M)3BAXB%YY);NT>V-;M;18G!56NNN"WB"ZR5;VK2,:Y&=TZEB3TM?+U=@1-M%
MC6=_T'S+\1W'\&D.?*_?6>-'?<6+\R>M*I7PW/VIYU^BB_AU,>@<9^C6>/\
M!+![I^\NZWPKE3SAGP    1*Y:_T=Q'\8S_:4/,/>=Z-@>//>>G>['TG'\2.
M^VUL5^R;#?\ )I_PF4VC@S](P.M/UI:QQG^KX_7CZL-MFSM8
M
M
M
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MG>['TG'\2.^VUL5^R;#?\FG_  F4VC@S](P.M/UI:QQG^KX_7CZL-MFSM8
M
M
M
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M(HZ( H                .;;PH/G0W#]![M^%4(7NU.DD*
M                           YMO#=^>I5?BS)?[H7NU.A[._Z#YE^([C^
M#2'/E?OK/&CON'%^9/6E4KX;G[4\Z_11?PZF/0.,_1K/'^"6#W3]Y=UOA7*G
MG#/@    B5RU_H[B/XQG^TH>8>\[T; \>>\].]V/I./XD=]MK8K]DV&_Y-/^
M$RFT<&?I&!UI^M+6.,_U?'Z\?5AMLV=K
M
M
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M[;6Q7[)L-_R:?\)E-HX,_2,#K3]:6L<9_J^/UX^K#;9L[6
M
M
M
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MA0?.AN'Z#W;\*H0O=J=)(4
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M3*;1P9^D8'6GZTM8XS_5\?KQ]6&VS9VL
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M0R4$\,*4JV]]$QRR=ZGI=7KK=-/XJA,15+<(
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MCJ!#C                '-MX4'SH;A^@]V_"J$+W:G22%
M                          <VWAN_/4JOQ9DO]T+W:G22% "/_*CYO.['
MXCD^V,,MN+T["\9U<[]S=UD*O#*_^S;_ *-_^M39N-O_ $?\_P#PL?N?^/L?
M"M5-#9H  1*Y:_T=Q'\8S_:4/,/>=Z-@>//>>G>['TG'\2.^VUL5^R;#?\FG
M_"93:.#/TC ZT_6EK'&?ZOC]>/JPVV;.U@
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M+_BEUC;3W*B[W7H>^-CY&/C<J*B/C>YNO8JH[L")BB100
M
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M']   '-MX4'SH;A^@]V_"J$+W:G22%
M          <VWAN_/4JOQ9DO]T+W:G22% "/_*CYO.['XCD^V,,MN+T["\9U
M<[]S=UD*O#*_^S;_ *-_^M39N-O_ $?\_P#PL?N?^/L?"M5-#9H  1*Y:_T=
MQ'\8S_:4/,/>=Z-@>//>>G>['TG'\2.^VUL5^R;#?\FG_"93:.#/TC ZT_6E
MK'&?ZOC]>/JPVV;.U@
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M540L8QNB-]:@BJNA/1:]6_6MT1"^N%WX4
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M&SR,Z)-/KM 70N]"@  YMO"@^=#</T'NWX50A>[4Z20H
M                       #FV\-WYZE5^+,E_NA>[4Z20H 1_Y4?-YW8_$<
MGVQAEMQ>G87C.KG?N;NLA5X97_V;?]&__6ILW&W_ */^?_A8_<_\?8^%:J:&
MS0  B5RU_H[B/XQG^TH>8>\[T; \>>\].]V/I./XD=]MK8K]DV&_Y-/^$RFT
M<&?I&!UI^M+6.,_U?'Z\?5AMLV=K
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M4,IXW-^N1$D;JWT@OJA>&%
M                                                      "I'Q;7
M97==M]K,2QW'+K?*"IO];?;Y56ZCJ*F*E^#J5*>#UA\3'-CZ_7I%;U>7I73R
M*%K4#]J]E?$6EVEL]5M:N7X?MY1I47:P6:VWN#'JJL2=5EDF2E944U3.DGE9
MWJ+UIIW>K>D)K"2_!CGMN37;E6K8C?VXS7Y<AJW6G&<IN,20W2@NK55K*&O7
MI8Z5LTB=VU7IWC9%1KE5J^@)A''Q5;C/6\IUII558[/A]GI*9%<JZ,<^IJ5T
M1?)Z<[NQ/W?."W4OYV0HZ:;8?:&@DA;ZG+@5@IWT[4Z6]TZUP-5B(W31-.SL
M"LN<?PVZJHI^9.TT4,BLCKHL@@JVZ(O7&EAN$J-[4[/3C:O9[@7NU+P^=/(S
M-^,>TF.Y[@5KL=WO%WRZDL%337^"IJ*9M-44%?5.>QM+4TKT>CZ5B(JO5-%=
MZ.NBH4B*JH_I=>2/]2=M?BV\?YY"VS!]+KR1_J3MK\6WC_/(-F'A^%!\Z&X?
MH/=OPJA!=J=)(4                                       !R$;5;Z
MY;QUWFO&Y6$VZT72^TLMUM\=)>X:B>D6*KD5KU5E-44S^I$3L]/3ZBAR4JF5
M]+KR1_J3MK\6WC_/(1LP?2Z\D?ZD[:_%MX_SR#9AA^?^)_O[N/AN0X/?,1V_
MI;3DM(M'75%#;[JRH8QRHY5C=+=96(O9YVJ=C*9J[+8MN+;2MLUBNI3%P8Q+
M9MG5*8_A'Y9<<H^4#Z_#30^H_FIW7J[7MU[WX8UZNM[_ .(FAWMZ;YQMX[/E
M(MC9K2E>6G/,\SKX&3LR]=F9T\_47+&)=@  1*Y:_P!'<1_&,_VE#S#WG>C8
M'CSWGIWNQ])Q_$COH-_+5W3VPTP2P6#%:NT8\B1453<*6NDJ7-E3OG=XZ*NB
M8J]4BHFC$[".&M^8V!N["P[8MI$3KB>E/5>P3[I=U;Y_^;CXF-%^)IF+;K(M
MT?)T5P[IU1SR?2);U_U7PC[RN7^<C.>T>8Z-O:GXT?L7N3SV8^EA_P#^2V;;
MC(JW+]O,#RVYQ007'*,=M=WN$%,US8&3UM)%/(V)KW/<C$<]4:BN5=/*JFVY
M;$G%PK+YUS;$]N'S1O[(V9#>.8RV',S;A8M]D3.NEETVQ6D1%:1II$=9F9SL
M2
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MN,[8XXVTPUKF2WF[SO6HN%PEC14:^JJ7^D[IZEZ6IHQNJ]+6ZJ$3-6Z @
M
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ML/7->2]8GL=^Q39_]",?_)M.;'D?1\/Q;>]#POC#];SW^XQ?^I<VD=IK@
M
M
M
M               _B2-DK'Q2L;)'(U6R1N1%:YJIHJ*B]BHJ 1'W8X0<7=TJ
M>LKLCVWMN+W%(WR391C:I9*B/1-732>KHVGD5$3573Q/":RH:Y1<=]@-GZBK
M_5=R8M.X-PBEZ4P9U.^LK8FI]<CKI;&RT3GM\[9$A7S!>):*VKY#;U;*5+)]
MLMQKQC%.C^\ELS)DJ+;*Y==5EH*A):9Z]J]KH]4U[%":+?\ BSXHTN:9-C^W
M6_-AH+1<+_4PVZT;A6='PTBU4SDCA9<*1[G]TDCU1%FC?T-54UC8S5S2DVKE
M@J    "*/+?BIC/*C!**P7"Y+C>6XS/+68;E;8N_2GDF:C9Z>>+J:KX)T8WJ
M1KD<CFL<BKTJUQ,314'3<"^?F!4]WP7",H?%A=Y>K+HRP9=)06FK;+Z#WS4D
MLE-([5J>EK#JJ=G;Y M6$\^$_A]TW'N[MW-W+NM%D^YZ4[X;%16[K=;[*R=B
MLF>R61K'3SO8Y6*[H:UB*Y&]6O6$3-4C^6G%S&^4NWL.-7"M2PY7CLLM;A&4
M='>)2U,K$;)#,Q%1703HUJ2(G:G2UR=K=%(B:*:Y/#RYS6^W5FV5!=X)MNJV
ML2:KH*7*GQX_/*UR.;4R6][HW.5%:BZK3]6N@6VH6S\+^']JXK8C=?A"Z0Y+
MN/EZPNRR_4S7-I8HJ?J6&CHDD:U_=,5ZN<]R(Z1RZJB(UK6E9FJ:H0  .;;P
MH/G0W#]![M^%4(7NU.DD*
M    $6.;GS3]]/T:E^VQA,:U=/@U_P#O'?Z(?^NPM<N]"@  B5RU_H[B/XQG
M^TH>8>\[T; \>>\].]V/I./XD=]MK8K]DV&_Y-/^$RFT<&?I&!UI^M+6.,_U
M?'Z\?5A7]XD?_+>T_P#D-W^V4IQ<2_.P^M/P/;/<)]QG/&P^]>L*V._8IL_^
MA&/_ )-IS8LCZ/A^+;WH>'\8?K>>_P!QB_\ 4N;2.TUP
M
M
M
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M=+U:]NO4JZZAQLG               YMO"@^=#</T'NWX50A>[4Z20H
M                                      18YN?-/WT_1J7[;&$QK5T^
M#7_[QW^B'_KL+7+O0H  (E<M?Z.XC^,9_M*'F'O.]&P/'GO/3O=CZ3C^)'?;
M:V*_9-AO^33_ (3*;1P9^D8'6GZTM8XS_5\?KQ]6%?WB1_\ +>T_^0W?[92G
M%Q+\[#ZT_ ]L]PGW&<\;#[UZPK8[]BFS_P"A&/\ Y-IS8LCZ/A^+;WH>'\8?
MK>>_W&+_ -2YM([37
M
M
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M"MCOV*;/_H1C_P"3:<V+(^CX?BV]Z'A_&'ZWGO\ <8O_ %+FTCM-<
M
M
M
M          (<<X.-\/([9:Z6NU4;)=P\.26];?5"JC7/J6,3OZ'J7^#5QMZ$
M151.\2-SET:$Q-'-%G6Q6\FV-HI[_N'MED>%V6KK&6^ENEWH)J6"2JDCDE9"
MU\C417JR)[D3W&K[@<E7VX?QXWSW!L-+E&$;391E>.UKY8Z2]6RVSU%-(^%Z
MQR-;(QJHJM>U6K]4%63_ "1.4/L$SCXGJOY 16$V>$W!'>^#>S"-Q]S\-J<#
MPW ;A%>T;=7QQUM;64S5DI(8*9KG2(C9NASW2-:G2BHBJ[L0B9="X4
M          '-MX4'SH;A^@]V_"J$+W:G22%
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MV+(^CX?BV]Z'A_&'ZWGO]QB_]2YM([37
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M9UA=VBO>+Y-2MK+/<XD5$DC55:J.:Y$<Q['-5CVN1%:Y%:J(J*%65@
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M[&+E@LF=TV)4.1S+6/JYZ9U='0S53'1U#8EZE5SX_0TZ>G74+;*YD*@
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M?1\/Q;>]#P_C#];SW^XQ?^I<VD=IK@
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M7O9(HU?W?K%-*K(EEBZ_0?JQKHW^B]NBL<\B8HE\$
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MK"O[Q(_^6]I_\AN_VRE.+B7YV'UI^![9[A/N,YXV'WKUA6QW[%-G_P!",?\
MR;3FQ9'T?#\6WO0\/XP_6\]_N,7_ *ES:1VFN
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M\CWR.J\6ZI'*YVEPG\JKK_Y*1[/9G^7M^!V;??9N&(ILXWT+?MOX^C]WV_\
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M64.X.9MG;>ZEE;*E(]*KNUJ$2D:J1_SLD397*Y%7K])- FJ0 0
M                                              JTYW<W=UN,&XF'
MXC@./XG=[;D&.)=ZR?(*2NJ)VSK5ST_3&ZEKZ1J,Z8D716JNNO;Y@M$50=^E
MUY(_U)VU^+;Q_GD)V8/I=>2/]2=M?BV\?YY!LP?2Z\D?ZD[:_%MX_P \@V8;
MZXP^)'OEO5OOMYM?E.*X+06#+:RII[E66JAN<58QL-'/4-6)\]SGC1>J)$7J
MC7LU_=!-J[,*                #FV\*#YT-P_0>[?A5"%[M3I)"@
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MYB'@^+;%M]T1JB9?2<CC
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M9BD+3 J
M   T7NGQIV.WLO%NO^Z.W])EUWM-'\'V^MJ*BLA=%3=X^7NT2GGB:J=;W+JJ
M:]H35K#Y 7$#V)VS[^NGOP%9/D!<0/8G;/OZZ>_ 5D^0%Q ]B=L^_KI[\!66
M5X1PZXU;;Y59\VPG:N@L&4V"1\MHN\577R/@?)&^%RHV:I>Q=6/<G:U?*"LI
M,!                 YMO"@^=#</T'NWX50A>[4Z20H
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MKSWWVG,X@
M                   #Y+A04ETH*VV5\*5%#<:>2EK8%56H^*9JL>W5JHJ:
MM54[%U U[MKLSM9L[3W:EVQP>V87!?9(I;PRW1JQ:A\".;$LBN<Y5Z$>[1->
MS5?=!5LT#P<GQC'\TQ^[8KE5II[[CM]IW4EWM%6WKAGA?Y6/3L]P#6UHX\;*
M6#!<AVRL^W5JM^ 974)5Y%BD39/4ZN=O=:22,5Z^E_,1ZJBIKTM]P)JSW"<(
MQ/;G&+9AF#V*FQK%K-WWP79*-%;#!ZQ-)42]".55]*65SE[?*H0QO<K9C:W>
M*"TTVYV$V[,X+"^:6SQ7!KG)3OJ$8DJLZ7-^N1C=?W 5;%K*.DN-)56^X4L-
M=05T+Z>MHJAC989H96JR2.2-Z*US7-545%314 T%A7%#COMSFM-N)@^U=IQK
M,*%:A:"[T;JAJ4_K<3X)NY@=,L,?5'(YGHL31%5$T":LXPS9C:W;S(LERW"<
M)MV.9)F#WRY/>*1KFS5KY)G3O657.5%UD<KNQ/*$5;.  :KL&R.T^+YY>MS\
M?P6V6K/\B]9^&\J@8]*JI];D;+/UJKE3TWL15[/,"K:@&N]Q]IMN-WK70V3<
MO$*#,;3;*KUZ@H;@USF15'0Z/O&HUS>WH>Y/[(*O:K<(Q.Y89+MY76*FJ<*F
MM3;)+CCT7U=UO;$D"4RIKKT)&B-\OD T%\B/B?["\:_Q4OW0)K)\B/B?["\:
M_P 5+]T!66<[>\;]C-J+\_*-NML[/B.024LE"^ZT#'ME6GE<QSX]7/<FCE8U
M5[/,"KVKILCM/>]PK=NO=L%ME=N+:.Y^#<NE8Y:N'U=JMBZ7(Y$]%'*B=@15
MM0#\*JEIJVFJ**MIXJNCJXGPU=),QLD4L4C5:]CV.14<UR*J*BIHJ :/Q7C'
ML)@]-D]'B6V-HL%'FEHJ+#E=)2=\V*OMU4U634\[.\5KFN:JIY-4U714U4)J
MP_Y$?$_V%XU_BI?N@*R?(CXG^PO&O\5+]T!66Z-N=K=O=H[)58WMKBE#A]BK
M:Y]RJ[9;VN;%)5R110OF5'.<O4K(6-_<:@0S\#6.1[,;6Y=G./;F9+A-NO&>
M8FRGBQS**AKEJJ-E)-)40)&J.1$Z)97N35/*J@JV<!K';79C:W9V"[4VV.$V
M[#(+\^&6\16]KFI4/IT>D2OZG.^M1[M/W05??N-M;M[NY9*7&]RL4H<PL5%7
M,N5);+@USHHZN.*6%DR(US5ZD9,]O[CE RVVV>UV>ST&/VVABI++:Z.*WT%M
M:FL45+!&D4<*-77T6L:C=%\P$7;WP4XE9#?ER2Y;)V9MS=*Z=[**>NH*-SW+
MJJNH:.IAIE15\RQZ!-9;2NG'S9.\.P9:_;.PO;MHYKL!ABID@BM2MECF1::.
M%6,;_.1,=Y/*FH*MQ!#2VYW'38[>61*G<O;*R93<6L;&EZEA6GN/=L^MC]>I
MG15'2GF;WFGU FK6&*\#^)&&W.&[V;92TS5L#D?%\+U5PO,*.3R+W%SJJJ+L
M_P"Y!64M8HHH(HX88VPPPM1D43$1K6M:FB-:B=B(B>1 AJG;S8K:+:>Y7B\[
M=8%:\4NV0,;%>KE1L>L]2QKUDTDDD<]RZO7J7M[5[5":MLA#X;G;+?>K;<+/
M=J2*X6N[4TM'<J"9O5%/3SL6.6)[5\K7M<J*GN :FQ'CQLI@=AS#&,/VZM6/
MX]N!1+;LSM%*V1(+C2NBE@6.9JO75%CGD;V:+HY0FK*-N=K=O=H[)58WMKBE
M#A]BK:Y]RJ[9;VN;%)5R110OF5'.<O4K(6-_<:@0S\#5^Y6RNU.\45IBW.P2
MU9HVPNF?9EN,2O=3+4(Q)N[>U6N1']VWJ371=$]Q 59OCN/6?$[%:<9QZB;;
M;%8J6.BL]N8Y[V4]-"WIBB8LCG.1K&HC6IKV(B(G8@'L@:QKMF-K;GN+;]VJ
M_";=5;D6IC8K=F#VN];A8R)\+4:[JT[&2.;Y/(H*LSR3&[%F%@N^+Y/:Z>]X
M]?J62BO%IJF]<-1!*G2]CT]Q4]P#P-O=LL!VGL,F,;<8K0XA8)JN2OFM=O8K
M(WU,K6,?*[5557*V-J:JOD1 /%S+9':?<'*<>S;-,%MF197BG<_F[?*MCW3T
MGJTZU,7=JCD1.B55>FJ>4%6997B.+YU8;AB^9X_;\HQVZ,1EPLMSIV5-/*B+
MJU5CD14ZFJB*UR=K51%145 (QVK@1Q#LUW^&Z39*TS5G4C^YKJNXUU)JG_\
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MAE_N[>M'>>'YC[R[KSWWVG,X@
M
M
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M[M^%4(7NU.DD*
M@KXAO[!*/]*[=]HJS:>$/39\2>_#&[U^Y[,'AY?L$K/TKN/VBD'%_IL>)'?D
MW5]SV91C\83]FVSOZ2U_X&AJS*6IA\ OF@;)_BRN_*E8$3K1F\2/_EO:?_(;
MO]LI34^)?G8?6GX'TE[A/N,YXV'WKUA6QW[%-G_T(Q_\FTYL61]'P_%M[T/#
M^,/UO/?[C%_ZER(/*/\ :7!^):7[9,>)^\?]3C^W;W[GJ7NY_3)_N7=ZU8';
M?^3J#_)HO_D(>X9?[NWK1WGA^8^\NZ\]]]IS.(
M
M
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MMO\ R=0?Y-%_\A#W#+_=V]:.\\/S'WEW7GOOM.9Q
M
M
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MPH/G0W#]![M^%4(7NU.DD*
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M ":+_P"0A[AE_N[>M'>>'YC[R[KSWWVG,X@
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MS4(>^    ,9LF:X;DUTR&QXYEMER"]8C.RERNSVVOIZNJMD\BR-9%6PPR.?
M]RQ/1&R(U5Z7>XH&3        83F6Y>W.W3;>_<'/\;P1EW65MJ?D-UH[6E4
ML'0LJ0+5RQ=YT=XWJZ==-4U\J 97;[A07:@HKI:ZVGN5LN5/'56ZXTLC9H*B
M"9J/BEBE8JM>Q[51S7-545%U0#_:ZNH;70UESN=9!;K;;H)*JX7"JD;#!!!"
MU7R2RR/5&L8QJ*KG*NB)VJ!C^(9UA&X-MGO.!9C8\WL]-4NHJFZV"X4URIHZ
MEC&2.@?-2R2,:]K)&.5JKJB.:NFBH!E0           JTYW<(MUN3^XF'Y=@
M.08G:+;C^.):*R#(*NNIYW3I5SU'5&VEH*MJLZ94357(NNO9YPM$T0=^B*Y(
M_P!=MM?C*\?YF"=J#Z(KDC_7;;7XRO'^9@;4'T17)'^NVVOQE>/\S VH;ZXP
M^&YOELKOOMYNAE.58+7V#$JRIJ+E1VJNN<M8]LU'/3M2)D]L@C5>J5%7JD3L
MU_<!-R[,*      8UF&98K@&.W++<UO]%C&-V>/O;C>;A*V&&-%71J:N\KG*
MJ(UJ:N<JHC455T @1=/%.XJ6^YR4%+793>J9CT8EYHK.K:9R:Z*YJ5,T$VB>
M7MC_ ' MLRE]L[OQM3OU8)LBVMRZFR2DHW,CNM$B/@K:*1Z*K655+,UDL?5T
MKTN5O2[1>ESM%")BC(=SMR\/V?P>^;BY[<G6C%,=2!;I7LADJ'L]9J(Z6)&Q
M0M<]RNEE:W1$\_N!"(/TF?$#^OUS^(;I[W"=F6S]HN:?'S?+,8<"VYRJMN^3
M5%+/6Q4<]KK:1BPTR(Z1W>SPL9V(ODU!,)6!   YMO"@^=#</T'NWX50A>[4
MZ20H                                              "-G*C9W)M\
M-LH,,Q.NM=OND5[I+DZ>[2S14_=013L<U'00SNZE61-$Z=/+VF:W%O'#R&8\
MKB1,QLS&BE>3GF'4SN!=C8>S;2M>571]'#O?_6K!OOZY?YL-Q]LLGT;^U;]I
MB?5.+SV]WXD/N9'&7/-@<,Q2NS&[6"Y0Y+>G04+;-/53.8ZFIY'/61*BEIT1
M%1Z::*IKO$._,'>-EEN'%T;,SKB/@F62W=D[\";MJ8T\RZC@%\T#9/\ %E=^
M5*PU9D)UHS>)'_RWM/\ Y#=_ME*:GQ+\[#ZT_ ^DO<)]QG/&P^]>L*V._8IL
M_P#H1C_Y-IS8LCZ/A^+;WH>'\8?K>>_W&+_U+D0>4?[2X/Q+2_;)CQ/WC_J<
M?V[>_<]2]W/Z9/\ <N[UJP.V_P#)U!_DT7_R$/<,O]W;UH[SP_,?>7=>>^^T
MYG$
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M?220UK&HLB.IZ>-R]B(K51V@5F:I^A   YMO"@^=#</T'NWX50A>[4Z20H
M                                               IY\83]FVSOZ2U
M_P"!H%K4P^ 7S0-D_P 65WY4K B=:,WB1_\ +>T_^0W?[92FI\2_.P^M/P/I
M+W"?<9SQL/O7K"MCOV*;/_H1C_Y-IS8LCZ/A^+;WH>'\8?K>>_W&+_U+D0>4
M?[2X/Q+2_;)CQ/WC_J<?V[>_<]2]W/Z9/]R[O6K [;_R=0?Y-%_\A#W#+_=V
M]:.\\/S'WEW7GOOM.9Q
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MN#0>%!\Z&X?H/=OPJA!=J=)(4
M              5(^+98+M?]N]HX;32I524^1USY6K)''HU:1$1=9'-1?[!V
M<MD\;,S,85LW3&NBMV+9AZ;IB%=VW&+>(E2858:?:Y=R*? HXI$QR&R7%6T#
M8EE>LG<)'/THG>*[73SZG%C8-^#?-E\4NC7$N2V^V^*Q-8?5DVT/B+YH^CDS
M#%-P<JDM[7MH)+N^.M="V145Z1K/(]6HY6IKIY=#J8V6PL:FW;$TYX97=V_,
M]NZ+HRN/B8474KL7765IJKLS%:,BH,0\4.UT-';+9'NM;K;;H(Z6WV^FN#XH
M8((6HR.**-DR-8UC41&M1-$3L0Y;;8MB(C1$.ACX]V/B78F)=-U]TS,S,UF9
MF:S,S.N9G3,H];K;@\L<%R>.R;P97EUIRQU#%4QTM\J>^JEI)'R)$Y'.61>E
M7-?IV^Z=#-;IR>:OV\;!LONI2MUL3-.O,.YE=ZYO*V;&#BWV6UK2VZ8BO6B5
ME26OG9*B2T$^X+Z&1.NB=%7/Z%B=VL5O\[Y.G30UF,/>4:(V^V^F,EF^!)R^
M'Y6,MM[-NU6V*[5(K71KJ_WX'Y[_ .&W$^_G_=1L;S_G[;M?FN .;*_1CXCX
M'Y[_ .&W$^_G_=1L;S_G[9^:X YLK]&/B/@?GO\ X;<3[^?]U&QO/^?MGYK@
M#FROT8^(^!^>_P#AMQ/OY_W4;&\_Y^V?FN .;*_1CXCX'Y[_ .&W$^_G_=1L
M;S_G[9^:X YLK]&/B/@?GO\ X;<3[^?]U&QO/^?MGYK@#FROT8^(^!^>_P#A
MMQ/OY_W4;&\_Y^V?FN .;*_1CXCX'Y[_ .&W$^_G_=1L;S_G[9^:X YLK]&/
MB/@?GO\ X;<3[^?]U&QO/^?MGYK@#FROT8^(^!^>_P#AMQ/OY_W4;&\_Y^V?
MFN .;*_1CXCX'Y[_ .&W$^_G_=1L;S_G[9^:X YLK]&/B/@?GO\ X;<3[^?]
MU&QO/^?MGYK@#FROT8^(^!^>_P#AMQ/OY_W4;&\_Y^V?FN .;*_1CXCX'Y[_
M .&W$^_G_=1L;S_G[9^:X YLK]&/B/@?GO\ X;<3[^?]U&QO/^?MGYK@#FRO
MT8^)KK-=P^5VW-5146<9KFN-5=RB=/0P5EPE:Z6-CNESF],B]B+V'6Q\SG<"
M8C$NNBO59W=&X^$][677Y/+Y?$BV:3-MD:)[2[[;>MJ[EMY@5QKZB2LKJ_';
M74UM7*Y722S2TD3WO>Y>U5<Y555-YRUTW85DSKFV.\^0M_85F#O',X=D1%MN
M+?$1&J(BZ8B(ZT,T.=B0                                       8
M;?MNMOLIKDN>3X+CV1W)L38&W"Z6NDK)TB8JJUB231/=THKE5$UT[3GP\SBX
M<4LONB.I,PYK,QB612VZ8CJ3,/%_4MLY[)L,^(;?]P+_ )[,><N^E/QK?G,?
MIW=N3]2VSGLFPSXAM_W ?GLQYR[Z4_&?G,?IW=N3]2VSGLFPSXAM_P!P'Y[,
M><N^E/QGYS'Z=W;D_4MLY[)L,^(;?]P'Y[,><N^E/QGYS'Z=W;D_4MLY[)L,
M^(;?]P'Y[,><N^E/QGYS'Z=W;D_4MLY[)L,^(;?]P'Y[,><N^E/QGYS'Z=W;
MEL.BHJ.VT=);K=20T%OH(8Z:@H*:-L4,$,349'''&Q$:UK6HB(B)HB=B'6NN
MFZ:SIF7!,S=-9UOI(0  *(>7])=N8W-S$.-F,7SX*L.W]#445QOJ4ZUD-%5R
M4_K]UJEB26+KZ6QP4_2KV_SC.GJ[0O&B&\T\-[>QJ(UO._-T1$T1$H+EHB?]
M(@C:0LY#;#;D\&=U=F]^9=T*_>*LJ[XD]?DE?22T=3WUM;"BT%3)-6USY&U5
M&KXFKUHJ,:YNB:($Q-5KW-3)+1F7!O<S+L?JDK;%D^-V>ZV>K33^<IJRNH9H
MG=BKY6N0*QK?[X<7S,=F_P#2'_6*Y@NUH>>,9_1O8?\ &=_^TT(3:F_S]^:!
MO9^+*'\J481&M_/A_P C).'^RCHWMD:ENN#5<U45.IEUK&N3L\Z*BHH)UH1>
M'?\ .VYB?C.Y?EZI";M3VLD\-3>:^9%?[U3<KKC;Z:[W&JK:>@;37%4@943.
MD;$BMN34]!':=B(#:2WXA<8,WXW_ *POSQW=J=U/SS^"?@[UB*IC]0^#O7>]
MZ?6*JIU[[UINO3T_6=NO9H1,U03XM_[T'D7_ *7?E.D"TZEWH45*^+[^Q+;/
M].&_DVL"UJ1>X_\ N\;S_L0I_P AQ!'*U9X4'S7KA^G%V_!:$)NUK,@J 4A;
MV_[U_:+_ ,P?@LX7C4NJO-EL^16RMLF06JCOEGN,3H;A:J^!E133QN316212
MHYKD7W%0**&=TK5FGAK<DK5G.W:5U=Q]W)J%EJL1[U\E*^%JIZY;'J]VB5%,
MCN\I)7+U=*HUSGHDR.+ZX7K8AEF/YWB]@S/%;E%=\<R:AAN-GN,2^C+!.U'-
M54\K7)KHYJ]K7(K51%10HK7Y:\S,S;FR\8^+%MERG>*ZR.H+]DE#T3I:9%:[
MOJ:EU7H2HB:BNFED5&4Z(NOIHY8RT0VMQ"X0XYQ^8[/LWJX\\WRO:2S7C+)W
M/GBM[JI7+/'0NF3K<^3J5)9W^F_M1.EKG-<1,U3U" "EWEU_O,N)WXLQ3_6*
M[!:-2Z(*J7?!S_HWOQ^,[!]IK@M<VIXNOS;L)_VE6W\CWD%NMX?-7_=Q;:?B
MS!/P*($:TW>(3FOXO;"*QR.1,)M#55%U[6TS45/["IH$3K5K>(3>**IYF\3;
M)#*V2NM558ZFMC:J+T-K,@:V)'(BZHJ]PY=%\V@6MU-B>+AMA<<@VPV^W4M=
M,Z9-N+K44%^?&B]45%>DA;'.]43ZUE131Q^7L65/JZ$6K#M@-W;)OEM%A.Y%
MEK8JIU[MT*7ZFC<U7T=TB8UM;2RM;ITNCEUTU1-6JUR>BY B8;C54:BN<J(B
M)JJKY$0(5K[,<U<WWLY=9KL_AF/6&\[+8XM;*W-8FU*5\5-;H&4[JA)FS.IY
MHZFO5$B_FVKW;^K5W2%IC0BOS>==N5W,C;3BUBMX^#K7B$#X;W=FPK4QTE=6
MP>OW&I=$V2-)?5Z.&)K6J]O\YULZF]03&B&Y(O#:WI@BCAAYV9K##"U&11,M
M]Q:UK6IHC6HF1:(B)Y$"-I"_DWQQW/X6YEM)O\N[5PWAN7YQ1=]D=SHYJ2>"
MLMS8YZ6DGDFKJ]TK*F".5FBN31K'-T5%"8FJZ3>+,;+N%P[W9SK'9_6+'E^T
M&0W>UR*J=20U=BJ)6M>B*NCV]72Y/,Y%1>U K&M$KPBOFW9M_M*N7Y'LP3=K
M21Y>\4L5Y*[>W.FAM]';MT;+3OJ<$R_H;',VIC3J;1U,S4ZG4\VG0Y%UZ%5)
M&IJW12(FB)7AT\JLFO5PNW&'>RLJH]Q,-=408?679SO7JB.@<YM9:JETB]3I
MZ3H5S-=56-'HNG=)U$W0W;ROX<;B<A=Q+-FF([Z5FV-MMF.4]DGL-/#5R-FG
MAJZRI=4JM/64[=7-J6L[6Z^AY?(B")HUCLQX?F[.V&Z6$Y_>^2]?EUJQ:XMK
M:[&I8*]K*QC6N:L2K)7RL37JU[6*";FL.0?^]0X^?BRR?;;D"-3*?$IL=SVR
MS_CSRRQJF<^NP2^4]ER3NU5KIH89G7"BB>J>1DC4JXGJO\=K?."WF?MFUTMW
M*OQ MG,8LT[+[MGL/C5/FUSF8J24\E56QP7&!Z:^@Y)'RV]CF]JZ-?KY%1!J
MAK7Q-_G(\7/_ ,A^6(0FW4EWX@_*G)>-6WN,T>!-AAS[<>JK*:RWBIB;/';Z
M2WLB=5U+(GHYCY4=41-8CT5OI*Y47IZ5*Q%6D<?\/[?7<:V45[W_ .6F:376
M\11SW;#K7/4S04G>L<KZ=L\]7W&K>\5JI'3(Q/2Z>I%U":H@[I[#;9\<^;W%
M/;W;JZW2\2/R3#KKE59>*J.JJUK*K(VM9WBPQ0QLUBC:Y&HQ%T5'+KU(H36L
M)#^(3,S$.8W#[<2^.2DQ:WU]FDJ:]VJ(UMFR&*KK%7LT]"*H8OE\X1;J73(J
M.1'-5%14U14\BH%4?OE-;6+OVO&UE9<)=S6TZ5+J:*D=)1-3U%;BK9*ECE2-
MR4Z=2H]$\K4357(BDT2"" "GGQ9?_=F_26Z?^KPM:N&"H!^-1404E//5U4S*
M>EI8W35-1(J-8R-B*YSG.7L1$1-54#G=VYVLS3Q ^2^^.[EAW*K]J[5C5;"_
M&LMI**6IJHJ=ZOH[72PMCK*)8G+1TSGR.;)]=_!]/4+ZDOOHW][?^WAG'WA<
MO_[B"-I%S9*U7K@9SMMNU^4Y*[(,2W)HJ2T3Y3)3K11UL-Y5JT5:Z!\TZ1K#
M<8EA>Y9%T:DCM=%T"9TPD/XPG[-MG?TEK_P- BU;5C']&\>_%E)]I8%5/.YG
M^]NVJ_%E'^1J\+<CVO%*D9%N+PSEE>V../([VZ21RHC6M2KQ]5557L1$0%JS
M7?3]B6\7Z#Y#^3:@*PK0\-/%Z[-^%.^F%VR[NQ^Y9?D^3V2WWYB.<ZAGN&.6
MNFCJ6HQS'*L3I$>FCD7L[%3RA:[6Q_Z,#>W_ +7-S^]KE_G,&TEA^IO(MB>#
M>_& 91G4VXEUI\&SBM?DL[)F/<RIM-2YD6D\T[_0TT^O"*UE%WPN=GMI-P=@
M,OO.>[6XCF]XIMP;A14UUO\ 9*"Y5,=,RU6F1L#)JJ&1[6-?(]R-1=$5SETU
M50FZ5FMLX][!V6J;6V;9# +36,5%95T6-6J"5%145-'QTS5314U\H15MR.-D
M3&11,;''&U&QQM1$:UJ)HB(B=B(B!"D7FU_O(^(W^@/^N%<%XU+O0HC5RXWC
MLNR.PFX.5W&N937>OM=39L/H^M&35-VKX7PTS8DU15[M7+*_3M1C'+Y@F(0L
M\,':&\4'&C<7(JJ1]FJ]Y*VKI\?K%1^K*&BII**&J1NK5_\ &9)]-%[4:BZ]
MJ:$W3I8+]&!O;_VN;G][7+_.8-I8+Q0V'RGCUMW><+R[<6?<ZY7/(ZB]P7ZH
M9/&Z&":DHZ9M,B5$]0[1KJ9S^QVGI^3RJI$S5)T(4N^$E_23E=^,\;^W7T+7
M+H@J 4N\'?G_ /,_\9Y;_K4T+3J3#\1WYF.\G^CW^L5L"+=;W. 7S0-D_P 6
M5WY4K 3K0@Y=?[S+B=^+,4_UBNP3&I['BH;@W3(JG9_C%A[EJ<ASVZT]WNU
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ML<*:JJ*][6KJBA>=$.HD.,  <VWA0?.AN'Z#W;\*H0O=J=)(4
M                                      5J^)3_ $'VT_'E7^#(;IP7
M]]B>+'?8C>_S+>NDKP^^;;M9_D-7^'U)A>(O3\7KQWH=S(?<6_XY4E3"NV <
MVWBO_.AM_P"@]I_"JX+VZG1;C']&\>_%E)]I8%'N                 %1_
MB._TVVW_ !)5_A*&H<2?>6=:>^^G/<-Z#FO[EOU5F>U7[+]M_P!%K/\ @4)L
M^4^YL\6.\^?>)/U3-?WL3Z\L].PPH
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M6Z-GS' '6>JAAM-!+ ^5+@Z2%8)=([=2KHUC9$7T_/Y%")HQO<CBANAE?.;
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MP@  <VWA0?.AN'Z#W;\*H0O=J=)(4
M                  5J^)3_ $'VT_'E7^#(;IP7]]B>+'?8C>_S+>NDKP^^
M;;M9_D-7^'U)A>(O3\7KQWH=S(?<6_XY4E3"NV <VWBO_.AM_P"@]I_"JX+V
MZG1;C']&\>_%E)]I8%'N                 %1_B._TVVW_ !)5_A*&H<2?
M>6=:>^^G/<-Z#FO[EOU5F>U7[+]M_P!%K/\ @4)L^4^YL\6.\^?>)/U3-?WL
M3Z\L].PPH
M
M
M    !6=XI&\>0;;;%VG$<8KI+7<=U;I):KI7PO[N9+32PK+611JU4<G?.?%&
MY4[.A7M7ZX+6PK,XL>'5GG(O$:7<:\Y=2[=8+<IYHK)4OHWW"X5[:=[HI98J
M=):=C(N\:Z-'NEU54<O0K417%INHDUE_@\5]/9ZFHP7>R*YWV"-[J6U7JSK2
M4U0]$U:Q:J"JG=%[FO<O\OFT"-I%?@YGFX?'OEI9=L+RVIM,&47YV%;A8C,]
M%C];<]]/!+HURQJ^"HZ5;(W75BN1JJUX3.F'3D'&                .;;P
MH/G0W#]![M^%4(7NU.DD*
M          *U?$I_H/MI^/*O\&0W3@O[[$\6.^Q&]_F6]=)7A]\VW:S_ "&K
M_#ZDPO$7I^+UX[T.YD/N+?\ '*DJ85VP#FV\5_YT-O\ T'M/X57!>W4Z+<8_
MHWCWXLI/M+ H]P                 J/\1W^FVV_P")*O\ "4-0XD^\LZT]
M]].>X;T'-?W+?JK,]JOV7[;_ *+6?\"A-GRGW-GBQWGS[Q)^J9K^]B?7EGIV
M&%
M
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M;PH/G0W#]![M^%4(7NU.DD*
M            *U?$I_H/MI^/*O\ !D-TX+^^Q/%COL1O?YEO725X??-MVL_R
M&K_#ZDPO$7I^+UX[T.YD/N+?\<J2IA7; .;;Q7_G0V_]![3^%5P7MU.BW&/Z
M-X]^+*3[2P*/<                 *C_$=_IMMO^)*O\)0U#B3[RSK3WWTY
M[AO0<U_<M^JLSVJ_9?MO^BUG_ H39\I]S9XL=Y\^\2?JF:_O8GUY9Z=AA0
M
M
M                                                    %2?B#</-
MZ.1NY>%Y1MI0VFJM-CQE+57ON%>RD>E0E943Z-8YJZIT2-[0M;-$!_HMN6'_
M #1C7QU%_("VU!]%MRP_YHQKXZB_D VH/HMN6'_-&-?'47\@&U"0W%'P_N1.
MT7(/;7<;,K;8H,9Q>MJI[K+272.>9&2T51 WHC1J*[TY&A$RO>"@
M        YMO"@^=#</T'NWX50A>[4Z20H
M                      K5\2G^@^VGX\J_P9#=."_OL3Q8[[$;W^9;UTE>
M'WS;=K/\AJ_P^I,+Q%Z?B]>.]#N9#[BW_'*DJ85VP#FV\5_YT-O_ $'M/X57
M!>W4Z+<8_HWCWXLI/M+ H]P                 J/\ $=_IMMO^)*O\)0U#
MB3[RSK3WWTY[AO0<U_<M^JLSVJ_9?MO^BUG_  *$V?*?<V>+'>?/O$GZIFO[
MV)]>6>G884
M
M
M      \N]WNT8W9[ID%_N-/:+)9:66MNUTJGI'#3T\#5?))(]>Q&M:BJH%'F
M^/BUY"^\5UFV!Q*WTMAIGNBBS/)8I9ZJK1.SO:>A9)$V!NO:WO5D54^N8Q?1
M0O%K2F,>*_R4M%RBGR&VXEEML5S?6K=-;Y:.3H1?2[F>FG;T.5/.]CT3^*#9
M74\8^4^WG*+$:B^XEWMFR&RK'%EN%5KV/J[?)(B]#T<W1)H).E>[E1$UT5'-
M:Y%:A68HDR$                #FV\*#YT-P_0>[?A5"%[M3I)"@
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M"@
M
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ML1>W5&^7R!>=,.G@.,                <VWA0?.AN'Z#W;\*H0O=J=)(4
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M9/"G"P[;9G$_AMB/X9YH3?/87CX
M
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M%4(7NU.DD*
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MU3\<,^[#V0X@ZOXD?:/:[A_J?AS]D_4IOU_&J?CAGW8>R'$'5_$C[1[7</\
M4_#G[+_';);\/:YC^_>QZ*CFK=XU147RHJ=\1/!^_P"8I-?Q(^TF.+]P1-8I
M^'/V4B=BMH*G;^"6^WI\T&27&GEHZZVI)%+3QQ),CXW,=&BKJJ,37TC?.#.%
MKMU6SC8U8Q;HFV;:Q-L16L4IUN=HG&7%-N];HP<&DX5LQ=%U)BZ9I2:UZ_,D
M0;VT0
M
M                             &LMU=U]L=I+!0W;=?)*+&<<R&X,L5/4
MW".26":IJ8I7I#(V-DFC71Q/ZG.3H1$])40"L3<;PS]B]['3Y_QRW3H,9MUV
M<LR6NWK#?<?=(Y>U*66GG9)3-UU56]4B-7T6M8G8A;::VQGP=[TZXQ.S+>RB
MAM,;VK/!9;3)+42LU])K9*B>-D2JGD<K'_\ <A.TMGV*X_[:<=L.;ANV]H=2
M4\[VSWJ]5;DFN%RJ&MZ4FJYT:WJ5$[&M:UK&ZKTM35=2LS5NH(
M      '-MX4'SH;A^@]V_"J$+W:G22%
M                         4?^(;^WNC_12W?;ZL]/X0]"GQY[T-=WK]]V
M(75V'_D.S?Y#3_:FGFF+\^>O+8+=4/5.-9S-[@_[T&@_VWXQ^4Z .3D=,@<8
M
M
M
M             *S/%#V9SS=/9O&;Y@MMJ;_+MS=Y[G?L?HV]Y424-13K&^IB
MB1%=(Z!6IJUO;TN<[3T0M;+4WAC;^[&XELS6[:Y)E]EP/.Z?(:ZX7&"]U,-O
M;<HZAD20SQ5$ZLCD<QD:1*SJZTZ-=.E44%T+4TW.VU<B.;N%C*HJ:HJ7:CT5
M/\:%7VV_/,&NU9!;K5F=BN=PJ55M-0TEQIIII%1%<J,C9(KG:(BKV(!E@
M             !S;>%!\Z&X?H/=OPJA"]VITDA0
M                                %'_B&_M[H_T4MWV^K/3^$/0I\>>]
M#7=Z_?=B%U=A_P"0[-_D-/\ :FGFF+\^>O+8+=4/5.-9S-[@_P"]!H/]M^,?
ME.@#DY'3('&
M
M
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MAZIQK.9O<'_>@T'^V_&/RG0!R<CID#C
M
M
M                                           #4^].].!;!X%<]P]P
M[FZAL]"Y(*.C@1LE97UDC7.BHZ.)SFI)+(C55$541$1SG.:QKG(3$54SY-XP
M>X4USG=AVT..VVS-<Y*>*\UE7753FHOHN>^G6D8U53M5J-73R=2Z:J6V4L.+
MGB7X;O9E-NV[W%QIFVV8WN5E-C5QAJEJK5<:IZHUE-U2,CDIYI%5$C:[K:]>
MSK1RM8XB;5H 5                  !S;>%!\Z&X?H/=OPJA"]VITDA0
M                                                  %'_B&_M[H_
MT4MWV^K/3^$/0I\>>]#7=Z_?=B%U=A_Y#LW^0T_VIIYIB_/GKRV"W5#U3C6<
MS>X/^]!H/]M^,?E.@#DY'3('&
M
M
M                                     %#7C"Y1739ILYA25+DMMNLE
MPO;J-$5&NGK:EM,DCEUT<K6TJHWL]'5W\8+VLIXB^&UM9N'LQC6Y6[M?>KC>
ML]I?A*SVBUU245/04$CE2F55[MSY99&(DBJJ]*(Y&HU=%<X3<KHY<\?IN+>]
MU5@]IO=3<K-/1TN183>)52.M;0U$LL<:3.B1C4EAFIY&=;$1'=*/1&Z]+28F
MKJ.V@R>JS?:7:[,ZYZR5N78C9+U62*B-5TM?00U+UZ4UTU=(O8''+8H
M             YMO"@^=#</T'NWX50A>[4Z20H
M                               "C_Q#?V]T?Z*6[[?5GI_"'H4^//>A
MKN]?ONQ"ZNP_\AV;_(:?[4T\TQ?GSUY;!;JAZIQK.9O<'_>@T'^V_&/RG0!R
M<CID#C
M
M
M                  #GN\7W]MNV?Z#M_*58%[5B'&'D]QXQCCQLOCN1;T8A
M9;[9<0M5'=K3676GBJ*:HBIVMDBEC<Y%:YJIHJ*%9A5AXG^X>V^YV\N"9'MS
ME]HS2DIL+AMMSN=GJV5<4<D-QK9F0O6-RM:Y$G5WNZ._<"UJV?C[RDXYX_L)
MLC8+YO9AUJO5CP#&K?>+7576GCGIJJFM=-%-#*QST5KV/:K7(OD5 K,-^8QR
M2V"S6_6[%\1W@Q3(\BN[W1VRRV^YP3U,[V,=(YL<;'*KE1C5<NGF0%&[0@
M       :6W[WYP3CKM]6[@Y[4R^IQRMH[/9Z1&NK+C72-<Z.FIVN5K>I6L<Y
MSG*B-:BN4)B*JBJCQB<J^&'2TNQ]J^ $E]"BEO,_KBQ>XM0VF[M'+[O=*B?5
M"VRM6XV\E]O^3F$R9;A3I[?<+5*RERO%*[I]<MM2]JN8UZL56R1R(U5BD;V.
M1%U1KVN8TK,42("  !S;>%!\Z&X?H/=OPJA"]VITDA0
M                                    %'_B&_M[H_T4MWV^K/3^$/0I
M\>>]#7=Z_?=B%U=A_P"0[-_D-/\ :FGFF+\^>O+8+=4/5.-9S-[@_P"]!H/]
MM^,?E.@#DY'3('&
M
M
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MFR3'<B;._'[_ &Z^LI5:VJ?;JJ&J2-7ZJU'K$YW3KHNFH'M
M
M
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M_P"C>_'XSL'VFN"+ET05
M
M                                                         "C[
MQ<]FKU55V ;Z6BWRUEIH;>N*YA40L5R4G1425-OFEZ471DCJB:-7KV(Y&-\K
MD"]LO+P3Q+,)QCB31;>5EIO,F\F-XH[$;&QD$?P?*L-.M%0U[JGO->F*%&.D
M:K.MSVJU.Q>L&SI8AX2^SMVO&YN4;U5]!)%C6'6N:RV*NDCT947:X="2I"]>
MQ>XID>C]/)WK.WW1=+H$"@  YMO"@^=#</T'NWX50A>[4Z20H
M       #P\G_ *-Y#^+*O[2\#GN\(KYR.;?[-;E^6+,%[M3HM"@
M         ,'W-_9MN#^C5V_ Y0*)O""_;;N9^@[ORE1A>YT(A0
M        &D.37S;N0?\ LURS\CU03&M3SX/?[2=XOT:H/PQ0M<OU"@
M            (Z<N_FO;]_H/>/P5X3&M5CX.?])-^/Q98/MU<%KE[(4
M             !%CFY\T_?3]&I?ML83&M 3P<_Z-[\?C.P?::X)N71!4
M
M
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M$=:+M;]ZMRI;A;*NAC?A+FLDJ()(FJ[X2I%T17M1%71 O<Z  H
M        #2?):*6?CEO_  PQNFFFVWRID43$5SG.=:*I$:U$[555\B!,*AO"
M'M-TMVX^[[[A;:JA9)C="V-]1"^)'*E8JZ(KT34+7+Y0H
M   "/'+6&:HXQ[[P4\3YYY<)O#8H8VJY[G+3/T1K4U554)C6J\\'^U7.W9'O
MHZX6ZJH$EMMA2):B%\2.5)JW73K1-=-0M<O*"@                  (N\U
M8)ZKBKOA3TT+ZB>7&Y6Q0Q-5[W+WL?8C4U50F-:!O@_VVXV['-]&W"@J:!9;
ME85B2HB?$KD2&MUZ>M$UTU";ER@5
M
M
M
M
M
M
M                                                  /AI;G;:Z66
M&BN%-5S0?W^*&5DCF=NGI(U55.WW0/N                  'QUEQM]N:Q]
MPKJ>A9(O3&^HE9$CE3MT17JFH'TQ2Q3Q1S0R-FAF:CXI6*CFN:Y-4<U4[%14
M\B@?V!\-;<[;;>[^$+A34'?:]SZQ*R+KZ=.KIZU3735-= /N
M      'G4MXM%=,ZFHKI1U=0U%<Z"">.1Z(G8JJUKE7L ]$#X:NYVV@=$RON
M%-1/GU[ED\K(U?IHB]*.5-?+Y@/N                 /EK*ZAM\39J^L@H
M87.1C9:B1L35<J*J-17JB:Z(O8!^\4L4\4<T,C9H9FH^*5BHYKFN35'-5.Q4
M5/(H']@?#57.VT,L4-;<*:DFG_O$4TK(W/[=/11RHJ]ON ?<
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M?0
M
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MJ<<IK-<I73/L-^IW/CBBIW*KE8R69BP/C3T>MS7IIH[J(NAT+!0
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M",1SVPO5]FS&T4=XMO5]<V*LA;,UCT[-'-ZNER>945 XV6@
M
M
M                         !RL,K_SE\0^DK*YBRQ73D)3M?!(NND"Y2R-
MD2JB)JC8T1H<G(O:\0BBIZ[A[O/'4,ZFPT=KJ(E\[9(+O12,5%_=;V_4[ I;
MK0 \'&X53;GO[:N\5:*6EQRK[I554;+&^XLU:FNB=2/[>SMT3W M<O,"@
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M"Y</=C7.[/ZZTJM/44&:VBYTST545M2^*BJE?JU47^^.5>Q0M&IU,AQ@
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MJODCC:@5NUII!
M
M                                                    .5K+*>GV
MQ\0BKJ+YI;[7CF^=->YWO=V1VY]_CN$;W.<O_D[VN554.3D7B>(W?J6Q\/\
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M]9=:;*]M3+?MRK=CE*^#546:GGIK8[3R_6OB75?)V+Y@M&IU-!Q@
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MJKNS$<FB]U=KC5W&%?-V+'4-5 K.M+X(
M
M
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M?8K7;;):*1E!:;/2PT-LH8NQD-/3L2.*-NNO8UC41 H]
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M     ?RYS6-<][D8QB*Y[W+HB(G:JJJ@83^LW;;V@XU\;4?W4#^X]RMNI7LB
MBS[')))'(V.-MUI%<YRKHB(B2ZJJJ!E]/44]7"RHI9XZFGE36.>)R/8Y$73L
M<U51>U /V
M
M
M
M                                         !X>3_T;R'\65?VEX'&'
MA^+7;.<MQ;";"R*2^YA=Z&R66.9Z1Q.J[A4,IH$>]>QK5?(FJ^9 Y4[YO"YY
M91122,L6.U#V-56P1WJ!'/5/,U7HUNJ_55 C:AHBFNO)?A7N,RA=-?-K\HIE
M95SV665);9<Z?JZ>I\<;Y*2LA<K%;U-5R(J=CD<WL&B72?Q6Y$V3DQM-:L]H
M8(K7?Z:1UMS3'8W]?J-RA1%>C-55W=2M<DD2K_!=TJO4UP4F*)(A
M
M
M
M
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MA:PZ99%2>KTMYHI=6)+Z")$E1%(Q6RHQ&MT<Q4:GI:$3%%AX5
M
M
M
M
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M4(
M
M
M
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MYHU7W 7.C0*
M
M
M
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M-<KI)7:(Z:>617232.1$17R.<Y41$UT1 JSP
M
M
M
M
M     @_SAXI7SE3B&&6?&<BMF-WK$+I45L55=8Y7PRPU,'=R1(^%CWL57,8O
MD5.SM3R!,31!_:[PA:JFO]%<-X=S:*X8_1RLEJ<<QF"=)*UK7:K$^MJ4B6%K
MD31RLC5VBKTJU='!;:786FU6VQ6NVV2S44-LM%FI8:&U6ZG:C(:>FIV)%#%&
MU.QK6,:C41/(B!1Z
M
M
M
M
M
M
M                                                           '
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tm2227887d1-lc_itcar4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_itcar4c.jpg
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MS*B=*I&CNC5?,4)L6!"
M
M
M
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M\+HIG(B(B.>J(FB!28L6N"
M
M
M
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MM'!/?=PZC=2<MB/C7?\ Y'E#MZ?!C"?S*X_"0Z28GQ:.">^=1NI.6Q'QKO\
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MZ,/?47<4S3,_!BJ)W-^J8]QPW^'IHIMBU8D]188
M
M
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MN[ZN:HBWLH V)^/]-_(JG_U4/-/9S^+4^15Q,O%> NX?036
M
M
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MK[.?Q:GR*N)GXKP%W#Z":P
M
M
M                   8N]L9\6]A_;._^DT(6I3AV4'V7KA\N+MZUH0596F0
M5                     8L]HU]-V+?(>A]\KF:K'>'&]WWDNWGKU'U<?*J
M:3\K'V>MI_:./TQYGX?Z.'?]G/PZY\E/YS-V         /+'VCOVSMY/^[W^
M[ML#DIR/4!C'Q;Q[VLI/26!QN<  0-S/_0!NI[22>F,-?K7U6\WG<_9Y_D&#
M^LCBEGSV=?TGYO\ )=?7M.=;V:^FJ\GWX>W^W3\+P_UW_2IK^=T?+H
M#J^;_$O+_:2X>MI#3[0_AF)^JO/D2Y+KPXWX5+V)^/\ 3?R*I_\ 50\5]G/X
MM3Y%7$S\5X"[A]!-8
M
M
M              ,7>V,^+>P_MG?_ $FA"U*<.R@^R]</EQ=O6M""K*TR"H
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M'+]"P
M
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ML8R*+K$5G4Q1KJJ_=,?$X>+J(F)=:VEV=N=5W=%5W55.E,QNV9NU$+L]GK]
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M43,TT3$1,Y=V(GL;[-NJ].F):&4/_8J/_01_^JA]/X?Z*G>CB:><KZCF0
M
M
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M/$3QN9AAAIH8Z>GB9!!"U&0PQM1K&-:FB-:U-$1$^XA+EB(B+(R/U"0
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M'"^%#_V*C_T$?_JH?1V'^BIWHXFJG*^HYD
M
M
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M^#CX.'BX5TUUT7N TE9NS,^U_@/M9?O>NH":LCU !Q@    P;YS_ +2NY/\
MJ?WFH3S[7GKE?<^3#[,]E'^,X7_]G\6MMY@_Q*P_VDM_K:,[YA_HZ=Z.)\B:
MX]=O_K*_E2[0<K7        %!=V_I$R?_3Q>D1GS7MM^,8C?CY,-MA_HX7PH
M?^Q4?^@C_P#50^CL/]%3O1Q-5.5]1S(
M
M
M #++FTW_ -^\JWOMW*3RN.9:,P=;8[CG>8\4<<U)'/$D[8F3R(]M+%' ]DCY
M4:LKG/8R/A7HD+1'90NO(OS_ -)*^_4G-FLV1(WK7-_6K)42231.*/K7TZHK
M>C1.)FB]&J(G<)MA9+DNYCMWK]GN><LO,C1MBW?VXI$KZ.]<$3'W"@:Z%KTG
M6#2&1Z-J(9(Y8T3K8W<2IQ-5SB)AI&%0             &+O;&?%O8?VSO\
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MB8<==$TS9+FC8*@
M
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M<;R>#T=B
M
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M^V=_])H0M2G#LH/LO7#Y<7;UK0@JRM,@J
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MW7UG_669@_"G>?5R\_$NY^W<WK:F.;V8?AEY];5\BA&,\.-Y/!Z.Q
M
M
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M*=Y]7+S\2[G[=S>MJ8YO9A^&7GUM7R*$8SPXWD\'H[$
M
M
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M"_N+K^)2R4Y$?I_MWM)<_2VG3MG_ %J-Z7TS[9?\?J^LHXY;>'?'R(
M     "MG,1=K>ZVV6R-JF/NC*OON2D;TN9#U;V(YVG<U5W1KW3RCVH8VYFYN
ML/%4?.:6E,9J;)BV<ULSN9V;@Z9MF>PC'$-T)L)PNJM%I@;+?*V[2577S-XH
M8H%B@;KIJG$YRL5-/,[OW#J.H]L*M3ZMJN+B+;ZJ\FJV?!IIT:8[LS9,=K+F
M<]Y<?.5VSDL6FP+/;7G5K2IIE2FN=,B)<[8JZNB<OXS?\YCO,7]A>D]BV;VD
MN-=7&G1N7D>%3V8G/&>F>Q/<G=8%[=3=SVG>SL;B
M
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M5TT"8=J-@=X-\5OB;58-69BF-I3^S<E-+3PLI^^NLZE'/J98FJK^J?HB*J]
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M,5
M
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M$JL3M3[YFU1"L-SW NZ,EN$C7)Y^.G1$1E-$J_B1HBJFG&Y^B*%9FU:T(
M          Q=[8SXM[#^V=_])H0M2G#LH/LO7#Y<7;UK0@JRM,@J
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M/!?:%^,7F]1\F&RPOT<+I6/^A;/_ "*G]+:>^:O]6NO(IXH:VK++E#,5
M
M
M                <576*R71_67.S4-QDT:WCJ:>*9=&KJU-7M7N+TH!]=)1
M45!%U%#20T4"N5RPP1MC9Q+W5X6HB:] 'U                ,7>V,^+>P_
MMG?_ $FA"U*<.R@^R]</EQ=O6M""K*TR"H
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MQ0UM667*&8J
M
M                                                 #%WMC/BWL/[
M9W_TFA"U*<.R@^R]</EQ=O6M""K*TR"H
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MEERAF*@
M
M                         8U;][Z\]O+?O%N#DM#B%3F^PU9=9*S'67"@
M;<[=34+F,XM:RWN2JH]':\+9WHU%3H8J=TM$1*4-HNU8V+S5:6W;E6BZ;37F
M71LE9*BW6T*Y5T32JIHVSMU[OGZ=&M\U_F@FEH_B>:8AGMHAO^$Y1:LMLE1_
MT5UM%7#60*NFO"KX7.1')YK5Z4\T*NS                ,7>V,^+>P_MG?
M_2:$+4IP[*#[+UP^7%V]:T(*LK3(*@
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ML[2EYA8HIF;5A3T]A@
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M"H                               9,=I9_3FTG\AN_IM*:W'Y:7F?M
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MXQA]^?DRS\1]'*_1]*-2
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M)O\ \'FA$96#^<;3_--1<CU+5TBTM_S>.++LA1S>!ZRW2[T[J9KVKTHZ.C;
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M/<F2MHKEG5UJ,?637A=1MI*"!ZQZ_B]\Q3)T?C:A-655SLT/M;<QWM9>/?Z
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MC>"_N+K^)2R4Y$?I_MWM)<_2VG3MG_6HWI?3/ME_Q^KZRCCEMX=\?(@
M             *"[2?2)C'^GE](D/FO8G\8P^_/R9;;$?1ROT?2C4@
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M;V']L[_Z30A:E.'90?9>N'RXNWK6A!5E:9!4
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MGTB8Q_IY?2)#YKV)_&,/OS\F6VQ'T<K]'THU(
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MV/B='-1UF-32*[H_Z9ET9PZ=U%185U_RA-3J6Z__ )MV$^V>.>\\83&1NR%
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M%!0Q22\*-ZQ[*=C&N=PM1-5371 .Q 8N\OG_ )J','[67OTVVA:<C:(*@
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MX/.N5=%TT1"T5,^MO.SZR#..8S<K8FLS.X8W9<!M]574.Y<V-RR4MT=35%%
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MVVI?66ZWUDJ-;+54T4TC6ZHU'/8CE1-55=-5^Z;2,CU>[JTJ8G/#[25P
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MA])RH
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MO#RM;3[YY;AF;9[27.HON!\/ZOR45:ZFB;P5#:E.L8U%1_GVIW?,"8FQ8L(
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M*62G(C]/]N]I+GZ6TZ=L_P"M1O2^F?;+_C]7UE''+;P[X^1
M     K?OSC&27&"EOE'4R5UCMD:]]VAB?]G=TZU"(GX:*G0JKTM_R*NGE7M(
MU1C<113B+NJ:KFB-VCQ?^?;C/V:=ZVS-PE=,;DY54.[T)TJIXLSTL[(_2):?
M]!5^D/.[>SW\8N]ZOY,L?%?1RO,?1#5@
M
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M+0FFQ?TL]SB>*;7?BE[^;\BEO+8OZ#LW\AI_2FFXC(]GN? IWH<J2Y
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M%?1RO,?1#5@
M
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M%O8?VSO_ *30A:E.'90?9>N'RXNWK6A!5E:9!4
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MK4Y84MV1^D2T_P"@J_2'G@?L]_&+O>K^3+98KZ.5YCZ(:L
M
M                                                     PF['/XR
M;\>UE@].K@O4W9"@   <#E-F=D6,9'C[)TI7WVUUEN95.;QI&M5"^)'JU%37
MAXM=-0*)\F/)!=.5+)\TR"X;ATN:,RRUT]NCI:>W/H5@6&99>-7/J)N+7N::
M(%IFU!&^O9>W[>+=W/=SJ;>&@L,&9W1]QBL\MFEJ'TZ.8UO LJ5;$=^#W>%
M14B?R.>2?7Q;/<";]."=(\CGDGU\6SW F_3@:2]G)3R<W+E,^<OV0SRFS;]?
M_8;J>]Z!]#WK[%=_<7%QSS<?6=^)IIIIP^;KT%9FU>T(              8N
M]L9\6]A_;._^DT(6I3AV4'V7KA\N+MZUH0596F05
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M6O?(JXI6IRPI;LC](EI_T%7Z0\\#]GOXQ=[U?R9;+%?1RO,?1#5@
M#AK7D-DO51<:6U7."NJ+3+U%PBB=JL;_ +B_=3S-4U35%3NHI@8/6F%QE==%
MS>1551-E41V)_+LQN6VQEB5JJ)IRQE<R9ZH
M         #C[K=;=9*"INEUJV45!2-XIZB371$[B(B)JJJJ]"(B:KYABXS&W
M.#NJKZ^JBFBG+,_ENSFB-V>PFFF:ILA^]'64MPI:>MHJAE5253$DIZB-4<Q[
M')JBHJ'+<7]W?W<7EW,54U1;$QDF"8F)LE])RH
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M;612K0Y3C$TB23VRX1M1SX7/1K>-CFN1\<B(B.:O<:Y'-:5F+%@ @
M      !B[VQGQ;V']L[_ .DT(6I3AV4'V7KA\N+MZUH0596F05
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M5GJXZ!:EY#S[STCG-YGXCYF=M?!O^>5GJXZ!:EY#S[STCG-YGXCYF=M?!O\
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M64OK5K*J]U=U;7,XI&K!"D,=.VB1L4;5<B(Y575ZN<XBIKF%0
M  &+O;&?%O8?VSO_ *30A:E.'90?9>N'RXNWK6A!5E:9!4
M                    !Y\.8G[4.?\ RJC_ /3$:6_^EG?>'Z]_%+SR^\]!
MYNGN            (NWP^A;=_P"1.0>]TYB8_P!6O/(JXI=BV0_&\%_<77\2
MEDIR(_3_ &[VDN?I;3IVS_K4;TOIGVR_X_5]91QRV\.^/D0
M
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M,8F(-8QJ:(B)<ZM$1$0)C(V_"@
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MI*H
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M,-:[Y>=K+W47NWX[51T5UEJ**IHE9-*SK&-1M3'&KM6^:@)BQ-P0
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MQN4+L<
M                             !T;<C;;"MV\/N^![@V&#(L9O3$;5T,V
MK7->WICFAD8J/BDC7I:]BHJ*!E'>>RIR/%;W6W?8CF+O&%4]8Y6MH*R*>"JC
MBU548^X6VHA65$1=$18&_P"7I"VD_O'^RJO^3W^EO6_O,'=\ZIJ)6M;043:B
M6JEB1456>R%QGF6)JZ:*C85^\J TFKV&8#C&VN&6W!=NK/1XI8+'2NI['0PQ
MNEBA<J*O6RHYZ/F<YZ\;W.?QO757.U74*J?<K/([!RZ[C9SNG?\ <Q^Z.7YG
M2R4S;A+9TM:TRU=3WW72KK6UBR/GD8SI3@X41R>>XN@F9M7U"'XU%/!5T\])
M50LJ*6JC=#4T\B(YCXWHK7-<U>A45%T5 ,_N6+D5JN6'=;)\[QO=Y]ZQ+)Z6
MKH*K 9K(L'#3OG2>CUK?9&7BDIM$;Q]0G$BOZ&\706F;7V<M?(YXO.]N>;Q_
M.A^M_P"NULNEN_5SV$]C^]?9*Y4MPZSOGO\ J>LZOO;@TZMNO%Q:IIHI$S:O
MV$(MWHVDQC?+;3*=LLMB_P#=>24JQP5[&-?-0U;//TU9!Q?CPR(CD^[TM7SJ
MJ")5XY0.4S*.5.#*;([>1-PL-R5\=9%C<EA6VK17%B(QU3#-[)5::2QHC9&=
M7Y[A8J.3A5'$S-J[(0 4@Y->37Q2/G'_ /XC_.!\X'L/_P#H_L5WI[%=^_\
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M">35\NIO)8_Z$L_\AI_2VGH-WX,;SXRQGT]?E3QN4+L<
M
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M9<;Y>H+C<I+A0U"/HW.B94SO:QL<]0W1W"K=4T;PA69AK$%0
M              *:\U?)5MQS306ZZ76OJ,.SZR4_>=IS6AA94.=2\:O2FK*9
M[HTGC:YSG,1'L<U571VBN128FQ(&,<N6*4O+79N6W,^#)L;I\<BL5[JX6+3+
M/*QW6K5PM<LBQ2-J$2:-55W"]$7IT!;NLB<B[)/>ZBOM7:\)W3Q>OP:MFU2K
MNDUPH*OJD=JG7T5/2U,3W-3314ET<O\ F(%M)J]RH<K^,\K6WDV*VJX.R#)+
M]4-K\RRF2/J>^ZEC."..&+5RQPPM548U7*NJN<JZNT0K,VK1!
M   #%WMC/BWL/[9W_P!)H0M2G#LH/LO7#Y<7;UK0@JRM,@J
M                      \^',3]J'/_ )51_P#IB-+?_2SOO#]>_BEYY?>>
M@\W3W            $(<S7V;N8/_  URSWGJ@F,K KLMOM86CY-7KTI@7JR/
M3('&    # ?FW^T5N=_+J7UC3GG>N?6[S?CBA]J^S+_',)Y-7RZF\EC_ *$L
M_P#(:?TMIZ#=^#&\^,L9]/7Y4\;E"['
M
M                         $(<S7V;N8/_  URSWGJ@F,K.CL>_HVWB^4M
M!ZS4)J;#!5AMVE+^:#/-S<+VBMN+UE)M'E%PH[?@ZVJ1\U)?;Q.J*BW.5K6I
M%)"NJLAD\ZUK'3(KNES2]-B-.;GD;NO+IAFS.YFS<MQK;YBR6^TYW<K7U[JQ
M<@=/UU)>*5&*Y[$DJ']2UK=.#2!$U<YR@B;6T?+CD6[64[/8A=M[\4_5#<:2
MF2.]4"NC1]0UB(D57+!&J][R3-T<^%=%8[5-&IHU"LIQ"
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M_;._^DT(6I3AV4'V7KA\N+MZUH0596F05
M       @WF"WOM&P^!39774GLM=:V=M!C=CZSJ^^JI[5=Y]Z(Y6QQL:KG+I]
MQO=<APWU]%W3:T^O-<4:LP_SLQ;5,V4QGGO1V6 69YW><YSJ];@W:.F@O=[N
M'LE414K'-IV2HJ*UK&/<]W"G"B=+E7[YIJZYJJTI>)XO&5XF_JOZK-*J;=S(
MVFY:>;6Q;R66X4>9R6S$,UL*1NKH5G2"CK8).A*BFZ]^K=')H^-7.5OG5151
M>C:W&)B\C=W)>L[/[37>L*)B]LHO*<N[9$QGBWW86?\ U[PCPRL?NC3>J&1I
MTYX=BYY<<I3PP^R@RK%[I4LHK9DEKN-9(BK'24M9!-*Y&IJJHQCU5=$35>@1
M5$]E>C$W5<V4UQ,]J8<\6<P       !"',U]F[F#_P -<L]YZH)C*P*[+;[6
M%H^35Z]*8%ZLCTR!Q@    P'YM_M%;G?RZE]8TYYWKGUN\WXXH?:OLR_QS">
M35\NIM[9<VPQEFM+79=96N;10(YJU].BHJ1MU14ZP[Y=W]WHQ\*,F>'R'B]4
M8V;ZO_XWGA3_ +*L^\Y/]>,*\,+)[H4WJA?G%WXT<,,?[GQO(7GQ*N\?KQA7
MAA9/="F]4'.+OQHX8/N?&\A>?$J[S[;?DN.7:=:6U7^VW.J1BR+34E5#-)PI
MHBNX6.5=$U3I)IO:*ILB8GNN&_U?B;BG2O+NNF,\TS$>[#FSD8@
M
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M,^+>P_MG?_2:$+4IP[*#[+UP^7%V]:T(*LK3(*@
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M/DS[S1>VO\"I^NHXJVTYWE\F
M
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M,^\^B/;7^!4_74<5;:<[R^3
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MI5_)>X>GTIU39WUF?)GWGT1[:_P*GZZCBK;3G>7R8
M                                                   B_)M[]EL*
MO%1CV9;O85B5_I&QOJK'>K_;J"LB;*U'QN?!43QR-1S51R*J=*+J@+$<YIS>
M\N6(8EDF40[S8/D\]@MU174^.6;([75W"ODAC5[*:E@BJ'N?)*Y$:U$3NKJO
M0$V/,MOSS)[J\P^45]_SS(JEUKDG>^RX;332,M-MA54X(J>FXN'5$:G%(Y%>
M]4U<H7B+'7MH=\]T=B\DI,FVURVML-1!,V2MM22.?;J]B:(Z*LI%7JYF.1-.
ME.).A6N:Y$<A,P]->TG.CL%N-MQB.9WW=3"\"OM[H6OOF'WO(;=15E!61N=%
M41.AJ9XY.#K&.6-SFIQQJU^GG@XYA+V/[\[&Y9>*+'L6WFP7);_<W.9;;':L
MBME965#FM5[FQ005#Y'JC6JY4:B]"*H+$KA   RXYE.<[=5-ZH>6#E7Q>CR'
M<Q%2"_Y+7,9-'2U#H4J7Q4S)7L@;WO#YZ:697-:NK.#B;J%HA'][V[[6C'[;
M+EE-O-C>45]/$^IEQ.VLMKZEW"G3$V"ILU/2.<J:Z-;)W>YY[0&XG3D-YQ\A
MYD*7+L*W)M-+:-S,#9%45,]%$^FBKZ)[U@?(^F>YRQ30RHC9414:O&WA:WI1
M!,6*<]H#]O\ Y9_:S#/]ZKB$QD;LA17'FVSG#\"Y=MVZ_,Z^EIJ.\8O=;-:Z
M&H5KG5U?<*.6GIJ6*-VO&Y[WIKHB\+=7+HUJJ$PH9V/^/WFBVUW;R2JADBL=
M]R&AH[.]^J-DFM]-(ZI<Q%Z%1.^8VJY/-14_%":D3]FA]K;F.]K+Q[_0!-61
MNR%%(^T*VRL^XW*YN'5UM+$Z\[?TJ91CEQ<B=93R4+D=4M:[NZ2TW6,5.XJJ
MU>ZU FG*CCLLL]K<OY8TL5QJ'SS[=Y+7V*B635SDHI8X*^%.)4[C753V(FO0
MC43H30)JRM(PJ 9C;<]G)8ZK<J^;O<Q>73[N9'<+M45]KQ:62::V01.F<^G9
M635*K-5]6Q6HD>C(FZ<*MD:%M)"?9=Q10;T\VL,,;888;A2LBB8B-:UK;C<T
M1K43H1$3N("IM*%0           0AS-?9NY@_P##7+/>>J"8RLZ.Q[^C;>+Y
M2T'K-0FIL,%0                               P0R3"JWGL[0+/\*RJ
M[5E!MILTZNMU50T\BLD;16.J90SP4ZN16LDK*Y[G.?IJC-=/P&A?)#8+$>6S
M8#!*&EM^+;.8C;8Z-O##5/M5-4U:^=X=9*NI9+/(Y4715>]5^^%;4.[[<B>P
M&\V+W2AH<&L^WN8NIW>P&98Y10V^2"J8U4A6JAIFQQU,6NB/:]O%P]#',<C7
M((E5KLKMP<GI;=N]R\9=,Z6KVGNW7V5BO61*=DT\]-<*5CE[D<=3"DC$1.E9
M'J$U-= J    #YJRKIK?255?62I!244+ZBJG=KHR.-JN>Y=-5Z$15 \HNP5D
MPC?[FG=7;Q7&EM. 91<\ARG.Z^X7!MLB9%)%55C4?5K)$D?%4OC:J\:=U0Y)
MW(:Y89R@]FQN+<76?!+S9LMO#4<OL1:\TJ:FK5K$U<YL#*Q9'-1/QD;I]\*V
MRN+4X_A7*7RZ9LFW=JDM^.;;8_?+_:+743S5CG538YJQ&.EF<]ZI),NG2NB:
M^8@1E>>SD;VLL_,3S/VVBW*1^26F&&Y9;E=+4O55N<T+D5&SN145S9*F=CY$
M_&;Q-7H4+SN0M7VI7+?MQME1[;[E;:XE;,)IKU655@R:SV>".DHY9FQ)4T<T
M=-%PQL=PLF:]6M\]YW7I3I(IE>SLR=RJ_<#E=LULNM4M7<-M;O68HR61W%*M
M' R&KHT5/,;'#5-A9_R8]/,4(JRM" JQ=[8SXM[#^V=_])H0M2G#LH/LO7#Y
M<7;UK0@JRM,@J                                     *C<V/,'A^T
M^&W;#JV*6\Y?G-EK:2VV2G>C.HIZJ*2F[[J)%1W Q'*O"FBJ]6JB:(BN3&Q-
M_%$6=F76-IM>7.!N:KJ=VNNF8B([$3N6SVN-D#R];I6_9O=;'<]NMKGN]MMK
M:FGKJ2E>UDR1U<#X'21\?G7*Q'\2-54XNYQ)W367%Y\W7%4O+M1ZQIU?BZ;Z
MJ)F(MMLR[L6/0CAV7X_GN,6;+\6KVW*Q7ZG;4T%4U-%X5U1S'M7I:]CD5KFK
MTHY%13=4U15%L/<,+BKO%75-[=S;35%L?EQNS%F0       A#F:^S=S!_P"&
MN6>\]4$QE8%=EM]K"T?)J]>E,"]61Z9 XP       "&N8CZ"]V?DO<O2'&#K
M+U:\\F7:]AOQW!?74<<,O>0'Z=*OY+W#T^E.J;.^LSY,^\^B/;7^!4_74<5;
M:<[R^3
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MZWK^]J3\+KM.'@Z-.ZNH5F+%F0AB[V8'TV\W/MG3>^5S"U3:(*@
M  A#F:^S=S!_X:Y9[SU03&5G1V/?T;;Q?*6@]9J$U-A@J
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M"S?#LH/LO7#Y<7;UK0A2K*TR"H
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MQWC5^Z='=E.1POF'SH<U/A5N'^^N'Y(YWCO&K]TZ.[*<CA?,/G0YJ?"K</\
M?7#\D<[QWC5^Z='=E.1POF'SH<U/A5N'^^N'Y(YWCO&K]TZ.[*<CA?,/G0YJ
M?"K</]]</R1SO'>-7[IT=V4Y'"^8?.AS4^%6X?[ZX?DCG>.\:OW3H[LIR.%\
MP^=#FI\*MP_WUP_)'.\=XU?NG1W93D<+YA\Z'-3X5;A_OKA^2.=X[QJ_=.CN
MRG(X7S#YT.:GPJW#_?7#\D<[QWC5^Z='=E.1POF'SH<U/A5N'^^N'Y(YWCO&
MK]TZ.[*<CA?,?X[=+FG:U7.RO<)K6IJYRNKT1$3NJJZ#G>-\:OW4QL[LK/\
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M6HJJJHB)J"(5*['OZ-MXOE+0>LU":FPP5
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MZ=+7(O2F@*LK28*L7>V,^+>P_MG?_2:$+4IP[*#[+UP^7%V]:T(*LK3(*@
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M.8OR:?ETM^#T1\5
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M:E.'90?9>N'RXNWK6A!5E:9!4
M     #.WM(/HMP7Y5)ZQJ3!QW@QONB[>^J7?E^])V;_T6YU\JE]8TPP/@SOF
MP7JEYY?O0T2,YWH    $(<S7V;N8/_#7+/>>J"8RL"NRV^UA:/DU>O2F!>K(
M],@<8                            !Q=\_H2\?R&H]+<4O/!G>9&#^GH
M\J.-@WRD?:*VQ_EU5ZQJ#S[4WK=WOSQ2^S?:;_CF+\FGY=+?@]$?%0
M
M                                                          &2
MN]W9;_/)NQG6Z'SY_JY^NES?<?8/]6>_.]N)K6]7U_LM!UGX/=ZMO^0+14BS
MR-?_ (CO[H?VV$Z1Y&O_ ,1W]T/[;!I+O<FO)KXI'SC_ /\ $?YP/G ]A_\
M]']BN]/8KOW_ /.UG6=9WY_R>'A\W7H*S-J[X0              Q=[8SXM[
M#^V=_P#2:$+4IP[*#[+UP^7%V]:T(*LK3(*@
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MJJZ:9W:9LG\O<[CY&UML]B]67&'OK^FRG$4:=&];DGMV:-7DUT]FU(1DM&
M
M
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MWL/[9W_TFA"U*<.R@^R]</EQ=O6M""K*TR"H
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MCX<Y8B9AM =X?)X
M
M          8O<HD-FLG:+<U]MS!D=/FMSN&1U&$)6],KZ6INR5CDIU?^,ZC?
M$]J-Z>J1VGG4<%IR-H0J_*?J.HF[YX.]N!W?'6Z<'!IY[BXNC33NZ@8M]EY2
MP?/3S65V'-1NVJ5T,%F?3]%*Z/V1KW6Y(_N\--QZ?<1?OH%JFU(5
M      8N]L9\6]A_;._^DT(6I3AV4'V7KA\N+MZUH0596F05
M                             SM[2#Z+<%^52>L:DP<=X,;[HNWOJEWY
M?O2=F_\ 1;G7RJ7UC3# ^#.^;!>J7GE^]#1(SG>@    0AS-?9NY@_\ #7+/
M>>J"8RL"NRV^UA:/DU>O2F!>K(],@<8                            !
MFQSKXSO1NAD-AQ'"L#O%VPS&(DK:BX4[&]35W*H;IQ)JY.)((EX47_.?(AU?
M7MUB,17%%W1,TQN[\_Z=][[[)-8:EU-A[S%8O$447]Y.C$3.[3=T]S_?5NSV
MJ:5&O%@W_P#JKO?H<?Y9H/NK%<G+V#K#V?\ MEWPSWCQ8-__ *J[WZ''^6/N
MK%<G)UA[/_;+OAGO-1>7/:7&[AMA:*+=387&[1F=@<ZVUM1=+!;G35\,2(L%
M6K^I<KW.8Y&O5R\2O:YR_A';-68.BJYB+ZZIBJ-S=IC=[;YVV[VFQ-UK2NO5
MNL;VNXO/A1%%[>643/A466Q9$3NTQ&Y%,Q$9$[?,?LM]4&$_[/V[U V',,-R
M='Q8[SIO2_7?VW$?M;STCYC]EOJ@PG_9^W>H#F&&Y.CXL=XZ7Z[^VXC]K>>D
M?,?LM]4&$_[/V[U <PPW)T?%CO'2_7?VW$?M;STCYC]EOJ@PG_9^W>H#F&&Y
M.CXL=XZ7Z[^VXC]K>>D?,?LM]4&$_P"S]N]0',,-R='Q8[QTOUW]MQ'[6\])
MB7G]MM]GYFK_ &NTT%/:[909]U%!;J2)D$$$3*]J-CCBC1K6-1.A$1-#HF(I
MBG&3$19$5^^^N-27]Y?[,7=Y>U3575AK9JJF9JF9HRS,[LSVY>@4]&?$H
M
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MMG?_ $FA"U*<.R@^R]</EQ=O6M""K*TR"H
M              &=O:0?1;@ORJ3UC4F#CO!C?=%V]]4N_+]Z3LW_ *+<Z^52
M^L:88'P9WS8+U2\\OWH:)&<[T    "$.9K[-W,'_ (:Y9[SU03&5@5V6WVL+
M1\FKUZ4P+U9'ID#C                                       !@/NA
M]JG*O\0W>^#3SO%^O5>7[[[5V=_Q2Y_M?^C?@]$?%0
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M*T5"H
M             &+O;&?%O8?VSO\ Z30A:E.'90?9>N'RXNWK6A!5E:9!4
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MY5_B&[WP:>=XOUZKR_??:NSO^*7/]K_T;\'HCXJ
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M&I(&\Q?:IU]+D:-N6.;>9!601VZ71\4<&'T[V0Q(QVJ*U]?$CWM7H7C?T:=
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M;W:<2MB?$Q%731-51 K&57_LH/LO7#Y<7;UK0A-65ID%0
M                                                     ,7>V,^+
M>P_MG?\ TFA"U*<.R@^R]</EQ=O6M""K*TR"H
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M  URSWGJ@F,K KLMOM86CY-7KTI@7JR/3('&
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M]</EQ=O6M"$U96F05
M   !P&5U=TH,6R6NL<#JF]45JK)[/3,C69TE5' ]T+&Q-U5ZN>B(C4[O< PI
M\:_M0?J3R7_Y<W/U +V0>-?VH/U)Y+_\N;GZ@"R#QK^U!^I/)?\ Y<W/U %D
M'C7]J#]2>2__ "YN?J +(7ZY'-U^:'<_YT/&1PFYX=[!^PGZF>R..56/]\]\
M]_\ ?W5]\QLZ[@ZJ'7AUX>)-?PD"LV+]A              #%WMC/BWL/[9W
M_P!)H0M2G#LH/LO7#Y<7;UK0@JRM,@J
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MS7V;N8/_  URSWGJ@F,K KLMOM86CY-7KTI@7JR/3('&
M                       # ?=#[5.5?XAN]\&GG>+]>J\OWWVKL[_BES_:
M_P#1OP>B/BH                                         !$.YFP^U
M&[SJ>?/<1I[M<*1B1TMXBDEI:QD:+JC.OIWQO<U%5=&N56IJNB:G%>7-%YX4
M-7K#4V$Q]DWU$3,=G=B>&'P;;<NNSFTU:^Z83AE/0WEZ.:E[JI9JVK8UR*BM
MBEJ7R+$BHNB]7PZIW=1=W%%&[$*8#46"P-6E<W<15GFV9[DS;9W$VG*VX
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M' ^8+#9<[VZJ*VIQ^&XSVI\E?3.I9>^*=D<CTZMRJNFDK=%")BQ, 0
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M"',U]F[F#_PURSWGJ@F,K KLMOM86CY-7KTI@7JR/3('&
M                        # ?=#[5.5?XAN]\&GG>+]>J\OWWVKL[_ (I<
M_P!K_P!&_!Z(^*@
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M'6)]2^L?:;33LI:=:B5&M?*L<:(G$Y&-15^\@0[@
M                           'G\Q+::V<X7:'[\4.Z,M168?M]<[RVOM,
M-1) ZJI;#6QV6AHFR1N1\3':)(]8U1>AVBM<[B"]MD/UY_\ EUV7Y><SY?,Q
MP[ *>VX#=;I/2Y]CC9JV:"KCH)Z2?A>^2:25%F@EF8O Y%\[JG3T@B;5V]XN
MS,Y=LZPZO9M?8$VUS1E*Z7'+[15U94T,TJ(KHHZRGJ)IVNB>JZ*^)&O35%U<
MC>!2(J?-V9F;6*Z[79;MS48;9L.W-VENK+'GWL704]%/<HV+-'1U=:Z!C5FG
M:Z*:%[G*Y55G'KJ\%32P*@             ,7>V,^+>P_MG?_2:$+4IP[*#[
M+UP^7%V]:T(*LK3(*@                                         ,
MP^TL_H/:3^77?TJE-?C\E+SSV@>!<[]7O)4[/7Z!:SY57'TBE.3!?1]ULMAO
M4)\N>*%Z#,=Q   "OW-;>+19>6K?B6\72CM,5?@&26^ADK)XX&S5=7:ZF*GI
MXUD<U'22O<C6,3SSG+HB*H3&5@5V9%XM%FYK,>DO%TH[5'76.ZT5%)63QP-F
MJ9HVI%!&LCF\3WZ+PM3I7S$"]61Z=@XP
M           8#[H?:IRK_$-WO@T\[Q?KU7E^^^U=G?\ %+G^U_Z-^#T1\5
M                         ?XJHB*JKHB=*JH'^@
M
M        &$-AW"LW)GVB>\]7NBR:W8/NXM?70Y*V&25M/!?JR.ZP5:,C1[Y(
MF5#)*>3@:JHY'*B>=T"^6%@^T[HK1NGRI8EN?@]?39/8,>R>ANC+_;W,GIW6
MRNAJ*!\C9&HJZ=\R0-7I[O0Y->X13E6&V#YO]CLCV#PG+<FW4QW'KM9,>I*;
M-;5=;E#!7T]?0T[(JK_JLCTGD21[%=&K&.ZQ%3AU7H")A33LTKU-N!S"<W.Z
M5KHIZ3%LNNC[C R3H1C[O=JVNIHG(G0KV1<6NG<_9":FT 5
M 8N]L9\6]A_;._\ I-"%J4X=E!]EZX?+B[>M:$%65ID%0
M                          &8?:6?T'M)_+KOZ52FOQ^2EYY[0/ N=^KW
MDJ=GK] M9\JKCZ12G)@OH^ZV6PWJ$^7/%"]!F.X@  !Y*>;?F/R7F.W9O^05
M=SJ%P>SUE11;>8_QN2FI;=&]61S]5KP]=4M:DDKNE=5X=>!C40Y(BQ5H);<<
ME/:+XAANV=7@?,9EEQ]D,5J(8L*R)U)57&>KMDC'?]6G?!'*[BI7,T:]Z^>8
M]K4_ 4*S2N1Y3/E \/KG[@W3]'"NC)Y3/E \/KG[@W3]'!HR>4SY0/#ZY^X-
MT_1P:,GE,^4#P^N?N#=/T<&C)Y3/E \/KG[@W3]'!HROG254-;2TU;3N5]/5
MQ,F@>J*BJR1J.:NB]*="A#Z                                !Y[]S
M[_:7\QN89'#6,J;-#G4]8M="BO:Z&&NXGO9HGGDT:JIIW?,/.,7>4\[JJMW-
M/WWV_L]@KZ-F[BXFFR\G#Q39.YNS1N1.;+W&K7CO\NOA97>Y5=ZB=O\ O[">
M-/!+YMZH=H^1I_:4=\\=_EU\+*[W*KO41]_83QIX).J':/D:?VE'?/'?Y=?"
MRN]RJ[U$??V$\:>"3JAVCY&G]I1WSQW^77PLKO<JN]1'W]A/&G@DZH=H^1I_
M:4=\\=_EU\+*[W*KO41]_83QIX).J':/D:?VE'?/'?Y=?"RN]RJ[U$??V$\:
M>"3JAVCY&G]I1WSQW^77PLKO<JN]1'W]A/&G@DZH=H^1I_:4=\\=_EU\+*[W
M*KO41]_83QIX).J':/D:?VE'?/'?Y=?"RN]RJ[U$??V$\:>"3JAVCY&G]I1W
MSQW^77PLKO<JN]1'W]A/&G@DZH=H^1I_:4=\\=_EU\+*[W*KO41]_83QIX).
MJ':/D:?VE'?/'?Y=?"RN]RJ[U$??V$\:>"3JAVCY&G]I1WSQW^77PLKO<JN]
M1'W]A/&G@DZH=H^1I_:4=\\=_EU\+*[W*KO41]_83QIX).J':/D:?VE'?/'?
MY=?"RN]RJ[U$??V$\:>"3JAVCY&G]I1WSQW^77PLKO<JN]1'W]A/&G@DZH=H
M^1I_:4=\\=_EU\+*[W*KO41]_83QIX).J':/D:?VE'?/'?Y=?"RN]RJ[U$??
MV$\:>"3JAVCY&G]I1WSQW^77PLKO<JN]1'W]A/&G@DZH=H^1I_:4=\\=_EU\
M+*[W*KO41]_83QIX).J':/D:?VE'?/'?Y=?"RN]RJ[U$??V$\:>"3JAVCY&G
M]I1WSQW^77PLKO<JN]1'W]A/&G@DZH=H^1I_:4=\\=_EU\+*[W*KO41]_83Q
MIX).J':/D:?VE'?/'?Y=?"RN]RJ[U$??V$\:>"3JAVCY&G]I1WT$<Q_.1M_D
MFUMZQ/:V\U=??LI5+=<:E])44B4UND15JG(Z9C$<Z1J=5HGF/<O1HAKM9Z[N
MKRXFBYF9FK<R3&YV>\[EL'[*M8836MWB=8W=--W=?"B-*FK2O(\#P9G<IGX6
M_3$=E9;E1W<^=K:6TU5PJNORK%N&S9/Q+K))+ Q.IJ7:]*]?%PN5>YQ\:)W#
M:ZGQG.;B)GPJ=R>_W>.UT#VE;,?<6MZZ:(LN;WX=WFB)GX5/YE5L1'BZ.=9<
MVCS\
M                             IMO#@'*IS<7.Y;79??[;<-Q,"JIJ-(K
M;71T.2VN31KYFPLF:KI8E315UBDB5>G\)-4)BV$X8GLSA>-;-V?8VKH_UFP>
MVV!N.5=+<VL5U;2=6L<BS]4C$XWZJY58B:.Z4T4%K+W)NQZQ:MR66LQ/>JX6
M#%)YN-+'<+-'<:R"/758V5C*RE:_HZ$5T.J=U>,)TFENP.P. \N6 TV X#33
M+3K,ZLO=[K'-?6W*M>UK7U%0]K6M_!:C6M:B-:U$1$UU52)FU-P0
M      Q=[8SXM[#^V=_])H0M2G#LH/LO7#Y<7;UK0@JRM,@J
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MX=.L=W-?O!:)>OW&/BWCWM92>DL#B<X
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MN_VF.C'ZWS?TCK[_ *']]_*/)M_\9_[N_P!ICHQ^M\W](Z^_Z']]_*/)M_\
M&?\ N[_:8Z,?K?-_2.OO^A_??RCR;?\ QG_N[_:8Z,?K?-_2.OO^A_??RCR;
M?_&?^[O]ICHQ^M\W](Z^_P"A_??RCR;?_&?^[O\ :8Z,?K?-_2.OO^A_??RC
MR;?_ !G_ +N_VF.C'ZWS?TCK[_H?WW\H\FW_ ,9_[N_VF.C'ZWS?TCK[_H?W
MW\H\FW_QG_N[_:8Z,?K?-_2.OO\ H?WW\H\FW_QG_N[_ &F.C'ZWS?TCK[_H
M?WW\H\FW_P 9_P"[O]ICHQ^M\W](Z^_Z']]_*/)M_P#&?^[O]ICHQ^M\W](Z
M^_Z']]_*/)M_\9_[N_VF.C'ZWS?TCK[_ *']]_*/)M_\9_[N_P!ICHQ^M\W]
M(Z^_Z']]_*/)M_\ &?\ N[_:8Z,?K?-_2.OO^A_??RCR;?\ QG_N[_:8Z,?K
M?-_2.OO^A_??RCR;?_&?^[O]ICHQ^M\W](Z^_P"A_??RGYR]G!%!%)//O6R&
M&%BR3328\C6L:U-7.<Y;IHB(G2JJ1.S%G_Y?-_26I]O,U3$1@+9G]=_*9IWJ
MEMM%>+I1V>Y/O-II*N:&VW=\'>SJJ!CU;',L'')U?&U$=P\2Z:Z:G5ZXB*IB
MF;8MRYWOV$O+R\N:*[VC0KFF)JIMTM&J8W:=*R+;)W+;(M68Y/MW/FMW:M]+
M<JKJ,5SGJ[-?N)=(XI7O_P"IU+O,3JY7<*JO0C'O4VFI<9S>_B)\&K<GWI_+
ML6O/_:CLQ]]:HJJNXMOKBVNC/,1'PZ?SJ=V([-5-+=H] ?&X
M
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MJJJO^5381%CIU54U3,SEE^@5
M                                                ?+75U#;*.HN%
MRK(+?04;%EJZZID;%#$QO=<^1ZHUJ)YJJH%%MVNT=Y8]K^^J.WY5+N;?H$<U
MMKQ%C:R#C3H3CN#WQTO#KW5CD>J)^*O1J3HRR1W0S[.N>J_U%-L_RAV.WU;I
MV]]YE::662Z-D5?.K7WIBT%$B.1--*ABZ>8X+9&HG9Y\IVX_+):-R:[<FMM"
MW/<7V$=2V2USOJ7T+;6E?QI4S+&R-7O6L31(U>U.'\)=>@BJ;6CH5
M       8N]L9\6]A_;._^DT(6I3AV4'V7KA\N+MZUH0596F05
M                               9A]I9_0>TG\NN_I5*:_'Y*7GGM \"
MYWZO>2IV>OT"UGRJN/I%*<F"^C[K9;#>H3Y<\4+T&8[B           #RC\_
MOVO][/;.A]ZZ,.2,CU.8Q\6\>]K*3TE@<;G
M
M
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M2FOQ^2EYY[0/ N=^KWDJ=GK] M9\JKCZ12G)@OH^ZV6PWJ$^7/%"]!F.X@
M         \H_/[]K_>SVSH?>NC#DC(]3F,?%O'O:RD])8'&YP
M
M
M                #@,KDO$.+9++CR.6_P 5JK'V-&-:]RUC8'K!PL>BM<O6
M::(Y-%\T"@G)+DO.O?<IS>+FFIKK!8(+53OQ5;A:;3;FK6+.J2\+[=3PN<O5
M^8Y50+38@+?S->TVM^\>X-%M#1WZ3;2GNKV8<^FL&/U42T? WAX)JJCDE>G%
MKTO<J@BQ$/S@]K[_ !#)?]F,8_0 G</G![7W^(9+_LQC'Z #<7ZY',AYO[]\
MZ'C6T]S@[U]A/U"]D;9:[;KQ]_\ LAU?L;!!UGX-/KQZZ='#IJNI6;%^P@
M           !B[VQGQ;V']L[_P"DT(6I3AV4'V7KA\N+MZUH0596F05
M                                     9A]I9_0>TG\NN_I5*:_'Y*7
MGGM \"YWZO>2IV>OT"UGRJN/I%*<F"^C[K9;#>H3Y<\4+T&8[B
M #RC\_OVO][/;.A]ZZ,.2,CU.8Q\6\>]K*3TE@<;G
M
M
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M0O09CN(           /*/S^_:_WL]LZ'WKHPY(R/4YC'Q;Q[VLI/26!QN<
M
M
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MU*<.R@^R]</EQ=O6M""K*TR"H
M      #,/M+/Z#VD_EUW]*I37X_)2\\]H'@7._5[R5.SU^@6L^55Q](I3DP7
MT?=;+8;U"?+GBA>@S'<0           >4?G]^U_O9[9T/O71AR1D>IS&/BWC
MWM92>DL#C<X
M
M                                         93<S7:;6_9[-\HVLP';
M6IR7,L7JUMUQO-ZG;3VYE3P-<G404RR35#?/(G2^%===/NA:*568K!VEW.+Y
MZ[5UQVQP"Y(J.CJG/Q2U+"_5>%::%JW"KC73H5[96]SSR="A.Y"T.S_9.[/X
MHM-<MVLDN.Z%UCT<^S4W%:+0BZZJUS87NJI=.A$7KF(O3JSIZ")J:6X3M[@N
MVUH98, Q"T8;9VZ*Z@M%'%2,>YJ:<<G5-:LC_NN>JN7S5"KN(
M   &+O;&?%O8?VSO_I-"%J4X=E!]EZX?+B[>M:$%65ID%0
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M.8Q\6\>]K*3TE@<;G
M
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M'Q;Q[VLI/26!QN<
M
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M        >4?G]^U_O9[9T/O71AR1D>IS&/BWCWM92>DL#C<X
M
M
M                  5AS#G-Y9,!R:\X;E^[%!9,FQZH6DO-JEH[@]\$R(BJ
MQ714SV+T*G<<H39+K7C^\H'UV6S\QNGZ&"R3Q_>4#Z[+9^8W3]#!9*8MI]_M
MH-\O9_YJ<VILQ_5?O7V>[W@JH>]N_>N[WXN^88M>/O>33AU_!Z?,!,)A"
M           &+O;&?%O8?VSO_I-"%J4X=E!]EZX?+B[>M:$%65ID%0
M                                       P%YV/M.;F?ZF]Y:$TV+^E
MGN<3Q3:[\4O?S?D4MT,$^)&&^T=N];1FWH\&-Y[%@_H+OR8XG:BS)
M /*/S^_:_P![/;.A]ZZ,.2,CU.8Q\6\>]K*3TE@<;G
M
M
M            "@VYG9Q<ONZ^>91N+E%;EL>09=6NK[JRAN5/%3I*YJ-7JV.I
M'JU-&IT*Y0G2=&\E!RO?UAG'NM2_H(3I2AC>/LDL);BMXNNR69W^++:&!]3;
M\;R.6EJZ.N=&W7O:.>"GII('OT\Z]_6-XNA>%%XFB*DE=EI6[25VWN>OPW$)
M,)W-HJJVV[=FUNK*RIAJ%I4JUMU9!%62RN@;)UD[7LUU1[7?B\ *FIX5
M          8N]L9\6]A_;._^DT(6I3AV4'V7KA\N+MZUH0596F05
M                                     # 7G8^TYN9_J;WEH338OZ6>
MYQ/%-KOQ2]_-^12W0P3XD8;[1V[UM&;>CP8WGL6#^@N_)CB=J+,D
M\H_/[]K_ 'L]LZ'WKHPY(R/4YC'Q;Q[VLI/26!QN<
M
M
M           ([NN[VTUBN%7:+WNAB5GNM _JJZV5U[H*>HA>G2K9(I)FO:O3
MW%0%CX/GTV2^N+!_]H;;^D L=*SSFPY==O,>N&0WO=_%:UE% ^:"SVFZTEQN
M-6YB:I%34E-+)(]SET;KIPIKYYS4Z0FQFGV4Z7C*]S.9/<]*!;=C]_FIT6!B
M<,*5E?6U5:D,:(B-7J8^A=/P4<W_ #@M4VT"@             #%WMC/BWL/
M[9W_ -)H0M2G#LH/LO7#Y<7;UK0@JRM,@J
M                   & O.Q]IS<S_4WO+0FFQ?TL]SB>*;7?BE[^;\BENA@
MGQ(PWVCMWK:,V]'@QO/8L']!=^3'$[469(       !Y1^?W[7^]GMG0^]=&'
M)&1ZG,8^+>/>UE)Z2P.-S@
M
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MQQ.U%F2        >4?G]^U_O9[9T/O71AR1D>IS&/BWCWM92>DL#C<X
M
M
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MV4'V7KA\N+MZUH0596F05
M      # 7G8^TYN9_J;WEH338OZ6>YQ/%-KOQ2]_-^12W0P3XD8;[1V[UM&;
M>CP8WGL6#^@N_)CB=J+,D        \H_/[]K_>SVSH?>NC#DC(]3F,?%O'O:
MRD])8'&YP
M
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MIP[*#[+UP^7%V]:T(*LK3(*@
M        !Y^.<FXV^Z\R>Y=;:Z^GN5&Z2UQ-JZ65DT2R06FCAE8CV*J:LD8Y
MCDUZ'(J+TH:7%3;>3^78>([5WE->L[V:9B8^#DW<E-,3P3N-T-M;C;[MM]A5
M=:Z^GN5%+9*%L592RLFB<K(&,>B/8JM7A<BHO3T+T&WNYMIA[%J^\IKP]W-,
MQ,:,;L;O8=W+LP        \H_/[]K_>SVSH?>NC#DC(]3F,?%O'O:RD])8'&
MYP
M
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MMZ=TK@R5:2Z3V_'[;6OU7KZB+K:ROU55Z5;UL'3_ ,I0M4VO"@
M   #%WMC/BWL/[9W_P!)H0M2G#LH/LO7#Y<7;UK0@JRM,@J
M                               *5<]FY=[V_P!GH+=CE9+;KGG-S;:*
MBOA<K)(J%(9):E&/3I:K^%L:Z=/"YVAB8R\FFC<[+J6V6L*\+@XINYLFN=&W
MM63,\.3NL,34/'5EN7GF9RKE^J[W'0V],GQR^1(L^-5-2^GACJVJWAJHW(R3
MA=P(K'(C?/)IK^"TR+C$3==N&_U%M!>ZKFJR-*FK_;,V;N?L[W;[BTWE++Y]
M4E#[KR_HID<_GQ79.L"OD8^-_H>4LOGU24/NO+^BCG\^*=8%?(Q\;_1.'+WS
MG7/>_<>FP2JP&EQZ*HH*JL6Y17!]2Y%IFHY&]6Z"-.G7NZG-<8J;RJRQN-1[
M65:RQ,7,W<4[DS;;;D[D+[F8[H    #RC\_OVO\ >SVSH?>NC#DC(]3F,?%O
M'O:RD])8'&YP
M
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MP#'-M\'H5H<>QNGZFG614=/42O57S5-0]J-1\LSU5[UT1-5Z$1-$0HD0
M          #%WMC/BWL/[9W_ -)H0M2G#LH/LO7#Y<7;UK0@JRM,@J
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MHY%T5.X$/K
M
M                                 ,7>V,^+>P_MG?\ TFA"U*<.R@^R
M]</EQ=O6M""K*TR"H
M     "*]]?H1WC^0^0^]M0<=]X%6]+6ZY]1O_JZ_DRR#Y!OM"V[VCNGI;368
M/Z1Y?L5^(QY-3= V[V(   ,(NUPWFR!V585L5;*Z6CQBGM$649/!"YS$KJNH
MJ)H*2*;N<3*=M.LC4_!XI-5U<QO"7IAC"%EC.5OF%OO+7NS9\_MS:BX6.1CZ
M',<;AD1B7&W2IYZ/SWG4?&]&R1N7N.:GXJN12)BUK3Y83;;ZG<E_/Z/]P*Z)
MY83;;ZG<E_/Z/]P&B>6$VV^IW)?S^C_<!HGEA-MOJ=R7\_H_W :)Y83;;ZG<
ME_/Z/]P&B>6$VV^IW)?S^C_<!HGEA-MOJ=R7\_H_W :)Y83;;ZG<E_/Z/]P&
MB>6$VV^IW)?S^C_<!HGEA-MOJ=R7\_H_W :)Y83;;ZG<E_/Z/]P&B>6$VV^I
MW)?S^C_<!HGEA-MOJ=R7\_H_W :)Y83;;ZG<E_/Z/]P&B>6$VV^IW)?S^C_<
M!HGEA-MOJ=R7\_H_W :)Y83;;ZG<E_/Z/]P&B>6$VV^IW)?S^C_<!HGEA-MO
MJ=R7\_H_W :)Y83;;ZG<E_/Z/]P&BQYYB-[LAY@]V,HW)OTDT<%RJ'08U9Y9
M.-MMM43G=Z4C-/.IPM7B>K41'2.>_NN"T18A );I]D=O+D-WH]P=DKW737&T
MXU2PY%AJ3.<_O**6;J*ZF8KM=(W2212,8FB(Y9%_&4*50VH"H
M
M
M           Q=[8SXM[#^V=_])H0M2G#LH/LO7#Y<7;UK0@JRM,@J
M                                          BO?7Z$=X_D/D/O;4''
M?>!5O2UNN?4;_P"KK^3+(/D&^T+;O:.Z>EM-9@_I'E^Q7XC'DU-T#;O8@
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M*@
M
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MK>&=NBZ]W7H,BZO8O(MAO]5:UN=974WMU;9$Z.[%F[9$YYSI7.1L@
M       #I>>;<X'N?8I,:W"Q*UYA8Y')(EONE.R=K)$31)(E<G%&]$[CF*CD
M^Z!7[&>1/E+Q&]-O]GV4M$EQ9*DT?LG45]UIV/155%;2W"IJ(&Z*O1HSHZ/N
M($VRME'&R)C(HF-CCC:C8XVHB-:U$T1$1.A$1 A_8
M
M
M   !B[VQGQ;V']L[_P"DT(6I3AV4'V7KA\N+MZUH0596F05
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M5M5F[$9IGWEQ.SE^A'*?EQ7>]ML,G ^!._WG:=@_4:_K)^32OZ9KNP
M
M
M                                   !B[VQGQ;V']L[_P"DT(6I3AV4
M'V7KA\N+MZUH0596F05
M        ?-645'<:6>AN%)#7454Q8ZFCJ(VRQ2,7NM>QZ*UR+]Q4$Q:K7137
M%E46Q.=U*P[:;<8M7.NF,8!C>.7-Z*C[C:[51T<ZHNNJ+)#$QW3JOFE(NZ:<
MD0QKG5^&N*M*[NZ*9SQ3$3[D.[%V6           #.WM(/HMP7Y5)ZQJ3!QW
M@QONB[>^J7?E^]+E>SE^A'*?EQ7>]ML)P/@3O]YR;!^HU_63\FE?TS7=@
M
M
M                                  P@YKNTCW/JMQ[SM9RX316BU66Y
M+94RZFI([E<[Q7LD2&1M#',R:)D2RZQQJUCGR=#VN;Q(U"\4H6M?/=SN;#9K
M;:7>>.YW2DF;%55N$9C9(K5-4T;UT62FGCI:>9BKHJ->BN8CD\\QVBH"R)>@
MC:O<K&MX-O<4W*Q"=TU@RVA;64C9-$EA?JL<U/,C55$DAE:Z-Z(JIQ-7150*
M2D #%WMC/BWL/[9W_P!)H0M2G#LH/LO7#Y<7;UK0@JRM,@J
M                                                   9V]I!]%N"
M_*I/6-28..\&-]T7;WU2[\OWI<KV<OT(Y3\N*[WMMA.!\"=_O.38/U&OZR?D
MTK^F:[L
M
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MK3E>*7:"^XY?8$J;1=Z956*>)55$>Q51%TU1?,"'/@
M
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MBIJ:5K'NJJ:E>CT?2O541BIHK?/:ZHA,3:]*_)']D_8OY-1>FR!2<JTX0
M
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ML1Y;JZU97CMSQBZ.S*Z3MMMVI)J*H6)]-1HV1(IV,=PJK51%TTZ%!5E:*A4
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M3N>L;7:)JV/A1?-0F[N*+O)"=7:CP> FVYHLJSSNSPSD[EB:#E;8
M                                               !@-VJ6V^XF8<P
MF'7/$<"R/*;;!MY;Z6>X6BU5== R=MVNSW1.DIXGM1Z->U5:JZZ*B^:@7I:Q
M<G%INEBY8-EK1>[;56>[4&.Q15ULKH7T]1"])9%5LD4B->U>GN*@5G*LN$
M
M                                    *W[[<I^Q_,4E-4[D8HLU_H8>
M]K?EMLF=17.&%%5R1]<S5LK$5RJULS'M:JJK4154)B;$/[;]G!RN[;9#29/#
MC-SS&Y6V5D]LCR>N[\I8)F*BMD[UBC@BD5%3H25KT\W3714&E*^ 0
M
M
M
M                                               %)][^?_EWV(R2
MKPZ_W:ZY7E=L7@O-BQ>ECK'T4G1_!3S3STU.V1/-8DBN;^,C5TU)B+7=M@^<
M/8SF.J*FU;?Y#44V3T<"U53B%ZI^\KCU"+HZ6-J.DBF:U5\]U4C^'HXM-4U$
MQ8M$$
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M<NBA$Q8F<(
M     XZ[W:V6"U7*^7JNAM=GL]+-6W6Y5+TCAIZ>!BR2RR/7H:UC6JJJOF 5
M,Y=.=O:?F<RS(,/V_L656VX8[;'7:KJ[[245/324[9XZ?2):>NJ7JY72HNCF
M-Z/-UZ F8L6_GG@I8)JFIF934U,QTM142N1C(V,3B<YSG:(B(B:JJA#/;.NT
M]Y6<*O%19J*ZW_/7TDO4U%PQBWQST:.1='<$]944C96I_G1\35_%50MHRGC8
MGFXV,YB7U%#MWE3OUBI(UFJL1NT*T5R;$G=D9$Y5;*U/QEB>]&_C::H$3%B<
M<PS#%\ QJ[YAF=\I<<QFPP+47:\5K^"*%B*B)]U7.<Y4:UK45SG*C6HJJB!#
M/MW:L<K27SV)2/,GT'%P_K0EHB[QTXN'BX%JDJ]-//?]!KIYFO0%M&5_L(SG
M$=R<7M.:8+?Z7)L7O<2RVR\4;E6.1$56N:J.1KF/8Y%:YCT1S514<B*F@5=K
M
M                                       A[F#W!J=JMD-T]PJ%[67/
M%L;KZNS/>B.8E>L2QT?$U>A4Z][-4"88/=FYR^X7S#;D;E95NS;%S.T8714L
M\MLK9I>"JNEZFG5E14N8]KI>%M-,NCET5SD5>X%JIL=!YC\4IN2[G-H;IM>D
M]LLF/U5JRW%K9ULCW14=2FE50++(]SY(GJR:'SSM5C=PN55U528W8>GBDJJ>
MNI::MI)$FI:R)D]-*B*B.CD:CFNT5$7I1=>D.-]
M                                    '4=P,MI< P/-<ZKHUFHL,L-Q
MOM7"BZ*^.WTTE2YJ+]UR1Z(!YO.3K;2S<V',%G6=<P%V6[8U8J"IRW.:JMK%
MHXJRJGJ(X:>":='L=% WC<[1CVHUL;6(J-Z Y)W%U-U>SKVCWGS:VY!RP;F8
MCA=EH:5&Y;:K57/O38:QLB+#4TT<%0_JE<S5'-61J:M:K4U5RA726![0?/\
M*]IN3J*R3W_OW,,UDM.%7O(Z=BPNJG2TLDUSG9'Q.5C:F.DD8J*JZ-DTUUT4
M$953>SIY.]G=V]F,JW!W8Q1F65N0WFJLEACEJ*B%M%14D,2/F@6GEC5LLDTC
MTXEZ6HQO#IJ[4FJ5<.4FZ7/ENY]5VTBN<T]EJ,JN^W-Z5Z*WOZ!:B6GH)G,;
MT(JU$4$J+IT)JG1JH)W8>ET*
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MV>C>JJR"HI9XJ&L='YB+,VI@XD__ +::>:$U-V@H
M
M                  I[S^(J\H.]B(BJOL90KHGW$N=(JA,95!.QK_\ ]CO^
MZ'_[V%JE<^U?^U#;_D/:?75<"G(]"FVL;XMNL!BE8Z.2/'+4V2-R*CFN2DB1
M45%Z45%"CNH
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M@@<Y>CS$1%50MV'I^#C
M              B_,,=L&+;29Y9L9LE!CUHI\;O#H+7;::*EIV*ZDE5RMBA:
MUJ*J]*KIT@8?=D%]-NYGR'=[Y487J>A$*,\.=GGIQ_ETMM7@F$R09!O1=*7B
MIZ71LM)8HYD\Y55R:],JM7BBATZ>A\FC%:DA:(M4I[.WE2R_/MP(.:;>&GK)
M+72ULMZPSV51RU5]O-0YTGLL]9//+%"]RR,>J?PDO"YJ\+%XB:I1QVNJ+XR&
M$.T71=M;:B+YFJ7B\:_^D%.1M#C'V2<>_P (J3WA8%>RQ$[)Z-[^9^YN8QSF
MQ8-=G2N1%5&M[[H&ZK]Q-51/V0M5D>D8*
M
M           (OWLV_7=7:+<G;EDK(*G,L=K[9;ZB75(XJN:%R4TC]$5>%DW
MY=/,0$//3R2<PU'R:[M;C8SO'8KO:+7?:=EJR>D@@ZRLMUTM4LCH'2TZN;QL
MTEE8JM55\\UR:MU#DF+7"9_=J[GZYT*9,+L]=2XUDE9;[;2NEC_ZQ18_;FL9
M5U]5P*]K%TZR1$UT17,CU5VFHR0]/L,,5/#%3P1MB@@8V.&)J:-:QJ:-:B>8
MB(@<;]
M   .M9IB]#F^'99A=T54MF7V:OLEQ5$XE2"X4[Z:7HU37SLB]&H'F@Y=-S+W
MR$\SN26W=+'*V2C@IJK%\THJ-J+.E-)-#44]PHVR*QLK56%CV>>1'1O71==
MY)W8=YY[>:+'^;S+-K,'V:L-YNM#CTM5%1.J*3JZNZ72[NIXV0TU,QTC^%B0
MHB*NBN<YWG=&M52(BQH;S$\K>4U_9_8EM-:J5U\SK:&VVB_);*7^%=4UU!!*
MRY0TW"BK(J1U51U2(FK]&M1-7!$3NJ3\B//9M]R[;7Y=MQN=;KU.E-=:B^XE
M4VN!E1USJB&*.:A>U\D?5+UD/&UR^=7C=Q*W1.(F8M=-Y&L+R+F+YS;CO1<;
M6^"PV"_W3/<HJF,5:>*X5\TTU#1LD5.'C[XF1[6]U61O5.X"=R'I("@
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M0
M                                        @+=?E<V!WOKXKMN?ME;,
MDO,3&Q)?&25-OKWQL_ 9)5T$U/-(UOXK7O5$\SNA,2[#M3L-L_LA155#M7@-
MLQ!E<C6U]93I)/65#6?@MFK*E\M1(UO=1'2*B+JO=506I<"
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M*%E/34\,:<+(XHHT:QC6HFB-:B(@0^\
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                \L>8<X'-DNY.
M4XUCN\&53O7):ZV6*S42MEE>O?CX:>G@B9$YSW+YUK6HBJJZ(@<ED.Y3;K=I
MM96I<:V/>6B@IUU=45N,UW4)_P ])J!6+^R#<2'LAVI&]F%9+1VK?)D6XN))
M,E+>:A**GMU\H6M<C'21+3,@BE=&FJNCECXGJFG6,7I")I>@O&<DL>8X]9<K
MQFY0WC'\BHH;A9KG NL<]/4,1\;V^:FJ+THO2G<7I"CG
M
M
M
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M[SK.!.,B8L:FA4
M
M
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M")B6GP5
M
M
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M^V5J5;TJYF^=U6!J0JJKHY[T:FJN1 M.1ZNPXP
M
M
M
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M_![XK*A\L\J-U7A1SU1NJ\*)J$6I:"
M
M
M
M               #+O<OLL]L-R=R,OW$JMR,EL\F:WJLOEVL]+!1N8RHKYWU
M$Z0R/9JUJN>NG$UR_P"4+:2Y.P/+9M7RV8W6X[MK:JB)]WE9/?\ (;E*VIN5
MPDB16Q=\3-9&WAC1SN!C&-8W5RHWB<Y5(F;4]A
M
M
M
M
M
K                                                      /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tm2227887d1-pht_profnd4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_profnd4clr.jpg
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MRDA;,I"PA124="".MZK:#;TY<30J[+G>ED&MJ\+AR[Z%LM(00H.J%K>0UO\
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M[AY6#!/^FB;^[3V KH?;S&G=6/DEN:$D'P_<1S\%\Y3$*9?DPYS:7&0XMLK
M]*K$@BNEMG,VT&/Z6M!D> ?8OG[=^$?@\C)&S]H<>D]FO#\<EALGP][/<6GX
M;#0VY4UXA$*"-NU*A8A730U ,A<.Q]S6<4'&JD?V_P 3=Y"Y9)$XDF1O4*_P
M@@GTKI=@.P^0X-S[!9KE,Q3&7CE:OD&[% 4I)"3?[*P;@SD%]C7&'D!7UKZ8
MGL#873!)P->*V([Y9Z0[DHV #@^3;;$E24GJKHD*%3C['X:.&W?=D:DN;[E1
M/W?R_F7#+9ATH''VT_'<M>)3[Z&'?8!WI;44*&OJ T%JO^9X:TO 5.VT4;Y
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M?9;%C8^-;T#>E[BZE%J32Q/A8!7J'$K,.*>;<:1[:UW3Z5?NIK2;D+2.<M!
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M/PWL<VI2F$&R5+4="X=";"^E?-$6!?CS+;4JPGQ.BLS?/W?CR+(W6VL@!Y4
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M#G1>Y(NG2M5VUKW==16.TQL$#2(P!JL311<8:0M0OT'A6Q=7#+.%SSR"]%Q
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MDJ:*P#J0>FIMTO7'O<U=ODK(355\;C-8"W\IX+&./.AXCEJ>Q<K.-;;:=*W
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M9KE;<E6.9;]J*"7'G%;4D@=!U-ZYV?W;880M;,3U.(  %?W:!;>)VQ>Y0%T
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M@']W,'Q]2ZXXUS?E$M$7@*X[,EE94M4E0!"#?P(-<+[BW<5M8-EGX4U6ML_
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M(]RW,[S\88[;_2QC^/0G8TDLIBI>E+ "W=]W5;3XFZK5W'L=TGLHKDN+&W?
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M<(#I; <MK=7C_+6X6GH YKG.(<XTX57Q&;D*"D/J!<6L!LCR4;"DC^B(N=Q
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MKJF_PDJ &E2?"NZ(:.X*R!DQDXVRQZ5HI-Q+&9<9"#DX6-<EQXCX4M1'I))
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MBPJ>?<:(WUI&('<'? K'@=M2W,X$S"&=_B%M?VWSW'XN&;@&8Q%EMK6$1EK
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MKW.%!7GWE=1K,($I3,@!"%.A#*^H42;)Z=+UV,CMDVUKYS=1TU(]%5YL-_\
MU&1,)%!U=(->.M%=Q[1R9&"_,Y4P.93;\Q&:0+)0BU]M5'BM^]60^B+0 313
M+=FW&7+678_<TU"H"87WY;S,@*9$)9:4CS(.I(^-7RR[QMA;ASB"7"O!?/FY
M\U<74_EOJ P=-/BN7YAX-%E#BFXY/J2-.M@=-*H[)3PSW)<P"A*CT=Y-'&8>
MHAIX@=_XX+D7-::AJAHR+J$NGUPW#9*R?%(!-JT7"1K^EHT/,+MV67N+&&MG
M/(PCB*:5[N(5D]ML_P 3PAE/<LRL>&@E+,!,M7IZ#07N=;U'L];7,KFMC![U
M97VS='E)I9+Z0O=RZM?QQ75YGF,=(RTF1"V-X\*O&]OHL'I;[:LK9FWIIX@>
M.BFV<RMCB8WAI %.2ADQ[%9.!(A25.&/-;4S(2D$62H6/4?U*V<X9\5*(Z<:
MGBH-?[_L1$(X:U(UT(H5A>W_ !GBW#FCC8"UMHGR0J3+6FX )V@?<#42?D)V
ML>X#EVK7V[OVWMY.B;7J-*TTU.GXX*T>\Z>)\4X<CD4!?S,J$$)6RT?4I*B+
MJ4*C>$N[BZN'5&E5*=R[*AS4/U,&CZ5%.?<?5Z%0F1[L\.P& 9DLS?S*9+"'
M1"9T6C>D7W ] *EMM:/9.'GDN/M+ &P<87@EYJ>'@/5HJ1Q?>>.I,U$O'E;C
MSSABH9%_2M1(W VOU\*N#&[K@9#Y;V\ O&<^W$]Q<^;&\4<=>Y5##Y1F<%EY
MV6A1G<>J>ZZE;:D;4V*C8$+2>E[U&_[M-:3N?%H':^M3U^W+6YMHH)Z/\L <
MN04UXYW@Y)CGIOS;3>4,UP+V.)(4E6VP (MI\*XV7G-_\S^*CF>V)8S$3=72
M&ZG3C1=J1VIYCF,ZG*95:(PFJ#CIW$^V%I%MUT#6PTM>O6)M)+E[61'VT7J;
M>F)QEF+-IZW- ;2AY>BBMSA?;C$\5R#.?="LGE8^X_,N*T3<6T&N@J?93:@E
MM:.?4T[1V*L[K>CY6F,1@ DTY4JIU)XEP_FLJ#)S[!4PA?IFI.PI3?U7MX7%
M4QD6SX_JC9J>2TMHYTXF]#931CCKKP6[7'>(=L<=@V9&$C06,4P@*6^VL678
M6*W%'QL*JJ\R-[+*YIJ"#WKZ5_MEGD6-F-#4#L5/]UW^+ XT\=ELR5K67) 9
M6'$;+$=1T-R*M+[=;3NLFPND)&GQ5._=2.UC,<<8 =U>RG^"H+$\D:F3<NC*
M0)&*QV+2$M9$INVX0?4K=6YF<8^PF=$-350B#;\,L3'EU 1R[:\U^]L>?8#D
MG<Y7$')"'L9D5);QF44;>I(457!'C7,OK=\=OYG @&OJ5B;9V+"*O>*@Z"HU
M6S7=7C>&X[ Q+,"+ME3G%@K !*U)VZ^'6]JANW;R:\N) 3HVGMJM'[D8&UQD
M,38V /D)X <13_!:M1.=8Z1R.9Q%XO,YF$[[+C>X*:4$ +0$F]]$J%3X0OZ*
MC@5"LEMV]LK)LY<[I^7GH-*B@[M%M-VE.3?;RF!R*T_T<R4=;C:&T[5(=>4K
M>C=X7!O5>;AC:R02,J',.OH 5[_;AU[/C6&4DC4_^T5YZ_4WVFQO:WE27,%[
MK_'LBCW6P!N]AR]E-DIOXFI_M3*.R4-'<10>Q2:1S6S%E0J$P6/S\^>TKC\%
M4N="=1(2$ Z!M8-Q_P"-:IICHC)+7LU]2TLE<Q1Q%LAH' CV*:\ZYWR'/Q5X
M+.PA"+#S;DAI0(<4ZR3M*KBP'V5V,MFWR-\FG#113;NVHX+AUX']0<:CT:!5
MWBYLO&SHN5A.%F7$=#C"_P":H:@U&&-UJI\7 MH5M#V$[A\FYC]0G9=.;D)D
MB#R-ER,C;M&\A1\-.H\J_7/+E@\L#4+^L)K^Y-^/I&OW5X1<E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B+P ^K3F>-3]2?</$0X[
MLN9!D,(R#S0*DM*+*+)5\:L?:5Z6-#.7^"IO[BX9LC_J*T.@]&JJ06D-H=-T
MA2;D'2K$+P14\%3G[#1<7O1WV'HP4A]*C8C123;P-8WN!C/1K[5ZZ',<':A7
M[)[)<-Q/ \ID, Z<?E<DT97SBU[TB1MTVITLDGPKY0_\_P C!F1;4(:2WEVD
M+ZANMGXW+Q,F?2HYUIP%.2HY2.5X2-$Q?])9,[C:VRB7 D'<E*[A22CR%QTJ
MV-GXADF2FOY*=757_J!!4/\ N/<&"PBM(1_3:.G3L!;TJY.P?)^)Y%[DO&9R
MV6,Y#>]LQ)!&YQE:4D*0%=.NM5U]W;R>2^880:-Z3ISZ2>Q=O[;60CQKA(:$
M]7'O 4/Y_AV>-<JEQ6%H7%4\A]A*?!*B"=/*]ZN'9E[-E<,PR AX:>/>2JGW
M)9,Q^:ZZCHZVN]5*U\5@,;S2^0E1(K4J,VP E<TW"%;AT%JCE[M*ZEF+@T'7
ML[U:#-^8YD;&EQ&@61DQ8^4<96V]O25?QG0;W2?Q"_W5U(\C/AK:2K=0TD"G
M/BN-F\5;;@DCEA<#KJ0:U'"GL4OYOVXXWQ'"XN=@EV3*5_'WKW*6ZYZE*&O3
MK7"^WVZ;N\R$[9 :.>>7<2M7?6VXK+&QR-&K6C7GQ ^*J5PH"R2D7"=>E73'
M\S/F&JIMM:*:\3R:(H4\_9;0;"65V\RJXOT-K5 MT_26SFR:=1K7AW+Z)^TE
MSELE$^U%?*CZ0TT-->JHKP-*>A8_DTF.'H[RBX^B22A##8-PK4[M+^%5OLK/
MM.9<UW"CN/#B%R_N%]MLXPNNQ5[ ?V@'3B:TX$^U=#%27\;)4N ^&U.(_A[M
M;J&HL?/72K-^X#G-M&AK2>HD:>"J'#Y:[LG.-NX!Q&M1QIV=_8LUEN:9G+I;
MBY)]$[V!9+)44J1?0DC7^I5=;2V);7KW22U!K\%9& ^]&;Q3>DAKAWBA^*AT
MI#2Y?S[D5 DK0&O=;'0#I>]S5TXK!6N,%(1Z5#-S;SR&XY>NZ>*#@T:#_%=J
M(L-2HKR[;!<*)UM<6%,Q;.FA(:N?MR[9:W\;WTI7GW@J3.Y2*TI(4X+FW36U
M5T=MRR$FBN:\WG:P.:"X5H%A\K'2XH3VG19S:-@ZD@@ @_"I3M^9T-+-[31O
M/QU4'WC9LG/]SB>!6F@XZ4%113#%=U,3@<(<%F7'69SK?MP7=BE@D"P*B/,^
M=5SNS9!=FF7,3?E-3IPU*M/9_P!PV.V^^&9U7,HWYJ$F@&NNNOO46QB$3XL@
M.DAW>5[NAW*2.GPKM;FQD<5Y%<AM*=/_ +*IK;^"&9BDZB 0XG3M('L[EP*B
M"$VXJ3(!4=&4@6)4>E?FXS-FF,CA;P7+S&V_[>"7OKV+!P1,@9";)C/[XLQ-
MG&5ZE"AXB_VUZ@^WOFQ 2=H[ERX<@Z&/I;0.I3AQ'YKG=4'O;NDA))VKM9)^
MSPJQL-8PV$ MP14+3\F1C>L@T/ TT]')? F_+OCV"/=;3J3J"/*NC<V<=U&6
M.6YC;R:QE$T=*\->]77_ ),!GN!R<JN8O&YZ7$+T6<SHINUR$U6.4#9)3:@:
M Z'Q7TKA=LLR&#%Y/_J.::JD6XSK#;+$A[WWHUVW'SIO*38DCXVJ?X>R$-N(
MR-*#W+YEOXQ#<21MX!Q'J-%VERD)D!M1"3MN#TJHMY;;=;2&5HJ"M)L9Z:A5
M[D\5F9/<!C*O*5*Q'RJVXV\_W(DW%A67[?ME;.UI::>Q3#^]QOL'Q_Q$TU[*
M_!3Q*D-H"";::WJ[)&OJ.FBB)!)JN,M-+)"&RX$ZK %P/MK!//'$\-<>*SQ1
M2R EH)IV#@N"3*<3%??;:*FHR1<)3>_V5CR%ZRUCJW4K:L\:^<.<. XK,Q%$
MQ8\Q*A[BU)*62-187N:J#<>;NKJ\9 X$-T/9S6MT" "4.'4'</#6I77RN=SH
M2AG&LQ2XHV=<<4H:? "I7#LV)TC)VG7CQ5CVWW)N#:?3RM%*4J/R49A9IUR8
M<;+86U*0+DA)*%:$DA53*WNG>9Y):=!QY*"SV+?),[7@U/#GKS6:=W>C:+I)
M]5;KW]*YK:+D"TM@M;]ON=4 V!^T5CHPFO2*^"!SJ&G!=F+*=QLAB?%>+4J*
MM*FR.NAO8_ UK9/%PY*!T,G A;F-R,UC.V6+B/5X*1<WY_R#E\7&,?+14B)?
MYE]9)6I*M+"WPJ";<V4W;\[S;FH<>]3/+[X?DV!DK  .RFJZ4N5CW,:6FE(<
M44I#;:;!05I8VZBWC7O%V5_%D"37H))/&B[V9R.(DPI9&6^8:4 (ZJ^''3FL
M<B7(C->RTZ$H/2XU3?RJ9SX.VFE$CQJJ]L-RWMG"88G4:?6/!=<*0HV4O<M6
MJEDW)MYFNBUL<= T +ARR22.+WDDGF=5U6I(<]STJ]*B$IMJ3X6K\\X1M+CP
M"]^0XD-;J2LX<1N@?,I</NH2I;B?#3P ^RH=!N=L][Y8_;6BLJYV ^WQ7U1)
M\P-ZB/#EZE!EP)SF9C9!+P5C6HZPIJ_[Y\:D,\#WRB0'Y0% 6SQB QT^<D>I
M9^4AV XA+D<.?,B^Y _#XV)L*_;7+0WA+&\0M[)X"XL&-=+H#PXK\;LDD>V&
M]WJZ6OX7KH-HTT"XLC'  GGP799>7&>1)2+[/QI'52?$5JY&U%Q$6K>Q.0=8
MW#96\N/@LO)S4:5!4VS[J'G4;=EB"DD^?2H19;:D9=MD/[059N5WY!<8Y\+*
MA[A3AP]*P32; :D^=ZL*-E JA>ZIU7(4^6E9'-JO-5QQFFYSLB-CS[LM@7>3
M>Z4DB^OE4,W!NJVQ4HCGJ:BNBW;>TFG<T4T//\RI+#Q<%]E"W4K][1+H*R"#
MYV%A4>&Y[N9C'Q_Z=>SXJX,9L?%3PZFKJ?S'X*(\=3/RF=SB)$)R+B8+R6X#
MB_\ SRD#U*\[7M64[V?))Y%.ZJ]1?;B)C_-!-&G0>Y=7F>;5@,;ELHM!68#%
MP@B]];"WWFI*V]BL+?S--?BH1=XRXRF4\@ Z4'HK1=#M=SO-YC"(GLSW\67'
M%-NA"]I"2;*-O"P-ZY\]G!G;-[RUI?0T--?QHNE<>=MG*1P];O(+A45TIS]5
M:JSFSCF%KEKE%Y]XE3LAQ84I96;DJ-]+DUP!<RRM;CW,-&BG#^3_  4RM(,1
M9%^08X=3B34NK^_]2IQQ#MA+YEB'\Z,@(K3[BTP_0-]VB4W).O[M<3.?="TV
M]<ML'0FM0#P_BU^*X6(V')N)K\@V8@&I';\AZ?AW*J^5\,RG#^;S6)$],R-(
M@,!I#9OM=2%>XI0\S<5.]H9'^[.?=&H8*=([G!1K>&.;CQ' :%X_<[FX]ZBB
MI4QC),1UL^Y'EK4EI].A2 +^H?=4I;/(V7YA\IT"B@B8Z(N!U U"SK0D['$,
MQWI(;(#BDIWD7N1>U+R\AMNELK@.K052VQL]V'/B:7!NIIRK_@NNQCV Y(=9
M:2RM]6YT@6)/2Y^-9R6-95G.BUI9GBC75TT\.Y<$N>QCD+<>*BTI26]R$[CN
M5H.GQK\OKR.T8'R'2JRV]I)<FC!4KZ9<2\D3VFG$H&F\I*0?MN*P020WCVR,
M=R[5FFL+B%OSL(':0:*1\2,!.=AN\K0VO%)=!79)4D"X(W6_JURMT6US-82Q
MP'YNEW#C^T_%=K:MY8VM\UT_[:<_YJC7WZKUT^EK-8'(S<_'PBVE--1V%@M
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MDL6WL;3,Q^7JQCFD^D+NY2*AQ@R$JLIG0CSW$"O64D>YX#]2I%]Q<-T_]R.
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M5Y%/C7;^V]M?-O@TQ_+KQ'@M+=.3M[2R<XO(IV+1V9CI*/R[\M2EI,1T!2$
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MS75Y9EP:\ FO,+]ABNX@3$7"O&A(]RZ#'/>)RYJX"<]%:E%P(*%N#<I94!M
M\[FN<_<=G#U-:35NE -%U+;:5_<$/D;0'F3K^=5(.1Q\A 3$>P#R7LC$EQY+
MC#MB%M(6%E(T UM7.NY+S*63VPT'4".SE^JZ)M<?BKEGFEQ<T@T_'@ME4=W#
ME7,,TTXG$,,I8_,65?PP%DD$;CI;[#5 9G[;7%C9SS2BKBW0UKP5WX+>UA?Q
M^3$[]O*A'&OK]"C/=]W _G4W).S&VXL>.AXRT. I(V V3U!J2_;[*WV-MC&0
M.FHY=P"XFZMMVN3'F$FHY@^E4I"D&?';DA(]EUE#[)M8E+@!%Q]]?0]I*UT3
M7#FOGB[M_II"P\?P5F(F2R..CRV($UV,U.1LE-(58*!Z_9]U:5UB;>YF;))&
MTEM::#FLMODKB!I9&\M!XT/X]BPS*Y@D;2TV8WME6Y0NHJ-;C@?,!' !:\G0
M6UJ>JJ]*OT_BOY_G84 $AJ-[0'EN<O\ RWJMM\%CY01Q'Q 5V_;$R?3NZOV\
MO6?BO3FH$K52B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$7G/\ 7WF,1CHO;V/E)C40RY$@,!T@!1LD>/QK;M[AT3'=)HN?E;6*XMG"
M45"\U<RAI6Z(J6(4-*VU%Y.U(2D$+N56Z5 [?J-7\74*^8)G%EX;=M.@D#@-
M ::U[JKM?,81^&XK&S!,0\X$*6A04$E'7IX5U,!D'65TV29@TKQ%>((6UEX+
M6TB>V$U<XC3LIV=RV9[-/0XG$S[LEMM3LITGW"$V!*0@F_@2*@OW2R<F7O6E
MC0&@-X"G"OYJ]_L_(R+%_,!U$O\ @K>DR1&B/2B$J0PVIQP^"BF^@JNFM=*1
M"!0<U9%Q<?30R2Z5 KJM NXW+\QE.7X]]]:'L;.F)@J;";+C@JL+7ZW-7#A,
M<RVM:"M:5\=%\R;DOHMQ7Y<]W265: !30.-3XFOL7-D'Y\WWH:'1&DN!2&7F
M.J5D62;Z]*W8&F(DL_BT_P %Q<?F+C^Z0]= 6O;^WGX]H[5U\E(S6#XT[*:;
M_.,OC6D*=:&I?4FQ<">G47M4KBCDN8VPD_+3CST5]NB%]%U.XJJ87=?%Y_--
M058J5$>E[4-%;2@DKL!;<=.M2?:.7CL"Z*4_*&N->=:JDMQ;8G^H<]A;Q IU
M#P5I@+B.@K2E*VP#[:P% $CQU(-07<5ZV^O97L<2TG3V*%R1R6,_2X#K;Q!H
MX5]H*^U)C%@%IQSWEBTA! ";$&X%O#X5Q"7!U.2]NFCA:'P/<)#QIH.^E.]0
M+CT"!!RG)X>/2RTS'GI6MAJUFW7&6RM( T N/#XU9> W3_;H ">/'GHNMF77
M#K>%\U/XA[?AP4Y3[R$>Z3L:0DE:B=H(M_+7 W3E/[E()6\/C5<BTQ]S.2(F
MG7T*.93DF,Q&5Q6)G20T_EEE##FU0;"DC=92R !>U1N!P>QQ;V?BBD#=D9(L
M+PT4H2=>0[=%9#?',RK'KD+A)$)93OG)!5L3?</4/ G2N?'>0R2= )ZNQ;=I
MM3(20&,L: ::_P 7:J*[O<QS_#'..Q,$AT-J=4[+D!-T."XLV3TO4KQ\ .MQ
MIV4]BLG9V.N,=_0/[=3JII(ER<M$@RBV(LJ3$;6XE0L$J<3?7[#5V;4F8;0=
M)^8]J@F_YX_[D6ENK0*T''1.,1G<7QV3CL@OW\DN2X^5HZ*"E%0-_@*KF:UF
MASO5V]5?25P;S)6]Q;F-@<.%!X!<Q4EX#VSN>)LVB_4]!I]M74QD,(J0.''1
M<"*)[GA@'$T]:QQA3E\D?3(@K$&-&1[,\IT4M>JT@BHE)N:%M^(W:C7E52/.
M8G^V0,Z23U:FJW&[)86$SQT9=+8^=FK45.?V@-@/V6KYS^\&XWWU^(!_IAH/
M#LJKQ^T6*;!9^<?W.J?=3V46OW>/EW-<)W.QD#ES;3?#9_NIP3T9._U$(T=M
MT-Z?;V6VBB+HW.#S2HK3M4HS#&R70:]M6U[*\E#.88.3R9[#Q#-+&$#A<R#2
M%%"W1IL%Q5JV=A)=-<0>=>*CN0S,=G,V%K1TGM"V.[/0,=&F2H+C0<0S&2B,
MV[Z@"--"?A56_<*[GM86%CSU=1K0GA12JR%M*71M#>D#L'-1OG,6+&Y!D6D-
M)2A"]P2!^T 5U-K-#[1DY<X.H*ZGF%$LC@<=%(^5S3U5]"UKA<HAYWD<C!8P
M.MR6'MSZ5LJ0E*4D;E7(M;7PJV[K?EM;6/2VI=0C4=R@N'^VMQN"2::$M#0"
M0!W=WXU5ASHJX2DA6K*UA#+QT"RK4 >?QJFFW8O)3+IJ:JNLMM:^Q\[XWQNH
MT\:&GK5F]L.-XCDV1<3E4J=,$>\AO4)4-+)TT.OA7'R^4NK4?TC0$%2G[<XJ
MQRET1= ES""VG#E3AWU6:[N<5X_QIG%KPV,^3=EO.!:(Z/X9T2I15;S!KA[:
MRL]TY[9W5H.:G'W3VG6'ZJ-OS-[.S2JT_P"ZL#.JXY,S<+.R8T>$$LR,<TO:
MA3:K)!%A^W6I_C91'*  -:\5$-CW\!B<V<=720 *<J:+[XCV^8X]'@Y1B6LR
MLC$:>EM!PJ:4I0O<@WUUJ:;.W (KTQOT:?>N-N_/W-U-Y,[6@#]O3R&OM5IX
MF#CI+S$R2DO2X:[H2?2$*\" .M23?<$UTV@'RZT*Z6T<587,9<7.,FFG  J9
MPN(<BS$Q4K$QOF0VL.MO*)(ND@@>?7RJFX)(+29K+JH;SIQ6O-LW*&_\V)H(
M#@YI)TT-0#S5YNX[E&;P Q B''2XX*'%O72V=-+7ZUM;KW78Q,#("2PZ'36B
MO_*1Y"ZQ/TXZ1)TD=VH6MW*>-9'C2EQ\H6$N]4AM=S\+ @$UU=C;V9:$A@/E
MNU-1W+YDRNT+_$CKF#:<Z&OY*C'N(\QY9GL1DUAO$8C'.*4V^E8]\D'P OY5
M*,MNG^Z4:=*=BG>Q)[.S+JFKG<U?6%B3<1F8N9;RLB4(H],1Y0+94/$BH]>8
MIMS"0^M%9LMK%.\3,H2.U?.6[NY/E^7S&-R&-5!&#6E$(E-DNDC56AZ5ZVAL
M2"5I,1-.JIJ5P=T;N..AZ7=)DI0#C^ HXF>MJ6)3JUK;(LH)Z?L^%7=/MZ,6
M@AC8VO:0/>J8QV>=]?\ 4W'/C0?!9![**F->TAO:T%7WKL";>55KGMC2V\1D
MCU/959MT;E9D6B-C: 'B1JL<MU*!M4HE";J2B][&N1;['O#;NFE   //710\
M%SFAO)=_"3)$E#SL-L+:"@ET.BUB+ZC45#I8NC5O$*182XO+&0F -/"M?\5U
MS-R1RLR-EL:A,)DA<&6TH%2TGP-STK%(1*WJ:[7O75W%?PSR-^H;\X _;^."
M_94V.^\&[I94E'\%D  G[=>E>(HGQCM45NY?.UZ>EH&E!^/BN"2R]+C*:8<^
M3<2@I;E-)).X_P ZVM;,43R"\"H"]6C@][>IM T<6@^VBB:>(MK5%&0RTO+1
MHCH>3&<60RI0U-T>5?OU/=0KI/S[H3T1 =&G*BD^4AQ<HQ)A@?(QGFRTA3 V
M% (("A;Q!UK '%NHU*P1Y.-]^V>5HZ*Z@#VK5S'LS.WW=' 1\S.?DQ'74.^[
MN4X'6G0I"2H::WM>XKLOI-">H*YC<V5]CVNA8T%M.0[./;V*\>X7&LSE_9R>
M!S#N+R^+3O@)CK4V'$J%]MQT^^N7;21GY2VK>]0';F?&$O7>>0!IH!RXZ=GI
M5*8'MMR+GCF<S?)>0O,Y3'R0PZ\^I3CA-A8$6/AX@UUVW4=L.EHI56EFM\VD
M=L)8=:@'4+:+L_@N)=H93_-\L^XXN/$6W-D+)<(!.I 42=;5%,_)+D!Y+/9I
MQ"T-K[SFO_FDZ0.P>/BKC=[K]C>]L.?@Y;T>;D&4.#&0\@DMN*5M)!:!\K5%
M;'"Y#%S@D'RSQU]2LF7(Q0M$DNAY+1+A/9V2US+-PN084N8J,X^_"4Z265 K
M5[:0H'6X5_)5H/F)A!9JH9NC+2WUMU60!<#K4:: _%3[YYCMCGFVL'QQV3"S
M: ER'&!VH6C5.A.E[^-:P'GM^;DJNP^0;=^9+>FCVTH. ](6&QO.LYF^Y.-Q
MRL8</"<*TNX]_0J2M*KD>.OA8UO6MJPMZ>HJ58G9V)O8G2BIZCP!X5'ZKM=^
M$_+,<<9=?]G%2)J??;W$+2H)*BH>72MF*R;"3TZU[5*=O;8M<:YS82ZA',E7
MA@I&,7AF(&$G"5':9&P>[[@1N38$W)KW!!';R?(T:J33 - ;&23WJ)X*/SG$
MJD8V=#CY"&[(68^2]Y-TMK(MN!(.@OX5U/+DBD:\=H6ED8?/C<!2A! _S46
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M#P[U8_U,P>.<^X5'X]C'8R\JS/CO,2F]ON--H6-Y21K?;<5"=D6$D>0 F/\
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M=;@UCE9 22[W+ENDI*6S@4/[>>G-:+2U!R1(<865[G564K4V*[W-_&U(@T>
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M7[_$"@E*BC4!:NMKGRK/+<M8UQYA>H8VR/:UW FBR1E^PV8\$[#HIV01KO\
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M*@%MTR7/RGH!.GY+I(7*B/N058MF)&:3MCO(<4NZ?]218:5W=IX%N5E#I'5
MY46SD&PL)#1\_,ZK[<F(;>B)*BA:W4)1M\R0*MY^+L<7;NJ!P*P8ECQ<L<WD
MX>]63CY4&'+AR,M;Y1MQ/O-"Y4H?8+DU1>=R8FE+8E]%1[QLL5"TSD5]-?4
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ME=6-P>\FE5-GVT.CB!4*7=UNY>4X8</.X!RPXZ=*=<_,(L)Q*V74)%]ZTD$
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ME2C=5@*M:PLXL9  2. 7SEE,C<96]=(027.) %33GH%(XZHZPL3$O(4 0 V
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MSU;I2DQ"%0MMDK5HLJ^[XU/]K0Y+R ;DMX=_Q6E.R!DCA$20#H3^.U<++;H
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MG;D=Y,'NT;V*'XS?U[:6QB.KN .FGB*:T_':I9Q/@.4Y[\V[^8?+-P/[FZI
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MU"^?I-I6%IEW75B1Y;2:!IJW56H9\X0S!8G+CPU*"G4I.BK'4$?&L^=QD3I
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MOE<8YDFFS[,1@N>T!XA-SH*K?=\5XRZ+A(X"O(]Z^W_M[F<&_"L;)$T'I'\
M_E"K'@W*)V8QTC-R@AQC(/J++-BE20VM03>UO#KI4SQ.'.=Q0CN'NJ":'B=?
M%4;E]ZQ[<W ^?%L:6D-Z@065+:GEX]BLMF%)F1B](<94XI?NQ@#8(;7;TDCK
M4 R$%YCNNTB)Z :5!H31;^^;:^W?;0WH8QLA'5^[^;4BJMKMCQB'-S!<5';D
M,0A=]Q:0=Q/3PJ-;AW3?6>,^8G1PUJ:KL;7V9!CHA%*UKGG7J(!/A7L7/WJX
MM#A,P\O!BLQ6]R6E!M("NMAT^VI)]K-WF^D$3Y7GNU*BWW+V]#9P>=&P U&M
M!6GX*UR+CJ7$@)*@;W-?1<A^4*E T$+L**R#M'KM=(/G7BAJL8HNO%>E70XX
MV&WFE7!&HK5N7QRCRSS6W#/]-*V2,ZC5=V0\Y+>#SP3O"0FR 0+ GS)\Z_+'
M'1V;.EA-":ZK9RV7ER4HDE !  T[!Z2N-0M_7-;PU7*"^TN(:&Y9T.G2_6O$
MC21HOPM+M IUVYY5#XEFUS9K2_DI*=JG4 J]L^)VC76H']P-KR9^Q#8@.MM2
M. KIWJ<[*W%'B;@^<XAIIPJ?8I+W&YSAL[/9D897S12V$J"DE(M\;BH!L/[=
MW]F'?6$L;7^$@JPMQ?<6T$8^G D<>T'VJH"J[JWBA(4X;E*19(^P5?$<(C8&
M@DT[51MY<FYD,A ;4UHT4'J4DX[S#/\ %W%JQ4H--.KWKCK&Y!5Y]0:X&>VM
M99IH;<,&G.@K[0NOA]RWF*!$#M#R-:>PA=7*Y:7RC+/3<L\D/OI&]:!8&U]-
M2;5A@QS<%:^3:MJVO/\ 1;L-P,[>>9>/Z74TH.-/$E8J9*#RW6 X/8879)2-
M3;S/VUNXVS9T^:ZO45CS^3?(\V[:=#3H>9_!7"VTIY26T)6E3FB5*20+>)K>
MFR$4<;C7@N3:XRXGE:P-(ZN9"R>4NS[$8M!#;:0I!2-20+6O]E<+;_EO<^;K
M)=KIRXJ4[P\V!L=MY;0P 'J'&M"*+%K6%H4L=0!J/,U+>H/;500"AHN:)*$*
M4E[;[B2V4+OJ=:X^6LS>0=+3K52#;F7&-N/-<T$4(61^8D9R\/V$)@/$-2@K
M6Z2;'J?+X5&'8VWQD!DG-74T'$*;1YS(9V81Q,#8B:$@ZT]?P6=Y=V0X3P_"
M1.5XUH?FLTH2\^A>UNR[7"0+#QJ$[4W*_(9AT;F-:QI<!32HH=5U]VX08_%5
M:][SH?F-:5(!72XVWL@(80VI:6U*#*C<WN;_ 'ZUU]YV[()O.$A)TT)T77^V
M]^XX\L<P<7:T[2OGD/(8'&(Z)63]Q*'7 T$M-J6K<1X@5'X(S>!C@!4\E+#<
MLMVO)/KX+C?S>)7#N9#2EO,^XU'_  J*2 ?PGRO6YBK.XEN@QV@!Y+3W)=PC
M'E[:</@HPR\TL)04%*?"PJZX06-#.2^7GL(U7XQ(CR4.B*Y[A0X4*4/W5)\Z
M]-+9&EH\%Z<U\3@3IS7?=R+TFPD!M*6M;(!N3]YKC8C%V]@]SF.))[5(,]N2
M?+,:Q[0 W72O&E.U9"#A84I"94Z&U(6I8<C^XD**+=#K44W-E 9N@:$<**P=
MAX)\<'G/ (=R/9K1=Z;B([P!CLMLK&FW;Z;'X"U><+G9+=I;.>H=YJ5ZW'L^
M&Z(-H QP.M  #ZJ+N0H;<)A#;:$MN 6=4@!.X]+FHGENF>\?+%P>=0I[@F/M
M;".&;5T8H"N/(S4PHY<24EU5@VA1T)/]BNU@\*;R0>82&CL7%W/GX\;:N=&&
MND=30]I.J@<J%!E+B.+(4J,K>RK2P)24_P!0U:<T4<A:#R7SY#<21!P',4*X
MW#$DJ5C7DA]*TW6VL7! Z:GRK]D+)/Z9U"_6A[!YC=%S&.O8A+;I92W;:E!Z
MCP%>O)TH-%X\P5J15=U2+I7OVD[;:6U^VLU#18 ==%WL($HGB^FYE2!;Q-P?
MZ@J);O@<ZQ^0 GJ"GOV]FC9D_P"IP+'>O12E4AAKU+< ])6H#J F_P#8JNSC
MKR[8PN)J3IJKJ=F["V?(XD -;4Z<E$\D\B:^R[&?]QIE*RLE)38JMIK;RJP=
MIXJ6S8\R\21W\E3>_=QVN6DB\@DAH.M".)';X+"Q&XEGI06VAAPGYIX6-D@^
MK]@J1!S6Q/DC K0^M0J.CI61RDAM17M KJ1Z%Z4?0#%BPLMS=J$M2XZX\922
MJU_WR.@%59N.]EN&1>8T#CP5_P"R\=;VCIO)>YP)''P[J+T]J)J>)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B+S]^NU#$C%<,AR&D
MNMR')*5I5I=)2 =1J*Y^18YT7RG73WJ-[EMIYH (N/C1>:F*@8SA^'S#.*;7
M%CR&WGI;:"?62#;^Q7*R.*FD?'(0/E(4*=C+FQLGS=;NH!QI7L&BA/'T\AQ\
M&)^:)2' MP12==[1_"5"_6UJLK:./Q]UU.E/]0'L'.O-5A=WK[6[%TRO417Y
MM=2*'2M?P%WEN/F_NV<4HDEP]=? ?95P,ACC95N@ Y+CW-R^ZD,DCB25DL7
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MYAT.3,?,E-Q#'025!H)!"D#6YO:]1#*X9EL[RW\ 5:%O@;08J.Y#C6@J>9%
MK\;=6]L?<WM%ZZE;KWM\?B:M>QQ=A>X\L9_*[6@J%3,@U(K59%*@E*E) 5TL
M5"]JHS)V@M[I\334-)"Q,>6\AKVK&9::K'8J?/9B.SY,9O>U&;MZS< #Q\36
M"*!\T@8.:Z6*MK>XDZ9W%H[J>U6) [T<,F<%CXV9QB?#Y3\L4,0C%4I*WP+%
M"7;;=:X>0VEDK2]#W5$9.I)Y+Z#AN<0W$^0P@NZ2.%?:HOC,]CVHZ?GE)PTU
M\EQ<"4I*5H) T^RI]C8Q'(UK7$Z:U7C8V,ALK:5[>;B=:=@6(DS6\K[SS<@;
M#N0R4&X Z$_?5]8>WBB@!-.HCN5(;BR4UW>N=(-&F@'+3\U"(.%S;BLI%S_(
M9F7Q$EP?*8I3R_ETH!W>I%]JM:XL>S+9]XZZD:TDDG0#FNS=[RG?:-MX@6@-
M .IY*89!UV%@<DYCHJ7WV(BD0V@@':XH;46'VU7&ZL>S&W;7V[BW4<-._EX*
M+XH]4]7@.!I7JUI4C7Q76X:]R:/AX+W)8@@Y8)"G&@H'<DG2]O,5$LMDO[A<
MF0.)K[%NY.F,R'5;D@ U'+T>"FKF16@.(D,P_EW!_&2\M.TIL-PN5 >/E7JZ
MNG.C#:&M.PJ7OWAEK@-9'$RE!SK[:CW%5%PMKBC.5Y><5##;GSY#$AM-VRFP
MND$^ -2/"X;*WC6F$EK#H[YJ+E;AG,L#?/)ZP26@:BG(&O)7]_E$Y","O!,K
M:1%<:]E)2DW".E@+^(TKA1[:M[3-@WKBX NK6CE^P_<+(1VHMF-:* "HK73T
MK 3X?S>,=C.(20I(]*QIIKI4W?-!/=M\EH#-. HK7M[A_P#;2'N)-#Q/<HG'
M;4TREO:"&QM!\P#5QPN9Y;1VA?.MU3S74/,KFBJ"E+ 0 ;V/V>50W?-G=7-H
M&1 4#@>.NE5@D!'-7WVRR^&A(=@;E(G2OQ(VZ=2?3;2J"^XV-R]]:122- A8
M20:ZG0 U"^K_ +#Y_&PVXM6O<9_X@1I4N)T/#\:KA[C<FP/)<!G.*/)EQ%O
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MOX??7T7C+3Z6 1U%0%6[[J26,->:TX+$X?/0LD[*$:6REV(^MEQHKLL*2+W
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M<?;4RN;.W= )&G4*R=WVF.EPCI8W NZ"1HM>,K*,1F#"=BK?F9-7MPB" $(
M%BKX:UP8H@7%P- .*HR"R'D@S"CC^T]C=*>_@N3Y)^(VRS*VA]"$K44'0*'\
MW[*[6"RD=M=L<[6+J'5X<]%S;ZW?9S4KKQJL%G.-P.0LQ8V;0\^W&6'XH6I2
M2#YH4;V^ZK!W/E,;/:]5L >\"G-="+-7]K3J<XM/)Q)!"S6-QK<&"IA4YZ0X
MV"IOWB5J"18!)4>M5(7^8[AHM6>2.\#I7&C^-*'DNW[Y*%*>4G^&A:T+<2%6
M<"%!-R=>M?L=(W5"VL/F9X)F@O-!6GC0\^Q0&=@$\\X9%A<@<4J8RB4_%FMV
M2 4*6E!4V0;Z)M6]+>2,> #H%846^+J.9D5.+:@U\1PIVA59VT[B<5X_Q;&\
M?2S*=R\N:MV?[315ZG%^VWK_ *FVM;4]K+.X%O%=;<FU[S.],S10=5>/*@&G
MH"NCN/PE_F6(A8:(^SCX >0_DISMRYH+I1;H03;QK]#WV_R3./@M"WPD.WJ2
MRT '$G7NU]:TPS_ ,_BLY+PK4-S(R(K?O>Y#:<=2MK^?Z$J(!^/2MQMPQPK5
M6)BMTVEY%UM?KK6@/+GX+8'LGQ08?$RLS+0XC(Y-:F/:=01[;"=A&VX'XE W
MKFW=R:D#4:457?<O<T=V]EO;N_:'!]*ZU+2/<0MS>(]SG.+XAS&HAHF[0IUJ
M05$*+EA9! !^R]0C(8%M[+UO-!7L6+9_W"&&C$$@JVFKM>)II2G+M6I7")O,
M9'U9]OLOR)/Y:[RGDT.:(T5]1;4TW9-]J; [0GQZU.L3:PQQB,:AO-7)BLK9
M9!QFMI.MQ )%" !P''M7]4"#="#Y@5UETU]41*(E$2B)1$HB41*(E$2B)1$H
MB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2
MB)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41
M*(E$2B)1$HB41*(E$2B)1$HB41*(O"'ZQ.+8?,][.9Y">AQ3F.R+2VD(60%+
M+"+7'3QJ2;6B,]QT\A7V44(WY,VULB_F0!ZZJC8$-+Z))6X6FXP%T@@63:^M
MQ5DY+(.MG-B8-7:*E<'A8[]DDLKJ-C%3K3MKR7 +_P 1(U;2HA"CXI\#7;MF
MN\L=7&BCURUC)7!AJVIIX5T6-Q_..2XC.Q<9QAEB.W%1[F4EOI5L5=8N!;J5
M W)JN\QM6+)W):1IV^SL5KX#?USA;%CFTZ@:4[1Q[=%,(R$9R;.R$U*%O*6"
M6[W&HZGSO7G,OEP-E%!#^UC:>T++MRRCW7DI[VZI5[ZTKW'EKV#U+'9: J*=
MT1(%[%#:B;%6IZZZ:=*[6V<Q+D;<B3CK\%']Z;?@PMTUT7[333CK4GX+%-\M
M7D7I&%=AN19<1#:I8T4A:%WL4*&IU3K<5AQ>/C@NY7R<J$+=SNXI+_&1Q0-.
MM0Z@\#R^*LCAV1F\?:7(CI1[KZBI 4.@6D"Q_94#WY#'E9.@:@4'J)5E_:GS
ML-:.>_0N<7>%6M_)1[N%EU\R8_*LRVW+B1U!>S;^%>A!3?K:I!L39D5C;EQ'
M$:>OP4-^X._YK^[\EAH 14^@:#58O&P9C 2M*& E#26V4K*MI;4!_-&FE=O/
MYBRTLYZ@=U!^U8-G;3SD3O[ICNAQ'#J#G5ZQW#L[UC,KBN19J0P]AN7/\/G8
MU+@=^2UW!?X2H*5IT-0;.[/L@YKK;YB:<=?@K'MM\9G(1G^Z!K*$C0%O#3F3
MWJ'<)SF>?Y'FN-\M>D9F9CR'H>>DG:);:K$!(!UM>VE>KS/3X2S%JQO2ZE.'
M85L[>^W&+W9>.NI)>MM10=>@J#V>'I6UF9SG#IW&L9$QPC1,[&2$2XJ;!24I
M%M14!PK\Q?W);)7I))Y]J[6<P>)P+PQCF@ 4XCP[NQ4CD[29KOR7\5;I0EE0
M(LIP@) !^VOHG%E^/LBR0:-!/Q7S%N:6.[RSC [J#BT<:BM -%(,EA^6XZ!#
M1FL;\K\PV L-@KT\-1<:CRJ-8"_Q4ES)*7ALG5P+@/8I!F8LPVS:P,JSI /2
M"3^/!8)B-(;GPWHJ7VUQWD+]P)-DE)O<W%M*E60N+:2S?60$.!'$<PHK@;*\
M;>Q.\EVCVU^4Z"HKR4EY@ZYF,;LRDAZ4EE:5,[EFV\D $IZ>-59L_$6L>2)8
MX<>WN*NG?-^&XTU!K3XA0Z*U=M2"H)M< 7J[W-ZA0%?.DKM:J2XF<\XMR.^I
M%RD>S86Z=>M03<N'^GM_.A_>*U^"MO9&XS=3.M[@BA IR\>?@NSDIB<>P"VE
M!=4=$'2Y\[CX5Q,!C_[PP^=Q"DNY,TS!Q_\ ;TJX\/\ #N6;XCEPO(X]Y*1\
MRVZDJ9)T%SU)/A7 W9MJ:VA=T<*'W+?V?NN/)1ACM'@ZCTK8GGV'R>:QC<R#
M.]MEM 6[$O9*K#6Q%47MV_,.5\F1I)ZCR[BK&OY&BWZNY:=3W"[E'$-D(4E8
M:4H] H'4WK[1QS?I+,.=V5IZ%\I[BD9?9(M:: D-KRK6GLJOR<Q\L\MHK0\2
M-R5 :C[:S6-V;J.I%"M#/888NX\H/#AW&I]*Z26U.!*$H)625**1N6?@+"]J
M]><8'5E-&^Q:D+7S@0PQESCV#J<?"@K1=6<M$%@RY:EQVTN!M04?45$V3\+5
MKMW#:R3&.-U?<I)<;'RMG;?47$):SPU]U/:LBVI#GL-2/2TL K=%AI:^I-="
M=KG1FFJC.-@BDNFB1W2VNIK3VK:?M;GI640]A"6I>/:;*5*38[">@(KX^^XF
M/;#.'@])J!6M.:^M,/)YEN61FHI\%2?<?$2<#R6<V6U-QY#EV'4Z6)'0&KA^
MVF%M+BV#W.ZG =O>OG/>6%GQM^Z<&@<="*Z&B@BB&T[U;G%JM<G4_M-7+$V-
MGR-THH5)*^9U7$D]I77=)58_M ZVK\N"X,=3LT7J.@.O!9)",2K8%KVFVOJV
M_MUJ.VC+L,<ZFO+136&#%2 =1IZ:*><?X<G-P7Y./2RXRTE7NN.+'0==34-S
M6Y;FTN&QD'B.2G.&P6+EM"Y@!K76H/M5?RH2HKTN,%;TM+*00=PT^-69979N
MK9CR-2%3>3BCM[I\;#HTT74:OL*$V"BH $]/*MJ4$1^&OJ6LR/S)&M'/3UJ7
M0('R"%K4X7%N >X>@T\A599O,-RDP@8VA:5>N VX,%'YSWUZJ5]'<N>:XPU'
M<D%(.U-P1:^O2M3%LG-VV#J]ZZFXWV<=FZY#=:=W-0QAQEIZ*X\0&D+&\GH/
MB?L-67DHWNMG!G&BH;#21LO(W2_M#A59?+NL/*C!E25J!*BI)!LG[O.H[M6U
MG8YQDX:*9[\O;681-A()U.E.'Z_!=)F=,B!;<<H+:SN]5]#:QZ5V<E@XKN<2
MGB!11S$;GN,=;N@92A-=:Z+IDJ6XIQQ6Y;ANK[:ZEO"(6AHX!<*XN'3O+W<2
MBU>VA2]I7M%]HZFL[G=(K2JP 5-%$,7RN1ELJ[COZ.Y)MIH@.2PT$MW)M<*5
MH?NJ)9'=(@/3T&O@K PVQ7WK0\R#IIR.ON5AS<0(;"I(E!#+:27-Y\!XW'2M
M6VW5$[]^BW,A]O9V?Z)KX_H%UL!C,3+;7D&]CB'E&[K2@$JMI>X.M<W/;A,$
MK3;'B!7TK=VYL\W4;OK ?E) J3P"EC.69P[;D>-,+*6[J4RA1UT\AU)K4N]L
MNS!;<2#YJU^"D4>;QV%A=;L<!0<*BO:H-(4IQ<A]*@ M97M/4[U$U.K;KMXH
MX:<&@>H*E[IS;F668'0N)_ZB5R,.R6D@-O*0GR%OZXK9=C8IM7BJ_(,M<VS>
MF-Y 7VZY(< 2M]2[D623I?PZ5^BRAMAUM%"%^2Y&ZNZ1O>2">"Z:05K2HFVW
MJ*V8G]>JTG?+4+OL/KBOI>0+CHM/F/[-:N3L&W<?25T<-E7XZ<2-]/@N27,;
M=F,J4H NL@MMDB_51-:6*MV64;FD\UT-T7;[V5DU-"P>TE<=@DWMHKQ_EKHV
M=U'*31P47K51[+YO%<:BNS)SJ(;;I*@\H$@J\C8'K6"\O[:R!>YVJZN,Q<^4
MG;#'QX:_@J*\)Y>_RYR=+;W1(D1U300E125'P5;XBN?CY8\J3(0"!P4CSV+F
MV^&PMD/4X5-"0%/3)AQG&G)0*8R5@K6!TUZFU9\V7BQF:T?PGDN7M>@R<#G&
M@#Q[U)VN3822T5P9*)NP !+)N1]OE]]5OBL!->Z\ KLSV[[?&#I-23P H?BL
M4B2_FLE(3$<#+L1I.Y!44FR@#KMOU/2I@!98AO\ 6;U'P![^:KSKR>Y)";9_
M0T<NHM[OX:KK369;(D,);"I13N85U2I1!UN;>-2&UR<%Q;&6,4;33N40R&$N
M;.]\B?5Y.I!KU=NIHN-Y')<'Q!Z6A")N>APRI+&[TJ(45*U/PJOGY6&=I936
MI5N08.XLRV3JTZ0.)6&X#SR+RY"YJ=Z)!4AJ<RO0-.I!01KIJ1:NJUC;BR C
M&K :^DKA.NI;++'SS\LQ'3Z!3VJ7Y7'J8WR /<C.*WNCJ4DG4V\JZN(S4+FB
M!W[AIZEQ-U;4GM2Z[CU8XU/<7$GLX?C@L2^TTVTTGTJ;2?2+: #7I4K=&UX
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MD2E@!!4F^@_8:[MCB+N9A,=2WGQ6O?XI]E$'2$&M.'?P^*FDA06J.ZV-K+:
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M79BZ=<QTXE4QO3$092)T,#&M[Z <ZJ%18R662VO8\L+*[VO;H!:_V5S,5!+
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M'-1WHV483[$F$XD(5N3^)5NGA5N1Y3ZBW;!;QN%16O%54YT>W<C(YAZBUW2
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M<E:.(.A!I^ N?A;IMM=QRNX!RS60R276VV(CME/_ -T4@_NCP5;K]AJ'6NU
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MZBFS=@VV#GZV ./:0!S7T-OO[@?W/$_3DTJVE:G6HI15.F66UM2&VTMK:\/
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M"YES<222ETVKJZU7:9LZ%H( =2DE#UKD*MI^PUWY3_3=U<*&O@L8D,$C7L/
M@^GBH%PGA:^.R<GD9D-#D[(2W5(EZ%7LD[@#KIJ>E5QCH\==3OMB XG3JZ=?
M:%*MT[B;EFQEKB*"A'*NBGTQXA2!L&HL0.E2K$[=M\4XF/B:ZT"B$+-%\J"5
M)2A/H*C8(2/[%=FW/0/F>7$<RLD3'R/Z6BI*Y%-F.$!TJ22+IW=#^ROR&4R2
M&AT6:ZLI[<CS&4JNN5MI<+C[FU*A9D'HI7PK8)$0I58 "11H\5GXT-!@EWW5
M>Z4[DBWI%_ ^=5EN2QAO;L>:!0$J:6VU+6>R$YE=UD5I33\>E1R5.;BQW)<I
M-FVK>X?'4^%JGD,$,%J&,:.D <E#8X'/?T-XKIH1(=?,Y&0<D1I"![$50"4H
M'G\:T++;UK;W#KMO$TTH*"BRN<UK>@L (.I[5FW,>J;%+%TJ=>24)0KHHD=*
MX6=WA]$\L:!37M_)8+4N=.UK!4UT52]H_E,3.Y1B)<UIS*X^>0Y'D.V2 %$V
M;"C:UB*I[(ELP):*]5=?%69N7%RE\7EL:XAK2:T'S<QW\EMWC.X3SL)4&$6'
M#&3[#SB!N 5;4 D:U'L)M6!]UYLCCQ[ 5=^T-U3P8SZ9T#0>D"O4JOG0Y3LV
M2IM*MSJRXG:4@$'4^7V5]*XN?&VENRK6B@ KTZ^Y?.V?P-]<9.8L9U=1+N(X
M>DC@L9CY(3D&IB7RVQ'#C;R&]0I6@.X?"WA6+/X:"_@,\ '7V@4)6MM?(18F
M]K<C3APK0^BJ[&8S$5^5#CMNK<N"LJVG9Y"]Q3;.+DLH"XL'6::Z+N;WS<63
M:SR'U:-::CPXT4,Y3RO'<3A)FS&7'VE&VU@)*B?_ !BD#[Z[&:R8L81(_M45
MV]AAE+D1/?T#M_!HH1Q#NG%Y1R1.)5'3 8E$B$ZZX"N]KA*A>US\#49@WNUW
M5UL'2.=3^2FN0^W/0&FVEZVDZG3Y>SF*U5Z.(>Q3[-U!S<E1(VE*;>1]1O71
ML,A;9J-T;11O;W^D+@30.VM>1RQO$CJ<".GW$J'\DA<>Y5.B,YK'1ICL(%;+
M"VRNX.A^VL,.U[&Q>275)[0%NWF^<E=RMG#0 #P!.OCJJRX_!S7#^<93$8+C
M[PX]D@E[8MEQ##)&VY0[MVCJ;CX56.Z["-DQ<#I7BNUGK%N4Q/U\_P#3D;30
M#JT\>7>K6S.47BPP\_ D2VUG:XJ(W[H1\5"X-JE&TMUB. 0.^:G,U_)5OB<:
M+USFM<13NK\0N?&9*'D&$RHVW8LG8;6.AMKY&K*+?K;73@0M2^M'V\KHS70K
MOA;CK:E*0&U).A2=1;H1:N1B]KVV/D,K!U$\:@<UKC^FX%IU5@8?N%DX'')?
M'V665(DH+:Y9OO-]+GS_ &UQIM@6\F2-^92/F#NB@Z=.2G,._KR"T%L6!VE.
MHDU_'I6O>:YGD(7*L5QV'$5)7.=6J;)+9VH0/(C34U[W%##?RQVC/E;S('8>
M"YUIAH[RTDNGO^>NC>VO/\>M6!?=N<;U0=;CH*FODMC8&L:*!1>E-"NVK'39
MC20N+[T5X#>24@D'X$_U:@EYB;!E_P#4RFI)J01HI)9;2R4\7G0Q]A'S-%:^
M)7.S"RV/^54Q(1C(D(%"HQ" '4GHG0FWW6J/;RFM)(:6]*Z<!3X*61VVXK2V
MZ?+  '\P[.X_DNW&*%9"/\V2ZE3@#V_UD^&M^M5-)5D9H.2KNV+G7C?J-3U
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MW=A5BYC&PW4%>)*KI&/AQ6UNI0AO:+[S:^FO6K6N,K)D@(QJH))MVRL+<R4
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M6N-*C&R[6"];+%<5%:#C122US+\;"8JDN/.IIQ]"YLGG,=!4/GW1$"SM+SI
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MZ59#++K"$RW&/=8!TNJPT-M/'K6JV%UQ4,Y<5$[:!\;1<.CZHQZ.:N?MGQ7
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M0@J]U1*]R1?:4W)TKU;6C)*O)_;JL.*Q%O\ 333>70]!-22>%:<U97;SDD+
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M5.H!(ZJ<G ?CL7(9+[\I,S)."0[(479BU#1:EW)44_:>E='^VB"S;!$X@-:
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M?$MBG+PT!Q[**';AW++GIXX 3T%S>WB33GXHEMN%&D%AD+26U%_>!=8 /XB
M+VJ0S6_5#(TZ$4IZU8%SM-N(P;Y6 .JPEU::T/.G'BJRY7CL]D\<TQA0RJ*7
MFSGTJ5M<^32H*4EM1\5"_P"RM"SN&Q'I<*ZJ ?;]MLV_$LX!:*@M(J-:4T_'
M!;'\BYCVOR?%F$\4Y#B),EEA+49,1UI3R4%-DIVH.AOI7?R+8C#\@#? 47T)
M]S/IK/%%UO&V,/:YN@Z?X>7#FJ@*Y$=II]N2H)E#>"VH@DCJ%"HKTA[J#4CM
M7RI(VZL R1KR.L=0HX^U7/VP<QN17+3.BEJ=*"T0(T@#<&_YWVWJ96=^VSM0
M^<4I7O7UWM^)C+$>8.HD'4ZG55CS7%3.-\D8PTM"%2,HT_.9"!I[+10E7VD%
M0K:Q>9Q5_)YM3WCI^77T=RH+[@;2GAN9;QIJTZGAI3I"QL?(8W$8J5*R$],1
MB(2\ZMT^EMJP%Q?2U<[,YF&\N6M@:&LT&@I6A/O"ZWVVW'2%]I,\FE2 22 V
MC1IR4J[$Y['9[NQP3(8=]+V.=S;'RSR!8+2%6W#X&U6?!B;-N*DE\IO5TG7I
M%=">:CHMHXMS,$;0UO6V@&@'RBNGBOZ"T_A'V56:^A@OVB_4HB41*(E$2B)1
M$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E
M$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB
M41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB\8^^_T]]N\]W^[A<XRL*9
M_2.5E69");,MYD61'8%MJ5!-C;72JSW3N6ZM+KRH30T'+Q5AXK!1W^-^?A7X
M*(=YV>!'@TJ&9[.+FQU-HB/QUEMUM:!8 K3;J1K?K79V%D,S-?Q^:2(RYO4>
MFFE==::*I=XX2SM[&8M +FM) KQ--!3FM7X2(T/&(5')?C);WAQ-UJ7YDD7O
M7UQ;]+8]-0OE>9SY):.T-?"BXTIARTH>0EI:/[HTI:?WA^Z--#6L_I)J LH#
MV5!)"N3M[R1?'HTTN#WV)!WH:O?:JPZW^/A5._<[%#)W%NUC"7!KJGTCL7T+
M]G,L<787#I'CI+FD"O#0UXJ&*R:59:7EGT7;EE7M-MIL4)6H*!(^[6I[?;9?
M)C8X&D5;TGGR;15;B]X1P9J6\D!+7]0% .!<"/8-5T<E.;F24M-(6E$8$EU0
MT5OMT_96YM?&R6,;F/[OC^:\;ZSD&4EC?":TZJ\.?3V>"ZP<";@V! \?&I35
M0#IJNG(2X[N0A6P*0;J_>!MX4?JTCN66,ANI73Q,)W&06X3DIV66KV=<&NO0
M ^-8;:(QLZ2:K/=SMGD+PT-KR"XL6S-2N5\^\F8H/*3&<  ]!M<&WE7B*,U/
M5KJO5T^,AOE@MTU\5...0X<R<B$E:7,C(="&(Y4+D:@V U^-0S==Q<1'ICX>
M'@K3^VF#M+]W5+0NKV\.*L+N;A\#V[P3.9FSD,-% ;<:4HJ6X\H:;$=3KII4
M(;E9+=I+W*]KS95A&P%H%=.96IG$.\LS.SG>-O890E/J<")?X=C9Z%:%6((!
M\J]X5YOKZ-S36C@3X*N-RRQXBPG!'[VEK:=I'>K14VOW6RTA2RGTV&M_B+5=
M5P8FD.<\-IVFB^=X())JAC2X]P)79=:D%#;KB"A*E%-C<$6\Q6M%E8KB7RXR
M#3LH0MJZQ%Q9Q"25I:'&FH(/M7XP@/R4-..!MLZJ\+V\!7[E+A]O$71BI]:S
M8.QAN[EL<K@UOC2O<N[DH<:,AIR.0%J4 H;KW!!\*X>$R-Q<RD2C3PHI/NG!
M65C UT!%:C^*O(K&[U[TE)];:@I*CKK4HN(1,TL/!0>WF= \2,X@U"[R&I64
M5O4XE#C/IZ:$'6HQ-<LPYI30_CFI?;V<^X_F) <W3AZ>2[4'&/&3NDH],?:L
M;;V4;W%CITM6GF=PQOMVB+5SST\M%UMN;*G^K<;@4;& X'4 FO(T'"FJL?C6
M%;S\I3(D^TVTC>IQ-B;7M8BJ1WG>S8D=3N?=^:^BMEXJ+*"C7#Y>_N[E@>9X
ME&-?6S'E(EICK*R4];!)O4S^UN8$H+GNK6HY=RK[[R;<>R,>6/V$$\>%"JAG
MYC8E9C1W\BMO\;45LN;3_;*_"/O-6=DMT6.//2YP)[ 1^:^>K:Q<_C1H[2>7
MO62A2'Y$5IYZ(Y$4>K+EK_?:XK>QV4AOF![/>/@M6:-K'D!P/>%FX#T=F.I"
MV@ DJ*?;M<E1*KF]O.HUG-E1Y*Z^H! K2HUY"BNW[?\ WIN-K6/T182T ])
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MNCC?N%<MC++@=780 /7^BBZ,L^]!7.,1Q+UU%48)U*KZV^%ZD]NXQPM;3]H
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M,/+QE>^S-6W[;:DD^L*-M;C3I7['DYFO'F. ]A7YMW*3XIXDGB>6CC4:=/\
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MV!#:2HZ_=5DR7GT]IYO.@/K7YC;,WD[8^WW*D>TG/,]FN1O,926E>.4DR&G
MBP;6E>[:%BXUL+5#<-E;F]$K91H6GDK3S6 L,4;>XC=1S'@G4:].M:5YT"V:
M5RS"RHS[F/R+$W)!I3C>-84%O*<VDE)2"?*J\R4PLKA]>TJPK>ZCRED9:T)
MT/$5[:+BRW%^=<_X=E,5Q"(AS*/NI2X77$L;$=5("M"#4)=F!9W0D>ZE?QS4
M%V/+<S7,\1^9@>X>[15GVSP_=;AV2E<.Y5QU;.,C+4',@^X-R"L?^;*5'>/C
MX5)YK^2^@=)&>H44\N<5$Z"XAC;T5;IV:^E6^)B,2V]'=NXMMXVVBZ;V%C>L
M^S\6<E.6N%!WJE\!FH\!Y]M,"Y_4>'A3G11M]UJ6PI#K?N>Z;/+4#M))N;'P
MO5E6FP[>UN1(2*=E2H,!*'.D]9IZ5#N6X:5EH+&/QY;BJ2^P^W*=25!'LJW
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M"R<CGW<J+Z'VIN=LEAU2_*0"0#0<."^>:9;*<NS$#()D)1E<8?8;E[ 0IAP
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MY-2XD4[*<US3,0S.9#TZ&B1$2;H<6 ?&W3K7E]U:RR^6^A<.Y9([&^@MOJ&
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MQ']FO G:30&I7Z;:0#J(T7)[9(*E.VT)2+7K, #Q"\]7<OI"E%#:E*WJ;4%
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MC_Y0G_>P=PO^R;CO^[9?]BG_ (_'_.?4G]\?_*$_[V#N%_V3<=_W;+_L4_\
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M%H6?U$[3%"":\0/4NP[)<@RHD:4RM*\B^&(PN-P41>X%_(5 =YXFTN+9LT=
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M''D.([ I]C['%-O!,0WKU-:-KJ*>*R_>R7BG\LUF<=)3+C)C(8D>P+6VE1!
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M*-MO2UJFEM]O(&7CBXDM\17W+Q(^<@%SB=>%31(#[4)"<=&]QLR/6TRFY40
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MMK2N]SSV5Q)%/PH*: <E9.)V9:7D+;FV/#7B36A_-?#T:7'D%3;"U*"E%EU
MO8$GKIY&N[:Y>VN[<=9' <U$<A@<GC[TRQ,=J7$$"O&O=V%<#\C(*BR&6G"E
MY:%@LN(&XJ4.FHOK>MP6MOY1DC TJ:U[%SSF<GU_32N=\WREI: 3U:4X5UJO
M1SZ F'XDKES,FQD*BQB^4]-Q4X=/VU5V>O?/=0]JO3:&&./MP"*&FOK)7II4
M<4Q2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41>?GU%_0!Q'OYW&?[CL\UD<
M&R.2@QXV<AQ<<W+1+D1MR$RE*4^T0LM;&R+=$ ]2:[%EEWV\?1TU'+5<J[Q;
M;A_76GH6Z';KBT_A'!.)\.R?('>53.+XR/BU<A?9##LM$5 ::<<;"W/7L2D*
M.X[CZCJ:YDT@D>7 4J:T71A86,#2:T'%3.L2R)1$HB41*(E$7FU^H4ZVB!VY
M2IK<M<J5[;O\TAL_UKU.]C&DSSW*L/NB ;*.O'JT7D0N!.F]P8<]O%N_(8^$
MY[N0V6;4MQ! ^!VU);B5L^0:T\!3UJ V EM\/(6UJXD\/X0#\58:8RE_WQ\L
MKV4 A;EK W\1_P""NY<9*TLOE<0">55&!C+Q\!G#'=';3M7;6\UL2TV>H "+
MW'7RJ)Q[28W)?4<BVO/C6JY #N?!0/E*.7?,M-\<7$1'5K)<=3=:-MK;-=+^
M-2#)-O"]OD_M4AQ$U@V%XN6DN-*'L4L@L.+B,?-'>_[24R5I) 4LI%^E=FW+
MN@>9Q7'DG+'N$9(:2=.Y=;(XR:^6)./E2L:_%!6AQ(5L)3KZ@001YWKC9:WM
MKUAC+A4BG%2#"7%]BI/J&Q/Z1J3TFE!WTHL9+Q<C/HQ3F?EJDRL8Y\PA;:O;
MN[XFR;>%:6*VW!; 'GXE=#-;TN[^K33I((X#GZ%(]C-@+Z)^-2OH910FKEP?
M/QX[Z8WO;7'KK2@=2E-@3]UZYE[<6=J0Z4@$\-5[\ASV]5- J::[I<D5W)C8
M+'^G$M+^5DX]Y%K[ 27 ="+BVM53E6_7W_\ 0X'\U?F"O78W B60\#0?](T\
M5>><CXCD4-,/)8N/*(2I#I>;0LB]K>VLC<GXVL:X>X,!=64OFM!+7<:#A0#B
MJPR&\[NXC:(STG7JT!\*&FGL4-R>6PO;G%M*<QSRL45):;*%K64*L!8;C4;9
M$Y\@+C6G)<['V<V<F+0*O/PX\*#O4:8[O83)NQX^/]Z1D93R6V<>$!14E2@F
M^]-QU/G5RXC<4#(@(VD4X\U(;K[<W5H!UN;4\![O7R4LYEGE<(Q#>:G0W'D*
M4 \P@$EO?TN:Z1W2T.ZN7H7Y!]O;Z6@) )[CHLYQK,(R#$3)*84A$YH-^U>Q
M <\ZP9_'ORUMYC>0KZJJ.06_TEX;=XK4])].BE,G$.*?;$5!'OJ#>TDFWB#K
M>H[C=V1X>UCMY3J">Q=?/[7-H8VPC5Q(XGT*_IW;#B$'B:,Q+<5CY$*%[T[(
M>X0#9.XG:=+_ '55=Q]V[^7)R10./3U._A:?@K7L_MAC9,8V20?U.D5/4X:T
MU-*TX]R@?$N-,9WBBN60\@A&(D(+L0.@ DITON.NMNE<BZR=W>Y -B872"A-
M-=/!<[$;#.,:9Y'@1 U%134=_@NGB>8S<$S-:Q,UM2)22A:00JRCI<6/C5B_
M^+QW_ER7C"TC^:K?R4DFW+!<6SH+61KW ?PD%:Z\M[J,\0FM-SEJER9\A+<U
M+FY107%"ZB!U^ J>9I]BR&**)[?E<T\>04"V;8Y;S)_-C?1S7<6_Q'F-.'AH
MN.=SCCS,-MMA_P"<ERB&H;#:5%3BU_A!\OOKO3[IL8H>KJ%:<*A0L[/R3+@M
M,;@T']U"&^LK#=O> \DP',,AE\D_\G"S3:ER\:TZ5 K=)5N5K;0^%4/FKUM]
M(XMX]1IZU+<_EF3MBQS 2[I#30U[1KZ5LCD^VV1D\<9Y+&?2IJ 7%/M)_P#.
M7&A U_#;PK:V/G8K+,?2R-/4>D>M:5]L.3'8\S.U=0UH#K354#RW@$CF[F"9
M9D;$QY:7'W-Q +8U4D)&E[7L:L+[BWXM"RAI4?%:6R<['9S.MW-/]3P[._TJ
MV_\ )\UB(#LJ!AG6%I0G^^2%E2@D:[E*.I/F:C>U\];VMZ&ND;\U!Q',JP=U
M[8BEQE+=E'@]7,UT^*8<ON(>8<;<2RE*=@<!3UO< V!J8;JB9%<0W,4C0023
MK7L49V7!>SLDMYPX1@ "K>GMYT![%B<BRB/(+ (+.T*3<WMJ1:_W5(\?FFRQ
M#S7MJ3W#10?<N*CQUX8XN%*]M-3I[%UFD$J0@'<HFR4CJ:V<NR)EJ]T8KIRU
M7!9&Z5P:P$D\E*IT)X8]/M K>3LNE&A( \1?[ZH;;MM%)E'.NFD,ZCQT4QN-
MKW?TH+&$G2M!Q%/P5 <CD$242(,28U&R6PH9]PA%G#H-"-3\+5;5P[&XNW=-
M:O:#0\'5U])6';6SKW(WL<)B<&EPZJ@C2NO+BJ=C8CN3QCEV,S&<E+SN-GO-
MM3E,-(VMM#^>$BPMYU7V-S][?2/,3ZD]@!7T;N_[>V&&LX9)F4Z=:DGEVU6U
M?OP$K8+BFDR @%DD@+ 5T %9Q:Y.2-SG FA_E7$ERN'MG1@.:'$"GS"NOI6(
MRF!1.R4++IDNHF0P4ML%9$=5_P">UTO\:Y\UQ=-B(:3U4[%^;@Q-OE0/* ZN
M(YKJOXZ+BGG'6HS(^:W*4MH;-Y(((OUTO6AM_&WV0N*$$:ZDA4+F<=<8:_ G
M^9M26\0*?I55QQ[C3V GS%(EON0Y3BG4QG7"L-E9OZ;]*OC&8H6@I6M5BRV7
MCOH6-;&&EO,<_%1CN?S*5B5QL% BI?DYU/RR'B-$;S:][BN?N&^,;1"WFI#L
M*RBZWSRG1JV!X3,7Q7#8UK'9#Y=Z#&2EQ:%W.X)NJ^OG56R[/FN9Q'(T]#C7
MGS[U:=AN#&P1ODC<T$ _Q!21J)F.3X^5E9#;CZ'TJ+SBNIZ^59[F\L]KWC;>
MWXU'.O?SJLF(L;S<N+>\@]+FGEZ.2KG/-0\'!3*FSTM-%Q+9#H %R; 7 ZWJ
M>XO>$5S_ *XH/0JVR?V[EM8SY;B9 >'OX+JY/C4[,8+*1HT<2)$V*40&$C<I
M94+V%O$BL.Z-T6\5J?+=IKV+=V3M*7SS)<-U' :]JJCCV6E]OL(QAN:X^;B)
MT<*##,EA0]Q .FP@$:7K2VKO.SEMJ$ZCP7C=6QKN:]=);MJ#RYJY>.AC*.0)
MJ=S<->QTE5P5!6H&M2#.YGRK5SZ$AS33U*+[;P4[[\!_R]!Y@Z]P6[TK(C"\
M),[%(1>-%!8 %[>GPKY#L<:W+Y\-G%.MX!KI[E](W][-9X\] )HT\ M*<G.E
M\CG/92>L_,O+ON5Z0 3H+#P%?748L]L609&-*#@:]W,E?)^3R4U[<E\KJEQ/
M'^$5[NQ0F)D<RC(96#/BEUJ Y_>DQA(*'$*U 3\17,L-]1/C<9=.S@LU[801
M]/E/!)XZJ:8=J1E,<N2[!<A.*>"6D/!25%*3ZC:XZBJQS5L<A.Z> U+M>U3?
M;/V_-XWS+C1G?4:>L+ACYK *Y<[QMIQR7(8;2Z_%3H0E1/IOY#[:BU;F",N;
M\KP:<.SN7'RVU!C+P%S'205_AKI4G2O93G56=SE/;R)PYN=AF_:S+*DH3';<
M6XMQ9.HZGKTKO;/WQE(;MD5V265'\+0*>- I-<;;P^0M?^PHV7_,7:]A%3^B
MKK&XV=+9:7/2&&UJO\I8[K> *KWJX)]X,>TAH\."U;;[;.BD8Z60$<QK[]%(
MWI:6F'G6'0M2%>RL(L2@J!L553V;G9/)JI#O?(FPLPU@-3IX5!XJ)90L)QK^
M0R24_+P2' ^I-C?IH?A6';EZRUR$;N6M?4J:@9<7#"1W:TXUTI51R;,4K&KF
M0$&0X4!R.A-KKZ&VM?0N;:ZZQY$?$C3U+S!!_6$;]-:%83&]WCDLE#XW X\_
MCIS9 R+DJ^U(3U*03XDU2N"VRZ:^C$@U!UXJQV64N*L#<Q@?)377W%2S*9IG
M#Q7<AD%+?3I[I0+J-_("K%W-@&/M?E'[?'DJY=Y^4N*N-7'M69ALS>08YR'A
MI2X\F:P7(3S825!9 VVND];U04SQ9O$C_P"$KH[=LC<7GTS^%?B/3ZECH6.Y
M1B6(2.0151,W%0!(4I(VD]-PMH+BKYP>YL4_'M!>VI KJMG(6=S@;WS PM%3
MTDBHIPX_@KZX;R'.Y[+\DBY''_*Q,6^VC&O6L5H4#ZKWUO4 RU[!&28^WM5_
M;3^JRMNV<<"*\%\XC*2L;WF:RAQ8;&*Q.W'918LDN..'>F_C^$5J18)V8LW5
M%13O[>[P76R.7@L98XIW .)-*FG8MP>']PU\@FO1\RN(VPVU[B'5 )0%#K?6
MJMW!LT88>8P:DCM/'Q6_C<QCYB6.<"[7FJ7S./AYON*PPQ($:#D)C:OF&C8!
M"0 L)/Q"?Y:SV\TL&.+W"K@#ZU\]Y/&MEW2R(:-D>SW"H]GM4G[L1<'Q^/BX
M6-;_ +Z>0!(V+W#:FUR1J+G[*[NP=LWN6ZII/V@]G:*\EV?N/##C6QP,&KP?
M4TCM6&C]L\A)PDC--(NT6%/,)-[V OX5Q[G,^1>?3-X\Z=A7+;]O'NM))VZT
M82./$"JUTY1PC$\JR>!EY0NF/A7EK6PTHH6L+ Z+%B+*2.AJ202OB!!%"HCM
M[/.Q8?\ \=.''FK!@/L8]05M46]A;;NK>KP/XE=36."X?%)U#BL>"SC\;>FZ
M .M1V\2#S4[X&UE.0=Q>W<?".JB%ODV-=R+B[:QTNW<3H?$"NJW(N+ZGFKBP
M6^G9BYZ"" *<:<_#P7] "/PI^P5TE9:^J(E$2B)1$HB41*(E$2B)1$HB41*(
ME$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$H
MB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2
MB)1$HB41*(E$2B)1$HB41*(E$7A3]5#J'_J![A-IN/EY#3:_B2PVK^O5P;/(
M;9AM..OL"^>?N4\G)Z\FCWE4UA78+$!V"5[/EPIUUO6^U:U'3[_*N#N; NDN
M6EFO4?@%+=C;GM[?'.9,ZGE@DZ'2I)]/H6!:DR7E.^ZA;333CC;!W$;TI)V+
M(O\ O)L:E^%QK8;<,E:"1V^ 5=;ES7U5VZ2WD=TGL)',\O"BP^8S^.XY%<FY
M&9\E$)#:U@D GX[:SWTEO$0Z9H-.%15:.(M<A<DQVG5KQH:?%<.+SN(S:&7\
M5-:E,I_BI*3X$::=:V;6_AN!_3(6K>XZXLG%D[2UW!2!MJ3*(^7;W)*@-Y-A
M?J16$WK8YW!QTZ:^U>[##W%YK&VHX<EV9$22PA2GF_;V@64D@@DFU>+/+6UU
M\H=\RRW^WKVQ;URL^7MJ"%T6TA1_B*LKP%=5HH*+CN-."RT""W*2I)=6B2G4
MI_=3KI]M1;+9*?'R N%6$_XJ:[=V]:Y>![6O/G <*<-=/%=";"DQI,5:R67F
MEE49QI77:>M;]O?092$LI4&E1[5R<AC+K!S .-#K0CN4RS?<+DN?Q:,1-?2F
M&+>YL%BL 6L3Y5PL)L?'XJY-Q%$T.[0!VU6QE-V7E_%Y3W4;SH>/Z*(Q9#D1
MP*90%H LMLZ7\JD63Q\62'21J.![*K0PN9?C9O, Z@>([>/YKZ<D%QTNEH,I
M(U;2;@GK?PUK:L;1UJSI<XN\5K9:]COIO-9&(Z\0.VI-?:NJXL.* 3Z;'PK9
M=V@:KGM% N[!DMQIC;CJMJ/;4DGR)KCYVT=?6ACIKHI/L_)QXZ_;-(:"A%?%
M?.5]U4HN;=X< ]E7P Z?M-:>VX8H[?RR=6DDK/NZ262],SR>EP 'AV>M8XW*
MA[B E::D(Z7-ZHS6JBG+0Z+O2F9;.-7D&I@QSB6P69*24J23;;Z@1U)J.Y#*
M6=S6UEU[B-*J;8G:=ZV 7T;ND#73C2E>-5T_F,E,BQW,O*5.G!("Y"C<D#I7
M3L<=#9P!D3 VO&@XJ+9&_DO+ATLCBXGF>Y<Y6I+0 -NE=,4:R@7- J5F\%G\
MOBFW(T.6XB$\"F1&"CLL3J0*B&Z,3C[B$S3Q-<_D2-=!HI9M[=MUAI='DQG0
MMJ:#7B/;XK,3H0F,#>=IL%-N@7(\:@FU<J;:Y+(Q1M:45KYG'0YZR$A=0D5!
M\5#/;*RI)6+MDBU[7MI5SQR>8 504K?(D<TBM"1\%UG5[%) &A\*].#3Q"\L
M%0NW9/M@$#X&O7 4"Q:U6"_,F?FODGD.ID%5D@()2J_2Q K5=<-;H[1;XM7E
MO4VA'M78:GLN9-[$EET38R/<*'$J'IO;2_6M=F0M@XBH6U)B[PM#BTE<GSR6
MYZH2HKX(:*BZ6E!%CYJM7IF1A,G2"L,F)N6Q>8YI 'BLBX[(<;:0MS<VT;H5
M^]]YO7J#'QPR&1O$KW=9B>ZA9#*:AG#M7&!<[@K81U4*WG#JX&BY9*^YD%^0
MV5%+C<=8'\9) 4+^-KW'[*T67UO<@L:_YEV_[#?VUL+I\1\OMT]U:^Q8YC%)
MC*0AJ4Z^1^)2U7)^VLMO"T-()ZO%<QUV7:T \%8>"YUG>++;=@RUOQV^L%Q1
M*"3XZWJ&;EV+8YB(N\IHEY.H*J3;?WID,:^AD<Z/^4G\?DNIFLY+Y=D$SIBT
MLO2%H;1Y-A:@"37!P&"N]N0NZW$MIPY:+0S67ES>0!=HTD =U>:OV9Q3BG%N
M&%[)F))DN,@-./*2 LJ&@2#UJGLAN3(R9FD3W-&IT/>OI"QVW;Q8QK7 .;0#
MI(%#HM>)N#;ERFI<=U<="4E)BM62V;_O$=*N?#;CN'5\Z0Z#MJH=N/9-I,T?
M3QAAK_" %]KPK2(C@:0KYE*;I(.JE>=?C]ZS]3FL;76E:K4=]O;?Z, _NIQY
MJ+P$S5>U(>"F)C9(V()N"#;0C6IC)>QQ633<- #CJ./%4O+6WF+(R:@TJ.->
M&BR+\>:0]*?C%9'J6ZM04OXGJ36>PS5C(&16[@!V 476EVWDC";F1IZ:5))!
M)[^-5AY+L7V4(D+0E+KB4H]SH2HZ"NK=RMMXRY_!<JSMY)IFLCXG13"+%A8U
M++\EYL%U21'"M+=?P=>M]:K+/;@?<_TXQ1I5X;7V=%B3Y]R0Z0\"0/E\.*S:
MPA2=1N"@="!:QJ*_1R%P#7D54T?<QT+I&!W951U>.:A+^;0M/R\516EG;8"]
M]!\!]E6+;YTWD0M:4=2G5[%4]WM=F,N#?]56 EW13Q-/ <M%RM96$XJS[!:)
MU2I0!'W$=*Y]SMF\LXW&&0FO&BZ./WIB[R4":%K#RJ*JN(?$^.,Y-[-_EGSK
MKLE;Z%R%;MMU=4H5H+UTX=KB:UJX_P!0\U&CO5L%V[HB:6!QI0GA7CZN2V>P
M?.,,QPY_".1A[;J%;%I%D@GKIX545SLZ]M,LR1M:=0KP5L_^1V=_CR010@JB
M5@*?6RP-P]Q26!YI!-OY*^AX)VL@:7Z4 JOG":W,ERYD0K5QIZU^J9>;6CW6
MRUNOMN195NO2]>K6^ANB1&ZM%^WV,N+(#SF$5X</@ODL$J W:$=*W?+(-:KG
M]>BYX43YB7[*B?;0G<NQMKX5PLUD#;,J#JI%MO%C(W'0X5:!JI8G'0P+&.@G
MX@&JWFSURYWRR$>E7=:[,L WYH6GT!0N8QMEOM>W[92XJP^%S;^2K2Q\OU-O
M&ZNO2*^--50^9MC:7DT=* /=0?\ #4T]B;@TIM1%]BTJ/W&];=U'U1.;S(*T
M+.41S,>>#7 ^HJ9PY;$MM19-PFP6D@C7[ZIO*8NXL92X\]0OI# 9ZUR<'3&?
MVT!T/Q7(\PRME32E!I"^I!M]WWUR)<H7_(]2*/#-;\[%PRE&/"6EI)LVT0$W
MZ:6'[*ZN#QT<]U&:T'4%&=SWS[6RF(;\P::'XJML]B$9K&.X^0MQI,@!:G4'
MU'6]_P!HJW7V\=S"86NX::=RH""XGL;AL[A\Q^85YUYK-M<=7A\1&87.]WY-
M(:!4G;NTT'6N%C<OYE;0_N .OBI?N':7T4'UA?\ N/"G.G+59C$2I<AU:'%@
MI;";I'A>^@_97+S=A:V<0ZV@O=S/H76V3F+^ZF,8>>AM-.S0_DN_F6HB84B9
M)0+P&7'@YU(2A.Y6WXV%1*SR+[1_R-[U8&<P<.2BZ)CJ>?/@5).V_!.VG=CA
MJ<OG5-Y&+,6I<6.]9#C(:)25@DZG=46W[NV>_?;0P_*6%W50\:TI[EBV?L08
MITKWO+NOIIH-.FOYJMN-=NHW"W,SB&<L]D<:9SOY,A9-V6-QV)W"QU&I\Z[6
MW]S75LP,KK^BS9_:%G='KF;U'05YZ=XU4H9E0VFY++*@!#L7A8Z$I"S;]M=2
M^@GO[AAD%2X@5]BPVEY9XFTD$1#0UI-!ZU@UY>2I_P!QM(]E)L$^*AYU/;+;
MC(H.DC7153>[ZN9;BH/],5T[0I$A,60$R TVM2K*#M@3\#>H-=W-Y;/,8>X-
M[*Z*T[.UQV18VX\MKGZ$.IKIPU[EN7] ^4SKO<SNEC93=L-'QN.7 46[74I3
MVXA=K'I:HY<=;I"2IE;%OD@<UZLUA61*(E$2B)1$HB41*(E$2B)1$HB41*(E
M$2B*.<MY=QK@?',OR[F&9CX#C>"8,G*Y:4HAMIL:#0 J4I1(2E*05*40E()(
M%>XXW2.#6BI*\22-C:7.- %Y#]UOU59J,A*Q_9CM_$<Q["RAGDW*BZM4@ V*
MT0(KC1;%A=)6^2;C<A-BFI%;X 4K*[T#\_T7!GS9K2-OI/Y+7-W]2WZG7'5N
M(G\;82M1*66\0DI2#X#>XI5A\2:W?[);=_K6I_>+CN]2MKM[^JIW$Q\UECN=
MP'"\EQ)(2[-P1>QLY )U7M><DLND>"0&[_SJUYL!&1_3<0>_4+/%FW@_.T$=
MVB]>>S_>CM]WSXDUS'MWF1D\=[GL9"$\GV9D&0 "6)3!)*%@&XU*5#5*E)UJ
M.W-M);NZ7C5=ZWN&3MZF%6I6NLZ41*(E$7G'^H-;\FX"#;U2Y '_ )%_ZU3O
M8[:S/\%6'W1<!91][EYLP<YB&UXW#3)"$9"<APQXBA<N)03N('EYUK[AFDM+
MWJ82.'N6?9<,-_BPR1H=HX$'7F0I&\$1H[FU"5(;'X1H+? 5R[-T^2N_ZGS:
MFA*[EXR/'XZ4>6"UH%!RI508,F4'DPE)$M2%K:%K);)%@3?P!-6]<W#;.#KE
M=P'P7S_C,5=9F\$-M$*N(T!H "0.9X:_D%CX,7+MP$'-!'SBEK1=LW! MM)\
M;D&N-MW<<>4=(QIJ8Z5]-5+M_;!NML.BDD;TQRD@"M:=('YK]<RT#'EN')E-
ML/O E#;AM>VFE2":Y8SY7'55ZVTDFJ]K20.Q2QC-PUPP%()N"/:(N%W\/+6H
M;<8>X?+UQF@KQ5I6V\K1MIY4K:FAJT@Z]W9JL"\ILJ<= #84HJ#0Z)!\*F-K
M"8H1YCJF@U*K&\F;/.]\;0UKB2 .0KH%Q1'XN2 =C.@M>*D_"M._O1;0&=OS
M 5]@K\%@FBDMSTO&O?WKJ-,.0^6X[(B,J3%3"D-%8 (;*EM&Y^VU4;NC<<F<
MZ0P='17@>-?\%V,7D6P6\G4*G3_'\=JC4"+B7.Z^3R>9B(8>.+8:@37TA*'%
MJ6YOVWT) "17BQGN(>E[7$4I\%:NPBV_L)&W)\P$G0Z@: <.'!3MWVDRUAO^
M($&Z=2? =+ZD?&KRQL[<G:M=,T:U]Y"J3.V3;2Z?%'HP4IZ@?>H=G4,\AS.
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M6N;V%6_+O['9> MB ZO2J0M/MC?[:F,\KM#X"@]9JM .7Y=[NASF2<-B7""
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M5G6_A78%05'NJO!?GM@[E'IU%>6UZCU)U*0X2!.Y(J%C,>E+LM+FUPGHA-B
MI7PJ&9*]ML))+<2D]/0?S4X9#)FK**VCUD:\ ^%* ]JFF3[:O827$BY8)4N>
MM($T*(2+G6WE4!@^ZK+R.MFT]P("LRQ^V%I#8_\ <$&2FIK3U=GXJLGS;@V
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M+'RXC8.<#[<5GU6*D**B;_ZGK4GO+4P1"0A6W-FHK5SG$@^D+)\8X\>)X>%
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MSU7#M[>[LK "X<*"@XZ^U6:LI9=*%JN&UE*R#^( ZV^VJUZ2[54B6>7,0[4
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M4UPW^V;XGWJ(9;_<.]'N7]!G;%AF+VV[>QH[:68\;C6):8:3HE*$0VDI2/@
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MR305TIV^E6#D+\3V1810T"U9A9.%(;+D5Y$AAIPAU:+[2D:$@U](YG&0Y>P
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M!*"$ 'TGXU.,7+8W<9DMQ0> "KW(XF?''RY@-=:@U68B86*[%2N4XXDN#<I
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M-0?(U,;N-ES'T.%055Q90ECM#WK*83-.-LJ8G]5+)CJ0F^U)-RDVJM,E]O\
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MW&8:?)SB)AU-3V]OKX)PR,ODO<3,<'C1BM$.&B7^8$;$[B2%"P.MZA>7D%E
M)"=>Q6+8_;9T@/F$FFE=1KV<5>>-[=XWC/($9'E+8.-:BD1E[[(WJ)W!5SX
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M-H7%3)?9W&,>GMJ(L5@VZ?;5?W]Q,9WEU2"21X%5G80W#I'V\;"\D$4'JZO
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MI]3J;%*M!H+$U6&+NHXI ][?V=G8I/:06^0Q5P[7J! :.;S7BK*DX]U#B5R
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M41*(E$2B)1$HB41>)7U18QN;WPYVMSTN)EM!#B;;K>PWI?RJ5VNX_P"UP,#
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M>1^%9MR7'F6@>TG7\EI[*P<]MDB)M.D4X@UJ?T5D8'AZN<";BW)Q@-%H[Y*
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M/,Q$I89=<4X&D^E(*K=!]U?EC:MM&](X+]R&1FOG^9)JY9':A*TE&O4K).@
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M07'SCY.STJQ\SOV/Z Q0O^8@@4Y5''L45>90_*9R$E16_$;+3;RO!'4C^2K
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MLHN!36FTB4!;X&NOCK,VL9836IK[!^2Y=_=BYD#@*:4]ZW5[0?J4\'[:]K>
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MPL'.SD>>&&(DAV,IO\*@MHD$D&VA(TJB<_NN^Q=R87,+Q4ZDJ\L);V4T0DA
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M;WW#RL4[(H+<?*17T<E^+8R!E,-282S$<6 MQM8LA-NJM+UT<+E#8VWDAM7
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MVYTKS]%596-?AO0HKT)Q#D9U (4@W";B^M4W/=3WT_F-K7\E]'VEI;8NV$-
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MB<6U[>0*N?BO!L+R/)M82?(6F#+9<9>:"DC<A2"G9>U]0:BV[-[WT%D1Y0U
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MWN3PCA6+_.N49^%%:Q&,]]B-[RVYL=Y0]V2XTTFR$*/J4.GG6YCY6Q3M>XT
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M6PKW)LB:4@H7(5N)"OBI72J<P^YKN:[=$20UKB.?)6=D=O6[HBZ@J=>7-4O
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MN(BNMA2@- 2*DF#@CD8XO:#KS *C^9FDC>WI<1IR-%YD_P"<9]0G_;OW#_\
MJHRW_LFNY]%!_P#;;ZA^2XWU<W\[O64_SC/J$_[=^X?_ -5&6_\ 9-/HH/\
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M<+UFO;3Z+:V(&EZJG-2^;>/#6FO4?>OH+;370XV)TCJ L;[0%A<HEA$I/R8
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MWMZ]7S5TYJ#[EWF[)QB)C>D'C6G"BXX,<S)"4B0&MZ=YM:ZNO2_E6]>3LQ$
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M;'S[<9Y28S;H*V D6)-AIJ+#6]1^URX;:AC3UO%>]3*?:%;QSY2(X32E/E/
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M5=W>VT<K)9:X@7&V_ *<GR H_>$)_94KV^/Z3O'X*,YP_P!5OA\5Z0_0QQ/
M<7^F/MD]A<<U#E<E@+R^>F)2D.RY<AYR[CJP 5;4A*$WZ)2!X5Q<K(Y]PZIX
M:!=?&1AMNVG/5>0WZB7&,/PCZG9TOC$1O#KSV'QO()3<5"6D)GK6ZTX\A*0
M%+,<+4;:J))U-2+#2&2VH[6A(]"X.68&7'RZ5 *B_P!-?T?]R_J<RCO*9LIS
MCO 53G%9[G<\*=>FO%>Y]$%M1O(=*B=RU$(2;[E%0V')>Y*.T'2-7<A^:\6=
MA)<GJ.C>W\E[[]F.PG;+L+QU/'^WG'VX*WD(&7S\BSV2R"T?ORI) *M22$)
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MO.##T@=5>Y=MY2&FT;B E92AL=+K6;(3]YK).]L3.IYX+GPQOE>&M%25B9O
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MB<&VQD\3,R3#3[#H<62AQ"E I-CT-<J_LIWSO<UA()[%T[&[A9"T%P!IVKS
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M)3O4;6)N18&_PK+E\FVTMFNA'[M O6W\*[)WS_J2?E%37B3WUY*3/0HLF*Y
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M8G\0HYFN89#AR),YO%'*PM@4X4+"%ME.F@MJ+:U#-Z8JXNGLE8?D:-156/\
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MFG^8U]5O_8[D?]VXW_V73^ZVW\X]OY)_;;C^3W?FG^8U]5O_ &.Y'_=N-_\
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M#<7K6RBK0*T[:?HI+QF-FL'Q['1.2-HEY1M*DSI"+^VH%5Q<ZZV(&M1NR/\
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MRT-6Q:7T&7B+:4KQ"J[*82YV[<L<7 \:$5_'-<7&A*XMBX^%QTQ<:(R+;6[
M'XZBO'_C%@US3T T[5K#=.1C<YT4KFUY5_%%F8DUUF2ZHK+JYBP7'75$D$>-
M8<[@+6>(.Z:!H.@TJNG@MT7C;BDCRXO(U<>"SDR.QD6%>VE06WJA:A8W'A]]
M0+&Y%UI<E@.E" /<K6W!@K;)VC9.CYA0D^''UJI,7#SS>3E3<J^R]!<)$!#8
M(4A(-M0;W)^%6-C8KF#K?<.!:1IW=JIC)W-C/&V.TB<U]==:]5>"J[G\[YGF
M_$L="FOPE2GO;R#[5P?9)T38VJ/9J[;)=,;&[2G+Q4TVMCI(<?+))$01S<.[
MD"KUPW%,"^^@O8]B0N&$NLN.I"UES^>%&LNZXFQ1,(;4UX^A8-@7,MS/*U\@
M#0VM#X\O#XK*3?X60>,<$+;4E,?9^Z+6V@5U\>T?VYM12HUKXJ-YZ62/,2&W
M=5W504\."ZJVPH^[("E.]5ARX5^PUUK=T8AK'0T[%';ETYE(FJ''^:J[TK#C
MY53[B&W&6DE;C8NNZ0;^*?A7(BW!!*X,E;0CMHI6=G7\-NZ5CVNJ.#:FM#X*
M-1(F%D[)T>/'<4VX?;D( W(_M0FWG73CMX97"5I%%&IYY8F&%X<'5UJ3P[*+
M-O1Y=A*3'6RA/I+UK*3;KH-17Z^_M)CY74"5L-P]_;1>>8WAHUKPI\0L+E,N
MALMPD3 N;+* B.I6XG:;D@>%JU7P0L(;'0.7ZR>[N6.,CG&/G7AW+,MJ*@TV
M2 MY03IYG2NA/=BWC)=K0+EVUJ;B9L;?XB!ZRIA @HAM!.X>ZX1[CO0JM>P_
MEJG\WE9[ZX!Z#TM/P"^C=O[?ML-;M#'@ODXGGH3^:^,@AT17PT^EM"D*#C82
M/65:'U:GI85%QAWW]V.G3_%1O=F&R#3]1',&M X4XU)YJO\ $XV+"AMX]A)4
M([6R.D K4F_4^>IKZ AMH;*$-IZ54ES=W>0D ^9YJ=!KQ\%WXF)G+]E@;R0@
M)>?=!3T\1>VMQ7-O\Q!#%TU!/BNUA-MW60N^AT;F-J=2"*:&BS#V%D[K.R3)
M0"G>-4D@'I;IX5Q9,Y8^0YH90D'L[%+'[-OX+QCG3=306D\>%>%."]&?H190
MSE.8MMH*$-18P2@F]M5U7=V:FM-#S5OV #6%O#IY+TIK46\E$2B)1$HB41*(
ME$2B)1$HB41*(E$2B)1$HB\=?U9L[E6H?93C*%.-8.:]F\G)3<^V_+BIALLF
MUK;F42'-;_\ G/VR3;S!5[N>@]ZC^=<:,;RU^"JWZ=/TX#W7[;X+N/SGGTCC
M#'+(XFX# XR&V^\F(I1]I]]]UP)NZD;@A*-$D$JN2D9[W->3(6,;6G$E8;3$
M>:P/<ZE>"OO_ +I_M[_VL\B_W%$_LUJ?^02?R#VK:_L;/YBI#Q'],#@?$>5\
M8Y7&[HYZ9(XQEH668B.0XJ4.KA/H?2A1!N HHL;5XDSKWM+>D:BB]1X5C'!W
M4=#5>H%<)=I*(E$2B+QL_5DY3G.,M=GGL,Z5J5(EK<QX!(>VE -[>22:[.&N
MI8)*QZ?X+D9K%VV0MS'<<%HKQ#,2LWA8.0F->R^^B[J""+$=0;U<>+N'SQ!T
MG%?,V>L8K.Z?%$:M"D;CC;*D))L%DA/W5T'N#2 N0UI<"OE]YMAL.O*"47 W
M7\3H/Y:\RO$8J5^L87F@XJ.\OR:<5Q^1/+)=L4!M">MRH:UJ9"X$$'F$+J82
MR-W=MA!I5=UK+PH$6)(R4AN 9:0K8^K992TZ^!\1:L)RL3(A(>=-/%>V86XN
M+DV[10BNIK3Y:_DLU"Y![#"EP']T;*)+14GU $V22".FEZV)8XK@-=Q!*V<9
MD[K&MFB:>D]/MJ.'HJJLE]M,&SDL7E\1!$?(QIZ);\GW#8I;5<$) M<_&N'<
M;=C=*'MX5X+MQ;YNC;&&1QK2E?T_'!6D4)T"+)(L$U*2VC:-4"J>:Z[LE2'$
MLI6"I0) MX#K6#J(;0G4+(V,$56=DXE;4?WVWU.JV[R@CKI?2U1.SW,V:X,3
MF\S[Z*PLKL)UI )8W]7RAW#NK10KE'&,IRSCF1QF+R2(4HEMP6O=002=JK:@
M&UJ_-V/C>V.$MU<2 >067[?VLK))+ICQTL +F?Q.XT\.&BPV%PTWB'##!CNJ
MD3<<TI2@1<*<NI:DI'D5'2M_'VK[*RHW4Z'V!<+<&0CRF5ZGCI%2T^@E</%9
MW]-\$Q/GQ58YUMY2OET+-TJ978W(^(Z5M6%T<A"USOE(=J/!>-Q8_P#LMX8X
MCU,+10\>(4VD28V/9+TM]#;:/WUFPL*ZTDS(6U<=%&8XGS.Z6 DGL64Q>6BL
MQ79*?XS;RBIMQ!&W;85'<GB9,@X2,D ;3@IAM[<$6)C=%)$2\FM=.P"GL0YI
MZ4VHH=0(Q-@M-B;>.IO7JSV_9BDA&OBO&2W?D)*Q-=1O+36GI6+7'3#@2YD>
M(4QHK:WW%= H ;B1YWK;N<I9V#:5'@%S\?M_(9,]36FG:>'ZJ(\2YM!Y>J8W
M%8<C)@N!#A<.I)%]!Y5BQN<BR$A8T$4U6?/;4N<-&V24@]1IHI@ZEA:_; 2\
MXGTAL@+ZZ&X-_"NI>"%["U^H7$Q\L\4K7Q:.Y+K8OCL#B61GR,3&:9=RA2],
M2@$)4=1;QM>HS88NVN8W/8TC4@:^U3;+Y^^Q]PV-[VO%&N-!33LYJ3*RCGSJ
M7KK$0-[51;)L5>=[UI.VO=%U?,'M73_\]LBSI\EWL6)D/!3KCZ&O;2026TZD
M_&I786\EM'TO=55WD[J.[G+XV](*AF)YI"S7()?&FHC[,N*GW"MP6"D@;E$#
MR KAY/>$%@\LD85N7&WYX;5MT"'--=!RH*J1R6\HQ-:6VMIS'E/\5-CO!^%9
M<1G1EG=40HWO7(C="Z,@U#O8NYM44AP-E0!](\;U)7OZ=*5*PU'"J[N-R4:+
M(=2XA2G%A/MI38J24W)N+_&HON&P?D&AK7!M*\?0IIL[.18F5[Y6.=U4IT]U
M?S5E\1Y-Q['Y=J=E#O;CG<VG317Q%5CF=G7TS*0'V55M8_?F-#^IYIW$A=SD
M7=7%\TY?^1\;>E.3(B R8[:% 76D*ON&G0U 68&+$]3KQP#Z<]%+[;*QY,&2
MWU!'BJ^3QO*<;,E&6BK>$F0Z][#FNW<="";Z_=7FWRK'/:;=XJW@0J&W7C[Z
M._?(^%SV$G2G^/N6(5B^/\FB9##2G427R/:GL)5JU?\ #H-/"]6$W<4UQ:!L
MSQQX+O[&Q$5C"+FX:6R$D:Z4"P7 ^RJH6?DX*#/V8O-H)=R"A_'CE'X0GP-Z
MS8K+26P(C=2JM'_Q:RS,[))BUPY54JY?VSR_:]^!-=Y&YF<#.7\L4NM +2ZK
M\.H)TJ583<,YNVLE)+2/:H;]R_MO;XZT-U; 5%":5I3X*9]NN:\9X2YDLGG'
M/[]6$H@M)%U.>0345^\UC<S6D38CH2:^I1O[5S6K)7A^C].)XCN\%/\ E_/6
M.68HX]&-##,BRVW'!=6HJO-G82;%SQ3L>&_+KXJW,S'9Y)IA>SJ"HYS#0<1(
M9GN,?.2@%>U)7^)L>2?C4@S&0NLA=>6YX<: :=Z^?L[:LP=T&,!+">'9^JKG
M@G(^9NY?/(Y&VI_%A]8QCA2 X$WT'AI4TP&T)71.#ATD]M5WHMV6^,#"RKJC
M4:5"G6;F8[-,IA2HJ7%H4ESVW5!*TD="-MS4BL]HQF2L[@ZG(+!G]^QY"+HC
MA=TGB20-?158B/&;AEV0ZJP(U!/0#H!4KML;;V1+HVT"K220RD-:%-<+[AQ[
M:U$^S(42T.A"5>%5QNFY9/<5CTHK[V-8W-K84F/$U [ >2I;FHY%P.1,SS4E
MW/XJ?)21"=/J84K3:CPM:M7!YF6RD^;Y@5L;HVO'DHQ\W20:U*N[MKQ"+W,X
M_)E96<YQMR4U9$2^UU/CNUM7YOW=HM[6K87<.5%&=H[39!.Y\DS3V $^U,YB
ME8S&S<?#9DYIS",*6V\VD'?[7A?S-J@F#W?+9/:9'#H=RYZK5SSAE)76<37.
M(UZA^T4-*>*JWC^5:Y%":F1VEQ?<-Y,5S^Z-J!L4J'@17T)896WFL?.80!2M
M*JN\I8/QTIBDU(5Z=O\ DF#X3+>RF?;5&Q[;?N)GK!V)5:Q.OCY5\Y[\R]WE
M7.CA</E/3W\58?VPR;[6<QRQNZ'_ #!U/EX?'2BRW-.X7&.Z#+)XKD%2X<%9
M0X]M(LZ""-#K6[]KK-V$C+Y6%SS7WA61O+%G+1F,Z-/#N*J-_P">C.RFXTQ+
M3J2@.+ ON\0+>>M7YY3<Q;MD>"VG;^.Y41%<W.WKM]O$0\F@T''L]Z^78,MB
M.)4A*27% NJOZKK\2+6ZU^669A?*+9C34<^6FBPY' WD4)NYJ .-::]7S:\*
M4772'%+94TY[;S*KH4-1]]=>_MVS1&-XK5<:RO7V4S9H_P!S34+$\@R[<4):
MG!V69I"2TE)4@G[.@KER0P6O0TL)TIHNBVZN\@Y[W2<ZG73T!?>&;QBDOLQH
MGRI00IQ*4;-Q-<7);EML0\CRCKV+FWCI007.KZ:KLR<[A<;/C8B9-1%ES2GV
M6R"3ZS9-[>9M577>ZKR:Y=/%4-KP6_8;>N[US2&D-(J33AQI7Q7--C3&XTYZ
M*A+LR.RXII(3=1*= !]IJQ+?>MNZ  ZOIW)BL6;V[-L#2E:^@T5)0T=WIK"G
M5R8L!UTJ6VR\V2MM-] K:L6)'PK9LCE;JDD;P&=X_13^ZAVWC1Y,\3GR#C1Q
MX^L>Y8OCW->28CE2L/R5I<QZ2$M%AA)4;KU2M(!5X:V'A7.M]RSV-VYMT:C5
M9LUMC'WF/9<6%&4I4$FIKKW\E.)O*LV>5X7"QL?)B8]PK=D./IV@D"YV@^0%
M=*'<(N[T-@H0:*--Q\+<8[SB2YO 5[>Y6%'C)8=D2@M2W9=BL7T%O(5,F@]8
M=0J&22%X#>04XPG-LCQ[&?(,2F&&E.$[W20 %'Q-QT\ZHS?VV[1^6^NN6.<V
MC10&AJ-5/=M[^S&,B;:65*5XD$Z$\Z=_-1:+FN)]Q'ICDHP\SDFG#&DEU(*_
M0;C;<WMX@UHO-ITN>QA8S^$$ZA6X[)W;[3SKIP\PBO"FOI4T1!CP(K<+&,IB
MLQ4;6VDBR$;1H /A7[MF)LKW/D!+:D:+CP75U<PNZ7=O+N4/7*4LD2"5/)]+
MI/[PZ:?:*G^+V5%'<,NV.%*@@:Z45!Y 3NG<9C5_XHNHEM+CP0-K3;JK^L7"
M;:B]3O(/;Y):]O5X+U90?42-C+@*\_0K?XME\!@<G"E<@FQ\=B&3M<??4$MI
M6K1(N?C7S1O/'DM/2PU/Y%?2F'Q%E"QI90 *_>;1N/<AX-F)"$1IL+*0%--S
MD!*KM*L$J0KX53F+=<6]V&O!H"I+N&>*RL?-CI^VOM"T$P'!./<;;EQFXXR:
MG5DF1*]9 %Q=(Z"K;?>RS-:VM&Z&B^9\EO;(7#G,+FEO#]H[U</8B?BW>[_
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MZEZ8RIE4DI%AN.U2A]U[58T$SKG&U=Q+3\52]W;1V.8#&CY6R-^!I\%BN>\
M=Y/D>.9S#?+L2\0^EV2A0VEUM*@K;<?954W#I+:Y#G< K^M;IMW9NC8T5(4P
MBP9\4!U:T,E+>TE)OUL;:_95ASY2#)1M8!4U5/VFW+O%3/E>X-'2=1Z_@L6[
M(>0TMYI*77VU%QK<#M4J][FU=^:V_P"S\IO&FBAT%R([X3.-1UU/?JHU@.92
M>2.38N6QK>-RV/>+2O;N4.M"]E _?TK@;7CFB>^.0FFJFV^3;3PPSQ 5=34=
M@!^*L+'Y)B.PJ/(44I0/X9MNW)/A;X5I;BP4L]RTP\''59MH;NALK5T5P?V_
MMXFNO#T>Y1]N/#2F1\DRB,TXXI2$-BPO?J1Y^=2G'6/T]L(R=:#W*"YG("\O
M'RAM 2:#NKHI)(S#+D1;;:%?,/)4E0(T25 @*/AI41M-K3Q7?F.=\M1["K)R
M6_;2?'&)C/G((I3A4$5[%5.'P+D'*Y#-9V2F6^IS;CW"+!EE(*0D>9(-26TL
MS;2NEE-==/!0'(9(3V\<, (%/F':>2MS%XY(CJ??2/=<%V[:E*2+C^I43W%G
M6N?TL/RC]59NR]G]-N99F_.:T[A044PXKP3D'('WY++UX44V;45:;B!<$6\+
MU#,WO_'8RU#'M'6\'D>5/S76Q.V\@_(/DD>?*81TBO:-:Z*E.[',.2=O.<-\
M+3@OS=IV.W(^89N566%%?[+ ??6GLW*.O93,QNFM/2*J4[E\J2U\KJ =0<>Y
M8[MQS&;F9TMJ?A5X>#[21'D.#^(XXE1N"?ZE3O(S9.])+6D,'?W:JN]L3X[$
MN\N5S"\\^W737TZ*:XSE\7D,W)8O&"1'FP+[W7FBE! 5MN"=#K4/F\TOH\JR
MF.;(WSH0-?BN])RDJ'(0TZV'?2"HC2_G4TQF"MKF*KGZJJ,WNZ[LKRCFU H>
M/>O0CZ!YIFY?G:BGVRAF+=!.MCOKC[CM8K5K8F&M%+MEY]V6?,\BFH]R]-:B
M2GR41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B+SS_4:X[VSY-VEPT+F/,H/"
MN9PILC(=MY4]M]34U]AM*9D%:V&7?;2ZVM%E&P"P@D[0JNQA7R,E):VK>?P*
MY.79&Z,!QH>7Y+6GZ2OU!^!\![9\?[8=WH>4A/<0:^2P7*<>Q\XP]!"R66Y#
M25!Q"V4JV H2H*0D7LKKO9'#ODD,D=->([UIV&59'&&25TYK;_\ [Q?Z4O\
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M#Q&BO+F#,J=Q;)P8$4RI\MGVX0N+-KN#OU\K5*\M&^:UZ6*![<N[>TN3),/
M]BUNXM-R?,^<#CO.7B\<,PME#+2MJ5+9-TW/0]:A%DQTTXB>>'+P5J9Z>.UQ
M@O+8:O(UIKK7FMK($*)"BB%':#3,8'8V/"]63%"(XPT<E2,\[Y7^8XU)7,&T
M1HU@H[64_C4?#KK7IPZ65[%C+B]_BJ.XYW*^:YUFL)*EH7B%//(Q,DG4J;*-
M#]MS:H5CL[(ZZ,;SH?S5E9G9\<6/9<05J!\WH"LCF$^7A\:K*04I=D^XVF.E
M716\A-OOO4DRTIBA+V\5#L%9-OK@0.T!K7T"JLF#EW#CHOS[243G& IUANY
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M?:$MW"U[:@FA[M0K*[.X#'P>[G!)\9A(DJS48NO!-BH[K:BIQMN9\%O*U_\
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M2=@"-=1;7PJ<XO$,@M>B4 G557N#<#LC>_4Q%S= !K0Z>"[#60DH*'7MC[2
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MX"XJ&TYJ&;EQV-G;Y6.:'2 _P^WQ5F9+!\>YM"0](<<>BHNIN1&64*0?,?\
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M,9_=1=;[G6DWR2#]@)KZ:46*QLZ1AIADPC=QY)2MO7U>/\E3.Z@A,5']JK_
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MCC<3);1QP1BC>"_)TT04@E!7O-D@6U-=3$8[ZT_TC1<;<NX3A-)&]0X*H\1
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MF1TJ@-K2#9WTN$^5C7>V[M>&&+KFU<>143W;O>YEN/*MB QO,<UUY^2EO.(
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MH$#QK-%9&=Q=<:]@6BS*NM8@RW/2[F>U9B2LI+ :27&WE[5&^N[S)KHAU&@
M4'!<EI+RXO.O%9)CWY#2HS;1>2D#<!;2_P!OG6*:]ALV@2D '@LUEB;B]>3
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MZ#$/DL[9E'=-*\AU"OIXJO.X_+9/#L4TG$H)G2E@-73Z !U*C]E2#-7O]LA
MBT"@>V<-_?KMQF/&I)[SJ?:ON%W'QDG"*G0&G\CD&V-SD1IL[@Z$7*#U%[_&
MD>ZX&VO6XZZK++L>]^L\AH^6HU\5*N,YM[.8B%ES&<C/O;RINUU((TU%M-*W
M[')1WUHV0T^8+DY+%SXF^?$RM8S2M%D.7=O>-9['KDO0@Q,!2ZJ6SZ5K5;Q(
MZF]5S#;R7-Z8Z_*2?>KDN+YMKB?//[V\#WT_-5#F.SZ'\I"=QN0<C18BFWEM
MK)4 M"@H$?;8U*I=H#S6/B-.G4J!6GW"E^EDBN&AY?H#H%>6.:W.QHKY*QL
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MBOA59]S[?MLA;O+ .OI/3_FH:>U8.'-D0X[8$??'7=34@_AL3?4@D=34XO\
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MIRC+''&0E$9LIE.I-TJN;V/]6GVOLLC'9.^M)J:TJ:\PM3[G7EA->M;:@=0
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M"5)Y#/:<?DN>XVPT@V2SH0 ;]34,;N:6S?(R4]3JFE.2LB#[?QW[(YX'@1$
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MS<%#C4F+($EE*% )#B3<#07L#KUJ%/QX.5,?0[RB/:2M&V^X.3C8(W.! %.
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MHXF#)N#.AU&M[5FR;]O6S7,<T'J_E_18;"*R!@LG+)'SQ3_%MHF_G4]LWS4
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M[.)S^FJV<-B(\I.V+J#:#LU.OH^*G43Y,LN1HQ0OY4AMQ(5<A1UMXZZU4_\
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M7O>AQ=\E00>TJ.N8B+FTRH,Z.)++C>@5T23XUU<Z\,:.OA51[:EN^6<^6/F
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MFQ(2"' #< >=Z[]KCZA?L5N7+7;ZBL3R=_E/$L/QMIY0R<.7L;8!4;ME!45
M D==*_;V*:&GE$]]%YO,5!+&:@=7>*ZK@P.7F\>AX?!<IQ<K&Y)#6Q]3J"4*
ML?2K=\:GN(S;&1-9+H50.X]CWL4DDT8ZFUJ*<5,\ED5MXV1/QR0^N(VIQMN]
M@LCPOX5(KF3RHC,S72J@EI9E]PV&30N('@JDP'=Z'G7(,->(D,SY[B?8!L1M
M4+FQJ)6&YWW=UY;F4&HX]ZL;+[!;C[$S"4$BA.E-.SBKK>4P2T5-A>PW"CU2
M#I?^6IK/-&"VNNJJ^-CZ&G8NGB\UCI>0>8@OHD/8]1^8:!OL5;H?VUHRB*^:
M^)KO%=2U=-C9([ES/"NE000LIE,PP5-O22B*E*2A.Y0U)U(OIY5I8C&LQ,;N
MI]0:]RZN?S,FX)F%D1! I0?,?<%]X9]D&0J4ZE34D@QB-0 FX/J&E>+YDLS1
M)$:M.HIZ%FV]-;VLSX;@ .T&O:*U641B(TLAUI92P+V"3>Y\P:XG]\D@=TO7
M?@VC!=N+X_VZZ#@NG&DG%KE1_:]XI_>O:UM4WZ^!KJ7V-;F61N!ITDGM_'!<
M;%YA^VKBXB+>HN '&G#4=O\ ,HMR/E,3#%B7F"LMRE^V';7;:"CH#;P%ZWF^
M1BHF@A<B3ZK.W#WUU%2 3P%:T"F>/PD5V,P^V_O9<0%M)0FR2%VVVU^^HA?;
MSJ\11LT)I6O;Z%8N+^V@>PRS2U=2H%.?K6#FPYB7'6(*$N30Z$H2M6W3=<GQ
M_=UJ7F]9;8\3?\(^ 5??V>6?*NL36O6X#P%37U:KMRXS\<(;>6%/K;"D[1I?
M6X^XU[PV69?1%XX@D+#GL!)A[AL+M>H UI3B:4YK3'D$_DR^<S\9!DN-Y-Q\
MM(2VJQ791*1;K:UJK>^NKMU^XLK0E7K9XO'1XAD<O3H->VJVHX\C+'#Q49ED
M,SV4A#Z0K=JG0U9^*?*8 7C5?/N4;%'<O;$:MJ5+8.,9RB-TUL.1$6*6C^\I
M)Z_=:N-N'+NA#6-%22I3M#;S;QSII#1H!IXK&9Z,93+V.B/_ "Z$)U<2+@+O
M< #X5L8^W=<1=;Q0E:&9N8[6X\F/5C>(X#P]"ZL&.XQ&0U)D(?>0FRUVM?[J
M[D48:*$ZJ-32!SZM% N>5^9)8;_*L8N<7'4I<4DVL"=5:];5PL]FH;"%QT<Z
MG!2' ;7NLQ+74-_F/XU6Q7(.-X;!\.QN7:D!J:IIOW&+W))2+I OYU06 O;K
M,99S"PM:2[7CS5\7EW;[<QXJ1\H IPY4HM3>9]PX>"RD./E6Y#34E0V;4E2&
MQ;J3H*NYV2L\$!;U!?SY<=54$HNMU3F1IHWDVM:>Y2/'Y*#FX+4V&[[K#EE-
M. 6N/ _?4GM+EMY"V5O A0F_LI+&X="\:M)"Y7I3,4I]]X(+AVM)4=5'X"M@
MRM:/F*P,B=)^T57.["5&CF<\TAMM:[.$V2==!?SZURV96!TICJN[-@+N.W$Q
M!IV<PNB_.QL%/]\R&VP_Z4H618@V%M:WY;J&(?,1JN-%;S3'Y&DT[%AN2Y;-
MQ.,948&4AA28^Z,D@:) U"*A><VQYDCKF,TIKP4ZVMN22T<(922*@#\E%NS'
M#<OCQ_2O(95$=B<G>Y"WW4HK'[V@M_+54><9KOR VIJ59+MSX^X<6OZ6])IJ
M=?<KHS4I#LA26E)4E#:4%23?Q)_KU8VV-H.@/U#]#7L52[XFMYLC6 @M# -.
MW4J/S)33$8J<W!*1ZDI%S;[*L6XN8[9G4\T 46M+62>4-8*DKK86$Z8[\F2T
M6S,5[L9*[[O;Z Z^=0R'>-J;KHTIVU6UEA+#(UD@(('-<S,N(9:HK;J5/C4I
M^'C>IE;W<=P*QE:3XG]'41HN/*12PV_/BI*I26B$"VI/6U?CHBRKN:]6TO60
MQW[:K'8O(Y*;"C26' Q,3Z)0(Z$'4:BM(Q_6,HX+ILE./N"Z,D=A'8LU+BC)
MR(LJ:$O/1+^TJUK7\J_8,+!":M&J7^X+N\;TR.J%@LCAF'<Q"R)%UL(*"DGT
ME)\;5YGP\4EPV9P%0*+6M[QS8'1]I6>9EQ-B0AQ 4=$IT!_96:^R45I'71:#
MXGUU!71RCDZ#*A2$$+A+5[<E'[P4K05"[+>C)KX15^76NJV[2!LX,8!,G(#N
M79?A1W)#;KS6R0S932U)UUZ'6IN^*VO6\B%ECFN\>_3J8[U*3M"/R"%+Q60:
M0XTX@-O(O^(6ZV\*K?<>#CA=5AXJZMC[GEO&D2#4<Z\=%QB-B>,8UUK$Q&U.
MQ&5&/$2?6H]0/$ZFM9L62FA$<0=T^Q;TUU@<?<NEF<PR$U.GS:^U8?!R>2<A
MC1YN9QK$".%%7R14%K%K@7TZUYQHO+%Q$@(<5^96"SS<;987!S!KP]"EIGQT
M-N-I<(=C;1M ZV/2]JC>[K:[ZV.DKT'7VJ'9G<]M#;NMF?O;I0=WH41RK2W8
MLDQ[J<6TI*$#QN.AJQ\-E+!V/$8(ZM=%5V.NWVTK7--->*J3@''>68.0^QDE
MMN8V6XM:4E1W-"Y( 'WUU,';W$+@3^PJ6;CRMC>L#XP?, U[#[?@KNQ''\K/
M;F.XZ.N2Q')<?>.B4WL/ZWA6?(9*RQDG7<. )^*Y.,V_>Y76".H'/DH9SB).
MB1(#+"BY+FRDML!*?PJ!ONOK:M*7<=K>D-@H7\E*H]GNQQZ[EU&\Q3XU78R>
M%C9Z W#G-AX+2EI-S8;R=%?<=:[%[!$;0^::$Z^E1?"WILKZC-0X]/H.E5V>
M/-<[QC"X'(YL5QA@>UCWX^JU(1H"18>%5QM7;<$MTZ0C3]5--UOGPH8Z!].K
M3AKP7YF,F\TE#<]U;P4^A#:;:$DZ$V\JL[Z&VMM6- -5"7Y.\R I)(2*$KN*
MDQ6D*,AQ"$@ZJ60.OVUO^9'3YB%Q!&]Q^4+YC-E(+N*AHE-!8]Q+*AKNZJ^-
M<BZS-I:.Z00N[:;=O[^,O:PD4Y_!8;-\CAX>6B)-WIDE6U+"$E1-^@TK]DW'
M;1Q]9.B\NVY=Q5#VT\2NZOD^*Q:HHY \K!L3/_=>2^CT*4?W;W%4ONS-')2$
M0&O=Z%XQNWWWTG2QU.^E?R7Q+@<=Y!(B9;'3!,^16E;<F."TE1 -K[3ZK#QK
MM;%VS(YWU%PV@!X'7DL]W=W>+>;=LA(I3^7A^.*C;.8P?+)&0X](84?R]5GB
MM)"2JW@?OJRW7D.0<Z&E.G_!>I\;<XN..Z8X$/%13ESU5Q]LY>"[9SOS%O$F
M4WE4%I]15N*6VU>D)"@;]:K[<6S(\^R6%LE'0C32M2[7MTX*=V6\9,9%!/+%
M42]7/@&FFFFM:UY>E=7F^&D]X\YD6>/PU0<KD6%-0'$2%,A"4#TJ7LL+:V-<
MZ3;=EMG%F2\H3U-%2*<13X+8Q6^+_*9$-M8B-":5Y=IT\!S4#Q7!>1]OL:GB
MN=F2E9!HJ]]:'#M]2RI2D*(]0-Z[6UK;%9.S#X'MZG5X>)"TLMNW)8V^>VY:
M0#2@K3U::JPT--9**E#F]6T(.]7XANL?"L\4#,/<FCM23^2[8L!N"V\UPT-/
M;JNDB-CG7E10D>XC4J%Q_+]]=.XEN[9GGU-/P5%(,;CKFX-J .H=E?#CZ5FX
MN.B1E!R/&0'WDH;6XD>M01<ZJZU767NWR%TSC^[57+AL5#96@B:!5H 4>Y9(
M5A,;.RZV#[.-B*>6D:"P6=+_ /C5#A$)R2'5U5#[AQ<]WDRUK33M_P"8_FLQ
M]+7=+ \Q[K<(Q[49<#,+RK#BXJK;2A*@+I-_ G6MF*S,)H353?"[1GL;ICRV
MAK4TX$#_ !7]%B?PI^P5VE;2^J(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB4
M1*(E$6@_>S]/#LCW8R$SD/'_ )KM=RB<I3LN5A&VW,=(=7U<>QR]J J^I]E;
M5S<JN3>NO:YF:$=)^8=_'U_G5<NYQ,4IJ/E/=P]2T]G?I.<S;DK3C.\6%EQ
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M5->8]5-%4>/<RRYV0,II+,4%(B?$#K4ZB=+U&H ')1.X;"(V=)J[FLUL6LJ
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ML5:B4D=7M5.Y3"Y7+7[H6@EE137Y> ^*J_,,YB9R+#(<Q,K$R,')]YY]YO:
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MO(7,%A]S6*=R:XI&]B.4A:D7_%ZB!I?6HGNK&31O,E26'\E8GV_S5O/ VV<
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MMRO*Y-6HS+6,3.EI \ J(=M_*W#B]['$\*D@GVE2O&LOL1TM.J-SX'6US?\
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MXZ:\3VJP\Y$[&V'RMT=4<.[OY*VORKE^6SF&Q?%\:)Z'-SF2<*@ VVD'P/\
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M.X.>VW.BRF3F8ZE**?:+#=[@=%5+[+*LLK=AC_?350'+8!V4O'B;6+2GB/\
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M"Z ? VTT%'0^8SI#Z#L7J27I'[*GM48QO'W&D2A/RK^0?EOETN+L/:!Z)0/
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MV,YL'R:/M?W"FG+W*-M=NLYQ=4%'&^'2&6LA)2K(.(C+59!L#^$6Z"NM9^1
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ML"XU8#!K(*\/#41J"6$'^M7@/<#6J]=(I1?OY#A.OY3#OY^RC^Q7X7$\5^@
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MFOP2O',H6-/)?J>.8!"_<1A8*5@6"PPV#;[;5^%[CQ*_0T!<IPF'/_WKB_\
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M$Q/_ $*/[%$!HOECC^"C)*(^'A,(4;J2VPA()\S85YZ&]B\N8UQJ15?C7'<
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M'4]3TIYK^TK]\IO8OW\EPX)4,7%NK\1]E&O\E/-?VE?GE,[ GY+B.OY9%O\
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MEH3&2XD74C>FX'V7KT->"./3Q7V9D0=9+7_E"OVA7GK;VKA.4QJ5ALSXX6=
MCW$W_9>O-0O0U7()\(WM+:-NMEC^S3J"_"0.*Y42&%BZ'D*'F%"OPO:.:_0:
M\%UQD\<HK2F<P5(-E@.)N#\=:]#7@ATXK]3DL>M10B:PM0ZI"TD_U:_"0$[U
M]_.P_P#UEK_RA3J"\]0[4^>A_P#K36O3UC^S7Z#7@O0^;@OSY^".LQD?^.G^
MS1!KHOM$N*XCW$2&UHM?>E0(M]MZ\E[1S7Z6D+B3D<>L$IFL* -C9:=/Y:]#
M5*+];R,!Y10U,9<6.J4K23_5KR7 <5^+Z>G0HX"GY;+(.@*UI3?]IK]#@>!0
MZ+J_GF&_X5B_^E1_9KU0HN9&2QSB=R)S"TG]Y+B2/ZM TG@OPD#0KD^=AVO\
MTU;SWC^S7KRW=B\];>U?0E1E"Z9#9'F%"L9-#0KT' KY^=AZGYIK3KZQ_9KV
M&./)?G6WM7RG(P%"Z9C*A>UPM)_KT#''DG4.U?7SL,"_S35O]6/[-?OEN[%^
M=;>U</YMBRHI&0CE0T*0XF_]6OP-)X!>JKE5/A)MNELIOTNL?V:=#NQ?@<#P
M*&?!'66R+]/6/[-.AW8OVH7XK(04 J5,92D=25@#^K3H=V+\Z@OI,Z&H!293
M2DGH0L6_JTZ'=B%[1S7X<A!!"3+9"CT&\?V:%CAR7Z"#P7U\[$MN^::VVO?>
M.G[:_ "5Z(HNN,QBE':G)1E*\@ZG^S0 G@O-5S*GPDI*U2VDI N5%8M;]M?O
M0[L7YUM[5\(R>.<%VYS#@'7:XD_U#7X&D\%^D@<4<RF-:_ND^.W_ *IQ(_KT
M+2$!!7X,IC2@NB?'+8ZN>XFW[;T+2%^K];R>.>O[4YAS;^+:XDV_8: 5X(31
M<GST/_UMG_RT_P!FOPZ<4&NH7X9\$&QEL@GH-X_LU^])2J_3.A)ONE-"W6ZQ
M_9KUY;NQ>>MO:N%66Q:/Q9&,F_FZG^S7DBG%>AJN5$^$XD*1+96E7106"#_+
M7[T.[%Y+VCB5^#(02OVQ,9W]=F]-_P!EZ=)[%^U%*K[,R(-3):'_ (PIT.[%
MY$C3S7Q^802-WSC-O/>GP^^G0[L7[U!<:<KC%D)3D(ZE*_" XG7^6ORFM%Z)
MH*KG,V&" 930)Z#>*]>6[L7CK;VI\Y$_]9:_\L?V:>6[L3S&]J^%Y" V+N3&
M4#S4M(_KU^=#NQ?H<#P7S^9X[8'?GF/;/1?N)M^V]>5Z7XO*8UM*5N3XZ$*_
M"I3B0#]AO7[TE?@<#H$5E<8A 6N>PE"B %%Q(!)Z>-?B_5^JR>/0 I<UA(-@
M"5I\?OHB_!E<:J^V<P;=;+']FB+].3QP!)G, #J=X_LT1<7YUB-3^91K#J?<
M3_9HB^OSC%%02,E&*E=$^ZFY_EK\J%^57VO*8UM(6N>PA)-@I3B0+_>:]47Z
MN=B5&E)*XS[;Z1U4VH*'[17XBYZ(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1
M$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E
M$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB
M41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B
M)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%XB]X^>\OQ7<CG$/'\BGLM
M#.3DM)^87M;2AY0"4IO86\*CMU(6O(5(;UW-=65P8X74U.OH_54IDN>=T7V_
M<@\YRS1;4DN$.*4.O30>-=+ 68R-VV![@T&NI[A51*RW5E'U<7N<!V >CDI9
M%Y;W8=Q+^65F\W(@1QM><WK!5YV";$?;6/<8@QN2%O'('&C3H>U2;",W'?2!
MSBX1U%:M'"NO('AS6IV*P7>KD"<U*D]P\SAPF:\8T5Z:^HJ25[QJE=QHH#K]
MU=5C'3-)/)7-&^YM(6]&KQQ5\<9R7,^V^(F2)7-\_E77DH6ZW)F.E <5;=LW
M*) O49DE=<24CY<?0JIR>Y+R&1[I*U)H!P%:G\<UG3W&[AO,R'X7)\HE;[84
MU_&<6E)M:ORY!:\!Q(]-%!QNG+/EZFN=TUX 5X>A1+!<Y[[XKE.+=S/+'<W@
MG7V7,A:4XV['94X-Q*-VH"3K78;E(X(:4UY*R<'GA=/8V1WS4X$BM*<:#O5T
M]Y/J'QB&\3A,/W!=7.?6OW&8\M14@E)2-QW:6N*_?M:))KA_UG[2.>G\0^"D
M>[;V[@M";:I.O#EH=?0JN@\^YTVAIQ/-,PIIL7;M+=VF_F-UK5:&[[VWL+8P
MQPZN&CM.1'I5 S[AOW2=7G/#O'X<%L7VOY?GYT6<OD?))2I1<'LH5*<"?;M?
M^=UKYGSN3NF2CR22/!7KL?./?;5NC\^OP52<LS>7Q',<_F\/R_,.JRKB&T-J
MF.^TRVA %D)W>)!KO[?RLX:#(%'-_P"ZY8CTV[B*GCIIH/U4;E<\[GEM9Q?+
MLDW+<3O8$E]U2%!(\-:F;LY%*R@ !5?X[<F2BE:7O<0==>?@J7[==R.7YCN)
MRG^E'.\F>0Q7U(A8]N8\F/M; 0IQ"=W\U(K"UX<02K[Q.6;)""XZD?'DK1_S
M@.2HS>2PS,_DCR<:D_,S&0^XA2O)-C_+6*X8))6=)T7+RSKO(R 6CJ!M>H\?
M0KN[3?5%QZ?A9#&1YC,QN79><0YC9DA8?LWX[2;B]5YN.UR@NFF$GHTX!23$
M3_115NC0]^BU[[?<KYUF.<<US".699K%97(.,8J$]+>_"'%K]U*2KH=VE3NS
MR'T,#?.XTU4<R.[+:[N6P0N'4XT&H[%NPU$?X]QR7-.<R(R"HX4Y+,MTW6=0
M1=5JK"7<L]U?.;&3TU/O4VOBR#'5)^:@]RUA?[K\V8?!/)LFIMY1#8]]=DC[
M0:L:QQ5Y>-_I!QIS"^7F[MR+I'.$AIR'8L\CGG,G TZYR?)*"@#;YAP=1]M=
MFPMI[=W0YI+E=VT+BY9 )KIVCJ'730A3C@>9F\H5.9S/,9Z41]WN1$3EI*D$
M$?B"KBN=N6/)8^,R-C=KW=R[F.SUG>W!9"\$CC0@\U>F$S0Q&(;Q./Y+)5CH
MS2FQOF+<4$_VRU**C]YJGWY/,2$O<' #N4R,;>+CQ58<[8S& Q$_D6#Y#E&H
M<5OYB;&9DO.ES<0+H]1\^@J4;9W;)YGES\>^BUKB 4J%57&.YG)\1*;S$#-3
MI;KR HQ'Y+@6=W@0I6A^VK$O88;NW=)&[6G:N-UNC>"5VN]O'.[O..)QN0<=
MY]FU9MI2'8G'8L@H9'N=;*2024@^)JNK+<;K&Y\JX%&Z_,5U6V_U Z@5HZGC
M'U"XZ:[$Y'R?D&$4DV+\B<Z+[M4[0%&]7#@H79J0-A/R\SQ"AFY]S#"-ZN@N
M]-%;W#<]W%XIB%PYW<',9)U;Q47U273HHVM8DVZU:N-VY;V#7!X#JE4KEMZW
MM[.7Q.+ >6BG8[@\^0V/;YCE1IU,EPZ?MKJ1X:UU/0-5QANC(@_ZSO9^2SV,
M^H?EW#HTR'E)F:S[F2;]K'?+O+44K\2JQTTJI]\[;^FN(KB,T;U?,.X*P=I;
MP!CE%Z_@-#PJL)*[B\ZR"7EJY/EX;+Z=8QE. C=UU!JPL#:6EQ:-):#HH?E]
MUW+[IQMY"& Z4*Z#?/>986!=KE>;3$:.X*]]YP7/FHW_ *M);+'6+^J4M#3H
M 3S7F',9R<=3'/+>VFGKHNPQW([@.LK/],,JM9L6D)E+)-^GI!K<;C+)K>LA
MH8>?=XK3=N').E%)75_'*BYOZ'\]P:)O/7>XF7D-9/\ N&$5,>*VEK-R;;C?
MX6%5GC<A:19-T- 8S76NBM_)W=\W%=49(?3EQX*+Y'N%S+)Y3&\?9YKF&9S3
MJ'UM*E/@I:;U457/3[ZDV1N,6]OEP%KGCL*B& ;F7!LLDA#'5X\?=\5/,KRK
MFB6H[HY9E2EL_P!R1*=2HGS!"KG[*QX>:U<[HE:*]Z[.[+7+10":"4TIJ&C7
M7GHH%E>Y?,LGDG.*_P!*LT1)C%Q]#4MTO-C]U=MVX:UV,B,6&EHZ:TY%<+;[
M\V]H>7N(K2A&OYJM(WU"=R>'[\!E<GR-*L6O8B093BBIJ_I4=2>GG41M]PV%
ML_H+ [TJ39#;F<N 98Y"&]G JVVN:\YY;!Q66@<WS+.YQ+L-Q$I=MQZA8!O;
MSKC;@W+;2Z01T45QV6SMC>1Q2=1:7AIJ >)H>2M-'<[D6$XLXOD')LC(E,L*
M^97'?>.\D?NC=I73Q;&7%N"&ZT5\2WD4+:S. \31:K]O.5=P)N4SV0R.=Y Q
M%6\?R54F6^E*6BHGINU/VUWL!@@]Y=*PT55;RWHV$!ED\%W:*&GYJQ.;]R^X
MD#C.87&YEE5%J,I*/[[<VA-M3UJ193%P1V[^E@T"@F$W#?W%]'URNU(_%."P
M_;;G?-87&,>^GGN4FR\BRF3(=5+6H[U$C: 2;;0!7*VYB;1T+BX FO:I#O'<
MF1ANFLC>6M Y =O@I7W0Y7S+)<.R#^.Y/F%9&*T'X8CRW0LK'P2K6H#E;.2.
M0]6C05:^&OH+F-M' F@/'N58=J%=YN<X)H+[D9U.-D2%MKQ*'G"\5)Z[EW].
MM]*T_K8+>GU+P&=YHLF4%U0_3\?"JN*-$[B]O''DR.0\@;&1NE#CDQYS?87T
M3N-JG>WQ@KUO5;R,)_S5^*IK,7VY89""'@5XAH(/J!HL5R#G7>P93!'%\IG1
M\&RDJS,H27"ZO:+@%)587KEW./AO;L-92E0IK;9>ZL<?YDU20TD^-%DLYW"Y
M_F6&,5CN7Y/%S)3J/:FF2LJ 3ZS8;O[6LF:PIQ[&O&H6+;F[?[L]T)^4]Y"Z
MT_D_<)E7R&1Y[EYS*VD+2X)+K:KW(-RE0.M=C;UI%?Q>8]O.GJHHWN_*W>)N
M1!#(=0'5\2>WP4=F<\R4#%O\><Y1F/S3(E?R+KDMX^LZ#UE6GA7/S^!#9!Y8
MT*[FU-WOF@<;AU7-XDT"[O%>9=R,+@8^/G\RRRY,0K]UT3G3<E15<'=J-:E.
M'PD,=L/-:":<_!0+<6Z+FZO'&&1S6 Z 'L/;^ LKDN4<F&;B<@8YWF1):86R
M\VB:Y[2AIKMW=:XV%M[.ZG?U ?+R4EW-F;RSM8XF.-75J?QXKKXSNOSW*/S&
M$<HSS3<8ZONR'BVI)Z%*E$@_=75MW8^>Y=!TBHK[%'[B/+XZT9>><XM=0\2:
M5X<5R<2[B\V<DYS#9GEF05[:]\-WYIT%3;H-P/5X6J+9BV^GDZ&#0E3[;.=^
MNCZI7?,!S6'7-Y!'R2ID7F^?7'CNER.DY!W8A1%E 65TU/6N]AMKP%@FE&I\
M5%MR[YNO.=;V[J-!I70U\-%E)G<+G[\?W,=S3+.RF_2THS7"GKK?U5VI,9;/
M']-@-%%8=P7S'4DE<&GBNX[W,Y^S$4XKE>8>=;0"MMN6YJL#4#U5E.,MFM_T
MQ581G;][Z>>X GM6'E<RYCRC'^WDN2YR.E]%E-F:\@BW35*@:UW8:VG;0Q]*
MVV;HR-G+5LY=3U*,=R^]^4XYPMSC4?DV:&2E1%M8U"9CQ*=MD[E.!6EKW%ZK
M'-6$=K-T5')7MM?+'-6P?J#K7N/#VJN>9S.^^/X3B\G.[E9.=$Q[;3B8C4IT
M.-)=%@HJN-_WUR[EW2P477M;8VLSGN)(/"O)0-[ZC.\,Q>"B3.6Y1QK%2&UF
M.B0Z%.>W8;5#=UM6GTZA='RZGBMF^Y'<'N;FNSO]+<5FL]C' 6)CZ/FW4/1V
M65$K41N%=,V!+.H+RT4=JM5>-=R>^G*,M&P^+[A\A,J8E2VMTYU((0G<3=2@
M.@\ZYM#6B]O(:KCQF)^H>2\V,AW/S+32)"6Y"/S)PJ]N_J( 41TN?Q5Z#"L)
ME'(+%]S9?=#BCN"3C.Z.?F0L[,9A):?G.[_=6JR5JU_"#X^%#'70++;M\UW2
M?Q13;G7'NYW!>)?TQC=VLY.EX?Y>5)A.RW@TX-Z;A!W7O<^?2NO<XIL,/6.*
MR&WH:*(<3[O]S.[_ "?%XK.<ER\#"8MAZ2M$*4^D/.#:FRU _P!L:XLUW'%$
M2>*QO!CX%>U/T#M2(W'.<19&>R&9]O)(++4^0J08Z2TV-B5+)(!(O:OP.#FA
MPYBJ\,)/%>@M%[2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB
M41*(E$6,R6:Q.(#:LID8\!+Q(:+[B6]UNMMQ%$6)_IMQ'_I'C_\ =#?^NK]H
ME5Q.\^X6PA3CW)\:VA! 4I4ANPO\;T )1<2NX?!T!)5RK&@+2%)_OA&H5T/6
ME-:(NW'YMQ&6A2XW),>^E/XBB0A5OV&O#G!I(/$+]#2>"_'N;\18]KWN1X]O
MWK^UN?0-U@2;:^0H'@\%^EA'%?,3G7#9Y6F'R;'2%-@*6$2$$@*-@3K\*_7'
MIXK\:"XT"Y3S/B8>+'](L?[R0"IKWT;@#TN+UECA?(*M!(7Y)_3_ ':+\;YK
MQ)V3\FWR/'KE@;C'3(05@>9%[T="]O$(SY_VZK];YGQ-YQUEKD6/<=8.UUM,
MALE)\B+UY#'$T U7A\C6?N-%V#RGCB1=6;A#[7D?V:R_32_RE8Q<QG@X+IR.
M<</B% E<EQT<N&R N0@7^RYK')&Z,5<*++&]LAHTU79/+>,@V.=A7L#_ '9/
M0]/&OPM(IIQX)U#77@B^6<9;25KST%*4]27T#^O7B0^6:.T*S1POD;U-!(72
M1SWA3DA,5'*<8J2H72P)+>XV^%Z]L:7_ +=5XE:8A5^GBNX]RWB\=!=?S\!I
ML"Y6I]  'VWK+]-+_*5A;/&XT#@OU'+>,.)2IO/05I4+I*7T$$?#6@MI3_"4
M,[!Q<%TY7/>%PEH:E\HQL=QP70AR2VDD=/$UC=&YO$+W&X2?M-5W$\LXRM <
M1GH*T*%TJ2^@@_RU[;!([@"L9GC!H7"J^3R_BZ4%Q6?@I;3^)9?18?RUX,;@
M:4U68Z#JY+Z1RSC#A"6\_ 65)W)"7T&X\QK7ZV%[C0 K$Z>-HJ7!<IY-QX=<
MS#'_ ,V1_9KW]-+_ "E>/JXOYAZUQ?TLXS<I_/86Y/4>\C3^6GTLO\I]2]?4
M1_S!<"N;<00[["N28Y+W7VC(;W:_"]#;2#^$KV)&D5KHNH]W$X(PK8]RW%-K
M_F*E-@_LO6-S'#B%^AP=P7U&[A<'F.>S%Y7BY#IO9#<ELG3KXUYC:9#1HJO<
M@\L5=H%DOZ4\<)"?SN%<Z@>\C^S65T$C>+2L39F.X$+Y>Y;QF.CW'\[":;Z;
MU/( _JUY?"]@ZB" OULC7'I!U7T]RKC4=@27\[!9CFUGUO("3NZ:D^-:S9V.
M- 02MEUO(T5+2 OP\JXV$>Y^>0MG7=[R+?U:W!;2G^$^I:7U,=:=07TGE/&U
M#<G.0B#_ /)D?V:UI7"(T?H>];<,+YA6,$CN7X>5<;3^+.0A_P#-D?V:1.$I
MHPU2:%\(J\$#O7T.4<=-O_:W"UZ#WD7_ *M97QN8*N% M5MQ&XT#A5?BN4\;
M0E2UYR"E*1=2B^@ #]M8&S,=P(6_]'-2O0?4NI&YOQ"8I2(O)<<^I'X@B0@V
M_EKVUP<:#4K6D_I_NT\5^R.;<0BW^9Y+C6-OXM\AM-OVFO3P6'I.A7J-ID;U
M-U':%]0N9\3R*E(@<BQ\Q:1N4EE]"[#ST)KP]X8:.-%^.!:.H\%V%\HXXVM3
M:\W"0M)LI!>0"#^VO8!+>L<.U?C?F=TCCV)_2CCO3\[AW\![R/[->(G"4T9J
MLTMO)$*O:1XKX?Y9QB,VEZ3GX##2]$K<?0D'[+FO;FEO'1?@A>> *[4;/X26
MTA^+E8K[+FK;J'$E)^PWK ;B,<7!8RT@T/%<CF:Q+*0IW)1VTDV!4XD:_MHR
MXC>:!P)7[T'L767R;CS=]^:AHMUN\C^S6U'$^05:"0L<CVQNZ7&A6-1S[A+C
M_P LWRG&+?O;VA);)OY=:\$$.Z3Q7L D5' +OCE7&RK8,[!W6O;WD=/VU[\E
M]:46(S, J2%^JY1QQ(W*S<)(\R\C^S7HV\@%2TKPVYC=H'!<?]+N+[5K.?@!
M+?XU>^C3[=:_&PO=J 2O7G,K2HJOI/*^-*2E2<]!4E6J2'T&_P!FM8&.#W%K
M=2.2VW6TC&]1:0.U?7]*..;=WYY"V^?O(_LUG,+VFA!6GY\=:=0]:'E/'!_]
M^X5O/WD?V:]?32_RE!<1DTZ@OS^E7&]/_:Y"UZ?QD?V:\/A>QO4X$!98W"1W
M2PU/8%^GE''!J<Y"'_S=']FM9L['&@(JMLV4X_@/J6-'<#A!=]D<KQ9=*MH;
M$ILF_E;=6QT.K2FJU7'I-#HNR_S7B49*5O\ (\>TE9LE2GT"Y/WU^OB<S]P(
M7EKVNX&J^6N;\0?:+[/)<<XRDV4ZF0V0#\3>OT0O/ +R96@T)7[)YMQ&&S\Q
M*Y)CF&#8AU<AL)UZ:WH8'CB"C9F.- 5T1W(X$HI Y=BKJ_#_ 'RV+_9K7AK2
M[@LI%.*_5=Q^!I66SRW%AP"Y1\RW>WGUHYCF\0OP:KZ/<3@PZ\KQ@MI_[L(_
MLUXJAT7?:YCQ5]I#[/((#K+@NAQ+Z""/@0: UU7Y5=YC.X:4CW(^4C/(!L5)
M<21_5K$;B,&A(7KI*P;W<+@\=;K;_*L8TME9;=2J0@;5#J#KUK,SY]1JOQ?<
M;GW"I:FT1N48UY;M_;2F0@E6VU["_A>AT1=P\OXN"4G/P=R0"4^\B]CT\?A7
MZ 2O)< L:ON1P)I9;<Y?B6UI)"DJE-@@C[Z\N-.*RMC<X5 JN_CN9\3RSGLX
MSD6/G.W ]MF0A:KG0: ^-?A<!S01/-=#HI-7I>$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB4
M1*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)
M1$HB41*(E$2B)1$HB41*(E$2B)1$HB41>$?=J,S-[H<XBO/!N7_2'(;1I>Q?
M7?\ J5$LO-Y<A(%:<52&\K2UO[[R6OI)U>\+K9K@DSB^(8G29#,R%)2@O*0G
M;[>X=5?&M/"96&>8M8\M?7E733M4_P #M.VQ]@'3 4H*F@U-.*Q?).Z<_CW;
MC*XG#XS\RS;<7V\>RD'U%S2]P-3:LW]BDR>4%TQSG1@-%3VM(6F_?=E:2BVC
MI4TIH1Q]"[G;/B>2Y1&QF6D0'<=#6&WIR9+90IU1&H"2+^!_96?<>Y1CS+!$
M:O&G9V*>V9?<,$C0#537NYQZ-+8Q<3&P/?/N%N1&805':D)()V] /.M+86=M
M8G/^L-'N+C2E?W4I[5%-R[6%^ 8VCB*\N!J57O'^+93*DQ<?%*&8SFQY1&U"
M0!<BYJ3YJZL[9W7*:!W#3L6;&[8M7VQ8UHZ@.P*/2<>]$S;N_8!&<<:=1<@D
MHW).@&HO7+%I+,P%@J':M_R_#15P_9>0CRAGB Z 3SH>:H?(]H\(QGIW()Q=
ME/S)RI:"3_#;WG=LV#R\_NJX]HX>!D3>O][>7=7M6QN_+9.UB\H- 8[0D<=1
MP_7T+8WM1PN%RN'D,JN:6&(BRU%C@65Z 020;7!\*AWW<W8R/R[:!H(H[J=3
M44+: +G;4V6ZYB-W/R_:/&M2?@HOR>4_AG9KS+DGY7'!1*&3N<4$JMN]M!*C
MX:6JN+)K)& R 5/:N!?6>0ENS%:5HWL<!SIPKX*U>S[?&N2X9_/9J,Y%FM*4
MRRWD$EHK:'J"@ARQUN:CVY'SVYZ(.?9Z%;>T=O1.8W^XM'F<#6CN9_1<_/I?
M$I3/M89L-N1MR7'VT[2$V T-;>-Q>0MFMDF&C@#QKQ6EOK%6=O Y[  !SI0T
MJM?N(=LF(G*#R/!8A^?*R;+R)+P!4&'!=142D$#<!:I-/D &](.H4.VY'DK^
MW!MZ%H!XFE.7IX?%3EEAR'D'X^=2(3GNH]Y]Q)"4!>ENGA6YBGR7CNB'YI#^
MT>''P6UMO<-QAKF>._T^8&NI [AW<%(L]VMX#QF&_P TXPA#DV=9$Z>I>]!4
MK\1%[[;D^%1Z7)7L5]]/<- (UXUYJ<;I?-D+$R6G9VTY*4]J>&8+,17<I*<4
M\^A8"F2$C:=?4DCPUZUQMRY69LOEN-!W*-?;S;-H:74I)E&NM#0Z\#\:ZKG[
MC\DS43W,#%AN.8UE.TO[5?N] 2!Y5K[>L(!5Y(ZB>Y>=]9^]MY#!'&XL-==:
M#U!:[8QZ+G/?$5?][XQ_VYCBAM *=5)L>NGE5T8+<9P\+V2-U<"&\>*JJQQ$
MK7-FE $507$D<.)TX\%:W&N,/\M+L7%2$(3&%G)&U0"=.EB/*N,W?$5E<>9=
MM !-1Q/N5VXR[&=M/(LCHT!M=6\/&BP:L YQC)3(+KY<DMK+2EMG:#8Z:5,K
MO=8S$%1&TL"];;V@,$YTDKB7T_4+[)6HR6EA?MH*4+LI0*TK2";5!GR07/5'
MT-'@NIBMR2W=W/$\4;&0 ==:BJV*XGS7CSN/C8IW^\1&:2CVWK%*MHUW$];U
M7>X=H7D+Q-$T 'O'-3NVO&/;0K7#N1D\?%[I8US#-NOX_DL81"E@%3?SJ%*5
MHE/FD@7J9X)DMC9]=UPUKK5:LX8]U IRN7RS@[368F,O""R %,NJ.S<KH">@
MK%=OQ.XF^1%0.',"AT[RC#+#^U=EG*X;F/(1.Y=9F (R1&A_NA0ZW-=."2[P
M-L8;,DNH:&M#KX+B9+'07YI<@$>%577.\#AVLRO^BVW\N4@*+14;!8\!>K5V
MCN5[;"/^XD]=!7^+7O50;@V/)]276;1T>-/4J_2\H[FW&E-N)5L6@CH1\1I5
MB8_(Q7C"Z)U0J^O\5<6+J3-+?QVA<[JHT>/)EN+0##0%ELD;CN-M-:IG?.7G
MGN1;:](/>L-I9RW+7%A_:/8L9GXLO*<?FIQDLPL@M@F$H#\2B+@;KZ5I8K<M
MS81>33Y.VNJRXHV\4]9SH#PI6OY*[/I8PN3Q?#<T.;%$B6N0I27I"D.J]H#H
M#J+56N]-QW]W.R*%YU((U/%?2FT[G'Y&W=Y#1TBHI2BQ>&Y7@L'W$Y5DN181
M+?$-]L)E&V=VIT45I N!7>R>:S<V(CMF$A[&T=\Q6U'MO&QS>:6#J[>D+9:-
MQKBN=5#ST5Q,F&X$2(K2%7:((N-.E5I%N&^M)"SIJZAJ2352:''VLK:<O!5;
MW9P2LKF(L+CN'"Y\>-\Q/E14)02T+V05BVM_C5C_ &TSMC:2!V2D-7:"H+M:
MJ!_</#7CK=D>/' ZT(;I3T<UJUS/MMW.S&.A\E&9_),3#>"8L)QMQ+X*392E
MC;J#4\L\U9Y/-?36;ZUJ1I0+1<RXL<*'Y('0"M#4_CM522W<_P!L<F]SB:__
M $A,YI$.<A0*5-I!]*]W2UZD&X<%);NZR[]VFG"JY.S\]:W$OE1@U[#4GCVK
M>/L9.P?/.'/.\DXY%0_G''6T/+0%J7'M9'JM<6UJF-U8R_QX\UE"/\P5RP2/
MD;TAH4=SWTN8W#9%O,<+Y-)Q..QB_FIN#4ZM;>EU* U-K^51O&;MED>(Y8P7
M$@#B>Y<3*X:&WC=,]H#@"1X\5")LI4UJQNAEH7=2@D@W_G?"KNP%W<8^[CAE
M8/G- OF;*[GOLH*&H:.(!/M40G9$M.1(\5H.+D.6*4G;9 ZFKIDG+"UC&CJ.
MJXT%OU!SG&@ ]JJ_F^:R(S6+XQ,CH;PV9>2AR;O.\I&JTD6L!\347S>0F\UL
M+A1CCQ4WVOBXI(7W3#65@-&TX=ZD[7;^,W)Q0XVW\K[+@<D)]PA/MCKI>QKU
M?018UC90318,7-=YJX=;$ O(/L6P/$\2PS.8CYA\IBO* <4@%02GI8?;4'WG
ME67=O_VXX:]BLO:6VKG$N(NG?,> !J .2OIO/=M.W\M> Q;+$/+R4_-L0$(.
M]TD7W7 \:^<&661S-QTND/EUI^[16O (VMK2J[F+RN#YJ\](SV/0W,QP6J,A
MPV 204WUKH7EO=X!S1;R$$D5H>^G):G0V[)#6 T6O&?@1)RLE%05MQ''5A@M
MFRMI-@;^-JN?$W5PV9C^6G-1G(V=M):OA>*$@CAVJJ,K@YF9^6@XQ]V/EHLA
M(Q[J392E V2/_&!UJV\HZ*:R$TQHT"I7SS9"?'9(Q1BKNH@4X]Q]2F_,^$<S
MPD7$NY3&./RL@XS&:^5W.^JUSNV V\=:A6.^X.!BC\J"0Z.U^4C7FIO?;)SN
M3N?-E:W]NGS5TY>]1_(XGY&8(N5C)1,CI#C:7$W4+]"+ZU8V-R%KDF"2,@^]
M5[EL1>XB4PSM+2>PZ%=?:OV%!U8<#BB!H=OJ%K$"WG70DB+VEM>*YL,HBE#P
MT&G(ZA:K\^XSGN%SF9D3.OIC9644O,M+T2%>H@A1.GV"JRR-@;%Q?"[0\>2O
M#:V5M-PL,<D#>M@TJ-"MK$Y=D\;<AX4,S7(L1(B2-^X%PC3W!;S%>[3$2R1_
M4V[B7\^7'O6'*;D@M[@V&0A:(J:']PTX:4[1WK&S'3QG#Q\MR-0CJ+:4RI+=
MCL6?W38W(UJ06>;QTC0V<_..T54,N]HY2*0NM ?+=V.Z?12M5T^W6&P/>KG"
M\(C/S\9A8$!QU[V+LAY>Y(VI4;7T/A59_<'><]D2+4GI'97N4]V+L2*:(OO6
M_/7G3O5A<@[5XOMIDE8S 3)>6BR6_?4)"_<6U<D$$DFN]]K]S.O<:Z6Y/S=9
M&O9HHY]QMNNBO&BT95G3K0<P3\/<HTZOV4^\&=P4;*V#6WV5;39>IO4!HJH:
MVIZ25 NX6?RF!XW,RF.2V2VMMI1)(6D.K"+C3PO7%S][-:VCY6 :4]I4GVCB
M[?(9&.">M'5]@)73X5V]X9RGCF RN<$G+Y*?'2N:\I]6U+JCJW8'2QZ_LKY]
MOLC</GJ\\:*9_P!_&&R0M65 ):"!I0UT&G8KJQ^;XY+@RH>/R#4Z/@6PU*;"
MPNP3H$J!Z[;&NT)&/8&GB5;QF,\(IQ(55IX7PASD$'EF"<9F/,S4OSHB"E3:
M=Z5Z[1>Q)'2MVUQES>._HBM!VCDN-D,Y;X=H^J<6@GL)XU[*]A64[C=S\IC>
M-OXQSC#\?!SGT0Y>7=VEDL+/J3MZ^?A6=V0CC<;9QI(.2S8[<UCD#_0<3W])
M ]H[EQ\KE<+XMQY[D.!3C(&68C!6(D(V J6H7V7'\[I7(HX.->975<ZI4>Y]
M&SF&QV/YD.:.I6),'W8K=A'*%.)"R #K:]SIT%)/DU*_.H#DH3WWR>"RK'&9
M>-S!FY$ 72PZ2EM"4WW6'X#NM7ICJ_.U>H)J.^7BK"<[<]R>X7#\-C)'/$2(
M3Z&W9,)QK;9L V"G!^*V@.E?F*RDU],^ \@:>P?%<+"[B_N+Z1FM*Z:C@:<2
MMB>P!X!Q/BV0[=2407>?XA4D98; 77"OU-J"R+D!"DU!LAB,L_)F)H'ED_S<
MJ*8V_1(_RS^Y;N?IR\6S7%L=W<C9E:GU2N0_,Q995N2MIYM"DA))N-O2UJFW
MT<EM&QK^- /4L$D18XCO7IE7A8THB41*(E$2B)1$HB41*(E$2B)1$HB41*(E
M$2B)1$HB41*(E$2B)1%X[_JX97*8KBG:QS%Y*5C7',C*2XN*\MDJ'M]"4$7K
M]Y+];Q7AA_3'EW_2K,?[ND?Z^ORJ]T"_#RSE2QM=Y+E76U?C0J8^H'[05VK]
M!H@ 7*KE7*?3?E.6() *3-?M;R_'TK].FJ. :*E;R=K^.97B6.:R[G+YDMO+
M1VGYD=QQPI22@62DE9Z#2M^WQ9N7QNCUZ^*X=YD8K>*261_3056*[NR^6<BP
ML2+QYR:9$>1[J76I+C:]B0J]K$$72:E>2VE]/;A[-3I7\54#PN_V75Z8I#1F
MM">=.&E%%.PTO-PF,AFY><ESGLBL00P_(=W-?+N$D^HWU*SI7+M,&);*65YH
M6M)]_P"2W=P;Z=97+(X&=0) K6G(:\/^+V*V)*,S#Y/E>0-YJ84S&T11&#JB
MALHMZAZM2;'PK%M2^:V?RB*C\@J[S&];^Z>]M2VCB.->?AW%2CBF5Q6'G93,
MS,JZOE,QIQ*4J?65+;0G=Z47\CX5+\CCH#=-&@ZJ:>*L'9>XGC%R3RDN,8>2
M3_P@.]RU^Y]/Y;Q/D[7/.-+R3L60XY(Y#CA,46U)"0!8>&ER16KEL"+%[9V:
MC4GV+1QF](,T9(IAY;G4#=2:\>X4_'8ISQ_N<SR.-&<8Y)+#SP_]UU270L+'
M4%.[J#4FL;NSNP-!U4[%7>3L\KCW.JY_2"17J/YJX,#VTQ?<.,QD^3YC,N2(
MJRB.RU.6VD#??47)-P!I5#_=;,SXZY:(V_*XT_\ 9"^D?LSA!D+'S9WGJ:*Z
MZG]SNT]E%F>8+F\6GMP(V1DOM%M(AM./+W[46ON/P%2+9-N[/P,>XTZ6@'GR
MKW*-_<;*-V[,YK?F+G&@X<#Z5 \?E\T\)<;(9*0\@*6X IQ04I"]2FV[6P/A
M6OO#:U^9WRLKT- -12F@5F?:7?VWKVS9;W!:)B2.DUKJ[3QXC@J;[F8[,R9_
M'I7%I$^+FXTUI,J7'>=0D1W#96ZZO :U&L#>2VLC?.?X^HJ<[ZVQ%E+-S;-F
MI&E.VH[_ !5@<BC<ER'&W<<]GY48RV$,/2DR7%*O8$D J&NGA5W03V>2@#&/
M <1V+XYN]L[AV].Z>5KBP$Z=5=/"ONU7['R.6PF&B1V\WD)RH;*6P1(<!7M%
MNFZN_96,=M"(R XCG3BH%/F;R\G<YTCF@GAU&@6OO>F3RZ?^699N5D8\5MI3
M"7?F7"LK/K*2-QM8:U =V1^6\$1@#]5:7VVO2)7,DE<ZM:<2-!WJ9?35+YSR
MIC-&;RF:6<44M-I=?=597XAIN&EK5I8;(=3'#III13[*;*%]=LFCF<QK2'&G
M\0'+BMAT2LA*7)X_,R[BW4J]G(*2\L!(<TO^+3K>JUW#DKFUN74<>)7T'@\'
MC+G'MCZ&O< -356? X+@L'@W/DL_/DRFFE)9>>F+4 ;7TL;_ &5&,!O"_P#[
MFQKR>DD#VCN47WCLFQ=82=+ T@$Z>![UKAR3,<M<AJ3C<UD?F&GTA91(<U2%
M6/[]?6\ULV6,&)HKHOA^PNVPS%LTKZ#J'$\16G-=I[/<@C,,+;FSI,EU2$.)
M$ERXOU*KJK(ZW=&/EB!]2T8\A<.>:S. &O$J/ Y;%Y>?R[.9Z2WO;2VV"\LH
M;"!;INZ_=7,=C@R5TT[0&GEV*0.W9=W%O':6Y=U@FKJZNKW*M#%5W"[@HE8[
M(3W\"AA'YA*;DN(2MY 5N2GU ^J_A4!W-937576;*M!UHKI^WF5MK.>.+*2
M.<*T=QX:_P""M7&\+;Q')8.4P>;GP!!:4W,QXE.++A78@G<JPT%0BPS4N-F
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MD^'QL4E:9$J0$)E,Z7(1:UA\*X.#VM=S9!\K&DLJ> /.JD]Y]P[=N,Z6$.<
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M,V^ZW&6,?_2#@13_ "ZU->VJQ7&<[D<UPZ#-S4=,3+9 DOL#J$MK.TG_ %0
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MYW/<8YUL^A<[J!/_  GL-5%+K[(8['YZ"_M>ML4;V.Z01KTD$Z!O.G"M#ZU
M^XW</DW&YG&7(&'^6@9&6EB<[-ZJ4I0L$VU&EZA%EBF7<@;U'7O5L[@W"[&,
M,L;1T@5H1K3A\59T1F1R1V"Y+4VG'--)?#:-R5%PZ@W"K6U\:FUUM2ZQ\(DC
MD_\ :*IO%?=NSSUPZ*2$T::$E@IQ[=?;KW+,/JA38TEYHI4J(%)]Y*;F[8/I
M)ZVTK+MO>TN/=Y4]74X\_>OW?/VGM]PV_P!78AK''@30<.V@X*GN%<[X[SF;
MGL'E,<'$XYT;/>05I(!V_A\ZD][E7YZ@@ 'BJE9MN#9L?7>N+B>;> Y*2+C\
MCXKG?G.UV/A-PYK2$Y7'/(4A!4G0+!!%K@:Z5IW./O,4QLC^BA--%(,#N^WR
M)?';%Q-->H< OM/'.599&;R.;R2L+E\V?4B"06D@)L-I(OXU76XLF]T_4Y@(
MUY+Z+V3A8;FQ);(?,H/XM*K']I^(<NXWD,JOD&;ESFG4I:C,O25N@BY)6$*4
M0*V<3]/(1)Y=".T!5SN.WO8IW1RR@L->#BK3GXU+2W7HV_VE'^(@6)UZD??5
MKVNXQ:6GG'73AS]2H3(?;EEYD V!Q <=:\.'+12[@W"<7RC)" _O0RA/N.R
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M^<MK+(NGCBJRIIJ1QY@%<')N3 XF?EEP2Y'P^QX005'<-1:X3IIX5O[@S R
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MU'P_Y4E<0IV/O7&I OI?QKN["V.UTQNA( X:TU5#_=7=<^#N_*FB<Z&0D"E
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M;BWE#7 GY>DNZJT[Q3@HKVXY7A<+EN1X*6ATY& [LDI2CTH(]-M_34)!K?\
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MR8K/S&+AL[&5H/J*E6))'P-ZL7[:;/;TDW3Q3Q[RLGW2L[K+OCFMV]303H/
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M!1\7M_=#R1H'=YYJCL!E^\O;#CO\:*RCCJ7@]*;NE:VTN$;NESK6M_?H7_\
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MZ"U5UBLZZ2=\3. J-%+<=BH[2'K[=5^<V[>\983B\_CLC).0E)0)$(O%;2T
M=2GPUK?V7G+^TR,K7@]!!U]*U-S8:'*P,:=0' ^I6CV[QQPF$RLS)8]/Y=):
M2XA.T'<D#R-1[?&8BO[\01G^I4]ZZ.$PT-G%1H  75X;GN*X^1DI,LB/+6ZK
MV]/3[2ST_96AD\'D'1-Z2>K3DN@;MC'450]R^9=O^/YP>WF4,LRQO<"R=B%*
M/0?;4RVV)XH6Q7%2X<5SIW]<A(5$\N[B')/Q./<&D(R66E$.2)"-4-,IU-SY
MD5.,2XR7 :Q1#<TC6PGJK0\PKE[8Y_&\?R!7GT(<;D1MJK@*2%I%R.FEZF&^
M<%<92RCAA-' Z\^2J3:&5M;"YE,W[7-H"?%8Z;EW,MGICV*;:C0GGO<6E:3N
MV 6%M?A4.&SY,9;1RA_]5@UTXE=7 7<,^5E>UHZ2:CU446R3,V:J:Q :0N2X
MM5FUFR0 +;C]^M63%*(+"LKN+?>%PXHG7&:+HV?M=6G^4\5S_3MVEQ& Y=EY
M7.'XHD26[X8A[8A:C;>#TU%?-N]<A<6WS6E3QX+Z4Q<@O(QYHZ316[W$P_%D
M<A_*XT=N6U':2]L6D.-I)-O23?6I'LC.W%[:D7(/4.WP7+R=BV)]3JU:M=P.
MX^=PW+('%H"FL? 64VGE-UD$$E";Z>%=> >?.R)[=.KCXK3RMS;#&O$#@'AI
M-/0KWX3[N0>8CM.GYB8\E+CJ=%V(&IM]M>]YXJTPE)W-JTCP5>?;9C3,^3_Z
MA<:]JL'NY@8W"L"UR"<[+R\!@GYJX+I:)M<VUL*KW:VY+1MX[R!TNH=:JY<O
MB(<C%T7(!;W]RTAFYT<NY]B3PA^5C\6F/_[5)<=K874ZD)]0(-O.K(QD[;RY
M'U#N?-0!\EOAXGFV:#0<!SYJZ(6&S3T5QK&L2<K,"=S1<_$HC4))M;]E6=<Y
M?'XJW'F2-H!IJJHBQ.1W%>N>R)VI-=- /BI8UE.<X;ADZ#B7Y&#SK\9;BH82
MG<'#?T'<#KK:J9W&['[GN1<QT-*=_#17GMK W& M?(EXZ\J<35>=.39Y2QFY
MB9BYD?+/N%<T[U(<62=2;6O7Y%"TTC8.&B[[YXH6=3R !S.BV6[38F5B^,JE
M9&Z)&3=^8=2J^ZUM K[*N3;6*CAM@2*%?.^^LN+V_<V(_( !H=#^*J-=S>XH
MA,MPN.Y1")@6I$]M%BMNW2X/G7*S^?\ I#T0NU7;V;L<W9\VZ:>GD."O?M9V
MWY7F^ 0^X>5Y0RY#<W.H@>W=1;;44D%8('5/E5?V/W$O)LE]%("6D'73\E+<
MKL.PAC,L?RD$$<>7I7;=S>9GY+$1,?'2J(70K)O)5?:V 3Y>-JD.X,;%CPV2
M,U+ECVEN"?/]4$HZ0P#OK7T!6!CLXWCIIBJU]P$V)T/PKS;8]T-K]4P5K33Q
M7=BW7'97WT)-..O@OKDDI<N,E_%J++S9NZEL"ZP =*V\9EK/]]PSYN&I6OO>
M"ZGAZK-WS<=*:Z'351?$9&:^"W*:<M?TK4-I\=#IK6?-8VTO81<0D!U.'%1+
M:V9R,3S!<M<0.9%/AJOKD&!:Y!%;CN278CC;J%MO,GU':;E)/D:B]OFKBU_I
M@E3NZV];9)OFRM%>"QV4AQXJF4QP4J)(<3N*KV'4WO8U96WK^XNVU?P5+[SQ
M%ICGM;#H3RU^*Z'N+8LZVOVW$?A7IIX'K?PJ07L(EA+'<#^:AUE=RVLPEB-'
M#@?$4YKK(RV:49[614MJ.TO^$Z4!M*FE C55A:HM;VEA!(2:!P.FI_-3JXO=
MP7<  +RT@U^4#QY J!93AW'^1QO:4Z\EL+]Q+K3RSK?H-=/NKKSXZ*]9J=%Q
M+/-7N*E.@#N!! 4UA9/&<3P2H&;F_,8^(TI;2Y(!)0D ;"#^*HSG,)%;Q@A3
M/;&[;JZF+'COT]&BU9YYW@S&?7DL1BGQ#XY)"&V8Z4A*MB4@$$_;>J\ED' <
M%<=M"^@<\Z]BL'M]V[QG.N!'(Y;+2\AE3[Z8\93Y4B.0M24>A5^H /WUCMX
MZI*V)9^[@M:WF\GQS-J:'N0<GBI!0NQ*5(<;)20"+?\ AH[Y':+)&0\56Z7$
MN[^2[F!C$3N/MP^.0S[>3F.*2I#RVTD!-CY*%_NJ4V=B^\@Z:5! 7 R^X+6Q
M_I3/ KVE8[D63RO..2X;#<26X_Q7'/AK/N)%F-S"[E"E 7TZ6J(#&B"<@+4_
ML,,I%RT]E.SC563%R^,Q?+XW"\)C6XRODEY&>6P&TA)4$H(2+7*B#63J+9P
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MI=;^75:RR'7 ROVW M2$J]L.7T/AZ>MJNRVBB<\1M'SNH#IVJ.RW+K6%QX@
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M5Q]LN#-<:Y5E\I*>=G,X=P#%2$[4I(4E6Y2CXVN*D\.VFE[Z<!S4(R>_C)#
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MA89C+6.I%E$ FYM?PK6^WEA+G\BV2Z_;&?#B"MW>.0EQ]B\P"IIIS[%H[R3
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M'\P0JSK(W>RMQ _"$C^6H[A]NVMI=>>-'.K6I[>*LD;D;)9-M[APT#: 4!T
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M-?QAPY]ZA7->()QV=@Y'+XAIK)1O5&GK3N7N3JFRJFNPCC,I9N#&@DUJ*<E
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MTJ5J/$VJJ8L5E<K="YD)IIV+=AR3L</+AT[EJ:KF>$G<DRG'XBE-2XBBI14
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M'<#.L4Z33\UH['PE]CX0V8DGW:<%HS]34K.1.Z['(GIJ3-D1TO8I3:;"/LL
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M/#E1,G/C\@G2&%JAR'5F0\Z5WV)! ZW^ZM&86;;85/S4'-=>27-F_P"-65/
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M8<"$&!NV@ WLJWC>H%D\M+C+R*:)NHK0C16C]KL=:WUM<QSR:'I!:> &OO\
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MZM:.8JHMBI,SCJ9Z<1,D18>4?6\_ +JE-J4LW587TN==*O2TV=9LA >QI?\
MS4%?71?.<^\KV2Y,C'$,K^WE3O7U)>>FI0_)0E#;-RV$Z&Y_G'QKLX_%MLZD
M57.S.X)<F6AS6BG8-?6K.[']VL1C6,]Q:3&D)=QT@OHF;5%"_>'0&UO21?K7
MS5]UMKW.1R7FMU&GLJK\^W^0;;8D-:!4 ^M??*>9R<QG'G'TA4,'9&(!W)1M
M%U?'7X5Q\':260#6Z'F.2K3,;RNHLF]LC1T Z&AKP]J@&1R32E*A@$MG\3RA
MX>7WU<F"VT,S8&:0T<"0*=RT\_O"6XMOIX7$&H).HT[!K^ J<5,;Y-S1W'(D
MN0XG%VF4HB->D.+4LKN=+V TK+MK#R7'GVDSW:"G'M6JZX^GP[>MC2]P(#B*
MGC7CQ[E:Y*?4UO2GT;@X3JH^  ^^HWG]JR8V8='S5%>U05C:@D_C_%<<9U4.
M>SM4E7N[&E%?@%*%[?LJV)[)KL9\[B" 3QYT*D6UK^6WO8_+ )<X-.G(D57=
MR_$,%GW$O9-A7\-)0IAMU;*5[O%00H7JJ8)IY7&)KC3AQ*^CYK2V?$'SL;7O
M 4$S7%L,K&3..XV*RTQL]M*UMI/MJOX&VMO/^6K9L[<7%MY;F-!H!6FO)4'E
M;^.TR/FV\CW!KB2"=*U.@I30?@K@>R^'X5"PL3)R6\8VEM,5J2C^'O4$I!)(
M\[5^GZ7'T;, :Z:BJP-R.2R;G?3N<*5-&DMXGGJN6%G..9?D+&-QTYB;F,BP
MIPR/[HKVVTF_JUTL/.L%WE;*V%&AIZM> 6>QP>7R#ZR.>.DTZB3W\ZKL2S@^
MSV.RN;M[@Y#EFG'6S9"4>ZH)(0 .B4$J-5GD;AKW%S117YB;5\$0:]Q-!S-5
M1W?#&<)#,#,X"0PYF<Q-*YS33N_<VII:E.VOI902-/.N42WTK=9> RB,=Z[?
M9C <35QK,YSDC&QR))4IC(.K6EL-H2+;2"!H;WK:LH6"X8XG04]ZU,Y<>="Z
M-NA[1IR[5V^XW<W%87CJHG$\W%F/9=8:G(CC>4M%%E*.NE[@7-2_<QM[QC6P
M@-.O"@[%"MGXF]M+DNG>YS=.-3P![>U>K?Z1"DK[4<_6@DI7R'<DD6-C'9MH
M:@SF].AY*S'<5Z[UY7XE$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB_F(^N7
M_2M[Q?\ &,+_  ;$J=8K_;,\/B5#,E_N'_CD%ZD?]ZE]/?\ T.[A_P#)^)_]
M^U<'^P3]K?6?R7;_ +W#V.]0_-/^]2^GO_H=W#_Y/Q/_ +]J?V"?M;ZS^2?W
MN'L=ZA^:?]ZE]/?_ $.[A_\ )^)_]^U/[!/VM]9_)/[W#V.]0_->4G8'*Q\[
M]7?;3.1$.-Q,SW'BSHK;P <2W(G^Z@+"2H!0"A>Q/VUW[QO3:N!Y-^"X=J[J
MN6GM=\5_454$4T2B)1%YX?7XTE6$X.ZHC^%*?L/M2!_7K;M<Q-CZ^4*ERK'[
MHMKCVGL<%Y6XGDN$=R<O&PY<965B.*;E0EE.Y6Q%R4:@FPO>QK@9.^NKTUN-
M1XJM,=)F,)$+JW<6BIJ*Z?+KPKZZ=RS?L3\DI2?>V--J&RX](*M;;0=;?&K2
MVWG<9C[&-K6@/Z16@Y^*ZUM_>=XN<^:8N:TTU.@)UT%>X<5T,+F'7YF7Q$J(
MY"_)%>F20HI=!-U$  Z6(KGW^!;G93-&X]E-/BK@^W._O_!H'65Q&#0/=U4)
MXD5_:#P4TQ4=W)%1C15.L)59$E8L@G4*Z^51BWP-[CYY8HC0&G5J/1XJPL[N
M&SW;9VUU'\W5U&A!%->G3J /\*M?&\_R. >@8;-8V+(Q##:2Q*%RYH>I21;2
MJ\W;M*5S^N&1W7ZN)-5U]M;=ANK)\LFG0XCER%5C>X.>P_*941>-:_@Q6CO?
M4@"]^J;5L;>VM>,9UW3G5&NIKS6A@]T48?+:TM.A->552N<P2,EA\C@([@AB
M=&7%0ZD?W/W!^(6I#TLOBSJ)U/%6O<O?-B1(PT%&\/0L7VWPG).V>-R7'HW(
M79&'E.H?C,BZ$MK*;+"4DGKUK]W#CZW#7AH)T48V3BK:9QD<*NUXCL(5@8C#
M3N09!&/B,J??DZ;SZ0G752JYN0E;'&'5+2WD%9-QE(K/_3H.A2ESM[R/B[^1
MY!,BR9+./"$PV(<BR%VW7647 ZFU=3;FY\(W6XH7C35I/9W*D\\XY2_'D'YC
MQ]9_-1?+Y>/GF8#KL+V764EQ"G-5MK5HH>7A4ASN7BO8FFW.FO<K VYM:3&W
M#G7+0ZE*5H:+"/NQA&<;D/E,=X6<2"HA5] ?2#T-9]N;*.3:92/3IV5YJ&?<
MS[JXS"SLM"T%Y%:=+N3J<@>Q='+14/165AI;K;#O\./M4;#:03MM?3KK4XV]
MM>TMKD=;FU&HX<:U[54/W)^X%]GL7T6T3F]1(=0._:6EITHK&[6\>S.;?DJC
MN-Q<<TI(D(>"ANO?T@6KUOO>./PH#209:<A7LYCQ4'^V[;^,&.=KA%I3JK7G
MR[*T5J<GXW+P<5R6RPF8RV/4H"X'G4"P_P!R[>^?Y=:.Y<?R5TW,,,4?4&@A
M:X<FBO2_FID,A$A])-M $$) "D_LUJWL1GB]HMG'Y^7I7S_OO;37RNR5N"8S
MJ\<-  *CXJ!N\HC\0Q$)C+%W(Y62\4);:%_=<58=:BV_\),8A,YU> ]JLS[&
M[HMXI76<+*--7GCQH!X+\Q_#,KRCE1Y$^_+Q#S/M"%$;>!2MI-E$+VD_LJN\
M-'$98V2 $=0K7Q7T%N9DD<$DS28ZL(!;X+;3M3+SCL^?A)66]MG&66S#4$J5
M[:@+:Z:5^?=6'%V0C=:QM:^AK0<Z]J^>ML,OW2S/NWF4=7R]793\U;6,P4_#
M8S,)D9)S)R)KC\AHN !""M)LC[JI6UN/-O8'EH #V5]84[N#_P!L]P%" 2/$
M#1:H/\ES*WY, XXNR"XH%"#O&Y/A<:#]M?9&2QK+W&EUH_4M\%0UUO'.7#6P
M&UH[76I/MX>U17A<B;S/(<H:ST5S%,8Z4(T7'G18LE)]R_Q)KA[:MI[(5<[Y
M@5-W[<.4L6LO?E) .AK3\%5;SSMUR',<L<^5G-1\'QQUE27%J4''@+.K-D#7
MRK=S%W<Y:X$)/2PT&A[5H,VW:[8MY9&CK:&D]3OW::G@MB>6<]C\EP&$Q#$+
MV)$()]XFP2 E-K#]E;6V=E?VR=\X>2>K3@JXW=O&#*VC8HVT.E>ZFJZL'E6-
MC8<Q6#[,P-E 6&SN"K?B40+&WVU)+O#332%U:#Q"EV+^X&.LK)D8)ZZ:CI/O
MI16GQ3A6$SW;=]69C?G\V9&<^84Z+7405)M?RKYOW3=B/<#;:20AH<14>"GU
MC??W"R^HAUJ 1RXJ.<!YO(XUCD\9;C18T" 5M0 %[@TE)M8U*L_M; W!C>'G
MKH/X?:LNRH,W>R/$C &@N_BKH%IC]2W$<OR+F\KE.,@.36I$9MW(*81Z$%M.
MTV2.N@%[5G^C@M(VMB<2%(+Q@#J 4]BH/BG<OEO&FORK"9%+,,/$.LNHWA*M
M+Z&Q&GE6QYCN@-(T*YTSFP-+WC0"JV-Y7AN;\\X[&@1\I%89=;9<G%L%.[=J
M0+B^O2NQG<1'B[..<T%2-/;R7&V/EO\ R/+2V]NRK6,KV:^FBMOMP<MVIPC6
M.PTWVVB$JDDA2PIP@;B=0=3]M;6/QF+W!;-#0!)3LI[U#-YVVXMG7\LX8/(D
M=7C7@!R!''TA2AK*9+-24NM.+,W(O*;4$]"3X7MK<&HQG<'<81](S4'O[?!7
MI]I=Y66<LB^[B:' D4()U [:+)YGA.1XVU D/QVVTY"0E"7$@ ^ZYT"JB=Y:
MW$#3.X^U6NZ_Q\-H\O X&@HLER+@N;B0FI,J.MF(0EQR0R]97W!(-ZY4&Y_J
M3Y1.H\5\D;WNLD;ATL#>B$'BTT=_TT6N/<*)RG#9?'<LXJP\\EEO9F(17NW-
MM'0@?$5WX;;ZME3R6QM3/7TK7EU6U:1Q]7K7>EY+/<\X'FN2<8PTIV<PU^%0
M'MMNH'K3ZK7M\*Y1O&6DXA=0+'C/MQ>R9)N4F>XU->(/*BC_  #*\_[GL,,N
M\:;3@\&L?FV4:5=25-FVB2+7N/"I]9;FM[*9C' :BNJZN<VVV_A=&'N&O)1'
MO]':Q6-Q+*K%7NK<2 FRDA*; Z:WN;U(,UF8KB(.B '@HKM3;D]G=>4YY<T<
MCPUY*B..]S.8<:EP\GB\]*ANPU#Y8%*['^U4+"XJ*W!=D83%*XN9V$Z*Q8,;
M!CY:PL:UYYM&OL6X_&.\.=[@0&9')<E_[5&O0EOVO;2?+T* Z^=2_96!Q+K5
MS&L;UZ\J*M-[7VZL!=_41S/;":4H=/ \UU\IP[$<@RK4S(2)D!]UYO\ OUM\
M[6T@]=OA75RFR(39O,+1UTTT7/L?NYD+B9@N)7-%=36OO"V@Y'QO!8;$8IW"
M3C)26VTO'?[JE$  DG6UZI;;US>VT\D%S%V@'CST5N763=F8&EDG9S[%-L1C
M,3RGAR<9'C_W]$(4O2Q"O,J\M:CM_$RSRO7.2 7#3BI1MS.3V,'EAVH':O-3
MZD> ,\<Y6ES"QGWW'FE/9=K<IX(7<6\P!:YJSP&2QMEM:EM->6O@N5>Y.6]G
M+97<:T64["=_N0]ML/,XOC^)G-)RKI>BI"%I<WJ])]2@ 1<GQJ)9K;7G2MN7
MNI0C3CP6K:-%N\QL_B/O5_Y%S&<BP9F<IQ:(B7D&7,AR%#^$JYZ'X5UG7;.F
M.)G8NE?[:N&P.N&\NQ8+B^5XUE^.PF,7E&_EX+KC,<WU!0I0"0/*QJ887)C$
M?/2M?BJXW-MHYF$1R$@M-?57\UU\I@,>Z76<A"BRY+J27)"FP5[#TM>]JL6R
M?!EV^<6JG,C+<8 &TB?J>)&A]5=%4_9SM!QCD7-.2-<]FN8/C\%Q;T9E?\!M
M_>JR4H<5:P2-=/N-4+O6[NL:YXA&O4?557_@Y#D[*%U:?(*GM-%OU+X'VVXO
MPR_%?9:90 J$ZV\'2\3H#NN2:KC$[GR+I2'--?$J8XO#1S2M->!6!@\WY5C<
M;\FW%39A(#4A8_ F^E639WD[J&4:'C56!FVPVE@'LIU-"LW&\]PN;Q",5R!:
M$S90#*D;='5'HH55N5P5QC\B)P/D)!X]]57-N^YN@Y^H%"-%CL-VH0G(/OYE
M_P!^#N4J'$;-MH-K:UW]S;X@N88X(6@.8"#2HXK7VK+>8V[F<22'$<3W+@QG
M&>.O<RS''5NNN*B0TR68XW62'"4C7IX5Q7;@FBMV.;&T_,.?8M6;&OR-S)-,
MX@5*@7/>&N<86R^B47H\I1#(Z6\2#>NU)NN;*W6D8 -%<'V[^F-L8^D'3F.]
M1*'QO*2\9)R46%NA0B2I=P +];5BN<D+2=K3S!4XGOX(+B.(&E05]83CF5SD
MJ/$QV/+K,AT-RWUI]#;9_$2?&NOC-R/PDGFD\>_T\E7?W(L;6\M_(F:"#W5X
M@A8CF'%9?%LE(QSK94VE04U))!"T*L$D:W.NE?1^TMUQ9VU;)_%3O[_R7P3N
M?:MQB;N8!I\EI^4DC@:<JUXFBP,*)$<=<3*61L;*]E[#:.IT\16UN"[NH& Q
M#31;&S,=8Y"8LN''J -!RII[5$N/Y[&YE&1?@QWDQ,?,<@H>=00%*:.TD7ZW
MM>LN$R3+F"CO]0#_  6MNS!R6-R2P?TCP/H%?;59]OY:1/:B2&"[$EMN)5<V
M0#M)UK8S$CHK8D$UT6/:4<+[QK9FAU:TKW E3W <GR_!XD#%\8P\63QU*ENS
M0M:@XV'% GV4I!W';<_;7RYN7;EOE'%\9/F>'CS7V)MO<DEBT1%HZ?S73[J=
MYLZF/C^/=L^.3<MG<ZAY,MI<9Y*V6RD)4L60;_BJ+8K9TT,KGW)Z6Q\""%*\
MKN^%D!;Q+N6JU.X-Q3NK"Y8VQR 3,9'CM"3/CY%M22\%J4GT@CQ(-6Y;[ODM
MK:D,A=TD#B=*!0/#;$M,].]YMV?-U'@*Z^/BO0OZ>9\7"=Q\%\Y$1(<R62C-
M0E(!)9]1)))\[UUKR_N=PV$,L9U9U%VM-*T'N5>WFRHMJY=[6'Y9"T ?RT%3
MZZKW*3^%/V"N(I@OVB)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB4
M1*(E$2B)1%Y<]Z.52^-<JS:V('SK+^5E!]9)&P!9.FM4IE<2RXRDG61Q!IJM
M;-9X6$76&DZ=W(+2SE^6F<PS,W(.1G%,W++<9"23;Q_#YU<V N\9BL2^,"DQ
MZ?XO '0GQ7S5NG+W>;O#(UCNEI(&E>?<.>BL+EDS!+X3AN.XB.W&G1RVI3:4
ME(  -[FUS5:XK!W#;PW+G=32.PJW][V$^2Q;(8F_,"T^H=RJ1J%DH;R'(;@]
MRX62FWI4@W'XAK4FF@$A-6FBIHX#)63V]#3U'L' CQ5R\:A,\[;=.=S"XN39
MU:C!20+I2!?9TL;5HQVMQCCYC8GEM>-.WQ5T[0RS[VW\B[TDKJ#0<*#@JOSR
MHV%?D1'5M2'TJ=:CL)5=3Q L$IL?ZE326>;,VK3U=-*\?T74S^V[)ML8@!U$
M$<3S'BOI1D2\:8+I7'C.!*W8C+BDI!L-#8^%:,5A;VLK&$ASB*D@\UBQ./&.
ML_(KTUH0.ZE%^-XA.2DQ4+DI9+[B&"ZL:)!/76N9G@;=Y>-13X*L]Q[2Z[IA
M,@'4X-]ZV2XCVWC<:R*<C'DEQLLA"T@DE2E#56OA559G//D!A.A[=-%9VUMD
MLQ,L=Q'P(UXZZ$<SWK'<^[AXF+&RF%;1\Q)2T ;6* +V-_V5L8+ R$B8Z]^O
M<5K;MWS$UK[=H+G@$T%.\+6*#\W*F)A0W5-KR3B$69]*2.MSM\A5K,@;=6TL
MTKA6( BO>:+Y]Q4-SD+ML$3NETAH>7#7DK)YOVX_(<#A)<!Y"\@[):;R2EDA
M*FC8+4@$G4=2*A>-S+Y)I []H+@*=W#DK2SOVZM<?CVN#QYM&U-3Q/'0D^-%
M7F,F(C..)6K:A](&^_0I.G]4U)(!5U2J\VEEX\=<.,G[7 #U'_%=S)[78#BT
M2@JRD6 4#<;Q<:5MOD!)8WTJ;;BSEM/C9A$15_3S&OS"JE'#>8YK 07&\?(0
M&_>/\%0&MP#X_?7'O<+:7/S24ZO$K>^V&?98VSV2. ^8TJ0.('QJM@N)\HAY
MUIQQP1X^=<;]O<1<D"^T&VI )J 9[&O:YHB!+6]BN'$[BM[DEK7"I[PHER/M
M]R')R')JY<:9*=.U0"BVA(\O4>M=3"[F&-;TACO9^2CUWMMS[SZAQ!X]O:H@
MYQO(?-Q^&\IFA.&R;2TR(A65-J0O0H.MK&IO_=H;NU-R&$/ )X]BD,5DYS@*
MZ*J,Q@N(X)_(<7Q;$1,?&O65CXCB6U"RA8JV:UNR9$7%K$6BCBW55_\ <I\5
MG;_,WJKRK3FL4XXMQU*4H :;0$M-W*MH U))Z_&M2&/S'!M>)7S]>73KMW52
M@ X<=%W.-_,,2L@IN9*6%J2I#84=C8U_ !TO:K N<)!86+9"02\:^A6U]M+W
M^F^,--6TUY:U]7>NIRA>3.5Q<Q $K<I1FO.+.Y*&[%/4_&NAC\C.+,Q6S":G
MD*\EM[UP,D1&08ZCF#W'J"[4F8[-^7CE*6QN418W"KVZ^.@J%7^(R :Z>6-P
M UU;15CEMP7.:Z&2_P )]_HY*MLIS##<?Y_CL-E<@F!'7#"Q*6JS?NJO^(Z;
M18^-<R(>9%U47=QNW>J/J!U%*GQ'ZJ?--%YMJ3!5\\PX=T:7'!6A8Z@@@5IF
M3J-':=Q43GQ=U;R4#'&G @$A6! YSRT8N3@FO9$ M%EZ0[N]Y)4+63T36? X
MK&QY%LTU.)YTY>*LC;^;R.0A-F10- %2.?J61X*YQW!P<HQFV%2I<QHMHD@$
M%(&H";7M]U3#?<E[F)8XK0T8.GEU>U2_:FU(\-U32'J=VZC3C2E5$'LK!$E]
MAO<VP@G8ZNP!Z:?;KXU(++;UW96+6R'J)[ LLGW#M'7;X".CIYDBA[EV^0\/
MS!QN/S12RC'202V\22L?8D&VM:^W]U265V;=V@K2FG)8-S;>9E;3ZAO[N(.I
MX^Q5RZXIAT1W5(]X6_@)-UV\#;XU;-IDF3BO4**D;O$36PJ\<33G^2ZPB+9=
MD.;76UR3N/N%1O\ 8%=/NK-!/!\Q:0>W589X98@ULC2.RHHI(QV]F8C%2\C
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MU$Q220Y[EMP]=B+&U:5K:27$P;P!)42@M'.NP]PYFIIS\?<I%PCBK^2[6R\
MI+ >QS$S%O**?2IYK===OB5>-2-F)ZF&AU4N-F&_.[@O.^9'D8^2MA]M8<:?
M4PXZA!+:5H44&ZS86N+"N>+*8 N(T"V!-$_1I'K7OO\ I')=;[9=P&W$K;W9
MWW0E2% *"V&=JDJ(L0=>AK5*\DU*]=Z_$2B)1$HB41*(E$2B)1$HB41*(E$2
MB)1$HB41>3GU _IV<T[R=X>;]R\9W%PN&@\KE,/Q\9*BR7'6@S%9CD*4@[3<
MM$Z5(+/,L@B:PM)HN'=8ETTI>' 55.?]T_W"_P"UGCO^XI?]FMG_ ,@C_D/K
M6O\ V-_\P3_NG^X7_:SQW_<4O^S3_P @C_D/K3^QO_F"?]T_W"_[6>._[BE_
MV:?^01_R'UI_8W_S!6/V?_36YQVU[I< Y_.[EX/)P^'9R'EI./8B24.O(BNA
MPH0I1L"0+"]8;G-LEC<P-.HHLMOAWQR->7#0U7K_ %'%WTHB41>;7Z@HR,J/
MV[Q<6#[T.<[+3.G;PGV$[18V/6NGCK\VG40*D]U5'\_C6W\;8W"K:Z^]>3.+
M[><6[6)S7+LIDW9VUISY9]Y(*V Z+$:"YZUP,IUODZ0/W'L[5Q<]B9)+!T,?
M\K@*CAU ]@4KX9RR=GX*L@K!RHV.=).,_A_Q'D^#BA?0'J*DN#P,3XZR.#7#
MC4T^"C&WY;S;+&QF)TK9-1Y;"XBG'L[?>M@N.\GXNU@9$-_%/+G2%+;?=4TG
M>+IUL21TT->C<-M7D,>#3L*NJTEA;:F22WE:X@_N93EWJN,+/7Q6!DL4A]S+
MRERGG8#KB0@?WQZFT*LLZ)N!6YBKJ>_;</93^F 36O.O#U*KX/N'Y&3-G(PT
M#@&=+>%0/W?-VGD%U<8]G<KC(+O)?;1ESN+C+%U(1=1 %SKT KC7 \UX<14@
M_%6D[.W-Q"8AHTBO,'AXK,XS&,<?E+?S$J-%Q[R$!MY]U+8*A?0W \ZL3(S1
M7MJSS*-()[E5NS,-)@KZ0"I:\-';S)[ LGGL0ZO%3,YQR*[F%QD%8C0K.ET>
M2"*JG-XJVB<9@]H](YE?3."SSHH#%*11U*> [:E:WQ\QSOA_'UR^1P$\BDO3
M/X<=IQ0?1\PO:T#=.NR]B*CUFX3R@M((TXGO74O)7[<QTMP"TU:^E-?X2[N[
M%>7%>5Y'&9!,MHLP9<EE"8\=9((*A=0)\]!4\RV-Q=_##"2?,8"#0BFM"OE?
M;V]K[/7T\DI  (X5 U![SV+9+C^</,..3<?D7TM.*WLN.(/JL;*W 'XWJ#V^
MP[%\A> ZFHX]_@KRVQ<QL/G2.%17GX%:Q\B=QF!E.,NSFT0E/^S'E/D)W+_F
MFY%8+W&LMHZ6U>^NON5FXW>5E=2T=4<.-!\52'(.Z&+P7-.,<:@+8G17@IN8
MJ.?<5'<<O;4&QN4VZ5(<3E<DRT,#!H:<BJUW9M[$76;BO9S\@:\U+F\2?4KJ
M2XVXI24/A1;'N*7?2RKZ$C^6F1VI>VD N974%>TCAKS"[."^Y>(R&4./A:'"
MC0:!IT<:<03^BD/'^8<@XQ(!QJHZHLG3()="BHN?N%&WK5>93&-RA%'$GQ_Q
M4WR^U;>60.C #->S\E:G'^[#2HTYCDC'OW2KV4CHN_\ YO6H_>8)]G(PL[OQ
MP7&RFPHY0VA^73G^BI:8^P_/>EMM; I2RPV>B6UDG8?LZ58&-RUUCG"8:GTG
M@LN0V#92V0MFZ@@@ZCGZ%2?+L.I[FO$'O?0G&M+>D)A("E*+R +&W2QZ 5.(
M-RNW 6Q7)Z1PK^WWDJGLMLUVQ87W6.C+GG7I +_4 &]G"JV?[4H9F\B0G)10
MV-J@RRI)"5D#]T'K7&WQ@K/$6S);.3J>XT/S!W+L:M;;V_,UGXBW)6YB:TZ?
M(YE?2XZZ+83.X+C[!1F77W,4[CTD!Z.MMLK;_FJ)ZZ^%4E/->7#R'-)![05T
M[F*W>>N.M1V47:R;K>?XAD1C9RVDR8#R&YB%>M"]A 43:U[UHQV$\=S%IIU-
M[>U;0K>Q%A:00.RG!:L=M^-O<;P#4?)R')>0>?<=DR7@0I2E*-K7)/3XU]:X
MR-T5JT CAR7)LHI(@YLC0/13WKGR27X<V7+2V8I<-MZ1?=^RM.MS+(6G3UKF
M.<ZT#Y6Z\>]15K,QY*G"XHAQ8U+EK+!\K7_EK/>8>[Q])G.;T>FNGH5?X7>$
M.;+XGM<'4[!2G#M/I7.F%&"7=K2?XAW*2;*U/GI1VY;LAK(_<?S6Z_:MNR"1
M[6MU-=0/R4-1Z7$_A]))4FPL">MK"]6,^.:7'NI_J%I[>PT7SU<2O<#&ZE 3
MP X^*O'!=PG\+QI&%9CI>4^T!\Q<@)"Q_8-J^1[[$7#,LXRM=7J/$'V5"^Q?
MM)MUTN#;+,YH;T-(UIH?$*FL_D<9Q/%2)<:*J4^7[MP&%!;KKSJKV&NG7QJ:
MWN#D\ELDC7!NE#K^2D>&WY98^Y?;QO95I-=6GAZ51_,^\G*\3 D09G"58E.0
M:4W'ERY 6L7%K;6P4DVUMN%9,?'1HC!]M5&,SNNWSF1<RV>TD$5&G9RH2J*[
M7<?Q/-.;XK&9C(*P</*3 7YBMJ2%$C\-[C6^E9\W-+:P$Q_,X#2FJ_7$UZ7+
MTM[F]NV>W/&<-/X7'G9^2TZS&D0W'FS[S &KI.U)]-0G';CS>;<Z"Y81&P$U
MZ7#AIQ.B[FT8;?"71N(A\\GRG@30^H\U6&8E\@:Q[$G'X9$]UY2/F89<V*2V
M1ZBFXL;?:*G6VGFWC=+6@:![U(ONI:P96.SLBTESRX'U<^)7;SW/F> 8A')%
M0U/.QBA4.$I!3=W^:5)W)2/C>L\N:;</Z1J>/XU45L]M382,.+:1C30'\@MA
M^U7>'C/<WB#&;SD5C&/LO;7,<XI3R0M(N%)5L%Z@>[X;_(R!D( 8#V'X56>Y
MR[+CY7AP [J?%9CN1W5X'B>*3/?RGS<N2VI.-Q49LN275C\(0T-;"H?@L=>V
M=^#,W^GKK0^\T6C?S6MQ!Y8^"U6PO-('*V9T-O&Y3'OM,V>;GPULVW#J+]:O
M3%^7/\L6M?3[E%;\_3PF0#]OP7#Q;-Y3MWV\S7&L6TSEI.05)>CR7S[*&_>O
MH0DK*K?=6?)?:AUV[ZESQ4:\2/\ X5S]O_>Z$ 6TD;A6@KTBG_O_  67^CKN
M-Q*#QOD. Y%EX6)R_P"8NN&/+6&4/H4HFZ%+LE0N=-:J+?6W[@W#!$=&M Y\
MCW!3FUN&3 OY.U'I76[V<&@<][BX7D.+DQH_'<0@)GQB-P>L;J*2"$V/WU*,
M+;W4&.H=2!WK@9NK&.Z-*J,<FPG;6!&7D9>.QT.%#*'/S)"$IWK"TBUQ?[ZU
MK8W4HZ.9/>H-L/*F3<?DG]O2[TFH7#RJ$CD7'/FN'IB2\C'6AW&.M+&P@#\"
ME(L1<5EQN3N<5>!S^&G:OK?<6(M]PXTV]!J"#PYBG>K+[4]O.:\YX^K+<AC,
M8!33ACH8]U2W%J1:ZB"T!M/VU-[S[TLM)FM>VH\/_P"2^2\E]EF6KG#S'=VO
M_P#!2/*]J><XQ#SC3293#/J(C+5J!U4 =NOW5WK;[I82ZJ]K?ZE.?1_\U5!+
MS8.8Q5N90ZH!X,+O7P K^*KM\3S/-F&,I%P,5#BVV3\V%I7O3;J!8C73QJM+
MUEEDLJRXO X-+@12@'IJO> W#G[H2QVS6GI'S5:ZH[A0\?%8O"R,A(CY^9D<
M/*S<QMU:Y;"&PITIV@%-EV%A?SJVL[DL=810Q,<*.8"-1J._53_[=&ZGBG-P
M'=?F<ZZ:#15"QW.[6LOLMKG1<;(CJ4D17FBTN.JY!"CM(N#Y&H?Y4%T*N.GB
MIG!=R-E+"#2G&GQ4CA<AXOS 3L?A<K'RJPRH/*02I("Q;RJ+W6.?]0&,_:?Q
MQ5GX'<3+.RD;H:TXT/Q6=[>=O^+\7P)BR(T>3,;==>?E*%CN6K<+#X"PJR\?
M$QL+8S2NB@-U>%KI)G4H:J,9N?&1(FS=X:A)7?WU^E(2G0:_=5BP.BL;8%Q
MH%\J9<NR%]++$TN!/(=P'P4Q>[;3^X&(;B8^(PYCV4(>=<=6XV5I2 4A)0@W
MO]M4?<[FQ++]S+LDASB>+>WO*OF]L;VVQD7T5 X,;QKV#L6LO=V+DN"P,8Y
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MJ_C27U-J:2OJ"ITN>E/A:U1O"_<&":-]MY='&M#U?HI?F[*#;P9?2TZ 14<
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M%G'-(X-ZV@\*\17M5SW?W*N;.9YM[<FA.@</B%'5-QYST5,F,IF1!4IZ.%7
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MI-54_='@O!<YS]/(^,I?Q:8__N]%C6;9E+L"%JVFY^\5/-A;9R#8637#QT$
M@"H/M"R[ZWLR0OLXV'J::$D"GHUJKH[<]M.-<HQ,G*9AX?,LI4(Q;7L,9*>J
MSTW?&]:WW#WI>X:Y8RW83^W7IZEAVCLF#)69ED>"75T#CIZ!S[564UK$,29S
M&'R[.6B0G-AE(-R3X@V%M*CL&6GW%>1MN12I[*?FH+N#;,^.G> '%@IJ0??0
M TY]RZ2;NH5=5D]!:I]EV-VZ8Y(Q6@\?R46/RE7AVK;S>&?6C$PCDFE)4J2
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M"S3LMWB4V+-X[R!O^$^IA]IJ9$=.W\+K86D*(_?22G2U2*TG%S"'D<>(]A7
MNH3;REH/#@5_4?PS._THX?Q/DOI__&+#0,GZ00G^^XZ'M 0"!Z_$5 Y6=#RW
ML)"FL;NIH=VA26O"]I1$HB41>2_ZEN0R&)Y#V2R,'%O99+3F30]'9)! 4UH2
M=I%:%]-Y(#JT4FVN(G7'2^,/[*CJY+4S'P!GVTLN),9UM(&X$!83;\-[:BL.
MV&2W-\VXC<>EI!U/\I"X'W6^TD-VYEZT!E2 >CI&@!Y=*D<-K%\7C2WE9!YX
ML-DKC$A>S8"3L0 -5"KJNG375*M;3M_-0W;%G:8$.8R>1SG4^5S@6MZ:_M
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M6^'<#M?)[?<*/(<:M_DN090T'8#WMEQ2U#U6(2D$ UV=L?=FYOYW0O8*-KJ
MZII_S%03+?;C'P@R&21H.M 6T'_LK =GLC)R;D25+Q2(:IHM-Q[Q!<0 5 6
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MV-/47$ .()T-*4H:'\U^93-277G\C-<#[\I=P5=5J4--OPTJ#[9VE=P3FU8
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MD9MPJ-'#J5.-@?SD$Z6K%OK[F9.Y:V*V:6>#OT5U[#V?!'#YDM'./.GZJO\
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MW$\1 K3T+Z6PVPL>P"1\?3(>()=7WKM=S>XO.8?&4NPI2)T+%64K'/-)LII
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M2@6V<9/BLC+*YM&.<75J.P#@%F.U^*YARK/3\]S 0F<SRYQIT.M[ EIHI]*
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MZJUTM7=OOM];8=OG1L%>V@'N56;<^Z4^X?\ M9&D/_S$BGI6L_&N+2^4Y?\
M+L6VVJ=(:4ZG3:5)1:]U 'H-=:XD]P61U<?E'?\ !=G,Y5N+MW3N:33D%:N$
M[#9^;DVH6:VQL?M4XN3'=0XHD=$[2GQ^-<Z2]86Z'\>I0AGW-@EC?],PF7I-
M :TKZ*<UO9V4X-@THB\>F3),MJ D^VU(ZE(.B04@ #X6JO\ <M[/;CK:?E\5
M/]B?>JZR$0LW1ALK10BKM>_]%L3([<\5A2TRU2%0XK'\0XY:@4:>-R;FN99;
MOOGPEL6O_,5W;Z/YC<2O->SDL3S_ !.'Y1A G I:DR\8^TLJ@D A#9N4*M\*
M]XF^N);BER*5]*V\/NF6)W5 >JG*I6ODJ$XPLH+:PM)_B*5I8WO8WJ?363XV
M"2, \%9^*W)!D('QW+NEQ/ 5*S.#YSFN+R3"Q[;;K4](5(;4/P@W3?7R&M3]
MNU[7,XHS7IH6UIH'<!IQ7S=NC.''[HBM<8WK#NDGBVE2:]RR.%YSDN.C(_)1
MV!)FKW&7M-T]3;IXWJG+K 1R2=+7$AO#0+ZA_L\]W:0RRZ&FHJ#S46R&0E92
M2].F.!R5(.YQQ.EC7N&)EE\M2%)8;:-T88[1H'M72*=02HV5^]_X:R37/FBE
M:K8@!A!Z6"@X#D5^*.U)";*5X?'[Z_&ESV^6[@LT4)DG;(\4;2A[BH[*Y%&C
M96/A7F77)4MLN,[$%:; V(40"4_;6W].+:.E=%QKRYAMKMS6_-4#B%A.0IF<
M<$_DN!Q3N4F/)2)^/2Z&VRTG]X)N!N%9+;R;F,U<:CN7'N[7Z-PNX&@N.M#H
M%%^#3<KS_(HYB_E)F#AP)!B*PC*TK0L(MN]PFXOKX&OV]D?;PEK0."UK&67*
MUE#BUPTH*TT\5OC,Q_&</P:5G,/$;$QZ$I*5N@*4I1%E6!Z5&MI&2ZS,,,Q+
M6O=0\U6'W%R]W902N:YSG,!^2IZ3IP*T6A_3U ;SCG,IBDR<6OW)!PLD;[.*
M45!8/X1J?&KMW1@V6[*P/+A0=RY7VJNYKYE;^-L;BXD4^;Y>7;^/4I?,RTV!
MGL9C40W7,7*9("VV_<0A?G>Q%K56CHF,8=!5?0D[_I;KI9JPTHIJA#H;>63?
M3^ RO:@"W56@TJ0[7CACF:^?U4JJJ^YVX;Z"RDAAC%7<#U$<U$7);,1PJF!#
M+35M[SB@ ?CN.AO5]Y2ZD^D\R !H[C3EZ%_/V[L;B.0LD!\P\1Q.OKJK>[?]
MS\7QC'2HLB B2P]N6W-1M*#N)/JOX:Z6JG9]F9/*N^K?*_I.O[AX<SW*P]F;
MP;BXC9SQ@@Z FIYDZCEQ7!P+N[Q_$9O.3<E(;5B)ZEO*7!:,A23?TH*6MYU'
MPK>WGM*:;$-9:RO>X%@(J!P&O8NYMW<@L,LYU\QL<3@YS2 3Q/R\*\1X>U4C
MR;O]Q3D?<W*8J'"?BXUY]F- F.M+;475)2DA3:@%)]1OJ*KBQVS<PPLA>VA)
M(.HK0E?5.V=^PB-SW2'H ^7]QUKKIR4NDP/RSD.*Y:TY[CV.C.14P=^T+2_H
MI7CK8U96SL.V&;RW</7R5=_<+[D7443YFQAS =*N(J"X45H<?SSV9>EM/1D(
M1&;"D/)Z^JUT^>@(J?Y+#P6CFOC/S&G)139N^;[<D,K;F)K8F@Z@DU/,=)[C
MQ5:Y..F3E\D8!;2TVZ"$7VIU)!_#KU2>E=&[SUOBX(_JGEO6#R+N'^(58Q;)
MO-Q9NZ&,B8^.)XZ@2&-'4#R[RUW#TJ#]T.01,)PGD$=^$XXJ1'4RDLHW!*UZ
M;B+=+#K4/SMJ)&MN)'?(X@-].HTY*9;>S;<1?'&L@:UVI<1H*U#7<./#BM@/
MI=X%Q;B.>[:28A>=F9&9CI,B0\Z5!3CB4K-A?:D7/A6!F.,5LYPU/3JIY+<1
M1.8TG]Q--/2O?)/X1]E1!92OVB)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1%Y*B"PCNYW0D):"5*S,S=8>DDREDG[351[XR$D4G2.'
MZ+A[=MQ]=,Y_"OQ4+YT.9X^?,R^-D*8Q02 E 5HBYM>U>MKR6MS'2X +=*BM
M.7<N_F+]UA ^YC%>@\N\TYJM,;A<ORG*,^ZI<CWS=Z6M/IM?6IBS=-I96;X>
MGIT=37M'@HU9-_\ (6'J- 0>_NY4[59&,XCQ3@W(L,B0MZ9DLPI<?%(]LN-I
MVIW+6XHD[;=!]M0V?>%[>X^6W9)2.@Y#A7PJOS ;(M,'>^8UM23W]A[2>U8'
MOEBL6ZQB%*=D8QYB7[Y=@K+*W2D)(2I:/41ITZ5I;6=,26NUX\1RT6#?5U8X
M:/S"*.<:BA())K^2X<!W7<_(),:4A1FQT;(QW;E'^:2;"]9,AM4FX;,/VUXT
M[/2HIA?N.]]H]I%' <*C\E*NU*YF49S&8S#1=FKFJ]A]Y/1LH20$&PN!YUI[
MEN7Q/BC@X!@!IKK7V*0?;QUSD8;B>Z!KYII44^6@.G"H[U<!2HK%EE158) '
M2YUM4-+SU@GBK5;;.>P@+6;NUA%8]:<C(GMOKG.>['AN *4I*%IZ ^76K*V[
M?RR,$3JAI''UJB/N-CI[5CK@.T:1I3M("C/'N%9Y*H^4CXQU]:2E^.XH60D"
MQ'0ZUU[_ "4+*0N>/FI[=%SMJ; E>&W1J3Q&G#@>U6QA<USSD62:>C1VX\+'
MK]J0T!L:64?BN3N-ZYV6Q>-M;6K@W4'F1P]*NG%&[A<  =%W^><%S/+RT]&R
M#;+1V[XQ22$D>%RKS\:C6)RUICR: 4Y:_HHMOO:M[F0T>;T@T)'37F>\+2#N
MIG\KVGY1%XYF..2<FW/0A>.G1G $2"KJA/I.H.AUJR,7<07\!D80/2J]'V@N
M&.!=,*?Y2/BMK>*<RQRNT[4QYA[#S9; ]_$2=7FG%V!020":A#H9O[H -6@G
MEW*Q9[F/;&)-75T'LTYU7<[59_!M-30^KY:6\LCWG/ #H#]H-;>ZA=%S?*!Z
M=."U-I[NM\C:O<_0@G0G\<E"<SE8D;DDE6.R"$ 2@KW656!!.HN.OW5U<3"/
MIP9AK1<+&YNP=E:,>.NNFO$Z^@K8R=@XW(L; >=DRH3[:4.L28;Q0;D=;=%_
M?5=3S>5=R%H'34]ZN0T>T/50=P>(?E,:+,7FY.0><!:7\\4K=5IX%"4#^2K+
MV?EH9[=XI0@'2O>N#NR#S[%P'8?<L)QCE6,X]@I./F8[\P>6I02X[U3I?PMY
MULP[6ES&2CI)1IK44K\0JRVH(H<?,V45Z'4J5U^ 8Z?S![(+B37,/&"EE3;1
M5^\;@&Q \?*I7NZSM=M1MZ&^830:$CEWDKJ[%NQ<6[G1B@ZG>]7-E>.X-?$I
M6)R4YN666E>Y)*MKF\#I>]ZJ_#9^^BRGU+6N9'U5Y'EVT4[S]M;2X=XFI\S>
MVBTND1G6)&U)4DM+(8>((W;38*K['Q>8M,E9B1Y%*:U/<OD<B6SDZFU%#H:4
MX=BP,G \VR.=CY")E(S&#>:#,Z.]N65V4JY;3<!)MXU6.?\ [?=7-8""&FNA
M5U[9BBS=K'/,*RL)(X\:D<!0>]7#A9;^'F1)< );?AI 00+70.J?O%0_<%I;
MW-JYCZ4J%+\K?W./M_D!TIV+FYSSA_/1HT?-HC)2XK9'AR DD$:7">BC4/QV
M#M[.<F/A3E555FMUY*6U)H6UJ-0#18UCGG*8<)J#$RSD6*PDH6T$MJ21X6W(
M)38>1K+/BK69Q<YM:]Y_-1D;[RK(611REM!0FC37LXMTHH3_ $HPLS*1F9ZG
MW\DLJ*YNTAG0W%R+)TOXU/MN7618SZ.UKT'D*'NYZ^U27;OTEZ?J<D:R-YN^
M4::C]M&^L+YY85YC%/8O&9)Z"^[_ '/)1CM*+:Z'QO\  U-[+:,TY\NY-/$?
MD5V=P;_@B8(+3Y@#K0Z4\:>XK#X7'SXK$6)(DO964V@!R2X;K<(\5$WJ6RX*
MQM+(Q&@H..OYJK9&S96X<86%SG'@*G\>E9%KDS.'RL=3F!S4J3%>05I:AE*
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M2'/N5\6YQ@N+XK'X+ '*Q'L%%FL/*>$IAC:M4F;*24[7";!(-[:UO93&QVK
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MO;&EQ9S', @%RX:$:.MQ)%OPE*0HW^)JQ\?O!KHRR8>[\U"\Y]N9G7(FM7
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M$\;XB_G\;Q61\O$8R+CFYMS5HK;;W)05$[@+#[*Z^9L#*T]<;: \*+A6;HG
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M-AUO7)DS&6EI ?\ W>ST*VL?/!=CK:0?2IPW/C*@*EQWDRHS8)2\T0L*V"P
MMX:5&IL/*VY#9M*D=H75,C TGL53,]UH,C()Q4[%J;]U2O5<$"QT)23?7[*E
MESMJ)EJ)(>(&NI*B<N\K*.[;:2&KG5IJ.7M4=[K<<_,!%S\1E28A;2DN-@
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MI*E!-]!=(/6J-QUM/=7@>X@FIUJI4]P$/0P#@O-.3RC$_4;*3V_XE/=PN3Y
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MY,U!!AL0)&-W*@36FD)V!20% @ &WWU%,=DI+2Z-'D\-*U^*M;%79CN!<](
M%.78JRR_!L9Q?!R'TY%Q_.H(<A)";=#_ #;U:VQKB?+7I9*VC">8/QJM#[B;
MBDO[4NB'S-'(?D5$7.X'(.50&<3,QS*FFP4O/^HW4!8).E@?A4@W+L,V=_\
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M\2%$=^1FD/Y6*RS(9/LK#"BI-T*.IO;6K"P6WX+.(?(WJXUH*J-[LW%+D[D
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MCXK<5B->_BOE7<.X[W)3%MR.D _MI0\CSYZ*')!40E-U%1]*1XGPKI.[2HN
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MVW#>VX>=9G1SQW#6<JCM6(7D)M7/CH=#V'DH#W,>R?\ 1//2<4I2)I;6MA2
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M,<1<#V_*'?M'.BMSL:F*]W%X&N+[@:DYF.G<H"W\-U0TL!XU-]Q[U.4+(PT
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MF:U )IX'1<J;9KH";G'2>63H2!44/'1QI[%S9US(Y(?.+DNR):S=Q)2D&_\
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MU8*!LM8 UH8C;(PK!=RG0'O' UYZ<E@?.9W= 629['L3EQ8_(%19&-:4V_\
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M*^;Y44I+NRA^(71V466E\\O%7D=(\.H4U4?9G1Y3HAQIC3KS2"IQMM84L)!
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M$=@350)39,J.X4,J1?75-Z\M=;N@9Y)%=:ZU4[^X-I!:F.-@/FU-*5_X5*N
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M/6]62RZQYQY<PCJ'?W*DL-NVZANP+MWRDT-0&T]@6X7:B)%&)DOG8ZXZL;E
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M:^"M/8V#.-@)%.?MHJGP^0ROS3DQ_'(@*(2IB2VO<H@]4FX%=Z2Z?9=(!*F
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MZGH)^9M=#_@I#=.@B;0@.'85ISVVY],G2W.!\AA(QV<X^PAC:%W#A;]((_\
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M+69L3OVD]BI?[L8YTK&O:.!'MT^*AG;KMKC>:<48Y F>][4\'Y).TI%QIJ+
MU;.Y/NZ+&[-NT?*.X>^JYV*^V$%S9MG<XESA7C^04!Y#Q7)\6G.09[?HW$L/
MCHI/QZ6-6!A-^V5[:A[C0T'9^:JW<.!FQ,Y8\5;R/Y]ZL/LU,P$"?D9.8E,,
MRP@!A+]A8 FP3?J357?=7<AR=M%;V9(=U\>7#N5E_:C'VDKY))' NIPKJ/\
M%63G^Z324F/@V2%A1"I"Q8"QZ 55UK]O;JZ#7W!J:<J_DKR=?Q1-Z!H%V^9.
MY'+]OFYJ?87,1L><:6K:E0O8@$>-8L3:2X_)^2_5M/BL3I8WL/3K54K@<.K.
M9*/ #R(_O?B<7<#XC7K5IY*^;:LZFC1<V*R(X%83E_(>/\-Y$[Q%WD"/FD !
MF&A74*\ D5SL.]F4DH&$'MHM>\O3:CYG#180Y5*%!J%'+CQ4"EI'0D] +>)J
MT[+:\;&--Q(&-\>GWT5:9K?K;>;HA'6\]FHK[=5;$(\]X[QQ?*VTL1D,H!5$
M=2;A!ZWOY"H]?38'+WXQ;RYW$5:X<N\&JZL^3S=OC_KGAO2 '=)!J!^BZ>/[
MO<GE.HBY%4'V)*MJEI1;:#KJ22/ATJ,[Q^WV/PG0^T\T&HU+B6J'VWW,OKR=
MD$P8(B172A'IK\%U^2Y3@TA?Y9C,E?D<A'NRH+=P$I(]=B.EJ[,5Y' &$D&B
MO"Z_MUWCC&UX!<""0X#CW@K)]K$X_#9Z1)EY#Y=M;.U+2UA*2+^(TN?MK@?<
M_,NO\>V.-NM!R[U =O;?L<%<NG,]2[EU]O=S\37VE6AROAT'ESJLSB9J?F&D
M^VM*3="@.E5;MG=+L3$VVD:=3QIV^*LID3+GJE8X$T[50W%>%?TNY5G,=*R*
M$,X)?M30TH*4A5A9)OTZU]$7V\K? 8B&>W9U/D:": .YT5+3[2GSF6E^H?1@
M- .'*O9P4:Y=Q=[C>0D0 \)\=M5VY#>IVF]MUO*IEM;=S,O 'O\ E<>1T[%#
M=Q;+NL2\N:"^/M%33QT]JB+3KC04E%E)(U %]*F$MS&P:D#TJ("$RG0$E3+C
M_*G8+;<>:4N8U*2$% NH&V@/F*X=]817 ZXS5U>U69M'[@RXREM,!Y0% ::B
M@TJNCEN1-3I"SCTIBQP/5N2 ;GR'A6K#MN&!WG/X^*P;CW[<7;BRWT8>=-?0
MHGDX\9&,D/9HN(QCQ2RZV$E2E^X=M_Y:]Y'*6S6%G1U:<@"N/B\!*X"ZF)8*
M@ZZ'4\=5SS,!@<;C8N/Q<5+44H2@L(/_ )M0.I']>M+;<EQT&-S?Z>O+M76W
MM!;VLS'0N_J4!X]QU]?-=3&8]J$TWCXB@A"5;8R>H0#KTJ1O>VSC)H !P4-;
MYV3N6M<27./$K+/8'(PV0M4HS6B3N2$67<DVL!4?QV<\\.9<&AJ:<M.2FNY-
MEBSA9-; NT%0*N-3ST4@B/L0,>TMQG8\Y;<T!92E=.E1V\LYLE<^4UU65[>2
MDF RUG@<>)Y8RV0CA0 EW@5]XB7'E\ACR,C#$K&PB%/PSJ2#NL;>8.OW5T,G
MB1C[!T4#J2&FM>RE5'(KQVY<F+B1O]-G+QK3\=RV=YOQW!YCB0R<=:L4J/'+
MF,?;&Q)64G8ERWA<BXKY0Q^2O/[F8W.KJ._^(+Z);B8([$NC(!H>?<M6^.3)
MS,Z'$Y5(:9;2XE,V=_<V@E1T(4JP M7TK=VS8,*)XW#SND:5[^SP5.6&6OV9
M-T-PTF,'C0TX=JS_ #[MOV^@<UX]S3C+B)&1DQY*)KT=WW6E[0T&U&VE[$ZU
M4.WKZYFF>)1_$[WA6S)(&0@#GK[%^^!00 DD $:C3SJ=#^E*'#M7/CB9Y+@[
MB0J:Y/G\=BLY$P&0CO+7G)/MQ'RR5-*+B]$D^=S5D6^YK9ELUCQ4T'9R"HNY
MV7?7%_*^/1I<377@25,5\<@X+CV8Q_'HOR+C[#[C*&O2H.NI)%O+4U#&W[YY
M?+CTK\5:LF-BLH/-DU('N'>H1QKN$,=QQO'<T6ZSR2,TIE41#2EEU1T04E((
M))K7O+"6*4%W.JZ>)R-O>Q'RM:471[+YOE&8<Y*KDK\O:PZT(<68E27&T^LD
MC</$$#[JY[KES#TE;LL="JLY9S.<]W6=Q>1SKL3B\;(,-2 RXI*/;2E*CN -
MOQ$@FL3AU&JS1-^6J][?H3>9?XMRIV.X'6')J%,NI_"I);04D? BOR1>HUOK
M6-9$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B+R-_5 [F\\X:OMSQ;C/)
M).*X[S/$YIGE6&0EM<><VA<5"4O(<0H* "U6^VI%@H&/ZG.%2"*=W%<'-3/9
MTM:="#5>.'&>;<RX5)=F<-Y;FN)2W]H>E86?(@.+V&Z=RX[C9-CJ+FI(^)DF
MC@#XBJC[)',_:2/!3[_.,^H3_MW[A_\ U49;_P!DUA^B@_\ MM]0_)9?JYOY
MW>LJ[_IJ[[=[\[W_ .SN&SG>3G.9P^3Y9C(V2Q4[D.2D1I#+DA(6V\R[(4A:
M5#0A0(-:M]:0M@>0QH-#R"V;.ZE=,P%[B*CF5_2I4)4P2B)1%YW?7LAXQ. +
M0L):2]*]P'X(!J/YR@#258OV\HVX<\BM/R*TW[<M<<GMY7"YE;*9LU*'(1*1
MN0@Z$I4:U)MJ9.X8+@#^G7M[.*U]P?<.$Y0X]DE'@---?XM%U<%V.[;]O7LG
M-;ENJS&>6IU<UY>Y5[J4;#P!)J;8NU\N!K'@$TUJN9>6L$C72RN)<[50QS(*
M:4^F#+4K<2-R%]0%6UM4=R\<>-?7I!K\5FVO@H<F2WK.E?910!CEN)R/),CB
M+^UG(;7LK) W;%64D!1U T)KD.9(Z,RQGIJ. THK(LL%C+?KB>UI>VFI JKW
M[;<BQN#RBFY<G>F<P@2"DWVV.T:_;4;O\ ^\B\TFM#V^E5%DM]0WN6.*Z15K
M20:'@QQ:->"F+67G\;YI.>G0DJ1G5I4VXG^8HC81\36-MBS)X^4 4\IKG>]8
M;F]E=(8G.)#-14]JS'/^ 2^2R8V8QA'O[$I<:4;#:H"YM4<L,M'CH>DM!.FJ
ML+ YN*VM_P"H:$@>Y9+DT.3C>W3D%]]MJ1$BMMJ<\#9:=!6OB[QD]SYE-=/>
M%S+>U%U> .'4TTX]Y51\!Q61R\F1/@2BR]C@GW&@2%+!\OA5KPY:R>^-EPT'
MCQ%5K[GP!Q5TTQ\'D^RBL'F.'YGDN-)2V[[OLK4X]#2#O<0.@N/&HQE;G%_5
M_P!+33@!3FMO9\\5O<$R 4H?@M3<9QW*\7[C*YQ EOXJ<_ 5$D8W9M2NYTWC
MQ(-]:Z\D\=];>43U 5I7E53?_P ?L[V<78X.-> Y:*W,=Q'/\^EGDBI!?F8I
M):BJ<42#?U%-NGC47?FHL=6W+!KSIZ%^Y"ZM<>.A@#? 4[EL%C>2\966L9*?
M:;G8]M*'RZ$I"5MCU@$^&E1JXQ\\9)B<?FTXJ#7%I<Q!TK"2PCM]:JGN=F^-
M9%QL8Y29D_:KW9\=0+13_-41XU+=NY2[M6>0YHTH*UUT6[MC;GG7++EW#CW:
M@KH]N^$XCE$&5.GR%%#3OM^VA0MOTU4>H^RO&=RMRSY@*^M=S/[C;:3B.)@T
M'(+O=Q>$XCCD.'-QH<;4XHM%"C=.GB*TL9F'W#2UPU(6? 9YUVYPD^*J9G-2
M(V68?#ZF&8X25)3T!"=" /B*LR3 2NM(JQ@]30?'Q7Q1O;<MSCMUS]4K_*#W
M::T -> \5<:N&\@YGC&IV4R2EQ4I+\!"3<D@$)&M_/6HC?7T>*D;''&UKZ\A
M0ZJ;93;<>YK!OSNJ#U"E-30BAJ#IJM?<[$S$XX_&XN6Q!C-S?[]F-7*RRF]T
MV(ZJ(U-=?ZMMTP.EZG&FE>2VMK;+W5A;9TD/1'#4'Y'&I'>*<>^J@G</E^+X
M9B,WB,-R:5A\Q+:0&X4-]8674JN5N$= :V+&P$A!D8#WT'#L4/L;O*OR;W%S
MG:T+7$T'S:N]7!:2<@Y?R7D[B%9W-R\O[ *&7)3JG%!%[VN=;5)8+2& 4C8&
M^  5J\34\5'4A9%DDV.MKUL47ZOC;MTL!;P%%^EQ=J5](M<#ST \-:+R5:?+
M.UV1XE@,=GY<YF0QD"D-1TILH%2=W6YTM\*]4HL39:FBJLD$ @6OU%>5E7Y1
M?J41*(E$2B)1$HB41?NTC6_6E$!7R;^/[*_%^U7VD*5902E13HE1 )'V$ZBO
M;7N H#HOQ?)!!N>OG7FB+\](!4XHI2+7(_MB$C^4U[CC,AH$79)""G<7$[!L
ML-NPV)Z@IOX^=9&R]+2TM'CS7X.*]0.Q3</_ ":X-<-#*'[*3)4@ %1W'51'
MPJ4XMH9#5;<(%>"N*4\F''=D^T' $W>MIZ1J3>M\/#M"LQ [%TLA.A'%+D/A
M2H4MJQ2D;B4."UOV&OUS>K18G"JCO$\3Q[M#B,DK&9#\JQN2<^9F/.JM=5B;
M_#K7&O,392'JF:VO> O<3@P*<<(C<5[DQ\AD,9E69T=A>UR1&6#_ !#KZJA6
MZ<VS'QB.V8-330=O@L;V>9Q6%?PD_(997!FN32<1BTRR7'6"G<H  @74"*B\
M]D]]@;T1M\QHKV<?:M1L8#^FM!W*^\7QR!BL(]@V)")SH0=[CB4E2R18%0'3
M6J^R&0GFGC=-^T$5]:[3VFVA+H9' J-81IOC?#\PUG_:B1F%/7]Z^P"W7[#\
M:[.>;:W-R#: '76HIR6OMFXGOI:7)KKS_54E@><SL:^R\QD YCV3_ 96H;/;
M/\V^EK5),=MV*2,%S1U$:\%-]XXA\%NQS&M Z1P/%7+#[P<7?2VW+3[$E85\
MJD6="R$F]CX5$;_9[Q<U:X@:<U#+*]GECZ8VEM.8JNQ@.:8#-9&1%<QK4)12
M;R' FZAX@Z5[S6#N+*V$H>=!V]ZWH;Z[E<&&1Q XZE2>/QOB[DEG*1HC:W%D
MEI: =H(_M>G6N([,Y"2(1ND=T^)6@&-C!<14ZJ#]S.1/-C^CC48)3*;2LRO
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M2GH)!&OA3N[54%QCG178G@87,#@[I'*AK1;,<4Y]B.=F1B\SCT1'(Z$$!T@
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M;FYXKV)H/[J*!G$7,-L9I6%K=-3W_@*=]O\ MRWRA.7F-YA$22^M*S'6G?\
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M\E<2.?UN!:]U#KWZ@>Y7/V3EX?D7<GA61@LHR*TY:(XC,N(*D+<2NP*%*UT
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MKIVK+=MNV/,^9\AR',\(F/ X[)9^36J2%I=D*1^)2$KL4C[:^=ON!O?'NN"
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M VM)00!^]N5X>==;%;N;))YS^!U]8HN$_9YO+("U-7=( Y<Z_FMA^"\(B8[
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M^E07$;Y8V/S[:2AEY#G15DQGLG*88PJI9&,(%XA(VA-[6MUM4YL<+CWW;2X
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M<(Q^9X##M-&>AHDK#Z[V2@ ?S;5XPFXI9W1A_P"_HI[%T;-@)+6NJVO&JCG
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MP_H%"O)ONCCLIG>79'G#&$F1N'YK)*D,Y)UM0"VEN [@!>UP3UJ5XB6"&V9
MYP$C0 0.[BN;%1KZGA5;^YWA?;F7V1PLAK#Q\?\ F$1A,#*HCA,@/*'I4%)
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M9Z'"A5M8[=]H^/S X>Q0WGO<^.VPQ$P,P/N/I(?V>&@M>QTKJX7;Q8>I^@4
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MW%G'V=/E!?W?MKS5VY/'L@P/7&=0UOP582>2X;#XY+F;<$=B(OTNJ25W4KU
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M[5^XN4]&D,LR7B6]4J2LCTD#Q/W6K'N#%MRF.ZX10FA'K7YM?<,UI?-9.X]
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M;7V[ 'NT<-=!R75LMPWC;N6&[EZ6@#I-.->*B&7CY"3+<F/N.3#(_NCJKDI
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M7&EO*WV6KJME\M@?V+2R6*L]N6#H7MZO+'R\S4Z\UZ#Q'??CM*N%>D)< \"
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M7$-P28N7%?.F;P][C?+CN#6H/2 2>'^*M+C?:=<@JD9EMUME#/N@D^@FUQ8
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M+KA%RH$5\K;P@?;W32P_* />OI#'X:%\3J#M5(]W.'1\!\B8<UQM[(.%&Y(
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MY_BIB758:-.W820-"O<D7M8V(^)JS-E3Y%C QXT(XFO.BYNY,?@K,4<X]8%
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MLJ6G<I2CX'6]ZL6:"V^G_P!,5HI +B[L[9K(R1&*T')7UV]C8#C7;N*]AY;
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M;-:&=P\QE6=_#3_%7MW4YEV*F]M>18B4TP]W!:C/L00ME2G43&[A"_< VBQ
M/6JU^BRIR#2:MBJ*BHI3FMFW@Q]L/Z,;>JNE!37BMC^SN9_I7VGXCD7FVUJ?
MQ#;;[:1Z"6VMIL/C5>[BA?#D7T<35Q(]:O+$2]=BW2A#0%Y\]F^[SW;/GTS
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M?F6PR1E[*Z/IIPK^BM:3V^S,1<>/AY;BX$QM*GU7MKX@B]>+G<4-U;U?3Y:
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MT/#VTH2.7=WJ<8W&8C$\HPW)%P&94K %28JUI%PE:;7OYBO65LGYNW<7&CW
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M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%_+?]0_^EGW2_\ AAS/]_5/+/\
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MM-"M:Y4AE^2E"6T1BX20T#<GSM>OI3%V,MK#Y<DA=XKYNO;AD[S(R,-'<LY
MA24X]UJ.X5-,$AN.2;%5MW2X'C5-;KPC8KSH!H#\U/$G5=[!;8O,[ Z2-Y#&
MFE.50 >%>]8EF&XS+;+["(\N04[TZ:%6@-ZG;;.*YP;K>#4M:?BN)D,7<6L_
MTDG[M .S7@K3D<2R.&@1,D_.!A3-BTLHTN2+CQ-4;B+%N1N7P=/SL<6^KBK
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M6BDAB,[1IK[%4%SL9N:R<[W/(J1S]'9W*Q\1Q[&]O<5D-\\JD/I6IDE5]0+
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M-56N+V_%%=273@.HCW%93E' )N<S<G(LO(BM;$):;\S8^5<'%[R;;P,MSK0
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M;=Z?_!6M>Y"S<QL3""XN&JO^UVS;R6!$4 8YPU](U53Y6$AB.G8XIR3O  Z
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MJ(2Q(2=5J4HI'3^S5AXBS=:VW5*:$>ZB^;_N%="2]%LV(%SJ4/>21^-5TO\
M)?G84R"J0 8ZG$+?<";!";WOU-(\]#.#&S]QT"U(/MS>QRPN)JTN%=. &O:I
M!SK@<;C4&!RC#/!:XZTIEMVWI=W$$GR&OC4\V/OF*0.QE^W34 D\.D*4;IVR
M_;T3<C9GI>*=5!^[J.M?B>SV3/&\RXWS)B%AY.)W7(2Y'L+I\-0/ U5>5Q\]
ME*^9CZC6A"DF,W'CMTQ"&6.KN8/JX*NNXF"Q<7*(BQ<(C'1VQ_#6D;=_Q!%6
MG]MMP7-M!7J+BZA*_,OL;'Q-<(X!Z-/<JHE1)+14AMM3BB"IA*OWA>UKC[:S
M[CR[[Z8OD?6@I3L5#385\=]Y+FEK2[2O96BW2X%"9QO',<RI](D2$)68P(]/
M]J!5!9R-\MUHOK#;UI;VF/\ +8\4 X*@>X3WR/(WU%KW/F)2$^P#8[2;$G[*
ML[ 7_EV!BI\P U\%7U[NL8V\\J1_R.-**WN./=N7I$5W&O1!EL:E/S"D*VJ0
MLC4'SJ*Y._S-RUT<\A='K0*=XZWQKA]1 P!W,A63&R$*<5B*^A_9HO:1I4.=
M82P1=3C1=JWRD%S^Q0+FO%<(N!DLK\FKYPI"D*;&F[S(%2[9^9O/,Z#+_3')
M?MU:]8JHYA>=0,)PV89<I+&0QT=Y332TD?A22F_WUUMP8";)7QF@C)82-0M<
MN;!!0G4+Z[']T&.Y7$VLA.<;3F&WW69<<C:+)5Z+7ZW%1;<N%-@:1 Z4U7YC
M\DQ[*2'58;N7@DP\PWEVY23&ED)^3L 4E/4_?4UV5=&YM7QD_.&E<^Y^DB>7
ML !(U70YQDN.+QF*;QNQ$XMI4YML#:VHJ2;=V[,Z5QDJ02HO<Y;'"4-<!U>*
MH[D'&V^0K@O+R<R 8:MZ$QG"D+\@L>52RWA@M)6LE:"VO#O6]<VD5U;.\O3Y
M3[E@FTA@JB@!8:.W<.AJ[;>>-D'FM;TMI5?+][ 8I7-)K0\5W4!+:1Z@/'[*
MI?+M9F\AT1.H>WTK1))*D7'YZG<[A_FY(<@N/A#R"D=-;=!YU,I<#'B\9.*]
M4S65ZO<K VIN.\?>16LS^J(FE#1;']R%<8@\>2TB+'5.D);,6.V@>X4DV*B/
M*OFK$Y3)7]X^.2KF@J^;O;>/N6T,8U508_MY+Y# GSXX$!B.TI2'U72DE(O8
M"]C>K1M-WOV^ WHJ2>'<5#)OMGCKF,EI\MU>(KZJ<%6^,Q<M"TQ)I2E]*=\E
M;71(Z_RUYW7NV3(AK^#/Y55/_B4T^:&-C/4:@5IR(KP]B[K\F.[+C8-N0\EY
M;96VCV[I(2GQ((J+6LD,\@J>D%6+E/M'E8V,B!(93F/U"D^!YI-XAF6TQ&$.
M1?;3[L<Z*()(-C4_B^V]KE,:9^H=8ZM:+@SYB;:%\(8VU8 "1P\5.LYWHR,E
MM/Y5'5 <1_/L;'XZU2YV=!%.YDH!H:+JY?[P/GA M6%KZ<32BK;.\NSO)DM1
MLI)3(V.)*$H T4>@-KU,]IR08*[\^,4%*'PJJ_SFX<MDV-ANCU5((TX]@T60
MC\.SN-PTGDDMG;"<3^"X"CL)M?KH:G.Y=_VV0C$,1XZ<>U2C;]ED-OVC[TL(
MJ*T_RUYZ]JJ_E'.N-X= &5?3#R 3_ 83ZRXG[;"VOG4/L6B24&05:N7)'<[L
M)E#"'MX<Z\Z<E(.-26,[AF9[3XEP,BWN82-04*&H-6'DQ9LZ6Q- 5B;#Q%[9
MQ$2G3D.S51&-QF1A)>7C.;G<?(=#L!*_4 A0ML%_(UV]I9L7$ILWFH%:#P"K
MG?K3'D2[F:FJN'M5S5GB615#R#Y:P\A)3[6WT(6#>X\O&M#[@[-BR,-8(_G[
MO K9V1NA^.N>B5](B.?;4<^\56,[C\FA<JY,^_C&DIB1V@VU)TLXX;^7E:MK
M[:8"]Q=JYDY/*E1V5_-/N%E[7(7;'6]" #4C4:T_)1KLM$Y/,R^3P7)9;3./
MWNRHTP+V@IW#:"D_#0U ?N+A;NW)O'ZU/2#W&NBZ^U8K;(W+60Z,;&.IO_&/
MXO3S6PW<69B3@&\'AT-KFL 6F- =0/ _&JPVM<26-VZ63]M1\JFVY<J^TL3#
M /GH0%1$K)<UP+,G&LS9$!_(QEJ83<;2'$D ]/#K7TS%B,1N.R$K6!V@![CH
M:*J8MQY;$3,,SSTD5+336NG&G)1G)<Q;PF-CC+3$Q'6T(3(E*MZST44IL3J?
M*LK\)9V3FNNW M!%!KQY+N3[QR&59Y6/8X.XNI0Z<#[2I'VR[EXG \IAS)D9
M<O"9]I1&92G<AIP%(;*O@H$U%/N7@[K(V;7XYI< TTIXC]5O;!RK+.[D%\\-
MD)!JX]Q4P[F<UQG(<NE.(*4)M94M&BG$C2P/WCI6WL#9\F-M^NYU>>1[2 O&
M^M[&['E6DFE=2WLUY^K@JP;QDW*3H>-Q*D)E2G@A(<)"+=3<_&U6'E<@ZPL'
MS@4+6DJM\#:-O;R.*34./ZJXLIP/*<6AM.2VT)94KU%"[@J( \=:^?CO=N;O
M#&!5[:BO93DOI7$[?CQ=J6Q#IC=0D<:F@UJ54I:C\JR:=Z'HD'C\HAQL;FR^
M[M*1J+73K>NW+>N+Q$\ZBGM7JU?;%Q%NRCNU3)R.TI'MNM)<0VG:E+@W#X&Q
MK(Z[EBD:83TT6>YQ$5PW_N0'CL*H[-=YVF>1/<=X]AG,[(:66RMLCU.]"$BX
MZ6K6NIV-^:34]J-NXX!_4(#> 'Y*,8[,]Q,;,E?GG#''<?(E*?<E-+"?:9-M
MV\Z?AJ2XG<+K>V^4_BI4%SNUXLM<_4"M.SMX#CZ%[8?0%D\;E.(<K?Q<MJ5'
M$UH#VE [?X2+)('0BHY>7!GD+R:U)/K4]QULVVA;&T4  'J%%Z"UJK>2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB414YR3ZA>QO#\W/XWRGNOQCC^?Q2TMY+
M#SLBPS(84M"7$AQM2@4DI4#KX&MEEG,\=36$@]RUWW<3#1S@#XK"?YU7TV_]
MN'#?^5HW^OKW_;[C^1WJ7GZZ#^<>M/\ .J^FW_MPX;_RM&_U]/[?<?R.]2?7
M0?SCUI_G5?3;_P!N'#?^5HW^OI_;[C^1WJ3ZZ#^<>M9/"?4?V$Y)E\=@,!W>
MXKE\UEY"(F+Q<3)L.OR'W3M0VVA*B5*438 5Y=93M!)80!W+TV[A<:!X)/>K
MKK56PE$2B+ST^O/OEBNS..X*[DL8_D?S=^0&_:Z)]L"X/VWK@9S'/O6M8W@%
ML6SWQOZFT]*\T(?)D<U0[R?$1TQL7EW7'FV7PKW4I63TMII4^P^#Q<&/(>2'
M_-S"CM]G]P1WP\IT;H@14:EW?SHH5R#M>SS#-\6QK.0D-IS.8;_-#[BO:7'V
MJ<<01>P"MMJ@^:=:6,;G,-3RU4VLKC*N@?)<"C7T(T(T5D]Y/I>X@[D<1F\+
M'5B<0Q%^6R<*,+76C;L<N;]?5>HQM?<;KUYB/&I]X'Q7+R%IY726'B150B7V
MMX>]@$83\I9/L-%,>4I(]T. ^E2E6UJR88&Q-Z>K4\=5S9X6,?\ )QYK6_*_
M3SR"%CI$R/+:ER(X6M,9)U4D7.@L-?OK\?;D:U"]MN".*@F8Y_R4X"!PJ:RA
MB/@5M)0V4$. Q]4[CUT(K$Z1[@6G@OQ]NR9I#]6N%#X'BNRWWM[A)F,R8N=D
M,/1DEM6W1M6X!)"DC0BW32O$,/TH'1SU6#%X*#&%TD3B2XUU/;HNM%[M<R:Y
MS@^;KFAZ=@"DQDV TU#B2!;1236*_@9>6QB=Q-1Z"*+HV\/D.+B:U[5=O=3Z
MEN:]S!B'N.0WL QB6#\VEC<XE3J@+DW'PZ5P-N;:CQ;B[C5;$UP[@>')4+R/
MN?SCDT!O#9W/RYN-CJ4$PUK4&P#8$;;V\*[@M(FOZ^G5:SHA(*.X*?8SOEW
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MP[]%PO99*76UQT>XA)/O[DVW7%@+U3[@9B6D:<EJ9+?8;DX[ZR9^PU-12NE
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M]M[I@N^IK34@:KGS*I!<;]PH]A*#[&W\5_&_\E;>S+*6+-MD-:'J/L*J;?\
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MG._WJTZAH&T:?$ 'XJ$<ABCC,]_'S"GY@:-[!>ZEC0Z5,L/BGY.V-Y2FA_\
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MY<JSQ]M;W3KMC )36KN>O%8*ZBXEU2UV0FQ:(!!.NMSJ*TFR-#"'-J>U;VO
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MZ<K0(L#UO<UJY/-?77?SR ]@"Z&[=DLQ]B)H10M-3QK0#M6%CM)DR(R9*BZ
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MM! *[6\S:OS-V;+,D,/XHFV\A+D8A+(* FGMHJM^I?+3S(XYB8<IEN&V%RE
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MI*4I2+   6  K3_\?9_.5M_WQ_\ *%S-_JP\^#C9>[2<?6T% NH1/E(44WU
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M&,R4A*\-B' ['*3;UI(&I!Z:U-\)DKO 8YPBKU/J#X.'Z*K<CEVYC-?3S/\
MZ4?S#_.UU![#P79[F<OEMN-87!/'\M5']E]QKU IL!:_A?6N1A,>YY==R_N-
M#ZM$WYN._9&+&W<?)((-.S33NXK$<'X'E,YC'Y!M':WJ]C?8DV Z??6YD,^V
MT/3U:%>MA[>OY[)]*CYC3PH%$N7\6S7'7(YRCGN,/$H8>(&A\=!]E=G ;@?$
MUWTYH2/BH1NW"7]BYGU3RYM: GE4=@[E;G&\7Q-_A!=*F!.]@E3]PE2G G0D
M=;DUP;NYR,61;/<5+7$D55L[4M,5!CHWCIZBT$FFI/?WKY[=<QQF)DM\<G?P
M9.0=48:@-%$ W%Z;OQ[;V(3-XBGL4^Q.3M7?*PA6'S?F!XK #[#:9+ZPHMI)
MMH /[-0C$XI]Z\-=H N7NK=SL5;O<S4@:"J^L%DU\SX^^''!&6Y9#RD>JUTC
M2O60BCQTHTZG+9M'.S%@)":$@>T553\W[;XK&8B5DG,J ^P26T*2+D>1'B*L
MS9&\KJ"[9U:,J/?JJVW1LO'QVSII)^E[036GL/:J-P&6S<#)LMX,N(D/+"3&
M;)"5$'2_EUKZ1SW]HRMCUW1:6TKKWJKMNY"ZLKC_ +;YB[EV]_<K [@.\C,A
MES+1_E4.MI;"T_O:=#7S;"ZS;</;:4 !Y+M[RN,A&6F04:X4K\%!L;C6ITF
MB8Y[4&0Z$2'NFP;NA/QMI79L\S+C)3*P_,.7;^*J-X7#R7D\317I>=:<J<CX
MT5S\KXOPO%X!*,0&7)2@09*5 N#:+DZ:FN;)N#-9:YZGEPC%=*Z%7)G=DX^*
MQHQ@#Z#6FO!5QVV@QN2Y9,%3X8]])5[2Q92DMD@FQ\JT<M?RV3"Z(_-W**;
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MF46QY+QQ<P]+.2L+(\9@Y;$+Q4HN%#R22M"UI4%J&JQ8CH:Y.9E?E+@2-=H
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M%_C7G;VX!EVF-W[OP?@N3E8K>UN (#7\UT>&\<Y6.:YGD>3RJUX8[V8L#<2
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M-R\M,S+R6FU/K#;8)2V3ZE* &E9(LM=RNZ64)\%CDQEK&WJ=4#Q40[??27]
M/=7)S</V[Y3.Y;D\=&^<G0H.:?4MMC>EOW%;FDZ;E@??62;(7T(J\4'@O$5C
M9RFC#4^*V!X5] ?T\\ Y;QSFW'L;G&\[Q;(,9/$N/Y1QUH/QUA:"M!2 H7&H
MK3ER\\C2UQ%#IP6U'BX8W!PK4=ZW5KF+HI1$HB\9_P!7_P#YI=J?^,Y7^Q5^
M\E^MXKP<K\61?2=I/KZ>- A4AP^5SK#:L3B<DJ*QDW$LNQNH45G;ZOAK6-[=
M:K5N(+9^LT?5Z*J>9OA'->U&2P7+/GHRW=ZU)D-)*K+4W^%>X_O D_=6P7B)
MS'#B*K<^HA,)CH?G&@YZ:^M;2]L,CF.4<8B<BR#[34B4MU"E( LM#3A221\2
MD^-=;*Y$W]GY;A2E*>A1O;F!@P.:%[;./4YIJ":_O()]2F\#.8W*H?3B\@S,
M^2?#<Q#:KEM(N"5 =-?.L.S+:VM8I?/>&GI-*GG52K[ONO;VYMWVD9DZI&AY
M:*AK.FA)IP'>ICC<VYQ]:<S'>1'^1;]<CJ-EM2:Y.7LK?(/+"X$>/I7)MK>\
MLFQN?&[H#>--%87%6!W=ARN1#/-266U+BLED@[5H!!O;I>H%?92+;[J,%1W:
M\=?@NPVV%P]Q((^55KRG#Y#%SY.(]WY><PK^'-(ND)%M;?&MZUSSKZ(SL KQ
M IJK)VMB_I["0ND: X"@)UXE7Q X5Q].(Q@D9Q;:O;0]D$H>"6WB4BX4C[Z@
MU[N6\DFHV,U!IP[U6%U#:Q2O8^5IJXGCWJM>YV#Q6&;:>XY)#TJ0C<B$5!2!
M8>8\Z[=I=W5T09FEI&IJ**X-DCJMNB(=/0*U/.I/!:R]RCF9?;G+-1X/O9*2
MT6GXJ#<A"C92M>MDZUWH6%SP0Y23<(E?8EH%7=3> [PNIP/@>$X)A7Y[\A+R
MI;"'LD_)L4!*4W])/0"W2LV1O20(VBI)HM;#8:WQ<!E<!4@^CG4J=MY.!R?%
MY,X.6E],EM^.V\G0;P@I 'E8D5K.+FAC3H0-5U?,&3M'1QN:6Z>^JU'[=9X\
M1[@ROZ6//S$QC)B7U=]M:BD((02?*I%D";V!H9\M*>Q?*.\\*&32,:T GJU[
M.2WQXMQ+(<XPL2=CL>M$-;BPF6\@@+!M8A"@#X5#[W*1V$SOF!I314M;?;Z[
MN8HHVZ.J:N%2"#P[%A>]W%LQVRX(M_$XX9-G(I7'<CM@E32G!<J(\KGI70VS
MN8W<I;)H-5<&+V\,,UC7R@BG,GXJ@OIDYCF>T^1>S').+S?Z-YW^&]DD1RI3
M+A5H0;7L17O=>+CR31#'* YNO'M4H9=".<R =32**X?JXYWA^8<,PT;"8=]Y
M0D"2YDUM;2R@I* @GKJ5 _=7.V?AY[%SA*33MU2ZO&2\J+5'BO<N#@."9CC(
MA+3/R!<2F8DD:+%B2+>'VU,Y;4RO!XZJ#97!7-U-U-?0$CF=&JN,=PGE7)V9
M&1PT!*XS:EJ<+I"2H 7LV+CI4GM,/)+$7EIHNU=YVUL7",N!=V BJR'#>0YO
MBN?8C8J2G&R,J\U#>><1N" M0 W)5IXUP[BW#W=#M-:+9FP\6:8 XT!%0>&B
M]&,]PT]O^"_GW*\E&RL5I(+\P-A*C[QNE"1KXFU;,=DVW;U--2NC;;6BPEFV
M.+]HK3GWK1/A?9WE?=K)9R9P^$E&/BO+6I;E@A)7ZMM[_&OQK'RFJV[.T?<M
MKP53YW"9'C?(<KALL/;GX]Q463$ZV4D@W!OXVK+)+\GETX:KS/:&)R] >R?T
MT=O^6]M(O+>3S77Y4V,7?:;>"$L62565<*Z56F;W!?0W!CA&C>ZJP,96IJM+
M\IQ6;QKD,K,1,8\]@L?-VLS"LJ"D(6#8 J/B/*IJR]^HMPQQ'46U[ZT6M!D;
M<3,!D;7J&E>]>F?T]<H@<CF_,P4-N%$5M4Q)-BP2-.OB:K3=&*N)F-:T$Z\1
MP5P[ES]M/9M:U[>JATJ*K!?59QB'SN3@X<7.B._BT+#\5"@OU+.EQ\ *FWVQ
MVK+<M>W@137T+YXWON08R!CVD%W9SXK7CZ>VN4<8Y7G.+,\E_+L2E'O/0DZ!
MY1ZVN=+U*\WM&TDFZ7_N'>NICLDS+X]MP'4)T(["!P6RT[!\8Y#(2<]C8\]^
M(X517W1N4@WZ@FMK#6,.-^4+)B[$-=4E5;W>[I8_!XN+@^+\@;AYOYMF,4(1
MOV-E02J_@+ UV[N_;&RH&J[5&2R!@<!Z5.^.]E>S>,@2<QS?DD?DN5S#8F29
M,MY+:D[DW(;%_ UQHXS)5Q4F;#:1-;5P/@53W-N;]DN*JQ6)[<11(G3GPSD9
M:@M/MMI4/WE#77RKHX'+-L[FA (JH%]R-OQW^/<;<U<!6@U.AJL3R+FW'^#K
M3F'6B^_-;2E"&[ WM=-_&QJ<9;(6CX"]M#7F**B]H8O(/N_)<US0!P((XGL*
MA_#^YO<SN!F)>'XKAF,@^\R7&HRO2EM/\[=YCXU1V9FM^OK>X-"NINQX[P=+
MAU'FME_I^PK4N5RZ'W+FF%R;'NA*H+KR4)2V+G>D7Z5$LCE[JVD:;-O4TC72
MJZ=MMV##QF%HZ1Q6H_U#<M_-.3SN/8Z0B5@\7)O#6R=Y4?4+E7D-M3'$^;=P
MB68T=2M."V+>:@T&BB?!>V4KF>+R&0CY%,5,!Q+:TK&ZY6 0.NGVU^SW?EO#
M %"-R[L;BR3T5#2*^E7MV8[%X^'S!B;R>7'?@P_XGR;JCM4X22DV5H1I7G>M
MA?6U@)V?Q=G<%)/MWN/'9Z^<XDM# #1QI^BN;ZC^WQYSCN.P>#8J,O.0):4+
M#"4M?PS_ &PM5=[6O3 USKC2NNJF6Z=QV%Q.;%NM:CE14!S[CG=;MO&XTGG+
MM^/MOMJVL*(U20-JU[E$]?&IC8Y&VOW'RN(5;WVTK5ULYK&4)K16MB\[B<SC
M4SHA^:CK0/X:CM4B_P#.TZBI/MS"1W%Q_4< !1?/K<3/879$L#W-![#^2RG&
M,CQGE&6>X- +<K(.CVW(3@"D^H:DGX6K<W%-:8OJ#16BN79$%NYWG"(QD'@:
M G3BN?C/8C-]J^<*8^?BR,%R4%3Q2"%Q]JB0D#Q'J-0/'[H-U;2%C3P<K799
M]5XQX&FBV)Y-R-7 V<,M&PX"(H_GSQU4VS;18^^H-#MBZR\<]U(UP(IT@\Z]
MBM*2\BL_+ <.GFH6SSWM]R=$Z?QQ;;L2$5*?E(:*=SGXE#XFK3V+9FR@+9@>
M?'T*%;BRUM<RD:4 [EKQ.[U<<5R9XY'!S,5 2GVH>;?:LEP)ZV!L1<^52*YN
MH908V-I50CH@<R.2.E=:CFH]/S7;SN%R_CK$1E.4DL+4I]\H_A>D7"5W^RM"
M" VSOF<M=P==U<'AH&E"MFL!PS(Y&*I.#QZ41F+(]ML!"$D^0KD9++PVT@#B
M!5/[<ZXU:1HJ;B9E[$=Q^78S.(^4;B!AKW5I](2E*[^K[;5@O2VY#9(^0Y*$
M;MCR'UEN8XRYC X$@=M/R4HR&)Q/+F(3<D!V!%FM2D>@*+B4*!L"? UU)^NY
MLC4]-/R4LQ#G3M#'C7L*V8R_=+@W#F<'&5CUHD3PAN!&CQ@D@  ?BMX533=O
M75W.X1/#ASXE2Z6MD '#IKPKHLJSS+!95V0\A?RA N@ND:W'2U:MWM*^9*&D
M@^ 4]PVXH'0>7(X<.WN6J/$T([Q=PN;\*SS;>/QN,6ZAV0E2D/.L;@$E*;VU
M"NM3&[$F%MV.;5W@%2N:V5C9LN+I[222#^X\O8MD&\5C^RW&,=Q[B"BK'AQ0
M88?<]Q25*!*E$]>M<6VM1G+@27#3T:\-*>*D-Q$S'-:R(]75J -:+LX[*<B;
MX^](Y<I&0D//+5&9B-]6%VV!2?,:ZUSV8BVO<C]/;N#&"FKCIQH=59,UV,3B
M2^:,O)#M -?VU5"\KD\@9AYG),ID8V&['=,6#+*DJ"4HV^E!Z7.HM5A_VNVL
M+CR1(R0QG]S3VZ\?31?'LK\ID,F;N'JBAD(HQ]00 .D_+RU!.A':J?[(?FB.
M*2$YY4IF6[-6Y:8HW4E:4[0DDZBIA9$N!+G4:.9X<%;N-LW] :XU/9SX!321
MR#,P^9L<=5QY]G$R&/<3FEI(;W!.Y* >GA:M>RSC7O?&)&G31=.7&2PZF)S>
M\C3\!9S*YF?B<IQ6<YR6?CL9'S4!J7!0\H,EA3R4KW) L  ;FN5EL?$^-S]"
MXK''<ESNB1X5M\[ACFO(\+ X7D68DDR0K*SUH]U+K/5:0;Z7 TJ,X.\N<7$Y
M[M/W<1Z5M31V[_W:^E94]M<Q R\),!]"PV??$DBPNE2;#[S7BZWI#/9S"7BX
M#L'-?MIC6]?4W]JA/>^'R7ED%W@?)#&C8B6AF4W+A[BXM:2H65?R(K6V)%9^
M<^=M>KI=Q/@5^7[C&X!7IV)[5XC$Y+MUME/NKA/0TH6X=;("0!_)69NYI9[[
MR7F@J*#Q1\-&-<%[ #H/LJQ5@7[1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB415GWI_ZG.[/^)N>_P>_6>V_U6?YA[UAN?])W@?<OYU/H:_TK>SO_
M !C-_P &RZF>5_VS_#XA1+&_[AGXY%?T[U!5,THB41>+W<SMQGLYS/FLQ>V&
MAW/9!:&=W[B9#FU9^"AK4!RN8AAN^F@ZJT4'W3M2XR[#0D &OL5%\-F]OWI.
M6BYTC*1XRW(<E!%]KJ;A5NAM6IDA>R,#H12M"% L';8S;U[6^-2*\:5&E-%7
M2CRF/S_)-8C'Q8G;UIU2,>D@!XQ=H]L@];[^OV5)+)[&0M=(:NYU[5O7MSC+
M>[\ZV93OH*4]_%7=VWR\Y',&(40)"72XF0X2?P)3KI]M<+=TC+BT)X"GO(6_
MMC>EY=9<6D3&]-3KSHT'XJ].7<V9XQ(:CB(9,B0T5H4/"VG6HOMC; R,;GO?
M2A(I6G !6WF;UUO'7IUIV+6CDO,LL\ZMAF:ZEN5=<E"2?2%@$)'W&K/VELF"
M]ZC*0.D"FH',KYTW5NBXED,4;R.WT@*,1,WDH:DN1Y3@4PK<T5$G:2+&VNEZ
MTLGB8&7#H* @$CU%1*RS][9Z,D.IKJ258G&.5\QRLF9 Q[OS9+)7)7ZKMIN+
MF]SK7G<>Q8,9&R5W,T'#LJIMM_=&7OY#$*$4U.NFOI6<X[P5KE#\O)2\@Y$D
M,+4E7MN645VMJ>H^ZHU-</MF,90=#AIIV*3-V1];<"XE>YKNYU/;Q'HHHQRW
M@2N-LIE*G)3)=6;LK6"2G4[K];FLF)S/UKBUPT'=V*)[DV8,<TRLDH:\W>//
MC54QE.0XK!>U^;9#Y9,UQ11[BE$$I OY]-*D@:Y[2&#0*'V=I>Y5W0PEU.-2
M:#O/J6R7!.Y#6,XT(0A+=?9($<I!7<%(L;"H)FMNFZG#NJ@/?3FK:VAO5^*L
MG0%GS1GIT!/  <E$>9\CSW*F8K\Z$IB/'WJ""DA2;7%R#T'6NQC;*&R/2U]3
MXJ);PRE_FH&3/B+6 D\"#IIK[57R7UL,(;9DN)"R2XTE1"1KY#]M3"YNHY[9
MK'M'4T4!HH,+B5D;6LD< :U%30:KN>_.QDEF18I<1ZF'5B]B1J4DZBN,SHE8
M0>"Z=OD,CB75#CKVU(4EEXWEG)<<C,RDJ<@M@E#BRH)MHDD W\JYL5Q:V<GE
MM_<>Q=PXK-;@B%PX58-1Q \::]BM;M!D$X7%9.') ]IAPNJ?3N5IX"Y\JXF[
M,09^F5NAH..BM78$UUBX#%=CY033B=*=ZJWN3R![D^84UBY;C+29 0=XW-J2
M2!HF_4?97;P-H;:,.F ]'%0/=>>L,MDFQ$R>6' &E*&M!PKR/<KK[7HQ$N*B
M(YCFF\AC -LG;^+3J2:UMUWTN/C#XY"6R:@5K[%<.W\!9MA86-^1H%*\:4YJ
M-]X<S$?/Y.E31,8!Q"TD;BH:UI;8MWRCSW"G%0?[H9"RD@\AI'4*$<*Z*+=I
ML)'S64DB6VER(UL)2L73OLKP^\5L;ENS!$*<351?[5V[Y;F32H^7UZK'NRL*
MOG4[CB)J-^/F)1-:5H&P;*M<^8J<X9]R_#GZ>.KCS(UX*YLE+;V\S6W#J</>
MK![D3L'Q\8:7@F8PR3&YL/1]J3L<%[J*=?"JZQ&(OF/D%V" X<Z^RJB^^]TP
MXR%AM0"XF@]7<J"GY7(9%2U2GR]N5NNHE5K^5R;5.,4SZ61AC/33T*A,IGKK
M(G^L:K#,*7O6%G2]7=OJTFN;1@CY:^.BY3P*:+YF<IQW#U0\WD4/&"S);1*4
MVG\*5JM>X\+515Q8RR-=&10TYKN[9@=)>QN:31NIIZ5N! YIPGE'Y9C5(!3+
M90[#]P6%CI>_2J]O<=>6]9&@4"^B7Y[&7$C+&5QZB :>Q2#*<3Q4*,[D<:V8
MLF$DN-*:)LJPKC6^2GFE$4M"':+IWNVK>U@=-;U!8*K7S_*)GI6>9E/K3:,I
M2$!(.X)3YZ_#RJ>28:+Z?H[O0J,BWU>SWXZZ=()'.NG;ZNQ7;@>X/%,RTK(2
M/::R,-O:MY: '-OD"=;&HGD<3=P@1-_:3HKBP>_K/*Q'K=3H%3RX>*YQW/XM
M)00%K=;.GX;@BEOLB^N.! ([UTK#>MC>O_I$EI[ H#W2D8"3QN#)Q6+=6N6Z
M$,.QF?2WXW6 /.I9M3&20WC;>:0:GM]"Y&_\);7U@Z1C34"HH.?%4;B7&4^]
M[RMJ2W[A4!>VTZ_'QJX<_AF8H4&H5(;)S,..FE,PJWIKPKP/ZJ11Y-MBT.[V
ME$;3?J!4)\ICP7#BOI+ 7V-R=@Z9C01X#L5SQN7<;E<3D09#:4R66U-H: LH
MKZ C[ZKV+'7#,DV4_MJ%&<?G\?-U0B@H2.'>LEV[/'H.'=F+?0)BSLE*=(!/
MD #\*S;KFR$]P/+!#!7A52^._M+"W)T%51G)XO'YW-ROY)DQ)LE*'W18 I4H
M#PJ08N.[GLG-8"9 ":<>2^?<SE(9<["_BWK;KZ=%9/->,<4P&(Q\C"QV8ZD;
M6][2MPVJ%K$7K'M"69TTGU3.DBG$$>]7S=V5E>$/DH1Z%6D"3&:R+"7%HO'V
MN+;OZMM_*I;?%CX7!E.*CUUD;6QD#8G4:K:YK@T\NQ,/)8-D EH)*&Q:ZAX*
MMX5RK?$RLA$[34]GY+!NO:O_ )!C6W%H:N/?V=M.2A/'.$Y/C&2A9W.H:9Q2
MECWD))4H*OH2"!:NSE]X07F*-E&WIG%!PIPXJ$[2PE_M^X\R[IY1XBI.O;0@
M+)=Y)F%R+&(=Q3C9*G%!TM6! VFU[?&N3]MIH,9(Z6[^:M1V\:=J\?<^>RN8
M(Y[:E>H#2G8XJA,GSF)QE["Q)T23)7E"4AZ.C>E"P2 5>0J4;ANV7,KVV^@'
MHXA>L7G6/Q8=U4DZ3W<"0I-"E2YV4;W2$H;? :8CC0%;BK#6N#97)MVE[G&@
M[2OS8.Z)KB]=!.>KC3G[5)^=]MN1P(&-R1SRL4PR][CS,< ^Z DG:;UHQ[UB
MN7>5"WUA3G=]Y-BK<NK3V\JJ!.///K_B*6][8"03J;"O3V]?SB@*^;,C?2Y"
M8R.J>SN"X' VI!3^)*OQ)/B*\L>X.J5SVD@KKM24%TPVPI2D ;4@7 OT _97
MJ5O4[J69T;W@$ZKNEMV,]&6L;0H[C_.!3KT\ZD6.VY+D65@.M%M-MY+7HE>*
M"H5D<AE9OCV'Q60PG(FVX>5)^?QB""0V4GU? UPL%M*3*WDMN]E"P U->:MW
M,.O;"R-S;S?+(*4KPTXCO5<O9.5.DM+?DJ<4E%FE;MNOF3<=:N6; VN!P\GE
M %^E>>M:*KKO.7]WTE\A!:*"AZ?2=>*DL=:S&8$AN[B00X5&_B0"?NJM;"2Z
M:?-CU!/>KQV8!+BP;S4Z\=?#CW*R\'F^(N\2R.)D);&5;*@E/MZDD#HJU<._
MN<N,FV3J(82:BI[%+(L=93P?*!3T*MI;:GX[C;+FST;$!6MC:PJ6Q@L(G8!U
M4Y]J\7N%M9R*@4 HK-QW ^'2N&-9&<^RUDXD5:I;^Y*0I:$D]#7!F^Y^7@OQ
M YM=0.!7/GV'C7Q%S8VUIV!:Q<:Y)E<WBRZ_.=#:9+S</:X2T4-N*2"E))!T
M%7KMJ2VR< GDB:'\ST@&OO5&YN2[Q-X6QR/#16FI([.'!3.)G%Q?2Z-CP-V'
MTBZ0K3:3UM8UQLAMTR=88ZA(-!6BE>V]]15#;P 'MIIQ'J]RFT[F^1RP*964
M2ZW[:$J0A5@2GX57MKLF>PN73R-+B37MY45C'=MA(W^G(/00JFSDMAY,YYQ0
M9CJ;4A;MP!8W%P?C5V6$!M[8-=I45\*A4)F[X7]^9(Q76@[Z$ZJ/<3Q<+&8A
MB+&7[L<)WA9-R5+-U:_;6UC[6.T9QT*UL]DIKR?J>*$<O4/@K<XOW&SG$HDJ
M#CG4+:D*);2X22VHBWIUT%ATM49W+L/';@D;++HX"FE.VJ[&!WI?8B%T,?S,
M)KK732FG=IP4/R<U[+Y&1DYB N3.7<H %E*/V^==NUQD.,L#;#]E':_YJU7$
MR%_-E+GK(^9U  /4LZC%I?A(W[FI"MI*DFVT7Z6U'32JOCN/[5?&2#5M3[J?
M%6/A/MQ%<VG7<$B0@'0\.[F%WA&3"C/HB62[M)3XW7;0FL%YF)[Z6K@K&QN
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M,9 :SKH1ZWD@?C*O*^E2B#+M,;8F:"B]8#?ART_D2.UK3\=RUA[<\MY["$C
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MQW"X&6X3,Y/-C9YV0C*O&5"@*L/9; )]!-S:LV3MFRQ4/-3O.Y&\L+0N#C4
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MCUS9DN5C,661,<*WT1T*4-Y-R5$"UZ[S)1:1^6]W#M[E\PY2]NLW<&;RR3W
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MH#ST4_Q>WYQC9G. <[^'N%%*DS(\9*9#TAMH)(+#BE62D_N_;5U7ABDMW=7
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M+./Q6-CEY<<@I^92I7I]'AH:Z3<*^6%S2>/>KQ^W$4N*B!N&-#NX=]?6I?\
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M5QOZ18Z5E59IQUV1D9*I 1(20IK>2=E=FVOVB,-C-6@4"B>=W7E+=HMY?ED
M^8Z\:J7<9Y/(PF5C3$L(62Y9S9H2%::UQ\A:"Y!ZBN%@MRR6MRUP:*N.I&G$
MJ1=R>1*Y$PF6F%9V&C^ VV?7]ECU%=C9^(ACGJ1\IXJU\_8LW%:-KH]@K7O*
MJ_Y*6F.B1(4I48I2$LJ-]BR#U'ATJYK_ '3:8QH9;L!>1V*L-R8:^Q\# ]Q,
M6@X\#0\E8G$T3\ UC,Z_ $B*IQ3D99 Z!1&A\*IW)AF9N)Q.>ASF@"FFOI5C
M_;_#Q/LHIWM'4"2-.\_!<_-<XYG)$K)IC)BM)3UZ)"?-1KN[/M?[>6Q%_4!I
MJ>P*:[JGD=9.;&-:*GVEN/ H:DJ4TX-4@W!!ZU]!2^5';F8@5:*^I?,?]QN(
MXS'U'I-:CQXJ0+:5+Q18;_NC)2@^1L01K]@JK<)G8SE'R.X%Q]RF%G=S9?&?
M3,%#& /4:_!=/$%+DE"7$A02DDI5^S4??4IWY9-N+02#C4?%<';>,;>7OEO'
M(_E\5F'9.2Q+ZORB:]"1+_$VRJUR#H/LUJ'[<QN.@@,]ZP.'>.JB[>=QUSMR
M<&UD<T2Z4![/\=.Q8\RG)&49AYB8M4U])6 M>]:DZZ@ZVZ5$<K#8W=P76>C*
M\A1<2+&W-Y>,;>.=1W,FI\.=%<7;_C'&9D3D;$AEJ*Y.3=3I("@0.H\JBF5N
M+G$RL>!U-!'%?09VIB8; @T!+>P=BP:ILG!-OXF)E'I,=LE"5E=[B_[*Z3;9
M]]<&]\IOSZT4:P=EY<7T[I'%G"I/)5;G82_G$)4TAV*M27=3=7NBY)JU]E;:
MC+7/N&BNM.Y5_O3;\&'E#X)"0_B*\U8_;/(8?'9GW<VVD;@!%4KH +WM_)59
M?<['/9*YC*D+']O<A965XYT]*FE*^VBN3D/*N*9C+8G'./H>B;E)=3<!0W"P
M%ZJJ&RN8X2YH.BN#)[MQ5S(V'J;4\EE\PSQ; <;E18;+"W'6%(9 LI1W^=><
M)->G)0R/)HUX)7;D@Q<%G0!M7U;P'-:OQN&9K+NJ&.A&5%2M*?<'XD(/6]QU
M%?74N^;*W@ >ZKG!4;-]O;Q]V1!3RB=#74#U>I;'\EXK"Q/ 71!Q@?R,6.E;
M8M96_2X4:^6W[M-UDW$'^(@>M7Y9X*VQ-GUN J!\%K5A)D_%\SQ'(G<BE&/A
M,[%8A-U!3QZ[B/*IME[I]U:= XT59.WW!!>B0.!;7AWJP^><@:Y0MA;T;V4Q
M$EQ;B/Q?9]]:VUL)2)SG<=5V=PXJ/<D397#I UJ.*I+'Y*3F#.FO8Q_&PV7B
MU'+P 4ZH:72/+2]9_);$[RZ_,J5W#BF6TSG-)Z>&O;^-5)N/-1I.5B(F7,(.
M?Q["X^PU@O+VXMHSY;R#XK2P$+'7C#**M![*A;9XOC?%L'#?SC#8?:]G>2L;
M@ ? "H')N"^GDZ ]P(/:OJV&6R98=;FB@[NY:G<[F?FK_(ACVA[>484U$1;;
M:Z+)/[2:GEC+-/TB1YXZZKYZ.X.C.NF _IO+1Z* >^JK#L:QRJ?A8^"<0Y%R
M$&0IF.HE39( %U$C4ZZ"LF4=#"[S'\/6F2M)K[)MBQKZ%S>K0].O.M/4K]Y=
MP7D&%E_-3I*<@9C=Q**O4!;\)N+:5W+;>]H,;]+%H37@.U>]T[+RT4WFS'S!
M0:DZ\/#W*#XB4TQ/BN+;2^$.$*L;@WT  ^%1N>!TD+@#2JB6&F;;W;.IM=5L
MNS.A<\A-\=C-I@.0VP7'% $:>51N"TDPCOJ)0373MXZKZFM[>WO;-@>T5!!X
M=RUYY?@QA.2O8M$H/A0:]UY Z*.@MK\*^G]GYQEQ@Q.ZFC3Q\2J%WC:6\>=Z
M XM!+:D<N T_&G>L8]S")VW2UGQDG425/B-9P;TJ*B!M5:QZV\:J3=5V[-3&
M,@"(>\$\EN64,D-P)\9*^2=NA#M?E'[N]<N11R#N!R5G,+6N1E'H@91$&B$M
M$I4"/'R\*ZVP,G#@G2>:X]%/BL&:S-[NFY;;.C#9&]_;3C_@N[(P&<XYDHL'
M),N,N+05>TI5T*2/%.NFI'A5E2;@Q.7MI/)(ZJ]E#59<%C,O8Y%D$@/1KSJV
M@'+LU[@K0XMSC(X5Z)%><+F+2I0<9MJ ?C5%;DVS!D6];OE=7B.Y7V,PVWC
M=P46[I\A1R*=&D1V0W%BDH2= 3<6"C;XU9WVIQ#,; X/=4D"E?2JF^Z$YNH8
MI(_V@FOLHJWPLQ>/Q;IFR_FY)D*"&0-4H).U-OLUO7?R6#GR%_T.-!3JKW56
MIAMR6N.PP/%_413FL2C)(>R3Z/4W(;4'"X!9*? 6)J8FS!MG6HU(%/6JUNKR
M=\WU8/2XFHIRHLKDN<Q,3"=:GSF$-E%F("B0IYQ6B;)UOK7SYF]O26]Z7/!X
MFA[EWK/)Y')-/FD.8T:M//T<Z+D 6JY4PE"W0/0K3;<"O>W-QRXJ0-:?D)U]
M8JH5,QPD+2*&O!1J)A,;A,W-Y0&6VILECVGG%^D) 4+JOX7T_94[9E\9D[US
M'$M<X\:=@[?0I9A=VW>/;Y+!U#L-5GGYQGH:?(;#21=*VU;MYN>AJP<3C&V;
M"R-_577T+7S^X),HX!T893UUU_-2V-V_Y#D>//<G:;;^10@NMME7K4@$I4;'
M0=*C63WQC[*^;B7G^HXAO#^85^*V;+9M_<6AN6 =-*@<S0_BGP4>B38HAR84
MI"G&U$H5=.X _A4-+]+5ZS6V!<F.6(#]H_Q4AVCNJ+#P2VMV#4NJ.=-*4]%%
M66;XQ%D0XJ62X&X3Z7_8"RH*;!NI/[*DLUBTPM:#^TU44L,R^*:1U!\[2WAP
MJIYB)34=^,VRKVT(40\PG1/J'ETK3SV-9-:%K0*@#WA;>W<K<6^19(YYZ234
M5-.!Y+@R64X9RYYWC$_(H=7%*ESH1<V)4M)Z$FU[7&E5+D;)O3T5H5]#V%X;
MN+K(X?!6UE^;0<[Q5OMV_C6UXYR.B*I2?PJ90@6Z? "M.S^VT09]>Z4U_=Q'
M+11U^]Q=79QI9W5Y:CJ6_P#] F+@83AW+,;BV1'A-Y!*DM#77VTZUGN9*T96
MH:*>I2BPM6P-/2*57H%6JMY*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%I_
M]5WU><5^F;%8Z$<:>5=P.1,J?P7%DN^PVW&2HH,N8Z$J*&MP*4 )*G% @6 4
MI/1Q^.==$FM&CB?@%H7U^VV%.+CR7EM_WHGU%?F0F?DW"A""B3B/RZ7[122-
M-_SONW %K[ONKO?V*WI2KO6/R7$_O4]> ]7ZKU)^D_ZN^,?4SB<E#.,_HKW
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MN#AG9$*$<ECF29,%:-JQ[K&J;6UO<5;M]=8BTL1+,1UN':5W[&PW-E;BD%1
M>X</>OWMTYG<S-BQ\U';X^I1+;I>-U* -B0-+:I-0O+[=GBLQ?6X\QI<-!R'
M'XK6VSMFWL<\Z.]E ?TDT/$EQ_0J[L?DL3Q#(S'Y[R7H3"56F)U(N-;#RJ+[
MCM9\GCF2!A;H=.U?0^#=:8VZ<X $:47-W)[8\7[N\3D/(AM#)9"$ES$990U3
M<;D'3XU7.%SDF.E\J76AIX<E8U]C([R$2MH*BJJ*!"7Q#"XK#NDRW\>RB,I1
MTNI U/\ )7TGM/&-RD?47"B^8]\9[^P24Z>JI\.TKX,X3GF4C&)D*8U.\!13
M?R41I]]2YVU;:V8X22"KN'H4%MM]WM[,T6\!<!^X ]O?P]?%71P?C\AX1\O.
MVB.DG?&)&@Z6\M*^?M^Y>WLW&WA%2>?K5_[(VT;^$7>0CZ::T/*FO)3=_A^%
MY.^XO'NLQ9C6CSC21=0\ 2.M0K;NY9L-42 ]+J:J19SZ&Z#1;.!Z:\%K_E>*
M2<3G9T3))2M+;RU)2%$[@572?#P\*^HK+><$V-8;/1U!7U:KYHL=B23Y2>6]
M'4PN?0:ZU.GLY*;Q&>)M\*RC.<EQX43VG$R@I6Q24F_3[:H/-NOKW+"6A-7"
MI5^[8Q.)M<8Z,Q@$-/O4#XQW#P/%Q$3BIC4QAU'M0X07J\!^$ JM4JS>WCD+
M=@+Z&@J*+0Q.X(<-<.%*-)T"B?+N?\R1FI'),OB6XG%4,H3\NP4NO-*"M56T
MO>M:VVV;&WIUUHN#OZZO<R6FT^45%32NE#5;-\)XM,R_%HF8*U,C(LF0PR\C
M8X=PTNGPO7BRW_:8YWTW35U:<5BP6+N+*SJZ3J>1KI3FJ8SN9R4;)2<9.BI+
ML5:@E)58V&@(T/E5YC!MS-G'+"_H+@T\*\16GM5;9;[AW>.NW0RQ]30>VFE:
M5X%0SBC?;SDO<W*-\^FIB06\,TYB8;\CVFUJ+JPZ5!)Z[0+55'W'L;S&21MA
M?776@[@K#VOFK7+P]?06@U!KXT5&N]M>(<@[N\NQ_%'4/\4PQ2[!CLE*_<Z)
M4@%6EA>]<FQO)1:M=-QYJ.[PS5Q9N,&//4ZE12AX$"FO=JK YWV12O@,Z5 Q
M$B/,QZF505-J*U*;"@A0M<CHH_LK1MMUQ"Y$;I 1V+2VCB=PR R3QN&NE:<*
MBO"J[_+N!<4PW!4G,X9O$MH@(7%EK;LL.[; J4.IW$=:[\V>LKC2!P+N8':K
M/9@+AM#("*\"K"X)]/?&N$XZ)R]O-OKG2\8T93[B@(I2_L5>US:Q^-0N;>4\
M=SY;(R2!R\5.V;3A;9]9D!/Z+:/@?;US$<PX5F43TS4'+PU7:%QL4H=#XBU=
M2QW7#/>.B+>E^GM5>LQCX3U@U!7L8G\*?L%3!%]41*(E$2B)1$HB41*(E$2B
M)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41>'?ZL&=EO\ /^T_&5*5\CC./S<FTB_I]V=*#*S;SVQ$
MU*=OL'0]W?3U?XJ-YQQZVM[OQ[E.?I,^@/M-S[LWQWN+W07D\WFN;L.S,?CX
M4Q4.- B>ZMMC;[0"G'5)1O45*VBX3M])4K%D,O+'*61T 'M62QQ<<D0>^I)6
MBO?SMH_](_U(0H'%<K)GQ.,RL5RKAV0DE(DED.!U"'BV$I*D.LK02  H"]A>
MU=6TG^MMZN'&H*YMU#])/1IX4(4 YIRKNK]57=^5E1CIW*N8<JDEG!<;@A;R
M(<1*B6HK -DMLLI-U*-A^)Q9N5&LT4<5G%2M .)6&1\EU+7B3R7K#]-'Z;G&
MN(#'<P[[F/S#DZ=C\3@K*M^(A+_$!+5I\XXG2Z=&@;BSHLJH_?9MS_EBT';S
M_3W^"[MGB&L^:74]G+]?<O5%"$-(0VVA+;;:0EMM( 2E(%@ !T K@+MKZHB\
M;>]G;6''Y!S;*-2TQW%YF=,?1M"0I:W%J'V]=:KS(9]IO/IVM)<#0J"[_P!K
M175H9R\ BKAZ J:X#V_1RER1)F25,M1M$-)MM<!&A)Z]36KF<R;$!G2=?S5>
M;'V(,L2^<'HKIV$4J#4+*2&$]O>30',@W\PTVZ2TAHW.P@ZV)\*ZD=VW)VIC
MA:>K7W44VO;RSVC,QE.JI&C>5?'P5C<J[B8R7@2SAINV?((( /J0/$&N1@-E
MW$-QYEP#2O9XJ<1[I9D6-9$X-)Y'BJ">R^1P^29S$.0E,U3?MJW"Y-R5%76I
M!D;*"4^50](]ZI+=UW)B\D+JW<.HMZ2/222N!.;DYR<Z<HOW9$TAM+P%AZM+
M&Y^ZO3G&R@,<?[0#^:U;3>UQ?@VUW0B3Y104_=H:ZK;CC.#@QN+Q(3C2'$/L
M)]P&UAIU_9529&_N&W?F-->/HU5^X3#6+,<UG2-0/<%K!W*XOCL'EUNXN4%Q
MI2@51QKL7U/]2OHC9/W#,=JV&9A)%344'/@OGS?6"@Q\_F0D4<:$=]*U5=)_
MAH0MQU"?=<*64D^I2K7( ^ %;>\=Q19@Q>4TCH!K7OI^2@WTY=&9!2@H*<UD
M$2'899R$<*2&E)0O;U.P D].GQKCX;"2Y<F,.  [>[_%=?'-GB+;R$'I80".
M9Z:$^@J4)S<C,,H=D/J? NA*7#?4&UOY*Z5QM06LM.FH'8KKM;R#.VS9Y!1H
MJ:'CQI\%+,GVTEXO -<EQTI3[\A+:W((%TD.Z^?@*X5S]QV7+38=!9Y;NFII
M_!HN9E]I7>%9]9CG5ZA7HX@]1^ 55Y94Y;T.3&87C'&7 5*6D^JUB+$@:BN9
MYD;W/)<'=0Y*K,QD9+B83R1.8\<]>(I3D."D[W)I^=,&/DM[ZX0/M.;C8 )M
M<BL&.L+>V<YPTZNU2#'9^3,S007#2[HK0@]W$KMF(^B.7WHJC'%S[RDDC7I8
MUT<K=LD8&@\*<%:>5VS;?2=095U/@OM?=)_MSQAU*./+Y*_+5["$QP 4A0/J
M7?H!XUQCMN?+SQACM*Z#5:NT[B:QL7Q7A!92A-*:=ZAW;CN%E59]<W-\69A0
MUE;D1KW I6Y9N;VTJ;Y'8E\S&.:UU"*:D=@7/VON"QL;Y\;'-HYSB*=_L[UN
MN>28Z-B\;DI3:8;.0 2BP L>MB15"/QMW*#"X.):3JKEGO 2V;0M!K1:U=S\
MOB\MR,Q<2FYLE3S_ .ZLG^QU-6?@=JW4-H)2:B@TYKYS^XETS*9+R;6,]1))
M_'M*IU[.16>22..HB.QYD1"9#,I:@4N)'BD?;6W%:O#>J0>A<+<NVAAHXWM!
MZJC7T?FI^TMQ]F.\1=UU NK^0UU\8^!D<CJAM.T\59^TKV*6TBZOW/&I[PI;
MS#A2L3Q!G,"8'%O*:+C(/@L^7PK9V+F+/)9GRBPD@.U)TT67[G6[&XNH>TZM
MT'BI[VBR^+RO&587)>TZ_BC;VGK6"57((OYUQ?O/@9[:_BGM^$CJ"G< LGVS
MS5I)C_(<:/8-=>\T]BF,W \0Y[A,U@$1TI@KO%E/LC8=1J4J%5C=7.3P+FO>
M:]8KP5AVTMM?%T?3H-%4G(>Q^,XWA$.\?EO+3CT;4-+]>Y*?,U8>)^Z<_D_1
MW!KU"E?\RJS>7V]AD8ZXMW . X#G0*MD>Q!BM^ZRM 4D>X +DK\;W(K?L[EG
MFCI/I43Q.7M,'8CS(G=;@*T[>=:J/8M%\DLGT!2%JL>ERH&P-79D;^&;&-8'
M G3W+C[-N8W9)TKW!E0:5[R"K;X;P$<JG?F$K(!F'CR+,(L5%5[ZGR-A579_
M>HP^+\@Q.!?4=7)6?-M+^\W[)W3-<QE"&CEWD^@>I3#EO;3CF'C/\@82M>52
MGVD+4JX*>N@\*IO![EG-T&N(Z":KJ9W:]M;D7'226CDJAQ$)SDN5&&A//0GW
M% ./$*"=+BQ (N*N?.XET%H+J1[2VE0.=:54*RER-Q@6MMUQN:14FM.RFAU5
MD<J[=Q.-<6>F/Y17S+,<I2V!8*4E/AXBHOL'<5SD<I'"QI+&NUTJ%,,SAX\3
MMPQ:^:R.G5PU XJAH<*1)D(]I+LEYQ/H0GU*^&IOI5V;MW3'BJ-93AK1?.L7
MG7TG00Z1U.1J?6:Z+*S^/9[%LB5D8:H\=9_AE=KZFPJL\EN"QR=NWI!\S7FL
M][@KJTB\V6,M'?Q6) 6I0"/6KJ-O72HS5H%"N2QI<?E&JD^(BYO.Y;%8YB0Y
M,W/)WK"E+#2?%2K@> MUKGSS06D3W%E20:<M5/=L8F\S=PV,7(I'1W$GGZ/>
M5MK&C0N$8);CA]T"ZEK2 "5U61GN+ZY J0*KZ,BF9AK7^L0X@<53<_N5E9R)
MC"O:,)Q2T$^2;V\*L^';%D )&L-:#GS4?AW'#DXI*N!: [2O8J6=C(V?-LJ0
MPROU,M+5_$_9K]O6MASG-?T.!)]B^:KRS:VLT1#6\0UQ^?\ '/BLO#F(E-)0
MM6YU%@\A5KJT&MAX5,K2WF;#5D9 5U[)W1'?6WT\AH\:'AKIQ70SCCB&F -&
MO<VI0$]"0?[%=C;N LKR8NN6D.[:T"BWW$P_T[62M<.DNI3T5K52#@^&EY1Z
M+&@-!:G'M\HJ!Z ^J]</[B6UCCV$0ZFG(KN;"P=M>V8<"*UU\5N0SC(K6-1C
MG&DECVPAU)Z"U?-,]_+YG4%=D..MOI_)<%K9W$[?3<?/?SN+:#V-0$K<8\4[
M.MK=>E6/@LM$^W#'N^<J@-][+FM;IUY *L%#TZU^7BJVXK/5C>005LO)AO//
M!(<VW 4HCPKM7D#)H"'J&;-O98,HUP-":C5;HY*#B<I%9CY13;H6FXW*"=5#
M4_9546D<L=S1@)%> YKZNNW031]4SVG1:Y<4[0RD<SYEND*:XHUL5@4$!9*W
M@HNV7Y"PJ;9?/?3QQMH0X\0>(IR40;LZPO9_J(V@4^*PL];W%<M*B_/?+N1P
MI.]LD+*3T) U-3/^ZC*6S6F)W2*'U!<?,;M@PMQY)<   :<^SX*KN:\F5C6A
MEH$!_D4\:_+)2=R_*Y/D>E;4-S*8C;L/3&>2J_)9"US.49<!PX\#4>'M6<[-
M<8G=WL@,ORWBZ<9Q/#N+7^7/G>X_(!%E?8"*C6Y[J3#P 1FKW4->5#R5K;(V
MVVSF=/&YM3U<#70JQ><3AP7E@D<78;,IEI+0:4DEMM)UL;=+UHXES[Z!PG/'
MLT4.W/-_8\L+UM#P!'=Q47Y7SISD4S&3)<=/O1V?;<=&FW=;=UJUM@[18VVE
ME8=:\*D\EXN?N6V>9CF-H.=0-*J.O\DQ@F)PC$I#^5E,J4W':(418&YN.EJY
MN;/R]+CJ"NWO6X>+0,CKUNUT\"HT\K-OYE!=E).$$)32X81_$+X5Z25'X5K8
M[,/LP.D\%6;-S!^.-I*TN?TT'C72JM+A7:IWE?S607*7!";-H;4C50 _$"?C
M\*ZMY]WVXU@+V]4M0*BE.GL78VEL.;,VYDE<6-!( I0G0:^'HY*+Y[B9P_)Y
M/'B]\P&&DO+F;"!8_N?;4\P_W&@REIYS&D.ISHMZ3[9SQW'1YH+*]AJH7R+A
ML*<VVF<$.(C+1(;DK.TM^TH*UT-=R.>QS4!$XUX+EW>WKW"SUB>.D@ZGX\5G
ML:H9)U3;VY22UO\ =N;W"D[=1\+U$=P[6Q>-@:Z/5Q=R/*A6AL_%1Y3(N%P.
MH=-?3U-_53_%X'$\ER&/PF;(_*93H&12#8N)2DD))\-;566X;46EJZYM0?,I
M4<Z:A7=:;8M8+CY6@"OP7SW$X?Q_C'(\- P#3#&$^4*7H0<_"O=Z"!?6]S4L
M^WF8S5S9/D<:$$C4<@ 5'-T;?P=O<,) #G4_BI4D]G-#S?D$.,YQ0)9:XR_"
M+!ED[5I6I:O2#4;N<5_<,JV_D8?-:0:]X%!IZ%/K9D-O9=(<*4*JF?MAJGQ8
M"BKY9I)*U&^YT@K-B?MJ_MO7,[K0NEY:#PH%\[[R@A;D1TD$$5-.]Q5%]K><
MYC*\ER^!SBDN-P$%+#8190<#EE;CXVM:M?!Y-\LY:XUT^*[>]]O6UI913VS>
MFI-:^"OQ'L-O"0$["E5G#:]P=#_(:E<S08W#F57N.N/)G8Y_[05C\_VOXOR.
M5$RD<?(2V7O>D2XA(^81IN0L@^8%45-;O=.[S.&OO7U)9OB;:CRR-?B%9+$9
MB.TTTRWL#*-J#U-AYUY9<GI,!)Z>"_&XZW:/.#/G[5Z._0G+4[C>>1+ )BS&
M?#Q4V@UIO8&Z+HPNJU>@58UF2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41?
MS2?J 9V7F_JL[E(D*5[&#3B\9CVB;^VTUCHZU ?!3KBU_P#C5-\0P-MF]]3[
M5#\JXNN'=U/<O2WBOZ8G9!C@4+%\NF9V=SN3"0<MRB).]I$>:MOUB+'V%HM(
M6?2'$J40-3K7$DSLW75M.GL789AHNBCJ]7:O)7BG,>8_2)W\Y4[A7&<CG^"2
M<_QAWW 4QI=VWX;3SB 22A+H;D!%]2D FI!)&R]@%>!H?C^BX3)'6DQIQ%1^
M/>HSP'MIW?\ J8[@3H_'(,[F7*<S(5.Y+R.:X?88]Y5UR9TM?I0GK8?B5^%"
M5&R:R33Q6K/FT X#\EXBAEN7Z:D\3^:]T?IF^A#MSV)5C.5\C4WS[N?%VO-Y
MV0W:#CGK?_>^,J_J3T#SEUZ;DAN^VHK?9:2XJUORM[.9\?R4EL\8R"CCJ[W>
M"WMKDKII1$HB\9_U?_\ FEVI_P",Y7^Q5^\E^MXKP<K\61?A\/*OQ LU@7X4
M;,X:3D&_<@L3FUR$VN-MB+D#P!(KJ8E[6S NX+EYR*22T>V/]U%O;C9J9N*D
M9K"MIGXQAHG<R0"XI('H23II?RJQK_<L./MPZ, U'N5'8K95QDYY!<.+2TCT
MU\>Q8?(_3QRR'+7R_(9*2(G)&69D1N I0=8+[8(:<M_-%OOJN<)E;+/W[VW+
M@W]WL/>IIG[&ZP6/C;;LZ@TC6E7:^'@%*<6T] @X["S7)+TG'H4VM<M*DK58
MBRCNZZ5:6 M[.!TD=N0X "IT[^Q5KNK)W5]%$Z=I:07::CL[5*<?!]IYF0MQ
M*1?>TE U ((%S]AK@[EW;;6O5;@'LX=A5B[ ^U5_>MBR#) *MZ@ =:.:?@5G
M7EM^V/4/M\35,95L$Q\QKBOIS9V!R$,Y\SD.WO"QCN5Q>#CR<EE)"(T)A))?
M6=-QL+6Z]2*CTQEE,8C]?-=;[E17AQA$;M0T\^\*:\=YMQ3+<0^9Q41;J9Z7
M-LIQ-@0A1!4"?#2MFWLK\3!U32G;WJL\=F+1EF&3"KZ]E>7YJH,#RC <SS4E
MS"K;5E<&IUEUQT'1"U;=H4 ;@E)KNY.\=%3J"J[<>W\WD;_S<::"/4@D@&H%
M- -1H5R<HP>!Y3+CX[/PV)DB*@>VTV\H;204[P ;]+]:P64KK@U:33\E#<IN
MC-6L[;.XA ?PTZM>5?#0KZXCQCF.%P67Q4MIUG'8^<ICCN:>]97%)]()\P.E
M=*URXN 8>Q7'CK>6Q\N5Y^8.%/74+<SML[QMV"?RU#3&6:92B<SN!=L.IMUL
M35.;RM[B*[+F5I4_!3,YM]^XB7DK FB/'2O)?)A^3&:VI6A(]VRCT!\JCD<[
MY" XK3OY(WQD-XA:6]SLL^G-LR\VOVT(?_\ :;OL2VLCQN-.MJM' 0Q^5\@J
M>:^;]TY+.6U\9+>1S(QJWI/=K4>GP4#YCP>'W QV-;RTU;:8JB[MCA/J"AIN
M%K7M4GQ]NTREPT4\VSFLU/;-?D))7 TY'ARY+M\?XEA>$85V' WHBH)6LN&]
M[_B5;H/.L^4LS3J;JKQVAG'VUPUC]&$@#QJLSB]N-6'\6L1E..^Y[K6EU*-[
MW'G47F^GD/1(-?!77=6L$C#(YH)=JIWQKFW)\9F9^4ESSDF9B$,,07"=J?;O
MJ/MK+%M>"8?*-%2&]6/L[H!@X@4\2I7B.[_R^8R#.2=^;46]RH+9(]KRL2-:
MT<QMRUBA#6<?0M;"82\R3>F04/-0[D_>S+\=QO)L\F/\ZR(ZU,PUJLE Z?U*
MY-GMAKRTA6)>[:;CK)K@==*K2KN-W Q'*>"8W)QLJW'SBI:'?D&5_P 1(40%
M@CKH*GMM9FVD#!P%%Q\Y?0SV/2 *T/N5$R^#<N8QRN0R\',1C\@0Z<FXDEM9
M587"J[POF3D,#@2-%5/6V,4X!9;MMP#(]Q>40>*8M26Y$TJW2' 0EM*>I.E_
MY*U\G>-L8^IZ#K=3HXU6PN4^E7D'$)KC<W.,A]A*7\>\TDKW*3=0%@$VU'C>
MN7;9_P"H Z :*,;ESCL=(&. UKR)JNKF>/2<MPAX\LG.KG1FUK;?4GVP%M V
MZ^=7;:/CO\720\/@%3\>8NK?*":!A:'4' \"M1IB S+DMH5=++RTMGX)40#5
M9.XKZ):=%:/;ON-R'AZ'H.+C_/Q)BBMR$4E1WD:D$"];'U/R]+AHO$I8-2:*
M*9.7(?S[F1RL);#C\@2'6EH4DVOY*%:E X4:L+_G8>@\EM=@^^/&)KF/P_R#
MN%C,L>PEQ7]P'IMKM'0?&N))8R-D+B[2JJ?/X"_?<MDC!TKH#IP[@M1^0+3.
MY'-^34E]E;J]OM@V5M( 4D>6EZ[D4;M.G4*T<*71V#/-;TO  ->X+;[L4<)V
MI<_R@Y%+TPI@*4J-:UDG6^NM_NKOYK8K+S$F1SR'4.@HH$-\L?D#"&U#30&A
M4'[A?4SG.1<Z/(,7CD18!BJ9;B.ZFR%"UU '4WJ%;<PC<3;$-<2:CBK,$[KF
M,=8IHJQPV*SW>KN!%Q\93;65S*K $^E*0;'6PZ7K?O;L6T3IG:@:K]8S31;@
MS.SV%[-XK'XSG'(D9;Y]2EQ0^I?M(">J GX5R<3NF++!P8.'<M>6"IH[FM@>
M*<!X)-X4B5Q*9"9RF007FU-N!8#E_P!Y -["H1N#/3178:^I9Z2O%O\ ;^UR
MTX>=' =W)9;M]C^4<"PN3P"4MYF:I3TF.^;MH*UW(&O@#7"RMS;7CF3AQH%W
MK;;US93_ $[&U:%J9R_Z3G\^,MS+(<@1&Y#EIBI<R"=6VRM5RE)Z^%2^QW+)
M$&Q",^53C0^A=G<-BW'6)N 1U 4IXK]QF%7VXP08DS'YT7%'W%!:?25*(.U-
MS;4Z"N^6_5CJ:*5"^-LJZYR.4 +"3UBG&G'OTUX*T.Q_>OACN.RN1YF@XYY$
MD_(2W&5%KV?W;+M:_G4>W#:7AB%O [B.U?2&W[;Z.W:'@!P');!P."<:RTR/
MS./E%RL-,<^=5$58LK2X.E_*HQ#?W;!]/$#7@>*D+'>:ZKBJ_P"]? N <N9Q
MB?RYE3L98VJC#V] #8**;:"I%A[7(6)ZI:D'TJ"[QNI8"#%7CR\%G.WN:S6.
M=Q7&\:E#^-A,H9CQ%:;&T"PL?LKWN+%026+[BFH(Y=I78VQ>RW$(<[D*>Q0;
MD797)\XY]R',\TRC\/$N-MMXG%0W $J1KN4KQ\:X=ON:.UM6L8-?#FI;@]CV
M&2G-Q.P%PYD \#HK+[>\:XQP/%/\4PV2#J(SBGG&77$EQ'NVT.M[:5P\IELA
M>]!();R K3U*SK#'6MA4-IIX+H\LX-C9[KN7@E+;S:#[B4JLFWB01I?K5C[2
M^X]Y#&+"5GR'MKW#U*N-U?;?'74_]R#CYC1I2G>?BJVQ43#29+>*SCZ1"?!:
M*'56"KZ!.X^=2'<\MQ#"9& 4 -6\AX+A;4EBN;GR9M!4"O\ BI!F^3YCC67X
MW XF([O$X'LLY1E9)<0TD@$(/C9-5[B]KR7S7S2MH2:CWJ=Y;<#+!IC:ZH&@
M7=[GN\=S:(:L(&_F=ON/.HT&ZW0V\KZU9'VVGN,;.63D]/ZJCM[8C^^PES!\
MW$>(!HJOXPS+R G1\=%1*>BO>U*421M7;I<7OI7:WUN-D$[3YIH:T\-%66U;
M'-8]\D<%NUWS#4UXTY$5T5BLYC/XJ&WC'(XBILH.=3H?B0*A$&*L\X.OJJ_T
M*^<5FLO/C'0W$8B.O[2>RG8%$'I'(\>S\[@\G,9E0P5+>3=>\C4A0KM6.UK>
M><6\[6@N-!PHJ_AAN=OV;I!(^1U*ZFIT78<R;V14N;*<4\\Z 77%WONMKUJ3
M_P!M9B!Y5!T]WJ4AQN:%U&'4U*X..X2!W,5D\3 ]O(,XY1:GM.7"4J'AKUJ*
M9?+6%G\SR0[P7:MV2O=1IT76Y!VTE8]R"[^0(:DX]5HCX2-J0#X>%3#9V1Q^
M2'SGCW=RA.]L=>2@?3#YA^86)R,+.2(SD:=C ]%<T6VI%TG_ ./J?G$8P,(<
MZHI^.2A<N6W/ T1NA%.%?PY7#A.1=PLK%CQ\2MAAK$14I>:3H$MM@A-M/(55
M-_B-N6%Z9):_.=/E'(:J7VT&=DBB=\NM>H=1]%-%5_*7)F6+V2D(_P#:C_YY
MU(.X)3UOM%[6-33"Y^*UG'4_IM^G3_X=/!1_=N DN8@[RP9--?7753_A_P!/
M_;ODV&B\GY'B!*S4M"KR"XM("1=*+=--.E4[]P=XFYRS_IW=3!T]/_2/BIGL
M_".AQ9A>WI+FD$BO,G6JJ/.1^$=K.6NMJDPX4B"E;DF*A5W"@@[ 0@'=?XU@
ML[B>^@HYM."@QP%]C<D)(ZR,'5H232M:?@J!<V^L%B9A)V&XUQL(DJ'MM2GU
MV0IM)U(2$G4@::USX=C-=*)'.->Q?2N)W0V*W#9(P#X*]^*\\X7WO[43XV82
MS'E+A+9R>(>4D.-+0W<+0#8FY'A7"O<7<8B_#8 75)_&GB5*8<I:9*S/51I
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M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB_F(^N7_ $K>\7_&,+_!L2IUBO\
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MIJK%*<EC0V,C*=;0ZXM)7O*AU) .TV_;6>QFP\U(QTEW>/S7,R!S]HWS7/D
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M?<'[H=RL]BN*)XCE(N88XG$/YC.><C+#@9?=;4F.R"1^)"W?LK@W^9B>QT;
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MDJ#VKG[H7[HH&ET8)KP\!315OVY['9I[NCCN.95F-D&$Q53OERL*0NQ( 5<
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M[RWBH/-41N7;,>)>9XOV\::\5C<A&7-0XMI_Y2>TX)..?ZA#R+E()5?3[:P
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M1S0VN@4IX_.SCDJ-B(LIU#<]7MAIPG:1U-CUKEW,<3?ZA JW52_:F4R,=[%
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M\7[9JE\-*L=DYLQB/$R$(CW$!P]3;K8?"HUMMLLMR1<:T[5]#RVMO8Q&>U
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MIUQSN)QF+BH<#&,KCS D-?*(1JDE.T*N-*D5CFK)UMY3J5*KB_P-]!?NN'T
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MQS+RIC3+N0>4"G;U)-O@+5^292*U>+" =-#V=I6YC]J22VCLG>/ZP6$BAJ=
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MU*))"\%O:HKCV26X'40:&M/2MJ>+=S>XV3XC%E\QQ\-[C<=A/R;4-M2I2RV
M$*4DWO?SKAP[>ABE) U*[&1SSIX/)-:+6+G_ '"S7-LL[@(K0C8V5.:^3AO(
MVK0X3[8W$'I<W-ZW!9LMJN%= 5#,9M>R9<^>!\Q=7EQ*NG'=F)79F;QGG/(\
M_'^1<02I2-S:FGU %(\;@:UP;;<,&3D\H ]-=585]A)\>\2M-*:\5('.\&.Y
M#R\XN)F'\BQ-0D-24E1;*Q9.VP\-:Z=Q@K:,AT#:5[:*H-]XS*9_I#) &MK4
M$D5JL3S3M!SODO+8/*L%"2[ A>PB9+"RGTMD%1(O<FU8A?VM@\0S'CV4YKI[
M<V%,_%N;/\Q-03KR6W';Q<2+*,=PHCOE *4Z)WJZ$>%1/?..=(&RP?M-5._M
MI@;+$3.:T=+JCLXKI<XB(;SLF1'4A*Y32DRI"!Z[G:$C2MC:.-?=-\J:H U]
M2B7W%MY[K.1](!CZ' GQ(HJMCP,5QB&\IG>7)*R775G<MQ?A<^0JU<+:?670
M8P],;:5J:>*X-_;V>W\>>EA<\@@4'5KR5SX+AT3,<-;SB9=INTN):0="!UTJ
M,;SS<MG>B$5\D5%?#AKP6Y@+FECYKP.H@&@'<JN;]B%G6))C/*8]U*'U*01?
M47(_8*ZECEYLE9.MW$$@$MU]2JAF7$6?%S'&X1DAKJMU[Z>H+;"=C^-<CX^P
MVN.AYHI00VE12M)%CJ4D&J&RUO?65V^IUKRX+Z@V]8663<)>GY>P@54E6XC&
M8%Y]J^W'PUJ:;OH/;1< Z7/2H];S":X'6"=5T,Q9-@!#-.Q>>V-P"F5YSD@<
M5,R>>F+E/)"2;!2] D"]B/C7UKM#,VEE:QLE(#7:4JJ;W-M^ZR$1-O0R-UJ[
MX+8''=ULS^41\<U'$:3!'L.NJ!N0D"UO*HUN'8S6WAF::Q2U>*'77T+9V5N:
MXFM9+:Z8 ^-W2:#F JUYKE,UR)463DW4OMPE;F';'W6R>J@?"U3C9&+QUFTV
M_P _6?YN&JB.[LCEX'_4Q]/EM-12O4#VGN5A\.Y[Q/!<?97R'YAV1"41\RL%
MW=8Z=*AN_<-D+>X,<#VM8[O/#T*:[2W9)DL>))JEPT/CW*+<DY6>3<B$S'L(
M:Q[J4@>DI-B+W/W$5UL/C['$XRCI"^4FNKNKBH=+O&YFSK;:#I#- [2GCS\.
M2KA[N_SSCW<+#]O>.NQ8L',@*=?D(WD)5^(H]2;'RJ*W.TXLM,)9:TK6E:#U
M*W^AMN\$.J"=:'599?%\IQG+S>093FD[+!]"U_+2EA+* 3<@#PJ7PX:.QZ(X
M/EJ/!8LK,XP%H=4_PU.M%,^WG+IB)JY<1Y#<*<VD,O#6Y)UN=?*MW)X'%26(
M$IJX$DT(_)07;N3OSD9&S-^0M ;0'MYZK8K/\21RK"Q5/.I:S "%?/(MJ@*N
M4G[J^=K_ #\F+OGQVX_HUT'/@K)NX&R-8P_N7!*X5AH4)V1AW3$RK36UAU#@
M)WCQM\:R?WFYZQ).UWED=A^.BV++'V\L)A:X==>U4OF.#YO*K;F9=Y2TL+/N
M+)NK;;I]A-77L'=]BR-T,.CW  <**'[I^V-Q<&.25P+&$DBO%86?QW,J92WB
M0'WAZ6@V"%[?NJ6MNX+:4RWAJTGT:\.*C^Z<=?LMFMM0T%K0!3]U/$<UU>'\
M6&1S[V+Y%"D&2TD%3:U$K2#T4JQO:^FM8-_;MDQM@R3&OBXFO9P/91139&U(
MLA<.DS+97$4Z:FOKK6OAP5P*X[V[[;RTY/D.2BPH^2'LH9EVLEP]+=;=*I3)
M;^R>?LO)D&H%- 0#S[=58\.P\5;W9,; &N.@--!ZM/0NV_W:[8<=6(F/R34A
MV6"I0B)]T6/3=MZ5!;;:V2OCU/!H#WJ061Q]I<BT80">VG,T6CV3QW;C'\VY
M-ROD>0C29V:D*F0HLFQ]I!2!;:;ZD =:M[!^99PB&0&M*#1=+<5@;,M:T@AU
M>!JM-N9Y''93EF8R>-;2S"?<VQF6T@)2D #0=-;5VW/!;3O7(CJ&4*BR5*LK
MW-FNB/;"A8$>.XG^2CBP4Z:KV.*[,="7'&&619Q:TH23XE1 KR^0E'&J]9NT
M& SG;7L%F,KR*1\^)<![)8F.RHK#*2RHIN#XW )JI\ODC)E&&W%*%M21V%;,
M30UA+>:T^RW:ODW<SBC?=W,YYI&3=A+D(QZ&REM;""0VE2KZ$#[:OMT7U-FV
M72I%2M?RI \@D46P_8?A/^0W@V<[C<[P+&7QF8AQI\=YAM+[T>,6]Y]Q*A8
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M/8X.:P'L(KKQ[UQ[D'4BO='-"B="N!X)=(04[DH%KVT 5Y5;^ULE:8[&F:8
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MIZA;QJDW">VD?T5#*DJ<;BZ) VG8%KCW+[C_ .3WFT+%_P"322]C););@Y.
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M9+.C_N'=+6ZZ@5]BLCC7)G\S C9),A$XR6@M^*W8EH]#<H&FOG7CZMT1,0T
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MY;>_+0X=]6O<Z5G&%*C0>Y<_-2F-@)7$D9)4]-DJT.YEP6OUO4\M/GM6T_E
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M<J_,XOI?H]P'K]/@J!P^3QN>QL>:Q);+<QD*.Q044A0!/0W!O7TG974<]NT
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M3O73+(<0FZ03:_3I4@B80WO43#Z%=W"X"3R+.X;%(G-0(KSX,M2Q^)*>J0?
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MA^%8T^4V0N!-#4:]G=QYJ\>,SY>&=5D,4XN.%'V5I78G0:6(MTN>M:PQ,.1
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M%]K;?H^:1U?0J^Q?+F)7+,G@H$E;4O#K!;=5Z5*(\M=;5*L=E8,RPPRL!!'
MZA0K/;;DP'3<,=U"M >SU*QI>1RG(Y4&+D\H[+7[B6TJ=L0@*LDZ"WAX5Z&)
MQ^$MI)K>%K2 3H/\5QX\MD<I(RW?,XAYIQH-?57P6Q&4X9Q/A?'X>24ZEB0?
M;2Y(>4/XJU#HD51N#WQ<97+R6TA('4:#6B^AL+M^RV[:"=P' 5)&I5;S0<R\
MXK'V.T$%WPW>&E3"]L'BZZ>G2@*ZL4EI>MZXJ%9_AF-E)AG'9Z2T[,;0IU;K
M:;(*0=!^RN+N/=+L/)&P#]RF&,P,<\)+QHH?S/',2H[4S'!"S'<(4$@ D V(
M_KU9&V<X)@!(: BJI+[F[::YO7;-JYIY#ES_ #4>P6"S4ER-.8/RC)<277"H
MI44 Z^GQ^^N_?WMJ ]IH74T_Q4%VIM?+NE;- 3&RHKK0D=[?SX*\\W-[<OXN
M+B)LCW<D$I" $DE3AT )M8:^=4AB<9N4Y.6Y:]PMVDZ=0I3PXJTLWF,0 RPN
MJ&1U*U!.M>>E./:H?D,#%P2H09B-Q)$U:3';<&S>!J>@UTJ:PY1V4)9UDEO%
M2"WQ=CB@'6[&MZNP441Y])R.*5C\K&QLK,L>X&7&(@NIH*L"I0\0*RW4_EQ>
M4U:,^WY[N];<N<:"OAJK+P,)W(-Q(\!LN/.)0YM60-I-B;_$5R\SE(<3:>?*
M  I79M+Y P'@%V>XN-E\:XW(GM27)^5<VH;Q#+J4(6F]U&RB.E5+!E6Y:Z;<
MQ0BE:UU6_>Y9[*P!VO!>2?=/E;W+.3/2Y$!6-?B7CN15FZDE%DV-M/"IAUO?
MJ\U^"CUO!)&7&0U)-? *M:_5M)1$HB41=A6W9Z@-?[GYVK([IHBXBVH6NDVZ
M7K&ORJL7MCVYR?='F.)XIB9+<)<P.AV0\%%M-D%=U6%^B36KDLG%86KI']R!
MI<0 MP^-?0])3DLPSRCE*$PX3*'(;D-&[W"J^I"]A%K>-ZA3M]Q?*&,K4ZUJ
MMBYC+!V*?\0[;X_B;<K%\<CO24^X?F5$[U*6WH%$C07\JF=SGXA;LDI18K/$
MR7()&I7UR?AF4BX/+YI.*?ERHH,EML)_?Z@!-=E_W&C+(XF$5 ';R4:MOM,P
MR2SS DN+N-.:KGA&,[G\HQ"<P[P]<:(+H;4IY*7-X-BHMN)0H ?"NG=?=1D4
MS()F-H33GS7#9]CVS0/EBE=H"1PI4*A.\/ ,OA@]RK*9E,M,R0&T1EE1*"K0
M@;KWKE74D5Q(9(&@-=4Z*5XRU=9PLMW&I8 *\S1:[(6I2-X2IKU$)N;E0%];
M6%JQ2,#- 5U%VF''62VMMUQD))W[%%.[K:]NM8'1AVM."_:_*X=JVU[#]]H7
M'.5P4<\=#_'(\!49+I:WJ#B-H;*O$Z7IN/)WMWC_ *>'B".![ HS:8%EI=>:
MVI!K6OHI\5MES#O)VORXQN4X[FX26XR2IS<?;5<:BZ/Q5"MLXN_CMGQW#CJ"
M-3WE2>XD8\@M'!3#ME]3'"N8\A'"URR,LVA B2]O\%]82"4@^>M1K<.U?HV.
MF-377VK;M[FM MH"HD)"3<CQJNK2;R0[3B"%T#JJPYYQW*9Z7CV\;*3L2E?N
MQBNUK?O6J=[,S5M9%SKB,:4H2#WKFW$1<[153R+L_+P?&\Y.Q603(RLU)=^5
M>!]H.*3M 2==-*F.&W1_=KPQQ"C:'MY']5KRVG2VJUL[)=H6.,]S.VF>RN5$
M?E$/DD9<J$C86RMQPW2WM-QZ5:5/;BW,3B"M.I! Y+^FUO1ML>21_4K661?=
M$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB
M41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B
M)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B+^??O2AQ
MKN]W'64+*3G)JFP-?3[JNE_C5D6][C_[7Y+RWKZ3V\35?-&]HW29F5IYEM/4
M!IZ:JJ(:HF:8@9GY<HCOIW07E*/J T*K)Z?9:J4NST2O#>!)IX*/7MM):$,/
MR@CW<5Q<DY)AN+X:1E<E)<2IH73!996XM>H LH62.OB:UXHW/=2FGBMK"X)N
M2) EZ7#ETUY^('-1_M[SI_G3\F"G$R\8AA*G8+D@?PUH)N?586O;XUEN;=L8
MZEULCM>6 -B$H.AH*>%>>GM4\<>BM!L27UL./J4EA.PJ22BU]RAT_%6%C%&H
M,>'1%[W=)!(I3LISKWK]97[VY4=Y+IC@K4VVNZVQN/J*>HZ7O:@8#44_5?AL
MKEL39F@EHJ01RH>/=VJ[^4]SH2N'P<.UCYKLL0VG)980%; E(!-]P)U!\*AU
MC@2+ETA(H''BKJR>^'7F-@L&M=UNB:336E!Z.PJN>(8-'(<GCHS;H;;R"$N!
M3Z-4H4+@[0K4Z>8KO9*X="PD!5]M_;<4UZ()W"I -"/YO2L[G<&]Q:>YAG),
M>9'BI"_G&;H*EZW"D'=;[=U=+%7K_)=)3LY]JMIV-;M:W\QFK *GEW=_:L1D
MHDUC&JGIC+<ANJ4TB1T .TDDW^RK!VE>6V1O&EY <VG'N(_-<C(9^27'22MB
M)!ZN8[#JHYA F(ZJ*XX@EX!3:5':21?=8:WMI4ZWNUE8Y ?VU^"X'VPR+?-E
MB<T&O3\5)5*!2KTW"M-IJNY+ITK"0::JY[N6&-M2 NW"S[O%74YN-$1-=@(*
MVX96&U+!T(22%7-1_./?>PMA$G$GE7BH9<[JM;,DU&G?^BZ'-^XJ>?)QTGY%
MW%MQ&BIR,\H&SB[>21TJQ/MSM&3;V/EF#^HR]+N%*>TJLM];G&9?$V.O2P&O
MB?R^*B&PHWV6DJ" 5J00001>UQ4<GLKS,WO2X&GH//T*!2!\)Z3I7XK[CD/>
MXXEGW6FDD2$WMHH$=?[%<[=&!.+>UO GN[*=Y66V@D%9.GJ:WCRXZ+/\2Q?&
M8CL>+[$?'PIDM*I2GE  NK/4DG6XJ,W#+B:(MC)ZE;6U8;#/@12, +>W7AZE
MN6VSQJ+!8AE4/Y5 !2C>C4^)Z^-57<XK)Q3GJ#JGP_-7;9XO'QL$(#:#N6JO
M<B;A>*=Q&58G*V>Y7$ $",M*@T6$V*E)"C8$"][5-<?;27%N&3,H6=O/U*O=
MZ17&+/FPDM81Q%*#O5AXSNM@,=C(D1C'N/9-M(0E_;MNHZ7WD5SKG;D]P[JZ
MZ <J?JN1CONA!;P^6 7/.G9J?$*B^9=P7)O*#A)LU1R<\!QC%I]5FB/[4?"I
M%C\4R&(.IJ.:@FXI\O?/DED+O*=P&AT[--5QM-Y%EIQQI"FFDB[BK#0=?'6M
MT3@&@.JCMF<E:L+H>IK>?!9?CF<P(S.)QG(LO'AIRT@-05NN(05G7</"WVFO
MV_N[ED#N@$FBLS[?7M[?2&*<DL=P)IWU4O[K\-X6_!CL(E-S8[CGN68=07/3
MY*25#PZ5'<1?7O6>MI'CK[EDWO9V^-E\QIH:GAH?;55YQ_CRLF^C&XB,6VT!
M(;9!W&QL.I\^M=F^OQ#'U/*K;$8A^<O"QAZ1I7GW=RL?DW;^;Q.!&SCLMN*T
MV0)!1=>Q:R$I'PN3:N7BLZU\I%:D</Q16%D_MS/CG1SVKR'Z\N?=5RATF(_.
M<+S\U1VIL@+1T'E:XZU-&W&1ZFN'54D<PN9DMDY:]D\R=Q-!I4#3U%1%R,DJ
M<"K$A2DW\[5>C,A-98D22@EX!)U5;W43K69T1XM-%B\ZO*1,-+D8:.)$F&PI
MWVKV.U/4@V-49=Y3ZRX,SA2I\>*WL'CSD+L1C7GZES\!R$/*83#Y!S(-R92T
M!4N(JQ6AS6X(!OI;RK&W$S70)C;IP4J_\>BM\C'U$=)(T(_527-<8Y=EHN0F
M\.Q)S$]L;C"W!MNW^K(.OW5-X-\Q;;LF6UP:. H*GL]!]ZE]W]N/K[HR0.HT
MG44_7X+:?ALC'8K@&%S.<X\U@IT>/:3&>;1[J74"R@%"_B-#7SEGLA/F<F7"
M0N:?3S]"M>-EMMVR!<  T>'+TJN.9=Q&.81#A8,):8KGK<>4+[" ==0*[>)P
M8M'AV@*J;/;Y.Y!]%;M=1U03R /<0%4F5R.*XSC9&1R*T1X<=(#CQ3<J)T T
MN235BV]GYK1T_N74CV9:VEA5P%2!734^U5+S>,OGV!;A\7?>B.%86IR6"RTM
M)!M90*CU(ZBMY[<M8Q]5U41.T%::JO<5-C</>MD<.O6E#P;WUJ5MCV<P^/[0
M=E73RS)1\HAEMR=E&46*4[AJWZCZNGE5-Y]DE]?-\AU#P7TKCLI836O6WI (
MJN'F_(.U?<#M--EX_&0YZ,G!<3BHR&&VW4O%)V;=$_A/QK+C;7)0W8;*YU!Z
MER;O=F.QS2Y\C1V?HO)?*<.RV S,+"YJ,K%O3'&TL(<*3N;6H)"A8F]JMD2%
M\9<S6@7G&YJ+(?.VO@>*] NX?TK<+B]IFN0<7BO/<DQT)J2M]LE?S!*05D(\
MNIT-5QB-USG(.@F!:VIXG]%)+@@15:O/?C>,FRN108D/'O39K4IDO16FE.K2
ME+FI(0"0*L*ZEB;&3U#4<5RY;=]Q& !5M?0O;\]LN&\NQ6"F<AX\VY,CQ&2V
MV5+;+9VC0A*@+WJD1GI1>R,;^VI_'!=>PL(X34:=JR<GCG".*O0\D]$:B $,
MQUG47_MB1>M2.^O+X.C83Q7#BV18"X-R&-ZM=::\:]JHGOQD9DUG&O=OSCW9
M;*7%91]U1;2&T@GT@(5<FI[M&>ZMP8YR=>%:+D[BR4'0;:(CJ-1^-%J1 [C<
M+YAB7)?,)<9B9@I%_P M6Z2IQ:-%*0 E-P;6M:IB;26"3KZ='?%4\_#Y6SD\
MUKWECNR@J'=WO6PO;WCV0[AX^%G\1C),7 REA+#L@!"BD&Q)]1J*9/,1XVHZ
MOF6[!]KI)7B0N(9V4^/4MH^/]NX6!?8?4MIU26RE3);TN->MU5 9<]+>/H#S
MXU_161C-F163 \ :#L_5:R]T6YTG/36>/IAP)9&Z.P^"EA3ER-0BVIJ?8-Q^
MGK(2=55.Z_)N,XR.4@1AHT)-*U(Y<UKWVZSG+YG<C+XKD@C!6.94'6HWI0@@
M#;LW:V7?K\*E)M621?(I&[:5L0V6S<*BM0T>KB5=R<WCGG7G7XRX[\=2F![K
M1WJ2/'TA5Q\:FN"QN2=;49U=->[\U[MLCBL9)6Z#?,I34'J]@.E5]M+Q4]TM
MMI;6YMN04%)M]X%2":URF.9YQ+B!X?F5^V/]BS5P0 SJ[P:^T!8V9 VR2MEF
MT%I&U2AT02?+QN36M;?<80@B:$D]O5__ !41WYMIV.<)81_2IR% -?'G7L62
MQ49J)")WEP/O*N"-+?S;7J,76X&3O)9^T_CL4G^WSVRX\@CAU+K3T8S&M_)(
MC-QW)CGN6;3=(5UN?(FH=>R":7JBX!0G=;HF2OC:*$FNG+A[UC9..BY_$Y'C
MTJ.749-!;2L6)!(TT-OY#6LZ00.$G9Q7&P%^8'&-C:O=P(I\5D.W6%[I(XX>
M.8R+E%8SCCRX\0J"&TE 5<;"L@D:U8.'R>U(8.N\+ \\2>KX*?W$>Z)NDVX=
MT4X#IT_ZJ%7'_0GG^7Q[+V5NM]I@BSRP"D)'0!(.MZC5]N;;K+P-L2PM-=!U
M#WA6%CL;EVV(,Q/F4%>'P6LO)L= Q<S(Y[+8PG,1$EIY26][J4I-DMD)TO?S
MJ\L0['Q6GFP ..O#C[53>2ESMQ<>1<N> [D2.FAKS;\JE,!J'F,.R[@<B6)C
MH9?8E-J <1L4%$+&MNA%J@>5OS?W!BN3\M?VE69M[;UO!;M?"!UD"IYDZ]ZG
M/%L;E.8\FCPN19!Y<-K<IQUY8LO;T";$?;7YO5^+Q./:Z#I#STC2O,'Q4,ML
M#D\S>/9<=7E-<[LY'0<1V\5$>='B$/DTW@$'.1GLXRH/-1P"JXVA205%1&X
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M#X+,<\X7C.)Y9DX>2\_&)"W&U*"U-VL=%"QM]M>L7]RLMDHS;SLCK3D'<_\
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M?/0=:^3=_NF%VUO26F@H/2OHG#23.8Z05>W52+-\MXACU3&I&5AIGM()]G<
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MC>7-U,9B/W#IT  X<.%. JLAP_-N<2RN+RDMEN2] 6H%E VI(4"FX'WU<_\
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M!!TK7T:CUJPG'G=JO9=/\1(2E J?X/:%OB:R2D./;J/BN-:Y&\Z!;L<:'2@
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M68FOO8+F\P)CH;?+X5'"DJ6A>EVRE)M8&HSCL]:7Y)LW.-./4*+MVV-!9_W
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M[JZ>!VH[)0R.<XAP(TT^*PW%YY?!0[DW>>0R?E^.\>=R)5'65R'7/:V+(LD
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MF+CJ#+:DC4E138 G3[ZDF1O(QT>5V:J)8BPF!D$YUKH?0N#+9;,Y?#<=PS6
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MYY?X;$-O;CIH-^X$UKXW*ORV.D:1K\P]BV=R8IEE<5;PH.U;2=YNZG%IG(N
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MS6.8R$Y#;2-@<OZOMZU%+K:-M<7#IWG5QK2FBD]ANNXLX6PL&C13B51'</\
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M_P"C7,_]QX__ -^-/_$[K^9GK/\ \J?6,["G^?\ ]G/^C7,_]QX__P!^-/\
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M^R?_ ,WN4;R/^\9_R^]>E_UC_P"C!WI_Q==_V5NN'C?]RSQ78R'^W?X+6?\
M2M_T>^8__##R'^"<36]G_P#7'^4>\K3PG^B?\Q]P7H]ELQB,#CY&6SN4AX7%
MPT[Y>2GOMQH[21XK==4E*1]IKBM:7&@%2NNYP:*DT"J>%]1_T_9&?^60>]G!
MY,XJ"6V49Z!9Q1-@EM1>VK)OT236P;*<"I8[U%8!=PDT#V^L*Y6G6I#33[#J
M'F'D)<9>;4%(6A0NE25"X((-P16J11;"Y*(E$2B)1$HB41*(E$2B)1$HB41*
M(E$2B)1$HB41*(E$2B*OLAW:[58B=+QF5[F\4QF2@.J8G8^7FH++[+J#92'&
MW'@I*@=""+UC,S :%P]:SMM9G"H8XCP*Z?\ EK[-?]K?#/\ E['?[?7YY\?\
MP]87[]'/_([U%/\ +7V:_P"UOAG_ "]CO]OIY\?\P]83Z.?^1WJ*?Y:^S7_:
MWPS_ )>QW^WT\^/^8>L)]'/_ ".]13_+7V:_[6^&?\O8[_;Z>?'_ ##UA/HY
M_P"1WJ*?Y:^S7_:WPS_E['?[?3SX_P"8>L)]'/\ R.]13_+7V:_[6^&?\O8[
M_;Z>?'_,/6$^CG_D=ZBG^6OLU_VM\,_Y>QW^WT\^/^8>L)]'/_([U%60P^S)
M99DQGD2(\A"7&'VU!:%H6+I4E0N""#<$5E6 BBTZ_4#_ -$3NW_[P?\ #^.K
MI8?_ '3/3[BN=E?]L[T>\+RN^DOZ'\5]2W;G-<[G=Q)?$G<3R23@4XUC&HF)
M6EB'#E!TN*D-$$F44VM^[>^M=_(90VL@8&UJ*\>\_DN)8XT7+"XNIK3AX+9B
M7^DOB5,."#WQEM2K?PEOX!MQN_D4IGH.OG?]M:(W">;/;^BW#@AR?[/U6O/$
MN:=YOT_.^V-[?\WSSN:[;9%4>1D\8TZX_CI>(E.+:_,8+3GJ8?:4A=T@)*E(
M*%;D%*JW9(H<E"7M%'>VO85J1R2X^;H<:M]E.T+^@=*DK2E:%!:%@%*@;@@]
M"#4/4J7U1$HB41*(E$2B)1$HBT#_ %*O]&#*_P",6(_V5==?"?[D>!7+S'^W
M/B%,OT_/]$3M)_[WO\/Y&L68_P!T_P!'N"R8K_;-]/O*T#[)?_%/N<?XP\Q_
MWM*KKW7_ *<WP;\%RK;_ 'Y\7?%>XU1925*(E$2B)1$HB41*(E$2B)1$HB41
M*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1
M$HB41:\9OZ@(>&S.7PZN,/2%8F;(AJ?$I*0LL.*;*@GVC:^V]KU6M_\ <:.U
MN)(# 3T.<VO4->DD5X=RV6VU0#58O_.3A?\ 1-__ '6G_:JU/_VC'_\ CG_K
M'_RK]^E[T_SDX7_1-_\ W6G_ &JG_P"T8_\ \<_]8_\ E3Z7O3_.3A?]$W_]
MUI_VJG_[1C__ !S_ -8_^5/I>]/\Y.%_T3?_ -UI_P!JI_\ M&/_ /'/_6/_
M )4^E[T_SDX7_1-__=:?]JI_^T8__P <_P#6/_E3Z7O3_.3A?]$W_P#=:?\
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M''_J&X9R?$N?*9+)\3@RWG4) 4)4&=*;;>W>)V);2+C]W]DMP3NJ!S3PJ?:
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M1#!9.Z/VZ4\*A<RP+C>#K_=K7U%;\_JI?Z/?#O\ X8>/_P $Y:N3@/\ 7/\
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M"<?P49$3%XR*IQ#;338L/_-W)/52C<J-R222:X4EC=2.+G,))789>VS&AK7
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M/U9_^CF._P#+X=_[*K4Z<7VG_P!K\EM=61[/_=6!^E#Z;OJ@X1]447NUW2X
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MMO36[G8"V42<B/:%J86<.C+.8/L7HQR[EF!X+QC.\QY1D&\7Q_CD)V=E9SI
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MRV-@\2>=-^[L_-7Y]8WTG0OJ5XMCI6%FQL'W(XFEW^CF5DI5\O*8<]2X,I2
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M?)CP]Q=U<5VX,R8F!G16@IQ_11+_ +NW#?\ :G-_Y*;_ /95>/[:/YO8LO\
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MB41*(E$2B)1%XPU\EKZR2B)1$HB41*(E$4T[;_\ 6)P+_&/%_P"^VJZ^ _\
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MA%-/!>XWTM=_N5]_L!RK,<K[;/\ ;:1Q_(,PXD%]Q]PR4.M>X7 7X[!&TZ:
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M=J']@\%<&'_V<7^4>Y0&LJZ*41*(E$2B)1$HB]<N.?\ -[!?\71?]B37"?\
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MEK_VE>-?Z3'_ #A[V_\ %V#_ -EFU)=P_M9XGX*/X+]S_1\5LQ^I]_HVP?\
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MW_+\2N?@_P#2=X_ *L_U;O\ ['__ ."O_P"D]9]O?_4_Y?BL.=_@]/P7I?\
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MY122-Z038IKN9BZGMRTQFC3W Z^D+C8JV@G#@\5([SP]"]&O^[\^D3_LD_\
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MI/\ _6%W9_Q=A?[[-2'<'^FSQ*X6#_>[P7N-464D2B)1%I'_ )H^1_Z<1O\
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M3UM?TUXC3W'_  7IMU=VXZ',ZJ<#K\/\5&>'?3E]1?UA]U<?W/\ J9QLOA'
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M^I:2D)VD[&/OH7P^1,:<NXCQY+#?64K)O.B%>?>#X<U*<;];GU>9Z*SA,/\
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M1;N&AI&9#Q<?=^M51/ZL_P#SA[)?\79S_985;>WOVO\ $?%:V=_<ST_!;_\
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M,ED(_++&&I/9R"NKZ ^R67[-]C8[O*(*\=RSN!./(,KCWD['XD=;2&H<9U)
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MU7K-R7MEF?J%^F2#P+NLROCO-N4<:QR^02%--E<#D$9#3QD!IHA&T26[E"%
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MQ4-UYR0M"''5O*!==4I:O6XHZFO,TSI7E[N)7J*)L30UO *"=Y?IX[4]_&<
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M0)9X=+D8ODN):2[FN&Y1*6YS#:B$^\WL4I#S6XVWH5IIO2@J2#R;RPDM3\W
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MQ]R_IXJ"J9KS>_4G[-<V[H=M>&Y[@V#F<FG<"RDIW*83'MEZ4J%.90E;[3"
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$2B+_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tm2227887d1-bc_119ct4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_119ct4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    4   _^$$8FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-BXP+6,P,#4@-SDN,38T-3DP+" R,#(P+S$R+S Y+3$Q.C4W.C0T
M(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N
M;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM<#TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z9&,](FAT=' Z
M+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;7!-33I/<FEG:6YA;$1O
M8W5M96YT240](G5U:60Z-SE!,C0T,CDM-D$Y-2TT-D0U+4%&,$4M04(U.$5$
M044U-#,Q(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.D0P0C5%-C9%.3<S
M03$Q140Y,C$S13)%,3%!,D(W-# V(B!X;7!-33I);G-T86YC94E$/2)X;7 N
M:6ED.D0P0C5%-C9$.3<S03$Q140Y,C$S13)%,3%!,D(W-# V(B!X;7 Z0W)E
M871O<E1O;VP](D%D;V)E($EL;'5S=')A=&]R(#(U+C0@*$UA8VEN=&]S:"DB
M/B \>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB>&UP+FEI
M9#HP8C@U9#%D82TR8F$X+31C-&8M.&$Q.2TQ-3!B8V,S.&$Q-S,B('-T4F5F
M.F1O8W5M96YT240](GAM<"YD:60Z,&(X-60Q9&$M,F)A."TT8S1F+3AA,3DM
M,34P8F-C,SAA,3<S(B\^(#QD8SIC<F5A=&]R/B \<F1F.E-E<3X@/')D9CIL
M:3Y4<FEM;65R+"!,>6YN/"]R9&8Z;&D^(#PO<F1F.E-E<3X@/"]D8SIC<F5A
M=&]R/B \9&,Z=&ET;&4^(#QR9&8Z06QT/B \<F1F.FQI('AM;#IL86YG/2)X
M+61E9F%U;'0B/E!O=V5R4&]I;G0@4')E<V5N=&%T:6]N/"]R9&8Z;&D^(#PO
M<F1F.D%L=#X@/"]D8SIT:71L93X@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F
M.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[0!(4&AO
M=&]S:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
M       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!9&]B90!DP     '_VP"$  ("
M @(" @(" @(# @(" P0# @(#! 4$! 0$! 4&!04%!04%!@8'!P@'!P8)"0H*
M"0D,# P,# P,# P,# P,# P! P,#!00%"08&"0T+"0L-#PX.#@X/#PP,# P,
M#P\,# P,# P/# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$(!!,'
M; ,!$0 "$0$#$0'_Q #X  $  P$! 0$! 0$         " D*!P8%! ," 0$!
M  (# 0$! 0            $" P8(!P4$"1    4# @(""0P," @*!@(3  $"
M P0%!@<1""$2$PDQ02(4M78W5SA1,K.4M!5UE1=W&!EAT=(CTW345846-E9Q
M@4)2DK*3-9%B,R0T5-6&L5-SQ9:FMDA8.:'!<H)#8R7$Y9=HHF2E)B='A_&#
M1$5&QBB(21$!  $! P8*!@@$! 8" P$!  $"$3$#L1($!34&(7%R@I*R4W,6
M!Y'1TC.S-$%1H5(45!478<$3-B+"DW3P@3)"HM.#1/%BXB-#_]H # ,!  (1
M Q$ /P"_P
M
M
M
M
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M,(U^N3WZK6JY8%M5"L524LW'Y,J32XSKSSJU:FI:UJ-2C/LF8*2Z\"
M
M
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M&K4QG0+-J%8I3<M735>9*9J5-C-/27$*-II)-R%Z--\VAGQ<7H6A:8L66 J
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MDQQM3+_>]#GR&N<DH(^Y=:2HN/9(%IC@:'P4
M
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M_O:VWYMJ<6WK0O\ :@W3.5R0K6KK#E,F/K,]$HCF^1,OK5VD-.*5]@$3$I8
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M/B9%H1Z"8L2:!
M
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MF+':@0
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M5JE:D"H
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M_D:D.*-+;E.??2S)Z5&NAKC']]1KV%HTUT,P6F+6M4&, <0W->C=N#^;6[/
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M5)6E*T*):%D2D+2>I&1\2,C(&-_H
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M8YL:T;!H*.2CV=2(='IYF6BEMQ&4M$XOB>JE\O,HS,]3,S!B>O
M
M                                        &8KK.+*EVKNPNJLN,&U
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M-I>0IUM2TK,ED9&I*C(^R1F#&]4
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M]><]3\BU",;M%Q)3%2X[BDZH.K5,EQ8:3XD7<M$^X79T4A/#MD14T?@H
M
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MEM)ZJ(C)F(:52+0B(S-1D7%1]D_\ */^@
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ME6-CN\]Q^'*C4*;C>HWK9%0JJTLU.BP&);73NEH2.DB*;-*G"["3-',1'H7
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M\@@
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MDDDN (F;76 0BMG39C@'<)-56[YM1<&[%(2TN\Z$_P!X5%Q"$\B2?425M/\
M*DB))O-K-)$24F2> )B;$4(?5$[?V9YOR[\OV; 2HU-P>^J8VHRUU2E;J:>>
MO#@?*E.O:T!.<GKAO .)L!T-V@XMM"-;S4SE.JU,U+D3YRT:FE4F6\:W7-#4
M9I3KR)U/D2DN (F;78P0
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M@0J5 A4NFQFX5.IL=N+ ALI)+;++*20VVA)=A*4D1$0,3]8
M
M                                             I8ZR/;CG;(V7;5O
MO$%G5>XJ2_:4:C7 [1GVT**5$FS7D=*UTJ'%:M22(E<IEH6FH+4RA%C/JW-T
M=^UB+%K=G(QM05+(I]Q7#(83T2->ZZ.&PXY(<7H1\I<B4F>FJTD>H+9T-'.'
M\56OA/'%K8RL]E3=$M>+T*)#NG32GW%&Y(E/&7 UO.J4M6G M="T21$#'+I8
M
M
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ME)D5F;4J00
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M;BJNR:W'M9V,S6ER(,F$;:Y:7%-$126VS5J32NQV 3,6.Z@@
M
M
M
M
M                       !RC,^&+(SU9#^/L@L3)%N2)D><ZU!D*BN]+%4
M:FS)Q)&>FI\2!,38B!]5MM/_ #1<OQT[]P"<Z5-N\C!UAX4W),8QL:/-8M5R
M%1GU-3)*I#_/./[]]]41'Q[7J M$KDOJMMI_YHN7XZ=^X!7.EW'!&SS"^W*X
MJQ=&-(-6BU6N4XZ5/74)ZY:#CF\V_HE"DEH?.VGB")FU*4$
M   *"=I%RW#=/649$GW)6YM=F1)%YP(DB<^M]3,2+*<;8CMFLSY&VTERI0G0
MDEV"!>;E^P*           CIN[]%[/?B/6/<JP3%ZNCJ<_V;SQ\)T#V&<":E
MT0*@
M
M
M
M                              C?NGW$T';1BBK7Y44,U&X)*O>^R;<=
M6:3GU)U)FA*N7NNB:21N.F6G<EH1\RDZDQ%J&FR_?UDC<ME^3CJZ[-MJ@TMB
MWIM83.I)3"D&[&>CMI0?3R'4\ID\>O#7@0)F+%K8*@       ,VW61>FI%^#
M+:_X07IN:204?EG3H=,@S*E4)"(<"GL.29TMT^5#3+236XM1]HDI(S,P&?BI
MYGW0]8+F.N8]PY=,G'&+:7TLE++$EZG,,TMITFT2JK(BD;\AY\S(TL$9H)7
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M1Z4
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M<?=,=2XUKO3JZVE9FXAJJ5Q;L>!&2:N!HCQ>FY?YO(W]@P6G@A?\"@
M
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M_K.\V8RNBGT#<UMY.V&9FBWUTV+/HTU,<U&1R(T2JN/HDD7 M">01F1]V78
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M%&<3,.5:1DOK%J)?5G3VJA0X61[0@6_5&32XR^5'D0(BGVU%W+C;CS*UH47
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MVW-.&BEJX:ZF92J].\$
M
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M6)2=48E2=MMZ&I)I)>2:DI!F6FI>]%'+4O5XD9 BJ]:8"H
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MW*.W#%U^WU5O?R[+C@RWJS5>@8C=,MJ?)90?0Q6VFDZ(;27<H+L>J#'+O;]
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MOJAJ>^YG_(-427^;0\?2HKIZ'Z^35::M''33L,*[?_K!-2X+='M8L3='9C%
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M(L:##81&APVD,18S9<J&VVTDE"$D78))$1$#&_0
M
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M:MCZ-58ZHE6NXY5TSHRTFE2$U-SFB:D?'4XB&5'J7 ST[0(JO39!
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MI7 @J
M
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MIF*DR7J?%)F9F1;]2X1MM#2$--(2VVVDDMMI(B2E)%H1$1<"(B!5_L
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M8E_JJ;4^LCSLT5MYBRPS0+1<,FZG#EUAKO>0UJ2CYX-$:Z.09'Q(GC(M2[)
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M04[WK9;4P\IK1$@B8:<[Y)OH"9(N&I)^]<Y O-EB_4%
M
M                  >;O&UZ;?%H75959)9T>[Z/.HE5)L]%][5".N,]RGVC
MY'#T 41XZ5NWZN:Y[MM[Y)I.7<47%-3)34*8S)7#?6UJVU+9E1&Y)PGG&R)+
MC3[9Z\I:$9))9E^"7OK\WN[LMP- J6-L+[9:]9$ZYHZZ;5K@3WY4Y,=E_F;=
MZ*4Y"I\:&:DD:#<=UY>)I-*]%)%D0F]L2VIR]L.-ZJBZ'X\O(U^R&)MVG$5T
MC$1J*E:8D%MS0NDZ+I7%+67 UK,DZI22C*S-J<@(
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MT@S(C42.8R(S,B*S-J2P(
M                                 9?^LS]+^_O@R@^"XX,E-R_7:)Z+
MV!/$>C^Y4 I-Z18(
M
M
M
M
M                             &7_ *S/TO[^^#*#X+C@R4W+]=HGHO8$
M\1Z/[E0"DWI%@@
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M(=14HBU44;NU-2BX&?WE:E$DM5)2"LQ8EH"
M
M
M                                                       &7_K,
M_2_O[X,H/@N.#)3<OUVB>B]@3Q'H_N5 *3>D6"
M
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M#^P
M
M
M R_]9GZ7]_?!E!\%QP9*;E^NT3T7L">(]']RH!2;TBP0
M
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M0IMQ6G$C;4>JU*,%:HL62@J
M
M
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M[+;K2'%QW%,ND27T-K+E6DRXI!#VX
M                                ,L?5Q>F=AO\ WA_[.U,&2JYJ<!C
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M6E4.FHAU%*I$R8ZEAAI*EQ4I(UN+))&HR+CQ,$V2E4"
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MXD!,6)& @
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M)%1H6G9UX@M$VM"NT3T7L">(]']RH!2;TBP0
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MA1)49:D>AF7$$/=@                 #*/A'TZ;%^=U'A90,DW-7 ,8
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MW13(E6I3Q]E<::RA]E7#U4+(P0^Z
M       #+_UF?I?W]\&4'P7'!DIN7Z[1/1>P)XCT?W*@%)O2+!
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M/'(?:C$2FNC4G0D&7=JX]L%9FU:2"H
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M+#QE=%PQ[JJUFP5T]5;BLK8:<82\XJ,VEM:E*+H65(:U,^/+KH6N@*2[0"
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MCE67!0,<N@@
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M8-91VT$K^,!Z8!^.H4ZGU:%(IU5@QZG3Y:>25 EM(>9=3KKRK;61I46I=@R
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MFQMLUZ6G=6.FI<7&USQH[%+D&ZM;U.K-.:0EYM3WKB4^E!2$*,]35TI)T)!
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M=N]:IU4NVR:^MY^V941AV8[;T@^[<-SD)1MP73XK,^Y:</GX$IPP*H7^@H
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M33Z]?-I0C@4*JS$=*EIOI>F;6IE7WM:V5FHVE*29H-2C3H?$B;77P0
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M34Y+9*=E2G%*4HNFDNFIU:4<QDA)JY4%P21$"9EUH$
M                      ,O_69^E_?WP90?!<<&2FY?KM$]%[ GB/1_<J 4
MF](L$
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M;KZ2-D_-K3?#%9!>FY=%M$]%[ GB/1_<J 5F](L$
M                                                   RCX1].FQ?
MG=1X64#)-S5P#&
M                                                  R_]9GZ7]_?
M!E!\%QP9*;E^NT3T7L">(]']RH!2;TBP0
M
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M]@3Q'H_N5 *S>D6"
M                           91\(^G38OSNH\+*!DFYJX!C
M
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MEV2,$/H@
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M,            !E'PCZ=-B_.ZCPLH&2;FK@&,
M!\&LW3;%NJ81<%QTNA+E$I45%1F,Q3<)&A*-!.K3S::EKH ^+\IN-O.#;7QM
M#_"@'RFXV\X-M?&T/\* ?*;C;S@VU\;0_P * ?*;C;S@VU\;0_PH!\IN-O.#
M;7QM#_"@'RFXV\X-M?&T/\* ?*;C;S@VU\;0_P * ?*;C;S@VU\;0_PH!\IN
M-O.#;7QM#_"@'RFXV\X-M?&T/\* ?*;C;S@VU\;0_P * ?*;C;S@VU\;0_PH
M!\IN-O.#;7QM#_"@'RFXV\X-M?&T/\* ?*;C;S@VU\;0_P * ?*;C;S@VU\;
M0_PH!\IN-O.#;7QM#_"@'RFXV\X-M?&T/\* ?*;C;S@VU\;0_P * ?*;C;S@
MVU\;0_PH!\IN-O.#;7QM#_"@'RFXV\X-M?&T/\* ?*;C;S@VU\;0_P * ?*;
MC;S@VU\;0_PH!\IN-O.#;7QM#_"@'RFXV\X-M?&T/\* ]53:G3:S"9J5(J$:
MJTZ3S=[SX;J'V7.11H5R.-FI)Z*29'H?9+0!^X
M            9?\ K,_2_O[X,H/@N.#)3<OUVB>B]@3Q'H_N5 *3>D6"
M             !5-UA>T;,>X^\L>5O&4*E2H-MT65!J:JA/1$43KL@G$DE*D
MGS%R]L%J9L5Z?5;;L/S1;7QTU]P"V=!]5MNP_-%M?'37W &=!]5MNP_-%M?'
M37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=
M!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP
M_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'
M37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=
M!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP
M_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'37W &=!]5MNP_-%M?'
M37W &=#0OA6UJM8V&\2V37D--UVS[,H-$K3;*R<:3+I].8C/DA9<%));9Z'V
MR!CETT                                                    !2
MMNTNS?SB[<)D&\,/,WG-Q',]Z7:&Q#@-W!24(:I,-J9RPU-RCBI.2AWG,D-Z
MJU7KW7,9:+'++)ZV_+EN2"IF5,64.Z%1%=#+=IKDFA3TF7!1NH>*8T:R_FDV
MV7:X=D$YJ:%@]:GMGNDF6;L*XL:S%$1/+J< YT,E'VD/4TY+AE]E3*01FRFO
M86<\.902U\GV3K;NM]TM2IT"H,+F)[?=Q#43Z/\ WD$"MCJH
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M"DS:FF"            &4?"/ITV+\[J/"R@9)N:N 8P
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MMV86VY8ZQG?#,9BZ;:]]_?1J&\4ADN_*O-FM<CJ2(E?>GTZ^H? %)29!
M                              R_]9GZ7]_?!E!\%QP9*;E^NT3T7L">
M(]']RH!2;TBP0
M                                                          /#
M7IC#'&1HW>=_6'0+SCDGD0FLTZ---!?_ "U/(4I!EVC29&0"%]_=6-M5O,GG
M:/;U8QU/=(S.5;E2<Z,U]HSCU IC1)]5+:4?Q'Q!;.E"J_.I^NN(MV3B_+],
MJR=34Q3;EA/4]Q&G83WU#.62S^ST* 3G/J[<\.;_ #".;\;T2[Y]SU#$+M70
MQ<1Q:VBM44H9H62C..MYQ<=.NG==$V8$S"\D%
M     &=+K=?21LGYM:;X8K(+TW+HMHGHO8$\1Z/[E0"LWI%@@
M                                                           &
M4?"/ITV+\[J/"R@9)N:N 8P
M                                                          &7
M_K,_2_O[X,H/@N.#)3<OUVB>B]@3Q'H_N5 *3>D6"
M
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MV!/$>C^Y4 K-Z18(
M                          !E'PCZ=-B_.ZCPLH&2;FK@&,
M
M     !&+<QNOQEM>M^!4;S7)J]PUWI"MJS:9R*FR^BT);JS<4E#+*#,B4M1_
M80E9D9 F(M5G3NN.JRI+ATW 41J&1Z-)DW&XXX9%VU&BG((M?4TX>J8+9K\G
MUQER>8>F?'[WY"!FO66#UL]PWG?5EV>[A*G4]N[*]3J,Y/37'7%,)GRFXYN$
M@X224:"7KIJ6OJ@C-76@J    J+ZPS?-=6'ZXUA7#\Q%*O)4)J;>=X<B'7:<
MU*3SL0XJ'"4E+RVS)Q3BB/E0I')W2C-!:F%8;-.WX5VSG\SLU3+DVTD,JJ)W
M@FKU0M8R2YU2FD]\$ZIE)(YND0GD(BUUT(%N!.K8+O[OBX+XH6$,W5M5SLW.
MKO*R+XF<O?S,[E,VH<UTM#?2^9<C;BB-PG#2E1J2K5!$PO&!0   !E_ZS/TO
M[^^#*#X+C@R4W+]=HGHO8$\1Z/[E0"DWI%@@
M
M                     59]:3N NC%F-K3QS9=2>HU6RN[4$5VL1E<C[='@
M(:2_';47=(.2N2E)J2>O(A:?Y0+4PZ+LBVJ89LW!6-KSEV91;MO:_K?@7%6;
MIJT-F:^W[ZL(E(BQ^G2X3*&4.);,D:<RDFI6IGP$R[_EK:O@S,=JU.VKDQ[1
M(,B8PM%.N>EP(T2J4]XR,T/1Y+3:5ERJ[HT*,T*["TJ($1*G;JW;\AT7-5>V
MUWS1J)>5#K"ZH5JSIL*/*7#J=))UZ049QYLU]!)99<6:-="4DE)(C4YS%JG,
M^LVQ?9N*-PM$?Q[2(5J1+LMB)7IU'I:2C-,U!,V7'6^RRT24LDXEA!]P1$:R
M6KLF8%+2);D]ZJ6]0:G(2M$BHTZ+*?0XDD+);S25J)22X),C/B7:!1]D
M                      9TNMU])&R?FUIOABL@O3<NBVB>B]@3Q'H_N5 *
MS>D6"
M                91\(^G38OSNH\+*!DFYJX!C
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MO2+!
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MNBVB>B]@3Q'H_N5 *S>D6"
M                                 91\(^G38OSNH\+*!DFYJX!C
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M=6QI<15^)F)G@LLL_P"=S7]=U:NF:/P,3$<.=;;_  LOGC=T'TWPP
M   4:=:EBRS9MS4K+5M9$MBG9&H-.C0KSQY(K4&)6WXB'%+@U&'#<>0^XM'.
M:%$DC4:"0I!=PH%Z4GL(]9QM_NZS:(65;E=QWD"/%;9N*)*ITMZ#)E-H^^R(
M;\-J0E+;AES$EWD4DSY=%:$HR)I=J^G[M \]E,]HU3\C!%DOI4;?+M2N&L4J
M@4;,5.G5>N3&*?2H28522IZ3)<2TRV1KB)21J6HBU,R("R4L00     *F=T?
M5P7;N!RKD'+L#+%,HM0KC4%NVK1DTMUQ@D08#$4D2)Z)!*;YUM&O5+"].;[
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M%OU6Q]+Z8QOT
M                           _X9$HC2HB,C+0R/L&0"LW<3M[ZNQ%>F2\
MHU.V\6W?.,W9T>BUHJ7,6;Q:D\JE,J<;(S,^;G[W+F/BHU M$RXYB_!'58.5
MN'WCDNFWG/-W6%3KKN-<-E;FI)2CHC13T.<4\$*YN;7L*(R ME;U2[>MVDV_
M%MJA4>#2;9CQ>](-&IS*(T1J,I)ET;33))0E)D9^M(@5<[Q=@'#6%2G'B_'E
M)M"14B),^H1FU.RWD$>I-KE/J<>-!'Q)'/RZ]H$VNP @
M          &=+K=?21LGYM:;X8K(+TW+HMHGHO8$\1Z/[E0"LWI%@@
M
M    &4?"/ITV+\[J/"R@9)N:N 8P
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M/MZ_FJ>1&6IT?Y/[)Q>_JZF&F4-8>K
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M<NBVB>B]@3Q'H_N5 *S>D6"
M                                  91\(^G38OSNH\+*!DFYJX!C
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M/?7^R=B?"TGV AMNZ7O<3BC*\;\Y/E-'Y=755H#>W/P
M +4=CODGN'QME^X( \^WK^:IY$9:G1_D_LG%[^KJ8:90UAZL
M
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ML@O3<NBVB>B]@3Q'H_N5 *S>D6"
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MS[1$1B8QJ)FR*H]*)P,2(MFF?1+]@R,0      ,H^$?3IL7YW4>%E R3<U<
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M0UAZL
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M6Z^DC9/S:TWPQ607IN71;1/1>P)XCT?W*@%9O2+!
M                              YQE_R6W_\  <WV)0^-O#L['Y%61][=
M;:NC=Y3E4_CGEU&         .CX@\J5@?#D+V5(^SN]M' Y=.5\'>G96D]W5
MD7 #H9RX      #*/A'TZ;%^=U'A90,DW-7 ,8
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M9^E_?WP90?!<<&2FY?KM$]%[ GB/1_<J 4F](L$       @GOK_9.Q/A:3[
M0VW=+WN)Q1E>-^<GRFC\NKJJT!O;GX                  %J.QWR3W#XVR
M_<$ >?;U_-4\B,M3H_R?V3B]_5U,-,H:P]6
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M71;1/1>P)XCT?W*@%9O2+!
M            YQE_R6W_ / <WV)0^-O#L['Y%61][=;:NC=Y3E4_CGEU&
M      .CX@\J5@?#D+V5(^SN]M' Y=.5\'>G96D]W5D7 #H9RX      #*/A
M'TZ;%^=U'A90,DW-7 ,8
M             X;N2\BUY_H[PC%&K[Y[)QN;UZ6X;@[;P.?\.I54/"'2(
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M%@@      $$]]?[)V)\+2?8"&V[I>]Q.*,KQOSD^4T?EU=56@-[<_
M            M1V.^2>X?&V7[@@#S[>OYJGD1EJ='^3^R<7OZNIAIE#6'JP
M
M            @ANGV#8OW)S9=XL3'K"RD^TVV]=T-OOAB>3#26645"(I:"<Y
M$(2A*T*0LDD1&:DI2DB8FQ33>6T_>AM<J\NJVE%N9=,:4:DWICB9,>9<;1J?
M-(:AFB2TDB]=TS1)[6ID"]L2\]2>L#WCVJ94X\N37RAKY'X=8I5+F/<R=2-#
MCDJ&M_4NWW9&!FP^E4^LAWB5)OH494:IC9I-+G>5#HR%*UTX\ZX:U),M/Y)D
M!FP_%2Z#OMW5J1%0[D:^J'4"Z-4BI2I,&WN17!1FN0N/!['9)/='ZA\ ."%B
M>WGJHK;M]VGW-N#KS=WU)HTO(L"C+<:I;:RT,DRYADAZ1IVT-I;3J7KG$@K-
M2X:)$BP(L:#"CMQ(4)I#$2*RDD-M--I)*$(26A$E)$1$1 J_0     XWN"RN
MO!V'+ZRJU0TW([9\-J0S15R#BI?6_):C))3Q-NFDDF[S'HD]=-.&NH)AFRS!
MD7<KO!@W;ERZ(3[F-<8,].ZQ"0J+;]'*0ZTREECI%*Z:2XIU',9J6[RGJ9I;
M(B27BR$O.I[\I.8O%J![L,$5+A=RN1)>*,"98R!3EFU5K>MV6JAOZ:]'4)">
M]H;AEVR2^ZA1EZA K#/OU=.#+4SUGBIED:FE<=L6=0Y%>GTJ2:U,SIKDAF/'
M;DF1D:DZNK=,C5W1H(CU2:B!>J;'0>L\VZV%A:]<=W5C>@1[6H.0H,]BHV_
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M^O\ R9 FI>F"@  ,Z76Z^DC9/S:TWPQ607IN71;1/1>P)XCT?W*@%9O2+!
M                                                YQE_R6W_ / <
MWV)0^-O#L['Y%61][=;:NC=Y3E4_CGEU&         .CX@\J5@?#D+V5(^SN
M]M' Y=.5\'>G96D]W5D7 #H9RX      #*/A'TZ;%^=U'A90,DW-7 ,8
M                                                 X;N2\BUY_H[
MPC%&K[Y[)QN;UZ6X;@[;P.?\.I54/"'2(         [EMM\M-F?I'P=*&T;F
M;6P>=U*FG[_;$Q^9\2E:J/=W-P     ^96Y3L&C5>;',B?API#[)J+4N=MM2
MDZEV^) ,UWUI.[#\[VU\2M?=@R9L'UI.[#\[VU\2M?=@9L'UI.[#\[VU\2M?
M=@9L'UI.[#\[VU\2M?=@9L/<XOZRK<_=>2\>6O5ZK;JZ3<ES4BE5-#5(:0LX
M\R8TPZ25DON3Y%GH?:!&;#16"@             R_P#69^E_?WP90?!<<&2F
MY?KM$]%[ GB/1_<J 4F](L$       @GOK_9.Q/A:3[ 0VW=+WN)Q1E>-^<G
MRFC\NKJJT!O;GX                  %J.QWR3W#XVR_<$ >?;U_-4\B,M3
MH_R?V3B]_5U,-,H:P]6
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M2U3[1/1>P)XCT?W*@&.;TBP0
M             .<9?\EM_P#P'-]B4/C;P[.Q^15D?>W6VKHW>4Y5/XYY=1@
M       #H^(/*E8'PY"]E2/L[O;1P.73E?!WIV5I/=U9%P Z&<N       RC
MX1].FQ?G=1X64#)-S5P#&
M              .&[DO(M>?Z.\(Q1J^^>R<;F]>EN&X.V\#G_#J55#PATB
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M2JDM;3U(JD5S5"N]W^D96I+A=RE1.<#2I*RT\,-,H,8             R_\
M69^E_?WP90?!<<&2FY?KM$]%[ GB/1_<J 4F](L$       @GOK_ &3L3X6D
M^P$-MW2][B<497C?G)\IH_+JZJM ;VY^                  !:CL=\D]P^
M-LOW! 'GV]?S5/(C+4Z/\G]DXO?U=3#3*&L/5@
M
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MV"66OKN):I?N"@  ,Z76Z^DC9/S:TWPQ607IN71;1/1>P)XCT?W*@%9O2+!
M                                                 YQE_P EM_\
MP'-]B4/C;P[.Q^15D?>W6VKHW>4Y5/XYY=1@        #H^(/*E8'PY"]E2/
ML[O;1P.73E?!WIV5I/=U9%P Z&<N       RCX1].FQ?G=1X64#)-S5P#&
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MIE.53;DRI<T"%;U,8,W5Q4_>($!!K[GF4TRVWS*[DM2-7<EV"]T->(,8
M         R_]9GZ7]_?!E!\%QP9*;E^NT3T7L">(]']RH!2;TBP0      ""
M>^O]D[$^%I/L!#;=TO>XG%&5XWYR?*:/RZNJK0&]N?@
M 6H['?)/</C;+]P0!Y]O7\U3R(RU.C_)_9.+W]74PTRAK#U8
M
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MUNOI(V3\VM-\,5D%Z;ET6T3T7L">(]']RH!6;TBP0
M                              .<9?\ );?_ ,!S?8E#XV\.SL?D59'W
MMUMJZ-WE.53^.>748         Z/B#RI6!\.0O94C[.[VT<#ETY7P=Z=E:3W
M=61< .AG+@      ,H^$?3IL7YW4>%E R3<U< Q@
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M+4Z/\G]DXO?U=3#3*&L/5@
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MGHO8$\1Z/[E0"LWI%@@
M        <XR_Y+;_ /@.;[$H?&WAV=C\BK(^]NMM71N\IRJ?QSRZC
M  '1\0>5*P/AR%[*D?9W>VC@<NG*^#O3LK2>[JR+@!T,Y<      !E'PCZ=-
MB_.ZCPLH&2;FK@&,
M         <-W)>1:\_T=X1BC5]\]DXW-Z]+<-P=MX'/^'4JJ'A#I$
M  =RVV^6FS/TCX.E#:-S-K8/.ZE33]_MB8_,^)2M5'N[FX       !FIZQR\
MLCVQO,N*KTZO5>UY%$HM#;L2L4Z4]#?13U0VWG%,/,J0HD]^JD:Z'ZXC!>FY
M?9MPFU.IX$P_5ZU=4F]JQ6[3I=4JESS%)6]*D3HZ)+O,I))]8IPT%J7-HDN;
MNM05EVH$                ,O\ UF?I?W]\&4'P7'!DIN7Z[1/1>P)XCT?W
M*@%)O2+!       ()[Z_V3L3X6D^P$-MW2][B<497C?G)\IH_+JZJM ;VY^
M                 !:CL=\D]P^-LOW! 'GV]?S5/(C+4Z/\G]DXO?U=3#3*
M&L/5@
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M/$>C^Y4 K-Z18(
M   '.,O^2V__ (#F^Q*'QMX=G8_(JR/O;K;5T;O*<JG\<\NHP        !T?
M$'E2L#X<A>RI'V=WMHX'+IRO@[T[*TGNZLBX =#.7       91\(^G38OSNH
M\+*!DFYJX!C
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MH_R?V3B]_5U,-,H:P]6
M                                 !%7=#M-LS=3 LZGWA<E:MUNS)$V
M1 71CCDIU4U+*%DYWPRZ6B29+333LF"8FQ#_ .J"PEYS+X_I4W\C!.<?5!82
M\YE\?TJ;^1@9SK>"^KBQ;@7*EK98MR^;JK%9M3O[O.FU(X)Q7._H,B OI.AC
M-K[E$A2BT47$B[0$U6K#P5                            9TNMU])&R?
MFUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"
M                      !SC+_DMO\ ^ YOL2A\;>'9V/R*LC[VZVU=&[RG
M*I_'/+J,         ='Q!Y4K ^'(7LJ1]G=[:.!RZ<KX.].RM)[NK(N '0SE
MP      &4?"/ITV+\[J/"R@9)N:N 8P
M                       !PW<EY%KS_1WA&*-7WSV3C<WKTMPW!VW@<_X=
M2JH>$.D0        !W+;;Y:;,_2/@Z4-HW,VM@\[J5-/W^V)C\SXE*U4>[N;
M@       $9LI;.]N6:;L>OC)F.OUENE^,S#=JGOO5X>K,<C2TCHH4UAKN2/L
M\NI]L$VN<_5Q;,?,W_UAN+_:8&=)]7%LQ\S?_6&XO]I@9TOJT+J_-HMM5NC7
M'1,2=Y5F@3H]2I$SW^K[G0RHCJ7F7.1RHJ0KE6DCT4DR/MD9 6RF4"
M       !E_ZS/TO[^^#*#X+C@R4W+]=HGHO8$\1Z/[E0"DWI%@@      $$]
M]?[)V)\+2?8"&V[I>]Q.*,KQOSD^4T?EU=56@-[<_
MM1V.^2>X?&V7[@@#S[>OYJGD1EJ='^3^R<7OZNIAIE#6'JP
M
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MWPQ607IN71;1/1>P)XCT?W*@%9O2+!
M                    YQE_R6W_ / <WV)0^-O#L['Y%61][=;:NC=Y3E4_
MCGEU&         .CX@\J5@?#D+V5(^SN]M' Y=.5\'>G96D]W5D7 #H9RX
M    #*/A'TZ;%^=U'A90,DW-7 ,8
M                     X;N2\BUY_H[PC%&K[Y[)QN;UZ6X;@[;P.?\.I54
M/"'2(         [EMM\M-F?I'P=*&T;F;6P>=U*FG[_;$Q^9\2E:J/=W-P
M     #.IUE64,EVIN?JM(M?(=S6W246[2'44RE5>9#CDM;2S6HFF'4(U5VST
MX@O3<@'\NF;?/%?'_2&I?E +6'RZ9M\\5\?](:E^4 6.M8.RIG:M9;Q6AS)%
M^5:CO7G0X]20JL51^,MI4]@G6WB-Y2#2:%=T2N&A\> (EK-!C
M  &7_K,_2_O[X,H/@N.#)3<OUVB>B]@3Q'H_N5 *3>D6"       03WU_LG8
MGPM)]@(;;NE[W$XHRO&_.3Y31^75U5: WMS\                  "U'8[Y
M)[A\;9?N" //MZ_FJ>1&6IT?Y/[)Q>_JZF&F4-8>K
M                                                        I/ZX
MFZZDS3\'V.P\MND5"16JW4V->X=D1$Q8\56FO9;3(>[/\X%J4E>KUVWXQLW
M]BY'>MJF5[(%_P +WYJ-T3&69;\9IY:R8B1%K)?0);:))+)&BE+YN?L)2D52
MF?D[#N-,QV_.MO(MGTVY(,UE3+<F3';.7%-1&1.Q9/+TC+B==24@R/\ BU(%
M;6<W:M&GX6W_ %"L>C51Z;'H5\URQITI/ IT-#DJGJ4ZA/ R,T)=T[!*21]H
M&2;FGX&,                           !G2ZW7TD;)^;6F^&*R"]-RZ+:
M)Z+V!/$>C^Y4 K-Z18(
M        '.,O^2V__@.;[$H?&WAV=C\BK(^]NMM71N\IRJ?QSRZC
M '1\0>5*P/AR%[*D?9W>VC@<NG*^#O3LK2>[JR+@!T,Y<      !E'PCZ=-B
M_.ZCPLH&2;FK@&,
M        <-W)>1:\_P!'>$8HU??/9.-S>O2W#<';>!S_ (=2JH>$.D0
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MO2+!       ()[Z_V3L3X6D^P$-MW2][B<497C?G)\IH_+JZJM ;VY^
M             !:CL=\D]P^-LOW! 'GV]?S5/(C+4Z/\G]DXO?U=3#3*&L/5
M@
M               5B]:1@VM9/PU0[^MB$NI5K$$N7.J$!I)J=71IS;:9SC9%
MQ4;*H[+AE_,)9]K0RU,JX]IG6*W7MWM2+C6ZK33D"P*>\ZY0.AE=Y5*F)D.*
M>>;;6IMUM]HW%*4E"B2I)J/[YRZ)(F:;4B\F=;W)J%N3J;BG%CU!N*:RIJ/<
ME>FMR$0E*(RZ1N&RUHZM.I&GG<))'V4J+@!FN&]67A^XLH;A5YDKC<B9;N-U
M2ZE4JW*U64VNU!IQIAHW%<5.)Z94E1D? TIYO7EJ*I:/04
M              9TNMU])&R?FUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"
M                                              !SC+_DMO\ ^ YO
ML2A\;>'9V/R*LC[VZVU=&[RG*I_'/+J,         ='Q!Y4K ^'(7LJ1]G=[
M:.!RZ<KX.].RM)[NK(N '0SEP      &4?"/ITV+\[J/"R@9)N:N 8P
M                                               !PW<EY%KS_1WA
M&*-7WSV3C<WKTMPW!VW@<_X=2JH>$.D0        !W+;;Y:;,_2/@Z4-HW,V
MM@\[J5-/W^V)C\SXE*U4>[N;@       %2>\/K!LE[<LT3L:6O9=LURDQ:3
MJ")]5*8<@URT*4M)]!(;1H6G#N06BFU%KZWW-OFSL?\ HU+\L!.:_+-ZWC/+
ML9UN!CVQ(4I9:-R7&*D\2->R?)W\C4_4U/3[!]@#-02HK&0]U&?*3'K$Q^X[
MZRK<$=NK5$FR3R-K-*'7C0TG1MF+'09Z)3HAM' M"!-S80#&
M ,O_ %F?I?W]\&4'P7'!DIN7Z[1/1>P)XCT?W*@%)O2+!       ()[Z_P!D
M[$^%I/L!#;=TO>XG%&5XWYR?*:/RZNJK0&]N?@                  6H['
M?)/</C;+]P0!Y]O7\U3R(RU.C_)_9.+W]74PTRAK#U8
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MZ;ET6T3T7L">(]']RH!6;TBP0
M              .<9?\ );?_ ,!S?8E#XV\.SL?D59'WMUMJZ-WE.53^.>74
M8         Z/B#RI6!\.0O94C[.[VT<#ETY7P=Z=E:3W=61< .AG+@
M,H^$?3IL7YW4>%E R3<U< Q@
M                #ANY+R+7G^CO",4:OOGLG&YO7I;AN#MO Y_PZE50\(=(
M@        #N6VWRTV9^D?!TH;1N9M;!YW4J:?O\ ;$Q^9\2E:J/=W-P
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MLG%[^KJ8:90UAZL
M                            ,_76+90S[:FY2ITC'F1,@6W;:*!276J9
M;M7JL."3RVU&XHFHCJ&^91^N/34^V"]-SKV^S(.9K;P)M'J=C7O>E KU<H"7
M;MJ%"J51BRYCWO735\TYR,XEQU72+6>KAF?,:C[)F"(5;?+INV\\67?^D->_
M* 6L@^73=MYXLN_](:]^4 60EYL.RON(N7==BJB7UDK(U?M6;[^>^E(KU9J\
MNGO='0J@XUTS,IY32N5U*%)YBX*(C+B1 B;FC0%
M       &=+K=?21LGYM:;X8K(+TW+HMHGHO8$\1Z/[E0"LWI%@@
M                                        <XR_Y+;_ /@.;[$H?&WA
MV=C\BK(^]NMM71N\IRJ?QSRZC         '1\0>5*P/AR%[*D?9W>VC@<NG*
M^#O3LK2>[JR+@!T,Y<      !E'PCZ=-B_.ZCPLH&2;FK@&,
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MU_-4\B,M3H_R?V3B]_5U,-,H:P]6
M                                          !#O=UNZIVT^G6/4*A8
M\F]2O63/CM-1YZ()QS@H86:E&MA[FYNF^QIH"8BUVG!.5X^<,369E6+17+=C
MWA&?D-T5U\I*V"9DNQN4W4H;)6IM:^M+L@2ZV"%95B=8DN[MT#6W2K8H;MA#
M=S5FU9ET(K9U!1S:8<AMM2&$P6$DEUV/R_Y0]"5KKPXELW@6:@J
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M*&T;F;6P>=U*FG[_ &Q,?F?$I6JCW=S<        S!]96NM3]XU\PIYFF*U
MM^+;:G5$E!1'*9&6K12CT2GOEQ[4STXZ_P (,E-R^3!>T[#."[3HE%H=D4:I
M7+%B-(KU[SH34BI3Y1)(WG3?>2M;:%+(S2V@R0DNP7;!29M=,O/#.)LATF10
M[UQS;UQTZ2VII3<NGL&XV2OY3+R4I=:47:4VI*B[)&0(M9;\\8O>P%NHN3'6
M/9KU2?L^Y:9(L=TS-<A*YC<6HP&5*3RFIQHWT-J,M-5),^ ,D3;#6X#&
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MY$9:G1_D_LG%[^KJ8:90UAZL
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M2(J)<MI*^@CQUR$H-]Q;ZDFOEUY4DHU<>4E$3+2@"@
M         #.EUNOI(V3\VM-\,5D%Z;ET6T3T7L">(]']RH!6;TBP0
M                                          .<9?\ );?_ ,!S?8E#
MXV\.SL?D59'WMUMJZ-WE.53^.>748         Z/B#RI6!\.0O94C[.[VT<#
METY7P=Z=E:3W=61< .AG+@      ,H^$?3IL7YW4>%E R3<U< Q@
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M1D#&_4   #+_ -9GZ7]_?!E!\%QP9*;E^NT3T7L">(]']RH!2;TBP0
M"">^O]D[$^%I/L!#;=TO>XG%&5XWYR?*:/RZNJK0&]N?@
M   6H['?)/</C;+]P0!Y]O7\U3R(RU.C_)_9.+W]74PTRAK#U8
M
M    $9=RVVG$VXBC4%S+54J='I%@G.GL5"!.8@--(D-M]\.277VG4DA*62/4
M]"+B9@F)L<PQQN.V6X(L>V<46UG>BR:%:I.0J6\[+54G#Z9YR0HW),1CHC+F
M</NN">UJ!9,NA?3<VG^?2VO[5W\&!9+\MG[V=NN1,F6IB?'UY/7G==VKF)B*
MI\"4B''*#"D3G%/R93;"3(VXRB3T7.?,:=2(M3(6)8@@
M           !G2ZW7TD;)^;6F^&*R"]-RZ+:)Z+V!/$>C^Y4 K-Z18(
M                                            '.,O^2V__@.;[$H?
M&WAV=C\BK(^]NMM71N\IRJ?QSRZC         '1\0>5*P/AR%[*D?9W>VC@<
MNG*^#O3LK2>[JR+@!T,Y<      !E'PCZ=-B_.ZCPLH&2;FK@&,
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MJ.QWR3W#XVR_<$ >?;U_-4\B,M3H_P G]DXO?U=3#3*&L/5@
M
M  5!];IE"M6[CW&N,*1.7$AY"J$^H7.EE9I6]%HQ1NACN$1\6W'I1.::<5-%
MZG$M2JHJVSK,M#V]Q]RE4BTN+84I$.2Q33DN+JQPI[R6(\TV$,J:2TM3B--7
M27HHCY-.P6M>ZQ1U?V;\U8FI>7<>5:T:O2JN<Q$6VG:C)C55+L)]V.XTXEZ&
MF*E2E-ZIUD:<JDF9EJ>@F78^K-Q7 7N@?GW/<SMIY"P^BJJ^3B9 /II_2Q9-
M(F)[Y-Y/1+B+DZK1T:C/AIPYC215<T; H
M SI=;KZ2-D_-K3?#%9!>FY=%M$]%[ GB/1_<J 5F](L$
M                                 #G&7_);?_P'-]B4/C;P[.Q^15D?
M>W6VKHW>4Y5/XYY=1@        #H^(/*E8'PY"]E2/L[O;1P.73E?!WIV5I/
M=U9%P Z&<N       RCX1].FQ?G=1X64#)-S5P#&
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MQME^X( \^WK^:IY$9:G1_D_LG%[^KJ8:90UAZL
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M5D%Z;ET6T3T7L">(]']RH!6;TBP0
M                 .<9?\EM_P#P'-]B4/C;P[.Q^15D?>W6VKHW>4Y5/XYY
M=1@        #H^(/*E8'PY"]E2/L[O;1P.73E?!WIV5I/=U9%P Z&<N
M  RCX1].FQ?G=1X64#)-S5P#&
M                  .&[DO(M>?Z.\(Q1J^^>R<;F]>EN&X.V\#G_#J55#PA
MTB         .Y;;?+39GZ1\'2AM&YFUL'G=2II^_VQ,?F?$I6JCW=S<
M   X+>NYW!..,A1,77[D:F6E=\Z Q4H\>I](Q$)F0XMMOI9JD=[,J,VS/E=<
M2?*9*[!@FQVVG5*G5B#&J=)GQJI39J.DAU"(ZA]AU!\.9MQLU)47V2,$/V@
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MJGD1EJ='^3^R<7OZNIAIE#6'JP
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MTWPQ607IN71;1/1>P)XCT?W*@%9O2+!
M                     YQE_P EM_\ P'-]B4/C;P[.Q^15D?>W6VKHW>4Y
M5/XYY=1@        #H^(/*E8'PY"]E2/L[O;1P.73E?!WIV5I/=U9%P Z&<N
M       RCX1].FQ?G=1X64#)-S5P#&
M                       .&[DO(M>?Z.\(Q1J^^>R<;F]>EN&X.V\#G_#J
M55#PATB         .Y;;?+39GZ1\'2AM&YFUL'G=2II^_P!L3'YGQ*5JH]W<
MW        ,UG6CXVN^W-R=8R#4H,AVS\AP*8NVZP2%'&0[ @,PI$,W/6DXE3
M!N\O\U9'ZH+TW+J-E]\8UNW;GBB!CJIT]U%LVQ3:=<5!C.H.5 J33"4S4RF2
MT6E2Y!.+YE)+I-><M24"LI5@@      $$JGU;NTVLU*H5>HV15)-0JLEV9/D
MJKM3(W'GUFXXL])&G%2C,$YTOP_5F;0/W!J?Q]5/R@#.D^K,V@?N#4_CZJ?E
M &=*==)ID.B4NFT:G-FU3Z1%9A06E*-9I9CH)MM)J5J9Z)27$P0^@   #+_U
MF?I?W]\&4'P7'!DIN7Z[1/1>P)XCT?W*@%)O2+!       ()[Z_V3L3X6D^P
M$-MW2][B<497C?G)\IH_+JZJM ;VY^                  !:CL=\D]P^-L
MOW! 'GV]?S5/(C+4Z/\ )_9.+W]74PTRAK#U8
M                                                   %//6WXKOF
MZK3QED:WJ?)K-L8^.KL7<Q&2IPX"*AWHMJ:M"=3)K_-E(<7IHGN->!\"U,NC
M]6=EO#36W2VL?1;JHU"R#1JA5';NM^=)9B394B5.=<8EM(=4A3Z#C*8;YT$?
M*:20?$BU%4+.8\B/+91(BOMR8[I:MOM*):%$1Z<%),R/B0*O[
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M1%)BQ. $   SI=;KZ2-D_-K3?#%9!>FY=%M$]%[ GB/1_<J 5F](L$
M                                           #G&7_ "6W_P# <WV)
M0^-O#L['Y%61][=;:NC=Y3E4_CGEU&         .CX@\J5@?#D+V5(^SN]M'
M Y=.5\'>G96D]W5D7 #H9RX      #*/A'TZ;%^=U'A90,DW-7 ,8
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M.C_)_9.+W]74PTRAK#U8
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M6Y4(JHCI2V*C49*R)"C,S3R24<?5U]0%HBQH*VB>B]@3Q'H_N5 *3>D6"
M                                              !SC+_DMO\ ^ YO
ML2A\;>'9V/R*LC[VZVU=&[RG*I_'/+J,         ='Q!Y4K ^'(7LJ1]G=[
M:.!RZ<KX.].RM)[NK(N '0SEP      &4?"/ITV+\[J/"R@9)N:N 8P
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M4\B,M3H_R?V3B]_5U,-,H:P]6
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M?;1/1>P)XCT?W*@%)O2+!
M           YQE_R6W_\!S?8E#XV\.SL?D59'WMUMJZ-WE.53^.>748
M    Z/B#RI6!\.0O94C[.[VT<#ETY7P=Z=E:3W=61< .AG+@      ,H^$?3
MIL7YW4>%E R3<U< Q@
M          #ANY+R+7G^CO",4:OOGLG&YO7I;AN#MO Y_P .I54/"'2(
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M>1&6IT?Y/[)Q>_JZF&F4-8>K
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MW;37J54<E][0[4@RFS;>31X9K6<HTJT4E,IY?<DHBU2VE9:I6DP15*V@%0
M9TNMU])&R?FUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"
M                                !SC+_DMO_P" YOL2A\;>'9V/R*LC
M[VZVU=&[RG*I_'/+J,         ='Q!Y4K ^'(7LJ1]G=[:.!RZ<KX.].RM)
M[NK(N '0SEP      &4?"/ITV+\[J/"R@9)N:N 8P
M                                 !PW<EY%KS_1WA&*-7WSV3C<WKTM
MPW!VW@<_X=2JH>$.D0        !W+;;Y:;,_2/@Z4-HW,VM@\[J5-/W^V)C\
MSXE*U4>[N;@       &7/K*CJ)[Q<FE-Y^]BB4 J/S$6G>_O-#-7+IVNFZ3L
M]O4&2FYI$PX5JEB;&A6/WO\ J@5L4HK;[V,C:[S[U;Z+0R[?+V=>.NNO$&.7
M2 &3#=45(+=[E4L9=%T7ZZF='[R,C1[ZFMLY/1Z</].Z3L<->P#)%S6>#&
M           ,O_69^E_?WP90?!<<&2FY?KM$]%[ GB/1_<J 4F](L$
M @GOK_9.Q/A:3[ 0VW=+WN)Q1E>-^<GRFC\NKJJT!O;GX
M   %J.QWR3W#XVR_<$ >?;U_-4\B,M3H_P G]DXO?U=3#3*&L/5@
M
M      <0SK8F![HM=-QY_HU!GVI8Z7IB*K<"^CC0>^.1#ADKG3W3AI0DDEJ:
MCT2DC,R($PAE2^L9V58KHL"R+ ;KR[5H!N1Z1#H5%=;B-MJ6IU2FBG.QG.52
MUJ/B6NO:!.;+]7UK^U[\WWQ\4Q?RX#-ETS#O6#X'SAD>W<769#NIJY;G[\][
M7*E3V&(I=Y0WYKO2.(E.*+[VPK31)\="^R")I3F!            #\LZ#!JD
M&93*G#8J--J+#D6H4^4VEYA]AY)H<:=;61I6A:3,E),M#+@8#GEK85PW8U61
M7K)Q+9EGUUMI;+=:HE!IU/EI:<+1:"?C,-K)*B[):Z&!:Z: \5?6-[ R=2"H
M.0[-H]YTA"S<8A5>(U*2TX9<O2,FXDS;7IPYD&1_9 >%L3;5@/&=617K%Q);
M5NUUK_1ZTQ";7+9U+0^A?=YUMZEV>0RU[8)M=O!#X]?MV@771YUOW11(%QT&
MIHZ*HT6IQFI<1]&I'RNLO)4A1:D1\2 <,H>T7;);E89KU(P?:4>J1EF[&?<I
M[<A+3FO,2VVG^=M*DGQ29)U3_)T!-LI%$1)(DI(B(BT(B[!$"'_0   9TNMU
M])&R?FUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"
M                           !SC+_ )+;_P#@.;[$H?&WAV=C\BK(^]NM
MM71N\IRJ?QSRZC         '1\0>5*P/AR%[*D?9W>VC@<NG*^#O3LK2>[JR
M+@!T,Y<      !E'PCZ=-B_.ZCPLH&2;FK@&,
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M<8U%FL5>KO)43,VIQ5$]#@,J/@XKI20XZ7$B;(R5H:T:BJ6G$&,
M    9?\ K,_2_O[X,H/@N.#)3<OUVB>B]@3Q'H_N5 *3>D6"       03WU_
MLG8GPM)]@(;;NE[W$XHRO&_.3Y31^75U5: WMS\                  "U'
M8[Y)[A\;9?N" //MZ_FJ>1&6IT?Y/[)Q>_JZF&F4-8>K
M                                                           I
M:ZX6]*U#H>&+ BO.L4*NRJO6JN@C,D2'Z>F*Q%2>G9Z,I3IF1]LTGV@6I1FP
M1U8&2,PXZM_(];OZE6# NV*W4;<I3D-VHRG(+Y<S,A_E=80WTJ#):")2SY3(
MSY3[DB9J2!^IK_\ NCO^J'_V; SG;]N'5H?1^S/9N7?EJ_6W]4O?'_\ )[]6
M^\.^._Z=)@?Z3[Z2>3D[YY_\FK7EY>&NI$35:M.!4
M        !G2ZW7TD;)^;6F^&*R"]-RZ+:)Z+V!/$>C^Y4 K-Z18(
M                                         '.,O^2V_P#X#F^Q*'QM
MX=G8_(JR/O;K;5T;O*<JG\<\NHP        !T?$'E2L#X<A>RI'V=WMHX'+I
MRO@[T[*TGNZLBX =#.7       91\(^G38OSNH\+*!DFYJX!C
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MJZF&F4-8>K
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M?FUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"
M                       !SC+_ )+;_P#@.;[$H?&WAV=C\BK(^]NMM71N
M\IRJ?QSRZC         '1\0>5*P/AR%[*D?9W>VC@<NG*^#O3LK2>[JR+@!T
M,Y<      !E'PCZ=-B_.ZCPLH&2;FK@&,
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M(RU.C_)_9.+W]74PTRAK#U8
M                                     $!]]>TV\]U-)QQ3[/N2BVZY
M9DNI2)ZZR<@DNIFMQT()OO=ET]4FR>NNG9($Q-BN;ZH+-OG,L?\ I5+\C!;.
M/J@LV^<RQ_Z52_(P,Y(3:MU<64L"YZL/+%QWS:M8HUJ>^G?E-IISCE.=_4N7
M 1T?31FT=RN0E1ZJ+@1]L$35:N-!4                           !G2Z
MW7TD;)^;6F^&*R"]-RZ+:)Z+V!/$>C^Y4 K-Z18(
M                             '.,O^2V_P#X#F^Q*'QMX=G8_(JR/O;K
M;5T;O*<JG\<\NHP        !T?$'E2L#X<A>RI'V=WMHX'+IRO@[T[*TGNZL
MBX =#.7       91\(^G38OSNH\+*!DFYJX!C
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M_9.+W]74PTRAK#U8
M                              '@\FY*L_$-CU_(=]U1-(MJW(_339&G
M,XXM1DAIAEO@:W75F2$)+LF?:+B HLREUMF6ZU4Y<?$UH42R+=2HTPIM7:55
M*JXDC,B6L^D;C-\Q<303:^7L=(KL@OFI1[>-X^6KBV@;A,X7_5H%>NW'4R1%
MM5Q4!B-&2ZN'%[T0\S%)@EI[YD$:N)&9<-01,<*0&S7>Y;6Z2#/M^JTMJT,I
MT"-WW5+=:<4Y%FQ"4EM4R"M?=<J5K22VUF:D<R>Z61ZD1,6)V @
M                  !G2ZW7TD;)^;6F^&*R"]-RZ+:)Z+V!/$>C^Y4 K-Z1
M8(                                                 '.,O^2V__
M (#F^Q*'QMX=G8_(JR/O;K;5T;O*<JG\<\NHP        !T?$'E2L#X<A>RI
M'V=WMHX'+IRO@[T[*TGNZLBX =#.7       91\(^G38OSNH\+*!DFYJX!C
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M+!       ()[Z_V3L3X6D^P$-MW2][B<497C?G)\IH_+JZJM ;VY^
M           !:CL=\D]P^-LOW! 'GV]?S5/(C+4Z/\G]DXO?U=3#3*&L/5@
M
M             4J=</>%2CTC"5AQWW&Z35)58KE58(]$.OPD1H\0S(CXFA,E
M[LE_*!:EZ?'FT?"5G["[LR5,M"E7CD2Z,/UB[U7=5F&YCL"5+H3TV,W!2Z2D
M1U1#4DB6@B7SI-7-V"2+>%\CJP\?VAE/;%F>P;]HK=PVG<5Z):J](=6XTETF
M84!]HR<96AQ*D.MI6DTJ(R,B,"J]#;!MN,X-ZQZAV'9]4>J%'MZ^:A;<60M:
M7''($IE^.IJ0:.1*UM(<T6>A=VCFY2,M 6GAAID!C
M         9TNMU])&R?FUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"
M                                         !SC+_DMO_X#F^Q*'QMX
M=G8_(JR/O;K;5T;O*<JG\<\NHP        !T?$'E2L#X<A>RI'V=WMHX'+IR
MO@[T[*TGNZLBX =#.7       91\(^G38OSNH\+*!DFYJX!C
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M]XF%L.0)4:=!Q-9L*;"=0_#F,4&GMNM.MJ)2'&UI8)25)41&1D>I&!:Z8
M           ,O_69^E_?WP90?!<<&2FY?KM$]%[ GB/1_<J 4F](L$
M @GOK_9.Q/A:3[ 0VW=+WN)Q1E>-^<GRFC\NKJJT!O;GX
M   %J.QWR3W#XVR_<$ >?;U_-4\B,M3H_P G]DXO?U=3#3*&L/5@
M
M      5U=9#MMN//.)Z)7[&@N5>]\62I<^!0FNZ=G4Z:VVF>Q'3PYGB..TXA
M)<5<BD)(U*20+4S8I.L?>9G+'6(;NP$U*IU:L*X:/5;=.EUV(XY*I4>JLNL2
MDPGFGF%H473*4E+O2(2K^1IJ0+6/X83WD9?V^8ZNC'F,?>>E-W74W*I+N>3$
M5*J,9U<=J,11>D=[W3HEK7[XROB?: F+4M.K,P%>.0\S%N)N^--<M6T')TR!
M7ZASK56J_-2ZPI2''>+W0]*XZXX1GHZ2"/4S5H15+0R"@
M            #.EUNOI(V3\VM-\,5D%Z;ET6T3T7L">(]']RH!6;TBP0
M                                             .<9?\EM_P#P'-]B
M4/C;P[.Q^15D?>W6VKHW>4Y5/XYY=1@        #H^(/*E8'PY"]E2/L[O;1
MP.73E?!WIV5I/=U9%P Z&<N       RCX1].FQ?G=1X64#)-S5P#&
M                                              .&[DO(M>?Z.\(Q
M1J^^>R<;F]>EN&X.V\#G_#J55#PATB         .Y;;?+39GZ1\'2AM&YFUL
M'G=2II^_VQ,?F?$I6JCW=S<        H.ZT_-RYU]KP95;#H-1B6_!@5FVKW
M7WRBL0'YR-9"&EH=)HVG$H)*D*09'P/UR4J27IA#7%>^W<UB"WZ=:5KW^4ZU
MJ.T3%)H=:A1J@B,RA/(AIEYUOIT-H+3E03G*G0B21%J0)LAU?ZTG=A^=[:^)
M6ONP,V'N<7]95N?NO)>/+7J]5MU=)N2YJ12JFAJD-(6<>9,:8=)*R7W)\BST
M/M C-AHK!0             9?^LS]+^_O@R@^"XX,E-R_7:)Z+V!/$>C^Y4
MI-Z18(      !!/?7^R=B?"TGV AMNZ7O<3BC*\;\Y/E-'Y=755H#>W/P
M               +4=CODGN'QME^X( \^WK^:IY$9:G1_D_LG%[^KJ8:90UA
MZL
M                #\LZ=!I<*74JG,8IU.@,KD3I\IQ+++++:34MQQQ9DE*4
MI(S,S/0B 0!IM&V);U;YO^! LFE7Y<5F)ANW'=\-B71^_CE./H)34Z$[$?E=
M&IC13BM4F2D<BEI/@6X8> RWM^V$;0+=H&1;XPW)K\*IU]BB1"<DS*VI+TAA
M^02W(,Z<F,MI"8RC5J@SX\"4>A 6S*?&(LEXMRG9=.N#$->IE;M!A*8<9FF(
M[W*$IM):178AI;7&4A)D?1K0D^4R,BT,C!673P
M      &=+K=?21LGYM:;X8K(+TW+HMHGHO8$\1Z/[E0"LWI%@@
M                                       <XR_Y+;_^ YOL2A\;>'9V
M/R*LC[VZVU=&[RG*I_'/+J,         ='Q!Y4K ^'(7LJ1]G=[:.!RZ<KX.
M].RM)[NK(N '0SEP      &4?"/ITV+\[J/"R@9)N:N 8P
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MJIFF9B;X?[$H
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MNOI(V3\VM-\,5D%Z;ET6T3T7L">(]']RH!6;TBP0
M                             .<9?\EM_P#P'-]B4/C;P[.Q^15D?>W6
MVKHW>4Y5/XYY=1@        #H^(/*E8'PY"]E2/L[O;1P.73E?!WIV5I/=U9
M%P Z&<N       RCX1].FQ?G=1X64#)-S5P#&
M                              .&[DO(M>?Z.\(Q1J^^>R<;F]>EN&X.
MV\#G_#J55#PATB         .Y;;?+39GZ1\'2AM&YFUL'G=2II^_VQ,?F?$I
M6JCW=S<        S@]9K>MY4+=+5H%$NVM4>"FW*.M,*#/D1VB4II?,HD-N)
M3J?;/0%Z;E?7RFY)\X-R_&TS\*(6/E-R3YP;E^-IGX4!VO 5>S/<.5\6RX=:
MO6N4-F]:&S59+,FHR8B4%.CJ=0^M*E((N16JB5VCX\ 1+6P)8P
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MXZ=7M-3\;;P=K/\ IT>P?(#@3]W(WQO._*P\)ZE[..G5[1XVW@[6?].CV#Y
M<"?NY&^-YWY6'A/4O9QTZO:/&V\':S_IT>P[<U/I++3;+4^,EMI)(;3TR#T2
MDM"+4U:]@;/3BX5,615%D?Q:C5@XU4S,TS;/\)?T]]*;^<8W]LC[8G^OA_>C
MTPK^'Q?NSZ)/?2F_G&-_;(^V']?#^]'I@_#XOW9]$GOI3?SC&_MD?;#^OA_>
MCTP?A\7[L^B7[B,C(C(]2/L&,K"
M           INZW['E5JMFXGR;3XCC]-M&H5&BW$\V1J)E-63'<B.K(O6H)R
M*M!J/AS+0G74TD"U+Y.S[K(,0V?B2SL7YD.IVM5[%@MTB#<L>&Y/@2X+!FF,
M:D14K?;<;:Y4*+HU$KEYB5JKE(32D5?O6C[7K9H\V59]7J^2*TAE1TVE4^ES
M*>TX]IW"7I%2:C=&C7URDH69%V$J[!C-E5)LEI-TYUWN42_Y<-+KC-?JV0+V
MF,MZQXRG%/2",B/4DDN6^VA''4M=>T"T\$-/ ,8
M      #.EUNOI(V3\VM-\,5D%Z;ET6T3T7L">(]']RH!6;TBP0
M                                       .<9?\EM__  '-]B4/C;P[
M.Q^15D?>W6VKHW>4Y5/XYY=1@        #H^(/*E8'PY"]E2/L[O;1P.73E?
M!WIV5I/=U9%P Z&<N       RCX1].FQ?G=1X64#)-S5P#&
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M6"       03WU_LG8GPM)]@(;;NE[W$XHRO&_.3Y31^75U5: WMS\
M           "U'8[Y)[A\;9?N" //MZ_FJ>1&6IT?Y/[)Q>_JZF&F4-8>K
M      *G-P/EAO?\98]RLCP/>W:F-QQU8=+[D;&T?BGK5.-C7&U
M          NYI?\ =M._%F?ZA#IK ]W3Q1D<B:1[VKCG*_<,K"
M                                #X%U6K;M[V[6+2NVCQJ_;=?C+AUB
MCS$<[+[*^RE1=DC(]#2HC(TF1*29&1& ICRGU0:I%7E3\-9/CP*1)6:V+;NI
MAU:HVIZ\B)\0EFXDM=$DI@E$1<5+/B"^<YW:W4_Y6DS&$WME:TZ)3^;_ #ER
MB-3JH]RD9<$(DLT].IEZJN'V0,Y;YMVVSXSVSVF];=@077I]44V]<]USS2Y4
M*D\V1D@W5I2E*6T<Q]&V@B2G4SXJ4I2BLS:D&"
M      &=+K=?21LGYM:;X8K(+TW+HMHGHO8$\1Z/[E0"LWI%@@
M                                       <XR_Y+;_^ YOL2A\;>'9V
M/R*LC[VZVU=&[RG*I_'/+J,         ='Q!Y4K ^'(7LJ1]G=[:.!RZ<KX.
M].RM)[NK(N '0SEP      &4?"/ITV+\[J/"R@9)N:N 8P
M                                 %<>ROR^;Z/']'A6OCZNG^ZP>3_*
M&H;N?.:;WG^:M8X/E-O  !PW<EY%KS_1WA&*-7WSV3C<WKTMPW!VW@<_X=2J
MH>$.D0        !W+;;Y:;,_2/@Z4-HW,VM@\[J5-/W^V)C\SXE*U4>[N;@
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MU])&R?FUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"
M                            !SC+_DMO_P" YOL2A\;>'9V/R*LC[VZV
MU=&[RG*I_'/+J,         ='Q!Y4K ^'(7LJ1]G=[:.!RZ<KX.].RM)[NK(
MN '0SEP      &4?"/ITV+\[J/"R@9)N:N 8P
M                        %<>ROR^;Z/']'A6OCZNG^ZP>3_*&H;N?.:;W
MG^:M8X/E-O  !PW<EY%KS_1WA&*-7WSV3C<WKTMPW!VW@<_X=2JH>$.D0
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ME[W$XHRO&_.3Y31^75U5: WMS\                  "U'8[Y)[A\;9?N"
M//MZ_FJ>1&6IT?Y/[)Q>_JZF&F4-8>K        *G-P/EAO?\98]RLCP/>W:
MF-QQU8=+[D;&T?BGK5.-C7&U                   NYI?]VT[\69_J$.FL
M#W=/%&1R)I'O:N.<K]PRL(
M    *2>N,HU9<C8'N%"5N6]#=K].?61=PS,DI@NMDH_5=;87I_R9@O2DMM'V
M;;;58 QA<]:QU1+^N*^+=I]?K]?K;*:@OOF>PE]R.TETU-M)CFOHN5"2UY=5
M:JU,$3,I8_1EVW?^'S&O_1.C_DH(ME]NV\%X2LZM0KDM##MCVK<5.Z3WOKU'
MMZFP9K'3-J9<Z*1'CH<1SMK4A7*KBDS(^!F"+75
M        &=+K=?21LGYM:;X8K(+TW+HMHGHO8$\1Z/[E0"LWI%@@
M                                         <XR_P"2V_\ X#F^Q*'Q
MMX=G8_(JR/O;K;5T;O*<JG\<\NHP        !T?$'E2L#X<A>RI'V=WMHX'+
MIRO@[T[*TGNZLBX =#.7       91\(^G38OSNH\+*!DFYJX!C
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M];]G[GZ][6GH4>H^EUG/]Y8GQ;#_  0>&]"^[/IGUG[GZ][6GH4>H^EUG/\
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M]?[)V)\+2?8"&V[I>]Q.*,KQOSD^4T?EU=56@-[<_
MM1V.^2>X?&V7[@@#S[>OYJGD1EJ='^3^R<7OZNIAIE#6'JP       "IS<#Y
M8;W_ !ECW*R/ ][=J8W''5ATON1L;1^*>M4XV-<;4                  "
M[FE_W;3OQ9G^H0Z:P/=T\49'(FD>]JXYROW#*P@
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MS:TWPQ607IN71;1/1>P)XCT?W*@%9O2+!
M                       YQE_R6W_\!S?8E#XV\.SL?D59'WMUMJZ-WE.5
M3^.>748         Z/B#RI6!\.0O94C[.[VT<#ETY7P=Z=E:3W=61< .AG+@
M      ,H^$?3IL7YW4>%E R3<U< Q@
M          #E><?(]DOQ=G^PJ'T-4_-X7*C*UO?#8VE]U7D4<#UAQ\
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MA8N@VY=E#Z?WJK+,N>ZMGOEAR*]HAZ2X@^9IU:>*3[/J@BU)($
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M^SN]M' Y=.5\'>G96D]W5D7 #H9RX      #*/A'TZ;%^=U'A90,DW-7 ,8
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M<2*M;=1BU6F+=J[BT%(AO)?:-2#1W1<Z"U+M@C.E/P$     "B;KC/VDP/\
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MNGBC(Y$TCWM7'.5^X96$
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MCB5_5L         =RVV^6FS/TCX.E#:-S-K8/.ZE33]_MB8_,^)2M5'N[FX
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M'9CO*=C=XR7>C,I#3J2+G0D]2+7@"*84Q?3]W?\ GLJ?M&E_D8+60?3]W?\
MGLJ?M&E_D8%D."Y2R_D?-5P0[IRA=#]VU^!3VZ5#J4AIAE2(;3KKZ&B3';:3
MH3C[BM3+7CV>P";&J?:)Z+V!/$>C^Y4 QS>D6"
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M=WMHX'+IRO@[T[*TGNZLBX =#.7       91\(^G38OSNH\+*!DFYJX!C
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M=,1;]7V+!!\QM8 I&JG]Y5'\9>_KF.9L?WE7'.5UWH_NJ>*,C\(PLP
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M\49'(FD>]JXYROW#*P@
M ^57*Y1K9H]2N"XJK%H="HT=<NJU><ZAB-'8:+F6XZZLR2E)%V3,P$7L2;EL
M#[L:]D"Q;7I9W;2K&:AOR)=>IS1P:DB6N0RIV)'D\SAH;Z,B4IUM!_?"+E!,
MQ8_/GG*.&-F%H43('R6TZ.Q7Z^Q051;5I]/@3M'XTB0X^DB2R3A(3&T,C4GB
M:>Z(".%U["^=\89_M8[MQA<:*W!CN)8JL!Q"F)T!]1<Q,RHSFBT&>A\I\4*T
M,T*47$"8L=@!                  HAQGU?VXFUMT%KY6JU-H2+1I60$W%+
M>:JC:WR@E/.1J31)U-7(?K07MX%[P**P]]&P=[<)4F\HXPFPJ1D]B*W$KM*J
M"C9AUIB.GE86;Z4J-J0V@NC)2B-*TDE*C1R<QEHFQ7(WL%WYWJ5 LJ[H,J+:
M%"5T5$7<%VQ)U(IJ"[C6/$CS9CC2>7L$VQKIPT!-L+P-JFVRW]L&,&+'IDXJ
MY7JE)54[QN;HNA.;-6DD$3:#4HT--(22$),_54?=+4"LS:DN"   9TNMU])&
MR?FUIOABL@O3<NBVB>B]@3Q'H_N5 *S>D6"        %9>\WTF]E7C?$\-4H
M?6T#W&+Q?REIF\7S^A\N.M2LT'R6Y@      \#<N5,;V;44TBZ[WHUO513*9
M"8$^6VPZ;2S,DKY5F1Z&:3T/[ _+C:;@8-6;77$3_&7[]&U7I6DTY^%AU54V
MV6Q$S%KSWT@,(^=2V?C%G[H8OU31.UI],/T?H&L.PKZ,GT@,(^=2V?C%G[H/
MU31.UI],'Z!K#L*^C)](#"/G4MGXQ9^Z#]4T3M:?3!^@:P["OHR_?2\V8CK=
M1A4BD9'M^I52I/(CP($><TMUYU9Z)0A)*U,S/L$+4:QT:NJ*:<2F9G^*F+J7
M3L*F:Z\&N*8BV9F)LB'4!^U\L                       !SC+_DMO_P"
MYOL2A\;>'9V/R*LC[VZVU=&[RG*I_'/+J,         ='Q!Y4K ^'(7LJ1]G
M=[:.!RZ<KX.].RM)[NK(N '0SEP      &4?"/ITV+\[J/"R@9)N:N 8P
M        %9>9O_,>VZ^*"/9*^/K8'R=?'ZFF:QVYH_(]M9H/DMS    4C53^
M\JC^,O?US',V/[RKCG*Z[T?W5/%&1^$868         7<TO^[:=^+,_U"'36
M![NGBC(Y$TCWM7'.5^X96$       !RO./D>R7XNS_85#Z&J?F\+E1E:WOAL
M;2^ZKR*.!ZPX^         'UZ#_>L;^!WV-0U+?S8.F=U4]+\G/[QU9W]/\
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M.73E?!WIV5I/=U9%P Z&<N       RCX1].FQ?G=1X64#)-S5P#&
M    K+S-_P"8]MU\4$>R5\?6P/DZ^/U-,UCMS1^1[:S0?);F    I&JG]Y5'
M\9>_KF.9L?WE7'.5UWH_NJ>*,C\(PLP         NYI?]VT[\69_J$.FL#W=
M/%&1R)I'O:N.<K]PRL(       #E><?(]DOQ=G^PJ'T-4_-X7*C*UO?#8VE]
MU7D4<#UAQ\         /KT'^]8W\#OL:AJ6_FP=,[JIZ7Y.?WCJSOZ?YO>CB
M5_5L         =RVV^6FS/TCX.E#:-S-K8/.ZE33]_MB8_,^)2M5'N[FX
M                        !E_ZS/TO[^^#*#X+C@R4W+]=HGHO8$\1Z/[E
M0"DWI%@@      $$]]?[)V)\+2?8"&V[I>]Q.*,KQOSD^4T?EU=56@-[<_
M                 M1V.^2>X?&V7[@@#S[>OYJGD1EJ='^3^R<7OZNIAIE#
M6'JP       "IS<#Y8;W_&6/<K(\#WMVIC<<=6'2^Y&QM'XIZU3C8UQM0
M               +N:7_ ';3OQ9G^H0Z:P/=T\49'(FD>]JXYROW#*P@
M                                      I_ZW;&%6KV/L:Y3I<1<F'8
M%0FTNYE-)4HV8U9*/WO(<T+1*$/QB;U_G.I+M\"U+E&TCK,+%QKBZUL5Y@MN
MM(79D5--H=V41MF6T_"0L^A1*CN.,K;4R@R1JCGYB3J9$?9)FE(*_>MHP31J
M/-.P+:N:\[C-E7O6U+BM4ZG]+IW/?#RWE/$DC[)(95KZI=D$9JN78?:]W9SW
METO(U3;5**BU:I7Y?M8;;(FD29!O.MEH>I$;TQY)$G77EYE%ZTP6G@AIO!C
M                           9TNMU])&R?FUIOABL@O3<NBVB>B]@3Q'H
M_N5 *S>D6"        %9>\WTF]E7C?$\-4H?6T#W&+Q?REIF\7S^A\N.M2LT
M'R6Y@   *<<G^4K(?C-5O=CHYTUWM#2.]KZTNJ=W=F:-W.'U(>&'RWV
M    !<=C#R:X\\6:3[C:'1>I-GZ/W5'5ARMO%M/2>^Q.O+W(^H^.
M            YQE_R6W_ / <WV)0^-O#L['Y%61][=;:NC=Y3E4_CGEU&
M      .CX@\J5@?#D+V5(^SN]M' Y=.5\'>G96D]W5D7 #H9RX      #*/A
M'TZ;%^=U'A90,DW-7 ,8           "LO,W_F/;=?%!'LE?'UL#Y.OC]33-
M8[<T?D>VLT'R6Y@   *1JI_>51_&7OZYCF;']Y5QSE==Z/[JGBC(_",+,
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M=T\49'(FD>]JXYROW#*P@
M   ^;6:-2;BI-2H->IL:L46L1G(=5I4QM+T>1'>2:'&G6UD:5)4DS(R,@%1V
M4^J*L*O5>55<49(FV##DK-PK7JL,ZO%9-1^LCR>^&'T(278)SI5?XP+9SG5K
M=3M..8P[>V;F$T]"M9,*AT=2GG$ZEW*)$F026S,NV;2M/4,$YRV+!^ \9;>;
M1*SL:4,Z=$>6EZL5>2OIZA49"4\I/2Y&B>=1%KHE))0G4^1*2,%9FUV8$
M                         ,Z76Z^DC9/S:TWPQ607IN71;1/1>P)XCT?W
M*@%9O2+!        "LO>;Z3>RKQOB>&J4/K:![C%XOY2TS>+Y_0^7'6I6:#Y
M+<P   %..3_*5D/QFJWNQT<Z:[VAI'>U]:75.[NS-&[G#ZD/##Y;[
M   N.QAY-<>>+-)]QM#HO4FS]'[JCJPY6WBVGI/?8G7E[D?4?'
M          <XR_Y+;_\ @.;[$H?&WAV=C\BK(^]NMM71N\IRJ?QSRZC
M    '1\0>5*P/AR%[*D?9W>VC@<NG*^#O3LK2>[JR+@!T,Y<      !E'PCZ
M=-B_.ZCPLH&2;FK@&,           !67F;_S'MNOB@CV2OCZV!\G7Q^IIFL=
MN:/R/;6:#Y+<P   %(U4_O*H_C+W]<QS-C^\JXYRNN]']U3Q1D?A&%F
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M[V[4QN..K#I?<C8VC\4]:IQL:XVH                  %W-+_NVG?BS/\
M4(=-8'NZ>*,CD32/>U<<Y7[AE80
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ML(       #E><?(]DOQ=G^PJ'T-4_-X7*C*UO?#8VE]U7D4<#UAQ\
M  /KT'^]8W\#OL:AJ6_FP=,[JIZ7Y.?WCJSOZ?YO>CB5_5L         =RVV
M^6FS/TCX.E#:-S-K8/.ZE33]_MB8_,^)2M5'N[FX
M       !E_ZS/TO[^^#*#X+C@R4W+]=HGHO8$\1Z/[E0"DWI%@@      $$]
M]?[)V)\+2?8"&V[I>]Q.*,KQOSD^4T?EU=56@-[<_
MM1V.^2>X?&V7[@@#S[>OYJGD1EJ='^3^R<7OZNIAIE#6'JP       "IS<#Y
M8;W_ !ECW*R/ ][=J8W''5ATON1L;1^*>M4XV-<;4                  "
M[FE_W;3OQ9G^H0Z:P/=T\49'(FD>]JXYROW#*P@
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M)7]6P        !W+;;Y:;,_2/@Z4-HW,VM@\[J5-/W^V)C\SXE*U4>[N;@
M                         &7_ *S/TO[^^#*#X+C@R4W+]=HGHO8$\1Z/
M[E0"DWI%@@      $$]]?[)V)\+2?8"&V[I>]Q.*,KQOSD^4T?EU=56@-[<_
M                   M1V.^2>X?&V7[@@#S[>OYJGD1EJ='^3^R<7OZNIAI
ME#6'JP       "IS<#Y8;W_&6/<K(\#WMVIC<<=6'2^Y&QM'XIZU3C8UQM0
M                 +N:7_=M._%F?ZA#IK ]W3Q1D<B:1[VKCG*_<,K"
M                                      "O'K%L 4K,>+J1==9R;2\8
MT_$QSZC(J-9C.O0I!3TL,I:6XPHW6U&MM*4$VTZI:E$E*#,R!:F6=BPJME.E
M5QR!B2N72U6U.&MHK.?J#4EXFU$E+J$1.1XRU,M#-)&6I=@P7=%OR\]VT6D$
MC)]UY=C4&4HVDHNB=7D0W%&6AI(IJR;49EV@1P)M=5U@FG7/E&CYMCY-HJ:E
MC551*H8R:8?753148$JG-O/+<Z%M#1]\<Y+:Z8N'(KD4? BJ6A8%
M                    &=+K=?21LGYM:;X8K(+TW+HMHGHO8$\1Z/[E0"LW
MI%@@       !67O-])O95XWQ/#5*'UM ]QB\7\I:9O%\_H?+CK4K-!\EN8
M "G')_E*R'XS5;W8Z.=-=[0TCO:^M+JG=W9FC=SA]2'AA\M]@         7'
M8P\FN//%FD^XVAT7J39^C]U1U8<K;Q;3TGOL3KR]R/J/C@
M     .<9?\EM_P#P'-]B4/C;P[.Q^15D?>W6VKHW>4Y5/XYY=1@        #
MH^(/*E8'PY"]E2/L[O;1P.73E?!WIV5I/=U9%P Z&<N       RCX1].FQ?G
M=1X64#)-S5P#&      "B?+WE8R?XVUKW>\/6]6_*X7(IR0XWWHVMI??XG7J
M<\'[7P@        !TJ!_H,/_ )!O^J0X9WMVUIO^XQ?B5/ZY>6W]K:J_V>C_
M  :'ZAKS=         !=S2_[MIWXLS_4(=-8'NZ>*,CD32/>U<<Y7[AE80
M     '*\X^1[)?B[/]A4/H:I^;PN5&5K>^&QM+[JO(HX'K#CX         ?7
MH/\ >L;^!WV-0U+?S8.F=U4]+\G/[QU9W]/\WO1Q*_JV         .Y;;?+3
M9GZ1\'2AM&YFUL'G=2II^_VQ,?F?$I6JCW=S<
M     R_]9GZ7]_?!E!\%QP9*;E^NT3T7L">(]']RH!2;TBP0      "">^O]
MD[$^%I/L!#;=TO>XG%&5XWYR?*:/RZNJK0&]N?@                  6H[
M'?)/</C;+]P0!Y]O7\U3R(RU.C_)_9.+W]74PTRAK#U8       !4YN!\L-[
M_C+'N5D>![V[4QN..K#I?<C8VC\4]:IQL:XVH                  %W-+_
M +MIWXLS_4(=-8'NZ>*,CD32/>U<<Y7[AE80
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MU')26DO3%F^XELE*6HDDI9D1&HST[)F.2-]M!HT+76E8-$S-,5S/#?\ XO\
M%-T1],OZ)^5VN<;7&[&@:7C13%=>%%L4VQ3_ (;:(LMFJ;J8^F]\\:LWT
M      7'8P\FN//%FD^XVAT7J39^C]U1U8<K;Q;3TGOL3KR]R/J/C@
M             .<9?\EM_P#P'-]B4/C;P[.Q^15D?>W6VKHW>4Y5/XYY=1@
M       #H^(/*E8'PY"]E2/L[O;1P.73E?!WIV5I/=U9%P Z&<N       RC
MX1].FQ?G=1X64#)-S5P#&      "B?+WE8R?XVUKW>\/6]6_*X7(IR0XWWHV
MMI??XG7J<\'[7P@        !TJ!_H,/_ )!O^J0X9WMVUIO^XQ?B5/ZY>6W]
MK:J_V>C_  :'ZAKS=         !=S2_[MIWXLS_4(=-8'NZ>*,CD32/>U<<Y
M7[AE80       '*\X^1[)?B[/]A4/H:I^;PN5&5K>^&QM+[JO(HX'K#CX
M      ?7H/\ >L;^!WV-0U+?S8.F=U4]+\G/[QU9W]/\WO1Q*_JV
M .Y;;?+39GZ1\'2AM&YFUL'G=2II^_VQ,?F?$I6JCW=S<
M             R_]9GZ7]_?!E!\%QP9*;E^NT3T7L">(]']RH!2;TBP0
M  "">^O]D[$^%I/L!#;=TO>XG%&5XWYR?*:/RZNJK0&]N?@
M     6H['?)/</C;+]P0!Y]O7\U3R(RU.C_)_9.+W]74PTRAK#U8       !
M4YN!\L-[_C+'N5D>![V[4QN..K#I?<C8VC\4]:IQL:XVH
M   %W-+_ +MIWXLS_4(=-8'NZ>*,CD32/>U<<Y7[AE80
M                          0<WY;7JAN8Q7!8M1QIO(=A2GJG:3#ZDMM3
M4/MDB7!4XHR)LWB0A2%'PYT))6B3-1$Q-C/#;N1-P^U^Y*Q;U#N*Y\3UYIX_
M?RVW>=AMQQ/<$X]"D)4R[P3HEPT'J7K3T!>]Z.\-VVZ/+E-59=QY5N"OTZL$
M41ZWZ<VS#[^2LB1T#K=.994^2R+0T*YB4?9(S,"R%E_5U;';ULZ[H.?,Q45V
MV)-)CO)Q]9DU/)/Z>4TIAR?-846K!(:6I+3:]'.8^<R1R(YRM4KKP5
M                      9TNMU])&R?FUIOABL@O3<NBVB>B]@3Q'H_N5 *
MS>D6"   4L[F?+GD'\;C^XV!ZCJ+Y+#XIRRY,\P=NZ3RHZE+A0^NTT
M   =,A_Z%"_%V?ZB1Q=YC?W!I?+CJP_JGY)?V9JWNO\ -4_0-)>I@
M "X[&'DUQYXLTGW&T.B]2;/T?NJ.K#E;>+:>D]]B=>7N1]1\<
M        !SC+_DMO_P" YOL2A\;>'9V/R*LC[VZVU=&[RG*I_'/+J,
M   ='Q!Y4K ^'(7LJ1]G=[:.!RZ<KX.].RM)[NK(N '0SEP      &4?"/IT
MV+\[J/"R@9)N:N 8P      43Y>\K&3_ !MK7N]X>MZM^5PN13DAQOO1M;2^
M_P 3KU.>#]KX0         Z5 _T&'_R#?]4APSO;MK3?]QB_$J?UR\MO[6U5
M_L]'^#0_4->;H         +N:7_=M._%F?ZA#IK ]W3Q1D<B:1[VKCG*_<,K
M"        Y7G'R/9+\79_L*A]#5/S>%RHRM;WPV-I?=5Y%' ]8<?
M #Z]!_O6-_ [[&H:EOYL'3.ZJ>E^3G]XZL[^G^;WHXE?U;         '<MMO
MEILS](^#I0VC<S:V#SNI4T_?[8F/S/B4K51[NYN
M       9?^LS]+^_O@R@^"XX,E-R_7:)Z+V!/$>C^Y4 I-Z18(      !!/?
M7^R=B?"TGV AMNZ7O<3BC*\;\Y/E-'Y=755H#>W/P                  +
M4=CODGN'QME^X( \^WK^:IY$9:G1_D_LG%[^KJ8:90UAZL        J<W ^6
M&]_QECW*R/ ][=J8W''5ATON1L;1^*>M4XV-<;4                  "[F
ME_W;3OQ9G^H0Z:P/=T\49'(FD>]JXYROW#*P@
M                 " VX;K!L:;<LCR<:719=S5RK18$6H+GTHH9QS1+2:D)
M+IY#:]2TX]R"8IM3BH%88N&@T2OQFEL1JY C5".R[ISH1):2ZE*N4S+4B5H>
MA@AS6XKGP!=]4:L^[;AQ]=%:8GG36;7J\NE392)YNDR<9,1]:UD]TI$CD)/-
MS<--02]A;N.\?V@^N5:=C6_:\ETC2[(I-,B0G%$? R-3#:#,$/8@
M                     #.EUNOI(V3\VM-\,5D%Z;ET6T3T7L">(]']RH!6
M;TBP0  "EG<SY<\@_C<?W&P/4=1?)8?%.67)GF#MW2>5'4I<*'UVF@
M  #ID/\ T*%^+L_U$CB[S&_N#2^7'5A_5/R2_LS5O=?YJGZ!I+U,
M 7'8P\FN//%FD^XVAT7J39^C]U1U8<K;Q;3TGOL3KR]R/J/C@
M        .<9?\EM__ <WV)0^-O#L['Y%61][=;:NC=Y3E4_CGEU&
M .CX@\J5@?#D+V5(^SN]M' Y=.5\'>G96D]W5D7 #H9RX      #*/A'TZ;%
M^=U'A90,DW-7 ,8      *)\O>5C)_C;6O=[P];U;\KA<BG)#C?>C:VE]_B=
M>ISP?M?"         '2H'^@P_P#D&_ZI#AG>W;6F_P"XQ?B5/ZY>6W]K:J_V
M>C_!H?J&O-T         %W-+_NVG?BS/]0ATU@>[IXHR.1-(][5QSE?N&5A
M       <KSCY'LE^+L_V%0^AJGYO"Y496M[X;&TONJ\BC@>L./@        !
M]>@_WK&_@=]C4-2W\V#IG=5/2_)S^\=6=_3_ #>]'$K^K8         [EMM\
MM-F?I'P=*&T;F;6P>=U*FG[_ &Q,?F?$I6JCW=S<
M        R_\ 69^E_?WP90?!<<&2FY?KM$]%[ GB/1_<J 4F](L$       @
MGOK_ &3L3X6D^P$-MW2][B<497C?G)\IH_+JZJM ;VY^
M  !:CL=\D]P^-LOW! 'GV]?S5/(C+4Z/\G]DXO?U=3#3*&L/5@       %3F
MX'RPWO\ C+'N5D>![V[4QN..K#I?<C8VC\4]:IQL:XVH
M  %W-+_NVG?BS/\ 4(=-8'NZ>*,CD32/>U<<Y7[AE80
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M^J)M=.&%^USC+_DMO_X#F^Q*'QMX=G8_(JR/O;K;5T;O*<JG\<\NHP
M  !T?$'E2L#X<A>RI'V=WMHX'+IRO@[T[*TGNZLBX =#.7       91\(^G3
M8OSNH\+*!DFYJX!C      !1/E[RL9/\;:U[O>'K>K?E<+D4Y(<;[T;6TOO\
M3KU.>#]KX0         Z5 _T&'_R#?\ 5(<,[V[:TW_<8OQ*G]<O+;^UM5?[
M/1_@T/U#7FZ         "[FE_P!VT[\69_J$.FL#W=/%&1R)I'O:N.<K]PRL
M(       #E><?(]DOQ=G^PJ'T-4_-X7*C*UO?#8VE]U7D4<#UAQ\
M /KT'^]8W\#OL:AJ6_FP=,[JIZ7Y.?WCJSOZ?YO>CB5_5L         =RVV^
M6FS/TCX.E#:-S-K8/.ZE33]_MB8_,^)2M5'N[FX
M      !E_P"LS]+^_O@R@^"XX,E-R_7:)Z+V!/$>C^Y4 I-Z18(      !!/
M?7^R=B?"TGV AMNZ7O<3BC*\;\Y/E-'Y=755H#>W/P
M+4=CODGN'QME^X( \^WK^:IY$9:G1_D_LG%[^KJ8:90UAZL        J<W ^
M6&]_QECW*R/ ][=J8W''5ATON1L;1^*>M4XV-<;4                  "[
MFE_W;3OQ9G^H0Z:P/=T\49'(FD>]JXYROW#*P@
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M5/!_SF7?!^9]1SC+_DMO_P" YOL2A\;>'9V/R*LC[VZVU=&[RG*I_'/+J,
M       ='Q!Y4K ^'(7LJ1]G=[:.!RZ<KX.].RM)[NK(N '0SEP      &4?
M"/ITV+\[J/"R@9)N:N 8P      43Y>\K&3_ !MK7N]X>MZM^5PN13DAQOO1
MM;2^_P 3KU.>#]KX0         Z5 _T&'_R#?]4APSO;MK3?]QB_$J?UR\MO
M[6U5_L]'^#0_4->;H         +N:7_=M._%F?ZA#IK ]W3Q1D<B:1[VKCG*
M_<,K"        Y7G'R/9+\79_L*A]#5/S>%RHRM;WPV-I?=5Y%' ]8<?
M     #Z]!_O6-_ [[&H:EOYL'3.ZJ>E^3G]XZL[^G^;WHXE?U;         '
M<MMOEILS](^#I0VC<S:V#SNI4T_?[8F/S/B4K51[NYN
M           9?^LS]+^_O@R@^"XX,E-R_7:)Z+V!/$>C^Y4 I-Z18(
M!!/?7^R=B?"TGV AMNZ7O<3BC*\;\Y/E-'Y=755H#>W/P
M   +4=CODGN'QME^X( \^WK^:IY$9:G1_D_LG%[^KJ8:90UAZL        J<
MW ^6&]_QECW*R/ ][=J8W''5ATON1L;1^*>M4XV-<;4
M "[FE_W;3OQ9G^H0Z:P/=T\49'(FD>]JXYROW#*P@
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M8         [EMM\M-F?I'P=*&T;F;6P>=U*FG[_;$Q^9\2E:J/=W-P
M                     #+_ -9GZ7]_?!E!\%QP9*;E^NT3T7L">(]']RH!
M2;TBP0      "">^O]D[$^%I/L!#;=TO>XG%&5XWYR?*:/RZNJK0&]N?@
M               6H['?)/</C;+]P0!Y]O7\U3R(RU.C_)_9.+W]74PTRAK#
MU8       !4YN!\L-[_C+'N5D>![V[4QN..K#I?<C8VC\4]:IQL:XVH
M             %W-+_NVG?BS/]0ATU@>[IXHR.1-(][5QSE?N&5A
M                                 %<&YKK$*-MMRE+QC-Q;-NQ^+3H=
M0.L,55N(A12TFHD=$J*Z?<Z=GFX@M%-J/GUQEM^8>I_'[/Y"!FGUQEM^8>I_
M'[/Y"!FGUQEM^8>I_'[/Y"!FNT[>>LIHF?\ ,%H8DAXEG6S(NWWPZ.N/5=J4
MACO"GR9YZLIBMFKG*.:/7%IKKVM )IL6<@J
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M8R?XVUKW>\/6]6_*X7(IR0XWWHVMI??XG7J<\'[7P@        !TJ!_H,/\
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MS]+^_O@R@^"XX,E-R_7:)Z+V!/$>C^Y4 I-Z18(      !!/?7^R=B?"TGV
MAMNZ7O<3BC*\;\Y/E-'Y=755H#>W/P                  +4=CODGN'QME
M^X( \^WK^:IY$9:G1_D_LG%[^KJ8:90UAZL        J<W ^6&]_QECW*R/
M][=J8W''5ATON1L;1^*>M4XV-<;4                  "[FE_W;3OQ9G^H
M0Z:P/=T\49'(FD>]JXYROW#*P@
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M.)7]6P        !W+;;Y:;,_2/@Z4-HW,VM@\[J5-/W^V)C\SXE*U4>[N;@
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M>E5BD5V(4^B52'6(*E*0F;!?;D-&I/KDDMM2DZEVRU ?1
M                !FTZU.XJ_-W++MR76ILFWZ);U,>I%#<?<5$C.R4+4\XT
MP9\B5N&1<RB+4]"(ST(@7IN5K19#D23'EM):6[%=0ZVAYIM]HU(42B);3J5H
M6G4N*5)-)EP,C(%DLH.^[=C2X42FTS,$RG4Z RB/!@1:;266666TDE#;;:(1
M)2E*2(B(BT(@19#]7T_=W_GLJ?M&E_D8%D)7;(-WNX_*.Z'&-BW[E&=<=IUS
MWZ]]:,]$@-(>[VHD^4SJMF,VLN5UI"N"B['J B8X&@H%
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MHU3\C LD^G[M \]E,]HU3\C LD^G[M \]E,]HU3\C LD^G[M \]E,]HU3\C
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MF\48)RSG"16HN*K,DWA(MUMAVM-QWXS)L(DFM+1J[Y=:(^8VU=C7L FUV?Z
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M$1 QOZ                         ,>FV7TD=OGSE6GX8B@R3<V%@Q@
M                        *S>M?]%ZG^/%)]RS@6IO18ZG/]I,\?!E ]FG
M FI>R"@                                                   #,
MWUI/I85?Q:HOL2P9*;E[V.<VX9BX]L2-)RY9<:3&MVEM2([M?IR%MK1$:2I*
MDJ?(R,C+0R,%+'L_ETPEYXK'_P"D--_* 18?+IA+SQ6/_P!(:;^4 6/J43*^
M+;EJ<:B6YDJU:_69O/WG2*;68,N4]T:%.+Z-EEY2U<J$J4>A<"(S[! /?@
M                   #*/NU]-3*?CPS_P + ,D7-7 ,8
M      A!UCOH8YD_W>_[14P$TWH"]3G^TF>/@R@>S3@6J7L@H
M                     HFZXS]I,#_!E?\ 9H(+TI]=7%Z&.&_]X?\ M%4P
M5JO3?!                                      K-ZU_P!%ZG^/%)]R
MS@6IO<KZGOR;9B\98'N,P*EPP*@                               ,Z
M76Z^DC9/S:TWPQ607IN71;1/1>P)XCT?W*@%9O2+!
M           ASO V@6QNIM:G-KJ)6OD"UB=.T[JZ/I6^1[0W(<QLC(ULK-)&
M1D?,VKNDZD:D+)B;%*M1ZLC=]3:B_2(5KT>KTYQSE=K$&O0T0G";/N%FW)<C
MOF7$]-6=2]0@7SH6;[(NK_3MZJ_RG9,J<"XLG=[N1Z# IIK<@T9J0CD>6EYQ
M#:G9"T*-LU$DDI2:B3S<W,"LS:LY!4                         8]-LO
MI([?/G*M/PQ%!DFYL+!C                            5F]:_P"B]3_'
MBD^Y9P+4WHL=3G^TF>/@R@>S3@34O9!0
M                       !F;ZTGTL*OXM47V)8,E-S@L'9CNEJ<&'4H&$[
MCE0:@PW)A24--<KC3J26A:?OG84DR,@+8?J^A'NP\Q=R_P!DU^$ M@^A'NP\
MQ=R_V37X0"V$M=B^UK<)CG=/BZ\[XQ17+:M:C>_?OI6YC;:66.^*'/CM<YI6
M9]TZZE)<.R8(F>!H?!0                     1GNC9UMJO.[JE?ESXK@5
M:[:O,*H5*M.2YZ%NR4\NCAH;DI01]R7 DZ FV4F 0
M  (0=8[Z&.9/]WO^T5,!--Z O4Y_M)GCX,H'LTX%JE[(*
M                 *)NN,_:3 _P97_9H(+TI]=7%Z&.&_\ >'_M%4P5JO3?
M!                                      K-ZU_T7J?X\4GW+.!:F]R
MOJ>_)MF+QE@>XS J7# J                                SI=;KZ2-
MD_-K3?#%9!>FY=%M$]%[ GB/1_<J 5F](L$
M                                   ,JNWC;QG^B9_P96:S@S(-(H](
MR#;,VJU6;;-5CQHL:/58SCS[[SD9*&T-H2:E*49$1$9F>@,DRU5 Q@
M                     *\^LSLJ\K]VYP:'8UI5J]*TB\:9*71Z% D5&43#
M<>8E;ILQFW%\B341&K30M2]4%J4;>JEQ;DW'5P9I>R#CFY[%9JM/HB*6[<-(
MFTQ,E33LPW$LG+::)9H)2>8DZZ:EKV0*ESP*@
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M4G4ORC[]F/S7>D<0AM)_?'U::)+AH7V01,NF@
M              #BV><#61N*LAJP+_=J;-"9J<>K(729"(TCOB,AUM!&MQIT
MN71U6I<OJ<03$V/A;>MLN.=LU&N*A8Y?K#\*YYK4^I'6)3<I9.LM]$GHS;99
M(BY>R1D8$S:D,"                                $0-P&R3#>Y.\J9
M?.0Y5QL5JE45FA144B<S&8[U8D2)*#4AR,\9KYY2]3U[&G $Q-B1^/[(HV-;
M(M6P+=5)70K.ID>DTE<Q9.R#CQ4$VV;JTI02E:%Q,DE_ "'L
M
M
M                <RNG"N&[YJRZ]>V);,O"NN-(9<K5;H-.J$M339:(0;\E
MAQ9I278+70@+71HL6-"C1X4*.U$AQ&D,Q(C*$MM---I)*$(0DB)*4D1$1$6A
M$ _N
M
M
M
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M /\ 8
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M7%2&U)_E@O9;"[]IUI]IMYEQ+S+R26TZ@R4E25%J2DF7 R,NP8*/]@
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M.H:?T5RES&I1F;1 O9;"\,%
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MI)EP,C+L&#&_V
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MYUWJ2\EW;K49M$;K5^UAQ9&;:I\ETH[)$?#3HWII.((NQT? M"!>K@AI+!0
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M6W?%5_S7^^:M4Z*B)7WSUYEU&FN+@3'%$?$ND>84O^!1=KB"LI# @
M                               %(77*?]W'_>__ )D!>EU/J@O(EDSQ
MX5X-A@BI;4"K(?N[]*'/?CQ6/=2P9(N:N,9>3;'WBU2?<;0,;W #&Q;'EMM[
MQXB>$D RMDX,3X=S_LW</P9+]A6 R(;9?21V^?.5:?AB*#)-S86#&K:ZT;%U
M&O#;94+^7!;5<N*ZC!G4RHI;-4CO*HRF8$R,2B(SZ-1O-O*UX?>B,%J;U>_5
M,7S-H>?KFL@WE>]%]VM(6Y$)6B3G4IUM^.Z9=OE97(3ZO=?8!-31:"@
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MXJF<T UJ,^)F?>^IGVSX@I-Z2P(
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ME5K=8%=DNG<W3PLB46K,=[MIY^G>5"F'R(["E<ZS[/KCXGV07BYJ.!C
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MM 57K, 5                                      !2%URG_=Q_WO\
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M0
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M AF1VK1%Y?ZP"@7#'YI$2??-=O21+4I2B2U'5+J3:U+(S,^9PD)(S,]346O
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M:59DR2V;+]XU.K5Y31\W,2%RE1&5&1\.[:BI66G#0R[>H(JO3[!
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M3P)Y<2.AIQ[B1<7%I-9\.V#&]\
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MS(C1K_SO5HBFFZB@K3L]Q:=.D:0M$FI/(U[*>=#+:5%VTN)[1@M5*[(%
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MLZU;(H:#;H]H4B%1J8DR(E=!"80P@U:?RC)&IGZH*/3@
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MIEF[9["([$!+J5(=*GQ$J<Z(W$*-*EK<6LTZDDTI4I)E9FU.T$
M
M                             B/NIV?6'NJ@VN5QU69:U?M-YWWON2FM
M-./KB2$_?8CJ7>"D&M*5I/LI,CT]<H$Q-B2EG4.=;-J6W;M2KTFZ)]"IL:GR
MKCF)2B3.7&:2V<A\D=STCG+S*T[)ZF"'I $>MR^ F]R./$8VGWM4K+H;]2CU
M"LKIC+3RYR(I*4U'=)T].C)TTN\/Y2$^H"8FQZ["6'K4P/C2VL8V<A:J50&5
M=\5!_3OB;+>4;DB4^9<.=U9F>A<$EHE/<I($3-KJX
M        .";CMO=G;E<<OX^N]YZFDW,8J-#N"(E"I4"6R9IZ1HE]R9+;4MM2
M3X&E7JD1D3$V/M8'Q.O!^,+>Q@F[9UYP+7)YFD5:I--M2$17'%.MQSZ,S(TM
M&HTH]1.B>PD@)=A!   (1V?LAM"A;CZUN7NB\ZK?EX5"9,J%+IE189:B0)$@
MB984WR:J646/]Y9)7K2Y5>N21@FU-P$
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M)J27!1@F93;!
M
M
M
M
M
M
M
M
M
M
M
M
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M2KIIK#ZHK]0I$QB<PA]*4K4TIR.M:2625I,TF>NAD?;(!]\
M                                 >=N2[[3LZ*Q.N^Z*1:L*4[T$:96
M)K$%IQWE-71H7(6A*E<J3/0CUT(!_BV[SL^\F),FS[KH]UQH2R:F2*/.CSD-
M+47,27%1UK))F7$B,!Z4
M
M
M                                                  4)9[ZM?</D
MK-.4;_MV;:"*%>-RU"K4E$RIR&I!1Y3RG&R=0F&LDJT/B1*/^$%XJ0!W$;6L
ME[8YMK0<COT5]^[V9;]).C2G)221#4TESI#<99Y3U=3IIKVP3$VO8;?]DF9-
MR=FU.^<>2K<8HM*K3U"E(J\YZ,_WTQ'CR5FE#<9XC1R2D:'KV=> $S8LIV3[
M#LW;?<YP,BWW+MEZWXU'J,!Q%*GOR)'2RD)2WHAR,T6FI<3Y@5F;5R0*@
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M6GQ9UR5J+.IB:?+3+2;34<VU&I22+E/F[0)JFU88"H
M
M
M
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MKGWQ:UZH?B6[5*P\J5/IM1996\R12W34ZXT\39M<BS5RJ-!I-)$HE"J%_ *
M
M
M
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M/M:*G&9^KP]0"I)[K':Q,H^S[*APC4VY4UT:GO/)/BEE^K1"=+L'P6@C0?\
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M)0:D&:3-*Y"4+3J7:4DS(R[9 R3<UV Q@
M
M
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M<U. QLA^T3TH<">/%']U(!DFYKP!C
M
M
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M[9U3CU:DHF5..['.1%63C9.H3#0:DZEQ(E%_""<Y8$"
M
M
M
M               'YID.)4(DJGSXS4R#.97'FPWDDMIUIU)H6VM"M24E23,C
M(^R0"D[,?5&2)]?J-7P?D*GTFC3W5O1K1NE$@DPC69JZ)J?%0^M;9&>B26SS
M)3ZY:SX@O%3B$+JB]Q3LOHI][8]APT+)+DMJ=5'EJ2:2,U-MG3&]=#/312D\
M2]30S&<L_P!HFQ>RMKCD^YWZXY?62:O$[RDW(['*+&A15FE;C$&/SN*3SJ27
M.XM9J422T)!&I*BLS:G4"
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M7ZC:?OGWQ5X;:VF7N_ZG+GIY$.=T7*F023U[9 B9M=]!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M:^-H?X4!]RE7/;==T]Y+AIE8YN;E[QELR->7UVG1K5V.V ^X
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MC+@9&0#_ &
M
M
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M_65.Z=Z][<G)RN(T_P JK7^(:7O?K_2=5?T?Z.;_ (\ZVV+?^G-L^F/KEO\
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MIE.FLGS-O,/H)QIQ!]M*DJ(R,%'[0
M
M
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M/4ZJL^W+D0VER#[!?_%-7'0%9=5!
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M(
M
M
M                      %+.YGRYY!_&X_N-@>HZB^2P^*<LN3/,';ND\J.
MI2X4/KM-        7CX.\CV-/%V!["D>3ZV^;Q>5.5V#N?L;1.ZHR.J#Y[9
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M?$B[*'",%9O2W!
M
M
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MEJ/':22$-H07*E*4IT(B(BT(B!1_4
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M^%2I%@W&\]#N.3,A*?>3.C*2\F,3QK)#92(YKY.X,]6UGKP!,1:G%CK*^/\
M*ME4[(%D7-"J]M5"*B2[*2\V2X9J02ULS$$H^@=;["T+T-)D8*V*8-^V76-U
MN6L6[8\&2V;Q*FU=:ZM6H2^E@O59]/0]PZC5"F8,<G5NNIU3HI6A]P>I>(L7
M=6+:5.L&RK0L:D&9TJS:+ HE.4HM%*9@1T1T*5Q/B9((SX]D%'J@
M
M
M
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MI\!OEZ1PR(C=><4:G'7#(B(UN*4H^V8*O<@
M        #G&0,5VEDSWH_6EF4[[R=\=X][/FSIWST?2<VA'K_DDZ#XVMM1:-
MK3,_KQ,YEMEDV?\ 59;DA][4F\FEZGS_ ,-,1GV6VQ;_ --MG6ESCZ*^)?\
M5*G[=5]R/C>!-6?55TGW_P!R-;_>HZ,'T5\2_P"J5/VZK[D/ FK/JJZ1^Y&M
M_O4=&#Z*^)?]4J?MU7W(>!-6?55TC]R-;_>HZ,'T5\2_ZI4_;JON0\":L^JK
MI'[D:W^]1T8/HKXE_P!4J?MU7W(>!-6?55TC]R-;_>HZ,'T5\2_ZI4_;JON0
M\":L^JKI'[D:W^]1T8/HKXE_U2I^W5?<AX$U9]572/W(UO\ >HZ,.EV!C"U<
M:,U-BUVI+3=76TN9WP\;QF;)*)/+J1:>O,?;U3J31M5Q5&!$_P"*RVV;;O\
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MHTF=<]09[VJ5ZUIU,JINLF9*-E*D(::9;-22,TM-IYM"YN;0M")FU)\$
M
M
M
M
M
M
M
M
M
M
D                                            /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tm2227887d4-lc_ct1119a5494c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_ct1119a5494c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@$( 3H P$1  (1 0,1 ?_$ 0
M 0 " 04! 0             ("0<#! 4&"@$" 0$  04! 0
M 0(#!08'! @0  $# P(# P,)#! 0" H%#0 ! P0"!081!R$3"#$2"4$C%%%A
M(C(S%;5W.'&!H4)#4]06EAA8&9&Q4F)C<Y,DM)755G:&%S?!T7*"DH.CL].4
M577%ME=(\*(T5"4U-CGA\;+2XL/C1'3$9(2D187E)J9FQB>(2<)EARAH$0$
M 0(#! 0+! <&!0(& P   0(#$00%(3$2!D%181/P<8&1H;'!T2(R!T*RTA3A
M\5)R@J(C8I+",Q4U0U,D-!9CH^)S1%0E%_*#L__:  P# 0 "$0,1 #\ O\
M
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MPXS2_P!D$0FDT\V\W2\Q52XW72E;5=*\*D7RA+=
M
M
M    !&3K.^29U(?%WD'[ = H%\&CY6-]^+N\?"%K ]&F;;R[0;:S8ELW#W4P
M[ KE/:63 @9'?8%J=>:UY?,H9EOL+70B\%5/4]<#J^XG4AL7M1B]FS7/]T;#
M8<:R.)3/QBYI*]-]]H_+I=5ZW,P^>]-:5MRE5K8H<I7O4+QX"1U[:;K#Z;=\
MKFMFVOW;M%_OJ]Y6[$]1)MDU[14]QBW-B,\[IVJK::)ZH(=*ZU=HM@MY=O\
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MU/X9,E.]]UBVW5)3:P*57L:CN1D5O5?JG+3S;=*(%V(
M
M
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MF<O@M"ZD+2
M
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MU;DS&M/TIJOCYQWEN-B5TX
M
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MRZ[ML[6]_;^5OE(RQC(/?RQ=[WGJR5;BDKT5;CS^,7SG+5KF:^Q[G>X$CTI
M5X>(_LIN=O[T[-8+M/C?VV92N56RX^]7I<*$OHT=N5S:^=->8:317*4T[_\
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M=+._'3A=]Z)&\>!_:>QED2PM6)[WTMEQ](<A.3U?1/>Z5(Y>G.H7V::@7,
M
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M3\CM+,F;DLB+WO1TFW"2[+<:;541*Z64=Y7?TUK[FJ\/8B3%+4
M
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MTRK[K41]YRFA''&Z%KTTUJI S4
M
M
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MMYMI'[1';5Q6VETU<H^:$NX>"Q\J3<#XJ[I\-60#T]@
M   CGU!Q-_I& .N=.-YL-NW)@W%F33$R)CF0)L+1VEZ+WE5>4XBK0ZE>OTJT
M_3< W>P</>^)MS;J>H.Z62Z;ERI#S]P:L#/*@Q8R]U&H]*JBHY72FJN5Z(GL
MA@) @                    @5OS;.NB3N?8J>GG*L#@[8W%F.U=:LCAK7-
MM<E51'WM.V2VC:<QON+KJE="\-%4)V,4N-M44.5\URFE$J=_-+ZH&Y
M
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M+K4'=EF6ZY)=JA06M&'K2V[WFVG=&^4M"Z-*M2.]O,1P)T-=-VS3.R?WO%&
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M28)(4"^"O\J;/_BLN?PU9 /3T
M
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M<)3,*7/BI;Y\^ULJWZ)*EQ.5'5IRKV:)I1YQNFAWZ<8HP3>"0
M        *3.NG?7KHV^ZD<+QC8FQWAS")D" YCL6V6-JZQ+[/==7TQN6]4R\
MK2TJG*6CF-JVWYS@M?,(3BNDC5OUQF:Y3=+$BJBE'F::N^E%=7:FOE)0WX
M
M
M           $?NK#Y+/4I\5F9_ DP"@;P5_E39_\5ES^&K(!Z>@
M
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MFJ!#?
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MHG,SCY*8^[$._/4KW-*:=:D]KQ/5<FOH>&-D;&_+B@
M                              !'[JP^2SU*?%9F?P',$HA0+X*_RIMP
M/BLNGPU9 EZ>P                    8TSS;C"=T<<DXAN%C$'+L:FNMN2
M[-<FD>9K<:75IS3AK6FB<440B9;C"L&Q+;K&[=B&"8Y Q7&;32M$"SVYI6([
M?>]O[&GBM6O'O+Q7U0ED,                    &#<WV%V=W.R6QYAGFVU
MBRK*<65M+)>[G#;?D,4QW><TVJ\>8W2[K6E%:^5?5 SD
M
M    8"ZB?YE\X_\ P[X1C&K<Y_[1>_A^_2W+D'_><O\ Q_<J=MVN_F[P+^#E
MK_8K9F](_P"SM?NPUW6/^\O_ +\^ME ]S'@
M                         "/_ %7_ "6>I7XJ\S^!)@DA0)X*_P J;/\
MXK;G\-60#T]@                    PGO%O/MYL)A4G/\ <_)$QO&8<IN#
M3*Y3LBM^2_WE:9::8[[M=:HW5HB)KI15J0EN=IMV\!WQPJV[@[:Y#1DN*7)R
MMMN=2V\RY0\UP=9<:>1'&W&_*B\>W335%)&8P@                   ")6
M['6'T^['YU8MN=S-QHV-91D2-/,PJXTF11$8?=Y3+TQ]AE6X]#BTJOG%3\WQ
M;T4"6B+KQ0#Z
M                               P%U%?S+9S\RW?",8U?G/_ &B]_#]^
MEN7(/^]9?^/[E3MNUO\ -W@/\';9^Q6S,Z1_V=K]UKFK_P#>W_WY];*![W@
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M>
M                    ,!=1/\R^<?\ X=\(QC5N<_\ :+W\/WZ6Y<@_[SE_
MX_N5.V[7?S=8%_!VV?L5LS6D?]G:_=:[K'_>9C]^?7+*![V/
M                                       $?NK#Y+/4I\5F9_ <P2B%
M W@K_*FS_P"*VY_#5D"7IZ                    !LI+[$1JM^2[0PPTG>
M=?<J2BBE$\JJH!E]F4U1(9<I=8=H[[3M-6M%5"IVHJ< AO0D
M       #CGI<1EZ/&?E,LORE6F,U76E%=:IY*$5=57Y@@ER(
M
M       !@'J)_F7SCYEN^$HQJW.?^T7OX?OTMRY!_P!YR_\ ']RIV_:W^;O
MOX.6S]B-F:TC_L[7[K7=7_[S,?OSZY9//>QX
M                           C]U8?)9ZE/BLS/X#F"40H%\%CY4FX/Q5W
M3X:L@2]/8                    (%=?>P.X_4CL))V_P!L[TQ;,BBW^#=Y
MUJG25CQ[K&CM/->B.N4ZHGLW6W414[G?;]4#F>A?8[<#IYZ?K+MKN7?*+OD3
M-QG7)(D9ZN1&M,:54WW(##JI2NB+34ZO#V]=>FJ!*;@0
M   !2CUR="?4%U!=1>)[E[<9E AXVS!M\-N3-G/1Y.-/0WM77XC3-*]_BO.U
M:7O\S5.'L 0N=B-N,Q6&G'JY3C3=%#DBO35Q43C7\\8#D0
M
M    &".I/^9K+OFP/A",:ISE_M%[^#[]+<^0?]ZL?Q_<J=VVL73;3;W^#EM7
M_P"RMF8T>/\ I+7[L-=U>?\ K+O[]7K9!,FQP
M                            C]U8?)9ZE/BLS/X#F"40H&\%?Y4V?_%9
M<_AJR!+T]
M
M             !P=QOEEM=33=UO,&V5N^Y-RY#32U_,YBIJ!@'J&RC&YFS^5
MQ(M_MDF2YZ"K+3$MEQRI$GQM>"*OK&L<Y43.DWL(_9^_2W#D"?\ \S9_C^Y4
M[AMEE6-,;>8*RYD=I:?:QZVTNLN3&4[J^BMZ:IS%U3R&8TF/^DM?NPU[5IPS
MEW]^?6RE;KK:KE175;+G%N;;?!RN,\V\E/K*K:J>]X',
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M=J(OEXA#D
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M./E77U2*;D553'4CNL8P<@7$
M             (_=6'R6>I3XK,S^!)@% O@L?*DW ^*NZ?#5D ]/8
M
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M*+UO\]1OIPB?%Y^CQ+#M*:Z^_P![NU5)[&G15[/7.I<,43,N*QC5MAR!6
M                                              (_]5_R6>I7XJ\S
M^!)@DA0)X+'RI-P?BKNGPU9 /3V                    "'?6-U/1NDS:A
MC<QS%'<QF7*]Q<?L]E21Z(W5(E-/2.8]*Y3RT-\N-7KK3Q7N^74#>](?4="Z
MI=FX.Z,/%GL-D>^DFSWFPUO+);;EP>6NK,CE,(ZW4V[0J:-IHOL.*T!"6X2
M                  !5%U7^)-:NE_>BU[35[92<NC0X4*XY=?%GI"K9:FJJ
MJU 81B0CU3;2\Q>8XVFOF]4[0+38LAN9&9E,][EOT4N-]]%I72KBFJ <@
M
M             #;55:4THG"K3V*=I;KXIQX4Q,8[5-FX,>3#S[+X\KO<]+S/
MJ<[_ )=775/GW6Z*HSMR*]^+Z@Y>FFK3+4T=-,>OM8TRC_J&X?VK^_-&7Y$_
MWFSXJON5,3]0_P#9KW\'WZ7(6K_JFU__  ;?]Z,#J?\ WMS]YGM$_P"QM?NL
MS;$P7YN[V&4QZJDKHF.2'E7L5MEEUQU/GF4Y7MU7L_1/5.+"<YWHL:1<IGIV
M>>5KG=YR4T+P;K[5^8NOK>H=ZJGAG%\XQ3%5O!RI
M                              C_ -5_R6>I7XJ\S^!)@DA0+X*_RIMP
M/BLN?PU9 /3T                    #&>>[<83NCCDG#]PL8@Y?C<MUMV9
M9KDTCS-=;*ZM.:<-:TT3BB]HP,6ZPK!<2V[QNWXA@F.0<5QFTTK1;[-;FN1'
M;[W!Q>[3Q6K7BM2\5]4#(0                    ,&9QL-L[N=DUBS#.]M
MK#E648NK:66]72(V^^Q3'=YS+?8O,;I=UK2BM?*O#B!G,
M
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M>M^^?R4[A6;/$QI(R7ZNTN\Y8GIW-Y/-71-.;Z.YIII[50,U
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MBZ\4 ^@
M                    #AV5>6FBA6]6Z]=.*</+\WM%4;<8(JXX^+?ZW1,[
MSZR;<VEV]9!)2A'-6[?::?=GG$33E-JB+JJIHIB]3U>QDZ?ZDX>?W,KHNCYC
M4;O!;C9U[,*?3M5T7[(<ZWXS)F.S&KD5O5K1:;,TJ>CPHZK[HXJZ>5?.5G'L
MYFLQKN8BFB,8Z*=FS^+9CUNZY'3LGRUE9N5U83TU;<:I\6,[>B$\]J=HK'MC
M;>7151<\AG4(MTO%5*HM?#O<NA-5[E">I^2=4T'EZUI5O9.-735AAZ,9<9YD
MYEN:Q>GBCAHC=3[YV,7=6>*X[_(SFF1U8_"2^QUME#%ZI:;IDHKUSBM<'E37
MZIPU4RMS(T5^/P[6'M9_,6]D3ZO:R)L?A^,VO;/;J\6['8,.ZW/%K/(FW2AN
MA)#CCT%GF:N^Z+PX:*3;R5%'A^E3>SM^Y\WL2$/6\H    *_O%&^0MOI_%C_
M %GM('G&Z<^BK>OJDL5_R+:QBRN6W&)S5NN*76?Z'7SGF^=YI.54BIH!(G\4
M!UB?\TP_]O/_ &('S\4!UA_\TQ#]N_\ V #\4!UA_P#-,0_;O_V '1]RO#+Z
MG-IL$RK<?+XN,T8WAL!VY7A8=VYTA&&%X\MM&>*^IJH$[/ Q_P!Z+^)/^GP+
M_@                                     "/W5A\EGJ4^*S,_@.8)1"
M@;P5_E3;@?%9<_ANR!+T]                     BQU0]-6(=4^VR;:YE<
M9]F:BW2/>;)>[;30K\6;':>91SE.ZTN4*U)KH6C\]V\$T#>]-73MB/3#M?;]
MKL,E3KE#;GRKI=+W.2CTF;.?Y:.NU<E$;H1:6Z&TH_,4Z*NNHQ$F@
M             5Q=1_AU[1]2>[EJW6RJ_7ZP7*EB)"R6VVI6>5=682IRE5UV
MA7&*^6G+6NC7@E/ "Q&+&8AL,Q8S2,L1Z$;::I[*:4X(B?D ;P
M
M    85W%W.QW;JSTW6ZN).G/:I9+4W4M#LAWBB]B+W*45$]FIA]:UFWI-K&K
MIZ/")9W0= NZY?B+6Z-\_LQY9CB\2OBAC/=^,TJJ5?39+G'L6F';HVOSUHI7
M3YKBG**ZLQS)F?@C"?)LC^7<[;-_)\KY3@Z?+C<J_FPE8;M_MC9=M;)Z!:(Z
M2K@_HMVN[B)2Y*K7CQ35>[2BI[5%.IZ#HUG2;7#'S=-6W;Y,9P<0YBUW,:O>
MXZOEZ*=GPQX\(Q93J:>7ETU5Z5IKH[HGJZ]GS.!EZ9KFK&=D=77Y6"FG9AT]
M?Z$<>K/7[W_/EI3V&EK\OD]](FGT2]1$RFN;D;:=_D9&V<1?Y)=KEK3A]J%C
M3M\BP&/G]A%<)HFO?++(     8"ZA]D[7U#[0Y=L[?;S+L-IS"J"DN[6]&ZY
M+/O?/C7!M6T=U1=7(R)Q]4#&/25TD8MTB8SE&+XIEETRN-E=T:NDR7=&V6G&
MW&6>3W&T91$TT]4)2)N^>X7CV2X[A]YRNTVO*<O<?IQ;')<QIF;<ECT<Q](L
M;O<UWET)JO=IX=JA#HV\F_>U?3[BK67[MYBQB=HE/5Q85+C;DB5+D::\N+$C
MMO/.JFBZZ(J4)QK5$50,/[*]>'3)O[D36(8)N$C682Z?^C\>O,65;)$KV*\(
MM3J(TY7^AT.=]?4 SUO'MI!WFVQSC:VZW&3:;;G5L?M,NZ0Z6W'66WDTJ<;1
MQ.ZOT=/H A'CH^Z*L0Z/'-P:,3S.\9:NX5-G6X+=6H[?(]ZO3D:Y7H^GNOIM
M7MM=.ZGJ@3H                                      (_]5_R6>I7X
MJ\S^!)@DA0+X*_RIMP/BLN?PU9 /3T                    #CY4J+ CO2
MY;[<:+'H5QZ2[4E+=%"=JJJ\$ _3#[$MEM^.[1(9?H[[;S=7?HKH7RHJ<% W
MP                    .%DW2WPWX<:7/CQ)5PK6B!&>>;H<?J1-=&J==:U
MT\B <T
M            ;+FN:>V^@A'=U=9C3UOBOJBZ55Z?._\  .[JZSBICI?IM7=.
M+?#U45/Z BF?VO0B9JZ8?AU:4[:^XOJ::E<8G%1&^&_*4@'%H_5WG$[NG=6G
MO4:]FOKZ?/+%6.,3OIGT>U-,X^-AK=K=^S[9VQ*':J;GD,ZA5M=GH545=.QQ
MU=%[E"+I\W0P?,.OV]+M_P#J3$X>&$PV?ECEB]K-S9LM1/Q5;-GBC&,4"K!C
M><[_ &8ORY#]<EQYU7;M>':/UO"CJO%MK3UU\VV<SR.1S/,&9FNJ?'.S_P"'
MT.O9W/Y;E/*Q;HC''=&W;/EXO*LGV_P&P[?6%NS6./311K2Y*FU(O.DN^5UQ
M>.JG7]/TZC)V8M4='AURX;JVK7=2OS>N=/AU0R.9!BP"-_5O\GO</YEK^%(8
M&1MF_P":#:K^"%B_8#! R42      =+S3)X6&8CEF8W)4][<4M$^\W.KR<B!
M&=?<3YO=;X@AY9ND^Z]074YUOX=O'&9>S#(+#E$+(<_N]5?+@VNQ+)1J6RSS
MW$Y;:1G'&HS"+]!' /GBE[Q3=SNJW*<89D\[&-I8[.+62+35JWZ4C2/7%WEZ
MZ([Z2[6UKY4:H Z'U&=$>[_2/BVU^Z-\R"*[3DK\7679JWHTVP7U&/36HBNH
MJ+S-&ZU:=;7V[3FO<T;5P/3OTJ[J/;T]/.TFYLQ]J5=LEL#2W^0SPHKND-:H
M5P5$151-9,=S350))@                                      "/W5
MA\EGJ4^*S,_@.8)1"@;P5_E39_\ %9<_AJR!+T]
M@3U][ [C]26PDC;_ &SO;%LR*)?X-XFVJ=)6-&NL:.T\UZ(ZXFJ)[-UMU$5.
MYWV_5 YOH6V,S_IXZ>['MMN1?&[OD;-TGW*B'%?KD1K7'F54\N#'<5*5[NJ5
M.K^?KJTU FV                    "D_KBZ#NH#J#ZB,6W,VYS.WQ<9;@V
MV&W(GSW8\G&WH+JJ\[$;9:5:Z=?.HC:]_F=[L30"Z"(VXS%9:>>JE.--T4.2
M*^VM43V5?SP.0
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M)-GG7=KMT6/>[I+NC']RDTZ_, G,
M       (_P#5?\EGJ5^*O,_@28)(4"^"O\J;/_BLN?PU9 /3T
M
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MZ!*]:SV:WV*V6RQVB"U;[19XS4.T6]BE:&F([%%+333:(G"FBA-$\@,79@
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MR\0-^
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M_P#(; E'170Y0E="]ZFKL4#4
M   $?NK#Y+/4I\5F9_ <P2B% O@K_*FS_P"*VY_#5D"7I[
M
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MA(MKSDB+6DV\SIK2M//-,+[G(H3C3Y. $MP
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M5Y5N8Y-:5N-M]US5QQ-5\WPXN 6HQ9+<V.S*:[W*?HH<;2M%I72KBFJ ;\
M
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M=F9"<7MJ:>;1VA?GHH',@ (_]5_R6>I7XJ\S^!)@DA0)X+'RI-P/BKNGPU9
M/3V                    #'&<[>X7N9CLW$L[QFWY=C-QY=4NS75BB1&<5
MOC0YW:M=*TT32O5% W.&X7BFW=@AXC@^.P,3QNUTU4P+':X]$>,WWE6NONT,
MZ(BU+Q7RKV!+OP0                   !@W--C-GMPLIQ[-,\VWQ_+<IQA
M:?>2_P!SA-R'XZ4NHXU1Q1>_0T[YQ$J72E>*=JJ,2&<@
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M]NOFTU ETBHJ:IQ10/H
M                     -A6G,H=:[=.[_3+<3\&**MLS#JU_A1;Y;I]BF<8
MEZC28LE$[>XXUW%_+T*,U8BYEZZ>QZK69JRN9M7(WQ./F5"Y!9I./7FYV.0Z
MV^_:Y+D6MQJI:Z*T:^:FI\ZYO+=S5,=3ZDT[/QFK=-<1A$Q$]NUQ/JH>*AE)
MC%\2I&NZVG;45U1-=2Q&%V(KZEA_3+M_)QC$YN0W)CD7'*N56RPY[>B&SQ9[
M/KG,JK7L[:3M')V0BS9BN=\N _4#6OSV8[J-UO9Y>GHC=N[-J71N;0P
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M-1U[C>04(GGKTQ6]YQQQQ?=J.*MZ_6M.X%N8%97BX?(RRG^$=@_98$8? _\
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MW[K=[Q<%;21,F2.6CKU2LHC="*C=#:4</84Z=NNH29
M  !7+U&^'AL]U*;L6;=C*[QD%EN*,1(F6V>TNL^CW:-"JT917'6ZG&*^ZO+J
M<:7C0B:=SC6!8=&BL0V&8T9I&6(]"-LM4]E-*=B)^0#%O
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MCOY::OY(,'VH3#_M<X89 ]"]/]/]]$_7?'SB,^C>;]3O5^J!:V
M        /'KUG?\ >!;H?P_M_P#\J!["@*O>M+P][3U59WA&>6C*5PW(H#D:
MS9O-D)7);EV%I77=8C2]DEE7%2GCRW%K\YIW.(3)PK8?:C =I6]DL?P^'_)P
ML!RW7''IC5,AN?2^B4R7)^J:/./+KS*ZM=?5TT&!B@7L7X7F#;,=2T_>!G)9
M%TP?&W&[AM/B#BN^D0+@[S>:DR5JBNMQ4T5CZYWO.^Y^<"VT"LGQ</D9Y3_"
M.P?LL",7@@?]BNH'_/=A_8TH"<OB"[%WG?\ Z9LRQ3&8'OMF.-R(V58C;4]U
M?EV_F(\TTFG%QV*Z\TWKVUU E2EX>'7/B?2E#SK;_=6R7B3BF3W%J[V^998S
M3DJ#<V6TBRFI+3[K&K;K;3?8NK:T=B]_V 8@ZC]T<E\0+JKL#>VN,RVUOL>#
MB&W%FGHGI5,)E79;TNX+'5]JC1R0_(=5OO(VTGYS50]7&WN&6[;G!,+P&S>R
MM&%6.!8;;76O>7E0(S<5M===?:T:KQ R$     $?NK#Y+/4I\5F9_ DP"@;P
M5_E39_\ %9<_AJR >GH                    &PE2HT".]+EOMQHL>A:WY
M+M24-T4)VJJKP0#],26);+3\=VB2P]1WVGJ*N_170O:J*G!0-Z
M          #AI-TMT)^'%E38\65<JUH@1GWJ*''ZD354:I5=:UT\B <R
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M3!N/N-==ULKP69<<VODYJYW&[-WJYQVZY+'<Y3E+;,BEKL;I]BB?- G(
M &&=XMG<!WZPJ3MYN=:';YB,Z1'F2K<S+DQ*ZGHKJ.M+S(SC+J<4TT_I@=7V
M)Z9=G.FV%D5OV?QZ3CD?*GHTB]-/3Y<WF5QD<1I468Z]W-$=J3AV@2. ACNS
MT-=+N\^0/99G^T\&?DUQ5:KC?[9*FV>3)=5$7FR_>U^.W(<X>Z.HJZ>7M []
MLOTN[#]/[$BO:/;6W8O-G-]V7?.\]-N3U"^R1I9\UU]_N*J)YM'4HUXHA$B2
M!(     !'_JO^2SU*_%7F?P),$D*!/!8^5)N!\5=T^&K(!Z>P
M         0.Z].G_ ''ZE-AWMO\ ;>^1[-?F;[!O+UKN$AR/&NL:*T[35;WG
M6>\FBNNMNHJIW.8W1JB>Z(',=#.Q.?=.^P-FVWW*OK%VR-BYSKC1#A/5OQ;:
MQ-K2JB PZZB+70E25.KP5.975V]JA-D                    %+'7!T';^
M]0W4/BVY>WN;VN!C;<"!;Z9<^;)CRL;=AN5.N/Q&F6_.=ZI>;3RZN9S>WN>Z
M 7,1**V8C#3SU4MQINBAR15IK6J(G>K7YHP,6_
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M7'7=-7*UT[5^:4C(P$;NK?Y/>X?S+7\*0P,C[-_S0;5?P0L7[ 8(&2B0
M&SDQF)C-<>2S1(:=31QERE*Z%^:B@;#[6\>_R#;?\4:_\T#[]KF/_P"0K=_B
MK7_F@/M<Q_\ R%;O\5:_\T#Y]KF/_P"0;;_BK7_F@/M;Q[_(-M_Q1K_S0-Q%
MMMO@=_T*#'A\Q-7/1VJ&^_\ -[J)J!R8
M         !'_ *K_ )+/4K\5>9_ DP20H%\%?Y4V?_%9<_AJR >GH
M
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M_P":#:K^"%B_8#!"62B0
M           1]ZKODM]2WQ5YG\"2P0H(\%?Y4NX'Q67/X:L@'IY
M           ! ?Q <XZ@-ONG^;D'3O#G/Y6MYAL9)/M4+WPGVRSJV]5(EL,5
M-/\ 8XVRTM?+\W1777P7SC8AS70OFF^^>]/6-9!U"VZ5;\XDSYK=OEW&(EOG
MSK714GHDJ7$1F.C5=6M:)YO2NBEMWCWP)O                     I,ZZ=
M[>NS!NI'",;V(L=]=P9^';W\;BVJS-W*#?+@\ZYZ6Q/>5E_1."4<OF-\MM.;
MP7S@%T<9Q]R.S7+HI8DUT4<YFFKOI16O:B+Y0.0
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M/X$F 4#>"O\ *FS_ .*RY_#5D ]/0
M
M             .-JK:I146OA335PT7CP55XEO'NZ9JJZ%483/"K@W[WCJS&7
M5A6*/ZX[;W/UW)9UJ]\)/ETU1/8-?17C^8.2<U\Q3GZNZM_)&SQ^B)=LY&Y3
MG3(_-9B/BF,8_LQU[)G;/B]K.O3]LRW@D*G*LC:IHRZX-HD6,XFOO='?\FNJ
MIS'43CZB>P-KY3Y?_(4S7<VW9C;'[,=6,3,3XVF\Z<USJU46[>RU3.R?VI\M
M,3Y_&E57WJ4I5*.X[3KW:=4737A\SBAMU,=Q^[ZO;+0:OB\;DB\J  $(NJ+^
M=[I,_AA5\(V8E";I"0# N\6^&'[06CTR[O>^%YET*MEQMBM/2I"\45SR\NBE
M>UQ4 JON=UW7ZH<_8C-T5W26^NMOM3*JW;+3&7ZKJNO*;_1/='/F Q66;&]/
M>+;/1&YB]V^YG,;TN.2.-\:$75%:BHON3?J_F_R429D2>(     1NZN/D^;@
M?U-K^%88&1]F_P":#:K^"%B_8#! R42         "E;Q#>@S>SJFWLQC<#;>
M?B\"QVC#(..R$OD^5&?63'N%SEN=UMB)(3N(W+HXZ@8QG>$M5#Z:[9,M4AZV
M]66)MW"Y>G6.Z..6F]2H]P==@Q6O3*8_HU?HJ,MM.M\KN.<7=0+A=BXFZT':
M;!+?O:[$F;H0;2Q&S"7;)"R&7Y,=>4DA75;9U>>:IHK=1$[B.=Y&^":@9R
M                                    (_\ 5?\ )9ZE?BKS/X$F"2%
MO@K_ "IMP/BLN?PU9 /3T                    "&_61U.T=)NT;>Y2XJ[
MET^YWR+CMGLBOK%CK)?9DO\ ,?>1MWN4(W'K5=.*KW>SB!OND/J.C=5.SD+=
M.%BSF&RJKG*L]WL=;JR&Z)4+E:N,O\ICF-U-N4+[71%UHXK0!+H
M           %3_5IXE,/I@WJM&U*[9/9?$CPX-RS6_+.2$Y0Q-55Y5O9Y-:5
MN-M*E?G'$1?<^'%Q M1BR6YD9F2RB\J112XWWT6FK1>*:HH&_
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M'3&9NQOVT^W=/3VIYXYIJF9R-JOBF,8N5;N+;$Q3AALX<-LQ.WSI[G3G*
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MX\]3D=R:I[NFB-MM-44-MMT(C;=%/<3@B:!.$
M                1]ZKODM]2WQ5YG\"2P*!?!9^5+N!\5MT^&K*!Z?
M                8XSC;S"]S,=F8EGF-6_+L9N*MU2K+=&*)$=Q6N-#G=JU
M]FFB:5ZHH&XPO"\2V\Q^#B.#X[ Q3&[7353 L=KCT1XS:UJM=:TML\$JJ7BO
ME4)=_"                    ,&YKL;L]N'E./9KGFW&/Y;E.,K3[QWZZ0F
MY+\?NNHXW1JJ+WZ&W?.(E2Z4KK4FNJJ!G(
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MO\#LM&,X?C4=(]ELC"UN4,MUUJ\XJN.K6Y76XZ[76Y6XO?KKJJJ6K750,H@
M                                     "/W5A\EGJ4^*S,_@28!0-X*
M_P J;/\ XK+G\-60#T]                     PAO%O7MYL)A,G<+=#(4Q
M[&HLEN%3(Y;LEQZ2^M2M1V6645QRM4;K5$T5=*:]= -WM'O#@6^6$6W<';2^
MTY#BUT<=:9G<IV.XVZRJ4N-.LNTTN45T^75-=!B8,R
M   B)N[UB]/FQN>6';O<_<9BP93D2-/1X2PY,AN)&?<5EIR8^RW4W'H<5M5U
M<5-%]FOFTU ETBHJ:IQ0#Z
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MV[>71H43),J8N-%W:MM-=$6IVV7.7;N:VV[4JM\WT='-/SVG8!*\
M                               1]ZKODM]2WQ5YG\"2P*!_!7^5-G_Q
M67/X:L@'IZ                    !%SJ<Z;L*ZI=LZ=M,UGW"U1HUT8O-D
MO5M5OGQ)[#;S#3G==U;<H5J571W--/9=HQ&ZZ:^GC$.F+;"W[7X5)GS[>S.D
M76[WFX*VDB9,?Y:.O5*RB-T(J-T-I1P3N4Z+QU DR
M "N7J.\/#9[J2W8L^[.57F_V2>C,2'EEIM3K21KM'A5:,HM;K53C%:T+W*G&
MEXT(B)W.-8%AT6.Q#89BQVT98CT(VRU3V4TIP1$_( W@
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MF"4                                      !'[JP^2SU*?%9F?P),
MH&\%?Y4VX'Q67/X;L@'IZ                    !Q\J5&@1GI<Q^B+%C4+
M6_)=J2ENBA.U55>" ?IA]B6RV]'>HD,/4=]IZBI*Z*Z5\J*G!0-\
M            #AI5TMT-^'%E3H\65<7%;@QGWJ&ZWZD35:6J576M=/(@',@
M                                         8*W#VVD;BT6I'<EN.+I
M:_2.7Z!4B\]'^7JCNBIPI[GE]4U[6=,HS]NW$WL,,=O#CCN]S.Z'K7^GS7,V
M(JF</M888,!YSL+(Q3$,AR%G<:_37;5#=D41:JE1JO14[:5>7M\AK&I\OV\M
ME+E4WYPPC[,]<=K=-/YJHSFH68_*TQMF-E4]4]&#1V^V)DYCA6/Y))W'OL%R
M[1U<JB45*K5*\VK@E-+Z<>'D+&G:!:S>GVI[_"/B^S/[4]JO5^::<EJ-VF,K
M$X</VO[,=$0D!MYMG(VX6[UM9-<LI]]TC]^BX5)3R>0M?!M:E7@O,\AN.EZ=
M3D9J_JXXX?9_6TK7=;C48HPL13ACNJZ\.OQ,[F>8    .G7N\P<?M<N]3W4C
MVVW,N29[]2ZI2W2FJ>3RZ(>;.YB,O:F[/0OY;+UYB]38HVXSAX?K5C[G[V99
MN,]+BTRW+5CG?I]&LT:I&^91Y/2G$3SB\/Z@XYKO--W/U\%.RF/#JCUN^<O<
MDV=*OTWYGBJPVXQTX?O3Y-F+$"=B)ZAI\UM\N4\48.3F76YW9(<>YW.3+9AM
M\B-Z0XY6VRW^AE<W:JL,9>"UE+=K&:*8B9VSA$1BM)VJP^PX%BUNM=@1N71-
M;:FS+Q15QFN/4)5S->*]S1?8)KHB'T!H6E6\GE*8IVX[?#:^:N8=9O:GJ%==
MV,,)PB-FR(Z\(\\];+%:\FE%;H[M5/9QU[=$\IEJ-M+"U1%$3@Y0K0    "K
MOJIZDDNOINV.WURUM36L?+LA8KT25KQ6*PYJNC7E=K7W3]*]TJ@E^=A>DF)D
M6-O9/N?!EM47Z)ICED9>6/(8;?35)KRI[5SRM4+_ &U%$R,?[O=,UIV]SO:S
M&;1DTN;;]S+Y[T\R4PTKD']=16N;JRB(Y_RKU6_:C$30VRZ2=M=O)C%WE>EY
M??X^KD:?<Z:$88<\KC$:E-$7],JKT\A2);          $;NKCY/FX']3:_A6
M&!D?9O\ F@VJ_@A8OV P0,E$@      #R6?BFNM3]X=E^Z&V?X8#\2/"EZTX
M[+CZ;>6F94U3JD9C(+9S*_F<U^E (J99L/G.U>XUIVTWNA5[.7&Y.MTOWJ\L
MU28+,5ZKDK+1Z#Z0DEBE475R-S/IM-0/6GT=;/W;87ISVYVJNU]MV23<9HNC
MGVP6BNM8<IFYW67<F'6N8B*J*W)I371?)IP E<
M                 (_]5_R6>I7XJ\S^!)@DA0+X*_RIMP/BLN?PW9 /3T
M                  "!O7GT_P"X_4IL-(V^VWOD>SWZ/?H-Z?M=P?<CQKK&
MBM.I5;WGF>\FBNNMNHJIW.8U1JB>Z(',]#.Q.?=/&P-FVVW)OK%VR./<YUQH
MAPGJY$6VL3:TJH@L.NHBUT)4E3J\%3F5U?-4)L@                    I
M8ZW^@[?WJ'ZA\6W+V\SBUP,;:@0+?3+N$V5'E8V["<J=<?AM,MKS.\J\VGEU
M<SF]O<]N,1<O#;K8BL-.OU2G&J**'7Z^VM43C7\\#D
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MXB^CHFJ.P&/4<^NUJOF_<^U5Y=402Z=TJ]-OOVY;=S=P;;K96U](Q+'GZ?\
ME3BHOZ[>U^I?6OKGZ5[HF1:64B$/5!_.]TF_PP7X0LQ,";Q           $;
M^KCY/FX']3;/A6&$2R-LW_-!M5_!"Q?L!@A+)1(         **/&LF8>Y@FS
M$&0[$<W#9O\ /?MK2U4>DT69Z,M,M?5Y=4EMA-?SH$^/#QRRXYCT8["7FY^Q
M?B62186D55J_6]BN$JT1N/Z3$;3UNP8";X
M             C_U7_)9ZE?BKS/X$F"2% O@K_*FS_XK+G\-60#T]
M
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M'[7PMF-I=N]JK>YZ6U@MDBVIV?2VM%,J2PVOI,GEZZT<YU:W-->VL#-
M                                   C]U8?)9ZE/BLS/X$F 4#>"O\
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M)@DA0)X*_P J;/\ XK;G\-60#T]@
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M9;F^D9=DCVG-ENJJ.^C-._FTUXK]23^UD"X:RV:UXY:8%DLD)JWVBVL4Q[?
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M?'8.*8W:Z:J(%DM<>B/&H[ZK76M+;.B(M7:OE7L"7?@@
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MXF18M=7'6FYZ-.QW&W6ET<;=9>2ERBNGCKPUT&*,&9
M   1%W>ZQ>GS8S.[%MWN=N*Q8,IR)&GH\.J'*DMQ(K[BLM.3'VFU;CT.*VJZ
MN*FB^S7S::@2Y145-4[% ^@
M #\*FE*E-%.!+@+W=X%@MDZ[7251$M]O8<?F2*UT2ANE-55?R"QF+O O6;4U
MS$0JXR*^9+OON30D-JO_ *1?]$LEOJ1.7$A:Z<QS33],<.):EF;FN9^.'=,X
M1XNO[/0^A<CD[7+.F535/Q1&,SUU>GQ0E=N%LW@./[4W=8EBC5W;&K56Y'OR
MT=R36XE*K4XXZRB=]=?FG0-<T.Q8T^*:8VTQ'7[W+-$YES5S4N*:ME4[8V;N
MS8Y'8K!,.8PC$LF7'(3^136:JUNKM"UNTN4NUZJUS-4H[?I$+O*^F9>K*Q?J
MIV^7H\OL6N<M8S,YVJSQSP[,(V1OB)\OEE)RE-*:EI=[RJFE/L=--#:^*+MO
MX/#SM,PFFK&IOB\   !PLAJF<RY&D1N<P]2M#E/>T314]1-"W5:BNF::YQ7*
M+MRU5%5,88,,U]..SE'LJL-[M.J)_P!87!?RI1K=SE?(7:\:K&,_OU?B;3:Y
MYU:Q1PTW\(_<H_"BACFU6!2NJS.,*D6'G8U;,88G1+6DN2G+=J:M_'F\_F_5
M:_*I[)Y9TBNSP=U_-7[WCIYMUJS=[[OOF_LT?A]B6373[LZW(C2F,0Y3\>M:
MV74GW!5147R(LG3AJG:>.GDW2-O]+^:O\3VU<[:S31-OOMD_V*/PNU;G;EXY
MM3BTK*,B=1&6_-6^!1P=E2%XML-IZJZIV>4VAJ*HRJK<CJFW5^N7"?\ 4O\
MW&S6Q5_\AG^Z.?I@%MNUVUV.;3XO$QG'FDJIHT<N5Q<H1)$V3Y7WE3755\FO
M8H&60                             &!L(Z==C-M;ZWDVWNT&)X5D3;+
ML>F]6>U1H4FEI]?.-\UAI%5%X</4]8)9Y"
M                $?NK#Y+/4I\5F9_ <P2B% O@K_*FS_XK;G\-60)>GL
M                  $6^IWIMPGJEVU3;3-I]PM,:-=&+S9;U;:F^?$GL-O,
MMN)2]JVY0K4JNCN:?3=H&[Z;.G?#^F/;&W;7X7)GSX#,^1=;O>;@M"2)DQ_E
MHZ]5R41NC5&Z&THX)W*=%\H$F0                    5R=1OAX;/]26Z]
MEW8RN\7^S7)&8D/++1:G6?1KM&A5Z-(KCK:N,.=SS=3C2Z+0B:=SVX%A\:*Q
M#89BQFD98CT(VRU3P2FE.Q$_( W@
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MNC='J?/4IQ&<@
M                            C[U7?);ZEOBKS/X$E@A0/X*_RIMP/BLN
M?PW9 /3T                    #CY4J- C/2Y;[<6-'H6M^2[4E#=%"=JJ
MJ\$ _3#[$MIM^.[3(8>H[S3M%7?HKI7RHJ<% WP                    .
M%D72WQ),.-*G1XDJXN=R#&?>;;<?J1-=&J576M=/(@'-
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M:>5'FFXNB<(^G%-%]G[9>S0MS*J$FR
MBSU=[RWOI\Z>\^WAQZU0K[>,,6U+$M-PYGHKB3[K$MSBNJRJ.)HU)K5.ZO\
M3 I0_'9[W?[(L&_LKG]E@??QVF^'^R/!O[*Y_98'S\=GOA_LDP?^SN?V6 _'
M:;X_[(\%_LKG]E@78=(F\UZZ@^GS =X<AM,*Q7G,ENRS+5;^9Z*UZ!=9=M;Y
M2O*KBZM1J%]DO;I\TA*4I*
M C_U7_)9ZE?BKS/X$F"2% G@K_*FS_XK;G\-60#T]@
M  @=UZ; ;C]2FPSVW^V]\C6>_,WZ#>7K5/?<CQKK&C-.TK ?>9[R:*ZZVZBJ
MG<YC=&J)[HDCE^AG8?/NGC8&S;:[DWZ/=\CCW2=<:8<-ZM^+;6)M:54P&'':
M46NA%2IU>"IWZZNW@JQB)M                     I8ZW^@_?SJ(ZA\6W,
MV]S>V0,;;@V^WTR[A-E1Y6-NPW*G7'XC3+?G.]4O-IY=7,YO;W/=$"Y>+16S
M%8:<>JE.--T4.2:N[JXJ(G>K^?V@<@
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MGOE+]/5F8Z\]S$]+YW%'*DUX)P0#/P
M         C_U7_)9ZE?BKS/X$F"2% O@K?*FW ^*RZ?#=D ]/0
M
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M5TR;:;59VS%8RW%O?FF[,P'O2&:%G7F=<&T1U$TJ\U)I7AY0)?
M                       !TO*LLQC";)-R/-,BMF*X_!I_7M[O,QJ%#9IJ
MX><??K1M%U]7@!TK!=\MF=TWY,#;3=7%LXN4*A')4"QW>).D,MZ\'7&67E<[
MB5<554TX 9I   (_]5_R6>I7XJ\S^!)@DA0)X+'RI-P/BKNGPU9 /3V
M               " WB YOO_ +?=/T[(.G:%.D96MYAL9)/M<+WPGVRS<IZJ
M1+CL5-/IP<;9:6OE^;HKKKX+YR@0YWH5S7??/NGK&\@ZA;?,M^<2+A,:MTNY
M1$@3YMKIJ3T25*B<F.C5=6M?=\WI712V[Q[X$W                     4
MF==.]?79@?4AA&-[#V6^.8+)A6]W&XEILS5R@WR>\ZXDMBX/*R]V:<M6^8WR
MVTYO#W0"Z.-4ZY&9KEMTL2:Z*.<RB]]**U[41?+Q Y
M                 &T6EMRA%1=*4U0B$3\;6JJI;1$1-51.PJBE$S@C'O\
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M/I9V_P!T;M)QWIUO-5O>O,^M]8T))+]WKBW=UU]7DH;Y$)8VKBIJU0[6YY=
M,4=8&T6TG3[U,]+;W2(S79-QKO<VG;ABV/W*3<DHY$R(S >6EUZ2ZB36W9#;
MM"KRW6Z%UI]TY@>DP   C]U8?)9ZE/BLS/X$F 4#>"O\J;/_ (K+G\-60#T]
M
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M<Y5GNUCK<60W3)A<O5R+)5IA'FZFW:%]SU1>\WQ6@"7(
M    *G>K'Q*(G2WO7:=IUVS?RZ)&B0;GF=_JG^@UT,S571JWL<FI*ZFFM*]7
M*TU7S?#BX!:G%D438S,IKO=Q]NAQI*T[JZ5<:=4 WX
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M^PX^PH\B?DB2&;0 $),4^7-N=_ Z-_>;6!-L
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M:-AMH\!VDLCGI5OPFVMPJIW=[BRI;KM3TR4K:<*.=)<<=5-5XU*!G
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MO#M]OEA5NW!VSR!,CQ>Z.N-,SD:<8<H>95$<9=9<II<HKIXZZHBZ>L,4,Q@
M                   B+N]UC=/6Q^=V#;K<_<5C'LKR*AI^B#5#DR&H<9]W
MDM.S'F&ZFX[;E3:^Z5)^;7S?$"7*+KQ0#Z
M  !^%5$(X(1B^Z>L1C4G [OK#&H?BBM*J45$X<?H$X13,0B)QC%T/.<UM6$8
MS<,BNO%B)14K<9%TK=<1/8-M\.U5,=JNHT:?:FY/AZV2TG3;FI7HM4],^:/0
MK2QRRY'OIN6X[,D5]Z?(]+R.<TFM$6%V)R]=.S3EM:'(<IE+NNYJ;D]?9LC'
M^%WG.9RURSI?#CT86XZZNG]KKQGB6@6BTQ[#;(=HMD!(4* PVQ!BT5:\NBG3
MAVKZBG:+5F(M1;ZHA\^YK,5WZIO5SC<JG&?#<[<>AYP    1/ZD-TMNK?MYG
MN(2<RMM643[7)B1[&R\DB4CJTHBM/,LZ\O\ MF@B!Q?3'NGMY*VUP7"DS*W-
M97;X:QW;"_7Z.^KO-=\TTC^G-77ZWJ3A*(;OJ$ZC+1M##<L5DJ9NVX$UM5C6
MU/.-P6EXH]+5%X:Z^;;[:OF=L8" &U&T.<]1.73[]=Y\GWFIF)5E^7R?..5N
MZZ(RRGU1S^Y-A*WK"L'QO;^PPL:Q:!3;K3!H3NLIQ<KK7VSCKB>WKX<54#OP
M #:2)#$5EV2_6C;+%"UNUKV4T(FJK] ##?WQ^QG^TRT?V;G_ )I*$1\=W7VX
MB]6N=YJ_F,!K%;IB[,.WWSF:QJW4:@>:[/T*O^Q(2EHUU"[+/O,18^Y%G=DR
MJN3':2MS6ISU$73U?(@0SF$@                                K(ZE
M^J;I<Z);FTQ:]M[)=-XIL57[?B>+6Z!;9#,9[ZI<+@TPGHK;RTJB:<RM>U&^
MXH%?$OQLMUUN:N0]EL3CVA*M%A/SYKTG]63DII\UH(6#])_B5;1=2-ZAX'=K
M9(VNW,N"=ZUX]<9+<N#<G.WE0+AW6.\]HB*C3K-"KP1M7-.!4LW"
M           82W9V/VGWOL=.-[L8#:\WMC7,]$2>WI)C*[I2XY%ELJT_&K5-
M.++M"\?5 C5CWAI]%^.7MF^Q=EH\YZ/6CL6%=;K=+E"HU[4KBS9CS3M/'BCB
M.(OK 3@MEM@V>%%M]NBLP+7"8:9B0X]"-M,M-)W6VVVJ46FBA$31$0#L0
M POO#LY@._6$R=O-SK0[>\1G2(\R7;F9<F)74]%=1UI>9&<9=3BFFG],#K&Q
M'3+LYTVQ,BM^T&/2,;CY2]&?OC3T^7.YE<='$:J19CKW<T1VI.';J!(\"&.[
M/0STN[TY"_EN?;309V37#6NY7^V2IMHDRG51%YLKWM?8HD.+I[HXBKIY0.^[
M+]+VPW3\Q(JVCVVMV+S9U'=FWQ*GIMR>;7V2-+/FNOO]Q51/-HZE'E1 E)$(
M      C[U7?);ZE?BKS/X$EB2% _@K_*FS_XK+G\-60#T]
M       BUU.]-V%=4VVJ;:YO<;A:8L>ZL7BRWFVU-\^'/8;?9;=2E[5MRA6I
M5="T:?3=NH&\Z:^GG#^F/;"W[7X3*GSX#$^1=;O>+A4VDB9,?Y:.O5\FE&Z$
MT;H;2C@G<IT7CKJ$F0                    5R=1WAX[/=2>Z]FW7RN\7^
MS7)&(D/++/:G6?1KM&A5:-(KCK=3C#G<\W4XUVT(FG<]NH6'QHT>&PS%C-4L
M,1Z$;:;IX)32G8B?D Q;P                           'Q%U343L(=?E
M9#983]4:7=H4:11[=IZ0VVXFOK*J'FJS$4RO19F=N#0^VO&O\NV[_&VO_.'Y
MRE/Y2OJD^VO&?\NV_P#QMK^F/SE)^4KZI<A%N<25':D17VGV74J6EYFOOT<.
M*:*FO:7:;D5T<<+=RB;=<43"LW??<I_<?*V;)97%E8_:7U8M3;'_ +[*7S=3
MNNB>7V#7_IG&.9-9JU*_-FG=$X>&R/$[OR7H%.G9>,Q<V53&/BCS^?\ 0F3L
MOMHSMIBS<*2U15D=S1M^^RZ5U[SO:C::*J)0TBZ(OSSI?+FB1IMF8Z9W^&,N
M6\V<P3K.=FO'^E&RW'9LQZ(G;,8[=OD9L6FCOHK57=;KX5KHJ]FFG;_0,_3'
MQ2U>J9IJQERI(   %>G5]OS=,3>:VUPV=5;KM.C))R:\,JG.C1WT5&XK*\.6
MX\B\Q*].'L"Y32*Q*ZW*ZN96G,<*N$-!@I9GV6P:'N]N=;L;R._N0DN:.S9<
MBI>9*N"L>==:9>X^<Y7?\XY^9(F,(%VV.8W9L/LT#'\=MS-JM%M;[D*!'IT;
M;3MX)\[1-"TJ=I   -H_'9EL.QGZ$<9?H5MUM>Q:5314 PW][AL9_LSM']@Y
M_P"<2A\^]QV-_P!F-G_L*_\ SPE^6>GK96.^Q)C[<6=J1&J5V.\E%>M%?9WD
M37Z) SD                                .A[@97!P#!LUSNX(B0,*L
M-TOT[6KN^9M\9R6[^2C>H'DIZ>ME\^Z^>I.__;-E"Q'[O5*R_<_+NYS'6(M4
MEMM6XC5:Z+6KCS;;+>NC;?K-]P"]*W^$OT<P[*EJD8QD5VGT-]VG)95^DI-J
M\BUU-L*Q$14_20*8.N?HZE=&&=8??,(RJYW7",IJ=EX5D+]?*N]JN5K<:==:
M>>B41VN8G-;<9=:1M5]GHVG+YBAZ1^E'=:3O?T\;2[G3G*';GDUB;]_G6T[K
M=5TA.UP[@XB=B)Z2Q6NGJ@28
M   $?NK#Y+/4I\5F9_ DP"@;P5_E39_\5ES^&K(!Z>@
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M2W:7[%KEM+P6.US$<7ZIW.^VX0OV"0
M         1^ZL/DL]2GQ69G\"3 *!?!7^5-G_P 5MS^&K(!Z>P
M
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M\EOJ6^*O,_@26!0/X*_RIMP/BLN?PW9 /3T                    "!'B
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M 4#>"O\ *FW ^*RY_#5D ]/0
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M*V8_I,EV6ZE*NK4XO>==JKXKY=2!DL
M         1^ZL/DL]2GQ69G\"3 *!?!7^5+G_P 5MT^&K(!Z>P
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M]U8?)9ZE/BLS/X#F"40H%\%?Y4V?_%;<_AJR!+T]@
M QQF^WN&;F8Y,Q'.\:M^78S<>75*LUT8HDQG5:XMN)35K[--$TKU10-SAN%X
MGMWC\/$<'QZ!B>-VNFJF!8[9'HCQJ.^JUU]UMG1$6I>*KVKV!+OP0
M            !@W,]B=I-Q<HL&89[MS8LLR?%^ZN.WJZ06I#\=*'.<VWJJ+W
MZ&W5YB4UKHE7% ,Y                   !LDHD:=U:M%\E6B%J:IG?3Z3A
MPZ?0_'*=KX5R>\GYGN(GT=2JJW;KWQZ5.%<=/H?E'XW"E:^]4G9[%4_H%5%N
M:(V057*9E^'7&Z>#B:4>3_@A135<Q^7TPFJ;>&WVM%A:ZVDY5'L7M4UU]KHO
M;QXE=4TTSA.\QC_A[NO]$HS;G=2&*X52]:<=J;RG(*%JHK1NI4B,.:\%==IX
M5Z:^T;4T[6.;:,I7-%OXJXWT[OYIB8;[R_R)FM5IBY<^"W/VMDS_ '>*F?.B
M#0WNCOO?T5Y)%XDI[%''%1NW0V]4T[-&FU_NCASN?]0UFY$3/%'\,8>ITVN=
M,Y7M3W>R9_>QJ\_%^A,K;3IPQ?!*8UTOB4Y+?Z%2NFMZC]:QG-.UEK5454X^
MSK]3@E!T31.4\OEJ8KNQQ5>7V2Y;K_.F;U.9HI^&CJV8^?"/-#/N7W%ZR8EE
M-XB:>E6JTSID77ZZPRXZGT3<FCO/+76Y74XXY7S''?=GG"]"'PE(!,7HAC09
M.[5QHN%LCW"IJP2I%OE/--..Q9+$N+YQI=/->ZUKP+=25P"EJK</I4
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M*]"NY3+U9J]LFO#A_=CQ3TX],1.S:G@:XZJ
M                                      C[U7?);ZE?BKS/X$EB2% _
M@K_*FW ^*RY_#=D ]/0                    ,);Q;V;>;"83(W!W1OZ8[
MC4631!:DHV[)=>DO=Y6F&66=7'*ZD;K73372FK70#=;1;P[?;Y85;MPMM,@3
M(\8NCCK3,VEIUARAYE41QEUEVFERBNGCKJB+HB>0)P9C"
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ME_0YMI-M=OONY=VCUQ_?]OWKQOOTZ+7%1Y'9;R)^8>=;;_L:RW4E8L6Y'TJ
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M1T4PYX
M         "/W5A\EGJ4^*S,_@28!0-X*_P J;/\ XK+G\-60#T]
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M<X_34?GS:N6<A3-47*MN_#WN0?4SFNK+15IMF=LTQ-4XX815NC=T]E4;X\2
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M/8Z3MHZ,6R<2:M/G&M4^E36E"*K=OI(KFK['I<^5(
M                                            1_ZK_DL]2OQ5YG\"
M3!)"@7P5_E3;@?%9<_ANR >GH                    ''RI46!&>E2WFXL
M6/0KC\IVI*&Z*$[555X(!^F'V)3+;T=VB0P]1WVGJ*N_172OE14X*!O@
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M'-9BN[5-7#Z6^:=D*<E:BW$XX>':[^4/8
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MYGZ&,19KAV$8Q@EH8LF(V5BR6UI*5Y3%/%VOM6MUQ=:W:]>VJM5^84COH
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M6/E2LK1$[GS5,/&VET3'XH;D(
M                                       !'_JO^2SU*_%7F?P),$D*
M!O!7^5-N!QU__=9<_AJR >GD
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M<7W"5C[9LGO=OBW.-=)="+1!<>:1>5&:7A2XSQ3F+YSUT+,JTUB
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MXP#;=(\YJU+?K^Q7WZ+]<5[SE%2Z:<IOO*W1\Y._ZYJ&<U6]F>G".K9[G9-
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M^LM/R%&2R5%NB,(IB(\/;XV0JDU5M/67\HL4ST/6UR4@
M                                                          C]
MU8?)9ZE/BLS/X#F"40H&\%?Y4V?_ !67/X:L@2]/0
M ($>(#FW4!M_L!/R+IVA3W\J]^H;62W"VP5N,^!9U;?JDRHK"M/HJHXVRTM:
MMKRZ*ZW$TTYC8Q<OT*YIOQGG3YCF0]0=NEP,Y?GS&;=*N$3T"?/M5"T>B2I<
M5&HZ-5U:N)3YM4K;HH=^GXB$X                     4F==&]?77@O4AA
M.-[%6:]N8-(M\!W'(EJLC=R@WN>^ZXDMFX/*R]I^8Y?,;Y;:([V^<'"GB711
M:WJV&JI3=+<CN4<YFFOOI17Y41=!PHQ<B  XZBIQQI4Y7<X^U[VOT2F:)GI*
M:^+YH:JTNTMZ4M]Q?*NNI157-$;(Q\N"KACHEM*Z^ZSWJW*8]-*5<Q:D1=-%
M\O$N5UQ1\54[$<$U?#&R>K>JHWYNS%YW4RF9#FLW*&U7'9B5,N=YOEM1FU75
MW]-[YPOFJJ:]0KKHG9UOHSDJU59TNBF[3P[YQGIQGJZ&)C56Z &XMT9R;<(<
M.O5?2WVFD6C3ZOP\A[<M:IN7:;?7+&YNNU9M57:>B,>E9CC&P&V^,JSW,>3(
MIK=*5+(NKM3O;V)RE7E=GYP[/I?*.5RL17._R^_!\]:MSOJ.=F:.+".J,(].
M&/I2"CL1XK5#$9FF.RTG=:8;I2BBE/41$X&UM5;P    1]S;J,VCP'GLWG+H
M]PN;/99K5I.DZZ:\NM6=6V_7YE5'S"<!6?U';[6W>RZX[5:K'+M%OQBF71'>
MG.-5NO\ I"M+Q9854;]S^NN%2E&LA 750!>UT]VF58=F-NK;,IJ;E4V9F0ZS
M5VT^D>?[NOK\Q"PEFP   V^C:4HFFB+]*(@QX7SSG9II1ZG CBA3MQ?FIY:=
M.8G*U[/+^45<,*J8JGH:,B11112YSN70O8O<U_H"F"JN*/FAJMT\JFJJI[OH
MOE[N@WHVQ\TOTCE:HJHG?I]7L_+)F#BQW0Q-G6[6";?0VG\KO3462Y177$MM
M.M<M[3AYIM.WBGME]CZY>RN0OYB<(CU,1JFOY#3;?>9JYP]6R9Q\E,3[NU!3
M</J\RR_4U0L!C)B<)U*J'9->KER<5.Q4K5$::_K>_P .VM#;<ERM33&-V?=Z
M\?.X]KGU4S%WX<G3%FC;\<S%<X1L^2JCIGHCBG#?@Z1@G3UN=N7<*+U<*7+-
M EUI5.O=X6IR0ZGUQMBNI'7-$^NK0OY\]^;UFSE:>&G;/5'1Z&#TCD/4=:N=
M[FOAB=N-6$\6.W9$51./;,[>F$[=N>G?;[;UQJX-6_W_ +VWI4E]N'NM-:KH
MBMMI5RZ-/63O&F9[5KF8GJCJ\(=HT+D;3](CBIIQKZ9G'T1C,1V;/*DP8YMH
M          <;12\B\4\VOMEX)I^1Q)JCJE3$UX[71<RPK$LXA>]V36J+=&&T
M7D)*;6JJE5\M%:*E5"^NBE5B_?L3C37AY(>?4='LZA1PW:(JB?#?$QZ$%;1L
MM@DOJ4R7;I^U*[BEIL[4^W6_GRDT<Y,*K57.?S5XN5^4W#-:I>C3*+V.V9F.
MCKF.KLZG%LEREI]?,F8R4V_@HIIJB,:HVS337OQV[:I^UY$^K!A^-8M!8MF-
M6B-9+?#32B/%;5NE%J3BNB+QUX]NIIN:S=V[/>53B[9E,A9RE---NG"([9=\
M(7P
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M3OGO*<(Z_L]$>?<FR:\Z,
M                                      C[U7?);ZEOBKS/X$E@4#^"
MO\J;/_BLN?PU9 /3T                    "''6-U/4=)VTC>Y?VK.Y=<+
MG?(N/6BR*]Z+'63(9DO\R0\C;G<HY<:M5T35?8]FJ@EO>D'J/B=4VS<'=&+B
MCV'R??.59KO9*G5D44R87+57(LE6F$=;J;<H77EZHO>;XK2!+H
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MQF<?1$U3$=?M24,<VX
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M]O\ $M%:;;I>6MNGSE7%ZO5>/#AP5=/R#0Z7?^"F)GK<D2D
M
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MS'XMC=DI
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MF<Y11&R/#S/1E<A5F=_AZ64,&Z.MT\H5AZ]-P\,M]>BJ_<*N=(T7APBL]O\
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MGF/Z59BJ[5>R,Q,3MX=D3CXZJL)_EEAN'TT[TRI:14P:MA:Z_9OORXK;5/\
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M*[G2KHX;481#>HCJ_3^Q]71"KAQ,)A^Z.XW34OD\M0PP3A@UR0
M
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M,GIUK(V8MY>F*8ZHC"&12R]@
M
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M=^CL[R+HJ<?(:Y55$1M=.FF8^.ES(0
M
M                        *&.K;Q4LMQ3<>\;2]-=FM]R<L%P=L][SRY1W
MISDJZ,NJT\Q:H=.B+0RZG+YCG,YOU)OE]QQP,%XGXJ?57M1F$&T]06"1[S:9
M*M2;S8[I9*\=O=$)U/=(6B,-<5XIS&JTKT[: /0;MMGF-;K8/B^XF&W%+KBN
M806[A9Y:TJW4C3^OFG:%JJ6AQM=6W*%[*Z53M R<   1^ZL/DL]2GQ69G\!S
M!*(4">"S\J7<#XK;I\-64)3DZR[_ #;MOA>+4^Y4L/%($&'#:1-/=XK4Q[]D
MDVK1-:*/S?G%RO8M3&((CB)GA<I9[O=,>N<"]V.<];KG;'/2+=<&*^6ZVZ3W
M:./%WFXYQNYDR.4W7*\FNC3G8P].E(UI^DIYDP][5LO9C&J[C_#,>QL-KEK-
MW9^'+8?_ -D3[7 PL)RBZNJD>W.2G7?J:+WW/[B8FOG/3*)PF.*?X_PLI'(^
MJQ3Q<,4QVU6_;6ZI50XRZXS6WRG&O-O&U6LS-_\ R/D\.O:U7-9.W8Q[ZK',
M=&R?%T?#N:7#^B7:[LVO\CY_#]K8\=JY-7^?3C7X_=L?=/5XEJU%R]_4S>W#
MQ1]UZ,+EF>[R\<6/VMD>BI(WIYV+3>2;D2S[A7:[/8F&D6X-M<SOR9#ON>B.
MLK[FW4ACL]?ISW]/+SPX>7[V#+96S9R.%S-?UIG[.VC#RTX]B8L3H:V\;2OT
M^_7:8J]J,<J/I\Y5=/-&2S'3F/Y(7+FIV9CX<O$>.N9]SFV^B;:9GLJOSR>K
M7+9_P"%7Y.]_]Q/]R'CJSE,_\"G^]5^)VV!T>;'0ZJ%?L$NYK];E37D2KYO)
M5@]G<+'?R[!1TI["4^TV\CI_5S)[GY<I2>Y1W\];GK?TZ[)VYON,[:V-U$_Y
MRQZ2G]V[QZ5AV6G:#:5/:;7XE\ZR0?\ ! P;IC;;;QA/UMM_CK'Z7:XE'Y31
M.*G!5_U@[/2,,S2O.++;J&\3RY5YZ,4HVW$N?+5'&]/)S].8G]L(4S2AR7>)
M4^:DXI2<Z?M@;[NC3>LAJDK:+3:&N79YKS/,;ESU[&?TMIO7FN?GZ##:]IMW
M.VIIB=L^+WPR6A9_\AF(KN1C$,BW'IWW<MTNMNC'?3F4UY<F'(8KHJ_)>YJ'
M(,QROG;-S"*,?+'O=[HYUT:_8B+ES#LF*\?12[OA?2YG-[D-/9DXUCEJ1-7J
M*:FI$RM/)RN0JMT?VQ%,MI')4WIXKOPQY_54P.N?4++6*>#(SQ3U[8^_2GEB
MV*6G%;+%Q^S04@VR$TE#;?>[RKV+WZU[>]JFJJ=.R.1MZ?:BBWNCP[7'=0U#
M,:E=FY?G&J?%[,/<[X>YXP   B9U'[0R-R,5HN5F\_E>.(X_;]5II](;<XN,
MJE2HG%&_8<.VE/7,UH>>IRES"J/AEHW/W+-&LY;CMTXW*,9B,=_IC;LV8[.A
M5G+2XVVIRW2+>[ ?BN=R='E+WDIK]5UA[730V7.\M9?6YQFK'LPGUXTN-Z+S
M_K'+7_3VKG#-,S$T<%&WQS537,3NZ\6C1(K1S2&K*54^VKH8;8X=J\=5]4Q%
MKD&Q1=BNYL\\_P")LNK?6CFFU1.6F[W43O\ ALU[)\5N>OHF6>MC=GYVY640
M;L]9W(V)VA])$^0_7WFYSC2Z>CM]_3F)]=]<S.KZA3IEF+5NO'9U8>]C^5-
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MTI6GY"DPHKIQ:,"VP[>WRXL5J+1];9;1M/R*1)31%.YRA"L
M
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M<52W/WV/2U^$KM5]V5C^S2H??OL>EK\)?:G[LK)]F /OL>EK\);:K[LK']F
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M +:O]M+Y^X00TG_!EZIVJ:*F\RVP?5:^XK3=TO.E"?7/.V>D):WXE?JG_?\
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MOD                               \@G_P#-+_\ XJO_ -N /7V
M                          >03Q0_ET;Z_-QC_5>U@>OL
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M4/DL]-7Q5X9\"0Q!*0
M       ,4[L8.YN=M?N1MLU<O>3^4+%KOC5=[J8])]#INT-R)Z3R>:SS.5S>
M_P!WF4=[U1@8H$=&GATN=(NZ-^W*:W?7<!;YBTK&:K+]KWO3R_2)L*9Z1SO?
M*=KIZ%W%HY?T_;P M-                               *=>F3PKOO;]
M\L&WJKWV^W.G#:KBBXXN,>]OI"3[9*MVOI7OO(Y:-)([_N:Z]W0"XH
M                         IZ_%8__ .TGWR/\NO'^5/\ E+^TS[5?+[]>
M_'H'OA[[?VKF\G]$Y?D"%PH2                              *=^IKP
MKOOD-\\XWF_EW^TI,Q6VZ8VF,>^7H_H%MBV[_E7OM&YG,2/S/<TT[V@%Q
M                            !5GUF>'/7U=[H6'<NO>#^3_WCQ6+C--E
M^U_WVYGH\V=,](YWOC!T[WIG<2CE_2=O'@$]=I\(=VQVPVWVV<NOOTNWN+6C
M&J+W2QZ-Z8EJAM0_2>3S'N7S>5W^[S*^[ZH&5P
M
M
M
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MBNARBFJFKO4U=B@?L
M  XR;/AV^)*G2GZ(\6&TX_)>K]K0TRFKE2^LB(!Y&++'R3Q$^MAF->[M-M=N
MS^Z2J^;4B/.V;&+2RZ^U%9;]DTVXD9I&D^I^D5\Q?;J!)#K\\.O!>FK;2P[K
M;3WF^W6TV^XQK+FUIO[\>2XGI+.D>>T\PS&Y>KS7<=HT7BY1R^YHH%EOA9[Z
MWK>+IP9LN57"NZ93M1=%QMV<^YS)$BVJTW(M[KBJG:TW75'1>/!HF"5GI
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M77&?RG:B1'_P2K@^YMOO?9J]$BPLDM<UA/+S9,1UIQ?G)&H(%XX
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MVJ@5!>"7<I#.Z^]5G1?UI/Q&#,=7RH[&GHTW]"36!Z10
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M9<B3LF2YY$K#G:L:XSW7(;B:*O!V,C3G;V5 6%
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M7IORK+9K"Q6<ZS22Y:*UX<Z#;HS,3FHJ=OZYY[?S:$&)@N&
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M;)5H@3*+G/PF/+=NTZ\2T7FJU=)52(TVWS-.;RW7E=3OT(K:*CBAZ$@
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MUQQ/K?J!Z%[7:8%@ML"S6J*U;[7;&&8=O@,T=UMB.U0E#33:>I2B(B =A
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M$W;K/%6I7*N4QKYUVM::5K<=75QRM>VNI5[0EDT(
M     !Y]NO;H,ZDM_NI+)MR=ML6MUUQ:YVNTQ(DF7=H4)RMR%#:8=16GW45/
M.:]J 7WVB.]$LUMBNHE,J/%:;=3]$I;1%^B!3UUR>&6]OWF<[=_9F]VS&<[O
ME37VYXO>5K9MMU?9HY7IC,EE'ECR$;;1':.7RW-.9K0YW^8$(X'A>];FYUXM
M,'=?+X5OQ^Q?K6#=K_D3U^]%C5+YRF!%:5]4U6A$Y:JTFOJ: 7\]/6Q6'].F
MU>/;4X8RXMOLJ..S[K(1/2;C/>5%DRW].]JKJZ:(G"AM*&TX4 2"
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                       IU\5'J:WRZ;JMC:MF,V^T
ME<O^V5,AJ][;9<5DI;_>KT3_ *QBR.7R_27?<]/;>R\@%1_XT7KG_P!N7_Z,
MXQ^Y #\:-UT_[=/_ -&<8_<@!^-&ZZ?]N2_<SC'[D 6T>(;U0;Z;$;3=/&3;
M6YS5BU\SQIRO*KA[VVR;Z6B0(CR+RYD-]IO5QRM?8=SY@&6/#%W_ -V^H;:'
M.<HWARY<NOMFS)RUP+@L&#;UHB4V^&]2WRK>PPTNCCM:ZZ:Z 6=
M       ,3[M7FZ8UM9N3D%DE>AWG'<7N]RM$Y4HK1J3"@O.LN*T[YM?.4(G=
M7@!01T3]>?5?N[U0[3[<[A;M57[#<FEW!N^V=+'8XG.H8M<M]I.=#M[+K>KK
M5"^;<0#TG@
M
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MV-;BX->6L@Q+*8GI=GN3*HE+C7!MQNMM=%;<:<IKH=HKTK;<IKH7CJ@,64
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M=G2/<FI;3]*.QD<7NMMU\UQ-:]'%;I3F 73
M
M
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M:+4OU-.70%VD9E(S-+#2.+0S1W:%KKK<K_5'%55^>!R
M
M
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M/U2,BRO";#=;W*JI[JR)4F"TZX_I^BU5<Q.[ZH&?
M
M
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M
M
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M'+Y='-\YJVV%Q
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M    #BILR);HLB9-DM0XD9M7)$I^I&FVZ*5X]]RK@B(!LK/DF.7]'TL5_MU[
MJC>QEK!DLR.YZG?Y=56B?- [$!Q-PGV^TQ')]UN,>VP8U/GIDMVEIFA/55QS
M33YZ@;:TWNSWR+3,LMUB7>)74M"RX#U#[25IVIWVE5-0.? Z+_*%@'(](^W6
MP^B<SD^E>^<7E\WL[G>YNGS@-3^4O;G]_P!CG[:1/\* _E+VY_?]CG[:1/\
M"@/Y2]N?W_8Y^VD3_"@=G8D1YC+4F,]1(8?H2IIZBI:Z*Z%[%14X+J!OP
M
M
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MU_-JJDH=W(2
M
M                                                %2_5YO=<K[DU
MPVQQZ<\QC>/N>CY)4PYW%G3UXNLO+Y6V>SN?F^]^AER(1*$)6!;4K.^CC?&Y
MY,U+VSRR<[<+I:XZR\7NC]7.K<BMKY^*ZYV*K*KJUZK>J?2$3"J%A92D
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M^ZVV&YSETIVWW(QC<)++R??BO&KM!NWHBR>9R5?]#=?Y7.Y=>G?[>Y6!E@
M
M
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MI1L]]H"V/%I>3+>OM@]]N9Z/-A0TC\CWM@Z:^F=]:^9])V<> 6F
M 'F%\:CY4V ?%9;/AJ]@9\\#'_>B_B3_ *? O^
M
M                                               *?NKW9RXX?G%Q
MS^UQJG,5S&0LB6\W3KZ+<WO=VG?TWW1KU^^A=BH0YXD\0^ZJ,19%T6[.SK=7
M*W5R&,Y#JDLUPL3B.T<IVMI_B]*5?4T\VWZRU^J4U5"R0M@     $8^L_P"2
M;U'_ !=Y!^P'@*Z/!'_F>WF_AC%^#F@+?LMQ>QYKC5\P_)X#-WQ[)H3]MO5K
M?3O-/Q9#=33K56G;JBZ=G #R8]0> [G]#^?;R['QI3DW;7>"QML0+A*T5N\6
M1):2[?*6IGN_KJ&ZW6TYJFFO,T3ENT:A;[X6V4VK ^A3,<YOU?)L>'Y#D]YN
MSGJ18$"*^_HNBZ+HVOD\@'&^$;BEXON+[Y]1>64=_)-Y\S<I])5ONHXW"J=F
M2GF5U7S;TF<XVJ:K[D!<P  \U7A'?+<WK_@)D?\ K'9@/2J
M   H!\<[_==_CM_H # 7@L?*DW!^*NZ?#5D ]/8         !YA?&H^5-M_\
M5EL^&[V!GSP,?]Z+^)/^GP+_ (
M
M                                   X2X0(%W@R+?<X;=P@S6T:E095
M".-N4+VHXW4FBH!$O(NB?:2_RJI]M=O6)5NJCOHENDM5QE7UVI#+Z_D.*3B.
M:P?I VAPR<W=9,&9E\V*J.1UO;K3L9MSRJD5AEAJK^VI6!+.FFFBGNIP1"!^
M@      8IW8V_B[K[:YUMI<IK]JM^>62=8IUPBTI4ZPW/:5FIQM'."Z(O!-!
M@,$])/21C'2)C64XOBN4W/+8V5W1JZ2Y5U:9:<;<99Y*4-HSHFFG'C_X@F8!
M#SJKZ2]ONK;$;-CV;29=CN&,7!9F.99;J&JYL3G)I+C)SD5.7(Y;:N)HGM&U
M^D('0,2Z'L?PCI:S;I9LNXU_C6+.YSLJY9>K,9+E0W(<C>E1FFM.5RWF8O*7
M5.%%=9(D?L+LQCFP6U&';28J_(GV?#F'V6KE*I;ID27),EV4ZZZC>B)54X]7
M\Q-4 SF  KTZ9^@C"NF/=S*MV\?SJ^Y'<\LM,ZS2K;<FHS<=JB=.BW!QQODI
M35P<C4\/7T L+                4 ^.=_NN_QV_P!  8"\%?Y4V?\ Q6W/
MX:L@'I[          /,)XU'RIL ^*VV?#5[ S[X&/^]%_$G_ $^!?\
M
M
M                                         "@'QSO]UW^.W^@ ,!>"
MO\J;/_BMN?PU9 /3V!!;K4ZP'.CK$\.RRK;Q-QJ<LO#MJIMZW;WI5A&8RO\
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MXD_Z? O^
M
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M)XT_RI-O_BKM?PU>P,^^!C_O1?Q)_P!/@7_
M
M
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MYX&/^]%_$G_3X%_P
M
M
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M<$^R4/,+XU'RIL ^*RV?#5[ SWX&7^]!_$G_ $^!?^
M
M                                                   :2ZZ>;_X?
MDDJ?$XEY7M=.]I^0I3C*K"YT>QOFJ%I31:.YZJ:E''5&^%4XU;VF]RFN/M-?
MFK_3+F''"B."G>Y$)                                !0#XYW^Z[_'
M;_0 & _!7^5-G_Q67/X:L@'IZ          /,+XU'RIL ^*RV?#5[ SYX&/^
M]%_$G_3X%_P
M
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M[]3KB-4-UUKI2GL4 SN
M
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M*FNB =K
M
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MMS^2M5*BJEXGW.++N-'E7A)D5T?,I0#8>"O\EO/?C3NGP+9 +@
M      'F%\:CY4VW_P 5EL^&[V!GSP,?]Z+^)/\ I\"_X#"V[FSNW.^&(2,#
MW9Q"+FF*.R:)U%ND..L/1Y,?BV_'DL.LO,.:+71WVG*%Y==;:^;KK0#R;=8.
MT/3MM#FL>T=/N^2[P6N2KM-X@<EJ3[SK3&B.LK[]PT9@7+TAQU__ )*TGH_<
MY3OG4 AJ!=7X9'2QTJ;Q+)RK/<OB;H[F6*,S<I&QLZ)(@QK(C%T=;;FOU5/<
MJ\MO4,L]ZA$6.TCW+DMN*XWH'HGM-GM5AM5OLMDMD>R6:S16H=JL\-IN/&BQ
MV:$:::9:;T;H;;;ITIH1-$3L&!B[4
M
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M,8W5=[GD=6.VV':_?^^2%FW2=Z$RVSZ5/EZ)S9#O+YCM>B=^OB$N[A
M
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M;77[;9,YIS^F^Y7)R5;PEL]Z>6LB! A^C*PLN;KIZ%W^_P SZ;VH(30   *
M/'-_W7_X[?Z  P)X*_RIMP/BLN?PW9 /3T          >87QJ/E38!\5EL^&
MKV!GOP,O]Z#^)/\ I\"_\ !CG<'"(&X^!YCM_>Y4F-:<ZL=QQZ\2H=;=,FB)
M<HSL1^MA76G6T<Y;BZ+4W5Y> Q$&=B_#)V-Z?-T\6W=PK+<\N&2XHLOWL@WF
M=;'H-:3X+UO>YK;%JCN:\N14B:.)QX@66
M
M
M                * ?'._W7?X[?Z  P'X*_RIMP/BLN?PW9 /3T
M  >87QJ/E38!\5EL^&KV!GSP,?\ >B_B3_I\"_X
M
M
M                          % /CG?[KO\=O\ 0 & _!7^5-N!\5ES^&K(
M!Z>@ &.=P<W@[;X)F>X-[BR9-HP6QW'(;Q#B4-U2:XEMC.2WZ&$==:;5SEMK
MW::G*4 @WL7XG&Q?4'NIBVT6%8EG=MR7*ZIBVV?>8-L9@T)!@O7![FN,720Y
MKRX]2IHVO$"RH     /,)XU'RI< ^*VU_#5[ S[X&/\ O1?Q)_T^!?\
M
M
M                                            H \<W_=?_CM_H #
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MNT:KW*P.\   'F%\:CY4V ?%9;/AJ]@9\\#'_>B_B3_I\"_X
M
M
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MOUJM]YLEQC7RSWB*W*M-XB.MOQI<9ZA'6GF76N\W6VXW5JE:+HJ:Z(!VL
M\POC4?*FV_\ BLMGPU>P,^>!C_O1?Q)_T^!?\
M
M                                              ;1.6VVJTU]U/+5
MHO\ X2(ICH/EWMB[RWE]FG,7YZ?E$S28VZO"6\[[-*=RE=47Z7C_ $1CBB*H
MC<_%57<XHO*2K1->W\O4JC"4_'5N<@4@       !U6YY9B]A=ICWW)[59WJT
MU;8G2V&*_G(ZXBJ!SL65'F,428S[<AAU-6GFJTKHJ3U45. &]
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M;$:)'9H1IIIIIO1NAMMM-*:$31/(!VH   \POC4?*FV_^*RV?#5[ SYX&/\
MO1?Q)_T^!?\
M
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M'QSJ:VBL.Z.,,I;'9#E5NRK''7UE.VJ\1U3GQE>X<Q-'*'&JD3SC=="K30O
M8)2@" "@'QSO]UW^.W^@ ,!>"O\ *FS_ .*VY_#5D ]/8 #JEUL]JOUKN%EO
M5MCWRTWJ*[%N]HF--R(TN.]0K3K+S3NK;C;C:Z54*FBIIJH&,L;Z>]B\(OL/
M*,+V6P+#<FM55?O?D=FQVV6Z<S4^VK+O)E1V*76T=;=KHJ1*E]BH&>
M\PGC4?*FP#XK;9\-7L#/O@8_[T7\2?\ 3X%_P
M
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MZ? O^
M
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MJ[ +3
M
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M>T-.,PWUU1%177I$G1/S'<<3VX%P@
M
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M$;:;;9I14HH1/8HE/D [*
/                #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>tm2227887d1-lc_carmno4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_carmno4c.jpg
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M0E*"LL(4X?%BDB-3<Q4UHM(D%D,'XE1C9"7R%__:  P# 0 "$0,1 #\ O\
M
M
M
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MT"
M
M
M
M
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M)UDZ1':=F5JG$/''=6@C6R;B/57T*,T]2? ^.2 <P
M
M
M
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MG1W-;D=+3Y#322F5%]"CV-5+)*D$[&E-I=97TK(E%U(41\&7((=H
M                              ,-S_8.':MQ*XSK/KUG&\4H6TNVEL^E
MQPD$M9-H2EME#CCBE*424I0E2C,^"(!F0  PVUV#AU)F.*:_M+UF-F6;M3G\
M7H.EQ;TEJN:\Z4YZB%);2A'YYPTDH_53RKP 9D
M
M
M
M    .%)K:Z8\S(EP(TI^.9''?>:0M;9D?)=*E$9EX^/@ YH#'K'$<4MYS5G;
M8Q4VEDST^382X3#[Z.@^4]+CB%*+I/T<'X ,A  $=.[OZKV^_P ![C[U6"8W
MO.EV!?6_TG\ISOFN8"\[GJX!C      !C&*X3AF"PY=?A.(TN'0)\I<Z=!HX
M$>O9>E.$E*WW&XS;:5.*))$:C+DR(O'P 9.                     QEW"
ML-?RF-G+^)4KV;0HIP8>8K@1U6K4575RPW--OSDMGUJY22^/$_#Q 9,
M                QW*,0Q/-ZI5%FF+U&7TBW6WU4]W"8L(INM'RVX;$E#B.
MI)^)'QR7P .^999CLM1X[2&&&$);88;224(0DN$I2DN"(B(N"(@'T
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M0A)F3DEP^3+GQX^ @5NBB> (
M
M
M                                                    1T[N_JO;
M[_ >X^]5@F-[SI=@7UO])_*<[YKF O.YZN 8P    !\9#/M,=^.;KC)/MJ;-
MYE70XCJ(RZD*+T*+GDC 1G[7>V:!VQXWEN.U^<V^<-Y7>N73DJU2ELV36VEO
MI)*5+)2U=/+CGAUGQZI< F9JD\"                    $7+3MAKK/NCH.
MYQ6>WC%A0TJZA&$H-/L+A*CO1O%SJZDM<.^8;1)\72)?5^=!-=B48(
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M=%?5NS;_ +E67S/3 F[>M.!4
M
M
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MRJ93]UG2U\3&I1,/*/A?G\I64A+;9->2KJ2?5U%R9H)V42C!
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MU0-V?)D'YTA@F-Z.GNBOJW9M_P!RK+YGI@3=O6G J
M
M
M
M         CIW=_5>WW^ ]Q]ZK!,;WG2[ OK?Z3^4YWS7,!>=SU< QJ'^S#ZT
MG=O\N67SW*%K4W]"T@2H *M,._K>*[_+?P!6*SO9(\*]Y]]J*P])D.$TQ'0I
MUYU7H2A!<J,_[!$(5:.T-W&ZQ[CZ2_O]93ITN%C=F=99(L(BXCG6:26VZA*N
M>4.I\4^/5_=)2?@"9BC>P(                    :#G]RFJ:W>U5VYRK64
MG9=Q!.;%BE%6<,O]'7*2PN1Z"<4PVIPBXXX\.KJ,B,FC?@(
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MZ*^K=FW_ '*LOF>F!-V]:<"H
M
M                                 ^;SS4=EV0^XEIAA"G'G5'PE*$ER
MI1G\!$1 ,3PC8&$;*IE9%@&55F8T2)*X:[:ID(E1RD-$E2VC<;,RZDDM)F7Y
MI .3F&:XEKZAE91F^1U^*8["6TW+NK-]$>,VMY9-MI4XLR(C4M1)+\T!B>9;
MOU!KQFBD9SLG'L38R>,<S'G;2<S&3-CI)!FZP:U%UI(G$^)?9("C!_Y7?:]_
M'W@_[<1?\,$TEF&*;[TMG+-_(P[:.-9,QBT!=ID;M=8,OI@PFR,UR'S0H^A!
M$D^5'X> %&'_ ,KOM>_C[P?]N(O^&!26U<*V5KS9$-V?K_.:'-HD?I]J>I+"
M/.)DU>A+I,+6;9G]A7!@AFP
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MRLVMAUC96+[<6OKXM[7O/OOO*)#;33:'S4M:U&1)21<F?@0%&R0
M
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MU60*NZ
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M]NT&&9Y1Z+UZ]K[*WD+*X*T6S(*&B2J/(<2P[8DLE)\M?!&GQX] )F(6> J
M,0SK/L.UGC<S+\]R&+B^,P%LM3+F:9I9;6^XEIHE&DE'ZRU$1> #0_\ +<[3
M_P"/3&O_ **[_FP326V=:[GU;N)BVDZQS:NS-BA6RU<.UZE**.N02S:)?4E/
MVQ(5Q_8!%&S@ !J_)MWZ6PJXD8]F6WL*Q*_B);7*H[J_KH$QI+J26VI;$A]M
MQ)*29*(S+Q(^2 HZ#^4UVW?S@]:_\V4_ZZ!-);L:=:?:;>9<2\R\DEM.H,E)
M4E1<DI)EX&1EZ#!#]@
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M+@S+CJ0?H,P59J
M                    (Z=W?U7M]_@/<?>JP3&]YTNP+ZW^D_E.=\US 7G<
M]7 ,:A_LP^M)W;_+EE\]RA:U-_0M($J "K3#OZWBN_RW\ 5BL[V2/"O=D*?1
M'?7&;2])2VHX[*E=*5K(CZ4FK@^",_#D0JC1VNY=W'YAC&4R^Y+ JO LAA7C
MD;'(E9ZJ7X*4)ZEJ1[5+Y)+G4E"^LNM/CQ^>43*3H(
M  19M<S[EF>Z3'\,K-=U<CMRE4RI%UGBU<2FI)1WE'PYY_JK*0EMLFO)5U)/
MKZB(S4@G91*8$                    ([=SV4[ZQ#6S%MVZX7 SG.E741B
M=53T^8EJL6ATWGVVO:(W6LG4M(XZ_!*E*X]7DB8;PQQ^[E8]0R<E@LUF1R*Z
M*[D%;&7YC,>:MI*I#32^5=24.&I*3Y/DB]((=R
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M<%X JY0# -H;-P_3N"WFQ\]GNU>)XY[-\:SF6'9*T>V2FH;/#3*5K5RZ^@O
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M3$5;2H[FMR.EI\AII)3*B^A1[&JEDE2"=C2FTNLKZ5D2BZD*(^#+D$.T
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M<>9'>0EQ"N#(RY2HC(^#(C ?<!QXT2+";\F'&:B,]1J\IE"6T]2O2?"2(N3
M<!%!0MVSE\W20&[UU'E.W28S12U(X(NE3Y)ZS+@B\.0';@(>=_OU0-V?)D'Y
MTA@F-Z.GNBOJW9M_W*LOF>F!-V]:<"K1?<GJB-NC2^<8&XSYD^;"5+H%D7*D
M6$3[M'-'YJE)Z/["C$?&R8+K<V.*WV3Q1'73?;^U;6WO;6CNL^)PWS2R[[MW
MHB>G]F:7=R/'N]MP2LZU"_KC)I)JSC3$@J&P8=/[JNL]8J]WQ])(2A3'@7H;
M29_;<GV.;V8[[K=3AVX\T1=$]N_[6K=BOPWW8K]EULS$]S/]N=GN"9Y;?3K
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M
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M"X5(RZ'G\C$J=_.:^&JO@Y@N$PJS9B+ZNIAN6:/-2@^I7@2OA5]D^0RL
M                !C.6X5A^?4ZL?SC%JG,*);S<A=-=0V9T4W6CY;<\E]"T
M=2>? ^ &1,LLQV6H\=I###"$ML,-I)*$(27"4I27!$1$7!$0#Z
M              J3[D/=[;=WAN[(=K5N[8M+#DNQ_HE6S/;W7ZEAEAM!M1UH
M7PTDW26YPWP7*C/TF8+1+!6_=U]V$=E#37>#8,,,()+;:;&]2A"$EP1$12"(
MB(B XH7$XO"D5F,X[6RYY6LJOK(D:3:$HUE)<:90A3W4HS,^LRZN3/X05=Z
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MFXA_G3=4AU1EY;71]GQYY"8H1-5Y(A
M                                                Q.HP3"Z&_O\
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M265$2FG'5ON'T*+J)))-7!GP1%TK,051T[N_JO;[_ >X^]5@F-[SI=@7UO\
M2?RG.^:Y@+SN>K@&-0_V8?6D[M_ERR^>Y0M:F_H6D"5 !5IAW];Q7?Y;^ *Q
M6=[)'A7NR&?:8[\<W7&2?;4V;S*NAQ'41EU(47H47/)&(51H[7>VJ+VS8QE6
M-Q<]N,\+*;QR[=EVJ2;\E;C:4*)+9+<(UKZ>IQSGE9\>!< F9JDZ"
M             $6K3M@@6?=)C_<Z>?7;$VAI5U"<'1Q[$Z2H[T;]%ZR4EHR>
M\PVB1XNIZ^KX 378E*"                    $=>Y_M\B]R^MF-=2\SLL(
M98NH=R=G7()[SCB(=03#[)K;)QLS=ZR+J+AQ"%_G> 3$T;QQRG^CV/4./E/E
M6I4==%KRM)R_-E2?9FDM><^X?VSB^GJ4?PF9@AW(
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M4M9N)6MY2DGU&7!^'@.KCMBVV(MW/7:?%9BQQ;9X>CIW[6?B[,
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MCD1=N3;O72"H
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M7([<95*N1=9XI7^E-2BCO+_1//+I64A+;1->2KE)]?41<F@G91*4$
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ML1Y7E$?CR2''UF7P<*(B] ^A:"Z;L>U]YY!ENR:;[W1/NB:?6GX-UVP
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MG/,JZF7EI]9!\<\EP9$8+1,U2+UEV"]I?T;U]E_XI_\ ZHOBRIN/C#X]OO\
M7?):D>;Y?QCY?Z)ZW3T]/P<<> (K*?8(
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MV[2KJ0G9EQ!.;%@E%=.*7W!<I+"Y/'23BF&U.$7HX\.KJ,DF31O@$
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MHN^G]&]8\-UW
M !'G9':CV^;=R9W,MC:UA91DS\=F([:ORIK2S98(R;1TL2&T>J1_W()JP+^0
M%V@?Q)UG^W6GZ\ K*6]=7PZFO@U5<P4:OK([42#&29F3;+*"0V@C49F?2DB+
MQ,$.8 Q3.L.K-A8;D^#W4B9%J<KKI%78R:]TF)2&9*#0M3+II5T+(C\#X/@!
M M_W7?;O*4PN5DVQ)*XJR=C+=O6EFVLO$E(-4,^DR^R0+<3?6B.T;6O;UD5Q
MDV%7N66L^[KCK);.06B9S"63>;>ZFT)8:Z5]39%SSZ.01,U2E!
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MSG:LAB2CC-0X9I;>.*V1J5YBVTIX(_#J_,!$T3T!
M                                   *]]*=^'XX>X[)NW[\5?T=^CLF
M]C_2WX\]K\[XD?4SU>Q_%[/3YO3SQYQ]/_F!:86$ J
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M\"PC7T&95X+B-/AU;83';"= IH3,)EZ4]P2WEH80@C49)(N3+T$1>@B(!E@
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MNLO^!G\<;I_6CZ?2J=@VW7
M
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MWACE/]'L>H<?*?*M2HZZ+7E:3E^;*D^S-):\Y]P_MG%]/4H_A,S!#N0
M                  4P;JWQWI;<[E]C:5[7I!4--JLDHL2;:K&''C0AI#LB
M5+LTJ^V><4EIMHRY1PHTJX-1%HB*/FG6GO;U)2H]I5R#41&:%3*;DN?@/B"9
M>'YA@;%Q.-M6[&.T#.0.D_?,UT5%V^DTF2Y:64D^HC21%XN<GX%P"K7&_KC9
MM!J#-K?3=7\=;+A1F%8I5^0F3YSJI3*7"\I:DI5PT:S\3^ $PJC_ !V^]?\
MXHO_ *01?\^"U(/QV^]?_BB_^D$7_/@4A9)VGY-OG*]7R+3N*Q_Z-Y^F\EL,
MUWLB(?->AI@V%^6VI9>*U.%SS\ *RDR"           0\[_?J@;L^3(/SI#!
M,;T=/=%?5NS;_N59?,],";MZTX%0   %7V^=,,WN7;4TV3+;43=%;]+=8R%^
MJB+E=9YCZ$)6?JH\X_/:69>A#J2'$Y'K/]FYY,?_ !YHKW_I1[9_NO6ZZW_<
M^3V9/_DP3PS^&=T^SU7)+]F^YI>Y])TD^_6M.=8:ZO&,]C/^$CXPKTI23[J#
MX42GVC0M7)%ZYK27VH]?SC1QIM1,6^&[;;V3]CQV*[BA*H<MD      !H;?^
M@,3WYB::>X4=/DU.:I.&YE&3_I=9+\#)23(TFII1I+K1R7/!&1I6E*BQ9L,9
M(I.]IZS1V:FRD[)C=/4TCH#?^64V6*[<^XQ)4^V*<DM8KE3JO]$R:)XDRXV\
M9))3RB3ZJO#S.#(R2\E23Q8<TQ/!?O\ :U='K+[;_@9]E\;I_6^GU]K"-J[I
M[X=2XED>?Y)@NK$8ECSK)/OLG8OR/+E2VXC!^6FR3R9K>1SQZ/$Q3)ES61,S
M$48=1JM;@LF^ZVRD=O73K;)U/G'>=EME@]WF&&:V@ZXR-J+86<^L7-*Q1 E,
MD\A32'9[J27PI/@:3&3'=FFDS$49]-EUE\VS=;;PSU5K3UIJC9=4
M
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M$GM[]O?_ +@6_E?[4LO^T_\ \M_K2PUI@_XM\)I<+^DMOE_Q-[3_ /5%?/\
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M%_SX%(62=I^3;YRO5\BT[BL?^C>?IO);#-=[(B'S7H:8-A?EMJ67BM3A<\_
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M$]O7"TP==Z\
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M,X\_)KK_ !R=Q[75VD%TV)<)_@B+J;6GP/@NI)I5P7/ $PS_ "3(*O$\=O\
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M+DRYV^3X+^/BG9$[/K=+RKI,GQXOG9$TB*].W?W/14/;/M0
M
M
M            ZYBHJ8TE4R-61(\Q9J-<IMAM#AFOQ5RLDD9\_#X@.Q
M$:NX?MQ3W!L8_72MK9KKRB@-S(F3T>*V"HD:]A3/*Y8G-*ZFE^7Y:B0:D*(B
M6LC(^2X)B:-X8;B&/8!BF/83B=<BIQO%X+-=35Z#-1-L,))*>5*,U*4?'*E*
M,S49FHS,S!#)0             !I?;/<1I;1\-4G9VPJK&Y)H\R/2&X<BS?3
M\!LP(Y.2%D?)%U$CI+GQ,@3$*I-R^]U=4<NIT/KXFD^+;68Y:?4H_'@ULUL5
MS@OLH4X^?P=3?I(%HM6XZ.R6YS/2FG\PR*44[(,LPC'[F]FI;0T3TR?6QY$A
MPFVDI0CJ<6H^E)$1>@B(@4EM(           $=.[OZKV^_P'N/O58)C>\Z78
M%];_ $G\ISOFN8"\[GJX!C4/]F'UI.[?Y<LOGN4+6IOZ%I E0 5:8=_6\5W^
M6_@"L5G>R1X5\8A5B6'X#@^OH4VMP3$*?#J^QF.3Y\&FA,06GI3O'6\M#"$$
MI1D1%R?P$1%X$0#+0                    &)/8#@\C,(FPG\/I7L\@0U5
M\+,EP6%6C45?41LHEFCS4HX6HN"5Z%*+T*/D,M                     8
MMF&#X;L&F5CV=8K59A1*>;DG3W,1F;&\YHS-MSRGDJ3U)Y/@^.?$R^$!DK++
M,=EJ/':0PPPA+;##:22A"$EPE*4EP1$1%P1$ ^@
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M1,1)*)"D6$]*$MDM1]'*?/+D_P P%XN3=]T5]6[-O^Y5E\STP(NWK3@5
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M)2%I/DE$?B1D9>DC&X[;]
M
M
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M3C3.P+?/RR>\<NER[1'E$PMQM*%$ALG'2-:S(U..<EUGQR1< F9JD\"
M               $7;3MF8L^Z"A[ECV-?QWZ.G54IP)!E[ X2H[L<R\SJ(TL
MGYA.J:Z#Y=22^KX 378E$"                    $=.Z#M\9[EM;,:[D9K
M8X*TQ=1+@[2N;\[SCBMO(*.^R;C1.-F;W61&KP6A"OSH)B:-YX[4?1_'Z*A]
MODVOQ)7Q8'QG-7YDF3[,TEKSGU_GEKZ>I1_"9F"'<
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M0V3+9DJ-$/K)1+,_4^$O$_@V\47Q'WM[L:6W-;9_BS$W5Z.KU0VR,C9
M
M
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MS*9;]SGRE*]K:E%&>7^B%((DJ*0AMHFO(5RE1KZN#Y03LHE("
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MCX/A25$7H\.:,MM8?0]%K+=5CX[>^&]!E;@
M
M
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M*4?!$1$KDS,PK!QV];M1*P
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MH+R1&I+2>])C(=8FQD-+2VM1I(T)49$?P$8+W1L7K H
M   JAW3[P#8G;9W 9;@>RM4KO-7/OLR,%R&*3E?/=AKC,&\MAQTEQIJ&WS6C
M@O+-)^"E^' +1%4B]>>\'[4MAL1S;V9'PNQ?(O,I\M:75.,F9<\+DN=4,_\
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MAFQA&KPXDQ5'U)+GP)9<H5^=4H;./+;DBL2Z>FU>/416R>[IA$[N6[1=&1<
MW5MEG&I:<W57W.3'9'93#;^,GO,E+=\@W?+X-Q1GT]/'P<<#7SZ>SANNIMWN
M=K^6X(QWY*?>I,[YWG;3VBZ,E8!I7;+V-2U9NFOILF*R*RF$W\9,^7*0[Y!.
M^7P3B2/IZ>/@XX#!I[.&VZFW>:#EN"<=F2GWJ1.^=ZPT;CM
M
M           *_P#);+WC*,COTXOCVLG<9392BQUR6MSVA4 GE>S&]Q)+US;Z
M>KP]([^.WE?!'%-_%2*]O3T,,_$]#I?C3WFW_#>JO_HCGZZ%^'E/7D^G<?XG
MH5_L.9S*[C=RO[L9A,;?24!,MB(:CCMQ_9TD90^M2ON?D^S]/!^C^V/4::,4
M::SX/@VT]?3Z=[7NKQ37>[/;B*E>N<L^.";-A$!U4,W./"61?Z-T\_#YO27@
M,^*O%%$2D[I2T]XF6HM;EA]%K^5B*<=KRQ61>*6FP76DPDH9OD4A'B;/3QX>
M)<#S.MMY7\>_CF_BK-:;J]/0SV_$I%&T/C3WFW_#>JO_ *(Y^NAK</*>O)].
MY;_$]":>I7=FOZ^Q]W<<:JA[(5[7](X](9G 3Q+>*-Y)FM9^,?RS5ZWVW(XN
MKC#&6?@UX-E*[]VWZV2VM-N]L<:ZP U)O^;8UFB-UV-.I:;>OP+))-6IOGK*
M2U5R%M&GI,CYZR+C@P3"-GNU8%?#[.M8R(;*&I%K*OY5LM'I<D)NIL=*E_F^
M2RVG^P1 7;TX;&MKK>&_76T"-:5\DB*1 EM(?9<)*B4GK;<)23X41&7)>D$.
M2RRS':;8CM(88:226F6TDE"4EZ"2DN"(B 5HVW]:AC'_ &B<_398+="PC-LW
MQ/7.,6>9YQ>QL:Q:F\GXTNYAFEECVAYN.UUFDC/UG74I+P])@JU9A/=+V][&
MR>LPS!]KT>2Y3<^=\5TD-QQ3S_L[+DAWH)2"+U6FE*/Q]! FB)_NOG')NIMS
MV\LNNSLMP7RY\DRX4M7L%8YX_P!A3BC_ +8)N?7;A-QO>9=JDB/()$JSP;(8
M=BPE'"E1F(-T\SUK_/)-PU&2?@-//P@1N=*_VP]T&1]S^^=G56RX>E,6SPH$
M&LRNMC1KBWF5U>PW'8C,,K4@HB3*.AQU9F2^>DD\\K,"L4<[$=B[^[:NXS7^
MCMX["1N76VZTR&=>;!DP6X-E"LX_!'&>2V9]9&MQM"B4IS]$;6A:.%M@;WW[
M-'')_=;[P*?-+S)D?+:2&P\HN%)80[<MH07YG0RC_P " G<^O?23;&Z^PFQ:
MD$S8M;<B0V4DC[HJ-+G529/#GP),DI2I/Y[DOL 0PCN0FWMWWDX<SVM0)$SN
M;PC'DM[$G3393B[6.R2)UMBW)PR<4YTRD*(VN%=*VR(U+2GH$;F)V\K:E5W:
MZ/RSOFA0(=-'?77Z,G8/RO$H>12E((_;SE*7,0MPTM&DUJXZDH5^AH7TCHV+
MBP5=1(A4%?+F91*B5\&<S#4W/R)UMIIU$-O[HI+LE1$HFD]/49&KI+CGX %6
MNP<BE=_VW\1UIK9EY[MKT_D3%[LW9BFUMQKFRB$HFZ^N4KI\PNA:T$KCCUS=
MXZ$M>:6W)R;I[<\(WK=ZMOLNM+RNF:DO"O\ &VZA^,RT_))V.[T2RD1I!K1S
M&3X(-!\&?K>C@B)HV/G&M\%V5%HX.?8M RVOQRV:O*BNLV_/C-V##+S#;RF5
M'Y;G2W(<(DN$I/CSQR1&1"#FLFT->\H[AVFD);;;UG1);;21$E*235D1$1>!
M$1 MT+&05        >=+W8_UQ<P_!K(?G"("]VYZ+04
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MX^]5@F-[SI=@7UO])_*<[YKF O.YZN 8U#_9A]:3NW^7++Y[E"UJ;^A:0)4
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MU'T?Q^BH?;Y-K\25\6!\9S5^9)D^S-):\Y]?YY:^GJ4?PF9@AW
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MO-2&6I#*R<9?0EQIPO0I*BY(R_LD8]<^MQ-7T
M
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M*"        'G2]V/]<7,/P:R'YPB O=N>BT%
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M:MF:Y'2KJ*/)\6Y4<S^$V7T+;/\ -2.;J]/.GS78YZ)_JGOA>V[BBK8XUU@
M              'G]VAK/*>V'+K_ !_(*&=,UK/GO3,)S**TIZ/[,\O[FP^Y
MX)0Z@N$K29D?5XI)25),>3YIRRZZ[BM^G]+Y1YD\N99R\=G]$QT;>N&*5.#[
M,[BTNTFJ,+FVM17$N7:WTTBB05K82:D12DN*2WUK5X)3U=1GX^JDE**G+N67
MVW3=.V6'D/EW/;?-\Q6:=T=_6M@U!W?8CD%HSK3:E$_I':==T1%XO>=3$*2H
MN$-^QRG207K^'0A?'5R1-J=](]-CU$3/#=LE])TW,K+I^'DC@OZIW=WT]:9H
MV74:YV?MK7VFJ")D^R<@^CE'/L&ZN).]DES.N6ZTZ^AORX;+ZRY0PL^33QX<
M<\F7-+\EMD5N8-1J<>"WBR32*TZ?<T3_ "\>U+^-7_Z1WO[GC%_-XNOZI:G^
M[Z7]?ZI^QO;6&VM?;EH)>3ZVR#Z1T<"P<JY<[V27#Z);333ZV_+F,L+/A#Z#
MY)/'CQSR1\9;,EM\5M;>GU.//;Q8YK%:=/O;&%V<
M
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MRQFDV)8P8LZHKYJ3:CS/;%.):CM23^Y^>?E\DTLTJ5U)Z"49\$11O $
M       (Z=W?U7M]_@/<?>JP3&]YTNP+ZW^D_E.=\US 7G<]7 ,:A_LP^M)W
M;_+EE\]RA:U-_0M($J "K3#OZWBN_P M_ %8K.]DCPKWGWVHK#TF0X33$="G
M7G5>A*$%RHS_ +!$(5:5T;W#ZN[B:6\OM7V\FT@8[8?%MG[7$>AN)=-!.(62
M'DD9H6D^4GZ?3R1&"9BC=X(                    :*G]Q^IZW>%5V\2[Q
MY&S;B%[;#K4Q751O%AR43*Y)%T)<4RTIPB/PXX\>HR($T;U!
M        #3V[MZZ[[>\/CYQLRRDUU',LV*>$<2,Y+>=F2&W7D-I;;(_0VPXL
MS,R+A)_#P1DQ%6S:.YK<CI:?(::24RHOH4>QJI9)4@G8TIM+K*^E9$HNI"B/
M@RY!#M                        4J;PL^YCN[[H=AZ"U/G#NM-=:B;;:O
M93<R37M/K-+9./3#A\NR5NNJ4EEK]#)".H^E74HRT4B&J=BZ@[QNQ&!6[JI]
MW'G6*5]A&BY+3JF3WXRO:5]"4S*^::VG&G3(F_,0HG$*473T_; FL2O;PK)&
MLRPW$LP9C*A,Y72P+AJ&LR4II,Z.W()M1EX&:27P9@HZ';6MJ7<&M<TUGD#B
MX]5F56]7O3&B)3D=Q1$IF0A*O U,NI2XDC\#-/B!"B?/M)]_NLM97O;D]B"=
MQ:5D*-%#(KHK5KY"4O$^T[#-M3=A&4VZ9+)#A="3(R+J;-747K#LL4F^]0RG
M#(NG:_'\BI,>*O11_'5Q60*F2S7$V3)-JLI3;3OJMEQUH,W?_,:N -BVOM#[
M>$]LVF:W7LBS:N,AG3I%YEUE&)11G+*4AII28Y+(E>6VTPVV1F1&KIZN$]72
M169JD^"           0\[_?J@;L^3(/SI#!,;T=/=%?5NS;_ +E67S/3 F[>
MM.!4       !ICN#PT\YU%F-0RUYMA$B?&=4DBY4<B"?GDE//PN)2IO_ .V'
M(Y[I/YG1Y+(WQ%8[;=OU[N]VO+VM_E-=COG=,\,]EVSZM_<YNH,IB[.U)C%O
M8I;L%6M6=?D+#I=277V2.+*2XD_@<4DSX/X%#-R;6SJ=+CRUVTV_BC9/UQ5B
MYWHOY/69,716L?AG;'U31#WLREOZ>VAO+M*N7S\C$;1>5ZQ6Z:E*>H[ VS4@
MEJ\#\M+C"C(N3ZUN^GI,>SYQ$:G#BU=OZ4<-WXH^D_4XF+[LS:L<'G68
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MGPA2_N)$7671TJY+J(T]*N#+@=&V8F*QN>EQ39=;6RE)ZF6BS(
M
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MAQ;"#(;EPIS*)$.4THE-NM.I):%H47@9*29&1CSTQ,32=[,Y(@
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M*4I1\$1$3G)F9AQV]9\:S]:/6RP69
M
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MWKUU[;9M^24?S$)1T(;\U[E:NGJ<<ZBZU>/2D$S-4G@0
M    BW:=M"[/NCH.Y7\9U]&11TJZ@]=H(S@NDIAU@B\[S2Z63-WS5->4?+I$
MOK+T FNQ*0$                    (Z=T';_\ RD]:LZ\^G-A@'DW42X^.
M*]KVCS?94.H]G?9\UCK0KS>LBZRX6E"O'IX!,31O/':CZ/X_14/M\FU^)*^+
M ^,YJ_,DR?9FDM><^O\ /+7T]2C^$S,$.X
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MD9'R1D ^H#72MOZF1E18(O:&))S<WCC%AYW4$K3SR]+7L?G>=U_^7IY HV*
MAYW^_5 W9\F0?G2&"8WHZ>Z*^K=FW_<JR^9Z8$W;UIP*@        "(NW^,
MWSI[9Z/N-7D2G,2RA[[5LB>Y*.MP_P SS37S]AK\P>6YK_XO,,&IZ+ON7=^[
MVU_9>OY/_P"9RW4:7]*W_$M[M]/53]IH7WA.WK?V2A[9<1@0Y%WM2"5EE-G.
M;)UN#3L2#-I3:%$9$MQV,L^OCE'1ZA=:DJ3]0\NZ*+KIU%T[+9I'IFGV2\3F
MO_10;J*/=>O(5?/USOK+H]SCS"$5M1*FNN53K;"2)N-[&ZXXR39$DB2A:5H]
M!<$7B7I,F#3YJQ?CMFOHV^O>P1,QNE<%VG;X<[AM05N:64!NKRFKF/469U[)
M*)E%E$0VM:VDJ]9*'6W6W"2?/0:C1RKIZC\-S70_R>>;(FMLQ6.R6WCOXHJD
ML.:N                  #0W</H6@[@\#5B=K-<I+:NDE8XMDC*"<<@S4)4
M@E&CE)K;62N%H)1<^!D9*2DRPY\,9;:2T]=HK=5CX+NY4<K0W<&C;RNWU%UB
MSF4?$GQ\C*5./DQ\6^9Y).&KR35U]7YWR3/GX?A'G?\ 9;/BT[]^S[7SV?)^
M/^9X.FE:5^[3U5[DSZ?W?S>%4-3;ZWW%D6(;CKD+<GYM'490;!UQ76IIZ$2N
MHFN>$_HBN2Y-:5^@=NW1Q9$<,TE[''R6,5D?#OFV^.GH]74Y+'<OO70<IJG[
MIM<+NL9\PF8VX\/;)V(OJ/I2J4PDD-I-1GZ.&5\%ZK2A/Q[\>S)&SKA>-?GT
MTTU%M8_6CZ?9V)KZ_P!G8!M.F3?Z_P J@916GT^<J(Y]V84HN21(862765<?
MG7$I/\P;-E]M\5B74PZC'FBMDQ,(P=PO;'VY2<;VEM/)L1CLYE+J;.R3D$FY
MLHR5V:(CBHYI9]M0P:C6A/""1P?HZ3&#-@QTFZ8VM#6Z#3S;?DNC[U)FM9WT
M[6H^T?MA[=,[TWKC8%OA[%WG3?F2;>S9N;)*VID::[Y/FQV)J6D*)"$'TF@N
M2\3(^1CT^#'=9$S&UK<MT&GR8;;YMK=VSU]JS8;SO
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M&?M34KV=Y?).^T$25%(0VT37DJ,TF:^>#Y03LHE."
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MFH*7942M*DLE2'JO)Z1*_-1%LHG2;J&UGP9H6A:'$<^))61'XD8*S%$B00
M  KW[8L'P[<=OW-[0V3B]7FF09#M'(,0C+N8K4XH>/4:68D.O9)]*^A/2I1K
MZ.DEGP9EX$"TLK[%K!V+A.X=9%,>E5.D=NY9@^(ID+6ZXU2P9#;L-HW%F9F2
M#>6E)&H^$D1>C@$2W#W29Y9:R[>-OYO323@W5-C<M-+.2HT*8F2B*+'>09?G
MFW'DJ3^:1 0KC1,[<V>WC'\5R?M_SMO4$J+"3?\ =3!J(B9)7+JVE/9"S)>-
MRQ\IR29\25,=)D9-I;4V:4F3M7"491RI:<HEHY>12A1_9KIYQ#SDQORT],A;
MC:4H6IPO6-22(CYY(N 5>=3N4[\.X/86.[3TYDF 8O78383GZJ3=1*JV9F)C
M09Z5LK2^]8.,DI1LIY,V^#Y/@B\ 7B$\?=%?5NS;_N59?,],"+MZTX%0
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MK
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MIPK;^A[3>EA%<PJLQ!-@UL&JE+\\ZN55,ID2FR<2A!NEY2T+1ZA*,E$722O
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MQ%6S:.YK<CI:?(::24RHOH4>QJI9)4@G8TIM+K*^E9$HNI"B/@RY!#M
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M"5F?W0C/:YWI;;,D9L?@R1Q1V],>_P#J5Q75BD[X3@'$90
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MGG@AN8L48]TS/:[6ETENGB8BZ9KUS5NX96V
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M !73[L?\@>8?]RLA_2X@+7+%@5 'G2]V/]<7,/P:R'YPB O=N>BT%
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MP+ZW^D_E.=\US )W/5P#&H?[,/K2=V_RY9?/<H6M3?T+2!*@ JTP[^MXKO\
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MTKV?0(:H$+,UPF%6;499*2;2)1H\Q*>E:D^"O0I1>A1\AF(
M       #%,RP7#-B4J\<SS%JO,*%;S<E51;Q6I<?SF3Y;<)MU*B)2>3X,O'@
MS+T&8#)F&&(K#,:,RB-&C(2U'CM))"&T(+I2E*4\$1$1<$1 /J
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M"0
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MD+DN-L^Q1U^6E2S,R3U*,^/LF.GH[YNMFLUVNGR7-?EQW3?,S->GL6!#;=D
M            1>M>VU^S[G\?[C_QH7\9BCIE51ZW1S[ \9L.L$9N^:1$U]U-
MU31M'RZ1+ZR] )KL2A!                    ".G=!H)[N/ULQKZ/GUCKE
MV/=1+<KNN9]H\THS;S9QGV2>CFMM1/=1$3A<+2A7CT\&3$T;SQVH^C^/T5#[
M?)M?B2OBP/C.:OS),GV9I+7G/K_/+7T]2C^$S,$.X
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MYB.GT<-.,IXY(QV>=X+;^'58_!DW^B[I^G7$L6*:?=GH6 C@,P
M                   BGWAZ4N]VZF^+,24GZ9XE:,9#C$9:TMIE/1VW&EQC
M6LR2DW$.F:35P76E)&9),S&MJL/Q;*.9S;13J\$V1O\ ;Z%.4O,[.BF?1W*L
M*OZ;,FC-EW''(2TO..HY(_+0OI69&9?W/_B/&9.4Y(OI&[ZWQ[-Y9U%F7AC=
MZ:U]5$I='=O_ '<8S[;OS!TT>*9=>,KA(UQDS!IDS*<E,N):<-:"..:ULH/I
M-;*SZ>5*21\'Z31:/)@LCA^OI?0N3<GU.APQ.*D33=.^>GNK/8E!0][;6*6D
M;%.Y76=WI3(7%&TW>*9=G4DI2/!3C3S25+Z>HR(O+\Y)>DW.!NQJJ32^*.U9
MS7@GASVS9/7OCZ>M-/&,MQ?-:AB^Q#(*_)::27W&RK9#<EHSX(S2:FS/I47/
MBD_$OA(;5MT716'5QY+<D5MF)CT,8S+%M0H3,RS86.X>E*$H*?DN11*\B)*$
M]*"=E2T>@DEP7*O0*W6V[YHQY<>+Q7Q;VS3WH->[^Q75&6:,8CW>.8GDN60K
MBQ58L3H<&98M,&M'E&ZEQ"W4H,C]7J\/L#5TEMLV;8BKD\FQXK\&V(F:SU56
M5H0AM"&VT$VVV1)0A)<$DB\"(B+T$0W7=?H
M
M                                               !Y[O>R9;6/;GQ
MW$U8=6-7E1C4"?#SYA<ANS4S(DRN8;Q$YY+C2%(ZT<HZT*4KA7"C(R]K2^&>
M\S[J\/J(-,]D=/F#%>P4>/,R"M2_+-""22#=D1UQUNJ(D\=;AJ4KDS4:C\03
MPPS#^E?[H?\ =^#_ +4ROU\".&'H TUEEIGNH-4YS>)81=9IAU%>W"(J#;8*
M58U[$EXFD*4HTHZW#Z2,SX+X3!26R0           1T[N_JO;[_ >X^]5@F-
M[SI=@7UO])_*<[YKF O.YZN 8U#_ &8?6D[M_ERR^>Y0M:F_H6D"5 !5IAW]
M;Q7?Y;^ *Q6=[)'A7O/J=0P\N.T3[Z$*4RPI702UD7*4FK@^GD_#GCP$*HS=
MKF<=P^=8OE,[N*US!US?PKQR/CL*$E39/P3;2OE3:I,DS\M:C03G41++X.2,
MS)ET/?C]5+:O[!_/M>-?5_*GN]KF<W_*W]WMAJ3M-^KUK;]2S?G"2.$T-'\F
MWL2*!LL2S[]XN:_(-E]ZN")5NW2T1[K[\D>P/PO/[PBCL:'PSVL?(/E7?B]T
M+,1O.\             (MVN<]R+'=#08/6ZRK)/;M*IU2+G8:EJ]K:E>SO+Y
M)SV@DI,I"&VB9\A1FDS7U<'R@G91*0$                    (Z=T&8[UP
M?6S%SV]8+#V!G*[F)&EU,Q"GDLUJVWE/2$LH?CJ<43B&T<$OP)9JX]4$PWGC
MLJXFX_13,AKD4]_+KXKUY4M.$\B+,<:2I]A+A<DLFW#-)*+T\<@AW
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MHF(]#D>2VEUM7'P'TJ+DO@/P'!RX[L=\V7;)B:2RQ-7>BB0
M              &O=HY_^++#;#,/HM=9G[ [':^(,?C^U3W?/=2UU-M<ER2.
MKJ5]@B%,E_!%:58=1F^#9-U)GT1O5EYGON]R7N+TYN2)H#9[%%KBLN(5I5NT
M3OM;Z[&))CMJ9Z>4<)4\1JZE%X$? T;LTSDB[AG8X.7677ZBS+&.^EL3T=<2
ML(TONG\<<7()/XNLLU]\0NQVO)RJ#[$N5[0EQ75'+J5U$CHX5]CDAN8LO'T3
M':[.EU7QXG[LVTZX;6OL>H,IJY-)DU+!R"FF%TRZJQCMRH[A?^9IU*DG_P"
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M;I\OQ<=M_7$2SP79@
M
M                            $6]Q[$[1,6RUNLWA+P)C,U5[+S2,EK8T
MN;[$M;A,F3CL=U71U)7P7/IY!,5:H_'1[N+_ 'CJ+]HX7ZS I)^.CW<7^\=1
M?M'"_68%)3<Q2;C=EBV-6.'*AKQ&?50Y.*KKT):B'6NL(7$..VE*4I;\DT]!
M$1$2>/ $._           !'3N[^J]OO\![C[U6"8WO.EV!?6_P!)_*<[YKF
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M=N^K[>95^ZWLZX@G.AU91GCC\>0Y*)E<GI\M+BF&E.$DS\2X+GJ-*3)HWF"
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M>QI=@6#2W%J\N0ISI43!\>KSXD"\6M\^Z*^K=FW_ '*LOF>F!%V]:<"H
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M:/7LY+T0HWE<&TE,GI5SU^/(T<F.ZV^VWBG;Z7 U&GRXLV/'&6_[WIG[4_\
M2^ELAU/*R"1=[GS+:R+IJ.W'CY5-=EHA&PIPU*CDZZYTFYUD2N./M2&WBQ39
MONF>UV=+I;L,S6^ZZO7.YOT9FX
M
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M^]5@F-[SI=@7UO\ 2?RG.^:Y@+SN>K@&-0_V8?6D[M_ERR^>Y0M:F_H6D"5
M!5IAW];Q7?Y;^ *Q6=[)'A7Q&1*(TJ(C(RX,C]!D(58=A>O,#US"G5N 8=38
M97V<M<^PA4L)F$T])61)4ZXEE*24KA)%R?H(B(O !'7OQ^JEM7]@_GVO&OJ_
ME3W>US>;_E;^[VPU)VF_5ZUM^I9OSA)'":&C^3;V)% V6)9]^\7-?D&R^]7!
M$JW;I:(]U]^2/8'X7G]X11V-#X9[6/D'RKOQ>Z%F(WG>             &'/
M:]P.1FD38S^&TKV?0(:H$+,UPF%6;499*2;2)1H\Q*>E:D^"O0I1>A1\AF(
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MX%),<C4X+L&2['=OB66V:Q5FXP)
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MO).<6Z_'7II7MC[8G>FX-UW
M
M                              02[C^_K6_;3L%G765X;DM]:/U$:X3.
MJ2AG')J2X\VE!^?(:5U$;)\^''B0)B*M!?TONDOXL\X_^5K?UX">%!CO?[\*
M7NAQ+&-?XAA$_&\=I+I&03K2X>:5+?ELQI$5IIMF.:T(0E$EPS,W%&H^GP3T
M^L3$47E]IE5>TG;/HZLR5#K5O%PZK\Z.\9^8TTME*X[2R5P:3;94A)I/[7CI
M^ %9WI# @          $=.[OZKV^_P ![C[U6"8WO.EV!?6_TG\ISOFN8"\[
MGJX!C4/]F'UI.[?Y<LOGN4+6IOZ%I E0 5:8=_6\5W^6_@"L5G>R1X5[LAGV
MB._')YR.;[:FR?9/I<1U$9=2#,CX47/)'P(51H[7NW*1VW8QE..2=EW&RU9)
M>.6Z)UJV;/LJ%(2VEM"#>?,UF2>7'.HNL^#Z$@F9JZ#OQ^JEM7]@_GVO&OJ_
ME3W>US.;_E;^[VPU)VF_5ZUM^I9OSA)'":&C^3;V)% V6)9]^\7-?D&R^]7!
M$JW;I:(]U]^2/8'X7G]X11V-#X9[6/D'RKOQ>Z%F(WG>             $6;
M7MKG6?=)C_<B6U;N+!HZ954K6:$*]B>,X[S!&;Y/D1-<O>:;1LGRX75UEZ 3
M78E,"                    $=NY[0DCN-ULQK^+L"SUN['NHEN5Y6M&_YI
M14.H.,^R3T<UMJ\WK(O,+A:$*\>G@R8FC>..U'T?Q^BH?;Y-K\25\6!\9S5^
M9)D^S-):\Y]?YY:^GJ4?PF9@AW                        *H]_=F'=5L
MO;^;9S@/<1]#L0R"2P]2XU\=WD7V1#<5EE:?)BH-E/4M"E>J?P\^D%HF$,]X
M]L_=SV_XU6YUFW<I;3L&5:Q*W);NFO[Z0]5(F.$TW*<BNFPIULE&1&3:C7R9
M<),$Q,2] F'-^3B&*M?&J+WRJ>"CX[;6;B)G3'07M"5J,S43OVY&9^/(*,D
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M7QRKI-*34.%K^39M);QS2ZWKCWLUF6+MB70Y#(
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MX[TEX)ZU$9\? -Z'H+8F(BKGB4@
M
M                          (;;Y[&=+=Q6;M9_G\K)6;UFLCU*$5,YF-'
M]GC+=<09H<C.GU<NJY/J^QX F)HTM_10=KW^\,X_;:+^L03Q2S_7GNW.UG7M
M["R).+V696%8\4BO:R:<<R*VXGCI-45IMAETBXY(G4++GX/ N".*4\P0
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M6I*.D_#A:B_/&,&2(NPY(N\/#-?4M&^'H8'S-O
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M9,6IQ99I9=$SZ&QA=G
M
M           %3_O&>]+)=+JKM.:FL4U6=WL$K'*LK;)*WJJ \:D,,1241I3(
M?Z5*-9ERVWTF@NIQ*T%K8=K[K&9MN5K/8DO9,"_=I\CO8V18AEU^MYURV5-C
MFQ-<:>D*4XXA'LK1]9^JHU^J9^L!<F7W3M;!E]OFU*O5M#*R/.+VD=J:BLA+
M:;?Z)ZDQI3K:GEH+J:CN.+223ZC,BZ2Y!$*"^V_O4W9VPYS&PO94B]N\ A3$
M0<MP'(2>.PJ6R]53D$I1>;'6R1]7D^#:R\#))F2TEYBKTT5UA"MJ^#:ULE$V
MNLX[4NOF-'RAUAY!+;<2?PDI)D9 QN8           ".G=W]5[??X#W'WJL$
MQO>=+L"^M_I/Y3G?-<P%YW/5P#&H?[,/K2=V_P N67SW*%K4W]"T@2H *M,.
M_K>*[_+?P!6*SO9(\*]Y]]J*P])D.$TQ'0IUYU7H2A!<J,_[!$(5:8TCW":N
M[AJ:\OM7W+]O QVQ.LLSDQ7HCB7>@G$+2AY*3-#B3Y2?]HR(RX!,Q1J_OQ^J
MEM7]@_GVO&OJ_E3W>US.;_E;^[VPU)VF_5ZUM^I9OSA)'":&C^3;V)% V6)9
M]^\7-?D&R^]7!$JW;I:(]U]^2/8'X7G]X11V-#X9[6/D'RKOQ>Z%F(WG>
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MQVV[HH[&+38L4ULMB)]#8PNS@
M
M                 #S,]UT&!D?O'+6DSITRQRRS?#ZV\-_U4HJ'HU6VY]@B
M3[.LSY^'GGTGR#)&YZ8(\>/#CL1(C#<6+%;2S&C,I)#;;:")*$(0DB)*4D7!
M$7H!C?8!1'[X7&<5A9'I;*X;,>-F%]#N8-XIM)$[)A0%0U1%O&1__#5(=2DS
M+E1'QSPC@%[5HO9M)GR^UC0[MD:SD(P^N9;-?//L[+?E1_3\'DI1Q^8"L[TE
MP0          ".G=W]5[??X#W'WJL$QO>=+L"^M_I/Y3G?-<P%YW/5P#&H?[
M,/K2=V_RY9?/<H6M3?T+2!*@ JTP[^MXKO\ +?P!6*SO9(\*^(R)1&E1$9&7
M!D?H,A"K#L*UU@6MX$VKU_AM+A5=8RE3I\&EA,P6GI*R))NK0PE!&KI21$9^
M@B(B\" 1U[\?JI;5_8/Y]KQKZOY4]WM<WF_Y6_N]L-2=IOU>M;?J6;\X21PF
MAH_DV]B10-EB6??O%S7Y!LOO5P1*MVZ6B/=??DCV!^%Y_>$4=C0^&>UCY!\J
M[\7NA9B-YWGPDR&HD:1+?5TL16UNO*(C/A""-2CX+T^! B9I%4,_Z0/M>_XT
ML/VFL/\ ,#6_G,?6Y?\ O.F_6GU2R[ ^\K0.R<MI<(Q'*9D_(K]Q;59$<JYK
M"%K;:6\HC<=:2A/J(,_$Q:S4V732)VLN'FF#+?%EL[9]$I2C.Z        ##
M7M=8%)S6'LB1AU.]G]?#5 @YDN&RJR:C*):3:1)-/F$DTN*3X'Z%&7H,P&9
M                    ,3S3 \*V-3?1W/<4JLQHO:&Y15-Q$:F,$^UST.I0
MZE1$I)*,B,O'@S+T&8#)8L6-"C1X4*.U$AQ&D,Q(C*$MM---I)*$(0DB)*4D
M1$1$7!$ ^X                      IF][#4Q;[,.T:BG&LH5U<9# F&T9
M)634F10M+Z3,C(CZ5'P? +6MS_T4':]_O#./VVB_K$#BD_HH.U[_ 'AG'[;1
M?UB!Q2L?I*F+0TU11036<*EA1X$,W3)2S:C-I:1U&1$1GTI+D^ 58WL?8>*Z
MHPF^V%FTURNQ;&FFWK>:TRY(6VAUU#"3)IE*EJY6XDO @$._Z3/M _X^L_VA
MM/UN">&3^DS[0/\ CZS_ &AM/UN!PRE+IS=6O=\XDYF^M+5ZXQUJP>K%RWXK
M\-928Z&UN)\N0A"^")U/CQP!,4;6!    "#C&P>X+>N<[;BZ1RS%];X%IZ^D
MX<Q97E.Y<RL@R* VA<]MSID,)B165N(;):"6L_%7!\]"2=S<_;AN&?N?7;UW
MD%0SC^<8G>66([$HHRS7'BWE.[Y4I+*E&:NA9&AQ)*\4DKI,SXZC$PWX"$!=
MS]U>247<%J/4&MH4>9C\C-ZG&MOY8\R3S+,JV2;S%/%6:B+SRCH6\\HB/R^6
MT\D9J($Q"?0(5B=[G<]H'*^W+<FOL<VG26^:2H[$&/CK#CAR%R(UE&4\V1&@
MBY03:C/Q^ %HAUGNBOJW9M_W*LOF>F NWK3@5              !#_:1JU;O
MW7FU&S]GQW.F_HIFCI<DA+A\%'==/^P2%?V&3'E>9?\ @\PQ:G]&_P"Y=[IG
MZO[KV'*O_P#(<LS:2=M^/[]GOB/K_O)@#U3QX ZVXIZO(*FRHKN S:4US%=A
M6E;)02V7X[Z#0XVXD_ TJ29D9"UE\V71=;-)@F*JR]=VUGV-[F+2V83WI/;C
MM:<Y+U-ELQ2E(HK%Y?KU\EU1\)29J(EF?J^*'O5ZGN/2ZBR.:8/C61_C61]Z
M/UHZX^GHZF")^'-)W2M&'F&<
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M4:4ER?'B8Z$12*/266Q;;%L=#MA*P
M
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MVVRY)1\*4W]L7F-NF.IS;1V7VQJL'@NWQ^K=]/K]$PQX[IC[L[T_QP&8
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MG^F4J1L.@
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MBYGR^=)DI&VR[;;/7'T^U.._BCTI,CFK@
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M?58\]M;)JV>,C8
M
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M=47D-BPJIJ24E+T:2VEUEPB625$2D*(^#(C!#L@
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ML>!4          $/._WZH&[/DR#\Z0P3&]'3W17U;LV_[E67S/3 F[>M.!4
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MJ+G@S(R,E),TJ(S\SK-)DTN2<=^^/KCKAGMNBZ*PV@-58
M                           &+YMB<'.\0R3#+.7,@5V3U[];-FU[B6I;
M3<A!H4MAQ:'$I61'X&:3+\P5NMXHF&/+CC)9-L[IBB#SWNV]-25,KD;!V2^N
M.LG(ZG+:N4;:R]"DF=8?!E]DAJ_R5G7/T[G)GD>&?TKO7'V-X:1[6,(T/D%M
MD6,99EU_+N*_XMD1LAGQI3"&S=0]UMI8B1S)?+9%R:C+CGP&7%@C'-8F6WI.
M7V::Z;K9NFL4VS_0DR,[? &DMT]O>LM]U4.OSVJ=5-J^KXFR.O<*/8P^LR-9
M-/&E:32K@N4+2I//CQSXC%EPVY(VM35Z+%J8I?'?TJ\.S;M9UGL5G+\YV =G
MF$G <ZLL:I**PD$NM6Q7LQ76W9#)(ZG%&I\^4FORSX\4&-'2:7'MFG2X7*.5
M8+N*^8W73%.C93>MU>BQ9$9<.1&:?B.(\MR*XA*FU(XXZ309&1E^9P.F]/,1
M.Q&O/.SKMTV#YSUIK:OI;!WDRM,?ZJETE'Z5FB*:&5F?V7&U?^(P7Z;'=T-'
M-RS3Y=]L1/HV(@[UT+M#MRU-FF8:I[B<R<PZIAM1)N!7"BF&46P?;@N'&DDI
M+;)H2_U=3;"5$1<DLE$0U\N*[%;,VW33J<W5Z/+I<5UV/)=PQT3Z=GTV(885
M2UM1CU84%IM2ID9I^5+27K/+<22C,U>DR\? O@(>&U>6Z_)->B7Q?F6IR9L]
MW%.Z9B(ZJ-C:!RNOU1W/X'9%=P\6QS,HLVNS/VM]N)!4TIAQ3*W5+4E"3.0E
MLTF?YXO_ #&.[R/473LNG9&Q[7R9K[^*E]VR)I6>JF[NE>W&DQID=F5#D-RH
MLA)+8DLK);:TGZ%)4DS(R/[)#U;ZG$UW/N"4;MX=L&%[[M:.WRC*<LQ^101'
M(<5G'9T:(TXAU?F&IU+\60:E$?@1D9> PY<$9)K,RT=7H+-3,3=,Q3JG^A7W
MI'M'PG96P>X#$[W.\[B5VJ<G12X\] M(S;[T=2I)&J4IV&ZE2_N*?%"4%Z?
M:>+3Q===$S.R7&TG+;,N3);-UU+9I&W^A;+K_"J[7.&8]@]1.GV5;C40H<.=
M9NH>F.H29JZGG&T-)4KQ]))(="RWABCT6'%&*R+(W1ULP%F4
M
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M"           0\[_ 'ZH&[/DR#\Z0P3&]'3W17U;LV_[E67S/3 F[>M.!4
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M3XX3YWS1'WL772?=_2SX.E:J/*-@
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M]'O?.N<>5,?'&29WS2L;)GMBD^N$O=*=A%+"1=9#W$+K]A9)>QBB1J&&Y(1
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ML6^C?N[4R!LNF
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M'PSVL?(/E7?B]T+,1O.\\U.+?E2VC\JS_OYP>+YQNCME\9\T[H_%+;@X+Q@
M^G:[]>;!OV3_ (,RQZWDOAL[_>^G>3MV']K^)?L/2OI8      (M6G;9/LNZ
M3'^Y$MJ7<:%1TJZE6LT-F<)XU1WH_/G^>24M<O>:;1LGRZ77UEZ 378E*"
M                  $=.Z#0<ON-UJSK^%L*QUK(8NHENF]KF3D^:45#J#C2
M&$OQC<;5YO61$X7"TH5X]/29,31O+'*?Z/8]0T!V$JV.CKHM>=K.7YDJ3[,T
MEKSGUD1=3CG3U*/CQ,S!#N0                     !A>7:WUWG[M2]GF!
M8YFSU"IU=&[?542R5"4\;9NJC'*:<-HUFTCJ-''/2GGT$ QS(-#:-RRXFY#E
M.F<%R6_LU)797EKCM9,F2%)22$J=??CK<69)222-1GX$1 FKI_Y,O;=_-\UK
M_P IT_ZU K+=$6+&A1H\*%':B0XC2&8D1E"6VFFFTDE"$(21$E*2(B(B+@B!
M#[@*:_>M8U]-,W[0,.]L^+OI9>7]-\8='F^1[?)H(_F^7U)ZNCKYXY+G[) M
M:T=1]PVZNU"DV)VH]S59,M<;ML5N*G7>8)-4CV4I<%YF*<>2I)'+A+<6E/B?
MF,?:\<)\M)-*II^Z@^J]8?AQ;?>L$$7;UF0*@   (FY1W*Y,YG.:81IK2=QN
M=S69(:V'>1;2%40X<YQOSBKXBYG)S)*4>*T-D709DDSZCX!-&Y]1;5QC=& T
MNP<3]I9K;7S6959/:\B; F17%,RH<IDS/H=9<0:5%Z#^V(S29&9$LPR7(Z7#
M\=O<KR.<BLQ_&J^3:7=BX2C2Q$B-*>><,DD:CZ4),^"(S/X"Y 0T1WEW5=CE
M'M3,] Y)AN@<CE0VZ_:DFRKWWX\.R=0S!LI].THY$>,ZIQ)]?4H^%)X2KK1U
M$T3E(R41*29&1ER1EZ#($(>]_OU0-V?)D'YTA@F-Z.GNBOJW9M_W*LOF>F!-
MV]:<"H               #\K6AM"G'%$AM!&I:U'P1$7B9F9^@B"9HF(JJXR
M/:.1WVY<DV-IAMJABO0$T4V\L"2XS8FR9?Z03)H7P9DVV22X/@DI-7!J-(^2
M\V\SVX-==FT^R9CAZ^+^U3HW13L?7>6^78NY?9I]7]ZD\41&SAK^C7OFO;WM
MYZG[DLGD9=6X'MBM@QI5^LF,;RBM2IMAZ09\)9>0I1ERLSZ4FGIX,TD:?6ZA
MWO+_ )O_ )W)&+-$5G9$QLV]4QZ>B8>?Y]Y1LTV*<VFF:6[9MG;LZXGT=,3Z
M^A-8>\>! &NMJ:JPC<V&6."; ITV]#8&EU'!]#\60V1^5)C.EXMNHZCX47P&
M:5$:5*2>QI=5DTV2,F.:3'TI*MUL7124 6_=BXV<E%;-WKFTO T++C%.&4NF
MR1D?EG)-2FN/#X(_'P\#T$^:,E-F.WBZ]OL_I8O@1ULXSSL4K,9759SVJ9)*
MTOM#%X:(\-*9+S]9<-M$G[E8)>\X^ISI+J4:5H6?Z(THSZBU\'/)OK9JHX[)
MGOCL^G9*9Q4VV[)=SJ+O)463M:=[F<<_$SN".3;3$J89-TESU'T(=BR5*4AL
MW5$9)+K4VH_!#AJ]0J:OD_W/C::>/'_U1VQ])]!;EVTNV2GD.$S
M                                            #J;^W9Q^BNK^1&DS
M8]) DV#\.&@G)+R(S2G5-LH-224M1)X21F7)_"(F:156^[AMF>I4QW.=R]1N
MC&< I<6U1LJ!*Q7.ZK)[!RUHFVFUPX+,IMQ#1L2GS-PS?3TDHB3Z>5%\//SY
MXOB(B)V37<\YK]?&HMMBVR[9=$[8ZJ^E./4?=)B^XLJ<Q*GU[GV+RVX#U@=E
MDM2Q"A&AE;:#;)UN6\?6?F$9%T^@C\1M8\\7S2(EUM-S"W/=PQ;=';%/>DT,
M[? %-O?)CEC@N_Z?9UA"5]"\XH&:E5TVV9MQI\11];3O3SPHT);41G]L1JXY
MZ#'G^=Z6[);]U\_\Y\NR9[>*R.J8[8K%/5-49KG.<<JJUZ<FUBS7?+,XD2.Z
MEQ;J^/5+A!F9%SZ3/T#R^+1Y+[J4F'S;3\LSY<D6S;,1TS,4HEYV[L]XV@]7
M4YTFF:G/L%R!3F0G1%-.'?Q/:TH]5;:W"Z>M"$J)M+#BBY\>#Y2/<8?BX[=E
MM8^M]ET,:O38HI9%UL[:5^]].Y(2I[]]=5\YNEV_@V8Z6O#/[JS>UCST8O1]
MJMI!2%?V?9R+CX1FC5VQLNB8;MO.,<33+;=9/ICZ3]24V&;=U=L-CVC"<_HL
MD)+:G78\*<RN0TA)<J-V.:B=;X+Q/K27@,]N2V[=+H8M3BR^"Z)[U6G=CW70
M=XXUD^GM58A)O\?*='*?L%Y]###KD&0AXBAM*+A:%&CP6M:3,O$D>@QR==S'
M%;'#,O)\\\PZ>VV<4S2)Z>R>B(VT]*6G;1W?X[MFRC:RR7'7]?[&@P__ )'U
M,AXI$:R9C-$:U1GC0V?F$E)K-LT_:D9I4KA7&YI=;9GC8['*N=8=;$1;OZ-M
M8G^GT)N#==L 1VWG>]R]-+QQ.@<+Q7*X;[4D\F<R-U3:F'$J;]G)GIGP^241
MKZO!7H+T?#ARSDBG!$2TM7?J;9CX-L3UU_KA#W%>Y#ODS/,LXP'']7ZVE9-K
MMQEK*H:SE-(85(ZO+)+J[DD.<]!_:F8UK<V:Z9B(BL?3K<S'KM;DONLMLMK;
MO^E5A6K)VQ[+ Z*;MNGJZ#8+WM7T@J*91K@M=,IU,;RE&_),^J.3:E?=%>L9
M^CT%N8YNFW[V]VM/.2;(G)$1=TTW>_H;!%V8
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M8)AO/'95Q-Q^BF9#7(I[^77Q7KRI:<)Y$68XTE3["7"Y)9-N&:247IXY!#N
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MQ9K+[MT71,]TJGM>RV8U4>-2V_8+VB??CV=8\70\EPG5FHS2?B?!^!_8,O[
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MS,3-*-G37:RZZV;^'AGJK5,@;+I@
M                                              @]W>][^']JQTU
M>//9QL'(8BK"!C;4E,./&A=:FDR9<@T.J22W$*)M*&S-70ODT<$9DQ%5=?\
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MVV)4^SNFQXLKDI97))/EI=4RV;A),_$N/A41&31O($
M  -1;JWEKKM^Q!C.-FVKU312[)BHAKC1G9;STR0AQU#:&VDF?@VRXLS/@N$G
M\/!&3$5;,I[>NOZBKOJ>4F=47<-B?5SD$9)>C26TNM.))1$?"D*(RY($.Q
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MY;:OD2NVFO\ BW717DM#\?RIK/\ \DB:8.0KIGF;OB@V_'[7['P@K*3((
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MCX\%&/F&;%=COFVZ)B8Z]DM^)JR48T@
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M6I9=;G!)2M/3ZW2DT>MU#:T',K<\4=/D7F+'K:6=W5W3'O6;CJO5@
M
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MO:ZP*3FL/9$C#J=[/Z^&J!!S)<-E5DU&42TFTB2:?,))I<4GP/T*,O09@,R
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MHNT&6=F_'/7'5].GB]#UO/,-G,=-;S'#&WPY(CHNZ_IT3;Z4PQZMXX
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MKI,TK0M"B2MM:%$:5(61*29&2B(QP<^"_!?-E\4NAEB8F*PRT8D@
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MRVVU.&1_W/H\2&[R7!?Q\71-'8\HZ/+.>+J3$3,4[IK7N>A(>U?9@
M
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M].UKR+7TE*NI7K%"%'!>-4=Z/R;WGDDFC-WS3:-D^74DOK+T$378E&"
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M_5 W9\F0?G2&"8WHZ>Z*^K=FW_<JR^9Z8$W;UIP*@
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M@^9L$W6X\L1-=L3-.C92OULV"=LPMV'D&R
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M:UJ-MLE%ST-DDO C,C,N1GPX[+(V;V]H=-APVQ-D168[TH1G=
M
M       =;+N:> [Y$ZUAPGS22B9??;;7TGZ#Z5*(^/ !7;W$]_;^D=ZXOJ&I
MP6LR^LR"-4OOY1\;FSY!V4MR,M/EML.I/RR1U>*RYY^ %HA81])\;_XAK/\
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M7(I[^77Q7KRI:<)Y$68XTE3["7"Y)9-N&:247IXY!#N
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M;Y>NQ8YOQ7<<1OBE)_I1;FK-)6,CSC.
M                                 "&4GL$[8Y<F1+?PV>I^4XMUY17%
M@7*UF:E'P3_AXF-;^4Q]3ESR?33->&?7+*,#[-= ZVRVES?$<6F0,BH'%NUD
MMRTFOH0MQI;*C-MUU2%>HLR\2%K--9;-8C:R8>5X,5\7VQMCTRE*,[H
M
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MQ77:+-/W\?AG]:SH]7L[)>A\Q:/'FMMU^"/\/)XH_5OZ:]OM[82M'IGE
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M(
M
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M"A1VHD.(TAF)$90EMIIIM))0A"$D1)2DB(B(BX(@'W
M     !4]W'^[OU_L[;&6;6RK?J, >SF2T^W3RX,0FT''C,QS2V\_-9-SP:)1
M^KX<@M%R/=A[M'0=5#?L+/O&I:Z#%2:Y$R2U5M-(27I-2U6A$0)XEX.&PX5=
MB&*U];/3:UT&G@QX%HDB),EEJ.A#;Q$1GP2TD2O3\(*,D 5*>\OP*+D>8]LU
M_GEG+@:0@9 ]4[(G1%\*K6;"1"(YBDDE9I2IM"D&YTJZ#(BXY6DE%K7;Q^T3
MW9[T=AYG*\9DM.MI6U(+/^2<2HB,E\IGD7B7CX$!64X>WO7NF-:8&]CNB9L*
M=A*[61,=?@6IW+7MSK;27B]I-U[@R2A'*>KP^QX@B6\P0    @?7XSW ]O&;
M;@;U7J6%NG7>V,FEYO1--Y!"HIE'<V;;96#$M,\B2Y&<=;):#8Y4DN?5,S!.
M]NKMFU)>:AUW.AYA.BV6P<\R.US;8TV 1^RJNKMTG7T,&HB4I#:$H;)1_;=/
M/@1\ 3(K(NXJ;I/,[4]>T]+N]*9\;"\79LF)$$U&LFH4MV0XLV_52KS5-J47
M/3T>'("%NB\7[NM(5EJ_'[5Z/,=@Y;(5.V!M&XSN NWNI:U=1FZYY2C;91Z&
MV4JZ4EX^*C4HR9I*T.BD6LRDII=]7(I[R5!CO7-2T\4A$66MI*GV$O)(B<)M
M9FDE%Z>.0511[_?J@;L^3(/SI#!,;T=/=%?5NS;_ +E67S/3 F[>M.!4
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M2V^5\%U$XGJ+K2HU>6Y[RRS3\.7%%+;ME.J?Z6QBOF=DK"!YYF
M
M
M        !#+;G?5I+2&WF]0[ .ZASCK(EA+R2%#]MA15S%+Z([[;*U2>ORTI
M7]S97X++X03$)E-.)>:;=02B2ZDEI):5(41*+DNI"R)23^R1ER0(?L
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M*NI7K!#:CA/FJ.]'Y\_V@DI:,W2=-HV#Y=3U]9>'%F:NQ*4$
M        (Z=T&A9_<9K5G7U=L6QUFZU=1+9R[KF52?:$14.I]ED,)D136VHW
M2<+[H7#B$*X/IX!,31O+'*EVAQZAHG[25=OTM=%@/7,Y77*EKC-):5(?5^><
M<-/4H_A,S!#N0                       4"; T?/[P.[KNTK,BR^PK[75
M5*^6O:)KRUF\J&TEB$P25&M*(_F\+<)'"E*=Y]5:E O6D(\+[5=?+[-\<[KJ
MK++.=-JK1F+L3 I+D="74_&Z:QQB#(;:ZV'%)6AY/F)<]17/'AXDUVO2IK^9
M36&!X388XEY&/3J"MD4*)/Z,4)V*VN.3OI]8FS3U?F@QLN 5:>\.IM%YOGG;
ME@.W['-JRQNY%S%Q27B+,%UM+UB]61R*:F81JX6XVA*#:(S+UNHN.."UKH/Z
M(+27\9F<?_+5OZS XD[NW#M\QGMIU\]KK%+JSOJM^WDW"IUL;)R"=DMLMJ07
MD-M)Z2)DN/#GQ,$3-6_ 0          "'G?[]4#=GR9!^=(8)C>CI[HKZMV;
M?]RK+YGI@3=O6G J                      "!'>&3Z<RT^[9<?1I*YQ$I
M?/E%+ZF/T3\Z7AT<<_85\'(^=^?HR<&.FZEWKV5^I]'\A39PYOUJV^K;[_<U
MNHTDDS49$DBY49^CC\T?(7T5N'LN\XXFUEQ#_P#J95?,_$Q)_0_-Z'?/-!<^
MCH-GX/1P/M'D6,G\O?Q;JV^NFWW/F'GS@^-BIXN&:]E=G\2;P]T\$
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M/<VXFKM10
M
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MJJZ4.<F7JJ5\/D\\\LU62Z^;[[+IGJK'O]S8CXEL;JLK_EU99AW0G=7:KL;
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M*GLXLQ]M"3Z36IIIQ2R3SZ%&7!_9&7-I,V&*Y+)M[8F$1=$[I;#&ND
M
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MU/*3.J+N&Q/JYR",DO1I+:76G$DHB/A2%$9<D"'8@
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MCUE=)'P7B8#G (>=_OU0-V?)D'YTA@F-Z.GNBOJW9M_W*LOF>F!-V]:<"H
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M4&?P*-I2N#_,,,.IQ9XKCNBZ/1,3[#/I<VGFF6RZV?3$Q[7>C,P
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MJ'+9
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M4:/"A1VHD.(TAF)$90EMIIIM))0A"$D1)2DB(B(BX(@'W
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M$@
M                                \^7O #O])]\. ;S=J%6M*]]'LCIT
MN$9,2':%QMF5")PR,DK(F4*/CDT^8A7P@O&YPN]?NSTSO_(NUG)\%N)S;6"W
M-E.S:KLH$B/)K&I,BG<;\SI2XT\9IBN_H#CGVOYJ>1$4?;WB'>IK/?\ B^+Z
MLU,<R_IJB]1D%OETJ&Y#:=>9C/Q8[$1F2E#Y^$IPUJ6VCT))/41J MBBYSM?
MPRWU[V\Z=P^_95%O*;%H";>$LNE<>2\V3[K"R_NFE.&@_P T@5EO@$
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M*&U'"?ZH[S!\O^T$E+1FZ3IM&P9FXGKZR\.+,U=B4P(
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MEDDCY/G[()C>T1[HKZMV;?\ <JR^9Z8$W;UIP*@
M       "LC-]0; U'D-VK&,4FYIKRUE.3:HZMM3TF#U^*F766DJ41(]'5T])
MD1*Y2?4D?(/,/E+/9EF_#;-UD[J16D=4Q&W9U[J/K_)/-&GU.*VW-?%F2(I/
M%-(GTQ,[-O5O]K@8UI[8^Z+.%"N,=L-?8+$<*196=DRIJ5(,B]5,=EU*#49\
M^!\=!?;&9GPD\?(O*&HRY*Y(FVWIF8I_=B=]>O<R<W\TZ728Y^'=%]_1$36/
MVIC=V;_:D*5#W.:F;26/W<'=6+12X35V9''MFVTEZ$.*7U*,B]'+KGYB![GX
M'-=!\NZ,UD=$[+OIWSV/&?'Y/S&?\2V<%\]-NVSU?T1VLFQGNGP2;-*BSROL
MM69,CA+]9?,K2P2C/CA,@D)X+P/UG4-D-C3^9=/==P9XG%?U71L]?VQ#6U7E
M74VV_$T\VYK.NV=OJ^R9;[G97C5;0/95,OH+.-QV?/<O//0J-Y9F1$I+B3,E
M=1F1$1<\GX%XCMWZG%9C^+-T<'778X%FDS7Y8Q6VSQSLI3;ZD;3[S=/E/]E)
MG(50/,Z/C\J]/L?IXZN#>\_CX?T+G\P>=_\ ;]#Q\/WNVFSV\7U/3?\ I6OX
M.+[E>JNWV</UI-T-_39140+_ !^Q9MJ>S;\V%/CJZD+3R9']@R-)D9*29$9&
M1D9$9#TF#/9GLB_'-;9W3#R^HT^33Y)QY(FVZ-\2[<96$
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M>J-;F7([M+9\2R[BLZ>B839EXII*=XX+,
M                                                   #4FY]':WW
M[A[V$[+HDV]8:S?K9K2O)FP)/2:4R(CY$9MK(C^$C2HO!:5)\ 3$T597ON<J
M-^Q?=QG?<ZJJ%*_T6#9XZU824)Y_/R6;"&A9\?892">)(G0'NSM,::R"LS+)
M;:=M7+*9U$BI79L-1*N-(;5U-R&X"%.FIQ!^*3=>6DCX42241&0FY8^"H
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MD\L+4A3R%&2CXY3R7P#E<RYAHILOQ688BZM*\-L;I]&UDLLNK$S*TP>79P
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M=BV&T$'&<=J6_*KZ:N81'8:3Z3,D((B-2C\5*/Q4?B9F9@JR(
M$/._WZH&[/DR#\Z0P3&]'3W17U;LV_[E67S/3 F[>M.!4
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M-/*6IT6.<ELQ?;&^FR8CKIU=D_4D\/3O*@
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M%N$E23)OE'4?)D1DE7CX&,&:8C3Y9N\/#/L6C?#T)#YHW@
M
M  !1GWN]IW==M7N)RS-=68?-M\+L854U73F<@JX"%.1X++3Q%'E3V'$\.),N
M307/I+D@7B85T;@T/W)Z#KZBTVU EXC%OY#D:F0K)*Z:_(6TDEN&B/!GR'NE
M!&74OHZ4F:2,R-22,F)B658QVF=Y^7U$:]I-:Y@JMF-D]%=G3$5JW&U$2DK2
MS.DL.&E1&1D?3XEZ *PUE;ZVWCC&P*C66:-V^!Y;>NMM5D?))ZJR,YYQFAM9
M2WW$L>6M9=!.=?1U>!J+Q >KG2N.WF(:;U+B>3M^5DN,890U.0M>:E_IG0JY
MAB27FI-25\.(5ZQ&9'Z>08Y;-           !'3N[^J]OO\  >X^]5@F-[SI
M=@7UO])_*<[YKF O.YZN 8U#_9A]:3NW^7++Y[E"UJ;^A:0)4 %6F'?UO%=_
MEOX K%9WLD>%>^\\U'9=D/N):880IQYU1\)2A)<J49_ 1$0A5IW2^_\ 5G<#
M375]JS(5W]=C]@=;:+=BR(:VWN@G$'Y<EMM1I6D^4J(N/27I(R!,Q1JGOQ^J
MEM7]@_GVO&OJ_E3W>US.;_E;^[VPU)VF_5ZUM^I9OSA)'":&C^3;V)% V6)9
M]^\7-?D&R^]7!$JW;I:(]U]^2/8'X7G]X11V-#X9[6/D'RKOQ>Z%F(WG>>:G
M%ORI;1^59_W\X/%\XW1VR^,^:=T?BEMP<%XP ?3M=^O-@W[)_P &98];R7PV
M=_O?3O)V[#^U_$OV'I7TM27[S3\M&M/P6:^<9(Y>N\4=CQ?FOPS_ *<^]! :
M+Y( .AR#_56?\:7]Z8.[R'YEW9[WJ2U]^\+"/D"M^]6QZ"SPP^VX?EV]D,#G
M=PVI:W<]7H"9E"6MH7$(YT*C\AXVS3Y2Y"6E2>CRDNK:;4XE!JY,B^RI)'9F
MHW6"%8U[[TG4-#=W%%)U[F#TBEG2(#[S::_H6N,XII2D\RB/@S3R7)#TMGEC
M/?;%T7V[8KT_8P3GB.A#3O,[V\ [D]7T.#8KB>045A593%O7I=J44F5,L0IT
M93:?(?=5U&J4DRY+C@C\1V>3\ERZ+--]]T3$VTV5ZXGW,67+%T42)P#WGVI,
M1P/"<4FZ_P ODS,8H:VIER6"@>4X["BML+6CJE$?29H,RY(CX'.U'EG/DR77
MQ?;MF9Z>F>Q>,\1&Y(O1G?YK??.QZC6F.8;DM/;7#$M]B?9%#*.E,-A<A9*\
MF0XODTH,BX3Z1S]=R'+I,4Y+KK9B*;J]/<R69HNFB> X3*             -
M2[FW=KG06),9MLZY<I*"79,5,1YF,]+<=ER$..(;0TPE:CX;9<69\>A)_#P1
MDQ%6R:>WKK^HJ[ZGE)G5%W#8GU<Y!&27HTEM+K3B241'PI"B,N2!#L0
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MYASG+K(X*1;9U1[UK,46[4OQR&0
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M]].\G;L/[7\2_8>E?2U)?O-/RT:T_!9KYQDCEZ[Q1V/%^:_#/^G/O00&B^2
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M0HT>%"CM1(<1I#,2(RA+;333:22A"$)(B2E)$1$1%P1 /N
M             ".?=MKS*MK]NVSM>X3";L<IR6%%9J(3KS<=#BVIT=]1&Z\I
M*$\(;4?B8)A6/B&O?>V8'B]!AF*6]958UC$%FMHZWG#W_(BQTDAIOS7X[CB^
ME)<<K49G\)@ML9%\4^^,_P")ZS_Z'A/ZT!&QKK:6D/>F;IQ-[!]F/UF2XL_)
M9F.U?GXI#Y>CF:FE^;":8=]4S]'5P?P@FL+O\'K)E)A>(4UBV35A44E?"G-)
M42R2]'C-MN))23,CX4D_$@490          (>=_OU0-V?)D'YTA@F-Z.GNBO
MJW9M_P!RK+YGI@3=O6G J
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MZ?0T.=^5<O+[/BVW<=D;]E)CMC;L]/U)-CT[RH
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M&3^E?[7O]WYQ^U,7]? <,G]*_P!KW^[\X_:F+^O@.&3^E?[7O]WYQ^U,7]?
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MCS#S=K-5CG';$61.^E:^N=W=M]*4W]*_VO?[OSC]J8OZ^'J7D^&3^E?[7O\
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M9^T^1Y7EOO=7^J+ZN>./#T\@B8HDR"
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MYLK"WLM0^TV-K)=F3Y'Q_D"/,>?6;CB^E%DE)<J49\$1%]@$\4N#_1Q=F/\
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MBFEMO91BNHU0\HQO"K^UQN6B\OY"FI\.N??BK2R[8.(<-+J$F25)41^@R,O
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M#;1&LS/I0E)<_ -W3Z;'I[.#';%L=4.?J-7EU%\WY;INNZY<[^CB[,?XF_\
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M;]$OI;['](?_ )(V,_VCV#S_ &;_ %^3)Z.CVES[3IYZO6YX+@3-6[P0
M
M            H []==U<'OIUAD>TO-8U%LE_'$6=NXHT1D1(+[4.SCJ=_.$V
M@DN.<>*4.=1>(+QN7:4^G]/U%=%A46L<1@5C:$^RL1*:"AKIZ2)*BZ&N#Y(B
M\?A!2KL_Q9:V_B^QK]J8?^: 9C%BQH4:/"A1VHD.(TAF)$90EMIIIM))0A"$
MD1)2DB(B(BX(@'W       !6YLKW7O;]L#,;7+ZVWR;7_P ?.K?M\?H'XB:]
M3KJ^MQ3#4B,\IDEJ,S-!*-!>'2A)%P"W$F9IG2NO="83$P+6]0=72L.JDS)#
MR_.ES93B4I<DRGC(NMQ1)(O B(B(DI)*2(@1,U;7!".G=W]5[??X#W'WJL$Q
MO>=+L"^M_I/Y3G?-<P%YW/5P#&H?[,/K2=V_RY9?/<H6M3?T+2!*@ JTP[^M
MXKO\M_ %8K.]DCPKWWGFH[+LA]Q+3#"%./.J/A*4)+E2C/X"(B$*M/Z9W[JO
MN J+J]U5D:LBK<?L/BVT=7$DPUH>-!.),FY3;2S2M*N4J(N/27I(R!,Q1J?O
MQ^JEM7]@_GVO&OJ_E3W>US.;_E;^[VPU)VF_5ZUM^I9OSA)'":&C^3;V)% V
M6)9]^\7-?D&R^]7!$JW;I:(]U]^2/8'X7G]X11V-#X9[6/D'RKOQ>Z%F(WG>
M>:G%ORI;1^59_P!_.#Q?.-T=LOC/FG='XI;<'!>, 'T[7?KS8-^R?\&98];R
M7PV=_O?3O)V[#^U_$OV'I7TM27[S3\M&M/P6:^<9(Y>N\4=CQ?FOPS_IS[T$
M!HOD@ Z'(/\ 56?\:7]Z8.[R'YEW9[WJ2U]^\+"/D"M^]6QZ"SPP^VX?EV]D
M,%G=PNI*W<E9H*9E:&=HV\/VV%0''?-!I-E<A+:I)-^2EQ33:ED@U\F7'PJ3
MS9FHW2"%&'8]^6CN0_5Y_.,P?0.9?)Q=GNAR,_O6<CBM< 5WZ[_K2[/Y.5_!
M-@=+7_\ %=_\3?TF^%TP\.Z              U1N/=FN-"8I'S7:%ZJ@Q^78
MLU,62W&?EK<EOH<=0VEJ.AQ9_<V5J,^..$F"8BK8U/;UU_45=]3RDSJB[AL3
MZN<@C)+T:2VEUIQ)*(CX4A1&7) AV(
M        U%L+0>E]KV,&XV-K+'\OMZU!-1+2PAH7))I)FHFE.D1+6V1F9DA1
MFDN3\/$P35M&NKJ^H@0JJI@QZNKK6&XM=6Q&D,1X[#220VTTTV24H0A)$24I
M(B(O @0Z3$L*Q+ JE5%A>.5^+TRI+TQ596L(CL'(D*ZG7>A!$74L_$S^$!KV
M!VY:'JLW+8];J3%X.;ID'+;R%FN90ZB2H^HY#:23T(=,_'S$I)?/)\\F8)JW
M2"
M
M
M                 48^\TQKN1S[:E?B.$8-F^;ZK9H:VP1#I:"9:5S5NEV6
MAUQ#\>,Z2'B;-)*)*R/I/@_ P7M09HL>]X)B]9&I<9H^X7'::&DDQ*FLC97$
MC-)(B(B0RRE"$D1$1>! G8[C_P#Z1_\ X2G_ %@!L>DC1?TD_$EIWZ9?&?TP
M^@^/?2OXZ\[XR^,OBV/[7[;[1]V\_P [J\SS/7Z^>KQY!CEM0
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M3:22A"$)(B2E)$1$1%P1 /N
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M"BY+DO$!TCFPL!9R)&(.YQC[66.+)M&+KLXJ;%2U$1DDHAN>:9F1EX=(#,
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M=25)4GDC(R/DC(!]0
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MJ219R;M^GKXL%ZYFJZI,M<=I+2I#ZOA6X:>I1_9,P0[@
M                               $2.^7,<@PKMDV'-Q:P=J;Z[.MQZ#;
M,J4AR,FXL(\)]Q"DF2DJ)EU9)-)\D9D9>@$QO:'[L=,:R[>>WBLVKJ;#JS#<
MV[?[3';'%LBK(Z(LZ6ERSB5TJ/82FB2Y)1):D*-WS37U'Z?28)B:K*F'VI3#
M,F.X3K$A"7674^A2%ERDR_LD8*OJ  (H[^R_(<MOJ?MIUA:NU>;9_"7.V!ED
M0R\W%L0)9,RYJ5'R294LS./%+TDHU.>KT$H$PP;W<T5J#VLXQ"CD9,0[_)6&
M24?)]#=Q*2GD_A\" NWIS@@ :XW%!O[/4NSJ[%;IC',EG8K;L4-_)=*.S#EN
M0W4M/K?,TDT2%&1FX9^I]MX\< 0I/D99H7(^W73FMM2X"S@O<@FXH*N@V@_$
MCP(T#(8,QM5G9JRPU%&EMR/(>\M+;[AN=:$H;Y)*2+K]P4 & ;.K=BW&'657
MJO(JO$<QGK98B9-;Q%3F8+"W$E(?;C)-).O(;ZC:2L^@U\=7@ AAV,XO*PK-
MN[7%Y^36>93Z?8$1F?E5PLG)T]]5>E;K[RB\.5K49D7P%P7)\<@M+:3';AIO
M"IN[-M[P^C^QI.:VLN\N,KS&LC.,TE"VTA,>J9]J5(2AF,E!D2T]*E^J2B,T
M)!%6/]@<2W8TA;S%1+"MU_=YOD%GI"ILU+.1$PR2\A58T:7#-24FHG5HY]*5
M$HO541@2FX"%67O"\%VA:8=D&<W^R$Q-88S?XNU@NL:9@V?:WY,R$S*F7LIP
MS-]2'5N^0TV1(27EKYZR42BUK=/?YG,?%-18ECECDSV(X]M'.Z7%,YR"*M:)
M,7''O.EVSC7E$;A]3$8VS2DN5$OH\>K@$0TW6N=M5ELO0E;#TQFW:QD5+?17
MM0YW)QN+0L9*EMHVUTDJ4E4AU136S,C;EDEU7/@HEN&E1.U:0"K2&^]+L[XQ
M2CP>TR6118JSDE9;YG51VE.%>5L!PW7:EY:7F5--OJZ3-:>3(TI,B!,31$7=
M&&ZWQWN-[6<0T'B%-BFX*K*&;?,_HI#CUR8F ,-*;M&[5,1#:?+D)4E#!.^D
MR4E/BLN289%IS"</WIO7NIS[:6,5>=O8AEJ==895W\5JQBU59514'(**Q(2X
MVV<IUXW%J(NKGG@R)2B,3L9'V8R$XU:]Q^DH$IU[%M.[$D1\&@ONK=774]LT
M4IFO0;AJ5Y3#B7"09J,SY/D$2G("$3FNV[4V/Y-NG<>Z3H=C2<SF.6$BZR^M
MC.1,>QV)&2VU6M>V+D-I;92E1K=23?61EU)]7DR:M/=H&74NM- ;?V9>ORL5
MT!#S?([[3[%F:_,BXDIQ!1DQVE^NEMY_K\AK[92E>'5UD:B9:GQ.MV#:]ZW;
MAMS9RI-7D>V*#,IE/@3JB\O&\?AP"^*J]1<<^T*0^MZ29_\ Q7#3TET@="VH
M%6F]\ZF>W?KJ?K<\LE8C57LR$>2RH;1NNS*UA]+LF!REUDVTR4IZ%*)1\%R7
M2HC,@3"%_<OK[5F'YEVVX/HG":3%-^*S:JFXQ]%HC$&9$QN&;GQK)LUQTI6N
M$;1*2HGN>L^OCJX<($PZS=-[K'!>\^1>]P./1]CXQD> 1HFL*QF"C(W:%R,\
MM5A[31()]]'M1J,T228,N.6R/P7TB-S:'8,<.=BNXLCQ%MJFU-DFP[*5J[!R
MDLN/4T,D-I?:=BLN.^P&Z[ZY15&1H^VZ")9*41*>X(0YV;K#2^#9CL'N(W?$
M>V<U?QJNCQO';.B5D35%'8:6A<6K@M,23+VMSEQQ9H+@^KE9$I7)+1_:UA-C
MMCM1W)B6&YN>O<0V1F.2)U8Q$>:MIN)8W/>:4BL?99E)\ETT&[RP;I+;)WJ-
M1J,$SO==W<ZATIJ[36#:_P!3X)54V^I]Q2UV@Y5#&8C9*JTBRXZWYRIK:2?4
MA+2%*?=<4:>HTFHR/I40B5G\1,E,6,F8M#DQ+2"E.-EPA3A)+K-)'Z",^> 5
M8#MO I6T-;Y;KZ)E=AA+F5PO8',FJB2<N.RMQ!O);ZC(ONK9*:5XEZJCX\0(
M5L[L@Z*Q+9W;SIO1N*5^M]K81GU+_P#S ^+RH8<>MCMDJ?$?M9*(Y6KLMIQ)
M&RA;INK-1*/K,R,M#O=JY_@V1=YF5X[L7#;K<2-/8S30]9Z4I:XKDI5O>,KG
M6%R]#>6W%3[-'4RTIR0HD():%%Z_28'0WEVF%IN3EV[+;5-?D6M;6PG59;&[
M?KV S4HQRQ:8<0U+CP&DJ2T4YLC4:FG%(7TD?!<$1$2FZ"$4=_9?D.6WU/VT
MZPM7:O-L_A+G; RR(9>;BV($LF9<U*CY),J69G'BEZ24:G/5Z"4"811T%EEC
MJOW:^<9/C#RXEKBT?-$4$M*OND=\[25'COD?]TTI9++\T@3.]WVQ.W+6.'=D
M7THQ_'(5-LS \/A9Y6;2ALI;OSR*(PW8/3EV)<2%J?=ZB,EK-)),B)/J(Z17
M:L%UCE+N<:UU[FKY-D_F&,U-V\3/Z'UV$-J2KH]'J\N> *LGN;BJQVHM+^\G
MLU5+21'I]M9R5$AF/&CH-QUUQ1^!)0A)F9_8 5'95,S#9_<%VG=P62NS*C%L
MQV [5Z9P=XO+]EQEF"MY-I*09<E)LW.'N/SC)-),S^ LGCW![*R.E:QW4FK'
MVE;IVVIZ%BSZTDXW15K1%\8Y!+3Z";AMJY;2K]$>-"$DKUB!$-'>[RQJ/A>'
M]QV'1)TJSBXGOS,*:-93E^;*D-P(];'2Z^YP74XLD=2CX\3,P3<L#!5&WN#V
M5D=*UCNI-6/M*W3MM3T+%GUI)QNBK6B+XQR"6GT$W#;5RVE7Z(\:$))7K$"8
M1^[",5=Q'7?=#A%%</N/XQO+-J.FR"S/VA]2X42OC,2I1^KYBS-!+7Z.3Y!,
MH%Q\L[?H/:MDNL[K7S-EW&LV\RKD;00S&DQ7<J?L#-BY3FQN%%;:0;J%&:Y2
M."Y0:>#Y,GI7P83%N8.&8C"R.R1<Y##I8#%];MJZT2YK<=M,A]*^"ZB<<)2B
M/CQY!1VEW:QJ*FM[R9S[)30I$Z5TD9GY<=M3J^"(C/T)/X %(FDK'35%I:DS
M[=O9WD6=-6$NTN-E;LDXU"DQF7I]G(=\Q#;SQ2W8T9M:4+=)OI(TJZ2,@7E9
M/?Z(UQO"\TCGSMG R;36"42I.%:R*$A^CG+G1VTP;!9*<)"T,1R)+32V5$7/
MP>)&5JTCKFHQ%COIREO0M-"HL&Q;!%5F]OB!IN-1.9"Y,-=?&\B.263FM(2H
MW%)3R1$M*C)761D]"Q4%5<??!95MGL[M:P*\P&WVEC+]Y>Y-D>"4M<5D_.76
MUQL5S*FG5-M=#CLE?6;BR2E"5J5Z/$M#L]-Y]V\8;D6QHE)V^%V[;EP_$)]S
M88U:U4.NE65%'),AUR)-AK<:D,>:PCKX5Z4\\&23,A-43=693H:[T-;9%M#1
M^9;RO-@,RK??&^*_&FK1JHFSB6ORV+&6ZAY'Q6PMLC*(E2&.DU>"N4@E;5I*
M+00M1ZYB8IF,O8&,1Z"$C'<RGK2N3/@DT7L[CRDH:]8F^E)]2247'K%U<@I+
M,<MOFL5Q7)LG?2E;..54VT>0I72DTPV%OJ(U? 1DCT@*9-693H:[T-;9%M#1
M^9;RO-@,RK??&^*_&FK1JHFSB6ORV+&6ZAY'Q6PMLC*(E2&.DU>"N4@ND+L"
MNQO+G.P7M[K\PF[(T[L1=I<6=U/=Y7D-7A]0W85\>?Y:6O,0LW$$M"T%R:"Z
MRZB,$,PSW&,1T3W:=LMUK:BKL&K]Q(R'#=AT-/'1 @6+,.$W)JGE1HY(9)YA
M]7!+Z.I23Z.HB WPL&!57'WKYMBOXT>WG5>PG+"PUK<OVV39IA%2R],F9+)K
M4LM450B'']>03\UWDVC]173RK@D]22T.9I]_1EUW)U5GCFNLK[9=M5V,3V)&
MM+.E@T,++J1U2#1(-$(WV'UQ%)2OU'$N$9<'UH:,R$M8][V2W>\L#W=08G:/
M0-0:"KW7L]NHIEQ?Y>TIKV>E;5QXL5Q+\Z29<\O>6C@C3U$(V+)M9?DVU]^#
M53]YM JS1YYJ.R[(?<2TPPA3CSJCX2E"2Y4HS^ B(@%*6E=B::S;76:[,V9H
M/+>XO--CV-I:;=RJMQQJ\C8S 5(>;@5<>9,>:-OV6$33OEP^5-)41J,NA!$7
MEMW<]3B,/L-U>O!L_D['TGC%Y1VN1/7=@Q GY#B$2<\Y(HVW7#AI)]KU&4,F
M1.?<?+))N$1 B-[AX7D^G]@]VVA)/;AB36KSQRAO).SS=JV\3.WII,0FX4!J
MM<2PY8J:?0:U+0TI+1$2NOU2Z1T+8 5:^S[4^M-ILUD?8^"TN;L4RW7*EJYB
M-RTQUODDG%-DX1])J)">>/L$!5 '0>D]2[.[BLLW/AVN<>Q356D+)[%-6LT\
M!F*B[R&*9'97;RFTEYJ(RS)J-XFCDO,3PLE<EIE(-CMPTWA4W=FV]X?1_8TG
M-;67>7&5YC61G&:2A;:0F/5,^U*D)0S&2@R):>E2_5)1&:$@BK'^P.);L:0M
MYBHEA6Z_N\WR"STA4V:EG(B89)>0JL:-+AFI*343JT<^E*B47JJ(P)3<!
M
M             "M/N0]W%2]Q.V;W:LW:TW%I%W&@QUTK-2W+0V4*,W&)1.JE
M-&?43?/VO@"T74:)_H<\;_CXL_V@9_7P'$?T.>-_Q\6?[0,_KX#B5V]RW;3L
M+LJV/ADF-EQ6S$\SN, SVO95!=]JK76S=2J.IQ[RG6%+;49$M:32M/K?;)(M
M$U>F+2.P%;5U!K;8SC26)68X[ LK".CP0W+=93[2A'B?JI>)1%^8#'+:0
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MWX_F$1$OREF:>HO3QR"'<@
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MI,JJ%4LK_1V&'26Q&4I7+'2\24J+PY2I/YT$2VR"
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M]=?U%7?4\I,ZHNX;$^KG((R2]&DMI=:<22B(^%(41ER0(=B
M
M
M
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M!F7H,R 97$B18$6-!@QFH4*$TAB'#80EMIIIM))0VVA)$E*4I(B(B+@B <@
M
M
M
M
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MR;M^GKXL%ZYFJZI,M<=I+2I#ZOA6X:>I1_9,P0[@
M
M
M
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M">*'*=:2M^/YA$1+\I9FGJ+T\<@AW(
M
M
M
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M9E,,R8SJ7X\AM+K#R#Y2M"RZDJ29>DC(^2'7MNBZ*QNEQ;K9MF8G?#ZB4
M
M                  "&'=;W??R8+#"X'XKK38GTPCSG_.KI?LQ1?8ULIZ5E
M[,_U=?G<EZ/0"8BJ'2?>\UJIAUR>W>\58)^V@E=(-XN"ZCY;]@ZO1X^@$\*0
M6$=_T?+]+;GW'*T[:X['T^56;F/R[ O,LBLWC9^YO*B()ORS\3]57/Y@%$G>
MV_=\7N)U-1;5A8Z[BT>[DSHZ*5Z2F6MLX4ER,9FZEMHCZC;Y^U\ 1,4;U!
M    Z7)+E..X[?Y M@Y2**NE6*XJ5=!N%%94Z:"49'QU=/'/ "MS1WO(OQX;
M Q7"JG0=]6U^1V::V7EJ;#VR' 4I!KZGC;A(3X$1>!K+T@M-K=FF>\:MW#W$
M;7[?HV!R:*9JWX]]HR=V>B0U,^)+=BJ5TQR80;?FF]YA<K/@BX\?2")A-$$
M        #"]C99+P3 \NS*!CLS+IN,54FQBXQ7]7M4]<=LUICL]"'5=:S+@N
M$'_8 0<T5[P ]Q[MK-(6VD+O6V0SHTN1*7<3ON\4HT-4U*78CD-APO,;(C3R
M9>"B5XD"TPL7!4
M
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M@
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M1UI67J$I*C45FB!U3_7&9/\ )C?\"8@)Z%T0*@
M
M                                     -9[5T[K;=F,KQ+9V*1,II37
MYL9#_6V_&>XX\V-(:4AUE?'ARA1<EX'R7@!5H;,\N[-7M?PNW#,MBX99XU'K
MJ[%8F&JN&),UI,5+4:"@BC+4ZT^V:$&E1=*DGPKP!.UH7#O=D=I^/[%<7)R.
M\S.?3I8MDZUMK2"XVU'<<433DR/&C,R7&%.-FE'4HDJX4E7F>()XI6>---,-
M-LLMI99922&FD$24I2DN"2DB\"(B]! J_8       ,"V?K?&=NX'D6N<R:D/
M8SE#+;%JU$>-AXT-/-OIZ'"(S3Z[:0'&U-JW$]+:_H-9X.S)8Q;&O:OBMJ8\
M<AXO;);TUWK=41&K[J^KC[!> $MC (Z=W?U7M]_@/<?>JP3&]YTNP+ZW^D_E
M.=\US 7G<]7 ,:A_LP^M)W;_ "Y9?/<H6M3?T+2!*@ JTP[^MXKO\M_ %8K.
M]DCPKWGVC?8>9)U;!O(4@GVC(EHZBXZDF9&7)>DN2$*HS=K?;]D?;UBV4X]D
MFU[;:\G(+UVUC6-FEUOV5I3:6R0E+TB2HUKZ>MQ761&?'"? U*)F:NA[\?JI
M;5_8/Y]KQKZOY4]WM<SF_P"5O[O;#4G:;]7K6WZEF_.$D<)H:/Y-O8D4#98E
MGW[Q<U^0;+[U<$2K=NEHCW7WY(]@?A>?WA%'8T/AGM8^0?*N_%[H68C>=YYJ
M<6_*EM'Y5G_?S@\7SC=';+XSYIW1^*6W!P7C !].UWZ\V#?LG_!F6/6\E\-G
M?[WT[R=NP_M?Q+]AZ5]+4E^\T_+1K3\%FOG&2.7KO%'8\7YK\,_Z<^]! :+Y
M( .AR#_56?\ &E_>F#N\A^9=V>]ZDM??O"PCY K?O5L>@L\,/MN'Y=O9#15K
MV\Y+8]T6/]PC>X+R)CE-2KJW=5H2LX3RE,.,\>9YY-DTI3A/*0;)J\Q)&2O1
MTV9J[$I 0HP['ORT=R'ZO/YQF#Z!S+Y.+L]T.1G]ZSD<5K@"N_7?]:79_)RO
MX)L#I:__ (KO_B;^DWPNF'AW04C>\>^M#H+Y+J_GM\>X\L_ELGXO=#5S^*'P
M'58@!&7N@_>ICORL?Z0X-C3>*>Q$[GHFUQ^3S OP=J_O1H?,-3\V[MGVM^W<
MS084@    ".?=#H[(.X'6K&"XWLJPU;8,742U5?0&W'?/;CH>;5%>0T_&4:#
M-TG"X7]NA!@F)HWICM4[18_14DBSDW;]/7Q8+US-5U29:X[26E2'U?"MPT]2
MC^R9@A ON<^L7I#_ -=1\[J'@/-'Y_#V1^\^C>5/^,U'[7[B4HSN0 (D]WO[
MSL6^63^]W!Q>=_+M[?<]+Y9^=?\ A]\)]XA^]+%_DB%^D('TO2_)L_#'L?--
M9\^_\4^UD0SM8
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M5K)E3L4S<?;;,^DS;Z_'I,R+G[J?ZXS)_DQO^!,0#H71 J
M
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M^*?:R(9VL
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M;*3\2]*@6G<NG!4
M
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M/FFL^??^*?:R(9VL
M
M
M
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M_P D0OTA ^EZ7Y-GX8]CYIK/GW_BGVLB&=K
M
M
M
M                           //A[TT]>46^\=R#'Y%[5;AC5%58VB2AQ7
M*64PR\ZF')*2<HGVY+7D="DG'4A:21PI)I5U%[6V<,]\+$1408^P-,R'KQA@
MD3[2BM$%'DO))/+B(LA@E,DKQ]7S5\?9/GP'"S#^F$UM_$[DO^WP_P#[ (X5
MJNN\QC;#U_@V?PH;M=#SG'ZS((E>\I*W6&K.(W+0TM2? U()PB,R\.059B
M         ".G=W]5[??X#W'WJL$QO>=+L"^M_I/Y3G?-<P%YW/5P#&H?[,/K
M2=V_RY9?/<H6M3?T+2!*@ JTP[^MXKO\M_ %8K.]DCPKWGVC?8>9)U;!O(4@
MGVC(EHZBXZDF9&7)>DN2$*HS]KN@,F[?<8RJAR?;5OMJ5D5XY:QK*U2Z@XK1
MMI:)"2>DRE&MSIZG%=9$9^@O#E1,S5T'?C]5+:O[!_/M>-?5_*GN]KF<W_*W
M]WMAJ3M-^KUK;]2S?G"2.$T-'\FWL2*!LL2S[]XN:_(-E]ZN")5NW2T1[K[\
MD>P/PO/[PBCL:'PSVL?(/E7?B]T+,1O.\\U.+?E2VC\JS_OYP>+YQNCME\9\
MT[H_%+;@X+Q@ ^G:[]>;!OV3_@S+'K>2^&SO][Z=Y.W8?VOXE^P]*^EJ2_>:
M?EHUI^"S7SC)'+UWBCL>+\U^&?\ 3GWH(#1?) !T.0?ZJS_C2_O3!W>0_,N[
M/>]26OOWA81\@5OWJV/06>&'VW#\NWLAHNU[?,JL>Z''^X!K<EW#Q>FIE5C^
MIT(7[$^LV'F?%PI!-^4I3Q/&E3"E>8GDE^)=%F:NQ*,$*,.Q[\M'<A^KS^<9
M@^@<R^3B[/=#D9_>LY'%:X KOUW_ %I=G\G*_@FP.EK_ /BN_P#B;^DWPNF'
MAW04C>\>^M#H+Y+J_GM\>X\L_ELGXO=#5S^*'P'58@!&7N@_>ICORL?Z0X-C
M3>*>Q$[GHFUQ^3S OP=J_O1H?,-3\V[MGVM^W<UQW+;GDZ!U%?;.AT#63/TT
MF!'33O2%14.%,E-QS,W4MN&722^?M?$;/+='&KSQBF:5KM[(5ONX8JISV_W_
M %'OC&(&);([=X]S0U]FU<1(\?)9L112V67HZ%^9'BH49$B0LN#/CQ_,'L='
MY>OTM\WXLLQ,Q3PQ.SU^AJWYXNV3'UH3N9+KE6Q6,D1J%;> -H-+VM?CR<?F
M*]F4UU?&AH\\ONQD]P2?@Z/08[7P,_PN'C^_^MPQU]6[=L8N.VJ96F^^O&=!
MUEU4ZS[<V*6!?26YEHW(R>=,-;K2/+2HE2(JS21)^ AQ]9R#)JYB<N69I_9B
M/>R69[;=WM6R=HO<I.[G,*R7+9V),8@Y079U"(+$Q4Q+J2C,O^8:U--<']UX
MXX^ >2YMRV-#DBR+N*L5W4Z6UCOXX9/W/Z1R+?VMX^#XQLRQU791[J):GD%<
MAUPWVXZ'FU17D,R(RS0HW2<+A?VZ$#E,L31O+':IVBQ^BI)%G)NWZ>OBP7KF
M:KJDRUQVDM*D/J^%;AIZE']DS!"!?<Y]8O2'_KJ/G=0\!YH_/X>R/WGT;RI_
MQFH_:_<2E&=R !$GN]_>=BWRR?WNX.+SOY=O;[GI?+/SK_P^^$^\0_>EB_R1
M"_2$#Z7I?DV?ACV/FFL^??\ BGVLB&=K.LM;NFH8Z)EY;0J:(XX3+<J=(;CM
MJ<,C42"6ZI)&HR29\<_ 8QY<UF**WW1$>F:>UEQ8,F::8[9NGT1,^QC_ .,?
M7G_'F._MI$_SHP?S^F_S+/[T?:V/]MU7^5?_ '9^QWM3?T5^V\]174"Z:CJ)
M#[L"2U)2A1ER1*-I2B(S+X#&;%GQY8K9=%W9,3[&#-I\F&:9+9MKUQ,>UVPR
ML(
M
M
M                                                (D;N[)]&=P69
M-9WL6!<2<@9KF*I#D"Q7%:]GCK<<07EI29<\NJY,$Q-&H/Z+;M/_ -T9+^W3
MO^ ">*6K]F]D'N^--UOQKL[)IV'1U(-R/'FY"X<N0DC,C]FAM-KD/\<'X-MJ
M,"LK(M0EB2=3:O3@*I"\$3B5(6%+E]7M!U)0&?83>ZR)76;'1U<ESSZ05EL0
M           $=.[OZKV^_P ![C[U6"8WO.EV!?6_TG\ISOFN8"\[GJX!C4/]
MF'UI.[?Y<LOGN4+6IOZ%I E0 5:8=_6\5W^6_@"L5G>R1X5[SZW6V'G&&?:'
MD(4IECJ)'6HBY2GJ/P+D_#DQ"J,O:WLW>NS\7RJSWOJA&J;JLO'(=! 0U(C^
MU020E9+-J4XZLS0H^GS4F2'/2E*>#!,NB[\?JI;5_8/Y]KQKZOY4]WM<SF_Y
M6_N]L-2=IOU>M;?J6;\X21PFAH_DV]B10-EB6??O%S7Y!LOO5P1*MVZ6B/=?
M?DCV!^%Y_>$4=C0^&>UCY!\J[\7NA9B-YWGFIQ;\J6T?E6?]_.#Q?.-T=LOC
M/FG='XI;<'!>, 'T[7?KS8-^R?\ !F6/6\E\-G?[WT[R=NP_M?Q+]AZ5]+4E
M^\T_+1K3\%FOG&2.7KO%'8\7YK\,_P"G/O00&B^2 #H<@_U5G_&E_>F#N\A^
M9=V>]ZDM??O"PCY K?O5L>@L\,/MN'Y=O9#15KL_?<7NBQ[6,#3Z)>BI],N9
M;;4^[&IF24=UPONY.$PCA]*&?(4@W%<^81](LS="4@(48=CWY:.Y#]7G\XS!
M] YE\G%V>Z'(S^]9R.*UP!7?KO\ K2[/Y.5_!-@=+7_\5W_Q-_2;X73#P[H*
M1O>/?6AT%\EU?SV^/<>6?RV3\7NAJY_%#X#JL0 C+W0?O4QWY6/](<&QIO%/
M8B=ST3:X_)Y@7X.U?WHT/F&I^;=VS[6_;N1,]XW]4_.?E&D^<F!UO+OYVWLG
MV2QYO"\]]1_[=%_])_WQCZYI_EP\]G\<NR&=B<>7_JLG_%+_ +TQ3)X9[%L?
MBCM7/^Z@_(UL;\,U?-T0?*_-7S[/P^^7H=/NE,+NAV'N;6>M6,BT7K9&T<S=
MNHD*11+9D2BCP'4/*>E>SQ'&G7>E:$-\)673U]9\I29'Y=LPWICLRTL<?HK"
M[K/B2ZGU\61;TWF$[[)*=:2MZ/YA>"O+69IY+T\<@A ON<^L7I#_ -=1\[J'
M@/-'Y_#V1^\^C>5/^,U'[7[B4HSN0 (D]WO[SL6^63^]W!Q>=_+M[?<]+Y9^
M=?\ A]\)]XA^]+%_DB%^D('TO2_)L_#'L?--9\^_\4^UKW?>>7FM=9W.78ZB
M*NU@/PVV$S&U.M=+\A#2^4I4@S]51\>(T.=ZW)H]+=EQTXHF-_IFCH<@T&/7
M:RW#DKPS$[M^R*JT]B;BVYN?&8%->T,5VFCST6<21607FU*>:;>8+UU..$:>
M'5<EQZ1\RYGYDR:VR,6:;8B)KLV36DQU^E]2Y7Y=TW+LLY,7%68IMFNRL3U1
MU-)?1'*/]P3_ /Z O_[ XG\SB_6AWFYM9;/VWINKN8F-8ZS[%9/)F3W;&"\Z
M:3:0:>24EQLB(D^GD=CEGF._0VS;BFW[T].WWN)S7D.GYE=;=EXJVQ2*33W2
ML1[:MH9+MK!;;(\I;A-V$*^?K64P6E,M^2W%BO)Y2I;A]74\KQY^P/I/E[F6
M77Z>[)EI6+IC9U4B?>^9^9N5X>7:FW'BK2;(G;-=M9CT=20P[KSH
M
M
M
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M_>N3,'K7C
M
M
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M;TAY7H0A!&I2C_,(BY$771;$S.Z%K;9NF(C?+3_\H;2G\8U1_P#+K_P!RO\
M?=#_ )MKL?\ KO,/\FYW./;EU?E=Q$H,=S6NM[F?YGL=>PI1N.>4VIU?21I(
MO50A1G_8&7!S;29[XLQY(FZ=T?6P:CDVLT^.<F3'-ML;YGT[/:V:.BY@
M     TMJW)LYNLKW)2YO(K'%8GD4*)0Q*IM:68T*740YJ&E/.D3CZ^I\S4M2
M4\F?"4I21$"3$<FSF7NK:^'9-(K#QVDQS%KO#8%>VOS&&K6=D,1Y4J0X1*==
M=*K;69)2E#?/0GJ,E..!W>W<WRS7V'/9'AFM;':]VU*88;Q&JD(BR%MNF9+>
M)QQ#B>&R+DRX!$,*[9=^1.Y+5L39T+&GL38E6,RN*G?E)EK2<11)-?FI;:+U
MN?1T^ )F*)!@@
M           '!LU62*VP73-1I%PF,Z=4Q-<6S&7))!^2E]QM#BT(-?!*4E"C
M(N3))GX -5Z7R;,,JU9#N\EE0+C,2G9!"DR&&E0(3SU;;S83));3YZFF^EA)
M>EQ1%XF:U<F9,FD,ES#)\4O).=3($[(JG+LCII#U8PJ-$)JMM'XK*&4+4I?2
MA#9))2S-2N.5>)@2T[W2]TV0]M#46Z/2EOGN$>QLO7&;1+%J%$@R9$E4=N*X
ME;#RC4H^DR,O[H@(BJ6];,*QKH%@ELVBGQFI!-&?)I)U!+XY\.>.00YH
M                                                       -+;LR
M;.<3JL+M,0D5D.OD9QB%1EK\UM;\ER!=9'65+D>(WP3:5.(F+-3JS,T$GA"#
M4LEMDP=P>39SANI\KRG )%9"N:**Y-E3[-M;Y,Q&6UK<..PDNEQY2B2A).*)
M"24;A]?03:Q#=((0[PWNFR&][A5Z RO2EO@$R5#M;.@R:?8M/-V%?6O+9;E-
M1T,),D/]!FGE?A^:":)B @
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MWU$9%R?6?)GP7 =P KI]UM]4^H_"6Z_34 M=O6+ J
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MD3])0"'>
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MIS_M%<??LD$]"?8(
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M03JEDVIW@^MI))]1)J\3+P!-&\00
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M&*A,=5B]#)WH;3+\SR#ZG$((R7Y2^..?0!1LH
M         !B>;4-WD^.3:.@S"=@D^>;:%9-6,1GYK#/61O%'*6V\TA:T<I):
MD*Z.>HBY(@$5;WMMI\2GT-M VIW 661Y);L4ZLBJ<HDV2H:I"%J]ML8TE*X:
M8C?E$2S4PI"3-!$CCC@FK=^<93CVL]62&-KYGCEY+DU4JL2_ELZLQN+DDPXS
MIE#<5(4B*VJ2E)I624]!$:E=!)]4@K3U=K[*%VMY;Z$[H-8ZSS&372IV&]M.
MN\F+*Z6=-92J2:)S=E/<;0:R2;;BHD1"6TGUI/A)]1*XJ&J4N)%5.;0U-4R@
MYC31FI"73276E)GXF1*YX,%6"Y_LW'-;_19-\S8RG\POZO'JF/71%R30_:SX
MU:T_)67#;##;TMHEN.*+[8DIZW%(0H/KFN?Q<-D4E8UC]OEV09"<I=7C=&F(
M<M<>"V3DN29S9,1DFVNMM)_=.HU+0E*5&8#)\>OJG*J"CR>@FHLJ+)*^-:4M
MBWR2)$28TE]AU/)$?"T+)1<E\("OFRS#$LN]X[K+Z*9349/\0ZPO*R\^*9T>
M;[%.9FR/-BR?(6ORG4<^LA?"B^$@6Z&P;/N^OX>-9EF\+1EK9X7A;^0HFWJ;
MRL:4ZSC4J5$FO(C+5YOVT-PTIXY,N/LB:*IH5TQ-C7P;!"#;1.CM2$-J\323
MJ"61'Q]CD0-%V_=/V_45E<U-ML^KAV&/395==L*1(5[-*@NJ9DM.*2R:2-IQ
M"DJ\? R ;V@SHEG!AV4!],J#8,-R84E'VKC3J26A:?S%),C(!R@ !HK-.Y'4
MNOLK/"<IL<ABY*I1)C0H6)9)9-R5''3+,HLF!62&)!H:62E^4M71XDK@TJ(B
M:-XLNH?9:?;ZO+>0EQOJ2I"NE1<ERE1$HC_,,N00C1LKNNUYJO,TX+D&-9S8
MW3RD-P':3&YMC%ENJC'+4U%?92:7EMLI4I:4<FDDJY^U,$T2-K+!FVK:^UC(
M=;CV<9J7'0\@VW4H>02TDM!^*5$1^)'Z#!"/6U^X6;J[+*+%RU3=Y<G)I[-3
M17%=;X[&9?L'8DB<<935A:1GV>EB*XHW'6TMGP1$LU*21DT2!IK!5M45EFY%
M5 =GQ6I#T!;K+ZHZW$$I;*G8ZW6EJ;49I,VUJ29EZJC+Q!#1NU>X)K4^18[C
M]AJ3/,I3EMG&I,9O*!JE<A3+.4P_)1#;.;;Q'B63<9PS-;24>'@HP3$-YT\]
MZUJ*NTD5<RC?LH;$I^EL/**7#6\VE:H\@H[KS7F-&?2ORW%IZB/I4HN#,AK#
M.]^Z>UC<LX_GN=P,9N'V6GV(,I+QJ6V^I2&S(T-J(^HT&1%SSX FC95%>5.3
M4U9D-%-18TUS&;EUD]LE$AYATNI"TDHB/@R/X2!#M@
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MK+4,RAMPER)!K0R7!)::4I1^@N1:81$U2DNN\C0%32VMFK.$1Y<""[+B5=Q
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MM)$-I;,9R22"\U3+3CCJT(-?)I2I:C(O U&?B"'-   !4+MC,U;;W#DLS+]
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MIA5E^/S3F53;FJ>ER-=XOBD6GOFW%PU+<:2_Y_GH]G/GKY:+J2D_ B,%I69
MJP#96'2<YQVNI8DQJ"["RK%,@6^ZE2DJ:QW(:^Y=:(D^/4ZB$IM)^@E*(S\
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M+2#SW'Z;(:&NQFLFUY0FK.&B6XQ)5,L)_G*3YJ4DI'EEX'R1\EP3+>H(
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MSCYMWXKO:_4'E7Y?[%OL?D<=ZX ;M[5OK!4'ZDL/O%P>Y\F?F\?9=[)?)?\
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MPWUO.FE"DM+4OE*5)5QZJ_ 8]/JYR7<,PG3:O-=DBW)%L1,3NKO3#&\Z8
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M)&/6VW1=$3&Z7C[[)LNFV=\;'(%E0                   &K-A:3U7M:1
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M'WJL$QO>=+L"^M_I/Y3G?-<P%YW/5P#&H?[,/K2=V_RY9?/<H6M3?T+2!*@
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MG'S;OQ7>U^H/*OR_V+?8_(X[UP W;VK?6"H/U)8?>+@]SY,_-X^R[V2^2_\
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M^ QZBS)-+97PZ[%FNX;:UI7=,)"#.W
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MQ^;X\ETVY;XI-.&8_5NCHCT3'WH[V3',;DVAQ64
M                            0XU;N[N'VA-I;R+HW':?6MG</0YUP_E:
M7+>#$C2EQWE/UZ89$4ALD&:F361D?JF8)HW)N^ZOJS#7ZVEUU'V9&RDGZ:_H
M9-_$QY)094=Q#RBDR_!741]'2@R5X]1'X 0B%VWZP<Q;/\/*1IRSQR/1.W]D
MC*+'8];DJSL;>(S'=ER(45M#K[I1XJ(K2OM6VU*\#,S4"960 J    @)F?\
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MKL=UMUL3;NF-G8\9EMNMOF+_ !1,U[>ES1=0
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MZ;+MMD^K[O[+SO.;..ZS44I\2/O>C);]V^/7][]IN8=9Q0
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MX[=8]:NQ'I$>;6.>4^DW8+\AA9=7H-#AD8(;.
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M0^&>UCY!\J[\7NA9B-YWGFIQ;\J6T?E6?]_.#Q?.-T=LOC/FG='XI;<'!>,
M'T[7?KS8-^R?\&98];R7PV=_O?3O)V[#^U_$OV'I7TM27[S3\M&M/P6:^<9(
MY>N\4=CQ?FOPS_IS[T$!HOD@ Z'(/]59_P :7]Z8.[R'YEW9[WJ2U]^\+"/D
M"M^]6QZ"SPP^VX?EV]D.ND:IUO+V#"VO)PJI>V/70S@0<R5'2<YI@T+;-*7/
ML]#BD=7VW29IYZ? 696P %&'8]^6CN0_5Y_.,P?0.9?)Q=GNAR,_O6<CBM<
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M :^#63DOX9BC!@UV6Z^VV^V(B[T]--R<0WW6
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MZ1(63;:"0A*EF2$EPDB(!##WF?U0,^^4Z'YTC@FW>F_C'[V\>^3(GZ2@$.\
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M6T;T9;B.I)*(S3SR7)#F9<-^*>&^V;9ZIBGM7B8G<R,8T@
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M024+(@0DD"           1T[<?\ 4-R?]W<R^_P3*18(
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MX(E6[=+1'NOOR1[ _"\_O"*.QH?#/:Q\@^5=^+W0LQ&\[SS4XM^5+:/RK/\
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MWV/R..]< -V]JWU@J#]26'WBX/<^3/S>/LN]DODO_P!B_E\W;9_"MX'UU\+
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M0LQ&\[SS4XM^5+:/RK/^_G!XOG&Z.V7QGS3NC\4MN#@O& #Z=KOUYL&_9/\
M@S+'K>2^&SO][Z=Y.W8?VOXE^P]*^EJ2_>:?EHUI^"S7SC)'+UWBCL>+\U^&
M?].?>@@-%\D '0Y!_JK/^-+^],'=Y#\R[L][U):^_>%A'R!6_>K8]!9X8?;<
M/R[>R&B[7:^[XG=#C^JH&FG9FE;&F5,M-M</^6Q))AYWCSR_T=/#J$,^2HO,
M/J\PCZ>!9FZ$HP0HP['ORT=R'ZO/YQF#Z!S+Y.+L]T.1G]ZSD<5K@"N_7?\
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M,@LE>=/6;:?(8>@M>6A#)&M7KJ41$2 $AP0CIFOUH= _@/L7[ZQ8$]"18(
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MU&J5);G2$N.J4?49K42R-1F9\GR,5V#'=OMB>Z&&_38K_%9;/;$.7^,+/O\
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MR4MDKJ-?5X<?9$1FLF:5BJD:S#-W#%\5ZJMN#(V0
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M51R;C*+\BEQ+K+Z&%CEQ9Q);\9XH-<Y8.Q?(6TM*F7&UV<A1.-F2^3+Q]5/
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M'SO9.MKV[V'S>GKZ.?,\KS/#GCIZOS0':@ ".G;C_J&Y/^[N9??X)E(L$
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MB(B(0RO93]&,;_X>K/\ 9&?\ 2Q'T8QO_AZL_P!D9_P #Z,8W_P]6?[(S_@
M'T8QO_AZL_V1G_  >?\ ][C7P*[=6M6J^%'@MKPE*EMQVTM)-7QE++DR01$9
M\$"]J;'NJZ:GG]L<]^=50YKY9M:I)Y]AMQ?24:%P74I)GQX@B[>LH^C&-_\
M#U9_LC/^ "I]&,;_ .'JS_9&?\  ^C&-_P##U9_LC/\ @ (3^\4HJ2'V<;AD
MPZ:#%D-_1_RY#,=IM:><AK2/A24D9<D9D";=ZJ'W5<*%/[G)[$Z(S-8+";51
M,OMI<1U%)A<'TJ(RY\06NW/1M]&,;_X>K/\ 9&?\ %#Z,8W_ ,/5G^R,_P"
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MO/J<=?JC%&JCCX/>PQS&)R_#X>FE:Q3^OT;TQ1M.D
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M?7-Q>2HVP\NAOE"5&:37278#3]AX'"9>E(0E3Q*3ZQ(:ZR\W@^FY4(T9)?;
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M!@5HJ\P;5.'87=+87%7<45%7UTHV'#2I;1O1F&U]"C21FGG@^"^P!5LD
M  :]S#4>J=A3HMGGVL<3SBRA,>RP[#(*6#9OLL=1K\IMR4RXI*.I1GTD?')F
M8%7?XMA^)8-4HH<)Q:HP^B;=6\W2TD&/7Q$NN'RM9,1D-H)2C])\<F R,
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M2:T/MJ7PLW4*0,_-<5V6R+[8IP12;:Q=2)F:7UC?$[IZNQ%EVW;TK#!YYE
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M6  (Z=N/^H;D_P"[N9??X)E(L$
M
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MM@RS(94M"5I);:E$9&:5$?C\!C'.:RV:3,->_68;)X;KXB8]+;@R-D
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M?X[)FR[MMW3^U%)[VYS?#;9GX\?@R1%]OHB[?'[-U;>YL\=%RP
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M.=4\XA)$M]:?64:N5&7I ;R!  CIVX_ZAN3_ +NYE]_@F4BP0
M
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MAA+[R4NNI:2DEK(EKY41& S@!73[K;ZI]1^$MU^FH!:[>L6!4
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M1,=J(FKMQ1(           ".?=N9)[<]J*49$15C1F9^@B]K8!,-X?2?&_\
MB&L_VMG_  P0?2?&_P#B&L_VMG_# <=%WB#<AZ6W;TZ)<@B2_)3(CDXLDD1$
M2EDKD^"+PY$UFE"CD?2?&_\ B&L_VMG_  Q _*LDQA:5(7?U:T+(TK0J4R9&
M1^!D9&H!U5,]KS'6'8N/NX[11GW#>?C5RHD5M;AD1&M26NDC5P7I,!V$>]Q*
M(VIJ)<U$5I;KKRVVI$="3=?<4ZZLR2HBZEK6I2C])J,S/Q,!PGY> 2;2)>29
M./R+J VIF#;N+BKE,MJYZD-O&9K2D^3Y(C ?F/(U]$M)EY$?QZ+=6*";L+=I
M41$I]">.$NO),EK(N"X(S^ !^8;NNZ]%FW <QR"W=+6[<(CG$:*6MPC):GR1
MQYAJ(S(S5SR ^]5/P2BA-UU',H::O:,U-0(+D6.RDU'R9DVT:4ER?I\ 'U?M
ML+E*>7)LJ22N3'5$D+=>C+-R.OQ4RHU&?*#Y\4GX /T=QAIE!([2E,JQ776E
MY\?_ $=1-J9ZF?6]0_+6I'*>/5,R]!F Y7TGQO\ XAK/]K9_PP&@LHLZVR[H
M="_%]A&G^3@^Q/.]G=0[T=4K%^GJZ#/CG@^.03T),@@   !5E3)RJ/M;6_T(
MR'NPR-3V:PTY579[!EP<5;I_,6<MUZ0NOB)Z&RX4A)K42R+HX]8E$63YW9>X
M!1ZOS1&R\TA8%BE_3SZ:;D,R0VPI'ML1Y!IC$L^77^CJ4VT@E+69<)29@K"
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MZI=T,S               ".EO];;7O\ VBS'Y^Q@$]"18(
M      1T[<?]0W)_W=S+[_!,I%@@
M
M                           ! :UB=RG\I_>TC2KN$0JE['<'3:/; BW#
M\=U:&K7RRK%5KS*.4\K\_JY]+?''CR3LHE)JI&[T5]J6[Y6#2K4Y"/B-6#,6
M3$<H_1ZY22LGGE&OJ]'09%P"$=]M;>[*JO89M[>IH$[8%.IZE1,L\&N;-3BE
M);<6PU)14OLR>$MI-)H6OI(CZ3+E0)B)2'TOF.J<ZP.!?Z73$1@*Y,F/7)@U
M+]+'\YEPTR/+B2(T51<.<D:B;X,^?$_$"6TGGFH[+LA]Q+3#"%./.J/A*4)+
ME2C/X"(B!#5>N]M5>PWVX[-%9XZ[84L/)L<39^S<V5)8*6F--:3'?>4WSTD:
MVW20XCK1U)Y,R(FCL:3:&.9#L;+M:529,BVPFN@S[NRZ"*$2YSC[91FG#/E;
MC7D\N<%TIZB3U=9+2DAW>9YWANNJ1S)<[R>NQ''VGFX[EQ:R$1HZ773X;0;C
MAD7*C+P(!!7W6WU3ZC\);K]-0"UV]8L"H               #^*2E:5(6DE(
M41DI)ER1D?I(R 8W"PS#ZV4S.KL4IZ^;',S8F1H,=IU!F1D9I6A!*+P,R\#%
M8MB.ACC%9$UB(]3#-G:@P_9$)R9.IV6,TK8KQ8GFD1QV#:5TGH5Y*V9\53;Z
M$I69&:25TG\*3%;\<7=K'J--9EBLQ][HG=,=^]0EH=.=UF\< N,=IK&URV%D
M"9=DDG$L.6;:%*<L&"F25(96J6T3B$&M?"E*(^2](Y&'BC)$QO?.>5X==9S#
MCF:VUZ]_HCN]:^3$-Y8#E=JG&),J7A6<\)\S <JCJJ;;E7@1L-/GT24F?H7'
M6X@_@4.O;EMF:;IZI?1<6KQWSP[KNJ=D_P!/<X51W(Z,OLCB8A3[*J;#)ITS
MV")2M*<-]<GJ-)M$DT%XD9&1\^@1&:R9I$[5;==@NNX8NBO4W<,K;:<K] ZH
MJ\H;S2#C3[.3-/HDIM3M;-:C6VXIY!*0N4I"D)6M2B0:327)^'B,<8;8FM-K
M5MT>*+N.(V]L_:V^\RS)9=CR&D/QWT*;?8<22D+0HN%)4D^2,C(^#(QD;4Q5
M3TSVC; :VRYJ.NNZ.LH:PFLN@9F7FN2&JKXR<.,DH"4-).43K72HB=)''K$K
M\Z//QRF8U7Q.+T^Y\_M\JWQS+XT9-GB]WTCZU@/TWW?@G*,^UPQL>E9].6Z\
M4?MA((C]9^AGN$[U<D1F4:0]Z?!/P#M<5]N^*]GV/9_%S8_';Q1UV_\ ;/NF
M4&+#=O;W*WZC/WM(5S^ *:=J[?+)M+ :D'<R+)MYR]>@OLD_U-.)4A;B^'^#
M4KC\Z?,G7Z?^8X*;>SI>:OY[H/Y_X4VQ7=N_2WUW;_K6WCLO9([V.TMLP]HQ
M=<1]34$IJRAV-S5WJ\M=:-=173HL-;[D?XE7T/**:VLF2<47VQ>9X<GAG)=Q
M<-/K_H:5VHRQEX.".F:\71$Q'ZOIW)$#,W0  :-RS0>-9AE[.;V&6YG!O(7F
ME4JKKQ^*U!2^VAMY,1M)?<B<)LNHD^DQBNQ1=-:RU,FCMR7\<S=7T3N[&ZY,
M:-,CO19D=N5%D)-#\9Y!+;6D_2E25$9&1_8,96U,5WJO]H1G-7YMGVKL&F8_
M58=LV=(EV[CM%<?_ %+.6%8PF2:6:V$N-+0ZA)*9)"T]+BNASP(U#D:C31\3
M9-(GT;G U$1BR39;2DSU3]W9Z(I/H2RHM;[HP2DJ*_ -OP,LHZJ#'B5./9S1
MM\IC--I0VA%A4JA.HZ4I(B\QAT_L\\#H19?;&R:]KI68,V.V(LOB8CHNCWQ3
MV2A]L"5DV:9;L+-<]R#%-;9KH>0X57C46%#LH+RSK&^9UD_8PVY,R/-;>-IE
M))1Y9<='W5/(YNHSWQDVQ&QS,TW9+YNOF+9LGT3&[?-8K,3]-J8&%=T&JI^/
M8J>97;>L,CLJR&Y/H,FAS*%B/)=82MQF/(LF8[+K:3Y)"D+41IX\1TK<]LQ%
M=D^G8Z6+7XIMCBGAFFZ:Q[6J]Q=P61T.9Q(6N=CU-QC23C2,P768?,R9O'*Q
MR*\X<^780+-MMTUN-$9,I0E26U&LS,DEUX<VIBRZ(BZ/56GUL&IUEUM]++HF
M.G[O%2.NL3M[$T,;GMVN.T-HU;1KYJRKHLIN]A-^5&FI>92LI+#?6YTH=(^M
M)=:N",BZC](W+9K#J63Q6Q-:[-[NA*P  *S^W2%WML:=Q)K$9>I(.-I<M/BF
M+F4#)%7B&SLY1G[8<>4VV:C49FGI27J=(+318%665W18/&N-COUWQ]3U!S<R
MD8_'EN0?.CM&Y*5"CK\Z2I'JF:$>LL_1XF"J"![V]W-26%RZ_0T,&SD3&Y]S
M[7K>[\U$B0AMMM:B>I#-KK)M/21<$9^)%R9F9:DK%X[K3\=A]CGR'FTN,\I-
M!]"B(T^JHB,O#X#(%6.YGEE;@V,V>3VK3\F+7$TAJ%%)*GY,F2ZB/%C,DXI"
M.M]YU#:>M24\J+J4E/)D' PW.(F61+]3]=)QRWQ&R74991V#D=;L&6F+'G))
M3L9UYE27(LMEY*DK^T67425=22#@ZTV;0;5IK6_QEF6BIK;F93L29;?E>U>R
M&GB4RGDS\EY*R6V:N#4DR5P7("#WO/\ .\-@=M^48!-R>NBYM>OTUA38L[(0
MF=*BLV;7F/-,&?4I"?+5R9%\!@M:L*QC][>/?)D3])0"KO     $9]F'^+?<
MFM=M-%Y-!FAMZWV0LN"0GVUXWL>G+\/#R9JEQC49_:R2Y\$CI:;_ !\%^+IM
M^_;W>*/5M_94NV3$MB[6TW@>YJBNJ<WKGWE4LKVVBN($EV%/@OFGH6J/(94E
M1$M!]*TGRE1>DC,B,L&DUN72W3=CG?OZ8E-UL7;V@,+QV!VDYFC%T+?D:3V[
M:M*K<IG.>?,I<M>:;C^SV<I1=;L>R2TGR7EG]S>+RE<)<09;^?+/,;..?FV1
MMC]:SKB.NWICIC;T*1'!-.B4B-JX->;%Q.=B=/F\C!X]RS(A7LN-!BSER84I
MAQAV/Q*2HF^27SUIX47'I'.TN>W#?%\V\5-VV8V]R]T5AB%%HFL7K1C5VS+H
M]J4%8W%CX\_/@1J^17,P6$,1CC.PB;6AYKHZDOI43A&?@H9LFNGXOQ<4<$SO
MI,S6N^M>CT;D19LI.U'';4C8.J8=!J[(JNC[C,8SZ5(@:OG9HI#=M2S8T5UU
MQ=JZ<60W,;8B]9ID(0A_GU%$LU]8Z.CMQZF9R6S.*ZWQ<.Z8KT;8I6>C<K-8
MV;V?]G5O @8K:ZED854XEF>IZ^A@Y+9TI-JC7S#\-;,.V4XEEAPW7CB.DXEU
M)J2HN>I1*&#G..[XD9>*9MOF9BOZ.W;;V;8HG'LV);6ES44<8IMW:PZ>&:R;
M*7.?;CM&M1&9)ZW%)+DR(^"Y'(MLNOFEL59*OE4W]%?MO/45U NF8ZB0^[ D
MM24H49<DE1M*41&9? 8F_'=9XHF.U$35VXHD         =5=T5)DU3.H<DIH
M.045HT;-G2V4=J7$D-&9&:'F'DK0M/)>A1&0#4O\F7MN_F^:U_Y3I_UJ":R?
MR9>V[^;YK7_E.G_6H%9/Y,O;=_-\UK_RG3_K4"LG\F7MN_F^:U_Y3I_UJ!63
M^3+VW?S?-:_\IT_ZU K)_)E[;OYOFM?^4Z?]:@5D_DR]MW\WS6O_ "G3_K4"
MLG\F7MN_F^:U_P"4Z?\ 6H%9/Y,O;=_-\UK_ ,IT_P"M0*R?R9>V[^;YK7_E
M.G_6H%9/Y,O;=_-\UK_RG3_K4"LG\F7MN_F^:U_Y3I_UJ!63^3+VW?S?-:_\
MIT_ZU K)_)E[;OYOFM?^4Z?]:@5EDV)Z:U!@5HJ\P;5.'87=+87%7<45%7UT
MHV'#2I;1O1F&U]"C21FGG@^"^P"*MD@   BKWCQ\LDZ=AMX,VES*2S?#ET_F
MMON1TNIOH1DJ4F,9.FPGCEWI,CZ.KQ($P^V+,]ZZ<CI#S:RTB[B)3&OI&W20
M<D19*A]1><414F6MHG>GGI-:33SZ0-C8&\,KU'C6&JB;I@G:8=DCWQ>[6JHK
M"_;=<Z%.EUQZ^)+6CI)!J)Q22))D7"B5P!#2FD-R=F&3YE28UH^%21LRL*R0
M[2N5^&V-0\[7QD$;RBGR*R,DT$22(S4[ZQ\%XJ,B F)3/!#4^P=MU>OYAPGJ
M*SR!<&EF9-DJZWV8BK*2 I*'YKI2'V3<X-1FEMHEN*)"^$\D1*)HYFT]K8OJ
M37=[LG(3D3J>F@.SF(-<@GI<[RV5R/*BMF:24HVVU+,S,DI0E3BS2A*E$0V8
M K9E9WAN<>\=UO\ 0_)Z[)?HUK2]J+_XND(?]CGL39'FQG^@SZ'$<^*3\2!;
MH63 J    @)EG<!-P7<6P+&AQMF?0I5#J\HCR7E-R),FH\Q#LF,:2-*#\MSR
M^%\]1(2?AZ!\VYCYPLY?S2_';96)X;;NV*Q6/9T[H?3N7>3KN8<KQWW7TF.*
MZWLNI-)]5>C?*1S,UFBVG3WD7E&.[DJ6VEK4722;BM9-Z*I7/@2I$)2T<<^)
MLI(>QB^,6KMOCP9K?^NV*QZ[:Q^R\9-DY='=CGQX+O\ HNFEW]V^D_M.BV7V
MW8OLR]L<GL,CO*RXE,-M1FH1P414*8;)+)N)]C-YU)*3U&2W3/Q,DFDN"+!S
M'R]AUN2<EUUT74Z.&FS=^C6>^>RC8Y9YES:''&*VRV;8GIXJ[9V_I4CJV1VU
M;*UKE,O*,;3\<-)B93C\ARFR^ @C)+5C$X2XI!'_ /#=2:76S_N%I\1T>7ZF
M<^+[^R^V>&Z/[4>Z=\>B7,YGI;=/E^YMLNCBLGKMG=WQX9],2V -YSP
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MT^7%DVV1%RHR\3!#+
M 8AGF>XCK'$KK.<ZO(^.XOC[!OV=I),^E)<\)0A*2-3BUJ,DH0@C4I1DE)&9
M@*NW/>^:A3DRH+>K\K=Q,EDCZ1>=#3,,NK@UE -?3QQXES(Y_,(%N%9;JS;&
M ;IP^!G6M\A8R+'IQFVIYOE#T=]!$;D>2RLB6TZCJ+E*B+P,C+E)D9E6Q@
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M #K8?N&!L/I;WB_Q+ZU_YUL/W# V'TM[Q?XE]:_\ZV'[A@;#Z6]XO\2^M?\
MG6P_<,#8?2WO%_B7UK_SK8?N&!L/I;WB_P 2^M?^=;#]PP-A]+>\7^)?6O\
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MS(ZC;JK%9\D1$E:_9G#/\ZM!_G1SM3_XNHC/'@OI;?Z)_0N_AGT3'4ZFE_\
M,TUVGGQV5OL],?IV>K[T>F)ZVZAUW$
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MF)!*+KDO,<FT,WL-[9F6U61P]@6N.I766!1V7()[&E4R"<;\I1*4W"432%?
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M2E)%R9GZ '!K+RENJIB]IKB%;4DIM3T6XA2&WXKC:3,E+0^VI2%)(TF1F1_
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M T(B9W+N/$M*R>I:(%C%FK;+J<2P\APTD?PF23/@3-LQO@<X5
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M.W;=%T5C=+@76S;,Q.^'U$H
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M,<1TK2IM:4</(,G/+(V^?T-39,31+WU4)\3X2@O%2C^ OA,S!"N'8WO1.W+
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MS2.<.QA&M_%,NBH2<ZJE*(B-;1JXZVU\$3K1GTK+CT*2A:28FC8NKM;XWJ'
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MV-&29QV)CB.E:5-K2CAY!DYY9&WS^AJ;)B:)?$7!$1<\$7!<GR?_ (F"']
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MN6T-,E$E*_+4RIHW262R672:3+GGP](KQV[JPK.HQQ-.**]L,Y%V5J"T[?\
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MP#VO+,\9]+COXN*>&*S_ &J;?K>(YMIYT^KR6</#'%-(_LU^[W4;#&^YP
M
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M-U >N;6GM<5BTU2W6S<?C3HTQ^0U%9-E;-BZ_"5%Y)9.)0KP21DHF:+0@5
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MEX&2B,C(QT;;HNB+HFL2Y=]DV73;=%)C9+D"RH
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MVHFS9::K)C5FGRH:JY31NNFYT(]=*R(NOT> )M66XQ^]O'ODR)^DH!5W@
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M<I"T.(2XVHEMK(E(6D^2,C\2,C+TD8O$U5F*/T"
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ML$Y)4WPGK/H2:TH)Q8E)$$(Z=P?^O]OG_=VD^\+($PD6"
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M)Z4GR^XX9<%\! (;>\S^J!GWRG0_.D<$V[TW\8_>WCWR9$_24 AW@
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M]2*6YSM6-J9A9NKNH4JV1 <PF;2>TMIFQVXC1,.1UP^"?=)XUIY49F7@7VO
M^?\ F>[F%O,>+#Q1;=PTFWIV=<;_ *>A[SRW&CNY=;;DX9FWBXHNI]V:S6M=
MT4[DX]6Y4WEV"XW8NV3=A>,U\6/E:$D;;K%JVR@IC+S*B2IM:7>KE*DE_P"
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M]SNQF8
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MV=1>9WCM*9QW)EK#6:7"1(0;:HSR93:FWW$)^[H]=/2M1N**UIL6B J
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M5J*EQ1%P2E$TE)&9%\)@.X 1T[@_]?[?/^[M)]X60)A(L$
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M1.T]E28PM2O:9,1BS;\QY!<<=*?*7SX_ "UJQ/&/WMX]\F1/TE *N\
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MD(60V> K05L7"-@^\=U[]"\DAY%]%-;W])D7LBE*]DL(TV1YL9SDBX6CDN>
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M'R1D8S6W1=$3$UB6"ZV;9FVZ*3'0^XE4
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M-35..U-;0T-;&IZ6GC-PZJJAMI9CQX[*20VTTV@B2E*4D1$1$"KL@
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M;(DKZ3\.HO P5=B CIW!_P"O]OG_ '=I/O"R!,)%@@
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M.+&=LV?,88F*0;S:%=:N4I41'R?)>)@M;O6 XQ^]O'ODR)^DH!5W@
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M>:7]HX@R4D_@\#+P$1,3MA,Q,327T$H
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MR/@_ P$&O>9_5 S[Y3H?G2.";=Z;^,?O;Q[Y,B?I* 0[P
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M.M=BXSN>1CJF[C$''>AI<R.M#\67$4LS4J(](:0E1GRIDU=*^?46X12DHO\
M9]WTT';?ADOMZ[A\=O<9GZ[G3VJ:P9AF\ZRAY]<EV!-CFI+J5I>=6;:R)230
MHDGTDDE*)F*MD=H46P[A.]#;/=SCV*S,3U0<-RKH9$UI+3EA.5$BP?M4*4@U
MFVPM][H-1(4I*3,U*Z@1.R*+CP55F^\_V5N/7NF:F/KM/Q7B&7S7:?8661'%
ME/C-NMD<>(CI(O*:E$3B5N$?/@3?J]?K%K4=.Q'OKGXZ]0:#[A;!<2,\Q%;U
MOL"Q7X(9D(2J+"G/J,R4RM"D^0^9\)\$+/IX4DF887)S;)_=[=YNS<BS'&+"
M[U#NF9.GLSX24FMV)+F'.;=BK<-#:Y$%QU3+C2UIY2HU>!*0HQOAS>Z';F,>
M\'SC2VE] X];7$JKL9-CDF:SX7LS=9!E)9:D*]91J2TTE/6ZI9))2TM(;ZU*
M(@(BB^,BX(B+G@BX+D^3_P#$P4?T  4<]Z$BLV+WWZHU!O6]G8YHM%?#.K3&
MD%&9<>L69!%*6ZLC2WYLY"(SCA_:-H]*?%0+QN8IN_MHVWV#93'W[VU9-:6^
MN674)RFHF%[0N$R:R_T>T::)")4-PS-*7>E*VC,N32OI=4(FJ=6&;D<W+V\9
M[N_M/US1([@<N2S!R^J=5#8FQK:.TADW)#[Z6T2O(8X<C$Z9(67'47/6@$41
MXQW0/>!W6["UY=]W<.OP?6VJY93X^-0?96Y%Q*(VEK(VHCTC@G?*2EQQ:DDE
M/4EE!&I1D*Q&Y<<"JO[WF.7YMA_:W=NX6^_"1D%W7TF76492D.L4\M+WG<+3
MXI)YU#3"O$N4N&GX> 3;O0;JO=\8!M3MRU]N'MGSJT_&>U2Q;&7&F3&_9YMN
MPV1S8B%MDVN!):D$I+9]9H+A)*\%><1;B;N[+NYN/N7):?1'=!C42=N_5L^1
M,U]D.00V_;GID%"T2&G4/((VY\9LE*ZB(C<2GK/AQOJ61,/CM8_>:;1O]CZL
M@X/18AK7.IDBLB9![37+;KZ)Y'D*2F<V^;ZTO-<J<,XZGN5J)"4%TI2-BPWM
MSTC3]O.HL6U=43EVRJ9#LBXNG$]"ID^4X;TEXD<GT)ZE=*$\GPA*2,S/DS(F
M:MOW#]A%J+234Q4S[2/#?=K8*U=*7I"&U*:;4HO02E$1&8(>>3M(T#K3O4/=
MUAN7.L@;WV[9^WM2&Y#:'&HSR2(Y?LKR#\Y*'^6G&RZ2;03:$]'4DP7F:,OU
MSM':W8)LYWMZ[AF5YGV^98;L6#-D-JE0D5TI7DN3H"7"7RSTKXEPSYXY,TEU
M'RZ-Z?G<#;=T6 0-65/93K+&[75\&N\Z2J&=>N,XAU*O9HS<5Q^,:&.@_.\U
ME1FM2BY47B3A6*=+@]H';+M#%-@9WW*=Q-HQ-W7LB.<(Z6(MIQFL@J-DU)<6
MQRT;G3&:;0ELS2VVCCJ4:CZ29E8>"KY/OL16'I,EY$:-&0IV1(=42$-H074I
M2E*X(B(BY,S 1UUQW<=NFU[^?BN$[3J)^109CL)NIDK7"=F+:6:.N"<E+:9:
M%<=238-?*?$$T8+W@=G^(]T6(]:/9\?VAC\=98=F)H\#+Q7[#.Z"-2XZU&?!
M\&II1]:.>5H6(FBE;1-1@]-W+L:Y[\(MW*DXS!8Q?%8^0SW55-<\P9%":EK)
M9&<)3:ON"T.>0742EDIM1K26G=L6ZYC[L_M*RUMU=?AUGA$J07)S\=MI*3+D
MN"-#,Y4R.G^TWP"O%*4>E=)X!H+!*[7^NZHX-5#/S9T]\TKFV$M1$3DN8\E*
M?,=7P7H(DI(B2A*4$22$S5T.VNYG2.C;O&<>VAG<7&;;+#4=;%4V](4VRGE)
M2))1T.&PRI9="7%D235SX\)6:1$,]?1KK<^"S82GJ78NOLNAJC2_9WFIT"8P
MX1&9$XRI2>2\#(TGU)/@R,E$1@AYU.[KM7V%VF6-V>(W=[8]NVR9,=F>J')6
MWQY#OGLUMLE)&VI;9D9L.K0:5^G@E=209(FJS#2?:QV#=P&HL<R'!M>-VM:V
MP46?+=L["/>1)Z4$;S-DJ-*1]W29]7!D;9D9*;+RS2"LS,-P:4[!>W_1.?/;
M&Q2#;W-\VT;="WD$IF:Q4J5R2W824QVE$XI)]/6XI:DESTF7)\D3-4G=C[(P
MS4N&W.>Y]>,T&,T37F3)KW)J6H_!MEEM/*G'7%>JA"2,U'Z 0QW56^-0[MK3
MLM7Y[5Y6EM!+EU[#AM3XR3\.9$%\FY#1<^!&MLB/X.0317EWP]CUE>V3W<5V
MZLOT>U:-\K?(L=J#-AZR>8/S/C&N\O@T34&74I*?T;TE]V_128E&7W?.&]J^
MZWLSQ?=M"]EN_;F=)GNN9/-D&5A%,_,=5 -#C2O:$+)2WR6:G3+UTJZ.LD$W
M53MN?=<=J%G;UUG7TV1XY$A26GY%! N7G8<MMM74IAY4Y,J02%EX&;;R%?84
M1@CBE8'34U3CM36T-#6QJ>EIXS<.JJH;:68\>.RDD-M--H(DI2E)$1$1 J[(
M                !PK)F5(KI\>$\4>:_&=;B/F9I)#JD&2%<D1F7!F1\D0"
M)&C:^VQ^=C,N3A]YCT+%M<8K@N41W:E^.<F_:F*97Y2201RF89NK6N4CJ82A
MU2TNJ(G>DF7]U!C>1P<TP6),QRSJ9F!56<PL_O94)V-%GRKF[A2H1QY;B$IG
M%))IR3UMFLD__%-#JN@!O7;N 7>RL.>Q?']BWNK;%V4Q(3EF.K)N<A#)F:F2
M49EZKG/"O$$0A/AGN^\FUU2-XU@G=OLO$<?:><D-T]4IJ-'2ZZ?+BR;;61<J
M,O$P6XF.:D[4^Z;(L478;;[I=I:^RLK&6RB@AV\:P;.$VOB,_P"<Q)>3RZGQ
M-/5R7PD0$S#9W\C;;'\]W;O^U)_S@(JUCJGM3[IL@I+F5M;NEVE@5W&O9T2F
MJXEO&GHDU+1H]DF*<8DNI0IXC5R@S(T\>)$":PV=_(VVQ_/=V[_M2?\ . BK
M5&H^U;NOR*HR61MSN?VCKVW@Y',A8U7P[F-8)FTK3;)Q9ZUL2GB;6ZM3A&VH
MR473XI+D$S,-K_R-ML?SW=N_[4G_ #@(JU3JSM6[K[_Z;?C3[G]HX)\5Y'+A
M83[)<QIWQG2M\>S3W/(E.^4MSQY;5TJ+X4D":PVM_(VVQ_/=V[_M2?\ . BK
M6. =J?=-;W>Q8N?]TNTL2I*6]7$UU:1[>-+7<U)$?3,>;:DN*849\>HLDG^8
M":PV=_(VVQ_/=V[_ +4G_. BK6.$=J?=-:97LJOS?NEVEC&*4EC'9UK?L6\:
M4Y=0EH6;S[S+<EQ3!H422)*TI,^?0":PV=_(VVQ_/=V[_M2?\X"*M8X1VI]T
MUIE>RJ_-^Z7:6,8I26,=G6M^Q;QI3EU"6A9O/O,MR7%,&A1)(DK2DSY] )K#
M9W\C;;'\]W;O^U)_S@(JUCB':GW36.>;.J<O[I=I8[@=$]6)UCE3-O&D/7C;
M[+JIZGH[<E:X_L[B4)22T(ZNKDN> 36&SOY&VV/Y[NW?]J3_ )P$5:HQ_M6[
MKYFU\^Q_(.Y_:-1JBHAP',!SYNYC/2;:2\PRN8T[#1*4ZR3+JG$$:VT]73R7
M/()K#:_\C;;'\]W;O^U)_P X"*M4U':MW7R-O97CEOW/[1K]0U]1&DXIL-%S
M&<DS[%?D^?%7"3*-UM+?4YPI39$?3Z?$$UAM;^1MMC^>[MW_ &I/^<!%6L:_
MM3[IGMLW^/6'=+M*)J:)11Y=!GZ;>,N3+MEN(2]#5#*2;J$H0:E$LVR(^/2"
M:PV=_(VVQ_/=V[_M2?\ . BK6+':GW3+W!,QQ_NEVDUI]O%BGP]B%;QCE.7W
MM:&SKCA%)\TD>SFISS#;Z>2Z>KGP!-8;._D;;8_GN[=_VI/^<!%6L7^U/NF1
MN"'CC'=+M)W3[F+'/F;$.WC%*;OO:UME7%".3YIH]G)+GF$WT\GT]7/@":PV
M=_(VVQ_/=V[_ +4G_. BK6-AVI]TS.V:#'J_NEVE+U-+HI$N_P _5;QD28EL
MAQ:68:89R2=6E:"2HUDV9%SZ036&SOY&VV/Y[NW?]J3_ )P$5:QN>U/NFC;2
MPVAINZ7:5EJVRKISV99VNWC-R*V:TE1Q&&XBI*772>41$:DMJ)//B9 FL-G?
MR-ML?SW=N_[4G_. BK6.1]J?=-"V9KJCQSNEVE<ZSN6;16Q<V=MXS,BG<8C*
M77I9BKDI<?\ :'B)"C0A727B?!>()K#9W\C;;'\]W;O^U)_S@(JUCE_:GW35
MV>:QJ<0[I=I9%@=Z]9IV=E3UO&CO4;;#+2H"F8[DE"Y'M#BEI42$+Z>GD^.0
M36&SOY&VV/Y[NW?]J3_G 15JC.>U;NOJLWU?5X-W/[1RG"+Z9-;VAD\BYC17
M:*,TE@XCK,=V4VN0;IK=(R;2OIZ2YXY+DFL-K_R-ML?SW=N_[4G_ #@(JUCG
M_:GW35%WKJ+@'=+M++:2ZO41-BVDBWC1%TU29%U3&6W9+:GU$?/J()1_F FL
M-W8IVG[-QS*<:R&?WA;1R:#0VL.QFXW824JB6#45]#JXD@O,/EMY*30O_P I
MF"*IM@@       !J7>=-;7^K\AKJ: [;2B?K)DJH922W9D&%9194^*AL_!U3
MT5IULFS\'#5T?G@3#2=E2Y)D.N.Y6!08Y<1"V_8V\O7-1*KY%<M45&,U4"0E
M]B0ALX1S9L64I"9!-FX;G6HB-9F VGJ1F1,R?:F5Q*.QQS%,FL*KZ/UMI7O5
M+[KD&L9C2Y7L,A#3K9&I*&24XA)K\GE/+?EJ4):V[F^U-_N6.' LMPY/A>)-
MPFHUGA563;E=.?8D*D-RGVG%$1N),TD1\?G2 B:([[3[2NYC%M<W5AI_NHVE
MG6=5J(;>-89)M8]?'DH5*9:?2<A^0RVV34=3CA<K+DTDDN3/@$UAL&'V<[A<
MB17)G>OMR-+<90J5'3+0HFW#21K22B=,CX/DN0*L+V?VF=RM%@>16VL.[+:N
M<9Y#9;5CN*R[1B"S,<4\VEQ*Y#TAI".ELU*Y-9>CCX0*PRNG[/-TR:BKD7'>
MCMJNMY$-ARTKT36W$L25MI-UI*TNJ)1(69D1D9\@58IL_M,[E:+ \BMM8=V6
MU<XSR&RVK'<5EVC$%F8XIYM+B5R'I#2$=+9J5R:R]''P@5AE=/V>;IDU%7(N
M.]';5=;R(;#EI7HFMN)8DK;2;K25I=42B0LS(C(SY JQS8O:3W&4V$9)::Z[
MN-K9CF\*&IS&\8DV;$-J;))1$32Y#K[:&R,C,^5*("KLL/[0]]V6)8M8YAWB
M;8QW+9]1!DY3C[-@U(:@6+L="Y<5#S;RT.)9=-2"4E1DHBY(S JXV==HW<'4
MX;D]G@O=]M?*LR@UTA[&,;D6+,5J=-0@S986^Z^VALEJX(U*41%]D"I@O:-W
M!VV&XQ9YUW?;7Q7,IU='>R?&X]BS*:@S5H(WF$/M/N(<)"N2)25&1_9 J[')
M.T#>4+';^;C?>7MFZR*)72GJ"G=G-,HES6V5*CL*=6\E*"<<)*349D1<\F9
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M)UHT*2XE#GF*0:U<D1$LTIXY]8CX&/G7E.W/AI@VW5W73[)I[5^3>;9QYO\
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M\J92($O));+T2:RM1<MME;(:Z%*4DC4126E.*_ND@3:FIB7;EI3O%S3 .[G
MX^6:@:*W.=F=![-\6N74Z$9+1,@RX[O#9F^70Z^P9^;PK]#>ZE&16FQ:^"H
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M,SJ]@XI59=3,R(]?;$\3<>43?FMN1GW(SJ34RMUM9$XTHB6VM2%%PI"E),C
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M&\AQLU$M"D>@T*0M1#J[_<%7BV80L:R'';>IJK*6_7U^92"C)@ORHU6[</\
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M3<U^2B72QYK)/^T=+CK\QRPES7WY+KQN+<>6[RODN2Y(S,ALT
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MX=BSD<&QK5W>-9'<W=C7&]DSL_&*J'5-(;LR?2E+,EN"A3I&T9_=)"2Y)_E
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M_C"-#8:G_%S*H\/SD-I2Y[,RM;BFVNHCZ$FI1I3P1F?I!#L@
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MJ&XB<B/[5)4I?7(<84LFU>2GI;ZB42WX"
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M#!-D;-P746)6.<[%R.-C&,UG2E^?(ZE*6XOGH99:;)3CKB^#Z4-I-1^/AX&
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M(BM%@"4I0E*$EPE!$22_,+T A^@
M
M
M
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MAC(:&DOXS2V(UY C6$=EWCK0B2TEU*5=)F7)$K@^#!#MP
M                                    :"WUO.1HC'UY;+UCDF;XM7PW
MYN27M&Y7I:K&F5-I+ST3)4=Q77U^'EI5Z#YX!,15_,4WG*NWL/8RC65_K=S,
M7K8H17\NI+R8E5 8GG-<]FFO<M.DZ:$]/*DFA1N$E/"C%&=KV[J=MF7(<V?B
M2&(#45^<^JZ@$AEJ<23BN.*-[A*7R41MF?@ODNGGD$.\GYMAE5.I*NSRZEK;
M/)22>.5TJ?'9?L"5QT^R-+<)3W/)<=!& PC<VVX^GJ''K=>*6V:S\JR.#B]'
MCU*J,F4_.L$NFR1*EO,-$1FT9&9K+TD"8AQ<"WO@F=6N08[\8Q\:RBBR:SQ=
MO%K:9$:L)LBJ)!R'HD=+RENMEU\<D7YT^0*-A(S7#7,D7AB,MI5Y@TCS7,43
M/CG9)1T>9U'$)SSB+H];GI]'CZ 0^B,OQ-PH"F\HJ%IM+!VIK%)FL&4F>P:T
MNQ&>%^N\@VUDIM/*BZ3Y+P,!CR=NZG7!GV:-GXDNMJDQU6E@FZ@&Q&3+ZBCF
M\X3W2@G>E71U&75P?'/ %&(9!O2GI,ZU3B<6@G9%0;>=<BXUL>JD09%,4IN/
M*E^0I:9'FJ,V8JE$I#:D>)>MSR":-Y @
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M*W&J7J[VJ39JBJ9LHEJN:F',AG&?>43;J8*ED3A(41*3RDCY(B:-Q@@
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MWY3DY]U25.P$I41QF^&U&\3A<+,T*;2?4I8)N6]@J
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M9&%G>LOR;:^_!JI^\V@59P
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M#SS+?0IP_%2EFHS"T,%0
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M)3'G0ROVI,5TVE*)#K*R-*T*X4E7@HB,$3N2\!
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M5]-5QD]#,>+&03;32$_ E*4D1 J[8
M                       ?AQM#J%M.H2XVXDTN-J(C2I)EP9&1^!D9 /E%
MB183*8\*,U$CH,S0PRA+:",SY/A*2(O$P'(   !QI4.).:./-BLS&#,E&R^A
M+B.2]!]*B,O !]TI2A*4(22$((DH0DN"(B\"(B(!^@
M                                      '%EPH4]KR)T1F:P2B43+[:
M7$=1>@^E1&7/B Y)$22)*2(B(N"(O01 /Z   #BN08+TEF:[#8=F1RZ8\M;:
M5.H(^?!*S+DO2?H,!R@
M                !Q3@P52TSU0V%3D)Z$33;2;I)\?5)?'41>)^'(#E
M .+'@P8CLEZ+#8C/3%=<MUIM*%.JY,^I9I(C4?*C\3^R Y0
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ME=R:-+2U&.5-=0T%9&IJ2GCMQ*NJAM)9CQV&DDE#;3:")*4I(N"(B!#LP
M
M
M
M
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M(8KB$60N7%Q6G@T\:4X1)6ZW!CHCI6HBY(C42.3(%&2
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M#JJB!&JJNO:2Q K8;2&([#2"X2VTTV24H2DO B(N"!5S0
M
M
M
M
M  !H#(NU7MPRR]<R;(=*XE97C[OG2YRJUE!R'3/DUOH;)*'5&?I-9&9_"":M
MW5-14T%;"IJ*LB4M/6M)8KJJ RW&C1VD_:MM,M)2A"2^ DD1 AV(   -:;#T
MWJG;3,9C96OJ+-/82-,&1:0VGI$=)GR:69!EYK9&?I)*B(_A J^VO=1ZPU/#
MDP=;8%284Q--)SU54-IAV0:>>GSWDEYCO3SX=:CX^ "K8H
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M(HN4!4
M
M
M
M
M    'X;::91Y;+:6D<FKH01)+E1FI1\%]DS,S ?L    !^#::4XAU3:5.M$I
M+;ID1J22N.HB/TESP7(#]@    /PZTT\VMIYM+K3A=+C2R)25$?P&1^!@/V
M
M
M
M
M
A                                         /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>tm2227887d1-bc_cyto4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_cyto4c.jpg
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M 0 "$0,1 #\ W\
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MPKO17;QJ<>DTE<RF1VHY2)2R;;-U:9BS2G4^IDD_Z@(V6@0(
M
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M\N9>JF&+'?K%3N2EJJ)'6#BM%2I":8HTO.1Y*7U*6A6FJ%;-%%U\@)P6X!
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M*SZ^F.B8E*5J96Z@F'74J2V\A3:^NJ5;=?IDZDS&"T@(
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M+!
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M5M4EQ.BCU0I*O9!,Q@F@$
M
M
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M",_8T!$Q@N6"
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M +0TGJ7L$QIAO."@
M                             _FV]9%\]2+]S+:_WP7IU+O^M]^1+&?P
MX3[FS 12L7ZN+YF.&_XP_P"D53!%6M=\$ "NW+3)E2P_QRRQD&BOG$K5'HY1
MJ)-21FIB;4Y#5.C/)(O9;=DI66O34NO0$PQ8X&X^XS':-\9IY0U.W7HCE=][
M5G4^Z)/M3LEJ.U+J#Z8IJ-4I>DQDM=JNWU4>AJ(R+3BNKQMX>XE@9R7R,X^Y
M^I]5L>GU*5X3']$CIF-Q8LUA3;M.ES%3E.D7GFI"7&"4DB0?G&6X$3+5L%0
M
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M$E[B+0U'L_XI F=,-W 4
M
M
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MY$A50JM>IU'4KRK0S3XJY!$7T"4J8>NGEV]?(0)J;(@J
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M.)2CUZ>4%'<@
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M]%X*
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M!_0<"@
M
M
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M[D(U+H"*FQP*@
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M$!!MP:5%9APVS/4TM,()M!:_L)20*/O
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M!,X0WE!0
M                         8,>M&P]EO(.?[0K-A8MNZ]Z/&Q]3X4FJT"B
M3ZE&;DHJM6<4PMZ*RXA*TH<0HTF>I$I)Z:&0+TRFWUJN";TR- Q+>N/+)K=Z
MUNBR*A1*W M^G2:G**+)2W)C.N-16W%I;;6TZ6XRTU<(O*9 BF3BC@B]+"X#
M<B(5:LFMTO(N3J%>*HMIRZ=)8J[B&Z.]3X$4H*VR?-;CJ7%-IV:J[A;2/4M1
M,Z7Q^J>QEDG'/Q^?&%CZY;$],^];T1[XJ3,I?BO#^E^]V/%M-=SM]U&[;KMW
M)U\I 5/+YR<%LA5G(:^1/'5IV3<[TAFJ7/:\%XHU1:J40TJ14Z8M2TDM:MA*
M6VDR7O+<C>:S)(B4$2.9?K&I5"=QP6+ZJS=2FO#NW*S9523<)$HNUN)LB\*E
M1G^V**1Z^0P3A"POJ^N#]\6#>"L^YQ@KI=U-M24V;:TQPGYS+\U)HD5&<9&L
MDN*;6M"$&HUEN4I9)42015*//6FXCRMD++^/*G8.,;LOBFPK.3%F5"WZ+.J;
M#+_I"4OM..167$I7M41[3/70R,$TRVWMUIUBWZ$R\VIEYFGQ4.M+(TJ2I+22
M-*B/J1D?E(%'L    I)ZPVU+IO7BQ>UO6;;55NVORZA15Q:'18;\^8ZEJHL+
M<4AB.AQQ1)21J,R+H1:F":=;CO5F65>5A<<YU#OFTJU9=:7>-3E(H]=@2*=*
M-AR/#2ATF9+;:]BC29$K30]#^@":FA@*L[?6@6!)O3BU5*Q!CG(EXZKU.N-:
M4(W.>&]LI\C30M=J43.XOV-$:GY 6IUNO]7+=[%V\1\:MH>2[-M1=2H%30DR
M]K<BS77&4GI[/AG6E?[H(JUJM\\>"M[WK>_Z0. 6E2+R<./)NRUHSY19CDR"
ME),5.FNJ6A/=)+:"6V1I4:DDM&Y:E$"8E78^9GK&XU$<QR[B^J*NSPY,)N15
ME5([A27]A)U+24^%4HU>11Q3U4"<(3CP&X/Y"MK(!<A<^07J97XJI4FT[8J+
MA/5)RH3"-+M3J'5>Q1)<<V(6?<WGW%$G:G<1,K=\X^(S?*&Q:8];TJ/2LFV0
M;[UIS91FF/,8?)/B*?(6G7:3AH2I"]#V*+V$K48(B<&7=C9U]81Q3HT?%$K%
M=1KM'I*CI]M1Z_;\ZK,QB49[&:?4*:ZVA]!'KVT]UQ)%YJ2VD1$6PB7ZXPXG
M\F>8F9(^4^2%,K%LVBX]'>K]1KD8Z5)E0(ZR-NF4J I*'&D+1J1.=LD$1J<W
M+</SQC$-*/6+6+<MV<7)EJ8^L^J7/4F*Y1O VY;\!^=(3&CK41]N-%;6LD-I
MT\B="(%:=;+C V3.??'6R'; L#CE<SU">J<BK+75K%KTF1XB2AIM9$MLFBVZ
M-)T+;]'J"TX2GBE<OO642:G3H\WCC4F83\IEN6\>/[A02&E+(EJW&O0M",SU
M,#"'(^LDI7([,F:_>K:V(;^K^,L<Q&(]ORZ1;U4ET^=.F,-R)LU#S,=2'%)-
M91R,C,B[9Z:;E:BE'>*,K^L(PK9%*Q[CSCW<=&MRDFXMML\=U1Q]]YY6]U^0
M\J/N=<6?E4KV")):)2DB$X-@.%N0<\9)Q;7J[R&M>=:5Z1+JE0*73:A17Z$Z
MNEMP8+K3I1I"$*4DWG7D[R+0S(T_M3!669&.(2LZ>M9NVYH;?CJ)8E>J-0J4
MHBU2EFV82*-%=29%H9'+;8T/V2/4%N!OF"@
M
M
M
M
M                      #_ "I*5I4A:26A9&E:%%J1D?0R,C 9+<<L*9(X
MJ\R\A6O1+)K%3P!E>(IVD75!C.OP*:I"G9=/;EO((R0J.HWXNBNNBT.'HE0+
M3.,-:P5             '_#/0C,]="+4]"U/_P A ,D^/.$,D97YEY,Y39BL
MFK6;0[>F.-XOH5=BN17I!FR<&"\EAXB,DQH:-ZCVE[>M*D]4J!:9T-;05
M
M
M                                                           !
MXMR6]1[NMZN6K<,%%2H-R0)%,K-/=^D?BRFU-/-G_P#5(49 ,UN!^)<Q\;<C
MYKPQ==KU&5BN=-],V'D(DMG!D/,FEGSC0K4G)45;1J+31"V5(_JEITM0P5
M           $?97K]T6OC:]:]9%NRKLO*GTJ0JU;?AH2X[)J*T]N*1I49%L2
MXI*E_002CZ^0!23U=/&6XL)6'<U\Y+ICM/RGDN::JE"EF2Y4&FQ5K[+3IZJT
M<?=4MY>BNJ3;(_.28+52T<!4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1G59%@E!5/JTJ(N)'EHG&^2%Q">-+RDI-@R4;C:/*6A&1Z@B8P6.!
M
M
M
M
M
M
M
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M)IU/M^Y6'6)<F(TVTXS-23K+.J'2<,O-)224E224K34%9A.((
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M3>=C5Z+<UKUQHW:76(:C4TXE*C0HM#(E)4A232I*B)25$9*(C+0$.J
M
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MD716X;1ONT9I3L>6II/TSC3$EMI;B$ZEN4@C(M2U,M2!."<P0
M
M
M
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M!
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MU^[)E]5F@TYB%4+OJ#;;,JH.,IV]YU#>I$HR+V34H_*I2E:J,J[
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M)0DC4HB+4_*8#[VW$.H0ZTM+C;B24VXDR-*DF6I&1ET,C(!_L
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M+7J1@/H
M
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MBSJ54&Y=;>CORS=EQWE+(UQH\9&TC+IYFO[)@G'&']$P*
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M-3H$]EN3!FL+)QIYEU)+;<;6DS)25),C(RZ&0*OJ
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MTS"/T3&E2X_<:7'<4K5Q1[M%EJ7T 5B4*^J"^1+)GPX5[FPP34UJ!4
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M:9JU6DRZ: .OCJ<5'84ZP49U3:3<C$HE$VHR+5&XNA[3Z:D _8
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MQ>D2E4ZPKBI\8I:FV7XSK%<[4TDM$B/W"<W-FLT+09)5J6XB,%NP0
M         C+&#D=R)>/AL6+Q42+LJJ78;C$%@ZTX2T;JX105*2OQA]=[A]P]
MOG:EH9A)H
M
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M]YVX=J^-C_%R5'*650\%V"\1Z5\09M=WO:[.SYNSR^< [0
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MD9*T,!W$4E%&CDN1XM1-()4O1)=T]I:KT1HDMWEZ= '[@
M                 .=N2T+3O&*Q!N^UZ1=4**[WXT.L0F)S3;NTT]Q")"%I
M2K:HRU(M=# >N=/@*@'2E0HYTPX_A3IQMI[!L;=G:[6FW9M\W;IIIT <):^'
ML26157:[9>+;1M"MO)4AZLT6B0*?+6E?TZ5/QF6UF2M>I&?4#%[UV619=^TY
M%'OFT*)>E);=)YNEUVGQJC&2ZGR+)J4VX@E%[!Z:@/KMRU[9LZDQZ!:-NTRU
M:%#-1Q*+1XC,&(T:SU5L8CH0A.I]3T(!R]2Q!B6M7*W>=8Q=:-6O!EQMYF[)
ME$@/U)#C/]C6F8XRIXE(_:F2NGL 8N[FPH=2ARJ?48C,^!.:6Q-@R6TNLO-.
M$:5MN-K(TJ2HCT,C+0R <=:&+<98^?FR;"QS;%D2:BDD5"10*1"IJWTD>XDN
MJBM-FLB/KHH!W8#$+U-?^L=_%#_#8+U-O04                <-;M,NZ)=
M]_3ZW?$>X;:JCU.59UHM4]F,[04-1MLI#LIM:G)7B7?;2-Q);"\U.I>0.Y
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MN ,G*USYTOF_<GR[EO.[FHS6$:V\A4?WJ-Q'"E,M=MGS=J7DDUN:(C-O>O\
MLKBC(MM+?*M')U+Q=9=K,YB;8OBA/49FX<D3Z3'?.K,1I#?BVE17G30AR6T1
MM[R4:MQ[B,E'J1":00                X2PJ7>%+C7*B\KZCWY(EW%4)5"
MDQZ<S3BIM+<4GPM+6EA:R>7&(C(W5:*5KYQ= '=@
M
M
M         #$+-O\ 2OXB_O!]BO@O&IMZ"@               "'LM.V(U*Q8
M5[WY4K(><OFEILUBG5%ZGE6:T:7?"TN431'XAA_SMS2]$J,DD9^0C)A,((
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MB($/]@                                     "+,Z?(EF+X#W#[FR
M(9T>J"^1+)GPX5[FPP6J:U J                B"PG,?JR)F5%K734:U=R
M*E2OC$H4N7*?C4J2<!)1&XK+Y$TREU@B6HFC,C/Z;R$1$I?!
M   (:SZK'",85E66+IGV98Y3*9Z2K]-FRZ?(;=\>QX9"7X7MQ$X]L0K0O(9Z
MZ?3$3"900                AK'2L<*O[,Y6==,^N7658@'DBC2ILN2Q2YO
M@DE':C,R/:V4K:+<HFC,M>AZ;22DE,H(
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MG:6B#071.TNFGL /I
M  8A>IK_ -8[^*'^&P7J;>@H          #SIE8I%/=2S/JD."\I)+2U(?;:
M4:3,R)1$M1'IJ1]0'R>^>V_QAIG[[9_=@'OGMO\ &&F?OMG]V >^>V_QAIG[
M[9_=@(<L:X\.EE/-3EMTHZ!>3C]!+(-VRVU1H==6F"HH*H4AUPVY!1F=6W#;
M26U1^=KKJ9*8_?/;?XPTS]]L_NP0>^>V_P 8:9^^V?W8![Y[;_&&F?OMG]V
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MNABJ0)$!52K6]LIM2CE(-1O,OF2=CB/,/;H1%M,B)E,@(
M
M
M              &(6;?Z5_$7]X/L5\%XU-O04                <%?,ZXX
M3UE)M_'C-_MS+EA,5Y]Z?%@^@H"DN=ZL(*2E1OKC]")IK1Q6X]IEH8#O0
M             '!6%.N.<W=IW'CQG'BXMS5&/1FV9\6?Z9IZ#1V*RLXJ4]E4
MO4S-IS5Q&WSC/4@'>@               X*\YUQQ*I8C5#QXS?$2;74-7!5G
M9\6&=O0S9<UJ;;<A*ER%)5HWVV=%Z*,]=",!WH
M                      "+,Z?(EF+X#W#[FR (9T>J"^1+)GPX5[FPP6J:
MU J                XFW*E=LNYK[AUVS(]O6_39D-%GW(U/:DN5MER*A4A
MYV.A"5QC9=U:(EF9J(M2Z>4.V               !PV1ZA>%+M*=,L.RX>0+
ME0_$3#M:=/;IC#S:Y+:7W%276W4)[+1J=(C3U-.A=3(!W(
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M:MZWFHBD5"/4$*4<IYZ4:C2M"TFDDI)/3_?#M              !#^=,RT+
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MR10X,VF4N[(?BXE.J+9-2V")Q;:FWD$:B)25(,CT,R^@9EU!5(0
M                           #$+U-?^L=_%#_  V"]3;T%
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MJ924(H)J3X!$WQ1ZG+).[NFW[7KIM^B [<
M
M
M    8A9M_I7\1?W@^Q7P7C4V]!0               !&^1(,J8]8"XV35XW*
M'=M/??8240TW"VE+NZAGXK0_[9+K[4>_S?-+V2"2                 $<X
MYARH:+W\5DM62_$W=5'XZU%$+T$TI2"*A%X3R^#,C+VWVSSO.]@!(P
M    @+DUANJ9[Q!7\9T:Z_>54*S)@/M7#V5O]HH<IN0I.QMUE1[R1M^F]D$Q
M.#+_ /5-9)_G,_P7,_Q@"VT?JFLD_P YG^"YG^, -H_5-9)_G,_P7,_Q@!M/
M-G^JRO*E.TYBI\K8=.?K$DH5(9E0I#*Y4E25+)AA*ZD1N+-*%*VIU/0C/3H!
MM/2_5-9)_G,_P7,_Q@!M'ZIK)/\ .9_@N9_C #:/U362?YS/\%S/\8 ;1^J:
MR3_.9_@N9_C #:/U362?YS/\%S/\8 ;1^J:R3_.9_@N9_C #:/U362?YS/\
M!<S_ !@!M'ZIK)/\YG^"YG^, -H_5-9)_G,_P7,_Q@!M-7, XQJ&&L063C.J
MW#[ZZA:D9]B3</;6SXDWI3T@E;%N.J+0G23U4?D!64P@@
M               $69T^1+,7P'N'W-D 0SH]4%\B63/APKW-A@M4UJ!4
M           !&]HL1FKTR<ZSDQV\'7YM.\39#DB(ZFUE%#3I'2VP1.M>*(R?
MT>ZGJ1IZ=3"2                1EF!J,]854;EY3<PPP<F":L@-/PHRHIE
M+:-+7=J"5,%X@]&=#ZGNT+770Q"30                $964U&1>&4%LY3<
MOE]RIPSE68M^$ZFU3*(G;#)N,DG6N^1]W1_SC+0R]E2@DT
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M+&'Q[WXNE,3DY:7;%&1=LAQ,\H:J2V](5!2TIS^U#62W%[B;\[Z/[8$IH!
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M26TE)>9;-IM;A$6]2&U+<-*3/J1&I6GDU/R@J_8
M               !B%ZFO_6._BA_AL%ZFWH*                (8L25C5[
M*V;F+5N2HU6_8S] +)U"DR9SL.F.*@*]')B-2"*,UWF"-;GAS/4].YU))$2F
M<$               AK.;F.&[0I:LH7'4+8MX[EHB(-0IK\R.\NIKF-I@,*5
M"2IPT.O&E*R,MFG59D1:D3"900                AC"LK&LJ!D(\:7)4;E
MBL7W7&;O<J4F=)7#N!#B/2$)HYY$M#32MNQ+>K?75)GJ9@F4S@@
M
M
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MU&KW5?%$LF'5+VO=VGIATR55&&XK,YIK:EGVQ3SJU^:RAK0C[>J= 1,+O @
M  !%&*'+<6UD)-N8QJ&,4,WM5VJRU4*8U3"KM02;7?KL8FE**0Q,Z;'ST->T
M^G0$I7!               (FR2[;;5>Q65=Q=4,A2W;G0W0*Y!I;511;,LV'
M#35)+KBB5%:3IL-U.NAF7LZ E+((
M            19G3Y$LQ? >X?<V0!#.CU07R)9,^'"O<V&"U36H%0
M        $96<[257QE-N#C*59U0:G4[TQ>[T&+':NE:H2>W(9D,J4Y(**@NR
M9ND1I/S2]D!)H               (NS([2&,?U5RNXME9FIA28!/X]AP(E3=
MEF<QDD.%%FJ0RLHZM'C-1^:2-WL 0E$                !%]D/TEV\<I-P
M,72K'G,52&FKWC(@1(K=TN'%2:)C,B.I3DE+*=&MSO5/TOEU(@E
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MXY9I4%RVZRS(=54WJDMQXIC4A@TDVEM"";-!D>O7V=3) =H
M  #D+]E7O"L^O2L;TNEUJ^&8^ZW:76GW(T!Y_>DC)]UHE*21)W&6GE/0M2UU
M(.J8-Y3#*I*$M2%(2;[:%;DI69><25&1:D1^0] 'Z@
M                          ,0O4U_ZQW\4/\ #8+U-O04
M    <1;]1O.3=M]0:]:,*B6K37*>5E7-'J"9+]92['-4Q4B*32%1CCN$3:24
MI6_J9="ZAVX               .,ONHWE3*-&D6-:D.\:PJIP&I-*G3TTYMN
M$Y(0F3)2\IMPC4PWJX2--5:=.NA&'9@                .(L>HWG48]QJO
M6T85GOQ+@GQK>9@U!-0*?26U)\)4'5)::[+CY&9J:/4TZ=3ZZ$';@
M                                  "*LJYPQ/A&DLUG*5\4ZT8LK?X!
MB2I3LN5VRU7X>(PEQ][;TUV(/34M?*0&#.^[O6Z85I,V3%M#']U7>RQJ3=2D
M'%I;#RB+H;9+6^Z23^BMM)_\D%MEP7ZXRV_R#U/[_L_:(&R?KC+;_(/4_O\
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MXRV_R#U/[_L_:(&R?KC+;_(/4_O^S]H@;)^N,MO\@]3^_P"S]H@;)^N,MO\
M(/4_O^S]H@;)^N,MO\@]3^_[/VB!LGZXRV_R#U/[_L_:(&R?KC+;_(/4_O\
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M?U0,)6\I-7I->IL.L4*IQ*U2*@V3T"JP'FY,9]L_(MIYI2D+2?T2,$/1
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MUR3<$Z1:BZ7#7#*+1'#1X*+));CG=?;T5O<+0E:ETZ:F'9@
M  XRZH-]RZC9SMG5ZET:F0JPEZ^(M1A+ENSJ632R5'B+0ZV3+IK-)DLR5_\
M2-*@[,                           $-98Y"88P?%1)RCD*E6L\\CNQ:0
MXM4BHOH,]-[,",EV2M.O0U);VE[)D"<%*Y_K9.,4.>F)'HU^56.:B2=4BTJ$
ME@B,]-QID5!EW0BZ]&]?V->@)V93KBWGGQ?RQ+CTJC9&9MRNRC(F*)<[2Z2X
MI2BU)"'W_P"UEJ,RT)*'C,S\A=2U(PE<,C)1$I)D9&6I&7D,@0_Z
M   "+,Z?(EF+X#W#[FR (9T>J"^1+)GPX5[FPP6J:U J
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ME=R!E"7=U56]1RKF/7I\60Q:JDPS)E#$5E"78WC4>W*[IGO,MR?9 2B
M          "+\N(H[EL045O)LS$\-5=I)-W)!FQX#K[WBV^U3S>DI6DTREZ-
MJ2751&9>34!*                 "+<5HHJ(E[%1<HS,IH.\*L=1E3)\6>J
MB2S6CO4-M45"":1#/0DM.:K1NZGIIH$I
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M]BV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_<
M'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< 'O8MO\7J9^]&?W
M ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G
M]P >]BV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T
M9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< 'O8MO\7J9^
M]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF
M?O1G]P >]BV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>
MIG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< 'O8MO\
M7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;
M_%ZF?O1G]P >]BV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]B
MV_Q>IG[T9_< 'O8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< 'O
M8MO\7J9^]&?W ![V+;_%ZF?O1G]P >]BV_Q>IG[T9_< .8N/$>*[PB28-TXW
MMBX8LM&R0U/I,1_4B(R+0UM&9&G7H9'J7L: 8LT^0WJP+7J24WMQDGKQM?%(
M<3,BVN[,D>CY#S2NXE<26M:WX3Y*ZI,E&WJ1$1-_3 M%3C>.7/3)^.+[IG'S
MF%0I=*K)26J7 O\ J*"C3(RW%=M@ZIY&I#"ST(I;9^3SUFX1J<2)CB;0@J *
M@\F>-UZ<CZA;ENN9AJ>/L0Q8KOORM2BM?VW6I*W2-"7'3-*";2@NA.$XG=U[
M>O4$Q.#E[.]7%Q(M&,RV]CEV[IK1%OJMP5*9)<<T_P",RRZQ&_\ (R0&U+FL
MS<6?5^V%0H=4RG95 QY3*G)*!3*PU.J-.-4G8MTD(.*^1*5M2H_.29=/V"!,
M3+Z<.\)EX#R5;UZ80S-<,/&=0<6[>N,*TI$R)48[T=PFG&'FT-I2M"S;4DU-
M&O0C+N^P8F<6@0*@           ,0LV_TK^(O[P?8KX+QJ;>@H
M      A;,;&+GI.)%9,BU"2\SD"D+QT<%-24ENY20_X%<CT?T)HBW[CD>T_\
M?H"832"                $+X7;QDAG)RL9,5%AM_(5=<OOTBFHI4JY34T5
M24SZ1Z]HS)&WL^T^79[()E- (              !"V5VL7+N3#2\A1Z@]6VK
MP;/&:H15(T-ULXKY(5(.#[63?:WZ^(]K^CTW E-((
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MNUEFX[?H5PQV'HL>NT^+46(TA"FWFT2FDNI0XA1$I*DDK0R,B,C!5[
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M9E17DVYX;F-2I=-:HM/5'RGW8AG55]QTSIYMH+Q)%&W&HC6>WSCVZ:]2B1
M              <)DV1+B6%<TB#C\LIRVXNK&/E+C-E5#-:2[)JF$;)$1'N/
M>1^3H1GH [2*:CC1S7'\(HVD&J)JD^T>TM4:HU2>WR=.@#]P
M             !X-&M6V;=D5B70+>IM$EW#,<J-?EP8K4=V=+>/<Y(DK;2E3
MKBC/JI9F8#W@%&*URFO"F<XK1XN-6]1W+0N&DNU"3<*RD>DD+12)M1)*#)TF
M=-\9*>J/I3/V>H)PT+F0;:MVEUBLW!3:%3Z?7;B1&;N"LQHS34J<F'W?#E)=
M0DE.]KO.;-QGMW'IY00]L            !B%ZFO_ %COXH?X;!>IMZ"@
M           "-;5>87?^4&F\7N6B\R[2._D-3,)M%UFJ(9I6EQA1R'/ E[2?
M?+IKHCIJ1!)0               (VRH\VQ;<)QW&*LL(36Z7_P#-I#41XV%>
M+;V5$D3?,_M-6CNJ?/3IN3IIJ022                 C3&3[+T2\.QBYW%
MA-775&UPW683)UE9+1NK9%!4I*BF&>NYP^X>WSM2T,PDL
M                        %=^4F?J/QNP]<&19[:)M8U33+,HSFNV;6)*%
MG':5H9'L02%.N:&1]M"M/.T(R8C%GAZMWCW7;KKM<Y@Y?[U6N>ZIDQVPUSTE
MW'')*UIG5@TZ%IO,U,L:$1$G>9%M-LP35/ V7!4
M
M  !0OGWQ91R(Q6NL6Q )W*F/&GI]I&TDN[48QENE4M1^SW23N9U\CI$6J4K6
M8)B<%9.-/*BK97X<9]QO<%0E-Y<Q!C.XRI\\C6F9-IK5+D-PY25%Y_?C.$EE
MP_+KVUZFI:M"9C2V/!4  &2OK??D2QG\.$^YLP%J6IUL?@W;WW,B?44 J]P
M           !B%FW^E?Q%_>#[%?!>-3;T%           0AR/QC<F9,,7EC>
MT+I]Y=Q7'Z.]'W-N>3X;P=1C3'.L=27/;&V%(\T_VW7IJ"898_JR.2/\Z/\
M^/6/KP+;4'ZLCDC_ #H__CUCZ\!M0?JR.2/\Z/\ ^/6/KP&U#QZMZM/E3%52
MRI'(QNK)E3VF*HIRHU>-X2(HE&Y)21K7W31H1$V6AGKY2 VH>Q^K(Y(_SH__
M (]8^O ;4'ZLCDC_ #H__CUCZ\!M0?JR.2/\Z/\ ^/6/KP&U!^K(Y(_SH_\
MX]8^O ;4'ZLCDC_.C_\ CUCZ\!M0?JR.2/\ .C_^/6/KP&U!^K(Y(_SH_P#X
M]8^O ;4'ZLCDC_.C_P#CUCZ\!M0?JR.2/\Z/_P"/6/KP&U!^K(Y(_P Z/_X]
M8^O ;4'ZLCDC_.C_ /CUCZ\!M0?JR.2/\Z/_ ./6/KP&U!^K(Y(_SH__ (]8
M^O ;4/'I'JT^5,OTGZ7Y%HH_AJ@_'IA(J-6D^*AHT[4I6U:.V;FI^UGJ:=/*
M!M0]C]61R1_G1_\ QZQ]> VH/U9')'^='_\ 'K'UX#:@_5D<D?YT?_QZQ]>
MVH/U9')'^='_ /'K'UX#:@_5D<D?YT?_ ,>L?7@-J#]61R1_G1__ !ZQ]> V
MH/U9')'^='_\>L?7@-J#]61R1_G1_P#QZQ]> VH3?QPX+9MPWF>S<D7?GOWZ
M6[;GI'TA;/=J2O$^,ITF&WTD.J;]K<?2OSB_:].N@(F6IP*@  XF[)>0(U3L
MMNRZ/1ZI29=82U?LBJ2G8ST2E=I9J>A);;63KQ.$DB2K0C\G37<D.V
M                        &//#[^D.YC_WZ]W(P+3J;# J
MBS.GR)9B^ ]P^YL@"&='J@OD2R9\.%>YL,%JFM0*@               .-H#
MM_+N2]6[GB4-BTF9,0L>R*:[(74'HYQR.6=20ZDFT*2_J3?:,R-/TW7RAV0
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M\FV8OA+ ^PS!-388%0       &(7KE/]7'^-_P#@0%Z6WH*
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M0MIU"7&W$FEQM1$:5),M#(R/H9&0#_NU)J)9I(UI(TI7IU(CT,R(_P!G0@'
MTZ#6F\E7-4'\BHJ5!DT6G,P,8%%BH72WVW'S=J!R4*-]9224222M))+9T-70
MDA(                .&R5!K52L2Y8-NWZC%]9D1-(5_.18\U%+,EI-3RF)
M:D,K+:1I\Y1::ZD9&1 .SCI<3'82Z^4EU+:2<DDDDDXHB+5>TNA;CZZ$ _8
M                         4ER?ZP'CMB*_+BQS>52KK%S6N\VQ56HE+<?
M9);K+;Z=CA*(E>8XD$X.#_6D\3__ !>Y?O*[^[!.S*G%B9GLC/7K1L5Y!Q\_
M,D6Y)HM0@M.SHZHKO=BVS54N$;:C,]-3Z&"<,(;N@H             ,0O4U
M_P"L=_%#_#8+U-O04                <';M/N>+>60)M7R"S<M J+E-.U[
M(;I\:,Y;B6HQIDH<EM+4]*\6LR=(WDIV?2IU28#O                <-D&
MGW-4J'%CVI?K..:DFJTYU^O/T^/4DO1D24&]!)F2XVA*I:?:261[D[M4ENT
M=R                 X*P(%S4^/="+GR$QD1Z3<E1D4B2Q3XU/]$T]:T]BC
MK3&6LGEQ-#2;J]%KU\Y): .]
M   !B)ZTNI5B_LR\=./U,DE';KJF9B6TD:S7,KU1*E17%MIU4?:[#FW3R[U$
M"]+:"VK>I5I6Y0;5H<<HE%MJG1:728I:>UQH;266D]"(NB$$7D!1[8
M
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MJY)JN24MWQ64W"[5:F5351*IN;.31(QDA'AV(FJ>VQUV$KZ8]0$L@
M        B3)9VD5?Q3[Y,FU2P)_OH1[UZ+3JHFG,W'.[#A)IDUI2%>*941[N
MUJG59)ZZZ$9*6P0                          #%VY_589$K]R7#76>1_
M@F:U4Y<]J'Z,EJ[*9+RW2;U*>1'M)6FNA MM/$_5-9)_G,_P7,_Q@"=I:CAW
MP:K?%Z_[LO>KY,CWTJYZ&JDJC-TYV(XA:I3,@WE.N27MW]BTTT]GR@B9Q:*@
MJ            BS.GR)9B^ ]P^YL@"&='J@OD2R9\.%>YL,%JFM0*@
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M_P "L?60-F#]9OR1_FN?_ K'UD#9@_6;\D?YKG_P*Q]9 V8/UF_)'^:Y_P#
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M4=A46/V6^Q&4@VU-HVEM0:#ZI-)=-/8 ?4
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MY)>2T3A]LDK?-M+9^::C4M)^:"9ALD"H
M      ,0.5R2G>L[XV,2]7V8IV:<9M1GHCM5F6^C;]#1SSOZH+QJ;?@H
M
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M*:O)4_&I8U4U=53:C-=V$Z=;92I&RN'X(S))S/*:7?;"V^=[!@)#
M       !'=\3*C&J^/6X6-/?ZS*KZ&Y]:[T)OWMM]AW_ .5"3*/>LTZFC1GS
M]%'U]A02(                           "I/.:_;WQKQ?R9=F/9DBEW)%
M:@Q&JS%U[\*/.G,19$AI2>J%I;=425EU09[RT-.H)C6S-L7U:N6\H65:61:M
MR5-J7>]'A5SLFS/J2D-SV$2&TJE+F-&XHD+(E'MTUUT,RZ@MM+P<0>%=U\9K
MWN:[*_EOXP8U?H9TEFF>#?C=A9R67^]N=E/D?1HTZ$1>7R@B9Q:$ J
M      BS.GR)9B^ ]P^YL@"&='J@OD2R9\.%>YL,%JFM0*@
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M#D"?R!]\$*SJY#JTJB>CI3?BT172<4SO7.6E.XBTU-)_U 1-37@%0
M           9@^M1H%R5O#5@.1GYD:PJ;>D1S)$J&VIWPD1YIQEB8\V@C,VV
MEK474]-ZD=-=NA:ER]!]6]PFKE(@5.CY)KU?@266U,U:-<M,<0^2D$HEZM1-
MNJB,CT(B\OD VI74XV\=L4\=Z)<M&Q35:A5:?<4YJ;5G*A.8G*0\TUVT$E3#
M31)+;[!D8(F<5D@0        Q"]<I_JX_P ;_P# @+TMO04
M   <K>[-YOVG76<>3*33[V<C&5N3*ZT\_3FY&I:'(;CJ2X:=-?I3\NAZ'Y '
M0PREE$BE4%LN3R904UR.E2&5/;2[AMI6I2B2:M=",S/3V3 ?2
M    #BX+&0$WW77ZC.H;F-W*9$3;=/89?35VZBE2O%+DNJ4;*FE)-.PDEK]'
M]D.T               !R=]-7N_:5<9QQ+H\"]W(Y%;LROM//4UM[>G4Y#<=
M27#3LW:;3\NGE+H Z=CODPR4DT*DDA/B%-$9(->GG&DE&9D6ODU,!^H
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M:;\LI)%H7D,NGE&GS&\+ENY-$4Q.#Z7N;N;DLYD+>:NW:Z9KQU888Q,QQ3/
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MEQ7>K<MK=.:ILVJIJB:(JG'#'&9F,-$1P1"T0]CF@
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ML6+3Z\EZMT<XD22=Q1B8=UIB5R3)3)J/VS>T1KT2>A?MDA(
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MJ#%X9'D2LDE=T27,@'!LOM1$';))B%NCFICVU7B=2>]N+7_B]#U 2&
M         ".LJQITNR:DQ3LF%B&6N1"[=^&W"=\*7BFM6ME0(V#.07M);O97
MTU/H8A(H                ".;0BS6+LR2[)R;[]6)%1B*AVAVX2#MA)14F
M<0SC$3JN_KW2-XMVAEIKU4H)&                               !F+Z
MTV5>9X:L*@T*J.T.TKJO2)2[]JZ%+0RVPZRYX9,Q2#+^U^YJM9*\TU(1[.FI
M:E%$#U/F/E0XZI6;*]-?6@E+EQ:9$:9<)74E(0IUXR(RT_;F!M+S<5>*MO\
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M$* FC4A-+<6]3$PHY4YUU3BUJ8)M/:4I3IFXHS3IJ:_./V>H#TP
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MF[,/UNAS,BTGQOO=CP[O.J/*[\)]B3LA^,=[FD=QPS\T]I>=[&H*S,K]@@
M           8A>IK_P!8[^*'^&P7J;>@H                A>PWL;.96S<
MW:EPU.J7XQ(H!9-HLN14'8=-<. HZ<F&W)(HS9.L:J7X8SU/^R:&1$1*: 0
M        /S>>9CM./R'4,,-)-3KSBB2A*2\IJ4>A$1 /']\]M_C#3/WVS^[
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M=[VZ+,@4U6YYVEIFO[I4QOIKHLRW*_8("(C!]QGZWXB,R*VE&1=$E[V-3_\
M*!H?/9?/G.^%,@TG&W-C&[=M0JN9)8OF!&)IQE)JV'*6F*Y(B36$JT)9Q32:
M"U/19^:8PXFP\27%GQ8TZ%(;EPIK2'XDIE1+;=:<22D+0HM2-*B,C(R!5]
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MFRL^KT^EG4&K?J!1W5IJ,QW<GPS24I,NYUT5M/3IJ1*7P0
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M9[ZKTFTI,*'<SIPD]B1!EDM1S$1F_:EJ,D[%ZEUU,P2E<$
M B7-Y6H>.*P5ZXSJF7;=.3 *78=&IB:Q,E+.8SVG$0UK;):6'-KJSW%M2E2N
MNF@)A+0(                1+8)6HF]<N)H.,ZI959*L0SNN[)U,3"BW+(.
M(DVY<&4E:O%MM(/MJ49)VKW%IKJ9DI:!
M  \2Y+CH=H4"KW1<M2:H]OT&*Y-K%5?U[4>.T6YQQ>TC/:DNI] %+>25FQ.:
M.,:99F"\_P!OPXJ:FF9=+E(JOC6)\ F'$^$ELT]XS4DG5(6:'2T)22U+<1 F
M-"DL+U7?(6FQ6(%.Y,,P(,5!-Q8<=RK---H+R)0A#I)21?0(@6VF@G#WCOD#
MCO;=XT:_\C_&/,N*IL3:?-WRU^&::9-M3?\ ;:UGYQ]>G0%9G%<,$ #(?AH2
M\_<P^27)*MI*9!LR1[U\==W4TQV7UNQFG&"/Z1:(431?D(SD+/V3T+3HARW(
MU:+"]9_Q]O&K.IA46Y*?2F&ZE*428Z7'U3J4I)+\TD[36@SU/H:B,^A@1J?+
MG>$SD?UI>'K;H\@I*[<HU.:N!R I+;D7P;51J;Q.N)(_.)EU/TWE)24?0($Q
MJ?Z]5-<E-L6A<E+3N^=&H4^QY\2KUUB4LFW&8\1N7'FNJ)1EYC"F")9D7FFH
MM?IB!%3X?59V!+O'#O*!$MQ=+IF2EL6NS46FR-IETJ?-)];3!;$:MIJ*#T(R
MUZ%TT!-2E'-;AS3>)GQ:>C[\DWM[_P#TSWO$0$0?"^BO [=NQ][?W/&'KKII
MM]G7H3$XOZC@8P               ')7Y/O"EV?<%0Q_;\.Z;SB15.6];T^7
MX&/+D$9:-N232HD=-3+70C/H9IUW$'1P7)CL&&[4(Z(<]QAM4Z(TYW4-/&DC
M<0ES:G>25:D2MI:^70@'U                XN#4KX=OROTN?;4&+CZ+2H+
M]O74W-[DR54'''BEQW8>PNVAI!-FE6O77V=3) =H         YZZZ),N.WJG
M18%>F6S,GH2ABNT\]LF.:5I6:FSU+J9)VG^P8P9JS5>MS135-,SPQKAZ,I?I
ML7::ZJ8KB/X9U3RJG9+QC?UB6'=%WQ,^7I/DT"$J4S#>D;4.&2DEHHTJU(NO
ML#F-X[NS&5R]=V,S<F:8QPQ=;NS>F6S>9HLSE;415.&.#IJ)A.^*K1J14W.0
M=[M.5&%'E+:2^1DDWFTK-)&:O(6H]%G<]^NBFK\U<TQ$Z^-Y;^^\M;N54_E+
M6B9C5Q2L]2XCM/IE.@/S7:D_!BLQWJB^>KKZVD$E3KA_\99EN/\ 9'1VZ)HI
MBF9QPC#'C\;F+M<5US5$81,S.$:H\7D?<+L;C[_J%YTJSJ]4,>6]#NN](L<E
M4"WJA+*#&E/&M)&ER09*)!$@U*+Z)EIJ6NI!U4=3ZX["Y+:69*FTG(92K<E"
MS(MR25H6I$?34!^P                          S_ ,A\Y.,<NL94P)D6
MXZ[CZHM>EK/K=6F4QQV,9O-N1%O1GHA2]$F2]R%.H27_ !B(@3A*J%D>KAX?
M9*:;<Q_R1JMX&XDU^'I-4HDE]!$6I]QA$<W$&1=3)22,@3M2M!@OU<6+<"Y4
MM;+%N7S=58K-J>.\'3:D<$XKGCH,B ON=F,VOS42%*+11=2+V )JQ:'@J
M          ,0O4U_ZQW\4/\ #8+U-O04                <30*E?4J[+Z@
M7%;,"DVA3':>5@W!&G>)D51MZ.:YJI,;MI\.;+VB$EJ>XNOL:F';
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MN$[$1_4:COMM%I["2 JUKY@@
M             8A<VOZ2/B-_$'_3"<"\:FWH**D<CN-5WYHK5N7786>;IPG<
MULP7H3#U#4\<66EQTG2\2VQ)B+5U(RZK,M#^E/V28E7)-"]:#B,E>BKFL/D9
M18Q:18530W"J!M%Y=RS*EF:_9(U2'?\ =\@)T/\ I>L*O_'*2;Y&\3[YQ^PP
M>V1<U&;.=3UF1Z*4@Y*(S1$7T$R5@;+3"B5:+7J-2*[!)90JU"CSX9.D25DU
M);2ZC<1&9$>U1:EJ"KTP            &(6;?Z5_$7]X/L5\%XU-O04
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M<NRJA0X=*8K"5WXS5X\AY]^D]I9*;IZV7$);?[FW0W"-.G]310=F
M                   #+^3ZMI=DO+J''?DCD#$4O4W$T]V2<V$M7EV*3$7
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M%Q?6Z1;UYK>BG3JI7(CDV$AI,AM4E*V6EH49J9)9)/7RF7D\I!W
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M9.F4XX]055XYQ6>Q55+0ZJ4C86U\W&R2A1N%YVJ2(CUZ= 'W@
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M/#*N4DV;F@SV*<X\_P"+;)J IV0E2%(E'[6I'E,C_J@)1
M  17BCT%X.]CH649F4VSO"K'4IDR='GG1IAJ1WJ(TJ,A!--Q.A):5JI.[J?4
M@3*5 0                                      #$+E)_2@\=/XH^Z<
ML%XU-O04    8^79\_G./P8IGN?0ASN:[35Y.:'VWN_^@Y?K5>W6FD4>@
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MK82IJ#N_9U<B+T,$U:VC(*@
M           #$+FU_21\1OX@_P"F$X%XU-O04 &*.;,O<_)'*6_<-X%O=BNQ
MX)IJE-MNFTZWI!4:EO);-HJC,GP22RM6\E$EUXU:*3_QDD"T1&"*+\R_ZT?&
M=TVC:-_WHQ;,B_9OHVUZQ+IUH*I,F4HBVL+GMPEL,K49D1)=4@S\OTO4$Z%K
M>,W)7DQ;F?J;QEY:T2*S<5UTEZH657F68##BCCM//I(UTL_!NLNMQG4I-"4J
M2XC8?4]$D3$<#5@%0           &(6;?Z5_$7]X/L5\%XU-O04
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MN.YC=J+./TRZ856<I:JBF23RI[!1-ITO21H<@VR/;TT^FZ F$U@@
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MU#*N#\69#JZ$HK%U6Y"F5KMI)"%3>V2)*T)+0DI4ZE2DE[!'H"DIC!
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MFAQ8QE&.&7:1I#,DD;7FE[7HG5/F^3IT ?0
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M5&:TJCJ-]7@M"9]O^B6WIJ1!)(               (WRE(.-;D%TL9*RO_\
M+=*2=MI1$6<?=+;(JCMF>9_:9GW=2\XM-2,M#4020                 C7
M&<M<R)=ZEXP<Q;V;KJS28;B8:3K))=+_ .6R\$9I/QFNXS<\\S(]3,M%&$E
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M37RD\F?[U_9E0!>IMZ"C^>SE+E6GX1]94>4ZK2I%<I]H1Z3(DTJ(M#;SQ/4
MHQ$A:_-+0W2/K] %XU+&*]<'CU25)C88N1^2HC*.RJH1$DM9_2I,TH49:GTU
M))_U#!&RAN\JERI]9'<5M6S%QU,P_@BCSD3I]0G$_P"%4HO,5)<E/M1_'/MM
MK433++9)2:M5Z$>\B=$-OK"LF@XWLNUK"M>,<6W[1ID>ETII1[E]J.@D$MQ7
M3<M9D:EJ]E1F?L@HZT
M        8A<VOZ2/B-_$'_3"<"\:FWH* ##3(>2\G\"^6>9<CU?';]]XNSG)
M1/BU?NN1$*,U*>;:9G$T^VV[%6ZXVIE:=5(VJ+:DTF"^N$6YJY'Y.]8M*L;"
M6*L0/V_2Z?7F*U5JFY*74#8?2T[$;E2I+<=AN+'8;DNFK7<I9[=OG$25"(P6
MEMRF9*S;ZQR)<LJ@/LXXXR19EN^^I3+S:);C422RCN2'M4NR'9<PU&E'3M(U
MT_;*(X&O *@           ,0LV_TK^(O[P?8KX+QJ;>@H
M XB\ZC?E/=M!-CVU3KB9GW##B7FY/G'".GT19+.5-CI)M??=;T226]2W&?ET
MU,@[<       '(9!_ *]_N!4OL5P5KZ,L5[X=7)*B_$WYO6-O[EF^Z$D<XT>
M3^#3R+% ](  (3MOYZ]M_FGG^ZJ1[,A\2>16QVJ.K//"_(W+=.*LJHWU44W2
M=]6W3[<5"N*?$M(J?-.:4ZAM&CP4Y_5".RZ[JK<UUVZ%UZ] [4
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M7<MW-NQB@4BLS5T^(XVI]"9"EOMM/*(T-&I22V]3+_<,.S
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M\X]"UU]@!UT=#S<=AN0\4F0VVE+\@DD@G%D1$I>PC,DZGUTUZ /V
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MBQ[6R"QC6HE5J<IVX9$"-44NQRDH)V"EF6MMLE2R/LI7J:DFK5!&K0!W8
M             #@[!A7%!C7.FX\A,Y$=D7'4GZ5*8@18!4J"I9$S2%IBK63J
MHFAI4ZYHXK7SB+0!W@                                       ,0N
M4G]*#QT_BC[IRP7C4V]!0   !'->P]B.ZJM+KUSXLM"XZY/[?CJS5*' F2WN
MTVEION/O,K6K:A"4EJ?0B(BZ$,55BW5.,TQ,\D-A8WOG;%$46KURFF-4175$
M1PZHG#6\?]'W OY$;!_S:I?VL*_EK7J4^:&;_/;Q_P#LW?YZOM/T?<"_D1L'
M_-JE_:P?EK7J4^:#_/;Q_P#LW?YZOM/T?<"_D1L'_-JE_:P?EK7J4^:#_/;Q
M_P#LW?YZOM/T?<"_D1L'_-JE_:P?EK7J4^:#_/;Q_P#LW?YZOM/T?<"_D1L'
M_-JE_:P?EK7J4^:#_/;Q_P#LW?YZOM/T?<"_D1L'_-JE_:P?EK7J4^:#_/;Q
M_P#LW?YZOM/T?<"_D1L'_-JE_:P?EK7J4^:#_/;Q_P#LW?YZOM=];5I6K9E.
M52+/MFE6I25/*D*I=&A,08YO+(B4X;4="$;E$DB,]-3T(9:**:(PIB(CQ/!F
M<U>S-6W>KJKJU8U3-4X<LN@%F      <]5[1M2X'6Y%>MBDUM]HC2T]/A,25
MI(]-2)3J%&7D(![$2'$I\9J' BLPHC!;6(L="6VT%KKHE"2(BZG[! /I
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M\33U2<@4NJ-4:5$4B8RIMM,Q]*D))]9$RHC+SDJ-/L@F$L@@
M   !$U@M6VB]<M.4?*-0OFJO5>&=Q6C+JC4Z/:[J8B4MPXL5M)'$2\1&XI*C
M/<KKY2,$I9!          HQZPSYO\;X9V[]E#>=W^T_AJYF*]T5YQHV4
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MMVI$0$),I_A_ 0O",JCQ?#M^&CJ2:%-M[2VI-)]2,BZ:& ^L
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MOZQ:GD&B(N&CJC46DP':B^S.*8WX26IEE25$VPZ9*6K70DZZD9'H9,)=!
M             "'L-M6(U!OXK#L*IV!&5?%:5<D6ITYVFG4JQO;*75(Z'3/N
ML2-$]MQ.B5$G0B+;H"93""
M 8A<I/Z4'CI_%'W3E@O&IMZ"@
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MV83I6RHX[I'55*EJ2MLDEJ@U,^?HHR\IDE024
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MI5.L:I2X>,EY??;DP238;9Q"5*)4MDC=+QWM.L<C[Q;O^)T,O*0A)
M          "-[-G2I=V9,9?QDNRF853B-Q[O6<3_ .<Y>$1K,(H_MFC):-$;
MIF>A$1::&E(20          *,>L,^;_&^&=N_90WG=_M/X:N9BO=%><:-E
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MV_9IKKLZ@.AA^+\)%](=GQ_91XWP^[L][:7<[>_SMN[737KH ^D
M      '%P?C$]_==])>]SXLO1D3WL^&\7Z=]);E>+\9O_M;L;=O;[?GZZ[O8
M =H          (9Y#?(ID;[D+_KT#4[][#=ZK==W?U"SUDB6A^"5K_<B%]00
M/?E?@T=6.9KLY\>OK3SNB&=Y@!RE\^_GWI5SXM?07O[\/_\ -KWS>)]$^(W)
M_P"M^#]OV;=?I.NN@#IF._V&?$[/$[$^([6NS?IYVW=UTU\FH#]0
M                 !S5Z-7&_9UV,6>\W&NUZC3V[6D/$V;;=15'6412R=2M
MLTD[M,]Z33]$C(!AS87%3UE.+CK2,>WA2;1A7!->J-2HU.JD!JF^*?,NXXQ
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M.$UI!<@P%-')4B.9+C[&4NJ(B>;<4OMF:U:Z&9.C4G7-//F]W.(F&+TL+PM
MRWFJ7-HLR1'0A94]RC.>&J3T1M_>25.NK9-O?NV(=\N\DF"(C2YZ1?G*+A3F
MS"5&S)F5W,6/,RNHAW U4.XX5/>2_'CRU1GGS6XDXGBFW"-*DI=29DIM)[5$
M-$MJP58A>IK_ -8[^*'^&P7J;>@H                XN@LY!;NN]W;EG4*
M19+ZZ>>.XE.9D-U)A"6#*>52<=6IIPU/:&UVB+1.N[4P':
M  XV^F;_ 'Z-';QO,H<&O^D82I4BX&I#T7T>EY)S$H3&4E7=4T1DV9GM(_*
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MF0RANAJ4GP+<LI"UFJ2E.[N*1YA]-OT3#M
M              8A<I/Z4'CI_%'W3E@O&IMZ"@
M
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M$R+LIKM/8FKKD F7-:>TX\M)QU*41+[C9&HB2?L:D8=V
M           #,.F>L9M>VJJ]COE;B*OX8O"*E!5%*XQU>D/[3+V]LD)[QMJ4
M6Y!MH>3]!Q7E,ML\2<(?,'A-.CMRF<H6<AMTM4ID0W([A?\ U33T9"T_[I C
M"447UZP[AM:K2VK<2[DRLF:6XU(MV@*3O=7T0GOSVHK1EJ9:F@UG] C/H"=F
M5K>.U^7GDG'97;>>*G<.+J-3D^]NSI!_VSZ*)+9L29"#0TI"W5FLS2IM!Z$1
MZ:&2C(E+MQT&G75;U>MBKH6[2;CITJEU1MM9MK5'F-*8=)*RZI,T+/0R\@(8
MI<_,5X]P_<?"FT,:VI!M*@,W/6G%1(:3WO.G+MY)O2'G#4Z\X9$1&MQ2E:$1
M:Z$"\2Z?UEIZ\A^'Z*F9)H)535Q2->X6M6IY2>A:_P#LR1IH7T012_YZT4W4
MYBXC*INOIA-4G''[AF3.XJA2NQU1YY>?KNT]C33J!2_[ZM\]_)SF&NIF15Y5
M4D&ZEO4V^M:FG)T/K_[39IJ8%6I1>N+J"6/6/II.GH)59C>D#?,R?)OW^L%'
MT)/F&>IF2O\ Z734%N)?:Z"II>I\C=HW3B^@:/J:?IO$^^V-O^F_:]_77_D^
M3V 5X5*[17,7E#U9Z:\:"@)B44X!M&LU=[W]U4F"5KUTVE'UZ:?3?M06XUQ>
M=)NIYX\-#IVOI7TA;)([IF3!D=S:-DHT>?H9[M__ "?)[(*QJ2ESIOWF-0JU
M=-O8BLOTQA6=8[OOMKGHYF1V>^W+14?[86XE2=D<DJZ%T\H$8/#]4%\B63/A
MPKW-A@5-:@5                <%;%/N6+=F0I58R&S==%GS(*K:L]NGQ8J
M[;;1%3WH[DEE:G9)R5F3Q&\1&DCT3YO4!WH               ."R9!N.HV?
M4(EJ9#9Q76W'X?AKV?@1:DB,DI37<:.--4AE1OIU9(U'J1K(TZJ(B =Z
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MN;/>5\5-\%D:YIUG60=.45QW-393\*7#8-:2[C+\<E.)5NT+1*3W:[3(R,R
MAW]$\%Z&I'HV6N?3O!1_ 3G75/K>9[:>VXIU9FI9J3H9J,]3\I@/3
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M5N)[_*[[\G*B_4'U1[B[C?I&.T=0(E$VVK;M)K5KRFDS,S,$RF@$
M                               Q"Y2?TH/'3^*/NG+!>-3;T%
M
M                     8A<VOZ2/B-_$'_3"<"\:FWH*/.J]'I%P4R;1:]2
MX=;H]2:-FHTF>PW)C2&E>5#K+J5(6D_H*(R 4-OSU97%2]ILBH0K=K%@291F
MI]-KU'L,;C]E$>8W,9;_ /J6T)3^P"=J7.6OZJKBS;\U$JJ>_"]F4*W'3ZW5
MVVV5=/I3.EQ8#FGL_3@G:E?*Q,<V'C"B-VYCVT:59U$09*5 I49N.EQ9%IW'
M5)+<XLR\JUF:C]DP5=H             Q"S;_2OXB_O!]BO@O&IMZ"@
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ME&>4F;*<94E++24$9&I>J==#V^;N22F<$
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MV/5+;NA51I1WW<\V ]%B5V1X$O"O0I#BC1(2RSYBS0222KRZF>IDI@!
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M3\&&_.B% G/,-KF04N$\3+JDD:VR<(DDO:K4MQ$6OE ?4
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M,_CZW:?<U<74X#,J!4IIP66X#DA"9CY.$A>Y;3)J4E/LG]'Z4P[,
M   %9N.O_>V?OSGUSZH0YW</3S/SJG3=X^AE/D4+,CHG,@  XJR)]^5"/<2[
M^MZF6[)C5^?&MEFES53DRJ,TI)0I;ZEMM=MUTMQJ;(CV].NIFD@[4
M                                &(7*3^E!XZ?Q1]TY8+QJ;>@H
M
M                      #$+FU_21\1OX@_Z83@7C4V]!0 0?DWDI@G#=19
MH^2LG4:UZR\TE]%%=6M^:32S,D.+C1D.NH2K0]%*21'H>GD!."+/T_>('Y;*
M9^\:I]I@82M['D,RX[$J.LG8\EM+K#A:D2D+(E)/KH?4C!#]@
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MY7=4B@NV@Y*AGCAJF(DIJ#<4HR2F%4S>]K-9R-3;[739]-UZ$':
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M.W3R::&")C!;<$        ,0O7*?ZN/\;_\  @+TMO04
M<%E!II_']UM/Y 5BME<%1.Y#0[&8.DEN+61W9?M*=/(9KT\O0R/0P'84TB*G
M0"34%59)1FM*JHVS5)+87MQFTE+9FY]-YA$GKT(B ?:               "-
M*7':3E6ZY!9.757UT.G$YB8WHJDTE'<=)%1)E']L)\4:5)W+\T]I[==.@26
M         (9Y#?(ID;[D+_KT#4[][#=ZK==W?U"SUDB6A^"5K_<B%]00/?E?
M@T=6.9KLY\>OK3SNB&=Y@!'^5&V'<>W4W)R(K$S"X>CF14/18YTHMZ?;N[-(
MV$Z_2&:M/INADK0R$.XB:%%C$4DYA=I&DPS29N^:7MFJ=$^=Y>G0!]
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M9.J$>H*HTQ2T&]1&E1TH)IJ&9D2&E:J02O+IH"92L"
M                     8A<I/Z4'CI_%'W3E@O&IMZ"@
M
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MV5%;JM7..ZE$22B.1I>;-!J/:YHG7H9Z*-*B4T @
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M3=K[C?<06QYIHU^;[)$")C!/0(        8A>N4_U<?XW_X$!>EMZ"@
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M?N3HKV,EVG'@NTE,;("SB?\ SIWQ#-2R)C5[2%H3/MQ^SYNA$9$$D
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MZJK':B+.(?IEM#B=M:2<3II,UW>V>?J1[M2T,PD@
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M.4[OQ95<95VN5"T)#,>358DN,VR\;T9J21H0LMQ:$Z1=?H M%+3 %0
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M7K!\+XO]]GOT\+4Z;4?3G@/1V[QC#RNWV/$2M-NGE[G7Z! G'&'])(*
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M/AWY=#3L4H-LSZ@BEL/H5(;2\M4IQIY*3:;-3A$:>IIT+J [<
M     !Q%LU*\YEP7S$N.SX=NT&GU!A%FUR-4$2W:S&5'2;LA]A+2#CJ0LMA)
M4:C,B^@1&8=N       #-WFM\O/#3[H7C]BTP=+N+X%_\//+%7TJ?*[(95P
M >/<7X/US[GROJ2A:G7 E3@M\T_#GW.F^Z4L:G?G;;G+'-"MKHPMH-2R
M           @;D59^![EQ])J_(BG4^;8%DN^F'9-1?DL-1GMIQTK3X5QMQ:U
M=W8E!:FI2B(B-1D"88SN9R]5RBNG3T<9;F=HQ/\ 9.X$J=))IUT[Q1U5DG-F
MO7KHO;^UW>:"V$MBN-=H\>Z%8+=S<;Z93X=C7TM-07+I[TIU,AYDC9/N)EN+
M<;<;,C0I!DDTF1DHM05E8<$        ,0O7*?ZN/\;_\" O2V]!0
M       !R=]0+PJ=H5^!8%>AVO>4J*:+?K]0B>.C17]2T6Y'W)WEIJ1:GT/K
MHK3:8=%!;F-08;50D(F3VV&TSI;3?:0Z\22)Q:6]RMA*5J9)W'IY-3 ?4
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M>FA]2Y)U4=+Z([")+B7I*6TE(>2G:E:R(MRB3J>A&?70!^P
M             _&0<=,=]4LVRBDVHY)O:=LF]#W;]W3;IY=0&,>1_644==Y5
M:VL!<?HF2J10W%MR+HD1UF4LD*V&['B0XZUH9-7TBW%ZJ+]HD%ME9SA_S,QS
MR+J]0M*984;&66*$R[)50M&G&I3#1]MY<1_M,N$MO=[8TI!&DCZ*61*VB8P:
M# J             ,0O4U_ZQW\4/\-@O4V]!0               !P%MP;BC
MWID.74\C,W10YKM,][EBH@Q([EM$W&,I"')3*C>D^,69/%WB+81;4:EU =^
M              #@LC0K@G6_';MK(C.,9[55ISKUQOP8E0;=CIDH[T$VIBD-
MD<M)]I*R/<DU$:=3Z&'>@       \ZK_ /=-4_N1_P"IJ&.[T)Y)9+/3IY89
MZ8>^3:U__<O_ &0Z/B5&I]CSGQJO#@26+/,  #R<:_.8B? %_P"SS'2=U.W?
M@GGAJ^\GZ9_[(YI7G'TM\U<!C^#<4&/=*+CR,SD=Y^Y:D_2Y+,&) ]$05K3V
M*,M,12B=5$T-)NN:.*U\\B =^
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MI'LR'Q)Y%;':HZL\\+\C<MTC3&C49IN^O#Y07D_?>-65(<6_#?\ 0#IJ02J
MGP9%VRA::;'?;2-7G>P1!)8               (RR"U&<K&-3D93<QTINY6U
M1J*A^$R5SN$P[I23*6DUN;RU7M9\_1)G[!*2$F@
M      I_SSOZY,;\5\H7%:<IVGUN0S!I#-584:'8K53FL1'W4*26J5=IU24J
M(R-*C)1'J1 F-:H_&SU<?&^\<%8]O.\T56[[EOVWX5<F5:-4W8C4)RH1TNG%
MCM1E$C6,:]BNYO,UI5KH7F$3-3X>"U.F82Y=\C^+]O7,_<V-*%2U7!3')*B6
MMF:P]3FDI/824$\34\V7S2E.]3*3VEM(B$ZFPP*@           (LSI\B68O
M@/</N;( AG1ZH+Y$LF?#A7N;#!:IK4"H               ",;-8I[=\94=B
MY0>O.7(GTU50L9R9%D(M52824HC(88]M8\41=\R=ZJUW%[*C"3@
M      1AF-B!)Q_5V:EE-[#$-4B";F0H\N)!<B&F8RI+92)Q&RGQ!D3.A_3;
M]O770Q"3P                $7V/'@-7?E)V+E-^^I4BK1%3[/=F1)"+544
M1!)A-LQR)QCO%[;M=ZGJ2B]E2@E        &;O-;Y>>&GW0O'[%I@Z7<7P+_
M .'GEBKZ5/E=D,JX  /'N+\'ZY]SY7U)0M3K@2IP6^:?AS[G3?=*6-3OSMMS
MECFA6UT86T&I9               91>MLD59&'<8137*9M"9>[174[&_XR(;
MYQTJ/KKYO=4DC(RW)(_*1 M2LG2\:<&58BC/QK:Q<_BXZ0EP[CDMTXE'%V$1
MOO5!S;)2]K],M3A.DOV240(TJO>J@?65LY_@4*3-EXVA7JT=C/2R-)*);3I.
MJT/31Q4=$4W"]CH":FM8*H_RO>?Q=8OR)?VC:EV9;54K3#;OTBW8,1Q]M!Z=
M3WK02="^B R9QIR.]9QF"SJ9?^.\263<%HUE<ANF5<S@PR>5%>7'>T:F5MAT
MB2XVI.IHT/3H"V$)IS_RRSK8\[C_ (&L2UZ*KDOE&@T>=?*9FQ^GTB=,03+T
M=E+3[C9_VRT^:EFXM"&D$9=S>2DB(??QNY39J3R!KG%;DY2:,WD!B&N9:UT4
M1)-,SC:C%-4VI)&3;B7(VYU"T(0:=BD+1K]*)A$]4Y;<LL[Y%R]!XHT.W&;
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M*#:%ORBOJ[XS#L5F<N-$J#+LE1*0A:D&4IB*2UI+>>A?2;5&3JAMD"@
M        Q"]37_K'?Q0_PV"]3;T%                $/6.=D_&AF8J!CNI
MVO=B7J$5[WM+I:H<.XU'"6<-<*8:C*641LU-.&1%L4>AZZZF2F$$
M       B3-'O-]ZE-.^; J>1Z0=Q49$6A4FGJJ3[,UR8VW%FJ92M!I;CN*):
MUZ^:G7HKR&3"6P0      #SJO_W35/[D?^IJ&.[T)Y)9+/3IY89Z8>^3:U__
M '+_ -D.CXE1J?8\Y\:KPX$EBSS   \G&OSF(GP!?^SS'2=U.W?@GGAJ^\GZ
M9_[(YI7G'TM\U0]AP[).#?OO'QW4\=14WO6DU^-4Z6JEG5:JE:"E5:,A2E=Y
MB29%VW2T)1)TVIVZ F4P@@
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MM I/5;DE]IJ&PPE?5*_"4]LD.FGIO6C;[)$6G1&#:0%0!B%S:_I(^(W\0?\
M3"<"\:FWH* #*KD[PQS,YF27R1XI7HFU[^K#2"NBW52B@J?>2VAE;L9U:51W
M$/);0IUF01)-:37N49[2+1/&ANB<+.8_(2\;9?Y>Y"-./;5EHDO4)-0C27Y:
M2,C6W%C4U)16E.IU;4^L]Z2/HE7D!.,1J;:LLLQV6H\=I###"$ML,-I)*$(2
M6B4I26A$1$6A$0*/T             8A9M_I7\1?W@^Q7P7C4V]!0
M        !%V3'J0S(QUZ5Q=+R6IZ\*<W2Y,6#%FE;LLR<-NN/')6E3#<;0]7
M6B-:=W3R@E*((      !R&0?P"O?[@5+[%<%:^C+%>^'5R2HOQ-^;UC;^Y9O
MNA)'.-'D_@T\BQ0/2  "$[;^>O;?YIY_NJD>S(?$GD5L=JCJSSPOR-RW2+\7
MNTAU%_>B,7RL8$W>=6;J*)4&+!]/RT&T3M>:**I7>;F=-KSFCB]GG%IH E
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M (            19G3Y$LQ? >X?<V0!#.CU07R)9,^'"O<V&"U36H%0
M          $8V:_3W+XRHU%Q>]9DN//IJ:A?+D.+'1=2E0DJ1)0^Q[:_X4C[
M!F[U3IM+V4D$G                C#,;\"-C^KO5+%CV9X:9$$G,>QXD2<Y
M+-4QE*7"CSC)E7AS,GM3^EV;NFFI"$G@                (OL>1!=N_*3<
M7%;]BR(]6B)GWB[$AQT74LXB#3-;=CJ-U_LD?:W/%J71)'T4E(2@       #
M-WFM\O/#3[H7C]BTP=+N+X%_\//+%7TJ?*[(95P  >/<7X/US[GROJ2A:G7
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M6?BX_2MI'HKPWICWA?VO2V.YO\%Z0_[M4K73;'^G^CYOL@F,']3@,8
M         #E;W>O-BTZZ]CR'2:A>S<8SMR'777F*<Y(U+0I#D=*G"3IK]*7E
MT+4O* Z&&<LXD4Z@AEN>;*#FMQU*6RE[:7<)M2TI4:25KH9D1Z>P0#Z0
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MOI4D9F")B6GP*@            #$+U-?^L=_%#_#8+U-O04
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MJ44AQPU24IU[BD:(/IM+V3#L@
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M/*:NJ4PFEI5$9=-Q'AU&LTJWD1GT^AJ2@[4
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M_;E0E0U69;K$!N,]1F41B*0T_(2M2I!O.'W"-1%M+H70^@=P
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MU5"R!5*C?"K<I**YC=VH&Y3J;";=?5'FL0=A$TX^IQ1+7O/4B+HG4S42EP$
M      J[RI_!W%OYR:)]1ECD^^'9*/F1[-3KNYO:;ORJN>ER ^>.P    =1Q
M"^32O_"ZJ?UK ^C=T.Q3UYYH<;WR[;3\NGZTKYK;M1W%EYMWQ?-1QK:BX22K
M5\TB?Z,G4]ONMZ.,2R0YVU*5HCZ4]V[;H>HZERD)(@]KP,/P\A4QCL-]F6M?
M<4ZC:6U:E_MC474S]D$/J                          %.LI3^(N+J_E*
M^;I?L"'ENIVQ/;N>BU"M0X-;K,-Z$1^!-A]\G#\6VRAM.UL]>FFH)TJKX55Z
MMW*>/:5>ES61BK%-7J+TIJ19-P7'!;GQDQWUM(6XEZ1'61.I22TZH+H9>7R@
MF<7HV;?W#FRN7F*L8X-Q'9]P52OP)<B-F6U:PB2W29;L2H-N1$LM(>;=4IEG
M19D^6B'2,B,RT,:<&K@*@            #$+U-?^L=_%#_#8+U-O04
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MKGN5!Q3-QDZCTBRUZ0(C)I![223/M7LI,S-1F3*:P0
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M.,REK?MU/3=MUTU!1[8            #$+-O]*_B+^\'V*^"\:FWH*
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MM>&>[<F4J&9(0V3>\M7]4>R9>::DDPFD$
MQAY\XGYF3XN3'+9O&=?W'BLG39B[#88C/U1E:YT=28;4>/%.4\B/*2AU*DJU
M)KZ<U;%&9:,'%X[Q=ZTYC']C,VE?T:W[59M^F(MF@S7J9'DPJ>F(V46,^R_!
M-UM;36U"DK/<1D9*Z@G0LMPKXIYXQGF+(F=^0%S0:O=UX4-5"2S'E>-DR#>D
M1'W),EQ+3;:"0F$VA"4F>I&>I)VEJ1,M/ 5            19G3Y$LQ? >X?
M<V0!#.CU07R)9,^'"O<V&"U36H%0               $-8_;QPG)&:UVE;E0
MI-Y.U.DGDNLRF)C4>I2BIZ4PW(KDA1LN);CD2%=@B(C^FU,]3)3*"
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M%N<4:C4?70B(B)G%;@$        ,0O7*?ZN/\;_\" O2V]!0
M   !Q.1YM7IUC7--H-BIR;5X\)2H-A+DQXB:HK4B-A3\M*F4$9&9F:DGY-"(
MST(!U=/=D/P(3TN$=-E/1VUR:<:TN''<4DC4UO1YJMA^;JGH>G0!]8
M         (_ITZM.9*N:GOXZ13:#&HM.>@9/*5%6NJ/N./D[3SC(23Z"C$DE
M$I:C2>_H2>AJ"0        5=Y4_@[BW\Y-$^HRQR??#LE'S(]FIUW<WM-WY5
M7/2Y ?/'8    .HXA?)I7_A=5/ZU@?1NZ'8IZ\\T.-[Y=MI^73]:<,ESZU3+
M$N6=;UA)RA66(NL*P%R8\--3-2TI4RI^4E;*"VF:CW)/73334QU+DW915.+C
M1UO1_".K:0;L7<2NTHTEJC<GH>T^FI= '[@
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M(C5Z='MEJE35SD2:,VI/@Y3ZG&FC;><(U;VR(R+0NO70@[,
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M7W);KSG4FTEINTZ>09*+=-$84O58R]%BG9HC"/#C2"+LP     B6[\"81O\
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MXUX$AS)E^SSKE]/)<2^IA>W9&A&^E2B=[*=RE*(S+N..:&I.AF1,XKJ @
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MKCV_*O<G8OHMFZ%RFZ8;1R&RE=Y4,E/$HF-YHVE]/MUZ:@.U
M     <1;*\C+N&^$WA'MYFU6Y\<L<.4A<I4]R%V$G(.J)?(FTN=[4D=H]-OE
M\FJ@[<       &;O-;Y>>&GW0O'[%I@Z7<7P+_X>>6*OI4^5V0RK@  \>XOP
M?KGW/E?4E"U.N!*G!;YI^'/N=-]TI8U._.VW.6.:%;71A;0:ED
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M4E%&CDN1XM1-()4O1)=T]I:KT1HDMWEZ= '[@
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MH5#*32KSK"JM*J-3:J:J+.4M!OT1E324]AF'T)#*M5()7ET,@3*600
M  A_+>=,>81CT.5?\RH0V;A<?:IAP*;+J)J5&)"G-Y16G#1H3A:;M-?8'LRF
M1NYJ9BWAHXYB.=6JN*=:"W?6!<9V'&&7[CKK+LE1IC-+MRK)4XHO*2".-JHR
M_8'MC<&;G@C^:/M4]]2ZVS.9."[]NBB6=;E6KC]<N"246FM2*#4XS2G#(S(E
MO/1TH06A>51D0Q7MSYBU1-=41A'CC[4Q<IF<%IQJV0
M       8A<I/Z4'CI_%'W3E@O&IMZ"@
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M%37 ;KE3[#J44^4T@C*2TI*C,VU:$9Z%KYVBB4P @
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M=\52Y+H34:45]VQ-GO2HE"D>!+PK,*.XDD1TO,^>LD&HE*\NAEH1*8 0
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MXMQQ22W&K33S=RB)G%=8$        ,0O7*?ZN/\ &_\ P("]+;T%
M        $;9@*W#QG>/ONL.HY/MPH!JJU@TB 54GU-LEI,F8T,UM]U>XB41;
MBTTU(]2 AW%(3%12:8B% 52H2(C!1*6IHF51FB;3L9-HNB#06B=I>330!Z(
M              (FHZK6/,MY)B8UJU+NXK?I?I?*;U,)JF52(3CO8@1ZCO,W
MG8YF9N(V%M(TZF>A:!+(       *N\J?P=Q;^<FB?498Y/OAV2CYD>S4Z[N;
MVF[\JKGI<@/GCL    '4<0ODTK_PNJG]:P/HW=#L4]>>:'&]\NVT_+I^M+F9
M"MH\8WA[[[!J>4;;3")55L"C4\JI/J:$NH-+4:&:V^ZLE$2R+<6FFNO0=2Y.
M$APB:*%$)B.J(P3+?9B*3L4TC:6U!I]@TETT ?4
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M]*#QT_BC[IRP7C4V]!0
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MG9T2&=O1#9=)54;;DI4N0I)F3?;9T69*,]=-2,._
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M6!,@IMJ\&ZA%E+N1M<5/>D.1F4)=C'&61,D3QF:B+5/F] '>@
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M/8)*G([IH,TGYCB%I41^<A23T(S,B(F,&67KE/\ 5Q_C?_@0%J6WH*
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MJCD^F.PF4M#DHFTE)6V1I0IS0MQI(]3(C/R /V
M    '(Y A5BI6'>U.MZ+&G5^?0*E&H<*8AIR,],=BN(CMO(?(VE(4X9$HE^:
M9?3= &&.,N.OK.<,M5&'BU<:SJ/4YKM0>MYBJT&73D2'B)*UM1)RI+3>I$1>
M:DO(7T"!?&%P^/-/]92QF"T'<_UV#,Q&GTA[[8S*+7):M:?)*'H=.CHD])?9
M/S%%_P KS=01.#3D%0            !B%ZFO_6._BA_AL%ZFWH*
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M3^E!XZ?Q1]TY8+QJ;>@H
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M-)1%T!5[P            #$+-O\ 2OXB_O!]BO@O&IMZ"@
M ".<A1)LEZPEQ,FGC=,:ZX#LIC9#65PM$ETU4/\ MOJ1R?*1LGW-$GM+V2"1
M@       <AD'\ KW^X%2^Q7!6OHRQ7OAU<DJ+\3?F]8V_N6;[H21SC1Y/X-/
M(L4#T@  A.V_GKVW^:>?[JI'LR'Q)Y%;':HZL\\+\C<MTCG',29$1>_C,F'D
MPY-W51^,O9$1Z":4I!)H7]J>7P>AD9N^V:J\[3H0"1@               1Q
M?<2;)JV.W(N33Q^U&N)MR71MD-17(CL._P#R41RO/(U:;_:3W:)/IY%)"1P
M                          9S<L><N#;"L_)%B0WJ5>^6K=E0H;F)[KM^
MK+I\EY$Z,IXGUO1&XJTML&J0TLGMBC2A2%*U3J6B' 65RU]794+-M*H7O2[
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MHU(725+72EPHZJ:MTW36<<VTFT:C?]MUVZ:[_._XW4$/3
M!"]#/&'Q[WXBE/SE9:1;%&7=L=Q4\X::2X](3!4TES^U"6:VU[C;\[Z/[8$I
MH!       *N\J?P=Q;^<FB?498Y/OAV2CYD>S4Z[N;VF[\JKGI<@/GCL
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M.*KC6.F]:TBNPZK2SI9U6J)<0F55XJ=RR?CRC(C;>+0E$G30M- 3*7@0
M     *,<HOG <)OAG6/L6,-YNOLV9ZL<\L5SI4KSC1LH
M          ,0N4G]*#QT_BC[IRP7C4V]!0
M
M&(7-K^DCXC?Q!_TPG O&IMZ"B,\NXCL;.%C5/'F0Z6JJ6Y5'&'UI:6;,AEZ.
MX3C;S#R?.;61EIJ7E2:DGT49 1+(^O\ !CAOAG(-SJS?FNGTNUZTTA^Q;!<J
M)PJQ 9->G=?<2XZ[(0K:9$KM)+77KT!?&7WTG$/JG:74H51<R7$JZ83J7?1L
M^NS5QGC3U)+J&VVU*3KY2W=?(>I:D!C+:2&J*N)%7!V%"4R@X9-$24=HTELV
MD6A$6W30%'T@            ,0LV_P!*_B+^\'V*^"\:FWH*
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M/S)1$R(!2L?TRF,U>5+4J8REMQ$.0I"%DPLR>49GYJ4FKV 3"5P0
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M1HS>.*G1J57DU. Y+D5R.](C*IR)"#FMI2PI"B=6SN)!^37RZ?3$'9@
M  \ZK_\ =-4_N1_ZFH8[O0GDEDL].GEAGIA[Y-K7_P#<O_9#H^)4:GV/.?&J
M\.!)8L\P  /)QK\YB)\ 7_L\QTG=3MWX)YX:OO)^F?\ LCFE><?2WS5Q5D1\
M@QX]Q%D*I42IR7:_/=M9=#COQT,T-:DG!9ED^M>^0A.[N*1HD^FA=#,P[4
M        48Y1?. X3?#.L?8L8;S=?9LSU8YY8KG2I7G&C90
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MTQP3/%+LQZWB
M                     &(7-K^DCXC?Q!_TPG O&IMZ"@ PUB<:+)S;SSY%
MVWR)K=1ASE&U6L<T)J6F&NLTZ1HW'6P^I!FXB)&0VC8WUW$>I^UK(%\="VGZ
MK;B?_P"$7+]^G?W (VI:&PXK4&)%A1R,F(;*&&24>I[&TDE.I^ST(%7T@
M    J7S"Y&%Q]QLV=O,'6,K9 D'0<5VVTCO//U%[:@Y)LEJI:(YN)/0B/<M3
M;?3?J1,1BH]ZN_-MST_C]R6RAD2YZS>IV$\Y64^EY\B8Z:8M-<DFPTM];AH[
MJTZ:%TU,$U0@2@JY=Y>P7DKF:WR4N.VIMI5*7*HV.J;)DL4MV!3U-+E[66I*
M8[2$$K1+:V'.YVO;#,UDH$Z-37OB+FB?GW -BY%K26D7++:?IUTI822&U5"G
MO+CNNI0GH@GB0E[:71._0NA K,8,U\V_TK^(O[P?8KX+1J;>@H
M      XN\85^37;258]>I5$9AU^)(O-NIPG)9S:(@E^*BQ30ZWV7UZIV.&2B
M3IU(_(8=H       #D,@_@%>_P!P*E]BN"M?1EBO?#JY)47XF_-ZQM_<LWW0
MDCG&CR?P:>18H'I  !"=M_/7MO\ -//]U4CV9#XD\BMCM4=6>>%^1N6Z<99D
M*^X2;H*^ZW2ZXJ3<,Z1:*J7$7$\+0W#0<*+*);B^Z^UYQ+<3H2NG3H>H=F
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M[GROJ2A:G7 E3@M\T_#GW.F^Z4L:G?G;;G+'-"MKHPMH-2R
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M= E4       %7>5/X.XM_.31/J,L<GWP[)1\R/9J==W-[3=^55STN0'SQV
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MX^^XHUK6M<5LU*4H]3,S,]3,QQ68C"Y5$<<\[-&IUXPI
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M;=076V;R:5C-<$J@;:*V<5]*#DG"]K)LVS41]_S/H]-P)38"
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M=1F6/4)6/O%4PZNQ2TU)<DWDSV#B;4TG^VC(I!-F>WI]'H"834"
M       $+8V:Q<W?^;56/'J#5X.UR K*3LHJD3#E0\ V48XWC/:#23!$1^&Z
M?\;]J"4T@@      &;O-;Y>>&GW0O'[%I@Z7<7P+_P"'GEBKZ5/E=D,JX  /
M'N+\'ZY]SY7U)0M3K@2IP6^:?AS[G3?=*6-3OSMMSECFA6UT86T&I9
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MNWB*-<6,I48X:E-(-40]-6C-)>9YO3S?)T ?0
M   /DJ#,"1 FQZHU'?IC\=QNHL2DI4PMA23)U+J5ZI-!I,R42NFGE 8G9!YT
M\6J7>#MKXNXJ6KD*E1Z@U3GKWETVFTR"M;CI-]V.RFG27'&U==AK-HU?0T\I
M?"5V,7Y=XSR^2M[X,MW&-NV1E"P'G$6W7HM(I\<ZFE,)*YZ8;[#*'&G64N.(
M6V9^<V2E$9EO2DKA."\@(             &(7J:_]8[^*'^&P7J;>@H
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M"\:FWH*    ,Y;B^=IE'[AP?L.E#Y3WC_4;OX?9I?5MR_I%GEJ]JI)(TST
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M/?R;9B^$L#[#,"IL,"H   #^4?-WSZ;Z_.ZOW62#)&I_5P#&
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MLW](J<MR,]#I)M.&I^$E"%$ZZ3A)(DJZ'Y.FNY(=P
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MEBYZ32(-IQ)4-./9\"0Z[,F1E1DJEJG-K2E+:D/F:4$D^J?+Y-5!V@
M         .(R),R! M2=)Q?1:/7[R2]$33Z979;L*"II4AM,E3CS*'%D:636
MI)$7E(O+]*8=N                 XBV9F0)%PWPQ=M%H].MF'/CHQ]4*=+
M=?E3(2F$F^N<TM"4M+2]J2229D9?U-R@[<       &;O-;Y>>&GW0O'[%I@Z
M7<7P+_X>>6*OI4^5V0RK@  \>XOP?KGW/E?4E"U.N!*G!;YI^'/N=-]TI8U.
M_.VW.6.:%;71A;0:ED              !ECZUM=01B7%:IC4YW'Z;\BJOU$'
MHM3)1WNRE75)=4]W;N/;OV]==H+4H0I%]\+[:Y8TZH6C5K+H. :K@&71;B3%
M:[$67+EU.04B).:V%(>ENQ-B5I=)3RT;2/7H"=."6_58(AN4SDA/M&+-AXLF
M7XGXO8\PU&:&$H?5L4:M3-U,9<4G#U^@"*FL0*@       ,0O7*?ZN/\;_\
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MU+DW71TN)CL)=?*2ZEM).22222<41%JO:70MQ]=" ?L
M         (YS%;M9N[$>4[3MQ9-W#<]H5RDT%PU]LDS9L!YB.>_IMT<6GK[
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MU,FU7)[)7I6/3<JK5-%451JD:T'(HL=2&V^PQ$U(FV3U-!*^F/4$REH$
M   S8S+\^6!^8IK_ $F?'4;M[!/S/Z88IZ?D=N++@  @SDM\A.2ON67U9L>O
M(_'IY5:^C+2_''R>6%\':7]B-#D,S\6KEGG7IU.T&%(
M     ,0N4G]*#QT_BC[IRP7C4V]!0   !G+<7SM,H_<.#]ATH?*>\?ZC=_#[
M-+ZMN7](L\M7M5))&F>@      'Q5+_NZH?W,[_6&":=<.CX4_([*^$4WZC'
M'T;NAV*>O/-#C^^W;XZD<\K=CJ7(    ,1<1T*G<D?66YKKV0XZ*Y1\,+J<>
MVZ#.3WHZ7:#.:H\,B95JC8A9NR=/_LIDK;J9Z%YT0V#R1CZVLJ6-<^/[N@MS
MZ#=-/?@3$+0E:FC=0:4/M&HCVNM*,EH475*B(R!13EKCS&XS<*.1..H%ZU*]
M:>Y9%XU1B3466V"C.2*&\AUJ.VV:MC2E-]S::CT4I1Z]03CC*"?5)8UM:'B6
M[\J+ID>3>=;N6316ZRXV2GHU.A1HRTL,K5J:"<=?6IS;IOT02M=B034A_P!:
MQ9%$JN:./3C49$"JWS'?HE:JK22)QQAF=%;8-7312FRE+T,_8T+R$0)I;36W
M8=G6E9T&P+?MR!3[-I\#T8S;R&$'&5&-';6AULR,G.X1GW#7J:S,S5J9F"C)
M;U8M-9MC-7,&T*6I3-#H=:C0X,(C/8E$*I56.R>AF?4D= 6J<_PUH\#/_-WD
M9F>^XR*W,L*H/E9\"<1.IA+=FNPZ>XE)D:35$B0S;0?L*/>1;B(R$Z(:@<E,
M26UFG#%^69<5-CS'G:1,E6Y/=01N0*HPRMR)*97],@T.$6[0RW)W(5YJC($1
M*A?J@OD2R9\.%>YL,$U(A]4T2H64N2%,J:T^FVV*>3R31L49L3IB)!DGKM(E
MJ3J6OT 34W(!0  '\_-4SGBK(OK&9N3,KWI%M_%N&'785E2)2'Y+4F30U&S%
M[!1FWC\^>Z[-0K:1;4D1GKIJ7PT+!<YN0W%#D!Q]N*U[<RY2ZC>UOR8]P65%
M\'44*=F1-R'&$K7&0DC>CNNH3N41;C29^0$1$PL;ZN/,Y99XW6_2JA*-^Y\6
M+*U:P2S+>N+'02J:][)[3C&EK4^IJ;6"*H44]9W&N&;RJX^0[1F(I]URZ/2V
M;8GNF1(8J#E<?3%=49I66B'329ZI/^H?D!:G4DVJ8I];-3Z?+FQLT42M/QFS
M6U2H4FG)D/F7[1LY-+8:W'_RW$E^R"-"J>,J1ESF;DB9A/DCR1K-F5>VIJS?
MQE4X9L29[L/^SHCQVRC1/$-:'_9"4M*=5H0M)+T)U-Z[0L_'O';$S= MR$JA
MV%CJD2ITE6BI#YLQT+E2Y+II(U.NN&2W%:%U,]$D1:$"NM5K]9GQ _'ZI_>&
MJ?:X&S*4:CFK'N>>,N9[WQI57JQ;K5KW/3%RWXK\-928]*<6XGMR$(7H1.IZ
MZ: 882S"XFXJ^./U;_(:SH\;Q-:;O6JUBV4)3N<.HTJD4:8PVW]!3W:-G7Z"
MS!:=:_'JZ<L(R3Q:M)FH3$KJ^,UO6G65N++5+-/2ER"H]W4DE#=:1J?35"OH
M:$5JC2KMQ ;/.>8>7'+6>RIRG3SE6?CIYPC,DP68Z5+T(^B5IB,0R/0O_:+\
MFIZDSHT/A]3W\FV8OA+ ^PS J;# J    _E'S=\^F^OSNK]UD@R1J?U< Q@
M                   #$+FU_21\1OX@_P"F$X%XU-O04 &7O+#@_1<EY2@9
M&QCEV-AW,=\(<BG1GY*XR*\Y#BF;SL4XSB)*'$QF]7NVAQ*DIW*2D]RE%HE7
MO%_JVF(5_P!HV-GKD#1Z_%MMI5;M["=)F/*?F05OK6\IEJ:MI3,=QYM?>-A@
MS5YWGH4>XB=IN&VVAI"&FD);;;226VTD1)2DBT(B(NA$1 H_V
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MWKDRJ8BMTI, Y=^4:IIH\R*LIC/:;1,6APD)?<VM++:>Y*E)Z:Z@F$M @
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MDI@!       *N\J?P=Q;^<FB?498Y/OAV2CYD>S4Z[N;VF[\JKGI<@/GCL
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M)BW5X[&I8R-BYZFU&AD["=]+LDXDTUG^TC-*3F:FHR<]LU+SM>A@)#
M !FQF7Y\L#\Q37^DSXZC=O8)^9_3#%/3\CMQ9<  $&<EOD)R5]RR^K-CUY'X
M]/*K7T9:7XX^3RPO@[2_L1H<AF?BU<L\Z].IV@PI
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MCR5-E(O0YV-BQL;%UU-F,V3D-STXRE2-E</P?0CF$>ID[[86WS_8 2&
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MFXT^-V8W(A&U8G=A,^)_MIK5TEU R8(XY>W%NZZHZ:'U()$
M    1W:,J?(NK([4O&GO+CQJC$1!NXW82SN='A4ZRS3&,W4]D_:B)_SM"+33
MJE(2(       #-WFM\O/#3[H7C]BTP=+N+X%_P##SRQ5]*GRNR&5<  'CW%^
M#]<^Y\KZDH6IUP)4X+?-/PY]SIONE+&IWYVVYRQS0K:Z,+:#4L@
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MVW;LW:;?9TZ&70=2Y-U3'?)ADI)H5))"?$*:(R0:]/.-)*,S(M?)J8#]0
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M5.95.W.7V'SDO,]G6*VM/TK9*Z]>H$1BJ5ZFO_6._BA_AL$U-O04
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MEM]@$S.*>@0    _E'S=\^F^OSNK]UD@R1J?U< Q@
M #$+FU_21\1OX@_Z83@7C4V]!0 9H\O.#-CY5N].8[?RFUA/(LI#;51JLM:4
M0*B[';)EIS>3\=UAXFR)"EH4HE))/M>NJC+1*NV+O5_XZ8O6F7=GSDW0,G0J
M(\V]%M=BI-FW,[1DM+<N7+EK<[6XO.;0@MQ?MR\@)Q;:-FA2$*:-)MFDC;-.
MFTTZ=--.FF@*/]@            ,0LV_TK^(O[P?8KX+QJ;>@H
M      CZ_:=<%0>L95!R.C'J8-T09-:87#BS"K\%"7>]12.2I)LJD%U)QK5Q
M.WS2,!((       .0R#^ 5[_ ' J7V*X*U]&6*]\.KDE1?B;\WK&W]RS?="2
M.<:/)_!IY%B@>D  $)VW\]>V_P T\_W52/9D/B3R*V.U1U9YX7Y&Y;I']@4^
MO4]%X^G<BHR+XVZ:G*HRT0XL3T) <4@F:(KPJE=Y40R41NN:.*W><1:$ D
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MXTMIA7;=4:O.;/7R*U+H"L2K-ZH+Y$LF?#A7N;#!-36H%0
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MK8MNW/T>O>];U,H/C/?9XST=$9B]WM^AMG<[2$[MNX]-?)J?T032W9!0
M           !%>;Y%AQ<3WT_D^NS;9L%NFJ.YZ]37I3$N-&-:2WLN0DK?)1J
MT+1M)F>NFAD>@)A(-$<@.T:D.TN0N73'(4=5.ENN..K=8-M)M+4XZ9N+-2=#
M,UGN/RGU!#TP               0U1',<'G.^6J9<=0DY01;5(7=%L./S%08
MM,6Z\4-]EE:2C)6XI*R4;:C7IIN(MQ:DIE!       *N\J?P=Q;^<FB?498Y
M/OAV2CYD>S4Z[N;VF[\JKGI<@/GCL    '4<0ODTK_PNJG]:P/HW=#L4]>>:
M'&]\NVT_+I^M*.<Y%@Q<37N_E&OSK7L!, BN:O4Q^7'EQF%.MI2IIR E4@C-
M9I+1"3U(]#(TF9#J7*0DZ";!P89Q5J=BFPWX9U9J4I3>TMIJ-?G&9EY=>OT0
M0^H                          >=5ZM3:#2:G7:Q,;I](HL1Z?59[QZ-L
M1HS:G7G5G["4(29F Q,RAZROC1>==<.K<5X>585/,V:97KLCTDY"FTF9$:&I
M$2<;:3U,R+?KUZD1] 7V93CQ9]8+864LF61@>R<#(QG3;B](^!<@38J(43P5
M/DU!6V'&A,)\\HVWH9=3U]C0$3#5,%0  5DY9V'FB_\ $TJ#@2^)MDY$I4YF
MHPO!R_ '4V&T+2[ 5)Z=HU[B6E1F1;DDE1DE1F1,,Y<D4#GCRWM6Q<#WYAZ/
MC&BTJH1I.0<E3)#9LS5PDJ93([27C)1>>IPVV=_<<VF2FT$"VB'792XS9HXY
MY^L?D!QDLM&3*'3+9IUL5ZRW'6VY*4T^E-45)J02FE+0ZPPRYO:U-+J5&M.T
M^I&.+W..G$[*&1+LY#YMY*4=NS*]G>@5>UJ;:;2DO2($.KI0T[)-.]PF^PVT
MVVPE:S7H2E*)/FF8F5>*9BKG;B_$-_<0*#B"-<MK7G5'D0<F1)31,-P9RFDR
M2;=4^VA#;R6C,^^E*T$M9&GJG0G1K6+S%ZO^X*EPWQGB6S)<.L91Q/)D5M)F
MLF8]5DU-3CM3B,O/;"1JIQ'94O:1DTDE[=VY)$3I1M4<5<NN9.2<)PL]XQ:Q
M=C_$*RDW/5'722JK.+<CJEFVT3JU*=DIBH0G:6QK5:MWG$DQC$-L 58A>IK_
M -8[^*'^&P7J;>@H                B2RFK2;R9F%5$QI5+4N5QZB>^^_I
M=,*)!N=7@E'%7!F$M7BRAMF;3A[4]M9F774S!*6P0        Y>\;TM7']!E
M71>=;C6[;\);3<JJRS,FD*>63;9&9$9^<I1$705JJBF,98[MVFU3M53A"&OT
MN>-?Y8:!_P!(Y];&/\Q;XWE_R66]>#]+GC7^6&@?](Y];#\Q;XS_ "66]>%C
M1F>X 1/F7WJ>].#[\,<5;*-,]/TCPUN4:F>E9+,OQ;?AYQL[T;&HJ_;''-?-
M02NA_2F(2P   "LV>_PVX\?#EG_>0.>WW\?*_,=/N#L^;^5*S(Z%S  \ZK_]
MTU3^Y'_J:ACN]">262STZ>6&>F'ODVM?_P!R_P#9#H^)4:GV/.?&J\.!)8L\
MP  /)QK\YB)\ 7_L\QTG=3MWX)YX:OO)^F?^R.:5YQ]+?-41X@;M%N%?96AC
M2JXR8.]*P=<AU6F%2SJ]2W-E(K$9)+63\>5HDVWNF\D_2EIH"92X"
M9L9E^?+ _,4U_I,^.HW;V"?F?TPQ3T_([<67  !!G);Y"<E?<LOJS8]>1^/3
MRJU]&6E^./D\L+X.TO[$:'(9GXM7+/.O3J=H,*0
M 8A<I/Z4'CI_%'W3E@O&IMZ"@
M                           /Y1\W?/IOK\[J_=9(,D:G]7 ,:,,SY3H^
M$\979E&OTZ95J1:,=F1-I]/[?B74O2&HY$WW5H1J2G2,]5%T AG)^M]PE^3.
M^/\ T:;]N MLO8H7K;^/E1J+$.LV=>]O0WCVJJSD6#)::/\ XSJ&9AN[?_J$
M*/\ 8 V6D-A9 LO*%K4R]; N.'=-KU=)J@U:$HS09I/1:%H425MK0?12%I2I
M)]%$1@J[$        !23D)SUQ!QLOQG'E\VW>-5K3]*CU=$JA0Z>_%[$EQUM
M"37)J$5>\C9/4MFGDZ@F(Q09^MUXW?B3DK[VT?\ QR"=F4IX4]8QA+.^3;9Q
M3:%K7Q3KBNKQOH^;6(--9A(\#"?G.=U<>IR'"U;CJ).UL_.TUT+4R(FG!?L$
M #$+FU_21\1OX@_Z83@7C4V]!0 8-5SC;7.8O-GD;;^3+_FVC%QLXR5!IB&D
MORETITR13RALNN$AICM&EYQ1$>JW"/3<X9D7QPA+_P"I[QM^6*Y?WA#_ /."
M-IKU3H::=3X-/0LW$08[4=#BNAJ)I!((ST^CH"K[             &(6;?Z5
M_$7]X/L5\%XU-O04                0_EE5E)E8M.\L=U._P!U5\TM-IR*
M;2SJ14*KFETXU7E*)2?#,1S(]SQZD@U)/3V2)3 "       <AD'\ KW^X%2^
MQ7!6OHRQ7OAU<DJ+\3?F]8V_N6;[H21SC1Y/X-/(L4#T@  A.V_GKVW^:>?[
MJI'LR'Q)Y%;':HZL\\+\C<MTB'$/O*[61RLK'U3Q\VB^ZRFYFZE3%4STS6"-
MHI58C$I2N^Q*\WMO%H2R3Y"T 2\               "'\GJLI-P8E*[,=U.]
MZ@NZVTV?6(%+.H-4"H^'=4BHS'247AFDD1I[AD>BC2>G3<DE, (
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M!QW4\J6OXJG%+LJCTLZQ,DNJFLI86W$2I)J)EPTN*/7HE)GU\ADPF $
M           (?QZJRCOG,16WCNIV?<"*Q"3>MSS:6<&/<,DX:5,RH<DU&4I#
M2#V*41%HK7IYVY1*8 0      #-WFM\O/#3[H7C]BTP=+N+X%_\ #SRQ5]*G
MRNR&5<  'CW%^#]<^Y\KZDH6IUP)4X+?-/PY]SIONE+&IWYVVYRQS0K:Z,+:
M#4L@              ,P_6EV9(N/$&/Z^_(<7;%EW@Q-O*E1W4HE.TY]E;+T
MB,VM1$XXPDSZ$1FE*E+Z(2HP6I>A0K']5I,HM*E0IN'D1)$5I<9-4N&*Q-)!
MI+3Q#4V:B0AS3Z8G4DK7R]0-*V6!J%QSH5(K[7'-^SGZ*_,:7<9V=48]18*4
M3>C??7'>>)*]GD(S+H")3T"        &(7KE/]7'^-_^! 7I;>@H
M        Y.^YMT4ZT+@FV7;,6\KI8B*.C6O-F)@1YKIF1=IR2M#B6R-)GU-.
MA^3IKJ Z.&Y)=B179L=,.8XRA4N(ASNI:=-)&M"7-J=Y)/4B5M+7RZ$ ^D
M             '#P*A>+E_W!39MGPX5DQZ5"<HM[HGMN2ITPUN=^(Y")!+;0
MR1ZI4:C(]QZ>4] [@       %7>5/X.XM_.31/J,L<GWP[)1\R/9J==W-[3=
M^55STN0'SQV    #J.(7R:5_X753^M8'T;NAV*>O/-#C>^7;:?ET_6GJ_IMT
M4ZSJ_-LJUHMZW2Q&UHUJSIB*?'FNFI)&VY)<0XELMIF?5.AZ:=-=2ZER;JF%
M.K897(:)A]:$J>82K>2%F6JDDK0MVA]-=.H#]0
M   !'.8*/2+BQ)E*W[@JOH*@URT:W3ZW7-BG/!Q),!YI^1L21FKM-J->A%J>
M@$,>N&?+?BMA+$2<9Y'CQJ==MO5>I>D+M@T=RIQK@;>E..QYJ'V6%.EM94EH
MDNI29)0GZ)I27F)7ZQ-S)XJY6R!0+!QM5O$WI7O%>A6/0,J%N\+$>E/^WN1T
M)1HRRL^JBU\GL@K,2NB"             !B%ZFO_ %COXH?X;!>IMZ"@
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M(LAUBC5B4_7YSUKKHL5V*ABB+4GP4>23RW#6^@MV]:3(CU+3R:F';@
M S8S+\^6!^8IK_29\=1NWL$_,_IABGI^1VXLN  "#.2WR$Y*^Y9?5FQZ\C\>
MGE5KZ,M+\<?)Y87P=I?V(T.0S/Q:N6>=>G4[084@
M  Q"Y2?TH/'3^*/NG+!>-3;T%
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M$$2U;E:&>ID9ZGU!1]P            #$+-O]*_B+^\'V*^"\:FWH*
M          .,O!G(#SMIG8DZAPF&J_$<O<JTQ(>4]0R)?BFH'86@D25'M[:G
M-4%UU(P'9@       Y#(/X!7O]P*E]BN"M?1EBO?#JY)47XF_-ZQM_<LWW0D
MCG&CR?P:>18H'I  !"=M_/7MO\T\_P!U4CV9#XD\BMCM4=6>>%^1N6Z<99;.
M0&&[F+($ZASW'+@G.6@JAL2&";H*C1X%J:4A:]TI);NXI![#Z;2\H#LP
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M#=RWN[=,ZAR;2?DQ#QY%IK+[<YB.F.12TU%;JC;6M3W5!MD1$GR_L!V@
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MFHRZ*T(R/0QU+DW?1"2F+&2B0J8@FD$B6I1*4Z6TM%FI)$1FKRZD6@#Z
M                      !YM9H]-N&CU6@5F*F=2*Y#?I]5A*-24O1I+:FG
MFS-!I41*0HRU(R,!AWE^]_5>XINRHV9$P5,R%5:,^N+69MO2)2H$=]LS2XR4
MF34V>ZM"BT/MI4CREOU+0%XQ6MX<0N"62:ZSD# -@(M')-E(>==I%2=F-U:
MU,9<AN/$RJ;)8=:<0\I&]"EDG<6[:HR!$XM*05             &(7J:_P#6
M._BA_AL%ZFWH*                (8L16-596S<5JJJAW^3] ^,\IAU+P9+
M\ HJ;X/Q7]JZ>'(]_A?9T[G7:"4S@@         5#YQ?-]K'W?MWW6C#SYKH
M>6&MWM\">6.>%O!Z&R  !#><RQH=FTXLJG4$VX=QT7P*J;Z0[Y5/QK?@=?1O
MMNSNZ;]?-VZ[O8!,)D!"F^:UTV7F2CT^Z;XK=F6; L>35ZG(I%1<@^VLS%(0
M9DDE$M2MVTB))J4>A%U')[XFFK.TTW;E5%N+<U3LSLZI\/&[+<D5TY"JJU:I
MKN3=BF-JF*M$T^'BA'>*\77!D>;5KTGWQ?-I8F0ESWLM3:X\53G-H(]9;KIZ
M-M-=#5]+^P1F1&H]?NS=MS.557JKERBQ_#C5.U/CQU1'D^UL=Z[TM9*FFQ3:
MM5W_ .+"B-FG[L1KF?+]CRJ#BEK,-_LKLV[[Q=QA94H_&7S5JJY)>F3D&6J*
M1N0@FS(NANZ'H7G?\5*L5C=G^0S'_5<N>YHGIU58S-7W.+E\O%#+?WK.[<M/
MOK=OW]R-%%-,1%-/_P"YQ\G[</\ 5PV9(N:_V<;89R!>]4F4ATE7W>,^NOOT
MVF-D9I-E)-$WW'=2/H2O*6WV%FA?RDWLS^7REVY,QTZIJF::?%HPQG]W'A&7
MSL6,M^9SMJU$5="B*(BJKQZ<<(_?Q8^=G:#0L9QU6U:>0\@W-?[48I=30===
M7%IL5!)-;\M+:",C61^:C<6FI*,_I273?5%O)1[NU=NU7<,9]+13''.$</%^
MS'+N&Y<ST^]O6;-%K'"/0C&J>*G'Z9_;A?&UGWI.+;=DR7ER)$BU8;C[[BC6
MM:UP4&I2E'J9F9GJ9F.VRTS5E*9G7L1S.#S5,4YRN(T1%R?:4BP]\FUK_P#N
M7_LAT?'*-3ZOG/C5>' DL6>8  'DXU^<Q$^ +_V>8Z3NIV[\$\\-7WD_3/\
MV1S2O./I;YJAC"IXT.#D,\9'4SB^_P KA7B=4]([O? 3C95#L>DO.[6[;M[7
MM7EV>R"93."       9L9E^?+ _,4U_I,^.HW;V"?F?TPQ3T_([<67  !!G)
M;Y"<E?<LOJS8]>1^/3RJU]&6E^./D\L+X.TO[$:'(9GXM7+/.O3J=H,*0
M                   8A<I/Z4'CI_%'W3E@O&IMZ"@
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M6,JY/KC?QA5TK[5/>G.G%N4E->D8K'CDI-#39[-J6=6NNJ#/4P3*: 0
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M"W; *92SJM5I;\^/(0]X^/X1)+II*D$2Y';2>TM-#U/334B834"
M       $*XV5C$\@9M39%<J%3NY-<@?&C3I;\]V/!J!P4'&;C(E$3""5'VFK
MPYFGR$HRVDDB4U @      &;O-;Y>>&GW0O'[%I@Z7<7P+_X>>6*OI4^5V0R
MK@  \>XOP?KGW/E?4E"U.N!*G!;YI^'/N=-]TI8U._.VW.6.:%;71A;0:ED
M             !EKZUR[Z_1\+6-9],J"Z11<@76U"NNH)-24JBQ65O(8=,C(
MC;4YM=41GU[9>QJ"U+N('JQ^(YV5&I"[>JE1JKD%*?C$16YJ9KBU((_%(:0\
M<#K],1>'-.GL&!M2CKU5UQ5GWEYGQF[<!7/:>,;M*/9=80:C97'F'([OA]QG
MM9<6P3Z4EY#<4?[8"IJN"H       #$+URG^KC_&_P#P("]+;T%
M       $?96?B1L=7:_/QX[EB&U!4<C'3$:/,75D[DZQRCR_:G/^,:5$?0NA
M&>A&'94I:7*93G$4]=)0N*RI%*<2A"XI&@C)E26S4@C;^E,DF9=.G0!]X
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M'2+R.:I(G@;9@H             ,0O4U_P"L=_%#_#8+U-O04
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MQJR%1:/1)+%P3V+6:H\MV6E^AH4DH,B2IU#>Q]Q.[>A):%T/IJ:2#MP
M  9L9E^?+ _,4U_I,^.HW;V"?F?TPQ3T_([<67  !!G);Y"<E?<LOJS8]>1^
M/3RJU]&6E^./D\L+X.TO[$:'(9GXM7+/.O3J=H,*0
M   8A<I/Z4'CI_%'W3E@O&IMZ"@
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M=]TUVT"LBV(%RL5"X8<.\US9_@E4^BN$OQ,Z.1H43[C1DG1K4C5K_ND';@
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M4DU#,F44%'D1.\U)>A0W'42)!27F2[/<>=;;]K9,VVT-I(CZ[4$3+1P%0
M        $69T^1+,7P'N'W-D 0SH]4%\B63/APKW-A@M4UJ!4
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M+&.&YDCQ$:0TF/N2MR-#1&-2&"-1)-Q)J4YJ1$I6A;2(F5ZP0
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M4'CI_%'W3E@O&IMZ"@
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M& X+".#K#X^V:[8F.H\V-;[U1?JJVY\E4IWQ$A#;:S[BB(]-&DZ$"9G%, (
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M"-E!=M4A%T7.XQ,3!E4Q#KQPV&7EJ.,I;:E+-1-I)>FFXSVEH2F4$
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M]A%YTPW1!0             8A>IK_P!8[^*'^&P7J;>@H
M CRV)E3?OC)$67C8K5@0W:7Z-OWO0W#N??%/N+-MCV]'@MI,^W^7]IYI )#
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MR$Y*^Y9?5FQZ\C\>GE5KZ,M+\<?)Y87P=I?V(T.0S/Q:N6>=>G4[084@
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MABMMLPG2ME?8=_\ E92I:DK;VEJC<SY^BC(NIDE026
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MSB+0B]E*0DT       &;O-;Y>>&GW0O'[%I@Z7<7P+_X>>6*OI4^5V0RK@
M\>XOP?KGW/E?4E"U.N!*G!;YI^'/N=-]TI8U._.VW.6.:%;71A;0:ED
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MJ8ZER;JF._V&?$[/$[$^([6NS?IYVW=UTU\FH#]0
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M?&)?+-3ILF1<OI.?5]T9YAXV&O%5)II\]A$9;33H7L G@?TD@H
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MX5KVS1V^U3J-3VB:9;(S-2E:%U4I:C-2E*,U*49J49F9F"KIP
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M*^(N.KG=>B*A7;,I[-3:CMHDM*?0<5]:&U&\T2FB,SZ&K4NI$/2V;O
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M<7X/US[GROJ2A:G7 E3@M\T_#GW.F^Z4L:G?G;;G+'-"MKHPMH-2R
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M+DX23 -E4&&J,^J5'4PV<>2M1K4X@TEM6I1]5&HNIF?E ?4
M              #YO!Q/%>.\*SXW9VO&;$]W9KKMWZ;M-?8U ?2
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M             /Y1\W?/IOK\[J_=9(,D:G]7 ,8
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M<IT"3-*EUTDO>$J,E4<R)EEDMVYQS5"=2,RZ:D3"900      #D,@_@%>_W
MJ7V*X*U]&6*]\.KDE1?B;\WK&W]RS?="2.<:/)_!IY%B@>D  $)VW\]>V_S3
MS_=5(]F0^)/(K8[5'5GGA?D;END-8:^+TF<F(Q[9]0LYI&0*XF\$5"$_"])5
M[<UXZI1B?4KNL/GMV.(T0>ADDBTT!,IE!               (:RFG'BKBP^5
M[VA4;GJWOM;]X$^#!E3&Z35BC.J1,E+CF266R02BWN:I(S)1EHDU))3*"
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M3<<E*U2A:D]5F1Z^0>/>V6L4Y:FY;HV9FK#7,\$E&,583.+24<TS
M                    (LSI\B68O@/</N;( AG1ZH+Y$LF?#A7N;#!:IK4"
MH               "'K :QZC(N:%VK:=0H5W+J=*+(M>E0Y,>-5Y)0$JB.Q7
MGC-IY+3"MBC:(M#^F+J1F2F$$       I%RX_#?BW\/7/L4:_>'1CE:K>73M
M<L\R4!JE    $<^K\^:]9?W0K/N@^-YD_APON;LU/+/.FW/WQ<_%?6OC6M.H
M7M9'BZ:52MZF0950DNNG.8*,M+$,R=,FGC0M1D?D(_+]*?I;:$S @
M!F]B'\#S^ZE1^RECXE7TIY9YWV7,]*.2.9* JP   Y.B_./PO_<U>]S9 W7=
MS]1M?B]F7CWS^EW_ ,'M0OZ/JKY:AC'!8Y]_V:3L^TZA0+K]-0$Y'K,N%*C,
M5684))QWHKSYFV\E#1[3-HB(CZF7G$I1*6*K+7 I=2G-I2MR%%>?;0K7::FT
M&HB/3V.@M1&,Q")93+YD\KX^'(6>)^.<94S'-20LZ;49=1E-R9#B7W(Y,,Q?
M&&ZMU3C2M$I29Z$:NB2,RZG_  ^2F_[B*ZYKCQ1SX,&W5LXZ';4+D'SEK>/F
M,GO89QU;=G/P%U7TC7ZC(IJFX*2-1276WYI*;0I);DFHBW),E%T,M<%S(;OI
MN^Z]Y7-6.&B(G3Q:EHJKF,="&^,5_P#,2L4W*.1L9XEL^JV[DR\I]QRZM6Y<
MB!'7*<2AMXJ>3LEI:XZ.WIO41^=J6[5)D7LWG8R-,T6[E=4313$81$3Y]&M2
MWMZ9C!W>-N6W,7+UPW7;^.\1X]N5%EN^'K=QL3)::1W]23VF)RYB6WE'U,NV
M9D9%N(]NAG@S.ZLCEZ*:KERN-K5&$8^;#0FFNN9T8)/PWRDS/<O([X@LI6O9
M-)GQ:1,J%75;,M^:[$?802T1W73D.M)7H>JD?3%J6NACS9S=EBC*^_M553&,
M1&U&&/T+17.UA.#R>:WR\\-/NA>/V+3!EW%\"_\ AYY*^E3Y79#*N  #Q[B_
M!^N?<^5]24+4ZX$J<%OFGX<^YTWW2EC4[\[;<Y8YH5M=&%M!J60
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M:3,]5I,NFGLCJ7)NO86ZXPRX^SX=Y:$J>8W$O8HRU4G<70]#Z:D _4
M                                      !B%ZFO_6._BA_AL%ZFWH*
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M+ZLV/7D?CT\JM?1EI?CCY/+"^#M+^Q&AR&9^+5RSSKTZG:#"D
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MI33-RXX7)<>B$DY3<.8VA+BE&KMID(>86LS6A>J-VS5)EM<-S 4
M    '\H^;OGTWU^=U?NLD&2-3^K@&,                     8A<VOZ2/B
M-_$'_3"<"\:FWH*                   Q"S;_2OXB_O!]BO@O&IMZ"@
M            #C;P^,+N6G[P?>[VO3\3W\^^#Q>[T!HOQGHWPO3QFNSM]WVO
M3=N]@!V0       .0R#^ 5[_ ' J7V*X*U]&6*]\.KDE1?B;\WK&W]RS?="2
M.<:/)_!IY%B@>D  $)VW\]>V_P T\_W52/9D/B3R*V.U1U9YX7Y&Y;IQMF?&
M%V[E^,+WN]WT_.]Y_O=\7M] :I\!X_Q?7QFF[O=OVO738 [(
M   '%W7\8GI*S?>/[W/0_I=/Q@^G/%^)]$=M>[T7X;S/$]S;IWO,VZ^SH [0
M       $,<COF\YY_-W='N3)'LW=VJUUZ>>%:^C/(I;AKY(,5? ^A>Y[ Z7-
M?%KZT\ZM'1A)(P+   C?CE\]K+OYMZ?]E1!&]>PT=>>:5(Z?D:<#EF4
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MGW/E?4E"U.N!*G!;YI^'/N=-]TI8U._.VW.6.:%;71A;0:ED
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M=L:.GQ!R]K2"\4K;J[HDO//:1%YWEZ= '[@
M                   ,0O4U_P"L=_%#_#8+U-O04        4TK/.[ M#K5
M:H,Q^XG)] J$FF5$X](>=;*1$=4TZ25I/0R)23T,:^O>=FF9B9G&'86>X^\;
MMNFY3%&%41,>E&J8QAYWZP+C]_Q[I^\C_P#YQ7_*V..63_0MY\5'\T*W8_Y:
M8GMWD9G_ "74D7 FU\B1+:9MMUNE/+>4JET]$:3W6BZHT6D]-?*0\MK>%JF]
M77,Z)PP\D.BS_=3.WMV97+4[.W;FO:]*,/2JQC">19']8%Q^_P"/=/WD?_\
M./5_E;''+G?]"WGQ4?S0ZRP^9V%<C7E0;$MUZNIK]R.N,TM$VENQFE+::6\K
M<XH]"\U!C):WA:NU133.F7DSW<_/Y*Q5?N13LTZ\*HGAP6P'N<LA>Q&\9(RO
MFY=IM5)O(*WK?^-)<LJD412R@*.F>$.5_:IEX<SW^%Z:Z=SSM 2F@$
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MQ&_B#_IA.!>-3;T%                   8A9M_I7\1?W@^Q7P7C4V]!0
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M&HW!=::E2E9 MV5.?DQ:-(. DHK41ATB;82\RDEK)LSU5Y=-"21*7P0
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M>22VG4&2DJ2HM24DRZ&1EY# 8B^N4_U<?XW_ .! 7I;>@H
M  C?+[M&9QG>3UPX^FY5HS=/4J?CVFP6ZE*JJ24G1AJ(Z:4NJW:*T\O34M3(
MB AV](-A5)IBHM.72(RHC!QZ2XTEE<5LVT[6%-(,TH-LO--)'H6FA /1
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MFZEU(AU+DX2%#[?A(O:C'":[*.W#4E*#93M+1LTI,TEM+IH1Z /I
M                                     8A>IK_UCOXH?X;!>IMZ"@
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MFB08]/C&\X24K=-F,AM&Y1)(C5IJ>A#%=O5W9VJZIJGCF<>=,1$:G1C&D
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MRN;!CS%QC-4=;[2'#;,]#,T&HCTUT+R?0 ?8
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MAUNQF+;H5-F0D6G=+4]B4Y7V5Q4*?>=C-H2Y&..[JT1.&9J(M2T3Y0[@
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M5P  >/<7X/US[GROJ2A:G7 E3@M\T_#GW.F^Z4L:G?G;;G+'-"MKHPMH-2R
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M@WVW?==J%0KM,D8]D4R(U;UO-1%(J$>H(4HY3STHU&E:%I-))22>G^^':
M     J[RI_!W%OYR:)]1ECD^^'9*/F1[-3KNYO:;ORJN>ER ^>.P    =1Q"
M^32O_"ZJ?UK ^C=T.Q3UYYH<;WR[;3\NGZT^WU#O*H6E7(>/JU3[=O-^.2:!
M6JI%5-AL/;TF:G6$K0:R-)&7EZ&>NAZ:'U+DW3L$\EAE,E:79"4))]Q"=J5+
M(O.-*3,]",_(6H#]0
M &(7J:_]8[^*'^&P7J;>@H        R*Q1_UC+GYS+G^RB',1TZ^M+[Q'P;/
MRJ/9A+8LH  #AV_G'<9?NS7?<Q0M8[11Y7CWQ^EYGJT^U#5(=&^+(BLE=HJR
M;F)-$R75;LN5+U$]]]@S*IXR#;"O!K\*B!#V%X0IB-SKA;E;UEKTVZ E+H(
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M7C4V]!0
M                                 &(7-K^DCXC?Q!_TPG O&IMZ"@
M                ,0LV_P!*_B+^\'V*^"\:FWH*                (TR.
MU'<>Q\<C**\9]J[J<MEE#\)GWQ.$ETDT%7C$J-92M?I&?;#V^9UZD$E@
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MN[H]R9(]F[NU6NO3SPK7T9Y%+<-?)!BKX'T+W/8'2YKXM?6GG5HZ,))&!8
M$;\<OGM9=_-O3_LJ((WKV&CKSS2I'3\C3@<LR@
M     (LSI\B68O@/</N;( AG1ZH+Y$LF?#A7N;#!:IK4"H
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M=,U56IB(C&=,:H\J;!N&D &;V(?P//[J5'[*6/B5?2GEGG?9<STHY(YDH"K
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M^I*%J=<"5."WS3\.?<Z;[I2QJ=^=MN<L<T*VNC"V@U+(
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MU(R,@4?Z
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M9413<:S;0JC<^F^G;UD0&(K%SK.$GM2(\EM1KDE&1[2HW"+:9:$ DX
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M.H4FD,XY9I4%RVZRS(=54WJDMQXIC4A@TDVEM"";-!D>O7V=3) =H
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M:^X\S0KBIE:=CI);[4"6S)4A)GH2E$TM1D1G[)BE=JNCI1,<L$3$O=%$@
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M5FQZ\C\>GE5KZ,M+\<?)Y87P=I?V(T.0S/Q:N6>=>G4[084@
M          H%ZQ?C]5<Y8+5/M6&4Z]<8RW+@I$)"#6_,A=E2*A#9TU/>M!(=
M21%JI324%U4":9?!ZN[D_&SGB:+95PRT)R7BV''IU694KVRH4MM)-0Z@DCZJ
M/:DFGM#/1PB4>G=20)JC!H8"H
M                                                "%^0.;;9X^8K
MN7)ESJ)Y%+:[%"I!*VN5&IOD918;?E/SU%JHR(]J"6O31)@F(Q8[\.[4R*Y;
M?*+GK="6DW,5IWA4,?29+)FT_6/#O3IDYII2NC#*VBCH+4R,C<06FP%IXF^
M*                   Q"S;_2OXB_O!]BO@O&IMZ"@               #B
M+SIE]U)VT#LBYX%M,4^X8<R\T38'C55"BMDOQ,&.9K23#CIFG1W0S3I_N&';
M@       Y#(/X!7O]P*E]BN"M?1EBO?#JY)47XF_-ZQM_<LWW0DCG&CR?P:>
M18H'I  !"=M_/7MO\T\_W52/9D/B3R*V.U1U9YX7Y&Y;IQ5E4R^:8FZ2OBYX
M5SJGW%/F6F<* 4$H%$=-'@H#VBU]YUG16YWINU+ITZAVH       *19O^<-8
MGP1D_9#X^==\.U6^I]<OHG=3L%SYGU0^P<JW0  .(R3^ -V_<Q_^M$5:F;+?
M%IY5Q,0_)-B_X)43[ 9'V'=78[/4I]F'RS?';;_S*_:E]MVTR^ZA4K+>L^YX
M%O4JG5E,F^(<N!XQVI4PFEDJ)'<-:>PM3AI/?H9E_P#>J][7.W       !#'
M([YO.>?S=W1[DR1[-W=JM=>GGA6OHSR*6X:^2#%7P/H7N>P.ES7Q:^M/.K1T
M822,"P  (WXY?/:R[^;>G_9401O7L-'7GFE2.GY&G Y9E
M             19G3Y$LQ? >X?<V0!#.CU07R)9,^'"O<V&"U36H%0
M         '&V_3[WB7)>\NY+B@5:V*C*B+L2CQ81QI%-CHC)1*;DO[U=\W'R
M-:3T+:73V=$AV0       *1<N/PWXM_#US[%&OWAT8Y6JWET[7+/,E :I0
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M+\'ZY]SY7U)0M3K@2IP6^:?AS[G3?=*6-3OSMMSECFA6UT86T&I9
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M56OHRTOQQ\GEA?!VE_8C0Y#,_%JY9YUZ=3M!A2
M  PJY-8'RUQ#SN]RKXY414VQ92WZA<]&C-+?CTQR41^D(LV(TI*S@/\ ]E2M
M.B65=/:]C2E%XG%?KB]SIQ-R1CQ*&;Z;%R=L+Q5BU)Y)^)62=5+ILDR0F2GH
M9[=$N$1&9HV^<968P7;!
M                                          @7//)/$W'.W?3F1[A3
M'FRD*50[4A[7ZK45%J6D>-N3YNI:&XLTMI\AJ(S(C)B,6,LR3GGUH&5;<UMM
MZQ,"V9/6F1.;4M42"PXI)R%JD.$E,RH.-I)"4MHT;U+5*$&M:BVINTQC6R8N
M-U8DC4)F/C]5 <ME5O-&I#9TQZ.J*XR:DF2M5MJ,E*UW&9FHSU/4%'=
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M%KZT\ZM'1A)(P+   C?CE\]K+OYMZ?\ 9401O7L-'7GFE2.GY&G Y9E
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MWOWM][KU<ZF>(?P//[J5'[*6/DM?2GEGG?4,STHY(YDH"K   #DZ+\X_"_\
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MR/QZ>56OHRTOQQ\GEA?!VE_8C0Y#,_%JY9YUZ=3M!A2
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MC_V"V/K@&@]^_K??Q1_[!;'UP#0>_?UOOXH_]@MCZX!H/?OZWW\4?^P6Q]<
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MQEX/9 9=M,K$@T.:P[7XC=[G6GY#*F:&9+\4[ ["%DN2D]O;2YH@^NID [,
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M%6&,FY-85;^'[?4N99=ES%DVB8ALC,ZC43,R3LVEKUZ&70O,U-REFS7O:O\
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MX/US[GROJ2A:G7 E3@M\T_#GW.F^Z4L:G?G;;G+'-"MKHPMH-2R
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M\6O0^>DTFJ\@:JSD/(;*[>PQ;RU3;/L^:HFBJ)-$9^DJEJ9)[>TC,B,]-/\
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MAF?BU<L\Z].IV@PI
M
M                         '#Y+ONF8PQ[>N1*R@WJ;9=%F5B3&2HD*?\
M",J<2PA1D9$IU1$A/3RF0#$J)FSGY=^'+HYBTG)M(H]B6]5W$Q<:-0(ZD.4Y
MN2W'D+;:7%7O:9<7M,W7^Z:4NJ)1:)WE\(U-A>/&78^=\,6%E5F&BG/75 4J
MJ4YI1J1'G17G(LQI!J\[8E]E>S7KMT,%9C!E5FW^E?Q%_>#[%?!:-3;T%
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MMMS<1)4AQ!IZI4,(F&D6=/D2S%\![A]S9 *PSH]4%\B63/APKW-A@M4UJ!4
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MQKF:9B//,(0Y4_@[BW\Y-$^HRQSW?#LE'S(]FIT/<WM-WY57/2Y ?/'8
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M_#RK@  @6^?G'\0_A94?L=@>B.RW^JQUZX:U#C68
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MA'KU P3H"
M
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M5[T_C072(OOT\?Z#]'+B3-WH[P_?[FUDMNGBF]/H]?H"/R-CU89([S;RG_\
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M*9C;'U-OV9Z0OFGVU28UZ3^X3O?JS4-I$YWN)(B7O?)9[B+KY04=P
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MZ1]]%*]+L2N[W*=);B>TH:2I6V4II70^FFOL B<&IP*@
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M=_)#_+8(VC]37_M'?R0_RV!M'ZFO_:._DA_EL#:/U-?^T=_)#_+8&T?J:_\
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M,G341I(BT\@(VI==^K,X@?B#4_O]5/M@$;4GZLSB!^(-3^_U4^V -J3]69Q
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MUJA3GD,M?]P%HE?K]69Q _$&I_?ZJ?; *[4GZLSB!^(-3^_U4^V -J3]69Q
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M*_5;FQ=;4NBU>M4_T94)$BI3)J5QC=0]M)$AU:2/>VD]2+4"9Q65!
M
M
M/(K]"I5T4&MVS7H::A0[B@2:968"S,DOQ);2F7VE&DR,B6A9D>A@,CI7JRLG
M1(%9Q=;')>;3./\ 7ZNW5*A9C\-UR09H-"R);:'D,.K(VT>=JE*C2E9HU21
MMM-5<=V%;N+K&M;'MIQE1;>M&G,TZF-K,E.*0T7G.NJ(B)3CBC-:STZJ,S!5
MV8    #X:G3859IM0I%29\33JK&=ASX^Y2.XR^@VW$;D&E1:I49:D9'] !%F
M'L!8EP'3:Q2,2VG[TZ=7Y+<RKQ_'SY_>>:1VT+W3Y$A2=$]-$F1 F9Q3""
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M(Q+:?O3IU?DMS*O'\?/G]YYI';0O=/D2%)T3TT29$"9G%,((
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M?O7^-:@2:Y[SO&^@?#SY4+M>D/#^(W>&<;W[O#-Z;M=-.GE,$Q."?00
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M1;M4J%<M^SJ'0JW5]_I6L4ZGQHLJ5W%]U??>:;2MS<LMQ[C/4^OE =4
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M%1;[,ZH4>FQXC[K6I*[:G6T$K9J1'MUTUZZ 8I-
M
M
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M/MQH[1:N/NJ)"$D9Z=5*,B+J8!'D1Y;*)$5]N3'=+5M]I1+0HB/3HI)F1]2
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M:7*S==NMS':>NIL-/LH*2RE"W&]LAMI>J2<2>NFG4#!(8
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M-7MQFCVI4(E=LFGKJ$JYW'FE1'TH;B.&E#1>>1Z2R+K] P3AH6K!
M       *V\H^25$XN8_H]_UZVIUTPZQ<$>WVZ?3W6F74.R(DN63IJ=Z&DBB&
M6GEU,@3$8IZMVL-7%;]"N!EE4=FNT^+4&HZS(U-IE-)=)*C+H9D2M#!#V
M
M                                                      &(?K-.
M..%,5X=H=_6!846V[ON+(4:)6JTS(ENK?9ET^J2GT*0\^X@M[S*%'HDO)TZ
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M1E"S8%5IE K3\N/%AUIIAF8E4-]<=PUHCOR6R(U(,RT</IY=/("LQ@EX$
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M>V3;SQ&6WRF9D"LQ@L,"     !_AQQ#2%NNK2VVVDU..*,B2E)%J9F9]"(B
M>4U<5OONMLLUVGO//*)#32)32E*4H]"2DB5J9F?D(![     #'/FWSFPM<^-
M,Z<>Z;%N5-^QIKUM.//064T_QM(JK:9!D^4E2]AG&7M/9J?3H0+1#YN&//'"
M-DXGPM@FLQ+F5>S;Z:$IV- 87!\54ZFZ;!]XY*5;/[83N/9TZ]# F&RH*@
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MDI2E):FI1GT(B+RF \MFX:!(=;8CURGOONJ)+3+<EI2U*/R$E)*,S,P'K@
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MKD>;;R#BN[;=19M2I_<VFMBBOQHJO2+Z4FO9HYM4:4DHM%*4@B8;" J
M*A1^>O$:7(8BQ\TTUV1)<2TPV4&ID:EK,DI+K$(NIF"<)6]!    #*SE]RXR
M_95=S'ARA\<*Q=-F%0'*=\9K!5#PO8JM&;=DR-6H+C.D94A:5>VZ>8>IIZZ%
MHA2#AURXR_A'$LFS;&XX5C*U%=K\RHKN> 50-I+[[4="X_\ :T&2C5!-D9^?
MKYWD!,P_HFITEV93X,MY@XSTJ.T\[&5KJVI:"4:#U(C\TST\@*/L      $+
MY7Y#8:P?(HL7*M\Q;/D7$V^[16Y$>4\;Z(QH2Z9>&9=(MIN)\NGE!.#T\59O
MQ9FZGU6JXLN^/=]/H<A$2JR8[,EDF7G$;T(,I+31GJGKT(P1@E4   $(\ALG
MW3A[%E;ORS;"E9+K],D0F8MH0B?-Z0F3);9<6GP[+[GM:5FL]$'Y.N@)A@9E
M;D]E*\.6N(,RUG E5MJ]+*I4*'0\8/%.\556F)=0>0ZV3D-M[1:I*T%L:47M
M9]?+H7B-#9[B=R,R3G_W_?&%A*IX<]Z7HKT1Z1*87I'Q_C.]V_%Q(O\ 8/#H
MUV[OIRUTZ:E)C!<,$       J%'YZ\1I<AB+'S3379$EQ+3#90:F1J6LR2DN
ML0BZF8)PE;T$    ,D.8O+C+] 5GG"M/XX5BL60_;M2H3F4FRJ'A$1*E23*1
M.,T05,[8Y/J,_;=OF'JHNNA:(5,XC<P<R87PY"LBR>--:RC0F*K/F-W7!*HF
MTMV0M*EM%X:!(1JV9:'Y^O[! F8?T1 H      "%\K\AL-8/D46+E6^8MGR+
MB;?=HK<B/*>-]$8T)=,O#,ND6TW$^73R@G!Z>*LWXLS=3ZK5<67?'N^GT.0B
M)59,=F2R3+SB-Z$&4EIHSU3UZ$8(P2J   "!>2&6+MPQC*5>]DX[F91KK%0B
M0V[4@E(-U;4A1I6Z7AF)"]&R+4_,T_9($PP8O?D]E*O\QL=9NJ&!*K1[YMBE
M-PZ7BEPIWBY[269R"=02X:7]#*0L_-9,O,/KY="V&AM5Q2Y!Y$SY3[TEY!PS
M4<//6S(@LTN-4"ED<],I#RG%H\7%BG[6;:2/:1_3== 5F,%MP0
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M<5UA4CM/0#*GIVHIS"O:U&@S]M]CV01.#3<%0
M
M                                &?7K(\09'S5@VU;6Q?:[]VU^!?4&
MJS*;'=894B&U3*FPMTU2'&DZ$X^VG0CUZ^3R@M3*9^8EGY;OOC_>MM84GOP[
MYF^%-EB)**%)EPT/H5+BLR5+;)M3C>OE46XM4:^<"(9B4[CCDB9<O%J[;(XA
M/8GIF+;SH51R949%5C3:]5W8TJ))ERS)YTG3CM%'<-.X]RE.:(01)!;%>K"N
M*,A6SS.Y0Y+KMM/4^Q[Z@4EJT[@6ZPIN8N.S'2Z2$(<4XG::%%YZ2\@*S.A
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MX5^^JM:LFWJ.5'9AT^,P\AQ!2'9'<4;IZD>KIEH7T 3$X)5XN<;:)Q<Q_6+
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M;>;KGY!4R+4$9%NZ&J#6)+DM2XBFEHCMF2(YEHD](R.NOT?H@G%/0(
M        !"^=<"8]Y%6E3K)R3&G2J%2ZNS6XC=/E*B.E+8CR(R#-:2,S3LDK
MZ?1T^@"8G!*]'I42A4BET2 2DP:/#8@PDK5N434=M+:"4KV3VI+4P0]$
M
M                                                          53
MROPQP9F"]E9'N&DU:BWP^PF-4;DMZJ2:8_+:0VEE!/\ :4:5&32>WN(B4:?-
M,S(BT)B4H89P;C3 5JN6AC*@>A:9*DJFU.0\\Y)ES)2DI0;TA]U2E*/:DB(B
MT2G]JD@)G%+@(
M                                                  ',WG9UM9"M
M6O63>-*:K=L7-#<@UJENFI*767"ZD2VS2M"B/0TJ29*2HB4DR,B,!2RC^KAX
M]TR306YT^];HMFV9QU"BV!6J\N30F7C6;AZ0TM-]#,_.+=YQ=%[M3U)VE^00
M
M                                      #@[[Q=C?*$2'!R+8M#O:+3
MG%.T]JM06)GAUJ+12FC=2HT&HBT/:9:^R _U8>,,=8O@2J9CFQZ)9,&<XEZ>
MQ1H3,/Q#B",DK>-I*3<4DC,B-1GH70@'=
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                 SIY=<_/T5LDT3'OQ3>_OTS;4:XO
M2_I[T7V_$3)D3L=GT=+W;?";MV\M=VFWIJ9:(Q58_7*?[./\K_\ (@)V3]<I
M_LX_RO\ \B ;)^N4_P!G'^5_^1 -D_7*?[./\K_\B ;)^N4_V<?Y7_Y$ V3]
M<I_LX_RO_P B ;+6G".3/CDQ/8N4/0GO<]^E,14?0?B?&>&W*4GM]_M,=SZ7
MR]M/]0%)2H      /#N>L^]RV[AN'PWC/0-,EU'P>_M]WPK*W>WOVJV[MNFN
MAZ?0,!B]^N4_V<?Y7_Y$!?9/URG^SC_*_P#R(!LGZY3_ &<?Y7_Y$ V3]<I_
MLX_RO_R(!LGZY3_9Q_E?_D0#9/URG^SC_*__ "(!LIOXX>LO_2!S/9N(OB5]
MZ7OM](__ #A]\GC_  _@*=)G_P#5O1<;?O\ #;/[(G3=NZZ:&1-.#4X%0
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MWO"Q-N[Q>W;L/3;KNZZ$5F,%IP0
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M^N4_V<?Y7_Y$ V3]<I_LX_RO_P B ;*[W#7F5^EO\8__ .;CXO\ XO\ T/\
M_OCTKXOTKXW_ /(H?;[?@_\ E;MWL:=2LQ@N^"
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MN4_V<?Y7_P"1 -D_7*?[./\ *_\ R(!LGZY3_9Q_E?\ Y$ V3]<I_LX_RO\
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MU 5F,%^P0                                    Q0J?KA_1M2J%/\
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M=NWEKNTV]-3+1&*K'ZY3_9Q_E?\ Y$!.R?KE/]G'^5_^1 -D_7*?[./\K_\
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M4$O;NT+737370%'W
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M+6B%(4E!^<9;UJ(NB03*B] RS8D^[<],YKYFYNQG>%%R%7X./K5MBL5J5 7
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M*4P>YHW#21K-LS\J===/V 4?6
M  H7GV\+MHW,?AQ;%(NFKTJVKG]\_OEMZ'.D,0:CX>&E3/BXS:TMO=M75.])
MZ'Y 3&ISMWSKMN[GC7\0?&-=UL677L(//>!H%7D0O!3GIQL^D8;>JV6I2$GY
MKW;-1 G@0U;^#;IJW+*_L$2.57(!%HVM8L"YZ?46[Y?*I+ERI#+2T.NG'-DV
MR2X>A$T2M?VQ@8Z'N'9-Y9GYJ\D,:2N066K"MC'M!M>7;,"T;HD4]A+\FCT\
MG5.QU)=:,EK4IQ9(2@U+4HS/4P.!/?#;(^0JK6,]81R;="KZN/ 5SLTN#>[Z
M.W+J-*J)2%0E2B(MJG4E&7J>IGU)*C/;N41*\@(     $,<B<GR,,81R5DV%
M&;F5*TZ,Z_2(SQ&II4UY28\3NDDR,T$\Z@U$1EJG7J7E!,*46?QOY$W9C6Q,
MST+EI?43-]TPJ3<TJDU>H=VRTM3T-R7()T=EE2"2VTZ9%H2FU++Z1)*W))Q2
M+S0O3(\FEX9X^8SNAZT\OYUKS,>3<E$DR8CE,I=)0F54Y;+K#B)+:"5M/H>J
MVDNI^B"(<19F<+OO/U?V4ZQ4JY5*1F+$5MU^T[SJB93S55C5JALJ0W*5)2I+
MQ/K:[;BG-=>X:^IF1F"<-*AU/RZPO%=EUG#/+C.F0>5LIJD+D8>E2:Q6Z0]/
M=>:\?'[$FGI94VTDU&1]]W70D^<2C41.#>"[9U;CXJN:I33*DW(Q:<V3+."X
MI)1IR8*UK[#J5;BV.$>U1'KT(]048BX)Y19/M#C/R2AWQD&X[HO>?;-)K>):
MW4JE,G51/OC=70G#AOON+=0<222%I)"NBMRB+74%YC2L5Q=Y%U["W';)57S1
M<-U9=OBEYKJ>/;2I3LU^K56J5-$&G(8I\1V8\X:&S<)USZ;1.JC22EJ)*B)A
M:^S.6$FHW1>&.<FXEK.(LG6S:<B]*9:E1G1*A'JU)CI7O<B5"'N:-25(-*DZ
M=/.\IH622,$:6SSW=K4##]W5C MS6WB_,%?B6I2,B/5& \RW6I;CC)-(AH,I
M+C*%M+U>4A&XD+V)7M(E$X.XOKF!/I-Z9%M+%^$;CS'%PXTAS*UQTN9#@QJ:
MM2#=7'BHDF:YCS:$JW-MD2M4F1:D1F",%EL6Y*M?,&/K6R59DAV1;=VP_%T\
MWT=MYLT+4T\RZ@C,B6RZA;:R(S+<D]#,NH(=^  *AY.Y352V,EU[$V+<-US-
M=X630VK@R Q3)\.FLTJ+(03C#1+E:JD2'&S)9--IW*)2=F]6Y*2<'.7+S*F4
MRX,-6G;>";NN*Z\U6_.K-!M&:MBA56)(@]S?$F,5$FT-)+M*6IY3A)[9=Q&\
MC3J,$;GZPY]JRZW?\CCK=K-J8\KWO<S)6/25--F@5%4M$5+$<C63DY6KB-^Q
M"$H-:$FKSB,$[*:;UY6R*9E.J8JQEB&OYDJ]H42)<619E&EPH2*3 FH0^PEI
M,U;?BI"V'$N(82:5+(R).I[MI&#/#%O('-50XN8&L>CY%K"\FY_RI-M%>3*S
M*>JE0IM);?81)<8>EK<5O03Z"1J?FIW;-%[5)+8:5][!XW9AQ)DVTZ_:7(^[
ML@XZD,2&<FVADNHNUI]]:DEVGZ4Z32285O4:CUT/S2)2G$J,DE<55.7F8<V5
M+--V3<(W-5*?:?#N@TFY\E4>FS9+$2MSJC/C/.T^:B,LFWFFX*%+43J5$DFY
M"=-3!,0[_GAF(W<-\<K]LW)ERX]LG(=Y4=^N75:U0E4Z>5 GP77WS-4/<M2F
MVSW;#0O1:?I#,M (A&>$<AOS.2>*J+QGY!95Y&8RJ;53^.LL@*J,Z#1V$,$<
M5U$N="A=I:E:FDDI^F)*=RNX:0)7<Y99(@TWCMFQ^R+]8@7G0;?D/17J'54M
M5.$ZR\VA:T*C.D\TI!GM,RT,O("(9JV_R!RT_P 19V)'<B7"[G>LY1HUFT*\
MU5*8NM-TNNH9K<:<<U3OB$H-I#K1GO\ -;,DZ[?(6PTM&> MSW)>/$O$]R7?
M<-3NJXJCZ=](5ZL2WITU_LUZHLM]V1(6MQ>QM"4)W*Z)(B+H1 K.M<,$   J
M7S7S1<V#<#UFYK([;5[5^I0;;M.:\A+C<6745JUD&A9&@U-M-N&C?YN_;N(R
MU29,0CBD<5L\6%7K#O.Q^5=Z75<,:I,N92M^_JB[4K>JD)2=92($)#1G&49E
ML;U,S2D]4N(-)$H8H;Y:8INFQK[P]5+:Y)YMIK.=\R4ZV[BH;%XOLT^ET^O2
MG%O-4AAEELHY,$K8PE9N)0DB(TJT!,+^6+1+8P9:L*T;@R[6[G6[(D2XMQ9'
MK[,VKODXI)J;*2ZF/O;;Z$DB3YNH(ULMLG9'S/=37+S/]NYFNNT$<:+ZCVOC
MNPZ7)0U;DMBGSVH<TZE#(E%+-XE;TFL^FNG5)DE!+O\ DMF#(%TY%PK'MR;F
M"@V'4L7E?%UIP_$<E5!3U3-*F4.]S8P:(Z&R4HW%$:4K+3SEI(Q$/^U?(M2R
M)3N&.$<39ZOR9:6:Y5SU"\,N>*1&O%Z)1C<EG!5,)!&PXTHW65&2>B6V].XC
M4E!Q%0SGFJC<8>0MLEDRH/W!@3+SMD53)C\EENX9-K(FG'4J,](-!.SS4E1)
M,E;S0>B?.(C,8:5B.#=]5FZ+WSY0J5DB[LAXEM:10T60[D:8F1=<:9)C+<J!
M2&W21,3'4O0FS>0E)[=&R,R<,"6C8*@
M
M                                                   ".,OXYA9=
MQ??>,ZA.73(UZT>33/2;:=ZHSCJ/:G]FY._MN$E1IU+<1::EJ!#.N7Q6Y<9$
ML+'/'3*UTXU8P=CV724R;EH+=177ZI2J*@FHD133[:&$J[6B%*VHZI)1J<T/
MN%L86^Y5X6NG.=D69;5I3Z53IUNWU1+GFNU=U]EI42FJ=-Y#9L,2%&XKN%M(
MTDD_940(B7,\PL%9)S?1,5_%=4;:I]R8VOB%=[?OI>F-07? M.]ML_!1WW%:
MN*3N+S?-UT41Z 1+E;:P!GW(69\>Y?Y-W98[K&($37; L3'S%1* J?/0EMR9
M+D5,B>W))"#));BW)3H:2W$L8KV@@      &?53P#R.P]DO*%Y\6K@L23;.9
MZAZ;NNS[^14"*F5EU3AOS*>Y3RT4E:G%+4E?DZ)V+VI,$XP\"YN'F9KNPQCO
M#5W9=3>L"I7VB[,]5^K3Y_??IZ5I7Z'H31LO$E@E:K22ULDEQ)+))$HT))Q?
MK=7 6BV9=6*\E\:)";9O_'USQI]21=5;JLF#/HNQ:)D(EFB:XVIU)[/-21&A
M2]3^E Q2)8_%%U%_\P*AE%JA7+CWDA,I*Z31HSC[LMAB"W.0XJ23L=I#+R52
M4+:6TM9I4G<1I,BU(Q=QQ3Q7ES"=D53&.1[II5ZVU;-2=;Q5<,61)<J14-2E
M=J)467XS2&U,D1&@FW7222NV1DAM&HE7?-7"R_LH75RNN.G5^WZ<[F)-CR\7
M2W94QN13JC:K##+[LTVXBNT3A(<2VIE3AZ*U,DGT!,2]G&?#"OV/>&#9DRIT
M1^T+ Q!4;"O6)$D24S)-6K#TF3.?A$J*E!L*=E+,EK6A?L[ ,4?(X@\EY6*8
M'$VJWQ8KG'6+5&WY5[L,STW8_2&JGZ41!\*M*HJ72?(CW;]I)T\Y6AI,8QK6
M>MO 5ST'D+G#*:9U(3:61K,H]M6Q36WY*IT=ZG141U'*0MC8E&J/--+JU&7E
M(@1BKK;'#+,F/L8\8I]FW3:2<Y<;I-T&S'FKG/VY5H5RS9;ST=3Z6&9*%$P^
M2-W:+SE*+70DJ!.*P_'W">1K9R#E+.>:JO09>4,J-TZ N@VJ4CT12:73&B;8
M8;<E$EUUU>B3<-1:$:?-,R48(F5N 0 *Q<I<&W'FNT[-<L6X(-MY$Q?=U,O:
MQ9M52ZNG.SZ::MC$SLDMQ+:M^[<A*E$:2Z:&8)B4*7EA'EIFC%.<;;RG?%E4
MVIY%IE,IUB8^HI2?0-*7#EL2)$N34'8;LTW'B:,B0G>@M?ZFPG&$DJX_WDK.
M_'+*!5.B^@,0V+.MBY8?>D>,?ER89QT+B(\/VUMDH]3-;B%:?M?8!&* I'"?
M*#>.[LCTNZ[<@9,IG(";FW%DS?+?IADI$=,:'4]T9MQ"C-HU+[:5D1DG11D:
MM"<7;VKQMS1=?(2L9ISM)L9ZA7=C&;8=<LVV'JB:XR)CNAL)7*8(GD*:-2EN
M[T&2E[$H-*"6H8N$@<;N:%BX_F\=,;Y2L1C#$A<N)0\B3T5-F\:72)CZGGHZ
M$QB*,;A$ZM*%)/7RZ+:\W8,8=[?7#"JY;RCC->5KM>NS#.)K&*C45ERKU KF
MJMQ.J;*35)[Z&V]G=2@C4:)"E&IM/FZ*/:1B^*W^%52Q'ERXKBPA4X--Q?D*
MP*E:]_6U<%4J,J<=5=0\<*=&6MF22TI5VD*)QTC0DW322MQ)!.+RX?!NLS.'
ME@X5K=;I%+S;BN14JQC_ "/1GI/9I]5>J\NHQR;F''8E)9<;>0AW1O5*B)Q*
M5J;1J,=*P"^-=I98HM@5_DW9%O7IE^U:0Q3:E<%)FU#P2W(SJG.\P1%!T)U9
MFZ:5,^:I1I(U)(C,C%43+7 G)>0:!GAFF7);%.N._LL)OZPJ@Y+GMHCT]R/)
MB28TYQN$I;:UMR==K:7$F:2(U: F)63P[QGKN*<ZR;]CSZ0Y8<?%- Q]1H#+
MC_I$I-&\,E3SK2F$M$VM+!GN)TU&9]4@B97,!    #-J!QUY5X+=O^S>,-X6
M 6*<@5>76*6Q>**BFK6Q)J""0_X%<-"VG&VR0GM]PE=23JC7>I9;&)6;MG#%
MRVUQJJ.%IM]S;\NZ;:56HKMZW#)D.F_-J4=]M!K6LY#J([2G20A);C2VDNAG
MY2,=+_&)L%1Z#QKM# F4XM.NB-3Z FBW9$@O2#@RR)Q3BB;=-,9[:>I==J3
MF=*",C<+X]I2\3WKQ1H]M61=V([BJ5=CVS779[E*JQ5B+&AS4O/DN0\VOM1&
MTHV^;Y>J3Z@G'C?I8W&C/-@X?OI5IY2HEL\ALD7_ "<B757&(AR*"^_*<W.4
M=1O,*?3%41FHW$M]PE&9%YOE(Q>"UQ$R9ERH9QOOD'6[7HU\Y7L1JPK?I5FM
MRGZ=2(C#[,U$I]<LVW'W#EQ67-NO1)&DE]2)).+_ %B?BOFB??MF79R KUJE
M"Q%CN1CG'L6S%RE/RD28JX+U5EN2V6R;=5&<-))06F[KM01:+$RXRSN'O(-F
M!@W#]YW+8?Q*X!OAJ\Z%=-'1/3<M4\)*DRHT9UAQLF&#4J0M+II<Z:I,C<4C
M50Q:G@J                                    \ZL4J)7:15*)/)2H-
M8AOP9J4*VJ-J0VIM9)5[![5'H8#*:/Q.YBT/#]1XH4.]<:2<&U"1(9BWY*8J
M*+CC4J7.5/D,'%0GPYK6XI1Z&:NBS23Q>:;9;&-:Y.:,!U&[^*M5X\6#/A1)
M;=LT>V[<J%9<<9C):I+D0D*?7'9?6G5J-^U;/K^P"(G2\'DAQ_O+,'%I.$;9
MJ=%@W6F';\<ZA4WI#5/W4EV.M\^XS'>=T43)[/:NO370")THJE\=>3N:*QC"
MF<D+NQO3L7XPK4&XFK5QZQ5G)%8FTU!HBHFOU4D]M!$I1*[9]24HMN[:M!.,
M-% 5      !2++. LO4G-KO([C97K8AWU7J$FWL@V=>B)9TBK1F.V<>0V["]
MM0^@F6T::DG1)><1;R63$N#J''+E37\/9XI]Q9;HM5RYGN1%C2:;XZIL6E;=
M(3HU+8IC)QY#AN2(Q=E9]I.I;=5J4DU+)QAS^0?5GXS/&B:?B";/MW+= 33Y
M-GW=5JS4E06ZA#>:6X\[&)4E+7=2E>AM-F:%&1IZ%H8VDR6IQWOM_DQ<6;LE
M':57MV\L1Q;&N>V8CDF7W:J;L!V;[1)AM-+AK\.Z234K>9&G<V6IZ$8Z'I\9
M<"Y%X[W#DBS&;BIE>X^U.H*JV*J6[+EN5JA.2%$J1!6T['-HXYFH]%)D&>Y&
M_9N><VB9Q>1G/B_<&8<T>_951H[-ERL35^P)\22Z^503/JWB>Q(::3'6T;;1
MO)4:C=)1&71)@1*!L6\$<D6%:_'J#/N.V9]R8\RP_D/)%01+G.(EQU(8C--0
M77(25NN$Q&1J3J6TDHST5[)DXO;G<7.3%H43,F&L3W;82\*YPK-8J,ZMW"BH
M^GZ%&KZ$LU&*PTPE3#^K/F-J4HM3U4K9KJ0QA,MK\7JO9&<L&WI;]6I[^/L0
M8K5C]QF8Z\57DR4J7LDDTEA3)I62B4KVU.AZDE.F@(Q1&OA)?LW$N2;3>O&B
M4:^I>=YV:,6UJ*<F5!8=-MEN&Q44N,,+)1I)TEDVE9),TJ(UZ&D$XI4QOA7.
M-RYVHV?>1%1LZ!5K$MZ3;UA6A8QSG(I*G*<*7.F/SR2O<I"S2A"=Q:&DSVJ2
M>\C%=H$ "!N3.%&^0F%;RQ7Z7*@S*\W'?I-74@W&V9D&0W*8[J"/4VUJ:V+T
MZDE1F74B!,3@A&DXYYDWM$O*!F"^K&H]"EV#5K3I5I6HB2_&J]7G17([=5J4
MJ=%-^.A)KW;8_4_906AI6-#P8?%#(D>R.%MM+K-N'.XY7'&J][NID2^U*895
MJI-.,X9*<6?L$ZEHOV03B_Y=?#BX[ZG\V8U>N.ET^A\E2M-ZR9,-;[TJ#)ME
M#CJ55!E;+2"2J2371IQ>J-W5)Z C%X4?CURHOO)/&6^\MUK'$6)Q^FR$/T^@
M/5-4F>P^S':=F=QZ+L-UTXR-&M&TI+56[56Q).,/\P..O*O!;M_V;QAO"P"Q
M3D"KRZQ2V+Q144U:V)-002'_  *X:%M.-MDA/;[A*ZDG5&N]2QC$OKNWA=?5
M]V[QOQ1?&2G;XQ7C.1-K&6:O5:E4/3U<J:VUE":AEL<[;$?>II!G)2I+:NA&
MI);AB]&)P@BXIS;B'+7'B8U0F+?DS(&5:/<U8J<LZG19J$-&F(M;<L^ZT1K6
ME"U(0I?;/<G:>HQ?18'"TG,<\D,;Y>=HM7IF9K]K%V6Q.I*GI#]+3-))PY&L
MF/'[<EA:=QD@U),M4FI25*($8NNQ_P 89UW8<M+&?+VGV_ENJ8[F/-VG<$&H
M5-:GX.PD1W):E-P5D^A'M2NKA&E*5&HU&H#'B0]DS@K7[JJN?&;3G6[;UK7K
M9%GVYB.$N5.*129=I>#\-XE11G3;:),7MDM"W5[3ZEJ"<728<X=WCBZ]>+E?
M56*!)IF&;/N"DWR3+\I4F95Z^N3(==ADN*DG6B>DF6YU3:MI%YGL 3+1 %0
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MD@@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MJMBWY:U-O3N\XMELF3-.Q2E.(-)%NUUT+3J6HP20
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M>FA?M3^@ [X
M                       !&UV9EQ!85430[YRM9UEUI;")2*/7:[3Z=*-A
MPU)0Z3,E]M>Q1I,B5IH>A_0 P=9<-T6U:, JK==Q4RV*6IU+":E5I;,*.;JR
M,TMDZ^M"=QDDS(M=>A@/]T"Y+=NNGIJ]KU^G7)2EK4TBITJ4S,CFM'1:2=84
MM&J?9+7H ]H   $<W7F'$EASDTN^<I6C9E36DEHIU=K<"G/FDR(R43<EYM1D
M9&1ZZ 8.MH%QV]==,8K=KUZG7)1I)F4:KTJ4U,BN&D]#V/,*6A6A^70P'L@
M
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MR9$ [X
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MU]@$8)%
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M)\0YN6@GGMI;E$22VD@D)+Q&#^G_  7\B6'?@/;WN;'!CEA1RBJ5U<LN=\/
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M0)JT*N)<95+O!"-"(JK3S[,A>TNB2>T2\22\B5D0(F,%DP0
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MR+GI:%UB(SKLCU&.I4><RG=UVHD-K).OE3H?L@B83."
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M;$/LJ8)"S(]4D;B"UUT,3IA_0F"@
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MM2"
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M'B<DJC5N0VU)HTM3:4DZEU!ZIU3J25MJ^G22P-</Z4 4
M
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M+52E$DB]DS(@0B+D:<LN/6>#@;_'%CNZ#A]LM5]WT3)V;2^CNTT!,,<?4]^
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MQ<;TJQ<UVBIXU1Z'7J56&H_G:)758KT=:O)IYQ4])=.O3K[ )J;(@J
M                                                    #^=+E_\
MTEEM?"6P?]ZG@O&I[F!+@@<4?6$Y=M*M+]%V=/3<T-S=YJ&*<;)W#35F1]-Q
MLL-MI/\ Y?T# G3"#<&T2HY&L7G1GFOH-^>BT9*')"]5$=2N:IE-D.(4?4U)
M3%61G]!SKY03*]?JPCE%Q6Y!' W^.*LU0X?;+5?=]!Q]FTOH[M- 5JUJV^J,
M.G_I%7J4@C]('CV=Z.4K;LT]*4SNZ:]=^FFFG[7=J":G]%0*/GC2XLQ"W(DE
MJ4VVXMEQQE:5I2XVHTK09I,]%)41D9>P8#^;[UK_ ,Z&G_ >D_94X%Z=23)7
M-GUC=8C/TRG88F0)TU!M1IE/L6KN2FU'^V90\;[9J+V-S:B_8 PAW/ CACEZ
M/F!KD5G:E3[<<I3LVHT2EUI7_P KU2KU!+K;LR8RHS<:2CNN+/N[5J<VGIMU
M,Q,KDYK]8QA+!&3;FQ3=]K7Q4;BM7P7I";1X-->A+\="8G-]I<BIQW#T;D))
M6YLO.UTU+0S*Q3B\9'K)<-5K#&3LLVW0[AA+L-Z%2:70[B8B17*I6*JW(7"C
M,'$F2_-(HRUNF9I-*$J-)*,M 3LJ4\1;"IMX4[,O+K.EY4:9D"[J5<";%I=1
MG1FY*'7XK[,FH>'6X2F^G]KQD$1;6]VTMIMF"9XGX^J'K]!H=SYL16JW I"Z
MA H+4!$V2U'-]9/32-+1.*3O/SBZ%]$"IO@"C'CUPE=F1L<8=MIM2B@5BXZA
M4I225H1NTZ(EIK5.G70IB_9__D6I:"<3:3%HO&/ 4.&DD,O6%09ZR(M/;:A!
M:F/'_NN/*,$3K85>K^4R?.Z"=;)9U=3MV>%[FTEE-\+*-W>2M#U[?=UV]?\
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MMR0^;Q6U>CZX39F9FU'G0HKFPM>A)-U#BNGLF8)J:L J
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M%DN)*1X)2=5H-,XR2I$AM1FLS0D_-4:B(JTP_H&!0
M                                                        !F;Z
MU_YKU/\ AQ2?L6<"U.MX? /Y@]U_QP^H* G6QQXLY@S=AN\+AKN#+1]^-PU2
MCG J\'T3+J_:A>(:=[G:AJ0I'MB$EN/IUT]D%IA93*5Z^L$Y>T^E8]KF);AA
MVXJ:VZ[3:;;DRBTU^4WJ;2Y\Z<?;(F]VI)6\E!'HK;N(C(C1#6KCGBZF<'^+
ME8?O>2NI3J,U.O3)#U+23^DCL-DXQ$)9M[R98CH06ID2E$I70E: K.F45_K7
M^+W_ (??'WIB_;P)V97<G8\Q9E6=863KBLNGW+5J-3RF67.K#!/J@M5!+4C>
MAA9K92[YJ#)>TU),O-40*L*.7_\ 266U\);!_P!ZG@O&IL?S25*3Q4SL</>;
MIVI+)?;(S/M'M)[4BUZ=LU:_L:@K&MGSZG)M!6]GITD))Q=1MY*W-"W&E+4\
MTD9^70C4>G]4$U*M\J#-/K/#4DS(ROC'AD9>4C]'T0$QJ?TD HSH]:379E(X
MHU6!%4I+5SW-1J74-JM-64..3B(^AZEW(B.G3_@!:G6Z7U:='C4SA[C:6PC8
M]7YM>J$X]--SJ:O+B)/]GVN.@$5:V3-C*9_6D33N EFCXY[B)@E[2/?XV:4
M_/T+3=VM/9T\G70%N!_2P"C\&Y49YZ1':D-.R(AI3+80M*EM&M)*22TD>J=4
MGJ6OL /^R)$>''?ERWVXL6*VIZ3)>42&VVT$:EK6M1D24I(M3,_( _CTY&5G
M&]PYOR76L1TY5,Q]4*V^[;\<S(FUD>G>>8024=MEY[>XTV9>8A24^QH#)#^D
MS@9<.+Z]QCQVWBV*FFP*+%]'W52UJ)<IFNH(EU!4E9$6]3SB^ZE6A:MJ1H22
M\U)2=;+WUOYROCAQ62]_@2LYPX^I>9W3J#_=T/Z.W9K_ +@+4MML'G3SPKB
MZ01II1V3;_HQ)[=2C^C6.U])YOTFGDZ?0!24E.2HS+T>.[(::D2S4F(PM:4K
M=-"34HD),]5:)+4]/8 5?YN?-/SI\&G?JK8)C6H)ZG/\&\\?=.@?49P)J;1
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MQY*R+R%TC,D?T?\ <!-3:L%0
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MH)QMQ.OL*2HC(%'V@
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M<T6EQ5&DB-::1$[AJ(]-33NG&7T-2/\ 9!-37H%0
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M+7TU(MT,DZZZ:J(O9(%J5Y^(%?C7+Q=P+48AD;4:RJ32EF7_ -EI,=-/=_\
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MW-/%_N?U034U"!4
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MP4REIW(2[+."VC8DS\Y2MIFE!J(3HA_2""@
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MH
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M[<
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MK QDUL<GT*GDY<,IL]R7ZI+4<F<XE7E-/><4E&OD022]@$3.*<P0
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MX9="[B/H]2:FI$Z#!JD.53JE#8J-/FM*9FP9+:7F7FEEHI#C:R-*DF70R,M
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MXB3H;DJ29>P;SZUN&7T5 K*30
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M?'5)]!6%:%'LRCFONKIM%A,0F5N&1$;BTL(02EF1=5*U,_H@AUH
M
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M>.GD(*N0X9S[M>09&3E6G*-^46XNBB:4KM(/V4(2")G%8@$
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MCTF)#DJ0YH:F^\TVE9(,R+S"/;^P"N*3@
M
M        ><FCTA$OQZ*7#3.-1K.:3#9.[E>56_;NU/7RZ@/1   !\=0IU/JT
M-^G56#'J=/DD29,&6TAYEPB,E$2VUD:5:&1'U( I].I])AL4ZE08],I\8C3&
M@Q&D,LMD9FHR0V@B2G4S,^A /L              'CR[=M^?4H=:G4*GS:Q3
MR2F!5GXK3DE@DF:DDT\I)K1H:C,M#\I@/8
M                                                        'CQ;
M=M^%5)=<AT*GQ*U/2:)U89BM-RGDJ-*E)<>2DEJ(S0DS(S]@OH /8
M           'CN6[;[U79N!ZA4]VO1D[(];7%:5+;3M-.U#YI[A%HHRT(_(9
M@/8
M
M
M 'CKMVWW*PU<+E"IZZ^PG8S7%16CF(2:30:4OFGN$6U1IT(_(9D ]@
M                >/-MVWZG/A56HT*GU"J4PTJIU2DQ6G9$<TJWI-IU:34C
M174MIEUZ@/8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M    58Y <M\<<;KGL&WLA0:J4:_&9[[-=@M(>8AMT_M[^\WO)U1K-PB03:%&
M9@F(Q1]C?GICZ^LL4K#UP8[OO%-T70@GK-*\:8F 50:<0I;!FV3JUM&\2%=L
M]%(5IIOU,B P<G6O6-6.U+N>99&&<F9-L"R9DB'=.3[?HY.T9A49!+=6E]2R
M224D:3U>-KS3W?2Z&9.RN?BC*=FYIL&W\D6'/7/MNXFE+C&\CM2&76EJ:>CR
M&M3V.-.)-*BU,NFJ34DR495(H
M
M
M                        /CJ%1I])AOU&JSH],I\8B5)G2W4,LMD9DDC6
MXLR2G4S(NI@.9G9&Q[3)E*I]2ONW:?/KK33U$@R:I$:>F-/Z=I<=M;I*=2YJ
M6TT$9'[ #U+ANJU[1A(J5V7)2[8ISCA,MSZM,8A,J<,M203CZT)-1Z>34 MZ
MZ;8NV$JI6I<=+N:G)6;2JA29C,U@EI\J3<86M.I?0U >\
M
M                      X.\\GV#CR9:U/O6Z(=NS;UJ":5:D>6:B5.FJ4A
M"6&MJ5:J-3B2(C^B [P!P=_9/L'%L"EU3(-T0[5I]:J#=*I4N::B0_-=2I:&
M$&E*O.4E"C(OV# =X X/(>3[!Q/1(UR9&NB':5#ES6Z;&J<XU$VN4ZAQQ#1&
MA*CW*2TLR_J .\ </D#)-BXJH!73D.YH=IV]XEN'Z6G&HFN^\2C;;,TI5U5M
M/0!VC+S<AEI]E9.,OH2XTLO(I*BU(_\ =(P'Z
M
M
M
M           #*;F_!B5+EYP.AS64R(R[H4MQE?5*C:J=,<22B]DMR2U(_+Y
M6C4\CF>I+/.;A1()E3KB)T8S0VDC<62*J@R2G734^IZ%K[($:E1(%+QW;WQK
MW;Q=Y@3\"1Z#4)SE2P=D,CI*I+C+>\VX\<WWRFI,R-A#;D1;R=NQPNI&HEK+
MP3S#D'.''VCWKDF$RS76ZI-I<2JQXJ(;52B0]B6Y:&6R)M/GJ6T?;2E.YL]$
MD"LPN,"
M
M
M      4\Y^_- S9]S(/NI#!,:V9V1N,&*Z5ZN&CYM?H[T[+)46V:Q[\GYDEU
MXVJA4(<!N'VU+[1,,PY"6T()'F[$GKTU,MCI?9E#%V:\@T/B1GIBPHG(ZV:7
MBFDP*UC&HRG#D+EHCN'(EG%:>:?D*>2ZVLW&NXK>W[8@TDG4)NX'7?A)C..0
M;;HF)[TX]9;N"E=VLXLJLUY^A=F*;*U^'CR(\9]EY)F;B2?1YJ5N);7M/:")
M:] J
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MIY#SBDMHADLNV3I&M!=WM(4M!F6AHOP?JV4+]M2MYBOO.\++U)R(W"]$4"#
M\"U;DJ$;Q2HG:+MI;67=2E:>UJK8AS>LE$I166??/TLOQ[ZN3$E/S G,L7)M
M07=C6#H],6<NVH-)95,9-#J'G%(249A6J$+1W2WO=HE*2H%H7RX-7!E7)U"K
MN:[YSO RC1KZCQHL2RJ?3_ M6W-@K<4[&-LC03;A$]M67;,W4DVYW%IV&965
M^00
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M]VU+FJ](AR[BME[JN!.=92J3&UU5J3;AJ21ZZF7E!1UH
M
M                                   .5K5BV1<E9H-Q7%9U#K]P6JZ;
MUKUVHT^-*F4UTU)6:X<AYM3C"C4A)ZMJ(]2(_8 ?XK-@6)<==H=T7#95!KUS
M6RHEVW<51IL65/IZDK[A*B276U.LF2RW:H477J XFZ./&![VKCMS7=AVSKCN
M"0HERZS4*-#?D/J3IH;[BFS-W0B(O/UZ=/("<4L0*? I4*)3*7"CTVFP&D,0
M:?%;2RPRTV6U#;;:")*4I(M"(BT($/K
M
M
M                              !%6;\54_-V++OQ95:K(H=/N^.S'DU6
M(A#CS),R6I)&A"_-/4VB+K]$"$;77QAH-U\7XO%^1=$^)08M'HU'3=#;+2I9
MHHTN++;<-H_:]7#BDDR]@C/0$XZ4.7-P!M2;&Q36+%R9<>,LH8GM^);=.R31
MDMD_/APV380<N,2D$:R0I2-4+3JA1H62TDDDD[3OL&<0J3B?(E>S)>&1:_F+
M+=?A'37;PKQ(:3'B'L+9'CH4YM4:&D(W&L]$EM0224HC(F5PP0
M
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M"T(NA$0#KP
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M:8(C,EI(T+/8?=<U+;31(BT(B,S49%U4?E/_ ,@*O^@
M
M
M
M                                                       /\.NM
M,-.//.)9992:W75F24I2DM34HSZ$1%Y3 <Q:%]61D&FOUFPKQH=[T>-)5"DU
M6@5"-4HS<E"$.*86]%<<0E:4.(4:3/4B4D]-#(!^EV7K9MA4M-<OF[:+9=%6
M^B*BL5V?'IT4WW"4I#1/27&T;U$DS).NIZ'] ![\65&FQH\V%(:EPY;2'HDM
ME:7&G6G$DI"T+29DI*B,C(R/0R ?N
M
M  SLYA<DLMVY6*I@? ./JI6,@S[;]-5_(9)(X% I3Y2$KD$KZ5#I)86:5O&E
M*3TVI<69)!:(1-ZL^^3M3A[F6_KAD2:I$LN[;BK,WNO*6XJ-3;?I<I:$K7NT
MU)!Z?U0*M:J5D42Y^5]IWMG7-'+5K$-U52KS*?AFTIE>:HU+3*AM-N$EII^0
MV:(Y*?2P1L%W",EN+-:CT43J3WR8S!R3XX\/\?V+?-]PY^7[XJ\JEHR+09C\
MJ2NW(C27S<5-<9CJ*6HWFV3=22C-O5>\W%&HB(B)E%V2[7R5ZNZ_,!Y I^8+
MAO.BWVZIC+%N560MZ*^[%.*=0)#1K-*TK;D*[*U$;C:D;MQ[M 3K2%?S]Z\T
MN;E]X!/)%>L/$V)*9,6_3Z&\<=R0]3E1HDEYQ)GL=<7-E$E*EI426D^:1&:E
M&1JA]?%3D-?F%JARVPID>Z)>16^.]%KUQV;4Z@MU]]QJ@OG%=C]Q:U.$T^MV
M.:$&K1O59:D7D$PKO;&-\R9HXZY2YHUO/-V0<CVO4:A/MVG1)KK$0H5,[+DM
M*.TM)Q]=5$TVT24)[:2,C)7FD^)L)PPS)6,Z\=K#OJY74OW62)-)NB4E!-D_
M,ISZV/$;4Z))3S:4.J))$1*4HDD1$0*S"TP(
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M"C=6Q4WW"+:T9%M;/KI_5 FEH*"H
M          ,1N1V2LM7]S.O?$UD\D',!6;8EN0WJI7)]873*.AY$:/(=4L^Z
MTGN+<G);U,]?-^@0+QJ3Q:<C,G%G!>;LZ9!Y"Q^15+*@PSQXZB;(GP&:BN2J
M&RLG5N.(4AR1):2OMJU,DF6I C6I4^GE_2>-T+G*?)RYGI\FK(DR<?.2'ETU
M%.>J9TMIPXQOG",E2#(_#E%)!(5KJ2B,@3HU+%<F^8^0[HPYQBH>'JF=FW]R
M4CQW*S5X3IM.T]1.LP'(L60>JFB<G.+3W4F2TH;]@U B(>%2KESOPMY4XAQ?
M?V<:WFW&V92AQ9TBX77W%1I=0E'"4ZSXN3+<9-B0I#AFES:M"S)2=Q;B&N&U
M(*@                              ^:9,B4^+(G3Y3,&%$0IV5,D+2TT
MTA):J4M:S)*2(O*9F Y#XS<;?E!MK[[0_KH!\9N-OR@VU]]H?UT ^,W&WY0;
M:^^T/ZZ ?&;C;\H-M??:']= /C-QM^4&VOOM#^N@'QFXV_*#;7WVA_70#XS<
M;?E!MK[[0_KH!\9N-OR@VU]]H?UT ^,W&WY0;:^^T/ZZ ?&;C;\H-M??:']=
M /C-QM^4&VOOM#^N@'QFXV_*#;7WVA_70#XS<;?E!MK[[0_KH#HZ17:)<$9<
MV@UF#6X;3ILN2Z?(:DM)=2E*C0:VE*(E$2B/3770R >J
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M4@S(S2I)I/Z!D9 A]0
M      #-3F\GE7>YW?CS&$>'9F$:59<BX,@Y(=4IJ5-)AJ2](I$=9+-:NXVP
MDC2TV6N[:ZZE"C2HM&#G/5%?-NO;\Y52]QZ,!5K4+YW)Y5WC;%"REGR/#L>R
MW;E<HF/,6Q%*2MHC9D.JJ,EG>X9+4ADDDIU>_J>U#:.BB8P;X6I<=!M'#=H7
M+=%7BT&WZ/:E*D56L3G4LQX[11&2-;CBC(DEJ9=3!1R=-Y5<;JQ48%(I6<+-
MJ%4JLEJ'38#%6C+=?D/K)MIIM)+U4I:E$1$7E,$X2GX$
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M0^0EO>C\6N1IYUJ5X2AM;7DQ7#BEOA+-XM7MI="_J] 1.#4 %0
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M[375\E'C-%0N:G0H$G?34%6)+IK-%&,ZE'D)TEDDR]IV/>;[6XGKJ$@@
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MVA9-31/4M=>;:><0F4PTK53J5H-I>K)*225[C,DZ&"<%[00
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M+KU>O-E=\0[G1%FL(:MZ.W&0]0R4PE9QI*F5J6M3FO<2;I)/:9$1'],8=D
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MD25MM*07D,E*3T/RD?4![\/=X2+OE%.5V4;IJ221/'M+5PB1YI;O+TZ /I
M             !QT*6M=\5R$=[09S;-,AN(L%MN.4R I2W"5,=<2X;QH?(B2
M@E())&E6BE:Z)#L0'DKKU#:AG47*U ;IY.$R<Y4EHF>X?D1W#5MW'KY-0'HJ
M?80PJ2MY"(R$&ZN0I1$@D$6XU&H^FFG74!\5-K-'K+;KM'JL.K-,+-MYR&^V
M^E"R,R-*C;4HB,C(RT,!Z0          Y2^)#L2TZW)8N^'83K$?>F\*@VP[
M%@:*3JZ\B2XTT:=/-/<LO+Y0'3,&9L,F;Q2#-M.LA)$1+Z?3$1=.OEZ /U
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MYNI4X\I2:.63#>JJ;91,5B#=3/:F#E]OTUM3'*H^<HNQYSW9_P"1OZD$@@
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M;I",F'/JD>A193^)]:;I :<>4E-3T;CIG^W&G9[8\ILO821F6@2$
M                               "+,Z?(EF+X#W#[FR (4$]45\VZ]OS
ME5+W'HP+5:WA^M]^1+&?PX3[FS *5^4X]H.5^/5%QU="Y3=OW=9M+@55<%Q+
M4@FE16%'VUJ0LDGJDNII,$,-N0W'#'W&GEKQKM3'3U7?I=>J=NU:<JL26Y+I
M2#KW8T0IMEDB3M:+IH?7V06B<8?T= H                BW*U1MFFTVTW+
MHM>NW5&DW91XU*C4"-)E.Q9[CQ^&F24QG&U)C-*+5U2M4:'HI*M= $I
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M)MW:EUIO9M7W#)[:1$@C!:9;B$1)(DI(B(BT(B\A$"C_ *
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ME8SGV=5VJA3$W#>TFG-Q(UT.'!2IJ1%E(4:I28R#[*E*(MJM4_1!*500
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M(=M2#852:8J+3ETB,J(P<>DN-)97%;-M.UA32#-*#;+S321Z%IH0#T0
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MI*M%Z:]-NI=2("$A0C;.%$-F*J$T;+9M0E()M3*=I:-FA.I)-)=-"\@#Z@
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MC,FM32]%H+4D$KSMAGIH3-30T%6(7JR/G(\H_P#G_=AX%ZM3;T%
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MG+5V#,W"2LMA:F?35)K"2P
M >?5J53Z[2ZE1*O$1/I-8BO0:G!=ZH>CR$&VZVK33HI"C(P'(8YQ;CW$=$E6
MWC6U(-GT*;.74I=,IZ5):<EN--,K>,E*4>XT,H3_ %$D _+(^)L<9>I<&B9+
MM"!>-)IDKQT"#4$J4AJ1L4WW$DE2>NQ:B_W0,7=08,2F08=-@,)BP:>PW&A1
MD?2MM-))"$)_82DB(@&)GK"?GM<4?XN?Z2. O3J;>@H                X
MR]F\@.0Z(6.Y%!C3TURGJN(Z^B2MI5$)TO2"(WACU*2;7]B-7F;OIM/*0=F
M                XRS&\@-^^KW_ ,B@R#7<4]=E>@D24=NWSV> 1/\ $&>Z
M67G]TV_:_)M =F              *#<YKRS1BRWJ5E6PLFVC:-D6S"EP[GLB
MYF7G%W+)GFDFHD?LM.N*<)#9DV3:FE)U<4IPD$9D3"E7J]:]R,K3MIXLMZ[K
M1L:Q\.5=50R-CFI,2F;HJT&J/.252#2Y%=2;9>(2A';=:))I1W"/<6\M4O=S
M5O#-6+;;H67,:90M&Q+:L1$M=U6U=+#KJ+C>D]OPT)HFF7EJ<]J43:6S;5JI
M1FXE!&9%89]>KZK_ "'J\NW\2V==MI8YM''%<BW5?MA59B6W<M;H]56W)6XS
MW8SR39-AQM*%(<;,C-LU[DK+<6J:+\S[DS-CZS:-E'%^4K3QS1; 5+FWE3KK
M9==8KA.);3%@M=IE]9K49+2E""2M2U)T6C0S!6&:W ZZ^1EP5N+BNQ;KL_&-
M$H=R1<BWQ9]9CRT5ZO4BKJBR7/"=V/(2J,N-VDI-"VUZ+2I2U)60+3@TZYBU
MG,-GV'2\B8LRI:V+Z?8#\BJWFY=33CD:J,=M+4>"GML25&;BEJ(D(1O6LV]B
MDJ(%89:<)+VY(71<U1QGCZZ;-Q2U5;L;RO=="KD:8BJUZG53PCKK-.-UB4E4
M4V&6R\U;;FQ9J[BDF>A:7]! *
M     ,0N4G]*#QT_BC[IRP7C4V]!0               !P5_0;CGLVHFW,AL
MX[<CW+3GZN^] BS_ $Q 0I??HZ"E*23*Y>I$3K>KB-/-(]0'>@
M      .#LF#<,.7?#E=R&U?;$RXI+U!A-08L+T!"-IKMTA:HRE*?4T>JS==T
M</>6I$1$ [P               '!7Y3[EG^\SWMY#9Q[X*Z:=*K_ 'J?%G^G
M*:WW/$41'BEH["I>J='FM7$;?-(]3 =Z
M                 BS.GR)9B^ ]P^YL@"&='J@OD2R9\.%>YL,%JFM0*@
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MG0:_7I=:A4BI/I<C4M$A9[(L)!)U2E+>U*C4HS6I.\]-= )G%8 $
M                            ,0O7*?ZN/\;_ / @+TMO04
M      <K>\2[Y]IUV'8-8@4"\9$8TV_6*I&5,B1W]2T6\PE2#66FI>7R]=#\
MAAT,-,M$2*B>\U(G(90F;(9;-IIQTDD2U(;4I9I2:M3(C4>A=-3\H#Z0
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MDL,IDK2[(2A)/N(3M2I9%YQI29GH1GY"U ?J
M                     Q"]61\Y'E'_ ,_[L/ O5J;>@H
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MQK\.I]M+;BB0G?L2O?MU5M\U6@F%K 0
M         #$+UA/SVN*/\7/])' 7IU-O04                0YFEW&[5(L
MOXR[@GVY <O6A-VQ)I\B;'7(KJI&E/BN'")2E-O+U2M+GM>G51EH1D3"8P0
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MRJJS[%J=FRUWE,]^,VHP'82*U5B99[U1B+<4KOLN)VDEQ&B3,CT+RF9*700
M        (0Y'_'/\3%Y?H]_*_P#_ "=[T?\ N[_Q&-XS_O;^U/\ JG>_LG_U
MOG[03#+'_P"[-_\ T?%V"V@_^[-__1\78&@_^[-__1\78&A&>2J?ZUFH>\ \
M@T%ZO>!O*E2[([--LJI>#N%ONE F+\ R[X=+6J]7W]K*-?/6G4@-"3/_ +LW
M_P#1\78&@_\ NS?_ -'Q=@:#_P"[-_\ T?%V!H/_ +LW_P#1\78&@_\ NS?_
M -'Q=@:#_P"[-_\ T?%V!H/_ +LW_P#1\78&@_\ NS?_ -'Q=@:#_P"[-_\
MT?%V!H:G<</CG^)BS?TA/E?_ /E'WW?]W?\ B,GP?_=/]J?]4[/]C_\ KO/W
M K*;P0                              "+,Z?(EF+X#W#[FR (9T>J"^
M1+)GPX5[FPP6J:U J                A?'A8P+)><#LQB<W?"ZI2%94=DI
MGI8<EE3D)@G&.3[09%'21*\/TU^FZZ E- (              !"W(-&+G,55
MY&9(]0E8^.53#J[%,14ER3=3/CJB;2I/]M:%()LSV=-/INFH)A-((
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MZBO2V(5L% N*?$M(H4XIWI"BM[#B5![1MOL.O:KW,]=FGTQZ@.S
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MNP-F5ZK$O.B9%LVV+[MIQYVW[NIT>JT=R0V;3JH\E!.-FML]32>A]2!5U@
M                                 ,0N4G]*#QT_BC[IRP7C4V]!0
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M^/1 \-Y)9^9VC<]K\N[V ':
M        (LSI\B68O@/</N;( AG1ZH+Y$LF?#A7N;#!:IK4"H
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MZ_Y=:LNJQJO2XM0GTMR*X_%<)Q"7D-4II9H,RZDE:3_9(#::- J
M                       Q"]<I_JX_QO\ \" O2V]!0
M!R5^2;UAV?<$G'--I=8OAF*I5MTRM/N1X#TG4M$ONM$:R3IJ?334]"U3KN(.
MC@JFK@PU5)IEFHJ8;.>S'6IQE#QI+N);6I*5*22M2(S(C,O8(!]0
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MC1/=)@;SN[VVGDGFEBO=%><:-E
M      8A>K(^<CRC_P"?]V'@7JU-O04                <6CXQ/C">[AVY
M\5/H!/8))2_?#Z?\3YVXS/PO@_#>33VSN?\ ) =H               #P[F]
M\GO<KWO-]&>^[T?)]['IGO>C?2':5X;QGA_;>SW-O<[?G;==O4!^MO>G_0%#
M]]9T\[H]'QO?(=))TH'C^TGQ7A"?U=[/=W=O?YVW3=U >N
M #BHI9%]_P#53FJMP\6^AX_H1+"995\JOW5>(\0:C.*<;M;=FPM^[77H74.U
M 1+BO!>*\*6E5K%QE:WO9M6N3GZE5*7XZ=-[LJ3'9BNN=V;(?=3N:80G1*R(
MM-2+4S,R<4?0^&_&N#C2HX@CXOBJQ]4ZPNX'Z)(G5&2XW5%L-1E2V)C\IR4P
MLVF4(]J=26FO3SE:C&7GXHX4\;<+W,Q>5C8\0Q=,,E%3JU49LNHN1-Z32I4=
M,IYQ#:S(S+>E.[0S+=H9@3,K5@@
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MV%.H2^ZE2FF341+4E&FXTI\ID6XM?ZI /T 8A<I/Z4'CI_%'W3E@O&IMZ"@
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MW_1\&1X1*NXR]Y^]#NC1Z%O/R F$R@@
M              !%F=/D2S%\![A]S9 $,Z/5!?(EDSX<*]S88+5-:@5
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M=<;,:)5*-76X-08IY2(BX2RJ&CIH-]U9QW24VC<DE>:E*M057-!
M       ")+ 7:2KWRZFW\EU2]*T57A'=EHSJH4Z+;,CPB4MQ(,8D).(V\E)N
M*1JK5>X]2T,B)2V"
M&(7KE/\ 5Q_C?_@0%Z6WH*                (US"JW$XRO([NORI8QMOT>
MHJM?M'GE3)],;-:2)Z-,V.=IS=HE)DDS/70BU,"'<TA45=)IBX4]55A+B,'$
MJBG2>5):-M.QXW2Z+-9:*W%Y==0'H@               B:CIM8LRWDJ)DJK
M52[CM^E^E\6/5,G:92XAN.]B?'IVPC9=D&1DXO>>XB3J1:EJ$L@
M      C+,OO:^+"\/?A?]3Q;;9PTE5;_ *-4/14^F(-U!)=CS=CG:6:M$$>T
M]=VW3J!"0X1M'"B&Q(5+8-EOLRU*WJ=1M+:LU>R:BZZ@/J  %&/6-_-/OG[H
MT3W28&\[N]MIY)YI8KW17G&C90
M     &(7JR/G(\H_^?\ =AX%ZM3;T%                $,LNXV/D#,9;NB
MH*RX5A-KDV:<R8<!-OG4C)$XH9_VIW?$^U[R/N$D]--JM3)3,"
M     <1DM=KMX[OI=[5610K.30*C[Z:U%>>COQ*?X9?B7VG8^KJ%(;W*(T%N
M(_)U ?3C]=O.6'9+EI5.16K470*:JV:Q*>>D/RZ><5LXK[KTCVUQ;C6U2E.>
M<9GJKKJ ZX               $,TQW&RL\7.U!NBH/Y51:,#T[:"YDQ4%BC^
M*6<>4W$7_:J7%.F:34@]VGE(MQFHE,P(
M          !%F=/D2S%\![A]S9 $,W?5@4#WU\.LR6MJ@O?+>%PTK5S787C+
M>I3'G;=#T\_KH"U6M7[A7GJP,)\;>3F,,FUZ/:EZ4>=69D"TJA[1-FRY5*13
ME0XZ#(S6ZF1#)M:2+S-24K1.ID3,:4_^KJP8Q>O#7(5M7VW-A6QF:X9RHYQ%
M$Q(736&(L0WFG'$+(C4_'=21[3+1/[/0BJ=*GG(;CAC[C3RUXUVICIZKOTNO
M5.W:M.56)+<ETI!U[L:(4VRR1)VM%TT/K[()B<8?T= H
MC3)\AJ-3K74]C%>4B<NFDH136V8KYTI9O:IK)E+\U/@C+?N1YZ?*G3R@)+
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M-,W9C)IS%SU\K?JLHF;O;9@N)M9115ZS5+E+2ZWWB,VM6"W&1F1^5*5!)8
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M@1+I\7/;@^BZ.[W/%U-GN(7WW(^B=K*=#7NZ*+0!W
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MT>9C;WF1(E3BE3[L[T-SWS)5%1NF&B/[:@V="9]N\[0BT/H9$$A
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MMR'T*(_-/II[ &#H[:O>R[S:7(L^[Z)=;#1$IQZC5"-/0DC\AFJ.XLBU =0
M             ,0O5D?.1Y1_\_[L/ O5J;>@H                X9N?>)Y
M'D4QRS83=AIMY$AB_P J@@YCE4\4:3IQP.T2R;)KVWN]S37S=NI] [D
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M*%06[3OEBPY4:OTV359C\!BH%4*<V\1RJ8E#ZT$TJ4CS"=3JM/[4M?('<
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M#K=1I+'8<4PNG$MU]))2X2",FW4I,E&?9/Z8A,Q+0\%7#Y-^3;(/P:JWV&Z
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MM?\ R1?P!%^O@80?';ZU_P#)%_ $7Z^!A!\=OK7_ ,D7\ 1?KX&$'QV^M?\
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M?>D,H/8P[5Z4ER%V9D6'[X9">[V[?7XK^S)F]=6FO;%;/-\A@).
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MC6(]8MNN..L5:-"6ZE#DB*<MQQ;9M-F:DMMRG$]-.RKH!HEJ4"H
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MTZ /V  %&/6-_-/OG[HT3W28&\[N]MIY)YI8KW17G&C90
M     !G#FK!7+_D3?URT*9EJ'A# E.EJBT"#05.O5>L1B2G<_,1&>:WI</<6
MQR0E*>GM)GJHRT3$.-H7JD./,&,DJ[>%\UZ<:2)YY$R!#8W>R:&D0EK3_P#7
M.* VGG5?U3V/J7+;K>(\SWQCNYH:N[3:K(7'F^'<(]4FTN&BFOHT\FO=,_9U
M,#:6PXSVYRCLAVZ;,Y W11LBV_2FHKE@9$@GI/EDM3J7X\]"B:6:FTI;42E(
M4?G'[:Y[!$X+8@@           !B%ZLCYR/*/_G_ '8>!>K4V]!0
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MING-ID.FFK%%3_;*#?,^WO5YIZ::GHDDA*(
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M .+W+]Y7?W8&S)^M)XG_ /B]R_>5W]V!LR?K2>)__B]R_>5W]V!LRD[#_.W
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M,&\CZG3Z_?\ 19L2YJ<RF*BYJ)*\',=C),U)8?W(=;=2DU&:34@U)\B5$6I
M1."0<(<?L7\>K5?M+&="53H=0>\36JC*=5)FSWR3M2N2\OR[4]$I224)ZZ)+
M4]1,XJV7)ZM+BM<UYRKQ>MNKTI,^5XR=:M,J2HU)<<4HUN$3)(4ZTA9GU0TZ
MA*?(@DET VI7GH5#I%LT6DVY;].8I%"H4-F!1Z5&02&8\:.@FVFFTEY$H2DB
M($,5^4G]*#QT_BC[IRP7C4V]!0               !%^49,.,Q8RIF*W\J$[
M>-):C1V(L.6=">4ISMUY13#(FTPS\KC?MB=VI:%J9!*
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MI26X79AQ9GO>D*[O;N!?BO["F%UU=:]L3O\ -\I@).
M                &0N(*C4'/6J9X@.3I#D%JVY"FH2G5FTD_"T;JE!GM+RG
M[ +3J:] J        BS.GR)9B^ ]P^YL@"&='J@OD2R9\.%>YL,%JFM0*@
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M                       !CSF+^E?P)\&H_P!BUD%HU-A@5
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M0^XEIAA"G'G5'HE*$EJI1G[!$1 *\?I=\7OR]V/]^(O[L$X2?I=\7OR]V/\
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M_7 ,9/T(^)_Y"[:_Z)WZX!C)^A'Q/_(7;7_1._7 ,9/T(^)_Y"[:_P"B=^N
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MFH$3$/Z Z%&>AT2C0Y*.W(BP8[,AO4CVK;:2E1:D9D>AE[!@H]4
M   !B%RD_I0>.G\4?=.6"\:FWH*                .)O:GWA4&[8*SKOA6
M@[$N*!*N)<V BH%4J2T:CETUHENM=ER01D272U-.AZ)ZZD';
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M>YMUI1+0LO.\I*(C(;ZC<F2HJBJFU3$QIASM>_\ /UTS35=JF)C">1+@VC4
M#A[WI]XU#WH^\^\(=H>!N6!+NGQ<!N=Z4H[7<\73&>XM'8<D:IVO)U-&WHD]
M0'<                                QYR;F#UF=,R3D&FV%B[TA8U/N
M6K1K+G^A(SO?I+4QU$%WN*>(U[V"0>XRZ^4%L(<1\=OK7_R1?P!%^O@G"'O\
M,<;\FG^7UW9NSOCBH6P]=EL36*E6G(S<:(J7N@-,MH;0M>TS;C^3]@P1.&#9
MX%0       $69T^1+,7P'N'W-D 0SH]4%\B63/APKW-A@M4UJ!4
M      !Q=O,9 ;N6]W;IG4.3:3\F(>/(M-9?;G,1TQR*6FHK=4;:UJ>ZH-LB
M(D^7]@.T               !QF0&,@2+6G-8PJ%#IEY*=C>CIEQQY$JG):)]
M!R>XU%<:<-1L[R1HKZ;37H [,          0'<UK\@YE>JDJU\GT.CV^\\:J
M53)%);?=9:T+1*W#;,U'KKUU&DS&6WC5<F;=ZF*>")IQP;_*YK==-JF+MBJJ
MO#3,581,\F*)[9E<EKFNF_;68RE0XLBPI4.++E.49DT2#F,&^DVR)O4B21:'
MJ-9EZMZ7KMRW%ZF)MS$=&-.,8\3;9JG=%BS:NS8JF+D3,1M3HV9PXUA\=4;*
M%)],?&3>-.NSQ'A_0O@(28?A]G=[^_:E.[?JC3Z&A_1&]R%K-V]K\Q<BO5AA
M&&&O'ZG.[QO9.YL_EK<T88XXSM8ZL/-I2:-BU@ XRW&,@-5^]7+LJ%#EVP_-
MCJQ]'I<>0S-CPR823Z*BMUQ:''#>U-)MD1;?+Y=J0[,
M         5FY87-GFU,7QZIQUM_WR7^JN1&'J=X1$S2GK:?-]?;<4@NBTMEK
MK[()AFW\=OK7_P D7\ 1?KX+80CG+-;]9GFG']?QG?&'9+]K7+X7THU#HT:.
M\?@Y;,UK8ZEXS3[:PG7Z)= (P:]\3+6N&R>.&(;4NNDOT*XZ%06XU7I$DB)U
MATG'#-"R(S+70R]D%96(!            #$+URG^KC_&_P#P("]+;T%
M           '*WNS>;]IUUG'DRDT^]G(QE;DRNM//TYN1J6AR&XZDN&G37Z4
M_+H>A^0!T$),Q,*(FH.-.STLME.=82:&E/$DNXIM*C49)-6NA&9GI[(#Z@
M             <9"8O\ 3?5<D5"?1',;N4R(FW:>PR^FKMU%*U^*7)=4HV5-
M*3MV$DB5KY?V0[,               ')7VQ>\BT:XSC>=2*;?#C!%;LVO,O/
MTYM[>DS\0W'4EPTFC<1;3Z'H>AZ:&'4,=\F&2DFA4DD)\0IHC)!KT\XTDHS,
MBU\FI@/U  %&/6-_-/OG[HT3W28&\[N]MIY)YI8KW17G&C90
M        !ECR/NGUCU-S/>4+ MN>/Q.SZ.]ZDOP="=W[J=&5+\^:LGCTE&Z7
MG%_4\W0%HP0A[]_6^_BC_P!@MCZX"=#XL.8CYK7CS"Q-FWD#8$AEFVR=@U2X
MDG28[3$-N%-2R2F(3W7VR1IJ2#/KUZ$!,Q@W*!0             8A>K(^<C
MRC_Y_P!V'@7JU-O04          !6;D7ROQ?Q@]YWQDQZX_[^/2'H7T-$:E:
M>C/#=_N]Q]G;_P!;1MTUUZ^30$Q&*LWZU_B]_P"'WQ]Z8OV\"=F3]:_Q>_\
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MNQD4]")<6H$ZLW9JYY.FM:'4%M)!H(BTZ>0]P=N
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M<=0N+9D.N)OOT@_,?\#<9=CTA!C^+2GMLL^9L0UJT6I[#\H)E,H(
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MA9%Z7+4:+=;U<FIQK2H<N='8J4[P2S?:E-1?:G4(9U41/Z)U\TC\XTJ)3."
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M3Z'C_P 73/2M2IKD]J2A_P >QX,D*IB52?.D=M)[2\A]="ZD3":P0
M   "N^*/E>Y%_=>A^YYC0[L[9FNM3[+HM[=AR?5K]I8@;YSH  (4QK\5WQ@Y
MO]Y%6GU"\O3D#XU(4MR>MJ'/\ WX5N.F6DF4I5'T5_:YFGKH9]"21*:P0
M                       #,+EUS S;8N8Z'Q]XYV#'NR^)U(15*K,?AOU!
M\CD$XI#<6.VXTA)---]QQUTU)\[31.TS,M$*_P#QV^M?_)%_ $7Z^"<(:TX1
MJF0JWB>Q:ME>G>B,BSJ8AV[J;V4Q^S+-2B4GM)-1)Z$70C!24J
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MS/\ & &T?JFLD_SF?X+F?XP VC]4UDG^<S_!<S_& &T?JFLD_P YG^"YG^,
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M^R8>;+;\%BU^2^5W2O!T%O8R45XVCWQ%F\7MQ(+S"_\ I:@B<&K@*@
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MO''WZ_%-6*G5O?EZ-]/^D:A'G]OT=XKP_;[#+6S7Q+FNNNNA:>0$3.*TX(
M   'DUYZ%'H=:D5*GKJU.8@27)]+;8*2N2REI1N,I8/4G36DC22/VVN@#^?1
MZV>#U8QQES(=AYOO2S;4B%.>8XVU6JLP3JU6\,E=/;9AM/.2),53ZD(W:J6D
MD*W.H).X%]*V_J_L 1KQX2WI:5\IJ-'HV<*Y4929D%2&)OHM#42&TXR;Z'FR
MU=B.J2I39ZI,CT,MI@B9TJ29ZXT6)Q@Y8\;;1L&K5ZKTVX*K;M7F/W _%D/I
M?.N^'VMJBQ8B21M:(]#29ZZ]?8!,3C#^D4%                '$WS/O"GP
MJ&Y9EHPKQEOUVG,5F'-G(@)B4QQW25.:6MMPG'(Z=%);Z&KV#U+0P[8
M           !Q5E5"\:@5U^_"TH=I>"N.H1+63#GIG>DJ,T:/"5)[8VWV'9&
MJC4R>XT:%JH]>@=J          *S9[_#;CQ\.6?]Y Y[??Q\K\QT^X.SYOY4
MK,CH7,   XBYJE><.X+&B6Y9\.XJ#4*@^B\JY)J"(CM&C)CJ-J0PPII9R%+6
M>PTI-)D1_0,S(.W                               !@7E+-F4[-YOYB
MG\0,<U.O5M33%(RI1&Z=(K4&JSX6UMV>Y#BH0N(3;I]O>3I$I1*69EW5),OA
MHTI2_2Z]9E_-.IG^:EQ?XV!&$-E::]*D4Z!(FLE'FOQFG);!$:20ZI!&M.AF
M9EH9F6AF"K[0            &(7*3^E!XZ?Q1]TY8+QJ;>@H
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M0] (F'A^J"^1+)GPX5[FPP*FM0*@               .-M^H7O+N2]XER6[
MI-L4Z5$18E8BS3DR*E'7&2N4Y)8V)[!MOF:$EJ>XNOL:J#L@
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M$!JZ54^*=RMTI3JH":@;2?%%$4\1.&R3N[MFLMVW3=U >P
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M>Q.BQFKI=5%42X;S#Z5+D)93JX26M#2?G>7:9!*8
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M,.7W146N[3:B_3O2E:W.G#I4E3!'WF)&BNXTO1*B3J9EMU!,)A!
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MY1F8;I)R8'?OZ!.CTU^*KQ;/;:3)E(<;23ZM&C(RZDHR]D$PE0$
M  KOBCY7N1?W7H?N>8T.[.V9KK4^RZ+>W8<GU:_:6(&^<Z  "*[%]!>_3*_H
MO*,R^*B=5A'7+.D3H\IFUW?"))$2.PRA*XZ7DEW#2X9ZG^R2M0E0
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M]Q==2+0!](  HQZQOYI]\_=&B>Z3 WG=WMM/)/-+%>Z*\XT;*
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ME2T'I[.A@/$K&1L>V[5V*!<%]V[0Z])V>&HE0JD2++<[GTFQAUU*U;O8T+J
MZ]QQ#2%NNK2VVVDU..*,B2E)%J9F9]"(B <E;N0K N^7+I]IWQ;]T3X"=TZ%
M2:G%FO,IUTU<;8<6I):].I .P 8A>K(^<CRC_P"?]V'@7JU-O04
M       0\PNQ?CYG-MWW4W,D^\=I4G&QU)Y5-;HWI R35$T[3LI?-_VHW==V
MW1.FBM3)3""               <5DERWFL>WPN[;@E6I:Z:#4/?!<\&2Y#E4
M^'X=??E,2&B-;;C2-5(4DC,E$6A'Y 'TV$[0WK%LMZV:W)N6VW:#3EV_<<Q]
M<J14(*HK9QI;TATB6ZMYO:M2U=5&>I]3 =8               "'J8NQ3SE=
M*(=]U.9D1-JT_P!,8[<J3SE.ATWQ+G8G-0#+M(=<7JE2TGKIIJ1;]5$IA!
M                          #SJO5J=0:34ZY5Y:(%)HT1Z=5)SFNQF/&;
M4ZZXK0C/1*$F9Z$ IQGF'1>8>(G[ P+R M^!/J$]F16IU'JWB#?II,O-R(,I
MB \3NQWNI-3;A;3T\X@3&A0VG^JVY 4B(S3Z5R4C4R!'(R8A1%55EE!&>I[6
MVW4I+4SUZ$"VTO7PUXQY)XY?&/\ &%E+XRO?CZ']$>V3%^"]'>-[W_6UKT[O
MB4?2_P#%Z^P"LSBN^"         !B%ZPGY[7%'^+G^DC@+TZFWH*
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M9L5F)<4AB@S&9\::=>@H:9)NK.)CH0<=3IZH[3NJTD@M3T,M [H
M 5FY._\ =.(OSGT#ZG*'.]XNA8^=1];IN['3S'R*_P"E9D=$YD  '!7Y4+E@
M>\SWMX\9R%XVZ:=%K_>J$6!Z#IKG<\16T>*0OOJB:)T9:T<7N\TRT,!WH
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MJ1.[>"VH3:;I6J(C^W$JC*-USLD1-;GNNA$1>0TI"2P
M        !7SD4SR,5;-"F<;)=O(NJGU3O5ZEW&2?#SJ?V'"[+:E(/:ON[#U)
MQOIKYWL F%*Y'*_DSC][7D7PDF5=J,DDSKRLQ'I",TVC]L:4E46M#UU+=+0"
M<(2%8GK ^&-Y*1%JDGXNJH9[%TVZ:&3&U9=%)5(B)E1TZ'_QW$@82OK:M>M>
MY[>I==LNK4VN6O46C<H]5I#S3\)ULE&DS9<9,T&1*2:3T/H9&1]2!5T
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M5Z$FUZK(IT5VIVTA]N2FG2%LI4[$2^R26W2969H):")*M-2Z& ]H
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M_'C,*U&J'$>@Y/*H15NSY9O.$NFJ@I04A"6$GW"<4HT'N,DEKJ [T
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MBOU6V:NN577H[\KOR:@\VM)+C1XJ-A$R6A;-?+U!..,/Z, 4
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MOV96[Y8N2A5*9"7:=K-0&(KE 91%0E]EV2VM3DDY#NKI&X1&DCT+5/D#N
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MDIVI1U(B8:[ J            Q"]<I_JX_QO_P " O2V]!0
M  !QV0*?<E5LNXZ?9]Y-8^N:3#4FCWH]"8J+=.=(R/O*BR32TX1$1EHL].NO
ML .G@-R&H,-J7+*H2VV&TR9Z4$T3[A)(EN$A)F2=Y]="/H ^H
M    '#P*==360+AJDN^6)]GRJ3!9H^/DP&&WJ=,;<>.1-5.2LWG2D)-*20I.
MU.SS>NNH=P          (9Y#?(ID;[D+_KT#4[][#=ZK==W?U"SUDB6A^"5K
M_<B%]00/?E?@T=6.9KLY\>OK3SNB&=Y@!QF0X%RU2R[A@6=>C..[FDQB32+U
MD06*DU3W"6DS=5$DJ0TX1I(TZ*/0M=>NF@#KF$.ML,MOO>(>0A*7G]I(WJ(M
M%*VET+4^NA /U  %&/6-_-/OG[HT3W28&\[N]MIY)YI8KW17G&C90
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MN2JB>37'8YVHW'+#VL38TOQIJ.MZ$7BM5%[06OF>7KKH1!)
M   .7O>.[+LVZXS%U*L5U^D34-WJCLZTDS87_;W]L>U>T?V0]^A=.IEY0'[V
MBRJ/:EL,+N15XJ8I,)M5W+-DU54TL((YRCCD31G(T[A]LMOG>;TT ="
M     *[TWYTER_F[A^Z)C0V_U:OY4>TZ*[^C4?.GV5B!OG.@  C:#!>1E>OU
M%6379[+UNPF48D-43MT\TONF=4)*?[8]O_L>JO-\T^I^:2 DD
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MY-+'M>AP9$J/1IO@EJ>?EO,J)#*'&D[4FX2BW:'H6TU))3."
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M>^^:.FB> IS=1][]0/O=BOR.X9>'9A]=[Z=5(W%H74!*H
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M;?NM52I2<@7%*@OQHM9D% 2<5V(^Z9MOI9942%FV1:*\NNI*,E+X(
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M]*(??DFHDDC:1FHU;]A,<+?,%            &(7KE/]7'^-_P#@0%Z6WH*
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M,E&6YM*3T/373H"<969!#$+U9'SD>4?_ #_NP\"]6IMZ"@
M ")67+?^/&8RC%DYJZ/>4VX[FCT:R4%V$=0-)4(JEN[JG4K+Q!LZ;=OG:ZZ
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M7IMP56W:O,?N!^+(?2^==\/M;5%BQ$DC:T1Z&DSUUZ^P"8G&'](H*
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MN3XQ/?!9/O0.W"M7QLCXQBK!2SJ'@NP?A_17AS)KN][3?WO-V>3SAG>=V@
M                             ,IN<_+?C]:EQ-XBN3"E.Y 7O1R;7*@U
M#M,Q:0[+0E;;3<OL2'^^M"DJ4AE*2T,B->[5)%HA /&KG#QPL&^HM)KG%^D8
M$D5U:8I9 I:DRW(S;YDG26<F*S);C[BU4IMQ1>R;?FF8)F&V=#M*T+?F5JKV
MW;-'HE0NJ3X^XJI3(4>,]4I*M3\1+=90E3ZSU/SUF9]?*"CI
M &(7*3^E!XZ?Q1]TY8+QJ;>@H                XR\X5]3F[:*Q:]2Z"[%
MK\&1=2JI"7-*71&S5XV)')#K7:?<(T['#W$G0_-ZZD'9@
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MO(/QB':TWXJSMQ-[=Z+Z..ZREG2NSXAOQ7=*"9/;NQO[>WIOV[O-U =H
M       "N^*/E>Y%_=>A^YYC0[L[9FNM3[+HM[=AR?5K]I8@;YSH  .+MOXQ
M/?!>WOO.W#M7QL?XN2HY2RJ'@NP7B/2OB#-KN][79V?-V>7S@':
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MY$-!.2V*348TU;2%'H2EI8<6:2,^A&8QW+%RWIKIF.6)A,3$NK&)(
M    #_*E)0E2UJ)"$$:EK4>A$1=3,S,!@9R6Y@<+KHR%5'XO%V#FB?$?5'J6
M05U)5M)J+C6J.\VY"8?=E(T(B2X\23,BZ%M).I>(E:SA/R6XL90CU/"EG8@@
M89KUQP7SFV8M+,N)7F"94F2V50)#;LI:&=VY+Z"5V]33N(E;2)B6E-KVG;%D
M4.%;-G6]3K6MZFI-,&BTJ,W$C-;C-2C2TTE*=5*,S4>FIGU/J"KH
M     &(7JR/G(\H_^?\ =AX%ZM3;T%                '&(@WV607JBY7J
M6K&BJ F.Q;)0EE4TUHI)J5*.;W30;)L>9V^WKNZZEIYP=F
M #P[F8N"5;E>C6G4(M)NB13Y+=NU2<RJ3%CSE-**.Z\RE2#6A#AD:DD9:D _
M2WF*W&H%#C7+/C52XX]/C-U^IPV3C1I,U#22D/,L*4LVT+<)2DH-1[2/34_*
M ]@          5WIOSI+E_-W#]T3&AM_JU?RH]IT5W]&H^=/LK$#?.=  !Q<
M6#?B+^JU0F5^E/8Y>I$=FC6VW!<14F:FEU1OR'9AO&A;:FS(B039=?H:&:P[
M0        !QF0;1?ONSJY:4:ZJU9+]9:;;;NFW9)PZG#-#J'=T9]/5!J)&TS
M_P"*9D,V7NQ:N17-,58<$Z8GE1,8PSPSQQPO3%&'[_R+1N66;JC5+2I:Y\*#
M-NJ3X=U:5I3M<[9H5IYWL&0Z'([QMYB_1;FQ:B)G#HPPUT3$8XR[VU>(MT5^
MU[;KLGEUG5F16J7#GOLMW4_L0N2PAU24ZD9Z$:M"U,>>[O:BBN:8L6M$S'13
M%N9C7*]]!I:Z)0Z-17*E+K+E(@QH3E7J#ANRY:H[26S?D.'].XYMW+5[*C,Q
MH[E6U5-6&&,ZHU0S0]84               4VYU\@+AXYX'EW=:"&TW=<=8B
MVU;=0>;2\W"D2V9$E<I32R-*S0S%<V$HC3O-.XC3J1DQ&+/2E<,_6&7A1XE_
M5;D=,M^ZJJPFHM6W,NFN,RXRE%O0PX<1I4=E9:Z;&S-"?)J770MC"VW #/66
M\@'EG#F<M\W(6$JBQ DUYTD>(?;<<D1W&)*FR)#BV7(IZ/%_9$J(SU,MRB)A
MH\"H      *;WEP#XHWW=4V\:YB]#=8JLDYE713JC4*?%E/+5N6M<:+(;;2:
MSUW=M*=3,S/SCU!.,K4VM:MMV1;U)M.T:)#MVVZ&P4:DT6 TEEAALC-1DE*?
M94HS4HSZJ49J49F9F"&,/K"?GM<4?XN?Z2. O3J;>@H                A
M[,[V/&:19AY'N:HVO3G;TH35NOTV3,C+EUM<C2GPWCA)4I;3SG1:5^UZ%JLR
M(M2)A,((                0[AYW';I90+'ERU&Y":R%7$7N50DS)'H^XB-
MDZA C%+2GM,M&:30AK5HMQ[#/4P3*8@0      "EN9OG 6G\"I'V:L?.^^':
MJ.I]<OH7=;L%SYG],/\ HY1O   1[E;Y.[K_ +C_ /72*UZGHRGQ:>5>#''R
M>6'\':7]B-#[-D.S6^I3S0^3;R[5=Z]7/+B\D/8U;OS"R+TN6HT6ZWJY-3C6
ME0Y<Z.Q4IW@EF^U*:B^U.H0SJHB?T3KYI'YQI5ZWC3."
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MXQ15<ON8Z8FLU!Z^9QY(5,3/2E=PICQDR%,>-\TV^V3>AL>U_P#%!,IF!
M       K-R=_[IQ%^<^@?4Y0YWO%T+'SJ/K=-W8Z>8^17_2LR.B<R  "%\S%
MC _BH^,UB<_ID:A'CWP*9ZMET>W^C5O^!\C1>?N-_P!I\F_V 3": 0
M                        "N'+RV*G>?&G,5MT>JQ:-4JC0'/#3)TEN''5
MV7&WE,.2'5MMMD^E!M:K42?.\[H"8UJ4<*[^X1T# %K4VN53'UKWQ"BK^,:-
M>"J?'JC]3;6LGE]R?HI]L_*RELU$E!DG0E;B!,XHAP3=O'.#SSR5E+'5\V;C
M'#%)MU5.-=1J<*WX54JDQMA+R*9"ENQUJ8[K2G#-+?;)2-2Z+;U)G4V>M.];
M-OVEJKEC7;1;THJ'UQ5UBA3X]1BD^V25+:-Z,XXC>DE$9IUU+4OH@HZ8
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MBH*J-2%4R4N;350HYT^8ZXMY;S!MI[;BG'#-:S4G0S4H]3\I]00],
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MUWZJV-GN?MEOE4N]&4S8X^3RPO@[2_L1H>+,_%JY9YUJ=3M!A2
M      HKZQ.@5NZ>-]2MZW<7U/*E8JE;@M0:71HLJ7.ISB6WUIJ3+<1IY?M2
MDDA6J=II<4DS+<":=:B- Y?>LBH=G1+9>XSURN5:!$;AQ[QJ%CW&J<LFT$@G
MGT-FAEQWIKNV$DSZFD^NI;"$;8,RSS3P6[?M7IG$>Y[MO')U976[XO6MVG<9
MS9KZE.+0WMC(9:0VA3KBDI2CRK5[&A$)B&Z>&+JO"^,6V3=M_P!L+LR\J[3D
MR;AM9V-(B+A2#4HC:-B5[<C0B(]%]04E)P        #$+UA/SVN*/\7/])'
M7IU-O04                </?=0O&G0Z"NR[/AWG+DUZGQZU$F3VX"85,6Y
M_;4]M;B'"<7'21*2V1:J/R'T =P                 X>R*A>-0]]WOPL^'
M:'@;EGQ+6\)/;G>E*.UV_"5-[MH1V')&JMS*M31MZJ/4!W        *6YF^<
M!:?P*D?9JQ\[[X=JHZGUR^A=UNP7/F?TP_Z.4;P  $>Y6^3NZ_[C_P#72*UZ
MGHRGQ:>5>#''R>6'\':7]B-#[-D.S6^I3S0^3;R[5=Z]7/+\KGJ%Y0[AL6-;
MEG0KBH=0GR&[QKLFH(B/4:*F.HVI$=A32SD*<6>PTI-)D7[!F:?6\3N
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M15?$7'!8O/TO(=C^&H"]_CI,/M)5W)*-$=M"M$JU/4P':
M                 JH_E'CCRJM2],.Q,D0Y+M=3(H=Q6NW)33:XVIE[8ZEF
M/+02U[5HTWH0M'T#/4@3IA7C]5!Q>_\ $+X^^T7[1!.U+Q;@]6)P\M.F/UNZ
M;NN:VJ-%_P"LU>JW! AQ6^AGY[S\1"$]"/RF!M2LCPVIW'ZW,?W19_'.[)MY
M6?;MS2"J]8F.&^GTG(C1UNH8?[$=+K9-DC12$FG4ST48(E;L$       BS.G
MR)9B^ ]P^YL@"&='J@OD2R9\.%>YL,%JFM0*@               .)MRI7;+
MN:^X==LR/;UOTV9#19]R-3VI+E;9<BH5(>=CH0E<8V7=6B)9F:B+4NGE#M@
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MU-DS3Y/.U!$XKQ@@           !B%ZLCYR/*/\ Y_W8>!>K4V]!0
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M-BGOTVU4U'*#V*D-W71W(U29F181U5Y#^J**:I?FN%-^D[://5Y"(^I&$G
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M2C]@@3@F<C)1$I)D9&6I&7D,@0Q#Y2?TH/'3^*/NG+!>-3;T%
M     $2Y;7::(U@*NW)=3QFT5[4<Z"_3*HFEG6JF2G#CT22:D+\1'EZ*[C!:
M;R3],1$"82T"                $58S*UTU')R;<R15,@2??A,5<D"I5--1
M3;U04RSW*1$0E"#C,,D1*2R>[:I2O.]@@E4          5FY._\ =.(OSGT#
MZG*'.]XNA8^=1];IN['3S'R*_P"E9D=$YD  $3973:ROBU]]&2JMC?;?=&5;
MOHFIE3/3]5+O>&H4O5"_$QYGG=R.6AN;2\XM 3"600
M            "D&?> & <\3)EPR*0_8-[S34Y)NNVNW'\4ZKKOF1%I4P\9F>
MJEDE+BO9<!,3@J&_ZMCD71#*!9O,*KM45O\ ZNPXNKT[81$1$79CSWT="+3H
M?L>0$[3L[.]53;<NK,5W.V9[ERQ*:4:SIK&^ TO4R,VWI4A^9(6E74S-M32O
MV>G4;33:PL>61B^VX=HX^MB!:=N0-38I=/:)M)K5],XXH]5N+5^V6LS4?LF8
M*NR       !%F=/D2S%\![A]S9 $,Z/5!?(EDSX<*]S88+5-:@5
M       1M:$:(S>F3WF,F/WB_)GT]4RR7945Y%K*3"028S;3!$ZSXHO;]'>I
MZDI/LFH))               !&.868TBPJFU,RF[AA@Y, U9 :D0HJHIIF,F
MEKNSTJ9+Q!D3.A_3;MO770Q"3@        &;V(?P//[J5'[*6/B5?2GEGG?9
M<STHY(YDH"K   #DZ+\X_"_]S5[W-D#==W/U&U^+V9>/?/Z7?_![4+^CZJ^6
MHQLEF,W>.47&<INWR^]5(9R[,7(A.IM511$[8:6XR2=:[Y>VZ/=3+0R_;*4$
MG                          #C;\Q[9&3[<FVCD"V*?=MN3R_MBEU!HG$
M$HB,DN-JZ*;<3KYJT&2D^4C(!F/>'JJZ#!K+]?P+FJY,32'5$OT6\3DUM&BB
M-*&9<>1#D(2@^I=PW5:^S[(+;3CF/5K<AJZLH%[\P*N_0U'N?8:75JB:NAD9
M=J3/906I'IJ9GY3Z'Y#&TM[@7U?_ !^P1.A7%%H\F_+U@J2[$NFYE-R#BO)_
M;PXC:$,-&1]4J-*G$^PX")G%=X$ #)[@#9EX6WR$YC5.XK4K% IM<N)3M$J%
M1@R(K$Q'I:J+W1W'D)2Z6U:3U29]#(_9!:4"635LI>KTS3GZEJPM<&1[(R>Z
M4RP*W2&WG6'?!O2GJ:EU]#+FAI1-4W(3T6E1:I):329DZWU8>X0Y,K_##.*+
MAHC]#RMEJITVX[7MF>1Q)';M]QQ^.W):7M[+DOQ,E*4+).W<VI6GL"9THKN>
M^\\9CX]8QX74SCW==-OFUJC"I]?KTR(^S#\)2C<:CFON,()@BWMFZXXO:6S4
MC/?YH\:=,_X'O[C'E7C1G['5FU#)ELXGM>C6Q>\"EH<=D]VDQUP79*D)0XII
M$J.^9)425)0XD]VFY.HB<70<?;=R%R;YLR^5EPXWK&-\<V73CC6Q%KC*V7I<
ME$%5.9:0I:&NZ9&\Z^M2"-*#)+9F9^4B=$(DQK7,M^KQOG/5A'A6X<@4&^7$
M/XMN.E,O/15JAG)3 6XZAATEDIN4DGD:[T+1M))DK<"=:Z'JUN/MT89PO7ZG
MD&C/4.Y\G5-$]^W)K9HD1:;%:-F*W*95](XX:W5F@RU)*DDHB5JDB*I51]</
M3*;3?T=O1]/C0.][[N]X=I#6_;Z%V[MA%KIJ>FH)I;E@H
M C_*K<=['EV-RLB*Q-&7!43V1D/QHQTE.Y.LCO3/:4?\4S49>7H9'H9"'94Q
M*4TVGI34%59*8S1)JJS0I4DB06CRE-$E!FY],9I(BZ]"T ?<
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M>B?>/9OH"X9-W4+T'3O0MUS)/C)-4B>&;[$UZ21)[RWT:.*<T+<:MWL@.K
M        %=Z;\Z2Y?S=P_=$QH;?ZM7\J/:=%=_1J/G3[*Q WSG0  0_3%6<>
M<+G*+DRJSKX*U8)57$ZZKW*9!@E(6;53:INSVI]U2MBW-W5.WS2W:J)3 "
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MNMS+5IZZFPT^R@I+-1D+<;VR&VEZI)Q)ZZ:=03P/Z  4
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M!F[(\*1]@S=ZITVI]DDA)H               (OS'(I46P*H]6L6R<S4Y,F
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MS3S2B6A1?1)1:D8#]0            &(7KE/]7'^-_\ @0%Z6WH*
M        (^RL_3HV.[LD5;'LC*].:A&J7CN+#CU!VJI):?:$Q91DT[U\[:KV
M"Z$9Z$8=E2C;.F4XVJ>JDM'%9-NE*0A"HR=A:,FALS0DVR\W1)Z%ITZ /O
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MZW4ZZ>5)%'5CCMVVFUFY;>6O%13[DSQBD'1?"D7B2VH/ODO7M]3+0E>4)"
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M]4Z[*C"H2+0O2-9$J-7Z;(K$V3!:GIG4UMXO%4Y"7EH)M<E)[$N)U4D_I2U
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M6BEZ]4EH [@       %+<S?. M/X%2/LU8^=]\.U4=3ZY?0NZW8+GS/Z8?\
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M"<;*AW33957>5#B3/34%M2R>HJ?%J231RS-)$XWJXG;YI'J8"0@
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M]YM?NN'6[;J,J&JRZ!'@)BO4AEN,E,EJ1()Q9R%.NGW",R3M+H70^@=F
M           #BLA4R]JQ:LV!CR[(=D76\]%.#<<^GIJC#+:)#:GT*BJ=:)9N
M-$I!><6AGJ74!VH        #-[$/X'G]U*C]E+'Q*OI3RSSOLN9Z4<D<R4!5
M@  !R=%^<?A?^YJ][FR!NN[GZC:_%[,O'OG]+O\ X/:A?T?57RUQ5MTR]H5P
MWO,N6[(=?MZIS8[EDT6-3TPW:1&0PE+S#[Y.N')4XYYY*41::^30R(@[4
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MWX5Z0N,WUB-=6VDF6W0CT,]2<4N AB%ZPGY[7%'^+G^DC@+TZFWH*
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M<2#)E,4>;X):GGY3S)DVRA;2=I&X1D:M#(O--2?6\:900
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MMMM));;21$E*2+0B(BZ$1$"&(O*3^E!XZ?Q1]TY8+QJ;>@H
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M4/0E9]N\)6I6BT>'8B^=O>/4D;BZ'J-FU27
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MEJJ?M<I)R#W1]I>8?7]KU C!X?J@OD2R9\.%>YL,"IK4"H
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M]]U*%KZ&74R(%)2H             Q"]<I_JX_QO_P " O2V]!0
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M^#%CS;KNN:]ESDWEQ[;(D)W/52OU1Y2=(D0MIN,PF7#21F2=5GM\W=VVTO\
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MU(@1,PU<!4             8A>K(^<CRC_Y_W8>!>K4V]!0
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M?XQ/!T/XM_>YX_TY ]\OOE\7V?0F\_'^$\'YWBMFG9W^UZ_3] ':
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M]T73&H3-I-2HA8[?ICDA4]V*<9)RSJ272)M*RD:DWVCTV>7KU,.R
M       !Q&1'<B,6I.<Q7#H$Z]B>B>CHUS.R6::;)R&RE=Q<1*G243&_9ITW
M[=>G0P[<        !F]B'\#S^ZE1^RECXE7TIY9YWV7,]*.2.9* JP   Y.B
M_./PO_<U>]S9 W7=S]1M?B]F7CWS^EW_ ,'M0OZ/JKY:XBV7<B.7#?#=WPZ!
M'M9F='+'4BE.R5S7H1L).0=22\DD)<)[4D]H]-OE\FJ@[<
M             &4O-7+N<+US;8_#_CU6G+4N"Z*854NZZ&9"X3J&G4O.]KQ;
M:3=8:9CL*=<4UYZ]R4)U/5*BT<:M=[\9N9_$:W9N=+3SXJ[8]H$W+NNBMS:@
MZE<3>E*U/0YN]B4RDU&:R49*27G)+4M2)QB6RV"\HQLTXAL#*,6$=-*\:4W+
MET[4S*/*0I3,II"E=5)0\VM*5'Y4D1^R"DI8             8A>N4_U<?XW
M_P"! 7I;>@H                Y.^G;W9M"ONXWBT>;?*(IG;46ON/-4U<G
M4M"DKCD;I)TU^E\IZ%J7E =%".:<*(=12RBH&RWX]$92E,D]M+N$TI9)4:=V
MNTS(CT\H#Z@               <;"<O\[ZKS51C4).-T4N$JVY<=R0=874E+
M=*8F4A1=@F4H)!H-)[M3/77V [(       %7>5/X.XM_.31/J,L<GWP[)1\R
M/9J==W-[3=^55STN0'SQV    #J.(7R:5_X753^M8'T;NAV*>O/-#C>^7;:?
MET_6GN_'+Z:M"NN8TCT67?2(Y';<>XEOMTM3^].I2512-TD[-VFWV=/(0ZER
M;J6.^;#)R20F2:$^(2T9F@EZ><2341&9:^34@&;G/:R862<@<2["J<Z53:9=
MMV52F5*9"429"8[[<-+Q-J41D1J1JG4R,NOD/R#H]Q7YL6K]R(QF*8GG8;D8
MS$%_W_4)U0@\,N&4&-1)5$C>"R#D&%N\!:D#<:9"$2$F9KF+,U;U[C7O,R(S
M>-2FF7R\1$YS.3CCT:>&N?L\-6N9G^&G]S[JM5K9XD6S;_&_C?;Y7WR$OLB<
M2EPDN/$\XD^Y6ZVYKHAM!:J;;49)2DM3T01FJM%%>\*YS.9G9M4^&S2=#1&M
M_P (K'X,6/-NNZYKV7.3>7'MLB0G<]5*_5'E)TB1"VFXS"9<-)&9)U6>WS=W
M;;2_[-ZW(HHC8LT>:F..?O>'')HHCCF7X619$+#,*O<Q>8M>9G94G,D=)I)D
MEUFWV74J\-2:3&W&E<I:3-/FGH@MWG:=UU4W[\YF8R>3CT/:^]5XO#B@B,/2
MJUI5]7Q\T'$?]_\ W?J(\V_^W7/)[,%GH0N:-,R@"F6+?GH\I_@[8_V&Z-SF
MNP6.6OG8J>G*YHTS*             / NNXH=H6M<MV5!"W8%KTJ95IS31:K
M4S"86^X22^B:4'H P7QSQPSAZQEFX,XY-S&FSK8>K$J%:-!3$=JK,8F#(ULQ
M(/BHC4=EHED@EFM3CBB4I9&?GJ+XX)BP&6:>%?*.R.-5[7HO(>*,LPW#M23J
M[VHCVCI-/1V'EK.,M+K.QYI*U(-+A+ZJ(M")TPVE!4             8A>K(
M^<CRC_Y_W8>!>K4V]!0               !Q2(E_ED.1.<K%'5C!5OH9C4),
M5TJLFN%*-2Y"I.\VSCG'T22-N[=UZ$7G!VH               /!NIFY)-LW
M!'LZ;"IMV/4Z2BVJA4FEOPV9RFE%'<D--J2I3:7-#41'KI]'R /UMQNO,V]0
M6;JE0YMT-4Z*BY)M.;6S#>GI:24IR,VX:EH:4[N-"5&9DG0C/4![(
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M"ZZC=9(R!6T7J=0ERI?HVX$]DI].C>)(NTRQYFQIO5M.I[3\H)E,((
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MB=$-W:;3XE(IT"DT]DH\"F1FHD)@C,R0RR@FVTZGJ9Z)21=04?:
M    Q"Y2?TH/'3^*/NG+!>-3;T%                $+9J/&7AL:%DZMU&B
M,*R!0DV0JG/3V#E7(:W?1L5\Z>1FIIQ6[<3NC6I$:C(R28)A-((
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M-RB)XFL@*@       (LSI\B68O@/</N;( AG1ZH+Y$LF?#A7N;#!:IK4"H
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M,1#8<%0            !B%ZLCYR/*/\ Y_W8>!>K4V]!0
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MWK-A7%0YT^2B[Z])GHBO46.F,OM2(["FUG(4XL^V:4J29$?T#,R];Q.X
M                          %/.4?Z6GODPO\ HT?@[Z3F_'!_W#_U+O4_
MPW_?/MG]C\5_U;SO^-UV F,%6,W?K3OC8OKXF?DN])K]Y7X$?]2VIV_]X_VU
M]-K_ &7S@3&"+/\ [LW_ /1\78)T-KZ9XWT;3_27_>/AFO'_ $O]FV%W/I/-
M^FU\G3Z */N             8A<I/Z4'CI_%'W3E@O&IMZ"@
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M<55>5C3MBZ4ZU?2/Z.[GHQG_ .4NW55M1.O=]OW0R2KSM-?*"VA5CX[?6O\
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M/H%T3[JC7#6+=K#TRH,M,K;6=<*/VTDUT,M&B/4_H@F)QA_2X"@
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MN2<J.V(_'J\M<*SFY41A-U+.(M)PEM2/;'B9(^[M:ZEIJ9=$J3ZWB2B
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MANH9)]%9-EY$<7=DM=5ITJ=&F%;DHVF=]'92PE*F$-%HHFG#-1;OV>H2>
M    "E.>_EUQ5]PZI_O+'S[OE\>UU9YWT'NEV.]UH?J.1;T  '/7=^"ES_<F
M;]06(JU2R6>G3RPL[@WY'<:?!V!]12/KNYNQ6NI',^9;][?>Z]7._3)[%'?^
M+LJODZ9C/M7M27*7X.?'@>^"8GO&U0'O$)5WVIG7<RC1:]I;3Z#9M4E$
M                           &3W.;F=E'#TF]L/TW%%0HKM<H[<FS,TTF
MO.M]MA]1%XE+"::7;<:6A;:T>(U_;;MJDZEHA &+?6F7Y:>/;4MROX(K62:Q
M2(*6*A?<FXGT.U-PE*,WUI.D2-#,CT_LBO)Y03LI8XCYTS[R-Y<W'D"?1[HL
M[#S-LO1YMDOSYDF@0I"&X[3&PGVV&%277"-S5#25Z;_VNX$3&$-B 5
M  19G3Y$LQ? >X?<V0!#.CU07R)9,^'"O<V&"U36H%0               $<
MVE'?:O+);KF2_?@U)G4];%E:0_\ YKDF&E)Q_:/;O[9,N][=UZ^;[*C"1@
M             1MEN#+J5BU.'!R<K#\ER1!-%^H*(HXNV6R9M$4W1G^V-.SY
MW_'Z:^0Q"20        &;V(?P//[J5'[*6/B5?2GEGG?9<STHY(YDH"K   #
MDZ+\X_"_]S5[W-D#==W/U&U^+V9>/?/Z7?\ P>U"_H^JOEJ-[-@RHEV9,>?R
M:N]69M3B.1[0643_ .;!>$1K#(X_MFCQ:.D3I$>AD9:ZFI020
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M ," O2V]!0   !2S$7SS.7/W/LGW';'@L=IN?AYG8[V_0\CRW?;E=,>]QP
M       X/)\1^=C^ZXD:_P!6+'WH*R;R$GP__P E&1D?B#\69-:%IH>XRZ'T
M4D]#(.PIR%MT^"VY..IN(CM)74E$@CD&2"(WC)LB1Y_TWFEIUZ /L
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M3:<4Y9$9[([DIEM"EGIT0:B6K]JDP3A*V@(8A>K(^<CRC_Y_W8>!>K4V]!0
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MHUJ,S4:E+4M2C4I:C-2E&:E&9F9@AC;ZPGY[7%'^+G^DC@+TZFWH*
M         (QRF_3V*;:JJCB][*J'+KH[<:FLPXLTZ4\M_1%:-,OS6RA?3]Q'
MGI\I&74R"3@       >/</\ W!7/N?)^I*$5:E:^C/(H!Q-^;UC;^Y9ONA)'
M-M!D_@T\BQ0/2  "$[;^>O;?YIY_NJD>S(?$GD5L=JCJSSPOR-RW2,<9/4][
MXP?1^+WL8=J]*LW-[T.+#]\,A/:[EP(\+_9DS>FCKOMBMGG>0@$G
MI;F;YP%I_ J1]FK'SOOAVJCJ?7+Z%W6[!<^9_3#_ *.4;P  $>Y6^3NZ_P"X
M_P#UTBM>IZ,I\6GE7@QQ\GEA_!VE_8C0^S9#LUOJ4\T/DV\NU7>O5SR\.^'X
M#5W8M;E8L>OJ3(J\I$"\&HD20FU5E$6I4U;L@R=8)XB[6YKJ>NTSZI2KUO$D
M\                               &-6=^;C^)<ZY4H''OCK;EPU^U&5.
M9<R2FE.+F23BI2Y+<EN4U#3I,15&2%NR'3+<E7D+0S+1",YWK)^8#U/MLX^
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MR6[':9L@Y&+EY1WW=2D,LML0G_03BE.$FO'XU2204/\ X[7MA;O-Z;C()+
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MFUZ)0Y-0K5>](O58T2TO--QF5.IA0VF>X2EF1*(S5M/3R&")C!I&"H
M "+,Z?(EF+X#W#[FR (9T>J"^1+)GPX5[FPP6J:U J                BN
MR5VXJ^\LII.-*A9]9:J%-3<EZRJ:U#C7.X<%*F9$24A1JEIC(/LK4HBV*U3U
MZ@)4               !$N;WK;CXXK#MVXNJ.9:&4F F3C^E4IJLRI:E3&4M
MN(A/*2A9,+,GE&9^:E)J]@$PEH$        ,WL0_@>?W4J/V4L?$J^E/+/.^
MRYGI1R1S)0%6   ')T7YQ^%_[FKWN;(&Z[N?J-K\7LR\>^?TN_\ @]J%_1]5
M?+436"[;:[URTW1\75"QJJS5X97%=TNEM08]T.JB)4W,BRFU&<M+)&;:E*(M
MJNGE,P2ED$                           S,Y=\G<*\;,S6G74X<3DS/S
M]%042JLR_1[D&E2%OQVF52>S*,UNFIW:VED^AZFHMR=2T1BKR[ZXF:F(4I/&
MM;3+QJ;C3'+K4;)N$7DU]"I)6GLD2@3LM:,*7K<.1\56/?5UVZJTK@NBFIGU
M&W%(=;.(IQ2MK9I?)+GTA$>JB+7RZ: I*40            &(7KE/]7'^-_^
M! 7I;>@H    I9B+YYG+G[GV3[CMCP6.TW/P\SL=[?H>1Y;OMRNF/>XX
M     1OE]ZB,8SO)^X\?S\J41JGJ54<>TR BJ3*J@E),F&8;AI2ZK716FNO3
M4M3(B AV](\/Z)IGA("Z5%\(QX:EN-DRN,WVT[&5-I,R0:"\TTD?330!Z(
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M5A58E=SWR/K< U*@UB'XZ$I:=JC:D51UQ!J3[![5%J0+5-SP4
M     1NW,D'ER53_ (LEM14VHV_\<)^$VNN'--/H0M/[:\TO;^OF?L:Z&820
M               #E[WD.Q+-NN2Q:JKZ=8I$U;=E([.M6,F%_P!H_P!L>U>W
M_P!C/?J77J1^0!]%I/.R+5ME]^W3L]]^E0G'K2,VC.EK4P@U0=6/:C\.9]OS
M/-\WS>@#H        9\4+\/<U?#6=_P#Y!O;ME[KSSOK65['E_ETNV&O9
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MU3)ULW%2:;=!:]R$] A)G% F175>VJ-XWG=Z5EJ@B;\AJ,B(J:P@J
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M9-/1+>K48XZNU'COJ=;5'4VLNX:DI49D7T",E>MXG<@
M              R/LC'M^V)S=Y"8\N&Q9-1QERLIE6D-W[L7X2/&7$E2%H2L
MFU-K63CZV%LJ4A75#GTIEN+<"A%YYGR=&P7 X!5W$TR7DVU+I1!I-:2XMR4I
MMF<Y+C(B1.SN-2NYL;=2YM-@R,O+J"V'"_I*M>/58ELV[%KSQR*Y&ID1JLR#
M7W#<EH90E]6_]MJLC/7V08WN@ ",<UT2Y;EP[E2WK->4Q=E<M*LP;;<09)5X
MZ1"=;82E9_2&I:B22OVNNOL 0PZX_<C>/F).(V7\(Y1ME^!E22NNQ*G:,ND/
MJ=K,U]LV8A//]LTL+B+T0KO*0IO9N;(U@O,:45W/@C*S7 3&F0YU,J)MV??E
M:KM-@FVM,FG6W6HT)I,PDZ;VVO&P3=U+3H\ESZ7SB)QTIFY49JM;GM=_&7%F
M&H=4FUE^3(?O WXCC!4M=2\(A]!J42B4F(VPZXZXDE(V[=JE'J1$1&#MV;PI
M'"SUA>6[MRJS/I&.,O4NI2J)<,6*Z_&5Z4DQ*D;I-,)-2^S(9<CKVI-235NT
MVJW&-<.=XV8SK7)R\N=>8J#2I%.MC*5OW/;-@NU!"4%(G5N6F?&(]24G<P41
MGN[5>:;A:&?E(3H1OCGE%:&,.$^8>,]ZPJQ3<N'*K5"I%LO0WMI(JBD(>-QQ
M6B651W%/&M"M#,]-I*-1Z##2TSX><=:9^A?:V+LQVQZ1@7XIRXKCM.8IU@TH
MD343H#;O:4TZA:4,L.*29D:5:I/R: K,Z5 ,KXHQ[AOUCW'BT<:6TS:ENN3+
M5J"Z8PZ^\@Y+U1D(<<W2''5ZJ)M)::Z= 6X']  *                .$OR
MF7C4V;539U\1K&<A7)3Y=Q/2:>S4/2=):4KQ5+;)Y:"97)U21/)U4C3S2U,!
MW8                #AK-IMW0)=ZN71>T:\(M0N"1)M6+'@,PCHU,4TT3=-
M=4TM1R%MJ)2C=7HH]WD(M" =R       "E.>_EUQ5]PZI_O+'S[OE\>UU9YW
MT'NEV.]UH?J.1;T  '/7=^"ES_<F;]06(JU2R6>G3RPL[@WY'<:?!V!]12/K
MNYNQ6NI',^9;][?>Z]7.]V]X%US_ 'H^]6]8UE^"N6!*N3Q,%F=Z6I+?<\52
MFN\M'87(U3M>1JI&WH1ZC9M4[@                               %:N
M8=DU_(O&;,-HVM"<J=P5&B=^F4UE.]V2N#(:F&RT@NJEN)9-*2+J:C(B!,:V
M497O*_1-XH<A+:L69!G<1[\;MV[H24MM*ET\T,>D9#:D:FEN2YVVEFXDE$ZM
M>I&7G*+<*7>,6<8.?^?5WY%Q/:M7MG']5L HM\HJ#;#2Y<F*MHH\R8W'<>90
MZ;AI:;T<6LT)4K70UDDB8PALH"H       "+,Z?(EF+X#W#[FR (9T>J"^1+
M)GPX5[FPP6J:U J                XNWH-]QKEO>5<U=IE3M6?)B*L&E0X
MBF)4".B.292);RE*)Y3CWG),B+0NG]0.T               !QF0(-]U&UIT
M3&U>I=M7<X[&.!5ZS"74(C;:7T*D)6PVZRHS6T2DI/=T,_\ =(.S
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M^D7U7)\^N4Q_'K],B-6_;[41:*@Q4$+6<I]^4:S2M"TFDDI))::?^4.S
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ML.VHJVFV6L4> BD^U.\69G63GDOQ)H4V1L=HT]O4MVN[H [\
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M-8)1I-YAQ+B-Q>4MR3,M>H#$SUA/SVN*/\7/])' 7IU-O04
M   0_F5%@+I-F?&':M1NV"F]*$=N1:;$E3%Q*T<C2!-=3%4DT-,+/5:U^87L
MD>I$9,)@!       /'N'_N"N?<^3]24(JU*U]&>10#B;\WK&W]RS?="2.;:#
M)_!IY%B@>D  $)VW\]>V_P T\_W52/9D/B3R*V.U1U9YX7Y&Y;I#V'T8]064
M/B^M6H6L2L@UQ5Z^D(DF)Z2N$S9\?48_B5*[K+Y[=KC>C:M#VET,$RF$$
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MOVAG9[5/@29YT^O;G? U!],8R-IECSS6XO5!:Z&1FHB,F$R@@
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M&H<?Z>N5;6&9N/8+DDE3IM LMRE-*<)!DE3[D>G&1JT-1$:C3[/EZ@A,0(
M      19G3Y$LQ? >X?<V0!#.CU07R)9,^'"O<V&"U36H%0
M  $+X\+&!9+S@=F,3F[X75*0K*CLE,]+#DLJ<A,$XQR?:#(HZ2)7A^FOTW70
M$IH!               (5Y!M8O?Q76V\R,U"1C\YE+.K,TM-15(4\F?'5$T*
ME?VSIX@F]=O33R] 3":@0        S>Q#^!Y_=2H_92Q\2KZ4\L\[[+F>E')
M',E 58   <G1?G'X7_N:O>YL@;KNY^HVOQ>S+Q[Y_2[_ .#VH7]'U5\M0KC9
MK%[>0,VKL=FH-7>[7("LI+EIJ)1W*AX%!1E1CF>T&78T)7A_-\F[]J"4U @
M                         &8^=.0M^8AYJXWMN^[MI]N\:[HI4=R<Y-AQ
M9,9B?':F.-/./FVI^,Z<LFBW[DI)O1?[0S26B-"U==O/B/?DNDU^Y[KQ#><^
ME$2J%6JI.H%1>C$2C41QGWEN*1YQF?F&74$:4^4FJTFMTV'5:%48E7I$YLG(
M%2@/-R(SS?D)33K1J0I/3RD8(>B             Q"]<I_JX_P ;_P# @+TM
MO04    4LQ%\\SES]S[)]QVQX+':;GX>9V.]OT/(\MWVY73'O<<
M(HSFUCY_$=^LY59FR,>.4M976S3DS%2CB[DZ]LJ?_;!F2M#\SV/IO-U!,)$H
MB:>BC4A%)2M%*1"CIIJ'2=)91R;231*)_P!MUVZ:[_._XW4$/3
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MTIFBTU;;R6X[:5KU<<0WMUWEH9:^R*WMW9.;%RNW35$TQCIDVJHF,6J(Y1F
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MQUO:&:O;%-(2:NIF?4![@#$+U9'SD>4?_/\ NP\"]6IMZ"@
M  "'F6K$+/4QYNPZDWDH[&;2_DLZ<\5-<HOI$S*EE4=>T;Y/EW3:TW;2)6ID
MG0B4P@@              '%Y'1;R\?7NF[+?DW7;!T*H>^"V(45<V34(91UF
M]%8C-Z+=<=1JE"4F1FHRT,O* ^BPTT5%C68FVZ'(MBW4T*G%0+:EQU0Y%.A%
M&;\/$>C+U4RMEO:A2#ZI,MI^0!U@       ,^*%^'N:OAK._X!\@WMVR]UYY
MWUK*]CR_RZ7;#7L@  (XO'\,\(?G HOV2@>S=W:[/S*?:@N]ES'RJ^:6C ^Q
MOD*'J8BQ2SE=*X=B5.'D15JT_P!,9$<IKS=.F4WQ+G8@M3S/M+=;7JI2$EKI
MIJ9[-$DIA!       **<\_P8X\?GUM+ZA4!OMP?$N_+JYX8KO!ROR'L7
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M;ENG&V;\86ET_&"5ND97%/\ >2=O'+/6WM4> .H>+(M)NF[O=KVKR;/9 =D
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M7I\8?;MGXO"MTW??!!]^/OB.7M] :K\?X#PG7QFFWL]WVOR[_8 =F
M          XVTOC"\5=WO[*W2A%7'_>&=!.6;IT38WV/212BVE*W[]_9]KTV
MZ==0'9        I3GOY=<5?<.J?[RQ\^[Y?'M=6>=]![I=CO=:'ZCD6]  !S
MUW?@I<_W)F_4%B*M4LEGIT\L+.X-^1W&GP=@?44CZ[N;L5KJ1S/F6_>WWNO5
MSNAO/XQ/_FI\7GO<_".#[^??%XO\'?/\?Z.\)_\ UOTG9[OM7TV_V!LVJ=H
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MTXDJ&G'L^!(==F3(RHR52U3FUI2EM2'S-*"2?5/E\FJ@[0
M '$9$F9 @6I.DXOHM'K]Y)>B)I],KLMV%!4TJ0VF2IQYE#BR-+)K4DB+RD7E
M^E,.W         9O8A_ \_NI4?LI8^)5]*>6>=]ES/2CDCF2@*L   .3HOSC
M\+_W-7O<V0-UW<_4;7XO9EX]\_I=_P#![4+^CZJ^6N(MF9D"1<-\,7;1:/3K
M9ASXZ,?5"G2W7Y4R$IA)OKG-+0E+2TO:DDDF9&7]3<H.W
M            !F-R0X_<6.0G)^AV3D.^[XH^9:I:K*J9;M!.,S3UTR&<M]+J
MGY-,E))?FNZD;OL%HGZ):)F(1OD/U8_$S%]E7'D"[;]RA&MRU8:IU7?CS:2^
MZEI)DDS0VFC:J/4RZ$!M2T*XQIQZW@3&+6*:G4ZSCQBD$S:]2K)(34'&&GG$
M*\23;3*26EPE)/1!%T!$IW!            #$+URG^KC_&__  ("]+;T%
M %+,1?/,Y<_<^R?<=L>"QVFY^'F=CO;]#R/+=]N5TQ[W'         #DK\E7
MI"L^X)6.J73*W>[$52K;I58?7&@OR",M$ONMDI22TU,M--3T(S21[B#HX*IJ
MX,-52:99J*F&SGLQUJ<90\:2[B6UJ2E2DDK4B,R(S+V" ?4         X^M9
M#L"VYRJ9<5\V_0*DA"7%4^HU.+%?)"^J5&V\XE6A^P>@K-=,:Y8JKUNB<*JH
MB>6'D_'%B/\ *G:'W\@?7A'O*>.%?S-KUZ?/#W*#?5D75)>AVQ>-#N.7';[T
MB+2ZA&F.-MZDG>I##BS).ID6IEIJ)BN)U2O1>HKG"FJ)Y)=4+,@ XN#*OY=^
M5^'4*32&<<LTJ"Y;=99D.JJ;U26X\4QJ0P:2;2VA!-F@R/7K[.ID@.T
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MP<K\A[%P   'Q^KF^1.\OSD7!_6Q1X^\7:*>I3]:EK5/*OX-"R@
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M[AA7#5[=K$F36#8-U#IUTH^Q'AVFD[=K1'U+74$Q.,/Z4 4
M   0YFES'S=)LH\B7?4;.@'>M"][LNFRY$-<RLI?-4&"\J,E1K:?61DM"M$F
M1:F:=",B83&"       >/</_ '!7/N?)^I*$5:E:^C/(H!Q-^;UC;^Y9ONA)
M'-M!D_@T\BQ0/2  "$[;^>O;?YIY_NJD>S(?$GD5L=JCJSSPOR-RW2'</+Q^
MOXT3L"[JE=I)R%7$WH=1ER9?HRX"[)3Z;&\0E/:88\S8VWJVG4]I^4$RF($
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MM_2-LM))#:4_L$DB(@5?6             Q"Y2?TH/'3^*/NG+!>-3;T%
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M HK=E^CILB%Z4KY]\X-+D^'2KO,2-%[VG-$+VEN/H0V;5PF$$
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M:[ZZJH4SWUV7.J93(=LNE!3V(\"(2$^$1);]M6G<K>O4^AD9 E+((
M       !$N;SM0L<5@[UR95,16Z4F <N_*-4TT>9%64QGM-HF+0X2$ON;6EE
MM/<E2D]-=03"6@0        S>Q#^!Y_=2H_92Q\2KZ4\L\[[+F>E')',E 58
M   <G1?G'X7_ +FKWN;(&Z[N?J-K\7LR\>^?TN_^#VH7]'U5\M1+8)VHJ]<N
M*H.3*I>M9.L0RNNTYU33-BVU(*(DFXD&*E"?"-NH+N*29JW+W'KKJ1$I:!
M                        CK+..X65\=W78$ZI2Z(5Q0EL0Z[ <6U*@2DZ
M+CRF5H4A6YIQ*5&6I$HM4GYJC AB),]6;R13F.DPFLG3)ULKI2ER,XF^278;
MVQ[2"4)=3\>HC,DIW(\SS_V% OM)1J'JJ<J5Q@J?7N5$FJ4U:TJ>BRZ=.E-]
M/VQ-.U/:9D1GIKI_5!&TUCPYB^CX7QA9F+Z#+D3Z99U/*&U4)6G=D.*6IY]Y
M1%T3W'7%*VET21Z%Y 5E)@            #$+URG^KC_ !O_ ," O2V]!0
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M>XN@(FIIJ"H             Q"]61\Y'E'_S_NP\"]6IMZ"@
M   "%V7\:?I"2XS=Q5->7BL!MR1:AR)YTU%O>D]$S$QS+P)/')\PU$?=V^QM
M,S,E- (              !P^37+8:QS?CMZU*51K.;M^I*NJKP5R&I46G%&<
M.4\RN(2GTK0UN4DVR-6I>:1F ^G'R[=<L*R'+0GR*K:;E IJK7J<MQ]V1)IQ
MQ6SB//.2M'UK6UM4I3OGF9ZJ\[4!UX       ,^*%^'N:OAK._X!\@WMVR]U
MYYWUK*]CR_RZ7;#7L@  (XO'\,\(?G HOV2@>S=W:[/S*?:@N]ES'RJ^:6C
M^QOD*%Z8_C4\^71&A7%4W\L(LZ NMVNY(GJI[%%.6X4>2TPLO!I<6Z1I4:#[
MFGE(B49J)30"       44YY_@QQX_/K:7U"H#?;@^)=^75SPQ7>#E?D/8N
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MPJ"Y:-E1KXE/U^FL5:'*G,P"@TYQXBE5)"WD+)Q<9'GI;3HI7[4]0'<
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MHU&0W>-P/3V8CE#BIBK-J2RPXE2I!N.:-FELR,B/KT,S+UO$[L
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MW+8K-EQ:?<#\:V);4]B<JMTY+37;JCB6$)..IU1J3VG-5D22U/30!W(
M  *4Y[^77%7W#JG^\L?/N^7Q[75GG?0>Z78[W6A^HY%O0  <]=WX*7/]R9OU
M!8BK5+)9Z=/+"SN#?D=QI\'8'U%(^N[F[%:ZD<SYEOWM][KU<[W;WJ-U4[WH
M^]:QF+X\=<L"'<??GL0/0]*=[GB:NCOH7WUQM$Z,HT6O=YIEH-FU3N
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M^I3S%O5/*GX>5<  $"WS\X_B'\+*C]CL#T1V6_U6.O7#6H<:S
MY*_ZK5Z%8EZUNWXWC:]1J#4IU$A[#<[LR/%<=8;V%U5N<21:>R P"P'P3OGF
M/8R\YWUGMZF3KBJDYJ.F93G:]+=\.Z;;SC[KD^(31FX1[4))1;=#U+R O,X+
MG8!]6)\1N7[)RM\=_OH]YTE^1Z!][7@O$]Z*]&V^(]*R-FG=W:]M7DT_9!$U
M-7 5             &(7JR/G(\H_^?\ =AX%ZM3;T%                '$
MHJE\GD1^C.6K"3C=-OHF1[U34".8JLG*-M4!4#MD9()CVSN[]-?-\I] [8
M             '@W1+K\"VJ_.M2CL7!<T.GR7K?H4F24-F9,;;4IB.N0:5DT
M3BR))J,M"UU,!^]O2:S-H%#F7%3&J+<$NGQGJ[1F'RE-1)CC252([<@DI)U+
M;AJ22]I;B+70M0'K@       SXH7X>YJ^&L[_@'R#>W;+W7GG?6LKV/+_+I=
ML->R   CB\?PSPA^<"B_9*![-W=KL_,I]J"[V7,?*KYI:,#[&^0N)BU2^5Y
MJU'EVK"CX\CT>/*I%Y(J!+ER*FMU27X:X/;(T)0V1*)S<9'KIY==H=L
M  "BG//\&./'Y];2^H5 ;[<'Q+ORZN>&*[P<K\A[%P   'Q^KF^1.\OSD7!_
M6Q1X^\7:*>I3]:EK5/*OX-"R@            #.GUH=J4^Z.,+CLRX85!EVO
M<\"M49F<X3+=1DMQID=4)"U$9$XIB0ZX@CTW*02=>H+4ZW*6-S.]78W:%N-.
MQJ#8SC-/8;7:,JSYTIVGFE!$;"GXE-D-.FD^F]+BMWE/J8&$K;8!S1QTR][[
M/B!J-,J'O>\![[/1U#ET;9XOQ'@^YXJ'$[NO9>TV[MO773<6I$PL6"
M   !B%ZPGY[7%'^+G^DC@+TZFWH*                (VR<S%>IMM>*R:[B
MU+5S4IQJIMR(D;TFX3WFT=1S"-*RF&>S8CSU'IM]DC"20       >/</_<%<
M^Y\GZDH15J5KZ,\B@'$WYO6-O[EF^Z$D<VT&3^#3R+% ](  (3MOYZ]M_FGG
M^ZJ1[,A\2>16QVJ.K//"_(W+=(TQJU%:3?AQ<GKR=WKRJSDA2Y$205ONFILE
M6^CPA>UE"TTV.^VD:CW^4B 26       "EN9OG 6G\"I'V:L?.^^':J.I]<O
MH7=;L%SYG],/^CE&\  !'N5OD[NO^X__ %TBM>IZ,I\6GE7@QQ\GEA_!VE_8
MC0^S9#LUOJ4\T/DV\NU7>O5SR\6]6XZ[OQ@I[*;EC/-U28<6S$/P6BNI7A%Z
MPS;DI-YSL%J[HQU(M3/R)4GUO$DT                               &
M-^?.(G-*^>0UU9@QMD&AVNTM2H-G5:)57J15&J1HDTQ9#D*$2W$DK7HXM?30
MM="(@6B8<E^BWZT'^<7_ "NJ?VH"<8;7TQJ4Q3:>Q.<[TUF,TB8]J:M[J4$2
MU;CZGJK4]04?<   "A>3?60<9L87C.LF;5ZU=53I,E4.MS;<@MRX41]!F3C:
MY#K[!.&@RT5V=^A^;Y241$[,K"R^1V&8>'&\]NWO%5BY^.3\6X$(=-3RS<-@
MHR(QH)XW^Z1MFULW$HCW$6AZ#!!F&_6%<=<V7M$Q_0*A6[;N.JNFQ;[=Q0FX
MK-1>(M2:CO,/R$DM1:[4N[#4?FIU49$8FEU_(/FG@[C95(-O7U4:G5;IG1TS
M"M>WXR)<MF,LS2AU\W76&6R6:3VDIS<9=23IU B,4C8-Y"8NY$6K)NS&E;7.
MBTYXHU<I4QHXTZGO*3O2B2RHST)22U2M*E(5H>BC-*B(3&"LER>LXXL6W><B
MT%UBO5EB%)7$FWA2J:4BD-N-J)"S2YWDONH(]=%M,K2K0S2:B-)F3LROE0:[
M1[HHM)N.WJE'K%"KL1F?1ZK%63C,B,^@G&G6U%Y4J29&0*L6.4G]*#QT_BC[
MIRP7C4V]!0               !&V2HJ9;-EI5D][&'9NRF/$^R[":.MF@W-*
M&KQJ5$HI?LI;]L/;YO34C"20                $<6!&3'GY"VY,7D+O7/)
M=73EN1'/>XI;3)^AR\,6Y!-%HLDN^>1+_9U,)'       !2G/?RZXJ^X=4_W
MECY]WR^/:ZL\[Z#W2['>ZT/U'(MZ  #GKN_!2Y_N3-^H+$5:I9+/3IY86=P;
M\CN-/@[ ^HI'UW<W8K74CF?,M^]OO=>KG?=D:,F0=AFK)B\:G'O"F/)V.1&_
M? :2=+T"HI9'N*9K]*U[;YGF>0;-JDC@
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M74X5M9%3BBL./0E1[Y5$B3DQ4IEM*<;-B::65>(01LEN/H:]2U,B(!(
M    #-[$/X'G]U*C]E+'Q*OI3RSSOLN9Z4<D<R4!5@  !R=%^<?A?^YJ][FR
M!NN[GZC:_%[,O'OG]+O_ (/:A?T?57RU'UI4ZX(=T9$DU;(Z+QIE0J45R@VH
M4.+'5;3:8J"<B*>84;C_ 'CT=(W2(R(^FNNIA((
M      ,HN;6#N6^2LV6/>V"J=#C4ZP:6TNV[LCSZ?3*I&GO./%,9[SKC;KC*
MT=O5"R4CJHB+SEDHM$PA_P!Y'K??QN_[?;'UL$Z&M.$8N2(6)[%B9>D^+R6Q
M3$)O&3O8<WS-ZMQ[HI$T?FZ?2= 4E*@            #$+URG^KC_&__  ("
M]+;T%    %+,1?/,Y<_<^R?<=L>"QVFY^'F=CO;]#R/+=]N5TQ[W'
M  #B,D0JQ4;%N>%;]]HQC69$):8%_.1H\Q%+7J1^(4Q+4AE9$1&1DI1>74C(
M]# =93VI#$"$S+FG4I3,=M$FHFA+9R'$I(E.[$>:G>?G:)Z%KT ?6
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M>0@$F@       I;F;YP%I_ J1]FK'SOOAVJCJ?7+Z%W6[!<^9_3#_HY1O
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M=C4RM4JBL56V:0N+768[$KOQJ@\XM1(C2)2-AD\6A[]?+T!.&$/Z, 4
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M[LUY[OJ3V&H9D9*>1JM&_P TNIC9M4E
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MN-2EI).TD::#&.!H)G3Y$LQ? >X?<V0"L,Z/5!?(EDSX<*]S88+5-:@5
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MMA:F?35)K"30       44YY_@QQX_/K:7U"H#?;@^)=^75SPQ7>#E?D/8N
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M;KT.X8,JZEU."J<F91&S7XV&P27&S:>=U3L<U/;H9:==2#M@
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MVM>X^OGF7D(AH<U>MW:L;=$41AJB9GRZ66F)C7.*31YE@
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MX8KO!ROR'L7    ?'ZN;Y$[R_.1<'];%'C[Q=HIZE/UJ6M4\J_@T+*
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MN.5GT"Z)]U1KAK%NUAZ94&6F5MK.N%'[:2:Z&6C1'J?T03$XP_I<!0
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MQ<7&OQJ4V;4V$7_0U6(F"W47%,W-N=]&O.%33)1(0>_4WM6O)O+7:"832"
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MBE"HT-UYQ];;*3-1)-UU2EJZJ/J9@,<?6$_/:XH_Q<_TD<!>G4V]!0
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MYZ5=R;W@42%#8KC[=CN4=]]UQ^C$ALV'9R7D))$@U&LE)09I\FG[(=D
M  "E.>_EUQ5]PZI_O+'S[OE\>UU9YWT'NEV.]UH?J.1;T  '/7=^"ES_ ')F
M_4%B*M4LEGIT\L+.X-^1W&GP=@?44CZ[N;L5KJ1S/F6_>WWNO5SNCO!^_6/>
MK[Q*?1:@3UPPFKS],OOL=B@J[GC7H780O?*1YG;0O1"NNY1=!LVJ=D
M     "C'!+\'N1OY^+O^HT\;S?G2L_*I^MBM:IY5YQHV4
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MRH>,*1R6LV_ZQ!MBI6/4(U4K$6<\AAU#4%$N+/7[8I.Y+"V4I5H7FFHM?IB
MJ/59X\FW;A3DRB8M=+I>2W&K58JR$&I*'$4Z6F0MMC5#?M15%!Z)TU^E/H1
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M\-XSP_MO9[FWN=OSMNNWJ _6@>GO0-$]]/@/?/X"-[X_17=\!X_M)\3X3O\
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MOY1W)]; VH;7TR._$IM/B27?$28L9IF0_J9[UH025*U5U/4RUZ@H^X
M      !B%RD_I0>.G\4?=.6"\:FWH*                (AR^JSTQ<?>_#)
M55QHR=\4;T _2JIZ+.M50E.G&HLI6Q??CRM%=QGIN).NXMNH)A+P(
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M8:2 J        BS.GR)9B^ ]P^YL@"&='J@OD2R9\.%>YL,%JFM0*@
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MPO.U21$>O3H ^\       &:7'O\ #CE/^>"XOLE8Y^_\2KEGG<[E^G=Z]2T
MQ/4  "NV:/E%XO?G1IO]8L9LM\2GE8+O3M]>/K:+#?M^BVDM4<LNW>ZQDZ;5
M:XJ@TTIV*%SF'(E*8-QTFZ@W#2DG6UR32:5+4>AZ?U $I        J[RI_!W
M%OYR:)]1ECD^^'9*/F1[-3KNYO:;ORJN>ER ^>.P    =1Q"^32O_"ZJ?UK
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M:QXJW$I<<+J7FH,]3\GL$ ^L!B%ZPGY[7%'^+G^DC@+TZFWH*
M     .&OVHW9385ON6A9$>^I4BX*;'J\.3.8@% IKCVDJIH6^E1.+BH\]+:?
M.5^UZ@.Y       !X]P_]P5S[GR?J2A%6I6OHSR* <3?F]8V_N6;[H21S;09
M/X-/(L4#T@  A.V_GKVW^:>?[JI'LR'Q)Y%;':HZL\\+\C<MTX:QZC=E0]^'
MOKLB/9/@;FJ$2VO#SF)WI>DM=OPM6<[*4]A<G56K*]5HV^<?4!W(       *
M6YF^<!:?P*D?9JQ\[[X=JHZGUR^A=UNP7/F?TP_Z.4;P  $>Y6^3NZ_[C_\
M72*UZGHRGQ:>5>#''R>6'\':7]B-#[-D.S6^I3S0^3;R[5=Z]7/+\;IJ=W0K
MBL*+;UCQ[GHM2J,AN[KA>J#,1RA14QEFW):8<0I<DW'#)LTMF1D1]>AF9>MX
MG<@       K+S+^:[FKX.N_56QL]S]LM\JEWHRK?B[Y,\=_!BD?830WE_P")
M5RSSE.IW0Q)  !XW$7YPW,3_ .U][DS!@WWV>Q^/GA2CI5>1H2.<90
M        8E9MLOG?1^5&0\M8$QN=$BU D4=JX*8=--FO4YA#9,.U&+/EN-N.
MH))(2OM(41)+3Z)EHPP?/[]_6^_BC_V"V/K@)T-KZ8J8JFT]51+;4%1FCG)Z
M%H\:"[A:)Z?3:^0%'W             ,0N4G]*#QT_BC[IRP7C4V]!0
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MH,HQBNS7&)U.)^]U,Q6RNDSAITDI<8]M<\*1$QJ]U+0B3TZ$$E@
M      C3+LAJ+8=5>>Q<]F5I+\+=C]AF"^N6?BVMKG;J"T,'X<]'O./IMU+3
M34A"2P        &;V(?P//[J5'[*6/B5?2GEGG?9<STHY(YDH"K   #DZ+\X
M_"_]S5[W-D#==W/U&U^+V9>/?/Z7?_![4+^CZJ^6HTLN0T]=F36F\7/6,MBJ
MQ2>N]QF"VFZ5'%1I-2N*M3KG9(B:U?+<1$1%Y%)2$E@
M          Q]YOL<DJ9R6Q_D3 &(:O4ZS9%OMMMY#H]-D3D3F9;LDI%*GH(E
M,NMMD>Y)$25)[BCUUV&DM&IPGZ4GK0?YNG\D:G]M@G"&M.$:_?ET8GL6X,GT
M7WNW_5:8A^ZJ)X9R)X:4:U$:.PZI:T="+H9F"DI4             8A>N4_U
M<?XW_P"! 7I;>@H ,?,,YS<QQ8][X^Q?;S=VY]R-DJX6K=HK+23*/'2II")]
M07T]J9T6:"6K3HHS-*"48YVQFIM1731&-=54X>:/V_3,OK&^-RQG,Q;S&9KV
M,K;LT;4\<Z?1I\<Z,</%PX+"4NEV?PVL^=?M^SGLG\B,GO=MUUO5ZIUJIO&D
MTT^GI-)K;C-K-)+62>OF^;KVFB]413DJ=NOTKE7AYN.>'S0T-V[?[Q7XL6(B
MUE;4<E-%,?Q5<=4\$?\ ZJGT6S;,;%L:M<L>6-:8>R*\QI1:*6CL>W8[I*-B
ME4I@U&2Y2R,TF:3Z>=YVG<<4MV_=8YC,3Z7!'%XH\?-YY5S.9G/33NO==,^Z
MQTSPW)X:ZYX*8^S1JAXUFV;6\\5MKDKR5::M;%]K-.5+%F+*DX28<2&DNX55
MJI.;4K-:4DHB47G]#,B:)"%5MVYS$^_OZ*(U1P8?9[75PB<V;S=O=5O_ !V[
MO3O5Z+ER-<SZE'-HU<N,QP4C,5PYMY/<<[HIUNNT;#T&OU^!CRN2T&W*K4AJ
MG+\=,)M?5+/1"$%I]'4]VY**1F9OYFBK#"G3AX^/ZOWO=3NFUNS=6;M55[68
MFBB:XC51&UZ-/6US/V:]31O7S,      '!90=:8Q_=;K^/U9491!4;N/$-1G
MSJQ;BUC]J7[2K7RF2]?)T(ST(!V%-,CIT TT]5)2<9K2E*)LE1BV%[29-*4V
M1M_2^89IZ=#,@'V@       S2X]_AQRG_/!<7V2L<_?^)5RSSN=R_3N]>I:
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M+S"_^EJ")P:N J             ,0O5D?.1Y1_\ /^[#P+U:FWH*
M        .&;J=W'DF12%V/'18J;<;EL9(*H,G(<JARE(52SI^SO$A+/MW>W[
M-3VZ:^0.Y               !SUVRJU!M:XYMMV^U=EP1*9*=HEKO26X;=1E
M(:4;,1<EU*D-$\LB0:U%HG74^@#]K:DU>9;EOS*_1F[<KTJFQ'JW;S+Z)3<"
M6ME*GXJ)#9)2ZEEPS02TD1*TU(NH#VP       9\4+\/<U?#6=_P#Y!O;ME[
MKSSOK65['E_ETNV&O9   1Q>/X9X0_.!1?LE ]F[NUV?F4^U!=[+F/E5\TM&
M!]C?(7#0ZG=SF1*U2I5CQXEDQZ)$?I>0TU!E;\R<IYTGH"H!([J$LHT63BE;
M3W:%U,] [D       %%.>?X,<>/SZVE]0J WVX/B7?EU<\,5W@Y7Y#V+@
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MZL5)FT44;(QXX7$N>FR:@\4>)(],Q6U+[M%TE]$>+U(M[?MA;?-]D!(
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M^K.#K,]\>KE5HZ,)S'D6  !Q&&OGRS_S%._Z3,"N\NP1\S^F5(Z?D:3CEV4
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M5&9"7:%KM06(SM!91$0F0R[(;4:Y!ONZND;A$:2/0NGD#N0
M  <-DBF7=5[0J,"Q;XCXYN5UZ(J%=TJGLU1J.A$EI3Z#BR%MMK[S1*:(S5YI
MJW%U(@'<@        ,WL0_@>?W4J/V4L?$J^E/+/.^RYGI1R1S)0%6   ')T
M7YQ^%_[FKWN;(&Z[N?J-K\7LR\>^?TN_^#VH7]'U5\M<+:U,N^%<=^R[AOJ/
M=%$J51CN6A;C5/8B+H,9,9!.1G9#:U+DJ=</N$IPB,B/IT/0@[H
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M4]I&>GD ?4       #-+CW^''*?\\%Q?9*QS]_XE7+/.YW+].[UZEH!B>H
M%=LT?*+Q>_.C3?ZQ8S9;XE/*P7>G;Z\?6T6&_;]PT"G78WD*XJG,O>//LR32
M(#-%L!,%AM^GS6W'CDS5S4J-UQ,A)H22%%M+;YNG7<'<@       J[RI_!W%
MOYR:)]1ECD^^'9*/F1[-3KNYO:;ORJN>ER ^>.P    =1Q"^32O_  NJG]:P
M/HW=#L4]>>:'&]\NVT_+I^M.N1(%SU.R;B@6;>;&/+GD1M*/>DF$S46H#I+2
M?<7%D*2TX1I(T^<>A:Z]=-!U+DW7L(=;89;?>\0\A"4O/[21O41:*5M+H6I]
M=" 9L\^KT1CJ_.)]\+I$JOG;%TU:<S0X7_6)CJ&H?:CM]%:&XLR3J1'IKT(_
M(.CW#9]];OT8X8TQIXM;#<G"8EZ=HVC[R?2W,SF95HS%[L1M]GV>OSX=J0UZ
MG&@P8QFKN37-VG351*,S,S6:UE6[=][AD\G'H\,\-<\<_=3$8>E5^YS]F69<
M7*BXF.1_(]A-H8(M!+E3Q3BFIN$U%<BM%O\ 3%8W[4*0I"=WG=%E]!DO;<EZ
M]3D*?R^7]*[5HJJCV:?#Z=2(VM,ZGVNNW-SPN8Z?3SGVCQ!M&>2)DQ!+B3+Y
MF1%_V-OZ53<-M2?^$_;="8K$4;JHQG"<Q,<L41/]7AJUNGR<[\+WO>O<AJ\Y
MQ9XLN,VEB2TF6Z9EO+=,;)$&)!01MG2:2;9I2O>E)H,T'[;U(C)DEK7-FS3D
MZ?S6:TW)TTTSKF?6J\-'*3.UHA,OJ^/F@XC_ +_^[]1'DW_VZYY/9@L]"%7L
M!?2YJ_.U=GV2@;O,ZK?4IYBWJGE3\/*N  "!;Y^<?Q#^%E1^QV!Z([+?ZK'7
MKAK4.-9@          >?5JI H=+J5:JLE,.F4>*]-J,M?TK3$=!N.K5^PE*3
M,P&'D?,?/KF56[DNKCT\K'&):%478-#-+\.GDXI.AI2_*>2X](?-M25.$W[4
MC4BT(]#47PB$W<9.2O(FQ,Y4[B_RXB$]7[FBK?L2[W"C&ZZM*7%M-KD0]&9#
M+Q,K2A>G<2X6Q>IGHDB8XFLH*@  _P"&9)(U*,B(BU,S\A$ HE1.=UDWARLH
M?&JQ*"U=E,J*9S-1R?&J9)BLSJ?3YD]]B/%**LI*$^&2WW2?26Y2MI*)!&LG
M#0Z+DUS-M/CM7K7L.%9]7RAD^[D(D4FQJ(>UTH[CBF6EN+)MY>]Y:%);;;:6
MI6U6NTMNX1&+[N,7,2S>2<ZZK7:MFJX]R)91;[AL>M;3?0R3O86XTLB0H^T[
MHAU*VT*0I22TZZ@3&"N=W^M$LZEW%=;%BX=NG)5A6/*1&N?)-.634%DE.FR3
MR2)AU!-.++1I3SC?<]C0$[*V%;Y:X?HO'N)R474Y4JPJG&0JDPFFD>D9$YQQ
M3'HY+)KVE(2\A:%EOVIVJ5NV%N!&"M.,/656K=]\67:%_P"(KFQ+!R4IA%A7
M;55D] G%*7VF'34MB-HRXYH@G6^X@E'YQI3JHB=EI@"K$+U9'SD>4?\ S_NP
M\"]6IMZ"@               ",VF&2S!*D?&DZ](5:3:/B8-Z#VV6_&G_P#+
MA,D@IFJC+L;S5V_*756W:$F                Y:^$-N69=C;MV*L-I='FI
M<O9+C+1TA)L+(YY.22-I/A_[)JOS2TZ@/WM!+:;3M=+5RJO1I-(A$U>*EL.*
MJR281I/-<8DLJ.07MFK9$@]WFEIH Z(       &?%"_#W-7PUG?\ ^0;V[9>
MZ\\[ZUE>QY?Y=+MAKV0  $<7C^&>$/S@47[)0/9N[M=GYE/M07>RYCY5?-+1
M@?8WR%&4!E@LMW \64W:A)5;D(EX>-Z":*<CQ#FVK$RA)2T]\R-LE+/8>AEU
MT22 DT       %%.>?X,<>/SZVE]0J WVX/B7?EU<\,5W@Y7Y#V+@   /C]7
M-\B=Y?G(N#^MBCQ]XNT4]2GZU+6J>5?P:%E             &<GK2+UN.S^+
MSD.WI+L-N^;HI]MW#(84I"RIKT:9,>;W)ZDEU<1#:R\BDJ4D^BM 6IUO@QUZ
MM?B;.Q?;!U.@3KOK5;HL68[D%NM3F77G);"'>_%9C/IADWJK5LE-+\W3<:_*
M8VI1YZLZ94+4O7E)@R!<JKLQ_C&YTE:%4-6]&JI<Z(ZX@R\PBD(BMK,D>9N)
M2D:DK<8J:V@J     /%N2N,6S;M?N23$E5"-;U.E5*1 @MD[*?1$94\IMAM2
MD$MQ9(T21J+4]"U(!FCD3(/#+FAA*^,F7*ZFF5+'=*K$"B*N&>BF5FF/]DGF
M7X\*-->0XF0XE';U2LW#3V]NI&D%M,/&X21+XY/<*;_QSE*XZJY3*E5IML6Y
M>$C21-]&)8B/[4J>\YXF7E+0E2S/IYA'HWH0G1*@F8N,-!XL\JN.5GT"Z)]U
M1KAK%NUAZ94&6F5MK.N%'[:2:Z&6C1'J?T03$XP_I<!0               !
M&64G:2U3+756,92LI,G=-(*)3HD&+.72Y)O>U5A2)2DDVF&?G*<1YZ=>G34!
M)H       /'N'_N"N?<^3]24(JU*U]&>10#B;\WK&W]RS?="2.;:#)_!IY%B
M@>D  $)VW\]>V_S3S_=5(]F0^)/(K8[5'5GGA?D;END8XR=I#Q9 .DXQE8S)
M%Z59NI>*@QH/O@EI-HG:^T492N\W,Z;7G-'%[?.+R ).       !2W,WS@+3
M^!4C[-6/G??#M5'4^N7T+NMV"Y\S^F'_ $<HW@  (]RM\G=U_P!Q_P#KI%:]
M3T93XM/*O!CCY/+#^#M+^Q&A]FR'9K?4IYH?)MY=JN]>KGEX%\KHI7CBMNI8
MNF7S/<JTOT+=\>!%E-6NZF(LUS'WWUI7'2\GVLE-D9J/IY=I'ZWB2D
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MJY5:.C"<QY%@  <1AKY\L_\ ,4[_ *3,"N\NP1\S^F5(Z?D:3CEV4
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M<QUN#\8=?F09$6-6)W@TJ9>B//*-#R6VE$E1MD1:GKUW;C)3."
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M^R4#=YG5;ZE/,6]4\J?AY5P  0+?/SC^(?PLJ/V.P/1'9;_58Z]<-:AQK,
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M8KO!ROR'L7    ?'ZN;Y$[R_.1<'];%'C[Q=HIZE/UJ6M4\J_@T+*
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M\TM '9@       I;F;YP%I_ J1]FK'SOOAVJCJ?7+Z%W6[!<^9_3#_HY1O
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MD"LRS;Y,PH4#UGG'5B#$9A,&JT5&RPVEM&XZG*U/:DB+7H"T:FXX*
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MVI1E61<UH,,%6[!=-LTQH[FJ6WH3C26TO,$HMFI(0:#T)2$[D&H3&"X((
M     19G3Y$LQ? >X?<V0!#.CU07R)9,^'"O<V&"U36H%0
M '%V]\8GOEO?WU^]SWG>)B?%OZ)\7Z3\-X<O&>EN_P"T[^_KVNQTV?3>< [0
M               '&9 ^,/WK3OBL.W2O7NQO1IW44LZ7VN^CQ/=*#H]N[&_M
M[>F_;N\W4!V8        #-[$/X'G]U*C]E+'Q*OI3RSSOLN9Z4<D<R4!5@
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MQI-5IM=I=-K=&FLU.D5F*S.I51CJ);,B-(03K+K:BZ*2M"B41EY2,%7H
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M@JQHJW40X]F)@$4U-:*4;BIZIV\S-LV/:^UMTU\[V.H=P
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M;&SW/VRWRJ7>C*M^+ODSQW\&*1]A-#>7_B5<L\Y3J=T,20  >-Q%^<-S$_\
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MS @  %,N)OX7\N/SSUC['CC<[UZ%CY<?6Q6]<\JYHTS*
M    RV];9'K3W'&U78&XZ3%ON Y7DMFHC)"H$]#"EZ=#03BB(]?VQH_W"U*[
M_'-S'[N#<7+Q>F&BR3MV#Z);A]O1*NTDWR>[9$7?[V_O:EN[F[=YVH(E6#UF
MQ8[_ $6KF5>10??*4V 6-3>V>-])G+9[W@]?._ZJ3O=TZ=O77KM IUI;X-M5
M=KB9@U-;0\B8=O[V4O\ 17A%R7E0C+_DG'-LT_\ )T G6M<"
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M;Y13KOJ,S)/O:I";DLMV7(7 A4Y#KZHDEF*I),H6ZIQ1*-*C/]A.XS42F,$
M"$;AL3,U2K=2G4#/'O;HTEXUT^A>]>G3/"MZ%HWXAUPEN:?1,AI[^2SM=R:J
M,SLTSJCW=,X>69TMYE\_D*+<4W,KM51KJ]Y53CY(C"$0VG$S[=%WY%M3X_O
M^\"7!B^/]ZM*=\7XV.;^[MZH[>S333<K7R]!JLK3O&_>NVOS.'NYB,?=TZ<8
MQ\GTMOFZ]V6+%F[^4Q]Y$SA[RO1LSAKX?H6(L&V[_M[TM[^<E?&'XOL>B_\
MY&BTGP?;[G=_ZLI7<[FY'TWTNWIY3&^R67S%K:]]=]YCAAZ,4X:\=6O'ZG.Y
M_,Y:]L^XL^ZPQQ]*:\=6&O5AIY<4B#WM<J[RI_!W%OYR:)]1ECD^^'9*/F1[
M-3KNYO:;ORJN>ER ^>.P    =1Q"^32O_"ZJ?UK ^C=T.Q3UYYH<;WR[;3\N
MGZTI9R]XWQ3WM\95SS[,L8X*2N*YZ7)?ARX;)O-DE;+\9*W4F:]J?-2>I'H9
M&1F.I<G"38!QS@PSB.F_$-ALXSRE&LUM[2V*-2NIZEUU,!G7SILRAY#R;Q!L
MFYFG7[?N6\JC"J\=EPVEN,+1"-:"675.XBT,RZZ>0R/J.BW'>JLV<Q73KBF,
M/I8KE,3,1+R[WO>O<AJ\YQ9XLN,VEB2TF6Z9EO+=,;)$&)!01MG2:2;9I2O>
ME)H,T'[;U(C)DEK7:S9IR=/YK-:;DZ::9US/K5>&CE)G:T0]RZ[KBXDBT/AU
MPZH;$C)LAC=7Z^K1V/;<=TDE)J]7DDDR7+61DHB473S")']B:52U:G,3.<SD
M^AP1ZWW:?%X<<DSAZ-+YZM5K*X/V5 QWCN ]E?DOE=XG6FG24_5*W5'U*(ZC
M43)2G&XK;BE=MO=YWG>=KWGBFBBYO2Y-RY.Q9H\U,<4>/PXH-%$81IF7^+<M
MRUN(%K5WD1R(KIW_ ,A[_,T..(-+\IR4^DNW1J,WIHE*2VI<<2DDI21$1$V2
M4FN7*]XUQE\O&S:I\-JKP^DB-C3.M*GJ^/F@XC_O_P"[]1'FW_VZYY/9@L]"
M%7L!?2YJ_.U=GV2@;O,ZK?4IYBWJGE3\/*N  "!;Y^<?Q#^%E1^QV!Z([+?Z
MK'7KAK4.-9@          8EVG(MBV?6PY&<RUX5F96(I_%O4JCM2PBH2*? .
MG+;<<+9N.&EUA!ZE[8>PCWZ$"W VT!5B1D&3:5>]:WBE>)SC2JC3V649)ETK
M8;9U2/'J)U$W7&_-4I,'M-NGY=Q&A7G$8+<#;<%0            !B%ZLCYR
M/*/_ )_W8>!>K4V]!0               !"K#6,RY#3W6J!4TY@58#12[G-B
MH%3E6]Z2/9$)XU>![Q22->TD]W;KU-)&1$IJ!               .&R>FUUX
MWOU%[TZ56+,7;]23==)@MR'9,FG*C.%*991$-+YK6UN(NV9*U\AEY0'TX]3;
MB+ L=%G09%,M%-OTPK6ILIM]I^/32BM^$9=;E:O)6AK:E1.^>1EHKSM0'8
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MANZ5!47PW4Y)-_V(E^9K]-KY ':        \>X?^X*Y]SY/U)0BK4K7T9Y%
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MY?\ B5<L\Y3J=T,20  >-Q%^<-S$_P#M?>Y,P8-]]GL?CYX4HZ57D:$CG&4
M            11FC"UA9[L.I8]R)2SJ%&FJ2_#ELJ)N7 F-DHFI<1TR5VW4$
MHR(]#(TFI*B4A2DF3$X,C*QZIS*% FRV<7\@([%#G*4AV/4&9M->[#A:+0YX
M)Q]#QZ)21]$DKZ"=- 6VEB>-7JSK.Q!>%-R3DF[EY-O*C22G4."B,<6F1)J5
M;DR7"<<==DNH5YR#4:4DKSMAJ(C(B:FH(*@            #$+E)_2@\=/XH
M^Z<L%XU-O04                <5>T^_(#5M'85O4RX7I=P08UTHJ<U4%,2
MB.&KQLM@T-N]UYHB3M;,BW:GUZ:&':@                .,M&??,V5=[=Y
MV_3J)$@UQ^/9<B!,.4J?1R;;-F5)0:$]EU2C62D:GY/]TP[,       %*<]_
M+KBK[AU3_>6/GW?+X]KJSSOH/=+L=[K0_4<BWH  .>N[\%+G^Y,WZ@L15JED
ML].GEA9W!OR.XT^#L#ZBD?7=S=BM=2.9\RW[V^]UZN=T=Y5"]Z?[U?>3;L"X
MO&W%!B7=X^:<+P-#=W^,G1]$+[SS6B=C73=J?G%H-FU3L@       1EFOY&L
MM_ RO>YSX].2^/;ZT<\*U:I9T\:?D)QK]RS^K.#K,]\>KE5HZ,)S'D6  !Q&
M&OGRS_S%._Z3,"N\NP1\S^F5(Z?D:3CEV4              &<?+'U?5"SS=
M)92Q]=1XURDI+9U2:;;BX-2<803;+SALK2['>0E*4]UO=J1%JC=YP+15@IZ]
MZOKG=<>MLW9R-BR[1(C;?3(NRXI\9;+IDIPFX3L9*5&9]5)7L(S+R^R"=J&E
MG%#B/9'%>V*C!HTYRY[RN0VE77>DEE+"WR9(^W'CLDI?980:C42=ZE*4>JE'
MHDDE9G%;($ #-/FCQ[Q+9N!^3.7*3:C+V2+TCQI56NZ:I4F4V3U1A(4U$W^9
M'0:2T/MI(U%T6I0+1* KF<FM^IYI?A$I[;D*G(GK,S)263O!'5.AEU->U)^7
MH9@<+U+L;IY>I[B%&=6M@J)1EFYMW**0=W1C=3HK9T)TU)U^AU+=[(X5,>_*
MDS_5D,UY9-T1*X9&^VM;BTM^_=YMWRD9EM80UH1)Z'J1;B(@6XUP?6)J=8Y8
M\/)$%6E2;J=/4QN,VTDI%=C&T?=3N47G:ZZ)Z>4M=>A6G4E3G3ESEK:E:NFS
M<58Q]\N'JK8[OOINKT++F>&\4W+:J']MM/(;1VF")75)[?*>H$1#P_5!?(ED
MSX<*]S88%36H%0               '#6W4+LE73?T2N63&MV@4^7"1:-SLSF
M9+M=97%2J0\]';2E<<V'=6B)PS-1%J70!W(               .$R34[QI%H
M3Y]AV/&R-<K3\-,2TI=09I;4AM<EI+ZSE/H<;2;+1J=(C+J:="ZZ .[
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M4N##IE-B,P*=3F&XL"#'0EMEEEE)(;;;0DB2E*4D1$1%H1 J^H
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M?9*!N\SJM]2GF+>J>5/P\JX  (%OGYQ_$/X65'['8'HCLM_JL=>N&M0XUF
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M8WR%Q<9[()W]5&)D&A(QDBCQUT>H-/2#K*ZL;RB?;>9-!,$P31$:32K=N_\
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M(JUJ?<_:A J/-?BF[3YL><VA5NI6Y'<2ZDE>^1P]#-!F1'H8)C4W)!0
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M,TI0E!(TVC&,-#1#.GR)9B^ ]P^YL@%89T>J"^1+)GPX5[FPP6J:U J
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M)@   *9<3?POY<?GGK'V/'&YWKT+'RX^MBMZYY5S1IF4
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M[-.VZ[(NBW3H=..@W+*DJF/U&%X9OP\MV2KSGEO-[5J</JHSW>R ZL
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M4+'[%V4:HU"2W=5SNU&/$5;T=$=2FY3<=Y"G))NK]JVM&1EKJ?FZZ>MXG>@
M      K+S+^:[FKX.N_56QL]S]LM\JEWHRK?B[Y,\=_!BD?830WE_P")5RSS
ME.IW0Q)  !XW$7YPW,3_ .U][DS!@WWV>Q^/GA2CI5>1H2.<90
M                     &(7*3^E!XZ?Q1]TY8+QJ;>@H
M C;)4I,1FRU*Q@]D_O793&289:A.G1#6;FE<5XU22243V5-^V%N\WIJ9!)(
M         ARL\A<&V]5:A0ZYEBUZ36*2^N+4Z9*J+#;S#S9[5MN(4HC2I)EH
M9&,<WJ(G"9AY:L[8IF8FN(F/&\W])[CQ^6BT/OK'_="/?V_6A'Y_+^O3YTA6
M9D6Q,BQ9LVQ+MI5VQ*<ZEB?(I<EN2AEQ:=R4+-!GH9EUT%Z:Z:M4XLUJ_1=C
M&B8GD=F+,H CBP)*9$_(6W&:\>]FYY+2ZBMN(W[XU(:9+TP7ACW+)TM$$IWS
MS)'[&A!(X       *4Y[^77%7W#JG^\L?/N^7Q[75GG?0>Z78[W6A^HY%O0
M <]=WX*7/]R9OU!8BK5+)9Z=/+"SN#?D=QI\'8'U%(^N[F[%:ZD<SYEOWM][
MKU<[[LC24QSL,E8S7DHY%X4QE.QN(Y[WS43I^GE'+,MI0]/IFO;?/\SRC9M4
MD<       $99K^1K+?P,KWN<^/3DOCV^M'/"M6J6=/&GY"<:_<L_JS@ZS/?'
MJY5:.C"<QY%@  <1AKY\L_\ ,4[_ *3,"N\NP1\S^F5(Z?D:3CEV4
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MZG?OIG]T+>[JXI1C#_I7%;ZC(BKM.,S/0B*4UJ9_^D'NZN*3%[(HD
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M6:7'O\..4_YX+B^R5CG[_P 2KEGG<[E^G=Z]2T Q/4  "NV:/E%XO?G1IO\
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M^R4#=YG5;ZE/,6]4\J?AY5P  0+?/SC^(?PLJ/V.P/1'9;_58Z]<-:AQK,
M                           ,0O5D?.1Y1_\ /^[#P+U:FWH*
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MH,U&22UU =^       "BG//\&./'Y];2^H5 ;[<'Q+ORZN>&*[P<K\A[%P
M 'Q^KF^1.\OSD7!_6Q1X^\7:*>I3]:EK5/*OX-"R@
M    .:O.U*7?=HW-95<5)11;LIDJD5<XCIL/G%F-*9>2VZGJDS0HRU(!0[]5
MMQ/_ /"+E^_3O[@%MJ5KL%8$Q[QUM*HV3C:-.BT*J5=ZMRVZA*5+=.6_'CQE
MF2U$1DG9&1T^CK]$$3.+*KUA/SVN*/\ %S_21P%J=3;T%
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MW2[KJC5K)M._FK!=A7'3YE===IT>HE5J8T:_$TA)2%H["I)&6CS>JT;?-+J
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MR7O-N.YH58MFIRHB[%HD>"49ZEQVXR426Y$CN*.0;KVJR,R+:73V=$AV0
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M_B5<L\Y3J=T,20  >-Q%^<-S$_\ M?>Y,P8-]]GL?CYX4HZ57D:$CG&4
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MIYBWJGE3\/*N  "!;Y^<?Q#^%E1^QV!Z([+?ZK'7KAK4.-9@
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M[<;:7QA>*N[W]G;IPCKC_O#*@E+)TJ)L;['I(Y1[3E;]^_L^UZ;=.NH#L@
M     4ISW\NN*ON'5/\ >6/GW?+X]KJSSOH/=+L=[K0_4<BWH  .>N[\%+G^
MY,WZ@L15JEDL].GEA9W!OR.XT^#L#ZBD?7=S=BM=2.9\RW[V^]UZN=T=X_&$
M9VI\7YVZDO?%"]_!W"4L_P#YO:.>.*G>$,O[=,]G:[OM7TV[V!LVJ=D
M  ",LU_(UEOX&5[W.?'IR7Q[?6CGA6K5+.GC3\A.-?N6?U9P=9GOCU<JM'1A
M.8\BP  .(PU\^6?^8IW_ $F8%=Y=@CYG],J1T_(TG'+LH
M            "+,Z?(EF+X#W#[FR (9T>J"^1+)GPX5[FPP6J:U J
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MJ2A:G7 E3@M\T_#GW.F^Z4L:G?G;;G+'-"MKHPMH-2R
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M<K\A[%P   'Q^KF^1.\OSD7!_6Q1X^\7:*>I3]:EK5/*OX-"R@
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M^_:G=%QG4:6J];4F5!4J+;[_ (%*8S$.,:4E&2^TGNK(C5N5J>OL$2EH$
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MYI^'/N=-]TI8U._.VW.6.:%;71A;0:ED
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MRI^'E7  ! M\_./XA_"RH_8[ ]$=EO\ 58Z]<-:AQK,
M            ,0O5D?.1Y1_\_P"[#P+U:FWH*                (681B[]
M(6>XU'J'QS>\%E$N4:*EX'WME4E&A!*/^T.[XHS/0O;M/^3J"4T@@
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MEGT^\9%YMW%6K=K*Y\B$F$II1UPH_;)"'GB46C6NNI>7R O$XP_IG!C
M           <;>KE_MPZ(>/(U"DSU5RGIN)-?<D-M(HINZ3UQO#$9G)2W_8B
M5YFOTWT##L@       >/</\ W!7/N?)^I*$5:E:^C/(H!Q-^;UC;^Y9ONA)'
M-M!D_@T\BQ0/2  "$[;^>O;?YIY_NJD>S(?$GD5L=JCJSSPOR-RW3C;.<O\
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M%OFGX<^YTWW2EC4[\[;<Y8YH5M=&%M!J60
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MORZN>&*[P<K\A[%P   'Q^KF^1.\OSD7!_6Q1X^\7:*>I3]:EK5/*OX-"R@
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M)  !XW$7YPW,3_[7WN3,&#??9['X^>%*.E5Y&A(YQE
M              8A<I/Z4'CI_%'W3E@O&IMZ"@               ",LFLQW
MV;()_*3N+#1=U+6P^T_"8.NN$;FVA'XU*B64S_B-^V'M\WIJ1A)H       /
M'N'_ +@KGW/D_4E"*M2M?1GD9X\//FY8Z_OO[KS1SDZW.[O^!3Y>>5F1#V
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M-?/EG_F*=_TF8%=Y=@CYG],J1T_(TG'+LH
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M5P  >/<7X/US[GROJ2A:G7 E3@M\T_#GW.F^Z4L:G?G;;G+'-"MKHPMH-2R
M                           ,0O7*?ZN/\;_\" O2V]!0 8U8:RW?Q6[>
M> ,&TQ;^5KQR#<<^J74Z@TPK=I#CC+*ISCFAEW#-"B3T/;TT)2S0D^<LW[D;
M5JW'I553IXHT>&/FTOKN]]U9?WMO/YV?^BBU1$4_Q7*\)G9CQ<?V8RLG/GV7
MPOLNG8\QY3G<E\@\ENDJ-&41O5&L5%XU$<^>9*-;<9M9J-"#5U\[SM>ZZ7KF
M:<E3L4>E<J\/-Q1P^>7.T47^\E^<QF)]UE;6N=5-%,?PT\=4\,__ *:7S4FD
MVUQ-MJKYVSM5SR!R#R :FDI:43LEZ2Z1;*324:'L:1JE+KJ4[23H1%MV(5%-
M-.3I][=TW)\/WSP:H\=KMV[OZ[3D<C3[O*V_-$>O7QS/!'[9?39-DR*/(J7+
MSEY4H\"YH$?Q%H6A(U.%:D(SUCLLQSW&N8LU$24D1J2H]3U>,S1-JUL__(S&
MO@CBXM''Q1P:Y]+57.9R+D1NK=43-$SA55'2NU<,S/J?1A]W7%#-YY3RKR1X
MSY.NRE*M#&]P5JN,8HM%_P V<<-BFJ6Y4I9:=#E$M&TM=-J?-+;HM>&B[<O9
MBW75&%,X[/)^WPT-I.4RF1W7G,M:JV[U--'O*HZ.,U="GJ\_FB>N=/X(X-_/
M+;/V//'LWI\.GK1];5=P.UWOD5^U2X0:QW8   #M/5_?(Y=OYP:[_6QALMT_
M!\OV."[_ /ZA1\JGZUK<F,2I-AW0S"O\L6REPE=K(*D17$TK123-]29OM!EH
M6T]YET/H9'H8V;AW6TY"VZ?!;<G'4W$1VDKJ2B01R#)!$;QDV1(\_P"F\TM.
MO0!1+F\U>;]9XXQ\=O1XU[R;U>8MB7+V]AB6[%V(>7N(RT;UW]2/R?2J\A^/
M-X^CAKQ:K>6WMVO=X;6U.&/(^6;-LSA79C-#H;+^5N1V5GR6VVLEOU2O51]9
MEXF3H:G6XC;JCVIUU6>I$9J-QQ,>CEZ<(TU2F9HR5&$>E<J\]4_8_P VS;-!
MXST&O<D^2=>3=F<;L2:3-)H><BN/(T:HU&:+S=^WS%K1HA*"-*3)HE*6IIBS
M'O+FFJ4441E8F]>G&N?#9I?[M&T9U4G2>6O+63'M]NWXYS,>8\F&9PK8A&9*
M:==:46KLYT]NU.W?OTZ=S8AJ*:<?^V[Y(XEK=N9GW]_1AJC@IC_D\"@4"Y.9
M5R1LI92C/VCQGM%]<RP[#F+["JZIC76I5(]2(F2(C]G;MU0@]N]:XIIF_.U5
MHIC5#'115G:MNO1:C5'K>.?%Q1X3)WJ_/FO67]T*S[H/C-D_APMN;LU/+/.B
M7CW^''*?\\%Q?9*QJ+_Q*N6>=XLOT[O7J6@&)Z@  5VS1\HO%[\Z--_K%C-E
MOB4\K!=Z=OKQ];18;]OT>4^+-1DZY)2\DE4H#M$@)9Q6;<,E4M9.ND=1[B/[
M9-,G381.%MU2>TS\B0D,!G+BF^KNK%CQ,.8I:7'NV=4JI(NN\'$**/0H#TQP
MB<)7[9]:?I-/)TV^=U1P&[<[>N6(RF5Z<S5-57!13,\_A&G5]'WMD+%O,3G,
MWIMQ33%-'#<JBF/_ !CA^G1KE^KU>B8"HE+Q-B:EG=.6+I/>TTO1Q];[A'OJ
M-17KT274TI,R(B+V$$9C:W;MO=5N,KE8V[]?GQ]:KZH^II[-FYOBY5F\W5L6
M*/-AZE'US];_ +!@VYQLMR5=MVRG+ZS'?3FQQQ&KLVIS73(RAPR,C4AA"C3N
M5MZ].FO;;)11:W-:F[=G;OU^>J?5I\7'/[(1<N7=^78LV8]WE[?\M-/K5?>X
MH_;+]:'0V+#8J?(+D%4VG;S=:TI=++1;-&961FU @-&9DI]1&9&9'T\[SOIU
MJFQ8C*Q.?S\_]G!'J<5-,>MX<<HOWYS<T[OW?3_U\,\-<\-54^K^S1JA%EMW
M!?\ >?([#5ZWE3BM^CW%'KRK&MM7]FC4YJFR-'7NA&:GS62M3ZGIJ1$C:-;E
M[^8S.\[%Z]&S35%>Q3Q4[,Z9Y?#1@VN9R^5RNZLQ8LSM54S1MU<$U;4:(Y/#
M3BF;E3^#N+?SDT3ZC+'O[X=DH^9'LU-7W-[3=^55STN0'SQV    #J.(7R:5
M_P"%U4_K6!]&[H=BGKSS0XWOEVVGY=/UILRA'E2K!N=B%D(L4REQ2-K(:D17
M$TO:XE1O*3-,F#(R+:>\RZ'T,CT,=2Y-VT4E%&CDN1XM1-()4O1)=T]I:KT1
MHDMWEZ= &:WK 8U\3;WXIP<:RF8%^3KHJT:U:A(-*6H\QYJ&A#ZC62B+M[M_
MTI^3Z4_(?2;AFW%N_-SH[,8\FEANXXQAK>A(D6%P.L*+;5M17LL\E\LO$;#!
MDM^JW!57UFGQ,G::G6X;;JE;4[MSBM2(S6;CB:Q%S>MS:J]"S1YJ8XH\?AQ0
MG11'',ODH-!M[B?;U=Y.\G:Z5\<B+X)3<:,VI#SL=UY&C=&HS9>8DTHT0ZZ@
MMB$>8CVO^RS775O"J,MEHV;5/AM5?5'UZG0]*K6_W8%@5"=4)W,WF;.C4251
M(WC<?8^F[O 6I W$J.M<=1&:YBS-.Q&TU[S(S(WC2EIF,Q$1&3R<8X]*KAKG
M[/#5K1'\57[GFTBV;JYGW+%RYF6,]8G%:S%+JE@6!47DQE5Y+!*,ZM5SW$2&
M-A&KSCTV>:@]AK=<M7=HW;1[JSZ5^K155'\/W:?'X>*$1MZ9U)M]7Q\T'$?]
M_P#W?J(\>_\ MUSR>S!9Z$*O8"^ES5^=J[/LE W>9U6^I3S%O5/*GX>5<  $
M"WS\X_B'\+*C]CL#T1V6_P!5CKUPUJ'&LP
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MW0Q)  !XW$7YPW,3_P"U][DS!@WWV>Q^/GA2CI5>1H2.<90
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M@2IP6^:?AS[G3?=*6-3OSMMSECFA6UT86T&I9
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MIZT?6UG<#M=[Y%?M4N$&L=V    [3U?WR.7;^<&N_P!;&&RW3\'R_8X+O_\
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ML#T1V6_U6.O7#6H<:S                             #$+U9'SD>4?\
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M[H8D@  \;B+\X;F)_P#:^]R9@P;[[/8_'SPI1TJO(T)'.,H
M              #Q+EN*D6A;E>NNX):8%"MFG2JK69RNI,Q8;2GGG#(NI[4(
M,P&/SWK&N1E3M^N9OM;CI3)7'"W:R5)J-9ERW2J>JG&DH-3R']J-Q.)2I:8C
MC2%K2@UF9><6V6K^+LC6]EO'MI9)M1Q:Z#>%/;GP4.D1.M&K5+K#I),R);+B
M5-K(C,MR3T,%6/\ RD_I0>.G\4?=.6"\:FWH*                .(O>F7W
M4VK9*P[G@6P_!N&!,NA<^!X],ZBM&KQL%HMZ#:<>(T[72/5.G[.I!VX
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M,G)#KY$3BS-2C5N^F7W%H].Z<G/O:<SF:O2JGT8X9GCY,/#5C6Y5HF*5[O\
M4V_^TQ__ (\-'_\ SO\ V?U,G\'D4VXT_(3C7[EG]6<'1Y[X]7*BCHPG,>18
M  '$8:^?+/\ S%._Z3,"N\NP1\S^F5(Z?D:3CEV4
M     5!Y=<L*9QAMVV$Q+;=O;(%^S'(5F6DTXII+IL]LGGWEH0XK:E3S:4H2
MG<M2B(M")2DDQ&*(<'<WKVK^9X6 >0V(%X@OZXHOC+2>;><<CR=S2GFV76W2
M4:36AM>QQ+BB-:3;-*5 F87)SI\B68O@/</N;(!6&='J@OD2R9\.%>YL,%JF
MM0*L]>9%\5S'.9>*]VVS;+MXW)"]_$2WK:9W&J5.J-.A0(R3)!&HTI<D)4HB
MT,TD9$9>4M5O"[-JNW53&,^EAY<(=[W1R5O.9'.VKE>Q1/NIJJXJ::JJI^B-
M'C?7;5M4+C30J]R1Y(UY-V9ONQ.Q2D;7G(SCR=&J+16B\W=M\Q:T:)2DC(C)
MHE*72BBG*TS>O3C7/AA'USJB-$:-=,SF;F^KE.[MW4[&7H\F.&NY<GZ8B>?5
M^EHVC.J<Z3RRY928]OHM^.J9CW'LQ1G!M>"9DIIUUI1:NSG3VZ%MW[].G<V(
M:6[<S/YC,:,-4<7[>*/KU5S6:IHIC=>ZXFK:G"NN.E=JXHXJ(\V'BQFKGZ!0
M+CYCW'&RAE",_:?&FTWUS+"L*8OL*KRF-=:G4SU(B9(B/V=--4I/;O6NM--6
M<J]Y<T6XU1X?3/DCAEZ;]^UW=M3ELM,5YRN,*ZXT^[Q_@H^]^^=.$1YF2+JN
MCE13;SM?%\EVT>-V.Z=,]]%[14=E5RRJ?'4XBF4U.A$45)H22S(M-O4^AH0J
MF8NU9FFJ+>BW3&OCPC5^S@USP0R;ORUK<55N[F8V\W<F-FB=/NXJGIU_>XOW
MS%BN%?S7\2?<^9[H2AL<A\"GPX6@[X_JU_ECV84-XX_@'4OA)5_JXT-KAY7U
MO.]..K3S)\&5XP  <C0_G6\8/XZ^X2AEROQZ/+S/!O[]'S7_ *_;AJ0.@?&7
M&V_$OMBY+WD7-5Z3/M69*B*L"G08SC,N'&1&2F4F:ZM:DNJ6^1J0:2+1/]71
M(>U</_<%<^Y\GZDH15J5KZ,\C'3C+9&3.2.+;"Q75#DV;QWQX_,<NRH1EJ;D
MW3.?J4B>F(TO0M&F2>2E6FJ4J(U&:E[";UEFBJ[3%.JF/I<YN^U<S-FFW.BW
M&./WM,SAR<?AA9B\;LKF7*B[QAXLG'M.Q+3813<FY2@H-,"E1"U0JF4U3>G<
M><(E$HTJU4>[SB(EN%FJJFO_ *[>B(URV%RY5>GW%C1$:*JHX/NT^/F?A<]S
MP<,0:-Q,XF49JIY5J;6M=KI[7$45#B4E(JM5D$DTG(-)D9$9:(+;YNG;;4JJ
M]W_UV]:*ZXL1&7R\>E[/CGQO1,[,X669#M>UX;V5.1N5'MS#"MSM2KE2=4K6
M5*/<;C4-IPU&1&K51[O.W=QQ,Z,O&$::I6]#)4;-/I7*O/5/'/B1ABG'M\6+
MS.L>?DZZ5W9D6^["J=P7=)(R\-$?<==8;A12(B+M,-LI26A$GR[2).@QVJ*J
M;T;4XS,8O-9LUV\W3-<XU54S,\7)'BA.?+C\-^+?P]<^Q1.\.C'*]&\NG:Y9
MYDH#5*    (Y]7Y\UZR_NA6?=!\;S)_#A?<W9J>6>=9[(4*_:A:LV)C.NTJV
M[O<>BG!J]:AN3X;;*9#:I)*8;<:4I2F26E/G>4R\GE+TMJ[4!2/D%4[RI><,
M5NX^IB*K=\JAU.'167"W-M+D[VE2%D?F[64*-9[O-+35734AQV_;E^C/V9L1
MC<FFJ(\NC'R:^+C=OW>M9>YNZ_&8JPMQ53,^33AY=7'Q.CC1K:XS6T[5*HZ[
M?V9K^=VJ4G<[/J\]U1'V6=24M$="U%N5IJH]#,C4:$%GIIM;EM;57_9F+G\U
M57%'#LX^?EPAYJZ[V_;VQ1_UY>WY*:*8X9X)JF/-R8R_W1Z/!Q9!JN>L]55N
MH9!J#>R+%1HXBFH<(^U3*8UJ9&X9&9*41Z$6[SMN]:YLV:<C35GL]5C=G5'J
M\5%$<?AQS,7KU6\*J<AD*<+4:Y];CKKGB_9HQPB//MBV*E?]2//&>#:H=MT-
MI4RQK&F*TBTV*6BTS)B5D6YQ6A&1&6JCT,R(B0@L>6RU6;J_.YWT:*=-%$ZJ
M8XY\?/YH9,UFJ,G1^0R'I5U:*ZXUU3ZM/B\..7,W>=R\B*!=MVRO%VUA:TZ9
M49MK4T]695P3H;#BFY3Q>5+"%IU(O]PO.W&CSYOWN][==V<:<O135-,<-=41
M.F?%X:\</5D_<[ENV[,85YFNJF*IUQ;IF8QIC[TQX8:[+X-^1W&GP=@?44CH
MMS=BM=2.9S._>WWNO5SJ9XA_ \_NI4?LI8^2U]*>6>=]0S/2CDCF2@*L   .
M3HOSC\+_ -S5[W-D#==W/U&U^+V9>/?/Z7?_  >U"_H^JOEKBK;A7[&N&]Y%
MU5VE52V9TV.Y8%.@0W(TJ#$2PE+[<QU;BTO*4[JI)I(M"_JDE(>W<GX/5[[G
M2OJ*A>WTHY43J9)\:+IQ-Q;XPV=DR!;[EUYSS?XN+;]N1_;ZK59#,]Z)&AQD
MH2:F8B#;0IPR(S4L_P!NKMI+J]Y6KV?S=5N9PM6]<\$:,<9XY\.-AHPHIQX9
M3?;5M4O %+K_ "XY<5]FLYCK+/;IM-;VNMT1MU*C8HE$8-1I4^I)FE:TGHDM
MWG;.ZZYXKER<W,93*1A;C_R^]5XO#BA:(V?2JUO%L2Q*UF&M*Y<<N%,6K8MJ
ML+J6*L55)>VGT:GIT<14:BAPBWNKT2I*5)W+5M,TDDFVRO?OTY:G\IE--4Z*
MJHUU3Q1XO#CDB,?2J?M3Z?<G.>Y&;ON]F99_$2SYBI%M6U(4J)*O.5$4>LV:
M>J31$0:3]GZ*4GOWK;BJJC=5&Q1Z5^K7.O8QX(\?ARNGR<[E;&R[8.6.?]I)
MQFVA=HX_Q]4K5@U&,VEJ#(5$6XXKP*$$1=ALG2;09$1'MU26W:9Y;^4N9?=M
M7O.E57%7C\OC5BJ)KT.SYK?+SPT^Z%X_8M,%-Q? O_AYY6KZ5/E=D,JX  /'
MN+\'ZY]SY7U)0M3K@2IP6^:?AS[G3?=*6-3OSMMSECFA6UT86T&I9
M                  !D[>GK$,DU:\<E0>/>"%9-L'#Q.KO>\7WWD[F6#=0Y
M(:;927;;-32S;UWK4A"E[$EKM+;*]7&_/UL<D\6TO)=LPWJ3WI#U.K]OR%DZ
M[3JC&)*G8ZG4I2EPMCB'$+(BW(6DS2E6J2(F,&77KE/]7'^-_P#@0%J6WH*
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M\D6Y[T;YKE,1)N:VO!R8'@Y)J41M>%F+<?:T(B/:M1F"DI4
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M\-U^]&Y*7X7P].DR(W]MSY;L=ON2&FV_/2>[=M3YQD8(F(:G J
M           .=N^3-A6G=$RFI4NHQ*1->@(2HT*-YMA:FR)1&6TS41==>@#(
MGU4D.G.X%SVMU:5/RZRJ/4&302R*,FED:#-/[8C-QPM#/V 6J>1ZK6N7+1<
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MK>]%5&C[H+33"F7_  U3=>>/>I:RW;MIZ="Z&"LK,@@
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M-1-()!&>GT= 0^P       %/,Z</;;SGE_&>7ZM>-3H52QGX#P-'B,,N,2O
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M]_WHKQGI%AECP_HKQFSM]H^N_P 8>NOT"!,SBN&"
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M'--Y9_%[Z0OR39/O ]+=GP\!$[Q7I7P6[=O?9V=OP9:::Z[O8TZDQ."Z((
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MY'L7Y)JTV_O2W>M1<!#+4;TK):D*VR2?6I?;-K0M4%KK[ )QT+H@@
M!2[ ?#FFX)S-E+,,2_)-R2<F^D._0GH"(R(?CZBFH'M>2^X:]AIV=4EKY?V
M3,XKH@@   !7SDU@.)R2Q;+QC-N5ZTV)51AU$ZPQ%3+6DXBC42.TIQHO.U\N
M[H"8G!VN&,:L8=Q;9.,8U677F+,IR:>U6'62CKD$E2E;S:):R3]-Y-Q@B4G
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M_C_"Q-JIM.I;B7I544TME:DN$RTA.LDXS27G%J2>Q/F(W&9@G&.!L&"H
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MYL6D8QL.T<>4"1,ET6RZ5&I%+E5!;;DIQB*V3:%/+:;:0:S(NII0DOV"!#M
M    %6*7Q%QM2.1]1Y01JW<J[^J?>\12'9,,Z.7>@%3U;62AI?+1I.I:OGYW
M7R= 3BM."        %6,.<1<;80RED'+=J5NY:A<F2?&^G(56DPW8+7CIR9[
MOAFV(;#B='$Z)WN*\WRZGU!,RM."    $+Y[P5:7(K'LG&U[5&KTNA2IT6H.
M2Z(]'8ED[$4:D$2Y,>2C:9GU\S7]D@3$X.IQ;CFB8CQ[:F-;;E3IM"L^"FGT
MR74EM.2W&DJ4HC>6RTR@U:J_:H27[ (=^
M  H9?WJWN,&0;TJ%\3Z#6*'.K$I4VL4FB5#PE/DON*WNK-DVW#;[AF9J)I2"
M]DB(P3M2NK:UKV]9-NT>T[3I$:@VY;\5$.CTB(C8RPRV6B4I+J9F?E,S,S4>
MIF9F9F"'O      #X85,IM-[GH^GQH'>T[WAVD-;]NNW=L(M=-3TU ?<
M ^.93J?44H14(,><AL]S:)#2'229]-2)9'H ^I*4H2E"$DA"")*$)+0B(NA$
M1$ _T       #X95,ILYUIZ;3XTMYC^P.O-(<4CKKYIJ(S+K] !]P      ^
M&%3*;3>YZ/I\:!WM.]X=I#6_;KMW;"+734]-0'W        _PZTT^TXR\VEY
MEY)H=:61*2I*BT-*B/H9&7E(!^$.#!I[2F8$-B"RI1K4U';2TDU&1$:C)!$6
MNA%U ?4     ^&53*;.=:>FT^-+>8_L#KS2'%(ZZ^::B,RZ_0 ?<
M ^%=,IKLM$]RGQG)S>G;FJ:0;J=/)HLRW%I_5 ?<     _PZTT^TXR\VEYEY
M)H=:61*2I*BT-*B/H9&7E(!^$.#!I[2F8$-B"RI1K4U';2TDU&1$:C)!$6NA
M%U ?4
M
M
M
M
M
M
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M"K=,N6B4:XZ))\;1J_!CU*D3-BV^]%EM)>9<V.)2M.Y"B/122,O9(C >J
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M\587MVXLT4&M97K5!I4.K4F956G:O)J[K24N-.MJ4;BGE.'H9'UU!$PNJ"
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MR$2'S7W%.()*C22=5)(U$9D",%V00            J[GSD9B6P[4RG:DK+E
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MK%(Q+?'OLJ- C-S*O']&5.!V675]M"]T^)'2K5731)F8*S&"?00
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MQM0>/GI;#+M6B4M_)?HZI+V4J;5E%.F>(0\3'M!.N'NV[2V]2Z&!,0W#!0
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M.\,969<V0[:]YUZUFGID7';':=9\%(-2B-KMOJ4XG0B(]%'J"DI)
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M5+#WK#(%Z67<=_6K)RC*.M6_:9ME5R;:J"WD2X_=41:Q7$)>/S5]$><A2=Q
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M)^"F$\JX,@7;F&P*P5Z/5BHQ7R?G5&F+\.PM),_VNAQHBZ&?7;U!,RVQ!0
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M8?U?V/*_'X<52Q[EHU1LVL7%/N.(^Q4H;T.4V4YLF$/J:=2VL]$F6A^R1=#
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MJEZU?#;,^(UA>H9"8<C5EYA)R"?6AIY;KB6=G9+Z?M[O[&1'W"(5-* 5
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M9@R ]GS!,=&0CK%1*2FXHCS$[PA+3X?5"E(/;IKMZ F9:O J          "
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MC+0R/R&0#YH<&#3VE,P(;$%E2C6IJ.VEI)J,B(U&2"(M="+J ^H
M
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MC95-A1YAQU;HYOMI<-"NG5.XCT/H7D ?6
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M;I3[3:4+=49F>JU)(C4>IF?4!]8
M                                                     _-YEJ0R
M['?;2ZP^A3;S2BU2I"BT4DR]DC(P&<1^KJI],IET679O(?(]GXIN]\UUG'$6
M2R[&4RXE+;L=+JTEYBFR[9ZH/<@DI<W[>I;:7NQW8-MXML>V,>VA%7#MNTH+
M<"ELNK[CIH1J:G'5Z%N6XHS6L]"U49]"!5V8
M
M              YRY+/M*\XC,"\+6I%UP8ZS=8A5B#'G-(69;34E$A"TD>AZ
M:D0#][?MBV[3@>BK5MZF6U3-ZG?1U*B,PV-ZOIE=IA"$ZG[)Z /<
M
M
M
M
M
M
M
M
M
M
M                           !6+-/,#!''ZZ8%FY0N:91:_4Z4U6H<6/3
M)DQ*H;S[\="S<CM+21FY&<+0SUZ:^R0)B,40_K,^('X_5/[PU3[7 V9/UF?$
M#\?JG]X:I]K@;,GZS/B!^/U3^\-4^UP-F3]9GQ _'ZI_>&J?:X&S)^LSX@?C
M]4_O#5/M<#9D_69\0/Q^J?WAJGVN!LRN98-]6WDRSK>OVT)BY]LW1%*;1ICK
M+C"W&5&:24;3J4K3U2?0R!#KP     !Y]6J<.B4NI5FHN&U3Z1%>FSG4I-9I
M9CH-QQ1)3J9Z)2?0@%%/UF?$#\?JG]X:I]K@G9D_69\0/Q^J?WAJGVN!LR?K
M,^('X_5/[PU3[7 V9/UF?$#\?JG]X:I]K@;,GZS/B!^/U3^\-4^UP-F3]9GQ
M _'ZI_>&J?:X&S+O\7\YN.&8KZH>.+"NZ=5+LN/Q/HJ"]29\9"_!Q79CVKKS
M*$)T:86?4^NFGE,#!;P$       C'+N8+#P;9SU^Y&J;U(MF/*8A.S&(STM9
M/23-+:>TPA:^IEY= (A5+]9GQ _'ZI_>&J?:X)V9/UF?$#\?JG]X:I]K@;,G
MZS/B!^/U3^\-4^UP-F3]9GQ _'ZI_>&J?:X&S)^LSX@?C]4_O#5/M<#9D_69
M\0/Q^J?WAJGVN!LRG;"'*/#7(F5<4+%5PRJW(M9J,]6D2*?*A$VB6IQ+1D<E
MMLE:FTKR>0"8P6%!       (1S;R&Q9QYI=#K.4ZW(HE/N*4Y"I3L>%)FFMY
MI'<6DTQFW#3HGV3!,1BKE^LSX@?C]4_O#5/M<#9D_69\0/Q^J?WAJGVN!LR?
MK,^('X_5/[PU3[7 V9/UF?$#\?JG]X:I]K@;,GZS/B!^/U3^\-4^UP-F3]9G
MQ _'ZI_>&J?:X&S*SN%LYXXY VM/O+%]7?K5 IE5=HLR5(B/PU)F,L,2%H)N
M0A"C(FY+9ZD6G73V# F,$O @                                  %(
M.95[\L+.^+C]&"T??5Z1],>_C^T&IW8[/@O ?V5Q&S?O?\GET_8!,8*0_';Z
MU_\ )%_ $7Z^"V$'QV^M?_)%_ $7Z^!A!\=OK7_R1?P!%^O@80?';ZU_\D7\
M 1?KX&$'QV^M?_)%_ $7Z^!A!\=OK7_R1?P!%^O@80TDXGW-GFZ\7R*IR*M_
MWMW^FN2V&:=X1$/6GH:8-A?;;4LNJU.%KK[ *RLR"       8NW/F;UI,:Y+
MAC4'%'B*%'J<MJBR/049>^(AY9,*W&^1GJ@B/4%L(>)\=OK7_P D7\ 1?KX)
MP@^.WUK_ .2+^ (OU\#"#X[?6O\ Y(OX B_7P,(/CM]:_P#DB_@"+]? P@^.
MWUK_ .2+^ (OU\#"';XRS!ZS.IY)Q]3;]Q=Z/L:H7+28UZ3_ $)&:[%)=F-(
MG.]Q+QFC8P:SW$73R@C"&PP*@      CG+U1O>D8OOZJ8U@^D[_@4.8_9U.[
M27^]4$-&<=';4:25JO0M#,"&1'QV^M?_ "1?P!%^O@OA!\=OK7_R1?P!%^O@
M80?';ZU_\D7\ 1?KX&$'QV^M?_)%_ $7Z^!A!\=OK7_R1?P!%^O@80?';ZU_
M\D7\ 1?KX&$+,\4,D<YKKRA(I?(JPO>W8":'+?9J/HMB'K4$.L$PCN-NK/JA
M3AZ:>P")P:2 J      "NG*6XLW6OB>75N/M"]\6145.$U&IOA42]8BU&4A7
M:<4@O-+3KKT!,,S?CM]:_P#DB_@"+]?!;"#X[?6O_DB_@"+]? P@^.WUK_Y(
MOX B_7P,(/CM]:_^2+^ (OU\#"#X[?6O_DB_@"+]? P@^.WUK_Y(OX B_7P,
M(7>X:WORPO'XQ_TG[1]ZOH[T/[Q_[0:@]_O>-\?_ &)Q>_9L8\ODU_9!6<%W
MP0                                    IYS"O#DU9]MV=)XS6O[Z*[
M,J;[5SQ_ MS>U$2R1M*VN+02=5]-2!,8*"_';ZU_\D7\ 1?KX+80?';ZU_\
M)%_ $7Z^!A!\=OK7_P D7\ 1?KX&$'QV^M?_ "1?P!%^O@80?';ZU_\ )%_
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M[S&O"Y+QC<F;+]Z]"ATQAVV)'HYF%W9:GC)U.YMQ9JT1UT,%9P7[!
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M$'QV^M?_ "1?P!%^O@80N]PUO?EA>/QC_I/VC[U?1WH?WC_V@U![_>\;X_\
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M;?H!<0/R)TS]_53[< QD_0"X@?D3IG[^JGVX!C)^@%Q _(G3/W]5/MP#&3]
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MY*YCK33"W35(<=5J;;#:="/3IY/*",4D@
M
M
M
M
M
M
M
M
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M!CUF:DUPZ2Y(:1)=26NJFV342U%T/J1 /5
M             !X\2XK?GTM^N0:[3YM%C)<7)K#$IIR*VEDMSJEO)4:$D@BU
M49GT]D!Y4J_[$A)B+F7K08B9[!2H*GJE%;)YA2E(2ZV:G"W(-2%$2BZ:D?T
M!F_[$DQYDR/>M!D1*<E"ZA*;J45;;"7%DVA3JR<,D$I:B21F?4ST\H#[Z/=-
ML7$IY%OW'2ZZN,1*D(I\QF4;9'T(U$TM6FO[(#W@       >=5JQ2*#!>JE<
MJD.C4R/IXBHSGVX["-QZ%N<=4E):GTZF _U3*K3*U"9J5'J,6K4Z21G'GPWD
M/L.$1F1['&S4D]#+3H8#\V:W1I%4ET2/5X3]:@(2[.I#<AM4IE"R2:5.,DHU
MI(R6DR,R]DOH@/-JUYV?0910:[=='HLTT$Z4.?.CQG30HS(E;'5I5H9D>AZ
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M@'^)-=HD*HPZ/,K,&)5JB1JI]+>D--R7R+74VFE*):_(?D(!ZH
M                            \Z36*1#G0:7,JD.)4ZIO]&4YY]MM^1VR
MU7V6U*)2]I=3VD>@#YIER6[3Y4B#/K].@S8D54Z5#D2F6G6HJ3T4^M"U$I+9
M'Y5&6G[(#P?C-QM^4&VOOM#^N@/MG7W8]+F+I]3O*ATZ>V2#<@R:C&9>23B2
M6C5M;A*+<E1*+IU(R,!U#;B'4(=:6EQMQ)*;<29&E23+4C(RZ&1D _V
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MFTU)(R,R(]2 >S2:W1J]&\;0ZO"K,,E&@Y<&0W(:W%Y4[VE*+4OH:@/3
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M26Y#2Y+23TT4XR2C6DNI=3(!ZH
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MG9BKPMI$-UQHI=1[CAI,FR;-QW5E)&@TJ(D;]$B8:N@J
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M^8>9+"H5UU"IT>A5Z<Q4V;?FF:X[L",N,2%MDR6Y*D.J4HEFLST-1D",5:>
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MBSX42="DHF0IK+;\28V9*0ZTXDE(<29=#)1&1D9 H^H
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MG19,&M%Y)C+K25MR/^<29*_W04>R
M     SIY'_/CX-_QM^PD@M&IXEQV[1+N]9'5[7N6FLUBWZ]@5V#6*5((S:D1
MWJB:7&UD1D>BB/0^H' CVU>,. 9O.?*..96+*(_8]'QI2ZO2[:4VYX9F<]+8
M0X^DM^NY25&1]0,=#Z[?PIBO+G/WEE;^2+*@791Z);=HJH\*7W"*,I=%IK1J
M:4VM"DGL+34CU(#'0E/@H<BT+TY5X)IE1E5''F';UCM8^3*=5(.%&JGBUO0$
M.K4LS2PJ.G4O^,I2C\Y1@2T5!4     5VY:7Q<6-^-^7[SM-UV-<=(H#B:3.
M8U[L5V4XB+XILR(]%,$Z;I'[!IU!,:U1++X2\:Z[QOQC=E<F.V==]6H]O794
M\ZQ:JJ+54U6H%'E./IF2W'&4D\Z]VT$I)Z&I)I]LT4"<9?ASXO&TZY4L \8;
MHR(S;5K7Y4&;ARK><^9'BK3;])2KLJ==-"&-\UYMPVS)&WNM)T3IT AP>)<I
MMWIZN[D'CR;7(M>N'!=NW!:$FIPW4O,RZ6RP\=*EL+29DIA3*39:5[)-:_L@
M<*FIT6S[KQ7A#%%I<9W\<YWR'#HC]@9ZJU6;HT*<_&=9<DU"/(-PB=4ZDC)+
M1:N;EI-"3<V)42_H)O:--AXANZ)4IQU.HQ;/GLSZD:20<A]%/<2X[M+HG>HC
M5H7DU!1_/5AC(%8Q+Q]S'B>&IQZL<C[.M^HXQIYJVJ?>J]4?MFK(1TZFM"5F
M6A:^UZ?LD9)6CXWY-KG&;C_?EF8^HT.Z;^NKDO4L8X[:JRW&Z>F<]"IL=J5.
M-LTK-M),EJE*B49J+J1$8(G2M_1,^9TL+*%U84S;$M&LW"_CNH7YCR]+48EQ
MXCAT]+J7H<Z+*=6K4EM*,E(4GH1%U-?F%<$-6SRUY.-V+QNS1=M-L!W'.9[T
MIMD3[;@1YZ:PE<U^2PJH)?4_V&]3B.*2WM5M+82C4:E&DG"$KUO._)/(U_9T
MI6 :98]*M/C[).EU-=WM3I$VX*LPTIZ1'8*(\TB.T7;4A*E'J>J5;BW'VQA"
MT/'?+[&>L,6'EEBEG1#NV&\J92C7W$L2H<IZ%*0A9D1J1WF%[#,M33IKU!$Q
M@F@$ "BE\YFY WIGC)&%./D>S:0>':!3JG=M;O!B9)5/J57CIEPH41,5YI+;
M9M++<XO4R5K[!:&3@YR]<Z<HXN4>/F'Z1;=E6G?>4K4JU0O2+5_$5*GTR=32
M=4I]EZ(^E2VS0UN0WJ9[E)2I>A*4"<(0:_S"Y8PL/9*S#)H^-W*)@&]EV5?D
M9#%2[]?E-U"-$=<A).011$-IFLD1JWFHS4K0B3L PA8ZLYUSWD+/5[XIP13+
M.IE)Q+;M&K5USKO1+>=JDRMQ6IT2!'5$=04="F7-JG#2O:HC/J6B3(P9FXNJ
M50K'%CBMA9VIRJ-9.;,V3*+D*7$=6PJ336Y45)T]3J3+0I!R-2+7JI!>4B,@
M6X6K%)XC\?<99=QO?F/9KN(+HID>;"BVK1ZBVRS<T?8V3C,N--[ZY"6B5JHV
MM%:J2I2MR4&17%FSS)R!1<IYWRY78N4:99U3XFTBG-X?ILF<U'<JEUQJ@S.J
MBH[+OG.+93'=8VHZFZVQUTZ&6A-W-K(E#S-Q_P"(61J?03NFDWOD"AS)5GL*
M(URG7(LAN92B49Z;^\ER.?73=[((AR.#:#0[XYB6/(POA1SC"]A>-4E9KH53
MJ;;=0JD6<REN+&12#6:W&]QD9NI2:-'$K-1*2SO$ZECN4/*'!>2\)\D,4V3?
M'IJ_K;MJI^FJ#Z,J<;L^C9C,:5_;$F(TPKMNJ)/FN'KY4ZEU B&>MLUVI'@-
M7"@Y#IUJ[LFVU-;9W:.MV;7*8S<RWB(BU5V5LI<49=//UZ>R3XVI_JXOF8X;
M_C#_ *15,%:M:[X(  !1;UBM]7-8W&BM':U4?H,J[JW3+;J5P1E*0Y"@3EK5
M)<WIT-)+0UVE'J719EKKH":=;\)W!_C/9,G%5?M>9(PU<ME5N&NAWI2JHB-/
MK$A+:S\%(7/[[4@Y.TU*22-QI)24Z(-1 8RA'FKQ\PO3;YXWUN#CJDQJKE/.
M]"@Y#G(0O?5H]6DK<G-R#W]2?6HS5IH"8E;.Y<I\6^%]'MVR*W48>**+<*IL
M^WZ)!IE4FM.J;4V4IPO!1I6P]SB-=YEKKT]D$:9999#H-OY-LWU@&>JTMV=D
M?&62HU.QE=:),EN;1X5&JC4>)X74TI:2MKIT+=J6OFF23!98S.^)LR\@[TP5
M?Y8/I&5+*I6)F*A/I]Q5TJ1#<N"JDB1*8)$5U$KN)0ELD:H0V:C\Y1$@$1H1
M; KV+<\SN 6*J!9!65A6N52]9EV8B?F2WXJ*O2DKD''==5HX^DI"W%MFK34G
MC2HD]2(EPE86=-XW\E\+PJI-:MNP^2"[7Q?99N2'/3K"Z@X;=L(6T:5(2OL*
MD&>OTQ&>A&>H'"M_PB@-6WG?DM;TVQ4X&JLV-;=0@\?F97CXT*(U%-IRJLS&
M=(KW?<<(E=DO-,]JNH(EIT"H                                   "
MGG/WYH&;/N9!]U(8)C6JQS%^8MQL^Z>/?<EP$QK>ESTP'ARG'AJ\8./J5&N?
M(F=+:IM[5I"%]ZI1*FB<Y,9?/=H:7E(2:M"+R 1+XN8N&,6V=/X;8SMBR:=1
MK#N3-E.:KMKQTJ*+*14'H<>43A&HS]M:+:KKY (E[-RXWL[C!S,XRIPC3#M*
MCYO9N"AY&LB"\\N%(9IS#+L:6;#CJ]IH7(-9&1$1=H]/IEZC7#4P%0
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MEDY)?7)OI4J7(1%@2X*C-^(4S:;6Z2>TTI6LC/VTS)E_0T"@
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M8NP/-G7#/J%X$U&J-3JCZ6?"QX\1M:E;6UQT&:M329&K=U)*5$ZFE0*@
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M,EA9:I6VXDTJ2HO9(R/0P&<KOJ[X[5&GXUI'(:_*1@&ISSFS,/H..Z@D*?\
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M*N;;VS'0\;RHU0LRR*RY'CTB/,AIV1WGH["/;NTDM$D9E[)*W)-23&*\X(
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MH%(I="I$9,*DT6&Q ID-'TK,>,VEIIM.OL)0DB($/1
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M-JUXU:/'A):I\/3M18L2*6QI)F237U/4TI/0NNHF5F00
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M@8O>QUQPM6P[AS[6I-0=NN#R"JZZG=%OU%AKPK+;I24NQ4D6O<;6F2I)[O8
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M7E47D4HC&*_((
M
M
M
M
M
M
M
M                                                           !
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>tm2227887d1-lc_polar4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_polar4c.jpg
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M;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T 2%!H;W1O<VAO<" S+C
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M_\0 \  !  $% 0$! 0            @$!08'"0$# @H! 0 " P$! 0
M       ! @,$!08'"!    4# 0,""10.!P0'!@ /  $" P0%!@<1(1((,1-!
M(C)3%#055PE187&1L5*2LG.3L]/4E7:6&#A8&:'10G+2(W2T-55U%A=W@<$S
M1+4V-V*4U5:"0R2DI6<IHF.#5"4YP\0F)\*C167A9(2FMD>7$0$  0,!! 0(
M"P8& @(" P   1$" P0A,1(%05&Q$V%Q@9&AT5)RP>$B,D(S4Q05!A9BDJ+2
M-#7PXB-S5#:R)?&"PD,D1 ?_V@ , P$  A$#$0 _ ._@
M
M
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M=RA713:G26H52[IU"1N(?F-MN%S;\A:#U29EM(!V\L/_ "/9G["IWYLV RL
M
M
M                                                   !SF\*%\VR
ME_S MKV=8"7\+M.)ZBWZ4@%4       "ZN?H>/\ E"_, 6H
M  %5*_N_J"/ZP%*              *F'VU']43YH#]U#MV5ZH8"C
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M>@     "J=[6B^2YYI *4              >IZHO) 7.L=O*^\;]*0"U@
M          "IA]M,??D IU=4?D@/         $"O"4_-/N_]KT3\_: =&K#_
M ,C69^PJ=^;-@2RL
M
M
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M-N6Z^V/HS3_'I\S<8UFP
M
M
M     .<WA0OFV4O^8%M>SK 2_A=IQ/46_2D J@       75S]#Q_RA?F +4
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M.589F_BZ(</-=T-N#TC6     %4[VM%\ESS2 4H              ]3U1>2
MN=8[>5]XWZ4@%K              %3#[:8^_(!3JZH_) >         (%>$I
M^:?=_P"UZ)^?M .C5A_Y&LS]A4[\V; EE8   -4YQR3%Q!B._LC25-DY;%(>
M>IC3O4.SW=&(+*MI;')#C:3\8QL:7!WV6VSKGT=/H8-5F[G%=?U1Z>AS"X:J
M/5>'/+^%I]>EOKB<15 ?HU_/2EJ-3=T.NJJ4);N^6O.+-XHI%T3WU&/2<SQQ
MFP33Z.V/%NGUO.<LS=WGB)^ELGQ[X]+LF/)O5
M
M
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M7X0!N0>OO>ME^$ ;D'K[WK9?A &Y!Z^]ZV7X0!N0>OO>ME^$ ;D'K[WK9?A
M&Y!Z^]ZV7X0" _A+4Q2X3;P-IUQ2^Z]$T)2"(NWVNCO& Z(V'_D:S/V%3OS9
ML"65@   Y]<8E2_?_(N#^'F,9.P:E4COO(;7W/<FC[R8S#I$9ZHDO;Z=I=4E
M&T=WDV*G%EGQ1Y=[A<YS?-QQXY^#TL:XDK1G77B>N2*(M;-TV6ZQ=EI2FO[1
MJ?2%&^DVRZ*E-\XA/CJ(=FRE:3NG9+@Q,Q.S>G+B/(,#*V,['R+3B0AB[:1'
MG/,(/4F)"D[LECE5M:>2ML]O*D>/U&&<.2ZR>B7M=/FC+CMOCIAL4868
M
M
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MF,F-#:)M)=6O[I9^*H^B/0XL5N.*6M>9JN R(      !5.]K1?)<\T@%*
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M=CGHVQXIW^E/\<-VP
M
M
M'.;PH7S;*7_,"VO9U@)?PNTXGJ+?I2 50       +JY^AX_Y0OS %J
M         !52O[OZ@C^L!2@            !F1%J>PBY3 8Y(O"EP);++!JJ
M,M+A%S#&AD1D?W2N0AI9]=CQ=-97BR98?6JU7:M+D\](*G15K/\ [-'ZHR_V
ME\OE#BY^:7W[+=D,]N'K61J(PR>\E&\L^J<4>\H_Z3'-NR77;Y9HMB%4*)
M          ?>/U3OJ2_2@/@               "XL?H^7]\D0+<)'Q=?:83O
M.N$@O'$Q;,[D3,0^T*#5ZQIW/B]CQU?WZ1TJ=/%26TS'1T_+K\FV=S%=FB-S
M-Z5:$""M,B8HZE,+:3KO4I/_ &4<GECN:?08\7AEKW7S++2(B+0BT(N0AO*
M        "J=[6B^2YYI *4              >IZHO) 7.L=O*^\;]*0"U@
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MI\4^J73\>0>Q
M
M                                                        <YO"
MA?-LI?\ ,"VO9U@)?PNTXGJ+?I2 50       +JY^AX_Y0OS %J
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MVM%\ESS2 4H              ]3U1>2 N=8[>5]XWZ4@%K
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MB!IML
M
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M:.G(M5<G14>ICI68;+/FQ1CF:O@,B               53O:T7R7/-(!2@
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M
M
M                                          <YO"A?-LI?\P+:]G6
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M29&0\;,3$TE[:)B8K"I$)
M
M
M  '.;PH7S;*7_,"VO9U@)?PNTXGJ+?I2 50       +JY^AX_P"4+\P!:@
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MM6VQ;NA5]Q8     %YB_HB?ZH@!9@               53O:T7R7/-(!2@
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MQAS'2
M
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MYN"TL]Y]PNF<=5YY:SU-1C:PX+,44MA69JRF-VPS]^7FC,A^IG;3_P!^8"G
M      !X9D7*9$ ^2I$='5OMI\8U$)BV9Z$5A3G48A;$N\X?B((U>80O&*Z>
MA''#[-N2I':M,F2=>126E:>6>P9[-%ENW0K.6%>W2+D?ZBE%'(_NGG"+[!;1
MLV<JRSO4G/"]P+.K;ZG>R*E'B%S+AFEI!N'L29]'0;5G)^N5)SRJ&K%B;#EU
M&5+\5.\2$^46HV[.5XK=^U2<LRO4:UJ#%T-%-:<67W;I<X?_ +6I#;LTF*W=
M:I-TKVVPRRDDLLH:27(E"227V!GBV(W(?42           O,7]$3_5$ +,
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M1+J<IS<&;AZ+HIY8W.DH\P]0
M
M
M     .<WA0OFV4O^8%M>SK 2_A=IQ/46_2D J@       75S]#Q_RA?F +4
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MGJB\D!<ZQV\K[QOTI +6              *F'VTQ]^0"G5U1^2 \
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MWNG^W#SGW?']I'I>C^\7_9SZ&_AJ-L
M
M
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M[^$5N_X>\.1SK=C\4]KO\E^GY.Q/<<)W0
M
M
M         !X>ID9$>A] P$-;]MZN8[O3%LJV,DW3<5[WA=S46JV_4I:9$.31
ME(=<G+.&AM"&6V$D@B6G3386TS$)4U*:K^<+DSA4)MYU^V(F.JL];MCP:%-.
M&TT[%8-U<N0E)'SRE+4DM%;-"TTV@-[X%N^KWYB&QKJKSB7JW48*VZJ^A.ZE
MR1%?<C..$70WU-&K^D2AS#\()Q&6AD3'<S%%(MVYZ?7;<R%3$RZK4Z:<>FN=
MRYKC+O-2=]6]OGM1LZ8A"756#1Y'84/\<Q_8-_\ 6%YTA*%5W'D=>8]<( [C
MR.O,>N$ =QY'7F/7" .X\CKS'KA '<>1UYCUP@#N/(Z\QZX0"O737CIK+'.M
M;R7E*-6^6[H9>* H.X\CKS'KA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<( [CR
M.O,>N$ =QY'7F/7" .X\CKS'KA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<( [C
MR.O,>N$ =QY'7F/7" ?=^E/KYG1UDMUI*3U670 ?#N/(Z\QZX0!W'D=>8]<(
M [CR.O,>N$ =QY'7F/7" .X\CKS'KA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<
M( [CR.O,>N$ =QY'7F/7" .X\CKS'KA /M&I3Z)#*S>9,DK(S(ED9[# ?N92
MWW93[B762):S,B-9$?\ 20"F[CR.O,>N$ =QY'7F/7" .X\CKS'KA '<>1UY
MCUP@#N/(Z\QZX0!W'D=>8]<( [CR.O,>N$ =QY'7F/7" .X\CKS'KA '<>1U
MYCUP@#N/(Z\QZX0"HC4I]M3IFZR>\RXDM%D>U23(!3]QY'7F/7" .X\CKS'K
MA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<( [CR.O,>N$ =QY'7F/7" .X\CKS'
MKA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<( [CR.O,>N$ N3%.>13Y;!N-&IQ:
M3)1++0M/%,!;>X\CKS'KA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<( [CR.O,>
MN$ =QY'7F/7" .X\CKS'KA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<( [CR.O,
M>N$ =QY'7F/7" 1BR7 ?*\I3:G&S-N,T1'O;-#+78.QR>:77>)K:G=#260<=
MQ\@6G5+7G241BFI2N),09&IB0THEM.$1\NZHBU+HD/18L\X[HNCH:-UM8HY^
M5/!>8:3-.GJLIVLGO&EBI4R3%7&=+H*U=>;4WKXBR+^D>GQ\XPW6UG9+G7:.
MZ)V)-8)P17++G2KPNYV*W7Y<0X=/I#+J74PF'%I6YON)U)3BS0DCW=A%LVCC
M<PYC]XFD1LAMX,'=QX4G>P'>N->B'-XVQ0[ =ZXUZ(.,H=@.]<:]$'&4.P'>
MN->B#C*/%4YQ1&E2VC(^4C4(NF+HI,;"-C-[+N:=;#S<"H/H?H#JM",U;RHQ
MF?5)\5/BD/.:W0]U/%9\WL;V+-Q;)WI-1Z><IEJ3&EQGF'DDMIU#I&E23Y#(
MQS6=]NX\CKS'KA /2I$C4OQS'+UP@%=4J:\_*4XEUI)&A!:*61'L21<@"@[C
MR.O,>N$ =QY'7F/7" .X\CKS'KA '<>1UYCUP@#N/(Z\QZX0!W'D=>8]<( [
MCR.O,>N$ =QY'7F/7" .X\CKS'KA '<>1UYCUP@#N/(Z\QZX0#[QJ4^A]I9O
M,F25:F1+(S ?$Z1(U/\ ',<O7" >=QY'7F/7" .X\CKS'KA '<>1UYCUP@#N
M/(Z\QZX0!W'D=>8]<( [CR.O,>N$ =QY'7F/7" 0$\)A3GH_"7>#JW&E$57H
M9:(61GV^UT '0JP_\C69^PJ=^;-@2RL  <QL!_IWB=_GQ>GLL<>RQ_58_<M[
M'B-1]=D]Z>U(<68@  :ZX0_]8N+OX16[_A[PY'.MV/Q3VN_R7Z?D[$]QPG=
M
M
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M&.:SOTGJD^20"YUCMY7WC?I2 6L              5,/MIC[\@%.KJC\D!X
M        @5X2GYI]W_M>B?G[0#HU8?\ D:S/V%3OS9L"65@ #F-@/].\3O\
M/B]/98X]EC^JQ^Y;V/$:CZ[)[T]J0XLQ   UUPA_ZQ<7?PBMW_#WAR.=;L?B
MGM=_DOT_)V)[CA.Z
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M)F1EY "VP;AH%3FS*;3:Y3ZA4:>1'/@1I+3KS!&>A<ZVA1J1_20"\
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MI52B12:?C=CR79JMY*$;AO\ 9!$HVR;+IB21F2BWC?T8@H
M                                   .<WA0OFV4O^8%M>SK 2_A=IQ/
M46_2D J@       75S]#Q_RA?F +4               "JE?W?U!']8"E
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MFN#)CFR=J8F)W,QX0_\ 6+B[^$5N_P"'O#B\ZW8_%/:]!R7Z?D[$]QPG=
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MMS-P9=*Q]=MW\[8$"49Z&W%;6W(=;WNJ+1331K+8:FE%KJD]"+G5L%0
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M7I?T64%JJL4.BLUU]$JMLP(R*S);T)#DI+22?6DB)):*7J9:$0*+L
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MF,D>5N::_P"BEY5S(YJC(]2-MLR,OO2'%;2V              "IA]M,??D
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M#_UBXN_A%;O^'O#S_.MV/Q3VO0<E^GY.Q/<<)W0
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M6(PA+;33:"T2A"$D1)21%H1$0"H
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MT63++=ER($-F,MTM=[1:FD)-6W;M 7X
M                     <YO"A?-LI?\P+:]G6 E_"[3B>HM^E(!5
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M_%/:]!R7Z?D[$]QPG=
M
M
M!SF\*%\VRE_S MKV=8"7\+M.)ZBWZ4@%4       "ZN?H>/^4+\P!:@
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M=U,X5VRZ8M6C-6BI6VG_ -ZR1']E.H\QS/%PY.+K;^"ZMM.IOX<YG
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MW?\ #WAQ>=;L?BGM>@Y+]/R=B>XX3N@
M
M
M             YS>%"^;92_Y@6U[.L!+^%VG$]1;]*0"J       !=7/T/'_
M "A?F +4               "JE?W?U!']8"E              %3#[:C^J)\
MT!^ZAV[*]4,!1@           C57(JJ?=-P15%NI?D=EL>.E[ICT\@QVM-=Q
M8X=/#=6R%&-AE?9CE<]37Y@K*'Q%D@              KV>T)7WR12?G0* 7
M               ?9S^Q8_Z7FB(WCXB1\GF6I#3C#Z"=9>2:'&U;2,CY2,$(
M^W+;K]MS#TU72I2S[">Y=PSV\VH_&Z WM)J>'Y-V[H:.HP?2A81U&B^2VB4I
M+B%*:>;/5MY!Z*2?DD+1*)BK-*)>*V5-PJZK:K1+-1(NE/Q"<+H'XXQ7XJ[;
M6M?BIN;'2I*TI6A1*0HM4J+:1D?1(:[ _0    #TN4O)$"[(G*I=PTJHH/0X
MS[6\?^RLMT_-''YICKBB[JGM;.GGY4PELDR41*+D46I?TCS[=>@
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MK3+4EI:U'XA))1F8"[@
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MB-*DGM(]A@A<0
M  !SF\*%\VRE_P P+:]G6 E_"[3B>HM^E(!5        NKGZ'C_E"_, 6H
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M )WI3@@         <R^,#YVO _\ ")[\^IX]+RC^BU/B^"6#)\^UTT'FF<
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MP:=]E;!$;S@C^:?@OX-->RN 3O2G!
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MK16J5;R%),3$=#L "H  (L<;GS3\Z?!IWV5L$QO."/YI^"_@TU[*X!.]*<$
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M;.BHQZ'ENINU.FLRW4K=%9IN>9YKI+-)JLF&R9F+9I%=_P #8 WG/
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M=&K>6.)SB XJ?W?DT2QKC55HEN%+(R4N75ZBS+W$+29(<5'CQS2[IJDE.)T
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M1%L(B(A9B>@ #77"'_K%Q=_"*W?\/>'(YUNQ^*>UW^2_3\G8GN.$[H
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MA0OFV4O^8%M>SK 2_A=IQ/46_2D J@       75S]#Q_RA?F +4
M      "JE?W?U!']8"E              %3#[:C^J)\T!^ZAV[*]4,!1@
M          "KA]6]^3N^D,!1F1&1D9:D?*0#5ER8WCRUOSZ M%/F.:J?A*+_
M +.\9\I&7W.OE#<PZN;-D[FUBU,V[)17J^#\<(K#KMQV''IU0D+-QY"3=9B2
M%&>U?-MK2TK4^74AW<7,\LVTMOEU+-9?,;+FT84.'3XD>#3XS4.#%;2U%BL(
M)#;:$EHE*$I(B(B+Q!ANNFZ:SO8IF9FLJH0@         5[/:$K[Y(I/SH%
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M#+220DO((B(@%ZK';ROO&_2D M8              J8?;3'WY *=75'Y(#P
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M!5        NKGZ'C_E"_, 6H               %5*_N_J"/ZP%*
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M26O)LU E,P$   BQQN?-/SI\&G?96P3&\X(_FGX+^#37LK@$[TIP0
M  (9UOYZUH?!)WV&:/)9O[Y9[GP7/9X/^OY/]SX;4S!ZUXP
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M95D9$E/Y,@YT5#Q;;D.LN2*E.CL5OFTLOH;=4ZY%5'-6\:B-![ ';@2@
M <YO"A?-LI?\P+:]G6 E_"[3B>HM^E(!5        NKGZ'C_ )0OS %J
M           !52O[OZ@C^L!2@             "IA]M1_5$^: _=0[=E>J&
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M6^Q-6S$6SREO*WBZ4S(^7;FQ<MRX;HNNG'%.BZZV8\VU6;XGK:$[@WC5R_\
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M&MPD)6XVYSK<>6XM"72-LDDLBU))J+D48P:C63FMX9LLC;]&V+9\\)BVG6W
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MHL?+.+,'V=2X;MVTVD7Q4U-.*J46#4729[(IIN.*T<;4>ID70_I$CHH"
M !SF\*%\VRE_S MKV=8"7\+M.)ZBWZ4@%4       "ZN?H>/^4+\P!:@
M           54K^[^H(_K 4H              J8?;4?U1/F@/W4.W97JA@*
M,              5</JWOR=WTA@*0       'Y6A#B5(<02T*+12%%J1^21@
M,+JN/K9JAJ<*%V!*/:4F(HVSU\=)=*?E#/9J;[>EFMSW6M>5''=S0%*52Y35
M7CEM2RZ9-NZ>2>A'Y8W+-;$_.;-NIMG>Q&44ZFJW*O3)-.47*M:#-']"DZD-
MNW+;=NEGMOB[=+QJ0P\6K3R'/(/;Y0NL^XD5[/:$K[Y(I/SH% +@
M      /LY_8L?]+S1$;Q\1(     /RI24D:E&24ERF>P![ B52OO]B4*,;YD
M>CTY1:,MET3-1[#\@AARYK;(VJ7WVV;V]+6M"!;3!J3_ -JJ;Q:RZ@O:HS\1
M/B$.3FSW9)\#GY<LWSX&7#"Q   ]3U1>2 N=8[>5]XWZ4@%K
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M%LVB;77P%0  18XW/FGYT^#3OLK8)C><$?S3\%_!IKV5P"=Z4X(
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MI *H       %U<_0\?\ *%^8 M0               *J5_=_4$?U@*4
M         5,/MJ/ZHGS0'[J';LKU0P%&              *N'U;WY.[Z0P%(
M           #\+;;=2:'4)<0?*E1$9>48#$JC8=K5(S6Y2VXSQ_]=%_$J_\
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M:(9:224E_00TYF9FLM:9F=ZI$(    >IZHO) 7.L=O*^\;]*0"U@
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M/*5HM:2W"1MWNI)7;YWS?3SIKK++HNNNBFS;YV#!ANBZLNW@^?M\
M       !PCOJT;FKG$]QKW3;_$F]PY5.QBI-4:I:):HCM?['I1NL\\I$N-O1
MTDWR;KO]JDU(V$2B_05:5-XZ+RX2,<97OJ30(%;QG5;GN2+17([#\BM,29<1
M$A3+B5-)4\U"2\1&T>B#<)O=2K>(;G0?P?\ =E?NKAMH#5Q7 JZY=HUFL6U"
MN5:U.+FPJ=+6B*X:U&HS(FE)0C;U"4ZZGM!6[>VYQ/9(N+$. \G9'M**S+N.
MUZ43])1(;-UI#KS[3'/+;3U1,DX;FA[#W=NS4"'\Z99VL[,LMNJ\6N8\R7BT
M2^<59-ITVCQZ8VLE&HE-*?J;4=&O(>Y!2?\ M;"!>G4Z$\+_ !(\ M!O^R+%
MP]@>Z:!>EU5./1Z/>5;IM-F2VY$M1-DMRH.U:7):0HU=,3):>(G38"LQ+LX"
MH  (L<;GS3\Z?!IWV5L$QO."/YI^"_@TU[*X!.]*<$         "&=;^>M:'
MP2=]AFCR6;^^6>Y\%SV>#_K^3_<^&U,P>M>,                :[R]_I-E
M#X)5O\P>&AS7^CS>Y=_XRZ/)_P"MP?[EG_E"XXX_T\L/X.TO\T:&30?TV/W+
M>R&/F7]5E]^[MEF8VVD          #DE%I^0L*3+XL&L84O&]I<VY*Q5;=N>
MUZ2[4Z?7V:Q*=DLN2Y:-4,/)2LFW2>ZE*->F26I^QMS8=1;;?&2VW9$3$S2;
M:13=TQU488GAV43QX7\>W%BO!./[&NQ##%PTJ/,D5.#&7SK41=0GR9R8B%D9
MD91TR":U29IZ7I3,M!YWF>HMU&HOOLW33RTB(KY:59+(I#?@T%@!S"\+13Y\
MWAEH$F&TMR/2;_I<NJJ3KHB.J!4HZ5*TZ'//-EMZ)D"UN]*;@WKM"N'A<P7+
MM]YEV)"L^F4N:3*R7N3J>PF+-2OQ%<^TLS(^34$3O?7BWRTC#'#SE"]XLXHE
M<8I:Z5;*T+(G4U6IZ18JD%KJ:FE.D\9>=09\@$0X(8WX@.'RV>#7)'#]<=MW
M=+R)D&5*K+EP1(%/=IS-3C*:52")]RH-/DTCL5OG#)G4M]TDI41],7IM3QX'
MLLJO;@5SGCR?))VKXEMVY(D=!JU7W*JE.ERXBE:[=CW9#9>(E"2\8BL[T,N'
M&QN*VI\*65;WP7EARV[,MVOU,[DQW!3S%2G.1J9 >F2HDM#*G"6<=;:2;2XD
MSW#W>F,B46FE72?P63&(3P15)^/H$J'>SU41%RNJHR$2)+DV.V:HJFC;0T28
MIMNJ-E.YJE1N)-2U)4HRMSIL"H       #GUQR-)HE=X=,E'8%8RJBPKNE.S
M[#I],<J3+\.5$-IZ2LDI4A#T<]U36^6BNF($PN-$XM,95*LTBG1N'#)5/D3Y
ML>,Q/?LKFFF%NN)0EU;A&9I2@SU,^@6T0)Z"4     #G-X4+YME+_F!;7LZP
M$OX7:<3U%OTI *H       %U<_0\?\H7Y@"U                JI7]W]01
M_6 I0             !4P^VH_JB?- ?NH=NRO5# 48              JX?5
MO?D[OI# 4@               +S%_1$_U1 "RFE*B,E$2B/E(]I +),MJ@3R
M,I=(BN[W*HVDD?ED0O;ENC=*\9+HW2Q25BVUWS-3!2H"CZ,=W0O*42B&:W5W
MPRQJ;X65[%*D;8%QR$D74HD(2LOZ33IY@S1KIZ87C5STPMCN.+I:UYBI0)1=
M G$K0?V!DC76],+QJK>I;G;+O9GDIL647BM2$I^PLR&2-98O&HL4*[?N]G7G
M;9?/3K;C2_2J,6C58YZ5HS6=:D5 N!O8Y;<])ERZ-Z^8+QJ+)Z4]Y9UOB;=4
M3U=#J"?_ ("A/?6=:>.WK?G2H?J6H>L*#OK.M/';UO214E=10Z@H^B7,*#OK
M.M'';UONF#7W/[.W)Z__ (9EYHB<]D=*.\MZUS_=V\'F(QM6T^DE;^UUQIOH
M_P"THA2=5CCI1.:SK5+5D7J]U4.%#(^NO;YEZ#44G6V*3J;%U8QC6WNWJZS'
M2?*F,T9GY:C(8KM=U0I.JCHA?8N*:"V9+G3)M27]TEQPDH,_O4IU^R,-VLOE
MCG573N9Q3K?HM*))4^F1XQIY%I06]Z+E&O=DNNWRPW7W7;Y7@44        >
MIZHO) 7.L=O*^\;]*0"U@             "IA]M,??D IU=4?D@/
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M(+5X3>'&Q[AI5V6GB&@4.XZ&]V12*O':<)V.Z1&DEH-2S+70SZ %4AP0
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MZ0P%(               "\Q?T1/]40 LP               *IWM:+Y+GFD
MI0             !ZGJB\D!<ZQV\K[QOTI +6              *F'VTQ]^0
M"G5U1^2 \         0*\)3\T^[_ -KT3\_: =&K#_R-9G["IWYLV!+*P !S
M&P'^G>)W^?%Z>RQQ[+']5C]RWL>(U'UV3WI[4AQ9B  !KKA#_P!8N+OX16[_
M (>\.1SK=C\4]KO\E^GY.Q/<<)W0  <!*;4N#^Q^+?BJ@<4:8=X,UJYY-2M"
MZGH]2J,. M^6^],I;T6&AQU+S*G$-$OFU)T:41*2DRWB^VB>'#==W@^:ODR-
M"X<HE%:R6NG2U1EPJ)6H+W8:4I.3H]/BM-$6FFI;VI] $35T+!5B5^WO;V-K
M+N>_KKE'"MVT:<_4ZL^DB4OFF$&HT-I,RWEK/1*$Z],HR+H@.2\#C!X]\U)D
M7?@+AVID?&SCRVJ',JC*GGI*4J-)K[*DS8+;VAI,CYEO=2>J34HR!:D)!\+_
M !G7ID/)=0P'Q!8X3BS,D6*[,I49IN1&BU%#"#><;1'DK=6A1,D;J5)=6AQ"
M5*29:%J)AT2!4     18XW/FGYT^#3OLK8)C><$?S3\%_!IKV5P"=Z4X(
M      $(J/DOB;S##N/(.&(MAT;'-,J=0IUBTBY6ITBHW(5)DKBR)"Y,=]IJ
M(T\ZTM#72FHC(]_9HH=J_3:333&/-Q3?,1,S%*6UBNZFVG2QQ-UVV$C,+9,8
MS#C"T\BL4MVB+N!A]-0HSQ[RHDZ%)=A36-_1.\3<AAQ*5:%O$1'H6HY^LTWW
M;-=CK6G3UQ,5CT2M;-8JVB-58
M!PCR+GK%'"YQZ9JN2M6/)R!3KJI\)NN-NQ6>SZ-5%Q&'EJIZY2S0\S(2:36>
MK9EO;I=*V7.%Z5A+OA_X_P#"F;\L6QC&S\6UZW+@N1,XX59E1::AADH4)^8Y
MSBX[ZW")2&#26B3Z8R(]FT$3#I""K ,J9 IF*<;WOD>L-*DT^RZ/*JKL1!Z+
M?4PV:FV$GH>ANKW4$9EH6NI@.1]C8\\(%Q94-C,,S/ZL+VE=2E3+-MJDRYL
M^P^</FE)CTXFS)DR+I%/O+<61:J+=42C+;(;2P?E'B>X?^(*T>'/B?N&/D*V
M\H1Y'\.<AMN'(44N.A3A-]E+:9?<)2B)IQM]!K0M;:DJYL]5":2ZN@J  "+'
M&Y\T_.GP:=]E;!,;S@C^:?@OX-->RN 3O2G!          AG6_GK6A\$G?89
MH\EF_OEGN?!<]G@_Z_D_W/AM3,'K7C               :1OC(%<J%;5C?%9
M,3[S423N.X74D[ MR,O7\;)T/1<A1$?-,\I]4HMWEX^LUV2^_P"[Z:DY/I7?
M1QQUS^UU6^?8[FAY?CLQ_>=76,?T;=UV2>J/V?:N\D;5!<./Z'C[".5H-+YZ
M94*E:];EW#<,Q1NS:E+5 ?WWY#I[3,S,]"+8GH%RZTSZ''I-#FMMVS-ETW73
MONGAG;,KZ?F&36<QP77[(B^R+;8^;;'%&R(;*QQ_IY8?P=I?YHT.AH/Z;'[E
MO9#F\R_JLOOW=LLS&VT@                                !^''$M-N
M.KUW&TFI>A&9Z$6IZ$6TP$%<DY[X:;JMO%^7+P?N^!#LZ^)Y6348%"J_9R*M
M2D.19;3S,6,\YV,ZA9Z[Q$ES9MU+0B449M:X&<@Y<A7*B],M,M7)=<*O2L8-
M4.OL6O.N WFR;ER8SE+V;ZR3OESA)/34]! [-B4     #G-X4+YME+_F!;7L
MZP$OX7:<3U%OTI *H       %U<_0\?\H7Y@"U                JI7]W]
M01_6 I0             !4P^VH_JB?- ?NH=NRO5# 48              JX
M?5O?D[OI# 4@               +S%_1$_U1 "S                JG>UH
MODN>:0"E              'J>J+R0%SK';ROO&_2D M8              J8
M?;3'WY *=75'Y(#P        ! KPE/S3[O\ VO1/S]H!T:L/_(UF?L*G?FS8
M$LK  '&FS,V65BB]^(Z@7BW6HU0J>9KPJL(HM*ERFUQ7I*&D+)QIM2=JF5;-
M?'Z(]IACBQ8Z>S;V/%:BV>^O]Z>OK;&^5WAWKMQ>\-0]J%^[GP>>&&G^*3ZC
MY7>'>NW%[PU#VH.[GP>>"G^*3ZCY7>'>NW%[PU#VH.[GP>>"G^*3ZF?\#M>A
MW;?O%#=M*9EHHMP5V@/TIZ9&=BK<0B$^VH^;=2E1:*29<@XO.MG=QX)=_DL?
M/\G8Z(CA.X  #CCGOBCX8[4RADND1N#"A9CFV//6UDO(CE"I)--U-;IMOG(D
MKITM:M'M6S<>4DU.$HB(]AF6B);(X3\YXPO[-2K,M;@MIF";I@T&159ETM4R
MGP9L:$LD)1O):ID1\FI!J2DE;VZ>SEU("8=1@50C\(TXMO@SS*IM:FU&FWTF
MI)F1[J[AIJ5%LZ!D9D8)MWHLXW\*1PT6%CVQ[(8L7(;3=HT&G4?=C4VC\T:H
M<9ME2D'W609DI23/4TD9\ID">&6KZEQ58WXF>-;A*N3&E#N*WY=LSYM)KTJO
M1HD9Y]F6E1M-MG$F2R4A*5/$>\:>KV:Z[":4AW2!0     18XW/FGYT^#3OL
MK8)C><$?S3\%_!IKV5P"=Z4X(         $,U\/>9[.F7/1,*9QAV/C>\:I,
MJJ[?J="14YE ?J*S=F=R)//M%N+=4:T-N%HV9F9&9ZF?8_$,&2+;LV.;K[8B
M*Q-(NINXHI_\L?#,;IV)'XOQU0<36#;6/+9-]RCVU&4RS)E+)R0^Z\ZM^1(>
M41$1N//.+<5H1%JH]"'.U6HNU&2<EV^?\>B%[8I%&>C D
M                    !RIXA>-[/5LY'RU:. <3T2ZK8P/"CR<GWA74R'VX
MYNL&^M26V)L'<2C12"+5:U&VLR+0%HA]>'[BQXM;USAB?'N9\:658UH90H=0
MN*CU.(Q,9EU"!'I[DEE5/<<JTMI2^<-I3C:D&LFC4HTIV* F(=4051@XS[2N
M>^N&'+EJV;1I5P7)5J9'*FT:$G?D2#9G1WG$MHU(U*YM"CW2VGR$1GL!,;T
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M2VFI4Q^.@I#KDMMY*B5#69[C*BT-.T]I$+822X(_FGX+^#37LK@(G>E."
M      !#.M_/6M#X).^PS1Y+-_?+/<^"Y[/!_P!?R?[GPVIF#UKQ@
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ME;!,;S@C^:?@OX-->RN 3O2G!
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M)BMF:5$1ZD9*U ;@!   (L<;GS3\Z?!IWV5L$QO."/YI^"_@TU[*X!.]*<$
M        "&=;^>M:'P2=]AFCR6;^^6>Y\%SV>#_K^3_<^&U,P>M>,
M   !'2MW+6\Q56J6+CV>]1[*IKAQ;XR9&/IG5EJ3E.I*M-%.'R./$>B"UTVF
MG>X.;49.87SAP33'&R_)'_C9X>N[H\ST>#38^6V6Y]1'%DG;9CGT7W^#JMZ?
M.W=;-LT.SZ'3[<MRGM4NCTMHFHD1HMA%RFI1GM4I1ZFI1GJ9[3'8T^GQZ?'&
M/'%+8</4ZG)J<DY,DUNG?*^C,P
M      (=<65<L^R)N%<E751KS>_<"Z'JC'N2SJ:54.$PJ(MF4Q462/G"C24+
MT,T)4>J>@"81HM?$>(^(F])]1QAQ/O5/#-=NEJ];NP'&?:;4[5D/-ONI6PZE
M,AN.XXVE2D;NF]M(]1 ZN"4   QRX+.M*["C%=-KTFY"A*-4,JI"8E\T9\IM
M\\A6[KIT %]C1H\-AF+$CMQ8L=!-L1F4$AM"$["2E*2(B(O$(!SL\*%\VRE_
MS MKV=8"7\+M.)ZBWZ4@%4       "ZN?H>/^4+\P!:@               5
M4K^[^H(_K 4H              J8?;4?U1/F@/W4.W97JA@*,
M   5</JWOR=WTA@*0               %YB_HB?ZH@!9@
M53O:T7R7/-(!2@             #U/5%Y("YUCMY7WC?I2 6L
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M/YLU^:^;[YK=.V9E<QD8@
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MDVE+9;3-(V0ZX@JIY<2+/BR8,V.W+A36EL2XKR26VZTXDTK0M)ZD:5$9D9&
MT+"X4>&FFS(E1@8+LJ+.@/-R(<INCQB6VZTHEH6D]S8:5$1D":RV-_"W&QUN
M[+D58= <KU^03I=[55RGQUO5:";9,JC35*0?/-*;225(7J2B(B,CT!#$[&X=
M,%8UKB[FL/$]LVO<*B62*U"@-)DM)<(TK2PX9&II*B/0R;-)&6P$U8!QN?-/
MSI\&G?96P(WG!'\T_!?P::]E< G>E."
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M2:_1X.XMU.GF>"9FV8NI6VZ(KOC?$PW$.LXP
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M5*2>PR/E 7@      18XW/FGYT^#3OLK8)C><$?S3\%_!IKV5P"=Z4X(
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M2(B.B(_Q4U_,;,V.W#ALX,=LS-*\4S=/TKIZ^KJ;3'3<H
M                  .78>TC <@\DY6P#9.3[CK'#SDH[&O^74SI=]V_-HU3
M=QW<$PS)EV).=9C$W'D*5HGLEE9((]XEF9F9E"5PPEBJPKWK$7$E\Y5RI9=0
MQ]+ARY?"I<E5AN4M#<"0W(B=BRVX9=G0.<;2;9-O;Q:=,?)K(ZV @     <Y
MO"A?-LI?\P+:]G6 E_"[3B>HM^E(!5        NKGZ'C_E"_, 6H
M       %5*_N_J"/ZP%*              *F'VU']43YH#]U#MV5ZH8"C
M           %7#ZM[\G=](8"D               !>8OZ(G^J( 68
M        %4[VM%\ESS2 4H              ]3U1>2 N=8[>5]XWZ4@%K
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M     18XW/FGYT^#3OLK8)C><$?S3\%_!IKV5P"=Z4X(
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ML(B+D(=^(B(I#S<S,S67[$H
M        ',JN</-6_=^NX0@\4=KTCA]JTV:JHV5(@TU==9CSIRY\J&FHJ>(R
MU><7HM2-\B/3H EON\7^&+B&NZK677*K!D7SB]^GKIMTPYI4^H09,Y//QE4N
MHM.)-P]2Z9*34G78I)@)= @     <YO"A?-LI?\ ,"VO9U@)?PNTXGJ+?I2
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MGH2-#4!69=7P5     $6.-SYI^=/@T[[*V"8WG!'\T_!?P::]E< G>E."
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MJ4ABL4B6S.BK4@]%)2]'6M!F1\I$8C)BOQSPWQ,3U3%")B=R^BB0
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M-SHF"H     BQQN?-/SI\&G?96P3&\X(_FGX+^#37LK@$[TIP0
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MLQ]7[5_7=X/H^-V-3K,6AQSI]+-;IBE^3VOV;.JWKG?=XDA!W7G@
M  <>O"21*XUDC%]9N)I:\8,T*3$HTEU!J@Q[A<DJ7(Y]6U"%N14M<WOZ:[B]
MWD/3VWY3NQ<%\?3K_#T>FK3U<7;**WP:\2MKO;*]6H+3K>,9%+@L3'D$I,&1
M7T/J-*HQ:;BE(CFHG31XJ-[E(5_-EV*8LCZ=9\W_ ,_":2+MM77@>+;@
M                              .7-LYOXY\T)N?+.$K5QV>(J37JE2+8
MLNX9,IFN5AJD25PY+J76V5LMJ4ZTLB)3J2U+Q-IDJR^>,1%3Q?2KAQK$5BS+
MS62;9MG+=C5:#$55H:)K_-R6WD.MK)QMQ/2H>(M=.0TF Z= @     <YO"A?
M-LI?\P+:]G6 E_"[3B>HM^E(!5 +/7:H5)I[LE*=^0LR:B-=%3BST27]'*,&
MHR]U9,IB*RHZ%2.Y[*I$D^>JDW\9.DGM/>/;NEXA$./$3OG?+/$47M3C:%)0
MMQ*5+V(29D1GY!=$3,Q"6!WAD:B6A(B4UV/+K-=J!;T&A4YLG9"RY"4HC,B2
MGQS\H<W7\UPZ.D75FZ>B-Z]F.;MS%V,QL0Y<6/=]HUFSF)RR;BU.:VE<;>5R
M$XM)D:=?(,:&#\QX;[HMOMFVO3.Y>[!=#>N^ARE1G&U$MMQPU(6D]2,C+4C(
M_''HHFL58%""0!238,6HQW(LMHG67"VD?*1] R/H&(F*H8Y2I4NBST4*I.F_
M%?(^X\Q7+HG_ *M1^*1#;TFHF)X+O(QWVLT'38P        !52O[OZ@C^L!2
M@             "IA]M1_5$^: _=0[=E>J& HP             !5P^K>_)W
M?2& I                7F+^B)_JB %F               !5.]K1?)<\T@
M%*              /4]47D@+G6.WE?>-^E(!:P             !4P^VF/OR
M 4ZNJ/R0'@        "!7A*?FGW?^UZ)^?M .C5A_P"1K,_85._-FP)96  .
M8V _T[Q._P ^+T]ECCV6/ZK'[EO8\1J/KLGO3VI#BS$  #77"'_K%Q=_"*W?
M\/>'(YUNQ^*>UW^2_3\G8GN.$[H C9Q4<.%)XH,9L8^J5R2;4D4NLQZ_0ZTQ
M';EH;FQF)$9!2(SBD<ZT:)*]4DM)ZZ'O;-#)B:.9[^">(KAO)2[@X7,-<5V/
MX&JE5*EVE2&*^B.@CT2:&8+;YK,BU49QY7WY@M6J3G"'Q"\(V5;U*B8VP?2,
M-Y>CP92G(3-M4V$\IAK=[*;8J-/929I+4MY+A-F>G4GH")B72<%4>>([B6L/
MA@M2B7??U+KM6IU?JR:/"BT"/&D2">4P[(WUIE28J"0263+4EF>IELTU,B8B
MJ&_UNO#=_P DY*][:/\ \9!/#+8V)O"380S+D*V<;6I9N0(]<NB3V-#F3Z=3
M4Q&#W35SDA<>IOK0@M-#,D'M,@)M=" 5  !15*4[!IT^:Q"=J3\.,Z^S3F-.
M=?6V@U):;WC(MY9ENEJ?* @!@+B6SMD#BJOW"^5K&HF/*50K(5=-,M6*X<ZI
MPU.RJ8F,W,GH>4RZLV9BE+)MM)$>A?<GJ6F-C-.._(F/Z)P\9>L>LWS;])O2
MNVJIZAVA-J<2/5)C3CY(0N/"<<2\ZE2FEI(T),C-*BZ!@B&1\&U3IM%X/\,U
M>LU"-2:33+33*J54FNH8CQV&ENJ<=>=<-*$(2DC,U*,B(N4"=Z32+EMQRWBN
MUNX*:Y:APCJ17,F6R=/[")'.G)[*)7-<T2"WM_>W=-NN@(>1KGMN9;R;NB7#
M3)5J+A*J2;G9ELKIQPT(-Q4DI25FUS1((U&O>W=-NN@#V!<MN52@,W73+@IM
M1M:1$.>Q<L66R]3UQ$I-9R$RD*-HVR21GODK33;J 4RY;<K5!8NJC7!3:M;$
MJ,J9&N.%+9?@.1DD9J>1);4II2"))ZJ)6FP I%RVY<-"C710+@IM<MJ8RJ3#
MN*GRV9,%UE!F2G6Y+2E-J2DTGJHE:%H8#VB7);MRT6-<EN5^G5^W9J%NPZ_3
M93,N$\AM2D+4W(94IM1)4E1&9*V&1ET $?7<\7753J5:L;&I7-9-,?=:8K+M
M31&E5)$99H?=@QN962DDI*B1O*(UZ;-#V#RV3\Q7S=,XL7%9$TK6DW4W\,4\
MW6]7C_+N*VVVW-FX<DQ6G#6+:[N*:QY:1L9(QQ,83<I],GR+ZB0E5.,B24!Q
M#KC[&^1&;3Z6$.$A:3/0R,_(U+:-^W\PZ&;8NG)$5BM-M8\$TK26E=^6>81=
M=;&*9I-*[*3X8K2L(V5//V5+JJD^NV;<$"W[69F/M6Y2UT]J3V;'8<4VEV6Z
M[JX@W#29Z-FG=+Q>C\_YG^>=39J9MPTBR)ZHVQX:_!1[G0_DS21@B,T3.28V
MS68I/@ILV>&K>UE<4F+JY0J*]<]RP;7N>4CFJO17B?YN/)0M3:OQQMFV2%&G
M>29JV),M3U'N-#^9M)FQ6W9+XMNF-L;=D^.CQVN_*NMPY;HQ63?9&Z=FV/%6
MM>C<_%(N3+.5SKMSX]NNA6K9],J,FGVK'E4\ZBNL'#5S:Y$AXG4\RTXLCW#;
M(U;O*71-BU&LUW%DP7VVXXF8MK'%QTZ9FNR)Z*;3-IM%R_AQ:C'??DF(FZEW
M#P<6VD13;,1OKLJVKBZ]W,@6A$KDR(U3JS'DR:;<-,9<)Q$>?"=4R^A)ZF>Z
M9I):=3UW5$.IR[5SJL$9+HI=MB8\-LTGR;')YGH[=)GG';/%;LF)\%T1=%?#
M2634"Z+9NN/,EVO<5,N2)3ICU.J$JE2V9C;$R/IST9U;"UDAUO>+>09[Q:[2
M&\Y[R@W3;%U-U%VV+CI=QM4><[3*L[2YC,Q,6='TYZ*^;*UDVZWO%O(5HHM2
MU(![1+HMJY3JB;<N*F7 =#FNTVM%39;,LX<UG3G8TCF5JYIU&O3(5HHNB0#R
MBW3;%R.UB/;MQTNOOV]-73:^S3IC,I<&8WU<:2EE:C:=3T4+T47B /:/=%LW
M#(K,2@7%3*Y+MR8JG7#%I\MF2Y F(ZJ-*0TM1LNIZ*%D2B\0!Y2+IMBX)E;I
MU!N.EUNH6S*[!N.# F,R7J?*TWN8EMM+4IES3;NK(C\8 I-TVQ7I]<I5#N.E
MUFJ6Q(3$N6FP9C,B13Y"T[R69;32U*96:2U)*R(] 'M,NBV:W4JY1J-<5,J]
M7MEUMBY*5"ELR)-/=>2:VFY;+:U+94M*3-)+(C,BV %.NBV:Q5:W0J3<5,JE
M<ME;+=R4:)+9?ET]<A)K93+8;6I;)N)(U))9%J6T@"!=%M56KUJWZ7<5,J5?
MMLV2N*B19;+TR <A)K9[*80LW&><21FG?(MXMI $*Z+9J-;J]LT^XJ9/N2WD
M,.5^WX\MEV=!1)3OL*DQD+-QHG$[4&M);Q<@!%NBV9U>JMK0;BIDRYZ$TR_6
M[<8ELN3X;4@MYER1&2LW6DN$>J34DB47( \C73;$RX*E:<2XZ7*NJCQVI=7M
MEF8RNH18[_\ 8O/Q4K-UM#GW*E)(CZ  Q=-L2KAG6C&N.ER+LID5N=4K8:F,
MKJ,>*\>ZV^]%)9NH;6>Q*E)(CZ!@#5TVP_<<JSV+CI;UVP82*E-M9$QE519A
MN+YM$ER(2^=2TI1[I+-.Z9[-0!%TVPY<;UGMW'2W+MC0BJ4BUDS&3J+<-2R;
M3)5$)?.DT:CW26:=W79J ]*Z+:.XCM KBIAW:F%W25:_9;/=$H6_S?9/8F_S
MO-;_ $N_N[NNS74!XJZ;81<;=G+N.EHNYZ"=39M54QDJDN"2S;.4F)O\Z;1+
M(T[Y)W==FNH#UVZ+98N*-:+UQ4QF[)L-51AVPN6RFHNPT*-"I+<0U\ZII*B-
M)K).Z1[-0'C]TVQ%N&#:,FXZ7'NRIQ7)U-MAV8RBHR(K)[KC[,4UDZMM![%*
M2DR+HF ]D71;42X*?:<NXJ9&NFKQG9E*MIV6RBH2HS&QUYB*I9.N(1]TI*3(
MNB OH    #%+WL6T,DVQ4[,ONWX=T6O6$I34:-.1OM.<VLG$*+0R4E2%I)25
M),E),B,C(P');-W#!AWACD2[UP_Q73^&*X%D<AJS9M1>J<::1$>XVF$RI4YQ
M'CN-R2_V06B:OIP0<<6?,OY6I&([XHM,R%;RTS^Z>5Z53Y,)R*F)$??9?E$A
MIJ/N/N-(:02F&%:N%KJ?2@3#L@"K1G$)7L\V[8;-0X=;*HM^W^JJQVGJ'774
M,Q2IZFW3?>)3D^G%OI639$7.]$^E/H$PYJU7B\\(Q1LF4/#LW N.%Y)N*"JJ
M4VV(AN3'"A)-:3D2'HUR.LQF]4&6\^M!>60)I#8EF\4'&] SUBW$.<L68[QQ
M$R!*YQJ7NRE*F0XZR[+:I\V/69T4Y26S,TMKV]3JG52"4*0ZL@J  "+'&Y\T
M_.GP:=]E;!,;S@C^:?@OX-->RN 3O2G!          BG5[4N5[BUM>[6J'-<
MMB+;+D637DLJ.*AXVI9$VIW3=)6JT[/''F<NFRSSBS+%L\$64KT5I/2]7AU>
M&.27X9NCCF^O#7;2MO0E8/3/*,2O2]:!85$>KEP23;:)1,P8+*><E39*]C4:
M*R73...'L))>2>A$9C5U>LQZ7'QWSXHZ9GHB(Z9EMZ+19=7D[O''CGHMCIFZ
M>B(:QM&R:_>E;I^2\L1$QZE!4;MC6 2M^+1&U=2_((]CLQ1:&:C+1'W)$9$2
M>=I='DU-\:C51MCYEG19X9Z[_#T=G4UFNQ:7'.FTDUMGY]_3?X(ZK/!T]N^Q
MVW           !8KFFUZG4&J3K7H3-S7!&9-=*H,B:5.:E.ZEHVN6;3Y-$9:
M]-S:O(%\5MMUT1=-(Z9I7T(E%:_,M9^H%EW7<=X<+=LSK7MJDS*Q7XSE^,2B
M.)3V5R7C)E5#,EF26S,BZ)CJX-)IK\EMMF>[BF8B/D=,[/:4FZZ(VQZ53:&4
M^(6J6K;E6MCA=MF%;M8IL:HT6*U?K$=*(TQM+[7XE-#(D&:5D9EXHC-I=+;?
M,79[JQ-)^1U?_8BZZF[TI06S-KU1H-+G710F;9N"2R2ZK08\TJBU%=U/5M$L
MFF"=(BTZ;FT^0.7EMMMNF+9K'1-*>A>%]%$@
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MD5NFD# XN6,<S)J:?'NZ"J2I6ZC>4I#:C\1+JTD@_P"A0Y]G-])==PQDBO\
MCIW+]W=U,BN2&4^D.N,*(WXI%*ANIVZ*;Z8C2?CD-^[;%88YA>*7-*H4^',+
M9V0TE2B\16FW[([F*_CLB[K8)BBO&1        "JE?W?U!']8"E
M     %3#[:C^J)\T!^ZAV[*]4,!1@             "KA]6]^3N^D,!2
M            O,7]$3_5$ +,               "J=[6B^2YYI *4
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M2A*-XT:JV&-D.O0*@  BQQN?-/SI\&G?96P3&\X(_FGX+^#37LK@$[TIP0
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MUF(>GB.),O+(307.E5RC2YD=$:JQ'EFLM&TO(-7H==1 K#/4S,MI:\H#P
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MI=G6U$H7$U!)B\5TJ(J"[$JSD6,MAV*TRKFN;<>DEO$I)F1$>BMNP4=$05
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MV71='@F)[')S:?+AFF2V;9\,3':O RL(
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M!MQUBH8-S_;F2;6I-_X_<>TD.4V9*-#DF"ZM".R84G81+27^R?0,PZM@@
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M>B3]H UA><>]$G[0!K"\X]Z)/V@#6%YQ[T2?M &L+SCWHD_: -87G'O1)^T
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MW/)LJUX%MOWG57:Y=#L)O<.9/?\ [1]S4SVGM/0M$D9F9%M,!FX
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MIA]M1_5$^: _=0[=E>J& HP             !5P^K>_)W?2& I
M      7F+^B)_JB %F               !5.]K1?)<\T@%*
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ME."         !#/,_P YCA]_^-[(H>2YO_=-*]GR7^T:OR=B9@]:\8
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MSYI^=/@T[[*V"8WG!'\T_!?P::]E< G>E."
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M/18K;D FI,QZ.CGGE/)4D]Z(O4B0>S3Q=A%L)#<$?S3\%_!IKV5P$3O2G!
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M 5<O!]5GM4.]*RPP[/I=>BO.$M+)H88)R,_'4R@C63QFHD-](2=[G"T;D?\
M)N1N-++&4\19%NKA#KJJ9AF<Y6+8LZ/3ZBVR]55*;6W+DR30;JN:6RTI*$[I
M:IVZD9@G8ZO<,V4,OY5M"N5K,F)7\0UV!5U0Z71'TR$*DPR8:<*1NR4I7_:+
M4G7DV K*2 ( $6.-SYI^=/@T[[*V"8WG!'\T_!?P::]E< G>E."
M        !IK.V<;0X>K"7D6^(=4F4!FHPZ:^BD,M/R$+F+W$N&AYYDC0C0S5
MHHS\0C!,15I_%/&ICW*>48>*"LN]["KUP4QVLV)*NVD]S6*] 92MPY$(E.J<
M-"VVUN-J4@DJ0E6TE%N@45]I<75NW]?D^U;'Q??MUVM2;H79U7RI3J:R[0HM
M6:-).DZKL@GTLM\X@U.FUH1*)6FZ9&8HEL"     !&7C+^:[FKX.N^RMCI\G
M_K,?C4R_-DX-/FNX5^#K7LK@<X_K,GC,7S82:',7
M                        <YO"A?-LI?\ ,"VO9U@)?PNTXGJ+?I2 50
M     +JY^AX_Y0OS %J               !52O[OZ@C^L!2@
M "IA]M1_5$^: _=0[=E>J& HP             !5P^K>_)W?2& I
M        7F+^B)_JB %F               !5.]K1?)<\T@%*
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MGH,=Z:Q;+B6)BVD*=01/(,B2LRWBVF?(8(C>K."/YI^"_@TU[*X!.]*<$
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MR_FNYJ^#KOLK8Z?)_P"LQ^-3+\V3@T^:[A7X.M>RN!SC^LR>,Q?-A)H<Q<
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M;'3Y/_68_&IE^;)P:?-=PK\'6O97 YQ_69/&8OFPDT.8N
M                             YS>%"^;92_Y@6U[.L!+^%VG$]1;]*0"
MJ       !=7/T/'_ "A?F +4               "JE?W?U!']8"E
M      %3#[:C^J)\T!^ZAV[*]4,!1@             "KA]6]^3N^D,!2
M             O,7]$3_ %1 "S                JG>UHODN>:0"E
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M_!?P::]E< G>E."
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MU%^2W=,[&:R*6Q#=0TE@
M   '.;PH7S;*7_,"VO9U@)?PNTXGJ+?I2 50       +JY^AX_Y0OS %J
M            !52O[OZ@C^L!2@             "IA]M1_5$^: _=0[=E>J&
M HP             !5P^K>_)W?2& I                7F+^B)_JB %F
M             !5.]K1?)<\T@%*              /4]47D@+G6.WE?>-^E(
M!:P             !4P^VF/OR 4ZNJ/R0'S<;;=3NNMI<2?*E1$9>48"TNV[
M0'S-3M%A*6?*OF&R5Y9%J)J/PBV;>;42DT2%O%R&IA"M/(U(PK(O#3+3"20R
MTAE!<B$)))>40@?0   $"O"4_-/N_P#:]$_/V@'1JP_\C69^PJ=^;-@2RL
M<QL!_IWB=_GQ>GLL<>RQ_58_<M['B-1]=D]Z>U(<68@  :ZX0_\ 6+B[^$5N
M_P"'O#D<ZW8_%/:[_)?I^3L3W'"=T       !ROSQ??%-FOB8NSAOX=[S@XM
MHF+J) J=ZW4^KFG9#]1CL26RY]#$AXB)$E"4(:2DC,EJ6OJ226BE%JQY>?%K
MPPYTQ%BWB&OV!ES'6:Y+]&M^X6%*D2X-2:0VE&KSK#$C7G'6DJ)TUI-"E+2>
M\E1 ;)=905     $6.-SYI^=/@T[[*V"8WG!'\T_!?P::]E< G>E."
M                                                 <=,WV]B*_/"
M$2+<XI:LQ QW3<?07<70*M/72:7+EK>0:D/2DNLETSJI6A;Z=]2$H,SW20HM
M&YBE_P!J<.>)>*CA.E<)U:IS%W7!>$>F7];]L5AVKPU4*4\RQ)=D'V1(2TKF
M%N])OD2B+?-'2ZF3T;7;8%   18XW/FGYT^#3OLK8)C><$?S3\%_!IKV5P"=
MZ4X(
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M0*@    "+'&Y\T_.GP:=]E;!,;S@C^:?@OX-->RN 3O2G!
M                                        UOE_)E'PWC*],GUZ.[,I
MEFTUR<[!8,DN2'-2;880H]22;KJTHWCV%KJ8$-!.8QQ;QO8=Q]?68\4=Q9->
MI_=6UFBGK.J4^%,/?CK1.C(8,TR&B0]S:DJ1TR=2WBV$[D?J)CKAVX+.(_#U
MK4;$$MR1F=$FDVIF&H5I<]ZGU/?2PN B \T2&R<Y]E//(62S)TTZ&DE G?#J
M,"H  (L<;GS3\Z?!IWV5L$QO."/YI^"_@TU[*X!.]*<$
M                                                     ##KRO\
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M@TU[*X!.]*<$
M     #1O$KBB1F_!>2,70I+42I733$E1WW_[(IT-]J9$)P]#T2;S""4HBU(M
MI;2!,.5N-?"&WAPSV=;V$,^X)K<.YL<T]B@TV<P\F&J3 IZ$QXV\S(;-"]QM
M"4D\TZI#A:*3IKM+<-5=:M]Y0\(#Q+82O>FXZFV)@_ M93<2:Q+<4XF1*9?8
MDD2I'-M-NNNNPV6TM-DKFT[ZC49&8&Z';8%%HN&O4JUJ!7+GKLM,"B6Y3Y-4
MK$Y1&:68L-I3S[AD6IZ)0@SV .<-.X_;T:@6%DZ[^'Z1:O#ODFXRMZW<CG76
M),]DG'766Y<JFMLDM"#-AQ1IUZE)[BE])SA:B1W&Y\T_.GP:=]E;!$;S@C^:
M?@OX-->RN 3O2G!
M                          ,9O*%<E2M6OT^T*I'HMSS83K%%J\MM3K,9
M]Q.ZEU2$[3W==2\?38?( T;A[&F5L?1H]MUV98\ZTI'9#MQ2*?%J7=>H29!*
M-<A^1(?4A:UJ/IC-/)L21%H"6(P^'O(B;.A87GWI2).&H4UI>^B*^FO.TUB2
MF2B IW?Y@B-22)2]W73H 53$0A+:$-H22$-D24)+D(BV$1 ASH\*%\VRE_S
MMKV=8"7\+M.)ZBWZ4@%4       "ZN?H>/\ E"_, 6H               %5
M*_N_J"/ZP%*              *F'VU']43YH#]U#MV5ZH8"C
M  %7#ZM[\G=](8"D               !>8OZ(G^J( 68               %
M4[VM%\ESS2 4H              ]3U1>2 N=8[>5]XWZ4@%K
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M-LI?\P+:]G6 E_"[3B>HM^E(!5        NKGZ'C_E"_, 6H
M   %5*_N_J"/ZP%*              *F'VU']43YH#]U#MV5ZH8"C
M       %7#ZM[\G=](8"D               !>8OZ(G^J( 68
M    %4[VM%\ESS2 4H              ]3U1>2 N=8[>5]XWZ4@%K
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M:F[6)M/[-FSM^:\RS'6[SDY^0X6K<=M.Z2MW9KIJ9F8F:MJ
M                ,'IN,L;4:Y9=YT?'UM4J\)YK5.NN'28;%2>-PC)9N3&V
MDO*WB,R/56T!G
M                                 .<WA0OFV4O^8%M>SK 2_A=IQ/46
M_2D J@       75S]#Q_RA?F +4               "JE?W?U!']8"E
M         %3#[:C^J)\T!^ZAV[*]4,!1@             "KA]6]^3N^D,!2
M                O,7]$3_5$ +,               "J=[6B^2YYI *4
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M752%$2DGRH61Z&7+@UF7N<%UW3/R8\N_T-WE^'O<UL=$;9\GQNG8\D]>
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MFM0);-TPH\)UUQUOG24RF/*E$I)%L,S,MO0 F*)"@@
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M5*_N_J"/ZP%*              *F'VU']43YH#]U#MV5ZH8"C
M   %7#ZM[\G=](8"D               !>8OZ(G^J( 68
M%4[VM%\ESS2 4H              ]3U1>2 N=8[>5]XWZ4@%K
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MN?FRDQ&DM$[(=T(E+42=3,B(O$(B!1E8
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M]EEV9SW<7L#=[&W=?[7HZ\FT"NQT*!4
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M<:,MQIY:2+730^0$5;#@P8E,@PZ; 83%@T]AN-"C(ZEMII)(0A/C)21$0"J
M     %NK%(IU?I%4H-8BIG4BMPWX%4@K,R2]&DMJ:=;4:3(]%(49'H8#7=M8
M0Q5:&.:IB2W;,AT['-:9FL52UM]]UA]NHI-$I*ENN+<_&$9EKO;.AH":OW9F
M%,6X]L2J8RLVSH=!L:ME,*KV^RMY3<CN@US,DW'''%NJ-QLB29[^I$1$6FA
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MOM[^XI1ON.:;O.*T).A;>0"K:8
M      #G-X4+YME+_F!;7LZP$OX7:<3U%OTI *H       %U<_0\?\H7Y@"U
M                JI7]W]01_6 I0             !4P^VH_JB?- ?NH=NR
MO5# 48              JX?5O?D[OI# 4@               +S%_1$_U1 "
MS                JG>UHODN>:0"E              'J>J+R0%SK';ROO&
M_2D M8              J8?;3'WY *=75'Y(#P        ! KPE/S3[O_:]$
M_/V@'1JP_P#(UF?L*G?FS8$LK :]RQC^G94QK>V.ZIN%%NVD28"'UEJ3#ZTZ
MQY!%H>UEXD.%L/:DAFT^:<.2V^.B6'/BC+CNLGIA!/AJNV?=&*:/ KJ%,798
M;[]HW=#<TYQJ=2%$P9.;3Z8VB0I1^>,Q["^E:QNG;'E>*F)B=N_I\;?@J@
M&B+-IO\ %KC#IC"TIDVKPWT)55FI,DK;5<5=3S<5"MG*VPGG4GKTJVS\<:?,
MLO=Z>G3=-/)&_P!3I\JP\>:O1;M\O1\,NE(\N]2
M
M                                           ^$F5&ALKDS)#46.WI
MSDAY:6T)U,B+52C(BU,R(!]&G6GVFWF7$O,O));3J#)25)46I*29;#(RY# ?
ML                                   '.;PH7S;*7_,"VO9U@)?PNTX
MGJ+?I2 50       +JY^AX_Y0OS %J               !52O[OZ@C^L!2@
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M$XC0MA.:#S_-\W'FX8W6[/6]3RK#P8>*=]VWR='H3.'+=,
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MO[OZ@C^L!2@             "IA]M1_5$^: _=0[=E>J& HP
M !5P^K>_)W?2& I                7F+^B)_JB %F               !5
M.]K1?)<\T@%*              /4]47D@+G6.WE?>-^E(!:P
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M(ATVE1FH=/AMZ[C3#"";;;3KJ>B4I(B'C+KINFL[Y>VMB+8I&Y6B$@
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M+"8JDBEXRDVI+2S!I!(D[S<B4RZR;KKK*7TOFE:T[YIZ5PR;- )C=L=R04
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M # MKV=8"7\+M.)ZBWZ4@%4       "ZN?H>/^4+\P!:@
M54K^[^H(_K 4H              J8?;4?U1/F@/W4.W97JA@*,
M    5</JWOR=WTA@*0               %YB_HB?ZH@!9@
M 53O:T7R7/-(!2@             #U/5%Y("YUCMY7WC?I2 6L
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M5'<=FT?&V,ZCV>JGVL:U/599+0;AI0:-BGDM$@UN*03:3,T-;QJ("L0ZU@J
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M= L:8>QAARDR*)C&R:79M/F+)V<F UH[(6DM$J??6:G7326PM]1Z= %:MD@
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MPH [!E]84 =@R^L* .P9?6% '8,OK"@%2[#E=CQD\PK4M_4O),@%-V#+ZPH
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M#;$[YVSXY22&DW
M              &LL@X;QKE2HV55K^MANX:ACNIE6+.D+D2F.PII&VKG23'>
M:2YM:0>ZX2DZD1Z 5;-
M
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M^6 J8:U=E1^F/^T3T?' ?NH*44V3HH_[0^B H]]?GC\L WU^>/RP#?7YX_+
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MLM#C!_[22VCT6JR=QBONZ=T>.7F]'A[W+;;T;Y\4;?4Z]#QSV0
M
M
M                                   YS>%"^;92_P"8%M>SK 2_A=IQ
M/46_2D J@       75S]#Q_RA?F +4               "JE?W?U!']8"E
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M"G5U1^2 \         0*\)3\T^[_ -KT3\_: =&K#_R-9G["IWYLV!+*P
M?E24K2I"TDM"R,E),M2,CY2,@$$N$WAB=PCDC/-QS8RFZ?,K)T/&).'KS5NK
M454,FC+I=Q3LI#:M"+\8PO80ZO,-=]XQX[8ZJSX]W^/&Y>@T7<9+YGKI'BW_
M ./$G>.4Z@
M
M                                                       YS>%"
M^;92_P"8%M>SK 2_A=IQ/46_2D J@       75S]#Q_RA?F +4
M     "JE?W?U!']8"E              %3#[:C^J)\T!^ZAV[*]4,!1@
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MUL7;V64JLPZLA7,J-J2ULDPG.E=;/QT^)XAEL,:5^.;)VL%UDVKL**
M      /4]47D@+G6.WE?>-^E(!:P             !4P^VF/OR 4ZNJ/R0'@
M        "!7A*?FGW?\ M>B?G[0#HU8?^1K,_85._-FP)96
M
M
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M5RJL=?.(*/.BJYN=%UUW5::D:3Z*5%M(QR\N.;)HU+[.&5Z&-0
M'J>J+R0%SK';ROO&_2D M8              J8?;3'WY *=75'Y(#P
M  ! KPE/S3[O_:]$_/V@'1JP_P#(UF?L*G?FS8$LK
M
M
M                                  <YO"A?-LI?\P+:]G6 E_"[3B>H
MM^E(!5        NKGZ'C_E"_, 6H               %5*_N_J"/ZP%*
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M
M
M                                                    #G-X4+YM
ME+_F!;7LZP$OX7:<3U%OTI *H       %U<_0\?\H7Y@"U
M  JI7]W]01_6 I0             !4P^VH_JB?- ?NH=NRO5# 48
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MW?\ M>B?G[0#HU8?^1K,_85._-FP)96
M
M
M                        YS>%"^;92_Y@6U[.L!+^%VG$]1;]*0"J
M   !=7/T/'_*%^8 M0               *J5_=_4$?U@*4
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M8$LK
M
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M]7:H]5:,IFG4^I1I#ZDHG-&HTMMN*49$7+L =5+#_P C69^PJ=^;-@2RL
M
M
M                                                 !@F1L8V%ERV
MG;/R1:\*[[9>?:E.T>>@ULF\SKS:]",CU3J>FT!'KY ?!Q]'ZU?6'/; #Y ?
M!Q]'ZU?6'/; #Y ?!Q]'ZU?6'/; #Y ?!Q]'ZU?6'/; #Y ?!Q]'ZU?6'/;
M#Y ?!Q]'ZU?6'/; #Y ?!Q]'ZU?6'/; $;[?X$L0+XFK^I]7P)23P@S;-/<M
M-AR.?<\JHKF^R3:,E[V_U6]J8)20^0'P<?1^M7UASVP$'R ^#CZ/UJ^L.>V
M'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L
M.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/
MUJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^
M#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V
M'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L
M.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V 'R ^#CZ/UJ^L.>V ,!RGP$\,
MD?&U]/V'@"WF[T9H<Y=JKAQUG(*>3*CCFUJO3>W]-/'!*VX6X"^'*7BJQI&3
M, T!V_7:4TJZ7)\=123E[=\W=U9%O>*"&T/D!\''T?K5]8<]L /D!\''T?K5
M]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''
MT?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D
M!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]
ML /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5
M]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''
MT?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L /D!\''T?K5]8<]L 1C
MOW@3Q.SQ'8B@VI@2EIPU)I4Y606(\<S@*ED:^8.09KUWB+=TT!*3R> ;@[3U
M. +73Y#+A?\ X0"JH1P(\(K>FY@FVT:<FC;I?_A!:+ICI3Q2^_R&^$\BW4X2
MH#?CH)])^63I&+QFOCI6C+='2^9\#7"O]QB*FM_>O2OZWC%OO%_6GOKGY^0W
MPO\ W.+X2/(=>_K68G[S>=]=X#Y#?#%WLH?KCGX0?>KSOI\#TN!OA>^ZQ9!7
MXNKKQ>8L@^\WG?7>!^T\#?"J6U>'J4]XSCLI1>5SVGV!7[Q?UG?7/5\#/"6Y
ML7@ZW5>2A[VP4G)=/2K-]T]*C7P$\'SG5X#MA>O+O,NGYK@K695K+Y_(#X./
MH_6KZPY[8(0?(#X./H_6KZPY[8 ?(#X./H_6KZPY[8 ?(#X./H_6KZPY[8 ?
M(#X./H_6KZPY[8 ?(#X./H_6KZPY[8 ?(#X./H_6KZPY[8 ?(#X./H_6KZPY
M[8 ?(#X./H_6KZPY[8 ?(#X./H_6KZPY[8 ?(#X./H_6KZPY[8 ?(#X./H_6
MKZPY[8 ?(#X./H_6KZPY[8 ?(#X./H_6KZPY[8 HZAP"<(*8$Y4/A^M;LLH[
MIQ=UA>O.;A[FGXSQ= &B^&;@0PG/Q1 DYMP)1W[].J51,IRK1U%)[$3+<*(1
M[JR+=)K=W?& 2 ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASV
MP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7
MUASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?
M1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0
M'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP ^0'P<?1^M7UASV
MP ^0'P<?1^M7UASVP ^0'P<?1^M7UASVP!^D< W!TVM#B.'^UDK;42D*)AS8
M9'J1_P!H EM$BQX,6-!ALICQ(;2&(K"-B4-MI)*$EXQ$1$ J
M
M
M                                                  !@F3KY8QK8
M=RWS(I[E59MV,4A5.:63:WMYQ#9)):M2+:OE,!9+&OB\[@;F3KPQPY85'9A)
MFQ:H_5(<Y+R3+>,C1'4:D:(Z;51 -;T_B.=D(MRYJACVHTG%EVU1NE4*_G93
M"]5R'#:C/OPDF;S3+RRT2H^34M2!*3P(
M &HL@9 O6UY;K%K8JJ=[Q8$,YU4JC4V)"80@M[5IGGUDIUW1)GNI+Q-NT!B%
M:XA(I6WBNNV5:<N\9.6WW(]NTGLAF XA;3"GW$NK?Z0C22%%RZ:ER@-MV56[
MIKM,?E7;9CED5!M\VV:8Y.CSS<:))&3O.1C-):F9EH>W8 S$
M                  1=E\2$AJG5&]X6.ZC4,24>I+I]2OY$N.2R0T\4=Z8W
M ,^>6PVL]-XMID1F1 E)R/(9EQV)49PGH\EM+K#J=I*0LB4E1>,9&"'V
M                         ?AQ?-MN.;JE\VDU;B"U4>A:Z$71,P$=XN<Z
M_#N:T:5>F*:O9-#OVH%2K6KDN7$?<.6M)K9;EQ6%K6P;A%LUUT/88)).:;RG
M7S>]G67B65=K5B38L&KU<JO"A)-R3&;E)W6Y!I49$ES39X@(2&96XXRTMUKF
M'5H2IUDS)6XHRU-.I;#T/9J0#Z@
M
M
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MTA,;7G%:J=2HC)/)M!*?MGT^32;3MBES.VZ;2H<:5MU_&-,(0HM?)($,C
M                          ?)]]F*P])D.I8CQT*=?>6>B4(06\I2C/D(
MB+4P$+:9DJQLY91MFN/7E1*78^.JHM5E4J3/8;GUVMK(V$RBCJ62TLM:F31&
M6\M1[VG("5HS# QU;*LF9-LG.-4M'(LB6ER;;]-K3:X\FJ0VD1$1GJ09'SAJ
M)LDZ&DSZ/( F-8\^L56R[1JEPQ^Q*_4J+ E5N+N[O-RWHZ%OHW>AHLS+0$,H
M
M
M
M                              %+-@PJE%?@U&(S/A24[DB'(;2ZTXG7
M712%D9&6I=$@%#1;>H%N1E0[>HD"AQ%JWUQH$=N,V:O%-+24D9@/C%M:V856
MD5Z';U-B5R61E*K#,5I$IPCY26\E)+/7QS 7X
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M@]4J2HFR,C(RU(R 5KEGVF[5RN!VV*4Y72VE650V3E:Z::\\:-_[(#(P
M
M
M
M
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M^*FT^(*-D.XX-O7KC:ET.+3GJ0=10K=E4V3'8:=>;8<22%$\HS/>(_%T)=C
M0
M
M
M
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MQ[B3/N3\E1;/I,*VI3%*:Q-'BR)"Y%.W8\AFJ<ZE:M/QQN(TWC5R= $L=I>
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M#?J+\N?&9(DN+BQ-&TLO.$6NJUJ21] 0E,42@
M
M
M
M
M
M
M
M
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MFDVE*,RT2X7+IM!"0P
M
M
M                                Y\TK_P"Y7='\FHW^(-"$N@PE  QJ
MX[RM.T&FGKHN.G4!M_7F%3I#;&_IR[I+,C/^@8,VIQ8?GW1'CE,6S.Y64.XZ
M!<\(JC;M9A5R 9[O9<%Y#[>OB&I!GH8MBS698K9=$QX"8F-Z\C*@
M                                      %@J5U6O1I;%/J]R4NE3Y.A
MQH4R8PP\YJ>A;C;BTJ/4_$(!?B,E$2DF1D9:D9<AD ]
M              !1SZC3Z7&<FU.='IT-K^UERG4,M)U\\M9D1>6)MMFZ:1%4
MQ;,S2'RIE7I-;C=FT:J1*O#WC1V7"?;D-;Q<I;[:E%J7DB;K)MFDQ1-ULVS2
M8HN(JJ                            YU<!/^:^-'^=E0_,(H)=%00
M
M
M
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M22U:J(B,]-=-1*%<     YU<!/\ FOC1_G94/S"*"714$
M
M
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M^X    #G5P$_YKXT?YV5#\PB@ET5!
M
M
M                                           Y\TK_ .Y7='\FHW^(
M-"$N@PE  H9U,IM4;)FIT^-46B/4FI+2'DD?D+(R%+\=M^RZ(GQIB:/K%AQ(
M+*8\&*S#CHZAAA"6T%Y"4D1";;(MBD12$55(L
M            UXQC*V6,IU#,*2E*O"I6S&M-Y2G=8J:?%EO34;C6[L6;CRMY
M6NTM" ;#          'Q<C1W5I<=CMNN(ZA:T$HR\@S+8 ^P
M                    #\K0AQ)H<0EQ"NJ0HB,C\DC ?EMIIE.XRVEI!<B$
M$22\H@K4?0                            !SJX"?\U\:/\[*A^8102Z*
M@@
M
M
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MV +G<O$Y@:T+G<LZXLDTV!<,=;+<V&3<A]$9<@DFTF3(9:6RP:R41ESBT[#
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M] -:8_S%C'*DNZX&/;R@75,L:HJI5V1H9KWX,Q*EH-ITEI3]TVLB,M2/0]#
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M#G?P$_YKXT?YV5#\PB@ET5!
M
M
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M$4$NBH(
M
M
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M<,RWE)5J?3$9D8#;-6I<.MTJIT6H-F[ J\1Z%.:2HTFIF0@VW")1;2U2H]I
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MT ;JM'&EI6/7[]N6WH;L:K9*JC=9NQYQY;J7I;3"8Z5(0LS)LMQ);$[-0&?
M.=7 3_FOC1_G94/S"*"714$
M
M
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@GD-*B(_& =-@                           ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>tm2227887d4-lc_persis4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_persis4c.jpg
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M;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T 2%!H;W1O<VAO<" S+C
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M_\0 ^  !  $$ P$!              D#!@<( @0% 0H! 0 " P$! 0
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MXC2Y_..;V\>7,967.S"+IGX^'N7A-QIYLN,=.9Q6XCN&ULB);B%[;6KV@]0
MZ><]W<TKS1K^3ZV>"ZSAF=_T1Z7MG1<XT<<5F9&93LF.&OGK=Z$D6Q[_ "N4
MVMA[_.1F#+RV[?>XB */IUZ-#1V^I? :RRS+S;K;/5K@^VR+[KLN)OCZU%Z0
MDDG5\8"CNG>O+%(FC-V.PK($! 0$! 0$! 0$! 0$! 0$! 0=2;0Y^DNH0/1^
M6D835$Q%V':C7\X_(N\MJ[IV[8;=S,V+@ECNS*R(,]HM\#34N::TU%:K67SQ
M.0?J1SO6:+/RK<C,FR)BZM(C'U>^)73Y2>=[W<[+W9F\LF;K,P/\7'W,H:UT
MD5&M#*-8T5!KUK59--GU^K.U[?T\ZJS-;;=I]3?Q9D8Q.$3-N'='9*V?,AR#
MO#;W.&V<-A<Y+8XN>[Q[7VK T@MD]WU@U!/745BU-]\9M*]SR]8\YU6EYMD9
M63F3;9==;6*1C6;:[8\L[&3/-!S=G^-]L87#;:>(,UN"!DDF3<&.T1.\1II&
M^-X)JSMU!9M1GS;O;CKGJ?.Y5IK,O(]>_P#S=T8]DQ/<PK@N$_,7GL'9[OM]
M]3-R=S'[Q!C6RV[XZ$^S5XN SLH2"SIV+!9EYDQQ=_P[WS>FZ8Z@U&3;J)U,
MQ?./#]68]/#L_P"G!N_L&]W;MGCJUO.29F?.V'L?%S%PWPJ.\-E7GY$%I[^P
M+WY4TR_KNG\KNU.GT-MVLGZ]MOUIP[(QV8?)YFAF[N=N6>;=Z2;5XIBDQ>+C
MD=&SPW12![0*>(^>6&,L#M!(!/P+P7YM]]U(V0Y/S'JSFG/]7^'Y;'#;$[8I
M,3'?-UUOU8PP[9>])P)YG,=;C)XW=\UYE11QL))[9K!WGVG7#V]WYE3&1F6_
M#_%[<SI7J/+M]IEZB9O[IX8CXZS'_P!+;/R^Y3D2[VPZTY*A<W<%E++#)*YL
M30YK)'-81X(##T':%[=/-U/K/O>D\_77:6(UWBQ6)V8TF:>KAL[FPK7C2T@U
MKW+T1ZTOJ*UB&@_FRYQW3M3+X_8>S)OFZ^R; ^\R'R;B6O+-#6B6.C>M>H<O
M!J<V_BX;7+?U ZJU&@OLTNEPONC&[#R1$8Q3&>VN]C^QX-\RME80[GQN]I+G
M+E@E&+=+;/BI\>FM]PYAK0?:+';DYG9\/E:W+Z7ZARLN,^S4S[2GJX3;\<SP
M_P#TU2&;)&<CVA@1ND-^?FV,/SMHTD>/I'B4T=/C5[%[LOBI'%M=8T'M?PUG
MM_7X8XJ?M4Q^5=EL234_&/QNY9:Q.QZ[8I&.UW%*1 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=&]_Z
M-=?K;_TI2SUX+MB&#;.TX-]>8'D?:MP6,=E(76]M+)\5LDHB8UQ]EU*5[@5U
MK4:J=+R[*S.Z?I<RTVGC4\UU%D]T?+$/7X'W3=<)\O[JX\W)-[CC<D;V%CWD
MLB#&.E#'^V8Q[9:/M5@YWIHYCHK,_+QF*?-O9.2ZJ>7:^_29F$36Z.ZE9W>A
M\\LPT>9C<(<*T:ZE/BU\)O8IZAPY59\.U3IZ*<XS]O9NV1\J[/,IY=^0<=OR
MXY&V%:SY*.[)F<VQ;,ZZAD#WR/-(H0T5+J ZUY>G^>Z>_3^PSZ13XI[.V7LZ
MAY!G_B8U61C=39V]L]WE[WM<1><S,XW*8O9'*>)GM) ]EK\YRM=XP>YWLF9]
MQ<M%!J'8WL7GYKTC9?9.=I[HGMI'^$,G*^KX]M;I]39-EVSZVR?/5X?GNW-+
MEKK8]E973Y,#?"UNH7,=6*03B4$]"0:@!>CHK3Q9&9=,?6BOR4>;KK/FZW*R
MXF>&ZZ//$UP;D;.RLW'OE^V_E-NX3YXGL[*1UOCK>(R:R9Y3\5CF5ZGN*^3U
M>5&JYA=%]U(F<9F?)#[#(S/P^CMFVW9&$-8,AYZ=ZX6XM+;</&SL'+=N:U@N
M+26(D.[*:KSU%?26=&Y&;;-V5F\5/+_]KYG,ZPS,F^VW/R;K.*:1,Q'\R0[9
M>XF[KVUBL^Z$VYR$+970TI0D5[-3OLKX/5Y$9&9.7MH^WR,WCMB_O7?$*./4
MFO5>>)F62E%=6! 0$! 0$! 0$! 0$! 0$! 0$%!X^4'9V*+HF83"+CSE0Q3\
MH\<Q3CQ(+FZDCF8:&K736K7 @].Q:?67S-\1W.+?J-DVW\PTMMV-MUTQ.ZME
M6*^4=L7_  ;R9MG>V%9*</E!%E(7-#A&7O<YSX*L$;?BT(&KM5;[9RYB6@Y_
MHK^G.:96KR(^I=];R?\ 5;A2,8QB*[:SV/6YSW)8[QY:X\W-C9VSVN5FQ9:Y
MK@?;9[LUX]DN'QO6F??QW?$]756LR]9S729^7-;;ILV;[6V/F0X3RO*>T\/D
M=MEDF<P=O'2TDU_*QM+RYC!'%(XN]OH.@7LU&1QVQ,8R^]ZUZ9S.<::V[)I%
M]E)B)V3&-8PB9KC@U)V+SURWP9):[<WAAKZ7%,>6"WRS+KQVM#B]W@>)+&PT
MUCZE%Y;,Z_+PN<[Y5U=S3D%UN1J\N[@[KXNXN_ZLS-+MOHQ;A\D<J8SD+R_9
M_<NVKES(KS'7$%["7-$L$CK=SC'((Y) UP!'34O5F9O%EUM[W2><\\RN9<AS
M=1D3A=EW5V5B>&<)I,TF-[&/D<Q]E9[9W7G&6S9\C,&U>&@N/@NETBO0_DJF
MBC#BC;#0_I?I[,O2YN;;;]:Z<9W5IYGJ;Y\V&_-G9;(POXVDBQEE.(QDY[.X
M;$\4K7Q!<!I2[5W;9B*?#RO1S?KW5Z#,NMG37<,3ZTVSPS^]6C-G$_/V/WWL
M6\WKN*W@P-KC72>]O%(XV-$OA DR2OI4T[2L^3J>.)F<'TW(NJ,K7Z+\5F1%
MD16O9$4FE=KU8O,=PU)+##%O6P=--(V-E+FWZEQH*_*^DJTZNR(V[6:WJWE5
MUT1&?9W>M;]+ 'FGX4S?)3,7R%L)HR=U;VP<ZRBUNEGA(9H-N(HGZG5Z]7@4
M7GU&5-T<5KY/K_I?.YI%FKTOUKHC9&VZ,*<-(VU[YB-K!7'?F:Y%XKN+';'(
MN*O[O'0.#729&.X-^QFL:B!/-&TT:>AI]=8,O4WY<Q$_*^5Y+UUS#E$VY&OL
MNFR/VHN]IM_ZICBP[?2E%VANS%;QP6.S^%N3=6.0B;*S46DMUM#J'0YPJ*^E
M;.R[BBL=KN&AUN7K<FW.RYK;=%5UPDN?4@].PE98G![*=KMH@0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!\)#14F@0<3(P=2[M]10
MG!]#VDD ]G:IHBK[J'I442:AZ4H&H>E*!J'I2@:AZ4H&H>E*!J'I2@:AZ4H&
MH>E*!J'I2@:AZ4H&H>E*!J'I2@^%[6@DGL%5-$5="[D:;:Y%>OA/Z?"TJMD_
M66NCZJ)7AE]/-QN9M/:;<15%/ST*Z?SC'DUL^2?G<ZY5-.>9T>2WYF0?/%QH
M+3YLY)V_:$9"(Z,H^(!M&UTM)J\5J7'L:O!T;S#BKD9DX=CW=7Z&_@C/R8^O
M;YL&!?)O=7&2YG9?7)(N;NTEDGD(KJH /53H%N>J\N+=%PQLB6DZ0SK\[5SF
M712;HK\S>1GF]XUL-TYW:6\&_@]<XNZGMF.D;>78E;%*Z,/TQ61:VNFM-17R
M$=*ZJ[(MS<KZT3'DCLV8W/KKNIM)E:F<C,GANW73Y_5I\K1KS';QV'ROR/MB
MWXPQ[+NZ]YCBO;VUAFMP9'NCTN+)H( *#UKZ_I_2:C0:6^[4W4BF$32>_NF7
MR'4.KTW,=5EY>GMXKK;HK,5MX=DUQB(\U6R7F(X>R>=X+V/DK2R=/N#9V.MW
M7# 6:G&.(L -90.A=W:E\_R+FEF3K\RV9I;?,^G<^CY_RJ[/T-DVXWV16W?$
M;UF^7WS<X#;>VX-C\EP^Y0XAO@V%[-'<2:PY\LCZQ06<G>X#JXKW<]Z8S,W,
M]KI\9G;%8\G?<UW)NJ\JRSV6ICAF.^)Q_P#I85\U?(^R.3MV;>N-BW#+NSLS
M;^\206L\(!:9:C3+#"3\8=@6VZ:T&?H<J^,Z*3->V/)W3+5]3ZW3\QORO8W5
MI=%:1.%*^2$L?#M/Q;;78\EO[T94$$'L"YGS7#4WS'>Z5HHID6U[F4H'&I;2
MC /9/I6NK,SY'KEV=0]*FB#4/2E U#TI0-0]*4#4/2E U#TI0-0]*4#4/2E
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MB*FMOI2A4UM]*4*OGB,]*B9HE]UM]*#D@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MY7V34D7MWU']VGXKD\;)M_TS_*G@Y[-*VW?ZH_F'<][M'Q>0LH1Z'7EV:?\
M#41JN3]]O^F?Y5ILY[&RV?/='\Q^/S=6DE_(66KWGWR[_OTG5<H[[?\ 3/\
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MC9'RP?@NH?VL[_R3_,^?CTW "U@Y)SNFE1^_K[^^4^QS_A/^*?P/4-/6SO\
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M?NVL)-L8-6HPC4_L=Z*+WU=,FZ799!&P_%:IJBKL&%KP*,'3M45*JS8HV]K
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MZLK=/WK$.7-U!G,6&U+Q:T/[(]:_EOASO>O]+OR&9_<G[MK5C.AP9?ANJNJ
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M,]6=S]-:7Q;=\(+L<SY)Y/9XDGZ8KD^JG^I+]L\FN_V65]F/0O?BUFX3RYL
M;3DM69PYBW]R=>1NDB#]+]&IK7-)'U5]#TS/]6:]WSN7_K#6='E;[O1"8[:T
M7F!.8M?PKR^VI,2UKO>8;2QFCEK]J XS. ^LON+[HA^<HMJM;FOC;E/=VZ,+
MF-M9O#V^W<6622X3)P37#))0*.\9C7ACV'T$+)%V"D1#*6,Q?(^,VL^T=>87
MYY;"/<I8+61EL#IZ QZZT[.E56;EJ0M/C3CG<N&W'D=\;XO;6\W)DK?W61F-
M8Z"V9#75J\-Y>:U_/*9GO1/=#9"$@QMTB@[O[*QVBJK @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M''7\]]!:Y&GB4+GZJ$:R?M6!3$U)AIZ+EPSS(C)K(;JC;T[#JIV*RJ43R<;
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M8IQ[T3+Y';^&YSR7/D<#K)'QO0"D1WHJX$!C UT)U'XL0J6U^%2M1W+5CF1
M/>7DFM2*4]7U$I15V$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MK\F-N0LHC;1GHXDL KW'H52W*ONB9C9"\THS!98R!C)+V1@D,'MV[W.+:$?
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M>6V]YX]F1VQEH,UCR*-OK?5H-/T0:?R%TB8Q?G^(F(7F@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MAI@K2ADI(UI]ICNQT?I5KMBEB=";"FUFDM]?AQ-ZM<WH2*T [/4L<8PR;)7
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M%FCG#BP^G/6_Z5R^PZ'NKFW;H]+GGZHS729>^[T0G#A[(OT ^PNGN$.P@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MH00B&V?$OF.W_L^X@P%S>R9K&W\C(-,CVQ&-KAH[3'(32M>T*)A-6Q_)7/\
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M#M1$.A\W0NC=4OH37PR217TTJ@[%G!);Q/-.@[!V=Z#T;:=[;RPF:TA[9V$
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M=O\ YQMFBGCF*6,_!29C#^0NURY/&Q=R@$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M!Q<'D$N[/4@R9?7 FXXQL374\&\+3V]T342QN7 %OM51#X:@]650!5P-1H"
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ML)_I6;Y]"3R&FF&G>P?87Z!<]=A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]UR,TS;O62\L<Z!K8S4= VE:U43*8V/0O<ID8-]1;;M960X0O\"*S,49:8Y
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M_P!58C[B2A5S'G.\R'_KTW[UXC[B2B:CO.9YB_\ U['WKQ'W$E$5?!YS?,8
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M_#D?>O$?<2415\_GF>8W4#^'(]9^:\3]Q)0JJ'SF>8H__AXW[UXG[B44367
M^<GS%G_\.P?_ ++Q/W$IHBKD/.5YB_\ UZ;]Z\3]Q)0J^GSF>8OI3?;1Z?\
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M]RL&8.1OGW8<RTCM71: YHT]975]*)MFJ8[R1_T3^"_]FHOVV1%9VMIT0("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(*<C-;=/UT$!?FOZ\N[B9VAL!/Y/8NP<EMIRR9<DZBFO-LN/)\Z&W*W%MB\
M]E)[LB*.2>6E.@^,5RG-]>=[J67ZL;E$;GP56@W (=\'18Z,F+O0[@P\C#X4
MA<P&FL$4%?2E$/3FO+6T@CN;AKV0RBL3^G4(EY]QNK#6YT22T=2H'1*2*;-W
M8B.W%WXKBSQ-('_:2@[;]]8(,B(\35+\6NFGV4X2LN];;JQUR'>%%+)H%7.;
MII3ZZBA5TW;ZPC'/#VR@--*>S6OUU-"JF-YXB\F99,$K'R>U4Z>P>NI3A*N
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MV<D;H7VT,8:PQN&ES2/00:*)Q'/";2V[MNVEL\!BK?$6LS_$E@M6-8TO[*D
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M\D?]$_@O_9J+]MD12=K:=$" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MX+A<R^S0?FSZTG8B6<N/-GY'<LCS8QZ1:N#YI'-%*"I^V+1W*DIAV=_;,R^
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M\I!F]N[ALXK_  V6MCJBGMYVA['MJ 14'J" 0>A **O<0$! 0$! 0$! 0$!
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MLO<K!F#D;Y]V',M([5T6@.:-/65U?2B]LU3'>2/^B?P7_LU%^VR(K.UM.B!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!']_6
M0<&_^J7(GWA9]U+?_P#\[J/VK/C_ ,&'VUOE/ZR#@W_U2Y$^\+/NI/\ ^=U'
M[5GQ_P"![:WRK3WAY\]O[_L<?L+ANQW1M/?>\\E:XJRW7N##Q0VV,MY7%]U<
MQ-?-*R6=L3'")CAI+R":@4.;(Y#=E7<>=-LVQ%:1.WNC=WGM>+"%N;BO=_\
M#^&ON3MK\K;RSM]LV)V6SNW]UYVYRV,S%C;_ "EY;/M[MSH[=\D8=X;[<1EK
MZ "G1>JW)RM1/L[K+8KA$Q$1,3V3AM\]4S%(K#)_]9!P;_ZI<B?>%GW4M?\
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M#)6,&H,=N/#PF0-8UH<3)+.V,:CT:;QQ- #01C#*7E"V#F,3Y5>5^7]Y5FY
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MM<8ZFKB2A.UNPB! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MX@@U6X <:-U:ZGL["P=ZB8K-(VUH1$2DAXVY,P^]=P0[8R,QM,G,2VV;)H;
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MS47[;(BL[6TZ($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<.A"$S5MFB&%^&.!]C\$6F\K+9$F3D@WSN"XW+F1DKAEP6WETUK7B$LCCTL
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MVA=NFE4QL>BI! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!A?S#<QVW '#^[^6[S
MR[FM]I?-_B8.&X;:OG]_R%M8"DSF2!N@W ?\4UI3OJB8BK\]'G2\Z6,\V&,X
M_P ?C^/[K91V5=9"XEEN,@R^%P+YD#  &00Z=/@^NM47B*)V/)'_ $3^"_\
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MLMO=-(DB<6N8X.!%#3L(!2>&Z*PV&CU-UT5B:M:^<HYY;[;KY(G-ACU4>X$
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M>".,O,7QENK.XODKF^'FCC&?&!VVKW(V+;//6F2$K-3)G,$GBQ&(N]IT[CJ
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M>8YWMLV9KY)F(?,7\DU5DTR:1'EBOSN_M?C3?W,>XI<WEL>^SQ40<ZZNG/B
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M! Z@L'7X NS/7+MH@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$+OTQG_5O@?\
MUGG_ -IL46M;]^2/^B?P7_LU%^VR(B=K:=$" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @("#13^;)YE/_XV<_\ ^S<?_G->7V&9
M^W\G^+4?@-3_ /OGXO\ $_FR>93_ /C9S_\ [-Q_^<T]AF?M_)_B?@-3_P#O
MGXO\5B[^X(YQV38X#?.\.=,[SQM796?Q^9S^P/F3W>1UM!(0Z^A;%>7#IGV9
M<)A'HZAI/:*'!J,C,X/6KY&+.TF?EQ%]V9-\1-9BGR[9V;3DOD38W)VQ\AQ[
MQ]FK#D'>/(5M\W;9P.'G%S<6]Q(6F.^NVPG5:1V;J3.?-ITZ/3T6NLLFZZ(A
MBS,RW-MFRR8FZ<(I\.Q?7\V3S*?_ ,;.?_\ 9N/_ ,YK<>PS/V_D_P 7J_ :
MG_\ ?/Q?XG\V3S*?_P ;.?\ _9N/_P YI[#,_;^3_$_ :G_]\_%_BRCQ'PSS
M#L+=4F<WUYCLKRKA'V$UJS;%YB&6,;9Y'QN9<>*V\G-6!KA33UU=JOEY5]LU
MFZKT:;2YV7=6_-FZ.ZE/G;-+.]X@(-8_-QP+EO,APY?<9X7/VFVK^ZREAD&9
M.]BDFA#;1Y<YA;&0ZK@>A1,31J)O;&?2"^6W8%UOVUY=V9S!LWCO'LN<SLJY
MP4-A+#B;&)HD,,EM!!)(V&-I+BZ</TMU>T:M1.$MD,_YH(,MY+<YYF]HVIQE
MY=;2NKO#V5Q286>8$S\:(W= )&PWP(K0:VM[JHBF*.3@7=?D.MN+\?>\XX/)
M\E<M[U9-E>1MV9K;N:RER^^O7ND>RWNVPO#1&UP;XD+@7.!?JJ46FK8OZ.W>
ME];6/F4X_P!LW.8S/%?'689D^%I\W;74<K<?D3?N]V(G9&\ >[1NT=/:=(X
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ML+C,?S%Q; V_DR^%:66>3QQ= PSEA)#7?OJ![7-#0]D@]ACFFI$PWW1 @("
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MY]N[GMH[W;FX\=N&S(ZW6-NH;J,GUOA>\?DKL$Q26P7.@(" @(" @(" @("
M@(" @(" @(" @(-;?-WQ/NCG#R\<A<7;,DL8MR[G^:?FV3)2N@M1[EEK.]E\
M21C)'#Y.!U*-/6@]:)B7YN?,1Y1>5?+'9;6ON1[C SP;OFNX,2,->2W3@^S;
M$Z3Q!)!#I%)6TI7O1>)J_1CY(_Z)_!?^S47[;(BD[6TZ($! 0$! 0$! 0$!
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M6M;]^2/^B?P7_LU%^VR(B=K:=$" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MU!H30D=B42JMW3C;:]FLKC(V]LZ*'35TL8<R$/H'N#G"G7IZ$B,4\5'Y_/I
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M[<1>ELQ 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MK8<NT%FJNFV^ZB+KYAJ-O3S<;WR>\AFH;VX^88HS:SXULTP:]D@ >2WQ=)(
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M0$?U<S='I;#EDUO2ZQ$Z8Q7II'V%U1O)=A2@0$! 0$! 0$! 0$! 0$! 0$!
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MC;,3N>ZI7$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M!@/0=3UKZECVXHJZ]NZ: /B:\&!Q/R/3K^6@^22.:X12 N!!-4'4DD )(U
M=E.U!G3.7$^.X/VO9O:6^]WEZZAZ5 N#W4]:A+7V6)P:'ZP*E2A5Q9/SG95%
M?E HNV//K/ OW)5?*UUY/VGW?)C[#5H,OQ?._._1?OFW]Y*[YE"/Q.;P(_Q<
M7Z<+=W^K.Y^D[O5E'AM9],+95/VI^ROSWS*/]S?OE\AFSC+OX%P/,_$5.I_"
M"'I_:%?9] Q_5S-T>EL>53]=+Y#U;%3K1@K]9=2?0.P@(" @(" @(" @(" @
M(" @(" @(" @(""%WZ8S_JWP/_K//_M-BBUK?OR1_P!$_@O_ &:B_;9$1.UM
M.B'FYEF8DQ60CV_<V=GG'P/&*NLA#)<VD<Y'L.GABE@>]@/:ULC2?S0436F"
MMU:3P[6HT7)?-DO*UQQ0WDSA\YBWPT>2\08;)&0W+[B2%UA[M^$6OQ6,C\0B
MM=)^+WKS\=_%PUCX>=K?;YWM?9\5E:5V3\7K-E-Q[J=L#CK,;RWE+#>S;1P$
MN4W))C87P0SS6=L99_=899)7,;(]I$;7R.(J 7'M6>Z[AMK/8]]^9[++FZ[L
MBLT:;"T\P.?R^,Y?.\\'MG?L.#O+'$;!DP_O&)M+/(RVUV['W=RZ5ES(\OM(
M?$F;I+7!VANGH[3SK;YNXL&IF_.NN]I6(NI2E,,:8=_9M>/Y>O+GMSEK;]WS
MESK?W7(_(>_Y;ADFN:YL&8'YOO);5]I9.M)89(Y(I8"TN86A@&A@ U.?[,G)
MMS;>._&J=%H;<Z/:YL\5T^:E)I2*,=Q\'[IL.)^-/,QPM>9.YYGVG;3Y'<MI
M?W][DG;CQXFD9<6SVW,TA+A&SI'&6AXU!H\3052,CALB^S;'RL'X6^,JS/RI
MGCC;C,\4) .$N8]K\Y[!Q>^=LO\ !,_[WSF%D<'3XZ_C \:VEZ"NDFK74&II
M:Z@K1>W*S(S+:PW&DU5NHRXOM\\=TO&\N'\5K?\ :_?'_P"]F649/J^>?3*N
MA\+]Z[[TM5-G[,P'-N#9R=R=#=;JW#NF\O+FUMKJ\N60X."*ZEAAL,?%#*QM
MN;=K-+WL^4<_6YSS5:3-S;K[IF9:N+8SHX[\9GY/)'=1G3RY<A6SKO?G$&<W
MQ;;AS_'6=-CMH7U[')E[G"RV=M=0B9KG"6=UJ^9]NZ6AKH&HZJD[31YTWVTF
M<8>[0Y\3Q9<W5FV<,<:4B?DV.'F-MN,\/^+>YSEOMC%Y#(<B;>N<A/?LLH)I
M[5MW6YDE=*&N?&!^J$]/S2R9W#%*TVP:Z,NWAK2)XH[N]LM@\;M['637;:Q^
M.L<=?4N&NQD444,VIHTR#P0&NJVE#Z%GB(C8]]EML1]6E/(]E2L(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @X2?$=\"B4QM0'>:W^.#/_
M *Q_QEV+DONV7(NHO>UF[YT660:#D;[_ +XD_3%<FS?7G>ZIE>I&Y3:.BHN,
M>:E@KVBHKT4#N0@LN&EM-)/6J#8?G32[&[*<'U(Q\5>O_)M0:]AE"V0.ZGN*
ME*HUP8?:J!WT- H0[UA(^"[M)6]L<K7-]/1$LY\\11G*[8NHV#7<X>R=(0.W
MY$%(0P10N)=33WA!];)&>KAT'<@XO=4^ST%.U$MG_%9:>7.YBBCTON\Q*U\@
MZ4'NQ]'P*]N7Q1,]R&L,1#6BK16G:J#A&YCNUWVW8@YN8UAJU$O;VO=^Z[DP
MD\DKX&,O(B98W%CVT<.K'#L([BL^FNX<VV:1.,82B5Y\QAC]W13-GEG9<8NS
M>)YGE\AU-)ZN/4IJO%F=GD1#%=0': "-/0K LXNZ.!0;.<:R^'Q#R.:_JC&-
MI\,4J#5T1M;4]Y"(=5\IE)B/8$'1<-+PT]E5([D;-3=7YE0*X TZCT)Z!!D_
MAZ2:/D#!.\5U'>.TBI[#$X(.?*]M'9\@[D9'U#KJ0D>NJ#';A4!U:&OQ4 :B
M\DFG3L09Q\NVG\;6U]8J/&DK^P2IVD[%I<FL8S?^XRP-TOGC(H/1#&@L9S7.
M/L4!)Z=$ #3^J&I0<M8'M@&C.M4&S7F'N8[_ !W&V2'_ ,MQUV*_K4D<7_%4
M0EK(#IZ#J .BE#[4/C([$E+-VR!3;<P]!/[6Q=/Z)\"[[4>B'+^N?$C[$^E*
M9S-_1SXN_6+[_.<>N9=6_FI^'<\G7GNO*W3]ZQ$#S$*YK'?][_\ '>M;R[PY
MWO;^EOY#,_N?PVL4,'8%L'397;L5E-Y[5'_UO8C_ /2(T&3_ #".$G(8[_\
M1=BT_P!K"$&$@ XN=WM[$'PD!CJ]I-?KH*S:Z11!LQLV,7?!FZX' 'W>YEN
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M:Y[A\1DIC<_II!J*VLUG'=2(CX_\'HR^97WW1;P1%=E9F*__ $^FC?)>UMQ
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MVDB8;GH@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M8(XVESJDT:T=2B'H(" @(" @(,(>8_AK^<#PQO+B+\(_P2_"WYN_](?<_?\
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MDO\ ^K?EQ_\ QNX?]IG1:UP^D4D9%N'R?2RO;'''RWCG22.(#6M$ML223T
M0M;3>;^6*'RN\]/ED;$T[*RS YY#07/MW,8VI[W.( '>41&UB_RX?T!]F_\
MXM<C^T7*$[5K?1AXW'V?E)VE>6EC;VUWE\QFY\K=11M9)<RQW\L#'S. !>YL
M<;6 GL: .P(F[:L'RBX7%V?G9\\\\%C"+F'*V3X+LQM,L?SA<7-S=-8^FIK9
M9 '. /4AM:T"$['?Y8BCMOI0O*[=6X,,^3V#F[>_>TD>+%#9;@DC:X5H=+C7
MZWH"$;$FZ*B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MX[4Y@XWY!O>'^;]D6[K/"[UL[=EY!=6A\0^ZWMJ]S ]ORKVAU2-+W->R1ND
M1*V]N<*^<7);AVY=<F^:ZT.U\%DK7(9# [4VW:V,^59;RLD=:SW>F)T<<@:6
MNTAP()!:>X5AO&B&KOFA\N]WYA\7QKC[/=4.UG[ WE9;IEDFM'78NF6K)&&
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M,#D<--M1UHZ26\=?6^0@$C;GQ6B,-]^!H6.KIIW]!7!M$B! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MYQ .EHZ?4'8MBZ:IN?( &$F@<"#ZAW*!ESDN1CK79TK37_1=LTGUMMXPE9G
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M6OSX_$W/6T;40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M3 MG)&F1NZBIUM_2A(2ZE>I%$"J(<2ZKFC53J@O[*3&YX_VX='_0'W#-5/\
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M%75/4]2F5;$6Q,1V(TF59;EVS$1$\,=GD9N65ZQ 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 04Y:Z>@)^!3")0'^:TM_&]N 5Z^">GU5U_DWNURCJ&?^
M5LW?.B.R3].3R/\ WS)^G*Y1F^O.]U#+]2-SKLE!- :GT+&NYB4GH#5"BNTD
M5KT([D'SQ34-TEVGT>M +R[XOLAIZE"BJ34@=I%*A!S?[)%#1WH[T'$.U"O6
MIZ%GP(*C7%Q!/0>A!S+FUZ%!]\2AIJ):!UIV!![.*OK>&VR<,CZ"YMBUA)'5
MQ<.@Z^I0/#UBIH>E>BD?=8Z=>WL0-?K0<M0/4."#CT+M!Z >T#Z:H.6MO=T/
M>$'PO'>>B#BZ8%K6:JAGQ?0@ZU:ZO;:WT5*"DZ2J#KO((Z%!V(G59TZT[4%=
MD@(#:]IH?A050\,-0>I1#CK=7U=Q1*N'>R"@X^(2>G1W<4%5KW:V%U:,ZD^C
MH@]G.9=N:S%WDG,+#<4(810FC0/2?1Z5 \C47NTN%.@TU4C[J+.SL]*#DTAX
M<*_&Z$H.+96Z0WVNWJ/30]OU$ &LCC7_ .!!]+R X]WI4);&<;.'X*W#B:!S
MR ?68HUU#HCP+OM1Z'+>NYIFVU_8GTI7.92/YN7&#:^T(+VH^&YQZYCU;^:N
MW_0\_7GNO*W3]ZQ#=SB_1G,63T'NPZ_\X]:[EWASO>S]+OR&9_<_AM87$IH"
M._L6P=-53("*C[3I1 <X #N';]=!\#NX=PJ@J-DZ4J@Y:Q2I-/A0*@&O5P<.
MP(.3BP$T!:13M]:#F03U J@!QIT/;WH#B&]G8#1Q]: YVD-%>AZH/KWD.:!V
MH.1> !4]3V(5?&O'6I0?'25(T/  ZU0'.<=!U=!T+4"M>H-:*"@XN%*UKZ%(
MX%U1U*"DYU.\(*+G>M!V\2\'+V'7_"!1=L>;6>!?N2X^5?\ C/VE^M#[#5\_
ME>+YWYXZ,]\V_O)8/,U_$WN_]:C_ $X6[NV2_2=^R47>W3_HNT^!W3ZJXIKX
M_K7;W,-1/]2[>N#99KS5Q,1U W! 2?[0KZOHZ/KW[H]+>].3_6GS)D))0(H=
M#O:(:!1= I5]K$XM<_,?S%N;A[;>,SVW\%;9@W%T8<DZXCE>R&,!OM-,<D=.
MIIU*O;LP5VSBOS<V_P"7;/&3-]'$WN3FDQ45Z,7CHA+,Z::W\4-:QTC*MU=#
M[55$6Q6J8K+&?ETYEW+S!CY\GN7&X7;[(SJM,'%[Q%DH?1[Q#(^1K?71R9D2
M1@VJM12+^V)4)EV$0(" @(" @UX\V&T]H;Y\NW*FU]];GM=F;<R6*8Z;=-\X
MMMK&ZM[F&XL)IM(+BP7<<6IK15P]D=2B81->2/SU\:^7SCS,<,<LQ7#(=KYB
M\GVQNO;L0R-M>Q74I=,Q^AS22V2KHY!4/8X"C2SVRTQ53\]?GYXKYOXC9Q5Q
M789/)NSN1M;W<.<RMI[FRT@L9!-'';L+BY\DD@%7$!K6 CJ7>R(AF7RU>>3R
ME\ \)[%XL&Y=QY2]V]:RR9K)1X28,GO[V>2[NG1U<#H;+*YK*BN@-KU1$Q,I
M;=J[EQ&]-K[;WCM^X==X#=F+L\SA+IS'1NEL[^!EQ \L> YI=&\&A%1WHJ]Y
M 0$! 0$! 00N_3&?]6^!_P#6>?\ VFQ1:UOWY(_Z)_!?^S47[;(B)VL<^>0_
M.4'ERVFVKG[AY<P1:QG1Y\,2P>RX^R#^^N_\I>358\,>5I^;8^RM[[X^'RM[
M5ZVW$%D\D[UM.-^/M[;_ +ZV?>VNS,)?9B6QC.E\_N<#Y6PM=0Z3(6AH)%!6
MIZ+-ILF<[-MRX_S3$?&BZ:15'F<9S1FLO9<I9/EV_P +RQ%C9[7'6=C96!V_
MCK6]EM[J?%>YR6\DLT!DMXVND?-XKM <' ]%]/%FGML]E%E;*]\\4S%8K7OQ
M[J,?#.VN+K\&>77<W.^%/F,Y.YKW(_E7<<E_C]NW&%;#!88&'&9">RFLFV=Q
M%)%/$9K=VIFAK""7>T\^*L6MYC;H[OP^5EQP129KMNK$36O9M^$8*V63.,SB
MSMY5>+H,E@-I<Z;TW'D=[;\RN-N8L*^\9;V]CAH)I'0SBQM+:.-@DG;&!)*_
M4\M]D:6U#O%S;5SQ79%L1;;$X]\[Y\G<O9%<9;D7>.Q^0#!?V-O>B(DQ"XB9
M(&D]M-0-*T6EBZ8V2R.M#@L);2LGM\-8P3Q'5'-';Q->T^D.#00IF^Z>V44>
MJJI$!!:^[[#=V2PS[79&Y,?M3.F6-T>7R>+?F+<1 ^VPVK+RQ)+AV.\7IZ"L
MN3=9;=6^)F.Z)I\M)]")KV-?]M\.\\;:W)O/<MMSGM6>ZW]E+/*[CA?L2<,,
MMGC[7&,;!3<7R8,%HRM=7M5/J7OS-9IK[+;9RKOJQ,1]?OF9_9[Y4BVZ.WY%
M/S/>6NUYMQ&-W-M._;L[FO8KV7O'>_82Z*6.:!_BLM+F2/VC"Y_5IH3&XZF@
M@O8^>6<RG2W3;?'%EW>M;\\>7TF99Q;VIVX/-I:;X\NG,W$/+UK/M+S'8G"9
M':V5V;'8SRNRM_)"^.&XLF6K)FZ9: O((8TG4T^&YA6UR^4SE:K+SLG')F8N
MB:[(\M?AYV/VE;9B=J2?87(^QN3\*=P[!W-9[FQ4<SK:YGM7$26\[ "Z&XAD
M#989 ""62-:ZA!I0KYO/TV9D7<.9;,3\/C9XF)V/9W1MK"[RV[F]J;BLF9'!
M[ALIK#*63^Q\,["QU#W$5JTCJ#0CJ%@NMBZ*2KF9<9ELVW;)1V\,;DS'$'XX
M_*)OZ]?<7.W,%F,SP]FK@_\ C+!S6T\IA:30%T8K(&MK0B9O9$%X\JZ;*Y<^
M9I=+?.1QZ:_LB9MGOCX?/W-Z>'?XH^+/]D,'_F$*]67ZL;FVTWA6?9CT,C*[
M.(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M@HWFPNGRPALDKQT)<74(:X=*)0K#RFRXEV],;D\GNJ&XM1.);J[9<P.:QO>
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MH54! 0$! 01W?2=[2W5O+RUV^-VCMO*;IR-KO#%W=QC\3:37L[(&PW<;I3%
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M37?:&G<:4RIRIC^E7A_ZJ5\]'LY;F67Y<\,X1,_#YX;F+*V(@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MM?>&_P#FE*7'% WFOR7DF./A=T;G=16X:?\ ]4A*2<4.;>:O)=U\3AAYDIT
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M9N.]L\F[3@OK;;VZX9I\9#DHV0W09#/);N\2..25HJZ(D4>>E/@0ED9 0$!
M0$! 0$$+OTQG_5O@?_6>?_:;%%K6_?DC_HG\%_[-1?MLB(G:QQQY3)>?OGZ_
M)U';>QL-B&.<XU O(\=>$, Z$5;UKU![.]>2S'/NW-/D8Z_,GNMB/1+=K-X;
M';BQ&2P67A?<8O+6\EK?P1RRP.?%(-+@)87,D82#VM<".XKVV7S9=%T;8;>8
MJBP\DG!G%W)V+YJY*SN GO(\MR/E\?M:6'+9.W?'BK<1311^)!<QR2-K/2LK
MG..GKZ3]1SK79V1.7EVSLLB9PC;\7D['GRK(FL^5*GB<78X/%8S"XR)T&-P]
MI#8X^%\DDSF06[!'&TR2N>]Y#6@%SG%Q[225\O?=-]TW3MEZ'H*H(" @(" @
M(" @(" @(-/?-;N78;\%D=E[UXFR'($@P=QE\#FX),$R+&W;V7$,<L3\AE;&
M\CEC,>HN@B-6D .<=31L>7YGLKN/VUMF.,36LQNB)B8WL&=FV6>L\CRA;HV-
M!M;;6S]J<3Y'9>2O]N6.4W1NF:3!/CRM]%;PLEGF?9Y6[OI'R.>7-,T(TBH.
M@^RK<QS(SKIO]M;?%<(BM8C=,1$(R,ZR^(X>YNRM8]"C<6\%W!/:W,3+BVN8
MW17$$@#F/8\%KFN!Z$$&A"F)I-8$<&<X5Y)XRW;L'BCC[?\ ASLO?=SD[/:5
MWG\7/>9+;MIC[-]X;=KXKN&.\;%&W3 9&M(]EK]0%3]+E<QR\[+NS<RV>*VE
M:3A=6:=V'E8J3%(A\N_*OY@>"IKK=_ECYHO]T7E[*<ANWC3>YBEL<U?2G5=7
M$4C?"BADG?U/ZF[N]XIT5(YIIM7]34Y<1V1=;MB.S?3S[D39=;C;+7_?_)NT
M>0]W8[([PQN0\G7F_P!K:),3N'+-?#@<TZ,:&1W%X6:1'( 0V65ACT'0Z29E
M O!KNG+[K?;:6Z+X[XV^>/A/D:[5Z6,V>.WZF9';W[VP.$\[/(%SM^#9QXKM
M<EYA,/>Q09S9UWE(,589#%^Z37$F7QUW+KCD'R<;O#:YP+'^+&Y\8<6Z?3Y^
M7Q3;G\43'=$3-?WIM]*,GFDTX+[9]I&V,,?+%9AZ7$/F[YQY9W9987&<"8*7
M"6F?AQ&],SCMWV=])BK<7+(+N[-O&S5(V)KB]I'LOI[+BMEJ,O39=(B;YF;8
MNCZMM,=E?K_'2)\E7HRM=.9=$1;/9VQA\J1->%L! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!!PD(#:GL00&^;"AYAW!3_$'],NQ<E]V2Y'U#[WLW?.B#SF.?+?9+
MPY'1/=<2T<TT/QSZ%R;-]>=[JF7ZD;EGW>$R#(FN^=;AO6M!*_\ LJM5GVQQ
MMZZ[G>[)7#HF- TF1_:1\*2,G6NTW3[2GR/ODYE8]S2=9KT'I5:I8PO,3=1R
ML9\YW,;6"KJ2O';\!5D/(MF73[+,,]^G>8+@ADID<7"C0>A*E,J./;=7-E8/
M9D;MKY9W->X3.[ :(B=K.NRMKC*Y@6$MQ/,'15+G25ZU[>M51*U=T;3GP]]D
M(9;JXB#7N\$^(>HJ?0IA%&-I;.1[\<QN3N")G=09'=E5:"KN6V-DM\TRV%Y.
MYCPXZ?$/;0IV%5R;<P>N$7%Q<RR:I:-!>21U[.M56XALWR-LBQQG&FU,DRT,
M%S?7='7 T N;X<AI5HKW*(6EJW>8^*&_,#I'@20O=4.]#"5:%7@8V+3MO*RF
M21SGV\A)<ZOVJ2F'9PN,BE%C(^>4ZV]07$]WP*90VIXGVE:9C$[FK )8[6SE
M<UQ#31P IVA8UF MW8B&R=EX-&F2.Y- :'H9:#L"M;*JP\W8VYS5LQA\,T+I
M!^AIZ K1L-CB+>%^9E#W:F,@CZ?#]1*C)VU=MC*Y*WML?:^/,965;[-!]>BI
M,B]][[*N\1=6C[C'B.W# )'T9\>CJ]B1*6"KFQM?]+#P@2RZMP.@[Z>I7JA>
M,..M6Q12QQ#6U@ -!V_65:BW<QC;]D/BQ9":%CG@$->X4J>ZA4P&)L[J2ZD@
MDOYWL9;ZVO,CB:Z@.TI(RUBMINN]GY'*.DGK"8QK\3\U(6_"JU2Q1D,9-"R)
MK,A<-+>PB1U3VJT(>%C[*YOK3-R/R=SXEHZ,1GQ7].I4E75QK+V[Q<[_ )SN
MF7#;N..OC/["#T[4E,RS1LC;TF0S.-M;BZFEMWL'C.+R>OADUZU[U6(J*.\]
MH_->9REO%>R^%$X"WE#R*CPP2>[O1##V2M+F!D,3[^X+IKB0>*97$::5 I]1
M6A*Y<I9N&Z[2!EY,63-)<W6ZGLM8/RU"'.UP[Y;B_:Z:5S6WL[>KST =W)(V
M.WILBPQVP=G901/@.1%R)Y@6@DLN2QM2T5[ JTF(K*6 ;G&06^=;$9I/#-JT
MM9JZ'Y1PU4IZE-<!;&$QT4MOFYYIGO($S8"3733Q!TJ/4%,C;_@8G\7CZU+M
M0#:GN\")=.Z)\"[[4>AR[KOQK?L3Z4Q',]?YN?%]7 :(+VH^&YQZY?U;^:N^
M'<P=>>ZLK=/WK$*/F)QUU=Y[$^[W,D(%J#5KB/\ "2>A>#EL_P!.=[U_I=CH
M,S^Y_#:U9NK?(6L=[KR=Q6-T0:?%?TU2!OI]:V4.F,I;.VQ?Y//X>S\>:5LF
MALSS(::C*P=03Z"JW75V"GO;:EQC,SD;>2]FB\*F@,>1VN/H41*98JDCOK?*
M6$+\E<21RWL$9897GHYPKVE7(>EE8)8-Q6,#;VX$%PRKVB1PZ@.*41&QZ^ P
MMW?7F1@]^NB(Y(F0-\9WVS:^GTJLC.63X?R9VK9W7O<C+GPFS2MU^UH+1VD>
MOUJ*I8!RV(=C[MHER%TTN8X!@E< "UJM$BW;2RENK'(SOOIG&VD+6GQ'=P![
M_A5BKV+#&R7=AA91=35EDG#CK/72:=5$H;)\+;,MLKG;VTNV.N0RR?,P$M(%
M"T?; JB88MWIM]EO?YR(%\ AF=I:' = X]E D22Q]<6L;G[>>R21K7LURU=T
M)#^]70JYECI=UV$<5P\131,:=#BT5:PGL2$O;M\'JN;XR7,SFLD  +S^9!59
M&R=ULQEWQ3;7T6-+IF.+??AX8- 8Z"M-2K4:W7>,C@O[77-**M<WPR[UCKZ%
M9"T8XF0VVYI'R.>'/DB94UZ-?T5^TF77?:P/R[*LZ&*I!IV@"B;(1$LI;5VQ
M<9R=EI9V;9"?:+J-Z"GKHJ1*R]>0]G3;<FL([NT:(G4]NC?M@WT?"H@8:R5K
M:M&3:V*/2T/<WV1_85X0N_:F.LVWV)E$+6REPZAK1^4J7S@\VL\"_<F3\JPI
MR?M,=@\(=/J-7SN7XOG?GKHSWU;^\E=\S/\ $SN_]:C_ $X6\NV3N?I/-V2B
MWV__ .*;?X'?97%]=X]V]RO4^+=O7+L(@\T\3/8-19GH*CNZ-<OJNC_$O\WI
M;[IOQKMT)E[1U*![=#Y!4-^!??OMYEZ" @(" @(" @(" @L?DGCS;'+&QMR<
M=[SM9;W;.ZK7W3*002NAETA[9&/CD;U:YCV-<#V5'4$=$'YJN<-JVGDKY;AN
M/+EYDSG<Q&][,ACL:3\X8QK35MKE'PL?CKMI(]ICJ$'XT %"C)&+CY>>$]Q^
M>+DK*9#DWGFSL,M'(#?1YF\-[N/(1@>(68RQE>QOA,!():[3%TI&1T0F:/TE
M\3<9;=X;XZVKQEM.2\FV_M&U=:X^>_D;+<R!\KYI'RO8R-I<Y\CC[+0!V  (
MQLB(" @(" @(" @A=^F,_P"K? _^L\_^TV*+6M^_)'_1/X+_ -FHOVV1$3M8
MY\M=<KYF_.;GR:L@S>#Q,+FC2QSK6.\BD!!ZU9X+17L-31>3(QS+Y:?0XZG/
MN\L1Z6V7*6Y/P-XSY#W=XO@G:^VLME62U((=9V<LS:%OM5JSI3KZ%LM+E^TS
M;+.^Z(^.6VNFD3+6WZ/_ &W^#GE2XS\1H;<YT9+,7-.H/O5_/X)_86QU6QY_
MF<>LO\E(^2/G8\F*6PW-6G91 0$! 0$! 0$! 0$! 06GG=A;&W3=QY#<VR\%
MN._AA%O#?93'6MY,R%KG/$;9)HWN#0Y[B #2I/I59LMG;#'?DV7S6ZV)WPXX
M/C_8>V;TY+;>R<!M[(NC="Z_QN-M;28QN(+F>)#&QVDD"HK3HD66QL@LR;+)
MK;;$3Y(7<K,@@U*SVP?,QN#=FP]WW.?XQAO=@3Y&?&VT5AF?"F=D;-]G()M5
MT74:QY+=)'7M6VR\_266761%]+J=MO9->YCF+IFN#9':;=WMP=LW?4V'GW)K
MD]\DP,=Q%8EFL^'X;+I\D@.BFJKNWLZ+6YO!Q?4K3R[?D7BO:\CD'C+8'*N!
MEVUR'M/';KP\@=X<%]$'/@>X4,EO,*20OI]O&YKO6KZ?4YNGNXLNZ8GX?&3;
M$[40W-OD;VWL#D+BC#XG?^<NN--X9+(VD6UL@6RW&-]UM9,B^"TO*M 9.6$4
M\,.;U=5[NJ^BR=3D\PB;\[)MG,LI,7=]<,8[:>6L>2'ASM#E9EULW16CU]V\
M5[(X3DVMR[QL[\7F=V-G<0ZYN67DWNE]8W=_!:75O>"XE<"UT4SJNJ">H<2#
MTRYMENJMFW,B)PFDTBMM(KA/=AC&RBV;I\N(B^*1-O;\.Q,O;W%O=V\%W:3Q
MW5K=1MEMKF)P?')&\!S7L<TD.#@:@CM7R+V1-<85D2(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @Z]R*Q@?GA5! IYKF@<O[BIVM@Z'ZJ[!R:?^-\SD_4,1_[6R?)\
MZ)K)U^<;YQ&O3<24']L5RC-]>=[J&7ZD;EMY=SC&US6^&VO4?_"J+N.$MW7&
M4FM&L+GS.B#6>FM.Q)&]FW-DXNWV];8^>UH+AO[\:2ZNL]O2JH-/-^X3YEW)
MD<<6/BA8"Z-I!K0U(Z%6A#$=E1MEG".H%R34]"/9'17[1QP["W$65#33</(<
M.O:Y))21>6'CNZS)^=/=*NNVB."<$_%=W^A8Y3#R?-'LJ^PM@Z\EMZS6<CF2
M2FM=/8/4I):"31QLEQ,@: [Q6APKZ2K0B5>1KSN2V=\6C7=/5I*=@R]PA9&_
MSMM!-&)&"1^AI-._MZ*MR829\V<09;,<0XG+^Z-F]S:3::'U=[+).E!\*K"U
M81#[@#V;B=:R4;)!%/&]GH+&D?E+):I,K.MI1#MZZC?VS1NJ6]3U:4G:1+VL
M141XPN>(RZH8 1[50!WI)"6KRV\>7)XYS8D;'XEY:R3RN\05]D%M /3ZDLS)
MLQA+2'S,;?.!R<Y,>B2:1K>I[FR'J5$?6E%S5W<@_P!+6DC:/K#(6#ZRM:.C
M:BF5EZACG6\1+.X]J50WN\K.V#FY\KEM0^0+8CU% 'M=W_VJI*T-A>8MB0':
MN3CCD8^&&W;<N+'AU'N-".A58$5%R0RZW!&7:M-[:B,5Z_%'<LB%[0-^0: !
MI+?:)[CZ0JREY6X!IQP.G6T2,K_=!3!+M;.A@N=Q6EH^.HN(65;UZ@O HIE"
M4_8O'<>3XNSV/-A^]KJ*W]V:"ZFIKR>VOI6*%\$8_(6#O-M;@NL)=P.@FMGE
ML+7 BK1T!%>ZJR0HQ_B8Y!!N1[>D0,&HCJ:U->BM*'EXM[#CKZ5]=+,C%I-.
M\ T22$@_EOV5=YR"TE@M2XY#5&R;K[.D:J^A4B<5MD+@\QO%-[BL#^$'NQ9<
M6D@MGD5-&OC?(3_P5%1'#DV_] ,C=6FZDH_TG0?R%>$/7R8_]+L<X2'4X'2T
MCIV1I&P9"XJL;?+;SDL[F,SQ_.MP)& '_&$4Z*+HJ1@DDW;P]F)>/_G6]MQ<
MV%^TNQD>KJSP2]AZ-H?C-[U[-1K+<W+LLB*<-?EFI%LU1A9JVDLMX26$H\.:
MTMA%,WOU-E>#4%>.F":K(PQ/S=G6$$$/GH:>ETBF4-L^!G5X]<.\$4_8(ET[
MHGP+OM1Z'+^N_&C[$^E,+S**>7+C GM=#?:O72YQ]%R_JS\U=O\ H8.O/=65
MNG[UB&WG*ASV-!;T%GT/_./6OY;ZD[WK_2[\AF?W/X;6J6;:&PY)P <-<-?V
M8+9PZ:WQ\N&#O<K>8Z/'Q:I[F>WTNKT),C0.OPE1;F763]6>R@N#S1\77V+Q
MKMQO86RP.E&1 ZAH#XV-/U2Y4A,HZLA"(\GAWFI#LI:DN(ITU*_8B%?..8_=
MN*(!)#'#X0 ZBF$,D\264.5W^<?+72;VU%1\;J&]RK<6PESRO#D!VW#EF02S
MR0G2 000P-!'0'UJDK51'<L8MF&WWDL6'.=!&UK@VG87QAQ^RKPK+%EBTNQ>
M>9"VK6W#VT/2GL-5IVH=K$4CQ6W7,!:?'N0!W?'HDPE*9Y1=DSW-GF,FRTK=
M9&UDBBG-10/;&>G=VK&EKEYF=L28.\R-S-"6R2/>R205).C2.SZJ6P2TX>--
MOMMS:/:("XO)]#UD0ZLL<S-PXQTK"&ND>65Z$@L*CL3#(V!L7Y+<D^+ACJ;N
MYB&EG7XVAGY:B4):V;!RN&X=V[$(6QV,459CJ]HDMC'4'KVJD56FB+7DVR]W
MW]+$ &AK=.DFE 0U7A5@Z]<189V.@;INI0*'M&L*Y&U\D$<67A- 3+$""#V$
M )V(B&X'E^LI;V>\9#+ID?'I?)TZ 4/?T5(FDUA,-Q>3>+K7)<?W%S-+')=6
M#'2M<) 3T!=V ^I52B@S3-%YF[5SJ&/Q6AI[31W8KPA?FV03=XF@+0"WHJ7;
M'GUG@7[DOGE7:'<H;2#A4&(?8:OG\KQ?._/'1L_\S;^\E?\ ,T .&MW@= (H
MZ?W86[NV3N?I/,]646^WC3$VQ] =]E<7UWCW;W+-3XEV]\LMMQ;OY,XVPEW<
MR64=[F8XO'A:'N >PBH!7U72'B7[H]+?=-89UVZ$P/&VQK;8F*;B[.^FR$)Z
MNGF8V-P/P-)7W]*/N+IK+):($! 0$! 0$! 0$&O/FNVEOK??EYY/V?QI!/=;
MVW!CH;3"VUM=1V<DFJ[@,[!/+)$QH="'@ZG $5'>B81]>7+Z*?:^WQ8;H\P^
M5;N[,-TS1\?8J62+%PNI4-O+MNB:Y(-*MC\-E10F1I1,W/,\PWT55E/-=;R\
MM&=.WLM;O][BX]RMS(+?Q&$O'S=DG%TD+P0-#9BX5_PK $(N20>5O'\DXG@'
MC7%\O'(GD;'8^:VW,<M.+J]UQ7<[(?&G#Y/$=X(9[6HDCJ22B)9^1 @(" @(
M" @((7?IC/\ JWP/_K//_M-BBUK?OR1_T3^"_P#9J+]MD1$[6./)83D]Q>:G
M=?1PSG+&6BCDU&0^';R22L8).QS6MN &T[!\*\FFQF^?*T_*\;LV[OOE>?GN
MW+^"_E4Y9N62!ESEK.TPULRI!?\ .-[!;2M!'HA?([KZ%]#R++]IK,N.Z9GX
MHF?2V>;-+99NX5VY^"'#W%>URW3)@-I8:PG])E@LHF2./9U<\$E>+6YGM,^^
M[ONF?E6MBD0R:O,L(" @(" @(" @(" @(" @(" @(" @P=Y@>-<ARGL:WVWB
M,1C,CE(,K;Y#'Y"_RUUA)\7-;LD,=]87MI97[VW$;B&@.BT.8YX=4>R[-I]5
MFZ:[CRZ5V3$[)CNEASHOF/J1$SY9IZ(E'9MGRP<M<\66Y</RKN>TW!MW;FZK
M_;+9;?/OL),=)C+AL,U_#9VNWHXK^=C-7AFXDC8ZI&B(G4W>9W-\W37V3EV6
M16V)NVSMVQ%>QYHMS[\+HMIVXSY_\N*R+7<_F9^CQSMOA=U0NY0X"O;OP\;D
MV:_=6->XG3%(=;["X(J3$_5&XZM/B?'%,SE^1KHG,T=+;]LY<[)^SW>COX6&
M<O,TLUR\;?V>S]WNW;$K'#7//&G/&WAG^/L\R]? UARV"N-,61L'O'1MQ!J=
M0$@@/:7,=0Z7&A6@F)MNFVZ)BZ-L3A,/;I]39G1]7;&V)VQOA<^6Y3XPP.0N
M<1G>1]KX7+63@V\QE_F+*VN(G.:' 212S->TEI!ZCL*SV:7.OBMMETQY(EGX
MH[WJ[<WKLW>'OGX([MPNZ?F[P_G#YHO[>^\#QM7A^+[O(_1KT.TU[:&G857,
MR<S+]>V8KWQ0B8E<ZQ)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 049_B#]$$)0*>;#^-_
M<?ZQ^6NO\F]W>9RCJ#WI9N^=%%?M(O[^@J?>)*#^V*Y3G>O.]T_+]2-SQ[ZV
M-W;R1Z0)&]6K&NSKY<.#\YR)NUV4ED;#BL<T23R.H1[-".E3Z/0E2B27'\4"
M;(MU.8+*!]2X@>V[T=GV0J56HT_\W7 &X-MY(;]QOA7."O(XX[@- !C.F@[2
MW\@*T2A'M+C(K&POI6O\3WE_B3!W5O93L5JJR]S8&P[W=5UC<-:7(ACEG! Z
MU&IPK4CI3ZBF9(Q33<9<<W_'.V</C;;(AK((V.GR,1<UVH5]EI%'#M6.<5JJ
M/.O%%OO[C_)QP9\39=C77$9/B:G4!<6N<YO4_540(5;K:N1QVX'6.2>&C'RT
M$)ZT<#T[R%DJK1\O;%[KV*XCD8V9KRVM#\6B5P&^_DWX1BW)<9/<N0G_ 'GC
MGF.!@I0NDC+AT+7=X59E:U)W:[1OI\='A,K?SW&$_P ';OD<YC >G1KJM[">
MP*E"L51E>9KR@R[6OK_>.W;OQK2?7*Z)I#7-$SNO8U@^V5[;D3%4?-CB(F0S
M8][ \PL)F<X F@Z&I*M5$0VM\LWE?N.6<Q%E,O>NM-O8R44C#NI#M7Q11X[0
M.Y1,II1+M<<5P;4D9:8&XGQ.-MQH-K$\1MD;6I#FQ!K37UA4G%/8U>\X/ =I
MFM@V>\\3"V2\LM#<C&6LJ^I;UKI'>2>I4VW=QM1"Y^RL8'P/$6M^ES6.('LU
MIV=%>%7FQ6=M*^)L-N#>76B)CZ-J/JT2HFM\M7E_BV1Q4V^R<H9E,\QMS-JH
M3&V-\S>T-)Z@@]JK*S,V#V!A<]<76,OX8<ECGL(N6RQM?5O9_A&D?D*M:)1>
M>93RY6/'6Z,GG,'X?S)?S:XK;2P :61M'LM:P="3W*W$AK#&X:"S2TZ.X"BE
M"G=6\%]9NMW'2XD.#?@-?0@R5P5QGD=Y[W@$#Q#!CF-=/.:=&-D8"?3]LDR0
MEZVUA<C@\'[A97D#[0-8Q\#FN]JA[1U [>O8JIJU#\QWEDS.Z!<[_P 5E(&.
MQ]LZ6YM&-<UQ;&'O->P&IIWJ=B$<8Q4F&LL^VX>#*Z1C)&CLJQQ:K5J/+VYM
MJ7-^[V%C+4WMU%IA],I=I;Z!WJ9E$)N>#N*!L#CC#7,F5 RES!'<4&JL)F8Q
MQ ( [*D="L<QBO&+(W)7&+M^[!RV+=D?$,EO//:WSM1+Y&PRL:VK@3U+N]1;
M")P02;PV!D=N;JOMO9.<M=B;N=C&5/4,>^(.Z$CKI62)5EY>7LS)?QW+2&7,
M+F^#(.AH0VO4=>Y(G ;H>2[AYFZM\RYG*NKC+4R7<I]DZY_%BU-ZAW<_O"K=
M*T0E>O=I,M88L7E+^=^*;5MGCB\EC&N-7Z6D%@J75Z!5VXE9: >8?R>8Z\RE
M[O38V=-K/.PONK"0D/U.DE>2"R.-M/::*5[E:)GM)1E285^#O+_;\TQDN6R2
M-NI.]U2X]OU2K3*L-JN'[)F/V9<01U\-DNAM>IH(8P*_673^B? N^U'H<OZZ
MG^K'V)]*77FCKY<^+1Z8;[_.<>N8=6_FKM_T,'7<_P#%96Z?O6(;.<7ANX<6
M'_J;K6A_9'K7<N\.=[U_I=^0S/[G\-K7J\V[=9B5]IC&AWO3F5! IT<''O'H
M6QJZ:E$\NO'5YLK%8S+7V1,;HC"87 NJ'-<'#J*G[54D9[YFX_=OC8-_8SY>
M%TN1;K)+7EY:Z6*05<0?0FP0J;JV-D\'GK+'99WAOQ]Q$]H;TU$.:[K0GTJ\
M2+.RMC[QFXO#E,,\;GLAFJ>E-5>SKV)$H;;>67B*XR^]X\[-?"*&"X@D\=U2
MU[A72*=3VLHHNE,)>LS;W^ M[=E]D'SVN1(>ZS#WZ0'#L:TDM 5(6B*HQ/.#
MP;;V60_&!M.]=)97S8VWML31T+FQL9U]E@ZD$]*J\2JT;PF'=;V>1CFE\;QB
MZ:X/K( /:IF<1ZFR-I7FY<MB<!8R EUR?=H^_P"4?5WH"3*$]/'O$U]QWL;;
M]EC[A\=_):1^_7,3M!:\MZBK=)[ .]8IP7E9W*WEEM>6=CY%YR3+/.60EECN
MI>HE)(U D,+CT9WE6K0C%"SO3CV?8&>^8\A,9I,:'0LC)U1CVJZ@.HZ*\36%
M)PE;><M'W)L)K=@CNF. BFZ4!H!W4/7X4B2<4FWE(\G\NXH/QC[ONQX+6^-9
MV,6D.>]FA[7'4V04!80>M5296I1N_>;7=<Z\3)>3S8BU>X''F0EC1V#V#[':
M!W*$HH?-?QLS:7(]Q<1U9:WL0DMG#2"*,:*= .]6A$M/3B+-]O<.>"_Q)7.E
M!H:DGKVA7JJJW6.LQ;B[\$"5O2.2@J!W]:545$GWE#XFQ,G'YW5E)(VS99S3
M%J:'$1OC8^H.DGM/I5)6;<8G;F/W R^Q[H8;O'^&67,;HVGV:$5 <VGY"5$9
MOF/X#LMH[BO-QX41OQEU)*'6;&M:&N?*]P!:&M'0 =RF)):Y81[6Y3'L;V-D
M I]7L2[8\NL\"_<EX\JIKRAM+];'V&KY_*\7SOSQT;[YM_>2O^9O^)K=_P"M
M1_IPMW=LG<_2>9ZLHMMO_P#BFV^!WV5Q?7>/=O<LU/BW;UR;%.GFSB354#Y_
MM^O=\5W<OJ>C_$O\WI;_ *<C^M=NA,S:5%:4<UWVS>@'U%]_7%]O+O*4" @(
M" @(" @("#!?F7W/R'LS@OD7='%%E-D.0</CXIMMVEO9'(RND-S"R5S+4-?X
MA;$Y[J:3V5H43"$;^=_])9_ZM;E_]@1_YO1:D+8S/GW\^FVLCC<3NC)/VKD,
MPYK<9;YS:]CC#,'/$>IKKRUB;I#C0N)TCO(0I">[R]Y/D_,\-;$RG,]HZPY-
MO+.63==HZ&&W<R7WF415BM_DVDPAAHW[**RS,B!!C+E+F;B_A3!-W)REO3'[
M/Q4K_#M'71?)<7+Q2K+:U@;)/.X U(C8X@=3T0HOK"9G&[BPV)W!AKH7V'SM
ME;Y#$WK6N8)K:ZC;+#(&O#7#4QP-" ?2$&$^6O-+P#P9D;7#<H\E6&VLS=Q-
MGBPK(+O(7C8GUT226V/@N98V.H=+GM -.A1,15>O%W,/&?-6WG;IXNWA9;OP
ML4O@7,]KXD<MO+I#A'<6\[(YH7%I!#9&--.J(HQMR3E_,OM^]W1GMM7W$F.X
MWPEM)D(\CN<YQM];V=M;B6YENS:5A 86O-6_:@=]43@N3RX[_P![<J<,;'Y%
MY P5AMO<&\+63),Q.-$H@;8RS/\ <90)GR/!FMPR6A<?C=W8A+-Z(0N_3&?]
M6^!_]9Y_]IL46M;]^2/^B?P7_LU%^VR(B=K'/T>I-WPKNC<!#J[LW]F\OK=0
M%WBQVL5=(Z-_4J47DT?J3/?+3\EQR9N[[IGT/$^D,?\ /VS^$^+8G#Q^3^4<
M)C)H>M9+8>)&]M *?JL\7;];T?5]/_4OS,W]BR9^'Q2V.=C$1Y4A"^?9A 0$
M! 0$! 0$! 0$! 0$! 0$! 0$!!9^]N/MD<D8JWP>_MJ8S>&'M;ME];8S*V[+
MF%ES&R2)LS62 @.#)7M!]#BLV3J,S)NXLNZ;9V8(F(G:Q_B?+1Y?L#E<9G,+
MPYM+%YC#7<-]B<G;8NWCFM[FW>)89HGM;5KF/:'-(["%GOYEJ;[9MNS+IB<)
MQ5BRV.QE[,X;$;BQ=_@\]C+7-8;*0NM\EBKV%D]O/$_HYDD4@+7 ^@A>2R^Z
MR8NMFDQVKS%417-GD;Y X<W#)S'Y0LODK.7'.?=7?']O.]U];M'M/;CGO+C=
M1. ]JWEU./8/%J&#?1J]/S&V,O5_5OCU<R,)_>\GR;MK7ZC11=/%9-+H[8V_
MXQY)8ER7F?Y%Y_V;?[/MN!L)?;^Q\]F-\[HBPYFNI9K*[AE8'B62S9:/=[NY
ML@=-(7T+&QL!JR^EY;K-+GQQWV^SB)I/%/UJQ-*6Q7MI6N'=,L67F:F_ZLVV
MX=O?YL*>5(OY2^<,%R>-[[8N=A8_CKD79LMJ-U8G'X_YMCN[>8/-O.('5D86
M'4US'/D:W4"R1[7K2ZK*U&5=%N=CVQ,36V8\D^F-KU:;.NNF;+XI='=LF.]N
M4O,]8@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @("#B_XI42F-J SS8"O,6>_6/RUV+DWNR=S
MD?4/O:S=\Z*K)1"3(7X-:">0CX0XKD^;Z\[W4\OU(W.OC;.:]R%I9Q. ?+(&
MDGIT6.5TJ?%6\,!LC;5CCY;]D+FQ-$H):>I K342L^GT>?JIIEVS*+KK;=K-
M^$WU@=Q'P;'*VMO$SK+)--&PGZCBLF=RW49,Q;=9,[HDBZV[%C_DC>.#R>-R
M6T3+%E;*Z@E:;NWD#@Q^AP'ZD?2?S2\^=I\W*GZULQOBB8F)0O[YM8\1?;FQ
MP=6#%RNCB_0AH/I)[_2JP=K9'RS;%NKG WVX-);!!$)92X$#2'5[:K)EY5V=
M?%D;91A&*0CC_E[$YBUL=F&)F,# (A>2R48[K3J7@ ?76[UO3>?D9?'$U\C%
MEZFVZ:.]N'9\YW&ZXV[>6^4$$8-V;21MP *'M+2^BT%V7F61]:V8WQ1GF(K@
MCA\RN$.&W=8Y22%\9O 1,YP<!J<^G?T5;>Y$M:KM[?G"U<30RRM8!]56A$)>
M>!\O:["V3CK_ $.F<^-LKXVU))H>GVRI,+,Z-YCM-SSPR9&\M<6V(#W:W=+'
MK+J] 0X-/85Z;=!GWV\<63\4JSFV[%7E3=$-KA+.UO[)]]CLQ UKIFZF@ AN
MD@L KV^E>;9$Q.U:8[4+?)N#L-M;XS,.-J+2]AF<S434^T /C.<?R5:V:HG%
M(WY<]Q8[CWCK'7MV/'-Z=1B!Z@&G4TK^:5:3=-(Q3$TVMD+;D7:F[LS%C[7/
M1V]TTC3%)X0:>H&@.+A4FJ]]_*M1EV1F3;/#YZ_$I;F6SL69R!O#-VDLN!EL
M?'PUTQT8O83KK0&A]EGJ'VR\'#2:;%Z5Q0O\Q8<8+<LT0=XEO(YSH#V$Z0WK
MVE6MJK+K\=6,6<WGMJRE=01R1N#_ (1V="%,X)A+6WD6ZL,C#C\U.['8NRC;
M'9QNC9\HW2TGJYK32O?4KUZ/E^=JL<N,(5FZV,+F<MC;GQTS'WN,R%JRQDKX
MY?-&"QW0DG43TZA8M3HLW)OI=;-=TK6WQV;&N'F>MK/)XV:1DC<DVX#WB>W=
MK8"W0/C1FBP3;-N%T3$]QZR*6:.EU/ UVET;RTU'<"A+MT  $IU!W8!ZO@0;
M?^7^3\&[89>Y+[:PEFK-+IJ"/9<0-7P+/I])F:F[@RXK*)OBV,6[NS-^;=W3
MG6XVTO? \0'0R>D;7:6$GVG$>A>_6\DU6FLX[HK$=RF5FY=W;BI\N8S<%I/9
MP8F,RP79$4[6-#_8<'5^U<5IHNEEHB>YHL[3$/W':N@=%*98WOUZ@0XR5=T)
M]*O;C*)7;Y4<'\]7L%U'9OE%G+%(+D:],;62 ESJ=.E*]4NB:Q%-I,4A,QC,
MGMG,[5M,1B<G:WN2M&B.]M?'8)"Y@:TM:P/)-"T]@7HS=%GY=O%?;--R*Q.S
M:Q]NK+[UVPVVPC;"4X>9P#HA$"\!Q(-:QEW83WKRX1N6F9E&=YKH)['=.&R#
MGT@O&#5$X .942.TFO6HK13%.Q$Q1JWDJW$]NR%A#[F:..-G>2XAJL)7>!\;
MD=J["PT>'M)9LE>6<$\T36N>=<L$)=T(?3JWT*E(G:5F&?-F7=WDI'VVY,Q8
MVV4MY&N]TN9H+=S!J+@*>P35ND]0LL:;-NCBMMF;=TIBG:OSF_;66S.T,=<8
M2/QG%K&.;"/%$HTO.II /0U'8L4UBM2D=B$#F?;+=O<GVEA=6\EG=W\$[YV2
M!P]J*")X^,?SZM&Q%&5^+VENUKUI.HB1P)_YJ-=0Z(\"[[4>AR[KKQ;?L3Z4
ML_,O3RX\7_K%]_G./7+^K?S4[Y^9Y^O/=>5NG[UB&OG%P&:Q3I!3]["A_P"<
M>M?RZO!._P"A[?TN_(9O]R?NVNSP/@KW-9W(R6M#;VL37SO/0 :9>_X0ME99
MQW1;':Z8W,V_R?;7\V+VH+9ME8SRQ6[KM[^@+WA@<[4!0 /)/5?5:KI6[*R9
MS+9K=$=WG[WER]9;??P+P&WL_;[I(V[>PY.R#622F QRM!>UQZN:'TZ^M?*Y
MF5?E>O%-[U5[FF/FAQ=CBMV8Z=T;K87L):YSM5!(YP:T5<>^BI;$1L.*9VM*
M+Q[&9S2YVNKG"*@^-U=Z/4K1")A*3PK"_;^TFY5MJ9+F!HD:27!K-+Y3U/4=
M:=X2S+NS+N&V*U6K$1BR3;<]-RN7MK3.1!MJQPADG;IHP ]M6L;7ZZ^GCI3.
MG*XZXTK1XK==E\7#$XKTWCPGEMQVN7SF%@=?8>^L'.;=L#BQS? HX:@2*CJ.
MA7S&;9.7=-LX2]L16*H@MSX>?:NX=RX*:(L%H^41,-:AK3I[ZGM"A#-?E2VT
M^7<;,V::XW:FU- T-,H->M.STA)(2J/YHPV)QKMN/ECN)96Z9KF5[8FQDC0:
M4Z&BR9&FS,Z9]G$S.Y$YD1MV+VVA?VFX]NY&*/)13@,+H9V%A;6KB6U::=RK
MFZ>_)FE]M)3%U=B)SS?8:"UR+LM;PO%PR=L-P]VJCM6LEW4D#L[@J6S4I2&N
M?%N'Q&YMQ8R#*/<Z>&37:1LU'6=+NGL.;V *9F40GJX4W'B(,,;*7+VEA<1V
M[HV65S-'&\NT@-: ]P<2>P*T:?,FV9X9F.^DIBZ(E7W?>'!6M_D\7=V\&8;\
MM##)*S7)J</B,?JU=">QJI;E7W?Y9F.^DX)NNA'=YD;[);YVK\]W5G)!D+(G
MQ8RT@Z6AY)H&M]'H2LUQ*41SQR"=I!/0'Y0'H5954CMC>W>*M&-]F>XC8&^H
MO /V4*T2?6>&N]J\>[4DNI&Q8ZWM8=-L:!TE(P.E?:^L5ZM#H<S69D661Y^Y
M&9=&7;66?>'=\8#)7.OWR/'W#*1S6T[VL:6DEHH]Y%>B]W,>29^DG'ZT;E,K
M-MOMK#'7F@QDUP)KG'V[YK%S72,E8'/8X%[Z.#A6HIZUI)K6C-&Q%C:,@.Y[
M<L!92:A::UJ#U[2INV/)K/!OW)=?*OTY.VG3K\F/L-7S^5XOG?GGHSWU;^\E
M?\S)KPUN[I3Y*/I_;A;N[9.Y^D\S9*+?;W_BRV^!WV5Q;7>-=O<MU/B7;UQ[
M+_CLXG_U_!^D*^JZ.]>_S>EO>F_%NW0F=A_P7Z$?87WUK[F7:5E1 047O )
M!+B.J#XQH'QFG4Y!U'M+BYT1,;W=-=*]!\/112$T<7$D:'>R']7//VWJ]7U$
MI$FQX..W5MG+7MWB<=N;&7^3L1^^\5:W4$T\33T]N-CR\>CJ$X:&U<EJT,.E
MGZEVM:>UOJ]*E#O(""V-Y[SVOQYM?,[TWIF8=O[7V_"+C,9BX#C'#&7-8"0Q
MKG$ES@T!H))( "#6/^?[Y0/Y;,9_D.4^XT326@GTB'FJ\L7,7#%GL_8V>AY
MWXS,6U[@,E:V%U",3$QW[ZD?<W4,/2:,&/PV%U3I<X#2THM;$M^?('N+<^Y_
M*5Q%DMV.FFR,-G>X^RO+@DR36%A?W%K9.->M&P1-8">T-#NPHK.UN*B!!%7Y
M_P#R\<>X?@OS \X9!N1W9R1E),$W#YS.7;[MN"LY<[CH76>(A-([:(L>\&@+
MCJ>-6EQ"+1*0'@O^)+AW_8?;W_DVW166D'T>V+Q?([N=_,EN*TM<SOCD'D3)
MV./S<S67$MIA[*&!UO;6LKM1C92<LHPT<QD8).D4+7*.U,+9\/\ TEFX-L;3
MM8<-MCF[C1NX\Q@+73#:_.-M<RL%RR%@#=9=9S.-.^61W>AV,X^;/(7F]3QO
MY9<!<20Y3GC+F/>-U YS)++9V'TWF;F#V]&.G8UELS50/\1S1U1$-O;*RM,;
M9VF.L+:.SL+"&.VLK2%H9'%#$T,C8QHZ!K6@  (A$_\ UOO"7\F>^/[G&_=B
M+<+0?SU^<K8OFIQ/'&/V?M?/;=DV9=Y*XOWYD6H;*V]CMV,$?N\TIJTPFM:=
MH1,11,GY6LD,-Y'..LN7!@Q7']U>%Y):!X$=Q)4D=1\55NFD3+#GW<-MT]T2
M[/D'QON'E:X\E<PQR92?,7DC7,T'KE+J)A_/59&T@^BG<L&DBF7#7\GMII;?
M+7TRQ]Y@G#=WG4\GVPP^L>VH\[O"^CZT&B$OMWN[1^J8XM;ZROJ>7_T]!J,S
MOI;\/]3VWXWQ"0=?/LP@(" @(" @(" @(" @(" @(" @(" @(" @((L\_F<5
MPQR;S%9<AVLVS\7O#>%UN7;&];ZV?%B\M!?P0.?&R\#/"$UN]KHRQQ#B*.&J
MI*^LTO\ N,FSV>,VQ28[8IVT[IVU8;9BV9C9BU_WC=^9O*[XN><O+'L[<[=K
M6&&M,/=[DLK1C3G6Q7%Q-XMOC;IIDOH8R[0'-@?U'HHJZS39&?9&1F9T9>9$
MUCMB*X4N[.RM*]SR:K+S,R8G+NFV8[:82NWC[Z4#=6 OAMWF[CELUY8O%ODK
MW&M?B\E"YOQC-8W1=$^0^@/A'J6EU')==IXXN&,RWOLFOR;?B>:-=J,K#,LX
MH[[?H_\ A(5QGYNN .5!;P8'?UGBLO<4#=OYXC&79>X5#&"<B*9WJAD>M5&=
M;,TG">Z<)>S(YCD9V$74GNG"5D>9OS69WRZY7&1LXK9N[;>3QC+N+<TV8GQL
M;KPRSM?8Q-CQ5ZQ[VQQ,DKXH-'BK0*./MT]N1?=;9F7S;==,1%+>*,=F/%'H
M6U.MMR+HB8G'M5/+/YI]P>8C+Y.%_%3-I[<QN.DN'[F@S%QDXQ>LE@8VQD9)
MBK%C'NCE=(/E":,Z-(.H1G1D1,VY=]UTQ-)K;PQAY>*?0C2ZVW43,6Q.#<A8
M'M$!!'A?^>B[L,K@L4<!Q9=G.ON(VY"VY.,EK:>[PF:MW)^#P\,/II8:&KNB
MV&7DZ.^RZ^,Z:6TK]2.V:?MO#_[#*_:M^-N5Q5OJ3D?96.W9(S!QOOI;B,LV
M[F/GW'_(2NB^3OO=;/6?9]H>$-)JWK2J\5_LZ_T[N*WOI3Y*SZ7JRLVW,MXK
M9B8\C(JHR" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(.$GQ'*)3" WS6_QPYWK_@3^F78N2^[9W.1]13_R
MUF[YT65\!\YWOM=L\E&^GVBN39OKSO=3R_4C<[.U+:2ZW3CF-=X8;. \]1TZ
M^A5B)NFD;5ZMH;ZW-W=BSL'AXCC%*U() ZTHNL\ATD9&1;$VTE\KSW6^SCZM
MSI6ES>69EBANI8)&>S+X3W-/3X"%L\_)MF=BO*]7.99MQ7/L_<=IALL9<M#[
M]97#7LG@>!(:N%-0#S2OK6IYMRJ-9E<,83&R7OT^NCBI=+2[G2TLX]U;TNL:
M',QV1?+<6C'4J&4: /9 'UES'4Z>_3YDY=^V&\MNB[&&P'$^[KZTX\L['&2>
MZV][$&7(9J8YP%.A+7 'KZ5]ATOR[+S(]K=%9:WF6J]CES-:+GM#=6L@?XDD
M$KO;#FN+7#X"%]KFV1,4AH^5ZB;YF9E?6UN2-T[*OWWF,R#YO>1IN8KA\DD;
MF^@MUM!^JM;J^59.KLX;K8\U/H;2[6SDWX[&'O,7NJ?>.*@RE[;PQ317<(B;
M%&&4!=4][N_UKX[GG)LO19476?#Y&QR-1;F[):R8W%#+[DP%H7:1+.T^BM!\
M!7RL16:0],I:,#N+8FU>-[NSO7-O,])"R/&P$,>&>P6DD.:"*'T%;_EO(<_-
MSHF^/J,&=GVV6UF:-5Y,E=RWGO1D=XH=J8031I'HZ]%TZS2669?#2*/E/_87
M79WU9K"2GA/);8Y-X^GQ^^)H'W6);%%CG.:TNZ= "9&R'[4=BY?S[ETY.?6V
M,)J^OT]W%;$RBB\UFW687E5N-MF!HG8]D+&  4,@ [ %H;899GN9[Q.[<5AN
M+\7MIEA'/G)(6&2[DC8_0*,(#75#ATJOL.1\@NNNC-S(P[(:_6ZNW+MG&DL<
M8Z[N;.YCN+>ZE@NXG![;B-[FR5!Z$.!!7WV?D6W6TI%'SW+M9=-\UELYP]R)
MCC?7>'Y N3?VEY$1C[R]/CB)Y![3*7D=E.@7QG/N31F6\>3;]:.Y]19FQ3&4
M=_FML(<?O.*VLWM>TR.$;V?%+?DZZ>@7PT6S;MVL\S"V>&;5L/(6#N[N,BQL
MQ!+<=G04/;7HL^GTV9J+HLLBLR3,6Q66Z7)>\X=VYIMQ:V[+:QM6B*U:U@94
M%K:EVDD'J"NI\BY5^#R:3MG:^6YKS".+ABZBW+#-9:PMI8;+(W-O!<-T2Q13
M2,:1T/8UP'<O5G::R^^MUL33R0]FFU5WLE[87>4#MLY[ 9QGSB9[9QQMU< 2
MOB<UKR?:D)(J2.P+Y?J7E'M+/:Y<1$QMH]VCU'%MG%'S>Q%V7R'MMZ3O^+7\
MTO@9>]V3#JDA:*]' 4]1[4K"6ZF-RF/L^,\+@[>VB==SR>-/<!C=0!8YM-70
M]J^TZ0T5;KLV?AL:KFN=P9>&UX.)O+S%9"&ZMKJ6"6!X<R2)[FNIWBH(/5?>
M:G+MS,N8F-KYWE>9?[;ZUR1G9W*W'V4Q6"M,[(9L[>L9$V:<,>UDKS0 EVIU
M1ZERW6<BSK+K[K(PCT/M>**;41GG,MF6^_=TP66F.UF$,C&L&D$$AP-!0=5H
MK(QQVK;<65/)MN?!;-XYW;?9&!EQ>9'&W%E8M<QKG-FGCE#'MU4II('4&JV?
M*=#=J]3;$;+9B9\TPIF7\%LRNG;N[\KMW<@SV-GECF%Q+,V'4[PW>)J^,P.%
M?C>E=/U.CLSLGV<QA1HM+JY]M..#9,>8CYUY*BW%N)IN-N7K0RZQ1%8H7%T3
M:QQ/D<QM&M<>GI7S&=TU9=I?9VQ'%';\?D;F[4?6HUB\^1VUDAMS<^W7L;C<
MHXSVS6AK:>(#(&$-:!4->%\/FY%V1?.7?&,,]TQ-&E&.LI[G=>UHJ:FRWT),
M?<-,T8ZCL6.HG@XQNMN<9;+LMX[G9"ZUCQT$=K"]C7ZYO#B?H:'- J #WK/I
M-%F:O,BRSS[B;XMK5'[G-UY7,;AR.<%[<12W$S7-?%(]GLL:&M'1Q[FCO77,
MG19>3E19%L4W-#^,NNS9B-B6_P O>4M]Q</87,Y)SLI/C7MLI1.?%H8[:"0C
MY35_C/2N7\_R?8ZRZ(BD3C\LMYE8VH@?/_C+.#F/;F5MHFV[KJ.]!\(!E--M
M8M%=(';7TK61L763Q?7\%KPGOD<?^Y1KJ'1'@7?:CT.6]=^+;]B?2EEYF(_F
MY\8#O\"^Z?\ A./7+^K?S5V^?F>?KSW5E;I^]8ASYO8),KCFO H+;ZWMO6OY
M;ZD[WL_2[\AF_P!R?NVNEPYF[K$MW!:V%Q+;27+86N?&YS#0.>>UI'<OM.F,
MFW,U7UHK3Z)=#U>9-F5-T?#%E"T>X7'B-<06'V7MZ&M00:^I=-S8^K1\QR_-
MF<[BJR=LGDS/[ RHR-I(;^W?3WBSN=4S7T#@/8+VM/5U>JT>NY1E:ZRET17L
MGX0W]VK]E=CVO \X.:V9N[:FWLYB6!MX)V.EHU@<Q[#+I:2T$]: ]JYSKN6Y
MFCOX;MG8]^7FQF6UA'&]C3E<9(\$ N<?$=W58[O7AKA*R1:+=>4L\(W#V4C;
M6RD:6SEFICGU)(ZM< ::CVA=#Z?Y/DVY=N=2MT_3/D:GF>K]E9.*SWL(-&'4
M9!J+O6?2OL[HCAIW/D=%?==G\==LI2-H<\[9VKPGMFP!=D73^]VN4A:&N?#K
ME<QI=J<T4-3Z5ROF')L[-U69V12L?$Z%9FQ-J%WGG)8[-\I[SO<,VMMHN#1H
M %3,2.@]17STVS;-)VK0S%Y/W6$>#O,GDK@MCA+_ !3JZD-GF%!4'T463)T]
M^?=PV1B3*^.2-Q8O.YV6;!VWNF/CJR-H:UA<=1(+M'0]"NH<AY1&DRL?6G:^
M;YMK<8MMEG/RT\G;?VKF1@]\N?\ @_D',;XXTD1DEY)]LD"I([&K6]1<GG4V
M\>7'UH;3E^?Q9>,NC](O@]E-V-%G]EF*:TOYXW07L36!KJQW'0%K&'N"YY[.
M[*OX;]L;6RF:PC]\JOS):[]VC>;A@9+;1R2NO&R-:XZ? EI\8$=M%DLRYS+X
MMMQF58PAM!NO<YGW7?9+;M_<V=D)P^Q9'*YE-)!'Q"!VCN75M!H;,O3VV76Q
ML[FFS=5,9E(EU\EO?=N4O+:\O\]>W$UNUK8M5S,X4:*4.IY[E>SE^1;;-L6Q
M2=N$?0R9NIG">QG.XW%L/=_'=O;Y-T$6X6ET5]!H8#*QVL?F7$]*#J5\+S3D
M&=EYLSEQ]2E7ORLZV^,)JBRWKC['';LS5IBXQ'9LFD C:  T!Y[F@#\A?.3%
M)I+.Z.VW,9N' R21:VQRM(80"#25IK0K-I\N,R^+9[91,T;JY[=>9SMO;V4U
MV\6-BP,M+74_0QK>@ ;J('3T!=:Y9RO*TF7$61V>?T/D^9<RFZML3L>-C[RZ
MMSXEK<2V\I((=&]S*EOITD+UZC*MOVQ$[U^6:BZ+=K8]G*-EG>.YMM92,39?
M&VC:7=RT2.<R-@:6M<YSG=75*Y[S_E$9-<ZV,)E])E7Q*,G0V?>(EB :SWCX
MK>@'7T!?*3L4UG@W[DMGE7Z<G;2IUI&/L-7S^5XOG?GCHWWU;^\E?\S))X:W
M<2*'PH^G]N%N[MD[GZ3S-DHN-O?^++;X'?97%M=XUV]RW4^)=O7'LKKS9Q/3
MK_I^#](5]5T=Z]_F]+?=-Q_6NW0F<A<VL3:^UH!I]1??0^XEVU940$%"62&)
MLLLK@QL;2Y[SV  5)4531:LF\,%)ICLLE'<W#W:(XVZJEWH%0%-)1&+7[#^9
MC;N0PVY\]D,;D,!!MJ=UK+;W9C'BR^*86!H8]P]MPZ5HK19$DQ,+:W#SSF,I
ML'?$5MBK[;V[K+&RW6'M+@-CFT 5$K#%*2!7O!"6VQM3,,>^5W.8_%[@EP.[
M\1!'R;D[*WRM]G;>&-AFM;T"2!DDCZS.<T5)J:>A6O@B4A=L7R$2586$&KFC
MM6.$3M=Y 08SYCXNPG-7&>[>+]QWMYCL-N^U9;7E]CW,;<Q>%-'.QT9D8]E0
M^-M:M-0A".'^J"X2_E,WQ_=8W[C1;B>]MOZ)3R\XG+6U_G-U;SW58V[@]^#N
M+NTM8)Z'XDTEK:QS:2.A\.1COSR'$DVP."P^U\+B=N;>QMOA\%@K2&PP^*M6
M".&WMH&".**-H[&M:  BKUD!!HE](YE<8?)]S)CAD;4Y"NWA[@)F>-4;@QCC
M\G75\7KV=B)MVMC. \ECKSACB.WM+^VNI[?9&WQ<00RL>^,C'0 ZFM)(Z].J
M$M'OH[-P83CBPYU\N^Y\C98+>7&W(F5N(<7=2-M77&,N(XH8I[=DK@9&!UJY
MVIM0&/C)Z.!)-ST=D9>PYI^D<W7OC:-Y%F=G\'\;Q[4R&X[0MFLY<K=W4LON
MT<S*M<6^]3@D'MB<.Q#L25&UMC<-O#;Q&[8PQ-NBQOB!A-2T/I6E>M*HJKH-
M(/ZN+R8_R-__ .P[B_\ .:)XI1C?24^6?A+@#"<2WG$FROP2N-S7V7ASDGSE
MDK_QV6L5JZ$4O[JX#-)D=\0"M>M>B+6S5(=Q5DCB?HUK&_:XLEBXFR[('MI5
MLDMM=1QNZ].CG K%G32R=TO'KKN')OG_ *9]#8#RDXYN+\MO#MLT- EV]#>4
M:7.%;Q[[D]7=:UEZCL![.BC3Q3+C<Q\MMIIK-S 6VO\ TP^D?Y$OI'&6#B?C
M&QQ$!ZT9<9&2WO&MZ]"/#O93T[_75?39G]/E5D?MWS/Q5CYH9XQS-T)!U\^S
M" @(" @(" @(" @(" @(" @(" @(" @(" @TV\T?+6Q?P%W=Q['?Y"XW?;Y#
M!F7$V^'RDXI!E+&\D+9XK5T+M,+2XT>>RG;T6XY7I,SVEN92.&DXUCNF.^NU
MCS+HI1L3L7E'9')/SI^!V4N,E\R^!\X^\8Z_L-'O/B>%I]]MX-=?"=716E.M
M*BNOS]+F9%..*5\L3Z)E>+HG8ZW(?#W%W+%E[AR-L3#[MC;&Z*"YOK9INH&N
M[?=[IFF>$GTQO:5.GUF=IYKEW3'P[MB+K8G:CKY/^BUV=?FYR/#6_+_9=VXE
M\>W,X#DL<3UI''.W3<1-[.K_ !CV^GIM+N;Y6ICAU>3;?Y8PN^/Z)AX\_E^5
MF[8^&_:UQXX\N?(^,W[O'CSF/>%ZR#86+M+:UQ^!RDSH[BTS;)JQPW+@V6"W
MDCB<)8F",R= _P!D4/IT^AT63$9^1;-U9PX\>"G[,=]>W&G8PZ7E]N5=-9F>
MZO9N>IO??6Z?)?R!MS?&QLJ_<V%WAB+K"WFW]SS3WQ8VQ=;NB:)V/CF>R(.;
MX6M[C'[;1[+Z"FIY3.LB<S3VVQF1./\ EMNB:XS_ -43V]O::FR_*NC,R8BN
MR8GMC_![V/\ I7]VQB/YUXQP-V1J\;W6ZO+;5VZ=.ML]*=*]M?4M?/(.91_^
M.V?WH88UNKC;EQ\:]<=]+-BWZ69/AIS"&'Q)[;/DU=ZHY,:V@_MRL<\FYE&W
M(_\ JM^E?_V&?&W)^*Z%ZV'TJW%DH!R7'>X+0Z 7"VN;.XH_I5HUN@J/7^0J
M3RO71A.1=\D_.F.9W=N5=\C#L&*\QO/!Q7-F7Y@N]A9:X?/EN-MK8_WMMOCK
M.\C+(0YUO<6[6>)"0"1&]SV'Y4OJYBW&7R[*R++LK,FZZZZG%,32DQ-:6X3L
MGMG:RV:;,S(XK[YB9[II$;OABD?\JO)6\N2^*_>>1;:.'?FS\U?[6W7<0AK8
MKJZQKF4N6-91H\2.1A): TFKFAK2 -)J]+.FS."9K&V)[XG9Y^R?+#U:>;^&
ME^V)I7O\K9)>9G$! 0$'A;FBW--A+V/9U]B\;N-WA_-U[F;6:]L64D:9?%M[
M>XM9'UCU!NF5M'$$U +3%U:8;5,SBX?JTKY<8^9KAA=P^97,[WWQLMNZ.,[>
M794&)GER!VUF7-N/G6.>1H:SY_!;X?@T/4UKW+!$YDS,5C#R3]+PV7ZFZ^ZR
MMF%.R>W]YM1$)1%&)W-=,&CQG,!:TNI[1:"20*]@)*]#8PJ(""A=1SRVMS%:
MW M;J2)[;:Z+!((Y"TAKRPD!VD]:5ZHB=C5+,1\]8ODC8VPV\TXV:'=^&S^5
MDR1VG;-= <+)C8VQB/WPAPD]_))J*:>^O3SSQQ=$<6VO8U]WMXS+;..,8F?5
M[J>7RMGL%:9:QQ%A:9W+LSV7@B#;_,1VS;-MQ)4U>+=KWB/X XK/%:8O?9$Q
M%)FLO64K" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @X2?$=\"B4QM0'>:S^.#/?K!_3+L7)?=LN1]1>]K-WSHLKYX;D;\TZ^-)3
M^Z*Y-F^O.]U/*]2-SGA;TX[,6.0)HQDHU]BOI\SV>;;?/9*U*Q+9K$Y=^.G9
M>VP$HDC/;3[8>L%=ET6;;G95MT3A1\-SC3W79E([U&25\L\MPZC7S.U$=%GO
M^M@MIH]C#KN:XNH!5KC7UJL3"]^7=QQ,,*<T6SW6,#FL&@P.J?2*KG755/;Q
MN?5Z2O!%7'@M]W/MF6.0UBMW'P*@#KK/J7KZ1U$VWW63LH\7-LCVN71G*(RO
M<WQGZRT4[A]A?=WSW-'H<C@PE4E;XG354!4LNX=KU:G31G4B)6OR+MN]EV8Z
M^D@+;,SQF&8UZT]"^/ZLU-DY,6=M6UY?I9R882X]LS=;SM&AFHV3!+3KW@A?
M(<LRXOU%D3WME?L;+R==-:N:WH :KKNGBVD/FN8\=\3$.H&/?(2!I;Z%Z[[X
MB&BTNDS(OJOS ;HS6+MAB["<LMKJ>)TL0#:DQO#AU+2[M]!6EU>19?6^>Z7V
M>DS*6Q#6[GC=&3RO*EM=7S1KQH<'-.GL:\'N:%RC.BF9-.R6PG:R;:77OME:
MW+1J8^)A(_M0NM\HS>+3V3Y(]#YCFV7=,X.X*>(US?9[P/4MA?-8H\>CRHLF
MLNR7=6T-3VM/90K!/U6XF_BI1KKSKBKOWK 9"9K_  WAYUO!%:N:._X%S?J.
M+;=1]5MLF)FW$V#)[GG[%C6U]^@B:X^C2VJQ]/7\.JCRF?'U)9^FBJ?JKK&5
M=2'Q.MTTWW5=N(4CIZ%@OVMOI8IET=2XU"SNWM;5W@O/3U K7\SOBW3WU[8>
MC19<\56I[6^+<WTKA0F9_3ZJY#.$X-Z]#PS(ZV:>E7  _542EM%98Z6UP&':
M_7IDA:X/TFG?TJNC=)WTT\[VGYII9SK8CRJL5NUAU@U=Z"OJ9SINP:O(Y=;E
M36KT[5L]Q=6MG;2%LTTC60FO8\F@HO/F4BV9EMK,RLT:O<XPY6VW5FH,O,9Y
MFP6[6D@#H!T[ .Y<CUF9;?G73;%,9;.W8NO@&QOYMH9!S8G26ML]A>X#L #S
M7H/15;WI?-BW4S$[9CZ'GU5LW631F.-I8\DFOY8]"Z-?=@T6DR9MOFKL%P)=
MW]*NKZO0L,5C:V%UTW16%H\N[8RV?XR9E)&O?CL1=.-O(YI JX1LT@BE:!P7
MPG55ED9EMUNV7OTU9MQ82V);NR?).R;4=1->Q$CTAL\0_+7R4['HJD=YTARU
MC+@\=)<N.)99VHM[8  "30\=H%3[(IU*^_Z7MLC*K'K=_P 3QZFV;[:0UY;#
M1VHG5J[1V$?47UUV9@T^5H9LNK,MW/+!R+88C#Y;95Y<^[W%U=RWMJ]Y 8[7
M';0AE7=!^IDKX?JG0W9LVYML;(IZ9^=O=//#%$>?G7R.4O.6\/!,XO@ N3"^
M@I3P;0FA 7Q5NQGG:[O&%?P4NJ]NLU_8F+J'1'@7?:CT0Y?UUXL?8GTI8.9?
MZ._&/ZQ>_P"<8]<PZM_-7;Y^9YNO/=65NG[UB'WFBIS%B--:VI'_  WK7<NF
MF7.][/TN_(9G]S^&U;W$.#NLON:6"VJ6"-SIP/SL4KA^2%]#RG5SIM3;=\-D
MND9V7%]LQ+,;8A$^AZ'[;TD^L=RZY[6;]SYZW2V9%ZJZ1I(':#TT^BGK5;8E
MZ+[[9GO6_P H;9ENN,/GEH_>]OD8O#-2:TCF=Z?SJ^ ZLS.+-LCR-MIK8MM:
M@7$39LEB;<-U22, :WUACB?L+Y/:SRW<DB;"!:R-HZ$4(]9ZKKO*K)RM/9;W
M?3+3:ZR,S"BBUC6>T3TK5;6;INP:G*T^7E35<&,NYV.=;13%D5TTL?#T<"3T
M%*UIV]RU6OR_Z5TTQI/H;[2YMMU(AJ1G\>^/=>_&3$MF@GF;0^@:?RUR3,FM
MTME2B^^"99F[7OXRYS6>(X1TZ _+RUZKZWI6)]I=AW?.\V?6;)94EBJX^U0#
ML:ND6WX4?$:K33-\S,N["YK6-IU(7FS+*[6ZT>9&79$58]YLR>=O]BPV;[MU
MQC+>^A:R$AOL^S)W@5[">TKX/JG(LRXMFV,9V_*W>GSIOA@+;>9.WLQ@[QE?
M#8\MD8/MM;"T#L/>Y?+Z//\ 89UM_=+T9MLS;@VS;XWB-KT+@'$$4[5V7*S+
M;\N+H[GQV9EWVYV+O/JYE >O911$TE[\V)NLP5<?!<W%S## #++(]HBC'2IJ
M .SUK'J9MX)KLHGEV7F1+6#DK%7>W][Y:"[B,=Q=-\4Q]30O<3WKC^LMMC.N
MX=E9?1P\7 1OGS.&:P5)D:[X*2-4Z'Q[=\>E&9&#:IS'-<0>S[8#O^JNRY>9
M]6-SXS5:.9S)\KG$*$BM'#O4WUHS:2EE;7F;GFO;?;V1N+.H<V$M>6@'H>\]
M"OE>ILW@TU([9H^@TD3+6S;8+\K:RNZN=+5Q]=5S:[8SZV*9%^Y+CY633D[:
ME/\ %C[#5H,KQ?._._1GOFW]Y*_YF#7AG=Q/?%'^G"W=VR=S])YFR47&WO\
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M.WBCS+IL//IY6;XAC^2)+"1SPQC+K#Y9H->\O9:/8!^B<%,:O+[V2.<:6?\
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M5C! !'>2N<\ZYM.LOX8GZD;&^RK."*2BKL+=MGN-MN!1K+DAOP:EI+MC'K/
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MFYTXOS7#VY[_ &%9\AW&8%]AXHXK@8MME9Z[B3%SW'B&)\K)=,8<UQB)+V.
M:U@^BT^HR^894_B<NV^[+I29VX]]-L=_9/;':\F9I;)OBZF*U^8>-(>/-CW.
MX<1R'NC%[<@W!C,IOB*]OY,E,3/D8&S9:QDGU2PW\;GB0/C>W6 YA!U)GZ#+
MYA'LYLB+XCZET1PS%(PC#_+V>3:IJM+;?ETC#9CYW3QUY]'-EIC=;XYVY%WA
M<L<V21VY&9B5LKR27:?<\9K [:U?7VNT]VGGI/5=MLS^];]+Q1RS3SZUUUV^
M?\&>MKW'T7.,-<=?[6N98 TR29N3,W(>33KIR.IAKIZAK:#T"JI__-ZBW_\
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MK]#89N,Q'E2#+0,P@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\L3)712,EH[1H+ 35>WF>DLS8NS\N9K&,Q/=LK$_%6%;:VTB6^J^?9! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$!! ;L%QB^D0V\8G.CU9.^\0OH*_O:][**THC8FSY"P&/W3L7=N
M%OHQ+;7>'OH712?%#I+:1H?TKU&I1 @S\AL4FR_-AOC:>.<Z"PN<B['OT_$=
M';MNGM /3L/J4]Z9V0L/:N\+;R]>=#*9[D6U?8V)8;:2X> S0+B2!P=6=\
M#14FJ=IMAD[Z0?S*<,<S;.P&'V/=RYC.65YXTMU"ZTD@;'IH!JAN9'5K^=24
MQ&+R_-%F;F?@/@G%3$F/+PRMN"[T"^TT[?0IE6$P/EPPV/M?+UQ;8,@T61VM
MC1<,[GD0L_L*LB)[R=AF$\Z&[L79L_>5Q+<RR4])8X_EJ9.R$\A>&ANIGL@^
MR/0%5+L AP!'84'U 0<7_%*B4QM0&>;"OXX\[^LG[*[%R7W9.YR+J+WO9N^=
M%I>2.ARUS*R/Q'Q73WM%*CV7DT*Y-F^O.]U3*]2-S-&U>;IK#(XNTW#B(78F
M MTW,+7&2 @_&&N5K1]58YQ72"Y?S;[:Q^$VKK;'E["\C$<]S'H>^'11K:_O
MAK13ZJB83#-6,YGQ^7P=AD-M7<-S&3\I5P):*=^AY^RDPF%V<G>8W&[8V!'<
MWEQ%'< ,-"6^(2!TT@RA1$8%<4/W,?,=GRQDW9+WF\N+^SJ^RU",@'N!I(\J
M8A$S5:& YYY+Q][:RGW>9UDUL=G&\RES0P:>P$=P4S"(ELQQ/YB-R9?<3\/N
MMOB09R9HB<T$B)[J-%-<@H/J%1*>VK/7,WF=O^-L?^!NWV"XOW,8^6<#4&M>
M*CJV9IZ_H4I@8M ][<[;VWI#=8FYQK)X,@ZCM3)/9)Z4;\H?R4B*"_/+%B^4
M^%-YVV]K)MJRRR3F-OL&_P!X\5]OJ\34(_#8#J];Z*;L2V:)EI?,UMC!V&/W
M+D\;-%:3!C;KQ(XP^&1_3L-P !TKU*I%L]JSO;C\P#<I98K-;2N(+BPOY0T/
MD=VFCB:^'(X4Z>E6LMXJP5A:&<\S6U<-G+:PN\A;V^7CM3)*'/8(_$,6H UF
M#J5]2K%E$3-816^8JWY'YMW>-[2Y3%7]CB)#-;XVUEN'R.B82\49X3Q7N^.K
M1@B6R_!',>$M./LQE&LFNW[/9;6^5QX$9>'-/A'2T2CL+3VD),5*XMNMI^:K
M:^^]DW+]I2>[9"<.'N-QX;9&N(( TQSR&JK$8)EC+D'S,VNPMM7 R,PN=P3=
M8K8:7.#213HZ9CO2IH(\>5O-CNS>>!L<98VGNTL<3A<2O:YOMD].HF?W>I3$
M(F6!ME[D>Z9\F4O&-GFE,D\#G4:XN-2>M#U*F81"4+@7-8R>QQ]_AK]ER^V%
M;FR+FET3@]U.C2:5 KU*BB:LT9K>CLR,K#?PV]C';AWAW!U->2'4)ZN([%$)
MF& 6<L;$LILG9;;N8<CN/%1O+_:C<Z6;27L# R2IZ=#T"0B48W*F7WKNS>&1
MW-NK&7=M))*YD#7Q/:UK&O<YH]NO0:CWJZ)7;L#FP[8RV%O,OA0Z3#U;!E+9
MA=+H=V@F29C>R@[%":KFWEY@=RY;>\FY-J9:XM\?,!))82$ %^JIJV-SQV?G
MDF");J\.<SVW)D%G',!%N;%QZIV&@UAH))_5'N-&MKV!5I5-:+(YV\W6=MLQ
M+M_;+!,W&QF*]D<"6^*-0(!9,>G4=H2(*S#0W,;_ -S[VGNL;N"*W-CEI?E)
MQXFJ(:M51J) _)5H5;F^7/S#8#RU0P[3L]R7>7QTYCAGMW/@?$&A_P 44DA/
M4/*3$)B>Q)S;\_19C:0R>WR/>LA#'=0MZ4I-H?0Z97'H"J46[5?<'F>P>QMF
MMRNZKYIGH]GN^IE'R4D<UM'S1DU#:=J4E-8F6FOF'\SF;WYQ5%9\4X:3,LS(
M9/F([2)TLD#W&&4M<(9GAM'"G6JF(5F43_'.4Y&VER=MS=^#P=]/N##SLFO+
M9L,CB8V/C<6N:TAWM,;TZA7PE6)I*;[=/G8=@N/-K;WN-M2LS<XM[3<6$N(-
M,T<C;82ROCC][!IXA+07.^$+'3%>N#U[#S98CEK"Q1[:R#\?E7M);CIC&R<$
M%S2 R.:;\S7M[U%#8P;RYYI\CQ]@H\%&793=]N=5S9W U:*!T9#@V9CQ1S#W
M*RO;5H_RCNBR\R>3Q>:RN<.V]TXN,LML7<O9#:2N<R)E&=9Y":6X^J?K6P)<
M-M8/*[?Q60QF9C\&[BDDH6Z@UX:QC:MUM:2"0>Y=0Z)\"[[4>B'+NNI_JQ]B
M?2D\YG+SY<N+S0:?!OJ]O\)QZYCU;^:GX=SS]=^Z\K=/WK$4'*F4VWB+VQN<
MGCGY3*>#IM('-:Z$-U.()]MCOC#N]*UO+O4G>]7Z6_D,W^Y/W;5FXCF3=&#;
M,=M8JSV\RXB$<DML)FR.:06^U5[AV./UUL*5=/JNKC?F?=&T6S8N^N&9#$Y=
MS8[V-Y<YK6.]AQ^,S[4E3;/#-8[,?B*MI=X<N9/BSC_"Q;6N8P[=WB7C2UQ(
MBUB&:GLN;3H\CO7KUNJ_$W1,]D1'Q(C!I9B>0KV*WEP.Y8/GC#9!P$AG!<(G
M$:-8]I@% X]J\<11-5MW?%=GN[,.RUEEFX';%N2Z7(ZQ''&YQ=[ =X<C:C4T
M4)4UP5HV&R_-S,+L.'C_  F5O<_-;R,?!FIO">87,D=(/#='(.A+^M6=RBBU
M99'XN\QFY<V<%Q_O67W[&WLD=JR^?4N8" VI+I !V?F5-M\V8VX2C:\'S5[Y
MS=ONJ#:&+O7-QN 9;S6\T1KJ,D44PZ]G0GT**S=C*6O6=R>:Y5PF.VRVR%QG
MG/;%)?EKR"RAJ7N:7FM3^94U11MKQ)REFO+;L:^VA?;RM[]YB+\;8VD_B.BF
M>]\SM37B"G5X[ 56;83689YXB\]M[F[;\'=_7'N\EQ\G:WK:!C@X-:*NEN.V
MI/8U11:K)V<Y89QKB\AN&_OI6VF7B>['NJS5(.T:-3V CVQV%11'%,HU^2?,
MUO+<#<C!B620P33ZF7+FD.<-)':V1X[U,03=+!^W8CNPW6=W_N"YLF8IPGMW
ML<P2%Q=HHP2MH>[O[%>582"[,\\CMNX+ ;4+,CF+?'S0L=D[N.)Q$0=0NU,N
M6BH!Z>RJ<*W$V?P_FHPEIG<5E+G.328V_#9/!#H3HU-)HX&8 =OI6TTO)L_5
M63?9$4C?]#%F:B,O:]3E/SX[6L-R8K;>)>V8ZHI+FZ^3,48!;7VFW51T-?BK
M5\$V3,7;6:9KC"-KS3Y[>_/&<DW?)FL;=;6PSAX&/MI9G2!C!X8.G0]M345]
MM6A7LHUYVSG[?C2ZD:,-X^X8*>'>EA+6AU'#KK8?1W).*$A7 WFFFW#@KS:>
MX+Y]CF)7!ME*"UH( ;T!?*3W'[55HF&6IN9QQ9MK*7.X,DZ:YG!=;P2EOB.(
MU.:&ASXZ@U"42P_B?._+E]K;JL67-M@\]-.]F$EN#X48CTMH7'QWN[:]@*M;
M&"):,#8FZMR;@GW+=;BP^?O[B82R,L[B::6E>E08!V#UJLQ2'FULUR+]R0?R
MO,+.4-K->"UXCTGT@^R*K0Y?B^=^>.BKHGG%M/*E>\RHT\+[L]HN(AC]H]I]
ML+=]DOTEF;)W(QMNBF)MB!4T=T^JN5ZRS^M=O<JU,_U;M[IQ[8&[^2^-,%\\
MW^#-]F8XCE,?X?C0ZV$:F^('"H]87T72T1%]_F;_ *;K&?=NA+YQEL8[!Q+,
M.=R9+<I-2+[)^'XI_8VM'Y"^SF<7W,XLGH@0$! 0$! 0$! 06KOC>FW>.MH;
MCWUNR^&-VYM6PFR.7O"-1;#"W40QHZN>XT:UHZN<0!U*"&?/?3%S-RMVS;'!
M;)L(QY;8W&4SACNI6 ]'R10V<C(R1]J'OI^:*+\+R1],7N9Q#6\#8TDF@ S\
MU2?\A0X4O' ?)N0YDXAV3R9E=N':60W9:S7%SMTROF]V,5S+ !XCXXG'4(P[
MJP=OU45EF!$" @(" @("#!/F8YCN> .$MZ\MV>!BW-<;2^;?#P<UPZU9/[_D
MK6P-9FLD+= N"_XIK2G?5$Q%7YW?-GYR\UYN;/8N(N..8=I2[-N;^XMQ97TF
M0?<F]CA:X%AMX2W0(*]*]OJ43,1C*V%L5F6\GEBW7M>UY3\IK\SN7$X>RV-P
MM/'EKJ]NX;9MMD+B[R<3K6=\SVM9)X<K'!GQNOH7CF^V<Z)K%*-%G9UDZ^V>
M**1;W[VUO*3!NGZ0CRZ;?)$UKL+9>9W/=Q  Z'WC;VUC)((H1)#$[ZW3K5?6
M:7^GRS.N_:NB/BI/TMI=CF0D'6@9A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!JYYI]D<<[UVKMZ'>V5W)M?
M.8G(NO-B;TVKB<GE<CC+UK*2.T8RVN7".1GLO;(&M=TH=0%,V3K;]+=Q6SMP
MF*5B8[IAY=5-L1$S,Q/9,1,^B)P:+\*<2\:\W/LIN>^0=\<KY&YO\S@]L;7?
MM?-X/#6AL[ZYQ\5]+=VEHRW\>2*W$A,DK/"<XQ2ZGM*VNMYOFY.;%F52S"V<
M(G'BMB[&;JX5G9\=7FLOC,NB+[IGNB+9B///^.&R68)/*CS]Y?3-E/*7S!/D
ML )737'#V]BRXLI XZBVVG(;&USB>T-A=0>U,>Q9XYII]9'#J[,?V[=OG^$[
MGK]E=;ZLJFV/I!HMI9R/8WFCXMS/#&[HZ-DRT,$MWBIP.AG8RAF;&3T:8C.T
M_FUAS^27S;[33W1FV>3UHWQ]&/D4_$7687V^>/HV_%5OOLOD'8_(V)9G-B;K
MQ>Z\6\#5=8VY9/X9<*ALK&G5&[\Z\ CT+1SA,Q.V&?+S;,R*VS5>",@@(" @
M(""U-[;YVEQQMK);OWOGK3;>W,4S7>9.\?I:"?BL8T5<][CT:QH+G'H 2LN3
MD7YU\661691,Q&,HQ;3>7-GF3Y0O.=.)N(/]U> P;MKXHYV^;C,EN2 7AN#/
M8^,3;M=#(74#G".FIKI2^C6?41EZ?0949.;F?7F:S2*Q;AV]OS^1ABZ;IK$8
M.W9<>^8CS X?:?(7'<F*X:Q^UKH;BV)?9^2WREUE<G$);6/Q(;9MU%;01L?,
M"9 ]Q<6GP^FIK-U>ETMUV7F5OKA=3"D;>VE9V?2F>*^*Q@R%C_.3R1PY?6FV
M_-]P_D-F,D>V"UY5VQ$[(X&Y-:>)*R-\IC)%'%L<CY.OZBSL7DNY/E:F.+29
MD7?]-V%WP^3RGM9M]:&\VQ^0]C\EX2/<6P=U8W=F&D.DWN-G;,(W]OARM!U1
MO'>UX#AZ%H\_3YF1=PYELQ/E98NB=B\EA2(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#\_6V<WB<'Y_
M,7D<U?QXVR@R-X9;V1KGM8/ O!6C03VD#L5T=B3CGKS8<0[#XZW0^+=4>0SF
M0Q=W:8NRMX+NKY9[>5D;M8MWL%'T^,0HH;4=_P!&ULC<NYN4]Z<Q9G%RVN+N
M)&75E/,6U?*\SL> T.#NR0==%#W(F4F/(.V_+%R/E[RSWL,==9K'T;>U;-;2
MMJVHU2-8W5T]93%&")/SLR\/1G;_  ]P%@(K_-23&ZN[J!LI<:!S'1:[F)HZ
M:*U#Z)*;>]E[SQ\:97:W"'&D[+%THVO9LDN7QZ3H?+.)0*!SOR*HB-K:_P N
MWF?XUL?+#M'+9G-1P7>S\#8V.7LG,GU^-##&UX ; :T+OM0X>M*&QI=Y K6X
MWYYC=^\CVL#SA[:XD$%PYA:US) ]K2TNT$]GYE$RG3B))<)2':C6(4^U^HJC
ML@4Z! 0$'%_1I/H42F-J WS7=>8L]T_P)_3+L7)?=L[G(^HO>UF[YT6]\6MR
M-]7OGDH/[8KD^;Z\[W4\KU(W*/QZM>T:CT:"*K&NJ-C=H;&Y[Y8FFL<>LAK?
MJ5HE1G?@O<F1Q^^\'BQ<2NQF0NHHKFS+B6Z2>O;7\A5E)SUN&^S._,O9>]R-
MQ-F6LM[,DZ12H]2F91$,'P6%NPF5C"UQZO()"5':@M&6\CY8WZ@ZA%0:^OM2
MHR1QR62[RP1+O";[S$23U^V293"[^=I7R<BY(./B-]TM@UQ] ;Z"H&$@R:.9
MTD;M+@=3#3T*45=J_P KNRY,$C<W-[%&-T.TZ6@=!T<$H.X[.;O?CSCKW/S7
M=I(YI="ZO=V=2XH-MO+%N^\-YFMNY6Y?=6,&-?-80.J?#E\6)H<#0GL)[U-M
MLS-([2E6M.^KV]R.Z<]/<WLKW&[F9'('N!:UDC@!T/HZ*;K>&2BZ^!-LW^5S
M>9S5[FI;;"X*V?<7K9I7/:61EKG -\2IJ/0TJNU-7F[TY"CNKJ_V[LF/YJP)
MF>,C)&*&[>'U).IC'BA!/5$*G$N7N<1OW:0MKQ]O:296U;=-J0QT9E;J!;\"
M$0O'S*7TMQR=*?%+[7YNM7QL!]GV@[K1)PE+7ES&$.D=\J/M>ZGU%-4.@Z"-
MQUCY.3N()_*45%Z;+WCN#:.4M+G$WTT(,S#<QA]0X ^AU1V)*8;><^[^S8V#
MLZ[QEP;)V;M8GWT[-)+GOC+G5H ?K(-"GWEY!.ZX@O98;]AJ;AKG N)]-#U^
MJB*KMQG*>?L7P19>WBS5ET#[=\<(<[N)UN8XBJ)6K>7#;VZFNHK46\<SR]L)
M((;7K3N1"@00\.$8T_;%I#>OP!*C8+RXY1N.Y*L&>.Z"*>VNVN<-1U$VT@ (
M />4C:+$Y!:6;VW/&06$W\K=1-:FJ)E94$!:[4]]:$^R!3\E$.M-CXWW;9XW
M>UJ!<'5)'9WE"C<?RIY;<,_)./L;B_?/A;>$>/"\AS&L#'@#223V@=@4=IV,
M+<G;[R>_=Q9"YN+F3YK<]IM+*M&L&AH[ &]]>Y3M)P61@=UYO9EVZXPF0?%)
MV"W=[<9;V %K]3?R$(A?.Z>5LA?&)^#MX<3<W3'C)7#88BXN%&QT/AM(]GT%
M,"88T^>,]EGO9DLC+<-%=37$Z":]3IK3O3 HOSC:_EQF\L%,R>2%IN8VN=&Y
MS009&CL:DD,A>9&42<L9N5AUMDC>X./YDW4]#U40F9:_>#)%<P7\4M)K9XDC
M+>E""#^4ID;)XS<]WNC!,N[Y@%S:Q>"Z2C07$-#B3I [W+J/14UR)^U'HAR[
MKJ/ZL?8GTI(^97-=Y=N,&L=4>!?>**=G[YL*=JYAU;^:GX=SS]=^ZLK=/WK$
M/_,[(W9G%ZF:ZP"I[*#6]:[EWASO>O\ 2[\AF?W/X;6*&M+32G1P CZ]P6P=
M-5XV^'$]W82-(;ZR$@;0\KF.7B_C&Y<VKVVTD;QWD,@M0.JK UCN&>(6,:.M
M/C>DJ1V9KK(LQ3L6V=PL7NURVS?9U..GO'P!!0Q]J( Z20T/0 'K0]5(N_;7
MBLW!@YHR3)%=L<"#2I"A,,P^9)L4F_'O<WPWOQ]@9 #4U]SA[2/2E4, X^XO
ML=(+G&W!M9:_''4T^J@\^<W=WD'RW$[YG.(+GR$N[NO:4'JQ2-;*Q_5IA<'1
MEO0].SL0;0\Y9VXRFQ^,&.N7^$+>9IB))J6Q0=O97L4)F*-7I*%C@\!S3\6G
M2BE#J&W#[=\'4B3XIKTK6O4=Z)=NWB\*%K"6NJ/;( '5*HHS+M2V=/LJ^NIB
MYTEK.X02EWQ1J H.J^GZ>U5]D9EM<*/)J\CVE&',HZ2>:2Z,CGW6JCG.))Z=
MG4KYO,OFZZ9EZHC!U8;C(Q6TK8K^6..3_I$)+BUP^"M.U4HFKJ7.NXN732$R
MO> ))7'MH*#M2H]3;TXQ>=QE\R1T?NLFI[FDBOLD=WPH-C?-;?SW.[\0T3.%
MDZPMW-B!HTDVT)/0>M.U+4J6!CXW@C2\&K:&E1]12BCN;<N<CCLW8RV5]*T%
MX#@'N /=V$JMVR7FUG@7[DJGE=Z\H;5<\%SM (%>TT:M!E^+YWYXZ+]\6T\J
M6'S+5/#&["YN@F*.K>VGMCT+=6]K])YOJRC+V\ ,/;$]@:ZOUUSC4V5SKM[E
M&JG^I=O>WL[2>9N)GAOL?/T'3LK[#EO>G<OAOO\ ,W_3%U<Z[="8ZU<U_AZ/
MBM;[0([.GI*^JMA]W,N^K($! 0$! 0$! 0$&EOTAUK?7GDXYHBQT<DMPRVP\
M\C8C1P@@S>/EN''J/9;$QY=ZJHFW:T'V9Q5QEEOHL=Q[NVWLK!WN_?FG)7^?
MW5)8P2Y6.YQ^;<Z?]]&-TL8CM(@&AI T=?MG$EJXK%R&;\I6Z/HZ;&UO+K9N
M.YKVUC(X+2SB;9VNZG9JUO2QKBQC1=3PS1/JYY#HRP]2',]D8U2D^1'?FY>1
M_*KQ3N3=MS-?YMEK?8J;*W!K)=PXJ_N+&"5SCU>[PH6M>X]7.#B34HK.UMVB
M! 0$! 0$!!X>Y-L;;WCA;W;>[]O8S=6W<CX?SA@<Q:0WUE/X,C9H_%M[ACXW
MZ)&->W4WHX CJ @A&^E0XPX\XVP_"-QQCQYMW8.0RV2S<-[/M?$VF*FN0R&S
M$;)'6443I*:W:0:]IIVJ)IVK128Q>IY&#LK)<O;2CW=%B'!_$]IAL=!F&Q.%
M_G?>;665D'CMTRW#(Q(T@$OZ'UT\-EUEV=-*;&@RYRK]==.'#-M([IG#8V[X
MY#MT?2(<]YQQ,]IQYL/$;<M7DDM9+D&V5Z=/: 0YLS>T=_0]J^NU']/E>5;^
MU?,_%6/H;>W',E(,M S" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(""Q]\6W)-S:V+>-LUMK"WS97')2[EQ=YE
M(GQ:?9;"RSR&/<QP=VESG"G<L^1.5$S[2+ICR3$>F)1->QA_B7CCG/CBWQVW
MLAOG8F8V?'F<MELK!;[=R=ODI#F<C=92Y9!<OS,D+-,UTX,+H748 ':G5<?7
MJ]1I\Z9NBVZ+J1$?6BGU8B(PX>Z.]2VVZ&S"UK(M'>NP=E<CX2?;N^]K8W=F
M%N 0ZPR5NR=K2?MXW.&J-X[GL(<.T%9LG/S,F[BR[IB?(B8B=J,[D+Z.G.;.
MRT^^?*GR9D]BYVWK);;3O[R>..AZNBMLG"?%:T@ !DS7ZOMI %N?_:9&KCAU
MF7$S^W;A='P^+R/%FZ*VZ>*,)[XPGXV.<+YY/,KY?<Q:[/\ ,[QI/E8:F.WS
M%Q$W'WD[(R&&2WO;=K[.[:WTM;4GXTM5@SN27S;QZ2^,VWNV7Q\T_P#TSY'G
MG.U.1ZT<<?%=]$I!>)?.'P-S +2UP6\(L%N"[H&;8S^FPNW/(KHB>YSH)CV]
M(I''U+23F<-W!=$VW1V3%)>C(YCDYLTK2[NG"6T"N]P@("#7SG_S)\>>7K!P
MW>Y[A^6W5EVENT]AX\A^2R<Q.A@:P!WAQZ^AD<*=S0YU&G8:#EN;K+J6X6QM
MNG9'P[E+[XM:F[:X*W[SYF[3F_SJ9*';6S<0_P![V/P3)<>Z8S'1'VF2Y8O>
MT:R/CL>?$?\ %E+&#P%L\_F.3H;)RM)M_P V9VSN^%.[O8J5^M?-(7'R'R[Q
M9R=O["<5[?Y-P]EQ-M/ /R&?L<'DFXZSR5Z+AEM:XYUU ^%KK:WB:9#'"_2\
MN;JJ&BGQVINS<^:9<3=WS%9^-K\_46ZB_@LNK;$8T[9^B&"?+[R1LSA';G"&
MZ8^0(<9@MWWEQ@.3]IRY(W-LQL[;V2TRGNCI)#:O@D@C:][&M#HW^UUH5L>:
MVYN5KLRZ;9X*QC2:;([=ZGM(TU\75I;,TGNV;?C2N8W,['Y'P$[L5D\)OK;&
M2C,-W[M+;Y*RGC>.L<@:9(W CM:Y4R\RD\5L^>&XLS+<R*VS$QY,6G6^?(AL
ML9N7?7 .[<OY>N01K<V[V[)(<5/JZF*6Q$C-$;B "V)PCI6L3EO<CGN9P\&H
MMC,L\NWX_IQ\JLY4;8P6:WS&>9KRZGW/S/<5G?VR;4M:[F?8;!*R.(>R9;ZT
MTQL;4]:N;;CN#7E9O_7:368Z:_AN_8N^:?\ _2O'=;ZT-R>*^=.)^:L8,GQM
MO7'[B+6:[O%->8<A;#H#[Q93!D\8!--19I/VI(6GU6ASM+-,RV8]'Q[&6V^+
MMC+2\BS7OD+GZ;C>;(OR_"O(>2PEAD;+&1;HQL6!?8W4^1NH;*T\ 39J&>DM
MQ.R,%\3:$]:#JMAI]![:E,RR)I,TGBKA%9_RTV1WJ3?3LEDC8V],IO&+(RY/
MCG=''KK!\;88=S-QC7W0D#B70?-N0OQ1FFCM9;VBE>M/-GY,9=*7VW;J_/$+
M1->Q?BP)$! 0$! 06QN/>NS=G^Y_A=NW"[6^<?$^;_G>_M['Q_!T^)X7O$C-
M>C6W53LJ*]H67+R<S,]2V9IW15$S$/,PW*'&FXLE;8;;_(FV,[E[S7[IBL?E
M[*ZN9?#8Z1^B&*5SW:6-+C0= ">P*U^ES;(K=9=$=\Q)%T2OI8$B @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((_>1OH].&N1MS
MWNZ\QD,Q;W]^]TDS+=MJ8RYSBX_'A<>T^E35&QY&W?HUN ,-?6V0FBO\Q[G*
MR3W2^CMO">&.#M/L1--#2G0I5.+?#;&U\#M'%6F!VWCX\1BK"-K8+&$$1@ 4
M ZDGI1!H_P O?1Z<1\K[KR&[<AE,GC,GE"WW@VONPC):T-'5\,A[O2E3&%Z\
M)>1WB/@_*19_#VTN=S\('NF2R#8B^!P%*M=#''W$]H2J&T6[]H8'?6W\CMK<
M-A'>XO)0/BFB=U/5I:'-'945Z(([,A]%KPI>Y8WPS^;M;"9[I/<![H&QZB?8
M:TVQZ#NJ4JFLMY>).&]G<*[5@VALFP;9XZV+WS7#FAKY?$>Z0UT -[7'L"5&
M5&/#C6(%C6C2S7T:?@*@=L5H-5*]].Q!]0$'%_Q2HE,;4!WFN _''GJ_XG_C
M+L7)?=L[G(NHO>UF[YT6V1<T9&]!%29Y*'^V*Y-F^O.]U3+]2-SBT/</C=/0
ML:[FW4TT/4%!DOBV<0\@;1#.WYQA^RB7;Y7>V7?^<=X9CJ\5-*=Y218K=  Z
MZJ(ASE:T4<@]W:LICW-@902VEY%4CT:DE,,H\]PLBW^Z9H-)\=9G7Z3X=4I(
MPL[VJ@N!U=I)1"BV$-)+GT [*%!48\C4TOU-=UH?4@SKP!DVV&]9&>$7MN[+
MP3TZ]96'TCT*^5Z\;TL8;NMF1[GS8JUKI+R=Q97N,CBK9ULQ=,2AXEI=7MBR
MYBM;Q\5O<M++B!I%'-/:#T6(>5#;^ 99.^1Q*#V\(7,S&)+"T.-S'I+S1M=7
MVQ]"R9,TOMWDKZYBE%QNFR<U\+W1X3'M+H7:F:A'0T/I5]3;,7S,UQ16L,4N
MZ-H>Y8%NQTK@]!\"(=;4]C'2QFCX^K?LH-J-Y^/D> MIY*X=62VO7Q-^!MNP
M_EHEJD1TJI0Z[JFH[U J1M?H+=7;V(*T;71M]H]Z#+_![R.1\'1O31=5_8'I
M*73Y++9-^;G(I07LAKW]J"Q0T:M8<23TH>Q$.Q(PM:"*::T> @V<\J+WMWW?
MG_YHT1_7*A,-;+D-%Q*"^OM#O]04H=:2*)Y%!U[B@^2-\0AA](*"IIT$,:-5
M4%U[(@$V[\$TD%SKJ(Z?@D:DIAD#S%/)Y4RS -(@8^+^YN9T&$2[V2H&:ME'
M_P!'9?A/[6Q=1Z)\"[[4>B'+NNO%C[$^E*9S-_1SXN_6+[_.<>N8]6_FI^'<
M\O7GNO*W3]ZQ$!S(P/S.-H-7R'P_;O6NY=X<[WM_2W\AF?W/X;6(6M+7&AI^
M=6P=-5VO\2I=TTA14;+<H74#>.>.;.H\06SWD BOMPVQZ]?4@UZ^3I'75T^#
MTH.R&M>*!U!Z"@H$4(92H075LJT?=[JP=NVH+[IC6CK_ &"HG!,+]YTU_C%R
MD3ST9:V+?[FUC"F$2P[IU?%05OBMH'!KO22@^M#2]K*.>Z5U.G4=42S[S/;N
MM-O\<VY;\6UD> WM]J&$]:HAKZ&!W;TZ_;=$'/2UHH2*GT%!S:S3T'>@RM@,
MBT;%R&+:RKIIWETGHHYI]/J]"WW*\K_;YU_DCTL69/UH8L  KJZD$CZY6@VP
MRPZUS0,?1NGHI'FS&H:"Y!V\;![U>6\#>IE>0/K>I$L\^94EN\L;;$]8;&UK
M]6VA*=J&N#C4O;Z"@[&*-<I9'_E HNV2\^L\"_<E5\K7\9VU/UL?8:M#E^+Y
MWYWZ+]\V_O)8/,O_ !-;N_6H_P!.%NYV/TGG;)W(S]MM_P!$VGP.^RO@]19_
M5N<EU7B7;WL[4%.:>)O]?P?I'+;<AMI=<^AZ8\:[="9*+XL/Z ?87TD/O)5U
M9 @(" @(" @(" @LGDF/8\^P=X6G)5Y86&P;_$W5GNZ[R<[+:T98W,9AF\69
M[FAE0^@-:UI3K1!KSY6^#."-A<2;FVOQ)O:ZY9XNW_>W<N4DR63LLO9O=/;M
MLKNVC-C!;Q-:Z-@;(TM+OS1[$3,M N1/HLN%]C9"\WKN;S'2<>\5,O6!]AF;
M&U9/$R9Q#+9F6FO(XR\GHTFV<>G4.[46XDNW$V%X^VYQMLS!<57-C><>8K&0
MVVU+W&W++RVGMF5'BMN8W.;*Y[JN>^IU.))ZHI+(: @(" @(" @Z.2R>-PUE
M-DLOD+;%8ZVT^\7]Y*R"&/6X,;KDD+6BKG "I[31!%9Y^]V<69[>GE<^=]PX
MG<&W+/<F3=N&*RNXKIL=JYV.\;QA;O<0UT(DKZ16G5>;65]E-'DUW@SW85W5
MQ\W?Y&8.;+G94W#.<\>2SN+*[QPCV +!S7R298LTXGYK\ U,HFT>%X79^AJM
M'%>QK,_A]G-?A/93R]SPO(<S*9[?/FQY#S9%QE,WOF' SWGL'4["MN [26TI
MJ%PPF@IV=31=#YQ6S(TV7.V+*SONI]#;:>LQ,SM2/+0O0(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MX#8[2"VTGK4PLTD]@[:+V:W13I)MB9K6(GXV/+S+;]DL1ES7  CKVBAHO$R
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M5:U<0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$'%_P 4J)3&U 7YKNO,>> Z4@/Z9=BY+[MER+J+WO9N^=%_=1-]_O\
M4XBL\E/[HKDV;Z\[W5<KU(W* ;X;7AIZN^V/58UG,,+M+M/LGX[>Q*I=Z&40
MWEI*QND,>*-JKV32Z%9BJ\]]T;>6,P8*SV[-=.G8%LN<^-6?V8]"F5A%%C1N
M)H>SU+5,DJ]>PD(/9PDX@S&,DTDZ+ACJ TK0K)E6<=\1Y2M'O[[O/>,\^3J
MZ)C@TFM":]ZV7.8FW/B*UI;'H4LBD+0JX^T2*]@6IJNJA@[":GMJ@X5'M"M2
M>Y!D;C&=MGG;JYDTL\*T)8'#4"=;>Y;'E67[34V1Y5;\(JM+.E\N6R4SG&LD
M[R&]U"X]BP:SQKJ]Z;7E,<:@'N'>O+"RD^CB:GL1#LXUQ;D+$_:MG9J'IZK)
MDW<%]MW=).QZV\)#)DXH7&D<=O&]OH]JO<MGSK,C,SK;O^FWT,&GV3OE:K7
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MVH.;B2/4B5S[3;7(RM8"ZL/M "O34%M.3S3/\S#G6UL6]>&-V1O #\660$?
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MXH9SM)R5L/,[(;N!^V6849BV?:NNC9#*FX\)KZ%P9X\=32GM?"BUTI<T5$!
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MH)>\>O2E$/AA-*.<Z4L-2=.FOUE2(35WH6EK ":]XZ4Z>A70JH" @(" @("
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M?3VETW4V5FK-PQ$X-RE@2(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MN;M66^2R=N64F9"YL@_M%>%7BO:U^Q:%@:8Y :^GV04[5NUWVO:VZQS'Q_\
M2&!L;AW$,'J1"0/@;85ZS9&XIY'-\7+V4H@;H:X /B8.W5Z1ZE1:(:5\BXRZ
MP63O;.\8&S1S-ZT!%"X4[*A6M5E9>@/W';ZB-3[1WVO2NH*P\G'Q_P#IM$PM
M$5'/]?\ @7=:)V)[&4^.L1<9ZYCL[-C72B2K@Z@H \ FI(]*K<B&X//V NL'
ML78T=Q$UVFQ960!H'Q(_02J1M7[&A%T6,N+F-PIJM)BT@=OL^I9%##M@.V+E
MND:P'.U4IU)"F=J'BX\M9F<BUQH3X6D_VH2=B6Y7ERVXS<F^<$)P70V<@<\
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MXT.T"IH7-"7(JF3R>V\9-PO9XUUU$Z^95KL?J^6<'S#KIIW#JL=5Z8(3^4[
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M'?8BR?;2ML-0LY&N:\^#;T-&M$GYGTH3M0JW5A>V5]F,5=VCXKR'*2.DJT@
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M89H4)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!3E%6T]:"!'S7 #F#</?2'M^JNO\ )O=OF<HZ@]Z6;OG129.0LR5X
M[II]XD#NGYXKE.;Z\[W3\OU(W*1M69 LM&#6ZY=HC[B2?17L6-=*9Y5^"+#
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M((7?IC/^K? _^L\_^TV*+6M^_)'_ $3^"_\ 9J+]MD1$[6TZ($! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @((7?IC/^K? _^L\_^TV*+6M^_)'_ $3^"_\ 9J+]MD1$[6TZ($!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MTA?6YUE+:;6DY;GSF7UE)[QUL786_N)<)DCEV7&>QP,4\<@=XH<R&.H!D -
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MQ!J/GVT_22+Y7K:VF19ON]$.D_I!F<>LSY_Z;/3<F6@^+%^A'V%S*7Z#AVE
M(" @(" @(" @(" @(" @(" @(" @(""%WZ8S_JWP/_K//_M-BBUK?OR1_P!$
M_@O_ &:B_;9$1.UM.B! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[P"-0[75/0"B^3S<Z_-FMTU9:(@<*3\]1U'4W)K_ '2I=L>76>!?N2R>5?\
MC0VI^MC[#5\_E>+YWYXZ,]\V_O)7_,QTX=W:.OZG'U_MPOH<F?KP_2.?ZD[I
M168AKI+.$-< /:[?14KOW++XLTUE>Y^).H]+F9O,<[AIZT^F5U<?M+.9^+BY
MS7CY^M?:::@48_M7Q_75\3DV3'?/HAU;]&=/?E:G/XJ;+/3<F?M7![(R 1I:
M!U[^G<N65J_1-*.X@(" @(" @(" @(" @(" @(" @(" @(""%WZ8S_JWP/\
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MH^")NNBOG^AX[LB:X-K/+CPAN?8^5FW'N]D>/N87-$%I< 2^(UHD:-(:YX%
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M,^)_9L]-R8WCG?5IOW&,RUG82V$3JCP97A]*?  %R_L=XNBDLEJ 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$$+OTQG_5O@?_6>?_:;%%K6_?DC_HG\%_[-1?ML
MB(G:VG1 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M7#O^P^WO_)MNBLM*/HWX;;>6 YUYYR;8K[>'*/).5;<YCX[VXVV9!-;6S'D
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M+3N-RVJ1L(VI'/+HV"XX$XEII,'X+8W2^OVO@-I51*$/?EBM#E_.'R'CXO\
MHN0M<A9RN'4 RV[X_P OTJQV.-SQ5YDO*USENW>W'VT;G=.&W%<W+X(;%LCC
M):R3'2V0LMKG02(P2.U0=C&?FSW]Y@^0[#961Y.VJ=H8(9 -P^,N)B93+T$E
M&R6EN[J#Z2DIA.-Y7K62UX/V%'<=)&V#?8<*:>I*BY$-@U"5.4T8373ZU$IA
M =YKNO,>=IU^0_+78N2^[9W.1=1>][-WSHNI+"XRF:N[*-\<?BSR /E>&,!U
M&E7&@7)\WUYWNJ9?J1N3!>27*9;"[;OMDY/P=&D26ES!*V5DG=IJT4_)6&62
MK9Z:1MM/<3Q6I?+',W5$*_FNVO54B5IAE; [GC 9*091>#P'PM[6'MZTZJ9F
M"V)<IW08Z<V\/QKBKR_\SJZ@'M5933M0N><O,9$<UX:+ -]^SF.NQ)[M&:D:
M7=ATAU/K+)$8*2EXX=YDVYNG;6W;/)/;:9*WQ]K!>B9P9IE9$QC@*Z:^T/0J
MW15:UE',Y[9<&0MK":>*2_>\&,%]".O;37U41@G:Y92QQ\[K:.RDC9!K#[B1
MS@'.K0D!I=U^HHH1=1&!Y_\ EK&XV;';+P9$\[@&7CX'![8VZR'!Q =3T]5D
MA6=C;SRK9FTFX1B+'":**!C)WM-:'2T$&BQWSBO;L5,KAL19YGPK&6MOE*OD
MH/9)[.W45:L=BE)9(P>TK"X?:8"*1[;&>DUS$V,N:ZITG4=50/JJ)E,1VKGV
MKC)\#ELC:P#791MD9&&]10M<.WK]E0F(E'MLR;&XWS3Y"PA<R.XO,B92P.K0
MF>,=Y*OV*[4I&)O[V*\EM)V2.LPT4FT]*N!I3IUZ^M47[,73O<+/%+%=92X:
M;EI#+=KBT%S*U[B.]3L1..+&DUE<Y/<-K;7CF.:)7Z"YP #&U+03T[@HVF$2
MT#\^._;:#D#8VVL5=0R,9*/>XH9&OTD2LZ=-1[#Z5>$2V5X0MI[K;.+:RW,D
M\NAT0-1T+&'["BXM;3YJRQN*E@=/D(V27;0!:R%K:.H!TJZI5:)K6-RT?F;Q
MX;BVMYR_Q9G2NT@'HZGK]2E%:L8<X;XV]Q'QUD,YD+^!F3\%T<$+I6L>Z1W1
MM 7'TCN4VQWHF:S@_./NS<D^\=UY7<5\07WUS)*QQ</BN>7 = WTK)"C;GR]
M[ZVQL[*6EWMO--AS%6"_QEQH@BE!#@:2R.>:@$]C5686A)NWE3 7-]A1E+J"
MU&;:QH/BM,8E<3[(>2T'H%$I91VWR?@8\O;X.8R2/?41O<VC2 TN!!]"K,)A
MX?F'YDP_'. O@V>)D]]92-9(R1IH2QY';4?:J8@E EG.9[B_Y,CW&*FVMKSV
M'ZAI]MQ:XUTT5Z*5Q?H4X_WKC-]</[5SV-O(KJ:'3[RUCVN<T>)-7HT_G?0L
M<PR5HR_M.^QF,LWW1R$3778H+>9S8J/J'.()=4J)+97;NDQV.US.V?Q0Z4&5
MU  0&OZ]I[%,^1-:[49OG>Y:P=EQQ8XG%N-U=RQQQ7KH_:8Q\9C+@7#5V%JM
M$*72OSR0;QPN\N#(K..X$F4LW7'CAI#BW7>WQ;4 CM:!W*+L4PVEVQ)>6&1)
MQ\OAR1RN9<CH-3 17MKVD*(V':R/F,C>3Q1VEA<"$/<'SEA:XD#J00?A*A->
M]6VY?QVM^Y@A(;2DMR^K6=HZEQZ#L2=B8H@8^D;Y-MMT<VP[7QLT=Q;X>&7Q
M[B&1LC:RVED^GL@@4+".U9+8BC%=M:_\8@C:=S0$#4:.](\*-=1Z)\"[[4>A
MS#KJ/ZL?8GTI8N9^GESXO( ),%]4D^BYQZYCU9^:NW_0\O7GNO*W3]ZQ'!@M
MS6>U^=MD7>0D;'97L<-M.Y[@T#7>L<34^IA6MY?X<[WM_2W\AF_W)^[:EBW5
M/;2XG Y"R:)+:ZMHI(W@]-+V1EIKUZ&J]M73H7+L>&07!DN+@&Y> <72AH:C
M33^V2<>U$,A;]LLJ_$8F.X9XIN#('3?F:",]PHHJNU/\\6\L=Q[P-E[&ZN8V
MY3<<%S:6<&MH<#/:7<;30DGXU.Y6MBBM:HU/H[^7L9LOFMN(W%<16MAN6 /?
M/-(V-@=('REQ<Z@^T]*O=$=J(G!^A"Z@Q62OH<C9Y&&XM&APB,3FO!!H.A:X
M]X*PTEDK@M'*YK#P9F/#.RL$ N:,EMO$94DD@]KJUZ)-LTK2?B1$NWDK'$X^
MVR=_)>PLC99RNC;K;J 9$:]-7?132D([7Y]_-QRO:P<M8#*8FY$YVU,V4B,M
M<=<<TWLB@=^:"RT4V)E>+/,]L'>'&F W7E[WW2&SAB@R'CEK"'L=X/>6_;-5
M)BLKQ+*>\.8L7+@;?-;.N(,K:2LU,DBF8[2VA.GV=?J58BDD]SE;\Y8.SV1%
MD]R21V]W(?8CDE:T>RX?;'3Z?0DXIC!%WYR?-_;9ZTDV]A'"ZEA ABDBD:]K
M!23O:QW>Y7B%9E5^B\FFOL]O"">8&YR-KXA=45U.FE>1042Z,"U+R^')6;W-
MMX7 -DHQ[AI+AZP0:+'$UA:8FJ^H;^2'&.DC8);T,92AZA]1J I7U]RBJVU:
M]_F9AFK:!SC').W48Q0]E!Z%*)A$1]([.PWEM&&!Y=I+NOI:.STJ]DX*7-=_
M+?R1B<#NNSL<)X6/BB:WQ9Y)0PR$N:2*25^#HIF$1-$G&.Y%RCLQ<Y._O&QX
M5A+XS,]C&%I/0AQ:*CKZ57AQ3Q8/ RGFEXI9N''8/(95N0O+F5HM_ <R2-AJ
MWJYS']*5[TH1L8>\T7.+-U;>O-J;4S$-A:Q%T%[=,DB?K:TN!-' ]O3L*MM1
M&"'W'V=Q#N2$.N?''CU,HI[53V]%-VQY=9X%^Y+-Y6FM')^U [K2,'\AJ^?R
MO%\[\\=%S_S-O[R5SS-$?B7W@1V>"S],%]!D>O#]*9GJRAJQ$X%I'ZB[],5V
MG2>#;N<-U>7'XB_#MED'B24/YVXL [L]:T^LY?,=6^#;Y_0^LZ.MB,^^G='S
MITHAT9Z0%SF'1ZJZ @(" @(" @(" @(" @(" @CR^D8Y V'/Y5>9=FP;VP$V
M[VOP,;MJ,R5J[)!\>>QLSV^Z"3QJMC:7D:>C17L1:W:V1\N6^=E;CXEXNPFW
MMX83.YG#[(P(RV(QV0MKJZM3'86\;_'ABD<^/2_V3J H>G:B):1^13?^S>"Y
M^>?+CR9N7%;#W)L;D#(Y/!19RYM\7%?8F]BB9#):&=T;7MTVXEZ?X.5A'L]A
M,XKBXMSN/Y_^D!WMRSLN^&;XWX8V!%LNUW9:4?8WV4N;E\[HK>8- E8WWBY.
MMI-=#2TECVE#9"39%1!JQ_,C\I_\A>VOV*7]T1-91<_2:^7CC/B[!\0S\0\9
M6FVKG,7^8CSK\-;RO=,R&*T,(DZOZ-+W4^$HM;+</RI^47R[[M\NW$NY-Z<-
MX3*;JS&"CN,YD+Z&47$LYD>"Z0:V]: =R(F6P?\ ,C\I_P#(7MK]BE_=$163
M^9'Y3_Y"]M?L4O[HA63^9'Y3_P"0O;7[%+^Z(5D_F1^4_P#D+VU^Q2_NB%9/
MYD?E/_D+VU^Q2_NB%9/YD?E/_D+VU^Q2_NB%9/YD?E/_ )"]M?L4O[HA63^9
M'Y3_ .0O;7[%+^Z(5EBCGGR=>6K <&\S9[;7"V!L=QX38NXK_ 7UK#*9X;VV
MQEQ+;R1#Q#[;9&M+>G:A$RCD^C*X#V!RCG.7H.7N-[?<MMA['#R8)F9MYF-A
M?-+=B8Q]6=7!C:_ $6NE+E_,C\I_\A>VOV*7]T16LG\R/RG_ ,A>VOV*7]T0
MK)_,C\I_\A>VOV*7]T0K)_,C\I_\A>VOV*7]T0K)_,C\I_\ (7MK]BE_=$*R
M?S(_*?\ R%[:_8I?W1"LG\R/RG_R%[:_8I?W1"LG\R/RG_R%[:_8I?W1"LG\
MR/RG_P A>VOV*7]T0K*$S>?"FU++Z1*SXXQ_'[8>*W[ZP-A)MZ.VF^;S97%O
M:.GC+NOL.<]Q/M=Y1:N";/\ F1^4_P#D+VU^Q2_NB*UD_F1^4_\ D+VU^Q2_
MNB%9/YD?E/\ Y"]M?L4O[HA63^9'Y3_Y"]M?L4O[HA63^9'Y3_Y"]M?L4O[H
MA63^9'Y3_P"0O;7[%+^Z(5D_F1^4_P#D+VU^Q2_NB%9/YD?E/_D+VU^Q2_NB
M%9/YD?E/_D+VU^Q2_NB%91<_2:^7CC/B[!\0S\0\96FVKG,7^8CSK\-;RO=,
MR&*T,(DZOZ-+W4^$HM;+</RI^47R[[M\NW$NY-Z<-X3*;JS&"CN,YD+Z&47$
MLYD>"Z0:V]: =R(F6P?\R/RG_P A>VOV*7]T1%9/YD?E/_D+VU^Q2_NB%9/Y
MD?E/_D+VU^Q2_NB%9/YD?E/_ )"]M?L4O[HA63^9'Y3_ .0O;7[%+^Z(5D_F
M1^4_^0O;7[%+^Z(5D_F1^4_^0O;7[%+^Z(5D_F1^4_\ D+VU^Q2_NB%98HYY
M\G7EJP'!O,V>VUPM@;'<>$V+N*_P%]:PRF>&]ML9<2V\D0\0^VV1K2WIVH1,
MHY/HRN ]@<HYSEZ#E[C>WW+;8>QP\F"9F;>9C87S2W8F,?5G5P8VOP!%KI2Y
M?S(_*?\ R%[:_8I?W1%:R?S(_*?_ "%[:_8I?W1"LG\R/RG_ ,A>VOV*7]T0
MK)_,C\I_\A>VOV*7]T0K)_,C\I_\A>VOV*7]T0K)_,C\I_\ (7MK]BE_=$*R
M?S(_*?\ R%[:_8I?W1"LG\R/RG_R%[:_8I?W1"LG\R/RG_R%[:_8I?W1"LH3
M-Y\*;4LOI$K/CC'\?MAXK?OK V$FWH[:;YO-E<6]HZ>,NZ^PYSW$^UWE%JX)
ML_YD?E/_ )"]M?L4O[HBM9/YD?E/_D+VU^Q2_NB%9/YD?E/_ )"]M?L4O[HA
M63^9'Y3_ .0O;7[%+^Z(5D_F1^4_^0O;7[%+^Z(5D_F1^4_^0O;7[%+^Z(5D
M_F1^4_\ D+VU^Q2_NB%9/YD?E/\ Y"]M?L4O[HA63^9'Y3_Y"]M?L4O[HA64
M7/TFOEXXSXNP?$,_$/&5IMJYS%_F(\Z_#6\KW3,ABM#").K^C2]U/A*+6RW#
M\J?E%\N^[?+MQ+N3>G#>$RFZLQ@H[C.9"^AE%Q+.9'@ND&MO6@'<B)EL'_,C
M\I_\A>VOV*7]T1%9/YD?E/\ Y"]M?L4O[HA63^9'Y3_Y"]M?L4O[HA63^9'Y
M3_Y"]M?L4O[HA63^9'Y3_P"0O;7[%+^Z(5D_F1^4_P#D+VU^Q2_NB%9/YD?E
M/_D+VU^Q2_NB%9/YD?E/_D+VU^Q2_NB%98HYY\G7EJP'!O,V>VUPM@;'<>$V
M+N*_P%]:PRF>&]ML9<2V\D0\0^VV1K2WIVH1,HY/HRN ]@<HYSEZ#E[C>WW+
M;8>QP\F"9F;>9C87S2W8F,?5G5P8VOP!%KI2Y?S(_*?_ "%[:_8I?W1%:R?S
M(_*?_(7MK]BE_=$*R?S(_*?_ "%[:_8I?W1"LG\R/RG_ ,A>VOV*7]T0K)_,
MC\I_\A>VOV*7]T0K)_,C\I_\A>VOV*7]T0K)_,C\I_\ (7MK]BE_=$*R?S(_
M*?\ R%[:_8I?W1"LG\R/RG_R%[:_8I?W1"LH-N3>&MMXOZ0?&\=XC80MN+Y>
M2-I8R7 0VTQQYQUY)CA=Q%W7V'B1^KVN\HO7!.3_ #(_*?\ R%[:_8I?W1%*
MR?S(_*?_ "%[:_8I?W1"LG\R/RG_ ,A>VOV*7]T0K)_,C\I_\A>VOV*7]T0K
M)_,C\I_\A>VOV*7]T0K)_,C\I_\ (7MK]BE_=$*R?S(_*?\ R%[:_8I?W1"L
MG\R/RG_R%[:_8I?W1"LG\R/RG_R%[:_8I?W1"LHN?I-?+QQGQ=@^(9^(>,K3
M;5SF+_,1YU^&MY7NF9#%:&$2=7]&E[J?"46ME*7Y*H)[7RJ\'V]S"^WGBVW$
MV6&5I8]I\63H6FA"*SM;1(@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0?F]WKOG)\-><$\DG;5QF[; WMU*ZUA\,.?XC;B$4UN:/\)56E$;&
M<^2O/QRKR[MZ_P!E\9<:Y/#WFXK=]A+/.Z-SS'<,="]K'0W#""1(*>M$MDO(
M-Y4LYQ);7O(6^SXFZ]S1QO\ =KJ.MS;_ !W:G/?J-:2$$AW51)6KI>:[SK2<
M?YO?O#T?'N1RGON)N,='G&/@,3C?VA8' .>UWL^)Z%-$;49OE4\P^3\N6X]T
M9^^V-D,ZW<3'1100NA!C)?KZZW@?61,PE \W''V:\Q_ ^.W]MS&RPY?'VKIX
M,6YHDE8R-[I'D$4 IIKT*>1$3VM+.-_/_NGB_B:WX?R&T<C/O'"6<.+PV2,C
M2V(6S&, (,VO[1WQ2$31L-]'WPSO&RN=V<\[UQ\L%[GGW$^(M)F5?5CIF.:'
MN+ZUH"*'O1$KGWI])+%QUO'=FU-U<:9)S\+?W%K97;)+=C98X7Z!34]QZD'T
M)1,5EJU>7?*?GYYCVY>OQ&0V[QI@I[::.VD<70PN94.>6,E?&-5!4AE2AL3O
M[9P5OMK"8K V4+&6>-MXX8VQM# "QH!Z  =2/0HE"Z%"5*8T8?8U^I1*80'^
M:ZOXX<Z::/D.H^JNQ<E]V3N<CZB][V;OG179$3#(7[HYG, GD)+200=1I0A<
MFS?7G>ZGE^I&YGKR_P#-NX..-S6;<CE+BZQ;Y1UDGE(B9U[:OI]8+'1>$DO&
MOF,P.\[Z_L72QR7<8+]375U]X[:J*)EL?L7?6-NKVX%Y9Q6EM![3[AS6TK7J
M10%5F$Q+YGN7MIX]N1S8<+RWC9)';0APH^5@(%*MIVA3@8T02<T;SW7F.:-Q
M[V;;W&+=+>2RXX.>ZC8W$$4TN'9ZE:%9EYV!Y8Y)Q=_;WEMN;(1L9*)9867=
MRUIH[52@E 283$T2:;,YE9N?9GXPLO*!=8* "[$CBZ5TC074UDD]W>5%*D31
M@6+SO[H9G<Y?WWOD]C)$(,/CX;F1C(BVHUZ3(6^T/0 E$K8FR5WS!:W.;S]K
MB\;)DF.-N_(6WC7DI/VS)JN/0I&")Q;@>33=FY-C8[<6P=X8>23$W%9K')/%
M(O#>\!H >YW8T5[%%T)JW0S.0VAMZTBOIXX;ZWF(DM"X,+V"O8USF=!7T*)B
M(3%99FV3DMNYC!/S4+H+&25AB$P !:SH>UK:]JC"B8K$K W_ ,G[9XYP61GC
M?%>Y6Y#O!D!%.II7J :]?2IV01690'9#D/D)OF/QF[]LN==W$V39-/;Q>)U8
M9V.+:"1O:1WJ],%(G%+7LGSHX"+<MKL;<S(&Y"6VM_%F<?:BE,6J1IU:C\84
MZ*M,4Q,+VW[RU>R[CQUY'?.M<+"]KYR^1Y;H!]KL=3L]23;5'%1KAN3S>[,Q
MVZ[_ !IR?NTEO#IAO?'<&B3VFGH!7N2(3,U:6[IEQW).=_".YS@RV19*)K2X
M8YSG-?TH-4@<ZE6]Q4THBM6T6U?,?8[ V]B'WF2CBNL,X17-O&]['O$;6LJX
M@]>H[TG$B6?,ERU;<BVF+WE9WTQQ5DSQ)9(IG:&Z7=_]P56E5JT:Z;_\\T>S
M,N,9MZ-^0\ !MQ<-F-:U<".UI[E/"K$M0.4/,1A>6[PLW?)EKBU+ZLQ[K[5
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MV*$K8EV1L^ZO!>76W++WO54O\(=I[?0%-4477%;06D(AMK=D4+11D#&@, ^
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M(2W1$:R $/;0M<TM#.7DLNKF\\JW!]S>7$MU<2;:A\2XF>Z1[J22 5<XDF@
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M1PO^=MN>8S>-KJ=@]W<QY^\P<Y+2R:$LAD\1E.T$2@5!H:=.PHM<D?140$!
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M!_N'B>]^^BZ'C^^^\-\/1[S\7P75T_&%>A-<'7\Q_EMPGF$Q>TYQN6^V#O\
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M7S!<9?Z]L_LN7S'6'@6^?T-WTWXM^Z/G?HPC[(OT(^PN80^T5E9 @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MZ&ZZ<\6_='SOT90]1'U^U'V%S"'V;LJ00$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 08^V_P L\7;LW+EMF;7Y%VUN+=N"$AS&VL;E+6ZOK80N$<OB
M6\4CGCPWD-?T]EWLNH>B%&04! 0$! 08^EY9XN@WM%QM-R+MJ+D&8#PMDORE
MJ,HXE@E#!:&3Q=1C.L-TZBWV@-/5!D% 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MX4J4409"'!QTUIV=_P *%%5OC$ET;7R$?%<T$AOPD=B!&V:0N<UCI*?&# 7
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M8+!,W/M/(X_%&:246\>3N(8KNT;+(YTCHI&F1M'.)TO+:]$(QA^DM%! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MT4F9:,3?GQ#"[6P#5&[I6O91#S*FX-K;ZR5AA[?#\4[EQUWBHVQ>\-Q-^X$
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M1IZ.]- N7OM)=Q2@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!PD^+
MZ/6B)0%^:^,#ES<?ZR>OU5U_DN'+7*>H?>MF[YT/,<38,_G"=+&FZE/M&E:N
M/I7*L[UYWNG97JQN7!#=0M;I\:(._1C^RL3(KMNK9S:"XA:?MB7M_LH.#G1R
M>T9HO8^(XO'5!S:^UC;4W4&IW:/$;_90=*&\B]ZDA\>#PQ\1_B-I]E*#U6S0
MN((N(&G]<;_92@[K/#()$L<@/QG-<" /J(/GC6PZ&Z@#&]E9&_V5 ZE[D[2"
M(OAN8'R#K3Q&_P!E305H;^QEC9*;N .(K(/$;T^'JE!S&3QT=/WW$Y[C1H#V
MFOY*B@Y29*R8:27$<;B*M!<!]DH.A+DK)I+Q>0T[_;;_ &5-!1=E+5KHG/O(
M1#*X-U%[:=?JI0=Z.^Q@]AF0@)=Z)&'\M105RZ QNF$[70-^-(2-/U^Q!Y,M
M[CG.JZZA K1ORC>M/JJ:#H7N7QS+=PM[V'WDN#2T/:34]G>IH*UGF,>(6&:\
MB\7L=[;>T=O>E"KUK22.]E,%L'7$Q&H>&-51ZJ54#HW5U9VLTD-P]\4C?U1K
MFTI]=('D29S$@!_O TS_ *F>G73TZ=5-!YM]D;.XM+B.WEU2Z#X8]:40]JRN
M(A;0M?/&UX:*M+@%$CN^/:/%'7$->[VV]OUTHERD+#'J;+'&&_;N< #]4H*D
M;[,1C]\PL/QC[;?[*#ILG@\:.MU%X+]?M:VTZ?53$>@);5YC;'=0DU'7Q&^G
MX4'?8(Y&O'O$3BT?:O:>_P!14#X)[5K@#=P-TBAK(WO^JIH//O;NVC;\G>0.
ME)):WQ&]_P!5*"K996TN;2*::YMVRD.\1OB-J '$>GT!*"L+_&M<"V[A.KLI
M(T_EJ*"I)D;$$,=<LAH*@.(%>_I4I0><_*6%7.]\AJT]09&B@^NIHAYIRL9O
M)!)<P-M&AM)/$;2I'IKZ4HFK:/C>:"XVM<203"1C7$5:00?DF'M"Z?T3X%WV
MH]#E_77BQ]B?2E:YE)_F[<9 CXT%[0_!<V"YCU;^:NWS\SS=>>Z\K=/WK$.7
M.#V-SV+#Y&,<;7IJ<!T\1_I6NY=X<[WL_2[\AF?W/X;6'&3VX/RDL)81VZQW
M?56PHZ:^"6!SR(YXGM=VL#P:?DH ,#7NC?<0AHZ]7M[_ *J4'7R%[#'"98[B
M$O8TD#Q&_#Z5-!VK&]ADMX'NN8!XS1J^4;4.T@GO2@[L+XW-+#=0.;4 $2-Z
M_DJ!VG^!;@"2>.(/%6![P*CU5*"B;FS;$XR7D  [O$;_ &5%!Y]ME[*2\=;/
MO;?P0S5J\1O;6GI4T'H-O\>PN#KN"H[!XC:_6JE!R^<[(ZPVY8]K>UX<"!]4
M%0*,V6QS=##=Q'UZV]_U5-!T'Y.Q?)%;BZB\1SA[.MM:?72@[MGD+&2&9HOX
M&NB<X:#(RO0T[*I0=H9'&M;UO(7:A0$2-[>[O44*N0R=A&UNNYC:^GL@N K^
M2@Z,^6L7!VJ[A:X=VMO]E30=!^5LR(S[Y"6O.FH>WM'U4HA3@R>(-6.R$.N,
M]6ZV]_7TI0>A!<6MS*V.V?X[YG>P(_:K]:J)4KJ\M+5SH[@N@D;U<'C3T[>]
M!XLN<Q+1XINFACC0.J*5[?2IHAVL3E<;/EK&.*8/D\1O04]/PJ+HP>;6>!?N
M3!^5?VN3-J ]&^".OU&KY[+\7SOSWT;'_-6_O)6/-$ .#=[ &H%JVA^JOH-/
MXL/TG?LE^<6,5;*/3*_],5W71^%;N<PU?KW?:^=EOR^[AL=L<V;#S60@N[JS
ML,O:2S16,#KBX+6:R=$3>KCZ OENLL-/;Y_0W?3..=?NCYWZ,-B[RQF],<W)
MXFSR%G:O_P 'D[5]I-T],;^JY>^UF*2OQ$" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[-)[^Q615!/CS!:7E]97!U&RE=%I/0DM-%=5MWY8-F/R'(%AGK^-C[2)I=
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ME\/KW84@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M0GXQ<T%8L[)S,J[AOB8DMNB4,.8O'Q9/;SCU=!D9HW4]3PU(V(HEKXGP&?\
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M$! 0$! 0$! 0$! 0$! 0$! 0$!!2F:7,Z=QJA1 CYKOXW]P#O,/Y:Z_R:/\
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MVQZ87&M7-?7XQZ:E[.=VY>HT]N=,Q%^]&5;-LS'8APW;-)D^1-P74W5KLA.
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MS\<?NO\ C[$Y8P:S9WC'/< 20!U-?9]2M$DPU,X"L;NY>3;3>"+6&*C*D$T
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MRLN8LYG.L?"MK8-?!<M:?#;0.+@7$GM(4T*T7QM>6VW Z<!['SQS.CU1FK:
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MN=B>8[#9886WO</GL;&]M[A;X6L4AKK:WPHH[NXD/1M34#M44-B(D<HNX/\
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MC$<:[TS R4C+:USC3;MB>^-FEH?(\#Y26/\ +4$43:76]]MW]J+^RNK>YL7
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MHNRN<NP+G:\(-[K8]Y<&5<2"&G\BJC:,.\@>;K?%QD[G\%'^%B(XQ#%K.KJ
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M:YO=1B]&DI[:W>3L6MNZ1[]P9&2<.,KI:%].T4"S<RB(SYB%;-BV9&,='(7
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M2DO;%F,R>ULQ;>T,/F;<65U+%2IFCA?(Y[F#L+@**LV42V":YNEOM T ZU4
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MO7_"1CN0:Q/:T.H&]2>M>U!2\,!U [VO4@K-D>&Z>_M^LI&:_+]<M_&CM@.
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MCGL3^*NJKH,SCR;;O(ME[N_O*T[UJ<CN@![.]$$>MS0  &CN07WM%[6XO+3
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M''-IE]\YBUS>X-9;=7=G[J8_C.H/WI'''V =RB^VDE6R2J" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MN(;';[) (X(98Y@&ZNUWAN!)^%,1;F=OY<UN*SAMVN;9XZ2.WM3V,I$X#7U
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9&^PE(3656.%\9):X4)ZM[A\ 0=E 0$'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>tm2227887d4-lc_tumor4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_tumor4c.jpg
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M# P,# P,#/_  !$( M0': ,!$0 "$0$#$0'_Q #K  $  @,! 0$! 0
M    " D&!PH%! ," 0$! 0$  @,! 0            $" P4$!@<("1    4#
M P$#!0@*# L%!  7  $" P0%!@<1$@@A,1,)02(4=CA1,K34%;57&6&2(Y46
MMC=W&#EQ0I.STU5UU5:&%UB!T5)BTC,DE#:6II%R0^5HH8(T)36Q<R;!HK)3
M8Z2%I2?"@^-4A&=X*5F7$0$  @$# P(#!04%" $# @<  0(1,1(#(00%0091
M80=Q@2(R$_"1H;$4P=%"4G+A\6*"DB,S%:*C%@BR%\)STR14-3;_V@ , P$
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M?*"HN\80M+>]&\]RD*2HTI/S0682?!
M
M
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M[FT##9(
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MP[)H%;@5R,PONGI%/DM24(7H2MJE-*41'H9'H8#UP
M
M
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M]V/]^(O^F!B3]+OB]]/=C_?B+_I@8D_2[XO?3W8_WXB_Z8&)/TN^+WT]V/\
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M*-M7C741ES%TFDU!F5(*.T:4K=-MM1GM2:TD9_9(##;8(
M                                       "-/+;/<;CEA&YL@I)#UQ/
MFFC6/"<3N0]69B%G'WEV&AE#:WUD9EN2VI)'J9 L1E"+%%Y<<\/\2LCVK+SK
M9UP9=R/;-?K.09J*U&E2JA<-5I[Q>CH62S-SNS4EI.GOE[EEU68+.K8WAB9$
ML25QVL_&\>[Z2]?U-?KE0GV<F4V=1:BJJ3JB>5&W;]ADZ@]=/VQ>Z!9ISF8J
M/BWD19UU<4YU09Y5W>A]%ZX]MV&F?$J=+6PITY=4B]4)>5L)6BDGO(N^5L4A
M*UB/FW5X<E'Q55+%N')5/KTJ\<^W),<3F^MU].VMP9ZW#6<'NUJ4IN,:D;DK
M(_NQIU5M4CNFA99,#*K'@-[2/B(_G*;^>+E!J=(?+S!-,;G%P=E5!M3E,>J:
MH\1.\B3Z6<]E*3).XM#);C1G[O9UTT C1:JZZTPTX\\XEEEE)K==69)2E*2U
M-2C/H1$7:8,JK?"*B2V>/-]2W7%E$F9!F%$CJ29)U;I=-);J3/H>XS))Z>5
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MOV]5*PJ=5C9.03LFAUMM2"[AMI.TB9+3IKU,%SF%\P,
M
M                ".G+OV7L]^H]8^"K!8U>'PC]D_!?JTU^^N 3JBMQF45,
M\0[F319?W.?/@1:E&:Z=8_>0U[O=][*;\GE!9T;?\2R;%B\.\EL2$H4]4YE
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ML3(S"JAWKC4%A<A:&]T1*=RDH,BU,BU W/)\*#VH:AZCU;X5! MHZ208
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M>Z;3[?((A6G@*X.6&#LD\B,A?H9W+=']OERIN+Y(^6&H7R3MF5.7W'?>AO\
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M'#?]8?QBJ8%M4WP0
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MY(CPD0B@MM)=)]"B0TUN[PU(/KKIM!)20!
M                 5[\D'>9=^TK*V*;.P;:U3Q]=<&91*/>+MQ,,35PY3.S
MOSC.NHVK+<?FF7D!J,/XXK1>7^-Z3B_$-]X5MJDXWM:&NFU:]F+@CR)R&6VW
MG&G"BM.KW*4Z:4F1%V'K]D"</DY"<>LU4+/=%Y6<8DTNL7TJG%1\@X^J[Z(K
M%9BMM):0:'G%M(,U-MMH42W4;5-M+29Z*(")]& W3A_EMS N&QZ!R*LJ@84P
MK9U7;K5P6S3*JQ5*A7'V2-*6R<B2)*4I-"UMD:E(V$I:]%JV$0S$) <Q^,U?
MSC;]AW-C"LQ[6R]ARJIK./:@]HU'7HIEQ<92TH5W9DY':6VHR-)&G:9;5FI)
M(EH"]VO$8SO9<[#MQ8GL[$-'NQ@J9>F245J-+[RGKT1+1'BQ9LMU'I"-2,C0
M>J3-.J-=Q%Z+"\08QH.&<9V9C"VE+=I%G4Y$)J4X1)<DO*4IV3)<21F1*?>6
MMU1%T(U'IT!F6R '+'CC]8=1OSWR/GQT')Z.IP'&          "EWQC/^&\#
M_P IU_\ >8(-52G\,SV0+!_E.O?.D@$MJWAR[]E[/?J/6/@JP(U4\^$%^6W)
MGJ.KYRA@U9T(@P                    U9G3\B68O4>X?FV0!"@GPH/:AJ
M'J/5OA4$&[:.DD&
M                            !6;XK_LO4_UXI/P6<#5=6#^$%^1+)GKP
MKYMA@66U RCIR[]E[/?J/6/@JP6-6J_#B]C'#?\ 6'\8JF!;5-\$
M?#4JI3*-#=J-8J,6E4^/IW\Z8\AAE&XR26YQPTI+4S(BU,!];;C;S:'6EI=:
M=22VG4&2DJ2HM2,C+H9&0#\Y,J-"CNRYDAJ)%82:WY+RTMMH27::E*,B(OV0
M'RU.L4FB1DS*S5(E(B*<2RF5-?;CMFXL]$();BDEN4?86O4!CUZ9"LK'<*G5
M"]KCB6]%K%1BTBDG)4>^3-FO(8889;02EK4I:RUVD>TM5*T21F0>0UE['3U_
M*QBU<B%WHEQ;'R<4:5W!RFHI3G(:9W<^B*E(BJ)]4<G>^)K[H:-GG -D@
M
M    J5R%^MNP7ZCS/F:X0:]%M0,@
M            ".G+OV7L]^H]8^"K!8U>'PC]D_!?JTU^^N 3JE."
M                                               Y8\<?K#J-^>^1
M\^.@Y/1U. XP          4N^,9_PW@?^4Z_^\P0:JE/X9GL@6#_ "G7OG20
M"6U;PY=^R]GOU'K'P58$:J>?""_+;DSU'5\Y0P:LZ$08
M    :LSI^1+,7J/</S;( A03X4'M0U#U'JWPJ"#=M'22#
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MT 9<     J5R%^MNP7ZCS/F:X0:]%M0,@
M                 ".G+OV7L]^H]8^"K!8U>'PC]D_!?JTU^^N 3JE."
M                                                    Y8\<?K#J
M-^>^1\^.@Y/1U. XP          4N^,9_P -X'_E.O\ [S!!JJ4_AF>R!8/\
MIU[YTD EM6\.7?LO9[]1ZQ\%6!&JGGP@ORVY,]1U?.4,&K.A$&
M          &K,Z?D2S%ZCW#\VR (4$^%![4-0]1ZM\*@@W;1TD@P
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MB63/7A7S;# LMJ!E'3EW[+V>_4>L?!5@L:M5^'%[&.&_ZP_C%4P+:IO@@
M    #7&1<1XZRQ&I<6_[9:KQ4-YQ^C2B>D1)45;R20[W,F(ZR\@G$D1+)*]%
M:%N(]" R]^TK*M*PJ#2+7LRW8%M4"@L+C4>EP&4M-,-NK[UTDZ%KJXYYZS,]
M5J\Y1FKJ QG(^&L9Y<I<2BY$M1BY*3"=>?8I[CTB.UWDCJ\I:8SK1+WGU/=K
MUZ]H&6+5SC+@NY+?M>V*YCZ+4*3993$6P2Y,Q,F(U4%FY+93,0^F0II]1ZN-
MJ<-"NA&DR(M"Y;EH]'I-O4JG4*@4N)1*)1XS<.DT> RB/%BQV4DAMEEELDH0
MA"2(DI21$1 CT@%6_+KV\O#P_E"[/@\4%6D @ BRZWS8[USN)N$>YWGW.^+<
MF[9KTW:/Z:Z=N@+T<_5 .K%"FG>!R/PY*7(/)"JEKZ?\N;S^4#G&OSC=-W=J
M:O)IY-!Z!Y>.7^JMNSKT^STQ^VK]D?3&_CH]O<7Z.S$5G];3._KN_4^[3=_@
MV^BS[@XURK_L/,\:2,?LXR5<E5/'R+T9K+DGY/WH)ST(X3J&RA^E=_W):?Y6
MW[GL'NO9?J?H4_4_-B,YU?E/W-/:3Y3N/Z3'Z/ZEMFW\NW,XV_+X?)9O8"<C
MIMY!93<MMVZ_2'>\7:J)C=/]'Z=UHF<M;N_MW==/<'E.B9L H"\2$R3XB'#-
M2C(DI.SS,S["+\+9 *N(Y1&1<9^1)F>A%C&[M3__ "-+!%+/ U2T>&'S=6@S
M0HD7IM670]?P2A]A@-5\)^"\CF/Q\JUP7YE^OTJ@V-.JEM8?LV I!P*;43)N
MHR9LIMY"TK0Z[-T4ELD.&7:[H24D&X/#:LQ/+7B9G+C7E"ZKA;L2@W'0Y- D
M4V6VF9 :>4J8<6,J4U(;2R;\(E]V:#3JM9I(E'J T=X5O$C'N?JS<>3[NKUR
M4JN82NFW*G;$.BR8T>-)=2MV829?>QGG33OBI+[FX@]#/KKH9!]-_8ENWD!X
MF6?,(4"^I-AT+(,Y;>0JG%-1N2*+3H<2:Y%[M)I)W>ZRWHA1DC<25*U).@*V
MGSS54N%?'C"O#S&.0:TW1+NJ-?K5WW:X?HTYRE*FDMN$HXIIU:6N6LW4H(M_
M=%^U6I("%F8JYQ!Q;2+ O;A1E#(<',UL5F/\JU"J-OQ$/0BCN*<DH7W+24J)
M]#:3:U-"T+42B,BZA<[R^IF%,T8@XWY'Y.9\JF$L>U&AM5ZNXVHZG.]N*=5H
M$*4A"([:9#RCA>>G4HSII)TRW-FK504\2;TP%ASE/@J[.$5\W9(M\ZG38EYQ
MJV<F,IY;M12T_%,ULQE.QY,99)4A1&1&1G[F@;D\2GCQ9UL\S,>LPJM6WT\B
M*C$JUY'(?86<1VH54H#J8!DP6Q*6RU23G>:'_F] $RN7%O(\.?A$>-,!7C<C
M4K)M_>B/754Y;?RM#9G0''IBH<B"Q$2R9E3VFR-*247>+41Z]A%5=VL\*Z'@
MRAW#B[*M_)Y84=NFU655U1Y<6#(JBG$*GM,.DA*F.ZWK4TZ3FXS;+7WYZ%31
MY@<L<JW%P XGQY-<DP;FSNW5DWY7(;BV)%0B6N\4!33BD&728MYIUXBTW&G3
MWJC(PP_F#X=E*XN<8:=DBU,EU^367ETBF9;MB:MOY-J;TIU*VUQD,)1L*-(2
M6U+IN:EYQ+2HO."Y?P\?8NX_^K[OPZ2"2F>
MA_@SVGN<'K%8OXGP 'QUO;R&Y%0K50DI>(^,-0BUNZG#3JQ5K_6V3U+AH=2>
MBT4=A?I#R2/I(<:2I.K?0J9@(     *E<A?K;L%^H\SYFN$&O1;4#(
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ML*LM5VV:^SWT*8WT4A1'M<9>;/SFW6U$:5H5U29:#LGIC.0
M                                        !RQXX_6'4;\]\CY\=!R>
MCJ<!Q@          I=\8S_AO _\ *=?_ 'F"#54I_#,]D"P?Y3KWSI(!+:MX
M<N_9>SWZCUCX*L"-5//A!?EMR9ZCJ^<H8-6="(,                    -
M69T_(EF+U'N'YMD 0H)\*#VH:AZCU;X5!!NVCI)!@
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MK'7%7"UEWM19%N750:&IFLT25M[Z.XN4^ZE#A)-1$>U9&9:].P^H$I3 @
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M.+7U]ZG1)=$D VJ      *E<A?K;L%^H\SYFN$&O1;4#(
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MK2>6'\;VU]Y6O],')M@^M)Y8?QO;7WE:_P!,#;#ID!Q@
M                       /S>>9CM./R'4,,-)-3KSBB2A*2[34H]"(B >=
M2:[1*_'5+H59@UJ*A6Q<F!(:DMDK_)-32E$1_8 >J \5FY+=DU1VAQZ_3I%;
M8W=_1VY3*Y2-O56YDE&LM/+J0#V@ !RQXX_6'4;\]\CY\=!R>CJ<!Q@
M     I=\8S_AO _\IU_]Y@@U5*?PS/9 L'^4Z]\Z2 2VK>'+OV7L]^H]8^"K
M C53SX07Y;<F>HZOG*&#5G0B#                    #5F=/R)9B]1[A^;
M9 $*"?"@]J&H>H]6^%00;MHZ208
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MJF^"                *M^77MX^'A_*%V?!XH*M(!
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M9^UU.41VJ/46D/5R.W$K3L*.NKQ6CW-M2E-I-Y"#U/4DKU(CU'O[\</4
M  %2N0OUMV"_4>9\S7"#7HMJ!D
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M^4Z]\Z2 2VK>'+OV7L]^H]8^"K C53SX07Y;<F>HZOG*&#5G0B#
M           #5F=/R)9B]1[A^;9 $*"?"@]J&H>H]6^%00;MHZ208
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MAQ>QCAO^L/XQ5,"VJ;X(                JWY=>WCX>'\H79\'B@JT@$
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M2^R9D0&$IK:NJV+SI$>OV?<=+NNA2S4F+6J/,9G1'#0>U1(?CK6A1I/H>A]
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MQ@      5*Y"_6W8+]1YGS-<(->BVH&0
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M'XCOMG9D_J]^+M,!R5T=3@.,
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MG,/$5KU=*$56V\DP:54T-*WH*1#GDPZ25E[XMZ#T/R@LZ.M4'&
M"EWQC/\ AO _\IU_]Y@@U5*?PS/9 L'^4Z]\Z2 2VK>'+OV7L]^H]8^"K C5
M3SX07Y;<F>HZOG*&#5G0B#                    #5F=/R)9B]1[A^;9 $
M*"?"@]J&H>H]6^%00;MHZ208
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MM"($1'P9[3W.#UBL7\3X "8        *E<A?K;L%^H\SYFN$&O1;4#(
M                                    P^_;]M'&%HUN^;YK<>W[8M^.
M<BI5*0?0B[$H0DM5+<6HR2A"2-2E&24D9F JOM.T[^\1F_H62\EPI]E\3++G
MK58%@*6IF1<LAE1H5(D*09:D>AI<<2>B"U88/=WKH-:+<Z;3:?1J?!I%(@QZ
M92J9';BTVFQ6TLL1V&4DAMIIM!$E"4)(B(B+0B!EH'EW[+V>_4>L?!5@L:O#
MX1^R?@OU::_?7 )U2G!    '+'XCOMG9D_J]^+M,!R5T=3@.,
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M?EW[+V>_4>L?!5@D:J>?""_+;DSU'5\Y0P:LZ$08
M:LSI^1+,7J/</S;( A03X4'M0U#U'JWPJ"#=M'22#
M                                                       K-\5_
MV7J?Z\4GX+.!JNK!_""_(EDSUX5\VPP++:@91TY=^R]GOU'K'P58+&K5?AQ>
MQCAO^L/XQ5,"VJ;X(                JWY=>WEX>'\H79\'B@JT@$ 'Q?)
MM./J<"-J?E[I'^(! FE\=^06)HDBQL-UVP+@QE%>=58J+Q55(52MZ(\X:T4]
M28#,E%19CZF32E.,.;3)*C/:2C^4^Y_I%XSSO?SWM[\G':V-\5QBTQ&,QNB=
MLZ9UCIIG,SV?;^4Y.&FS$3\$F,)X7IN(;->H,RIE>5SUVJS+AOF\I,1N,NJU
MBH*(Y$DHR5.(8024(;;;2HR0A"2U,]3/Z9V/9</9<%.WX:[>/CK%:QKBM8Q$
M9GK/3UGK+K[WF]IM.LMSM,LL([MAI#*-==B$DDM3^P0\IA^@#GV\6?Y9QYRE
MXN9SET9^99]N,4W26V7F.3*#6UU-Z*:NI)6IEY!IU]]YVFNU6A4T.5'/#C#,
MXK9/=M'+-OWA7LCV?5+?M:T:=*)RJG)K$1R&E4J$1&]%2R3QN+[]""T3M(]Q
MD",;\'6Q:]:7%.I5NMPW8+.0KTJ%<MY#J=ANT]N)"@(?(CZZ+=BN[3TZD1&7
M0R,!%KE#^M_X]?\ ?M#]_DB*LL\1;V*L_?R'%^<8@J(5^'CRVXX86X<6;0\F
M9=H-L7#1Y]=D3[:<=6_4D(>J4AUHRAQT.O'O09&G1/4C(%1VXS(JO-CQ*[BY
M,4>B3X&*["FIJC<^6R;>U$"G)IE&C+6C<VF0\M"9"F]QF24N=3(M0'1F".<3
MPP,<4;+Z.>&,+@(BI5\TF!2)#QIWFPJ1(JZ6I"4ZIU4RYM<3U[4D"H%V,]EO
M)2<=>'].6]2(3&79,BI1W]37!G+0BG24*;V;DHA$B6\9:GJI:NA&74+1N:E'
MIEN^(]P'M^BPVZ?1Z&Q95/I,!HM&V(T:YI#3+2"]Q"$D1 C LDW!3,#>,9%R
M)E]Y-+LFOKCRJ/=-1+NXK$2HVU\DQY1..Z))N/*2II:]=$;5'Y 5^/BOY2QY
MR+O/CIBC!EQ4K+%Y,RZFE4JUI3%6CI=K3D*-$AHDPUNH4XM<=2EH(_-(DF?:
M",WYMTM=/\1/@)1I[J:BY!9L6'+?66XGE-70\VM9DK77<9:]0)?7XY"4_(G&
MU>TMQ3KJ(E:=2(VZ5J6O^ !@_-*HLXC\3/CWEK(DI<''CD2UZBS6EI6\U&BP
M7G8TOS4DI7W%S[JHDD9Z+(]#,P5EGBX\@<,98QGB;&&*KUH64KTF7@W7$+M2
M;'K/HL5N%*A%&6Y"4Z279+TMO:UKN/N]33[W4B['#] J5J8DQ;:]9(RK%MVC
M1*55B5V^DPX#+#VNO^>@P&Q0             !%OE9_] L*?GNQW\^, L)2
M@  (0W97*ORPNFL8HL2?(I?'RUI9P\S9+A*4@[HDM*T>MBARFU)^XI,C3/E-
M*U3IZ.CJI9@J95$HE'MJCTNWK?IL:C4.BQ6H5)I,-M+3$:.PDD-M--I(B2E*
M2(B(@1Z@"'^#/:>YP>L5B_B?  3        !4KD+];=@OU'F?,UP@UZ+:@9
M                                       8??M^VCC"T:W?-\UN/;]L
M6_'.14JE(/H1=B4(26JEN+49)0A)&I2C)*2,S 57VG:=_>(S?T+)>2X4^R^)
MEESUJL"P%+4S(N60RHT*D2%(,M2/0TN.)/1!:L,'N[UT&M%N=-IM/HU/@TBD
M08],I5,CMQ:;38K:66([#*20VTTV@B2A*$D1$1%H1 R^T!'3EW[+V>_4>L?!
M5@L:O#X1^R?@OU::_?7 )U2G!    '+'XCOMG9D_J]^+M,!R5T=3@.,
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M%00;MHZ208
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M:@91TY=^R]GOU'K'P58+&K5?AQ>QCAO^L/XQ5,"VJ;X(
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MB7U/S4]/*"QA"R]<&^)ED&TKCLBZ,U8EFV[==/?IE:B-L2&5N1I"#0XE+C=
M2M)F1]J3U!<P^>P<">)9C.SK>L*T,T8F@6S:\4H5&ANLR'UMLI,U$DW7: I:
MNJCZF8&831X[T#D]0H5THY*WM:=YSI+T0[2=M9I32([24N^DD_N@0-34HV]O
M178?9Y23A) $  !RQ^([[9V9/ZO?B[3 <E='4X#C
M                            <L>./UAU&_/?(^?'0<GHZG <8
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MH]6^%00;MHZ208
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M+9S!B6]:HFB6;E&T;MK2FUO)I%&K<"?*-MOWZR9CO+7M3KU/30@&Q0
M  %6_+KV\?#P_E"[/@\4%6D @
M           (M\K/_H%A3\]V._GQ@%A*0$1!RQD2\,G7G/XYX*JKM'K$9ML\
MVY@BD2V[/ITA)**%"7U0NL2VS^XH_P# 0??KZ[ 5(K'F/K2Q99U$L2QZ2W1K
M;H#/=0XJ3-2UK49K=??<5JIUUY:C6XXHS4M1FHSU,$9H   "'^#/:>YP>L5B
M_B?  3        !4KD+];=@OU'F?,UP@UZ+:@9
M              5D<"WF5YNY\)0ZA9N9:FN-D2B,U(^4JQYQ>Z77M!J4_LD9
M(LS$EF5J_K^K3-!MF@L][,F.]5+4?1MEELO.<=<5YJ$)ZJ,&57MAV'?WB%7]
M3\S9FI\RT^,5IS%KQ;BU:U-KKJVU&DY4HTF6Y"M-''"[>K+)[>\<,UHMRAPX
ME.B1:?3XK,&!!91'A0HZ$M,LLM))#;;;:")*4I21$1$6A$#+Z0
M <L?B.^V=F3^KWXNTP')71U. XP
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MJ"#=M'22#
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M3THX'I37IQ-$^</>GO2:-6TG-FN[;N+37334!5_RZ]O'P\/Y0NSX/%!5I (
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M;.S)_5[\7:8#DKHZG <8
M       #ECQQ^L.HWY[Y'SXZ#D]'4X#C             $=.7?LO9[]1ZQ\%
M6"QJIY\(+\MN3/4=7SE#!JSH1!@                   !JS.GY$LQ>H]P_
M-L@"%!/A0>U#4/4>K?"H(-VT=)(,
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M:.DD&
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M8IAK5%ID7>K5QU1K====<4MQUQQ1ZK<<4I:CZJ48W$8>):TVG,ZLV%0
M0_P9[3W.#UBL7\3X "8        *E<A?K;L%^H\SYFN$&O1;4#(
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MD0O''8O3P            !RQ^([[9V9/ZO?B[3 <E='4X#C
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M/</S;( A03X4'M0U#U'JWPJ"#=M'22#
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MY*<?IC/WS./X8_B_1_T*[#B_3[KN<?\ <S6D?*OYI_ZIQG_3#[!ZP_0+SJO
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M1%V$0,O]              '+'XCOMG9D_J]^+M,!R5T=3@.,
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M-J7W:#T+5"$F9:Z@DSE(($<L>./UAU&_/?(^?'0<GHZG <8
MCIR[]E[/?J/6/@JP6-5//A!?EMR9ZCJ^<H8-6="(,
M -69T_(EF+U'N'YMD 0H)\*#VH:AZCU;X5!!NVCI)!@
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M7<1>-&(+GCWWB[%%'M:YV(ST6+7H;LEUQ+,@MCJ4=\^XDMQ%H9D6NG0$24
M       5;\NO;R\/#^4+L^#Q05:0"
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M=]L[,G]7OQ=I@.2NCJ<!Q@
M         .6/''ZPZC?GOD?/CH.3T=3@.,             1TY=^R]GOU'K'
MP58+&JGGP@ORVY,]1U?.4,&K.A$&                    &K,Z?D2S%ZCW
M#\VR (4$^%![4-0]1ZM\*@@W;1TD@P
M               (<\]<B7GBWC)>UWV!7G[9N:),I$>)68Q(-YIN34&&G=AN
M)41&I"C3KIJ6O0%C53S:UT^)]>UO4FZ[4JV0Z[;E=8*32*O&.,;3[1F9$M!F
M1'IJ1^0&NCW_ /\ RO\ _P#4K_\ %0.A_P#Y7_\ ^I7_ .*@='E5VM^*3;-$
MK-R5Z=D:ET*WX,BI5JIO'&)J/$B-*>?>69$9[4(0:C^P0'19WX:^6\AYCP)<
M%?R5<LBZZY1;WJ%'AU:62._.(B!3I:$+4A*=VUR4O0SZZ:%V$"6A8.#(
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M<$        5;\NO;Q\/#^4+L^#Q05:0"
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M>H]P_-L@"%!/A0>U#4/4>K?"H(-VT=)(,
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MDNUBHIL:9DUB.U66Z4VI"&([;D63*:?CLF2D-N)46IDI.Q.W0"4UP0
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MT15F0J       J5R%^MNP7ZCS/F:X0:]%M0,@
M                             #EC\1WVSLR?U>_%VF Y*Z.IP'&
M                         "E?D5X9>5<P9LR'DR@9"M:#2+QJ13X4*I'.
M*4RDV6T&VX34=U'FJ29%HKWNG9V U%FEOJ@LV_298_VU2^)@NX^J"S;])EC_
M &U2^)@;FT,)^%SEK&F7L:Y"K.1K4E4JR;CI];GQ*><XY+S<%]+QM-][%0CS
M]NT]5%T,P)LO!!@          '+'CC]8=1OSWR/GQT')Z.IP'&
M   (Z<N_9>SWZCUCX*L%C53SX07Y;<F>HZOG*&#5G0B#
M    #4F?9<6%@W,3TR2U$9.RJ\V3KRTMIWN4]]"$ZJ,BU4HR(B\I@L*"/"IF
MPX7*%\IDMF(<RSJI&B$\XEOO7ER81I;1N,MRE:'HDNI@U;1TI P
M                                     #3W(9521@+."Z-WGRNBP+E.
MEFS_ *PI!4N3W1HZ'YV[33[(+"G#A5R;Q)Q[XAY=ER+AIT/+Y5JHS*):[I&<
MZHR'8$9BE&E.T]["'B5O,M2;+>HR+=YQJ8S+6/![A72>5E*R3D?*U<KT*CMS
M54ZA5&G.M(D3:P\GTB9*><D-/;R9)QL]-//4L]5>:9&)G"37A#URL1O[?\?.
MR%S*!0*A2:C 66I--2Y'ID60HBZD1OHBM'V_^'Y?(2RZ0&0
M          $=.7?LO9[]1ZQ\%6"QJU7X<7L8X;_K#^,53 MJF^"   Q^Z;MM
M6QZ',N:];EI5H6W3S:*?<%:F,0(3!O.)9:)V1(6AM&]Q:4)U5U49$74P%4&5
M,VY_JN0+JG8EY_<8;9QQ*E[K1HM6K5*>GQ8NQ);7UG&D$I>XE'KWBB_8["&8
M2RX'XSHN*\"LT*D9<H6:I%5N&J5NXKQMF5'E4A-3G*;5)BPU1E*0E#9D1F6B
M3W*-6Q.I)()F@        *M^77MX^'A_*%V?!XH*M(!
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M[!?J/,^9KA!KT6U R
M          .6/Q'?;.S)_5[\7:8#DKHZG <8
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MWBC6A2#;U6A;6WM>+ECDKF'G4O%ZYA:8.5H
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M2_L6MM"E)WZ*4E)F1FD@1NL    !4KD+];=@OU'F?,UP@UZ+:@9
M                                            '+'XCOMG9D_J]^+M
M,!R5T=3@.,                               !1QG5V+C;Q5,87G=AIB
M6]=)41Z#.?/[BDI,%VAH<4HSVI)N2WJKL(O?'[H-QH]_FO>3G'CG?@#D%5:7
M*J-IE;1PIB8Y(-U9-*J$&I(8)>U*EM1JBTX1&HM5*TU3KJ"1UAI3+7(>T.1?
M.'C+=."Z?46IE$K% I4^NS(YQ'IO_P T[YY*VT*4LV&8[BTK4K0S2:RTVD1F
M7&(="8,   @]F;C!GC)&1*Y>%E\Q;IQ1;531$33K#IM-=?C0O1XS3+IH=;JL
M0E=\XA3IZMD9&HRU/0%B4!>3-B<G./CN,Z'1>:M\Y)R#E2OMT6UK+;8DTY2T
MF:4+D*>^5)AZ)>=9;)/=^=O,]?-,&HQ*>/+[/%_8+QSC*Q;!?9K>=<O5&):=
MHU20VA2"E$EAF74$L+(TK6;S[24)41I)3I*42B3L49B,M'W[QHY9XUQ[6<KV
MUS$O2[LF6G3G*[5K1EJ<<H,WT5!ORHT2&\\XT6B4J)O<SHX9$6UO=YI<PFCQ
M5S?^D+@ZS<ER8K4"N3VWH-TT]C4FFJE!<-B0;9&9F2'=I.H29F:4K))F9D8)
M,82)!'+'CC]8=1OSWR/GQT')Z.IP'&             (Z<N_9>SWZCUCX*L%
MC53SX07Y;<F>HZOG*&#5G0B#                   (">)FU57>(=]?)J5*
MC-5.AN5LDD9_[(518T,]/(3QM'U!:ZLZQP_1Y6/+$D6\I"Z ];U,715-F1I]
M$.*WW.AIZ>\T[!Z]RYWSGXRZB^=TY9H.-E5CXBT:LU.[>/M+QVU5).6'Y-9_
M!UF@&Z53[I11"3W1QS)TE&M)[#3[B_LCL_'YQ;X='G=EGK\%=3F1^1MGW_"M
M*\LB9"H%>IM4ALU>@U*M51E]DW%-K)#K2WR,MR%D>AEV&.R><Z\ <8
M                                    (F<L^)EM\KK9MRCUBZ9]GU:T
M9,F50:Q$9;E-$<MM"'42(RU-FXD^[09;7$&6G;U!8G"GRO\ !7FOQKJDBZ<-
M5Z7<<5H]SE3L2HO19RVF^J4RJ8Z;2WM3_P##03Y UF)9/CWQ2.0&,ZE^#&=+
M%CWJN M+51]*C*MVO,Z'HKO$I9[@S(NQ)QT&>G5774AM64XE\1/C#E7T6$]>
M*\<U^0:4?(UWMI@(-9]NR<E;D,RUZ%N=2H_\DNP&9K*;T27%GQF)D&2U,AR4
M$Y&E,+2XVXA74E(6DS)1'[I&"/H                   !KZL9:Q5;U2E4:
MOY-M2AU>"HDS:54*U!C265*22R)QEUY*TF:5$9:EV&!AYO\ ;IA+Z8K'_P"8
M:;\8 P?VZ82^F*Q_^8:;\8 P^VFYBQ'6)\.E4C*=H56J5!U+$"FPZY ?D/NK
M/1+;33;RE+4H^A$1:F!AKKEW[+V>_4>L?!5@L:M5^'%[&.&_ZP_C%4P+:IO@
M@  -59KS'9N \;5_*M_*G)M6VUPT5$Z;&.7)UG2VH;6QHC3K]T>3KU+0@$#T
M^+IQ 0IQ:57FE3IDIU16^9&HR(B(S/ONO0B(%3=P+GJPN1U@HR1C==17;CE0
MDTPCJD14.1W\7;WGW,U*\WSRT,C!&Z         %6_+KV\O#P_E"[/@\4%6D
M @                          (%-9'QZOQ#)%+3?ENJJ9X6:MXJ<54B&_
M\L)N9QXZ=W?>[O22;,E]SIOV]=N@*S>\\S7CE&Z*KA_C+)BKJM&D'"R?G"6Q
MZ50K4T\UZ)#2?FU"K$1DI#!?<6^UY9&6P!N3$6%[,PS19U/MIJ54:W<$GY1O
M:^*NZ<RMUZHJ+1<RHS%EN<6?7:DM$(+S4)270$;:   !C=Y?\(75_(\[X.L%
MAJ7BC[+?&O\ -79WS)#!&_@        $2,J<=,FY0K#,E_DK7*%;])N:!=5J
MVQ&MN@/-TV;2I"94';(=BF\\EIQ)'HZI6[L5J"MWXVM2^K3I]1BWWE2=E6=*
MD)=@U.=2J92516B02392W3&64+(U>=N41GY.P$;(   !IW,&;K0PW3:8JL-S
M;ANVYWSA6'CBAME*KE>FD6O<PHVY/FH(]7'5FEMM/5:RZ:AIRWN/E<RS5F,C
M\L8]+NRJ]RZFT<'L'Z7:=K,R6S:7WB'"VU*H+;5H[)=2:$*-28Z4H)*C*U!Q
MZX_XDIG)CD7%:M14Z%@ZO6FUB*G52H5"IQ;?*I6S#G2508\Z2^TVM4AU3B5[
M=R#/S#20X./MN+CO:]*5BUM9B(B9^V?7[UF\S&)E9(.=D      %2N0OUMV"
M_4>9\S7"#7HMJ!D
M        <L?B.^V=F3^KWXNTP')71U. XP
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MBLQN7F'(UQIE(N&/D:GMUY$XUG**:B<12"?-S51N$X2MV[KKKJ"SHZVP<8
M           CIR[]E[/?J/6/@JP6-5//A!?EMR9ZCJ^<H8-6="(,
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M(>;6D4C$*F.:WMQY+]9:-\"@CD<L:.IP'&
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MS>U)Q[;DNZ*W!K-1I\)QEMV+0*3.K<Y1O.$VDVX--9D2%D1JU4:4&22ZGH1
M(!8DSM;U SSR<NZK6#E2)0,IUVTW[+G*QS=NDANFV[#ILE3B2I>K)(D-J3]T
MVZD6XO-Z@JRP$      !4KD+];=@OU'F?,UP@UZ+:@9
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M(   .6/Q'?;.S)_5[\7:8#DKHZG <8
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MM"M$FXRM25$E9I2>J5)4E)D.]B8F,P^47I-)F)C$PE *R
M   #^'&T.H6TZA+C;B32XVHB-*DF6AD9'T,C(!X=+M2UJ'(>ET2VJ51Y4C_7
MR8,-B.XOM]\IM"3/M/M >^ Y8^:WMQY+]9:-\"@@Y(T=3@.,
M                               !C5YW53+%L^Z[VK?>_(UG4>=7*OW*
M26[Z+3XZY+VQ)F1&K8V>A:]H#FSNCE7S0Y77O4Z9BZ;=E.@'WCD&Q[!.1&1!
MA&K1)S)D0FW5Z]$J<><)!J/1))(R2#DQ$/,K"_$3X\QBO*NU7*5MT:&:7952
MF5"16:2T:]I)5+:6[,BIU/1/W9/;YO;T Z2N<X(\L)O*#'U;_"J%'@Y$L"1&
MB72J&DT19C$Q+BHDUML]>[4YW+B5H(S(E(W%HE9)28F,)T @
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MAJGI4DI"XY+)HU[E*]Z2U:?L@SELX   '+'XCOMG9D_J]^+M,!R5T=3@.,
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M0GLU/0M3/M,^TSU,^ICY=S\UN;DF]M9G+]\>#\1P^)[+B[3AC\/'6(^&Z?\
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MEU1+4U2HB$HB4YHE%YJ8S2#+4R-1ZF!E)$$ $/4>W](__M^9_&IT%3"!
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MX:.B6HT5M+33:?L)0DB(&7I@*S>;'M0^'MZ\5?X500:C25F0,@
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MO0F<                      #ECYK>W'DOUEHWP*"#DC1U. XP
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M(/:GB@              J5R%^MNP7ZCS/F:X0:]%M0,@
M    "K'&?_Z?_$9RED97^V6AQGHB;1MMXNJ$U9[OHSNI'T/1Q=0ZE_DH/W :
MTA:<#( K-YL>U#X>WKQ5_A5!!J-)69 R                 (Z<N_9>SWZC
MUCX*L%C5X?"/V3\%^K37[ZX!.J4X(    Y8_$=]L[,G]7OQ=I@.2NCJ<!Q@
M                             QRHV?:-8J].N"K6M2*I7J/_ /0BMRX,
M=^9%ZZ_<'W$*<;Z_Y)D K&Y6\\9W'KD">/JMB*AWU:<>B4^8N<\ZJ-5#.6;B
MEFV\XV^T:$:'HCN^IZ^>6O0U$9;*Q7S\X=Y*]&B5*5$QE6WB(E4V[:<Q$8W=
MBC*H-=[$).O8;CB#,OVI==!B4[*)%LVI1H=<MR/1:A#?+O:?6*:B.ZTLO\II
MYDC(_P!DC!EDP           .6/''ZPZC?GOD?/CH.3T=3@.,
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MT:349+LIQMDJ527";0IU2C2DEN*5M+IJHS[3,$LLW!D
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MWB^UIVO:TBG%2,5B/WSUGK,S,S,S/69F9EXW+R6Y+3:VLI,#L'&
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MJ.KYRA@U9JSQ2?:PJ_JU1?WI8+71T68R_)MC[U:I/P-H'&S@
M          <L?-;VX\E^LM&^!00<D:.IP'&
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M";=<(MI+6EA""4K0M-3 9"               "I7(7ZV[!?J/,^9KA!KT6U
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M^^N 3JE."    .6/Q'?;.S)_5[\7:8#DKHZG <8
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MJ>?""_+;DSU'5\Y0P:LU9XI/M85?U:HO[TL%KHZ+,9?DVQ]ZM4GX&T#C9P
M                    .6/FM[<>2_66C? H(.2-'4X#C
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M4%;ZQ;F*-DB5,I3..,A62Y28;;RYEXVY*HD9_51(V,.R.CBR[32773J W0"
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M+CRUJ2G]J1D7D'Z6B,1AZ\VD*
MJ5R%^MNP7ZCS/F:X0:]%M0,@                   *LK"(\_>(_D:]W".7
M9_%ZAE;%#6?GM)K3_?1G24GWI*)UR=UZG]R1[A;36D+309             %
M9O [\MO/O\[LWYRK -2LR!D      $=.7?LO9[]1ZQ\%6"QJ\/A'[)^"_5IK
M]]< G5*<$    <L?B.^V=F3^KWXNTP')71U. XP
M          '/IXC5 7C+EG9F<E5*AW9!=>MVJR["=J49%1971EHT8?@$X<KT
M64F*9D^ELT;C6DS)6W<;KHLMMOQ$^)->H5+K$S*#=M2ZA'2[*H%3@3REQ'#Z
M*9>[B.ZV:DF6FJ%J2?:1Z SMEGEI\TN,%\W+1;0M7+E.JUQW%*;@T6F)BSVE
M2)#IZ(;2MZ,A!&H^A:J+KT Q*40(  "EJ^[IRTKQ,LB?V26%!R)>UJ6+!I=
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M""_+;DSU'5\Y0P:LU9XI/M85?U:HO[TL%KHZ+,9?DVQ]ZM4GX&T#C9P
M                 .6/FM[<>2_66C? H(.2-'4X#C
M                            !%CFA:65+XX[7O;>&CG*OJ>[3CAQJ;,*
M!+?C-SF5RFFI"G623JT2MQ&LMR=4]==#+"F^S,C<^^%\B%<>0;6NNX,:N*)%
M6H-QR5U:F$V6FI-SF7)?R>YH1[#W$D_*A9%H#725\F$\LT'.>+;/RK;463 I
M%W1G76H$PD]\P]&D.Q)+*S29I5W;S*TDHO?$6O370&9C#:8(
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M+\(?0H_R]\F]YZ%Z;W:?2/1N^^Z=UWF[9O\ .VZ:]14>F
M                    "I7(7ZV[!?J/,^9KA!KT6U R
M  #7F6L@0,4XQOS(]2V*BV91)E42PLS(GWF&E&PQTTZO.[6RZ]J@(1 \-S'\
MZV>/A7_<.YZ[LV5N==]:FNE]V<9=<-F+O/H1DM*%/E_]5/\ 8(U98$#(
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MD2R9Z\*^;88%EM0,HZ<N_9>SWZCUCX*L%C5JOPXO8QPW_6'\8JF!;5-\$
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MKMK&.D3-M9Z]7'WG=SW%]TQC&B6X]R>(
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M[-^<JP#4K,@9      !'3EW[+V>_4>L?!5@L:O#X1^R?@OU::_?7 )U2G!
M  '+'XCOMG9D_J]^+M,!R5T=3@.,   !0YR'\1^F74UF+ U\X!C7!;)S:K;1
MSX]Q*B2$N092VH\YLETV0E+C;C274%U(E$6IF6I&;BJGI-9JR*.];Z:E)*A2
M)C51>I'>*]&5+9;<:;?-K7;O2AU:25IKH>@-+4\#^))3,.V)C_$%C<?XL2FT
MHFHE2J\FXE.O3ILIPCDSG$HIK>BG7%*5M-2MI;4$>U) S-70J#
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M,CZ&1D8#":3C+&U JQUZA8]MJBUQ1K4JLP*3#C2S-P]5GW[325^<?4^O4!G
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MTFONH[;32>A%T2DB!B6_00
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MOFV&!9;4#*.G+OV7L]^H]8^"K!8U:K\.+V,<-_UA_&*I@6U3?!
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M'HTAM1*0XVLB4E25%T,C(]2,AYKG?L
M                       J5R%^MNP7ZCS/F:X0:]%M0,@            "
M.F?N+6)^2OX)_P!J$2IROP+]/^0_DZ:J'M^4?1^_[S:1[M?16]/<Z^Z"Q.%=
MW*[P_N.V(N/F2LC6;3:ZS<UKPHK]*=EU1Q]DENS8["M[9I(E>8XH%B6<X5\-
M_C+?.&\2WM7J7<#E=O"S*#6ZTXS5W&VE2ZA3F)+YH02-$I-;AZ%Y" FTIY8(
MX\XXXY6[6+7QI&GQ:37*B=5GHJ$I4M9R#9;8U2M1%H6QM/0$F<H36HW_ &]^
M)+>MTJ44^S^+=NMT*E*[6DUN43C2TJ3V;DNOS/./KJRCW"T+I"TH&0
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M.MK6F;6G'I&9G$>D8C,ZO6>?FGFO-Y]65\:O;%Q+^<J%\X#V%P3HZU <8
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M""(><\NJTOA'[)^"_5IK]]<!F=4IP0
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MAK6/4*-@2;DRX^\?N_.-Q5&ZZU.?+1YUDWE,1S5[J5FAQ])GV][J#5EA8,@
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M ^RV[9MVSJ+3[;M2AP;<H%*:)FG4:G,(C1F4%Y$-MDE)>Z?3KVF ]P
M                >75ZY1:!%3-KU8A42&MPF42Y\AN,T;BB,R02W5)+<9),
MR+7R (H9@X4\?.1-VM9+O2)4ZC6)U.C1$5&DU1;,9^.P2C961():3U2O3<D]
M#+0%B<(.Y3XW^&%A:ME;61[[JM$N DDM^BQJE4JI)8)1:I](:IL22IDS+J1.
M$DS+0RZ&"YE-#B1C'AQ2*9*O;C(Q1Z_*6@H=5NHY,B;5V"=+7N7DSS[^'WA)
MU-!-MDK34R/0$G*:H(          #ECQQ^L.HWY[Y'SXZ#D]'4X#C
M      &OL@XGQIE>GL4O)%BT6]8<51KA)JL1N0N.I6FY3#JB[QHSTT,T*+4N
MA@-56?PZXPV)4V:S;6%K<8JD9:78DV:RY4ELN)/5*VO3UR";4DRU)2=#+R N
M948^*3[6%7]6J+^]+!NNC1_&KVQ<2_G*A?. $Z.M0'&
M   ^6=!@U2'*IU2AL5&GS6E,S8,EM+S+S2RT4AQM9&E23+H9&6@"+T[@_P 3
MJC5/EB1@RW&Y>[?W,9#\6+KJ9_\ PC#K;&G7L[O3R=A N92)M:T+5L:C1K=L
MRVZ9:E AF9QJ-2(K4.,A2O?*)IE*$[E>4]-3\H(I(\8S_B3 _P#)E?\ WZ"#
M=5F7"/V3\%^K37[ZX#,ZI3@@
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M\*^;88)9;4#*.G+OV7L]^H]8^"K!8U:K\.+V,<-_UA_&*I@6U3?!
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MI+QH3[Y7=M.*5H7E/0!E(    "I7(7ZV[!?J/,^9KA!KT6U R
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M5%?5OTW*T4T>AFE74FL.D$&           <L>./UAU&_/?(^?'0<GHZG <8
M              #F;\4GVL*OZM47]Z6#DKHT?QJ]L7$OYRH7S@!.CK4!Q@
M                     *)O&,_XDP/_ "97_P!^@@W59EPC]D_!?JTU^^N
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M63/7A7S;#!++:@91TY=^R]GOU'K'P58+&K5?AQ>QCAO^L/XQ5,"VJ;X(
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M0IH9%GWQ);AK?_Q=F\5;:32X;B3)3"J]-)Q"B4GR+2Y(D%K_ )49(+Z+109
M             !\LV;"IL1^?49;,"#%0;DJ9(<2TTV@NU2UK,DI(O=,P%6W
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M=5F7"/V3\%^K37[ZX#,ZI3@@
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M?JUIUYFW+GN&G4&1(HM/G/,LR"*3/2>QM*6WT*4HRT(NH+A(<$
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MO_OT$&ZK,N$?LGX+]6FOWUP&9U2G!
M        1]Y56Q:MY<>\H6W>]Z-8[M:HTMLZO>CT<Y:("&)++Z'#CI6VIW5;
M:4[$J)2M=$]= 6%/N/\ PQ\<92M%^_;$Y<1:[9\9V0S)N#\#78L=M41)*?W'
M*J[1DELCU-1EI]GH#6YZMG>%AC[(D>;+Q_S(MZ^8M-<2S49-O4.)4VX[BR-2
M4.KB5]PD*41:D2M-0-S,OJ:__4=_TA_YV!N3JX<</6N)4"_HI9!7?[]]2*<Z
MY(.F'2T1D4Y,A*4DUZ;,)1J.2HS41I["+KH6AF9RFF"
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MA^X+&@5:(]3Y;M*BTR!3437(<E*'F/278KBD)=0E1H)"S+11 2EZ"
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M9A]&IFAQ#$M"5H/JA1&D]#(R!)2?      %2N0OUMV"_4>9\S7"#7HMJ!D
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MCU5;$BS:%=SM%CG>;-4,I$55:=..VIV'Z,:2)MW35/>:FCS]>N@+$=$_P0
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MQBJ8%M4WP0
M                                 !4KD+];=@OU'F?,UP@UZ+:@9
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MU]R41ET-&AEV%T!<MT@@ Y8\<?K#J-^>^1\^.@Y/1U. XP
M ',WXI/M85?U:HO[TL')71H_C5[8N)?SE0OG "='6H#C
M        43>,9_Q)@?\ DRO_ +]!!NJS+A'[)^"_5IK]]<!F=4IP0
M                                !KZ_\8V=D:@W%1;@H=/>D7!2I=).
MN+AQWID9$MA3'>,N.MJ,E()6Y/V2(!&7C#P>Q_QRI=VP9E18RA(NJ5%?]+K=
M(B)*(B*AQ*6V4*-\RW=Z9J/=UT+H6G4LSE*/^S+&WT?6U]Z8?\$",@H]NV_;
MK3S-OT*GT)F0HER&J?%:BI<41:$I1-)21F1>4P'L
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MT-WG;.R2Y&AN2'I*8I1YKS#")).-1]ZC;(]AGM5U+4R)>
M       "I7(7ZV[!?J/,^9KA!KT6U R             *<?$ZR;6*S=&.^-]
M+GOT^WJK3_PQR(J.>BI49M]UF!&4HNQ/>QW%&1ZEO-I9I\PAX??]U_3<%N36
M8T^V>D/8O:G@K>;\GP]G$XWVZS\*UB;6F/GMB<?- */'CQ&&8L2.W%BQT[&(
MS220A"2ZZ$1?9ZG[I]3ZCYQR\U^6TVO.9E^W?%>)[7Q?;U[?M>.*<<>D?'XS
M.LS/K,]9?E4($.JPI%-J,=,J%*3M?867_8I)_M5%KT474O(-]OW-^WO%Z3B8
M_C\I^3QO/^WNS\WVMNW[JD6B8G$_XJ3_ )JSZ3'[ITF)CHM$\,/*M=JMIY P
M5=$]RHR<02HCUH37S(W5T.J$XIIGH:NC"V]2(S\U+J4%YJ"T^D]MSQS\=>2/
M6,OPWYCQM_&]YR]K><VX[VK,QI.V<9CY3K"TP<[K0            !%3F%R+
MC<<L23Z_3]DS(-SK51L:T79WRGZF\G0GU,]JVXQ'O46GG'L;Z&L@6(RQ+AGQ
MF:PYB>:_D.$U7<I9:=*NY6E5)")+BGI&KK=/>->\G"8-Q1KUUW.J<5J9;=!,
MM"<"K1M1K.?-Z0U;%);D6OE29"ME]$)@ETZ-\H59/<0U$C5E&UM);4:%H1=.
MA LK4P9      !'3EW[+V>_4>L?!5@L:O#X1^R?@OU::_?7 )U2G!    '+'
MXCOMG9D_J]^+M,!R5T=3@.,   !SG9L\-_)UFP,IYBO3)EAT*U*=*J5=429%
M2>?6R^^MQE@DJ@-)[]U2TMH02C)2S(B4#<65==P^3!2396492S:3(VGL-9$2
MC22NS4B,CT!I:3ACPVLGW;#Q9F"S,FV'7K3J4FFU]I1R*DR]Z.R^AQUK:4!P
MN^;4A3:T*,MJR-)GT!F;.BT&                       5T\Q>3?'KCK>-
MLU.XL0T;*6<BB-5"@/JA0&IM,AM.K3'><K#\:0_'U<)?=):2H^BC/81D:C41
ME#SZXRY/H'IGW_>^(@NUL?#_ (J=;R=E3'N.IF&(=(C7Q7X%#<JD:L/27(WI
MSR6"=)KT-.XD&LC/4R+34S,@2:KD@9          !RQXX_6'4;\]\CY\=!R>
MCJ<!Q@               .9OQ2?:PJ_JU1?WI8.2NC1_&KVQ<2_G*A?. $Z.
MM0'&                        HF\8S_B3 _\ )E?_ 'Z"#=5F7"/V3\%^
MK37[ZX#,ZI3@@
M                   *S?%?]EZG^O%)^"S@:KJP?P@OR)9,]>%?-L,"RVH&
M4=.7?LO9[]1ZQ\%6"QJU7X<7L8X;_K#^,53 MJF^"
M              ""OB16!>F3.(F1+0Q_;-0N^Z)TVA/0J!2V52)3R(]6BNNF
MVTGSE;$)-1Z>0C,!%?)=%Y \Z:M@[&E0X[W-@O$&-KKIMTY O&]'V(TN9\GL
MK83&@P4EWAJ4VZZDE$:BW+2:MI)\XK3G+*W>6&3)?*&P:Y9F9[A:EUY*<+V[
M9D*$SC^3;3+Z9*9-4=0T;TV8:4)/NR4;G>Z>1.B0_P!\0*P\CXRDX,R3C=I4
M"ZLY8Y;P%?\ 06=&9\N1/BM'%09),W'%K/5M1DGS>Z;2:O.3I!M7E+@$L94;
M$-$PQC?,J<K8BQPU1,4YFQ3'3(A.SFWG2=IUP1>\)333[IJD..),]>^7KOV[
M3HL%)>37.(M7<S,B(WE1>,JF=](A$V3)5 Z8]WNA,_<B5V;^[\S=KL\W0#U4
MB8RH&7>0O%?B;QOL[CY7Z)3J3?S5X3,^FAM5NJID>544/RO26T)-$E"I"VU-
M+/>?<I)._O$D@)/W%1LUX1K_ #NQQ^C->684\J*O5ZKC>^[<B-3:235=:D,-
M1ZO(,S]&1"](,R)7E(^B$J)P!@V1>/&2<.XJP)1K6LC,A\G,;8X]#M3*V*DI
MJ%#1,G5:;.?MRNIWEM88.1_K4ZI62NI*2DDG!NK)E(Y(6/R*X=\D+LPY7\M5
M>@8M=MC*E/L2.U*>C7',C2DOFMI!DVTUWDPC-?1OHO:?1)'1-?G'8=UY-XH9
MILBQZ.]<%U5JC,G2*+'V]])5%FQY2VVB49;EFAE6U)=5'T+4S(@1"*Z+?R1G
M57AXU:I\?KPMJF8OO7Y.R#0;GI9&J+%@0::U\H2F3)9-QG76G";4Z1&>S70M
M2$5]G+'$V2:'S HN>(E%S)<.-+BQ\FTIE2PA(:3<M'GQYAR2:<CK2XIR(\1;
MU$6PMZMV[5&URC#JG9&8<0X/P#2,!6%FRQ<4W)?-?J6;Z5%8IU3RC!A27FD1
M3CMMLJ3&3)2PXZK8GS#-!+4>OG!K&U^.>=ZMQ8\0:V9&-KTBW3E"Z:-<5CTN
M[-C]=J\://9JCJG7V4H:DR^Z29.FV7G/:I+SN@#?5^T;*.<KH\..\O[![TM.
M!C>\IC5^4>X*;M?ID>&BD-IG3$)W$RRZN.X;1N;3,DZZ%T$'G57!.0W*5XJS
MC&+ZFJIY2D-_V9O)IQ]]6VE1Y#CI4]6W<\1NFE1D@SU7I^V :WO7!V9+5F<*
M,HS+*RV];EF8.HU@WY#Q.ZVS>E!JK3"W5F41U*UFA1.$TZ1$7O=IJ(]J54>W
M6..,I[!N!*-C?#&3X]%J'*JBWO>EL9&9C3JXFF'&<BSZI48L1LFXT5PFRW(<
M(]-3-1F2R$&^RPSD:I\V.9]PQK/GP;4R5AB-;EIW;(84S3)U4<IT"*3*))EL
M4I"FS)775)),!L#PV#OVVN.M#Q!D3$UUXTK^)ERH,B=<43T6+5E5&IU"=WE-
M49[G4,H<0E:M"+<KS34745%@X                      J5R%^MNP7ZCS/
MF:X0:]%M0,@            "COQ);9G6KR'QKDJ0DV[7OVU#M1ZH*+5MFHT^
M4[)2A2BZ()Q+[)%NT[%JUT2>G6>8[>W/VUJUC,QUC[O]CW;Z>^9XO$^;X.XY
MIQQYFMI^$7K-=WV5F8F?E"'YD9&9&6AEVD/G;]M1.>L/\_["^R?0A8B9G$:N
M/FYJ<-+<G),5K6)F9GI$1'69F?A$)^^%O;%0JURYXS"IDV[=J;M,M6W99:[)
M:Z>V:Y3B=2+H2>X,C_SS+M(?2O']O/!P4I.L1U^V>L_Q?A/W5Y2OD_*=QW5/
MRWY+37.NW.*Y^>W&5Q \QZ^            ^&IU.GT6FU"LU::S3J528SLVI
MU"0LFV6(["#<==<6KHE*$)-1F?80"J/ M,J7-7DK6.4=VQ'DX7P_,51<%6_*
M)242IT=1.%4%-J(NJ#,GUGIKWBFF]RB8,@:GI"VH&59O [\MO/O\[LWYRK -
M2LR!D      $=.7?LO9[]1ZQ\%6"QJ\/A'[)^"_5IK]]< G5*<$    <L?B.
M^V=F3^KWXNTP')71U. XP   $-N;'&R\.3>,H%H6A?B+2ET6<JJG19C:CIU8
M>0V:&&I;S6KK1-&9J2HDK3J>IH,R2I)8G#1[_A_4H^%",&--PO[56?\ Z[BN
M+S4H7=?=F9LJ>T_U'='Z$2O\C1S;N!=W5O;A7QQO#C-BZ79=W7VB[I%4G_*K
M=(B,FF!2'74$E]F(\YHZZEPTI4HU)0G<1FE!&I1J),Y3#!
M         <]G/FPZ;1^<MC73EMF2C#>0G[=5/JB-Z6ODZ ;$.J1R=1M4DVR3
MWCA)/>E#B5)ZFD&XT7)4?C-Q=72J:Y2<$XUJ-+=C-.4VH?@[2II/L+22FW2D
MN,.*=):3(R6:CW=NI@SF6347 &"+:JL"O6YA2PJ!7*6Z3],K--MNEQ9<9U/8
MXR^S'2M"B]U)D8&6VP0          '+'CC]8=1OSWR/GQT')Z.IP'&
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M:VKIA-SZ3.1TW-N%U0M/[5:%$:%I/JE1&D^I#RG*RP
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M-\;V7B*R:#CG'=%*W;,MEMUJAT8I$B43"'GG)#A=]*<>>5JXZI7G+/M]P!G
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M?LGX+]6FOWUP"=4IP0   !RQ^([[9V9/ZO?B[3 <E='4X#C
M                   5 <[.)O*7D'E%,RQJPQ4,5Q:= .EVO/KBXT-BH,I=
M2^^4!1=T3I]X9=YH:C2>F[0M"-1,0A@QX:O,V*TW'C.4F.PT6UIEJX]B$E[A
M)(B(@7=#<.!.!7+FPLTXNO2Y:G!BVY:]RT^I5]QJO'(6J%'>2N0T3.A[^\;)
M2-/L@3,+[08          !RQXX_6'4;\]\CY\=!R>CJ<!Q@
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M0,HZ<N_9>SWZCUCX*L%C5JOPXO8QPW_6'\8JF!;5-\$
M
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M/P7ZM-?OK@$ZI3@@   #EC\1WVSLR?U>_%VF Y*Z.IP'&
M                 JZYX<W+QPE<="PUA>G,3\F5^&U,J-8<C^GK@(EK4U$C
M18>BDNR733O\]*B).WS%&OS340C-Q1SWS"?Y@XYQCGNY;DAQ;P@U635K.N"G
M,0#<C-4B?+C/(CE'9-K[O%(R4@DZZ*2?0S(%F(PEAE'E/EC$_.G'N%JTY2IF
M(<FIHZ*+$3#VSV3J^^FMJ.42S-2BJ+*E&1IT[L]NG[8$QT67 R  #Y*A/A4J
M!-JE3EM0*;38[DJH3GUDVTRPRDUN..+5H24I21F9GV$ J]PQX@-Y9>Y-V?BR
M/CNGT?%>1DUN78USR/245293*6Q43:G:*636UY^F.-FCNRV]2W&:=3-3'1,K
MDMR(MCC5CEV^*]!>KU4GRVZ5:%I1%DB15*B\E2D,I7M7W:$I2:G%[3VD6A$I
M:DI42(RAU<G)3GMCNU7,N7]QPLY.,H+2)]=MV!/D%<-/@+,C-V2KTM]*30DR
M->D8S1U-Q*22K0N(6"8FR=;&9<=6IDVSWENT"[812HK;Q$3S#B5*:D1GB29D
M3C#R%MKT,RW)/0S+0P9EL0!RQXX_6'4;\]\CY\=!R>CJ<!Q@
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M6G$,$I"T*(C2HCU(^I L2JF\(+\MN3/4=7SE#!JSH1!@
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M4P29RW<"(><_?9 S9_)D'YTA@L:MJ<9?9NX^?FUM/YGB@3JW>"
M _AQQ#2%NNK2VVVDU..*,B2E)%J9F9]"(B 5&6RVOGURJ=O>6VJ7QDXW3/1;
M4CN)(XM?KFY+ANJ2K4EH<4A+BR/4NY0RA24F\H&M(6[ R  "LW@=^6WGW^=V
M;\Y5@&I69 R      ".G+OV7L]^H]8^"K!8U>'PC]D_!?JTU^^N 3JE."
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MJ5VF9@RR\!I#DU[-W(/\VMV?,\H%C52[X07Y;<F>HZOG*&#5G0B#
M          _-YEF0R['D-(?8?0IM]AQ)*0M"BT4E23U(R,CT,C 0AO;PZ.)M
M[51ZLN8[<M>;*6;DI%NSI%/C+,_\F(E:H[9?8:;2"[I;7PWQ/P%@9_Y1QQCZ
M'3Z^ILVW+IG..U"I;5:DHFY,I3BF247126=B5>4C F<I%@@      (">)G[(
M%_?RG0?G2."UU18\'/\ X;SQ_*= _>9P+9=$#(
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M_P!>*3\%G U75@_A!?D2R9Z\*^;88%EM0,@
M
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M4IP0   !RQ^([[9V9/ZO?B[3 <E='4X#C
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M(AK;PXL:57&O%JTTUR(NGU6^9TRZWH+J-CC;,[NVHAK+MU<C1VG"UZD2B+R
M6U2LK&)<57#4I59K^,K4KE7G*)4VJU"BP9,EY24D@C<>=94M1DE)$6I]A F7
M,YBV)%@>(';L&#&:A0H6:G6(<-A"6VFFFZTXE#;:$D24I2DB(B(M"(')Z.J0
M'&                YF_%)]K"K^K5%_>E@Y*Z.BS&7Y-L?>K5)^!M XV<
M#2')KV;N0?YM;L^9Y0+&JEWP@ORVY,]1U?.4,&K.A$&
M            ! 3Q,_9 O[^4Z#\Z1P6NJ+'@Y_\ #>>/Y3H'[S.!;+H@9
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M]>%?-L,"RVH&0
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M/A'[)^"_5IK]]< G5*<$    <L?B.^V=F3^KWXNTP')71U. XP
M                     '/]RPK- IGB86/4<KO)1C^BR;463L_4XC$!#:72
M6LNA=PB8IQ;FNI>_UU+4@;C1?= K=&JM+9KE+J\*I460SZ1'K$60V]%6SIN[
MQ+R%&@TZ==2/0&'/IGN]+3JWB7XTN'#-3B5>6=T6? N"ITIU#D695%2FHLQM
M+[:C;6DXRD,NJ2>FI+(SU(P;C1T/ P    UQ4\18XK&2[>S%4K6CR\E6I3W*
M5;UUJ<>)Z-#=3)0MI+:7":,C*6\6JD&?GGU[ ,LJN:V+=O.@U2U[LHL.XK=K
M3)QZK1:@RE^.^V9D>BVUD9'H9$9'VD9$9:&1 (P6_P "^(]LU]BY:5A:F*JD
M9[OV$SYM2J,1+FXED90ILM^-T,NA=WH7870%S*79$22)*2(B(M"(NPB!'^@.
M6/''ZPZC?GOD?/CH.3T=3@.,               !S-^*3[6%7]6J+^]+!R5T
M=%F,OR;8^]6J3\#:!QLX  &D.37LW<@_S:W9\SR@6-5+OA!?EMR9ZCJ^<H8-
M6="(,                             " GB9^R!?W\IT'YTC@M=46/!S_
M .&\\?RG0/WF<"V71 R                             -"Y:XUX=S#'N
M*7=-@6[,O"MT=^DQ+XE4QB3/B&IE;4=]*U$E2E,&O<C51=A%J0+$JT;'P7PX
MX81[JHO*#(-E93NJNNQ)-'HDF@+FU"FQVFUD9%&95.=04@W"/5:4)\TNI]="
MYF6T[)ROX5=RUIBG4ZVL=TFH/'LC'<=IG"AJW%H>Y^?#**C3_P#"++[ '5:%
M1H-&IE*@0K>APJ?1&64_)D2G-MM1$,J\Y/<H9(D$D]=2VEH#+TP !^3[[$5A
MZ3)>1&C1D*=D2'5$A#:$%N4I2E:$1$1:F9@*U8'*?DIR)K-R)XC8SMIK&]M3
M7::K*U_.R4,5*2SH:B@QXZVU)U(R,M4N:),C7W:E$DC6(C5*O E8Y)SV+GIW
M(RT;4H=0I*X96Q<-HRG'8E5;<2Z4@UQWG776EM&A!ZJVDK?YJ2VF"2D(" ".
M6?\ DQ9. HU%IU0IU4O/(5X&MJQ,9V_'7)JE4=09)\U*$J)MLE&1&HR,^W8E
M9D9 L1EI?A?RARAR%NC/ENY.LVBV/.Q+5:=3HM#IJ9/I4=V4]4V9,:<\](>0
MZXRJ"E.YM#9&>X]O4M!,8;JY/<B[=XT8W7>M6IKUPUJJ3$4FS;4C*V.U&HO)
M4M#9K)*S;;2E!J6O:>A="(U*21B(RB%<N;?$5QY:4K,%Y8>QQ-L:EQ?E.X[%
MISTQ-;I].26]QQ:_2W4DMM'5PTD[M+<9MD1'M+B$]<*Y;MG.>,K5RA:1N-TF
MYHREJ@OFGOXDEE:F9,9[;TW-.H4G4NBBT470R!F809\27$D&I8(RQE>O737J
MS*MUFWFK&M!<LV*)1UNU>!$E2FXC!()^0^A]U)NOFO:E6U!)TU!JLMZ<ZKRK
M=J8"G4RW:L[0:MD>X*-935;CJ-+\9BKRB1+6R9%T4J.AQ&NI::ZD>I$"0T5R
M:P=B_C=C_&N8<,6A"L.[,27?;C:JM2]T>55:5+E-P9D*H.H/664A+B=YNF:C
M+=YVBC(RQ.5G0,JS?%?]EZG^O%)^"S@:KJP?P@OR)9,]>%?-L,"RVH&0
M
M                        !6;X4'LO5#UXJWP6"#5M5F0,@   (8<HN8=N
M8'5#L2T*8>2,[7/LCVECF 2WU-/2="8>GI8U6E"C41H:3HX[^UVIU<26(RUA
MQWX>7%.N]'(WEC4DW_FRIK;FT2V9!I>IEM$D][*$-%JTIYG4MA(+NVE=4;UZ
M. LS\%CP,@    "'G/WV0,V?R9!^=(8+&K:G&7V;N/GYM;3^9XH$ZMW@@
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M3[IO>C(6=KV_24N*IM.?=0:%2G'WT-K?=2A1I07=I2@]5>>K8:"39:L#(
M       .6/''ZPZC?GOD?/CH.3T=3@.,               !S'>)[4:?4>5U
M?53YT>>F)0:1%E*CNH=)I]MI6]I9H,]JTZ]4GU(')71T68BJ5.JV+<=S:5/C
M5.&NW*6E$N(ZAYHU(B-)41+09EJ1EH?4''+8H  TAR:]F[D'^;6[/F>4"QJI
M=\(+\MN3/4=7SE#!JSH1!@                             0$\3/V0+^
M_E.@_.D<%KJBQX.?_#>>/Y3H'[S.!;+H@9
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M'I$9#K:"-;DETMNCJM2V^YU!N(PM(\(+\B63/7A7S;#!FRVH&0
M
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ME'IKV:F R<   '+'XCOMG9D_J]^+M,!R5T=3@.,
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MEDSUX5\VPP++:@9
M                                %9OR3XJ'])\1?N;OQ0&NC2U(S'XC
M-:SI=''N'<.-2OVT;?;N6JO.1#33SA.JB)23;Y,FM2]9K?0T$7ONO3J,0D+:
M]+\3%%RVZN[+CQ6[:R:G$.Y6H:'/254\GD>E$SK%+SS:W;>I=0.BQ8&0
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MA$781 C_ $    !6;XK_ ++U/]>*3\%G U75@_A!?D2R9Z\*^;88%EM0,@
M
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M'[[>EVU39!                       <L?B.^V=F3^KWXNTP')71U. XP
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MM2&#=U64AQT]R3(^P]-#+H#,QA.<$                    5F^*_[+U/\
M7BD_!9P-5U8/X07Y$LF>O"OFV&!9;4#(
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M-.H%L4^-2Z- 1J9-18C:6FD:GU/1*2U,^I]ICZVZI[P
M      .6/Q'?;.S)_5[\7:8#DKHZG <8
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MY->S=R#_ #:W9\SR@6-5+OA!?EMR9ZCJ^<H8-6="(,
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M9Z\*^;88%EM0,@
M                                K-Q[^M0SI^:*'^^V\#7HLR!D
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M                         <L?B.^V=F3^KWXNTP')71U. XP
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MN4_]./\ U?\ ^2 ;3ZY3_P!./_5__D@&T^N4_P#3C_U?_P"2 ;3ZY3_TX_\
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M\(+\B63/7A7S;# LMJ!D
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MU[-W(/\ -K=GS/*!8U4N^$%^6W)GJ.KYRA@U9T(@P
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M .H;B_G,#=)]7%PQ^AO_ *AN+^<P-TGU<7#'Z&_^H;B_G,#=+2_(S@=Q1L/
M^7+SM3%7R5<ML6K4JE0ZE\N5U_N)4=A2VG.Z?J#C:]JBUT6DR/RD"Q,H:^$%
M^6W)GJ.KYRA@MG0B#                                "LWQ7_9>I_K
MQ2?@LX&JZL'\(+\B63/7A7S;# LMJ!D
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M=%AEE+NIRS;2<OIJ&Q>ZZ+ 5>+-/U.(BJG';.:F.9FH^[)[>2.I^;IU!EDP
M                      .6/Q'?;.S)_5[\7:8#DKHZG <8
M                  *//%CLZ^ZI?^&+EM>UJO684"D3F"J=.A.S&V9;4IMY
M*'.[0LDJT,E$2B\[KIKH>ANJ+WZ:'B+?TCN7_DBD_P S@N(:(LZ^>5-@9-N7
M,5I4VY:3D>[W:@]<5Q?@RV_Z0NJR"ES#]&D07(Z.\>(E>8VG;V)T+H!T3:X]
M<L.=MV9PQ7;-\5>O3[.KMR085SQ9-HTZ&TJ"\Z27S7(8I;+C9)09JW$M.FG;
MH"3$.@$&           <L>./UAU&_/?(^?'0<GHZG <8
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M$%^1+)GKPKYMA@66U R
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MLB,RW.K4?V09RV,     K-\*#V7JAZ\5;X+!!JVJS(&0
M  5Z\V>0ET4-5 XUX--=3SSF#;":5#7M<HE+D;DN2EN)_P!4XXE*MJO_  VR
M6\9IVHW&HA(CC/Q[M?C9BZDV#0"1,JB])MX7'LVN5*IN)(G7CUZDA.A(:3^U
M01?MMQF29RD$"                             #EC\1WVSLR?U>_%VF
MY*Z.IP'&                                                Y8\<
M?K#J-^>^1\^.@Y/1U. XP                !RQXX_6'4;\]\CY\=!R>CJ<
M!Q@#2')KV;N0?YM;L^9Y0+&JEWP@ORVY,]1U?.4,&K.A$&
M                                       !'3EW[+V>_4>L?!5@L:J>
M?""_+;DSU'5\Y0P:LZ$08                                5F^*_[+
MU/\ 7BD_!9P-5U8/X07Y$LF>O"OFV&!9;4#(
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M/R_R,S@:ZKGS,)'.G*EIT=HM-D;5MPTH/_5.+2E&]!:=VA*&2(MBM1,K! 0
M                             '+'XCOMG9D_J]^+M,!R5T=3@.,
M                                          !RQXX_6'4;\]\CY\=!
MR>CJ<!Q@                #ECQQ^L.HWY[Y'SXZ#D]'4X#C &D.37LW<@_
MS:W9\SR@6-5+OA!?EMR9ZCJ^<H8-6="(,
M                          ".G+OV7L]^H]8^"K!8U4\^$%^6W)GJ.KYR
MA@U9T(@P                                K-\5_P!EZG^O%)^"S@:K
MJP?P@OR)9,]>%?-L,"RVH&0
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MC.:G/>;ZI5W;B26XHM26^1-[C;C[3-3TZ+; 9
M         <L?B.^V=F3^KWXNTP')71U. XP
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MCF9M2(SZ"6VXG4B,M2/L,B,NPR(P9>V Y8\<?K#J-^>^1\^.@Y/1U. XP
M             !RQXX_6'4;\]\CY\=!R>CJ<!Q@#2')KV;N0?YM;L^9Y0+&J
MEWP@ORVY,]1U?.4,&K.A$&
M               !'3EW[+V>_4>L?!5@L:J>?""_+;DSU'5\Y0P:LZ$08
M                             5F^*_[+U/\ 7BD_!9P-5U8/X07Y$LF>
MO"OFV&!9;4#(
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M15/;NS*K%9;@*63BF$SZF<@FS61))1H)>FNA:^X#4Z.L,'&
M    .6/''ZPZC?GOD?/CH.3T=3@., :0Y->S=R#_ #:W9\SR@6-5+OA!?EMR
M9ZCJ^<H8-6="(,
M       ".G+OV7L]^H]8^"K!8U4\^$%^6W)GJ.KYRA@U9T(@P
M               "+/(#E]B?CPU*CW)\JW5<5/9C3*M:MM12F2H$*4\EAN7/
M<6MIB*VMQ:4H[YQ*EJ4DD)5KJ"Q&6^K[OBV,:V?<-^7G4T4>V+7AKG5BH+)2
MMC:-")*$)(U+6M1DE"4D9J49)(M3!$;+<YA6_4+CL6CWGBC(&*:1E&4U QW>
M%UT^,S3JA,DENBQ'%1I3[D9Z01D;2'4ENZ]2T!<)?@BLWQ7_ &7J?Z\4GX+.
M!JNK!_""_(EDSUX5\VPP++:@9
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MT*FVOSOLJV:,RJ/2+=S 5,I4=2U.*1&B5=;+*36LS4HR0@BU,]3!N='5H#C
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MY$LF>O"OFV&!9;4#(
M                      K-\-#_ (;Y'?G=K'[RP#5EF0,L(R#DFP\56W+N
M[(EU4^T;>A$?>5&>[LWKT,R:9;21N/.*(CVMMI4M7D(P%:-4Y&<E.8M1F6CQ
M,MN5B[%*7EQ*]GNX$''D.MDK8X5/T)1-JTUT2SO>]Z:E1^H-8B-4H^.W"K$^
M %E<A-.Y!RG+-3M6R77TD_,-]T]751&UFM,8E&9^<1J=/4R4XH@29RF$"
M  "LW'OZU#.GYHH?[[;P->BS(&0    !JG-5Y7Y86/:K<V-L>NY1NV&]%;@6
M:R_Z,N0AY]#;RR<V+T[M"C7V>0"$(_TL.:G]Q2I_?H_BH-8A@N/>?G)C*]!7
M=&.N';UW6^W*<@KJL"N+4T4AI*%+;U5$2>J26DSZ>4#$)6\?\W<A,E7E4Z%E
MGC9,PY;D2BO3X5S2*@<M+\UN1':1#)'<MZ&MMUQS77]I]D$F$OP0
M 8O<M[V79C'I5X7?1+4C;=_I%9J$: WMZENW2'$%IT/J J0RG?MB<@>?.(H%
MO7;2KVL;&-H2JG3%TV6W-@N5LW)#CIH6@U-FM!)CK\TS_P!4D]?(7S[ZI^0Y
MNQ]N=UR<,XM,5IGX1>U:6_\ C,Q]LO/\=QQ;FK$_MB,IY#\./;@!$W@PA-F\
MF^8&,J(H_P $&YM,N"##0K[A#ERN\6ZVVDBT3J4C9V]C22\G3]_>S._Y>^\+
MVG/S9F]N*LVF=9G&-W_-^;[WI?=TBG+:(TB96KCV9XP
M                Y8_$=]L[,G]7OQ=I@.2NCJ<!Q@
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M25)4G4C(R/4C(%C53'X07Y;<F>HZOG*&#5G0B#
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M]@-Q*W_P@OR)9,]>%?-L,&;+:@9
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ML26287)):FB5Z2TT9[B;5V:]@&&VP0  '+'XCOMG9D_J]^+M,!R5T=3@.,
M                                             !RQXX_6'4;\]\CY
M\=!R>CJ<!Q@              U?F^W*C>.%LO6C1VS>JUU657Z/2V4EN-<F=
M3GX[22+IKJM9$!#F6Q[+1,L^CFE"6G(:%0I3">UMV.HTF2^A:*4G:LR_SB'H
M'G>.U.[M,^N)C]V/YP_87TB\AP]S[?XN*D_BXK7K:/G-IO$_9-;1U^,3'HS0
M=.^G,)O]F14J$U;-.CJFUN[ZA"I-"I[>ANOR79+:D)2G74]322?V5)]T=][=
MXIMW,VC2L3_'3]OD^,_6[ON+C\3Q=O,_CORQ,1_PTB=T_=-JQ][67(3C_>7&
MR_&<>7S4Z+5:T_2H]71*H3TA^+W$EQUM"37)CQ5[R-D]2V:=G4>\ORS$Y=,.
M3?8ER#^9"K?BVZ#'JJ5\(+\MN3/4=7SE#!JSH1!@
M                               !_AF22-2C(B(M3,^PB 5/<E>8C.8:
M?DCC?QPQW4LRU6M4J70[IO>$\EBD4XI)*86MEY230\1'J1+4MMLS]XIPAB]Z
MTC,S@FT5ZS.$+..% Y)\&[KKV3KCX_3KQMNL4?Y)KS%,JD.1(BQCD,R%R$E
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M426%I<4;BU)0HU*+5/=J4XI8R][/F>[EPO(MF/;^![\S,5P-RG)+]FT]Z:W
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M0$F<I'@@   "LWQ7_9>I_KQ2?@LX&JZL'\(+\B63/7A7S;# LMJ!D
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M9;<<W)8)9=-5251TL[=?+N(OLCH8]L1GKR=/L_MS_8^NW^N_<3PXKVE(Y?\
M--YFG_1MB?\ ZGWK#N(O!.Z+3O*EYLY"N0'KSH9&JQ\=4]2)$*C/&7_Q<AY*
MEH=D(Z["0I9(/1?>*42.[]A[3M./M:;...G\9^<OC7G?/]YYKN9[CN[[KSTC
MTBM?2M8](C/[\S.9F90,\5_VH:?ZCTGX5.'DNHKHNBR;[$N0?S(5;\6W09]5
M2OA!?EMR9ZCJ^<H8-6="(,
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M!?D2R9Z\*^;88%EM0,@
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MO&<[;6B(BN=/PUK6)QTW9Q,QU>I>0[F.;DF8TTA<"/H+P
M                            1TY=^R]GOU'K'P58+&KP^$?LGX+]6FOW
MUP"=4IP0   !RQ^([[9V9/ZO?B[3 <E='4X#C
M                         <L>./UAU&_/?(^?'0<GHZG <8
M         #FV\5_VH:?ZCTGX5.!NNBZ+)OL2Y!_,A5OQ;=!GU5*^$%^6W)GJ
M.KYRA@U9T(@P
M    A)XA&**SEKC+=<&VHCE0N.S9D2ZZ/3V4FIUXZ?O1)2T1:J-917GE))/5
M2B))=H+#'^/V:;?SIC:A7A29C"JN49F/=]';41NP*DE!=^TM'0R2I1&IM6FB
MD&1EY2+H.?AGCMCT]'5<O'-+8;M4I*4J4I1)2DC-2C/0B(NTS,<+C0&LVHM<
MFN=UFU.SS^5,:<9J;*E5RYV-519%7EI<;;:9>3YI[GN[V_Y:6'3+5.ACNNSX
MIXZ==9=EV_'-*==97#CRW,                              "LWQ7_9>
MI_KQ2?@LX&JZL'\(+\B63/7A7S;# LMJ!D
M            '@77<U'LJUKEO*X9"HE M*E3*U7)2&U.J:AP&%R'UI;01J4:
M6VS,B21F?80"$?UF?$#^GU3^\-4^+@NV3ZS/B!_3ZI_>&J?%P-LLWQQSPXU9
M7O:@X]LF\)]1NFY77&:1"=I$^.AQ;32WU$;KS*4)T0VH^I@8E,0$
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M^([[9V9/ZO?B[3 <E='4X#C
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MA4X&ZZ+HLF^Q+D'\R%6_%MT&?54KX07Y;<F>HZOG*&#5G0B#
M                                          KMRGX?E!J=XSLF\?LB
M53CY?E24IVK,4A!NT6:M1FI6Z&AQDVMZCU425*;\I-:ZF>;5BT8F,DQ%HQ,9
M:[?X+\E<@%\BYCY=39EENZ)JE%MNFE$=FM'KO9<6DXZ"(^GOT.E_F#%>"E9S
M$0S7CI7K$+ L.87QY@>RH-AXWHB:11HJC>F2'%=[+G2E$1.2ICYD1N.KT+KT
M2DM$H2E!)27*W,Y;4!                               5F^*_[+U/\
M7BD_!9P-5U8/X07Y$LF>O"OFV&!9;4#(
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MV#=U,:?8IMTY:;J]/8E)2E]#$ZJJD-I=2A2TDLDK(E$2C+7L,^T&IT=78.,
M                  !S;>*_[4-/]1Z3\*G W71=%DWV)<@_F0JWXMN@SZJE
M?""_+;DSU'5\Y0P:LZ$08
M                                                  %9OBO^R]3_
M %XI/P6<#5=6#^$%^1+)GKPKYMA@66U R
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MLK&5N0;1L"V*?:=N4Y.D:ETYDFD;M/.<<5U4XXK352UF:E'U49F#+,
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MM)GN;4[O3JVKSD(;:)6B]Z2[JM8K$1'H[*(BL1$>BPL:
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M3=(I[\I25/K8@U54=M3JD)0DUFE!&HR21:]A%V U.CJ[!Q@
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M^O%)^"S@:KJP?P@OR)9,]>%?-L,"RVH&0
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MU)E$70S/?&26A=ON%VM*9KM/Q$.4N-+HH]TX^M#%MA)B_*S5CD]W];JJJ?\
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M4JH3K-M*;5C4=4F46 _4C66BO2'([:G=Q'V'N,]1^OWJS)@
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M9TA$O>M'?1BE..HC*T+_ ,%* 696+ R
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M9F9GH74S,S,^IF9F#+W@'+'CC]8=1OSWR/GQT')Z.IP'&
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M]>*3\%G U75@_A!?D2R9Z\*^;88%EM0,@
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M?J/6/@JP6-7A\(_9/P7ZM-?OK@$ZI3@@
M                          .6/''ZPZC?GOD?/CH.3T=3@.,
M          !S;>*_[4-/]1Z3\*G W71=%DWV)<@_F0JWXMN@SZJE?""_+;DS
MU'5\Y0P:LZ$08
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MKF,[/CVS.OV4W*KG<J6IM!-$>QB,A9F3#)+4I?=HT3JK_)2A*23+=@(
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M$PN.^+,QXQA72QE[-TG-,FL/1'*%*D0SB'3T,I=)Y"2[QS=WIK2?DTV@DI(
M@                                                     Y8\<?K
M#J-^>^1\^.@Y/1U. XP                   '-MXK_ +4-/]1Z3\*G W71
M=%DWV)<@_F0JWXMN@SZJE?""_+;DSU'5\Y0P:LZ$08
M
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M:<0I!_9(?@?WUX[F[#SG=\7+&)GEO:/G6\S>L_?68^_H]Q[.\7X:S'PC^#:
M]3>2K[YH19F0[]XUX3M"J.4R_P"Y[Q:J4*L1$J7)H\9HR:^4-J%MJ(FMRWBT
M,C/N5:&6@_2GT \?S5CN^ZF)CCG92)]+6C=:WS_#$U^7XO7TZ+S-X_#7UZRW
ML?"GE*V1N,^(->KCR"W-(<I$G8:BZD2O_GBNAGV]#_8,?I!T.8^ ?$_FKH>W
MG74C/3H1T8R+7]GTDP,P%QV\0<B(BYG4W0BT+6AL&?\ VG% S 6'/$W:(FFN
M65E+:;+:VMR@0#6:2Z$:C.A*,ST[=3/]D#,!8Y\4YG[DC/N)YB&S-*);\%3;
MKB2[%K0W;VQ*C+J9)Z$!T"H'BHP_]F.]L1U3NC,OE VG$][Y=="@,Z>Y[P@.
MCRZW4_%,HM%K)OP<651B#"D/.U>&;A2#0EHUJ-A'>,^>@NB=6^TO*!T8)X?$
M2EL<;Z-*@);*=4JU57Z\XG3>N4E_ND&X>FIGW"&NWR:#\@?7+DY;>?K6_P"6
M.&FW[)FV9_ZL_N>S^)B/T9Q\?[DW1\:=HBOS6B4>7QFR<=9V);BQH<BGN*TU
M3,1-8*/L,U)ZJ69)Z'V&?0^P_IWT?Y>:GN;MXX\XM%XM\Z[+3U^6Z*S]L0\#
MR<1/!.?E_-LOB;Q#X]T?#N)+YGXBHE4O>Y[3HE;K=4KJ%U9?ILR$S(6XVU/-
MQI@]R]=K:$[3Z>34?M9ZE,I^1X\>(PS%B,-Q8L=!-QXS*20VA"2T2E*4D1$1
M%V$0(_8    !\T>'$B=[Z)%9B^D+-U_N4)1O6?:I6TBU,_=,!](
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M]V2#4AO57:\'#'%7$//X^...N%M0YF@
M                                  '+'CC]8=1OSWR/GQT')Z.IP'&
M                   YMO%?]J&G^H])^%3@;KHNBR;[$N0?S(5;\6W09]52
MOA!?EMR9ZCJ^<H8-6="(,
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MCB-I&9?L?N]Z=-DVK5\/OB-:1-+C8AAUJ4@BWRZY,G5+>9==5,R'U,%_[K9
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M@B\UII2CZ]A SAOT$
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MOD.UZ+>EEUJ-<-L7#&3*I-6BJW-NMJZ&1D>BDJ2HC2M"B)25$:5$2B,@89.
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MVQ
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MM16RC6]6"-9H:9CMI-;;*W#+[F:%FA:M4:-N;4*\JEZWC,2YZVBT9A94-@
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M;3BTMH22#\]"25O\]Q9)[;CI%*Q$//K6*QMA9 -J
M          #SJQ2*7<%(JE KD!BJT6N0WZ?6*7*03C$F+);4T\RZA6I*0M"C
M2HC[2,!H7]$3B]] EC_>>+_H N9/T1.+WT"6/]YXO^@!F61VEQSP/8=P4^Z[
M,Q':ML7+2N]^3:Y3::Q'E,=^TMAWNW4))2=[;BD'IVD9D!EN@$
M                                                !5UX@\N7D#(G
M%?C2F8_'MS*=W)G7ZQ&6:''8$21&9;3J@]3(D.R%Z&6F]"%=J>AJJ6F7>..*
M;RP?=&+XUAT2ETQF@R6;3*'!9:739C#"CB2(RT(-:%H<2DS,NJBU2K<2E$9(
MEHOPR;]J5\<5J!#JDM4Z18%:J%K,ON*-2RC1R9EQFE&?D:9EH;27D0E)>0"V
MK8.1^>'&K%%[5['M[7A/IUTVTZVS5X35(GR$-K=:0^DB=994A6J'$GT,#$N>
MBS,FV?1N85-R[/GNM6+&R@]<SM3)AU3A4U=47*)WN$I-S7NU$>W;N\FFH-^B
M^#ZS/B!_3ZI_>&J?%P8VR?69\0/Z?5/[PU3XN!ME@V2.=? [+=F5JP;^N.;7
MK9KS/=3(;M!JA*0HNK;S+A1]S;K:O.0M/5)@N)4,U6MP,/Y;_"3 F29E8@6W
M.*=9%[(BOT^:EL]=&I4>0V@C423-MTMIMN)UZ;5&@C:SFITS'?B7X[=N"WVJ
M;87,*PJ:GY:HNXF(ER1&")*5)4H]3;,]"0LS-3"C)MPS:-MP&=$6N*O*K(G#
M7(E5LB]Z54G;#=J2HN0<?2DFB73I:#)MR9#;<,B0^@B+<G4DO)(B,R,D+068
MRN+^LSX@?T^J?WAJGQ<&-LGUF?$#^GU3^\-4^+@;9/K,^(']/JG]X:I\7 VR
M?69\0/Z?5/[PU3XN!MD^LSX@?T^J?WAJGQ<#;)]9GQ _I]4_O#5/BX&V3ZS/
MB!_3ZI_>&J?%P-LGUF?$#^GU3^\-4^+@;9/K,^(']/JG]X:I\7 VRJBSUF:/
MRASU<=_1I3U0QM8[;-&Q=3)3*VVMBDDN1-4RYH1...D:SW))6AM$?^J(=!Y_
MOK\''%*3B;9Z_"(_OS_-]9^DOM+A\UWU^;N:Q;BX(B9K.EKVSLB8]:Q%;3,?
M&(B>DS#$S,U&9F9F9GJ9GVF8]'?K6M8K&(Z1#&;JH9UNFFJ(IR/7:6?I=MU*
M.HVY$>6T>]ONW2-*D[E)(CT/H>BO?)2.T\5WD\'+%9ZTMTM$Z=>F?V].CYM]
M3/:7!Y?QG)W$5B.?AK-ZV]9K6)M:D_&)C.WX6QI$VS<=QQR&]F+!EC7C6VD/
MU&KT]V#<3;B$FAZ3"=<A2%J1U3M>-HUZ=FBM/L#\L?4#PL> \_S</;YI6+1R
M<>)QMBT1>-N.L;+9K7U_#'VOS7V7+^MPQ-NOI/[?-%N'=MN<#N5D>J*E.4#C
M]FZCRG[CH$-EQ]FFU*$2C0[&B,I,R)#JD$DDEYJ'W$DG1"=/T]]*O=G-Y_Q.
M[N)SS<5MEI_S](FMY^<Q.)^-HF?5Z_Y+MHX>3%=)ZPF+]9GQ _I]4_O#5/BX
M^F.NVR?69\0/Z?5/[PU3XN!MD^LSX@?T^J?WAJGQ<#;)]9GQ _I]4_O#5/BX
M&V3ZS/B!_3ZI_>&J?%P-LGUF?$#^GU3^\-4^+@;9/K,^(']/JG]X:I\7 VR?
M69\0/Z?5/[PU3XN!MD^LSX@?T^J?WAJGQ<#;)]9GQ _I]4_O#5/BX&V3ZS/B
M!_3ZI_>&J?%P-LGUF?$#^GU3^\-4^+@;9/K,^(']/JG]X:I\7 VR?69\0/Z?
M5/[PU3XN!MD^LSX@?T^J?WAJGQ<#;)]9GQ _I]4_O#5/BX&V3ZS/B!_3ZI_>
M&J?%P-LGUF?$#^GU3^\-4^+@;9/K,^(']/JG]X:I\7 VR?69\0/Z?5/[PU3X
MN!MD^LSX@?T^J?WAJGQ<#;)]9GQ _I]4_O#5/BX&V3ZS/B!_3ZI_>&J?%P-L
MGUF?$#^GU3^\-4^+@;9/K,^(']/JG]X:I\7 VR?69\0/Z?5/[PU3XN!MD^LS
MX@?T^J?WAJGQ<#;)]9GQ _I]4_O#5/BX&V3ZS/B!_3ZI_>&J?%P-LGUF?$#^
MGU3^\-4^+@;9/K,^(']/JG]X:I\7 VR?69\0/Z?5/[PU3XN!MD^LSX@?T^J?
MWAJGQ<#;)]9GQ _I]4_O#5/BX&V3ZS/B!_3ZI_>&J?%P-LGUF?$#^GU3^\-4
M^+@;9/K,^(']/JG]X:I\7 VR?69\0/Z?5/[PU3XN!MD^LSX@?T^J?WAJGQ<#
M;)]9GQ _I]4_O#5/BX&V3ZS/B!_3ZI_>&J?%P-LGUF?$#^GU3^\-4^+@;9/K
M,^(']/JG]X:I\7 VRFY:ES4>];6MJ\K>D*ET"[:5#K5#E+;4TIV'/81(86IM
M9$I)J;<(S)1$9=A@CWP                        %7OBB5F?/L+#.(X,I
MZ*WEB_8<2IE'2:G'HT3:@FB+0R/[O*:<(NTU(3IY0:JL;BV7:L*SV,?QZ%$3
M9D>E%0V[=-LCC?)Y,^C^CF@^AI-OS3U[095G^%_+D4!CDMA[TY4NEXPOTT4E
M#BS6I")2I4-1EJ1:)6=-)73INW'H1F>IJSZ/%$Q75*G8MCYXMUM+L_#DYQJY
M(AJV&_1ZJXRTH]VNI]V\E*#(BUVNK5^U'%S\,<W':EM)C#S/&]_R=AW/'W'%
MTOQVBU?MK.8S\OBJRH==I=QP45"D2DR632DWVNA.L*5^T>1J9H/4C+W#[4F9
M=1\Y[SL>7M;[;QT])])_;X:OVO[7]Y>/]P<%;\%XCDQ^+CF?QUGUZ=-U?A:(
MQ/RG,1]%4JE/HL)RHU66B%#;U+O'#(C6HBU[MM/:M9EV)+K_ (!CMNTY>YMM
MXXS_ "C[9>5[A]T=AX+@GE[KDB)QF*1,;[_"*UUG,],_ECUF$<Z#DPJ/<=>F
M*@K5;]>G.2W("%:N,*6HS[ULE*V[U$?GD6A*Z:;2).GNO>>(CN.&E)M^.L8B
MWQ^W[?WQ^_/Y6]L>_P#F\%Y+F[GBXX_0YK3-N*)Q$1,S-=D^DTSB.F)CIC28
MV^WDZQ7&FW%5XF5K1O4PN-*-:#Z>8HTLJ3K^P9E]D>M3X'NXMC;$Q\<QC^_^
M#[K3ZR> MQ;YGDBW^2:?B_A,T_\ GZ_;C3-_Y%.Z$)I5*9<B45I9..K=T)Z2
MM)=-Y),R2A)GT3J>I^<?70D^R>*\3'9YM:<WG]T1\(_O_:?B'O[Z@\ON6]>+
MCK/'V])S%9_-:VFZ^.F<=(K&<9GK.4_N-_B&P+&M&AX_RU;DR;3[9B1Z9;US
MT)MI3J84=LFF6I45QQI)]TE)));:M33IJC<1J5Y7/V6^=U9U?*^;M=TYJW)D
MWQ,,=4RCRXV*[=JES7(\V:850JS*85-84HM"<6GO%/N[3Z["2@C_ ,LAQ\?8
M3G\4]/DXZ=G:9_$T3Q-YKXHP;+OW(&2;;N^_<S9+F&NY+HBMT\HS,)M9K;C1
MN\D-J(EJT4OS4I\U"$IT;(S[.L16,0\[9B,1HFC];[A+Z,[X^UIOQP4VH<<R
M.;.$>2.,CMBUL95FW+T:K,.I1[FJ$2FI-33)/)=96^P\X]HHGC5H70U%U!8C
M#8^,,?YDM"V:7E7A[<U,O3&M[L)J%2PS<3^B:?4#Z2HT9YUUI)*962FS4;S:
MM"3O[TB)0]&]T^TO%>X:[._XYB]>E>2O2\1]N)S'_#:+5SUQD[;R=^VM,?[I
M_;Y-FS;TY\7Q&50J#ANV\5/2D=W)O&IU./+]&WEH2V6DO/&2B[>K#NGN:Z#T
MKQ_T9]O=IS1R\M^7FB/\%IC;/V[*UF?^J(GUR\[E\_:8Q$Q'V1/]JO;D!9ED
MX;R78=NU:_Z[<^0H$MRX\S9$HRB.J-3I:V7H;,$GGD$VZPELW4J4LE:NDLSZ
M)0G['V=:UXXK2L5I$1%8B,1%8Z1B(TCTB/1UO%R6Y,VGU?LKD?-IA&FU>5?(
M*G,(2I#,.HH:GMI1VH2DOPD:2DR/M42/\ \MRX#YV\E*&9KMOD-==56DTN-I
MK5#I!I->NBB5WKDXMI)ZD6AD9^0NT#$,FIGB<<NX"23*O6D5HR1M-<RA4]!F
M>NN[_966"U\G9I]@#;#8],\6WDC$413[4L"K-&O<O?3JBRYMT]ZE352))>[J
M:#!-L,7J>5[T\17-&/K4NYV+CE5M4"LJH+E#[YUENH$VJ2F4:'W%++<IIE*R
M2O7:CS5$9ZEQ<W)LI-M6.2_Z=<I7TK-/*?"K#=KYBP;5LK0Z81,0LD6<:Y:I
M;1:$VY):::<(U'V&I9,J,]-4F9[C^%>X/HKXSR/-//V/-_3S:<S2:[J?\D9K
M-(^6;5C2L1&(=KVOG<5Q;K]^)_VOPK>2>5G(6.Y9^,L25+!ML5;5BMY&NLUL
M3$1%^:[Z,RXTTI*E)/0C:2XK_)6CWQ>5[7^C_C?"\]>Y[OE_J.2LYK7;MI68
MQ,3-<VFTQ.F;17XUSU8[SSFZNVO3[.L_[&F,&<@;7\/G+F<<57$S<%^VI)51
MOD]RGIC)<34&8A.OOJ;>>;0@G"D[?-,ST0@CUTU'VSBOOK%OBZVEM]8E+#ZW
MW"7T9WQ]K3?C@Y&MI];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\< VGUON$OHSO
MC[6F_' -K#>%$4LLW+F;E1=4;TJZ[\NN;3[=<D[77*=2VD-.$RPKKM(D.H8]
MW:T1=A]>L[_DG,5^]X7>7ZQ5,BHX<Q%5ZBFL5;%=H52KI4E2:K+H<!^22D*W
M),G7&%+U)1ZEU[1X/ZU_\T_O>+'):/66DN8N*;>O;CS>1)I[$&?CFF2+EM25
M'0EHX:J8T;[R&B3H24N,(6@TET[#[4D.;M>6:\D9]7)V]YK>/FU+CSQ;; I-
MB6A2K]L:[JW>E+I$2'<]:A>@*8FS6&DMO24FY);5]V4G>9&DM#,R'=NSVLQ^
MM]PE]&=\?:TWXX!M/K?<)?1G?'VM-^. ;3ZWW"7T9WQ]K3?C@&UJ'/?BE6-D
M3#N0+$Q]9UUVY==W4M5)@UJH%"3'88E+0W,,U,R7'"4J,IU*#2G4E&1].T%B
MJ:'';'E'QAABP+6I##:#32(TZL2D)))RJA,:2]*?6?:>Y:M$ZF>B22GL(AT'
M<7F_),RZCEO-K3+=8X7&KDYB5*+@G+O'[E#18ZVZK1*]\C7G'B&A#U4I1MFI
M;/4TD:SC>D-$I6I><C7WI#M/'WF8FOP>=V=IG-6??6^X2^C.^/M:;\<'8O,V
MGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\< VGUON$OHS
MOC[6F_' -I];[A+Z,[X^UIOQP#:_)_Q?<,DP\<;&5Z*DDA7HZ72IQ(->GFDH
MTRS,BU[=" VO+\/^W$3,97#F6MO%5K]R[<-2J%PUYXB-]2&)*V^ZW::D1O$X
MX9%TU47^26G4=_>9M%?2'7]W:9MCX)[#P7BH8\[;&@7+@6N76@_0[HQE(C7!
M:U::5W;\=QM]MMY*'"-)D2VU&9$1^_2@^TB'F=E>8Y,>DO([6\Q?'Q870_%Y
MQ[$M:WF:WC2Z*K=S%.AMW(^RY!8ANS4LI*4XPKO5*V*=(S21H+IVZ=@[EV6U
M\TOQB;.0Z10<'UF2QM+5Q^LQV5;O*6U,9TM/L[@-K$97C(RUM&F%QX9COZEH
MX_=2GD:>4MB:0T?_ -L"[6,R_&'OQ;NL'"U C,;2U;?JDIY>[RGN2TT6GV-H
M&U&?D/X@.2.2%@IQO==H4"W: NK1*G+DT4Y:93A1=^UHSD/NH-)FO=U3[Y)&
M"Q7"^BE*IZJ7354@VSI2HK)TPV?]7Z.:"[K9_F[--!ZW;.9SJZ.=7WB"IWQ%
M[I=LG(_'NZK;K\NU[PHK=;?7<%,0AV=%C&N&AAQMM:VDJ/53Y$1K(CZ]1VGC
M\XGX//[+243T\H;JJGW6X^66=TK6:G%QJ-%9@)2X9]-'&KD1JG37S>[(M?V!
MV+S<']J> :KHF\LG\D[E:,B0XW\ITIO5KM4C_:)4LNI]2Z:?8,!]4.Y_#Y:=
M.15;(SG<LA>O?2*G5Z+O<,^PU*C$P9[2Z%_[=0.K/J7E7PSZ=M-_C+D&L.([
MLTN3:X]T-':9I8K#2#W>4C(R]PB!,2V)3.3_ (<-(-LXO$"J.FT:C3Z:S#FZ
M[B,CW%*J+N[MZ:]GD Q+85,YW\#Z,E)4KB"Q!4E*4&ZU;5M$XHD]FYSO-ROV
M3,P,2R^=XF7%6=0:W;7]@UQ0J1<,*73ZI'A0:-&-;$UA4=\B-N2G0U-J-.H)
MMEH/@YRULNPZ?)PO?]7.BVNQ4)4G']X5$DL---273<7$G;5+0QN6HW4K-1H)
M2EI4K3:9]?W?;3?\5=7B]SP3:=T+:)%\V5$I2JY*N^BQZ*EKOCJ[D^.F-W>F
MN_OC<V::>74=;^E?.,2\#;.F%/O,;ECCW*EQV?C6B2IM:Q+0*W&J60JQ2TDE
MZJ$RO:J/![U;1&E#:EZ+49$I9DHNB"-7:]IV\\?XK:R[#MN":=9U3+:\7C!K
M#3;+.+[U99922&FD(IB4I2DM"2DBEZ$1%V$/->3M?W];[A+Z,[X^UIOQP#:?
M6^X2^C.^/M:;\< VGUON$OHSOC[6F_' -K5.:O$YQCE/'M5LNV6<I8IJ]1>B
MNQ[VM]4)N?&3'?0ZM#:F:G'61.I2:%:++H9]O8"Q5 2Y,P6M>-.71[OY%<@+
MJI+A[ETNL$Q.C*/W3:D7"M!_]@+AC5JW;B:Q)1SK(R_F>S9JM=TRAT^!3G3U
M+0]5QJ\VKJ73M 2WX_\ .:UL-7E4[GN[*.<LTTV?17J6Q:USO,.Q([[LB.^F
M:A,BMRD]XA+"FR,D$>U:O.[2,DPE_P#6^X2^C.^/M:;\<!-I];[A+Z,[X^UI
MOQP#:?6^X2^C.^/M:;\< VGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^
MX2^C.^/M:;\< VGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C.^/M
M:;\< VGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\< VGU
MON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\< VGUON$OHSOC
M[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\< VGUON$OHSOC[6F_' -I
M];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\< VGUON$OHSOC[6F_' -I];[A+Z,[
MX^UIOQP#:?6^X2^C.^/M:;\< VGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#
M:?6^X2^C.^/M:;\< VGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C
M.^/M:;\< VGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\<
M VGUON$OHSOC[6F_' -I];[A+Z,[X^UIOQP#:?6^X2^C.^/M:;\< VOKI_BX
MX5J,^%3VL:WLAR=(;CMK4FF[24ZHD$9Z2S/0C,#:M?!D
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M$/\ Q@;CZGO&WTQ7+_N$/_&!N/J>\;?3%<O^X0_\8&X^I[QM],5R_P"X0_\
M&!N1RY6^'19?'G"EQY3HV1JW<50HDJG1VJ5-B1FF5E-EM1E&I;9[BVDYJ0+%
MLM0\(.&-L<K:7D.H7!>E4M-=ERJ='BMT^.R^3Y3D2%J-?>GTV]R6FGN@LSA.
MOZGO&WTQ7+_N$/\ Q@SN/J>\;?3%<O\ N$/_ !@;CZGO&WTQ7+_N$/\ Q@;C
MZGO&WTQ7+_N$/_&!N/J>\;?3%<O^X0_\8&X^I[QM],5R_P"X0_\ &!N5+\K<
M)4OCSFNX\64:N2KBI]$BTZ0U59K:&GEG-B-25$I#?FEM-S0@:B<K6:3X0^.:
MC2Z;4%Y?N1M<Z*S(6VF##,DFZ@EF1:GY-09W/O\ J>\;?3%<O^X0_P#&!N/J
M>\;?3%<O^X0_\8&X^I[QM],5R_[A#_Q@;CZGO&WTQ7+_ +A#_P 8&X^I[QM]
M,5R_[A#_ ,8&YK'-/A;V%BW$N1<C0,IU^JS;)H$ZL1:;(AQ4-/KB-*<2VM2#
MW$2C+0S(%BR&?"7BK;_*FZ;WM^X+KJ%J,VI2H]0CR*>RT\IU3SYM&E1.]"(B
MZ] 69PL:^I[QM],5R_[A#_Q@SN/J>\;?3%<O^X0_\8&X^I[QM],5R_[A#_Q@
M;CZGO&WTQ7+_ +A#_P 8&X^I[QM],5R_[A#_ ,8&X^I[QM],5R_[A#_Q@;E:
MW-;C#0>+-^VI9] NB?=4:X: 58>F5!EIE;:SE/Q^[2370RT:(]3]T&HG+I X
MR^S=Q\_-K:?S/%!B=6[P0                       !59XHC;]!I7&_*'W
M5%/L#(;2ITAM'>=UWR6I:%&G:>O_ , K37IKTZZ@U5:,W4J>[3D5=N='52G(
MQ3$5(G$]P<<T=X3W>:[=FSSMVNFG4&577ADQ4UR3RFRO#CFBB9$R(XFC2E%U
M=;BKE3-",]-22FI)\G:9_P" U98?E?&5N9DQ[<N-+N7,;MVZV6F*FNGNI9DD
MAE]N0GNW%H<))[VBUU2?0&84C\X^#F'N-V'Z;DG&]5NE%P%<L*E*14I[#[!L
MR6)+BE$3<5E:5I4RG:9+TZGJ1]-),-UM.6-\#>&F*^4-B7M?&4*O="ZO1KA*
MCQ&Z;.99;4RB&P_O<-Z,^XI>KFWW^FA%T"(PMK3E-RK>$QQOETV9'I-PWM2*
MDZV90JDN?$DI9<[24IE4-)+3[I;BU+L,CZBL[D9)/@ZW455[N'G*E+HAK/\
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M3F)][&_">;?9)55C&G>VHE)U+T(NFI ;I64@R
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M!0J.N4LG'SBTZ.W&9-U:4I)2]C9;C(BU/R$",F
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M*G;F)[6_!2C5B=\I5*'Z=.G=Y*-I#/>;Y\B0M/F-I+1*B+IV:@LSEMH$
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MMWN'9RV#U-9^:;>W[ +F4IP0
M                              'PSJ93:HF*BIT^-44PI+4V$F4TAXF9
M+"M[+[9+(]JVU=4J+J1]A@/N ?#'IE-B3*A4(E/C19]64VNJSF6D(>E*9033
M:GG$D2G#0@B2DU&>A="Z /N
M
M
M
M
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MR%:=OWO:%3;K%LW1":J%&J+6I$XRZ6I;DJ(E(4D]4J2HB4E1&E1$9&0,LG
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MY\79(>0I<&T+UIZ:>_,VI-PTQE)==)2MA&HDKV*,B/:E1%J!,)E @
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M%&\3+#[;U-GW'C/)]G6/6WD,TC(E7H+::6[O_P#$W,R75*1T,R[HG%&7[7R
MUM6%4:LTJXJ13*]0JA'JU%K,5J;2:I%63K$B.^@G&G6UIU)25),C(R!EZ0
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M?MJKDHF9*$J;<:=;/:ZP^TLB6TXV?125%[AEJDR,S+8
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M'H8G1\?/8D4'+7"2^X*":K=*R?'IAOH(DK=AS)$(WF%KT,]JDH-.GDW*T[3
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M03$&^L81*G6(C9$ALYD=5.0E\TD756UM6I]-36HSZ@>BS(&0
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M,]9*W,<Y4IE;K[A&<:B269=,ER-I&I11V:BQ&6\:4D9F39*,B(S/H0)A(T$
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MV/\ +%OMW3CB[J;>%"<6;2IU.>)SNG2(E&T^V>CC+A$9&:'$I5H9'IU!AG0
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M:&9LHC(4?^87:#5EL(,@
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M D:)0GS6^ZEO[4D7O.\4V6A'H#4Z+A@9            58\@/UEG$?U:F?\
MTJN#4:)6\U+>E71Q5SC2H3:W9#=LOU%+;?52DTQQN>LB+0]?-8/H"1J\;@A=
M$*Z^)V&94.8F6ND4=5$G)+:2F7J8^Y%-I:2TT,DMI,M>II-*O+J!.J,1(CW[
MXKC$RCI3-:Q!CY:*_*09+0S(>B/,[=Q&1$HOE9"#+J>NXO(>A?1:N#(
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M4R+9K5X_)MMU=!DMN4@YL]]Q3:TGIH;9,+_86GJ#4K5P9
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M[4K0LC2HC]PR ?-2:)1J#&]"H=(A4:&:C6<2#';CM;C[5;&DI+4_=T >F
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ME>%Z7I**=?60JXYWM1J<@C4HMQZGL02G%J(C-2C4HS6M9]2),Y23!
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MZ_)DK)V7-ENZ=]+E.$226ZX9%KHDDD1$E*4I2E)$F<MJ @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         "*7(3F3ASC16J#;N1%5
MN16;AA*J,.%1H*9)HC)<4R3CBW764%N6A1$1&9]#U(NFI8C+0L+Q5N+$M]++
M_P"&%,;,NLJ31VU-EU(NI,275_9]Z"[92^Q%R)POG:*_(Q9?].N=^&CO)]'+
MO(M1CHU(M[L*4AI]*-3TW[-AGV*,$F,-T@@                     \"XK
MKM:T(;=1NRY:5:]/>=)EJ=5YC$)E3ID9DA+CZT)-1D1GIKJ ]"EU6F5NGQ*M
M1:C%J]*GMD]!J<)Y$B.^V?8MMULU)4D_=(P'W@/(KEPT"V*<[5[EKE/MZDL*
M2EZJ5.2U$CH4L]$DIUY2$$9GT+4P"AU^@W/3F:Q;=;@7#2)!J3'JE,DM2XSA
MH,TJ)+K*EH/0RT/0P'K@        /R??8BL/29+R(T:,A3LB0ZHD(;0@MRE*
M4K0B(B+4S,!C=M7S95YE+59]X42["IYH*>=&J$:>3!N:[.\]'<7LW;3TU[=#
M 92             _)]]B*P])DO(C1HR%.R)#JB0AM""W*4I2M"(B(M3,P&-
MVU?-E7F4M5GWA1+L*GF@IYT:H1IY,&YKL[ST=Q>S=M/37MT,!E(
M
M
M
M
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M3O<6HB+4B+<HTI,1&5:WUR$3T_9^CV]\F;]OI'X4)[_9K[_NODK;KI^UW_\
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M[M-Q$6O;H78#C9X
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MB36:K&*+(;EQV6)"D[$K<2:3;D-J(R4?;IVD9 3&&[@0
M
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MZ)%I]/BLP8$%E$>%"CH2TRRRTDD-MMMH(DI2E)$1$1:$0,/I
M
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M1JAM1FUJELN;??.,.-K;42>U2=$Z] 9PINJW//F%R.R'5+7XIVN="I%/[R1
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MW374%G#IX!Q@
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MRN;4Y+<52V(B3-"E[&UF6[1*#4M9$9K2%GGBSV+7+DP5:5UT>"]/BV)<Q/W
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MZ"5\4&#6RHSCO?JC%-92]W7?;&^\).[0E;$[BZZ%V XVP0
M
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ML'\(KV;KV_.54OF>C 6U6G R
M
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M1'J!EL%IIIAIMEEM+++*20TT@B2E*4EH24D70B(NP@']@
M
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M/J#4XETH P
M
M
M
M                               *+^>N ^4/(KD=%B6GC*H2[ MNFPJ1
M:=?7(B-P%I?TD39CJUOD2#[YPT&1^<:&D^;J#<3$+I+"LZE8]LBT;$HB232;
M.H\*CT\]I)-34)E#*5J(M?.7MW*/7J9F8,,L   !BE]TZ95['O*DTY@Y-0JE
M#J,2!&(TI-QY^,XVVC<HR26JE$6IGH J%\,WCEFW#V5,AW!DW'M0LZCS;8.E
M0YLY;&CTLYT=W8VEMU:E%L:4>XBV_9ZEJ:M*Z4&0
M
M
M
M
M
M
M
M
B                                          ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>tm2227887d4-fc_antibody4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-fc_antibody4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@&(@@T P$1  (1 0,1 ?_$ /4
M 0 ! P4!               ) 0<( @,$!@H% 0$  04! 0
M 0(#! 4&!P@0   % P$$! 4*# X*#@D "P ! @,$$04&!R$Q$@A!41,)87$B
M,A2!L2.SM!5U=C<XD:%"4K(S<W0U%C89\,'18G*2TM,D-)475QB"0U.3PY34
M);56X:+B8X.$566%)D9F)W?QPJ-$5&3$14<HI#EG6..6IH=(*1$!  $" @8(
M! ,&! 0'  (#  $" Q$$(3%!<1(%48&Q,G(S- 9AP2(3\)&AT4)2@B,4X6)#
M%?%S)#62HK+"4Q8'TD2#5"7_V@ , P$  A$#$0 _ )_
M
M
M                                 !0S(B,SV$6\!3B3OKO 5J1[C 5
M                          !IXD]8"M2KPUV[Z *@
M
M
M
M
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MFN*L<-DX+G$=2J*(G%6J)  $3("0
M
M
M
M
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MK7FN'7U[T:QY79KU)_\ AX$^/(7^U;<48D=E2KB*N[P -0
M
M
M
M
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M5QJ$@
M
M
M
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MZ949BK&F*NC0F=(]B3I3;](6:M$PJC4W14
M
M
M
M
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M2J4(CW^$5453.I353$,I2K0JBE+4)
M
M
M
M
M          !%MSP*26H]@J9%_P!6]U?_ )AP6;4?U*XW=BNJ?IB>C%(9I:HO
MYM\$(MM+!;SKXV$#*O3]4RL6HPIB$;/-DI):\H(U$5(-IZ>M0Q\K3,U]<2R+
MU7]./AC^J5J'_$XOW%O[$A>K[TK-.J%JM?-FC6HIF9$16=ZIGXTC%S48VI_&
MUE97S(8I\BAD9ZC&1D=/>TCIT5[<9L^7'QG']&!$?U)^$8-_GL,BCZ:5,BJ_
M<_L&!A3&-^(Z8F/UAGQ.%B9Z*HG])9/\OBB/173@RVD=G:^R4,_,U8W)ZNR&
M#EXPHCK[5X5GY"O$8Q;G=E?IUHH>5923Y@"+B*IL7C97P*%[*>GJW1'Y+=_1
M=B/C,_FRLYM=*[QG^(VJ]XU$7<+WA[SSR[6T579,-Y)$\ELNE2#22B26_;3:
M,>JG3$LBBK1,2QJT2YH_YLL<;PG+<?DW6U6IQWWJE1%H;EL)6HU*8=:>-!&2
M5&=#J2BW&0OU7>/3M6(M\&A<#)>:_*M0"/$M%\(N2;Y=4FRBZO<+TIA*RHI;
M337$VV9%_;%KHG?2HHFW5.J8A7%=,:]+%3(L2O6C.I&-P\L?;.? >MMYF/LK
M-:.%QTG%T6JG&:%$:5'TG6FP56IBFJG#8IO1-6,[)C!-0U(8F1D2674N1)+2
M7&'TG5*FW"JE1'U&1D8HN4Z%5,H=(5\OV@&MUPN<ZRG(E66=.;<MDA1LIE09
M?&E"V7*'L4A1*2HB/;O+>0JLW(IHFB8V1^B+UN:JXKB=&,_JD9T-UF1K1:<B
MN1V5%E59IZ(1VXG_ $FK3C7&E;B^%!'Q;2W4%4T84PIBK&984:QZ-YGHKFAZ
MA:?M2#QI$U4^V7*$@W7+4ZM1J7'D-T4?9&:C(C,C2:=BC(6;4_;B(V1&'5\5
MVY$7-.W'%<JP\\B$6UI.1X,N1=D(HY*MTQ*&'EEO5V;J%*;KU54+DSCJ41$Q
MK62S+.=3>9_*+;8[#CZDVR X9V^Q1%*7&C&Z=%2ITHR(JDG94Z$1>:FIG5;M
MSQ8S,8)JKB(PB)Q25:0Z=0-+L(M6)PW42I$<C?O,]*>'TB:[0W7"(]R2H24_
MK2(5UU8RMT4X+GBA6 ,&^>):?Q*PHZTK?7*5^]U"Q7&-RB>B97*9PHJCI=_Y
M/%$>BML(MI'=;F9&6[[>?ZHSK\ZHZ(B&+:C#B^,S*RO/8I)2--2-1%4KEOV?
MW 8%4?U8^,8?JSJ9_I3\)Q_1EOH49'HYIL9;CL,,R]5!#/S/F3^-C7Y7RXZ^
MU\SF%,DZ+ZD&>S_-2O;$# OQC1P_&.V&9:G"K'X3V2QHY$U).'J,1&2J/V_:
M1U+S'ND9]R?Z=-/1,_JQ:*?KFKIB/T2 F=*>$Z#'Q7D1>'45S:,()1<1YM<"
M]6CXN9+Z;<X]&"<S.%4QTI#N8)23T8U'.NPK)(.M#\!#%O?NS\5RQ5PU8L7.
M15:>#4DR,C]EMJ:%MVFAPAF3&%'7\F-,?7C\/FD'47F^,A9U+B)>S&G^N"2>
M(J_CU(/?X5&&3^B*L?\ -_YC.SQS3A_E_P#*EI+;MZ-P8"-CGJ6DLDP0C,B/
MWIG4(_ \@6J(QO35LB([5VJK^G$?&9_1FYH\?_A3I[PGM58(*B/QLI&=FZHF
M]5/3+&MQA3$(_P#F=TVRC"=1G]3L>BR?>*ZR6;DW>HB37[W7)KA-?;&1'P$I
M226DS+A.ID,*Q,VI^"_>B+L1AKB,/U=WM'/'(9M"$7W VY][:;)+LV'.*/'>
M614-1MJ;<-%=E2(U"[KC0MZITK,:C3-3]7L=O&L68,%9<1Q_L(>,6U*%MLNG
M*=)"BC$O:LB\Y;JCH=").PJ%1-/#K5Q5Q:F:')PHOYEHA%Y1'>;CM(MFQ21?
MO3C$;H6+488[Y8J<YBB3J_;2,R_ <$_HR'AC6*)^YATSBRZYQM1\/^"4*S%6
MUVG];#8K_>TC(NSQ53/QECVXPIB/@Z3K*HDZ5:A5_P"0)Q_0:,8]^,:)A>M3
MA7#"CD46GWZU 42B,DV^ 1T/]>X,BB?Z4;_DLU>8RDY@-'#U=P],:$XS%RFP
MN*EXY*<,R0M1E1R.ZKH2Z1%MZ%$1C'JIF*XKC9$Q_P"+6O6ZHB)IJU3\M3!+
M3;6S4'EYE2\+RC&WI-H8>6ZO')ZE1GXKBS/C<B/44DT*WF5#29[4TJ+T7(G1
M.*UP33IA=3+^=Z7-M;L+"L1.T7:2CLT7:XR42"CFLJ<3;"$D2E%O3Q'2N])B
MB::IU*N*(UN!RRZ$Y%=\FBZJ9W"?BP(3JIUBBW!*BDW"<Y512G$*\I*$&9K(
MU%Y2J;*$+M,\%."BN9KG%)*@C))5.I])BC:J:@
M
M
M
M
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M!\>VZ<X!9GTRK1A-BMDI/FR8UOC-N%XE)01D [CP]-=I[S 5(J%0!4
M
M
M
M
M                                    4(B+<(B("E B,!42   H9$>\
M!4,!2A5KT@*A@                     "E*"(C 5$S      *4VUZ1&&G$
M*!@*B0   1@*$5 B,!42
M
M
M
M
M       ;MX"E2ZR 5          %*EU@*@            *5+K *EUD J
M          5IOV *5*E:E3K 5
M       %.)/UQ?1 5(R/:6T@
M
M               4XBK2NT!0E$>ZM:5H94 :@          ,R+:>P@%#41=/
MT-H 2B.M#W;P'5LJSK#,&CQ9>995:L6BS7#9AR+I+:BH=<(JFE!NJ21G3H(!
MR<:RS&,RMB;UB>06_)+0IU;*;G;9#<E@W&]BT$XV:DU3TE4!V$
M  !\'(\IQO#[6Y>\KOL#'+.RM#;MTN+[<9A*W#HA)N.&E-5'N*H#A8KG6&9U
M'F2L,RJU93&M[I,3G[5*:E(9=-/$2%FTI1),RVT,!VL
M
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M3B]HLSHE*7:J:-2N@N.IAAI,5_R41F9%O+>08#4
MH9D15$3. ZVC+\:>R8\.8O,9_)FXBYTBSM+XWFHZ%)0:W234D>4HB(E4,Q5%
M.,8J9JB)P=E$*@          :5TX3J=!35.$)A83736MC16WX]<G,8>R5-^D
MOQR0S*1%[)3+9.5,UMN<7%6A%0A%$S-VFW_$3A%NJOH7FLEQ*YV2TW131Q3N
M4)B6<92N)3?;-I<X#,B*IIK0SH+DQPS,*8G&,7UR.I$?6(2
M
M                                    (B>\_P"=/.>7$M/<%TAO<:T9
MUD1/7F_S5QT2'(]M:5V4=))=2I%'W"<KTEP>$!Q>[ YV,]YBY6H6 :P7^->L
MTL;;5[QN2U%3&<=MRC2S)0KLB)LR:<4BG3Y6T!+_ %KZH"H      T&JBN&G
MJ@,%[/WC'+)?-4H6CMOOE[7F\^__ (M1XB[4\ECT\W#:H;U:$CB*G$ SJ/<
MBR[U/6G7'1S2##W='7[CC\7*KP] RW-K5Q)F0$H:)<9EIUORFC?/C\HJ'Y%*
ME4 [JW6O7/6+2++3UA.??HF*W=J#BF?W52U3;B3C1KDQGEN54Z<8^$R</:?:
M4/< L3WW/R9Z+5_UFE[/^)+ 7[[H J\G<+;7_KC?-^WI8V$"92D@@
M    !&-WN!5Y.;Y7_6:S'0O MV@#'[N1/DHUN^-L#W" FZ
M
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M3CLA1*))I4E7[4MPJ_>G'0C9$0D;:XC;0:TDA:B(U((ZD1F6TJ]-!0J;@
M
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M6M!%L+: []KEK9I%H=B\2]:RWJ-9\;OLHK:PF5'.2V^\:36:%-$E1&5"J=2
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M1TW;*;[<DVFU6UB')4;LI2S;(B,D4X:E7BW4V@,S$F9UK3U &H
M
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M1%L(BV$*(5-0D
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M&%.**FXR(!Z<D'6H#6
M
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MZA$1$#4)
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M'B70S-I"3,CI]6 D>
M
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MIB=F/ZRPK<?75.[L8J%\\#__ "%_ZXQ^5ZI__P C)YA^[_*EO$J0
M
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M42DFT.N)/IJ72 ]:MEM<6R6JV6:$2BAVB(Q!B$HZF34=!-HKNV\*2 ?4
M
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M9$1'M\_QBGEWT15_/^JYGOJP_E2WD=00J
M
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M+VBVD:F%KMD(U>@19-P=*,TZZ^Z9'(DN;B2FO GBH1%4S"37N1:?S4:W4/\
M[6P/< ";DRJ \YW?/Z)^]&;X%KG:83A1,KAGC^3N,Q2)A$R$:G(SK[Z-ZWFU
MF@N+H;V /A]S+HTSDFJ.=ZQW2*T]#T_MS5JL1.M&9IN-S,S-]EP_)JVRTM)E
MO\L@'I,)-/5 :@
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MTOM_[KV_!VG'^NXJB:=&I-4XNUD5"H(A"HD
M
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MZ.\J6G5NN$-Z#?\ +VUY3D$9Y9+-#MQHIE*31N2<=+:J'N,S 9U
M
M
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MGXKYI*E3+<8M*VH
M
M
M 0D]YQKUS9:4:F8G8=$[GD%KPG(,66JX+M%I3,0J9Z0ZAQ1228=6VXE!IV$H
MJ;R 8;<H7(#KEKSJK8M6^82UW:UZ?,26+U=KGD;JEW7(%-$E4=AIMU1N&A9D
M7&M94))<-#J ]/,>-'B,,18K#<>-&;2U'CMI)*&T((DI2E);"(B*A$0#>
M
M
M                    !I-*3WI(^@# X4_6E] ,!7A3OX2KUT 4X$TIPE01
MA"<52(BW%02A4                        RKL/<>\!IX$TIPE3JH$AP)H
M9<)4/>(PC'$:B(BW"0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M.5F*J9F*HPWZW.01%N4:MG2(4MP2
M
M
M
M
M
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M@
M
M
M   *&="J H2JTV'M ?&O.2X[CC3;^0WZW6%ATZ-/7&4U%0H^I*GE)(P'5UZN
MZ4-U[34[$T4WDJ]02_PP C5W2AVG9ZG8FNOUMZ@G_A@':++DN.9(TX_CM_MM
M_99/A=>MTMF4E)]2E,K41 /LFHBWD?C 5(Z@*@
M
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MBB,(<'S#/W,]?JO7)TSLV1\%RD*,S42MAEM(O!UBMA-T
M
M
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M5FU*O.GN5P<EB-D2I#;"S3(8(S-)=M'6276ZFDZ<22KT +BI57Q'M :P
M
M
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MF%V;E<Z-D;(A>CA(S(SVF6X7<6MP5(B+< J
M
M
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M++"FQ;C%CSH$IF="F-)>B3(ZTN-.MK*J5H6DS)1&6XR <L
M
M
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MR!
M
M
M   Z_E&2V+#[#<\FR:\1['8;,PJ3<[I)5PMM-I+>9]/41%M,]A (!^:3G$RO
M7:Z3L<QB5,QG26,X;,&SI4;4NZ\)_P 8G\!UX5&54M$="*E?*J"%TN6/D'ON
M?LV_-]86I>+X/)93(M>)-U9N=P2JG9K>IMCM&G:1>>>SH,!,]B>'8O@MEAXY
MB%AAX[9(*"1'MT%HFVR+K53:HSZ5*J9]8)=H         *%U .M93B6-YK9Y
MN/Y98H>162>@VY5NG-)=;61^ RV;MY4,!#1S.\@=\P9NZYSHNP_D6&Q4>DW'
M"U*-ZXP4%4W5QC5MD-IW\/GD5=Y$ LWRM\WF5:"7>/8L@D2\ETHF.DFY6%2U
M.2+69G3TF#QG4B(ZFMHSHK;N41 )_<3RO'LWQZV95BMV8O>/WEE+]MN<99+;
M<0>_PD9'4C(]I'L,!V/?NV@
M              I4MNTMF\!0C+ZXC$88!Q%4Z;?%M#$.+U/&&,@1[]M:F$2*
MUVT#$5$@
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MCA33R2Z2/P"9E0W@2
M                                                  -)&76(T@9D
M7^P)%.(NI7TP0HE1*,]Y4Z]@B=&U+3M-23)="KNZQ&B32WA4
M                                     C$!.(!B C$!(
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M$9F1=&\1$XBHD
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MVY;JHJFBJ,)C7B^IQII6HE0J1D>T@%0
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MN[5ZB[3Q43C#LR5I654G4C*I"UCIP76L2
M                  #0:^$]I4+H.HIXDX.F7343"K.\J-<,@BM2$E4V4F:S
MW5^H(R^F,BC*7*XQBE7%JIP(>JN 37$--9 PVZXHDMH<2M)F9[OJ:"JK(W8T
M\*?M5._,R69#2'H[B'V7"JAUM1*2HNLC+88QIQC6MS$PWQ,(
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MZWF:MOD^<V5?UI= )2[%N(!4
M         $2/B7Z^VC%[/<K]D%R9M-FM#"Y5SN4A1(;9:0534HS^D1;3/80F
MU;JJGAC3,J:[D41C.J$(7,=SAY=J[/N..83-F8IIBD^P98:/L9]U27G/2G$F
M9H;49>2VD]WG5J.SY;R>FQ$5U::NQR',N:UWJJJ*9PIC]6%R4H2G@05"3]26
M_P -?7&^F(KT:FCHQM_$4XA!MDM1$;IT07UQ^#K$3333WI51-54_3#[K&,Y3
M*:2_$Q6]2F%%Q)>:M\EQ!EX%);,C%$7:/X\%RJS7MHF7S+A#FVEPF[M EVEQ
M1T2W-8<CJ,S\#I)"FJW5KG%35%=&S!Q]QE781E4U>(7(X:=6I;QFK6[;A&=Y
M?IMD$?*<)OTBPWE@T\;S*O8GT$=>S?:/R'$'NHHC&-F,M9O1,51K9%G,7;$Q
M53.J4XG+#S0V+7BSNVZXLLV'46RL)5?+ 2_8Y+94(YD/BVJ;,]Z:F:-Q]8XG
MF?*Z\G/%KIEV?+N94YJG#55#+)"JFK89;MA_I#61ITMDW!(
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M!U2M)[_"DT[C(]I&-C37%6IY[?R]=BY-NY&%4.R(/>1D9'X14LXXM8
M
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MHO$>W?PV?R->4KPG33LEVV1SU&:HQC1.V.AD$E1K*NXNH8--6,,V8;A;!(
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M(SH9DAU*B(^JA@+J
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M1T,SIQ%5-=Z3(QYWFLO-BY-.S8] RN8B_;BJ.M=W:,;2R 2
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M&+S.JB::IB=DX/J I
M                                          %#KT -EQWLB4MPTH;;
M2:W%GL))$53,S\!"(QZR4 _-EK[/ULU"F0K;-,]/,0E.Q,7@I,NRDO-GP.SU
MD5>/C,CX*[DTV5J8[SE&2C+VXJP^N=;AN9YV<S<F/W(U,5C,B(U*51)%7B49
M%XC.NX;6)X9XI:R=,80SNY>^2/(]4K? S#4&?)PO#)Z>TMMN83PW6:R9>2Z7
M'LCH5O2I1&9T\VAD8Y_F'/(MU86IQ;[)<FJNQ_5T1\-:53 ] ='=.HJ8N*X!
M:HCA&A;EPD,)E2ENH*G:&\^2S2H]Y\%"KT#EK^;N9B<:Y=-9RMNS3A3"\A(2
MDB)/DI+<DMA%3J(6&0Z3EFFF 9U%EQ,NP^TWYN:V34AV5%;4\:"Z$O$DG$^H
MHA<MWJ[<XTS@M7+%%R,*HA'!KUR!Q&H4W)M"W742HY&Z[@$M?&VZ@JFLH+ZC
MJE5*4;57B^NZ!T/+>?83PWM72T&>Y'],U6=>&I%M*BRH,J3"G1G(DV&XIB7"
M?0;;C3C9T6A:3VD9&5#(QU-%45QQ;)U.9JIFF<-L:W?]*=4,CT>SBS9QCBS<
M=MZR1=+6I1I:G0EG1V,Y3911;2,]RJ'T"QFLK1?HFBM?RN9JR]?'0]&6#YA9
M\_Q*P9ECD@I-GR&&W,A.%6I$LO*0JI$=4*JD_"0\[N6JK5<T5:XEW]J[3=HB
MNG5+MXH7                                           =<R^>[:\7
MOUP842'XL%YQE1]"B2=/IBY9IBJNF)Z5RU&-4(YTJ-7&XL^(U^4H_P!<>T]@
MZIGRTD5/&)2KL*@"I[-JZT5YOA$$+^Z*9\=EG%BMV>,K9<#+WK>4>QE\_J-N
MY*Z_1&LYAEN...G7&M8O6^*-&MEV@S,CJ=>HQHHGI836*@
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M1<FW.W5U)E4G4C\ X^)Q=8U"H
M                                      'S;A%A3X\J!<([,N%-;4Q*
MBO));;B'$\*D+2>PR46R@B8XHPE537-NJ*HG"8U(\LTY=-2M%,BN6H'+!-*1
M8[@X<C(]'YRR5&=VU<*'Q["\!5JD^L8=>7X--#N,CSZSGZ8L<PT3LN=&_9^C
MZ&%<W.GUXE_B_J#$F:49BP9(F66]-+0R3A>=P/*W)_9"S%6*[?Y!>F.*Q/W8
MZ:=/[&3EIO%GOK)2K%>(%[C&52>A26WD;>GB09[!5K:.Y;JLSPUQ-,]$OK]@
M[LHC?X2#"5OCIZ73\DSG"\.8<D95EMIL:6B-1M2I3:'5?L&Z\2C\!")T,C+Y
M6[F9PM435/P8H9'S7W#+[@]B'+EAT_4')GE=D5_>8-NW1#5L[11+I4B_7F1"
MF*YG1&MOK7):+$17G+D41&G"=$[ER]$N5&1 R).K&O=Z+/\ 4]Y12(<1T^TM
M]L/>5$F5%K(^KR2Z*[QDVLOAIN:9:;F_N+CIFQE(X+73&N>UG6U11<94,U;S
M(9;D\6Z
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MAUG(,Q,Q5:G7&E)^BAI*E:>$<TZ%J
M    !I423(N+=79XPQ1+0OCV<)DFG28:-I..QK2>SUS,1CBG# (_"6S>& U"
M1US+[>[=,7OUO83Q/RX3S;*>M1I.GTQ=LU<-=,STJ[<X50CG3Q)):5_;(YFE
M1>%.P_ID.I;"=+3T[?5$I5_4 4\8#41&=-M*;:D=#+JV[RVB)&:.D&?EE5I*
MU3U_Y]L[:4OK695?:+8ESKJ6Y0YW/Y7[-?%3W98=ZUAI7I2=2(^L8;'5
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MP]!,NG:/Z]81?+B4F =@R#WJR:(T1=L;#KAQGF#(Z5J:DU(!Z=2/:?AW& U
M                                         "BCH1U.@B9$>W>-79$;
M1O&+.AU2)-WRB*\2$[ELQ6G3<(_VZ1OO;],3>J^%/S:/GM6%FG>AB];H]4=I
M+D(3,]W/C$*VZ09!EC2C.XY;D#[4LE$5$)MR2:;))[_*XC,QQ7N.[-5^*.B(
M_5UWMVWA8FOIF?TT)!TT*AE4B,RJ7AZQHYQF6\C!O@D   !MNMH=:=:<02VW
M4FAQ!E4C2HJ&1D?@#'#2B8QC!YE]4L8BX5J;J%B$#C.WX[D,^% -P^)9L-O*
M[,U'XC'H^3N\=BB?@\\S5K@O5Q\7W-";TWCNMFE=\>*K5MR**MTJTJERK1_9
MBGF5'%9KCX*^7U\-^B?B])Y>#U1YP]!5%4      TU_74$H4J=?.V"B9GH2$
MM)_5D)C&=B,8:B,C*I'4NL2E4
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MQDTTX:H<U>S%=Z<:ZIF7::"5H
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MMI%0]HF-(U
M          H>XZ;?  VB2="-7GGU=!^,!%EWE2>&)I*DBH12KC7I_M1#6\QU
M4[WH?L&,/OQTTQVH[](Z?SK:<^'(87MB1@V)F*X=SS:(G)W>GAF7IAX2/:9;
M:]8W^#P,IN\DO&)&H
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M<"4RATSXN)+4V0VGA5TD1)H5 &5)'4]WB :@
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M5TT]+L>7\PHS=/15&QDLE=5$G:1C7X;6P;HD
M                                    4ZO  BO[RW^+Z4??5Q]J(:SF
M&JG>]$]A=Z]NCM1V:1?*MIQ\88/MB1A6O,AW',_27?!4],9#H'@:H
M
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MG(,^C9MH9C@\[DZLM=X9U3J=QDLW3F;<5;8UK\#%98
M                                           BN[RW^+:4??5Q]J(:
MSF&JG>]$]A=Z]NCM1VZ1?*MIQ\88/MB1A6O,AW',_27?!4],1#H'@:H
M
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M(N@:?GF0^UPW*=O>WMMR//3<B;=6&C5N27-&LR5QTKQ;*=0Y_1L= W1(
M            HHR(C,^@!9+7+%G\BP],F(E3DNPO^FI;3M-39E1PBZS(MHOY
M>OAJPZ70^VL[&6S.%6JN,.O8P5(S.M3VIWC82],HF,<#9T"5,1@ EJ2=-BOH
MB"8QTP)4;3C;K*S:=:42VG$[#2I.XR/K$HFF9C3JV[F>>E&H",XL/92E4O\
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M&>:+0_7F&P]IYGUON%S<(B>QB4OT2YM.$GB6@XSW"IPT;E*;XDEU@,A
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M1.EW&QO"0
M        !%=WEO\ %M*/OJX[?^"(:WF&JG>]$]A=Z]NCM1VZ1?*MIQ\88/MB
M1@6O,AW',_27?!4],1#H7@:H
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MM:SW$E.TS]0$O,!K'D;NJ6NN=7ER;[Y1\ERQ5OMTQM-..#Z0F+'-)%M\EK8
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MTF9HJ.!S=N;=RJGXNZRMR+EJFJ-L+LBS"^
M                                  BN[R[^+Z3_ 'S<?:B&LYAJIWR]
M$]A=Z]NCM1VZ0_*OIQ\88/MB1@VO,AW',_2W?!4],8Z%X&
M
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M$OR%^<MYJ,AMTS_LTF.'SE/#>KCXR[;*5Q59IF.A=$8S(
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ME8^$S'Y3@S5*M-N_I&G;E4
M                     $5W>6_Q?2C[YN-?[R0UG,-5.]Z)["[U[=':CLTB
M^5;3CXPP?;$C"M>9#N.9^EN^"IZ9!T#P,
M                                                        !0SH
M5>K:8#X&5;<6R3PVJ9[0L5V8^NF/BHNSA1,_!YY>6&A<P.D)?\_%4_\ @G!W
M_,)QRLS_ )<'!9"G_J8\6*>17E*KX:'XQR.S!UL]Z)V-=?4$AX@%*?1  %0
MC# :3I3I\'ZH0B6MK[8CJJ7KB94Z<$ NOM"UMU.IL+\99)E3[J.OY?IL4;G)
M9[SJ_%'9#T-Z?[<%PI6\_>*WE4]_\70//[TXW*M\]KO;'ET[H=O/SD^J+*\\
MO>7?E=EWAOMS]UNCTS+^31NAYU=\^OQ5?-?'E$^<;IC]]O\ M1C"YQZ.O?\
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M)J?-5+C%1*)*2Z3Z%TW'XQQW-<E_;U\5,?3/Z?!K[]OAG%DD1U(CZQK&.J
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M5=@#I^B_>R:CXHU'M^M>,1]1;0V1$YE5I)N#=$IW\3C"4DRXE"=W"7$H^GI
M3R83EMNSS$\?S*T1ID2UY-!9N-N8N#/8228?3QH[5JJN$S(ZTJ [2
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M'7_ZI9RC2-\
M           BN[RW^+Z4??-Q]J(:SF&JG>]$]A=Z]NCM1VZ1?*MIQ\887MB1
MA6O,AW',_27?!4],1#H'@:H
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MQX:>QL_;OI9\=?\ ZI9RC2-\
M                        BO[RW^+:4??-Q]I(:SF&JG>]$]A=Z]NCM1V:
M1?*OIQ\88/MB1A6O,AW',_27?!4],1#H'@:H
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M%27OE3^;WI=\$E[:X.1YIZFO?\H==RWT]&YD(,!G
M-IS:1EQ<-"ZCZ?$$288Z'SY4.-<(<J#-93)C2FC:DM*3L6E6^IGX C&)Q5VK
ME5JJ*J=%4;4?.HN$2<%ORHGE/6N55VU2C(Z&V?U!GUIZ1L[5S[E.+U3E',Z<
M]:QC15&MT4RJ?6H^KP"XVVJ=&ITR_P"90+.2XT+@N%RH=>$_8FC_ %Y])^ A
M<IMS.F=$,BUEIJTSHA9VX7&;=)"I<]\Y+ZOJCV)274DMQ$+L3AJ9]-,1&APO
MIB%:[VB^J<O2C+VKH?$]CUU-$;)X)&?E,D9<+Z2+8:FCVUZ2J72+5^S]V,6C
M]P<GIYGE^']^G33/QZ)^"8:VW"'=(,2? E-S84YE$B)+:\IMQMPJI4DRZQI*
MHTO%[E%5NJ:*HPF-$N)D5AM636:XV&\QD2[==&5,2V5$1[%%YQ5W*2>TCZ!7
M:KJMU153KA%-6$XHA]2, N.FN5S\8GJ-YIDB>M5PX3),F*KS%D1[C3YJO".X
MR>:IS-N*XZXZ);.W7Q1#H>^HRE:@D5\/4(%-BO\ 9 AD#R_:M.Z<9.FVW63P
MX=D+B&KDE>THSY[&Y*:;2+H7X.BHU7-,C&9HQCO1^L="Q?M8QBE-:=;>0AQI
M:76ED2FG4&2DJ2>TC(RV&..C1.'0U\PW14@      #I$;1\B]WBW6"UW&]7>
M4F';+8PI^9(6="2A)5^B9["+I,311-RKAA,0B&U0U#N&IN73LAF$J/$35BR6
MY1FI,>*D_)+JXU^<H^L=SD\K3E[444]<_%M+,?;ACOJ3A2,NL:O1D?YZM=7;
M:>SB<(_*4R==_%MI3I%GF.2C,V\/WHU+68M17&+&/"\NN.$7HY)(7Z(XKT>]
MVU=4\24GMV'N6@]PYK)9RK)WIIJ[LZV);N314S6M]PB76#%N4%],F'-;)QAY
M.XR/H\!ENH.THKIJC&F<8ELHJXHQ<L5I7[T TD7J7DQ3+JRXG$<=<0[=72V)
ME/;5-QD'TD9E5=-Q;-YC5<SS\96WA'>JU?#XK.9N<.B$IR4-L--MI03;;1$A
MM"2H24IV)(B\!#C:<=NN6NF75,YS*RX%B]VRF]OFW!M37:$TG[8\ZK8VTV72
MI:MA$+ENF:IP9.2R5>;O4V:-<RAHS?,[SJ#E%URR_.J<G7%9]@P:JHC1TG[&
MPV6XB26S9OWC=V;<6XX7N'+>7V\C9IMT1HCMVNJ'MW[A5%,\3,B8B<9=TL&9
MS[028DLO?"WU+A2L_9&NCR%'ZQ^H*:J<=>M8O9>FOX2O!!N$*Z,>E6^2F2Q6
MBJ;%)5U*3T&+<Q,3A+7U6ZJ)PERQ"A?7133PLENR,BNC2O>>RN<49I2?)D2$
M[BV[TIZ>O<,;,7>",.ES/N+FW]M;^U;[]4?E#-I*2H6SI.NSUAKYC&,)><N2
M)'7LKR:Q89CMWRO)[HS9K!88RYETN3ZB0AMI!=9GM,S,B26\S,B*IF \X_,E
MK[DG,=J*=S0W)3C4%X[=I[B;:34I*'%<*7%-I*JWI!T,Z[2+85"V )AN3+EO
M+0K #NM_CJ1J-G#;<G)S<-*E0V2\IB"BA4+LR.J]IU74!FD6X@%0
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MXY\L+OQT5[N,>D3Y$>'Y/./]>KQ_-Z#T_:F-F]EK[ AQCM(5_10 V= "@!O
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M[1_C+>/;$#2\_P#41X:>QL_;OI9\=?\ ZI9RC2-\
M                             %2      #],  :3/;OZ# 18]Y;_ !?2
M?[YN/M1#6<PU4[Y>B>PN]>W1VHZ](OE6TY^,,'VQ(PK7F0[CF?I+O@J>F,AT
M#P-4
M                           &E?F*\1AMA$ZGPLH_)?(O@J7[0L5V/,IW
M_-1>\NK=/8\\G+#\X'2'X=3[4X.^S_I*MSA.7^IA/(73XQR4ZX=9.QJ%05,0
M*^(@#=XS Q4_V0%:]!@*'N,3!+4UYZ#/;4R]<1.M3/=0"Z^_+;J;L_[22/;1
MV'+O)IW.1SWG5>*.QZ'-/OR#PKX#M_N9 \]N]^K?/:[ZSY=.Z.QVX_.3ZHMK
MKR]Y?^5V7?#MS]UNCTS+^31NAYU>\^O?5VROCRB?.-TQ^^W_ &HQA<W])7O^
M<,CE7J*'H5' N] 'FMRGY?;_ /\ F.]_I4QZ+:]+_+\GGE_U/\WS>@65_&I/
M@<5L]4<;1W8=C5K;-.JM2$H.LA(H K3=],!3U %?%NZ# 5J(&GH/JH8J)0J<
MZOR_99\'V[W*@=/RGTO6Y;F_J*DO7*G\WO2[X)+VUP<CS3U->_Y0Z[EOIZ-S
M(48#.                      ]QTW@.@9[A43-<?D6B4E*)2?9K;-_N3Y%
ML4>RM#W'UBY;N\-6+8\KYC7D;L5TZIT51TPB6SF_WZV7>ZXL[$=L4BTO.1;B
MTLR[9PRV5XBV$DRVE0]O6-S;X<.+6]GR5-JY;IN43Q15&.Y:\BILZ"%4SBV"
MH@  NGH,5X8PIIG@F:IVLX.4S6,K7+3I=D,A*+?-4;F(3'5<)-/*,S7#.NRB
MMZ/H=(UF:LX?4\_]V\A^G^[M:?XH^'2D021&2C02349[3\(PGG&Y9O6_2J-J
MCBCL-DFV,BM/%)L$Y::^R$55,*,MO"X14/J/:,W(9V<M<QV3K7;5?#*)U^-(
M@R94*8PN--B.+9EQED9*;6A1I4DZ^$AVM-451$QJ;2)BJ,6R*@  "A&E1'NZ
M?"(A%6E)#RI:A2,HQ.3BESD*D7/$%)3$=74U*@+V-<2J4\A1&DOUI$.3YSE8
MM7..-57:P,S1A.++(:=C@      TJ.E:;^@15.$"/;FSU)>N5YCZ<VUWAMMJ
MX)5]-"CJ])5]K:52E";+:9'6IGX!T_)<IPT_>G7.B&9EJ=K#?HZQOV8&1'L,
MB,NH]U>@!8G5;3I=U)W);%'([DVFMTA(*AOH27VQ)%]61;^L:/FO+OO1QTZX
MV=+$OY?'ZEI]/]0IN%RE1I*7)M@E*/TNW?5LK/>XU4]AE3RBZ1JLES3^UC"O
M5CJZ&/:OS1/"S=T\M<C5&XVBV8897,[PX242D^;'25#<6]NX>S+:9'OW#IJ\
MW;IM?=F=&#83>B(Q3'8+A5FP#&K9C%D;-,6$GB>>7M<??41=H\LZ;U&0XK,Y
MBN_<FNK\0UM=?'.,NX/+0EI:W%$EM"34XM6Q*4D53,Z]!"S*F(QG!$US&ZPJ
MU,RD[39WE_B9C+RVH"=R9DA-4N233TE]2BO1Y6PQMLKE\*>*=;UWVMR2,C:^
MY<T7*HQZNACG7KW]8R=;J(T=8"H]2O@ <RW7&;:9*9<"0J.Z1D:Z>:NG0I)[
M#(R$S,;5-=,51A+(_2?M=4<BB8RRPJ'<$I[>YR&T&IE#"#\I=?J3ZB5TBQ?P
MM1CL<_S>_3D+,WJYT[(VRE%L%HA6&T0;1;FR:AP6^S927CJ9GNVF9F9C435Q
M3B\@S.8JS%R;E6N7UJEM\ A8=/SK/,1TYQJ?E>:7V-C]BMZ:O3I"J<2]Z6VD
M[W%JIY*4D9F @&YJ^;"^\PUX*S6I#]CTML\DE6.P*,R>N#R3,DS)I%4C,Z^Q
M-[D;]J@&:O(QRA2L;.W:V:H6PV<@>1V^"XQ)31<)I953-D)47DNJ+:V6])>5
MOH E4+80"H                    #&_FSP#4[5+0G-, TFN%MMN49.RB&^
M]=%+0VN"HZR&FUH\UQ9$24F="WU,!YD,BT[Y@>5C+6)MTL^1Z67^W/(<B9';
MUN)AO.4J@T2F*L/'3:9&9TZ0$XW=O\P&NNOF,YM.U0E0+UC6*O1[9C^4-LDS
M,E3#3Q/I?X3X5\"3*IT+>0"3@MQ=5 #B( J1G0!4!2H#2EQM1J)*R4:#X5D1
MUH>^A]1[0&L       'F==^6)[XZ*]W&/2/]"/#\GG'^O5X_F]!J?M;'W%K[
M!(XQVD*[0"@!6@"H!U@'A$"@D#_08"'SGT^6^+\5+=3^^/#I>3^1_-/R<US?
MSH\,=LI2.4+YM&CGQ?:]L<'+\X]9<\3I>3>BL^".QD<>XQK)U-F\XG,C\OFK
M?QEF?9F/0^7>GHW0\_S_ *BO>M[A'Y;X9\.V_P!T(&5F.Y7X9[%BSWZ/%';#
MT^%YQ^H/,NAZ.J8B1YP^9KYQ&M7QH>]J:'I/+/3V_!':\[YCZB]X_P#VTIN<
M!VX'A'@L<*O][(<E?\RO>ZNQJIZG;R+>+6Q?G7+73Z?2(0ITT$AO,_!T !TI
MX>L0*[:;P%-Q;Q(T=9]%/TA,;%->U&=WANR=I'T?P:[^V,#?<B[MS\=+1\[[
MU'XZ&47=Y?-VC_&6\>V(&FY_ZB/#2V?MSTL^.O\ ]4LY1I&^
M                     #< Z5D.H>%XK?,7QK(,BBVN]YF^N-C<!XSXI3J"
MJ:4F1&2=NPN(RJ>PMH#J*M?]'$VF3?3SZV^]<:_%C#TLE+,BNBCH3!%PU/?7
MC+R:;>*@#DW77+2:R+S9NYYQ;XR].NP+,$U4HX:I&QM%$)/C49[.%%3(]AE4
M@&A[7722/<7K0]G=K;G,6(LED-FX?"W;5$2B=6NG"E1D9&2#/C,C+9M(!Q8G
M,%HY-<PQJ/G<#M-0([\O&$K)Q!NL1^+M''>-!=@FJ%$1N\-3(Z5H8#A-<RFB
M#]MM]V;U @G NE[5CT)TTO$:YR#X5)-!HXB;(_[:9=G^N 4G\R>B-MCY9(F:
M@0$M85,9@9 2$NNJ;>?,DH)I*$*4\FI[5MDI)=)@/H/<P&CC$^]6Q>H%L5+Q
M^SIOMR0VM2TE!6GC)QI:4FET^'::&S4HND@'*M^N6DMTGXM;8&=6V1-S.W.W
M;'&B69=O%9*KBC49$2%%0_(69*J1E38 X\#7W1^Y0,6N<+.K>]"S.Z.67''O
M9$]O/:/A6RHE)(VS(S+:NA;4[?**H5EZ_:/P8&1727G=N9A8I>4V#('3-9G'
MN"U&E+)I))FJID?E)(T[#V[#H'/N.M.EEJFY?;Y^:6Z/+P*W,W3+&C69E$BO
MT[-9J21I6:N))$E!F=5)*E3(!H;UMTH=N5JM"<XMGIUZLBLC@-J=X4G;$H)P
MY"UJ(DH\CRN%9DJFV@#Y4+F&T:N+.&O1<\M[B<^D/1<72HG$*?<8-27.-"DD
M;22-)EQ.$DCZ#!#B*YE=#TVV3=SU!@*M\6^ECCDA"75<5P-1)X6TI0:EMU/:
MZDC;IMXJ ERI_,3HQ;DYBN7GMO(L![$LF-OC<[,Y%.S)G@0?;GMV]EQ4Z: -
MP^831@KF[:/YP+7Z<U9/QA-'&K@."1<7$ASAX%.4*O9$?:?K0%;7S!:.7AS#
M6+?GUM=<SUMY>,$LUMD_Z.7LB'#6E),K+<2'.%1GL(JF T1^831J3;+?=V<]
MMWO==;\K&H<I7&A/OF1F1LKXDEP%LKQJHFFVM 3\$=7>!YOB>8S,,L.,WQB[
M7?"[M<;?DT%HU<<5_L$F25<1$2BVTJFI5V5J,+.4S5-.'2[CV5GK65B]5<G"
MG".U@EII*8L^H>$7BY.^B6RV7F/)G2UD9I;:95Q.*,BVG0BW# RUFJFJG>[3
MFG-<I58OT4U1Q11,S^6YZ&H>M.ELZ;B]NC9O;'9>9VYZ\8VT:S1Z1!8)2W'C
M4HB)LDDE7G\)^2KJ.F[>)S&&B7QXW,+HS,@8W<X^>V]R'EUV79<?7[(2GYC:
MS0M/ :24A*3WK41)VEMVD)0X\WF0T2@6[(+M(U!MY0,9NK=DNKS9.N&4YTR)
M+;*4(-3Q;:\39*21$9UH0#ES^8/1VUR\M@S<\MR).#P6[CDB$&M9,L.D9I[-
M24FEU?0:&^)1'L,J@-:.8'1YRX6NV)SZV>F7FRGD%O0:U$E< BJ:E+-))0Y3
M^U*,G/UH#@V_F2T1N;6(OQ-0[8MO.7WXN/*6:VS4]'V+0^2TD<<ZF7#VW#Q5
M\FH"JN8[1--MD7A6H-N1;X=]3C<IU7:)4W<%&9$A2#22R0=#]E,N#8?E /IS
MM=M);:6<*FYM 9_FX1'7F*?+4J(B4:2961)29NI4:TE5LE%4R(]X#F?ST:7>
M^KED_'6W%<F\?_&E3!K.AVC@[3TE*Z<*B)!<5".M-M &U;=;]*;JO"68&:V^
M0[J,R^_AS?$I*IC<8S)TZ*21M\)I-/E\-3(R+:0#A-Z_:.NVRW7EO/;:Y;+K
M?EXU;925+,GKFV=%M)(DU,BJ7ETX-I>5M(!MW+F#T:M47+YDW/K:W'P26S R
M5:36LV9+Y^QM-DE)F\HS(R/LN*E#KN,!R)&O>D,2YWJT2,\MJ)V.V9-_O#?&
MHTLPE$7"HW"+A-PR47L1&;FWS0''M_,+HW=)6+PX>?6U<G,+<[=;&APUM$J*
MRGB6IY3B4DPJA[$NFE1]!& X$;F7T.EPL<N#.H5N*)E5R<M-G<<)ULU2FC4E
M27DK01LIJDZ+=)*3Z# 5D<RNA\6%?;@[J#;RC8Y=TV2[FDG5+;EK62$\"$H-
M3C9F?VU!&C]< ^M+UZTAA2<KAR,ZMWI&%V]FZ9"AM2G>RB/DE3;K9H2HG2,E
M)KV?$95*N\!<BP7ZS9/9K;D&/W!BZV6\1T2K;<(ZN)MUI95)1'](R/:1[#V@
M/L
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M1DHC(R,!S0     !YG'-FL3WQT5[N,>D?Z$>'Y/./]>KQ_-Z#D;6V:?W%K[
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M%SOO6_QT,H^[R*G+M'^,MX]L0--S_P!3'AI[&T]N>EGQU_\ JEG*-(WP
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M1&9T2DS/S0$E^AF!3-,=)L'P2?,8N$W';>;,F7%2I#*UNNK>/@2HB.A<=-I
M+L
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MN6YOZBI+WRI_-[TN^"2]M<'(\T]37O\ E#KN6^GHW,A!@,X
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ME:O3,B?;-NXY?<"2[<'R41<2272C:#,J\"*$ R&)-/" U
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MCH91=WG\W:/\9;Q[8@:7G_J8\-/8V?MSTL^.O_U2SE&D;X
M                   /$ L_G-V1!RFUM*(U&<.,M%*[#<N<=FI_M@%MKEEA
MKL&7MQB/CN]OC'#4DE'52("GE<'379M!+[4R_JG7W(E%]IEVE5B8(ZD7I#4]
MYC8?37@W;P&[:&$KFXA>9SW9,X]C!6F]+^I0Y)AQ33Q&>ZIKV$"&Q:L/?MT3
M2E4A;;<G [G<WKHVK8IJ)*<D\#RBWD1D1;P&TQBC:+7&MZE%6)FB\E2CI.&:
MDJ)ZGUNW>"2\8(Y>K;G<&.M"G<SR>'<VT[S5!COM\3Q%O-)$D]H(<G);"[+G
M:K7*(\A:<NLD.!CJFS)7;)8CD;G!]=0SZ &[*DE#O3TTE\3/XJ%C#!I\WTE#
M\@J%^NJWN ?*MN3(A'A'&1DC%;"F'<*D9$E]V/;322SZ#/MRI4!LHOYMVPHJ
M6E]HJ--=?3PG4C-%V,C.NZO8D"7-B98\W?K3+HOL6HOO4LS(Z&IZ9 :(Z^'M
M3V"!LXO='6U::/2%\)8S$FE=N+9P]O"><2:J[MW2)00K'(3$Q2&I=)F-9N]<
MULF1E6WKF.(-XS/H(@&Q=; R]:\_9B'VR;QE42^V3A_]X0E$=QQ:.M*>+>0)
M<[*L3*[-ZM)BN&\O.$0&H!(H?:G$=2ASL^OAI4Z ASY&($[=LLO,>4AU%UP;
M\6+&HC+^$/I:<-9(\)&BE 2UV:R%9+[I^\Z\11<8L+EDE*(RHF6^ZTUPF?0H
MN+<"'6+5-/'[7IX[)-2CPE%QDWGB(Z-E)A*<;-?5YVP1.M.&,PPKYO'%*1B%
MN?2IEU$K+I:267"HR<F$A%*]=-@PLU&.&]UOM2[-->B,<9^3%S3JW=AJ)IX5
M:\&2VPED709W!Y!_8BQ:ICBATN<S>-F_,TZJ)3 %E3Y>]32E*XL>OBY\DS(R
M(VW4W>E3_P"!&UF.AY71A@U+D2G8,QA)=H_^-+5Z@M[2-4=<J"@UEX$D\>T%
M3?OV//WFT:S(MIIE(R\K=-LA$=3><;:);J&Z><:> ]P(?8O6/(E7S+Y1&2DY
M-B<>RI,C(R5-0M2"93UJ(CW -,7&27><?GMN%P6;"7,?6=2(BE.)^U'4]BBZ
M@&W9L-?LS.D3MR6U';T_B3DW57$7"V[+-I#:3ZC.O2 ^)'M+]EL=AM[ZB)_'
M\F>O]S2=/)9<;FN)XRZ"\@MH)5F33-C)+83:ER+KEC%\CH(O*5#3<(;1GX4D
M2Q WI^5LR).3W-AE1E=[>R] 4DCHM+=K-Y:4==*&0E O)E,RX+*4J2F).*6H
MSJ7DIN4ELR\5&]XA+Y\K))=X@7A#1&IR_/1I]O2=:FEN';'E;.G8Z>X2/M7#
M_/!YX7$789A:2BVXR,SXY4<YY<!=9FIHB!#Z<:WQU9#:;O(6E$5&)+Q:]O5*
MC<Y:HW Q^R/M 'S\7L[=H;TQG2J-+P>V3(=TXMG8');63:5U\TU</2 K;\&3
M'+3Z(Z\TTC"[_-O-UXC(B9)\EK:-53V<1KV&!BX3V#R&K7<;>XZDI%RSL\ID
M-5*I0RD.*):NI)DC> U7IER2UJ RP1N+SF="DVE*?*4MJ*F!Q\%-Y4< 7YQN
M\LW^T1KI&X38>6^VC@\WV!Y;)TVGTH,!]X
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MD1&E)(S-:75/]HHR/87DT$XI9SZ9\L6A^DRT2<.P*"S<VG.U;O<XCG3$+X>
MS;?D&M3=2WDBA +]\)'6M=N\J@-0
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MS =H
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MR('3\I]+UN6YOZBI+WRI_-[TN^"2]M<'(\T]37O^4.NY;Z>C<R$& S@
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M1"YG#Y?$6ZE*"WL:YJH6ZFSJ 5
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M>@Y'VMC;_:6OL$CBW:0KZP"NT ]7:0"I[]@"GJD7C 5(MA5+8(%/T&8D:3Z
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M:+;>K1,9N%LNL9N5"FQU$IIU#A$KB29==0'UP
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M]?RA*_?!/!'\,?H*_C;EO1E=[_E&5^[#@C^&/T#\;<M_UKO7\HR?WP1-%/\
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M,5R                                        "FVO@ "KT@*@
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M+N\_F[1_C+=_;$#2\_\ 41X:6T]N^EGQU_\ JEG*-(WH
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M
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M;^HG\=*7KE3^;WI=\$E[:X.1YIZFO?\ *'7<M]/1N9"C 9P
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M=)L,R"]8':KA=YT-7OC,6A?&XXAU:.)1DHMID1#47;M=-4QBIF5W/ZNFB/\
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M42BX3VI(BIL&M>5ZV\
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M+1\[[U'XZ&4?=Y_-VC_&6[^V(&FY_P"HCPT]C:>W?2SXZ_\ U2SE&D;T
M                                                      %#W& B
MM[RLOX+I+7;21<"/^\D-=S&8X8WO0_8,4S-Z)Z([4=ND?RJZ<_&"%[:D:_+1
M'&[GFD1_9W:M,1-,O3(G=ZI^N.A>!PJ
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M[SZ_%5\U\^43YQNF/WV_3^]&,+F_I*]_SAD\J]1;>A0<"[T >:W*?E]OY?\
M[QW?]*F/1;7I?Y?D\]O^I_F^;T"R?XS(^Z*]<QQU'=AV%6ML_IB4*4$XF#53
M;MWBD:>F@D5+:=-W4 IT *]/5X0#H/Q;Q*)0I\ZOR_99\'V[W(@=/RGTO6Y?
MF_J*DO7*G\WO2[X)+VU8Y'FGJ:]_RAUW+?3T;F0HP&<
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M+C4D]FWH&!?RLUU8PB878_KQ8-_J;?OHQ_WP6O[&>DP/Z\6#_P"IM^^C'_?
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M0A*2W)))$1$0Q>*9ERE6-6F9QERZ421)Z"V -0
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M^W?2SXZ__5+.4:1O0
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M^:I*D&9&1]8#ZI'4!4
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M2[X)+VU8Y'FGJ:]_RAUW+?3T;F0HP&<
M% &E2$JIQ%6FX$3&*I$1;"!*H"G"74 J     C"YW_E*Q#9_V9.G^..C99"-
M$IAAGOW].P_",ZF<)5+R8'H)J5J58SR/%+?"EVM,ER(;LB:VPOM6B2:BX%%6
ME%%M%BO-4VYPF%,NZ?U1=;_^1;7_ "DU^H*/[^CH1C)_5%UP_P"1K7_*37Z@
M?W]'08RJ?*+K?_R):Z_";7Z@1GZ,=1C+I.>Z#:DZ:V(LERZW0HMJ.4U#)V/,
M;D+[9^I(+@25=M#%=K-175A"86;Z3Z:[3H+\*F9?)(==1LH^ ?\ ZAL86>[B
MF4GXUB     !I)"2*A%LZ@%.S1L\G<=0)TM1)26XJ5W@%"J9])[P#A+JW@*@
M                                                    /,XOY8G?
MCFKW<8](GR(\/R><_P"O5X_F]!Z*=FSTF;+5#_L$CC)=F;0%?I@'@KN+8 =&
M[U % #K *5\ "AD1&5# V(?>?3Y<(O27XJ6[VQX=+R;R/YI^3FN;^='ACME*
M/RA?-HT;^+[7MC@Y?G'K+GB=+R;T5GP1V,D!K)U-F\X?,C\OFK7QEF?9F/0^
M6^GHW//\_P"HKWK>8/\ EOAA_P#/MO\ =*!E9CN5^&>Q8L]^CQ1VP]/I><?J
M#S+H>CJF(D><3F9^<3K5\9WO:FAZ1RWT]OP1VO/.8>IN^/\ ]L)N< _(+"-G
M_P!CA;?^#')W_,KWNJR^JGJ=O3MK7KI46EZ=<JGX-H  ?J !].RA" KT[=N\
MQ(;?]@!I^O$PIKVHS>\-_CVD?WM=_;&!ON1=VY^.EH^=]ZC\=#*+N\_F[1_C
M+=_;$#3<_P#4QX:6T]N^EGQU_P#JEG*-(WH
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MU&530\V=%-J+<9*(C(P'>2W *@
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M/YO>EWP27MJQR/-/4U[_ )0Z[EOIZ-S(08#.
M                4-1%O,M@",/G>H>I6'T,CKC1TZ?_ 'QT;/ET3,3PZ5=-
M,RPT4E22J:5)(NDQG\%4:9B4X)5>3-2?YH'"KOOT[A+^P9&DS54?<42RRJ76
M,?%"HD &)7.@9?S.-=/_ %BMI%X_91D92?K3"*PDK.E$&9> AO?LW-?#*YPR
MS(Y):?SC937<5@/B\'L[>\:[/Q,4Z5N4G]2ZQJHG%"HG$
M                                                 >9QSY87?CFK
MW<8](_T(\/R><_Z]7C^;T'(^ULD14]A:^P2.,=G"OA 5\(@".@D4KT=0"I'L
MH?2 =&\_&(#;ZP#2?1ZHD0^\^GRWQ?BI;OLWATO)_(_FGY.:YOY\>&.V4H_*
M%\VC1OXOM>V.#E^<>LN>)TO)O16?!'8R0/<-9.ILWG#YD?E]U;^,LS[,QZ'R
MWT]&Z'G^?]17O6]P?\M\,^';?[H0,K,=ROPSV+%COT>*.V'I\+SC]0>9=#T=
M7J$3L'G#YF?G$ZT_&A[VIH>D\M]/;\$=KSSF'J;OC_\ ;2FYP#\@\(^ H7M9
M#DKW?KWNJL:J>IW NG;X>H6EZ=<JUV[JUZ! 4_4(2!=9%3K(0![Q(4_](!LI
M0O5 :#^J$PBO:C-[PW;.TC^]KO[8R-_R/NW/QTM%SK71^.AE'W>?S=H_QEN_
MMB!I>?\ J(\-+:>W?2SXZ_\ U2SE&D;T
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M$]8G'"5&GI(J*=@.*.JMOG-GY2>M0#-;9N^D J
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MO>EWP27MK@Y'FGJ:]_RAUW+?3T;F0@P&<
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MO>E7J&..SV2KRM6&R=4L"Y1-,KM5&)C"TJ)
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MQL_;OI9\=?\ ZI9RC2-\
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M'U%A-\%BO*Z)1>8[9>8HZ_QA);3^O+;OWA) 2B,Z -0
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M^HJ2]<J?S>]+O@G_  K@Y'FGJ:]_RAUW+?3T;F0HP&<
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M4LWZ,:<4N9%U^H.(B&L5%0
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M?-VC_&6\>V(&FY_ZB/#2VGMV,,K/CK_]4LYAI&]
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MF"KB9 ^PQJ5B2$,95!;HCTIL_):GM-="7-RR*I)5T[2(!F,1UZ* *@
M
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MGC=68Y'FGJJ]_P H=5RNKBRU$_!D&,!L
M          $3&(^3?%&FRWHTG0TP9!D9=?9J%5KO1O54ZX0AGYSGW1?V1CT1
MMH4  "FSU1 S'Y-C/\:LP37R3MC52\3J1H?<'ET[V)F=20OI(<Q.N&$B^YJS
M,]7)M3,R3;89)(^BK9'L'7\E]/&^6QRO<EC<-NO@  [%AYF678F9'0RO$*GC
M[4A8S'E5[I[$7.ZFPZAP$-0J)
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M[0^,J=KD5V<1^Q4XB@T?/O41X8;?V_&&6_GJ_P#5+. :5NP
M                                  '2M1<YL>FF$Y)G>1ODQ9\8@NS9
M53))N&@J-M(,]A*<6:4)\)@/-==+CJ#S,ZRE([)<_--1;HEB!&)"C;AQB41(
M2:$5-+4=KRET/911@/19HII#CNBFG5AP+'T(=1;FNTNMU)!(<G37-KTERG2M
M6[J*A +M      ".CO"?XEH+\=C]H(:_/:HZ_D[KV3__ &?^7':RW5O3^P3Z
MQ!5KZFFZ%! P0YR?R[Y8OC/_ /5QQ;N_N_C:ZCV]Z;.?\OY2E0&TVO-@2
M +&<P&BF/Z\Z<W?";LVPQ<^%4K%KVXFJX$]LO8W"4GRB2H_)61;TGNJ1 //M
MIWFF:<LVM3-Y>B.0\@P:Y.VK+K*=4IE14K)$N/0]II6GRFS/=Y)[P'I9Q')K
M-FF-6/+<>E)FV7(H3,^V24_5-/)XB]4JT/P@.Q@
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M9CRZMT]B*^[*;$MQ#@8:A4
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M9]9I-(Y#F=[[F:KG'&-4;G6\KL_;RM$:IPQG>R%+Z(U\0V"HD
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M'?4128Z:GQ*-+E5D1%0BJ EB+< J
M                                         VW.+9PB! -SIZ=+P'7?
M)%1VTQ;-G+"+_9C:XCX%/&I$HU*/ZOMB4JG50=WR*]]W+X5:9B9QW;'#<\L_
M:O\ TZ(F(PW[4FW+GJ-%U-T@Q.\H=([E98J+'?F"J9LR8*$HH==JN)OA5Q=9
MF0T6<L38O3&&B=,-WD[\7[43$Z8UKZGUT&.RVFH"I[# 4 5*E?6 -H#2>T-"
M)64YA=1V=+=),KR),KT:]S6#M>,DDT]H<Z5Y"%I2?G$V1FI740R<G9^[=IB-
M3&SMZ+=J<=:+[DPT^EYUKQBLDB6=OP91Y#=Y*$\2$J9/V%"R/H=<.@WW.;T9
M?+S&V=$-'RBU_<YB*MD:9^*?Y)[RZ>GU1P,1A#N53\Y/JB1Y>LN_*[+OAVY^
M['1Z9E_)H\,/.KWGU[ZNV5\N43YQVF/WV_[48PN;^DKW_.&1RKU-MZ%1P+O6
ME?FJ\0B2$+G>%Z>KL>IM@U BQFBM6>0#BS%IJ:EW&WD25*61["(V301=9D8[
M+V]?FY1-C'3&ER'N"S%-<7<-$Z&2?)5J*QF.D,?%WY/:7S3UX[?*;69J<7$?
M4IR,\I2M_$?$FA;B(AB<SR\VKLSLEE<MOQ<M\..FG6R\.O7L/;]$:Z-,-C,8
M2UF6SK\()4ZP%>GUP%.H VU+;O$C29GU[ V(G6ZIGF9VS3W#,ES6[J_@6.0'
M)*6N(DK>?-)DPTW78:UK,N$56+4WJHHIURHS%VFS3-4[$'6DN*7?6O6[&[1,
M=>DW#*[ZJ[Y%/;))NH9;=])DR#(]A\.RM>L=7G+L9;*XTZ,(PT.5R=JK,9KA
MJTS,XZ7I":)))HDB(BV$22H1$6XJ#SN->+T%N"0
M                !$ZQ\B__ ("O7WA)]J4*[?F4[U5.N$(A^<Y]T7]F8]#;
M6-2@)  !F-R;?E9EWP8W[:D:'G_E4;V+F=20SI(<M.N&"B]YJ_E<G?!T+VLA
MV')?3QOEL<KW)8WC;KX  .PXC^5N*?#$+VTA9S'EU;I[$5=V4V);AP#4*@
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M$8["'":;8B,D>Q*&TDA*2KU$1#S^J9G3.MWU,8:(U.<"0
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M@
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M[5$XTQK;GD>3FBG[M<853JQZ/\4CR"H0Y^(P;]K$@
M                  ")UCY&0?@.]?>$GVI0KM]^G>JIUPA$/SG/NB_LS'H;
M:QJ4!(  ,QN3;\K,N^#&_;4C0\_\NC>Q<SJ2&=)#EIUPP47O-7\KD_X/A>UD
M.PY+Z>-\MCE>Y+&\;=?  !V+$:?C=BGPQ"]M(6,QY=6Z>Q%7=E-@6XO$.!AJ
M)5
M     !U7-,1L>=XS>L1R6&B?9+_%7$G1UI2KR5EL6GB(Z+0=%)5389$8KM7:
MK5<51L6[MJ+E$TSM>>C4G3_-N7#50[0<YR+=L>DIN6'Y2RDT)E1B55I])'4M
MA42XBI[=@[W)YJC.68QTS.OX.%SEB<G>Z(C3'Q2S<OO,#C^N./)-XV+1GUI:
M3^,F+)5YU-ARHA&=5LJ/:9;T'Y)]8Y_.Y.<O7A&FGI;[(YZG,48U=[H9"EX#
MZ*UZ/HC$9T3$M1&9&8F5,*T$)5+JZ>L0-)[C,2.GYQG.+Z<8Q/RS+[FW;+7
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M81F+G!3W:=O3\73<GY?.7M\=7>JV='P9QD5!IFY5
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MJEM(P%0
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M0O;2%C,>75NGL*N[*;$MQ>(<##3RJ
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M^<Q<_IV^NKI^#?<JY3-O^I<ZJ>CX[TEZ6R2KBWGMV^,<ZZ%N"0
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M _8BIQXE?IL59]-)!E)*O[<!(,
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M?ALQWI)XT2/#:9CQ66XT:.A+4:,TA*&VVTE1*$)21$DB(J$1#GG01&#D@
M                                      B=8^1D'X#O7WA)]J4*[??I
MWJJ=<(1#\YS[HO[,QZ&VL:E 2  #,;DV_*S+O@QOVU(T//\ RZ-[%S.I(9TD
M.6G7#!1>\U?RN3_@^%[60[#DOIXWRV.5[DL;QMU\  '8<1_*[%/AB%[:0LYC
MRZMTHJ[LIL2W%XAP$-1*H
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M60A-H*BJ;=]1K^&-;88M=2J15VGT"4*B0
M                    !$9WI_VK1+9M])O=#Z?M+ "YO=BQD(T9S"81>R2,
MMDMK/IHRTWP_9& DF         1T=X3_ !+07X[?X$AK\]JCK^3NO9.O,_\
M+CM9;JWD7ZQ/K$%6N-S3;%! P/YR?R[Y8OC/_P#5QQ;N_N_C:ZCV]Z;.?\N>
MR4J(VFUYL"0      $6O>C)+\1M)E4W9%-*O@.$8#F=UR1'I?J9\;B]QL@)/
M@
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MI^-V*?#$+VTA9S'EU;I*N[*;(MQ>(<!#3RJ
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M,N[B(IIB(?0*A] B$E"ZB$BH"E"K6FWK 5
M                       1'=Z<E?H^B;A(,VT2[R2W*;",V6*$9^$!<'NP
MK@V[I+G%K)9=K!R=R0M'2126DT/_ &@"3         !'/WA/\2T%^.Q^TD-?
MGMG7\G=>R?\ ^S_RX[67"OJ>O@3M]0@JU]33=#3^D(&"'.3^7G+%\9__ *N.
M+=W]W\;74>WO39S_ )<]DI41M-KS8$@      (L.]&DM?B;I-%[1)O'?IKW9
M5V\!1.&OBJ8#Z?=<I-.EVI9F1D1Y=Y)F6^D1HM@"3P
M
M*%U!@(:N\H^5;3/9_P!E)GNT=C[;\FOQ1V./]R>?:\-7;2CG?_BTC[FOUAT%
MO6T=?<>E#04JZ+:7$>TOQ;@>TI'FV=G^O7XI[7H>3\FG<N[0NK=N&.R0
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M.3Y*<S<BY7&%-/ZIWF]O$KI4>VHX>(P=KBW#(CV&51(J
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MNRFI+<7B' PU$JB0
M                       !&7WE7Y(Z:_#$GVI(Z'V]YE>Z.USON'N4>*>Q
M$<6X=?4Y=.#W>OS=XGQCN_MB!P_N#U=75V.RY%Z6G?/:SC&EVMPJ*@     :
M%I,R*F^I'4Q$QB,'N;+E28UEA?CCAJ(]KU,M;)(/M?(8N\9LJ]@Z:=B72W-K
M/Q'LW;?EO-JLM5%%4_3+4<RY73F(XZ8^J/U0I7ZPWO%;S/QS);5)L5]MKG!.
MM<Q!MNH,^FA^<1[ZEL';T547*8JHF)AQDQ515-%43$P^0I"7"X5I2NAU(E%4
MB,ND7(XHVX_!$Q%6C##XNX8QJ%J!A*7D8;G-^Q9,DR4^5NG.LDHRW<1<1D?@
M%BYE;-S351'6KIS-VWHIN3U?XNY+YA]?7$$@]9LO))[Z7-TCIX3J+,<OL;+=
M'_A7O[^_,>97^<?L6ROE\ON43W;IDU\GY%<I-">FW%];[BB+=7B,R.GB&1;L
MVK?=IB-T8+-=VY7IJKF=\OF;J_0/]'J"[,_<T:ENF9B<=:Z>DFC>>:UY$C'\
M(MANM(4DKMD3Z3] M[:MRWW"(ZGL.B$[3I086:SEO*4XS5I9>6RES-5<,1HZ
M4]FB&BN+Z&X=&Q3&VNWD.F3^07YTB*1/E<-#<</:9)+:2$UHDMW2.$SF<KS5
MSBJ=OD\G1E:."E><8S*
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MLS*GVEXXZ?I-U 9X@
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M,_6'#7[]=ZN:ZM,NUL6*+-$44ZH=T05*E2E!:B-O2O-8D
M                             !$ZQ\?(/P'>OO"3[4H5V^_3O54ZX0BG
MYSGW1?V9CT-M8U* D  &8O)M^5F7?!C?MJ1H>?\ ET;V+F=20WI(<M.N&"B_
MYK-FK<OX-B?8$.OY+Z?KELLKW&-HW"\  #L.(_E;BGPQ"]M(6,QY=6Z>Q%7=
ME-B6XO$.!AJ)5
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M7#3B4JA<2CVGTF.=N7J[L\5<XRWUJS1:C"F,(=H%M<!(
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MU,SZ3!*YH
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MMH(DI+P$0Y^JN:IQJUM]31%,84QH?5!4
M                   (G6/CY!^ [U]X2?:E"NWWZ=ZJG7"$4_.<^Z+^R,>A
MMM&I0   &8W)M^5F7?!C?MJ!H>?^51O8N9U)##WEZHY:=<,%%_S6_*W*^#8G
MV!#L.2^GZY;'*]QC:-NO@  [#B/Y6XI\,0O;2%C,>75NGL15W938EN+Q#@8:
MB50
M           $9G>5?DCIK\,2?:DCH/;WF5[H[7/>X>Y1OGL1&%N'85.63A]W
MM\W>)\8[O[8@</[@]75U=CLN1>EC?/:SB&EVMPJ*@      %*;2/J 5 :. M
MO6?2(@F3@36I5(Q'!&.*<6JFW?7P"I#0INJB/B,B+>DMQ^,1%,#42"(N&IT#
M 5(J$1=08"HD
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M#I\)=%3(!Z2DD1%0B(B+81%NH U
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M5V*?#$+VTA9S'EU;I15W938EN' -0J
M                                       C,[RK\D=-/AB3[4D=![>\
MRO=':Y[W#W*-\]B(PAV%3EDX?=[?-WB?&.[^V('#^X/5U=78[+D7I8WSVLXA
MI=K<*BH
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M>/V0R,B,M@"1.E-P
M                                    "&GO*/E6TS^*DSW<.Q]M>37X
MH[''^Y//M>&KMI1T/_:'_N:_6'0V];15]UZ4-!?D7TM\.-0/:4CS7.^?7XI[
M7HF3\FG<NZ,=D@
M                    ")UCY&0?@.]?>$GVI0KM]^G>JIUPA$/SG/NB_LS'
MH;:QJ4!(  ,QN3;\K,N^#&_;4C0\_P#+HWL7,ZDAG20Y:=<,%%_S6_*W*^#8
M?V!#K^2^GZY;'*]QC:-PO@  [!B/Y6XI\,0O;2%G,>75NDJ[LILBW$. AIY5
M
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M'-1W[6\>4KOZ7$7(WBEODCTE+I)62NSX*5+=0"630(
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M#T@1(L>%'9AQ&$18L5M+,6,VDDH;;07"E*2+81$1; ')
M
M     0U=Y1\JVFGQ3F>[1V/MOR:_%'8X_P!R>?;\-7;2CF?_ (N_]S7ZPZ&W
MK:*ONO2CH+\B^EOQ:@>TI'FN<\^OQ3VO1,GY-.Y=T8[)
M                                                   $3K'R,@_
M=Z^\)/M2A7;[].]53KA"(?G.?=%_9F/0VUC4H"0  9C<FWY69=\&-^VH&AY_
MY=&]BYG4D,Z2'+3KA@HP.:WY6I7P;#^P(=AR7T_7+8Y7N,;!MU\  '8<0+_K
M=BGPQ"]M(6<QY=6Z45=V4V);B\0X"&HE4
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M>(EI2LO*29EM(R/I =Z
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M[@
M                       !#5WE'RK:9_%29[M(=C[;\FOQ1V./]R>?;\-7
M;2CG?_BS_P!S7ZPZ&WK:*ONO2AH)\B^EM-WXMP*_WE(\USOGU^*>UZ)D_)IW
M+NC'9(
M             B=8^1?_ ,!WG[PD^U*%=OOT[U5.N$(A^<Y]T<^S,>AMK&I0
M$@  S&Y-ORLR[X,;]M2-#S_RJ=[%S.I(9TD.6G7#!1@<UORM2O!;8?V!#L.2
M^GZY;'*]QC8-NO@  [%B'Y78IT?YXA;?^%(6,QY=6Z>Q%7=E-@6XO$. AJ)5
M$@
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MALI891Q*,S/A0@BV@/O
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M$2C.A?P:/6II90>[Z[>?01!E. J
M                                                 (:N\H^5;3/X
MJ3/=H['VWY-?BCL<?[D\^UX:NVE'._\ Q9_[FOUAT-O6T=SNO2CH)\BVEWQ:
M@>TI'FV<\^OQ3VO0\GY-.Y=P8S)
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M3Q5H9%3H,AP%..UJI:Q4@
M                            !&9WE7Y(Z:_#$GVI(Z'V]YE>Z.USWN'N
M4>*>Q$86X=A4Y5.%W>WS=XG@R.[^V('#<_\ 5U=78[/D7I8WSVLXQI=K<*BH
M      !;?5W3>Q:P::YIICDJ359\TM3]ME*+B(VS61*;<(TFD_(<2E5*[: /
M*-<L%YI^[CUK<RB!:'X+EM4_&M^7-1?3+)?+0:VUJ)2R(R2AQ))XTJ-*T*V;
MR 2*Z7=]C;'F;/!U?TD>BRENJ1>[_C,CBCMMU/A6U#D&I9F14J7:^J D^T*Y
MK^7#F;-*-/,F@W+)4QNWEXC=HZ8UW8:2HR\MESB)1%2OL:U4+:8"Z>N%^?P_
M1;4_(;<VE#]BQ:YR(:2(N%)HC+X*$5-W00#S&=U/:+7D_.?B[][M[-P5;[3>
M;Q!)Y/$3,UALEM/(KN4A2JD8#UFD1$1$70 Z]EF*6#.,9ON'Y3;D7;'<EA/6
M^\VYPS)+K#Z32M-4F1D=#V&1U(]I;0&/VB7)IR]<O&33<OTGPIS'+_<;:=IE
MS%W"9*)<4W$NFG@D.N)J:D),U4KL 1X]]Q\CNC'QSE?Z/<!.Q'#R=]W9=.;?
M3R\Y[!U-B8>BSW=5J7:WX#DE2N!M*^TXTK06WBI0$,N/S(&1'OUYMU?@=W]^
M 7:T&[I"^Z-:Q:>ZH/ZS0+TQA-W;N+]H;M;K2Y"4)6@T)6;IDDSXMYD8";*?
M!AW.%,MMQC-3K?<67(TZ$^DEM/,O)-#C:TGL4E23,C(P'D=MZ9O)%W@L<I<@
MK9:,-S%;;ESD1E):78;MQ-./-M)+S#COJ))ENH ](7.'K%&T?Y8-3M1;=<51
MIKE@<AXC/8;)XCGW-!LPED1[.$U+(ZGN(!"CW-NCLO*=8,QULND.0NU8%;W+
M=:+@:4&P[=KDDB=;.OE<;;"N,J%LJ6T!Z60
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M[@EF3$.22%7J]/4<G3W4%3CD/4J>TS,DE1*:G0BV@+P4 5
M
M         !#5WE'RK::?%.9[M'8^V_)K\4=CC_<GGVO#5VTHYW_XO(^YK]8=
M#;UM'7W7I1T$^1;2[XM0/:4CS;.>?7XI[7H>3\FG<NX,9D@
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M0=>H<WSC/TS'V:)W_L8>8O8Z&=/4.>PEA*B0
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MZ+CM.$NAF;+' BM"W ,]@
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M=EI#3#*20RR@B2A"4E1*4I*A$1%L(@&\14V
M
M "&KO*/E6TT^*<SW:.Q]M^37XH[''^Y//M^&KMI1SO\ \6?^YK]8=#1K:*ON
MO2CH+LT7TM\.-0/:4CS;.>?7XI[7HF3\FG<NX,9D@
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MI2E*20E)$24D5"(BZ*$-<LM0
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M1$24((DI(B+=0B ;X
M            .GY+@6%YBW)8RG$K5?TRF3CO.38C3KAMGL-).FGC27B,!C[>
M.2'ECN[+S/\ -=#M3CI&7IEO?D-.E7I35Q:2/U $17>,\L&F?+[8M*[A@3EZ
M<?RN\7.-<V[M,3*;2TQ%2Z@F4DTWP'Q'O,S =L[O#E-TIU\TIR?+<[5?"NEH
MRV5;F&;9-3&CKCLLM*03C:FEF9U4=3(R 2G6KDFY8[4VRV6E4&X.L[IDUZ0Z
MX9]9T=27T@&0N/X9B6*---8SC%KL26FD,)5!B-,K[-!4)*EH22E4\)F [0
M
M                            (:N\H^5;33XIS/=P['VWY-?BCL<?[D\^
MWX:NVE'._P#Q=_[FOUAT-&MHJ^Z]*&@GR+Z6_%J![2D>;9SSZ_%/:]$R?DT[
MEW1C,D
M                 !3=LZ!$A0B"(P%1(    H9$>\ .O051$BHD
M
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M<H?5Q +K^L ZWDN'8IF4:-#RW&;7D\2&[V\6+=8C,MMMVAIXT)>2HB.AF52
M:\<Q3&<0AN6[%<=MN-P'73>=AVR,U%:4X>PUJ0TE)&>S> ["   #0I)JI2A&
M6XSVT =&LFF.G6-7,KWCV X[8[P7:$5U@VV-'D$3IU<HZVV2BXZ^50]O2 [V
M6PBZ %0
M    !##WQ?Y+:#?#]X]PH =][H0__ +//CW.]SL )80
M
M               $-7>4?*MII\4YGNT=C[;\FOQ1V./]R>?;\-7;2CG?_B[_
M -S7ZPZ&WK:.ONO2AH*?_@OI;X<:@>TI'FV<\^OQ3VO0\GY-.Y=T8S)
M
M
M                             !&7WE7Y)::?#$GVI(Z'V]YE>Z.USON'
MN4>*>Q$<6X=?4Y=.#W>OS=XGQCN_MB!Q'N#U=75V.RY%Z6G?/:SCH-)M;A45
M
M                            "&+OBOR6T&^'KQ[A0 [WW0?R!9Y\>YON
M=@!+$
M                                      AJ[RCY5M-/BG,]VCL?;?DU
M^*.QQ_N3S[?AJ[:4<[_\6?\ N:_6'0V];15]UZ4-!2_\%]+?!C4#VE(\USOG
MU^*>UZ)D_)IW+NC'9(
M
M                                                    (S.\J_)'
M33X8D^U)'0>WO,KW1VN>]P]RWXI[$1I4H.PK<LG![O7YN\3XQW?VQ XCW!ZN
MKJ['9<B]+3OGM9QC2;6X5%0
M                                                   AB[XK\EM!
MOA^\>XD .^=T)\@6>?'N;[G8 2P@
M
M(:N\H^5;3/XJ3/=P['VWY-?BCL<?[D\^WX:NVE'._P#Q=_[FOUAT-O6T5?=>
ME#07Y%]+?BU K_>4CS7.^?7XI[7HF3\FG<NZ,=D@
M
M
M              C,[RK\DM-/AB3[4D=#[>\RO=':YWW#W*/%\D1A;OTAU];E
MTX7=Z_-WB?&.[^V('#^X/5U=78[+D7I:=\]K.+J]0:;:W#4)
M
M                $,7?%?DMH-\/7CW"@!WSNA/D"SWX]SO<[ "6$
M
M                         !#5WE'RK:9_%29[M'8^V_)K\4=CC_<GGV_#
M5VTHYW_XL_\ <U^L.AHUM%7W7I1T%^1?2WXM0/:4CS7.^?7XI[7HF3\FG<NX
M,=D@
M
M                                      C,[RK\D=-?AB3[4D=#[>\R
MO=':YWW#W*-\]B(PMPZ^MRR</N]OF[Q/C'=_;$#A_<'JZNKL=GR+TL;Y[6</
M4--M;AJ$@
M                                    "&+OBOR6T&^'KQ[A0 [WW0?R
M!9Y\>YWN=@!+$
M                                              AJ[RCY5M,_BI,]
MVD.Q]M^37XH[''^Y//M>&KMI1SO_ ,7D?<U^L.@MZVBN=UZ4=!/D7TN^+4#V
ME(\WSGGU^*>V7HF3\FG<NX,9D@
M
M
MC,[RK\D=-?AB3[4D=![>\RO=':Y[W#W*/%/8B-+=^CPCL*G+)PN[V^;O$^,=
MW]L0.(]P>KJZNQV7(O2QOGM9Q#2;6X5%0
M
M AB[XK\EM!OA^\>XD .^=T)\@6>_'N;[G8 2P@
M
M          (:N\H^5;3/XJ3/=P['VWY-?BCL<?[D\^UX:NVE'/(_B\BG]S7Z
MPZ&WK:*YW7I1T$^1?2[XM6_VE(\VSGGU^*>UZ)D_)IW+N#&9(
M
M
M                       (S.\J_)+33X8D^U)'0>WO,KW1VN>]P]RC?/8B
M,+<.PJ<JG#[O;YN\3XQW?VQ X?W!ZNKJ['9\B]+&^>UG#U>H--M;AJ$@
M
M                       "&+OBOR6T&^'KQ[A0 [WW0GR!9[\>YON=@!+$
M
M                                 AJ[RCY5M,_BI,]W$.Q]M^37XH['
M'^Y//M>&KMI1SR/XO(^YK]8=#;UM'<[KTHZ"?(OI=\6H'M*1YMG//K\4]KT/
M)^33N7<&,R0
M
M                                             1F=Y5^2.FGPQ)]J
M2.@]O>97NCM<][A[E&^>Q$86X=A4Y5.'W>WS=XGQCN_MB!P_N#U=75V.SY%Z
M6-\]K.'J]0:;:W#4)
M                                             $,7?%?DMH-\/7CW
M$@!WSNA/D"SWX]S?<[ "6$
M                                                      !#5WE'
MRK::?%29[N'8^V_)K\4=CC_<GGVO#5VTHYW_ .+O_<U^L.AHUM%7W7I0T$^1
M?2WXM0/:4CS;.>?7XI[7HF4\FG<NZ,9D@
M
M
M       C,[RK\D=-?AB3[4D=#[>\RO=':Y[W#W*-\]B(PMWZ/".OJ<LG"[O7
MYNT3XQW?VQ XCW!ZNKJ['9<A]+3OGM9Q=7J#2[6X:A(
M
M           AB[XK\E=!OA^\>X4 .^=T)\@6>_'N;[G8 2P@
M
M                    (:N\H^5;33XIS/=H['VWY-?BCL<?[D\^WX:NVE'.
M_P#Q=_[FOUAT-O6T5?=>E'03Y%]+?BU ]I2/-<[Y]?BGM>B9/R:=R[@QV2
M
M
M                                ",SO*OR2TT^&)/M21T/M[S*]T=KG
MO</<HWSV(C2_1],=?6Y9.#W>OS=XGQCN_MB!P_N#U=75V.RY%Z6G?/:SC&EV
MMPJ*@
M                                !#%WQ7Y*Z#_#]X]Q( =[[H3Y L]^
M/<[W.P EB
M                                          0U=Y1\JVF?Q3F4_P =
M'8^V_)K\4=CC_<GGVO#5VTHYW]D9_P"YK]8=!;UM'7W7I1T$^1?2[XM0/:4C
MS?.>?7XI[7H>3\FG<NX,9D@
M
M                                                         C,[
MRK\DM,RZ[Q)]J0.A]NQC<KW1VN>]P]RWXI[$1A;2_1X1U\Z7+)PN[V/_ /1X
MB%_WCN_MB!P_/IQS=75V.SY'&&5IWSVLXZ;AIL-+;JB0
M
M           !#%WQ7Y+:#?#]X]PH =\[H3Y L\^/4WW.P EA
M
M                  %",C 44?"5:&?41 (:^\GVZK:9GT?BG+]VCL/;4XVJ
MX^,=CD/<<8W[7AJ[81T/_:'RW>QKV^H.BHT3+17.[ATO2AH*=-%M+OBW;]G_
M  *1YKG?/KWR]#R?DT[EW1CLE0E$9TKM 5 /I
M
M
M      *5.A[ &A2R+9]+I$3C@8PC.[RE23Q#3,RVTO$LS/Q-('1^VXG[E?AC
MM<[[AF."WXI[$1Y%0J=6\=;#EI3?=WPJG+Q$IO\ QCO%*_=&QPW/,?[JKJ['
M:<DF/[6GK[6<A*/94O&-2V[74
M                                                     !#%WQ7Y
M+:#?#UX]Q( =[[H3Y L\^/<WW.P EB
M                                                          $#
MK^19/8<3MDJ]Y->(5ALT)/'*N4YU++2"Z"XE&53/H(MI[B%=NW7<G"F,947+
ME%N,:IP8291WB&C-FFKB8]:KYF3*4&:;G#90Q'-9'3A_A"D+IX230;BSR#,5
MZ]#47>>Y>C5I6X7WE-DXE<.F4_@2>RLINI%T5ITC+_\ K=43&,L7_P"PTX3A
M'X_-A7S.Z\0^8'+,7R6'C[^.IQZSO6QR*^ZETW%N2#>XR-.XB+9M&XY7DIR=
M%<?%J.99S^[N43T1/R8V.(XT+1MJM)D:O&-I-6.AKIIP2;Z?]X!:,+PC$\1<
MT[F3G,<MD:WJFHE(2EPV$$CC(C*NV@Y>]R&;MR:L=;I+7/(M413AJ7#MW>48
M8I2RNVG-[9(MJ#AO1W3]4EJ1ZXLW/;=V(T2O6_<5J9PF&4>E/-)H]J^^U;L:
MR1$'(EMI6K&;H7HTOB,C,T-DH^%TR(JGV9JV;1J<SRV_8TS&AM,OS&Q>G")T
MLB&W"<(_ =.G=T#!WLYN;@B, $@
M
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MKX:XP=18OT7J>*B<7?197@
M                                              !#%WQ7Y+:#?#UX
M]Q( =[[H3Y L\^/<WW.P EB
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MS<G&N-O3"1QM7$A*M]>DQS^&#H(G%K!(
M
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MDI#C3B24A:3+>2B.I#@=,3,2[R)B8QARA(
M                                                          AB
M[XK\EM!OAZ\>X4 .^=T)\@6>?'N=[G8 2P@
M
M  B][R/.U,6C =-XDI/^<Y+M[OL.A\1LQR)N(9&6RBEFX1D8Z3VYE>.[-V?W
M=3G/<.9X+<41KEU'D+TQM?O1D&KETC-R;LJ>Y9,7)PC,XB&D)7(?27FFISC)
M*5;R(E%TC+YSF:IN\$:ITRQN4Y>F+?'.N4C1D74?_IWC2Z6XPI4WT(MGA$Z=
MJ(T24Z=GT1'6JZBAD?1X@ZS'X%-OZ0=9C\%>H-*,(^+XF18U8\PL5TQ7([>B
MYV._1U1;C!65>)*]A*2?U*DGM2HMI'N%5-VJW,5Q.I;KM4W(X)CO(%9S=WT2
MUFD-6^03EWTPRHDQ)9U)#_HCQ4XJT-2#0K;7?0=?-,9K*3CIXH<IQ?VV:C#1
M-,_CM>DBRW.->K1;+Q"<)V)=(K4N,ZDC(E(>02R,B/;M(QYW71-$S3.N'H-%
M<5TQ5&U],4J@
M                                                        !0SI
MO 4XT[#KL/<8!QIW5VEO .)-*UH76 <1'3;O .).^N\ XBV>'< IQIV'7?NV
M& J2DGN]8 XD]?Z" "6D]Q@'&GK .)-*UV *$M)[:@*\1;J^  XT[=N[H "6
MDZ%7:8!Q)ZRV@*\14K78 IQ)V[:T .)/6 IQI/IW> !7B3U@'$G;MW;P%:EU
M@*<:3W'4 XT]?@ .-.S?MW; #B2>XP$<O>0W]Z)IGA5@C2W&2O>0=I.CIV(=
M9C,K/A<ZR):DF7B'0^W+7%?F>B&@]PW.&S$=,K3=WWC5N*%J/F;C1G=NVC66
M,^>W@BK0;ZR)/6I:2J>^FP9_.[FFFF-6E@\FMQ]54ZTCZCIO]0^OQ#2:<6XB
M8X5.(]FPR,]Q=8JT&,M15VT^@8B4Q.(2C/=^CQ"$Z%*]-2\0F%,RH9D5*GL/
M=U'XJ"295/90RV'LHHC*I4VU(Q1ITJIF-"%SG6PZW8WKG=7(1I;B9O:H][>B
M-H)"&5NF;#O!0MO&I!K,^LQU7)KGW+$1/[LRY7F]N*;U6'[T)>>5G))^5<ON
MEE[NJR5.?LZ6'%EL(RBN+CH_VC9#C>8T13F*\.EV/+ZIJL43/0OZ2TGN/]!#
M#9BO$GK .(OT$ $M)[CW *U+=4!3B29$9'4CW4 .)/6 KQ%L\("G$D]Q@'&F
ME:^&E %>(NO< IQIK2H"O$1'2NT!IXTU,J[O 8"O&FE:[ %>(MAUW[2 4XDG
M3;O .).ZH!Q)Z_  <2=FW?N 5XBZP%.--:5V@'&GK\8!Q)Z_  <:2WG3Q@!+
M2>XZ@'&FE:U 5J0"N_:0
M       (8N^*_)70?X>O'N) #OG="?(%GOQ[F^YV $L(
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M/]08/-(F,S4V'+>'[+)<JF52VE^CIW#"T,O&5#52AGLKU]8:#B:B/8>X^O\
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M#(ZD>XP%.).S;O .(NL XD[Z]7TP&H
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MQM9.-N))2'$G4E$>TC(RZ# ;@
M           AB[XK\E=!_AZ\>XD .^=T)\@6>_'N=[G8 2P@
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M,C(SZ &[J/S^Q[1<,93I_BC-\MTR#&N=[>G/&VX@WB/CAH))42XW3:HZENV
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M?SRU1';>S>&E%(M[QDI<=]E1MO-U+>1*2?"="J5#H0"YH
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MW4VUI09GLZ0&XCE(O*=?V\.]\(GXDMWLI3=Q*IJ]#2?I*8AM?7DCR#.M.G>
MF<CLM1V&8[*";980EMILMR4H+A(O4(@&\
M                   (8N^*_);0;X>O'N) #OG="?(%GGQ[F^YV $L(
M                       -LEF9F5".F^A_I;P&X
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MJ5,!JUGY1;QA=BTXGXK<XUWD2[,47)XZ_8E+F,I5)7*;/:1M\"N&F\N$CVU
M:-8.3^_8A8=/[SB-RBWAZYVI+62Q%J-JDUAA4A<IDU;#;-NI&1[2H5*U :=6
M>3N_8=8L"GXI<8]YN%TM;BLJCN.*0E,J.SZ0[(C\22]B)NI&1^5X &K5_D_O
MF$8SI[-QN?&O-UF6UT\O2IPTI.4FCRGF%&6UI"%D@NDR*O2 DUY?]-_YI]*,
M4PUV<W<YL9A4NY36T\"''Y:C>62".ODHXN C/>15V +V@
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MU :-(T+:LV8FXDR)5ALBTF?P69'ZP#E:7R&8^'Y P@B[5NP09BZ=/';Z[?H
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ME8SCLDMO;VR(NOC928#[X
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MWA(MH#:9CN./6G(B;<5+DZGNM*\D_)8JY$4=*;J-EM (\5^3*@Y)V3O97'5
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MB)29&6^J=P(7DTY-7XAXBAPE$ZQ:HK+Z5$9*)QILD+(R/J,C(!W0
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MJ4MN$9>$!HR3/)]J?S=$2)%?8Q1NS*2ZYQ&:ESI!MR"<X3+[6W0TTZ=X!?\
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M0@?#?QRXN<7";15ZU'^H ^/(PZ\.'Y/8'X>,_P!0!\1_3_(7:F1QNG8;G^P
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MO]P ?FKN:7JQ3^4O]P ?FKN:7_NK_*7^X /S5W-+U8IX_?+_ ' !^:NYIO\
MNI_*7^X /S5W-+_W4_E+_< 'YJWFDZ2Q7^4O]P ?FKN:7H+%"_Z2_P!P %W5
MW-+_ -U?Y2_W !^:NYIO^ZG\I?[@ _-7<TO5BO\ *7^X /S5W-+U8I_*7^X
M/S5W-+U8I_*7^X /S5W-+U8IX_?+_< ,3]>^7_/N6_+;/A6HIVX[S>[25ZA'
M;'_2&BC&\N/1:J%17&VK93=M 61^D TK6AM!N.*)M"?.6LR21=53/K 9.:&<
MH.N_,%)8<P[$G;5C"W.SFYM?$JAV]I!*)+G9<9<;RTDJO E.TMI& GMY2>2&
MQ<KS3EU3GE_RC*+FBMX83+=BV/M%-\"NSMR5<"R(O--RII/:5 &=(
M       XTLG#CR.R;2Z[V*R:;7M2I7"="4749[# 6NLN<OW-G 83%OCL2LF3
M<6YC9$9,Q_>HNS>2VG>55F1$74 UV;/)5V:P1IF!'9E9-)GIGL$9FAEBVJ<;
M=4WX36E-*@.-9\^FW2/INM,"-%<RR;/:G14U/L689/IXF^HS4A-?&8#58<ZN
M=TC:>58C%(R9ZXL75*"5PM+AL.K3P=7E)21UZP%;'J#,NS6#P_0(Z+CDDFY0
M[J7E=G&>MC:U.\!;SJI-"J K!S^5<8>&-M0647.]WE^VSXYD9H;1;U+3*6V6
M\J&DN&H#<AY_)N$3#'6HC")F17R7;Y;!\1I0Q"=?:=<;/?Q50@RKUF VK5J!
M-FP\*<<@16Y>0WV7:;A';-5&$QDR%&M'A]B36O6 6;/IDZ+A3+L*.W/R"[3;
M7=&$5)$=4-#SBC01[3.B$[^L!HL^>NR6<4MC5I8CS[I>9EGGL,I-+#'O<2G'
MU-IWE5);*@-YG4&7)38(WH+";G<\GE61UBIJ0EF ZM+[R>GBX4D9>,!LQ=09
MTN'C;R(,5,N\Y;)L3\>JS),:,Z^AQY'3QT;2>W9M :[;J!-E0L4<>AQBG7K)
M9=BN32.+@93'5(,E(KMXC0V@SKTF8"MLS^7+BX\V[ 8*Z7')'[!<DI,^S95'
M2X\I:2/:9FV@M_28#1'U#F2(]IA>@LHOD[*'\<D-JXNQ+T12ER'4EOV-)J1'
MT@-:-0)<EJ$EN'&3+D9FYCG9>49''8>-#KQ?KR;*O54!N,9Y-<AV]XX,8Y$K
M,W,;=:(U>0PE]U!.D5?/X$$?5M :86H$M4.V=O"CHGR\O5C,II'$26D^RN)<
M*NTU&V@O!4P!O/)BX3$5,&.5Y5E:\9=:*ILI4@S>-S9M^TT/Q@*/9_+*&^VW
M 8]\VLO_ !:8849FAY*'$*6\1%M(^R49TZP&L\\EE$DNIA1E/M9L6,M-*XMK
M7I"6S=WU-9(,U=0#2C/IS<=1.P8Q2_QV3C"F4&JB&'7^%MX^GB-NA]50 LZD
MLLO0DVZ,FY-Y:G'5LIJEDBD*4ZAXRWU-O:?6>T GY_+CQ;HRS 97=8N5,XW"
M2JO9.*=)#_:*(MOVI1[ND!Q[EGLGWNOW%;(CLFW9?'QV"P[5;;R5.,*)Q2>A
M9(69EX2(!K?SR65OO[[ULBO2;3F+5@BQE5H;3K[#;4A5=O$7:&K9U -;NH$R
M,W=V50V%7&%E;-@:;/B)!LS'22RZJFTU<!U.@#7=,_F0G,CMK=N9<N5MOT"R
MVXC-79N^^3;;K:UEOJE*SK3I 17<\#JLKY@H-IG(]#BXMCO8./LF=5M%QRB<
MV[".KI),AU');D1EZH_S0YCG%J9S-,Q_#+(;E7RMRW<M>/2FV&%S;?<RM[$9
MRM'$R9*2XU>$B4HR\1#%YE7$7JM[*Y=15-FC<R1F9?*AM9:11&?2<?R"+:HS
M>TB<CRW6VT.KZUT49^H,**F=%*LS+Y4!&2QUQ&3N%EOL6U16Z4;6U.4DHZUE
MTF15J)XE$TRT77+Y=OB9<TF,PJYX_<(EMA-&2C9><FI);9K(]NZI&'$GA:KU
MF$FV1,W4F*PJ3C$Z'#MK2O*0^<MMIRKA> EF14ZA1-6,JN'0I=,P?MD?/5HC
M,+E8G=(<*WLKJ7;-2C922W#WF9&X?T XM/Y'#CBK<LOE6M&8-+AM+F8[<HD2
M&@JDAQB<IMMIQSK5Q&JM.B@KBI1%+5<\ME6IO,&7(C*YF/28$:$@B/@=.Y&:
M6>-/311'7P")KB-:K@F=2*GFJL)S>8F:X[(6Q[ZL-.2U,[%,HB-DA7 ?61%7
M:.AR&8BFQ-+GL]EIF_%23_3K/9MCT9);<.*\O#,;Q[WM0X:S](*;$941NTZU
M*,BX>H<GF?-JWNKR\?TZ=RY=\SZ?9TZ@(]!BN2L5?@';6UFJC[$XF4DIVFVI
M+6HBIU$+*\WKSG\FQGGK<B RI_&O07;8DJDEYNX*)EHW#W['*UIT -%XSJ79
MT9W'=@1E3\8A6YV(HB/@?=N"30VA9;Z)<*FSH ;=TSB=;(NH;BK9%].Q6VVV
M1',R,BDOS&%*)#G31*RX2IT --UU"G6MG4%;D.*<C%;?!G0&CXR)],EA*G.T
M.NXG#X2H UWK4*18E9XF; 9>/'8$&X6UI'$7;LRTI;/M*]3M2V= #D7;.'K'
M^.<*X08ZW<?MD6=%X*]D\4PC92A:3Z"=29?L0"5F\RV,9<S*@1F96+X_!N++
M:>(FU2);;J2945?-)QLB*G08#B2=0;A$AYJ[)@Q6G<9QV%>(J*J]E=D1UN+0
MLM_"E:225-NT!2=J)+MB,S<DV]A3]AL,.]VR.DS3Z0EUGV4EF>XDN427@ <J
MY:@O6)W*$7"WMF=EL<:]1#:J7:I=(FUH57J=V%X &[.SJ3:/?EBXQ(Z56O%X
M]\2:#5PF\\IQDV3+ZWM$;/ 8#B+SZX16K^F7;XK3]EQ&+?D;5$E<I]MWB9,M
MY():"(NG: TMY_/:9R)V;"C-2+5B<+(8;234GM%K9<6^A9G]2E:4D5-NTP&M
M[423 ]_3G6YDEP,69R6$EHU%VI$V7;(57H):B)/@ P;SF>OVMR6W=(3*6X^)
M-Y(:VZEY9J-"V3(^@E&5# :$9Y.CF[&N42,R_%PYK(WEM\7"4AQ:D&R1']14
MB\(&"D;.;EP/%-@1&GF,)CY*@DFHN*2M+ANL[3\Q)I*G3M P:&=09C7I;T^
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M%_QRRWR2RW'=NT1N7V#1F:4)>+C26WP&50'8@
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M7:#2:OHD R@(
M                            !0]Q@/.KWNKC;?,3I^MQ9-H3IZDU+49$
M1$5RE5,S/=0!BKH9RA:[<P$IIS#\1?M.,&OAE9K>TKAP$$5.(FN-)+=4:553
MPIH?6 FPY?N[.T2TI]"O^?-(U=S:.:5IEW5DBM499$HE%'@&:DFE1&7$3IKJ
M9%L 2/,QF8S#,6,TB-&CMI:CQVDDAMM""X4I0E-"(B(J$0#?
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M8;BL4RH;%IAHIXF4@.T@
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M>L&GZ>9<\3_&%@GRO? J69_P;T[T;L?1^UW<?%Y/579O 9Y),S21GO,!J
M
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MDA:$F9;*F U<S>K^GV/S\*BNW]B6Y>K0MQOT/V;@@R^ V9*S36B%TJGI,MM
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MBP7%BZ6B=;H[D&='42D+239$95+<9&5#(]I'L/: [6
M                                                *'NV ,'.?7#<
MGRK2BSS<=A2+JQC%Z1/O-NC(-Q:6#:<04G@(C,R:,Z'0MRC,!&9:=&-4+OI5
MD.>6ZQ7->,VNZ15R;7V+O'*23:T'-9:)-74QS5PJ,JT(Z[J@-BSZ,ZH7C3?(
M\_MMBN2L9M,IA$N"3+W:2R70C?8:)/LB&:T4HB.G@ ;E@T9U0O6G&5Y[;;%<
MDXU;7XK#L(F'>TGT6:E.M-</EMQR\HU;BW%M <K'-&M3[YI1G.;6RP7%6.09
MMM[6VDRLESTQU.FN0TV9<2RBD9;2+ZHZ;C 5QO1G4Z_Z59GFMIL5R78+3<+>
MY(MQ,K)R<ADGB7(9;H1N%&XMO"6SC,^@P'!QW1?5+(]/<JS>SV&XGCM@?C'.
M@]DZER=Q5(W8[1)]F)@_.H1\.\!Q[#H[J;?\!RC.;5C]R7C=B>81/C$R^2YA
MK/:XPUP^RI9WK,O- ?8Q31?5'(=,<]S2TV2Y%C]N5!2]:R9<)=R-MXEK6RV:
M2[1,<O+,R+8>S> TX?HOJED^F^?9E9+)<O>&RJ@G+@=BI*[D3#JUK4TV9<;O
MHI'QGPD>_P 8#9Q/1G4[*-.LYRNR6*X^\=B>@N2K<3+B57%+:EDM3"*%VIQ^
M*I[#I4^HP'&Q71?4_*L)S',;'8KA[PXXVS[X1"9>2[<"6JAE':X?9NRIQ+(B
M\DMH#?PS1C5#+,(SW+;%8;B5EL$5E$V/V+B5W$S?2:FH[1E5[L>'C52M*=8#
MDX+HUJ=EN"ZDY18;!<CLUFA142XG9+0NYFW*0ZMAELR)3G8)+M3X=QEUT ;>
M%:-:GY;@>H>16"PW%RTV1F$Y.A=BM!W+L'U+<0R@R+M%L%5PTD7TP'#P[1C5
M',<0S3*,>L5R*T8RRT]<HO8O(7/)*E&M$=%"[9;-#4:=M &K!M&M3LPQK.LC
MQZP7%%JQN 17%DF7DJGF:TUCL(X?9333B46WAH W\"T7U1S+%M1,@QVQW%%J
ML%K2B<SV*T*N:O2&U'":09$;AMD@W54K3A+I,@&K M&-4<UQ/46]XY8KF5NL
MEO:.?$-A:/?,VY*'%Q&R41&M;1)[:A%L-/#2H#9P31O4_-L:SV\XW8;D5OQZ
M"V[<&#:=;.?V+W$N,TFA=HXV1&O@W^J V<"T8U/SBT9I><:LER8M^,VYQVZ-
MFR\VN<1GY4)E'#1U>SB-&VE '(T^T:U/S6RY_=L=Q^XH@8_9WO?%LV7&SFN&
MXFL%M!I]D6? :E)H=.$MU2 <C3;1C4_.;)J+<<<L%Q;A6.R.)G-J94R<]?;-
M+. V2R(UJH@W#21?4\.\R ;.G>C.I^>6;4*=C=AN+;%BM''/9<9<9]\%-R&U
MK@-DLB-3B2(W>#K33SC(!QL"T7U/SRUYG.QJQ7)F-C=O.3<VG&7F?33961KA
MMD22[1W>HD>#< W=.M&-3\\B9E-QFQ7&-'QJT27KF;C+K7I)TH<!HJ%QNKIM
M1ZH#=TRT7U/SMC-9&,V&Y1&<=LDM-R4XPMHY+A\/^;$DLBXEN\)\22K0D[0&
MC3G1G4[.X>>OXU8+BRU8+(^JY-N,K9.8I+K9JMR>,D\2U<)K-)?6]= &_IIH
MSJ?GD'/W,:L=QCE9+(\J<EUEQGTM3;S:U6]'$2>-U1)-1(VF9IH&&,F.$2L[
M<+?<[6PW)NEIF6]E<@XJ7)3"VB)Y.TVS-9%12:[1F9.U7?KJ^WHC#3@Q,Y=H
ML4Q]S3CTKE:5Z:9OJ$_D\C#X3[D>PV2<]<IK>Q"^-HR3$0?U:W_-)!5V5,RH
M+%%FJC&)A>KNTU1&$N9IEI+J+FK^7,8]8Y\1RT6*<FXFZV;).KX"+WOJLB\M
MZE.$O5$6Z*HF555<80V-.=(]1\ZD9/$QNRW")(M%GEJN1NMK8)PVZ&J!51%Y
M;E#HG>=!%-NJ(1-5+1I[I+J-G<O)(F-V:?!D66UR7[FIYIV.2R:HI4+BH7LB
MZ>2BM3,1%NJ)DFJE73K234;.+E?(N/6>=;7[!;)DFZR'FG&*$VV9'#VD57':
M\!-](JBW,$W(ER-+])=1\VN]_AX]9+C;9-CM$]5R<=:4SPJ[!2/03-9)(UOG
M['PD=:;:4%5%%4*:ZZ9PQ-,=)=1<UO%_M>/V.?;I=HLUP3<''FE,)XDM&GT%
M2EDDB4^9<!)$44U8RFNJF8<;3S2747.+O>K/C]EGP)UKMTM4]<AMQA*3914X
MBEJ(B);E*)2>\Q1;HJCB5W)IF(6JN4>1:'EP[M"?MTQI1(=A2FU-.H,CH?$A
M9$94,AE93)7;OU4XL;-9RU:^F8A>'1C2W/M2LC>;PV!+:1;[9.DRKXA*DL)0
M<=Q!,)=IPFI\S[,D[_*/H(8OEUU4S#)T7**:H?2T;T<U,S#,KI9+'8;A9KA9
M;/=6KK+?:5'1&<5$<9*&XI9$1*D*431;=QF?F[113CAI5U:]#X>GNC.J.:Y+
M<,5L&/7"V7FUPY:;F<IEV.A@V6E&J,XX9$23>H:$D9T.HE#=TXT:U/SK*YN-
M8_8;E:+M:X\I=RDR67HR8W8I.K#KAD7"IWS4E7: W-,=&]3LWS->/6"R7.Q7
M:T(?D7:Y2&'HQ0B;0JJ5FHDF2W*\!)^JKL(!S=)='-3LMSUW'K'9;ECUWLD6
M<=VGO,+:*$91G$=DM2R(JO5)HBKMXNJH#9TIT:U.R[-W\4LM@N5@O-GASF[G
M(D-+81#6F,XCL''#)*4]L?L9;=O%U AQ-.=&-3\SS5W#;'8+C9;_  &I+=QD
M2FG8S4-3#:JMNO&221VE#2DS/;4J5!+7IYHUJ?F.=*Q*R6.XV:_6[TA=RERF
M7HJ8G8I49]JX9%PFX9421GY5?" YFE6CNIF6ZCQ<7LUEN5@O-I<>=NEQDL.1
MT0":2HC4ZM1%PJ76B2Z:[*@&E6C6I^3:EQ\1M-CN>.7VS*D^^5P>84RBV]FT
MX@S6XHB27:5X$T/RN(!QM/=%M4<EU /!K78KECV0VTI;-QF/LNLMP30RM)I<
M<X2)*7:<!'6AUKN ;.":+:H99GK>"VFQ7&R9#"<>1.FR6GF&X1LI4I2W7>$B
M0E=*(,S\K93> WL T:U/RG4F+A5IL5RLF0P)BUS[C(8=81;R9,S.0ZX9%PU^
MHV^49[ ')TXT<U-ONK%NPJW6.YV'(+3<5JN-U>86TFVDSQ&<I:S(B+];MVUV
M *:>:-:G7?5.)@\*PW+'\CM<E]%PFN,K0BW\*%D;JG"+A)*_-2HCH==FP!\S
M#M%M4;_J UI[;\=N-ERB%(=8FR'VG6FH78I41NNO)(N%"J4)1'0ZEM!#<Q+1
MK4^^ZE1L @8]<K=D\.>I$R8^P\TU#)E1FJ2Z]P^2GR:I5]5LIO!+G87H[J9>
M=7+?A$&QW*U9' N_'-NK[#C28*&734J:MPT["*G$DZU5T;0#"]&]3KEJY#P6
M'8[E9,G@79?IET4PM*8"6W%5FJ<(B22?JB,CVUV .)C&C&J%QU.CZ=1<?N5E
MRN%/6U)F*:<2U"X37_"E/(29=F>\EI.AUV& T6#1G4^XZG0]/(^/W"!E46Z)
M9D3G6GD,Q.Q<\J6M]*3HWY/$2RV'LH9U <R-HWJA<M7G< BV*XM94J]+X[DM
MEQMMM)/&L[@;QEL;IY9*/:?C :L<T;U/EZPP\ :L5SAY1#OI+E793"TH80T^
M:SN)N&1$2*>R).NWQ@*V/1K4Q[6.)I^BQ7*WY/&OM)%S[%?!%1VRC*?VQ%PF
MBA]IQ$=#Z#J ^?;]%M4']36]-F\>N$#+$7(XZY?9.]@Q[(HBF'(01EV7U7:$
M= %(>C&I\C4Y.F[>.W%.5(N?H[LM33J6$\#AUFF^94[*A<1.&=#ZP'-+1G4]
M[5U6GC>/W)S*BOE%7$V'$M<*7^([B;RB)/9T+M"54!O?S.ZF_P \I8(=AN;F
M3-Y!QKN?8+X3;*3QG<NTIPD@R/M.*O@W@/0+":=8AQ&'WCDO,LH;>DF5#<6E
M)$I9E^N/: Y0
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M
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MI4!O$
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MAY!*)1)<22B(RW&1&6\@&\
M
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ML_50LC''\PKX\Q7/Q=?R^C@L4Q\&10PF:
M
M
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M$8;BQ8\9DB)F,VEIHB(B+A07"6PMFXAY],XN_B,(P<@0D
M
M
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M+:PU$@QBK1MEE)(;21F9F?"E)%M'GW%Q53,N^BGAB(A]($@
M
M
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M'/Y0?[S7_#'Y_P""O]?[5W:?XGXC2FP^"7T]?L@F.143^_/Z(GG5<?NQAO\
M\'SKGSYZS3H;\>)9L:LC[C9I1<8C#SCK)_7I2\I2#,NI14%5/(Z:9QQF=ZBK
MG4UZ*88_PV=7>8S,V6HR[GJ%DTE1H;D[?18:%&1*,U%[#':+8I1%39T#,KJL
M9.C&J8CHP8]NB]FJ_IB93.<K'+/"T%QR7,NTEF[:@Y&E)7^ZL$?9,,I,E(AL
M5VFE![5*/SCV[AQG-.8SF[F,1A3'XQ=?RWET92C"9QJG\8,LR*A4K4:N&S5$
M@
M
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MHD
M
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M3:4\1D6RI[1@UW*KD_5,SO9=%NFCNQ$.Q$1)*A%0A"M41 "0
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ME$CC;4LBXB)1D1U(C 7F
M                        I7> 4+J :32D]Z2.N^I *T+J 5"1&9WE1G^*
M.F::^25YDG3P]DD=#[=G"Y7NCM<[[AC&BWXI[$1O5^CH'852Y;!.#W>I_P#Z
M.T3;_P!I+O[8@<-S_P!75U=CL^1>EIWSVLXQIMK<%"ZB$@1$6XB(!4
M
M
M                                                      !0R(]A
ME4@$-?>4?*MIIL_[)S/=P['VWY-?BCL<?[D\^UX:NVE'._\ Q9_[FOUAT-&M
MH[G=>E#04O\ P6TN(RK_ -6[?[2D>;9SSZ_%/:]#R?DT[EW:%O&,R0
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M-E$>)&BJ;CQFT\*&T)E,D24I+90A(DG
M                                         $9?>5&7XI:9^&\2:?WI
M(Z'V[']2O=':YWW#W+>^>Q$:6PAV%6ERR<'N]C(N7>(1].1W?VQ X;G^G-U=
M78[/D6C*T[Y[6<?5Z@TVW%N&H3B
M
M
M                          I4MI=6\ J1>N TFX@B(S41$>XP%>--*\6P
M1,X:Q#9WD^W573,RW%BDLC]6=L]8=A[:JB;5<?&.QR/N2F?NVYV<-7ZS".>1
M_%W_ -@KZ9#HZ=$XRT%<_3@])^@JDEHOI=4_^S<#VE(\TSM41?K^-4]KT3)Z
M;-.Y=LW$)WJ(6&2J:TET@'$D^';YVX!J
M                                  &&G/9\A$GX:A?8N@/AXQ^36.?!
M</VA A+[8(/%OZ  !4MBB\8"T_+'\Y[6C[R+VQH2+F\^/R*L?#D3[%8#8L_X
M&L_WBQ[6D0/H@   UI\Y'[)/K@E:;E5^<SK]]P<]ULB4)(@
M                                                    !I-5-E*^
M(1,C;6ZVVE2W%=FVG:I:C)*2+PF81,] V/?&W_\ QL?^^H_5$S28HTN\E?8?
MQ'3,V7VW>&\RJDA9*,O8D=1F.C]N:+ESPQVN=]P]RWXI[$2A;BVTZ#'7.63<
M=WW)CL\O,-+S[;1JR.[^2M:4_5M]"C+Z0X7GD8YJOJ[':\EG_I:>OM9P>^-O
MZ)L<SZ")U%?7&HPF&UQARB5M+8K;] 1C\$X-1'7H$BH
M
M
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MZR^DELNH42DK0HJI6E23,C(R.I#+B<8<=AA.$Z)<LCJ51*%0
M                                                &&G/;\A$GX:A
M?8N@/AXQ^36.?!</VA A+[9@'Z8( %2WD7A(!:?EC^<]K1]Y%[8T)%S>?'Y%
M6?AR)]BL!L6?\#V;[QC^UI$#Z(   -:?.3^R3ZX)6FY5?G,Z_?<'/=;(E"2(
M
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ME_4K+Q#C\[DKF6KPG5TNMR>=HS-&,3IVPO\ (4:B,SI2NR@PL68W"KT[Q(
M
M
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MA;!E9+,35],M1[QY!;X*LS9C"JGOQ&K#IZ="8-/FD-D\R:@
M                                               &&G/;\A$GX:A?
M8N@/AXR?_5K'?@N'7^\($#[8   *I\XO&"5I^6/YSVL_WD7MC0E"YO/E\BC/
MPY$^Q6 V+/\ @>S_ 'DQL_X-(B1]'K   !K1O1U<1>N(2M-RJ_.9U^^X.>ZV
M14A)$
M         >X!8WF%U31HSI1DV:LH1(NL9DHMACK-)<4R4HFFE457B)LU<:DE
MO(C&3DLO_<W8C8Q,YF/[>U,[4%FD>FF3:^ZFG9%7!YV3<'7+OF^32%FXXS'6
MNKSRUJJ:EK,^%!=="/<.]SE^G)V8B(<1E+-6:O3CMTIMM/=-L*TKLS-DPJQQ
M[6PTV29-P-"52Y1I.IKD/&1K69GM(C.A=&P<G>OUWIQEU-G+46HP=^-YVM3?
M7]$6<(Z%_#XP=J[T.J^B&'P,/C"AO/E_;5_1,,/@C".F#M7>EU7T0P^!A\8:
MB?>+^W'3J,ZD&'P3ATRQXUPY=,*UHM4QQR(Q8,Y2GM+1F$9LD.&\A/"AN81$
M7;-+*B3KY1%N,9F5SE=B8TZ&#FLG1>QZ42.G^:9?RXZN,7AYDX5SQ*<NWY?:
MZK-M^$2^&2W0J&M)I+C;ZZ$9#H\S;ISN6FG#3,:'/9:]5E,QCCHC6]%UDN<*
M^V:U7NW.*7 O,1B?!6LN%1M2&TN(,RKL.BBJ0\\JHFB9HVP] IKBN(JC:^N1
MD95+:1@D
M
M
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M;2O;]$;^F<8Q>%9FS]F[51T3,.Q"5@
M                             !AESV?(1(^&H7K.B4/BXQ^36.G_ ,UP
M_:$"E4^V"#]%0%?T4!,A5J7C 6GY8_G/:S_>1>V-"4+F<^7R*L?#D3[%8#9L
M_P"![/\ >+'M:1 ^EU@* 'AINW -:2VM^-/K@+2\JGSF=?\ [@Y[K9$B2,
M
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MV]S),8#8
M
M
M   A8[Q_Y9L-^*2:?XX^-3S'7'XZ7JOL7TM7B^4,LN4.G]7W!=FY$KZ;ZQ<L
M=QIN?^LKZF270+C3'J^( W 'AI4 W@*>#U*@-Q&TZGX/7"$3JE"5SB?."S;K
M*-!]I(:^_P"9#T[V[Z*GK3AZ(?(]IE\6K;[G0-U:[D/'^:^JN>*5TA<:\
M                                                        !AGS
MV?(3(^&H7K.B4/B8Q^36.?!</VA I2^V  'K@*I\X@%I^6/YSVM'WD7MC0D7
M,Y\OD58^'(GV*P&S9MMGL_WBQ[6D0/H[]W2 >  Z0&XG>BOUQ>N(2M)RJ?.9
MU^^X.>ZV14A)&
M                 &(B^[RS\!Z6_",RG][0.F]M1_4JGX.:]R>73O</N_J?
MS?9\?_/T;W,L7N=>93U]L+7)^Y7U=C/7I+U!J>EM]D-RFZA[@Q%>H0 !U"!0
M]Q]74)2T'YID7J",=*C9UHC^?WY:,6\.&Q:?XT\.FY)HL3O<YSGU$;DE')L?
M_P"C/I(?_-C_ +K?'*<WT9JYO_8ZCE/I;>YD^,!L
M
M
M                                   0L=X_\LN&?%-/NQX:GF.F8_'2
M]5]B^EJ\4]D,LN43YOF"E7ZB5]#TAP7+$_0TW/\ UE;)(7&F/6 #_00"GAWF
M KZH!0!K1O\ H>N$(JU(2N<3YP6;?>T'VDAKK_F0].]N^BHZTX>B'R/:9?%J
MV^YT#=VNY#Q_FOJKGBE=(7&O
M                        89\]GR$2?AJ%ZSH(?$QC\FL=K_R7#]H0(2^W
M^D ?J;0#I_2 5+>5>L@2M/RQ_.>UG^\B]L:$H7-Y\OD58^'(GV*P&Q9_P-9O
MO%CVM(@?1  #UB ;B=Z?&7KB$K2<JGSF-?ON#GNMD5(21@
M                                                 ")$7W>6_@/2
MSX2F>UH'4>V^]7N<W[C\NG>X7=__ "?9_P##T7W.L7N<]^C=/R6>3]ROJ[&>
M_5MV[#&GZ6WC5#<\1   1[:@&[PT/<( R,Z^&NT2F&@4QK4_NQO^:(_G]^6C
M%?B;&]U/#I^2^1URYSG'J(W))N3;YLVDGP8][K?'*\Y]5<WNFY3Z6WN90#7M
MB
M
M                                                       "%GO'
MOEEPSXII]V/#4Y[O=4?-ZK[&]+5XI[(98\H?S?L%_82MG_&'!5E^ZTW/_5U]
M3)(7FF/TP% %?$ H K_Z0&M/3Z@0B=4H2N</YP6;?>T#V@AKK_F0].]N^BHZ
MTXFB/R/:9?%JV^YT#=VNY#Q_FOJKGBE=$7&O
M                                    89\]GR$2?AJ%ZSH(?$QC\FL=
M^"H?M"!"7VP%>D!0ND!4MY>,!:?EC^<]K/\ >1>V-"1<SGR^15GX<B?8K ;-
MF_ UG^\6/:TB!]'Z8  J"6I/G(\9>N M+RJ?.9U^^X.>ZV1*$D8
M                                                       B1%]W
MEI_YCTM^$IGM:!U'MOO5[G-^X_+IWN'W?_R?9_\ #T7W.L7N<]^C=/R6N3]R
MOJ[&>^\T[/$-1TMK&J&H0E7I *TH ;*%T5$ HM]"]020T=?TA3&M'[L;_FB/
MY_OEHQ7XFQO=3PZ?DOD=<N<YQZB-R2;DV^;+I)\&/>ZWQRO.?57-_P"QTW*?
M2V]S* :]L0
M
M
M    0L=X_P#++AGQ33[L>&ISW>ZH^;U7V-Z6KQ3V0RRY0ZER^X+3^YRMG_#N
M"K+]UIN?^KKZF2/0+S3 "OC *>H IT@*[OH@-:.DO$$(JU2A*YP_G!9MX8T#
MVDAKK_F0]/\ ;OHJ.M.)HC\CVF7Q:MON= W=GN0\>YKZJYXI71%QKP
M                                                     &&?/9\A
M$GX:A>LZ"'Q,9_)K'/@N'[0@0E]L$@(/6 53O+Q@+3\L?SGM9_O(O;&A(N9S
MY?(JS\.1/L5@-FS_ (&L_P!XL>UI$2/H^(!4Z_J@*;?$0#<1O1XR]<$K2<JG
MSF=?ON#GNMD2A)&
M                   (D1?=Y;^ ]+?A*9[6@=1[;[U>YS?N/RZ=[B=W]\GV
M??#\7W.L7N<]^C=/R6N3=ROJ[&>NZA#4=+;1JAN>,0* *]&[U0"ITW@*'N/Z
M(A,-/J"(UJ?W8W_-$=S^_+/BOQ-B^Z7ATW)/(ZY<YSCU,;DDW)M\V723X,>]
MUOCEN<^JN;_V.FY3Z6WN90C7MB
M
M
M                    "%GO'_EEPSXII]V/#4Y[O=4/5?8WI:O%/9#+'E#H
M?+[@M?K)7NAP59?NM-S_ -77U,DA>:8 /T4 /TP  ZP&M)[?H>N$(JU(2></
MYP6;?>T#V@AKK_F0].]N^BHZTXNB/R/Z9?%JV^YT#=V>Y#Q_FOJKGBE=$7&O
M
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M+EXUSUYS"W)](QY]1Q&KBG:VIYV0AQ*4GTU2VHQ(D>
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M_>GW'YJ;2\AE$8G>V\M!*-M2DI/ZDR/I 9_
M
M
M "%CO'_EEPSXII]V/#59[O?E\WJWL7TM7BGLAECRA_-]P4MWL<KW0X*LOW8:
M7G_JZ^IDF+K3 "@!X0&H!I_3 :T?2V;/5"$5:I0E\XGS@LVZ_1H'M)#77_,A
MZ?[=]%1UIQ-$?D>TR^+5M]SH&[L]R'CO-/57/%*Z(N,
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M-PR7 KF6F&(W]Y<NR8I,D'+4B.HZIV*29$D^O88"YWXJ<Q._^<FTG7H[(OW
M&!^*?,3_ $D6G^]%^X P4_%/F)_I(M/]Z+]P ZMF&F_,'>[)+BNY_%NK:T&;
MUEBJ]&.0A.TTI<))'4]U#.@#,/E!RO [SITYCF(XV>(WC$I"8V86-Y7:/G,4
M1UDJ=.AN$YPF?@W=0#+4
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MI+822(MA$1; &\
M
M                                        (6.\?^67#/BFGW8\-3GN
M]^3U7V+Z6KQ3V0RRY0_F^X)U<$GW0X*LOW6FY_ZNOJ9)"\TQ], ]0 \("@!T
M@-:-Y^I3Z(1K15JE"5SB?."S;[V@>T$-=?\ ,AZ=[=]%1UIQ-$?D>TR^+5M]
MSH&[L]R'C_-?57/%*Z0N->
M                      PVYZS46@LWA4:25>8)*(NDJ.; 'P,8(DXQCA)2
M22]ZXFQ)$1?:4=!"$ON5! "3]! A5)T4DRZ]AEL 6HY8E*1S-ZTM(4:&EQ"4
MMI.Q)F2VJ&9=>T2+F<^!J+11M/$?"N]Q"4G:1'L6=#IT ./92)-ELR4$24E!
MCDE);"(NS3N(A ^E0B  #]&P!J0=%)\9;:[MH"U?*<9ES#:^-),T-DE1FV6Q
M-2DM$1TW"1(\
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M+%B.(VB/8,;QJ$U;[)9XB.S9CQF4DE"$I+Q5,SVF>TS,S =C
M
M
M               !"SWC_P LN&?%-/NQX:G/=[JCYO5?8OI:_%/9#+'E#V\O
MV"_<Y7TY#@JR_=:;G_K*^IDC],7FF"H  *D 4 4^D UHW_0"$5:I0E\XGS@L
MV^]H'M!#7W_,AZ?[=]#1UIQ-$?D>TR^+5M]SH&ZM=R'CO-/57/%*Z(N,
M                                                        !AMS
MV?(+-^&8/K.@/@XS^3..;*_YLB>TH$#[94W& ?I@*G]#P@!%M+Q@+3\L?SGM
M9_O(O;&A(N;SY'315GX<B>LL!L6;\#V;9_[DQ[6D0E]'U@0=0!X/" JD_*3X
MR 6KY3_G%Z^_L%>Z6A(D?
M                         $2(O>\M_ >EOPE,]K0.H]M]ZO<YOW'Y=.]Q
M>[_^3[/_ (?B^YUB[SGOT;I^2UR?N5]78SVINIU%4:C;+;1JAJ 5+8 ;/]@0
M*;A('TD9 EI+?^CJ$1K4?NQO^:(_G^^6C%?B;%]U/#I>2>1URYWG/J(W))N3
M;;RS:2?!CWNM\<MSGU5S?^QTW*?2V]S* :]L5#W'3> \V7?9DK^>;1]2DT2>
M'2.%?09E/76A^J E'[KE25<EFEI),CX'KL2J'6A^GO'MZMX"0<  4W@/D9#^
M +Y\'R?:E /&_P G'SW-$/\ S&B^Z5 0]G  8#ST]][(-60:#Q:HX2M]W=H1
M^74W64[NK8 SF[I2WRK?R:XN<IE3/IV0WN7')14XFG'T\"BZR,B 28 ,%>93
MD!T9YHLX@Y[G]SO\.\6^V(M;;-LE(:94VVM2TJX5(4=2XC+> C7U[[FIO'\/
MON3Z&9[<,GO]J)4IG!KRPTV<AAI!FXU&DMG53QTJE*DT5NWT ? [MCGQU#LF
MHUDY;M:KT[>L9O2SM.'7>[KX)MDN,9)MMP7'7#(U,K)'9I0K:A=.'89D ]%O
M$JGUIEMV@/,WWPNM%RSC7#&=$[6^:['IQ$:D/QVW$*:D7>YI29K5LJE32/8Z
M&?28";#DLY?+5RX:!8;AL>WHBY+=(S5XSN95*G7[I*02G26M/G$T1DVCJ20#
M+@
M
M                              !"QWC_ ,LN&?%-/NQX:K/=[JCYO5?8
MWI:O%/9#++E#^;]@M/K)7NAP3E^ZTW/_ %=?4R1%YI@!4   %/& UHW[^K;Z
MH1K15JE"5SB?."S;[V@>T$-=?\R'IWMWT5'6G%T1^1_3+XM6WW.@;NUW(>/\
MU]5<\4KHBXUX
M           ##;GL^0697_EJ#ZSH#X.,_DUCOP9$]I0('V_#U  !X?" J6\N
MJH"T_+)\Y[6C[R+VQH2+F<^7R*L_#D3[%8#9L_X&L_WC']K2('T?$  'J@*I
M\Y/C 6KY3_G%Z^_L%>Z6Q(D?
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MQ&@BXOJ>SI3P /9-:W&'[9;GXZTNQWHK*V'4F2DJ0I!&E1&6PR,CV& ^@
M
M
M                          A9[Q_Y9<,^*:?=CPU.>[W5#U7V+Z6KQ3V0
MRQY1*_U?L%ZNSE>Z'!5E^[#3<_\ 5U]3)(7FF "A& >   /I -:/H[O7"$5:
MD)/.)\X+-?O:![00UU_S(>G>W?0T=:<31'Y'M,OBU;?<Z!N[7<AX]S7U5SQ2
MND+C
M     8:\]GR"S/AJ#ZSH#X6,_DUCGP9$]I0('VP#U0#H_5 5+SB\>X$K3\L?
MSGM:/O(O;&A*%S.?+Y%6?AR)]BL!LV;\#6?[R8V?\&D0/H@*^(!0!J3YR?&0
M"U7*?\XO7W]@KW2V)(2/@
M                        ")$7O>6E_F/2WX2F^UH'4>V^]7N<W[C\NG>X
MG=__ "?Y]U>_T7W.L7N<]^C=/R6>3]VKJ[&>V\RZMAD8T_2V\:H;N_8(%/#O
M$BGT"$AN$ =-NT$PT^KU"(UJ?W8W_-$?S_?+1BGQ-C>ZGATO)?(ZY<YSCU$;
MDDW)M\V723X,?]UOCE><^KN;W3<I]+;W,H!@-B .N9?BEASG%[]AV46YN[X[
MDT%ZW7FVO%5#T=])H6D^K8>P^@P'E0YB^2[F Y*]36=0M-2N]WPRS7%,[!-3
M;,VIR1"54S;8FMM$HVW2*J3,T\"RJ>ZI$%^L/[Z?6JTVB+;LOTVQ7)KC#C-L
MKO;/I4-V2XA))4Z^TEXVR4HRJ9(2DNHB 6/UN[P#FFYP;8C2S'<<;L-@NRRC
MW7%L*B2GG[D3KJ291+><6\X2245*)-"3^JJ D[[M/D!ON@[[FM>LD%J-J3=H
M!Q,7Q)79N*L<601&X\^M-:27$^1PI/R$FHE>4?DA+KD)D5@OE=G^;Y/M2@'A
MXP#4JZZ/ZTV+5.P0X=SO&#9(J\6R!/)PXKSK#RE(2Z32D+-)]/"HC\("3<N^
MLYBEJ)*-,]/S4HZ$DF+H=:[B(O3@%@LZUGY\.=RY'A9VW);S9+T\Y(C858K:
MNWVDF%K;427G"2CM6FC2DR-YQ5-IUW@)=.0;NVV>7FXPM6]7)4>^ZLICK19;
M'&4EZ!8S=(TN+)RGLT@T'P\9'PI(_)J>T!+::3.A;O" @Z[T+D.S/4^_)Y@-
M&K(O(,@*$U$U$Q2,HSERFXJ>S8FQ6U*HM2&R2A:$[3(N/;M 82\O'>>:Z\M>
M-VO2O.L4:SG',<)+%LBWQ,B%>;?#0DDMQ&W3--6T$7D]HA1D6PCH5 ':M<.]
MHUMUDL5RT\TLPJ)@$7)FE1'[A![:X7QQEQ"B=99,C-"26DSJ:6^*FXR 9 ]V
M#R&YSC68P.8W62S/XW[W1E.Z;XQ,JB<\]*2:3N$ENM6T$TH^!*MJC5Q;*;0G
MS))T,B^F @M[RON]\_U.S*1KYHE;%9/=[I':8S? 62;;E*5'22&YD$O)[92R
M^VH,S57RDU*M P4T>[PCFXY5;3"P');*61XQ8T';;-C^;0)++D)+#BC4W'EM
MFPZJA>21*6M*4[BW )0=$>^"T3S^[6_'M3L9N.E<ZX.QXT6_*6F=:S><*BU/
M+027&$$HBH9DK895V5,!+Q$E19L=B7#?;E19;2'HLEE1+;<:<(E(6A::DI*B
M.I&0#D@
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M +T ?UZ>4;^G?&_V[_[T K_7IY1OZ=\;_;O_ +T I_7IY1OZ=\;_ &[_ .]
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MV@AKK_F0].]N^BIZTXFB/R/:9?%JV^YT#=VNY#Q_FOJKGBE=$7&O
M                                                    8:\]GR"S
M/AJ#ZSH#X>,?DSCGP7$]I0(2^UZP "%0!.\O& M/RR?.>UG/_P"2+VQH2+F<
M^7R*L_#D3[%8#8L_X'L_@@L>UI$#Z?K@* *]0"J:\2?&0"U?*?\ .+U]_8*]
MTM"2$CP
M           B1%]WEOX#TM^$IGM:!U'MOO5[G-^X_+IWN'W?_P GV?\ P]%]
MSK%[G7F4;I^2SR;N5]78SVK]+<-/MEMHU0UU^GO!*O@Z@P#U@%* % 2T^#Z
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M276S9<;6F.BC2VSVI4VFB#\) +P@
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MYI.K"_Y47_DX!^:GYI.K"_Y47_DX!^:GYI.K"_Y47_DX!^:GYI.K"Z_":_\
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MT]5<\4KI"XP
M           &&O/9\@LSX:@^LZ"'P<9_)K'>OWLA^TH$*I?<!!X@  +>7C(!
M:GED^<]K.7_R1>V-"1<SGR^15D_^?(GV*P&Q9OP/9_O%CVM(@?2 4_08!M 5
M3YR?& M7RG_.+U]_8*]TMB1(^
M                            "@ID1?=Y;^ ]+/A*9[6@=3[;[U>YS?N/
MRZ=[B=W\?_A_GWP]&]SK%[G7?HW3\EGDW<JZNQGKLJ6S8=!I^EMXU0W"^@ J
M>S=ZH!0]M0D/I5 .C](0-%?IA&M'[L;_ )HC^?[Y:<5^)L;W4\.EY+Y'7+G.
M<>IC<DFY-OFS:2?!CWNM\<MSGU=S>Z;E/I;>YE ->V(
M      #;=;[1MQOC4V;B5)[1!T4FI4JD]M#+H 12:?=U_B^,<U%WUXRW.IFH
MF.-S#O\ C5BO:2>GJO3[JW%+N#QD2'FV*$:"))5.E2(D[0E=)-#-729;3 :@
M
M                         !BUSLL]ORHZYM4KQ8T]L\3K9_I (..Z^DG'
MYJ[(1'LE8U<F:^,DF ]-:2H0"H
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M4$X(B6M*B452KZHA,2J
M      B1%[WEOX#TM^$IGM:!U'MOO5[G-^X_+IWN)W?_ ,GV?'_S]%]SK%[G
M/F4;I^2SR;N5=78SVZ2\-*C3]+;QJAN>( .H!N /T&8#29[ 3#2(IUJ?W8W_
M #1(<_WRT8K\38WNIX=+R3R.N7.<Y]1&Y)-R;?-FTC^#'O=;XY;G/JKF_P#8
MZ;E/I;>YE ->V(                         TDE);BH U
M
M                QNYP&>WY8]:VB*O%C$K9XC2?Z0" ;NUY!,<UN"%7^,VZ
M<UXS-KB_2 >HD@%0
M           0L=X_\LN&>#$T^['AJ<_IJZH^;U7V-'_2U>*>R&67*'\W[!2_
M62?=#@KR\_2TW/\ UE?4R1_08NM,J ;J *>/>  *@-2.GU/7"$5:D)7.'\X+
M-OO:![00U]_S(>G>W?14=:<31#Y'M,OBU;?<Z!NK7<AX_P U]5<\4KI"XUX
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M,C%QP%VU7:JFBN,*HT2^H"@
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M[W6^.6YSZJYO_8Z;E/I;>YE ->V(
M
M                      + \U#?;<N>LK?UV+SOL*@/.GW>,KT?FOTDVT*2
MY+8IU\45T_T@'JJ(
M            !"SWC_RRX9\4R]V/#4Y[O=4?-ZK[%]+5XI[(98\H?S?L%Z^S
MD^Z'!7E^ZTW/_5U]3)(76F-P!4!3]% %0 !K3O\ H!"*M2$KG$^<%FOWM!]I
M(:^_YD/3O;OHJ.M.)HC\CVF7Q:MON= W5KN0\>YIZJYXI71%Q@
M                                8B1&OS]5<NNB;#A<;/OG+4;1[2JI
M"",Z==!I^:]ZC\=#T3V)HHO]7S6W5OV;MR?$7Z-PP=KM9::^ 0@V?0 5V=.T
M3"JG7"W5Z-3>K^B<EL^SD-WV*E$@O/(B>V4,+?FPMYKT5_P5=B2[FLXD<O>J
MRD*-"CLBRXB,RWO-=)#L^7>IHWO%>7^HHWHWM+DDC3[&221)3V+IT*A5]D45
M=G2.CO=Z6]O=^7?196@  =#U.:;>P#*4/-I=0B$MQM*BKPK(]BB\(N9;O]<+
MMGOPDFY6WG7]!-,UNK4M?O6:24HZT2AU:4EXB(B(ASW,(_KU[VBYAYTOG<V.
M!WG4'13([58&52KO;G&;I%@H*JG_ $8SXT)_7<"C,O%08;#8T:5ZFXME.-6F
M&5RCVN_VJ,W"N]@F+)A]EV.DF]B5TJFB=A@+I^^=KK^%[>9]!>E-?NA T^^E
MJ_Y6M_\ C37[H!7WSM>P_?:WTZ_2FOW0#X]ZS+$<;A.7*^9);X,)DN-QSMT*
M49%T)2E534?0)P'Q^3NPW?(\WU0UIDVY^UV')W$PL<0^G@.4@E$I;I)41&22
M)"?'4!>?F[P*]Y]HQ>8>/1U3+O9'VKI'M[>U3Z&*]HE--IF2%&="WT 8^Z:Z
MGXKF./6Y+-UCVV\08Z(]WL<M:69$=YE)(41H738>\C 7**YVNOX6M_\ C+7[
MH0'OK::?ABW;.GTIK]V >^=J/_[O;_!24U^Z ?&OF;8AB\%RZWW(H$.&P1J-
M9/H6M=-O"A*3,S,SV$)'SN33'+Q=<EU0UDF0'K39<VD^CX_'?2:5OM$X3BWB
MKT$:"+U? (F=">A\GO"$DJQ:0-.$2D+R:02T]'VA._K&\Y)WZ]T-QR?77U?-
M:Q?0GH)*:%381$1$1$70,V=;,PTRH)0J IX=PC8F5KLT/L]0-'92/(DM9)%[
M-XO.31XE%0]^PQ?H\JK=*[1Y57AGL2H<QIJ1H5JFI)FE18_*+B29D>TB(]I4
M,<<U7(].>L^*$8NDR>'3^P$@B3Q=L:J%2M'#(C.G40PKO>E[AF(^M<(Z5V5]
M44L=0!4@-KJ6>H0YA>2)<0E:2AK425;JI*I&1=8BWK7;&FJG>D!Y1G7'>7_
M.U<-PVX[[:#,S.B$ON$E)5Z"+80V4/'_ '7'_P#T[N_Y0R2!SH
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M*"2IQ5/JEJJHSZ3,!W4 $2(ON\M_ >EOPE,]K0.H]M]ZO<YOW'Y=.]P^[_\
MD^S[X?B^YEB]SGS*-T_)9Y-W*^KL9[%T>H-/MEMXU0W-FT +U]P2%=VT(#Z0
MD4ZQ"6@13K4?NQO^:)#G^^6C%/B;&]U/#I>2^1URYWG'J8W))N3;YLVDGP8]
M[K?'+<Y]5<W_ +'3<I]+;W,H!KVQ
M
M                      !9#F5:[;0'5YOZ[%[A])HS >:KD)<4GFPT)(MG
M%=GT'XCA2#]<@'K$
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M[Q<]831HE79T5T[V?7*'\W[ _N4GW0X-B\@]U_\ <KN^.R&2P.=
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M7DV^;+I)\&/>ZWQRW.?57-_['3<I]+;W,H1KVQ
M
M                                !:/7UHG]$M5VC*I*Q:Z'3Q1EG^D
M\RG(74^;#0<Z_P#WE_W#) >L<
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MC_NM\<MSGU=S>Z;E/I;>YE"->V(
M
M                     +;:RL]OI%J@U]=B=Y^E"=/](!Y@>0HJ<V&A'PR_
M[AD@/6.
M    A8[Q_P"67#/BFGW8\-5GN]U0]5]C>EJ\4]D,LN4*O]7[!2/^YRBI_P 8
M<$Y?NM-S_P!97U,D?6%YIE0#]% %/$   #6G?]#;ZH0BK4A+YQ/G!9M][0/:
M2&OO^9#T_P!N^BHZTXFB/R/Z9?%JV^YT#=6NY#QWFGJKGBE=$7&
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MV]S* :]L0
M
M   ="U43QZ7ZD(^OQ:\)^C"> AY=>0OYV&A'PU(]Q20(>L<
M                                           !"QWCY_\ C+AA?]TT
M^['AJ<]WNJ'JOL;TM7BGLAEGRA_-^P7K[.5[H<%67[K3<_\ 5U]3)$Z^J+S3
M !LZ0 _T& = !ZW6 U(V_H\(0BK5*$OG#^<%FWWM!V?\ 0UU_P R'I_MWT5"
M<31'Y'],OBU;?<Z!N[/<C<\=YIZJYXI71%Q@
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M/WRU\J.FO+3C*;=BT!-XRR<A!Y)GDUM/ITQQ)4-*%;3::(S.B$GXZ[*!E*
M-I+#"''7D,H0\_P]LZ22)2^$J)XCWG0MU0&[NW    ")$7O>6_@/2W;_ /<I
MGM:!U'MOO5[G-^X_+IWN+W?_ ,GV??#\7W.L7N<]^C=/R6N3]RKJ[&>O2750
MAI]LMM&J&LMA[?5 5/Q^( ^D IMV>N =!U!+3U$9_HH*8UJ=D;_FB.Y_?EHQ
M7XFQO=3PZ?DOD=<N<YQZB-R2;DV^;-I)\&/>ZWQRO.?5W-[IN4^EM[F4(U[8
M@
M                                                       Z3J9\
MG&H'Q;NON-T)3&MY;.0P^'FQT),]WOW(*OCB22!3#UD@D
M                                        !"SWC_RRX9\4T^['AJL]
MWNJ'JOL;TM7BGLAECRAF7]7[!-WVN5[H<$Y?NM-S_P!97U,DA>:93Z0!](!7
MJ( J H UHZ?4"$5:D)?.'\X+-?O:![00UU_S(>G>W?14=:<31'Y'],OBU;?<
MZ!N[/<C<\>YIZJYXI71%Q@
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M-R0EEPN%79O/+6V9D>W:DR,9U,80\<]SW:;O,+E5,Q,:(QCX0R($M
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MEN<^KN;W3<I]+;W,H!KVQ
M
M               !TC4SY.-0/BW=?<;H2F-;RR\BRR1S5Z#J,Z?]85)Z_.8?
M+],$0]:(!4
M     $+/>/\ RRX9\4T^['AJ<]WNJ'JOL;TM7BGLAECRA_-]P3]A)]T."K+]
MUIN?^KKZF27307FF %/!N 5Z #UP"F\!K3T^&@0B=4H2><3YP6;?>T#V@AK[
M_F0]/]N^BIZTXNB/R/Z9?%JV^YT#=6NY#Q[FOJKGBE=$7&O
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M:D.J1Y3+]Q--#;25"-+2=O68"=IIHFDI0FA(0DDH014(B(J4(!N@
M  (D1?=Y;^ ]+?A*9[6@=1[;[U>YS?N/RZ=[A]W_ /)]GWP]%]SK%[G/F4;I
M^2SR;N5]78SVZ2]0:?;+;QJAN'4]_J * *_H\(8B@"IGL\-*5 AH\'TQ&&E&
MSK^:(_G^^6C%2ZL-B^ZGATO)?)ZY<WSCU$;DDW)M\V723X,?]UOCEN<^JN;_
M -CJ.4^EM[F4 U[8
M
M         #"[6GGQT.T$SR?ISGT?*6<B@Q8\Q*X=H6_$?:DMDXE3#YN))?#6
MBJ%L/8 QMSGO3>7B]8EE%CM5IRN1)O5IG0(ZW;>322<D,+:2:C-:J%50"$#0
MG41G1S5;3_4N99WK^SA5R*X/V6.\EAV11*T\"75DI*3\O>9'N 3 _GCL8(Z?
MS WTR/=_GN)_DX#.'E*YIY7-78LJRR+IK-P+&<?FHML*;.F-S/?"223-\FE-
MMMI(F3+A46TZF0#,
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M=;XY;G/JKF_]CI^4^EM[F4 U[8@
M
M                   ",CO,.7)S5C2EK4W&(:7<[TI;<D+2GBXYED,^*7'(
MDI4:E-G[(A)4J=:F \XB%$HDNHW'M2>S_9 :BV%0MW4 Y=NMEPO=RMUDL\1<
MZ[WJ4S M4%JG:/29*R;9;14R*JEJ(B >O#EMT>MNAFBV#:;P64(D6F AZ^R$
MIX%2+C((G)3JRJ?E&LZ'X@%]0
M                  !#'WD4&4C5?!;DIE28<C&3C,23(R0IUN4ZM:"/<9DE
M1'ZHU7,(TO4_8EV/[:Y1T5=K)+DRO$6Z:"X^Q&,R78ILNVS.+^[)5VIT\27"
M$V>Y#6>Y+<T9SQ1BRG(7FB   ]?P@'0  *I+B4DBW\1$5?\ 8!$SA$R@UYJ+
MQ'OVOVHKD-*DE;YC5H>)1;WXB$MKX>LC,RH-?>\UZER&W]K(T3.V,?S3T:16
M^3:M+=/;;,;-F5"QZWM/M**AI4F.@C(R&[MQA3#Q?F-R+F9N51MJE<05L,
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M(5P[N"6M<ENG]@X0XSF5R+F8KGIEV/+[<V[%%/1"_P ,-F
M
M                                       #8?CL2&'X\AI+L>0A3;[2
M]J5(67"HC\!D= 'E/YV>7E_EVUQO5FM\13>!YAQWW Y"4J[)N.\M7:PN(]G%
M'61I(C,SX:*/>0#$4P$D/=C:(GJ9KL_J'>(!R<2T@CIF)4KA-M=YE<28;:T*
MJ:N!*5.I,MRD@/2>6T@%0
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MR$UH5=_2*DJ@
M
M    *'N/Q ,*.>_EV/F#T.NL6SL)//,&[2_80[PU4MYI%9$/>5$R4)))TVF9
M$1 /+*^;L<GTOQWF9$92FWX2D&3R7$F:3;-&\U$HJ4I6NP!ZJ^1?1!&A_+MA
MUHF,):RG+&BR/+72/B_A4])+0TE1I)1(;;-)$D_-/B 9C%N+H 5
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M$+_-$HFTDKSBK7Z(NRT\8[6X
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M,JO?[#(/LUCA?<GK)W0Z_D/I*45B?-+P&?KC0MRFNY)_D QW[]G>V@,L@
M $9/>0_@[2+[_NWM#(Z#V_YE>Z.UNN3=ZO="-;#_ ,M,*^'[;[I0-]>\JOPR
MW][5.YZ7QP+A@  45N,(%@N:#Y =4O@O_#-");WVQ_W*SXOE*"!/VM/B%N=;
MW7;U)Q>4'Y <(^YO>V&+D/#_ '7_ -RN[X[(9,"7.@
M      "WFJ6I>(:/8/D&HV=7 [=C..,$_<'TH-QPS49(0AM"=IJ4HR(OI@/-
M-S9\[>?\S5S?LL3TC#])F7R39<+8=4;UP-/F/W!3=.T6KH;(J$1T^N 2T]V?
MIEK[IKIA/C:I*1:L%O"D3=/<-F$OWSMZ'*&M2T^:TTZ1U)L]I'393>$F8
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M:X
M                                                          TJ
MW;Z4 0U9OR$NRN>K$<OM5L0G1K)'GLSR'R#)F-=+>I)N04&W4DF\ZI#Q&YL5
MY9= "9-I))29%0BKL(MQ$700#<
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M8[:"0@O$E-"+Z KPP84U35IER@0
M             "AGL5X" 19]XO\ A'2/[E=/69&GYOL>D?\ Y[_K[J?FP,TY
M^4;3X_\ O);/=*!JK7?I=WS#TUWPR]'_ $F.LVOGQ42   Q@YS/FV:F?>T/W
M;'&?RSU%/7V-AROU$=?9*!MWS5_L5#M*'5T;$_\ RJ?-[TM^""]M<'$9_P ^
MK>X_/>=4R$(85.IB D  !U[+OR4R?X)F^T+ ><-7VQW[LY]F8)2S<H/S9\N_
M9WGW.8N6N_3OA;N=V=TH1%_@Q[[FY^F/8Z-<;X>55^35NGYO3!HC\D.FOQ=@
M>TI'D?,?4U^*7IV1\BC="Z0PV4\V>NWRV:K_ !GG_9$/6.6>DI\-+SC/^JN;
MTG_*W\RJ]_<\A^S6.&]R>LG=#KN0^DI16)\PO&?KC0MRFNY*/D!QW[]G>V@,
ML@    $9'>0_@[2+[^NWM#(W_M_S*]T=K=<F[U6Z$:^'[,TPOJ._VVO^,H&_
MO>57X9;^]JG<]+XX%PP  **W&$"P7-!\@.J7P47MS0B6]]L?]RL^+Y2@@3YB
M?"1"W.M[IMZDXO*%\@.$?<WO;#%R'B'NO_N5W?'9#)@2YT
M        &E1\)5I7K :$/(7QDE1&;9\+A$=32=".BJ;CH9'0P'Q,EQFQ9G8+
MQC&36UF[V&_Q7(=TMDA)+;=9<2:5$9'T])&6X]I;0&!G+UW=NDNB&<W[.KJZ
M>=W5JZ+<T]8N#1=A985>)DB094=?(]G&=:$1<("1 D4.M3,!K
M           &VILSI15"Z2IO$81.L5X/"9]0D:B*@"H"AE7J# Q:#;K7RS(N
MH,(,0D&1$1JK01AAJ&X)
M
M                 !115*E:>$!I-'3Q4/Z7T &HBH5*U 5  &E1\)>, )52
MKPGX@%4G4J[O  J
M      "E-FW: IPET4+U $-G>4;-5=-/BG,]W#L?;6,6:_%'8X_W),_?M8?P
MU=M*.=_^+R#_ -[7ZPZ*U.$Z6CO3553K>D_08C/1;2\JTKC4#VE(\USGGU^*
M>UZ)E)F;-.Y=E#1)(JF:J#&EDXRW*;3/K!"H
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M\7RE! GS$^(J"U.M[IMZDXO*%\@.$?<WO;#%V'B'NO\ [E=WQV0R8$N=
M                 &E9\*5*K0B*IG_Z0$7_ #D=X=C>CB)^GFD4B%E^J2D&
MW<+D2B>MMDXBI5Y2*I=>+:9((Z)^JKM(!A/W=&MW,1>]?,@B);O.J&*YTYZ9
MJC<)[RRCVN2>QN>EY56T+(B)LVT[TT+J,!Z&$[B_3 4X$\7%3;U@-8
M
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M/2V?/DNS9TW$;+(FS'UFXZZZY!94MQ:U&9J4I1F9F>\P%R
M                                        !#5WE'RK:9^'%)GNTAV/
MMOR:_%'8X_W)Y]KPU=M*.=_^+O\ W-?K#H;>MHKG=>E'079HOI:77C4#VE(\
MVSGGU^*>UZ)D_)IW+N#&9(
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M*<<495,S\14+8 N81$6X
M
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M]^(9U46\C-+ID7J@.]8_E.-97&>FXQD5LR.&PYV3TJURV9;:%E]2I3*E$1^
MS ?? #W;-_0 Z)DFIVG6'2'8>5Y[C^.36&B>=@W&XQH[Z6SVDLVG'$KH?0=
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MH1-I0XKB/P%M <H]5=,43CMBM2,7*Y)>]&5!.[P^V)ZO#V9M]KQ<7%LIOKL
M=_(S.O5T&0#:>>;8;=>?<2RRRDW'7EF24(0DJFI2CH1$1%4S =)MFJ&FUZGQ
M;79]0\:NMSFK-N';H=UB/ONJ+;PMMMNJ4HZ$>PB =\
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M-3-"BW;S(^@S'*YG+W,M7PW(PEU%C,47J>*B<87.3NWU\(LPO*@
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MT*(CH9&0#L0
M
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M>9;'N5C1V\ZB75")]^DN%;<'Q]7%_#KHZDS0A7"520VDC6LZEY)4K4R >;O
M=,N:_O*]2KY?[AD*I]OMCB/?K);JXMJQVA*R6;,:-';XBXN$U<*4)K2IJ/I
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M!S%OZD7"W*DV#2& <UJ83B4);NTU*V8A*0?E*\@G5%381D!B]3
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M,N-A]!+0JAD6\C(<!<MS;JFB=<.\MW8N4Q7&J7VN(NL6\=."M42
M                                  H>XP$6?>+G_G'2/[E=/69&GYOJ
MAZ1_^>ZK^ZGYL#-.=NHNGQ_]Y+9[I0-5:\REW?,/37/#+T?EO,=9M?/BHD
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M#UJL!T=MEC^JV)VI?D$>]9U)/U-=AD$IA(.M3WUV@-P
M
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MIQUPS-IN/HV#41&EMVL2
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M,JO?[#(?LUCA?<GK)W0Z_D/I:=\HK$^87C/UQH6Y37<E'R XY]^SO;0&60
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MC3M,R.AF5 %2*E.GP@*@
M
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M9& RP/P%4!Y"^]#^>AJC]RMON)H!ZH]$C/\ F9TC(J;<+L7^CV 'F,YZ-?\
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ME%R)+A[5N+IM,_$6PB(!=(
M
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M-(CWC+Y!R6H[+79,LQ4%V<=EK87$EMM))XCJ:MY@/:5HE4M&=(SZ"PRP]/\
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MQI3ZG[K<U42ZA]=2)QE#9F=3KY0#TT
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M6R#'MT&.1ICPHK2&6D$HS49)0@B253.NP@'+(B+<5 %0
M
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MNS=&3T@Y5<+?GQGHF1ZCFO*[XTZXEQ))F;(79\&PDJBI;53K,P$A1;B
M                              !@CWB/R!0_C;:?6>&ZY!ZN-TM-S[TL
M[X[6./=UGLUJ\'O'_AQN.>]ZC?+4\CU5=22DZ5ZR&B;P\) *%4!7;TGZ@"GJ
M *T/QT 4/P] &V$8_>$?A33/[UF>V&-_R354T7.=<,E.[P^0ZX?&"7]B@:?W
M#ZB-S9\@]/.]GN71XAHV]5
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M'Q&TTZELMVXDC0MRO=!@Q+;$CP($9J%"B()N+$803;;:$[DI2G81 .6
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MNWJA_B[!>4FW6R([Y1M.$FA/N[3J9^2GHJ>T@DX
M
M
M                                          !I7YI^'J 0D\\'>6:K
M<N.MV4Z/X1B&.SF+1 M4N'?KF3[SA*G1$2'"4TA:$G0UD2=H"-[0+237'O#N
M9"/G^HBI=SQM$^/-U#S9UE,>&Q;XJ_)@0B-!MJ49)[-#:2.A;5&1;0'K+MEO
M@VFW0;5;(C4"W6UAN+ A,))#;++*20VA"2H1$E)$1$0#G
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M:;:OF3H:+TETD$9&:3,O(-9'Y9IVJZ0%T4E0B+JZ@%0
M
M
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MVZ'W'XP2_L4#3^X?41N;/D'IYWL]RZ/$-&WJH
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M3BY3A*J[&BH<KZ4;J:I7Q>21>=T /3PRE24I2I7&I*2)2Z4XCZ3IX0&^
M
M
M                           #29T/U &*_,#SFZ!<M/91-2\Q;1D4II3L
M+$K6@YMR622J1N,M5[%*MA$IPR(P$?R^^VT52LR1H]FJVR49=IVUN*J:[#(C
M>Z>H!?31GO7>6'56XLV6_3+EI1=Y;YLP49*A'HCA<)F2E3(ZELMUI3RS+: D
MOB2F)L=F7%>1)BR6T.Q932B6VZVM)*0M"TF9*2HCJ1D L-S+<QN$\KVF4[4S
M.&)5QB-268-JL=OX#ES93Y^2VWVBDI(B(C-2CV$0"UO*/SPZ:\WK661\0LMV
MQ6_X<;+ETL%W)I:U19/DM2&W6%*09&LE)-->(J>$!FF
M (:^\WYR]=>6#.],K#I+>;7;+;E%AF3[LW/MK$Y:I#4GLD*2IXCX2)/07J@)
M#N5+4+*=5^7O2S4/-9#$K*,ILK<R]2(K*8[*WC4I)FAI.Q)4+<0#(8
M                                      !@AWB/R!P_C;:?6>&ZY!ZN
M-TM-S[TL[X[6.7=U_P#YJ_Z#_P .-OSWO4=;4\CU5]22JFVG2-&WBG1NVET
M&TO& ;Z>#< >"FP V;N@!0]A&9=0&V$8_>$%_G/33[UF>V&-_P DU5-%SG7#
M)3N[_D.N'AR"7]B@:CW#ZB-T-GR#T\[V>_3Z@T+>JB0
M                         &UL[115(C,B\?T -!1-#.I&?29"!7A2DB*G
MD_2$3,D0)21+,R3392HJ,=C<  %#W'3?T *4J5%;>L!MFRV1FJF\CV&(P&X5
M.'R3*O@ZPB8%2K3;OZ1(VG741VG'7G4M--)-3CSADE*4EO,S.A$1 ,!-<^\
MTSTV.;8L"2C4S+F34T91'*6N,Z6RCTI.QSA,C)26]OA 11ZL<TVMNMDJ1 R'
M*)$.SSUF4?!["2V(G :B43:VV^)Q^AIV*6=0'<]+^1K7W4=#$]W&F\ L\I7"
MJZY'Q,/&FG$EPHFQYQ"JE11 ,X,$[L?!K>BW2M1<\N>2S$)([K9[8A,."I==
MS3AD;U#ZS.H#)!KD^Y=L&PS(&K5II;;D_&@39,:?=R.X24.$RLTFEQ_B,J'M
M+J%=N(FJ,=6*BYCPSAT(!.S2BW/&2$I,VG*G3QCU^UE;=JJ**:*9U/,KF8O5
M6ZIJJU2]*VBEOMSVD>F[CEOC+6K';>:EFRBIGV"=M:;1Y-G?/K\4]KT?)3C9
MIG''0N/+Q^PSF'(LVRP)<9XN%UAZ.TM"B\)&DR&,R7FYUKLUH@ZPZGP8-MCQ
M(,3))S,2*R@D(;;2HJ)21;B(>DY'EF5NY2W5-.F8B9W_ )N"SW,+]J_7&SBE
MF)H!R3:6ZY:)V3+9USO.,91)N,]F;=;>ZEU#K;#QH;3V#Q*0BB=E2WCB^=6:
M+.9JIIIP==RR]-VQQ3M=-U"[M75>P^FR,#R*TYY;DNJ*);9%8,[T<BKQ.FX9
MLJ7LIPHWC5,]ATQ*UGY>,G(B5DFE&1-]FX;+O;0VWFR41H)9*+LW&U&7F])
M)!=&>\MNL0XMGURQ\IT=/ @\TL;)(>VU-2Y,(O)/H(B:/PF E8PG/\/U&LL?
M(<(R2#DMGD'_ !R$ZES@5TMN)+:A9'L-*B(R =T  &E2$J.IIJ9;C$28*<"3
MWI")D:Q(    I0M] &P;:#<)7"=:5-709B4:!&QVE*529^'?TAL3C.IR!
M   /G3KI;K:N&B?<8L!=P>3&@-R74-*??5YK;1+,C6H^A)5,!] MQ ,0]>^3
M+1SF)S3"\VSN)(:N6+.&BY-P5$R5YAIKV<28JG$:$JH=2VTV5W4#*.Q6&RXU
M:+;C^/VJ-9K':64QK9:8;26F&&FRHE*$)(B*A /LT(CJ1;0%0
M
M
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MUF>V&.@Y)JJ:+G.N&27=WG_X'7#XP2_L4#4>X?4=39^W_3];/@NCQ#1-ZJ
M                                         "E"WTV]8"M"Z@
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M-4G]+,-5K1$AP]24V]M.2M05DZV;I%0E*41$GC41561;"/< NS0NKP@*@
M
M
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M*OUR5$8#SI]]Y\J6A_Q5N'NX@$P7(9\T70SXN,_9* 9=@
M                             ,$>\1^0*'\;;3ZSPW7(/5QNEIN?>EG?
M':QQ[NS=K7M_Y#_PXV_/.]1OEJ>1ZJNI)1ZHT;>*[3V'Z@!](N@ I]/94 $!
MXMXD4/<>P-AMA&/WA!?YSTT^])F[[H8W_)-56]HN<ZX9)]WA\AUP^,$OUD#3
M^X?41N;/D'IYWL^"Z/$-&WJH
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MM9/JA<6"+(,ZE-D;B367EL0DGM::+=L/B5TG3809G)*B2+J]4!4
M
M
M                          ''DL(DM.L.MH>8?;4V^PXDEH<2HJ&E23V&
M1D=#(!!7S<]T6C)[Y<\_Y:)T&R2;M()^Y:77$R8@H6JINN0))5[(C/:32DF5
M3\E22V (N(DCG@Y+[PXPPWG&F3<1EUY452'9-F-AQ1H4]P>S1**4BO%L,!G;
MH+WS&;VAZW6/7W"XF66A*&8[N7V CB7--*DY(?CJ-3+YF5/)038">G2C5[3G
M6K$(.=Z9Y/%RG'K@5/28ZO9&'2\YF0TJBFG$'4C2HO%4MH#!'O=3KR9Y ?\
MWHL/NA0)8J]R%^3NN?PC;?:E@AVWOK,_O-ITNTIT\A*2W:<NODFZ7D]O&L[8
MR26$%0R+AK(4:B.M3(NH!]?N;]$;'8-(\EUMF6U9Y=F]S<M%OF/I09,6N"23
M_@RJ<:>W<69KV[>!("9OA756PB-734^K> \P/?&Z;XEA7,%B62XY;&[7<M1\
M<7=<J0PE*&7IK,E;';DA)%Y;B2JM1U-1[3 3P<DWS3M!/BE#_P#6 >;+O/&^
MUYU]3VN+A[4K2CBWTXH3)5H ].O+%IIA>E.ANG&,8+8X]BM+EB@W&6VRGV23
M-F,(>D27W#\IQQQ2MZC,R*B=Q$1!]CF%QJVY?H7K!CUXAQY\"Y8;>DJCR6TN
MMI=1"=<9=X5$9<3;B4K2=-AD1@/,/W5TF9;N=G3^"Q*<;9E0[[&G-H4:4/(;
MMTA9$M)'M(EH)1$?20#U):N::6K6+37,M+\@GS;79,VMKMKNLVW*0B2AAXJ+
M[-3B5IJ9;-J3 8>\O'(3R]<GF4W/5>W9/<I=T*WG;8U]RR9$9C6YIXZ/*:6E
MMA!*=+R3-1GLW;P&4=QYAM!K0EI<_67#&2<,R3P7N$[]$FW5?3 EYN>]EONF
M>6<P>.9?IOD5FR5N^8M'1D$ZRN-/(.1'=6A"GG&JU<-LR+;MH1$ GRY"94J=
MR><O\J9)=ER5XNT3DAY9N+427G4E52C,SH1$1 (?^^\^5+0_XJW#W<0"8+D,
M^:+H9\7&?LE ,NP                                            &
M"/>(_(%#^-MI]9X;KD'JXW2TW/O2SOCM8X]W9NUI_P"@_P##C;\\TU4[Y:KD
MNB*NI)3XOHC1MV=%0@4 -I$ KX^C< %O(!0S+Z0$:X1C]X/^$]-.C^"S/;#&
M^Y)JJ:/G.N&2G=X?(=</C!+^Q0-1[A]1&YL^0>GG>SW+H\0T;>*@
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M:VO6HFL>E,RRY]9KE*/ 5,P+)J+)(^QO$4TF2&^T5M<=9H9*452,J5V[PDF
M
M
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M69[88W_)-531\YV,E.[O^0^X?&"7]BD:CW#ZB-S9<@]/.^6>Y='B&B;U4
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M,%$U_P!,HEZD);AYECZD6W,[4E1&:)"4^1)06P^S?(N)/AXBZ &4
M   L[KOI':M=-+LNTPO%QE6B+DD7LV;I"<6T['D(\IIRJ#2:DDHBJGI(!#=R
M\]U=E\W,;E+Y@G6+7@V,7!4:UV"VOH<?R%ME5">6MLZ,1W"(O)/RS+90N@)V
M<?QVQ8I9[=CV-6F+8[':&$QK;:H;:6F&6D%0DI0DB+Q]>\]H#[0
M
M
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M.!?0N/[@ _-'<QG](6!?0N/[@ _-'<QG](.!?0N/[@ _-'\Q?](6!>'9<?W
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MV,E.[PV:'7#XP2_L4#4>X?41N;/D'IYWL]RZ/$-$WJH
M                                   "+/O&]>7+!C]OT.QV:;=WRQE,
M_-76ZDIFV(55E@CV&1ON)J9EMHFFY0"R/=W\OS68Y1+UFRFW)=QO"WO1L.B.
MI/LI%V*AK?(O-4F*5.&NY9D9=(";=!4(^LSV@-8      X%S_!\[[W=^P,31
MWZ=ZFYW9W((M%?P?F7P^]ZP]+SNJC<X/*?O;UZVOMC?W1/KC"JV,N=2XW=Y5
M_&/F)K_RO:Z?M90UONK58\-7;#+]N=Z]OCL<_O!_XUHE\8%>N@1[4UW?"K]P
M_N;UJ5><8V>Q@RLOK<9_B_COPY$]L0-AD?V]C#SLZM\=J=>T_@VV?>C/V"1Y
MA7WNMWMONQN?2+<"I4   %#(CWE4!BGS>:!Q-==+9\.!%:1G.,$NZ89<S15W
MMFR-3L7B(C5P2$EPT+>KA 0L<KVLURT!UAM=VN9OP\>N;_O%G]L47";;*G"0
M;BTJH1*C.)XE&>TB)1%O >DR+*CS8\:9$>3)BRVD/1I"#XD+;<22DJ29;R,C
MJ0#D     **W& QPYC.9_33EJQ7W\SBX^D7JX)4G&</AK2=PN+I%L)"#\Q%=
MAN*V$ P+Y.^\9O\ J_J_=].M7(4*RHS:2IS2]=N:\B&LCH5ND+)/$LU),C)U
M?U6S=M()@4IJ7E;3Z3 :N%.^A *@
M
M
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M.M&]!F5%?0 3,8599&-8CBV-RGD29./V>#;I$ELC)MU<6.AI2T$>TB,TF95
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M[NCAUATR=IYV,N%7Q27 &<?=5/=KRLDC_P"&R^[,T_8M13_3 23@
M                 # _O$B_\ H?17+;21_0>&Z]OSAFHW2TO/HQRL[X[6.7
M=U__ )I\!V.OT'QN.>]ZCK:GDL:*^I)41[3H-"WI7Z'3TB0ZOI] !2N_876
M4\=>K],0*^ RV] "A[MGJ"2-<(Q^\(_">FGWK,]L,;_DFJIH^<ZX9)]WC\AU
MP^,$O[% T_N'U$;FSY!Z>=[/<NCQ#1MXJ
M                        #Y5\O,''K-=K]<G#;MUEAOSIRTE51-1VU.+H
M6RIT2=" >8K,<@RCF%UGGW>/Q3;_ *BWY$2R()"N%EA2R9C>0530AMHDFHO&
M8#TDZ6:>V72K <7P&P,)9@8[!:CFLCJIUXB(WG5J,B-1K69G4P%P0
M<&Y_@^=][N_8&)H[].]37W9W((=%?P?F7P^]ZP]+SNJC<X3*?O;UZVOMC7@<
M3ZXPZMC)G4N/W>?Y2<Q!?\[VO[&4-9[JU6/#5VPS/;G>O;X['.[PC^-:(_&!
M7KH$>U-=WPKGN']S>M2KSNH;/8P)UK,:W?D_CO@OD7VQ(S\C^WL8N<V;_FG7
MM/X,MGWHS[6D>8U][K=W;[L;GT4[B"52H    #0JM2I6G@ 0#=X#HRSISJ^6
M5VF,36-ZHM.W!4="2)MJXL4*6VE*2(D)6E25[=IJ4H2)%.0/5U_4O15BPW65
MZ5D>FDA%FGK-2UN+AK2:X+KBU;U*22DT+<22$#.@   %.).W:6S> VI"5K8>
M0T[V#BT&EM\B)1H,RH2J*V'3?0P'F6U^Y5>:'*^::ZX5=F;GJ7D.5+.?CV?R
MB--O.S\=$K<=IV<=,>O I!;MG60"93E/Y*-.^6FTLW533>7:H3V2]^\VDM$9
MLFHJJCP4*KV32:TKYRBVF S905$EO]4!J
M
M
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M'7'XP2_60-1[A]1&YL^0>GG>SX+H\0T3>J@
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M4U      ##WGDTT<U(Y?<K] B'+OF&+1D=G;29),SAI/MR-1_4DRI:C+IX2
M1B=WCJ(K%=>HV/+DK*SZCVU^ MHWNR8*5&2<EEY23/A4LR0;9=/E; $_A'4
M,R+> V)$N-$:?D2GVX\>*VIV5(=42&VFT$:E+6I1D22(BJ9F C3OO>;Z-0-=
M;)IE:F%7?!'7W+=DFJ*%D46/<%&264L)_MC*5>2XYX=FPO*"2UF0Q*89DQGD
M2(\E"78\AM1*0XA952I*BJ1D9'4C(!N$DZ^#J :B(R+: J
M
M
M                                       HHC,J$ L'JYRP:$ZZM._S
MHZ:V?))SS:&E7OLSC7$D-F:D)*8P;;U",SH7$ Q_@]V'R56^;%G-:0D\[$63
MK;4B[W-YI2D[2);:Y)I47@,@&:&(81B>G]F8QS!\9MF*8_&4:F;3:H[<5DE+
M\Y9H;21&H^DSVF [:5:%7?T@                               @0[X%
MKAU T<?(OMEGG(/^Q=,_TP&6G=+_ #7[Q\?[U[G@@).P
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MFEJ/'03339&9F=$H21;3 ?2
M
M
M                                                        00=\
M,BF6Z(.T\ZWW-/T%E^J RD[ICYK]XK_K_>O<\$!)V
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M#*'VDR&#JVZ25D9<23/88#[R&6T)2A""2A!$E""V$DDE0B(BV$1%U -T
M
M
M
M                              05=\4BE_T)<^NCW=)'XNS/],!DUW2_
MS7[Q\?[U[G@@).P                         !@AWB/R!0_C;:?6>&ZY!
MZN-TM-S[TL[X[6.7=V;M:O\ H/\ PXV_/.]1OEJ>2:JMT)*?T;QHF\4_1O$B
MI *'LV;@&K;TUH(%#W;A(TGN/U@3&N$9'>$?A/33[UF>V&-_R354T7.=<,E.
M[P^0ZX?#\O[% U'N'U$;FRY!Z>=[/<NCQ#1-ZJ
M                             #RUZQ//7+6[4TWUJ<<DYG<6#6KZTIBF
MTEZA; 'IMPE@H^&XBQ0O8++ ;(_V,=LOT@'9P        '!N?X/G?>[OV!B:
M._3O4U]V=R"'17\'YG\8'O6'I6=U4;G!Y3][>O6U]L:^Z)]<8E6QE5:EQ^[S
M_*/F)^%[7]C*&L]U:K'AJ[89GMOO7M\=CG=X/_&]$?C ?KH$>U==WPJ_</[F
M]:E7G&-G.I@SL67UM_ &._#L7VQ S\C^WL8F;V;X[4Z]I_!MM^]&?L"'F5>O
MK=Y;[L;GTQ"H       !YZ^\ZN+]DY@GYZ(_I!R,7M3;1_4(,E/U-SP=0"/O
M3[ -5>8K.;3AF(09V7Y$F,F*RMY2O1+5;VSH1O.'Y##*:[ME?"8#T]<I'+[*
MY;-(;9IU.S&;F,]MY<R>^\HRAQ7GB(W(]O:/:AE)[B,ZF>W9N 9/
M
M
M
M                             (-N^-12?H"Y3SO?U%?V*(Y_I@,CNZ7^
M:_>/C_>O<\$!)V                          ,$.\1^0.'\;;3ZSPW7(/
M5QNEIN?>EG?':QQ[NS=K5_T'_AQM^>]ZGK:GD>JK="2H^OKZ!HV\4 *5\0D*
M;.H0*[NC< 5J6TO5 4,@-L(Q^\'_  EII]ZS/;#&_P"2:JFCYSL9*=WA\A]P
M^,$O[%(U'N'U$;FRY!Z>=[/<NCQ#1-ZJ
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M>%W.QV2- NF7L+N5]NJ4$<F8M3BDMFZ[YQDA)42G<1 ,V@
M
M
M
M                       !!_WQZ.$^7ES=QRLB17Q,Q#_3 9#=TQ\U^\?'
M^]>YX("3H                          8(=XC\@</XVVGUGANN0>KC=+3
M<^]+.^.UCEW=>[6O_H/_  XV_/>]1UM3R/55U)*?T;1HV\/'O,0'JB0$!MIO
M -_B$BBMI'T@1KA&/WA'X3TS^]9GMAC?\DU5-'SG7#)3N\-NA]Q^,$O[% T_
MN'U$;FRY!Z>=[/<NCQ#1MZJ
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M?A,W0$V/*Y:9=BY>M(+5.BKARXN-Q.WC.%125+(W*&7AXJ@+^
M
M
M
M                           "$7OD?M7+K]^Y'[1# 7[[I95>6.^(Z4Y_
M>3^C'A?J )/P                         !@AWB/R!0_C;:?6>&ZY!ZN-
MTM+S[TL[X[6./=V;M:O^@_\ #C;\][U'6U7)-574DJ+J^@-&WAT^N8"GZ>\
M 5*OT.D!3KZ %#Z3\ &V$9'>$?A333[UF>V&-_R355O:+G.N&2G=X;-#KA\8
M)?V*!J/</J(W-GR#T\[V>Y='B&B;U4
M                     $'?>9XA,MFK6'YF;#35IRFPG;VGR,N-R9;W5J>X
MTEN(FG6]H#-SN\<Q_&?ERLUH<-I$C!;G-L9,(,N/L$J*0VXM-:EQF\JAGOH
MSH         <&Y?@^=][O?8*$T=^G>IK[L[D$.BO\0S+X?>]8>E9W51N<'E/
MWMZ];7VQK]FGUQB5;&5.I<;N\_RDYB2_YWM?V,H:WW5JL>&KMAE^W.]>WQV.
M?W@_\:T1^,"O70*?:FN[X?VKON']S>M2KSS&SG4P)UK+ZV_D_COPY$]L2,_(
M_M[&)G/G':G8M/X-MGWHS]@D>8U][K=Y;[L;GT@5       XDV=%MT.9<)SR
M8L* RY(F25^:VTTDUK6H^HB(S >7/(9UPUFUIG29DIOWPU&S!,9,YLN%L_2I
M:6&EI+H+A))@/4-:87O;;;=;B<[4H$5F-QTIQ=BA**^K0!]$
M
M
M
M                          0B=\C]JY=OOW(_:(8"^?=)+KRW9(CZS.KH
M?[:/%_4 2D                          #!#O$?D"A_&VT^L\-UR#U<;I
M:7GWI9WQVL<N[KW:U?\ 0?\ AQM^>]ZC?+5<CU5=22C8-&WBIF53]<0*4+HZ
M!.(K3]!AB%/_ $AB%/\ TAB*'M VPC'[PC\)Z9_>LSVPQO\ DFJIH^<ZX9*=
MW@?_ ('7#XP2_L4#3^X?41N;+D'IYWL]RZ/$-&WJH
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MJ$ J
M
M
M                                          (1.^1^U<NOW[D?M$,!
M>KNCU5Y>,M1];F\\S]6/'_4 2H@                         #!#O$OD"
MAT_UMM/K/#=<@]5&Z6EY]Z6=\=K'+NZ]VM?_ $'_ (<;CGFNC?/8U/(]574D
MI\ T3>GZ*" W] !X?H4$B@#5](!H/UB VPC)[PC\)Z:=/\%F>V&-_P DU5-'
MSG8R3[N_;H=</A^7]BD:CW#ZB-S9<@]/.]GN71XAHF]5
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M1A66W*/V%]U0EINCI55Q% 8)3<)*T*(N%?E+-5-AD9 ,^P
M
M
M
M                      %*D6\Z *@(1.^1^T\NQE_\9D>W_@(8"\7=&+,]
M \U1];F<H_VS#/Z@"5FI                          #!'O$:'H%#K_K;
M:?6>&ZY!ZJ-TM-SWTL[X[6./=V4X=:?'8_\ #C<<\UT;Y[&HY'JJW0DIVC1-
MZ>, /_TT #V^K2I"!786P2*&1^H TGNZP-L(R.\(_">FGWK,]L,;_DFJK>T7
M.=<,E.[P^0ZX?&"7]B@:?W#ZCJ;3D'IYWL]BZ/$-&WC4
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M#F@
M
M
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MQ:+?86.66+D]U1>\B8ALIO=V;81&0_*)!=JM++9FE!&JM"(P'WP
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M +9)C1\^KBK,U1&QNN143&6B9VLYB*@T\-RJ
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M+D
M
M
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MY-?3+O,O9^S;BB-COPLKP
M              H9$HC(]I'O 6#YB- <8Y@<$?Q:]*]!O$)2IF)9 DJK@SN
MR2HR+SFU[G$])>$B,!Y^B_G6Y7M7")QMW&,^PN3M+:<>;$4=*I/<['D(W'Z@
M(3Z\NW,AAO,%B;=TL[S=KRJVH0G*L1=61OPW3^K06];2Z&:5%XC!+(T    !
ML*2EY+B'$\2#XD*3T&D]AB)C3$]"-<3$HG,ZY8]8=+\PR:Z:4V.-GN 9+,7<
MFK$EY+4Z"XZHZM)0I1<9(Z%5W#MLISRUFK<1>JX:HC6Y/,\JO9>YC:CBIG9M
M=6:PKF:G.(B6_0R5;Y;Y\,>?/DLIC,J/S5N&2]A$>T9DYO(\/%-Z)F/QT,6;
M&=F8I^S.'5^UF]RHZ 7/1''<DEY/<FKAF^=RFYN2IBGQ1HQM$OLF6SZ33VBJ
MJ+8?5L'*<WYG_>UTQ'=HB8CK='ROEL9.*IU35.,OJ<S^A4C6_"H4*QW)%HS#
M%)B;GB\UXJLN/I29&PZ>]*5U+RBW'2HCE',IR-V:L-$QA*OF62_NJ-&N&"*]
M/.:"UJ]!N6C1WB7'(DKN5NEM+CO4*G$E2EEXS'4TY_)S&/W,,=G1^CFO[;.4
MZ/M8_C>^WC7*]K7JUD%@_G,LD?3O +-,1-F1"?2]<93C1DHD)0DU$FM/./9X
M#%C,\\LV*)BW5Q53&ADY?E=Z[7$UT13&.E+6TV2$-H0DD-MD24)ZB(J$7J#A
MIKFK3.UUN$1A'0Y!4J=-_2)Q%1(H>PC/J ?$R#(K)B]EN>0Y'<XUGL5H85)N
M5TE+)#3+2"J9J,]_@(MI[BV@//[S<\U]QU]OA6*P/2+3I1C[ZG+3 5Q-.W-Y
M.STN8DCV_P"](^I+H,P&7_(ARE3+$Y;M<=2[7Z+=WVNUT]QJ2@NTBLNIV7"0
MA1>0XLC]B+>DO*Z2 2O%N*@"H
M
M
M
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M8AMG4T),_.4?E*\6P<AS#F5>:G_*Z[(<OIRU,?Q,LT["IM]4:W#!L6H
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M-MH_V2MY$ EZ21&6X!K
M
M
M
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M<E"2/Z)$(XIZ3ACH<BA&(5!$1;@%0
M                            66UGT'T]UUL)V'.;1VKT9*SLF01C[.?
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MHV9ZDN1,UU!22%V^*3?%;;2JE3-E*Z]JZ1_VQ1;.@J[0$A!%0SZ?" U
M
M
M
M                                       L+S*Z,6W7S1G-=-IS39SK
MG#7(QB6O9Z+=HZ%+B/$HR\GR_(-7UJC .6C1>!H%HQA6FT5#2KA;(:9&3SFR
M+^%760E*I3RE%YWE>02NE*2 7Z
M
M       <&9 BW&*_!N$1B="E(-N5"D(2ZRZ@]Z5MK(TJ(_"0".37#NY\'S%V
M5D&DER:T[OSRE..V&0E;ME><5PE5*4\2X_29\!*J9[B(!%9G^BNMN@UU3/RC
M&KMBQQ7:0\NM;BU15\+ADV93(QF1<1I(TH6=>L@%_P#3'O"-<\(2S"R=Z'J9
M:F$+(BNGL,XU'2BE3&B,U$GJ- #./!^\GT4OBVX^9VJ]8$^4?C?N#[)2X2GJ
ME5MM;!J<.O09H 94XWS+:"Y5!C3[5JQC2&Y9DEF/-GLPI'$9T(C8DJ;77U %
MYH=P@7!E$BWS6)S#I<3;\=Q#J%$?22DF9&0#E@-*EH0DU+42$EO4HR(OHF Z
M#?M5],,6D^A9)J'C=BF\)J*'.ND5AVA?K''"5](!C1FG/WRX8DS<$0<HD9C=
M(*R0BTV6*XXIXS50S;>=)MDR(BK7C 8;ZB]YKE%P;F1-+<&C8^VI:#BWZ^J]
M*D)21^62HB*-[2IMXSIX0&">19OK3S!Y&VQ=[ID&I%ZD<28=@AI<?9:;4OCX
M41F?(2A*CWF1T\ #-+1GNWLZR7T>[ZQ7=O!K22R/\5[>I,JYNH09&9..E["T
M2R,R(R4I1=*0$M>F>D&GVD%B9Q[3_&HMBAHVR9:$DJ7)4=#4N0^?EN*,RJ=3
MIU$ N<
M
M
M
M
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MM49G3I,!W;A.A$9[ND!J
M
M
M                                             4(_  K4  :>+:1&
M5#,!J                          &E2J4H53/H 4)7@H?4 U@    *&=*
M^ J@++6KF/T%OE\AXU9M7\2N>07"7Z#"LT:ZQW)+LGBX.Q0VE1F:N+93K 7J
M
M                             4H 4+P_1 *$ TJ;;49*4A*C3N,R(Z -
M9%0!0TD94 4)!%2G0 U
M
M
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M30J%J<W0NC9-70$O9J"
M                                      :%G2A5I781^$!8'.>:;E[T
MPR:9A6H&K5AQ;*[<RR_/LDUU:7VVY*"<:4HB0HB):3(RV[@'4OZ\O*1_3UB_
M]_<_>P#^O+RC_P!/6+_W]S][ /Z\W*/_ $]8O_?W/WL!]?'N<3EBRV^6K&<;
MUJQR[7Z]R$Q;5:V'U]J^\OS4((T$53\8#)8J]("H            ")GF1[TV
MQ\N^L>2Z1S-(+ADLG'CCD5X9NC3"'NW0E=2;4TKAI6FTP$J5MGG<K9;[BELV
MBGQ69*6N(CX>U0E?":BZJ[P$6G,SWHMEY;]:,ET>FZ1W#*96/(@K]^F+FU'0
M]Z;&;D$1-J:4:>'M.':?0 D\P^_EE>)XQE*8JH*<DM4.Z(A+42U,E,80\39J
M*A&:>.E0'8P
M
M
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MJ]8P)>-'E>^?+I5_YG(]V+!+V: @
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ME9?<+("XP
M
M
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MLZDEU*D*;41>=7:>P@'J8=_B[V_[6K?XC"!XTN5[Y\NE?_F<CW:L0E[-!*
M
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M^*5E]PL@+C
M
M
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M_P!P/ /-'W2ZUIYU,(2E1I2NQ9 3B2/8HBM[IE7U0'K1 >0CEZ__ &DF$?\
MFS)]U/ EZ]P0AB[ZOY#=,?C:Y[E4 N3W/7S24_&R[>NV D:U!U$PS2K$KWGF
M?Y%%Q?$\?;[>ZW:7Q<*2/R4I2E!&I:U*,B2E)&I1["(!#GJ9WU."VF\MPM*=
M*[AF-M;6ZW(O%YD>]W:FE?"A4=EM+JC2HMOE\)^ !:EWOM,W-T^PT#M:6_J"
M<N,E2Z>,FRJ",88!<E=[7DW/1I/DBV$Q7,@SERYKBMJ,TM'+==>-LE&1&9)X
MZ;03+V)O_:'ON:O6,"7C1Y7?GRZ5_P#F<CW8L$O9H"
M
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M47[VL'^C8P$O4YH_\DNEWQ2LON%D!<8
M
M
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M-'9DFB232E*;*!")>OI_[0]]S5ZP#QH<KOSY-*O_ #.1[M6"7LT!
M
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MB>IF)W##,C<S6[3F[/<D=F^<9V/"0V[PU.B5*;53Q E!AWFGSU=1OV5M]I0
M]:>*?DMC7P5#]H0 \GG>E?/@U%^]K!_HV,$$O4YH]\DNEWQ2LON%D!<8
M
M
M
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M[4WS(V'C+:1MJH?J /&?RO&1<\FE1UV'J<WM\<U8)>S8$
M
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M!4/VA #R>=Z5\]_47[VL'^C8P02]3FC_ ,DNEWQ2LON%D!<8
M
M
M
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MY9.7C'[_  \IL>BF&6G([=,.X0+Y$LT1J4S*-1K[=#J6R4E?$9GQ$=:@+Y
M
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M$9'0P0[R
M
M
M
M
M                                  --#ZP%:;NHN@!4    !2GA, Z/
M" $5 %0 !2GA "(R 5 4H &1] !3K^@ $5 %0
M
M
M                                                        4-1%
M2O2 H2R/=7Q4 :B,C*I;2,           &GB*M.D XBV;#V@-0
M    TJ422J?T"W@*\1& J
M
M
M
M
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M+U>Y6RTQL^E$>UQ).9E.E73(+E%.9P(B&A"8[32J-D:C<XC4=3V4(ND!?WD
MYA,[YE>7^)J#J+&AHR9F\SK4_/M[!QHTI$92>!Q+55$E1$JBJ;/$ SB(
M
M               %#W& XA3X9&9*F,$95)1&XC89'XP%?3X/_P 8Q_?$_J@-
M]MUMY)J:<0X1=*%$HOI -P
M
M
M
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M29D9& WP
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M29UH F;29[C :Z@ "E2+>= %0"I%O,!2I=8!4MFW?N *EU@*@
M
M
M                                                         ,7>
M<K6F+H+RYZCY\MYE%T*WKM6,L/$LT/7*>DVF&_(VD=#4JO@ 01]T#HRK4'7R
M_P"K%[BM3[;I7"[>,]+2XM:KQ<NT0RZVOS36TE*U*J=?*(!WKOF=%/>'43!]
M;;1;5(MV;0CLN3268I(91<87E,+>>3O<>:,R+B*M$> !+CR!ZUEKGROZ=Y%)
ME'*O^.1_Q9RA?9DR7IEM0A)&E"3\TVE(\KI.H#-)5:'3> @W[U'G?R73J8SR
M[Z37N38LCEPVYFHV2PU&E^/&E)XF(,=VA&A;B/*<4DZ\)DG9M 8G<J/=3YQK
MMB]MU0U>R>5ISB>4,+E6"ULM%(O<MA9$;$QPG^)#3;FTR)?EFFBMQD ^CS3]
MTWF&BN(7/4S1K+IFHEBQ>.4O(+%*93'O++".(WY3'8\+;B&DEQ*27ETJ9$=#
M 9,]U+SKY5GTISERU3NR[Y<+-;53=.,HEND<IV-&-*7+:^I2N)Y2$JXFE;R2
MDR56A .M\PO=,X=C^+ZRZSEJU>7Y=IM]ZRMBS'!C);4ZVAR4EA2RH?"9EPU+
M: BMY,.7&V<TVM$72Z[Y')Q:%(M4VXJNL-I#SO'%1QI3PN>30^D!Z9>37DML
MG)_ S6#9\TGYB692([[RYD9J/V/HZ>$B3V>^M0$.??3$1<P>GITH9X4WMZ?X
MX^ F'Y#;+;,CY&='\>O$9,RT7[$Y5NNL16PG8TIQ]IY!F6WRD*,@'G2Q:;,Y
M+^>QIJ0]&@P=.<X<MUQDK0M;";/,<-MQ9<9$HR3%>V*\%0'L)ARH\Z,Q-B/)
MD1)C2'XKZ3JE;;B24E1> R,C 0\]\MJRUC.AV)Z5PI317746](EW%A#W#(1;
M[:1KXC:+:IMQU1),SV5(!\_N:]%?Q4TBR_6:Y1#9NVI=Q.W6.03O$2K1;3X=
MK9;$F<GM-M:F1$ LEWJW.YF%KS"1RWZ5Y&]CT&S,(<U,O%O6MF6_)DM&I-N[
M4J4:)EQ*EDGSC45=P#IG+?W/]VU+P:UY[K-GTK"OQJ@L7*P8[9&F94MMB27:
M-KF.O$INJT*2HB29GM\H!:_G*[L&^\MF&2=6M.<T?S7![ IC\8F+@A$:Z0NT
M5P>DI[$DMK;)9I*B?**M=Q5 9Z]TKS6YGJWCN6:,:B7.7D5[T]B-7+&,FE*)
M;J[4ZLF?17W.(U+4RNG 9EYATJ= %QN9KNO<8YE=8\DU=NNJ-TQJ7D,>$PJS
MQ8;#K;?H49N.1DM>WRB14!YZ=-]#K=G7,_8N7^1?7X=MN^8/8PK(66TF\AMM
MUQM+I-J\DU>052 >CGE([M[&^5#5.5J=:-2+EE<B38Y5E.V3(C+*"3*<9<-S
MB;VU+L:4\(#"_OP"+M-!#Z>&\E7U8X#,/NAB+^IM9=G_ &KOM?[Z@!WWO!^;
MI?*MI.EW%GV'M4\Y<7;\,CODEQ$1)%[/<'&MM2:3YA&7"I>P]P"!7EJY0M=.
M?3*L@SS(,LDQL;BRDIR34S(%.RG9<I1D:HL-!G5Q9(J9F7D(V$>^@#//4SN3
MX,7&WI&DFKDVY93');B+9DT9EF-(2E!J)I#L9)&A:E$1$:_)+IH PSY5.;+5
M[D;UBF:3ZJ(N/\W\>[IM>H>"3E&XY:G",D>G05*,R2:4F2S)*N%U%/UID'JW
MMEQAW:VV^ZV]\I$"Z1VI<&052)QE]!.-J(CV[4J(P'C$YU9#D+G(Y@ID<R0]
M$S^Y/LJ,JD2T2.(C,O&0#/71OD!U_P"=Z6US!<QVH<S&+1FJSDV]+[1.W67"
MX"2R]$BG[#$8\DB0A24U3Y1%0R,PZ7S?]UCD/+[A%[U5T\S-6<X/C33;N00+
MBRF/<XK)^2Y)]C)+2VTJ,BV>5MW ,HNYQYCK]?DYCR]Y=?I-V:LL;W_P!N4:
MG5L1R4EN;%0ZI1F3:5*2M*=Q&:J;P$\I5IM 5
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M(=CJ3VR4-\1&;1J(^$MAT 7L
M
M
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M2 >;#OI-,;3CFK&FVID!U#=PU#M$J#>(+;*&ZN6=3)(D*<30UJ6F023XOK2
M2Y]W5FKN<\H&D$Z5+D3I]E@.V:X2I3IO.K=AO*))FM1FJA(4DB(^@@'F=YRZ
M'SI:\$9$9'J).(R/<?\ "2W@2]E-B:2Q9[2RRVAJ.U"CH8:;22$H2EI)$DDE
ML(BZ"Z %FN::V0+SRYZTVVYQTRX,G$KEV\=952KA9-::D?4:2,!YX.YQI_6O
MG[-V%77VV, ]38
M                     ./+_BLG[DO[$P'BYT.EQ('.=@4V?*9@PHNI[;LJ
M9(6EIIM";BHS4M:C(DD729F ]A/\\&DQ5KJ?B14.GX:@_OP"Q&LW/'RT:*6>
M;<,BU,M5YNS41<BV8O8GDW";.4G8EIHV.)I!F9[W%I(@'F">_'[GRYM')$6T
M$S>]5+^EV1#C$9,VRTM&23-;E#V,1T$1K47E*\8#V*6&T6["\4LUB3*)NTXG
M:(T!,V29(),: PEHG'%'0BHE%3/<0#R5ZW9WJ)W@7-[%QZPI>3$N]Y+',!LR
MUFMFUVIIXTNRG$I,TU)"5/.J215(O  ]$&B'(#RT:,8O'LT?3RVYG>WF&T7[
M*<C91/D2WD$?$M*'2-MHJF="0E.S?4]H"+_O-N073W3;"5Z]Z*6,\9BVZ:EK
M/L3CK<=B&W+<HB9';5QFUPK49.%Q</#2A$ R6[H/7^YZD:/7_2/)9\JYWS29
M]L[-,?2:J6:::C89[<U*-9M.$M)$9%1'"6X@&.G?'\Q]Y;N^,\MV.SG8-G*&
MWD&?+CN)X9JW5J3#B.$GRB2UV9N*29T4:DGT +J=WYW;VF;>FN*ZR:YXPK*<
MUR=*;K8,5N*E)@6V'Q$J,IV,DD]HZX1<1DLU(X3+R:@,T]?^[ZY<]<,1G6=C
M!;9@65M1'48SE]@83"<AOJ/C0;K+1);>;-1$2B4FO#7A,CV@("^3//<VY2.=
M.)IU=KG'BPY62NX'J/"6_P ,!Q/I!L=N:BJ7$TXDE(/KV'L >D#F_P!>V^6_
M0'.=3VDH=O<)A-OQ)AQ*EMN76;5N*2^$CHE)U6==FRA[P'G'Y(>6.\\\^M^7
MY;JGD4N7B]A?1>]1[MVO\/NDR6X?8PVE*2?"2R0HU*IY"4DDBVD ]&/]2SE:
M_$W\0?YD\;+'.Q[#@]'5Z7P\7'7T[B])K7I[2O1N >;3G8Y;KSR.Z_8_=M-[
M[,B8W='$Y)I=?#<3Z=!=B/$;D5Q2:<78+,B)1EY:#+B+> ]/W+EJRWKAHEIQ
MJD33<>5EEG9DW2&VXEPF):2X'T&I)$7GI,Z4V /)5S$8C=<^YU]8<*L9(5=\
MIU1O%MMY.'PH[5^XN(2:CZBK4!Z/]!.[9Y:-&K!:6[OAD74?-F8Q)O667XC?
M2\^LB[4F8IF3+;9'YI&DU4WJ,!BISY=VCI9*TTRG5?0?&58CG.),.7:ZXO;W
M%*@W6$W5<HD,NJ,FG6T561H42:),N$S,@&)O<]\P,_$]6KOH1=KDM6+ZE1W9
MV/PE$I9,WF$V:S-H^*C1.L)7QT3Y1I3U )Y\XY9M!,_O-PR[-=++%DN2S&23
M+O,Q@U/N$VCA3Q&2B+814+8 \B_+9CUBR+FQTCQ:]VIBYX[=M0X%ON5F?35A
MZ*[.)M;*DE]2:3H!+UZX-RXZ&:8Y G*\"TQL>*Y"AAV*U=X+)H>2T]3M$$9J
M,B)5"J A[[XSF9N5N+'N6G%IZHT2Z1&[_J+)C.EQ/(4XM,2 YV:B4DJH-U:5
M;%$:-FP!O]W=W;V!WO K#KIKY8CR6X94E,[",%E&ZS%APT.%V,J8V7 IQQW@
MXDI,^ D&52.NP)'-9>07ECUFQQVRW'3>V8E<F67$6?)\;81;Y<-QPR/CHT26
MW2JDJDXD]FZF\!YM[?<=4N[LYM9$0I3IS<*N:8]U80HVX^08_(42D\:3J7 ^
MU1::D1I50]AD ]>F(Y+9<SQNR9=CDYNY6+)(3%QM,]JO9NL/H):%)XB2=*'T
MD0#QB:UXE>\]YNM5<+QN&J??LGU.O5NM41.PUO/W-U"=IT*A5J>T!Z#-&.Z5
MY:\(Q.)%U.M,C57,)3;:[S=94N1$AM.T\M$)F*IE1(J="[12C/?LW )&].].
M\1TIPRP:>X':BL6'XPPN/9+0EUUXF6UNK>47:/*6XJJUJ/RE'O =W
M
M
M
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MK%\4KI[G6 \Z7<X_.OG_ !*NOML8!ZF@
M                                       <>7_%9/W)?V)@/#C;\%N&
MIVO3FG=JEL0+EFF92+1!FRN+L6G9,U:$K<X2,^$C/;0@$F)]RMKX2C(M2<,4
M1&9$HO3*&1=/VFH"/;F0Y;LXY6=32T[U"1'NBCBQKG;KO;U+1&N,-Y)<9LK6
MGB3PK)39U3L41@/3YR"Z6<N6,:(XAJ#H38F3=S>VLN9'E,PRE7=4HMLF$_(4
MA"D$R[5'"E*2.A*,CV& R'YD9?H.@&M$FBE<.&7E-$;_ "X;B.CQ@/&WR_:Q
MYKH+J;:-3]/[5#N^3V"/*;@L3XRY3*$RFC8<<-MLTG4DK,B.NRH"0S\[ISB%
M0OQ5QG^1)/[\ MYJOWE/-#K%IUE^F.6XI8"QW-("[==5Q;/(;?2VLR5Q-+-Q
M1)41I*AT 9!]RLY<[7K%JU;)4"2Q'NF*QE&MUM:$DIB54O.(BJ9*H Q%[PYM
M=SYY]484EY2VW[W;8A&H_-;4Q'30NHBJ ]9VG\1N!@F%P6OM<.PVUAOJX6XK
M:2H?B(!VTTD9UJ9& MW(T?TFF79^_P S2_$IE_E23FRKX]9("YCLDSXC?6^I
M@UJ69[>(SK7I 1*=]AD5WMFD>D&-PYBF;/DN2SG+U$+S7E08[2X]?V!N*,@$
M3?++SP:X\LF'W?$]+,:L,ZWWBZ*N%QN<ZV.2I*GC;2@FE/-K35*2*I)/=4^L
M!DC^=UYQ/]5L9_D63^_ ,3>9SFKUJYKU8HYJ9C,".[AY24VI^TVUZ.LTRN$W
M$K4I2ZE5!'0!Z .Z35/+D[L+,]+Z5L9->VXZ'R41I:)ULR(B50R*IG0!")>O
M_P!II??_ #MF_P"E' 'KP(J&9]8#A7*W0[O G6NXL%*@7.,[$G1E>:XR^@T.
M(/P*29D \@/)W-;PSGYT\;M\8SB6_.[G;(T5M/FLN>E1B(B+<24F!J>P65_%
M9'W)?V)@/%WRI?/0T2_\SK9_I%($O:495 >0_O!XB,@Y\]1K3*JTS<K[9[>Z
MHMADVMB,SQ%ZAU >L7!K%&QS",.QV(I2HE@L=NMT52CJ9MQ8S;*#,^DZ) =L
MZ* /-3WUF/VBVZU:57Z#":8NN28I(]^9B2HM_P!#D]DSQ'^M0=" 3/<B%X<O
MG*-H7,=)1+:QMF*?$5*E'6MM/^U21 /.1BW_ .TV(O\ ]]UPV_\ 2CP#UW[@
M
M
M
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M[60"TG,G\@.L/Q2NGN=8#SH]SC\Z^X?$JZ^VQ@'J;
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MF9*\I1[A \Q.*_\ [3=/_G=</]*/"1Z[P
M
M
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M+TZTPT^THQR/B>G.(V[#\>B?:K=;VN C.IJJXLS4M9D:CH:U&8#OI$1%0MA
M, L_[MGE:U+S[)=2<GL%\=RC++HN\WEV/=%M-JE.*):U);))\)&95H1@,]8K
M28[+,=NO9LMDVV1]"4%0J^H ^/EF-6G,\:OF)7YE<BRY'!?M]U8;4:%K8?0:
M%DE1;2.A[# 8HZ#\B/+URWYLK4'3&TWB)D;EL=M*GYUQ7+;]'?4A:_8U)3Y1
M\!;:[@&9R3J1'U@*@
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M>[B[NF]Z7W>V:]:Z6M,3,F6./!L"D$2W;4MTC)4V;6I)?X3HA!;45,U441$
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M@C_2 >1[%K=<3[RXI96Z5Z-_/=<#[<V'"13WU>*M>&E/" ]<H
M
M
M
M
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MC[SJ'W\?MCKS5#9>7%94M-.HS14O4 ?49C-1T$TPRVPRD_):;224[3J9T*A
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M*A$74 J
M
M
M
M
M                                      " 6X]W#S%2N<ZZ:ZMIQHL&
ME:ER<I94=R/TOWN=FJD),V>RV+X5>;4!/P2JUV>J U
M
M
M
M
M
M                              T<!;.FG2 U$DB/I 5
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                          !I4HDT,^DZ /@9'E-D
MQ*QW#(\@E' LUJ;[6?,-"W.S09DGBX6R4H]I]!&*9JPE5%,SJ?/PO/<6U"L_
MO]B5Q.Z6GMW(WI9LNL%VK5#6GA>2A6SB+H%<QA&*B)QG!VXUD5=YTWB$K=W'
M5_2ZSSY=JNN?6.VW. X;,Z!)F--NM.%O2M"E5(Q335%6K\8)JB:=?XQ<+^?'
M1[^DO'?\?9_="J-*,#^?'1[^DO'?\?9_= !ZY:.D1F>I>.T+?_#V?W0$Z%S(
MTN/,88E174R(TE"78[Z#(T+0LN)*DF6\C(ZD8B9P(TN0)
M        =8R/,\6Q!AF3E5^A8]%DN&U&DSWD,(<615-*3495.@B9B)P(C&,7
MT+)?[-DMO9NU@N<>\6N3Q>C7&(XEUES@4:5<*TF9'11&1BJ8F)PE$3B^N(2
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MI)F22-:U'0BJ9$(FJ(3$8K?_ ,^.CW])>._X^S^Z$HP/Y\='OZ2\=_Q]G]T
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M*FPZ'TB,=. KQD70>ZNX2.FW[4; L7=]'R+,;/99&TCCRYC+;A&6\C0:JE]
M1$XIP;U@S_",I7V>-Y9:;XZ6]F%+:>7N,_,2HU='4)1B[9QEX?$(Q&H2
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MSI,M2I[J6$*<,C,D$:C*IT(SH&.G C3&+Y>/ZDX#EDYRV8QE]JO]P9:-]Z'
MDMON);(^$UFE!F=*G2HJPG"9V0C&,<'=4J)1&9=!T$)AJ   !US),OQ?#XS,
MW*;]"Q^')=[&/*G/)90MPRKP)4HRJ="K01CIP3@Z=_/CH]N_G+QW_'V?W0G$
MP:DZWZ/J,DIU*QTS/<7I[/[H$.Y67+,8R-OM<?R"W7M%*F<&2T^9$729(49_
M2 ?>)1&1&6XQ$S@-0D<5^;&C,N29+R(T9DJOR'E);;06ZJE*,B(A$R1I6^7K
M+I.W)5$7J+CQ24JX#:]\&*\6ZGG4$DZ%P(T^'-CM3(4EJ9$?*K,IA:7&UEUI
M6DS(_4,!RDGQ%4OIA T=JC;MI2M?$6\PD6_N>K>E]FEG!NN?V&#,(Z*CNSV"
M41]1EQ;/5$1.*<';+3D-CO\ #3<+'=X=X@JI27">0^WMW54@SH)0^N1U]0!4
M    !\+(<FQ_$[?[ZY+>(ECMA.)9.?-=2TT3B_,3Q*,BJJFPA3-41,1TIB,8
MF>ATC^?'1[^DO'?\?9_="I&S%4M<-'SV?SEX[_C[/[H!VRQYKB.3$7XO9-;+
MV9U\B%*:>7L*I^0E1JW> !V0ED>ZM>DNH)T$-1'6N\J'3: J         T+6
M2$FI5:%OH")G!H6^VA/&I5$UI786T]Q%7>9] B*L4X-SB*E:&&(Z,>J&G97[
M\5CS2T%DGI7H/O&<IOTGTFM.Q[.M>.O0%$\>HJT:W>Q(         *&=!$S@
M.K7?.,/L%TMEDO626^UWF\\/O3:Y+Z&Y$CC5P)[-M1D:JJ+A+PB8TS@3HC%V
MA*R5N(RV5H88C4          -*E$DJF V2DM46HU<*6R,W%*H1)(MIF9[B(1
MCJ(TQBWD+)Q*5I\U15(_ )(:@
M
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M/;N(6*8F[7A&J-:].%NG&=<ZGT<2Y(4/6=E_,,N>MUZDM$MVV6MEM;492MO
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MGBJCX2N7HBBU%73BDF@D10XM"I5EL_\ :D+U?>G>LTZH<L4JFFI]!5 5(ZU
M5
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M!<D&9LKH3K#J#X7&74EN6A14/Z);#%5482IIJQAW,4J@
M
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ML_R]LJZ_*ZY[&<>CZW%Z7:=FX7"O\7K?QEXHZ!DWX_J5,>SHHB%RA:70
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MK0O*'<B;NTIN8;2HY,-1W20:%]D1*49\9$FM>H7JJ\<(6J:<)E?,4J@
M
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M'9[]Z->Z&Q9NZZ?%"[:_>\,L9N1C\)ZC?<8'KN#,_P!+K^3'GOQN^:10658
MX\S^*2ON*_L3$5:I33K1"<L_S@,:^^+K[2\*N7^1_)':C-^;_//8F 6GBX=E
M:*J*9&,?,CHA&U,QIZ]V6"A.<X\PIVW.HHE4UE.U<1U5*J,R(^S,]Q[-RC%N
MNG">*-<*Z9QT,3^5O6Z3A5_CX!DLI9XC?9'86U4@Z>]D]:J)317FM.J\E1;D
MJHKK&337]ZCBVK=5/VZL-B4I*B\E.PCW&7A%F8P3CB^=>KU:;!:;A>KS/9MM
MJMC2GKA.D*X6VD)WF?AZ"(MIGL+:)F4X(O=6=;LQUYOC>GVGEMFLXU->[.):
M6?)EW3A_MLLR^UM%3BX#/A(MJSV;*8H^Y/PA555]N-&N676@O+O:=*XC=\O)
M,WO/9;7!(N)%5B"A1>4S%KTGN6NE3W%0M]Z:M&"S%.G%DXFO"52H?20H5M0
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M,7 M.06&^MF[8[U O#2=JG(,AJ0DJ[C,VU*H)PP1B^N5.CI 5
M
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MYIG9."F-,8OIB
M
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MIQ?2:T3K)BBYRH5PE',?]/?](7VAI)'DJX4T*B2V"NJJ:HB.A;IIBG4N6(5
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M:(P?0
M
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M1VTM,,-$24(;01$E"4E0B(B*A$0F=*(C!O@D           ,    ,     #
M  BH H95V& K0            !PIT.-<(LB#+9)^),96Q)9.I$MM9&E23,J'
MM(Z;!371%=,TSJE,3A.,.BZ;Z5X5I=:)%JQ"V'$;G.=K<)CR^UD/J*I)[1S9
M4D$=$D1$1>,S,5\4X1'0IF,9F=LKC$1$1$6XMA"$J@      &    (P 2
M  C !(
M
M                           *$1%N*@"M
M
M                                 %*$(F!42
M                                             *4+J 5H1;M@
M
M
M
M
M
M
M
M
M
M
M
M
I                                                   /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>tm2227887d1-lc_poten4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_poten4c.jpg
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MTB,T5!?B0W.3TR0(8S55@Z.S)<-$&/_:  P# 0 "$0,1 #\ O\
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MYDR&LN.[N[?89;,C7M^5IY:U>'I >X
M
M
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MRZ&1EX&"C^P
M
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MK4J'/B$:4*FP/,-2TI2M1)6TM2E(U3ZZR/4BDQ1.\$
M
M
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M49@F-D,\]VUF<K;?EO1XW:DNN3FD*TQ&XCO>KY<E*?:F4+3^V]IAH;+XU?9
MNW'O-]RCSSE#>44:0;U5ME60\<BDE6K9R>TYDQ1$7@HG9!M*_P#F_B MW+T^
M&^UR=H>-FU>)NQO9K>34-W>1I4GM<^<+?_'7D.?"IGS29U^!! I.])T$
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M"M#4VX9*2?B1&")JDB"    $/.?O]$#>S_1D'^-(8)C>HF]W%_3.V;_Y0_\
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M*BST,R)4&W<*OE$9%XZ-2%*(C])$"T[G78#&
M
M
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MZQ.';9=79E39LU.<H;.(RY$DD=<I@GTR8JU.DW_OE!I-+JR/UO#M!:)JMO\
M=-9QDV2[$Y7C5Y)?GU>"Y*<3&)3ZE*\F+*C-OKAH,^G8TX:ED6O3S-/#M!6Y
M5C[QW^F=O)_R>_Z.U@+6[E^G"(R/B?L89&1E^;31:E\).ND8*3O2H!  Y?\
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MD[:QWG)I.I6PV1N1"97ZZ>O:X9%Z3TZ@F:KOP4
M
M
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M8CN,XIBD1:9+--YZ30[)?D)U;<D*09H239FA"34?<M2B["LW+7P5
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M        ?++FPH#7GSI;,)@U$DGGW$MH[C\"[E&1:] 'U
M
M
M
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MK^58,Z_#G5+K<;*<6G=J9M;(<(U-DX2#-*VW22HVW$GHHB,NBDJ2DK,42&!
M
M
M                                               "D_G]S^]A^>]B
M]B[O_'OND'<+<*"Y_>/%#M=7.H/Y?BEYY)^KU0@^[N4DM$*@]G]X,[V,SNIW
M"V]ME5EW6*['V%ZJBS8JC(W8DMHC(G&G"(M2UU(]%)-*TI41>8=2_&'D]@G)
MW!&\FQEQ-9DE8EMG-,+><)4JLE*(].NA&XPX9&;3I%HHM2,DK2I*3',425!
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MY0UG\+9_=@/Z3DF.K4E"+^N6M9DE"$RF3,S/H1$1* >T
M
M
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M*6?<MQ%<^[!:4M1]34;;"349^)]01.]*$$
M              .3OG"NR@<O-ZWUOO,3V,B;D1)*7#\QM/LT=R.I"TGJGM1V
M]NAZIZ%TT!DC<L>B^Z6QF?LXW/DY[??SX3:@K%2EJC_,A6;C7F^Q+96P3YH[
MS\LW3>)6OW3LT^Y@KQ-3>ZCWXR:MW(LMAK:R>GX=D];+M,8@/*4LJ^SA$3SQ
M1]=>QM]CS#6GP[T),M#-7<3="P;W@W'G<?D;MIA>+[:1H$JVH\F*UGHL)28B
M"CE#D,:I6HCU/O<3T!6V:*E/U6W+#_-&-?EIK]P"_%!^JVY8?YHQK\M-?N .
M*$75;;Y-M%R$Q_;G,FH[&38OE=*Q:M1'B?9);KT9]/8X1$2O4<2('8,)8P
M
M
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MNVU4\<F%A=+$JDS%%VJD.,-D3TA2>NANN=RS(O S!26P@
M                         '.C[U;9NWQ/>^+N[&@+7BFY\"(U)LT)/RVK
MFM83%<CN&6I)-<9EIQ&NG?\ =-"/L48+VRFSBWO3-D&]E(MUD+]FC=^MITQY
M&">PR7BFVK3/9YK<XD^SDPZX7>9K=)Q*3/U5*+J1PH1^ZHVTR#*=_P"RW04V
M\G'=O:B8F;:+(S0_8VS:HS4;O,O64;2W75:'J7:6ORBU)N=&(*   Y?^5_\
M6#Y5^G&-_O%<#)&YU  Q@
M
M
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MM' ?K=M,#I<+C2^WVY59%0T]([->TY#^ANN]NIZ=ZCT] (JV.
M                               ,3S?!</W(QJSP[.\>A91C-NCRY]1.
M;[VU:=4K2?12%I/JE:#)23ZI,C 0/<]UEQ27;JLDU^4LPS=-PJ!%RHXA)/7[
MF2E-*D=I?&]W?&"W%*=. ;=X1M9C$##-O<9A8IC-:1^S5<%':DUJ(B4ZZM1J
M6ZXK0NYQQ2EJ^V,P59F   #E_P"5_P#6#Y5^G&-_O%<#)&YU  Q@
M
M
M
M                                                           .
M7_E?_6#Y5^G&-_O%<#)&YU  Q@
M
M
M
M                                 .7_ )7_ -8/E7Z<8W^\5P,D;G4
M#&
M
M
M
M          Y?^5_]8/E7Z<8W^\5P,D;G4 #&
M
M
M
M                                            Y?\ E?\ U@^5?IQC
M?[Q7 R1N=0 ,8
M
M
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ME_Y7_P!8/E7Z<8W^\5P,D;G4 #&
M
M
M         #0N]&_5!M"U%@JA*O<HL6C?ATR'":0VSJ:2>D.:*-*341DDB29J
MT/P\1,15$RC91<V;DK)!9+AD)RH6LB<56O.(D-),^JB)XUI<,B]'JZ_"0MPH
MJGEC>15&6457D=%+3-J;=A+\.0735)]#2HO%*DJ(TJ(^I&1D8HL]L
M%=/O2?Z)]O\ I+2_OJP6MWMI\ OZ(&R?^C)W\:3 1.],,$*"O>K?TD=DOT:A
M?QQ)!>W<OU!1%CFY_1/WT_1IW]];!,;T6/=%?T;LV_ZRK+^)Z8$W;UIP*J"N
M*']:#O9^DNXW\9O@O.Y?J"C3V_NTU-O?M%G&VUQ$:D'?5CQ4LAQ*35%LVD&N
M%);-6G:IMXDGXEJG5)]#,$Q*K'W/VXDU^OW=VJEOJ<@USL')Z)DSU)M4CNB3
MM-? E>7',B+IKJ?I!-RZ\%0
M                  '+_P K_P"L'RK].,;_ 'BN!DC<Z@ 8P
M
M
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MNA*Z5.W9WCR4FDMQ(F,QXDA+2"0TAV?/2\VE)%T26D5>A$7A]@%[E^X*
M                                                    .7_E?_6#
MY5^G&-_O%<#)&YU  Q@
M
M
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MLM'845#?9 @N_P!NVA2W%EIJE;JD'\D$735/<$
M                                  .7_E?_ %@^5?IQC?[Q7 R1N=0
M,8
M
M                 "-_(C+>2F*PL6<XY[64NYTV:]+3E3%S/CP4PVD):.,I
MLWYT'N-Q1K(]#5IH7AZ28H@A<<P>>E#N?B>S5MQQP>)N3G$&198MCGSHVY[5
M%BMR'7G/:6[A49OM1%=/1QQ)GV]",S+4FD);;#9]S/R7-W:[?S8O&MNL&362
M'F<@J;6+-D*GI6T3+!M,VDQ7:I)K,S\O3H74O21-$R00
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MPJXW;*6L;(L+V[CNY1"42X637+[UG+867@N/[2M;;"RU/UVD)5\8(F92J!
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MM_;><J..VZC\:'@N[V.VUE-T]DIGY!U\]TS]"(<Y+#ZCZ^!( HW^"
M     '+_ ,K_ .L'RK].,;_>*X&2-SJ !C
M
M                                                  14Y9<B)7&W
M"JO-6X57/ARI+L1Z).>),AY_M2IAJ(R3S3CJE>L:C22B0DNY7:743%"CG2SS
ME]O-G&^]5R"5=HH\PQAPD8;"A)UAUD%/F).$AM>OF-N(><2]WZFYWJUZ&1%#
M)1>OPVYBW_**781IM%1TCE! \W(8,1\REM2%*0EM;3#TA3BV%ZJ]=*#))Z)4
M9&9:SL8YB86 B
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M>4$W=#9XYD>'*6[*<N:Z,PI9-$N+/;[Y->DM?5)YM+?_ )LS,#9*^@%
M      <O_*_^L'RK].,;_>*X&2-SJ !C
M
M                                                <JO/;)]V+SD5
MEU9NID-9<.8Z\N/B5?1RTR*R#5N*-3+;3:5J4T\HB(WR=(G#7X^IV R0A<"6
MX-A/YV_YV\)_F,]O_G/]O3^;?S?IW=VA^;Y_=]S\CR^[SO-^Y^7W=_JZ@2[
M<;_.'\WJ/\[?8/SI]@C_ )Q_-7F>P^W>6GVCV7SONGE>9KV=_K=NFO4&)[0
M
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M!0              '+_RO_K!\J_3C&_WBN!DC<Z@ 8P
M
M                                                  &D>0>WT?<W
M;F3BTG<^SVB:=GQ9)YE42R@R4&RHS)DGE.-$1.:Z&7=U B:*6N3>W9;#V6TT
M*EYJYOD[><Y"B!E*E9&ZM=74DMI+T_LC2EGHCO/3N+0].G@8+Q-4\-HN+E-B
M>X.&YA"YHY?N(FJF-S(V)S+]N7#LTF@^UM;:9;GF)42M>A&%%>)9"I24)4M:
MB0A!&I:U'H1$74S,S!""F\7O!]C=M; \4PUZ9O9N*^Z<6OQ##2*6V<KP2T].
M02VR,U$:32R3SA'T-L$Q:TC^8G/3EB1/;A92UQ3VGGF9_FA2DXK(94<_M)!H
M<0^7>G5*R=>:+TG'40)V0W!%]VQQ@A;;7F!,XU+DW%Y'2E6Y,Z1[1>,26^K<
MAAS1++6BNJFVVTH67JK)1 CBE1+G_$#>/!M^JWCZBF*_RO)WN_"9\4R1$M(!
M^8KVU*EG]R0VAEQ3Q+/[GV*UU(B49>KH8XE\0L&XO8HA$5MF_P!RKJ,E.99R
MI!][AF9+.)#)75J,A1%H713AD2U]>U*"DS5+T$
M                                                         \RZ
M=MF*>U>H(L>=>,PWUTT&6ZIF._*2@S9:==2E9H0M9$E2B2?:1ZZ'X .?S?\
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M[>Y6$-916JRHKNPO'*TX)/I\_P!K0^\IM37;KW$LM-/$$31T. H
M   Y?^5_]8/E7Z<8W^\5P,D;G4 #&
M
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MI)9&7F:=2Z'Z(1-$R00
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MI"B^(P)M7K H            Y?\ E?\ U@^5?IQC?[Q7 R1N=0 ,8
M
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M+IU/51F.9JVN"   13S;^ECLY_H"R_R:Q%NA'2E8*I
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M\^':U&UF(55I7NI?@64.C@,2&'4'JEQIUME*D*2?4C(]2 JV,
M  Y?^5_]8/E7Z<8W^\5P,D;G4 #&
M
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MD_<HZ%&1D2GG#2VDS]*B 5J\'.8VYN\^3<A,MW<>\C!,8HV+ZJ1#A^564<>
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M?*OTXQO]XK@9(W.H &,
M
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MCT?-<E]FJU=NFBV(F)NB)XIKNBMUF[?TM#?68WQ_[(N3_E!__50MPQUO9_\
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M'C*E/899K0[[0TWU=7!EMDE+Z6RT-1*2A>FI]G:1J!68HFJ"
M'+_RO_K!\J_3C&_WBN!DC<Z@ 8P
M
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M6QIL7GNGIF>B/KIYEN07YM??=K<WEMLCHB/SICS[J^2>BB5X\^]6
M             *D.0O&+?'.=Y,YRO%L(^=*"XE,.5L_YRK&/,2B*RVH_+?E-
MN)T4@R]9)#+;=$0_37@?\0N1\MY-I]-J=1PY+(F+HX,DTK==.^VR8W3T2TS]
M3?DC]'/_ +XI_P =$\</5_\ *GAO_=?_ +>7_ LEX=[:9MM7ME>X]GE+\Q7$
MS)Y5C&B>TQI7=&<A0FDN=\5UY!:K966AGKT\-#(8[YK+X)^*?B#0\ZYGCSZ+
M)QV1AMMF:76^U%]\TI?%L[KHZ*)8"KYJ      "#GO"MDK'>OCE?1\>A.6&6
M8#+;RK'X+"36])]D;<:EQT)21J4I<9YQ24)+52TH($VSM:;]VER=Q3.-IZ'9
M/(+J/7;C[?(<@TU;*=)#EK4DI3L=R+WF7>N.@S:6VG4TI0E?@9Z$W0M'!523
M[PKE5?9%GVWNP_'++[-W+J:[2_D%MB<YUEYRY>UAPJEJ1%<1WJ1YCAO(U-)*
M4A)GW(6DBUL+@=MZ3(\;P##*',+YW*,LJ::'&R;(7E=RYD]#*2DO=VB=24YW
M&6I>&@*M&\W/Z)^^GZ-._OK8)C>BQ[HK^C=FW_659?Q/3 F[>M.!53S[R'E)
M:&[&XI;/O/VF:9DMB%GZZS5R0EN::"C4K'9ZQO2^])ND7^#-*.OF*)):V$L^
M)'$7%]A-EY>'9/60L@RW<2%KNP\\A+[$@GVE-G6)UU)<=A#BF_[=1K7T[B2D
MB9JJGR"NS'W9O*V)>5#<ZWV7S<W/9H_=W?.-$IU)OQ%&HR0<RO4I)H49D9^J
M9]J'5$"V^'0;BV44&:XY29;BUHS=8[D4-J?36D<]6WF'DDI"BUT,CT/0R,B,
MCU(R(R!1[P  \#*\?C99BV2XK-4:(>354RJEK3XDU-86PLR_868"FOW564E@
M.:[Z<><Q<349E%L6YM?4O&:5.R:I3\*T:02B3JIOM:41>)I)2M-$F"URW+=;
M<6AVEVZS#<7))C,.KQ2L?FJ-]9()YY"3*/'1J9:K?=-+:$EU-2B(@555^Z*P
M*U11;P[OV[2NS+K&'24TE:"0;IPO.DSW$Z$1&E3DEI/JEIW(47HZ%KF!<.),
M7CMSUWNV7REXJB-F:Y\#$ER#-!2'2EHL:A.JB(M7X3JS3\*S)):FH@3.V%X%
MS<U6.U%G?7MA'J:6FBNS;:TE+)IB/'80;CKKBU:$E*4D9F9@HI.]W=7S-W^6
M7(;D<J*M&.J=MOFEQ;?812LAL?:([:3,NILQ&5I67CZR34?7J7NW+PP44A>]
ME_VD\9O_ &I_EE>"]J[T%               >/D./T^5T-UC&0P&K2AR*#(K
M;FM>+5M^+*;4T\VKXE(49 */<_\ =3XG39GI7<BZ?$,-L7E/1:W)([7SK&CZ
MEZB%>U,-R33KIWZ-_&7PE^)+W='8/9Z;Q!E\8]I]QL1K7XSE=(I;N]NHID[-
M:LF9<R9,=8[U&MY!.EZC>A:DE*201$1%=K:G#38/:WCUA%AC&&9G5Y[F5VMF
M?GF30I##BWG&TFAEIMIIQPVX[/<LFR49F9J4HSU5H1$S5,D$ #EZXT87MQOW
MR^RBNY&7BFHUS-N[15?,E+@?/%W[:GLKG'R6VXWW)<=624J2H_+)M)ZF#).Y
M?A#X<\68,=N*SL-ARVVBT2J16M2'#_W3KW>M7[)@I67X6G#/BK:0W(DS8G$6
M&%$9K<APDPG2+0R/1Z*;3A=#]"OC\2 K*B*]QO!]F_> X/0<>\@7:8[5YWCC
M%;[-).<4=V=(8:GUB9*5&;Z$DZME6JC5VF:%J4HE*,OT.GD&,
M!R_\K_ZP?*OTXQO]XK@9(W.H &,
M
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M9GU,_A'G<^:[-DF^[?,U>LTVGLT^*W%9NMBD/1&)G
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M,!R/<Z)N%A[LGV[%X:*]V&]5ONF?M+:%KD/DIIT]%]G3M7W*+Y:@)FJ80(
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M<8W^\5P,D;G4 #&
M
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MR:Q%NA'2E8*I
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MU  Q@
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MGXYCM    (IYM_2QV<_T!9?Y-8BW0CI2L%4@
M                                                        #6V\
M&VT'>#;+,]LK*R?IX.95ZJ^39QD)<=92I25=R$K]4S]7T@0JAR7W5.Q>&5YV
MV8<B9^*59'VG97":R#'U+KIYLAQ"?^Z"W$\G'?=D<;LOJ)V08ERC_.BAJWRB
MV=W4/T\V''?423)IY]AY;:%F2TZ)49'U+X2!/$G%Q5X2XMQ6R#*\@Q_-[7*W
MLKKV:^1'L([#*6DLN^:2DFT>IF9].H*S-4VP0  "+O)'ESM+QBK8:LUFR+;*
M;=I3M'A%22';!]LC-/GN=ZD(89[B[>]9]3U[$K-*B(F(JKQ9]\A7*G(;?X^2
M6ZPW-%RV\H0M\F_VQ,'5(2:OB\POL@GA63\>>4.U')>@E6^WEF\U9U)(_.#$
MK-"&+. ;FI(4XTA;B5MJ,C[7&U*2?AJ2M2(B8HD2"    'G6]M64%597EU.9
MJZ>GBO3;6RDK)MF/'80;CKKBSZ)2A*3,S/T .5/F/R,O.3FZ%MF$1N8SMEB3
MR:3!(3B%);8CN^8M+[Y?)3(FFRMPR/KVI)'4F]09(BBZ?W6W]$^H_26Z_?4
MK=O6+ J  #E_Y7_U@^5?IQC?[Q7 R1N=0 ,8
M
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MM:B4K15(     BGFW]+'9S_0%E_DUB+=".E*P52
M
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MQLK>-'!#;?&'$,R,XR#<JIM-PKAO17FSU4ER28S:RZFS%2?EHZZ&?<O0C69
MF)K*<WNMOZ)]1^DMU^^H!%V]Z7O$MY-XMEML<(OMF+N117UKE!0+61'K8EFI
M<3V*0[V&W,C24I+S$)/N))'Z-0+85!_7WYY?2'9_\TZ/_5(+4@^OOSR^D.S_
M .:='_JD"D(YLYMFNXV_V.9KN+/<L\TOLJI7;V<[%9A+<<;?CM(,X\=IEM&C
M:$EHE!?#X@.PP&,
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M3(WB(2
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MB5%)\ZM*6@E^N:>[[B>I_"")HZ.P4  !R_\ *_\ K!\J_3C&_P!XK@9(W.H
M&,
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M1F1GW.*)9Z%T%:)JD8(2
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MK2HD>4IQT_5T\>[J!,U24!   .7_ )7_ -8/E7Z<8W^\5P,D;G4 #&
M
M                       *NO>>9/MU1X#BOS]N%DV/[@1#G.X-AV*3T0WK
M!4E+;:I-DHT+-$5@VNA]#4HS0CKJ:2UKGEDY/DDRU8O9>0V<J[B]OLUR]+>7
M*;[->SL?4LUI[=>FA] 76H<!M^-CMO9%_N%O'O1F-)FU)72(#N.W<I^TI;&)
M+=;4B1 998=?]H:-LD*;49]#[TF:3439683/F^\0R+<>1*J.+''/,-V9;3IL
M'E%DPJ%4L*\$N+\GSO5,_0\ZP?V/ $<+YSV7]X3OL;;V[.^55Q^QF2KN?Q#
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M_P#6#Y5^G&-_O%<#)&YU  Q@
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MZ)'WZD(KJY+++$),$R23+)$E+9?=3T+M+0*P42P%4@
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M>()JV\"               <O_*_^L'RK].,;_>*X&2-SJ !C
M
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MFDI-*"U]!&HQDOR77129V5KZ98[,5ML\41MI$>B$N!B90
M           :8WBQ'=G*XU"WM7N*SM[(A.R%7+ST5,GVI"R0322)3:^WL-*C
M_9&QI\F.RO';5R.;:769XM^&R]W,5KLK7J0JOD\JZ'>/"-G7M_&Y%EF]=*L8
MMRBNCDPPF*U*=-"T''[C,RBF1:?"0Z-OP]V*<G!N\KQ^?[WQ:W'I)U.V^)FO
M#%(I$SU?HI6;4;?[^8SE#EEN5O#&SK'507644C4%$=125*0;;W>EI!^J1*+3
M7TC1SY<-UM++*2]/RS0\QPY>+49XR64W4IMZ]R2 U'H
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MO]R-?BGK=?N<?V8[#YCI?\SPOX.W^Y#BGK.YQ_9CL>F1$1$1%H1="(A5E?Z
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M49Z$1 4;U!            #E_P"5_P#6#Y5^G&-_O%<#)&YU  Q@
M
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M6X.5N-2,TR5E"DLGY)*)B'$)9$HF&>]1D:B)2U*4HR(NU"")FJ8@(
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MOTXQO]XK@9(W.H &,
M                                       $6^0'+_9OC?;8E0Y]:R'K
MK*I325U58V4F17UZU&A=E+;)1*2RE1:$1$:UZ*\M"NU6A,15(F%DN/6./,9;
M!O(,K%I4$K1C(FY#9PE0C;\WVDG^[L\OL];NUTTZ@A5WN3R3W6Y8Y?:;$\-U
M.UF*0'$L;D\@%DXS'CQUF:5H@.:$I!*T425)^ZNZ'Y78V1N&6I3>FCQPXO[:
M\9\5.DPR$<_(+-"#RS.)J$G86;R>OK*+7RFDF9]C23[4^)]RS4M1$S5(E]]F
M,R])DO(CQXZ%.OONJ)"$(06JE*4>A$1$6IF8(5J<@,@KMYL@/^;JED6T/$6_
M+R#,B(T0EFI78TA!F6FAJ/M)2C]?[4NQ/<?0TUN746Q@MBLUF8V^3;'IHY>K
MNPZ.Z[57S,12+;ME>GV9V;=E9A$Q^GM8TM,!ZND(FKU\N-Y:C6LBUU-!$1]Q
M=#ZD,=^FRV7\$VSQ=5-K8LUF"_'WEM]LV==8I'GGH2OX^;29F].D916E$K[&
MO4A$>1-T4A@U:J(^WL<)2]4DK3M/MT+7QT'9T^+%H+)NU436^*1;&_AZ:[8I
M7=VO.:S/FYIDBW13'#CNK-\^[Q;:4V36F_=2M$QOYK,FM_6RK<6RF(7_ 'R#
M"U9;^/357;_]3%/OG!B_8X+8\L[9]?SK?P[J<_\ J=3?/DMV1]-/ZKW:S9S
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MZ'VOENNLUNGLS6[KH[)Z8]$L^&)O
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M)U5IU+4I#I<!0           !R_\K_ZP?*OTXQO]XK@9(W.H &,
M
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M9/8J57U;Y%[-F&7*-A@VU:?=$-FIAHS(CUT0Z[]@_ ;'PF'%^TOV]4.3]_\
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M&.F.=L36V:7;IW3,[8^CRIX#F/;
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M !C
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MD=:U.*0RRDDH2:UF:E:$7B9CE7WS?=-T[Y>\T^GLT^.W'9%+;8I'FA[@JS
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MN\.2+KJ5I2=WIAMP8'5
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M;G4 #&
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M&*>*RRVV>N(B/H9.*-D
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M-*5+0V2EGH:ANATE@H            Y?^5_]8/E7Z<8W^\5P,D;G4 #&
M
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M?L!)L6\CQZ@A2,@PR]))&IN/%G,PI#;;AZJ\E\Y#3J$:Z)/O,OEF"UT+M 4
M !4KNYN5P2Y=;E*V<W(3=XCN/C]A-QRDW!=;8JE)E1)"VE0VYYN2&EI<<2KR
MDR6C2:CT1VN+(C+16'CH]SYMD4TW'-W\G57:EI%3"A)>T[CU+SC(T_)T+^]^
M/7XB'$^W8_=;BMQ?WVD<9-NMK\I//K?(HN)W.Y5DY"E.S'7EH\LW'_-;4AE)
MK(S0TR@C,M>PU=0)K*W4%0           '+_ ,K_ .L'RK].,;_>*X&2-SJ
M!C
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M\3-7B>A$-?566V9)MLFL1-*];8T>2_+AMOR6\-TQ6G57H\_6D,-=M
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MB,C\# Z'20"@           #E_Y7_P!8/E7Z<8W^\5P,D;G4 #&
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M7?54U^!/^W&7^C$_]_BBE^Y\E_&C_P"QV_\ C6?1<N;&)^4@
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M(VN(RHS>%;,(9DQG)OS>Z<AF"RY(0;))\XS6\E3JGW3[DI;2C0T"=D.AD%
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M81.NJZ >.9AC#K,;,\26Z3WLZWTFIF0P[HDUL/=BR29D2B4E23+H2E$3%$L
M0  "@_AOB.5UOO"]QKFQQBVKZA^QS=3-K)A/M1ED[,=-LTO+02#[BZEH?7T
MO.Y*/FS[O2HWB1:;G[-0XM!NKHN3=8Z1HCP<A5ZRUJU/M0S,69_WPS)#A_WS
M0S\PB(N4Y\8JJ\HN7.RE'DD"95WM-GM1!LZR>A;4F,['DH:-EQ#A$I)H)/;H
M?AH"T[G6R#&            Y?^5_]8/E7Z<8W^\5P,D;G4 #&
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M_<2=3_:Z_$+19-7HO#/X4<XT',M/JLLXN#'DMNNB+IF:1-9_-I7TJH1D?I,
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MPW>-.'*R[.#PM.-G8% 5W1TE).;[-YA?XPI/R/(3X?"+6S1]!\!^+]9R#O\
MX73]]WG!7WO9X.*GNQT\4[^I7MD/'#;RHWNP';*)N7[9C>5U<N=:93WQ#]D=
MCLRW$-ZI7Y9=QQTEZQZ^M]@7XII5]PT/CSF.?D>IYA=I*9<5]MMN.EWM1=-D
M3.[BV<4[NI-?83CAMYM3G#N3XON7^=MDY5R(*JKOB*T:=6TI3FC"U*]4T$7A
MIU%;KIE\D\:>/.8\[T,:?4:3NK..+N*EV^(F*>U%.E,T4?*0
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M1N=0 ,8
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MG0-5J   Y[^0G^W'=?\ 2>Q_?U#/;N?M[P1_]CT?_@V?1#3HEZE85Q@W[OL
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MQP37';W7%?$[)MCANF=OD6E#6?!   11Y2\=;_D% PV'0YM%PM>,2)KTEV3
M.<4@I2&4I))$ZUV=OE'\.NHW-)FPXYGO;)NZJ31Z7PYXKU_(+LEVCNBV;XB)
MK$7>[6GO1/6JZR?BEF^-<@MMM@U[H0)<O<6HFVS.2IJ.QN*F$Q->-M4<WS-9
MJ]C,M266G=\77NXK=%?IK\_=3[,Q%.*=M:>MZR/Q:Y_-LSWMOZEG^%/_ (V<
M/LLV+W#>S6ZW,A9=#=J)-:55'JCA+);[C*R<\TWW.B2:,M-/2./JM1ILEE,>
M.;9KOXJN#S_Q[S3G>G^'U5\76<474BVV-L5IMB(GI3T'.>,
M       8CN!B;>>X'FV#/355K69T%E1.V*$$ZJ.FQBN1C=)LU))1H)SNTU+7
M3Q&;3Y>ZR6WTKPS$]DU3;-)JJ\_50X_]-5C^1&OQP>F_BJ[]W';^1L?$>0_5
M0X_]-5C^1&OQP/XJN_=QV_D/B/(W1L!P$J-AMSZ;<N)N9,R1^GCS&$U#U6W&
M0X4R.N.9FZF2X9=O?K\GJ-/7\^NU>&<<V4K3;7J]"E^;BBE%A(\^P@
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MVD23,S] (VIU@@           !R_\K_ZP?*OTXQO]XK@9(W.H &,
M                                           !H/&>3FRN7[NY%L?0
M9I%G;@8TUWRH)=(\AUON]IC19&O8\]&).KR$GJGKXFASL)HWX"&J-V-\=J=D
M*4[W<_-:_%HSB5*@PWEFY-EFGQ3%AM$MYX]?'L09%Z3(@3$*_P!_E!REY3OO
M4W$G;->WF /+4Q(WSS1"6R-!'VJ7#:4EUHC(^ADVF2LNAF38)I$;V98#P<V2
MVFFJW6Y&YLO>;<60Z4J;DN9/F=<4DBU^X07G'525I\"\Y3NNA&EM!A1$W(9\
MC<:PS>')LQ7%T^:YE@](QBV:8\AR,1D1(4AM1),DF1$1H,BU+T$>FF6ZMV]C
MLB+/=BGY=J(>V/'=ZKNY%MG2&);%7(--/6-J)QJ2:#]60[_:>E*#ZF?RBT+0
MZ1:O=?U+V^,6SV*R]OZW+LDQUJ9<6DF0Y7O24J+2(A9-M^KJ6I*-"C+4M#(R
M]'4;./5WX8I92)ZZ17MZ/0TL^AQZB:Y*S'56>'TQ&R?35,:#75]8R4:M@QZ^
M.7@Q&:2TC^Y01$,&3+?DFM\S,^6:MC#@QX;>'';%L=413Z'V#&R@#R[JHA7]
M5/IK%!KAV#1M/=NA*+7JE23,C(E),B,NGB0S:?/=@R1DLWQ+7U>ELU6*[%?[
MMT4^7EC?#R\2Q&IPRK.JJ?.6TMY3[TB0I*G7%JT+51H2@NA$1%H0S:[79-9D
MX[Z5I39N^MK\MY9BY?B[O%6E:S,[Y[(AE TW0          !@.Y6Y6,;48P[
ME^7NR&:9F0S%6N*R;[GF/F9(]0C+IT&7#ANRW<-N]H\QYCBT&+O<M>&L1LBN
M]'7Z]FP/^<+O\FN?NAM_=F;R=K@?QKR[KN_59-AW,#9G.LGI<0H)MLY<W\@H
MM>A^ MILW#(S+N6:CT+H*9-!ELMFZ:4ALZ3Q7H=5EMQ63=Q732-B3ZUH:0MU
MU:6VVTFIQQ1D24I(M3,S/H1$0TGHYFFV42MQ^8& 8Q/_ #6P"'*W:SF0LV(=
M+0$;L8GOVJY+:7.\_B92L_0?:-_#H+[HXK_9M\KR_,/%>GP7=U@B<N3HBW=7
MS[?FJULC9OD/R#6B=OGEZMN<&?43C>VV/F27W&]=22_HI:"/30]7E.J(_M$#
M+\1AT^S%'%=URYT<IYES;VM;D[O']BW?Z?R\7FAH'FGM/@.TM3M!3X)C[-.U
M*^?3LINJG94M;15W8J0^LS6OM[U=I:]J=3[2+4:MV>_+-;IJ_5W_ ,=^5Z?0
M6:ZS!;2O<UGIG]KOGY>1 P5?I-+SA1DN.8IO')M,HR"MQNL5CLY@K"UE,PV#
M=6]'-+9./K0GN,DF9%KKT,5OC8^8?BWR_4Z[DT8]-COR7][;/#9;-]U*7;:6
MQ,T\JVC^>S9GZ7,+_+]=^'&*DOS1_"/.O]EJ/_*R?X3^>S9GZ7,+_+]=^'"D
MG\(\Z_V6H_\ *R?X3^>S9GZ7,+_+]=^'"DG\(\Z_V6H_\K)_A5+\V,EQS*]X
MXUIB^05N25J<=@L*L:J6S,8)U#T@U(-QA2T]Q$HC,M=>HRV;GZ7_  DY?J=%
MR:<>HQWX[^]NFE]LV32ENVET1-$0Q9]/3,XC[[8ULO\ S@,W='=Y!896=0FF
MKZ2.V^M1P_;/,\SS'6]/]\(TT)1G\ I=;5\J_$WP;J?$/PTX<F/';B[SBG),
MVQ[?!2E(G[,UK1,A/(_?G*NU&W_&2Y:;=U]FM,A?<BLKU^2K1UJ*C0O29/&7
MHU(5X8ZWRJ? ?(=%MUW-L<S&^W'$73\TWS_4/8>=68:&_;X5M:PZG[JS'0F4
M\@O#1/<BQ(U'\).%\1D8>R=]X$T&ZS4:F8ZYFV/IQ;/Z(?%?<W)BUW&Y*Y3;
M-/:>?4U1.1(_@6I$2I"FS^\D'%'4?\C\KT?^@Y5AMF-UU]+KO[-?ZZJO=;&8
M6&[E9SBE=)E3(./W4R#%ES5I<DN(9=-)+=6A*$J4>FIF22^P,D;GZ0\-\POY
MARS3ZG)$1=DQVW3%NRV)F-T1,SLZMLM?B7:7-\"?]ATO])Y_[Q%&*_>_*?XT
M?_?+?_!L^FY-<4?) !#3G3NOGVSFRL7+=M[[\W,A<R6!7KL/98LS6.\S)6XC
MRYC+[?4VTGKVZ]/$=CD>EQ:G4<&2*QPS/3'5U,N*V+KJ2HQE<C=SYS<EJ;E%
MS*;F)6F6RNTE^6XEPC):5-]_;VJ(S(RTT] ]'/ARS]Y<^L:?Q_I<'#-O+-+%
MUM*7<$<58W36F_IJ^2NW^W!IX;-=4WMI5U\?N]G@1+.6PRWWJ-:NUMM:4EJI
M1F>A>)ZB(\-V1_W+F?5?B3AU>2<N?ENFOOG?==;%UTTBD5F8F9I$1'F6Y>[D
MWMW+W<A;J5F>Y*[?UN$-8\QBD=YF.ER*U**Q)Y*I#;2'GS44=OUGEK5T\>IZ
M\;GW+\6DC'P1MFM9V[:4]?0^7<WSV:G47YK,=N.+[IGAMV6VUZ+8Z(CH69#S
MSF "OOGER.R[8FOV]I,>IJ&WJMR6;V-DI74%4]2&H104H]G:4\VP9J*4ON)Y
MMQ)Z%T\=>YR?EL:N,DQ,Q=;3AVTVS7?LF>CH=/D_PT:FR[51==BBZ..+?>FW
MIB-L;:>6/.JBR'DRK)*>92S,5QZ#&F^7YDJKQ:DKY:?+<2X7ER8S3;J-321'
MVJ+4M4GT,QT;N1:VZ*79(F/+==ZGV+E'B3P?RK56:K3:;4QDLK29F+O>B;9V
M3EINF7I5W*^751H$>+AV*._-K33<=Z3B%$ZZKR2(DJ<>-GS%*/34U&KN,^NN
MHM'(];&SO=G\Z[U-'6\U\%ZF_)EG2ZGO+YNNK79Q75G=WNZJZ;A[OCEG(+::
M1G>9U]166[-_,JDQJ5I]F-Y,=J.M"C3(?DK[C-T]3[]/#H.)S?0V:/-W=DS,
M4B=OIZHA\<RV1;-(2I'+8P!!WD1SAQ7CQGS. W.#6V13'JJ-:E80I+#39(D.
M.MDCM<+74O*,_P!D=OE_)+]9C[RVZ(VT9;,4W157AR'YPXKO39;/3JO!K:D1
MMIET;))S<J0PX<IIA;:C:;["]51]GB?0>AY?R2_31DB;HGBMHSV8IMJDS^M7
MV_\ HHR'^&Q/_ .9_"V7[<=DL?P\]:R+;?-HNY& X?GT&"[6P\OJHUK&KWU)
M6XRB2V3A(6I/0S+70]!YS4X9PY+L<S7AFC!=%)HS884 "C;?+GKR#P+>+<O"
M\>L:-NCQ?(I];5-OUC;KA,1WE(02UFHC4>A=3'M]#R+39L%E]T368B9VMNS#
M;,1**UUR_P!YK_=?#MY[&;5*S?!8$FMH'VX"$QDL2FY#3A.,]VBS[93FAZ_!
M\ ZEG*,%F&[#$3PW36=OF]3)&*(BC:OZR/DW_G3'OR0W^[&K_#FDZI[5>XM=
M#H^?-(
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MTU,B FY=\"@           #E_P"5_P#6#Y5^G&-_O%<#)&YU  Q@
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MBD1#5PVE@!V)CY Y@
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M1 4            <O_*_^L'RK].,;_>*X&2-SJ !C
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M?^EQ_P V/H=#'[L-"#?7 '8F/D#F
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M NIDN9CU-N'9T;S;T&QESYKD"6SY[!J0ZM4%YMM:D]Q$HD_;I4!&Y?F"@
M        #E_Y7_U@^5?IQC?[Q7 R1N=0 ,8
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M:2/3U3T&#489PY+L<[[9H_#]]>*:[99J,*K^5*2A*EK42$((S4HST(B+Q,S
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MQ+M=K;8K=??':Q<=_7*3@YC&
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ME_Y7_P!8/E7Z<8W^\5P,D;G4 #&
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MU1U\V,PTV2)#C3AK[FSUU+RB+]D>>YASN_68^[NMB-M6"_+-T43B'$8@
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MUTU&KJN:ZC56<&2:Q6NZ%;LEUT4E)$<Y0
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M*            .7_ )7_ -8/E7Z<8W^\5P,D;G4 #&
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M(R?Y%>'R[V"ZE=C:HU50
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M[2<2I*S+HI1@O,52WA^]KY,14K2_C6WMB:CU2N15V233\1>3:-%_9(P1PPL
MX&<TMTN466Y[0Y_0XK3P\6J(UA7N8_%G1W5NO2#:43IRYTLC21>&A$>OI!$Q
M19R"H  .>;/MR\<X'<W<YR7;.97;@8QED=].=X&PZXR_4JLGT3'X29)M+:2X
MR\A+C?;W]J#-IPDJ]8%]\)6->]]V6-ILWML,U;>-)&ZVCYN6E*M.I)4<I)F1
M'X'H7V"!'"SS;/WH.T>Z&X.&[=5&W^7U]IFMO%IX$Z84#V=IV4X3:5N^7*4K
MM(SZZ$9@<*S$%0           '+_ ,K_ .L'RK].,;_>*X&2-SJ !C
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M2MSL2E/<9%UT(B'G]1FG-DNR3ONFK!=-9JS(84
M                                                     CIR<W*_
MF]VVFQX,CRLBR[OJJ?M/1;;:T_XU(+T_<VS[2,O!:DF.IRC2=_FB9]VW;/U0
MSZ?'Q7>2%:&SFX3^V.X-%E"5+.O0Y[+?,(U/S8#YDEXM"\33T<27[9*1ZS7:
M6-1AFSIZ/.W\MG';1=I'D,2X[$N*\B1&E-I>COMF2D+;61*2I)ET,C(]2,>
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M'-?;CTED73%L][6*[)IW=*QTTK-'2(/./SB
M
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MB(B^P*O&7Y+LETW73,S/3.V54%3[L2SIHIPXF_;!M&LW-7,3-1ZJT(^I7)?
M.YK.:8=5?QWXIK2FR_\ Z7O?#WXC\RY'IITVFMLX)NF[VHF9K-(ZXZGI_JVK
MWZ>HO_-%7^NAJ_$Z;]W=^O\ ]#N?\T<[^SB_5G_$R+!?=Y3\1W'P#<";O0U<
M_F)<Q[9JH:QHXGM/DN(<-HWCM7NSN["+N[#T^ QGQ\SQ8L63'CQS''%*S=7K
M_1CK>4\4>-];XBC'&JBR.[XN'AB8]^E:[9^S"S <9XX
M
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M70&.,_-0
M
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M+O=+F;_RMR7L%/&9[;*,LN9L^![>I^,;)DS(E/)\SM)?:?;J1:]05FBY(%0
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MK;2V?3"6@TWEP
M
M
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M9?"IFLU>^,:
M
M
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MSR1NZXJRK?.O\PM:)UY37SBZU/:89@]Z%(62&_:25VH,ON;7;T2"\[(7[O\
M'78&34*H7MDL%54*:-KV%./UR4)29$6J32P1I5T(R41DHC(C(]2!6JA3-\&K
M.*OO$L&I-KY+D6B;RK'9-;6*=4XN+"OE-,3*];JC4I23;?=0DU:J\M2>XU'J
MHRV^'2@"@           #E_Y7_U@^5?IQC?[Q7 R1N=0 ,8
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M:?RD_"-W'R_+DPSFB/9CMV,D8KIMXNAMP:3&
M
M
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MH;)OU>Y! 3-'16"@           #E_Y7_P!8/E7Z<8W^\5P,D;G4 #&
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MNLFW?#*QA5
M
M                                               'Y/L,2F'HTEE$
MF-)0IJ1'=22T.(67:I*DJU(R,CT,C <^?(KW7^;8:K<S<3;:]KK;!:M;UIC6
M#M,SI%Y[.XI*BA---,.)<4TI9H0??JI"24>AF9 O%S2^Q7NYM[=[\2L<K]K@
M[;?-]N]4_,>7Q+*#.=\J/'?]I;:]E5JTKS^PE?MDJ+T F;FZ/U06]OTF8/\
MW5E^)@CB6+\+N#U?Q6?R?)[?*V\TSK*(C=:<Z/%5%BP8"'"><89):UK<-YQ#
M:EJ5I\A)$DM#-169JGT"   5[\C_ '@^PFS-]<[8VE+8[G9#%2<3*:*N9C+K
MH_F)(UQ9;\I9(6OM41*0A"R+JE9I41D"T6H#-\W.$+-@FT;X1TZ9B5FZE7S=
M2>62_A)HV/++3Q+U>A]2Z@FDI8[2>\^VYW$S[ MK:/:2[Q]666L.BK)!RH91
MHGM"TM(/RFDEZB-?!/H!$VK4 5            <O_*_^L'RK].,;_>*X&2-S
MJ !C          !I;D9:/T6Q>Z=]$:9=FT..S;* E])K;*1%;-YI2DD9&9$I
M)'XCH\IOFW5XZ?:B.W8U]5HL>LQSAR1[-SG!SGF#NM*J+#'8\VNKIMBR;,FQ
MKHZFI$5"_E$VX;B^UPRZ:D6J?1HKY/H.=<[X:X<,[>F>KR1ZW*Q>$=!I\D7Q
M%UTQMVS6/H1XVOW:S':3(EY#BL[M5+1Y-O6R-5QIC?4R)U&ORD&9J0KQ2?Q&
MHC\SHM;DTF3CLGSQUPZG,.78-=C[O+%8Z.N/-*;&#\R>05A8R'MNZ2EFVC4=
M;2,AEUYMQJM3Z2+S]7'U-FXE!K(DK(RUU,DK';YGSR-5C[K';-)I6OT;/+_(
MYFD\-:+1Y8RX^+BCKFOU,.O*:ZS&_/--W,GL=X,U=).LVXD+:IXQ=VOEL-Z=
M[K:3/4D,MI:T^U(<C'IK(VY;J>2-MW9NM_I3'F>VY+X=YESF::'3WY(^U$4Q
M^G+?-N/T1=-WZ,MXX=M-N[N?!]EH:6PDXP;?E2G(C946/(92>BT.R7%(\YLB
MZFA3I_$C4;5NNLP[,%D1/7/M7^J)\SW4?AWHN5Q%_/.868IV3W.#_,RSY)ON
MB9BN[V<,4Z,G2]C<+9*-M_A7_H+<;%[_ #I<MIG\RJ G'H3$51+4ZX[8))#:
MUMGVI[#+TGHH]!M:319=7DXM3Q</7/7YIW>B&SIO%O)N1S/W'R^VV^E._P U
M;\L^F9NO\OOQ;^A&YJ3Y@M_^!G_=H_=#G_ Y_L3V/OG\>\B_W5GS^H^8+?\
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M#,1[T;8]7I;N?'QV^5<>/"N6
M
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M4CXQL\YT%NGNBZR*6S\T_E]:^HQ19-8W):CBM8
M
M        '@Y15R;K'K>KA2EPIDR,I$62VHT&EPNJ2-1=2(S+0_B,QLZ/-;AS
M6WW16(G;#3YCI[M1I[\=DTNF-D^7Y;_(@$_:7T9YZ._93FGXZU-O-*?<)25H
M/123+N\2,A].MPX;HB8MMI/DA\7OU&>RZ;;K[HF-D[9?E\]7/^=IOW]S]T)^
M'Q?9CLA7XO-]N[MEMS9F)>WN6M35VDPZZC0;\PS>6I*U+(T-M'J9EZVIF?Q$
M8X?/[\6#3S;PQQ7;(V=LO2^%<>?4ZN+YONX;-L[9Z=D1Z?HB4Q!X-]1
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MLZNL1T15(6Y'<-"B(VX>I*=29EWR#;9U2I)]Q,;-J-6X6W.*[2>\5XZ[=87
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M#C7Y6A_A05>S3Y7BV1.O,X_DM5>O1TDN0U7S&)2FTF>A*432U&1&?I,![X
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M]2?Q.Y?I>7ZW%IM+3N\>&R(VUZ;IF9GKF9F9\LKRAY]\S
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MZ12^R;+IMNBDPB8I-)?>*H
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M^9\WPZK#-D<5:Q2K%ES676TA8J/--0
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M0O9CNO\ =B9\R8B9W/3%$
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MUMEB68U=D5'M'6N5.%Q*V:J)Y,5UF(PI#G8D^_1$)HB^#K\(*Q+2/ZK;B?\
MYHR7\M._N 3Q2JYWBXR[6X7SGVZV#HXEBWM[DLW'&+2,],4Y+-%FOMD=D@RU
M3J7ATZ F)V+Q=O>*.U6U>U>XNT6#L6$+%]S(]@Q?^W23FNZV,'V!U2#62>GE
M$7J_""M59/N\-WZOCAG>[/&#>VRCX/:*O_::.?9N%&@JM&4%%DLJ?=[4I]J:
M;8<CK5HEPBZ'JI!*+715.SF?RFVZVAV7S.!"RNNM=P,RII=1A^/UTIF1*2[/
M84R4YQ#:E&VTPESS.Y6A*,B2GJ8*Q#7WNP-G++;/CZYE=_#7!N]V;+Y\9C.I
M['$5++9,U_>1D1_="\Q]/7Y#B? ]03=*R(%0                       $
M=.66[N2;$<?L_P!UL0@UECD6*_-7S?"N&GGH2_;K6'!<\U$=Z.X>C<A1I[7"
M];374M2,F(JI=_6Z\D?Y$[:_DVX_UR"W#!^MUY(_R)VU_)MQ_KD#A@_6Z\D?
MY$[:_DVX_P!<@<,)Z<#.:6Z7*++<]H<_H<5IX>+5$:PKW,?BSH[JW7I!M*)T
MY<Z61I(O#0B/7T@B8HLY!5_#C:'4+:=0EQMQ)I<;41&E23+0R,CZ&1D JCY"
M^ZOVZSV3/R;92W:VNR&4:G7<6D-J>Q]YP^OW)*-7H>IGJ?83B"+HAI(+1<@5
M+V6]Y)Q[,Z[&%[@2:.*6D-.'6C]Y7+26I:MP([CRD>)]%L)/X@36)><6_'O,
M'R*K0YNFMU9>SI9;Q)SV@S^3H2DUOF=WQZ]VH)I#W*_CE[QCD8I$;.)V8U^/
M2^DES.KI^M@-$YJ2M:M2S>ZEKKV13Z=#] (K$+#>.GNQ-JMJ9E?E6Y\].[.8
MPEMR(<%Y@X]'"?1UU3$-2U2C2KP4^?8?0_*28(FY9X"H          .7_E?_
M %@^5?IQC?[Q7 R1N=0 ,8  ([[Y\B]I=HL<OH^3[K5.%Y0_72FZ1)(39SH\
MI32B9?*M;,UN^6LR5V*[25IIKU$TZU[;)G;T?+M]%7(Y9J>=F2)#DA4U#KJT
MLS^Q2$/)0?:2D)41=I:::)T+M+0M"$Y+YONFZZ:S/2O.]YXJA(WBG29!;[\[
M5,TMFBC389170'K&1%1-CN(=D-^:PN*X9(?2:3+N2H]"+0]2/MUV=/ILF:+K
MK=UL5F?ETST)X:PZZVFFF&T,LMI9::226VD$24I270B(BZ$1#6F:L+^P
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M_%97I3 (R41*29*2HM4J+J1D8X;6?Z
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M#MJ-K=O),R;@&VN*X-,L6DLV$O'Z:#6.OM(5W)0ZN(RV:TD?4B,]-015GX
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M'%L>U6:4MBR.&(B*5NWU=$(\@Y8
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M(O@5\!C<R:'+CQ1EF/9EDG%=%O%T-GC38P
M
M                                                          !R
M+\MW<H7R&W>+)F8D:2K+K=7D5KCCL,E%*7W=CCJ4+4HBTU-24G\1),AMZJ[-
M,61DW1;'#U</D^MFVTA&P:B'W5K#\B=&;CQTRG"<2OR'-?+423U/S-#+U="Z
M]? 9,6*[+?%MD5F>@I5V#;,[.85M;B./Q:;;C&,(R+YOC?G$UC[1N-)FFT7M
M"69DA/M+K9.&KM-P^XR\>NHQL3<X
M                                               *W^4^+[MYYN&F
M-583;V>+8[$;9HI$-A;[+JY"$NR'M4$9$HUZ-F7P((>JY/FT^##6;XBZ9VU^
M;Y>5O:>ZRVW;.U&?^9'=[Z-\A_@+W[D=;[PT_P!NWM9^]LZX"V2W?(R,MM\A
M(R\#]A>_<A]X:?[=O:=[9UPMTVFG978[=XK(S>M?JLH3#\BUC2>CRE,*4TEY
MPO$E.H22S(_ S'B=;;CMS71CFMM=GR\CFY(B+IIN;$&JH *M.86XC.2YS'PZ
MM4A=?AB318/H(M7;!TB-Q)J+Q)E.B"+T*-8]AR/2SCQ=Y.^[Z/R^IT--92VO
M6B .XV6486JM+*:-%S;3:&JD2D,3[FO<)M^*VZ?9YR5'KT;,R4HO2DC(NHPZ
MCB[N>&(F:;IZ475IL63%M'R&Q5!*P??0L@C)]9J%DC*G"-'[4G72FGX>&G;^
MP/*?&Z/+^TPT_F_*&AWN.[?;V/\ ?YR.3N(EIE>ST',HC70IN/2#2ZX7PFVV
MJ4K7_P"A2'PNAR^YEFV?TOE'TG=XKMUU'VP.7."LOI@9IC>1X)8_X5N?"-QM
M/[*#)X]/3]R%;N299BN.ZVZ/)/RCYT3IKNB8E[><\E=N8&W]_?X?EM?<WJ8Y
MLT=6E1MR3DO>HVXJ,\E#G8V9]ZM4Z:%IXF0QZ?E.:[-%N2V8CIGHIYT68+IN
MI,*LL5R^XQ++JC,X#ZG+>JG)FFXXH]7S,S\Y#BNIF3J5*2KXC,>QS8+<N.<<
M[IBGR\SH76Q=%%X>,Y#6Y;CU-DM.[YU;=Q&I<11Z=Q)<3J:5$7@I)ZI47H,C
M(?/<V*[%?-EV^)<FZV;9I+W1C0  #'LKR6MP[&[O*+=SRZZCB.2I&AD2E]A>
MJVG7[9:M$I+X3(9<.*[+?%EN^96MMFZ:0BUQVY'VVZ&27.+Y>Q @V+C'MF-^
MQH4VEQ#1GY[*N]:^Y:4FE1&6G0E? .QS3E5NFLB^RLQNFK8SX(LBL)C#A-4
M  !_*E)0E2UJ)"$$9J49Z$1%XF9@/Y:>:?;2ZPZAYI>O:XA1*2>AZ'H9=/$3
M,4'Z"
M
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M]$40
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MGOM<7[S_ ,(DB]KCIU^%)$Z1%\"S](W>?Z2L1FCS3]4_5V,FJQ_G+#1YAI
M  ,'W W$Q?;.B3D.5RUQ8#DEN(PEELW77'G"4HDH074]$I-1_$0V--I;]1?P
MV1M7LLF^:0]S&LCJ<NH:K):*3[74W,=,F$_IVGVJZ&E23\%),C2HO09&0QY<
M5V*^;+M\*W6S;-)>X,:
M
M                      <QG*NRL6.?N706;"2S"=SC'O,AH=6EI7FQZOS-
M4$?:?=Y:->G7M3\!!65XMC>Z<P4
M
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M5_ZVVOLY'[>UQCO/['M;"=?V'2(O[<QI<_TF[-'FGZI^KL8]5C_.6"CS+2
M  0MY'<C;S;?**C%,*5#<GQ6"F9,J4UYR2)[0V(Y%J1I4:"-:C^!2=/2._RK
ME=NHQS?DK3='URVL&"+XK*5N'936YMB]'E=0ON@7D1$EI)F1J;4?1QI1ET[F
MUD:%?&1CBY\-V')-EV^):]ULVS262C$J    U+?;UX)CFX-1MK9S7T9%<^0E
MI:&TJC,N23,F&GG.\C2MPR+0NT_E)^$;N/09<F&<L1[,=NQDC%=-O%T-M#28
MP
M                                                '+_RO_K!\J_3
MC&_WBN!DC<Z@ 8P
M                                                          &-
MY=B5#G./S\8R6%[?367E^U1R6MM1FTXEU!I6@TJ29*21]#_[@RX,]^&^+[)I
M,+6W3;-8:0^J7L?_ ";E_E&7^%'0^^M5]J.R&7XF_K/JE['_ ,FY?Y1E_A0^
M^M5]J.R#XF_K9-B''G:K!L@A9/CM ['N:XG/8I#TN0^ELW4*;49(<6I.O:HR
M(].@Q9^:9\UDV73LGR0K=GNNBDMVCGL0 C7RIR')*?:^15XS5S9TG*Y*:J=+
MAMJ=./%6A3CQ&2-5?=4H\OPTT-74CTUZW)L5E^>M\Q'#MV]?Y&?3VQ-U9Z%5
M7YI95_)FV_@3_P"X'L>^Q_:CMAT>*.L_-+*OY,VW\"?_ ' =]C^U';!Q1UK
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MZDTN$7H)6GH'A>8:7X;--O1OCS?+8Y>6S@NHVZ-)C
M
M                           !R_\ *_\ K!\J_3C&_P!XK@9(W.H &,
M
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M;Z.GUM?4X^*VO4M>'C'.
M
M      !R_P#*_P#K!\J_3C&_WBN!DC<Z@ 8P
M
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MM1&>FO0>2OF)NF8BD5:$[]C[Q5
M
M            Y?\ E?\ U@^5?IQC?[Q7 R1N=0 ,8
M
M
M
M                                                #E_Y7_U@^5?I
MQC?[Q7 R1N=0 ,8
M
M
M
M                      #E_P"5_P#6#Y5^G&-_O%<#)&YU  Q@
M
M
M
M                                                           .
M7_E?_6#Y5^G&-_O%<#)&YU  Q@
M
M
M
M                         (,<U^9E;Q9Q^IK*2KCY+N?EK3CV/4TM2BAQ
M(K2NQ4V:3:DK4@U^HVA*DFLR5ZR208)B*JJ&O>+\W:2-6;AW-5#D8%;2CCUK
M\_&%QZ.6ZCUEL,3VR:6M1)2>I)D&HNH+<,+J>+/)7%^3^VK6:4L4Z6]K'BK\
MRQ9QPG%P)Q()?J*Z&METC[FEF1:EJ1D2DJ(BLQ1)4$   Y?^5_\ 6#Y5^G&-
M_O%<#)&YU  Q@
M
M
M
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M-??7?P8%)/KN<3_ITQK[Z[^# I)]=SB?].F-??7?P8%)/KN<3_ITQK[Z[^#
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M/KN<3_ITQK[Z[^# I)]=SB?].F-??7?P8%)/KN<3_ITQK[Z[^# I)]=SB?\
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M;C0HR'7>YQUU1(0A/W/Q4HR(@*2DZ"
M
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MDGT\5GY >_'@.(_4YY)]/%9^0'OQX#B/U.>2?3Q6?D![\> XC]3GDGT\5GY
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MDGT\5GY >_'@.(_4YY)]/%9^0'OQX#B/U.>2?3Q6?D![\> XC]3GDGT\5GY
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MD;'\HH&U4JZ;R*1A^74<=RZ:8.,A\WEQ)/<32EN&G0G=/E'X GH== ,8
M
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M *(&??Z3H?XTC@FW>CI[GO\ V;;Q?I+ _P C,$W+A@5
M   <O_*_^L'RK].,;_>*X&2-SJ !C                    0$]YG_1 S[_
M $G0_P :1P3;O1T]SW_LVWB_26!_D9@FY<,"H                   #E_Y
M7_U@^5?IQC?[Q7 R1N=0 ,8                   " GO,_Z(&??Z3H?XTC
M@FW>CI[GO_9MO%^DL#_(S!-RX8%0                   '+_RO_K!\J_3C
M&_WBN!DC<Z@ 8P
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MBN!DC<Z@ 8P
M                                                          &F
M[OCQL9DN4OYOD&TV+W&7R9+,R1DDNM8=F+D1R0EIU3RDFHU()M)$>O30@35N
M0$                    ,8S#"L2W!H96+YOCE?E>.S5M.2Z6S81(C.+963
MC:E-K(R,TK22B^,!Y.!;6[<[6Q)\#;G":?"85J\F191:>(W$0^ZA/8E;B6R(
ME&2>A&8#/0                    &F[OCQL9DN4OYOD&TV+W&7R9+,R1DD
MNM8=F+D1R0EIU3RDFHU()M)$>O30@35N0$                    ,8S#"L
M2W!H96+YOCE?E>.S5M.2Z6S81(C.+963C:E-K(R,TK22B^,!Y.!;6[<[6Q)\
M#;G":?"85J\F191:>(W$0^ZA/8E;B6R(E&2>A&8#/0
M  &F[OCQL9DN4OYOD&TV+W&7R9+,R1DDNM8=F+D1R0EIU3RDFHU()M)$>O30
M@35N0$                    ,8S#"L2W!H96+YOCE?E>.S5M.2Z6S81(C.
M+963C:E-K(R,TK22B^,!Y.!;6[<[6Q)\#;G":?"85J\F191:>(W$0^ZA/8E;
MB6R(E&2>A&8#/0                    &F[OCQL9DN4OYOD&TV+W&7R9+,
MR1DDNM8=F+D1R0EIU3RDFHU()M)$>O30@35N0$
M
M
M
M
M
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M(E?]B64TN<8MCF98Y*]MH,KK(MM32]#2;D68TEYI2DGU2?:HM2/J1]#!1D(
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MB,A<G'<OKVY]<;I$EUONU2XR\E)J)+C+B5-K(C,B4DR(S\049R
M
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M:F18E;3<6M\..TGH+1M<V?#K9\LFNA'Y:'I"TH,RU-)%KU!-:PZUP8P
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M,_H'G)5I#L#DINZMV>AUI:E-/29""0ZEUQ'<RI3?7MUU+0A-5A8*@
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MWL1I]3,/+(=Q2VB4Z_=&EU[\MI!D7B7M$9H_V-?0"]VYU% Q@
M   ^&SLZ^EK;"XMI;5?5U,9V993WE=K3$=A!N.NK4?@E"4F9G\ #G'KUY-[R
M+F.@K%R9#VLHE+>*&DU$FLQ>"X1$VDR(B3(GN*22E=3);GI0V1$7W0Z \JVP
MQ7*ML;?:)3#M!A5O1GCAPJ8T151JTVBC^1',T+2A)-%V%ZI] 41XXW<(=J^,
M&5Y'EV#7617EAD-6BI,\@=AOJC,$\E]PFEQ8D7^^*0C74OM2!,S57/[WO<#$
M+?)-J=NZQ]B=F&'LV=EDBV^U2H3%F44HL=:RU,EN$PIPT'H9)[%>"R!:U8M[
MOS$[G#N)&TE?>H<8FV46==,Q'"47E1;6?(F1="5IH2V74.>'BH_LF5G>F8"
M
M                                          <Y/O:ZUV'R3QF<9J4Q
M;8#7.MK[=$I6U86+2D$>I]QD24J/_= O;N7@\7GVI'&OC\XRX3B$[<8NTI1?
MMVJJ,VLOV%),@5G>YQN&<1R\YK;5E6FF0E663IZ'$ZJ2IB,Q*E+67:1]/+;,
M]?#X="Z@O.YU7 Q@                "B;WQG_&38?_ $9?_OT$%[5BW +^
MB!LG_HR=_&DP%9WI+YUG.+;:XC?9SFMNU1XQC<54NVLGM3)"$Z$24I21J6M:
MC)*$I(U*49)(C,P0YO=^N0F\G/O=2DVSVZH9C.(E.66%8&PK0W.W4CM+=TE>
M62TMF9F9GY;*-229F:EK,D11=IP^XHX]Q;V_<JR?9N]P,G\J3G>4MI,D.NMI
M/RXD7N(E%'8[E=NI$I:C4M1%J2$E)FJ70(              !7;SAYR5?'"N
M/!<&*->;R744G667B\R+1QGB/LERD^"W5>+3/I^6YZG:EPM$55K</.&F;\I<
MQ_GOWJDSW=MI5FY86=A8.+]ORJ8APE.--K,R64<UZI=>(R\#;:];539,S1<C
MR^WEF\<>/.39GB-8RFYBHBT6),H0A,:"_,/R&7C:T[>R.@C4E!%H9DE)EVF>
MA6(JH<X8;_[';&9_D>[F]%3F.;;A/FZC%I%7%A3&HRYG<<Z<^]-L(SBI+O<:
M"/M/1)K,U&:_5+S%6O\ D%OKB6Z_*ZVWUQVNMX6)3[?'+!FNL68[=B351!@1
MGR4TS(>:[E+BK-&CNAD:=33U(A$;'1WQMY1[?\HZ3);[ *?(*>'BTYJOL&\@
MCQ([JW7FO-2;11)<LC21>.ID>OH!28HDD"             !\DVP@5C"I5E-
MCU\5)Z*DR7$M-D>AGU4LR+P(P$/M[N"^P^_][D>;9;&MVLUR.&Q'C91!L74E
M$*.PAF.IF,9G'4DB1W&2T'W:JZ]2T)B:*@N#N\^X>P_)^%L5.OY%W@]]DTK#
M+S'W'5KBM3VWUQ6)\-"C43*R>;22NWHILS)6IDA22TQ6'X>]8JGZ_E(W,=[O
M+O,.J)D8S3H7:AV5%,B/4]?68/KT^#XS%NY9_P 3.)''][C%MTO)-M,<S.UW
M&QJ'>9/D-G$9ESENVK)2/*9EFGS8_LZ7";23*D&DT]WR^Y1D3.U4QQQ=F;"^
M\%@X3B\]YVIK]P[;;^3W.),YE6[->KTE([-4F9=K;IEZ%H+P,@6G;#IX!C
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M7N\Z^39<PMFVXR=?99-K+D+,E=J&F*B:XHU&1'IKIVEKT[C(O2"]VYU5 Q@
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MC^P
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M%TVW<>8TIIR6F4I"Y5@VE9$?E$A!--JTT7W+T^3U(NE=Z"@
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ML2T5C*X\8D0YKL=OM;6XZ9'V(+7UO$%9BB4@(
M
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M)6G7]@!\6.81A>')?3B.(4F*IE:>U)IZ^-!)S3P[RCMH[OV0&4
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MP ]2+$BPF4QX49J)'09FAAE"6T$9GJ>B4D1=3 ?0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M#K3;G/:5Z?#CL6DAAYF9-K'%)DQ6EM]I]_8A3B-2T4E)F1^!&3,)R@@
M
M
M
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M:O ]SJE*6HN95#$]V(A7>4:29=DJ-W>DV'TK;,_A2"DMF@
M
M
M
M         U9OI_L2WB_0?(?XMD 0YMO=Q?TSMF_^4/\ T=LP9+MSJ<!C4A>^
M4_\ M<?^5_\ ]9 7M2G]UM_1/J/TENOWU (NWJ&,[;R61R=SZ!AL]ZLRFWW'
MNJNBG1WE,.HD3[1^*CM=1ZR-?-TU3U+7H"W0M5W,]U=MAA6PV8Y'5YMD=GN9
MA^.S+T[)Y<5NKF2*^.N0['*&3'>VVZELTH,WS4E1DHU*(C297B58<;L+SK>+
M<.IV$Q3*YF-TNZDMI.8I96OV9<*I;>FK>?9)2$NFPVAQ3:5&1&LR3J6H+2GQ
MS2]WOMKL%LDC<[;S),AF6&/3H,/)(ET]&?:E,S5E')YHF6&#:6EU2>FJB-)^
M!::@B+JMM>Y[S:WF4>\^WTR6\_3T4FHNJ**H^YN.Y/*4S,[=3U3W^SLF1$6F
MI*/Q/J1<A[[PC>_*][^15OM?52W5XCMS<GB^,X\VX:6G[AM91IDIU)GVJ=.0
M:V4J/Y+:2(M#->I:V$[:WW16UO\ -VW!MMP,B+=!V%WOY%&5&.H9GF@C[$05
M,$ZMA*NG5XEJ\>Y.O:17B0AX&[MYKQYY0,[,9!.6WC>7Y&_AF8XX;O='9O$/
M*A193)*T(G$R4):-1:=S:C(R,R1H3,5ATL H .6;E%.7O)SNS&DEO&[%L<_K
M\):1WGVMLPGH].I"31J:?6;4H]"U[C,_$&2-SJ6;;0TA#32$MMMI)+;:2(DI
M21:$1$70B(@8W'ON;'O)7)'<&+C#C[622=RK9K'G8JS:?3.7<.IC*:<29&E9
M.&GM,CU(P95SE=[HW:96$'%OMPLIE[E289KE9-&<C%6MV"DZZHAN1C=6R2_$
ME/=ZBU/N09]"G$J\X59/DFU?+S;2NC23BOV.2_F=DT,EFEJ0Q.=.$ZVLC(NX
MD.FEQ!&7RT)!:=RYSWDG(Z[V,VAJ\;PNQ>J,YW5D2:ZON(ZC0]!K8B$'8/L.
M%U0Z?GM-H475/>I:3)22,%;8JJZX4\#W^4%9<[AYSD\[%]OX%BNMC'7(;796
MDQ"$N2#;=D)6AIMOS$D;AMN=RC4DB+M48)F:/NYK<!?JST-;N3M]E%CE&!/6
M#=?:1[5#1656^Z1G&=6_'2TV\VX:33W$V@TJ[2T5W>J(FJR3W:?)/(-[MK[W
M#,YL7+C-=JG8D;Y\D&:I$^IF)<]C<?6?]\=:4PXVM?B:2;4K5:E*41="E3FY
M_2PWT_25W]Z;!:-SK4!C<H^]W].G.O\ K=7_ !LD&2-R[WWF?]$#/O\ 2=#_
M !I'!2W>HLXF<>\JY19T]M; R=S%\.K63R3+K T*?;:2P916E-QN]M+CZS?[
M$=RB[4FM770TJ+S-%P>#\1$\'L!Y,;N87F+V:Y/_ #?SBPN3)@)C/UA1&'Y;
MYN=CCJ7B-QIASH2"^YZ&774%:U4T<::O8/-=TIQ\H\VN*#&9L5^6Q;QU.K5.
MMW7VS[9TI#,EU"%I6XM2]"U41=SB>NI:5B^Y'NYME-TJ"HMN'>ZE);7"9*$7
M-?8Y"S9URH:R/N>\Z&T_(9=:5IW(-*M2Z:)47K$<76LBX?[,;F;![3,[;[D9
MM7YL=5.<<QAZ F0:8$%U"#.&3L@D*6A#O>I'J%VDKM\-"25F:HH>]RQJ/8[!
MX1DY(2<[&LU8CH=/74HUA!ED\DM"/J;C+)]=/ $VO2]TSF,F]X[Y#BTMXW#P
M?+I;%<WKKY<.>PQ+2G3T:OK?5^R!<M&!4
M
M
M                                                       &K-]/
M]B6\7Z#Y#_%L@"'-M[N+^F=LW_RA_P"CMF#)=N=3@,:D+WRG_P!KC_RO_P#K
M("]J4_NMOZ)]1^DMU^^H!%V]2WC:4KY^4"%I):%\@8J5H46I&1Y4DC(R,%NA
MTS[Z?[$MXOT'R'^+9 ,<.=+W9G]+_ ?]&7W\5R 9+MRX7WF?]$#/O])T/\:1
MP4MWH0^YS_XR;\?Z,H/WZ<"URMS?"A?KN3^ZE!=V1X^K^<FW:EWID9^S,OVK
MBDS"+N;,R)M9.EZR=2]) F-RUHO=A;V*(E)Y=61D9:D91K+0R_*8*\3 ]J/=
MZT#FYV*YI1\NL.SVWQ?)X-W8PJU#4J:_(@S42'6UK;LG5I=6MLTF:B,R5XEJ
M"9N7O H .6"Z4=![QF7+L&U(;A\ATV#J4Z&HV5924A)EJ9%J;:B/J8,G0ZGP
M8W)7_P#;M?\ Z[__ +) 9.AUJ QN2O;+^FUM]_UWU/\ TD:!DZ%AGOC*B?[=
ML/?$T:JSR+^ MXO!#_=!=2E73IWIU,NOVI@BU*GW6>3TESQ;KZ&ODM+M\0O[
M6+?PR,B=;7+?.8PM2>A]JVW2)*O S2HM?5,B(NWO9]YUD])2<2LQI;)YI-GF
M5I2UN.L+,O,7(CV+%@ZI">I^JQ%<U,O#7QZZ&+=Z$_N=Z.R<RO>O)"CF51%J
M:FL7*5J1*DR'WWDH1TT5VH9,U:'TU3K\H@3<@5S=(RY8;YD9&1_G*Z>A_ ;3
M1D"8W.M!IUI]IMYEQ+S+R26TZ@R4E25%J2DF70R,O P8W)=N7<-7_-/-+>,^
MU*B3-XY9P9+/][<CHO5(96D_3W(2D]09.A>S[S/^B!GW^DZ'^-(X*6[T&_<Z
MQV599OG*4@CD,U%(TTYUU)#K\M2R^#J;:?[ +7+RKN521*J:YDDB#&I'&C9L
MEV2VD1%-/?<S0Z;QD@TK[NTR5T/70%%(&?\ NY-D]U,HR#ZK>_\ C)VD1'MU
MAMR].9N8\%#RNU';,@NNR&&B5T(G6G%=2];PU+\2#F[_  TY*\:8*\_R"H0Q
MCU')91^?V-6:76XKSZR995ZJF9;)+6LDDM322U42==3(@3$Q*V#W9'*#/]YZ
M7-]N]S+A[)[O V8<ZARB7JN;)@RE.-.,RW?\*IE:$FE:M5J)9]QGVZ@K=#-O
M>HS&8O%62PZ9]]CEE/'C:?MT^>\>O7]JTH"W>U)[GV'(1M5NU8*;,HDG*XT=
MEWT*<8@H6XG]@GD?V0+EO@*@
M
M
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M6>>R)>73FM-#[+ TMPU'J1&??#885^SIZ 1=O3I!
M
M
M
M                       *_/>,\>7=[MCI&08[7'-S[:I3UW1--)[GI4!2
M2*RAH+Q,U-H2\E)$9J6TE)?*!-LL<]U_O,UN+Q^1@<^23F2;02OFEUM2B-Q=
M5*-;]<Z9>)$G[HP7Q-%\()NA9,"H                   #G;W9K[#GASY>
MPS'G5R=OL,=;HIUU'/5N/0TKRE6<I*RU3K(E.NH947RN]KT=07C9#H9KX$*J
M@0JNMC-PJZMCMQ8$-E));99922&VT)+P2E)$1$"CZP
M
M
M
M                          'GPZFKKE+77UL6"MPNUQ<=E#1J(NNAF@BU
M >@                     \^'4U=<I:Z^MBP5N%VN+CLH:-1%UT,T$6H#T
M
M
*         '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>tm2227887d1-pht_ipsc4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_ipsc4clr.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@%E =L P$1  (1 0,1 ?_$ /$
M 0  !P$! 0             ! @,$!@<(!0D* 0$  @,! 0$
M 00" P4&!P@0  $# P(#! 0&"@D,# P #P$  @,1! 4A!C$2!T%1$PAA<2(4
M@9&Q,A4)H<%"4F)R(S.5&=&R<],D-#465O""DM)#LW0E=1<W&.'QHL)38[15
MU397.(.31%1DE$5EM29V)Z.$A48HXL.DI89'.69W*1$!  $# @,$!P8$! ,(
M 0,%  $1 @,A!#$2!4%1<3)A@9&Q(A,&\*'!T3,4X4(C-%)RDA7Q4R1B@J*R
MPN)#%@?21%0U\F-S)?_:  P# 0 "$0,1 #\ ^_B @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @@L:@E:B*R! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 00)I^R@@7 4J=3]E!-Q0$! 0$! 0$! 0$! 00)IV
MT0 :BJ"* @(" @(" @(" @(""0D T+Z>A103_94@@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#TJ:#+()&&)I8>9K@"UU="'<""H%THJ"D$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MP@!_O+.6H/S3P[8'T#BYB 7:5IHIA$JPIV((H" @(" @(" @(" @(" @E<:
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MU3*(3(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MC5A9DCDX]KZ9,8X/.A 8/8]!7#K/,YU^J_9P/I)6U"= 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MF5=?!M*Z\4E$0F H $2B@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:YQ./N3!<76/MY[FU-;>:6-CWQGO8YPJ#IV*45FCU&,: TTX5HH2JH" @("
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MI3B3HCW:FI]*"/+6E36AT4":E 1WJ0.M% BI! 0$! 0$! 0$! 0$! 0$$":
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MA!->VJZ^TW'/#A[K;39-8X-IAQIJWL"N54T0>X:=Z0)E((" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M&36.2,U%.Q;XNK.G!4NLF-)>BTU6U@F2H(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+!\- N]M_P!.'G=S%,DT9FMZN(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M>P12R'G-Q=S7S+)5N:! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00J.]!% 0$! 00KI
M5 KZ$"OH*"* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+K?3^WYXGU?BUY98%LK-[3VQB;+>VX=P9'=F&N<-)>NL+MP(AR%O+ QS&4'
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MR-8 &L$;!4FE& FO;5=#;X.5PMWG^9=IP9Y;Q-;S <HTH*<:5_95VE%*R5X
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M6$Y.X]LS2 <S_:->',I'VE:[AW=BEBG4)$! 0$! 0$! 0$! 0$! 0$! 0$!
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MF\O]STTJ>Y()EZS&N=0 TY="-.'9H/0@N * !!% 0$! 0$! 0$! 0$! 0$!
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MT:R-H %!Z.*BE2='3,37-8UKSS$GBLF*L.VG>H2B@(" @(" @(" @(" @("
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M@!]R7 \%Z*S-$O-7X9AFH>TM/M4Y/N^ ]5"MT7PU3;*M&>"RF881$JRAD("
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MI[4$] /@X((T0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MELQMH AS*@C04JN>V*;G<C'$1\S^RB"E')+REU/"?VDH*[&BG.YW.YVI)[U
MCJ:-IRL)X*:T3$T6EY:6M_;SVEPP.B<*2 =Q[0$B]%^J^V5N<X28;8W)=D,K
M_BS)71$1D:= VKN7@0NKM\\.'N]K,ZQ#<T4D3A5A8:\/:K4=A%#VJ_.2L.;.
M+EE?@!1;JA,LP0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$$CB.%?:/!!\8.HO\ _=;Z?%U!_ C[7_\ +=P@]3ZS;#1[BWQY
M<=O&::"//YZ.QFN(#RS1>\7#(@^,D$@@NJ$2ZC?Y./+_ &_22ZPTVPK>\O';
M=DEDSL\DSKUUU-:DNE=*7U)#O:I2@1#E/ZM''XS?G2CJOTRWECQN/:6.W?)=
M6EG?E[F@R6MK"&-=4$!HCJ #VE1*8:IZ0]*NG>6^L&ZF["R>T["[V?CY\I#9
M8&0.,$<=O#,Z(#VN;V2*\?6I&]?K-]_76Q-G])NDVU;[^:^&WA<Y%^7FMW>&
MZ*TQ3+5D,()^:UYNR3^**=J"3%_JWL3T_P#YD_SBVQ?5M##+GI;]CL@^4-HV
M;Q/$T<XZZ"GH089]7EU.GP)\PVR+#+G<.RMF,N,MLG(2W#;B4VEK<26T/M,T
M+9(Y8W&@[ H%GY*.CVV?,IN_JGU[ZO6)W?/?9:YML+B;R1[;6$W$YD_)AKFD
M^$V(L KP.NJ%&-?61^7[IITQL.F>[]AX ;=O,WN"+&9'&V;Y#;/;%$^9LW(\
MOH[V VM4)9]]8,T?ZGG05S0.>6/"OY#JXA^-89#\ )-*(2ZN\M/E.Z+[)V%T
M_P!W0;;^F=WW>'LLQ<[HOY9I+CQ;J-MS&(PUS8P(@\, #>#=4&C-R]'O+QTQ
MZRY_J7YDNKN+WIELNP/PFTLU=PQFT;(YPCY;1KV.=0<U 1J5(XO\U/4GRV3[
MMZ5[X\L]S'B=X8/+Q27T>-CEM89_!N(9(:M=5AY2T\.-=5 ^B7G.Z?[)W#Y9
M]U=3<GM>SFWO#MF#PL\\/\9A; 7CEHX-/M./$*11^KMZ:;%CZ&;.W]'MFR;O
M*YDGAN-P4=[PZ,%A#?G4XCN0<Y] Z?K.NL=#H8-SD'UWD?RJ!6W]@+CS4^>?
M,=,=W3W3>FW2RU-W-A;>1T4$\EK<06DK9"=2'^*XFA]2#K+S"^3SHGF^DFZO
MYL[+M-J9[;V-DR6#SN-=)#/&^QC,Q +GD/JQC@:U^-2-$>4'JGF=^^3_ *P;
M>SEZ_)Y'IMC<EC67=PXNE= ;>X, >=/N(P H(:F^KA\NW37J+MK=._=^8=^Z
M+NWOG18W"W\LON=J9#/'(Z*)A8"2&$ZUU)(07?F+Z9[9Z%><3R_;AZ8V8VE:
MYQ]LR_QUBZ3PGF=]Q:2.<U[GGVHS3712/MI&/8#Z5#V \Q!KJ*UH*(A?-^:.
MW3B@B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(""%12M13O00YV:>VW7AJ$$2YHK4@4XH(<
M[/OQV=O?P03(" @(" @(" @(" @AVK&NHHR5U]7!;(87,=W#GK/ 8Z>_O;AD
M#6M<(P2.9[Q\UK6\3QUHJ^3-;;"QBQ3=+1V BNA:S7EW"(\EF9WWM^P@CD,A
MJ=*]Y[5YG<W3.1ZBW'%NG<][DLS:A\+Q[VQK:-J2330Z5[U=RTBGBUW3+YF9
MWF/F"R)#9 X;EDYRW2C^=]=*>M>LMNKL[8],_BBR-7TL=;F2:&2.1S0QI,C7
M'B0"/0O&;SS_ &[FVU=MUJ> (X^I8V\&V$M7=M">P*;6,H%Y;4D<SNX*4)(^
M2I]EX<?0>/Q**T1=P7$=M//S.A<UO)\X.X&OPA96QS-5M\6K<%_.X2-Y#PJ.
M'P$U^58WVS"Q$Q/%XU[M[&7KG7#XWPS@!SYH9'PZ#MY6.:*^L++#DFV6G+BB
M89-L7(Y.RW+)MJ[R<V6L)K&2]L9I>7FA$4D3 VK6BHY9.U=C;Y*Z.)N\/+%>
M#=;:$:G1W:?D5USV*;FW!:X+'WUY<SQM>UO\$@<X!SW_ #6AK>)U/8%6S9*0
MLX<?/+3&WX)XL:ZZNFTN<B^6[G)U+732.D#2*]@(&JX^3+67>Q8J0]N5MK[F
MQ\;B+P5<2TU)H>%#7B%-M.+*9FOH?-[:?-_K$6K^1P!S9CY!J0T@?;)*]EFN
M_P"D]GX)A]&GP.?.'L<60MT\,T.O>3Q7C,5\5ELC@N:: \1WK3$U9)P"[0#U
MZ*4)'GETH"A*5I87'V'\P'<?V%-&NJM!;RW(>X4:W[D\*T3E1-T0IEI$G+*W
M\HW0,'=WD:K&ZO8RB>]X5[M?$7<_O+FOM+CG#C=02OC=S=Y#' &GI"8[YB65
M^.+H99L/,96US]QM:_NWY.W;8MOK6\DH7M:Z5T?(2P ?<]HJNSM<E8</>X8L
MFO#_ (-SM)- 36A5Z7-6MS,V)K)'2-8&!SI'.( #6ZDDGN'%:[[J0RMBK0&=
MRC=R[RB]VD;+B]OPN,<S#5CYYM" [@>7E'#O7*SYJU=W:8*6UEZL3;8S/-U[
M+2/9%337TA4]O=\5U?1^*W?6FCD#S9.:<-MLQ./AMO+@L<]I&H;'2G!>E^FK
MHC+?XQ^+%L_H+&Z3I9@XV/\ #>[F<7:U)(%: JCUN8G<W>,L\;=<;/#C +N8
M@"I^VN.V*@.@UX]J";DJ*N-?0@HE]#3E-!HH%2KWR1QQL-7>A32K#)-+4]Q;
M2V]&R<G)+JYQ].E#0K7=;,&*ZO%Y][C;+*0""]@$S6Z-<XD. ]#VD$?&MF.Z
M89W6Q+&[]]_L>QGSN"R$[[?&,?<7F'E>9(Y&M%1J^K]:$:%7L>:7/S[>+IX.
MI8W575LX.'="J5-TL$5D" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(""1Q]IO'3L"#XN]1'D_6N;!T I9'T\=M7 X)(S3ZQ(\_
M5KRG!H=6'>6/YG\/_+H375)XD<'TTNVEVQ+EKS1DF!>'O[>4VE*H/E7]5"X_
M076:#\IR#<TE3(* UAAJ:T"1-"6$].-PX397UEW4VYW7E[3;UED+G,2V^0R$
M\=I;.:^&5K*2SEK?;)H-=>Q0GBS[ZT#;$F7P?1[JMA[$[CV[L^YR<6>DM&/N
M;=]M?MM'1/\ $A) ;6W-'5H:J4-P[)P/D'WELZSWO!C=H8>"]MA<W.+R&X#!
M<P. J8Y8WWH+7"O"@4)9+T N?+=U'Q?5W&=!]JOVW)9P287,Y6-\TC+N.1\G
M@O@?+-,TL>Z"H([*:J1R[Y"NJVVNB.Y^J?EYZC92QV?D<1G;V3$7>:NHK".4
MV]RYCFAURZ/F<_Q.=@'%H)U"BB&-_6<=9>GV\K;IIL?9^YL?N7-87/,R64^B
M[RWNV16SXW1>UX+WD.YWCCV*:)F64_6"\Q\GG0)L8^9!@VAY'M$.Q$8/RH2^
MGO2;F9T>Z;RVX,DL&T,3[LU_:\8^+2@XU=P0GB^.7EI/23/^:'JU>^86_@CW
MU87\SMMQ[@NV6%DT-,?ANC9*Z+G(:7BA)'H0F5A]8GO_ *&WU]L#9W3)^$RF
M4Q-R^_S^7P<UO<PMA=)'X<3I;5Y8UWY-QHX5U"@J^AGFFMY[OR8;JCLH9+F:
M3:,4D<,3"][FBVUHT5.G:4&,_5R;VVC>^77:>VK?<F)DW#:RW)EPK+^W=>!H
M$=7> 'E_*.8:\O:I',?0(D_6>=8?R<@8^'<X8XMH*MO(^85X:5"02K[IW/)Y
M6_/SGMZ[MM96;'ZKV9MFYMPY8;=MU=6]U+(Y[@&4C,?*27!!VQYC_,UTDV7T
M:WAD;7>N!W#D\QC9<9A</BLE:W5Q/+>QF$.9#%,]Y:T.)- 4.UREY-.G66V9
MY0NL^[\Y9R65YU,QV0R<%E*US7>[QV]P(G<I .K9 4&7_59-<[H_NH<SJQY<
MAO-0#VY;O3@.%:(ABOGM#F>9ORPD-+A[S9LDY07#V;N<]B#ZWVTOB00N;Q#&
MU;36E!V*4+X< H2B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(I#SM\JQ2[@Q14P"D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 04I-#4?.I\ 0<]97RZ=.,WUFQW7&^Q\\F^L8T,MKQL@\,-%F
M;05;RU^8X]J#TNJ'0;I_U<S&T,_O3&W%S?[$OHK_  ,L,@:&RPR-E87 M=7V
MFHEMB7&VTN+.(=&X6$EFZT?$#4F%S#&1S4X\J(:CZ.= .G?0VVS<&P,=/9Q;
MCNC=Y(SRM?S2EK6U;1C>P!"6$=7/*!T6ZS[CM-T;NV[*S.-C>RYR%A)X4LIJ
M"PO<6O Y2#V=J#=EAL/;MIM&PV.,3#=;8Q5K#:6^/N1XP?%$" TU[1WHF'*6
M2^KR\LU[=3WD6U<ACA=O\0XVSNN2U;K4L#'L>X-];J^E$.H-A=--D=+<(W![
M'V[;[=P]J:BTM&._*!K>5G,YY<Y[J=M5$)G5\X.I.[_(WUBZH[XP/6&U/3K?
M.S,C+;7FXLE.W'NOS:.-L75>QVCJCEH*D:U[Y'('7O:O07=FX>F713RLXUFZ
M<@_,Q9G<6X,=(;QTD0B?S,\1H^8UKN8Z=B#[0[V\N>P^J/3/973GJ#839#%;
M-MK%EE%!(&/;-9VS+;F+BUP(HWN0JW9A\):8/"8O;^.B$%CA[*&RQS'Z@0P,
M#&#LU#0B'.O5/R=="^K>79N7=NUC'G1'RW&3QTG@23#VM'U:\&E3PH4H58;<
M^0WRY3;6BVA)LZ9EDV\-Y/DF2\US-,\-:TR/+".5@8- $'50VGA7[9CV=/CQ
M>;=CLQ8SV5T"X2V_+R>&XCE[!31*Q"=7/733R;]$ND>\!O?9&"N\;E8VF.WA
M?<!UM 'N:YYC;R ZEC>+BH&7;<\N?33:O5[-];<1C;B+?&X1>#(WCI6F%POY
M&RREK>0$$N;WH59;U-Z1=/NL&'^@NH6V+;<6/]HVPFJ'1.(HUS2PAP/*3VT4
MU'/.W/(-Y<=LYNQS;-K7.9DLBV2SLLE<>);ME8V@EY6L82:\-::HAUCD-K8C
M(;;O-KS8YD6%R%B<=/BXB&L9;OC\,LC('8WT*$L)Z0=$MB]#L+=[<V%936..
MOK@SSMD>)/RA+WUJ&MIJ\J4+#J#T Z>]3MW;2WKNJQN+S/[*>V;"OCD#(P^-
M[GMJ"UQ.KCVJ$MVPQ-:SE:TL(%'-&O90:^A2A>@4 '<$$4! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6<K98;J(/CF8[F9J*]GK7<LFL//7V\LO:;J*G6JS:TR @(" @(" @(" @("
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$CY
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MZB.*V1;HTQ.BD]A=4T[#]A&4-=]0[N6.TQ5HWYMV\OF'HB=7[:-ELM:%H#G
M'V0[0CN]*A8LC1'BC+E2I4Y81^'@B9A N=;EEQ&X!\$@>T=P!K7[2-<PZ"L+
MUMY8V=VQAD-S"V25H["0/D.BSA5R31<N$LGY2/V2/G,/<-5JG26VV[1Y[(S?
M;OVGCX#62V=/<7,HU(C,;B!3UZ*_MI<K>W.B&CE&M#V#XM%V+;M'!IJU1U1R
MMPVSL-N6CG-N<_/X%Q(/N;84;,0.WV7JMN+Z6T=#98N::L<9"+.&V@MV -A<
M6D=G*0 =/@7#OR5NH[UF.D57 K73CPH5*:(G72@/H0E:7+C:VMS*3^;C<0?2
M$96N=_$=.Z6[>*ONI7SD?NI+_MHW6PF!/+^RH;8@IIZ^*%"G]00H=M7&M-*G
ML1A?&C8FP+VD5[CIG![+=WCP-&AU%?LEJE7N;)#WT+0PA]33TU'8H:YHMKJ\
M99V<]]>$>%8QND<WOJ. ](Y5-MU)HB;:PV+TULI['9.!MKMI;/%:Q^)&:BAY
M&BE%WL'E><W/GT;!:*"BL*R9 0$! 0$! 0$! 0$! 0$! 04B35E!VZK)C/8B
M30NKP&JQ9]B1D@<YS2:$C193%&%LU4Q(&\Q,E:_-41%6=]T45(W_ 'QI45"F
MZ&%NJ8FCFT[1HH@GB@Z5K2==.*0FJ(>QY(8\$A1,)JA&' .YN]1$(A64I$!
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M-I;;&&:][5G\M'W3:X=IK[(X+SE[SU*2NFD.%1P]*6IE,I! 0$! 0$! 0$!
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M<P@?^[( K>;X)F'%^B8FS!DUXS#4H^Q1<R)K>]5%M9E]4_([4='2X?<YJ_\
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M(" @D^Z=ZD@E\L/K8O\ 0;MC_P"H8O[V4D=1^1W_ +JO1W_)MU_R^Y0=7H"
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MM>33Q/>(V>#2FOSU7C!66^=S9$<6Q\%TVQ#<?;_3UFW(Y*1KG7DDLCW:NJ:
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M+%X?^J6K!P"I6^9ZR_S1XMWWE/\ 5A@__P!E'_D-@NG_ /%[7SNS_P#K&?\
MS1[Y:.=PD_$_97*[9?1<7_QM_>5C_O"[-_P;(_MK9=+IWGCU/$?7WZ/JN_\
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MCJ%?,(ERV.L) >5KK*SET:?O2^>1OQK3.\F5BW86Q"S@PL$<INK^YN<K>_\
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M-;O;3.K[UTZ_'DQXYK-:0O;'+8_)7UK88_(P75_<7$;(;-C@]SBR1I=0 ZT
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M27:5-5,W5919RIG.[=0*+5-\0S2Q2M>7-%:CO4Q=5A"NLTB @(" @(" @("
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MC[1G27!WCK:%LTU/&GB #I!X;""_0$D$Z:]I6G<3RRW9M_DG-R=E9CV-ZY\
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MBDVAG9-TX&'1FW\K/*2U@-2V(.,C&\:BE%U-KO;L?;HPWG1=CN;9YHI?3O\
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MK3THFJVE>6EOMAOK"F$5[G.W7;K;9=,,5%:X\C([QRPD9@\3& \N=[(YY 7
M!M7#BN3OMY=ATMEW.C=+G=7Q-\?#$Q7CV_;5Q7@MKY>^R,VZ=_WKMS;IN#SQ
MFY>ZXCM8WGF+(Q(*,U^]"X%V><D_'-7T_%ML.VLB,,4T]S6'FP9R](LC74MO
M;=@J2[[B7M/'UJ;+N7@SVLS%TSVR]3RQ-'^:#;HY6Z@'FH.!BC[5JS1\SBV9
MYY9YHXMW[@=7 Y@5X8^X^&D3EAC^#2%>W';DOBZ[C#C3R<T][ZET[<F*_P"Z
M2^9E8RV6NXCQXK3,*M(A'B7D\&BM5-J+[IJM;Z]M<;;>]WTS8(2.8EQ]J@[
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M[?6=$?ZIVZ371N9PO;VF\8B5'ZL5_P#^BYC6@ZMW!D*CN_)VY2$2^AP.B"*
M@(" @(" @(" @(" @(""VD,H(H]H!.H/<FB*2M))962/#9HP!2HKPT]23-&=
M;9T[7-_67K_B]@PC;^'/T]O;),='C\5;-;,QKG AKIB7-# #J52S[NVR)IQ>
MAZ/T2_/?;.72VL=_>^,'0?&1[WZP;[=N&W+)'W#I;C%M<?#:09G$.H:$&G K
MS.>Z;^+Z??BMLLLLCA9P][Z+V5C:6445O96K+*W!#600M#&L [&\M**G;9%5
M?)=-W%P)UZ(/F-Z9/ Y29;0NIH#^7:K,73$-V&*Q2>S@^A98SFJ1KR @E5\E
M\HRWS&@:G2@I36BBR^8:;<ET< $#U+&>+5-D3-3F T-7O/S1V)5,60D)()(+
M7$?/K0-'K2=8HF<;',KNS"8H.Y[L7-PW1UM;MYG ]W8L8LB&=MLL+NM]9F[=
M3$8QL<1X2SD!P[]"2%E&BU;C>;/E-T7?Y_-/MFFG-!" RGPL 65F2>?E[&<8
M;9G5YLD5W+S&7+W\[VM-6FXE Y2.[FHL?GWV9:1W-F?#;%KG:Y;&S*YN.1OB
MAF0D:U[@'.%&MUYG:K[#TN*8:QQK^3YOU:[ENT^W%FW3BW9-<;BD,LOB>/
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M-IGB^R.^CY9UKIT['/=;V3,T]K>T0(;J .P? KCC2JH@0$! 0$! 0$!!*YP
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MU)[**9BC".+674KV;7#E]&MDNV^%Z=1Q[EZWZ>R1%\>OW//=;LFZR?5[VKY
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M7\'T.>XS![AJ-*.[ZU_87I9UH^:VZ7+FU86APUUHL[NQC/FE?K%(@(" @("
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ML>I(/NN((X>]-!/]<%[#Z:LCFB9FFL^Z'F.MS-)BG9'O:PFCY;G$5#J.R-H
MX"M?RH7T/J_+.&L71V/'].PW1?-WBZ8C%(H7GCR\I'J%?MKX;N<E<U*/J&TN
M^9915K4]ZV;B*0<ORI1)6+8@@(" @MKUH=:7+CJUL#Z#T@$K.&-\Z-J[0E\;
M;>*D.M8B/[%Y4N7EG5DO-0$@]A1IGA+5756[^BXMN9:)H<[%YB&X@!]):?\
M>K+#%;X\5B)IL\U>VS\WU0YO9:'CPPZM2?@H%[O;S6R'Q6ZWS+^%Y<P <K9
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M&+0.<P.'-*=0..I(I18Q7)+&ZEL<5CMO'Q[JW7>75PP38C;T<3.9H)BGF?S
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M5 R[_4^\_3@/$S]V_E%!S92.@'H]I!#_ %.O/K_SW<_I2/\ MD$?]3KS[?\
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MY\^O_/=S^DX_[9 _U.O/M_SW<_I./^V00_U._/M_SW<_I./^V2H?ZG7GV/\
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M<?\ ;H \F/GU_I3)^DX_[=!'_4Q\^O\ 2F3])Q_VZ!_J8^?7^E,GZ3C_ +=
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MT]9X_'190C)Q59WEH(-*46%WE)G5\OLU9# ^8#J7C7,,8SE,FS\(R.CD _\
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M>==1LY,7DRZ2K> D>>;U=I6J>*[BOT4>W049Q:/0>U8KULU@[!Z484U0*,D
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MJBB:P:>KTHBIIV@^M$H:4)X4%431;S7,%NPS32%K1\UE.)]2FE6K+,6TJO\
M!;?O-Q/%W>,-MBHB"&/T\4=H#1]M9Q:K79;>R6Y(8F1,9#"UL A:![( 8YOW
MH [?@6<*.6L\%2H.K06!W!G:!Z5%LQ?-(XHLB9C3L22/8QM9'$,D(8:=GKIZ
ME-WP\66*EUU(XO!Z;;;=U(ZWV[_",^W^GK?&NN;VHW7+6^&(Q7M!>3\"O]/Q
M3?FMF.$.;]0;['@V=UDS\5W#VOI=;1%HK0U)JZO]78%["-(?*[IJO::A:YB:
MHA.LX0*00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!*:U1*0@E[NZBCM0MY&N
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MR%C!&R&-L<48^Y:VM!HO:<7RG+DF[B]5E3771)BC5$U3T4)10$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MZ>XVA%O?7=H:Z<KR\?[KF4<C+]Q/<M3L&Y940YVX/K;%_:)R)_<3W)6[!O\
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MS#UW2_J?+AI9DB)COGC]SF'+774[IO>"PZA[7N+G'MU;NFQ8)F.CK0E[+8R
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M=4S6/YP1\WL/H6N>*(B87([>[L4LD4! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJ4XNP_\ ,X#Z#&W]A1\NWN@^=?\ XI]LHC&V8-?=8FTX ,:/M)\NWN@^=?\
MXI]J9MI&QQ<R")GWM&@'3MT"F++8[$3DNGC*MX-*?9.E:^A3RPBJ(C< :U=W
M"J415.6<" *]O>I0@(AVZ^M!/RC44%$(T VE/0@F44!2" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @((&O8@4]7I00+1V!"B'+P^R@I^&ZI<-#7
M@=:C[")2NB<3HQHH*5[?2A52%FQPH]HIS$D$ UKZ:+&8AESS'"7CW^V\#E&2
M0WN$LI6R?/YX6.)^&BUWX;9XQ#.W<Y+9TNGVRU%N'R\]*\[SNO\ 9]JV;[BZ
M@)C>W76@X:CT*M?L[;XI1T=OU;+@F+XFM.^L_BU9E?)ITVO:/Q63W#@WM=S
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MPCO5@SB' 4X!$)J:4[N"@ T#L&O&BRJBB90D0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!! BHU%4$O(.[4:A$41I3L]:42$5[OA"" 8!Q
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MB7 (41!J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#1OAL&FO"I4):ZW7O?S7>3C?W3V]Z@]1K;J3TJW5DHL3>NEA@?(PS<X+&O\
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M4 :@@]W'[*"/B"A-*T[!JH*'B"I%-0*GX5*:(E^N@J.^J(.<=@J2*T]""'B
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MG-<208P>6A[E(Z69\QM>X(A,@(" @(" @(" @(" @(" @(" @(" @(" @("
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M'?\ "4%ZUK&Z 4'&AXGTH+H5.NB"FXDG71*BQ?CX)>0S.;*V+2-I' 'CV]M
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M0JJ",M#0'.%.%-.'8DP*$5I%$'M#!1_SM"./$\2B%WX8-"35C1HQ*)6WN])
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M(" @(" @MYN;PW4T=]R*5J>P))#Y8>=OKCOG-;TP/E5Z46HBW1OAL+<[EI9
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MW4S3RR00S,D>">!'*2A+W6R!U  >[5!50$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!2F Y-210
M@U;Q0?)7SA])^IFQNN.SO-1TOQ1W/-@66MOF=NP,>9HXK20R/)HPM(E#R-2*
M44):]ZJ>>K:?6_I[E>G.+Z"[JW)N?,0R-EQN2M[=MM:3<ACCF9*RXE>7-\0@
M?D]*E!ISR;[1WGY9NN]A'U9Z:9:V@WGC(H<3G?!I'CW.(<X2-?RT</$:) VO
M*0*<R5*/T%0!S7-8ZIY64![AIH@NE*! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV9$[F8"34]I05$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$$*@=J"0R,J!S"IX((U((K\(4H1Y@E"J0RM!H5"4S7!
M]:=B"= 0$! (!%#J#Q""UDMFOYO9;[0IP[.P(+3W"W;=-F9:0M/*#X@C;6HX
M'AV*4*HMHR12%K"W7G: #[7'4=]% O0>VE.S12(ES1VJ$G,"*C7T()D! 02E
MS6ZDH)!+&33FU[D$X-:ZU4RB$RA(@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M5[I3LSJ(^U%I)N"S,US UE Q['%C]'??%NE$0W?%HRE *'LX(*J @(" @("
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MA,'9V44)&QTU)X(*@]=4$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$"B!1 0*! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN$NI7RM=;OJ7<S>1X!U)XU4HJV=%;LCY.2H#!R@5[ *=JA*N@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MM*FB*JB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @^ /29KK;ZRK<['Z4S-TQGJ]ZMU"7WZC-6!U./"G
M<LD*G%0" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @("#X"[%<(?K,]Q"M!_."=A_KKRW_84)??A@ 8T-X 4
M"E"9 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0?G[VP]L/UFVX/$);3<T@/P7L")E^@$</9-:E(1*= 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$$KW<C2ZE0T5(""W,W-[0:>72A[3\'%"CX![:/TA]9CN2:S#;B&7
M<KYF/;P#??(2[XM%"7Z 8M1S#0'L[BLD*J@$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$*@$ D G@$%.4^P:
M'7C2H[$&"[[WM@^GFV,UN_<EXRQQ& M7WF0NWN# &1BO*TNTJ@^(?U<^WL]U
M:\Q>_>M.:LWMBQ=L'7LG*6Q17V1>7PAI/-5P]U<2*GL4)??>(\S:@4%=/2.]
M2A40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$$I>&\4$.<*45 ZJ4*IU"1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$!! F@)06[S775II\[O UI5*CQ\MG\5@L?-E
M<QD+/%XJVC?)+>W<\<,31&"YQ+Y'-% !KJB7P9\XGFLSGF8W+9=!.BN/FRF$
MEOHX;VX@:;F;(3EW)[#8>8-B;]]KS5[**!]6_*EY?L;Y=.F4.SX3[YF+N87F
MX<J*@S3T+&4' !K1H/25*'4\(HRE1H:4!K3T(*J @(" @(" @(" @(" @("
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MCE(O(F\K34UJ2>%.*@E50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%";LXT%":>A*E'R9^MGR]S!TDV3B&S
M.]TR>8FEGMVDCF=;"'DK_P",*#L'R>;:L=M>7+ICC\<T"(6,DSB1[1<^9X<3
MZ:-"A,NJ(X^1G+]E2A.!1!% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @(" @AVGU!!\?/K</\ 1_TT_P HWWR6R2B'T&\KO^@/IB._%/\
M[_(C)OY$" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @A72O'U()2\ ZU%:"GK0?'[ZW#_J!TT ()^DKX?8MD
M(?0/RNN;_F$Z8Z\,4[3UW$O["%70* @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*4I<UGL#5!9B9Q?RN(:\
M<ID:>/(3H1\-4'R&^MKE;+T_Z<>&_P 0LR=_SB-O,02VUY= ?6@[]\LUQX'0
M?IM$ZC9H\4[F:X\I(\>2FB#H9DO.XBB(5A75$HH" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*;Q[))UH@^77U
MF'2K<>YNGN)ZE[2R5Q:7NPVS.S%A"2&S630;ASW%I!]CD?\ &DD/SW93.YO,
MP^'ELG<Y'PPXQ^/*Y_(7<74-:#0=J#*]I9'>^X,Q@-J[?SF0FNLC,RSQEI'<
M/:#+,]K8VZ5^>3]A"C]:?1_IW!TKZ>[8V0R]FRK\#9QVUSDI]))Y&MH9'4KK
MIWJ$U;7AY1&T-  ;IRCL]"E"J@(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @D(J#7B0A#&MP8BQSF,O,)E+87N
M-S%O-8Y"S=\V2"Y88I1V_<N*$/R4^8SI'?\ 13JQNW95YS"SLI7##WM"#/:/
M>^GV^U!]!_JM>@T>X]Q[AZQ;DL6G&[5DM;+;<;FU#[X%T[Y02*?DN6/A]\B>
M#[W-B8>(J137MTX)"%9C&QBC12IJ3WD]I03H" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""A)'S.#@&Z--#37
MXT'S*^L,\KF2ZQ[=VSNO9%E;2[VPMX+2Y$@#3<6D_+0N>&$GPRT\?OD':/0W
MI+A^BO33;W3W#.\2VQ#'B:Z+6M\>60^U(X"M20 -==$2W2T4"(E,@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(""'?ZD%"9E0'B@Y1\[N].B"DT<K6CD:&CV71QCM[#K10E>J4" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @)4$J" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(('1!*'@DCL':A1+X@]=-3J-%C*46/YB
M1RT(I76O%3$(5/0I! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 00/ T-/2@\B_O8;&&2ZNKB*RL[1ADN;J5[
M6M8!I5Q)H!KVJ8AE;%7-7^M9TO;G),<;C*,Q++H6<6]'8ZY;@IKEQHT1Y(Q^
M[/!UIROUIHML89EG-FCI>RN(Y8HKB*Y9/#<L9*RX808GM>WF8YCN!!!KH5JG
M2&IZ@<TD4-3V46,"-1WC7@I$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%K,_E#AIKI5W#[2PB:S2A.CA_S<
M];+#!;+S_3C;4SY-\9F*%D#&O8(K:&&YB?,9':DN<QI:UNG$GL71VFSNRS7A
M"U@P\^M5IM#=G3?J)Y<]S[8P>-$#=M;5?#>8RY#73M?:VH;[RTMY7.(> [F
M J?@3)ANQ9->#+)AY9I5[73KK1A.G'EUV#G]XW)N2W'6N/QEMXC&SW$=NQL4
M-*TX-8"30J)V\Y<DQ;HPMV\WS2K(>F?FTV1U$W-:[7?C)\%E<BUSL;X\S7QR
MEK.:E>5FI .FJRW'3KL-O-6IDVTVQQ=8M( )Y>4U[Z]G%<ZV:J\PN5D@0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!;3L):X@5<-6FE?L*(MBJ)?$/KO)S=8]^S3.D+VYBZ8P.-0!'/*UFGH;5
M>JZ=96R)]$>YU=E&B\Z 321[IZD11RO:R;IMGO>!S5$@]XM6M]D 4H*!5M_9
M2Z/%GFCXECU!GN'=/.BULXM=#%@I9&,!JT.$[F5IW\NBSVMG]2[[=B,4,)V5
M)+;[UV9+!*YL[,Y9")P-*,DN&M?KZ>8A7-_CB,4^!FM?>JS#A$SVG$AC="*C
M@.!7D.URYXO3' (Q$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 02NX'M45'PZZ]Z=8NH(I_[;N_^42KUG3;J61X
M1[G8V45CV+_H&:;OZB"I%>F6?%>S2XM%5ZA/Q1XLLT?$\W?O_4+HR>S^;T__
M "IRV;6[^I=]NPPQK+!MH?\ 7#: [#F\::?_ (Y&K>_N_I3X)S0^^MNVL$)_
M :!30C0+Q\N-=Q7H% !W(Q10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$$%)P)-. KQ6N(FJ9?#_KYIUAZ@ZUKF
M[NG_ *Q,O7],B.2/"/<ZVQX+OH&\-W=U%<=:=,\_I_\ C%HJ_4[8[.]EN:K#
M?;P_I_T4>-!_-^<'_P!:<FPCXIKZ/<C;?;V,(VA_URVCW#.8[3_\<C5C?3\$
M^#+<\'WUMG 015/!K=/@!7E9<:8FLKP:BJA @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?;$IMRS'>V%A\W#?QBI+9Q02--:*KDQS"[BS1=Q9$QP<T$&H[UJE8B:IU"1
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M#*%O=PKK3TA8,4S(0RE#PUH-->_1)%9 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M@"-*5I7M1+T\&YPRL%.!8:GXEJRM^"_5N.M0#74G14G43H" @(" @(" @("
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MP"F&,HM)/%)(3*$B HJ"D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!(>(6,<1\6/,V!_GRWEI]U#\CUZGIOD]GN=K:</5#<?D<_P"O6ZO1@Y"/
M_6+54NJ]GBI[OS2^HC."XJBG0$!! \0@E:ZM->]3.B(FJ8$'@5C6$T2!_,[V
M=0LZ,:JBQ9" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MI_3F7;XK;[Z4YHC2>VDMN;<M\GGMOVF4NNIN5L[NZ!N+N&)S&1L<^I<&@U(
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M\!34I**J<TC8PYSG<HC%7DBNG?515E29U?$_S&96RR?6W>LUA*)X6.B89&Z
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M<T[F*Q#"*@N=Z_MK1%\3*E1M&PK[I;_N;5<QZNE9Y8<Y=3=/,[Y5A_Z;G_\
MX->J]APW2MX/-#Z Q.:0*#A77X5MG1T9A68[F!/X2BV[FX(5%D" @(" @("
M@(" @(" @(" @()7<#QTUT08?OD@;9S'-P]UFY*?N;E7W$5MHN[")G+$0XYA
MD8XPL'-4-;J?65Y#-BFVZLOJ6&R;+-5=[Q'#%6I_)N'QT65N.<G!KB.?@JOU
M=( :'34+5%LRQG) >8LGD#26L\.H[R05G\J6/SK5*<<KY6N<6T?J>SYKEA?B
MG3Q9V9(NK3N;?Z./ NKZ3YS!:M8*?C-_87H.F8IC[>EY'KT3/M_!T2R1C@"
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MVWF5WA<L:^+;EDUNH(,SAKI_Q:[.'KUWVAYC_P"EQ/;]Z\'F+WB/GX"P-/\
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MD8RU+XV^&27<.WN!2RPOWF6>/N7YM'U>TWTU&-\0\>!U^^]*L1CJKSNK_1[
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M4E>)X ZGT*^XN;BR?:Q_QA*1V6[_ -LU:,G!T-MP>#NO(V.,FR-]DI66EK$
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M%GF,;,V'(6O=S@EI![M"NQ@R\T.'N<$63Z&U1PT^-6X4Y5A6FJB4HH" @("
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MH.KR1J>];=O&/'DB9F(];B;[<9=Q6VVVZ8GT>FO<V:-P;:)]C<>%/<1>V_\
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M_P#Q]BG';,3_ (I_\BWO)K5]2+=H#FN'S37E&O'M7T&R-7/E?!;K98HK($!
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MZ#["[NWBD:O)YJS<]#B#Z^"W,4PX!$HH" @(" @(" @(" @((<S>\:<4"H/
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M=Z5V\%:.%FNE1#26>T974=V1. ^.I6O-DF>R6>++S\&JK^GTC<!K2RF0C-7
MC[B7O7+F)F>+OX+9I7BD<:->00:V\0K_ &"SNQTCS56JUTI15'!_;^5:M?+Z
M4\OI0F_.7/\ A,/^\2;/2R[/4@QP,36<PJUL_KUYEG,7XK.:DS$U[%;<7S92
MELS5E_2%U.I6PV\>7<F-<3_^,0J[T.VZ=Q;DI/FM]\.5]0VS_MF:9TKBO_\
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M9JVN((]Y[>L;NS)I<7UBZ2W>QIXGED?*#0=BHY^C12L7?<Z&+ZAM[;/O=R;
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MBZ[EBKDO?_4"_P!P7;L3;74D. M9P\6K'$-<\"E33T%;[-O16NW<RU:T.9[
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MU$B$3*/ (R :::ZI*3MXGYI JB'@[CF='@<HX'5ML1\!(!24V:N?["@L[?E
M'Y-I;\(H5"S;"[ T ^%0V414B* @(" @@@4U%$%QBI76^Z<%.#3GN#&X]]8W
M!2T7NA88??+^>%SW-$/*33MY@'?;4Q&JK?=2%U=XR*"W=-;R.<6'VV_U%;)M
MA7MNGO6T;A)'S<0!\/IHL)6+92RN9'1[G<C(M7N[@-2?@6N9GL;J1VL+Z78]
M^^][9/>]S'7$X0,M,'45$CBXO+P=.'*.Q=/:8;>,PY&_S3&D2ZM:T&I&HK4
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M^ZLX37VKV8FOXQ79V_!Q-QQT8Y9MYKRT'X8(']<%CE1BNJW5UEMK>V_F[[O
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MOT=)1M=.#EQ^M12W3T>^7<^F)FZ^:]\^Z'U:C)Y0:Z=R\U+V,*JQ2(" @("
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M_J^)>?WVWF:KN'!,VQ*7%O8V^MSS FI;0>HG[2C8;2:LLN&;8JST2-=1]14
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MCXXVQP#F;S$5HX=H)HHBW5EC\[IOH9E<_<R,LKZ23Z*M+W'G'#7D!,KN:GK
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M!U$;SPKV47-ZC?R8IGP][K=+Q1DS1$^GW,$ZR8CZ$ZE;OQ(D,K;.Z$;9"*5
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M@P@<M  XGV@.Q>@QVZ//9+M:0N6Z"BF9A$)T2(" @(" @(" @(" @(" @("
M@E=PIWJ81+4G63"]0\_L3*XOI;N:SVAN^XHVSSM\'&*)IJ'5Y(9W G3@U1*8
M?.;$>7CKYB]X8RPW/O/I[U"W_+939;&Y#=,]_E'PM@EAC?/:,O</<0VY:Z9K
M0(G T=II5!]/MGP9JUV[@(,]/9RYJVQ=G!F9+"K;9UZR!HN?"9X<0:SQ0>7V
M6Z4]D<$'.OG L,L.@W4&Z?G0ZT+;%S+#W9@-#D;:@$H]H4[^U89+>:V86-I$
M3DMAJW9U[>C:.T^6\FH,/9AO*XBE(&>E>:W>V^+@]YL<-LV_P;RV-=W4EG<\
M]W,[\N-"X]S?2K^UP6Q:H[[#$7<&:7US*+.[I-)5L3M>8^GTK?=CMF)_)5QV
M16-&@Y[Z_P#&GI?S"KSRCF/[*Y67;1,\'H<.WB;>#.MBWUR^XO!+=3/I$#JX
M]M?2K6#;Q#E[W#$=C9+IIG:BXD!YG$>T?1Z5<C%$<7-MQQ'9#GR>_O\ QIZW
MTP'.2WVCPKZUQ\FVBZYZ#%MJQ6C/]@WUX^;(&2ZF>.4<7'M/K72Q8;(MTX^"
MEO\ %;RQ$-BS74Y8X>+(-./,>[UK=&*.US[<<=T-#Y/(7OTGD@;R>C+E_*.8
MZ4<>&JHYL%LR[.##;,,FV5>7<E]<%]U,YO@$@%Q[7 #M]*C!MHAJWN*VV.#:
M8N)>4?E9/FD'VCKI3O5OY,4<KY<5:&R=_>^_WH;>3,;SN ',>P>M4<NWMJ[N
MUP6\L3^#UMI7UX[-1B6\F>!RT!<[T^E;,&"&K>8(I6(;B=-.:.$DE-=>;_95
M[Y5OVAQXLB*Z0T9F+Z]9D[MK;V9HYSH'&GRJGEV]D]ST&'!;-L:/1VI?WSLT
MQKKV=P\/@7'O]:;7;6VW:J^[V\6VUHW&RYG -99 .->8_LJ]ELMNC1QYLM]#
M3F[KZ\9FKAHNYFL+6D!KB/MKF[C!$NOM,-MUD4A0VU?WLF:LVONIRTS/T+S0
MT#O2L]IALMG5&ZV\66S6&ZQ/,UA;XTFH.O,>W7O5V[#%:]CD?+CN:9W5?W;<
M[?,9>3,:QL=!S'_@6\-5S]SMXF79V.&)MX/,PM_?G+68=>3/CYP".8\?C6&#
M;1$MV[V\1:WOX\U/SLA![>8Z4'K71^5;7^#@\D5X0U%O2]O8LNQK+R85C8='
M$<21W^A:-UBLNX.EM-O$V\'CX:^OCE+%KKN8-\4:%Q]'I5;;[:(G@M9,%L6R
MWNZ[G=2DLA_KC^RNE@Q19YG#^7'H:OWQ>WD<]B([N:,'G- YP^][BJV[P673
MI[G3V>&+HX,2QE_?>_V@-Y.X.D%07N[?A6G'M[(_X+N;!;%NM&^8Y[CE!]XD
M!+/OCW>M7HPVO/WV1W-9;[O;QMQ8-BNI6ES 74<>S0]JK9\%KH['#$L(BOK\
M31#WV=WY0%PYSPYJ=ZJ6;>(EU,^WMY>#?EC<3NL[.LTII *^T>T>M=.S#;3^
M#SE]D<TZ0U_O>ZNV26Q9=2M)' ./I]*U9\%LQZG3V.*+NSM8&S(7O.QWODWY
MQA^<> /K5/%MK8G^"SN,%M'0=K=3B"*LTA)8VIYCW>M7_DQV.'=CCNAA._;R
M[996ACNI8O;?6CCW#TK"_#;,?$N[#';,S6([/Q:Q;?WP(K>SN_*-)'.?3Z52
MNV]M='1R;72M&_<=/<&SM7&XE;6,'YQXT]:OX,41#@Y\<<TL2WU=7#+.T\.Z
MD:?&.H<1V'TK'-AB>*SL\43+5QO<ASM/TA/H74]H]Q]*JV[;%7L]CL7;>.5>
M=89YW]+<07SR%WTWMOF+G$U_QO9>E7[;(B-'G=QBCFFC#>IDCY?,[Y51(XO_
M (5G:5-=/H:]5K%#D;BVD2^B !YP17EI\"LN8J* 4@@(" @(" @(" @(" @(
M" @(""!X(/&SI:,=.#I[)_:E1+.R*L<M_P U$"1\Q4<G%?QQHFE/Y*G$U6%K
M*YJ'%?R5:?X,SY HM=RU+G/Y-O/Q3^V:IO97/;A'Y*(T_N0^0*I*O$5F?!(W
M7'Y<G_S>;]H5%&JS2YJ.P_B5OV_D&T'Q#Y$I+TV&:V),D0VRNZC7W1X IQH"
M?D6WY&.;.:;J3X,K^:(B8BKG+J18XIALKVWO8X,E. RYC'SF@,!:>[5>+ZW;
M;$S2[[4>Q^FMWDB:78XII[VK6X>]N0)FW<$K>SQFPEU/07$E>:MVL7?%S:O9
M9=SCK2=%9V.N&1\LEY#:@_=M=&3ZS1U5M^7-6,9K9X*1MK>-@%SG \'@]H<X
MT^!.3OEG6ZFD+22?&Q 1V[)+IY_N[Q5KAVZ$D_86-;;+HJ71DY9FCM[I+N.V
MW'98:YM[4VK+,/M3$0 T\@ #F@?; 7O^CY8OLBGH?"OJJV_'NIC69F9]Z[MZ
M>\Y+M(O[IM.\B0KLYXGE6MK==9MXFZ*?#'N)@&0W#@>8N:\.]!Y3HIQ7Q%L5
M;<NZNMMCX=*- ]3+/%1XRROO'CM\HQC&1,=4AS214T%?D7E^N9/AFGVU>G^G
M+[\E\4LT_@TNW$W5X\3LOXG$CVP]D( _%<7<P^)>-I?,T?09SV6VTNBD^M?.
MQ]U"P-DOH[<??M='\H=59_*EKC-;/#\5+W.%H9XV;:\ U/+++I\ "3CF&43=
M/"V?N6\TN-@<&ATE]).0PS<SG,;737G(=V]@6N;[++J3Q9VQ=$UX0ZMZ,[EM
M,GB<?@X;-UK+A+^S<^6@ D\20CLXTY>U>UZ/?$P^+?66.;LTS;K6GXMAWAY<
MON&NG^,9Z$?BQ]B])F^+@T]+F)LIZ94WM))IV\"%%ET1"[$\EE)::ZFVN-FP
MMS?7%R8,A9AS;%H]ES^<U=RD$'2@7&ZGGMBWBZ7TYEOQY:\D<)]\.>68VXNB
M3;WS) R@<'EI=[6M27'T=J\'ES_,O?3[]U$1\44CO7@Q%]&WVKF 4T^=&/MK
M%JC=8N]+[HV!O-/EXSWL;+(>7X *?$I]9&XMGA$_<M)G8F-IY[B7($:$#FDC
M)/"K9BWA7L!474F([6=E^2^L1;2'8WEQWU;7F&=LF/'BWGQM_9W;[Q@:&.CE
MN8F4Y13447N?IG)%L1;/VU?&OKSIT?.G+S=DQ3PBKNN/G!8PMJQCO8>-*\"O
M<73%*OF6.9MK#U&]JA,ID! 0$! 0$! 0$! 00(!X@%! ,8!0- !XBB":B @(
M" @@>SUH,#WE\VS_ !IOD:K&'BI[G@P,]JN]CF=JXMOSS/QQ\JT9%K%QAEV\
M.-E^*[Y0M6+M6MQY6&/-/3HK$.9BXKBR%+VT H6%U'M=J*D'L6NZ;HJWXK>:
M[5M./&639&W$=A;>+QYQ&T&M.^BK3DNGC+J68,<:Q$>QY>\F$;9S!X?P633N
M]DE3M_U(:-[']*7#XX'T-_WQ7H,<O)Y(0<!22M *5^PMLRU1#=^&P&,DZ:Y3
M*26,,]U&)7-N'1M,@#6 BCCKIV+EYLDQEB/0[6UP6W89F8[6CS\TM I7LKV#
M@NIABG%R]QR]CB3?%#NO-Z?^73$?V174Q37@X^6)B7E[>H<]ABT<K??(^:O
M^T%CN[9NMK#=LXMMNB)XNV/.? &P;%+6,8^0S%T@ J0&#B:+@=/F;KYB-?\
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M_P!.$=;B/F3X0TGP#=>'%=*[BXMG!'L63&Z10'?ZD'4?E3I_/K/:_P#L%_\
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M^(5NV];KFG<7\MOBZ^B:6T#N#*T*]!CX/,7SJKTJVO?132DL.Q4'!36J44!
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M3?Z[Y%:AYN?,T_O;^6HOW"/]N]5LO%V=EY?6\?"?RI9?NGVPF/BWYO++?,?
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M/P6]CQ:N_N@/I=\A5".+MW^1?]8/]%^*/_OG;?\ \6LUT+?*\UG\\L.ZD?\
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MGQ))[ H>@F-$A&CO4?VJC+Y&F.,>+46WO]/NP?3N*R_;1*=CYO8U_4']C/\
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MQ:<D:.&LN!]*Y76M+M^G]<N]MYK#RN[BDO-U[=>T%;\CGVRW]T;UL<[Z6/\
MVK5R-QYH\7H>F^6?!HJ]_C=Q^ZN5_$XN\_N/7'X+7L/%P[:<5:[&O>S2;71'
M0]@E@W!,]]>0VHY:#M\73AZ%Q^HW\/7^#T/1;:VSZOQ;%ZAD,V;GG Z?1\]
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M+V'3^'L>B:=B+=_%1G<1',X4T8?E"PNXPVXXK=:UAT5S=OAMZYR2>&:4^'&
M(QZ'>A6<4N+]1XYK'K_!OZU/.)IZN'O4SI&QNT(#B7?;6V95MGIBCPA=7 Y8
M+G\5U!Q^Y*QENS9(Y6PML_R)COW!G[4+7+SV>ZLO<K\[TUI\2P84T<SS_P#6
MG>'^&0?\CA1ZOIGE^W<K#L]*.E=Q1+@*]Q!I\2QEGF\C36RLA;XKJU9W-Q&Z
M2*"7F+6"KM"IA5Z]9,[;UPZ6\<7-[E;UH<UMWD)I;</T-'-C&OQ+;6K@;*VF
M'UJKJEI[N2M0LI='YD49[MBON/#BU82\WO9K<R GV?@^V%@U?RQXN<=QZ[^W
MKZ#CO^2,1Z/IO#[=ZG3V?C1Z&>"GV._%=\BC+Y&J.,>+46W?]/NP?_J*R_;1
M)L?,PZ__ &4_Y;O=+ZP<)_Z[[07I(\L/C=O&5V."Q$4! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 00HB2@K5$(J!BN]*?S8S??[K+^T*W[?SPK;W]*7#([?4/VR
M[F-Y3(@?F'\0_;6Z6JUT=@?]#^7_ !)_VC5R-Q^M'@]!LO[>?%SEV-79G@\[
M?YD :'A6JU6<&=SKOI4*[2M&UT,CS\BXN[\SU73?(Y"\\.D^RQ^%<?M0NATC
MC+C_ %!.D>/X/GX/F/[."]1'"7D)[/%D^R-=Y[4'?EK+^_,6J[^VGPG\5S#_
M '4>,?@Z\\Y_\>V!5H_DYNGP/7$Z'&MW@]!U_P MOC^#AHG]@!=^.+S.WCX[
MF6;"%-[[/[*YBQ_Y0Q5-WY?5++:?W4?YK?>^ZUIK8V]=3X# /B7A\GF?3;?*
MOVBK8R?A2$QP<U]<-+W! #0-NQ]F%=/9//=5C6/6T5J>)X.<NO/8XT^67M[=
M_EO'?NOVBJNZ\JQTW]2&S^M?\J8C]P/RE:>GK_6/+ZOQ:4/:NA'%QY\L>#W]
MKZ;@Q/HNH?VP5;=>65S8^>/%W*#6,'\$?*N#VO5QY7Q=\Q'^FG?_ /A\?_)X
MEZWI'Z4/%=<_4GPAI<Z_":+I3Q<:'6?DV:3U5E[0,?+H?4Y<GKG]O/C#N= _
MN/5+67F$%.KN]Z#A?.H/C5CI4?\ 2_\ >5>LS/[J8_[,-,=_J5VW]/UN9?'Q
MSX.RO)3_ *2-Q=W\W)B?_6[1<;KG#UQ[I=_Z=\T^$^^'U*H"2O+6O9RM[P?P
M:?\ <W4_L2L[.+"^-'!V8_E3+:_^5R?MEZ3;^1X[>3\<O,&O9\*?S,(C1OWH
MYK89T?@N_:M7+W?ZGK=;I/&[P:+N_P"-7'[JY=/%P<GJ7]QZX_!;C4Z]A6V.
M)F_E=#]"B3#N$UTY[7V?_'+C]3X^W\':Z%_\G_=_%LOJ-_U*W*0!KC9_@T"J
M;+]2/%T.I_VU_@^$O"OH.B]OB\L/G^7]*[P0-14UX#0>L+=?P:,?Z,^$/HIY
M< !Y?=]Z:^#="O\ 62+S'4/UK?6];TG^UGU?@^=\NDC^SVC\J]!C\EOA'N>7
MZGY_;[TE">0#TD_ K/\ (UY?T_5#ZH^3%X=TTR7;RY1W]Z:O%]2_4C[=KW'0
M?T)\?PAV&SAIV+G.VG(KQ00IIH*((H" @(" @(" @(" @(" @(" @()'M)X*
M!(&<M3Q/:$I"%.0Z4H*GL/!94@JYBZZXZ+&Y':V\;>)L,L%ZVVO96:.<V2I:
MUWH'+W+E[FR*S+K].OFM)96QY>6FA<UQ(KZ N5?.KKY(T!J\BG]55,<&6/RI
MQ&22:D#3L4U$#Q0$!!%00M[B9MO$Z5_S6J12M;UEW$'L';1!<N8PN!,8<1VJ
M$IZD4+2&M'$#@I$?FFG.'&35H1 6OU9R^UVK&891=$,3W/NS&;;M)722B>^(
M\.ULA\^1[AH-*]_<IMQU:\F6D/0Z0;2OKB^O.H&X;=T&2R6F-MGZ"* #PP17
M74573V^WI27&W>YYJVPZ1CX \:BI*Z<.6J*00$! 0$! 0$! 0$! 0$! 0$!
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MC_Y/$O7=(_2AXKKGZD^$-*GB/6NC/%QH=;^33_2I-_D^7]JY<KKG]O/C#M]
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MWWPZ\\Z'\>V!_DX?[]<3H7&[P>AZ_P"6WQ<-#M^%=Z.+S6#SW,LV'_UWV?\
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M.A_'M@?Y.'R/7$Z'QO\ !Z'Z@\MOC^#AG[=5WHXO-8/-<RW86N]]G_Y8L?\
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M>TI+Z%,:1(TZ$%NI %:^OBK<35QETI! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!*6U_800Y!VHBB!:T<.W0E*IHQ;=;1/@=PQ1!OB?1ERUCCQYC"X!8Y+:V
MRW[6[^I$>F'S?VCD++)8YMI+&P7V,FFCE( 8]KO%<X.:10@T(U"X62V.9]-V
M6PYL<3=PHS?FR3@&'/Y22)M/X.^]N"T-'W-"^B1,<LQ!FV&TB^(FV>:NFO;[
M56WB9;0PPQ-Y(X6EL8)KH23J5IBVY?PX/EIN9C?SCBWL8!Q6R+>]MNLF6.;I
MRD6+Q4UR7M9-J(&]Y[=%%_PT6=ECO^9$3P5?*T2W?N?:&U#66[P1P#*.T5_:
M4EYGZXBSX>^(N_!]&O!862!H!:\@DC["ZD/F4Q$Q*QR;/#QMZUHHUD$A([7$
M-( 47Q6*ED3$Q$/F^+FU.<W#A;ZUC9?0W1G@#VM+VMF_*:..HT<N/DMCFH^H
M]%V/S,/-D]'#P9.QN39'%''N#*\C:>' ;ZXY&"G!K>>@^!5[ICA#?GV&"<G)
MR\5:UMFV</AM>^6KG.<^1Q>\EQJ:N=4GBL:2O8-O;BX*G/30@ DU /<E+FZZ
MRO!Y>7R4&.L;J]EH!#"]S6-XN(:2!Q'<M5]\VS26S#BR732>##NA9DEZJ8RY
M !I<,?*XZTYG:571V<1$U<CZMOB<$V3Z'U"8&>&0*M8-0*Z^M=>[TODUD1PC
M@DNHP00T5#:%NO;0K"8B64ZR^>V^;FU/5W>>.OXXIXYH;1UI'-&PM!H[G+:\
M#4C@J&:RV)?2_I[#;?AB8]/O5&-NXHH8[7-Y2U8SF(@9?7 C;0T :T/H./8%
MSJ:Z+63I5E^76-/&48H'1^-(;F>YN+ES7W$UQ(^1SR!3BXD^I*2NX-G9BX>]
M=$BA<#1V@(^5*2LS;,Z1*VO;VUL[.6YFDY6,8X$=[A7ET]:PNN[):=OBRW9I
MMG6W2C3FQ99\GUHZ>7,;?:=N&VF+^YK9&<?@"V;6D7:,?J>Z,>VNM]%W_E?7
M&(-)#J@U[>"[]DS,/CLZ2NUD@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M!1<T.!YJN:3H.ZBB8JF)6EWC["^9X=[:QW43A0QS,:\:]X<"L[;IMX2PNMMN
MXPH66%Q>-(]PQT%D> ,,;& 5_% 4SDNNC641CMMG2%_X+*UUJ#5SEA#;S319
MW.*L+UO+>6D5VWL$L;7_ "U6<7S'"6J<=L]BG!A\9:"EI816Q&CO 8V,Z^EM
M$G)=/:?+M7_(!7M -1J2?LK1?Q;+=.#YY^=XUEV5^/<_M5Z'H_&7F.O16(K]
MM'S_ &_->O3TTGP>/F=8CTLGV1_UTVG_ )6LO[\Q:;O[:?"?Q7,/]U'C;^#K
MWSH?Q_I__DUOR/7$Z%QO\'H/J#RV^/X.&AV_"N_'%YO;^>YEFQ/^N^S_ /+%
MC_RABJ;SRSZT[3^ZC_-;[WW9L-;6T'=$WY%X?)YGTVSRO1 IHD 0#Q4BGX;"
M6DBI8A.IX;36O:>Q1.J:R!G+S!NE>)2(B$)FM#1K3TE22B=-0:? I0MI>W\7
M[:F.*)X/BWYA_P#35U _PZ/_ )/$O6](_2AXGKGZD^$-+E=*>+C0ZT\F_P#I
M4F_R?+^U<N3UW^WGQAV_I_\ N/5+67F#_P!+V^/\H.^VK'2O[7_O*O6?[N?\
ML?BTQV!7;?T_6YN3SSX.QO)4/_N7N'N&VYS_ /OEHN/UR=/7'NEW_IZ-?5/O
MA]4 O*VR]FBIF!*0#6NJD2\C>QOQ\%%UL21*(92FM/0$B*12$U1+0=:5/I63
M%(6 \1\"QF(3$H\@%./%2A@G4K_J7N3_ "?-\@6_9?J1XJF^_2GP?"8\?A7N
M,44LM\'S_=>7(F=V_BGY%LNX*]GZ$^$/HEY<?^[[OK]RN?VDB\QU#]:/6];T
MG^UGU>Y\[YOSC_QC\J]!C\EOA#R_4_/]N]!O9ZPK,>5AE_3]4/J-Y*O]'&>_
MRP[^\L7C.I?J>K\9>VZ#^C/C^$.RXOF_%\@7-=Q40$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\7U/]2/#\7M^@_H3X_A#LA@HT#T+G.XF0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD+-UL'\E7M=6OWKJI-$15=QQ,B9%%S%SHPT'NT4,Z2\>SQ#;7+9+*&4O&0Y
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M_-5!U51 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @A0((H""%!W(  '!!% 0$! 0$! 00H$"@0* (% .Q H-?2@4"
M!V((I0$! 0$! 0$! 0$#TH" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M2AZ==*_(@B@(" @(" @(" @(" @(" @(" @(" @HR2.:32AX::UU02>\@CF
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M$Z @(" @(" @(" @("#F?S?AS_+?U@8?F'!BGK]XA0AI?ZM84\J6T1SBOO\
MDM>[^%.2"6=>?,U\IO6*GM 6..JW_P#*MGJB(XN0-G2,;]4Z'LD'Y+$Y,,D
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M%[3WH-[=+,WC;F\VM(V\COHX9(KJ(VXAG!>0&P/<TCFH=*U("#6F1Z.#KO\
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MVQ@,%G$?$GYO=GLEHV($GE)=1$-V=1.LF*Z[^1/J+U#QD3(AD=IYB#*V$;G
MPW$%K*)XPT\KA2O, 1P(XJ$RY"\LN^?.#O#HSM'9W03!XW;FU]G6!L;C>.4A
MLY'WU\9))Y!&+U].41RQ@$,XU]KL$PB70?EK\U?6>7K=E/+GY@\9:#=WA";
M9:WBAB=*V)LIE+_=2Z&CB&!O \:51-'U$9("V)H'*7-]AO#A3L1#C?SC^9X>
M7C9=G]!P6V4ZA[FD$&UL+<"1X?Q#Y2R.E0TT&KAJ4',&(W)]9"S;AZ@S6F"N
M[&>TBOF[.N;;&,D9$6!_+[,K):M8XUJZM0@V1Y'/,KU+\P69ZK0]0(;?'P;=
MO7MQ.(MX8HW6P\2GAN=%5Q K]VXH'EP\R'4WJ3YGNK?2W<M_:2[6VE:7MSB(
MH[:&*1CK>[B@8#(Q@)]F0\2E2C9/GFZU[YZ$=(8]Z[!NX+7,OR5M:>)<013,
M,<TC6.);*UVM'(EEVX>O,G3_ ,N&'ZP;AM)<QF;S!6ER+*U@>_Q[^ZC'AMY(
M(W$-+W"N@T[0H)<?;6WC]8OU9VY_G VZW!;*PM^9)\/MR>TQIDFAC-6ZW+GR
MMYQI[3AJI&Y_)GYJ-V=;+S>/3_JCC+3!=0MFR#Q[>!GA/DMY&CEYF!SF\U0X
MZ'@1HH0Y3QM3]:86AQH^"[#JU-06R"E'5HI2Z)\P'F3ZD].O-?T.Z4;=NK./
M9^^<GC;3<=C/:022NAO+N*&7PYG,+V^RXTHY"CFKZRB+K\VWADSE[C).DLVX
M(&;5MFQVC+B.<,?J]U1*1R\.90.K_++-YG,-L6\R?4^ZQ#MDV6RI+G9$=A#8
ML=%<Q"-\7/[N22 P.%"$$_D5\P^_^OFTM_9WJ1D+2>;;ES:LM9(+>&V8R-YN
MO$YO#8VND(U/I4C5>\?-#YA.K?63=G2[RNXS&,Q&S+F:SS.\9[>"<>-;O\.5
MHDO"(@WG! HWAVE$+)GF1\TOE[ZC[.V[YF+'%9W8V]KJ/'MW18P6T)@GF;^1
M-;,D"CZ!U6</C1+I#S3^9S,='=L[6BZ=;:.\=Z[[8S^:,?A22VK1,6!LLCF\
ML8!87$<SVHAS5N/=?UCFSMFW_5;*W. NL5BK%V6RNS6VF,+H[.WC]XFYGQ.Y
MB/#!^;)S]VJ#?_3_ *\=3?,?Y<#OKHU%88KJ/!F)L+D;>XC8;>.6&)DLI:VZ
M( HR>(C4]J)?,'HY!YIO]:+K2=D9'$Q=6/>)6;WGN+>SDMWS1F0O=$R3\FVI
M)^;IW(/HOYWNO'4[H%LKI=D=J75BS+;@RD]MGI9[6WN8GLA;&:L9*QX:1S\6
MZHC1T5UIZXX?HCTDN.H6>\*YNC$UF,Q_M,==7;VEP8 P:\*E!PGLKJ%]8CUF
MV]#U*VI;X7:&V\G&ZXP>"FM<67S1$!S7$W+WR4([R$&ZO*CYM-T]3-V;CZ-=
M8L-:[7ZO[.@E==V<3'1-N6P3MA>:-+XBYP>UXY'4I6@IP02T[YAO.#UNZ9^:
M"]Z2;%QEINK&RV=C]'8)]O Z5]S=V44P/B'DD(:Z0\'<!JB7A=3NJ7UA'1W;
M<G5C>$6#N=GV#K>;-;<MK7&EEK%<2,8P$Q/-P:.>T&CB:G71174?2WH%U0@Z
MT=(]C=2K1C(SN7'B2^9&'!C;N"1]O=-:':@-FB>!ZN*E#= K05XH(H" @("
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MOH02.>U@JX\J"QGNXXG%KW!KZ>PW[[2H^/@B5RV7F#374@%P[CW(A< U""*
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MAZ]$&ZOK27L=Y<H2'"HSECS-/%OY6.@/=IV(AL?=/63;/0_RC[#WEN3$6FX
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MY/C5!.E1Q4C'MHW!=]7I,\.,4G\UF\TIYC0\\5*@FM'<*U[5 YS\DGD]Z?\
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M7364/)R9:<@N'93E*B93$/KI;M\.*)CJ@M#6\W"O*-?C0>@I0(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MO*"#7CRZHE]_1&V6./L%- -411R)YJ_-+;^6:#9L]QL=V]&;IO1:%C<C[@8
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MU2+B"CAS<?N'M ]14E>UPIYQMWX387G=Z-[NW!.ZUPN$QT%W?2LC$A/+("0
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M:GM4H7* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @M9'>V>7B-'
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MWUZFS0>K.1^MNM2#4?1+A7T_S4 2I1]CU*! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ARCN010$! 0$!
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=" @(" @(" @(" @(" @(" @(" @(" @(" @__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>tm2227887d1-bc_icar4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_icar4c.jpg
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M9 3.YH@8VKI)6#B@^DJ @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M2@5*!4H%2@5*!4H%2@5*#SF)\&7C]@[ZRK;I*U>L,/#W_JC]5>5F7KX@UO\
MU1^JF9,0:W_JC]5,R8@UO_5'ZJ9DQ!K?^J/U4S)B#6_]4?JIF3$&M_ZH_53,
MF(-;_P!4?JIF3$&M_P"J/U4S)B#6_P#5'ZJ9DQ"V9&20&*CW#@>1/H7G>=:<
MQRZO&K'*V^++_E'?5*X>Z?=U=L>QXLO^4=]4IW3[G;'L>++_ )1WU2G=/N=L
M>QXLO^4=]4IW3[G;'L>++_E'?5*=T^YVQ['BR_Y1WU2G=/N=L>QXLO\ E'?5
M*=T^YVQ['BR_Y1WU2G=/N=L>QXLO^4=]4IW3[G;'L>++_E'?5*=T^YVQ['BR
M_P"4=]4IW3[G;'L>++_E'?5*=T^YVQ['BR_Y1WU2G=/N=L>QXLO^4=]4IW3[
MG;'L>++_ )1WU2G=/N=L>QXLO^4=]4IW3[G;'L>++_E'?5*=T^YVQ[-/YRXG
M&6OP)Y /&/V1_P *UBTXZMZUC'1:_>+C_+R?LC_A4]T^ZW;'L>\7'^7D_9'_
M  IW3[G;'L>\7'^7D_9'_"G=/N=L>Q[Q<?Y>3]D?\*=T^YVQ['O%Q_EY/V1_
MPIW3[G;'L>\7'^7D_9'_  IW3[G;'L>\7'^7D_9'_"G=/N=L>Q[Q<?Y>3]D?
M\*=T^YVQ['O%Q_EY/V1_PIW3[G;'L>\7'^7D_9'_  IW3[G;'L>\7'^7D_9'
M_"G=/N=L>Q[Q<?Y>3]D?\*=T^YVQ['O%Q_EY/V1_PIW3[G;'L[$V62[:FWW.
M)<3915)XGYJ^Q\+]"GPA\3YWZ]_C+)UU.40$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$!!AF];JYM+"T?:W,ML]UQI<^)[F$C0XT):0J;)Q#
M?QXB9G+63LWEF\\M>"O_ )^3[99=TNOY=?:$XS&6H",M>&O_ )^3[91W2B:5
M]H0=F<OI/_M6\_S\GVR=TH[*^T#<SE](_P#:MY_GY/MD[I.ROM [,Y?2?_:M
MY_GY/MD[I.ROM#S=FLQ1G_M:\X_^?D^V66VULQB9.ROM#T&9R]/QK>?Y^3[9
M:1,XZG97V1&;RC&O?)F+QK6BI/C2'E_SE%9M[IK6L>D*%FZ,G>\+'*WCB#QK
M-)3A_P Y7S*V*>T?P>GTUN'63)EKEH=P $[Q3_Z2O294O6L](A-'GLPR3W>X
MR]T*\8WB>2I^74HM,D:Z^RH.8S%:G*W@]'CR?;+.;3[IMKK'I"4YG,#_ -ZW
MG^?D^V49GW1V5]H0^FLP?_>MX/\ Z^3[9.Z?=$TK[0?3.8_UM>_Y^3[9.ZWN
M=D>R!S.8_P!;7G^?D^V5JS*)I'LA]-9BA_\ :UY_GY/ME%K3[G97V!FLQ_K:
M\_S\GVRBMI]SLK['TUF/];7G^?D^V5^Z4=E?9.W,9@_^]KSA_P"?D^V3NE/9
M'L/S67X 96\X<_N\GVR=TG97V0;F<Q_K6\_S\GVRB;3[D4K[/09K+ <<K>?Y
M^3[93%I6[*^SS=FLN:4RMX/5/)]LIO,JS2OLE^F,R>66O?\ /R?;*F9]T=D>
MP,QF20/I:]X_^?D^V4QW3ZK12OLF^G,HUVEV6O 1WSR<?_I*LVF/5/97V@?F
M\N>65O !W3R?;*GS)F>JMJ5]D69G,$_C6\_S\GVRZ8F<+5I7VA%^9R^H_P#M
M6\'_ -?)]LLIM/NFU*^T(?3.9H:96\/_ -?)]LH[K>ZL4K[0\QFLT30Y6\ [
M_'D^V3NGW3V5]H1CS6;<]P=E+S2VFD^/)Q_^DG=/N=E?:$[LSF ?QK>?Y^3[
M9.Z?=6:5]AN9S''_ -JWG^?D^V3NGW1V1[#LSF!_[UO/\_)]LM*6E,5K[0E^
MF<Q_K:\_S\GVRBUI6[:^T(C-9CBT96\->WQY/ME6MYCJ=E?:$)=Q9"TT&;*W
MKG$T:/'DI7N/M+HI;)V5]H8C>[JW<[WACLE>6\<SBV!\<T@+1WU#N"Z:5B4=
MD>RU6VY<^QLEO+N;*2RM;2OO<U:^O6M/EQ['RX]E7CLOO>6*1C\[?-A:26S.
MNY7/(/>2ZJ=D>R)UQ[/&PW)NF.ZN?$S&6<RW:3KFNIG,>>/+VZ<*)\N/9'RX
M]EU?N?.7]C)+%G<A9Y!@'A1BXE#'@UKP#NRBF*1'HF-43Z,>.X-VAD4<VX<K
M"U[PSQA=SU->?'7V+2*U]H:5UUCK$*/,;EW%<QOQ%CNS+QW$1X74=[.R0D\Z
MO#Z]BWUUI$YF(_@ZM,:L\UC^$-([BRW6''7+Y(=W[F=::2&O9EKTT/#CI$G%
M>GJKX\QS6O\ "'5\C5;I6/X0HMFY7JUN#,VXGW[NR*RM)F273'Y2]8UX;7V3
MJE' ]JGR::*UXK7^$,[^-KIZ1_!UOC,SFI[6Y9/GLDUSG$1GWF4N;0<*.#J\
M5\_>*]W1SVU4]H_@UGNG<.[HK"\M;7=N9BO&!PA\*^N&2>CBU]5Z.G7KF8_#
M'\&FC5KS.:Q_!Q?F>IG5VQNY&-ZD;K8&.+'QG,WW"E.SQ?2O?U^+X]H_)7^$
M.R/'U?VQ_"&$9?KEUFM2R&WW[NR=K35\C<U?-=0^GQN*Z-7T_P >>M*_PC^B
MUM&G^V/X0NFUNJ?5_*QS75QU1W? P.]B.;-Y \JU'WXJN_Q/'IQ&NO\ "/Z*
M_(U?V1_"'7713(]1<U?/RV;WWN2ZQT3-,5M<92\D8\NU5.E\A!I0+Y[ZE356
M8BM8CKTB/L1;1JB/RQ_"'2<N?R^O3%E[_0WV:^\2UJ._VEXDTST>9;56;=(4
M]UNB]L877%[N6>UA;\Y\MU(W]'6MM.B>F,NC_'K_ &Q_!B\W5C"Q%\<G4&,>
MR0"W)$N%?0TBA[JKHCQ+_P!G\G5'B4Q^2/X0JML;WM[YTT..WW=Y2:4%S()[
M]TCA^M)=4+/R/&M&/PX8;/&K'_F/X,I^G,N':?I7(-+0*L=<2'B>XZN*X;UF
M&,ZJ1_YC^#W9FLP2/_:U[Z:SR?;+&N?5S[:TXQ$)SF<Q[7_M:\_S\GVRB9EE
MV5]D69G,4XY:\^6>3[95[I.ROLB_,Y?3496\_P _)]LG=)V5]DGTSF--?I:\
M_P _)]LJS,QZIBE?9%N9S%/QK>?Y^3[91W3[IFE?:$XS.7_UK>?Y^3[93%I]
MT=E?:$?IK+@?C6\_S\GVRGNE/97VAX_3&9J3]+WO_I$GVRK;NGI*MJ5]D?IC
M,CGEKS_/R?;)$6]Y6KKK[0I[G.YB*)SOI>]'_P"T2?;*\1:)ZM/EUQTAJ_,[
MMW9;W+G6>X,I)"T\6B[F[?\ GKV].JMJ](5KKKGI#S=O3=-S$&G<F2M)*5H+
MN8']!ZO736N<Q#:^FO'$?P4K-U;O;&71[KREQJ-'$WDYTT[O;[5%JT]H_@I\
MFOM#R.ZMZ2-+!NC*-U<W"]G!'J]M3KUTMZ1_!:OC5MZ.U=OOEDP.$?-*^>9]
MA;.EFD<7.>XQ-)<YQJ22>))7EWC%I^+RKQBTQ]J[JJH@(" @(" @(/D#UD_^
M<EY3OZJLE_ZIO)!MWXK^S#NSR7;[R$44T]UL3+X3<5M! QSRX-O68^9S@W[&
M."]DD<3P ;4\JH.J/*UNS&[X\MO0C=&+O;:^M\GL3 BYDM)631Q7D%C%!>6Q
M>PD:[>XCDBD;S:]KFFA!"#Y8]%MI?[ROG.^)ENG;UU%88V\V5?\ 1^":X>',
M?=9&!F(;=M=%J#HB_ /D!!KI>WA4H-[?!^W]%NGRE,V?)X$&0Z6;KR^%DLQ*
MTW!MKY[<O%<2Q?.8U\M[-&TD4<8G4/ @!K[S1XVVZN?%#\G/36"X>Z#IIBAO
MG-W=D!,ZTGL;F[RT,%UIKX0D=B[=OMTX3,(^<VH>_DIDGZ9_$)\_?2#./B=E
M]^9-G4'&RQ$Z#9R7\V1ACJ:>WX&XXM0':UW8$%^^,9DY[CR[].^GV$#<GN[J
M'U)Q=E@]JV_W;)7\<%G>EQL[5E992VYDMHSH::.E8WF]M0U[U2VUC^CWQ3?)
M1D<K)+C=FW?3MNSL)N.[C<RVNLM!C\WAH+.*0 M,KGWEDTM'(S,K0.!0?0GS
MO;MQ&RO*)YB\QFY70V=YL3+X&%[6N<3>9^!V(LFT:":.N;R,$\@#4T'%!KGX
M?_3J?%^1#HQL?>EE'/;;HVSD[Z^LHY7@2XO=%_>Y*W:9(RQ[2^SOF:M)!:2:
M&HJ@MG]UQY$_^XS_ .Z;<_\ *R#6W67X:_DJVIT@ZK;IP'1?W#.[:V=G<KA;
M[\H]QR^#=V>/GG@D\.7*/8[2]@-'-+3R((0<U?!'%-K]; .0RUG3_,-1+[NH
M@0$! 0$! 0$%OO?G1^HK';U;:E"LFH@("#5G67K#LOH7L#,=1-]WKK7#XP"*
MVM81KN;V[D!\&TMF$C5)(6FE2  "YQ#6DB:US*)G#E;R>^:OJ;YF-U[]R&<Z
M9.V?TOM+.)^Q<U'#<R1R3PW#X[B";(2:89YBU["6QL:&Z#P5[UB(5K,S+NS*
MW%Y:8O)7>.LCD\A:VLTMCC6N:PW$S&%T<0<\M:"]P#:D@<>)6<+/D1TO\_W5
MWIEOS'],_.7L&3:@RDK66V^&V+K!]NV1P:V:>!M8+BW#C1TMN1H_4O(*VG7$
M]%(M/J^P-O<07<$%U:SQW-K<QMEMKF)P?')&\!S7L<TD$$&H(6*[V1(@(/*;
M[S+^L=]95OTE->L,.')>2]A% 0$! 0$! 0$%JR/.+U'])>=YW6'7XWJMJX'2
M(" @(" @(" @(" @(" @(-.YS\;Y#]V<M8Z.BO1:5*1 0$! 0$! 0$! 0$'9
M6ROS2V]^ Q?M5]GX7Z%/A#XGSOU[_&64+J<@@(" @(" @(" @(" @(" @("
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MRMNSRL8+=GFQZ8^;"XW7?VF?Z9;9N-M6.THX(G6=U%<19:(S23$^(UP&6>:
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M=0,8&MR>#OW!M9(7.^?#*6,$T)($@:T@LE9%+&')%U\.+?G4O([)L?-!YO\
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#!-_?BVR_"?\
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M#31RX.ZF;>,&X9Y'B69H<9(R:T -%]3XFW-'ITM,1U:CR%W-CYF/:'/8XTT
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M(" @(" @[*V5^:6WOP&+]JOL_"_0I\(?$^=^O?XRRA=3D$! 0$! 0$! 0$!
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MUZPPX<EY+V$4! 0$! 0$! 06K(\XO4?TEYWG=8=?C>JVK@=(@(" @(" @("
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M<,G_ "XGZF.IPJ#18S&)PTB<LX4)$!!Y3?>9?UCOK*M^DIKUAAPY+R7L(H"
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MBG/U+FFT>JL>2ZIQ+@[%8QP-0ZUA(/>"P+EGJ\+9.;3/VK@H4$! 0$! 0$!
M0$! 0$! 0$! 0$!!I[S#_P! '7+^K[<W\57*$/D)\$?\V.MO\+VG[RU$ONXB
M! 0$! 0$! 06^]^='ZBL=O5MJ4*R:B @(/D'Y]8[?*>;;R6X3.!LNVI\]CVW
M-M(:QN%SG;*.X:\'2 U[&,#CJY=G#CM3\LL[=7ULRV4LL)BLGFLE,+?'8BTF
MO;^X/*."W89)''U-:2L8C*\OC;\,+$7?4#JIYAO,)FH2;_,73K*TF?5Y\?-W
MDF3O@'$4JSPH14=CNY;;.(PI3J^A'G,DQD7E9ZY.RVGW4[6NF1:^ ]Y>6MM>
MT<?'+*>E9TZK6Z-;?#D%^/*#TQ-[J\-UQG3CM9!^X?3%X!3M UZJ5^M13LZE
M>CN-46$!!Y3?>9?UCOK*M^DIKUAAPY+R7L(H" @(" @(" @M61YQ>H_I+SO.
MZPZ_&]5M7 Z1 0$! 0$! 0$! 0$! 0$!!IW.?C?(?NSEK'1T5Z+2I2(" @("
M @(" @(" @[*V5^:6WOP&+]JOL_"_0I\(?$^=^O?XRRA=3D$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 08'O\ _%MG^$_XCE2_1OX_66I^
M;@HKATUF<K7N60LQ570FYA#@)(1QX'N"[-&S$N[5>*]7-.\^G-I=7#\GC+?P
MF3LJ^W+1Q-!V +Z#Q_*F(Q+LKOS&,M%7?3.YR=T&7.,F\*)P<"UM!PY?8KTJ
M^;%(ZJ6Q$QRZ'Z?[!APCH;F[A<'R-]BG)K17EP]*\3S/-[F]]U8JV5:,M\=>
M7$UI*_W< ZNP5*\J^Z=O7T>-LOW2V'C7N?912>$&!XJ !0>OY5Q7OSRIC"IN
MK..^MI;9[RTRMJUU>1'(J\6B86SGJMDNV<=(VTN?%>;NW ;,''@^G*O>JS9;
M,O>3"1W%T)97@0M:-$?8"/0L^Z91-L/:#%65O=NO'/>^5X#2":T Y4^JF65M
MBX/DTUC!# >+:<*J)G"L3EY!SN3CR[0H[TA->VJB9RM"+:<:U*C"1Q H6\#W
MI$Q!VYZ("IX5Y*>^#LD(IV\U$SD[<#:N/?3L6E:BVSW+I;E]NUE P"H'#G_Q
M+6*BRWN4MXW_ $>Z!X;*=,ND5YKIUU6K$,>MLC+C+F;%XZ?0RY<3K>.-!S%?
ME71'"\P63)OI<F:?7;D>PXFO'MY_(MYK$QT3%)E)%(8\Q)&_VF1N!A?J '&M
M:U]06<:>)RO&K+)<A%9WH9&_2Z8D%A80X\.=*+FIIM'5:VK$=%\QMY#>0%D1
M<3 ?"=K%""WTKBG,6ERQ..JM>UC@&O%0/_+BIRI:T(110Q$F.-K2>9  5+2K
M67L:$&@IQ55GA<,=+;R1,D\*20$,?W%3F%JQE2V%O<VEBRUNKCWF9KB?%))-
M#Z2L>[E?"J<2&4 J0#5;UYF%;<S"UWN6QN$QUSELO.VVL;)I?/*2*GN8T'F7
M+T)T3LM$5_D[]6GNC$.+]V===W9?+228;)RX##AQ;;VL#@USH^ !>:\ROIM'
MT[56OXHB9:QX\UGGE6;8ZPYO&9*W9N6_FS.&NC24R.#Y(Z\G-H>'-9[OI]+1
M^",2V^7$QPW\_(Q7UQ!>V-U+[M*VL#0"UFEW(NIP)*\NFGY<SEYVVDV4%XW)
M"[8+>^;!(7!WB,-33MX!3,Q[.:,UE=)+N6ZB;%-=.D,4@I<T/RU'U%GUZ-IQ
M94LR,]C;S6\=V,A<FIMGM90-U<QZ^"SM62^8CA=]HYK(SV^G*02>&9'-CD=7
M4TMYU)]8HL+?A<^J\Q,Y9K/'%)[%S!%<0R?.BD8US7#_ )505;OB.DX=M=D3
MU8I<; Z=7$QN)-F8]UP34Z6T:2>W0P 'Y5>OE[9_]S_%K;;&&2X\V.-C9CL=
MBH,1;TTL$,7A-/H[*K&^R;<S,RY;[5L+[>[S0MKV<PS6['&&1OR< ?D7-::U
MZ0Y[7FWJKG7KY+AD#G^(RE-7J[2J?,A:LJM[M!#(N!/,MX?659O'HM:4=.MN
MAXX#L/:J]RF5+=64,\8:_P!G3R<.8"K:V432;(Q6T=N-<;R(FCE7@MM=I:T_
M"Q3(9"XO99;2T-=!JUO>NS7,FR_=C"V!UY/(TSD6T=N?:#10.]=/4NF+2OZ+
M0_,32.N#:3AMP'Z&-Y!791"K@=>.DC^ECX\CA[.H5''UK*],IPO-E->8J\$S
MY6NM9*:F _-'93ZJY-E.SIP9F&8R0V5UHN'0-NFN'L3. +AJY\3Q[%I2[HB(
MF.6%9O R6]PUUID8/!E>'2PS\0!W4*[M6ZL1.6%ZYGA:I(V-G=X5] R!O!HX
MT)[>"K\W,MZXB.86^;)V5M-&V"75,#[?A-X4[>/8ML3,*6OCI#)#E[;&6QN1
M: L+=9E)!->Q<5]<S*GSICT9!9[EL\C%!+('1&5HT@CAP59UQ3K"U;?,]%XC
MEMY=38I@X\.'*BX-DQ,]$3KE[T(X&G#D0J=K&])JFU4J?J+.R8A106CGW+I.
MSM-:*M(]U\/2ZNH[)C2 V<DD>&TU(Y+HK$"RW6;;$6QR2Q6DLKAX37GCZN"T
MB,JS?MZK4^[\5[VS3#QFN)U,)IZ/JKH[(QT3$]PR>Z:Q\LL@8!2C1W+.M)RT
MC%>JU7EPZ>)_@N^Z#O'!;UJK'XI4,&NVADGNB97&@#>RO'L6]*9=$T[5$;JK
M'ASG-FYL#N)(*T[;(2V-VZ-A:Z3234.;RYJU:2GMB>JB#(673ZU]KB30$?HJ
M8I[E=>5+D]T8G%,CBNLII?K&F(:3ZZBJM_B?,]'1_C1/H[XVU,RYVY@+B,UC
MGQMK(P]X="TCZZ\;97MM,?:^<VQB\Q]LKVJ,Q!SYYDO,MTZ\J^QL5U!ZFPYB
M? YC.P;>M&86VCN[CWRXMKJ[87,DFA 9X=H^IU<Z<./ .)?[Y'RC_P"K]_\
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M=X!(#I7ESW =I6,SF<M(C#/%"1 0>4WWF7]8[ZRK?I*:]88<.2\E["* @("
M@(" @(+5D><7J/Z2\[SNL.OQO5;5P.D0$! 0$! 0$! 0$! 0$! 0:=SGXWR'
M[LY:QT=%>BTJ4B @(" @(" @(" @(.RME?FEM[\!B_:K[/POT*?"'Q/G?KW^
M,LH74Y! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&![_\
MQ;9_A/\ B.66V>&^CK+5 [52MG13JENX3/;NB:[2\CV74K1:1;EKNMC#"*,B
MN#!D6DM973+3F3Z5WTV6P:[R];=D4IN(&VS"YS"8"&@&BB?(F)YET1F5!;PY
M)M[$)(6L@C:=+:^S3[(46F:VAE>\K@RVCR<SXH[?P+4N%13M'/@N'R-U:8PP
MK#-H8V0P,AC^9$*#Y%P]_=*R+R6L%!SYE=,1VK0@T @&NKU]BSM9(\UI^BE)
M1:N3BX/]H@\*$\5=A;6IO D<]DDLVH-^:/\ "J6KDI7"I(%#0"G>%7L61 %
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M)\[]>_QEE"ZG((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MUX<^S5'HV*^\NX8K%\EHYCQ(-+"!J/U%P:^>KS[Q.4MQ;/FDN+ZXNWP3RO\
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M=/\ 8W2*[]^_*W=.$O;::_M?#L+B2S\%D>Y<@X^)=MAC=2W?[+C\WYS0^CZ
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MSELI=Q8_&8O.ON\C?SN#(H((,KBY)99''@UK&M))/(+;7T9WZN_O][3RR?\
M?OLG_MBU^W6?9*W=#YB;9ZR]*+;XFW4/J;<=1,!#T]R&WX+>QWF^^A&.FE;@
M<9;EC+@NT$B6-[* \VD=BTQ/;A7/.7T[_P![3RR?]^^R?^V+7[=9]DK=T-T[
M:W-M[>6#Q^YMJ9FTW#M[+,=)C,S82MFMYV->YA='(TD. <TCAW*LQA,3E?42
M("#RF^\R_K'?65;])37K##AR7DO810$! 0$! 0$!!:LCSB]1_27G>=UAU^-Z
MK:N!TB @(" @(" @(" @(" @("#3N<_&^0_=G+6.CHKT6E2D0$! 0$! 0$!
M0$'S!\P/FUWM#O'-[.Z:Y"+;^$V[<28^\SD<4<UW>W,)='<%CYFO;'$U_LLT
M#4=.O71P:WTM'BU[8FW,R\_?Y-HMBOHT%T<^*%YB.BO4-F-WKN"3JKTKM+I]
MKDMI92*W]]@MWR,+IK#(-C9.)HVM(8R9[XB"YI8"6O9]-HB(UUB/9\KY,S.V
MTS[OU'[6W-@]Z[8VYO+;%\,IMO=N+L\SM[)M8^,7%C?PLN+:8,E:Q[0^.1KJ
M.:"*\0"M6"_(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @P
M3?WXML_PG_$<JV;^/UEJHU 905!YE<]I=:+@!2AXGFHB9,):J_=/N(<R.U36
M?<R]=(TG@*JMI2\QP6?*DA^QX]ZTJC$@IQ[5814"5U>"I?/HM T5/%1$R/4T
MX4%%M3HLE^Q-.:1G*,*>YOV6%M)=3LJ(Q1C>\GO7777D[98(_<-S,;B7,,BN
M+%C==O"P C5V<%V:O'*:[3/JP7<%Y]'XVYN(B^1MRWQ/#!-&UY =U*KT/'UQ
MW8==M7#5V,SFXY]U;?P%E)!':Y-X=E3(^KVP<RX<5V>1X]9US:/1R16>YN^\
M@Q]LS)3X[(Q-MK>0-NM-&NC/&HKPYT[%YE*\QF'H5UUF.8:.W7U7R^/R8\"X
M L61B*V:]@<2!S=4E>II\.MJ\]6M=<0]=K[[9EVSXK.9.>RCG:9;:^C-*.XD
MM-#V\%7?XW9S6%[Z^_HWK@(VW.-LA/"0U^MD-Q* -8X>W3O7F3&)8;:Q6.BK
MMXOIVPN\;*(C/C9J#B Y[.-#^@L;YK9PZ[1;.4L.-<^:W@AN6VTMH?$+FNX2
M-_4\.ZBWB\1!%N7I!BILK?W$UQMJP<R,DV]W/#'K[BYI+:K.=TQ&(F?XM^[A
MEUGA+2R++B,@7!;]U#.7'N]:X=F)Y9S*Z.D:2V@/#@0>Q<ZL[)]43*VK&N!T
MNYT6/.5.Z AIK2H Y>E;=O!,Q*SYRX;!;1&7A%(XQO '%U1R5]?5>(F6!Y:"
M2]O,4YH]UQT$0X#YKC7F0.%5ZVB(K$YA,:ISPM,PQ>,EDDO)) /%UAAKI>'?
MH<%M'/1O&F<+E97=Y;W\$5I90_1TU91+P<>/?7DJVS+GM2T=5VMX[>29]XRX
M)E9-I;"PT'M<^ ]2I,X6K#US%C:V%W'-+#+(VZ!((K0/X4)^JJ5MEIW3'1@M
M_:7\F0MJ-8(62%PDB<*]GSO2NJLUB%XBUO65VO-MQY&]]ZF8V.TB8#(:@:SW
M&G.M.U4C;&/M5G1$3'=&6%[WW-/M_&2Y/PF1PP@0VC". IPJ&\BNCQ?'C9;#
MHV;.RO$N:).K&Y9+GW^?-RRPP:M5M(:C1PX!E>/U%[T_3M>,15Y6GS/Q3F75
M&QM[X/.7=C#':3--_9!TP>P-=6AY#NXKYCS=-]4XR]"=M+5Z0VO@(XGLDM+<
M3-CMY2[2\4]GNX<UY>VV7%2(C.&:M#&C2QNGM( IS7+8SR$5X]W:L;Q[+W]'
MF:<#3GS4U9IZ#APIWJ-D9F"4M">2ZNVO;T@0+16I-!V+SYK,RM7"GN[N*UMI
MIJ^TQAT^LKMTU^Q>*9:<O'N=-/,+I\#IF5?*TDGMHO7\;7'.8)\>T]%FL9\U
M%;L='*UT$4I+)*T<^O.H]"WMHKE,:IKU9,R_BNKV&>6V'O&@_=J  4I7ZJQO
MHFO24S;M76)E_?1RW,;@;, MGBY%I[#\O%4IQU->WEJ3J;T]DW+B3?868SW=
MDVLEJ.)=RX<O0O0\3RXUVQ/1Z.K9'JXQRNV9W2-L;V.>RG:^G@:7-?4]@U,J
MZM.Q>_3R:QSF&TQCI+I[H3TMOY,G!N3*V$UIC,2W59"Y:6OFE%0* CE1>-]3
M\N)CMK/7V91NXF,NH\O;MBM9KCP->J0D.:>.GF*?5*\3YD0XMEIF6.NFCDM&
M"$.#J@N:\?-]*VK?,PFE>YJC=.]FVLYL[=S72QBAD<> Y>E=^KQYGEZ.G7&.
M6H[_ *B9*.4,BF)FC<"P-^;Z>U=U?%AI%8G*ZXG>=WG,K;Q9&33J !=P'Z:K
M?1%*\,IUXAO$FTBMF!T+)N'L@-!*X(F9ER[*>RKPD1-V);F$,MW4\(F@ISXK
M#R<^DN.;36>K;6/>R4B2$M="!IX&O$<ZKQ;1,2FU\]$F6LQ-;B74ZK#QIW+3
M7AE+",C RU='<0R/?&\@20U- 1RX+OI;NB5NZ5DGDO)YW2W;AX3>$?=3_@5]
M-9RTTS.6A]]V3A<O?XYTFO'B>ZB]GQK<='J5F9CB<- Q;2?-F!D9[EP8TZJ
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MGH.\T! 0$!!\A?C/?^&_I?\ UL8K^)\P@^C7F&R.2P_0'KCE\/-);Y?%]/\
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MGS'Q)&L8''5(?L1P5)G,Y6B,,^4)$!!Y3?>9?UCOK*M^DIKUAAPY+R7L(H"
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MV?<EQTZ6]E5SV=BK80YC'>&6:A72>)XJM4)AI',!6$"6\* *)G C4T4QR(M
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MUAAPY+R7L(H" @(" @(" @M61YQ>H_I+SO.ZPZ_&]5M7 Z1 0$! 0$! 0$!
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MIMIK,^SXOS*Q7=>(]Y=RKH<P@(" @(" @(" @(" @(" @(" @(" @(" @("
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ME?FEM[\!B_:K[/POT*?"'Q/G?KW^,LH74Y! 0$! 0$! 0$! 0$! 0$! 0$!
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M&:,D&GR+TM-<HM5C!R.,>RYAL82]SSI>Q_ @"OU5V3KQU6U:._/V,4RVX+7
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MFQFYGO 6,-!&.?%<\:&$P\H\_>LNXFL;XT<II1XK0?*J6T(9<+^/Q/ -'RM
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M9RUCHZ*]%I4I$! 0$! 0$! 0$! 0=E;*_-+;WX#%^U7V?A?H4^$/B?._7O\
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MX(_YL=;?X7M/WEJ)?=Q$" @(" @(" @M][\Z/U%8[>K;4H5DU$! 0$! 0$!
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MP;Q'Z:\"]L1#BV3E-<6L]I:".*D-Q=FCJGD/_(KGML<]GOC[">VE9#+()0P
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M'#L7S]XS$/.BF%[!!#:<NP+"U3"GD<1("'"IY-/:L^S*+522  &4MJX TKQ
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MEX&NX=!$X>U0?65Z[H6YPHI,9=WMNZWAOR;=XHZ1Y(<!ZUI.Z)ACBUIZRO\
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ML'=/NA0(C,HU/>F$]T^Z!/K43PF)]TCJ.8^-PU!XI0K>DJUGEK[/6L[K6[L
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M]B;BZ0P>_P#Y78?#6]DR^FU6%PVS\)T6)M7C3=F%SJ2M]D'F.!#Z3H" @("
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M_"_0I\(?$^=^O?XRRA=3D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 08'U _%ME^$_XCE$MM'5J;37Y%5TFFGRJ)6CHF/S2JL?5,T M!(X
M]ZO3U;YPFX46?JKDY^E;63V]Q3U*A\I#BHD[.T!-1Q4)1/,CL[E,""LA&I[U
M61#4!\ZIKR4)1:.=*CUJM@((/$U[E:I($NF4P%:K-#S)XTKRYJ8OVJ7E/V=R
MB?Q)K* X52([6F421V@'N4]QE+ITU(X53N,O,.I4<_6IRSM9.T'C4GT)W(K.
M4Q /;2G)9VE=,S4 ^O#E16U<Y3$X3\2UIYK;M3W ]*B8PB9R'ARX>I0J-[56
MR834!Y\559$ =RO2,I@H%?M2E=P"B8PK9 $Z>55E9"9H+A2FDGD4HA3-G;XX
M@,;M?&C_ +$K0>[@&T%?:XZJ( XUKQ1"![%G<1')*I"K61E"JJ90X'AV=RK:
M)E:M>Y&E.P*U:RB:X2@=O"O>KVB4ZYGE/4\@:!5Q):R#:<>%*J)15!_8BT)*
MJ]8RK8UM8'.=]B*@4K4#FK]JJPWLV6NH#-B&A@:ZFF04=Z52\83"^C68[?QC
M2;PV^+3EJ[5-4IG  "G%:>A9YOX'D%RS;$J]V!K:_(M.+=6E+HN;V&AKSJK?
M,B%^]32QQEFES/8/, *._'1%K92!G@M:7FL ^]MI4^E._+&UDC],VGP8]337
MD-)'K59ZJ1.54R(,%',H3SKQ6WHVJ]&<!PX>I<EXS*[TX=O'TE;1IX$KW$#A
M]5*\95F<(,#WC]3116>65;<K=>^&&N:7MUD4<>TKT=5GI:=D5CEC.2P>W<[;
MLL<UB(,K"\%NBXBC>T 4Y&1II\BZ:;[TG-9F&M?)IGJU+EO+3TZRTXDLQ/A'
M.=Q%K,PLX\A1S2!\B[8^L;]?$\_N=U?)KC_X4F*\K>P[.Z;/>9N_OG1O.FV#
MX6 T](8"5?9]9W3'%?O5V>7$1PWSA=H[9V[$R'$8B*W\,#[J8Z2&G:7D<?D7
MBW\W9LF>_/V/,MY4WGJOU&MJ6PAA[7+GG3-N7/:9EZ1-9'\P!I>:NIPXI\J9
M_-Z%+1_Z',H^H[>:3OUQQ_16T40)+C0$\%CB/13NK/1T+C/Q;C_P:+]H%M#S
M[=95RE40$'QU\Z.=QW0;S]>4;S.]2'W5IT:LMO9C:66SEG:SWOT?D3;99@DG
MBB8ZC7#*Q2-#-4CV0S%C'&.A#6MKU&VEYY?B==(<ITYNY]Z=%_+IMB3.7>1N
M/&M+-V2MG33LR-E;W4<,NH9&ZQ\)!8"_W<O&J)H<@O\ YI.I>Q?,KYZ?(GTZ
MZ);KQV_,MTDW=<[HWMFL3<QW6*@M(KG%Y6:&.^@<^.25EMB)M;6F@<Z./5K+
MFM#[:H" @(" @(" @(" @(" @T]YA_Z .N7]7VYOXJN4(?(3X(_YL=;?X7M/
MWEJ)?=Q$" @(" @(" @M][\Z/U%8[>K;4H5DU$! 0$! 0$! 0$!!Y3?>9?UC
MOK*M^DIKUAAPY+R7L(H" @(" @(" @M61YQ>H_I+SO.ZPZ_&]5M7 Z4.7$H/
MF?YA//&YMZWIQY=J[DW5?7HQ\^\;:W]\B\9S_"9;XB#2\74LDAH)-+HZ?>Q+
MK#V>CH\/_P!;.(]OZN+=Y7_FG51] ?)#=Y#(S=2?,:9,]GLI.+^#:-Q<.G<^
M:1WBOGRLU3XKW./&(.+>>LNKI$[_ #,1VZ^GO_0T^+_ZN^G,444$4<$$;(88
M6AD,+ &M8UHHUK6C@ !P "\UVO1 0$! 0$! 0$! 0$&G<Y^-\A^[.6L='17H
MM*E(@(" @X$\R.,M-\^97R[=.=SN,^R[F.[R5WBW.TPW-PTR.\.05&K7[LR.
MG.CG ?.7M^!,Z_&V7K^;_K_MXGGQ&SR==+?E_P"_^EP\W-M;66Z/*W:6=O':
M6MMOVUBMK:%@CCC8V>S#6L8T   <  H^ES,UVS/7']4_5*Q6VJ(Z9_HVKYMM
MH[9W/T+WS>;@MH?>MLX^3*8#)/:/%M[R&GAMC?S'C'[F1R(=ZER_3-MJ[XB.
MD]75]3U5MHF9ZQT_;[64^6[)Y#,=">EM]E'/?>.P%O"^24ESWLMZPQ/<3Q)<
MQC34K/ZA6*[[1'O]_+3Z?:;>/69]ONG#=JXW8(" @[*V5^:6WOP&+]JOL_"_
M0I\(?$^=^O?XRRA=3D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 08'U _%ME^$_P"(Y1+;1U:G574F;QK7BJV$U!W*J,)3I% 3IKRHG=A:
M$P:!QJ37O*CO3@/H5HMDCA DU'%$YE.16BO4SE+2B6PB4P;58S(@10\U>LB+
M.-:\4N)B!PX*F1"I[U6<K51%#SXJ.4HD#L5ZS[JV0XJ_"J4@=RI;$F!0G!Q[
M!53D0/,5%% G=V(/%P:*N-!17K",)V$$5!J"HV<8:4B'H *<E6(19(XFG-:1
MB$5>C?FA4M,K<'%5K,HD5LJH%P(X<*<Z*%H>K1J!':5>L+#FD4'U5IT$6QD\
M ZI/,%,CRD=I(:YI%.WO4]T0K*</:T5#:BH!"SMB486R(Y5F5N&S:#BW1UB=
MV@\:K/&$+@'&@H.0X5Y\4Y#GS%$Y!3D0+FB@)XNY*)$U&@ :J45ZX2D=3A0U
M4W1,( 5*S,)B*45H,XZ(*QE _-*BTD(CYM>VG-4RE,/F_(F5+_8\G5()KR5X
MPK&0$$#O'-3>?9-?M3M[53,KH/<& >WI'*GK4QRB4CJZFM<00!P^52A(:ZCQ
M29G"4*NU <US3')A,>!-'>L+;"T5R@:]O:KUK'LGLD2]81-<(@M', ]RIA&$
MM-/$<">Y6K",0GYM)<X@]ZBTRF$HX 4)*4QZF414@T/'LJM,R922W,4,3BXA
MTG8VM*)6J](RLOTG<.U%[1&P\(RT_P"!;5UQ[*VUK=)X4M6/GT2\P]Q[_25T
M4US*F+1ZO/PX9HW6MQ(YS.'W0&H^13S5KV\);1L,<K;9CI)(XW LJ21]14G9
M,FNTQGEF+8P]C7M #3V =RPOLM'K+3NSU>VENEH  HN2UYF>95XA$TI1=5;3
M[L[2-#0>+>/85E>UI]95I&>J9P;S>0.ZBK&N)]%^V'AXL )]L#O*UQ@BL0Z%
MQE#C<>0:@VT5#_S KO-O^:5<BH@(,.W[L?8O43:V4VKU'VSB=V[1OH]>3Q&;
MMXKFTI'[0E(E!#'1_.;(*.81J:015!S-THSWD-Z 666PG2C?W1_I_'E)F.SX
MLMS8D7=U);F01MN[B:\?/((3(\,:]Y#-3M(&HU#P\O&TO(ETRW-=X[RZ9;IF
MW?>\#="5V'W):YW<%Y$6MNKFWAGGO;R]\ "V$SH8W>&-'B%M15!VB@(" @("
M @(" @(" @("#3WF'_H ZY?U?;F_BJY0A\A/@C_FQUM_A>T_>6HE]W$0(" @
M(" @(""WWOSH_45CMZMM2A6340$! 0$! 0$! 0$'E-]YE_6.^LJWZ2FO6&'#
MDO)>PB@(" @(" @(""U9'G%ZC^DO.\[K#K\;U8-O#>FU>G^ OMT[SSMKM[ X
MYA=<Y"[=0$@%PCC8T%\DCJ'3&QKGN/!K25Q4I-YQ$<NBUHK&9?)7J#UUZQ><
M;=$/2OHMA+_;.Q9G&/-222&-T]O(7--SFKJ$/9!;MC!^X,+M;JC[N\Q,;ZFO
M33QX[K\S^W1Y]]M]T]M>G[=7=OEW\JVQ^@V/9?Z8MT]0+G4<AO*YA#70M>TM
M]WL(R7^!&&DAQ!UR$G4[3I8SBW^3;;/M'LZM.B-?Q=2+F;B @(" @(" @("
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MN9QQDBQU])QI9R1W$DKH9W4^YGQ"V4G0 Q^ALGF[=';&8>GKW=TXE]%%SMQ
M0$! 0$!!R[YJ/,A8^7;9EC>VM@S,[VW4^>WV?B;ALGNM;9K#<75T]A;]SA\6
M.K&O#WES0V@UO9KJU]\_8SV;.R'R$A\\GF:@RMID[GJ#'E(X)(G38JYQ.,;:
MSQQ2:S"]L%M$]K7U+7.C>U].3P0"'E>+KMC,,]/D7KZMF;/V;UG\^6](MX;Z
MS,6 Z:[:G?83RV%&VUF]K(Y9;/&V3Y)'.GG#V.DFE) ;2KG>''">*]Z>+7%>
MLNJM;^1.9Z/K3TSZ8;,Z1;3L=G;(Q3<;B[3[I<W#J/NKVX< )+F[FH#)*^@J
M>0 #&!K&M:/+V;+;)S9WTI%(Q#8*S7$! 0$! 0$! 0$! 0$!!IW.?C?(?NSE
MK'1T5Z+2I2(" @(.5_,=YAMQ]"9,)/CNF\^\,+D+>27*9SQYK:VLI!*R*..6
M5EM,P&0NX:G"O95>EX/@U\B)F;8G/1YOG>=?Q[1$5S&.KG["^>CJ5N2V-YMW
MRY9+/6;7%KKO'7-Y=1APYC7#CW"H]:[;?2-=>M\?P<5?J^RW2F?XK7)\0/>$
M.4;@Y>A4L6;<X,;AWY&X;=%Q%0T0FPUU(XTHK?Z6F,]\J_[J_P#9#8^T_/EM
MBZSUG@>I73W,=,9+Z411Y"XE][MX0XT#[CQ(+65C*\"6QNIV\*E<^SZ-:*YI
M;/\ +_F71K^LUFV+UQ^_/_$.\XI8IXHYH9&S0S-#XI6$.:YKA4.:1P((Y%>-
M,8XE[,3$QF$Z @(.RME?FEM[\!B_:K[/POT*?"'Q/G?KW^,LH74Y! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&"[]%<;9_A/^(Y1+H\>,
MS+4Q%%5O:DH$  ]_>BM:S'4J:#BF%D1QY\5$\=%H0D#B &D@U[#11F4O2H:=
M)%2 %$Q-A&H/92BCLD/556K&.J)0H7?(IX0F:W36O:IK%?9,(T X@"JSSRE'
M_P B5M.%HKE'Y5C9/$(5';7CVA15%K19!L3(JZ*^US"LYNV<I@.!X*MG3$0B
M%-HC"9A*>16%91* - >]:552-!J:FO<K6'H #S%540<*"K1ZT$I-:5;0A:5$
MJM:$Y3M[57",IJ \U$URB4?9Y'AW)V(Y0TZ3P-:JE\QA,$?&1U7<!V+2D964
M=_=^[QO,;#*ZH 8.:TG7GHB;86JZ#S;2N>QHD\,N8]G>MJ:4QF6/ORICL(]3
M73W!X/AIQ'<5VZM?;E>*3'5;L8RZFRA,;"]SXW.DC/S3^I%3R6LQ$+87F%YA
MOX'Y. 6\LA\.%[J.:T^M5M]@CDLG%;7#_%A\1]N>,H;4$>A<]JS/5C^+*[6N
M4CGMF7ML7LB?P$+Q[1(YKGMKQT7O7,0R&*5CX!/-]R9]DT\2LYA2.$C;NPE<
M&0W%7'DSD?E65D]V>B=P+32O'M5<(&Z7!P< :TY\4Q \9+?0QSV/-1Q#0528
M'M'('L;(6@=A'8E%ZX><NASXW5#3QTT^17PI9Z"HK4UKR*M53$GR*W!@J!P(
MX%9W6B"H(H.7<J)2D$T]"O6(]592/D+0 UM:\RKXCV6J]&@Z03S*I=-WF30F
MI56?*+2#7MHIA:!QY&O)65M"  <.)IZ5,*UB5/=WD-O"1XS/$XT'>MJ4B?1?
MEBTMW-H=/,SWB(FFBM:>H+6U(X6I]JSP-E%X7LO7P,>/O9)% NBNN,=$6AZN
MR]Q#(V")PN=+N)IQI_PK*^K*D5F4WTI>VY][%J1 )*/C9[-/D"Y;Z;)^79E>
M&R\&4:]FHB9IJ&.YBOI^19UI,=5Z5F.JZ2%M*UTFM*#@JVJ61)+CRI0!96AG
MD/$%ND.KWK;7PTJQO*6\D+'S1$APKP!HN[5*-E,XPQ*W%UJ?)'$T.^RX]ZZZ
MTRM319:KJX#&/-QX;!7M< MZ:_?EV:O'E465U:RQ,?:W4=R]E-<(>*T/<.U5
MVTF/1I.J89.+K4('P@,:'#Q >=5P8M;.6&RF&4XMX<R4L]ISCR7+:.6$X72-
MQH X4=4U"F:U]F-H0EFCB-7 >A6K5M1B^4OF-8][WU;7V=!XCO71JUQSPZ<U
MQT8\^\?5CVO!C?V'G\JTBF989C*GNLA! 3%I)D>.+AS"ZHI$1RV[,](=E8 Z
ML%A7=]A;'C^Y-7DW_-/Q>+L_-/Q7954$!!\L/B9=+?,#U'/E\R/EXZ91[MWA
MT]W!D-R6^^H)[6#);>O+1^/DL6V_OMU# ^*Z>USI6/BD!=!'\T AX:RQ_F ^
M+_:V=M;7GE-V-DYX(F1RY"4LCEG<UH!DD;%N5L8<XBIT-:VO)H'!!O'R_P#6
M;XC&Z^KFTL!UW\MVTM@]*;_W_P#*K=N,DU75IX5A<2VGACZ<O/OETR*,_<7<
M''E\X!]*T! 0$! 0$! 0$! 0$! 0:>\P_P#0!UR_J^W-_%5RA#Y"?!'_ #8Z
MV_PO:?O+42^[B($! 0$! 0$!!;[WYT?J*QV]6VI0K)J(" @(" @(" @(,3WY
M89S*[&WGB]KW7N6Y<E@LC:[>O=9C\&^FMI&6TFL$:=,A::UX)"'Y1[=KF7D#
M'M+'LF:U['"A!#A4$+6>BL=5YV#@-T;IZA;4V]LF>:SW;E<U:P;>R%N^:)]I
M=&9ICNO%@#I(A 1XKI&BK&M+NQ<UIB(Y==8F9X?2MOE3\]CB ?,>]@/:=Y;E
MX?4M2N;YNOV_DW^7L]_YO3_=/\]7]I7_ .[+<_\ U-/FZ_;^4)^5L]_YR?[I
M_GJ_M*__ '9;G_ZFGS=?M_*#Y6SW_G*WR^3GSK3-<R;S!VLK'?.8_=FXW ^L
M&R4_.U^WW(^5?W6V7R.^;FZ(-WULQ$Y9P89-QY^2GJU6/!/GT]CY-_=0N^'_
M .9:9QDN.K.WWRO-9'.R^9>3ZR;*I3_(I['R;^Z0_#HZZR^Q<=4=NNB/SA[W
MDW\N7 VP"?Y%?8^1;W3Q_#4ZISU-_P!4-OM+?O>AM]-P/.NIC*)_DU]C_'GW
M: \Q7E'WAY?,!MS<V4S]KNO%YR]FQ]_>V4+H665R&"2V8_Q7E[_'8V0@AM&Z
M""?:;737MB\X9[-4T<A2\PJ;_0UOL;\-[966P_3[?&][Y\L6.WKE+:UPEE)&
MYK718ALS9;N-Y-'-DEN71&@X.A/$]GA?4+Q-HK[?\O6\*LQ69]WT?7GNP0$!
M 0$! 0$! 0$! 0$!!IW.?C?(?NSEK'1T5Z+2I2(" @(.#O,G%%O?S!^7SI-N
M29_Y!Y.2XS&5QFH,BO;J'Q?"CE[P?!\.G=(ZG$KVOI__ .?C[-E?S=/Y/$^H
M?_IY&O7;\O\ V[JM;6UL;:"SLK:*SL[6-L5K:P,;'''&P4:QC&@!H %  %XT
MVFTYGJ]JM8K&(Z.1O.KM;;UYT<RF^;D1X[=VP[FPO-H[CC!9=PSOO88S#'(R
MCZ/UD@<@X!_V-1Z?TG;:-O9_YG.8_<\SZMJK.KO_ /48Q_%[]2;+'=6_*'/N
MC>5A!+EW; 9NFVNWL:U\&2AQ[;P20.H"SQ)&:2!\YKM/$%--IT>7VTZ=V,?9
M_P!&ZL;_ !.Z_7MSG[?^V9^5#,W^>\O/3"_R6OWF/'3V+3(27&&PNY[. U('
M.*%I'H[UC]2K$>1;'V?=#?Z;:9\>N?M^^70RX7:("#LK97YI;>_ 8OVJ^S\+
M]"GPA\3YWZ]_C+*%U.00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$!!@N_3IQEH>ZX_Q'*):Z;]LM2-D!97O/-5=E=F4200*?*B;3E!%4S2:
M\!6O-1*83T =P-?0JI#Q<:_HJ8M@0IQ%$^89>G#@JVOE$H5XBA5<H0J=5%:M
MN$P$^T5EW<I1!-:573$\'?VO0\AR6=D3/<@.:B$17"(/M"O)6='R^$>URI+*
MKS<2*45[=%Y*5"YHZJR$4 6M54H5K"8$#FJB.H_8\>]0)"3VBBTJ(*]B150:
MG#D-5>?H5;7[5JQE.VAXD5*K\U;M1-.%%2U^Y68P]&-:6R5%"10.[EOK1##I
M7">_E?'>$QP,<Q[:$ ./+ZM%V:SL[E!&ZZLW.$L^IQ ,4#B:$&M>"ZZ8:UKV
MK=+<>++(^2=MG-H.FO#Y NFJ]IRMT5[[U:,\&YDMHS)X=S(T>T:=M>:MA5Z3
M8_[RUN3?>V)?21TKCJ83R+:GF%68R*F*]@]UNK02NN'QG3&]XU.=I[=1XK.:
M->SA5?2DUM:6S7P.C=&1X;J_.KS64T<]K]K*K S3SA\K@V*=C:1GE7CV+CVQ
MA3\RVW,,%C>R3.$D$S2-(:/9</13DN3*(KVLMMY!/;Q3EO,<2>91*!YDC@#R
M00=4QN':>15+"5[FLMFQGV2X_.'-11$SAX.U@Q@1ZPWD2*\UHF.5<UVIHJ "
M%697FH:4X*,H[7FWB37BDSE$P\3<5>Z&-@,@Y=G)0*.6ZRD4@<+2.2'DYHI7
MUJ8G"EGH)GN>"&%K*5+:U)/_  )E>J>&:=QH6G17V:\TSE>85CP.'LHKA(2&
M]E*J81,82U#@?0K)K7*25VF+T'YSNY7I"TTPQ"_AL8Y_&EE,I)%(:U]?!=>N
MJN%FREW+'/$Z&'PK:HJSYH^4!;]N3&'C?9,"$7$ELT2DEK T<QPYKKK3A>L9
M4ENVX,OCPZ(YR YK3P5(K$+]L57:"^D,O@W/%[N+VUJTD=M%A>(,PKL8SP[R
M6]9[+6T]EO"O/N7+>(5LRVUN;:_!+1I>P^T#Z?\ B6%JL;*EW"H_4]JRFJB:
M,U3HO5;[^T%RQW&I972WOK_Q+;3;EO1I3>&=.W(Y&V\I;=NJ SLX4I7ZJ^@\
M?5W_  =^JL2Y7;NS=N2S-U'DY7.L:G0TN(''N%:+V)T:ZUC'5VTB,<+QB<QD
M[2Y#H[B2!VHB-P>[_"J7UUF&6)F73>T,G-F\/XMTX^- [22*BIX\?T%XV_5$
M6Q#G\G7AL#!SW+KH0QZ@UO%_$KQ]L8EXLVY9N6M>=6JA/.GH64RZ9KPLN8?$
MT>&Z0LX$@@TJ5TZHRKT8%*YQ)\3@TGD3W+LBN%Z?B6Q\\8E ;&0UIIJ[#57U
MU7IJS+%=P[F@Q%PT3#6^4'0>%1IISX^E=>O1.QW5I%8Y?0+:LPN=K[;N!RGQ
M=G(/^= P_IKP=L8O,?;+YK;^>WQE?EFS$!!Q#YS_ #D,\JMCT\PVW>GUYU5Z
MH=6,E-C=D;(LI9(G2&#PHW2'P(+F61[IKF&.*%D>J4N<&N&DH.(F?$=\Z+]\
MW?3-OD?NOR_LL+^4<VTB_)MO3B?&;;^_1Q&W!DA\9XCULJ-=6?.! #VZ'^:_
MS>^9WS==/=C9#8K>@^W>C[+W)]:]@W%T;3(W=AD+0&VDOL9E'07<T;7^ V(P
M6Y\)UPV21P9)&0'VU0$! 0$! 0$! 0$! 0$!!I[S#_T =<OZOMS?Q5<H0^0G
MP1_S8ZV_PO:?O+42^[B($! 0$! 0$!!;[WYT?J*QV]6VI0K)J(" @(" @("
M@(.)_.;YHV] ]I0X#:=S;2]5-W0N^A(I V7Z+LB7,?DI834..H%D#7C2YX+B
M'MC>QUJQE$RXSZ6?#VW5U+V-)U%ZI;ZR6T=^[KOFYBRLKJV.2N!:RZY9ILJ)
MIH9775T]PD \2L;?ONJ21S(5[XB2M<RZ]Z!^3_IKT)OQN>VEN-W[[,+X1NC)
M,8QMJ)06R^X6S*B#Q&'2YSG/DTES0\,>YI\K9NF_'H]6FJ*NLEDU$! 0$! 0
M$%CW)MK;^\<'D=M;JPUIN# 9:,1Y'$WT39H)0UP>PEC@15CVAS7#BUP#FD$
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M'$TJ5W^5]*^77->8>E;7$\PZ$D,,4GADZ'O <P$ZFD'D:]M5X=(S,PY-M>W
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MU[W,,MMBMU[MNK>]N<9!<,$<[+&.UM;.")TC06NE\(RZ'/C$@C>]K@[F0$!
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MOP&+]JOL_"_0I\(?$^=^O?XRRA=3D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0<4^>"V?<["V:&2NB\/<;7N+>T"TGX%>]] G&VW_ /C_
M ,P]'Z;COG/L^>37OLHCD XN= ?$CB82"7-Y4TKZ.T1:,2]6\\\/HKLK,/W#
MLS 92^MRR9]FP.@!/B @4!/;QIQ7PFWQYT[K\\3AA,1SEEEM/<PP@S,]BM&=
MO!<5HY<-XG*Y5JT5[16GK5\8,G</J!$P\?&>7^'H  ^<ZBE$O;M([.PHKRF
M![%2\RF$' BFD>M4YD2&H(J*54Q"8>M 10BH[E.(24 % .'<K5@A$<U%D81/
M,+/*<(T'<F"8@H.Y)Y$KNQ!*KQ,X1*72YQX$\%EW3GJFJ)I0\.(6V5K0F#"8
MR[]01S-%>(RKA;+W+VUH]FL &O!H[>^JO&J93G#&W9B3+3R6T370M:XEKP:"
M@]2TKID[H1?>7UNUCH+MLC6N#? ::DJUM4UA&626F4\:X;;2L:V8M!)'(U7'
M:ELKU7$@M<03ZEI$1A-H*GO5;1"F)2/:UX+3S/(K/$PF(3VS6VY#@>)X5'/B
MNC6LP?-8^VAR/CMD<)YG5+7'A3M^NNW7$3$LYQ$K;NGQ!C?$;<>';Q-UEY/L
MU;3EQ73HKR]+QYAQ#U"WM>9NY=;BY+X(B6<'$--*<:57TGB>/%(SATS7.,-4
MOR+H@X4+W-'-W%=G9ET1%8CE6XC+/+99;6\;;WD(JP1OH]M>9 !![%&S5[QP
MSKLST=A=*=SC>F*AP=Y*^?+6C=08YP!G8":FI/,47SOU#Q_ESF.(9;]>8RVU
M#9V[\@RW@G?:&V;JDMIGUY<QSXKBVX[8Z/$W4F)9[B;2D1N7_-<:PL/V('.G
M=5>+NZHKE=G/+B#3U%9<P;,SAYD\16M2M:SE:FN40):C3&2%IC'6&MM4H$2Z
MJN9I [U6:Y9S7")(-"#\G<H[<=41RF;S*SM!E,5%48>;A5KFUTU',<%:82\8
M Y\;HWDD#E4UJE:9Z*7B9Z*:1XBU1M+H6_9N [O3V*)K)$2]6/:Y@?&*M/V?
M>HK$PM,355-,3V4>\BG$>OL5LHS+R\!\K_&F< &_, [O2JVDR]G4H*<E&3*5
M6A,2\Y(R_2VND<:J4Y6#*1O@: V(3>)4>(14-'"M5T^/.,L[Y]%J9C+;0P3/
M,T#@7%K>6H4X46L3$RO3[5ODFABCEH', X1QN_P+JK2)Z-K6BJPFZO2\M<*M
M:"8W T(JNRD1A.N>Z6 ;[S$F&Q3Y("6SW;2P$'CV5X@^E=/CT^9;GT>EKB*R
MXXSTLMZ)89229>!=6O/YU5[NJ.UU8RL&R+2RPUS>QQ3F0R\X^P<_\*U\JTWB
M%M=<1.?L=+=+<M/8YJSABFD,%S(UCVEQH=1=V57C>?6.S,N>\3,.ZFF%CA$&
M@%K1J%.'%?(VY>;NKC"H:![1IW47);JY;/0DGMJIF%,92.:W3R''FK5E,9A!
MK01R5UZWM'J]&L!/)3W2GNGW>S6T)J.7)971-I3K/$("*\>U7B^.J82N:"UP
M(K7O6U=L+L?O,8^;[V\0BM7FG-:Q>)(IGHL4N-@9<ZWSN-!32!P*WILPM'X6
M/9S;N-S8$;X&L>RM)3S/+T>A=.OS/E^KIT^1$=7:&VX&VVW<!;--6V^.M8FG
MT,A:!]9>=>W=:9]Y>%MG-YG[97I59B @^37G\WIU0ZJ=:.B7D.Z5;N/3@];L
M;>YKJ7O/3)K?@8H[S791.@D8][708^[=-#[ G/@Q.E9$Z:H6FR^"UY7(L<RV
MOM[=2KS(.8SQ\G'DL5#20 :S%%]%/:UI() =K(!IJ/-!K#96U]]?#5\UO1;I
M)C.HV4Z@>63S/9.?!X7;.7:V6\P^8=<PVT,D3(Y(X62,GOK3QKB)D;)XI) Z
M#7#"]H?<I 0$! 0$! 0$'*OF#\Z7EX\L=[]!]5]Y3X_=USA'Y["[-Q^-O;Z^
MR%L'SQ1-A?%%[M&Z:6W?&PW$T3-0]IS6U<@U!\-WS$=1_,YT?ZD=1^I61BO,
MA'U.S&-VYCX+>W@BQF(&/QEY;8^-UO#"9FP.NG@22ZI7#Y[SP0>OGE\U>]>B
M[^FG1GH=B;//^83KU?NQ.RA=NAEM\- ^2.U&1N('R ZW2S 6YE9X'W.:24N;
M"8I YYZP[A^(GY0MF;?Z][TZY;9\QFQ=L3V8ZQ=-3MW&8 6\%])%:ZK'(6=I
M%<3-;--H;-I8YCC'(^VEB\5K0^J_3G?>!ZH[!V7U'VPZ5VWM]86QSN';<!C9
MV07\#)V1SMC?(ULL8?ID:''2X$5-$&9H-/>8?^@#KE_5]N;^*KE"'R$^"/\
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MI\(?$^=^O?XRRA=3D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^%^A3X0^)\[]>_QEE"ZG((" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M]1>D(GN'8^ZM+S%7<4;K&X8]QDB;?^ZS^ZW <QK@Z6.5GA10(/I&@(" @("
M@(" @(" @("#3WF'_H ZY?U?;F_BJY0A\A/@C_FQUM_A>T_>6HE]W$0(" @(
M" @(""WWOSH_45CMZMM2A6340$! 0<E>;;S*X_R_[(<S%W%M<]1=R1OBVKBI
M*2&%O%K[V6+C5D9^;JX.=PXT(4UC*)ER=Y*?+)G-RYN+S*=8KJ?)Y;*7$F0V
MGC+T^)/<3R$UR5VYX)''[TP>LT #3:T^B(A]9E180$! 0>4WWF7]8[ZRK?I*
M:]88<.2\E["* @(" @(" @(+5D><7J/Z2\[SNL.OQO5;5P.D0$! 0$! 0$!
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M'#V3SKQ^1933M3-^Y?&SRS,:)8A'.P4)!KJ]*JA51DF@<T-(Y\%6RMDQ:2X
M#AR/RJ%JL;W!E'6+H+:!Y9.]QJ]H)-.'<NOQ:]V?W*[>[CM89#?/GREQ#,[)
M7Y8PB.X T,A<[E3CQK3]!;VU0Q__ $_;+-=NS93QI8[^];-!X>AD$P DKQX@
M\R5R;ZXPVT]W.60:2VHTZ6@ "IJ2>VJP6LD(KJ"K:N58>8;,.#35O;Z%3Y<K
M)PUS02X\2JVCM4M.$X^Q/>K5LKE \S0#TE6FO<F)RC0#B.WL2/PI0H%%MF<!
M^FM>L"!%1\XCT!<^,+0C&#[6H=U"M*I3'ARX*\SPK*4NH#\BYN[E"8D:N  [
MUO'*T/0GE0>M3VI2$G@IB,*RB.*SLO1-4JA>4-5 :J5,I@=00B<H]A1,)F\E
M65ZI^(H00 .=5-4RD9.Q[GM:X$LI6GI5Y@= XW\76'X-%^T"Z8Z/,O\ FE6J
M51 0$! 0$! 0$! 0$! 0$! 0$! 0:>\P_P#0!UR_J^W-_%5RA#Y"?!'_ #8Z
MV_PO:?O+42^[B($! 0$! 0$!!;[WYT?J*QV]6VI0K)J(*/(7]CBK&]RF3O(<
M?C<=!)<W]_</;'###$TODDD>X@-:UH)))H @^(G4S>_4GSY=9H.FO3V1V-Z5
M[:NG26\[@\6T<#"629:_Y&25XJ(8OL0=+><DATB,0KU?8?I?TVVUTEV1@]B;
M5MA!B\+ &.F+6MDN)CQEGET@5?(ZI)6<SE+8")$! 0$! 0>4WWF7]8[ZRK?I
M*:]88<.2\E["* @(" @(" @(+5D><7J/Z2\[SNL.OQO5;5P.D0$! 0$! 0$!
M 0$! 0$! 0:=SGXWR'[LY:QT=%>BTJ4B @("#D;S3]9=V[%M]H].^F-N9^I7
M4RY=:8>X:UKS:0ZF1&1@?[.M[Y &N=[+0'./(+U/IWBTV9V;/RU_;^3R_J7E
MVUXUZ_S6_;^;15CY <QN=GTYU3ZP9#*[JOHM5Z;>!UV(I""=/O=W*7S-#C7Y
MC.WUKKM]9K7BE./CC^6')7Z-:W-[\_#/\\L8W-TOZU^3J.TZA[#WW/OGISC;
MF-FY=L70D@BC@F>&#QK4R31Z7.<&^-%1[7$'3IJM-?DZ?._!>N+>G_4L]GC;
MO!_'2V:^O_</IKM+<N-WGM?;^[,.\OQFY,?;Y&QU<'".XC$@:X=CFUH1V%>!
MMUSKO-9])>_IV1LI%H]89 LV@@("#LK97YI;>_ 8OVJ^S\+]"GPA\3YWZ]_C
M+*%U.00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!IWK3>2
MV>V[%T,QAEDO0UCAVGPWFGZ"Z/&KW6:ZNKEVX(G\.?-,#IKD4C;V$#F:+V.V
M8Z/2T5S/+76?W]:;0NI[+;<4,TUTWP[DO8U]#W<3PI4KJU>-;=&;O1BE?;#6
MTG57(1.N([Z-EU$&<6GYH[Z &A73_A1Z.BM:RW/M_>V-WEM['P6,KHIK9S0Y
M@XF,U[:G@.'8N&_CVTWG+GVZHB>C+;&''W5QE;^?<L9R&+M'/$;''47 >RTU
M/;1<V^,UB(AY]^);3Q3V;FVIC;]XT/FB#7CL)'H^1>?%OER9X6R]VU<2O8^P
M$<;PWPWN< *T5YWY]6&)R@[$9AHM+-[89;=A+Y;R8U=&UM"0*]_8JQ;/1MF(
MZ/.3-F5SF&S\/"P:XO'<XETC^ KQY 443&49E;VOQ][![M,V1A:7.\9I^Q^Q
M /8K4UY8[(M..51A[@73;NVCQ[[:"*,^'=-IQTUXU46U(K2SWM+H26;F^\3Q
M3,J2\N-7!O=0KFVZFD5QU7;&[GM)F1L+7O+B6%SO1S*PFN%F0N+!4Q'5&\5#
MA^B%%>%Z1&)8[N:VM;E]H]]Q[M&P !GV+B:=GR+JURY9SEB>5GM,7/X4<3X7
M.8/"G JUW#CZEV:Y=<XX:DWWM:2ZPMQ=N>ZXG!\8-J27--#^@O5\?=BV';IF
M'&&[+.[9:RRV=LZ2=I]B,CERKV+Z#QYB9Y;VM-/WJ?!X>XF]U=>1M\>0-^XT
M)-37EP4[=D1G!2O=+N_IW@[K;&&MHI;=EW-<@R.A+J@!U:5!]:^:\G;&VS/?
M,1T9WC);FV=&_P!Q$HEN""Q_$-J1R!7E[^7AVC-FS(FS1LT2$\ZBG97L7FVA
MO>.(3T)Y?HJO/NRY""*5/JHIKP(<^:E.<)7,;)]S=P:[F[N5ZW[96B9EC^;Q
MS'P1P,+& NX2Z17ZJ]'7OC!ECDNW8&8^5DMPV9CGZI&/%0X-_P"-5OMBR];X
MZO%UGB/=8C;68ACCJ"VE7.*CYL^ZEKQZ*>S%Y[Z8F0_Z'* '>(*T Y#CWU3Y
MDXZE<W9OB\-;,<+BYC#6QG[E& -(KV@+S]MYF>J^,=60/<2= H8P1P/<E(E/
M=$K7-<>'=W%96NCBB+FCM8?^%=%88=W+"HKV]@;=71NM,4E3X)% 3W@=ZUPV
MB_:\WY9DT#?$>[WP-]MAX%P/+U\EI7+6NZ7FR>_\'WDOBBB@<VOB&A:#7O\
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MN)VVL&1S-[!80/G>USVQ-EN'L:7EK'.#0:T!/84&#_[?.A7_ 'T[#_G'C/\
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MT8^W,?U:T^M:\?BK.?LQ/]%R_O$.BO\ \+[V_P#0L;_*2K_IMWO7^?\ 1?\
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MX'F)MO*_T)W5U2%G;93/PNBQ>S,/>/DCM[K+7>KP6RNB:YVF-C))7-JW6&:
M]A<' /S#X#S!]:NL&9W!N[J)U+W!N/,LOVW..,M],RWL#*7R.986T;FQ6K Z
ME&PM:!0=RI9I1V_Y.(<!U8\T&W9^LF0R^],U=V]QD,#<9&YDO'7F8Q4#)K;Z
M1FG<^22*&VMY'-:74+F1L=6/4PYVXAI#]#*S7$! 0$! 0$! 0$'E-]YE_6.^
MLJWZ2FO6&'#DO)>PB@(" @(" @(""U9'G%ZC^DO.\[K#K\;U6U<#I$! 0$!
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M>-W+?SX:3%7&/OVA^F21GW.9K?G<?1P^JN*,UF>YI79W=&<PSR6C3#$?"#>
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M^YV+U3V[%B,!B+2>Z?EH9V?1-7744EK' UG^@2<63//%O#B:!WJ@(-/>8?\
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M0$!!V5LK\TMO?@,7[5?9^%^A3X0^)\[]>_QEE"ZG((" @(" @(" @(" @("
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M_$M&B*?F>K[*SEG-P"6R'@7=OU5G.88]M,O=D,3.+.)[7'FJ]S6T5CHBXEO
M4 /,>I.Y1(YSCQ)X]X3.1$.I6O:L[$(5Y]H/8LIG!)Q '=V!6CD1#])%>U3:
M,+52N^=ZRK52M&=%Q[G&ZW=1S74+/U52NK3;$RI=AN6B+G,\6(1/+>3>''Y%
MZNC9#/7U8A>LC@CH\%SV@G4>)[%V9F7JZN7.^[<BU]V]CRX5<1J)/H7HZ*<.
M^+8AKFXRMC%=MMIKT1OY-%>9*ZXI.,Q"L?BYEE^W);U^;Q]X;S3:6C@9(:$A
MX]7+L7/OQ%)@[Z5CEW+CLI:7]C$;-@)FC%6M %!Z@OE*;8M:T>V'G>1MK?\
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MYO\ A]-ML70OMM;>O6B@O,9:3@>B2%COTU\WLC%IC[7R&^,;+1'O/WKXJ,A
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ML9S;H3;* )/;5(F:H1]DCPW@.8[B0>(X*];]S2G26*;@PUZYCLCBP+B6/_\
M5R>'R!;5LPMUX80ZZ#IF>\Q/??$CQ(0. ([UU:K>Z\3[L,WU@+C+8B>\9')X
MD1<XM )T@:>Q>MXNW$P]3Q]M7(.[MGQ;GCMHI;V2W$!#FN (U%M*U'9R7O\
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M(.RME?FEM[\!B_:K[/POT*?"'Q/G?KW^,LH74Y! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$&H>L4%M<87$"YMWW#(\@'M8SGJ$3Z+?Q[=
MLRW\><2UQC8]=NR9\7@R?J*4H!R5+WS+NKRNAF<\:7 GB*GU)UA3;&,/*<VV
ML1 B.:04:X\#Z>*PQ.5:R](["WB8?N(D>\4D>6@U"UF<0O,=ST?[+(F %K&<
M&L[!3N"16;([<,.W=M.PW=CV65^Y\8BE;*R6/@\.::CB./8NOQ]D^/,S[MM.
MWLRR6T@=:6MM '!_@1MC:]W$D-X"I7+M\J)GA:^W*I$LI&DD!FDCU$T6<;9A
M%)CG*CN,?:7><P^X)H_].PD;V6FAHK20!KJGF.'#Y2NC_(Q&&=^R53%!C;*X
MR,^-QL%C/EY!-DI(6AIF?V.?0"I])7/?;\S]RNGMKG"?6":$<>U95MRCK),\
M06\SR'$N&EH:./&JWFG1>_&&!76-REOI?C9'/EN7'WCQG4T,X>GMJN_7:*PB
MM<O/*X>Z@QK9+3)-\!OM26\+JO+SS[5,VBZTUP];2QRKK&R]YN@)JE\+YN8;
MPX4[5A?9A-M?"ECS4\DM_;922/W6!I#+F$<0?UOR+DM.6%6<XU[?<[7PY_>(
M7Q@QRCA7Y%597N!'RJ86B,CV%\?#F.)IS4X3VK)<92?4(;2%P(J'OH*#N4=N
M43"VP[@FCOH;*9S9O$?21]0"RG?3OJMOD<*UMSAD4MQ;UD\"42F(ZGBO(+''
M:TVTSA& Q2L#V.JR0DBAJJ6LR^6]'@<@:@=_8JUOA,5P\&NTFIY=RF?Q X5<
M7:B >0416:ISA&.4Q.:X< *T%.=5K66=>9>$^.QEQ(;D6HCN^R5M >/;4<5K
M%\-[TSA8I<!D=;_=KZ.2!U1)!)7V@[F/T%T4\CMZE9F&'3='MJWMQ/-?8_VI
M 7?<Y'M;J[>#*+KCZM:(Q$NFFZ67[<V+L[:KH[K%X*"'),: ,@6:I>VGW1XU
M#Y"N?=Y]]O$RO?=.&0SN?)(Y\KG2N%:CT._XER5V_+SGU<5?(Q+%MR;-P&[;
M&:'(VS1/II%=@ /CY<B!6G!=_C^7:DYB7HZ[S,.;<OY<<Z;T28M]A- 6\+R4
MD/#?11M3Z5[6OZQ3'.4XB97; ]$L?A;R.ZS.0;?W$7$VS&^P'"M*U'%4V?49
MV1BL87M?MCAGAMKL7KA$Z)T$3:,'"C0/FT"QXPY9V]RF:X>%<NO;DSNX^&QA
MY$<Z_H)-<]%>KR;)?W<?APRL?"UGWEQXT]*C':=CQGLX7NA8(&T90O#0.)]"
MK9S_ "^5:V821-(A,3HGZ6.K5Q':IUM^S$)A=R-OH6Q-#+<??)) :$GN4[*Q
M->7/LX;"M8K.(Q75M,U]Q+0/8'$AU.X=E*KPML\L8CN94ZAH0""0"[UKGLMV
M '8>1YGN6:8K@/<.('(]Z)0U-'!QI7D:55JT[CNPL^0R;<2Z)[_](;<$M#.P
M4IV?*MJZD_,6B]W0PW,=K8@M>X>UZ^U=.K7C*LSW+;>Y'+.$A9?L#6"K&D\S
MW+2?'[EYXA/C+W)7-J][[M@N6@D0D\'#MX=JROH^7^]SUMS+*<'=F]MWND!8
M^,T<T]_%86A?*YL)TN]HGCS)6%^%Z[8KU0>R)[/NK [5V$5^JM->S!-^YC5U
MAFR/+[>&I/S6C@WY5V4\KM1$]LL*S'3QV;$GO,0B>>4C:?\ EV+OT^=$/0IN
MQ#"QTAAL'A\MUKC'%P:P:N'IHNNWU#,)_P C#;6V,3CL39L99VQ8X\Y'-%33
MTTKVKS/)\ON<MO(FTLO8!&TZ(PP//M4%%YL;.Z6>R<86+.6;WTN&#70$$'B!
MW+JUV93+#;B"Y\$BYHUHXM>.?JJMXOB8;Z;XRUUG]F,SL;KFW:'SMKJ Y]E.
MST+U]'DX=M-S7CNFLF1EM[6?&ZFMDJY[N0IW\%U?Y?;SEM&UTSM[&VF&LH+&
MUM]4D+&LD(%0.=.SUKY[R_)[Y>?NVYEL2VA\"%D8<2.8^5>;L8S94 GB*E<]
ME>KT8"VI/:J1.%JT3&JGN1;A(]FMA%:=P[U:O**3ECUZTM!865<>T#N6]9PN
MH7^*8 QC75%20NBF[#37ZK!?P,+!.YOM _- X_(N[5MRKZL WEC)\AB'"W8:
MM]K3VT%%Z&C9$6>AXWJY(S>+G9-*QT?W1WHXT[N2]NEXPZ]=L2PKZ%E<YP?&
M/9Y5'_ M_F-^ZL]7WBZ=,\/I]L5AYLV]C&_4M(@OS_R?U;_&?O?%[_U+?&?O
M9BL60@(" @(" @(" @(" @(" @(" @(-/>8?^@#KE_5]N;^*KE"'R$^"/^;'
M6W^%[3]Y:B7W<1 @(" @(" @(+?>_.C]16.WJVU*%9-1 0$! 0$! 0$! 0>4
MWWF7]8[ZRK?I*:]88<.2\E["* @(" @(" @(+5D><7J/Z2\[SNL.OQO5;5P.
MD0$! 0$! 0$! 0$! 0$! 0:=SGXWR'[LY:QT=%>BTJ4B @(."_-KYE^H70_=
MFU\)LZTPUQ9YG$OOKMV3MIIWB5L[XQH,<\0 HT<P5[/T[P=>_7-K9SG'\H>-
M]1\[9HV16N,8S_.6HMO>9?SE[LQL&8VQTPQ&?Q=PT.BOK#%W,\9U"H!<R^-#
MW@\1VKKO]/\ $I.+6Q\9<E/J'EWC-8S\(7O_ &X^>S_N5M?^Q+S_ *XJ?X?A
M?WQ__4+_ .9YO]D__P R?[<?/9_W*VO_ &)>?]<3_#\+^^/_ .H/\SS?[)__
M )E]"-@9'<>7V1M/*;OQXQ6Z<ABK6XW#C&QNA$%Y)&UTT8C<YSFZ7DBA)]:\
M3R*UKLF*<QGA[GCVM;7$WC$XY9<L6H@("#LK97YI;>_ 8OVJ^S\+]"GPA\3Y
MWZ]_C+*%U.00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!@
M>_XXWX^P,@X,NJM]>AP6FOU='C]9:M>X.!TB@:*!96ZNMY,!+@ 2*\Z<RIMG
MA/9-E/DL=9/DBNKZ_9:.A-6P!_M.';V^A:QHM:.%9_"QBZWG=1/\&UM(_<VR
MB)ETYU:5X<NU87T7K/,RFEXE<8MP3>\?Z7$R6SC:2^=E10^KTKIK2<+]\+G9
MYS$9%K3%.(9)'$1,'/V>?UUG;/JB;195OA]HN:_4T]G(+":1)A$-X4 KWA16
MN.JMT=)'M%M#V'M58C,LYC+Q=*:@-')=,4BOHOKTS;.$:/(+@ 33Y5K\F/9I
M\J86;<LU_;PX]MLT!S7A\I/:!3ZJMKC.66V)K,98LRX&5%]++D7"5O*WB!!]
M %%MAK6\86?$7$48NPVW?%>-:[P_%Y$=I-5G:L^BO-E9!D,PY]E,QU8("YKI
M923353O]2VBE<<PBW=[IW7^'AO',E@,UW*YWO$E*M-:4Y+&U*^RM(95ML^);
MSO8:1!](F<:-''@ >2X[=6D,F%7$"M16A5\0,7W#F+F&X;88T^#+'[=S(1R8
M.P%7BN6/=.5KDR5O*6.BR'AAY%6N'SC]DNG5KCV;+#8V&*?F+NY=*]SY* !I
M]BHK0@=BWO:L1T1B%VR$UU5\>/ACC:&!LSFD!SOE'Z*XN+9X9;9M.,2O6VW^
M)![1T^%\Z,'O[PN.\<M:SPR#5J+J\!V*DPI.0AO9QJLYSZ(Y2NY>I93-O>4Q
M" =0!6K,^Z< JX\!Q_5=JWK?'4F9]WJQN@@"0,<.\\>/<K?,5S+S+*N/;Z5:
MLQ)F4P8>->(X</4K<)[I]T[G5H.[FJWY4Q#S: UVH"CN6H<^*TK.&U+6]WK'
MJX^T=(!+N/<M:WB)=.N;3$\L"W ;DY"&6UC#X6C[M7D1PK]5=LSQ$0R_%,]9
M8;N+*[;PL3I;@NM'2 O\%KJN>:#@WCPYKMTTO?B.7977CT:?;U+L8Y)1#AW&
MWF.ALCG"H]-*]J[?\6WK+H^1$PR[!Y?"7KWWMK>%ET(]#[9SJ"IK3A7BLME+
M1Q,,)TS261VTIMV.FN1H--3#S!KW+EM6<\%\1'1/!/"R\%T(O%MO#)E8!0:C
MRX>E3'1R1:<KOCIH<@V5]U![O;1DGP^\+.]L-+1&.B\,MHI;VRDQ.LQ-YQ]@
MY=@7F^1CC#C^#8LKJZ&@4#6BI]/:N.R<R\JGE7@5C8E*XD"GU$IF91"FFR%K
M9L/O,S8JFC2ZO$KT==%Z3'JU]?Y*.\?,9KEK!"YSHFBO'N792C/,9Z+';7+K
MA[IHV"V?Q'C4Y^FJZ*ZX]F^(M'#RBEC,Y]XN/$##RY@U6G8QQ,3RK)I=+F36
MQ%0> :>SMY+/9K[FO;6T<0R"UNKZR?%=MGC=:34;(P'D?3]5<>[3PP[)RV$0
M/!8\4^Z-#N'I7FQ3KE?93&$. 94C41R!7/.8EGC"!DHT$>S7YS1P6](RWU5S
MG*G^[N<-$C@#V5*TYA2;XE4QQUU-D+7TYZBM=4S.2VZ$0U@.D&-H;R;P_05-
MD%9B4#4DBFH>E8QPKMSPE=1S"U[ 6NX%I'#_ ,@MZWPK$+#?XIKXS P%[75.
MOGS[%M\R):1&%E9B)K-CFP0%VKF\#CP]*F-L^ZV955M:2/:6,A='(::GD45X
MWXCF5;VMZ3+)K&U=:M!FTN/(\/KKSMDS:>$1]JMY$_55+9CK*UL/6/MJJ3*J
M=QY<5G<S+S))(XE*PJ]FGT<EK$)K.$CXF/I5HKWT5E^^%BO[>9I:8'$#CJI\
MBM6<*6M/HLK[5Y U-\1XKI%%V:]L0THMC[-\CG,D (?P,=.SU+6WE=LPZJ[.
MUKW/],+/(W#I(BRWF>/9#A2OJH%ZFKS\0Z:;H86.AFX;JX9':BS#7$_=9">
M/;R6O^UI'[?]M+[(GH^G>U;%^+VQMS&RN:^3'8NSMI'L^:70PL82/02%\YMM
MW7FWO,OE]OYY^,K\J,Q 0$! 0$! 0$! 0$! 0$! 0$! 0:>\P_\ 0!UR_J^W
M-_%5RA#Y"?!'_-CK;_"]I^\M1+[N(@0$! 0$! 0$%OO?G1^HK';U;:E"LFH@
M(" @(" @(" @(/*;[S+^L=]95OTE->L,.')>2]A% 0$! 0$! 0$%JR/.+U']
M)>=YW6'7XWJMJX'2(" @(" @(" @(" @(" @(-.YS\;Y#]V<M8Z.BO1:5*1
M0$&+[JV1L_?%B<;O#;.-W+94(9#D+:.?17MC<\%S#Z6D%:ZM]]4YI,PRVZ*;
M8Q>(ER=G?)-M7'W\FX.C>]]P](]PMXP&QNY;BTX&H:YKI&3Z3R(,Q%/L3V^E
MK^K6F.W;6+1^W[ON>;L^DUB>[5::S^W[_O60[H\Y_1UKSN7:N*Z];9M]9^DL
M,?!R@8TC15D,3)"2VM:6TG'[/]5?Y?A^1^6>R?V_=_"5/F>9X_YH[X_;]_\
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MC)5FT$! 0=E;*_-+;WX#%^U7V?A?H4^$/B?._7O\990NIR" @(" @(" @("
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MPA\3YWZ]_C+*%U.00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+;W\SMZ?RPG^M\?^W[_ZG^S\G^_^4?T/]_'SO_V0MO?S.WI_+"?ZWQ_[?O\
MZG^S\G^_^4?T/]_'SO\ ]D+;W\SMZ?RPG^M\?^W[_P"I_L_)_O\ Y1_0_P!_
M'SO_ -D+;W\SMZ?RPG^M\?\ M^_^I_L_)_O_ )1_119'X@7G/P]A>93+>5':
MN+QF/A?<7^1N]I[Q@@@BC&I\DLLF9:UC6@5))H$_UOC_ -OW_P!3_9^3_?\
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M8]/=XDOVZIW2?/O[H/V#M"0!K\+&X-Y R2_;J>^43MM/665P0Q6T,-O"S1#
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M2 @T]YA_Z .N7]7VYOXJN4(?(3X(_P";'6W^%[3]Y:B7W<1 @(" @(" @("
M@(/S=^0+_P"9MU:_ =V_^MVZ)?I$1 @(" @(" @(" @(/SS>8+_YR723^$MH
M_P#JB)?H91 @(" @(" @(" @(/SS?%S_ /%/Y7OX-M/X\1,/T,H@0$! 0$!
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MG/RM[(ULUM<,9(PN8YK@'-%00>10=BH" @(" @(" @("#GKS:87,[D\L77W
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M;"9S?S<G):[@O'V..AQ=LVYE,D<?B.+@^2)H:!_ROD43;"8C+F7^\S\N7_\
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MME8R>*KM#P' .;7@>"E"]H" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%KV.)UM U,:W6YU&UFW.(6B.,RRGIQU&\QF2AWYA^I?1&RP6ZMO8:3);.O\
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ME7;X^B\^;$.*QLSV.D?D7SN?%<#0'-<WPFR %KZ<>7%$R^W*($! 0$! 0$!
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M/R_3WH1T6V%N"VBL]P;+V+MW!Y^U@>V2-E_88VWM[H->SV7CQ6.]H<^:#;B
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MA.6&YK+R5[$?GY_$Q^0S.?NMGVY^=!C#D)6%A%!35=LN)!WAX/:@^DJ @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M@M;2TMHVQ0000QAK(XXV-#6M:    .""XH" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#
M!>H'4[IYTIPT>X>I.\\3L?!S3MMHLKF;J.U@=,[YK ^0@5/<@R['9"QRV/L<
MKC+N*_QN3MXKO'WT#@^*:"9@?'(QPX%KFD$$=B"L0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_;&#WILW,V^X=K[DM&7N%S%J28YX9!P-' .:YIJUS' .:X%K@' A!DB @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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C @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>tm2227887d4-lc_ipscmacs4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_ipscmacs4c.jpg
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M%1=BPN(CDS;Q0V.#HV1$)"7_V@ , P$  A$#$0 _ +_
M
M
M
M
M
M
M            !1-\\9DG]0]L^'YO:(3X3YXS)/ZA[9\/S>T0<)\\9DG]0]L^
M'YO:(.$^>,R3^H>V?#\WM$'"?/&9)_4/;/A^;VB#A=8V*\4*_;Q;NX%MC4[/
M4%A@S.Z,MTMXBO,M0^G1S'.YTB6D8CO8]G,@4FJX$(@
M           'E\WRZSX!AV4YQD$W<63$;55W>Z2(J([N:.)TSVLYE1%<Y&Z-
M3RJJ(!2=\\9DG]0]L^'YO:(3X5OVQ&[5JWSVDPC=.T0-HX<KMZ35MM;)WOH=
M;"]T%93<_*U7=U/&]J.5J<R(CM.(1F'6PH 5&]0WB:WS8_>7.=JJ7:&@R*GP
M^JIZ>.]2WB6F?.DU+#4ZK$VDD1NBRZ>R7L"456;[6YC+N+MEMSN#-0-M4V=8
MQ:,AEM;)%E;3.N=%%5K"V16M5Z,67E1W*FNFNB!%[L
M
M
M
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MN6R9!B-:VOM3*ZY4\M.LK6JU.\8VD8KDT<O!'(%.)/D*
M             %5OBN;Q?:=LM8]JK95=W>=UKBCKI&U?.;9[4YD\VJHJ*WO*
ME8&IY'-21/5"584T6'8&Z7KI:SSJ%@BE?!B6:VRP*W1>1M#)3O2KFX+QTJ:N
MC8BJFG%W'M0)8[5D_A%[SJV7/]A[M5IRO:F6X;$]?UR<E-<H6JO;JBP2-:GJ
M2.]4*6A>$$ #*/U^_*_WL]\Z'[%T87(W-)/3+\F[I\_W:XG]AZ4(3O=O"@
M
M
M
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M)U3#\(KY-V;?[RKE]A[,%+;UIP1 *L>H_P 2_P"+]O/F6T7Y%?MM^U+W._\
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M!BR-GV\W$G1?1<0O$T;V5JHFKDM]8U&,G<B<>1S&2+Q5&*U%4(S&"<X4
M
M
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MWB);YW#>#J'R6Q4]8]^';45%1C&.4*.^E>DTS^2YU7*BZ*Z6H8K>9.V../U
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MD%EMSI&T%?;%>C*A6TSG.9#) CTE18^5JL:YJM55:K2L2I;P'*MR*:GO>V.
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M(C=$"$Q@FL%
M
M
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M;V2<+C8'TNY//F73GLGD=5(LU;78;:&5\SM=9*BGIF4\SUUX^=)&Y0MR[P%
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MT=0%?7W#);AD:UEEDN%Y2]O;0^B01Z-F2:?D3O&/\W5/5TXA&4X@H
M  ,]WB^_GMVS^\=OV2K G5,/PBODW9M_O*N7V'LP4MO6G!$ RQ^([\L[>3\'
MO_+ML"Y7<T(](GR7MA/O'L_U*P(3O2+"BLWQ7_DO6_[^+3]2UP2KO0\\'O\
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M)07S#67BIC3V*S6JX4]/$J\>U&W&33AY5[/*+-! 0
M
M
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M)MP\&R3,;K>I[546A]+?:RWSTO<5,D4CW(RFM]*_G184T7GT[> 4F<4VPH
M
M
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M-Q,@RO#DEBL>%4-ZJ'57?542][75399M9%2-%CB:O,J*JR)VL"EEK@1
M
M
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M%_\ ,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
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MNA<MS=OKKAM#>+#1TULJ;@QC6S2QU2O<QO*YW%&\0I:4R^OK <QW,Z9,RQ#
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M!B]CPS#[1!8<9QRE916>TTZ*C(8F>NJJYSG*JN<YRJYSE5SE5550@]*
M
M
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M ^]E^^Q=0%;;FH +8
M
M
M
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M4 ^7A^Q.RNWU8RY81M-B.*W2)56.[6RST=/6-U\B5+(DETX]G,%<75@H
M   I"\93^SC^%_\ ,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
M
M
M
M
M                                              "D+QE/[./X7_S(
M$ZH>>&9\K_ ?>R_?8NH"MMS4 %L
M
M
M
M
M                             I"\93^SC^%_\R!.J'GAF?*_P'WLOWV+
MJ K;<U !;
M
M
M
M
M           *0O&4_LX_A?\ S($ZH>>&9\K_  'WLOWV+J K;<U !;
M
M
M
M
M                                                        *0O&
M4_LX_A?_ #($ZH>>&9\K_ ?>R_?8NH"MMS4 %L
M                        '\:BHIZ2%]153QTU/$FLD\KD8QJ*NG%SE1$X
MJ!_&CN-ON+7OM]=3US(UY9'T\K)4:J\=%5BKH!^P      'SG7BT,J_0'W2C
M;7*Y&)1+/&DO,[L;R<W-JNO9H!]$
M
M
M
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MCW*RJ_V:M]WO3+1<KS75=+-W=@N,C.\AFF<QW*]K7)JG!41>U E.YI="
M
M
M
M           %(7C*?V<?PO\ YD"=4//#,^5_@/O9?OL74!6VYJ "V
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MR7M^_O'O'U*\*QO9[O#B^6=LW^$/_EVYA.VYJ<"V
M
M
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M74M33UM-3UE'.RJI*N)DU+4Q.1S)(Y&HYCVN3@J.145%0(/[@
M
M
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MTUX:Z!&72@
M
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MU5]1<>K;?"HJG\\L=]92M7C_ ).EI*>GB3BJ]C(T0+D;FEGIFM4-EZ=-B;;
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MK:=[989H96H^.2.1BJUS7-5%14714"+](
M
M
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M*J&!7.UU2*221&\>#.5NB(B!&RS,(@
M
M
M             !2%XRG]G'\+_P"9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
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MK5E-,ZAS#-J^7*,CMLB:243JN*&&GI'\$5'1P0,5[5]C(Y[?($)G%-L*
M
M
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M]/.Z=DW3LVXU[R*X62GK:>*U5M)310O2MII*9RN?&O,G*DFJ!6;8K& B
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M%11M;#$Y%1%:]_>2-7BUZ!&9Q3G"@
M
M
M              *0O&4_LX_A?_,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
M
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M0HK84=^N1B+Y0A,XI+!0
M
M
M                 4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M
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M*
M
M                                                           !
M2%XRG]G'\+_YD"=4//#,^5_@/O9?OL74!6VYJ "V
M
M
M
M
M                                          4A>,I_9Q_"_P#F0)U0
M\\,SY7^ ^]E^^Q=0%;;FH +8
M
M
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MCZS1TL2H[771.;B%)P6_A$
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M^]Q0KRS2V^JBJ6M7U'+$YR)^J!]@       "D+QE/[./X7_S($ZH>>&9\K_
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MZ=-]JVDLF+9@ZPY97<*7#\EB2W5\KE37NX7<\E/._M\R&9[N"KIH%)C!+H*
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M'=[?!5-:V=D%= RHC;*UCGM1Z->B.1'*FO8J]H1??
M
M        .6;Z?F2WB^\?(?L;4 A3SX.?])-^/>RP?OU<$[+V0@
M
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M_P"9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
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M9W[Q\>^QM.%J74P
M                                         #EF^GYDMXOO'R'[&U (
M4\^#G_23?CWLL'[]7!.R]D(
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M9&QJ>1&M1$1 0U3[%_F2V=^\?'OL;3A;EU,
M
M!YK+LQQ7 <>N.69ID%#C&-VEG>7&\W&9L$$:*O*U%<Y>+G*J(UJ:JY=$1%50
M*C^H3Q3-IKCC6<;>[;87>LWAR.SW&QNRNLE9:*)J5U/)3K44\4D<]1(UB/YD
M;)'$KM-.':$HJKZZ)>KFU]*-_P VK;UA-5F%NSBGM]-42T5:REGHTH7SOYF1
M21/;-S]]IHKV::=JZ\"4QBO_ -@^KO9#J-B=!@.2.I<FAB[VLPB\L;1W:-B)
MJYS8N=[)FM_7.A>]&_KE3@$)C!)L*
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MT_<WN.Z[N>;F_P#='\VNFG#MU"M8P>5\,SY7^ ^]E^^Q=0%;;FH +8
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MK#@^SNUF(01I&W&\4L]!(FC45TL-'$V5[N553F>]%<NBKQ4+4NG@
M,MOB0Y'49!U>[EPRN>M-C<-HM%O8_M9'%;:>:1$XKP6::1R?1]4+E=RYSPTL
M5AQOI&P.M;&D=5F%PO%\N":-XO=7RT43M6JNNL%)&O'BG9Y A;>GL%
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MZJ>%8W-3NQ?YDMG?O'Q[[&TX6Y=3
M                                                     _+75U':
MZ&LN5QJHJ*WVZ"2IKJV9R,BAAA:KY)'N7@C6M1555\@&5+K'ZK\FZFMPJR2*
MKFH=KL:JYHL QE%<QBQ(JL2X5+.'-43MXKK_ )-J]VW]<YQ<B,$.PJ ?8Q_(
M+WBM[M>28U=:JQW^R5,=7:;O12NAJ*>>)=621O:J*BHH&I?HAZH6=3FU*W.\
MI#3;C89+%;,]HH&HR.221BNIJ^)B<&LJFL<O*GL7LD:B<J-52W,8)F!0
M
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MMQ;<9[\L]RG-U&9ES.?CCCLQCAV8=4)(F"94      !05XPGYR=G?O:K_JQ
MG5,/PH/DO7#[^+M]2T(4MO=3\1WY&.\GX/?^8K8%*[V8K#\AS/%[]2WG +Y>
ML=R>G9*VBNN/U-125[&2,5DJ1S4KF2HCF*J.T7BFNO +CLGY=.K;^N+=W\8;
M][8"F$/X5.]75;60OIJS=K=BJIY-.\IYK]?9&.T5%35KIU1=%1%!A#\5#M1U
M);Q7.GJ(,$W W KZC1([M545QK&-;)H[F?65#59&U=47F<]$X]H,86@])7A@
MW^VY%9]P^HYE'34EGECK+5M?3S1UCZBHC7F8MTFBYX>Z:J(O=1N?S]CW-:CF
M.*39>&$ #A6\W35LIO[2Q1;GX-1WNOI8^ZH,BA5])=*=B:JC8ZRG<R56(JJO
M=N5S->*M"L3@K.W#\'VQ5#ZBJVJW=K+8BJJTUDRBB95MX^1:ZC6!6HG\7<O_
M *RO$@UN)X;O59@#9ZFFPNES^VT^JNK\4K65CE1.*<M).E/5NUT_6PJ$N*$4
M[-D&Z>R67/J+-<<CVPS6U.:VJB8M3:ZV/14=W=1"Y(W*U?*R1JM5.U%0*[U]
MW0KU^.WUK(-J=VUI;?NHD+Y,>OM-&VGI;]' Q7RL="W1L54QK5>K6(C'M1RM
M:SEY5(3"TD(L3N1T4MMR&_6Z=TSYZ"XU5/,^I7FF5\4KF.61=$U=JGG>N%UM
M Q"HAJ\3Q>JIWI+3U-HHI8)$U1',? QS5XZ+Q10M/1         ,HG7U12T'
M5[O;!,Z9SWW2CJ$6H75_)4VVDG8B+HGFHUZ(S]KH%R-R_+P^ZB&IZ/=E9('I
M(QM!<HG.35//BN];&]./J.:J!"=Z9(4      S->)OO%^4KJ,K<2M]6L^.[1
M4B8_2QM=S1.N4BI-<Y435=')(K('?]2@7*PM<\.G \>VEZ:<9JKG=+=29-N3
M*_*[VR2IB;(R*K:UE!$NK]41*5D;^5431SW)IKJ$;;T[?MGQO[H;9_*X?W81
M4(>+'MM:*/</"MY,=JJ2LI\VH767*5I)62\MPMC6^C2R<JKHLU,Y&)Q[(?)Y
M2=7?O"1WH2\8;FNQ=VK.:OQ"H7(\1A>JJY;;7/1E;%&G8C8:E6R+Y56=?U"E
MH7&A%2[XQG]&]A_?._\ [S0A*JJ38WIEW?ZB_MH_)38*:^?:=Z%[O>D5]+1=
MU[H>D>C\OI,D?/S>C2:\NNFG'M0)3.#OOS9G5_\ <#;/AZU^V <4(Z[O=-N]
MVQ$L3=T=OKACE%4O[NCOC5BK+;,]=5:UE;2/E@YU1->17H_3M:@(G%Z;IGV$
MQ?J!S"'#KSO-8]K;I5S,AM-!=*6HJ*FXJ_3S*/C!3.DUX)&^H:]R^P:[R"9P
M:%>G+H5V2Z<JJGR.T451F.X$43HVYM?.226GYT5'^@T[$2*FYD56\R(Z3E56
M]XK55%(3.*9X4<RRG>K9O!KL^PYMNUAF'WV.)DTEEO=^MUOJVQ2)JQZP5,\;
MT:Y.Q=-%!@\[\9KIN_2#VU_&RS^V@KA)\9KIN_2#VU_&RS^V@82[+0UU#=*&
MCN=LK(+C;;C!'56^X4LC9H)X)FH^.6*1BJU['M5%:Y%T5.*!1CBWT_/;O%]_
M&0_9*H"[#7=N9@EKW/V\S7;R]-:MMS*S5EIJ)'-1RQ+4Q.8R9J+^NB>J/:OD
M<B*%IEMZ6\YN?3KU6856Y$JVI+%DDV*9Y3O?RLAIZJ1]MK>]]5*=[N]^C&@7
M)VPUEA;4(^+KNPZZ9MMYLS;ZKFHL5H'Y)D4#%\U:^X*L-(R1/V4-/&YR:>2;
M^X3JLKZ#MI_R0],>W=JJ8>YOF64ZY;D2*G*[TF[M9+$Q[>U'14J0Q.U\K%^@
M$9WLZ75W\J'?O[^+Q]5/"<;FIW8O\R6SOWCX]]C:<+<NI@
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M+KRNJ*!T=;#+P3V3&12M37AH]WET"-MS2*$
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M-[6\OX\N-16-M=ENKHGP3YVR=G]9PWG)G=.V.O\ +'F6A'/VW
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MO[^+Q]5/"Y&YJ=V+_,EL[]X^/?8VG"W+J8
M                                                X%OETR[0=1?V
MK_E6L%3?/M.]-]P?1Z^JHNZ]T/1_2.;T:2/GYO1H].;733AVJ%8G!P'YLSI
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M
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MIX)/IG(DJ-D>][6+S,:C45.901"O?IZVBNN^F\6"[:6V"5\%^N42W^KB1?\
M1+5 J2UU0KNQO)"UW+KIJ_E;VN0*S+892TU/14U/1TD+:>EI(F0TT#$T:R.-
MJ-:UJ>1$1-$"V_N     %(7C*?V<?PO_ )D"=4//#,^5_@/O9?OL74!6VYJ
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MMRZF
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MP4<+U1JNBIF.5&JO:]TCTT1VB%N9Q2_"@
M                                                        #YMY
MI):^SW6A@Y4GK:.>"%7+HWGDC<UNJ\>&J@9R/FH.J'ZX8/\ "U5[1"?%"\GI
M9VRR/9O8+;C;3+GT<F18I1U,%S?;Y734ROFK:BH;W<CV1JY.25-=6IQ",I !
M1!7J]Z&L)ZGH(LDH*YF$[J6RF[BBRED/>4]?$Q-8Z:Y1-Y7/:WL9*U>=B+V/
M:B,"L3@I<ROPVNKG&:Z2EI=O*7+J1KU9%>+%=J"2"337BV.JFIJA$5$UU?$W
M^Z$^*'0MK/"QZC,PNE(NX4=KVJQWG:ZOJZNLI[G7K"O;Z/2T$LK'/]:6:/3R
M\> 4FR^_9'9+ ]@, MFWFW]N6DM=$JSW"X3JCZRX5DB(DM75RHB<\C]$3L1&
MM1K&HC6M1",SBZX%' .HOIPV\ZE\'=A^<TTE-64+GU&+951HQ*ZU53T1%?"Y
MR*CF2<J)+&[S7HB=CFL>TK$X*'MR?"\ZG,-N-2W$+7:]TK&U[EI;G::ZGHJC
MNM5Y5FI+A+ YKU\K8GRHGD<H2XH>>PSPT>K3*ZZ*GN6$V_!:"1VDEYO]VH^Z
M9IVZPT,E74+ZWTK1?5"O%"\+I-Z/,$Z6+!6>YU2N4[@9!$V+)\XJ(4A>^)KN
M=*2DBYG]Q CD1RIS*KW(CGJO*QK"$SBE^%      *0O&4_LX_A?_ #($ZH>>
M&9\K_ ?>R_?8NH"MMS4 %L             !YNZ8;B%\JEKKUBEGO%:K$C6L
MK:&GJ)>1OL6\\C'.T37@FI?R]5G9<84O:([TS"U?(R[SC:L3/?B'S?R:[<_<
M!C?P51_P1<_C]1\Y;X4^E#^$R?<5\4'Y-=N?N QOX*H_X(?Q^H^<M\*?2?PF
M3[BOB@_)KMS]P&-_!5'_  0_C]1\Y;X4^D_A,GW%?%!^37;G[@,;^"J/^"'\
M?J/G+?"GTG\)D^XKXH>FMEIM5DI&T%FME):*%CG/9144,=/$CG+JY49&C6ZJ
MO;P//F9M\R>*\S,]V9Q7J4K2,*Q$1WGT""0           *&O%XM-TN.X^T#
M[?;:JN9'C=<V1]/"^5&JM8BZ*K$70)U2\\*NBK:#ICKX*ZDFHIUS:ZN2&>-T
M;^5::BT7E<B+IP"EM[J/B*4M36='&\--1T\M542?:_W=/"QTCW:9#;571K45
M5T1%4*5WJ:_#5L=ZHNKG ZBML];24[+;?4?/-3R1L15ME0B:N<U$XJ$[;FFP
M+8    .?;I;7X7O)@U\V\SZTMN^-WZ+DGC1>2:"5B\T513R:*L<L3D1S7)Y>
M"HK55%#.-U">'3OMLW<:^X8G9*K=C 6N?)1WZPP.FKX(=55&UMNCYIFN:B:N
M?$CX].*N;[%"Y%D<<)Z@NH+9O6Q8?N;E6'4UO?RNQEU5-Z) ]'<RIZ!4\\+%
M5>WZ7Q\H,'1*_KNZN+E2RT=1O?>XXID5'OI8:*EE35-/-FIZ>.1OZCD!A#R>
M";,]1O5)E"U]DL>2;@W*XOTN6=7N:=])&B*JJZINE8Y6>;Q5&\ZN7L:U5X Q
MP:".C/HHQOI=M%5?+M6PY5NOD5*VGON1QLTIJ*GYD>ZBMZ/:CTC5R-61[M'2
M*UJ\K41&H0F<4Z H_-64=)<:2JM]PI8:Z@KH7T];15#&RPS0RM5DD<D;T5KF
MN:JHJ*FBH!0IU5^%_E-@N5SS;IQIG9/B]2]]15;;22HESMVOG.2ADE<B542<
M>5BN29.#4[U>(3BRN_&MR>HGILO-7:;%D68;3W1'JZX8U5-J**-\B:)S3VZK
M9W3W)IIJ^-5"N]UVK\1'K(K:26BFWGG9#,WD>^GLMBIYD3]K-#;V2-7AVM<B
M@X8<BLV)=1'5#E;JJW6W+MX,EG58I[U5/J*V.!NO-RRUM2[N*>-%=P1\C&)J
MB)IP!N7D]%?A[6O8>MH-SMT:JFR;=>)CULUMI5[RVV+O6\BNC<Y$6>IY55%D
M5$:S548BJB2*1FV*SL(@    J*ZS?#<9N;=[ONKL2ZDM.;721]7D^"U3VT]%
M=*AVBNJ*.9=&4\[U15>U^D<CEYN:->;G)1937-0=0W3%DZU$E/F6S61\_=)5
MM2KMK:I(U7S6RMY8JJ/M[%>Q?7"6]V2#Q$^LFGIFTD>\\SHF-5B/DLEAEET7
MU97VYTBKQ[5=J#AAQR\YAU#=3614MNNEWS'>"^H_GH+'"E3<&4ZN\U7PT<#5
MB@33M5K&IZH-RTSI!\,>XT%VM6Y'4C30PI;98ZNP[5Q21U'>2L5'1R7:6-71
M\C537T=BKS+IWCD1'1.*39=UYK&^1C&)]!$1 @R9=6V=9+OEU ;B9[3V>YU-
MAEN"VS$E2EFY$M-N3T>E<U.5=.^:Q9E37V3W!<C8T6=&6TB[+]..VV)5=*M)
M?JVWI?<JC<FDB7&ZZ5,L<G[:!KF0_P#(_5"$[THPH  *B?%EV5J,IP+"-X+#
M;I:V\837+8\@93QJ^1]KN2\T$CM-55(*EJ-1$3_GE7R!*LH=>&'N-?\ ;'?M
M^%7NWW&BQ3=JB6USOF@FC@BNM)S3V^9ZJW35WTV!/7E3R(%;)3^,!;;C<<<V
M+;;Z"IKUBN5^65*>)\JM18:+3FY$7370*5?$\'BV7*V_&)]T+?4T'??:CW/I
M$3XN?E]VN;EYT3735-= 677A$  4:^*-TJ3LN5+U%X!9I*B.Z/AMVY]KHHE<
MK:CA'273D9JOTU-(951/9)&[BKWJ$ZRC[X=>_>2;%;IIA664%QIML-S9XJ2Z
MS3T\K8;9=/84E>JN1&L8Y5[J9>'F*UZ_Y-$!:,6DP(   !CQWPQS(9=ZMWY8
MK#<9(Y,VR!T<C:656N:MRG5%14;HJ*@7(;#@MO&[B85:]Q\#S' ;TU%M>96:
MML]:[356,K(71=XWL\YBN1S5\BHB@8Z\CV[S3%LAOV,7;'+@RZXY<:JUW-D=
M-,]B5%'*Z&5&NY$U1',710NM5O1[M-^1?ITVSPRII/1+[);&WC*F.;RR)<[I
M_I4\<GJNAYTAU]1B!;F4F0HR3]6N/7^HZG-]YZ>QW">"7-KPZ*:.FE<QS5J7
MZ*UR-5%10N1N:A]CXWQ;*[012L=')'A./MDC<BHYKDML"*BHO%%10MRZB
M
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MQ"$SBD(%
M                                                       !2%XR
MG]G'\+_YD"=4//#,^5_@/O9?OL74!6VYJ "V
M                      #S][Q+%<F1K<DQFU9 C6+&U+E105:(Q==6IWS'
M\%U7@!YFW[/;26BI;6VG:W$;96,TY*NDLE!#*FCD<FCXX6JFBM1>WM0&+H<<
M;(F,BB8V..-J-CC:B(UK431$1$X(B(!_L    ?.NEGM%[IEHKU:Z.[T:JCEI
M*V".HB54[%Y)&N3_ ( /"Q[+[.PU/IL.T^&Q5G,K_2V6*WMEYG:\SN=(-=5U
M75=08NB4U+344$=+1T\5)30IRPT\+&QQL3MT:UJ(B?J ?W        _A4TM-
M6P24M93Q5=-,G+-3S,;)&].W1S7(J+^J!SNHV7V=K)UJJO:?#:JI736HFL5O
M?(O+P3SG0*O#R Q>ZM=GM%DIDHK+:Z.T4:*KDI**".GB15[5Y(VM3_@ ^B
M
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M(NVV3S;4QIZ95JS,3.,S'0P_/>Q6=RK33J+YE;1$Q&$1/2[Z;LTD
M
M                                      I"\93^SC^%_P#,@3JAYX9G
MRO\  ?>R_?8NH"MMS4 %L
M
M
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MY/.S;6KOPGO/:F78@
M                   !S;=S=C#-DL OVX^>W!:#'[#$BO9$U'U%5/(O)#2T
MT>J<\LKU1K4U1$XN<K6HYR"%#>YGBP[[Y%=*ENVMEL6W6/,E7W/[ZF2ZW)T:
M+P[^:I7N.*:<&0)I^R7M"?"XG)XC_68][WMWA;$USE5L3<>Q[E:BKV)S6U5T
M3UU4*\,/\?..]9W]<G_A['?]F X8/G'>L[^N3_P]CO\ LP'##OO2UUT=4^XW
M4)M1@^9[H^[.+9+?(Z.]VOW$L=/W\+HWN5G>T]!%*WBB<6N10I,0T/A
M                              !2%XRG]G'\+_YD"=4//#,^5_@/O9?O
ML74!6VYJ "V
M
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M7@%)F%OX1
M            43^,%N'72Y'M+M1!.Z.VT5MJ<LN=*CO-FGJIGT-(]S=>V)M/
M.C5T_P"<=^H3J_KT#] 6 ;A[?4&]&]]MFR&DR665<)POTB:EI?0X)'0K65CH
M'QRO=)(QW=Q\R,Y$1SN?G1&B96A4_1[TMTT+((]A<+<R--&NEM<,K^*Z\7R(
MYR_JJ$<9?V^*)TO?U"8/\#TO[@&,GQ1.E[^H3!_@>E_< QE]K'>F?I]Q&]VW
M)<7V;Q*PY!9YDJ+5>*&UT\-13RHBHCXY&M16KHJ\4!B[B%
M                     %(7C*?V<?PO_F0)U0\\,SY7^ ^]E^^Q=0%;;FH
M+8
M
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M:A_QYCF'JO\ WFHZJ^>SIOK/_=Z?KMYJIN'8'(0
M                                           !0/XP.'5M-N9M/N!W
M+W6V]XQ/CWI"(JL;/:ZV6KY7+V(KFW#5/5T7U%"=5HG0OE-IROI1V8JK3+&]
MMHL;+)<86+YT57;)'TLS7MX*CG+'S\>U'([L5%",[TM H
M                        "D+QE/[./X7_ ,R!.J'GAF?*_P !][+]]BZ@
M*VW-0 6P
M
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M_P"\U'57SV=-]9_[O3]=O-5-P[ Y"
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MU:V@M3ZZVT\5.DKFJY.\>VK>K4T:O%&J%.%/D*
M             *0O&4_LX_A?_,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
M
M
M                                        ,P_B=9/<+]U<YE::QZNI
ML*M%CL]J:JZHV":WQ7-VB>3Z;7/"Y7<K\"H   :K/#XJ:&OZ0]G[C1VFBM,E
M31W""O2BIXZ=*B:WW*JH%J)4C1.>21M.BO>[SG+Q5=0MVWIGA0  >5R;.L(P
MOT+[<<QL>)^Z7>>YWNS<*:@]([GD[WNO2)&<_)SMYN7735->U /+?ETV2_KB
MP?\ &&V^V 8*Z?$^W,VWR[INH;5BFX&-9/=&YE:YW6VTW:CK:A(F4U8CI%B@
ME>[E17(BKIIQ0)5WO9>'3NGMCB_2E@]FR;<?%\=N]/<;VZHM5SO%%25+&R7*
M=[%=#-,QZ(YJHJ:IQ0%MZ<GY=-DOZXL'_&&V^V C@]9C6;89F;*N7#\NLN61
MV]S&U\EFKZ>O; Z1%5B2+3R/1BN1JZ:]NB@>G     #S&;?T,R[WEK_J>0QW
M-_J6?]'?XLLCRCZ[D?24^-")72/_ *QSC^+4/^/,<P]5_P"\U'57SV=-]9_[
MO3]=O-5-P[ Y"
M                  ("=<?1[DG5A^2_[7LQMF)_:#[M^F>Z,$T_I'NKZ!R=
MWW2\.3T-==?50*Q." OS/>Y/]<6-?R"L_OA+B/F>]R?ZXL:_D%9_?!Q'S/>Y
M/]<6-?R"L_O@XCYGO<G^N+&OY!6?WP<3KVP?AB9WL_O'M]N;<MT+#>*'#;JR
MX5-LIJ.JCEF:UCF\K'/7E1?.\H4FRY<(@
M       *0O&4_LX_A?\ S($ZH>>&9\K_  'WLOWV+J K;<U !;
M
M
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MOK/_ '>GZ[>:J;AV!R$
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M;=*.5D]/40RHCF212QJYKVN1=45%T4(OH
M         4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M
M
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MNY43735=#WZ/ENFT43&1EUICOX8PQP>#6<RU.LF)S\RU\-W%..&+[Q[7B
M !YC-OZ&9=[RU_U/(8[F_P!2S_H[_%ED>4?7<CZ2GQH1*Z1_]8YQ_%J'_'F.
M8>J_]YJ.JOGLZ;ZS_P!WI^NWFJFX=@<A
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M$9.]7-MUV@8^IE@B5WL(JJ-KU5NNG>M;RIS2/51:&@((
M                   *0O&4_LX_A?\ S($ZH>>&9\K_  'WLOWV+J K;<U
M!;
M
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M>SIOK/\ W>GZ[>:J;AV!R$
M                           9^/%_R6MJMX=K<.?(];=8\.?>:>'5>1)K
MK<*BGE<B:]JMM[$7A_\ D)U6N]$N!6;;[I<V;H;/31POR3'*'*;Q4,3SZBMO
MD#*Z221W:YS6RMC37L:QK4X(@1G>COXK_P EZW_?Q:?J6N"M=[X?A%?)NS;_
M 'E7+[#V8%MZTN2-DK'Q2L;)'(U6R1N1%:YJIHJ*B\%14"+*K>K#1[+]>L-E
MQ>-:2U8=N]0.L=%3HYW=43KK#-%2M:FCG(V&1(M/*G#RA<Z&JT+8
M                          "D+QE/[./X7_S($ZH>>&9\K_ ?>R_?8NH"
MMMS4 %L
M
M                                           8I,MNE=>\JR:]7-)$
MN5WNM;6W!)EUD[^HG?))SJGZ[F<NH77GP  #^U/434E1!54[UBJ*:1LL$B:*
MK7L5'-7CJG!4 VRVFJ=6VNVUKXD@?5TL,SX&]C%D8CE:FOJ:Z!:?0   *O\
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ME/C0B5TC_P"L<X_BU#_CS',/5?\ O-1U5\]G3?6?^[T_7;S53<.P.0@
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MYZ16U>5;A+FE]IX]5CIJ.BJW7:HBYT1-&MBB[IKETX\J=JA<G9#5<%L
M                             !2%XRG]G'\+_P"9 G5#SPS/E?X#[V7[
M[%U 5MN:@ M@
M
M                                              $8=^.L#8KIY@G@
MSC+65V4L9ST^"67EK;O(JIJWGA:YK*=')Q1T[XVKY%5> 5B,64G-;O:K_F66
MWZQ6Y]GLE[O5?7V>T2N:]]+2U-1)+! Y[$:URQL<C55$1%T[ N/,   ':>G?
M:ROWHWJVZVYHZ9U13W^\4_NX]J*J0VRG=WU?,[3LY*=CU3735=$UX@EL2"T
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M/I*?&A$KI'_UCG'\6H?\>8YAZK_WFHZJ^>SIOK/_ '>GZ[>:J;AV!R$
M
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M6TWN<QS)FV.VJJ2+2)*Q7-=-,Y&NF<U5:G*UC5X.<\C,XK)0B
M                        I"\93^SC^%_\R!.J'GAF?*_P'WLOWV+J K;<
MU !;
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M/MN+RETL]4Y8:REE:D59053419*6L@U<L<K-4X:JUR*CF.<Q6N4C,8.K!0
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MK'ZMG^_CS)GXW_1VP^]U+^\M.M<O^K9?O*^:')M?]9S/?V\\OM'K>0
M!''JC_-I![]4O[W,:#ZQ_LR/I*^:S??5S]IS]';SU?9Z</S36+^,UWU3(>OL
M#]D9?7;XTO)V]^U\SJK\6'=3<VF@      /,9M_0S+O>6O\ J>0QW-_J6?\
M1W^++(\H^NY'TE/C0B5TC_ZQSC^+4/\ CS',/5?^\U'57SV=-]9_[O3]=O-5
M-P[ Y"
M            'P<EQ;&LRL]7CV78_;LHL-<B)66:ZTL592RZ=G/#,U[%T\G#
M@!"G+/#6Z2<HJ9ZRGP2NQ.HJ>995L5UJX8^9R:<S()WSPLY?(C&(WU@KQ2\I
M:_"OZ5+?4)-5TF5WR-%1?1*Z\\D:Z=J:TD-._CY?.^@%>*4OMK>G_9C92"2+
M:_;JSXE--&D-3=((G37":---&2UU0Z6ID;JFNCI%37CVA3%V$*
M                          %(7C*?V<?PO_F0)U0\\,SY7^ ^]E^^Q=0%
M;;FH +8
M                                                           !
MG_\ %4ZC+CD.=4O3WC=R?#B^%LIZ_.8H7:-K;O41I/!!(K?9LI87L=RZZ=X]
M>9.:-JH3K"H0)  "7717U%7/IWWJQ^[SW%\& Y340V?<2WN=](=0S/Y&5;FK
MP1](]W>M=V\J/9KH]P4F,6L!%1R(YJHJ*FJ*G8J!;?\ 0
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M(
M   "JOQ'>J/>7IVO6U-%M5D-+9*?*:*[37IE1;Z6M61]))2MB5%J8Y%;HDKN
MSM"58Q5I_.9]7_W?6SX!M?M<)<,'SF?5_P#=];/@&U^UP<,'SF?5_P#=];/@
M&U^UP<,'SF?5_P#=];/@&U^UP<,'SF?5_P#=];/@&U^UP<,'SF?5_P#=];/@
M&U^UP<,.\=,/7UU-[F;_ &UF!9?F5!7XSE%[CHKS1Q6>WP/DA=&]RM26*!KV
M\6IQ10I,0T$!                                   !2%XRG]G'\+_Y
MD"=4//#,^5_@/O9?OL74!6VYJ "V
M
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MF-E9:KVTY)H=+RR^9DY-*VB:[8B(GVT)]G;7$P
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M6)3MF<YS&O6*5S^\1R+&JNYV<A6T-! 0
M       4A>,I_9Q_"_\ F0)U0\\,SY7^ ^]E^^Q=0%;;FH +8
M
M                                         !E@\0G:FX;7]4&?5$M,
MYEEW&J79A8*SET9,ES>Y]8FJ<.9E6DJ*G;IRN7V2!<KN0C"H  ]GMW@M]W-S
MK$]O\:@6HOF7W2GM=O:B:M8Z=Z-=*_U&1MU>]>Q&HJKP0#9ACMCH<8Q^Q8U;
M&JRVX];Z6V6]CM-4@I(FPQHNB(GL6(%I]@                        BQ
MUN6.IR+I0WRM](BK-#C<EQ5$355CMLT5=)P_XD"A6-[)6%P   )E^'Y8:N_]
M7>SL-,DG);:VNNE9+&O+R145OJ9E5RZ+YKG-:Q?5YM.&NH4G<U8!;   " E7
MTK[A5%753LO&/(R:5\C$=45>NCG*J:_Z(OJG$LWU;<QM>;1F96V9Z;?L.V97
MK(Y=6D1-,W9$=%?VWY_BI;B?7G'/Y15^U"']M.9?.97CM^PG_<KEWS>;XJ_M
MN/5>WUYHL]9MW+4T3KV^M@H4JF/D6E[R=K'-7G6-'\J(]-?,U]8U7-Y'GY?,
M/X"9K\IQ17'&>'&V&&W#'#;W&U97/,C,Y?\ Q\1;Y/AFV&$<6%<<=F.&.SNN
MP_%2W$^O..?RBK]J&U?VTYE\YE>.W[#5?[E<N^;S?%7]L^*EN)]><<_E%7[4
M']M.9?.97CM^P?W*Y=\WF^*O[:P,[@X@     !!;JU_I%B/O=/\ OQQKUG?6
M<CWD^=V3U8_5L_W\>9,_&_Z.V'WNI?WEIUKE_P!6R_>5\T.3:_ZSF>_MYY?:
M/6\@      "./5'^;2#WZI?WN8T'UC_9D?25\UF^^KG[3GZ.WGJ^STX?FFL7
M\9KOJF0]?8'[(R^NWQI>3M[]KYG57XL.ZFYM-    !'[J9_-;5^^-'_C*:/Z
MPOLJWOZMX]7OVK7WEE<1P-WH   .Z=.'YV;%_%J[ZFD-S[ _:^7U6^++3>WO
MV1F==?C0LJ/H%\_@
M                  ,]OB^7BY3[W;:8_*YZV>V8.VX4+5]@E377*LBJ51=.
MU64D.O'U G5<%T?T%CMO2YL+3X\C&T$F%6JJJ$9P3TZK@;45Z]B<5JI)=?7]
M7M",[TD H  ,LV>U%%8O$.N-5ABM;';]ZZ26C93JQK4JTO,3JF-NJ<B)W_.W
M14T\B\ N=#4R%L                                  !2%XRG]G'\+_
M .9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M
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MWOVOF=5?BP[J;FTT    $?NIG\UM7[XT?^,IH_K"^RK>_JWCU>_:M?>65Q'
MW>@   [ITX?G9L7\6KOJ:0W/L#]KY?5;XLM-[>_9&9UU^-"RH^@7S^
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M^O%4"5IV--P6P                                  %(7C*?V<?PO\
MYD"=4//#,^5_@/O9?OL74!6VYJ "V
M
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M
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M(MFW^W5F;9[#;M9)'N7O*FLJ7HG>U57-HBRRR:)JY>Q$1K4:QK6H0F730
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MNS.\MUYMTS9X)$1>5R(YJ\'-5%1S5T5JZHJ(J!%Z4      %(7C*?V<?PO\
MYD"=4//#,^5_@/O9?OL74!6VYJ "V
M
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M7U6^++3>WOV1F==?C0LJ/H%\_@
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M@M@     4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M
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MA[TS3"@     5^7[Y4<'WQVW]Z@.'ZW_ +7'TM/-5V_1?]5GZ*_GLL#.X.(
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M-+R30Z7,C,R<FE;1TQ$1+SZKG>NU67.7G9U[5GHF9F'KC*,6
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MX9GRO\!][+]]BZ@*VW-0 6P
M
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M"6R%?=52U-%4U%%6T\M)64DKX:NDF8Z.6*6-RM>Q['(BM<U45%14U10J_@
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M)+Z9Z'G  $(^KC_6.#_Q:N_QX3C_ *T/WFGZK>>KKWJP_=ZCKKYK(>G*W5
M  F?TA__ +0O^R?_ -,.M>J[_P#J_P#C_P [DWK1_P#YO_D_R)GG6G)@
M>8S;^AF7>\M?]3R&.YO]2S_H[_%ED>4?7<CZ2GQH1*Z1_P#6.<?Q:A_QYCF'
MJO\ WFHZJ^>SIOK/_=Z?KMYJIN'8'(0
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M.QR: AGC^<SZO_N^MGP#:_:X3X8/G,^K_P"[ZV? -K]K@X8/G,^K_P"[ZV?
M-K]K@X8/G,^K_P"[ZV? -K]K@X8<"WRZFMW^HO[5_P JU_IKY]IWION#Z/04
MM%W7NAZ/Z1S>C1Q\_-Z-'IS:Z:<.U01&#OOAF?*_P'WLOWV+J 6W-0 6P
M
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MO-5-P[ Y"
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M1'S-?_VCO_"'_P!;"?$?,U__ &CO_"'_ -;!Q'S-?_VCO_"'_P!;!Q'S-?\
M]H[_ ,(?_6P<2$'65T:_%(_)Q_\ ['_*!^4#W8__ %/[E>B>Y7H7_P#.UG>=
MYZ9^UY>7RZ\"L3B^YX9GRO\  ?>R_?8NH!;<U !;
M
M                               @)XC>^GY'>GN[66TURTN8[K/DQJQ=
MV_EFBHWLYKG5-\NC(%[K5%U:^5BH%:PX5X3VQGVJ[<9%OA>J-([SN/*ZUXL]
M_LH[+02JV5Z<$5OI%6Q=47M2)CD[0K:7\,V_IGEWOU7_ %1(?+G-_KN?])?X
MTOI_E'U+(^CI\6'F#',B   %M6V_YN\"^]RU_4D1]/<@^S=-]%E_%A\Q\_\
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MT(E=(_\ K'./XM0_X\QS#U7_ +S4=5?/9TWUG_N]/UV\U4W#L#D(
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MA>,I_9Q_"_\ F0)U0\\,SY7^ ^]E^^Q=0%;;FH +8
M
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MCAN]M$]UX[XO6S_W(?\ >%P]LF*^XO)OF/U[_M,I]^><_/\ ZE/V7%=^MJ,
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M1]=R/I*?&A$KI'_UCG'\6H?\>8YAZK_WFHZJ^>SIOK/_ '>GZ[>:J;AV!R$
M
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M:[F;'4P2(J.T7BUR:/;JO*Y-5"4QB])O[U2[Q=25;:Y]R[[#+;+&KW6;&K9
ME);J>21$1\J1(KG/D<B:<\CG*B<&JB*J!2(P2'\/#I?O6]&[=EW!O=KDBVNV
MRN$-TN5PG8J0W&YTSDEH[?"J\)-)$;)-HBM2-.5VBR,U%I::PM@     4A>,
MI_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M
M                          BIUH;Y?D!Z?\QRZ@JTI<LO$?N!@ZHY$D2Z
M5['M9,S7M6FB;)/_ ,C3RA6(Q5U>$GL:Y\N9]0=]I%5&H_%\&?*U%U<[DEN=
M4SFXZHG=PM>GJS-]4)6E> $%1&;?TSR[WZK_ *HD/ESF_P!=S_I+_&E]0\H^
MI9'T=/BP\P8YD0   MJVW_-W@7WN6OZDB/I[D'V;IOHLOXL/F/G_ -HZGZ6_
MQI>T,LQ(  KV\1;IHN._FT=)D&'T+Z_<3:Z2HN-DMT+5?+<+?4-8E?11-;Q=
M*J11R1IHJJYG(B:R:A*LX,R$D;XGOBE8Z.2-RMDC<BHYKD7145%XHJ*$W^
M'3]G-I,PWQW$QW;;":%U5=[]4(V>K5KE@H:1JIZ16U+D]C%"U>9R]J\&MU<Y
MJ*)EKVVWP*Q;78%B.WF-1+'9,/M=/;*!7:<\B0L1'32:=KY7ZO>OE<JA:>V
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MKY[.F^L_]WI^NWFJFX=@<A
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M=0%;;FH +8
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MG/T=O/5]GIP_--8OXS7?5,AZ^P/V1E]=OC2\G;W[7S.JOQ8=U-S::
M\QFW]#,N]Y:_ZGD,=S?ZEG_1W^++(\H^NY'TE/C0B5TC_P"L<X_BU#_CS',/
M5?\ O-1U5\]G3?6?^[T_7;S53<.P.0@
M                                   ""76MUC7+I,_)I[GX'39M]O\
M[L]]Z17OH?1?<KT'EY>2";G[STQ===-.7RZ\"L1B@G\\9DG]0]L^'YO:(2X3
MYXS)/ZA[9\/S>T0<)\\9DG]0]L^'YO:(.%P3>KQ/=\=U<8N>'8]:+1MC9KW#
M)37>MM3IZBZ2T\J.:^%E7,Y&Q-<Q='+'&C_4>U%T!%7X/#6V!N^Z6^UEW$K;
M<_[0MHZEEWN%R>U6Q37=C5=;:6)R^R>R7EG=IKRM8B.TYV:E;2TQA;
M                             4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%
MU 5MN:@ M@
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M_P#6.<?Q:A_QYCF'JO\ WFHZJ^>SIOK/_=Z?KMYJIN'8'(0
M                                                   !%CJ7Z1=M
MNJG[2ORA7O);-]HGNE[D?:[4T=/WGNIZ+WW?^ET=7S<OHC.7EY=-7:Z\-"L3
M@BQ\T5TW?=MN5\)6?_8P5XI/FBNF[[MMROA*S_[&!Q2?-%=-WW;;E?"5G_V,
M#BEZW%O"OZ6,=K(*NY0Y9FK('<ZT5[NS&0OXHJ(]+;34+E1-.SF^CJ#BE/\
MQ3$<7P6PV_%\,Q^WXOCMK8K+?9;93LIJ>)%75RI'&B)S.555SEXN555555"+
MT0                                   %(7C*?V<?PO_F0)U0\\,SY7
M^ ^]E^^Q=0%;;FH +8
M
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MW^6OZ,>69:SVSYU_4M=;AG'+R_8U_P UOTI\D0C+NS\HNW>^-B_]$!SSM/\
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M+=6O](L1][I_WXXUZSOK.1[R?.[)ZL?JV?[^/,F?C?\ 1VP^]U+^\M.M<O\
MJV7[ROFAR;7_ %G,]_;SR^T>MY       $<>J/\ -I![]4O[W,:#ZQ_LR/I*
M^:S??5S]IS]';SU?9Z</S36+^,UWU3(>OL#]D9?7;XTO)V]^U\SJK\6'=3<V
MF@      /,9M_0S+O>6O^IY#'<W^I9_T=_BRR/*/KN1])3XT(E=(_P#K'./X
MM0_X\QS#U7_O-1U5\]G3?6?^[T_7;S53<.P.0@
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M-D>,9!3MJK1>*1RK'+&NJ+P<B.:YKD5KF.1'-<BM<B.14"#TP
M                        %(7C*?V<?PO_ )D"=4//#,^5_@/O9?OL74!6
MVYJ "V
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M]=O-5-P[ Y"
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MY;L/=ZY\MCR&BDR+$:>1RJVGN%(K&UD42:\$G@<DBIV:Q:\%<NHM"^H(
M                               *0O&4_LX_A?\ S($ZH>>&9\K_  'W
MLOWV+J K;<U !;
M
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M_P#=Z?KMYJIN'8'(0
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M!#,GT"WB6R=7FRM5$YR>DW2LM\B-T75M?;JJE5%1>&GTW7_A3B%R=S5T%L
M                                !2%XRG]G'\+_ .9 G5#SPS/E?X#[
MV7[[%U 5MN:@ M@
M
M'RK[>[7C5DO.1WRL9;K)C]#47*\7"7@R"EI(G332N]9C&JJ@9NMC[)=.NCKA
MK\VRBA=/B$5T?E61T$Z+)##9+8]D5NMKU5=%[S2&!R(J<R+(]$X*$YV0TM!
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M[D."&DMU   #INS/YTL)]\6_XKC8NR?VKI_?^EKW:S[*U'O/0M1/I)\W
M  5^7[Y4<'WQVW]Z@.'ZW_M<?2T\U7;]%_U6?HK^>RP,[@X@        06ZM
M?Z18C[W3_OQQKUG?6<CWD^=V3U8_5L_W\>9,_&_Z.V'WNI?WEIUKE_U;+]Y7
MS0Y-K_K.9[^WGE]H];R       (X]4?YM(/?JE_>YC0?6/\ 9D?25\UF^^KG
M[3GZ.WGJ^STX?FFL7\9KOJF0]?8'[(R^NWQI>3M[]KYG57XL.ZFYM-
M >8S;^AF7>\M?]3R&.YO]2S_ *._Q99'E'UW(^DI\:$2ND?_ %CG'\6H?\>8
MYAZK_P!YJ.JOGLZ;ZS_W>GZ[>:J;AV!R$
M                                   !1-XQG])-A_>R_P#[]0A.J4_A
M0?)>N'W\7;ZEH0I;>LR"*GGQA/S;;._?+7_4:!*K[GA!?F2W,^_AWV-HP66U
M!%X?<W\VVX/WM7;ZCE RQ]$?RL-B_OEB_>I N3N:U M@
M                  *0O&4_LX_A?_,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
M
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M1$3E=Q550V'LID9D<UT\S6?;=R>Y+7^U>=ESRO/B+1[7NQW86C'T:^<P
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MX[^',B,?%*_G]LN1:C#Y68MANXLN9P\</J?DFZB_KC<?AU/X<]/W8[2>ZO\
M\O\ J>;[S=F_<T_XO]+J.S^!;P8]F<%RS.LK)K(VDGCD9-=/2V=X]$Y/I7>O
M\OET-C[+<DYSI-;&9J[6G+X9WWXMO1LQEKG:GG7)M7HIR])6L9G%&ZG#LZ=N
M$)9'37,P
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MAI*2'*;1)+++)22-8QC&U2JYSE5$1$355!@SE]$?RL-B_OEB_>I G.YK4"V
M                                  I"\93^SC^%_P#,@3JAYX9GRO\
M ?>R_?8NH"MMS4 %L
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MF=5?BP[J;FTT
M                         *</%.V<W5W3O^S51MQM]?LW@LUOO4=VELU%
M+5MIWSRT:QMD6-J\JN1CM-?44)5E4]\43JA_J$SCX'JOW 2Q@^*)U0_U"9Q\
M#U7[@&,'Q1.J'^H3./@>J_< Q@^*)U0_U"9Q\#U7[@&,'Q1.J'^H3./@>J_<
M Q@^*)U0_P!0F<? ]5^X!C"1O2+TS]06(]2FSN2Y1LWEMAQ^SW^.HNMXKK74
M0T]/$D<B*^21S41J:JG%03.QIC"V
M   I"\93^SC^%_\ ,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
M
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M[KO)NK2P
M
M    4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M
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M%<>F\^VMX(GQSWG1_6%SB--IZ:#*V3:(FV'12/:QX9CQ5[Z<YV1QP
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M[I_WE>N/.@MTG?TSR/WE7ZHB.->K+Z[F_1_YH=E]9GU+*^D_RRGL=K<5
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M[IB<8\</%FY5\JTUO$UM&^)C"?%+]!<6P
M
M                                       "D+QE/[./X7_S($ZH>>&9
M\K_ ?>R_?8NH"MMS4 %L
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M5R[+Y?I::?+W5C#KGIGPSM<?YKS',YAJKZB^^TX]4=$>"-CTID&/
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M%
M
M        %(7C*?V<?PO_ )D"=4//#,^5_@/O9?OL74!6VYJ "V
M
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MG'O3B6;V]YO6\Q%*81,_F6]+MF5V"Y1:D3-[XS$?GU]#\_QD=W/K3;OY!/\
MPI#[_P#./<4^!;TI_<#D_N[_  Z^AR:JRO+:S.&[@2VU$OK*R&N1C::1*?O8
M&M:SS-==-&)JG,:QF\SUF9K_ ..FG^YQ1;VL\.-<,-G@[K9\KEFCR]#_  ,7
M_P!OAFOMHXL+8X[?#W'6?C([N?6FW?R"?^%-G^__ #CW%/@6]+6/N!R?W=_A
MU]!\9'=SZTV[^03_ ,*/O_SCW%/@6])]P.3^[O\ #KZ%@9W!Q
M
M                         %-WBA]2>XVUV5;2X'MEF-QPNXQ4L^67RMM=
M0Z&:H1\KZ*ABE1JZ/A18JA71O1S'KRZIY@2K"4'A\[T;R;[[/W?--VZNVW!:
M2]OL^-7.EHDHZJKCI88WU$]2D3T@<BR2HQO=Q,T5C]==4T*6C!/$*
M                                 I"\93^SC^%_\R!.J'GAF?*_P'WL
MOWV+J K;<U !;
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M]%IZ9&7[6D1$>GKG?/??.>OUN9K<^^?F>VO,S/HZHW1WGVCUO(
M     0]ZN/\ 5V#_ ,9KO\2$Y7ZT/W>GZ[>:KJ?JP_>:CJKY[) [4?FTP;WE
MI/WM#>.S/V9I_HZ^9I':7[3U'TEO.Z"9Q@P      '%^H7\S^7_]G_9"F-2[
M=?8V?^A\>K;.PWVSD?I_$L\9TI?F[O/WQU'U)2&)]6GV;F?2S\6C+^LK[1R_
MHH^-=)LZ&YX       _%<O\ 5U?_ !:7_$4LZC]W;JGS+NG_ 'E>N/.@MTG?
MTSR/WE7ZHB.->K+Z[F_1_P":'9?69]2ROI/\LI[':W%0
M
M                                IX\4WIGS#<"GQ??'!;5-D%1AMJDL
MN:VBD8Z2J9;8YI*JGK(HFHJO9"^:9)43BB.:[3E1ZM)5EX'PQ.J_;O#\1N.Q
M&XU^H\0KO=B:Z83?+C(RFH:IM:V-):*2=ZHR.5LK%<SG5$>C^5/.:B.*VA=_
M3U%/5P0U5)/'54M0Q)*>IA<CXWL<FK7-<U5145.Q4"#^P
M                        I"\93^SC^%_\R!.J'GAF?*_P'WLOWV+J K;<
MU !;
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M^0X>.9C'CQPPB9W<$=SNL7SGL!_3M)F:GY?BX(C9P88XS$;^.>[W$HCHSG0
M
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M5_@/O9?OL74!6VYJ "V
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MOM9F*[\,=W3O:SS_ +)<OG3ZC5329S."]\>*WMHB;;L<-_1N6*'>'"
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MF9^9:L[XF]IB>N)G!Z@R3'
M
M         #^-144])!-55<\=+2T[%DJ*F9R,C8QJ:N<YSE1$1$[54"-63=9O
M2SB%7)0WG?'&'54+^ZFBMM2ZZ<C^.K7+;V5"-5-%1=5X+P7B%<)?%M_79TD7
M.I;24V^%CBE?IH^KBK*2+BY&\9:FGC8G%?*[LX]B*#"4C\5S7#LZMWNQA.66
M?,+3KR^Z5EKJ>O@U7R+)3O>U%X=FH4>F
M         4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M
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M+1I\R:<6_#IP>K7\HTFOF)U&7%^'=CT8O2?EFW2^[:X_X3?W)D/O9S7^8O\
MAX'@^Z?*OY>GX>%W3IZW$S;*,\FMF09'5W6@2U5$R4LZM5J2,DB1KN")Q1%4
MW+L+SW7:WF$Y>?FVO7@F<)[N,--[<\BT.BY?&9D95:VXXC&.YA*;IV!R   >
M+W(_-WGOWN73ZDE,3S_[-U/T69\666Y!]HZ;Z6GQH5*GS"^G    ]IMO^<3
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MKAA,SNQQWQ'=:7VQ[0Z/FM,J--68FLVQQB(WX8;IGN)%&^-$
M
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M!!:-TL,9"S,+5 G)3U44JN;%<*1JN<O(]6Z/;K]+?P]BYBJ6YC!. *
M                             *0O&4_LX_A?_,@3JAYX9GRO\!][+]]B
MZ@*VW-0 6P
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M=F$.HFQM<
M
M                *0/& W*N$<NT^T5'5.AML\-5E=_IFZHD\B/6BH%7R:,Y
M:A=/55%\B!.KMGAG=+>-83ME9M]<GM,%RW#S^)]7C5351(]UGM"N='#Z-S(O
M)+5-19'R-X]VYC$T3GYBEI6IA$ XOOQL1@?4-@%SP/.K<R5DS))+#?F1M=66
MJM5JMCJZ5Z\4<U=.9NO*]OFNX*%8G!G(Z5+[DW3=UIXGC5VF6EJJ7+IMO,T@
M8Y6P3PUU5[FO5RN1.:)D_=U#5\O(U0G.V&I\+8
M            "D+QE/[./X7_ ,R!.J'GAF?*_P !][+]]BZ@*VW-0 6P
M
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M_5<1E^0?:6F^ER_C0Q//_L[4_17^+*VH^G7S&
M
M
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M&4_LX_A?_,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
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MOIP   /:;;_G$P+[X[7]5Q&7Y!]I:;Z7+^-#$\_^SM3]%?XLK:CZ=?,8
M
M
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MLWTOUND@PG;=9F8[43,^EW"^31.B:V/F]DVDCD61SD[).[3]EH+2T0A
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MM- Y\:_1U[0E+8Y0UU)<Z&CN5!.VJH;A!'4T52SV,D4K4>Q[?6<U45 M/U
M   !2%XRG]G'\+_YD"=4//#,^5_@/O9?OL74!6VYJ "V
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MS:9<Q:LQ:/96WUG&.GNK.I[;<TU&5;*OF1-;1-9]C7=:,)Z.X[,;8U,
M
M
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MU_\ Y/.[?VR^P:?_ !^98&=Q<0
M
M                                                         !X?
M<?<?#=IL-O>?9]>X;!C%@A[VNKI=5<YRKRQQ11MU=))(Y4:QC457*NB 4S[A
M>,%>'7&HI]JMI**&U1.<VENN554LL\Z:^:]U'1.B;%Z[4G?]$)\+D7SNO4C]
MQ.VOP;>/]L@X8/G=>I'[B=M?@V\?[9!PP?.Z]2/W$[:_!MX_VR#AAVGIV\2_
M?;=S>[;?;;),3P.BL687=EON=7;:"Z1U<<3F/<JPOFNDS$=JW]<QR>L":KQ
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MSO>XZN_DO;]_>/>/J5X(WLAX7     3[\,SY7^ ^]E^^Q=0%+;FH +8
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M.Q-HZ^Y"
M
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M^FH/2.Y]Q^Z[WT>-G/R<[N7FUTU73M4)U1F\,SY7^ ^]E^^Q=0%;;FH +8
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M>(K./#,6PV]Z92>.BN=@
M
M
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MIB'/>U_.=+S344S-/$Q6*X3C$1MQF>B9[KM)MS4@
M
M
M                             !R'??;G;G=3:K+\0W4DIZ/#:FB?4U]\
MJ)HZ;W+?3M5\=PCJ)=&1/IU\]'.\W35KT5BN:I6&;#;/J.S#HWW0S*V;*Y[;
M-T]NIZU8JAE32U<5JN\<7".I;!+W,L$[&JK%?&Y6KIVRQ\H3PQ3^MWC&VU:.
M'W7V$J65Z)I.M'D+'0N5/US>\MZ.37U%UT]50CPOV_/&8W_4/<_A^'VB#A/G
MC,;_ *A[G\/P^T0<+I^S'BA6'>+=+"=L:;9ZOL,^9W%MNBO$MYBJ&4ZN:YW.
ML24C%=['LYD!-5J81          "B+Q0,0WTW5WDQ.R85M3F^783A&.,]$N-
MEL5RN%$^Y7*9\M8YDU- ^-5[J*G8J(NJ*WCZB$ZJT?BR]2/Z/FY7XIWCVJ%<
M8/BR]2/Z/FY7XIWCVJ#&#XLO4C^CYN5^*=X]J@QA*KHBV&WRQ/JGVAR'*=F<
MZQJP6RX5C[E?+KCMSHZ.G:ZW53&NEGGIV1L17.1J*Y4XJB F=C3"%M3KUU^'
MI=MQ;]==Y]BZ2&;*KHKZG-\#5[(/="=$U=6T+W\K$G?HJRQN5.\7SFKSJJ/)
M191SE>"9M@E=);,UQ&\XE<(GK&^CO%#/12<R:\$;.QFO8NF@3="VLZ<M[-YK
MI26W;[;J\W>&J>ULE]DII*:UT[7<>>>NF1D#$1..G-S+^M1R\ 8M*'1WTH6'
MI:P":V.JX;]N#E"Q5.<Y/$SDC?)&CNZHZ5')SI!!SJB*[B]RN>J-YD8PMS.*
M7P40+ZW>BVV=3U@H\@QJIIK!NWBU,Z"Q72H16TMQI%<K_0*US6N<U$<JNBD1
M%Y'.<BHJ.70K$X,Z&Y.Q>[^T-QJ;;N-MY>\8=3/<Q*^HI7NH9>553F@K(T=!
M*WAVL>J!<Q>>PS;3</<6NAMN!X/?,PK9G<K(;103U>GJJ]T3'-:U/*KE1$\J
M@7\]!70;6;$U7Y6=VF4T^Z-53/IL>QV%S*B&PP3M5LTCIV*YDE5*Q58JQKRL
M8KFHY_.O*0F<5I81      I"\93^SC^%_P#,@3JAYX9GRO\  ?>R_?8NH"MM
MS4 %L                                               #B74-255
M;M9>X*.FEJYW5%$K886.D>J)4QZKRM15X&H=NLJ^9RG,K2)F<:[(C'\Z&W]A
MLVF7S;+M>8B,+;9G#\V6;GJ\VRLV&Y%09+2K[CW?+)))+GC,L3HGO>U-7UK$
M5$T1[E1'Z]KEYDUU=IX>P?,]5J--.1J*3'R6$1:=F,=%9QZ:QT]S#';OR';K
MENET^IC/R+Q/RN,S6-N$]-HPZ+3T=W'#9NAN;ZT4 ZWM9LGN%N[<&P8GC];4
M6B&9([KD:4\CZ.D3@KN9[4T<_1>#&^<O#L3BF.YGS/*Y?DSF9F,]RM8QM:>Y
M$?CW1TRR'+>6YNOS8R\O".[-IPK6.[,_BWST0O+Z1=JF[7YG@M@MECKJ6W4"
M7"2NN533O8Z>>2@J$?/,]6HG,]VB)ZB:-3@B'*.2:W6<R[0Y6ISZ6K'LHB,)
MPK7@MA&,QW]_3,^!U+G>CT?+NS^;ILB];3[&9G&,;6XZXSA$][=T1'A6JG:'
M&'F[_A^+93'W60V"AN^C>5DM1"UTK$7]A+ISM_Y*H>#6\JTFMC#/RJWZXC'P
M3OCP2]^BYKJ]%..1F6IU3.'AC=/AAP+).EC#;CSRXW=*W')U1>6G>OIE.GJ:
M-D5LB?JR*:1S#U;:+.VZ>]LN>Y[>OE]E^LW;E_K(UN3LU%*YD=WVEO)[']5'
M?,.FS<.STE<D5#193:GQ2)4>BN;)K&K51>]IJA&J[AVM1'&JV[)\ZY/?Y73V
MFU8G&?D[3$S$=VLX8]7LFU5[5\FYQ3Y+/K%;3&$?*5B8B9[EHQPZ_8LW-QH*
MFUW"NME8SNZRW5$M+51_L9(7JQZ?J*BG;J6BT1:-TN+VK-9F)WP_&21  'J\
M$MU3=LWP^V4<;I:FOO5!!"QK5>O,^H8GL4[=.TL:K.C)RKYD[JUF?%&*]ILF
M<[-KEQOM,1XYP:1:;9G>[<*:.KRJJGI('*CF5%]K'.<U/+R4[%D>Q?65K3B6
M7V3Y[S:T6U-IB.[F6GR5C&8ZL(=HS.UG(^55FNFB)GN9=8\MIPB>O&78,<Z4
M\6HDCFR:^5M\F;HKJ:F1M'3KZK5_RDBIZZ.:;5H/5II,O"=1F6O/<CV%?QV\
ML-5U_K*U69C&GRZTCNS[*WXJ^27?,=P#"\31JX]C5#;96IHE6R)'U&GJ+/)S
M2+^JXW70<DT.A_<95:SW<,;?"G&WE:5K^=ZW7?O\VUH[F.%?@QA7R/7F58M5
M=O-^=+-O?%W^*T^;>UGVKJ/?^A](]D_LK3^\]+F1KK80   M#V*_--AO\6G^
MJ93Z-[&?9&1U3\:7SIVS^U\_KCXL.MFSM8
M
M
M                                   I6\7/>.]6RAV^V/M%6^CMF1P2
M9-F#8W.:M5%!,L%! _31%C26.61S55=7-C71.5 E6$-.E3P]MP.I+'8L_N.2
MTNWFW=3/+3VN[34SJ^NN#J=ZQRNIJ5LD+4C:]KF+(^5/.1>5KM%"4VP3JA\'
MK;QL4:5&\N12SHU.]DCMU(QKG>56M5[U1/6YE"/$_I\SWMM_7%DO\@H_[X.(
M^9[VV_KBR7^04?\ ?!Q.D[/^&)@FS^YN&;FVW="_7BNPVX-N%-;*FCI8XIG-
M:YO*]S%YD3SO(";+/0B                                   I"\93^
MSC^%_P#,@3JAYX9GRO\  ?>R_?8NH"MMS4 %L
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M[N7&$?XJ1NG]'VL^">EOG;KD%M'JIU-(_P!K,G'WMYVS'Z7MH\,=")!O[0P
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M?P^7[F/%!_$9GNI\<OUL8R-C8XV-C8U-&L:B(B)ZR(78B(C"%N9F9QE_HJH
M
M
M                                                           !
MG^\7_$Z^EW9VKSET;EME]Q*2Q0R]K4GM-?/4R-7AP56W%O:O'R=BA.JU/H<O
M-FOG2?LC461S%IJ/'V6ZL8Q?85E#+)3U:.3R*LS'.X^KKY0C.]*X*
M                                 I"\93^SC^%_\R!.J'GAF?*_P'WL
MOWV+J K;<U !;
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M(V1$8+ECZK?*P
M
M
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MVJ2&)97-5R(^17*C4T:O$*<*<04
M  4A>,I_9Q_"_P#F0)U0\\,SY7^ ^]E^^Q=0%;;FH +8
M                              (7]<74W!TV[0U=79ZF)=R<T26U8#1N
MT<Z&3E1*BXN:J*BMI&/1R:IHLBQM5.55T*Q&*OSPNNF:HR"\UG4[G]-)60T5
M14TNW+*WZ:ZJKW*YE;=7J_57+$JNCC<O;(KW>R8U2,3C*=MD+TR2V
M ?EKHWRT59%&WFDD@D:QOJJK51$+>=6;4M$;YB5S)M%;UF=T3"KC\C.Z7W$W
M'_!;^Z/G'[I\U_E[_AX7T;][.5?S%/P\!^1G=+[B;C_@M_=#[I\U_E[_ (>$
M^]G*OYBGX> _(SNE]Q-Q_P %O[H?=/FO\O?\/"?>SE7\Q3\/ ?D9W2^XFX_X
M+?W0^Z?-?Y>_X>$^]G*OYBGX>!^N@V<W/CKJ*1^%W!K&3QN>Y6MT1$<BJJ^<
M7<CLIS6,RLSI[;X[G=ZUK.[5\KG+M$9]=T]WN=2T8^C7SF
M
M
M                                                          %>
M_7AT@YOU6?DK^T[)K'COVA>[GNC[LK4IWWNI[G]UW7H\,OL?1'<W-IVIIKQ"
M43@KV^:"WM_K,P?_  KE[3"O$?-!;V_UF8/_ (5R]I@XCYH+>W^LS!_\*Y>T
MP<1\T%O;_69@_P#A7+VF#B=CZ?/#*W9VAWHVZW+O>?8E<[5AUV9<*Z@H5K_2
M)6-8]JMC[RE8S7SO*Y I-EUP1
M4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M                         !\7(\BLN(V"]93DEQAM%@QZBFN%YN=0[EC@
MIJ=BR22.7UFHO9V^0#-)<*O./$:ZMXV0)4VO%)94AH8G><VQXO1/5RN=HJM[
MZ7F5[N*ZROT3S41$LYV9P1$1OF<(Z_R1MGJ[KTY67CC,[HC&?P[\[(:5<3Q:
MQ81C-AP_&+?':\?QJAAMUGM\2(C8H(&(QB<.U=$U5?*O%2Y2O#&"Q>W%.+T!
M)$
M
M
M                              #P^9;F[;;<^YOY0MP<:P3W9[[W(^V*
M[4=K]*]'Y.^[CTN6+O.[[UG-RZ\O,W7M0#Q'QFNF[](/;7\;+/[:"N$GQFNF
M[](/;7\;+/[:!A)\9KIN_2#VU_&RS^V@82?&:Z;OT@]M?QLL_MH&$OJV3?W8
MG)KM0V'&]ZL#R"^W25(;99;;DEKJZNHE5%5&0P0U#WO=HG8U%4&#K04
M                              4A>,I_9Q_"_P#F0)U0\\,SY7^ ^]E^
M^Q=0%;;FH +8                                             49>
M*-U/2WBXTW3%@55)4,I9Z:KW,J*15>M15KRR45I:C->;NU5LTJ)KY_=MX*QZ
M%)G#;*=*XIK] '3)#L%M/!>[[1QMW&W!BBKLBJ%:G>4U*J<]-1(O%=&([F=Q
MT5R]B'BTD_+3\O.Z8PK[WN]=]_5P[(F)>S6?[,?(1OB<;>^[G53=U\6V8P3V
M/<\
M
M
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MH>>&9\K_  'WLOWV+J K;<U !;
M          $5^L#J.MG35L]=\L;)%/FE[1]JV]M#]'+-<I6*J3O8J+K%3-^F
MR:\%T;'JBO:%8C%3SX>73M<]\]U:_>S<>.:]V#'Z^2YRUE?K*ZYWB61TCI9'
M.]G],5RJJZZNYNQS4,1K+?Q6;&EK[7#BS/>=%.O,G?\ X(MNQJS&DK_"Y4ZJ
M=^/#E^^Z;]67&[_'-=^%FBY$1$T3@B=B&788
M
M
M
M           #D.^&RF$;^;>WK;[.+9#5TMPA>ZT758VNJK96HU4AK*214U8]
MB]NBZ.;JQVK7*BE8G!0/T&[KY7TY]4TFS613O;8LSR&7!LOLR.58H;W!4/HZ
M.IB:[3SVU2=RJ\-6/=JBJC="4QC#2L$
M      %(7C*?V<?PO_F0)U0\\,SY7^ ^]E^^Q=0%;;FH +8
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MNHS?]N,,NL<-([E8[O\ BM.-K?XIEU8R+'
M
M
M
M          ?@NETMUDMEPO-XKH;9:;332UESN-2](X8*>!BODED>[1&M:U%5
M57R 9.+7D?Y5^M*UY9C<+F1Y[O)3W2Q1)&U'MAK[\V:!7M5&)JUCD5RNT\JN
M\H7.AK6"V                                   I"\93^SC^%_\R!.J
M'GAF?*_P'WLOWV+J K;<U !;
M       *8_%)ZHW6FW0]-F#W'_YM>XXJS=&IIUU?#1OY9*2V:M75'5'"65."
M]WW:<6R.0)5A[_PV>F%-O\8?NCE5OY,EOB:44<J<8>"IRHG_ +)KE:O[=S_V
M#36-%;^J:R=3OR<J9KE]R]]U\SJCVE-_YTQO;+KH_IFDC3;L[-B+9G=K3?3+
MZ[>WON_-B=RUTV=K
M
M
M                                                 J_\2+J:W?Z=
M/R,_DIO]-8_MQ^V+W>](H*6M[WW/]S/1^7TF.3DY?29->7377CV($JQBJ_\
MG,^K_P"[ZV? -K]KA+A@^<SZO_N^MGP#:_:X.&#YS/J_^[ZV? -K]K@X8<3W
M6ZN.HK>NU/L.XNY]PN^/R.1TM@I(:6V44O*Y7-;/#;X:=LR-5=4[WF[$7M1
M1">_AE])>5U^=V[J$SRQU%DQ3%X9)-OZ6OB6.2ZU]3$^%*R.-Z(O<4\;G.:]
M4T=(K%8J\CM"EI7ZA                                   !2%XRG]G
M'\+_ .9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
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MS,SWY?1+ZP
M
M
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MZBHB?JBHZ.:=LCV*BIP5JIH#%WH*
M    %(7C*?V<?PO_ )D"=4//#,^5_@/O9?OL74!6VYJ "V
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M^[O^?>?#LCR;)2F-I:L
M
M
M                                                  43>,9_238?
MWLO_ ._4(3JE/X4'R7KA]_%V^I:$*6WK,@B
M                 I"\93^SC^%_\R!.J'GAF?*_P'WLOWV+J K;<U !;
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MI,N*<?%Q1'1,88UGJG=W8V]*;AO310
M
M
M
M"B;QC/Z2;#^]E_\ WZA"=4I_"@^2]</OXNWU+0A2V]9D$0
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MF=D6FT?I1$3\6J[ ]CQ
M
M
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M#RV9^(/TE87WD4^Z]-D=:S7EHL=I*JY\^G;RU$$2TW]V5-?(;:U3AE$W,_&
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M-6Z=J'BC55MJIR8G;6D6G]*9B/BR]-]-:NFC.F-EKS6/T8B9^-"ZT]KP@
M
M
M
M                           %$WC&?TDV'][+_P#OU"$ZO3^';TL[!;R;
M!5F7;E[<4>5Y%'E=QM[+G/4UL+TIH8*1\<?+3U$3-&K(Y==->(4M*=_Q ND#
M^I.V?RZZ>W IC)\0+I _J3MG\NNGMP&,GQ ND#^I.V?RZZ>W 8R?$"Z0/ZD[
M9_+KI[<!C)\0+I _J3MG\NNGMP&,O2X?T9=,F Y-9LRQ#:>@LF38]4)5V:ZQ
M5EP>^"9$5$>C9:E[%X*O:U08RD\%
M   %(7C*?V<?PO\ YD"=4//#,^5_@/O9?OL74!6VYJ "V
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M^7NK-]O=GV.,^&?%N6!'3G,@
M
M
M                                                      "B;QC/
MZ2;#^]E__?J$)U2G\*#Y+UP^_B[?4M"%+;UF01
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M5;8Y5C1.S5TJ>NI.-+[J]K>'#R4X8\B$ZG#VM:U\&/EMQ3Y43M]MLM\\#O\
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MX_BU#_CS'0_5?^\U'57SV<[]9_[O3]=O-5-P[ Y"
M
M
M
M           5K]>_1SN;U37?;2OV^ON,6>'#:.YT]T;D-56T[I'5LE,^-84I
M**K141(7<W,K?)IJ$HG!VGHDZ?\ ,NFS9NJV\SFYV6ZWJ?(ZZ[LJK%-43TO<
M5,--&QJOJ:>E?SHL*ZIR:=G$*3.*7X4
M             4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
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M=8WF/.]9S&*QJ,R;\..&R(PQW[HCN/8&58H
M
M
M
M                                                   %(7C*?V<?
MPO\ YD"=4//#,^5_@/O9?OL74!6VYJ "V                ,;>^MAJ,9WG
MW2LM2US74N3W-\*N75703U#YH'KHB<71O:O9Y3S:34UU.57,KNF/+NF/!.,/
M;JM/;3YMLNV^/-T3X8VN4'I><  ?0M%LJ[W=;99J!J/KKO5PT5&QRZ(LM1(D
M;$541?USD+>;FURJ6O><*UB9F>Y$;97,K*MFWBE8QM,Q$1W9G9#:/AM)%08A
MBM##PAHK/0P1)Q]C'3L:G:JKV(1TV;\KE4O/YT1/CC%#4Y7R6;:G<F8\4O2%
MY9  '&<QV*PG.+]59'>I;FVX5;(F2MIIV1QZ1,2-NC71.7L3CQ-3YKV,T/,M
M1.HSIOQ3ANF(C9&'<EMG*NV6NY;IXT^3%.&,=\3,[9Q[L/ 7OH]V9R2A?;,@
MH*^\V^145U)62P3,YD['(CX%T5/(J<2SHNQ&DT5_E,C,S:6[UHV]?L<)CO2N
MZWMMJ];3@S\O*O7OUG9U3Q8Q/?AP>Z>%CTJW&59:>DRJS:N5SHZ*[IR+KY-)
MX)M$3R(FAMN5ES2N$VFW?G#']6(CR-4S<V+VQBL5[T8X?K3,^5Z_%O#BZ7\0
MJF5]KQNYSW")4=%6W"N],>QS5U:YC9XW,8Y%\K6HIX-?RR=96:VSLRM9Z*3%
M?+P\7E>[0\T_A+1:,G+M:.F\3;R<7#Y'7_BN;:)_S]Z_E4?\":M_;GEG=S/A
M1^RVG^XW,^YE_!G]IV?#L1M6#V&EQRRNG=;Z1\KXG5+TDDUE>LCM7-:U.U>'
M VSE7*\KENGC3Y./#&._;.V<>\U/FO-,WF6HG49V'%.&[9&R,.^]09%C@
M
M
M
M
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MC7_6<SW]O/+[1ZWD
M
M
M
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M5XKP0V_+RXRZQ2NZ(B(\#4,S,G,M-[;YG&?"_N30
M
M
M
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M=Y]TLK@
M
M
M
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M]]9PEO>5FUS:1>NZ8Q?;+2X
M
M
M
M                                        !05XPGYR=G?O:K_JQ G5
M'3PS/E?X#[V7[[%U 5MN:@ MJZ?%)^2?=_OELO[Z\)5WLS03;7\8_HWCWO92
M?O+ M*Z/%@5$Z7[<BJB*[.+2C4]5?1:Y0E7>S=1QOE>R*)CI))'(V.-J*KG.
M5=$1$3BJJH3;)=]/S);Q?>/D/V-J M0QKA=:G/#B^1CLW^$/_F*YA;MO=OZF
MU1.FWJ#551$_)KE::KZJV>J1 1O8] N-7?0+&^/I"V2;(QT;EM=8Y&N147E?
M<JMS5X^145%0+<[W7.H?#[]N#L9NSA&+TK*W(LKQ>Y6RRTDDK(625-1 YD;7
M22*UC455[7+H"&>/YLSJ_P#N!MGP]:_; 3XH/FS.K_[@;9\/6OVP#BAS;=OH
MOWTV,P>JSG<S'*6RVN*NI:.GD@N5)6<ZU'.UVK*:21R*CN315T3BOET+-\ZM
M+UK,[;8X>",?-BNTRK7K:T1LKACX9P\Z)I>6P   DATT=2F;]+V77;-\,L5I
MOJWRW^XMVI;S%4.A6!TT=1I$^GFA5DFL*:*O,FFOFJ44F,5JV#>,'AE6D4.Y
M.S]XL;TT;+<,<KH+FQRZ<7^CU;:%6)KY.\?P\J]A5'A3&P;Q!.DW.UBAI]U:
M7&*^33FH,FIZBT\FJZ)S5-0Q*7^Y,NGE"F$I8X]E.,9;0I<\4R.UY-;7:<MP
MM-9#6P+S)JFDD#WMXIZX4?%W*O=QQS!,GOEIE;!<;91NFI)G,:]&O1R)JK7(
MJ+V^4P_:#69FCT&=G94X7K7&.EF.S^CR]7K\G)S8QI:V$]"@_JNZ\MW;A#=M
MI,7R]]NB>U(,OOMLCBI*GBFKJ*">%K7L33A*K7(J\6?LD7&=D\WF.ITT:G67
MQXXQK6*Q&%?=3,1CMZ(W8;=N.S*]JLGEVFU,Z?1TPX)PM:;3.-O<Q$SALZ9W
MX]S#;5:JJY5<Y5557557M53:VKO^ >OP7/LRVRR>VYE@>15N+Y+:7H^CNE#(
MK'Z:HKHY&\6R1OTT>QZ*UR<'(J 23O.6[^=<>>P5.89$E936-D,+8(H^YMMJ
MBG7E_P!%H8U\Z696*JKQ<]4T<]&M;IA><<ZR.4Y,7S9FUIV5K'MKV[D8;.N?
M_#,<GY+G<TSIIE1%:QMM:?:TKW9QV]4?EE=UTJ=%>(;/VFEN][L[);S.D<RT
ME6C9)WO:B\LM:[315375D2>8SRIS*NF%T')]3S'-C5\SZ-N7D_FT[]_=7Z]W
MZM<OK^<:?EV5.DY;._9?._.OWJ>YIU;_ -:T_P W1I8   0QZT-T?M1P&+![
M94]W?,\YXJOD7SHK7$J>D*NG9WSE2)->UO>>H;3V5Y?\OG_+6CV-/C='BW^)
M@N?:SY+*^3C?;S=/CW>-4B=):4LPZ&MT?2K?=]J;K4ZSVWGNN+<Z]M/(Y/2H
M&Z_L'N21$3BO,]>Q#0^UW+^&U=36-^RW7T3^+P0VSL]K,8G)MT;8_''XUAAI
M+9@                           'R,@OMMQBQW?(KS4)2VJR4DU;7SKVM
MBA8KW:)Y55$T1/*O NY.3;.O6E8QF9PCPH9N97+K-K;HC%$SI=Z@Z_=:ZYO8
M,GE9'>&5DUYQNGX)RVR9Z-6E:J(G-Z,JMT5>*H[UC8^T'):Z*N7?+]KAPV]]
MW?TOQ,+RCF<ZFUZWWXXQU=SP)E&KLZ
M
M
M
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MF5BU=TQB^H6TP
M
M
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MOC;'5^2?.GT::V0
M
M
M
M@)UA=#GQL,DP[(?RH?:#]J=LGMWH?N)[J^D=_,DO><_I]'R:=FFB_1"L3@YU
MTR^&[\73=^P;K?EF^W'W#IJ^G]P?M=]S^]]-I9*;F](]TZGEY.\YM.[7733A
MVA6;8K0 B 1TZB>E[:SJ8QV"SY];I:>\6ILGVMYA;U;%<;>Z33F1CW-<V2-R
MHBNC>BM7M31VCD*Q."HC*_" W:I:Z1N#[J8C?+8KU[J:^QU]JG1G'3FCIH+@
MU53A^N"7$Z%M9X0=1#=*2OWFW0I:JUT[VOJ<;Q."7FJ=.*L6X5C8UC;KP7EI
MU54[',7B#B7+X5A.*[<XM9<*PBQTN.8OC].E-:;11LY8XV:JYSE7BKWO<JO>
M]RJY[E5SE5RJH0>I \!N;M?@V\.'73 ]Q+!!D6-75$6:DEU;)%*S7NYZ>5BH
M^*5BKYKV*BIQ3L544*:=R?" R!MQJ:G:+=6VU-KF>YU+:,M@FIIH&JJZ,=64
M,=0DNG#SNX9] )\3SV&>#]N54UT/Y0MV,9LEL:[6?[78*RZ3N:GZUOI<5O:U
M5]5==/47L!Q+B=B>GS;/ITQ#[4-M[.ZEBJ7MFOE^JW-FN5SG8BHV6KG1K.;E
M151C6M:QFJ\K4U74C,XNVA0     "D+QE/[./X7_ ,R!.J'GAF?*_P !][+]
M]BZ@*VW-0 6P !\J]6.S9';:FSW^UTMYM=8WEJ;?61-FB>GKM>BIJGD7M3R%
MS*SKY5HM29B8Z80S,NN97AM&,=] /=KH@I9_2;WM%7^A3ZK(N(7&55B5>WEI
M:MRJYFGD;+S?\=IN?+>ULQA34QC_ (H_''H\36];V?B?99$X=Z?Q3Z?&X/;=
MWMZ<+I[GLUN'35530W.G=1)27V-_IM(S158^GJ5762->7AS*]JI[!4,/ZP^6
M:/4<BU6JR)B)BDSC7=.V-\=$^*>ZS?8+6:G+YWIM/FQC$WPV[]T^./&J$W\V
MHK-M<NJIZ.E=]J5]F?46&J8WZ7"KU5SZ1RIP:Z+]:GE9HOJZ<Z[+<_IS;21:
M9_W:X1>._P"ZZK;_ !QT-U[3\AORG536(_V[8S2>][GKKNGP3TN$&S-;  %H
M_0Q@,&VV0V3=O.5]QVU%33R4_?1R*^DM<4C9I9WL:BNUEY45&HU5Y6II[+0Y
MYS?G?\9SC2<NT\\6&;7BPZ;8X17P?G=_#IB70.4<DG2\HU6OSXPQRK17'W.&
M,V\/YO>QZ)A9%N/UV4</?V_:['%K9-'-3([TBQQ(O%.:&DC=SN3RHLCV^NQ3
MO6A[(3/LM1;#_#7\<^B)ZW$]5VBB-F37'OSZ/PZG#Z';?J5ZD:N"[Y%45L=B
ME?WE/<KX]U#;8T77SJ6C8U%=PU1'1Q*B]CG&6OKN6\ICAI$<7<KMMX9],^!C
MZZ76\PGBMCAW9V1X(]$)>;<=%NVN)^CUV7239[>(]'.CJD[BW,?V^;2L<JOT
M[/ICW(O[%#6M=VJU.?C&5["O>VV\?HCPLWI>0Y.5MO[*?)XO2EW0T%#;*2GM
M]MHX+?04C$CI:*FC;%#&Q.QK(V(C6IZR(:S>]KS-K3C,],LU6L5C"(PA5KO=
ML?U%[J;D9#E:X$Y;8^7T/'8776U)W=OIU5L"<KJQ%:K^,CD_9.<="Y3S;EVB
MTU<OY3;OGV-O;3OZ/!U0U#F'+]9J<ZU^#9NC;&[Q^%R?XI'4)_5__P![6GVX
M9+[R\O\ G/U;>AX_Z+J_<>6OI/BD=0G]7_\ WM:?;@^\O+_G/U;>@_HNK]QY
M:^D^*1U"?U?_ />UI]N#[R\O^<_5MZ#^BZOW'EKZ7K<#Z>.I? ,PQ_,;1@&E
M=8:QE0V+W7M34EC]C+"Y4K/8RQJYB^LIYM9SOENJR;95LS9:/<V\$[NB=J]I
MN6:W(S*WK3;$]VOI6^1/?)%%))$Z![V-<^!ZM5S%5-5:JM56JJ=G!50YG,82
MW:']"BK_ (J(J*BIJB\%10.497L7M'FO>OR# K5-4RHO/<*6+T.I55\JSTJQ
M/54]=5,EIN;ZO3^TS)P[D[8\4XO%G<OT^=[:D>:?(C-EG0=A5?WDV'9;<\=F
M=Q925\<=PIT7]BU6]Q(U/75SC/:;MAG5V9M(MU>QG\<>9BL[L[E6]I:8Z]OH
M0AW9VOR_8F[,QFX932U3<CHW3R06BIG8DM)S\B>E0N;'HCW-5$1>9%Y5-MY;
MS#)YE3Y2M)CAGIB-_>EK^MTF9HK<$VWQT3.[ON)&58]ZW \QN> 9AC^8VAVE
M=8:QE0V+7E26/V,L+E3];+&KF+ZRGFUFEKJLFV5;=:/_ !/@G:OZ;/MD9E;U
MWQ*^7#\UQG.[+17W&+Q2W6CK((IW-@FCDD@65J.[J=C'*L;VZZ.:[BBHJ''M
M5I,W37FF968F/+U=V'1<C44SJQ:DQ,/5'G7@            /GW2[6NR4,]S
MO-RI;3;:5.:IKZR9D$,:=FKI)%:U/U5)Y>7;,MPTB9F>B-J-[UI&-IPCOH7;
MF];F%X[W]NV\M[\TNK%5BW6?GIK;&J>5JJB2S:+Y&HUJ]J/4VK0=D\[-]EGS
MP1W-]O1'EZF!U?/\O+V94<4]W='IG\-JOS<G>3<W<Z5KLROU3);95[^BL4#5
MIK>UO,J-<R!NB/T5%1'OYG?MC=-!RO3:./\ :K&/3.^WC_%&#6M5KL_4?O)V
M=S=#DYD7B /NXUDU_P /O-'D.,76>RWF@55I:^F=H]O,BM<U475'-<BJBM<B
MHJ<%0M9^GR\^DTS(B:ST2NY6;?*M%J3A,+#MJ>N.DJ$I[1NU;/0IO-8W+;7$
MYT+O(KJFD35S?55T7-JO8QJ&D\Q[)3&-M-./^&?Q3Z?&V;1]H(GV.=&'?C\<
M>CQ)]6+(+'D]MI[SCMWI+W:JI-8*^BF9-$Y?*G,Q51%3RHO%/*:;G9-\FTUO
M68F.B=C9,O-KF5XJS$QWGURTF
M
M
M
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MC8CO553ZFUW/=7J\8M;"O<KLCP],^&7R]I>59&GVQ&,]V=O_ (=Z,.R(
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MT8Q.,/UD4@
M
M
M
M            4A>,I_9Q_"_^9 G5#SPS/E?X#[V7[[%U 5MN:@ M@    ^5?
M++;LCM%?8[M"M1;;G$L-7"U[F*YB\>#FJBIV>13S:S1Y>KR;9.;&-+1A,;O,
M].CU>9I,ZN=E3A>LXQ._SHN;K;8;,[8X#D695MBFD?;*=4MM(^OJ4](K)?,I
MXN$FNCGJG-IV-U7R&#Y=ZM.5:S/KE1ESMG;[*VR.F=[/ZSUC<VT^5;,G,C9N
M]C7?T="JK[><@_Z>+_--.B_V:[,_,6_Y+_M-0_NWVA^=K\"OH/MYR#_IXO\
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M\BPHTILP
M
M
M
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MC5[T8U9:69%1NKG(B+)"WBNB+JIGLO4\MYM/#,1-IZ)C"W@F/Q2Q5\C6\O\
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M*[1/571%48#_ $
M
M
M
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MVKTUM-FVRK[ZSA^7P[VTZ?.KG9<7KNF'J#SKP
M
M
M
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MU-5.]L<<;&IJYSWN5$:B)VJJE:UFTX1&,RI,Q$8SN?W**@
M
M
M
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MNR?Q2DP8%E@
M
M
M                                              *0O&4_LX_A?_,@
M3JAYX9GRO\!][+]]BZ@*VW-0 6P
M                        !_ES6O:YCVH]CT5KV.35%1>"HJ*!SG\CFT7]
M5>'_  '0?P![OZIJ_GK_  K>EY?X'3_-U^#'H/R.;1?U5X?\!T'\ /ZIJ_GK
M_"MZ3^!T_P W7X,>@_(YM%_57A_P'0?P _JFK^>O\*WI/X'3_-U^#'H/R.;1
M?U5X?\!T'\ /ZIJ_GK_"MZ3^!T_S=?@QZ'^X]H-I8I&2Q;78C%+$Y'QR,LE
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M'L:88^'\-O<6+ZFE,RN7,^RMCAX'M#RKX
M
M
M                                     I"\93^SC^%_\R!.J'GAF?*_
MP'WLOWV+J K;<U !;
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MO!&O<OD-B[2<O_BM--JQ[*FV.KICQ>9AN3:SY#/B)]K;9/XI_#NKFSEK>P
M               _A4U-/14U165<S*:EI(WS5-1(J-9''&BN<]RKP1$1-54K
M6LVF(C?*DS$1C*C+=7=Z[YQNY7;CVRKEHEME="N'.['4M+02<U*J-7L5RIWC
MD_9.<==Y=RRFGTD9%HQQCV7?F=_HZH<]UFMMG:B<V)W3['O1&[TKEML,\M^Y
M>"8[F=OY6)>*5'5M*U=?1ZN->2HA77CYDC51%7M31?*<MYAH[:3/ME6Z)V=^
M.B?$WK2:F-1E5S(Z?/TO?'C>D
M
M
M                            I"\93^SC^%_\R!.J'GAF?*_P'WLOWV+J
M K;<U !;
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MA;_=8U$XN-/[6\O^4RHU%8VUV3[V?1/G;'V?UG!><F=UML=?Y8\RTLYZV\
M
M
M
M I"\93^SC^%_\R!.J'GAF?*_P'WLOWV+J K;<U !;
M
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M9\8Y=HG\.YO>U/(]
M
M
M                 %(7C*?V<?PO_F0)U0\\,SY7^ ^]E^^Q=0%;;FH +8
M
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M(QN;V=R;>UM,>7\/&X7?.A7<BT3+58EF%HO7H[N:G=-W]MJE5.Q6HB3L1?\
M\ZGT3+Y/:_37C#-I:/%:/Q>9C\SL]G5G&EHGQQ/X_.\_[F]:.UK5[A<LJ*.D
M\YC89&9!3M8G'5(]:M&M\JIRIIY2_P#*<FUF_@QG]"?\JUP<RTV[BP^%Z7!M
MT-WL[W7JK1)G%9'/-CT$E+2P0P)3M1TC]99'QMX=X[E:CM$3@U.!F.7\LR-%
M%OD8]MMWX]7@8[5ZW-U,Q\I.YRTR#QI#[9]06\6&8W!M[@3HZJ):N:IML;:%
M:ZMC6;1SXH6+SMY.9%?IW:KS.<NO$PFOY+H]1F?+YVS9A.W".N?-O932<SU&
M53Y++[NS9C+HWN1UK;D\WI"Y?2T]0[Z<RHG9C\*HO;K"KJ-%;QUT1J^LAX?E
M>2Z3=P3/5Q^7V3U<',M1OXOB^A]:U=#N[%\G6MRK*;-:WSN19Y'S5%PJU5>U
M7:1M8O\ G"WF=K=)EQAETM/@BL?AX$Z=G]1><;VB/',_AX79;!T$X52\CLES
M>\WES>+F4$,% Q5]1>\2J=I]!4,7G=L<Z?W>76.O&W[+W9?9S*CV]YGJPCTN
MV6#I4V*L",<S"(KM4-TUJ+I45%7S:>K$^3NO[C#$YW:+79O_ *F$=Z(C\OE9
M#+Y/I:?F8]>,_D=JLF*XQC4:Q8YC=KL$3DT6.VT<%*U4]32%C4,5FZC-SO;V
MFW7,SYWOR\FF7[6L1U1@B?UH;H_:C@,6#VRI[N^9YSQ5?(OG16N)4](5=.SO
MG*D2:]K>\]0V/LKR_P"7S_EK1[&GQNCQ;_$PW/M9\EE?)QOMYNGQ[O&J1.DM
M*  $BNG/%=N=Q,GKMN\]IIJ>IR&G63$\AHYU@J:>LIVN<^!.;FB<V6/54YV.
M\YB(WBY3"<\U&HTN5&?DSLK/LHF,8F)Z>[LGN=WO,IRO)R<^\Y69T[ICN_E=
MCS+HJW)Q"K]VML<C9D24KEDI(FR^YETB5.*=V_G[IRHGZY)&*OD:8O2]JM-G
MQP:BO#C^E7T^27NS^0YV5/%DVQ\D_AX7P[!U0[^;1U\=@W%M4]^AITY5MV10
M24M?R-\L=8C4<_7]G(DA>SNS^@UU>/(F*]^LXQXOQ1@MY?-]7I9X<V,??;)\
M?_E,';_K!VCS3N*2[5TN#7B71KJ6\:)2J[]I6,UCT]>3N_H&L:WLQJ]/C-8X
MZ_X=_P '?XL6<TW/-/G;+3PSW]WC]."45+5TM=30UE#4Q5E)4-1]/50/;)&]
MJ]CFO:JHJ>NBFOVK-9PF,)9>+1:,8W/T$50"*_5)OE7;08_8J3&9X6Y??ZUD
ME.V5C96Q4-*YKZASF.14^FKI$G#L5RM5'-U-B[/<HKKLRTYGM*QY9W>+?XF'
MYOS"=+2(I[:9\D;_ $) 85EMKSO$[!E]F?S6Z_T<=5"Q5171N=PDB>J<.:)Z
M.8[UT4PNKTUM-FVRK[ZSA^7P[V2T^=7.RXO7=,/4'G7@
M
M
M                                    4A>,I_9Q_"_^9 G5#SPS/E?X
M#[V7[[%U 5MN:@ M@
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MFUO,Q6<<)PGK?9+2X
M
M                                                "D+QE/[./X7_
M ,R!.J'GAF?*_P !][+]]BZ@*VW-0 6P
M
M              4R=66Z/Y1=SJNW6^I[[&\)[RU6KE75DM0CO],G3R+S2-Y$
M5."M8U?*=2[-\O\ X731:T>ROMGJZ(\7G:)SG6?+Y\Q'M:[(_'/X=Q%XV!B
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M&=_5U&O=01Z]KW\JZ(7,O*OF8\,3.$8SWHC?*%\RM,.*<,9PCK?4+:8
M
M
M     *0O&4_LX_A?_,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
M
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MB-EHPB=^Z=L3U>)F^3961GVG+S:XS.V-\=<;/'XTSKAT6;'5FOH]!>+3K_\
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MM5LJ)Y$=IY#D?.=!.BU-LO\ -WUZI]&[P.A<MU?\3DQ?IW3U_AM=F,6]P
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M+1$X]_\ .CP3Y)AX.7Z^NKK:8V3$^3HEW$Q#(
M
M                         !2%XRG]G'\+_P"9 G5#SPS/E?X#[V7[[%U
M5MN:@ M@
M
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M(U[E\A9[2<O_ (K33:L>RIMCJZ8\7F7.3:SY#/B)]K;9/XI_#NKFSEK>P
M   $*.M7='[5L'IL!M=3R7K.-?='D7SHK7"Y.\UTXIW[]&)ZK4D0VOLIR_Y;
M/G.M'L:;O??DW^)@.?:SY/*^3C?;S?E]*"_39NBNUNY]IN%94=SCE]TM.2HJ
MZ,;!.Y.2=?(G<R(UZKV\O,B=IMW/>7_QFFFL1[*NVO7'1X8_$U[E6L_AL^)G
MVL[)]/@7?(J*B*BZHO%%0Y,Z _Z
M
M               4A>,I_9Q_"_\ F0)U0\\,SY7^ ^]E^^Q=0%;;FH +8
M
M
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M8]C?;'7TQX_)+>^3:SY?(B)]M79/XI_#N)0FOLN
M
M                          *0O&4_LX_A?_,@3JAYX9GRO\!][+]]BZ@*
MVW-0 6P
M
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M'S)MEMGYXW1/VLQ)K7::K'9J*-W!=>#F1-<GZBER.:ZR/_6O\*?2A.@T\_\
MIU\4(4=8=JVGV]Q>T8OBV"V*UY;DTR5"UU)211STM!3.U<]KFHBHLLFC$]5$
M>;7V8S-7JLVV9F9EII79A,[)F?1&WQ,!SRFGR*12E(BT][='Y?2KF-X:N =]
MZ;-T5VMW/M-PK*CN<<ONEIR5%71C8)W)R3KY$[F1&O5>WEYD3M,-SWE_\9II
MK$>RKMKUQT>&/Q,ERK6?PV?$S[6=D^GP+OD5%1%1=47BBH<F= ?]
M
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M ^]E^^Q=0%;;FH +8
M
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M\IRWM)R_^%U,VK'L;[8Z^F/'Y);WR;6?+Y$1/MJ[)_%/X=Q*$U]EP
M
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M\!;      I"\93^SC^%_\R!.J'GAF?*_P'WLOWV+J K;<U !;
M
M
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M4
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M[./X7_S($ZH>>&9\K_ ?>R_?8NH"MMS4 %L
M
M
M
M
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M9*V*XSLC:^>H?)(Y&M1&HBKP1-$"%MZ;84
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MA1-I;\,SY(& ^^=^^RE056[;T^PH
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ME5>"(FJ\ FV>T5%2VZBI+?0PMIJ*@ACIZ.G;[&.*)J,8U-?(C41 M/U
M!2%XRG]G'\+_ .9 G5#SPS/E?X#[V7[[%U 5MN:@ M@
M                                %6/BZ_)NPG_>5;?L/>0E7>I=Z1/E
M0["??Q9_JI@2G<UX!;
M        (>=?OR0-[/>RA^RE&%8WLHX7&WL+0
M                          !RS?3\R6\7WCY#]C:@$,:X76PSIE^3=T^?
M[M<3^P]*%N=[MX4
M     ,7FYOYR=P?OENWU9*476DCPS/D@8#[YW[[*5!5;MO3["@
M
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MOWV+J K;<U !;
M   *L?%U^3=A/^\JV_8>\A*N]2[TB?*AV$^_BS_53 E.YKP"V
M                                       0\Z_?D@;V>]E#]E*,*QO9
M1PN-O86@                                                 #EF
M^GYDMXOO'R'[&U (8UPNMAG3+\F[I\_W:XG]AZ4+<[W;PH
M                                    8O-S?SD[@_?+=OJR4HNM)'AF
M?) P'WSOWV4J"JW;>GV%
M                                    (Q9WT8]+NY%?/=,KV9L<URJW
MK)5UUL6HL\LSU757ROMDU*KW*O:KM57RA7&7Z=O^CWIFVON%-=\,V=L5%=J)
MR24-TKTGNU33R-75)(9KE+4OC>B]CFJB^N#&4E H       I"\93^SC^%_\
M,@3JAYX9GRO\!][+]]BZ@*VW-0 6P
M                  "K'Q=?DW83_O*MOV'O(2KO4N](GRH=A/OXL_U4P)3N
M:\ M@                                                 $/.OWY
M(&]GO90_92C"L;V4<+C;V%H
M             Y9OI^9+>+[Q\A^QM0"&-<+K89TR_)NZ?/\ =KB?V'I0MSO=
MO"@                                                 !B\W-_.3
MN#]\MV^K)2BZTD>&9\D# ??._?92H*K=MZ?84
M
M   %*'C#VRY7+XNWN?;ZFO[G[;N^]'B?+R<WN+R\W(BZ:Z+IJ$JHA>&K8[U1
M=7.!U%;9ZVDIV6V^H^>:GDC8BK;*A$U<YJ)Q4)6W--@6P
M                                  "KOQ::&NN'3EA4-!1SUTS=R+:]
MT5/&Z5R-2T7A%<J,15TU5.(2JIKZ2L>O]/U.;$3U%CN$$$6;6=TLTE-*UC6I
M4LU5SE:B(B!*=S6P%L
M        B%UZT]15](V]-/2P25-1+;:%(X(FJ][E2YTB\&M157@@5C>RN_:Q
MDGW/7/\ DDW[@+C:^%H
M         Y=OA&^797=^*)CI)),)R!L<;457.<MMG1$1$XJJJ"&/'[6,D^YZ
MY_R2;]P%UKSZ:8I8.G+8"&:-T,T.V^*LEB>BM<US;12HK7(O%%1>U MR[8%
M                                                 #&MN7C>1/W&
MS][+!<7L?DEU<Q[:6945%K)5145&A=:-O#5I*JBZ1L#IZVFEI*AEROJO@F8Z
M-Z(MSJ%35KD1>*!;MO3S"@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M   !^>KJZ6@I:FNKJF*BHJ*)\]963O;'%%%&U7/DD>Y4:UK6HJJJKHB 5Z;D
M>)]TPX'<*BU6>OOFY=;3.6.6HQBCC=1->W75/2ZV:E9(WA[*'O&KY%4)<,O,
MX?XK_37D%?'0Y%:\NP5DK^7W6N%OAJZ-C5T\YZT%143IQUU1(5^B#AE8QBN6
MXQG-AM^48=?Z#)\=NK.\M]YML[*FGE3L5$?&JIJU>#D7BB\%1%"+T(
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MJXF34E7"]LD4L4C4<Q['M54<UR*BHJ+HJ!%_<
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M@L-VA2HM=YMT\=32U$3NQ\4T2N8Y.':BA%]<
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M$1SHIF+H^*1J*G-'(UKF^5$"+VH
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MU0
M                        *&O%-ZGKK7Y.SIOP^YR4=AL,5/7;E34[U8M;
M73L2:FH'JW3FB@B>R5[=51TCD14UB0)UA61LML5N9U 98[#ML; MYN5/3K5W
M.KFD;3T=%3HJ-[VIGD5&L17*B-1-7.7@UJA*9P>XW_Z2MZ.FMMHJ]R++2+8[
M[*M-:\EM-2E70R5+6J]:=SE:Q\<G*BN1'L;S(BJW7E=H4B<78.@3JCO>PV[-
MFQ6[W-\FU6XEP@MN3VN9ZK!0U=2YL-/=(D7A&Z)W*DJI[.+75%<V-6B8Q:A
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MO;*HJ'JY]%5TS73U%O8YW_,RQ-?*Q-?,>U41/IG C:%[H0
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MJ,I*F#7@QL\G+#*B:(O,UZ\6<2EH:3 @
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M9I9-Q\)Q3/<;F6>Q9A:J6[6M[M$>D55$V1&2(BKRO9KRO3R.14\@6GK0
M
M               #_BJC45SE1$1-55>Q$ QA[J9K4[C[EY_GU7(Z2;,,@N-W
M17)IRLJZA\D;$1>Q&,<C43R(F@75\?A(851V?8K-,W=3-9=LSRR6E=5HGG/H
M+530MIV*NFOFS3U"_JA"R4_7-@]%GO2IO+055.V::P6*7)K=,J-5\$UDTKU>
MQ7>Q58X7L54XJUSD\H4C>R;A<;%NG?-I]QMB=H\VJY73W#(<4M=1=IGZZNK6
MT[(ZM>/%=9FOT7R]H6Y=E"@
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M:J(J!<;/MM<K;GFW6 YPQJ-9F>.6J^M:B*U$2XTD52B<J\4_RG8%I[4
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MG/UYO_DM3+;XM57V6L,#':Z^7U=0MSO2X"@
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MI:AL5RCT<O#3GJY&HFO#3U- A;>LH"(
M                                                  \=N)4S4>W^
M<UE,_NZBEQ^YS4\FB+ROCI)'-7145%T5/*@&+4+K3WX9$$472'A,D<:,?57:
M^RU#D_7O2XS1HJ_\EB)^H%NV]*??N"*JV+WHIJB-)8*C!,CBFB=V.8^V5".1
M?HHH(8W0N-4OAV54M9T;;,33*BO9#>X&Z)IYD%^N,3/_ +EB!;MO36"@
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M?\EZI^J"N]F$"XVF;?54M=@6$5M0J+/66"VSS*U-$YY*6-SM$\G%0M/7@
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M4=+4D,BHK*',KO!3Z)IYBQ4LJZ^KYTBA"V]92$0
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M%R%O'@[54K\/WQHG*G<4]XLL\::<>>:GJFOU7Z$30C9<R$0
M
M     !XW<:"6JV]SNFIXUEGJ,=ND4,3>USWTDJ-1/HJH&+8+K3[X9,L4G2%@
MS(Y&O=!=;ZR9K5158Y;E.]&N1.Q>5R+HOD5 MVWI2;^5$-)L5O355#TBIZ;
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M%:29J(J+YDZNE8O#U6O10MSO2?"@
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MO!$"+$4%UI1\*:EFI^EJ665J-96YE=YJ==475B14D2KZWG1N0(6WK*@B
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M7-!$
M                       ?XEBBGBDAFC;-#,U62Q/1'-<UR:*UR+P5%3M0
M#%SN)B-5@&?YO@U<US:O#K]<;+/S=JNH:F2#F]='<FJ+Y0NK\_"3S:CO.P^7
MX0L[5NN$Y5-4/IN&K:*ZT\4D#]$1%\Z:&=..O9V^1"%DI>N3,Z3!^E/>BX5-
M0V&2]6"7':&/F1'S37MS;?R,1>+E1DSG*B?K6N7L0*1O9-0N-B'3?A4^W>P>
MS^&5D3H+C8L3MD5V@=JBLK9*=LU4WCQX3/>@6Y=K"@
M                        !X/<[<C%-HL#R7<;-J]+=C>+TBU5=*FBR2.5
M49#!"U53FEFD<V-C=>+G(G #*#U)=1.:]2NXU=G&5RK26ZGYZ7$<7B>YU-:Z
M#FU;%&BKHZ1^B.EDTU>[U&HUK2Y$8)*="O1%7]1EY;GF=QSVO9K'JSNJGE5T
M4]^JHM'.HZ9Z:*V%O!)I477]8SS^9T8F<&D['L>L>)V.U8UC5JIK'8+'31T=
MHM%'&D4%/!$G*R.-C>"(B!;?8 X-U189-N!T[;S8E2PI45USQ2XR6RG5J.[R
MKI(5JJ9J(J+Q66)J(OD[0K#'Z%QK,Z'<VH\\Z5=E[C2SMEDL>/P8W71)IS13
M6/6W\CT1$T560->FO%6N1>.NH6YWHK>+=F=):-A\-PMM0UMUS++8:EM+S(CG
MT5KIIGSOT[51LTT"?JA6JAG:S"ZC<;<O ,"I8W2RYCD%NM"HS75K*NI9%(]5
M3L1C'*Y5\B)J$VSU$1J(UJ(B(FB(G8B!:?\ 0
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MQL\VPQ/[0MM=O<&U15PW&K38W*B\R*MOHXJ95U\NJQ]H6GN0
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M(
M                     4#>*'TMWNQYG4]1>'VR2MQ+*64\6X3*=JO6VW.)
MK:>.KD:GL8:EC6-5VFB2HO,NLC0G65<VQN_^YG3OES\QVTO$5!6U<'HEXME9
M"E30U],CD>D-3"JHJHCDU1S'->W]:Y-5U)3&+WG45U@[S=3;;31;@5UNMN.V
M25:FWXE88):6W)5*U6>DR-FFJ)9)$:Y6M5\CD:BNY$;S.U*1&#WO0?TRWCJ
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M;5>[M:I&;1X5<(:O,[O,WEAK)(=)H[7"JI],?,J-25&^PB5554<Z-'"9P:E
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MM1D<4,349&QC4X(UK41$1 MOU
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M7#K52VJ@5R(CY&TT:,663EX*^5R*]Z^5RJH6GLP
M                                                           !
M^6MHJ.Y4=5;[C20U]!71/@K:&IC;+#-%(BM?')&]%:YKD7145-%0"N3<[PMN
MF_.[E67G&GWS;"NK'NEDH+%/%+;$D?JKE;25<4JQIJO!D4C&(G!K43L)<3R&
M(>$EL)9JZ&MRO+\MS2&%_-[DK-36ZEE;P\V5:>)9]/\ B2L4'$LHPG!</VWQ
MNWXA@F.4.+8U:V\M%:+?$D4;57V3W?KGO<O%SW*KG+Q<JJ$7K
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M2QMA@@AB:C(XXHV(C6-:U$1&HFB)V!%^L
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M:[$:;'XJQ6NNMS<KJBOK7-55:M35RJZ61&JY>5NO*W5>5J!29Q=D"@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                      #XN27EN.X[?\@? M4RQ6ZJN+Z5KN19$I872JQ'
M*BZ<W+IKH!3O\\9C?]0]S^'X?:(2X5B72UU$474YMI/N/0XM-B$$%ZJK,MIG
MJVUCU=2QPR+)WC8HDT=WVFG+Y.T*3&"2 4
M
M
M
M
M                                   >'W-_-MN#][5V^HY0,7@76DGP
MH/DO7#[^+M]2T(0MO69!$
M
M
M
M
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M$5%0(O3@
M
M
M
M                                        \/N;^;;<'[VKM]1R@8O
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MUDEMMETIHN>"M=4-B=%$V9K.X>JJB.5T:JOF(%+-!00
M
M
M
M
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MK#=*.]V>Y1)-;KM03QU--41.['Q31.<Q[5]5JJ@1?1
M
M
M
M
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MNW0PV^W0\[&JG:LC'M54[>5/4"%D;_&,_I)L/[V7_P#?J$*U5D=-<T5/U&;
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M74L3:I[84N,+%72.6!51SG-]FQ%8[7S5:4F,6J(+8
M
M
M
M
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M'5'M6>9K72<S>+48U5<KOUJ(J^0)-H06@
M
M
M
M
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MST=^W;J:=\-KI:15EHK#!.U6RMAD<B=[42,56/D1$1K5<QFJ*Y[R$SBLP"(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
<                                  /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>tm2227887d1-pht_myloid4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_myloid4clr.jpg
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M# P,# P,# P,# P,# P,# P,#/_  !$("K0'; ,!$0 "$0$#$0'_Q #R  $
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M%Z+"TB5CDT2#XJ/#_]H # ,!  (1 Q$ /P#W\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MY&J[ON2GI$5G9)-8BM=BXDH
M
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M/$6B^!J8FV*6S'H?1OR[ZS^?Z;%LS6_'/+/?V2ZS-([H
M
M                               4UY/_ .784SN51P?GGW'_ +P[@_G6
M^_CWGL6F_A6_LQ['QMU7^:R_MW>U;:/1C'MK'JX12N]USF\_VO N6WQ%]>,,
M>VD6<U)VTMKW[_8[W\CV_'6V3SG3N^G;\/EHGY;"1KS;+"K8[AJNKQU)I<B>
MJIQ_BK21-T9XK7=/8]C^5/59B<FBOF*3[]O;79%T5\T6S]/%Z7:_QDU<_P"Y
M.+X]SVRNQYQ^>3?R(_;_ $XL9VZ(V_;6?@3BKE571VS5]"H[4Y?D.Q\*Z.N2
M<\\-W8\9^:W6)MMQZ&V8V^_=V[(F+?-&_P!-.R7GHU)%:JJBRT6LKF_-U)I1
M/ETJ=IDOB;ZSOG8\5WV1-)I$T],\/5#Z<9_K+&_Y[;?QK2G+]R?-*O0_Q;/V
MH>^FX-U;?V9@8LSN;*0X7&,6*)]]<U1C7R<D=3TJ>08\-^6[ELBLOL3/JL>E
MQ\^6Z+;>,SN8)_:!Z.J]L;>H6)<KWL8QJ/?Q5[M*<:?.<9-W2]5;=2;)W-7'
MBGI=8CX]M9W;>W<W+;S-N(8YF/;)'(FN.1O)6NXHJ?(86V-\4;N)B8K$U32.
M<U>&FGK](F=BJ-_<UON7JQL#9^4=AMS;ML</DO";,EM<*NI&2>YP:B\S)P:+
M-FMK9;,^9K-9UK1Z2[DS9(LFE=IMKJST^WAEUP>U]V6&;R21+.ZTMM:O;&WF
M]>")2I&?19\,5OMF/.IT'7=!KKYLP9K;[HWQ#9+GOK1M%IS;VF-,T;5K3>O6
M#IWT]5L>[-VV&+NGI]5CE?XES\L4>MR)[40R]-H<VHGW+9EJ.I=>T/3H_P#(
MRVVSV;[O5#5S?-]T1<]K';D>QCN<K[:;2GW&*;'^W=93[K0Q\PNC3_ZOT3]C
M<>S>I&R^H%DM_L_<%GFXT]^*)^F9GY<2T>GRH:W5:/-IIIDMF'1=-ZSI.HV<
M^GR1='9QCT3MCTL];7M,6&S<X^;+^H;?/^)M_P#M,1N.A?SECC_'G^RY_-'_
M %0\;\)_KO"?Y]:?QR'I6I_AY/,^9M#_ #&']J/^I^@^PK\%;:>?@Q<_R$/'
M[OOW/L>W[L*ZRNU41NI$JFKD4<T*MK5^\>M73/83GP[HW;8V-ZQ*+CXW.N+A
M%^BZ.%'*W]D9NGT&?4?<MF6GZCU[0].C_P C);;W<6N&>;SH@Y\;'[DDA22G
MUDEM+I2OK1%-A_;VLI]UHH^871IFGQOHEMW:'4W8^_XG2[0W+99ES45SK6)Z
MMG1$[71NTOIZZ4-=JM#GTTTR6S#H.F=<T74;>;3Y(N[N/JG:S^-RO8URM5B_
M14Q6TWK=E<C98FPNLEDKAEIC[.-TMY<R>ZQB)Q<OJ)MMFZ8B(K,J<N6W';-U
M\TMC>YTCW[Y7HLLS<,>5VK%FD>NC(M@1LNO5S3N(E:FTG3:Z8Y:74I]#E8ZC
MT'XO/%V+GKW5K_BZ,L;NVOK:VN[.5MS:7C&2VMRG%LD;TJBHOH5#4S'+/+.]
MUEM]N2(NMVQ,/L61432B46M./X1S1551I?>'F"Z5[$NGX_.[MM%RC%3Q<9;:
M[F1B+VN6-'-3Y50V&GZ5J<^ZW9W['.=2\6=,Z==R9\T1=V1[T_1N6#">:?HI
MFKV*P9N]EA-<O1ELZ]BDAC>J\JOI1O[*A>U'1-5@BMT,32^..DZB^++<T1,[
MJ[&CO/5<PW>RNG=U;O;<6D^:G5L\3D5JHZU56JUR5145/0;;PK,69[Z]CD_F
MQ,3H,-T36.>=W&ML[I<>^7!%_IKV&B^\V^<B^U(U.EZW_)7=]7FG@6>;K6"Z
M-U?_ +=KW!9R^53RRWCYWU(F*Q*J5X+R TIN[H!TLWSF[C<6Y]N-R.7NV1LF
MNW2/;PC2C>#53L7F;#!U/-@LY+)BGF<_K_"W3M=FG-FQ1==,1$^ACB^53H;I
M<GZ',:J]WA/)^^,C^O:S\; CP'T;_0CZ7E!U4PV+VYU*WG@</;-L,7B<G+;V
M%LG>1D;$3AWE6O/M4[[IF6[+I;+[MLS&WUOGOQ-I\6FZIFQ8HBVVV[9'"-G?
M]K>?E,Z:[+ZE[AW3C]Y8AN6M\;8PSVC'2/91SWJU:HU4JE$-9X@UF72V6W8Y
MI,S1UGRZZ+H^J9<ENILB[EB)C;->RGFH[H7RF]"5:B+LB*G^/DK]]3D?ZUJO
MQ/6O[&Z1$U^##,,9@^EW0+;M[<6\EOL[;U_?L?<3SND6);B5K6-;7O+5R,1$
M^4L9LVHU^2)FMUT1NAG:?2].\/8+IBF*RZZLS/XIV;_0A:]>>D5_<V]A8[_Q
M4]Y>2-AM;='25?(Y:(WBU$]11DT&>RV;ILF(A.+Q/TS-?&.S463=,TB*\>QE
M.[NH&TMAV#LCN[/VF#M417?7R)XJ]G<B:JO?^Q:I:PZ?)FFED3,MAU#JFET&
M*<NHOBRWO^J.*W=/NJ&UNI^.R.6V?D/C[#'7:6DTJMTKXBL214HOM+FJT633
M7Q;DV2L])ZSINIV77Z>[FBV:>FE6PED>C4JJ(Y>#>%>)C-IRS/G:MWEUMZ8[
M#D?;;FWA86=]&Y&OL(G+/-7E1T<:/5GRF;I^FZC/2;+9HT?4/$G3M#,VYLUL
M71OBNWU-<IYO>AZRHQVY98FHM'2.M974_:-<IFSX>U<17EHTT?,'H\S3XOT2
MW!M'J9LG?L'B[0W189I=*.?##(B3,2M*NA=21$KPXH:S/I,V"??MHZ/0=7T>
MOC_Q\MMT]D3MCT,Y;)WT8O%>2\/08ULUC:V5.S@^3*9*RPV/N\MDKB.SQ^.A
M=/>7<E=$4;$JYRT[$1*E=MLW3RQOE:S9;<5DWWS2V(K,]D0U3_:(Z+:=2=1<
M3IIJYR_O#+_INI_TY:+^[ND4K^9L];*\]U%V7MC!VVXMP;GL,7B+V-DUI=SR
M:/&8]*M6-B]YU4]#3'Q:7+GNY<<5;35]4TNCQ?%S7Q;;OK,TKV-..\X'0]KV
ML?N.9&ZM#KCX271[:TY&TGH.KB/NN7_^0NC\W+\7;YI]K<VSNHNS=_VBWVT-
MP66;MVU\1('_ %C7)V.C7OHG'G0U^IT>;3W4R6S#I>G=7TG4;.?3Y(N]OJWL
MR5[)4<Q:M5./ Q8[6QJP/?&[=B;8M(X-_9/'V.-RU8X;?(L22*16IQ;I5KNS
MU&1IL.6Z?W5:]S7=3U^CTMD?FKK;;9V>]N\S!-A[UZ 6^5M\%T^RFWK3,9F5
MS(++'1:)KAS6N<K=21IV-5U*]ADZK!J[K>;+%U([=S4=*ZGT2W)&'27XN>Z=
MD6TK/:W^C&HGJ->ZGBHK(J-5]=+4XN5>5/:2B8IQ:5W5YB.D.SYUL\QO.R=?
M(KD=9VFJY<US>"HKXT<U%1>'%38:?I&JS?=LV2YS7^+>F:*9C)FMK'"-L[/,
MQ.U\W?0^Y>C'[I=:ZU1&R36TRM2OI1K:_>,K)X>U=D5Y6NP_,#H^68B,M*]L
M4;SV]O#;N[+3X[;.:LLW9HVLDMK*V1652J:FUU-7U+0U.73Y,,TOB8EU.DU^
MGU=O-AR1?'=,3Y>ED[':^VM.=.1:9FS@JA"5W)P3#S[\^_\ NYTW_GF]_B$.
MK\(?Q,OF^UY'\W/Y/!^U=[(< ]//]^]H?SQ:_P 8=CKOX&3S/'O#_P#/8/V[
M?:_0"S\VSV(>23O?7<;DY"0#CKSL_P!4EM_/5O\ Q<AT/AO^8G]GZX>=_,[_
M &F?VH^MY*(URZ$:W4J*M&H>C7328?-_NQ-;MU/5O^M>,%GLGMW+XK<>%NUM
M,GB9TGLIF>\CV*JIRXJBTHY.2HJIVF/J,5N?'-EVZ8ELNGZ[+I<\9,4TNMF)
MB?-MIZ=]W#?VO;7HWU2QG5C9&/W'9/:S)1-;:Y_'HM7VUZU&ZVN2J*B.]YM>
MP\NZEHKM%EY;MT[I[GU)X:Z[BZUH[<]DQ7=='9=]G&.Z6U[_ /R*[_Q,G[E3
M"L^]'G;O+]R?-+\\N4_UKE_YPNOXZ0]BQ?<CS/CCJ'\QD_:GZWJ5Y%?ZL,__
M #_-_%1' ^*OYJ/V8]LO?/E3_M=W_<GV6ME^:[^HO>/Y$/\ &H8/0?YRQT'C
MW_9\_FCVO%>1:0SJE/<4]/OMK,P^6(VS'G>PW3KRZ=%LOL79N7R73['7>1R&
M&M+J[N)%DJ^2>%KWJNEZ(O%5H>9ZWJNIMSWVQ?-(G8^G>C>$>E9-%AOOP6S-
MUELS7MF(F65W?E:Z$W-I+:Q[ M+!)&JBW-K)-%,E4YM=K5:I[#'CK.JMV\\L
MW+X'Z-DBDZ>WUS]KS4\P'1E>CFZ;6SL;I]QMC/Q.GP\LJZI8Z.T+#*_@CE;S
M543DIW'1^IQK\?//WX[-D>IX=XR\*_T34Q;CNGX=_P!V9X<*3NCZ-U5O\O&Y
M[S:?6#9-Y;SNMX,E?)B,BQW%'V]S1-*I[4Y]E"OK>",NFOYMLQ%?2L^!];ET
M?4\4Q-.:[ENCMMG9N]$[>W8]OXT[K4]*'F+ZCI14)0 05*@<M^;G4WH3N]\;
MWM>RZQRHK5<G_MD2.3N]FE3<^'<5M^MLMNW3]GZ'$?,6ZZWHN6;9F)B;?INB
MOT.4?(HYS^HV]-4LCFIMQ',1SW.1%6[C3AJ7T*;[Q5;'P;)I$;:;/2X'Y4ZB
M_+KLTW3,^Y[)MAZIG$/=0   QG=NX<;M+;F9W/EY&P8[!6K[RZD7M;$E4:GK
M<M$0KPXKLM]MEO&6-K-7CTF&_-DFEMD3,O"K?^^\UU(W3E-XYV=ZW-_,[X"V
M55:EO;5^KBB2CM'=Y^E>)ZKH-'9IK.2R.#Y2ZYUC)U353GRW;YV1PB*UBF_=
M3;YZ[FP^A_0K.]8<NYD:R8S:N,D_[VS*IW%6E/"B1>;W)S5.1B=6ZSCTEM+/
MO^MN?!_A3/UK)6:QAB=L\.^([:QQ^N-GI5MKRM]$MO01L_0V'.73-*KDLH]U
MS*Y5[46J-^XAPN?K&JS?>OIYMCW'1>!^CZ7[N"+OVO>]NQCN^/*5TEW-93MP
MN#39V7E:];.^Q;G,C\:M4\:%RO:Y%]' NZ7KF?3W16:QW[V-U/P#TS6X[ILQ
MQCOX3;]<;8GS/,7>O2O=^Q]Z2[$R%A-=YR2DN/\ @(73NO85Y/C:U'+1:\:\
MN-3O=/U'#GQ_$YXB.SS/!^L>'-;H=3^4NMF^Z9BE(WUX\9W]\TVO0GRH],.J
M?3J++S[K6+%;>SL+)K?:TLOBS17/+Q5I5C55OO(B_?.-\0:W39YB;)K='&-U
M'L_R_P"A=1Z99=&IV67>]R\8N\O\7:<<B55_)7<_8AS</18V[7,'FUWY)M'I
M+D<;9RHF8WK)]C63&<')&]%6XD:M>&F.O'L-UT#2QJ-36Z-ENW['%^/^JQH>
MF7VQ-+LGNQYI^]YMG'@\BL;87>8O;/%V$*W%W?W<=K:1-]Y7NTL1$;VU53TC
M4Y+<%O//"'S;I-/=J.3#9'O77[.W;2-WJ;5ZW=,I.DV]UVQJFN;.YQT%]C[N
M5:_$.<U&RHBT2FA]?8:_I6MG78INMWQ/T.B\6= GH^KG%%>2;8F)G;6:4G;L
MV1-9[G1'D@WRS&;IW'T_N)T9:;C@3(XJW=S;<VK52;2OXT:5IVT--XITM<=F
M6-\;)]+LOE3U6+,^72S-(OI=;'&L;)V]T;/0]1$X\3AWN:1??;[%(A5&YX0]
M<%IUEZG+\YNXKM6J>J])FFCQ^9\G>+-O5]1^U<Z$\H'3/8W46YWNS>NW+?<#
M<=\,ZS;<K)]6Z6NI>ZYJJO=1/1ZC5>)M;ETO);BNI7;Y=SMOEQT72=2^-=J<
M<7\M(B)K3C6:=O"NYW GECZ#*VO]&F,3]E-7^-.2GK.KG?DGZ/L>I1X,Z/\
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M4_RG4)Q73[N6*1]7=7>]@CSU]#B>L
M
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M_?S9W\[6W\:=CKOY?(\=Z!_/Z?\ :CVOT L_-L]B'DD[WUW&Y.0D XZ\[/\
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MNF^YTVWF[I6[1W)-&R=CWKHL[UZ(UDR>A'+P<G#[QJ_$'2?BV?$MC:Z7Y?\
MBC^FY_RN>:8KIBG==.ROZ.#T^ZER>-TYWMI='WL'>JQ^O@K?"=QKZ#BM#LU%
ME?Q0]SZS-=#FI^"[V2\#8/S4=/=T)^Y/6WQ_MYI]/UO:SRH_U [ _P 1>?\
M;K@\QZ]_.Y/1[(?4?@#_ &33^:[_ *[G0CZU;I]:&GAV/!YA>=W?#<EG]L[
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MI(Y*4DCU42NER+V'DNKP3@R39.VDOKKI/4+=?I<>HMW76Q._=V[6=%AL
M
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M=L[MCR3J$3^8R<?>G:]1O(M_5AG_ .?Y_P"*A.%\4_S4?LQ[9>^?*G_:[O\
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M_9G?Q[8KZ7H*BHO%#E'K<HD@
M
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MF7&OEOX=:MA]JKD'_N''2];V:.^'F?@6?_W>#S_5+W#9R^53RNWCYWU,F*P
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MU'M5.2M7DIY9W<7U3%T3MA61:\4)2B
M
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M(X2'NCD#SN?U)K_\P8W]U(=%X9_G/^&?J>>_,W_9Y_;M^MY;]/U_^.]G<O\
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M'4NEX[Y^];[L^>.WT.B&\D-9+JD0
M
M            4*(Y$5OT55HE%:[7 -_Y',=?Y#(7S]^2L6_NI[IT/P2*C5FD
M5]*Z^-*TJ=5C\4WV6Q;R;HH\FU'RJT^;)=?.>[WIF:4CC+HOH=T?AZ-X'*X.
M',.S<=_=K<I.Z+PU:JM3YM5I]TTW4NH3K;^:8H[7PSX=MZ+@G#;=S1VRW>B)
M$]*K5-/#Y#7.FX>9Q1=>3K;EQU"=O+]))&8V3-)F'[>\/N.E\3QE:J_EG01X
MASQ@^#PH\YO^76GNU_YOF_6YJ>FKM9?K7(C5HBM[WRG/O1N'G:9ZX=)8>L.V
M;#;4V7?A66E]'=NN&Q^)56-7AHJE:4])G].UTZ*_GB*N=\2] MZUIO@77<L5
MW]CF>V\B^.MKBVN$W_,JV\\<R-^#;Q5CVNI77VZ3>7>*[[HF.1PF+Y48,=T7
M1GNV37='EM>@$4?@QZ5XZ6M13E(['K<;'THE."!+RX\]2X'],MI_"2JNX8L7
M+]KQ1TTI;ND^J=)3Y_.E?FG<>$_B<M_8\-^:]^'\QABW^)RS7S</KW[*5<^]
M ]@R=1>JFW<#<6Z2XFTF3)9Y5541+>TI(YK_ ,M_=3VFWZOK?RNDF8X['&^#
M>C3U3J6.S]2V>:_NY>WT[/3+W!@:UL3&LY-:C6+ZD2B'F,[=KZCB(C9#Z2$O
MANX(;JWGM[F!EU!,QS)H'M1S'L<E'-<U>"HJ+144F)F)K&]3=9%\3;=%8G9,
M3NHXQZB>3#8^Y;VYRNT,E/LR^NWK+-9MC2>P61>;F0]UR>Q'4]1T.B\39\,<
MM_O/..L_+30ZS).7!^[NGTV?\OV4::?Y#=W).V--^8N6V^=<.M)FK^U\1WX3
M;QXLQ4_AN7GY1YIG^9C_ )9^ULG:'D:VKC9(I]Y;GNMPKK1TF.LV?"0/;Z'N
M<KI%3V.0U^J\5Y+HICMY6[Z=\JM)BNB[4WSDF.$;(_P=J[<V]A-K8J#"[?Q=
MOB,58IHM[.V8D;$1.;N'-5[54YK+FOS73=?-9EZ=IM'BTF.,>*V+;8W1&QBG
M5G8;>I>R<MLU^07%MR[&HMZUGB*Q8WM>E$JGH+FEU4Z?)%]*L+K?2;>J:2_3
M732+G(-OY&;*UN[.Z;OV:7X6>&9T3K5&ZW12-DYJ_P#%[#H\GBJZ^V8Y:<'G
MF'Y4Z;%?COMRS6V:^=WQ;P,9;Q1-6J1M8QKW?.TI2IRMT\TU>KQ92R+8VT?/
ME,;8Y:SN\;E((LAC;V)8;RQG:CF2-5*.:YJ\T5!;?-LQ,;X1DQV9+)LNBL3L
MGOCL<7[Y\DFT<U<3W^R<W-M1UPNMV-GC6YM6I]&-K58]OR.4Z32>)<N.?WGO
M/,>K_+#2:B_XFEN^%/9OM^K8U5#Y#]VRSM^(WWC([=%1'2?#322*WZ2)XB?A
M-E=XMMX6.=M^4FHF:WZF/^6?_P F].FWD[Z?[-NK7*;CGDWCF;1Z26SKEBLL
MXG(M4<V#6Y'+2GOJIJ-=XBSZFWEC9;V.NZ%\N-!T^Z,F:?BWQV[+?5M^EV%;
ML9&Q8V(QL;%TQL8E$:U$HB(B<J'/O0HBD48]O+ MW1MC.;<=-\.F;LIK);A6
MZM"2IIU*G;0KQ9IQ7VW1%:2L:W2_F<%^*OWHHX7;Y$K%E'R[]ED5NA61-MT1
M*-]:.Y?(=3/BJZ;>7EIL>68?E1AQW5^-.^OEZW>.WL9'A<%C<.R5TK<3:QVR
M3.HU51K$2OJ.7RW\]\W=KU738(T^*W'$UB(HFS>$Q>X<?=8C-6460Q=\S3>6
M,R(K9$7L5%X%O'DOQW\UJO4:>S46<F2*VRX9WIY'L/?7K[G8NZ'8*"5._B<A
M"MPUBKQ^KD8K%:GJ5''5Z/Q7DMVWV5>3=7^5&#-?SZ3+./NG;'V^AC6"\B62
M6\9)N;?ENF/:B,DAQMJYLSD;V)*]RM3]K4R=3XNYXI9926'I?E--V6+]3FBZ
MWLMBE?I;QWMY5]H[AV7MS8NW+O\ 13'X*_=DI[M(?'GNY9(EA5TKW.2JK7AZ
M.PTVEZ_DQ9YS76UF=CLNK>!M)J]'CTF*?AVV3,]NV8IY?4Q?I_Y0[38F\\!N
MY-Y39!</*LS;1($C1U6*VOO+3F9.M\1W:FRZR;:5:OHWRVQ=-U=FHC+,S;3T
MT=MQ)6CD30E*Z?:<W2CTR[?5] 0  *#6:757L3W@F-U'#F]?)K8[OW7N#<\N
M]9;"3.W;[IUFRT;(D2NHFG5JX_<.DTGB2[3XK<<6UY8>8=7^6N'J.KR:F[-=
M;-\UI$1LW?8V7T/\O=MT9S&:R-ON%^;;EK:.'PEA\+1H=5%HKG>GTF'U+JTZ
MV(K%&\\,>$<?0[KILOFZL<?9Q=,1,TH[\:BFGC8[)J;K3TOAZN[,_1&?++AF
M?:%M??&MC\7C;JO=TU;S1>=3.Z=KIT67XD179,-!XCZ%9UG2_E[KIMCFB:QW
M.8\)Y);#"9G$YAF]YKM^*O(KMMLZU1B2>$Y'*W7JX5ISH;G4>)[LV.ZR;:5B
MCBNG_+##H\]F:W-==-EW-28C;W.\%C:KV+\U$4Y>FVKU3=,/L)%@RV-L,W8W
M6*RUG%D,;?-=#>V<[&OC?&O8YJ_JE5MUUDQ=;OA;S8K,MDX\EM8EQ5OCR0[5
MS-U=7NQ]R3[6?*]'.QUQ"EU:L1$Y,:UT;D15X\5X'2Z7Q1DLB(R6U>9=6^5V
MDU-]U^"^<=>%*VQZ-F_CYFL(O(ANU;B:*3?F+@B_]X2UF?J3G^;\1*>PV5WB
MO%39CVN<_P#B74S6)U%L6_LSY>AT!TT\HNP-D7-KE\]))O+,P46/QV-;:1R(
MM4D9!WE5W"G><J&DUOB+-J(FRR.6':]"^7NAZ;,9+_WET;J[HGMB.]UM;M8U
MK$1-"-32QE*(B)PHB>@T$5XN_P!DQLW0UMUK_JDZB?S%??Q;S.Z=_,X_VH]L
M-+XE_P!LU'_;N_Z9>#O'0E?H?J'K3Y#G>]<-P>6W9/5K:6U,[(U^W]TNPMJQ
M^8M&HC;A$A;1+F)*:_:BU]9YMINMYM%?=;,\UM9V/IKJ7@G0]:T]F6ZWDR\L
M4F-D;HWPT0WR(;I;<^&O4#&_!*SNW:6DJ/1?1I=)Q]M3<_W9CY?=Q[7$_P#Q
M%EF8YM1;3]F?M=%=)?*CL;IM>,S.3D7=NY+=6R07]Y&C887-3WHH:N1%KZ5-
M+U+Q!FUEO)2EO8[CP[X"T?2;HR73\3)VS%(CS0ZEHLK7\N\B*UWR]IHIBL.Z
MNI2D-$=<NA]OUGM\!9SYIV$;A)9)62LC\57^(B)ITU3\)LNE]2G073,16L4<
MMXJ\,6==QV67WS;%LUK'JI]+5?3?RA6/3[?&W-YP[RER,F N'SLLG6B,\77#
M+%37JX>_7EV&QUOB.[4XKL4VTJYWHGRWP]+U>/4VYKKILFM)B.R8^OZ';:^H
MYQZ6PW=>TMO;TP]S@-T8V'+XJZ966UE8BHUR<GL7FUR>E"[@S7X+^>S>Q==H
ML&NQ?!S6Q=;/"7$FZ/(IC;N>2?9V\Y,;"YSG):9*W^(;15JC6R1O8[ARJM5.
MHT_BNZ*?$LKY=[RWJ'RIPW3==I\TVUG=,;(VUILI/KVL.Q_D2W0^9'7^^\;9
MP,=Q\*WEG>YJK\VKVHGW#*R^*\=/=Q[6IQ?*3/=='Q<]L6QV1-?L^AU1TJ\M
MO3_I5<-R]M#+GMQL7ZG,WS&*Z#A1?!8E$;7TI53GNH=;S:R.7=;V/0_#_@O1
M=&]^V.>_\4TK'='E5T=$J5II5KG)544U$;G7[]KZ"1*Y:(JH3")<\==.B</6
MFSVS93YMV%;MZZEGHV/Q?&\1B1JB)7D;+IG49T5\W4JY7Q5X6MZ[9CLNOY>2
M:^57/']@[&?\?3>SX)/WYNO[MO\ P.)_^(]-_KW>J$/[!V-KPZ@3^SX)O[X?
MW9?^"$?_ !%IO_<7>J#^PCC/_,";_0T_?#^[+_P*O_B/3?\ N+O5#<'1;RUV
MO1[=61W);[GDS/Q^/6Q6W= D6E?$:ZJ<75Y&LZCUF=;9%LVTHZCPQX*Q]#SW
M9;,DW<T4V\&R>LW2N'JWM6WVS)EUPT<=TRZ==-B276K6.:C53AP[U:U,7INO
MG17S=$5K%&Z\0=#MZO@C#=?-L1->WAN^ERG+Y#<<^)[4W]-5]42EKIKW:<]:
M_@-Y?XLONMFV;=DO/K/E+@MV_&F?0[]QMFRQQ^-LFN\1MA!%;LE3YR1,1B+]
MXY2Z:W3+UO%CBRRVV.$4]447<A<8MN/ 8G=N#RVW<U:LO,9E8'6]Y;/;J:Y'
M\.+>U4YEW#ENPWQ?;OAC:S2X]5ANQ9(K;=%)APR[R(XGQ)O"W]<,BU/\*)UJ
MCU:VO=:KU<E:)P.FM\69*;;*R\KR?*72W73-N:Z(GA2-CJ'HETCAZ/;9O]O0
MYA<TR\R$E^MR^/PJ+(UC=-*NY:.=32=2U\ZW)&28ILB'=>&O#]G1--."V^;X
MFZ;JSWTCZE^ZK["AZG;+RVS);U<:F7:U'7[6(_0K'(Y%5%5*IZ#'TFIG3Y(O
MI5F]<Z5'5-'?IINY>;BXZD\AV.5LE>H%PZ=U48JVJ(U%5J-XJCZ\#I[O%U]]
MO+-FRE'FT?*/3Q9%L9IKYH=T;0P;=L;<P.W&S+=)A+&&S^+I3Q/!8C*T^0Y3
M+?\ $OF[M>J:'2QI=/CQ1-8MB(]3+2VRP              #YYTK#(B-5ZJE
M$:G-?4*SP)<Q=1/*ITRW]/<9""RDVMF;E7/N+W&(UD<KU3G-![B\>>G2JFXT
M77=1I=D36'%=;\!]-ZG,W\G)?/&WM[W-V3\A6X$=KQO4"QGB_P !/9R1_N)'
M&]Q>+HG[]CA\WRCOF:V:B/\ E_2^S$>0R^66%^X-^0)9M5/&M+&S>LBIZ$D?
M)1$_8E.?Q=/ZEBO1?*.;;JY\\3'^6V8GZ9I]#K#IGT!Z>]*W?$8#&+=9I&HC
ML[?HV:Y1/G>&M$1B+^*<[K^K9];]_=V/1^A>%=!T>(^%96^-]T_>ELO=F'N]
MP;<SF"L+]V)O,O926T&31B/\%9$TN>J<E6BF#@R6XLMMTQ6C>:O#.HPWXZTY
MHF'##?(?8:%9^GTJK14X6J53Z.GO'5V^*[[=D6/)X^4N")VYIX_2Z@Z(=&K'
MHU@\GB+3*NR\^7O?C+R_>Q&.?1FAK:<?=H:'J749UN2+IBCNO"_AG%T+!=BL
MFO--6]C7NE ,2W1MRRW1MO.;;R"*ECF[66TN57BM)$HC_D7B7,&3X-\7V[X8
MVKTMNIPWX;MUT4];AU?(EC:*GZ?3HU5JC5M4=3U5UI7VT.GM\57VQ$<FYY3/
MRET\Q_'NB*[J;(=+]$^D\W1_!Y+;3-QOSN/N[E;['LD@\)('/1&S(E'.KJ=Q
M-)U/7?GKXR3%)=YX8\/QT3!.&W)-ULS7:T5O'R98_=^[]S;IFWG)9?I!?S7O
MP;+=%:SQD1$2JO2M*&VTOB6_3V6V<M>6*.3ZA\M<>LU=^INS3'/,S2([6VNA
M'02WZ+7&Y'P;A?G4SB0HJ/B\-8O"7@GO.J8'5.K7:ZE;:;6_\*^$;.A?$Y<G
M-S=VYTF:AV#2'63I'B.L6VXL'?S_  %U9W"7&*R<:5?"Y5^L]O#FAG]/ZADT
M=_-;_BT'B3H&+K>E^%?-*36O9+EW^PAC%;1=_3?C?R)/WQOO[MO_  0\^_\
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MU/J?YV8F8I1U_A/PK_0HOMC+-T7S7:Z28B-;1$IQ4U6]URH
M
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MOLGILUTF*9_#'LAFJ)W6H6Y9D(*UJ\5:A'$H(B(E$1$3T$E$=+:ZNTI5)B4
M$BM:[FU%]H$R(B)1."($H43Z)-5-#2E=5$K](A55,$  "FK&*M5:BN]-!O11
M4"0 !"G: 5$7F@*(@2:6HE.0(V)P)4:B+P;Q)$42G!"!$"56HO-J*35%$JL8
MJ\6M5?81.V"B9K4;P:B(GJ F"0              "%*\P(41%JB<0FJ8(
M"32U5U*U*_2)JBD)D1$(2B  $1L D2T10%$^B35%!K6M3@0E,!(C6IR:B("-
MB<"FC&4THU$3T4"*)T2G! E$ !2\-BI16M5%]*5$F]/I1.30(JB+P4)2Z6JM
M5;Q)0G($%1%YH$U4_#96NA.'&M"%-$]$Y4)HE+H975I35]*A%$415C574J)7
MTDU5)PA*K6JO%.($J-8U%1&HB=I.\C8F1$;P1$1/40F93! 1,!3M) "GH9]%
M! G1*<$ @J(O!4J$)-#:4TM_)(C8E.UJ)R1$]A5,HB$Q"0"%$4!I3T!-4FAM
M=>E-7TJ<2%-%0E(
M
M          <P;O\ *KTOWIN+(;FR<-_;Y3*3NFOWPW":)7.Y\%:M/D-OAZ]J
ML..,=MT1;'=#C^H>!>FZ[47:C);,WW;]OU;F1[*\M_2+8M_!EL1M:.?+6ZZH
M,E>227#T<G:UKE5B*G8J-*-3UO5:BWEOOV>:(_2O]-\%]*Z?DC+BQ>_'&9F?
M5$SRQZ(;W2-K>24HE*H:JFVO%U*J )
M              !9,YA<9N/$9# YFU2\Q>7@DM;^U5SF>)#*FE[-351R51>Q
M2O'DNQW1?;-)B:QYUC4Z;'J<5V++%;+HF)CMB=E&BO[)?0&FG]!&4Y4^/O\
M_P#&#;?W!K?Q_1'V.3_^/NA_Z'_U7_\ Y-^XW'V>*L+3&V$7@6=A"RWM(4<K
MM,4::6)5RJJT1.U33W3-TUG>Z_%CMQ619;LB(I"YD+@
M
M
M
M                         %/0B5HM-2U)(V)D2C:?A"(BB8A(
M
M
M
M
M
M                                      4W/TKQY"4Q%4JS,KIU4<ON
MD1,3MA$[)I*"2HJ<N*_-)MVD]R*/:JT;WNQU/FD51567@2E\_BTXJQ43YSAY
MD\*JB2?BN^X4U4U3I6G'@3$JI1)0
M
M
M
M                                             !21Z*Y6\:IZN 17
M:F5>-.))41R*NE'(JE*4RJB<5*D*2RL2J+W=/TB(VIG=5KS=/5GI]LV3X?<&
MY[2UO%6B6#'>+/\ P;*N3Y34:[K>CT<TRY(B>S?/T-_TWPUU#J,<V#%=-O;N
MCURM."ZZ=*]PW45C8[OM(KV9=,%M=JMN]Z_BI*C:_(8^F\3=/U-W+9DBO?6&
M1K?!_5=)9SWX;IM[8][V-J1SQ2L;(UU6N2K7>E.RBF^B8F*Q-8];F9B8FD[V
M+[PW=@MF86\SN=O?@;&TX/T_G)'=C(V\W.7LH8/4.I8>GXIS99V>MG=,Z7J.
MIYXP8(K=/T=\SV.&-R^:C?&4OIUV7C+3;V-2K;>>\C2ZN947DY[7=UB^H\OZ
ME\P\\WTP1%MO?MG[/:]DZ;\M-!I[(_-779+^-)Y8CNCC/G6W#^9WJUC9XY<R
MN-W%:HJ)):NMVVKG)7FU\6E$6GI,/3_,366W>_RW1YJ>S[&3JOEWTC+9,8N>
MR[MKS?1+LWIAU;V]U/Q\EQBFS6.2LW(W+X>XHLD+E3FU46CF+V*AZ?T3KN#J
MN/FQ[+HWP\F\1>&]3T7)%N6DVW?=NC=Z>R6V5EBTU7D;RCG.%6K^H75?9G3J
M")=PW\C[R9M;?$6C%FN'_C*QO%&^M33]2ZWI>FQ'QKJ5X1MGU?:W_1O#&MZQ
M,_ M]V/UIGEM]?:T _SBX9LRLCV%E'VFKNS+=0-6E>>A4K\E3CKOF+@YMF*:
M?M;?52GTNZM^5>;DVZBR)[.6?:W3TZZX[&ZA.CL<?=R8W,N3NX6^;X<SEXU;
M&[W9%1$JNE3INE>*-'U*Z++)F+Z?=GRI+C^M^#]=TFMV2V+L?XK=L>GC;Z6Y
MV/:_5I55TKI=4Z28<LBYZ-5&\>]Z$")E/4IJE3;*UW)>((FJJ2
M
M
M
M
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MXYVJJ$@
M
M
M
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MNH^]3W9X[.$_5ZGE/C[PMBP6?G]+;RVS-+[.$3/ZT=W:[7/1GE
M
M
M
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M9NX<X^@D
M
M
M
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MC_PQCT<VZS3[++YI='"V[A1UXQU7N2NIM/>/08BCS)]!(
M
M
M
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MF5(IV*P
M
M
M
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M2WLDC]3M34THVNJOSO0=1Q<9,[Z/J"0
M
M
M
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MTX/5OUJ<.'O(I])],U?YS2X\W;$2^9>LZ"=!K<NG_#=,>CA]#.#8M8
M
M
M
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M^54O8F\&M63\Y&O9S[Z'CW5L<^&NM6:RS9ASW4N[([8]?O/0=#=_6>G3@O\
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MO(FB50@
M
M
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MQW6O"VOZ1MS6ULX71]WR\[;<3FJCE:[4CG+]XWNV-[G:45R4
M
M
M
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M=/GBG^+YS\4=&CI.OOP6S6S[UO[%VYM4W;G0
M
M
M
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M%2(>7Q-50)
M
M
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M:^TJ
M
M
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M45$72U/:E3H?#/2,_3--.'+=$^]6*<+:1L:GK74,>MS_ !,=M(I]+8!T;3@
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M[UX9ZW_4]-S7??MV7?;Z7S]XN\.ST;5S;;'[J[;9/=V3WPW<=*Y0
M
M
M
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MF1/3S)4OFFFC@:CI)&1M548USG(VKE]UO'M4BDSN51#Z6NJGH7Z)*$Q
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MHU=V.NSDGZ)BGMES?S+Q6STW'?/WHR1$>:8FOL>BA[*\+
M
M
M
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M+-'BNK%FVZFZ+NQV4>BO+
M
M
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M&JH2D
M
M
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MRP
M
M
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MY'5,++H<^+[UDQZ)6;M-EMWPV?%+!/&LL-PR>-$]Z-Z*W[K3%FL;UF8H^PE
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M8+J_]+66IZ_\M9NIF[*6_7]3@OFI%OP]-7?[WJV.[#U-X\
M
M
M
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M4^A/"W1/Z7I8MN^_=MN[NR/0\#\:>(;>KZNN/^%9LM[^V?2WZ=,Y
M
M
M
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M<NGVQQM^S[%G5Z*V=N-ZQ03-E1',<BM5K7-5.**CN-47MJ<?'?O:J>Q]94I
M     ^>5RI1&NTZNU$J16F]$[=SE+JKN'*[AW&NW+6QNI+#$2)KMXVK6:94X
M.JG'30\5\==3S:[71H[+9FS'[U(C[UV[?V1P[]KTGPSH<6FPSJ+KHYKHX\(^
MU=[7 ]5MPVEM9/NX=J8:"-L,$;$\%VAJ<:M3BM?P\3*T_2_$/4L-N/FC!CMC
M92*33T,7-K>DZ3).2(G)DGMFL,GQ71?;]M*VXSEW=9NZJBNJJQQ*J^FG-#?:
M'Y=Z2(B[5W3FO[YF(:W5>+\]U;,-L66SW15LR.SVSM>P=*RVM,-:P_WY41J_
MMEXG61@T/2L-8MMQV1QI#13DU.MOI6;KNQJ7+]7;S(WOV1L/#.RUS)P;DGM5
M6)^2SFWVN.$UOC^[47_ Z7BF^9_7_5]7VNFTGA>S%;\76WQ9'X>+X;'I=NC=
M$K<IOW.3,=(E?LZ!VIS&K\RONM5/Q2U@\&Z_J=T9>J9YV_JQ[-F[T+F;Q'I]
M%;./18XBG'M[VY,#M# 8"!(\;C$MW,[K;F1=<RHG+ZQ>)Z#TWH>CZ=9%F"R(
MIQWSM[YVN4U?4]1JYF<ET^;<^7=^P=J;WL?L_<V+9D(41R13*Y631U_P<C:.
M3[I=ZCTO3Z^SDS6UCNV3"_TOK&JZ;D^)I[N6>SAZG.MQY1ME_$.2TW+FK&UE
M?W;94BDHGT4D>ROWSC\GR\T=]]8R71'9L=U;\TM;%L<^'',]NV/HB6>;=Z;]
M'ND[XKI;NRLLJB_ZQS-ZQTZN1/>8DCM,:KZD-KH>D=+Z5//6V+HXS=]6YI.H
M]<ZSUV.68NFSLLMF(\TS$5GUMRXS,87,QK<8?+VN2CY^-;2LD3VU15.CP:O%
MJ-N.^+H[G*:C1YM/-,MDV^>)A=F22/5$:Y'HGO.:J<3)B-C&V3MB7V
M
M
M
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M7Q+;U.R<>2D9(^F.UX9XT\*1TG-&7#7X-W;^K/X?-WNEV\6HJG84HX6$P2
M
M
M
M                              -(=>,A>8WI3O2:U5T4LUBL'BHO&-DL
MB,>J?L54T/B7)-G3<T\:.H\%8;<W5\%MV[FKZMOM>;.W;>"-6T8O<;IB:[CI
M7LK[#YNSW73-7T-K;[I;7L[")]LU7O1SZ*KG*E*^RA8IMJYW+FF+MC$,[9PZ
M9$:U%TM=HD^C7@Y?N<B<7NW3,Q78V.DRW5AL/R\;UW%MJXWI9X/#KF\?*L%U
M=6ZH[ZEZ?5ZDT)2CF\SNO#O7M=TVV;<&&<L3$3,179W_ %>ASOCKI&FU=N"_
M-?R7;8B>V-]/0ZC@ZY6\#V-RNV;RWFX^(D4C5HOY#U13JL7S'^'--3IKK.V:
MQL]&QYU/@Z;]N+-;/GK[62VO6W9D]$F?=VBKS\2%5I^U539Z3YC=+SS2>:WS
MQ]E6%F\(ZVS=$7>:5\BZI['F:BMS;$K\Q['M_=(;>SQCTR[_ -6GHEA7>&]?
M;_Z<SZE*YZI;(@CU/S3)4[8XHW/K]XM9?&_2;-V:OFB956>&=?=OQ_2Q*\ZV
M[<B5T6-QU]DWUHUS$2-')['K7[QIM1\QM%CF8Q8LF29[H^N6?A\&ZJZ(G)=;
M;'TM:9R7-;[\5N,Z<PV;I'JOVDC521?:ZB-JAQW4[M5UW9CZ?%M?U^/KIP='
MHK,/2OXFIYO\O!LKIGLG>6WYTGR^31N,6-628ASUD<JTX47DE#J_!_ASJG3<
ML79\D?#I]V9FZ?1V.?\ $'5M%K+.7'C][MV4;SC:Y.=*)P2AZ5MVU<A/<K$H
M     (F12C>CN!-15             !;[JVBNX9K::)DL%RU8IH7MU,>QS=+
MD<U>:.:M%(K,;83NW.&>M6_MK^3_ &_BL/TDZ.6]QG.H5Y-\)%CX'LLVW3$8
MJK/X:.E=JK1D;>'#L-YH=/=U2_\ \C)[MOZ6?BMNU%.>[9'EY2\^\W/UUZ;]
M8.E?F)ZL8J'#9G?.:B=':PL9:ODM(_#AN(;BV:M8U\&5O!_%:<>)TML:7/I\
MFFP37ECRI+9VQ9DQSBMG=];WNMYH[AK7Q.:]DB))&YO)S7]YKC@+HI+G*3%8
ME]A      !1>[0K4I57<&IZ")F8C81M89O'>N,V?C'7EXJR7,JI'962*FN5Z
M\N"]GI4T77NO8>DX/BY-MT[+;8WW3^CCW-KTGI.7J&7ELV1&^Z=T-0[8V;F-
M]Y%^\M\L<V!7)]G8>JM;X;5JRJ)PT_?.&Z1X?U/7=3^?ZI'N1,399MB-FZL>
M5>+I>I=5P],Q?E=%O_6NV>EOB2_Q&-C;%)?6EA%&Q&P1OD;'I:G913T>[5:;
M3VQ9-]MD=E8BCC8Q9<T\T1,SYI66YZA[.M&ZILY;JJ>\V%RR?N#7:CQ5TO!]
M[46>B:^RK.Q=#UM^[%,>=C=UUHV3;HJ0W%U>.;V10/1/NN1$-1F^872K/NW3
M?YHGZZ,_%X4UU^^V(\\L;NNNN'<_39X&_FK[KGN8RJ^C2U54U=_S*P3LQZ?)
M/GI[-[/M\&9(VY,ML>M\#>J.\[Z1&8G8KU1[7*US_%>CUIP1>%$15,?^^>I9
MY_<Z68COB?1Y0JGPSHL,5R:B-\5IV//.:^OMP[CSN7S+M>4R%_.^^<OO-DUJ
MU647L;2AYKU;4Y<^:;\DUNNFL^=[SCP8])IL>+%'N6VQ3S4WMG8C'0O8Q*IV
M5K[#572T.ISS&U\^7L(8U=3BO'BA1S5[5W39IDZ+7]WA^L.S76*K']IW,V-N
MV=CH)8W.<OR*Q%.V\%YKL?4<=ML[9FD^;BL^+L%NHZ-GY_U;8NCSQ/Z7JFVN
MEM>"T0^@9?-T;DY"0
M
M
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M
M
M
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MO^:8B?:T6IZ#K-/=2ZR9\VUL&-\;Z*UR*CDJUR<E0Z2VDQLW-3.R:3O5RM2
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MU#/KL]V;/=S7W>6SLAEJ<C)B=C"1*@
M
M
M
M  :]WWO7"]/=LWVYLS+6VMNY!"Q/K)97<&1,]:J:WJO4K.GX)S7[HW1WMMT7
MH^;JNJMT^+?.^>RWC+SBW9UAZE[^N7ZLY<[?Q&IRP83&N6"-8U6K4F>G>>Y$
MYT4\3ZOXQUFJF8F^EO"(V4]3WKI?A+I?2K=F.+[^-UWO;>Z-T,2LLSO?#RI?
MXG=65QEXQ:K<,NGK5/0K)%5')3U&HP]>U&"Z+K<MT^F?M;?-HM#GMY,F&RZV
M>'+'MAUQT/\ ,%D,_EHMG[YEB?E;M&LP>81OA)<.:E%CD3EK7FBI0]/\+>+\
MFKNC#J)B;IW3'U][RWQAX%QZ3%.KT,3RQ]^VM:=\=SLN*36O!=6I*ZO0>CR\
MJC;%7TD   P[*[PVY@6.7)YB"-[-2K QZ/D]FE.\:7J77-'H8KFR1$]D;9;#
M2=,U.JFF.RK2^;ZH,W+,_'[4V@S/.>JL^)NH/$I^-I1M$_9.//NH^,K===.+
M1Z.,U>-T5]-(CVS$NKTGAR[26QDU&><7=$T6W"]&<OFYOM#<L[,;&]Z/2PMD
M1'(U.-.%4:8?3OE_GUMWQ-93';6O+'WH],<.R.#+UGBW#@M^%@]_9]Z73&.M
M8K*VBLH$?X%K&UD;W+74B)3F>O:73VZ;%;BMK2V*15Y]FRSEOFZ8VS*YF2M
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M\Y\1^#M5T:.>[W\7XH^OL;X;1416\J=TZ>7'0F(2
M
M
M
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M#+V(B,2G(V$M=2B<@
M
M
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M=BMR;Z5]$[GSSXPU%N?JNHOLG9S4_P"79]3<;4IP[3H'-)@
M
M
M
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M]"(>W6XXMB+8W1%'@5U\WS-T[YVOJ1*)0K4(@
M
M
M
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M>'!YWS73/?Q71JU:U4[28A15,2
M
M
M                                                          #0
M_7S>5[LGISFLACU\'(9"2/&8ZX:O>BDNG.:Z5/6UM:?(<]XHZC?HM!??9LNG
MW8]+J_!/2;.I]3LQY(]RVM\]_+P],O-W"8[7Q<GB/<J++,Y>+G+S<[Z2JO,^
M=<V6;[INFLOH759Z=S.OL-/"KX;=-*_*8]9NG=1J/S>W>PO-XM8XD5C%1VM-
M+F\',<WBU[53BBHO:7M+DNQW\W8VFES\T[?+N===*;[JGU)V997$&XVVUOB9
M9,;-,^162R^%1$<Y4:JN6E$154]'T.#Q!U?'%V+/%N*-F^D^SZWEGB3%TKH^
MONB<-9OCF[8BOIV-HQ=$);IS9=Q;HN+U'=Z:%BNXKV=^1R_@,^/EM\>>;6:J
M^[MMK[OT]CG9\7?#V:?#;'H^QE-ATVZ;81$=<1V]W+'WD?>SM545/55$-YI/
M!_0M%2;K;;KK=L3?=&R8]36Y^O\ 4M3,Q$S$3PMAD:;DV1A&>##E,9C8:41(
M7-1W]P;O^K])T>R,N.WS4^IKKM#K\TUNLOGSU6N?JML&UJ_[:BG=Q33"US^*
M>NB&#E\<=(Q_^OS>;:RL?A?7W[L4QYUCN>N>RX4='"MY<R-2J(V+@J>GB^IJ
M\WS)Z797DYYI_E_2SL?@W7W;;HMCTK%===L?' C[3 3R-?WHWSR>&U?6J:56
MB&%K?F3BPVQ?;BG_ (MGT,K#X+RS.W);Z-OTMM[.STNYL)!F9+"3'_%^[!)R
M5&]K?Q5[#M^B=2GJ.FMSSCFSFX2Y?J6AC1YIQ<T749>;A@   !\ZSM2O;3WE
M]'M*;KJ046O](< BN;]M6&IO!S?B8JHOK347?AW=DL?\UAW<]OKA'](MO<_M
MS'_)<Q?OA\._LDC5X9_7M]<(_I#M_P#V[8?Z5'^^'PKNR4_FL/X[?7!^D6 _
MV[CO]*B_?CX=W9)^:P_CM]<'Z18#_;N._P!*B_?CX=W9)^:P_CM]<'Z18#_;
MN._TJ+]^/AW=DGYK#^.WUPA^D6W_ /;EA_I4?[X?#O[)/S6'\=OKA'](L!_M
MW'?Z5%^_'P[NR3\UA_';ZX/TBP'^W<=_I47[\?#N[)/S6'\=OK@_2';_ /MW
M'_Z7%^^'P[NR3\UA_';ZX0_2+;_^W+#_ $J/]\/AW]DGYK#^.WUPC^D6W_\
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M>=V2=]$/, D
M
M
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MY_\ :Q?K$?W5?_I6^H_^+-+_ .XR?1]B/]@[;G_F)G_VD7ZQ']U7_P"E:?\
MQ9I?_<9/H^P_L'[;_P#,;/\ [2+]8G^ZK_\ 2M]1_P#%FE_]QD^C[$/[!VVO
M_,;/_M(OUA_=5_\ I6H_^+-+_P"XR?1]A_8.VU_YC9_]I%^L/[JO_P!*T_\
MBS2_^XR?1]B/]@_;?_F+G_VD7ZP_NK)_I6I_^*]+_P"XR?1]B']@[;G_ )B9
M_P#:Q?O1_=5_^E:C_P"*]-_[C)]'V']@[;7_ )C9_P#:1?K#^ZK_ /2M/_BS
M2_\ N,GT?8?V#]M_^8N?_:Q?K$?W5?\ Z5OJ3_\ %FE_]QD^C[$?["&VO_,?
M/?M8OWI/]UW_ .E;ZD?_ !7IO_<9/H^Q#^PAMG_S&SW[2+]Z4_W9=_I6^H_^
M*]-_[C)]'V']A';*_P#\1\]Z?=B_6)CQ7=.WX=J?_BO3?Z^3Z/L2+Y$]L1L<
M^3J-G8F=JO;$Q/NJ@_NJ_P#TK?4FWY5Z:=V?)]'V+/-Y-NFL*Z9^L]W JU[L
MES:-3AS]YQ<CQ)F_T8]2J?E3@G_U\OT?8^BU\EFP+Y^BRZO7]\[_  <,UJ_]
MPJD3XFRQ&W#'J1_\5:?CGR?1]BY_V$=LIQ7J)N#N_P#HV?O2C^ZK_P#2M4__
M !;I?]?)]'V(-\B6V7MU-ZCYYR?DQ?K#^ZK_ /2M1_\ %FFG_P#J,GT?8BOD
M2VVJ4?U%S[D=\U61_K$QXJOB?X5J9^5FFF*?'R?1]C177_RVXGHULJ+<^/W1
ME<Y-=Y.VQR0W>EC$9,BN5:L7THIG]*ZU.LR\MV.',>*_!&'HFD_,8\U\S6FZ
M.^>%'I;TUB>WIUL;55VK 8Y51SE>M701K74OM.,U4?OKXGME[1TB/_"Q;:UL
MM]D-AM]UO8ICQ%(;.=Z<J0 6+/Y/[&Q5WD4M9+M;5BO2WBK5U/10P>H:R=)A
MNRQ;-U.$,C2X(SY8LF:5XN:/Z7=U;BO/@,+%;8E9'.:QLM&2,5O*JOIQ4\C_
M +ZZIK\DXL$68YKLYJ1/TO0?[6TFCLC)EK?'EV,B78?4O<")-G-UMLX9$3NP
MS.?1%_Q>A/OFSCPSUS7>]GU7+$]D[*?\,PP/ZUTS3;,>"M.V/M?=%T*Q\C5=
ME-P7-[3WUTT_=.>9./Y;XLG\?/=?Z/\ \IE;O\:WV?P<5MOEW47->A.RE:C4
MFOD>[W9/$9^\+O\ \8=,_%?ZX^Q8_O76S^'U3]JWR=!\6SCC<_>6DG-JN1%5
M/VNE2QD^6.FMVX<U]OEW47[/&N:=F3';=Y>E\/\ 15OK%JKL+O-\J4[K9W3L
M3CS[JN>A8M\#]3TW\#5S/INCZYA<GQ)T_/\ QM/%>ZGZ'R7\/6W$V=W$Z6+*
M,^'F2.1KF.7A&ON=UJU5:43B1./Q3I(FD_$MI/&)^Q<Q9.AY[[9IR36.WM>>
M6!<][YGW-4N5GF^*1WO+)KJZOK13S'7W7<\S=MF?:]TUFR8BW=2*>:C<V*2W
M\)B.<WBG%%]AKIK/!S.IFZ)V+5G&PMU*RCDX\A,S3<RM),SO7CR[MGCZRX1M
MJJN5+*[==JU>'A*Q.?JJIZ!X#Y_ZA9R]DU\U-OU-?XZFV>C9)N_%;3SO3Q%J
MB*O#U'O#YX3$)
M
M
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M!\P_$5FJR6Z/!-;+)K=/";OKIM=@)72VO/M/0(W/,DY4
M
M
M
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MNX.2ZMXVZEU&V;9NY+9X6[&^41&I1.ZC3J'(;DQ"0
M
M
M
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M]CJ'(
M
M
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MA1MNH] S:##;ER716=E.+:)UC0@%NR'^1W7^;3?N2;?O1YU&3[L^9P/Y)/\
M>#K-_.L7[N8ZGQ+]W%YOL>5_+3^+J_\ N3[9=A=2=L.WMLC=>T4R]SMZ;<>*
MN+%,];JC9;1)6*WQHW:J)IYKQY'-:?+\'+;?2M)W/7,5\V71=':\7NA'FVW-
MY:<MFNF>ZKU.K'3G!9":U@S>-GDFN;7PGJQT]E)*KDEAD5*JQZ\_=7T]OK>C
MV:[';EL]V^8\J^;M;?4Z*+Z36GM]+U"V9YP/+WO>T9+8]1\;A[MZ([[+S3EQ
M]U&G)R*V:B</Q7*<KGZ/J\$TNLF>^-K77Z/+;-*5\S;"]8>EJ0I.G47;:1/;
MJCE^TK?2OM748OY+/^"[U2I_*9OP2UGN;S<>7G:4<CLMU6P5Q(UVE+.PF6]G
M5WJ2%KD3Y3(Q=(UE\_<F([]GM3&CR\8IYW*^_/\ Z3#8&-\>RZ<;'SN]+_0Z
M6"^O(UQ]DB-]YSU5KI-+4[:)[3;8?#&;9.6ZD3PC;^A>QZ&Z;N6=_FG_  :.
MLMS>=7SAXS*Y':N2Q^R^GUK)/;>#CKM;&.6YB1*VJ2LU73U1.=7(TS[L73^E
MW1%_O73W5F._A#)NC%IKHB8V]NV?\/0LWDBZ3]#^H6X=^;8ZHX"[ONJN!NY4
M_1[*3.B@DM6N\*=S6-5KI)X9*H]7+PX.0KZWK=3@BV[!-,<\8CRWJM7J+\>V
MST[/5]'%N/RT8/JCY:_,KNCH%=83*[EZ7;O23*[?W$R%WP=M$FJ2&[=)Q:QV
MA%AF8G-^ER<.)KNI7X==I+<\3$7V^4Q]<=S'S7VYK*\8BOZ/LHZIZ6^5';G2
M;K;OGJUMG<%[;8[=]L^WAV*QC6VEHZ>5L\ZZFJFIJN95B.3NHY43L-;J^K7Z
MK3VX;HVQQ\VR/TL7)J)OLI.]UK';P1^(Z-C6>,Y7R4X:G+S<OK-5W,>7T-8Q
MO) A.    %*@4GQQNX.;4FJ)B)3HUJ<B$N*?/3_4]C__ )CL?W,IT/AC^8]'
MUO.OF?\ [5_QQ[)=-]-_ZN]A_P P8W_LC#3ZW^/?^U+L^B_R6#]BWV0SMO)#
M%;),2)7-1W,0B88YG]N8G<5HMGE+1D\:HK4>J)XC47Z*\T-=U'I>#7X_AY;:
MUX\8\TLS2:[-H[^?%=3Z_.T+=8'>O2Z[?D]LN=F=MO7Z['.3W&JM%16_-ISJ
MAY?GZ1U3PQE^)HIG)@WW6]GEW.TLUVAZW9R:C]WEX7-J;/ZBX7>%OIMG?"Y.
M-:7.+F=H<E.:L5>:'<= \5Z3J]GNSRW[IMG?7N[8<YU;H6HT$UF.:R=UT-B-
M5':DTJE>TZ>*Q/<T:*11HVB-^4FD5JFK&<UM#;>?C<W*XJ&Z=R29$I(GL<VB
MFGZAT'1=0K\?%$SV[I]<,_1]4U&CFN*^8^GZ'./5+I1%@MD[OS&W,O=6W@8^
M1;FT_P )%6BLUMXK1JJAP/5? WY*R_4:;)-L1&VW?6([][N?#/B:=5KL.+46
M1=/-LGLKW.'=LMB6WM7)3C'&BHG!$I6B>T\IU4W3?YIE[/KIGFNCOEN&RBMW
M0I6GN^DQ9F8ES.6^Z)8MG8F-9*O=5$3W?EY$QEF)BC8Z2Z9F&XO*8^=N\-WP
MQ*J0S6<,ES1.ZCT>J-3U415X'K'RXOO^/DB/N\OUN/\ F;9;.BPS.^+IIZGH
M$>O/%
M
M
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MW8>^^#NB7=-T\WY?O7TV=D<'A_C[K]G4M5&+#-<>/97\4\?T.FCLG!@
M
M
M
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M5M5HE:N1.TZBW8XN=U'UD@
M
M
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M6*J(G/A]\[QYJJ@
M
M
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M@S6F_P O8Z#7])S:*VWXD4KN9LRJHY5X*OS3;PU]54D
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M\O;[HUM*?J37UPTWS!I/1]O^I;ZZ2])FLU.:YS=*I13V^9> [X?42
M
M
M
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MUXSX_P#$EFORQI<$UQ8YVS^*[[(VPZL.Z><
M
M
M
M                 QS<6WL)N;'28S/XJ'+6<R+6"6-'JE4I5%YHOK0Q=5HL
M.KLY,ML71WLS1]0SZ+)&3#=-MW<Y\O/*KTPNI73V[<IB8WKJ^$@N^XG&O=U(
MJHAR>3P)T^Z^OO4[*_H^MVV#YE]5MMI=%ET]LQM?9/MKI-Y?\!?[MBQ/BY"V
M:D5M=73UGN[F>3\W%&YW!O'M1.!?NZ=TWP_BG/%NVDTKMGT=E5C%U/J_BK4Q
MI9OI;7;$;++8XS/;3Z7'V[^L_4G?]V^6;,R[?P<KU;;8?'O\-K65X>.OO/4\
MSZOXOU>KOF(NFRR>$=GGC:]6Z7X3Z9TNV(BR,F2-]UW;_EX0P_'9?=^"G;>X
MG<V5L[B)=396SN<BKZVN5>!S^'KNJPY.:W),3YY_P;?/I-'JK>3+BLF)[F[N
ME?47';JW=%;=6K]UQ=(U&XG+O71%<*SBD4R<$;I[%^<='TG/I.H:[\QU&^9F
M-W97LGNXPXSQ-T'+H]'7IEM+?UK8WQ7C;/>W[EMV[CZB9&YVMLN+[/PT2^%=
M95R*QJQM[NI53W&_11.9NM?UO6>(<LZ+IT39AC9-\_3_ (<7%:7IFEZ/CC4Z
MN>;)OBWV?XK7OK=VT?+9MJPNGXR7<>YLUJCB]UJRI'I\1RN7@QC5<E3TSP=X
M(T^DMFS%]Z*<UW;.W<\R\=^/YTMD7Y8F8FO+9'9%*S],+?'F<)YMNC^:Q./^
M(VOE+:X;XL-PY)&P73*Z%56\'QN:KD3M0ZZVW)TC51,Q7[''QGP>,NE76V1-
MEW")X3%:3WPTILSI'F.D-WE<;/E[7.[TW7"F-^%L$>C+.R>YOYQ7(FJ1]*U[
M$]IYS\U/&,ZW';TO117)DV7=ML2Z[Y2_+N_H^2_J6MOB:1LILBL<9W5\MN]W
MMM;;UIL[;%IB];&I:Q+)>W+^"*_F]YE]#Z5@Z-HK,6R(B*W3_FXNCZGK+^HZ
MFZ_C,[(]C2^Y-Q9?J-F&;2VKKBP[9$3)9-$5OBM3@JJJ>ZQ/1VG ]<ZQJ?$>
MICI^@BF']>_A,<?5P[9=9T_I^#HV&=5J9KDG=;V?I;6@P6+V-LW+VN/33':V
M4KKF=><CUC5%=\JJ=KI^F8>A=*OQX?U;9FO;-*5<SDUV3J6MLNO_ !1ZF*]"
MK3P-KWL[E[U]=K3]C&B&@^66&ZW0Y+[M]U_V-OXUR\VJML_#:W0J+333AW=+
MO6>C64W^=QT[J-"=0.JEYB=PX["X&6%60S,7+3N;XC7-D5$T-IR5%[3R[Q/X
MTOTNKLTVEI,<T<\^>:.TZ/X<C/IK\V:L;/=;ZADU>#I;W7HJJIZ=9?S1$]L.
M,NMY)H^XN(             LF7R^,PL'Q65NV6D%4:V5ZT[SC$U>MQ:6WGRW
M1;:OX--?J+N3';,R^RTF@GB2:WD2:*5J/9,U:HY%[4+V'-9FLB^R8FV5N_'.
M.Z;;HI,/J>O#UNY>TNK<N9^K&"BPV8Q>\V63+W'SS-CS-BY*L5W)%5/8>0>/
M>EQH]79U*+(OLW7VSNNC=Y=[O_#.NNU6GOTDS2^(K;/>^NXZ7QRPVNYNG.8?
MBIY6_$P6;W*]BK3BUK_FU+^?P56VS5=(R3CFE8MK7;V1=79YENWQ'?;DG3Z^
MV+K=TS16Q/5'-8"\9A^H.-E@E7NQY2!E6M7\=O:GXQ<Z=XSU>BS1I>J8IK^.
MV-W[4<8[U.K\-X=3CG-HKXI^&6YM6+W'C)8XYXLAC;^'0^1M%JCDX'H-UVEZ
MCIYMB8OQWQ2:3PER46YM'FB;HI=$N?+=;GI/NS[.R+?B]HYA_BPR*U'+"[@B
MO:J\G,7@M.P\OTM^7PAU"['-9TN6?*Z.^W=,<8[W:YL&/K^B^)2/CX_9V?9/
M:T%YK>G'4?>.],)N';EA>[GVU=XZ.VQL-B_A:R:JO1S4I5KU77K^3L/HWP[U
M#26Z>>:8VTF)[IC8^8_F%T/J&IUEF3#;?='+-M+9IRS7CY;>QT1L^^QW2KHY
MM7#]9\Y"RZGADAFAO'>-)1ZJYD#5XJJQL5$5>PT/4]!CZGDOQVV<UD[XX.TZ
M#KI\/].P?G,LVY8C9,SM[:1YH6I;.YVE':[XZ89=NX=I7[5?+8MD\6%$[45R
M+Q:G):<6\SQOJ?A_7>%<\Y]#$SAC;?9._;]7?PWO8>E=;T/B/3Q9GF.:?NWQ
MQ_3W*V^]R]/MR[%N-Y9*\7"9G#(C8UB73.MPO*!B<WM<[@UWS:U[".JZKIGB
M/03JZ_#SV1Z>:-T?YHK]VZ-S*Z+H.H:'7?D\5O-9?O\ PQ;^+NF(WQQ<P7?F
M#ZK9.T@QV+R,6"Q]LU(X)V1ZKM6)P37*ZJ5.<M\8Z_#IXQ<]8B*5B/KWO1\7
M@;I&&^<F6V;[YWUGW?4I8;KGUFPLS+G])US,;%^ML\E$V5KD3V4<WVH-+XXU
M^"_WKYN_:V_8N:KP=T746\L8N2>VV9AUSTSZJ;9ZT8FZVSN3$6L6:;'3+8">
MDL$\:IPDMU=QI]]#TSHO7]+US%./+;$7TVQPGS/+/$'AK5>',UN?37S..9]V
M^-EUO==Y4E\63\JO3'*2R2VC\GAM:ZO!M[I71^UK')P0MY_ O3[IK;%T>FOM
M7M+\R>J8;8B>2[OFW;]#+]H= NG>RKR._L<0[(Y""BQ7^2E6=S')VL8O=;7F
MO SM!X5Z=HKHNBR9N[]OZ&LZKXUZIU&V;+KXMMGA;%*^?BW;$U4X<T<B]XZ6
MOJ<C%8V2^DD
M
M
M                                                      H/8U6T
MTI5O)/01,T@I67GUYM,U<W.\-L[9\>1;'&V"WLELY?JW3S2:6R:?I-:BI4\E
M^8NMNG)CQ1-(B*T[Y>W?+#1V8]'EST]ZZ[EKQI$;O-,M-8*PC70_2W4J=Y53
MF>4765=EJ\T[F3W.(9#;O<BIJ<BJO#F6;LDU:_'J>:ZC4NX+9L.J5LC6S1)6
M%$X*CF+6M?2IG:;+-8CAY;/0Z+17S.R=T[W0O5#S$;BZ91;/VYT^Q./QZWN
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MILGA,QZGW:4]!6MH@
M
M
M
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MS5<RM:
M
M
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M715HM41./"GH.WC<\XXJY(
M
M
M
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M,:LKT21JIRI7O(<]U6R?#G6[=5CBF++OB/\ -/O1V?YH]+:=/OCJW3;L%_\
M$Q[I\V[['0MVJ7-C=(SO-F@?H7L5'Q\*'K&:.?%=$;8NMFGIAPF.>3)'=,5:
M2Z&S(RRW-:.5:QY!%:GHJKD_4/./EG-,.HMGA?\ ;]CL/&<5OPW\)M^QNO(8
M^URMK=6%] R:TOF.AGB<O"CD_='H^KTN/5XKL.6WFLNBDQ+D-/FOP9(R632Z
M-U'/.U[BYZ8;R?M3(SODP.7<GV9(]:M1TBJC75[/HN^0\JZ-GR^&^J_DLUW_
M (^3;9W3/;7LB(C9W3Q=SK\<=:T/YFR/WEFR[OI'UU9EUJQ?VAM1,E;,I<X.
M9L\3TYI&JHCU^ZU#>_,CILZKILY+/OX[HF)[JQ7=YH:OP=JHQZOX<_=OB8]6
MYGNS,O%GMMXK)-75)-;HDJNYHZ/N.K\J'3] U]NNT6/+'&V*^=INK:7\MJK[
M.R60W$$;X)HI&-DCE:K)HW\6JU4HK?E-O?CMR6S9=$3;.R8[FOLFZV[FMFDQ
MN<U4FZ1;YB1$5FT=PN5BM555K>/-:T1%CK3UH>/VQ=X3ZO2VOY;+ZN[TV[H[
MGH<W6]?T%/\ U[/I[?1=[5TZK8]^)R&"ZAX9=*VDT3<A,SBV2/G$_P!B^ZIG
M>.=).FSZ?JV#?%T<TQV?J3]6W@P_#&>,^/+H,O&)I7MXMY83,VF:Q=AE+1Z+
M%=Q->C6K72J)WF+ZV\E/2.G:^S7:>S/9MBZ(GS5^QQ^JTUVGRW8KM\3,+HCU
M=W]/"G<KS,RZ>6&-$SN<1>;_ #,[G;(VG&YT=A<NEREPUB]V5T7U;&N]*)J5
M3S3YB:ZZS'CQ1QK/U/7_ )7:.V(SZG]:*61W5VRYLP%C'*Q%THK^"*J\D[:)
MZEYGC$WUF8>AZS+-LLRGQ+6V[E6C55*M5/3V%5MVUK+=3,SL:QW!8QI&K:(C
MUJKG-6GW%I5"Y@OFRZ)AO]%EFKTHZ=R6W4/I'MIFX[6/*V^:Q3;?,6\[4T3>
M&FAVI.//3SY\3Z9\/:[)ET>'-7WZ1'U/FKQCTK#BU^ITMUL78YNG9.ZEVVGT
MK#ANE6R.AV$W9NW8NWGS9B'&7$S73R.N)7L8BRI"Q74T-5R)RXT0ZB_69===
MCQ9+J6QLCN>>:3P]HN@X\N?28_?FV:UF9KW.5NA?F7ZH[NZGX_ Y^:+.8S<L
MDBR8V&V2+X%415^J>BU1K*<4=S-[U;H^GP:>+\?"-_:X/PQXTZEK>H_"RQ%U
MET[8B*<L]E>ZGIJ]*XY*1UHKD2J*[E6AQT=SVBZ)B7T(ZOJH2I3
M
M
M
M                                 !05[/$8G-W&@W0.7?,5UWO.CUE@
M[7$6$%]F\\DKXY[E'+%!##2K]"4U*KE1M.%.9N.D=+_/771.R(CZ7$^,O%?]
M!QV1;'-??.R.[M[.[TL<VID,;YN.DE]8[GL_L+,XG(MA=?6*JY(;N-J/9-#J
MHBHYJK5"YELNZ1JHNLV[/T,?1Y,?C#I-UN:.2ZO#]6[A,,ZZ'>7[#]&ERM]'
MDY\]N'+1,MKC,S1MAI;1/1S(4C:]R>\E5,?J?5+]9,3,4B.#9>&?"6#H47<E
MTW77<9[.QT:]%^CK-6ZWFF%+0J(BTU.[JZ1.Y'"'F1Y@=HW&SNI^1S"0O^P]
MW3I?07#FTB;<*FF6+5R1>%:*>'>..E7X-9.28]V_;$^U]"^!NJV]0Z9;BK[^
M&.6G'EX2PW%Y=(FHJ2(U5JY6JO%%7L/.LD4K/>W6?3\W!4R.81[7(LK:N1=*
M5[!;$S%8,&FIP9?T VA=;QZB8[,N@D?A-K3.O+NZTUB?/&U4C@JO-55U>'H/
M0/!/2+]1K+;[K?<MBLSZJ-)XXZK;H.FWXHF/B9(Y8CCRSOEW=U!ZE[3Z<6#+
MW<UVYDUVNFRQD-7W-PY.QC4X)[7*B'L'5>MZ;IMM<MU)G=$;Y\N]XOT/P]J^
MLW\F"W9&^Z=EMOG_ $5ERY?^;_(NN7?9>Q&2V;55(Y)[QT<JM];6QN1/NG Y
MOF/=;?[F..7OG;]#T?#\JL?+^]U$Q=_EMK'TRH]+^LVT\EO6]SF^5?@\M<(_
M[/?)5ULCE3DCJ.5%1M&I4T_AGJ.FCJ6;7ZW)$77?=K68B?5LV;%?B/PEJ\&A
MMPZ+W[(WQ'WI\IVMLX*TN>J&^+C<.48]^W<&]/@(J+X;T1?JVHO)R5[RJGI,
MGIF&_P 4]5G59XG\OBF>6V=U8G9ZZ5GM<QJL]O1=#\#'_%OC;VQV_8Z<B33&
MU*U7C1?;Q/8H\U'G\0ED>K>.GL33[5)FD;RLN<<!_P#%75_*Y-R>+9[>C<V*
MGNHC?JV<_6E>!Y)TRV[JOB3)FNVVX*T]D?3$N]UL?D.CX\<;+LD_I.I5[<;M
MW=@-CV3J1P/2XRS$Y-54U+J_):M2OQCEGJO5-/TW'.R)YKZ<-FV9_9C;Z5/A
MVVW0Z++K,FR9]V/3N]<N@K*SM[&WM[6WBT0VL3886=C6(G!#U+!BMQ8[<=D4
MMMB(CS0XG+?.2^;[M\L9W_*V/9FY]2IQLY$1/;P-%XKFG2L_[,QZ6QZ'MUN+
M]IC71FD&P[17KPDO+E8_6CI%HAJOEYCF.DV=]UT^BK/\6WQ^?N\T0PUFC<_6
MN:1562VVS"K&*G)KXTHO/\8YO3WQU3Q5=?OMP6_3'_\ DW%T?D>B1&Z[+-?1
M/Z'1*M54JG%%13UFDQ7SN$V3#GGJNQ<9O'9.;BK%)73+(GSECD8J(OR'EOC>
M?RG5-)J;=E:Q,^:8^JKN?#4?F-!GPSY_7$MF=1+E(]D9Z=JHU9+=C5]DCD1/
MPG8>+,D6=)SW=MGM<]T&V;M=CCLN]BU]((/ V#B7+W?B7RS:O:J\?O&#X#LY
M>D8IX36?0R?%%W-U"_MBCY>L&)3+;,OWQL5;O%JES ]*53YKD3Y%J6_'?3XU
M/3;KJ>_9[UOHW_1M3X8UD8==;$S[MVR?3Y47SISEDS6R\%=NDURLMDMIT_&C
M[JK]PV?A771J^F8<E:S2(GS[F)U[3?EM;DLI2*S,>9K/HN_P\OO:V<O&._X-
M[>[)(AQ_R]NY=3K<?^>?HF[[8=#XPB)PZ:^-W+'LAT536WCV^Z>HTIN<0U-U
M>VNF>VU/?0PNDR."K=6KHT^L<U.+XT]JHGW#B_'?1_S^@NOQQ^]Q>]';2-\>
M78Z/PQU*=)JN2[[E_NSZ>*;9N7@WWL-;:[HZY6U?99%JT5?%5M&JOM_"A7X=
MU]O7ND<F3;=-O+=Y_+V*.JZ2>DZ^+K)]V)YK98QT3R+[/[?VM<KI?C;ATL#7
M+Q2B^&]*?E)7Y30_+C5S9.HT=\[;+YF([HV3]39^+M/%WP]3;NNBD^UO]SVJ
ME$XN^:AZC#BIW587O;:D&[]OWF,E:U+AR))82/HOARMXI^LIH?$71L?5]'=A
MNBD_JSQB?TMIT?J-_3]3&6W=QCN:=VAN;&.VKN':&_;EEC;X:":*:YNWI&G@
M-5=3>]Q5T2IP1*\.53A/#75,6IT>?I74)I-D3'O;Z=GGMG=1U?5NGY+=9BUF
MBB;IOF*1;V_9+3NRO,9M78[,EA9(LAN/'17#GXN^LHT:QU5[[F^(YBHU_-*H
M:_PSXC_HUN73Y??LBZ>68V.GZOX"U?4[[<WN8[J;8F9K7OI6*M];+\PO3G>E
M]#BH[^7"Y.YJEK99%OA*]WH1Z*K*^BKN)Z'TWQ;H-7,66W<LSPFN_P ]*?2X
MKJ_@3J6@LG)-G/9&^ZW;]'WOH:Q\W&VIKO#[8WC:122I@KE;7(O8E4CAGII>
M[MIK1$J<]\P]!\3#9GCA[OKW?2Z3Y7]2LLS9M+?,1-\1,=]UO#U.3L%E6PL8
MB:=2NJ[V<ON>L\5OQ\MTUW/4=7IZS5F%SF6OAT:FZ=/%47T%%LQ5K,>DY9:W
MR\TM]/#:6S?&N+R1(;6)JI6221=+6IV555H9NDQ79KXMMBLS-(]+=8.7#9-]
MVR+8K/=$;WJETSV\[:6Q-J;;D:Y+G&6$+;E7<UD<FI]?7J53Z6Z-H_RNCLQ\
M8MV^=\T^(>H_GNH9<T;KKYIYN#.Y(VO:K%B1S7-IH=145%X*BH;*(IMXM/\
M>K$[I8-CM@[2VM<YC-[9VGCK#.7S'RS7D4:-?+*B*J(Y>RJ_11#(OU.7);%E
MUTS;PAK<72]+I;K\N'%$7S69FF^7F9M+J7USN>M]G9RY3,W>8N,W\-D]M3-_
MDR6GC-8_3%P1&LB551W+@=AJ=%H[='%\3&[Z7C&AZSUN_K7P[KIGWONTV<E8
M]&ZO'A28AZS)=V45TEFMU!'=2IJCM'/:DJIVJC*U7[AP\6SMFFQ[S=?'-29B
MK[4E8M>]R]1%8*IFR,<B:5JBDIC;N5
M
M
M
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MTZ51R*E4>E**GJ+$U9VS@^A%1>"$E42$@
M
M
M
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MEEFL-=QW^,R4+9K.\BHK9&/[>'88%^.['=-MV^'0X<^//CC)CFL3MA?RA=
M
M
M
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M:E$:GJ+#90F(2
M
M
M                                         !\\SW,:CDXI7O4]!3=-
M!ICK1U9MND>SI-QS6#\M?7<\=KB\>BM8Q\SUJBO<M-+41.->)L-!H;]7DY8F
MD-!XEZ]9T;33FF.:9V1&[;WRU#T_ZG8?S3;.WUL+-8V3;E\VSC6Y=;N1Z>#<
M*J13M6E$5KVK5JFRU_3;^CY;,E>:)<]T?KVG\6Z3-IK[9LNB-O=V3$^>.W8I
M]%/*])TMWD_>&8W(S-WUK!+;8JVMXW1M1LU&ND=K<Y*N1$2@ZIU_\YC^'$4M
M[#PSX'_I>JC/DR<UT12/MH[+2-'(QSD[R<4]2G/;'H5:*J)3@A*E$
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MXQLWT[OJ=!1N56MU)QIS-6ZA42M./,(1"0
M
M
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M^M1?CSV[;(B>:.-?5_A1V.DJT76FCY%.>YH>B4E/'*UZ-5%U52J$D;8JK
M
M
M
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MJ-M[:"-(VM:GH:TQ<F2[)-;IK+<X-/CPV199;2(A?"A=
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MF]O>1.1QLQ=;$;'K\3$[(7%'(I4JG8F"
M
M
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MQLXLEMO-,31[3;K-/?E^';?;-_96*LE29BJC?=5>'$M1-8JRJ*Y(
M
M
M
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M.A7)2BIP_P#JG(TKMJ]<F9B-DOKC1R5UM[W#ER*E/!7
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M3%=T]D]GF;?;+$].Z]')ZC"BZ)KW-[$53ZVT][Y2J$)D5')5.**$[D0@
M
M
M
M       4WJB,6O*G81)P<X>8SJSE>D>TK#)8+'LO<ME;M+.TFGX0P\%=J?Z>
M7!#;=(T$:S),2Y3Q=U^_H^DB^R*S,TBN[N^EKGHMU!G\RFR=][,ZC8UB? MA
MM[N[LJQ,FCG34QS%Y,>QS$4S.IZ6.EY[+\,UXM-X;ZM?XGT>?!K<=.$T[X^B
M6P>D7EQVGTCR]WG,?E+O/9J[8Z&"[R",:L<3G<&HC$[$0P]?U;)K(I=L;;P]
MX,T?1<LY+)F;IV;>$<(]&YTJQ.Z:F'743D@
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MFK3QYE*M,
M
M
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M5=*C%<Y[W]JOD=55-;J-1DSS6^72=.Z;IM!BC'@MY8AGQ99P
M
M   $KO==V>LB4QO<1=4O*-:;^WW+O&PW6_!VN5<QV>QSX4E<[1VQ+1$2OH<=
M%HO$&33XOATJ\YZ]\O<?4M7\>W)RQ/WH[?M?7U-Z_P"#\OUSMSIIM_;<N<?@
M\9:I=2.E\-MO;41L:*JK5SW(E2G0]'R]0MG/==$1,JNO>+\'AN<>BLQS=%ML
M>B.#IC8&\,;OW:6'W7BHI(;7+0)+\+/3Q(I/G,>J<*M7@:C5::=+ENQS.Z7:
M],ZC;U#3V:BS9%T1/K9RU*:OQG&/$,U.$@
M
M
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M:G"
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MJ^BMU$QRS,S$^>W>W1"KE15XZ5]UJ\S7RZ"E)?0
M
M
M                                           E<YK>*A"T97*6F)Q]
M[DKZX2VLK")\]W,Y*Z(VI574]1599-]T6QQ49LMN+'.2_9$1O<T;#\U>QNH&
M]&[,MK'(XQ]X^6+%Y"Y1B0S.95'(BIQ15^:;C5]#SZ?%&69V.,Z5X[T74M7.
MDLMF)V[9W3_CP<^Y/R>[XNNJ%UDHL[:R[7NLL[*RYM7/2]1'/1_@JWEJ9R1R
M&TMZ_C_*?#F/><IF^7FJOZI.?XE<=:_H]'=OW2](K6#P+>"W5[I4MX61I(O-
M=+:5]JG(W>_->U[!9;R6Q;V/K2-$=74[A\VO#[A%L4BB:;54E(
M
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MQ7TTGC]>QU9'(K^-$5J^ZY%J:2VO'>[;?%85R0
M
M
M                                     $JK3BO(E"1SU1S6\.]R0IF8
MA529:EZN]26=,-A9K>4F-^T[G'K#!:V.I6-=/<N:V-'NYM:BN17*AF:'3_F<
MT8ZTKQ:/Q#U>.DZ._476\TVTBG?.S?V=LN?>B?7N[ZZW6Z=@;TV_;6]O=X][
MX;C'RRJV6":K9(7:D145$7@J<S<=8Z-'3)LNLNFZ>^/L<GX6\7?W#&7!FQQ;
M$Q.Z9G9.^-L?2N_37RD[9V'OB+=KMQ76<AQ<SY<-B986,;&]:HUSWM6KE9V4
MY\_46=;U[+J<7PYMB(I1E](\!X.G:KX_Q)NI,S%M(B-N[;OV.P61I1RN6NK@
MK5[#0Q#O:OHHE:DH1
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MM%.:NMNMFDQ+TO%GQYHK9=$^::KP%T
M
M
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M]7U#-JJ?$FM'4](\.Z+I4W3I[*3=V[?1YFW8T=3OTUU[U#";M.B=O:2A,0D
M
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MNMF(>EZ/K>BUF2<>');=='".[9-.UG^M*\N'T^!CMJJ@
M
M
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M$1W+V4K@
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M6;?=\\.WT_C+IN?5?E[<GO<W+NFDW=E9BGEW.B45%X=IK'4I4<U[=3>\T"<
M
M
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MZ<E:Y*HJ?(:"E'H$71=MC=+Z@D
M
M
M               Q'=VX++:F S6Y<BJ)C\#:R7=Y3FY(VZJ+ZEJB%S%B^+=%
ML<6-K=79I-/?FOW6Q5R5TH\V$/4W>EML?,;5CPUMGX[B'#W44[GO<YK5K'*U
MR(K5<VO%.TWVNZ#=I<49HGT. Z#X_P ?5=7&EOQ\L71-)^BD^5%H@\EV/M]^
M1;@?NZ9^V(+]V0ML*D2)<5\3Q&0N?7BC'=JE7]Q3^6^'%M)XK5GRUPVZZ,T9
M)BV+N:(^GR^QW;$K5<RG&C-*+Z4.;IMJ]-I2(H^T
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M'=-M:TEZ;I=1&IQ6Y;=UT1/K9 4KX
M
M
M               &ANO_ %"SG3'IEE=S8*U;/EVSQ6=G*]CGPP+.J_7O1..E
MJ>DSNGZ:S49XLNW.<\5=6S=+Z??GQ6\U^Z-E=_'T.?\ RU=9=U]7Y]T;)ZAL
M@W!8NQWCNOXX$C9X<E6/BEYHJ+5=/ W/7>F8M#%M^.=KDO _BC4==^+IM797
M9OIPGAQ\J-T=/?+3TUZ;[EDW7A+6\GR#$5,>Z]F29ENUZ_WNK4HOH4UFLZWG
MU.*++MT0Z7I/@OI_2\\Y\,37A7]7S.BV-[:UJG=X<C51N=5WJJ(B<B2(1"0
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MG_#9]<M82^9+K9/,LK=P6,:?^[QV#&,3[KJG/7>/M=/X8]#I+?EWT>W?;?\
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M0XL^2*771MCO;0,=M@
M
M
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M+7QI<12>/%(B:'L<CFJB]J*A%VR:3"F)B8YHFL/N8JJWCSJOX0N2G"
M
M
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M6QT3[FZVO<2K-!=P1\7MC5R5:^BJJ)5:FQZ=XAR3EBW-3EGC$4EH?$WR]P_
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MBHGJ*_$7PYSVS9%*QM\ZS\N,F;)TV?BS7;LGN=C,2C4KS5*K3UFA=_M50
M
M
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MKZ2VR(3A(
M
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M?Q?OQ;'-Y^+-6>ZWMX)Q+>]E0G"0
M
M
M       .:^J'EDZ?=2[J;+2PS8#/7"?RC)XY6L2=?_30Z=+Z]J\%-KH.LZC2
M;+9V=CC^N^".G]6O^+?$VY.VWZX:'@\B=BR[=)/OQZ6G+3;V+$E5OY:O7C\B
MFWN\67S93DV\9<K9\JL-N2)G-/+'"(V^O:ZNZ8]']G=*,=):[8LI&W%TC5O<
MA<*C[F=6IVN5$I[$.>UFORZRZMVQW_1/#^DZ19-N"W;.^9FLSY=FYMIJ<.*:
M?48<11NZJ4S$DC<Q[$E8]%:^-R(J*B\%147@J+VD[>"F8B8I,5<F=0?*/L'>
M.0GR^%\?9^7G=KG6SH^TD5R\7.A6B57T)0W>DZ_FT\4F.:(<1U;P!T_79?BV
MV\E_;&[U=K6.+\B..BNHW9;?DMU9Q+7P[6T2"94_+=(]&_(AL[_%<S&S'$3Y
MW/X?E5@MR<U^>Z8[*1]'9Z'7/3SI=L_ICBGXK:.*;9_$N1^1R"T=<7#T^=)(
MO>7U=AS6JU6347<U\O1>E=&TW2\?)@MB*[YXSZ6RXZ^&RO!U./J,>6T\ZL0
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MT8VII:ORGOG1.DV]-TT8HW[YGMK]CYO\2]?OZSJ_BSLLB.6V.R(X^EHWS/\
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M.W9LG;],S1I*GOJOOS2/D>OT?$=JTZOG&TC=$=CDIBMUT\;IF?-7AWU"0
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M*WO*:1WW-P5D2B(@4H@
M
M
M             ^6YACN(9(9&ZXY45LC%Y*B\%1?40EQ]U'\J.$S-Q=9G8M\W
M;&2N%=+)AW,UV3WJM7:.V/4O/YOXIQ?6/!FFULSDQ^Y=/JF7H_0/F)J=#;;B
MU,?$LC9V71'UT<WY/R]=:\5*K&[;ARS&>Y/C[ICT7VH[2J?<.'S^ M=CGW8B
M[S3_ (/0=+X_Z/GCWKYL\\?8EL/+SUFRTS6Q[7BQ:/\ \HN<A>1PM97GP;K<
MOL&#P+K\D^_$1YYA1JOF!TK!'NW3?YH^UT9T]\J.%Q$MOE=_7K=T7=JJ21XB
M%%CL6R(J*B/1>,BM5?8O:AVW1O!6#1S&3-/-?V<(<)U[YC9];%V+2Q\.R=DS
M^M3S\'8=JR**WBBAC;'#$FB*)J(C6HU*(C43A1.1VL1,;*4>;3=6:UJ^B9VE
MJJJT3M)4UB-[ =Y;#VSU!Q/V+N?&MNH:Z[69BJV6!Z(NB2)_-%2O):IZ4,+7
M:#!K;.3-;S0V/3NJY^G98R::^;9]OG<4;L\I&\\3++<[)S-KN&RXNCL\@OPU
MTUOH1]-"^K@AYYU/Y?UK=IKMG9/VO6>D_,[%?$6:VSEG\5N[SS#6$G0KK-'<
M.@_0>X>YO]_9+&Z+Y':D.<N\#=0B?NQZW2V^.NC3_P"K/JEF6V_*OU-SMU N
MX;FQVGC7\94=,MW=.3T-CCHC5]KC<:#Y?Y[I_?71;'=26FZC\S-#@B8T]LWW
M=\4AVATRZ.;1Z76\CL1:OO<O<MTWV<ND1US(B<%:VG!K?4VGKJ>B=*Z)INFV
MTQ1MIMF=\^78\HZ]XEU?6+^;-/NQNMC='EVMQ1U\.KOO^@V]*-!52D8OB:DT
M^Y1JKS)3$SZ'+?4_RQ[6WE>76=VU.FTMP72N==OBCU6EP_L5\;516K7GI.5Z
MOX1TVOGFM]V[NXNZ\/\ CS5]+L^%DCXF/A$[X\TN5LGY<>LF&>Z.'#6N?A1R
MZ+S'72.1WY43]+VK]TX#6> ]99=[D1,>AZ5I/F'TG416^Z;)[)CZWQ6/0+K1
MDG:(]H_9RIP6?(7#(6)7T*BN6B>PLXO FONG;$1'G7<OC[H]D3//-U.$1+?N
MP_*);6TL>5ZCYE,HK41SL!CE<R!:]DDR_6._8Z3LNE^!M-I_>SSSW=G!P_6_
MF5FSVSCTEO);^*?O.R<7C+/$VMMC\=;QVMA:L;';0QHC8XV)[J,1#N<.*S#;
M%MD4AYCEONRS-]]TS=/:\M]^;EP6U?-3O7.;DNULL1%!) LS(];M;HHUY-X\
MCOL&//EZ79;;;Y5>#Z[68=)XGRWYII%/JB?J96O6KI3\_=DJM9W8E2T?[O9R
MH:^>D:OLAOX\6=*F*_%F.ZD^OTG]-/2C_BR;_1)/UR/Z1J_PPJ_NOI7^O/JG
M[$/Z:>E'_%DW^B2?KC^D:O\ #!_=72_]>?5/V)OZ:.E/_%4O^BR?KC^D:O\
M"?W5TK_7^B?L2_TT]*/^*YO]$D_7)_H^K_#"/[JZ7_KSZI^P_IIZ4?\ %<W^
MBR?KD?TC5?AA/]U=+_UY]4_8C_33TH_XKF_T63]<?TC5_A@_NKI?^O/JG['S
M7_6;I5+C,M;Q;FEGEN;&:*&%+5R?6.8NE./K*\73-7COBZ;=BSJ?%/2IPY+;
M+YFZ;)</PJK88M2HQRHM$IIU'8Q-UT1S0\8LNB;+9C96OMFJMW?I?>"JG?\
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MZ7L='[C/8AP<[WOENY5*50
M
M
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M^.5=GA3I5DUC#:W@B(U$3L::^KHJ43$)
M
M
M
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M10%4$8Q.3$X>H%93A
M
M
M
M            4G,5W)W%"8HA9+=^-2SO9+>Y:ZS;)*ES*CW+I=\_O5[M/4)A
M1%+8E\\DV'2QQSY;UK+)\T;;";Q7IXDBKW&ZM5757L4G<INOLI%9H^WQ+),C
M"UUQ3(NC?HM?$7C&G-=/+@O:1P55MYZ5VEE)8.N[YMK.DEPDB?%Q>(Y^AWY*
M\&_()@LFVLT7LA<
M
M
M
M                                             !\[GN:KJ)5."-1"
M8@G91B]MD6_969N?L.>W;92W+78QS6Z[GPDJKV)[J^)V%5-L,:W-6RZ[EG97
M9VT4KF_C9C,%-^CL\B7L\#&6#6LK9^)_?'IR31VT*K<=9F*[E%^:.2RZ;)VS
M&SLKV^9<OB$7,06OP,CW26CYVY5K$2-J->UOAK\ZKZU**3RUJOS=$9>7EX5K
MP\R7%W;+F]S+&XJ7'K:721.NY&M1+I4;76S3Q5.-.(NBD0IPY>>Z^.68I-//
MWPR4I7P
M
M
M
M                                     ?-,BNX42E/>4JBB*378QZVC
MW$VPRJW,N/=E7R3_ &2^-DR0-C_O"3(JZE5$][21LJM6QJ.2:S;S;>7?3NK]
M:2:/="8_#MMI\8E^R:)<X^1DJQOC_OJ6Z(NI'>C45VS96:Q.[9YU%T:CEMVV
M\U8YMDTIW?4^SP\M]K,>BVWV+X#E?&B2?$_$:TTJBU\/3IK5*>@M6\G+LWU]
M"[/Q(OV4Y:>FO=W40Q_VREWDW9!]G+:/G3[*9;I(V1L-./C*Y5175^B573%(
MIO1CC-%T\].6ONT[.]D1"Z
M
M
M
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M'X6=%MF
M
M
M
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MVW<T<TS%(NGMB9WQYFQ2TV
M
M
M
M                                                     /FD5Z+1
MK$7NKWE[!'>BZL;F"6%_O>7;^>GOL#C[;/P37*8'&,N'K#<Q,7ZA\LBIJ:K^
MVG(NS&/FBDL*S+J9Q7W39$716D=KYKO)=0(\#M>>RVYBY\_<W5LW=..ENGLA
MM+=U?'?;R:>^Z/@J(I5;;CFZ8F:1[5C+FUD8L4V8[9OFZ.:)FD6QQF.V8[.*
M[RW.Y6[KL[:'&63]J/L7/O,S).Y;MEUJ1(XFPTTJU6U55J6[8Q_#K7;V,J^_
M4?F8MBR/A\LUNK[T3LI$13US5#!7>Z9\KN:+/XBRL,;;7S6;;NK:=TDMU;:4
MU23M<G<<BUX(+XMB(I*-+DSWY,D9;(MMB?=F)K-T=L[-C-RAF
M
M
M
M
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M1=;9$64[9[>\T6&['ERW79IOBZ=ELTIC[H;&+38
M
M
M
M
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M@MI?%W[R:3MN]/U-Q&,W0
M
M
M
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MU&7+FC-A^';;=[MWXX[>YL\QFV
M
M
M
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MU:Y55:\.)3J+L,VV<EDQ,;]N]/3,&JQY<TYLT7VS=6R*1')'9/:V@8[;
M                                         !\BRR:GHUJ.1G/CQ_ 1
M-8*2K:W_ .#I^R!M5$KVDB(     45D1'*G&C>:T":)M6I*(G%>Q2GFBM"B"
M/U.HG*A),3"J2@                      I*]$5R4JJ<1M15.BU2HVIJF
M
M
M
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MW8LEG)DB*[)V3&SV3Y]E)XT=:([5R]!HW><$X
M
M
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M
M
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M\\>UJ>O_ .WY_P#MW>QX/=C?9^J>NOCZ7LCY1OZA]E_YUDO^VS'F?B'^<O\
M-'LA]/?+?_9,/GO_ .J6K_/%L5,IM? ;[LH46YVU<+8Y9[4[RV=YP:JT[&2<
M>/I,SPSK/AY+L<S2L;&C^:G2?C:.S56Q[V.:3V\MWV3[7F5!.^VN8[J"1UM<
M0/1]M*QU%8L:ZE<W]0[Z,7Q(Y)W3;/V/"\5\X\EMUFSDI._?3?2N_N[GNSTB
MWI'O_IWM;=".1]S?V;6Y&G9<P_5S-^1R*>2ZW3_ S76=DOK'H'4XZCH<6HC]
M:(KY^+9DB]Q>]3\8Q6X>57G<WI)E]^XC9MM=5L=KV'CW\37(K5N[NBHJHG:U
MG#U<3N_"VEY,5V:>.QX/\T^I3GU-NFMG9CBL^>?LCZY<L=/]J7._-Y;>VK9J
MY9,S>);WKFHY=$']^=^UJIO^HY_R^'XCS[H72[^I:O%@B?O36=^S]/VO>C&6
M5KB[*SQ5G"D5MC8(K>V@:VC4CB:C4T]G8>37W<]TW3VOK7#9;CLC';NB(A<X
MT:D;4[!*N%4A*"K3BH&"]1-VVFQMD[DW;=249A+*6>%O-7S:5;$VGXSU1%+V
MFPSFRVV1QEK^J]0MZ?I,FHNW6VS/IX>N7@M?Y*YRM_>9>_5US=9":6[O)'.6
MJR3/<Y^IWM53UW#AC%9&+A$/D3-GOS9K\U\5FZ9F?3/UNOLQT.^!\J^&WFN/
M5-U0W_V]?O1OUGP%W2)8W]M$:UCOOG+XNK3/4OAUV?=]/:]1U/A.,?AB-13]
MY7XD[-O+=LY9X[/=KYJN3<!G+O;&=P6Y[/6EU@[VWO8'Q*Y'.9"^LB>CBU**
M=)GT\9\63'/%YSTW67Z+58\MDTF*3-*[:;9VSOKNGAV/?7;F>L=S;?P^XL>]
MLMCFK.&[@<UR*W3,Q'454X5;6BGDF7'..^;)WQ-'UOH]5;J<%F:R8FV^V+H_
MXHKO9$BI2J<BVR=RS96_Q^)L[C)Y2[ALK&QB66[O;A^F*-C>+E555$0JLMF^
M[EMBLRMY<F/%9.3)-+8XSLAQ#O?SO;>Q5^['[*VV_=,4+GQORTTJP1:F\E8U
M&*YZ>O@=1H_#%^6*Y+N7T/+^K_-'3:?)\/38_B4K6:TCT;)JPG%>>V_^-M_M
MS8EM-9JY$F6QNE2X8SM5K'MHY4]"JAE7^$>:V>2^LM;A^;5O/;&73\MM=LQ=
M6GT+UYD.IFT^J70:USFT;];N*/.VK;^Q?1)K1ZHM6S,5:I2O"E4XEGH>AR:3
M6S;='#T?XLSQOUG2=6Z+\7!=S4OBO;&_?&^CB+I#_6MTZ_\ F&P_C4.JZC_*
M7_LO(_"O^Z:?_N6^U[XGD[ZV<2;T\YFW]F;MW-M.YV9?7EQMS(S8^2[CN&-9
M(Z)417(U6+1%7LJ=)IO#.;/CMR1=%+HB7FO5/F5IM!J<FGNPWS-ETVUB8VT9
MEM7S0;%S^R<COO/LEVGCL=D$L(+:>5DUQ<2*S52!C$34JUXF%GZ+GQ9_@Q%9
MI6O#UMQH/&^BU&AG69JXK8F8BLQS33LB*U:&SWGL<E_-#MK8[9;)*_"W.1N%
MCG>C?G+$Q'(VOH-SA\)S-M<E])EQNL^;6.S+-N##SV1QF:5^SO[&2;"\[F'S
M&5M\7O7;SMN0SN;$W-0R^-$V1SD1K9&JU%:E.*J6=9X7G%9S8[^9G]'^:6FU
M6:,>?'\.)W75K%=FR?MJZ:ZE]7]C=+\1:Y;<^2;7(HCL3C[3ZZYO$6E'1QM6
MNGCS7@:+1]/RZK)R61M[]D0[OK'7]'TO#\3-=6NZ(VS/FCRAQID_/7DUN)XL
M)L&WM[5'JEK\9<*^61O8KD:B(U?3Q.DQ>%)I[]VUYAG^;,3?,8<-8[Y]5?2V
M5TN\Y&WMX9FUV]NW#)M6[RKF08O(LE\6UDE=PT2:FIX5>S@86O\ #>33V<]D
MU[N+?>'OF3I^HY8P9[?AW=O#UNWXW,THK7(K=**CDY*GI.;IVO2H[8<W=:O,
M)BNC66P^/OMN7.:ES,3IF30S-C:UC."UJU3;],Z/DUU9MG<Y'Q/XQP="FVW+
M;=/-V+!TD\TF%ZK[OBVC8[9N\7/-:S73;J23Q&Z8M*K6B(O-Y<ZAT#)H\?/=
M,,3H'CS3=7U7Y;'9=$TF=O9VNG,I?)C\9?Y%S%D;96LMVZ%/G>%&KZ)[:&DL
MMFZZ+>UVVHR?"Q7WTKRQ,^K:X03SY;<=;I(NR;]SF-1SW)(U&UI557NG5?VG
MEIS5BE'EG_RKI8B*XYK/EV-V9;S,[#V]LG ;OS;Y8+W<ELMQC-J0JDU\ZBJB
M:D1*-:J+6KC58>C9LF;X<<)WSN=7JO&6ATVCLU%\^]?NMC;,SV=WGESA?^>[
M+/N+A<9L"""U:J^"EW=*KGIV*]6I1GLHIO<?A6?UKW Y_FQ=-_+BP;.^?;V,
MSV!YU]OYW*VF'WMM_P#1B*_D2TM\S;RK+"DSETHDC%1%8GXU:&+K?"^3!CY[
M)KW-ST3YFX-7F^#J;/ASV\.QW9;3PW-O!/;RLGADC:^&2-4<US')5%:J<%14
MY*AS$Q,32=[T^VZVZ(FV:Q.Z6GNM75VRZ-X''[@R&,GR\%_>):-@@>C',<K:
MUJM3/Z=H)UF3DMG:T/B/Q!CZ-IXS9+9F*\&CMG^<O!;NW7MK:\.SK^S=N*^@
ML8;U\S)&M=,[2CE1$1>:>@V6K\.9=-BNR73N<MTKYE:7J&KQZ:S'=;-\TK-/
M,[36B4T_5M<FEK:'.UI#TGCM:"ZK^8/872-[<=DKF;+;BD:DC-OV-)9D1>;I
MEK2-*<>/8;/IW1\VKV[H[9^KM<IX@\8:'HWN7SS9/PQMGT]CE&Z\]^<<Y[K+
MI_:P0*_1&V:Y=(JHOSE<QM-7JI\IT.+PG7[U[S[+\VLD73\/!$Q7C/UPR#;G
MGNLY+AD.[MB/M[=4XWF-G;.]/;"]K5^^6M1X5NC9CO\ 6RM%\VM/?/\ Y&&;
M?-M]M'9/3_J;LGJ5C69;:6:AOXJ5?;JJ13Q^E'0N74E%X55#F=7H<NEOI?'V
M/3>E=;T?4\?/I[J]W'U-&]3_ #5X7ICO?(;.OMJWN5FQ[()GWL,S6LTS-5=7
M'G1*&TT7A_)JL/Q8NBCENO>/]/TC63ILF.9GW=NRFW[.+R=R5VR_R>5OVL5J
M7EY/=1QM3OQI-(][4]UONZCT7',668[>,1$/G76WVY<^2Z-UU]TT]=/*OH=C
M]$_--A.EFP,=LN\VO>Y:YL99YI+N-[48[QG:JI5%YG+=5\/Y-1J;KHFD/4_#
M/S!T_3-!;@OLF9MKN>B/37>UMU(V1@=Y6UH_&PYRW=*VQEH]6Z7JVBKVK5#C
MM7IYT^6<<S6CV/HO5+>I:2S4VVTB[:YGWAYR\#M+=6X=KS;-O[Z3!7;K.2Y9
M*QB.<WFY%6M$^0W&G\/9,^+XD2X?J7S(T^BU673WXKIY/I\N^C8.TO,WL3/;
M!R74/.N_17&XR]FL([*XE26XN'L:CD;"QJ5>KE6B40Q]9T/-ASQCM]ZL<-S<
MZ#QMH-1H)UF2>2V)I2=_FB(WU:DPOG,BW7O[;^UL!LE8,5F,G'9.R>0N*3(C
MTX+X,;52J?E&RS^%\F#3?&NNX;OMXN=T?S+Q:W7XM-AP^Y?,1S3.WT0[IN;J
MWLK>:YNIH[6VMV+)<32.1D<<;.:N<M$1$3TG+6QSS2-[U&Z^VRR;KYB(CBY"
MWUYSNFFVI+FRVU:7F\LG"_PWOMD2.T5R<*^._P!Y.RJ(;_2>'=1FMBZ[9;/K
M]3S[K'S'Z?H;KK,<3DOCLW?\S2,OGMW!K>L.P[%C5[S'.N7K1OK=H2IM;?">
M*=V28<G_ /+N2)FNEBG#WI^SZV9[6\].'N+R.#>NTIL%CWHU%R]E-\4U%<NF
MKXM+5TIZC%U/A:ZVVN*_FGR]K;=.^:N#+EBS48?AQ.Z8GF\]=D;G<6W]PX#=
M>,L]P;>RD&5Q=TW5;7<#];:=K:)R5.U%.8RX+\-_+?$Q+U#2ZO#K+(RX;HNM
MGC#3'6_K_C.C5SM^TO\  W.;7.,EE8^%R,\-(>?%:4-ATSI%^NB[EG<Y[Q-X
MLQ="Y/B6S/-V/*[K%OZ#J9U"R^\[2SEQEME(;>)MM)WE;X+$9Q5OL/0NFZ&=
M)@C'<^?/%'6(ZKK;]39%+;HIQX1YFS/+UUWQW1>+=4-[@[C,OSKX)X?!>B:4
M8FES5JB<4-?UKHU^OMLNB6\\%^+\70[,L7V5YIC[.S@]$^B76RPZT8S<.0Q^
M&N,)]AWD-HZ*=Z/<]9HO%:JJU5X)7F<5U3IEV@OBVZ:R]M\,>)+.O8;\F.V;
M8MNIM8GU>\SV(Z0[JBVM>;;N,O<2V<=TV>*=L;422O!45J\J&7T[H.36V?$M
MNB(G9ZFL\1>-]/T3/&++9=.R)K%.*OT9\R.,ZS;BRV!Q^WKK"2XC'ID)III&
MRHY'2HQ6HK43E4M=3Z1?H8B;IB:]BYX7\:X.N9[L>*R;8MMKMIVT^AT[JU-:
M[3H:_P!Y?P&FB=E9=EQAJWJ1UAV)TMLH;G=F52*XNDK98F!$DNYE3C5L=:T]
M:F?HNG9M9=$8X^QINM>(-'TBSFU%\1W;)NGS0XUS?GMD6YECP6Q86VC7K\-/
M>77ULB)R58VM2GLJ='B\)S/\6ZDO-<WS9MG)-FGT\W1PF9HEQ/GOODN8VY?8
M$#K)O^4W%I=+JC_8JPN7>$;^%ZC3_-F>>8S8)BF^CK_IAUJV%U9MFS[9R:,R
MD+%==8.Z5([R-$YJD=>^U/2AS.OZ;FTEU+HFG;P>D=#\2:+K%G-AN][\,[+H
M]'9WMQQJU6MIV\J\S!K5OJN>.N'7W'=%KC;L>0P$^:7<3)_#2&1&:5MZ+VUK
M74;7IO2;]=,Q;-*.3\4^*\?0K;)OQS?SSP8)TV\VFWNHNY[?;2[:GP$<EI/=
MW&6O+J-(H&PL1_><M*5K3GS,C6=!RZ:)G?YH:OHOS!TW5=5\#X<V129YIF*;
M-M/+O8SOSSL;/PEVZPV;A9]XOAD6.;(N>MM:KH6BK$JHJO3T*J<3)T'A?)FM
MY\EW+$^NK!ZQ\SM)IIFW36_%F)I-9Y>-*QLV]W;W-;0>>[.MG5UWL6RDMD?1
MT<5R]LE/G4<K52IGSX1B8I&2LM)_\N3$Q734BO;ZZ;'8?2;K=L_J_CKB?"22
M668L$1V2P=S1D\*N7@YJ576U?2AS74.E9='=2[=VO2?#WB?2]9QUPS[U*S;.
M^.'ICO;T->Z$
M
M
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MDE^.^VZ-DUX=[V4\IV?O-P=%-M27MTL]QBI;JP;*[FL$+W)$GR,H>:>(-/\
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M*N@F>]=\ ZJ_3=9P4C9=6ST7;?L>W1YF^GP
M
M
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M&\4?SGHA[U\L9_\ T]O[5WM8YYZ/ZNML_P ^)_$O*O"W\S/F87S6_P!NQ_\
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M'E_9AY#X(_WC3QPYWNF>6/JL
M
M
M                %IO%E8R=UNUCKI4_D^M5T:T3NZZ<:5YT)MBN_<INBZD\
MGWJ<7-V"R'F138>_)LO@L,S><-]39-JBQI%):O<GBNDTNT*K4XLK2O:;B^W1
M1FQ1%WNT][?Y>IQF#+UZW0Y[K\=GQJ_NXB8I3C7AYJTJDSE_YC(MB]-Y=OX+
M%S[RDD1=]6DRL2&+EH1%551$[7*Q>'83@LT$ZC+%]TQ9PG>G6W==MT>G^#;9
M.;_U*_=]'97NW=[,9KWK-_2_B+:VQ6.=TJDQR?;>0<]/&9<^$]7^$B]_A+I1
M$5**VIBXHT=VDNNBZ?B<VR.%*_9]+8W7=5CJED<MOY;D]Z=E>:G#C]ZGH1Z7
MW/6"YW%O=G4K&X^RPR7NK:TMHK5<Z.JHE-*JJMT(U55_'5ZBK76::,6/X4SS
M4][RGCYD=#OZK=FS?G;;8Q\WN4W[Y[.%*;]M:M\&M=(     !))[CO81<-7=
M8OZK^H?\QW7\696B_F+//'M:CK_^WYO^W=['@[V-_)/7GQ_+V3\HO]0^S/\
M.LE_VV8\R\0_SM_FCV0^GOEO_LF'SW_]4NH%:U7:NWD:5W#F7S4[!3>G2;*3
M64'B97:+OMC&4JY^B%%^(8QJ<U?'5**;?H>IC!JK9NW3[>#CO'71OZCTR^VV
M/>L]Z/KIZ'C51%7A5'(Y&M9^-7U^AW ]1_B6717?N?,5O--\UK6*S]D>MMOJ
MAU3O^IK-EI>L<Q=I8*'%2ND54\:XJCI9$1O:M$^X:GIO3ORLWS^*:RZ?Q)XA
M_J]NGMG?CQ\L\*SLC='?M9+Y9]B/WYU;V_:20I-B-N.7+Y5KE70UD+T\-%I_
MA)*(8W6=9\#2S/ZTUCULSP%T>>H=3LB^VMN+WI[*V[OI>UJ1,K5&^BGR'FSZ
M<50  #GSS+;]CV!TGW'>PR*S*9F%V)Q#&4UK+<M5JJGY+-2U-GT?2?F-5;$Q
M6V-[EO&/5HZ?TW+=6EUT3;'I^S?W/%%42BHG%%:U72-X^[V_MCU.DS%(BM-G
MH?+%ON5W3.^-OG]>^-BF^6W1SW^,Q_B\'1*ZJ-7U_<*.:+XC9&Q%DS2DQ,1Z
M:>;O]:AXD';X2IVI5"OFCN]2.6Z?*7T-6%')$WX=B-74RCD:YSE_%;4732[E
MFDSY>9<FVL1?6FS;OV[?3[%1JR1HUS'>'<12*^*X3WDD;I<W^Z**QELNB=^Y
M$7TB+[=_-7V/<SHKOF/J'TSVGN7Q46\=:M@RK:HKTN;?ZN1'IZ7*B+\IY5U/
M2?E<]V/AP]KZS\.=4MZGH,6>V=LQM\\;'E+YD<+)@>M.^;>:*1K;J=M[!,[N
MH]D[&R*J(G-*U:=_T/+%^CL[8?/?CK33INL9ZQLOF+HW[IX>FDQM;N\F'4RP
MVWN7.[%S%Y!81[H\*XP<[U1K'W<351T;U6J(Y6:4:GZIJO$VCNRVVY;;:S%:
M^9UGRNZQBTV3)I+[HMYJ3'[7VTV4^NKU"\1Z:.Z]41*N7A7V4.&YHX[WNDQ-
M:<'#WG>W1@4V%C-IOR<3MPWF3AO&8ME'2-@A5=3WZ5[J(GI[3IO#.+)&;GB-
MFZKR[YI:[!;H;<$W^_==$Q$;Z0\_ND7]:W37_P"8+'^/.SZA_*Y/V7C?A?\
MW/3?MV_]3WP/)WUJ\(NN_P#71U2_^9;[]VAZMTC^4Q_LP^3O&7^[:G_N7>UW
MEY%_ZNMU?SXG\4AQOBK^:CS0]A^5/^VW_M_5#N1GOK[&G,_K/49?G@R_^NLO
M_.-W_'2'LFD_AV>9\9Z_^-D_:E[!>4#^I#;O^>WW\:IYKUS^<O?2?R[_ -DP
M^>[VRWIU!_W"WQ_,&3_[+(:_1_Q[/VH]KJ.K_P EF_[=_P#TR_/I#_D[/\6G
MX#UY\=7?>E[M]"OZHNG'\RP?A/).H?S63SR^NO#/^V:?_MQ['$/GR_WEV/\
MS?/^[0ZWPA]R]Y1\W/XN#S2UYY*_Z\+?^8K_ /\ L9F>)_Y*/VFD^6'^\_\
M]N[ZGJ[NC_=K<G\V7O\ $O//L/\ $M\\>U]":_\ E\G[$^R7Y[(/S$'^*9^
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M_P ^Q_N'G7=:_E,W[,/'?!'^\:?]M[JGECZK
M
M
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MN*HGZ2WJ?W:'JW2;9_*8MWW8?*/B^RO5]3[T?Q+O:[T\BNEW3S=*<41N<_\
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MMO2QFJJIG8J(U=7-CN?L.NZ[9-NBR3LK2CR/P59,=9T\5C[T3O[GNH>5OJ<
M
M
M                                                   %DRZVS;&^
M?>1K+9I"[XR-K5<Y\6E=2(B<5JGH)QQ//'+OE:SS9&.Z;]MM)K#@C:F9\OB]
M'>LEQ8;.S]KM5F8CCW?C)=4MS/.Z33;.ME1:-:UU%I\WFXZG-CUD:G#;==;6
MDTV4COKV_6\LT>KZ%/2]9=&*^W%$Q%\<9FM+>6=T;?\ EWSO4-X9WR^1=*^B
M\V;V?GI]OW#Y5VY:Q-5+B"-CD2Z^)E1%;+J6E&MXOYMY%6EP:^[4YHQWV\W&
M>[NCR[V-U+4]!MZ;HHR8LDXYGW(C?'XN:=TU[ML[X;2N<ET>=YF-K6+]MY5O
M43[$A=B,SWTLHHOAGK"CHNQR0:FZJ\.2\3!MPZO\A?=S1\/FVQQW_;M^ET5V
M;IG]P8H^'?\ F)Q^[=^I$<NRMO;R[*^B4WE[R72._P!Z=2X^GNW<IA<O'?.7
M+7%ZBK',U)'(_P &OYOZQ7+I=Q7FG =6MU,Z?%\6Z)LG=$1M]/Z-AX0U/2LN
MLU7Y/'=;DK[TS&S?^KV;:[)VNQ30N_      @J(J47D$K/EL3;9O'7F*R#&S
MV&1A?!?0KR?&]*.3Y4)MGEFL+67%;EQS9=MB8HU(GEMZ))__  _L/VTW[XV'
M]6U7XY<U_9/1O_;6>IL?;>TL-M##0;?VY9Q8O$6SG.MK-B*K6)(Y7/Y\5JJ]
MIA9LU^;)SWS670:/18='AC#AMY;8W1'#BREC%8VE:\54M1%&5,U2R,>Y6JQ^
MBB][UH34:SW3T@Z>[XR4>7W;MBTS&1BA2V9</1R+X2+5K55KD5:4[3+P:W-@
MBEEU&FZCX?T'4;XOU&*+YB*;6-/\MG1-[:+L&Q:J]J.EJGRJY4+W]6U7XY:^
M/!G2+9K&GMB>VFUMK"8:QV_B['"XJV98XO&1-@L+2)JHUD3/=;Q,#)?=DOF^
MZ:S+H\.&W#CC'9%(C<OI2N@ "@]CG.145$I2J*1&\:;R70+I)FLED,UE]F66
M0R>6G6YO[UZR:Y)5K555'(9V'J6HQ619;?,1#0:OPKTS5WSDS8;;KIXRO&V.
MC?3?9>5;F]K[5M<1E6Q.A2]B5[GHQ_O-34Y42OI(S=0SYK>6^Z9A<T'ASI^@
MR_%T^&VRZE*Q'"6RTB6K:K[M%T^PP:-Y,U?05(2HE.?$#4FX>B/2[=67N\_N
M#9]EE,Q>JCKN]EU:GJUJ-;54<B<$1#+Q:_/BBEEU&EU?AWI^KRSES8;;KYBD
MS3?"AM_H3TLVKF++/[>VG:XK*XY56SNX%>CFZTHJ55R^]4G-U'49K.2^ZL&E
M\/:#29(R8<46W1NHVVD*Z_$<ZKE2E4,*D5;IJ'>?0;I=OZ[DR.Y=K6T^4DK7
M)6ROMYG*O"KG,5J*OM138:7JNJTVRR_9V.>ZKX4Z9U.>;/BB;NV-D_11A>'\
MI71+#W$-VNV7Y.XMWI)$M]<S2QU3DBL5R-<GJ5#)R]>U=\4YJ5:S1_+_ *-I
MKHF,59B:[9NGVRW#N'I[L[=&#MMMYS 6E[A+.1LMEC%;X<42QUTJU&::4XFN
MQZG)COY[9I/:Z75=*TNJPQARV1..)B8MX5C<PNP\O72/$Y&VR^-V996N1LIF
M7-G<(LBK')&M45$5REZ[J>JNMFWGWM9A\)]+PWQ?9AMB8F)V=L<6[C"=$TWE
M^@_27.Y3(YG,;+M+W)9>X?<Y&[D?*BRS2<7.5$>B56G8AG8^I:C';%MM\Q$;
MG/:GPITO4Y+LF7!;===-9F>,][+-H;#VQL*UN,?M+%PX7'7<OC3V<55:LFG2
MKD5RJO%$])CZC/?GGFOFLMETWIFFZ=CG'I[(LMG;2-U68T?551W%?2A9G<SX
M[VC7>6_HR^:2>79%E++/*Z>>1RR55[W*YR\'4YJ9_P#5-3$Q2^E'/_VKTV9K
M.*)G>VCM;:>#V9B8<'MRR9C<5;O>^*TCY-61VIQB9L]^:^;[YK,MQI-)CTN.
M,>.*6QP7J]L[;(V5WC[V))[2_B?;W4#N3XY6JU[5IV*BJA1;=-LQ,;X7,F.W
M)9-ET5B8F)CNG>TNGELZ)(UK$Z?V&AJ43OS?OS8_U;5?CES7]D]&_P#;6>IM
MK"X:SP&,L\/C&-ML;CHD@L+9J<(XV^ZU/8G U]]W-=6>+I,&&W#CMQV12+8I
M'FX,3W?TLV-OZXM;K=VW[;-2V+'1VCY5=W6KQ5."IVE[!J\N")BRZE6%U#H^
MDZA3\QCB^G:^';/1GIQLO*,S>U=K6F&R<<#K=+J'6CO#?2K:JJ^@KS:_/FMY
M;[JPM:+H&AT63XF#%%MU*5CL;$N[*.[MYK69&OAN8WQ7#%3WVO:K53Y453$B
M9MF)AM9MBZ*3%8:53RS]$T:U/T$LET4TK5^JJ)I3YQL9ZMJ?QN=CPCTO_1M\
MMC;>!V]B]LXNSPN$MFV&*L&HRUM(^3$1554XF!??=DOFZZ:U;[3:>S3XXQXX
MI;&Z%_5&JE%Y*0NM'W7EWZ0W][-D;S9=E->W4DD]U,KI$622155741R=JF9'
M4]3%L1S[G.Y/"72\E_-=AMF:S/K;$VKLW;^RL6F&VSC8<3C62.E2UAJC=;E[
MSJK52QGU&3/?S7S66XT>AP:/%&+#;RVQ-:/FW?L':N_+*#';MQ,6:L;6=+FV
MMY=2(V2E%=P5",&>_!=6R:2HU_3=/KK(LSVQ=;$UI+"<9Y?>DN$RF,S.(V=:
M663Q$[+FPNVZZQ2,=J14174YF5?U/49+9MNNK$PU^'PST_!=;=CQ1$VS6//6
MK<?A*O%7\>2=WEPH8$-_,L3W1L/:F\HF0[FP%CFHHT5&ONH6ND8B]C).#FHO
M:B*7\&KS:>:X[J2U^OZ9I==;RY\=M\1VQ];1]_Y/^B%XLCHMNW%BZ1VMW@7D
MZM3V(YRT-I9XAUD12;JN7U/R\Z-GFLXIM_9NF&1;<\L/1;;4\=W:;-@OKN-N
MGQ\A)+=HO["1SF?W)C9NKZK+ON9V@\%])T41R88F>V?>GZ6\H[*&"*.WA:D-
MM C4@@8U&L8UJ41K43@B(G8:Z9F9K+I^6*1$12(?8K'*G!4^5"G:JF>Q@.]N
MF.R^H=@EAN[!0Y:)G&"1R*V:-?5(U4?\E3)P:K)AGW+IAK.I='TO4;.748XN
M]OK:9M_)[T4@F65^#NKEM=3()+J9&M]56JBJGM4V5WB#6712;MSF<?RZZ-;-
M9QS,=E?+Z706V]JX':&,AP^VL7;X7'0<66EM&C&*Y>;E1.*N]*J:C-EORW3=
M=-9EU^CT6'1XXQ8;8MLC=$-?9GH!TESV2N\OEMFV=Y?WTZW-U<O5VI\B\W+Q
M0RHZGJ;;(MMNI$-9J?#/3]3DG)EQ1==,UKWLRV?L3;&P;";%;3Q<6'QTTJSN
MMH:T5[N:U6J]A8U&IR9[N:^:RV.@Z?@T..<>"WEMK,^F=[-RRS'RI"B*J.74
MWFVO/C^H)CBB&CMW>7#I'O:XDO\ +[5C@R4SG/=D+&22V?J=Q55:QVA:^M#9
MZ;K6KP;(NK#FNH^#NE:Z:Y,,5F:UC9[%LVYY6NB^V;RWR-MM1F1OK=&^%+DI
M9+F.M:ZEA>JQJO[$JS];U>:*3=L6M%X(Z3I+XOLPQ,QV[6Q]T=+-B;TCQL.Y
M]M6F4AQ".3&VZHL<<".HBZ&L5M*HB<##P:S-AK-MTQ,[^]M]?T31Z^VVS/CM
MNMM^[$[HGMA;]L=&.F>S<M#GML;4M<3EK=DD,5["Z151DR:9&T5RIQ1*<BO-
MU#/FMY;[IF&/H/#73M!D^+I\-MEVV*QV3O;56M.',Q&[EB^Y-I8'>&,EPVY<
M9;Y?'S+J?:SL14:OTFUXHOK0KPYK\-W-9-)8VMT.GUEGP\UD76]DM"2>3WH<
M^Y;,W;]W%$GO6;;Z?0[[KZ_?-O'B'6?B^AR,_+KHM?X7_P!4_:W!LCICLKIW
M:NL]GX&VQ$4C=,SVHLDSTKJHZ1RJYR:O2IK=5K<NIFN2:NEZ7T;2=-LY-/9R
MP^#=?1OIQO?)+F-U;9MLQE%B9 MY+KKX<==#51KD2B5+F#J&?!;RX[IB&-K_
M  WT_7Y?BZC#;??LBL]D;H\T55-H])-@[$R-SD]I;>ML-=WL*07<D.IRR1HY
M'T57*M.\B+P+>HUN;46\M]U=M5WIW0=#TZ^Z_38HLFZ*33C26Q60.2CI)*N1
M%6B<J^DQIC;5N(FE8?+>XRTR5J^RR5K;Y&RDX26UQ"V5CD];7(J+]P8YFR:Q
M.U:R8K,MLVY+8NCLF&@]P>53HMN"ZGO9-K_9US<*YTCK&9]NU7._$;W?O&UP
M=;U>&*6WN3UO@/I&KOFZ_%2?\LS'L4\+Y4.B>%N(KMNUOM&Y@]Q;RXEE9\L:
MN1OWBO)U_67;KZ&C\!]'TTUC#$_M35O['8C'XJSM\?C;2&QL+:/1;64$:1QL
M3U-3@:B^^Z^>:^:RZS#ALPV19CB(MCA"Y,9HC1OH"ND1N8!O3ICLGJ#+92;N
MP,&97'M<VQ=,KT6-7TU*FE4+^GUF;!7DNI$M9U#HVDU\VSGQQ=,5I7A7L6C;
M/17IML[*P9O;>UK/%Y6V8K(KV/6K]+N#O><M.!7EU^?+CY+KJPLZ#PYT_09(
MR8,46W1%*PVFL-5:JKQ8JK'\IA3$31NHHQ'=VQ=L;[L8<7NK%09?'P2I<,MY
MD]V1..I%JBIS,G3ZG)I[INLFDL'J'3M/K\7PL]O-;6M&%8;H%TIV[E<=G,'M
M"SQN5Q=PVYLKN)9/JWLJB*B*Y4Y.+V7J6IRV39=?6):[!X6Z9I\MN7%AMMNM
MF)B>RFR/H;K,)OP
M
M
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MY[=3@C'CK[LQLKM^FN^KIDU#K0
M
M
M
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MNR:N,ULW?=B[FY?/^']EU@:5VP
M
M
M
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M\Y]Z0
M
M
M
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MP
M
M
M
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M5."M5.Q2FET3,7;)56W6WQ%ULUB7WA4
M
M
M
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M52G90T_4;LEVHOG)$6S7='!V'A['AQ]/PVX,DY+.79=.^?.VP8;<@
M
M
M
M
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MFFN]ZMX;S8\O3L-V/'\.V;=EO9OXSO[?2VR8;=@
M
M
M
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M_D\7YF*9>7WO/Z-FZF[BV*8[9@
M
M
M
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M;.V6>9? W2=9IH\O#:VTL>WU276J-M-+84FXPHV1.^J.6O&G.AK;,V2=!?\
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M7[_XML[=NWNV]C;1AMT
M
M
M
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MC)&HO^),3->'F>P>&;]/?TW!.GMFW'R^[$[9WS6L\6X3#;T
M
M
M
M
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M9;P,HUK&HE$1J)P1*<C13=,[9FLNXMQVX[8MLI%L1LB%U"0
M
M
M
M
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MJ-Y(C0)R0
M
M
M
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MIB'U(B)R(5(A
M
M
M
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M3"K>K$@
M
M
M                    ):K]$2(IR(J)7.HM"2DJ2SPM2CY8XU[*N1/PDTGA
M"F;HC?+Y9,KCH:++>PLJM$J]"J,=\\%$Y[(WRH.S^%8E7Y*!$_*)^%?V*?S.
M/MA33<N"Y)DX?NCX5_8?F<?XH5/M[#?[2M_VP^%=V'YG%^*%1N9Q<GN7\#O_
M %A3\.[L5?'L[8?4R\M9$31<Q.K^.A'+,;U49+9W2KM>UZ5:J.3Z2<4(55JC
M5?H_?(E4FXBJ$20
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MFLNW1/;79=&WL]KKA(T:C432B)R:B4^X:";8=W&Q]!*0
M
M
M                                                        @JT
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MLCAN()V))!(V5B]K%J6IB89=MT7;E5SJ)72KO4A35,HM6J5 F)
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MV:J*VC>^JN2O-#0>AZ!S31]I*
M
M
M                                    !"J<BF+HW"TWN9QM@G\HN6->
MM=,2+5RT]2%V,5URQDU./'OEA5[O:X553'V::*T229:+[:&3;I8B*U8&7J7X
M88E>9#(7ZN?>74KJ\HF+I;]XR+<46M?DU%^3?+X6QL9WFL1KOI)[Q7\2FZ%C
M;.^50A*(2 3>]ZJ!3N2A4 3?C?>"GN2A4    "*HCN#DK[5H$)%1*+2-J)]#
M3S$)JJPW%W:JBV]R^"BUI&J_@(NI/!7;EOMXLELMXY*!=-Y$V^B]*=V0L7Z>
M)W,W%U*ZW?%68XS<^)OJ,;<I#*O#P9%HJ+Z/D,6<=W8S\6LQY..UD[7(Y*M5
M%1>U"W.QEQ-34B.TUXD)3$@
M              H/1RO;1J*UO'Y13M36>#7>\^E^Q^H,V-DWAMV#-OQ+G.QS
MYJUBU\7-56JE6JJ<E,G3ZS-IJ_#FE=[5]2Z-H^HS;.HLBZ;=S.[:"."*&"*)
M(8;=C8[>%$HUK6)1$3V(8TS=,S,RV-EL6VQ%NR(V+@%0
M
M
M                                                       L.3S^
M.Q+56YF1TG^";Q6I799-S'S:FS'&UKW([JR5\KV6[?A;=4HCVK5ZJ9MF&VW>
MU6;777_=W,;;J5SW.D?(]WO/?S+U;>#!FZ;IVI@      3?D_*%/G2A4
M   BG,(G<@$@ !SX 4W:7(KE:NI/=5O GE3SQP7;'9W*8YS$BD\:!G]YD7DB
M\>!;OQ6W1WLC#J[\<TG<S_';KL,@K8Y95L[FM/!>E*^M%,._3W6-KAZACOV3
MLEES7(Y$5%147W50L3LFC,B:IPD
M
M
M
M                              "UWM];6,3IKN9D4;6U;5>\[Y";;>;<
MHORV8X]Z:-<9+=UY=H]EA&VUMWU19'_G%2O8WL,VS3\NV6HSZ^Z[9&YC-7N5
M'N<KWJM5>[FJ^LR&NF9F:RE]@$0                   F_&^\%/<E"I-I]
M84\R4*@"G(UCTI(VK:<PF.7?.]>L9N'(8UR-B?\ $VM$1T#UHK6HOS"UDQ6W
M[V7AU=]GF;,Q6>L,LQ$MWJV9$[UN_NNX<_:85^*ZW;P;C#J+<FR-[("VO@
M
M
M
M                                                         "5S
MJ)7F!B&:W5:8Y5MHG?$7J)[C/=;7M5?47L>&9WL+4:VW%LC>UC=W=UD9GSWE
MQ\0]/S<-55K?94SXLMC=#2YLLY-\I.5%7WJ$UE:B4 E$
M    $WY/RA3YTH5   !#\(0C1%YM1?D!5'Q'QN9+'(Z&5G"*9JJBHB\^/H]1
M$Q6**K;[K)K$[6<8;=[JMM,LFE*HD5\B\'>WT>TP\F"=\-MIM=6EMWK;!B>U
M[$=%(CT<E4>BZD,:8HV<3$QL?0$@
M           #XU5^MZ(KM*=M.!3S0G8ME[FL5C/$ER.4L[&-J57XB=K53]LJ
M%RW%DOW6RL9-5BQ??NMCSRPNZZR=*K)R1774+!P/2J4=>Q?JJID6Z+47?J3Z
MI:S-XAZ;AF(OSV6U[9A\+NNO1]5TIU-P"+Z$O(OU5)GI^HC]2[Z5&/Q-TO),
MQ;J<<S^U"]6G5;IK?:&66^\-</D_-HR\B55^XI3=HLUL5FR:>E?MZWH;II&:
MRO[4,SM\G8W\226%[!=M<E8WP2M>B_M54QKK;K=\2V6//CR;;;HGTOHA=)3O
MJC>'KK]\B-O!<I,;WV$H
M
M
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M*9B8X)6N<Y%<BUKQ:NIO!/PC9P*;*IFK7FZJ^P(K$IJ4Y@JCI]81S)0J
M   13T\.5.*5!$TW*3V(C'<WHB<N9,3P)K=L7[#YVYP[D8]SI[.1$K;\U3V*
MICYL,3N9FGU5V#9.UMFRO[6_B;-:RI*U_HYI[3"NMFW>W=F2V_<^\I7
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MF)I,4=W$\T5MV][[FK5 E,
M
M
M                     /CN;F&UC=+/(D4<:55[A$3,J;KXMBLM39G<$^7>
MZ.+^3V2*ZD?'5)3YR^HS\6&+=K1ZK5W7SRQLACS8T1$XUT^[3@A?84;*J@
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M#W2RSJ*P
M
M
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M:[)CFV:.@TVHMS6UXKXCD4HAD)@
M 4WO5B51JO55Y(15$M.=:.K6'Z0[0ESU]&VZR5T_X; XM5HMQ<4541:<=+*:
MG4XTY&?T[I\ZW+R1-(WS+1>(NNX^CZ;XMT<UTS2VWMG[+=]U-M(V/&O>&[<]
MO;/76Y-S7KKK+99'2O>_BD#&TTPL9[K6-3@B(>DZ73V:?'%ED?I?-O5NHY]=
MJ)SY[JWS_P ML>:>R-E88Y7O51[DU.76]OO:?HMH7F!$]LUW]WHBB4)
M    !%U/3Q*/73]4U.3?6OTFDUI&Q;FWGNB;Z32-D1NIVW=OGAMGI!U=W!TE
MW-%F,<KKO"SJV+<> 5SO#N8'JM'HK_=D8E5:J^Q>!J^I=.QZO'2E+^$\/+M^
MATGASQ'J.BYXR8ZWV3/O6=TSOBN[NF=M/O4BDQ[-[5W+B-V8.PW+@KA+S%9>
M%L]K,Q>2.XN1R=CFKP5/4><Y<-V&Z;+M\/I/1ZS'J\-N;%-;;HJRE'M551.P
MM<68G)0
M
M
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MOIRU[9K/_#7U=CU*:Y%=SX\CAK)F8>X3/!6*T
M
M
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M=%(U.U%IZE]9K;HI+H<=\7VQ,/OKV=I2K1
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MU2WJ>AQ:B-]T;>Z>/TMF&*VX
M
M
M                -=;MSCHF_95G+IDE_P KN$^8GH^4R]-@YO>[&LU^IY8Y
M+6 M2C6HG-#+EIJ=J(2FT^L*>9*%0!"@*)Z5XUI4A%:+%G<]A-L8B?.[DR#<
M7AK1BN6[DX+*Y.3&_3JO#AR*[,5U^2++-\J=5J<6EPS?EF(MCB\]^K'7?/\
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M*-7Y3C?%&#]Y;D]#V7Y6=0YM-?IOP^]_S;?K>@IRKU@
M
M
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MR[A?K[=?J'*O-A@9L<[VXT&IBZ.2=[8)CMD
M     /CNI4AC=*[W(&.?)[&IJ_4(Y>:8CO4WSRVS/9#P7WUF9-Q;SW9GGNU)
ME,Q<RP)V>$KU>GWE4]6TMD68K;(X0^5>L:K\UK<N>)^]?/JW^NDRQ,R&M
M            (M54?W6ZW=JB4Q6NSR['2_E)SR8+K3A+=[OY/N*UO+"FJM97
MHU[?OQJ:7Q!CY])=W3$NT^7VIC!U:RL_?BZW?QFGV2]@&QT5KD7@E>!YS&V'
MT5+Z"M
M
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M/,^4-D[8XS6G#?2OJ1)2               3,5S75:G>_6!;6N[RAL#H_?\
MV1U6Z>Y!'.B2'.V])4=5-,B*QW[95J8?4K(OTU\3V-QX:R3BZG@NC\<;:\)W
M_P#-O>[;>"_\O2>5V;(?4TIRL
M
M
M             07U :_WCE7,CCQ4$B-EN&Z[FB55&)S1/0IDZ;'6:SPW-;U#
M43;'+;QWM>HB4T\V_14S9VM+5$)   "#E<C>[[R^XGI_^HG$F(0LV<W!B=M8
M7(;@S5TEKB\:U5N9']U7JB=V)J=KGKP*L5GQKHLLWRC49\>CQSER[H>7O47J
M+F>I>X[C/915AQT#5@PF'Y1VEM7NL1J\%<[FJ\U.YT6BMTF.)B/>G>\&ZYUG
M+U767<\^Y&RV.$1YMVWUS&YK^K:5:QE53YAE1%.+3UC?$1M[./=YDI*.\"0
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MK12UJ/X5]?PRR^GY)LU.*^VE8OMGMB9K2=K] &JCN')R5/)7UI16*D
M
M
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M)8^-7KHN86>%*VM5X)PD^4UF:WENF'1:3-\3'':RA$HE"TR4P
M                -'>9!%7H9U.HW5_W)*FG]DTV'2?YJSS_ &N>\61_^IU/
M_;N>)Z51$3M:E3TV)]KY<QQ=2*[Z51"\                +AB$:N6PM.7V
ME9>'[/'C+6H_A7_LROZ3;ELINYK:>:L/T#IP2.OH3\!Y,^MXW/I)
M
M
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MKZNQ[^JJ+)RX-7B>3QN?6?<G=(B<FJY?Q1,T1,*I(
M
M
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MFLPW)M[)+D<7;S.<GBLI'*WT*U*<379K>6YTNERQDLB60(M6U7@689"8D
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MVGNTV2<=^^'<:#6X]=@C/BFMLLO+3*
M
M
M               !A6\[];;%MM85I-?R)&VGHK53(T^/FF>Y@Z[+R64[6L&J
MC7N8B<$HUOR&=NV-!7@F"H   *3]2JV%$JZ61$93CWEY?W1%]\1$1Q51%9MA
MP'YG.H"[CW5%LG%7.G";/16Y!S'*K9;]ZZIN*<%T]AUO1M#&*SXEV^=SR;Q[
MU6=9J/R>*?<LC;Y_+UPYC?H1R(Q.Y&G=_9<C=S;=,\TSLEP>6D9(M_#;_@@
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M/LGK]5>IXD=5Y*G88VHLV5;#09>6[E[6US!B&["0
M    /,7SSW]P[>.S,:LRI9P8B:[\!5X)))(]FK3[&H=EX7LYK,DO%?FCDR1J
ML%L3'+%MUV_LJX<7WN"<5:VO[4ZFV:VP\MI2(V;9C;]*0J4@
M  $WS?E!2*)0 $Z:E<J-X5[2)FD53MF9IY2]3?)3>RW72O(VZSODBL<Y+%:H
M]5[D;HXY%:GJ34IP?B2SEU43VP]X^6>:[)TJ8G]6^8CS;)]6W8[0.?>B@
M
M
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M$*6AL\W3G,TUO_O#_P !L<'W(:C55Y[J;_T+4KJM93Y"Y.]8F=D>=($
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MQUET?AO7)QS>0FN$_8TA_ PX'Q)DKJJ=CW[Y;X.3I%L]L^S8ZZ-"[\
M
M
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M<:MJ;3OFSXF*):J^S^J=5:]O U^>VETRZ#07Q=CB.QER*BEEF(@
M              ''7G/VTN8Z5MSL,+IKG:61ANU<U*JV"7ZN;BG%$HB5-]X<
MU'PM3-OXH<'\Q-#\?IOQ8WXYYO1QV[XKN>4:T=1R?FZ.T(O+0=];LKYWSWRQ
M%.RGHI1$E4                  "%'N5D<:/DEE^KA1OO.5W=:U5_**K;HM
MGFG="<=>:(V[=G?QC;YI>Z'2';+=H]-MG8%T:036F.B=<Q:416RS)XCZ^M'.
M5#RC6Y?BYKYK7:^IN@:'\CH,6'LMAM$QVW
M
M
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MZJ?*IYI2FY],Q,SO?4
M
M
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MP9;&SM7^^JQ[5Y44IOCFMF%[37\E\-Y)RX&KJZ5,
M    4)(D>K>^YM.Q.T$O-#SD=)+O&9AO5'"64ESB[]D<.YUB34L$S*-9<.:B
M>ZYJ-:OKYJ=CX=ZC;3X%\T[/+N>,_,;P]?;D_/XK9FV8]Z(X3VT[)I%?36=S
MA-'QR)]7*CG(W4Z-O?0ZV;9B>[A/%Y)%]MT4BM8VS%*V^:$Q"L
M     F2J47BOK]">L(K,3&S?/HB._P!&Y+XS(E33WI'=UEHVBOD<[NZ6M;[W
M>)FSC=.[;ZERZG/-ED3,\(V4F9V<-^UZN^4_I#?=/MK2[DW!:?#[CW8D;_AY
M$37;6:)6.+AQ1RTU*AY]UWJ4:O)2W=#WSY?^';^EZ7XF?^)?M\T=CL!S$<:)
MWZ<
M
M                                               D7YQ&X:6STWQ.
M7NY$]Z-^AJ^Q#98K>6USVLNYLBU(J]I=8E*E5!2$ E-^+]\*>]+6C45.T)B.
M:7#GFWSZR[CVEMF&1'Q8>P==W,*+RN+M:-6G;I:JH=/T'#'PK[Y[7F7S$U=,
M^"R-UD;>_FW3Z*[7(M5?WW<7/Y&_C<\YB8NCF[4"4@     1020VML#_ %-?
M?YROX4,+4_?]$-IHOX?IEG;N;O:8[,0"0 $2Z \LG]:=S_,DO\8IINO_ ,O'
MG=I\O_\ <9_[<^UZ&MY-]AR#VN4P0YS\S6W9LWTRO+RW8DTNW+N')N8U*N\*
M)526GK1JU^0U?5L/Q,.SA-7;^ -?;I>IQ;=-(R6S9Z9W?2XKZ9]4<UTQNLMD
ML1C;3,+G8HV/;=.<UC6-57-5-"HJKV*:+2:R<$S,1MG8];Z_X=P]8LLQY;[K
M.29W4K,^EN"#S7;SN[S'6C]JXB*.\NX8))&.F54;*]&U2JJG:9\=7NF8B;=C
MD\WRUT=N.ZZW-?,Q$SMB.'F=W1ZG1155&N<C'=W@B._6.@L>-W;+IB'._7#K
M'G^F&2VW8XK$V669F;:XDN'WBR(YKH%:B(B1N1%KJ-9U#6W::;8B*U=QX/\
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M3%?I[.7WZ33?-:4<&JUVIR+_ 'IR(=5VO*+XI?-O9/\ A*0E0
M   BBT1SW=VB.HY/FUX:B;;.:Z(1==RV3?/#A&_;LB7J]Y=NCNT']-=B;DSN
MVK6YW,^-^0CO98T5[-4K_#547G5M''GW5NI9KL]UMMU(C8^@O"/AW21H,&7)
M9$WS',ZW\%VIJHK=+:432:.-CO?8^H@
M
M
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MT_Q&#LGJJJY$TK7TH:O+;,7;71:._FQQ+)"VR@
M   <W^:G;;]Q]%]SMBB5]QA4BR\2-2J_R5R/<C4[55*\.TVO1,OP]79MWS1R
M7CC1SJ>DY:16;/>_Y?;YN+QP8J:'=GUCG(]WTG<''I%T^]+YOLF)MF[=S36*
M^J?-/<@$              /HM+)^4N;3%Q(_Q,I=PVR-:E7)X\C8DX>Q2C)?
M\.V;NR%S#B^/?;BBO-??&STTV]D4>^VV<3%@<#A,'$B(W#V%O9\.7U4:,7[J
MH>49<G/?==VR^L=)@^!ALQQ^K;$,B*&2
M
M
M                 "V929(+"]EK1T<#U1R\N159&V%K+=2V9[FC(558VJO;
M1:^DV<.8F:S,JA*0 ! "BZX99PSWKU1(\;:3W,CUX>Y&O&HI6ZRWA4F[DLF^
M?U8EX[Y6]DR65RN0G6LU]>33/?ZU<Y4^\AZ)BMY;(B.$/G+5Y/BYK[YWS=/T
M5I]$/@*UE-J7TBB>:4H0    "*"2)VMJ[!_U/??YROX6F#J?O>AM=%_#GSL\
M=S=[2Q#+0"0"(1+?_ED_K2N/YDE_C%-/U_\ EX\[M/E__N,_L3[7H:WDWV''
MO:Y3!#Y9&:WLXIH1M=/;4B8XIB9AB&\-B;>WQAIL)G[1+JU?5T$B=V:W>J4U
MPOYM7LJG,LY\%F>VET-CTGJFHZ7FC+I[J3QCA,=DQQ<*[P\LF_MM33R[:='O
M3"*M;9CJ17MNVO!JQ\G^U#0:GI5\75C;;V1O>Q]+^86AU<1&HB<-_&=]EW?W
M>9IJZV+NZT<K;OI]FX[J-R(YK[5[M2^EJIS,"-+?68^'?3S.KLZSH[ONZK'R
MT_%#)L#T8ZG;@D9]F[.N+"U5JJEWDVK:-:G:B:N/'V&1AT.>^-ELV_M-=K/%
MO2]+9,WYHNF.%GO5=B]*?+WB=D31[ASLJ;@W:]$5ER]G\GL_Q;>->U.URF[T
M?3;,&V=LO*_$GC?/U.WX&"/AX?\ ZKOVOL=-,8C&HUO)#95JX.(HG"4%YH!R
M]YJ?]P<1_/5O^XE-YT'^//[,_4X/YB?R%O\ W(]DN$_FM4ZQX[Q0"0",?YRW
M_*;^Z"EHC<'^\&:_QSS8X/N0U.I_BSY=BS?0+LL?L2D*0)      FI&J*BIQ
M5KO#$1MK*:1,71QY9F.^DUI#TY\O^5^U>D6T^^KY<2ZZQTR\Z+%(BMK\BG#=
M4LY=3+W'PEJ/C]*Q3.^W9/V-Q<#!="B  F_&^\%/<E;Q<GY2I]X*FS=D3([$
MOB54U0SO33VTHE#!U,>\W?39_=T[V:F.V                          +
M+G,=;Y?$9+$W*-=#DK>6V>CN5)6*GZI<Q7SCOB^."QJ<$9\5V.=UT3'T/!+<
M>&N=N;@S>W;M5;-@[V6S6J45RQ/6-'(WUTU'J>FOC)BLO[8?*74<$Z;4Y,,[
M.6Z8^J*1Y]JS%YB@1W 2C[:A/G0"        "/%R^L;B*W3WM[>6W:4FZ.L>
MTH9F:K/"SOR=\U>]PMT5$14^;5[VJ:CK>?X6FGA,[O+N==X'Z;=J>JX^:*VV
MUF>-)WQYJS['M$U4=JU(B+54^1#SA]'PKDI
M
M
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M  "9O:$2SO8[ZMOX_0]%_;&%J=[<=,G9+8*+57.]2&-Q;-4"0
M             I/7W:)J6O\ ]4(EY*><'97Z,]46YNUB1N-WC:-NG.3LN85\
M)[?E1%<=[X<U,YL$VS^J\#^8W3+=)U"W+;&S+'TQY3+D\Z!Y\
M !-Q5KT;RT]_UL]!%L5N5;[+Z;XBOGC;L]+T=\D>R_AL1N;?UTQKY\K,VPQ;
MW<V10JKWJGY2N3[AQ/B36<]]N+LJ]E^5O3+L>FOU>3;-]*=VV?M=](O?:G:C
M553F-VQZO*N2
M
M                                                          Q3
M>+M.$E7_ -+'^$NX?O,/7_PI:H3FOY;OPFRN<^$)0 B!-[WJH%.YJ;K=<I9=
M)MZ3.Y31VMM\JRH9G38_\F&D\4Y/A]*S3YGEQSX]AWD[WA5UT73-W"0A
M   "-.P%-K:VP/\ 4U]_G*_A0PM3][T0VFB_A^F6=NYN]ICLQ ) (^@(EO\
M\LG]:5Q_,DO\8IINO_R\>=VGR_\ ]QG]B?:]#6\F^PY![7*8(4WIJY\$;WB4
M5:3ZE]>^E?2&_P 7C.H>YH]OWF<ADN<;&^*:;Q8XUHJZHV+I[Q"6OO[;?EJK
M1>I$'^C77_4@/[;?EI_\R8/]&NO^J A_;:\M/_F1!_H]U_U8'V8'S>>7W=&=
MQ&VL+O\ BO\ -YV[6QQUBEO<M629>;:NC1$3A6J@=3  (+S0#F#S4?[@8?\
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M5ZK3U'EVKSSGRW9)XR^J>D].MZ?I<>GM_5AGYCMB
M
M
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MVQV<_;V;*^QZM0M5*UX_13T(<-+W;?M?00
M
M
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MM&M1J40T3O4P
M
M                                                           ,
M1WFG_<<RHG*:+]T7M/-+V'K_ .%+5;5[/1W38S#GY"$IF]H4W)0J.*J#<TOY
MA('3]&]S:4_R>[LYM/I:DAG]*OIJK>YS?C"VO2<O=,2\RG<SN)>(W3-:H!
M     "*"2&U]@ZEQ-\FESOY2O_1,'4?>]#:Z.?<GSRSI51'.2E7:BPRZQQ*)
MZ'?W)%45M[4.'H=_<BJ=G:43T+_<BJ*V]K?_ )95:O5&YHK7?]R2>ZO_ *13
M3]?_ )>WSNU\ ?[E/[$^UZ&I72B+P4Y%[5.UK_)]/-D9?)7&3R6+CN,A=4\:
M1TTC5<K>ZWNM>U"!\G]%73M?_P CL_TB3_K ']%73O\ V,S_ $B3_K (?T5=
M._\ 8S/](D_ZP!_15T[_ -C,_P!(D_ZP"/\ 15T[_P!C,_TB3_K ']%?3O\
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M.
M
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M^U])^";Z])Q6\;?=GSQM^MT2CM7-*+Z%-4ZS<G)0
M
M
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MO4^CL=UQHBJY_)7>]\AS$/3J*P2
M
M
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MFD\-L4\\5K+U=Z3XAV"Z7[$QCF:7MQC;N5*:55UPNMR_>.#ZADY]3=,;GO\
MT+3_ )?IV&S_ "U; ,5M  !,[L"FU*G=<G9P<[[P2VILIFC!QNI199'/^[0P
M-3/O>AO>G13%Z67%AG@                         A6G,# NH>]\3T[V?
MF]X9FX;%98>!7L8KDK)*[NQ1,;\YSG*B(B&1I=/=J,EN.V-[7=6ZCCZ=I<FH
MR32+8^G=$>GL>&^Y,WDMS9[,;AR_UE_F;R6XO7(NI466CU:WU)JHAZC@PVX,
M<8HX;7RSJM7DUNHOU.69F;JQ/=6DTIW5W]JREQ8          "/%%"=S;_0S
MJ0[I;U&PNX+F5T6$NW+89U%6NJTG1&JZG8K'M:]/4:WJVAC5:>Z.,;?+V.A\
M+=:OZ5K\>69ICF>6Z.VV[9]$Q%VSA+VNLKJVOK>&\M)63VUU&R6VN8W(YLC'
M)5%14X+PH>:3%-DOIJV^+XBZ)K$[5R"H
M
M
M                  "G(FIJI])%0B42T7>P_"WU[ G][E<O[9:FTLW0YG-9
MRW2^?3ZRM9YDH5 $U>'W@IXI6T:D:_X-:A-CSC\S&"3$=5;R_1*0;DL[>]1/
MQT2LGWT.OZ1?\72S;V2\=\<:/X/4OB?BM^G?'L<_OXZ/:OX#<S=7U0Y')P\N
M"4A2     !%?=^Z!M/8_^H\E_CW?N##S_>]#:8/X-WG=V;:_W8V[_F$1R>?^
M)+UG0_RV/S+N6F2 1[0,_P"F'^]5W_-Z_ND,36_PVXZ%_-3YG1!J(W.P1*@
M         -8=4_\ 4-O_ )_%^Y<9NB^_Z&BZ]_ C]J&ANQ39N40  :0ZL?[P
M8C_-/U4-ST[<X[Q-_,6?LN,MP_[Q9K_.'?@.@P?PX<%J/XL^=9W>ZTN+$[D@
M0       NN"QLF<S>'PT25=E+N"U7VOD1K?[IQ;S3RV77=S*Z=AC4:K'CX3L
M^SZ9>PT=O'9QP647YG&PPVMNGH2-B(OWSSNR[GYKO\SZ*NL^';;C_#;$)R4
M  !3F7N*[Z'$JMW24K,0W?A+=+;%V478D37?=XFIR3[SI=/;RV1"[E*\
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M,>>R+\5T76SQA?RA=
M
M
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MZ7U33]2P1FP71-L_1/9/>V"6&Q
M
M
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M[Q/_ #-G[+C'<7^O\W_CW?@.AP?<CRXN"U/W[O+@L[NPN+%^_P!*4A
M$7<$X?/=P]HI4F8BRZ?5YZ.^/*EME,?LW/;MNK=(KK<M[\/;)VNMK6J*C?4Y
M_$Y'KF>,MUMG"(>M^ ^GSI]+?GNB.;)._MB-_HKM=2Z7)1STH]U5^133.XF=
MH   3-[0IN7G;%I\5F(7*W5';.=([U+3F6\UU+=C-T-G/?YFYD2AK70(@
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M[XETO6L'/AFE\?>MG[UL^;L[VYS =$
M
M
M              %@W'9NO</=PL2LFC6Q/6A<Q74N8^JLYL<T:8C>DC4>E*O]
M[U.-EOVN;I38J!(   2L<L3_ !FHCD:ZJL7BO#@J+ZB%5ET1$]KR^ZX[2_0S
MJ3G[-8TAL,@K<ICV<T=#==Y49ZF*J_=.VZ5J9S8(K]ZLQZ(W/"_%FBLT'4+X
MG[M]+H\]V^/-$3/KEJ7YO'Y/RC9.?G9$^5*[J]Z 0    (102F&T]C_ZCR7^
M/=^X,//][T-G@_@W>=W7MK_=G;G^81?@.2S_ ,27K6A_EL?F7@MLD C^ #[L
M;D[_  UVZ[QTRPS.A6%4HBMTKVT])1?9%UO+.Y>P:B_!?SV;Z47]-\[L1$1,
ME1$3N]QOZQ9_*XV5_5M5^(_3K=O^U/[AOZP_*8^P_JVJ_%]!^G>[?]J?W#?U
MB?RN/L/ZMJOQ'Z=;M_VI_<-_6(_*8^P_JVJ_%]!^G6[/]I?W#/UA^4Q]A_5M
M5^)'].MV_P"T_P"X9^L/RF/L3_5M5^)#].]V_P"T_P"X;^L3^5Q]A_5M5^(_
M3K=G^TO[AGZQ'Y3'V(_JVJ_$C^G>[?\ :?\ <,_6'Y3'V)_JVJ_$A^G6[/\
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M6N_9._ANA2<ZJ<657\3C]\1;11=?6(V5GU^N>*!(         (NYJ(3=O0"
M     (\6J"8H-5NE%56OIVB83;.R)V31?]K[ISFR\[9;CVWD),9EL>ZD=U&N
ME'-3BK'MY.:].&E>"H6=1@MU%O+?%8EE]/U^709XS8;N6ZV=_#OCTQPW4B*3
M38]:NAOF&P'5JT^RKQT.%WO9QZ[W".72DS6\Y;;4JZD3M2JJGK//NJ=)R:.>
M:DS9V^7:^@_#'B[3=8MY*Q&6/U=U>V;?-QWNCVOJJ>OT\Z&HB:[77TE61:DB
M(
M
M                                          $BM1R*UW%%2CD"*5:(
MOK7X+)7]JK=*)*KXT_$<;2S[L2YO4V3;DE0JI4L4A )  $CF*JJK5HYW"M.%
M.T%U-E-CFCS1[.^W=FV&ZK.V62^VC.L5\Y&U5UC<51RK3FC'>DW'0\_+GY9W
M.+\>=._-:*W-;%;L<[>^W]%?7#S_ )%J^J+W%TMA_).OG?+R*^Z+KN:)V74H
MIA2    "*"2&T]C_ .HLE_CW?N##S_>]#9Z?^!=YW=FVO]V=N?YA%^ Y//\
MQ)>M:'^6Q^9=RTR4>0$ (U]) C1.9*$*-"3@ X . #@ X . #@ H X .'8!
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M>*J[Z7O/U?2<=9'=N[/J_2\ENBE8BL=LS],UX3,;(@5WH]WTBBY?=$[MWE5
M*0                     (W['V8W(7F&O[')XJ[FL,C82>/9Y"W562Q/8E
M$5KT[R-^D49<<9K>6^*QV+NFR3I<L9<<S%UNVV8X3&R*\:=NYZ<^7WS08S>K
MK;:.^[EF+W?P;8Y)Z(RVOM/=HU[J(R1?0O/L6IP_5^BW:>9OQ[;>S\/VT>Y^
M$O'./74T^JF+<W#LOX5CLKV.T4F1B(BM5?8AS=L]KT>:0K-<KJZDT\>[Q*DJ
M@0
M
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M]W[@P\_WO0VFG_@W>=W7MK_=G;G^81?@.2S_ ,27K.A_EL?F7@MLD
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M/AOBZ.Z63(Y%6B%IE2:FH[37BOS2JB*IR$@
M
M
M             L>X,>W)8JZME2K]*OC].IO%"YBNY;H6-19SV2TLQ>*JY*.6
MC=*\]3>9LKMM)<Y$;)KO3A   FT^L*>91?W4549K5WNHG91*<1-U8Y:*YNI2
M8X.:?,QT]FW+MVWWMBH?%SFUV>%EXXTJZ?'.=5KO;&Y.)N.C:R<%_).ZZ7%>
M/.B?G]).IQQ[]F^F_EK6OH>?:Z$9%X?UC5;JU?2=\XZ[ECFK$[)>033DMI%8
MIM[*_A\] D   "*"2&T]C_ZBR?\ CW?N##S_ 'O0VFG_ (,^=W9MK_=C;O\
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MY9B;H[ZS7CQV>M1<Z-NNNI8V5\)L?J+BW,VQ/ELHE      !'V5"?,@$
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MV\MVR[M;VU,HCM24=[J^TUTNDK KV)P5R$*J)R4
M
M
M               "1R)147DY*$5I)2K36X<>F/RKD:E(+E%DA]&KM-EAOK:Y
M[6XOAWT6?\GY2ZQ/.E"4W+EVA3O2A4 4I? <UT5VUD]G)5MS;O2J/8Y-+T7U
M*U5*9NNM]Z"D3%+ML<7F)UHZ;2]-MXWEC;1/=MO,.6_VM>+VV[U37$OH=&_A
M1./%%.XZ7K8U&&(_6C>\1\3]#GI>JF+?X=\\UGFGAW;=U-O'@U#\IL7,0!4
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M6WZ:[)KZ):62FEK&K1J:NYJU:-1M;:4I$.5FDSLNYHV^>/VJ[:A(
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MVY$2B&$WJ(
M
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M+R['8@2   $%Y+7T"E42S?9>+=)))DYTX1KHM?R>TQ=3D_4;7IV#]=LPPVW
M             2.KI?1-2]B$C%=Q;GP.T,3<YK<N3AQ6,MF*LD\SM+:-[&IS
M5?4A<PX<F>_ELBLL76:S#HK)RYKXMCMF7F?UE\VN?W@^[P>P&S[;VUWHTRR*
MK;V_KPI5J?4M7T5U+4[/IWAZW%3)EFMSQ+Q'\P<NNKBT5<>/MXW?5$3QVUV^
MEQXY%5SU?76YVIU>+M3N#]9TELUB'F]T<UTS,4F9K2-M*[)B:\ E(
M          3:E](HGFE*$ $=*^@53RR@$     !$[@&\"0   C[*A/F0" "9
MOO=A$]R;9FM=C[<=?7V'O[?)XF]N;+)6K]5C=0/1DC?4JEN^R,T<EZ[I=1DT
MV2<N*L73/;28_1#T"Z*^<!D[;7;75E&6MS&]L%KO"W[UN]SN#6W+$KH=^,G#
M\!R75/#O+$Y,&[\+V#PS\PXOI@UV_=%\?73VQZ=KT!M+FWO+6&YM;B.ZM9V(
MZ&:)R/8]J\E:Y."HIRMT3$TF*2]5LOMR6Q=;-8G=,;I?6UNEM/>(543A(
M
M
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MBC*5"H
M
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M<,Z*-<K.U637#4\")5]UOI^4P=1?6:-OT_31;[\[V?>&Q./I,9L^-50
M       *3W*VBHJ(GSA,T&I^J?5C!=*-KS[@SST?<2+X>&Q43D\:ZG[$1.QO
M:J]B&;H=#?J\D6V;FDZYUW!TC3SES3YHXS.[_'L>.&_>H6X>IFYKK=.Z+E9K
MF95^!LFN^IM8=2:8V,Y(J)S7M/1M)HK=%CBVR-L[^+YOZQUK)UC679<MU;8^
M[&Z(I.R:;MD;:SO8:KW(RC7IIIJK^,941M:Z^^9MWQN[/H0]?K"FE$
M              CQ:H3MB4 @           $>**$[D @        C73J:B58
M_P!]GS4_8$4XD1%L[JQOIPC_ (6\^B'7+-]'LRVNO*;2O95=E\)J351RI6>%
M56C7(B<?I4-3U3I4:V/=BE\1Y;'5>&/%V7HN:+;IYL5UVV-G'];F]GFJ]A-M
M[CP^Z\)8;BV_>17F+R\#)K6Z:M/>2NER)Q1S>2HIYYDPSBOFRZ*3#Z+TNKQ:
MO%&7%=%UMVZ60QN55HYW>:G>84,F)]:N
M
M
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MM$HD6K0O/W_?,ZG;-6BC9/NQ3]._U($H              3.YJ(3=O2A
M                  !'\7UA/<@$      *U9HJVNIKM?S^[VT^C^*3;/+-8
M\O+M*Q2FRO;7;3CLW4[+>#J#RV=<Y.F.>AVYG;AZ[%SURR*1KUUK8W,M4;.S
MBJ(Q55-:^M%3D<]UOI4:BWXEGWHKLCCYW?>"/%,],R1I\L_N+IB(KOMNFN[;
M,3$[YGS4>NMO(V:-DB2-D:]J.21BU:YJ\45%[45#@MTT>_1,715]85
M
M
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M9NBV*RJMMFZ8B.+<>$Q;,190VC**YO&9Z<U5369+^:72:?#&&RB^E"\
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MC=5V\DK:JBI3O4.;B:O2J*Y4@
M
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M9(
M
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MP],I?M5$C_R2-R4X*G%?NF+GRTV0VNATU8YKH\S9;41J41*(AASO;:-B8)
M           ^*5RU5K45W!:^K@4W31,;X>57G+WPNX.H>,V=!<.^S=F6['/8
MURJU]_<=YSEIPJV-*>I3N_#FEBS#.28VS.SS/!OF;U6[5:N-+;=2VR-O[4_7
M[-[D-RU1:IQ:[N?D]KSHHMGFYJ[WG-T[(B>'LXS'<E*@    $?94)\R 0C^3
M4)\R 0     !'M[U0(            !,[FHA-V\U+Z10YI0X^]ZPA
M       $>*J$[T @  1:G>KVM[[?RN!,(FV=]:4V^>E/;['IOY)]^293:>7V
M%?7*2W6TYO$Q:O=WW6DW)$3FJ,=6OHU'">(M)\/)&3\6][G\MNL3J=-?IKIV
MXYV=\?9]KN@YQZ8
M
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M1?1XJN5L?R-X'JFCQ?"Q6V=D/D_JFO\ SVKRYI_6N]>R=GJV>ECID,0
M                           $>**$[D @                 )F*B.8B
M>\]R^&A3=M1S66;;NVL1]#H;RO;JDVMUBVW$LB1V>YG2XVZ]"LD8Y[7?MV--
M/UW3?&T]U_X8^N/M=GX$UTZ3J]MOZN7V4F?JCUO8YTCG)W/>UI]P\\W/HRZ-
ME8?4
M
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MJ;Z^J91(5  ( D   (^VH3YT @
M         4]50BD=BZ8/(2XK/8/*Q/<Q^,R-I<H^NG\W,QS_ .Y0M9[.?%=;
MVQ+)T>?X.HLR5F.6ZV:[N,5^BCWYLKN.\M+2^9^;N[>*=E/1(U'(>3WV\LS'
M>^L\=_/;%W;%?6N85@
M
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M,7+G[&VTNBB-M\5;$:QC$:UB(UK41&HG)$0Q6SB*12%1$:U*)P(2F
M         <?^=*[\#HY/:QOTKD,Q8,<B?/1CT>K5^XBF_P##=G-JZSPAY]\R
M\DV](F(XW6^UY1.1$1JIP1.2>T[R*\UU7@<VQ;$1&R(W>E(5*0)
M0!(          1=S40F[>@$  "/MJ$^= (    !-I7T"J>64H0
M       %*X1/A[A4]Y&.7^Y%*[$Q%OZT/=_IA=?:73C95Z]RR27.%M$=([BJ
MTC:WC]P\JUMM,]T<*OJGHN6<NAPWSMF;(;&,=M
M
M
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M'\S/F>;?,^ZF@QV\+KXKZGEVG)J^H[J?O2\*K6V)[O8
M                            $?94)\R 0       DD_,O_(?^$JMFDK=
M\3R3YI]KW!Z"N63HYT^<_O.=B(OO.<>6]3CEU-].U]2^&O>Z9@K^"&XC";T
M
M
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MI_V(;@,)O@
M
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M5^2-3H_#'\S/F>;?,Z8C0XO^Y#RW8G<]/BJJG=3]Z7A%L;)_S3*(5
M $=2^D43S2@$                       ".E?0*IY90"         !-I7T
M HAJ7TBB>:4 @    $LO>B?3Z!-NR5&7;9/F>X70=:](.GWKQ$?[IQY=U.*:
MF_SOJ/PQ_MFG_8AN PF^
M
M
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MMY;;:\?M2A  "*0!(!'BJA.] (                           ! $@
M             !(O&)WIT$\5'+-UDQ&^CVZ\O\K']&>G2U:M<4Q$5?2DCT5/
MD5#R_JD3^9R>=]1>%KHNZ7IYC=R0W28+?@
M
M
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M+5BR)_?G)5QBW9;Y;"S3X[=T+ZB41J)R*5Y%$H!$
M     <&^>Z6FT=A0ZN,N=E5$_(MZ_JG4>%(_?9/V7EOS4NII-/\ ]SZGFJ[7
M1M>>I-53L[7BD73-EO=O]JF5(
M                 "/MJ$^<1%7_ )PG'LNJ]H_+7-\3T-Z:RU1R_9RH[MY3
M2H>9]5BFJR>=])^"KIGHVF_9^N6_#7.I
M
M
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ML?96B?R>VCBX4[K41:>TMS?==O95F.VS<N)2K
M       'GIY\[FF/Z<6WSH[V\N%3V1(TZ[PG_$R>9Y!\VKZ8-/'^>KSN>VDB
M^MFG]H==$[(>1Y+??GOB%,E0                   !'\;UA/>@$
MBL 2                       (HE:KV$7*;K.:V8\NU[%>4ZX;/T-V8SDM
MK%/ OR3N7]4\]\0Q_P";>^D? F3GZ/ACLATJ:5UX
M
M
M                              @B(@$0   1, *"%$44'R7%NV>.2%Z5
MCE:K7UXHJ+P5*>LGVJ+HYHI.YR]Y>'K89+J%MN9=,]K?^.R*O"C7.8M$[*JJ
M&]ZU'/CQY([*.!\$9)Q9=3IYWQ=7S.J48SGI2IHZR] I"H0D AI3T"HB
M                           >:_GLNV?;_3RQ556EI>7#HN:4U(RNGU'7
M^&+)Y<ET=SQCYJ7Q\73VSNF+O\:."*N=[W-G=.NFCRJZ)GO0"D CZO6$]R 0
M  (_B^L)[D @                        (Z5] JGEE (
M     !%*\^*>M")4W1,Q2)EZU^3.Z2YZ,64**[5C\G=V[VN=7316.I]\X#Q'
M;35SYH?0ORZR<W2HCLOF/-2FQUH:)W8
M
M
M                              .3-H+^CGF!W9BY.XS/I(^!G8K7Z9F_
MN5-YGCXFBMNG@\[Z7_XO7\]G"^*Q[?J=8M3@:-Z)2B8
M                 'E9YW[U;KJ=MNRUU;CL$J4]"S2JY/NI4[?PS9,8+Y[7
MAOS.R3EUV+'^&V?7MGZ7&BZ:,5$H]Z*DGW#I8VVQ+S2M;;>V8I/J2DH
M                                      (_C>L)[T @"(W 2     !.
MBK6O847;MBNW;+TZ\D%ZKNGNY<>V7C:9MT^A?_3,:BK\N@XOQ/934Q/<]O\
MECFYM!DMKNN^F=_K=QG,O3
M
M
M                      <E]357;O6G9.>_-Q9!((W2+P3NO2!R53\62IO]
M!^]TE^.>&UYUU^)TO6M/J.%U(GV?6ZS1:I4Y^'HJ)(
M              #YO$<C]*4I15^^1*>+R"\W>12\ZW9YD:M>W&V&/AC3VP)(
M^OKU<#T3P[9RZ2/\U?:^>?F#J:]8OG?%EML1Z8K-?3%/2YFTT:JK_P D-S&R
M(APM-_EL0)2
M    !RJOH03M+9Y=O=/T0]"O(G?(O](6+<YJZDLKF-B^]SE1?PH<?XKMF;[;
M_0]?^5&2/AY\?&L7>MZ+')/7P
M
M
M                        <Q^9#&ROV]@<[;LI<8B^77+]!KVJK?[MJ&VZ
M3EI==;VPX?QQ@NG369K=]ES?>V<I%F=O87*0KKCOK&&9CZ]JL2OWS7ZC%.++
M=;/"76Z'/&?3V9(_6MB?H9"666                                "@
MK%][Y/[HIF=J7A]UWR297J_OJY:ZJQ9%UIWE557X6K-34;V=W@>G=(LFS2V1
MY;7S%XNSQFZKFGOB./ZO&*<.SO:H[>-38N>V<4 @
M            0!(       $ 2          $.:*M:)Z2;=ZBZ:6S+L[R39+X
M;J1F\8E4^TL+(]>/=K!)$M*=O!RG,^)[.;#%_9+T[Y9W_#ZCDL_'9$^S9Z.U
MZIG#O<P
M
M
M      :TZGX?](MB[BQR-57-MUN(./-8._\ ?HJ&5HKXLS6M-U[23J]#EL[J
M^K:PWH%G5RW3NUM%_P HP<LMEX?T6MXL2ORF3UO%\//,]NUK/!>K^/TVVVNV
MSW?4WO$CD;WZ57B:QUJL$                               !\%U.D$%
MW/JHD,4CM/Y#:BR*S$(ONBVV9G@\"MT9%,ON;<65U+)]HY&XN&N5-*N6235W
ME]'>/5]/;RX[8[GR9U#-\;4Y;]];YILI7;LB>[:LG%5+S&WH!   !'F D
M                                           $WSOE">*4(1KI35ZT
M1/NH%-T;/3'MAT/Y6\G]D=<=HL232W,LN+25?I+)&YS6_<C--UZSFT->R7:>
M!]3&+K=L<+Z_7$1ZHE[,'G;Z,
M
M
M                        !\CXHYHGV[V?5R,<Q[>Q4<E%0BV9B(E3?;$Q
M-L[G*G1Z;]$^HF^=ASR.2*:ZEN;37W=7A.X:?35K^'L.@ZI;&7!CR\9C:\]\
M+W_D^H:G1SLCFF8[_-Y<'6,;M3.5%Y<30O1%4@
M         #7'4[,?8&P-[Y=%1CL?A[R5BJM.]X:T^555*&1H[>;/9$=L-9UK
M41I]%ER3-(MLEX4*K7.D6-CJO>YR1O[7.X./5IMI2.Z'RI,Q-T[)K,S.W=->
M,"M=R:PB(+[:;*'*J+R%")V=R4        !,WF@E-N]*$
M                       !,WF@(2@ )F]OI)MI57BC;Y=_ULYZ8YAFW^HF
MQ\S56NM,W:,<ZNE*3/2)SE3T47B8.LQ_%TU]L]DT;'PWJ)T^MT^2=D\])X;Y
MC;Z:>M[P^(Q*5<G%:)[?0>7/JNB9%U<4Y!"8D
M
M
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MXK8GUPR=$TMHG840R$Q(
M
M
M                  &C^NNVEW%L>_FCB5]W@7?'P,9S<QO"1/VJJILNEY_A
MYXCM<MXNZ=^<T%TQ]ZR>:/1O7;H_NA-V;#PM[/-KO+6)+/(-7GXL-$^^U6EO
MJ&"<.:8]/K97AOJ,:_067\8]V?/#:C$5%?5O+D8#?U5B0
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MR'3A(
M
M
M   'P7-M!=0SV\S&NCN&/CF8Y*HYCT5JHOJ5%H3$S%T71P4761=;-L[8F/:Y
M0Z2W$FQNH^ZNGN0DTV=[.LN(:O#0Y%U,T^IS?P&[U]-3AC+'WHWR\[\-7STS
MJ.;0WS[MT\UL<(KV>CV.MH:4HE>*(M'&CEZ/2FQ]
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M)K^BW3R8PW^UP=TQ-VR-GE2( D  3:E](HGFE*$     C[*A/F0"
M             $S%1'K(OS.:?C?,(FM*0B(MNGWHK]O"?1#T(\E.P()\3OS>
M&2MDECRJK@K!DJ5:^&-B_$*GJ5RZ?8<=XCU=;[<=O#;+V/Y8])Y,&;-?%8F9
MMMKV<:>=P[O3 3;3WCN[;5Q5LV"R4]K#J[NN-)'2,?\ *AU&ESQFPV71NH\N
MZMH;]%J\V&_?%U8X<9GZJ,7,IK@      $?R:^A1N3;OBG:]-O)#GWWFQMR[
M<=(KI,3DUNH51>"13MHB)ZM3%4X;Q1@Y<\7QQW][VWY7:KFT.3%,UY;YF.Z)
M[.ZL2[H1:HB^DYRCT^J)"0
M
M
M                    INC1U57FK:$U(V35RSU^P=SBK[;_ %$P[52_QEQ%
M#>RM[$:M87N7T<VKZG&\Z-DC)S8+N,5>?^--)=@OQ:_']ZV8B?-V_4Z&VOG;
M;<V!QN<M'ZH<C"V6GT7<G-^1R*AILV*<5\V3P=KH=7;J\%F:W==$2R0MLL
M                           HN<UB5<^B<T]HJ/#[KON)^Y^K.^<JR9SD
M@R3K*WE['):O2*.B^E$1*>OB>F=+PVX\%D1&^(]FU\Q>+-7=JNI9LL75GFY?
M1;,<M._VLPZ;^9_JET[DM[&;(?IMMUJ.2XQ.7D5UW$C?\%>-[VJG>1')13$U
MW0,6>MUE8NGRW-KT;QYKNFQ;CF?BV;=EV^/-?OFF]Z#]+O,MTWZFK'96^2_1
MW<CF_6;<RJMAD<ZG!(GU5DG[%:^HY+6](SZ7[T5CMAZWT/QEH.J>[;=R9-GN
MW?5.[ZW0C7RJCZKH3G'PYFJI+KICLE]37([BG($Q1\[[=C^*JZJ+6J+Q3V$J
M:/DR&)QF6M);#*V,.2LIDTRVURQLL;D]:.14*K+[K-MLT6\V#'GMY,EL71V3
M%7GQYAO+ATEVCMC,=0L1E;C8UQ;I2#$Q*V:TO)WUT010.HK%<O"K>2<:4.GZ
M7UK4WY+<=U)CS>WM>6>,O!_3=/IKM7;=\.Z/N[:Q,[?=BNZOI^IY],55B;(Z
M+1K72D*?-<=M=&V:/&;LML6?$F-DS]&Z-G"7I5Y']H_!;5W)O::-K?TBOO@<
M<JI1Z06GOI7Z+E5/N'"^)M3-^2,<;HBOI>W_ "OZ=&/39-33[\TC]FW=L]3*
M_.+LU^?Z80;GCB1U_M"X;<2/1*JEO,Y&2-_;(Q54L>'M9.++R<+OJ[&=\Q>F
MSJ.G?&L^_CGT<LTYJQZ(\SRO>]51]'ZT3BS]D=_=$5BFYX)/NVS%>V/3Y^RD
MJ84@               "9O- 0E               F:USDHQFI]&I"QOSG?-
M(FZ+/>GAM5V6771/+&V(I'?W^K<]PNC6T6[!Z;;1VV]%2[MK)D^25$KKNIDU
MRN]7>6M.P\OZCGG/GOO[9?3_ (;Z=&@T&+#QBVL^>=_F\SSR\Y>T5P?5"UW#
M;IIM-W6#9Y7JE6I<6OU;J_1U:JG7^&M1\33SCG?$O(?F7T^<&OMS6QLOBO=6
M-GHV5VN2#HGG8      "9.ROND2F-F]V/Y)MP+C^I&7V](](H-P8ETL<:\ED
MMGU;I7M[KE]IS?B;%-V.+XX/1OEEJYQ:^_3S2(NLKZ:SQX[/6]5432B(G)#B
M'NU*)B$@
M
M
M       QW<&&M-P8K)X:_:V2UR$*Q2MIWFJON.3UHM%3V%S%DNQWQ?&^&-J]
M-9JL-V*_;$Q1S?T/SEYM3/YWI;FG*DEI<R28A9%I^-H1/QTHJ<>Q3<]4QQGQ
MVY[=]-KAO">LOT>HR=/S?JS[OF=512:TJKF>UJFAB=CT.8IO?02@
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M;?O8YYO1Q[X>4B4>KD;(M$;K1R>H[W]:E'@7-9?2+;IV[?5.U3*E,[P
M(^\FGL!3F]UM/HIN5-L]6MBYJ:;P[=N1BL[E46B.9-JBHY?QE=7Y#7]4Q?$T
M=\<8=%X7UOP>K8<W"O+/LK/?/WGN8>9/IP
M
M
M                                  "@YJU54=34G'Y 1LFKF/KOL^]M
MG6'4; .6WRF#DC=?/BK58V.16/<B=B<E]INNDYXFN&[==V[G!^,>G7V1;KL&
MS)9OF.SRV>ENC86[+/>6V\=G;;3%+,S1>VJ*BNCG3WFK3T\T-;JM/.')-KJN
MD]2MZAIK<L;Z;8[)[&<HZJ(M*>TQIV2V28D
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MX
M
M
M #X+VW@O;>2TN8FS6URQ\=U"Y*M<QR4<B_(HC9M49++;[9MF*Q+CS'RWW0KJ
M#<XQRODV7N"5'0S2\61-?16+Z=4=51?;Z*G14C7X*Q]^V/H>:8N;PWKIL_\
M0R3OGA,[H]'%V+!<0W,<,\,C9K>X:CH)FK5KFN2J*B]J*ASD6S$S$\'IEM]M
MUL3;MB7VDJ@                         "*T'FSYY]QMN<AL/9\<FKX6.
M;*W36ZN;ZPMJG9I1*H=CX5PQ[^68V3LB7C?S3UM9PZ:N[WKHV[MU9\V^'$&W
ML#D=QY)]ICF.; B5O[UWN1L7DY'.XZO5S.FU&2,416=KR_2Z>_/?-+=FW;W3
MNFL]G8V5FLYC=DXEVW-M(Q<M*W5=7K.<6KYSG?3=\WT)SXF/AQ3DNY[MS89\
M]NFQ_#QTYOT^WO\ 6TVKEDI(][GSRN<Z9ZNU.<[Z3G?2,Z)[J4::[;3;69KZ
M*;IKVP@2@ BM'->0;XE.[O*]%<C6O<WQ(=+=+VDU.7;-:?1M[$BII8KZ=U&N
M<S\EI$364\L\LSV>CRJ])_)#LN.SVUN+?%S%_*<U<I8V+W<=-M;(NM6+Z'.5
M%3V'$^)]57+&.)V1O[I>W?++I<8]-?J;K:77S2)[;8W>AWG&C4;1/8<R]0E,
M]*^TCBAP?YW]IK=;4VSO*.)SI\-??!73FKRAND5R*[U-6.AT_A?/RY+L<SOW
M/,/F?H>?26:BV-MD[:=E-M>YYJ.141%7DO([?C,<8>(3]V+N$[N]*
M                        3(G<56^\]=/[/YA%^V.^/9Q51'[NZ?+FB:V^
MM[0>6O:OZ(]'MGVCXO#NLK;KE;[4G?66\=XM%]B*AYKUC4?&U5TQNC8^E?!V
MB_*=+PQ2EUT<T^>[M;^-:Z=!W)1 \E?.+LIFW^J$6XK6-(K3>UDEU.]&\$N;
M-=$M?6^J.4[KPUJ/B8;K)_5W/!_F3T^,&OMR1%+;XYIGOM\JRY*.C><@
M  'ZH0]:_)]N3[9Z066,FD\2ZVO?3XYR+WETK]<QW#L^LHGL//O$6G^%J]D;
M)BKZ%^76OG4]*MMOGWL<S;/=MV?H=9,6J(J\S1TH[J4X
M
M
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M5[7&Y4"0
M
M
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M+W<4+/\ T2R*YG]Q0]4TF7X^&R[N?*'4]-^3UNHQ;Z7S'KV^QBYDL$
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MQSS&)?3:)(
M
M
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M-_FF)V1W;?3=,1#0AMG*             1_)J$^9 ( (\6J#<@
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MBM:C9:KZ=35/+=9AG#FNL[)?572-9;K-)CS6[KK8^SVL^1*&,V2(
M
M
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MM"RM&LC:B<%557GQYGE62^<ETW3MF9J^J='IK-+ALPXXI;;$1$1PB(9 4,D
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M1N3A(
M
M
M         D<UJJBK\WB43;$RF)6S(XC'9>!]OD[&&_@<BHL=Q&R1./HU(M/D
M+ME]UDUB:+&;3X\UO+DMBZ._:TON'R];"S"R/LHI\-</[R);NK'J].AR+3Y%
M-CBZKELCWJ7>=RVK\%:#--;(FR>[=ZFOG=#-\X65R[9WLJ,]U+?Q)X$1&\4K
M5RM7Y$,R.K8K]E]D-1=X0ZAIZS@U$TGAM3+A_,?A:K'DERD$:Z4ACEBD5:]O
M>8B\/:+LFAR1MBDD:7Q#I]U\7QZ$S>HG77!Z4RVQUOX8^,DRP*JZ4Y]Z-WZA
M$:717[KI]<*?Z[U[3?Q-/6/+LE]<7F-S%DNC.;$N8'_28LD:?W;'$7=(LN^Y
M>N6>.<N/9FTUT>:)^R5^L_,SLYZZ<AC,ECU]3&R_@5I3=T'/39-K*Q>/]#=/
MOVWV^BK)+;S =-+I&US,EFY4[R7,#VT]M*F/=T?4QPAGX_&G3+__ %)CSQ*\
MP=9^F,U$_3&P21>Q=;?PM,>[I^>V:3;+,M\4=,N_]>U=$ZI]/7I5F[<<Y/7+
M3\*$?D\WX)7XZ_H)W9K/6@_JGT]C;J?N_&M3T^-7\"#\CGG=9)/B#01&W-9Z
MULFZT=,8:M3>%E*]/[U'XCE7V4;0KMZ;J;MG++'O\4],L_\ 6M]#&[[S$].;
M36C+B_O7<=/P]M5/NN<TO6]'U$[XA@9?&_3<?ZUT^:&'7GF9M7JZ/"[1O;]R
M_FWN>JU_8,:Y?OF1;T:D^_?#6Y/'V.[^#AON\NY:5WGUUWFK8<%MU,#;2<$N
M4C\-J(O*KY554X>HJC3Z/%]ZZ9]2S_5.N]0BF+'&..VD_6J0]#-Z[FD6YWUN
M_P 9L_>NK=CW7*^BB5HQ.'H2A-_4\&.*8K=W;"+/"&NU5W-K<\[=\1/E#<>U
M^CNP]L(QUKB(K^XC32VZNT29?D:J:$^X:[-U#-EV3-([(=1T_P ,Z#1TFRSF
MGMNV_H;09$R-J,8B,C:B(R-O!$1.5$3D86]OXBD4B$[&:5<NMSD=\U:< )9I
M8X(I9I'HR.%CGRO7DC6I55^1!29V0BZZ+8F9W0\*>JFZEWKU)W?N)DFN"_R$
MOPDC?=\&+ZN*FKZ342IZ?T_!&GTUN...]\O>(=?.MZEDOKLNF:?\/G\^VC7I
MG-'O D    !KJ=Y%3VD3LC8CGI679ODPV3]N;ZRV\+B%'6&T[1(;:541&.O+
ME*\EX\&(KO4<YXGU,68;<5N^[?Y?0],^6G3(SZW+JJ>[;$1_Q_5LV[7JF<+$
M/<PD  %.3W%H4W;B'C_YNYDEZU99$TKX%A:,D5/4U%_5/1.@6_\ B0^>?F+D
MYNK3'9;'JV.8S=N'                              'H7Y$9F^%U$@UM
M5S);.3AZF4_Z)QWBJ-N.>Z?:]?\ E5DV:BWOM]E)>AT;EKI3DUIR6YZ_,4E7
M)  !\[X6/16N1%1Z*BHJ51:\Z^TB(VU.%'B'UTV/)L+JKN? -:L-A>77VAB%
M?1-5M=+J:M4:B<'(NKV'IG2-3&?21=7WK8H^8?%G2YZ?U*_#;&RZZ;HK^&=N
M^E-_T1WM2*K5?)X?N:NYK^CZC8QMB)<],^],1V\=U.Y E(     '5_D\WDW;
MO55V"N)4CM=Y6+K-NI%5%N8566!C>*M6J*XY_P 1Z?XFFYXWV._^6_4?RO4K
ML-WW<UM(W_>B:Q;&V8W;=G:];(]5%U4KV' 0^@%4J0
M
M
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M/C>M^^FI2EI<0VZ\:^Y;L=R/1^B6S9I+.]\W>.+^?J^;=-*1WQLK]30AN')
M                             #NKR,7:)N;J'CZ4>_&6EPUVKG25S?=^
M4Y+Q59[N.[SP]6^5E_[_ %%G;;$[^R>SAO>F3&4..>TSO5"4   !P+YVMBK=
M87 ]0;6WJ_"O?89I[6I5;6>OAN<OH:^B+[3J?#&IB+[L-WZSRWYF])G+@LU5
MFR;9I=-/U9[>ZN]YM<%5E6:'+_>SLXV5CLV/%)NMNNV13;N[>V:=B!*
M +Q@<[=[7SN&W%8O?#=X>_AOH)&IQI;JGB?MFJY"WDQQEQ9+)XPR-'J[M-GL
MRVS/-%\3;3N^]Z-\2]X]K;AL=U[?Q&X\7(DMCF+:.YM^-5[Z55J^MJ\%/*<N
M.<=\VSP?5NCU-FJPVY;=UT1+(FNJO!.'I*&3L3@
M
M
M
M    'SR^ZC6_.72I!5Y->;GJ.W=^_(MK8J7QL+LI71>)&NIDEX]$2X=3M\.B
M-^13O?#VA^%BY[OO3['@?S&ZS.LU=NFL^YCG?_FXQW\//$3V.3#H7GH
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M1N5M/E1IZIBOC);%]NZ=KY6U&GNP9+L5_P!ZV9MF/HV=VSUQ/8^:B)IHGO\
M>XE2Q;=$[H^JOF2$@    )D<J-EH_P"O?1L:_,T\.7Y)%NR9[#FGEN_'.R.R
MDTX]STB\E_4KX[#Y+IKD;I'WV&1U]@M:JBOMGT61C4YJK7=YR>AQQ?B30_#N
MC-;'NSLGMKM>V_+3K?Q<-VDR3[]NV/V9B./;V]CO6-.+GKP62E#EHEZC2(FJ
MN2
M
M
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MT;O0YB\%3TGEV;#=BOFV=\/J/0:[%K,%N;%-;;HK^CT,K+;,
M
M
M
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M_BL?_5D?W%HNV?4?_'O6/PV?\T?8C_8^Z[?[&PW_ (K'_P!63_<6C[9]1_\
M'G5OP6?\\?8E_L@==_\ 8V%_\69^]']Q:+MGU'_Q[UC\%G_,C_8_ZZ_[&PO_
M (M'_P!6/[BT?;/J/_CSJ_X+/^:/L/['_77_ &-A?_%H_P#JQ_<6C[9]1_\
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M_P T?8C_ &/^NW^Q\-_XM'_U9']Q:+MGU)_^/>L?@M_YX^Q#^Q_UU_V-A?\
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M/_QYU?\ !9_S1]A_8_ZZ_P"QL+_XM'_U9']Q:/O]1_\ 'G5_P6?\T?8?V/\
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MBG+2:^>O9LVNNN:U]"*:5W"H0D
M
M
M
M
M
M
M
M
M
M
M
M
M                                      IJY$TI](#XXKQLD,\_AR-;
M$KD5KF=Y=/H](1$I'9&)D$%PL,VBY<UK6(Q=3=7TD[!2J)NB%7XMGQ+;9$?K
M5BOUZ?J_NDT3S16A!<MEEGB;'(Q;=VASGLTM=^2O:0E]P
M
M
M
M
M                2/5R(M"81.Y8HILNEG=ON;>UCOF/D2PA8]RL<U/S>I52
MJ*J<Z$TBM%N)R<LS,17@A-<9CX.Q?':VLEZ^2+[1C<]R,CC7B]6+2JJG8B\R
M8BVLJ+IR\ELQ$5V5\W&CZ%DO6Y&-C88$QKHGNDN%<OB^+J16HC42FE4XKQ(C
MEF%R>?GBD12FWM1LYL@^>]2\BMX[=LVFP=$YRO>RG-Z*E$7V"8BB+)R3=/-$
M4C=^E>"E=
M
M
M
M                                       !1?[W"B/T]U5)A$L9M;.9
M,9E87YIUP^XEN*7ZJU76RO\ F-^;]7R0JK286HK-ET3=Z>Q\]SCWR8W#0+N.
M2W=:3P/7()X:NNTC2NAU>ZJ/[:$UVSL6K[*V6Q-]*3&WM7&2!9<Q#=)D7,C9
M;.9]E(K-+]3D7Q%^?5*40B-D;EZ8CXD71=MB)V?68ZT?#>961<H_()<W+9&V
MJZ42U1$IX::>*>GB+IK$(Q1-MUT\U:SZF1E"\
M
M
M
M
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M[C?X,L6N?PZHNMZ(CTIPU-X$76S$1WHTV;#DOR19,UMFEV_?Z=_HV,Y*&8
M   !!5IQ4""N1O,!J3_DBE-4T4_%CHJUX,2KOD*D3L5$5')5.2BHF      !
M3<]K51%YKZ@E%'M5*IR(G8B-HKFHFI1&U,[$XJ@) "CXD:+35ZDX$5VT!)8U
M70CTU>BO$FB*\$J31NU:55VGWJ-4*J;:)_$9JTU[_P!$(B%2O&@$0
M
M
M
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M^DD
M
M
M
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M*66;OL;'P3X,NZ/=.HU$Q.68I%.$=CM5C::E^DM3G8V/0X3DI
M
M
M
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MQSI>L6Q;?[F2>$SO\SJ:B.TMIP1:._":68KO=UNA]!*
M
M
M
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MC1_EM5=$12W?$=CZF\)=8_JO3L>:9K='NW=]T;*^G>WV:YT@
M
M
M
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M=+'+KT^W2ASOB^(^/93L>F_*2^9T^HCA%UM.S=+T..1>N@
M
M
M
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MG>[0.<>B
M
M
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M#?=-\\T[Y?0>.RW';%ML;(BGFB%V(5
M
M
M
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M8_35/NDY-7FOBEU\SZ48NEZ3%=S68K(GMBV(]D,S1G?UU5%7FTQZ2SYE7)0
M
M
M
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M_'9$V<D1NFE*J^A8K+,VHFW4_%F;]MM8]R>SN_0WZ:]T8
M
M
M
M
M               +?=*U&2/<RM&]Y>/NHO>Y<2(B9FD;R9B(GFW.,=KYWH%<
M=+NK-[A]F92'9]OE)/TSQDMG.DUS=*Y:.B;K6K6KQ2E-/:AT-]FJ_,8HG)[U
M/=GL>>:+4]'GI^JNQX+XQQ=/Q(IMNGNV[H[.#Z=R9GH2SIET5N\OL_)7>S+V
M]MOT'LF02NDLGIR;,UJU5*UJE5U#38=7.HSQ&2(OI/-.ZL=AK]5T;^G:2[)A
MNNPS,?#BE9B>_M^GF9O=93I.GF$P&,NMN7C^J4N$:[%[@;:RK:LM%BE5&^+J
M5C51B/;54[:<U,6S'J?R$SSQ\/FVV\9\I^UM<V;IO]:QVSCG\Q-GNW4V1%)]
M6RL5IW(=$\ATKO=T]3&=.-OWV%R;,I7=UQ>02Q,GG1SVHMOK56HU':EI1.=:
M%.OMS_"Q_%OK;PCL4^&<W3+]3JHTF*ZS)S>_,Q2)FL[MOGFFS?7C5T^:MV
M
M
M
M
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M&^#!=(
M
M
M
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MU3O%&U.P[PVFP75V$Q"%)ST91'(J(O;V$[B%1%6O$E%=M$X2
M                                              /DE<]->A]'(RK4
M5*H@3#5&^.M?3;IQ>6^+W;NNVL,E.C598-1TL[4=\]S6(NE/6J&9I]!GU-9Q
MVUHTG4O$?3^G71;J,D6W3P9GM3=^W=[8QN:VOF+;-8J1SF)<6[D5&O;S8Y$K
M14]9CY\&3#?RWVT9^AU^#6X_B8;XNM[F7EME@
M
M
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ME7]4&X.'[$8UCUQ_PZ6\J1N<]/GK"KN?#T\3"MNU?Y"ZV:?#BZL]N_[6\O\
MZ5_7\4S-WYGX?NQ^I3EGZ>6O^)T"7HVF\NI_]&5UEKC,)D%_2!,DCTA:OB25
M^%5WO-\35Q=WO1P)ZI^:^!C^+$1;&ZG'RCRJM^$K>D6ZS5?DING)S>_S;M\_
M=[J\W^#KDTCO0     *;Z*Q:MU)]$B=R&MNJMY=XWIUOB_L;J2UOK/#W,UK=
M,6CXW-;5JM7L5.Q3(TD1=FMMG=,PU_6LUV+19;[=\63/IB'BXG5[JM1O_P!T
MS<__ (K=?OSU'^EZ7_2M]4/E?^Y^J?\ N<G_ #W?:F3J[U7574ZE[H:D>G6J
MY.ZXZOH]_D1_3=)N^%'JA7'B3JE)G\UD[O?N/Z7>K"K3^DK<]'(NE79"Y7W?
MV95;TK31/O88]2J/$O5II34Y?^>[[>#+]K>8OK'MB9ES;[TO,C$YR/N+;,.6
M]:^G"E95U,2GT%]9A:CHVESSRQ9R^9L.F^.>JZ&9N^-=DKMY;IFZ._?-8V<(
MV<7HUT%\Q>(ZO,DQ&0M(L!O>R@\6?%I58+F%KJ+-;.<JN5J5XIV'&=6Z/?HI
MK&VW<]N\)>,\'7+>28Y<T168X3&Z:>9TS&^1[U32B1K16N3FJ=M32Q+MHKZ'
MV$@                                                        !
M\LB-U<4[$2ORBM$Q#PHZR1YVVZJ[Z9N:.:/)29:=S7SK1SK9'JD#XEDX*U6H
ME$/5>D7XYTV/X=(GCYJ/E/Q9CSV=5R?F8FZ>;9V4==^0S[>==[]F=$]FUY8+
M30YR*C'7^I_B>&WDE64J<UXMG%SV\LUEZ/\ *:W/%N>)G]W6*>?NX;OJ>DQQ
M[V0
M
M
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M>]5XT1J.]1<NTF6V*W6S"QCZII<ET6VY+9F>R6<&.SPD
M
M
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M\U=NV-N^ET^GCM>XK?=XGEMKZEE,5(
M
M
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M;W=7#FIV?A?59+[^2Z:Q#QCYI](TV/'9GLMI?=-*QLB=V_@Y?\N/]>?32O\
MM5W#_P!1(=#UG^3R^EY_X%B8ZYIXG\7_ -LO<=O)#RNU]3IBH
M
M
M                                               "P9B2."PR,\MF
MZ_A9;O?/8L:CW2M:U55B(O-7<J%6.WFOMB)I-=ZUJ+HMQ73=$W12=GU>EP+M
M3>^QKCHYUGR5MT,AL<7C<E;LRNW&2O<S)22R*D<LKWIJ8L'ON1J41/=.HRZ7
M+&KPQ;FVS$[9B-GF>3Z/K&CNZ5K<D:'EMMNCFMK/OUG9,SPY=\]D3L?!N[?^
MR+7I=T4O[OH%'E[')R7"XW"N=(R&R6.1B.9#(UNJ5;A5JU'\'(G$N:;29[M3
MFB,U)C?.S;O6>I]9T$=.T.2[0\UM\SRQ6D6[8VQ/'GG=7?%:MKR[JVXOF8VU
MA%Z3QIGI<5;K'O:17-FMV/M7N:U(D3PU1C5\+5S1%,"W3Y(T%]WQ?=YON]NW
MMWN@NUVG_N'%B_*4R39LR3.VV.7A;NFGW>V$WEVW1MG-[VZFVN!Z4)L.ZM,@
M]U[EV*^1;E&RJU8Y-2(C'N7OZ6<.U>PIZGILN/!BNNR3=$QLCL/!W4M-J-9J
MK,6E^%=$S6[?S;=TUW3QF(V<79YHGH8     $C_=<1=N&KNL7]5_4/\ F.Z_
MBS*T7\Q9YX]K4]?_ -OS_P#;N]DO!WL;^2>O/CZ7I9Y>.@72S?72;;6YMS;<
M=>Y>\EODN;IEU*U%\*YDC;5&N1$HUB' =9ZKJ=/K+HLNIL>^>#?"72^I=)QY
M<V*MUW-6:]ETQV]S2/FFZ&8OICD\3G]H6SK7:.:;\)=6ZR.D6VO(TJBHYU51
M'IQ]IMN@=5OU/[O).V'+_,3PKCZ7=9J-/;3'.RE=T^7TM#=,-Z_T?[UP&ZWV
M$%_8XZ1R7=I,U%22VE73*O'AJ1JU1?2;GJFFG-I[K+9]YQOA_J4]+UV//-L7
M1$TNB8_5GZ*Q$Q/JA[FX3*6&<QV/R^*E;/C,E;1W..NFK5'12-U-5J=G \KR
M63CNFR[?$OK#3ZBS-9;DLI-LQ6)CBXL\]]K._9.QKB*/Q8;7-SLF>GS5?;.1
MOWT4Z7PI?^_OCN>6?-RV;M%ANX?$GZ8_0\WMN8=VX\[B<)%<1VDV7O(+.*>=
M%6*-T[T8CWHUKETHJ\:)R.WSY8Q8[KYX1,^IXCH=-.JU%F*W9-]UML3P]Z:5
MW3LKPI$=LNOE\BO49:UW=MR9B(JI*UEPG=_:G,QXKQ?AGR]+TR/E'K)_]>S_
M .K[$W]A'J/V;MVY^TN/WI/]V:?\$^7I/_B+5_Z]G_U?8-\C'4E&\-V[>IJ5
M7MT7*HM$IP[A,>*\,1-+)V^7:F?E)K9B8^/9_P#5]CNSH/T]RW3#IOC-FYJ]
MMK^\L9IY&W%HDGA>'*]7,1$DHM4KQX')=2U-NHRS?;%(H]8\+=(S=*T-NGRW
MQ==$S-8K2D[HVO,#S4?UX[U_Q]K_ !#3OO#W\I9Z7@_S&_WC+YK?9+I;R"_F
M.J7^/Q7[BY-'XKWXO-/U.U^47\+4?\'LN>B3UHU3CWL<N'_/#F;&#I;A\(Y]
M,GE,Y:W5G OSV6S)%D5?DD0Z7PMBY]9$]TO-OFCJ<6/IUN.[CDCZ(FKS/VO:
MRWF[-L6<2>-+<9BQ;X;?FJD\:N=\AW&JOY<.2GX7@_2[.;6XJ;^>WZ;GOIN-
M*;;W#_-UU_$N/),'WX\_UOKO6_P+_P!F?8_/$S\Q'ZHF_@/9;.'F^I\9SOGS
MO>'H7_5)L+^:8?P*>3=3_F;_ #OK;PS_ +;@_8AM5Z<N&KBFHP)FD-Z\5?-'
M836/7/>3)(]3KMUK/#I[&R0M=S^0]-Z%DKHL?G?,?S&LBSK.:.Z)^B&^_(AG
MK:#.[XVTYC&3WMM:7UE*[WWZ%5LC$_);1WRFH\76;;)AV'RFU5MF3/@G?,1=
M'?Y13Z7IJ<4]L<^^93/8[;W1C>DU\ZC,E;?9MLU?\/=N1K/N5J;+HV/GU=KF
M?&&KMT_2LTW[KHI_S/$]J.91JU<Y'L;(S\;_ /J/5+HY)GS/E3'[\^[NV/9S
M=>#N[;ROWN'>ZM]C]FMU.3M6&W:Y?P'EVDR?^=$]MWUOJ7J&#_\ 0W63PP__
M &O&%>$=$3W8^]^-1/WQZG9[^2;>Y\L6SMIY=OJ>Y_0G=%CO#I;LS,V"M5J8
MZ.SNXT6JQ7%LGARQN]BM/).HXOAZB^.]]:^&-?9KNFX<MOX8CTQLGV-RF$WS
MQB\VDD;^N6YUCD5\C+:U:Y/H]T](\.4_)QYWS7\R)F.L9/V;6_?(-^<ZD_EX
M[]S,:KQ;]ZSS2ZSY1_=U'GM^MUWUZ_J;ZC?S/)^[0YGIW\S9YWI'BG_:M1_V
M[GA//^8D_P 4O[D]9R?5'UOD[]>/1]3]"6QO]R]H?S'CO^S,/']5_%O_ &I]
MK[#Z7_*8OV+?9#()W45C43BYU%]25I4L3'%GVS27B?YA>I&6ZC]1\ZZ6ZE3"
MX"[FQ^$L%_,L2V>Z%\BHO#4YR+Q/3^B:''IL%LQ]ZZ/\7S#XVZ_FZEK\EL?P
ML=U([-FS;PA=>AWEWS76-LV4^UUVQMJSE2WDO_"2::9ZK54B:]R)6OI+75^N
M6:'W;8K<R/"7@G-UN9S7W<MD3OVSZMO;VN@MP>16>TL776S]_P UYEK9?&MH
M,G:LA:Z1.*:9(>\BU]*&GQ>++KMF2R*.RU?RGLMMY]/GGGC;[T1Z/I<%[EL,
MQB<[E<5N%KDS5A=+;Y6.63Q%69J]K^W@==I+L=V.N/<\>ZGCU&'57VZF?WD?
M>[_/W4>E?D-JNP=\5]Y=QMK[?@X*G$>+-N>W]GZWMORCI_3\W_<_^V&:>=/^
MI"^_GK'?QAB^%OYST3]3=?,W_9;_ -JWVO+CIU_6%LG^?+3]VAWFM_E\GFEX
M%X<_W'!^U;]3WZ@_-H>21N?7,."?/O\ [I=/OYZN_P#LJG6>$_XN3T/)OFY_
M)8/^Y/L<=^6C^N[8?^=S?Q2G3=<_D;O.\Z\"?[UB\\^Q[@'ESZ?>7_GS_P![
MNGG\SWG\=&=OX2_@Y//]4/#/F]_'TW[-WMA@?DK_ *XE_FB?\)E^*?Y2/.U/
MRK_W*[]F7JSN?_=S/?S3>?Q+CS_#_$M\\/H'5?P;_P!F?8_/G/\ Y1<?EN_"
MX]AL_AQZ'QOGCWK_ -K[7MKY9OZB>E_\T_\ V64\NZQ_.9/.^J?!?^SZ?]GZ
MY/,]_4+U,_FMG_:(BKHG\YC\_P!4J?&O^S:C]F/^J'B#/^8D_)=^ ]2E\IV;
MX\[] VP_]S-E_P#R_CO^SQ'D&I_BW_M2^QND_P GA_[=G_2YO\[G]2;O_F''
M?AE-OX9_G(\TN+^9_P#L\_MV^R7E#@O]>8+^<[+_ +0P]#UGW)_9GZWSUT_^
M9Q>>/:_0VOO-_*_4/'(?93Q3\U']>^^/R[/_ +.P]/\ #_\ (V^=\P>/_P#>
MLOH_Z8=;^0K_ '.W]_/UO_V=ISOB[^/9YGH?RC_D<_[<>R&XO-=_4=O#\NU_
MC6FIZ%_.6>=U7C[_ &;/YH]L/&FU_P IMO\ '1_NVGJ%^Y\NZ?\ B1YX?HFM
M_P#)XO\ %M_ >-SO?9]GW8\S7?6+^JCJ9_\ +.5_[-(9'3/YC'^W'M:CQ-_M
M6I_[5_\ TR\$E_--_(0]@^Q\BV[_ $OT [&1';&V>B\OLFQ[O_JF'CFLFF6_
MSOL7ID5TF+]FWV0\2NK-C]E=5.H5DY'5LL_<HD;W<7=^K>/[(]1Z9=%VFQ>9
M\O>)[)Q=7SQ_GGNX^UWEY%]U6D^V-R;+?*Q,EB+]<C$RO&2VNDHKJ?BN;0Y+
MQ7AY<\7/6OE3U&S)I,NG_6MNKYXGB[X?[CO8<M&]ZK.YP/Y[I(EVILV%9-,L
MF1F<V'Z7U9U7A**9+WE/S:G_ ,+#^W]3C#RW_P!>/33T_:KOXB0Z?K'\GE\S
MR[P)_OFG_:G_ *9>Y#>2'E<;GU0F*@
M
M
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M9O)#RRU]3IBH
M
M
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MF/T/;]*TXGF$/J%$D
M
M
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MI?=%(M[+9VU[=NSRJ[WC2C$1>2)VG+P]4G>J!
M
M
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M4JG#[AK*NG\VQ7:CD:B*NI?G.!"<)
M
M
M                     !1E;J:B*W5144B=R7$_4_;.4NO,=T_RMOU9M,%
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M$14:BJO)#F.HWVW:B^EO+MW;GJGA_#=BZ?AMNR?$F+8]Z)K%WIWSYVTS#;D
M
M
M
M
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M97?OG?Z:MQ&$W@
M
M
M
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MN
M
M
M
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M-D
M
M
M
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M=ZJ
M
M
M
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MIJBFLBLQ$SO43"LU:HU2NJ$P
M
M
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M-9#'"0
M
M
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MT;2? NR<_O3-:4IW<9]+>;&Z:56J(B(U36Q$T=/,UE61*)00A$D
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MS'6OOV?L_7+%U6R77AHV*
M
M
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M%]%TK-DS8(GFR;Z]E:TCNJW=1$Y(8+H:(D)
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M3TI@NH#6\VYZW_\ U?;'+]9^_C_9^N6)K(]YUN:.&*$@
M
M
M                     2*]OTD^Z31%84W3Q-^>B_**2CFA3=<(G*B%?(HG
M(HK=N1:4X>P<L(^)*5;J5>2H3RPCXDI'7$B\_O#EA$WS*7QW_C"B.:3QG>A1
M2$\TGCO]8H<TI_B9B.6.PYY3)<RTYH3RPGXDJB7+Z<:5'+"?B2BETO;0B;4Q
MD567#%]Y4:1-J8OA426-5IK2OM(Y95<T*B.1>2D435$A(
M                       6;*6-EE+>2SR%E'D;.9$;+9S1I)&ZCD5-3751
M:<^*%5ETVS6)HMY<-F6R;;XBZ)X2Y.\Q6(ZHV[-C6/2O86-SN*LI)'W,"V4%
MRMO.U41D?AR(C8H7-555[4Y_?W?1K\$QDG47S$SN<%XSQ]2L^!;H,%M]D3-8
MI$TW4C;-(M\JPZ6LMOX^6?&9K(X"P_2**UB\7)>"QTL<JL1'L8]4U(UJU1.)
MILF:;:VVS/+5VV/2X[[K<M]EOQ(MC;2*QW5WLJC:J,5>]S]UWM+4LR9YGU$H
M                                     "M *:R1M]YZ)\I525,W1"FZ
M=C?=<COE$6HF^(4777"J4J3%JF<BG\6[T$S;L4_$EX_^=]ZKURC<O;MK&]W_
M -9.IWOAN/\ P_\ BGZE<SM]#G[;_>5KD6M%-EF96'>V];M1UA=JUFO5:3JE
M.=?">B??-9=]Z//#8VQ[LP]4^EJ23=*]FV[TU+<[?MXGHO-%6!&T4X_71'QK
M_P!II,ETQ?,-?=#9/A,KNVQ1R.:C(D1J?-=#)+&[[FGB:^W;6J;II# //6]R
M]$[)O.FY[#^*N#I/#,4U7_#/U*)G9Y=SRHP:.\:-K>*NHB.]"G;9MR_AET3M
MN.26*%L:HYRIV=II<\TEM<#OKRMKX&'ZAU14U9^WT(O-?^[K8YGK&VZS]GZY
M86MFESJYL\*I[R&EBV:,3GA421B\4<GW2:2<T)T6I"I$
M
M
M                *4DJ,*HMJINNH^9UTBIW6E46*+KWSNG>OL)Y:*)OE(LC
ME["452DH              1JJ+7M J),Y"*)YJ)VW#_G*OW2(M5<\OJ;<M4I
MY%SG5T<CD1R<E*:*HFJ8A(
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MRT*)M5Q?57*58
M
M                                      %-96)S4GEE3S0^5]TE7-:G
M%/G$Q:HG(I>(YR5=[Q7$443=52=V%2)2!                      !5:M$
M2G,A,*C;A[>ZO(IFU5%\P^AEPUVJJZ2F8HKB^KZ$<B\B**XE,0D
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M*=A$Q55$T5&W2]J%$6*OB/K;,QW:4478NA41:\4"40
M
M
M 4GR-9[28MJIFZCY7W*JE$[I7%JCXCY5<[M52JBW5*2A&M.0$
M             "-5](!7*O-0''TD3%1.V5[%JBJOXI$VU51=,/N9<M5*.YE$
MVKL7J[7(Y*IR*5<)@
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MY4Y*J$4@K+Z(IW([2Y55I1RJXO?8R=KUH1-J[%RL4J@
M
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M5BOG)LNBWFI-/,^ASW_-[WIX<2:\$2^A/62(@
M "A),V-%7M)I*F;HA\+KA[TIPT^PKBV)A:F^5)%5$5.Q2J(B%"")Q]I(
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M^B.Y<WNN[VKD470N6WT?>UR.Y*4S%%V)JG(2
M
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MV:3"Y.E<B48U/QW.Y(7HFK&F*[E>)VIM>'R!%)A4)
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M$>'9]\D0     "='.^;V$3%542^N.2FE'%$PKMN?6BHJ53D4KB8A(
M
M                                                           !
M*YR-2J\@B9?#+/JX-J7+86KKWS-<J<RJBW4<ZI(E   (I1?4!+7B[T-^<4U'
MQ7.3M+6K7*LKZ5TLIV^TN6V3*U?GML6.?,7DE/"1(F+72J^]]XN6XXC>Q;]1
M=.Y:7:Y7JLTKI>WCSJ7*1"S-UUV^4Z-1/=X#8BB*M:J)5*KZP(A !%$7L"4*
M H44%%OR^0AP^*O<K<+2WL8_$E1/><B?-2O"J]A7BQSDNY8WK.ISVZ?%=DNW
M0^;!9BWW!CXLE9*O@2\V.5-35]"TX%.2V;)I*-)J+=3B^)9N7FBD+]"@*%%!
M0HH*%%!0H"A]\"#U5:4>K4]% 2D=%$O*/C[2*%(?7!?7MO1&3:VI\U__ #%/
M(N6YKK>*[V^98Y6MN&.1WSU;337U5XE'PI9-NIB=^]>HI8IFZHI&N]5>);F*
M,FV8NW*E$1:*NGVA-!>=*U"$   "=')VH$IFRN8M6\B)BI%U'V1W#7\%144M
M711>MOJ^HA6                )'.I\U7>P2A)(Y$TU34M4^3UE,W1VIHYK
MZQ]:9MB7]MMO;N/BRVYKN%MQ/+<._D]M$Y::7(SO*Y>:>HXOQ5XNLZ3,68XK
M?.WA2//Q=UX4\'QU3'.HU%TVXHFD4WW>;A2.+$^G'F&S64W!:;7WOC+:S=F)
MVVN+RUDKF,9._C&R9KZ>_P"E#4] \>SK=1;@SV4F_9$QN]->'#TMMX@\"8L&
MFNSZ.^9BR*S;.^D;YBG9WN>MSVLNUNHV[[3=%HYL]UD9[N.6:BMNH)*^$_4O
MWJ'G7B;3ZG!U#+\6LW;=T;-N[?PF*.[Z=EC6].P7::Z*19$;/U;N,,ZZ#V%W
MF.KMKD\1!(F&PEE<IF;YO".L[%;%"Y?G+K5'(GH0W_R[TN:=;.:DQ;$>]Y]U
M/3.YIO&F>S!T>[%EF/B7W6\L<=D[;O-38N74;HUNK:VY)<GLEC<KA\]>HR+&
M2/1DEK/<+72JNHU6*J]VBU+_ (J\'WZ?/\?%2;,EVR.,77<)X4KNFN[9P8WA
M[Q=I-;I_A:SW,F.W;=PNMCLXU[6P>A_26>V7<6?WJL4^1R$=Q@WX-'U2"-W"
M=)%3@KG<DHO+UF[\#^&[;+<V7-'O5NQS'9%?>KY]E.[SM%XP\4VY(PX=)6+;
M9C)S3QN_5IW1Q[VMMT=!?LG+9RSPV[)K7 XN.RN%LIVZIV1W<^CPV.3AI:WT
M\3F^M^%<&GU&>;)]W'\.:<?WL\OT.CZ;XTG48L<Y<,3DNFZ*QNGDBM9[Y=4X
M[I5M.TV)?; AM%7#7\:?&3*OUDTBJCO&5?I(Y$5#UC#T+2V:.=);;^[NC;VU
MWU]>UYCG\3:W)KXULW?O+)V=D1NF*=E'&F.Z+[VO<ECL'CL]9-PV7DO4QN0N
M4E\7X>T?H<Z1&MTJJ_-HOM/%]'X:G59K+<=(MRW7Q%=],<TFZE./#ZGKF;Q9
MHL6*_-DQW3?9%O-$4IS7179MKYV[.J?3"7;'0_\ 1S:S9;Q,'?197-._OM[1
M').][4X+2J.5%[&GH/7NA?D^B3I\%:63%UT_B[?5[(<;X;\11K>N_'U-(Y[9
MLM[+/PT]GI<G_;^%^Q97M<UURZ)-,_:^M$1NA*\>P\/G3>]2DS,<=SU"='F^
M-&SW:[NSOJZ.P74/)=&>E6T\)=8]UYNW.13W>*PLRHC;*W>^L?C\=2(JU5$:
MA[)AZ[?T'IF+'ECFRWQ,VQ^&*S3F>?ZWH=GB#J^;-;=$8,<Q;==&^^:17EX>
MM]&T/,EEY,UCK'?F!MK&QRT[+>'*V;GHD#Y%1K72M?S8KE1.!3T;YA3FS6XM
M1;2LTK&[ST]JSU7Y=X8PWY-'DFZZV)FEU-M.$4=FPO5R)5BM7DZO9]P]/V5V
M2\IBM-KZ$6O J2F                 *$LR1HB+S)B*RINNH^"259."\B[$
M0LS=5+J:GNH2BJ0(   "+J-[45?HH1,T31(]4:U7O5(T1*U7F(VHG9&U:KK,
MV]NFF*-[W?22E"Y&.6/=J;;>"R39*_G33XC86_B5J7.2&-=GOE\*QM=WG5?(
MO%7JO-?25Q"U.W:F:CFI1'49V-1 0BB4KZPA,  ::HJ*J(B]H54>5'G,5$ZR
MP46M=NXYM$[*NFI]T[/P[MTG_%<V>+=$=SFRQF2-S>]Q0V]\59MLLWL,JR.&
M5CWJFJW>UJ-YT<B\?DH8E]DU9F.8F.]Z:^7*[==]-,5;/5S7VS(ZZU1:M>U$
M;2AR_7+>74W3'9'LAP'2[IONS63OC)?_ -4OLZJV\EEEL)FF(JR>"UCI&\_Y
M-*U?OM<M#G\MM*7.CTOOQ-O%NV&X9<M9>6]6LE1DT$B_1<VK5]G$OQ/-%8[&
M%,4GS2T1U.Z$=*M\)>[BW+MR.++PV\D]UF<?*^QEE5&\%FTHK7KP3BJ5,[3]
M4U6ELI;=$Q'"=OJ9&/4732V8JUUT,Z#]-\*MYN%=N_:>;Q<T;;2?*2?$MB<B
M(]7,B5$95*I152I5EZWJ]3[M\Q%O^78OZC+-EON[)=@(Q&N>]%5TKVT>YW;]
MSL-=;;29GBUTHHG&BKQ]95&[:@1*+5$2OTB442*U56CEJU>(2@U%B=JB56JO
M;43$2B)FW<N466O851%5L[4YZO>^3L*+K(F-B_CU%T3MVPO4&8MKBC7(L#ZH
MG>IQ^X6YQS#(MU-MVS<N&M*5:FMOTD+4S1?5%1/34J$   "+5HM0)E=5*=HH
MFJI%,L?/B4S%83;=1<(Y$D2J%I?B:J@2
M
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MBB_%T2K%*H
M
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MR>:ZDQRSWUVT9W+';XWJ1CW.<L3<O@Y+:!%2E%MI&.1J+Z:*=/DBW2];Q_\
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MW2N&JJTX+3T%-5Q D   "+'.8M2")HN4,R/1$5>\6IC:OVW5?00K
M
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MP
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M]/DMC[0O[J5TUQ=8BT?-([BYSO":E54Y+4V19FOB-W,Y;/\ ?EF998Z0D3D
M!(2 $5YD"DYCY%HQS45$575HG#VD2KB+J;-RU7&:PMA,R*\R,7Q#W:60HY*H
MOK*XQYJ5IL8EVJT]EU+KHJN:(G-BZHY41S7^TI[I7Z1PW)M*@HDHGK)VHHD]
M7WR$)BJ$2D7BI*$-/J!15BO)[)WB155%[KF5X47U%-UL2JMR39-895:7EO=1
MHK74DI[E>TQYMI+869+;H?4%8   $6CD(D7&&9'4:O-$+=T+UEU7U%*X
M
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M<T;GTM7NM[5$;4[DX      /CGGT]U'<?45Q:M7WK?1*U7BI71:F:HTH3
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M] F(E,31<X9-:<7<2W="]9=5]!2K
M
M                     )7.1J55=*$Q%43-%MFD63V>HNQ%%BZZJ@B4)4@
M!VT[0/BOKZ*SC555'R.X(SMJ39;,SM6\F2+(8G+*^XD6::FMU--.2(G*A?BR
M(W-?=?-TUE(B>U?6I4I1H!%$2H*)T:)50A5?24\R:*B,(3141O!. 31.B)[
MD C0B9HE%.'H(YBB*IP=3G3NB;I31@F8ZA[=PV4M<5<SHL\RM9(Z-R/1CG+3
MC3DAFXM%DR8^;BT^KZYI=/FC'=.V6<,>R22/0JOC=1-:<^/%%]E#!I,;)WMW
M$Q=/N[G.G4[J;M^YCO\ :^.B^T<K9O6.[>C>["]6]C^2FYZ9H<MMWQ)W2X;Q
M-U_3\DZ>V.:^/H<3W\]PWPUD:Y[WO572-7BWO=AT>^7ELW<\1P\N#.=KS726
MTN3OKIT]C:MJRT>M5:J<JIZRWEB9V0SM)=R5ONGW;>'Z'0^QNKFUK>3X6YMW
M6B6T;5E>L:HNM_!-->PTVJT.2Z'=])\2Z3'LFD>7T.F\5E++,VC;W'7++VWF
M35K8Y%T>I?6:2ZV[',Q?#N]/FLU%G/CFL2^Q7(BT5%9[>/ZI:YK5^L1O3+I^
ML<YR1L9Q5SE[/:(V[B8IOV0TGOWJTF R"8?;MLS)WT*:KQSJ/9%]Q4-MH.F_
M&B9R5B'(=<\3?D\GPM/'-=Q[F-XOKED&*UF9PC7MYK<6R*E?4B<>1DW]&BE;
M9EK=/XSOB:9L?IAE[.M6V'(U5L;YBJG%%C5?N4,3^EY&W_NW2SPN]3Z/Z8MM
M.3ZO'9-[Z=U&0*[]:A1_3KXW[%S^Z--.ZVZ?0^6;JK=3IHQ6TKRX>_W7W#DA
M;[5KR*XZ;$[Y6[O$ET_P\,SY]C <MN'<.Y)G0Y++/B:_N)A<0USY%1>'AO>V
MJ)JY*IFXL./%&SZ6EU6NU&LNI??,?Y;-_FF>]?MI=+;A]]99[,6GV1;6$C9+
M6R1RNG72M41Z\:_<+&JZC'+RQ$4\S-Z7X;NG);FRQR1$[(X^ET JZE5>Q>*>
MPT_,[280H.8H@J4*HFJ)-/K)J@5*$"72BHJ 45:%-"@J42+Z_O$U11*YJ*U4
MIS^<51MA3,/NQV1=:2-@G75;R+P<O%47V^@M7V=B_AS<LTG<RI4XU:J/C<E6
M/0LL[O1)  !!$T\A N%O-5$8O9P*+H7;+N#["VN@     :3ZY;VO=B[&NLGB
MO]:Y&ZBQ=A+S2*2YK1R\N2-6AS7BOJ5^@T-V2S9.ZO>ZKP=TC'U/J$69/NVQ
M-T^:UP9$FZK58]SMW;E(<NCU5,A\9*KJ^]1&(NFBKPI0\#Q>(];9D^-;ENKY
MYW[MKVNZW29(G33ALFSLY8]=7?G2#?D6_MFX;,7MY%]MO:ZWR%FQ]')- Y6K
MW%6M7(B.7L/?_#W6;=?IK9NOB<G&-E?5O[ZT>'^)^A3TO77X[;9^'OMGA2>_
MNW+_ )C9L<MXS,[>NG[?S\7O7,*(MO=)3\W<P\&O;Z%X+VE/4.@V7Y9U&GGX
M6?\ %'W;NZ^W[MWGWL/2=6FVSX6>WXF/LG[UO?;=OB6&LLMN93*.QVZ,+^B>
M[)TI#?VLJP,O$8GO0RL5J.5>UKN)SV+'H=1G^%KL7Y?4SLMNMGEC)3]:RZ-D
MSQI,5\[:7W:C!B^)IKXRX>,3'--G==$[8\\+M>]-Y;I;!&;MRE,9)XEE\0L;
MY&/[-+U1'4]53.S^#IR39S:C)=R3S6\TQ-ULQV74K]4\88>/K_)$_NK(F[9.
MR:3'FK1LV*"2.".*23QG1HGBSNHU7N3FJT.SQV3%L<TUFE*M#?=6:VQ3:N.E
MOH+BAR)UU\OEGOJ3/;PPEE)F>I.4BL<?MG*97)2Q6FVH[9W>OL9%$G<D:OUK
MDXZW<%HE4-IH>I788C',TLK6:1MN[I[67IL_+-)W-(]/_,CU9V/9XC&[YVY>
M]5L)E,OD\/L[<5C:_9^Y\E!AF/?<WUQB9]&J*C%I(BIJX+2JI7.S].P9ZWXI
MY9B(F8G[L3.RD7=O<R,FGQW_ '9V\6]]O^<_H!FHK1][NZ3:%S>.3X2PW%97
M%C+(CE5$=&[0^-[-2*FM'*E3!R]%U=ETQ%L74WTFK'NT>2.#<MAU@Z692)LM
MAU'VS<L<NEBIE+5CG.;Q7NND:IB7Z+46[[+H]$K,X;XX,NQNX\%ET9]EYS'Y
M1)F:XDM+F&?4GTF^&]U4,><=]L>]$QZ%,V71PE>UD<O)G[8I6Y3_ '*?2*A.
M0E3T5=J5RU]!3,52UOU'GS$>#EL,%8W-_D,NYMJC+?@YL3U^L57KP9PX(JG,
M>+,^>-%.'3V77WW[*6[)Y>.W@W'0[,7YB,F68MMMVU[^&SN8^FV;C[,9+O#)
M,QNU\3;M:S;6.>L=NV*).5Q,G>>O91%2IKKNC3^6B[77_#P8[8_=6S-ML6Q^
M.=]TSV12L]K,MZA;\6FDMF[+==/OSMF9GLC="?$X6;<]M:>/#)MO9:(BV&V[
M:D$ETQ%[K[I6I70J<=/!5[2C3=,GJMELWQ.'1S]W%;[DY(X?$IMY;OPUBNRJ
MK4:W\C?.V,FHXWS[W+V\O"L=OJ; F9@\%C712I:8[&Q,HVV=IBB1C$JJ(Q>?
M#BO"IUF2_2Z##%MW+CQ1'&D12.[C[6BB,VHR3='-=?,[]M:SWO.G=.\-Q=3<
M]DW-S$]GMS'SR0X7#VDSX+;3$JHU^F-6*Y7HE5JIX5X@\2:G5ZF;;+Z8XV1R
MUBVG;3M>]],Z3INCZ>SW(NRW1$W73$77;8W5FOH;@\O6^L_;;JN^G^;R%QEK
M">QDO<+-<O\ %DMW6_YQ%>O%6JUR41>TZ_P!US49\]VERW3=LF8KP<IX\Z+I
MYTD:[%;%LQ=$74V1-=U([:NVVJY6-7M4]7>2T5      HRS)&GK*K8JHNNHM
M2][F7*+"")1*$B( "%'.HC*55?>7DGK(D6+*9-&O6SMGU5>$TJ=GL7L4N66U
M8N?-3W88]'&V-5<G%SO><[B7XV,*(5 (A($ID7@1,T3"=J*I%4T3HU46M!5,
M0GIQY$*DP%%'JC]"TJO'Y!;65,S38JHCW*FGD]>XJ]HE7%LSMA-WNZO)K7*V
M5WI7U$3=$;T\D[):.ZV99L.+LL/'.K;R[D<LBL<J.2-.WAR2IM^DX^>^;J;G
M'^,=3%F&W%$S%UWL8IT2P=Q<WUYFY&JVRM(EMH9DX)))K1U?7P0R>LY[:\L;
MVJ\&Z*^;IS3]V(I$]NUE'7S.OQ>U8\<DS6?;2JV7AQ\-%U+3T5I13!Z/BY[N
M:6V\;:Z=/I>2V:3=_BXTOLUCFXAMC% ZCZ(B+W41OXOL.GFLO*_C1-G+$3OX
MN7]]O<[<[I'.5RK:P)Q]":C:Z?\ A1YY]LO7? 4UT%W_ '+OJ7';&A9F47M0
MQ]1N>CX=[H?"PHZ&>K57Q+:=J.7BE$C7E]TTN6=L>=LL<5]3:W2;J]F]F;2P
M^*O;=N1QT"+X4B]Z1C%541.?)*>@=0Z=;ES7717A[(>#Y_%F70ZO+BOMBZV,
MEU.W?+<D_F:V9:LC;>HMM),M&M5-2.=ZJ<J&JGI=]6QQ^.--=%*37S-1[YZ_
MW6Y$N;+;LDF.LV*B+<LKXCG+72C5KP:O:9^EZ9;CNYKMKF^L^+,VHGX6+W;>
MV-_FKP:XP&?L&3^!>WTD=Y?=VYO)*JUZKZ7>@RLLW5BFZ&BTN2V)F;II,[Y=
M(;=Z3W.>LH,@N;CCMKA/JD:]%X<S79^IQ@FDNQT'A>=79%_/LEE"='?"8CX=
MS41>>J-J_J%B.KUW1#9?VE%F[+['UP]-)6.1&;HU4X4;$W]8IG7QQB%W'X?F
M-V6?4O\ 9=-+-_#(9J\NT[6,D2-BIZD:U/PEB[6S,UB(9N/H5FZ^^Z?33V0R
M[%[/VWA9?&L,7$MPG_M$R+*_Y%=6AC9=1?=LF:MGINF:?3S6RR*]N]D+F*YR
M/JJ4]U$6B)[$,>-]6=-9-*ZG/<JN<ZG%W%4IZ";KJHB*(TXU%442Z?65U0:?
M6*B"H0)',15KQ"*)590F$3"54TI4511)ZZ?=$240HZJ.1:/1:H_MX?J$S%4;
MF1X_)I<_5RJUDR<Z<$7V&/DMF-S-PYN;?O77\!2OBT[.1( % F8Y8^*.X$43
M;-%VC>DB50M3%&1;-4Y"0
M
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M7(Y*H6YBB_$U3$)
M
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M(BVLS$1PB=M/0VRG(W4;(:&42I !*Y:)4F$3*VRO65R\?=+EL46+IJH%2D
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M]<+U9[Q1,57+9HN!;7@
M
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M62P[6=>;@E<D3\A?WMPCKW@[NR^'RH0N9I^/?SW4MI$[./T1+.MP;QW#:X[
MV]VD]]=1-75&Y&HK)/FNHWG01$1+&LC)EM]^ZL1&QK[!;FV]N[<ZXFQNL3>[
MPTSO9%.V>.=K&I5Z:7:6+3MXU%67FT66S#%_+/+V\.V(WK[C]HX'9U_>;AVU
M>7.'W%,]8+K%+-)/BG2.^=\/.KD1?8*(G67Y;8B^*TGLBOZ?I9;CL9NK/V^;
MM][[@;E;5LL-UC;?$^%;I;HC:)PT5UHO,C9"C4Y8V3;%U(BLQ-/9N\[',5:[
MKQ&8@@R.8AW)AK5KH67-W9M=<0LD75 DDC4[VEO)2I:RY\=T1-L<L4I2?;]C
M85S?WZ_'37]W!<WEI"U+3PNZGA]K=(V0Q;INNF)GRA@M[?WN.O;EEK,JVEXQ
MDT_SJ.=[P9');?%+MR#<A>S11R0V#8VM]V25NGQ/I#9V*)PXJ4BK8&U-^YK:
MMY'<V*W#(-37:XY5=%J1:T5%7DI9R:>S)LGBR]+K=3I;HNQW;(VT\NW@[*P7
MF:VDF(B^VV3LR>E726T3:H]&^]IU)1?D-#GZ1?\ $F+=L=KT/1>.=/&")S6S
M%_&&4[(ZU8_<V6D@O6QXJQE:YUK,YWO-YIRKQIS(U'29Q16S:R>D>+[-9FFV
M^.2.%>QFD?5+927:XY-QV[ID>L:+QHY:]BZ:&).AS1MFR6UCQ'H>;X<9K:LX
MBN+:X;%-%<QNAHY[IZ]U&HE55?8G$Q<EDV328;?'?&3;$Q/>UYT\ZD[6ZFV&
M9R&U[B>>VP>7N,/>MG9I59X%:YTB4U=Q[52GI*;JV[]BNV>;<V7X:]J(WA6K
ME1$^ZJE,3$G+*RY'-83%M<[(Y2VMFM2KF+(U57V(E3(QZ7+EFEMLS5B9];@P
M17)?$4[V-V&_-I96]^ L+QMS<=B1HJU^ZE"YDZ?EQ[;HF&%I^N:/47\F.Z)G
MN9K1"Q5LZ(47T %1.P"FK:K4(2*GHX^DF$2IO;PJB]Y%JWVD[%,POV+OW3M\
M"X[EQ'P[W:WU%B^VFUG:?+S12[>O*<:T^;S*(E>"0 G14I10E]=O(G%JKZ*%
M%T+EES[2VN@ #YEGA1%57HVE*_*(BI.ST.*.N&+Z1S;JEOI]ZNVUO&=6QY%;
M.W6]B1ONM=<1,I3@G%:GEGB[2=(U.3W\_)DKMI$W1Z:=GG>M>#]3U>W2_#C3
M_$P;XK/)/_#,LRZ0=)NGGP,^X(,_;[_NK^L#,FC5CC@TJNKP65UQJO;5:FSZ
M!X4Z7.'GB[X\_BW4\T5K'K:KQ3XGZC&6W!..=/R[:;YN\\[I;=CV)\.]9MO[
MCR^(5$TLB6;XB!%_Q<VI43V<#:3X6G%=-VFU.;%_EYHNL]5T3/TN5_K49?XV
M&R_OIRS_ /3L]-%.:7J'@E1;B_P^;LN3I[ARV$J4]+N\U:EG+EZUH8YKK\.2
MS_-,X[O7]VJ];;T[4[+;<EEW=[\?:^S9^]X]SW-Q;)B[JU?9JYDMRJ^);*Y.
M:-F30CO5P,OH7B2.J73;\.ZV8WS2MG_-L8W4>D3H[*\\37ANN]39)T[3@%ER
MS<H[&7R8A86Y98'ICUND<L"2T[J2-:K5<GL%OWMNY5;2NUYQ;;WOOWR\;WZF
M.W3C[WJ)LFYGCW3UESF)M'6MGM?+Y3OK'CFW$B)=0K$J/E:Q=35HB]Y:'0Y,
M&/7X[(BEMT1RVQ/Z\1YMWI;*<=NHLB(F(F(I'?1U_LWS&]%-\1,7!=0L2VY6
M))IL3D+A+&[BU\VS076A[%KV<359>G:C%]ZR?57V,.[2Y8_5EM%=X;31KG+N
MC$HUB(KW?&P435[NKO\ SBQ\#)^&?5*UR7=DK#E^J_3/ T3,=0,!CE5:(R7(
M6R.15XHE-:KQ0JQZ3+?]VR9]$J[<-]VZ):Q7S:>6Y':?Z8,!5%5CU2:1:*Q:
M*M6LI[%,S^C:S_3E5&ERSNA?<%YE.@VYKF#'X;JQMZYO+E5;;V[[MMN]RI]%
MLZ,+>7I>JQQ/-CNV=Q.DRQ%>65RWSTPV%U<L\#^DT:[CV_BY?C+;&17;_LZ\
M>G!/'9"Y6S,:YONN56F/BU&33UY=D_2HLR78MS:MM#!:PV]M!$R"&&-L<%NQ
M-*,:U-+6M:G)&H6IFNU:K67WE( 6?)6..OFQ,R-E!>,B57QMFC:]&JG:B.14
M0Q]1I<>>GQ+8NB.V%_#J,F.:8[IMF>R:,#NMP6\=TN+V;M^',Y1%5)IH&,AL
M[5>6J69&\5_%3F<UJNJV69?@]/P1ER1OF(BVRSSW4VSW1O[6UQ:2^ZR<FKR3
M9;V3,S==YH^N4[=HY[)0UW/NVZ2JHK\?B_Y+ GXJR)]8Y/V2$7]"UFLC_P S
M57Q'X<4\D>:9WSZ*)GJ6FP13!@MW;[_>F?16D+;G.DNR]QX>^Q5YCGR_',TO
MRDLKWW#'HO"1CWJZBHJ=G,R;_"?3[K*39,S^*;IF[Z97M%XJUNFSVY++J1;P
MI$6SW<-CE]W1G:>-W';X3<O5W%NM)IFTP+$;'=2U7W7O62C:^L\^Q^">GX-9
M$9-193\-?>>CSXKU>;2SET^BR<U/O_JQW[MKMW!V&+Q.,Q^.Q<;(K#'6S+>T
MB8J/;X3.#5U)S]IZ_I\%F##;CQQ[D1$1YGCFIU&349[LF6??F9JO\;D>RJ<E
M5:?=,ACJY"0#Y9YFHW2CDKVE=L*+Y?&JIQ]9<65(( "JB<5Y(*CX+^^990JY
M%US/3N1IS2O)2;;>9;RY8LM[V(HLDB^),M97<7?J&1$4:VLSMG>G1%)(A%$4
M)5$HB$52@B+V-*53YKJQAO[:6RR$#+VVG:J*Q[4<UM?0JDX[[K)K$HRX[,MD
MV7Q6)<[;TZ57>'9-D\ GQF,8OB7-DG&1C>W2WM-WH^H17EOFC@NL>&K\,3DP
M16W?,<?0LFR=Q7&)NV26LZMA1:OM9%6B)RHJ=BF1K--;.VG!A]%ZC=AN]V=G
M9+J#%96VR4#)FL^'D>U%6'LX]J'.Y;.67H^#51GCFG>O*HC51'+15++(3-I5
M./!5[W JILKP(V[%IS.;Q."@6ZO[R*W1$JBR.I5$+F.R[)]V*L;5:K%IHKDN
MB/.YLWGUD7-P28[#W*6MJ_NOE:M'.]2&\TG3_AS[T. ZOXLC4VS9BNI#0-Y8
M:[>^7(6KYTN'*OCJM7I7M=ZS<<L13EEPV3'-+IR6S-9W\?2UQ'%>6<MI!+&O
MPOC^)%/-[VGYNGMX%<,?FJI2VS;B?*X]R4L]2O5WTWN^:)+:<\5G]+$+?=%G
M/A\!E(K">Z?9Y&?'310)J<W16KG?<"_?BMB^8OFDTKY>E'<>T\A,YEY9-MXL
M;>2-='=J]==9.S3[W/GP(KP7,&7X5NS=.[O\MZS?$8'$Y-=M7LMK)-$K5R^;
M1OBP6TB\M+4U:W)^$)R8K[YV[._RW]C$MRX3(7EU<9?#RW6Y\9;QHR?+) Z-
M&I'Z6K3V\C9:*^V<<6\8F=GTU>A^">MZ>S%=I,E\1=;,[]E?JKQWL*AR+$<M
M5HK4XHJ4H95V-Z7AR<V[:NJ9Y((G)$CI)%2C4:B]O-4[.18G#QNV1VFLZIAT
M>.<F2^+:1QG?]K:^ VWD,W8R28MUGE5N+58[>RE8]R,JG>;[O#5Z379LT9+I
MG=&[]+Y[U>LC4ZN_-%OO73,QYOLV,5Q&SLOLG<'Q.!VSC,+F+N)8+SX-SG>*
MQ5JD<S-3FM6ONEN*;U.?73FB+,E]>7=$Q2E?\&>Y"TO&+;QY/%W]KDK=SI6+
MCXO&:^1S>\^5S7.T^HJC;N:^Z_';-)FD^GR[5LAWA=X:U?+<I<V<L[E2YME[
M\DG[%Q3,POX\/Q-T[^Q</MNZE@2^6YL[7;M^J)=YUTK9TME_'C3BW[@YH6KM
M-2:1/^/EW,R?%B68N7)RYF'-1Z/#M\C:O5S)&M[6U5*B)6_A763-M:TGA7ZZ
M,&RM_9L=87=VD<4#XGVTCI7]Z=6N[K?:2NX[9F=U1,M%(CK=+58;'5IBTL]W
M5^,%V;)B=L*D39'TCQ&0;=JJ.\6PN.Q6_1$HK393>^?#9F'*S7.,N[=;._L'
M:IHG]UK6KW?$_)(6K\$4K-6R-NY!+#7+\>KVPN189(.*ZD]'ZI,WUV3:M66Q
MCFML3$QQ\OI7I-Q7.2R3[N[N9;F3@C7.>K41$Y<"F;;*4Y5S)GNR9^>ZZ=D=
MN^6]=H]2;[ 8MT'QKX&QKJ8]55RKZC7:CI\9)V.KZ7XBNTN*DW-;[?R]QC^L
MF1ZO7$DU[F,G936#\<Z1%C;%5/"C1W:C$2J%%_2K*;)9>+QGDC)]VN_UMR7_
M %RWG=L<S&XJ.T5W)9%U*GRE>+HV*/O7+&H\:ZV^*8L5/.P^XW/U#W%+X4^4
MN5>ZFF"!%X^K@9GY72X(K,1+57=3ZKK;N7GF.Z&>;6Z29W*7$.2W Y]O:ZFN
M=!-59)$Y^GL,#4]6T]D4Q6[6]Z9X5U6:^,FINV=D[Y=.6=E!8016EHUK+>!B
M-8B-HO YVZ_GGFXO2+,5N*V++=T/L_ 114@J5JB#<;U*E.:A"2B^C@55440C
MEFMI6S0<'HO?]:=J$71$IMNNMFL,P@GBN8DEB<BIR?3L=Z#'F*-C;=%\5A6(
MJJ"1%O,"HCD[%":OKMI5<VCTHI9F%ZR:OK(5@
M
M                       "UW$RN=W>2<"[$4ACW75E01=253M*E(  CR^X
M1.P8QD[Y956UC6NG\Y3E0OV6;*L'/EK/+"TM0N,>B8"=/=4)3*BU*)5)FI7F
M$PF5J5:Y5HV-:J*Q&]52KX<OBL=F[1]KDH&75K(W2KM/>3T4+F/+?9/-:LZK
M38M1;-F2*Q+F'>/3R^VE*M[91NR. D=JAE9571+]%43C\IO-'KHS1-MT[7GW
M5^@9-!//9'-CGZ&5=/=TW-HUELEPLEO)_>7+56>HL:W2T]YL>A]2F(Y*[/8Z
M%M+EMTW4G'ERXFHY(=K9DYGTZ:*6I75":^L["*6:\N&6L3&JOC/5*+3LXDVQ
M-T\L$Y+,<5NG8YUWMUYL[>67'8)SG2)J22[CXJG8E$3Y3<Z/I%\S6[BX;J_C
M*S',X\.V>,PY\N[N7/W:9%+G7<N=J=-<UUK7L1/0;SELQ6_#C>X'+??J\GQ:
M[>V=[ MRP+\7+<PW%K:SXWA-+5*=[N]Y/V1<LW,#/]^8V>AC5S5N,QZI)I\&
MXU/O7^[I^=I*UB9I"PRWT5MO'["@L6/^W\+<W-K=_,U1HJM1WW"&9CQUQ<[Z
M+/#9+<& M691]OM[*LA5()-6O4VG#N^E29E9QW33LV?5YJ58DMK=;>N8,3A+
M&ZS&ZYVK)\$Z!'LM84]]SU]U[G)Q3T(I#(K-WGGR]GJA=[G%),ZQRZ[?NL.D
M/&^R6XY_ MWR(O&D2*O[41*FZ8B(V3Y_+9Z%VN+S!2W5E=PW6*3QWLMK=\-L
MJ6KE=[S6IZ=/:%F['ENGW9W>6Y;\YE;G I=Y' VT-]9N>MODK=(]-Q Y/S>K
M\5P7,5G//+/EV/BV];R[JF3*WKI,#/*SX>*X>K&PJCOG(KG<*"=RN/=NIP]4
M>OA1\>=V3G\;?6DD>>CFFB\6Y?/!;,9X:?X5;FG%/4BD1-5V[/=$TNBMO=M\
MH\RYVT,N5C@QEM>XW>=PUGQ"_#W3F/@>[YSJTU$L:ZMN[:QW+9K([3EEL\B^
M*/->]'%&_7JA_&>G!5%5^S3SFWQMCR]*LS=-K-:,N9<_+':(Q%S.!@;(EZV-
MW]\BHVC_ %>@E1=@K$VSY>9L7[2P,. BR]HVZN8LQ#X.-GRD:13.1G#W5X$1
M59NIPK3A6.SZ&$Y3+/@3&7=Q%(]5:L,L5I%K[WXWT4]9*YBV[_+T"WN1D<DM
M[;-DQ=Q[C=?B._%]A!-M)31VT,\DJ8]9L=D7-7PH)VKHD=\UK?RB4QMDP^:E
MG@O8,]'\-<8A?!D]'>]X(NMVL_Q&6AL<>UUK<-?<R<($151R-4B6-99?9MB5
M\Q5_,QZ,6-Z)*_6LE>+5*<D<T45X\M+J<>+;DW4#*,PLF,@FGB=/ ^U65'+1
M8Y$T+\O&GRF'^3MNFMSHX\19L6*+;*UW,?Z;9G*].<3F</LN.''Q96\^+O\
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M_2YMK./!BGS9.;VR^V!>ELT[)\QN67/7+%UPMRTLRL8]$XN;$K6LK\A?MO\
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M,
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M]M*BII7L*+H7;+GV%M=
M
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M6'T$*@ !/&ZCN"D2F%V8NIJ*6IAD1-4Q"0
M
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MKN&_EFG!D-:NJWW:%F:Q+,1*@ )PX@??;/541J^LHNA=LE]A;70
M
M                                 6RX>KUH7K86+KGSDJ  !3FF2"%\
M[O<C155%Y$<4S,6VU82Y[IW/GD]^55T^IO89-K573S364&MIS)F41"HB4X(1
M551.C*\U(3$*Z(@5(Z?634340IYJ)HFHG%K457]GH(WJJ4CO5&-DT_6,[]:4
M8O!/;4B:0JY;J;4^E6^\J)7LKQ(I/H3,40HJ<42O F-Y$TVL8W5NO;^U<5<W
M>:OHX8G-7^2JK5E?ZT;^N7\&"_)?[L,'J/4-/H\4W9;HCNXO-3<5C;YZ[N+R
MT7P8II73639$HO%54[*S9%'@F>^S+EF^-TS,Q]+$&9&XLF?9]VCI&*Y8_%=]
M%?G%:BD3-8XL-WC]A8IF+NK3*OP]];.TQWT3WOCG3WG-D:WM3U!D8[9X[(\I
M8QO'$;I3:K\E/NRXV?97<B.<QFF6>]M7*BO:J/XQ^(G=;3Y2*U9VENLQW3-U
MD7QPK/JNBE-W"O8NVUW27>7V[>W#8+&*."5,-A8&N<VT@@B6CM7I>[BJ^D0L
MZBV+*_BF=_=MV=C)\=%C9\EMO+Y.\TS7L,T&$@>U96NOG.=IEE[&HB)VDL6R
MZ(BG;N\]?+>O5U#?7%]>L?6*>*+P-Q82)-/Q+?FWD/K[51. 6IBZ9[.[Z_KV
M,)SFXFXN]L,7?MB;M9\;H)EC;K69')I<YRN[?4%Z--=/O1O[.'EYES_23<,T
M-WB\4ZSZ?=/L7:HDF78J27TT+F(B*QRI1JKZ"GEVU9GQ(MI;;/GX=G'NW4V>
M9JW9VW]G17%[>26=[N&9LRR7&3R$KGQM5SOJ7=_FKFTX%1K-3?,1;$1';3T4
M[^QE>X\Y?XRTM8[FRER#;^;1'C8E3O.;^;9I_&](XK.+%9=,5F8CCYUHL+/J
M1?M;+NQB[+Q#T\''[1Q4M<G>M5RN\/773&Q4YJ*49F6W3V^Y9=,S.^9V4-RL
MR:9':&!VUBK2U?!X]SOF\J^6WQ^-8G"-[U6LEPY?=KVB:RIZ?9AFR^;YIR[H
MC=,SW^NN^=T*><V?)NB>PQMQG;W'[7NX%GE;(C8YHFZM+7(K?I]A&Z84:35Q
M9?-T1&S;%>WZXEH'J#MRVZ?W45]MG?&0E2UA6%4E5CD>U?>:J<C&U.:CK>CY
M?S/\3';Y?0Y3RF[,ADKM98955R_WR1RN7GV(O T\\TNLLQ8[-T/BARF5CFK)
MD)E5Z56CUTU]")R+MMNPFZ)V,HQ>^=U8699;>1;JUX5C<J?J<2J(HM9+;+HI
M,-[;7Z[0W:165S??9>2<E&R2)1JTX41>7W2OXTV[&LU'2K+XYK8;GP?4&W;K
M2>YEQ]Q(W1]IQ+K=WUIXCOFE_%J9F:3$.7UG3+XG=L9@S/Q[@6YV9OFZ=<16
M*I+M;>-@Q6JQ')J1MRUJ55'<N':9ULQ,-3DPSAFLQ,TX</3LK^E=;S:=UN*"
MU5^4@R$7AI;RWS&.D2!O+4D?SE3F546L>HBR[FI'F?5A\9<;;Q=]M?J%<_:]
MI8O27%;KQ"Z;IT#N58']K?0*)SW69+^>S;/EYO4^R7"6MS:Y3;=ODX<QA9&1
MQ8;><D5(&NN$1[8Y5X*Y'>[J['"BSSS9,TI,>G;Q]GK9[A</M>RQ[\=<6#9\
M=A[9EM=.>][GU;^<U*[WDK6E.PF(JQ[\T77S,QY>>?+>Q/J)DL!AL"R[VK:)
MDHK&!9H,/;JO?TJVK:>]7O$71,,O2X?B9(I7E[?+_!C$]]F'NQ\SL2[&74UK
M!?VN+CE;J\*1NI4[WSFE$735<R::(NGEV^7J;:V?NZ.Z<QMW(_7(J(QU>+?I
M:BY.3FCEF&%=%UDUG=7VO0;H9N2#(6]WBX\FV]6&'4R-JZE;0YKJV#X<UAZM
MX.U]N:R;)FM(= *G8II:NR4E9ZZ%2FBGI]84I53B!*O (4_4$"IVDP3"G54)
MBY31 J0D>W4E.P2BBY8:9?$EM7NHB<82W?'%D::[;RROJ*JM:CN"IP*&5,U1
M" "/%%X<R)BL"YP/U,3A3@6[HHOV36%<I5N9O,QMW+YO8L%[BX);S["R,=W>
MV4:5=)!Q1ZJB<5T+Q2AQGCGI^;5Z"F+;2:S$=GZ'>_+W78M-U";,DQ$7VS$3
M/">'K<476:L,AC&XZSL);R]F5665I&QRSR/?P1-//@J\44\$PZ3)DR199;2:
M[HK+UO%I,F')\2^^(MC;,S/NQ#O+I?TQLL-L_;,&ZK5<IGK:U1+B"[D=)%!K
M>KTB; Y=":45$7AS/?.D>%M-BP8[M5;S7Q'ZT\T17A$;MCQ;Q%XBOU.MS?EI
MICF[AOFFRM=^UL/.[BQ>UHK>V; Z:_G1(\5@[)E9INRC6-]UJ=JKP0VO4NKZ
M;I=MMO+-U\[+,=D5NNGS1NCOEHM)H<NMF;INBVR/O7W;H\\\9[F)03P[>O)=
MT;PN8[C<]['X.-PMHU9'6T3O[U$Q.-5^>[D:+'J,>@OG6=0NCX]VRRR/>NMM
MG]6*<>V?6VEV*[561I]'$QBC;===LBZ8XS]3[,/NG<V8WA'B[FPM\/C[:S2^
MN[215?=JV9=,+)*=UKJ\53T%_1=6UVLZC&"<<8\=MO/=MK?2?NQ/ZL5X\5&K
MZ;IM-H_BQ?-UTW<L3NMK&^G&8;4;*JND:C5[G*O:=C6CFXFKG'I;,YN]/,&Y
MD,DKG;F@9##7P_%?]GMHQCUX-KP[W)#;]1F/A:;;P[)V;7*>'.6-;KYVUG+%
M:_LPY#V5E_-CT<W%9;&LHL/N*RW;8YK>-OM+<\MU<0[0QEO=4CQZ[@B<[XE[
MT<B-:]%IV)0V%^+1:BV;KIF(MY;8F(^]--_+/^+O[K,%TTK/GCR[7T2^:CS1
M[FP-U?[2Z7;2P5S)L.?J-BXKZZO+^YN,/!.L+HXF0JUB73E17-B?S3A2O)'2
MM'9-;KKI]^+.$;?IV(C#IXC?=/=Y>56)3]*.O76^7.S[NWGE-Z3VEIM[>'3*
M#(0KB=B9VQNG-EO</D[*WTR)<1-16+6JHBIZRY.NP:2>7'9%OWK9G?=;PK$U
M53FQV12VWRX>?M=B['\K^RMJSRI,UTV#L=SQ;RV%M2WC2"#:^4? L5['83P:
M7/@G=Q\)_!OHXFGS=2R7^?EY9G\4<*L*<\NG;.SL["%EO96S+."/5HMX8T9$
MW4ZKM+6HB<56IK9K=-9FL]JS-U=[[-+$X(CD_8J*(JF71R5'>K@I$6T*I.ZG
M'0YR^FBDTDYMC1_2-=.Y^MR:D7_XWDYKZ;*U4V>NK&'!,_A^N7,]!I^9UM/]
M;_[+6<YW?V P>53"W[[EF1="D\36VTDL:L6O>1S4HJI3BAQO4/$FBT6HC3YI
MNYZ<VRV9V>>/8[W2]$U.JP_&QTY:TVS$,8OKW9^Z+NWN,1N:WQ&Y7,7[/OHG
MI'*Y5YMDA?P>G#MXH:G5ZGIO4KK9P:BW'GV\DQLNKQK;LK;Y]S,PX-;I;)C)
MBF_%QXQ'FG;M76VW9?XN[ML3O&VCL+J2D=CG(ZNL;E5Y<5XQN7UF7INMY=-D
MMTVOMY;IW9(_AW^G]69[)V+&3I4:BR<NENYHC;-D_?M^WT,@R6V,!E7MFO<7
M;J^B.9D8FI',BJO-LC:*IL=9T+0ZW;=CCFX71%+H[XNA@XNHZG!%(OGE[)VQ
MZI>;V:QL_3_>VY,9GK>>*6?(32XZ[F15;-',Y70N1Z]JL7BB'@_B'I>HT6LF
MW+&R-UTUF:>?B^@-)J/ZIH,>3!=$TMBL1PF-\4[&T?+QB,AG.IDNZ;")\&W\
M)87%M=2O8YK9I+A$:UL:_.TTJOH.H^7.@O\ SEV>DQ;$3MGOV>:O%S?CO58\
M'2XT^28G)?=$Q3A$._V)I:UOH1$/:M[Q2(H2/T)4F"9HM3EJJJ78BC'F:I24
M "M./T>)$BU9:X\&U1K51LTR\D[$*\=O,LZB_EM\[&6-1G+Y3(:]4I5:\O4$
MIM*%,JH56MTD*HA4[:!(B>D3L$R<?E*>951:LWG<7MZSDO\ +7"VEI&M'OTJ
MJK[*%S%@ORW4M8^KUN'263DRS2V$V"SV*W)8I?X:\;=P.7@]OS4_&3G49<-V
M.:2KT6KPZRSGPW5A>V(K]57-:UG'6O*E"S%9946UKW.>.K?52]P5I-CMJJR7
M)/1$=>+54CXJG V^@T$9/>O[7%>)?$DZ6R<>#[W;Y;'(ZY"]R-U=9/<UZ^[F
MEB5TE[P16*G'2J>A3I(QQ9;'*\JG47:K).3/,S,_1_BQ"?(XK,17,;%8]]I1
M9',]_BO=TM=S*Z+46WQ%:,'O[W)V#FRV=Q%=V+NY=VM=+V-^DXAE8[*[TVVH
M+? XZ]SL=<AE'-^*5+F37;XZ)R\U3WE5W81,+GQ9O]VD13TM86MY=W6X6YS(
M7$GQV;OO@=KV\=MXLBI_?-+6U[OTE(F*LN^S%;9%L6[(V^GM;<M;&/$Q;4D5
MWCV4=]=R3/MT1\SIW\M2.]Q"J(I# SS-TQ=P\O4K7>1Q.U(I7RRW%Y@MPW+_
M +81VF9V/N'^Z^O8WU<B%%+IV\)^CR]2HCFO:S ONVNF;:^+B=T(NJ*>![M3
M8W?D\O22B8FV=OEV>6]K:;!2V.Y)FL<YBW,*+-BT=]3,W_#-]09OQ?=I&R5+
M?J7,5GC;F3/V6.VAA(M.4A8E'2JYU$:W\=SNZ15&EMF_W+=M\[N;R]K$\-U#
MQ%WD[C X+%RV]G@[9LK;29OB32N=WN\[T^@EGZKIE^*R+II6-_F[(2YB2XGR
M,-[=KX;\C;0S,A5-*QM[R-1:>PV>FVXH]/\ U2]*\$3;^1NY9V<]WU=C,]KN
MC\:.J\4<A8U&YWV!T7A?#N+:YCHK%\&5&RI2J58O*G$TF;9/I;;#69V[J.<&
MY*[L[5UW"]D#]4C'2MKXJ]]>'$VFKFE_HCV0^:.J88R]0SVS'_J7>VKFCJIO
M:X=([#132/GN4=\1-7W/_JFMNVRZ;1X/@V1#0,4Z.31%*K)8^]5_-SD[2*LO
MTIKB:1\;9%<BS)[RL;WG-]O8*DP^"9]QX?@LMD8Q_.=W%WZQ1,U7(GE?%97^
M9P][%?8B^DL+FUIX4;7?5N_*:JT+=]L7*OC6SO\ +Z6\]F]7[*^N(['>MNMC
M<2HC?M>V5S8Y']BO1?=7V%..R;)K+$U.BQYHKQ=#0W>!S-]97WQK[_X&)&.N
MDE1DDB?WOPY&]M/29^/)$N;U^COMMI2O<W=LY[,G!FWWEP[)/C\-EMAGN^N1
MKD]][F^CU%Z)<[JK.68B[96/KX+MO*PRR8O&W]Q=6T%O#6TDMYV=U(G<T<_F
MBE4TA:QUV1-9MX5^EKG$7C<7#<X_=<*Y%D<3H<%F$G69MI;.74UK-/'N_-5>
M2B&1GQQ$1'#]-?-YI9G9[GQ\-Q:9)UTZ:58/A8,A,^L<K.7UK5^>A-5F<-U\
MQ,1Y?:M>5AS%Y8+%@L^DCO#5UQ:3IW)'5U-; XFZZJ,-MN*^>:V*>7T,>M,'
M%C-NS8J+'Q[;R>0R#LJMPB>-&^X<E%61SN2>I"URLO-J+LM\1?M\_P!"?'6&
M7;/%>I;LAU)23X9:Q?E-KQ%:+>:.:9C='EV]C>'3W<F9BW+B+2*[6*W;<LCF
M1J>^BKQ^4M:J(NPTE<Z9=^7U-G+,[9W>7%ZPVJM?9V:MKI6"-WRJG$XR_?,/
M=\>VRWS*CF_=*54PDHI*$%3L%!(K2$):=A(E5":T4S"1>PJB5,PE5*^T"DJ*
MU*I[R<6KZ_03"F62X^X6XMT=1NIO=E1"Q?LEL=/,7VS7@^XA(  JQ/5CV4XU
M(F*PFV:2NJ+5*EED1*(2
M
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MJ?6F.D]6WSKO_P#7:BO37K*BQN;UQ1BLHB+'MS'LTM_P:43W*_-7@1.LTO\
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MGN_C*6KXXKN"ZEU.UDJM5"AEI0 $R+3B!<;9^ME*4T<"U=%%^R:P^@I5@
M
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MC9G(>]#1K>]'%'[R(O:@5V9+9XOCO-S76)O[3#P.^S\/'&N/M;>+4ES/<O\
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M$H4KP["I2IN<K$29.$D+D<GL0B8V(K3;V,JMY7306\O9(VM2S1L<<\T5X*X
M !]5J]&O<U?G%-T57,<T7$M+P
M
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M%V:NI*H699$35$A(
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M51>/(J0A:3+:WR(ON2_5)\I1D3BNFRYEI;9P  BG,"Z0+5A:NWK]FY6*58
M
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M&5L[(I$^<A9;&+N:(3TIP]  "=O)0E]ELOO-]"%%ZYC?86UT
M
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MWG;=[>F8OQ%J[NS:V\E>OSJ&19N<5FF.:ZK&8(X7[A?=Y.VG@:V=8;V9/?\
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MK5T+U:Y2U=&UE:::V^9=*JO%>92O $45>P"M Y4D3C[R4*;U=D[5T+2^
M
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M]&'>L<UW$WW9425OM7]0M7K^GFDS#(BED@ ">->\4S%4PNZ<412VR(1(2
M
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MMT7UC=65K3X+'W,NB1DB+5KE8^G)37=5RY,>/W9WNL\+Z#3YL_Q,T6Q,=_\
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M^V9S1[%8J^PB^U5AFE\0R8MLT  11:<0+NSW&KZBS.]DQN3D)
M
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M  !147:%:QH69WLBW<JD*@
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M&V8F)C@U#MVXL\;GL=>S3-9=I#<W#[/W7.C^:[2XI;'+%U]E+=OEYU?[/O\
M<F[-KY?#7,T38IY;G(NM'?630N]QLWIT^LFBJ[/;CQ\DQ'E];.,]MSXJRRS;
MJ\B?\1.D]W91Q-DC>Z/_  CO2&'AOI='+Q:CQNZK_)S9ZQ2!EGMW$,23PY&:
M'6SH>ZYT/Y?O*0W&3!LYN--WUK_D-U6>V+)N:Q&2D9D<[ R1UVB]WN=UO=^:
M477TXK&/0WZB:W6THT)NCK-N3(3P6B,AF;;KI6Y:B-D<_P#*;ZC'NO=!@Z79
M;':U#D]UY/)R2VL]S-XKJ^!*LCNZJ<7(O'T$5F6?9H[;8K'#REB_QMXDEO'(
MKIVHJ-DC547A7VBE%R,<;:[*.C.CCT3;=PQK5B?]HS*YJHE4;P1%H;OI_P#
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MW$+=T47[-RN4JP
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MA7TL0L3O;"W[L(NY@2@"8%RM_=7Y"U>O6;GTE"X
M
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MY H4U"$CN80D=[B_($3N7+#_ )J;\LB5W3[I7<I9   K6WYU"BY59O74ML@
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M$[N82E F3DOL ^^U]PMWKV-]10N
M
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MSK/NPF=S)$H$4[?82+A:^X6KU[&^HH7
M
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MW=L3/O>F.##Y>E&4Q6&NL;>8U,QBKYKGMDM)_%C;5=2*QKZ.93T(=5TKYA]
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MO$1KW+$Z2&WII;XB:M+=/O40FC*NLLLNNLIPV?H^ED[LM'<0NDFB;)%$UO\
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MIM^&EUMMU.6)FO>]*Z%XEMU%<6IR8HR?$FVRVR:UI2GMHZ29(]:->VGTJJG
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MF66_"V@1.2,:43O9UOW81=S E $P+E;^ZOR%J]>LW/I*%P
M
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ML
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M*BZ0MHQOK0LW2R+8V*Y"H
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M;V1;N5"%0
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M(A,0D
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MHB46G+_F%)WUDIV0D='$K]:PMKS;(NFM1$W1LB=AR1/ZK[6<ON=I*I5"
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MM78M,@
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MR^[5J-^1%*;E6#C*]4I^R(9"  "K'Q<)3"ZMY(699$(D)
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M"I$D3LX<0F'V6Z=]7>HHNW+ED;7V%M=
M
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MGU5[O37TEMD8XI:^P+@  ^FV3OU["B]<Q[UR+:\
M    #X;M*T5"JU:R0^(NK0 Y<0))8DFBEC7CJ:H1,5B88? CFODC?SBJB5+U
MNYKXV317;S0H7%1 *J<B54*K>1"85DY!4F(E*HSFA3"J%;MH%2J4I56\B82A
M(QDC71O1KVO2BI3G[03%8I+",KL'!7EE>.LL;#:Y&X14^T&,1LC:\Z.])DX]
M;DLV<TT:W4=(P9+)FVR(NGCQ8CC]F;FP$$>/VXQDL+^,\MX]7T7M6GK7F7;M
M39DVW;)A@XNFZC3V\N';$[ZK1FN@Z;M>R7<61@@E2JHRRC1KD?V+K+MO5IQ1
M2UB9_"<:R:YIBO=#A+JUTZN-DYR7"RL?=6SY4?!<HG><WZ+W'1:36QJ;=D4>
M7=9Z-=TO/-LS-ULRUU-+:38?[(NY:>&[5XO8QOH<9C571,[MBR+C-5I;^!<Q
M7$=KW8)6O[[11<LR39P8OD,]:8*7X+,V:SQWW>[BZO"C_7])"_9CG)$W1LGR
M]@^QLW8MOV*](;69ZSV[%;ITZ?=%5-L[.6Z:^6ST+EMO=\>(\2:\=+<6LC/!
M=:L7NQN^DUI,2IRX8NW1Y?H7'<^=RD"XZ+#NMKV>[A\6.1[O#K&[YGJ?ZQ,H
MT^FFZZ:S2D+5;9G 9:VD^/N&X#+64?\ *\3(FI6N3_!?2KZ2%5+[9['RMR]I
MFFK'!F(;^PMXE2]7PM4W=_O<D/I]"A$8Z36/+R^E8LMM+<E_98Z;&WEG>8ES
M'SV7QB(VXC:SFUSD]!%*,G%K)MBD1L\O*6&Y7;V/BN]O38>.]DN\JZFY)[2[
M9X=B[_"Z:U<VG$F69@NB;)FZ._S^G?NW-AX/=&9Q-Y:+AI[[*PX^18;W&7SD
ME2Y;73JME^;5!RPQ+XYXK%M&Y;6\M,SX]RCYK6>&)9;FPG8ULT&GO.37VIZB
MKFEKLF*;.^&"YK>UBD3[>QN/"<B:G7+J-G<WM:WZ*%,KV#373'-.Z6D<MG[7
M;[(KO#;?M,SE,O*[1)>7"1QL?JYN<U55%]1#<:3!$SR7W3;;-=W;ZZ3+;'3W
MJ/?V6+EN,CMN>;/03JV_P6/FUVS&I[CF/6O83MF.Q@YL.+'E]RZ9V\=WII6C
M[.H+<M?[5M;RRQT^T(<M<H^ZN+US9U3\5(:]HW[YJHT\QBNK-DS$]FUJYEK:
MR6$23VLFF!VF7,Q.TNT_1\,AD7W<T;&4)MW!W,=I9*Q;NRN6ZTNV_-;\UKB6
M-\>^RZGEY2N]KCK+'1V\%MDI76]M.LC'RL\1B?-[OL$(NR3DNK+3_4%JVS<C
M+%'8PLEF1V4W).FB?P]/<@@;\YSD$MKT^ZE_;/9/W?3[&I-LP2Z'18>>9^,R
M<SG:+IB,E:K?Q?7Z2J:4;75TB:<>R*4\\>R9;*CP?V@SP[ELDK6U:DFKW7)[
MM/44M3=,6SL?=8VN9QJ.M/!GOI_[U-&O=:TBBB[-;3;%5\??,9/<NO:M?% W
M39L][5](JHLV[9V;/+V*,+KAS;6Y1*V]RW2Y6^\WB)BMFQ=QTB^D[8\OH>[7
M0K&;<AZ7[63!XZWMK=U@SX]S8V)XTE$U.=Z:KZ3B.HW9(S369V2]DZ#9CG1X
M^6(^ZNF=Z+=)=SODES6Q<7<S/XRS^%H>[T]YB)^$MVZ_46;(OEDYND:+//-?
MCBN[<U;F?)ST'S,4C6[8N,<DG%WPUV^)6^MJ(KC)MZSJ;>-6%?X:T62-U&H,
M_P#_ $>W3.\8]V W;F\)*C.YXVFZ1J_+13-Q^(<ML^];#7YO!^GOMI9?,- [
ME_\ H_.H.,5TVV=S8W<BQU?'XJ+:7#O4J\$K[5-MI_$V/9S6T:+4^"LENW'-
M9[>+1N7Z8^9#I+<.GAM=S8>.!VI)<5/)/%W>-?JT=P2E3<8M=TW4Q[])GO:V
M[IW5-+]V9V=_Z.&]VMY6^MG6;<E['@=_V[MPV#^[#EI89(+F)/\ TSW(FHY[
MK73M-9$W8IB.Z'5=#ZCJK_=S1,^?RAZ'*O8<NZE(JDH4'<5(E3*F3")4WJ50
MIE055KRJJ=A*(WJ2L66ZMX$XL<_6].S3Z"%$Q6Z(9-V\RAG5V(HE."<@@ F:
MO82+E E&U+-R_9&Q7*58
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ML@  3-3O(@(7=B:6HB%F9JR8BB8A(
M
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MBZ>"O#9$SS+TB<*_-^B4KZ($43C0"?3Q2GI0)HNC&Z&T0LS-61$43D)
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M4-8N3*[-S%UC53XG$7+-5LKO><[M=P)EL<-,]M*\%NS.7RF9C8C+5\<-NO\
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M@*+EZL8O"M61=J\7O[54HG;M9.*VEM'V!6  *L+=4K5]!1=-%5L5E=BVR
M
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M3TJ6YFLLFRWEMH^C\'S0K )F\P*\":W<"F9HKLBJY%I?
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M@B%++0  11.- /NMXE:BN6G%>Z6[I7;+:/L*%T
M
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M0N  "=J+5HG<1"ZM[K$3T(69WLF-R<A(
M
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MZ:1 2I  'UV[*\53W5X%-TKED+@6EX
M
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MRV6&!9)/STJU=[.PMSO7L-DQ;65R"X  (M3O)ZR"%UA;IC1"W=O9%NY5*50
M
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MX(Q$U4X?@+;*B*11,   3L9K<B(OK(N3$575C=*4+4S5D1%$Y"0
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MBA3+*KLH@$  #Z;>'4_647*[+:KBB(B40MKZ(
M
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M\KIRY$+PB=B  %%7@G,#[[:+3WG)QI[Q:NE>LM?84K@
M               /GGCUMX-JJ>Z3$J;HJMJM5%IZ/>+S'F$  #LIV ?)?VK+
MN!D=$\1G>8_M1?0+;E&6SGAC['R.>K)%[\?==7U%[8Q-M:2^E")50BBTY$)5
M6JM2%4*J*$IN7$MJE=J\*$JE1%X<"4IZE,I3M40E41?02E,CEJB5 K-7[Q"H
MX(0)J]@XI132]SHT]ZB]WU%,[U<3P<7==]E;JW9U/VW;8*PFN;6;');27B)]
M5;,?(B3.5>Q50VV@SVXL5]>,PY?J^COSZJR;=W+,3Z9AU]A,9;X/%8W#6S4C
MM\=:0VT+&\M,;:)3Y357W<U\RZ3#CC%9;9&Z(7?AR0*XE*J+1RM7OO2C7>@C
MEA.]YF>;SJE#@[Z?IQLQVG,YF&NZ,G J)/X;^+HG.Y_<.BZ1IYF.?)MC@XKQ
M'U#DGX&&:7<9C>X5V'TTW#U)W98[.VK:+<7LK4;>7FE?"@BKWY)W=E&_*;O5
M:F,%G-=+E='HK];FBRR.Z9]M7M_T<Z/[8Z-[6@P.WH?$NYFM?F\V_P#.W,U.
M\YSJ)P2E$1/PG%:S67ZF^9NG9PCL>G],Z7CT&*++(]ZFV>UN%B,76Y.\CUKJ
M,:);"BJG=2B$*MR;4XFA634OI(HD5RDT1,J.KUE5%-2J@05?3Q"$JN3D30JE
MJOI)0>L""J1,H2HM2!"B$H1 I/547@50B5%7.I2I"E35RKP5> 0D<M. BA*F
MJDJ5%7+7F*J:J:U*J0A*]:-JG,F$2^9ROD<VVAJLL_!7_1:512FU1,3.R.*]
MVT,5O"V*)M/#6CG=JJ6IFLLJV.6*0^A5KS"4  $S&.>Y$[""(JNL;48U$I3A
MWBW,U9%L4A4*50
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MR[>+[_9P]2<O:1$+LS5$E   ^VU8ZFIW,M3=5=LM?<4KH
M
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MVJO*G$B93"X11T2JEN97K;7T%*L
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M>5:]HOFFQ5AMV\TKQ6NI5YKS<6X7Y"0  5(XUDY(4S=15%M5V1*<$+3(1
M
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MEJ:U9%MM(5R4@ "%4$R/NMXJIJ<G:43=V+MEK[BVN@
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M2E4
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M!B)R0H95(A,JUXHE/Q24(  )M+N5")DH^ZWAT)J5**477=B]9;1]90N
M
M                                                'R3Q\-2=I79*
MW?#XM56^NI6M2D)0  )94K$]%^B_]R47?>M\Z>$^9X*;[C>N\=V-1VE?MBZT
MKZM;_P!8]9T<VW88CC2'R3UBZ;-=FO[+[OIF6\NN&S/A-B]%-_6-NBV^8VO8
M8[,1)[SKJ&!)&.5?QHUH:GHVMYL^7'?OBZ9AU?BKI$6]/T.KLCW;L5EL]M:;
M_35NWRQ]6;;#=)-^8O.RJLW3J-V4M(7N35\+<HM&)7T2NTHAJ^L]-NC5VSPR
M2Z_P3X@^%TK/;FWX(K%?PSN\SCK:V*R?5+J5C+"X>Z?)[JRR39.9>/U*OUS+
M\D=3H,__ (FEG_+'M>9Z##DZ[U2V)_7NK=YJ_5#,_,A9V^+ZO[CQUG"D-EC(
M;*VM8V=UJ,;#I;]VBJ8_1<LY--66T\>X[<?5;K;(]VVVVWLX;/M=T>45WA]"
M<?(U=2QYK+.X?XU#E?$7\]/FAZM\O*_T:W]N[VP\K\M*^;*YFX>Y9G3WMX^6
M1>>M\[JN^\=],19ACD[(]CY]UTS.>^;HWS,_3O\ 6]RNG=A9XS8NS<?8(UEG
M98FU2UB9\YBL147[JJ>9ZVZ;L]\SOK+ZLZ3@C!H\..W=%EM/4S6JJJKITU6N
MFM3$EL(8YN^SMLGM/=-A>QI+;7&'OFS5Y(G@/JOR+Q*\%\V9K)CMACZ[#;ET
MV6VZ-DV7>QX/V6NUO;!T$GUMI<QOMGI\YT4K:._N3U6Z/B8KKN[ZGR?IKHQZ
MBR.,7Q7OV[/;+UL\S<KIO+]E9I7(DC[3&N>[\9R,5QY[T2VNMM\\_6^B?&\3
M=T7)^S;]3SL\OEK#<];>G%K=1,EM;O(R07-O*E6RQ26LR45OKJ=EUK)-NCOI
MV1[7BG@B,=_5\%E\5]Z?5RS[5X\P/1Z[Z2;KF@LVR7&T=Q2/FVS=-3@U%6JV
M[U^DUJT;ZBGHW4K=;AB.-OWF9XS\-W=$U,W61^ZOFMD_5/FK-(^QU=Y6NMJ;
MBV_D.F.XKE4SF,QT[ML7+U_RJU9"]%A55XJZ&GRH<WUWI<8,EN6S[LS7ZWH/
M@#Q/=J]/.BS37)%GNS/ZT4W>BGIAYS7J+]HW2JZO\I=1_P#ZT[?'?%V*9[H]
MCQ34Q^^R4[9_ZMKURZWW$UOY8LPL%=<NW;"%U/H21QHOX3SGIL5U\?M2^C?%
M%_+X>OC_ /AVO,CHK86V2ZN].<=?1I+839ZTBN8G<EXUH=UU>^<6DR3&^7@W
MA+%;DZKI[;MTWQ[=SW-8[ON8C-.E5^^IY99MJ^K+IBD1"JY5HOH+BARAYR;2
MTNNBU]>R1(Z\QF7QS["1>;%FD1KM/M8M#<>',DV:R(CO<+\R[;;^CWW\8NM^
MF8<'^5^9]OURV9+%(]'SK=6\K47WFR0J==X@L_\ %O\ .\E\ 7_#ZQBMCOV^
M>%\\X$SINNN?5SW5L\?CVQ,]"+'_ /?%GPWCIHZ][+^9-;NL9)GA9;]7VNP/
M)5C;.UZ27F0CA:EYD\W=QW+^U8X%:UB?)JH<YXFNF_5S'"(AZ3\L<6.WI7/$
M4FZZZOH=?QJBHE&Z4:B4^4T$4X/0KNQ45?10J452ZVHE%<C=7#[O A-:/CN;
M2&\BFM[R..>VN8G0W5K*E6RQN14<BIZT54)K-NV-_!3=CB^)BZ-DQ2?,\9.O
MW22]Z4[XN[*V:DNT\XZ6_P!MWB5T^%(Y=5JKOFOC3NIZ4H>C=&UWYO!'-^K]
MY\V>,?#E_1];=-LSR75NL[-N^.Z8W1VQ$-:X'!;@Z@[EL<+C&RY'.[AN8X(+
MJ=5>JZ4:QT\J\5:UC&\5]"&;ERX]%AFZ-S1:#1ZGJVJQXHVW7TK/&F[]%>+V
MLZ?;$P_37:&-VCAXD6*RB:V\O:4=/,J5DD7\IZJIYEK-3=J\DY)XOJ#I/2L/
M2M+;I\,;(C;WSVLV;5&HUW9W6^PL5B=S8W</,DF_-S_YO+^X4FW?'G6[MT^:
M?8\#,W_O!D_YZNOX]3UBW^!;^R^2=?\ SE__ '+O:]V-L_[M;<_FFR_B6GEN
M;^)=YY?5VD_@8_V;?8O:+WDY%ID1O>$&_..^]YM7W?M_(?\ :)3U;1?R^/S/
MDCK4S^>U'_<O_P"J65XGK7U8Q&,L,3BMWWUM88Z...SA8U%1D3$HUM=/)$X&
M'?TO37W3==$5EN,/BGJV*RW'9ENBVV(B/-&[AZ'W+U[ZS.;W=Z9#FJN[B?O1
M'2=+V0OQXOZQ3^+=ZOT.[?*!O+=.\]O;UNMTY:XS5U9Y.WBMKBX1$6.-]NKU
M8E&MX*O$Y7Q#I\>#+9%FR)B?:]8^774=5KM+FNU%\WW1?$1,]G+7LC9.]V,E
M%5WIX'.QO>AA4  "K#'XSN/84S*JV*RNC&HQJ-3DA;F:K\11,0D
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M<%?-J[\CO6J\S7] U$ZCXU\\*_X-]X_T>/0SI=-;OLQ16>^=E?3.]T+Y$?\
M=/J)_/=G_P!E<:;Q5_%Q^:78?*G^3S_MV^R7=IR[U,*A37FH0E5:$H47+54(
M1*2I,*5*5Z,C<]5HB)4JI53=-(JEAM7WBH^5%CMN"I%VJ1-W*FRSGVSN7ML;
M4:M.XUOH*&32B:M>)*  !.VB5J"'TVS5<NI4X%-TKED;7WEI>
M
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MIW'4]3&FPW73V4>#^'.FY>I:NS%9^**^:M9>HWFJ;%%T,W##&W2R#X.&-?\
M%R,:U/O'"="N_P#,M[YGV/>_'T\O1<L<-D>J8>=OEQ_KTZ8_SJ[_ +-(=KUS
M^4S>:'B?@?\ W?3?MS_TO5OJET\Q/5'9N4VGD7^!+<,U8O(TXV]TSC$Y/4B\
M#S[1:J=-EC)'#>^BNM])Q]5TEVGR;IW?M/&G)8W='3C>5S9739,/N7;5U(V&
M6E&HC6Z5E8OH>CJHO;4]+PWX]7I>9\PY\.JZ/K)LY9B_',^K=7S4X]L]K%)Y
M77$[II75EFD;+,Y/G.D=J5W]T9,1$6W1&ZC S36;ZSMG;-.-=N_NK1[7;JVO
M/O?HC=;3M5T7>9VM#%:.[?&;;,<S[M*'E^'-&#5QD[+OK?4VNT5VMZ3\"/U\
M5/H>,^(R&5VAN7'Y..%;/,;:R,<WAO3@R>%U?#7Y$5$/3-33563V76OF+29,
MW3-9%]M>;'=3U?;MIVO;SIMU$P'4O;6/W%@;N.X^*B:Z^LM2>+;34[['LYHJ
M+VGEVJT632Y)MOC9P?4O1NLZ?JNFMS89K,QMCC$MA2)5C]2*C42JKRHGM[#'
M;3@\V?.1U>QF93&],MOWK+Y+"Z9D-S7L+D=&V5J?46]4YJB\57L^4ZWPUTW)
MCOG-?%.QXW\S/$V+);&BP3%T1-;_ +/M]3!?)KM"\S74V[W3)#*S%[.LY4CN
MG)P=<W58DC7UHU=1G>)M9%FELQ<9:KY8=*G)K+]3.['%*=\_7"_>=G9=S8;[
MPV][>%TF.W/CH[*[O43NQ75DJ-8U?RX^7L,?PSJHG!?B[U_YJ]*NQZK'JHW7
MQR_\4;-OH]B?R@]8,3M'(Y+8>YKKX&PW'=-O-OWTCT;'%=-9I= [Z*.]/I*O
M$G2\F>(S8XK,13U+ORV\2X]#==I,TTLNGW9_#,[XGLK]4O3*)8I(XGQJBP2L
MU,5JU8J)VHJ<Z^DXB*QLG>]NB8OB*;F"]1^H>V^FFV[O<&>G2&2)O_=V+5Z>
M/=OI5L4:<*+VJJ\D,G2Z7)J+^6R*M;UCJNGZ9@NRY+HBD;(W5[H87TQ\PO3O
MJ@VWAL;UV*W$K6H_;60:C+E%TJJMA<WA(U$2M4,K6](SZ/;?%8[6LZ)XOT'6
M+;?A33)^&=_Z6]7/74J_/C5/N*:]T<2XF\[[&KTYVP_5WOMUJZ?5X4ATGA7^
M9O\ ,\S^:=?Z7C_[GU7.?/)5'$O5[*:XU<^';%\NO_U]N;GQ1_*1^U'LEP_R
ML_W2[OPW?]5KU9>M7<>TX&7T$IN4F%+Y[A?J;C_$2_N%*K=\>=%VZ?-+P2S'
M^\66_GFX_P"T//5+?X%O[/V/DO7?SN7_ +D^V7NAMS_=S;7\TV7\2T\NS??N
M\\^U]5Z3^7Q_LV^Q>V>^GR%J%]X2;[_WWWK_ #[?T_TF0]6T/\OC\SY,ZW3\
M_J/^Y?\ ]4O6?H_LW!Y7I?L.XNML8Q8W8:T66ZDM&.EE56(KE5=/&J\54\ZZ
MAJ,EN?)2[]:?:^D^@=.QY>GX)NQV_P .W;2.R&X6;(VA$W0W9^*:B<?\BC[?
MV)K_ (^7\4M_'2]-;L^'9ZH77'X;&8>*1N+QEMC&3.1\D-M$D37N1*(YR(B5
M5$X$3?==]Z:KEFGQX=EEL1$]BY<52J\PK0 4KP GAAU+I4IW*K;:KLUJ,32A
M:7XBB8)                                          2*FI%:OW0A;
MI(]'=[$4NV[EF[>I.1$7ARH5*)2@  !4145%Y*BHOL7@!8;FQDM?K+!-34_.
MP^CV%7.Q[\/)/N*$4S'K5%X]OM)6[;E=5U+7TA4F8H3"LB^DB54'(H2BJMHJ
M/]U>#Z^@F9H;.+A+SO[-O+FPVGONTA62+">)B<OH2J,25_BQ2+ZM7 ZGPSJ>
M2^<7XMKROYI=+NS8\6KM_4]V?,T)Y7^K&.Z9;TN;#/W#X-L[JA;9W=\M$2"X
M1:Q2/3MUKW57L-MU_I_YO%S8]]KE/E]XBLZ7J[K,T_N\NSS3PFGE39VO6NTN
MK>ZMH9[66.XM;AB+!?0.UQN:O)45/2<!-DQLG>^@,>2+[8FV:Q.Z8W+)NC<V
M$V7A;[<&Y;Z&PQ5A$KWS.HW4K4[K6IS<JKPIZ2O3Z>_49(LLBLRHUNLPZ'3W
M9LUT1;$>MI7IYYG^F._)&X]]U-MC/OD6&'%Y)*(YBOTL6.1O=<KZ<N9L-9T?
M4:>V;J;(<ST;QOT[J,<L3-M\S2EWE]&]K?SH;ZCQ&T<1L&PN6_&[DG^*R+&\
M_@HJ<%]:O5JH9WAO23ER3DF-T-'\SNLQI-)&EQS[]_L>>&R]VW^R=RXS=>+M
MH+J[PKY'6EK=)KCUO:K>\SMX*AV>NT]NKQ_#NG9+Q7I/4\O3<^+48XB;[)FE
M>V8F)V>:8CZ'22>=3JXRJ+9X34BHY7)$[A7W4U:C2?VSIYXR[BWYH]2B9]RQ
MS;N_==[O?<F6W7?6\5I?YF5)[Z*#A&_2RCJ*;_2Z6S2XOAV.(ZMU.[J.IG4W
M??G_ !FCT4\E._&Y?9E]L6]G1;[:<SI\?$[YUC<<4_:.14^4XCQ-I)LRQFX2
M]J^6/6+=3I)TL_>QS7;V7;9GUU:N\]:JNY]D*O/[.E_=H;'PE]W(YWYM?Q=/
M^S/U,.\MG1#:'5W';GN=S37\$F(N88;/X-[$KK:JJJ\.+N/WR[USJN70S;\/
MC%?:P? WA72=9QYK]179/+%)[HFO?.WZ6#>8/HTG1_=EI:V$ES=[6S<&K$W<
MB(CF/919(7O32G!:+\IG=&ZI&LMB9^_&]JO&7AFWHNJBVR9^%?%8[YMWV^GA
MWU=#^2K/[+FGRFW+K%6=MOJV9)<V&;5B>-<VBT22-CUXIX:4JGH4TGB?%FBZ
M+I^YY4=C\K-9H[[+\7)%N>*S%W;;QBN_9L^AZ%N:UR>&L:2-5':Z\J=IRCU^
M*TIP44M;+_W>/]H@V(Y858X(X7-5B1MUJFG2E1$&UXN^8]/_ +M6]J_-NF?N
M&GI71_Y*SSOF7QS'_P"YS?\ #]3NOR[[?L]W>5RTVI?)2WSZ9BQD_*?=247Y
M.!RG7,OPNI3?'#E]D/6?!6CMU?ANW!.Z_P")$_\ -+S#R5MFMF9G,8>5SL9E
M<5+-B\BB<7455CD:GJ5IW>&ZW4XK;YXP\+U5N?IFIRXOUHK;/FX4]%'1WE"V
M'^E'4YV?O(E^QMCVZW:R*WN.N+CN0-KZ6(JO.?\ $6IMPZ?X=N^9=I\L>CQJ
M]9.IO^[CC_ZMWLE?_.YJ?U.V\^O=7 ,>E/2LO>'A79I\G?,^QD?-B?\ S<=.
M-C:?D4_W3ZBK_P#GVQ_[,XUGBK^)C\TNB^5'\GG_ &X]DN[]2',O5%,*4'*2
M*#UJ0IE*M."=I,(E\\TK&=U:K(O!K$[2J;:J9NH^BTL9%='/>*Q%K6&)OS?:
M4S?LHN6XMO-*[I7W5Y%*Z@2  "HRE*J0F%6.)9'57DA3>KMMJN*)1*%M=B$0
MD
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M*O753@WYI1=*JVVJX-1&I1J40IE>B*)B$@
M
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M(MKOI%%X<B(Y9/G.[I;HNJ[(E?1!=.Q5;%97&.-(TH6YF97K;:*I"H
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M  !-P:G>3B$JT4+I%15_-ENZ9A7;;5<6M:B43D4S*[$43$)
M
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M,@0  ';Z@/IB@<Y:K2A3==17;95][&(Q*(6YFJ]$43D)
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M-:C4HG(IF:KD11,0D
M
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MH1)  !-I5>($*+6@'U16ZKWG*FDMW2N6V/O1$1*)R*5U$A(
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M*.;K7Z2E.U=F8E E2    "=D;G\B)E,15]\=NUG%W%2B;EVVRCZ2A<
M
M
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MHFI*H#>JQT>NE&\4X%/-"J(J^R.%$74YO$HFY=MM?24JP
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M=]I3-T456V3*X,C:Q."<2BJ_$452$@
M
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MK>)1,KD114"0
M         !(YC7^\@12KY)K;5Q:O N1<HNL?(YBM6BHJ4*H69A+S)
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M25(      "=L3WJE$6C?41,IB)E]S+=J45W[4HNNJNVV4?2B(G!"A<1
M
M
M         @J(J47D2A\<UNCN+>15%RW=8^7P5;S*X6Z*9*            5&
M+2H3"?5ZB*!J4)-2@3$#YW>\I4IE            11-2T02/H9;UIZ"F9HKB
MRK[61-8E$YE$W578MB%4I5
M                         *;HV.YH3%TPIFV)?$^VHM6\BN+H6IL?.YFD
MJ44HE)            ?0B\"%2%53@ U*!'4!(]:H$2I$H           !42/
M5R(E,156BMN/>YE,W45VV/N1J,]U"BM5V(HG(2
M
M                                                        !\SK
M=J^ZM%*XO6YQOCDA>CEKQ*XNA;FV:J5%3F3$U4TH@           (U4"
M         5&,5Z<!6B8BJO';5KJX?(4S<KML?6R)&+5"B;JKD6T52E4
M
M  "1[$?P7L)B:(F*OE?;<-2<RN+EN;'S.B<U%7T%7,HFV5(E2
M             !$J!.D3UY(1S)Y9?:RW7YZU*9O7(Q]KZ6M1J(B<FE$S5<B*
M)B$@
M
M                         "56HO-*A"B^!CUX(B%7-*F;(E0?:N3BU:DV
MW=JB<:@Z%[2N+H43;*"-5%2O(FI1,K4]!%2BB2@             !,B56B@3
MZ?0A"4/#52:E%=+=SN-*%/-"J+)E59:L1$1]%4HFZ5R+(XOH8QK$[J(U/41,
MU51$0G(2
M                    )7(CDHJ51281,54EMXEX(U&CFE')#YG6JIRXER+U
MN<<J*QNJI5510T42M 42N1$Y!"0              "HB52M D<U>Q!4HBD3W
M+P$R1;*JVU55JKJ(43<KC&^AMNQ%15:BE/-*N+(5]*)R0I543!(
M
M
M                    INC8Y%JG,FM$3$2I^ S\;[I/,IY(4%M%['#GE3\-
M26W<GM*ZJ.24BQR(M-*DU124NE4YHHJ4-+O0I-4&EWH&P0TKZ"=A0TKZ!L*(
MZ7?14!I=Z"FJ:(:7_16@J4E5;"]>;505A,6RJ);/7EW2F;DQ9*=+1%7O5IZE
M(YE<6/H2!B<J_=(YI3R0J(U$Y%*NB8
M                                                  @J5 I.A8O,
MJBZ5,VPHOM6KQ:Y?ND\\J9QPHK;/3C[Q,7=JF;)2.A>B51"KF4\LI-$GT5%4
M4E+I7T$U*(Z7?14E"&E?0-A0TKZ!L*(Z7>@@-+O0H$*+R1%(K!1-X<GT%%4T
ME42!ZBL)Y95&VKUYN*)O51C5VV[$3C5/E(YI5Q9"HV)K?7[2)FJ8MB%4A4
M
M
M                                     !(K&NXJ@11#PV>@FI2$?#9]
M%!63E@\-GT4%9.6#PV_105DY8/#9]%!63E@\-OT4%9.6$R(B<$!")"0
M
M                          "3PV_10FLHY8/#9]%!63E@\-GT4%9.6#PV
M_105DY8/#9Z!S2<L'AL^B@K)RP)&U.*-X@HG(2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
<                                  ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>tm2227887d4-lc_lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_lnp4c.jpg
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M# P,# P,#/_  !$( HT&H0,!$0 "$0$#$0'_Q #Q  $  @,!  ,!
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MV@ , P$  A$#$0 _ ._@
M
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M](CE#HU S%>%.H\$E*4EB+&=8;::2:S4K1*2TZGK]T"5[P0
M
M   I=1^067+F;DR[:QM'JT%AXVE.1F9<CNSTW$A:T+(MVTR]0OY!S/3>M_%-
M5$W8--%UL3R1=-.Q,Q+J6I]3.$Z28MSZJ;;IBNV;;:]F(F&8_>[G[Z(#]Q3O
M;!D?:+CGHGZM_A8WV:X#Z9^M9X#][N?OH@/W%.]L#[1<<]$_5O\ "?9K@/IG
MZUG@/WNY^^B _<4[VP/M%QST3]6_PGV:X#Z9^M9X#][N?OH@/W%.]L#[1<<]
M$_5O\)]FN ^F?K6> _>[G[Z(#]Q3O; ^T7'/1/U;_"?9K@/IGZUG@/WNY^^B
M _<4[VP/M%QST3]6_P )]FN ^F?K6> _>[G[Z(#]Q3O; ^T7'/1/U;_"?9K@
M/IGZUG@/WNY^^B _<4[VP/M%QST3]6_PGV:X#Z9^M9X#][N?OH@/W%.]L#[1
M<<]$_5O\)]FN ^F?K6> _>[G[Z(#]Q3O; ^T7'/1/U;_  GV:X#Z9^M9X#][
MN?OH@/W%.]L#[1<<]$_5O\)]FN ^F?K6> _>[G[Z(#]Q3O; ^T7'/1/U;_"?
M9K@/IGZUG@/WNY^^B _<4[VP/M%QST3]6_PGV:X#Z9^M9X#][N?OH@/W%.]L
M#[1<<]$_5O\ "?9K@/IGZUG@/WNY^^B _<4[VP/M%QST3]6_PGV:X#Z9^M9X
M#][N?OH@/W%.]L#[1<<]$_5O\)]FN ^F?K6> _>[G[Z(#]Q3O; ^T7'/1/U;
M_"?9K@/IGZUG@/WNY^^B _<4[VP/M%QST3]6_P )]FN ^F?K6> _>[G[Z(#]
MQ3O; ^T7'/1/U;_"?9K@/IGZUG@/WNY^^B _<4[VP/M%QST3]6_PGV:X#Z9^
MM9X#][N?OH@/W%.]L#[1<<]$_5O\)]FN ^F?K6> _>[G[Z(#]Q3O; ^T7'/1
M/U;_  GV:X#Z9^M9X#][N?OH@/W%.]L#[1<<]$_5O\)]FN ^F?K6> _>[G[Z
M(#]Q3O; ^T7'/1/U;_"?9K@/IGZUG@/WNY^^B _<4[VP/M%QST3]6_PGV:X#
MZ9^M9X&<Q]F>^*]D")8]X6C&M]Z7&>?-&Q]E]ONVE.H4:'5*U)1)T]3[HR^#
M^LVLU&NC2ZG#%DS$SRQ,4BNZ6)QKU6T6FT%VKTV:;XB8CDF)K-)VQ$;EG1[E
MX$
M                                        %/.._P ^W,[Y<4+_ &?B
M F5PP0
M            "D'!3]3,Y?[[[W\I9!,KO@@
M                                                  !5+B5^IUS?
M#)>3M#P'X>_5<OE^U#HGXC_6\7D?&E:T>_<[
M        52D?Q70/@8_(G!S^_P"\UOD?%ET2S[K7>7\>%K1T!SL
M
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M9!,KO@@
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MU+?;-#FU1^!KMT+J+FKTUF+'9-LUF:UGDV*-/GOR7W1=%*4IS[5WQKV6
M        JE(_BN@? Q^1.#G]_P!YK?(^++HEGW6N\OX\+6CH#G8
M
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M2=3/:1%H0*)2*          *0<%/U,SE_OOO?RED$RN^"
M
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M'L)T?BW3SW7=]]\1_P :W+?X+LO_ $2R(S_5L7_EWS%^^R?^/>7;& RP
M       %4I'\5T#X&/R)P<_O^\UOD?%ET2S[K7>7\>%K1T!SL
M
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MUP!@QJ9SVNBFPKJ5?4.GE=\:)>ZW.]566FGU(145.;W-QR2(G3/>K7=KN/M
MG<QU_P!9KEU<_P#,5?PAD2W\ 7=:TR?'CW#>53;@P:E4J5W-+J#*#?8D,J5+
M63CB&G4*0HDFH]#T)(Y%N^./&*YK\S]3N07(#D+9N7+ZMM;<JAV]:-3C5#\-
M$;VQUO\ B[49IAN.:N\2TPUM-1DI2BU4E1$RKEZ6"F3H7)/%]Q3I4JG4.?9L
M"+$K4=L^\CK@U:<Y)[@TFG<MI,A#A>%KJHNSH";5F"]'M5+ZM!-35SBO*Z[%
MN"$4CQIY;LNF2X:RW;E;ZJII:.FIZ] 1UED\.8!P+AWB_<N.+BR13,@8BO*I
MRW+EO&J3HL6F.2)SK%,[EB0T^IIC9(CH0G:[N2_KU)?0B)G:YG<BN'U[<+:.
MYG?!>=*A$ME$V+$*-XPJ!5B3,69,(2[%44>>C0]5$:$>#J>Q22,%435UZX<Y
M?N7.?'>P<C7BTTFYZDB;"K,IALFFI3U.F/1/&4MI(DI-TFB4I*2))*-1)(DZ
M$"F86=!          I!P4_4S.7^^^]_*603*[X(
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M!SL
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M!,KO@@
M                     !5+B5^IUS?#)>3M#P'X>_5<OE^U#HGXC_6\7D?&
ME:T>_<[                                52D?Q70/@8_(G!S^_[S6^
M1\671+/NM=Y?QX6M'0'.P
M                                                           4
M\X[_ #[<SOEQ0O\ 9^("97#!
M#'U:E4^NTNI42KQ$3Z36(KT&IP7>J'H\A!MNMJTTZ*0HR,!%V)<!8@P6W76L
M463%LY-S+CKKIQWI+ZI)Q>][C<J4\\HB;[]S:1&1%N,$S-4P@@      %>LE
M\4>.V7ZH_7,A8HHU;KDM.V97&>_I\U_0MI&])@.QW7%$70C4HS(M-#Z$":OW
MQIQ9X^8?J2*UCO%5%H%;:3MCUQ:79TUDMNT^YE37'W6]Q=%;%%KZNH%4_ @
M              !2#@I^IF<O]]][^4L@F5WP0
M                                                     JEQ*_4Z
MYOADO)VAX#\/?JN7R_:AT3\1_K>+R/C2M:/?N=@
M          *I2/XKH'P,?D3@Y_?]YK?(^++HEGW6N\OX\+6CH#G8
M
M                              .=C-6Y!87S=R&JUM<:*OE.V<FW!3*Q
M0KA@5ZET]ONHM*CQ%I-I]2W->\0KUQ)/IV>J"INGG'\FOJ-W+^UM%]B"*0><
M?R:^HW<O[6T7V(%(/./Y-?4;N7]K:+[$"D'G'\FOJ-W+^UM%]B!2#SC^37U&
M[E_:VB^Q I!YQ_)KZC=R_M;1?8@4@\X_DU]1NY?VMHOL0*0><?R:^HW<O[6T
M7V(%(/./Y-?4;N7]K:+[$"D'G'\FOJ-W+^UM%]B!2#SC^37U&[E_:VB^Q I!
MYQ_)KZC=R_M;1?8@4@\X_DU]1NY?VMHOL0*0><?R:^HW<O[6T7V(%(/./Y-?
M4;N7]K:+[$"D'G'\FOJ-W+^UM%]B!2#SC^37U&[E_:VB^Q I!YQ_)KZC=R_M
M;1?8@4@\X_DU]1NY?VMHOL0*0><?R:^HW<O[6T7V(%(/./Y-?4;N7]K:+[$"
MD'G'\FOJ-W+^UM%]B!2#SC^37U&[E_:VB^Q I!YQ_)KZC=R_M;1?8@4@\X_D
MU]1NY?VMHOL0*0><?R:^HW<O[6T7V(%(/./Y-?4;N7]K:+[$"D'G'\FOJ-W+
M^UM%]B!2#SC^37U&[E_:VB^Q I!YQ_)KZC=R_M;1?8@4@\X_DU]1NY?VMHOL
M0*0><?R:^HW<O[6T7V(%(/./Y-?4;N7]K:+[$"D'G'\FOJ-W+^UM%]B!2#SC
M^37U&[E_:VB^Q I!YQ_)KZC=R_M;1?8@4@\X_DU]1NY?VMHOL0*0><?R:^HW
M<O[6T7V(%(/./Y-?4;N7]K:+[$"D'G'\FOJ-W+^UM%]B!2#SC^37U&[E_:VB
M^Q I!YQ_)KZC=R_M;1?8@4@\X_DU]1NY?VMHOL0*0><?R:^HW<O[6T7V(%(/
M./Y-?4;N7]K:+[$"D'G'\FOJ-W+^UM%]B!2#SC^37U&[E_:VB^Q I!YQ_)KZ
MC=R_M;1?8@4@\X_DU]1NY?VMHOL0*0><?R:^HW<O[6T7V(%(/./Y-?4;N7]K
M:+[$"D-AX763?]EXYOIW(]I.V/7KVR-<=UQ[;?DQY;L>)5'&EM)6Y&6M!F1I
M47J&9%KH6I 2M\"
M                               %4N)7ZG7-\,EY.T/ ?A[]5R^7[4.B
M?B/];Q>1\:5K1[]SL                               !5*1_%= ^!C\
MB<'/[_O-;Y'Q9=$L^ZUWE_'A:T= <[
M
M
M
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MQ&IU)J<=6YI]AY)+0M)_<,C&FNMFV:3OAAS%-C,"E
M "J4C^*Z!\#'Y$X.?W_>:WR/BRZ)9]UKO+^/"UHZ YV
M
M
M
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ME\-[GFTRK169M.F(N"G;76'T$XTXG5HCT4E1&6I#+G18HFDY;>Y+'C4Y)_\
M7=W;?"N%:=6JE=MNC5BMV^_:E7J,5#]0MR2ZA]V$ZKUS*W&R)*C3]TA@71$3
M,1-67$UAL(I2  "J4C^*Z!\#'Y$X.?W_ 'FM\CXLNB6?=:[R_CPM:.@.=@
M
M
M
M
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M9=$L^ZUWE_'A:T= <[
M
M
M
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MYK?(^++HEGW6N\OX\+6CH#G8
M
M
M
M                              *I<2OU.N;X9+R=H> _#WZKE\OVH=$_
M$?ZWB\CXTK6CW[G:G_)_BO3LV,1[PM.:U:N7+?C]U2:^IO<Q48J=RO>^>@E)
MW-K4?@KZJ;/J6I=!L-!Q"[37<]J_@SSCGL.2M?3<-@5XK/RE;TBP[K+4FHLP
M]T281'M[V%+3^#=0HRU+0]1[+3:W'GBMLMQCS6WQL>TC(R(R/4CZD9=AC+7@
M!X:C4Z?28KDVIS&H,5HC-;[RB2GI_+V_S")NB-Z)FB3\08%R3R)E1'*,Q,L;
M%3JC.JY'ELFA^8TD]%L4J.LT+4:^SOC\%/:6IEH>FU_%K,,=6W;<P\^KBW9&
M]VDQSCJT<4V?1[&LBE-TBWZ*T:(S">JW%K4:W'GEGU6XXHS4I1]3,>0RY;LE
MTW7369:FZZ;IK+>!;4@                    "J4C^*Z!\#'Y$X.?W_>:W
MR/BRZ)9]UKO+^/"UHZ YV
M
M
M
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M_BN@? Q^1.#G]_WFM\CXLNB6?=:[R_CPM:.@.=@
M
M
M
M                                             JEQ*_4ZYOADO)VA
MX#\/?JN7R_:AT3\1_K>+R/C2M:/?N=@  T+*GS9Y ^3U2\F<&1I?WUG3'?49
M/%GH<%_1Q?Q/V]\!UCR8>X]8?JD],--H/WO:?T2CG[>
M        "J4C^*Z!\#'Y$X.?W_>:WR/BRZ)9]UKO+^/"UHZ YV
M
M
M
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M9KBVTE3.Y[DM5[%FO=WG8GUHHFR(LK7;6E/;7.M/6I393?[251:5
M    *I2/XKH'P,?D3@Y_?]YK?(^++HEGW6N\OX\+6CH#G8
M
M
M
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MUOD?%ET2S[K7>7\>%K1T!SL
M
M
M
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MP    !5*1_%= ^!C\B<'/[_O-;Y'Q9=$L^ZUWE_'A:T= <[
M
M
M
M                                                     !5+B5^I
MUS?#)>3M#P'X>_5<OE^U#HGXC_6\7D?&E:T>_<[  !H65/FSR!\GJEY,X,C2
M_OK.F.^HR>+/0X+^CB_B?M[X#K'DP]QZP_5)Z8:;0?O>T_HE'/V\
M     'BJ-,IU7B.0*M3XU3@O:=]"EM(>:7IV;D.$I)_SD)B9C</-1Z!0K=C>
M)6_18%#AF>IQ*?&:BM:EZNQI*2_Y@FZ9WE&6$        "J4C^*Z!\#'Y$X.
M?W_>:WR/BRZ)9]UKO+^/"UHZ YV
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M;JU:H5CD=)H[]8D^,R5,Q:DMI"W5)2V@UF1=32A)?>("=SL<"D
M
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M1_%= ^!C\B<'/[_O-;Y'Q9=$L^ZUWE_'A:T= <[
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MI9P$SN=:@4@
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M=3,QIWIWYLOL2$FMAY#Z2/0U-J)1$9>IJ6H4*OU  'P:DITW&1:GH6OJF?J
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M@%(
M                                            @K-_&[$?(F+;L3*U
MNNUUNU79+U#<8F2(3C*I:6TOEOCK0HTK[I&I&>G@D"8FB5[5MBB65;-OV?;4
M%--MZUZ=&I5$@)4I9,Q8C2664;EF:E&24EJI1F9]IF9@A#5@<7<*8U9RA%MF
MTS.%F4B1D2GU"5(G,5!'^5:MFW(6M*$J*:Z1DG37=]X@35"U%]&]Q+HLFK/E
M8,NJ-52+*B,P:E59DEB$F6@VUN14J<U2ZE)^ XHU+09$I)DHB,#K2E&=Q"P9
M4L-T? DVWI[^,:!5%5BD4154F]XQ*6X^ZHTR>][W::Y+BMN[351@5:!4_1X\
M4*K>;5[2,;]U*2^W*DT"/-DM4E]YLR,E.0DK)&BC(C4A.B%?TDGJK45E,V7.
M.&),WQ[-B9!MUR?%L!Y;]JQH4M^ W&4X323(D15MD:2)E!$D^A:= (FC]KVX
M\XLR'DRQ\NW31)$V^L==Q\5*FW-DLML>+2%2F]S#;B6W-'%F?A)/[G8!4A\>
M<60,UU;D)&HDA&4JW%3"J-:.;)-E;*(C,(DE%-SN2_ QT%J2?4U[3 JCJI\)
M^/U1S+&SP5LS85_QJTQ<:EPZC)CPGJM'<)Y,IV.A6FY3B24LDZ)6>IJ2K<O<
M*N:F:$77Z0+D#AVW*-@^[; LVQG9$3(=UW#"5&6F&Y):=F-+D-FIDMC;"DL)
M)S<IQQ6FA=051L=V(\=B)'8B1641XL5M+,:.V1)0AM!$E*4I+H1$1:$0*'/#
MTGUKW-=W&Z#2K4MVIW/5$WE2WU4VDQ'IL@FD1IA*<-IA"U;2-1$9Z:=2!5;O
M;#BLK8YCX,7CG+N'+LLFA68JC0'J77O&:6]/?@Q4[),=;9,.;"4DR,M?Y01.
MPC>C2X?1Y#+ZL=3I26E$HX[U=JIMKT]11)E),R_G ZTK=TW&6/J/8CN,:59U
M*I^/WX#],D6DQ'0B$Y%DI4A]M;9%X7>DI6\SZJ,S,S,^H(5,HOHWN)=%DU9\
MK!EU1JJ1941F#4JK,DL0DRT&VMR*E3FJ74I/P'%&I:#(E),E$1@GK2]^1KML
M_@WB&U[,L'$5U7]:L]ZJPZ%0*:IRJ-Q),C=+-J8N0IQU+,AQUP_!2K^ETZ@;
MT(>C"XZ7)BNR[SR9?ULR+6NO(LEJ+1:'.9<CRHE'A[EDI;+NCC7C#SAGM66N
MUM"OZ0)NEU,!2U"_K%MO)EG7#85WPUS[9NB*<*LPVGG&%N,J,E&DG6E)6GJD
MNI& C2H1[=XMX(?8Q_8]8N:WL<PR*B612EO3JE(3)F$:T-*<[UQ9DJ0I9ZZ^
M"1@G>H7Z.^%>-0SGRVR)<F/[BL*GY)K**]1H=?I\B&LD3ZG4I?<DMYMM+BFD
MO))6W_\ $$W.MP*0                        !5+B5^IUS?#)>3M#P'X>
M_5<OE^U#HGXC_6\7D?&E:T>_<[ $=9>^:K)'R:JGDK@NX/WEO3"QJOW5_1/>
M5RXP?,5C[_L3OE#HVFJ_>2\WH?W%O0GP8[*5MF?QE8P^1%0_K9(NY/JUW3"W
MI_KMGDR\E\09?(ODQ<V$;AJ]0IV(L04"FU:Z+>I<ER$Y7*M5DDZPU+DL&ATF
M$,K+P$*3U(SUZEHQ3&FT\98CW=TS$3/)$<W9;/)$ZC/..9]S;$5B-E9GGGF;
M1(XFT['MUV??''&>>.*Q3*BVU>-"G5"?-H]8HRTJ*0T['D+DJ)\O!-M:321'
MJ9]=#%N.(3DMFW-'6BFR:1$Q/@5_0HQW1=BFFW;%9F)CP]E"3>'<?9IYL<D:
M/DBD2J]3J#1;9D4>,U4ZA 2PZ[2X25J+Q&3'W:EZBM2&5.HOP:/%-FR9F>2)
MY9YV+9BC-J\L75I'5IMF.2.:7ONRR$</,LX9N#&-?K$?%V4[D9LV^[$JDUZI
M16G92=T65%7*4ZZVLMJC/16O@Z:[5&0LVY?IF.^+XCK6QUHF(INWQ+(G']&O
MLZLSU;II,3->29B8JT;)DG#<CD5F:+S!KU4I5%B1:8>$8QRJI'I_O<J.HYCL
M8J5ZY\G-FI.=3/\ HF+F&,OF;?H\5G;UMD5KR;^1&6ZR,EWGII'Z.V8BG+NY
M:^TM9PDFWW4,!4)^^W9TE7OA/3:$RJ'NG/4(G"\27),_"-9ZJ(MW7:21A<0B
MR,T]7L5INKRLG2=;S<=;L[]]*[*]IZ.0?''#E\T>_LDW/:TF?>D&VIKL6KM5
MBK14H7 AN*CGXM&F-,'L-)=K?7^EJ)TFLRXYMLMG97FCP&?369/=75K3GF.]
M* N$_'+#]Q88P[F&LVS+G9%0](JI7 JLU=*?&Z?59"(SAQ$3$QCV$R@MIM;3
MT\(CU/7*XCK,L9;\<3[G=2D>"K&T.FLG'9DFO6I7?/>K17SB5=-:LGE#7I<^
MI/+M'+EV7A:+Z9"U*99JE,D>/PMIF?@J6E1MI+U=Q_S9&OMC)AB(C;9%L]J8
MI/LT6M),V99F9FEUUT=N)FGL5;QZ1.\*S<%U4"PJ)4'(]%QM"A71=2F%*3K4
M*E-1!A1UFG3KW*UN$7W#%KA5L61UIWW>YCHI69[R[KZW3$1-(MI,]VD1WW78
M:1L@          52D?Q70/@8_(G!S^_[S6^1\671+/NM=Y?QX6M'0'.P
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M-%L 0
M
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M6KM4V5ES+C8:1#J)2.D9/>H7N;6^9Z-^";:CZ$YJ:2,F;70@%(
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MOX\+6CH#G8
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M+&EHE)^+UHV=(B4]<UWOI#FYBD.N..K(DD:EN+4H]I$DM=$D1:$"9W.XP*
M
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MPM:.@.=@
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MKD=504@
M
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M'/[_ +S6^1\671+/NM=Y?QX6M'0'.P
M
M
M
M                                    52XE?J=<WPR7D[0\!^'OU7+Y
M?M0Z)^(_UO%Y'QI6M'OW.P  :#E4R3C/(!F>A%;M2U,_^S.#(TG[ZSICOJ,G
MBST.#'HX_P")^WO@.L>3#W'K#]4GIAIM!^][3^B4<_;P
M         52D?Q70/@8_(G!S^_[S6^1\671+/NM=Y?QX6M'0'.P
M
M
M
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M2D?Q70/@8_(G!S^_[S6^1\671+/NM=Y?QX6M'0'.P
M
M                 !'.7K__ '58OO[)/O3[_?$>AS*S[R]_XKXUXHT;G==_
MW;W=[M--VQ6GW# AO%,F^^5-I]0[ON?'XS4CN==VSO4$O;NT+737370![@
M  $68MR9^\K]XO\ ^9/>7X@7Q5[-_P#>?&?&_>KNO\K_ ,4UW?>=[_B_"VZ>
MO,!*8
M
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MN%EHB2F0[%<=6VZLB[5:-)+7[PM8]F>*<L-OJ/\ [>#7];;U,D4[%5^ALGB
M                       %4I'\5T#X&/R)P<_O^\UOD?%ET2S[K7>7\>%K
M1T!SL
M                                          5TY=_PO9[^0]8\E6"8
MWIOMC]6[>^#(G]2@$,X     JQQ;_P#N+_WWW=_\("96G!
M                                 *@S>85@2^2^/^-EE.1[QK5P'5RO
M6OQ)!'%HSE.ILF<W&2I"5)??4J,:7$DHB;UZF:]4D338D[/6<Z)@FU:769E$
MJ%W7+=57C6]85C4DB.=6*O,,R9CMFK4D)Z&:UF1Z%T(E*-*5"(JB:T>3=^T_
M)%GXRY X0>PU4\DG(;Q[<$2N1;@I<Z8P6]4!]Z,TWXN_L,MNNI+/LTU("C-Y
M7Y'7';V1V<+89Q;(S%E1NDIKMQ055)FC4NC4YQ6QER9.?0LN\=/38T1$9D9'
MN[",4;'@OD 66JE?-E739$[%F6<9R6&+VQ]/DMSNZ9F)-R)+ASF4-MR6'D%J
M2TI+^3:I"E"86+!
M                              ,?5O\ NJI_]D>_P#%&3Q9Z%K-^[NZ)
M[R,,!?,YC[X*1_AK&%POZKCZ&H]6O[;@\E+XV#>     "J7$K]3KF^&2\G:'
M@/P]^JY?+]J'1/Q'^MXO(^-*UH]^YV (JSI\S&5ODI5_)'!9U'[N[HEL>$?7
M,/EV]^%?>,GS#8T^"O\ VS@PL'B0]+QSZ[DZ4[B\U*M%1_C0P_\ (VJ_],D6
M;?W]O1X6XN_L^;R[?:7W&S>'                        52D?Q70/@8_(
MG!S^_P"\UOD?%ET2S[K7>7\>%K1T!SL                          %?.
M36?(G&W%LO)TVVGKL8BU&'3CH[$I,1:CEJ-)+[U3;I>#IV;>H)B*N<'VQEM_
M0/4_T^S^0@GJKU\2>5M/Y6V[=UP4^RY%EHM.HL4]R+(G(G&^;[)N[R4AEG;I
MV::&")BBVX(     'EFS8E-A2ZC/?1%@P&7)$R4X>B&VFDFM:U'ZA)21F8#D
MQ;N>N<?*F;<EY\:X%J8ZQ#0JA(@6Y/N9M"Y=8..9&>\W&97AJ29&9(0VA&NS
MO%*2:@5;(64XC\G[HR^>0\=YBMJ/8^9<.OHCWG#8U1#DL*-:/&VR4M9-FE39
M[R):D&1I6A6U6U)$PN#\9[;_ -8:9[K9]F"&9;<0ZA#K2TN-N))3;B3(TJ29
M:D9&70R,@'W   ! ET\A;0MBO5*@'"F5=^EN]Q+E0E,J:2\G_&-&:G",E(5J
ME1&70R%46U&_X_R%0\BTJ35*-O95"D'&G0'E(-YE>TEI[PD*41;DF1EU[!$Q
M0;X( !BZK6(5&9;?FJ6EMU?=HV)W'KH9_P#X#$U>MQZ6V+LFZ9HR=+I,FINF
MVS?&UBHMY4&4YW12C8\$U;WR[M/3U-3/M&)BXWI<DTZU.G8RLG"-19%>K7HV
MLO'K%+ENI8BU!B0\HC-+2%D:CT+4^A#,Q:W!ENZME\3/-$L3)I,V..M=;,1T
M,D,IC@  \D^:Q3H4J?)5M8AM*==/4B,R26NA;C(M3["ZBWFRQBLNOG=;$SW-
MJYBQSDOBR-\S$=U&K.7[9>=:9*'4FS=6E!+6VR22W'IJH^^Z$7JCS&/UPTF2
MZ+8MOK,TW6\O_D]#D]5=59;-TW64B*[Y^2E0C)1$I)D9&6I&789#U;S3Y
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M3B\[YG)U.?JS2G/NW=G<VL;-K56.+?\ ]Q?^^^[O_A 3*TX(
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MHEI;6XDM=-2\+L&VX?KK-;AC-9$Q$UW[]DTY)EGZ356ZG'&2V)B)YVW#-9(
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M:V^TM*FW"-70E)/J1C0>M-?Z7GI[R6[]6Z?U'#7WT*,V)2(E5O2W:94HT>=
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M+A<1.HOI,[HC;=/:CD[,TAM^$\!UG%)F-/96(WS.RV.W/+V(K+\K+R;9E_\
M?HMNK%(EQ4[Y%.>0IF0E&I%OV+(MR=3(C-.I%ZHIX1ZQ:+BM8T]];HWVS%+J
M<])WQV8JKXMZO:WA=)U%E+9W71-;>BL;I[$T;\-VT@
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MBQZ-!2U&CI2AI!=P@SVI1HDBU/7H/6X_%CH?26BF9P8Z[^K;WH;8*V4
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MY:41PJ[49. :OZ76<=(\W-U:];L5Y.MU:<E:K9CI[F0
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MC'K-KN*Q%N>[W,;>K;%+:\_//;F:<B21Z!H
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MTUX;D.R*F_)27]!"UR4I,_Y3%JW]_;T>%M[]G!LM>7);[2^PV3Q
M               "J4C^*Z!\#'Y$X.?W_>:WR/BRZ)9]UKO+^/"UHZ YV
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M*HNH-_L:S(%AT!NWZ=*?F1FWG'R>D[>\U=,C,O 2DM"T^X(F:C<1
M  /S>:;D-.L/()QEY"FW6S[%)46AD?\ *1BF^R+[9MNBL3%)56739,71OAK+
M=D6FTXAUNA1D.-J)2%$1ZD9'J1]HU=O M#;,3&*VL-C=QG6712<DTEM0VS6
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MTV/'J4Q,B7(D(:?6A+STA9&IU:R+<I9GJHSU/M'S5Q[0ZB[B.HF,=TQ.6_\
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MV74P>T=>  !Y9\QJG09E0?2ZMB"PY(>0RVIUTT-)-:B0V@C4M1D71*2U,^A
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MQ?*6!Y&8*KG88%(
M                    KIR[_A>SW\AZQY*L$QO3?;'ZMV]\&1/ZE (9P
M !5CBW_]Q?\ OON[_P"$!,K3@@
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MTLI@CT4DS(]#(R!7R.\ *
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M\5T#X&/R)P<_O^\UOD?%ET2S[K7>7\>%K1T!SL
M    %:^5]A9@R3B*9;&#KN>LF_':I!D1ZZQ59='6F*RM1OM^-0R-TMQ&7@]A
M^J"8<H+DXC^D?IUNU^H5OD349M&@TZ5(J\-5_7 \3L5IE2WFS;6C:O<@C+:?
M0^PP55A-OH>_FVS%\I8'D9@BYV&!2
M                                  *6\M+SJQ6Y<^)Y=)C%;F1[;DT_
MW\:?5XXT4E*V7C)HT;"-&I&G4SU]70>,]:/6G)P?)CLLLB[K1,S69C=+VOJK
MZJX^,8\E]V2;>K,1%(B=\)%P'E&OY$8G0I5"A4ZCVS#C1DS6I#BGUO&6UM)M
M*1MVFA"C-6[H>A:=>F1ZK>L5_&+,EU]D6]28W;=]? Q_6OU<LX-?CMLOF[KQ
M,[8INIX5C1ZMY(   !5CBW_]Q?\ OON[_P"$!,K3@@
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MV_%*IH__ 'A\3\0\8\?MI4__ -V[^3LV>,[/\8K7;NZ:Z$3,UA_22"@
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MC= <L?0]_-MF+Y2P/(S!5<[# I
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M56G0)WO@AY*U*<95 ==))(VEKN[=Q:#H=MT716-SGUULVS2=Z7A*D
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M:B92V"'":X?^,9'^$Z9_L2P"OD=V04
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MP57.PP*0
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MVJ)E!(W'V]N@ZGI<'F,-F.M>K;$=R*.7:K-Y_+?DI3K73/=FK("^L
M                                              #A-</_ !C(_P )
MTS_8E@%?([L@H
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M7=:;KN7;&SFY*4B9YY7C'I71
M                                   :/DWYML@_)JK>1N@.6/H>_FVS
M%\I8'D9@JN=A@4@
M                           #ZI0A&[8A*-ZC4O:1%JH^TST]41$1&Y,S
M,[WV$H
M!PFN'_C&1_A.F?[$L KY'=D%
M
M                                              C_ "3E"Q\16ZW=
MV0ZVFW;:5/C4YZLN-.NLLO2U;&3>[E"S0@U:$:S+:G7PC(NH"'.2F;IMA\=+
MCRUBJKT>M&HZ:S2+N09U.EQ(]1G,0W:DHHG>=\B.ATUZ)U+4BU)1:I,F(57X
MV\ALFU?.]JXTJG(FV.3MNWC1*K4*U.H5!32'[9<IS3;C+CCD>,PTXT^XLV2)
M>JM=IZ(U(E$S#J6"EH^3?FVR#\FJMY&Z Y8^A[^;;,7RE@>1F"JYV&!2
M
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MZ9_L2P"OD=V04
M
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M05=64 ^A[^;;,7RE@>1F!<[# I
M
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M,4A_2$"@
M
M                             1AF#$EJYML6HV#=ZYT6G37H\R'5:5(.
M+/@S(;J7HTJ*]HHD.-K21D9I,O4,@(E$6'N*%"Q9>JLC5S*%_P"8KUCTYZD4
M*M7W65U0Z9#D*2M]N(E22VFZ:2W&9GT["+4]29E:P$(QR[A^P\Y6<]861J8]
M5[9D2F)KL-B2]$6;T8S4VKO6%H7T,^S4")4JOCT;_$RB67=]9IUBU%JH4BB5
M";!=57*DLDO1XSCC:C2J09'HI)=#!5UI0YZ'OYMLQ?*6!Y&8%SL,"D
M
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MF>A=IZ@KY'><%
M
M                                    .=G)3FQ>&-;MOBP<+XG5DJL8
MKHC=>RI=$QY;-)H4=YGQAMMPF]INK-HR69$XD^U*24HE["J(2WB_E"N\<T5#
M"5UV3+M.M/VE2KPLBX5FKQ.NPI4**Y.[A"TD:>XDNNH09+62DMJU-*DF1D46
MX!#1\F_-MD'Y-5;R-T!RQ]#W\VV8OE+ \C,%5SL,"D
M
M                                       0MR)RT>"\*Y RJBF)K$FT
MJ>ARGTU9J)MV7*?:B1B=-/A$V3SZ#7IUVZZ&0)B*N<=!OWF_3JEE&DW+E:@U
M6^IN%(>5;+IK,6$W2:0E=:0AV-O3#-+KA0XSR"-1K0:EIU<_]*1.QT=X[Y2D
M9KPGCG*$VGMTNH7;2DOU2"SKW*);+BXTGNMQJ439NM*-!&9F23(C,SZ@B4T
M@       !PFN'_C&1_A.F?[$L KY'=D%
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M]#+7J+^GXA;FOZL1,-WZO_B!I^+ZN--;BNMNNB9B9F)C9%>\M:-@]^
M                  Y)<CL"YGJV4<_3.,5Z6K<J<ST2!1<\XEJ$Z*BIP7D0
M$LQ9+9.J2;1*C2"=0:G$&1N'HE:%)))5$I7XO\?,_1LGQ,X<E:O2&J_:MGMV
M1CNRJ(;:VX,!*DFMV0XSJ@U:$HB\-PU;U&I222A($RZ+ I:/DWYML@_)JK>1
MN@.6/H>_FVS%\I8'D9@JN=A@4@
M
M                      "$>2%2QK2L'Y$EY@@2JGC5=.1%NV+"0;DGQ>7(
M:CI<:(E(,E-..)61I/<G;JG4R(@3#E)BSAAC+-LCQS&W.NX+NLA5(109EDL-
MK:K;-NI=-]%*D$_/2IJ.EQ9J)"X)-;S-1-ZZ@JJ[/6-95NXYL^V[$M*"5-MN
MU*>S3:/#W&M266$DDC6L^JUJ/52U'U4HS,^I@H;6         X37#_QC(_PG
M3/\ 8E@%?([L@H
M                                   %&N!WS=7A\HS\DCC4<(\2[I<N
M_"C^W9?G9_9M7E&W=1                                4;G_QST7Y-
MK\@?&H_WW:]IS'4_?'#\S/>O7D&W=.                        <B.<%L
M<-J-?E9R#<F8K@Q9R)[J*ZZ]8TM^?5EO,PVFHARH*5;8QG&0WL_#Q=R=JMQ[
MM5%45;)P#R;RZO6O5&#D^%6[CP<Q3I#EJY&NVDMTJKR'DNME$2@R?-<A+J#<
M-:C\8VF1)[[[HFCJF"EH^3?FVR#\FJMY&Z Y8^A[^;;,7RE@>1F"JYV&!2
M
M                                                       (SS'D
M&T<5XRN^_K]@O5.T+=ADY7*='CMRW7VGG41R:2PZI#:]RG"+12B+[I@0X?5_
M"]Z<K;IIEW\;.*:>-E+1*3(9RU4ZC*H27D'KH]&@QB;;06NNJHC#OJ^'KV%=
M:.Y6)K8NFR\;V;:M[76[?-V4*FM1:]=KYN*<G2$Z[G5*>4IQ1]2+51ZGIJ8*
M)2&         X37#_P 8R/\ "=,_V)8!7R.[(*
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M\C= <L?0]_-MF+Y2P/(S!5<[# I
M
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M 0X37#_QC(_PG3/]B6 5\CNR"@
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MP1<[# I
M
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M1\8;K\?F53QKQBVE2(W^5SVVI#G=QW6V_#26W;M3X)$8)G<_I)!0
M
M             *-<#OFZO#Y1GY)'&HX1XEW2Y=^%']NR_.S^S:O*-NZB
MJ/D?CC=;V3)6:,&9'3C"_P"LQ&H5X0)D$JC2*TVSH32Y+)K2:%I26FY)'KH6
MFT]5'FXM5;YOS>2WK6\FVDQT,;)@GK]>R:3R[*Q/3&SOO'9_&^^JMDN@9;Y
M9-CY&K]G$X=D6O2:=[VT>EOK-)^,I+>I;KA==#41>H9FK0A-^JLC'./%;2)W
MS,UF>\68+IOB_)=68W1$4B/9G;VV_<B<'RLYT2R*1%N)JW%6C=M/N5U]V,J2
M3Z(6_5@DI<;VFK=Z[4]/N"SIL_F9NFE:VS'=5Y\/G8B*TI,3W);EFBS+PR'C
MRN679-X-6)4[B)$2=<JXRY3K,%1_Y2B.A+K6CCJ2V;C,R))JZ:Z&5.#);COB
MZZ*Q')N59;;KK9BV:3SM=B\=L;1<&?N 32^\LI5+. \M9$<A<A1]Z<Y2M/\
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MS-+9,F1)T]4"9="P4M'R;\VV0?DU5O(W0'+'T/?S;9B^4L#R,P57.PP*0
M
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MI:BQV]=2;1KZFIFE*"2)E8,$.$UP_P#&,C_"=,_V)8!7R.[(*
M
M          !1K@=\W5X?*,_)(XU'"/$NZ7+OPH_MV7YV?V;5Y1MW40
M    :3<&-,<W;.*J758%MW-4TM)934:K2H<U\FTF9I03K[2U;2,ST+707+,U
M]D4MNF.B5-UEMV^(EA$X/PLA25HQ!9*5),C2HK?IQ&1EV&1]P*OI.7WT]V4>
M:LYH[B4195@                "C<_^.>B_)M?D#XU'^^[7M.8ZG[XX?F9[
MUZ\@V[IP                           #1\F_-MD'Y-5;R-T!RQ]#W\VV
M8OE+ \C,%5SL,"D
M
M                         '":X?\ C&1_A.F?[$L KY'=D%
M
M            HUP.^;J\/E&?DD<:CA'B7=+EWX4?V[+\[/[-J\HV[J(
M                          "C<_\ CGHOR;7Y ^-1_ONU[3F.I^^.'YF>
M]>O(-NZ<                            T?)OS;9!^356\C= <L?0]_-M
MF+Y2P/(S!5<[# I
M
M                         !PFN'_C&1_A.F?[$L KY'=D%
M
M           HUP.^;J\/E&?DD<:CA'B7=+EWX4?V[+\[/[-J\HV[J(
M                         "C<_P#CGHOR;7Y ^-1_ONU[3F.I^^.'YF>]
M>O(-NZ<                            T?)OS;9!^356\C= <L?0]_-MF
M+Y2P/(S!5<[# I
M
M                  :G>]]V=C:VY]WWY<D"U+:II)\<J]0=)II*EGM0A.O5
M:UGT2A)&I1]"(S 1)B[EAQXS/77;8QME"FW!<+:5J117&9=/DO):(S6<=N>Q
M'4^22(U'W1*T+KV=031MV6,Z8DP;3(=7RK?$"SXM14M%-:?)U^5)-LB-SN(D
M9MU]TD;BW&A!D6I:]I 1#*XTRSCC,5 5<^,KO@7A1&WCCR)4)2B6R\1$?=OL
MN)0ZTK0R,B6DC,NO8"*)$ <)KA_XQD?X3IG^Q+ *^1W9!0
M
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M(W0'+'T/?S;9B^4L#R,P57.PP*0
M
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MRQWI+]K7+4XWO6[,9..\?B=J%"=WM*,S3^%85I]TNH)Y']#X*
M
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M/XI]WWOBK*W>[W^_*MN[;IKH>GW#!5UDI^A[^;;,7RE@>1F"+G88%(
M
M                                                         "AG
M.+E7^X"B6G9=O5B);M]90><C1KQGL/2HEN4Q"T-2:L[&CM/.OK1WGX)M+:M3
M)2C)6W8LF(JBWC3GW@GBOQ6UK/S#)O3)^1JI';NF_JO0K@55[AK$YU+:5/R'
MZ?HVA3J_ 0:]B-=RE&HUK43,2VBL7;1>+7,/*%\Y)<>M[$_(^@T)VGWSXNZN
MF0J_;[!PS@S%,H5W:GFC6Z2U%U-7;Z\TC?#)XAJT/D-R]N3D':*),S$>-[#1
M8=H72]&=CQZQ6),Y<R;(A=^A*EML-J4RM1$6I[#(]#ZB=D)H?X5<593[TF1@
M^VW7Y"U.O.J:=U4M9ZJ,_P )ZIF"*RY/4JR+3QSZ6:BV98]"C6U:U&J<+WKH
MD,C2RQXQ:#<AW82C,_"==4H^O:8*N1_0&"@
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MV+"7!>3(?0RDM7%-MFI1)+M,M!3AQ:7SEM+[JUC]'L]*K+DU'4GW%NZ?TO\
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MA[^;;,7RE@>1F"JYV&!2
M
M                          #\9$>/+97'E,-R8[I:.,.I):%$1Z]4J(R/
MJ0#[M--,--LLMI99922&FD$24I2DM"2DBZ$1%V$ ^X#A-</_ !C(_P )TS_8
ME@%?([L@H
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M;;,7RE@>1F"JYV&!2
M
M                           #A-</_&,C_"=,_P!B6 5\CNR"@
M
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M?0]_-MF+Y2P/(S!5<[# I
M
M                               !PFN'_C&1_A.F?[$L KY'=D%
M
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M0'+'T/?S;9B^4L#R,P57.PP*0
M
M                               4CR#E/-61LY7+@'C_ %>AV0G&U'@U
M3*&3*W 55%Q9551WL"G0H9K0VI2VC)Q2EZEIJ6I&G19+8\!YAR-4,D9(X_YN
M;H[V3,>Q8E;H]ST)M<>%7Z!./:W+3&<4M3+C+BDMNIUV[E:%V;E"86Y!#A-<
M/_&,C_"=,_V)8!7R.[(*
M                                         !1K@=\W5X?*,_)(XU'"
M/$NZ7+OPH_MV7YV?V;5Y1MW40   '+7TKOS+6'\KD^1OC"UWBQTO6^I_UF_R
M?;AF_16?P[7%\N*AY%!$Z+Q)Z5'K?];CR([\NEXS'E0
M      %&Y_\ '/1?DVOR!\:C_?=KVG,=3]\</S,]Z]>0;=TX
M              $'<AL[V[QRQQ)R7=%'J-<I,6?%IZX%*)DY!KEJ-*%%W[C:
M-"TZ^$"8BKG+=WI9<,W#:EST"-CB]&)-<I,VGQWG4T[8A<EA;25*VRS/0C5J
M>A GJOU]#W\VV8OE+ \C,"YV&!2
M
M                                 "@W&!)QN5//"'._[Y.XK2DK4K4E
M*@O4Z6N&1:Z:DE"ON>J7W2!,[GP:/&O28=Y3-4HIF "1<:D:I(UN7 HVT.&7
M11FE;1D1^H6O]$#D4OJMO^F .IU$Z<_4O>\Y3QP-*G99%W.\^[Z*?W>MT[>H
M*MCP8 XO\T/.\L3.^=[,=>[F<MZ[KN>J]ONKV-4EVGQS./3YBE'HE+;?X-O[
MY^J8$S%'=D%
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M ,<]%^3:_('QJ/\ ?=KVG,=3]\</S,]Z]>0;=TX
M     &%K]MV[==/52+HH%.N2E+6EU=,JL5F9'-:.J%&T^E:-4^H>G0!HW[B\
M)?0[8_[/4W\G JVZV[,L^S6),:S[4H]J1IJR=F1Z/!CP4.K26TE.)CH02C(N
MA&8#90
M
M             5*R9Q^OI[+)9VP1D*#C[(-4I#5!OFCUNG'4J)7X<=1'&<D-
MMN-.M/L$1$EQ!F9I2E'@IW[R:MAP7@:K8XK]]Y+R)>O[R,PY,5%1<USMPTP(
M42#!1LBTZG124ONF6]?",U:N&25*+4@)E90$
M
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MFU^0/C4?[[M>TYCJ?OCA^9GO7KR#;NG
M
M
M
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MD#XU'^^[7M.8ZG[XX?F9[UZ\@V[IP
M
M
M
M                                   *-<#OFZO#Y1GY)'&HX1XEW2Y=
M^%']NR_.S^S:O*-NZB    Y:^E=^9:P_E<CR-\86N\6.EZWU/^LW^3[<,WZ*
MS^':X_EQ4/(H(G1>)/2H];_K<>1'?ETO&8\J              #Q5&FT^L0)
M=+JT&/4Z;/:4Q.I\IM+S+S2RT4AQM9&E1&7:1D)B9B:P(QLC V',;U5^N6/C
MJBV[6)!&E=3C,:O))7:3:W#4:"/U=NFHNY-1DR12ZZ9A;LQ66;;8B$MBRN
M   "C<_^.>B_)M?D#XU'^^[7M.8ZG[XX?F9[UZ\@V[IP
M
M
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M<]%^3:_('QJ/]]VO:<QU/WQP_,SWKUY!MW3@
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MZH*9E9D$
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M]VO:<QU/WQP_,SWKUY!MW3@
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M>/WQ0E/C/B?OMW_=[5*_Q??MZ_\ E$"JZ76H%(
M                                            *?\ *'AK8O*F?9U0
MO"Z*];KEF1YL> BC'%)+J9JF5K-SQAET]4FR6FFG:8)B:+@ @   !$N=,043
M/6*[IQ/<=3G4>C77XCXY4J;W12F_$9T>>CN^^0XCPEQTI/5)]#/U03$T,%X@
MHF!<5VMB>W*G.K%&M3Q[Q.I5+NCE.>/3I$]?>=RAM'@KD*26B2Z$7J@3-4M
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M#7>/."+=XY8XC8TM>L5&N4F+/E5!$^JFR<@URU$I:3[AMM&A:=/!!,S5.((
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M7KR#;NG
M
M
M
M              HUP.^;J\/E&?DD<:CA'B7=+EWX4?V[+\[/[-J\HV[J(  .
M?_.7_OCC1_O!1_5)&'J_T>ENN#_^SR4U"EDODNTOY0$'\(J8W6\7YUHSJ^[:
MJ]_7#"<677:F1'9;,_YB4+NANZL5YI87&HK?;'_;X7Y<2,OV7B['Z./N5*[#
ML'(V))=0@SZ=674Q43(3TMZ9&EQG'-J5H4T^GL/7U>PQZ#B&GORW^>QQ6VZF
M[N4>5T&:W%9YF^:76UW\L<_<;W!Y#'F*Y,QVSCVG1J[B*S+)GE4LDH[TDOU]
M;2O\CBJ/P'&R949FK3M2>AF1D+4Z/S-MEU^R^;HV=CG7K-5YZ^Z+-MD1O[/-
M",^'W(#"EB\:L>TB[\G6_0*K2XLCWPILN8A,AHU275))31:JU,C(R+07^(Z/
M-DU%TVVS,2Q]!J\-F"V+KXB:<[%X@OVWZSECDIS(J;<ND8>IU(@4*UJU(84A
M=3:IZ2:DR&&U:&9&ME"4$>AF;A$>AD9%1J,4VX\>GC;?69F.:NZ%_#DBZ^_-
M^A2(B>>E:ST;6C6=E3&W(*[Z5ESD3E6U[;LZWY1RL9X"<J"'6F%H4HFY];(R
M)#S_ *J4;>A=NA:I.YDPWZ>V<>*V9F?&NI[%O8[ZC'DMS3&2^8B.2VOLW=GF
MYF_Y7J&/KNY:V1 S?6(D["E4L!BK8J@5)\_BY4*P_(5N>?2LR86X;*C-)K[4
M]W_(+6"+[-/,X_'ZVVF^(IX5>7JW9HMR>+-NR)W3-=O;I1F..1VO2>4N8K6P
MA4$2,(P[:@S*O2J>\MVBP;E<?)*T0"(U-I-;1&:R1T]<7]$A&JZTX++LGCUG
M?OFWL]M.GB+<MUMGB1$;(W1=MK3M4JZ(C5LY13B%\Z',S_>M+_Z7AL=;^[Q>
M1[<L/2^/D\KVH1M=V.V,L<JN5..WEMM*NK$%+B0GWBU0U*[R,N,XK0C/1#R4
MJ,R+7IT%W'EG%I\=\<E\]Z%%^.,F;);/+9$>S<CG$=UUSD.U5+LN2,Y%:XU8
MBJ%M2(SYFOO;FJ<&1$FR/"_I=Q"(S/U#5I]\7,^.-/[F/T[J_P#C&[O^PIT^
M2<T]:=]L4GRI\;N4]E<W@]_"IASX,E?Z0E#"XE]9OZ5_0_N+/)A:T83*
M  !1N?\ QST7Y-K\@?&H_P!]VO:<QU/WQP_,SWKUY!MW3@
M
M
M
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M9FLC("       %&Y_P#'/1?DVOR!\:C_ 'W:]IS'4_?'#\S/>O7D&W=.
M
M                                      !KLV\+2IVGOA=%(@:DHR\8
MFL-=$^N/PUEV>J+MN#)=NMF>U*B<EL;YA@(V6L53:G!HL/)MJ2ZQ4W$LTVDL
MUJ"Y)D.+/:A#+*7C6M2CZ$22/47)T6>+9NG'=2-\TFBB-1CF:=:*],)!&,O
M
M
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MY-K\@?&H_P!]VO:<QU/WQP_,SWKUY!MW3@
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M$W3=6G5B.9Y/URX-H]!;IYT^.+)F^DTY8H[$CI+SX
M
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MU9_?W>3[<-=Q+Q(Z68]%]\P%Q_+6=Y%!%'K+]9CR8[\JN'?NYZ?:AT@'GF>
M                       HW/\ XYZ+\FU^0/C4?[[M>TYCJ?OCA^9GO7KR
M#;NG
M       _)^0Q%:4_)>;CL(TWO.J)""U/0M5*,B+4ST$Q$SN)FC59V0K!IFXJ
ME?%OT\T*V+\9J<5K11_T3WN%H?WA>MTV6[=9=/:E;G-9&^Z.ZT^;R!P73E&B
M5F&S4N)6;:VFZW"=6E2>TE);=4:=/OD+UO#=5=NQW=R5N=7AC]..[#3IG+SC
M= T[_+%*7J2C_P G:E2?6]O^(87_ #?=]07[>"ZR[_US['A6YXA@C]*&GSN=
MW&:(1G'OB74S)!J),:CU))F?][^'CM=?^;[XOV^KVMG?9$=N/:E;GBFGC]+V
M)81_GOAE/>>]UO7Q7.[))Z0:,D]QJ["+OI#6A_RZ"S=PF;/'RXK>F^(78U<W
M>+COGHMECGN<U-D&OWCP1DJI)WI0VM^FMQT]=-=ZD./DG37[O\Y#5Y]7PC3;
M,_$=+9-*TG-97M1,Q,K]MFLO\32YI_\ "? QKO,_(#ZM*1QBK\@C<-*3GU=J
M!X)%KJ>Z&YH?_-]\8&3UE]6<4>[XK@_\9B_]F63;P[BE_BZ2_MTCOL:OE3R+
MFDA5/X]TJFMJ-?AS[@9=T(O6D:4=THNS[G7[PU6?\1?4S!=-MW$>M,>]Q99C
MX463;/=[&]D6< XU?NT\1'9OM\-?88MWD#R^F)VQ;(QS1M[1[G)3DY]:5'T+
M;W4S;J6NO4C(8.3\6?4O'NSY[]OZ..8_:BWPLBWU5XU=^CCCINGVJL>_DSF3
M.)9G=F/Z+N01(*'!D/&D_5/_ "AI9:_\I#4W_CEZIV32W3ZN[IC''_\ I7O,
MBWU*XM=XV7%'1UI^*QK];Y;5$W$R^0$*FLN*3^"@6]3_  2+34TK-A#GJ:Z;
MO^88.7\?N V1_P#7P[+=/_=DBW;VNMW:=ID6^H>NN\;56QT65]N&/>H6>IYF
M=3Y-7.O<YWBBI\5N!ZFFA=R]T[>SL^\-5?\ _HK#'[OA-D>5FF[_ /RC_'*R
M;/P^O_3U=T]%L6_&EC5XPO.<:#K?(+)M2(EJ6I":Z^VDC5KZQ*S=)/\ ,7_(
M-?J/_P!&:ZD^8X?IK9Y.M%U_=I-E>[';7[?P\T_Z>HRST3$>U+&+X^VO))!5
M2ZKOK)(0I!%-JZU]%=OK4)[?O=!K+_\ ]$^L<^+BTUO1CN]O)+)L_#WAL>-.
M2[IN\$0^(W&G#S!:.VV_,/:1:O3YA'J7]+\$ZWU/_D&LU7X^>MV;Q-19CV_H
MXL<]KW=M^SV>RR;/4+@]N_%,]-UWM3#/Q\%8DC?XNQX*NI'^%4\[V?\ [1Q0
MTV7\9?6[)OU]_:MQV_LV0S;/5'A-F[3V]NL]^6>C8NQM$,C8L*@)42MR5JIT
M=:B/[REH,R_F&EU/XC>LNI\?B&HW4V9;[8[<6S$3VV9C]7N&X_%T^/X%OMPS
MT:U;8A[3B6Y2XIH,S1W,-E&AGVF6U!#4YO6GB^:OG-7GNKSY;Y[]S,LX?IK/
M%QV1T6Q'M,TVTVRA+;+:6FT>M;01)27\A$--ES7YKIOONFZZ=\S-9GMRRK;8
MMBD12'Z"VJ             $4W=\[G&SY>Q/\) ^E/\ \Z^-Q/YFSOW.=?B#
MXFF^<]IU9'<GC
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MN]4M5H\,WVS;EMWS-DUIVM[J>1D9$9&1D9:D9=AD,5I7R
M        "C<_^.>B_)M?D#XU'^^[7M.8ZG[XX?F9[UZ\@V[IP
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M?LM#]D'Y;^I?_&S_ #\_^H?U_C7I/^79\D\U7D']9"!^RT/V0?EOZE_\;/\
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M^<OOK$5ILR77;J\E&!K=5K]?-GTG-UXLFL1U;;?V8A?T750
M
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MLET]-T^%CW:W/?XV2Z>W/A?L1:="Z$780QIF9FLL:9F9K((0
M  #SH_6.P_E32_ZX>R]2?K67YF[OVO=_A[_<;O(G]JQ_1X*WTF
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M?6QQ2V^V+XCFKO\ 96G&4\Z                      "C<_P#CGHOR;7Y
M^-1_ONU[3F.I^^.'YF>]>O(-NZ<
M
M
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MUPCT6?YE_A/RVX9[SV;_ )1]GG?OTW0/T"7Y0'FN$>BS_,O\)^6W#/>>S?\
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M]>O(-NZ<
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MWL40%$C
M
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MET65P             4;G_QST7Y-K\@?&H_WW:]IS'4_?'#\S/>O7D&W=.
M
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M&70P4N=_HU4I1C3.R$))"$9NN=*$)+0B(H=+(B(B!5<Z, I
M
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MG[XX?F9[UZ\@V[IP
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MZ3:^A:*1NVJ(R+0R,@4*,>C7^;;/'^^^Z/(Z6"JYT6!2
M
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M,SWKUY!MW3@
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M4)>C7^;;/'^^^Z/(Z6";G18%(
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MD2RZ$[%F1._97_\ E(61@H4Y]&9_"!8/PG7O]*2 3=O7[!
M                 *-<#OFZO#Y1GY)'&HX1XEW2Y=^%']NR_.S^S:O*-NZB
M  "CO+[]=.,/RY5_5M# UN^SI\#U_JO^ZU7S?A6"%3 ?)=I?R@("X1_]P9H_
MWEU?^K9#1>+/2SO6[][@^:M[\KN#->1                      !1N?_'/
M1?DVOR!\:C_?=KVG,=3]\</S,]Z]>0;=TX
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MR)<B:X[-D-,L..J=DN.*ZML-EH1Z=-=-3,$S-4M @
M
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MU2)3ZM2C>-I=/5WKL9M??MM*W-)6;9:)TVI3ZNH)G>B7T9G\(%@_"=>_TI(
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M4,]/4%_28YLLV[YVL#UEUMFIU=,>VVR(LCL]7E[JSXRGGP
M        4;G_ ,<]%^3:_('QJ/\ ?=KVG,=3]\</S,]Z]>0;=TX
M
M
M                                                        8*Y[
M:H5YVY7;2N>G-U>W;E@OTRMTMTU)0_%DMFTZV:D&E2=4J/0TF2B[2,CZ@(@P
M[QAP;@*H5JJ8EL?XIS[ACM1:P_[YU.?WS+*S6A.V?+D)3HHS/5)$8)F:I\!
M      -3MVP[*M&HW-6+7M6EV_5;SFG4KMJ4"*VP_4I9FM7?2G$))3JM7%'J
MHSZJ4?JF VP              1-E_!N+<\T&FVSE>U_C71*1/*IT^%X[.@]W
M*2TXR3G>09$=:O =46BE&77LUT!,31G<:XRL?#]GTVP<<T)-N6G2%ON4^E)D
M2)6Q<EU3[JC>ENO.J-2UF?A+/[A=-"!#?
M     4:X'?-U>'RC/R2.-1PCQ+NER[\*/[=E^=G]FU>4;=U$   !56_.'6';
MWK<BY8\>J677YBC<FU"W9?BA/+/J:EM*2M&I_P#5(ABWZ/'=-=ST>C]:-9IK
M(QS,7VQNBZ*T>O'7$;$..ZY'NAN)4;LN6&LG(-9N"5XVMA:3(TK:024()1'U
M(S(S(3CTEEDUWRHUWK-K-79..9BVV=\6Q2JSXR7GP
M    %&Y_\<]%^3:_('QJ/]]VO:<QU/WQP_,SWKUY!MW3@
M
M
M
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M\7V^:F*VS6*]6_8Z"#=NL@
M
M
M                    QB*W1G*N_;[=7A.5Z+&1-DT1,ALYC<9Q1H0^M@E=
MXE"E$9$HRT,^FH#)@        ,"JZ+<3<S5F*KD$KM>IBZRW;??H\=.G(>3'
M5+[C7?W1.J)&[33=T]0P&>      &,J=;HU$3!76:M"I":G-8IM-5-D-QRD3
M)*MC$9DW%)WNNJZ(0G52C[" 9,  ?4U)2:24HDFL]J",]-3T,]"^[T(S ?8
M ?D^^Q%8>DR7D1HT9"G9$AU1(0VA!;E*4I6A$1$6IF8#S4RITVM4^%5J-4(U
M6I5191(I]3A.H?COLN%N0XTZV:D+2HNI&D]# >X    !BJ37:)7Z<Q6*%68-
M:I$EQQJ-5($AJ3&<6TZIAQ*'6E*09I=2I!D1]%$:3ZD RH
M ,8S6Z-(JLVA1ZO"?K=-9:D5&C-R&U2V&7]>Z<=8)1K0E>T]IJ(B/3H R8
M    PL:XZ!-KM5MB)6H4FXZ''C2ZQ0VWD*EQ6)G>%&=>9(]R$N]TO:9EUVGH
M S0      @9SC%@AQQ;BL=024XHU*)#\M"=3/7HE+Y$1?>(M!B?0,'O>^\G/
MJ-P69K]'M[MWA?7S7\#?1W#]TS/;Q'T#![WOH^PO!?1X[MWRCS7\#?1W#]TS
M/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?
M1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWR
MCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?
M1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]
M\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P
M^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#
M]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7
M\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[
MMWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^P
MO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8
M/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS
M/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?
M1W#]TS/;P^@8/>]\^PO!?1X[MWRCS7\#?1W#]TS/;P^@8/>]\^PO!?1X[MWR
MFRVE@_%5BUEJX+4LV+2*RPVXTS/0Z^ZM"'2VK)).NK(C,NFI%KIT]47,>EQ8
MYZUMM)9W#_5;AG#\L9M/ABV^(F*UF=^_?,I6&0WX
M
M
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MNTNA]H'(N@"
M
M
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M"R,][,J>:U)/_J&!*[((
M
M
M
M          !K-Z_%[XFW;\;MOQ4]Y9_QGWZ[?>_Q=SQK=IUT[K=KH UC"WQ3
M_=!B_P"(7CWQ&^*M)^)?OEKXW[T^*->(]]NZ[NXV=H$I-
M    !7+C=^[+WJRU^[7WXW?O2NG]X?O[L\:^,_?M^^.G=^#W6G=]U_U-NO4$
MRL:"         !7+.'[LOCOQV_>)[\>/_'LOW=>([/>_XP>(R/%O?'=X6FS?
MW6W^GV]-03"QH(            :3DGQ#]WUZ^^OOQ[U>\D[WU^+V[WU\6[A7
M?>);/#[[9KLV>%KZWPM &,P[^[W]UE@?NH[C]W'O'#^)OB^[;XCW9=WNW^'O
4_P#6;_#W[M_A:@2DD      ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>tm2227887d4-lc_2lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_2lnp4c.jpg
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M# P,# P,#/_  !$( F\&HP,!$0 "$0$#$0'_Q #R  $  @,! 0$! 0
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M@
M
M
M
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M*ESPH_[*5NAT1S4
M
M
M
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M\           !46I_2UMWWO7^BY(YW>_-%OP?X=3I5C\J7/"C_LI6Z'1'-0
M
M
M
M
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M_2UMWWO7^BY(YW>_-%OP?X=3I5C\J7/"C_LI6Z'1'-0
M
M
M
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MZ6MN^]Z_T7)'.[WYHM^#_#J=*L?E2YX4?]E*W0Z(YJ
M
M
M
M                                                "J7$K^YUS>_)
M>YVAX#U>^BW?#]J'1/6/Z7:\#]J5K1[]SL
M     !46I_2UMWWO7^BY(YW>_-%OP?X=3I5C\J7/"C_LI6Z'1'-0
M
M
M
M                                                          52
MXE?W.N;WY+W.T/ >KWT6[X?M0Z)ZQ_2[7@?M2M:/?N=@
M               *BU/Z6MN^]Z_T7)'.[WYHM^#_  ZG2K'Y4N>%'_92MT.B
M.:@
M
M
M
M         JEQ*_N=<WOR7N=H> ]7OHMWP_:AT3UC^EVO _:E:T>_<[
M                          5%J?TM;=][U_HN2.=WOS1;\'^'4Z58_*ES
MPH_[*5NAT1S4
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MS<;?*#;7PM#]M ;53JG3:Q$;GTFH1JI!>U[F;$=0^TO3MVK;-23_ )C >X
M    8&FW3;%8J=6HE(N.EU6LT!245VD0YC+\J$I9F24R66UJ6T9FD]"61=@#
MQMWU9#U132&;QH;M64^<5-+14(RI!ODK:;1-$YOW[NFW374!M0
M
M                         ([KV7L36K5TV_<^4+2MRO+/:FB52MP(<LS-
M.XB)A]Y#G8>O9V 8-_8?8E,,R8SR),:2A+L>0THEH<0LMR5)4G4C(R/4C(!C
M*Q<5OVZTR]<%=I]"9D*-$=VH2FHJ7%$6II2;JDD9D7D(!DV'V)3#,F,\B3&D
MH2['D-*):'$++<E25)U(R,CU(R :O.O^Q*9+?@5*]:#3YT56R3"DU**TZVK_
M !5H6X2DG]PR >JDWA:-?D*B4*Z:16I2$[UQH$Z/)<)/^,:6EJ,B^Z V,!J]
M3OBRZ),<IU9N^B4BH-$E3L&;4(T=Y)+(E)-3;CB5%J1ZET ?FH7U9%)>1&JM
MXT.F2'&D/(CRZA&96IIPM4+)*W",TJ+J1]A@/71[KM:XG7F;?N6E5UZ.DER&
MJ?,8E*;29Z$I1-+49$9^4P&?      &!JETVQ0ZA1Z36KCI='JMPNJ9M^F39
MC,>1.=2:24B*TXM*W5$:TD9((SZEZI /Q6+NM2WGVHU?N>DT.2^CO68]0FL1
MEK1J:=R4NK29EJ1EJ0#,0YD2H18\Z!*9G0I:$NQ9D=:76G4*+5*D+09I41EV
M&1@/2                             JEQ*_N=<WOR7N=H> ]7OHMWP_:
MAT3UC^EVO _:E7+FEGR^8=\0<'X]KSUIQ&:2W6,@W+!(DU T25FF+!BNK(R:
M)9)-:UI+=IHDC+KKUW<^[Z;V-=>F'B<I8BO3*EEL92RGA6:5Z69?=<JK5-44
MBXK5KLURI0JE"09*D-FF1N4TX:2,TN-F1D?W#&[S6Z[-RB<(PEF7<K153HAW
MKM"Y(5Y6G;%WTY*D4^ZJ3"J\%"_7)9G,(?;)7W22LM1XBNF::IIG@::8PG!L
M0I0  "E/-3.=V8GM:T[6Q_(13+VR=-DPJ?<3C:'BID2"VE^7(0TX1I4X:%$A
M&I:$9Z^0;/=>3C,W,*M4,C+6?&5:7*^!/R!0*J5TVWE2[H=XLJ[YJLRJH],;
M==+KH_%>-3*T*/HI.SL'K*]W6:J=G9AM9R]$QA@[6\:,MRLVX<M6^ZK$:@7"
M]XFFW3"8U)INI4Y]<62;9'V)6IO>DM3T)6FIZ#Q.<L>(NS1Q--=HV*IA/(QE
ML                   !46I_2UMWWO7^BY(YW>_-%OP?X=3I5C\J7/"C_LI
M6Z'1'-0
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M/W 3$Z';8%
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M5QM1ENZ&1D6A%,K0<1/HO8$^(]']RH!$ZUBP0
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MM^#_  ZG2K'Y4N>%'_92MT.B.:@
M                                       #C3S[I-=PUR>P%RU11I-<
ML:A+I]*NI,=.Y49Z#*?=4@S/:E"I,:2HF=QZ;VU:GU(C*HU8)MSC]95@^U<6
M2J[A^[H5\Y%JS+96M;CT*:EMAQ:TDX[44K0P;:6DZGLWDI1Z$GIJHA%*)>9O
M(C(2N%>/J5>MO,V?EOD4I$>;:=-[[='I+#J9+VUMTU.I6\VJ,VMI6II[Y2-=
M4@1&E&=/XA<_6\%?N":K>.8^+IS!KD6R^;1RB6[*](&IR5Z.4YWJ7]#)7>'M
MT(B/:1 G&&2XFY6FUG@[RPP=<QN1KKPU9=XMQX$@S)Y%-G4R<HVC(^IG'EH>
M2KKYI*0GIT G6U'AIPTQ%R0XH735*]2#IN2W+BJM/MJ_F9$DG(:V(T5<8G8Z
M7.Y=:)QP]Z5(W&DSVJ2K:HA,X2EOZN++#N.;QO;B'D^V*59V0Z%,?71*C%A1
MX<BJ.0B4;\66\PA'BEH:^_1WE;C<:-7G&1(W$5<;KI<_]V[A][)?^96"ES-^
MJ*^C=>W^LJI?H>C JJUJB?5E<AL-8/H>7HN5;YBV?(N*?1W:*W(CRGC?1&:E
MI=,O#,ND6TW$]NG:":H;_6;PI/-CZP+#E<Q&W+J6/,*M4RIUJ[W(KL=M::/4
M':F;NQXD+0AYY34=LEH2LSW*V[>P:H;?6N0U^YAY*YJQ;<_)*G<3L>XOF3J7
M2]C$&+4ZTW EJCK6W5)ZFEMJ<2@WR)M?K%)VMKT4X1&&AC?JP'J%.S/RV:I=
MPS+RHM1EL.4FX*VYW]0J\ ZC421-F&LB-QU]"TK=49=5+Z]H%2HN3ZO>/&F9
MR@X:T"#,DTS*ERT9ZPB9U-28,I]+Z$-GNT4J5&4Q&7IKJ:#2>G70JUZ7]"&#
M,90L-X@QYC*$2#*T*+'B3WFM=CTY9&].?+7_ ,])<<<_^<"B4K@AR5X'?2VY
M]_'B;^GJP"J=1S)^G3PB]\XOZ6; C4ZU I
M
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M6W?>]?Z+DCG=[\T6_!_AU.E6/RI<\*/^RE;H=$<U
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M)*VI3KU[ 5:,'80%(
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MBXK<M2F4^M4QQ2%K8DL,)0XVI3:E(,TF6FJ3,@1*;00
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MLLMI:::22&FD$24I2DM"2DBZ$1%V$ _8  J+4_I:V[[WK_1<D<[O?FBWX/\
M#J=*L?E2YX4?]E*W0Z(YJ
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M.T]4P3,8+2 @
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MZUU*3I\M#JDI:><4:&MC2E*2DW&S<0G4C4I*=5$5;+I<"D
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M+&CD*HS6B*F4E9D9&5-AGYJ3Z_Y59&OREM'G,YO2YF-&JEK[V9JN<B[ UC&
M                     !46I_2UMWWO7^BY(YW>_-%OP?X=3I5C\J7/"C_L
MI6Z'1'-0
M                        !QE^M8E/UF\^+M@3GG$6M7:Q/>JT9M1H)YQ<
MBG124:O(IMIUPDF79O,%5+KK4[1MBJ6E.L>?18:K/G4MRCRJ EM+<7P"VC94
MPE"-I(039Z$2=-/("EK>+,2XWPS;)VIBVV8]K6U(DJJ"X,9Y]]+LAQMMI3ZG
M)#CJUJ4AI!&HU'J1$!BY39,_^+=BKWLA_H:>"K@=EZA A56!-I=3B-3Z;4H[
MD6H07T$XT\P\DT.-N(5J2DJ29D9'VD"E_*%?U Q];W(>Y,#T7*<R'QU?R)#*
MJ5=*E.Q(B6E''>?V;C2ZJ$F0\P3W8LD[^J= 7'=OFM3*3C;@IDJWK#@-4NWZ
M)0J+1*-!AF?=MP)%4@0UD2BU-6K+JC4HS/=J9J,]3,%$:U.:]2*8CZG6"XF$
MT3D9B#/87IU3)?O-#;CNO^,I#JT_R'H">%7SE/<U;J/ [A+!G$\F/*1/[XG#
M5II1VS@P3T,B+3P[A[/_ !>S4NH)C6LY]:\VW:R.+M9MZ"3%4MBL51% 3&(R
M<0F*5,<99;VD9]%-)V]#T\@(I7VS=Q0L3D'?EBW5DJJU6I6U8D=PHN/&'C9I
MTZ4X[O[^89&:E%M+9M1L,R[5[?-!$3@IS]4%_!+)GQX5^C88)J=:@4@
M
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MZHN=[/(X,?5Q_2?M[[E#K'N8>XZP^B3RPTV0^E[3^B4<_;P
M            5%J?TM;=][U_HN2.=WOS1;\'^'4Z58_*ESPH_P"RE;H=$<U
M
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M.1:-7JUUG4*?"D/1WE.QO QFN\(X[KJ2+>A1:&>O0%54NC8*0
M
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M=IZ? B4J!"IE/83%@4Z.W%A1DZ[6V64DAM!:F9Z)21%U!2]8
M                    "J7$K^YUS>_)>YVAX#U>^BW?#]J'1/6/Z7:\#]J5
MK1[]SL  &A94_AGD#XO5+W,X,C*_34<L=U1<[V>1P7^KB^D_;WO'6/<P]QUA
M]$GEAILA]+VG]$HY^W@                         J+4_I:V[[WK_ $7)
M'.[WYHM^#_#J=*L?E2YX4?\ 92MT.B.:@
M
M
M
M                                       JEQ*_N=<WOR7N=H> ]7OH
MMWP_:AT3UC^EVO _:E:T>_<[  !H65/X9Y ^+U2]S.#(ROTU'+'=47.]GD<%
M_JXOI/V][QUCW,/<=8?1)Y8:;(?2]I_1*.?MXHU?\V[<[<B:[@.G7A5[$QIC
M6WX57R+)M^0<.J5:95"[R+$1+01K992VI*E$GUWG$?:6FTLQ3E[$7IB)JJG"
M,=48<.#779JOWIM1.%-,1,X:YQU1B]_S9KKQ/<EH71QXOFKQV$55EG(%C7=6
M9<^D5&DN:]^ZCO4OK;DM_P!0TEUU[2(C)4>>TWJ9IO4QJT3$1$Q/0JG*U6ZH
MJM3.O3$S,Q,=O'2B"1B^G9KYF\AK:NRZ[LI]%M:D6W*HT"A5J53FVW'Z9")S
MS&U&G11F9GH7;U&3X^;&4MU4Q&,S.N,>&6)%KQV;NTU3.$8883,<$,K<=.NK
MB!E+$LNC9+N:\<-94KJ+7NBV;NG.55RF2W4[F)<.2OSDD9$9FDDET1H>[4MM
MB*J<W17C3$5TQC$QHQCAB65LSEJZ8B9FFJ<,)TX3A,Q,3VFJ7_4K.NWD)F2W
M^2F6+AQK;UH,4Y>':/"JTBB0GH;T=2Y<]I;):/O)<2CM,S(^FAET*JW%5-FF
M;5,53..UHVM/!'8+DQ5<JBY5,1&K3-.CAG1ACIYNVM%PVNB]KNPA3*I>U0G5
MQ;-5J4.U;GJ:5)FU:B1WML*;()7G;UIU+574R(C/7748F>HIHNS%.C5C'%.&
MF&1E:JJK<35V>W&.B>W"(L[7U"LCFGQMFW'=)6W9Z+<N!=9<E2E,0=ZX<]MD
MWDFHD&9N&@DF9=N@O9>WMY:YA&,XQW5J]7LWK<8X1./<?#F3G_%]<XX9#I=B
M94I$VZY3E$]%1:144^,5LK4%;W==THE=&DK-6G]77R"K=V7J\?3M4Z-.N.Q*
MG/W8BS.S5IQC5/9A(UO5^TVN2])@NR;H=O5K$+<]Z.<AHZ"J"E^-N5W)J[SQ
M1K,O.,M-NHQIIJ\1,Z-G;[>.$^PR-NGQT4Z<=F9[&&,>RU-GGG;E2H=1NFW,
M,Y"N>V+:=D-WM7J?#C+CTHHRU)43CAR"2M6Q).&1&1$DRU5KJ17ONVJ)BFJJ
MF)G5C,Z<>TM3G*<)F*:IB,<<,-&';[F*9KTY/8ZM.P+#ON"W4[Q/*9-%CFUZ
M)')ZI55UU"5FTAI2DI0;6XB<W*\T^G4^@Q[>4KKKJIU;.N9U0NUYBFFF*HTX
MZL.'A:U8W+*B7;DZV\.UG&UWV#D"NQYTJ11Z_'8:3%9AQ_$H=[Q#RN\;?22D
MH4@O7)5N(BT,Z[F2JIMS<BJ)IC#5V>TIHS,55Q1,3%4Q,Z<.#DF6.KW,:VX=
M5NANTL8WQDBT["E/P[ZOVWH#+M-@/12-4E*#=>;6]W*2W+-)$1%U(S$TY&J8
MC:JIIF=43.F?8X>R59J(F<*9F(US&&$>SC.'8B5F[*O*W<A6K0[UM*H)JENW
M%%3+I<Y)&G<@S-)DI*M#2I*B-*B/L,C(8MRB:*IIJUPOTU15$3&J6T"A4
M  *BU/Z6MN^]Z_T7)'.[WYHM^#_#J=*L?E2YX4?]E*W0Z(YJ
M
M
M
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M_P!E*W0Z(YJ
M
M
M
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M_I:V[[WK_1<D<[O?FBWX/\.ITJQ^5+GA1_V4K=#HCFH
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MB00
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MTZ)0?4G%F1)21;C2,%SP0
M                                             JEQ*_N=<WOR7N=H
M> ]7OHMWP_:AT3UC^EVO _:E:T>_<[  !H65/X9Y ^+U2]S.#(ROTU'+'=47
M.]GD<%_JXOI/V][QUCW,/<=8?1)Y8:;(?2]I_1*.?MX
M        *BU/Z6MN^]Z_T7)'.[WYHM^#_#J=*L?E2YX4?]E*W0Z(YJ
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MSN]^:+?@_P .ITJQ^5+GA1_V4K=#HCFH
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M"_WS?^'R=@KX';T%
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M2>NFY) :G0,$.//UPG\-L._&6?[C(%5+J=C+^&V/OBU2?<;0*6\
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M'4Z58_*ESPH_[*5NAT1S4
M    !Q"_WS?^'R=@KX';T%
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M;48Z8PT:Z9T\.B=>*VH]X\"
M.//UPG\-L._&6?[C(%5+J=C+^&V/OBU2?<;0*6\
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M(PY-4+^4F-B:>&)G'EUSSXXPM=>7]S[K]YYWN=8P[??1RLF=2L? CZ)6(?\
M["K_ *9G#,WIZ37R^TP]W>CT<BB-$4]CC+ES\AHNPH=I<C;MM"^$J(]#HUR2
MW6.^69::$PZ6I:GIO4D].T;"O_DI\5QVZ9CEICHQ8MOW$^,XJZHGDJJP[N!S
M;662YF<L@LNE)MS$+='QW0C,CVG5),HIU5<;\FYLT):,R\A_T1NW_CJMT\-4
MS5VL,(]M.\(VJ+E7%&'<F?:=KAH6V          !46I_2UMWWO7^BY(YW>_-
M%OP?X=3I5C\J7/"C_LI6Z'1'-0
M         '$+_?-_X?)V"O@=O04
M               ,96J3%KM)J-&FFLH=3CKC23:,DKV.%H>TS(]#_F&-G<I1
MF[%=FO'9KB8G#7A+(RF9KRMZF[1AM4S$QCJQA$]*P+8]'JE-J\1VIG*I4IF9
M&)R0A2.\863B-Q$T6I:IZ]1Y/*=0MW9:]1>HFO:HJBJ,:HPQIG&.!Z;,]=<_
MF+5=JJ*-FJF:9T3JF,)X4UCVKR(                 @/-]I7)45VA>UH1"
MJ5<L6:J5Z*(MRI#*E-K/:GM4:3:+S2ZF2CTZD0\3UQW7F;TV,YE:=JY8JQV?
MA1HG5PX;.J-,Q,X:<'M>I^\\M9B_D\U5LV[].&U\&=,=K':USHB8C'1BCF[;
M[O?+U&.PK?QU4J([57F45ZIU%*TL1D-.)<,C6;:"3YR2,S/KH6A),SZ:#>F^
ML]O^QYE8RM=$US&W55CLTQ$Q.O",-,<N&B(F9;[=FYLCN&]Y[?S5%<4Q.Q33
MAM53,3&K&<=$\F.F9B(;I0N)^#*')]*-6<MVMR4:U6I'4ZF293RO.<<6QXON
M2W+,U:$G0M>A$/?_ '+EJ\K;RUZB*Z:*8IC:C'O8V<8XIY'@OOK,T9JYF;-<
MT55U35.S.'?3M83QQROM7>*6 [DDM2ZS8JI3S!:,DFK59E".NNJ6V9B$$?W2
M+47\CNS*Y&G9R]NFB)UX1KY9USVUC/;SS6>JVK]RJN8U8SJY(U1VF%;Q5E*P
M*A5F\47- ;MFKNJ?31ZIJI45Q1:$:-S;I&9%T)6I&9$6XE::CQ$=6][;KNW/
MNR[3%JN<=FOWL]C1,=O1C&&,3@]M/6/=6\[5'WG:JF[1&&U1[Z.SIB>UITXX
M3&*0\6XRE62JM5RX:N5P7C<KA.5BIIU[M*2,U=VV:B(S(S/4ST3Y"))$D;SJ
MWU=KW;-R]?K\9?N3[JK@Y(_^(X(PC!H^L?6&C>/B[-BCQ=BW'N:>'EG_ .9X
M9QG%+X]4\L                                     .//UPG\-L._&6
M?[C(%5+J=C+^&V/OBU2?<;0*6\
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MIIL4TSCKC'&'CMU;RLWLU;HIR]%,XZXQQCLNI(]ZZ&
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M+?@_PZG2K'Y4N>%'_92MT.B.:@
M         .(7^^;_ ,/D[!7P.WH*
M
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M2]5'N47:1=3Z:CS-_.>,IV*:<(;G)[L\3<\975-56&$=A: 83:@
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M!#BM&E1IGURJ),.0U*CN:]W(96EQ"M,>&1Z*29D>AD9 KX'<0%
M                                 *W\B7WF85K&R\MHU/2]VQ1IU\UK
MMT'-O6-753;L83,::NY#H'4.BFJN]C&.BGVU7*S9T^[\<Y2K\?(]\V-4L?6U
M4*Y2GK0KTFC^)D,0Y#K:)IL=7FTJ:(R3J7:?7J,7U<W*JJ[\3..BG]ID=>Z*
M::;.$8::O:;SA^GQ\.V[CC(M:R1E/)=7R+8\*1/H]TW5(JU*CO3&84MYYB))
M+1#A+\U"]QFE"E)_K#UN_P#K+;W/51%=$U;<3JF.##I>8W+U?N;TBN:*XIV9
MC7''CT+:6!D6%?\ Z6\'3GZ?Z)[CO.^6E6_O^\TTV^IW9BOJ_P!8[>^/&;%$
MT[&SKF-.UC\U3OS<->ZMC;KBK;QU?^.'2D8>C:
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M']T1E\]8S$S%JNFJ8UX3BBUFK5Z9BBJ)PXI68&4O@
M        /RM"'$*;<22T+(TK0HM2,CZ&1D?;J")C'1*M=4XFX>J=5=J::=4*
M8AYSO'*5"EFW%U,]5$E"D*4@C]1*B(OZN@TU>XLK55M83'8B=#R=[J5NZY<V
M]FJG'@B?<_Z=J>1/U H%&M>D0:#;]/:I5(IR.[AP62/:@C,U&>IF9F:E&9F9
MF9F9ZF>HVMJU3:IBFB,(AZ;+9:WEK<6K5,4TQJB&8%Q?8ZJT>DUV&NG5NEQ*
MQ3W3(W(,YAN0RHR[#-MQ*DGI_(**[=-R,*HB8[.E:O6+=ZG8N4Q53Q3$3'-+
MPT&U;9M9AR-;5OTZ@,/&1OMT^,U')PTEH1K[M*=QEZIBFU8MVHPHIB.2,%O+
M9.QEHPLT4T1_XQ$<^#/BZR0  52XE?W.N;WY+W.T/ >KWT6[X?M0Z)ZQ_2[7
M@?M2M:/?N=@  T+*?\-,@?%ZI>YG!D93Z:CECNJ+O>SR."_U<7TG[>]XZQ[F
M'N.L/HD\L--D/I>T_HE'/V\                         %1:G]+6W?>]?
MZ+DCG=[\T6_!_AU.E6/RI<\*/^RE;H=$<U
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M6/\ 6W]4O2/_ .8?!^ \1X^S),__ *-W\G9L\3L_RBM=N[IKH1,SC#^BT%
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M@G![IKNU..3XL1PG3<[PC22#3M))[M3,B]<\NW\
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MP_<,D[WF_P ?,WZ]FFA?R@JB<7])&,OX;8^^+5)]QM MMX
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M42H41U2UIWD;3=0884XG3M4DC(CZ A)(
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MGW9M0J,M1><_,ER%+==5VZ:JVIU/:1:F!,I5!#B%_OF_\/D[!7P.WH*
M                                       %=<^WHS'H5>QP4%YQR]+;
MGPIU2-#C;<=FHM/0T+9<-!MNN)T6I2"5JDMAJT):=?*=9^LE6YO%86XKV]KA
MPPV=GL3KVGI>KVX(WKXS&O9V-G@QQVL>S'$^6!+ZC/4FW<8*I\AM^T+8AQJ?
M4TM.N,2(]*;CPG%/O$V33+BS6VI#9JW++O#3J3:S)U8ZR5;Y\;C;BC8V>'''
M:VNQ&K9.L.X(W5XO"O:V]K@PPV<.S/&L>/5O-
M                                K!FSC.SEB[*+D*V\HW=AZ_Z32%V^
M_<UIRDLJG4E3YRDQ);9D1K2V\I2T:*(B-1ZD?F[28EN^#,)T;!EJ5.WJ=<5;
MO*K7'6)%PW=>-Q2/%5*IU.4AIIQ]YS0M")#*$I3Y"+J9J,S,3.*9]"U-6A:F
M1$9^70NS_C!#_0 !Y*A3X-6@3:75(;-1IM2CN1:C3Y*$NLOL/)-#C3C:R-*D
MK29DHC+0RZ *>_,(XY]^4=5&N%=HIGE4T8T5<-3.VTR27WA**G&_LTW==NNW
MR:;>@)QE9&]<86!D.QY>-[PM6#5[(F1FHBK=-ON6&FH^WN"8[DT*9-K:7=FV
M:33H6TR!")<;<3,.XPNN)?-*A5JY+MI,54"W:[=-8F5IVE1%I-"F8!2W%H8(
MTF:=4IW;3-)*T4HC)Q66!#CS]<)_#;#OQEG^XR!52ZG8R_AMC[XM4GW&T"EO
M                                     #!W/_=NX?>R7_F5@(0XB?1>
MP)\1Z/[E0"9UK%@@                                       !5+B5
M_<ZYO?DO<[0\!ZO?1;OA^U#HGK']+M>!^U*UH]^YV /%4JA$I-/G56H/%'@T
MV.[*FOJ[$-,I-:U'_(1&8B9PC&5=%$UU133KF<(<U+&M63REJTO,V6EO5"S%
MS)$?&^/.]<1"8B-+-HWWT),MREF@M=#\Y1'KTT(:J(F].U5JX(="S%V-ST1E
M<OHKPC;KX9GBA-U>X[X7N"F.4R3CRCP4FVI#$VG1TQ)+)F1D2VW6=JM2[2UU
M+U2%R;-$QJ:ZUOG-VZMJ+DSRSC'LL!QUNB[,=9+K/&^]:T[<=.8IAUW&5PRU
M&J2NGI5W:HCA^7NR0HR+R:*\FFE>5KFFKQ<]I1O[*VLSEZ<]:IV9QV:XC5M<
M?;7I&>\<                        J+4_I:V[[WK_ $7)'.[WYHM^#_#J
M=*L?E2YX4?\ 92MT.B.:@                              @#/.?,?X=
MM:Z&:SD"@6O?OZLU&JV91*K*:;?ER&F'BBFVPM1&X2GVR1H7:?0$Q"'^'?+"
MV\TXRQU%OC(=M/YSN7TOZ4LN&\S'FGX.;-4UL@I4:D_Z"PET_53YP$PN^"
M       !Q"_WS?\ A\G8*^!V]!0
M           C#)&-_P!X/H;_ +9]$>B/$?\ W?Q'>>([K_ZUO;M[O[NNH\OU
MEZM??/B_^38V-KWNUCM8=FG##9>CZO\ 6#[I\9_Q[>WAP[.&SCV)XS&^-_W?
M>F?^V?2_I?P__P!W\/W?A^]_^M<W;N\^YIH'5KJU]S>,_P"3;V]GWNSALX]F
MK'':.L'6#[V\7_Q[&QCP[6.UAV(XDGCU#S@
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M7^^;_P /D[!7P.WH*
M
M:/D2@X\N2U)U)RE HE3LQYQE=1B7#W/@#6VXE;)N>(,D:DLB-.OE 4(Q;P:Q
M^SGG,&0*_8%@7+A*\(<#]U=#C-M3&H:VD-)D+1'[GN6B6I*^J%JUU!5BZ%6E
M7+/KM%C/6-6J17+>IY% BR*)*8EQ&NX0DB82N.I:"-"33YNO0M 4ME
M   <>?KA/X;8=^,L_P!QD"JEU.QE_#;'WQ:I/N-H%+>
M                    &#N?^[=P^]DO_,K 0AQ$^B]@3XCT?W*@$SK6+!
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M
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M"?PVP[\99_N,@54NIV,OX;8^^+5)]QM I;P
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M6I_2UMWWO7^BY(YW>_-%OP?X=3I5C\J7/"C_ +*5NAT1S4
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MW0WI"92V/ 67)@'J\E#9*WG'-?K2TUT\FH)F,(?T3 H
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M]POK(
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MDJRUVG5)%0<E2*BB<3Y/LDUL)*([.W3MUU,%41@_HYQE_#;'WQ:I/N-H%MO
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MVH49#==O)U353,SC'"F ;QLP
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M9?=]JW<C9JB)QB>67@-_7Z+^>N5VYQIF8PGM0W0;MJ
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MDJ-I"3,B/R&"JEUMQE_#;'WQ:I/N-H%+>
M   !%&7_ /N&W?C51?=21HNL'T-OZVW\IK]X]Y3X=/=2N-ZV
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M9=I'J!AI=%:%)>F42C3)*^\D2H,=Z0YH1;EN-)4H]"(B+4S\A I94
M !Q"_P!\W_A\G8*^!V]!0                                     *L
M<I/_ '=/]=]H_P#6P3"TX(
M                        !2/(F:LA6]SBP!A*EU5EC'E^VO5ZG<U)5%86
MZ])B0ZL\TI,A2#=01*B-GHE1$>GW3!.&AD^..>;WRKFGE=8%SM4QNA87N6!2
M;/7!CK:D*CR7JHVLY2U.K)Q6D-O0TI3Y>G7H)AY^"N6<@9DQ%<ET9(K_ .L=
M=@7Q6:/$G>%B0]D*(B.;+7=PV6$'M-Q7G&G<>O4S F%T00        X\_7"?
MPVP[\99_N,@54NIV,OX;8^^+5)]QM I;P
M   (HR__ -PV[\:J+[J2-%U@^AM_6V_E-?O'O*?#I[J5QO6P
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M<[O?FBWX/\.ITJQ^5+GA1_V4K=#HCFH
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M*>W=1T^*=RMTA3JZ>FH=TGQ11%/I2Z;).[N[-9$K;IN(C!#,
M                                                YD<N,-\G:UR/
MQ3G+CK0*74ZC8%KR:8B;5)<)MIN3,5.9>2J/*=;-9>'EGH9=",_N JB85LQW
MB3ZS+%]Y93ONU+1M1FX,Q5%BJWHY)FTAYI<B.N2XV;#9RB)LM9;FI%]SU 3C
M"^_ _$&1\*87JMJY3I<>D754;NJ=:7%C26);9LS&HQ)62XZUH+53:NFNI IF
M5TP0        X\_7"?PVP[\99_N,@54NIV,OX;8^^+5)]QM I;P
M                  #'3*O2:<M+50J<2"XM.Y#<AYMI1IUTU(EJ(S+4@'D_
M6>V_VAIGXVS[,!0C/ER3I&1*HQ3J^^]26D0GHK,:4I4=+J&4'O02%&@E$KKJ
M774<EZVYF[&?JIBJ=F-F8C&<,<(TX/'[XNUQF)C&<-'#V%D,"75&<Q[&7<%R
M-.5 YTK5=0F)-XT;BV]75[M/4'M.J=VN[D8JKF9G:G3,X]UO-SUU5Y>)JF9G
M&=:9_P!9[;_:&F?C;/LQZ9M&78?8E--R(SR)##I;FGFE$M"B]4E%J1@/J
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M2Z$1$7D(9EJU3;C"'F]X[RO9^[XR[.G@C@B.*$F"XP
M      %1:G]+6W?>]?Z+DCG=[\T6_!_AU.E6/RI<\*/^RE;H=$<U
M                      !Q\Y \$+EHEO9MS1$Y,W@@Z13KEO6-:K;;S;!'
M':DU%$)+J:AYJ"V]V2B1T+KM\@*HE'^"N!=UYBQ%863I/*.]*"_>=+14':.T
MA^0B.:EJ3L)TZ@@U>M[=I F9=N*?%.# A0E/*D'#CML'(5ZY9MI).X^I]3TU
M[04/6         XA?[YO_#Y.P5\#MZ"@
M         58Y2?\ NZ?Z[[1_ZV"86G!
M                                  *4<F^(56Y$790+GI^;KAQ@W1*0
M5+72*.TXXU(43[KW?K-$N.6[1S;ZT^A=H)B<'-C#O#R\,I9=Y$XQ?Y*7E1F,
M&U2DTZ)6&SD/+J)5-$Q1K6T<]!-;/"EH1*5KN\F@*IEV"XX81F8!Q\]8T[(%
M3R2^]5Y-4*X:LA3<A*9#;*"8(E/OGM1W6I>=Y3Z IF<4^ @       !QY^N$
M_AMAWXRS_<9 JI=3L9?PVQ]\6J3[C:!2W@
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MI$6@V_1V2CTJCP6DLQX[1&9DAMM)$22U,^A AF@
M                       %4N)7]SKF]^2]SM#P'J]]%N^'[4.B>L?TNUX'
M[4K6CW[G8                               "HM3^EK;OO>O]%R1SN]^
M:+?@_P .ITJQ^5+GA1_V4K=#HCFH                              .3
M^4>.7UC-]S,BT2)R%LI.-[R>J\&-;4IU]"RH=14ZVF(Z;= 6HC\,YL4:7#/U
M%'V@JQA!&(<;<Y4.US"N(^6V/2=PSLI5;M*,=0_[)^^.H2TIV3;'G^>VLM4K
M5V=H)G!W,I[<MJ!":GNI?G-QVT3'T^M6Z22):BZ)Z&K4^P@4/6  ,'<UR4.S
MK>K5UW-4F:/;]NPGJA6:F^>C;$>.@UN+5Y3T(NA%U/L+J YU\7L^Y=R_RGR0
MU>:)ML8^J-A1KDQOCR22$G$ILB=':@S9"2+<3\IDS>5JH]"<))="(B*IC0W6
M[JYD_D)R*R)A&Q\G57$6-\(TJDNWW<%M)8*LU2LUQE4B+'9E.H7W#+31*W;2
MU-:5$9'JDT$:FR8 OO(EK9LR;QBRG>#N1:C;%&B7GCB^Y3#3$^;0);J8[[$]
M+*4H4[&D.(02R+59&9GH6B2$KK@AQ"_WS?\ A\G8*^!V]!0
M                        *L<I/_=T_P!=]H_];!,+3@@
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M /W#;OQJHONI(T76#Z&W];;^4U^\>\I\.GNI7&];
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M %WVC_UL$PM."
M                1?E7-.+<(T-BXLIWG!L^ES'5,P522==?DN(+<M,>+'0Z
M^\:2,C5L0>FI:]I 8*JY"M;$G(^Y<(\J[=SO1:9C_ %1?J54E*C)7&D&E^+(
M6S*DORHJH*DDTDC)QI2O/(]O9J3JT+08=S78F=K>K%V8YFR*I;=)K<JA-U9Y
ME3");T1MEQQYA"]%]T??$236E)GH?FZ::D3"6@ !6WEA?V2\=X8KM4Q%9U;O
M*_:N^S1J,U0:<]595.*62^]J7A&$J4OPZ$F:=?-[PT;O-U!,.4^7LC6Y:F(N
M-V-;:X]YOM*/8N7;:N2J7#>=I^CGKCJ#+<U4LFG3EO'(J,YQTUH:,^I$9$HD
MH(@50N#FN[BNS,OU>^5IEKW!9-'GW9<E(>MF[814VJ1)M7CL1(2)D8W'":<6
MMA2FRU,S(R,C+4$1PMQ^L23Z1P[8%JQM55>]<I6K1J&TGJX<EU]UQ.Q.I&9Z
M-F70_*"*6@<NN*W*?,N58]W8;S)#L.T6Z##I[E$?N&N4M9S&77UNO=Q3HC[1
MDI+B"W;MQZ=2Z$"8F'*;EMQNY'X/MVT:KF_*T7(5*KE1?B4.''KM8JQQY#;.
M];AHJ45A*-4]-4&9@JB7]+&,OX;8^^+5)]QM MMX
M          $49?\ ^X;=^-5%]U)&BZP?0V_K;?RFOWCWE/AT]U*XWK8
M
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M*?-(]-3Z 3*=@0XA?[YO_#Y.P5\#MZ"@
M         <X.0E_YEN*Z[;MZ)B.WV8.*LCT^ZJ;5'KO<)RJQ:0M[PZ%QTT51
M1526W4K/[X[W9^;Y_:-!F^L^[\I=JM7;F%5.N-FJ>SP0WF5ZNYW,VHNVZ,::
MM6FF.[*Z>);QNR_+0:N.\+.A614),I]J)28-6.LM+CM&2">\2J'!,C4LEI-!
MM]-NNIZC:Y+.6LY9B]:G&BK'"<)C5,Q.O3KAK,WE+F5NS:N1A5&&,:)UQCP=
MB4F#*8P
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M.//UPG\-L._&6?[C(%5+J=C+^&V/OBU2?<;0*6\
M         "MF9\DVA&5!MARI*.L4>O4J=4&$-.+2AEEY+SGGI(TF:4_U==?(
M/'=8]\Y:G9LS5[NFNB9T3JB<9T\G TN\\[:C"C'3%5,SSXIMM2\*!>U,.KV[
M-\;"2ZIA:E(4VM*T:&9*0LB470R,M2'I,AO"SG;?C+,XQCAQ-GE\S1?IVJ)Q
MALPS5\
M
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M,1W8;J-VU
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M[F2RGB[L1%6,S.J>34VN[,M58L[-<83C*71OVQ
M
M                                !_/1R0Q[GJ%F2XKKY6VEDC*. 6*S
M.E6Z5FU9DZ?"IWB5KBJ6PTP^TPE+'F+):8ZU'U[[U2N$F\)K\XU0N7V0*ABU
MR'C['5:L*!3['I=R2$Q9BJB3D$Y<=*YDAY3KZEH<49(=7N+4RU2!..#N4"@
M        <0O]\W_A\G8*^!V]!0
M
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MFA6J
M
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M(]#(]-#(P0WT!Q"_WS?^'R=@KX';T%
MQ->JL>A4.M5N6;I1*-!DSI)L-K>=[N.TIU>QILE*6K1/1*2,S/H0IKQV9PUX
M*J,-J,57/WAWG^?7?P;7L!R'\1[P\K/-'0ZE]PY'R<<\]*T]&JT2O4>E5R!W
MO@:S#8G0N_:6P[W,AM+J.\:<)*T*VJ+5*B(R/H?4=@<K9(
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M#"U2$);0AM"20A!$E""Z$1%T(B&1$8:%U^A(
M
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M\W9OV>7;KU&A_#&[O)?K5?.;K\19_#Z3]6GH6X&_:0
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MQ$DT[')M)I4I1[CW>0%5,8.]6,OX;8^^+5)]QM H;P
M     "K$_P"FU:?^I"X?_P!R44$\"TX(
M
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MZ<WJ\55S2M@-FUP
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M<A:"47W2 QE9($
M                               #RQH4*$3B8<1F(3RS<>)EM+9+6?:I
M6TBU/[I@/4 X\_7"?PVP[\99_N,@54NIV,OX;8^^+5)]QM I;P
M             "EDG_I,C_[1?_&8\)7WTO.U:UQ:9_W;3_\ U9K_ )A#V]KO
M(Y(>@H[V.1[A<5
M       "C7 [^'5X?&,_<D<:C='>5<KEWJH_IUWZV?DTKRC;NH@
M                      *%5WZ>-F^\[OZ'G#33Z='Z>]<KSWYSR_U<_(N+
MZC<NJ                                            .(7^^;_ ,/D
M[!7P.WH*                             !^5K)M"W%>M0DU*_D(M1%4X
M1C*8C&<%1O3,#YRG[TN\5^JO[M/U5W;3\1Z0],>.T[K_ !.Z_K:]O0>:_%N0
MXZN9Z#\,9W5A'.MV/3//
M                                           X\_7"?PVP[\99_N,@
M54NIV,OX;8^^+5)]QM I;P                      /+/1,<@S&Z<^U&J"
MV'$P9+R#=:;>-)DVM:"4DU))6AF1*+4O*0"KYX=RHLS4Y=-JJ<5U6HJ?-(C,
M^TR+Q1Z#3SN:W,X[4^PP9R%/'*R-NQ:M!H5)AUZ7&GUF+%;:J,R&TIB.XZE.
MBE--+6XI*?4(U'_*-O33LQ$,V(PC!F1*0
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MT&XHC4:4$22UT(B(=8<R9
M                                            <>?KA/X;8=^,L_W&
M0*J74[&7\-L??%JD^XV@4MX
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M\[OZ'G#33Z='Z>]<KSWYSR_U<_(N+ZC<NJ
M              *1Y!RGFK(V<KEP#Q_J]#LA.-J/!JF4,F5N JJ+BRJJCO8%
M.A0S6AM2EM&3BE+U+34M2-.BR6R8#S!D2H9&R1@'-R:.]D['L:)6Z/<M":7'
MA5^@3SVMS$1W%+-IQEQ26W4ZZ;E$2==#48F%N 0XA?[YO_#Y.P5\#MZ"@
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M[%5,1&&.C%E[QW5;RUK;IF9G'#2WT>A:,
M                                                       %:.3>
M:[AQ%;EGTFP*+#N/*V5KCB6GCFDU)2TP42Y.IN3)IMFE7<1TEJHDJ(]5)_J[
MC(F(0S*R1R.X\WQB]K/=WVODO&&5J^U:<FY:/2E4>7;];GDM4!*DDXI#T5PT
M&DUJ(E$1&I1EH1+&M?T$.//UPG\-L._&6?[C(%5+J=C+^&V/OBU2?<;0*6\
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M2++:?6M^/WO>$;32G"TWK474T^H)FG 6C%(
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MVN;=-%&1Z]"+U!BY'<]O*7-NFJ9G##3@R<YO6YF:-BJ(B,<=#:AMVK
M
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M@-.L7 ])L:Y(=R1*]+G/PT/(3&=:;2@^^;4V9F:>O3=J)FK$3P*0
M                                                  %&N!W\.KP^
M,9^Y(XU&Z.\JY7+O51_3KOUL_)I7E&W=1
M     4*KOT\;-]YW?T/.&FGTZ/T]ZY7GOSGE_JY^1<7U&Y=4
M                            5+R9Q^OEW+!YVP3D&!C[(-5H[5!OBCUN
MG'4J)7H<=1'&<D-MNM.M/L$1)2X@S,TI2CS2W[R<6?P5@6K8WKU]Y*R)>IY(
MS!DQ<5-S7.B(F#"B08233%IU.BDIPVF6]?./=JLR2I1$9 3*RH(
M$9Y+PWBW,=-CTG)UC4J\H<)2E0%3V=7XQKT)9QY"#2\UNT+78LM=.H&+_<9X
M<Q=ARF2:/C"QZ59D*<I"ZAX!G1Z2ILC)!R)"S4Z[M)1[=ZSTU/3M Q9RX<?6
M%=TN-/NNR*!<\Z$G9#FU:FQ9KK2==VUM;[:U)+7KH1@-K;99:91'::0VPV@F
MVV$I(D)01:$DDET(B+IH @>/Q9XY1;H_7./A2SV[C[\Y29Q4M@T)?,]>^2P:
M>Y2O=YQ*)&N[SM=>H)Q3X"
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MWK1HT"W;5H<"VZ!2T=U3J+3([<2*P@S-1DVRTE*$ZF9F>A=3Z@AF@
M                                                          !1
MK@=_#J\/C&?N2.-1NCO*N5R[U4?TZ[];/R:5Y1MW40
M             %"J[]/&S?>=W]#SAII].C]/>N5Y[\YY?ZN?D7%]1N75
M
M
M
M
M   4:X'?PZO#XQG[DCC4;H[RKE<N]5'].N_6S\FE>4;=U$
M                 !0JN_3QLWWG=_0\X::?3H_3WKE>>_.>7^KGY%Q?4;EU
M0
M
M
M
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M>=W]#SAII].C]/>N5Y[\YY?ZN?D7%]1N75
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MZ5<E.BU6F+=3L6<>8RE]HU(/UI[%EJ7D!2S0
M                #GC,^L_XJP9<J%(JUR$_#>6P\2:,Z9;VU&E6A[^O4@5;
M,O/]J3Q/_.]R_ KOLP-F3[4GB?\ G>Y?@5WV8&S)]J3Q/_.]R_ KOLP-F3[4
MGB?^=[E^!7?9@;,GVI/$_P#.]R_ KOLP-F3[4GB?^=[E^!7?9@;,GVI/$_\
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MO]7/R+B^HW+J@
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MWVP#&5EZ32J?0J73:)2(B(%)H\5F#3(+71#,>.@FVFTZZ]$H21$"&0
M                                   5=?X5<593[TF1@^VW7Y"U.O.J
M:=U4M9ZJ,_OGE,P3C+Y?,CXG_(7;7X)WVP#&3YD?$_Y"[:_!.^V 8R?,CXG_
M "%VU^"=]L QE6'F;Q3X[6#QDRQ=]FXEH5O7-1($1VE5F(VX3S"W*A&:4:#-
M9EU0M1=GE!,3I:CP%XPX!R9QDLV[[]Q91+HN:?/K#4RLS6W%/.(8J#[31*-*
MTEYJ$D1= )G2N9\R/B?\A=M?@G?; 1C)\R/B?\A=M?@G?; ,9/F1\3_D+MK\
M$[[8!C)\R/B?\A=M?@G?; ,9<E?JW<(XGRQ?>?*;D:Q:9=T&V?1_H&-/0I28
MO>RIJ%]WM4G35+:2/^0%54NM7S(^)_R%VU^"=]L!3C)\R/B?\A=M?@G?; ,9
M/F1\3_D+MK\$[[8!C)\R/B?\A=M?@G?; ,9<?LCX8Q;2?K*K3Q+3K)IT3&\V
M?0VI=GMI441Q$FEH>=(T[M?/6>X^O:"K'0[ _,CXG_(7;7X)WVP%.,GS(^)_
MR%VU^"=]L QD^9'Q/^0NVOP3OM@&,GS(^)_R%VU^"=]L QERL^M"P5B+#M!P
M])QC85+LQ^O3ZRU6':>A:3D(CM1#:)>Y2O6FM6G\H*J9=)K X8\6JG8EE5*?
MA.W)4ZH4&FR9LE;3NYQUV*VM:U??.U2C,S!3C+;?F1\3_D+MK\$[[8!C)\R/
MB?\ (7;7X)WVP#&3YD?$_P"0NVOP3OM@&,JP\S>*?':P>,F6+OLW$M"MZYJ)
M B.TJLQ&W">86Y4(S2C09K,NJ%J+L\H)B=*._J].-&!LH\<*9=>0<846Z[C>
MKU5C.U><VM3IM,N))M!FE:2T21].@%4KQ?,CXG_(7;7X)WVP$8R?,CXG_(7;
M7X)WVP#&3YD?$_Y"[:_!.^V 8R?,CXG_ "%VU^"=]L QER5X!81Q/DW.W(6V
M[]L6F710K7[[]7Z9-0I343;5'62[LDJ29:(22>OD!5,NM7S(^)_R%VU^"=]L
M!3C)\R/B?\A=M?@G?; ,9/F1\3_D+MK\$[[8!C)\R/B?\A=M?@G?; ,9<E<L
MX1Q/1/K'<:8HI-BTR#CJK^AO25HM(441[Q$=Y3NY)J,_.-)&?4%43H=:OF1\
M3_D+MK\$[[8"G&3YD?$_Y"[:_!.^V 8R?,CXG_(7;7X)WVP#&3YD?$_Y"[:_
M!.^V 8RYA?6=X#PYA^Q,7U+&6/J59LZL5Z9&J<FGH6E3S3<4EI0K<I70E=05
M4ROSB'AQQ@KN)L7UNKX6MV?5JQ:5$G5.<ZTZ:WI$B RXZXK1PNJEJ,S!3,RD
M3YD?$_Y"[:_!.^V 8R?,CXG_ "%VU^"=]L QD^9'Q/\ D+MK\$[[8!C*N_+/
MB9QPLGCAEZZ[4Q#0:%<="H+DFD5>,VX3K#I.-D2T&;AEKH9^0$Q*#OJXN-^#
M,K\?9MT9%QG1[NN!N[:E!159Z%J=*.U'B*0WJE:2T2:U&73R@52OS\R/B?\
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MJ-RZH
M J5R1X@V1R9KU@U^[+FKE DX^\1Z,9I)QB0_XEUAU7?=^RZ?0V"(MIEVF"8G
M!;4$    (9S[A2@<@\95G%US56H46D5J1#D2*A3.Z*2A4*0B0@D]\AQ&AJ01
M'JGL!,3@]F"\043 N*[6Q/;E3G5BC6IX[P=2J7='*<\=.D3U]YW*&T>:N0I)
M:)+H1>4"9Q2T"   >2H0T5&!-I[JE(;G1W([BTZ;B2ZDT&9:ZEJ1& JKQ;X@
MV1Q3_7K]3KFKEQ?K[Z,](^F3C'W/HOQ?==UX=EKUWBU;MVO86FG4$S.*VH(
M   4_A<-;%@\H5\J6[HKR[Q7(D2#MU1Q?1FZ125TA1:$SWVA-+-9??/7?<Z
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MT<E:ILA<A9*[E#:-"4LR+1/8"9G%,P(
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M-F^\[OZ'G#33Z='Z>]<KSWYSR_U<_(N+ZC<NJ
M
M
M
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M7GOSGE_JY^1<7U&Y=4
M
M
M
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MZ>]<KSWYSR_U<_(N+ZC<NJ
M
M
M
M                             HUP._AU>'QC/W)'&HW1WE7*Y=ZJ/Z==
M^MGY-*\HV[J(   #EK]:[_!:P_C<CW&^,+/=['*];U/])K\'VX9OZJSZ.UQ_
M'BH>XH(G)=Y/*HZW^EQX$=V72\9CRH                       "A5=^GC
M9OO.[^AYPTT^G1^GO7*\]^<\O]7/R+B^HW+J@
M
M                       ,+/N2W:6:BJ=?IU.-*^[44J4RSHO0SVGO4770
MNP7*;5=6J)GM*9KIC7,-/FYGP]35;*CE>SH"C4I!)D5VGM'N3ZXM%OEU+RB]
M3D<Q5JMU3_MGH6YS-J-=4<\-.F\I./,!)*?R[;BR-*E?Z/*\2>B>WHP2SU]0
MNT_(+].Z,W5_ZZN9:G/6(]_#57>:7&AN0S$;R6W+E2#2F.S&IE4=WJ6K:E.]
M,381F?\ C*(7HW%G<,=CV8Z5'WEE_A>Q/0M*-0S@
M
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MU,^*4@  H57?IXV;[SN_H><--/IT?I[URO/?G/+_ %<_(N+ZC<NJ
M
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M +$=99CW%.7H\&W/MURRJ?5]NSWVW/+5T1#U1N-^'8^AJM14E9*W$MZ=-/\
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MV3L44T^[IU1$</8=C1W]X0
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MOT\;-]YW?T/.&FGTZ/T]ZY7GOSGE_JY^1<7U&Y=4
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M((S]4R(B&FS&;O9B8F[757,?"F:NZRZ**:.]B(Y'V&.K
M03R&_N+3_C%2O\^.Z?\ UY_,T_47/V7B>O\ _2Y\.GNNO(^DG/0
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MNFFFO?16^WR:?SB]'5_.S[S#MQTK<[TR\>^]B>AK#_U@N V]GA6;IJ>XC/\
MT:E%TT]7O7V^W[@JG<&8I[ZJB.6IC5[^RM&NKN>W+6Y/UBN,NGHW'%]S-4F?
MWZ'"9Z^0O,F/=/NBW5NFBCO\Q9C_ '].##N=;-WT:[E,<M5,>VUJ3]8O#_\
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MT?WCL/XTTO\ SP]EU)]*N_4U=VE[OU>_U&KP)^50_H\%;Z3
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MQLWWG=_0\X::?3H_3WKE>>_.>7^KGY%Q?4;EU0
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MS<PF-JW:IHJPG7&U3$3A/$LWZ,QF*=B[F+M=.O"JJ:HYI7N&.R
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M$S$QC33LSA/(R<KU7R65KV[5$4SQTTTQ.&O#1&K0Z C3/1
M  *-<#OX=7A\8S]R1QJ-T=Y5RN7>JC^G7?K9^32O*-NZB    Y:_6N_P6L/X
MW(]QOC"SW>QRO6]3_2:_!]N&;^JL^CM<?QXJ'N*")R7>3RJ.M_I<>!'=ETO&
M8\J                        H57?IXV;[SN_H><--/IT?I[URO/?G/+_5
MS\BXOJ-RZH
M
M
M
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M%]1N75
M                     5,M'F/C>^LG5#%UJVE?=8GTFXI=L52ZX]!6Y0HT
MZ$I:7>^G(=5W:-4:D:TD>AD>FA@G!8Y=Z6<U=3-BN791F[VD0SJ,>SE3XY55
MR&1J(Y*81K[XVM4F6\D;>A]>@(;* TNB9(QW<MP5>TK<OVW*_=5OFXFO6S3:
MK$EU"";+G=.%)BLNJ=:V+/:K>DM%=#Z@,S<=RVY9]&FW'=MP4VUK>II-G4:]
M5Y;,&%')UQ+3?>R)"D-HW.+2DMRBU49$74P'SGW7:U*MQ=X52Y:53;1;BMSG
M+IE3&&:<F*Z23;?.6M9-$VHE$9*W:'J6A]0$=0.1?'RJS(].I>=L>5*H2UDW
M$@Q;GI+SSJS[$H;1)-2C^X1 G!,9&2B)23(R,M2,NPR!"N^=>0<'"]:Q%:D>
MV'[SN_,=SLV];M!CRD1#;:-3:9,U;BVW"V,&\UJ6A>NU-22($Q"Q((  !K=U
M7C:%BTI5>O>ZJ/9U#2ZAA59KDZ/3XA.N:[&S?DK;1N5H>A:ZF TFB9\P5<U2
MC4:W,TV'<%8F*VQ*53;CIDN2ZKLT;99D*6H_Y"!."5)$B/#CORY;[<6+%;4]
M)DO*)#;;:"-2UK6HR)*4D6IF?8"&KVAD"P\A0Y50L&]J!?$"$Z3$V=;]2BU-
MEETRW$VXY%<<2E6G70SUT >FX;SL^TG:,S==UT>V7KCFHIMOM5:='A*GS'#(
MD1HI/K0;SJC,M$(U4?J -E :9%R/CR==LRP(5^6[,ONGH-R?93%4B.5=A"4)
M<-3L%+IOH(DK2HS-'89'Y0&2NVXV+0MBOW3*IM1K$:WH#]0?I=(C*F3Y"(Z#
M<4W&CH,C<<41:)21]3 0E@[D_8&>ZW>EMVO1;HMRX+!1#<N*C733/1DEM,[O
M#9T:-UQ1'HV9F2B2>AD9:D8)F,%C@0
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MAG?'M'R78Q3DV[6G93,5NI,%'DI7$?7'<);:5N)+SFS,M%'T!$Q@E0
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MQ^5)2A9:I4MJ*TZI!&74C41:EV#:V<E>O1C13,PT-W-6K4X5U1$MTL7*&/\
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MT]ZY7GOSGE_JY^1<7U&Y=4
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M7HTALR4A;:R)25)470R,CU(P4.=_'#Z<?.3_ /27N)0*IU.BP*0
M
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M^GC9OO.[^AYPTT^G1^GO7*\]^<\O]7/R+B^HW+J@
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MSJ9]JB4")C2T3CA]./G)_P#I+W$H$SJ=%@4@
M
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M622M%%Y#Z H5(^K,^B!8/OG7OTI(!-6M?L$
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MIT?I[URO/?G/+_5S\BXOJ-RZH
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M4A1$I)D>A]I F=3I2"D
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MH]AGH9$>F@OY6B::=/#+4[UO4W+L;,XQ$8+C#):P
M  %"J[]/&S?>=W]#SAII].C]/>N5Y[\YY?ZN?D7%]1N75
M
M1#%P!A&#>1Y$A8IM:)?*I[M5.ZV:9'1.\<^:E.R>^)!*[Q:EJ4I7:9F9]H)Q
M2\"       8Y=(I+E39K3E,B+K,=DXS%64PV<E#)F9FTEXT[R29F9[2/0!D0
M             !BJY0Z-<U&J=O7#3(U:H5:C.0ZM29C:7H\B.\DT.-.MK(R4
ME1'H9& TVP</XLQ6JIKQOCZ@V0Y6B:35G*-!9B*DDQO-HG5-I(U$C>K0C[-3
M Q2.
M                              ,=5Z12Z_2JE0JY3HU7HM9BO0JM2IC2
M7H\F-(0;;K+S2R-*T+0HTJ29:&1@-#L+"^)<6RJA.QSCFW[)FU5I#%2E4>"S
M%<?:;4:DH6IM)&:2,]= ,4F@       QT&D4FF.SGZ;3(E/?JCQR:D]&8;:7
M(>5VNO*0DC6H]?7*U,!D0             !H]]XTQ]E"FQ*/D2S:1>M+@22F
M0H%8B-RVFI!(4WWJ$N$>BMJU%J7D,!D[1LZU+!H,.UK)MVGVK;E/-Q4*B4N.
MB-&:-YQ3KAI;;(DD:UJ-1GY3,!LH                           *-<#O
MX=7A\8S]R1QJ-T=Y5RN7>JC^G7?K9^32O*-NZB    YC?6E:_N<L7J9%^MB=
M4Z]#_P!#?[2'I>K/T]7@^VUV\N\CE9GZKXS^;_<?4S(KUGZ%ZG^A01;ZR^DQ
MX,=V56[OHYY?:AT@'GF>                        H57?IXV;[SN_H><-
M-/IT?I[URO/?G/+_ %<_(N+ZC<NJ
M
M
M
M                                   HUP._AU>'QC/W)'&HW1WE7*Y=
MZJ/Z==^MGY-*\HV[J(   #F-]:49%AVQ"UZG=B="_DAOCTO5GZ>KP?;:[>7>
M1RLQ]5]_ "Y/N7M.U_$H(M]9?28\&.[*K=WT<\OM0Z0CSS/
M           4*KOT\;-]YW?T/.&FGTZ/T]ZY7GOSGE_JY^1<7U&Y=4
M
M
M
M
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M+L,O(I)ZI47D,C(7Z*HJC&'D<SEZ\O<JMW(PJIG"6PBI8
M       !0JN_3QLWWG=_0\X::?3H_3WKE>>_.>7^KGY%Q?4;EU0
M
M
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M]Z<)!?<)2E'_ #B<CWDQQ2RNM]..9MW.&JW3,\NE=49KR8
M        *%5WZ>-F^\[OZ'G#33Z='Z>]<KSWYSR_U<_(N+ZC<NJ
M
M
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M4FZZ]4WE$3LVH5Z2[.4M9Z^<ONUI1ZNB?5U!,ZU<\TV/<N-\X<6*K>64:IR
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M3WKE>>_.>7^KGY%Q?4;EU0
M
M
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MAL@             4*KOT\;-]YW?T/.&FGTZ/T]ZY7GOSGE_JY^1<7U&Y=4
M
M
M
M
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M*KOT\;-]YW?T/.&FGTZ/T]ZY7GOSGE_JY^1<7U&Y=4
M
M
M
M                                                !1K@=_#J\/C&
M?N2.-1NCO*N5R[U4?TZ[];/R:5Y1MW40  4?Y>?WRXR_'=7_ #61@9W71R]#
MU_5?Z+-?5]*P J8#_2[2_E 0%PC_ .X,T?ZRZO\ YMD,EWL\K.ZW?2V/JJ>[
M*[@S7D0                      4*KOT\;-]YW?T/.&FGTZ/T]ZY7GOSGE
M_JY^1<7U&Y=4
M
M
M
M                  !1K@=_#J\/C&?N2.-1NCO*N5R[U4?TZ[];/R:5Y1MW
M40  4@YA_P"C7#QRJS_WNGT^^$E,E*Z(;[U+6S<9]"UVGVC SNNF>R]=U6TT
M9FF-<VT_BI@FI%U,]"+J9GY!"4"\'TFY:F6Z@CSHE0R16'(;Q=BTDA@C,C\I
M"<CWL\K,ZWS_ ,UF.&+5/MKM#->2                      !0JN_3QLWW
MG=_0\X::?3H_3WKE>>_.>7^KGY%Q?4;EU0
M
M
M
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MGY%Q?4;EU0
M
M
M
M                %&N!W\.KP^,9^Y(XU&Z.\JY7+O51_3KOUL_)I7E&W=1
M   ?AQIMY)H=;2Z@^U"R)1?T&"8F8U#;;;220TA+:"[$)(B+^@@)G%^P0
M                     H57?IXV;[SN_H><--/IT?I[URO/?G/+_5S\BXOJ
M-RZH
M
M
M
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MFJ**HV:L<<-BO3[J*9G''@C@F>-TY&_=N
M
M
M
@                                       !_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>tm2227887d4-lc_3lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_3lnp4c.jpg
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M# P,# P,#/_  !$( K0&@@,!$0 "$0$#$0'_Q #\  $  @,  P$!
M    !P@%!@D#! H" 0$!  $% 0$               $" P0%!P8($   !0,"
M 0(,#@T'" 4(! \  0(#! 4&!Q$($B$3,4$B%-1U5I875Q@X4=*SE+05M=46
M-G9W6 EAD=$R(Y/3-565I3<9<4(SI.2V:(%28I(DA8:FH;&R<W2"4S0E)F>7
M.<%R0\-4Q"A(1(3%UJ)C@T7&>$D1 0 ! @(#!PX,! 8!! ,  P ! @,1!"$Q
M!4%1<=$24P9A@9&AL3)2<I(3%#06!\$B0J*RTC-S5!4V%_#"LS7A@N*3PQA#
M\6(C16,D"$1TA/_:  P# 0 "$0,1 #\ [^
M
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M9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[,
MQD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/
M$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG
M9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+
M:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7
MU4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,G
MD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ
M9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[,
MQD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/
M$G3/7U4[, QD\@+:!XDZ9Z^JG9@&,GD!;0/$G3/7U4[, QD\@+:!XDZ9Z^JG
M9@&,JT[P]GFVS&FVS*5\V-BV%;UV6]"AOT6M,3*@MR.XNH1FE*2EV2M!F:%J
M+E2?1!,3.+JR"D
M
M
M                                        %=-W?FO9[^0]8]BK!,:V
M\8+_ ')8=^0]O>YL<$2E,
M                           4\W^^:!FSM9!]U(8)C6N&"
M
M
M
M                5TW=^:]GOY#UCV*L$QK;Q@O]R6'?D/;WN;'!$I3 <S?+
MTN3RR"VS>#ZF%;_PE.WCN7KQXYA_[.;A/\WP$W]__-]#DUUY058:'0:_KE79
MEBWI>#41-0<M.@U&LMP%+-M+ZH$5R039K(E&DEFC370]/0!2IEL<WAW%NP3D
MXK@LVG6DNP3HO6JJ=(>?*055Z^XB63I%P\'69::'R\7V 3,8+\@@
M                          '&K:[N?SGD'?#D'&%W7V[5[!@3;L8I]M*A
MPFF6&Z9+6W$2VXU'0[^#2@BU-9FK^<:C/4%4QH=E04@
M     IYO]\T#-G:R#[J0P3&M<,$
M
M
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MD'W4A@F-:X8(
M
M
M                                      !73=WYKV>_D/6/8JP3&MO&
M"_W)8=^0]O>YL<$2E,!\WM;H5$N;ZTF=0;DHT&X*%5,C&S4Z+4H[4N)(:.,1
MFAYAY*T+3J7041D"O<=BLR[<]O=+Q!E:ITS!&/*=4J=9U=E4^H1;7I++[#[-
M/?6VZTXB,2D+0HB-*B/4CY2!3$N?7U-?_P"<=_PA_P#ML%52(\ W;0+ ^L\R
MK)O&IQ[<A5F]+\IT6H5!Q,=A+\V=*>BDMQPTI23Q))*#,^4U)(NB0$ZF9^MJ
MRK8-[W5B*S;1N6'<5:L)BNO744!Q+[$4ZJ=.ZV:4\V9H-S2(LU((]4D:=?O@
M*4]?64>9+@?Y2VO_ ';J@(IUK3[*?,<QI\FJS[-G B=;G3]3W^\G,7R:@>S#
M!54;K_\ YH.$_E+CGW38 C4G/ZQ+<UE^SLHX]V_XJNCP=)NVGP*A6KS2HXSZ
MEU.<_!9:*6:5*88:-CC<<:ZH]=.+1*DJ(IA5[>_MHNK".+*%7;[W4W-EFX*_
M6HT=NR:Z_)4V^M+#JI$UEN34)2U$P9)3Q&CDXRU,C41&3$K._P#_ ""_X:__
M ,G!&ZWCZHKS;KV^<JI>X]& JUJ>8=_^;=5_EQ?7N-5@3.I]"(*'SW;U?_F.
MXT[9V)[-:!7&I=_ZU_S7J?\ +BD^Q9P(IUI3^KB\S'#?_$/]XJF"*M;G3]3W
M^\G,7R:@>S#!54_&-L@[B=_>=KYMF-GFL8.L:W8LFH1+<M]R1$>3!0^F*TQS
M$=Z(Y(69K)3RWW#)*CY$D7"A(U(&N"P?!CO_ ,,V2YE>=F291+_LANI7=4G5
M/242%52*I<-Q2I$DR-C4B-/'R'R&1'R G<2[]8^MRR-ZN-+[KL9V;;C=,MNL
M-MJ1QMKCTRI/=<QT:ZDH_P $:C3_ *9<G*6I%.IVSN+<%A*T[.B7_7\H6[!M
M&H-MN4ZL)FMO%))W[TF&F36ZZKT4H29ERZD6A@IP<3_K??WVXS^0Z?=*8"JE
MWWN*GR*E;M=I4%WK:74*=*BPWDZ?@W'65(0HM>3J3,CY04.!WU3MWT"R\QY/
ML2ZGX]"N6Z*1'CT5J>I+#JY5+E+*3"0:]#YTR=XN N4^;/DZD%=3>OK?+[M:
MK5##^/Z55H]2NBW5U>HW!3HRTN*A-S$Q&HR'R29\"W#:69)/ET+4RT4G44O7
M^L0M^HVEM)V=VK6&3CU:V:93:55&%%H:),*@QF'4F7V%H,@*=:\FU;</ARE;
M0K#KTR_J0PSC&T8T"\J>]);9F1)=/8X%L''<4EPU.*1HUH7X34N#74%,QI<[
M?JCJ/-J.=\KWA%AG&HE/LYVGR6FR,VF7JI5(DB,UQ<A%U$)WA+3E(C] %53U
M=E7_ ,QW)?;.^_9KH$ZF\?7&?&3 _:RO^K00*4_;UMRV0=O^WC!%)QI**B7#
MD>C,,/763)/.P8E.@0E.IC\XE3:77CD)(E*(S))+-!<6BDD1&*L>7MMF1Z3M
M;F9RREO&N:Y9=?MV'4V;*DSY<BEU!RI$V]'IS+TBH&3VJ7-=$LZ<AF2.$M03
M$Z4@[%KBH%J_5Z;E:Y=-(=K]O1:]<[57H;*^;7,8DV]28ZH_.?S"<YSA->A\
M)&:M#TT!$ZU2]JK.X6'C>N>!7=)CS$U$N6J/LW'95RUV'!J4=TFD,E/0W+A2
M%L\ZV1$3L=25GP%TT%H52Z[[#]L-M;?++N*KQ;]I>2KOOUV*NY+DH;Z9%,9:
MB)6IB+%<)2E.$2GUK4XHDFOB3U">$M2B9Q<8\,8QEW/NYR'BZN9BK&"KBF5.
MX*=&N>FJ5&?F5!FH$LH"S1(B:)D$A2TEQ:*6E!)29FD%<ZG0&^_JTJ3-31IF
M7=XEP5&G1)/,4QRYTMF25REMI6U%=GU)Q*%O&E">I(]3)/(>A$"GE+:;D]KV
M#]Q,"TL67#=Z+:R=:%')^QYS,IAVM%32+F%K?A.J2N7'4MG59EPF2T]2M.JB
M41$X.55%K6>M@&YFRL.MY,*_;)KTFEN/VNT\\Y3Y%,JLQ<3E@O*<ZPF$;9K+
MFE&?WFJEH4:3*M</HO!0         *>;_?- S9VL@^ZD,$QK7#!
M
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MO[-RU68FY35%.&,1$Q.F8CNS"PP]B\4
M
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MF:G18%(         IYO]\T#-G:R#[J0P3&M<,$
M                                                  *I;2OB=<W;
MDO8[0\![O?5;OC_!#HGO'];M>)_-*UH]^YV
M       J+4_.UMWM>OW+DCG=[]46_%_XZG2K'Z4N>-']2E;H=$<U
M
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M[J0P3&M<,$
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M]^J+?B_\=3I5C]*7/&C^I2MT.B.:@
M
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MJ1\UI]\6FNH)C"'4,%(
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M_P =3I5C]*7/&C^I2MT.B.:@
M
M
M
M                        "J6TKXG7-VY+V.T/ >[WU6[X_P $.B>\?UNU
MXG\TK6CW[G8  -9O*SK<R!:]:LV[::BKV[<$946J4]PU))QM6A\BD&2DF1D1
MD9'J1EJ*Z*ZJ*HJIG"84U4Q5$Q.J5.86T[+]"MUS'EK[L+DI&,G$+CLT%VBP
M)-0CQ%\AQF:FM1/I29&9:I-.G2+HZYTYVW5/*JM1-6_C.'8U,6,M7$81<G#K
M8]G#%:/$V*;0PQ9%+L.RH:HM(IW$X\^ZHUORI+A%SLE]9_?+<,BUZ1<A%R$0
MP[UZJ]7-56N61;MTVZ8IIU0U+$^#XN++WS1>D>XG:R[F.O-UR33W(R64P%-F
M^?-(63BS<(^?Z)DGH= 5WLQ-RBBG#O8P1;M11555'RIQ[6#T8& HCF=JEG:[
M;G?NVKQX)4VP* ]&2Q$MYA2>%XV.%Q?.N.%KJM1%IQ*^QI,YF?->:B,(QQGJ
M_P#HCS,><Y<SC.&$=3?[+$9?PG;]2ORU=P$6\GL;7+C1AQVXZ\Q&*4S4:(P1
MNOQ)C7&C5)))75EJHBZ!<B=*K.8JBB;6&,5=J=^"NS$UQ7JF.YO2>65MD\;E
M*_$3.QQ/H%_P>XCTFUX4/4N)_"6\BQ[ALVUKX*K.6W*@5)FO4E+S<FCU'5U4
M"4CGD-DH]6G.3H&1&1Z<AA3%W*5Q5,:\=>[&["*N1?IFF)[&Y.Y+U[-VX7,W
MD:WLFYDR[-S#7;(BO1+#B/4J)2(E.5(T)V4IF(?"Z^HB(N)1<GV=$\*YFJ>1
M-%NGDQ.O3,X]G<*+$Q5%554S,:MSN;K'7/MCNMB\[TNW#6:JEB!K):C>ORAL
MTN-56),Q9*2[-C*E+(X[RDF1:MZ<O*1D)HS=/)BFY1%7)U:<-&]HUPBK+SRI
MFBJ:<=>J=._IW4[8DQ=;F&["HE@6NEU=/I*7'),Z0HU/S);ZS=D2GE&9ZK=<
M4:C+H%R)+D(ACW[U5VN:JM<KMJW%NGDPP-J8>C6MF3*V7VZZY-DY1C4:,_0E
M1R0B&5(B(BI4EXEJ-SG"1Q'JE.G0Y157?FJW31AWN/;*;44UU5;^':3.+"X
M           J+4_.UMWM>OW+DCG=[]46_%_XZG2K'Z4N>-']2E;H=$<U
M
M
M
M                                                         %4M
MI7Q.N;MR7L=H> ]WOJMWQ_@AT3WC^MVO$_FE:T>_<[         'X<;;=0MI
MU"7&G$FEQM9$I*B/D,C(^0R,!B?@Y;WZ!IWK5KTHG&1[D2G4^G\YUA CPN>T
MYWK=I#?%PZZ<7"1:Z:GH(Q'N@                 "HM3\[6W>UZ_<N2.=W
MOU1;\7_CJ=*L?I2YXT?U*5NAT1S4
M
M
M
M                             52VE?$ZYNW)>QVAX#W>^JW?'^"'1/>/
MZW:\3^:5K1[]SL                               !46I^=K;O:]?N7)
M'.[WZHM^+_QU.E6/TI<\:/ZE*W0Z(YJ
M
M
M
M                                *I;2OB=<W;DO8[0\![O?5;OC_!#H
MGO'];M>)_-*UH]^YV                                J+4_.UMWM>O
MW+DCG=[]46_%_P".ITJQ^E+GC1_4I6Z'1'-0
M
M
M
M                                    !5+:5\3KF[<E[':'@/=[ZK=\
M?X(=$]X_K=KQ/YI3]?%_69C6WY-TWY<D&UJ!$-*7JG/=)M'&L]$H27*I:C/H
M)21F8Z%;MU7)PIC&7/*:9JG"$68YW38%RO7DVO8^1(%3N)Y"W(E&>0]$D2$(
M+52F$R&V^<T+ET3J>G+IH+UW)W;48U4S$*ZK55,8S"P0QEL   !C:Q6*5;U*
MJ%<KM1CTBCTIA<FI5.6XEEAAELN);CCBS(DD1=$S$TTS5.$:TQ&*LM'WM[8J
M[7V+=@Y3@)ERWBCPILEB3'A/.J/1*42GFD-<I\A&:M!EU9"_33RIIE<FQ7$8
MX+5D9*(E),C(RU(RZ!D,-:?T                    !46I^=K;O:]?N7)'
M.[WZHM^+_P =3I5C]*7/&C^I2MT.B.:@                           (
MV<J5ZU2N5^%0Y%)BPJ,^TPDIC;JG%&MI+AGJ@].B9](<VN;2Z09_:.;L9&O+
MT6[%5-/_ ,E-<U3RJ(JQQIG#=ZCT-.7R%C+VJ[\7)JKB9^+,8:)F-U['6V3O
MTE;_ .)D?=%_T;IASV4\FXH\YLGP+O9I.MLG?I*W_P 3(^Z'HW3#GLIY-P\Y
MLGP+O9I.MLG?I*W_ ,3(^Z'HW3#GLIY-P\YLGP+O9I.MLG?I*W_Q,C[H>C=,
M.>RGDW#SFR? N]FDZVR=^DK?_$R/NAZ-TPY[*>3</.;)\"[V:3K;)WZ2M_\
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MJ+-J]8Y417RM%4Q\F8C<X6[CW#3
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M\%*8R&^
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M[ER1SN]^J+?B_P#'4Z58_2ESQH_J4K=#HCFH
M   #1K7^,5^=L(_L9 \-T7_NNU/OJ/Z5+=;2]5RWB5?2EO(]RTH
M                T:A_'>^_^YI/J+P\-L/]1;4\7+?0K;K.^H9;AN=VEO(]
MRTH
M                     (GSM^YG)WR<G^HJ&/F_L:N"7G^E?]IS/W=7<;K9
MWQ1M7M/!]CH%VWWD<$-GLWU6UXE/<AL8K9H
M@3;'^Y2U/_&5SW9G##R'V,=?NR\ET&_L]KAN?U:T]C,>M
M           !RVW$QMZ2]S%I^"UVNHQJX^^=#1$?I!<2"IT;VV)M3S*X[230
M1IC^V9&?/\XIKD-)@JC# W$QMZ2]S%I^"UVNHQJX^^=#1$?I!<2"IT;VV)M3
MS*X[2301IC^V9&?/\XIKD-)@1A@;B8N])6Y>TU8ND5U.-7I$@Z&S$?I!:H*F
MQBJQ-J>85&:2I!&4?VSXE=<<XIKJ308$88/>S]%WJJW(4=6*Y%63C1XGCH[+
M3]()9M%%@%5BBJ>85':XB+2/[9<2N=YY374F@P(PP=.P4@
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MJ_<NQC353RO!G<ZD[O7PZRS&2,F9?N[-UOX"Q)6J;CJHQK41=V1+QGP6ZR[
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MMY'N6E
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MW>'=[:<ACKH J+4_.UMWM>OW+DCG=[]46_%_XZG2K'Z4N>-']2E;H=$<U
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M_<TGU%X>&V'^HMJ>+EOH5MUG?4,MPW.[2WD>Y:4
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M6W>UZ_<N2.=WOU1;\7_CJ=*L?I2YXT?U*5NAT1S4
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MD^HO#PVP_P!1;4\7+?0K;K.^H9;AN=VEO(]RTH
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M8;0S'K&\
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M\[6W>UZ_<N2.=WOU1;\7_CJ=*L?I2YXT?U*5NAT1S4
M         !HUK_&*_.V$?V,@>&Z+_P!UVI]]1_2I;K:7JN6\2KZ4MY'N6E
M!R!J6"=R6S;,%XY(VPVHSE3#E_NJE7#BOGR1)A+U-Q*$-&I"U<TMQ9,.,DXH
MFS-#B#T)1E6,2D";N WZ9>:^#&,=K?@-ES3YF=?]YU I+<!M71?99DQ(9*4G
M4N@P_P!/J#Z0PATMH\>H1*12XM6FE4JK&AL-5.HI0392)"&TI==)"="3QJ(U
M:%T-04N=FSS$F2+"W)[S+NO"T9U MN_;MDSK.J\HD$U4([E8JDA+C/"HS,C;
M>0KE+^<0*IG0L-NZN'+U%PO7J=@VT:I=60[M45$ITBE\).4IB2A?7%0-2EHX
M5(;2:6S(]2<4A7028(A_=J.WBD[>\'T+'<F+&F5^J-*J.1)6B76YE3F-I*0V
M9F6BVFD$3"-2T-"=3+52M1,XJO[:\2Y9VN;F<D8THUHU.M[9LDO+K5KW*R9+
MBT29S2G6D.D:S4G1*51'#TXE\+#AF1:D"9G&& O_ !?GO;#N>O'<1@W'CN8<
M=9;:4>0; @/DS/8FNJ2ZZXA))6LS4^E3K;B&W-.-QM:4ZI68UPPU]VON2WX7
M58=J7YANH;?L V;6&ZU=R*W+XZI5GFTFV3;+:FF5\7-J<;1HUP(XU+6M1\"
M-2R>^';1<.>,;VN_C)YBEY,Q14RK%A-&M$5MU))03L-IU6B&5F;32VU*,D$I
MM*5&E)\22(E"LS<[O?N&SE6)1]GE<H.5:C#.ENW^_+)FBQI2T<VNH,I>90RG
M0SXT)5)-"3Y34LBX3)PA:'9SMU5MIPW"LVJ3&:I>5;FNUV^*G',U,KJ$A"&^
M996I*5J;9::0@C5]\KB7HGCT(B9Q5(W.90W29>QYE#"M/V7W% @5]TZ;!O9N
MO,RT*9ASFWFY*8J8+9*)U+!:$3VA<7WRM.4F,$C;3LG;B*#3,0X.O/:=7;2M
MFW:.U1*KE*76FE,LII\)9HD+@]9ITYU;:4<)/F9<7(:M-#$NC@*0  :-0_CO
M??\ W-)]1>'AMA_J+:GBY;Z%;=9WU#+<-SNTMY'N6E
M              8*X;8MV[:<ND7-18=>I;CC#KD&:REYHUQI#4IE7"HCY4/,
M-N%Z"DI/HD0#\UZU;:NBF+HMQ4*#6J2XZR\NG2V$.LFY'D-2VE<*BTU0^RVX
M7^DE)]$@"O6K;5T4Q=%N*A0:U27'67ETZ6PAUDW(\AJ6TKA46FJ'V6W"_P!)
M*3Z) /[7K6MNZ*4Y0[BH<*M4=UUA]RFRV4.LFY&D-RV5FA1::H?90X7^DDCZ
M) ,VAM#220VA+:",S)*2(BU,]3Y"]$S ?L
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M2U$GC69&9)3KT3T(ST( =?88-HGGD,F^LFF"6HD\:S(S)*=>B>A&>A /*
M                            "NF0_.+VX=K+Y]B4X$K%@@         5
M2VE?$ZYNW)>QVAX#W>^JW?'^"'1/>/ZW:\3^:5K1[]SL  &A94_=GD#Y/5+V
M,X,C*_;4<,=U1<[V>!P7^KB\Y^WNT=8]C#W'2'U2>&&FR'VO6?1*.?MX
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MWTJLW_K>A>\0&)Y,U>^E5F_];T+WB Q/)FKWTJLW_K>A>\0&)Y,U>^E5F_\
M6]"]X@,3R9J]]*K-_P"MZ%[Q 8GDS5[Z56;_ -;T+WB Q/)FKWTJLW_K>A>\
M0&)Y,U>^E5F_];T+WB Q/)FKWTJLW_K>A>\0&)Y,U>^E5F_];T+WB Q/)FKW
MTJLW_K>A>\0&*%]Q.++YQ'A')&2K;W09AFUVSZ0NH4R)4JI1G(CCJ5H21/(9
MH[*S3HK^:M)_9!,.AX*0          1/G;]S.3ODY/\ 45#'S?V-7!+S_2O^
MTYG[NKN-UL[XHVKVG@^QT"[;[R."&SV;ZK:\2GN0V,5LT
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M.-,E^8GGFFDH<TDR?PSQ<1'U;G5J^^5U1F"EF0
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MD_O!403*Q8(
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M8[F+,#<,0   !73:A^XFU>V=R?W@J()E8L$
M                                  JQO<\T_.GR:=]5;!,:UIP0
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MK]RY(YW>_5%OQ?\ CJ=*L?I2YXT?U*5NAT1S4
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MY-JW;*E2F9M!*#.@JCMM.:-)64Y#9NJ-&AJ=:+F5GRM\G(1$IW!
M                     JQO<\T_.GR:=]5;!,:UIP0
M                       A#<UYMVX/YM;L]QY0)C6W?&7[ML??)JD^PV@0
MW@                                                   %6-U_YA
MPG\]^.?=U@$PM."     !73(?G%[<.UE\^Q*<"5BP0         *I;2OB=<W
M;DO8[0\![O?5;OC_  0Z)[Q_6[7B?S2M:/?N=@  T+*G[L\@?)ZI>QG!D97[
M:CACNJ+G>SP."_U<7G/V]VCK'L8>XZ0^J3PPTV0^UZSZ)1S]O
M  !&64,/8\S)1XE$R#0$UB/37^NJ3+;>>BRX;YEPFY'DQUMNMF9<AZ*T/ID8
MNV;]=J<:9P6[EJFY&%4?QPL%BO;YBS#<BHU&RZ"\FO5A"6ZK<U4F2*E47VT&
M9I0<B4XXI*>7[U'"1],CT%5[,W+N$53HC<T1'8A%NS1;[V-?5F9[,Z4U"PN@
M       *BU/SM;=[7K]RY(YW>_5%OQ?^.ITJQ^E+GC1_4I6Z'1'-0
M
M                   >M,AQ*A%D09\5F="EH4U*AR$)=:=0HM%)6A9&E1&7
M1(R ?R3 @S8;U.F0V)=/D-&R_!>;2XRMHRT-"FU$:329<FAEH 28$&;#>ITR
M&Q+I\AHV7X+S:7&5M&6AH4VHC2:3+DT,M "3 @S8;U.F0V)=/D-&R_!>;2XR
MMHRT-"FU$:329<FAEH ]A*4H2E"$DA"")*$)+0B(N0B(B ?H
M                  58WN>:?G3Y-.^JM@F-:TX(
M                    0AN:\V[<'\VMV>X\H$QK;OC+]VV/ODU2?8;0(;P
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M5%SO9X'!?ZN+SG[>[1UCV,/<=(?5)X8[K39#[7K/HE'/V\
M           %1:GYVMN]KU^Y<D<[O?JBWXO_ !U.E6/TI<\:/ZE*W0Z(YJ
M
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MUK,U*,SZ)F8$ZU@P0    JQO<\T_.GR:=]5;!,:UIP0
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MH9,Z:=#EZ Q,S11<LS7A$3$[C,R%VY:S,6IJFJFJ)G3N8+]#4O2
M               *BU/SM;=[7K]RY(YW>_5%OQ?^.ITJQ^E+GC1_4I6Z'1'-
M0
M   5TVH?N)M7MG<G]X*B"96+!
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MUMWM>OW+DCG=[]46_%_XZG2K'Z4N>-']2E;H=$<U
M                                          !73:A^XFU>V=R?W@J(
M)E8L$                                                   P=S_
M !;N'M9+]16 A#:)YKV!/D/1_8J 3.M8L$    *L;W/-/SI\FG?56P3&M:<$
M                                        (0W->;=N#^;6[/<>4"8U
MMWQE^[;'WR:I/L-H$-X
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MP          5%J?G:V[VO7[ER1SN]^J+?B_\=3I5C]*7/&C^I2MT.B.:@
M                                                           U
M.R+,HF/K:A6G;C;S5(I[TM^.A]PW7"7-E.S'M5GIKJX\K3T"Y &V
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M<&(J(XV\S(D.R.<29K<<E<+_ #RG$K21)2")6H!
M     P=S_%NX>UDOU%8"$-HGFO8$^0]']BH!,ZUBP0    JQO<\T_.GR:=]5
M;!,:UIP0                                        A#<UYMVX/YM;
ML]QY0)C6W?&7[ML??)JD^PV@0W@
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MK=#HCFH
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MH!,ZUBP0    JQO<\T_.GR:=]5;!,:UIP0
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MFUNSW'E F-:4[8^+=O=K(GJ* 0S@    "K&Z_P#,.$_GOQS[NL F%IP0
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MZHM^+_QU.E6/TI<\:/ZE*W0Z(YJ
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M='[% QD\F7;=]'S&O>G1^Q0,9/)EVW?1\QKWIT?L4#&3R9=MWT?,:]Z='[%
MQE'.SVF4VB6?ERC4:GQJ11Z1F;($*E4J$TB/&BQH]:>;9889;)*&T-H224I2
M1$1$1$6@$K:@@   !@[G^+=P]K)?J*P$(;1/->P)\AZ/[%0"9UK%@@   !5C
M>YYI^=/DT[ZJV"8UK3@@
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M?T"H5.I42VT.L4EZKOIDRFXZWENML&ZEMOB0RE9-HU+BX$IXE*5JHR&^@
M                  "$-S7FW;@_FUNSW'E F-:4[8^+=O=K(GJ* 0S@
M"K&Z_P#,.$_GOQS[NL F%IP0     *Z9#\XO;AVLOGV)3@2L6"         !
M5+:5\3KF[<E[':'@/=[ZK=\?X(=$]X_K=KQ/YI6M'OW.P  :%E/]VF0/D]4O
M8S@R,I]M1PQW5%WO9X'!?ZN+SG[>[1UCV,/<=(?5)X8[K39#[7K/HE'/V\
M                       %1:GYVMN]KU^Y<D<[O?JBWXO_ !U.E6/TI<\:
M/ZE*W0Z(YJ
M            "NFU#]Q-J]L[D_O!403*Q8(
M                   58VH?F'-GSWY&]W7P3*TX(    8.Y_BW</:R7ZBL!
M"&T3S7L"?(>C^Q4 F=:Q8(    58WN>:?G3Y-.^JM@F-:TX(
M                            :7DB\6L=8[OW(+T!559L6W*K<+M+0X32
MI*:9$=EFREPTJ)!K)KA)7">FNNA@*^4G-FXZMTNFUFG;33=I]7BLS8+JK[HZ
M#4S(03C:C2IDC+5*BY#!.#(>%G<U]$K_ )]HOY$#"#PL[FOHE?\ /M%_(@80
M>%G<U]$K_GVB_D0,(/"SN:^B5_S[1?R(&$'A9W-?1*_Y]HOY$#"#PL[FOHE?
M\^T7\B!A!X6=S7T2O^?:+^1 P@\+.YKZ)7_/M%_(@80>%G<U]$K_ )]HOY$#
M"#PL[FOHE?\ /M%_(@80>%G<U]$K_GVB_D0,(/"SN:^B5_S[1?R(&$'A9W-?
M1*_Y]HOY$#"#PL[FOHE?\^T7\B!A!X6=S7T2O^?:+^1 P@\+.YKZ)7_/M%_(
M@80>%G<U]$K_ )]HOY$#"#PL[FOHE?\ /M%_(@80>%G<U]$K_GVB_D0,(/"S
MN:^B5_S[1?R(&$'A9W-?1*_Y]HOY$#"#PL[FOHE?\^T7\B!A!X6=S7T2O^?:
M+^1 P@\+.YKZ)7_/M%_(@80>%G<U]$K_ )]HOY$#"#PL[FOHE?\ /M%_(@80
M>%G<U]$K_GVB_D0,(/"SN:^B5_S[1?R(&$)4PGDU.8\86MDA-#7;7PE1*4NA
MN2$RE1U19;T123>0ALEZFR9ZDDNB")2F     A#<UYMVX/YM;L]QY0)C6E.V
M/BW;W:R)ZB@$,X     JQNO_ ##A/Y[\<^[K )A:<$     "NF0_.+VX=K+Y
M]B4X$K%@@         52VE?$ZYNW)>QVAX#W>^JW?'^"'1/>/ZW:\3^:5K1[
M]SL  %4<_P"?K,ME%5Q-#I56ON_+GILB&JUK>2E<B,W):X>-]Q6I-GPKXBZE
M1^B1"S.=BQ<B8C&J)QP;W9W1Z]GK<W*JHMVO"J^#?<N]NF.\B;8<DPLM7SC2
MY:G;]-ILR*^FFLM*<83*22%/.IXU:I0C4]-4\O3&WVCTIJS5KS<VN3&,:<<=
M76A=R_0RQ%?_ ,6;IJJWIIY,3U\9[CMQCK)%H95MB)=ME51%4I,HS;<Z"76'
MB(E*9?1J? M)*+4O_H&JMW*;D8PU.>R-[)79M78PJCM]6.HWH7&&
M                J+4_.UMWM>OW+DCG=[]46_%_XZG2K'Z4N>-']2E;H=$<
MU
M   !73:A^XFU>V=R?W@J()E8L$               \3#[$IIN1&>1(8=+B:>
M:42T*+T246I& ,/L2FFY$9Y$AATN)IYI1+0HO1)1:D8 P^Q*:;D1GD2&'2XF
MGFE$M"B]$E%J1@##[$IIN1&>1(8=+B:>:42T*+T246I& \H
M          *L;4/S#FSY[\C>[KX)E:<$    ,'<_Q;N'M9+]16 A#:)YKV!/
MD/1_8J 3.M8L$    *L;W/-/SI\FG?56P3&M:<$
M                   (0W->;=N#^;6[/<>4"8UMWQE^[;'WR:I/L-H$-X
M                                   58V4^;+C3_?/NU.!,ZUIP0
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MED^@7\XQ;L_$O81JF&XVCCG-D^=KTUVJHC'=Y,X;O7="!LGA@
M            %1:GYVMN]KU^Y<D<[O?JBWXO_'4Z58_2ESQH_J4K=#HCFH
M
M,#;-L4&S:+&MZV:<BE4:&Y(=C06U+6E"Y3[DEXR4XI2NJ==4KE/I\G( SP
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M?-EQI_OGW:G F=:TX(    0AN:\V[<'\VMV>X\H$QK2G;'Q;M[M9$]10"&<
M    58W7_F'"?SWXY]W6 3"TX(     %=,A^<7MP[67S[$IP)6+!
M  JEM*^)US=N2]CM#P'N]]5N^/\ !#HGO'];M>)_-*UH]^YV (JSI^YC*WR4
MJ_L1P6<Q]G5P2V.R/7+/CT]V%?=LG[AL:=JO_OG!A6.\AZ7;GKMSA3N+S4JN
M5OSU\&_):K^HSA9I^WC@XVZ_^FO^/3W8= QLWA0
M  %1:GYVMN]KU^Y<D<[O?JBWXO\ QU.E6/TI<\:/ZE*W0Z(YJ
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MW#VLE^HK 0AM$\U[ GR'H_L5 )G6L6"    %6-[GFGYT^33OJK8)C6M."
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M^Y<D<[O?JBWXO_'4Z58_2ESQH_J4K=#HCFH
M                                     *Z;4/W$VKVSN3^\%1!,K%@@
M                                   !5C$WG-;M?^ O<5X$SJ6G!
M   JQM0_,.;/GOR-[NO@F5IP0    P=S_%NX>UDOU%8"$-HGFO8$^0]']BH!
M,ZUBP0    JQO<\T_.GR:=]5;!,:UIP0
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MQ;9>';1AV18-,52+>A+6\B*IYQ[5]TBYUWJU&E'.*+B-+9)02C,TI+4$)"
M                 !5C93YLN-/]\^[4X$SK6G!    "$-S7FW;@_FUNSW'E
M F-:4[8^+=O=K(GJ* 0S@    "K&Z_\ ,.$_GOQS[NL F%IP0     *Z9#\X
MO;AVLOGV)3@2L6"         !5+:5\3KF[<E[':'@/=[ZK=\?X(=$]X_K=KQ
M/YI6M'OW.P!%6=/W,96^2E7]B."SF/LZN"6QV1ZY9\>GNPK[MD_<-C3M5_\
M?.#"L=Y#TNW/7;G"G<7FI5<K?GKX-^2U7]1G"S3]O'!QMU_]-?\ 'I[L,U9L
MR-:F_+,]-K[A0964;.M^?8RW^H*6W2V"CRF6#/[Y25-+49%RZ),QZBY'+R5$
MQ\FJ<>NYG:^)FZXGY41,=;1*Q^6\S6CAJGVW-N<I4V3=E;B4&@T2G);=G29,
MI7"1M,+<;-24<G&9'R:EZ)#"R^6JOS,4[D8SO,R]?IM1'*W9PA6_%'GU;J/D
M_:ON;!&=F/4K7#5W98&6]<O<%/<A@]ZKS%VWKMEQ70);+][U#(,>ME%:<2J1
M#@06%D](>;29J0@^=XB4K37@5IKH>EO(1R:+M<ZN3AUYF%_-_&KMTQKY6/6B
M)Q3G<WP'W-TN][ MS)5R6W(L2JR:'>C=O/+ILA,S@<9-B3SK1FZSJE7(GJ5Z
M<BAC4<K+S%4TQ.,8QCI9,\F[$TQ.K1."L>W2_P"P;-V_Y+HN6H=N5JR-OEV5
M&WZ+7RA1W(M8YI//-=;1W$J2N4XITRZDS-7$1GTS&;FK===ZF;>/*KB)UZL>
MKO:&+E[E-%NJ*L,*)F.QU.OAPMVVXX47=UW^4UD6T:=:U4J*%%B3'T.$Q%:H
M=(=(U,RGR80V3DIY#AZFM.J2_E(DV\UF.33YFF9F/E3OSQ0N6;7*J\Y5&G<C
M>CCG=["_(UK+              !46I^=K;O:]?N7)'.[WZHM^+_QU.E6/TI<
M\:/ZE*W0Z(YJ
M              "NFU#]Q-J]L[D_O!403*Q8(
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M@    "K&Z_\ ,.$_GOQS[NL F%IP0     *Z9#\XO;AVLOGV)3@2L6"
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MI^=K;O:]?N7)'.[WZHM^+_QU.E6/TI<\:/ZE*W0Z(YJ
M                                             "NFU#]Q-J]L[D_O
M!403*Q8(          !CZ75J77(+%4HM2BUBF2N+K:HPGD2&'.!1H5P.MFI*
MN%232>A\AD9 %+JU+KD%BJ46I1:Q3)7%UM483R)##G HT*X'6S4E7"I)I/0^
M0R,@"EU:EUR"Q5*+4HM8IDKBZVJ,)Y$AAS@4:%<#K9J2KA4DTGH?(9&0#]T^
MI4ZKQ&Y]*GQJG!>4M+4V(ZAYE2FEJ;<)*VS4DS2M)I/EY#(RZ(#W0
M            58Q-YS6[7_@+W%>!,ZEIP0     *L;4/S#FSY[\C>[KX)E:<
M$    ,'<_P 6[A[62_45@(0VB>:]@3Y#T?V*@$SK6+!    "K&]SS3\Z?)IW
MU5L$QK6G!                                        "$-S7FW;@_F
MUNSW'E F-:4[8^+=O=K(GJ* 0S@                            "K&W_
M />ENX^<J'_=FD F5IP0     *L;*?-EQI_OGW:G F=:TX(    0AN:\V[<'
M\VMV>X\H$QK2G;'Q;M[M9$]10"&<     58W7_F'"?SWXY]W6 3"TX(
M%=,A^<7MP[67S[$IP)6+!          JEM*^)US=N2]CM#P'N]]5N^/\$.B>
M\?UNUXG\TK6CW[G8 BO.9&K#.5221F9VI5]"+_PC@LYC[.K@EL=D>N6?'I[L
M*][8S(\#8TT/7_U69<GV'G!A6.\AZ7;GKMSA^!/ O-2JY6B,]Z^#R+E--JU=
M2B+I%S4XM3%FG[>.#C;K_P"FO^/3W8= QLWA0
M%1:GYVMN]KU^Y<D<[O?JBWXO_'4Z58_2ESQH_J4K=#HCFH
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M>UDOU%8"$-HGFO8$^0]']BH!,ZUBP0    JQO<\T_.GR:=]5;!,:UIP0
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M^Y<D<[O?JBWXO_'4Z58_2ESQH_J4K=#HCFH
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M@$     "K&)O.:W:_P# 7N*\"9U+3@@     58VH?F'-GSWY&]W7P3*TX(
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M%;;;:0AII"6VVTDEMM)$24D7(1$1<A$0R&EF<7[!
M    "HM3\[6W>UZ_<N2.=WOU1;\7_CJ=*L?I2YXT?U*5NAT1S4
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MJN F=:TX(                            58G^>U:?S(7#_>2B@G<6G!
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M&<     58W7_ )APG\]^.?=U@$PM."     !73(?G%[<.UE\^Q*<"5BP0
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MMV]VLB>HH!0S@          JQLC\T_!?R::]5<!,ZUIP0
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MS8U,B-6A EL'@NSM]*"I]Z=O_D #P79V^E!4^].W_P @ >"[.WTH*GWIV_\
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M15;'Q;M[M9$]10"AG          !5C9'YI^"_DTUZJX"9UK3@@
M                 !5B?Y[5I_,A</\ >2B@G<6G!      JQB;SFMVO_ 7N
M*\"9U+3@@     58VH?F'-GSWY&]W7P3*TX(    8.Y_BW</:R7ZBL!"&T3S
M7L"?(>C^Q4 F=:Q8(    58WN>:?G3Y-.^JM@F-:TX(
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M<)_/?CGW=8!,+3@@     5TR'YQ>W#M9?/L2G E8L$
M
M       #4K_:HC]B7JQ<LMZ!;CU!J2*_.CF:7F82HKA2'&S21F2DM\1D9%KJ
M Y38^Q7O(O\ P51,5X_S#CFK;<KJH;M$HN0WZ748M?<ME_CB.,' D16^%?,\
M2"(^B70?Z"P5:'5VQK4A6'95GV/39#TNG691*?0H$J29*>=9IT9N,VMTRZ*E
M);(U'Z(*6T@     #BY];=:UL4''N)9-"MRET63+N2<F7(@0V8RW2ZT)6BU-
M(2:N7EY054NP]L?%NWNUD3U% *6<          & M:UK>LFWJ3:EJ4EBA6Y0
MF"C4BD1B,FF&B,S)"",S/34SZ8#/@                            *L3
M_/:M/YD+A_O)103N+3@@     58Q-YS6[7_@+W%>!,ZEIP0     *L;4/S#F
MSY[\C>[KX)E:<$    ,'<_Q;N'M9+]16 A#:)YKV!/D/1_8J 3.M8L$    *
ML;W/-/SI\FG?56P3&M:<$                 " MTS=EO;><N-9#8JC]F+M
M^05>.BM(?J#+6J>&1&;<4A"EL+X72XU$GJ>J/AU!,*94#:=GK+]HV3;N5MU,
MB^=O$J/2*NS:,>A1(-3JM/:2U+AQYLQHU+Z2#4:GG^4M2U425$3BZE I
M  !Q=^L0\[;9WVSION]&!53J=H@4@        #U9T&#5(,RF5.&Q4:;46'(M
M0I\IM+S#[#R30XTZVLC2M"TF9*29:&7(8#RL,,16&8T9E$:-&0EJ/':22$-H
M07"E*4IT(B(BT(B >4                    !72D>=MD+YHK.]WKG!.XL6
M"     !5C;_^]+=Q\Y4/^[-(!,K3@@     58V4^;+C3_?/NU.!,ZUIP0
M A#<UYMVX/YM;L]QY0)C6E.V/BW;W:R)ZB@$,X     JQNO_ ##A/Y[\<^[K
M )A:<$     "NF0_.+VX=K+Y]B4X$K%@@
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M;:EQYBIA,1$UB.EQ!J5'C\.J^730P5QA@^E@%
M           KI2/.VR%\T5G>[US@G<6+!      JQM__ 'I;N/G*A_W9I )E
M:<$     "K&RGS9<:?[Y]VIP)G6M."    $(;FO-NW!_-K=GN/*!,:TIVQ\6
M[>[61/44 AG     %6-U_P"8<)_/?CGW=8!,+3@@     5TR'YQ>W#M9?/L2
MG E8L$
M                               #'5AZHQJ15)%'AIJ-7CPWW*73UK)M
M+\E#:C::4M1I))+61$9F9: .664;WWV90M"O8DN7:Q8U!\(U,ETB+,GW;1GW
M8_7#2FE3(T?VQ4XMR,2^<0I"5&E1$K0]-#*M#IAC^CURW;#LFW[GJYU^Y:%0
M*;3[AKIZF<V=%BMM29/*1'^%<2I?*73!2VX      <:OK>:I3)^.L0M0:C%F
MN,W+/-UMAY#BDEUH1=423,RY054NO-L?%NWNUD3U% *6<
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M@                                 5TI'G;9"^:*SO=ZYP3N+%@@
M  58V_\ [TMW'SE0_P"[-(!,K3@@     58V4^;+C3_?/NU.!,ZUIP0    A
M#<UYMVX/YM;L]QY0)C6E.V/BW;W:R)ZB@$,X     JQNO_,.$_GOQS[NL F%
MIP0     *Z9#\XO;AVLOGV)3@2L6"
M                                                      !S?WT-
MM7=D[:AAJX[RJ-FXTR36+FD7W)IL]--<=*C0HCD-*Y"]4$DEOJ+19&6ID?WQ
M$8*H<\*CC#&]RXNW8WQ=^3*Q=61<"W3-M/!E=J-Q$J:FCV](04!;"$J23_.$
MHS-2$Z:]4CA5R@EWOQ-6*A<.*\9U^KR#EU6N6I1JA4Y2N0W9$F"RZZLR+_.6
MHS!1*0      !\U6^O9C;&V>C6M>%"O2J7-)OFNS8\N'/CLLH8)+9R-4&T>I
M\JM.4%<3B^CFV/BW;W:R)ZB@%#.         (8SK<M=M6RF:E;U173)RZFPP
MJ2A*%GS:FW5*3HXE1<II+I"S>JFFG&%%<X0C7 -_WC=MS5B#<===JL2/3#?8
M9<;9027">:3Q:MH2?049"W8KJJG3***IF5L1E+@          ,*_;EO2GG)$
MJ@TZ3(>/B=?=BLK6H_14I23,S&/5E+-4XU44S/!#(IS=ZF,*:ZHCAEEFFFF&
MFV&&T,LLH)MEELB2E"4EHE*4ER$1%R$1"_33%,81HB%BJJ:IQG3,L#7[4H%T
M%%*N03FE"XSBZ//-</.</%_1+1KKPET1BYK(V<UAYVG'#5IF-?!,,K*YZ]EL
M?-SACKT1.KAB2@6I0+7*45#@G"*;P'*U>>=XN;XN'^E6O33B/H!E<C9RN/FJ
M<,=>F9U<,R9K/7LSAYR<<-6B(U\$0V(9;$          !5B?Y[5I_,A</]Y*
M*"=Q:<$     "K&)O.:W:_\  7N*\"9U+3@@     58VH?F'-GSWY&]W7P3*
MTX(    8.Y_BW</:R7ZBL!"&T3S7L"?(>C^Q4 F=:Q8(    58WN>:?G3Y-.
M^JM@F-:TX(                 ')[=/1<.Y!WL6)8>XJX:?2<4TO#\FLTQN
ML5OVBAMUJ95Y,;G$R3?CESBFF$F2>+JN;+4E)+0%4:E!:-'PJG:78.26KDHS
M^Z@LDPI\FHKKA.W2EIFJ+::<5$5)4\3:64-K(S;TZ"^CR@G=?2V"@     8*
MZ+>@7=;5Q6I53=32[GIDNDU)3"B0Z4>:RMATVU&2B)7"L]#,CY>D ^?3<7ME
MQSMFW.[7:%CE^L/PKGK](GU(ZQ*;E+)UFM1VD\V;;+)$7#T2,C!7$XP^B@%
M         HAN>2D\@4G4B/\ ]GHW1_\ %RQA9GONLLW-;W-KQ$5XU_0B+_U,
MKH?^(9#+=]);UKQC-7@                   %=*1YVV0OFBL[W>N<$[BQ8
M(     %6-O\ ^]+=Q\Y4/^[-(!,K3@@     58V4^;+C3_?/NU.!,ZUIP0
M  A#<UYMVX/YM;L]QY0)C6E.V/BW;W:R)ZB@$,X     JQNO_,.$_GOQS[NL
M F%IP0     *Z9#\XO;AVLOGV)3@2L6"
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M?-//QFDMJ4C4E<)F72U(C$11$:H(B(;(*D@
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M     "K&W_\ >ENX^<J'_=FD F5IP0     *L;*?-EQI_OGW:G F=:TX(
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MIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\
M956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7
M/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%V
MIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\
M956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7
M/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%V
MIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\
M956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7
M/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%V
MIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\
M956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7
M/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%V
MIXC]PMA_B/F7/J'E:[?>[_\ 956[##\QL>%VIXC]PMA_B/F7/J-HL[<#B"_J
M]&MFT[P15*Y,0ZY%@*A3HQN)90;CG"N3':09DE)JTUUT(_0%RUG+5RKDTU8S
MUV=LWI?LK:-^+&7O<JN<<(Y-=..$8SWU,1J3*,EZ4
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MBL!"&T3S7L"?(>C^Q4 F=:Q8(    58WN>:?G3Y-.^JM@F-:TX(
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M     58W7_F'"?SWXY]W6 3"TX(     %=,A^<7MP[67S[$IP)6+!
M   YS;-,<V'>=B71.NNT:5<,R+7C8C2I\9M]:&NM65<"5+(S(M5&>@T>S+%N
MY35-48Z7'?=IL?)9W(7*\Q9HKJBY,1-5,53AR:=&F%P? 3AKQ8VY^KV?2C9>
MA6?!AT7V7V5^%M>13Q'@)PUXL;<_5[/I0]"L^#![+[*_"VO(IXCP$X:\6-N?
MJ]GTH>A6?!@]E]E?A;7D4\1X"<->+&W/U>SZ4/0K/@P>R^ROPMKR*>(\!.&O
M%C;GZO9]*'H5GP8/9?97X6UY%/$> G#7BQMS]7L^E#T*SX,'LOLK\+:\BGB/
M 3AKQ8VY^KV?2AZ%9\&#V7V5^%M>13Q'@)PUXL;<_5[/I0]"L^#![+[*_"VO
M(IXCP$X:\6-N?J]GTH>A6?!@]E]E?A;7D4\1X"<->+&W/U>SZ4/0K/@P>R^R
MOPMKR*>(\!.&O%C;GZO9]*'H5GP8/9?97X6UY%/$> G#7BQMS]7L^E#T*SX,
M'LOLK\+:\BGB/ 3AKQ8VY^KV?2AZ%9\&#V7V5^%M>13Q'@)PUXL;<_5[/I0]
M"L^#![+[*_"VO(IXCP$X:\6-N?J]GTH>A6?!@]E]E?A;7D4\1X"<->+&W/U>
MSZ4/0K/@P>R^ROPMKR*>(\!.&O%C;GZO9]*'H5GP8/9?97X6UY%/$> G#7BQ
MMS]7L^E#T*SX,'LOLK\+:\BGB/ 3AKQ8VY^KV?2AZ%9\&#V7V5^%M>13Q'@)
MPUXL;<_5[/I0]"L^#![+[*_"VO(IXCP$X:\6-N?J]GTH>A6?!@]E]E?A;7D4
M\1X"<->+&W/U>SZ4/0K/@P>R^ROPMKR*>(\!.&O%C;GZO9]*'H5GP8/9?97X
M6UY%/$> G#7BQMS]7L^E#T*SX,'LOLK\+:\BGB/ 3AKQ8VY^KV?2AZ%9\&#V
M7V5^%M>13Q*C-VU;]I[W[*I%LT:)0J6BE2'40(3266B6NCSC4KA21%J?3&MI
MMTT9V(IC"/\ 2Y]7DK&3Z89>W8HIHI\W,X4Q$1CR+FG"'1$;QUX
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M9ZNH=!Z-^I4\-7=>"Z1^N5<%/<2V-\T8   "K$_SVK3^9"X?[R44$[BTX(
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M=\_&S>T[ON/.&FGUZ/X^2Y7GOUGE_NY^A<7U&Y=4
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M:22&T)+I$E)$1$"'(/ZX3]VV'?E+/]AD"JEUJMCXMV]VLB>HH!2S@
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MZXT*K4MJ9(H\Z/.0TM5=C*)+BHZUDDS+E(C!7&IW&!0
M #5*U8]JW#,*?6:.W.F$VEHGUK<2? DS,BT0M)<FIC'NY6U=G&J,98M[)V;U
M7*KIQEY*'9MLVW(>E42DMT^0^WS3KB%N*-2-25IU:E%T2(3:RUNU.-,8)LY2
MU9G&BG"6SB^R0                  58V__ +TMW'SE0_[LT@$RM."
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MAII]>C^/DN5Y[]9Y?[N?H7%]1N75
M       :K?3CK-D7B\Q5ET%]JAU!;-=:2:UPEIC.&F2E*2,S-H^K(B+I /G8
MQ=6/JVE6/1/"_1[XJV2R0LKQK*'JBMB9-XC-V3'..^U^"<,^)'&A+FGWY<7*
M"O2^A_'2K=7CZQ5V>VZU:2K>IAVNT_Q&ZFG'$:ZT)SC,U<1-<.NIF>O1!0W(
M      ?,WO@V>U/;A2;:NV=EV5D1N]JY-CM4I^F+@IA&ELW^)+BJA,)?(?#]
MZG_Z 7(G%])%L?%NWNUD3U% +;.
M        *L3_ #VK3^9"X?[R44$[BTX(     %6,3><UNU_X"]Q7@3.I:<$
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MK_P%[BO F=2TX(     %6-J'YAS9\]^1O=U\$RM."    &#N?XMW#VLE^HK
M0AM$\U[ GR'H_L5 )G6L6"    %6-[GFGYT^33OJK8)C6M."
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M_-K=GN/*!,:TIVQ\6[>[61/44 AG     %6-U_YAPG\]^.?=U@$PM."
M!73(?G%[<.UE\^Q*<"5BP0         *-;#OW=7A\HS]B1QJ-D=Y5PN7>ZC^
MW7?O9^C2O*-NZB          ""<CX!M_)E?1<-4O:^;?D-Q6XA0;=KS]-B&E
MLU*)9LMD9<9\7*KI\@R+68FW&')IGAC%;KM15.N>M.#1&MH5G-.-NEE'*JC;
M42B2J[99D9D>NAEP] 7)SLS\FGL*(L1&[/9E;$8:^                 *%
M5WS\;-[3N^X\X::?7H_CY+E>>_6>7^[GZ%Q?4;EU0
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MK45+BBKL8B4HFDI(S(NF8*XU.W0*
M         !5C;_\ O2W<?.5#_NS2 3*TX(     %6-E/FRXT_P!\^[4X$SK6
MG!    "$-S7FW;@_FUNSW'E F-:4[8^+=O=K(GJ* 0S@    "K&Z_P#,.$_G
MOQS[NL F%IP0     *Z9#\XO;AVLOGV)3@2L6"         !1K8=^[J\/E&?
ML2.-1LCO*N%R[W4?VZ[][/T:5Y1MW40
M  %"J[Y^-F]IW?<><--/KT?Q\ERO/?K/+_=S]"XOJ-RZH
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M9FF/';2V@C4>IF24D1<IB_;MTVXY-,1$;T:%FNY5<G&J9F>KI>R*U
M     "K&)O.:W:_\!>XKP)G4M."     !5C:A^8<V?/?D;W=?!,K3@@
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M6@W! J\EAOG7F(CZ'5)1J2>(R29Z%J9$$5Q.J2)B6R"I(
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M*KOGXV;VG=]QYPTT^O1_'R7*\]^L\O\ =S]"XOJ-RZH
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M7S[1<24NK41'H9EJ0M9>J9F<94T3.*XXRUT
M          !5C$WG-;M?^ O<5X$SJ6G!      JQM0_,.;/GOR-[NO@F5IP0
M            JQO<\T_.GR:=]5;!,:UIP0                 *,[OKFW38
M[@5G)N)KUQ_;.*;.ME,RYH=S1Y;]4=J3<A_C**EF&^V:76UL-MDIQ/5ZZ\)=
M4"8P5SNW(WUAN,;"M_+61[SQA2[ E2Z.5SJBPW)$VDQ*M)9C(?DM$PEM24*?
M02^8<<46NI$9$8)T.N0*0    !^''$-(6ZZM+;;:34XXHR)*4D6IF9GR$1$
MXJ?6"5&GU'=IL^73YT><ANJ4Q+BX[J'229UZ,>AF@ST!5&IVN!2
M*);G?W@4KY/1O9<L869[[K+-S6]O:_\ '&O]IE>R&1.6[Z2WK7B&8O
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MYM;L]QY0)C6E.V/BW;W:R)ZB@$,X     JQNO_,.$_GOQS[NL F%IP0
M*Z9#\XO;AVLOGV)3@2L6"         !1K8=^[J\/E&?L2.-1LCO*N%R[W4?V
MZ[][/T:5Y1MW47Y6M#9<3BTH3_G*/0O^D!_2,C(C(]2/E(R ?T    !_%*2E
M)J4HDI26JE&>A$0#\MN-NI);3B7$'T%),C+[9 /V
M H57?/QLWM.[[CSAII]>C^/DN5Y[]9Y?[N?H7%]1N75
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M+J#Z"T&2BY/LD)B8G3")B8T2_8E                    "K&)O.:W:_P#
M7N*\"9U+3@@     58VH?F'-GSWY&]W7P3*TX(    17EC)G@OHU-J_M)[>>
MV$WK/K?KGK;@_!K<XN+FG=?O=--!YKI/TA_);%%WS?+Y57)PY7)W)G'55O/2
M=&>CWYU?KM><Y')IY6/)Y6[$8:Z=]AL29C\*<FN1_@Y[1>TS;#G'UYUUSG/&
MLM-.89X=.#[(Q.B_2O\ .ZKE/FN1R(B>^Y6../\ [:<-3+Z3]%/R2FW5YWE\
MN9^3R<,,/_=5CK3:/8/(    *L;W/-/SI\FG?56P3&M:<$
M   ",<TM8^?Q+D5K*ZTMXX70)Q7DZHUDI,'FE<XIOFR-?.%T6^ N+CX>'JM
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MVV:W[?NNH76S==QT:H2)%09:94TIFLQVB2DFN0R,N7E!7$XP^DP%
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M-7\G4^QH3%612#L^^[:O%QQQDWN?10)[<U48B):.$W21PDKEX>CH8)A+((
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M>I-Z]#ICT>0S4YJQ3=F,,<='!,Q\#T>0S4YFQ3<F,,<='!,Q\#=1F,P
M     $'[@ZW5[?QV]4*)4I-)G%4(K92XKBFG"0HU<2>))D>AZ#5[8NUV['*I
MF8G&-31](;]=G*\JBJ8G&-,:%+[5R9D.5=%MQI-ZUE^/(JD-I]A<QU25H6^A
M*DJ(U:&1D>ACS.7SU^J[3$UU88QN]5XK*[3S55VB)N58<J-V=]U 'NG40
M !5C93YLN-/]\^[4X$SK6G!    "'MP],J5;P!G.C4:GR:O6*OCZYH5*I4)I
M<B3*DR*5);9889;)2W%N+424I21F9F1$6H)A)-NM.L6_0F7FU,O,T^*AUI9&
ME25):21I41\I&1]$@0S             "NF0_.+VX=K+Y]B4X$K%@@
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M-H.8,97GC*I5)^CP;RIZJ?)J<9"7'64J4E7$A*^I,^IZ8$))
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M<346^B^6MUQ5%5>,3$ZZ=S_*L>-T](     *L;*?-EQI_OGW:G F=:TX(
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MLE0JN^?C9O:=WW'G#33Z]'\?)<KSWZSR_P!W/T+B^HW+J@
M                        **;Q<E8GQ=<N&;CRAD>^;(X6;I9H=(M(E+B5
M3GXL.,^JHMI^^.+S[:V/04:C!,.7OA VG_3%W*>N7?N JTN_.-WJ?(QW84BD
M5*=6J4_;E*<IE8J9ZSI<=41HVGY1GT77$&2E_P"D9@H;H      /F;WP;D<P
MYKI-M6]D?"\K&5)M>N37J)6'XM083.6;9LFE*IC2$*Z@N+J3/[0+D0^DBV/B
MW;W:R)ZB@%MG
M                        >E/J5.I3'7-4J$:FQC42"D2G4,HXCZ!<2S(M
M3%F_F+5BGE7*HIC?F8B.VO6<O<OU<FW3-4[T1,SVGG8D,2F6Y$5]N3'>3Q,O
MM*):%I/II4DS(R_D%RBNFNF*J9B8G=C3"W71515--43$QN3HEYA4I
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M<]EO2;%=K'#E1,8Z\,>IH4R\B/\ ]YO[%_MX\Q[+?_E^;_J>']@__P _S/\
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M0JN^?C9O:=WW'G#33Z]'\?)<KSWZSR_W<_0N+ZC<NJ
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M3YT><ANJ4Q+BX[J'229UZ,>AF@ST!5&IVN!2
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MON/.&FGUZ/X^2Y7GOUGE_NY^A<7U&Y=4
M          !A+EK$:WK<N"OS(KLV'0Z;+J$J$PCG'7FXS*G5MMH/[Y2B29$7
M3,!Q4^ V;,_XXL6;0-C6+G,2M/3+@QE3)%Q2(4F,S6'CDO*-R%58*^!]9DHV
MU(2CD27-D24D17J=HK,8GQ;/M2+5:/"MZJ1J/!:J5 II)*'!D(CH2[%C$DU)
MYII1&A&AF7"1 H;(      /F;WP8'W#XFI-M5S,F;I64:!<-<FM6U1GZQ5JD
MF X39NFM+=1(FV_P9DG5'\G0!<B7TD6Q\6[>[61/44 MLX
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M;KN.C5"1(J#+3*FE,UF.T24DUR&1ER\H*XG&'TF H
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M\?)<KSWZSR_W<_0N+ZC<NJ
M UN\9-0AVA=4ND2HL"JQ:/.>IDZ=P]:LR$1UJ:<?XN3FTK(C5KR::@.$F#8F
M!BQO09%?^L"R'B^Z)B7'KHLFWJX]1J= GK<4I]F,PPVME;9+4?"XTHT++JDZ
M$>A%<\#NQ9)0BLRT2IM>DW53BHL#K"YYCIOR:DQUNWS<QYTR(UK?3HXI1]$S
MU!0V<      <(?K0\ZXBRM9>-J)CJ_:7=M5M^XISM:@P%K4N.@XW-D:R4E/\
M\M 5TP[A6Q\6[>[61/44 H9P
M           $=99HU3N#']>I%'B*G5*6<0X\5!I2:^;ELN*T-9I+D2DSY3&B
MZ2Y6[FMGW+5JGE53R<(X*J9G7U(;OHYFK66S]NY=GDTQRL9X:9C<ZLJ9JP]D
MLTJ(K2DZF1E_31ORHY5/1?:?,SV:>-U".DVS>>CL5<3HB.Y.*
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MOU6IP;/*HVQ?C=VFF%UWUV]4%K3/U3Q<:HLE+!D3G30DBTZ1 JTOH?!0
M ,%=%PP+1MJXKKJI.JI=L4R75JDEA)+=./"96^Z3:3-)&KA0>A&9<O3 ?/IN
M+W-8YW,[G=KM=QRQ6&(5L5^D0*D58BMQ5FZ]6H[J>;)MYXC+AZ)F9 KB,(?1
M0"@                                       !BJS0J/<4(Z;7*;'JL
M!2TN'$DH)Q'&C[U6A],A;N6J+D<FN(F.JLW[%N_3R;D1,;TM7CXMQU$D,2HU
MF4EB3&<2['>1&02D+09*2HCTZ)&6HL4Y&Q3.,41CP,6G9.4IF)BW3C'4;Z,M
ML    %&M['YOQY_XBI?]B,-)MK51U_@>5Z3ZK?7^!7?;-^_&Q?\ ZU3]RY8U
M^S?6*>OW):;8GKEOK_1EUM'JW0P           'S:[COW]Y@^5M5]DK&@O\
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M$FI3&UFVIEHC;(R,E),NK(B%Z;%R)F)B<:=?441=IF(F)C"=752N+*L
M    4*KOGXV;VG=]QYPTT^O1_'R7*\]^L\O]W/T+B^HW+J@
M                         -3OXW"L6]#9=98>*@U$VGI,;KQE"NM7-%.1
MO_MDD?*IO^<74],!QHPON,V;-X_MVGYFVU4I[(T".XU=%=B8QHQP9KZ75<#L
M=,6,WPI4V:>0V4:&1EITS*YB7:&T)M$J5IVO4;:A)IMN3Z1"D4"G)CE%3'A.
ML(7':*.DB)HD-FE/ 1=3IIT@4-B      'SZ?61;7,-8&M6PKFQI;TJCU>[;
M@G,UR0_4)4Q+J"8YXB2B0XM*>K,SZDB!73.+O?;'Q;M[M9$]10"AG
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MUVGO/OOO*)#;33:'S4M:U&1)21:F?(0&"20       0%>V#*O>-SU.XXN?\
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MG=]QYPTT^O1_'R7*\]^L\O\ =S]"XOJ-RZH
M             #7[MK3MM6K<UQL05U-^@4J;4F::WR+D+BL+>2TGH\JS3PE_
M* X\PF<]5K;]+WK'O.J,"YH].E7(G'37"5HMJC*<4F@'!5(YHWUZ$RGB:-7&
M9)ZH_P (95U'7+&]T2[WQW85Z3Z<='G7?;E*K<VD*UUBNU"(U)6P?%R_@U.&
MGE] %+=      !\S>^#>%4]Q])MJTIV(I6.V[)KDV0U57ZFN<F::FS8X4MJI
M\,D<A<7WRO\ Z07(C!])%L?%NWNUD3U% +;.
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MW*;:9>Y*QH]C5N#<E&:MJ)'AJAD_$56(ZG%FE4B1Q:+Y-=2!7&&#Z6 4
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M^O1_'R7*\]^L\O\ =S]"XOJ-RZH
M     "N>?\SW[B(K439&!+ES@5QE/*JE;RU)*F%$ZWYKG](TC7KCGE\/0_HU
M='I$Q#B?D*Y-NMC9(A7%D385=EI5ZX))U&!8U0N1Z) E.J<Y5MTPXA&;:G#_
M *-/X(SZDD</4@J?0W:-5=KUJ6Q7'J.];KU9I,*<[;\A)I>@JD,(=.*XDTH,
ME-&K@,N$N4N@70!0@C/N8;RLROXOQ7BBD4JL98S!.G,T%VO*>]JJ73J5'ZXJ
M%1FIC*2ZLFTJ22$)-/&HST5JGA43$-=QSEG+=NYD8P1GUFV9M9NBA2+AQI?=
MJM2HD2IMP7"3.@2(DIQY3<AE*R<(T*X3;_T@,%DKWN^CX_LVZKYN!Q35#L^D
MS*S5E-Z&X;$)E3[B6R4:2-:B1HDM>4]"!"AS^==VU"Q=3MS%Q6I8;V*I$.-<
M-9Q3!14"N2%;<LT.)E(J+CI,.26V%DZM"F4IX=2T)1:$580Z$4>K4^OTBEUV
MD24S:36H;$^F3$?>O1Y+:76G$Z])2%$9 I<BOKA/W;8=^4L_V&0*J76JV/BW
M;W:R)ZB@%+.                                         .6=>N*IH
MJ%92FNRD*1(D$1%*61D9+5_I#C&9S5R*Z_CSKG==QRN3MS11\2-4;D.I@[.X
M<    P=QW#3K5HTRO593B*?!YOGU-(XU_A7$M)T271ZI9#$S^>MY*S5>NX\F
MG#'#3KF([LLO(Y*YG+U-FWWU6.&.C5$SW(1;Y06.^F_4"+IGUJ?IAYSVVV=O
MU>2]![&;0WJ?*3</7/*    (\R-DNA8PI<"K5Z)/F1ZA*ZS913VVG%DO@4YJ
MHG76BTT0?0,:G:^V+.S+=-R[%4Q,X?%PWL=V8WFWV/L6]M2Y5;M33$TQC\;&
M-W#<B=]&]N[F[#N:NTBWH%(K[,VLRFH<5V0Q%2TE;JB2DUFB4M1%J?+H1C49
M3IED\S>IM4T5Q-4Q$8Q3AI_S2W.<Z%9S*V:[U==N8IB9G":L=&]\6%BQZUX\
M   !JMV63;%\0HU/NFF>VD.(]UQ'9YYYCA<X31Q<3#C9GR*,M#/0:W:>Q\KM
M.B+>9HY5,3C&F8TZODS#9;,VOFMFUS7EJ^35,83HB=&OY42]*T<<V98CDYVU
M:-[5.5)+:)JNN)#_ !I:-1H+1]US33B/H:"SLO8&2V9-4Y:WR9JPQTU58X:N
M^F=]=VIM[.[3BF,S<Y44XX:*8PQU][$;S=QN&H
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M7'][H"=;HP"EQ=^L0\[;9WVSION]&!53J=H@4@
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M?ZS7XOPPS?U5GF[7'\N*A["@B<EWD\*CI?ZW'B1W9=+QF/*@
M  TV_P"P+4R?:=6LJ]:4BL6]66R1+BJ,T*2I)DI#K3B=%(6A1$:5)/4C%=NY
M5;JBJF<)A371%<83J0?9VT?&5IW5;MWS:U>%^U2SM#LQB[Z[(JT6D*21DA4-
MAPDI0:->HUUX3Y2Y2(QDW,[<KIFG"(B=>$1&/#@LT96BFJ*M,S&K&9G#LRM$
M,-D     "A5=\_&S>T[ON/.&FGUZ/X^2Y7GOUGE_NY^A<7U&Y=4
M                             !2W>=?>YZU+9MJC;9+"=N:MW2=01<5U
M,,(E/45J.F.3',L.J)HW'S>7PJ<)1))L^H,S(TDQ@H-@R+FO#U5>ONM["[RR
MQF:IK5(K>6;HNMN1.4^LN%1PVG*6ZF*DR,RZE2G-#X3<4G0B*I=L;;J-0K%N
MT"KU>CKMZJU2G19=3M]USG5P9#[*7'8JG"2CC-I:C0:N$M=-="!0ISDHB@;[
MMM4V<GFHE;L>\*917UZ<+DV.AN2\V@S_ )Q,GJ>G+H"=Q_,SI34-[FRV-!03
MDR@4O(M3KAH(N)N%*I#,2.M>G+PF_JDN+DUZ'*!&I(^\R#-J.U?.T: RM^0F
MTILA3;>IJYJ,1/O*Y.DEM"C/[! 1K:GDRMT->PF[:PEUE='J6$GBIKI<'-J.
M;0>:B<.I\/*XXCATZ?0Y= -U UY8JW?W+A':I!V]Y!CX^5;F-:/"OR'+G+A+
M>EE38"6N0HKYJ-O@<(]=--03C"J>2=CGU@>8(--IN3<HVY>4&COKDTR-4*R^
MI++KB>!2T\-/3RFGD!.,.[-&B.P*/2H+_";\*&PP\:3U3QMMI2K0^3DU(%#)
M                                                BS-3#\G&=R,Q
MF5R'EG"X&FTFM1Z36#/0BU/D(M1YSI9157LR[%,3,_%U>/2]#T5KIHVE:FJ<
M(^-K\2I0M5$K1I414B:9F1Z%UNYZ4<:G*7O J[$NOQF[./?T]F'4<?1#Y_
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MO%!DMR>9)U=9=YOCYO3BX3TUUT/H <IV'!2
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M=\_&S>T[ON/.&FGUZ/X^2Y7GOUGE_NY^A<7U&Y=4
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M(0@B2A"2T(B+D(B(@0_0
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M80CD,RZ )Q6(!
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M7^[GZ%Q?4;EU0
M
M
M
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M'\?)<KSWZSR_W<_0N+ZC<NJ
M
M
M
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MIY;LFFYDW9V5A2O3W;&L_&]CMW-:K]%YJ%5Y\DWU1N8B5 T*=:9:0GE0V?\
M,4?)KJ2Q<FSEZKD:9JJY,XZL,,=7&7:?.WXHG1$1RM&O'3&OBWV3VY6ZUA?<
M]F'!UNU)RZ;5GV]"O.17*@3+]8ASY#Q-'%GSD(0X_P 27#6@G-3(C29=%1G&
M:J\]8HNSHG&:>IAOQ&YUC+T^;NU6XTQA%75QG&,)G=U:,70P:QG**;0OWH;S
M/G6E_P#6\-CG?L[7B?#+#RO?W/&^"$+Y4QHK+NY;=78L=)'4ZGB:BO4)?31/
MB2(LB,:3Z1FMLD_Y1?LWO,V+=>]7/8P6KEOSEVY3OT1W:F'H>1)FZA^VKBEL
M\4#!6)ZW5[PXB,R5=%9@R(#:5](E-HB..I(]#Y3/[ FJUZ+C3X541'BQI[>,
M*K=WS\Q5O4XS'5G1VL)[*WVQ[S5,.=K)7NA*&'M+UFOA7<C]A1XL+6C"90
M    *%5WS\;-[3N^X\X::?7H_CY+E>>_6>7^[GZ%Q?4;EU0
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M:U*?];+>MK6U>5O7LJ70+MI4.M4.4N9;32G8<]A$AA:FUM$I)J;<(S)1$9=
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M+?:6S2X2G%.FVA;BG5$:UF:CU4LSY3%%RY5<JFJJ<9E-%$41%,:H;<*%0
M   *%5WS\;-[3N^X\X::?7H_CY+E>>_6>7^[GZ%Q?4;EU0
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M=I==M^P[;IM:ICQ$3L>7$I<=E]E9$9EQ(6@TG]D@)2T"
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MN+ZC<NJ
M
M
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M63LF.TVHN)9%U*C/_(+6:V;F,M3%5VG")T:X^"5=G-VKTS%$XS'"F48+)
M             4:V'?NZO#Y1G[$CC4;([RKA<N]U']NN_>S]&E>4;=U$   !
MS'^M*_<Y8ORL3[#?'I.C/V]7B_"UVTN\CA9CZK[]P%Q_+6=["@BCI+ZS'BQW
M95;.^SGA^"'2 >>9X                       "A5=\_&S>T[ON/.&FGUZ
M/X^2Y7GOUGE_NY^A<7U&Y=4
M
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MXC>=$A>2
M                          # 3+KM>GF13[DI4$U&:4E(F,-:FGHD7&LN
M4NF+E-FNK53,]91-RF-<PU.7FG#L#AZ^RS9L+C,R1S]>I[>IET2+B?+H"]&1
MS%6JW5Y,\2B<S:C77'9AJ,K=#MZA\'.Y>MI?.:\/,3$O]#377FB7IT>F+\;)
MS<_^.KL+<YZQ'RX:E+WJ[8X?#SN467#61FDF*957^AZ)M0U$7^47HV#G9_\
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ME<B3/DZ(IVSM++YR_%5JK&.3$;L;L[Z/R#/;/MXW[4TQCKT3'9C&'3@:QC@
M                      *%5WS\;-[3N^X\X::?7H_CY+E>>_6>7^[GZ%Q?
M4;EU0
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M35W*O\&33D=I5][E+G7CD]UCGMVV>9R5G2-M3,+J"-'7]RQU:*/IF1LQC/\
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MLKSS<4_)2K>HS!]>^XC]*YS_ /V?Y+;DW3C^Z6/NY[LNHHZ2T
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M@&DC=T+D(UH4E1Z<FNHR\K=FY1C.MI.D.SZ,EFIIM]Y5$54\$[G66(&0T8
M                    *%5WS\;-[3N^X\X::?7H_CY+E>>_6>7^[GZ%Q?4;
MEU0
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MR9/*&L7]'W%^JGP_Z\])M^Q_N?Z3V_V7OU^3)Y0UB_H^XOU4^'_7GI-OV/\
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ME1R>313O1IQIEX;I#MG+[4VA:N6,>331,3C&&G&9=;AO&,
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MZ/X^2Y7GOUGE_NY^A<7U&Y=4
M
M
M
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M%]1N75
M
M
M          $!YUW&V%M]:L_X8P*_6:A?=0=IML4.W*>=1FR7F4I4OA:XV]=.
M-"2(C-1FHM"/ET)B,6UVYEZT*SC.%EBO+E8RM*2EQ4MR^VT6^_!)$M4)'7J9
M;B4L\ZZDN;XE=62D&7WQ C!(\&=!JD&'4Z9,8J--J+#<JGU"*XEYA]AY)+;=
M:<09I6A:3(TJ(]#+E(!J]WY%Q]CY%/=OV^K>LANKN+9I3E?J<2FIE.-D1K0P
M<IULG%))1:DG734@&WMN(=0AUI:7&W$DIMQ)D:5),M2,C+D,C(!KM%O.S[DJ
M=P42W;KH]>K-I/HBW52*=.CRI5,?<-9(:FLLK4MA:C;7HEPB,^%7H& TZX,[
MX.M*KS+?NK,MC6S7Z<I*:A1*M<5,A3&%*22TDZP_(0X@S2HC+4N@>H)P;I;-
MWVG>M.*L6;=%(NVD*5PIJE&FL3XQJT)6A.QUN(UT,CZ((9B=.ATR#,J50D(A
MP*>PY)G2W3X4-,M)-;BU'TB2DC,S 07MMSJWN+QT[DN%:,NT:%*K4^G6XB9(
M1(<GPX2DM]>]0A'-DMWG&^ ]=#0?5'J"9C!/P(  !#,W<;MZILR73JCGC'=/
MJ%/><C3X$FZ*2T\P\THT.-N-KDDI"D*(R4DRU(^0P3@D^AU^@W/36*S;5;@7
M#1Y6O6M5IDEJ7&<X3T/@>94M"M#] P0P52R1CNCW13K'J]^VY2KUK!(52+/F
M52(Q5)1.FHFS8A..I><XC29%PI/70_0 ;BXXAI"W75I;;;2:G'%&1)2DBU,S
M,^0B(@& M>[[3OBDMU^RKHI%X4)YQ;+5:HDUBH1%.-'HM"7XRW$&I)\AEKR
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M_0N+ZC<NJ
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MV1>V0:P=?NJ9*JT6?65--,K?1%J#[31K0RE#?$EM*4ZI26I$1GRZF8G6MZ"
M
M              <Z=Z/[_-AGSE/^J4X%4-W^L=\S',G_  ]_>*F BG6L9@O]
MR6'?D/;WN;'!$N<_UDMC0<FY=V6X\J<AR'!O6N7+1I$QKE<9*8NB-$ZDN@9H
M-1*(CY#TY054IBV 94K\VTKJVYY*6MC*NW6:J@3&GCU5*HS:U-07FE*T-:62
M1S1&1:<WS*M3XP):MLG\Z'ZPGY<4CV57@)U0CW!N)\:93WG;V8^1[%HM[L4:
MJTIRDM5F(W+3'6_SY.*;)PCX342$ZZ>@0$ZGK3+'H6V?ZPK#-KX+:50;;S+0
MI!Y QQ&D+5"2TTB9_M26EJ5P)3UOSR"_FJ;62=$K-(&N%G/K!,BU*S=OU1M"
MV2<?O?--2BV':L%@]'G550S3*))$9'HIA*VM?\YQ((IUMMN:Z+8V/;6[?DO4
M63<E&QC3:117X5/6VR[+DR7FH[\GB<(DD;C[JW5<G1,^0#7*'+H^L+IU,A2[
MTM+ M^WYA>C/$Q7<OPHY1Z<E25\V\N&EU&DAMM?4&XIQM''R:Z:&9/);'<&_
M*VJDRE>!<5W?N(*%2XE8N>;;493<&DLS&B>1&DR%-NF<M*#U6PE!FG123/B0
MM*2,%B< 9XLO<7CJ'D6R"E1H:Y3M.K%'G)2F53ZA'2A3T9XD*6DS)+B%I,CY
M4*2?)KH0F,'.+8?@W#V5*1N%J>1\;T"]*E#RE6(,.H56$W(?9CFVTOFVW%%Q
M)+B6H^0^B>H)F65VJT6DXSWZ[@<4X9EN.84AVXU/K-$9DKEP*?6$]8:-H>6M
M7X5IUY]HBXE*(N-"M3;ZD3J0INYQ%6\Q[U<F4:TY,F->]J8JAW;8ZHJC2ZY4
MZ0[&=;90:=#XW4&M#9ZEHX:5=($Q.ATLVX9XB[AMMS-\.*2BZ(5+F46_8!$2
M38K,*-I(/@+[U+Q*2^@NDE9$?*1@IF,)0W]5MYI](^4M:]50":M:/-U-J'NS
MW2VEMD8G.QK5QE9E7NN^)K*C23%6JD7K>E\1D1]4PMR,Z1']\AQ9:&!&B$Q_
M5T9&J%V[?H]B7)Q,7GA&JRK*N" Z?X9IJ&KBA\:>D2&CY@OLM*!%37_K*/W;
M8'^>^U_8=4!-+HL"D                           !1K8=^[J\/E&?L2.
M-1LCO*N%R[W4?VZ[][/T:5Y1MW40  4?W>?'+;+\MU?]ED8&=UT</$]?T7^R
MS7W?&L *F _I=$OY0$!;(_S!FCYRZOZFR&2[V>%G=+OM;'W5/=ENUW[4;2K5
MWU>^[(O6\,.7+<O"JZW[*J:H$>IN)TT=D1C2MOG-"/JDD6IF:CU49F>\MY^J
MFB**J8JB-6,8X/"7,E355-5,S3,Z\)UMPQSMWQ[C*@772J*FI52M7XT^B];Z
MK$M<ZMU-<A*TJ6_*=UY4DOD)*23KRF1JU,[5[.7+M43.&$:HC1$+MG*T6HF(
MUSKF=,RAFB;';;MVD1[<H>=LRT:VXR%-LV]3[L<B0T(69FI"&&F4MI(S,S,B
M2,FK:E54\J:*)G?Y+'IV=33&$55X;W*E82PL'XPQM8DW'%JVM'C6K5V'F+@B
MR%+D.U+KELVI"YCSAFMTW4F9'J>A$>B227(,*[F+EROEU3I9ENS1;IY-,:$!
M1-D%CMMTRW*ID2^[@Q719B9E+Q#4*L;E$1S;AN(96DDDXMI*CY$&KT>7E,9,
M[0K[Z(IBJ?E8:5F,G1AR<9Y,;F.CCPZDS@R]W;.[6N?(\G*%.R3?-D7(Y!9I
M<$[<J3<)$*"PV3:8L4R9-;36A?>$K3E,449VJFWR,*9C''3&[V5566IJKY>,
MQ.&&C>2OBS$$O&4NKRI.5;ZR*569::1&N^JG46HO-*4KCCI-">!2N+11],B(
M6;M[SGR8C@A<HM\G=F>%,XLK@             H57?/QLWM.[[CSAII]>C^/
MDN5Y[]9Y?[N?H7%]1N75
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M;H*5//JS/- L'MG7O=20":M:_8(
M                                         !SIWH_O\V&?.4_ZI3@5
M0W?ZQWS,<R?\/?WBI@(IUK&8+_<EAWY#V][FQP1*D&]CSH?J]OEQ5_95!!5&
MJ6-WD4>I[><T8TWLV;3WWZ9"?9M7.],B?_IE)E<+#$A9<A&HDZ-$:CTYQ$;T
M (TZ#8=5Z9<&XK?I7J+-:J5'K=V4&?2:BR?$U(C27JXZRZ@^FE:%$HOL&!*&
M\?8XRSD/>5O*9Q5G63A"12ZQ3EUJ5'H4:MG44.D\32%)DOL$US1I4>I:Z\7V
M -Q>O!>T:B8GO>KY;O*_J]F?,=:BJ@/7[<1DGK6*KA)34*,2G>9U)))UYQ6B
M.H1P)-1*(F4(W%IG[ZPNU[=(BF6/M,M]5<JA&1*95<U5)M;"=?\ .02F'$Z?
M>J866NO("=4-P^LS\T"_NV=!]U(X(IUIAN&ETV/LYKU(8@1V*6WAV6PBGMMI
M2REOV@67 2"(B(@-U&'U;,&%$V;XID18C,9^J/W!*J3S2$I5(>379[!..F1$
M:E$TRA&I\O"E)= B JUHU^KH(HU6W<TN.1-4^!ERIE#B)Y$-D;CR#X2_^JVD
MO\@)J51VJ;0,>;C8.X"OW9<MUV_6*5D:M4FFN4"H-QHZ4&E+R7'6'&7"<42W
M#UY2U+D^R"9G!9SZO:<C%ESYKVF711*12[_QC4_;.+<,"*B-(N&CNJ2EJ7),
MNJ=-I+S*D*4>I-O(3H1I49D5;[)TG_YJ%S_-$WZK$ W&@707D;[MJ^M*%0<%
M;MX,I*C(^&)2KKT7_P"2A*GGO]%)(?/I,\@UPDCZL^L4VWMG!5^L2D0:10ZS
M<-0JLYS[QF-&,G7G%?82A)F8%6M67:OF;-$2OYGS_1]KEU987GNXG)M-NB!.
M8BQXU,ISS[#$!DG6WE&3"C4VHR5R\VDN7AU!,PV3;SD:[;#WY7A&O;%]7PO0
M]TT%<Z#:-8D(>_\ 74%LWRE$\VE"%\\ZF4DBX=>-XB_E(G4L3]91^[; _P ]
M]K^PZH!2Z+ I                            4:V'?NZO#Y1G[$CC4;([
MRKA<N]U']NN_>S]&E>4;=U$  %']WGQRVR_+=7_99&!G=='#Q/7]%_LLU]WQ
MK "I@/Z71+^4! 6R/\P9H^<NK^ILADN]GA9W2[[6Q]U3W97<&:\B
M              "A5=\_&S>T[ON/.&FGUZ/X^2Y7GOUGE_NY^A<7U&Y=4
M
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M5F>:!8/;.O>ZD@"K6OV"
M                                   <W-\52IU'S;L7JM7GQJ52Z?D6
M2_/J4QU#$=AI"Z<:G'77#2E"4ERF9GH0*H6CSCC>@;I,#W3CRAWQ$AT2^T0^
ML;UI:6JO'0JFU)B7Q(2T^VAXN<BFVHB=+3EY=2!$:%6:3LSW/T*ETVB4C?M<
M4"E4>*S!ID%JU&B0S'CH)MIM)'5SY$H21$"<83?D+;#5,CW/M7N^O9.=?KNW
M"04RL3W:2A:[FE+33N?>7P2FDPU.K@&L^%+I%SFA%U/*1BL7?=DV[DBS;EL.
M[(15"W+KI[U.JT;D)7-/)TXVU&1\*T'HI"M.I41'T@0JML^V<0MI1Y*ZTO\
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MW?<><--/KT?Q\ERO/?K/+_=S]"XOJ-RZH
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MZ[GOO-(YYLS0H^;4DSX3T(STZ0$RM:"
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M-IL=Z:IZ$EM$9:G5H-2C:2TA*3/H$DBZ! G%+@(
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MKSWZSR_W<_0N+ZC<NJ
M
M
M
M                   "C6P[]W5X?*,_8D<:C9'>5<+EWNH_MUW[V?HTKRC;
MNH@                               *%5WS\;-[3N^X\X::?7H_CY+E>
M>_6>7^[GZ%Q?4;EU0
M
M
M
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MQ,XPVVP_=]D]DYNG-6[E=55..$3AA\:)IW(C<F5IQL'O0
M
M
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M?O/]+H /:
M
M
M                                    !SCWIV$G/^4<+[?6W-&Y-N7O
M=]2U/A2S)8I?M=0WU&6O(B=)XCU+H)TZ?(51H:57<FR<_;:MI]IU)U4FY<HY
M'MNU,GTQTR*1K:LAR57%O-]%)FNG)=X?0<3TC U2MY?>5=P%O775J/9>U:H9
M"MJ$IHJ;>#=XT"EHF$MI"W#3$END\V2%J4CJR+7AUZ!D"&31<%:OC#][2L[8
M-JMI1#3)B5+&4&8U=<ZJTU+32B-I-#XS<-]:EM\R7+HDS5U*@%-;%;QUES=O
MB]W%V-&,%Q-OE(JU2N"G56D-VM<-<35XW6+,>/1TH;>.'&-9FMYY.G$M2$D6
MNJR=Q?3-^6*5A+&=R9%JD!VL*I"&6*10(ZB0_4:C,=1&APVC,E:&Z\XDC,DG
MPIU5H>F@(B,5!=Q4K=%<5JXQQ=F.E8\.VMP-]VS;U1IMJG4$5"C<,]FIO1Y*
MI;S[4QHF(BR=<:)!$I)Z$I*T@F,%DZIES,^2\DWW8.WR!:--H.*9+-+O?(]Y
M-SIL:36G&TO.4NG0X#T97%&0HN?=<<T(SX21T%&1@C27O!O:E[8,Q9.J]K41
MK+F';TF8XJ=!A]=2J/-N"+/B0^<BMFXW(4RI,LEDCG>(^$RXP3AI;9'S1N'M
M[+V$+?R/:UETBSLZ2JK$I]IT]4UVXZ$=/@+GMG,EJ>.*^HDD27B:9)*3Y$K/
M3B41A#,R,N9ORM?V0;6V^0+-I-IXHJIV[=&0;T:GSFZC7V$H<F4V!$@/1E(3
M$XB0\XXL^J5HA/\ . P1S,WCW?!VM7-EB3:%,3EFT[U\'DZU8A2)M.E5QBJ,
M0Y!PT$ZR^XE3#BG&T<YKQ$2#4?1!.&EF\@9UW#X?Q]%NW)]%QW0ZSDB[K?M?
M']-2_/.G6M[;E(7(?NBH*<)#[<5#*>)48FT\?%HKA-.A&"T.+SRPJG5%S*E7
MLVO./.M/6S6+-C3HC#T-QHE*-]F;(EZ*XSZE3;II4G0]",$*[YU6>5-QF"=O
MBS4[;%#CR,M9-I_\R5#I#Y1*)'=(R,EM+J)FIQ"N0R0GID6A,,]N+N?#%B5B
M/>>1L%7#EBN4NWWB@U>G6D_<,*##2\I1LKEO(5!B+<7J:E*4E7#IQGP<($,7
ML3LU-L83G7$Q(HZ:=EF[:S?='MZWI29M+H<2JK;;9I$5]!$@RBIC\*R26B7.
M-/2U E'NZ&1FRXMQFW#&E@5^UJ=37IM1O>F,5&+4G5-2K;B*(UU8XLQ@G8SJ
MY1(:;;))\9&I:S+1()AN5Y;B+U@WLUAFAW-CBW;XLRW8%7S7DRZU2(MN4R54
M&TG'A4RGJG,R'WGR,WDDY))#;7#Q+6L^ $8,%:^\"XCP37LB5^UZ9=EX>$.1
MC;%C%K*D1J/>U26\AFGRJ8N8;SC<=U1N$I1K<+\"LTJ5R$!@F"@7%N2LXKAN
M;-R,:S;"HULU"MS7K/358LZ#*@(2_P!;K.H./(D-+:)?X0DMF1IUX-#(@-"@
MV&,H;B<+;4+)RO$MBS6+"DUYF?7:;6^OW+DN15T5SA>FQ%1W41XJ>*8264K0
MXI3;7.GR*)*B9B,5V,SYSR=;6<,;8/Q)9]'NFOWI;M4KE9E5A;[4>F,LOLQX
MLV0ZPLC1';,GC<22%K=5S;3? I7$"(AB<=[@,B1(6Z2#F&);$FM[;FD3GZW:
MK<N-39\9^D+JZ6^:F/2'$+:2C@7U9\IZ::EJH8-7MS,MVV_C+;E8V-,:6;2<
MT9ZHBKF8M:%$=I%JT&&Y'34)]3F1HQK>))'(0GFR62W75*+CXBT,8-VNO,6:
M\(X_N*MY@HEGWG=E2K%)MW#=-L@YT%%>J]84IEF%)9J#DA3"T.)XS4EQ25-Z
MZ$2BT P:E,RYNLL+).$,?Y#HV,JWX9Z[UKU_;2:JRY2HE-CKF5=HV)<E?/J)
MC0VGTJ2E)I5QM*XD@80V+#7_ +7[LMU5^+0;L.T(]KX[MZ7T2+K6(NI51OT"
MTDR$<GV->F!.IF=PN<\C8]R+A3%V*+0I=YW;E=5=-^)4UO-,PX]-BMFU*=>:
M<3S3*'GB<=,TK-3;:VT)YQ:5$(AK-XY[RA84G'V'JU4<<N9]NN#4*_<]RR5S
M*;9E!M^))<::G/(DR"EOK=T2TVTEU/$Z2S4MM"248P:S;&Z^\&K!W3W%<+MG
MWPUM_I[;MJY'M!N6U;E?GR*>X^F":7I,D^=CR":;?-F0M/X0M.$^B3@QM3W%
M;F[3M'$F8;YLBRJ'CN^*S;U%KUC$FH_"9AFMFAGVQ)WGU1V5&L^<3%4A:D(4
M2''3<XC2,(;J53AUC>WD&Z)YG[0;?L/Q(4YP^5,>?<$QVI.O=(B4<*)PD1]+
M4_Y"-QJ-CY^N*EX.P?-M+%=IT[..Z&KU*?;=E4B.NDT,C6\[)E5RHFT3KRT,
M0"9>DK(S<=4?4Z$9$DG!)]?RUFG!E@Y#OK/L&RKGA4:/3TV"U8:*C"D52JU!
M\XJ*8]&J#DLTF;RVM'4+/J#4HT=28(PQ1W<N8MWN-JCB"-?EMXPGEFF\*-:\
M2GT7VU3*MYR:ZE^44DGI*DS2;A-/ZN-&V2'2)6CB#)!DX0UJO.[B[QWLUVGV
M;<UC18N([+)RG1ZI J[\)J+<DOJ&YC,>H,<[--J,2B<2:&R3R<&I<0&C!MEW
M;J;@K5Q9,CXZO;%V-[(Q+.D4&KWEDEV2\Y6:["0;DJ+38,29#<*.P9<TIXS6
MIQ6I,MJX=01@_M=W97Q&P?MVO,K8H-C7YGZIQZ24F\')+-NT4UMO.G,DFA33
MRD2$-)5';YQ)F3A:N=3U0P6XQNC)[=$FMY6J%K5:MIJ#GM/5+2CS(D2133::
M-EQ^/->DJ;?-SG.(D.K1P\)D>IF1$*XW5G#-5:W$7?@?#=J6U,8M*V:35*]>
M]R%,5"I,RH*>=,I28CS:WN=8)I+##9(4:N<<4Z2$<()P:Q;V\"KVWB'+=SY=
MH--DY"Q'?TO'":5;*G6(%PU<C9* <0YBEJCI>Y[\)SBE<"4*7Z" ,']M#<1E
MA.9\68UN6O8LR&>1&:F[<] QTJ=(GVHB#%-]$F9+<F2676%.:,FIQI@U+/\
M!D?0 P>Y9V;]Q.8,FY3MO&=MV71L>XIO]VV:G?-PMU!Y4UB!UNB;#AM19"27
M+2OGEJ<5P-H0IE'"I2E+(8+$9VRW#PGC>K7N[2G+AJO7$2E6I:[#A-.U2L5%
MY,:%#0M1&2>-Q>JE:'PH)2M#TT B%%L[O[F;C>P9B;,L#'LJW<S9"MY-2CVA
M[8-2J>S2)#=4G0Y"9SSR)39M,FKG4<!$I!D:=%IT)C!861ES-^5K^R#:VWR!
M9M)M/%%5.W;HR#>C4^<W4:^PE#DRFP(D!Z,I"8G$2'G'%GU2M$)_G C!'$[>
M/>$':S<^6'[0I99:M.]/!Y-M2(4F939=<8JC,-\X:"<9?<0MAQ3C:.<UXB))
MJ/H@G#2W:F9BW"T#.>%;%RC;EDTRV,ZQ[B<IE HJYK]:M]="I_MCP39KCO6T
MHS):6G%,LH02SZD]"(UD8/U$R[N!S/6[[?V]4^Q*'CVPJQ*MN)=U[M5*:Y<5
M5IY\,PX3-/>C$Q%:<_!<ZHW.,^J1T#)(P:34=Y]T.;9<69BH-AQIN0\AWQ!L
M7X!)4Y(0Y42J,B+,:AF3C)J4ZU#<-CB7HA2T<9K))DHG#2V?-,C+Z-H^XV;G
M<K0C5*;:E3.@TJT2F\U"9?A<+<>7(FJ<Y]U#ZN$UMH2E6FI</%U)$:VG\W?7
MHO\ FD<'WS7Y]^W]_P#9^]!+HF"D
M
M
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M #70^\_T>@"'M
M
M
M                                                           "
M/5^#GPK1^+VO\+GP3>YC37VP^#G7S7.:Z<G,]=\&FO\ .UT_G )"
M           !$V0_!/\ "O$WA#ZU^%'M^]X*.NNN/SSUHYQ\US?X+G.8X^'G
M?_)ZK0!+(           (FPEX)_![3_ KUK\ >OZIUIUIUQIU[U^_P"V'.==
M_A^/KKG->/\ \GJ>$$RED$            (RIW@N\+-R=8^UGAA^#\'V^XM?
;;/VBYYSK7@YSEZVY[CUYKJ><^_ZK0!)H#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>tm2227887d4-lc_4lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_4lnp4c.jpg
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M# P,# P,#/_  !$( M$&Y ,!$0 "$0$#$0'_Q #U  $  @,!  ,!
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M@R1C_]H # ,!  (1 Q$ /P#OX
M
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M_ 8R>8%T@?,G;/;UT]^ QD\P+I ^9.V>WKI[\!C)Y@72!\R=L]O73WX#&3S
MND#YD[9[>NGOP&,GF!=('S)VSV]=/?@,9/,"Z0/F3MGMZZ>_ 8R>8%T@?,G;
M/;UT]^ QEJF>="729:<&S.ZV[9JW4UPMEBN-70U+:VY*L<T--(^-Z(ZK5%Y7
M(B\4!C*2NB:1\G2CL6Z1[I')C$#4<Y55>5DDC6IQ\"(B(@)UK2!
M
M
M
M            *L=;GT3]]/DU+^-C"8UIOVR_=MM]\FK3[CB"&\
M                                         -'W-_=MN#\FKM[CE A#
MHC^B?L7\FHOQL@3.M:<(
M
M
M                                        !5CK<^B?OI\FI?QL83&M
M-^V7[MMOODU:?<<00W@#F9C77IDU]ZR*KIFFV^ME/C\.37;'F9*RLF=6*ENI
MZB1LRQJQ(_'? FK? B]JJFH58:%]]T\QFV[VQW'W IZ%ETGP7%[QD,%LD>L3
M*A]LHIJML+I$1RM1ZQ<JJB+IKV!2JET0]6V0=5MHW"K\@Q"WXG-A59;Z>G;;
MZB6=L[:Z.=ZJY)416JU8? O'7[ 3,8+TA
M    P^17VW8MC]]R>\2NAM&.6^JNETF8Q9',IJ.)TTKFL;JKE1C%5$3M @'I
MUZK=K>IZ++I-MF7J%V$NH6WN&\TC*5R)<4J%IW1K'-,UR+Y-(B\=4T[.*!,Q
M@LL$            T?<W]VVX/R:NWN.4"$.B/Z)^Q?R:B_&R!,ZUIP@
M
M
M
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M^YO[MMP?DU=O<<H$(=$?T3]B_DU%^-D"9UK3A
M
M
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M_NVW!^35V]QR@0AT1_1/V+^347XV0)G6M.$
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M6G,57*:HB8B8B)B=,X+ GKWC
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M%+-       T?<W]VVX/R:NWN.4"$.B/Z)^Q?R:B_&R!,ZUIP@
M
M           "J725^AV3?'*>YXCP'N]\UN]_UH=$]X_G=KO/I2M:>_<[
M                        52J/I74'Q,ON*0Y_7^IJ>\^C+HE'Z6J[_P"G
M"UIT!SL
M                                JQUN?1/WT^34OXV,)C6F_;+]VVWW
MR:M/N.((;P                                 &/NUKH+Y:[E9;K3I6
M6N\4LU%<J1RN:DM/4,6.5BJU4<G,URIJBHH$2;2=.FRVQ,EXFVHP.DQ&HO[6
M,N]7'/554TS(WOD8Q9:R:=[6HYZJC6JB=G#@FA,SBFL(              :/
MN;^[;<'Y-7;W'*!"'1']$_8OY-1?C9 F=:TX0
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M9?<4AS^O]34]Y]&71*/TM5W_ -.%K3H#G8
M                                                          !
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M
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M::SX3%34T+49'&QEH@1K&-:B(B(B:(B%-_S:URU=5-K[:Y_QZB\)KV6
M     %4JCZ5U!\3+[BD.?U_J:GO/HRZ)1^EJN_\ IPM:= <[
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ME945#(%DTIX^ZJ$[M6(]JZZI*_L:58.Q84@
M
M
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M$;44=3&V6*1$5%1',>BM7BB+Q0#EWZ1C]Y/1+_O*;[LM(54NIP4@
M
M
M
M        %4NDK]#LF^.4]SQ'@/=[YK=[_K0Z)[Q_.[7>?2E:T]^YV
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M"E[@
M
M
M                    *I=)7Z'9-\<I[GB/ >[WS6[W_6AT3WC^=VN\^E*U
MI[]SL                           !5*H^E=0?$R^XI#G]?ZFI[SZ,NB4
M?I:KO_IPM:= <[               (4WLZ>]J^H6SV6Q[IV&:^4&/UCZZU-I
MZVIHGQS21K$_QJ:2-7(K5[%U[ F)P0%:O1N]'UKJV5B[837-T2HL<%=>KM+"
MCD7758TJVM=_ [5/L VI7*QG%L:PNR4.-XA8+?C./VQG=T%FME/'2TT3>U>6
M*)K6HJKQ5=-57BO$(0;OATG[(]0E9:KON+B\DN1V5B0V[*+752T%P; URO2%
M\L*HDC$<JJU'M=R*J\G+S.U)B<&GVCH1Z9++8+;8:7 7R+;\AH\HDOLU?5ON
ME5<J!)FP/J*WO4D=&U)W_>D5(U5>96\W$&,K&[C9?8, P',LVRGD=CN+6:MN
M=XA>B.26"GA<]T*-<BHYTFG(UNB\RJB:<0AS:]%1M7%8MK\UWDJK3':ZS=6]
M20V"EC1ZL@L]KDD8UL*R*YW*M2^5O%554C;JJA54ZL!2U/.L)QS<C#\AP3+J
M)UQQK*:*2@O-$R:2!TD,G:C987,>U=4145% IA_AF=('Z@W/\O73WP$[4IYV
M/Z7]F^G:?)*G:K'JFR398RECO;ZBX5=;WC:-95A1J5,DB-T69VNG:"9Q6""
M
M
M
M               %4NDK]#LF^.4]SQ'@/=[YK=[_ *T.B>\?SNUWGTI6M/?N
M=@                           *I5'TKJ#XF7W%(<_K_4U/>?1ET2C]+5
M=_\ 3A:TZ YV                     Q%^L%ARFT5V/Y/9*#([#<V)%<K)
M=*:*LI*AB.1R-F@F:^-Z:HBZ.1>* ?M:+/:,?ME%9;#:Z.R6>VQ)#;K3001T
MU-3Q-[&10Q-:QC4]1J(@&1
M
M
M                                           "J725^AV3?'*>YXCP
M'N]\UN]_UH=$]X_G=KO/I2FS<K=3 -H<<ERK</):7&[.QR1POG5735$KE1$B
MIX&(Z29ZZ^M8U5TXKP.AVK-=VK9IC&7/::)JG"$.[:]9&P>ZF24^(X]E51;<
MBKD7X*MM]H:BUNK533Q:9]2UK)'KKP8B\R^!#(O9"]:C:JIT*Z[%=,8S"T9A
MK0   8/)<EQ_#K#=,GRF\4MAQ^RP.J;I=ZV1L4$,3>USGN5$XKP1.U5X)Q*J
M:9JG"(QE,1,SA"I5FZ_>FF\WVFLK<IN5J@K9D@I,CNEIJZ.UO>Y=&_ZW*Q&M
M1R\$<]$3[)G5;LOTT[6RO3EZXC'!<V*6*>*.>"1LT,S4?#,Q4<U[7)JCFJG!
M45.**AKUA^@                  JE4?2NH/B9?<4AS^O\ 4U/>?1ET2C]+
M5=_].%K3H#G8
M
M
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MN_\ IPM:= <[
M
M
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MPV0 52J/I74'Q,ON*0Y_7^IJ>\^C+HE'Z6J[_P"G"UIT!SL
M
M
M
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ME]Q2'/Z_U-3WGT9=$H_2U7?_ $X6M.@.=@
M
M
M
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MO_IPM:= <[
M
M
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MIK;01-BC3AIS.TXN<OA<Y55?"IJ*ZZJYQJG&6)-4SIELQ2@
M      "J51]*Z@^)E]Q2'/Z_U-3WGT9=$H_2U7?_ $X6M.@.=@
M
M
M
M                                  %4NDK]#LF^.4]SQ'@/=[YK=[_K
M0Z)[Q_.[7>?2E:T]^YV  -"W4_=GN!\GKE[FD,C*_;4<L=51<[6>1P7]'%])
M_'OB.\>YCW'K#YI/+#39#[7I/Z)3G[>                      %4JCZ5U
M!\3+[BD.?U_J:GO/HRZ)1^EJN_\ IPM:= <[
M
M
M
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MD]7C;<JA5U,Y*7X/=)'$FL^NG><TB>+H/%5;&WP8X=-.W&UL\.&*3BTK
M      "J51]*Z@^)E]Q2'/Z_U-3WGT9=$H_2U7?_ $X6M.@.=@
M
M
M
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M3&$RGPQEX    %4JCZ5U!\3+[BD.?U_J:GO/HRZ)1^EJN_\ IPM:= <[
M
M
M
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M2'/Z_P!34]Y]&71*/TM5W_TX6M.@.=@
M
M
M
M               %4NDK]#LF^.4]SQ'@/=[YK=[_ *T.B>\?SNUWGTI6M/?N
M=@ #0MU/W9[@?)ZY>YI#(ROVU'+'547.UGD<%_1Q?2?Q[XCO'N8]QZP^:3RP
MTV0^UZ3^B4Y^W@           (_W%VLP#=BRQ6'<#&*/)+?33)44/E#/OU-,
MB:=[3S-T?$[3@JM5-4X*7+5ZNW.-,X**[=->BJ,6%VQV,VMV?;7OP'$Z6SU]
MU1K;I>7JZHKJEK-5:V6IF5TBM15UTUT*KM^N[AM3C@BBU31C,1ABEHLK@
M   "J51]*Z@^)E]Q2'/Z_P!34]Y]&71*/TM5W_TX6M.@.=@
M
M
M
M                               %4NDK]#LF^.4]SQ'@/=[YK=[_ *T.
MB>\?SNUWGTI6M/?N=@ #0MU/W9[@?)ZY>YI#(RGVU'+'547.UGD<%_1Q?2?Q
M[XCO'N8]QZP^:3RPTV0^UZ3^B4Y^W@                     !5*H^E=0?
M$R^XI#G]?ZFI[SZ,NB4?I:KO_IPM:= <[
M
M
M
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M\^C+HE'Z6J[_ .G"UIT!SL
M
M
M
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M0?$R^XI#G]?ZFI[SZ,NB4?I:KO\ Z<+6G0'.P
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MHB+HDD3G-7@J>$#SWK*,9QOR9<BR*V6!*U_=T:W&KAI>^?P3EC[Y[>9>*<$
MS;7->UKV.1['HCF/:NJ*B\45%0##5.2XY17NVXS69!;:3)+S')-:,?FJX8ZZ
MKCA:Y\CX*9SDDD:QK'*Y6M71$77L S8
M
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M);LTPZ\7BNQZT999KI?[6FMSL='7T\]93I_\M!&]TC/_ !D0#90
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M:GO/HRZ)1^EJN_\ IPM:= <[
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MHQE3WB:K(U&L5&HK6M30BK6AK!<?WQLGI*>G^X=0F14-[W#S'%;O?I;7:_\
MF-DI)K5D--!:J?3Q%2%*97.5FJ*Y[M7R.UD>3P.Z(4
M
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MFGRFP6V[S4S?6QOKJ6.H<Q.W@BOT"AMP
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MAS^O]34]Y]&71*/TM5W_ -.%K3H#G8
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M/(R1$<G?2)*]JZ>,Q6/151R!%37-U_\ O7^F7_=K7^Y<L!&IU."D
M
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ME>E_29A6.1X=AN)8C%.M5%BMEH+/%5.319&T-/'3H]4_X2,U"VV8
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M_P!.%K3H#G8
M             #R0V^@IIYZJGHJ>"JJEUJ:F.-K9)%UU\=R(BNX^J!ZP   !
M])(V2L?%*QLD<C5;)&Y$5KFJFBHJ+P5%0#\Z:EIJ.%E-1T\5+3QZ]W3PL;&Q
MNJJJZ-:B(FJJJ@?2IHJ*M2-M920U:0O22%)HVR(QZ=CF\R+HOV4 ]0
M
M                                           \D-OH*:>>JIZ*G@JJ
MI=:FICC:V21==?'<B(KN/J@>L        !Y8:*BIYYZF"DAAJ:I46JJ(XVM?
M(J=G.Y$17:?9 ]0                              !5+I*_0[)OCE/<\
M1X#W>^:W>_ZT.B>\?SNUWGTI6M/?N=@ #0MT_P!VFX'R>N7N:0R,I]M1RQU5
M%WM9Y'!?T<7TG\>^([Q[F/<>L/FD\L=5ILA]KTG]$IS]O
M       "J51]*Z@^)E]Q2'/Z_P!34]Y]&71*/TM5W_TX6M.@.=@
M
M
M
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MC]+5=_\ 3A:TZ YV
M
M
M
M 52Z2OT.R;XY3W/$> ]WOFMWO^M#HGO'\[M=Y]*5K3W[G8!JF=9$N(X5EN4M
MC25^.V>MN+(G=CG4T#Y41?L*K2BY5LTS/%#(R=CQ]ZBWW541SRI-TFXO3TNV
ME/G]PTKLQW)GJ+QD=\E\:>7GGD[N-7+Q1J<5T3PK_ :W+T_)QX9>V]8+\SF/
M$TZ*+<1$1TEH^W@O%%[4,AH57\%H8-LNL#X QYJ4..;LXI472YVB/A RY4DL
MBK+'&G!JN2+P?SE+5GY%["-4PW&\)G-[IVZ]-5JN(B>'9G@= 39/#@
M              *I5'TKJ#XF7W%(<_K_ %-3WGT9=$H_2U7?_3A:TZ YV
M
M
M
M                                          52Z2OT.R;XY3W/$> ]
MWOFMWO\ K0Z)[Q_.[7>?2E:T]^YV 15OI^YC=;Y*7?W)(6<Q]G5R2V.Z//+/
M?T]6%?>F3]PVVGQ5_P M(85CM(>EWYY[<Y4[EYJ5:+C]-#9_Y&W7_34EFG[>
MGD[+<5?X>]W]/67W-F\.                     JE4?2NH/B9?<4AS^O\
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MHJ(NJ.1!,)7"
M
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M83"$
M                   JETE?H=DWQRGN>(\![O?-;O?]:'1/>/YW:[SZ4K6G
MOW.P"*M]/W,;K?)2[^Y)"SF/LZN26QW1YY9[^GJPK[TR?N&VT^*O^6D,*QVD
M/2[\\]N<J=R\U*M%Q^FAL_\ (VZ_Z:DLT_;T\G9;BK_#WN_IZR1-T=V=Q[UN
MM!L!L:VUT.74]F;?L[SR\Q.J*2Q44KN6G;'2IIW\\JJFC5U:B.37PJWT=C+V
MZ;7CKN.&.$1'"YU>O5S<\5;PQPQF9X.RUV6^=4&S.4XC/G=ZHM]]O,LN<5FO
M-39;(VVW6R2SM<L55W-+SME@YDT>JIP3U%5"N*,O?IG8C8JB,=,XQ*G:OVJH
MVIVZ9G#1&$QT>C#4;YF74EGW4SO#M3MGNA9<%QS;N@LE=1PW*Q07)TB7"@I9
MI6]XO*_^DE<O%>S@7*;67MY>BY73,S5CPX:IE:\=>N9BNW35$13AP8ZXCHPS
MMHW;WSV=W4P;;GJ!FL68XSNK4K;<+W'L%.M"L-U;R:4E72:KHC^9-':)Q7@Y
M41R-LUV+5ZBJNUC$TZXG3HXXED4W;ENN*;F$[6J8T:>+#D9[(+KU3[@Y]GUL
MV^K[3L[A6 SQT5ENF0VE:^7))G,5TD[%>J)% Q6Z(YJ:JCD7CX**(L441-6-
M4SQ3AL_&N5>-JJF*<(B..,<?AC![-H^K#$L@V0Q_=3=FY6[;Z6KNM7C]PD<Z
M5U'+<*-[VN6F<C7N5LC6\R=NG%->!%_)U4W9MT8U:,>DBUF(JM[=6C@YIP2#
MC/5%L!F-]MF,8QNC:+Q?KS,E/:[9!WW>32N[&-YHT35?X2W7E+U$8U4S$*Z;
M]NJ<(JB9Y4]F,O             52J/I74'Q,ON*0Y_7^IJ>\^C+HE'Z6J[_
M .G"UIT!SL                        .3/I(=B,2IMG]T-[[O<KWE.;RU
MUEI,82ZUTDMOQZBFK:2">FM-&WECA29&<TCE1SG.<[BB+H%5,K!=?Z/N&SV%
M8?+-W5HW"W/Q'',B8NO+)0U%:LSV.1%;JG/ Q537P!$/S](A3QVKI9R#+K<V
M.BO>V5^QC(<.J&-Y5I:ZGO%)2Q/AY%:K%;'4.1-/!_E04ZWS@,+;_P!?F_UW
MN3FU%3@&WN+6'&T>G,Z"ENJON%1W:JOBZRHNNB<=?X=1P/)2U28?Z03<:.W(
MC;?EVP=)EV2T4:JSRBXV>]K;J:1_%45S:?5J*J<$7^'4<"I_^,9C?S#W/\OP
M^\0G96WZ2>M^U]5N19=C]OV\JL+?B=N@N,E547%E:DZ33=UR(UE/#RZ=NNJA
M$Q@O6$      4<ZA>JG-,.W,L6P.P.W,6Z>]=YH/A:OI:Z?R>UVFA756R53^
M\AU<YJ<RHLL:-:K/&<KVM"8AA]E>J[="HWBI.GKJ:VOH]L]R[]02W'"[Q9IG
M3V>[L@C?)+'$KI:GE7DBD<U4F<FK58Y&OT1PP7["    C:NW?VWME=66VNRF
M"GK;?/)35E.L4ZJR6)RL>U52-471R*G!2<)&SXWEF/9=2SUN.7-ETI::7N)Y
MF->Q&R<J.Y=)&M7L5%(P&Q   'X551'24U15S:]U2Q/EET35>5B*Y=$_@0MW
M;L6J*JZM41,STM*NW;FY7%,:YF(YVJ?GW8O_ -X_!_\ PC3>T.5_FYOC;3\D
MS'0YVUTM1'5TU/5PZK%4Q,EB54T7E>B.35/X%-S:NQ=HIKIU3$3'3:NY;FW5
M-,ZXG#F?N7%   Q=TO-MLL44USJ?)HYG]W$[D>_5VBKIHQKE[$,3-YZSE*8J
MNU81,X1HF>I$LG+92[F9F+<8S&G@Z[%TV9XU5U$%+3W-))ZE[8X6=U,WF<Y=
M$35S$1-5]4Q+6_<G=KBBFYC,SA&BK7/29-S=&:MTS551HB,9TQV6T&V:T
M-5NV:XU8ZQU!=+BZGJV-:]T24]1)HCDU3QHXW-_SFHSF_LGD[GB[M>%7%LU3
MKZ,1,-GE=SYK,T;=NG&GEICJS#T67++!D,TT%HKG54M.Q))FN@FBT:JZ:ZRL
M8B\?4+F0WQE<]5--FO:F(QG15']40MYS=>8RD15=IPB>C$]29;$;-@   !J[
M\VQ&-[XY,DMS)(W*U[%G8BHJ+HJ+Q-35O[(4S,3?HQC^:&RIW/G*HQBU7AR2
MS=ON5ONM.E7;:R&NI5<K$G@>CV<S>U-4]0S\MFK69HV[5454\<3C##OY>Y8J
MV;E,TSQ3H>TOK(
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MO7A%F.O8M_L:(Y%7R^FX:_\ RK3R&[*H_%VN_IZL/39^)_#7.]JZDK2G77-
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M:=FKFHJG:;-4UT4U3PQ#EERF*:IB."7[EQ0
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MU^3]8:K]ZFWL1&,X:_B:O(^L]69OT6IMQ&U.&./Q+?'IWKP
M  !5+I*_0[)OCE/<\1X#W>^:W>_ZT.B>\?SNUWGTI6M/?N=@$5;Z?N8W6^2E
MW]R2%G,?9U<DMCNCSRSW]/5A7WID_<-MI\5?\M(85CM(>EWYY[<Y4[EYJ5:+
MC]-#9_Y&W7_34EFG[>GD[+<5?X>]W]/66IW/V:VTWDME':=Q\5I\BI[;*Z>U
MU"R34U52RN317P5--)%-&JZ)JC7:+HFJ+H;JQF;EB<:)P>!O6*+T85QBTG;K
MI<V5VPR./,<<Q>>KR^"-\5)D]ZN-;=:R".1JL5L#JR:5L7B*K-6-1W+P55U4
MNWL_>NT[-4Z.*(B.HM6<E:M3M1&GCF<>J\N=])/3]N7EUVSO-,$ENV5WQM.V
MZW6*\WBB[Y*6!E/"BQ4=;#$G+'&UO!B:Z:KQU4FUO"_:HBBFK1'0CKPBYD+-
MRN:ZHTSKTS'4EM.V73YLYLY65]QVYP:DQZYW.%*>NNSIJFMJY(45'=WY36S3
MRHU51%5$=HJHBKV%J_FKM_MZL?XXH7;.6MV>TC#J\\Z6M;B=*VS&YN339CD-
MAKJ')*]C(;W=++<ZVUON4#&HQ(:Q*66-LC>5$371':?RB;><NVZ=F)T=&(G#
MDQB2YEJ*YQG''H3,<^$QB]U^Z7MB,DPC&MN+IM_!^9>(5;J_'K)15M?0-@JG
MHY'3++1U,,LCUYUU61[EUX]I-&=O45S7%6F=>J>JBO*VZZ8IF-$:8PQCJ,/C
M?2)T_P")7^SY/8,-N%'>[!615]JJI,CO]0V.>!R/C<Z&>XR1/1%3UKVJU?"B
MDUYV[73-,S&$_P M/8*,K13.,8^%5/5E90Q&0            !5*H^E=0?$R
M^XI#G]?ZFI[SZ,NB4?I:KO\ Z<+6G0'.P
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M>YSWT<#GN55<Y8VJJJO:JKH!^L4$,"*V"%D+5756L:C45?5X ?J
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MK#ZM9')Y&Y>M43%5.SAIF==41PSQ2MB=D<Q
M                                  "BG5MU9Y[TZ9%B-EP_9>JW1ILC
MMT];65]/+51I2OBF[M(E2GI*A%YDX\50)B,52/0Y_HWOQ\9V#\37!-3M$%(
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M/4+K78+Y3ON%CMCHHX'4]'4W:66GA6*)SHV*R-R-Y6*K4TT150*JG<D*
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MB8TQ,<<2T==%5%4TU1A,:XG6_4K4@
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M6AM"6.&2GET="Q*-*FJT5K>UW><?40V5-451C&ILZ:HJB)C5+>B4@
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M5L88[-.UAW6'8P32>\>1
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M3W%E$D"0S=UR*U]/-S:]NNJ!,1BJ1Z'/]&]^/C.P?B:X)J=H@I
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MF)^%/9N6_  $3[Z+IM'GB]G_ *L=Q_\ '::[>_FESD:C?_F%WO7(7G7^>O\
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M=0?$R^XI#G]?ZFI[SZ,NB4?I:KO_ *<+6G0'.P
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M'J;5JBU1%%$133$81$1A$1Q1#07+E5RJ:JIF9G3,SIF7[EQ0
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MLSZQTUVJHJIV-<:8[67LKV4O97U9JMWJ9IJVXT3HGMH7".CN9
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M7G/6W=]K)9^:;484U1%6'%CKCGC'H:DK'L7F0
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MIR2K5U-(J.5>S1%33P@B)E5'T.?Z-[\?&=@_$UP34[1!2
M                                     %8^I/;S+L_H\2BQ2R_##[9-
M6/K6]_30=VDK848O^L2QHNO*O9J>?W_D;V:IHBU3CACCIB.+CF'F/67=U_.4
MVXM4[6$SCIB->'',(-VOV+W/QS<'%+Y=\22AMELKV35M7Y902=VQ$5%7EBJ'
M/7M\"*:?=VY\U:S%%==&$1.G3'9:+=>XLW8S5NY7;PB)TSC3UI=#CW#H@
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M#>[JQVAW(R:H=T\IO!L9)41/QN\8E/KD%+"M/&LZ3TC'3OEY)$>J)W#$T_\
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M 6^\=S3QR\DC.\K'L<S5_'1O!0F(E3CT.?Z-[\?&=@_$UP34[1!2
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M?P%5V;6$11$PO79LX1%N)A:PL+
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MN'1T[VXFK72O;\&)=I4H]'3JLJIW/+Q>O-_.XA54[DA0
M                                    &@YQN+9< ^"_ABDKJKX6[_R?
MR)D3^7N.[YN?O)8]->\3337PGG/6#UGRVY/%^/IKJV]K#9B)[7#'':JI[J,-
M;=[FW#?WKM^*JIC8PQVIF.VQPPPB>)@,7WHQC++[0X_;K==8*RX=[W,M3% V
M).ZB?*[F5D[W=C%TT;VFMW3Z]Y+>>:HRUJBY%56.$U13AHB:M.%<SJCB9V\?
M5'-9'+U7[E5$TTX8X35CIF(X:8X^-+I[5Y8         13O-7;QV_"9ZG8JS
MX[?,^2KIVT]!E+IF6]:57+W[G+!/3OYT33E\?^)2Y;BB9^5CAT%RU%$S\O'#
MH*A?G7Z3WYLMD?;%S_M8R-G+\=7\=)D;.6XZOXZ2R6PMTZE+G29*[J-QO#,=
MK89J5,49ATE2]DL2MD\I6I\HJJI45KD9RZ*G:O:6+L6XPV)GIK-V+<8;$STU
M@2TL@                                  -4S/.</V[L<N39UDEOQ/'
MH)8X)[U<YFT],R29>6-KI'JC45R\$U7BO #BS@MNZ0=],PW W#ZC^HZZ99):
M\VO5#C."Y7?X[7:FV]LJ2T\UOCAJYIGTBLE1D3V2PH[D=K&@5Z86@P[;WIBZ
MLK/+9]G\6HMMK?T];D4DEMS+'K;0QR7-*!'2HZBK(5YU@JG<KU<]5<O*URM5
M>5R$:8=,0I      HIU;;W]*>U.18C;^H7:VEW O-VMT]1CM948U;+ZM/2LF
MY)(TDKW-='J_CRMX+VA,1*I'H<_T;WX^,[!^)K@FIVB"D
M                                            .=O4'LYN7F&Z-ZOV
M-XK/=+354]$R"MCFIV-<Z*G8QZ:22M=P<BIV'C=\;MS%_,U5T48QHXN+E<S]
M9-QYW-9ZJY:MS53,1IQC@B..6^=+.V.=X'?\JJ\MQZ:RTU?;X8:2622%Z/>V
M7F5$2*1Z\$]4R]PY&]EZZYN4X1,=!L/5'=.:R5VY5>HFF)IC#3''T)76/3O>
M
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MW:5M*YLJJJO18D:J.55U[0JJ=Q@H
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MX8X<&..'/A+&SV[<UDMGQ]$T[6.&/#AACU86?-FP
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MX%5-0F,5./0Y_HWOQ\9V#\37!-3M$%(
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MXS1.&/&W/JQF[MZS7;NU;4VZYIVNZB.KV,%BS=/2@
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M(DJ>O1T2-7F\/:$U.Y(4
M                   !SGWF_>;E?_'P^YXCY>]>O\UF.^C^FEWOU2_Q=GDG
M^J4R]+O_ -^?_LS_ .MGNO=%_=__ ,__ +'DO>/_ &__ #^@MF=G<Q
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M:(*0
M        !])(XYHWQ2L;+%*U621O1'-<UR:*BHO!45")C%$Q$QA*J=1TVWZU
M372AV_W8NV&XE>I7R5F.-B=,V+O$T>D4C9XNU.'8CM--7.T//U;CKHF8LW9I
MHG7'\3#R,^K-ZU-5.6S%5NW5KIPQPY)QCL]&4[[>8!8MM<9I<8Q]LCJ:)[IZ
MNKG5%FJ*B1$1\LBM1$U5&HB(B<$1$\!M\GDZ,K;BW1JZLO0;LW;:W?9BU;U:
MYF=<SQRW@RF>
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M[&B-?S1M:O,W@O:@34[C!0
M                     '.?>;]YN5_\?#[GB/E[UZ_S68[Z/Z:7>_5+_%V>
M2?ZI3+TN_P#WY_\ LS_ZV>Z]T7]W_P#S_P#L>2]X_P#;_P#/Z"V9V=S$
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M-]#G^C>_'QG8/Q-<"IVB"D
M
M                          ",MXLVRC;K;C(LRPS;VNW5R6S^1_!N!6V9
MT%57^45D%/+W<C(*IR=S'*Z9=(G<&*G#M00Y1X3O7U.8)O1N[NQ:NA/,)J/>
M*.T27W'YYZI:JFK+13OIFR4]Q;:D^\RM=S.B= NC^+7HB\H580L?T<IN1F&]
M/4)O)NSLK?-I<ISB"Q4ULBKH98:'X/H874[8(5FBC?-/]Y:^:55T7Q4:QB:Z
MB71H*0 !JEHP3![!=:R^V'#;'9+Y<4<EPO-!;J:FJYT>O,[O9XHVO?JO%=5
MR=]QW'\HM\EHR:Q6_(K5*YKY;9<Z6*KIW.9Q:Y8IFO8JIX%T _>TV>T6"WTU
MHL5KH[+::)O)1VR@@CIJ>%O;RQQ1-:QJ?81 *L]5O3ILSU!V_"Z/>'.+CA5-
MB]1736*6WW.W6U:A]4R%LR/6X4U2C^5(FZ<B)IKQUU0)B<'/#T7ECM>,]0W4
MSC=CJWW"R8]#);;/7RR,E?/2TEVEAAD=)$UC'J]C$55:U$7M1$0*JG<8*
M                                                         CF\
M[2[?9#<ZN\W>P>5W*N<CJJI\KJX^96M1B+RQS-:G!J=B'E\_ZF;ISU^J_?L[
M5=6N=JN,=&&J*HC5'$W^4]9]XY2U3:M7<**=4;-,]'7-,RS.+8-BV%^7?FU:
M_@WX2[KRW[_/-S]SS]W_ $TC]-.=W9IVF=NCU>R.Z=O\);V-O#:^555CLXX=
MM,\<ZF)O+?.;WCL_B*]K9QPT4QACACVL1Q0VTW35@
M                      (,Z@,DWVQ?#;9<.GO;VU;E9G->H:>YV*[UD-%!
M%:W4]0^6I;)/6435>V9D+$:CU71RKRKIJA,.;VV#/23;13;B1XCTR8?\#[@9
M)79:ZR5M[M<L5ONER:SRKR>2._12.A>]B.[M[E5O8US4"="W71%@^ZV'XQNC
M<-[L)IL1W.SG-JS(\CJH+A05RW!:V.-[)49;YIXZ>.->:-D2NUX*[^4$2NT$
M      44ZML.Z,<FR+$9^J"_4MGOU+;IX\7CJ+I74"OI%FUE5&TCFH[23PKQ
M"8Q5(]#G^C>_'QG8/Q-<$U.T04@
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MC%5[&([5J:<>' *JG<D*
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M9J1TW-(]&.]?H_AJ$QBJ1Z'/]&]^/C.P?B:X)J=H@I
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MRLH;M+3MD<C>"*Y&:JB!54[C!0
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MDEYY')',]JR:/X:IV=@3$RI3Z'/]&]^/C.P?B:X)J=H@I
M                                                         %&N
M@[]W68?*-?<E.:C=':5<KEWNH_QUW[V?Z:5Y3;NH@  !%FYV]NU>S=)25>Y.
M:4&+I<>;X.I9U?+4U')HCEBIX6OD<B*J(JHW1/"I>LY>Y>G"B)E:NWJ+48US
M$,/MCU$[-;PK71;?YQ1WJOMD#JFY6AS):>L@B9IS/=!.QCU:BJB*YJ*FO#4F
M]E;MG#;IPQ+=^BYCLS$X(\EZX>E6&62&7>"WLDB<K)&+17+@YJZ*G_-?5+\;
MMS$_,E:G.V(G":XYV<M'5[TY7ZVY'=[/N;27"W8E1QU^1U,5%<%2DII9XZ9D
MKT6E1W*LLK&JJ(NFNJ\.);JR-ZF8B:9B9U*Z<U:KB9BJ)B-?03M;<FQ^[XY2
M9=;+O2UF,UU VYTM\CD1:=]&Z/O4FY^Q&\G%=>SPF/-,Q.$ZUZ)B8QC4Q&![
MA8=N;84R?!;TS(; ZIEI([I%%-%%)+ J)(D:S1QJ]$5=.9J*U? I-RW5;G"J
M,)137%48Q.,-S*%2!,WZH=@=N<BFQ/,]S[39<BIE:E9:U2>=\"OT5$G6GBD;
M$NBHNCU0R;>3O7*=JFF9A8N9FU;G"JJ(GE339[Q:LAM=!>[%<:>[V>Z0LJ;=
M<Z21LT$\3TU:^-[%5%1?L&/-,TSA.M>B<=,-=Q_<3"LKR++<3QS(J:\9!@LL
M$&64%-SN\BEJ6N='&^3E[M7:,75&N56JFCM%X%=5JJFF*IC1.I$5Q,S$3IC6
MT#.^I?8C;+(OS3SG<NU6#(FI&LUID[Z:2%)6M<Q9^XCD2+F:Y%3O%;P77L+M
MK*7KL;5%,S"W<S%NW.%541/*F2UW2VWNW4-XL]=!<[5<X&5-NN-+(V6&>&5J
M.9)&]JJCFN1=45#'F)B<)7HG%[R          4;K_ISV7Y-O]P3FH_ONEUG,
M<S^L;/W,]2M>0V[IP                   $5;V[5TF]>V&3;:5N07'%8LB
M\BDBR&TN:VLI)[?6P5\$D2N33^EIVH[L7EUT5JZ*A,2YW7^R=<_25:YKY1[Z
MX9O=MG;%1?(=QZR.T7%6)ZYC:VOJ(U1W+P;S5[TU3A'X%)T2L9T>]9MJZK8,
MKH/S(JL+R7"8J.6]0I61U]!,VK=*QCZ>=K8GZ\T+E5KH]$331[@B8P7:" #Z
M22,B8^65[8XXVJZ21RHC6M1-5557@B(@'-'&.I#<+='K"VHI\<K);7T[9+1Y
M;08>QNB?G/)8:54J;PYJLU\G\I<D=-XW%(W/5$Y@JPT)1W&R;</=SJ37IZP?
M<*Y;789@6*093N;D^/LIOANMJJ^?NJ*VTL]5%.RG:D>DSI$C55U5JIIH$<#*
M;%9IGN*;W;E]-&Y.9U&XL^/V.BS7;7-;A%3PW.IL57,M+4T]>E.V-DCZ:I5K
M6R(Q%>BJJ\J<K4$O1U==(MNZL+=@]ON&<5.%)A537U$4M/0,KEJ%KF0,5KD?
M/#R\O<_9UU!$X.?7HN,:9AG4'U+8?%5NN$>)T[[-'7N8D;IVT%VEITD5B*Y&
MJ]&:Z:KIZH55.Y(4
M                      !YWTE))/'4R4L3ZF)-(JAS&J]J?8<J:H6JK-NJ
MJ*YIB:HU3AIYUR+M<4S3$SA/!CH>@NK8
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MTO>N65*NFJU5R+V:*B:> $3,*H^AS_1O?CXSL'XFN":G:(*0
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MSK&KY%:LBLYM.9VFO:O:$U.Y(4
M
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M3M$%(
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M         "C=?].>R_)M_N"<U']]TNLYCF?UC9^YGJ5KR&W=.
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MA54[EA0
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M<^HAY=.S310F)P5(]#G^C>_'QG8/Q-<$U.T04@
M                                                 "C70=^[K,/E
M&ON2G-1NCM*N5R[W4?XZ[][/]-*\IMW40        !!^XG3]@^YU^9D617')
MJ6OCI8Z1L5IOE;;J?NXU<Y%[FGD:SF\9=5TU4OVLQ-N,(B.G$2MUVXJUX\\P
MT:+H]VJBDCE9><YYHG(]NN5714U:NJ:IWQ<G.53P4\T*8LQ'#///96I,1>
M             *-U_P!.>R_)M_N"<U']]TNLYCF?UC9^YGJ5KR&W=.
M              AS?V\;46':?*[GO7:J:^[>110QW6R5%'Y>ZLFFF9%2P4],
MB*Y\[YW,2/ET5KM'<S=.9"8<R,-H:;.W9)M7L)-D28]\&+=Z[I%ZAK14I;*R
MTPU#(N_L%S=)/4T;8I',[M%D<B/<U[M.5="5N^DUVU&+W3)=O,?Z>+CTZ;GQ
M43+CE>/5].^KBKZ6"5(4GH;\CI8ZZGCDF1$T>W17+HSM4(E=\(      IWU=
M=/\ NKOS;L'I-KMW*G:B?&JFOFO%13U-=3K6LJ60-B:JT4D:KW:QN7QM?7<
MF)P<^O1<66XXYU!]2V/7BY.O-VL-.^W72\.<]SJNII;M+#+.KI%5ZK(]JNU<
MNO'CQ"JIW)"@
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MMT=+3VYE:DZ33=[SJY]1#RZ=FFBA,3@J1Z'/]&]^/C.P?B:X)J=H@I
M
M      %&N@[]W68?*-?<E.:C=':5<KEWNH_QUW[V?Z:5Y3;NH@
M                 *-U_P!.>R_)M_N"<U']]TNLYCF?UC9^YGJ5KR&W=.
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MR2_?'K)(U7<S_&775>(55.Y(4
M
M          (EWBV7PW>_'*#'<O?<Z!UFN4-XQ[(;'6/M]TMM="U\;9Z6JCU5
MCE9(]BHJ*BHO9JC50F)8393IYP;8M,DJ<:N&09)D&8/I79-E^4W*2ZW2L90M
M>RFC?.]&(C(DD?RHUJ=O'7AH)G%.H0       HIU;=&5TZG\BQ&_6_>*JVS9
MB]NGH)*&GM;[@E4LTW>]XKF7&BY>7LTY7?PA,3@J1Z'/]&]^/C.P?B:X)J=H
M@I
M              %&N@[]W68?*-?<E.:C=':5<KEWNH_QUW[V?Z:5Y3;NH@
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MR*[-D?,VJKH+M+'4SI)(UCWI)(USN9S45==51%"JIW)"@
M
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M5S/*999DD;)_JCV)XJ<./$$3@JQZ'/\ 1O?CXSL'XFN":G:(*0
M
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M!]2UORRL;<<IH:=]/DMP:_O&SW"*[2LJI4>K6\R/E1RZZ)KZB!-3N2%
M
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M
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M5O16(UJHZ5'+P1$]1 JJ=R0H
M
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M$%(
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M-3M@25)?)EK$HD<LRTG?>)WNNOAY#,G)U1.SC\K#'#K<O068OTS&U\W'7_'
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MM_N"<U']]TNLYCF?UC9^YGJ5KR&W=.
M%+NL:R]6=XMN!MZ5KM\%7""IKUS-W?VV#GA<R#R1-;BUR+HY)/6?Q^ )C!07
MT6L620;_ /4G!F4G?9?#3.9E4VL;N>Y-NLJ5;N:+Q%UFYEU;XOJ< JJ=RPH
M
M                                                      "BG5ML
MOU6;HY%B-?T];R4NV5FM=NGI\BH*B\7.V+553YN>.1&4%'4M?RLX:N5%^P$Q
M,*D>AS_1O?CXSL'XFN":G:(*0
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M
M                                                       **=6V
MVO5[G.18C5]-NY5+@UDH;=/%DM)45[Z-9ZMTW-&]&MI:CFT9PUU0)C!4CT.?
MZ-[\?&=@_$UP34[1!2
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MI-S)HWQ?4X!54[EA0
M
M          4YRG>S>7--WLSVBZ=,<P^H=M334$FY.=9Q/7?!S*ZYQK/36NBI
M[=I*^7NFJY\BN5K%U:YJ.1$>3@D/IZWIN>[EFRVVYAC+,)W/VRODN-[BXI%.
ME33Q5<;&RQ55)-VOIZF-W-&J\>#DU<B(YPF$#]85@ZU[QDF'2=+-Z^"[!#;)
MVY5'Y3:8.>L69%B72XM<Y?O?\W@",%6/0Y_HWOQ\9V#\37!-3M$%(
M
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MK=W>[.MX\ N.(3YY1-J_+*N)D,-175->^JG;$UCW::*]5T\"!%4NOH4@
M
M                                                %&>D=&P[I]:=
M)5M>E[9NU-45'>/YE\AJ*1CJ'1.9=$Y$=IP3AHG@T0F6FX(S+:G?CTEL^ULC
M8<NFM6(4V!52I"D+<DAQ>L;'JE4U8=6U:L5_>-5B_P K5H3Q*Z_!/IC/UGMG
MX/"?>@-"=O1Q=-^[/3M9=UJ+=6Q4UDJ,IK;3-964]=35J2,I(ZILJN6FDD1N
MBRM[>T%4XNE@4@
M                         "C70=^[K,/E&ON2G-1NCM*N5R[W4?XZ[][/
M]-*\IMW40   Y:>E=1%V6P/U?SN;HO\ ]#G,+/=K'*];ZG^<U][UX9OT5GT=
MLC^7%P]Q4).2[2>51ZW^=QWD=673 S'E0                    %&Z_P"G
M/9?DV_W!.:C^^Z76<QS/ZQL_<SU*UY#;NG
M  *O[M;&9A>]Q['O;LSG%%@.Z=KLK\9O*7>@6XV>]69\WE+*>L@CDBD:^&;Q
MV2,=S?R5X::$XLELCLA>\!R'/-S=Q\OBS_=[<QU''D5^I*/R"WT5!;XU926Z
MW4ROD<R*/55<YSN:1='.35-5$RL<$
M
M                        !5//NG+*:O<F\[M;)[PU.RF9YC0TM!N U;+2
MY!;+RVA:K*.HEHJJ6!&5$+%Y$D1Z^+PY>+E<3BD39#9:S[*8W=K;37FMRS)\
MLN]3D.>YQ<T:E;>+M5JBRU$C(_$C:B(C61L\5K4\*JKE$RF@(
M
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M\FW^X)S4?WW2ZSF.9_6-G[F>I6O(;=TX
M
M
M
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M[MXQ.NF<)ZJQYBKP  HW7_3GLOR;?[@G-1_?=+K.8YG]8V?N9ZE:\AMW3@
M
M
M
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M #JUVZG=5W"Y8]<Z6AI6>NEFFI)61L;KX7.5$0Q*)PJB>BR)U.<F+[.;H4>
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M*BU%/3JG*O#@BA$Q@MN$
M        <DMR.L;K?QC<3/<:Q/I*N&28KCV1W6V8UD3,7R6H;7V^DJY8:6J;
M- O=2)-$QKT<SQ5UU;P"K"&E>?%U_P#U,+G_ '2RK[H&$'GQ=?\ ]3"Y_P!T
MLJ^Z!A#7<I](EUHX-:7W[-NEF+#[%'*R&2]7O'\CM](V61=&,6>IEC8CG+V)
MKJH3LP]UDZ_^N/)K30W[&^DF7(+%=(DFMEZMN-9-5TE1$JJB/AGA>]CVZIVM
M54!A#*>?%U__ %,+G_=+*ON@C"#SXNO_ .IA<_[I95]T#"#SXNO_ .IA<_[I
M95]T#"#SXNO_ .IA<_[I95]T#"&D9/Z2_JVPFY6NS9GTXVS$;Q?-/@2U7JSW
MZ@J:S5Z1IY/#43QOEU>J-\5%X\.T)V8;OY\77_\ 4PN?]TLJ^Z",(//BZ_\
MZF%S_NEE7W0,(//BZ_\ ZF%S_NEE7W0,(//BZ_\ ZF%S_NEE7W0,(//BZ_\
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M/ >F6CSBVT4_DM9<,?L>07."&?E1_=224LTC6OY7(O*JZZ*BA.S#;?/BZ_\
MZF%S_NEE7W01A!Y\77_]3"Y_W2RK[H&$'GQ=?_U,+G_=+*ON@80>?%U__4PN
M?]TLJ^Z!A#7<I](EUHX-:7W[-NEF+#[%'*R&2]7O'\CM](V61=&,6>IEC8CG
M+V)KJH3LPR-HZ^NNC(+707RP=(D]\LMU@956N\6_&,FJ:6I@D3F9+#-$]S'L
M<BZHYJJBA&$,CY\77_\ 4PN?]TLJ^Z!A!Y\77_\ 4PN?]TLJ^Z!A!Y\77_\
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MS,X:L5J3$7P    4;K_ISV7Y-O\ <$YJ/[[I=9S',_K&S]S/4K7D-NZ<
M                                   "GG7[]$#>SXLH?]J483&M@_1Q
M?0QV;_[0_P#M%<P5:UWP@   .+OI;?TDZ4?C/)/QUB"JEVB"D    '$+"/\
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MG_M)(%=.IV]"@   *-=!W[NLP^4:^Y*<U&Z.TJY7+O=1_CKOWL_TTKRFW=1
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MW772FOE;CULK+U1\GDEXGI(9*J+NU5S.29S%>WE555-%X 9P
M
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M&W=.
M
M
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M\     !1NO\ ISV7Y-O]P3FH_ONEUG,<S^L;/W,]2M>0V[IP
M
M
M
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M/9?DV_W!.:C^^Z76<QS/ZQL_<SU*UY#;NG
M
M
M
M                   %&N@[]W68?*-?<E.:C=':5<KEWNH_QUW[V?Z:5Y3;
MNH@ #G_UR_\ 7'31_O!9^*:8>;^;RMUN?_R=ZFHI9+Y3M3^$"(^@;]"MWO\
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M&87P6QM7+WTW))*^9W/)HWF7FD7P%N[=JNU355KE5;HBBF*:=4-X+:L
M"C=?].>R_)M_N"<U']]TNLYCF?UC9^YGJ5KR&W=.
M
M
M
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M97<J(B)HU$1/43BJKQ,>U;BW&$,/-9FK,5[4Z$PEQC
M  4;K_ISV7Y-O]P3FH_ONEUG,<S^L;/W,]2M>0V[IP
M
M
M
M                          !1KH._=UF'RC7W)3FHW1VE7*Y=[J/\==^]
MG^FE>4V[J(   <Q_2E?N<P7Y6-]QSGI/5G[>KO>NUV\NTCE9CT7W[@,C^6M?
M[BH2CUE\YCO8ZLJMW?9SR]:'2 \\SP                    %&Z_Z<]E^3
M;_<$YJ/[[I=9S',_K&S]S/4K7D-NZ<
M
M QE?>[-:D<MTN]%;48U'O6JJ(X=&JNB*O.Y-$52NFW55JB94S5$:Y:?7[N;4
M6OO/A/<[$[=W7*DOE5ZH8>7FTY>;GF3375-"]3DK]6JW5/2GL+<YBW&NJ.>&
MGUW4ST_6_F[_ '@Q:3E?W:^37"*JX\>*=PLFJ<.WL^R7Z=U9NK5;JYL%N<[8
MCY\<[SXUU0;$9CD]IPW&-PJ:]9)?)I(+7;Z>DKE25\4;I7IWRTZ1-3E8JHKG
M(B^#4F[NG-6J)KKHPIC7ICLHHSUFNJ*::L9GE3V:YE@
M
M                                                  "C70=^[K,/
ME&ON2G-1NCM*N5R[W4?XZ[][/]-*\IMW40   Y@^D^J*6X;6X=9Z*NI*B[4>
M2,JJJTMJ(_*FPNIIHTD[GFYU;S*B*NANMQ9ZQEKU4W:XIQCAY47-TYO.TQXB
MW55IX(9GT94]+0;)7VRU=;217FHRNMKH[3W\:U7DSJ6DB25T*.5[6JZ-R)JG
M@*=^9VSF<Q$VJHJC9C5RR6]UYK)487[=5.GAATE-.D
M  !1NO\ ISV7Y-O]P3FH_ONEUG,<S^L;/W,]2M>0V[IP
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M5VXB:ZJJYB,)U35,N?>O&6M6,WE8MTQ3&%>J(CBXG6<Z,T
M
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M/ZQL_<SU*UY#;NG
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M>*B<$--F=X9G-?;7:Z]./RJIJT\>F99E%JBCM:8CDC!ZC$7
M $6,^E5TW_\ &WKW&\^L/_S[_A-Y?>6^I+EGK_YYE>2OK.JQU9YH
M
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M;?[@G-1_?=+K.8YG]8V?N9ZE:\AMW3@
M                        8'*;+-DF-9!C]/=ZW'ZF]6^IHJ:_6Z5\-712
M3Q.8RI@D8YKFOB<J.;HO:A<LW/%UQ5,1.$XX3JGH2HN4[5,QCACPJ5U_1/?+
MIWBW/J:W)N/?<JR^55TLW-RZ(WFYYUUTT30WM._J:=5BB.E\36SNV9UW*FH5
M_HYL=NBJMSWBRFXJY_>.6JBAFU?IIS+SO7CHO:7Z?6>NG5:IA;G<],ZZY8W_
M  S<&^<V^^TZ;[95[57?)QSRC\EH[J3_  S<&^<V^^TZ;[8]JKODXYY/R6CN
MI?M#Z-7#:=7+3[J9# KDT<L=-3M54^SHJ%%?K-57VUJF>72KHW3%':UU1R,Y
M3^C\HJ156DWUS2E5=-5B<UGK>SULB=G@-;?SF3OZ+F3LU<M%,Z]>N&719S%'
M:YBY')5/997S&J_ZQVX7MI_LQJ/RO</^JR?_ $V_J,CQN?\ 2[WAU=D\QJO^
ML=N%[:?[,/RO</\ JLG_ --OZAXW/^EWO#J[)YC5?]8[<+VT_P!F'Y7N'_59
M/_IM_4/&Y_TN]X=79/,:K_K';A>VG^S#\KW#_JLG_P!-OZAXW/\ I=[PZNR>
M8U7_ %CMPO;3_9A^5[A_U63_ .FW]0\;G_2[WAU=D\QJO^L=N%[:?[,/RO</
M^JR?_3;^H>-S_I=[PZNR>8U7_6.W"]M/]F'Y7N'_ %63_P"FW]0\;G_2[WAU
M=D\QJO\ K';A>VG^S#\KW#_JLG_TV_J'C<_Z7>\.KLGF-5_UCMPO;3_9A^5[
MA_U63_Z;?U#QN?\ 2[WAU=D\QJO^L=N%[:?[,/RO</\ JLG_ --OZAXW/^EW
MO#J[)YC5?]8[<+VT_P!F'Y7N'_59/_IM_4/&Y_TN]X=79/,:K_K';A>VG^S#
M\KW#_JLG_P!-OZAXW/\ I=[PZNR>8U7_ %CMPO;3_9A^5[A_U63_ .FW]0\;
MG_2[WAU=D\QJO^L=N%[:?[,/RO</^JR?_3;^H>-S_I=[PZNR>8U7_6.W"]M/
M]F'Y7N'_ %63_P"FW]0\;G_2[WAU=D\QJO\ K';A>VG^S#\KW#_JLG_TV_J'
MC<_Z7>\.KLGF-5_UCMPO;3_9A^5[A_U63_Z;?U#QN?\ 2[WAU=D\QJO^L=N%
M[:?[,/RO</\ JLG_ --OZAXW/^EWO#J[)YC5?]8[<+VT_P!F'Y7N'_59/_IM
M_4/&Y_TN]X=79/,:K_K';A>VG^S#\KW#_JLG_P!-OZAXW/\ I=[PZNR>8U7_
M %CMPO;3_9A^5[A_U63_ .FW]0\;G_2[WAU=D\QJO^L=N%[:?[,/RO</^JR?
M_3;^H>-S_I=[PZNR>8U7_6.W"]M/]F'Y7N'_ %63_P"FW]0\;G_2[WAU=D\Q
MJO\ K';A>VG^S#\KW#_JLG_TV_J'C<_Z7>\.KLGF-5_UCMPO;3_9A^5[A_U6
M3_Z;?U#QN?\ 2[WAU=D\QJO^L=N%[:?[,/RO</\ JLG_ --OZAXW/^EWO#J[
M)YC5?]8[<+VT_P!F'Y7N'_59/_IM_4/&Y_TN]X=79/,:K_K';A>VG^S#\KW#
M_JLG_P!-OZAXW/\ I=[PZNRV; .C2DPK<3$MQ;ANWE&9U^(2SRVZAO*MF9]_
MA?"]J/>]SFHJ/U\7MT0S\O=R>3L5V,GE+-BFO#:\513;QF-4S%,1CTUFNS>N
MW*:[UZNY-.K:F:L,>+&9P76,)E
M                                  CK='<']F6*393^:E[S/NJF&F^!
M,?I_*JUW?*J<Z1ZIXK=/&4R<IEOQ%S8VHIZ,Z(6;][Q5.UA,\BIE;UL9+&J_
M!W3!N+5)SJC5J:2:GU9QT<O)2S<?L?YS<T[AHX;]'/\ '# G>=7!:J_CI-2K
M.N#>!RZ6_I+R>)$<OCU$MPDYF^#Q66EG*O\ &I>IW!E^',4_!]9;G>=W@M3\
M/8:E6=:G4V]4\@Z:ZFF35>9*BUWJ?5/ B<C(N*>$OT[BR7#?^&E;G>68X+?P
M2U"KZP>L^I1B0[+P4'+KJL&*WMW-KIIKWU3)V>#3^,O1N3=T?^7'_E3V%N=X
MYN?F?!+5*KJ=ZY:K1(\7O%M1&JBNIL.>]55>Q52:GD["[^5;MCYT3RU]A:KS
MV=X*?@^*6MU6^77%7II55V>P^(K%\EPZ"#M[>,-'%Q^SVD3D<E3VM%J>6Y/8
MEAW,YO/@ICGF.I1+6ZK/>KVO14J[QO$G-&L:^24%=2<%[53N6MT7CP7M^R4>
M)MQVM&7Z=<S]%AUW]\SJBF.G7UJ8:U5S=15RY_A23>ZX]XSNY/*'7>3F;_-7
MGYM4X]A;F+\=I^$CI3UIAA7/SZK5-'3\9/7AK=7AFY-Q[SX3P/<VY]ZU&2>5
MT5PEYFIX%YF\4*=K>,=K>RT<D3V6%7E/6"KY]OP:^OBQ[=L<D3MV9S9W\-IN
M'_N(8]=.]ZM6<LQR13UZ98=>ZO6&K5>ICDH[-,O4S;S)V=FRN8+_ .%9*QW^
MEBF/5E-[5:\];YXCJ0QJMP>L%6O,?^V8ZE+T-P;+&\6[*97KVHOYO5"_Z8C$
MKW1O*O7GX\.J.HQ:_53?M>O,U<]<=1ZF8GG$?]'L[F#..OBV&I3CZO",QJ_5
MS.5]MG:9Y:ZF-5ZD;WJ[:_,].M^Z8[N$U-$VFS5$]1+)5^QF+5ZG7:IQG,VI
M_P"4L:KW>;PKG&JN)Z578?/YO[A_-/FOY$J_8RGV+K](M<ZG]N<]W4<U78/S
M?W#^:?-?R)5^QCV+K](M<Y^W.>[J.:KL'YO[A_-/FOY$J_8Q[%U^D6N<_;G/
M=U'-5V#\W]P_FGS7\B5?L8]BZ_2+7.?MSGNZCFJ[!^;^X?S3YK^1*OV,>Q=?
MI%KG/VYSW=1S5=@_-_</YI\U_(E7[&/8NOTBUSG[<Y[NHYJNP?F_N'\T^:_D
M2K]C'L77Z1:YS]N<]W4<U78/S?W#^:?-?R)5^QCV+K](M<Y^W.>[J.:KL'YO
M[A_-/FOY$J_8Q[%U^D6N<_;G/=U'-5V#\W]P_FGS7\B5?L8]BZ_2+7.?MSGN
MZCFJ[!^;^X?S3YK^1*OV,>Q=?I%KG/VYSW=1S5=@_-_</YI\U_(E7[&/8NOT
MBUSG[<Y[NHYJNP?F_N'\T^:_D2K]C'L77Z1:YS]N<]W4<U78/S?W#^:?-?R)
M5^QCV+K](M<Y^W.>[J.:KL'YO[A_-/FOY$J_8Q[%U^D6N<_;G/=U'-5V#\W]
MP_FGS7\B5?L8]BZ_2+7.?MSGNZCFJ[!^;^X?S3YK^1*OV,>Q=?I%KG/VYSW=
M1S5=@_-_</YI\U_(E7[&/8NOTBUSG[<Y[NHYJNP?F_N'\T^:_D2K]C'L77Z1
M:YS]N<]W4<U78/S?W#^:?-?R)5^QCV+K](M<Y^W.>[J.:KL'YO[A_-/FOY$J
M_8Q[%U^D6N<_;G/=U'-5V#\W]P_FGS7\B5?L8]BZ_2+7.?MSGNZCFJ[#%7O$
M-R+G;*FAAVJS-DD_)RN?9*SE3E>URZZ1JO8AMMQ^K?X#.47Z[]N8IQT1.G33
M-/7;7<GJ1F\AG*+]<Q,4XZ(BK'33,<71?T56-CX[+:(Y&JR1E%3M>QR:*BI&
MU%147L5#67.VGE=TIU0RA0J              4:Z#OW=9A\HU]R4YJ-T=I5R
MN7>ZC_'7?O9_II7E-NZB  *.]7WZ:=,/RY=^+B,#.ZZ.7L/7^J_V6:^[[*P1
M4P'RG:G\($!=$?\ U!O1_O+N_P"+A&2[6>5G>MWVMC[JGJRRL_4[F>:Y)DEA
MZ>MF)MV;7B54M!?,YKKU3V*T>61IK+!2OFBE?4*WUJJG*B+QXMT5=_&1HMTQ
M-ZO9F>##&?B>"G-UUU3%JC:PX9G".EQMGV[ZE&9;-N+BV68%7;=;J[96N6\7
M[;^NJXZILU&R))(ZBDKX8T9+$]7-;S<B:<R<%+=[);&S535M453A$]F%RSFM
MN:J:HV:J=<=>)XD68'U4[_;C8E;,ZQ7I(?=<6O$;Y;?74^;T'>R-C>K':034
M$3^UJ]I?NY"Q:KFBJ[A,?RSV6/:SMZY1%=-K1/\ -\26ML^J3!,]P/.\RO%%
M7X%7[5.EBW-Q2[,5U9:9(N\T1W(GWQ']TY&JB(JJBHJ(8M[)UVZXIC3M:ICA
M9EK,4UTS.K#7$\"*(NLS*J#'L;W,S+I^NV)[)Y-6TU+2;@.O=)55<$-9)W<%
M54VED+9&1N545521>'9S<$6]^ IF9HIKB:XX,)PT<4K7XJ8B*JJ9BF<-.,8Z
M>./C7P-<S              %&Z_Z<]E^3;_<$YJ/[[I=9S',_K&S]S/4K7D-
MNZ<
M
M
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M83)           !1NO\ ISV7Y-O]P3FH_ONEUG,<S^L;/W,]2M>0V[IP
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ML[P?;^WP7?/<RL>$6JJJ$I::YW^XTUMIY)W-<](F2U4D;'/5K'*C4771%7P
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ME@N4"4]3%44O*KV/8U\C>+7M<BHY>"IX=4"9C!,00
M
M                #X5431%5$5RZ-3U5[0/D
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M_K&S]S/4K7D-NZ<
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M04@
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M9G61Y^F#;J7?'[#=\IN4UTKVT5%'#'&QU1.JKQY>94:B-YE54:FH52Z#!2
M                      %&N@[]W68?*-?<E.:C=':5<KEWNH_QUW[V?Z:5
MY3;NH@ "CO5]^FG3#\N7?BXC SNNCE[#U_JO]EFON^RL$5,!\IVI_"! 71'_
M -0;T?[R[O\ BX1DNUGE9WK=]K8^ZIZLKN&:\B                   !1N
MO^G/9?DV_P!P3FH_ONEUG,<S^L;/W,]2M>0V[IP
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M+B[>Y:$*JM;ID%(
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M[35M[)::KB;-"]/_  F/10I4 ]'M_P#I7?[[\C_Y,*JG18*0
M            HUT'?NZS#Y1K[DIS4;H[2KE<N]U'^.N_>S_32O*;=U$  4CZ
MVJ2NME@VLW+IZ22LH=L\PIJ^]QQIS*RDJ&\CI%3U$>UK?_&,'.QHBKBEZWU2
MKIJN7;$SA-RB8CEA-ULN=OO5OH[M::R*X6VX1-GHJV!R/CDC>FK7-5!$XZ6+
M71515--483#R9#?[7BMCNN1WJJ916NS4TE76U$BHB(R)JN5$U[5731$\*\"*
MIB(QE59LU7JXHIC&9G!%_1#::Z+:O(<LKJ62C;N'EUUO]MAE:K56DE5D4;]%
M\#EC<J>JG$KR43L8SPRN>MUVF<W3;B<?%T4TSRZ^NN29CRP
M      %&Z_Z<]E^3;_<$YJ/[[I=9S',_K&S]S/4K7D-NZ<
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MZX?+B[>Y:$)JUNF04@
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MW2ZSF.9_6-G[F>I6O(;=TX
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M))-!9K531TM.V29ROD?R1HB<SE755 VD
M                                                         !X;
MG1?"5MN%O[SN?+Z:6G[[3FY.]8K.;EU3737734"C/1WLMU-]/UEL^U^<7';"
MZ[2V5MRGIZVQ27J7(WU=9.ZH9SNJ88*3NT<]VJ(SF1-.*]H3,Q*^@0     !
M6*/IYJ:SJIJ.I'(\JBO%-:,4;C.WV'I1N8ZU+)QJ:I:E9G(]S^\J$1$C3Q9=
M%7Q4U)QT+.A            -"W+_ &H?F=<OV.?FM^T#GI_@C\\O+?@?D[YG
ME'?_  ?_ *QKW7-R<O\ *TUX:@5\Z/MBMQ=D+#NDNZ%SQRXY/N5G%?ET[<6D
MJY:"%*Z.+GC:M;!!*FDC7Z-5':-T\=5U"9E< (
M  "C70=^[K,/E&ON2G-1NCM*N5R[W4?XZ[][/]-*\IMW40
M             %&Z_P"G/9?DV_W!.:C^^Z76<QS/ZQL_<SU*UY#;NG
M
M
M
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M/GWR3\%)[\'Y3_//-\9^WN9_V%[X?KGF;WCY]\D_!2>_!^4_SSS?&?M[F?\
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M/GWR3\%)[\'Y3_//-\9^WN9_V%[X?KGF;WCY]\D_!2>_!^4_SSS?&?M[F?\
M87OA^N>9O>/GWR3\%)[\'Y3_ #SS?&?M[F?]A>^'Z[==K^ER+;O/J+/ZW<*Y
MY9<+?2ST\$%93HQ5[^-8M72NFE<J-:YVB)IQ\/@6]E]WQ9KV]K%L-R>HWY?G
MJ<Y<S-=VJF)B-J..,-<S5.$8SH6O-B]\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M).ZD8J2=R^1&+KP?IJ$PGB&:*HABJ()&RP3L;)#*U=6N8Y-6N1?"BHH0_0
M
M
M
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M17*B(FNB<> 4O4
M
M
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M% M]LM14Z)%D&6W&)8X)86(Y56*UP<SD>J)]^?RIS-10G@6K"
M
M
M
M
+            _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>tm2227887d4-lc_5lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_5lnp4c.jpg
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M# P,# P,#/_  !$( IL&T0,!$0 "$0$#$0'_Q #R  $  @,! 0$! 0
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M_]H # ,!  (1 Q$ /P#OX
M
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MUK$A
M
M
M                       JQWN?-/WI\6I?YV,)C6L7C']F\>_!E)_,L"&<
M                                                   :/LW^[;8/
MQ:NWN.4"+.T3YKVA/B/9_<K F=:Q80
M
M
M                                                *L=[GS3]Z?%J
M7^=C"8UK%XQ_9O'OP92?S+ AG .9^M^_3(LY[QKMVS5&OK=06*BR3*,>ILGC
MK)GU:KCL-=(D[XE8C%\Y:)4Z4XZ>KTKQXE6&A>3<V>U&K=3[%V/26Z.[U6$X
M_7WBFMDTBQ1SR4L+I&,>]J.5&JJ>/"!3"N/9+W57[NIQ3-K_ '_$Z#%*G%+M
M!;X8;?/+.R9D\'F]3O-1%145%3P4)F,%V@@
M     :[E^46G!\3RC-;_ "20V+#[16WN]2PL661M);X'U,[F,3Q<Y&1KPB>D
M"%>WCNBUEW-V[)KEK=MXACQ*IIJ:[P7BD92R(ZK8]\3F>7+,US5\MR?9<IQZ
M/0$S&"Q@0           #1]F_P!VVP?BU=O<<H$6=HGS7M"?$>S^Y6!,ZUBP
M@
M
M
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ME BSM$^:]H3XCV?W*P)G6L6$
M
M
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MCJZZGITME1:Z2.EJ8)FN<Q6=#X5Z.6IU-Z7-3AR!3,:4?=YF'XWW/]GU]RC
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M/8]YHHK==\OL-+7W2D@14A2H<WIE=$CE548YS5<U%5>$5/%?2%,I@"
M-'V;_=ML'XM7;W'*!%G:)\U[0GQ'L_N5@3.M8L(
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M3&B,6IWUT+O[LRTYBJY35$3$3$1,3IG!8$]>\8
M
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MDP      :/LW^[;8/Q:NWN.4"+.T3YKVA/B/9_<K F=:Q80
M
M       %4NTK^QV3?AE/<\1X#W>^JW?'[T.B>\?UNUXGTI6M/?N=@
M                    *I5'SKJ#\#+[BD.?U_B:GQ/HRZ)1^%JO'^G"UIT!
MSL
M                           JQWN?-/WI\6I?YV,)C6L7C']F\>_!E)_,
ML"&<                                 #$WZQVK)['>L:OM&VX6/(:&
MIMEYH'.<QL])5Q.AGB5S%:Y$>QZIRU47ZB@1EJ7M^T[HMEZ9JC!J/$%R%85O
M4T,M342U"4ZO6)KI:J69_2Q9'<-143Q] 3,XIC"              &C[-_NV
MV#\6KM[CE BSM$^:]H3XCV?W*P)G6L6$
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M,ON*0Y_7^)J?$^C+HE'X6J\?Z<+6G0'.P
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M,.RFA][,CQK$[7;[Y;O,CE6GJH:=C98E?$Y['*QW**K7*GU%5 2F@(
M
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MW%(<_K_$U/B?1ET2C\+5>/\ 3A:TZ YV
M
M
M
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M!::-L37M5S&(KNI[N5]''H)JO5544T3JIQPZZFFW%-4U1KG#M)0+2X
M    %4JCYUU!^!E]Q2'/Z_Q-3XGT9=$H_"U7C_3A:TZ YV
M
M
M
M                            !5+M*_L=DWX93W/$> ]WOJMWQ^]#HGO'
M];M>)]*5K3W[G8                           "J51\ZZ@_ R^XI#G]?X
MFI\3Z,NB4?A:KQ_IPM:= <[
M
M
M
M      JEVE?V.R;\,I[GB/ >[WU6[X_>AT3WC^MVO$^E*UI[]SL
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M&K46.!*BY5T*.XZ?.I+?%4S1\HJ*G6Q.4\?0$8-BU-O[3F\Z6NJ]4Y];LO\
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MY57-6-JU%517%JT]-$KG=$$21(C&^">RC6(J-:5<#MP%
M
M
M
M   JEVE?V.R;\,I[GB/ >[WU6[X_>AT3WC^MVO$^E*UI[]SL
M               !5*H^==0?@9?<4AS^O\34^)]&71*/PM5X_P!.%K3H#G8
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M )K^LO\ EK4>Y;L%7 ZG!2
M
M
M                                        *I=I7]CLF_#*>YXCP'N]
M]5N^/WH=$]X_K=KQ/I2EK;.Z-<Z2L$>1;$R!EGIJN18;501L?45M=.B(OE4M
M-$CI)7>*<\)PGI<J(=%L9>N]5LT1BY]11-<X0A+6W>_I#8V2T6(NJ+U@]]N\
MB0V"GRJ@?;XJ^5?1%!/U/BZU]ACW-5?0G*^!E7]V7[-.U,:.HN5Y>NB,9A<
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MJGI0*)A+@
M
M
M                          "J7:5_8[)OPRGN>(\![O?5;OC]Z'1/>/ZW
M:\3Z4J%]Y=?6WCN@JJ"Z/\^AP_$K<N,4[OL85N#Y'U4K4_SG.:C57ZB<';-P
MT4^;F>'%Y#(4QLS*KV844==C=W:YJ^=2TTE70S-\'Q5%.U98I&*GBCFN:BHJ
M&\NTQ53,2SJHQAWPT?D57EVF-391<*GUVXY!A]DK[C5JJ*LE1/0POF<O'LJ]
M5Y.=WZ=FY5$<$R\]7&%4PE(M*0 !S ^D5KYJV\:'P^297VBKKKU?+E;N?:2R
MVZGA92ND;[*,=.Y41?#DW^X+<57*IG@9V1IQJF5')H(:F&2FJ(VS03-5DL3T
MY:YJ^"HJ'K9AMG5+L#N=QN';5C5-7U#ZF"P7F^V>RRR+U.2@HKC-'3L5?91C
M?:)]9$/";UIBG,58-%F8B+DX+H&N6$5Y;MW&L-V)K;6ET@K)+]M'WQ_)^:%B
M.@9[VQLDF\YRN16\I(G'"*7:+-5=%5<:J<,>NMU7:::HIG7..'6UO1M_:F/:
M7P*\;$RF&KJ+)970,JHJ)B23*M1*V%O2URM3[)Z<^(LV:KU<44ZY+MRFW3-5
M6J$@6ZNAN=OH+E3HY*>X4\53 CDX=T2L1[>4^KPI:7'L P&4Y3CV$X]=LKRN
M[06/';%3K4W6ZU*JD<,2*B<KTHJJJJJ(B(BJJJB(BJI511-<Q33&,RBJJ*8Q
MG4KG8N\+55WN6.TUQMF6X?9<SJ&4F%9GD=AK+=9KK-+_ -TRGK)&='\IZ6*[
MA%3V4,JK(W(B<,)F-<1,3,+$9JB<-<8ZL8F.ZM68;(  &B;-V#9=58'DNPLB
MBJ)K+BU,E5<(J5J/F<Q9&Q\,:JHBKR]/9+EFU5=KBBG7*BY<BW3-56J%<J+O
M"@N-'27"W]O6Y:^@KX8ZBAKJ?$*^6&:&5J/CDCD8Q6N:YJHJ*B\*GBAE3D*H
M^71Y4,?[Y3\VKR:N9:O&+XN2X_:+^MIN-B6[4S*A;/=J=])74W7_ .SJ()$1
MS'I[**854;,S#*B<8Q9TA(  JE4?.NH/P,ON*0Y_7^)J?$^C+HE'X6J\?Z<+
M6G0'.P                 I[WST&V\B[?<@P?3.)UN59/L"LI;!<FT,D,;Z
M2UU"NDK)7NFDC;T2MC2G=["-E55X1.0F$R:#U=1Z6TWKO6-(C.O%+/#!=)H_
ML)KA+S/7S-^M+4R2/3]T$I>"
M
M
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M:= <[
M
M
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M$H_"U7C_ $X6M.@.=@
M
M
M
M52[2O['9-^&4]SQ'@/=[ZK=\?O0Z)[Q_6[7B?2E:T]^YVH'W5=I5;GMPGVQJ
M!*6V[,BA:W(\>E5(:/)8(D1&ME?]C'4L:G$<BIX^#7KQXIM]V[SG+SLU>#W&
M7E\S-O1.IS'@NRMN-7C][M]5C&5VQZQ7;%[K&M/602-7I<B,?QYC>4\'LY13
MV%J_1=C&F6WHN17&AER\K /Q))'$QTLKVQ1L3E\CU1K41/955\$ S.M\ S[?
M=^7&-5TOEVN"1&9-LNJC7WJM<7*(_P ERIQ55''V,;.4Y\7*B<JFMSV\K>7I
MUXSQ,6_F:;<=5VJTKI;#=%X728?B%*JJKO6+]?9_;5ESK7\K)4U,B\JYRJO#
M4YX:WAJ>!XO,9BN_7M5-/77-<XRETL*                   52J/G74'X&
M7W%(<_K_ !-3XGT9=$H_"U7C_3A:TZ YV
M
M
M
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MET2C\+5>/].%K3H#G8
M
M
M
M%4NTK^QV3?AE/<\1X#W>^JW?'[T.B>\?UNUXGTI6M/?N=@ #0MJ?W9[ ^+UR
M]S2&1E?KJ.6.ZHN>#/(X+_1Q?.?Q[\!WCW,>XZ0^J3RPTV0^MZS^B4Y^W@
M                   !5*H^==0?@9?<4AS^O\34^)]&71*/PM5X_P!.%K3H
M#G8
M
M
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M.P
M
M
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M5>/].%K3H#G8
M                          /Q)(R)CY97MCCC:KI)'*B-:U$Y555?!$1
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M*N;U-:]$7A53D(;$
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M\ZZ@_ R^XI#G]?XFI\3Z,NB4?A:KQ_IPM:= <[
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M5>YW4[ESNE6HY444RZ)Z+_N2T[\1\>_W;3A3*4P
M
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MZ_Q-3XGT9=$H_"U7C_3A:TZ YV
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M\56ZX1XG9:"S1U[F)&Z=M!3QTZ2*Q%<C5>C.>.5X^J$-G
M
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MX&7W%(<_K_$U/B?1ET2C\+5>/].%K3H#G8
M              &-O-XM>.V>ZY!?*Z*V66Q4<]PN]RG7IBIZ6EC=+--([V&L
M8U7*OU$ J)EO?QVW8=)KWWQR>X5=%L>ULOEKN=%;IY(:.V2U#J:*LKVN1DL+
M'R,>B)T.>G2O4UOAR3A*Y4<C)6,EB>V2.1J.CD:J*US53E%14\%14"'[
M
M
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MKD:B\H%#,
M
M
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M?$^C+HE'X6J\?Z<+6G0'.P
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MJJ*O]3EJ84J:2>GK(6L;44]1"[KCDZ&*O"^U3CQ$PG (
M
M            !4[O=N^46/MLSRX8M=+I8I6S6F*_WVR=:7"BLTUSIH[G/3K'
MR]%;3.?U*U%5&]2^QRA,:W,7&<COV=[BQ??V.93F%7D&;[KM6%:&MR>MMI+A
M@V/MCBOE16P+&QC8):66-\W/2J/\U>GE)'-*G>L*
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M- VP         JE4?.NH/P,ON*0Y_7^)J?$^C+HE'X6J\?Z<+6G0'.P
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MU*BH>BBAMMLJ&1>70P4\:\25$CNI6]7CQSPB(A%48+]A
M
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ME9)')'(UDD;V.14<Q[6N:OI1 AN(
M                                        !5+M*_L=DWX93W/$> ]W
MOJMWQ^]#HGO'];M>)]*5K3W[G8!I>Q[76WS7V;V:W1+/<+I8KA2T4">E\LM.
M]C&I^ZJHA<M3$5Q,\:SF*9JMU1&N8ESZT=O_ %?@>L,8P[,+[)C^2X\R>DNU
MIJZ:9LL4K9Y%5%1&+]4W=^Q777-5,8Q+R.6S=NW;BBN<)C7$I<7NJT6GBN:Q
MHGUZ>?\ HRS]UN<3(^_V/G0T[ \NLFV>ZS$\IP66:\X[BF'UE->;PD$C((YI
MI)>B/J<U/%?,3C_]1&8IFW8F*M<RNY"N+V;BJC3$4SC*_5ZL=ER2V55ER&TT
M=]L]<U&5EKKX(ZFGE:BHJ(^*5'-=PJ(J<H:FFJ:9QB<)>FJIBJ,)8'$M=8#@
M25:83A=DQ/U_I]>=::&"D=-TJJM21T3&JY$55X1?057+U=SPIF>531:IH\&(
MAY+WJO6&2W.HO61ZXQ?(+Q5HQ*N[7*ST574RI&Q(V=<TT+GNZ6-1J<KX(B(3
M3?N4QA%4Q'+)-NF9QF(;'8L;QW%J+WMQFP6[';<KNM:"UTL-'#U<(WJ\N%K&
M\\(B<\>A"BJNJJ<:IQE533%,80U[+M8:YS^:BJ<WP:QY74V[E*&HNE#!521-
M5>5:U\C55&JOCQSP547:Z/!F8Y)15135KB);E145';J2FH+?20T%#1QMAI**
MGC;%%%&Q.&L8QB(UJ(G@B(A;F<53]U--3UE//25<$=5254;H:JEF:CXY(WHK
M7L>QR*CFN1>%1?23$X#Q6:R6;';;2V;'[116*ST2.2BM5OIXZ6FA1[E>Y(X8
MFM8WESE<O">E545535.,SC*(B(T0\-#B.*6RBNUMMN,6FWVZ_OFEOM!344$4
M-:^I16S.J8V,1LJR(JHY7HO5[),UU3.,S.,$1$/C-A.&5%@IL4J,1LL^+T2L
M=1XW)04[J"%8W=;%CI5C6)O2Y>4X;X+XD^<JVMK&<>/A-F,,,-#9RA(
M    JE4?.NH/P,ON*0Y_7^)J?$^C+HE'X6J\?Z<+6G0'.P
M                          (^VSG;-7ZPV!L9]O==DPC'[A>FVQKNCUAU
M%3OF9$K^%Z4>YJ(KN%X3QX4$.<F5-ONO.VK7O=]0:FTQ#MNEJ:+-=AW"EM--
M3LK+)=99GT]/;JKR%DCK5964W5*DG5UL?TOFY1KRKAP=2;)=(KY9K1>J>-\,
M%XHJ>MAAE3A[&5$;9&M<GL*B.X4*63 CO6^L<;U;9[W8\:=62T5_O]TR2O\
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MF,$6?1%?-NS;_F5<O]SV8)JUNIP4@
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M MG5-I989\SM;+A+9XIEJ&4ZN>YO0DJL8KOL?3TH$2ED(
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M@FK6ZG!2
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MHF\Z.1*R@JD;U>L>7_XQK8?^Z]"_5\0FE>'LC^:?HOXM1?SL@1.M:<(
M
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M4<_1%?-NS;_F5<O]SV8%6MU."D
M            %(=A]RN=8EFV28W;;389Z&SU;J>FEJ8*ITKFHU%Y>K*IC57Q
M]AJ'*]]=.<[DLY<L446YIIG",8JQZ^%4=QU?<G07(YW)6K]==R*JZ<9PFG#K
M8TSW5B--9S=MB83!DEZIZ2EKI:NHIW143)&1=,3D1JHDDDCN?'Q]L>TZ,[VN
M[SR<7[L1%6,Q\7'#1RS/=>*Z4;IM;KSLV+4U33%,3\;"9T\D1W$K'H'G0
M                                "%^X+4,>\]49+KGW\EQBON;J2LL6
M1PL\UU%<+=515E+,L?4WK:DD2(Y.4]JJ\*CN%0F)P5/H.W7NVV9EFOF]RVW\
M-O6N-;Y)0Y72V3$J&6&NO%QM2N6C6M?)1TC86]3E<]L:N;XJU&HO2]I.,.C
M4@     <=_I)JKNL3$MJTM-;;*O:XM/C_OA<5=2>^:3>N4"IPBR^L<>^'0G@
MS['_ +/B%5."\/9'\T_1?Q:B_G9 B=:TX0
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M7S;LV_YE7+_<]F!5K=3@I
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M;-3F-C8QB(PQVM75PCN)$-TT@
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MI;;=*M].Z&Z1/\N5:BE2&61[6-<]8U25K'=35X14X4\;TG^LHY)[KFG3N/\
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M$G*_77ZI:M?%OX1PPW&=F<QN>9KTS;KC">I/!VU_S9/#@
M     *I5'SKJ#\#+[BD.?U_B:GQ/HRZ)1^%JO'^G"UIT!SL
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M;LV_YE7+_<]F!5K=3@I
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MXP?9-Y^R]L$TRO#V1_-/T7\6HOYV0(G6M.$
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MU/B?1ET2C\+5>/\ 3A:TZ YV
M      JCWOY_F&KNU[9V=8%>Y<<RRQ^\OO5>88XI7P^LWN@I9N&3,D8O5%*]
MOBU?3]4)C6LQ8:B:KL=EJJAZRU%304TL\B\(KGOB:YR^'">*J$,L     '-O
MORJ^SFGEM4?<5;*FMV#)C5R_1M-"Z]HV/Q<C.I+9+'#_ .(Z5_E47_[$*HQ:
MK]$5\V[-O^95R_W/9@5:W4X*0
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M2?A*M_\ 60ZGT"_U<>-4Y3T__P!I5XM/<6)/:/$@
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MSJXY3G@N]',O=M57-NF:<8C7$QQ\:]T4RUVS7<\Y153C$:XF./C7-/5/9@
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MTB\^"/J**-C4\/2YR(6[F1O44S553HCJQSJZ<U;JJV8G3/*LJ8B^
M    !5*H^==0?@9?<4AS^O\ $U/B?1ET2C\+5>/].%K3H#G8
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M%0W?-MOXUC=1=:REJY)Z"*HJ$>E70K%5PHRHB>QKF.D1[45/%BA,3BZ7A2
M-6@P;"J6_P N5TN'V2FRBH5RSY)%;Z9E>]7\]755-C25>>?'EP'MR#&,;RR@
M]ZLJQZV9+;.MLOO==:2&L@ZV_8N\J=CV\I["\ 9*BHJ.VTE-06ZDAH*"CC;#
M245-&V*&*-B<-8R-B(UK43P1$0#B9])3@7;"^7:&=5&>U+.Y:&EL#*#!?76I
M"^)9J*G5WJOJ_*_ZBY\G_>^E.?K!73BZ+=D?S3]%_%J+^=D"F=:TX0
M
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M8+)             JE4?.NH/P,ON*0Y_7^)J?$^C+HE'X6J\?Z<+6G0'.P
M                                      (]VUDF18=JW8N6XC:$OV48
MUC=SN>/V=S72)45E+2R2PQK&Q6N>BN:G+&KU.^Q;XJ@(<_, Q#Z0C9>$8IL&
MU]WF(T%OS.UTUXH[?28Q::R*FCJXTE2#S_>Y>IT?5T.\5X<BIRO'(5:'3RC9
M4QTE+'63)4U<<+&U50U$:DDB-1'N1J(B)RO*\!2]( "MMQ[O>W*U9-48G7;-
MI8KC17-+-7W!M%<9+135ZNZ%IJB\1TKK?$]KO:N1]0G2O@[A0G!(6S=SZTT[
M2VBIV)D[;&[(*AU+8K=#2U=QKZV6-O7(E/0T$-14R)&WA7N;&K6\IU*G*!&#
M*ZZV;@FV<<CRS7F1T^2V)\\E++4PMEAE@J(51)(*FGG9'-!*WE%6.5C7(BHO
M'"H!23OI[F];:2][\,S/5OY<WC.<:N7O)>_+HW^H=?53IXU#'/3A[D=[5?\
MI"J(:/\ 1%?-NS;_ )E7+_<]F!5K=3@I
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M9TQ.,?'KUQ^T]#<Z:[WN4S35>T3&$_%HU3^RF ]6\L
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MCYUU!^!E]Q2'/Z_Q-3XGT9=$H_"U7C_3A:TZ YV
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M[J5.I/1Z4"=E*_T17S;LV_YE7+_<]F!5K=3@I
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M]Z6HF,]LZ+"[K)(U/\EJNJ415_?+-/U]/)SMO7_IKWCT]Y?8V;Q
M            "J51\ZZ@_ R^XI#G]?XFI\3Z,NB4?A:KQ_IPM:= <[
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M[N:[<KKN15M1$:(F-4X\)TFZ36][6Z***)IV9F=,QQ)P/</'
M                                   HSW9[<TE=<)W3I#8F4Y/BK+'C
MEEO6;W7':7JJHK97WBAIH64\CD<R3SY9612L5O\ W;W\A,0H5I39/;JS9FK+
M!B?=WW%7:JJ,KLE+9,.N=9.RS5U1)70QPT=;"G#%IYG*D<J<<="J@52[MA0
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M,\U*E%<*6IX=)ZA%(O6R!8D_E$^R]E/ )B,'7;LC^:?HOXM1?SL@4SK6G"
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M4^)]&71*/PM5X_TX6M.@.=@
M   52[B+Y?L"NE@SK'NXC$]4W!]-[WQ:_P!B3TL6-9!Y<JOY21TD-733,\Y$
M?- YR(Q&];.E.0F%(LICMV<9YE-=L;85U[5:G?=%;Z/+VU-LLF3X=E3*>A;0
M0S6#+YHGQ4RRT;6HC56-Z*J.X5P2ZV8M9;5C>,8YCMB<K[)8+71VZS/=)YJK
M24L+(8%63_+]HU/;>SZ0I9X     *"=ZN8]V&.TT-OT)@-LRO!KEC5S_ $@7
M2MCB?+2<HYCO+5];3*G$"N=X,=X_P!,8(L^B*^;=FW_,JY?[GLP35K=3@I
M
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MEX!-,+W=D?S3]%_%J+^=D")UK3A
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MY6.3T.:]L:*U4^L419HC3$0R[F\\U<IV:[M<QQ35/.D0N,$
M         JE4?.NH/P,ON*0Y_7^)J?$^C+HE'X6J\?Z<+6G0'.P
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M;_F5<O\ <]F":M;J<%(
M          KMNG.;E:KUC6&6_)8\)I;S#-6W[*WLZWP4T7*-C@1/%7N5J^#?
M;<]*(J)R>#Z7;YNV+]K*478LQ7$U5W.&*8X*>K.$ZM.K3&E[OHEN:U?L7<W7
M:F]-$Q31;X)JGAJZD8QKT:]$Z&IX'GM7;=AV+&:+8CMEXOE4<\:3U35;64-5
M!&LGMD?P_I=PB)SX+RO"<M\=9N7?==G>5O+T9K[S9NQ.F?#HJIC'ATX3V)T\
M,:=GOK<M%[=US,5Y7[M>M3&B/ KIJG#@T8QV8T<$Z+:G3W,0
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M3E=29CRQS/Y:A\'<?YL_U%4SNCVJOK=]G]')QBYUN^M.>C>E
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MTQXLO79C)7LGT:JMWJ9IJVXT3U:H7&.DN8@
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MO+9!0537<PHK/;/9XK^^",$6?1%?-NS;_F5<O]SV8)JUNIP4@
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MT5)%H%J./?!62>%4GM4_S?:A53@O#V1_-/T7\6HOYV0(G6M.$
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M-J*:N/3.OEF6)G>D.?SMOS5Z[-5.O#1&KDB$@&W:8
M                     "N'<)W)Z>T#16&#9KJJZW#*99/>'$K70I<JZI;3
M]/FSI Y6L:R/J3VSW)ROV/5PO!,1BKCI/8';+I;0FV=^8CE=1L3":_.JG+<A
M?!;H&WBS5N05%#0-MR4DBPOC2)ZL<WJ5.6JKFJYO"J3.+HG15<5?14E=!U)!
M6PQSPHY.'=$C4<WE/'QX4*7J T79UPSJUZ^R^OUE88<GV!3VR=<0L53/%30S
MU[F],*22SOCC1K57J5'/:BHG3U)SR!R*R^3>FNL6[;,=OO;'=*"_P;OLN477
M*Z_,<?K:O,,NJ::XOJ&2K32+ZN^K<]ZLDE7RXHXVQJOV(5+I8U<JNV][-3/E
ME!^3%SV?I.SU%FM4\\<S6UUJN<[KE;8ZAG$<\U,E0USO+5W+/;I[7T$<#$X;
M;*C9'</WM3XK=6VRBFQC', H\QHWK(V*^,MM:ZI=&^)6+YM"ZIC21$?U-=PG
M*+STA4W*_H^.XBSXMDMWK>\S([G1VJU5E95VU[KOTU$4$#Y'Q.ZKHY.'HU6K
MRBIX^@)VDK_1%?-NS;_F5<O]SV8%6MU."D
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MY+=M.7KFY55-=<\,\2G=VYJ<K<JO5UU7+M48;57!'%$<"839-T
M
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MO!5$M'^B*^;=FW_,JY?[GLP*M;J<%(
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M\6IZ/2A,2ZJ=D?S3]%_%J+^=D"F=:TX0
M
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M[C!+--S,U&?R3D]/'I"J)EH_T17S;LV_YE7+_<]F!5K=3@I
M                  "@EWS_ #:&[72*+*;G'%%5SLCC;4/1&M;(Y$1$Y]A#
MY_SG2#>%-^N(OUQ$53\J>-V_*[DR-5FB9LT8S3'!'$N3KVMJ[CA6.5M=425=
M74TC7SU,KE<][NI?%RKZ3LW1V]7>W?9KN3-54TZ9G7+DV_;5%K/7:*(B*8JT
M1&J&Y&Z:D
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MM)I(UFHJ%7^]ZIZZO%(]T_*>PG5]AR%=,NBW9'\T_1?Q:B_G9 IG6M.$
M
M
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M?Y-D;T?_ "Z-3Q5/J!5&+1_HBOFW9M_S*N7^Y[,"K6ZG!2
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M6Y5=1$R1%C1$D1O4C5<U%X<[G?--BE<(
M                      ./F_;1V^Y3W@[AI>X^\6NFM5JU5:Z37\=ZN3J"
M.*MJ73/>ZDZ9(^96JY7-]*(KE7CG@*HU- [(\<[?,EDU3M+>F\[7GN\(5MUE
MU=KF[76-J8\ENG;0V>GAHNI'25/\DQ\?*=*.>CNETO\ *J3+N$%      '$+
MZ2FE[15EVA555RJ4[L$I;![W6[IO/DK#YU$B^*1>]W_R=UKXOYY_[?"!73BZ
M+=D?S3]%_%J+^=D"F=:TX0
M
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M01._ENE>9&K]?P"8B82)]$5\V[-O^95R_P!SV8%6MU."D
M                (KJ-,:_JIYZF:U3.FJ)'2RN2JF3ESU557A'_ %5/*7.A
M>[+E4U31.,SC/QJN'KO2T=+=XT4Q3%<81&'@QS)#M-JHK);:.TVZ-8J*AC2*
MFC<Y7JC47GA7.557TGHLIE;>5M4V;<84TQA'"T.:S->9NU7;DXU53C+(F2L
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MO'+9N>.3-W!,S%?6[[.Z/3,Q7UN^M">B>C
M
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M )C&63^B*^;=FW_,JY?[GLP*M;J<%(
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M"J7;6=M7:MFF=+9;JZ9;LWG?BQE[DS7,3,1--48X:],Q@FXRGJ
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M3@I
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MXHQ52E6G\9F)!XS>E?\ .]J$TPO=V1_-/T7\6HOYV0(G6M.$
M                *5; L>U\NRJYW:AT_=Z:C9(M)2OGNMAYGCIG+&RH8C;B
MJHR5J(]J/1'HB\.:U>4-%G]WW;UV:J<,,(:'>&[[MZ[-5.K"$A:1I,_QVX7&
MR9-K6YV&WW*-:M,EEK[144T<D/2QM.Z*EKIJA7R(]514C5B(U>IR*J(N5NW*
M5Y>FJ*N&67NS*UV*:HKX963-FV8
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M%/FIG"F(B,=FO3A"_P";IU@
M   "AO=#F>^KSM_4_;]HG,[?K6X9K9[MD>19M5TL=9*RGMBM;'!$R2.5&HYW
MV72WJ7E/;(U'(XF%9<,W+WM]RUMJ=*X3+;L(NF W&X8WN[N,9%Y4,M71U<D/
MEVF.-C$9,Z!&O=Y3&OZG(J>K-Z7.)PB'8&WTSZ.@HJ.6=U5)24\<,E4[E'2.
MC:C5>O*JO+E3GTJ%+U@    !1+O,WSMO5="F,8!H*^;8L.68U<_RARFV0U\D
M%HZFO@7SG4E'41IQ&Y9/;O;X)]3Q"8A#WT17S;LV_P"95R_W/9@FK6ZG!2
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M2W>WRJYL5=13,J(7*Q>ER-DC5S5X5.%\0,@
M                              "'\S[?M([%O<F2YWJK&<NR"6&.GDO%
MUMT%34.BB3B-BR2-5>&HO@@3BJ!VUZ+QQ^X-^5.9]OM@QFU:ZSBD?HR_/Q."
MU+ZI3S5$D=50U:4\2U/ENBB<DJ.=PO"\^(3,NCX4@     <=_I)LX[GF8EM7
M"J?6=ED[:9:?'WU^R%:[WSCE2LH)T:B^^*)QZ\C(O_"+[5?_ *]"JG!>'LC^
M:?HOXM1?SL@1.M:<(
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MC^NZW><QS/XQL_8SW*UY#;NG
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MJQ*P4CI'TMCLM'!04<3I7*^1S(*=D<;5<Y5<JHGBJ\J$,^
M                                         #F#O:W;JW/W+9[KC"MZ
MW_36-ZAUY1Y-;J;'I)H??&ZUCY',6M6":!9(_:HUS7*YJ-:G2SESE"J-35^W
MRF[I.\%VI-O;.S9->Z8PFLM-UM.*69$CJ\PNM@GB=+6UZ1HQK:>:LIG.Z'>U
M:B=,47HG!.$.LP4@     <=_I)J7NL7$MJU5-<K*G:XE/C_OA;E;2>^:S>N4
M")PJQ>L<>^'0O@_['_L^ 54X+P]D?S3]%_%J+^=D")UK3A
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MQ;?[@G-1_7=;O.8YG\8V?L9[E:\AMW3@
M            .>'?;3=VE1!BGZ!'WYVO$@F395-ALE+%DCE61.EU&YZ>L^$7
M/2E.O*N^R3CA4*HP4![>)^TRU]UF*K<J6Z6:A@PZX-S!N[TI4N#<R=71NB?*
MZI1*9LJP+_).1&K[*HCU"9QP?T%1JQS&.B5JQJU%C5O'2K>/#CCPXX"A^P
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M514]9L+**JFD="]'HR:":XNCE8JIPYCT5KD\%144]L\CBGX(
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M<D2TKGN1$8U47J5[&>/C]0RMW9.O+4U15,:>)E;NR=>6BJ*IC3Q)2-BV(
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MNMWG,<S^,;/V,]RM>0V[IP
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M^DH
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M1=H6'121RIM':KEC<CD:[+:M4547GA4Z?07)SLS\FGL*(L1'#/9E;$PU\
M            HW7_ #Y[+\6W^X)S4?UW6[SF.9_&-G[&>Y6O(;=TX
M                                 "E/<OIW;U=L/7/<+V^2VBLVAKNA
MK+)<L0O[_+H;U9ZU5<L#9.J-(Y&/>]459&<]7/6G1PXF)0)FF/\ ?9W46K]$
M&R=7XUH/5E\J:;\O\H@N=-=;C44M).RH6"B93UE1XO=&WCEB-7CQDZ>I%)T0
MZBVZ@I+5;Z&UT$*4]#;:>*EHJ=OH9%"Q&,:G[C41 I>P
M
M                   4MJ=L;8R_O,;IS"ZRV6+6FIK!3WW:25<22UEZDNU.
MYM+3T[U8]8VPK-'(G2K.7,=U.5JHQ2<-# =Q>=[/U3O#2N1WW\G<M[=\_P H
ML6%3XE6T,<MPL^15$LU11WJGF?&Y_6QT?6BM<J-2+A&)(YL@(7Q"    CS8N
MIM:;;MM):-EX1:,TH+?*L]OBN=.V5U/([A'.@D\'QJY$1'=+DZD\%Y0&+9<8
MQ;&\*L-NQ?$+%0XUCMHC6*VV6VP,IJ:%JJKG=$<:(U%<Y5<Y?2JJJKRJ@9X
M
M            HUV'?W=9A\8U]R4YJ-T>!5RN7>ZC_77?M9_=I7E-NZB
M                       HW7_/GLOQ;?[@G-1_7=;O.8YG\8V?L9[E:\AM
MW3@
M
M                      %-=Y]L>8Y?L2@W;HO;53IC;<%K;9+W7K1QW&V7
MBWQNZHHJREEY9U1JO@YS)$7AOM$5J.0F):-@/:=N?(MAX1LKNIWNFV:G6E:E
MUPC";1;H;;:8+FQ$6&MG\B&E;(^%R(YG$+7=36\OZ>ICACQ.@80
M
M          *-=AW]W68?&-?<E.:C='@5<KEWNH_UUW[6?W:5Y3;NH@
M                     *-U_P ^>R_%M_N"<U']=UN\YCF?QC9^QGN5KR&W
M=.                                                       KSW
M-=O5F[F=<P:YON15N,44%XI;PERH(HYI5?2QS1I'TR^UX5)E55^L$Q.#G_\
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M )\]E^+;_<$YJ/Z[K=YS',_C&S]C/<K7D-NZ<
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MW"KN#;G711Q2JZK<CG-5L?M>&\> 3,XIZ"
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M1?%$5>.0JI=5?DR]MW^'S6OYIV?[U"G&3Y,O;=_A\UK^:=G^]08R?)E[;O\
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M'-<SCGCA?!51<O>.[[=RW,Q&$PNYC+TU4X\+^@)JHY$<U>4<G*+]93Q+3/\
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ME^+;_<$YJ/Z[K=YS',_C&S]C/<K7D-NZ<
M
M
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MW=.
M
M
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M)Q1UH6],)DJ-U_SY[+\6W^X)S4?UW6[SF.9_&-G[&>Y6O(;=TX
M
M                                &NUN7XG;41;CE%IH$=U*BU-;!%ST
M?9?9O3T<^)=ILW*M5,SUE$W*8US#+6^XV^[T5-<K57T]SMU8SS*2OI)630RL
M]'4R2-5:Y/KHI153-,X3&$JHF)C&'L*4@
M
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M3&N9.U7X5,2MU6:*M</\N=IJ<B<UV8Y/DF=]#D='%DEYK;E$U4]"^5/*Z/\
MA:+>3M6_!IB"FS13JAE888:>*."GB9!!$B-BAC:C6-1/0B-3A$0R<,%QZ,9Q
MK,=JY93:XUA1I7Y%5JGOQ?'HYUOLE,OBZHK96([I7IY\MG'+G<(8.=SM&7HQ
MF=*S>OQ;AW"TMJ#&-(:_L^!XQ&LL=$U9[Q>96IZS<J^7VU165+D\7/D=]7T-
MX:G@B'ALQ?JO5S74TE=<USC*5RRH                 "C=?\^>R_%M_N"<
MU']=UN\YCF?QC9^QGN5KR&W=.
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M=IT.[4OFZZD_ 4?\X\^H-\>MW.5S7(?44<BPAK66
M
M      /Q))'%&^65[8XHVJ^21ZHC6M1.5557P1$01&(UNNS;#+9U>^6766W]
M+/,=ZS7T\7#/'VR]<B>'@OB7:;%RK53,]:5$W:(US'9:E6[STI;NM*[;N&4S
MV,\Q87WVW^8K?JHQ)NI?1["%^G=^9JU6ZO)GF6YS5J-==/9AJ5;W5=NUOZ_/
MVY8)/+;U.]6F?4^"_4\ADG*_63Q+U.Z,W5JMSW%N<_8CY<-3KN]WMCH>M%V4
ME7*Q$5(J6U767JY]A'I2='/[KB]3N#.S\CMQSK<[SR\?*[4\S5:OO^[>(/-]
M4N-^NWEHG3ZI:94ZU7V$\]8O1]?@N>SV:CPMF.686:]\Y:C7/Z==K=9](EJ&
M/S66_"<\N4C.GRWMMU''$_GCGVSJY7IQX_Y'I^MXE,[FFGP[UJGEJ^!AU])\
MC1KKCLTQWVMUGTBV/IYGO7I[)JM$5J1>MSP4O5SQU=72V;CCQXXY_>+?W'*1
MX6;M=:J)[[!KZ;;MI_[:/+I[TRURK^D4O[_,9;-#N;XHD4]7D+$\/#GJC;0I
M_P"N43;W;1X6;IZU,SW)EAW/>#NVGY=/9F>Y2UJJ^D"VW-U^]^JL=H.7IY?K
M=?/4=+?9Y\MT7/[OA^X6_O&YJ=>8JGDHF.[#!N>\O=\:JL?V:N_$-<K.^KN*
MJNIM)CV"6MBOY8Y*:X2R(WZBN=6.:O\ ]BA1.\=RT?*NU<D1W\&%<]Z&4C5$
MSR4\]4+@]G6[<^W79-@5^?26]];CEZBH*%EMIUIXFL=$KG)PKG.=[9/!57DR
MMYY>Q;HM5V8G9KHBK3KTZ8Q>]W)O*<_8B]P51$QR51CIUKDFI;D
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M?L9[E:\AMW3@
M                    ,)79-C=L56W+(+;;W->L;FU-7#"J/3TM]N]/'ZQ<
MIM5U:HF>LIFNF-<PTVMW7INW(BU^V<-H^KJZ&S7VWL5W1]ETHL_*JG/L%^G(
M9BK5;J\F>9:G,VHUUQV8:=7=T_;Q;T5:C;N/2(C%>OJU0M4O"?6@;)X_6])>
MIW1FZM5NKN=U;G/6(^7#3Z_O=[9*!'HNR4K)6(BI#2VJZ2]7*\>#TI$C\/2O
M+B_3N#.U?([<<ZW.\\O'RNU/,UF;OXT'RYML?DU^X>D;?4+/*O4JISX><Z+^
M!?'ZQ->X[]OZRJBGQJHA-&\**_ BJKDB98QW?AAE2YK+)J'9MW<Y[FHYMF@:
MUR-]EG15R*OHYX5$,#,4Y+*Q-5_.Y:W$:]J[33ACQXX+]%68K\#+W9Y*)8R3
MO7RF9K5M7;5E]0YS'.Z:ZH91)RGV*<NIY/3[/*<_64U=>_NCEOP]ZY;K5TU=
MRIDT9+>5?@Y2YUXV>ZQLW=OOBN1WO/VTQ4*^6BM]?R6G?PY5]*HL--SX?Y/I
M^N:Z_P!.NA^6^LWG3.G#XMNY7^Y37V=3(IW+OFOP<K,<M=,=V88ZH[C>[&J5
MZ6_5^"VE%5J1NKZRIJD3_.5?(JH^?^C]\UM?O4Z%41ZU=J\6U5'[U,,FGHOO
MJK_KMQRU<S'2[<[R;BJN]?UMC[%EY5M/2UTKD;QZ&I+YZ*G*^R[GP-7F/?9T
M0LSA1;S5S1KBFB(Y/C5TSVL&11T-WQ7KKLT]>J?H]]C),J[P*WH\[=MDLZ*K
MUD2AL%#-Z?0B+44W/A^\O[I@7??WT<IQ\WD+]7C54T]RJKOLBGH+O"?"S%$<
ME./=P8R6W=Q=>WBY]S5[;U1*QS*"UT](J*[TJCXI6JO'L+PB_N&JN_\ L1DZ
M9GS6Z8PQT35>G5R>;G#RI9%'N^O3X>;GK48=O:[S&SZ[V-<4>V[]QFR*N-[6
MM?!!=YZ>-41>?&-)'-7Q^L8%S_V,OQ]5NVQ'+,U=ZED1[O+4^%F;L\F$<['S
MZ(M->Y[KQL#.[[YCVOD]?O;I>KH1$1%XB;SX)Q]4U%?_ +%=()\"QE:>2W7W
M[DLFCW>;OCPJ[M7+5'>IAYH>VC4K9%EJK/6W*1[W/EDJ;A4]3U=XJKEC>Q5\
M?'DU^8_]@>EEV)BB[;M^+;IT<FWM]O%DT= =T4Z[<SRU5=Z89RFT%J&EZ?*P
MFE=THJ)YT]3-Z?J^9,[G]\TMWWT]+[NO/5=:BU3^[1#-M]#MT4:K%/7FJ>[,
ML]3:FUC2\)%@-A=PU&_RU##-X)_]M:[Q^OZ33YKWF])\QX>\,Q&G'XMRJC]R
M:='4U=1ET=&]V4:LO;Z],3W8EGZ?#L1I%5:7%K13*O'*Q4-.S['T?8L3T&GN
M]+=]7?#SN8JY;MR>[4S:-VY6CP;5$<E,<S.PT\%,U64\$<#%7J5D;4:BKZ.>
M$1/J&ES&9NYBK:NUU53AAC5,S.'%I9=-%-$84Q$/L6%8          :KG7]B
M,Q_ =Q]S2'I>A?\ O<A__IL__LI:_>WJ=[[.K]V5J>U+YNNI/P%'_.//O/?'
MK=SE<,R'U%'(L(:UE@
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M)?1R_P!G-Q?&F+^9<=-WAZKE/L:>Y#ZBZ&?ZZUXE'[L.D1IWK
M    "C78=_=UF'QC7W)3FHW1X%7*Y=[J/]==^UG]VE>4V[J(   <I/I8D1=5
MZV^K^4<_"_\ \L8.>\&'L.AWU]?B]]M?T5GS=LC^/%P]Q4)5DO GE6>E_K<>
M)'=ETP,QY4                    !1NO\ GSV7XMO]P3FH_KNMWG,<S^,;
M/V,]RM>0V[IP
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MGV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\ $>U6^_GV_)^ ^3YWE_#C6?\
M#</^&#\J.A/]O>_F3_$>U6^_GV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\
M$>U6^_GV_)^ ^3YWE_#C6?\ #</^&#\J.A/]O>_F3_$>U6^_GV_)^ ^3YWE_
M#C6?\-P_X8/RHZ$_V][^9/\ $>U6^_GV_)^ ^3YWE_#C6?\ #</^&#\J.A/]
MO>_F3_$>U6^_GV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\ $>U6^_GV_)^
M^3YWE_#C6?\ #</^&#\J.A/]O>_F3_$>U6^_GV_)^ ^3YWE_#C6?\-P_X8/R
MHZ$_V][^9/\ $>U6^_GV_)^ ^3YWE_#C6?\ #</^&#\J.A/]O>_F3_$>U6^_
MGV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\ $>U6^_GV_)^ ^3YWE_#C6?\
M#</^&#\J.A/]O>_F3_$>U6^_GV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\
M$>U6^_GV_)^ ^3YWE_#C6?\ #</^&#\J.A/]O>_F3_$>U6^_GV_)^ ^3YWE_
M#C6?\-P_X8/RHZ$_V][^9/\ $>U6^_GV_)^ ^3YWE_#C6?\ #</^&#\J.A/]
MO>_F3_$>U6^_GV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\ $>U6^_GV_)^
M^3YWE_#C6?\ #</^&#\J.A/]O>_F3_$>U6^_GV_)^ ^3YWE_#C6?\-P_X8/R
MHZ$_V][^9/\ $>U6^_GV_)^ ^3YWE_#C6?\ #</^&#\J.A/]O>_F3_$>U6^_
MGV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\ $>U6^_GV_)^ ^3YWE_#C6?\
M#</^&#\J.A/]O>_F3_$>U6^_GV_)^ ^3YWE_#C6?\-P_X8/RHZ$_V][^9/\
M$>U6^_GV_)^!XKEVV=X5UMU?:ZS-]:NI+E32TM4UK[@URQS,5CT1?>SP7A5,
MO(>[7H=D<Q;S-JQ>BNW5373.W,_&HF*J=&UITPM7^DF^;UNJW55;PJB8G1P3
M&'$O3I/"+MK;5&#8+?*BDJ[OC-M;1U]10ODDIGR-<YRK$Z6.)ZIX^RQ#UN?S
M%.8OUW*<<)G'2U66M3:MTTSKB$I&(O@
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MJ>'[BGHM\V*K%K+6JO"IMQ3/+$1$N\=%+%5C)46ZO"IIIB>6*8B72<T+TX
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M@       %&Z_Y\]E^+;_ '!.:C^NZW><QS/XQL_8SW*UY#;NG
M
M
M
M                                4:[#O[NLP^,:^Y*<U&Z/ JY7+O=1
M_KKOVL_NTKRFW=1   #E+]+#_=7K;XQS^YS!SW@P]AT.^OK\7OMK^BL^;MD?
MQXN'N*A*LEX$\JSTO];CQ([LNBV17-UDQ^^WED7G/M%OJJUD/^>M/$Z1&_O]
M/!G44[541QO*53A&*F'8[@U@NNH+?N7(:&#(MD;:K+C=\IRBX1MJ:I4;75%-
M#3QR2(YS(V1QHG2WA.?8XXXV>]+M47?-1HIIPB(ZS7;MMQ5:\Y,8U58S,]=*
M-=HW$L N.ZMD8C)/8FYYB533W_#Z-L<-I?5TU/)TU[86M3IF5O+55O"+RY51
M7+R8\9JJY%%%6G"=$\/(R(RU-NJJNG1C&F.#E1GV3X/A5][7M:3WO$+)>9JF
MEJ?6)JZWTU0Z3BJE1.MTL;E7A/JE_>=VNG,583,==9W=13.7IT1J19K;7--9
M]Z]V';)BMWK<4UWE&-VZ_6F&@<JK9I[BV-M2VC:YRI&CTJ%3A%^Q:WZA5?NS
M59MWJM-43,<N&K%-FW%%VNW&BG")CJ8XXX=A^^Z#"]6X%H_%NV;!L2I,AVME
MC**AUU;J2EB2Y-E@J(W3W:>9C>J).&/ZGJ[QY7_):[ADKE==Z;U4X4QIJGO=
M<S5%--KS5,:9T4QW^MKQ?#>$L^M]]=N5WO5K=O?);)@RV.LUE11/JKM+4MZV
MRY%3Q31R1.ZGL<U5D<UW*>"^RD9:/.6:Z?!B9QQX/%XTWYV;M-7A3A.B-?!\
M;B_\MG[0;C09+O#N.S"GL<6K*F[R6FFJ=(S1O@N- M' C'7.KA2&&!JU3U5?
MY/J7E5ZE\4<Z,]&S:MTX[6&/QN#DCD,K.U<KJPPQP^+P\L\O>9KZ1&I=1Z>Q
M"K932UCJ7/+',VD@3JEE5DCW)'&BJG+G<<(GU2G=<8W9C]6KN)S\X6XG7\:G
MNP^>>]U.473!<TMDO:MN&UQ7&PW&FDN5798V4].V:ED8LTSO.\&,1>IR_404
M9&(JC_EHU\<\Q.;G#ZNOL1SH9U-FU7BFGNPNU4UCL=VCS#+I+;55=VH(ZRHH
MF+,Y?.H)7^-/-X_9M\3(S%J*[U^9F=$8]S6M6+DTVK,<>$=J9[R9TV?W,[)W
M5O'5>L+IB6,6?5U=;59E%ZHIJF1D5=3J^*E2&-RI(Z1S)'*]>.EK>..5,?S-
MBW:HKKQG:QT1U%WSMRNY713A&SAIG3KCBQCNL?1=W^98_H[/K_FF)45;M_ \
MY?K5+/02K';Z^]R='J\[7*CE9&G4Y7,]GH\')U>UF<C35=IIIGXLT[75B/TA
M$9N8MU3,?&BK9PX)G1AUM,/#L?97=_I%FNJ[-[Q@N4VG/,OL]@N-5:+?4POM
M;JV7^4@1)7-25KXT<C)/!R*WQ;XDVK.7O;6S%4333,Z9UX1VB[=O6MG'"<:H
MCAC#&>73VN1M&<=P>>99MS-]6:JS+!M:6[5[::+)\TS21)??"X5+4D6CHJ5S
MX>$AX5LCU<OCSQQX<T6\K33;IN5Q55M8X1'4X9G2KJO555U443$;.&,SIU\&
M&,=G%*O;;O"[;6BSO%<M@M29UJVY0VS(KI8:E*JTW*.J8^6EK:)Z>*,>QJHK
M55>%3T^/"6<UEXM;-48X51C&.N..)7+%[;VHG73.$]U9TQ%\  4;K_GSV7XM
MO]P3FH_KNMWG,<S^,;/V,]RM>0V[IP
M
M
M
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M[IP
M
M
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MQ;?[@G-1_7=;O.8YG\8V?L9[E:\AMW3@
M                                                       'AN=S
MMMDMM?>+S<*:TVBU4\M7=+K6RLIZ:FIX6J^6:::16L8QC45SG.5$1/%0/A9+
M[9,FM-#?L;O-#D%BND236R]6VHBJZ2HB551'PSPN>Q[>4]+55 ,J
M
M
M        4:[#O[NLP^,:^Y*<U&Z/ JY7+O=1_KKOVL_NTKRFW=1   #E+]+#
M_=7K;XQS^YS!SW@P]AT.^OK\7OMK^BL^;MD?QXN'N*A*LEX$\JSTO];CQ([L
MNEYF/*@                    *-U_SY[+\6W^X)S4?UW6[SF.9_&-G[&>Y
M6O(;=TX
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MZEYZ6=+?K> 58Z'68*0
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MUM'TJYT+G>/0YKT5$555/%.5])FV;OG*<7G,]E?N]S9B<8F,83^7F&
M             !1NO^?/9?BV_P!P3FH_KNMWG,<S^,;/V,]RM>0V[IP
M
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M#X?5!5K>?<__ )B_9S\6LP_W3<@1J=%@I
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M_P"?/9?BV_W!.:C^NZW><QS/XQL_8SW*UY#;NG
M                                                     YT__G0?
M_P 2'_T3"K@?;Z1;"-@YA@VH*W7N#77/Z_#=AT-\N5EL\+IJCU:FIYUZE:Q'
M.1JNX;U=*\*J<@I?>V]X^]JVXT%'4]BVR*&GJZF*&>M=,Y6PLD>C72*CJ!B<
M-1>?%R)]= C!][;K[.(OI&[_ +'DQ6YLP*JU@RV4^7+3O][WUB24W-.D_'3U
M^T7VO//@#@>GONT'EVQ\7Q3:^H:-TFZ=-5R7''XJ9K?6;C;GJBU5"U%5OFJU
M421C'*O4GF1M172\*(EDOH[=?YKK7MIL^.9[C5=B5_6^7:K6S7*)8:EL,TR)
M&]\3O;-ZNE51'(B\>/H5 5:V%^C8U]G&M.WFNQS8&*W/#[\[,+G5MM-UIWTT
MZP24]&UDJ,>B*K7*QR(OU@5+:[EV1;]0:KSW9ES1CZ?#;-4W"&GD7AL]2UO3
M2T_I;XS3N9&GBGBX(A6[Z/W7%PPGMYLV49(KYLTW)7U6>Y563>,LK[LJ.I%<
M[T^VIFQR*GL.>_ZX35K:WWE:]SC--M]EEXQ/%;ED-KPG9U)=,NKZ&!TT5NHF
M5]KE=45+FIQ&Q&0O7J7P]JH(;=]('A.7;![7LUQ?!\=K\JR*LK[-+2V2V0NJ
M*F1D-Q@DD5D;$5R]+45R\>A$Y!&M+V16&]3]L]]Q>&V5$V0S:QJK7%9F,5U0
MZM=9G0)3M8GBKUD]JB?5!PJN:0UOGMD^C8O.L[OB-TMNP*C -@6^'#ZBG?'<
M'55QJ+PZCA2!R=77,DT:L3V>I F=:<.R_$;_ (CVM:HQ'-+!56*^6ZVUL%YQ
M^YP+%/%YMPJGHR:&1.4ZF/1>%3Q10B=:#^S77>PM![=[AM)5N*76+3<MV7+-
M59:^GD][4;4^4R6B94N3I?)Y,L#5:B^#H)5"9TLOV::^SC"]N=Z=VRS%;GCU
MLS79U5=,2KZZG?#%<:)]?=)&U%,]R(DC%9*Q>4_SD")5Z^D.[8-F7?))MP:(
MQRMO]9L"S)B6X,8L\/G5%9!')%-25BPL]M)PM/$QZIXM6*)>..I0FF6\]P.O
M=RY)VD=KG;CBN&WE+QEUOPZQ[2KH(7206*CM%#1MJ6W!\?+(T;5=#E57<*D3
M^.?8$:UNJ3L\[7:2EIJ1NB<-G;2Q,B;//:J>65Z,:C>J1[F<N<O'*JOI4(QE
M636&G,G[>.^3)XM?8!6TW;]N?%XI:FJM5(J6>R76AC?)&R5[$Z8O;P2HQO@G
M^LM1/1X$XXPS&Y__ #%^SGXM9A_NFY C4Z+!2
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MA51<B_,5<5.,^-.CM:>RM?V/?-4TY^#*K_>%48F\O6:^5=R/U%'BPM:83*
M    HW7_ #Y[+\6W^X)S4?UW6[SF.9_&-G[&>Y6O(;=TX
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M'=Z:JIDIUK*2J7S$A;4\]3XE<[I]*<A..A=H(
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MK_GSV7XMO]P3FH_KNMWG,<S^,;/V,]RM>0V[IP
M
M
M
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M?/9?BV_W!.:C^NZW><QS/XQL_8SW*UY#;NG
M
M
M
M                  4:[#O[NLP^,:^Y*<U&Z/ JY7+O=1_KKOVL_NTKRFW=
M1   #EO]*=_=AKGXPS^YCT_1CZVOD:W>7@QRMH^B^_N R/XZUWN*A+/27UF/
M%CNRKW=]7/+WH=(#SS/                     4;K_ )\]E^+;_<$YJ/Z[
MK=YS',_C&S]C/<K7D-NZ<
M
M
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MFC<CF.:OH5KDY144#S5-RMU%'535E?34D-$UKJV6:5D;86O^Q617*B-1?8Y
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M!.:C^NZW><QS/XQL_8SW*UY#;NG
M
M
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M'OE2ABJJ9DR1>=+[>7Q>J^8_VTG/6[Q<H)5)H])ZEVUWN[UK,DUOCU^L^O\
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MGN5KR&W=.
M
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MM>0V[IP
M
M
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MSV7XMO\ <$YJ/Z[K=YS',_C&S]C/<K7D-NZ<
M
M
M
M                  !1KL._NZS#XQK[DIS4;H\"KE<N]U'^NN_:S^[2O*;=
MU$  4=[OO[:=L/QY=_-Q&!G=='+S/7]%_JLU]GSK!%3 ?ZGI3]T"LO:71UEP
MUWW%4%O<K*^NS?(J>A>G@J32TL;(U3]QRH5;NF(QF?G,WIA&-RS]E'?;?V$7
M*VU';'@MDII(V7?%)[O;,FMO*)-2UK;I5RN;,STHKVO1Z<^E%-[O:F?O%4\$
MX3')A#P6ZYC[O3'#&,3RXRE+.-K8957?8FGZ2JFJLVMV"7"_W.&"%7T]-2.B
M?$QL\[>6QR*KVJC'<*K7(J%BUEZXBFY\G:B&15?IVIM_*PQ1YV)?-9U;_P"Z
MU7NN4N[U]9K6=V^KT<B)L!RW&:/O([JMDRWJEH\ Q#$[':\JR5S_ /4X:]B0
M-<U\C>4Y9Y$C5X]"HI<N453EK5&'QIF9B.H451Y^Y5P1%.,]F>X\G>+A5UOF
M#U7<%;-G_E;K_%/>K)+7J&Y-YQFXQQ+"QKU?32PR2/>YZR-1ZJG*]'''@K(7
M(BOS4TX35HVOE1B9RF=F;F.,4Z<."<-/+R<'49+?&1:;OV(:^RZ72>.[#WWN
MVT6QF 8K<Z*&JK&OK:=KHIJR1[4<E+2J_A7NZ47CA%1.52,M3=IJJIVYIHIF
M<9B9B.MU9X$YB+=41,T155.K&([?%$<*<>UWMSLW;[AE33N92U>=9;*VX9Q>
M*6)L,"U"\N;24L3$1D=/3J]S6(U$Y\7<>*(F/G,W5F*L>"-$?IQKF6RU-BG"
M-<Z9_3BXEG#$9(           *-U_P ^>R_%M_N"<U']=UN\YCF?QC9^QGN5
MKR&W=.
M
M
M                                                 HUV'?W=9A\8
MU]R4YJ-T>!5RN7>ZC_77?M9_=I7E-NZB  *.]WW]M.V'X\N_FXC SNNCEYGK
M^B_U6:^SYU@BI@/]3TI^Z! 79'_\@;H_YEW?^;A&2\&>5G=+OK;'V5/=EN^6
M]J6)W?*KOFF#9MF&FK_DKDDRMV$W-U!2W.5O")-44JM?%YG'/MFHG*JKEY<J
MJN[MY^JFF*:J::HC5M1CAUWA;F2IJJFJF9IF=>$Z^LW'7?;U@&M;#E=KM"W.
M[7O/(9H\VSN]5CZ^]W-TK'Q]<]5+S]@UZHUK6HWV517<JMN]G*[M43.$1&J(
MT1'67+.5HM1,1CC.N9TS/70Q8^Q_',;M--CUBWON6RXY2M='!C]NRR2DHV,>
MJJYK((86QM15555$:9-6]*JIVIHHF>/98].[J:8PBJO#BVI3]A&B-5:^P6X:
MYQW$*1N+7N*2/)*:LZJN6Z.F;TRR5LTRN?*Y_*^E>&_Y*-3A#"N9BY<JVZIT
M]SD9E%FBBG9B-'Z:^-!=%V281&RW8]=]AYWDFJ[/5-J;9J"Y7=\ED9T/62.&
M1K6MDDBC=PK6.=_UKSDSO"O7$4Q5\Z(TK/W2C#9F9FGBQT<\\DLMF?9_C.6;
M)J-I46R\ZPO)744=LMRX[<8Z*.@H8F(Q*6CXA5T,7'*]#7<>*E%O.U46_-[-
M,QCCICA55Y:FJO;QF)PPT2E35FH*O657=ZJIVKG6Q4NT,43*;+[JMQBI?*<Y
MW73M5C>ASNKAR^RB(6;M[SGR8CDA<HM[/#,\J9RRN            HW7_/GL
MOQ;?[@G-1_7=;O.8YG\8V?L9[E:\AMW3@
M
M
M
M               *-=AW]W68?&-?<E.:C='@5<KEWNH_UUW[6?W:5Y3;NH@
M"CO=]_;3MA^/+OYN(P,[KHY>9Z_HO]5FOL^=8(J8#_4]*?N@0%V1_P#R!NC_
M )EW?^;A&2\&>5G=+OK;'V5/=E=PS7D0                   *-U_SY[+\
M6W^X)S4?UW6[SF.9_&-G[&>Y6O(;=TX
M
M
M
M             "C78=_=UF'QC7W)3FHW1X%7*Y=[J/\ 77?M9_=I7E-NZB
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M[&>Y6O(;=TX
M
M
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MAMW3@
M
M
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M<<>B21N1S>4H)^?%.4-5$Q.=T<7><TS%43TQLX>AGN5KTFX=/
M
M
M
M                                _G/EZ?,DZ>GIZEZ>CJZ>.?#IZO;<
M?4Y\3Q3XSJUOF%(                           "TG9QT?IVL'5Y?5ZA<
MO+Z^OGGU9_V'3X<\<_9>''/^5P;#=GU\<DO>>[?#_-6_%KX_FSJ^'1AU<'9
M]*^D@
M
M
F                                               /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>tm2227887d4-lc_6lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_6lnp4c.jpg
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M# P,# P,#/_  !$( LH&@@,!$0 "$0$#$0'_Q #Y  $  @,! 0$! 0
M    !P@%!@D$ P(!"@$!  $% 0$               (! P0%!P8($   !0,"
M @$*$ D%# 8%" L  0(#! 4&!Q$((1(3,4$B%-265Q@X"5'2LY2T%55UE;46
M5G876!EAT3(CI=4V-W=QD4*39X&Q4C/3)#6&MBDY6:%B<K)S=,'#-%0E@I)#
M4\3%)DBB8X/C1(3D1:8H:!$!  $" @0#$0T' P0" P$!  $" Q$$(3$2!5%Q
MD4%A@;'1,E)RDA-3%#05!A8'H<$B0J*RTC-SDU0V%_#APK/#-56"XI3Q8D-T
M(T5C@PA$)/_:  P# 0 "$0,1 #\ [^
M
M                                            "NV[E2D;7\^&A1I,
M[&K23,CTX*BK(R_ND>@*QK0U8>Q+:95K&LRJU'#5.DU"IT*G2YTE4VI$;CST
M9M;BS),LB+F49GP(#&6U^(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M
M\"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ
M=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q
MMH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]
M?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R
M>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3
MIGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP
M#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M
M\"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ
M=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q
MMH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]
M?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R
M>(%M \"=,]?53NP#&3Q MH'@3IGKZJ=V 8R>(%M \"=,]?53NP#&3Q MH'@3
MIGKZJ=V 8RQ->V%;1HE#K4J/A:FM2(T"2ZPX4ZIF:5H:4I)\99EP,@,99C8(
MI2]H.$S6HU&5+FI(S/7@FIRR(O[A%H!.M<$%
M
M
M
M         !73=WY+V>_H/6/8JP5C6E/&7[ML??1JD^PV@4;P
M                                              ,'<_[-W#[V2_45
M@*L; O) PG[V3OC28"LZUPP4
M
M
M                                                         %=-
MW?DO9[^@]8]BK!6-:4\9?NVQ]]&J3[#:!1O #F86_2YO')\6<\?4PK>^4QV]
M\I2F/'-T[6Z0GN3DZ/\ QG]'_!X:Z\02PT.@]_7*NS+%O2\&HB:@Y:=!J-9;
M@*6;:7U0(KD@FS61*-)+-&FNAZ>@"*F6QS>'<6[!.3BN"S:=:2[!.B]JJITA
MY\I!57M[F)9.D7+R=IEIH?'F_ "LQ@OR"@
M        ,?5JG#HE+J59J+AM4^D17ILYU*36:68Z#<<424ZF>B4GP(!7';QN
MWQ/N;DW5#QNFMM2+/1%=JK=8AHB\S<Q3J6E-&V\\2N+*M2,R/J< 5F,%G@4
M            &#N?]F[A][)?J*P%6-@7D@83][)WQI,!6=:X8*
M
M
M
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MOY/8Z @WD       &#N?]F[A][)?J*P%6-@7D@83][)WQI,!6=:X8*
M
M
M
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MP!&86)!0      &#N?\ 9NX?>R7ZBL!5C8%Y(&$_>R=\:3 5G6N&"@
M
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MJQPF<)C1$STHEJ]\^A5_=N6JS$W*:HIPQB,8G3,1TYA84>P>*
M
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MDOU%8"K&P+R0,)^]D[XTF K.M<,%
M                                               52VE?L=<WOR7L
M=H> ]GODMWM_>AT3VC^5VNT_BE:T>_<[
M    5%J?E:V[[WK^*Y(YW>_-%OM?Z=3I5C\J7.VC^92MT.B.:@
M
M                          "NF[OR7L]_0>L>Q5@K&M*>,OW;8^^C5)]A
MM HW@                                      >6;#C5&%+I\UHGX<]
MER/+9,S(EM.I-"TZI,C+4C,N!@(9Q/MMPA@V=5ZGBO'\.TJC76B8JDYI^5)>
M<9)?2$T2Y;SQH1S<>5)D7 N' M"LRG %                &#N?]F[A][)?
MJ*P%6-@7D@83][)WQI,!6=:X8*
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M_3J=*L?E2YVT?S*5NAT1S4
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M6_-D2$(4ME:T&?(XG711Z'PZH$ZUE 4
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M%J?E:V[[WK^*Y(YW>_-%OM?Z=3I5C\J7.VC^92MT.B.:@
M
M
M
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M%J?E:V[[WK^*Y(YW>_-%OM?Z=3I5C\J7.VC^92MT.B.:@
M
M
M
M                                             "J6TK]CKF]^2]CM
M#P'L]\EN]O[T.B>T?RNUVG\4K6CW[G8         _#C;;J%M.H2XTXDTN-K(
ME)41\#(R/@9& Q/R<M[W!IWK5KTHKC(]D2G4^G])VA CPNFTZ7M=I#?-RZZ<
MW*1:Z:GH*8CV@                 "HM3\K6W?>]?Q7)'.[WYHM]K_3J=*L
M?E2YVT?S*5NAT1S4
M
M
M
M                 52VE?L=<WOR7L=H> ]GODMWM_>AT3VC^5VNT_BE:T>_
M<[                                5%J?E:V[[WK^*Y(YW>_-%OM?Z=
M3I5C\J7.VC^92MT.B.:@
M
M
M
M                    "J6TK]CKF]^2]CM#P'L]\EN]O[T.B>T?RNUVG\4K
M6CW[G8                               "HM3\K6W?>]?Q7)'.[WYHM]
MK_3J=*L?E2YVT?S*5NAT1S4
M
M
M
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M_-%OM?Z=3I5C\J7.VC^92MT.B.:@
M
M
M
M                            "J6TK]CKF]^2]CM#P'L]\EN]O[T.B>T?
MRNUVG\4J([UJM-N;<FW;U84;]%Q];,*5;5.5Q93)JBEJD231U#69()!&?4(N
M [5N&U3L35S<7C\A1&$RJM=T,GJ)+G,*5&JM#0=3H=2:,T/Q9D0C=9=:66AI
M,E)ZPWMZB*Z9B6=73$QA+O[AVY9MYXDQ?=U2>[8J5SVG1JK47R(BYY$N$R\Z
MK0M"+5:CX$.>7Z-BY53',F7GZXPF82.+2(  .9/G%J]4'UX5QUVVM-MW74*K
M4KFI23_-S4TAEEV*V\7])"7G"7RGP,R+7J#>[BM4U7)F>8S<C3$U:5#)=/A3
MX;M.F16Y$%]LVG8JTD:#09:::=;3K#U\Q$Q@V^#K)L/N.LW%MOM9%;FNU%VV
MJE5[?I\]]1K=<A4R<ZQ%)2CU,^1LB;+7K)(>#WG;BC,51#19FF*:YP7%&O6$
M>W'E&S;4O6QL?5NH.QKHR-V[\E(2([KB'_:]"')'.ZA)H;Y4K+3F,M>L+E-J
MJJF:HC1&&/1U(57*::HIF=,XX=#6].1LC6IBFT:G?-[3G*;;E'Z/M^6TP[(6
MGI5DA.C;*5+/4S+J$%JU5<JBFG3,ERNFW3-56J&WPID>HPHE0B+-R+.9;D1G
M#(TFIMU)+2>AZ&6I'UQ;3>H!CZM5J;0:74*U69S--I-*CN2JC4)"B0TRRTDU
M+6M1]0B(M16(F9P@F<%>+6W@[=KRN.GVK0<A)=JU8?3%HIRJ;4H4::\K@2(\
MJ5%:969GP+L^R_HZC*KR-ZBG:FG1'/CI8XL>C-6ZYPB?<G3Q3JGH++C$9
M-1OR^+<QM:%=OF[I:X%N6XP4FK2VVG'UH;-:6R,FVB4M79*+@1"Y:MU7*HII
MTS*%=<44S55JA5M._P#VTK2E:+CKJDJ(C2HK=JID9'U#(^UAF>:\QV,<M/58
MWG"SPSW-746OM"ZJ-?%L4.[[>>=D4.XH;<ZEO/LN1W%,NEJDU-.I2M!_@41&
M,&NB:*IIG7#*IJBJ(F-4MC$4@  5%J?E:V[[WK^*Y(YW>_-%OM?Z=3I5C\J7
M.VC^92MT.B.:@
M
M
M
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MOM?Z=3I5C\J7.VC^92MT.B.:@
M
M
M
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MUT 5%J?E:V[[WK^*Y(YW>_-%OM?Z=3I5C\J7.VC^92MT.B.:@
M
M
M
M                /'47)K5/G.TUEB146X[JX#$IU3+"WB09MI==2AQ2$&K0
ME*)*C(N.A]0!P*N'SA68:-N!HCU=H]+77+3HTJS:Q9E#NXBL>IUR3(/M>KK=
MZ9V,VAHG2)72N*4@D\JW6S)7(3V7<_'=2NBLV):56O5BCQ[MJ-*C2+@:M^2J
M72RE.-DIPX;R^*FS,]4\5:=0EK(N=1!N0
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MPDI+MNI2RUT-2B+4FVR4:6T=1*?PF8\3FLU7F*]JII;MV;DXRGH8RV
M               *BU/RM;=][U_%<D<[O?FBWVO].ITJQ^5+G;1_,I6Z'1'-
M0
M
M
M                            'EG08=4@S*;48K4VGU%AR-.A/));3S+R
M30XVM)\#2I)F1D?6 4P/87@=G(%MW+3K4H\*QZ%:LRVIF,5TU$F+/7+>6]V_
M(EO.J>4^CF225JYEERI,EEH6A7%;:T+2MRPK8H-F6C2FJ);-LPFJ?1*4R:U)
M9CLIY4)YW%*6L^NI2U&I1ZJ49F9F"C8P
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M4K=#HCFH
M
M
M           "NFXC<S9&VJFVE4KSM^Y;C^6E372:) MB)&F2524H)9)4W(E1
M=>;4B22349GPT!6(Q5T^\HQMX!\W]Z\/]: KLGWE&-O /F_O7A_K0#9/O*,;
M> ?-_>O#_6@&R?>48V\ ^;^]>'^M -D^\HQMX!\W]Z\/]: ;)]Y1C;P#YO[U
MX?ZT V3[RC&W@'S?WKP_UH!LGWE&-O /F_O7A_K0#9/O*,;> ?-_>O#_ %H!
MLGWE&-O /F_O7A_K0#9/O*,;> ?-_>O#_6@&R?>48V\ ^;^]>'^M -D^\HQM
MX!\W]Z\/]: ;)]Y1C;P#YO[UX?ZT V3[RC&W@'S?WKP_UH!LGWE&-O /F_O7
MA_K0#9/O*,;> ?-_>O#_ %H!LGWE&-O /F_O7A_K0#9/O*,;> ?-_>O#_6@&
MR?>48V\ ^;^]>'^M -D^\HQMX!\W]Z\/]: ;)]Y1C;P#YO[UX?ZT V3[RC&W
M@'S?WKP_UH!LGWE&-O /F_O7A_K0#9/O*,;> ?-_>O#_ %H!LGWE&-O /F_O
M7A_K0#9/O*,;> ?-_>O#_6@&R?>48V\ ^;^]>'^M -D^\HQMX!\W]Z\/]: ;
M)]Y1C;P#YO[UX?ZT V3[RC&W@'S?WKP_UH!LGWE&-O /F_O7A_K0#9/O*,;>
M ?-_>O#_ %H!LGWE&-O /F_O7A_K0#9/O*,;> ?-_>O#_6@&R?>48V\ ^;^]
M>'^M -D^\HQMX!\W]Z\/]: ;*7\";R,>[A;UN"P;:LR][1N&VJ259J+%VTZ)
M +M=3S3*22EF;)<YC-Y)ES((M..H*3&"VX*    *I;2OV.N;WY+V.T/ >SWR
M6[V_O0Z)[1_*[7:?Q2M:/?N=@  T+*G[L\@?1ZI>QG!D97ZZCCCIH7.MGB<%
M_-Q>4_;WO'6/8P]QZ0^23QPTV0^MZ#_1*.?MX
M  *BU/RM;=][U_%<D<[O?FBWVO\ 3J=*L?E2YVT?S*5NAT1S4
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MG.Z\M7:N5V;^U-%.UAL33HQPUS+?A[YH@
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M]7[R=C7\;Z%[,B E#HL"(
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M;V)_X-6]19'AM^?F+=?:YGYE#=9+R#,\=OIU-Y'N6E
M       &C7?_ *3L?W[3Z@Z/#>E_EF[/_9CYE;=;I^JS/V?\4-Y'N6E
M
M               5RVU?L]DC^(UQ^JMC"R/6U=M+QGH3]1F?_9N].%C1FO9@
M                        "N5L^4]DWZ(4;U10PJ/*:NUAXS(_F+,_8V^G
M*QHS7LP                !SIWU?O)V-?QOH7LR("4.BP(@
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MB%*9F,&9I)YA:7$:EU2YDF9< '\ES84!KIYTMF$P:B23S[B6T<Q]0N91D6O
M!Z@& B77:U0J;E%@7+2IM89YNFI,>8PY)3R?E\S*5FLN7KZEP 9\!@ZQ<]MV
M[T/R@N&F4+MC7M?VPELQ>DTZO+TJTZZ?@ 9EIUI]IMYEQ+S+R26TZ@R4E25%
MJ2DF7 R,NH8#]@/+&FPIAO)B2V91QEFW()EQ*S;6752KE,]#_ 8#U    T:[
M_P#2=C^_:?4'1X;TO\LW9_[,?,K;K=/U69^S_BAO(]RTH
M
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MM].5C1FO9@                #G3OJ_>3L:_C?0O9D0$H=%@1
M      >5Z?!CRHD)^8PQ-J'2=H1''$I=?Z)/,YT2#,C7R$>JM"X%U0"5/@P>
MUNW9C$/MQ]$6)T[B6^E?<UY&D<QES+5H>B2XF 39\&F179M2F,4^$QR]-+DN
M)::1S*)*>9:S(BU,R(M3ZH#ZOOL16'I,EY$:-&0IV1(=42$-H07,I2E*T(B(
MBU,S ?F+*C38T>;"D-2X<MI#T26RM+C3K3B24A:%I,R4E1&1D9'H9 /N
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MYW&1MSF*=K#K:M$:<-,<W1KXF>M7$>>L&4.X,761AFS<NVTF5+<QSD6KU"%
METQB6M2T-U**^PXN3T"E:_FU)UZGH$4+EVSF*MNNJ:9YL88X\6G1BE;MW;,;
M%$1,<S3AASIT3J71PO9MS6)CFW[>O.NL7'=;:7)%?JD6*Q#CG(?6;AM,LL(0
MDD-$9()1EJK3F/370L"]5357,TQA',9=N*HIB*IQE*@M)@    "HM3\K6W?>
M]?Q7)'.[WYHM]K_3J=*L?E2YVT?S*5NAT1S4
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M;6-YMV;1BN"=7<47O2W+@QI%J3IK=B/)C*FZMGH22U;9D-.\A$2U-H<X&1I
MG3&*V>?\>;E,Q7C&Q]9=\Q,/X,72V7;OO:FJ-RY*G)><=)Z!$)*B-AM+:$:K
MU;UYS[)PM6R*1@K)YJRDQZ!1=QE"B..O1:+?I0(SSYDIU;<9MQI*G%)))&HR
M3J9D1<>L"M3K$"(  -&N_P#TG8_OVGU!T>&]+_+-V?\ LQ\RMNMT_59G[/\
MBAO(]RTH
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MD97ZZCCCIH7.MGB<%_-Q>4_;WO'6/8P]QZ0^23QPTV0^MZ#_ $2CG[>
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M5.IP(@  T:[_ /2=C^_:?4'1X;TO\LW9_P"S'S*VZW3]5F?L_P"*&\CW+2@
M
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M:M#*\QW !   %<K9\I[)OT0HWJBAA4>4U=K#QF1_,69^QM].5C1FO9@
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M,5C]\--[H P/KTPEX8K'[X:;W0!@?7IA+PQ6/WPTWN@# ^O3"7ABL?OAIO=
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MG_%#>1[EI0
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MF6OX3PO7J_9M$J%>OVN**B63#I\-V:IF?*0LRENH:0YHB.A*G.R+E4HDH_I
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M\#I""(  *Y6SY3V3?HA1O5%#"H\IJ[6'C,C^8LS]C;Z<K&C->S
M       '-#SAEOT>[+IV;VM<,)-3H%RY?I=*KE-6I24R(<Q^,P^TI2#2HB6V
MLTF:3(^/ P2I39X@6T#P)TSU]5.[ 4QD\0+:!X$Z9Z^JG=@&,GB!;0/ G3/7
MU4[L QD\0+:!X$Z9Z^JG=@&,GB!;0/ G3/7U4[L QD\0+:!X$Z9Z^JG=@&,G
MB!;0/ G3/7U4[L QD\0+:!X$Z9Z^JG=@&,GB!;0/ G3/7U4[L QD\0+:!X$Z
M9Z^JG=@&,GB!;0/ G3/7U4[L QD\0+:!X$Z9Z^JG=@&,GB!;0/ G3/7U4[L
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M_BN2.=WOS1;[7^G4Z58_*ESMH_F4K=#HCFH
MT:N?MO8G_@U;U%D>&WY^8MU]KF?F4-UDO(,SQV^G4WD>Y:4
M            :-=_^D[']^T^H.CPWI?Y9NS_ -F/F5MUNGZK,_9_Q0WD>Y:4
M
M                   !7+;5^SV2/XC7'ZJV,+(];5VTO&>A/U&9_P#9N].%
MC1FO9@                        "N5L^4]DWZ(4;U10PJ/*:NUAXS(_F+
M,_8V^G*QHS7LP                !SIWU?O)V-?QOH7LR("4.BP(@
M                                 (0W->3=N#_AK=GQ/*!6-;1]D?DG
MX+^C37JK@$ZUIP4    <Z<;?\2S<5_#6A_WJ6"7,=%@1    52VE?L=<WOR7
ML=H> ]GODMWM_>AT3VC^5VNT_BE:T>_<[ $=9>_=5DCZ-53V*X+MCZRGCA8S
M7U5?%/25RVP?N*Q]_P"2=]D.C:9KZR7F\C]13Q)\&.RE9*GY9^(_H?4O_M@O
M5^35<<+-CRZCM9;-E'(.3L@9H5MVP]6V;*10J,S6\J9(4PF3+I[$L_\ -8M/
M;6HD=,XG11J4D^"M2TY5"U8LV[=GOUR,<9PICAXVXO7;E=WO5N<,(QF>#G1S
MV.?M/<CA*ZK0J] OZN;A+#KM48I=[VO7&(_MK3V7^;6HPY#*6DDAHRU6E?6T
M+0_RBK%S+WZ9B:8HJB,8F-4\Z5-B_9JB8JFN)G3$X8QSXU-'J?URY4W5YQQO
M;N=J[C.V;#IE!FT>GTV%"E-\TVG1%NI/IT<Q:N.*5KS'U1>B+5G+6ZYHBJ:I
MG7CS)E:IKNW<S<HBN8BG##"(YL1PPRC%Z9PVX95QU:>6K]C97Q9EFH'0Z7>$
MJ(B#4J35>1)LI?-KE:-MTSZ^O C/L>4^:S51:S%%55NG9JIC'#'1,+]-=RS7
M337.U35.&.&$Q.OB>>LW/E3,.<\SV%2\U_490<.-04TB!$CQ53*H<R,J0Y.D
MJF&?-';-&AFC0B)1:^B=(IMV;5%<T[4U8\4<[1S4MJNY<JIBK9BG#5AC./-T
MXZ.9RIMVD98NG,>'(-TWDVPNO0*K/HLFL1&C:BU-,%PD(FQR,S(TN$>AF7#F
M2K33J"QG;%-F[--.K1/%CS%S*W9N6XJG7IXM$X8]%^,QXNRE7)]>O&T]PUQ8
M^I4&EJ>9M&G4^"_&)R(RI2E$Z^DUZNFG4_0$LO?MTQ%-5N*IQUXR7;5=4XQ7
M,<6'OQ*!-K]JYSROC;&V8*_N<N=**VZ]+J5HE3:>N,XW"GO1U,&]R)7RNI8X
MF1:EJ,G.W+-NNJW3;C1HQQECY.FY713757,XQCAA&'2Q:#M7W$Y2K>Y"\K#R
M-<\BX+1NJHW+3K"3(0TDHDZ@2C=5';4A"-2.(HS,CU/@G\(N9[*VZ;,541A,
M13CS]J-?*AE+]R;M45SC$S5ASMF<,.3I-A\X)N$R)C;Y-6=B>X'[<KD6$Y=%
MWU>(EM;C5/Z8H$9E72(6E).O.ZZ::GREUNK'=66MW*L;D8Q.B./7TH-Y7[EN
MC_XYPF-,\6KW<?<=-AIVS          !46I^5K;OO>OXKDCG=[\T6^U_IU.E
M6/RI<[:/YE*W0Z(YJ                         -&KG[;V)_X-6]19'AM
M^?F+=?:YGYE#=9+R#,\=OIU-Y'N6E                         &C7?\
MZ3L?W[3Z@Z/#>E_EF[/_ &8^96W6Z?JLS]G_ !0WD>Y:4
M
M    !7+;5^SV2/XC7'ZJV,+(];5VTO&>A/U&9_\ 9N].%C1FO9@
M               "N5L^4]DWZ(4;U10PJ/*:NUAXS(_F+,_8V^G*QHS7LP
M              !SIWU?O)V-?QOH7LR("4.BP(@
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M*I#A2T4BG4]E23<D/-<S:#63RM$\VNJ2UTYDZPRENJS;N7*XPB:=F,>;,_\
M1>S%=-VY113.,Q5M3AS(B)U\K3+,QMC;<=FW<I.W!NK=NBRKA>MZV;8]L'J.
MF#06C>;B2T=KN,+?Z5MM*^=9J0?5Y=%"==^O+6K?>M4QC,X8XU<V-/ C3:IS
M%=??-<3AAC,81S-7#K3GL9K=0EV-D*U(U3^4F/\ '=ZU"W\87:;:$*GTEHDN
M)U4VE"720I?!9%QYM/Z(Q]XTQ%=-6JJJF)F."5_)U3-,QKB)F(GAC_KC'06Y
MO+]C[K]YYWL=8PK?71QLJ=2M&PWR3,0?^5JGQO-&7O+RFOC8N0\GHXH<^:!0
MYT7$^5,P4",;ESX)SW-NJ,\WS=*=-[:)BI,D1=5"FEI6LC_HM_W#V5=43>BW
M.JNW$='#1[K#HC"W-<:Z:ZIZ&,X^YB^V>7?K-PAN&W'OM..4^^KPIMN8VF.I
M4@CMNAN''2XRE7]%^0A2U?\ 72?4%,K'>[]JUS8C&>VGJ1@9J=NQ=N<R=$<4
M?OQEV[&@;<          %1:GY6MN^]Z_BN2.=WOS1;[7^G4Z58_*ESMH_F4K
M=#HCFH                         UZN6S3K@<@O3%R67Z=TO:DB*^MA:2
M>))++5!]?E(>>WYZ,Y7?%5JN]-=-=K:V:J*YHJC;PVM-/#LQ^V+/R6\;N4BJ
M*(B8JPQBJ(JC1JU\;#_(&F>ZU;^$7_QC3^H&3\/F?OZ^JR_/MWL+?<4GR!IG
MNM6_A%_\8>H&3\/F?OZ^J>?;O86^XI/D#3/=:M_"+_XP]0,GX?,_?U]4\^W>
MPM]Q2?(&F>ZU;^$7_P 8>H&3\/F?OZ^J>?;O86^XI/D#3/=:M_"+_P",/4#)
M^'S/W]?5//MWL+?<4GR!IGNM6_A%_P#&'J!D_#YG[^OJGGV[V%ON*3Y TSW6
MK?PB_P#C#U R?A\S]_7U3S[=["WW%)\@:9[K5OX1?_&'J!D_#YG[^OJGGV[V
M%ON*3Y TSW6K?PB_^,/4#)^'S/W]?5//MWL+?<4GR!IGNM6_A%_\8>H&3\/F
M?OZ^J>?;O86^XI/D#3/=:M_"+_XP]0,GX?,_?U]4\^W>PM]Q2?(&F>ZU;^$7
M_P 8>H&3\/F?OZ^J>?;O86^XI/D#3/=:M_"+_P",/4#)^'S/W]?5//MWL+?<
M4GR!IGNM6_A%_P#&'J!D_#YG[^OJGGV[V%ON*3Y TSW6K?PB_P#C#U R?A\S
M]_7U3S[=["WW%)\@:9[K5OX1?_&'J!D_#YG[^OJGGV[V%ON*3Y TSW6K?PB_
M^,/4#)^'S/W]?5//MWL+?<4GR!IGNM6_A%_\8>H&3\/F?OZ^J>?;O86^XI/D
M#3/=:M_"+_XP]0,GX?,_?U]4\^W>PM]Q2?(&F>ZU;^$7_P 8>H&3\/F?OZ^J
M>?;O86^XI?:+8M(BS8<\Y=2EO0'>FC(E3''D)7H9<W*H].H8O97T%R-C,6\Q
M-R]75;JVJ8KNU5TQ5A,8X3//1N[[O5VZJ-FB(JC"<*8B<.@W,>S:<
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M.<AM:7W/;9:Z@E?1=JI3_FYD\?!*B F,'3$$0
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MN6LM3;F9C'&>&<6PW5Z/9;=MVN[;FNJNN(B9KJFN<(U1I2@+[>@
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M<S$:'D\GF+=-JF)JB)A-7U\89\)MN^OFOQBSWBYV,LGQJSV<<J(J#<M R#O
MQ[5;*JT>YJ9;UH3TUFHP%=*Q'4LY))2MPNQU,W4EU>N)7J9HR\Q5HQF#)UQ=
MSM,T3C$4SC@N]>E@63D:D*H5]6M3;KI)GS)AU*.AXD*/^FV:BYD*_P"LDR,:
MJU>KM3C1,Q+TURU3<C"J(F&I6#@7#F+Y[M6L/'='MVK/)-M=799-V62%:D:$
MR'C<<2DR/0R2HB%R[F[MV,*ZIF%NUEK5K313$/+=NWC!]^5^;=-Y8NM^Y+BJ
M1-%/K,Z(EU]TF&TLM\ZSZO*VA*2_ 0K;SEZW3LTU3$%>5M5SM54Q,\4-HLC%
M>-L;(D(L&QJ+:)RTDB6[2X;4=QU*=-$K<2DE*(M-=#/06[M^N[.-=4SQIV[5
M%N,*8B(YS6;^V]X7RA5&:Y?>.Z57ZRR24^VJDN,27$)T(D.NQUM*=21%IRK,
MRTX::"5O,W+<84U3$%=FBN<:HB4E6];E M*CPK?MBC0Z!0Z<CD@TJ RAAAI)
MGJ?*A!$1:F>I^B8M5535.,SC*<1$1A#*2([$N._$DM)?C2FU-2&5EJE:%D:5
M),O0,CT$8G!5A;6M6W+(H-/M>TJ-%MZW:2E::;1X2";89)UQ3JR0@NIS+6I1
M_A,2KKJKF:JIQF4::8IC"(PAA:7C+'U%I%RT"E6A3(-%O)Z5(NFF-,))F>[-
M(TR%OHZBC<(SYM1*J[75,3,Z8U= BBF(PB-?OO)+Q'C*=8\3&LNQZ1(L&!R]
MIVDN.GM)OD6IPN5KJ%HM1J_E,5B_7%>WC.UP\U2;5,T[.$8<',2*+28
M     *BU/RM;=][U_%<D<[O?FBWVO].ITJQ^5+G;1_,I6Z'1'-0
M
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M5F1$DJFDRA10UPJ:W2&>T$&7+$3VFTEI1,DDE)UUUU,#%)H
M
M       #'3Z/2*H[!>J=+AU%ZEOIE4QV4PV\J.^@R-+K)K29H61D6BDZ& R(
M            #GMYP['V:[_QE&BXB8K,R+"@U8[UI=+GN&F?#<*,2()T1F+(
M<J#SRDF;*DJ1T'*L_P#Z0$J6"N_%.ZZ1M5D6>[<-8J6;F[FGSZS<\>ZU.,2X
M*F9'2.):33>9V$\E71MTQ+1<IJ0K75/*0QC%JVWK$VYZC;2KNM:K.7'3L@5N
MG4(L8-JNARCO4J(T371QT1WJ>2Z6J&DO\Y:-*SDZ*1J7-J8F8Q8_97BC<O9]
MDY69R*U<)QJU1KCBV52BKCM Z&K.3Y)NJ9A/TY"XSTUY1OLU#LR0VI&C?6(3
M,/QM Q#NNL[.UVUS+=3K-2M)-0>;KKRZPXQ'EU!5$AMQY[[:Z<R5:2EHFXO2
MH6A*7VW'#YC+LA,PZQ B                    A#<UY-VX/^&MV?$\H%8U
MM'V1^2?@OZ-->JN 3K6G!0   !SIQM_Q+-Q7\-:'_>I8)<QT6!$   !5+:5^
MQUS>_)>QVAX#V>^2W>W]Z'1/:/Y7:[3^*5K1[]SL  %>LLX?Q<[:5]W2NP*"
MNX6*//F-51<)HU]L-L+6EQ1::*/F+7B7$9N5O5S<IIVIPQAAWLG9JB:IHC'B
M<4MAM-@7SN$I%MWA"9N2A3:-5')-+J"">:4MEGG;41*ZAI46I&0]CORB+66F
MJB,)QC4TV1R=F;F$TQJ?Z!+5L&RK&:?9M"UZ;;J))ZR>T8Z&E.:=3F41<QE^
M S'A*[M5?73B]!:L6[4844Q'$VX070                       %1:GY6M
MN^]Z_BN2.=WOS1;[7^G4Z58_*ESMH_F4K=#HCFH
M                                                        HYO7
MSSE7"D7#L'$C5!=N')MUIMK6OQW7XR5OI0E@]6G6S072++F/LN'6!6(:9_O0
M?[$/TF"N@_WH/]B'Z3 T'^]!_L0_28&@_P!Z#_8A^DP-!_O0?[$/TF!H/]Z#
M_8A^DP-!_O0?[$/TF!H/]Z#_ &(?I,#0?[T'^Q#])@:#_>@_V(?I,#0?[T'^
MQ#])@:#_ 'H/]B'Z3 T'^]!_L0_28&@_WH/]B'Z3 T'^]!_L0_28&@_WH/\
M8A^DP-!_O0?[$/TF!H/]Z#_8A^DP-!_O0?[$/TF!H/\ >@_V(?I,#0?[T'^Q
M#])@:#_>@_V(?I,#0?[T'^Q#])@:#_>@_P!B'Z3 T'^]!_L0_28&@_WH/]B'
MZ3 T'^]!_L0_28&@_P!Z#_8A^DP-!_O0?[$/TF!H/]Z#_8A^DP-!_O0?[$/T
MF!H/]Z#_ &(?I,#0UR@YNWDV/N*P?B;.K6.54/+3U4Y7+68F./I:IL1;JOSC
M[B20?.:-.Q5J6O4 PATY!$
M                     !K5R7G9]FL1I-X771[4C35FU#D5B='@H=6DN8TM
MJD+02C(N)D0#4?KTPEX8K'[X:;W0!@?7IA+PQ6/WPTWN@# ^O3"7ABL?OAIO
M= &!]>F$O#%8_?#3>Z ,#Z],)>&*Q^^&F]T 8'UZ82\,5C]\--[H P/KTPEX
M8K'[X:;W0!@?7IA+PQ6/WPTWN@# ^O3"7ABL?OAIO= &!]>F$O#%8_?#3>Z
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M+O6SQ."_FXO*?M[WCK'L8>X](?))XXZ;39#ZWH/]$HY^W@
M           J+4_*UMWWO7\5R1SN]^:+?:_TZG2K'Y4N=M'\RE;H=$<U
M
M             ',WSB'[2;._XNTWU:,"5+ID"(
M                   YT[C_ "X]C?\ K;["2"4:G18$0
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M[[WK^*Y(YW>_-%OM?Z=3I5C\J7.VC^92MT.B.:@
M                                                       #F;YQ
M#]I-G?\ %VF^K1@2I=,@1
M  '.G<?Y<>QO_6WV$D$HU.BP(@
M                         .=.^K]Y.QK^-]"]F1 2AT6!$
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MSMH_F4K=#HCFH
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M=Q_EQ[&_];?8202C4Z+ B
M                     YT[ZOWD[&OXWT+V9$!*'18$0
M                 !SIW<>5AYO[Z2W5ZE202C4Z+ B    A#<UY-VX/^&MV
M?$\H%8UM'V1^2?@OZ-->JN 3K6G!0   !SIQM_Q+-Q7\-:'_ 'J6"7,=%@1
M   52VE?L=<WOR7L=H> ]GODMWM_>AT3VC^5VNT_BE:T>_<[ $59T_<QE;Z*
M5?V(X+.8^KJXI;'='EEGMZ>G"ONV3]PV-/>K_P!<X,*QUD/2[\\MN<:=Q>:E
M5RM^6O@WZ+5?U&<+-/U\<75;K_Z:_P!O3TX= QLWA0
M     %1:GY6MN^]Z_BN2.=WOS1;[7^G4Z58_*ESMH_F4K=#HCFH
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MKSQG8>0W[:DWM:\*XW[/J**O;#LM*E'"G-FDT/M<JBT41I+J@-Y
M      !1#>SM&JFYRBTF51;ACP*W:K3;="HK\6(RV\Z_.C]M.O50X[\M"$0^
MGY6$=@IWHU*_)/4K$X/AD+90FZ=M5!P!#OA#D>SG9LND5 Z%2(CLWD1(53(J
MW6XRNU5)<4R4B4RGI7R2YS_XT]!CI2GM.V[*VVX[79YUY%954W(]1E,%!AL*
MB2UQFRF,G,CLLNS4]/SFVX^7.EOE07!($SBM&"@
MYT[C_+CV-_ZV^PD@E&IT6!$
M             $29WO\ J>+,2WID"C(IKU4MF*S)AQJLF8N*^I4EIKH%%3VG
MI'.Z2S0WRH,B6:35HCF,%849VJ;P,LY7I^66K_I%+M698]!N*XZ0Y7X]0:D+
M[7GO)90[VG3F&#ATU)=J/\A*E*6CFY#5S$1688[:CO.S!F3-,VQ;XMB%;E K
M,R5)ICLR-/:-#<:C,/II]*6FG,$I2UD<XSG.$OH'22G4R1S"8=4@1    5 W
M0X8O?*UY;8JW:+$-Z#BK)M+NF[52I"6%(I\21'<=4RDR/I%\K9Z)(%8E;\%
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M1SN]^:+?:_TZG2K'Y4N=M'\RE;H=$<U
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M+\"N^G V9/O2=I_NO<OP*[Z<#9D^])VG^Z]R_ KOIP-F3[TG:?[KW+\"N^G
MV9/O2=I_NO<OP*[Z<#9D^])VG^Z]R_ KOIP-F3[TG:?[KW+\"N^G V9/O2=I
M_NO<OP*[Z<#9D^])VG^Z]R_ KOIP-F3[TG:?[KW+\"N^G V9/O2=I_NO<OP*
M[Z<#9E<C#^7;.SE8=,R-83TJ1;-7>DL0W9K!QGC7$>6P[S-J,S+LT'H",PDX
M    !SIW'^7'L;_UM]A)!*-3HL"(
M                   #"T&W*#:\)ZG6Y2(M%@2)DJH/Q(;26FURIKRI$EXT
MI(B-;KJU+4?7,S, I=N4&B3:[4:12(M-GW/,34+AEQVDMN392&6XZ7GU$6JU
MDTTA&I]9)%U@&:                  &)KM"HUST:IV[<5,C5JA5J,Y#JU)
MF-D['DQW2Y7&G6U:DI*B/0R,![>TXO:G:':Z.TNA[7[5Y2Y.BY>3DY>IIR\-
M 'BH5"HUL4:F6[;M,C46A46,W#I-)AMDU'C1VBY6VFFTZ$E*2+0B(!E@
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M=22?5XZ)M9K,X4]YHF9B-<]E/4X%RS9VJN^5QA/,CL8ZO#R+X#7,L
M       %1:GY6MN^]Z_BN2.=WOS1;[7^G4Z58_*ESMH_F4K=#HCFH
M                                            #2<AY'LC%%J5&^,A
MW%&M>UJ5R%-JLDEJ(E.*)*&VVFDK<<6HST)"$J4?6(!H.&]R.',]G66,9W85
M6J=O$VJM4.7%DT^=';=_Q;IQY;32U-JX=F@C21F1&9'P!68P;#EO-.-L&VVQ
M=63;D1;]*F2T0*:E++TJ3+EN$:DLQXT9#CKBC))F>B="+BHR(%(A[<69:Q]F
MJTF+WQI<35RVZ](<B.2D-NL.,26>4W6'V'T-NM.))23-*DEP,E%JE1&8F$C
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M6#[YU[XTD K5K7[!0   !SIW'^7'L;_UM]A)!*-3HL"(
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M$)I\4?=A_P P&Y>]5K]; 8P>*/NP_P"8#<O>JU^M@,8/%'W8?\P&Y>]5K];
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M=[\T6^U_IU.E6/RI<[:/YE*W0Z(YJ
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MF>2!8/OG7OC20"M6M?L%    '.G<?Y<>QO\ UM]A)!*-3HL"(
M                    "FF6=^NV_#-YU&P+LN>H2KHHII36X5)IS\M$1Q:$
MN):<>T0V:^51&9(4KEZBM#X K$):P1N&QQN-MVL71C23/E4FAU$Z5/74(JHB
MRD$RV_HE"C/4N1Q/$"8P3#5G*DS2ZD[1HS,RKM17ETJ'(<-IEV2E!FRVXX1&
M:4J7H1F1'H7$%'+.??6[3"^1]N?UFYDIE[71G"\D46[<#0J/!1$IE)>?)I<R
M#-CZ/FF*VI*C6K0C4?9FLDK,R6A<S=MF*J8'V_Y R5066GKBI4>-#MU+Z.D:
M1,J$IJ(VZM'443/2FYH?!7+R]<%(C%77"F0\YX^W&VO@O,N3$98IN4,<HO.W
MZXNFPZ:_3ZJTM?;4)!121TC)(9<41J+_  .4DZ+!64DU/SAFSZC5*H4BI9>[
M6J-*DNPY\?V@N!?1O,+-MQ',BFJ2>BDF6I&9>@"FS*5,/;H<%Y\J58I&);X^
M5E1H$9N95X_M94X'0LNKZ-"^:?$CI5JKAHDS,"8P3Z"@ IYO]\D#-GO9!^-(
M8*QK3A@O]R6'?H/;WQ;'!24I@         #!W/\ LW</O9+]16 I!YLSR0+!
M]\Z]\:2 5JUL)L5_>3OE_C?7?9DL%9=%@1                         '
M,WS=_P"TF\3^+M2]6D@E4Z9 B    YT[N/*P\W]]);J]2I()1J=%@1    0A
MN:\F[<'_  UNSXGE K&MH^R/R3\%_1IKU5P"=:TX*    .=.-O\ B6;BOX:T
M/^]2P2YCHL"(   "J6TK]CKF]^2]CM#P'L]\EN]O[T.B>T?RNUVG\4K6CW[G
M8 BO.1&K#.54I+4SM2KZ$7_E'!9S'U=7%+8[H\LL]O3TX5[VQF1X&QIH>O\
M\+,OYGG!A6.LAZ7?GEMSC]Y/ O-2JY6B-6]?!Y%Q--J5=2B+K%T4XM19I^OC
MBZK=?_37^WIZ<.@8V;PH                       "HM3\K6W?>]?Q7)'.
M[WYHM]K_ $ZG2K'Y4N=M'\RE;H=$<U
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M,]3T2DB+B8#^,0XD53ZXL5F,N4LW9*VD)0;BSXFI9I(N8S]$P'I
M                 ',WS=_[2;Q/XNU+U:2"53ID"(   #G3NX\K#S?WTENK
MU*D@E&IT6!$   !"&YKR;MP?\-;L^)Y0*QK:/LC\D_!?T::]5< G6M."@
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MMN^]Z_BN2.=WOS1;[7^G4Z58_*ESMH_F4K=#HCFH
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MN3TS.B?SAJ46G5+E$H6ZM:=\32I,B16RD2'7R2VQRDXM2M-37U-3,)(34(I
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MT3HGZRE<\=,<M
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MKO\ DP,)67I-5I]=I=-K=(EHGTFL169U,G-<4/1Y""<:<3KIP4A1&0*,@
M      ^;CK3*24ZXEI)GH2EF22U]#B(7+M%N,:IB(Y\X)4TS5JC%\TRXJU$A
M$EI:E<$I2M)F?]PC%NG-6:IPBNF9XX5FU7$8S$\CT"^@
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M2NQ=LV\*XU3C5.OCF6'G_2;>.>M39OW=JB<,8PIC5ICK8B4EC=M"
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M&4E"$NJ(B(G5:$1:B<(2FK&#SS]MN+?=6\OMUTN=:C4>G*CAJ8C*4)%%%0
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M[:>FZ59ZRGBA8#'_ .R5+_[4GV2Z.T>A7]IM<=?\RMXK??E=?^GYL-R'JFJ
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M^WUGLTEF,N9TI&U'T=3'0:>C?6VY^46O+H,_VG?EW,__ *_YM"QZ.3'C]O\
MU?-EMU(_TM3/_-L^J)'RONKRRS]I3\Z'2LU]57VL])?L?<KC
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MQ4(R;>N TMOM]BX@C13329)41EV)F7H#T-&.S&/ ]#;B9ICB6BQEE"Q<Q6?
MOW'%<^4=IU1U]F#5>UI4/G7&=4RZ70S&F'2Y5H,N*"UZVI":3?P
M!S-\W?\ M)O$_B[4O5I()5.F0(@   .=.[CRL/-_?26ZO4J2"4:G18$0   $
M(;FO)NW!_P -;L^)Y0*QK:/LC\D_!?T::]5< G6M."@  /D\PS):<CR&42&'
MDFAUEQ)+0I)]4E)/4C(_PBDQ$QA*E5,51A,8PPWR5M?YMTOUFQZ06O%[?8QR
M0L>)V.PIY(9TB))$E)$E*2T(BX$1$+S(?T
M
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MY?I+7?\ :26"4ZG88$0!3S?[Y(&;/>R#\:0P5C6G#!?[DL._0>WOBV."DI3
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M@E&IT6!$   !"&YKR;MP?\-;L^)Y0*QK:/LC\D_!?T::]5< G6M."@
M
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M+DI"NT9$-!$Y*/5M"M4D2CTY5<.;E25E!60=ZF\:O6%>]"KFS"XJ#1*U0*E
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ME+4X9:J-2C8,S,SZIF.HY:)BU3%6O",>1Y6[.-<X:L9>"9A"Q2=)-#M*VZ'
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M*YNUI+4CDTY^B6E>FO4UT,]-=!*SF;5['O==-6&O"8GI*5VZJ.NB8XWH%]
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MM9*(E$1\>) K5J=G@1 %/-_OD@9L][(/QI#!6-:<,%_N2P[]![>^+8X*2E,
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MC37JK@$ZUIP4
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M$TU3\&F8G&-7QI9V^]PY?)Y:;EO:QQB-,\/03R.W/&@
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MW#T6>AJY3T,M!)*4C
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M?[-+FX<_&;JS$5Q%-4813-/7<_:EE[V](J<]8FU%$QIB<<<=703$.LO+@
M                    .5:M_P!;V%L^YZQOG&YZG<=!IU>9/'DNBTEHV:1&
MZ)2GZ?*(DQWW%I4:-'-7DJXF2D%P!+!>/!&X;'&XVW:Q=&-),^52:'43I4]=
M0BJB+*03+;^B4*,]2Y'$\04F,$X@H     ./.Q7RVM\OTEKO^TDL$IU.PP(@
M"GF_WR0,V>]D'XTA@K&M.&"_W)8=^@]O?%L<%)2F
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M$DBT(AL(C!N(C",(?L55
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MZ+ B    A#<UY-VX/^&MV?$\H%8UM'V1^2?@OZ-->JN 3K6G!0
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M,]=3$:DQC)>D
M1)GK(57Q/AK)&2*#1D5^L6;0Y-3@4MTEFRMQI/Y;Q-FE1M-D?2.<ID?(D]#+
MJ@K#G1;-F^<,KRZ9E*A4_!%.J]V0F*JQ7D4ME%1-F<TEU).2D0W'%'R+(C_.
MJU_PCZH*Z'5^B%54T:D)KJF5UM,*.597'_Q)RR;3TYM\"[$UZZ<.H"+)@
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MLZ,<)G'7'#ST^#M+Q@   #G3N/\ +CV-_P"MOL)()1J=%@1
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M<[U<HJHJG5CS>DQ,EOZ+MZ+%ZU5:KGK=K55T=&G]M:>1MWH
M                        !"V>WWX]@.N1WEL.=OQBYVU&D]#YN&I:#4[Z
MJF,OHX8:C?<S&7T<,*I8]J51<OFT6W*A)6A=6B)6A3JS(R-U)&1D9CS61N53
M?HTSUT=-YC(UU>,4:9ZZ.FZ+#W;WP   #G3NX\K#S?WTENKU*D@E&IT6!$
M !"&YKR;MP?\-;L^)Y0*QK:/LC\D_!?T::]5< G6M."@          .;FSO%
MN/;[L:YZC=]IP*_-AUTX\63*0:E(:[697R$9&7#F49C0[MRUN[3,U1CI<:]F
MVY,CGLA<KS%FBNJ+DQ$U1$SALTSA[JW7BZX1\&U'_JU^F&R\0L=CTW1/5/='
MX:WW,'BZX1\&U'_JU^F#Q"QV/3/5/='X:WW,'BZX1\&U'_JU^F#Q"QV/3/5/
M='X:WW,'BZX1\&U'_JU^F#Q"QV/3/5/='X:WW,'BZX1\&U'_ *M?I@\0L=CT
MSU3W1^&M]S!XNN$?!M1_ZM?I@\0L=CTSU3W1^&M]S!XNN$?!M1_ZM?I@\0L=
MCTSU3W1^&M]S!XNN$?!M1_ZM?I@\0L=CTSU3W1^&M]S!XNN$?!M1_P"K7Z8/
M$+'8],]4]T?AK?<P>+KA'P;4?^K7Z8/$+'8],]4]T?AK?<P>+KA'P;4?^K7Z
M8/$+'8],]4]T?AK?<P>+KA'P;4?^K7Z8/$+'8],]4]T?AK?<P>+KA'P;4?\
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M$8[%S2Z+#>.P
M("W3S*Y VZ9EE6W6HUO5MNUIQ0:O+?;C--&M'(LNG=,D-J6@S0A2C(B49'J7
M5!6'(?&N-]B#MAVH[/WI9#MVHNTYARJ4*+744IF)*<3SOLMPW*2XILD.&HOR
MU$?Y1*,CU!+2[LVPU3V+;MYFDSW:I2V:9$13:F\OI'9,=+*":>6LB3S*6G11
MGH6IGU 09P    !%F=/W)9B^@]P_%L@"%!/-%>3=>W\2JE\3T8$JM;J<"( Y
MT^<H_=M@?^-]K^PZH"5+HL"(
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M>0]T#MPZH7R*)7*HNCXD>FACMCQF+H<"(  .=.X_RX]C?^MOL)()1J=%@1
M                              <@:!>&X:V=QFZ&5M@V_4W(=HO7BAF\
MIUP5"!39C=?1$1VX<.2_*B+[7>49.$V9.D6I+)2.DY02YCH;@BZLXW9;M8FY
MWQ? Q5<4:HFS1Z/3ZI&JJ)$+H6U=.IV,_(2D^D-2>4S(^&NG$%)3B"@
MX\[%?+:WR_26N_[22P2G4["F1*(TJ(E)46AD?$C(P15*@8TSAC-=6H&*:W09
MEFU66[)IB*R2^V:8;Q\=.Q4E1$1$6O9$?5Y",S'G*,AG<IM49>JF:)G&,==/
M[='B>/M[LWEN_:M92JB;4S,QM8XT8_MS^)&M6V*R+C<CU*=N&R/:E4?;-RLP
M[2J2:= >EN+4MU\T=&:UJ/4DFI1ZF1%P+J#:;NR7BEK9F<:IG&9X9EO-S[N\
M0L[$SM5U3-54\-4_M[[Q0]OMP[<JS:E^T>Z;USM3Z+/DO5V/<\PZG4(C,B.3
M!*B$22,D)(U+/AP623/AJ98.]:+EN[:S%-.U%&.,<W3S6LW]1=M9BQFZ*)KI
MM[6U$:\*HPQZ"1)%?GYZR/C2=;-IU>AVQ8%1.K56YZLP4=2UH6VOM5KE4M)\
MQM$DR)1F>NID1)U/%F]5O+,6JJ*)IHHG&:IC#@T>XP:\S5OG-V)M6ZJ:+56U
M-548:L/@QQX83U(7)'IWM0                                    !@
M[AMNBW53CI->AG.IZG$NFP3KK/9HUY3YFEH5PU]$6;^7HOT[-<8Q^W LW\O1
M?IV:XQCH^\U"FX?QU2*A#JE/M]3$ZGO(D1'SFS%\CC9\R5<JWU)/0RZAD,6W
MNO+6ZHJIITQSYZK$M[JRUNJ*J:=,:=<]5)8V#8@   .=.[CRL/-_?26ZO4J2
M"4:G18$0   $(;FO)NW!_P -;L^)Y0*QK:/LC\D_!?T::]5< G6M."@
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M/>$]ZI&\2'8M.8F-.,M]"VX?2*.0DRU(BX'J8*Q."TH*
M                                        .=.X_P N/8W_ *V^PD@E
M&IT6!$                               !Q,S?6,-VUG[+555O[N[#%V
MUFIM-799]!M>MJ98<B,I;8:=?@H2S)4TWV*7#U,DGRZZ< 2A>?937[>N&PKK
MDVYN+KVY.*Q7S:?NJX*?/IS\!SM5A7:3;=0(EJ1H9.<R>&JC+J@I*Y@*
M #CSL5\MK?+]):[_ +22P2G4[# B
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M7%/0*    (0W->3=N#_AK=GQ/*!6-;1]D?DGX+^C37JK@$ZUIP4
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MAQ#S+A<S;J#)25$?7(RX&*Q,3IA6)B8QC4^@JJ
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M?+QLWWG=^)YPTT^71^WQ7*\]^<\O]G/S+B^HW+J@
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M_?EZWA:L45;7>Z<)GGSAHZ&"21TMY\
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MZ+<9/>5W*6JIFUL;6&..Q5C&CW>EP+;#T;V
M                      *%U+;?D2549\IIRD]%)DNNMZR5D?*M9J+4NB]
MQXNYN#,U53,;.F>']SP]?H_F9JF?@Z^']RV.*;7J=F6%0[;K!LG4:<J8<@XZ
MS6W^?EO/HT49),^Q<+7AU1Z;=N6JR^7IMUZXQU<^9EZC=>6KRV7IMUZXQU<^
M9GWTAC.;   $(;FO)NW!_P -;L^)Y0*QK:/LC\D_!?T::]5< G6M."@
M     *-;#OW=7A](S]B1QJ-T=95QN7>RC^W7?M9^;2O*-NZB          "#
M\B;?K'R=7D7%<51N:+/;BMQ$M4FN3:='Z-LU*(^ACN)1S=D>IZ:F+]K,3;C"
M(CHQ$K==N*M>/+,-&:V>XJ:<;=16;YYFE$M.MU50RU2>I:ETPN3G*IYE/)",
M68CFSRSU5J1B+P                 H57?+QLWWG=^)YPTT^71^WQ7*\]^<
M\O\ 9S\RXOJ-RZH
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MV[IL9"F8M1.,ZZITU3QRD89K9@
M                  "$-S7DW;@_X:W9\3R@5C6T?9'Y)^"_HTUZJX!.M:<%
M           4:V'?NZO#Z1G[$CC4;HZRKC<N]E']NN_:S\VE>4;=U$
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MX$0
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ME>$%     !QYV*^6UOE^DM=_VDE@E.IV&!$
M                                 $(;FO)NW!_PUNSXGE K&MH^R/R3
M\%_1IKU5P"=:TX*           HUL._=U>'TC/V)'&HW1UE7&Y=[*/[==^UG
MYM*\HV[J(                               "A5=\O&S?>=WXGG#33Y=
M'[?%<KSWYSR_V<_,N+ZC<NJ
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M]Z>;QXQ&!G\A<R=S8KXXF-4PSX]"P0
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M@T)*2N""@     X\[%?+:WR_26N_[22P2G4[# B
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MY?[.?F7%]1N75
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M1RIY7/S?+KZ!F.F//S*TH*
M       #0;ZM.==+=,3"D,,'"4Z;G3FHM>D)&FG*E7^"/%>F/HU?WU%J+-5-
M.QM8[6/QL-6$3P-UN?>5&2FO;B9QPU<[%K=K8ZJU"KU/JLJ9$=8B=+SMM&X:
MSZ1I;9:<R"+JJ]$:'T<]!<YNW/V\S<KHFFC:QB)JQTTU4\VF.%G[QWY:S.7J
MMTTU1,X:\.9,3P\Y,0ZF\L
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M8TS$QSFRB"0 H57?+QLWWG=^)YPTT^71^WQ7*\]^<\O]G/S+B^HW+J@
M                                          "JVZ6K6'>&+<KX5FY,
MMFSKPK-I.3WVJW-)DH5.-]".WI*$DIQ+!++EYB3U05ARYSCB#;;7K&H\W"FY
MO'5DY-?MBEVWE"E)KR(]!NAN*U&2\\Z2.8VW.ECD[KT1DXI)*4E+FJS)0[A6
M!%[1L2RH7;+$SM.@TUCMN*OI&'>CBMIYVEZ%S(5IJD].) @VT    !%F=/W)
M9B^@]P_%L@"%!/-%>3=>W\2JE\3T8$JM;J<"(
M
M           .158VAY<N#+^X3.&/*Q4<79@HM[>V&):Y)414ROTMV&VF1%?0
M?.71K6DTDHTFG4S2XDTF2D$L4V^;[HF4*=1-P%<RU8M1L"[+XRG5;CETB;#?
MB,J7/:9=>7"-[7IF"=4I*%H6M)D7Y1@2Z$ B     ./.Q7RVM\OTEKO^TDL$
MIU.PP(@
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M%=J<;=<8QCKXO=AN@]LU
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MU:H4>J15DXQ)BR;@E.LO-+3J2D+0HE),NJ1@K.IV7!$
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M%NFO*ZL?;>,NWG9+BF+HH%NR7Z3-0A*UQEJ-+:Y*4JU29L(4ITM2,NQXD9<
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M@]LU
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MCO LVWHZHE M*H5&BT.*MQ3JFH<"NR(["%.+,U*-+;9$9J,S/JF"M6IVE!$
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M_P!G/S+B^HW+J@
M "*\X7_1\6XBR%?]?H1W11[:HLF3/MO1)IGH4GHBC.<Z'$DAPUDE9J2HB29F
M:3Z@$.3M;1G;*E"L&14O-O6C6K:MB"TYCUARJMQTQ:<^27V6.1N4P:FC(R/H
MG$<NNNJ"U,@3Z+L_0')CM!HCM1IR*/4'($94ZDM:&B*\;23<83R\-&U:I+3T
M 09<    !%F=/W)9B^@]P_%L@"%!/-%>3=>W\2JE\3T8$JM;J<"(
M
M                          ./N><@;77<F[@;"IN%<G9+NB^&J93<N5>P
MHG31HM4HZR>C/Q36X9M2V5DCI%DWT:E(+4EZN<Q*,5G=AM'L6C8VNYJR;"R+
M9:Y5S.R+AFY0;0FNU:6Y'95VR:VT-(4TE)D@N5!=D2C/51J,RDKR@H     .
M/.Q7RVM\OTEKO^TDL$IU.PP(@
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MS,U/29#AJ=>69F?%:CTZA:%P'G;UZN[5M53C+7U5S5.,I%%I$
M          4*KOEXV;[SN_$\X::?+H_;XKE>>_.>7^SGYEQ?4;EU0
M                                        ! ^Z&178VW?,SMM4>/7Z
MR=IU)J+2)3")+3Z763;=(V%ZI=,FU*,D&1\QD2=#UT,K#G1BC$&5)V-K)ET;
MSF;5'IC]'BKAT5F/$GH@H4V1E$*1(K+;A] 1]'RJ0DTZ<O*6F@*S/.=>J$P]
M&HE&C2:I[>2(\&.W(K6A)[<6AI)*D:$I1%TIES:$H^KU3!%E0    $69T_<E
MF+Z#W#\6R (4$\T5Y-U[?Q*J7Q/1@2JUNIP(@
M
M           Y&T8]V<S<1NBE[9:=95JVG#O"/%NNWKQ<=7VY5TP&^>J-(:0I
MYLI2#2YP4E"B-.A&HE@EH= <$>,%\G:QXQ/R2^4_MB?M)\C^V.U>T.A;_P =
MVQV72=+S]3AIH"DIQ!0     <>=BOEM;Y?I+7?\ :26"4ZG88$0
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MYY?[.?F7%]1N75
M  %=]V;L=C;=F*1+HU+N&+&MU]Z10ZS*?A092&U(6;3S\:1$=22B+0N1Y"C/
M0B46H*PYOXVLKS4=W6;:E6N!%JV]<]2H\27<=%E71<T!,.<MI';4=)3*DD_S
M;IJ2GLCYB+F(S3Q!72[(T!FD1J#1(]OFA5!8@1FZ(IIQ3J#B):23!I<4:C47
M1D6AF9F?5U!%EP    $69T_<EF+Z#W#\6R (4$\T5Y-U[?Q*J7Q/1@2JUNIP
M(@
M                                    Y%R,%89SIN1W!HO+(F4,19 H
M-8BL)A-W938**Q37&EJ8DTV,]3>F3%239FE/2.$GF_*(S,B)8X0OQM\PO:>$
M;:K5 M"_KFR#"JU3.H2:G=%58JTEAWH6VNA:=CL,)2CE02N4R,]3,]>(*3*?
M 4     ''G8KY;6^7Z2UW_:26"4ZG88$0
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MN>EH6DP        !0JN^7C9OO.[\3SAII\NC]OBN5Y[\YY?[.?F7%]1N75
M                                              $69NKEC6SB3(5P
MY*HS=Q6+1:+)F7)0'642$S6&4\Y1R:<,D*4XLDI22C(M3+4R+B!#CLH[CMBW
MX.;\A>;OQ;3]O,M$6HS?:V/$<N2#2)JTDS+<0Y)/G,DN)4:3BM_]?HRU4DGT
M7<&VIE$J%N6_/MHVE6Y.IL21;ZF$\C1PG64KCFVG0M$]&:="TZ@(,V     B
MS.G[DLQ?0>X?BV0!"@GFBO)NO;^)52^)Z,"56MU.!$
M
M                '$?<M:NWZY,\Y!I=D;4+WW'Y&I\EF9EBKT&NU.FTZGRY
M;1+0R2H[4M*G.1):I)"$ZZI(S4E1$3A=_8HC!A8KKSF$;3K%@)3<4B-D.Q;@
MD2'ZE2J]%::9?8>[96I1$2$HY3+37B1I2LEI21E=D%     !QYV*^6UOE^DM
M=_VDE@E.IV&!$
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MG3]R68OH/</Q;( A03S17DW7M_$JI?$]&!*K6ZG B
M
M               #FG<^.]W6!,O99O';=9UJY6L?-M5:N&JT.N2T0IM(JO)R
MR%<[TR$EQIQ2E*+E6L]-$\J329N$M$I[VFX:OO%]O7]=&5Y]/F94S'=,J[;S
MBTG7M" M]))9A,&9GS=$7,9J(S_*Y>9?+SJ*3*V(*     #CSL5\MK?+]):[
M_M)+!*=3L,"(
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MHQB+X  *%5WR\;-]YW?B><--/ET?M\5RO/?G/+_9S\RXOJ-RZH
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M@VO>Z%\?"T7N$%-J3[J#:][H7Q\+1>X0-J3[J#:][H7Q\+1>X0-J73($0
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MIK[7WX9OS5GD[7'].*A["@BN2ZR>-#TO\KCM(Z<NEXS'E0
M         %"J[Y>-F^\[OQ/.&FGRZ/V^*Y7GOSGE_LY^9<7U&Y=4
M                                                      !57=#M
M-LS=3 LZGWA<E:MUNS)$V1 71CCDIU4U+*%DYVPRZ6B29+333JF"L3@M4"@
M    K#MNVLV?MF^7WR3N&L5_ZP9\>H5/VV..?0+C=/RI9Z!IK@?3GKS:]0@5
MF<5G@4    55W*;3;,W.3\<5"[;DK5 <QI(GR*4BD'')+ZJ@J&MPG^G9=/1)
MPDZ<NG5/\ *Q."U0*    /)4(:*C FT]U2D-SH[D=Q:=.8DNI-!F6NI:D1@*
MV;8=K-G[6:#=% L^X:Q<,:ZI[-0F/5@XYK;6RUT1);[7::+0RXGJ1@K,XK/
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M['5J5JIUZEOU>36%3JL;)R"=DMLMJ070-M)Y2)DM.&O$P5F<4^ H
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M64S(?(:EM*,B[%9+(]..AZEJ?5&;9N]\IQ>;SV5\7N;,3C$QC"P0O,,
M                 %"J[Y>-F^\[OQ/.&FGRZ/V^*Y7GOSGE_LY^9<7U&Y=4
M
M
M
M
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M\O\ 9S\RXOJ-RZH
M
M
M
M                *-;#OW=7A](S]B1QJ-T=95QN7>RC^W7?M9^;2O*-NZB
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M<--/ET?M\5RO/?G/+_9S\RXOJ-RZH
M
M
M
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M]OBN5Y[\YY?[.?F7%]1N75
M
M
M
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MWR\;-]YW?B><--/ET?M\5RO/?G/+_9S\RXOJ-RZH
M
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M,M=[Y;NT[5-41A$QS)CC8ENN[%RNW=HV*J)PF,<5FAB+X
M
M                            #SORXD5329,IJ.I]7(PEU:4&M7#@DC,M
M3X]85BF9U*3,0] HJ          "C6P[]W5X?2,_8D<:C='65<;EWLH_MUW[
M6?FTKRC;NH@   .8_G2OW.6+]+$^PWQZ3T9^OJ[7WVNWEUD<;,>:^_<!<?TU
MG>PH(AZ2^4QVL=.4MW?5SQ^]#I //,\                       !0JN^7
MC9OO.[\3SAII\NC]OBN5Y[\YY?[.?F7%]1N75
M
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MC/Y9W7]A'O.&[R_NF:[>.DON,]9
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MM7AZYI9$:2:[;?8B\VNG-S<J7M-..FFO]P6_$<I'79NUT*HGWV#7Z;;MI_\
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ME^*K56,;,1S8YL\*GF#/;OMXW[<TQCKT3'+&,.G UC'
M       4*KOEXV;[SN_$\X::?+H_;XKE>>_.>7^SGYEQ?4;EU0
M
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M>NV_QB/Z5^E/^/O=R>LVZ_Q%ONH/K>Q?\_:)Z[;_ !A^E?I3_C[W<GK-NO\
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M[@W;E\Q1-%RBS%-5,Z)IF,,8ER7-W[=_>.9N6ZHJIFJ,)C5.AT$%U0
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MM*\HV[J(  *R;K,E7!C_ !S'@68Z;-[WW4F*!;+R2U6TN0?YUU.I&6J4<"]
MS(^L,7-W9HHT:YT-_P"CF0MYK,XW?JZ(FJKH:H:7C' EB8YI#+2Z5&N.Y9!$
M[7+JJ;29,J5(5Q6HE.DHT)UZA%_=U,8U%FFF.>VN>WM>S-6O9IYE,:(B.@\6
M5L"6C?5'?F4.F,6M?=+0<JUKHI2$Q)#,QHC4T3BFB3SI-7 ]>)=4CU"NU$QH
MT2ED-[7<O5A7.U;G153.F,.;K2IM>R;5\HXI@U*Y$D5UVW.DV]<ZBX=)+@&D
MNE,NL:T*2H_PZC+RMV;E&,ZXT-+Z0[OHR6;FFWUE4153Q3S.@L0,AHP
M                 4*KOEXV;[SN_$\X::?+H_;XKE>>_.>7^SGYEQ?4;EU0
M
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M/6G\&1_2AYTS7A*N63Q*SV$<AXM> / ]:?P9']*'G3->$JY9/$K/81R'BUX
M\#UI_!D?TH>=,UX2KED\2L]A'(>+7@#P/6G\&1_2AYTS7A*N63Q*SV$<C>[.
MQU8F/6I[-CVC2K4:JBFUU%NF1FXQ/J:)1-FX2"+4TDH]-?1&/?S5V_AWRJ:L
M.&5VW9HM];$0W,6%P
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M><--/ET?M\5RO/?G/+_9S\RXOJ-RZH
M
M
M
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M'LH-WVE=)R2MBZ*1<9P^4Y94N:Q,Z+GUY>DZ%:^770]-0JIFG7&!$XMB$50
M           !0JN^7C9OO.[\3SAII\NC]OBN5Y[\YY?[.?F7%]1N75
M
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ME*KDB THUH874(C4E3:5*(C,D&YH1F W0
M                                                &-K%9I%NTJHU
MVX*K#H=#I$=R75JS4'VXT2+':2:G'GWW5)0VA"2,U*49$1=4!I]C9<Q1D]RI
M-8UR=:>0W:,EI=7:MFM0:LJ*E\U$T;Y0WG3;)9H5R\VFNAZ=0P$A
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MQ7*\]^<\O]G/S+B^HW+J@
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MR)<=D3<G[(<J3S?R)MZJ#YVA+=(T>V5K/.(-AUDE&I7(V;R%HU/@T^TDOR#
M>'S4O[+;HOXU5OU". ]V:/\ _8CSB.#L+MI1/LC;)1G<EY#CF2NC.LRNB.F,
M.D>J%*;,X;J2/JH<=ZO$!A-@KR\#[A-U6S">XIFE6[6_E_BIEPE<:-4DL)=;
M0I1F1DVR]#X)_I]*?5U 39YT7R%,Y?ZL_P"T]) 6?V]_N#P?] +:^*HP"7P
M
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MN5Y[\YY?[.?F7%]1N75
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M!+X
M                  *@[^_(WW"?15[U9H!G]E/DD;<OH!0_8B %0?-2_LMN
MB_C56_4(X"S^_OR-]PGT5>]6: 4+R-@ZX;^\WGM:S+C%;T'-&V^SZ'>-E3H:
M.>2]$C1F'I\5!%J:C)+*7T)T5S*:Z,B_.& P%[YQH.XS<5YKK+5!)$<KDD5Q
M-<I23U.!5(ZHK,Z(?$ST;>2KD,^*D&E>G9 )'\YG.N^F;A/-\5&P*'%N:]H5
MW7$]:MO39!1(TV<B1;QL,.OJ-)-I6K0C49\ &;R;AK?5O,A4C&>;Z-9.WO";
M=5BU&]8U!J*JS7*NW$43B&&E(6\P227HI)+-'*LB6KI.5*#"5O.(7J>)MJ3&
M(\<Q3C7-EZ32\4X\H44^S*+,2EB0TA.O,:#AMJCZ]93J->J N5A7&5,PUB7'
MF+*3R+AV-0H=*5(1KH_(:;+MF1Q(N+SQK</AU5 .4'F><+XRJ6"[DRI6K1I]
MP7S4KFJ%O%6JJRW,5%I<:/&<*)$2\E264.+D.*<Y2U<,^R,R2DB#$;/MOF)9
MF^O>!3IUHQ9UNX>KS,W'%GR2)VCTN96G'5/R6(*B-DG&TL);9/ET;1P(M4H-
M(2=/MVAXR\[OC^'8M*C6U"RIB&7/O6# ;3'8ER4N50C<-IHDH(U'2XZE'IQ4
MDU'V1Z@-)W6VYDZZ_.A8/HF(,CLXHON3AMQ=,O9^E1JRB,VW,N-;Z#A2TJ:7
MTK9*1J9=CKJ7$@&DL6EDFC[X\*V1YPB^967H=12=0VXW)3CC4RU%5]AU)DS.
MI<:#%2J0;J6DD1'^6;*7.E;<[ +#>=]_<'AS^-5O?%59 8_?;;]<VY9IQ1OX
ML&#(DP[>DQ;1S_1(2.,^@2U="W)<XDDS))] 2E\"<**?] !YL)7!1[L\[!FB
MZ;=GM56@7)@:DU2B5-D]6Y$26=L/,.H/T%H41D TGS@.=<6'NWVP8BRO=*+>
MQ/BV<G(V3Y2HDJH-.U!*7%4B$[%AL2'EF9,<JB)'+T<G51\. 0UNSWH[;*IN
M&VN;E<'9+.Z;GQE5G*)DBDM4>LP'Y%KRU&;O1N3X$9M7(V_+1RDI2N9Y)DG1
M*C =R\G28\W$>0ID-]$F)+M"K/19+2B4AQMR ZI"TJ+@9*(R,C(!2?S4'D38
MY]];B^-I(#H\                      *-;#OW=7A](S]B1QJ-T=95QN7>
MRC^W7?M9^;2O*-NZB  "C^[S]LMLOTW5_P!UD8&=UT<?4>O]%_JLU]GU5@!)
M@/Z75+^4! 6R/_0&:/XEU?U-D,EUL\;.]+OK;'V5/3E=P9KR(
M           *%5WR\;-]YW?B><--/ET?M\5RO/?G/+_9S\RXOJ-RZH
M
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M.JT%S\MF3%I[#3S:M.NE:3(P$E@
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M\]^<\O\ 9S\RXOJ-RZH
M
M
M                            (^ROC2W<QXXO+%UVKF-6Y>],=I=5?I[J
M69;;;NADXPXM#B4K0HB4GF0I.I<4F7 !$^W/;#1=M<"I4>W,KY+O^@RX<*!2
M+>OJNMU6!1H\#I";;I49F+%;BDHG-%DDM#)*"T+E 69       !$6,\%XUQ%
M7<E7-8U$=I]?RY77+BOVJR9DF8[-FK6ZX7&0XYT;:%/N&A"-"+F,!+H
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M;;;9;;99;2TTTDD--((DI2E):$1$7 B(AFO*S..F7[!0
M      %"J[Y>-F^\[OQ/.&FGRZ/V^*Y7GOSGE_LY^9<7U&Y=4
M
M
M
M                                                  %&MAW[NKP^
MD9^Q(XU&Z.LJXW+O91_;KOVL_-I7E&W=1
M     4*KOEXV;[SN_$\X::?+H_;XKE>>_.>7^SGYEQ?4;EU0
M
M
M
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M4SH6L&Q>]
M
M                                                   !R;R5:NYF
MW-Q6",+4'>5><Y.7&;HK%U3%4&WTJHM-HD5#S#C2$P]%=.^YT)<W4T_G"YN*
M*V6.KU\7F^<P7#E[*M5H<K(,2N5VG0X1(H:),>E]K-*@,LL]@_V9),E+/G6H
MSY221!N=B9\Q?D>I98IMK7"F6K"E7=HF0)KJ#:C193#:G'^5U7!:&NC6E2BX
M$I"BZP#1).[["L3%=@Y<D5*L%1<J..,8VMIFD2Y-PUMYMQ:.CA4F.V[(<-1(
MYR5R\I)4E2E%S%J&U8?W$XZS74;KM^VDUV@7C8YQCNRQ+LH\R@UJ$U,2:HS[
MD.<VVLVW22>BDZ];FTU3J&XY9RE:6%<>7+E"^Y$F+:=I,M/UF1$87)>2A]]N
M,CD91V2NS=3KIU"X@,/?F<<<8WN[%EBW36CCW-F6INTJPZ>RV;QR76&TN..+
M-/!#9=(A/,?]):2ZX#T_7+8?UHW!B)52<1=5IVJU>-S2%M\E.@4U]]3#?;,Q
M1DVVXKD4YR*/7HRY^H K=4?.'[;J73WZ],F7<U:3RY#%K7PJU:NBB7%*C+Y'
M(M&GKCI9E.\Q*))$HB5RGRF?#4+.T'*UGW'DF_\ $]-E2#O/&L.D3[FANL+;
M:*/6VW78BV'3[%W@THE\OY)Z$8#YXTRU9V6V;SE65(DSH-C734;/J]0>84RP
M[4J4:$R^U%JX/-(6OE)Q/8F9'IU $6[J<LW'CFQ*;;.-B;DYKS#5&[-Q#!62
M5$U49A'T]4=2I*RZ&FQ^>2XI231V*4KX* :WL@R#?=^X6GQ<H7"[=F1,=7M=
M-DW=<;\9J([+D4>INI;4MA@DMH-+#C:=$EUN)FK51A6+:'NARW?.X"NTG)MQ
M)J^+,_,75<&VXG(T:/VFS:EP3*:]2VELMMJ>4<)"7U*6:CT02M=5*,PF*B[D
MZA;%<WU9<OVO/R\+X+K-,MFS+>;;81T=1I%*:<JK#+W*E3CTV=.9:23B]$F:
M"X<3 >6T\8;M<U6?"R3?&Y&K8.N&ZHZ*Q:6+[,I%+>IMOQY"%+B1ZF_.8=D5
M%TFUH-XC6V@E:I27 C 0C6=T>=).Q2\,MRZVS2,MX&R,U:N2*S2(S!QZLS1Z
M[%@SW&XZVEH0E]B4DUDE*>*5&CD+1)!=C=9F:KXEQ*J58+358RKD>HP[/PU2
M2Y72E5ZLJZ..]R\24W&;YY"S/L=$:&?9 -/S5?V1,+8-L''=$N95_;E<F%!L
M6Q:]*:90J77Y3)%4*XZPVT3:(\!OI)2M6S0DDH0O@HS >O9!D&^[]PM/BY0N
M%V[,B8ZO:Z;)NZXWXS41V7(H]3=2VI;#!);0:6'&TZ)+K<3-6JC"X(#GCO\
MLK9;L"ST0L2-U<WYE#J;-W)71$N4%R'6>2DQEO5]4F*Y"FL2'B5%:C=*XZXM
M)+:Z/LTA*VS5W*3V+%,Y5>K%/J]O26;:A636*%[4*HC5%B,Q#:8FJDS'*NV]
MRDYV\;II=4:C0E!=@0;]EW<KB3!M<M>W,B5R33JQ>,*?-MZ#$AOSGI)0%QV3
M9:9C)6ZX\\[*;;9:;0I2U:Z%HDS(/9AO<#8&<'+P@6HU7*-<>/Y<:%>MFW12
M9=$K%,7-:-^(J1"F(0M*7VTJ4@^N1& U7(^[#%%@U]=B4AZIY7RKRF;6*K!B
M*KE809*)!G,Z$RCP4I-1&I4MUHB+CQ 1'=%[9>S[G2YL&8SO>7A2SL14"E3L
MU7G2H\*?6W:[7V5285#I[\IM^.REAA/2O/H0I6NB"Y2/509C:1?N2IE[;E,)
MY)O1W),G!-TTV%;E^38L>)4)E-K4'MUEF:B*AMI;D?EY3<))&O7CUB >S>)D
M"ZJ!]16.+(R9]4=>R[?A4ZJWP3<)Q<*@TRFS)]2<1[8(6P2N9#*2-6GY6G7T
M,)!P?C:_+4F3;DN3<S7L\T&LP.@H\2H0J-'@LK)TE'*9>IC"#<5H@T<5\NAG
MPUTT#:=P%R7-:V*+GJ%EKN)F\)*6(-KRK7H#=S5%F=*>0VRM--?6TPM',>BU
M/.(;0DS4I:2+4!078Q>^XB_,A7-7\D%.M:V+RJEP76N-3Z,JI4&NO17RMQUA
MBONSY::>B'(@=*S#;1S.$I3W3.M*+0-&W09?W)RL[T.VK!HMRU>QK:NV5=U#
MC2;8.-4&3M* NEU,Z1$8J<21<%.:?J+4XR>2T3KI):8<=1V* MWG_)67\4X'
ML&L6A5Z]=62X49FL5NO2;1C]H5*)2H*I523<C2I$)BAL.H/G<<0ZEQM2#0RA
M:OS9AHGF^)^:7K!F1LK.UZE1+>I4-RD6A4*&M,>0=:6_6#JT6X7I4IVIJD%(
M,E-))HHW8M*;YRYE!59>6-UM\;BX:(+EW4FUZ##<@T6^W+)0NX*'2;]JNE-F
M5.TFZD;239]J7HK$F2USHCJ*1(B&:TK,.X):Z%S&1JT[(R+0M?Y.("D#_G"M
MM[=%5<L.?=-<MJGNNHNNXZ/;53J,"WVFY[E/0_6),5EQN(EU;1K;2L^D4V:%
MDC1QOF"W%<O>S;8MI=Y7)=5(H%I-QTRUW-49C,6 3"T<Z'.V'5I;Y5)XD>O'
MK *V0MY./*U;F2,@V[;5TU+$F-;6G7'-RY*IKE,H=5>A\IHI]'5.Z%^8XZ7/
MHXVUT6I)(EJ-:0%3<@5'=U2-M-5WA5C/DVS[S@4B/>E)P; I%-<M:'2)3S#S
M5(F],P<R0Z<99$X\IY*DK,TITTYC#J9:-<.Y[4MBY51RB*N&DPJFJ*2N8FCE
ML(>Y.;0M>7GTU <_[)F9WWBQ;XRE9N=JM@S$L>MU.AX+IULTZG27JNW1WEPW
M*Y5I,UEY;K+\MI9(CM&V1(29&HU=D8:+8N[G,N6-NVTRD6?+I=.W$[FY=:I;
MUVO0FWX5'IEJ2Y4>M7 J#V+2W>BC(4VR9):4ZX9$6B2082#1K@RQM\W3XRQ7
M>><JQE_'&7[1N:KU!^[8E.CRJ+/MQM,QR5'DP(\8B9<:5RFTI)DGB>O4T#4J
M15-R&Y#$M[;EZ)G:LX-M9<>M5;!6/:'2J8\VJETE,AN+-KSDZ.^](7-4R:S:
M2I*$)-)IUUX!.MBY;SAEC:SAW)=D,6G1+TOJA,3;ZNZX.V%4JB,-1W>W:BQ3
MHYDY*6IQK5I@W4)3S=FYRIT4&0V'7CDG(VV2QLBY7N:3=5V7Q)JU5*H2HT>&
MM,$Z@^Q"0EB*E+:$FPRE9$6OY75,!<(
M
M
M
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MWJ5;%5JM&DMRF4U2#3XQRVW%M&:2=-3A.*+_ *_X0%D0
M
M
M
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M(YCZI\J"(M3T >L
M
M
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M@O-6(;!RNJW';21?E+15H]OOR"E.1V'EJZ'5Y+;1*YVR2O\ )+\K0!+(
M"J%J;J85U8CO#,5,Q;>%R4>W[UJ5I4"V[2BIKE9K+,"IE3$U&/&(XZ4-K7S+
M62G-&T)49K4 M>   #4[.OJT<@TN56K+KT:XJ3"J,RDR:A$-2FDS:>\J/*9Y
MC(M3;<2:3,N&I<# ;8          (5>S-#+<-"V^QJ"]*J2[ >O^K7(3Z4L1
M(Q5-%,CQC9Y#-2WG.=1'S%H2#X'U@FH      0I<V8DVMG7%N&9]O\T?*]!N
M*J4*ZDR]#1-MSM1Q^$N&;/$EL2ND)TG>!IY>0]>8@FL
M
M
M
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M)>(K+R!7ZU,GOG+F.0*A2XE#C2);RNS6MU]"N9Q7Y2M>N Z%@
M
M
M
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MJI,YY1MK+@DD'_2 7@
M
M
M
M
'     !__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>tm2227887d1-pht_reprobw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_reprobw.jpg
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M]MJB% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H%!JO.^<>'>+\MX[P7DGD_&<#R_ETLT'B^!R&3'COGS8X0R1
M8W<*B1P)%.P>XWT'6@VJ@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@TG[E>78_P!O_MWYWYUE,J8_AWC_
M "7-2%M0?H<62<+;6Y)2P &O2@_&/^R!\1R.0\I^]GW/SD[LV/A8' 8V?(+R
M229\\F;F -;XXT);76XHU]/J3^U6\U3QS^&1/&$GVY/W!\GXWC7QAU?&PM_)
M2.?]RLN-$#\V%$^?7@GDN[[*?V3/!<<D8@Y?[G8.'^U?VF0>2\B>08D:$WX\
M%1\K'4=:>R][_L_>/Q?LY_ ]E?<;DH5QAR*^2>=<H9;B\& CP1LYO^4P<>K#
MY&]0GU\T?V1/C.9S7E'WU^[/+.<GD)(L'ADSW'OFFY">7/SB2+ >Z&$FWQ^5
M%^FJ>(G^O/\ M7^:Y;N?5\/X!SV=(3;<D<?BF#^[X3'>PL<V)&N/5MPO5.'\
M?W@.#X!_&#X-]ZON=XAD^8?9#S+]U1>1Q0=PH3@1#$R\-F5DV2")5GC7<O<U
M"M</M$>('W ^YG]GU'R7B'CWV!_A@'WV\H\DRUBR>%BEYSA^V'3VPQ&=999)
MRY LD3( &._I<5+]P?M=X?PO@7V_\5\4\?\ $L;P/C.,P@R>'XF2V9#QTV2S
M9.1 N2VLNV:5[O\ SCJ-*C+X1_M6OJ/^RW!V3:/^F?$?5Z'6/LY=NG^[V]?[
MM%CU[U_#/R_'>$?P9?:OR6:,1\=XY]MX.<SEOU6'";,G-R=+D,:J2_.7^R3\
M=SO)?N!]]_O#RT229;XV-Q2YQ&KY'+Y4F?F!.I !QHBUS_.'76HU]->_BJV_
M>W^TL^UWVS[@R^+\2RO&>'Y'&!+1]B)CSO(  :;C#.RL?]S8_EL*1XW7^UH^
MWGED/D/VF^]O$\:W)^.^/XK<+S,JQO)'AY,64<S%;)"@;8Y][(#<"Z[;@LMQ
M\MX^[G]J=]J.2^RG*0_;G"YG^M7RKB),"'B,O$[>/PN3E1&.:>;)+!)1#N8Q
M]O=N;;N"C=:)^91/X'_X?_N%]FOX7?OU]SN0X++PON-]R?%,^;PGQB9#%EIC
M\;Q^8^!OC:Q1\K(FN%87VA#I>J?4V^6O[.G^)/[,?P\<)]X)?.Y>4?S;RJ3B
M5\6X;C>/GSI^43$&0J86*T2LD<KRY&O=9%;V^XD6J-?42VG^!B3G?OU_'IYY
M]Y?*N*.!F\#!S?D&5@."RX.3E,O%8N&=UCNAAG95)%_V=]#52<A<??E8?OE_
M:D^!^#DMR/%>&\CP'%SQKJK8_#P-SV=%_P"*K/,C_@WXT./V8^]_G7EWVT^V
M'E7G7A'@;_<KG?&\89:>(Q938DL\"L!/)&R09#.T*$R=M5NX4JIW6J,OQPSO
MXAOX"/XFO&.6\A_B4\$?[5?=R.:=,CD/&L7/?,S%4D02QYF%CM'-((R$89J6
M#+I[=MJU4PR_V3OCOFB?=3[J^2>.2<K%]D5XR;C^[R"E(\[D/JXGX^Z+^R.1
M%C+(9"A.P/MZ.*A]-C^]&(_\3?\ :8> ^!<2?WAXQ]EXN/;RF>(7ACCX>8\I
MGB0VO[YYH\,VZ/8?$U4X_;ZHA0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0?B[_;&?\ 1O[#_P#.?/\ _ X-
M&OE\)_8#^T*^_GV.^BX?.Y;^L[P;&VI_1;R.622:")?YN%R/NGAL  JOW(U'
M2.C4_+]O?L!_'C]@_OY]%Q.#S_\ 0?SG*VI_0GR-H\:::4Z;<+)OV,FYOM5&
M$A&IC6C$Q3[1HA0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0?$?WJX_^/+(^
MX7*R_8OG/MYA?;=H<7]T8_D".<\2B!/J>X5QY!8R[MONZ6HL4\I_=/\ :H?[
M3_:+_-R_ZI1</W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H
M?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,/W3_ &J'^T_VB_S<O^J4,/W3
M_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,
M/W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^
MJ4,/W3_:H?[3_:+_ #<O^J4,/W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R
M_P"J4,/W3_:H?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,/W3_ &J'^T_V
MB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^J4,/W3_:H?[3
M_:+_ #<O^J4,/W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H
M?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,/W3_ &J'^T_VB_S<O^J4,/W3
M_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,
M/W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^
MJ4,/W3_:H?[3_:+_ #<O^J4,/W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R
M_P"J4,/W3_:H?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,/W3_ &J'^T_V
MB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^J4,/W3_:H?[3
M_:+_ #<O^J4,/W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H
M?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,/W3_ &J'^T_VB_S<O^J4,/W3
M_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^J4,/W3_:H?[3_:+_ #<O^J4,
M/W3_ &J'^T_VB_S<O^J4,/W3_:H?[3_:+_-R_P"J4,/W3_:H?[3_ &B_S<O^
MJ4,2^/XK^U#&?@GDO)?M,W'#(B.>L4<G<,.X=P)_HHUVWM1,?I/1"@4"@4"@
M4"@4$+DN-X[F,#*XOE\#&Y7C,Z,PYW'9D23P31MU22*0,K*?4$4%7X]XEXKX
MCCSXGB?C/$^,8F5)WLK%XG"@PHY)  N]T@1 S6%KF@Z>1>&^(>81XL/EOBO#
M^418+,^%%R^#CYJPLX 8QB='"E@!>W6@XY7POP[G>(P?'^<\3X;F>!XLQ'C.
M$SL#'R,/',$9BB,,$J-&FR-BB[0+*2!I02D\9\<CX(^+1^/\:GC!QVQ#XXN)
M",#Z=K[HOI@O:V&YNNVU!B\>\3\6\1QI\+Q3QKBO&,/)E[^3B<3AP844DNT+
MO=($0,U@!<B]J")Q'@?@_C_*Y?/<#X9P7"<YGK(N=S.!QV-C9<RS.))!)/%&
MKL'=0S7.I%SK2Q;<WP/!^2\;D\+Y'PV#Y!P^8 ,OB>2QXLO&E -P'AF5D:QU
MU%!IGAWV<^TGV\S<CDO OMAXIX7R.6"N3R'!\/A8$[HQ)V-+CQ(VW4V6]AZ"
M@](H/EC^-7[897W<_AF^Z?BG&8K9G.X_&KS?C\$:[I7R^(E3-$40]7F2)X1_
MX]",:_\ P/94GE/\)/VTX/RW@)8,CB>,R_&?(/'N9Q'4-%AY$N/''+!DK[TE
MQNV;$;2&M5)?4WCOB/B?B$&1B^)^,<3XOC9<@ER\?B<*#"CED VAW6!$#$#2
MYJ")#X%X-C^0GR['\+X*#RMGDE;R>/CL9>1+RH8I&.4(Q+=D8J3NU!(.E!L>
M9A8?(XF1@<AB0YV#EQM%EX>1&LL4L;"S(Z."K CJ"*#RKA?X?OL3XWS?])/'
M_LSX3PO/AUDBY?"X'CX,B)UU#Q.D(,;$FY*6).IO0>O4'FG$?9?[0<!Y/D^:
M\']K?$^'\OS)&FR/)\/AL*#/:1R6=_J$B$@9R;L0;L=3>@V+Q_P;PGQ/(R\O
MQ;P[@_&LK/4+G9/%<?C8<DR@E@)&@C0L 3?6@Z8W@7@V%S\GE>'X9P6)Y3,\
MDLODL/'8T?(,\RE96;*6,2DNK$,=VH.M!ME!Y!S_ /#[]A_*^4;F_)OLOX/S
M_,22&6?E,_@./R)Y6-[F622 M)^8FSDZZ]:#0OXAONIA?PV_9_*R/ /"6Y/R
M7)1N,^W'@OC_ !K/$<V0:2-C8D=D@@+;WL!?1![G%4>:_P #W\,G(_8OPWFO
M,ON%(>2^]7W7R/WMYYR,S"67%$K-,N%W 2&822-),P_-(;:A%-19E]S40H%
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M5F"*SFY"@DA06.GP N3^B@_F8^YOV3_C4^Z'WKYG[T>1?8/F^8Y#.YD<CQO
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M.-CYSODSY.0L2J"%[:[5W;1U+D/WJQ\>'$QX,7'018^-&L4$8N0J( JC6YT
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M#_\  YZ$7^-*+8S][?!@5439K,WH,8Z?,ZZ 4_);G^NWP8WM/F, ;!ACFQ_
MWI^2W/\ 79X-_OV;_P G/^&E%G]=G@W^_9O_ "<_X:46O^&^X_C7.XG,YN!)
MD-!P.*V9R!>(J1&JLQVB^ILATI1;?*BE H% H% H% H% H% H% H% H% H%
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MM% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M]N!Y /LRL'E$.'-UZ+W3MDTZ%&(H-[QLI)([ME7PF)$4JDDLMNH*7]+==*#
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MCKD.[?M550A0L JKIU -SI0!CXD.1-.8URI_>GU0-@P8[M2 &.NNIH*_/GS
M<<0(J12'=E.WL 4VWC<@-O7^]04</,S)R<&"0^5'DN0^4TF_8?4EBJ'4^AZ4
M%QG9>5 T:X^,)!W%$KNP1=AZE23K:@U*3+3)YG(XX%XL7!315.MB%<E6(-]Z
MOZZ$7%!N6- I@QI(,H_2!%7'C1C&Z[!M!W+M;7\:"(V%A8^8LG>C>5D5UQV
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M;3,R1K9IF-MJB]_<Q 46-!JL_D0CY:7C"4PX(@>]D,EPS!DW@'<2 A-AU/\
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M/E#-#Q\9"^P"XW'XT%K#,J8D6/B+VL7;[%L Q4DLNX@>@-J#K01,3-@S5D>
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MT6O\?TT$+*E!D_9N "MBS@#1B2#<7/KTM053$EB3;]'2@XH% H/<\*_]3F&
MNZ_.M^C1M?T5GJ\>?+=?YMB?:BGY=3<#UK2(,XR,O&S8XGV&Y6$V8'3K?<!^
MBU!#XGB&Q<1XI9'1Y,A<AMC$&Z,&"DW-P;:B@[+Q>3#FY.3!E.8IR"F*+"Q)
M]UB>@H)4N,LKY"SQKDR@E'53>($:6N#8_B*#SORC(R8^,Y3$[2RY&7:&-HP0
M&>1U5%0 VT -!8\;Q4'&XV"/J>W (990N4IB%Q& J*4O<^RX!^-!L$L\K18\
MLY&%&42-Q&"69'.[0)U 'SH,YDB9%BPT:3+9-D:0+_EMY) V,VAMU^%!40+-
M'D).VU4EQD9BZW5I8Y/=';Y6L".H%SUH+&.?9([OCQL/=(^R16 0^TI8V%[Z
MV%Z#)*<I5B^GB41J")H]P ,9U8@6OI;6@H%Y+%?)^FB[;*P+M=2I4H-[ DG\
MI4BQ]?2@EY&/B39K9B*6E36(V/Y3J0;'TH*=URO(4R9X<>;%(9T8NI3<$/M(
M7Y-0:=C\3A/R85Y._P"08^XO(/?<686"DVN;: _*@WGC,3"P8GR6A.)D.@:5
MD4.0>K C_!09\E\?.Q8\F ]K">&TM[ L;V!U.E[=*#6L?(R<)^R,))()WVXQ
M,8 4+JSL2>GN H._E#YD&/'/Q^+),[R'ZIXVLT8(L'13H;"WZJ"IQ>0Y1)0F
M3)/F8\UAB9 0+T8!@U@NNE!N3Y<.+&6[:S&:4(I0^Y2=;6!MT!O>@E/)#&PS
M(7V@I:5EN;:$-8#0:T&->;B[<9BG!@G#=LCW)UVGI\;T$K%S/WB&@C!=8FM&
MJV73\3\J"=/C<;Q_>RLR4QRY0M(EPQ;3;>P N=>M!$Q9>2YI3%C$\=@Q'9+)
M8%V:Y#?AN)O:@<=AIQ$N04ECR 0X20"[:G<"QOJ10;2F0IQADN=JA=SGH!;K
MUH*K,Y%Y<?'R.-VY4.]6GM[M!J%N#8&^I_[]!>*254D;20"5^'RH.20!<T%1
MD9@,H39M9">VQ)4G<K"ZDC3X:T$.27#E#.87 952-_0-J3KZT%6="1U^= H%
M!P0"""+@]10>Z*NW[->/>_\ ^SDEB?G]2+>GQTJ=7CSYE2/=*Q)"I8CKH-?T
MU44.7C1<JO>0*I@NL#:B1&/5MUSU'I:@L.+PVP<**&1RS7!) M8DC32@Q\A"
M9IH8GG[&.P+&QVG<#<Z_IH/-LWQO,ES)3@907C\=C-)(PO(21:XUUMTH-F"P
M\?Q?=EF>:'CX#D@.UKR,-OO;J/32@U/PW)CQ\.;(=(X\R5,F;)R)"2I#GKU]
MQVGT^%!.R>4PW/'K XR_J'[6*R,(X"-IOM8VM8BYW4!,GE\_B\3+XZ>**29(
MV,9%_:.JWN!<^M!NN-($61>XQ98#',B)L<*1M<::6(-! BQH&GQ%RBN3# =J
MR,-P17)]MV Z:VH(44N5%E0Q,XDQ,>,10[B=W^Z;=^JP-!VYN)..^ES&EF6)
MYE2+8H)9FO[74CY4$_(BR(H8B\*A4='[KZA-Q +>MMHOTH-7RI9/JL+*.:\'
M%Y"A#!&EY&8NUWL?RBPZF@MI.+X*+(AS,51.T09=UP1<#JQ) MK08"8^4Q%D
MQ2Z,RLD.05OL<':=AZ&U!$QN2^@D7C\@3YY:3Z6;*F![RS&Y0M8 ;2+?JH(G
M&+@1960F)RD<1S<G]G'.%<R.OYNV;$BY:P^-!L9XO!EP<S]X8,F7VB^5 5D>
M4R%%W>Q3:W2VV@J\+!APL;$Y5<1N//(K:?&UW%R?;O07UVZV]*#ND,,^ TG/
MM!AQ1*HEF:1$6*S+9O2URHZ^M!D=%''2+%FXYQ\HJL$9&\%_YCJ5M<'Y4$#D
M<]QA\GBYN/D3)@CL3XPCV!D8;24V[B5UO<:T%GP7'X+<$K<;C]_ [3+%C,6+
M[F.N[=\+W-!UDDCX7$:.#/;*DEL(,9P5E %B-Q-]0!8Z4%7F<QR,^%#G<K(<
M?CUD6)L5+ASKM)9@"?3I0;;C28F#A0MQTR3_ %;=V*3:MQ':VFE_UT&/-4Y.
M!(DJWR\A"T4KL03_ #0++J%)OT/3\;4$O*Q\23C&AF4JT>^""?\ *1I=3J18
M=.M!YAQ'#+B\PW)-STL<&21W(LB0'O.IM95N#<D: &@]7XB'D@TTN?,I5I)&
M@A46*HS%E#BY%P#09^3R,3%53EYT>&F0=IW_ )G5?YJ_A?7\:"9O';C: EHF
M"K$R$'0^NOPH*K)G=D<-(A9"=KV!+*VEN@^?I05!8D >@Z 4'% H/8OMC_T=
M^Z/_ #!+_P #/696'U_66B@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4&F?</_H;SG_FH_P#A4JPDOD28H(W,ALH!
M)-;9:6PN]U8A1?VZ:WZ7H.:" W%X+YJ\BR'ZR,6CD(W!;BQ-KC6@G29$:3*F
M1(1,VJ*WK^).E!-$,2.B&6.:1NHO:(7]2]P>GPH/-1CI+]PN2=LH0MQ^'&0N
M0LI[CN&=E3:C6W-8"_K\*#T!,E'F?"6%HSLWHD(&S4WN[.P.IOTO05.7%R';
MM![(3:*25 6DE#L"Z#_Q@H%O07^-!&[LD*X.%ODB+M+'%D.1[4#,YB[9)VAK
MW(*B^GQO03)\S';9 D9R-Q F>,FY+,3N+7L3\EZ 4$7+QPN,QQ,B&"-=^Z>2
M1EV%M#[E-CJ=0U_A04V9E1^.8KF3*#3S(T@R'*K'&[F*/=9BHL2!N"BYM^F@
MBQ<L>3PIG,@CFGC#XRP26[A#'17((VL!<C4@7UH.#D8N/@/(<B3+Y*']I)BP
M@RN+?S=BD@D#4B]!$YKRK#X3B</E9D&7EPLX,AVW4#\R$MM"[A?72PH/-Y_.
M<F1^8[!,6/R432QX)=)9.Z3J\()4A=+W-P 186M0:9B_<CE,.'Z,9;#'#[H0
M?>9!+8D*K*NX:]=WX7H4]E\,\LBYB-I'PI6TV8\<*AV*FRDVT4;;ZBY(]:"G
MY>;,\:X[-SQR4'.2&98DFPMA,3D[MTRJ-I8Z6!] 3\J#K]NASG,\[D<UF;7X
M[<[L7"Q2M,0H#;8Q8V%M-!\J#U2;.QY>2RUEADBCXM4,^0Q"(2UR"6!T46U)
MH,S8S2QM/CRK%+E*S1L6,L+[ORAG3:;'UUUOH:"=A?Z'QZOEO"JPINFE@N8[
M*/<1TO:U!7GRW$G-O&I1G9$WMA]AV@>MRQ!'Z#0:]Y#F2<) <KGHIN3Y"2-I
ML/C44E  ;$LH-R%+?"@M_#>2Y/.P9<Q\@K@9!*X\&U%8E2%8D(3ML5MM].FN
MA(;2]RYE>4VZD-MM<^MR+_RT&$9>,TBPB93*PW+&#K:Y%[?B#02:!0*!0*!0
M0LC,[&3B8_8DE^J9E,B#VI87NWRH)M!A(O)[@Y46*]-M_P!&OZ]*#V3QI57[
M-^>:KM/)X@N@U $N*+'74BI/J\>2((S<.2"?RD=!\SUO^%5$B/\ 9),%ECE4
MAB\K#M@+:_Y=U[_R4&/K@%$G89+ B78+HH86W*2+C4@=:"-A8^3*\7'=UFQ+
M,LC,;;BMB&6QO8CH#;YT%KDX8!R$@R)()((P1)(H8&Y]+6_N4&B^>S,>(^FQ
M\MI)L_MXUCJS-(;?E N "*"VX/C\#B..P>,CG3(R./*KR$:FX%RI #K<%K$G
MK\M*"=*$F9HLL=R$.5E$5P"IMM56)8C9TW=#04D_(#!QDQH'"Y&0EH1)M8"Q
M]Q#)<D ="JZT$C!R4S8,=LG$>+,F&](XXQV[)[F.^XMMO<BU!C3(7,GRQ>0/
MFY143L4(961]B[;J3?4DE?36WJ&:;NXR0Y6'*%V ---)T9=/10H4$?!:#/R0
M23%"F*+(,Q!0*QVD$C6]P=+CX4&-8=F&D63)VXEV%HP38-;;J69[BY_PZ4')
M6#BFRER9%BBA8VF<60*3;:')-]?C8T&JMSD.#RLROG((KMMP &<,S=&TN?U?
MJH*O)\SX;BN3S<7)G$N-':5QC",(&DL+.7*ZW^)O>@@'[K\-F9CXF'A96.LD
M:F/-=% 9$%W86=B0+ZD#VFX.WT#>L<1_NA5QFB..$>98UE%Y8]-Q$BMZ_A0:
M%P7D\<G-Y&(.)ABX^=VQ4S?J"9I)$Z;U)M;Y^G76@V_'DDCY"<-D[H805GQ"
M2Y5%U&B&]]OI8_JH++BY3CXS*L9FA5@JF$B0J;:JUF)%A;K07;:KN4A+B^YA
MT'Z;4$!ILG%.*TC?4+.YL^P*-HZDZZ6_"@\_\A\T@'UG!\+C+^\\O_X(RX2?
M=M]P7=MU)(VCYD4%]X$\7(\+%RF=-]3'"0P,D;1*QVWDB".JV*2;@PUV_$T'
MH,?+'?%(B[(BI$<9&RZDZ ^EQ01LO)FSW3$C.1A/*&/UN.-[HBC:%N0%7?N/
MJ;_#TH)4<F5 $Q_?.B[H!(1;;(MV!#W^"KIZGTUH)C9C-A2F<B:.1Q&I 5B1
MNVL=MUTN"103(&ACQ03;0A9U=BY]V@6Y^-P!Z4$*;/QI[Q2]IMC#:\;[KJ""
MRBPO<C2_3YT',K&6..6'#-H6"1ZMOV@!@2!Z6^=!$+8\D3*#)W+_ +)/S6%[
MD :6_700RFOM8,"; WM^N_2@CF>,9<V$3;(@4/(GH 21UZ>E!FH%![I@_P#M
MG,7_ )[?_P!U>L]7CSEI9$2$QP-+<#?&H"D"W^Z8 6/I>M(BYP,D:Q12VD:1
M49R"21>Y "@ V_DH+$[E467=MU<WL%4"[,?P H-5Y#&\BR^5XS+X_+&/Q49(
MSL"6ZLXOU)&O\M!.Y?,^BP99$QU9 7CB12"Y8+<D(IW ?C0>>\QDXO-\SXKQ
M'%--*^09,KD,=%/[.2*_:4EM& ;4VH-\W20))%EQH<A2^_%*;T@5@;@$L";V
MN=/;^-!J_(<]Q_&2"$<MV96*!8F1CNB(V]P%F[85?AU-!/PT:\BR$KD/M,>4
M 8B4V:'W  ZG2[&U!.ACDLQB7MQPP%IO>%#1(?>1O)%ST]H_#I08OJ!W@L<9
M,/MV@W%@QN1=@I]O_=ZT$Z#-=I)A)O)"VA:X).XVL!8:^MOE05)P,7':69&V
MOE!HE%S?4>[0AE_+U /]^@CB'"1S!QTDW>QS;,D5F=>H7^>2MO@>IH)4G-XF
M$#%&W>:2(JXCLK W]26*ZG0"]!2<#-QLF9R'+X.&B30B3N3F16<LQVL2+L%(
M;TO01.1Y-)^#SN5P>0@,..Y*@D@.JK[E-U!TM<V_70:CP_F'$<KDR%ISC<=(
MJ)G&5XQ!&\?MW(DI#.#:WM]?4T'J8P^/R5R)FR<'.QT6,XV/$=[,@]RAT9AM
MZT#(FPTVQ-]5DOD0NT=HW2, 6&TR$?G ((0&]K]0*".W'EL/!1._BH'[C&14
M=5W#<54^Z_P^(^-!&Y)8L:?9C"Q<I+%=/:%!NXW$VW, ;"_Z/6@E3Q2Y*0P8
M40$4P/<V&_M ) 6USKTOKZT&@)Y-Q/!Y7*\+R<\>!'Q")) D[KW,@2(#:($!
MF ;7H302<7F_K0LW _49;R(.X([/>W07L"?D/6@W+#CQHYFR.>[N1+&FYYI"
MHB&ITZVL+^IH-GDY7$D*X,5\=V3<K  %0#8-M'77YWH-=A3D(<N;&S#&N/;M
M*^]AN!&MMWN!)U&M!=K) @Q^&R\>?(AY%+"P)"J5)][*05&EKFVO3Y!63^+P
MX7&9W&0<GD"#D,F.:".0+)VA&J@H #&74[!U-_F3K02LA8UX[$A[V4WLL,R%
M5 9$/YF]Q-O7I^B@O<:)L?\ :3371E 4W-W)]2IOK;T%!JV-#S3S9;\SE060
MCZ<!6!V,25O8&QM_-(^?2@LSBY8$A#K(L2ZE6#:,+:#KT^5!#*%1*7O&8A=M
MPM;\;]*#'0<T"@]W3_VS?CW_ #U+_P#U-9ZO'D'.\UB\3 ?J49@XT4?SOD+7
MU_DK2)/"R19''X\\'<5)+L5D*EKGXD =*"7FY#XV)DY4,+3RPH2L(N-Q7X"@
MIXWEY2# R\QTPHW#AL9P%<;2+V.X^IZG]%!QFRXZSM%B/WN\BG+Q\<GN%(]?
M72UAZ4&A>;9DV1PL. D;0+RK(D<!<M)*"Y]VU>F@'4T%S'AXAXR3BQ@)B]G%
M$6[W-'*[QZ$ $6"GKK?TM05^-XUAQ8L,4N:N7C1,!)AF(Q['0EE("&Y^)ZWH
M-RQIL2#$;MB)V)((0V]UK, HML ^1H(D[1PPN992RV%C$5[BGUL7.RUSK<Z^
ME!S<2B5I"5,R[D4 %[L%# [&T-]WZ/QH*24]V3&R%,\<&.V\",#:;7 W*1NM
M:Q]NE!<KS44D^.,^8#&RE81J=JC<O2]B+7]#>U!4<%S(Y*7D,/*98\;CY622
M5[WD+$!"FT"_6VM_PH*D\SQT'-9F!])VWXV 3=V=8Q$ZL0;@"4'0$?K^5!S^
M_P#B<N5<'ZAF&6X"F"S1V(#;=_NN#\Q07/,XLJ3\>V"BC'XHA_IWR&QB25!]
MK;2&ZDG2U!0\ASL,L,L.++@+%E^V;E)IXE+32WC46.TL][BUQT'QH)<'BT*1
M)G8N5%FJIM$V.T):.=.LH+;T+"UB%'Z+T&P>*XG*08$#<WR*Y$YQNYO17"QC
M=<,'EUO8ZWH)/(9?&\/%)F\IFR2\=G/''C, TK=PDV8,@(MJ+?RT%?G>.<;S
MV#A9$L2\CC9+"3'1VDBLDEV0M9ENRZ>UNAOTZ4$Z#CACP-/QF3!+%$@Q8\8
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ML8B@VJ-&C=<B7LJT84)BZ#=&H+,Y8]7NP&V@P.KSHXE594<F1H(ORH.ES?U
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MZ<!QF)RRXV#Q$.#",<=O*A8IM9FV#:ITZ_&@B<MPO.P\GB9T+;YX,V$94DC
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M*"1.RMCR L51#W R&Q!4'UH*J;Q_&^L3+>:1E6.Z0;[JI9;$W^?6WQH+9,7
M3&Q-V61 R[9$;0^[7=K01.=YML?BI5XY ZK)'BXN0&W71AN?<-+:+H:#SC[@
M>5<3R7CL>)GRIQ^1E2+'E27-FCA)[BL1?VW4&_QM0?,L_P!P.>3E<]N&Y/(C
MP928<!)6LHC2X46%@#:Q%!<\!]PLGZ+R:+F9FSLCFL1(5FE#.T=FOZG7X_IH
M*+E<WB).,PGPLXRYN0Q$@F0 1[6L J^EM305>%F'$R6QW:-LB)-JDB^Y@I&O
M6^VQM\Z*MN4X_CQCQY/&X>3%F20Q(DLI#?M !OZ=#ZW/H:(I9>9SFQT,)CBQ
M8;QS*H (!T( /4T5QQ'*=_'R(\F25(L:PC<%2HL;)N+:^AZ41&X#,BFY@DQR
MR8S,$=0=I#>TDCXV)-!](S1\5-XW#D<,T4.><5H^2B>0QY"H K"1"MKZFUC5
M&A8N--(Y221<B-L=Y(V+6[9]HV%NFK6O0?7?@G(XN9X[CX6+GOD9/'ILGGE-
MR65B"=?YMP14'5HLCE(I>33,6+ S>[%,K(1(SX]X5>,7 LQC+#Y$4$?,FX_B
M,&&:(!7F<"64WV@-H+GY6ZT&2.3$3C,GDX-!(Y#.GO[NP:,H!UL3I00^YR&0
MT!BQ]Z+$)9[WZW#(-OH3J306N%A130Y$>7)+W)6,YW7_ )JD!;?"QH(_'+F\
M3@RX_(,CX<DI&+,[DM<FXU_308\C(PRYQ\PE% $J[2-Q"-<E1ZVM03T=9>+;
ME(UDB9'8G'U)*J/RV^(N30;-BM.X[C3"2$!BL>A<@]"309+&4$2QMMFC /;-
MP "3:_QH*F56$4P5V$36*1M^8D6+7/P&E!$GA^EVQSZ32:Q[3?0=;T$<VN;=
M/2]![%]L?^COW1_Y@E_X&>LRL/K^LM% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H-,^X?_0WG/\ S4?_  J5827R
M%(-H#@%F6^TDZ:_&_P"JMLM9F.US:0WN;L.H8&]C^GYT$2Q(+6-KZGYF@C18
M>) VZ#&CB<DLSJ-26ZF] RL%<Q$9LAX# VY AMN/P/X4&+,QYI!!+ARK%EQ2
M LTJ"2-H[;64J?4[B?T4&O9O&9>=SV)S./']'&B&#(A5A8J(V,3ZW/\ -;=\
M#<4&S9D*38N2N/>".4-VNT=Q7ULH/]R@UW.A.#B8^1DERD)"S.5!5FEVA25&
M[:1<C2@JHLCZPR2J>WE1-^W9[HK!G9"Y9R"1L5;$+T8WM:@MY,/&R<%US)D:
M%!W&R-Q8( MR$##I87]:#Y/\[Y&&/.FCP)3-&]I.XZR /[A[MI&A  -QII0:
MIB\]-(DT:Y"8YW1SM+&MPKHRJH8:';8L238 @:^VBL4F;(AWRMLA]D)0(62-
M5VK_ ),@DL+[3;0'6@IGV,\3M,>]OO#*CDEI WJ%%Q;2XH-BP7PL82+-&F3*
M @+L=@< C<B*ECU)U.HH*?DQ'F\D9>+9H,<LNV"8W/;>XL"3[E*G6@P+FYNT
M)' K/ RQ')W^U2NHMK8WH-CS,B/E,>#(EF0YLJE&8@C:L?MM<FQZ:41J(R)L
M&2&)6$QV-,KL;;+D!0I)U/M)L/Y:*V?)RX>5X7'AFRKN $Q,120L94F[&WJ2
M#>B(V#C9>*4DR8I>Q*@WNA9A90WNU&B]+ZT5/PER+NR+O@9FW-'>S]J!W2-%
M^>Y;$?+K1'NOVJY:#+F$'*9TR9^9CKC08W<W)*%T#:$D,MR ?A0>F9.?F8?,
MQC(,/'8Q5DQ3).G<EVBURC=;_&XH+W!S,0#"?#=\N#E7<1O&R,D?;!)N0?2U
MM+T&:'C,9<_+G602([J[XU[]J7:-1KH&6QM:@QX7"8W$_O&7C5*39[]PASN5
M6^"WZ"YO:@KN'X?(PL[/Y',G[,,SEXL)6_9(3^9]3Z_"@VQ'210Z,'1M593<
M'\"*"HS,K/B>15QPT+';$0"2;C4FU[4'(BPL^"?CI)&E90#DQ@E&7</B+4%D
MHCQXHHU!V@I%$O4DL0B+K\20*#(K*ZJZG<K@%6'J#TH.U!T<N$;M@%[>T,;"
M_P Z".T7?8#(B!,,G<@8=-/RWUZT$:7,EB1[/$\D5NXA!O<];:^E![AXQN;[
M+^= Q%".2Q?;?<+=W&-Q\JD^KQY2D9NMG&PC]HWH!ZW]:J)10;CO93  VYE]
MM[#V@?I^%!QC/L?'$,9;)+_SP; $$"UO2QN:#G(GGR&5RZS8X=E>)258A6!#
M6^%C_)04/(0SSC(QL;&@D[22IDAVLWO%E/MM<@6O01O'^,;A>#Q^+>/]X3)/
M&@R8_P":SDD@+?YVN:"2\3_3?LE EL CE0)=929#)?1CMN%!TZ4&**/*A:22
M1]JR,#' RJ@"^NXA1K:VHZT'.="DY.9+&LDD:@*(4_,!_C'4_B:#B$7??/"<
M?%A93O.KK&""%/2Q-KT$A9()5,F-?;D!GBW+9?V9L#Z7)MNOZT'R9Y9RF'G9
M'D&WD(USHLDN(7&A9"%TLHN?D#?UH/)L;D,I>6B&,T(CFD6)()01("+,3<W
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M/:-IO<V4@D=3UH.^?-#(V,?J$_9_Y-1N?<[>W9[;'W E;W^=J#C'$0D=93+
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M&@LI<#$F=WEA5^Y%V74]"ER;6_%C0=,;%P>(Q6C@5<3$C+2-<V5=QN3<T&*
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M_P"V;\>_YZE_N9-9ZO'F&5EQPX\TP!R&0.4@5?<VT:J/\-:1JW!\X.3Q9W/
M#CW,VTD@J\@'X#6@LFY'):3+CB,7?B1#V.XB$*^H(+$ MI:U!J_EW%>.>2\.
M/WZ(X,F/''TN26!DCG8V .VYN#;I\:#1?'LKD?!T3B^=[N3PIF_T+E)B.Z 5
M N^M['T%!Z!RF:O)XD<7"3#*BR&1(U9B=P!_FD?"@\9\KXCG(CCR1-],(Y>X
MLD98++WGCC .OMVJ2?\ PT&M^0<9Y;-X^D9P9L82X[C(=%!9XW?NONU]I4@
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M\:#Y3\FX#/XV1AE@IVMZ9V)E8[1( 6LNV5E.\!+'<!:ZFW2@T7.18TAS<?\
MT1U;MS(CB5"QNYM<M<,I ^%%0\^:'(A65GDV*X[4.RVT6]P6PL;M8GY4%7#C
M(9VQ\BP:53)('(TC+,%/6PL=+$]>O6@M,;CH4G97#-DY'L8NK6+ @;KBY-KG
M7^Y08L?%5W<))W(XR"LK D%B;[=S[0+^@TH-@@88V-.[%S.S 0E"B@(5_P H
M26O8#53\1092?JI)XU<IDL6<V8 *B  -)\2P]*"L$^%C%\+*QF8E]QE=C(JV
M&EAU(/RH,^!"@RVR<F*-,<H>S&BL1N86#!>H_3064&3'+BY''"T\D[H(44$$
M3)UVC0W /I01YT[4F&D+OC0RC9/');>"3?H0-0-=:"&>0_TX]MF?%67MH5#(
M"/G;U8B@V_"@GS9),C&B>,QP3M)E>[MQ%(S(3OMI?4?I^=$<X/$<?+WXLS-Q
MY\R&.2;%[$BQWL-?:X-PUK>V@XG!QTQL) 4P\@EF%R-[G10;G37YT%-.94FD
M,*[4*[V+JLBJ7NMTVDC\]KZFP)^%%>_?9&"1,;F<?*A,;A5,,;*%0H['W[20
MY_+87%K=-+41Z=/P'%<9A3QY,Z0<>\[3SRS,-TC2ON,9+ @B_0=:#8<./'R<
M2,B9,V#?W,9U LH4^T#_ ,7I04'.\IY) W'XW#X,,T\LRIGS,UTBW E5 -B;
M@:GI06N;R6+'Q^5D<MC-#Q\09,E)HRQ<@V&U!>X/44'7D4>?ATFXO+;CTCC6
M6)U1K=NP)!1?=^7X4$_C,A9\6*TC2NBV=W4@G4CUZ]#ZT%C0*!0<"^MQ;X4%
M<TH^J 12&96$I+6T3X4'M'B.\_9?SLSIVV;E,0M9;7!EQ3?YU)]7CSW'C7Z&
M5(ECA1G8)N.I).X@$G7]55$?&<B&9PG[3&?< PM_N;V^5!4Y<\2S<=%*DDG?
MED39&EQM*W)=K'332]!*RL2?(CBQ^])"F)*A7?N4 $G5_P 0?7K00.4XW YK
M'EQ.1$9@?>N'$D=BH2^VWP)^)H/'>5XSD_$,(Q13-D<?R,X+]YF=X%N-P]M[
MW!MI04/CV-C3\WY"K>5C@<GAG,N/.6BB#KDIN#,9;71; ,!J-:#USP_F<SE_
M'^*Y7D$9)<G$67(8V!OM6]E-CUU^&M!7<QP,'.8^Z3'$/:+/CV1AN-C>Y.A!
M^ H/ O*N&Y7AHTF6"4'+?O#(G"J"5).TL%<>H8ZC0G0T'B4^>TBQLXC$V.'Q
MLB0?EC,;!@6ZJ&<)KKK;XFBHJ1+&\<JPI#* "'"$I*59C=02!NU%]*"NER(7
M;)>6TF2A8]HK8J"1NW!2>@^%Z@N.,X=.0R(D@F$<RG=*VUGM&RG<Q&TDZ#TU
MTTO5$K-XK$BER(<:89,L4*L'BD_9MW0K&S6&NHO^F@M^)Q\3%432NT>3CR6:
M!069CU*[; @W^%[T%M#R*M]1)-VHX[$+.XLJ;V-MJ?F&TG72B*7-RX8(9I6/
M<#B1 RN7B<W_ ,HQ.FFOK16/!ABFQ\:2>.14GEM+(%ZDBP6YZFYO>]!M&(8^
M3:?"QXV[>'?ZB:(6=HQHQ<VM>WK>B*K(QAB*N1CR$0XK;H92!W H/H";,0.N
MOZ**XQ^0ESITFR2W(;557R&!C4%++HYM8[6U'X4%YE8(R,>7Z=DWS;$QA*#N
M!%KV+:-1%/B<9BQ3/CY4ZR9;2=N7:MR0VK&[;;6MTUO16Q-!#%(<4N)86 .,
ML1ZS*+*9E_F)[B;V_5>B*&4F&0XR'ZE\?NC)(+/$BGJ@1=ZOL:X) U^-%>N?
M:OB.1AY"'G1QZKB8(99<EG$;,Q2S(4+$B][^X6HCZ1QT*\?#)B3O(,B1Y;NI
M;:&(9@&M8@7LH% 6\GM617A6VQ@REVD4_E"_EL%%_P#OT%.J219'(OG+((,J
M?MXL(!8FX6S%QH!=?CI0;'!C*!&J)[D30$]+"YH(>+-)F<CDJZH(L+:D?O )
M;=J"3M(N+=#:WZ:"W=9(&>*0;6%MR:'TT_D-!BH%!R18*;@W%[#TU(UH.*#J
MJ[01<FYOJ;T'LLZ._P!C%[0)E3FG:*W7< VM3J\:"%^IX^!<UA"TBHTEF U'
MNZW^55$1<M'SCC3K]0T1[K8*/9G@ M<-;XVH*F.+)>+*P,'D(&S6$?<AR#L=
M7)N-Q-@ +6 ]?2@KGX-9H,:++RY<?(95ER$/M#N6NRLS?E M_P!^@U+F?%N6
MPYY>9\<=>/.0Z2OP8.],DC52"!8Z#4CI076+S<7,XLI*QP\CCK?.QG:Y0WNQ
ML.G2U!GR>7R43&/=CCRFNDN/&R%A?4B1-;^P@'6_Z>H7L*R,(<H[@R1]MF*V
M]OJ+BQTO>@\K\\\3^L!RN/:"Z*3--*KKNN1>S+JMQIJ/PZF@^?\ D^.R^!=8
MLV"7NY.X)W(B8VO"B)NDL ;$[OU7&MR&D<IS_(9,#1)D=C#PX]D:%P"JB^YE
M%]!H;FP_N7*T>4IE1?6)L[1/76)CMN0=1>P(!N#01$R?J D-O<P]TR$H2JD'
M>!8?F_+01]TC[(I5^H:9E[$.T,&4=2"@/X]!06J9BRQKCX\BB41L&M;:JCH#
MT'Z#K07_ (_ARJ$Q&DC5>TQR5E>Q>P+6VDW L*#:>+RL"V7//(<N+L*1'M>S
ML#M *[@P%Q;]%$:IG0;9BL@$RA@&='-E#$D+J2#H?2BK+"Q$8J@G,?;6\9W6
MC<=+MNM;\!02>8A:/&@S>/B+X\@!D>1-8ST%B;_XQO\ "^M$9<;D9N*3'1X!
MDB1M\BPM;WGU-@?2@F3944CSB:3M1RH2L!8,AN-;[;].M%:YD09*9%N+CE..
MR""650&&Y3_C#2XN+:T1L'#\=%;%;ZM)FE<*%16,DUK@*-";:Z4$SD<=L7O(
M71GQ&=?JRUW2.0$$ D@7 /2U!JF.QGR,9OIY'BQ6!FF!+.1&U_<!JER0"?AK
M17W+X4^5B^-\!]3+%QRX^''"8LDL%D5VDV;E(O<J%(O_ #2/Q)&T\G/@8?)G
M(Y X^-!+%VTR9)1%[P-NU2UNE!6YO(00\?)!QF7'G\DD#G$0ENV;"R"24!@"
MIM?6YO04Z97(X^5'/R?&S381#R*8%[G;G9MFJ@AMH%R"1T/XF@W)\?)63%R%
MENDGM"!ORZFQV_,T$+D>.GQ.2S,W&[:Y>2EUC<#;(0MKD_"_72@L\#-RFXB.
M+D0JYZJ0RI9D]Q(T.MK+IU]:##W';\QO;HP8,.A7J/EH:#L%,F@1GV@%@A"G
M:/S:V/IZT'07MKUH.&W>W:0!?W7'I\J#IW@9.SV)%*BYF(]C?@030>Y3R2Q_
M9OQ?M"[/Y ZL+=5ME$_W*SU>- 5;S J"BJ&&TJ+&_6QZC7XUI%+G9'8ES)1D
MQ8PQXB.[O"B,-IK?^<?2U!JIS\;EL>"7AH9,ETR81E3+L!2*)MS.V[\RW^'X
M4$B/C./Q(,K"R6D8&'ZR("[6[\A+N2#<7*@#3TTH,N3QL/(X!P9RLF+.-I#W
M6P'16+&_0:F@\7R,U/#N9@Q>*D6;![C,\32DQ([NJLL 8#<VHT!Z7/I0>J8N
M7%-DN%>'_203CXL_YF(MND4-<W (TL/QH)&"^.Q:;-G6>&5V4AR55U!(8;&M
M00GX[)FXKD(>+X[$<QG;!'!(HVQ7Z6TMI0>5>>8_(1&?$Q[R8L&+&P$I#-%K
M<]2- 0.E!XCE\=+!$,J.)\*;?+"S." @ 56N6W#H0O\ XWZ*H\SYR:=LD.TT
MC"-6%BS^Y19?:&'1=#>HK7VPFR6AD.0&C4[M.I_ BXJ#C)1S,LS3;<92QDBB
M9B5"L->I];$VH)>'C<GGX^_#@.1!$0)9(@'$8-R+IZ&U@>M4<-!E.%?.8@!=
M@2*^UP-+DC\U!LN+A%L23,CG3&EQ44Q(Q*!R20-3<'3K;IZT$T3X(XC*Q,B1
MH925CRY/399K@'7U)H*F.;!.2JX<Y$?<'<%P=I]+DD]/PH)D>6N+-(D,2JUW
M09$B@#7H6N*#!C9>1&RI(K3RRM>-I#8%3Z+>P_ T%EA^29F.RPK*5P[EC#(-
MX#%MWML+CT%$6.4\6?CPL-^-)(MI4U 2QTL**H#CQ<;G(3&F1$Q#/+*OM.X'
MJ-1\Z(W%.3WXKY.9.T$(1EQ94U.T A0^TV()%E ^'PH--RLSZ[(2"*4I$B*$
M0 DD+JQ"*/B;ZBBOI/[0\2<D2B""+)3**2/DY;-&\+Q'<!%KL8GJ01H/2B/H
M]<7G..SX)$@_>29>2\LF=&Z1!(VC "3J[V;W@!2ES;^;05,4(E?D^0DCQ(<_
ME(^Q*<4G:H"@1LVX@N=!8D6;2PH-=./]'R4'#NLV1D\V^1*G*N0L< %C%#<B
MQ!L  :#!COD<)F\L>9PX(N)BA2#%R]=TTCMK'M(L=Q.EC09/'Y<:3C\K&XW"
MFA&2%;*Q66\,9E6S1JX]MP=2!TH-](RH\ <?!D]A]T8=K6("Z.#>UKV'K02&
MS?HV&;F9#_3O'V8\;N 1D]+VU]U!3YZS\ECHO%SOBMW0SRW.X!3=E(MKI066
MU0% >_L&XG_& U&GSH.I)8EB;DFY-!U554$*  3<V^)H/9/MC_T=^Z/_ #!+
M_P #/696'U_66B@4"@4"@4"@4"@4"@4"@4"@4"@4&B_<C[:>#_=SQ'D_!?N'
MX]C>2^,\LH^HP,BX9)%OLFAE0J\4J7NKHP8>AH/S&Y3^R"^T.1R<V1Q/W2\M
MXWBI'+1\;/%A9,J*3?:)Q'$" -!=+_&]&OT^Z_X>_P"%[[3?PT<%F<3]NN*G
M?DN7[9\@\KY.1<CD\XQCV+)*J1HB+<D1QHJ7UMN)-$F;5'\1_P#"/]HOXG<#
MCQYWA9?&^2\+$T'!^:</(D'(00L2_P!.YD22.:'>=VR1#M);84+,2(FGR#X'
M_9)_9;QWR&#E_,O-O(//N*PYA+#XT\</&X\P6UH\J2 O*ZWO?MM&3IKUN7]/
MO;[Q_8_Q3[Q_9OFOLCG33^*^)<OC\;B0GA$@A?#Q^*R\;+QXL:-XWB1 <54V
M[+!=!;2B1+G[!?93@/X?/MEPWVN\9Y7D.:XCA<C,R,?D.3[1R7;-R'R'#=E(
MTL&<@67I0F;>,_9_^"GP+[-_>[R[[Y\%Y7S_ "GD/F/[V^NXC/.+]%%^]\M<
MR7M]J!)/8R66['3K>A,O//XDO[.?[:_Q#?</(^YW]+^7\&\EYB/&C\G3#AAR
M\7-^EC2".58Y2C12]F-4)#%3M!V;MQ8L?5+W[I_P!?;K[L_;O[)_;GGO-_)L
M/COL=Q67Q/C_ ".']$N1EQ9BXB,<G?C,ET&&@78HZG=<ZT2WVWP'#P>/<#PG
M 8TKSXW!X&-Q^/-+;>Z8T2Q*S;0!<A;FPHCXA_B(_L\OLI_$!Y'E^<-D\G]O
M_-^1(;F.8X3LMC9[@ =W*Q)D*F3:+;XV0MU?>:+'U2A_A_\ [-C[+?9+RCCO
M.>6Y/D?N;Y9PLJ9' S<O'%!Q^%DQZIDQ846[=*IU0RR.%-F50ZAJ+/T]I_BA
M_A-\,_BIP/#N/\P\DYKQV/PS(S<C ?ACCAI6S5A1Q)]1#*+*(1:UNIHD33Z(
M\0\;Q?#O$_%_$,&>7*PO%>(PN'P\F?;W9(L&!,='DVA5W,J FP O1&N_=G[<
M<7]WOMQY?]M.;SLKC.)\QP&X_.S\'9]1$C,K%H^XKI?V^JFA#\V?_P#D%]DO
M_P IGG'_ ,=QO^IT:_3T3[3?V97VF^T/W'\0^Y?">?>6\GRWAV>O(8.!G' ^
MGE=59=LG;Q4>WN]&%"?I[-A?P:^"X/\ %"_\5,?E'//YB^1D9!\=8XO[LW9'
M$OQ#"PA[UA$Y<?M/S?+2B7CWC[N_:SQ7[U?;KR?[9^9X[S<#Y/B]B6:':)\:
M9&$D&3 S!@LD,BJZD@BXL002*)#Q+^%O^$'PC^%/^G7]#O)N<\B_I[^[/WC^
M^3C'L_NOZOM=KZ>&+\WU;;MU^@M;6BS-M=^U'\#OV^^TGWTY_P"_7"^6^0\E
MY'Y!D<QD9/#YIQ/HD;F96FF"=N!)+(6LMW_&]"WVO1"@4"@TS[A$#PWG-W0Q
M1@?B94 _EJPDOD@@$6-]?@;?W*VRIL["DF8R*%W%@J+?4CJ22?Y *"@<.I!L
M JD]TGT%CT_3:@C"9L9&3.R(EN[%64V4J"=IU]0#02691J2B[5 W@ 7 Z$G2
M_P")H*W-;B<9/J,L"\S*BR:! 6)!)(.M]PN2-*#7/)H2>#63B\@0[)D#RAMI
MD57VL-X!/7UM_)01)K9'$P<5@E<2>8*W=C(!WZDL18K^-Z"PB=O&.&[N0878
M!F/;CLNGNT*6%OP4:T'S]]P/.I^<QYEC@C;!$BK!)+8=M +N8T#&Y8H;L;^B
MVZW#QB?$295[0M(L>S=(04!8:$$)K8_#2W2U%:PV^!9(HT*NKD_4@G9O!%C=
MK6! -SKZ4&.,*DC9#P;F5FC.C,^\#?N(MM(&[:.MP;:4&7+FR0R++D63&7M2
M10!H)&=?YVWYN+Z$#Y4$?'R,N=Q!)E]HEP&8LI!!TVN6]USZU!L1"C'>)R9X
MY%"QY<A)9+_^_#8D'3]&O6U'8YBHDG'9.*L<8A[61-$1OFO^4G<2/:+= *"N
M 1(X\?&61EB<F264[I& .N[:!T]#0;&)4Q8LR.6%9L;+CC5%:^]7L+%+VOU]
M305*8[X<I<RNER8XB@LS&P.JZ@J>G6B+AY8)<5I)<!?J()QW-HTVLH"ECU'Q
MT HKJ<=(%BQV@+9DNZ8M( D)"GV6(L>G7XT%YQ_)/&N?QD4(FFR8C"7F>3M0
M$.DF^-4958MML=]Q8=*(QI%'DMEY.?/)'(R&/%9;AO<+L6/<]>HTM^%!D[^<
M,3!@F=,V6 ?LYWFNMB;J7:RVVVT_-;XT':+&?*R#%++)]-(TD,D8D:6W4H-@
M*@KN-];#II0?1'!<AE\5XG'-P&!CI)AY$<$N5G,6FR,21M\01U16?MK((P7
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MDBC,@C%G4>FX#<+DT$65X(9QE+.N1'(1W8!_/T]NGI8&@MRAQ\?OO&ZXV6K
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M$/SK2Q8^#];%CI@$D/-NN2B1D:*!>Y/Q'QH-03+DV9DN'G-@JDF\8TBZ?)"
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M(N>E[:"B,2Y5\V.#+E?MNN]X@KHJKZEO;J!ZVO15A]=CI.\,3-)-))=<J/\
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M=(MJ0B-F9F8FY5_RC;IZ4'G6/P,7(1Y'.><9<7C' QHV9-ERD*I3T4 &[O\
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MJ3I<7JHZ[!*Z8<("-(S?MC[0ZL#U^5!&*../&)!E?0X\(9)2I "1*0S,6(L
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M49 ^VO$9!QY\R%+E?WGE ET0V#%%U/32@WG%EXZ/%QN-XF/!P\#C4$4/&8#
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MZ6-$,+/@Y+DH$:0"20,_<WD(MAK>_2_PH)T\<>1&V#C^Y87WS3W8$$J5L6]
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M&[6**@N0$L;W! L"+6'X4'E/->!9V5F39_$R+E+CEI^WD$2LJNJKNC60NAW
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MQI+HDY(#K;I'>][?&BH:1KE@)'(Z3QNKF*UMRVOM)^-$2)XYE19'4)VR$(
M:X%]0/[M!-.6^0B2R8\<@B41N#>Y7J3:_7YT5>\;!@9>*3(#&L>Z98Y+DNS*
M5"6'0"Q.GQH-_P#'9^ Q>*S.>R(S-R*/)%B8N[=92C!'1NB[;B]Q>B*KAN=X
MO@.9RLZ**7)^IQW0X[R7<_4"['<!^8$Z4%C%@\AS:KR&+CR3R2R%1'*_O 1=
MH4KT)L#0?5_BF+Q/'>*<9XNHFXYUQ2KN^UT[^AE7>1J0[G3YT'$O-@<DN/CR
M?6Q8F.T#0+$RF3*]I6[VM8 Z_.@XS,.8<G)R>*P!&(8)P[DJ&N"IV7M<=;T!
M,V7*B?'26.3,QTV9*,2J,)-+@_(:T%Q'%C22)EJBO/VP!*?S!2+_ *+T%9SG
MC?%^00Q0<A#O6"021E3M((-_2@N888\>*.")0D42A8U'H!H*#I)CNV3#,<B6
M-(0P.*I 1R1:[BUS;TH,P4!F87!;\PN;'YVZ4':@]B^V/_1W[H_\P2_\#/69
M6'U_66B@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4&J>;KN\6Y<?[B,C]$J'3YU827QOY)Y9QW!,T.XYN>;)!QD'[
M5V8:78 ::'4GI\ZTR\3\O\OXC@HDY'[D\HPS')'&>%<2VZ1P02HEZD$CUM5$
MKQKPS[E?>2"#)YH)]I?M5&@$/%X0*9V9&.C$DDW((NQ'X"I:O:^,X/PS[:<)
ME<#X-PB84*PLG(\PQ#YN40#=GEM>Y];4&H_3Y<L<>3'E20<2^)[\.;61V<_$
MZ@V]:J*IXH\'<(75\K*#R)C._N8H+7(_&PH*SDL^>,X,,4 F;)W]R959EB:-
MU5B2OY0/=U^%!6\K)R$)Q\?%FB2!R-RR;NY-N_,P0_F73J"*#2O+N/X^!Y6Q
MIUP\_+B0E'50K$H5 1F!/12NAZF@\?@Y'$6'(BSU'U9>9(5FW,[RF7MQQJJD
M;=J,]S8WL-?2@H.;C&1'-EX;)$(MJ3 ,Q817,A(1@KV!W"YM\/G0>?R9"O,C
MQJSB,[H;C;N LPD##0@=/TVO15>^.KY$78QY.Q+&'9%4+<D6!5@20Q(_3^F@
MP-)&[0XTV&L,L$KSSY5B-K!=!(=2=I4DBP_"@SY$B\AR(7%B&,V,NP%'%WN-
M6L.E!.EDR<9>X$>*!F9,:)OR[MEMQ.C'0_"U!GQ8HYHU#RA\E0O<"7L=O0WU
M)-NE!BY+%ERU4;3M5AL(8!U8] U_6VEJ"WQ\5L'#VC'EA265!D3W"R#VK8JQ
MZ $=*(G>1)EMD2<CF2&)U!:%G)"[;W4M^(Z?*BM8>01Q#)>$Y"Y+*LC?E*N3
M?;8GIM&AH)>!FXN1/ME2**!@563:Q:X(]HMIK\Z"5.$5Y5"O)CQ)MQH[V(L=
MQV]=2/2U!UAS%$:R*>[$UX=L@)?:!I8J.HH-AFGQ9C!#' ^V/'C2+'F(>02-
M^9@-+?'6B-UX;FL/Q[BIX<2+'Y/.Y5=N/CRIO966RA54;2+W-K>NWYT%!C02
M\E#BO),F2[9#@3+KW&4!FO;:+@$7L" !U-!]'>.^)<=P7!XLG)_2Y<[ -',[
M"-093>RL2!<T%]PV#Q_%9F;B8##<\/>R>/,@>0.Q+#73J#057(<8_*\+)CXX
M2'M0P8[8+A@888V%O<VOY5T_3067%_OO+A?&EB&-B8VQ,:=C=Y%72UP?EUM0
M;9'C1I)WK7F9 K.3\!:@SD @@BX/44'  4!5 51T T%!TED[2ERC.H_Q=3^J
M@HY6>2:=L><1V&J.=I-[W'N^8H(+!X2\4T(WL%&XC4"WI;2J.&5EF*1!MY-E
M%K$?*PH/H/PI+?9GS]6D5F_>N*7;^;<28IMZ7K,^KQX-S'E<.)(,#BE3/Y)A
M:6;<JICV_,SDZ&WP%5'D.7Y[A)E/AX/&R^>>8M*$PL2,%<5)";;I+:L%]-:#
MT#B_M/R_DC?OS[X<B_TT927B?"N.;LP7*[E5E%[  6-0>TQ9D P(^#X/CL7B
MN%CW)C\1CH8UC$:IMD9A>Y:W\E!0YJV,YGF9IX5VKBXZBYN;[KVT"WUJCG(^
MJC1?IC]5(-IE+W[;!5L ZJ";!CJ:"EG3(!A DCRGPPS2YT 9#(P"@*I/50K-
M;3J*#O/C+EP"*X4L")P6))6_Y7%K:@ V'Z:"J\APN'RN.GQL]QCXR.7B))#"
M1!<&ZB^A^ H/DCR9L_A^6S8\['R<9L4GZK%R=R3J-XU8607]WIU^-!K_ ".5
M!F_3O&HB4/+D)%=-J=ZQ8 ;F-PJ6W,=?2BM8R"F,9Y\:=G #$[K,"+VB'YAT
M47H*7+#9YA<9(D@G@^G&449X]K,-P!'3:?6]!VERNU!!BX\KKAHSP2;G)#L2
M"G0B[*UB01;]%!VS\O)D/T-DE@;',N1/&F\NY#!6!%EL;V(^5!*>-(<?%AQI
M%EU6,H%-UT%V)N>A^ H-@3CC$PGE#M!(RJV2&!#(_M=@-.G04%:N1QBYAQLA
MI8L;%G5L?( 4MM.P"XOT-CK\:"\FX_%P\9I,/*)R2Z2'':X3M,.EPM[Z:4&#
ME9GR(HIH-R!P&RI /:&)LJ)8$VMZF@H6R'C?#7'1F7'%T#J=S^IO\0:#G":/
M$'U<<BR2'<>P@(93NUU/XWH):B9I"(%:0R/WMQ4AKJNJA@=1K:]J"YE^H@MO
M%_JDW(Y!=5VG0$C\=*"YXKF<KB<:3(1$$!<Q3Q;R"7:)PH '1&U+'\*(M.*Y
MP<I$_&"&#%3$[DDF=$C1R2,Y0,"#;=N)-A^)H(/$<'S?(\]#Q6!C=N>,@] #
M$I<E5=KFXVG0T'TIB?;Y\>,+BRH,C9&'G=-Y4W(8J5(U -A\Z#?LLJT VS%(
M<0C< 1ME;0!21K<L!>@J>8X;'Y>*+]Z2?310L9 ZN ;V( -Q:P!-Q01^!XB+
M%FE:#<^+""N),RA0]_7K<@4&SNJK/BQ!MDA:ZQ'0-N!UN=!I<B@[R2/%+VS&
M65$+/+I8D&UA:@R(58$J0;GW$&XO0=Z!0*!0>XXI ^S6*2NZW./:]M#M?7_P
M:U.KQ\]<IY-''ER\3P&+^\.95")44GMP*="22+ @7OK51Y;S?D/CG!YJPN9O
M//,'-L7QGC[R10N>AFF6_0]0*#;>-^V'*^:1CE/O-SB\+QV((I>/^V7&-V%E
M[C#;WR;FP)4&^NIJ*]2GQ^*CQ,; X7%AX;A>/8+#@XBVB4LHM(X!]^HHC6,G
M-FFQ&AS54M(&AO<I&"39=JFY]WI5&/CH\I\N1UG6/(8/V=Q6R J3(R%FVZB]
M[^E!9\9B2-C0)LEB[,FZ"-SO"AE]X9@JCW.#M_502<8M97R(T6);F3')]P()
M'6^OPH(/D/$R^0\?E\<L83ZJ$B LH9018 @$Z?KH/BSFL'D/')N0P\Y0K2WP
M\A#>P[CL3*JW4[E8^T>X:'KZAHN7)B@OQ[0B)I+?43LK* Y!MJUM6%_2BJ&1
MH,?8$R.W)'&X7.B%]J+I8W]2+B@UF3CUSYUR%E2/'<%I61;$L"N@N3^8 GIU
MJ#8<,X^/W'W"6:%A)CL$_*J @ @WUTZU1$7F(94QX?IS!WY%C:4"X"WN3:Y)
M_1:H++%Q(H\G&RDE>=I&6/'B<B[B46("G46MZU1LB\8,#.RV#)-'DF1#"R;R
MJ2*!91<6(Z@T%*F'B92M]7R#+F(A?%A9;:J2"AOTT%!?/B8S<9C9./ER+DQN
M@S\:6Q+6"G<IN++Z>M! SY5C[LN&XG_:+W+D/M#IN(!Z[;C2_P"F@I,@3/DS
M2E555][@D=;] !:^MZ(FX4V--D/]1'VHY-HD=;[5M?4_ >M%6V-;$RUEP>Q,
M-K)-(Y(B?JI*WN;BYMI\Z#-A1YC+'BL3[Y&DQXQ[M[>GS)!]:"?!F9B2P/#C
M*LHEV333(!$VX^@%]3ZV-!8<IY%-BY,V-CP)C8^0J]^!;LD=P"\R*XZWW%>N
MA(Z418^-^&<SYED?NV3*EPL. 1N,ITW* 5WH54&^JD$#K:@]Y\+XGB_&>/@G
M&4\SY+F)<R6-GDT;W%%4W4;_ $-!Z"_(-@194N^'+ED:1< RE;EW86L%(OU)
MZT$N5XN4Q\IL/)C$R*K8XVG8'8="01<#UMZWUH,F)/'*K(C;QB@0R2V*C<@U
M%C\+T%;C2/!+%BLSY4DO>DBR#T&H]A-M!^B@@<=XT<+G<SFLC*$YR=_:A(_(
M\K@W!).H'M'R-!LT R!W!D.C^\]HJ+>WT!UZT$B@4"@4'M.=EPX7V2X&::58
MA^_'578@#<?J?CIZ7J=7CY?\A\VEDC>'C<M>-P(FMRO*9 9>N@6*WYB3^NJC
M0.%\@\F\HY,^/?:KQ^7/S Y3+\WY:,M#CC^>\*Z*I/0$WH/6>/\ MMXC]MDD
M\K\XSV^X'FK@.)LYM^+CR$&_;C&EP=%O03L?GCYA@R9K869D!1VF@5CVTVN!
M"]EL!HNTZ6TH->YG FS\!U69VCD98YWB8AW56+;1U"W/2@V3AUECXG&7L2(Z
M(UE-W86 _G$"]O[OK03,5GR<5\G'=49X6B42V"R,'91(GKJPM0<8_8^AB?*6
M2=IM2^AM:Y)N;DWN/2@DX.-+)!+#C.HAAE*E6 0["=PO8:VH(DLV&<')X;*B
M^LCS59 VT-&%8;;DFUK^GSH/CWD^,7C<F.!]F%EP2F(Y"V#$1R[0S;V_FE#M
M)!)UO;T#SGF\F+ALJ?C,*7OKG+[\IE.UP?S$#;U))L0==:*\^RLO'B#XLJ=R
M*%2(V<:W/HH!_OT$*62*2'W,%R,1U18H[@D"X4H"3ZVO09<!G3C\F-W$,",6
M#2+N#N+%64'TL;5!2%I96=!($1V&^QVJ==/T4$["DF3,7&D;:CG8X&M@ ;;:
M#U'&QL:0XH1))XD1Y&=4WRH$/N?=<*;-Z?.J->MGPSOC)EK$%W$ASI>UQJ*
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M'DWE\8\;G*F;8#WY%4WLS$W-SKZ54?2WCOB/B?V[PFC\;P(_KU4=WE)AWIB
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MUF5A]?UEHH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MUT('ZP308\-(L)9L=)N\$<]O=NL'U)/4ZB_I0=)HP%GGGD=U*B^V[:^ENE]
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M0DP[;V4"*_\ . /K02<H9+XRK%9I"H,R]"=/A\S0:XXYCC8,*'&./$A=FS%
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M6%R" >ATH,F1'D.(OIYQ RS(T[%0V^,'W)KT)'K02  .@M0<BX)/H1:Q'\M
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MH+/+C,C17A29D#,&M[X_0N.EK#J:#S/S?Q0>0X^'@Q]M9G&^"39NN48!KL
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MMC_T=^Z/_,$O_ SUF5A]?UEHH% H% H% H% H% H% H% H% H% H% H% H%
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MB_\ W"@W7Q;/YK(XN7"^M@SLS&DV%I@\86,&POVE%S;IK>@W;%P<?"B2+&B
MQ(PR)BF1G #L7:X<DFYT!N2.F@.H899!E(D$L,BL[D*A-MNS^=^8:?A04'DG
MCTW+XBXBSQZ;KS]E&+7MIM C"V%[&@JN \=3CLB3&CYOZJ'CX#'FXLB^\,S[
MHW-[!!9#?;^;J"*#?81''[8'CD0@72]R@(TZWZ]?Y;T'1YHY/RR;%@-YB58
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M5'G,@:/'@"JZ32J)'9^IB  N"A%[DW%VOKH$^'LM.SAPV)CH'>0$7"GT.SU
M/_=Z!'SL?$DDBGPLC]C*AW*FMU:VX$G76PH,F6V'C.V1L"B**V/$J64J0N@
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M@/PH+6@UW&\>QL?E\CERSME9.Z27:0(V+2R% 5^*#^[TH+LB0R./<$*@1L"
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MPN64L#^/7X4#%GPY)N['"D.3,"97L!<*/5A^%M:#B!DQ)CVL5DQLE#/+D7N
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MYF30*%TN]M!:@[8L&)'N;#,;EFW2R ACJ/B/C05^'.\,^6\F+(DD\OMB4"[
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MX:B_KI296(?0-94H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M>&;N9$D2+8V/5F(&EKVH-N[\KY&]Y#-DRZW8*2U@%_* !TMT%!+PL]<=YE5
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M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H//_NG_P!
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MO/\ WN\TF3QL^.N%(#!W@R)*#KH= VTKKZ7H)W&MB/FSY4^<\0C95AC_ /)
MD7( VC\-#K:@V3)Y/ S9&PEDBDFA&Z4,!< @] P/6U!$PL>7DX3A\A(4B@=6
MQTB8AKHV]'W #:5VC\#ZT%WCY<*-^[XXWC..HAQU?^?L2]M=>@ZF@UCAN0\D
M//Y?'9^-NPDN_P!19MJ_ *^H/X>E!O=K]=:"/DY<&&BOD.45CM6RLYO^"@FP
M]3099'$:,YZ+\P/Y306/#YKXV.L67-W6#M<K9@H8WMN4F^WII4%JG)B3M(J
MR2-M)&HN+= 2#8_.@M:@4"@ZM8 DD@+J2/EK08I<A(XFE_.$ ) ZV:@J<C)
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M "4.-&\)@ %M=RDL+VZ$W^5!8>48B<OPN3QS9TG'-E;5CS(?SAE.YNV+$L0
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M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!Y_\
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MX_C4$C!S.7RN0G$D&*O$(+1RJ7[I;X7)L?3T'\FH9^2P?WE!&F),D4D,JMN
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MF!!)!E#)"SR39<S*&B;:K;I=SL-![6Z].E!'Y+$S,&*9N9R8!/(J/+)!)),
MI#+M(>)=]DL/<=#K\*#:^&QY(^,QH<K%C@+1RN,@,H*QJQ,>YBQ.YEL3K0:]
MD<?EMEX.7%G\E!#D21RXD*%1&I0E6+E;,ZN#<[@PUT(H.W.1H<]TYGEL/&CR
MA')QD,F.5R%BA<N3'+$N\D$ZASKJ-%ZA<XR23X:110PXO),2L^5 Q",C %98
M.]=V8@W]WN_W7K03,5,+AL*27.SG?Z5&CFY;+R7D9X[W!W.WLO\ XJ^M!'.?
M)QP1U@>;C)ISD'E))%6,02PRR&RV:1@CJ"6 /MO\+T$!^6S89\<\'Q>/SARL
MB=N1EBS43]B26ADC-F5K*1=20;WMUO064G-')?!@P;129VXI)*5(7M_G5@I:
MQ%J":^7GXL^/!+@OF02BSYV.RML?</S1L$(6US<7Z6M>@G3-/V@^(L<KZ$)(
MQ56'_C -;]1H*F;R/BL0E,^?Z"91[H9_:>MM#T/Z#06F'EPYT"9$!/;?47M?
M^0F@E4'!-O33U/PH%!S0<$ @@BX/44'"JJ@*JA5'10+ 4%7RO)<?@?21\@Q"
MYDPCAT)4N!>S:]*"5F&-8B99"JFP" *;G\&!H*W!1W21;V53M>4"X91Z;K@@
M#Y4'NF0@3[%^,K&UU7R&8%CKN%LO4?#6IU>/)I)%B1Y'.U$!+'Y"JC4L/R'+
MYKDEXW&QVQL2)BT^0WJH%[[@1U^5!MDJP7[LD36U4-$A9Q<'13<$?KH*CB\K
MEYXY<:7 7'-_;EY)VD@&X(0EF%]=-Q_3UH)30&-@_P!=))DLU@J&P-OYVT6L
M!^-!59O%6:66*283+"?I63:Y?(<ZO,TMVL1<>TB@U2?!X_#,\O)RMQTZPP#L
M8ON#N'#AV<ANC=;$6%!JW$>1>28?)S\MF9&3/P/*9$H@RI1V]PM:RGW!C;3^
M_0>R<84R,6.8"-U**P[6A MU8:#</C01\S(Q(RY58YCCW[$0).T*!N5[@G3K
MU-!K>)R61F94(C(BD)4PR1ED6YD8[DNLEEVQJ+VOZ6H+[/EF[4<:"-\X/;WD
M.@+%0>JQ@Z>MK_W:"OR,'BQ(AR8XWY)@)&20%TC .A"$,H_5?YT$=.1:3-FX
M[$=,G(CC(,:*"JANITMT#7 M\:HUKS+G<Z2../$ S8X)VCR?I4)$4B&X9PY%
M[6TMU/RJ"%Q?ES1\EBX0:4+EA7EDVR*;DE2=OY>J_P#=TH-YG@63.OOED["A
MBP=@KW6YN 3<CI<BJ*WCN<R!D+@<BV+)&'9C"FZ1D",$"J6D.ON6]ST/3J*@
MA8<?&IFY<63"8NX6GQ^1[O[&*Q&DBKLU;=I^:]NHH-5\GSLEL:3&X*3OY )D
M1('$MU74C800JGT-M*HN/%N3Q.#QGFR\!L%\B57R\+&7>$DDL [@W.MO332U
M0>FS84$\PFC)CED.X."49571RC+_ (VG7K08AG9<C%E@D;'AO^W5D(=@;?SN
MV"!\B*##RF+Q_)?2C/Q$S3B/'.MXQOB<'<K*6N!>UB+T&9,\3GO97%MC-BI(
M\(F$;O=;#VE"^T&UOCTH(O&>2XG,QK#!?'S9U<1PGW;2H)U-A\/A00^/P/(N
MVC9_)#B%1VV8V.R9&ZY.A:6/IZBPH+Q,;D\4RR_7'D=VVT,J*E@.MBEA?]%!
MK_.XO+<EQLT_BF6.,YC'D"E3MVL?:74W!'3XC]5!+X+)\C+X^/S9Q9I#C[YW
MQM2K@A;D^U;$W^=QH+:T&VT&)2^YE9?:H&V4D78^N@ M09:#@"PL+_I-_P"[
M08I+FR&$2HQLPN+ ?$@_.@R$+[;@>T^V_H>FE!2<=^]XH,A.7>+)G:5C"L*W
M4Q7OT-OCZF@PD.^1)(TVJ_Y8J64+;U1M>GSH/=OM6S_T<^Z[,Q"?T=E95)8M
M_D<CW:B^OX5)6'V=6&B@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4'GOW5&[[?>2@=3#%;\>_':K'J2^'K+;9Z #2
M^M;9</OVMVQNDM[!\_2@Q0F9(5.25[M_?M/M%S\3;I01>6DC3"*%VD7) 1NS
MJRAR0?P-A08<;(P,6>+B./@E,<2 E]&5?_&/Q-!*R6$<,G=E6 3,R&<$W 8;
M4 &HO>@@XD,>*L$>,5,:I/'.<SWO* 0K,&7H?A:@[3G<5P.X9(4B+PIN 178
MVWDDZ]+6H,#3XACR(YVCQ<4L$:*/V@!5N9-]AJ2*#'G\QAX\4&Q%GC%R[EA=
M8456<B^MR&  ]=:"!GQXV1&TF!''*N3(&R(V4+NN#MV[0-+G7UH-?PI,3 ?(
M,F9M#@11XK,2H>^K>\C:3:U!IN1SV:G(9W*\<DBP\5%']3+92'::8]J,(3N9
MM-?@*H]'AY4\A%-/)&<94"A9Y3;N-?IUL1ZZ"H.S9<N/M=(BS,Y4=K4@/TZ_
M#XU17\IP.#%NY.>81''5LF3:Y(#+=B^TW%Q\OT5! CC/-8$,^5D&&!W,@6VT
M,@<[;F_Q%42.8QH/IF$QDGP$C5I'QW.X@6T4#\UQ0,LS?NUH^/4P+!$K(S,%
MN@6]KZD&WRH,?.39&7PT?T&;+C+.R30S0DV8,!:^W6QN#03,+R"/Q_ ,G)Y"
MS3[-TD(8;SK[;#XVJ"^XOS/B.3XJ;EQWL7'QW[<PF2S ]1TO>]!H_P#27&R>
M5D\D$LT\>/>'"P8E:[*-ZJS@BP(+ZZZT'IG'SY\\?=RDCQ8Y8AVI ;2A]>HZ
M:#6@B+Y([9O]%8\[+3D1$S)R#H+';J6U.NE!L.7R'*[%@Q@':4#NY+&P4*+:
M#77UH,V,K\7BQQASEL5L6=S(Q6^MR;7U^-!L.)/&N)CO'C,S.P1@@%P?4DF@
MM:#J=P(9=MP&%F!(]PM>P(U'I06,'(S0QM&3O&VT1/\ --0=WS+]D.20J$.1
M[6#&^HL1\J#O/G6@:")M&]M]"=MM;F^I-_A\:"NDFDE/N8VZA;D@?K)JC'0=
M22"!M)!]?U]:"!)R4*@[1N(<*0=.HO\ R4%-+E2.6D70R B2P-A?IJ3UM0>K
M\&5/V<\[V#:O[QQ-H/7_ "N+UJ3ZO'BTLJ0H9'-E'4U42871\9,A01&6M*W1
MK'X7Z:4'#PP2.)\.8NL<9[Z,PLH+>W0>M]*#I#B$YN5G8H6&,(H,-[EBWYKW
M'QH(F9+BQ+]27^F$; S!=5=NBK\C05V1)D/E8#/'&L3J[1L7W$]+KM_ T%Y$
M9>X1"_:DL\P9AN52H%]#H"= *"D&-BQ\E-- THQL]=S02L!KH3<>ESH/6@@1
MSI)-%*Z"7%BE!CFBD%UR&'\[=8;0:";EX\.=C2=J,.DB6C:([3&R@WD+>I'6
M@BX\$&!BE<:24Q KE@JPD1VD*^Z1B-YOMO0=\/*?DCW<:\J3E@\+$F,C:IVA
MAH 0;Z_.@I!R/C</*8O'8.#;*24QM.HW1I<DLES>UNN@M07'*M]+A1SM*,81
M$Y$D)VVW* 38?FZ7_*?EZT%?/DMG(K0&2/=+N[C("+ V-V#"VNX6-]*#O)QL
MT@>2,0A6]SMNVV8"P(4"W2@GP/E0(F//+#)&T>Z,W(M8:EGN;_JH(N'"))9\
MO*[C*@+,JL;%1<(I.E[?]VE!BBY.&7DY\3>(XSN[<B$JH6RBX(];T%=ESYN#
MR$447;Y+!G%I#+HUSH+$]?UT$K.BFPWB/9.)&[J\,J/N"L'&G06%OC>@QR?O
M1,K&R)\L/BNYE@((N&/0=-00P_2*#8OWE%#O59 T\B*X5[JH8Z$DD>OI0<2R
M39N(W[%9T5B)X3=+CX@@^E!8H(\3&!1=J@"P:PM?X_(4$H@.K(X1@?S #34#
M2Q)H(^0N.XAQY,@K)%)O6-2+C<!J3:^M!(E?<RQ*FY=@NS+[+^JFQ!-_QH.(
M9"[LA([J*>X1J+[03:]_0^M!RD':7>JD*QL"6)]2;"Y-A<F@[4'%Q>U]?A0<
MT ^FM_C0*#JI)W74K8D"_J/C0=B2>IO0*#U+EL//SOL7@Q<>=DX\B#MK_-59
M+_'UM4ZO'ET:--V7RXT2:!-IFZ%@!8&X_P %5$/E,'(R\"3'@E;'DG_R4ZFU
M['I?TO0<QAN*X>898GFDQL.4(<:,,QE9;==-#\:#IB-!@\-QG&XT0@ 3='$H
M+2%VU)8?&YUH*Z7+8OD31M+C=@1("44QRE3=S(S'2WP H(TDJSM^W<*F9JLJ
MWLTBOO[@!O>P%]1Z4$?(Q\6\F7'D$E3M_;@FZG\QUU-]1J*"5BPK"RS-""N/
M$6D6YOK_ (H)VD 6]+T&5.33(!>>.T; *!&Q##KM!M8Z_C057(YV/X_AG&B:
M3)?(D+--.ZG:2PLIW];DZ#]-!,@F*<7'+).LLL<9FW;;^UCKMVCXWL*"+@IC
MP<7EO-R,A.0XDD,B*JP]2J*MM!IZWH.IRUQLC'BX^%<B6>97DRFD:9Y8MK7!
M5?:K*0?A<[?T!L'$33Y,TCYBY&+*D4>[#F&U(VE6^I4D-M];=*"@R<H/)!SD
MLGT./N8/D9!VJ-I_,K$>W0&VE!$\=S^.YF;D,GC^1GRD,R/DY."R%1VR3N<;
M=6*@W*GIZ4&TY6-B9N*^*RNN#(&=IW)WY,D@1E?=<D@+[3Z _A0:_F8$1CS,
M;Z94D0XV0LJMO3=%;;$4+:Z]?[E!9R<MAR^20X?)9LELW%&7A8@@[:XX5@DA
M+_E(++>WPH+O(XV*"::>T>1R')/&DHR!OLBDJD<:6L%CNNXFY^=!K6;!Y5&T
MN7F+:."7LKBN4OVT+%9=VPG8-UAKT^=!TR(1D<?C\EG+&BR9"2X''F)721X]
MP"R!HW;;(=+]1^F@O#DQYJ]W(P3BQ1[)%7+16(8E'"[;D$*ZB^GRZ&@XXW"X
M^"#)X_ PDXQ,*>42)B^P%9MSK)&26]K*_M'I:U!28G!+QV?!D13)]%'W$FPI
MHTBE5C^5_82&W7ZDZ_"@D94F=G0XF%B-D<+D3$J.0F16*J8W96$5R&OLMJ=*
M";C\>O[7*Q.5FV95WL2&C5[D.5!%U#$7MZ&Y&AL TV;$XSF)!P WY63.7.=G
M9169TC1B2J7Z;A:Q  M0>@X.%C\=B086,NR''18XQ\E%A084RLF3/DB2 '#B
M_9RRDV<2[=_3_%L1^N@L&574JPW*>H-!STT&@%!S0*#K[5];;C_+08I\;'R>
MW]1"DW9<21;Q?:PZ$4$.>2.<,FYNW$&D>8"Y&UB+#]7ZJ".C+&ZH+W=0T*(-
MN\MZM_@H/<L^7M?8OQQ\F9;IY#*KR'07_P!* %3J\>2-'%DQO$WOCD!5@#UJ
MH@<7QHQ6E"(%+FR@:#:NMS08&YM3S4' !G![@EE5 #N &HN>GPH,',SY RLA
MH7=#D;"S%ORIJ"H8W]/6@Q<.\_T,TN%C(\N2/V,.2[;NI&XOIUM>@EQR,H=\
MK%5BH6+MLP<@>K$WOU.E!0\EBKE!HH4[4"I^S::[DL+LPT(&UBU@+]0*!B>+
M1Q8>*N9R.1R6+CP'Z+!G_P C"7778J]-3I>]!8Q6P2!W%QX(EVJK/8J4/L5=
M0!8#X4$7*Y#ZU=T#1Y$#%ED"?DVGJQ;_ !E/RH*/B,SC>*FF=&=P(WER+*0"
M'D9^ATN9'OI01\KR^";!R9N,QU@R,4WDR)>FU]-#>Y_"]!#CY=<7 DS<XR9T
MF3'^VR=WL"L-JJ@TM^;]%41/",>"5.1Y>!PB,S"(WNX(<[ETZ:'T_"@V&+BL
MS,XR/'EE[22GNKD0JIFD)?W;[!1?2W3_  5!L7&>/PX:/-W5F=E*J9HU9D4?
MS=W7IU%!6\MQV5^QR<;*@PX@K2E&4ET[8N-@.C7%]#;]-!6'@1R&QW,<L^3-
M) BPDHJ7LQE8J?S,+ZV)OI^(;)PV'P'&8L7%X<2[5D,8WC<Y8FXW.23?6_6@
MK<7@6XWELS)6=\?*S6?OYDNYX^VHW;&9FOM'4W%!:\IQV!A8&1FOFK@OC1I/
M^\"J$ )[_P F@(<7NM_72@\Y\>YZ#D/)>6DR^0R8UPL-7EB#$QN)2D:&.Q/Y
M6C8WM_.U^ #T?#QQC<>,9>Y)V)))TF<6WAY&-_;8$Z]*"TBRL6:00K(D^9AQ
M]QX1[74./;[;VUM:@PQ94'(38[1=T(T+&56 5"C^T!K@F]^EC05T''XV;%F9
MG'0IQ^:\BG&R(R0"40;691I8DF^FHZZT&>-,ANQD<PC19&(+;8&)@8[K!KZ'
M7X$4&P,S  JF^YZ @:?'6@\EG?FN%\LR,W(CRE\=Y21_J"BBT3*H(<[3TT(O
MZC6@WW!R,8Y$F5!,)L?.5'BD5@;V!"C:!ZW-!L%!UT)MU(U']R@[4"@4$>TK
M !T0LK!E;J+7]/6]J"'E9$21 &?MHZ^Z7^>PMH1\M:"&.U/%(=SOCPHO;46!
M8KU(ZT'M?VI,?]%/NQ(LI>7^C<V\;KA1V,BWII4E8?:U8:*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0>?\ W3_Z
M >1_^9B_X>.K'J2^&_:@NQ Z#<?7X:UMEW;W! +H4-]RFQ/XT%1R/UTLL.-C
MJJXTC+]7.W4*6MM%_4T%C+"^/&L&P(@4+('T*H1U'SM088D8, F/'BHC&Y75
MG7^:"?E01^3SN-Q(A^\)8PFX6C)%[^AM>@R9.:N^+&@[,CQPNO<NI6!)#N+:
M?SFO84%/FPCD\%8(PL+H;09#J0+VL%++^NU!SEQQP8RPY+_42R8XABVJ"-J+
M^TZ#X T&B\U-#G3P86(\8>!?J<2%MR2M(TB8\:H@0EV1)-Y!L  3?TH-JD:'
M#2+86V!5WE]07Z,P OUW51K7/\4DD4SP0PQ%RCJ[&Z+N.UG/P(!O00)/'^*.
M ,^'!:3.2,/')O/<W@BS':;$KZ:&@AXTV9)@=IH9'D@<$1-<G4L&51;I;X_.
M@V_%P981#.^43,4ME1]02?11Z 4%)POF$G*9L_#Y/%JCP%PDA*NC1D6;<";Z
M@Z:5!2^3\M-)R X3"P'F:""SI'81!96N$L-0=0>GK5&\\9@2X_$F.12_83:J
M[@1K_-)-C05^4F+C/QTDF2F(8T=I<5;L'14L5;T%O2]!WQ(GAXM)>-6\V64G
M6+)NJHKJ@L0+D64'0>M!5S<'PN?R61F2NF1*ZJN3 /> XL5(MTT%!L^)#BPP
MIB)"HPV8++$%LMM;D@_"]!<8''\'@8N9CX,*I$[=V5W4LNYK ?J(&E08^3=H
MXH9&GC^G0$EFT&T 7(] !;UH& ^!E9,?(JD0R-H1,F]_;\->E!:=G*3-RN0C
MS!/B/C;8L(D;5E0WN&Z $=:"JQN<Y'+TCXMU:'D&Q<BQ!!A N)5)MH:#=\;E
M8>/Q\B:8R2Q1 D1Q+O-QUL!K>@N8.4@R,9<A 0[BZ8[':Y)M86/XT%BK*ZJZ
MFZL 5/R-!VH."=1<ZG07]:"N&:OUYA+[8U78H^,A(_\ !03E?<SK<$H1T^?Q
MH.Q900"0"VB@^M!7Y3)+($#NLF.P(1--VZQ&O04%0<&=BRHI.WW(GZ;$7Z7%
M!D.%,@4I^9K61;D!OG<6H/4N#4K]F_.@00?WCB7!ZW$V->L]7CQY(7S63% #
M[_:JG0?&M(,D:1[-QW@E3'_-L-*# ,80+,V.NLQ+!3ZV%];>E!T3+6".^9(,
M&:0*$@<^Z16T)4#J*" S)EQY6*81/$V8N\$[=H2PWZ]109PF"#*@3NXN/*J[
M@RAR"1[4).I^0H*WDN33CHN5G+R*\09L2!@2L:;U12[$ $W)T'PH-:S.:XW)
MSLG"ER$?/AFCC@QW#QEBK6.W2P)MT-!98LD+YCQRQ#'3O-]/BA0" 1J-AZW]
M309(\N#DQD\3AY;)D8P9<[MMK[KH0- #;4$ Z4%CWOIXY8/IUEDB$4LG:9?:
M@"KL;75@O\E!'5H^,@F^G#]AU9MJ1VL&M:XO<F@TO,Y7!X1LC.PT#9<H AEW
M(&"L;DLM[J +ZVJBNXCD6\NDG@RYRJQ[G[UB%!4ZZVL;'X&H/4(\:+ [D21,
MYEU!V[DL?B .MQ?\*#5?+O*.,X^+#@;)$.;)(D@P39#(BFQ4L=!05N/@Y7.Y
M"Y,$Y^DF_:+&'("^Z[*UJH]%Q$QXUG@L 4&V:[ @BVMO@!>H-<CCP,/B<@=I
MIBCO&DT8WNQ87#+J/T&@Q86"#C8^)F2302.5?'69AO:Y_G!"UO[E!&9>8Y3Z
MGCIYDC,N.X@D0;]C6-B&(%CH.M!FXQ,C$@QL?G94ACAA9Y,QW"EBQ#B,K_-5
M;VO07TT$>884&P3Q#N0)'(&4QMT+@ZD'\*"7D2O@8)?:&E%A^S%[D#X>ITH(
MF#R@Y' .3/B/&T1?>MCH0=H*D];@DW]*#%#GSQ"7.GB9HIY>VD2@@W%@#9K=
M+6-!-&!#/D/GMW(99% ;6VB=-"*"U <O CDF%2.ZU[-;K\*#LN.B=V=54%V0
M3,O5B5-OU 6H,SQFP9"TB=-Y%@/E?I01G=8U+N;*.IH.P&[51<D7T^ UH.P(
M 8%02PT/PUH.*!0*#I[]][CMVZ>MZ#MK<:Z>HH/9G9D^RF&ZDAEY\D$?@_6I
MU>/(G:261)-I&\^Q2#8 'T/PO51.DA;$QYWF=!L!D,A.B'UL/B104QYK&S&A
M2/)#-):-K!NV!>PL0+:GTH-8SXLG+VSX.2_'9F*XF8,"5(31B+ZV:@YSUGF@
M6-.V_P"<K(39&9A=A^)/32@KXN.S9\%DSEF^HA!,<D9)U5O=:]M;:;:")A<[
MQG*K)C8<I#Q3F261R'/;#W0$=/>&T%!:<UR,,<;%9FFVJ-B+95#=-0?0T'D?
M)>:\OC0_L,18(VF)!37W+T+$@ 6N*HW^+'SN?X'A,G,C"SS1*F7-(0YNK69@
M%!N;7(/RJ#99<"!\3&2*3LX6-#O6UA%=3I=V(/4T'F/E?-<S+DCAH(&/%F*^
M7F8\;,6C/HK_ .,"OI>@U#C_ "F'Q#,B@S7GRLLI+)%BQL%]TL@202$@DLJ@
ME1Z-0>WS2\SR'%09>&^/P$?("/Z=9Y6DR3#*HVM)M1A&;:V%]:#OG\#Q4G%Y
M/&<BD^6G)3IA8T4MUCVY V1$IKJ2;:VH,V(W@7A\''<!OCXG&P,U&5L9PK=]
MG:-8YV4[B"";^@H,V#E\I'D/CY44\BY4YQ^-=R@C7#6[=\.BW(:Y]P%C:]!4
M<MP^?B<HV-QD^/@\CG9BIB221F9(B4ON(-R20+ECZT%WR4;?22_7=B7Z?'DQ
M<Z16N%9EWF: B[68]4:UATH(O&^7-G<)B9>*J<AR?&J>-S,[\HEFD4@3(C@;
MT37=9KW TZT';B,WD9^0[$44N=@QQ;.:R<A[L99&-U2YT10/A0;-+B2X6-*W
M%S O@AY$QG&\S#:2R"U];#VD>M! BY#%Y658<<._)QPPOF0Y0&^.&?W7="0-
M;6)^-J""/K#R$N+PC)%EXN7"O*8V;&Z)])VBY:%@&#L#?2XL*"/S\7$8V7QK
M9>1],)F?(Y"4'MQO$1TDZD^[04%OD<C#CS+)%@-,L<3,\T:CMQQ&$N)"U]%5
M22;#]%!!\;R<;.@R6Q$4P9&1--CPJ'VM$YT*A@/;UM^'RH-9Q_'N,Q/-LSD.
M.S.QR9P(@V$S%DV#V_D_ 6H-^AR!(61@5=&*-H=I8=;&@XQV5I<T 6*3 -^/
M:C/]PT$J@4"@4'5E5P587!]*#I*RQQL[*66,;B!UTU_DH*7&#9.,2DI,DAO+
MBZ* &;7I\J#$[N,ESBQV:("-BUFM;0$4'MOD7'G.^P?C.+%,"'\C9I92>H R
MBW2IU>/,,6-,:48 NV+#$'$X_G,/2YM51G62,S+CI,JS2J6[1-B /B:#6V\9
M=?*8N27+0YIC,<D2?Y.*,ZL[$^MKT%E/BR2/BKBE9<N)U:*";1"B@@Z_SC\J
M"!)),6E3'1CCQQA9(7C_ "R)^8V4Z >E!7\GR3X2XB/&DW?(,I) 0*Q %B!H
M?QH+N',Q,G CF +8SH(RZV8*"=H!9=/2]!3XO*.RR8D=X&Q([%'7JHL 5-_4
M:T%/Y)Q<F?A8T23128\'OF@.Y6.@L2RW/XT$3*XO(PN%Q(\#*&+!#NGR&"DO
M8ZZ ZD6^-45O[?+XO,XZ ;I(H5D0B^Y4D((M?H2 +:]:@IL7Q9LKC,>!%<0B
M1I,UG)#,+:1H1\"1<_&@MN;\?E'BF+Q&!,(@9#V59B\N@/MN0-2; 4%AX;Q/
M*^,\(-\>)/CR 3Y!7>\INZ[O8HU*J3?YT'H218^,WT\H8?62,[2V(C9F:YCW
M#1=/C;]=!IV9Y9Q7'^0\AB9YR8OHHT3$Q4CW]\LH9F6Q'0?&@MLG(PO(,!>5
M@C7(XU 6AF#V9E$=R""1:S7&M!DX[C<[*X>''QIOI)8X@B9F*=RP2OM<7D N
M[AM386H)6/A\6(&P<K&C&.VR19H@6M,-US=MIW$ #\ !0:MSW-XOU\N+CHV7
M(T5ID#MVMY]I1FL5!L.@-!SRGBTWDF,,N9D[D\&,,3C,:?>L2[+;V&ZY(O;I
M07F!XWQ7#RVA<0QY3R[CN[D[ (0L1-AH"Y>WSH-0SO,OHO(#P<$KOC<=&\_(
M2RV>-(5TO9;D@&P^-!L6?S7[GX_&S%XS]Y29B")<_&L#+NN4!.C#KI<4%E%G
MX&.<'CLN4PY.3$TN.$!97:$CVHRWN1K;XV-!+RH-P$6)%M@R3MR&0A+'KIJ"
M#K;\:#!!+)BLN-(TDL,,;!XW!:0JA(+$$#0GU]:"#QO/R-R,W'YD,F/VS:)I
M%"AEL"I!!/H:!SW*9,G#<M'!$^!D[9(\62;:PD"@$N K&P(W#4=:"'X)B/\
MNQ<R?)ARNXQ^F6(6[2@[2K#76X-!OM!C(LVXO921[3TOT_EH.X(-P#>VA^5!
MS0*#!*\5UBDN>Z;"P)%Q8V-NGQH*3(A4Y*&X,2 1,)-$:VA4:?(T'7*QDAC9
MXEV .?=?381[0+4'M/VEBV>'_=N2X/=\;G(('2T&0+7J2L/MRL-% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H/-O
MN_D?2?;?RG)V[NUCQ':-?_+Q_"K'J2^%B%S,2&;()A _:,+6T]+@ZUME,61/
MV:EE5G%T2^I'RO8T&";&EE8 931PDAGB4 $L/RG=\J#'EQSS9 *SJIF!$N]B
MS,/7:I_PT&%^8QXX<^66*:-L'^85_./E<C^2]!4YV!Q&7-NE_9S9Z),F3)MV
MH$86 #D:DFUK4'<X:PH_%8H,)$VR*#MB[2(QA):1F70!;Z7ZZ?&@I\Z#,668
MX>4!%#=DV.ZKLV!2+L=.ERVMS0:3C9<V5DRI-DO)'&RQE7#E0&D:TSEKKL8
M  7]/C0;4,-,7B\W+5Y%9?VD&5*QC6-WD5 KML.T#1M+^W\2 'E^#Y3GP\Y+
ME<G#-D0XL>WZF"2*=25"E>X%90D;*UP;7_50;A!YOQO(YL6&6_:Y*;X2NX(8
MO4L2/:1?YCYT%_E6QK9&-!)D'&5I&QX0S,P;8-% -_:";WTMZZVHJ<CG\7$R
M8HCA,D^="DT$4EDD,ANP20'\FVQ))_10=.,YB#R3 _>.//-AS<=(5RHX;R*=
M-UK$"Y('PH*B%T7/GBP,:4<CE/MQ\N<;%.NYS8*Q L#9K&@W'B^(CQ\,9$F1
M'/R';$.=R1MOD=%/YG.W0$6ZWTH*#%PL\8?-<@\N0<[)9AC1E6B950D"UR3T
MU&G^&@K.(QN,&1%R/*<C'ES.&CRL:0+O#M87++(VT6^5]=:#<(\ 31Q)@YCQ
M8!C5<>&*S>V][78$_P#=;\0[XF#!Q\C[G:;)S':7O.OO(T%KJ.@M;6@F%<Q&
M=\L_3XDK!,"X+[VL3>\=R+VZ-:H*CB\'F$R,[+Y3-9Q+(@AQX)&[ 501^0JM
MMU@;7.HJCE<?DLS(S,?E(UBP3"87A4FTA8G5=;K8=?6@S1<0F+$PPIGCG M%
M+(3( 0+"ZW&E!.7D>9Q,+&CDEP4*SJ,TR$B,P;B7VDJ#N*^AT^=!(_?D7&RP
M16!_>$@6( $KKT&Z_P Z#;<%B\&_M+$KDE54W_$_+6H*E>1XN3G3B%)HL^**
M\4Q%HI%W&^T@D$@D]10;,T^6('B@R#$2I5"?<%)]=IH)*<AE_3)%)(3*+%IE
M-B?E0=I\Z29(TU1E.LAD"C\MM;V&O06H,^%BS2[<Q2K.KFRR@V-A^:X^=!:X
MD0 EE[AE^H8DFUA8$C34_P!V@D&*[ EC900HL-+Z:'K0$@BC9F1 I8 -;UM0
M9 H ( L"2=/B3<T'"*44*6+6_G'K0;VSOB_9CS>2'',K_788BB&FXG(QE%C^
M)J=7CQ!#*I!VM'*HNRCJI]1^BJB-CXV1B94TLV;>:6_90V(1;>EKZ_*U!-PX
M,S _:9+F:69K01?S@NGN^()Z6M04BRKS_+S9K<6Z/Q^V/'4@D^PL2SBP'4V'
M_>H)#F>?=KC0K*5:3#[HOL72UP#Z@DT&#)P2<K#63#C2 !S$D#K())'4[;&X
MV]/04&'.P_WABXHRY(9H-\4J[3MFW [3'NZ7!Z#Y;C0:/%P_$-E?701"?DLN
M>T>+D7!BD<%BPOJ?4W)H-DPI7R,+'FR,=\9\=9%19%)?>6Z!U"]?]U:@TWR2
M2#A<F!H(^2<Y6)FC&Q\.9N[#*;2[NTZEA$\CW8;0?[E!GX:/G9<-9H(!GI(R
M))D3$>\J9W81OI[%D(!8B]!O4N&/I8A-N+,4N5;JUA;6X%OA?I\^M!JOEN+Q
M^'QV;E2HLAF!;LH^^0N1_-4ZDGII_<H-6\ Q&Y-LP)CMBXK1AXYI(V1F5F&E
MG-P;%NE_QZ4'JW?RL;$R#D1S%XD>18E"V*J#8*XLJ_$ F@^;_,N)SY1@>6\@
M6;CIF(1)=J. A(TNWK\@?D:#V#[894N;XO9HSBQPNXQ@%?=V[]07 W&]^E!L
M4TN-.^5@R)VSM1UCD= V5929%(N2=EMS ?&@J?H%S\5\7%@QL.)+]B''D;9)
M;1;MVP->AO06?$<(^+VVR'BP/IDV3!&<I(E_;KUT/KL_306.&JY9DR8,B-95
M=T/;82 @ K[MA'J+Z&@BY/#I(R8F9&>5Q9$82YDUUVH-65PTC'72UKWUO:VH
M=\'-XCM-#B9 D556",0J25# [44@7]-+T&1^TW#A<+);)$/L1V;<S%3J&-QJ
M/6@DXRM_H^0LI:%E?OD,@B U-]H+#KZ@T'$@R)<S$@$)CQUB[DMCH"/YHL1<
M@V]*"REGM$%:%BY!LBJ6O?H"0+?RT$3$.7%]1&R,+1K8D@J['W':2-/04'6*
M/,(R)8W/?)=AB2-W!<+<(NUAH=+:7H('$1\TO(\I-R,B_1S6.#%:UA=;V W6
M_P#<C>W\@7F7/@OV\3(DB,LRDC%;=?8OKK<6H,RG;^0VTL+? BW]R@4"@4"@
MX(N0;G2@'4$?&@]D=F3[*8>M[\^RFWP*2"VM_2IU>/)#DG'/T<D4D<V1M&-*
M5V@6#%MQ/Y?A<]:J,6=%!RN,<+D<LXN"2!*D?MW#YOZ"@HWP,/&XYX.*7)FQ
M907/;VO(Q(]KBY&B=>M!1YT+YL^%/).-F-$&>74M(P38J.1:UF!-O4&_2J+B
M/"$N+]-'*#L*F1+G:K"Q&TE;V/K4$8')>26+&59&4%&9UVV)(NHW%6(L"+Z4
M&C^->*Y/&-RF=DQPB3)96CAC#G<69MCA6T6RD+8$ZCX4%;RW-2\9+*^5##):
M>,8<)0LJ :EBJFYM?4"J*>+BH^9S/W]DYICXU9$+&!;JLQ-E9E9E(N3<WT%M
M?A4'L^5@RRX?9Q)$@QACN7=P5$CFQ%Q:RCVZFQT.@H*/-XG+GX.'CL9YLB N
M!RV7 KRRF#_*NXC*A6'NL+-?Y4''[NX7B\/$FBQ\C(';OQTTTAD624D;"5!M
M&+GT&FOPH*#E> P?(,7F.2BQAD<N,9F.7#LFA7.*1=R!)5LOL2, N+WWM87M
M0;P<?*XWQJ(1XT67!QD..DV(-WUT'<"G<QDV7==Q)!]*"'YCSG)^/>/MR63&
M#/FS(9,61X8LC"G1@PEB8J4*.HT!UO0:D^5P.-XYXWRO+>(\EY?S.$C97%YL
MTBQ1<FT^2Y,497?W-C-T*&X!&E!Z%E8&7A^/R9F'P67R> F'$#@&>*";'A$.
MTIC[W %F8JQ#;KW^%@%KBF>;#Q1FM^[L@X7<?CV59)%N T?[96%MBD?C\:"A
MGQX^5@QIDDPHX9Y,A<O9D]N0=8G/;MJ#H=Q-J"#F\/Q"QP1'$R\W&XH=G#B0
MIV<B5_V,:F%@K;]\9.AUW7]*"HQX/'?"^;<Q-R7 \E--#!RO'<KCR@J77>5B
MN3'M=EMN8^W36@N<[S#G,K)R.+X7Q#-Q9\\QX\/D9R$R(\4Y+6#NL"2 E5!-
M@;^HH)'CO$2^/SS(N0G*/#+-B^29@+-'*HBB:'(264*UG(( *^VVFI) 2H.:
M\<R^>S>(Q_(Y,+DN*DC9\91W#,DC;Q$) 65K*UC\=;4$E^1C?!R,ODL?!PHL
M5W;$R\NV\Q(]HV=;.%U/0D4%CQ\_<P^-EDR4&)GQV.6JAG L=K, !>Y T_+>
MPUH-4YH\U+@0?T5Y?CH<N'':.<YD)[@^ED82HFRZ64J5U&C6L=38+3!PA%V^
M10?6SSF5<C+EW!BN[]FZJ0Q0%0!8&Q^=!TS.)_>,LG<>;#CM^SDQV4!NC;F5
MP?=?Y4%#FYO->.\IQV/^TY?B^4?;)ELJ!XG%MYD(8$ *!9CH=;+I0;[0*!0*
M!0==H*LK>\-<$'X'TH(423Q=P1P(BEVV D#32Q]HZ$>G6@B*A.89>V>TCL(W
M2VVXZ[_A^-![?R\CM]BO'7PD#-_2&2UB+&PRKD>AO4ZO'DF+))D1H[X[X[M>
M\+6+"WX&JCC,@B?+X[("E),7<56P4SH=-1?H/QH.\,+2._= ::8 Y62WM0[B
M5"_@!_?H*;.R^WR Q.])%CPHLCYT8)4NQ),5S8@[1<:?W*##'*I7)R\20MA2
MR!3#*5+@LH-R =1<^M!W;&A>&7'F4946P29$"RK+&^FA) L"+=*#SS(R,U.6
MEQXH,6R/$(L(RNP:.9'W.J[0+QB, W.FX?.@P9V4,+-Q@F[<RGZEQ(ABVMJA
M(75;:6.V_P >FH6N)R4V2^%+DZX<H[9:&07NH_G*0FT&WSJC8^4@R.1EX]T@
M,>.ILDJ2!2&M^5M;$?(U!WQ\Z&;D3EP=EH>TL<NTJ)3MU.\J2E@5UU_OT%JT
M6/G1#(@8QK$0\8&TJ0#NN+$@AOB#01N0PTRL>%XV[2ENX) $47(MM]Q4]=;T
M''CV&V/!-A8[K/%A3CZEXI0QB!DW.C(NX*VT$VO\!\Z#,LXPERYL;N/)F9$K
MX^/+,"0T1*2.D<SA0!M&BM8FX!^ ?/[>/>9\UY3#GYZYN7QSQB2;+QPXC 0"
MZQM+8$FX-D<FQL-=*#VOA<YL<Y?!9G#8T'CO&)&^'S4<R2F:0KOE#PAV?37=
MNM;UM08N%Y++7R3R' 9N3.'QL(,$BXNW&E;)VR0 E2VT]JYL3KMZWH,G*\FF
M;#-_1Z"7-Y'C8S/],8)'(#@>]TN %&\[=Q#$]%/6@USCO&_J^:S<KE.&S.)X
M_B_])RN4E,L@?0FZQA&M<7/7]=!,\BX?(R$$?CZ'%@E^J;.YN-7R)"F-$2D5
M]R[%<'VD#5M+:T&#RJ<\AXT,CB>?R/)%X$(O*''C,,IG4)^P,<G[0C:2;F^U
M5/4F@UKP5<'(R<Y.)1N3Q4<9.=/&D<**A 4Q2OD->VYCN4"Y(%J#UD8VU7R%
M>+NDH)<0%$.UC[ VT.=0--*#3N7\=?FY^%Y-2),7C,A%FQX"B! 9?VTK7O=X
MTZJ+;K[2-:#:>1QFXC!C@PT"JTQ7#3:)!),UR4-[C4ZC:;_ 4$'#XOG9)L;D
M/WOV"0R9_&20+M]I(V^UA8CH=3\101,[B^6&1]0F1BSX[$JV*8V,FY+ ,H
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M2LL.+ H5LA6V[BNH-A8W7TH-JXOAL+B\)X<=0ZY!59F7HQ)V[M;Z^M!SE1Y
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MOVP^X?VCY>+@<WS7FL:.>3+P\?,)PLGC9\M4*9"2*K;E6Y O1(A\G>5_>O\
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M^.+M1^^(8A)0,D6T#WV (8FX(ZT5%R<Z;*CGR7B^EQ83&(XBUY!W!<AUM[K
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M'\/X[C,^#-FS<CD(]D<D<<#LP6$-W&9K!=MC[B%)F(U^;OV9^U7FW(_V8O\
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MC[6_VAOVJ^YWET3MX@N3XCSZ93H72/#XS+6'+,>T:O"T#2[>MROQ%"/'VO\
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MF(R6P(LOZ/*B;N'?(@#[=WM15!51<PT?[;>;?Q'_ ,(/\5'@'V%Y/[J+]R>
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M,>3D/ LLC79X@UR+#J;"PL!H?[M!8\7P17";EWGBN%#G +_M>RVXJUMP;0J
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MPQ&I %KF_6BTVC%_B+Y:-<7-CXS ,N-*\V4T:O$Q=A;3W'V^NVUJ(V;)^_\
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M+GY$_&]N;$Y!V2/'RFE(D4=BQN44VN20!?I03_'_ !N3BI<UR(<O/R0[03O
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MK'[O8[J]T_S/6@D4%?C\I@Y69F<?!,'R^/V_50V(*A[[3^FU!-9@ UQHHO\
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M*_ZR+AYLI..XP9F=/MR'"D*\LBMM[1!""UNFNIH.N7CS961B8'$\A)+D<?\
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M2=)$MO19E .YM0JWO<BW7I0;/A-')A2;8!W9E;M\@Y,BQ*@W#M]M;!K[A=E
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MU '7YT'K?VI-N&^[A)/9_HX[*S&^AAR#IZ6J2L/M2L-% H% H% H% H% H%
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M*Q&C,?6@L5DBQY53:BI,A;85#*H8V U-!BR,7$Y2'Z8[8I,>968^H8:"PO\
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M0^@HCZ*^P61RJ>028_&J%CR 1FY!4,47:=1I?H=;4'UCPLG-<!BS>.<YCPM
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MXFP%$:+S;$- %<C<&W(#Z:6THL*"BM\X3'5/HXF'YF#..NIUHR^U_LYAIQ6
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MUM8^AO06^+ES2/($PS/B1-N,:^C$V#EM>ER=*(M..GFCY.6>+'"B-!8N^Y%
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MS#+S3DRPI)*XGL65;'\UST T.NOZ:#R[S'SS*@6/$X<PXL6;$T<DV5L4(IW
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MJHN!KH*"+B:9N1AOB%9""LH(%B&TW?.U!8MQS+F1B(R)&-H+=%L!<D'76_\
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M4?L@ I5T8[Q\KA;_ #!^=44N9@</F\PN)S.*<J6>;M0,XN8RWY@^HTLEM?\
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M0F+P1PYZ"-))@I8 *;[5))Z=;@^M!7R.N/R<.']3C\5*%2>/+$3*',A*98U
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MV*9XHVX_*V!U25- =CC<IN+7M0=LJ+!@/'<K]6,3)R47"7'EWK]1+D?M%W[
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M)X_=&/VH97)M8G_PT5\\7;<5*$ #1M-?E\:@O.'D8R&$+H S7!.ITZC^Y0;
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MS3M"[[;-!8*OP'IUH.F&P5H<)X8A&\98!B=_K<;;4'?-G;",1!WI$@,U[%B
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M  O01)<:3)>)"L#QXVQ7:X=90#NW;0?:U@ 010=)<<8ZPRRQ]\J)FF2'<S*
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MBF">6>-H%29HF>>)MXV,FW\M@2#\K@T&3E_,IO',EL+(6+/.4!)Q6'$J"56
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ML5,R7'P',&9@Q2(4$@M995W$;AU -!/\>3-P\F6.?D9)P@TSI80&&0+!@P(
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M9&/@0X$N5(C;]_ME:61HV!=ET5D9KGX']-4;)'Y9Y-QV,G'R\F.5CE6:,94
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M6,E0/E5'V5_#^[/]@/N>'MN7R#%!4>FN'69]7C#51%RLR/"6.20$[G"BPO\
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M<M/BRQ?3-,W&3A"VQ#=@A&W3I0:YG9T'+<2_'\1LDQ,M&DQ'QUL\#0LI(0Z
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M^ 6@B8*1)Q\L6XP[W*QR2>P#^:R["!J"/32J*K&P%P'R<:;M.<E&>)8D+;"
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M!KW,X*8F/'A00+-'"W=CV.4FW7N.FAM04W%\9RG/<BLW,I&<+&._#0C;+'(
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MENV7_N7IIC)_U+?^TY_Z*FF'_4KK_P!'+^O^2IIA_P!2W_M.?^BIIA_U+?\
MM.?^BIIA_P!2W_M.?^BIIA_U+?\ M.?^BIIA_P!2W_M.?^BIICA/ZD]J[/Z.
M;+#;;M6MZ4TQPW]2?MW?T;ZC;?M=?2FF-A;^KG^CJ;OW1_1CZK]G?9]+]38]
M/3=:]-&NC^I+WV_HWU_:?Y+K;U_133&1/ZEKKL_HY?39;M?HM33&*3^I#<G=
M_HUNW#MW[5]WI:FF.'_J0UW_ -&OR&]^U^3U_133%>?^S[M:_P#13;8[O\CT
M]:NF,A_J"W)?^BV[:-G^1OMN;6_3>FF.P_J$MI_1>W_OFFF)(_J-V/M_HSV[
M_M+=FU[^M33$%/\ L_?5R[/Z*?6:=ZW9W]3:]-,1>5_[.?TN1^]_Z(_2=K_2
M>_V-G;]OYK^G2KIBFXG_ +*WU#_N7^@_U6U]_P!-]/OMIO\ R_RTTQN'_4;M
MA_Z,[>V>Q_D?R6]/E:IIC$O]0_<CV_T7[O\ Y+_(WZGI^F]73&>'^I#M#L?T
M;[5VV[>U:]S?^6]33&'+_J(WP_6?T8WV_8=SL]/E>FF.5_J*^BDV_P!&?H+-
MW;=K9;?[K_\ N5-,8<7^H/ZK*^C_ *+?5_\ T7VNSOO<_FM\[TTQE']1'TS[
M?Z+_ $MW[ENSMO<[KVIIC'#_ %"=K [']%^UL/[NV=FVW=KLMZ7JZ8[3?U#;
M<GO?T7V]R3ZO=V;=S<.YN^>ZUZFF,4/]0&T=C^BNS>-NWLVW[M+?.]73&N\G
M_P!EJ^1^]OZ$=/\ 2>_]-_C?SK_[JFF-GY/^H;Z*?][?T7^@[/\ I'?[.SM;
M?6_IMJ:8B\;_ -GOZ$_NK^BG[OV:]CL]O;<_#2U[U=,<9G_9YW<;]?\ T2W;
MA^Z^]V.MQ_D[_.FF+R3^IG=^T_H[NL.O:Z6TJ:8HY/\ L]?4\GW/Z)_5WB_>
MU^SOOVE[7<]?\G:U_2FF)O\ U#]^+_HM]3VQV?\ (;]E]-OK:FF)#_U(W3N?
MT:W7_9[NS>_RO33$'D_Z@NP/WK_1;Z?<MN]V=N[>NWK_ +K;^FFF)X_J2WOM
M_HWOTWV[5_E>FF.W_4M_[3G_ **FF'_4M_[3G_HJ:8?]2W_M.?\ HJ:8Z'^I
M+>M_Z-]S7;_DK_.FF.K_ -1^Y>Y_1K?==E^U>^MJ:8[R?U)[&[G]&]EO??M6
MM33$$_U!WU_HM?Y]FKIC:_\ JS_HQAW_ '-_1/ZIOH?\G])]3[]VS^;N_/\
MRU-,:P_]0^G<_HQ\K]GXG^_5TQ+_ .I3:/\ HWMMI_DK5-,8)/ZC.TO<_HSV
M?YE^UMZ4TQD7^I"R;?Z-VV?L[=K\FG3Y=*:8B)_4)<[/Z+;K:V[/2KIC"_\
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K_M+?^AIIC9^"_JN^AYS^CW[D_=_T;?T@^D[?;^DVON[^W39;=U^=33'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>tm2227887d1-lc_macro4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_macro4c.jpg
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M# P,# P,#/_  !$( VX'40,!$0 "$0$#$0'_Q #^  $  @(# 0$!
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M!\+21"47-O)S5&1%_]H # ,!  (1 Q$ /P#?X
M                                            "(+B_P!=3_[M/]XD
M>D>*"
M                                             /7H/^N*?_C2_6,2
M53$(H
M
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M?ELPS\+EE_=^G?PX4*OTC-6&W%)0C+5F+6LR2A":]3C,S/H1$1/A0JDP
M              1!<7^NI_\ =I_O$CTCQ00
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MEMJH+93$6I2C(DDET]Q]"U!:2L8"
M #UZ#_KBG_XTOUC$E4Q"*
M
M
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MEMU^FW7;M!NFC.F_2+EIT6JTIY1:&N-,92^RHR(STU0LC[0&M3_]Z'_\+_\
MU#!>#KX _P"8QR2_!RH_9U%$XK^JVFBO#2=S>Q#EQ-IU[,.7LA%5VVKJ*DXY
ML*GD10J;2I+DA3;C^B$(-Y332"5M(S/YYQ6A)*2]VRNSR?NJ?:/"BN3Z6^N-
M/J-KT.CM/-F9&3527$BR"U(R,M6''"_5%EYMWJ1W]AO'=*^+QLF_J?:]/BWL
MTJFU=Z[&XZ$U%YVH3S8=;=DD7>*;)#I$E!GM+:G0M2$X/43M;4^/ET3;TP?B
MBYZD^J54ZM:]-<J<I1F:G9*&$MO.*-74S4M)F8KS*800
M               !Z]!_UQ3_ /&E^L8DJF(10
M
M
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MOLU@2[<R8OFA;D:[H                 "(+B_UU/\ [M/]XD>D>*"
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M>V+(6AV7:EOT^FSWFR(D+DL1T)?6G3P*<)1D*\)$!
M             'KT'_7%/_QI?K&)*IB$4
M
M
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MUO6DK;?DLX1-?6V0#CM\  $!\H?Z!LB?Z'&^S6!+MS)B^:%N1KN@
M         (@N+_74_P#NT_WB1Z1XH(
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M$(H
M
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MK=JL6HQ)#S"4M-.$I:B6D]"^01A42,(H
M
M
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MK^<!*^ ',?XJJ^V!CYX>OR]Q^<!*^ ',?XJJ^V YX/R]Q^<!*^ ',?XJJ^V
MYX/R]R,\QY+K^1<:W395$P3EB+5:\RRS#D3[8<;CI4B0TZ9N+0ZXHBT0?8DQ
M)OA[LPW6S5L/&%M@
M
M
M
M
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MJ(1)I3;ZGV:C1)J2=IM6BN*0V9H?1T6@M3:66U1]2!9A/((
M                       A_.&<L?<?+%F7_D6I+ATMIU,6FTZ*@G9M0F+2
MI3<6(T:DDM:B29]5$E*2-2E)21F"Q%6K^1\:[>DB/+NFA<7*I-QY"?-MVXW:
MG))O:D]#[R2U3%QVEGI[7<K3QF"\K8=QHY18[Y06E+N&RSD4NL41;3%U6E/V
M^=P'74F;:MR#-+K3FU6QQ/;H9&25$:2),442N/XU&MTO(%Z6#0>,TZ[IEG5>
MI4QQ^GW&ZMUYJGRU13DFPU17C;2HR(]-QD1J(MQ@O*]['OQKV/JQ=,.V,L8N
MK6(BF/)8<K+DPJI&B+49D2I:%183[:.A:J2VLR\):$9@<K:ZR\S(9:D1W4/L
M/H2XP^VHE(6A1:I4E1:D9&1ZD9 \J!9EY_V5C/.EE8,M>VV<CU>NU6#2+NK,
M6KIB,4.5/F-Q4L&E,624AYLE&MQ!+1L\E!JW&HD%B%YKDN2A6?;]9NJYJFS1
MK>MZ&]4*S59!F34>,P@UN.*T(S/0B["(S/L(C,$:H:O\;'2DS*G5;2X]7-<V
M,Z1-1#GW^]/\S)LUGY.YA$*2RA2RZH0N2DSZ:[0>N5?6E\GL2U3 2N2":P]%
MQRS3US9IO-I\^8?;=\W5!6PA:B\X[\R:))*VJ49&2MADH$HH&CXV6(EYBO2^
M-USQL6R:@<&/?WI$E*7M]LE+!P4QC>(B,S:*8?9[8%Y6U6QKVMK(]HV_?5G5
M)%7MFYX;<ZCU!!&G>TOP*2HB4E25$:5),M4J(R/J0/+*P$!8MS6[EK(&5:/;
M-":7CG&,]NW$WZ<@U^E:^VDG)\>*RE&WN8B5)0I9K/<HRVEMZ@M%>>+O/*G<
MC<H7+BZ;CA6/ZE2*=*J5%G+J_I%%21"E)C/H2@X438HM^\M#7J1+[-H$Q1?.
MK52!0Z74JU59*8=,H\5Z;49:_:M,1T&XZM7L)2DS,$4HX@<U&N6%8R#3&,;+
ML1BR&(,AB4[5BJ*YB)SCZ4[FRAQB:-),D?12]=>WIJ99BCS)/-.[;SN:Z*)Q
MNXYU[/%%LR:[3*]>_IB+;])5,8(S=:AORF7RD::%IIM,R,C))I4DU"B9>/G)
M>W<\G=="<MFKX[R18$A$:^,<U]!(FPE.Z]VXA1$GO6E;3+=M2?C21*2:A,4>
MYBG,[M[WKE3&%TT-NU,A8LJB$2:4V^I]FHT2:DG:;5HKBD-F:'T=%H+4VEEM
M4?4@)A/((
M
M
M                   "DEG\DLMW#RXN_!%3PQ)I&.*#'E+@W\MJ42S*.RVX
MU+<>,CC+9DK5M;2G11;DZF9DH@6FQ=L$
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MI*C3G654Q"DHZ'LDR5.:GV&A&NJ2Z%;#@0
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M-V\D2)F*KV;+=I*C3G6E4Q*DH[=DF2I>I]AH1VD701N;#@0
M
M
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M..XNKU3J.22K\EELS[Q%.HZXKTI>A)/3Z&:C(S_8GT/0]*L-D B
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M&JS_ +JQ_= 'YT/'7X:K/^ZL?W0!^=#QU^&JS_NK']T ?G0\=?AJL_[JQ_=
M'YT/'7X:K/\ NK']T ?G0\=?AJL_[JQ_= 'YT/'7X:K/^ZL?W0!^=#QU^&JS
M_NK']T ?G0\=?AJL_P"ZL?W0!^=#QU^&JS_NK']T ?G0\=?AJL_[JQ_= 'YT
M/'7X:K/^ZL?W0!^=#QU^&JS_ +JQ_= 'YT/'7X:K/^ZL?W0!^=#QU^&JS_NK
M']T ?G0\=?AJL_[JQ_= 'YT/'7X:K/\ NK']T ?G0\=?AJL_[JQ_= ,_LK)>
M/LCM5!^PKQI-WLTE;:*FY2I3<DF%/$HVR<-LSVFHD'IKX@&<
M
M                                                  "EEI<Q&+JY
M877Q>_)E4Z<NVF92T7PY*W)=5$8;?4MV#YNGNF'"7HV[WRMQFCR2W]"TV+I@
M@                  /%N5-15;M?31XS,VK*ITHJ7#D?X%V0;*NZ;<U^=4K
M0C]@!_/MQ;Q[>\/-N%V*985XOWK0GKR9S30;QI"HUH4)BHJ4<<J&X;6QHGSZ
M+[K74NGL"/2TO&'@SE_"^>;;R[<<*R*C1:PFN'5K/C/2ULV:<N0;S'H+O-R5
MJ=3T69D6FY1:EVG4933L')MKF5F2A8]L0[3LVM8+E4FBSH4-;%..I37$DI)2
M-NQ3IK4:E:J-7A$55SC=CJZ<@WGQ-Q#<6+;CH\?CM0KQIN:)E<IST.F.M5.7
M*)N/'E*T*04EM]/M#^>5XM0-S;A87%K#^,+?O2W['I-2HI7["*G5ZN*JDR74
M_-6VC9898ERW7EM(80HR;2GHGM%2K7IRWX@V5@S!%W9.LC).3UW+;LBF>CTU
M*Z9$B-_G-0CL+WM$A&[R'#TZB%6W>V%K<MJWG'%&MQRF1%+6H]3,S909F9^R
M*DO< ?#(E$:5$2DJ+123ZD9& @RH\8>.57JKM;J>#+%G51]SO9,IZ@P5=ZOM
M-3B3:VK,_#N(]?" FF# @TN'&IU,A,4ZGPVR:B08K:666FT]"0VV@B2DB\!$
M0"*:GQXP!6ZE4*S6<&8^J]8J\EV;5:K-MFE2),J3(6;CS[[SD92W%N+4:E*4
M9F9F9F>H+5DEI8JQ?8#KLBQ,;VM93[^O?O4&CPJ:M>XB(]RHK+9GJ1%V@C.U
MH2XE2%I):%D:5H46I&1]#(R,!"#7&;CPQ7_6AK"-DMU\I!RRJ)42%N*09F??
M$GNMI+U/=NTUU\KMZ@)P(B21)21)2DM$I+H1$0"%ZGQQP#6;D=N^K88LRI7,
M^_YU)K$FBPW'G9&NO?.FIHR6O4M=RB,]>NH"9FVT-(0TTA+;;:22VVDB)*4D
M6A$1%T(B(!UJA AU6!.I=1C(F4^I1W8L^(X6J'67D&AQ"B\)*29D8"GG$N@7
M/AQZ_P#C;<4&>]0<>U%VL8DNQUEU46H6Q6'W'VX_G)D:#?AOJ6AQ)JU\I)I+
M;U%%KK:M&U++@/4JSK8I-ITN1)=FR*;1H3$!A<E[3O7U-1T(2:UZ%N49:GIU
M,0<-N619=G.5AZT;1HMK.W#+5/K[M'@1H*ITM1F:I$HX[:#=<,U'JM>I]>T!
M]I-E6;0:W7;EH=I4:C7'=*D+N:OP8$>/-J*FM>[.9(:0EQ\T[CT[Q1Z:@/1K
M="HES4F?0;CH\&X*'5&C8J=%J4=N7$DM'U-#S#R5(6D].Q1&0#DI%'I%OTN!
M0Z!2X=$HM*81%I='I[#<:+&8;+:AIEEI*4(0DBT)*2(B 4VQI9U:RGR>OKD5
M=-*ETNU\>PW<?84IU087'=?0VI1U6M):<0A24/N.+:969>6V9G[4DBB[0@
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MNEVOCV&[C["E.J#"X[KZ&U*.JUI+3B$*2A]QQ;3*S+RVS,_:DD47:$
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M
M
M!$6<<R4+ F.ZIDVY[?KUPV]1'H[568MYB/(E,-R7"92^M$F3%3W:7%)2HR7J
M6XCTTU,BQ%6NQCXW/!!7+.6YBN]&:&N*@H]P--4M53>=+35IV(<Q"$MIU/11
M25'V>06O0O*V;XSOR'E"P;5R%3:)5K=IEX0&ZG2Z57&F69Z(KVIL..MQWI#:
M>];VN)T</R5)UT/4B/+.0                         !1SXQO]$3)?^D4
M3[[1!)6%Q+5_DO;?\5P_\@@4E[X(
M                 .C4:93:Q"D4VKT^-5:=*3ME0)C2'V'$ZZZ+;<)25%J7
MA(!^:72*50X+-,HM,B4>FQBTCT^$RW'8;+Q);;)*2_4(!W7&VWFUM.H2ZTZD
MT.-K(E)4E1:&1D?0R,@'BN6O;+M&.W7;=ICMOJ(TJH2XC*H9D9[C+S<T=WU,
M]?:@/0I]-IU(A1Z;28$>F4Z(G9%@1&D,LM)[=J&VR2E)>P1 .Z U]U+_ )EM
MM_\ !:1]\UB+P;!!4
M   !A^0_Y 7S^#]3^Q7!8)03PH_1<Q%_%TO[X2@D6F$
M                            !2CC1_3OS*_#"D_8T@477$
M
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M/4%HS:W+PM2\(J9MK7'3K@C&DE&Y DMO[2/3VZ4*,TGU[%$1@C)
M        %'/C&_T1,E_Z11/OM$$E87$M7^2]M_Q7#_R"!27O@@
M                                               U]U+_ )EMM_\
M!:1]\UB+P;!!4                                              !
MA^0_Y 7S^#]3^Q7!8)03PH_1<Q%_%TO[X2@D6F$
M                        !2CC1_3OS*_#"D_8T@477$
M
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MJM)C2\D9 L2V;M)I$:35X3:ZG!0>I1IJ/(E,=3,_H;J5)+7KH",Z
M       !JS^,KNS,[&);XM:!B>+.Q!(30W*GE$ZU%;?CO^D8ZC;*F*5WZR)P
MDHU)/AU\ DK#9;:O\E[;_BN'_D$"DO?!
M                             !K[J7_,MMO_ (+2/OFL1>#8(*@
M                                         ,/R'_("^?P?J?V*X+!*
M">%'Z+F(OXNE_?"4$BTP@  #%;TO2V\?6Y4;KNRI(I=%IB2-]]1&I2UJ/1#;
M:$ZJ6M9]"21?V %%W.7&9[^ES',)85<J]!A.&WZ5J4>5,-?BW^:N1VFE&7SG
M>+/V0'I4#F1==JUV%;^?\82K'*<9$BO0V)+3:"Z$:_-9'>*<;(SU4IMU1EX$
MJ,!?2GU"#5H$.J4R6S/IU191)@SF%DXT\RZDE(6A:=2,E$9&1D [@   , A9
M0L6H9'K.)(=<[[(5OTAFO5>W_-I2>YI\A:6VWO.5-%'5N4LBVI<-1>$@'>O^
M_K2Q=9];OV^JMZ#M.W&FWJS5>X?D]RAUU#*#[F*VZZK5;B2\E!]OB 0ODKF)
MQRQ!4J#2,B9%]7JC<U#BW)0X_HBKR^_IDU;K;$C=$A/)1O4RLMBS)9:=4EJ0
M+1'/_B.\,?AD_P#\>N+_ '8!RRDV]N7?'C'5KX]O.\LA>A[:RK!>J5A5+T35
MI'G\5A+"W'.ZCPW7&=$RFCT>2@_*Z%T/048W:?.SB7>M4C4:AYII2)\MPFHR
M*K%J%';6M7M4D]4HL9O4SZ%Y74^G:!25M2,E$2DF1D9:D9=AD"/H
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M24-I=<)I#IIU4>JNT^H[/4^G8M/@BZV-M8BKC]-ZCEU&>;;IV4F:-MP^>?0
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M1F9$DM")K=/&GRSCB:TI]T2:+43GQ1DF*5K]\PG(:K:
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M)DO_ $BB??:()*PN):O\E[;_ (KA_P"00*2]\$
M          8G>]W4>Q[:J-QUPE+@0TDDX[9$I;RW#VH;22C(M5&>G48LV:W%
M9-UVZ&[T_09==GMP8HK==-(_&5![*S=:U'OZI7!4+"@PZ55WHOF_FI)4[328
M;-OO&=Q$1FK=N7V=>P<#!U'';EFZ;*1-/0_5.I_0VMG0Q9;GF^ZVLS$UI=6D
MTW\*;*^QL>C2&I<=B5'63C$EM+K+A=BD+(E),ODD8^CB:OQ^8F)I+F%0
M               !K[J7_,MMO_@M(^^:Q%X-@@J
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MK5HDC,]"[ D;#[5_DO;?\5P_\@@4E[X(
M    KCRCDTMO%[\6?-*-+E3XQTJ.1;EO.MF:E)VZEY)(UU/P=/8'-ZK-OD36
M>RC['Z#MRSU;'..VM(GF[K9BDS[5"K.QQ=]\U)NG4.C27$EW2I<];:D1X[;W
M5#CCBB(B)1$9IZZJ(N@^>P:/)FNI$>E^R=6^JM#T_'===?%UT5B+8VS-T</1
MQ;;:#2T4.AT:BMK-QNCP8\)MPSU-28[26R,S]G:/L;+>6(CL?S=ER>9?==VS
M,^MZP],8                   #7W4O^9;;?_!:1]\UB+P;!!4
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MI2YEI/R'7V4Q)=-?CI4O35;;-;C[V%+[5$T6F[4]3[3[F36:#43S9+9KZ?\
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M8LBU+5*C(Q)6&S*U?Y+VW_%</_((%)>^"
M    Z\N7'@1)4Z8\F/$AM+?E/K/1*&VTFI:E&?81$1F8DS2*RMMLW3$1OEKX
M=])<ELMK;0IV-95"+4E=G=0D*(C/7]\?5V>(O[DS'SVW7Y_[EOV]K]<CE^D^
ME5_^ZS?[/Z+8_P!I:ZU,2KM*M'5X5ZU=U#WFZ9]/4B,EF0W$;-IAM9);+1*$
MGH6W0=G'IN2[FYI]G#=P?FVIZG&?'Y<XK(I68F)OK$S29G;?-:TXQ*81LN6
M                 #B=?9CI);[R&4&9));BB26I]A:GX3 <H#7W4O\ F6VW
M_P %I'WS6(O!L$%0                                 43R?9M=R9GQ
M%OLVS+M1NG1B7"R=!2Z2E)1#)Y"G5D9-J+O?H22(R4G7Y)"*DNQN-D>CW-!O
M&_+NG7_7:0M#E'\[-?<L.-GJAPR6M:E&D]#(M=",M>HI5:$$         &'Y
M#_D!?/X/U/[%<%@E!/"C]%S$7\72_OA*"1:80
M                      %*.-']._,K\,*3]C2!1=<0
M                                                    5IY8X3K^
M?\0S,=VW5J?1JG)JD&<B=4^])@D15J4I)]RAQ6IZ].@W>GZJW39>>Z*Q3@TN
MH:6[48N2V:35T.(6";BX[XID6#<]8IU;J3U>F59,REF\;!-2&F&TH/OFVU;B
M-H]>F@]=1U=NIR\]L3$4IM3IVENTV+DNF)FM=BTHT&\
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M.D9?.MEY)?+\(Z&DTT8,<6\>+Y/K_6<G5=7=GNW;K8[+>'Z>]*0VG%
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M-=>K]%@8BE4^5*>@3:>:9"*@;AH[N:PPL_)61ZD1E[(#:T*@
M                   "/LDMW'4K5K5"L:MQ:3>LV-NI!NNI0YM)9=X:.TTZ
MIU(E:'H8+#L8VI]W4JR*!3[[J**K=<9IQ-6G(5O)9FZLVR->A;C2V:4F>G4R
M!&<@           P_(?\@+Y_!^I_8K@L$H)X4?HN8B_BZ7]\)02+3"
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MK+#LMNG,H-7<1FFUK-Y]?1*$J-&U):FHS,NFFIEDC%=-LW\(>>:*T9H,;T
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M+%.=KT)+$=:UFE*$FLG#4G<I1%J:-I>%1#S=HKHMFZ)B:=BQEBM)V++C390
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M#]3^Q7!8)03PH_1<Q%_%TO[X2@D6F$
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M9C6FP*GZ.IS+<5^:@DQX<A2&'9$V2Z7E&VT3IMD@BZK,NWVJNA9I\<8HOO\
MMW,,WW<U(?:IE#,EI>KV*W#HU[9NN>0](3*C-FBF4ZF:FEMU_:E@U*T;6YU2
MG1/:1GH2EN'%?6_;%D>N9)ONC9Q?;@OK..%)5N5[)E8H5ZV/69S--K3U/C'%
MD4YQTC5WC>B&R6DDI49&HCUTT,D&9&%F+%FK%D3$Q[2;KK-^Y(U<R)<E)Y$6
M9C@G8YVI=-O/S>[4T1O>>,%,6HDN$>I$28Z3ZEIU&&W%;.&;^,3^#U-TQ?$(
MUO?D%7X&?+9QS;:H_JNU5J71;JEJ8)Y2YM0=ZM(=(_(VH,D^/<2_$,V/2Q.&
M;YWTF8>;LD\U(2'>^1[F<S#8^*+&>8:>>:55K\J#S)/%'IZ=%);1KT2M:4F1
M&?A6WXS&+'AM\J;[O"/%ZNNGFB(>9C7+E>N:L9SK-7>CKLC'<Q]B@(9:2A:V
MXGG"WEK=Z[O(929?W0N;!%L61&^4MOF:]D(KQWD3DUE^V&JC:AV_0V8,EY-0
MN2IL[$S%DI.D:*REM[HVGJI2B+51Z;BVC/EQ8,-U+JSW/%MU]T;&7Q<F9:R[
M<E:HV'I5)H5HVDX4*J9 J<?OCGS$=%E%9^B()"O;)+0S).BE+3N2D8YPX\-L
M3DK,SP>N:ZZ?A95C+)%^Q\BUG#V544^7<4.GE5:!<M,0;3,Z+J1&2VS(B)1:
MGV)27DJ+0]"4?C-ALY(R6;MU%MNFO++&Y.3LJY6O2X[9PJY2:#;%FR/-:Q?%
M4;.04F21FDVXZ-CB#3N2K3R3U21*W)U(C]QAQXK8NR5F9X)S7732U%"JMD*^
M^0N*\?9&A04UG&,Z54YU3IVXHLU)--S6)24&1&G7N6TD6GMC[$]2+-RV68;K
M[-UW]CQ69OB)X-A;O>]TYW&TWMI]R2]=N[3R=VG737MT'*;+7?C&F9=N[/\
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MFZ9K,NT*\@                       -?=2_YEMM_\%I'WS6(O!L$%0
M                           $!9(R;;#%ZT3"UPVY-JT>_P"(AF7+;/:R
MAN6MQE):=%*T-&JC2?DEU!82G9EEV[8%"8MRV(1P:6PXMU+2EJ<4IQP]5*4M
M1F9F>@(RH            !A^0_Y 7S^#]3^Q7!8)03PH_1<Q%_%TO[X2@D6F
M$    %8KUY>X0LFINTAZX)%Q3XRC1+10V/.VFE$>AI-\U-M*,O"2%JT\(#*L
M:<C<396E%2[8N+N*ZI)K1;]3:5$E+(NI]T2M6W3+M,FUJ,B+4RT 3F     P
MZ^<@V/C*@/W3D"ZJ9:%OQU$VNJ520AAM3BB,TM-[CU<6HB/1""-1^ @$)V#S
M-XPY.N)FT[,R]2I]PRGBC0:;,9F4Q4IXSVI;C+J$>.A]2CZ))M2C5X-06DK.
M@B,+*S/B_(MS7I9ME7C#N"YL>2CA7E26$NI<A/DZZPI)J<0A*]'&5I,VS41&
M74^I:BCN9-ROCW#=N(N[)=RLVI;KDQJGHJ;[3[R#DO)6MMO;';=7JHFU'KII
MT H@6/SUXB27D,-YNI"5N'HE3L6H-(Z%KU6Y%2DOU3!:2L_;%TVW>M!IUT6A
M78-RV[5VS=IM:IKZ),9Y)&:5;'&S-)FE1&E1=I&1D>AD"/>
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M77MZ+;<01ZGM69=B2&UK+(NMC+''>QXII,VRN2.>S
M          #^>_A,X<;$R$J/_.(5TU9$I7A-:7TJ/7]0QU]#MQ3$/S?ZHGEU
MUL]S8PE6]*5D?11:D?R>HR3LV,5LUMK("OI]GZ@D;8F$MC=XJY\+DN/G\8R]
M'7M:?N:>W&,NI)<*)4C,_P!TD<:_YI?HVC_DV>$+!X_D-IHUI/-_X)=.B$7R
M%,I(>6PF05  Z=IEJ1=I /=XO&1X3ME1%HE=2N%39?VJJ[4#3_8,@64_@@
M                 "CGQC?Z(F2_](HGWVB"2L+B6K_)>V_XKA_Y! I+WP0
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MXMM!)01D:C4LBZD7:9$(*Z?G_P"'/YM7G]9T_P#WB"5/S_\ #G\VKS^LZ?\
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M8BLJJ([F3"H<C0F5&R9J4VE2$H0DC/RMF].J5$I1;FP@'D
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MAF?ZA )1P%0GK<PWCRF2/^T*I+<Y\M#(R74%*F*)1&1'J1O=?9!92^"
M            #X9D1&9GH1=3,P'BT&Y;<NF*[.MFOTVXH+#ZXS\RF2F9;2'F
M]-[:ELJ6DE)U+4C/4!3?XQO]$3)?^D43[[1!)6%Q+5_DO;?\5P_\@@4E[X(
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M#J" F%T@0                      %*.-']._,K\,*3]C2!1=<0
M
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MBE>:S:W;<B#!1W-1CNJ[V0I:B1J23(M2[02C<):O\E[;_BN'_D$"DO?!
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M54L2S*G*14)TB>X<ARH&V9I7(4HTEH@NA=!%;8A4
M        1;DO)]CX_;I%+O.9(C(O!3T*+YNRMTR;(D(><6:?:I1WJ==-3Z]"
M,"''BK$5KXF@56);,J?,:K;Z),AZ>ZAQ1;$F2$H[MMLB(B/PD9^R E8
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MMTW>SV@/1 =5$&"W+=GMPV$3GT['IJ6TDZM)::)4LBW&7DET,_ 0#M
M                  I1QH_IWYE?AA2?L:0*+KB
M
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MC4,HWQ3UTRXJ[&3$MJVY&U3U%I6I*[IW;T*0^HB6[H?D]$> R%58H$
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MUT[3\)CH:331I\<6QOX^+Y/K_6<G5M7=GOW;K8_9MX1[Y[THC:<4
M                   !K[J7_,MMO_@M(^^:Q%X-@@J
M          'T(S[?8 5ML&YJ=G:H7$U?.+&Z<>/JFVFANU1!OGWCBG"6GZ*T
MC:M'<I-:2U+JG4NA:EW+) @               ##\A_R OG\'ZG]BN"P2@GA
M1^BYB+^+I?WPE!(M,(
M   "E'&C^G?F5^&%)^QI HNN(
M
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M=,Y[]\[OQ?9_6W5\>''9TK2_R\=.;OF.'HWSW^"ZP[;\U
M  &G?(&8^4\^]L[U+'_*_&EJXZQ3=[U!JT.O6Z^VY15O/K;BPY$F1 )+ZRV[
M=[2EI,_GA'JBWO'"W^8T"XIE6Y Y5L^_;'J%()5 B6[340WBEN+;6V^IQ++9
MJ0;6[IKX2%25RP0       !K[J7_ #+;;_X+2/OFL1>#8(*@
M              (:S*WF)RF44L//Q6*@4W_UR<@HQJ-C0MNWSI*D;=WMM/*\
M7A!82W"\Z*%$*>:#G=RWYX;?M.]VEOV^QNUT!':   ! .<<[TS#\.#':I_IJ
MXZLE:X$ U[&FVT:$IQY1:JTU,B(B+KXR!4?88Y3L9$N-FTKEH;5#JM2W%1I4
M1:EL.K21J-I9.'N2HR(S(R,R/LZ +?@@         P_(?\@+Y_!^I_8K@L$H
M)X4?HN8B_BZ7]\)02+3"
M      I1QH_IWYE?AA2?L:0*+KB
M
M               #6[=/\I;A_C.7_EE"CP0     !]$G<L;T<Y7U]29>G7_U
MG1/OM$^:-O1Q7+#@_4EW_0S'>Z-3+_V^QV?B75?L0=+6S2R'R'TM$7ZZ*Q&Z
M?9$)3(<-^F   QZHD9W3CW3P5EW7ZQDB2.Q7NF5%$?;ZJLGI_P"G/! ]D4
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M\ZI)*T,O&"*.U+_F6VW_ ,%I'WS6(O!L$%0
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M5^&%)^QI HNN(
M
M *NU6Q+:DU2HR78*E.R)3SCJN]66JEK-1GIKXS ='\GUK?4"OIKGS0#\GUK?
M4"OIKGS0#\GUK?4"OIKGS0#\GUK?4"OIKGS0#\GUK?4"OIKGS0'S\GUK=?\
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MIZ-D9Z>2WJ9%^J?A&[H]-&GQQ;QXOF?J+K>3JVKNS7?+NMCLMX>GM2T-MP@
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M\'ZG]BN"P2@GA1^BYB+^+I?WPE!(M,(
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MJNT\6S;3;=3:M:-!O@
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M5M0DB+52C,S/M,SU,$9$ U]U+_F6VW_P6D??-8B\&P05
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MI.[RMWD[O3]7;GYZVQ%W+.V-E8:/4-+=@Y*73-O-&R=M);GQ\T^E
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M1Z=5:@-E8(        U]U+_F6VW_ ,%I'WS6(O!L$%0
M     '$\\S':6](=0PRV6KCKBB2E)>R9Z$0"$+>HN64Y<KE>J=S,3L7RXR_0
MM,:<2I)&HD]T24$6I&@]=RM>OZQ4Z @ Z\N7%@19$Z=(;B0XC:G94IU1(0VA
M!:J4I1]"(B :Y\I93NO/]T(Q?BQEX[;[S_/9J#4@I:4'HM]]1%Y$=!GT(_;=
M/&1 JXV(\0V]B6@)IM.2B=6)6BZU7EMDEV0X1>U3VFEM/SJ=?9[01+0
M         P_(?\@+Y_!^I_8K@L$H)X4?HN8B_BZ7]\)02+3"
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M=M2C*;,HL=U;B]RR)/0NFNH2-OEJ_P E[;_BN'_D$"DO?!
M     =&IU"+2:?,J4QU+,:$TMYU:U$DM$$9Z:GTU/L(29B(K+U;;-TQ$169:
M>+QNZK7Q<$ZXJRILYDQ9F2&T$E*$$?DH+0B,]I=-3ZCXO4:F_-=-TOZ8Z+].
MZ;IN"W';;6[969XSO^_<O#Q&33SLVO.,P"9J2:ELF5 RZO-FV1MI(_[3KT]D
M=_HU/)FD;:OR3_V/.3_4Z775MY(I'[/;ZYBJV@ZSX
M               :^ZE_S+;;_P""TC[YK$7@V""H
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MPY%A0XC:68L1B[9[;33:"T2A"$J(DI(BT(B(#F6VL"R*1CBSZ)9-"DU"92:
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M<21F7EH+4")2<               "E'&C^G?F5^&%)^QI HNN(
M J5D/%%[7!RUX_97I=.:>LFP:/7X=S5%4AE#C+L^#,88)+"E$XO<MY)&:4GI
MX1T,.HLMTN3',_%,Q3T3#GYM/?=JL>2(^&(FOIB5K(T*'#[WS.(S%[Y6][N6
MTHWJ\:MI%J?R1H3,SO;\1$;G(\PS):6Q(90^PZ6CC+B24E1>(TGJ1B1-%F*O
MD>-'B,HCQ&&XL=O7NV&DDA"=3,ST2DB(M3/469JD11R+0AU"VW$)<;<2:7&U
M$1I4DRT,C(^TC$5^6FFF&D,L-(99:226FFTDE*4EV$1%T(@'(     ZDB!!E
MN,O2H3$EV,>L=UUM*U-GJ1ZI-1&9=2+L%B9A)B)=L15 \JV%R!Y$9"I6-+WL
M*EV7Q[M2Z_3=7NA-38ER;F@P'5'"BE$;<4XR3R%%WB7$$1'Y6XC2E"NMI\N#
M38YOMNF<DQ2E/EF=[DY\6?4Y(LNMB,<36M?FIN7[(B21$1$1$6A$781#DNLZ
M;U-ITF0U+D0([\MC;W$IQI"G$;3W)VK,C,M#/4M#%BZ82;8G:[HB@#J,0(,9
MYZ3&A,1Y$DS.0^VVE"W#,]3-:B(C/4^O469F4B(AVQ%=1V!!D2&9;\)AZ5'T
M[B2XVE3B-#U+:HR,RZ]>@M92D2[8BN%B-'BH-N,PW';4HUJ0TDD$:E=3/1)%
MU/PBS-4B*.810!UI<*'/;2S.B,S&DJ):6GVTN))1$9$9$HC+70S%B9C<DQ$[
MW.E*4)2A"20A!$24D6A$1=A$0BN.1&CRVS9E,-R63,C-IU)+3JD]2/11&70Q
M8FB3%7(I*5I4A:26A9&2DF6I&1]I&0BN")"AP&U,P8C,-I2C6IIAM+:349$1
MF9)(BUT(A9F9WI$1&YSK0AU"VW$)<;<2:7&U$1I4DRT,C(^TC$5Q1HL:&TF/
M$CM16$F9I990E"",SU/1*2(NIBS-4B*;G.(H
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MJC#Q-,AQZ!7GF'WY#**@:DR4&QT)"C4:=#+7H(K;**@
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MSW74HU'H6;K2DU.8ZAB'#>J#<5;SKFI(;:\X[LEJ49:$2=3UT+M,M125B00
M      !TWJC3XTN%3Y$Z/'GU+O/1T)QU"'I'<IWN]TV9DI>Q)ZJVD>A=H#N
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MX[;;KHV7;F''GLR776VSMMWL_&%F
M  !@&-,HV+F"UVKSQU7/6*VGY#T1JI>;2HFKS!D3B>ZEM,N>29]NW0_ ,V?!
M?ANY;XI/V[&'!GLS6\UDUC[=K/QA9@
M  !#,Q/^=R>O_6N?WP#K[?9 -OL@&WV0#;[(!M]D!%>=4_\ R(YCZ_\ UCW#
M][9 +&]KAXN?T XS_BQ7V0\/FM;_ #I?N7TK_P!LP^$_?*?AJOH44<34Z\U.
M4O7_ .MFUC__ $6./I='_)A^(?6/_=<OC;_N0VE$GH74;<OFH?=OLB!M]D V
M^R ;?9 -OL@&WV0#;[(!M]D V^R ;?9 2;:_2D,_W:_UP&0@
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M8OV;>,=\^Z*0LFA"&T);;03;:")*$)+0B(NPB(NP=-\:_0
M                      #7W4O^9;;?_!:1]\UB+P;!!4
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MMS$]O(H]';3*J$C1=8KCC9)?E.Z>'M-*$_.HUT+Y)F9D2B
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M[3$4VF ;3 -I@&TP#:8!M, VF ;3 -I@)*MG_5+7]VO]<!D
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M-.I\5.V/$802$)+V"+^R8[-ML6Q2-D/SO)DNR73=?,S,[YG>] 5X
M                              !K[J7_ #+;;_X+2/OFL1>#8(*@
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M3V_B>W44>DEYW4).CE9K3B2)V2[XNG8A/8E/@^3J8(E,
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M5U+;:2(DI23<4B(B+L(AO=:_G1^['O:71OY,_O3[E_AR'6
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M:PX+,-M+(H_-NH]4U/4,LY<]\W73ZH[HC=$>#-1F:
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M 'TB\8#[M( VD _.G7V #3K[ #];2 9_;G2F(_QB_P!<$>Z
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M-H,6#;$5GME\/UKZIUO59F,MU+/V;=EOZ?2FH;KYP
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M/"C]%S$7\72_OA*"1:80
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M+<)T^E^5?*:Y(&LFDL4RWZ0Y4$$9M>>1V&TNM$KLU2;:M2U\&H^LT-E,40_
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MF?4B29GUU]@!R+?9;6VVX\AMQX]&4*41&H_$DC[?U ')J1&23,B4?87A/3M
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M+F(OXNE_?"4$BTP@
M *4<:/Z=^97X84G[&D"BZX@
M
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M;_EAPJXH8X/VLJJ)_P#GZ3_^9#_1\'?ZUC_V'U;]JW_+#@7Q,Q\KVM2JJ/\
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M>C5G*%8I]4CP:+*.3'0<=I]MTB-1FI)%O3IJ9B"W@
M
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MO,JU_46!5@=3X;XCG=8;]=HQD6A%%F-N),_&9267C^49 (\J/!ZFGWJZ3?\
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MT@C+                     &ONI?\ ,MMO_@M(^^:Q%X-@@J
M
M
M
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M2@>->25YNE5OU5N5-,DVU%MQN6JF.DGSQJHR'E*,_ WL<(]PBTV++BO(
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M'WS6(O!L$%0
M
M
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M" MY3JE3ZO#9J%+FL5&#(3N8EQW$N-J(_$I)F0([H   /A$1&9D1$:NT_'H
M^@                    .C4X)5.FU"FG(>AE4(SL8Y<96QYKO4&C>VKKM4
MG74C\!@-56+,1,X;^,*I5NL7U==_)GXEF3SJEVS_ $A*:-=0-'<M.;$;6RVZ
MDG3M,Q%;8Q4
M
M
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MLD>XO9\06]I58I5<A,U&BU*+5J?(22F)L1U#S2B/J6BT&9 CT0
M              &ONI?\RVV_^"TC[YK$7@V""H
M
M
M
M    "K'%C^@'''^AROLV0,=^]N8?DA8$>&0                       !7
M[E/_ $ Y'_T.+]FQQ[LWL>;Y)65I?_9E?XP_UB&1IO2             4<^,
M;_1$R7_I%$^^T025A<2U?Y+VW_%</_((%)>^"
M      "'\A8,QUDE#KM;HJ8M77U;KT ^XE$KQJ-/DN%["R,%JJ'5<(YNP?->
MN'%=P/5VCH4:WH<8M7^[3UTD0G"4VX1EX4:G_<]# 9_8/,6D/:TG)U'?M^JQ
M]4.5.(TI;!K1T-+K)GWC:OD$HOD ,UHO,#%%8K4>D*8K=);E.DRS5YT9A,4C
M,]"-9MR'%I(S\)H^3H M,A:'$)<;42T+(E(61ZD9'U(R,$?H
M        !K[J7_,MMO\ X+2/OFL1>#8(*@
M
M
M
M*L<6/Z <<?Z'*^S9 QW[VYA^2%@1X9        $5YFRG!PU8-2OVI4E^M1*:
M_&873XSB6W%')>2T1DI9&70U:F-;5ZCR+.:E78Z%T>_JVKMTUET6S=$S6=VR
M*L>P5GFWLYVE6+KIM/=MUNA5!R#4H$UYM:VTH9;>)Y2TZ))"B6>AG^Q,>-)K
M(U%LW4I3O]K:^HOIS-T;46X;YB_FMK$Q$[=LQ3QV>U%^&^8ML9FR"W85&M&I
M4MQZ/+DL5:2^TIM3<4MW^#21*(UE\H:VFZGYV2+.6E>_]#K]=^AL_2-)^9R9
M+9VQ%(B:[>_N2%G?D;96!Z= <K)*KE?JCR4PK5A/-IEFQH9KDN;M20VG30C5
M[8ST3KHK3/K-=;IZ1ON[/?\ ;\7,^G/I;4];OF,?PV6QMOF)Y:_L]\_=Q3Q
MEIGP84Y"#;3-8;?2V?4TDXDE$1G[&HW++N:V)[7SF2SDNFWLFCMCT\
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MCYWP]8F7(M#<MN/?$!<YJANOE)7')+[C.U3R4-DO_!ZZ[2[0$P
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M)3;QMFWKMH_?>B;FIL6J4SSALVG>XEM)>;[Q!]4JVJ+4O "*-5+_ )EMM_\
M!:1]\UB+P;!!4 &%WED2S,?>K?KC7F*%ZW5AB@6YWY+/SJI24K6U'1L2KRE)
M;49:Z%T 9H PNZ\AV98\^T:9==>8HTZ^ZLW0K2CO$LU3:B\6J([>U)^4?LZ$
M S0
M
M
M                       !5CBQ_0#CC_0Y7V;(&._>W,/R0L"/#(
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M"I_X=F+?A=S+^-Z_M8"I_P"'9BWX7<R_C>O[6 J?^'9BWX7<R_C>O[6 J?\
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M(ALC-?QA=]Y)RWC&E0,(M5O#SE';N*0_#K:6'55EE]YGN%%4#-6THZB5J1>
M!+W?_&7?O.!?K:N_;X!W_P 9=^\X%^MJ[]O@'?\ QEW[S@7ZVKOV^ =_\9=^
M\X%^MJ[]O@'?_&7?O.!?K:N_;X!W_P 9=^\X%^MJ[]O@'?\ QEW[S@7ZVKOV
M^ =_\9=^\X%^MJ[]O@.I/J?QE-.@S:@^Q@8V(+#DAXDQJZ9[&DFM6A>?]NA
M(UPKF+XPW.6.:%DNUH&$(M%KRY2(L>=#KB'TG$D.1E[DIJ"BZJ;,RT/L 2KW
M_P 9=^\X%^MJ[]O@'?\ QEW[S@7ZVKOV^ =_\9=^\X%^MJ[]O@'?_&7?O.!?
MK:N_;X!W_P 9=^\X%^MJ[]O@/1HSWQC)U>EE7F<&E1#EL^F#AQZV4CS7>7?=
MR:YQIW[-=NI::@+U @
M
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M_P#0#D?_ $.+]FQQ[LWL>;Y)6:@?X-S_ !A_K$,C3=T
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MJ9H7_P X6 IY\7,A;?$;&R5I-"BDUK5*BT/_ %K*\!@LKQ @
M
M
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MA6T,H/4INA52K(>BW!1V7#=:CSX;JF)"6EJ(C-!J3N3KU(C(CU/J*BP
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M8MR+#PK5;L9H%RE*BPI$*'3)7HRGRZBK_-6)<MACS9A;ZE:EN47]L9 +6 @
M
M
M                                                \UM)F1:%U,A8
M27+W:M.SJ _.U6NFG45'Z)M7A(10FU>$@'Z[LS[2T]D!^31H>TNI^ !])M7A
M(!^5),M.@!W:_$*AL474RZ" :3/J1=/&"OA-GUTU5\D!])I1'KU/V# ?>[5K
MV= 'PTGNTT ?K8?B ?";5X2 .[5KV= 'PTGNTT ?K8?B ?N,6A.EXEE_>)$5
MV0                     !%.<\9HS)B#(F+ES$T[UWHDFF-3UD:DLNNIU;
M6HD]3)*R(ST 4%PUQAY1VA<LS*-W3;#5D/&^*XF-,+TV%)F.T^6N V33<^IK
M4PA325I06J4)4>JC[-.L6J?N2V$<J9XQ)ARWB?H$2^K4ONV+MO4S?>:IYII:
M7CFIAK[E:U&:G"[LE)+4NTR 72%0         4\Y>8&O3.L+#T>S9-+C+L._
MZ/<]:.ION,DJ' E,O.I9[MIW<X:6ST(]"]D%A<,$         $,<B<?US*N#
M\G8ZMMV*S7KPH4BFTIV<M34=+SNFTW5H0M1)Z=I),"%*;\XHYTIM/XPWSBF;
M:DO*>#K%EV/7J-6Y,EJG2X]3IYPGW8\AME2C-I2U+3N06O\ 8$6JV/%'"4SC
MW@VS\9U6HQZO7Z<4B;<E0A[RC.3YKRGWB8WDE6Q!J)"3,B,]-="UT%18P
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M9+O;N<0VE*C_ %3(5Y>B
M
M
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M"EMI6IL]S9J(C-)^,M>P!QKBQG'VI+D=I<E@C)F0I"36@E=I)49:EK[ #G
M
M
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M[FIF\S:.JVT3[K,LD'T2HXZ";,R[13@V'@@
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M5MY'5&<R=AJ\JG9MZ28C266I2XCRRCRDM(T2CO6RUT21%TUT("5N 0
M
M
M
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MD,5-3RWSCQS.(:"8W+,M%)4O3Y\"K'*W\7G:T[(-_9&MO/>5L>57(]1])W%
MMJIT^)%4Z222DB)5/6LR21=-RC$H5=FQ./\ >;/+&V+WKSE;JEAX!QT5I6/>
MEQR6'ZC<%4JSCSLZ6X;1),^Z:=[HU&A&IETU ; 14
M                         :%:%PNY56%9>!)UN630ZY>>)LJ7'>S]"EU=
MEF,[&F^:G$)3R3^?-I6XD]2$>EZ%8NS7RMMJL6=RMLAC#M)H4R#4K0G8_N-U
MR3-?-,A$E$A9:FE"$]V9%X=3\0)N>#RKXH7==>$N/F)\0H=K[.*+\HU5F2JW
M/3YR=,@LRDN.N/NZ=XO<\GIVF*(WY(\:.13>8\T7I@RAT2ZZ%R8Q_P"H-XJJ
M4XH+M"-:$L.S$I41]\1MZF1$9=IZ]A:P3[DOCM5Z=P&KG'N@O'5:_;]@II\-
M4=*C.7+@I3)6AI/:?>K0I*2\.I"B$,*V)<N7\D<#^1-N08DC'N.,5S[;NV0M
M]LGXE4*GO0";2PKRC,G2T/0O)\(A*GV2L*WUQJI6/\CW;4K>MF[;;Y!5^\+
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M6*G*M%Y232B3 ICCT=$EO7VR7349D9>(4EL4!
M
M
M            8>JJW,2C(J*G0CZ=I_V=PJ/GI:YO>5/RE>Z /2US>\J?E*]T
M >EKF]Y4_*5[H ]+7-[RI^4KW0!Z6N;WE3\I7N@#TM<WO*GY2O= 'I:YO>5/
MRE>Z /2US>\J?E*]T >EKF]Y4_*5[H ]+7-[RI^4KW0!Z6N;WE3\I7N@#TM<
MWO*GY2O= 'I:YO>5/RE>Z /2US>\J?E*]T >EKF]Y4_*5[H ]+7-[RI^4KW0
M!Z6N;WE3\I7N@#TM<WO*GY2O= 'I:YO>5/RE>Z /2US>\J?E*]T >EKF]Y4_
M*5[H ]+7-[RI^4KW0!Z6N;WE3\I7N@#TM<WO*GY2O= 'I:YO>5/RE>Z /2US
M>\J?E*]T >EKF]Y4_*5[H ]+7-[RI^4KW0!Z6N;WE3\I7N@#TM<WO*GY2O=
M'I:YO>5/RE>Z /2US>\J?E*]T >EKF]Y4_*5[H ]+7-[RI^4KW0!Z6N;WE3\
MI7N@#TM<WO*GY2O= 'I:YO>5/RE>Z /2US^\J/E*]T >EKG]Y4?*5[H ]+7/
M[RH^4KW0!Z6N?WE1\I7N@#TM<_O*CY2O= 'I:Y_>5'RE>Z /2US^\J/E*]T
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M%I$!)HA4R$QW+#23,U&2&T&22U,S/H0*]7TO<WO*G]JKW0(>E[F]Y4_M5>Z
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M>\J?E*]T >EKF]Y4_*5[H ]+7-[RI^4KW0!Z6N;WE3\I7N@#TM<WO*GY2O=
M'I:YO>5/RE>Z /2US>\J?E*]T >EKF]Y4_*5[H ]+7-[RI^4KW0!Z6N;WE3\
MI7N@#TM<WO*GY2O= 'I:YO>5/RE>Z /2US>\J?E*]T >EKF]Y4_*5[H ]+7-
M[RI^4KW0!Z6N;WE3\I7N@#TM<WO*GY2O= 'I:YO>5/RE>Z /2US>\J?E*]T
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M[H ]+7-[RI^4KW0#)8#LI^(T[-8*-(5KWC)'KIU/3Q]I"*[@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M"A4]:J+]4+^EK^8%"IZU47ZH7]+7\P*%3UJHOU0OZ6OY@4*GK51?JA?TM?S
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MN*E2GVX[+ZE.NGM0DT*+4_DF0E![@
M
M
M                                                         "(+
MB_UU/_NT_P!XD>D>*"
M                                                          /7
MH/\ KBG_ .-+]8Q)5,0B@
M
M
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MQ3_\:7ZQB2J8A%
M
M                                                       %6.+'
M] ../]#E?9L@8[][<P_)"P(\,@                       "OW*?\ H!R/
M_H<7[-CCW9O8\WR2M.,C3                 $07%_KJ?\ W:?[Q(](\4$
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M53$(H
M
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M:M<.H^-  !7[E/\ T Y'_P!#B_9L<>[-['F^25IQD:8
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MP%$6I*;*2T?>DKM[I2?"1BE:0VT$1$1$1:$70B('@
M              >O0?\ 7%/_ ,:7ZQB2J8A%
M
M
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M4U<7[HRQ3Q_A[/MVROT.R_-@  5^Y3_T Y'_ -#B_9L<>[-['F^25IQD:8
M               B"XO]=3_[M/\ >)'I'B@@
M               "/\=8SM;%M+K%)M5F0ABOUJ;<%8?EO&^\_4)YI-]U2S(O
M;;"Z>#0%2 "                     "#\/X LC"=1R#5K3E5:=/R55BJ]P
MR*L^T^I+B5O.(:94VRR9-H5(<,MYK5UZJ,%F4X @
M             ]>@_P"N*?\ XTOUC$E4Q"*
M
M
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M?_<^Y"I0]2X'U4_^Y]R%2AZEP/JI_P#<^Y"I0]2X'U4_^Y]R%2AZEP/JI_\
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MN0\M;"MR4JVZ'\G0@J490(H
M
M
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MEJU"JB4(J-.73Z:@G4(6EPBW(9)1>4DCZ&$4A)ONF*3*UH/(
M
M
M
M
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MV9T%YU6Y9,KDG%C3HRW$(4IM6FSQDHRV ;);!\V\MH%I<1V^1^.HC56>NJ#
M3:$6:6YJ/-J+A,K3+2A1:G$43A+2D]#6C;KH>H/,1M:YIMQ?&(V]@J#RZEYU
MB2[;DM1*R_9CC<93A4Z9(1':=5"*"F(25[T*-"%$HD*U+11&0/6S<V-4;E]
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MHY]9MU&BJ?7[?S)Y"E,D9FLF=34>FTB'!<@$
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MZM^3Z.?6;=1HJGU^W\R>0I3)&9K)G4U'IM(AP7(!
M
M
M                                                   4JM#ATU:O
M+&[.4!Y-J=25<K,I#=DN1=I-+F,ML*;=F^<*[UAHD:M-=RG;HCRC[ORBUV+J
M@@                              -#OQI"VBY+<?TUO7U:11X2I?>[C8
MV'67?.^A%^]DC=IUTT]@'NUOB!X8O0+NLNX)=:I=KW-1JU.MZ:_$N&FTN9'D
M/09B'5)?:E-,K4IIPG-Q*2LB/=KKU :3N'7_ #,N2?\ &>0O_LB;![G<O=\9
M/YE^9QE/SK9W_G%O^C=_;W_IR#KL]GNM_P"IJ#S;O4FL"][)LSXJIC\K-NKN
MNW[DJ]5H5GVZU)5%=DS'JK)DQUM2%)7W)QWF'G]4I46C9EH9F9 ]<5::K@CF
M.SP]I%W5J]"J''AB%$N5.*D55TJBFC.O)DLR%-G$-KN2)27TH[]6S4E]UN(R
M(5BJR/)"_K(R!\6AC>IXKMYZT;4IES4JB3[44YYRNGNP$2T/MO2--726]M=)
MU1$I>]*E$2E&D"-["L7X8Y65[B/3\Z6IR6KMCTZR:#/G6+B:C.R84)ZDT-QX
MWSD.QI+31OO*9=6DG&'=WDDM9$O1L5BK9AP2Y"USD9@N-<MW*:=O6UJH_;MT
MS64(93,>8:9?:F$RV1)0;K3Z=Q)(D[TKVDE.B2/,Q1[7.NZ9EG<2LVUB XMJ
M1(HK-'[QOVQ-UJ;'I;NG4M/(E*Z@1O2-QJH4*VN/6$:-3T$B/%L>A+49%MWN
MOP6GGG#+4]#<<6I1^R8$M,5E6[4HG#,\YVQ'-V\..F=YUWTY2"U6Y -RGLSX
MY]OT->K3CG]JV>O0'KBO[RUN:G9NI?&W ]K2W95+Y+5ZG5^MNL*VJ59M):;J
MTM9[3,DFM)M+09GH9H474$ABW$EEF/S.YS1X[2&&&*A0VV&&TDE"$)\Y)*4I
M+0B(B+0B("=R>N95!H=&XJ\AY%(H\*ER*W1'YU9D1([;*Y<E;C1*>D*0DC<6
M9%IN5J>@)&]F7$3]%[ GX#T?[%0!.]6CFY)1:6<>#^1HBSC5*!D55NS'FT^6
MY3JRN(Q)0:B/4R2UWA$G^W5V:]2PV1 \@
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M(]973T0TV24EJ9F9].I]3Z@L;EL/C6%2D\6FRC[^Z7>5(*=L(S+NNZE&6\_
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MJMV8\VGRW*=65Q&)*#41ZF26N\(D_P!NKLUZEALB!Y
M
M
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M)72-$ISC1P%K(O X_%4WIX34GP:BJV*"(
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M$
M
M
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MC(]#(Y;.I'^W%>7KLO,R6D/QW4/L.EN:>;42D*+QDHM2,!R@
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MY>Q.]?73IULBPX@
M
M
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MSE(/:XDCT-)EXRT$H569X6N./<5,$NNN*=<7:D0UN+,U*,_*ZF9]125G@0
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MUP8MJL"F&=KMRTQG%26GG'#-4N0\I>G=IT,B3X>A@+7
M
M                                   UZ\E><,O&=^'A/"=A)ROF!F.W
M)N!N1(.-2*$VZ2%MG-=3H:UJ0LC-!+0224DS7J>T8LF6W'%9;N@Z?FUN3R\5
MM90XSR7YVNQ$/O4[!$&6X@UE!<A7*YL,^Q"W6ZB:3,O":2,O$-+_ %*RNY]9
M'T)K)MK6*]CI4WXP+D/CU]Q6=..4*XK?;\N1=>-ICBTQVD:FXXJ%,<D*46G4
MMSS>GA&>S6X[^+C:WZ9UVEVWV33MC:V#X1Y(8;Y#4=RK8LO*+778C:7*M0G-
M6*E!)9[2\YB.:+26I:;BU29]BC&U$U<"8F-DIS%0   !K0L#@E3;1YKW;G X
MC!8YC1_6.R*66PR;N.JJ=1*;[K7HB(9./(\DB(W6=AZMJT+S;&R\$    <,B
M1'B1WY<M]N+%BMJ=DR75$AMMM!&I2UJ49$DDD6IF?8 KO5N1=+F2%0,86K/R
M6\AQ33U<8<13Z&TM)Z*2JHOI4;AE_P"8:<^7T!:/%5?V=I*E+3ZAT9'SL546
MIU,_U7BE0>S_ !8#]-9RO*SW([N4+9IDBV5N;)][6RZ^3<!)]"=F4Z4E;B&M
M?;+;><V^$M %H8\AB4PS*C/(D1I+:78[[:B4A:%D2DJ2HNAD9'J1D".4
M           $!\JOT9>07_#NY?O8^ QKA3^BC@?\$XGZZ@65H00
M                        4<R+>=-BYUM5EVQJ'+>I7I:,Z3M1IB//U22C
M):>D&X9=TMO89I2[Y1ZGM[#$>HW+OLJWM-+VDG>A)[4F2B+4NPC+H8KRY
M          '%W#&PF^Y1L(]Q(VEIKX] #N6>][_ND=_MV]]M+?M\6[MT <H#
M\&A!K2X:$FM):)69%J1'XC ?DF62=-\FD$^HMIO;2WF7BW=N@#E 5EYF?HKY
MW_!&=_>D"PS+CC^C_A/\!Z#]@,@2F@$
M                &'Y#_D!?/X/U/[%<%@E!/"C]%S$7\72_OA*"1:80
M                                         %*.-']._,K\,*3]C2!1
M=<0
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M",[^](%AF7'']'_"?X#T'[ 9 E- (
M              ,/R'_("^?P?J?V*X+!*">%'Z+F(OXNE_?"4$BTP@
M                                       *4<:/Z=^97X84G[&D"BZX
M@
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M%%,U&GZ)'?6EUW1)$KR"/M\8+"SO' S/C]A,S+0_4>@]/_0&0)32"
M                                      ##\A_R OG\'ZG]BN"P2@GA
M1^BYB+^+I?WPE!(M,(    .A4*K2Z2TEZJ5*+365GM0[*>0RDS\1&LR(!SQ9
MD2<PB5!E,S(SI:MR&%I<0HCZZDI)F1@.P
M           *4<:/Z=^97X84G[&D"BZX@
M
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M5:EK\C0%7$MZW*':=)C4.W:8Q2:5$(^XAL)VI(SZJ49]JE&?:9]3!'M@
M                *R\S/T5\[_@C._O2!89EQQ_1_P )_@/0?L!D"4T @
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M0S+J#S*0@                       4HXT?T[\ROPPI/V-(%%UQ
M
M                                            &&Y"L"U<I65<F/KV
MIB:O:]U0EP:O!49I,T+ZDM"RZH6A1$I"BZI41&78 T5TZ/>G%'(Q<=LL3"DV
M[+-4C#^0EZIC5" XO:U$<6HM$NMGJDTF>J3Z=4J0H^'U#2T^.(?J'T=]1VW<
MNCS_ .&[W?@M AUITDN-JW$HNI^R.79=-UK]%FV8V2Y.P5Y?DS+0(5Y-;H\6
MX*+5Z+.;)Z+6(;T*2THM=4/(-!_KZD/5MW+,,&JP6YL5V.[=,2K9Q!KDB9BQ
M=K3GC<J&/JS4:&X:NW8W(6ZV1GX=I+,OD$0V=?92[FX/G/I'/,Z2<=\[;+IM
M]JU6Y.I=2\KVNGA&G$U?4QM!5?0 !'UXL.S+IP="C:^<R<F41QG3MV0VY,U_
M33_S##FOL#?Z=%<D^'OA\9]<W\FAM_?C_=N;"#+3IXNT?02_'=\0^ H Q2[+
MI;MJ)%1&@O5RX:P^F';5LQ#(I4^4K_JV]>B4I+REK/HA):G[(35B+&\BQ*34
M*A<,MFKWY=;Y3;NK+*-K9K26UB)'UZDQ&1Y"->WJH^J@5+H(
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M L,RXX_H_P"$_P !Z#]@,@2F@$
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M^]:J3(R(J?WR$)(MQ$>G?)<[=?\ R ]7;VPT'D
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MK:2E::Z:F+J=/.#)-DS68I]U4TVHC/CB^(I$U^^B4Q@9P
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M)$>OA&SU30VX+;9BZZ:SQG]#6Z7KKL]UT3;;%(X1^EJTRODK,=U\B*=D.^;
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MR+5L&D)H=HT6/1:=WAO/-LEY;SRB(E//.*U6XXHDEJI1F9@C*@
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M6A;M5'V%T 7TB4Z)$;BI0RA3T1A$=N4I)=YL0DDD6[37P CO
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M9<E1LG']%M>==Y**Y)=.C)8<EI6:E*2M2>I),UF>B="UZBO-5"^5'"+BQ:&
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M3XB[Y"^@#O4B@T.WXQPZ#1H-$AFK<<2GQVHS9J\>QI*2U_4 >J
M                            *4<:/Z=^97X84G[&D"BZX@  #2E\;/\
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MO$K]N9$:-#-1:'4.D^79SV73,1PGL[F_T_JWF7\E]L1,\8[>]MN'SSZ
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M"!%2:8\1A)(;01F9F1)+IU,S,P1W$I2DM$I))>(BT ?0
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M$H)X4?HN8B_BZ7]\)02+3"
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M;KTT^2 ]SC :4X:H<5)ZG3ZO<<4T_L2;KDXD)_41H"RL "
M      (#Y5?HR\@O^'=R_>Q\!C7"G]%' _X)Q/UU LK0@CHU.ITZBP)54JTU
MFG4Z"VIV7,?62&VT)+4S-1@(<Q!F2/ERJWT=+@^:4"VGH3%)?<U[Z1WY/FXZ
MLNQ)'W9;4^ NT%3@>NAZ'H?@,$>"=JVRJO(NE=OTY=RMM]TBOG&:\\)&W9M)
M_;O(MIZ=O9T >^
M     "LO,S]%?._X(SO[T@6&9<<?T?\ "?X#T'[ 9 E- (
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M^Q7!8)03PH_1<Q%_%TO[X2@D6F$
M            !2CC1_3OS*_#"D_8T@477$
M                                          %0N<&+KZS!@BH69CJA
M^L5ROUFFRVJ;YS%B:LL+4;BN]ENLM^21]F[4_ .CTO/9AS<U\TBD_;8YW5,%
M^;#RV16:Q]MKS.".)L@89PE+M#)- ]6[B<N:?4$4_P ZB3-8SS,9#:^\AO/M
M]3;46F[7IU(>NJZBS/FYK)K%(]_:G2M/?@P\M\4FL_;8N@.8Z0
M                                 #^=#B^RJEVW?E"<(VY5OWY7H4J.
MKVS:D.H+:9>#0R,?-]4BF2K]L_\ 7E\7:"ZWLOG[H7&863C+:O&DAI1-7U5\
M4NF'./3R_)%KKTU423-)>SKH$[HF.VB3+R/B_*:]<$OG;-B-F^W<=U^BH3A=
MCCC,2<G81GX2\X3\L?3:6WEQQ'<_ NMY.?799_OS[-B7,8U'O[(LRH(5N_\
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M]VVE!ONMFI*C)6_:6O1.@"Q0(
M                  -?OQ@<;/SF&LA/8\GV9'Q>U9\[\H$6ME,.L.'N/7S
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M_(?\@+Y_!^I_8K@L$H)X4?HN8B_BZ7]\)02+3"
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M'"[MA!?W;BDI_5 61QC:Y65CRS;6V[7:-28S$LO'(-!*?,M?&XI1@2SH
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MANQFJA#/13D=9FH]BC)2=IJ4:5)46Y1:*,3%%H 0
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M;UF2F+CR$X1$:$N,?1J3#7KT,W'T)=-/7R$=>T15T14
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M*Z'V#6U&GG#=2?0[?1^K6=2P\]L4F)I='9*:QKNL
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MIX-3\ U=/9-^2(CM9+YI$J(U^!5*=Q=PW8:]8U3R-<B7&VE=/\T?D/.LF?\
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M$;([^UW\/6;<'3;])BLI?DNB;[Z[9LMVVV1'"*[9V[4S#9<
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M(WJ;4([<IA9IZD:FG4J2>GLD(,'_ "*X<^"6S/N#3_X  _(KASX);,^X-/\
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MUI.'(A&UI(;0Z3R6GR<0HS01FLM",M26HAFQZB;+)MI6)>+K(F8E+HP/8
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MKK8Y,D32)G==V?V[I7C:=:?:;?8<0\R\DEM/(,E)4E1:DI)ET,C+PCGOKW(
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M ]4K4_FS2?K)CW !ZI6I_-FD_63'N #U2M3^;-)^LF/< 'JE:G\V:3]9,>X
M/5*U/YL4GZR8]P ]UIIIAIMAAM+++*20TR@B2E*4EH24D70B(NPB <@##\A_
MR OG\'ZG]BN"P2@GA1^BYB+^+I?WPE!(M,(
M                    "E'&C^G?F5^&%)^QI HNN(           \BCV_0;
M=9?C6_1(%"CRGE294>GQFHJ''ED1*<6EI*24HR(M3/J/5U\W;YJD1$/7'E0
M                             8K<EC6;>'<'=5K4NX%Q2TC.SXK3ZVR/
MJ9(6M)J(CU[",>[,EUGRS,)-L3O=NWK5MFTHBX-L4"GV_#=5O>CT^.W'2M?[
M)?=I+<?LF)??=?-;IJ1$1N>^/*@                #QZY;]"N: NEW%1H5
M<ISA[E0I[#<AK<1&1*)+A*(C+7H9=2'JV^;9K$T28B=[QK=QY8EHR'9=L6A2
M*#+>3L=EPHC33II_8]XE)*T]C70>K\M]_P TS*1;$;F8C&]
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M+Q'T,<R8ILE]S9?%\1=;-8EZ(CT
M #0?;$O(U[6I:M_Q?C!\EVW0\A7C)LVU851HZ4OKJC1F9L[8\A]*4:=BC5\D
M1Z;7>.6(,JXDIUSQ,I9UK.<959DQWJ1.K#1-*I[;2%I<;;T4K4G#41G\@5)6
M3!         !67F9^BOG?\$9W]Z0+#,N./Z/^$_P'H/V R!+&[G8R34,D4VM
M,XM34[>HL.J48UKK,)!38T];1=_W:BW(+8V9F@R,^N@BPJ-==%JO&G--)J=)
MGRX=EUF0U*)3![B=@FYI)B.H/1*C;ZZ%XC2HC(^RHV8T:MTBX8#-4HE2C56
M^6K<J*ZAU&NFII,T&9$9:]2[2!'J
M          ##\A_R OG\'ZG]BN"P2@GA1^BYB+^+I?WPE!(M,(
M                                   "E'&C^G?F5^&%)^QI HNN(
M
M                                             ('>_P ,]_C%_P!\
M8#C      '7ERX\"+)G2W4L1832WY+RO:H;;2:E*/MZ$1:@L-1:TY"YV5:Y;
MCJU[U>PN-U)K+]-LRT:,KN7[@1!<-)SI3Q&1&6]!*22B625=$EJ@U'L8=-YN
MV7'U_5ORD\MGS/2E<$[;H?<5O%V5KZLF^:4OOZ#<CU3.8EA[0T^4VA+"C2LC
MVJT5U29D9&1Z#-=HK(W2YV/ZFU,33)MM6?XBYTN[(L*]L8Y:9:CYCQ#4"I]S
M/,I2ANI0G2W1*BA*222>]+4C(BT/R5%[;1.E,4FCZ7#?9ELB^.,+EB/42ZLV
M9&IT*74)CA,Q(+*Y$IX^Q#;:34I7ZA$8*K\W:D_+$:!<M]5"?3J4X\FI6C:5
M-?.&<%M2%(9?D26-KJWUM.&:B)1)1N-)$?:(.?\ ),5OR5W!8=R5:DW2U'[A
MI^I2WJI%?9)?>G%?;EK69(6HNU"DFD^I>(42U9=R^MEN0:RY"53)JU/1:M2U
MGN.--B.K8DL[BT(R2XVK:?A3H8#*@       2E9_^J3_ ,>O]9(#*@&I3XRN
M=CFWKLP5=]U9JNO#%UT#TN5FUBU*%Z8DN*DM)8D>44F.;1]VX:>P]248BPI+
MQUN"RK0OW'MM61RSS.5)K%Z0)CUIN6&]!IE2E3YS2GD2GBFJ)")!GM<69'HD
M]=.@*_I%%>0       $!\JOT9>07_#NY?O8^ QKA3^BC@?\ !.)^NH%E:$$
M    &"9!QU;62J&Y1+CB[R(EG J#>A/Q75%IWC2C(].I%J1]#TZC)CRW8[N:
MUJ:W18M9BG'EBML_:L=Z@)US)?%:YI= 2[&K=!JS2Y%-C2#4J,\6NU+Z4(4E
M;:TJ+11:]?E&75BRS6Q7==&]\'DU.J^F[_+_ )F&ZO+6:3'X=^RDIGP_RHGW
ME=,"U;SI$"FO5EPV:74Z<3J&B>,M6VG&W7'3\LRT)1*[3+IX1KZK03BMYHFL
M.OT/ZKMU^;R<EG+=.ZDUB:;:=RZ0YS[
M     ?RU1[0R)0*':5DTOECQ]CV]CB])-Z6K#?N*&I]FJN&I)J>6>BEI(CTV
M'TZ"/3=CPDR9EG)-$OV3E7,..<NRJ7.A-4>7CV1%?9A-N-N&XB7YL1$2EFDC
M3KX",5)7D!         !67F9^BOG?\$9W]Z0+#,N./Z/^$_P'H/V R!*: 1$
M6;<91LI6+4:&EM)5N(7G=NRC,DFB4@NB#4?0DN%Y*ODZ^ !"?#%B1"M"]J;,
MC'%F4VX51Y;2]Q+2XAA!*2HC/0C29:="!5R00
M                  8?D/\ D!?/X/U/[%<%@E!/"C]%S$7\72_OA*"1:80
M                                            %*.-']._,K\,*3]C
M2!1=<0
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MI<5Q+B#]@S29Z&6FAD?4ASYB8FDOK;+[;[8NMF)B>,/6$>P
M                 ?R?9.IW$R#=%4/BE6+VK5R>>.'/A7)3:%*H!.FH]VYZ
MN*0O0CU_ZD_DB/3<G\6G&O5BPK[5>]%QI2*B]/@FR>/7:8MQY!,N>55&Z4ZX
MRVX1GY!>2>F[H*DMEP(         -?7Q@N-+]NC#>0+PM[--:L>V+8M"<5?Q
M[!A1GX=;T4:_\X>=/>C5)DGR2/H0+"SG' C+C]A,C/<?J/0>O_H#($II! !C
M]'MFD4*H7#4J9'\WD7/+3.JQ%[5<A+:6C61> U$DM?9 9
M                            ,/R'_("^?P?J?V*X+!*">%'Z+F(OXNE_
M?"4$BTP@                                             *4<:/Z=
M^97X84G[&D"BZX@
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M$V6!:\BT[9B4RH2TU"L27I%1KU00G:EZ=->7(?-!=I(2I>U&O7:21$9IM+Q
MAM+Q &TO$ ;2\0!M+Q &TO$ DZT/]4G_ (]?ZR1592 H+SGY86MQDI%GIJN+
MFLC7%>;C\>W':BF.W2X2FC02E2GWDK4DCWET277PJ(%:\KHK')2N5'COF&ZL
M@XYHMA7;E>U:1!QOC)N&]L1*GM+4FHU&.T2E&24Z=WWJBZGJ1"*_H'%>0
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M8,Z%4XC$^G2VIT*4@G(TMA9.-K2?8:5),R,:#ZF)B=L.T"@
M              -!%V5WA+>MQU2T.*O"Y?(Z\HKRDU.I1F)]-I$=U1GJ;K\E
MQM6F[74S)"?$9B*M!\6E&KU&KW)^T;EQO:N*ZU:5R4>#4+0M)*E0XSOFTA2D
M*D./R5/J3KH:N\,OV/0"6U<5         !67F9^BOG?\$9W]Z0+#,N./Z/\
MA/\  >@_8#($IH!   <;KC;3:W774LM-EN<=49)2DB[3,SZ$0#'K8O&U[TB2
M)]K5N-7(D1]4:2]&5N)#J2(S29&1'V'J1]A^ !DH
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M[+J4K;<;/M2HO$HM4F1F1(8              I1QH_IWYE?AA2?L:0*+KB
M
M                              # KYL.+?3EH>?U!V+$M.X(EPE#;0E2
M93T+=W33NX_::J,S+PC<TFKG3\](K-ULV^%7%ZQT6SJ<X.>Z8C%EMR4C]:;-
MT3W;6%W/AZJ5F_9F0:'D6IVC5I=+:I"FX<6*^28C2R<-!'(2OHIPMQZ%VC9P
M=2MQX(PWXXNB)KMF8V^CN<GJ'TMEU'4+M=AU5^*^;(L^&VV?AB:T^*)WSM9=
M9EH71;DR9)K^1ZI>K,ADFX\.=&B1T,JW$9N)..V@S,R+3J>@U]5J<66(BS%%
MGA,S][I]*Z7JM)?==GU5^:)BD1=;;;$=_P ,0D,:3NL'IMCQ*??MS7^N<]*J
M%PP(5-:B+2DFXD>'N4:6S+JKO%JW'KV#;OU<W8+<-*1;,SXS/X./I^CV8NH9
M=;-TS=DMMMIPMMMKN_>G;+PKJQM-JMS(O*T[PF6-<KT J75I4>-'F,38B%*6
MV3L>0DT]XVI1['"/4BZ'J709=/KK;,?E9+(OMK6-LQ,3XQPGC#3ZET"_/JOS
M>FSW8,LV\ETQ;;?%]M:Q6V[9S6S\MWHVPZ2\-T9&.;DL"'5YS+UWJ=>N6ZWM
MK\^;)D+2J0^\9D23-:4[-"(B)/8/<=3O_,6YIB/AW6[HB(W1#%/TIACIN716
M7W1.6LWY)I-]]UTQS73PV[NR(2G2J='I%+IM)B%I%I<5F)&+Q-L()M/]A(Y^
M2^;[ING?,U];Z/38+=/BLQ6[K8BV/"(I".;5Q/1[6I%]VVS/D2[9OB=.F*HR
MR2A,)-1;-N0PPLM3V&G30C[/U3&[J.HWYK\=\Q$761$5[>7=,N#TWZ:PZ+#J
M-/%TSBS777<O['F12ZVV>SL[&!JX^RY=AR,=5C)E9J=LQXJHMO02CQXZ8Q$>
MY@Y"F22Y*[DR\E*EI1XTZDDT[G^LQ;GC/;BMBZM9FLS7MI79;7PKWN+/T1?D
MT$Z#+J\EV*(I9%+;>7]GFY?BR<O")F+>[9%+!4N$=-IE.IQOG*.GQ68QR5)2
M@W.Z02-YI01)2:M-=$D1%X!QLE_/=-VZLU?<:;#Y.*W'6O+$179%:12M(V>K
M8[X\,R#G4EWKG]VO^^ <>@!H : &@!H CW+A?_)3DW\$ZU]@O"2L;U&>%/Z+
MV)/] F_?"4.MI?D?"]8_J)6E&9S%5\#%KS\Y&?@!;W][#'(U/S/NND_TT-E9
M$,;I&@#[^J8#YM+77PEV'X2+Q%XOU #0 T - #0 T - #0!)MH_ZJ5_CU_K)
M 90 \2XK:MV[Z1+H%U4.#<5#GIVS*348[<F.X7:6YMPE)/0^I=.@"@EP?%E<
M>G;^M/(V/_2^,:S:]RTRY'*)29'>T::[3I:)1-O0GB5MW;#22D++;KV'V M6
MQ8$        0'RJ_1EY!?\.[E^]CX#&N%/Z*.!_P3B?KJ!96A!
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MX^UW.%2R;D2-E&HY,K%.J<2[T,KC2Y/FK#S3BIC"C427#W),S2M1'XP)7B!
M      ?#,DD:E&1$1:F9]A$ CNR<N8QR14*_2K#OJC7;4K6=)FX85,E(?<B+
M-2D$3B4GT(U(46O9J0"*N9GZ*^=_P1G?WI L,RXX_H_X3_ >@_8#($IH!
M1[EIIQ_&5^---J=<51)FUM):F>C2C/0B]@%A1[!&<\?XVM>C4*-;,U^Y;CJO
M<7(Y'<-71.Q##Z2<,]2,EGHA.G4E>,A#>V1),E)2HM=%$1EKT/J*CZ
M                                ,/R'_("^?P?J?V*X+!*">%'Z+F(O
MXNE_?"4$BTP@            TE\JK'J-V<H.05Q6V@RO?$&,+;R+9$E*34MJ
M=;U1C27#2E)DI1JC=\DB(^JC+PZ ]1N7+Y'Y57D#C!9D7'DGNJ]RJ70K2M#:
MHC6PU<B4N5!3A=#T8AI?0X?3:?;IV D;V(\$;=I5H7GR_M.@1TPJ+;.2_15&
MBD1:-1H<=3#*=$[2\E""+IH"RB/(G'NS<(\B>&E2I=2K-WWQ>E]U1^^LB7),
M7.JM5=9B1^[[Q9Z(0AO>HD(0DM"[349:@5;<P>0  13E/+-&Q Q;E=O"([%L
M6JU%-+N&]4JUC4-Z3HF$_/023-$9YW5I3VNC:U-[BVK-2"T2?%E1IL:/-A2&
MI<.6TAZ)+96EQIUIQ)*0M"TF9*2HC(R,CT,@1K,YV8_IF5<[</<<U@DE O)G
M)%+6\HC/N7'J/!)E\B+YYIS:X7LI('J&?X8Y!NVWP@J&0KMVMW?@NBU.U+KI
MT@]%^G;<U@18SJC_ .LD'YOK_;. DQM5\XAXVFXKY>4BVZVE9W;.XXIKU]2'
MM#?=K=8N6-.G&\HO;J0Z\;>OB00+.Y>>0[A#A/AFI2C><MRR*5+E368CTA<V
MHU*ISE*=-AA3ZS=DR'E%HG<H]$EJI24),R)O8'P=Q_>-I8[ON\[WH9V=5\W7
MY6,@Q[#T-'H6)53;\WC+;T+8O:WN-.A&E)H2HDJ2HB$KI@@
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M)V>UZ?)&YI-).HFZ*TI%6IJ]7&GBV9BM9HL$--M@
M                                  A%XM77/[H_UP''M]D V^R ;?9
M-OL@&WV0$>Y<3_\ )3D[K_\ 6G6OL%X25C>HMPH+3B_B7V8$P_\ :$H=;2_(
M^%ZO_42M*,SF*LX%+7GYR,_ "WO[V&.1J?F?==)_IH;+-OLC&Z1M]D V^R ;
M?9 ?=.F@#YM]D V^R ;?9 -OL@&WV0#;[("2[2_U6K_'K_62 R<
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M2DU[&Z,?-/I0
M      0LZ1=XOIX3_7 ?C0O$ :%X@#0O$ :%X@#0O$ CS+I?_)1D_P#!*M?8
M#P2L;U$.%'Z+V)/] F??"4.KIOD?"]8_J)6F&9S%6L"%_P#?^\C/P M[^]AC
MDZGYGW72/Z:&S#0O$,3I/NA>( T+Q &A>( T+Q &A>( T+Q !%J :%X@#0O$
M :%X@$C6G_JQ?^/7^LD!DP           .LQ,AREOMQ9;,E<5?=R4-.)6;:^
MW:LDF>T_8,!!G*K]&7D%_P .[E^]CX#&N%/Z*.!_P3B?KJ!96A!
M       '$^PS)9=CR642([Z%-OL.))2%H46BDJ2>I&1ET,C 50R5Q1M6Y._J
MME/>JM;,S<.&7E073T["07E-GKX4GI['A&[AUU]FR=L=[YGJ7TOI]5/F8_X>
M3MM]\>^*2A^F95S9@:8W0<B4=VOT E:1Y$E9N&:?V4::DS)1?VJ]?^B8SS@P
MZC;CFD]CEV]5ZCTF>766>9C_ &XW_;QI/?*=E<ML3HI<&<;E4<F2M2D4=J(9
MO1S+MWK6I#9D?@-*C]DB&O&@S3-*.O=]5].MQQ?YF_A2>;TQP^U$PX_R5:>2
MZ4Y5;6G+?1&63<V&^CNI#"S+4B<1J?:789&9'XQKY<5V.:71278T6OPZW'YF
M&[FM^V^&>C&VP                       %:<M<5\99.H=SL4V&>-[SN:=
M'JLC)-L-HB5@I\9WO4/.O(VF^DSUW(<,TJU\9$9*+5&=H<+W[0I-TR8>=;R<
MR7?]S4JX;^RFCNH]0J;=)):6:>IIDTMML&EQ1*)/;K\@A*%6.U3XO6P*ME23
M>DB^KA1CZ9>#=_RL-([HJ2NXD)-/G?>_X4DGN5Y'9HHR(RZ"E5F)/'#!4N9,
MJ$G%U">GS[G;O*9-5'U><KK2^\1.4O7=O)7737;KKY/4"KI7;@:C7;G;&.=I
M-<EQ*QC&EU&EP*(VVA4>2BHI6E:W%F>Y)IWGIH!57^VN 5BVWENF7^U?5?FV
M1;]V3K[MO$#Q->BH5Q3T$AV8EU.CJB(T(42#Z:I+77KK*%5^145EYF?HKYW_
M  1G?WI L,RXX_H_X3_ >@_8#($IH!    $59EQM$RC8U3MY:$)JK2?.K?F*
MZ&S+;ZIZ_L5EJA6O@/QD1@* XPC7'D!VD8>JEYRK,J=@U.3*I;)[]'D)6DI,
M4]JT&3C"FS4WKJ6BE^(M8]-D5K7W:%W/5*#;=PQZW*H2R9JB&C,UH5U3JK4B
M(]3(^I=-17EF(                                    ##\A_R OG\'
MZG]BN"P2@GA1^BYB+^+I?WPE!(F+(V3;<QE3(M0KQ2)#M0<4U3Z=$2E3SQH(
MC69;U(224:EJ9GX2[1FT^GNS32UR>K=8P=-QQ?EK,SNB-\_V(5_.WLK^;5;^
M5&_AAN?Z7?VP^>_\ZTO_ "[_ &?B?G;V5_-JM_*C?PP?Z7?VP?\ G6E_Y=_L
M_%'>4.2T2Z[4E6_:=/J-&E5-:6JC.DFTD_--#[QMLVUJ,C6>A&?['4O"-C3=
M.G'?S73$T<GK/UA;JM/.+!;=;-V^9I\O&(I/'[JJACJ/A'/&DR(<AB7$?<C2
MHSB78TEI1H6VM!ZI4E1:&1D9:D9!,1,4EZLOFR8NMFDQNE>.A<LZ$S1Z:S<%
M!J<JM-1T(J<J*3!,NO)+13B"4XDR)6FNFG0<:_I=W-/+,4?I&F^N<48K8RV7
M3?3;,4I,]N]ZWYV]E?S:K?RHW\,/'^EW]L,__G6E_P"7?[/Q>Y;7)^Q;AK5/
MHKM.JE'74GD1X\V4ADV$NN&24$X;;JE)(S/3730O#H74>,G3LEELS6)HV=']
M9:349;<<VW6\TTB9I2O?25DASWUP
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M=.ZD>^&/1XYR:&^V-]9]TKH<=>1F(:EQ^L2IU6_*%;DNR[:@4J\J549C,.1
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MGNVH-6FAD9Y.DZ:^WGONBD<LQM8^K:FR[DLMFL\T3L;3QP7=
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ME0);,Z*Z6K<F.XEUM1'X24@S(QJ.]$U=H%
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M:2VMJ2,GO)+Z)KNZ%U"=5EF9F;IK,4G;P["-+BB(B+8I$UC9Q=V_\1XRRHU
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M-3&6[69KIK-\UI3?P8K='AMBD612M=W%-(UFR
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MCI]S*\9EW2]#,R\.FHT<F*_'\T4?4Z37X-5;7%?%WA/N2*,;;
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M33M$8W;GB5(0PAULW4I-*%&O757B/J?0"CVY>=;,I6.[<R16T3:92KF-*(4
MV>\DDX9J)2=I&1&1;#/77J74@*,JJV4+"H%*M^M5RY8M)I]T=V=$>D&HC>)Q
M)*UT21FE*2,MRCT2GPGU("CT;NOBU['ILBI7)68E.2RPX^S$=>0E^031:FEA
MI1DIP_821@E%5FL^YONIJ1<U@8C1,LEA:O-GI7>N29*&S,EJ0:%M[CZ'T0A6
MA]-5: JPF)<J4?+-N.5JG1ETR=!?\UK5$=62W8KQ$2B(ST3N2HO:JVEKH?A(
MP1*0        #RJS7*-;M/?JU>JD6CTR,6K\Z8ZEEI.O0BW+,BU,^A%VF PN
MULP8SO2<JF6U>,"HU%/M()FMAUS_ !2'TMFY[.S4"B20         !A^0_Y
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MDZEX>HMULVS28HEMT716)J] 10
M              !$A^V5\DQ%?G;[(H;?9 ?H!\,M0'T!'>7_ .B;*'X(UO[
M>$6&L3AC4E4W .,'3U-ER%+2\@O%Y_)T/]0QW-/9S8H?F/6L_D]0S3X?="ZB
MJI3TL><'+:[O;N]L6OR-/&/7)<Q1J,?+S*S<;9J:ASQY$R6T&A"[$H1))7;H
MCS-.OZN@Y>J_G/N.A7QDT>.8_:G[Y78HW(;$]P9:K>$*7<O?Y$H+2W)U+\W>
M2R:F4I<>9:D&@FUN-)41K22NG7M-*MNM+M)K(M  RU -.F@ 1: /H#X9:@!%
MH ^GU "Z /AEJ SFV/\ 5[G^/5_>I!&1@            (#Y5?HR\@O^'=R_
M>Q\!C7"G]%' _P""<3]=0+*T((                         ,;N6T+8O"
M'YC<U$B5B.6O=E(;)2T:]NQ?MD_J&/5MTVS6)8LV&S-;RWQ$QV3M55O'AW;L
MM2IMC5Z509F[>F!-/OXY'X.[6DDN(T]DU?J#>Q]0OB*7Q%T/E]7](::^[GP7
M78K^%)V?C'HE'::]R9P>I!5>$Y=5N-="<D&=1C&GLZ/-*)YH_%NT^09#)RZ;
M-NGEEISGZUTWY[8S8XXQ\WX^R4R61RVL.O&U$NMEZSZ@O1)ON$I^(:SZ&7>-
MI-2.OA4G3QF0P9=!DLVQMCN=/1?5>CU$\M\SCN[+MGMW>NBS=*K-)KL1$ZC5
M*-5(;A$:9$9Q+J>I:EJ:3/3]4:<Q1]);=%T5B:P],1Z
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MX *@5VKW91&+?RCCBY)#L%BI,PMOFDV'-9;<[J0VE"6S)Q.W87A,] *NA;F
M,H94JN6+OY*5J'349+M%=C43%5K3I,BET6E+4IPY;SKQ(1(G=ZLU)<)O1&IZ
M'HK8@58E;UJ\[L=6!'PI;36.[HAT6GIH5EYMG5"7#DPJ:V@V8SDREE'>-R1'
M:)))-)J3T3N[P]QF78P+EECB^+5P5Q'QPC)U3N+(Z,XVA!9RK6E.2Y/IF6U5
M#;FJ2XM2S;8><(VT&HS)"4I-1GJHQ"1KQQ/R;Y'N6IC_ #I2[(L7$MOUB'5[
M]5;-0EU*5=2Z<LUM16&7V6BBQ75D2EDXHW$^3H9F6@%8AE.=\1YN>S_C+/\
MA-BUJ[4;8MV7:E?MNYY,B*WYK+D*=\Y96PD]QI)U6I&HC+0M$KU,B)$NG4\0
MYTPUF'(N4./T2V[XM+,;\>I7UC.Y)SU+>B5AA!H.=3IJ&WD;7MRE.I6G74]"
MU(D[15DN"L(9)I^5[YY%9TJU&D9.O*D,6W0[5MLWETN@4-AU+WFR'Y!$X\ZZ
MXVA:U:$1*WZ&9+T2)EF'$3$]T8/X\8]Q=>;D%VY;8]+>DG*:ZI^*?GM6F36N
M[<6AM1_0WTZZI+KJ7L@3*R0( *4<:/Z=^97X84G[&D"BZX@  "K-:>Q 7+^T
M6)\2M*S<K'KJJ+-;,O1":%YW-W(<+?KWW>][\[V;>HW[8R_E9I3DYO36D-"Z
M<7YJ*UY^7T4VNA=?-'#=HW#>%GS&KBJEYVA5VZ)ZH4FG%,J-3DN-*>4=/8;=
MU<;;2GRUK-!$9I+M,A<?3,M]L713EF*UF=D>*9.I8K+IMVUB:4B-L^#),+\I
M\99PKE:M*A1Z[:E\6^TJ35+'NJ!Z.J;<=*DH4[W:''FS(C<3J1+W%N(S21&/
M&IT&3!$732;9XQ-8>]-K\>>9MBL71PF*2LB-)NJ@9$YNX5QE<%\6E7TU^7=5
MBSJ?3Y%O4Z$T_*J#M0CKDDJ E3Z"6AEM&KJG#023-)=341#HX>EYLMMMT4I-
M=O93M<[-U/#BNNMFM8IL[:]C,:[RHQ':^++/RU<4^HTBBW\TERS[?>AJ56IZ
MU]C3,)M2S,]#(]V[9HI/E^4G7'9H,M^2<=M)FW?/"/2RWZ_%9CC)-8B=T<9]
M#'+%YCXOO"[:38];H%Y8GN6Y%$BU(-^T8Z0FJK5MVIB.I=?;,U;R))+4G<9D
M2=3,B/WEZ;DLMFZ)MNB-_+-:,>+J6.^Z+9BZV9W<T4JD#,O(/'N#D4&/=2JG
M5[ANIU;5L6;;\-50JT\VB+>;,=*D%H1F1:J4DC,]"UZZ8=-H[]17EI$1OF=D
M0S:G668*<U9F=T1MF6)8SY9XUR1>;..9%&NS&N0)C#DFEV=?%(52)LQIHEJ6
MJ.1./-J,DH4K::R49$HR(]JM,F?I^3%9SUBZWMMFK'@ZACRW\E)MN[+HHY,C
M<M<18MO6L8_NQ^KMW12J?"G1:?"@G+745U!9-QXD%#2S<=?49Z[3222(CU4&
M'I^7-9%]M*?=3M,W4,6*^;+JUCVU[#&7*W'>2;T7CB30KLQCD!4<Y<"SK\I7
MH:=,921J4J,CO7DK,DD:MNXE&DC41&25&3/H,F*SGK%UO;;-8,&OQY;^2DVW
M=ET4>]F?DEC/!KU'I=T/U*MW;<1&J@6);L0ZC6):",T[T1R4A*4F9&23<6G<
M9&2==JM/&FT6345FVD1&^9V0]ZG6X\%(NK,SNB-LL=Q5RTQ=E6ZSL%N'<>/[
M^6RJ3#LJ]*:=*J$IE*36:V$DX\VOR"-6TE[C21J).B5:>]1T_)AMY]EUO;;-
M8>,'4,>:[DVVW=DQ27;R5RMQ'B6]*G8=ZSJC KU/MYFX8[;,7OTSD29:8;$.
M&E"S<=DN.*U)LD:;24HU$E)F4P:#+FLB^VE*T]]9[ESZ_%AOFRZM:5]U([V/
M8VYEXKR+?<3&LBBW=CB\ZL@W+?H]ZTGT8JHD25K_ ,W4AY\BU2A1I[PT;M-$
MZJZ#WFZ;DQ6<]8NMC?RS6CQAZECRW\E)MF=U8I5F&8.2^/,-5NC6E5H5P7A?
M-?CJF4NQ+1IQU2K.1DJ4GOC9);:4I,TJ(MRR,]JM"/:8QZ;19,\3=%(MCC,T
MADU&MQX)BV:S=/"(K+@Q'R?QMF"X:E9=-BW!9E^TF/YY-L.[Z:JE51,<C21N
MI;-;B%$6XM22LU$1ZZ:=0U&AR8;8NFDVSQB:P:?78\UTVQ6+HX3%),N<H<9X
M?K]/LRI,UV\[^JC)28=@VA3U56K&PK7:XMHEMH01Z="4LE&74BTZAI]#DS6\
MT4BWMF:0:C78\-W+-9N[(BLNUA_DMC;,U4JULT0JQ:U\T)HI%8Q]=4%5+K+#
M![='C84I:5I+>G4T+5MU3NTW)U:G19,$1=-)MGC$UA=/K<>>9MBL71PG9*>Y
M+Y1H[\E2%N)CMJ<4VVG<M1((ST2GPF>G0AJ1%6U,T:IN.G)"5</*O-GIJC9
MJ<"])U&H]G4V737W"MV.E;Q;*@RIPTT]HS7N/IU/<H^H[VLT46Z:RDV[*S.W
MYO#M<'1ZV;M3?6+MM(C9N\>Q<;+7*_%^)+F8L:5%N&_;^=93)>L>S*=Z5J,=
MA1;DN/I-QEM&J?*VFO?MT5MVJ29\[3]/R9K>?9%O;,TATM1K\>&[DVS=V1%9
M>QAODOC+-T^KT"VW:I;]YV^CO:Y85RPSIM8C-ZDDUJ8-2TJ2DU$2C0M6TS+=
MIN3KXU.BR8(B;J3;/&-L/6FUN//,Q;6)CA.R5@1J-M5G"3V(',T<F6[ B5IB
M_&:M1BRP_43(X;LHT3?,S@$2U&22+O=VI%\Z-_51E\G%STY:3R^RM6AI9Q>;
MDY*\U8YO;N8(US_PG4J+2JG:M"O>^:E4FGY+]IV[1DSJI!CL/+8[Z:VF0EIE
M*S0:DD;NXTZ*VD1EKEGI&:)F+IMB.V9I'H8O]6PS$3;%TSV1&WTI6L;E#C+)
M&-;FR992*W7HEG>1<=HQJ>M=>C/:$9,>9$H]ZE$>J30M23T41*U2HBU\NAR8
MLD674BNZ:[/6V,6NQY<<WVUFF^*;?4US<4G\492S=DFY<BXNNJ[[_N7)4NH6
ME=DVF25P*$U!6<V*Q-=2\EN*ZVI!(-M25:$2&_:]!V=?&7#AMMLNB+8MVQ7;
M-=FSM<;03BRYKKK[9FZ;MDTV13;M[%A?BW9L.FX0RU4:A*:@P(&3J])G37UD
MVTRRU3:8MQQQ:C(DI2DC,S,]"(:G6HF<UD1^S'WRW.C3$8;YG]J?NAGT_GSB
M9)S)=LV-DK(%L07'&Y-\6Y;:GJ.GN?\ "J[^2_&5H@NIGL[.HPQTG+NNNMMG
MLF=K+/5L7ZMMUT=L1L3O;/(#&EY8AKN;;7JKU9LJVZ;4:E6DLLFF;']%1U29
M49R.X:#2\E"=229D2M4J)6U1*&I?I,EF6,5T4NF8]K;LU>._%.6V:VQ$^Q M
M4^,"PG$IT:K46@WO>U-33XU2N*?;M&1+CT1N4V3J6ZG(7):::<2@]5I2M>T]
M4GY1&0V[>D9IFDS;$UV5G?X-2[J^&(K$73'&D;O%D%=YQX3@TVC3[39N;*[U
M7IR:L]2K)I2JE*I\12EHWU!+CC"(RB4VHC0M6\M-33H9&?BSI>:9F+J6TFGQ
M32OAVO=_5,,1$VUNK%?ABM/'L2]C7/6.<LXXGY1LFI/U"W:0W*.L17&>ZFQ'
MH;)/O1WF5'H3A(,E%HHTF1D9*,CU&OGTF3#D\NZ-LMC#J\>;'YEL[(0#*^,"
MPF=&I]8MV@WO?)/P3J5;I]N49$QZBQM[B"75%');98,R:-6TG%&23)1D1&-N
M.D9JTNFV/&=_@U)ZOAI6(NGPC=XO?G<Y<'^K]N5JTRN3)=1N2(N:S9MHTI50
MK,-AESNG5SHRG&DQ]BR,O+66[3<C<G10\1TO-S3%U+8CC,TCT=KW/5,/+$VU
MNKPB*SZ>Q+^%,\X\SY;,RY["G23;I4HX5=HU29\UGP)!)W$B0UN6DB4GJE2%
M*2?4MVY*B+7U6DR:>[EOX[NR6QIM7CU%O-9PW]L(4K?.G$\2IU2!9UI9 RY%
MHDA<2JU^QZ =1IK+[9:K;\Y>?C)5IV[D:I,NI&9:&-JWI668B;IMMKPNFDM:
M[JN*)F+8NNIQMBL)+LKDYC+(V,[CR?9!UBY*?:6J*_:T. M==8>+0R9\QW:K
M4HCU2:5&E6AZ*,TGI@RZ')BR1CNI%=TUV>MFQ:['EQS?;6:;XIM]2HWQ>>;Z
MC=L*_K8NF->%PW/<M[5BO*O.?%>D4UIA,"GM(AOSUK,FGD$UHEG3R4FG30M!
MT.L:6+)MNMI$1;$4X[YVT][G](U4WQ=;=69FZ9KPW1LK[ECN)E6PC P058Q&
MJIT'&%.GU.3(DW0ZAMYA;)DN6Z\X;BTI;21:ZFKH0T^H6YIS4R4F[9N;G3[L
M,8:XZQ;MWL*D_&!8:2[-F4NT\AW'9=.=4U.R93+=4Y0&B0>U:U/N/-O$E)Z:
MZLZ]2Z#)'2,NZ9MB[LF=K'/5\6^(NFWMB-BR3V9L?GB:H9KI58]8[ I](D5I
M52I:>]<<CQDJ-U*&G#;,G$FDTJ0O::5$:5:&0THTU_F^5,4NK3:W9U-GE>;$
MUMI78KE5>?N%XD-BI4*W;YONEHIT.I5^K6U14S(E&3,CHD]S4)"Y#33;K2'"
M[U*%+V*U29[B,BW;>D9IFDS;$UV5G?X-*[JV*(K$73%-M(W>*T^-LDV;ENSJ
M5?=AU=-:MRL$LH\G8MIQ#C2S;=:>:<)*T+0HC(R,O9+5)D9Z&;!?AOFR^*3#
M?PYK,UD7V36)9T,3*
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MJOT9>07_  [N7[V/@,:X4_HHX'_!.)^NH%E:$$
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M="(B%1R         ,/R'_("^?P?J?V*X+!*">%'Z+F(OXNE_?"4$BTP@
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MV>P(&SV #9[ !L]@ V>P ^&@_ 0#[L]@ V>P ;/8 -OL ,QMW_L3O^/5_>I
M>^             @/E5^C+R"_P"'=R_>Q\!C7"G]%' _X)Q/UU LK0@@
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MT >L- ]_*?\ 7+7N@#UAH'OY3_KEKW0!ZPT#W\I_URU[H ]8:![^4_ZY:]T
M>L- ]_*?]<M>Z /6&@>_E/\ KEKW0!ZPT#W\I_URU[H ]8:![^4_ZY:]T >L
M- ]_*?\ 7+7N@#UAH'OY3_KEKW0!ZPT#W\I_URU[H!3SC$\S(SES'?CNH?9<
MN^DFV\VHE)47FTCJ1EJ1BB[8@              ".(F*+)@Y2JF9(].=1?U8
MH:;<GU0Y#QM*IZ767B;*.:NZ(]["#W$G7IV]1FG47SCC'7X8FOI88T]D9)R4
M^*8IZ$CC"S
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MQHYF1O&3)J61:'J9: J2N%/Z*.!_P4B?KJ E:$$
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MK3YU+GM><0*E'=BS6-RD;V7D&A:=R#)1:I,RU(R,!4S\PKB?\%/^W:[_ +P
M/S"N)_P4_P"W:[_O  _,*XG_  4_[=KO^\ #\PKB?\%/^W:[_O  _,*XG_!3
M_MVN_P"\ #\PKB?\%/\ MVN_[P /S"N)_P %/^W:[_O  _,*XG_!3_MVN_[P
M /S"N)_P4_[=KO\ O  _,*XG_!3_ +=KO^\ #\PKB?\ !3_MVN_[P /S"N)_
MP4_[=KO^\ #\PKB?\%/^W:[_ +P /S"N)_P4_P"W:[_O  _,*XG_  4_[=KO
M^\ #\PKB?\%/^W:[_O  _,*XG_!3_MVN_P"\ #\PKB?\%/\ MVN_[P /S"N)
M_P %/^W:[_O  _,*XG_!3_MVN_[P /S"N)_P4_[=KO\ O  _,*XG_!3_ +=K
MO^\ #\PKB?\ !3_MVN_[P /S"N)_P4_[=KO^\ #\PKB?\%/^W:[_ +P /S"N
M)_P4_P"W:[_O  _,*XG_  4_[=KO^\ #\PKB?\%/^W:[_O  _,*XG_!3_MVN
M_P"\ #\PKB?\%/\ MVN_[P /S"N)_P %/^W:[_O  _,*XG_!3_MVN_[P /S"
MN)_P4_[=KO\ O  _,*XG_!3_ +=KO^\ #\PKB?\ !3_MVN_[P /S"N)_P4_[
M=KO^\ $S8JP9BS"4>M1<8VOZLL7"XP[6&_/9TWOEQR6EH]9LA\T[2<5[7377
MJ ED
M                                                    !'Z"\A!_
MVI?K K][3 -I@&TP#:8!M, VF ;3 -I@&TP$#43CS8]"SU=O("''(KINNAQ:
M2]&V))MEYM1IDRT'^SD--L(/ITV*/4^\/0)YVF ;3 -I@&TP#:8!M,!\T,!]
MVF ;3 -I@,CH7_9G_P#'G_>(!'M             (#Y5?HR\@O\ AW<OWL?
M8UPI_11P/^"<3]=0+*T((
M                  *R\S/T5\[_ ((SO[T@6&9<<?T?\)_@/0?L!D"4T @
M
M
M
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M8^ QKA3^BC@?\$XGZZ@65H00
M                     4EYW96QO:. ,K61<UZTFAW==EH3CMJWIDA+<J:1
M^07<MGU5Y1&0+"<N.!D?'["9D>I>H]!Z_P#H#($IH!
M
M
M
M       !4;B]_0-CO_0Y/V:^-BW<Y^7YI3X*Q@
M (#Y0_T#9$_T.-]FL"7;F3%\T+1T?HS(_P >?]X@:[H/6             0'
MRJ_1EY!?\.[E^]CX#&N%/Z*.!_P3B?KJ!96A!
M                                  !3WG#8]E5WCCF.Y*Y:%$K-Q4*T
M9Q42OSJ?&D38?3=_F\AUM3C74S/R5$"PEKCB1%Q_PF1%H7J/0?L!D"4T @
M
M
M
M                       J-Q>_H&QW_H<G[-?&Q;N<_+\TI\%8P
M%0.<]S7):/'BXJW:EP5*V*RQ4Z4VS5Z3+>A2D(<E(2M*7F%H61*(]#(CZD.A
MTRRV_/$71$Q2=[3UUTVX;IB:3L^^%>N&6>[IA8MSPUD^XZA=-;Q6RJZH\VN3
MWYDIZ"_!6XEE#TE:UFWNBD:2\;OLD0V^HZ6V<EG)%(NV;.VK%HLMUMMT9)K-
MOW40=PIR;F&Y>0UJP+WR/=-P4:X*%5:HBB5.KS940R)+R6U>;/.J;+139FCR
M>A::#9ZEAQ6X)Y;8B8F(W0U]#?DG+\<SMMK3TIWN#&'+._Y&7LC9#R[<&!:;
M;#,J=85JT6I(53W(49#KR3DKILY*4I2AI)+4X1K,U&HR));5:MF?38XLLLLB
M^9WS,;?;#8G#FR3====-L1.RG9VRL+PFRK>&7<'0J]?$CTA7:-5I5$565))+
MDYF*VRXV^[H1$:]'MBE$7E&G<?E&8U.I8+<.:ENZE6?1Y;LN*+KMZW(T&T
M      @/E#_0-D3_ $.-]FL"7;F3%\T+24HM&Y/^/_\ F$#7=!ZH
M    " ^57Z,O(+_AW<OWL? 8UPI_11P/^"<3]=0+*T((
M                                         *R\S/T5\[_@C._O2!89
MEQQ_1_PG^ ]!^P&0)30"
M
M
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M@       (#Y0_P! V1/]#C?9K EVYDQ?-"T]-+1,HO\ S_\ ]#0-=T'I
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M0XZDVE*+8O=TUZ^,%F$V@@
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M$%<U@X[QG'=4TO<V9JT\I)Z=0$F
M
M
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M$O\ **?5&:#EA'&*5F>GU"M45J:HJBJN$O<<R(9+)\J4ETR/R7"+NR3IH9=
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M;'/$Q/S_ &Y49<OEA9[\5#J%26$V5$2I;9*(U))6WH9ETU V+[@@
M
M
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MQAR+-BU^9&=(B=BOU^IN-K(CU(E)5(,CZD%3EA9* 6GG9=GT?_Z&@>'MZ
M    _!M-FM+IMI-U!&2'#(MQ$?:1'V@/V _!M-J6EU3:3=01DAPR+<1'VD1]
MH#\%&CD^J43#925IV+D$DMYI+P&K370!S      #\(;0V1DA"4$HS4HDD1:F
M?:?0!^P'X0VALC)M"4$9F9DDB(M3[3Z /V  *9\"K!O'&O'*A6K?=OR[8N*-
M6ZW(?I,U))>2U(GNN-+,B,^BDF1D"RN8"         "G'/>P[PR7Q>R%9UB4
M"5<]SU14#T?1H224\[W<MM:]I&9=B2,P6%P8Z33'82HM%);22B\1D1 CF
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M0XC<1;DJ+L,N@+*]X(
M
M
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M!$N]FG6]6[(NNP*DBF7C8]R1RC5*"Z\WWC*G&R,RVN$2M#\:3(P*+$ @
M  .K.G0J9"EU&I2V:?3X#*Y$Z=)<2TRRRTDU+<<<69)2E*2,S,ST(@%1;"YO
MX5R)$SG7*#.DKL[ S3;]P7B9).'.:<;<7WD+0]RTZMFDC,BW:EH"T8K8O/[$
M%SV]DBOU^W[CQJK'ELQ[U?I-Q0RC2JG0YQ$<29!0E1]X3YK;))'H9FXCP'J0
MHDKCURML_D'4[GMR!:]P6'=UJ1(-3GVK<T8HTM=-J;:78<UI)*5N:=0I)D?L
MD!1:0$
M
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ML^N6-:F4:Q2XUG4BXHIP:@^W 843S[D8S4:2(UDDCUZGNT[!4EL7!
M="J4NG5NF5"C5>&U4:55HSL.I0'TDMI]AY!H<;6D^U*DF9&0#3I,X^WC5XGQ
ME=AVA9+] A7G&I,;&T5N*<2',1":6X3,(]J4*+1&SR?"8CTK_5,1Y=Y$T+*-
MR6[B^Y;3*R,$6O9+5(N"&<"15J[178;\R+#;,U=ZDBA.$A7SWD=AJT 7*X84
MB\+SY&Y*SE/L.X+#M$\9VI84"-<<,X$J54J6Q&\\6VR9GJVVME24JUZEIV 2
MVH"O(
M
M                                                    #A9:[EIM
MHE;B;22"4?B(M '-U .H!U .H!U .H!U .H!U .H!U .H!U .H!U .H!U .H
M!U ?.OC <;;1-FZ9&9]ZHE'KX-$I3_\ ,@.4
M
M
M
M
M
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M4QBI0-WMT$ZG53:_[9M6J5>R0#.@
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MMQT!^)%RY"G':-Z]^CS5RJ0#2;E-6R:243BFUI6E6[KKIH GX$
M
M
M
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MU>C\-L.L5E#C;\F'*E1&G2,E)C/2G5-%H?@-/4A25YP0
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M9*T&;S;C92T$3B4JT))IW=- 1MW%0
M
M
M
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MJGLEHVS'803;;:?82DB(!ZH
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M[@6JSH(
M
M
M
M
M
M
L                                                       __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>tm2227887d4-fc_carm4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-fc_carm4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@"]P@T P$1  (1 0,1 ?_$ /(
M 0 !! ,! 0             ' 04&" ,$"0(* 0$  @,! 0$
M 0(#! 4&!P@0   % P($ 08$# P/"PD$"P ! @,$$04&$@<A,1,(05%A<2(4
M"8&1,A6AL<%"4G(CU)465QG18K+2,Y.STW4V%QCP@I)#4W.#)#1TM#55=EBB
MPF-49(24)84W.>&C1*1EM296./'BP\1%I2>61RA&9H9W*1$!  $# 00$"@8(
M!0,% 0$   $1 @,$(3$2!4%187&!D:&QP=$B,A,&X4)2<C,4\&*"DB,T%1:R
M4W,U!_&B%\+20V-4)"7_V@ , P$  A$#$0 _ /?P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                          6R7>K3 FVVW3KG%AW"
M\J<1:(+SR$/2E,IUN)80HR4LT)XF22.A +E4!BV,9MB^9*OB,;NS5T7C=Q=M
M5Z2V2BZ,MGY:#U)3J+R*34C\#"B(FK*@2
M
M
M
M                                             Z-SNENLT"7=;M-9
MMUM@MF]-G2%DVTTV7-2UJH1$7E,!W@   =*WW*WW6,4VV369\12W&BDL+)Q!
MK96IIQ.I-2JE:32?D,@'=  '09NEMDSYUJ8G,/7*V(9=N,!"TFZPB3K-E3B"
M.J27TU::\Z& [U2\I *@
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M]4]":*EY1I.B5+R@
M
M                                                 #Y-24DI2C)*
M4D9J,SH1$7B8"*[WO3MY9GW(+=Y/(+FT9$NV61I=P<(S(SHI3)&VFE..I9 ,
M,>W^<6XKYOV[O#T>OW-V9)AQ%GZ6C<6I/P@/A._LM*BZ^W%S)NOKJ8G0G3(O
M,DW$5] #*[-OE@MSE,0;@Y.Q27+42(:+[&.(VZH_K42"4MFOF-9&?@ F$@
M
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ME4\5T1&YDLNF=Z>15D
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M)+0HE(41&A:3J1D?$C(R&-E?8
M
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M3&F$24ZS\&W"2KP(E A-=2.OFY@*@
M                                            U=[IKO=+?C>$Q+5;
M95P-_)V;C<S80HVFX5HC/SGNNM)&2$JZ22J? 3$TV]2)MXMG7,1XY>=N2]]^
MY\2UXK=[%MKC#3.0Q'Y+D65.E.+;2V\:$)U_<R.J>)\.8XM_.)B(F+8V]\^F
M'M\'R;BNNNMNRW5MINB(WQ7I=;$N^[/LLR2R85E&V%@CQLKF,6IRZ6VY22>8
M.6XE"72;<0I"B3XEJXC)IN;_ !,EMLVQMF(V5]<M?F/RACT^"_)9EN]FV9I,
M1T=SVX;0:$-HK7II)-?05!U7D6A]ZW2R.RRLSM5FL%O?_%>\.Q&GY<APE/=1
MPUJ69)(B*FJA%4>-YQ\W7Z+-EQVXXGX<Q%9F=M>S8[7+^16ZC'9?-\QQ5V1T
M48)+[B<\M11W9^(61Y#CFDB3*>*M.)_)U4'%Q?\ (&2=^*V?'ZW0R?*^.WZ]
MWD;O;,W([UMUCMZ-CV55X2_,7&)1KZ9NO+5I)9D5:>6@^BZ;4_F<-F6E.*V)
MIU5AY:[%\*ZZS?PS,>5\79#AY^ZE"4&3EJ:6>NI_(-ZE"])C+??-M(CM19CB
MZ9F>BC"W7[RTTI?3BFE!$9D:U4/PY$0U_P Q?'1#8C2XYZ9858\:R"3O=A.X
M%KMRI42.Q=,=S%]EU*6X\-Z&W+B.*2M1&HO:$&GU2/B9#8LR3?;$RP78HQW3
M$-OA9
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M&0
M
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M=N%@N3A1L4R"2HUOQ7U5T0)CBOEI5R9</C]8JOJF"&TX
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M2=S;MWLFVP5J/)T_83&"_P#5TC;PQ[$>%J9I_B3X$KC(Q@
M
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MC;18"=<)Q0RY':HOG_K9>0>?R>]/>]=B]R.Z&7"BX
M
M
M      XGGF8[3K\AU###*%.//.*)*$(255*4H^!$1%4S,!I9F&7O[F7-$LS4
MC!K:]KQJU*(TE<'$'0KC)0?--?V!"BX%ZYE4RH2MAF9F9F=3,^)GX@     #
MJNG.D3+?9;+$3<<@O*U-VF"HS2V6@JN2'U%\AEDCU+/QX)+B8"?K=M%B36*?
MBM?HYY(4V<Q=<CN+QFTY<9S!D:3<T'ZK*::4-$="3PYUJ0CZ?LWDUBCF6(WJ
M+D5NB%IAX_=D%#E(9372TU-;JVHTE0D]1!>D@& MRU>V2K7/AR;/?(!$<^QS
MD=.0TD^2R(JI<;/P6@S2?E!+M@.K.A1KE#DP)B-<68@VWB+@HO$E)/P4DR)2
M3\#(@&SNS^6R\HQ<HUX?)_),8?5:KZ[XOJ;22F95/(^T:5_;:O("$L
M
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M*3&UA_#COEJ9HIDGP)?&1C
M      ?)J2DC-2B21<S/@0#B.5&3\J0TFOE6DOJ@.1#B'$DIM9+2?)23J1_"
M0#[  %*D1&9GP+F8#KE,B'RE,F?D):?T0',AUMPC-MQ+A%S-)D=/B ?8
M                  @;N3PG+=PMH<IQ3"S:^?KHP;,=MXR2A1+2:55,S+P,
M_I^ 3'%9=;&R9BC/I,MN'48LM\3-MMT3,1OI'4\,,QVFW:VMEMV7+L$G+4RR
M2T3K:1RV=!)K1:FR/29%QXERXD/.YN79L?16.N-K['R_YKT&LB:9.&8G=?[,
M_3X&T'9$4N1?<@NZX#\6WO&U'B2W4F27EI0YKZ:C(B42>1T\1LZ+'-N.ZZ=T
MS'I>8^==5CRYL..V8FZV+IF.JM*5[WITZZX^M2WEFXLR(C4?.A</I#<>)I1A
M-T(OQYP6I?\ I#Y_^9,='EN_)]UR>;^[C^\EBXD?S@]Y-1?1(AN8O=AS<_XD
MM>;G1660%<R_&&-6M/!\AOY?P)[G.T_\S;WI=SHR3NCARCY*M,LOB74<S3>[
M<[NL]ZU?[Q_A[GA5*#I\ RX?=8<_OK)+_P $D_VI7TAFC>PSN8,X?W)WPHVK
M]28S,#*,"_B'C)$=224LJ_\ .%G]4:=GO7-C-[MK!]R.,ETO);5T^'4.AI]S
ME:GWO V*V^4:L'Q0SY_-<;E]H1#@Y/>GO>KQ>Y'<S 49
M
M
M         !K?OEDZYKT/;> Z:6KBR5PS)U!\4VXEZ6HE2XD<IQ)DK_@TJ^R
M1&1$5"21)2142E)4(B+@1$1<B(@2J     ZLV;&MT21/F.=*+$1K>72ITY$E
M)>*E&9$DO$S(@$\;5X7(L$"3DE_C]'+<F;1[3%67K6Z D]<> D_ R^6[Y5G^
ME($)8$!_08##LTPFT9M;D1IRE0;M!JO'\C8(O:8#]."DG]<VKDXVKU5%YZ&4
MC6!E4]F3<+1>8R(.06-_V6]0D5T$NFIMYDSXFT\@R6V?DX<R!+M ,PVINB[/
MN:U#,S3#S.TNQW4$7JG-MA]9E:C\ILK<27H\P#;L$
M                                                      #&,QQ>
M!FV+W_$KFZ\Q R"$[!EO1U:'4H>2:3-"O Z&'1,=<3'CV)B9B8F-\3$QWQ-8
M>,._G8W+VPF82WMMD<FZ6;*;O!QTD7M'44U.N#BFV%)<93726GUDF53\!Q-5
MRK''#-EU*S$;>WIV0]QRSYJS9..,]D3PVS=$V[-EN^)B9W]70Y.UGM.P[/\
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MR*=3/!C90
M
M                                '&ZMMIM;KJB0TVDUN+5P(DI*IF?P
M -#(]S>R*=>LOE$I,C*YSDQM"_E-PV_N,)KT)902O2HP2[@    "BE)0E2UJ
M2A"$FIQQ1DE*4I*IJ,SX$1%Q,!F>V>&GE4R%FUZ8-&-6YTG\-M;J3(YTA!F1
M7)]"N)-H/]@29<3^Z'PT@ALIQXF9U,SJ9GSXB!0!4 ^F @7>FR(BG9<]BHTN
M0'6K-DYI+]DM\M>F.ZKRG'?45#I\E1D)$9F1D9D94,CH8)5@O.Q,HP&<RLFG
M(V3P&U.'RZ4LU1G2^%+E &]) A4
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M*4(UR92E$B.N,FOL<KZQPS/X12^:VRS8K:7PV"+D0UV\J
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M+K+K=\49",:H
M           ".MW+N=BVTS6XI6IMQ-K>CLN(^4ER411T&7G)3A -4X\9N%&C
M0FTDAN&RVPA)<B)M)(^H"7,   !_1Q 7S",*5N'(1<[HA2=O83I])LZE\_2&
M5<4E_P D;47$_P"NJ*A>J1@AM21$1))*20E*22E"2HE*2X$1$7 B(N0BHKZ#
M  #@  ,8S:SED.&999.D;Z[C:9;;#:3TJ-Y+2G&:&7(R<2F@#5"TS#N%JM<\
MSU*F1&7EGR/6I!:_]U42EU;^M;,&-):5H=AW.V2&E%X&W.9/Z)5(!Z"@@
M
M            !I GCO;O)_J38?\ WH\+YM_@CS0Q8/<\,^>7F#[P[_ZH\D_U
M?L?^3J%&1I& S6$IVY8#>[:R9&YC=W8OJV>.M4:4U["^M)>1M9-&KS*J,D;;
M)CJVL4^SDB>N*>&-OK88C]E8_MK?ZHAC97Z+.X+_ +DMT_\ 5+'?\K2(6;./
M?L6%?V]O_)'!EQ[KN[TPU\WO6]_HEEQ<ACAG5
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MI?.5IEG&D+90;:76U-H=:=Z9J5I-25T,M1E4CH=!3);PS0PY..VK/!1E
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MHFID:O/Z1OZ[/BR<$8[9BEL1->F>MS.6Z?+A^).2Z)XKYF.R.J7I*-!TP
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M<IZ+%-QM+K13VS)SVIA#J5'J)3:^- 'M&E1*2E23U)454J\I'R ?0
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M)<]"ZDM/F.G@/*:[2_ELLV[XWQW*Y\7P[J1NG;'<EP:;"
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MF7BJ9 2DO*9S&2(@'H."
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M2H_,XPMOZ:B&;%NN[F#/OMG];ULS&)G
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MD^AM1T2YIJ9+0?@M!J3X5J,%ULV[VY9?%VYDPJN
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M-'FF+XFGBZ-]D^2?I;<?Q,';;/DEZ"CS+5
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M^%7F#X>4TB1A614^:T*4M+:4S[<HU*,B(R1-94=*\^! EZ#^4$
M
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M1N6W1=%8<PA(         5        J7E      %*EY0%0
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M:2_9#-%5L:O$C(R+RT'9P:^R=EVR?(^=<R^4M1CF9P>W;T1]:.SM2M+EML%
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M3@E9F1>0!*&/X[8,3M$+'\7LD'';%;4=.!9[;';BQF4UJ9-M-)2E-3.IT+F
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MS+YE=4]9_GNWQYWLKBZ:EL=="]!GI*IIIR(!FA$22)*2H1%0B+P(!4
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M>L<FL6>@Z5H<9XD.'2G-)&7G'+SZ'-@]^W9U[X\;'DP7X]LQL\B4:C580
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M0DE&=2H1$!1MO:4Y]:[BU"DYVC-K0M!MQISMM3!D]749%I6V:T2.%*J]4B\
M$PI(R2DE*U*))$I7E,BXF($);A6B/?;7D<%]PV%H4J5;YJ2]>-*CGK8>13Q2
MHN/E(S+Q 1O8\ ZEO=O.=P8&07>>RKVJT+0I<:)%,J&U$,U%H6I/KFNFJO"O
M 2-A]H;G-EXY<;1<)CEQ?Q&[2K*S<7CJ\_&8)#D9;Q^*^BXE)GXTJ?$S 2H
M             +$O)\;:<6T[D%L:=:4:7&U2V24E1<#(R-=2,@*.Q$OEFN#B
MF;?=H4]U"=:VH\AMU24\M1DA1F15\1":+9+S;$(6/7#+I.3VIK%;2AQ=TR,Y
MC)PHZ63TN&X^2C0G0?!53X"4/O$\RQ7.[+'R/"\AMV4X_+6XW&O5KDMRHSBV
ME&A:4N-FI)FE14/CP,!DH        "V2[Q:H$N! G7*)"G75:F[7#??0V[)6
M@JJ2RA9DIPR+B9)(P%R+B1'Y0%0
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MS+*.\AWI.%S0YH,]*B\A\0'U,N$*W1G9EPEL0(C!5>ER'$M-(+RJ6LR27PF
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M(-2"2HT&HS29Z3XD D6%>+5<G)35NN42>[!7TYK49]MU3*_L7"09FD_,8"Y
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M%T3N2[(D4KQ 5
M      8'N-N+CFV&-2LFR5]28[:DLP(#!:Y,R2YP;CL-_7+4?P$7$^ V--IK
M]1?P6?\ 3M9,6*<EU(: 9;DF;;N36+AG[Q6G&XSQ2;-MO"69QT&GBVY<'.;[
MI<Z?)(^1$/3Z?38]-%+-MW3=ZNJ&:[-;CCAQ;^F[U.7F,K44 * *@ "@ 9T
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M6Q3;28[?4W!'$:P
M         (*W_+_X7QE7UJ,JMIJ/R$9.E],P$%4,SH1<3/@0)9=L\VVNY7K+
M%D1JN5P.SP7.'JP8/W-1),O!Q]2E'Z"\@(;+^;R"!TIC,AYM2&T19+9TU0YB
M#-!F1_*)2:G7TD)@8N=B=(GFV,5M4(I!D;DMB0:3,_LC21)-1EX5()'U)QU,
M2,N4F1U)"3;-Y))HE22,DEQY\"/@(&9GPX%X !E4C+RD9'\("U-VN-&AJ89B
M,R%J,E/]3U3>4FM#-1<C+D0"WI@R4OKD1\9M$.6X6E=QD+0^X?IZ:#4="\IB
M1=HT):'?:9D@YTVFDGS3H0VD_K&T5.A>?F8"X)YE7AQXB!#>1.FJ#>72+6H]
M:B3XJJLJ%\(#B94E]N62'29AOMM.D\?R66UH,WCX^"229^8!E^RC:G\1E9&:
M";:S.[S;W":YJ3%>634;4="K5II*OA$B7@             !^;'M[[:=N^YG
MN5[DL;W&OM[L-OQFZ72YVV199K,1Q3SMW<94EPY#+Q*3I/@1$7'Q\ 'J!M;V
M.[%=N$?=#-\7RG,,B1=\)NEER*)*N<1Y2;>XV;SQQC9CLFV^9-T0HU4("&I>
MS3.SR/=S=SZ=FRS)>/J*Y'<UYLJ)[6J2;$95&FH3KK*4$V:2,ZZEJJI7,B(0
MGWL8W/PK9;L$LVXN>7 K1B^-S;T[+<;1U'G5JN#B&F([2:&XZXHR2E)>/.A5
M,@LED][+M?*M^07?(MH\XQJSQ&5.8C=5,MR(]Z<2X23C-OT;8:>-)FHDFXHN
M!EJKP,)ZS[OOV\V]V4VEWQNF'Y),Q[=Y\V;/:8Q1/;(FE*U&J3K?2W0B;/Y"
ME ECVW7O&-FMP9N\-R.W73%]M=H;,Q>9.XUTTI9N3;[Y14HCQ4$:R4MTR2V1
MJJNI<$@A%4/WK.!^TVJ^7S9#/L>VDODLXEIW5DLMJB.F1T4LF4EI422]91(=
M4JE:$9E0!N1OCW4[4[#;:67<_);F]>[3EJ6/Q&MMG03\J\KD-)>;]F2HTD2>
MFHE*4HR))'Y3(C#7;;CWC.(Y!N'C&VV[6T^7; WK.U,IP:9E*$^R7 Y2M$:J
MS0TILGE>JE6DTUX*40#2G?+OKSNT=XV/2K&]N+8=K]OKD5IS7:EN.A#]]<@.
MR&Y#L*&9_=DO>KI,UIU$GPH GGNCOVPF:[\]E>:9_;MR+9EV3,6NYX/:[.N'
M'B-)F3&WF&;J3SR'6%MO++J*8(U&FJ &QF[_ '^[4[*;PWW9S+L:RA^\V:TL
M7)JY6N*U+:F/2X_7C08K+;O76\[\@O4)->)F1<0$1X;[U;:"[GED/.MO\NVX
MO]CCF_8<:DQSFS;P[J)*83++:&UM25ZB-*%I))E4]?#B$C=N7O!L&W[W)>VH
MN> Y#M9FDAA^38+=?C2KVU$9/4<;46AI;+Q-U62%(H:2.BCY&&Y^XN;1=N<&
MRO.YMKN%\AXG;'[G)L]I:)^=(1'3J4W':,TDM:BX$5>(#Q-[2N^'.KEW)YA;
M,YF;@YOB6YMY1:\!Q5UIM]O&#G7'[DN>WZAQT--*Z:C(U4,J4 ;<;F>\\VAV
MSR?=?"+AA.43\MVSN#MI@VUHHQ-WN8R\;3J8KJ7'%-I0DM:E.(+AR(SX )-W
M;[[ML-G=N=M,OR&T72Y9ANM9(=\Q7:ZUZ7[D;,MI*]3RS)*4-H4KIDNE5JX(
M0KC0+?VW]_.W>_V8N;:73$[[M/N4IE<FV8GD2*>W--(-;A,.FAI6M*"-1H6V
MFJ>*=0"P;P>\2P7 MQ+UM5MQMWD^^^;8IU/QPA8N@O9[=T?V="W=#JEJ:^OT
MHTD?#5JX ,JPOOUVLS[8_.]YL;Q[)KC)VU]F:S+;:-%0[?([DIU+31M-DOIN
MH4:C,E$HODJU$1E0!I5[O'O#SS)MPLEVVW1N>;;DW#/[VE6&W^0VF3;[!&C1
MY3SK$Q[U#9-RB2)-#J9 E.DOWJ6U/LN6Q['M;G>09;C=S<M\7%(D1IYR6W'<
M=:?F&]%5()EAM3=#4M-3-142?&A#YA^]5VBN6WR,@M.WV77G<94MR*[M+;HY
MRYC332=:IJY;*%ME&H=->G5J]71X@-FNU?NXP7NKL%^G8W:I^+9'B;[3&38G
M<U(6ZQUR-3+K3S=$NMJTJ(S(B-*B,E)+A4-;]R_>C;88EF5YQ7 MNLIW?@8L
M^N/E666%!)M\931Z75,KZ;O40@R,C6K0@S(Z*,N(#8!SO3VEE=M]U[FL<;NF
M2X?8UMQ[O88S;35UBS%OM,+BO-.N);2XV;J5'Z]#2=2,Z@-9LG]Z_M?:H6.7
M;'-J<TRRQW&.TYDM[0RB)$M3[A^M"]I6E;+\ALOE)2X2:\"49@.?O7[R8\#M
MTPV_;,7#*H$W>>$W<\+W'LS!,LVMJ)(:.2U.=7JZ+BJJ:TT,C41E7RA,78'W
M#W#?+:6+:K_"R>1EVWD"WP\JS/(64H:ODF7UU^TPWDG]V21-44HTI\. #?
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MDT,+BK/0Y+2W5;14;TGJ\2H?$)E,12'M^(2@G?-9% QA%:&<]]9%]K'65?\
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M4KLHW('M6^
M"A@/-?<3*'-S-UKY>'7>OC&W<EVQX;'29*:5+10ITVI<%*-9:$GX$1#UFBP1
M@P1'UKML]W1#:RS\+'%D;[ML]W1#H>/TQL-16OAX@*<?$@%>0!6O+D >'#F
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MMN!G^9\M15/BXR7P?C ? !Z4=CRB5VE[#&1DHOQ89*I<>).N$?Q<@&UH
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MZ_;*92,/RU;75W3U6^F%=)[_ (&[H]XZ(
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M9)QC\AO3FR5] AH\VFFFCMN]#:C9I_VO0W\'FFL
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M4T(O7:2=*<-1^49(R4LFWKFK'\+BR1DGHBGE3H,;.
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M55[O9JNG!JQ-HKY#-YC] 6^6/YC)]WTITGO3W-TA[AT
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M%SBPV&9#FKGK=0@EG7QJ8#(
M !0ZE2GE 8'ANY^ [@R;["P[++;?KAB\^1;,DM<=Y/M<&5%<-IUN1'51QNBR
M,B,TT/P,P&>@         "%]P),IW*K;#A(8<E6VT.S&4236E!E(?0RLB4BI
MI4:6Z$=#Y\> @G<QL[A="X'CCU:<=,N.HOCX5^(%:0?.-S_^77_^E1_T1**'
MSC<__EU__I4?]$"@5QN:3)2<>D$9<E%*CD9?1$)?2KG=5TUV"2NG*LN.=/C4
M%"KY.X7+_P"7)'#_ )5'_1$HH?.-S_\ EQ__ *5'_1$)H^D3;NX9I:QI]Q9%
M72<N.FOPF9T$D0N&-JNS.56"7<D,0'779<%<**XIVK#S/40AYPR(E*);)*J@
MB+TB$PGH2D                              'GA[SC)LEP[MNA9'B&0W
M'%LAMF;V%RWWRU2%Q93*M3Q'I<;,CH9<#(^!ES(!HGL'[UW-L8]AQ_?['"SN
MSI4EH\YL;;<:[,MUH:Y,.J69.DO['H4?,ZF ]H-I=]=J-\K,=]VNS:W95%:)
M/M\-A>B;#4JGJRHCA)=:.O"JDT,^1F EL      >5_>15&T>]J#_ -,*(O)0
MY\1S_?"FO_E;O!YW5^4?]YQ?M>9"/NM_XU[S?P):O\J<',Y1[MW?'I>L_P"0
MOQL'W;O/#V,'6E\[.()"(1O%19"@  'R 9:Q^PL_:)^D(7:G]Y'_ ':63_6.
M+^XOC5UGX?AAW_EG^>M^[=YFH_9D9^R[_**M4W-:BIPY6N47U1CY+[N7[T>E
MUO\ D;\;2?Z5WH>K]L22+;;T%P)$9I)$7F00WI>)C<[P)
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M;Y_6]$,NDCV9:H4'I6T *_4 4 >DO:FV2-HVUTIUK[<E'Z4J0GZ@\%\PS_\
MV3]V'.U7OMQNWEO5N1N+(\&X<=JOI61_[T;/RM;_ !<D]D+:/?+<<>U;X
M    "E2\H"H           %0         !2I>4!4      *EY0 !!'= \]'[
M=MZI$5]R-*C8?=78TEE:FW&W$1UJ2M"TF2DJ29$9&1UJ \)>WSWG&]^UC-OL
MNY*?Y9<0:;;03LYTF+]'014^YSJ&E_T/),_(L@'MSL3W<;&=P\=IO ,O9;R0
MVNI,P:[$4*\,<#-7][+4?5(B*IJ:4M-.9@-F     'GAO-94XQOQ=5M4*'N)
M8V+LA!%1*9EO5[,]3SJ025'Z1ZCEN3XFFB/LS3P3M;-_M8(G[,T\$L7,;C5
M RJ 5H0 1U 5 4 5 ?;?[(C[8OIB)):5WMQ#M[O+K9ZFW)TA2#+Q+J*XCI6[
MH>DQ12RV.R%L%F0     5 ;%[/Z_Q<N%:Z/G!73\GR"K0:>H][P.+S'\2.YG
M626A=[LTN''=5'N#>F5:)2?E-3(Y]1A9>A14&&R[AG;N]#5P9/AWQ=T=/=TO
M079O/D;E[=8YE2S2FY2&/9K_ !TT+HW",?2DH-)$6GUTFHB\AD/*:W3_ )?-
M=9T='=T+Y\?P[YCHZ.Y)XU6$
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MB?@RZ_>8!^<:[-/RT1/P9=?O, _.-]FGY:(GX,NOWF ?G&NS3\M$3\&77[S
M/SC79G^6B)^#+K]Y@'YQOLS_ "T1/P9=?O, _.-]F?Y:(GX,NOWF ?G&NS3\
MM$3\&77[S /SC?9G^6B)^#+K]Y@'YQOLT_+1$_!EU^\P#\XWV9_EHB?@RZ_>
M8!^<:[,_RT1/P9=?O, _.-=FGY:(GX,NOWF ?G&NS3\M$3\&77[S /SC?9G^
M6B)^#+K]Y@'YQOLT_+1$_!EU^\P#\XUV:?EHB?@RZ_>8!^<;[,_RT1/P9=?O
M, _.-=FGY:(GX,NOWF ?G&^S/\M$3\&77[S 5+WC79F9D1[TQ$D9\5';+K0O
M/_@8#\Z6XFXTR/W ;E;I;69;/LSETR^Z7?%\LM#SL)]R-(D+6RX1^JK2I!_)
M67F,@'HGL)[U[,<<*'8.X+'3S:U)4E'X]V%MN/=&6RX&<F#ZK,BA>+9H4?B1
MF ]G=I]\]IM[K-\];79Q;,LC-I2J;$C.:)D35R*3$<TO,G7AZZ"(SY5 2R
M     "%,N_[PT?ZM(_RTQ!=N=82QJ'R :)=P>[O=1A>Y<NP[1;>/Y'A+5L@O
MQKNUC[MS)<IY!G)0<A-2JA7#3X LA3^<1WZ?D@E__N>]^M H?SB._0__ .$$
MO_\ <]_] "C:WMBW#WZS_P#';^7##7,3*TE"/&'7;0Y:3D*=ZA2$D2Z=321)
M.I%P EM8"KN0?V5?VOU06M5C_P :,?\ X05_DSPA,;TSB4@  X)+*GFS0E>@
MS\0&(SL7F2M6BXDWJ\R_J*(!B$[;*[2ZZ,A2U7]*[]1P@&'3=C;_ "M6C,4M
MU_2/_4>(!A\_MHRF89FC<%+5?^#D_4?(!A\[M#S.571N>VW7RM2_J2 &'S>Q
M_/)533NXRW7_ (&;]\@,/G>[ZW&EZM&]+#=?^ G_ %)0##IWNU=T)6K1OO&;
MKY6+C]26 PV?[K#=N62NGW#16J_\!<_J3 &-'[I3>0S,_P"<E%XG_8;O]_ E
M3\TIO)_M)1?VF[_?P"OYI3>3_:2B_M%V^_@%/S2F\G^TE%_:;O\ ?P!^:4WD
M_P!I*+^TW?[^ /S2>\G^TE%_:;O]_ 'YI3>3_:2B_M-W^_@#\TIO)_M)1?VF
M[_?P!^:4WD_VDHO[3=_OX _-)[R?[247]IN_W\ ?FD]Y/]I*+^TW?[^ :\]S
MW8=N#VX;7JW'R?>-G.;:5X@VKY@;:GIJY,-9)=,Y,IU'J:?L:^0R$#S^MUON
M%YN4.S6:WRKQ>+BXEJWVF"RN1)?6HZ$EMILE*4=3\"$H>J/:_P"[:W^N5ZLF
MX>99A<>WF-'6B1&;L[YIRMQNE4I/I*Z44E<2,G34HO[& _0):H*[9;8%N<GR
MKJN#&:CJN4Y25R9!M))/5?4A#:36NE5&22*O@ N     #RU[UDDWM9O4@TT7
M\[-*(BY46Y;U5^$4U_\ *7>#SNM\I?[UB_:_PH,]UO\ QKWE_@2U?Y4X.9RC
MW+^^/2]7_P A?C8/NW>>'L73X/,.L^> E"G,1*51* _("8/#RB(@4.M#X^ 4
M*LM8_8&?M$_2(%FJ'>/_ -VMD_UCB_N+XU=9^'X8=_Y9_GK?NW>9IWV=R$Q[
M?OXI23,UW-;2#+P4Y;WD%7^J&/DL>SE^];_ZG5_Y'FF;2?Z5WGAZYQD&W'CH
M/FAM"3IYB(AO/%N8!U7F%N5TN::^D!;G;6\NM)!%7T_H@.@YC\E?*:1? K]$
M!T7,4FKJ97(DU\R_UP"WN81<%\KN15\SGZ\!T7-O;FOE?2+^E<_7@.@YMC=E
MUID1)K^E=_? %O<VEO*ZTR9)?TCW[X(2Z+FS5\76F6$FOZ1[]] 6]S8Z_KK3
M,$E7](_^^B4.BYL)D2^6;)+^YO\ [\ Z+G;SDJZTSI)?W.1^_@+<[VV92Y6F
MX"4U_P"#D_OX"WN=K^5KY;BH3_<I/WP [&,X YM1=<E7DN5Q[K$=M$9V1.?U
MM-1FB?=U$LWG%E15/ _@%[%99A;%X;D<1,ZRE9KU#4=#D0TLN$1^1>DB4D_M
MB(75I#D58,6<D>S?-EN5.)LG3AI-/7)L^2^D2M9)/[*E K)P6]2BL7Q\SX6[
M1Y";>?13^I<(35'!#Y+&+2DZM+GQCYD;,QY)_&:E&%3@A]'8&R42F[U>4*+D
MI4U;E/ZHA%3@[9??S3/(R-&67A)I^353*J?&W7Z(5.&>N6$9ADUEVXB0I.1Y
MVJQ-Y')<AVTCMS;BY4K171J909D?K$6M7*H5@F)ZW;P&5A.28E,<PY^VW M+
M]HOTJ"T;9E<&44=9>U(2K4A2B.G+Q(*[4Q'LT['4N5DQW((N#W.]6^/*4PXF
MVW>>K4VHB0V9%&?6A23T*>27JJX?&%%:[(9]>,;M&26MVPWBUMS[:Z24E").
MDV^G\A3)IH:%(IZIIY<N7 &1C&/8G9L:O[S-E:=Z;=M)4N6^[UW5K=<TMI-1
M$E))0A)DE*2(B"-RF^[P.[FZR^9([!\Y=SA-%\#FL_U(+(GNDAAF]2#DOMQB
M<B,DR;JB02B2I9JH:J%P,^(\-\U5_,6339P^EI:KWH1)G>TNVVYL^%><C6X]
M<(<7V1B; N!,ZF24:R2HDFI*J&HZ&./I.:9]);-N.8I,UVQ5CLS39%(1V]VG
M[4NU.-=K]'/PTS6G2_W;1C?CYEU4;^&?!]*\:J_L6Q_M!PAS_!,KO;%>1J3'
M=_WJ1ECYGS]-ML^-:-5<M+G9Q9CKT,_GI/PZL%H_U+A#)'S1D_RX\<I_-SU+
M4]V;/E_@VXC9EY'K<9?12Z,L?-,].+R_0M^;[&S6U6!'MKA<#$UW$KL]'DR9
M4B>EOI)6Y)<UF24&9F1$5"XF.!S#6?F\\Y:4K39W-;+?QS5#VX_:CF7=-D4Q
MG$MR6=O?Q(F/'.-QN6LY?M9$E!%[*^S31T_KJ\^ [?RK'M99[O2V-'OE@7YI
M3>7_ &DHO[1=_OX>R;Q^:4WE_P!I*+^T7?[^ /S2>\O^TE%_:;O]_ 'YI3>7
M_:2B_M%V^_@#\TGO)_M)1?VF[_?P!^:3WE_VDHO[3=_OX _-*;S?[243]IN_
MW\ ?FD]Y?]I*+^TW?[^!"GYI3>7_ &DHO[3=_OX$J_FD]Y?]I*+^TW?[^ /S
M2F\O^TE%_:+O]_ 'YI3>7_:2B_M-W^_@#\TIO+_M)1?VB[_?P!^:4WE_VDHO
M[1=_OX$'YI3>7_:2B_M%W^_@#\TIO+_M)1?VF[_?P)/S2F\O^TE%_:+O]_ '
MYI3>7_:2B_M%W^_@#\TIO+_M)1?VF[_?P!^:4WE_VDHO[1=_OX _-*;R_P"T
ME%_:;O\ ?P!^:4WE_P!I*+^TW?[^ /S2F\O^TE%_:+O]_ 'YI/>7_:2B_M%W
M^_@%/S2>\O\ M)1?VF[_ '\ K^:4WE_VDHO[1=_OX _-)[R_[247]IN_W\ ?
MFE-Y?]I*+^TW?[^ /S2F\O\ M)1?VF[_ '\ I^:3WE_VDHM?[3=_OX!7\TIO
M+_M)1?VB[_?P!^:3WE_VDHO[3=_OX!3\TIO+_M)1?VF[_?P(83N5[L;=7;O;
M[-,[NO<#'O%NQ&S2[M,M"6;H1RFXK1N*9JN8I):R33UDF7E(!Y0(<)26J%Z[
MYI)IHBJI2E<DI27$S/P(B ;\=O?N].X7>*1:\GF1W=F<60XAZ%E]Y2XS=5)X
M'U;?!0I#U:'5*W%-I/RF _1UM;@LW;?"+)A]PS>_[B2[2UH>RS)7D2+A),^>
MM;:$>J7UI'4R+@:C 2$  !\ &AG<;<H=SWGPJU0G$NRL6Q^;*OAH.O1*<M*8
M[:_(:M!J(O(=1Z3E%DVX+KIW3,4\#9C9@FO3,4\".QT&J>8!0SH J1U\P#[)
M"S*I),R\M!%45.FY]@KXC!-5";7Q]17/R&!511=-)K<,FD%S6LR21>DU4(@1
M5&67[CVFT1I,*SR$7.\N(4VA3)ZF8YJ*FM:RX*,O!)#/CPS=-9W-W3Z*Z^8F
M[9;YVM''F9FHSXFH_$_*-UVU02  "@"H"AG0C,^1<0&VV"6A5DQ6U1'4FF0^
M@YDI)\R7(/53X$T'/RW<5TR\]JLGQ,LSX/$R[SEPIXBC F3M2N!PLDW>Q*ID
MPB; OT)HOD)]N:4A[AX&:FR')YU96W'?V3'B;66>+%9=WQXFZ0X+6
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MCB?N+XU=9^%X8=_Y9_GK?NW>9IEVC)([7OR=::;TV:?^B."G)/=R]\>ET_\
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M>^7[&\Y 0MR0I)\C-"G$E4<KG-]+;,?3MGQMO+'#BLMG?MGQMV!P&J
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MZ\_TM!(O()7C"K;\^[DX=;NF3K%F.1D,\C/Y)14=",9E_;GB,OM0&Z?($
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MU*/RGY!Y3/GNS7S?=OEAR9)R73=.]E@PJ
M                            UO[B,=1)M=FRDDF35K6]:;^XDB(TVZ[)
M)@W5'Y&7NFOCRJ9@()QN0N58;8MXC3(8:]CF$?@_%,V7"/SU14$KV('UB>/,
M75[+W8<Y5ER.SWEE^R7QA)*<93*AMJ<;>;.A/,.J0>MM7/F5%"4)2QC,Y4>Y
MHL=[B-V3*#1J5;"4:H5R;3S>MSRJ=0O$T']T1R,C+B($RPKA&GHU,+HLB]=A
M7!:?@\2\Y .[Y_( >(#K2ID:$WU)+I-D?R4<UJ^U(!$66YPIJ6S:(4-=WO\
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M(4Y)[N7OCTNG_P D?C:/_2GSP]?V^+:/'U2X_ -UXU]@
M "+\@R"#C.:QY=TZCYW6S'%L,*.V;LF1);D$IUB.T7%:C)25'X$1549%Q%NA
M2OM>!%[F2RDW&^NR,,R1LY%S?=+I1XT@B31*2*K<DSKZO(B%[8V)=.Z7JPW>
MVRK5?L=OAVV8DT2&)EFD&CTU2A95$JS%5M8R2V0FFV(N;,M-,I2AB'<K6\T3
M:$E0DD:&6R(B($4F.EW497J]9K(<6E)\$JDN1S^)7CZ0V'M=BX-9'),M1V^'
M/25?5M=RCR754XGI9JE1GYB.H)K/4Q#=*Y1W\2LEPBGUX3MWBR75$1U2TTEP
MUF:>9&V9^L7A0QJ:O46X>#BV1-U/"B;XBD]:,",E)2I*B6E9$:%I.I*(^1D9
M<R,9F5@][3)N>2VV%:DK?DVAA<F[DPO2XAA:B(V274M*W"X$52/CX#G<SU&#
M%CMC/MMNNC9W=/=##FNMB(XG4R%IYAAE!1Y,*VO./+@0Y1JZA*)K2XHDK4I2
M4J,RH1GSJ? >+Y]ETV7-;\"E*;9C9$ST-+43;,^RW?B1D(M<&"LON10&6%I_
M2FRE)D/I%D<-ML=41YG0B-E%GM=P*U,L66\J*&_#+HP9R^$>4RG@V:7.1*)-
M"4DZ&+RI;--DLEI527B2A2S+U'R(C.GF7S^B(9&)9?E+V-LVM,6&S.NE\E*B
M6]$M\HT5*D-FZM;SI\2+2G@1<3,$2QNR9W&SS#LI>1;W+7/AVR6F5"6XEYM2
M3:=03K#J*:T&I)EQ(C(8-3MPY(_5N\TJW>[+ XJE>R1#J9?<&OU!#Y+9[L.6
M@3>"\W>R9!CCUG=;:E3'F$J<>(S+2TEU>GA6E:4/@.QR'369]7[<>['%'?$[
M&;!9%]U)ZF3[.WB9E.*3KM?$-2ISUU?0I3B4NT0A*"0DC4@N"2X%P%>=X+,6
MKNBR*1-)\,[T9[8MOI#/KS;X'S1=EE"82MN%(4VM+:4FE1-J,C(TD5#(<F8I
M#%"V[(L&[G$1TB]6!8Y;A^0NJ3+1?1,>@^5K*ZN9ZK)\LPSZ6/;\"65J)5WR
MI9?7WR41'YDH:3]0?0702QM!_GC)?\5A_3=&.],)Z%4@
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M2$D#68@
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M3<5F2X9ZU-L%J<57U3-1)2DBJ"&QA$1$1$5"(J$DN! *@
M      #P#M6[VW&R?O.]Z<XW/R=C%,79:N4%=T>;=>24F1&B])O0PAQ=5:3I
MZM/* [>]^=,>\:[D]H]O=D8-PN.V>V3ZIV4Y\_&6S&;:>>:7+DD3A$:4]-A+
M;25T4XM7 J ,^[R=V\DN'=]B';YFV[U\V([?/FB$_>;Q87UV]RXMR&'''#=E
MI(U:%.H3')7%#9EJ,M0" ]E&MI+9[RC;JW;-9W<MP<#B1I$>%E-ZN+]SDOS"
MM3Q2&FY<E*5N-MK]5-"T\]->8$K][P:+D_;AW)Y/N9A+)0K3W$8#<;)>5I2:
M6C?>:3"N)<.;V@FWD^=0#U6[&-H6MFNV3;3'EQO9;U?()9)DWV2YMU)+_K^)
M&AHVVS+]* D;N [=MN^Y;#X&$;E%=#LEMN;5VC?-,PX3WM#*%MIJX25531P^
M% $=[(=H^U_:E%SZ_;.6^^W>^9';4]6UWBZG)*4[!2XY&8;6MM)-&XM6DU'7
MF U\VF]Y%L'F&*;@GN]:HVRV4V*3+8O^WURK+>N2":T.:3;80EUU:DJ:4A95
MY<:'P"-/=#V.[HQ'?',RM[UMP[+,HCHQ9"R,FW#B-O&]TB/F3:7FT5+@9E0N
M0#V'                                      $*9=_WAH_U:1_EIB"[
M<ZPEC   ,!0@%0 !W(/[*O[3ZH+6[U8_\:,?_A!7^3/")6A,XD
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M8CRMG21MEGC!FN5>W/%R\SU?$[I_WH]RWDO;0?YXR;_%H?TW12Y,)Z%$@
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MBN7<0H ,)S\J8]'\2.]6@C3Y2]K14OA%\6^>Z?,VM%^+X)\SUL'B(:P
M                                                     .-;33NG
MJ-I<T*):-1$=%)XDHJ\C+P,!@^6;:X;F;B95[LR#N;*=,>^15JBSF^%"I(9-
M*S(O E&9>8! EFL$7%MP\VL,.ZS[RS!MEI4Y)N'34ZTI]4AQ+1.MH1U"TE6J
MBKX ,[$(*_T& ^B6HBH2S(O(1@&M9\#4HR\Y@/DO#^@@#D Y6*D\T?D6GZ8$
M+WL>M!;=6R&1FIRV3[M"D'2A=1JX2*T\W$2E+E"\@
M     "'K_P!OFQ>57BX9#DNT&'W^^W9SJW.\3[/$D29#E"3J==<;4I1T(BJ9
M@,^QG#\3PNW%:,/QFU8M:R,E?-]IALPV3414U&AE*",Z>)@,)W2V+VBWL@Q+
M=NKM]:,WCP%ZX"[@S]V8J=3)M]M2'4I,^)I)5#\2 ?-HV%V5L,[&KK9MJ<4M
M=UPYIMC%KI&M49N3!;:U&@F'THUIH:U'6M3J=>8#S-W5VX[FN\/N0QC#-Q-J
M6MOM@=E,PE3DY0_K0F^P&W4Z'&E.*-3JY#;24$EM.A-3-1@/8M"4H0E"4DA*
M"(DH25"(BY$1$ ^@ _, @'/^UKMZW1R"/E>>[0XYDF1QG2>^>'XO3?=<+@2I
M"F5-]?@5/NFH!-=FLUHQZUP;)8;7$LMFMC26+=:H+*(\=AI/)#;39$E)%Y"(
M!<P                                     !"F7?]X:/]6D?Y:8@NW.
ML)8U %0     !W(/[*L_TGU06M(_\9\?_A!7^3/")3":!*0           'G
M#MM_XG?<;_\ ZFQK]UC *^\I8;Q[;+:S=ZTH*)G>UVY>.R,4O2"HZTF=(]GD
MLUYFAU--1>8!,7<C;=WLFGX9:,?W3M^Q&RBVW9F[&YJ)T>)?BI_@]NM[DI/2
MCDY3UWJZBKP+AQ#5S:S<5[:CNGVUVGP#N2D=QFT&[]JNGMMOO5ZBY#<\=NEL
M:4\VXW/C>L3;]*&ASST+@1@)L[<-PLZL6_G<KV^[J9?-R65BUP8S3;2\75Q"
MG#Q:ZIKT>JE+9&459I32GJ\:F [W9EF^X.\#V^&\V2Y)<IF Y9F\RU[.XM*4
MDH\"R6=2H_7:2E)?X0Y4S5J.ND!L'N=W [*[+RK1"W5W*L>!R[\TZ_9H]WD$
MPJ0VP:4N*;(R.I)-1$?I HNUBNFU.^&-XYFEE58-R<73)7,Q>^FRS.CHDLJ4
MPIZ.IU"M"TF2DZB(C+B TU[65&KO![\S,S,RO^-%Q\A6]9$ ]%0
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MC9+((*^H4YPN3UPG+^.2X/8-Q,>T'^>,F_Q:']-T8[TPGH52
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M;..V<D]5([:O44N)#Q[45
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MF2EGU),MXR]9^2\?K.+5Y3X%R(B+@/-ZG4Y-1=Q7SM\W<P9,MV2:W,X&!C
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M?PR^J^58LC9.W/UI7U%N_<7>'(VUJ 282TJ(E)/4E1$:5%Q(R/D9& ^JU 5
M
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M>2^[E[X]+RW_ "+^)H_]*?/#V;82:&64'S2A)'3S$-YXYR@
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M=74.R"5":>982V@FT,M&\@U&1$53,^9@/B3M?MO,.LC [*:U\U-1B9/X#9-
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M=*U\!H<SU5V&R,=DTF[;/=T0W)F<.*(C?=MGNZ(;_$1$5"*A%R(>;:BH
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MH42T*(E)6DZD9'R,C ?0
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M$9-1M16DM-J6=5&2"I51^)GS,62EW:#_ #QDW^+0_INBER83T*)
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M&1&RXKC1MXDGX$I0D3*1UKYN8"H
M                              -0.X7^-43_ %4F_NQCL:#\*[O]#SO.
M/QK.[TPUHVI_B>T?_+7_ -0T+\O_  8[Y8>;_P S/="1OZ.(W7-5] "GD 5]
M "@  MM[_P R7O\ @Z7^XJ%;_=GNE?'[]O?'G=_M>_SIA/\ C-X_R=8Y=O\
M)_IUN[=_N4]WH>B8YKM
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M26+I?4_+3&C15&Y&CNJY=1]ZBC27&A&?(AN7S2'F\-G%<VC+EY1KN@J
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M-8KOZ^UFQWW76Q-ULQ,QNZNQ>(]OO,.,E"FRRJR-5K%H:U,F?,TJ2E#[)^/
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MJ[/DKYVR96D])1X1&JG C,W3(C/RT%+DPGH42
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MI9\TTVRVAIEM+339:4-H(DI21>!$7 AKL3[
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M19G5'I1&?=7ZRXRCHEM:N+9T0H]-#*1.H
M                                    -0.X7^-43_529^[&.QH/PKN_
MT/.\X_&L[O3#6C:G^)S/^.O_ *AH7Y?^#'?+#S?^9GNA(W]!#=<TIQ  #S@
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MG@)TLPV$T(SH1&M:C]9:U4XJ49F?B8Y.7-?FNXKYK,L%]]U\UNFLLDY#&H
M                                                      Q=N&5R
MO3EV?+6S:B5%M+1\22XK]F?+SG\DC\A><!>%-4KP\.((<*FR\E" <)H/Q*A"
M!Q&@$ODT&7$J^<!\@    *'](!4  %_=$FA='&U%13:RU),O(9'P,@'7CM=!
M*F2KTFC+V>O$TH,JZ:^)).I%Y@'.HS0A2B2:S21FE/E,N1?" Z<*(44WI'RI
MLP]<N3]<HR*A)(_!*>1$)J.\:C.M3,_A$"@!2A&  *5K\ "H   *DFO_ -H#
M[2CX2 ?9-\J\BY@.5*#^#R^D2A9[K:8TEMSK,)>C3$*9F,**J5I45#KZ2!+L
MXJI]B$NT2G%/O6@R99DKXJ=CF565F9\S)/JGYR 90
M                                           -0.X7^-43_529^[&.
MQH/PKN_T/.\X_&L[O3#6C:K^)S)?\M?_ %#0OR_\&.^6'F_\S/="1OHC=<T
M/H>8  5\0 _CH ME[_S)>_X.E?N*Q6_W9[I7Q^_;WQYW?[7O\Z83_C%X_P G
M6.7;_)_IUN[=_N7@]#T3'-=H
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ML?$X#G4=*9>K@:7+M<*4)2B+U6FR^M;;(Z)+X3XF,<S5:&;B$@
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MPY]SM6![C8WF-SLJE(NMOLUSBS'V#3P,UMLN*41$9D5:4 2*1U\P"H
M                                            H?$C*M/. ^&FDLMI
M;05$IY /LTD?,@'$IJOP\P11P*;XT+R .$V^?#X@'&;9TKQ <9H/Z(@<>CCQ
MX^@!\FV8)4TF1T^(!\F1^DO, 4/Q(_0 H &  'H\0  _HJ IY@H/HP"A^0!7
M2= %=!GX /KI^'@ Y$H/D?(@0^B07A7AX"4N5+=3Y>D$.8FCJ5/ !SI:+AYO
M* ^ELI6VI"N2O'R .JU#Z<E$DJ$KIFTZ7E36J?B,$K@
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M7P(U*4HRT\BJ9CC_ !K;=+%E=LSNZMKT7Y>^[779*>S$;^N:=#?D:+I@
M
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MK7HLJ,B,ZGQ6JA5/S$0QS-5HBB6>0A(
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M$J-)I-1$>D^95*M# ?8
M              ',!\&A)@BCX-HC\XD<1L\.7+Q$#A-HZGQK4!\*;X^2G,!\
M&V9^'/F ^31PH?+T<P'STZ\N/F 4-OCR,0*&V?H](!T_-\ )4Z?F!!H+Q*E
M%>F5/+Y 2$W\ #ZZ9\R+AXF"%2;,_P"C] 2/KI_!3P,!]DT9\>1& ^R:IPI2
MH#D2T9_2 <Q,T^ !]DT1<#Y>024<A$1<A"50
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M,_ !]$?/RD J      !\"J? B ?*5)654F2B/D9<2 ?0
M                       (:[@,8W!S/:3,<7VQN\>RY?>8B8T.7)4:$*96
MLBDLDX1&;:G6M2"5X5\.8#RTV.[1.ZK!-U,,RAN';,-AXY<&BN-V7<VI2%VY
M1D4J.AAM:S63K=4TH7&G$N8(>UY<N'($J@
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M"B5)C6NWL$E9JD4-*5N++01UK7B WH33C0J<>0#Z
M                                         4H7D 4T%Q\_(!\&WY#^
M$2BCYZ)>8P**&P7A] 0/CHG7EX\1(IT3\"^ !\]$_)7X! KT3KR/TT .B=.)
M&?FH $P?D^@)%>AYO34!]DQ3P] #Z)KS"!]$T1>@"CZZ9 4?6DB\ 2K0@
M
M        >57O4_XB;._ZTS?_ ':\ TU]WE_]4V*?P%??\F2 _0^       #R
M%]ZZ1%$V!X?_ *1R/_)88#6CW<G_ -45L_U4O?TXP$/T(@
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MUQOVP[!D<9,RT.SX;\!]R.LSZ;AQY2&W4$LBU)U)*J3(^1@AE8
M                             'F\
M                                 "A>0  *%S\0  H 4 4H7D 8=FF/
MM9QC&18:J]W7&_GV$[#5?K')]DN,37PZL5\B4:'$^!T 8'L;L%@FP&/7:Q8=
M\YW*;D=P5=LMRV_2U7"[W><M))-^9*61&LTI*B2(B))<BXF FX H
M
M
M                               #S)]Z#BV07G:K LAM5K?N-JP_)')&
M2/QD*=5$8EPW6&WW$((S)LG#)*E<DU*O,!IE[M[&K[>>XF-E%NMC\C'<4L-S
M*^WHD&F,RY-0EF.UU3(DJ<6JID@C,])&JE" ?H#+B0       /*CWIF(Y%=\
M,VHS&VVQZ=8,,NUS:R:6PA3AQ"N3#"(SKB4$9DV:V32:^23-)&?K$ UF]VEB
MM^NV_DW,85N><QC&,:GQ;M>U(64=,F>XPEB.ARFE3BB0I6DCX)(S >^
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M+]F4:2M;4N_)KJ2A1N*1&0X1(JFI\#68#]$R4)0222DD)25$I+@1%Y"(@'V
M
M                                                 ,1@2^ID4R/7
MY!N\/10!EP
M
M                                                    ^5H2XE2%
MI):%D:5H452,CX&1D?E =>'!@V]GV>WPV(+&HU=&.VEI&H^9Z4$15 =H
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MD$1+61^M35S,P$K
M
M     "*;',ZF?7>-7Y!R>'H-("5@
M
M
M
M                 !@^.;;8-B63YIF>.8Y&M63[AOQI.:7ADUF[<'8C9M,+
M=)2C21H0HR+21 ,X
M
M             0%BLSJ;MY'&K\A4SAZ%( 3Z
M
M
M
M
M
M                         U;PF7U-^,MCU^0JX</0ML!M(
M
M
M
M
M
M                                      TSV[F=3N5SB/7Y"[IP]#C0
M#<P
M
M
M
M
M                                                   !H9M=+ZG=
MAN''K\AV\E3T.M -\P
M
M
M
M
M
M      'G-M!+ZG>7N;'K\AZ^\/0\R ]&0
M
M
M
M
M
M                     'E]LG+ZG?/NQ'K\A_(>'H?9 >H(
M
M
M
M
M                                      I4@%>?$
M                                         !Y+;"R^I[P+>%BM=,C)
M.'H?9 >M(
M
M
M
M                                                           \
MT,C[H=S6\KN<ZUR8UOL5NFO-1L<=C-K2IAA9I-+SIEU-:R3Q,C*E> Y%VLOX
MMF[J?1]/\LZ2<-MM\3-TQ'M5Z9ZHW4>C5BN97NR6>\I85&3=X,>:F,LZJ;*0
MVES09T+BG50=6V[BB)ZWSW/B^%DNLK6DS'BE=19B
M                                  !XW=O$PG/>.[U1Z_)DY1P]#[ (
MA[(@D
M
M
M
M                                                      :-9O@>
M(O=UNWF..V*,=ER['[M?\AMY:R;D3X:_N3ID2B(B/FI)<%?7$?&NADPV3FB*
M;_I>OTG,M1;RO)=%TUMNMMB>F+9Z/5U-XT(2VA#:$DE"")*$I(B(B+@1$1<A
MOO(3-7T
M  #Q$[:9G4]YSOI'K\B5E94]#S $/;L
M
M
M
M
M                     :D9G_\ 63LS_J/D'ZL:M_X]O=ZWHM-_M.;_ %+6
MVXVGG0
M 'A-VOF?YTW?PJF9>UY9P_NL<"'NR  /+7$O>41;WW,%L!?=M$V"WNY?-Q!C
M-"NA.D<EAU;,9Q4<V$T)YQ))XK]6O,!Z%[J;@VK:G;?-=Q[W15NPVT2;F\R:
MM'56R@S:9)5#H;KFE!'3F8#2_LU[ZIG=?EV78M(VS3@WXKV1F[E+*YE.-Y3L
M@F#:-!,-Z:5K6I@/0\           &N^%=S^UV?;U9UL'C[UV7N!MVT\]D;4
MB XS"),=QII?2DF9I<]9Y-*$ V(  %LO5VB6&SW:^3S64&S0WYTTVTFM9,QV
MU.KTI+BH]*3H7B AG8#N-VV[E<9N^6;9.W1VT6.Y':IRKK!7!=]H)I#QDE#A
MF:BTN%Q 3R                 X9+BF8[[J2(U--J6DCY521F T&[$NZ?</
MN<B;O/Y]9K#:5X#?8MLLQ6-N2V3K+Q2-2G_:'GJJ^XE330N8#?\
M
M
M
M                                                         :CY
MF?\ _.3LQ_J/D'ZLAJW_ (UO=ZWH=-_M.;_4M;;D=2J-IYY4
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M2,$R9G-<)Q#,8[7L[&5V:!=VH]:],IL=#^BOCIUT 96
M
M
M
M                            X9#[46._)?<)EB.VIUYU7)*$$:E*/T$0
M3-$VVS=,1&^6G4?O"L3V2(A.8K*8Q=V03"+Z;Z3?2@U:2?5&)%-'C0EU(OB&
MA^>BM*;'K[OE')&+BXXXZ>[39W5^AN2E:5I2I*R4E9$:%$=2,CY&0WWCWT
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M4=HT)2DTMTTE0B*A<@%V
M
M
M
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M[6]W.Y>[8S8\<WM7MYM-[#[)G^((9==.X.ID]9$A*$&A#BDIX$EQ9)J1&9&
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M-LQS%H#-ML\%/'0RPDDIU']<I7-2CXF9F9@,GIYP%0
M           !9;SD=@QQMAZ_WJ%9FI*C1'7,?0R3BBXF2=9E6E>-!EQ8,F79
M9;,TZH4OR6V>],0Y;/?;+D$54VQ76)=XB5FVN1#>0\@EEQ-)F@SH?'D(RX;\
M4TOB8GM+,EM\5MFJZC&N
M
M
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MYQ3JLDX?<XIIW59\,K1
M       >$O:]_P"*=OY_C>6?NL<"'NT  (@S;?\ V4VXR2U8?G>Z&.XKDUY4
M@H-FN,UMIZCO!M3I&=&4J\%.&E)^!@/-CLPW/W1R[ND[OL?O.YEWOUEQ]JZ*
MPVW7N<Y,M5M6BZN-L.--&K2EM":%ZI_(X$ G[M)W,W&L>W6Z64=RN_NW><1;
M1D.FRWVS7^UR8T%EQ!T9E3(QH9:]H73H-+/615*G(!I%VO;L[O=R&]=RW-W
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MG[KXU%SJ8I+;&.KGM=;JKIH:4JNA+BJEI0I1*.I4+B F@          4H7D
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M@(
M
M
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MB)FDNT14*GT1*JH
M   #PE[7O_%-W[_QO+/W6.!#W: =>6_[-%DR>F;OL[2W>DGFK0DSH7G.@#P1
M[$-BMMN[G,>XO=;N!Q]&X=V5D#;<>V7!Y]MIER>I]];AI8<;55M"$M-E6B2(
MZ%4!=O=\X];L1[C^\3$[03I6C&;)<[5:TOK-QPHT6YN--)6L^*C))$53 <ON
MU-LL#W5V'[D\,W"QJ-DV+S,HA2I5G?-QMM;T6,XZRLS96VJJ5I(RX@0ZWNN]
MB=I-S;?NKEN=83#R+),.R [7C5U?<D(7$AS8DAB0R@FG4)-*VUFD]1&?'AQ
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MY"7N'M+-EW3:O;.YW"0N7/N&*6:3-E.&:ENO.P65N+49\3-2C,S 2$
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ME=VBW7([\VQ%<. R;$9J-&KTTDE7K*49J.IF!,I,$H
M
M
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M3EQ',U.",4Q2=DNQH]3.:)K%)AF@UFX
M
M
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M\72(_ACD/,736_\ :]+Z3=LT$_Z/_H>T8]8^"
M                            \)>U_P#\4[?O_&\L_=8X$/=H
M
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MJ;^X?,Y#::^@E#0U\[;>YT^5QLOGM2N.>ZH
M
M
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MEH=2HC(RX#F76S;FFV?M1/CEZ^_+&3E<Y+=WP9CPQ93].Y[7CUKX.
M                                           #PE[7O_%.W\_QO+/W
M6.!#W:
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M]ST')IF<<S/6G(<]V
M
M
M                              !'>XVZN";4VA-ZSC(HUEC.F:8411FY
M+EN$7!N-'15QQ1\N!4\M!CR9;<<5NEN:/09]9?PXK9GKZH[YW0\N]Y[AN+GF
M1N;EV;$YF"6O)9ML61WLF%SF;!'2EI<A<+4:V#G&UI:4\DD<Z*4I(\]J;9C+
M=EOLGANC9WTB-O4^K<DRV6:7'H,&>SXUEU;^GV9F9F+-E+IZ.RM5I]J5\HX,
MA->1))*J%X<24-+BGJEZSACKA\G-;*FIB2BOE94?ZFH<<=4^(X)GICQN,[K
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M-9)3(21GP-'&G'20])CSVW[-T]3Y-K^39M+;\2*7XYW7V[8\/5X4_C.Y
M                                              \)>U[_ ,4W?SC_
M .EY9^ZQP(>[0
M                       B[=]HW,.<415Z,R.L_-51I_WPM9O8\ONH+@NL
M3V(ZE%J=ATJA1<"72A'Y_,+3L88VPN?D!8 =>6DUQGD$=#<2:*^35P,S^ .E
M$[DJ[0FAUO(WV3K'ZT9AE7@9--JJ?^Z$7,F+I3**,H  .-[]B<+RH5](3&]%
MVYJGMD1(NF7).FKVN57T$HJ?3'7U?0\SH/>N\+'?+Z3&1K(\RK_.B?[0W]49
M+=S6R[VS^P/'$'^?^%&9^'B?Z Y_,/>M[GH>3?A3WIV'/=@
M
M
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MD9))Z5?-[!D2Y:^)&1TT^4J<1BG-=DV8X\,_I^G4ZUO*L&BCCUUVWHQV^_\
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MZVV;J4V=;)F^5-1CQ3?Q1-T16;8KY)Z6UPW7E@
M                        >$O:]_XIV_G^-Y9^ZQP(>[0
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MS7R[VT.P7#$G2K7[KJ^,UCG\P]ZWN=_DOX<]Z=1SW9
M
M
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MDA-2(B-1UX%4>?C:H^FGF7VT/,.H>9<*K;K:B4E1>8RX&$Q0<H
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M<T5I12B4?F(<ZW0S%VV=CVF;YNMNPS%MDQDF.OV8[>OP-ZRY>0=)XA4
M                                         >$O:]_XIV_G^-Y9^ZQP
M(>[0
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M;#=/HC);N8,N]LYL&LOQ6<;J1*]51)+R:W",:',(VVSV._R:?8F$\CG.R
M
M
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MQ2%$;>DEIU)40F+IU439DVS29MGIB8VTKTQ/;N(_AS$QNZ8;:%XCAMQ4
M                                      85N'DE[Q+"\AR'&L4F9QD-
MNC$=EQ2"9)>F2G5I::0:E<$()2R4XKCI02E4.E '=Q3&;3C4.?\ -UE@V2=D
M,]Z]Y0W;ZFU(NTTDJER#6HDJ6:U)(M2B(Z$7 N0#*    ?"ZI2I1)-1I(ST)
MYG3P*ID \%LEW-R*Z[LR=UYMNMI97;9[K4."N$T;+;#+RDE"6T:?7K2BC551
MJXUK0>8OR<63BF(K7J?=M+R['CTD::VZ[AFVE:S7;&^)Z.Z-E'NU9I;MPL]J
MGOQ%0'IL-B0]!5P4RIUM*U-GYTF=!Z6V:Q$OAN:V++[K8FL1,Q7K[5R%F,
M%FR+'[)EEBN^,Y+:X]ZL%^B.P;Q:92=;,B.^DT.-K3Y#(_3Y.(##=O+WD4M[
M,<;OV#NX=&PF\':L4E(=]HA76RDRVN#,C.F1&2M!]-UL^*%I,JGS 26
M                                            \)>U[_Q3M_/\;RS]
MUC@0]V@
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M1)KR,ZU/AR&AK[[9B(B:R[W*,5]E>**0G\<UVP
M
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M)N(YDJG/B?$:-^*SX\33]-KUVEYAJ/Z1ECCN]FZVV-NZV=\=S>(N7$;SR*H
M   "+]PK.EB?C.Y+^7W7&K;M<BZ73(;9"2M^'=+8[#44EF7%1Q<4UTTNM*21
MJ2I)DDCU& SC'[]:,IL=GR3'Y[5TL=_A,7&SW)DZMOQI+9.M.)K3@I*B/B O
M                                                /"7M>X>]-W\_
MQO+/W6.!#W:J0!SXD
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MUN>:<#J<HTT;<G;,-CJ><<UW50
M
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MW%YBVM)47C5"'3(9KIX=+?/VKHCQ5N]1;%;X[(;&#DMD
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M:FTDA2%T^4DP$FD9F53*GF 5
M         >$G?YN[W7=O.])*Q+=N\V[;'<"+\YX:ST(SC420SI1.@$XMDS^Y
MJ,EH2=3)"BXF \O\>WPW9Q3<:][N8[FDFU[DY(<I5\RI#3"GI!S=)R#4A;9M
MD:S27))4IP >XWNU\O[C-X(.9[J[O[D7/),)965BPJS26F&FY$MLR<FS#Z;:
M%&37JMHXT,S5Y 'JH14*@"H
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M)==J+8MNX[HV=FR>F=UT3'@;9#AO4
M
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MI@QV]<W7>6D>9.*/:NGNA/XYC8
M      ="Z7.!9K9<;O=)2(-LM,5Z9<9KGR&6&$&XZXJA'P2E)F8"']K;=C.9
M7%[N%M7XQHD[GX_;(UHM60ET#MMIC&XXTB-#X]$I2G/:%ZE*-54GP^2 F\@
M      >/N9XKGZ=P;W:KC:KG*RZXW5UV(ZVTZM4AQ;AJ8>9=21D::4,E$?J^
M:@X5]E_'2=[ZWH]5IORUMUMUL8XMCJV;-L3'Z5>M>/LW*/8;)'O+O7N[$",W
M=7ZZM<E+22>57QJLC.H[=E:17>^4YYLG)=-GNUFG=78NXLQ     "/\ /]O;
M/N#&QI-UDSX$O#\A@9-C]PMC_0D-3K>I6E)F9&E;;K:UM.(61I4A1ESH9!V-
MN]P+!N9B=OS#'?:FK?/=DQW(5P8.-,BR8;ZXTB/)849FVXVXVI)D9^<JD9&
MS@                                            !IQWR[ %W ;"9'
M9K9%ZV;8E7(<%=2FKBID1)FY%*A&9E):U-T+FK3Y 'Y>L'P_(-QLOQ; \7AN
M2,DR^Z1[3;8M**;>?<T+4YJX))DM2EF? M)U ?L%VCVSL&SNVV&[:8RR35HQ
M"V,P6G"*BGW4EJ?D+XGZSSIJ6KSF D<
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M'CW5F?#=,W3Y99@,#:
M
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MBE3S"W,_9R6V?9MMCPTK/G7P;;:]<RG8<YF
M               1KE3N77C)<3M&%7ZRPK5:;JF1NLW(T2Y_S:<9Q4>$S&H9
M-G+<--7%FDTH29H)1F D="$MD24))*2(B2DN!$1<B(@'V       "E/2 $5.
M "H      H95 1E<'\NL6X3-REWFQQ=HYUF*+*BS%(B3HN1*EI)AQIXR)+K<
MIMSIFA2B43B4FFNHR 2<
M     ^5<J^3D0#03:'LFL6V?=CNIO\V<95@O;!.[=6%LB([?/NI*.\N&DJ$D
MJITM$7#2XKQ(!OZ
M                     -4\OGG<<JOTFM4-R/96:<2TQDDWP]*M0Q3O=_!;
MP8[8[*^-C9JHI!>"S,J_!40R4WNI.4EIE3AG12E(;-7F-1&(EDQ[9HXK=]U]
MJEJYR7E:/M4\""$YME+>J%Q$L( J H   "U25MNW2"PI149)3BDG]D9>J1_
M(G>V+(F,<SULOP^<<;*;%.)>EI4Q,8E>!H>(VU*]!F8F-[6U%E<=UO97Q-M1
MF>>0;OQ_%VQ?PNC]P=$2M:[.Q/\ %"X_PW+_ %+007;TTB50
M
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MV?0S<EI41*2=4JH:5%Q(R/D9&-9N/H
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M7;K)98+5MM-ICMQ;=;V"TMLLM))*$)+S$0YU]]U]TW7369WL\1$12%S%4@
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M/,*TN(,E.$9&D^'(<S4\KR::^<>6ZVVZ.BKHZ?F>/461?CBZ;9Z>&>CO9/\
MRL)_)QG7X&/]]&#\K'^99XV?\U^I=XESQW<NV9#D!8PY8+_CMW=@.W*(U>H"
MHB'X[#K;3IMKU*(S2IU-2/C0ZBN33399Q\5LQ6FR:K8]3%]W#28FE=L477/L
M#QG<S%+OA.8VTKKCE[0VF?$UJ:5J9=0\TXVXV9*0MMQM*TJ29&2B(QK-AEK3
M?20AO4I9(2224M1J4="I4S/F9^)@.0
M
M                     '6FR$PX<J6OBF*RMY7H0DU'](1*UEO%=$=;3="U
MNIZJ^*WC-U:O*IPS6?TQB>BNC:XI)J2RIQ!&I3!DX22YGI/B7Q"$V;9HZ-X6
MA5N-:#U)4IM2#+Q(^)!=N9L$4OVN]$:Z,6,T1?);*OI/B80PY)K=,NP)44
M    &/3XJ'KK&0L]*)*2U&7Z6O O2*S&UN8KZ8Y[&0=0XQ-O-^K[*MMU!%X=
M)1*+Z0LU8VSWMRV74OM-O(XH=2E:#\RB(R&9YR8I-$);\?Q=L7\,(_<'1$IM
M=C8G^*%R_AN7^H:""[>FH2J                      "VW>\V>P0'[K?KM
M#LELC%63<9[[<9ALC^S==4E)?"8#CLE^L>2VYB\8Y>8-_M,G44:Z6V0U*C.:
M3HK0ZRI2%4/@=# 78   '$A]EU;K;;R''&#)+R$J(S09E4B41<CIY0'*
M   #AD28\1AZ5+?;BQHZ#<?D/*)#:$)*IJ4I1D1$7B9@+'CN7XIES,J1BF3V
MG)X\)SHS'[3-8FH9=I70XIA:R2JG@?$!D0
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M*I -(O=X=PFYO<7M?F>4[I3X-PO%ERAVUP'8$-$)!1D1VG")2&^!GJ4?$!Z
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M(;622;2I*DUI0R6PI @
M
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M)E6A&Z>26BZQNC(4RZW'5!4^2%K:4GY)R$ZN- $=8!V)]NV5Y);;5B_>A?\
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MZB+6RH_K7:$1<?!7 CY'0^)WLR1DV3O8[\<X=L;;56UH=3J;5J27/P,O,9>
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M U5
M    !B.<6.7D&.RH$%22F)6T_&;6>E+BFE$K0:O#52E1%T5ALZ7+&/)$W;FJ
M<^1)M,IR%=[7*MTEDR)UIPB.E>)&1EP,C+B1D8PS--[O68[<D>Q=$OIB;$D?
ML+Z%&?UA\%?$851=BNMWPMCAD_>VDEQ*,BJO215^J(Z6:/9Q3VKX+-4
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M6;B[3[19]8]R<-NN%W:;F#TJ%"NK/0<?8]E91UFTU.J#4DZ& ],
M           :S[M]SN%[<+?LEG(LRS$C-M-FA.%T(ZSX$4E])*(C(_K$D:O
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M;&K@BXVBY(UL/IX*2HN"FW$GQ2M!\%)/D/&Y\%^"^;+XI,)9*,0
M
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MY1\&/B8MMG3'5]"N3%2.*W<W?'#8
M                             !KIFJR>R:ZDLB4DE-H-)\2]5"2Y&+1&
MQANFEU479!;8+<-4QIE+#[:DD1M\"5J.E#(8\MD1%7:Y5K,MV6,=TUB8G?T+
M38FZKDOG4]*201GY3XF,-KM:F=D0R,6:8       "TWK_ C/[%Q!D?PB)W,^
MF]]=D'J2A9?7)(_H"6&8VIVV></\7KE&H9HC7-_IK\#)PDJH1^8SXB]CF\S]
M^V?U86;?C^+MB_A='[@\+2T+78V(_BA<OX;E_J&@@NWIJ$J@
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MR;2I9_TI&8",,036=B[9\37=FW/@)"W:_&-W5>Y/W6IH=M]OWO0VD'!>G
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M63X(KYA(,&\6FZ$9VVZ1+B22J9QGVWJ%Y?4,QJ7676^]$QWBXBH
M
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M6GVT.LN)>:<*J'4&2DJ+RD9<#&)5R
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M.[*Y*NU'=+;,=2=LGW1?1J7%A\T-E7[5? C\AB8C8K?=2YM("0
M
M  !!>Y!?_$1%XJLR#_J7W/T1U>7^[X7"YK[_ .SZ7UBY_P#P[:/[2LO_ #JP
MS>_*F'W+>YF%J;2J2I:OZR@U)])\",:^3<V]/%;EVN*=<-XC(C-%%D?D,C&.
MR?:;&>*V,7&PT%.(    !7X '!*.D26?DCNG_N#$QO1.Y@&$(ZMZQ)/V,AQP
M_P"DC.&-K6;++NZ&MR^*Y+>^?-+9L<-Z8 1!OQO+CFP6UF5[I9.TY,@XW&)4
M2TL*)#TZ8\HFXT5M2B,DFXX9$9T/2554.E 'EOB.Z'O1-[\47O7MU'P_%\(G
MD[+Q7!GXL4Y%QBH49%T%2DK=41Z3)*G%HU\TD1&0#;;LV[T;3W$[=Y?=,[9M
M^#9KM4\4?<9!O$S;DM*)9HFH4\JK2?N:DN)6H]"B^49&5 V5=W\V3:E8K"/=
M7%W96</.1\288N<=Y4]QDU$X3'36JNDTJ(SY5(R 9=B>?8/GC,R3A.86;+H]
MN<2U/>L\UB:EAQ9&I*7#86LDFHBJ5>8#BQ[<7 ,MNESLF+9K8\CO%EU?/%KM
MD^/*?BZ5],^LVTM2D466GUBY\ &!_P Y;M^+*/Q+_EDQ'\9NIT?FKYTCZNK6
MG3UZ]&JO#3JK7@ DO*<QQ/![85ZS+);7BMG-Y$<KI=I;4..;RR4:6^J\I*=1
MDDS(JUX ,#F=P.Q]ORN#@T[=?%XN6W-MER#8W+DP3SB9"4K9IZVDC<2HC21G
M51&5.9 ,UR?.\*PI5L3F&66C%U7MXXUG3=9C,0Y3Q:2-MGK*3K46HN":\R 6
M[%MT-O,WO63X[A^96G);WACR(^56ZW242%P77-1)0]H,R2=4&5*\#(R,!AS'
M<EL#*RHL)C[PXD]E)NDPFSHND<UJ=,])-I5KT&LSX:256O"@"4,BR?',0L\O
M(,JOL#'+' (CF7>Y2&XL=NIT+4XZ:4D9GP(J\3Y ,"V_WXV9W5E2(&W.YN/9
MC<(I*4_;[;.:=D$E'!2NC4EFDO$R*@#(\ZW*P#;&U(O>X68VG#;4ZHVV)EVE
M-QDNK2532T2S(UF1<3))&8!@NY6 ;G6I=[V]S&TYE:FEDV_,M,IN2EI:N))=
M)!FI!F7$B41 ,5NW<)L98[3<[Y=-V\3C6JS2V[?=9A76,XEB6Z:B0PLFUJ,G
M%&A5$TKP/R& RRS[D[?9!?96+V/-['=\E@M&]-QZ)/8=FLMD23-3D=*S<21$
MM-:I\2 <CNX6!L96U@CV965O-GTDMG$53F"N2DJ;-TC*+KZM#;(U?)^3QY ,
M(R[N,V'P._(Q?,=V\7Q[(E.=)=GF7%E#[:SIZKJ"4?3/C]?0!U]Z=[<;VJV@
MR/="->;%<3C6B1/PZ/*N+3,6\R4,FZS'C/)-75-RG#IDHS+B0"">VONKG=RV
MQ62Y4W+Q3;S=>/%O90<;7<BEMV],1O3%N,QIXFW4L$XM)K4I&FA'Q,!DW93>
MMY[YM'*E[Y[B8IN3EJ;[,;BWC$YT*XL,Q")LVV'Y-O\ N"G*F:R21:DH4DE>
M0@E&3W*]OT+*#PN7O'B4?)TNFPNTKND<E)=(])MJ7KT)41\-)JK7@ DO)\RQ
M+";65\S')K7BUF4\B.FZW66U$CFZX1FALG7E)3J41&9%7B C^]]P^Q6-WRTX
MW?=V\5M=\OC3#]KMS]SCI6ZU)2E;"ZZ]*4N)42D&HRU$9&7 P$Q)4E9$I*B4
M1\2,O. ^@ !2I ([SO=; =MX_7R[(XUN>4DU,6U)F[+=\2T,-U7Q\ID1><;6
MFT.;4S3';,]O1XQI[E/=_E62./VW:;#5L(.J$9#=2)Q9%X+2P7W-/].I7H'H
M,'(,>/;GO\$>M""96,Y+F5S3?]SLFE9'/YHAFX9MME]BFE$H3YD$0ZEN7'AM
MX,-L1 SMAAB*RW&BLHCQV2HTPV1)2DO,1#7F9F:R.4Q  'E 5QF/\X[L8#%,
MD+;LT:[WQ]L_E)-MA,5A9?T[YD/$_..7;@Q]MUWBBD>=V.66TQY;ONV^6L^9
MM#<;BW:+;<[L]P:M4.1-<XTX1VE.G^I'C)NX8F[JBOB;D6\4Q;US3QM-,'C+
MBXACJ'4FEY^(F7(2HZF3DM2I"R,_2X8^J<CP? T.&S]6)\,[9\[C\PR?$U.2
M[]:GBV>AE/$=5I@#Y<;;>:<9>;0\RZ6EUE9$I*B/P,C$UH,'F;:X?,6ISV!<
M12OE%'<-)? 2M5!L6ZO)'2+7_)C'@K3)QW(+A9I["B7&>0LTDE:3J1U;-*BX
M^)"WYN;ME]L3 FK NY?/=N;A&L>[:7,GQJ0I+<?*&DDJ6P7V2E)(B>+[(E47
MY#/D.;JN38=1'%@]F[JZ/H'HC:[I;KU;H=VM4UFXVVX-)?A36%$IMQM15)23
M(>3OLNLNFVZ*3"5P%0                 87G&X^!;9VN/>]P<PM.&6B7)3
M#C7*\2FXC+DA25+2TE;II(U&E)G3S (M_G:]L?Y>L&_#43]\ HS_  />#:S=
M%VY,;<[@V'-WK,EM5U;LTYF8J.EZI-FZ32E:=6DZ5\@"1P       4.M.',!
M!\ON-V?A;T1>WV3EA-[L38R)4?%_99)FII;!R4JZY-](JM),_E^;F G$   "
MH#JS9T.VPY=QN$IJ# @,.29TU]9-M,LM)-;CCBU&1)2E)&9F?(@&)X#N/@>Z
M>/IRK;K*[;F..KD.Q"N]L>2\R3[!D3C2C+DI-2,R/P,CY&0#-@        'R
MM:&TJ6M1(0DC4I:CH1$7$S,P&!X#NGMSNG$NL_;K-+3F<.QSEVV[R+5)1(3'
ME-\VW-)\/,?(_ S 9\      (]L6[6V.49;>\"QS/K%>\UQHG%7_ !:%.9>G
M0R96EMSK,(4:TZ%J))U+@9@)"(R/B7$@&!;F;EX9M!A=XW!W O!6'$K"32KK
M=#:=>Z1/.):1ZC*5K.JUD7 @%ILN].U]\VM@[U1LQ@Q-L+A#]O9S"XJ.#%3'
MZQQR<<.039H(W"TEJ(N-/* PL^[;MB21J/?O!B(BJ9_/43]\ 2U?,\PW&\.D
M[@WW)K?:\(B0&[H_E#[R4PRANDE3;Q.\243A+3HI754B34S(!&^SG<ELOO\
MGDQ;2YJSEGXH.,MW\VX\F.3'M!+-I7]\--ZB5TU<2\G$!D,#?+9BZ9*O#;=N
MMB<[*D*)!V!B[PURC69Z203:73,U5X:2X@,WR3)\=PZQW+)LKO<+'<>L[76N
MMZN#R(\:.V:B22G75F24EJ41<3YF A4^[?MA2DU*W[P8DI*IJ.]1*$7[8!1.
M]INULOUKM][LL]BZ6B[1VY=LN459.,OL/));;C:TU)25),C(R 7
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MVYDQ3672P@G#2^31(-?SUZA*X<:-4^ 39N1D]YNX*K@
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M8)#%T27L>16])E_>\YDB)TB+[%?!:/TICP^NTDZ;+-G1OCN8<EG!-$PC34
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MD$24(,BU>)UY$0FV?93?'M-O158
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M1QT=11*73C2O'Q >:MYR?=_>CM$SW?C='O 1!*[,2H;6QEKCVZ+#D=.2EEN
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M$I"T**J5)47 R,CJ1D/$[MDM1R@
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M*2*A$70=\!662UV-B/XH7/\ AR73^H:""[>FL2J
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M E+$,8MV$XIC6'6A;[EJQ6V1+3;7)2R<?4Q#:2RV;BTI22E&E)5,B+CX ,C
M                      !0^0#ST[NLJ=RK,L1VDMCQ]" I-SR/2? G'4_<
MDJ+](UJ5_3$/5\AP?"Q79[NG9'Z=Z&&-MMLH;993H980EMI!>"$%0B^(AM;Q
M] ']%  !4 J H J5*E4J\2X?" P'&MH,HW1LF4W.5E-F]G*YSK/8)UQM9S9"
M#8JW(>9=2MM3!)4JB"37BFH\!SWGOQM3=99AQS9CGA]NWBFZ8][;]6*[J;7H
M-'AMT]MLS-_%=$7>S/#$5W;.F>NI9-M;IL\[C5BR-J#>Y%WCR(%ISF*_(?D2
M%1"ZZV92)):F36@]1=,])Z:'Q&7Y<U^G_,SCC!9CNOB:3968V;9M]K;'7U*\
MRMORXYOC)==%M*Q=$1OV5CAV3X=K/1[IP0!7S@*>("H"E0 !6ID=2/B1\# 8
M&L\EVURB/N1MZLVY4=1JO=F(C-E]E1U<2MM/%3:^:B+BD_62-BF/4XYPY=W1
M/Z=(]%]H=Z,4W?LQS+*Y[!>H24_/6-/K2<F,9\-94IU&S/Y*R*GEH? >1U_+
MLFCNI=MMG=/7]*4PC0                $"Y+VT;/Y=N_C>^U]QQZ7N7B:8
MZ;'>TS93;;11=?2K'0X32J=0^:>(#+=W-H,"WRPJ9M]N3:7+UBL]]B3*@-2'
MHJE.1U:VSZC"T+*A^%0%WL.W>'X[@5NVQM]G;<P>V6@K$Q8I9G*;7;R;Z)L.
MF\:C<(T'0]1G4!I[:?=G]H5IOEUO:=O9-P3<F'X\>SS;E)>A02?0;9JB(U$M
M"TI,R0HUJ-/UM $ER.ROMZE[0,[$RL2EO[:1KVK(8]C7=)IK1/4E2#6F1UNK
MI,E&>G5IJ=: )$SOM]VLW(VKMFR^76%VX[>V=FWL6^SHER&5H1:TDB*1OMK2
MZ>DDE6JN/B MN8=LNRN>[56'9G+,,9O."8M%8BXU#>==.3 *,WTFG(\O5UDK
M)/ U:O6^NJ B_9WL)[;MDLLBYSBV+3KQEEM,SLMZR*>[<W(!F1EJBI=HA"B(
MZ)5I,T_6F0#+M_>T#8ON4?M5PW.QEZ1>[,T<:'D-MD*AS3BFK6<9UQ!&3C>K
MB1+2=#^32I@.I@W99VX[;9GA^?X3@",?R?!K:5KL,V-+DD@FNFMI2WF>ITW7
M%I<5J6M)J/X" 8]O+V%]MF^N:*S[.L1E?C'+Z7ST_;)KD-NY=$B2@Y;:*I4H
MDEIU)TJ,N9@,_P!L.U+8G9G-[KN!MIA*,5R&\6Q-GE>RRI!Q4PT&V9-MQEN*
M;1Q:29F15,ZF9\3 1IN][OSMBWJR^1G>689(@9-<'2?O4VRRUP4SWB(BZLAI
M)*0;AD7K+225*YF9GQ ;%X;L]MI@&WJ=JL3Q"!:L!.(_"E8XE!K:DM2D&B1[
M2I9J4\IU*C):EF9GY>0"!-K.Q+MWV<OF:7[",?N<1[.K#+QF[PI-R>?CMVJ:
M9=:-'(Z+05"(B,U&9%R,!+NT?;]M3L?@USVWV]QE,##+S+DS;K9)SSMP:?<F
M-(8?)SVI3FI"VVR2:#]7S<0&L[ONQNS][+#RL\ EI2;W65C*+E(3:SJ>HT=$
ME=0FZ_6$YIIPI3@ V7W7[?-I]Z, MFV&>8NB7@]FE19=JL,!YVWM1UPFULQT
MM^R*:-*$(<,B27#S< %<Z[?MK=R-K+9LQEUA=N.WUH:@,0+0B7(96A%L22(I
M&^VM+AZ225:JX^("0,+PZP;?XICV%8M$7 QW%X+5NLT);JWC;CLEI0DW'#4I
M1D7B9U 1!O[VM;-=RL"TQ=T<==FS+";A6:_6]]4.?';>IU62>14E-KH1FA9*
M*O$J'4!'F']@G:Y@MQV^O6-;>J@7O;69\X8]>$SI1/N2^J3Q/RS2XE+ZB414
MUIH1<"*G !D&^G9AL%W#7F-D^?XQ)8RV*RB,66V.8[;;@XRWP0V\ZUP<))<"
M-2341<".G !E^R7;/LUV]V2YV3:_%$6?Y](OG^\ONN2KA.TD9)Z\ETS49))1
MT2FB2YTKQ 8[A_9]L)@> ;A[98SB<B#AVZ9D>:VY5QF.KE&2326EY;IK;X']
M89 ,TQ'M]VLP?:2?L=C=A=A;;W*-.AS+*J7(=6IFXZO:$E(6X;I:M1T,E</
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M6I*T+29DI)D=2,CH8\G,3$TG>U)=D0
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M_J&@@NWIK$J@
M                        "(=T"_OS&?(:+@GXVVOT!T=!];P.3S3ZOA\S
M#;/0V8A>'4/Z!B,_O7*Z?W;4F6#Y,O[9'TC&G<Z-BYW/_ )7VA?3(1"984,C
M">CF J7B*RF%!).U9)/"0]YU5&:W<U[_ 'I< E5\N?L;GVBOI .3 "_^*+1Y
M.A<:?&V-O6_A^+S-3EWXW[WG;##CO0
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M(R41U(R'CIB8FDM1S@
M         H9$=:E4CX&0#3'<./[#<EV\N3$I_33[&I4^@8IFG9#K\CM]K)/=
M#&["Y1R2U]DDEE\!T/Z8Q6NOJ8V1+)?3Q(^!BS4A@<IDX\EYD_K%'I]',ACE
MT[+N*V)7FQR:&Y$6?/[HS_OB^J+6RU]19]9<7'"8N;)'\B8UH/[=!\!/2Q1'
M%CGLE<1+  *@+[AK7M&=XJU3]B7)D'_<VE!&^$9YI@OGN\[; N0S//*@(-WX
M_B[8OX71^X.B)6M<^P_\4+G_  Y+_4-!!=O36)5
M                                                    $1;G_P"&
M8MZ9Y4_N2!T-!];P.5S/ZGA\S"[!ZS$3[91U^B)U.R^[O8]'MLL[DFV'Y,O[
M9'TC&E<Z5BY7+_ )7G1]4A%J;MS"QD83Z(@.(%0"%EE?X0[Z2^D,UNY@OWNN
M)5?#O!IW[17TC <V!?QIL_G8N%/AT']0;>M_#\7F:G+OQH_:\[84<=Z
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M-*C;7-?29_;/)'L?D_%$W9LGW;?)6?.T^9W4Q8[>OBN]$/D>X<<\:>   I]
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M/69:J:E-%J]8O6(Z$ ]JYTZ+;8<NX3WTQ8,!ER1-DN'1#3+236M:C\B4D9F
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M91<KFTTF+%<-IQ:U5=>-&HC4=:F8#\^N.X9G>QNW_;MWO+DR9%QR+<*=(O\
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M?'%:]1$G4B,CK7Q(>4:JH
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M:YMA_P"*-T_AR7^H:""[>FL2J
M                                      (BW/\ \,Q3SKFE_P":2.AH
M/K>!RN9_4[Y\S"<;/5'B']L7T!.KBE]W>Q:&:X[.Y)]AY2B\:H^J-*8=.Q=+
MDD_F^57[#E\)!!=N82+,0) 05 (665_A#OI+Z0S6[F"_WG )5<3W["]_:U?2
M,!S8+4LHL?&M6IWT4)/Z@V]9^'/@:G+_ ,6/VFPPX[T
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M^-CC9._OZ_"OFLB8XHW-_1Y]K@
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M 9$
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M:[<ZY=; I1\#09I1(;3XT.J7"+[8:'S!IXNMMU%O3LGT>I+?@>8
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M^XWN)DMPQ2S3LC@:/8<@D08[LYGI&9M].2M!N)TF9THK@ R,TI41DHJD? R
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MC9GY4+(TGZ!X'489PY)LG?$L%UO#-&7#$J
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M7-R.P?\ Z+%^XH+^IXG\)C>LT]EO0FC%E&:S-3BC<4?-2S-1_&8S4%-)>0@
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MWJ#8H<J4S"BR9\AN.AV3(62&66S<,M2W%'1*2XF OH
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M\28E))Y*:>!$O70>9Y_BBW/%T?6CS,NHCVJ];=P<-K@
M                               #07(E&K(K^KEJN,DZ?W10UIWO9X(I
MCM[H\RS_ $A#*R*Q1SJ[*,_5XMH3Y?$S%HAJ:F_ZK(19J*&DE&@SYH/4D_)X
M F)?1<#J"&"3$&U+D(+@:'3-/QU(4G>Z>.:VPS9IPGF6G4G4G$DKX?$7<ZZV
MDT=>X/="%(76AJ3H1]LK@(G<OBMK=$)CV&8T6>_R/[--;1^UM%^N%\;1YS/M
MVQV>E/ R., (-WX_B[8OX71^XNB)6M<VP_\ %&Z_P[+_ '-D(+MZ;!*H
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M1;J[.VL>0EI'ASZ).*V)U!D9)BDVJG(E(4:3(>ESQ3)*&2_T4&(#^@ H K0
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MV"X23YDLCD)X>DN8X?S#$?PY[_0SY]UKT<'FFL
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MEI*4--((DI2E)4)*4E0B(B\" <@
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M]K?^E]P?PZU]Y@'YI/M;_P!+[@_AUK[S /S2?:W_ *7W!_#K7WF ?FD^UO\
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M[=^\EPC2+A"8:\ZB)]:N/F(R'!^8;MN..R?0SZC9$0]%QYMK
M                                     #1?*D%'S6_).OW.[.F?PKK]
M4:\[WK]/MP6_=7H^9^D6:2@   4 &/7YO_!G?MD?5%;FWI9WPQT5;8 W)VDC
MDQ@5D.E#D]=Y1>=3RR^H,]FYY;F=U=1=X/,DD7:  @W?C^+MB_A='[@Z(E:U
MS;#?Q1NW\.R_W-D(+MZ;!*H
M                                    BC<TONN,'RI(DE_YD;^AWW=S
MF<RW6=\^9'UD.B*EX2#_ %0R:KWY\'F:VC]R.^?.S^!)*)*0ZHC-!$:7"+G0
M_$O0-%TK=B[7&Z1G8SC#"C<4[0C.E"25:GS\1$0M-T48X+* E  KX"JRPO\
M[,[]L8SV[FM=OEQ"57P]^Q.E^E5]("'%A9TR+%3\KDDOC8=&]K/<N\'H:'+_
M ,2SP^EL@.(](          "E0"I$ J     5(P !0C(^7AS 5
M   :'=W6W4NW2K3O3C;)E+M*FHF6H01GK9(R0Q(5YBKTE>8T^0>FY#JXNB=/
M?NG;;Z8]*$2VRXQKO;XESB'5B8V2TEXI/ZY!^=)\!T;[9LF8GH'?K0R,CI3D
M*BSP\?LMOGRKI"M[<>?,KUY":_7'56DC.B:GSH+W9+KHI,[(%XXB@H ?" P3
M*L$C91,CSDW!5OD-MDR^>CJ)6V7$J%4J**HV<.HG'%*5&86^"Q;(,*VQM1QX
M;26FM7%1D7B?G,^(P7W3=,S/2-<]PIRIN67(JU;@Z(K1>0FT\?C,S'5TMM,<
M=HPL;"0  *&%13S^ (K"H)"(SY%4 !$S10$KI9KBY:;M;KDV=%1'T*5YTF=%
M%\)&8IDLX[9@EMSJ2K2M/%"R)2#\Q\2^@.'1"@#@EQFIL25"?U$S,:6R[IX*
MTK(TG0_*)MFDU@8QB>'Q,31-Z,QR:].-)+=6DD$EM%=*221GQX\3&;/GG+39
M2@R\N8P"RX/:EYEW#X+:6DDN-BZDW.>KF1>RUD&1^E6A(MJLGP=%?=TW;/'L
M'JL/$)     %* (+W,[;MF]VKUC^49CA<1[+<6N4.ZV',(1>R7-F1"=0\T2I
M#5%.HJBAH<U)I6A$?$!.I
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MS],S^$>4YYFX]12/JQ$>E?436YN(..P
M                    #1_<!LVLXR0C*E9QN%_3$E0U[M[UVBVX+>Y<:UH?
ME*OQBS3D   "H M5Y;UPC5XM+2KX^ B=S/III<Q'R"C?4/Q^B WAV]8]GPK&
MFS+2906U&7V]5?5&Q;N>1ULUSWSVLR%FJ (-WX_B[8OX71^X/")6M<VPW\4;
MM_#LO]S9""[>FP2J
M                             (GW-477Q9-?E/RC^)G_ ,HW]#ON[G+Y
MG]3OGS(YLZON3WZ5\_IU&75>_/='F:NDG^''?/G9Q6HT73D! ) 0F@") 3"R
M22I(>\ZAFMW->_?+@$JN)_\ 8'C_ $BOI 0Z^''2_8B?ED/%\;+PW]9[EW@]
M#G\O]_'X?2V5+D.&]*          #R,R?:6S[_>\)WPP+-<HRZW8UCFW>.WF
MU0<>OLNUI1*7T65J-+*M)DI*SJ6GGQ 9EED',>Q#,=M<DL^Y&39[VV9[D$3$
ML[Q/,9IW65CDN=J3"N-NFJ)+A-FLC)QM52/RU,J!N?O7W"[=[#0;"O,GKA<;
M[EDSV##L)L$1=RO5VD$55(B0VCU*))4U*,R27B?$!AVT'=IM[NWFD[;1=BRG
M;3<F'!^<VL%SBUJM$^7"(Z*?ADI:TOI1S423J1<:4(S()"VGWPP?>5>=1\07
M.:N&W&02,:RZTW.,<65%G1RJ9&V:E&:%EQ0KQ ?6 [VX5N7FNZ&"8JJ?*N^T
M%R9L^93'8QMPD3GD*7T&']1]12"2>O@5 %HWP[>L+W]B8Y#S&]939FL7?DR(
M"L9O#]H6XJ4A"%D^IC]D(B06DCY<?* \U.ZKM/VYVOQW"L3VTS#<J;N_O'DD
M3%=O8TW,+BZQ'4XHESI[S9&6IN,P1F=3I520'K]B&.L8ABN.8I&ER+A'QNV1
M;8S/EK4Y(?**TEKJNK49FI:].HSKS,!D8            "VWBTP+]:KC9;K'
M3+MMUCN19T995);3J32HOB/F+69)QW1=;LF!Y.0[)-VTW!RK:ZYK4MF(^J18
MI*_ZZPHM;2B^W;,C/SD8]W.6-3AMS1T[T,Y&N*  #'H4?)&\ANDF=,9=QYU!
M%;(B2]=*N%.%.%.-3,^(RW39P1$1[72,A\1B%0%4\T^D@&IV3ZCR2_&KG[<]
M^J';P^Y'<E8QD'PXXVRVMUU:6VFR-3CBC(DI27,S,^ K==%L5F:1";;;K[HM
MMBLSLB(VS,]4,!S'*IL)^#CF--IEY+>"(V5\%)C-'_7%%RJ9<2KP(N(S8K8N
MCBG=YWGN<\SRX;[=+IXKFO\ ^R.N>WOW4K/4P6^N9;ACT5QO,7[[=)A*7+M2
MFC<;TD7%24F9\*\"H5?'RCFZSF^FPYL>FNK%^6L6S$5X>JZ8[_THWM#\K<YM
MTN;F6/+\7'IZ79++JVQDB)K=99.W;%N^E.S;L7"SM91=K,C*+-E2[A+*OM%K
M4FA$M'%31I,S36G+@52\1YC/R7G&FB<MNJF_)&WAV\-T=45V>"D/IO*?F_Y9
MYM9;C_(QCP7;..L<>.[KNIM\-9V;:,[L>86^Y665<YJTP7+4@SN[*N;9EXI(
M^-%>'GX#N<CYO;S/#Q1%+XFEUO5/JGZ' ^;.2S\OYI^)=7#,<5E_VK?_ '1Y
M=D]+!F7LKS5B9D#E^<PW&6-2K:TV1]1Q#=:N+,C*I>4Z^8B'<RY<6GMFZ_=$
M5F>J'S;1X.8\]OB['=..RZ8C';;[UT]'5X>CSL>L]^R7(+A%Q^XY,[;VGB<*
MW7(FM"I1H/@1J2:3J=*%Q\Q\>?E<UF7GN*S/H\]V+%MBZVE+N*.F*;X\-/#5
M]$Y5S"WY1UN3EO.M-9J-3LNQ9*Q-DV71NF)C9/5[-:[)Z)F=;+#G0+<U$N,T
M[C*94LE3#J1K2:C--2/Q(J$.QRS3YM/@C'FO^)=$S[77%=C%S?5:?5:J[+I\
M7PK)B/8Z+9I[5*=<[5S5\E7H,;[FMN;(ZI^R6=Y1U4Y#9,S]"2+Z@X>2*73'
M:A=?**"@"H"VW:ZQ+';I-TFJHS%35*/%Q9_(0GSJ,7LLF^8M@37V>X%<"9R+
M=R_-*;FY:I42Q-J(R_O0G"6Z\52Y+6DDIH?))^4<KY@U4>S@MW6[9[TPWC+D
M5>8\X
M                            T=[V-KCOV'PMT;&SHR3 %).<XV7KO6UQ
MPM5:<3Z*S)9>8U#N\BU?!D^%.Z[S_2V,%^WAG=+3JS71J]6J%<VJ%[4W5U!?
M6N%P67QCTTQ2:,=]O#-%S$*@"UWINZO6N4W9'T1KFHB]G><Y$5?6*IUH9ER,
M3%*[5K*5V[G:@IF(A1$7!Q#TY#22ENME1*E^)D(FG0BZE=CM @ 8)N/7\5UT
MY>V1]7H]87Q[V;![R!!F;:GP<P O_M 5^J H >0!7Z0!YO$!0!4@$@[:.*1D
M+Z/!Z&X1_P!*9&0IDW,.>/93J,+4    85=K==MP,HL&UF+(.3=K[+0F<I)&
M:64%ZRE+,JT2VBJU'X4$7Y;<-DY+MT-C#;PQQR]J,3QNWX?C5AQ:U)TV^P06
M(,4S*AJ2R@DZE%Y5'4S\YCP67).6^;YWS-6M=-9JR$8T
M                                 #2W=-GHYW?BI3J&RX7],TDZC7OW
MO5\NFN"W].E5!ZFVS\J$G] 6:]V]] AT4R]$Y<-TZ$X251U^DN*3^H(KM9OA
MULXH\+O>82P@#KS&^K$D-TJ:FSIZ2XE](1*^.:71+!"Y%XBCIOE?R5%Y2.@$
M-_,>9*/8+(Q33TH$=)EYR;34;,;GC,\UR73VRO EB $&[\?Q=L7\+H_<'1$K
M6N;8?^*-U_AV7^YLA!=O38)5
M                                     $0;EK2Y<L:82?W1A$R0ZGR(
M4EMM)_"9CH:&-ET]SD\RG;9'>CZT?L<WS2%#+JO?\$-;1_A^&6;MG5ML_*DO
MI#1=/H??A00FH" $GTQ* 00LLO\ PASX/I#+9N8;][KBRCB?XL/%^D5](!;,
M>>1%FXM*6=$L7%E*SYT)Y2V?IK(='516V^.QS-%/#..>WSUAM ."]0
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MM=W8.3:;E%ND9*S;5(AO-OMDM-#-)J;4HJE4N "X
M                    M5\M,6_V6[6.<V3L.\0WX4IM7(VWVS;5] Q:R^;+
MHNC?$U3$TEX>;=)<AQ\ALKBM?S-<G&$*\.!J0=/A0/H5\UB)ZX;&??$I$%6
M      &,9G$5-QB[-H+4MEM,A!?VHZG]"HM9LEDQ32Z&MY<2(9VZ</@
M/I> !Y: 'H+CY0#]$  2+MDT:[]*>I5$>&JI^=:B(B%,FYASS[*<AA:@  ,6
MRO)$X_!0F.DW[O//I6R*DM2C49Z27I+G0SH1>)\!-MM9[&3'9QSV-_NU78%S
M;.R/9GE\?7N-E;1+F)>]9=NBK/648O(XL_6=/RT3X'7RG-N8?F+N"SW(\L]?
MJ3FR<6R-T-OQQV
M     &G>\223G<\_%R'%5_N#+Z@P9-[U'*_P([Y6Z,=8\<_^"3](A+'?[TN<
M%6.7ULR5&D)X'Q0:BYU+B0K<V]-.R87*W32F,T4?W=HB)U/E\BOA$Q-6/-CX
M9[%P$L"I4\>1\#!+ 'T=)]YK^QK-/T> QNG;-8B7PA'4<;;+FXM*/ZI1$"U:
M/0B*UT8T=JE.DTA%/M2(ALP\3=-9EV!*H @W?C^+MB_A='[@Z(E:UR[#?Q1N
MW\.RZ?M;(07;TVB50
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M=["[,8_L#M;C.U^.RWKI&L*'7)U\E(2B3<)DEQ3TB6^2/5UN+5X<BH7@ F,
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MV9!=*WMZILLRHN3*7Q>?6?B:U>7D5"\!XG5ZJ[4Y9R7=/DCHA+.AK
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MN QH>P\"WP\ R22N^PW[7,<G193LE"$*?;><==J2B;27!5.'EJ"4U
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MEL9)X+8MAZJ#R35
M       :B[T$7XZJX<3M[%3^%8P9-[TW*OP/#*P03K"BGY6TA!ECVI=H2QK?
M=&NK!>X>LU1PO@Y_0$3N9L$TNAB<=]R*\AYKY2>9>!EXD?I%(EO76Q=%)9PR
M\W(:0\V=4.%4O*7E(_0,CFW6S;-)<@*L0O#73G.&7 G4I67II0Q270P36Q\6
M=GVB[VF/SZ\V.BGG-U)!"V6:673V2] 1LO%@  @W?@JX[8OX71^X.B)6M<NP
MW\4;MYK[+_<V0@NWIM$J@
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M%;$9/W,6(GD=6)B4%Z=I\$N,,T0KX'7B,1S"_P"%H;J;[IIY?5 ]12'BT@
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M4;C3,5:$N/QV'3,R4AM=.!'0J^<!Z0@
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M^A.EW)'YEYD>E]XVD?\ FVD#R'.LG'JKNRD)SS6^6T@Y;"
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M1$K6N78;^*-V_AZ7^YLA!=O3:)5
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MU3%O2T-J(R,FWW5+14C\J3(QR=7,3DFCNZ&V;<,5[_'+-QKML
M                        !IEWIXS(G8+CV70FC<D8?=4JDK27%$>61(-9
MT\$N(1\8]!\NYHMS78Y^M'E@E 5LN#-VMT&YQU:VIK*7*^17)1'YR,C(=>^W
MANF)0[HJ "M3I3P+D <0#S<@%/J@ "QY#CT#)+>J#-(T.(,UPIB2JMASRD7B
M1_7%XC)BRSCFL#66]6.Y8_-5!N;/3<YL/IJ;3R?LVU>)>;F7B.OCRVY(K M(
MR)5  %    9]A6&/9#(1.G-J9L4==7%G4CDJ3_6V_-]DKZHU=1J(LBD;_,AL
M:E*4(0VVA+;;:22TVDJ)2E)4(B+P(B'*'T1F1U(Z& &HU'4SKYP%2-*3U+/2
MA-5+5Y$EQ,_B 9KV:VIR\9?NCGZR/H+-JUPU'R4;SAR%T^U2ANOI&G\PW\&+
M'B\/H(>@Q#RR0                                !K]W ]N&$]QUHQ6
MTYG>LDL'XFW<KY8KEC$Y%OF-3$MFVE9/+9>,M-:D:2(R/C4!$E@[!=DX5^M.
M19M>\[WJF6&04JR0]QLCD7N%%?2HE$XB(:6FE&2DD?W1*B ;,[H;789O#@.0
M[:9W:OG/$\FB^S7"*VLV7$:%)6TZPXGBVXVM)*09<C+Q+@ TV<]W?A61XW-P
M_=3>?='=?%HT4X6#V2\WI*6; @B2AJ1%0AHT.R64)T(=>2HDI,Z(Y&09_P!P
M>[^T_;ALVSM?D4R9E607C$'L;VZP%QAZ=<\D-J*FWM,*.,RE!FHUI)Q7J<*J
M("K+NSG99>PG;QMY@$V*B)D*89W7+FTUX72XGUY"#K7BSJ2US^L ;/@-&,A[
M'+'^,&073:K>?<38JPYK<';EF^#8?<6VK3,DR$Z9#T=EYMPXJW>)K-LZ5/@D
M@&S.T&S^";&8+:]O-NK2JU8];%+>6;SBGY4N4\9*?ERWU>LZ\ZHJK4?H*A$1
M$$G                                         /$^_6)6W>]>X^#R&
MU1X\BX.3+*2^!.,/&;[)E]LVOZ%![W2Y?C:>R_LV]\-K)[5D7+X,K7  CIQ+
M@9 'T0    %2.AU+F7(0(DS3"%J4]>K$R:C75=PMK9<:\U.-$7T4_"0RV7]$
MMG%EZ+D1<_Z/H&,K8  OI D!!Y  !R,LOR7FX\9E;[[RM++#9:E*,_ B("L1
MO;!8?BJ,=BJ>DZ7;O+(O:7$\2:1SZ2#^F?B,%]U>YIY<G'.S<S$58E=2B*E3
MIY % $=[F27"L<6TL$:Y=ZEMM,,I^4HTF6DOA6I)"^/?7J9]/'M5ZGM7@>.I
MQ+"<2Q@DDE5@M$."Z1<2-QEE*'%?"HC,?/\ 49/B9+K^N9E@NFLS++1B5
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MVB50
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MP4HR&"_6WS%(V-G'RZRV:W3-WF\21R(B(B+D7(AIN@J
M                    LV06&V9/8[KCUYCE+M=XC.19S!^+;A4.A\:&7,C\
M#%\62[%?%]L[8FH\G[K9+SL9F4S!<K-:\<F+5(QN^FD^DXTHZ)<(_B)Q/UJN
M/(>ZQY;==BC+9[W3'Z>1#/"-*DI6A1+0LB4AQ)U2HCXD9&7,C&N   J H8
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M0D)_2I(>.YAK)U6:<G1NCN2E,:0
M     #H2+5;)<N'/E6Z+)GV_4=OFNLH6\P:RHHVEJ(U(J7.A@.^
M                                     -*>[S8VX9Q:H6Y&%1U+S?#6
MC.5$8+[K.@(,W#)!%\IUDZJ27UQ&:?(0[?)M?&&[X=_NW>26?#DB/9G=+1K%
MLHB9)#(R,F;G'32X0CX&2BX&M)'QTF?Q<C'J;K9M1DQS9/8R<48P2
MJ1F1U(Z'X&7,!A.18-;+XI<J.96RY*XJ?;35MT_^$07CYRXBUM\PRV9IMV="
M'[MBE]LQJ.5!6['(^$MC[HV?PIXE\)#-%T2V;<EMW2QS4GB5>/B0EDHK\(%
MCJHDI]91\DEQ,_@("C+K/A%_NYI6J-\W1%4,Y<HC3P_2H^4H5F^(8KLMMO:F
M?'\7M>.-F<1!OS5ITOW%TBZBO*22^M3YB&&ZZ;FM?DF]D0AC  !P2I4:#&>F
M3'B8BQTFMYU7@7D+RF?@01%4Q%9HS3MEVPN6\.Y$;<R^0EL8!@LDE6AEY/J3
M9[7K,M)KP432J..GRKI3Y1S>;ZV-/B^';/M7>2/I;%\QCMX8WR]9QX]J
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M3:)5
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MM4>Q0T*YDHV]1_[LS"<U\[YD7M))0@FVTI;;+DV@B2GXBH0Q;Q]'4P#R^7R
M'U0#CX ,%OV07:5=8N%X3"<N^7759,M-1RUFRI7.G@2B+B9GP27$QL8L=L6S
MDR32V!O)L)V_V[:F&J^7I:+SG]V;_P"LKJ?KHBH7Q5'C&?'B?RU\U>@>9YIS
M2[53PV[+(Z.OMGU);)#D
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MM/(BYF9F?$S/B9U,S,S'C,F2[)=-UTUF6K,UVRO(J@
M                                   8[EK)OXW=VR*IDP:R_I#)7U!,
M(NW-;BXTH+L"Y6B'\X76W0O"3(0E7F21U5] A$IB*RV@(B(B(BH1<"(A1G5
M15O!$)_$O:"35<&8RY7R)55!_JB%[-[%FCV6KO\ 1496JGC9&(DW,BGG\I/L
M\9'#P/4M7U!CO;&&-Z?QC9P   $&[\?Q=L7\+H_<'1$K6N387^*-W_AZ9^YL
MA!=O3<)5
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MF")$C08S$.(TEB-%;2TPRGY*4)*A$0T9F9FLNI;;%L1$;H=@0D
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M(
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MXGQ'AK[[LETW7369:LS,S65T%4
M                     ZLYGVB%,CTU==EQO3Y=23("6JR2,B)*N"D\%%YR
MX&,C79OM]&-_)&G:53$8=</TJ(D%^J$2M9O3X*,P CC=<S+";E1-=3C!*/R%
MU4\1:W>QY?=:G_T$,S4;);*H(K!='*>LY/,C/S);33Z8Q7[VUAW)E%&4   !
M!N_'\7;%_"Z/W!T1*UKEV&_BE=_X>E_N;(07;TVB50
M
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MA&34Y_RFENO^M=LC]/*/5Y*201)2DDH25$I+@1$7(J#PR7T
M
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MK';6%N-R8[Y,-FZO0\W0ZDA)G12"Y<PJ3%$S @
M                                                   1)O7,EQ,&
M=1#DN1#N%PA0Y#[*C0X3+KR=9(67%)F14J7$*T3$1.R6I2YMSMJV;G#O%Q1-
M@/L/1G%RWG4DI+J>"D+4I*B,CH9&0CBGK3\.WJAZ'EXB54(7%XB?F(Z3RM,Q
M[UDMF:3^Z*Y'XC:MW0Y^3?/>E#%...VD_*P7/TF->_WI;F+W([F0"K(
M                                        !@-4^X3M]/<7IYIACB+9
MN):6TZ5:B:;N+3530VXNGJNIY(6?"GJJ]6AEVN4\U_+_ ,/)MQSY/H[!I9!S
M63;;@[C6>VQ_&,CA'TY)2FU-)-7*JTG\FOV152?@8])=@BZ./%/%;*$@H4EQ
M"'6EI<:654.H,E)47F452,:P^@"GQ@*?0 5\P"M#\A^<!0 ]'B >(   !)4?
M(C,_, P3+,R8M+?S79U'<LDG&4>'#C%U5-N+/2DS)-:JX^JDN-1LX,$W36[9
M; WI[;=H'-KL.7*O;7_QGE*DR\@,Z*5'253:C$OC701U5Y5&?D(>7YQK_P U
MEI;[ENR.WM2V.')
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MP(B(J$0\/,UFLM1S"
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MC2H-S:ONI).(BQ?9C63NLR4;9D\E"2.I5U:/$64>Z(
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MX*]G:(B0U7RD6K],./KN;9]5'#,TMZH]/6)[+@.8*@
M
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M8QH
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M[;N,J+@V&6?%&G$);>5;8C3#CB4\B<<2DEKI^F,P&;@
M                                                           *
M& _/%O5LQDFU&Z?XA3IT"[R,A?:FV.XQUK0A3%QEN-,$^A2*H4E1&2B+47B1
MF/K_ "GF]NITGQ(MF(LBD^".A\#Y_P @OTW,8Q3=$SENK;X9I[75M[WM?V[;
M67+9K:BP8'>;G&N]VM[LN3<9<-*TQR=ER%OFAHW"2M24$LBU*(C/G0N0^9<W
MUT:W4WYK8I$]$]D4?9.0\LNY;HK-/==%TVUK,;MLS/I^B$WCFNP
M                                         "G#P 5"@ % H "E"\@"
MH4 10!(4+R
M                                                           *
M&1'X *@     "E""@K2@
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M1*&55XT 5
M                          >/'>Q_]3^WWF@8_7\*/#Z#\M?[9G\/^%\L
M^</]YTG[/^)[#_!0?/GU,
M      :I;V]TMNVQS*P[381@=YWGWHR.(=RB[>8^MIHX5O2>GVRY3'ON<5LU
M?)U$9GSH14,PQ##.[V]QMP\6VN[@MDKWL'D6?K7&V_O,R=&N]DNTQ'%4)$Z*
M1):?H940HN->9< &Y]QGPK5 FW.XR$1(%M8=E3I3AT0VRR@UN+4?D2DC,P&I
MO:=W;V'NEA9XY QJ1A]RPJZ(9;M<J03ZIMJEDI4"Y-GTV_4?)M? B,BH7'B
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M6771EABY91CULNUP9C$I+"'ID5MYQ+1*-2B22EG0C,SIX@,XJ 5\P 9T\_F
M*^8 KY.8!7S *@
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M<P%241\N( 1UX<C(!4
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MT3"8W\HLA;E[DR'7X<-]PGY,.$LD]"-*?)*>JZGB:E>?34Z"RB50
M
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MZE+I-RFR55!\.%? C >OQ'4J@*@
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M3 RK:_-I\PI\^+%DJ2Q+M3\HTI4[T'%)TFHN!>2M 0]/P
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M+"7%Z'WI:#JF9.0A1DA+9G]S;/UC5Q50B(E!ZS4 5
M
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M!.UO.GD"%0
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M[<EE$A$=LR+2MQ5%']:1\A5ML7($
M                     #X<;;=0IMQ"7&UE1;:B(TF7G(^8# Y6W-BD.FXR
MJ1")1*JTTLC34^1EK(Z4\@FJG!"ZXYB<''>JXVXN7+>+2N4X1$9)K72E)<"+
MRA,U3;;1E1?$(6     '6D0H<OI>UQ&9705K9ZK:5Z%>5.HCH?H =D
M    4H7D 5
M
M                      ^J 4            H0  QK,[+(R3$,KQV(ZW'E
MW^SSK=&D/5Z:')4=;*5+TU/21J(SIX (F[6]I;WL3L#MIM)D=S@WB]X3;G8<
M^Y6WJ>RNJ<E//D;762A="2X1<4EQ 3]0    !!^]>WNY>;0L;N&T^[DS:K+<
M3F/3(Q*B-W"S79+S?3.+=8:S2IQLN:#0LC0?K%4Z4" ,6[9]Z,YW(P/<WNIW
M3L6;KVHEN7+;S;_#[8Y;K,U<EEI3<9CDA1O/NMD1:$4TI/C7F1AO:DJ%QY^4
M!]
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M/Q 5
M
M
M
M
M
?                                      '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>lg_svbsecurities-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_svbsecurities-4c.jpg
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ YP/H P$1  (1 0,1 ?_$ ,X
M 0 # 0 # 0$!           ("0H'! 4& 0," 0$  @,! 0$
M!08! P0"!P@0   % P$% P4&$ D+! ,!   ! @,$!08'$2$Q$@@)05$387$B
M,A2!0K05=1F14F)RLB.STW0UE18V=E<XH8(S<Y,DU!<WDJ)#4X,TE"755I;!
MT6,8HT3$I!$  @$" @8'!@8!! (# 0$   $" P01!2$Q05%Q$F&!D:$R4A.Q
MT2)"%0;PP>$S%#0C8G*"PO$'DJ+BTA;_V@ , P$  A$#$0 _ +_
M                                         0MYQ>:>7RMT*RJQ&M=N
MY?SMGRH:VW7#;)KV9I#G$6BD^MQ_P#LL[7^0VL<,"/S"]_BI-+'$@7\[S5_V
M4Q/^(<^^"0^D+S$5]??E/WYWFK?LIB?T[GWT/I"\P^O/RGY\[Q5OV4Q/^(<^
M^A](7F'UY^4G-R;\VDOFFC7])DVJU;'YF/4YI!-.&YXQ3DR5'ZRE'Z/@?PCA
MO;16^&G'$D\OOW=<VC## G .$D@
M
M
M                                             IWZO_Z"X7^7:I\%
M9$QD_BEP1 9_X(<64/B=*P   %XG1[_%6=_PNW_N<\0F<:X]?Y%DR#5/J_,N
MD$*6(
M
M
M                       *=^K_ /H+A?Y=JGP5D3&3^*7!$!G_ ((<64/B
M=*P   %XG1[_ !5G?\+H'V$X0F<:X]?Y%DR#5/J_,ND$*6(
M
M
M
M     *=^K_\ H+A?Y>JGP5D3&3^*7 K^?^"'%E#XG2L@  !>)T>_Q7G?\*M_
M[">(3.-<>O\ (LF0:I]7YET@A2Q                       !R6HYFL&G7
M-3[675TOS);O@2)D?A5%C.'L0AYW4B(S5H1\.O#[[03E+[?O*E"5;EP26*3\
M4ET+WZ]A5[C[ORZC=QM>?&3>#:\,7L4I=+T:,</FP.M"#+0
M
M
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MBO@;^:*^7_='O72F2F%,/I0
M
M
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M$M8
M
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M6T:])Z'K6V,ML7^-*TGV X"6
M
M
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MID]SS:Z<L%./1O7^J.S>M#UZ+*J;4H-6I\.ITZ2B9!G-$]%DM[4K0LM2,O\
MV/</DE:C.E-PFL)+0T?H>WN*=Q3C4IO&,EBFMJ9[(:3>
M
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MN,?,3[D?H
M
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MU3&D^O*IRE;5H+>M!ZJ1VZEZ0KMW92H/'7'\:RVV&91N5AJEN]Q.<<))
M   <AS-817Y9\IB*UQUND<4RBJTU-2TEZ;)>1U.SZ[A[A/?;^9_P;E.3^"6B
M7Y/J]F)5/N_(_JEE)07^2'Q0Z=\?^2T<<-Q6DI*DJ4E1&E23,E)/89&6\C'U
ML_/36 &3     !-OE]RU\:L,6+<<K6I1$<-OS73VR&D%_NZE'O6@BU2?:G9V
M;?G?W1DGI-W-)?"_$MS\W![=S/L?V)]T>O%65Q+XUX&_F2^3BMF^/#3+ 4D^
MG
M                                                        %-74
M^YGI]N1(_+S9=15$GUV(B=D>>PHR6W!>U./3R46TO'+5;A:^IPIW+,3&5VO-
M_DEU>\K^=7CBO1CMU\-Q18)TK(   ?2VI9MV7U5V*!9EMU*Z:U)/1FETN,Y*
M>,MVIH:2HR+O,]@\SG&"Q;P/=.G*H\(K%DT+7Z;'-;<D5F8_:%,M=MXM4MUJ
MJ1VG2+LXFV#?4GS&1&.*6948[<>HD89/<2V)<6?8S>E=S.QF2<CR+0J#FFIQ
MV:JZA?F(W8J$_P"</"S6B]_8>WDEPMW;^A%_*G*GG_#+#\Z_,;U*#18ZC2Y<
M4,D3Z>DB+7B7(BJ=2V7=XG".JE=4JOAEI..O8UJ.F<=&_9W$>1TG(!@  =TY
M=\[W5R\9,HU_VT^XY$:6F-=%!XM&:G35J(WH[B=VNA<3:C]59$?D/1<4%6AR
MLZK2YE;U%./6MZ-8EF7=0K]M2W;TMF6FH6_<\!FHTF66]3,A)*1J6NQ1:Z&G
ML46@J<XN$G%ZT7FG-5(J4=3*[>JAC@[JP)2;ZBL&Y.QM7&GGEI1J90*D117]
M3WZ$[X)GJ)'*JG+4Y=Z]A$YW1YZ*EY7[3.R+&5(#   E[R(W]_=[S28NJ#KR
M6(-P3EVY45+/1/!56U1V]?,\;9^X.2_I\]&2W:>P[\LJ^G<1>_1VFJL54NX
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M]\T*[6C22_\ E4]B4I)::ZJ0TM2T^Z.>=*</$FCKIUH5/!)/@=!'@V
M
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M92:M$7XC+[#Q$I#B%D>TCU_]#VB!DG%M-8,M$9*233Q3/HQY/0
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MA>K"CZ5",=N'M),CF.PIWZO_ .@N%_EZJ?!61,9/XI<$5_/_  0XLH?$Z5D
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M&C(7Z:N)>BEK5IQ<)>B7#MY+V]==I)8)';E^7JU3;>,F3N'"28
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MD>PR,C ''O\ Z\8%,S4K#5EJ4H]34=#@ZF:O]B-W\BKYGVG/_$H^2/8C]_\
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M+=VMO)8FQK?DPJ6X9Z'[74=(4<R\I+>(QT6D.>K%=)RWU7TJ$I=!DB%M*&
M ';N6['2\L9TQA8?A&[$K5=C*JQ$GC(H,57M,LS+N\%I6\:;FIZ=.4N@Z;2C
MZM:,=[[C7HA"&D)0VDD(06B$IV$DBV:;.X5 OI_8 4[]7[]!,,?+U5^#-"8R
MCQ2X%?S_ ,$.+*'Q.E9   ";/(+@]C-?,!0FZS#*9:-A-_G)<K"R)3;_ +,X
ME,2,HC,B,G7U)XB/>A*AQ7]?TJ3PUO0265VWKUECJ6E_D:CQ5RZ        !
MF:ZD.%XV*N8"97J-$3$MS*48[@ALMD1-M3^/PZBVDB(B+5W1W3L\067+:WJ4
ML'K6CW%.S>W]*MBM4M/O*_!($4!D 8!=%TA;V6W5,OXZ><(VI$:!<<!LSVDI
ME:HDDR+RDXSKYA#9O#1&746+(*FF<.#+QA!ED       ]'<%#@7+1*G0:FWX
MD&J,+8?(MY<6TEI["4E6BB/L,ATVMS.VJQJPUQ>/XXG'?V5.]H3H5%C&:P?O
MXIZ5TE5UT6[/M*X*I;U23PRZ8\;9KV\+B-AMN)UV\*TZ*(?9[.ZA=48U8:I+
M_P KJ>@_,^96%2PN)T*OBB\..YKH:P9Z$=1Q     #W1@$A,%98.S:DFW*[(
M/\UZJZ7AO+/9"D+,B\0M=S:]A++L]8NW6K_<F2?S*?JTE_DBO_DMW%;.PO?V
M7]T?3:OH5W_@F];^26__ &OYNW>6!I42R)23)25$1I41ZD9'M(R,MY&/E[6!
M]T3QTH_H,'H     KTZG+4EWE0N)3!*-MFO49<S3_5^U<.WR$LTB0RO]]<&1
M6=?UGQ1FB%EQ*<:8NFC6Z15>52UH---LIEOU6K0:XR@R-29*Y2Y"366\N)IY
M!EKV"M9G%JL^G N6323MTEL;+!A'DH   &:[G@Y9\@0.9*_JACO&MPUZU[K6
MQ7H\JD4J3)BHDS6R5+;2MAM2",I"7%&6NS462QN8NDN9K%:"H9E9S5>7)%M/
M3H1S;ENQAG7'>>L27>[B2\X46DW- *HR7*+.;;1$D.E'E&XHV="1X3BN(SV:
M#;<U:<Z4ES+5O--G1JTZT)<CT-;&:FA5BZ@ >NG3X-+AR:A4IC-/@0VS=ES9
M#B6FFD)+:M:UF1)(B/:9F,I-Z@VEI9 W)?4DY9\>2I5-IM<J&1*K%,TN,VU&
M)Z*2TGIP^V/K995NWMFH=]++:T]+6'$BJV<4*>A/F?01X?ZOEC)>),;#->=C
M:[77*G%;7I]8EI9?YPZ/H\O,NPY?K\/(^TZ19/57Y?[@DMQ;JH=S6&IQ9)*;
M)CM3XJ-=",U+BN*=(O\ 9F-4\JJK4TS=3SRC+Q)KO+!K'R%9&3*&S<U@W33K
MMH<@]$U"FOI>2E6OJ.)+TD*+3:E9)/R"/J4Y4WA)8,E:5:%5<T'BN@^\'@V
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MK&2[UIUJQG^(X;$ES65(,M=D>,WQ.NZ;?429=^@V4J$ZKPBL336N*=%8S>!
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M\_\ NG(^7&ZI+1\R_P"WO[=Y]=^P_NAS2L+AZ5^VWM7D?#Y>C1K2QEV**?5
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MT4K5M\!W3>VL]=?5XBVBS6UW"NM&O<4Z\L:EM+XEHW[",PZCB P
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M^P?9,IS!7UO&JM>J2W26OWKH/S9]P9/+*[V=!^'7%[X/5V>%]*>P^#$F0H
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M6HDMLREN$N ^HS,M")W[69]A.&8C\QH>I2T:UI)3*;E4:R3U2T>XTZBLER
M      #,KU',TQLL<P$ZB464F7;.+HZK>@/-F2FW9I+XZ@ZDR,R/[;HU_LR,
M6;+:/ITL7K>DIV;W*K5L%JCH]Y $=Y%   !=ITA[%<2WEW)+[?"TZJ!;=,=-
M.\T<4N5H?DXF1"YO4\,>LL>04O'/@OQW%V@A"Q@      ?-77<D"T;?JMPU%
M6D:FLFYX>Y3KA^BVTDS[5J,DD.RQM)W=:-*&N3[%M?4M)'YIF-/+[:=Q4U16
M/%[$NEO!(JNK];G7)6:E7*F[XLZJ/JD2%;="-6TDI(]?126A$7<1#[/;6\+>
MG&G#5%8+\;_S/S1>WE2\KSK57C*;Q?Z=&&A=!ZH;SE       DY@+$OYQ3&K
MSN&-Q4. [K28;A;);Z#]<TGO;;/W%*+3L4*?]S9Y_'B[>D_C:TORKWON74?1
MOL?[6_F35Y77^*+^%>>2V_[8][X,G>/FI]K       I1ZMN+)<F-C?,E/C&Y
M'IY.VO<KB4Z^&EQ1R8"UF6W0U>,G4^]/>)K**OB@^)7L^H-\M1<'^120VXMI
MQ#K2S0XTHE-N)/0TJ(]2,C+<9&)LK1JIY.N8JC\PV(:'4_;T?GS;49FFWY2#
M5]N1,:3P%*X==3;DI3XB3W:FI.](JM[;NC4:V/47C+[M7%)/YEK_ !TDO!R'
M<   %,/5SO\ I!6]B_&3,E#M>>J3]QSXB=#4S%:97%94ON\5;J^'ZPQ,Y13>
M,I;-17L^JKEC#;CC^11J)PK1KFY7+9F6=R[X:MV>@VIL&U*<N8T>Q2'7V2?4
M@R/N4LR%2NI<U63Z2^64'"A!/<BE'JHX\DVWGVEWTVP94K(E!CK*02="]NIF
MD5]!GN,R;\%1^<3655.:ER[F5S.Z7+6YMC7L.'\A^7(&'N9"SZM6I28=NW0A
MZVJ[+<5PMLMU#A\%U9F6A)1(0T:C/<G4QOOZ+JTFEK6DYLLN%1KQ;U/0^LU0
M"K%V   ""7,SSV6#RS7A2;'K%LU*\*Y/IR:G.9IDB.V4)IQ9H92[XNWB<X5*
M(OI=#[2'=:V,J\7)/!$;>9G"VDHM8O#9L.?86ZCUJYOR;:^,K;Q3<42HW*^X
M@Z@]*BK:C,LM+?>?=)&I\*$(,]GF[1LK9:Z4')R6@TVV;QKU%!1>DL8K-*BU
MRDU2BS4DN#6(C\*8V?:W(;4VLB\Y&(Z+P>.XEY+F33VF.#(MF5+'5^7A8E7:
M6U4;2J\NE2266AJ.,ZIM*R\BTD2B/N,7&G-3BI+:?/JU-TYN#V/ N'Z2^7H2
M8%_82J4LFZ@4E-T6LPM1$3K:FT1YS:",]IH-#2M/*H^P0^;47BIK@RP9%<+"
M5)\5^9=<(4L0 '/<GWE3\=X\O:^JH^F-!M2C3*BZZH]-5,-&IM*3^F6O1!?5
M&-E*#G)16UFJM45.#D]B,ISG,[S$..N.'FR]$J<4:C)-:F$1&H]3T(G-"+;N
M%J_BTO*NPI'\VOYWVLO@Z;%5R'<^!JE>>1+JK-VS+EN68=#E5F6[*6B%$::C
M\+:WC/1)O(<W'IJ(',U&-3EBL,$6?)Y3E1YIMO%[?QQ.,]7EI9XPQ*\1?:V[
MIEH4?<:X2C+[$QORCQRX'-GW[<>/Y%&UE55FA7E:5;?/1BCUF!.>/N1'D-N*
M_@2)R:QBUT%:IRY9)[FC9O&DQYL>/-BNI?C2FT/1GTGJE:%IXDJ(^XR,4S ^
MA)XGE@9/&==:BM./ON(9990I;SRU$24I(M5*4H]-"+37:&L&0SF0OJGY+SQE
M:^:2KQ*1<%QS':2]KKXD5M?@L.%Y%MMDKW1;[:FZ=.,7L10;RJJM:4EJ;+&N
MD#^GF9OD"F?"G1'9OX8\27R#QSX(O3JGXNG_ (,]]@8@EK+,]3,6M4_&=1_"
MGOLS%T6H^=RUFBCI3_NT5+]<ZE\'B"NYK^]U%LR/^O\ \G^19B(PF0 /ALG?
MX;9!_5NJ_!'1[I>-<4:ZW[<N#,: N1\]-,_3+_=+L_Y:KGPUT5K,_P!]\$7+
M)OZRXOVE@(CR4,W/50_>B3^I](^Z2A9,K_9ZV5#._P"QU(]7TO\ ]ZRC?JY6
M?N21G-/V7Q1YR7^PN#-+0K1<0 ,DO-]^]!G;]<JG]V,6VT_9CP*)?_V)\66.
M]'S_ 'S.G\S0OLIHCLXU1ZR7R#7/J_,M[RA9K.0\;WW8KY)-%W4&H4E*E;B7
M*CN-H4?F6HC$/2GR34MS)^O3]2$H[U@8Z*I3)U&J=1H]285%J5)E/0Y\5?K-
MOL+-MQ!^5*DF0N*::Q1\_DG%X,T-]+K+T*\L'.XTDRTG<>+IKS91%J+Q%TN>
MXJ1&=26\TI<6ZV?TNB>\A7<TH\M3FV/VELR2X4Z/)MC["SX1A,@ >HJ=4@42
MFSZO5)3<&E4J,[,J$UY1I0RPR@W''%J/L2DC,QE)MX(Q*22Q>I%3DCJZ8Q;D
M/M,8JN65'0ZM+,@I<1OQ$$K1*N$]I:EMTUV"6^D3\R(+Z]3\K)R\L_,+$YE+
M'J%_4FSJE:5'C55VF04U%YIU<HV6VUN.-^%LX$J<X-O:1C@NK?T)<K>+).RN
MU<PYTFEB1'YT^=S*?++DZC6A;=G6[6*#6Z Q58M0JB9?CFZI]YEY&K+S2>%/
MAITV:CLLK&%>#;;QQ.#,<RJ6U11BDTUCIQ.;<M/4FOW+^:[)QO?%IVS0:'=K
MS\)-2IQ2TOIE> XN,E)O2'$?;7$I1M+MV;1MNLMC3IN46\4:;+.)U:JA)))E
MRPABP  <3S=A>R<Z6!7+,O.CQYR9,5[XFJJFT^TTZ6:3\*3'=,N)*D*T/8>B
MRV'L&VA7E2DI1-%S;0KP<9+]#(9,C*ARY4-Q1*7$><96M.XS;4:3,O)L%P3Q
M* U@S0#TE:Y4)V$K]HTEXW(-!NY9TUO_ %92H;#CB2\G$DS]T5_-XI5$^@M6
M12;HR6Y_D>-U:;.74,0V/>D=KC5;MRMPI[A>\8EQY!)/^D21#.4SPJ..]&,]
MIXTE+<S/\)\JP   :,NEUE6#=^!',?ORR5<&,*D_&7$,RXSIU0<5*C.D6\TD
MM3J/XHKN:4G&KS;&6[):ZG1Y=L66;",)@      #+GU$+CIMQ\V62G*6M+C5
M'33J1*=3M(Y,.$TA\M>]"]4GYA:,NBXT(XE+S::E<RPV8+N(1CM(T #RX$*1
M49L.GQ4&[*G/MQXS9;U..J)"2+SF8-X&4L="-G5ITGX@M>VZ%N^):7#@$1;-
ML=E+1_8"F3?,VSZ'"/+%+<CZ,>3T !ESZA6.#QYS07PXQ'-BEWR3-T4WT=$F
M<XC*41:;-2DMN:BT9=4YZ*Z-!2\VH^G<2W/3^.LA&.TC0 /,IU0E4JH0:G!=
M-F;3I#4J&\6]#K*R6A1>91$8-8K RFT\4;'L:7A%R#CVR+ZAK2N-=M#@55!H
MV$2I+"'%%_%4KA%-JPY)N.YGT"C4]2"DMJQ,^_5%O\KKYCTVM'?2["QU0H=-
M-*3U(I<PCFOGY^%UM)_6BP973Y:6.]E5SJKSU^7RK]2MT21$  ?J4J49)21J
M4HR)*2+4S,]Q$0 UV\L^.DXHP/B^QEM):F4FA1G:L@D\)G.F)]IEF9'_ /,X
MHO,*C<U/4JRETE\LZ/I48QW([T-!U   !3OU?_T%PO\ +U4^"LB8R?Q2X(K^
M?^"'%E#XG2L@  !^I4:%$I)FE23U2HMAD9;C(P!H=Y#.=JE95H-&Q-DVLM0<
MI45E$2BU*4HD)K\9I/"V:5*V'*2DB):3VN>LG;Q$5>O[%TWSP7P^S]"V97F2
MJQ5.;^)=_P"I:4(LF@    "M'GJYUJ/A>W*KC?'M8:GY>KK"HS[T59+30([R
M=%R'5%J1/FD_M2#/5/KJV$DE25C8NK+FDOA7>1&9YDJ,>2#^)]QG(<<<><<=
M=6IQUQ1K<<69FI2C/4S,SVF9GO,Q8RH'^   #379O/N &K?DMQ,YAOETQ_;,
MZ,<:O52*=?N5L]"6F;4S)XT*+O:;X&S\J15+VKZM5O9J+SEU#T:$8O6]+ZR6
M(Y3M       @KS)W^=7K+%DTY_BI]#63U64D]CDQ1:$@]-ADTDS_ (QGW#Z1
M]I99Z-)W$U\4]71']7W8;SXM_P"PL\_D5U9TW\%/3+IGN_XKO;W$7A<CYN
M    !UC$>,I61:^E+Z%LVY2U(<K4Q.PU$9ZI8;/=QKTW^]+;YX3/,WCE]'%:
M:DO"OS?0N]]UG^UOMV><7.$DU2CIF_9%=+_^J[[)X4*)38<:!!81%A0VTLQ8
MS9<*6T((B2DB+L(A\DJ5)5).<GBV\6S]"4*$*%.-.FDHQ6"2U)+4CS!K-P
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MOV?),[S>685L5H@O"OS?2_T/T+]K_;L,HM^5X.K+3.73Y5_ICLWO2=8$(6<
M
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M &?<OAVLDP*@?1
M
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MQ&7E'V+)LN5C;1I_,],O]WZ:C\X?<N=2S6]E6^1:(+=%:NMZWQ.="5(
M E-R_8E.L26+YN.-K2H:^*@PG2V27D&9>.HCWMH,O1+<I7UNVE_=&>>C%VU)
M_$_$]RW<7W+B?2_L7[6=Q-7MPO@CX$_FDOF_VK9O?#3.4?.3[,
M
M
M
M     1AYD;_^):$U9U/>X:E<2..HJ2>BFH1&>J3TT,O%46GUI*[R%Q^TLL]:
MJ[B:^&&KIE_^?;@?./\ V%GG\>@K.F_CJ+&71#_]:N"D02'TD^*@    '8L.
MXOD9#KGC3$+9MBE.)75I1:I\96],9L^]7:9>JGR\.L#GV<++Z6$=-27A6[_4
M_P :7UEK^T_MN6;W&,TU1AXGO_T+I>W='IP+'XL:/"C1X<1E$:+&;2U&CMD2
M4(0@B2E*2+81$1$1$0^33G*<G*3Q;TMGZ!I4HTHJ$$E%+!):DEL/*'@V@
M
M
M
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M(.0D
M
M
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M>T_0_P!M?;U/)[;D6FI+3.6][E_ICL[=IT\0Q9
M
M
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M_DUU_FFM"\D7L_W/YMVK>2.%3+^
M
M
M                                                  '(*Q1<02[U
MI]6J<RA,WA3Y*>&(<QAIYV0K8WXT?C(W%DH]4:EQ:Z>03U"XS*%K*$%-TFM?
M*VDMN$L-"W["J7=GDE2^C5J2I*O&6KFBFY?+S1Q^*6.'+BL<<#KX@2U@
M
M                                                         ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>ft_svbsecurities-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ft_svbsecurities-4c.jpg
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M# P,#/_  !$( (@'GP,!$0 "$0$#$0'_Q #J  $  P$! 0$! 0$
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MRUW-%5';D)9-!,FIEQK,:36>;]TQZ2'C9[0F >'H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5%?F8G@NJ^5EG@YOCJC^9>DOT()8
M                                         !\>X*U$MRB5:NSCPBTF
M*[*>+' U<M)F2"/Z5'@1?68WXN/+(NQM1YR:1$SLR&'8G?G\L(M^;H[^1F]&
MUCU%8K$>KNW/4'V6YA27*<I]?9EI2LEJ9R8X9#+Y</H'UF>PX4K;@K<4Z4K3
MCRYUZS\^V_NS<XWE==Z;6JNFKTOC733JZ*=1I52JE$K-,I]6@N<V%4X[4J*Y
M]+;J26G_ +ACY)>LRLSE"7.+:?<?H;&R(9%J-V#K&2378U4J[N4NRYK:G6DB
MWZ[-HZ);$Q4I,1Y31.&A31)-64RQPQ/ =C]HX-C)C=\6"E1JE57K/F_]P]TR
ML.Y85BY*%5*NEM5HT=AH%J8[>E">HE:EG(N6@EBX\X>+DJ*H\$/&9]*DF>11
M_P!*9\5"#]S;0L.ZKEM4MR]$NKOYKOZBU^Q_N)[ECNS>E6];Z7SE'HEVKD^Y
M])S.Y>ZKDMG[E?=^MS*-VWQ+M?9'5-<SE]ER9LIECESGA^42_M#"L9/B^+!2
MIII55I745W]Q-SRL+Z?P+DH:M==+I6FBE>RK)]L65)G639TZ8^N3,F4.GORI
M+AFI;CCD9M2UJ,^DU&9F9CF=RA&&5=C%42G))>1-G<;+=E=P+$YNLG;@VWS;
M<4VSJA"+,I?JGJI>]=O=[3S3]]Z"4>3V W(BB;E2I2?W3]N,R-I"#(RX&70:
ME'AP+Z!LVRXMC%65E).JU<?E4>CATM]_4CY%]R_<V?E9[P,%N-'I^'A*4NGX
MOU4O(UR;;ZN;JVG^OMJTV1<BKEG/H@-JD36XE6?=>0VDLRU*0LR)9)(L3(C4
M)=C=-HRIJUX<57@JP25?9Z"ORMB^XL&T\CQI/2JO3<DVETU3Y^7F31H+JS4;
MZ9GV_<2TOUZDLE)9J"22@Y,;,2%&M"2(B4A2DD9D6!D9?'IY_P"Y=DAA.-VU
MPA)TIU/\'Q.N^R/NB[N<96,CC<@JJ7+5&M.*ZTVN7.O7SAB=?=[:?:O*I5;N
MBI3J!3JLDGHTJ0MQI=/D\4J-*C,C-+3A'_3$.@M[;BY^W:[=N*FX\TN.I?BU
MYCD;V]YVT[SX5Z].5J,^*DVUX<NGCU1=>U%\R/'B7$CZ#'S0^VE&M4]0;SJV
MJR[4L^X9M,89D1J-&8B/+:;7*6HB<6LDGTDXX:3/Z$CZ-LNUXUK;_'OP4FTY
M.JKPZ/0J]Y\8^Y=]SK^[_2XEV44G&VE%M)RZ6Z>5T[$=7N(N6Y[079$*@W)4
M8!*A2$2WVGUH7(4SR4I6Z9'\RN)GB?TB%]JXEC+\:5VW%\53ARK7@BT^_=PR
M]O>/"Q=G'X75INLJ:>+ZV<52+?W'UVEP*S3;@J3T"IL(DPW559"#4VX6*3-*
MG",N'TBQOY6RV+DK<X1U1='\'N*;%P?N;*M1O6[LW&237\1<GWGX'-0]9]*+
M@AQ+PE2*@PZDGW*;/=;DMR&#4:5&U(0:S2HL#PP5P/[23+@>Q;5MFZ67*PDG
MRJDU1^6/Z>1FF6_;YL63&.7)R3XZ9-24H^22K1]_#I1?"F5"-5J;3ZK#4:XE
M3C-2XJS^+;R"<0?^P9#YK>M2M3E"7.+:?:N!]LQK\<BU&[#Y9)278U5'[AK-
MQ6+6[6V9:$O[IVFIKQWEI74ZFM).=D)PL4-MH/%)N&1DH\Q&1$9<#,^'8?;O
MV]'+CX]_Y.A<M7E?D[#YS]X_>,]OG]+BT\2GQ2YZ:\DERU=/'DJ<./"*&=/]
MQ-;B)KCM6JS#SJ.:Q$D59<>1AAF21-<PB;/Z$JRF1])$+N6Z;-9EX:C%KK4$
MUYZ<>WB<Q#8ON7)AXSG--\4G<<9>:OP]CH?;TNUINRBW1'LK4)YZ6Q(E% [5
M-+"7"DJ5D23JS+%:#4>!Y^)8YLV!8"/O/V_CWK#R,5)-+51?+)>3J?9V4)GV
MW]WYF-EK#SVVF]-9?/"7)5?2J\Z\N=:%I[\O6F6#;<NX:F1O<LR9@PDF25R)
M"\<C:3/'#H,S/X$1GQZ!Q>V;?<SKZM0[6^I=?Z=)]*WO>+6U8LK]SC3@E^U)
M\E[7U),I;$K^N&L<^:Y0ITR+3V%_MK<%\Z?!CX\2;-PE)4X?QP,U*^/0/H,\
M;:MH@E<2<GUK5)^6G1Z$?(;6=OWW#<D[,I**?ZK\.$?)6JKWN3/]U>+KYI2A
MJMS:S4':8APB=?[8=0B)4H\")UITUY<W1B:2^H\1Y8GM&Z/PXPCJ[-$NYK\3
M+*M_<.Q)7IW)N%>>KQ(_YDZTKUT[ZEJ-)-4(NI5$=><91"KU+-#=9@HQR8K(
M\CS6)F>1>4^!GBDRP/'@9\7OFS2VZZDG6$OE?L?E7I/I?VM]R0WFPVUINPIJ
M71QY27D?HY=3=7]:K]O:C:G7+2J/=%3I\".<(HT&-(6AM',A,+5E2D\.*E&?
MY3'9?;VV8M[!MSN6XN3U5;2_:9\W^[][S\?=;MJU>G&*TT2;2XPB^7:R?MO-
MXU&[+.FMUJ>[4JM1Z@MEV4^LW'5LNI2XV:E'Q/B:DE]1#F/NG ABY*=N*491
MK1<JK@_8=S]A[M=S\*2O2<IPDU5NKH^*]J[B']P&I%STR^DT*VZ]-I,>DP&2
MG-0WE-YWWL7C4K*9=#:D"]^V-IL7,3Q+T%)RDZ55>"X>NIRGWS]P95G</!Q[
MLH*$572VOB?Q<?\ *XG?[:[GN&Y8-VKN"M3*PN(_#3%5+=4Z;9+2Z:B3F,\,
M<"Q%9]W8=G'E:5J"C5.M%3J+S^WFXY.9;ON_<E.CC34ZTJF0G=]XZDR]4*_:
M]O755&5/UQZ#28"):FFTF;II0@L5$E)#H<' P88$+UVW'A!-NE7RXG';KNVZ
M7-VNXUB]-5N.,5J:7.B74C[=2M[<O18;]4?JM7?CPD&Z^3%2;D+)"2Q,^43A
MJ7A]!$?Y!'LY6QWI*"C%-\.,6O33@3<C ^Z<:#N2G<:CQ=)J7HK5]R9(^@NL
M59NV>_:=U/)F5%$=4FEU7*E"W4MF6=ITD$2341'F(R+H(\<3%3]R[#:Q8*_9
M5(UHUU5Y-'0?9'W9?S[CQ<EZITK&7)NG-.G3TI]M2TBUH;0IQQ1(0@C4M:CP
M(B+B9F9]& XU*O!'TEM)59FS>&L5ZU6YZ[/HET5.G49V6LJ9$COK;;1'1\C1
MY4X$1J2DE']9F/K6!L.+:L0C<MQ<Z<6U5UYL_/>[?=F=?R[D[-Z<;;D]*3:2
MBN"X>5<7Y2^6G5U(O.S*#<&9*I,J.2*BE/#+*9_:WBP^!&M)F7U&0^:[KA/#
MR9VNA/AV/BO0?;=@W-;C@V[_ $M?%_B7"7IY>0Y?7.KU2A:<5>I4:>_3)[+\
M1+4R,LVW$DM]"5$2BX\2/ 3/MRQ;OYL87(J4:/@^QE;]Z95W%VR=RS)QDG'B
MG1_,B"=!M8:N_<2[7O"LOU)JN&14>=,<-Q;4HN!,YE']ETN!%^RP(OM#I/N7
M8;<;/C6(*.GYDESCU]WJ[#BOLG[KO2R?ILNXY*?RN3JU+]FO5+_53K+ ZUU6
MI433*Y:G2)SU-J$;L79YL=9H<1GFL(5E47$L4J,C^H<Q]O687LZW"XDXO5P?
M+Y6=U]X9-W&VJ]<M2<9+31K@U6<5ZB*=*GKQU!TDN8OO94FKF:K+Z:/6#DK)
MQ*FHT9:&5+QQY:C4HC+X8X])"ZWJ.-@;C;_AQ\/0M4:*G%R5>W\*',?;,\W=
MMFO?QYJ\KCTRU.O",6HU_9=77MJ<CHMJQ<4*\I%H7Y5)<LJHZ<2.Y4%J6Y$G
MM*-)-&:CQ(G#Q09?LLOUB=]P;)9GC*_C12T\7I_6B^GNY]E2J^T/N?)MYSQ<
MV<GJ>E:G5QFNCOY=M/*3[K+?Z;!M"1(BNDFNU?-#H:.&*5F7SO8?0TD\?Z8T
ME\1S.P;9]=DI27P1XR]B[_54[G[MWS^E83E%_P 2?PP[>F7^5>FA!FFKVH=2
ML:_+]KEV5AR'!H=31;;#LES!<EN,X:I)$9]#1E@D_P!EB?2D='N\<.WE6<:W
M:A5SCJX+DVOA[^GR=IQ?V]/<KV!DYUZ_<TQMST)R?&2B_C_R\EY:_LF2WNI_
MI-P/S)I7\)FCG]L_*[SN-U_.[E[27Z;[N=Q4ZG0*>G0^G.E!CM1R=.NO$:B:
M02,<.Q'AC@-3VM-_-Z#<MW:7R^GW%;+8NRE[U=VM$NC6NZZ!IK19TB VW1G#
M=2U*BP5))BDQ7G$J;YLA6)*6\M!&:U&A)GE:$B47C6:03?Z<R-&:RKZ<VDOT
MX&D7NR5ZH4[0.SJ)$>4S%N*](R:H22/!UJ+"EO(:4?1AS<B\.G%)8=!BOVN*
M=QOJ19;M)JTEULZOVNK0I-"VS1[EB1T%5KXK]2EU>9E+F+3"=.$PT:NDT(2R
MI22Z"-:C^)C'<IMW:=2,]K@E9KULT9>99D,NQY#2'V'T*;?8<22D+0HL%)4D
M\2,C(\#(Q7ED>9_00V=(O<.@VY;KCD:D4;4VO6;&93C@N"]*ETM#:TX\2)*D
MGQQP,B5TD0Z*_P#Q,:KZD_:<QC_P\JB_::]A=KW*-IVH%_W#1=<=+:))NB5
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M*$8Q_2A1;;9\:<I2X\/2SG]F%TU;:_O,J6D]V/FQ N&IR[!KZE$:6U2R?_\
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MF25FQI785F#%W\C6^CC^!8+WAO\ L[?X7?\ ,HT;5^OW>TD;S^IW^PM%I_\
MZLB?_F3N7^+9PC7/YK_,B5;_ )/_ "OU,J%[0']\>NG]K:#^_31*W7E'O(>S
M\Y=WM-RA3%Z4H]Q3]#C6'_!__K#31,P/SX]_J9!W'^7EW>M%>/:/_D6U*_/9
M7\71!OW3YUV$?:/RY=OL-7A6%L90^[A_(MIK^>R?XNEBSVOYWV%3N_Y<>WV%
M(=NGN)UG;WI30]+8>ED*Z(]%D39":R]5G(JW#FR7)!D;28KI%E->'VN(F9&
MKLW+50@XVXNS!0TU[RQ]K^[/<-PW+;M 7HE3HJ*Y4XE/7)37'5FV4EY#1K))
MPBQRYL<,1HEM:2;U>@DPW=R:6GTFUHIR[  Q0]O_ /33W4_X0_\ 6-L7&=^1
M#N]12;?_ #%SO]9M>*<NS-?W5/T9('Y[4K^#318;9^;W%9NOY/>O:8Q3]'[L
ML71;1G=!9TV6S'J%8F1*E46/W2D5JEU%XX#Z3(OE0ZVTG*9XX.(/$_G00MU=
M4IRMO_BBE=F4+<;L>OS-,TJW+:^TO<9[>L:^HYM,7#'N.BTR]Z2WP[+5HZOV
M[*GX-NDI+K?]"HB,\Q&*_'L.SDZ>BCH6>3D*_BZNFJKVECO; _15I/YR5G]]
M0(^Y?G=R).U_D][,.]&=;)6WO7IS5*';S5T2*+*K$=-&>D*BH<*:AZ.9FZEM
MTRRDO'[/$7-ZSXMO36G(HK-_P;NNE>9H/_._W'_D+IO_ "\]_P 2$#^E+]KT
M%C_6'^SZ?<:/;/\ <A-W0::5R_Y]J,6>]2+FDV^FF1Y:IJ7$QX<*43QN*:9,
MC,Y9IPP_6XX\17Y>/X$E&M>%2RP\GZB#E2G&AC+6FU;=O<G*01>'TMG4=F62
MT?*ANDW7@ITD'QQ2W'J"T8%^Q-/2+=?QL7N]7_ I9?P,O_-Z'_Q.XWLR']?]
M]MHZ/P'ENP*._0+-4I!GRVU3'4S*@^6&)D;291I69%C^U?40PP_X6.Y]K-F=
M_&R5#L7XGXD0V-L?N9Q(T1E-*M>KW>VB(RA)-QDTR[V,F5)$1$349R8:2^">
M5]0]KXV+Y:>H\IX&9Y*^L^?O,)S7??W3=-8KJGXD>H6W8S3R5'^UM.FW(F*+
M]B33DQ['#]B9AB?PL?5VL\S?XV3I[$>B9AAF*PS&CM)8CQT):8906"4(06"4
MI(N@B(L"%"=&?U &"7N2[=ZCI=J#2MRFG+3E+I-R5-AVXWH/R*I=QM*YK,Y&
M0BR)E&WGS?!Y*C,\7$D+O;[ZG'PY='J*#<\9VY>+'I]#(-L6GZD>XGN:I$R]
M3.-1:; AJO"3!)2(M-HT!*2<:CYL<CDQ]2LA<3);BE89$'ANFXXEKAW=IHMJ
M>;>^+ET]GO/0C?CC.G&C-Z/6C$:HL>Q+,J3ELPHK>#45-,I[BHJ&FTD?!OEI
M(B(O@**'QS5>EG0W/@MNG0O882^U9:=+N/<77;BJ[*9DNS+3F5&BFZ68VYLJ
M3&B&^1GCQ)EYU/\ NL?@+K<Y-6DETLH=J@I76WT(]% H3HSSZ^[-:E(I.M=C
M71 CICU&[K7)-<-"2+GNT^0MEIY9])KY2TM_TJ$B]VN3=MKJ9SV[P2N)]:+/
M;OKFEWE[<.FETU%Y<FI5V#9<NJ2'.*G)2XR.T+,S,\<SF8\1&Q8Z<EKM)69+
M5B1;\A3S9IOKM/;%IA7;"KMB5:Z)=7NB57VY\"2PRVAN1"A12:-+I8YB.*9X
M]&!D)>7A.]-23IPH0\+/C8@XM5XU]1T.Z'?N_N@L!&C&G6E%4A+N2?$?J#[S
MW;YSW8W2?:CQ(D1LS,U.)29J-1\"-)(XYBQQL'P):Y2Y&65N'U$=$8\S1?V\
M- [HT,T4F*OJ Y1[OO\ JIUJ=0WCP=@Q$LMLQ&'T8GE=P2MQ9=*<Y(41*29"
M!GWU=G\/)%CMV/*U;^+F^)B5#U21HKO#O/5%5+56EVC>UW28E*)9-D_(=7/C
MQTK7^M1S74YS+$R3C@1G@0N';\2RH]:7L*17?"ON?4W[2/Y^IOXLZWTO4?<+
M)J%=HEPUF*_>14X^SN)I2'2;4S"3@K(VRVDTI2GYC(C+,2SSC-6_#MZ;?/H-
M;N^)<U7.*;X]AZQ;*B6G!M"V8UAL0(UE(ID55JM4PDIA]@6TE<=3&3@:%(,E
M$9=..(YB;;D]7,ZV"BHK3RZ#IQB9%>-VOZ,FN_YDUC^#+&_%_-CVHCY?Y,^Q
ME7O:K_1DG_GM5?X-"$G<_P WN(FU?D][]AI0*\LS(SW*]I]]ZI3K=UETQHKU
MT5:@TGP2[;7@H)<UR(R\[(C2XS)?,^I*GUH<2G%>&3*DR)66TV_*C"L)<"HW
M/$E<:G%5IP:*?:=^Y9N2TK;C6C?=(IM]M4$DPY+5Q1GX-;;2T1)2V[):4WBL
MBX&IYE:SZ5&9XF<NYM]J?&/#LY$*WN=ZWPEQIU\R_NVG<MM(W$:A,&YHM;6G
MVN<J2JKT^94J/2Y$J=.;Q><>A5E$=MYR0C UGG2VX>&9.;!66#D8]ZS'YFX]
MK]188V38O2^5*78O67]U.OVE:7:>7GJ'6S+PVSJ1*JC[6.!O*8;-3;",?USJ
M\J$_6HA!MP<Y**Z2PNW%;@Y/H1@Y[>^E[NX;7[4C5/4>*FOTJEP*G+N)3Z34
MU+JUTD_&-"DJ,R,C8<DJXXY3)'U&5WGW/!MJ,?TH4.W6O&NRG+C^+_1G.;7:
M]4MI&]Z;IO<<A;5%J%8E6'77W?E2['F/).E3L#RD1+<)AS,9%@VM71B,LF*R
M+&I=OXF.+)XV1I?*M/P-:?<4_0XUA_P?_P"L--%7@?GQ[_4RVW'^7EW>M& -
M,T*KE4VUR=Q-NKD2$VC?4NW+NCM&>,2)V*F2($Y!I(C(BD2EMN'CP-3>'ZXQ
M>.\E=\-]*JO2<^K#=GQ%T.C]!J54MR3>XGVYM77ZS+2YJ-8],I=(OMH\"6^O
MQ"+V:HX%@6$I"#,\"(B<2X1%E(L:U8_@Y,:<GR+5Y/C8DJ\U2OGYG6^T?_(M
MJ5^>ROXNB##=/G789[1^7+M]AJ\*PMC%#WAO^SM_A=_S*+C:OU^[VE)O/ZG?
M["+M%?<]_!_2JQ],OP0^\7W,IJ:?XW]Y>R=IRJ4K/R/"GLGVNC.K\HV7MN\2
M;EJI7R>\U6-T\*"CIK3R^XT VC[Z/5/>MRV?^%WW$^[U$.L>(^-^*<["2S'Y
M7+[!$R_NN;-F/HPP^(@Y6%X$4ZUJ^KWEAAY_U$G'32BZ_<9_^[A_+3IK^9*?
MXQEB=M?R/M*_=_S(]GM)9L#W5-/[.L2RK1DZ4W!,DVM0:;2)$QJ;$2AU<&*W
M'4XDE%B1*-&)$8U3VR4I-ZEQ9MM[K&,4M+X(J-KGJ3J3[@^KUKL:9Z5S8L:A
M0RI%+B-J5+Y*'WC<=F5*83:&8Z,3+IP))%]I1F)5FW'$@]4B)?NSS+BTQ_3R
MGHDTNLAC333:P]/8T@YC5E4"GT;MIXD;ZX<=#*WL#Z.8I)JP^&.!"AN3UR<N
MMG16H>'!1ZD>?FYI#F]C?Y'IC*U5*R%5]%,CX&9M)M>WLSDE2%$9Y2E):=6D
MS/[;Q?3@+V/_ &V/7IIZ6<_+_NLJG17T(_7O'MVJ;6MZ5-U3M&&4:G5JH0K\
MM]A!<ME;QNY:I#4I*2+!UY#AK270VZGZ1YB25^QI?9^ S8O'R-:[?Q/0S:MR
MTB\[9MZ[J!([70[HIL6JTB3P(UQIC27FE&1&>!FE98EB**47%M/FCHH24DFN
M3/+?8.BLK7W7O5K3^E23BW M%U52V#-1);=J$"0MUEATS+@A[ VS/];F)7PP
M/I)WO"MQD^7 Y:W8\:[**Y\2\/MD[B)MG735ML>H#KU/9J,R2]8[,TC;7!J[
M1J[=3%DO T<[(:TI/#!Q*BPS."%N-C4O$CW]G63MKR7&7A2[NWJ(QVC?ZR*X
M_P Y+\_^R>-N5_*KL1JP_P";?;+VGSO=6N295MQ])H+CBR@6K:$!F+&Q^3FR
MWY$EUTBQ/BHEH29\.""^C$_=LC2U7K9YNTJW:=2-_=/K7I]DV)9EGTIE#%.M
M>B0*7#;;,E))$2.AHCS%P5CEQ,_CTBCN2<I-OI9T%N*A%170CX6H.C>ENJ\B
MWY6I%C4J]';66^Y04U5GGML'))!/%RE'D62^4C$ED9<"X#VW>G;KI=*F-RS"
MY34JT*][VZ)1K<V9ZNT2WJ1"H-&I]*A-P*13H[<6*P@ZI%4:6F6DI0@L3,\"
M(;\-MWXM_IP(^=%1QY)<%[RG?M ?WN:Z?VRH/[S-$O=><>\A[/REW>TJKK]H
M+K]M!URK6KVE$2J-6@JIRZI:E\4B,4MB%&G*4IR!4F<CB$$V3AMGS4<MPL%)
MXXI3)L7[>1;T2Y]1$R,>[C7'.'+H?XDD6C[JUUSH#UMZWZ16WJ%;%495#K2*
M>2HBI$=PLKA/Q)?;(SY*+$C1@VD_J&$]L2XPDTS9#=I-4G%-&IFU6]MM>I5K
M5*\]OMFV]93KRF8EXT6FT:#1JE&=22ELM3FX:"):?F4;:B4I!_-E5B2B*LR8
M78.EQM]7&I:XD[,XZK:2Z^%#$ZA(1J][D2TW$DIL.9JS.4J/(46"HE#E.JBL
M+S&HC(F8:&S3T&7RD+B7\/%X?L^LI(_Q,OC^UZCTMCGCIB(*[H!HI=-YR=0K
MHTOMVYKQELL,2*U5H+<Y1HC)R-&3<@EMDI"<")1)S8$7'@0VQOW(QTIM(TRQ
M[<I:G%-F??NWUZH0](=-;>CO*:@5VZW)-10DCP<.##<)I*E%PP(WS5@?29$?
MZT3]KBG-OR%?N\FK<5Y28?;-M"D6]M3M6X(,="*E?E4K%4K<HDES''(L]^FM
M)-72:4MQ"P+H(S5\3,:=QFW>:ZJ?B;ML@HV$^NOX%^ID2+4(DJ!.C-S(4UE<
M>9$>22VW6G4FE:%I5B2DJ29D9'TD(*=">U4\T^TA\M+=^]%MJC/O)H\:[+BM
M%;6)F;T,TS(K*7..)Y5H;<Z>E)'Q'0Y7QX]7U)G-8?\ #R4EUM'I@'/'3
M
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M(S[=<?B[)<^VJZ#H]K7\GU8_.&1_!(@B_>?\Y'_;7^J18?VU_P#'7/\ =?\
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M3J?6T$>1FK49IN&MDE'B1+0TPPX7TYOJ,7VW7%*UIZO:<YNEMPNZ^OUHV3T
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M9GAB?#B,]R5+/>C#:G6\^QGHK% =&5#WZ?HCZT?VM@_QG$$K"_.C^G00\_\
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M-?)GP^5."?L\-MB]:G\-OHZ#3DV+T/BN+GTUJ:NZVZOMZX^V#<-_N2$OUJ5
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M):W'W'4D9\2:4+C/FK=G3U\"CVV#N7];Z./G/1N* Z0
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M':4IQ<BR$F2XTIK$R^=AU*7$_ S+ ^!F0B6KCMR4ET$R]:5V#B^DI9M5]O\
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ME?V[QKFMR[J='G-*V668[+4>.TAAAA"6V&&TDE"$)+!*4I+ B(B+ B(5Q9D
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M<6HUK4H\5*,S,55RXYR<I<V7%NW&W%1CR10K;[[>?X$ZW0=9/Q>^]/8O%/\
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MG$CC:!LR@;4G+ZF'?7W_ *I>B8#*9QTKPOL<>$;ZC;2GM<O/S5/$:CQ+[*>
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M@18X$1$1)224D22K+MZ5V6J1;V;,;,=,5P)3&HV@
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M1:RQ_P#3.J42?_ ,;LC[U=*6K7'KD_8OQ(^'_;)*5;]^JZHJC_YF^'_*RU5
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MQK'@P4*U)R&DW@
M   %0MV>TRG;JJ=9-/J%[2+,*S)$Z0T['@HFG(.:AE!D9+>9RY>3]>.(E8N4
M[#?"M2'EXBR$N-*%L*;#*G4Z!3TN&Z4&.U')TRP-1-()&.''#' 1FZLEI41^
MT>'H                                              %-=!]H%-T-
MUCU/U>BWU)N*3J7XASZ&[ 1&1$[?4$U \KR7W#7D-.3BDL>GZA+OY;NP4*4H
M0L?#5JY*=:U_$N4(A-
M   . U5L-G5'3:^-.GZDNCLWK1I='=JK;1/*CIE-FV;A-FI!*-...&8ORC.U
M/1)2ZC7=M^)!QZT1GM@V]P]M&FS^G4&Z'KN9?K,JL'57XJ8:B5);9;-OEI==
M+!/)QQS?'H&W)O\ C2U4H:L7'\"&FM>)8L1R2
M
M
M
M
M
M
M
M
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MI,V\#,N(SG946N/,U6\AR3X<D:,".2P
M
M
M
M
M
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MJU\,&S??^.XHD"[0?[Q-W7^:6L?P62,[O./::K'*78;XB"68
M
M
M
M
M
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M #6BQJ+J3MVOVP=/&Z8_$51C9MFET7D'$3)IBFYD6(RAC]K1BME""(L,N)=
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MF%CE+L-\1!+,
M
M
M
M
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MDC".)%/BZFC<"!"I<*)3:;$9I].I[*(\&#'0EIEEEI))0VVA)$E*4I(B(B+
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M-)(
M
M
M
M
M
G                                                /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
